PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Chua, SMH; Wizrah, MSI; Luo, ZY; Lim, BYJ; Kappler, U; Kobe, B; Fraser, JA				Chua, Sheena M. H.; Wizrah, Maha S., I; Luo, Zhenyao; Lim, Bryan Y. J.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.			Structural features of Cryptococcus neoformans bifunctional GAR/AIR synthetase may present novel antifungal drug targets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLYCINAMIDE RIBONUCLEOTIDE SYNTHETASE; GLUTAMINE PHOSPHORIBOSYLPYROPHOSPHATE AMIDOTRANSFERASE; RAY CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; PURINE; PROTEINS; CRYSTALLOGRAPHY; PURIFICATION; MENINGITIS; VIRULENCE	Cryptococcus neoformans is a fungus that causes life-threatening systemic mycoses. During infection of the human host, this pathogen experiences a major change in the availability of purines; the fungus can scavenge the abundant purines in its environmental niche of pigeon excrement, but must employ de novo biosynthesis in the purine-poor human CNS. Eleven sequential enzymatic steps are required to form the first purine base, IMP, an intermediate in the formation of ATP and GTP. Over the course of evolution, several gene fusion events led to the formation of multifunctional purine biosynthetic enzymes in most organisms, particularly the higher eukaryotes. In C. neoformans, phosphoribosyl-glycinamide synthetase (GARs) and phosphoribosyl-aminoimidazole synthetase (AIRs) are fused into a bifunctional enzyme, while the human ortholog is a trifunctional enzyme that also includes GAR transformylase. Here we functionally, biochemically, and structurally characterized C. neoformans GARs and AIRs to identify drug targetable features. GARs/AIRs are essential for de novo purine production and virulence in a murine inhalation infection model. Characterization of GARs enzymatic functional parameters showed that C. neoformans GARs/ AIRs have lower affinity for substrates glycine and PRA compared with the trifunctional metazoan enzyme. The crystal structure of C. neoformans GARs revealed differences in the glycine- and ATP-binding sites compared with the Homo sapiens enzyme, while the crystal structure of AIRs shows high structural similarity compared with its H. sapiens ortholog as a monomer but differences as a dimer. The alterations in functional and structural characteristics between fungal and human enzymes could potentially be exploited for antifungal development.	[Chua, Sheena M. H.; Wizrah, Maha S., I; Lim, Bryan Y. J.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.] Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia; [Chua, Sheena M. H.; Wizrah, Maha S., I; Luo, Zhenyao; Lim, Bryan Y. J.; Kappler, Ulrike; Kobe, Bostjan; Fraser, James A.] Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia; [Luo, Zhenyao; Lim, Bryan Y. J.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia	University of Queensland; University of Queensland; University of Queensland	Fraser, JA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, St Lucia, Qld, Australia.; Fraser, JA (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, St Lucia, Qld, Australia.	j.fraser1@uq.edu.au		Lim, Bryan Ying Jie/0000-0002-0554-909X; Chua, Sheena/0000-0003-1501-7254; Kappler, Ulrike/0000-0002-2642-1319	National Health and Medical Research Council [APP1130192]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This research was supported by the National Health and Medical Research Council, http://www.nhmrc.gov.au/, APP1130192 to J. A. F.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALMASSY RJ, 1992, P NATL ACAD SCI USA, V89, P6114, DOI 10.1073/pnas.89.13.6114; Anand R, 2004, BIOCHEMISTRY-US, V43, P10328, DOI 10.1021/bi0491301; Antle VD, 1996, J BIOL CHEM, V271, P8192, DOI 10.1074/jbc.271.14.8192; Arras SDM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-18106-2; Arras SDM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163049; Arras SDM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122916; Bera AK, 2000, J BACTERIOL, V182, P3734, DOI 10.1128/JB.182.13.3734-3739.2000; Blundell RD, 2016, ACS INFECT DIS, V2, P651, DOI 10.1021/acsinfecdis.6b00121; Bruggemann RJM, 2009, CLIN INFECT DIS, V48, P1441, DOI 10.1086/598327; Burdett TC, 2013, BIOMED CHROMATOGR, V27, P122, DOI 10.1002/bmc.2760; CHASKES S, 1975, J CLIN MICROBIOL, V1, P509, DOI 10.1128/JCM.1.6.509-514.1975; Chitty JL, 2019, MYCOPATHOLOGIA, V184, P273, DOI 10.1007/s11046-018-0315-0; Chitty JL, 2017, J BIOL CHEM, V292, P11829, DOI [10.1074/jbc.M117.787994, 10.1074/jbc.m117.787994]; CHRISTENSEN WB, 1946, J BACTERIOL, V52, P461, DOI 10.1128/JB.52.4.461-466.1946; Chua SMH, 2020, IMMUNOL CELL BIOL, V98, P819, DOI 10.1111/imcb.12389; DAUBNER SC, 1986, BIOCHEMISTRY-US, V25, P2951, DOI 10.1021/bi00358a033; EELLS JT, 1983, NEUROCHEM RES, V8, P1451; ELION GB, 1966, BIOCHEM PHARMACOL, V15, P863, DOI 10.1016/0006-2952(66)90163-8; ELION GB, 1977, P NATL ACAD SCI USA, V74, P5716, DOI 10.1073/pnas.74.12.5716; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fanos V, 2000, J CHEMOTHERAPY, V12, P463, DOI 10.1179/joc.2000.12.6.463; Fawaz MV, 2011, BIOORG CHEM, V39, P185, DOI 10.1016/j.bioorg.2011.08.004; Fraser JA, 2003, EUKARYOT CELL, V2, P1036, DOI 10.1128/EC.2.5.1036-1045.2003; Friese G, 2001, AIDS, V15, P2344, DOI 10.1097/00002030-200111230-00026; Goins CL, 2006, FUNGAL GENET BIOL, V43, P531, DOI 10.1016/j.fgb.2006.02.007; HAMILTON L, 1954, Ann N Y Acad Sci, V60, P304; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Janbon G, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004261; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kanagawa M, 2016, J BIOCHEM, V159, P313, DOI 10.1093/jb/mvv107; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li CL, 1999, STRUCTURE, V7, P1155, DOI 10.1016/S0969-2126(99)80182-8; Loyse A, 2013, LANCET INFECT DIS, V13, P629, DOI 10.1016/S1473-3099(13)70078-1; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; MESSENGER LJ, 1979, J BIOL CHEM, V254, P3382; Morrow CA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002957; Nierlich D P, 1978, Methods Enzymol, V51, P179; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; PRICE MF, 1982, SABOURAUDIA, V20, P7; Rajasingham R, 2017, LANCET INFECT DIS, V17, P873, DOI [10.1016/S1473-3099(17)30243-8, 10.1016/s1473-3099(17)30243-8]; Roemer T, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a019703; Sampei G, 2010, J BIOCHEM, V148, P429, DOI 10.1093/jb/mvq088; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Schlee S, 2019, PROTEINS, V87, P815, DOI 10.1002/prot.25744; SCHRIMSHER JL, 1986, BIOCHEMISTRY-US, V25, P4366, DOI 10.1021/bi00363a028; SHEN Y, 1990, BIOCHEMISTRY-US, V29, P218, DOI 10.1021/bi00453a030; Sonn-Segev A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15642-w; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thoden JB, 2000, BIOCHEMISTRY-US, V39, P8791, DOI 10.1021/bi000926j; Thoden JB, 1999, BIOCHEMISTRY-US, V38, P15480, DOI 10.1021/bi991618s; Wang WR, 1998, BIOCHEMISTRY-US, V37, P15647, DOI 10.1021/bi981405n; Welin M, 2010, NUCLEIC ACIDS RES, V38, P7308, DOI 10.1093/nar/gkq595; Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235; Zhang Y, 2008, BIOCHEMISTRY-US, V47, P205, DOI 10.1021/bi701406g	58	0	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101091	10.1016/j.jbc.2021.101091	http://dx.doi.org/10.1016/j.jbc.2021.101091			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34416230	Green Published, gold			2022-12-28	WOS:000755323700005
J	Paranjapye, A; NandyMazumdar, M; Browne, JA; Leir, SH; Harris, A				Paranjapye, Alekh; NandyMazumdar, Monali; Browne, James A.; Leir, Shih-Hsing; Harris, Ann			Kruppel-like factor 5 regulates wound repair and the innate immune response in human airway epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR KLF5; CFTR EXPRESSION; DIFFERENTIATION; PROMOTES; PROLIFERATION; MACROPHAGE; ELEMENTS; FOXA2; ROLES	A complex network of transcription factors regulates genes involved in establishing and maintaining key biological properties of the human airway epithelium. However, detailed knowledge of the contributing factors is incomplete. Here we characterize the role of Kruppel-like factor 5 (KLF5), in controlling essential pathways of epithelial cell identity and function in the human lung. RNA-seq following siRNA-mediated depletion of KLF5 in the Calu-3 lung epithelial cell line identified significant enrichment of genes encoding chemokines and cytokines involved in the proinflammatory response and also components of the junctional complexes mediating cell adhesion. To determine direct gene targets of KLF5, we defined the cistrome of KLF5 using ChIP-seq in both Calu-3 and 16HBE14o(-) lung epithelial cell lines. Occupancy site concordance analysis revealed that KLF5 colocalized with the active histone modification H3K27ac and also with binding sites for the transcription factor CCAAT enhancer-binding protein beta (C/EBP beta). Depletion of KLF5 increased both the expression and secretion of cytokines including IL-1 beta, a response that was enhanced following exposure to Pseudomonas aeruginosa lipopolysaccharide. Calu-3 cells exhibited faster rates of repair after KLF5 depletion compared with negative controls in wound scratch assays. Similarly, CRISPR-mediated KLF5-null 16HBE14o(-) cells also showed enhanced wound closure. These data reveal a pivotal role for KLF5 in coordinating epithelial functions relevant to human lung disease.	[Paranjapye, Alekh; NandyMazumdar, Monali; Browne, James A.; Leir, Shih-Hsing; Harris, Ann] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA; [Browne, James A.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Case Western Reserve University; Yale University	Harris, A (corresponding author), Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA.	ann.herris@case.edu	NandyMazumdar, Monali/GLS-8973-2022	Browne, James/0000-0002-6473-3567; Leir, Shih-Hsing/0000-0001-9524-3379; Paranjapye, Alekh/0000-0002-4069-1761	National Institutes of Health [R01 HL094585, R01 HL117843, T32 GM008056]; Cystic Fibrosis Foundation [16G0, 15/17XX0, 18P0]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by the National Institutes of Health (R01 HL094585; R01 HL117843; [A. H.]; T32 GM008056 [A. P.]) and the Cystic Fibrosis Foundation (Harris 16G0, 15/17XX0 and 18P0 [A. H.]). The funders had no role in the design of the study, in the collection, analyses, or interpretation of the data, in the writing of the manuscript, or in the decision to publish the results. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Aksoy I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4719; Bell SM, 2013, DEV BIOL, V375, P128, DOI 10.1016/j.ydbio.2012.12.010; Besnard V, 2005, AM J PHYSIOL-LUNG C, V289, pL750, DOI 10.1152/ajplung.00151.2005; Bialkowska AB, 2017, DEVELOPMENT, V144, P737, DOI 10.1242/dev.145441; Browne JA, 2016, MOL CELL ENDOCRINOL, V425, P94, DOI 10.1016/j.mce.2016.01.021; Carlson M, 2019, ORG HS EG DB GENOME; Cervantes-Camacho C, 2015, ADIPOCYTE, V4, P248, DOI 10.1080/21623945.2015.1007823; Chanchevalap S, 2006, NUCLEIC ACIDS RES, V34, P1216, DOI 10.1093/nar/gkl014; Chen Z, 2017, SCI REP-UK, V7, DOI 10.1038/srep46746; Chia NY, 2015, GUT, V64, P707, DOI 10.1136/gutjnl-2013-306596; Conkright MD, 1999, NUCLEIC ACIDS RES, V27, P1263, DOI 10.1093/nar/27.5.1263; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; De Val S, 2009, DEV CELL, V16, P180, DOI 10.1016/j.devcel.2009.01.014; Di Giammartino DC, 2019, NAT CELL BIOL, V21, P1179, DOI 10.1038/s41556-019-0390-6; Diaferia GR, 2016, EMBO J, V35, P595, DOI 10.15252/embj.201592404; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Edelman DA, 2007, J TRAUMA, V62, P89, DOI 10.1097/TA.0b013e31802dd712; Fossum SL, 2017, J BIOL CHEM, V292, P10938, DOI 10.1074/jbc.M117.775304; Fossum SL, 2014, NUCLEIC ACIDS RES, V42, P13588, DOI 10.1093/nar/gku1146; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; Galambos C, 2007, PEDIATR DEVEL PATHOL, V10, P1, DOI 10.2350/06-06-0122.1; Gao LH, 2017, ONCOTARGET, V8, P109952, DOI 10.18632/oncotarget.21972; Grandjean T, 2017, INT IMMUNOL, V29, P377, DOI 10.1093/intimm/dxx047; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herriges M, 2014, DEVELOPMENT, V141, P502, DOI 10.1242/dev.098186; Hogmalm A, 2018, AM J PHYSIOL-LUNG C, V314, pL936, DOI 10.1152/ajplung.00256.2017; Ikeda K, 1996, MOL CELL BIOL, V16, P3626; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Korfhagen TR, 2012, P NATL ACAD SCI USA, V109, P16630, DOI 10.1073/pnas.1208092109; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Leir SH, 2003, AM J PHYSIOL-LUNG C, V285, pL1305, DOI 10.1152/ajplung.00255.2002; Lentjes MHFM, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.2; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li J, 2020, CANCERS, V12, DOI 10.3390/cancers12030748; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu XF, 2018, MOL MED REP, V17, P5484, DOI 10.3892/mmr.2018.8542; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matsumura T, 2005, J BIOL CHEM, V280, P12123, DOI 10.1074/jbc.M410578200; Miyamoto S, 2003, MOL CELL BIOL, V23, P8528, DOI 10.1128/MCB.23.23.8528-8541.2003; Mossman BT, 2006, AM J RESP CELL MOL, V34, P666, DOI 10.1165/rcmb.2006-0047SF; Mutolo MJ, 2018, BIOCHEM J, V475, P1323, DOI 10.1042/BCJ20180044; Nakaya T, 2014, CANCER RES, V74, P2882, DOI 10.1158/0008-5472.CAN-13-2574; NandyMazumdar M, 2020, NUCLEIC ACIDS RES, V48, P3513, DOI 10.1093/nar/gkaa089; Nguyen NTT, 2018, NUCLEIC ACIDS RES, V46, pW209, DOI 10.1093/nar/gky317; Oishi Y, 2005, CELL METAB, V1, P27, DOI 10.1016/j.cmet.2004.11.005; Okada H, 2018, J BIOL CHEM, V293, P6214, DOI 10.1074/jbc.RA118.002372; Pace E, 2008, IMMUNOLOGY, V124, P401, DOI 10.1111/j.1365-2567.2007.02788.x; Paranjapye A, 2020, AM J PHYSIOL-LUNG C, V319, pL126, DOI 10.1152/ajplung.00023.2020; Parisi S, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-128; Presnell JS, 2015, GENOME BIOL EVOL, V7, P2289, DOI 10.1093/gbe/evv141; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Rankin SA, 2014, J CELL BIOCHEM, V115, P1343, DOI 10.1002/jcb.24810; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Reddy SPM, 2002, AM J PHYSIOL-LUNG C, V283, pL1161, DOI 10.1152/ajplung.00140.2002; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; Shiraga T, 2005, EXP CELL RES, V308, P41, DOI 10.1016/j.yexcr.2005.04.008; Shu SY, 2017, GENE, V629, P76, DOI 10.1016/j.gene.2017.07.076; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Storr SJ, 2017, CANCER IMMUNOL IMMUN, V66, P1287, DOI 10.1007/s00262-017-2020-0; Sun F, 2015, DIS MARKERS, V2015, P1, DOI 10.1155/2015/473742; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tremblay M, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164384; Tugores A, 2001, J BIOL CHEM, V276, P20397, DOI 10.1074/jbc.M010930200; Wan HJ, 2005, J BIOL CHEM, V280, P13809, DOI 10.1074/jbc.M414122200; Wan HJ, 2004, DEVELOPMENT, V131, P953, DOI 10.1242/dev.00966; Wan HJ, 2008, DEVELOPMENT, V135, P2563, DOI 10.1242/dev.021964; Wang P, 2018, J DIABETES RES, V2018, DOI 10.1155/2018/3274084; Watanabe N, 1999, CIRC RES, V85, P182, DOI 10.1161/01.RES.85.2.182; Wu Q, 2019, INT J CANCER, V144, P582, DOI 10.1002/ijc.31908; Yang YZ, 2005, CANCER BIOL THER, V4, P1216, DOI 10.4161/cbt.4.11.2090; Yi G, 2018, INFLAMM RES, V67, P539, DOI 10.1007/s00011-018-1145-8; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang BT, 2013, MOL CELL BIOL, V33, P4919, DOI 10.1128/MCB.00787-13; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138168; Zoso A, 2019, SCI DATA, V6, DOI 10.1038/s41597-019-0256-6	81	2	2	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100932	10.1016/j.jbc.2021.100932	http://dx.doi.org/10.1016/j.jbc.2021.100932			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34217701	Green Published, gold			2022-12-28	WOS:000690871000002
J	Patel, A; McBride, JAM; Mark, BL				Patel, Ankoor; McBride, Jessica A. M.; Mark, Brian L.			The endopeptidase of the maize-affecting Marafivirus type member maize rayado fino virus doubles as a deubiquitinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; ESCHERICHIA-COLI; CLEAVAGE SITE; UBIQUITIN; IDENTIFICATION; PLANT; REPLICATION; PROTEINASE; EXPRESSION; INTERFACE	Marafiviruses are capable of persistent infection in a range of plants that have importance to the agriculture and biofuel industries. Although the genomes of a few of these viruses have been studied in-depth, the composition and processing of the polyproteins produced from their main ORFs have not. The Marafivirus polyprotein consists of essential proteins that form the viral replicase, as well as structural proteins for virus as-sembly. It has been proposed that Marafiviruses code for cysteine proteases within their polyproteins, which act as en-dopeptidases to autocatalytically cleave the polyprotein into functional domains. Furthermore, it has also been suggested that Marafivirus endopeptidases may have deubiquitinating activity, which has been shown to enhance viral replication by downregulating viral protein degradation by the ubiquitin (Ub) proteasomal pathway as well as tampering with cell signaling associated with innate antiviral responses in other positive-sense ssRNA viruses. Here, we provide the first evidence of cysteine proteases from six different Marafiviruses that harbor deubiquitinating activity and reveal intragenus differences to-ward Ub linkage types. We also examine the structural basis of the endopeptidase/deubiquitinase from the Marafivirus type member, maize rayado fino virus. Structures of the enzyme alone and bound to Ub reveal marked structural rearrange-ments that occur upon binding of Ub and provide insights into substrate specificity and differences that set it apart from other viral cysteine proteases.	[Patel, Ankoor; McBride, Jessica A. M.; Mark, Brian L.] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada	University of Manitoba	Mark, BL (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.	brian.mark@umanitoba.ca		Patel, Ankoor/0000-0002-9096-1619	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2020-05682, RGPIN-2015-05310]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was funded by a Discovery Grant to B. L. M. from the Natural Sciences and Engineering Research Council of Canada (NSERC) (RGPIN-2020-05682 and RGPIN-2015-05310).	[Anonymous], PYMOL MOL GRAPHICS S; Bailey-Elkin BA, 2017, J MOL BIOL, V429, P3441, DOI 10.1016/j.jmb.2017.06.010; Bailey-Elkin BA, 2014, J BIOL CHEM, V289, P34667, DOI 10.1074/jbc.M114.609644; Bailey-Elkin BA, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003894; Bartel B, 2012, PLANT PHYSIOL, V160, P1, DOI 10.1104/pp.112.203208; BARTENSCHLAGER R, 1994, J VIROL, V68, P5045, DOI 10.1128/JVI.68.8.5045-5055.1994; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Boudreault S, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1543; Bransom KL, 1996, VIROLOGY, V217, P404, DOI 10.1006/viro.1996.0131; BRANSOM KL, 1991, VIROLOGY, V184, P351, DOI 10.1016/0042-6822(91)90851-2; Braten O, 2016, P NATL ACAD SCI USA, V113, pE4639, DOI 10.1073/pnas.1608644113; Calil IP, 2017, ANN BOT-LONDON, V119, P711, DOI 10.1093/aob/mcw200; Camborde L, 2010, PLANT CELL, V22, P3142, DOI 10.1105/tpc.109.072090; Capodagli GC, 2013, J VIROL, V87, P3815, DOI 10.1128/JVI.03252-12; CARRINGTON JC, 1989, J VIROL, V63, P4459, DOI 10.1128/JVI.63.10.4459-4463.1989; Chenon M, 2012, EMBO J, V31, P741, DOI 10.1038/emboj.2011.424; Dang LC, 1998, BIOCHEMISTRY-US, V37, P1868, DOI 10.1021/bi9723360; Dikic I, 2009, NAT REV MOL CELL BIO, V10, P659, DOI 10.1038/nrm2767; Dolja VV, 2011, CURR OPIN VIROL, V1, P322, DOI 10.1016/j.coviro.2011.09.007; Edwards MC, 2015, PHYTOPATHOLOGY, V105, P833, DOI 10.1094/PHYTO-09-14-0250-R; Edwards MC, 2014, VIROLOGY, V450, P290, DOI 10.1016/j.virol.2013.12.018; Emmott E, 2019, J BIOL CHEM, V294, P4259, DOI 10.1074/jbc.RA118.006780; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Espadaler J, 2006, BIOINFORMATICS, V22, P2237, DOI 10.1093/bioinformatics/btl382; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fieulaine S, 2020, J BIOL CHEM, V295, P13769, DOI 10.1074/jbc.RA120.014628; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Gildenhuys S, 2020, BIOCHEM J, V477, P1479, DOI 10.1042/BCJ20200223; Hammond R. W., 2011, SPRINGER INDEX VIRUS; Hammond RW, 2001, VIROLOGY, V282, P338, DOI 10.1006/viro.2001.0859; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Hunter MC, 2017, BIOSCIENCE, V67, P385, DOI 10.1093/biosci/bix010; Isono E, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00056; Jakubiec A, 2004, J VIROL, V78, P7945, DOI 10.1128/JVI.78.15.7945-7957.2004; Jakubiec A, 2007, J VIROL, V81, P11402, DOI 10.1128/JVI.01428-07; Johnson A, 2016, PLANT PHYSIOL, V171, P1808, DOI 10.1104/pp.16.00619; Jupin I, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006714; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KADARE G, 1995, J GEN VIROL, V76, P2853, DOI 10.1099/0022-1317-76-11-2853; Kim H, 2018, GENE, V638, P7, DOI 10.1016/j.gene.2017.09.069; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lefkowitz EJ, 2018, NUCLEIC ACIDS RES, V46, pD708, DOI 10.1093/nar/gkx932; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lombardi C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003560; Zambrano JL, 2013, PLANT DIS, V97, P1418, DOI 10.1094/PDIS-01-13-0037-RE; Martelli GP, 2002, ARCH VIROL, V147, P1837, DOI 10.1007/s007050200045; Messick TE, 2008, J BIOL CHEM, V283, P11038, DOI 10.1074/jbc.M704398200; Miricescu A, 2018, J EXP BOT, V69, P4511, DOI 10.1093/jxb/ery165; Morin L, 2017, FRONT PSYCHIATRY, V8, DOI 10.3389/fpsyt.2017.00100; NAULT LR, 1980, PHYTOPATHOLOGY, V70, P709, DOI 10.1094/Phyto-70-709; Nemchinov LG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203477; Peng CW, 2001, J VIROL, V75, P12153, DOI 10.1128/JVI.75.24.12153-12160.2001; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Rausalu K, 2016, SCI REP-UK, V6, DOI 10.1038/srep37124; Rodamilans B, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00666; Ruiz-Garcia AB, 2017, PLANT DIS, V101, P1830, DOI 10.1094/PDIS-05-17-0700-PDN; Saeki Y, 2009, EMBO J, V28, P359, DOI 10.1038/emboj.2008.305; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Snijder EJ, 2013, J GEN VIROL, V94, P2141, DOI 10.1099/vir.0.056341-0; Spall VE, 1997, SEMIN VIROL, V8, P15, DOI 10.1006/smvy.1997.0102; van Kasteren PB, 2013, P NATL ACAD SCI USA, V110, pE838, DOI 10.1073/pnas.1218464110; Walsh CK, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00122; Wolf YI, 2018, MBIO, V9, DOI 10.1128/mBio.02329-18; Xu P, 2006, BBA-PROTEINS PROTEOM, V1764, P1940, DOI 10.1016/j.bbapap.2006.09.004; Yost SA, 2013, CURR OPIN VIROL, V3, P137, DOI 10.1016/j.coviro.2013.03.009; Zhou BJ, 2017, MOL PLANT PATHOL, V18, P1313, DOI 10.1111/mpp.12521	71	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100957	10.1016/j.jbc.2021.100957	http://dx.doi.org/10.1016/j.jbc.2021.100957			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265303	Green Published, gold			2022-12-28	WOS:000690871400016
J	Schell, E; Nouairia, G; Steiner, E; Weber, N; Lundin, D; Loderer, C				Schell, Eugen; Nouairia, Ghada; Steiner, Elisabeth; Weber, Niclas; Lundin, Daniel; Loderer, Christoph			Structural determinants and distribution of phosphate specificity in ribonucleotide reductases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SWISS-MODEL; BACTERIOPHAGE-T4; EXPRESSION; MECHANISM; EVOLUTION; SITE	Ribonucleotide reductases (RNRs) catalyze the reduction of ribonucleotides to the corresponding deoxyribonucleotides, the building blocks of DNA. RNRs are specific for either ribonucleoside diphosphates or triphosphates as substrates. As far as is known, oxygen-dependent class I RNRs (NrdAB) all reduce ribonucleoside diphosphates, and oxygen-sensitive class III RNRs (NrdD) are all ribonucleoside triphosphate reducers, whereas the adenosylcobalamin-dependent class II (NrdJ) contains both ribonucleoside diphosphate and triphosphate reducers. However, it is unknown how this specificity is conveyed by the active site of the enzymes and how this feature developed in RNR evolution. By structural comparison of the active sites in different RNRs, we identified the apical loop of the phosphate-binding site as a potential structural determinant of substrate specificity. Grafting two residues from this loop from a diphosphate- to a triphosphate-specific RNR caused a change in preference from ribonucleoside triphosphate to diphosphate substrates in a class II model enzyme, confirming them as the structural determinants of phosphate specificity. The investigation of the phylogenetic distribution of this motif in class II RNRs yielded a likely monophyletic clade with the diphosphate-defining motif. This indicates a single evolutionary-split event early in NrdJ evolution in which diphosphate specificity developed from the earlier triphosphate specificity. For those interesting cases where organisms contain more than one nrdJ gene, we observed a preference for encoding enzymes with diverse phosphate specificities, suggesting that this varying phosphate specificity confers a selective advantage.	[Schell, Eugen; Steiner, Elisabeth; Weber, Niclas; Loderer, Christoph] Tech Univ Dresden, Inst Microbiol, Dresden, Saxony, Germany; [Nouairia, Ghada; Lundin, Daniel] Stockholm Univ, Dept Biochem & Biophys, Stockholm, Sweden	Technische Universitat Dresden; Stockholm University	Loderer, C (corresponding author), Tech Univ Dresden, Inst Microbiol, Dresden, Saxony, Germany.	Christoph.loderer@tu-dresden.de		Loderer, Christoph/0000-0002-3795-8250; NOUAIRIA, Ghada/0000-0003-0081-7347	Fonds der Chemischen Industrie (FCI) [SK201/03]; Zukunftskonzept of TU Dresden (Federal); Swedish Research Council (Vetenskapsradet) [2019-01400]	Fonds der Chemischen Industrie (FCI)(Fonds der Chemischen Industrie); Zukunftskonzept of TU Dresden (Federal); Swedish Research Council (Vetenskapsradet)(Swedish Research Council)	C. L. was supported by Fonds der Chemischen Industrie (FCI) (SK201/03) and funds of the Zukunftskonzept of TU Dresden (Federal and State Excellence Initiative). G. N. was supported by a stipend from The WennerGren Foundation to Britt-Marie Sjoberg, and D. L. was supported by Grant 2019-01400 from the Swedish Research Council (Vetenskapsradet) to Britt-Marie Sjoberg.	Andersson J, 2000, J BIOL CHEM, V275, P19449, DOI 10.1074/jbc.M001278200; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; BOOKER S, 1993, P NATL ACAD SCI USA, V90, P8352, DOI 10.1073/pnas.90.18.8352; Crona M, 2016, MOL ONCOL, V10, P1375, DOI 10.1016/j.molonc.2016.07.008; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Eliasson R, 1999, J BIOL CHEM, V274, P7182, DOI 10.1074/jbc.274.11.7182; Fontecave M, 2001, METHOD ENZYMOL, V334, P215; Gleason FK, 2002, J BACTERIOL, V184, P6544, DOI 10.1128/JB.184.23.6544-6550.2002; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hofer A, 2012, CRIT REV BIOCHEM MOL, V47, P50, DOI 10.3109/10409238.2011.630372; INUKAI S, 1979, AGR BIOL CHEM TOKYO, V43, P637, DOI 10.1080/00021369.1979.10863489; Krieger E, 2014, BIOINFORMATICS, V30, P2981, DOI 10.1093/bioinformatics/btu426; LARSEN IK, 1982, EUR J BIOCHEM, V125, P75; Larsson KM, 2010, ACS CHEM BIOL, V5, P933, DOI 10.1021/cb1000845; Larsson KM, 2004, NAT STRUCT MOL BIOL, V11, P1142, DOI 10.1038/nsmb838; Loderer C, 2019, PEERJ, V7, DOI 10.7717/peerj.6700; Loderer C, 2017, J BIOL CHEM, V292, P19044, DOI 10.1074/jbc.M117.806331; Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499; Lundin Daniel, 2015, Life-Basel, V5, P604, DOI 10.3390/life5010604; Nordlund N, 2006, ANNU REV BIOCHEM, V75, P681, DOI 10.1146/annurev.biochem.75.103004.142443; Parks DH, 2020, NAT BIOTECHNOL, V38, P1079, DOI 10.1038/s41587-020-0501-8; Parks DH, 2018, NAT BIOTECHNOL, V36, P996, DOI 10.1038/nbt.4229; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Sievers Fabian, 2014, Curr Protoc Bioinformatics, V48, DOI 10.1002/0471250953.bi0313s48; Sintchak MD, 2002, NAT STRUCT BIOL, V9, P293, DOI 10.1038/nsb774; Stubbe J, 2003, CHEM REV, V103, P2167, DOI 10.1021/cr020421u; STUBBE JA, 1983, MOL CELL BIOCHEM, V50, P25; Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002; Torrents E, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00052; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wei YF, 2015, BIOCHEMISTRY-US, V54, P7019, DOI 10.1021/acs.biochem.5b01092; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Xu H, 2006, P NATL ACAD SCI USA, V103, P4022, DOI 10.1073/pnas.0600443103	33	3	3	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101008	10.1016/j.jbc.2021.101008	http://dx.doi.org/10.1016/j.jbc.2021.101008			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34314684	Green Published, gold			2022-12-28	WOS:000690868100010
J	Zhang, N; Kisiswa, L; Ramanujan, A; Li, Z; Sim, EW; Tian, XB; Yuan, WS; Ibanez, CF; Lin, Z				Zhang, Ning; Kisiswa, Lilian; Ramanujan, Ajeena; Li, Zhen; Sim, Eunice Weiling; Tian, Xianbin; Yuan, Wensu; Ibanez, Carlos F.; Lin, Zhi			Structural basis of NF-kappa B signaling by the p75 neurotrophin receptor interaction with adaptor protein TRADD through their respective death domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; MOLECULAR-CLONING; NMR STRUCTURE; GENE-TRANSFER; EXPRESSION; ASSIGNMENT; P75(NTR); SYSTEM; VISUALIZATION; RESONANCES	The p75 neurotrophin receptor (p75(NTR)) is a critical mediator of neuronal death and tissue remodeling and has been implicated in various neurodegenerative diseases and cancers. The death domain (DD) of p75(NTR) is an intracellular signaling hub and has been shown to interact with diverse adaptor proteins. In breast cancer cells, binding of the adaptor protein TRADD to p75(NTR) depends on nerve growth factor and promotes cell survival. However, the structural mechanism and functional significance of TRADD recruitment in neuronal p75(NTR) signaling remain poorly understood. Here we report an NMR structure of the p75(NTR)-DD and TRADD-DD complex and reveal the mechanism of specific recognition of the TRADD-DD by the p75(NTR)-DD mainly through electrostatic interactions. Furthermore, we identified spatiotemporal overlap of p75(NTR) and TRADD expression in developing cerebellar granule neurons (CGNs) at early postnatal stages and discover the physiological relevance of the interaction between TRADD and p75(NTR) in the regulation of canonical NF-kappa B signaling and cell survival in CGNs. Our results provide a new structural framework for understanding how the recruitment of TRADD to p75(NTR) through DD interactions creates a membrane proximal platform, which can be efficiently regulated by various neurotrophic factors through extracellular domains of p75(NTR), to propagate downstream signaling in developing neurons.	[Zhang, Ning; Li, Zhen; Tian, Xianbin; Yuan, Wensu; Lin, Zhi] Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China; [Zhang, Ning; Li, Zhen; Tian, Xianbin; Yuan, Wensu; Lin, Zhi] Tianjin Univ, Sch Life Sci, Tianjin Key Lab Funct & Applicat Biol Macromol St, Tianjin, Peoples R China; [Kisiswa, Lilian; Ramanujan, Ajeena; Sim, Eunice Weiling; Ibanez, Carlos F.; Lin, Zhi] Natl Univ Singapore, Dept Physiol, Singapore, Singapore; [Kisiswa, Lilian; Ramanujan, Ajeena; Sim, Eunice Weiling; Ibanez, Carlos F.; Lin, Zhi] Natl Univ Singapore, Life Sci Inst, Singapore, Singapore; [Kisiswa, Lilian] Aarhus Univ, Dept Biomed, Aarhus, Denmark; [Ibanez, Carlos F.] Karolinska Inst, Dept Neurosci, Stockholm, Sweden; [Ibanez, Carlos F.] Peking Univ, Peking Tsinghua Ctr Life Sci, PKU IDG McGovern Inst Brain Res, Sch Life Sci, Beijing, Peoples R China; [Ibanez, Carlos F.] Chinese Inst Brain Res, Beijing, Peoples R China	Tianjin University; Tianjin University; National University of Singapore; National University of Singapore; Aarhus University; Karolinska Institutet; Peking University	Lin, Z (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin, Peoples R China.; Lin, Z (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin Key Lab Funct & Applicat Biol Macromol St, Tianjin, Peoples R China.; Lin, Z (corresponding author), Natl Univ Singapore, Dept Physiol, Singapore, Singapore.; Lin, Z (corresponding author), Natl Univ Singapore, Life Sci Inst, Singapore, Singapore.	linzhi@linzhi.net		Sim, Eunice/0000-0002-0955-8807; Ramanujan, Ajeena/0000-0002-6843-5372; Kisiswa, Lilian/0000-0002-1800-0645	National Natural Science Foundation of China [21974093]; Singapore National Medical Research Council [NMRC/CBRG/0107/2016]; Singapore Ministry of Education [MOE2018-T2-1-129]; Swedish Research Council [VR-2016-01538]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Singapore National Medical Research Council(National Medical Research Council, Singapore); Singapore Ministry of Education(Ministry of Education, Singapore); Swedish Research Council(Swedish Research CouncilEuropean Commission)	This research was supported by funds from National Natural Science Foundation of China (Grant No. 21974093) to Z. L.; as well as Singapore National Medical Research Council (NMRC/CBRG/0107/2016), Singapore Ministry of Education (MOE2018-T2-1-129), and Swedish Research Council (VR-2016-01538) to C. F. I.	Bittner S, 2017, FEBS LETT, V591, P2543, DOI 10.1002/1873-3468.12747; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; CHAO MV, 1986, SCIENCE, V232, P518, DOI 10.1126/science.3008331; Charalampopoulos I, 2012, CELL REP, V2, P1563, DOI 10.1016/j.celrep.2012.11.009; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Demir IE, 2016, BBA-REV CANCER, V1866, P37, DOI 10.1016/j.bbcan.2016.05.003; El Yazidi-Belkoura I, 2003, J BIOL CHEM, V278, P16952, DOI 10.1074/jbc.M300631200; ERNFORS P, 1989, NEURON, V2, P1605, DOI 10.1016/0896-6273(89)90049-4; Fernandez-Suarez D, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1970-x; Gong Y, 2008, NATURE, V454, P789, DOI 10.1038/nature07089; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HSU HL, 1995, CELL, V81, P495, DOI 10.1016/0092-8674(95)90070-5; Ibanez CF, 2012, TRENDS NEUROSCI, V35, P431, DOI 10.1016/j.tins.2012.03.007; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; JOHNSON D, 1986, CELL, V47, P545, DOI 10.1016/0092-8674(86)90619-7; Khursigara G, 2001, J NEUROSCI, V21, P5854, DOI 10.1523/JNEUROSCI.21-16-05854.2001; Kisiswa L, 2018, CELL REP, V24, P1013, DOI 10.1016/j.celrep.2018.06.098; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Ledoux AC, 2014, BIOCHEM SOC T, V42, P76, DOI 10.1042/BST20130156; LEE KF, 1994, DEVELOPMENT, V120, P1027; Li MF, 2006, BIOPHYS J, V91, P4201, DOI 10.1529/biophysj.106.093187; Liepinsh E, 1997, EMBO J, V16, P4999, DOI 10.1093/emboj/16.16.4999; Lin Z, 2006, ANGEW CHEM INT EDIT, V45, P1960, DOI 10.1002/anie.200503558; Lin Z, 2015, ELIFE, V4, DOI 10.7554/eLife.11692; MOBLEY WC, 1989, NEURON, V3, P655, DOI 10.1016/0896-6273(89)90276-6; Natoli G, 2008, NAT IMMUNOL, V9, P1015, DOI 10.1038/ni0908-1015; Park YC, 2000, CELL, V101, P777, DOI 10.1016/S0092-8674(00)80889-2; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pobezinskaya YL, 2012, CELL CYCLE, V11, P871, DOI 10.4161/cc.11.5.19300; RADEKE MJ, 1987, NATURE, V325, P593, DOI 10.1038/325593a0; RODRIGUEZTEBAR A, 1992, EMBO J, V11, P917, DOI 10.1002/j.1460-2075.1992.tb05130.x; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tsao DHH, 2000, MOL CELL, V5, P1051, DOI 10.1016/S1097-2765(00)80270-1; Vicario A, 2015, J CELL SCI, V128, P1507, DOI 10.1242/jcs.161745; Vilar M, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001918; Vilar M, 2009, NEURON, V62, P72, DOI 10.1016/j.neuron.2009.02.020; WYATT S, 1990, NEURON, V4, P421, DOI 10.1016/0896-6273(90)90054-J; Xu DC, 2020, NATURE, V587, P133, DOI 10.1038/s41586-020-2757-z; Xu YQ, 2007, J AM CHEM SOC, V129, P7722, DOI 10.1021/ja071442e; Xu YQ, 2005, J AM CHEM SOC, V127, P11920, DOI 10.1021/ja053539b; Yuan WS, 2019, BIOL REV, V94, P1282, DOI 10.1111/brv.12502; Zanin JP, 2019, J NEUROSCI, V39, P9119, DOI 10.1523/JNEUROSCI.0990-19.2019; Zanin JP, 2016, ELIFE, V5, DOI 10.7554/eLife.16654; Zhang N, 2017, BIOMOL NMR ASSIGN, V11, P281, DOI 10.1007/s12104-017-9763-6; Zhang N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07348-9	45	4	4	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100916	10.1016/j.jbc.2021.100916	http://dx.doi.org/10.1016/j.jbc.2021.100916			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34175311	Green Published, gold			2022-12-28	WOS:000690873500009
J	Buchberger, A; Schepergerdes, L; Flasshoff, M; Kunick, C; Koster, RW				Buchberger, Astrid; Schepergerdes, Lena; Flasshoff, Maren; Kunick, Conrad; Koester, Reinhard W.			A novel inhibitor rescues cerebellar defects in a zebrafish model of Down syndrome-associated kinase Dyrk1A overexpression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								The highly conserved dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A) plays crucial roles during central nervous system development and homeostasis. Furthermore, its hyperactivity is considered responsible for some neurological defects in individuals with Down syndrome. We set out to establish a zebrafish model expressing human Dyrk1A that could be further used to characterize the interaction between Dyrk1A and neurological phenotypes. First, we revealed the prominent expression of dyrk1a homologs in cerebellar neurons in the zebrafish larval and adult brains. Overexpression of human dyrk1a in postmitotic cerebellar Purkinje neurons resulted in a structural misorganization of the Purkinje cells in cerebellar hemispheres and a compaction of this cell population. This impaired Purkinje cell organization was progressive, leading to an age-dependent dispersal of Purkinje neurons throughout the cerebellar molecular layer with larval swim deficits resulting in mis-coordination of swimming and reduced exploratory behavior in aged adults. We also found that the structural misorganization of the larval Purkinje cell layer could be rescued by pharmacological treatment with Dyrk1A inhibitors. We further reveal the in vivo efficiency of a novel selective Dyrk1A inhibitor, KuFal194. These findings demonstrate that the zebrafish is a well-suited vertebrate organism to genetically model severe neurological diseases with single cell type specificity. Such models can be used to relate molecular malfunction to cellular deficits, impaired tissue formation, and organismal behavior and can also be used for pharmacological compound testing and validation.	[Buchberger, Astrid; Schepergerdes, Lena; Koester, Reinhard W.] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Cellular & Mol Neurobiol, Braunschweig, Germany; [Flasshoff, Maren; Kunick, Conrad] Tech Univ Carolo Wilhelmina Braunschweig, Inst Med & Pharmaceut Chem, Braunschweig, Germany; [Kunick, Conrad] Tech Univ Carolo Wilhelmina Braunschweig, Ctr Pharmaceut Engn PVZ, Braunschweig, Germany	Braunschweig University of Technology; Braunschweig University of Technology; Braunschweig University of Technology	Koster, RW (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Cellular & Mol Neurobiol, Braunschweig, Germany.	r.Koester@tu-bs.de		Kunick, Conrad/0000-0001-7041-5322	Deutsche Forschungsgemeinschaft [DFG KO 1949/12-1, 427719460]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was funded in part by the Deutsche Forschungsgemeinschaft (DFG KO 1949/12-1 project: 427719460 to R. W. K.).	Guimera J, 1996, HUM MOL GENET, V5, P1305, DOI 10.1093/hmg/5.9.1305	1	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100853	10.1016/j.jbc.2021.100853	http://dx.doi.org/10.1016/j.jbc.2021.100853			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34090874	gold, Green Published			2022-12-28	WOS:000678068400053
J	Liu, YN; Chen, JR; Xia, P; Stratakis, CA; Cheng, ZK				Liu, Yuening; Chen, Jingrui; Xia, Peng; Stratakis, Constantine A.; Cheng, Zhaokang			Loss of PKA regulatory subunit 1 alpha aggravates cardiomyocyte necrosis and myocardial ischemia/reperfusion injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISCHEMIA-REPERFUSION INJURY; TRANSCRIPTION FACTOR NRF2; PROTEIN-KINASE-A; CARNEY COMPLEX; MEDIATED PHOSPHORYLATION; HEART; ACTIVATION; AUTOPHAGY; PATHWAY; STRESS	Reperfusion therapy, the standard treatment for acute myocardial infarction, can trigger necrotic death of cardiomyocytes and provoke ischemia/reperfusion (I/R) injury. However, signaling pathways that regulate cardiomyocyte necrosis remain largely unknown. Our recent genome-wide RNAi screen has identified a potential necrosis suppressor gene PRKAR1A, which encodes PKA regulatory subunit 1 alpha (R1 alpha). R1 alpha is primarily known for regulating PKA activity by sequestering PKA catalytic subunits in the absence of cAMP. Here, we showed that depletion of R1 alpha augmented cardiomyocyte necrosis in vitro and in vivo, resulting in exaggerated myocardial I/R injury and contractile dysfunction. Mechanistically, R1 alpha loss downregulated the Nrf2 antioxidant transcription factor and aggravated oxidative stress following I/R. Degradation of the endogenous Nrf2 inhibitor Keap1 through p62-dependent selective autophagy was blocked by R1 alpha depletion. Phosphorylation of p62 at Ser349 by mammalian target of rapamycin complex 1 (mTORC1), a critical step in p62-Keap1 interaction, was induced by I/R, but diminished by R1 alpha loss. Activation of PKA by forskolin or isoproterenol almost completely abolished hydrogen-peroxide-induced p62 phosphorylation. In conclusion, R1 alpha loss induces unrestrained PKA activation and impairs the mTORC1-p62-Keap1-Nrf2 antioxidant defense system, leading to aggravated oxidative stress, necrosis, and myocardial I/R injury. Our findings uncover a novel role of PKA in oxidative stress and necrosis, which may be exploited to develop new cardioprotective therapies.	[Liu, Yuening; Chen, Jingrui; Xia, Peng; Cheng, Zhaokang] Washington State Univ, Dept Pharmaceut Sci, Spokane, WA 99202 USA; [Stratakis, Constantine A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Sect Endocrinol & Genet, NIH, Bethesda, MD USA; [Xia, Peng] Harvard Med Sch, Massachusetts Gen Hosp, Dept Med, Cardiovasc Res Ctr, Boston, MA 02115 USA	Washington State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Harvard University; Harvard Medical School; Massachusetts General Hospital	Cheng, ZK (corresponding author), Washington State Univ, Dept Pharmaceut Sci, Spokane, WA 99202 USA.	zhaokang.cheng@wsu.edu	Liu, Yuening/GYQ-7182-2022	Liu, Yuening/0000-0002-6891-0006	WSU College of Pharmacy and Pharmaceutical Sciences; National Institute of Child Health and Human Development (NICHD) [Z01-HD008920]; National Institutes of Health; National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health [R00HL119605, R56HL145034, R01HL151472]	WSU College of Pharmacy and Pharmaceutical Sciences; National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by WSU College of Pharmacy and Pharmaceutical Sciences (to Z. C.) and the intramural program of National Institute of Child Health and Human Development (NICHD, Z01-HD008920 to C. A. S.), National Institutes of Health. Z. C. was supported by the National Heart, Lung, and Blood Institute (NHLBI, R00HL119605, R56HL145034, R01HL151472), National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackers-Johnson M, 2016, CIRC RES, V119, P909, DOI 10.1161/CIRCRESAHA.116.309202; Amieux PS, 2002, J BIOL CHEM, V277, P27294, DOI 10.1074/jbc.M200302200; Ashrafian H, 2012, CELL METAB, V15, P361, DOI 10.1016/j.cmet.2012.01.017; BENJAMIN IJ, 1989, CIRC RES, V65, P657, DOI 10.1161/01.RES.65.3.657; Chen J, 1998, J BIOL CHEM, V273, P1252, DOI 10.1074/jbc.273.2.1252; Cheng ZK, 2019, ACS PHARMACOL TRANSL, V2, P361, DOI 10.1021/acsptsci.9b00052; Cheng ZK, 2017, J BIOL CHEM, V292, P2065, DOI 10.1074/jbc.M116.758268; Cheng ZK, 2012, ARTERIOSCL THROM VAS, V32, P924, DOI 10.1161/ATVBAHA.112.245134; Correa R, 2015, EUR J ENDOCRINOL, V173, pM85, DOI 10.1530/EJE-15-0209; Cung TT, 2015, NEW ENGL J MED, V373, P1021, DOI 10.1056/NEJMoa1505489; Davidson SM, 2019, J AM COLL CARDIOL, V73, P89, DOI 10.1016/j.jacc.2018.09.086; Del Re DP, 2019, PHYSIOL REV, V99, P1763, DOI 10.1152/physrev.00022.2018; Ellison GM, 2007, J BIOL CHEM, V282, P11397, DOI 10.1074/jbc.M607391200; Fukunaga N, 2020, AM J TRANSPLANT, V20, P1262, DOI 10.1111/ajt.15724; Haushalter KJ, 2019, AM J PHYSIOL-HEART C, V317, pH1231, DOI 10.1152/ajpheart.00237.2019; Heusch G, 2020, NAT REV CARDIOL, V17, P773, DOI 10.1038/s41569-020-0403-y; Ichimura Y, 2013, MOL CELL, V51, P618, DOI 10.1016/j.molcel.2013.08.003; Jain A, 2010, J BIOL CHEM, V285, P22576, DOI 10.1074/jbc.M110.118976; Jewell JL, 2019, ELIFE, V8, DOI 10.7554/eLife.43038; Katsumata Y, 2014, HYPERTENSION, V63, P80, DOI 10.1161/HYPERTENSIONAHA.113.01639; Keleku-Lukwete N, 2019, BLOOD ADV, V3, P1285, DOI 10.1182/bloodadvances.2018017574; Kirschner LS, 2005, CANCER RES, V65, P4506, DOI 10.1158/0008-5472.CAN-05-0580; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Lai L, 2013, CIRCULATION, V127, P1692, DOI 10.1161/CIRCULATIONAHA.112.001212; Lee LY, 2016, LIVER TRANSPLANT, V22, P91, DOI 10.1002/lt.24303; Lee Y, 2017, CELL REP, V20, P1994, DOI 10.1016/j.celrep.2017.08.019; Linkermann A, 2016, CELL DEATH DIFFER, V23, P1, DOI 10.1038/cdd.2015.151; Liu Y., 2021, CARDIOVASC RES; Liu YN, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14405; Makaula S, 2005, J CARDIOVASC PHARM, V45, P341, DOI 10.1097/01.fjc.0000156825.80951.14; Nakayama H, 2007, J CLIN INVEST, V117, P2431, DOI 10.1172/JCI31060; Ottani F, 2016, J AM COLL CARDIOL, V67, P365, DOI 10.1016/j.jacc.2015.10.081; Prabu SK, 2006, J BIOL CHEM, V281, P2061, DOI 10.1074/jbc.M507741200; Qin QY, 2016, HYPERTENSION, V67, P107, DOI 10.1161/HYPERTENSIONAHA.115.06062; Shanmugam G, 2019, REDOX BIOL, V27, DOI 10.1016/j.redox.2019.101212; Simon JN, 2021, CIRCULATION, V143, P449, DOI 10.1161/CIRCULATIONAHA.120.046761; Song MS, 2015, CELL METAB, V21, P273, DOI 10.1016/j.cmet.2014.12.011; Srinivasan S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077129; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Virani SS, 2020, CIRCULATION, V141, pE139, DOI 10.1161/CIR.0000000000000757; Wallner M, 2016, CIRC RES, V119, P865, DOI 10.1161/CIRCRESAHA.116.308687; Wang WJ, 2014, J MOL CELL CARDIOL, V72, P305, DOI 10.1016/j.yjmcc.2014.04.006; Whelan RS, 2012, P NATL ACAD SCI USA, V109, P6566, DOI 10.1073/pnas.1201608109; Xu BB, 2014, BBA-MOL BASIS DIS, V1842, P1638, DOI 10.1016/j.bbadis.2014.06.002; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yin ZR, 2008, CIRCULATION, V117, P1414, DOI 10.1161/CIRCULATIONAHA.107.759233; Yin ZR, 2011, MOL ENDOCRINOL, V25, P1786, DOI 10.1210/me.2011-1008	47	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100850	10.1016/j.jbc.2021.100850	http://dx.doi.org/10.1016/j.jbc.2021.100850			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34087234	Green Published, gold			2022-12-28	WOS:000678068400050
J	Rufenach, B; Van Petegem, F				Rufenach, Britany; Van Petegem, Filip			Structure and function of STAC proteins: Calcium channel modulators and critical components of muscle excitation-contraction coupling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							II-III LOOP; TYPE-1 RYANODINE RECEPTORS; INDUCED CA2+ RELEASE; AMINO-ACID-RESIDUES; PROTEOME-SCALE MAP; DIHYDROPYRIDINE RECEPTOR; BETA-SUBUNIT; SARCOPLASMIC-RETICULUM; MALIGNANT HYPERTHERMIA; CONGENITAL MYOPATHY	In skeletal muscle tissue, an intriguing mechanical coupling exists between two ion channels from different membranes: the L-type voltage-gated calcium channel (Ca(V)1.1), located in the plasma membrane, and ryanodine receptor 1 (RyR1) located in the sarcoplasmic reticulum membrane. Excitable cells rely on Cavs to initiate Ca2+ entry in response to action potentials. RyRs can amplify this signal by releasing Ca2+ from internal stores. Although this process can be mediated through Ca2+ as a messenger, an overwhelming amount of evidence suggests that RyR1 has recruited Ca(V)1.1 directly as its voltage sensor. The exact mechanisms that underlie this coupling have been enigmatic, but a recent wave of reports have illuminated the coupling protein STAC3 as a critical player. Without STAC3, the mechanical coupling between Ca(v)1.1 and RyR1 is lost, and muscles fail to contract. Various sequence variants of this protein have been linked to congenital myopathy. Other STAC isoforms are expressed in the brain and may serve as regulators of L-type CaVs. Despite the short length of STACs, several points of contacts have been proposed between them and CaVs. However, it is currently unclear whether STAC3 also forms direct interactions with RyR1, and whether this modulates RyR1 function. In this review, we discuss the 3D architecture of STAC proteins, the biochemical evidence for their interactions, the relevance of these connections for functional modulation, and their involvement in myopathy.	[Rufenach, Britany; Van Petegem, Filip] Univ British Columbia, Life Sci Inst, Dept Biochem & Mol Biol, Vancouver, BC, Canada	University of British Columbia	Van Petegem, F (corresponding author), Univ British Columbia, Life Sci Inst, Dept Biochem & Mol Biol, Vancouver, BC, Canada.	petegem@mail.ubc.ca			RyR1 Foundation; CIHR [PJT159601]; NSERC; UBC	RyR1 Foundation; CIHR(Canadian Institutes of Health Research (CIHR)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); UBC	This work was funded by grants from the RyR1 Foundation and CIHR (grant #PJT159601) to F. V. P. and NSERC and UBC to B. R.	Abe T., Solution Structure of RSGI RUH-051, a C1 Domain of STAC3 From Human cDNA, DOI 10.2210/pdb2db6/pdb; Abu-Omar N, 2018, MOL NEUROBIOL, V55, P1183, DOI 10.1007/s12035-016-0375-4; Ambalavanan A, 2016, EUR J HUM GENET, V24, P944, DOI 10.1038/ejhg.2015.218; Anilkumar N, 2003, EMBO J, V22, P5390, DOI 10.1093/emboj/cdg521; ARMSTRONG CM, 1972, BIOCHIM BIOPHYS ACTA, V267, P605, DOI 10.1016/0005-2728(72)90194-6; Avery RB, 1996, J NEUROSCI, V16, P5567; Avila G, 2000, J GEN PHYSIOL, V115, P467, DOI 10.1085/jgp.115.4.467; BAILEY AG, 1987, ANESTH ANALG, V66, P1043; Bao YL, 2019, CELL MOL BIOL LETT, V24, DOI 10.1186/s11658-019-0162-0; Beck H, 1997, J NEUROPHYSIOL, V77, P1526, DOI 10.1152/jn.1997.77.3.1526; Berrout J, 2009, CELL CALCIUM, V46, P30, DOI 10.1016/j.ceca.2009.03.018; Bi XY, 2021, CELL TISSUE RES, V384, P195, DOI 10.1007/s00441-020-03312-8; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Bower NI, 2012, J BIOL CHEM, V287, P43936, DOI 10.1074/jbc.M112.361311; Campiglio M, 2018, J CELL PHYSIOL, V233, P9045, DOI 10.1002/jcp.26767; Campiglio M, 2018, P NATL ACAD SCI USA, V115, P1376, DOI 10.1073/pnas.1715997115; Campiglio M, 2017, SCI REP-UK, V7, DOI 10.1038/srep41003; Chavis P, 1996, NATURE, V382, P719, DOI 10.1038/382719a0; Chen D, 2004, J BIOL CHEM, V279, P4829, DOI 10.1074/jbc.M311196200; Chen SW, 2018, NAT GENET, V50, P1032, DOI 10.1038/s41588-018-0130-z; Chen YH, 2004, NATURE, V429, P675, DOI 10.1038/nature02641; Cong XF, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0088-4; Das J, 2014, CHEM REV, V114, P12108, DOI 10.1021/cr300481j; Davies A, 2010, P NATL ACAD SCI USA, V107, P1654, DOI 10.1073/pnas.0908735107; Dayal A, 2013, P NATL ACAD SCI USA, V110, P7488, DOI 10.1073/pnas.1301087110; De Crescenzo V, 2006, J NEUROSCI, V26, P7565, DOI 10.1523/JNEUROSCI.1512-06.2006; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; Dirksen RT, 1999, J GEN PHYSIOL, V114, P393, DOI 10.1085/jgp.114.3.393; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; Eltit JM, 2014, J BIOL CHEM, V289, P36116, DOI 10.1074/jbc.M114.615526; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; Fernandes CR, 2013, REV BRAS ANESTESIOL, V63, P296, DOI [10.1590/S0034-70942013000300012, 10.1016/S0034-7094(13)70234-4]; FISHER TE, 1995, J PHYSIOL-LONDON, V486, P571, DOI 10.1113/jphysiol.1995.sp020835; Flucher BE, 2017, J PHYSIOL-LONDON, V595, P1451, DOI 10.1113/JP273423; FRANZINI.C, 1970, J CELL BIOL, V47, P488, DOI 10.1083/jcb.47.2.488; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Gabelli SB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6126; Gardill BR, 2019, P NATL ACAD SCI USA, V116, P10763, DOI 10.1073/pnas.1818618116; Ge XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101207; Grabner M, 1999, J BIOL CHEM, V274, P21913, DOI 10.1074/jbc.274.31.21913; Grzybowski M, 2017, NEUROPEDIATRICS, V48, P451, DOI 10.1055/s-0037-1601868; Hardy K, 2005, MOL BIOL CELL, V16, P943, DOI 10.1091/mbc.E04-05-0392; Hopp SC, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0262-3; Horstick EJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2952; Hsu IU, 2020, P NATL ACAD SCI USA, V117, P29914, DOI 10.1073/pnas.2009224117; Hsu IU, 2018, CHRONOBIOL INT, V35, P1016, DOI 10.1080/07420528.2018.1454937; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Huttlin EL, 2015, CELL, V162, P425, DOI 10.1016/j.cell.2015.06.043; Iyer KA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2964; Jeong E, 2018, CELL DEATH DIFFER, V25, P1364, DOI 10.1038/s41418-017-0048-5; Johnson BD, 1997, J NEUROSCI, V17, P1243; Lau K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6397; Legha W, 2010, GENE EXPR PATTERNS, V10, P368, DOI 10.1016/j.gep.2010.08.003; Linsley JW, 2017, TRAFFIC, V18, P622, DOI 10.1111/tra.12502; Linsley JW, 2017, P NATL ACAD SCI USA, V114, pE228, DOI 10.1073/pnas.1619238114; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Mellor GJ, 2019, EUROPACE, V21, P1725, DOI 10.1093/europace/euz215; Mouton J, 2001, BIOCHEM J, V354, P597, DOI 10.1042/0264-6021:3540597; Nakai J, 1996, NATURE, V380, P72, DOI 10.1038/380072a0; Nakai J, 1998, J BIOL CHEM, V273, P24983, DOI 10.1074/jbc.273.39.24983; Nelson BR, 2013, P NATL ACAD SCI USA, V110, P11881, DOI 10.1073/pnas.1310571110; Niu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35222; Niu J, 2018, J GEN PHYSIOL, V150, P1145, DOI 10.1085/jgp.201812005; Norris NC, 2017, J BIOL CHEM, V292, P8401, DOI 10.1074/jbc.M116.763896; Opatowsky Y, 2004, NEURON, V42, P387, DOI 10.1016/S0896-6273(04)00250-8; Pancaroglu R, 2018, ANNU REV GENET, V52, P373, DOI 10.1146/annurev-genet-120417-031311; Perni S, 2017, P NATL ACAD SCI USA, V114, P13822, DOI 10.1073/pnas.1716461115; Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6; Polster A, 2018, J GEN PHYSIOL, V150, P613, DOI 10.1085/jgp.201711917; Polster A, 2016, P NATL ACAD SCI USA, V113, P10986, DOI 10.1073/pnas.1612441113; Polster A, 2015, P NATL ACAD SCI USA, V112, P602, DOI 10.1073/pnas.1423113112; Polster E, 2018, J NEUROSCI, V38, P9215, DOI 10.1523/JNEUROSCI.0695-18.2018; Qin N, 1999, P NATL ACAD SCI USA, V96, P2435, DOI 10.1073/pnas.96.5.2435; Reinholt BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062760; Riazi S, 2018, ANESTHESIOLOGY, V128, P168, DOI 10.1097/ALN.0000000000001878; Rolland T, 2014, CELL, V159, P1212, DOI 10.1016/j.cell.2014.10.050; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rufenach B, 2020, STRUCTURE, V28, P922, DOI 10.1016/j.str.2020.05.005; Rzhepetskyy Y, 2016, CHANNELS, V10, P346, DOI 10.1080/19336950.2016.1186318; Satoh J, 2006, J NEUROSCI METH, V152, P278, DOI 10.1016/j.jneumeth.2005.09.015; Schredelseker J, 2010, P NATL ACAD SCI USA, V107, P5658, DOI 10.1073/pnas.0912153107; Sheridan DC, 2004, BIOPHYS J, V87, P929, DOI 10.1529/biophysj.104.043810; Sheridan DC, 2003, BIOPHYS J, V84, P220, DOI 10.1016/S0006-3495(03)74844-9; Stamm DS, 2008, NEUROLOGY, V71, P1764, DOI 10.1212/01.wnl.0000325060.16532.40; Stamm DS, 2008, AM J MED GENET A, V146A, P1832, DOI 10.1002/ajmg.a.32370; Suzuki H, 1996, BIOCHEM BIOPH RES CO, V229, P902, DOI 10.1006/bbrc.1996.1900; Tae HS, 2009, CLIN EXP PHARMACOL P, V36, P346, DOI 10.1111/j.1440-1681.2008.05130.x; Takeshima H, 2000, MOL CELL, V6, P11, DOI 10.1016/S1097-2765(00)00003-4; TANABE T, 1990, NATURE, V346, P567, DOI 10.1038/346567a0; Telegrafi A, 2017, AM J MED GENET A, V173, P2763, DOI 10.1002/ajmg.a.38375; Thalappilly S, 2008, PROTEOMICS, V8, P3071, DOI 10.1002/pmic.200701157; Troiani S, 2011, FEBS J, V278, P3676, DOI 10.1111/j.1742-4658.2011.08286.x; Usachev YM, 1997, J NEUROSCI, V17, P7404; Van Petegem F, 2004, NATURE, V429, P671, DOI 10.1038/nature02588; Van Petegem F, 2008, STRUCTURE, V16, P280, DOI 10.1016/j.str.2007.11.010; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Waldrop MA, 2017, PEDIATR NEUROL, V74, P11, DOI 10.1016/j.pediatrneurol.2017.01.026; Wang CJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5896; Wang CJ, 2012, STRUCTURE, V20, P1167, DOI 10.1016/j.str.2012.05.001; Wang HB, 2002, J BIOL CHEM, V277, P4541, DOI 10.1074/jbc.M107150200; Webb B. D., 1993, GENEREVIEWS R; Woll KA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21141-3; Wu FF, 2018, J GEN PHYSIOL, V150, P475, DOI 10.1085/jgp.201711962; Wu JP, 2016, NATURE, V537, P191, DOI 10.1038/nature19321; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yang H, 2019, ONCOL LETT, V17, P4245, DOI 10.3892/ol.2019.10137; Yasuda T, 2004, EUR J NEUROSCI, V20, P1, DOI 10.1111/j.1460-9568.2004.03434.x; Yoder JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09570-7; Yu HY, 2011, NAT METHODS, V8, P478, DOI [10.1038/NMETH.1597, 10.1038/nmeth.1597]; Yuchi ZG, 2016, CELL CALCIUM, V59, P209, DOI 10.1016/j.ceca.2016.04.003; Yuen SMWK, 2017, P NATL ACAD SCI USA, V114, pE9520, DOI 10.1073/pnas.1708852114; Zaharieva IT, 2018, HUM MUTAT, V39, P1980, DOI 10.1002/humu.23635; Zalk R, 2015, NATURE, V517, P44, DOI 10.1038/nature13950; Zamponi GW, 2015, PHARMACOL REV, V67, P821, DOI 10.1124/pr.114.009654; ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X; Zhang Y, 2014, J ANIM SCI, V92, P3284, DOI 10.2527/jas.2014-7656; Zhao YY, 2019, CELL, V177, P1495, DOI 10.1016/j.cell.2019.04.043; Zierath JR, 2004, PLOS BIOL, V2, P1523, DOI 10.1371/journal.pbio.0020348; Zong XG, 1996, FEBS LETT, V378, P121, DOI 10.1016/0014-5793(95)01434-9; Zuhlke RD, 2000, J BIOL CHEM, V275, P21121, DOI 10.1074/jbc.M002986200; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	123	8	8	7	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100874	10.1016/j.jbc.2021.100874	http://dx.doi.org/10.1016/j.jbc.2021.100874			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34129875	Green Published, gold			2022-12-28	WOS:000678068400074
J	Sawada, N; Ueno, S; Takeda, K				Sawada, Naoya; Ueno, Shiori; Takeda, Kojiro			Regulation of inorganic polyphosphate is required for proper vacuolar proteolysis in fission yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC PHOSPHATE HOMEOSTASIS; NITROGEN LIMITATION ADAPTATION; SACCHAROMYCES-CEREVISIAE; MEDIATES DEGRADATION; CELL-DIVISION; VTC PROTEINS; DNA-DAMAGE; E3 LIGASE; AUTOPHAGY; COMPLEX	Regulation of cellular proliferation and quiescence is a central issue in biology that has been studied using model unicellular eukaryotes, such as the fission yeast Schizosaccharomyces pombe. We previously reported that the ubiquitin/proteasome pathway and autophagy are essential to maintain quiescence induced by nitrogen deprivation in S. pombe; however, specific ubiquitin ligases that maintain quiescence are not fully understood. Here we investigated the SPX-RING-type ubiquitin ligase Pqr1, identified as required for quiescence in a genetic screen. Pqr1 is found to be crucial for vacuolar proteolysis, the final step of autophagy, through proper regulation of phosphate and its polymer polyphosphate. Pqr1 restricts phosphate uptake into the cell through ubiquitination and subsequent degradation of phosphate transporters on plasma membranes. We hypothesized that Pqr1 may act as the central regulator for phosphate control in S. pombe, through the function of the SPX domain involved in phosphate sensing. Deletion of pqr1(+) resulted in hyperaccumulation of intracellular phosphate and polyphosphate and in improper autophagy-dependent proteolysis under conditions of nitrogen starvation. Polyphosphate hyperaccumulation in pqr1(+)-deficient cells was mediated by the polyphosphate synthase VTC complex in vacuoles. Simultaneous deletion of VTC complex subunits rescued Pqr1 mutant phenotypes, including defects in proteolysis and loss of viability during quiescence. We conclude that excess polyphosphate may interfere with proteolysis in vacuoles by mechanisms that as yet remain unknown. The present results demonstrate a connection between polyphosphate metabolism and vacuolar functions for proper autophagy-dependent proteolysis, and we propose that polyphosphate homeostasis contributes to maintenance of cellular viability during quiescence.	[Sawada, Naoya; Ueno, Shiori; Takeda, Kojiro] Konan Univ, Grad Sch Nat Sci, Kobe, Hyogo, Japan; [Takeda, Kojiro] Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo, Japan	Konan University; Konan University	Takeda, K (corresponding author), Konan Univ, Grad Sch Nat Sci, Kobe, Hyogo, Japan.; Takeda, K (corresponding author), Konan Univ, Inst Integrat Neurobiol, Kobe, Hyogo, Japan.	takeda@konan-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Society for the Promotion of Science (JSPS) [19K06647]; Foundation of the Kinoshita Memorial Enterprise	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Foundation of the Kinoshita Memorial Enterprise	The initial phase of this study was carried out in the G0 Cell Unit (Prof. Mitsuhiro Yanagida) at Okinawa Institute of Science and Technology (OIST), Japan. We are greatly indebted to Drs Yanagida, Kenichi Sajiki (OIST), and Shigeaki Saitoh (Kurume University) for valuable discussions. We thank Ms Sayaka Kanzaki, Ms Yurika Kourogi, and Ms Hina Habara for technical assistance and especially Mr Yosuke Ishihara (Tokai Electron Microscopy, Inc) for his assistance on TEM analysis, and we are grateful to the National Bio-Resource Project (NBRP, Japan) for S. pombe strains. Parts of this study were supported by Special Ordinary Expense Subsidies for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, by a Grant-in-Aid for Scientific Research (C) 19K06647 provided by the Japan Society for the Promotion of Science (JSPS), and by the Foundation of the Kinoshita Memorial Enterprise.	Aono S, 2019, GENES CELLS, V24, P172, DOI 10.1111/gtc.12665; Azevedo C, 2017, TRENDS BIOCHEM SCI, V42, P219, DOI 10.1016/j.tibs.2016.10.008; Azevedo C, 2015, MOL CELL, V58, P71, DOI 10.1016/j.molcel.2015.02.010; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Beckley JR, 2015, MOL CELL PROTEOMICS, V14, P3132, DOI 10.1074/mcp.M115.050039; Bentley-DeSousa A, 2018, CELL REP, V22, P3427, DOI 10.1016/j.celrep.2018.02.104; Breus NA, 2012, FEMS YEAST RES, V12, P617, DOI 10.1111/j.1567-1364.2012.00812.x; Bru S, 2017, DNA REPAIR, V57, P171, DOI 10.1016/j.dnarep.2017.08.001; Bru S, 2017, MICROB CELL, V4, P6, DOI 10.15698/mic2017.01.551; Carter-O'Connell I, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-697; Desfougeres Y, 2016, J BIOL CHEM, V291, P22262, DOI 10.1074/jbc.M116.746784; Eskes E, 2018, CURR GENET, V64, P155, DOI 10.1007/s00294-017-0743-2; Estill M, 2015, CURR GENET, V61, P175, DOI 10.1007/s00294-014-0466-6; Estrella LA, 2008, J BIOL CHEM, V283, P5327, DOI 10.1074/jbc.M703630200; Gachet Y, 2005, J CELL SCI, V118, P4231, DOI 10.1242/jcs.02530; Garg A, 2018, J BIOL CHEM, V293, P4456, DOI 10.1074/jbc.RA117.001352; Gonzalez A, 2017, EMBO J, V36, P397, DOI 10.15252/embj.201696010; Gray JV, 2004, MICROBIOL MOL BIOL R, V68, P187, DOI 10.1128/MMBR.68.2.187-206.2004; Gray MJ, 2014, MOL CELL, V53, P689, DOI 10.1016/j.molcel.2014.01.012; Henry TC, 2011, EUKARYOT CELL, V10, P198, DOI 10.1128/EC.00216-10; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Iwaki T, 2004, MOL GENET GENOMICS, V271, P197, DOI 10.1007/s00438-003-0971-7; Jimenez J, 2016, INT MICROBIOL, V19, P133, DOI 10.2436/20.1501.01.271; Kamada Y, 2010, MOL CELL BIOL, V30, P1049, DOI 10.1128/MCB.01344-09; Kanki T, 2009, DEV CELL, V17, P98, DOI 10.1016/j.devcel.2009.06.014; Kant S, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002021; Kim DU, 2010, NAT BIOTECHNOL, V28, P617, DOI 10.1038/nbt.1628; Kohda TA, 2007, GENES CELLS, V12, P155, DOI 10.1111/j.1365-2443.2007.01041.x; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Lenburg ME, 1996, TRENDS BIOCHEM SCI, V21, P383, DOI 10.1016/S0968-0004(96)90127-9; Lin WY, 2013, PLANT CELL, V25, P4061, DOI 10.1105/tpc.113.116012; Liu QB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139045; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Lorenz B, 1997, BBA-GEN SUBJECTS, V1335, P51, DOI 10.1016/S0304-4165(96)00121-3; Lundh F, 2009, BIOCHEMISTRY-US, V48, P4497, DOI 10.1021/bi9001198; McCarthy L, 2019, FEBS LETT, V279, P17289; Mochida S, 2006, GENES CELLS, V11, P13, DOI 10.1111/j.1365-2443.2005.00917.x; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Morrissey JH, 2015, J THROMB HAEMOST, V13, pS92, DOI 10.1111/jth.12896; Mukaiyama H, 2011, APPL MICROBIOL BIOT, V90, P203, DOI 10.1007/s00253-010-3031-3; Mukaiyama H, 2009, MICROBIOL-SGM, V155, P3816, DOI 10.1099/mic.0.034389-0; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Murray JM, 2000, GENETICS, V154, P155; Nair U, 2011, AUTOPHAGY, V7, P1546, DOI 10.4161/auto.7.12.18424; Nakamura A, 2018, GENES CELLS, V23, P904, DOI 10.1111/gtc.12639; Nakase M, 2012, MICROBIOL-SGM, V158, P659, DOI 10.1099/mic.0.053389-0; Nakase Y, 2013, J CELL SCI, V126, P3972, DOI 10.1242/jcs.128355; Nakashima A, 2006, CURR GENET, V49, P403, DOI 10.1007/s00294-006-0067-0; Nakashima A, 2014, BIOL OPEN, V3, P542, DOI 10.1242/bio.20148367; Nakashima A, 2012, J CELL SCI, V125, P5840, DOI 10.1242/jcs.111146; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; Okamoto K, 2009, DEV CELL, V17, P87, DOI 10.1016/j.devcel.2009.06.013; Oshima Y, 1997, GENES GENET SYST, V72, P323, DOI 10.1266/ggs.72.323; Otsubo Y, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7030050; Park BS, 2014, PLANT CELL, V26, P454, DOI 10.1105/tpc.113.120311; Peng MS, 2008, J EXP BOT, V59, P2933, DOI 10.1093/jxb/ern148; Peng MS, 2007, PLANT J, V50, P320, DOI 10.1111/j.1365-313X.2007.03050.x; Rao NN, 1996, J BACTERIOL, V178, P1394, DOI 10.1128/jb.178.5.1394-1400.1996; Sajiki K, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aat5685; Sajiki K, 2013, METABOLITES, V3, P1118, DOI 10.3390/metabo3041118; Sajiki K, 2009, J CELL SCI, V122, P1418, DOI 10.1242/jcs.046466; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Shiba T, 1997, P NATL ACAD SCI USA, V94, P11210, DOI 10.1073/pnas.94.21.11210; Shibata M, 2013, PLANT CELL, V25, P4967, DOI 10.1105/tpc.113.116947; Shimanuki M, 2007, GENES CELLS, V12, P677, DOI 10.1111/j.1365-2443.2007.01079.x; Su SSY, 1996, J CELL SCI, V109, P1347; Sun LL, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003715; Suzuki K, 2007, GENES CELLS, V12, P209, DOI 10.1111/j.1365-2443.2007.01050.x; Takeda K, 2011, P NATL ACAD SCI USA, V108, P16950, DOI 10.1073/pnas.1103617108; Takeda K, 2010, P NATL ACAD SCI USA, V107, P3540, DOI 10.1073/pnas.0911055107; Takegawa K, 2003, CELL STRUCT FUNCT, V28, P399, DOI 10.1247/csf.28.399; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Tanida I, 2017, METHOD ENZYMOL, V587, P87, DOI 10.1016/bs.mie.2016.09.054; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; van Leeuwen W, 2018, J CELL BIOL, V217, P2261, DOI 10.1083/jcb.201802003; VANVELDHOVEN PP, 1987, ANAL BIOCHEM, V161, P45, DOI 10.1016/0003-2697(87)90649-X; Wang LH, 2003, P NATL ACAD SCI USA, V100, P11249, DOI 10.1073/pnas.1534805100; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; Xie LH, 2019, J BIOL CHEM, V294, P2180, DOI 10.1074/jbc.REV118.002808; Yanagida M, 2011, PHILOS T R SOC B, V366, P3508, DOI 10.1098/rstb.2011.0124; Yanagida M, 2009, TRENDS CELL BIOL, V19, P705, DOI 10.1016/j.tcb.2009.09.006; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhang CM, 2019, P NATL ACAD SCI USA, V116, P12833, DOI 10.1073/pnas.1819813116	89	2	2	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100891	10.1016/j.jbc.2021.100891	http://dx.doi.org/10.1016/j.jbc.2021.100891			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34147496	Green Published, gold			2022-12-28	WOS:000678068400086
J	Zakaria, A; Berthault, C; Cosson, B; Jung, V; Guerrera, IC; Rachdi, L; Scharfmann, R				Zakaria, Albatoul; Berthault, Claire; Cosson, Bertrand; Jung, Vincent; Guerrera, Ida Chiara; Rachdi, Latif; Scharfmann, Raphael			Glucose treatment of human pancreatic beta-cells enhances translation of mRNAs involved in energetics and insulin secretion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROINSULIN BIOSYNTHESIS; PROTEIN; PC2; MASS; PROLIFERATION; PATHOGENESIS; INHIBITION; CONVERTASE; PUROMYCIN	Glucose-mediated signaling regulates the expression of a limited number of genes in human pancreatic beta-cells at the transcriptional level. However, it is unclear whether glucose plays a role in posttranscriptional RNA processing or translational control of gene expression. Here, we asked whether glucose affects posttranscriptional steps and regulates protein synthesis in human beta-cell lines. We first showed the involvement of the mTOR pathway in glucose-related signaling. We also used the surface sensing of translation technique, based on puromycin incorporation into newly translated proteins, to demonstrate that glucose treatment increased protein translation. Among the list of glucose-induced proteins, we identified the proconvertase PCSK1, an enzyme involved in the proteolytic conversion of proinsulin to insulin, whose translation was induced within minutes following glucose treatment. We finally performed global proteomic analysis by mass spectrometry to characterize newly translated proteins upon glucose treatment. We found enrichment in proteins involved in translation, glycolysis, TCA metabolism, and insulin secretion. Taken together, our study demonstrates that, although glucose minorly affects gene transcription in human beta-cells, it plays a major role at the translational level.	[Zakaria, Albatoul; Berthault, Claire; Rachdi, Latif; Scharfmann, Raphael] Univ Paris, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France; [Cosson, Bertrand] Univ Paris, Epigenet & Cell Fate Ctr, CNRS UMR 7216, Paris, France; [Jung, Vincent; Guerrera, Ida Chiara] Univ Paris, Struct Federat Rech Necker, Plateforme Proteom Necker, INSERM US24 CNRS UMS3633, Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Rachdi, L; Scharfmann, R (corresponding author), Univ Paris, Inst Cochin, INSERM U1016, CNRS UMR 8104, Paris, France.	latif.rachdi@inserm.fr; raphael.scharfmann@inserm.fr	GUERRERA, Ida Chiara/GOJ-9151-2022	GUERRERA, Ida Chiara/0000-0002-4832-6793; Scharfmann, Raphael/0000-0001-7619-337X	IDEX University Paris; Agence Nationale de la Recherche (ANR BromoBeta); Innovative Medicines Initiative 2 Joint Undertaking Rhapsody - European Union's Horizon 2020 research and innovation program EFPIA [115881]; Swiss State Secretariat for Education Research, and Innovation (SERI) from the European Union's Seventh Framework Program (FP7/2007-2013) [16.0097]; Innovative Medicines Initiative 2 Joint Undertaking [115797, 945268]; Union's Horizon 2020 research and innovation program EFPIA; JDRF; Leona M. and Harry B. Helmsley Charitable Trust; Laboratoire d'Excellence consortium Revive; Fondation pour la Recherche Medicale [EQU201903007793]; Dutch Diabetes Research Foundation; DON Foundation; Fondation Francophone pour la Recherche sur le Diabetes (FFRD)	IDEX University Paris; Agence Nationale de la Recherche (ANR BromoBeta)(French National Research Agency (ANR)); Innovative Medicines Initiative 2 Joint Undertaking Rhapsody - European Union's Horizon 2020 research and innovation program EFPIA; Swiss State Secretariat for Education Research, and Innovation (SERI) from the European Union's Seventh Framework Program (FP7/2007-2013); Innovative Medicines Initiative 2 Joint Undertaking; Union's Horizon 2020 research and innovation program EFPIA; JDRF(Juvenile Diabetes Research Foundation); Leona M. and Harry B. Helmsley Charitable Trust; Laboratoire d'Excellence consortium Revive; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Dutch Diabetes Research Foundation; DON Foundation; Fondation Francophone pour la Recherche sur le Diabetes (FFRD)	The R. S. laboratory received funding from IDEX University Paris, Agence Nationale de la Recherche (ANR BromoBeta), the Innovative Medicines Initiative 2 Joint Undertaking Rhapsody under grant agreement no. 115881 supported by the European Union's Horizon 2020 research and innovation program EFPIA and the Swiss State Secretariat for Education Research, and Innovation (SERI) under contract number 16.0097, resources of which are composed of a financial contribution from the European Union's Seventh Framework Program (FP7/2007-2013); and the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement no. 115797 (INNODIA) and no. 945268 (INNODIA HARVEST). This joint undertaking receives support from the Union's Horizon 2020 research and innovation program EFPIA, JDRF, and the Leona M. and Harry B. Helmsley Charitable Trust. The R. S. laboratory was also supported by the Laboratoire d'Excellence consortium Revive, Fondation pour la Recherche Medicale (EQU201903007793), the Dutch Diabetes Research Foundation, the DON Foundation, and Fondation Francophone pour la Recherche sur le Diabetes (FFRD).	ALARCON C, 1993, J BIOL CHEM, V268, P4276; Alarcon C, 2012, ENDOCRINOLOGY, V153, P2082, DOI 10.1210/en.2011-2019; Alvarez-Dominguez JR, 2020, CELL STEM CELL, V26, P108, DOI 10.1016/j.stem.2019.11.011; Beckelman BC, 2019, J CLIN INVEST, V129, P820, DOI 10.1172/JCI122954; Bernal-Mizrachi E, 2014, DIABETES, V63, P819, DOI 10.2337/db13-1146; Blanchet E, 2015, CELL REP, V10, P1149, DOI 10.1016/j.celrep.2015.01.046; Braun M, 2010, DIABETES, V59, P1694, DOI 10.2337/db09-0797; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dadon D, 2012, DIABETES OBES METAB, V14, P101, DOI 10.1111/j.1463-1326.2012.01646.x; Drucker DJ, 2013, DIABETES, V62, P3316, DOI 10.2337/db13-0822; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Ikushima Y. M., 2021, DIABETES; Irminger JC, 1996, BIOCHEM J, V320, P11, DOI 10.1042/bj3200011; Jaafar R, 2019, J CLIN INVEST, V129, P4124, DOI 10.1172/JCI127021; Jing G, 2016, MOL METAB, V5, P1208, DOI 10.1016/j.molmet.2016.09.010; KAHN SE, 1995, DIABETES, V44, P173, DOI 10.2337/diabetes.44.2.173; Kobiita A, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.107846; Kwon G, 2006, J BIOL CHEM, V281, P3261, DOI 10.1074/jbc.M508821200; Leahy JL, 2005, ARCH MED RES, V36, P197, DOI 10.1016/j.arcmed.2005.01.003; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Ma T, 2013, NAT NEUROSCI, V16, P1299, DOI 10.1038/nn.3486; Marciano R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0056-x; Mastrolia V, 2017, DIABETES, V66, P897, DOI 10.2337/db16-0336; Mi HY, 2017, NUCLEIC ACIDS RES, V45, pD183, DOI 10.1093/nar/gkw1138; Miyamoto-Sato E, 2000, NUCLEIC ACIDS RES, V28, P1176, DOI 10.1093/nar/28.5.1176; NATHANS D, 1964, P NATL ACAD SCI USA, V51, P585, DOI 10.1073/pnas.51.4.585; PESTKA S, 1971, ANNU REV MICROBIOL, V25, P487, DOI 10.1146/annurev.mi.25.100171.002415; Ramos-Molina B, 2016, PROG MOL BIOL TRANSL, V140, P47, DOI 10.1016/bs.pmbts.2015.12.001; Ramzy A, 2020, DIABETES, V69, P1451, DOI 10.2337/db19-0276; Ravassard P, 2011, J CLIN INVEST, V121, P3589, DOI 10.1172/JCI58447; Ravi Venkatraman, 2020, Curr Protoc Mol Biol, V133, pe127, DOI 10.1002/cpmb.127; Ravi V, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22903-8; Richards P, 2018, DIABETES, V67, P461, DOI 10.2337/db17-0595; Roux PP, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00070-18; Scharfmann R, 2016, DIABETES OBES METAB, V18, P128, DOI 10.1111/dom.12728; Scharfmann R, 2014, J CLIN INVEST, V124, P2087, DOI 10.1172/JCI72674; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schmidt SF, 2016, CELL REP, V16, P2359, DOI 10.1016/j.celrep.2016.07.063; SCOPSI L, 1995, J CLIN ENDOCR METAB, V80, P294, DOI 10.1210/jc.80.1.294; Shibasaki T, 2007, P NATL ACAD SCI USA, V104, P19333, DOI 10.1073/pnas.0707054104; Skelly RH, 1996, DIABETES, V45, P37, DOI 10.2337/diabetes.45.1.37; Stijnen P, 2016, ENDOCR REV, V37, P347, DOI 10.1210/er.2015-1117; Tran KA, 2019, J BIOL CHEM, V294, P5408, DOI 10.1074/jbc.TM118.000831; Truyen I, 2005, DIABETOLOGIA, V48, P2322, DOI 10.1007/s00125-005-1959-0; Waanders LF, 2009, P NATL ACAD SCI USA, V106, P18902, DOI 10.1073/pnas.0908351106; Weir GC, 2020, LANCET DIABETES ENDO, V8, P249, DOI 10.1016/S2213-8587(20)30022-X; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	49	1	1	2	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100839	10.1016/j.jbc.2021.100839	http://dx.doi.org/10.1016/j.jbc.2021.100839			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051232	gold, Green Published			2022-12-28	WOS:000678068400039
J	Buckner, BA; Lato, AM; Campagna, SR; Downs, DM				Buckner, Brandi A.; Lato, Ashley M.; Campagna, Shawn R.; Downs, Diana M.			The Rid family member RutC of Escherichia coli is a 3-aminoacrylate deaminase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLONING; VECTORS; PATHWAY; AMIDE	The Rid protein family (PF14588, IPR006175) is divided into nine subfamilies, of which only the RidA subfamily has been characterized biochemically. RutC, the founding member of one subfamily, is encoded in the pyrimidine utilization (rut) operon that encodes a pathway that allows Escherichia coli to use uracil as a sole nitrogen source. Results reported herein demonstrate that RutC has 3-aminoacrylate deaminase activity and facilitates one of the reactions previously presumed to occur spontaneously in vivo. RutC was active with several enamine-imine substrates, showing similarities and differences in substrate specificity with the canonical member of the Rid superfamily, Salmonella enterica RidA. Under standard laboratory conditions, a Rut pathway lacking RutC generates sufficient nitrogen from uracil for growth of E. coli. These results support a revised model of the Rut pathway and provide evidence that Rid proteins may modulate metabolic fitness, rather than catalyzing essential functions.	[Buckner, Brandi A.; Downs, Diana M.] Univ Georgia, Dept Microbiol, Athens, GA 30602 USA; [Lato, Ashley M.; Campagna, Shawn R.] Univ Tennessee, Dept Chem, Knoxville, TN 37996 USA	University System of Georgia; University of Georgia; University of Tennessee System; University of Tennessee Knoxville	Downs, DM (corresponding author), Univ Georgia, Dept Microbiol, Athens, GA 30602 USA.	dmdowns@uga.edu		Buckner, Brandi/0000-0002-7173-7312; Lato, Ashley/0000-0003-4076-9714	National Institutes of Health [GM095837]; National Science Foundation [MCB1615373]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by an award from the competitive grants program at the National Institutes of Health (GM095837 to D. M. D.) and the National Science Foundation (MCB1615373 to S. R. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 2017, BIOCHEMISTRY-US, V56, P3708, DOI 10.1021/acs.biochem.7b00493; BARTOLOME B, 1991, GENE, V102, P75, DOI 10.1016/0378-1119(91)90541-I; Borchert AJ, 2019, TRENDS BIOCHEM SCI, V44, P849, DOI 10.1016/j.tibs.2019.04.011; Degani G, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19040945; Ernst DC, 2018, MBIO, V9, DOI 10.1128/mBio.00084-18; Ernst DC, 2014, J BACTERIOL, V196, P3335, DOI 10.1128/JB.01960-14; Galloway NR, 2013, CRYST GROWTH DES, V13, P2833, DOI 10.1021/cg400171z; HAFNER EW, 1979, BIOCHEMISTRY-US, V18, P411, DOI 10.1021/bi00570a004; Hodge-Hanson KM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185544; Irons J, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.02058; Irons J, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00434-18; Irons JL, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00024-20; Kim KS, 2010, J BACTERIOL, V192, P4089, DOI 10.1128/JB.00201-10; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Knapik AA, 2012, ACTA CRYSTALLOGR F, V68, P1294, DOI 10.1107/S1744309112041796; Lambrecht JA, 2012, J BIOL CHEM, V287, P3454, DOI 10.1074/jbc.M111.304477; Loh KD, 2006, P NATL ACAD SCI USA, V103, P5114, DOI 10.1073/pnas.0600521103; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Mukherjee T, 2010, J AM CHEM SOC, V132, P5550, DOI 10.1021/ja9107676; Niehaus TD, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1584-3; Niehaus TD, 2014, PLANT CELL, V26, P3010, DOI 10.1105/tpc.114.126854; Rehberg GM, 1995, ORG PREP PROCED INT, V27, P651, DOI 10.1080/00304949509458523; VanDrisse CM, 2016, PLASMID, V86, P1, DOI 10.1016/j.plasmid.2016.05.001; VOGEL HJ, 1956, J BIOL CHEM, V218, P97	24	2	2	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100651	10.1016/j.jbc.2021.100651	http://dx.doi.org/10.1016/j.jbc.2021.100651			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839153	Green Published, gold			2022-12-28	WOS:000672866400622
J	Carlos, AJ; Ha, DP; Yeh, DW; Van Krieken, R; Tseng, CC; Zhang, P; Gill, P; Machida, K; Lee, AS				Carlos, Anthony J.; Ha, Dat P.; Yeh, Da-Wei; Van Krieken, Richard; Tseng, Chun-Chih; Zhang, Pu; Gill, Parkash; Machida, Keigo; Lee, Amy S.			The chaperone GRP78 is a host auxiliary factor for SARS-CoV-2 and GRP78 depleting antibody blocks viral entry and infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 global pandemic, utilizes the host receptor angiotensin-converting enzyme 2 (ACE2) for viral entry. However, other host factors might also play important roles in SARS-CoV-2 infection, providing new directions for antiviral treatments. GRP78 is a stress-inducible chaperone important for entry and infectivity for many viruses. Recent molecular docking analyses revealed putative interaction between GRP78 and the receptor-binding domain (RBD) of the SARS-CoV-2 Spike protein (SARS-2-S). Here we report that GRP78 can form a complex with SARS-2-S and ACE2 on the surface and at the perinuclear region typical of the endoplasmic reticulum in VeroE6-ACE2 cells and that the substrate-binding domain of GRP78 is critical for this interaction. In vitro binding studies further confirmed that GRP78 can directly bind to the RBD of SARS-2-S and ACE2. To investigate the role of GRP78 in this complex, we knocked down GRP78 in VeroE6-ACE2 cells. Loss of GRP78 markedly reduced cell surface ACE2 expression and led to activation of markers of the unfolded protein response. Treatment of lung epithelial cells with a humanized monoclonal antibody (hMAb159) selected for its safe clinical profile in preclinical models depleted cell surface GRP78 and reduced cell surface ACE2 expression, as well as SARS-2-S-driven viral entry and SARS-CoV-2 infection in vitro. Our data suggest that GRP78 is an important host auxiliary factor for SARS-CoV-2 entry and infection and a potential target to combat this novel pathogen and other viruses that utilize GRP78 in combination therapy.	[Carlos, Anthony J.; Ha, Dat P.; Van Krieken, Richard; Tseng, Chun-Chih; Zhang, Pu; Lee, Amy S.] Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA; [Carlos, Anthony J.; Ha, Dat P.; Van Krieken, Richard; Tseng, Chun-Chih; Zhang, Pu; Gill, Parkash; Lee, Amy S.] Univ Southern Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA; [Yeh, Da-Wei; Machida, Keigo] Univ Southern Calif, Keck Sch Med, Dept Mol Microbiol & Immunol, Los Angeles, CA 90007 USA; [Gill, Parkash] Univ Southern Calif, Keck Sch Med, Dept Med, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California	Lee, AS (corresponding author), Univ Southern Calif, Keck Sch Med, Dept Biochem & Mol Med, Los Angeles, CA 90007 USA.; Lee, AS (corresponding author), Univ Southern Calif, Keck Sch Med, USC Norris Comprehens Canc Ctr, Los Angeles, CA 90007 USA.	amylee@usc.edu	Tseng, Chun-Chih/AAS-3712-2020; Ha, Dat/AFS-3983-2022	Tseng, Chun-Chih/0000-0001-9285-0712; Ha, Dat/0000-0002-2592-1223; Zhang, Pu/0000-0003-4174-8202; Lee, Amy/0000-0002-0378-5443; Van Krieken, Richard/0000-0002-7118-0577	Natural Sciences and Engineering Research Council of Canada (NSERC) [171359]; NSERC [04802]; U.S. Department of Energy (DOE) [DE-AC36-08GO28308]; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office; Center for Bioenergy Innovation, a U.S. Department of Energy Research Center - Office of Biological and Environmental Research in the DOE Office of Science; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office(United States Department of Energy (DOE)); Center for Bioenergy Innovation, a U.S. Department of Energy Research Center - Office of Biological and Environmental Research in the DOE Office of Science(United States Department of Energy (DOE)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This research was supported by Discovery Grant 171359 from the Natural Sciences and Engineering Research Council of Canada (NSERC) to L. D. E. and NSERC Discovery Grant 04802 to M. E. P. M. L. D. E. is the recipient of a Canada Research Chair. This work was authored in part by the National Renewable Energy Laboratory, operated by Alliance for Sustainable Energy, LLC, for the U.S. Department of Energy (DOE) under Contract No. DE-AC36-08GO28308. Funding was provided to R. K., S. J. H., and G. T. B. by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office. E. K. and G. T. B. also acknowledges funding from The Center for Bioenergy Innovation, a U.S. Department of Energy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. The views expressed in the article do not necessarily represent the views of the DOE or the US Government. The US Government retains and the publisher, by accepting the article for publication, acknowledges that the US Government retains a nonexclusive, paidup, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for US Government purposes.	Aguiar J.A., 2020, EUR RESPIR J, V56; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Chu H, 2018, J BIOL CHEM, V293, P11709, DOI 10.1074/jbc.RA118.001897; Cuervo NZ, 2020, ELIFE, V9, DOI 10.7554/eLife.61390; Elfiky A. A., 2021, RES SQUARE, DOI [10.21203/rs.3.rs-189975/v1, DOI 10.21203/RS.3.RS-189975/V1]; Elfiky AA, 2021, J INFECTION, V82, P225, DOI 10.1016/j.jinf.2021.01.015; Elfiky AA, 2021, J INFECTION, V82, P301, DOI 10.1016/j.jinf.2020.09.004; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Ha DP, 2020, J INFECTION, V81, P478, DOI 10.1016/j.jinf.2020.06.017; Hardy B, 2008, BIOCHEM PHARMACOL, V75, P891, DOI 10.1016/j.bcp.2007.10.008; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Ibrahim IM, 2020, J INFECTION, V80, P554, DOI 10.1016/j.jinf.2020.02.026; Khongwichit S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79803-z; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Nain M, 2017, J VIROL, V91, DOI [10.1128/jvi.02274-16, 10.1128/JVI.02274-16]; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Rayner JO, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114227; Reid SP, 2014, ANTIVIR RES, V109, P171, DOI 10.1016/j.antiviral.2014.07.004; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Roberts JL, 2015, J CELL PHYSIOL, V230, P2552, DOI 10.1002/jcp.25014; Sabirli R, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118781; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Tsai YL, 2018, P NATL ACAD SCI USA, V115, pE4245, DOI 10.1073/pnas.1714866115; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Tseng C. C, 2019, LIFE SCI ALLIANCE, V2; Van Krieken R, 2019, J BIOL CHEM, V294, P7755, DOI 10.1074/jbc.RA118.006939; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800	32	47	47	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100759	10.1016/j.jbc.2021.100759	http://dx.doi.org/10.1016/j.jbc.2021.100759			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33965375	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400727
J	Delerue, T; Ramamurthi, KS				Delerue, Thomas; Ramamurthi, Kumaran S.			How bacteria block their own biofilms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Bacterial biofilms are surface-associated multicellular communities that are highly resistant to removal. Scheffler et al. discovered that Pseudomonas aeruginosa secretes a small molecule that inhibits other P. aeruginosa cells from adsorbing to surfaces by interfering with type IV pili dynamics. The inhibition of cell adsorption could present a method to prevent biofilm formation on sensitive surfaces in hospitals and industry.	[Delerue, Thomas; Ramamurthi, Kumaran S.] NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ramamurthi, KS (corresponding author), NCI, Mol Biol Lab, NIH, Bethesda, MD 20892 USA.	ramamurthiks@mail.nih.gov		delerue, thomas/0000-0002-8900-247X	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research	National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by the Intramural Research Program of the National Institutes of Health (NIH), National Cancer Institute, Center for Cancer Research (K. S. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Berne C, 2018, NAT REV MICROBIOL, V16, P616, DOI 10.1038/s41579-018-0057-5; Davies D, 2003, NAT REV DRUG DISCOV, V2, P114, DOI 10.1038/nrd1008; Gallagher LA, 2002, J BACTERIOL, V184, P6472, DOI 10.1128/JB.184.23.6472-6480.2002; Marathe R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4759; Mccallum M, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.PSIB-0006-2018; Scheffler R. J., 2021, J BIOL CHEM, V296	7	1	1	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100392	10.1016/j.jbc.2021.100392	http://dx.doi.org/10.1016/j.jbc.2021.100392			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839681	gold, Green Published			2022-12-28	WOS:000672866400366
J	Ningoo, M; Plant, LD; Greka, A; Logothetis, DE				Ningoo, Mehek; Plant, Leigh D.; Greka, Anna; Logothetis, Diomedes E.			PIP2 regulation of TRPC5 channel activation and desensitization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Transient receptor potential canonical type 5 (TRPC5) ion channels are expressed in the brain and kidney and have been identified as promising therapeutic targets whose selective inhibition can protect against diseases driven by a leaky kidney filter, such as focal segmental glomerular sclerosis. TRPC5 channels are activated not only by elevated levels of extracellular Ca2+ or lanthanide ions but also by G protein (G(q/11)) stimulation. Phosphatidylinositol 4,5-bisphosphate (PIP2) hydrolysis by phospholipase C enzymes leads to PKC-mediated phosphorylation of TRPC5 channels and their subsequent desensitization. However, the roles of PIP2 in activation and maintenance of TRPC5 channel activity via its hydrolysis product diacyl glycerol (DAG), as well as the mechanism of desensitization of TRPC5 activity by DAG-stimulated PKC activity, remain unclear. Here, we designed experiments to distinguish between the processes underlying channel activation and inhibition. Employing whole-cell patch-clamp, we used an optogenetic tool to dephosphorylate PIP2 and assess channel-PIP2 interactions influenced by activators, such as DAG, or inhibitors, such as PKC phosphorylation. Using total internal reflection microscopy, we assessed channel cell surface density. We show that PIP2 controls both the PKC-mediated inhibition and the DAG- and lanthanide-mediated activation of TRPC5 currents via control of gating rather than channel cell surface density. These mechanistic insights promise to aid in the development of more selective and precise inhibitors to block TRPC5 channel activity and illuminate new opportunities for targeted therapies for a group of chronic kidney diseases for which there is currently a great unmet need.	[Ningoo, Mehek; Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Bouve Coll Hlth Sci, Sch Pharm, Dept Pharmaceut Sci, Boston, MA 02115 USA; [Plant, Leigh D.; Logothetis, Diomedes E.] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Greka, Anna] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Greka, Anna] Harvard Med Sch, Boston, MA 02115 USA; [Greka, Anna] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Logothetis, Diomedes E.] Northeastern Univ, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA; [Ningoo, Mehek] Icahn Sch Med Mt Sinai, Grad Sch Biomed Sci, New York, NY 10029 USA	Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Northeastern University; Icahn School of Medicine at Mount Sinai	Logothetis, DE (corresponding author), Northeastern Univ, Bouve Coll Hlth Sci, Sch Pharm, Dept Pharmaceut Sci, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA.; Logothetis, DE (corresponding author), Northeastern Univ, Dept Chem & Chem Biol, Coll Sci, Boston, MA 02115 USA.	d.logothetis@northeastern.edu		Logothetis, Diomedes/0000-0002-0576-884X; Plant, Leigh/0000-0002-1622-1655; Ningoo, Mehek/0000-0001-8318-3508; Greka, Anna/0000-0001-5697-7791	 [R01HL09549-23];  [R01HL144615];  [R01DK095045];  [R01DK099465]	; ; ; 	The work was supported by Grants R01HL09549-23 to D. E. L., R01HL144615 to L. D. P., and R01DK095045 and R01DK099465 to A. G.		0	13	13	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100726	10.1016/j.jbc.2021.100726	http://dx.doi.org/10.1016/j.jbc.2021.100726			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933453	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400696
J	Paananen, A; Weich, S; Szilvay, GR; Leitner, M; Tappura, K; Ebner, A				Paananen, Arja; Weich, Sabine; Szilvay, Geza R.; Leitner, Michael; Tappura, Kirsi; Ebner, Andreas			Quantifying biomolecular hydrophobicity: Single molecule force spectroscopy of class II hydrophobins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Hydrophobins are surface-active proteins produced by filamentous fungi. The amphiphilic structure of hydrophobins is very compact, containing a distinct hydrophobic patch on one side of the molecule, locked by four intramolecular disulfide bridges. Hydrophobins form dimers and multimers in solution to shield these hydrophobic patches from water exposure. Multimer formation in solution is dynamic, and hydrophobin monomers can be exchanged between multimers. Unlike class I hydrophobins, class II hydrophobins assemble into highly ordered films at the air-water interface. In order to increase our understanding of the strength and nature of the interaction between hydrophobins, we used atomic force microscopy for single molecule force spectroscopy to explore the molecular interaction forces between class II hydrophobins from Trichoderma reesei under different environmental conditions. A genetically engineered hydrophobin variant, NCys-HFBI, enabled covalent attachment of proteins to the apex of the atomic force microscopy cantilever tip and sample surfaces in controlled orientation with sufficient freedom of movement to measure molecular forces between hydrophobic patches. The measured rupture force between two assembled hydrophobins was similar to 31 pN, at a loading rate of 500 pN/s. The results indicated stronger interaction between hydrophobins and hydrophobic surfaces than between two assembling hydrophobin molecules. Furthermore, this interaction was stable under different environmental conditions, which demonstrates the dominance of hydrophobicity in hydrophobin-hydrophobin interactions. This is the first time that interaction forces between hydrophobin molecules, and also between naturally occurring hydrophobic surfaces, have been measured directly at a single-molecule level.	[Paananen, Arja; Szilvay, Geza R.; Tappura, Kirsi] VTT Tech Res Ctr Finland Ltd, Ind Biotechnol & Food, Espoo, Finland; [Weich, Sabine; Leitner, Michael; Ebner, Andreas] Johannes Kepler Univ Linz, Inst Biophys, Dept Appl Expt Biophys, Linz, Austria; [Weich, Sabine] VTU Engn GmbH, St Peter Str 25, A-4020 Linz, Austria	VTT Technical Research Center Finland; Johannes Kepler University Linz	Paananen, A (corresponding author), VTT Tech Res Ctr Finland Ltd, Ind Biotechnol & Food, Espoo, Finland.; Ebner, A (corresponding author), Johannes Kepler Univ Linz, Inst Biophys, Dept Appl Expt Biophys, Linz, Austria.	Arja.Paananen@vtt.fi; Andreas.Ebner@jku.at	; Ebner, Andreas/C-4233-2013	Paananen, Arja/0000-0002-4019-233X; Tappura, Kirsi/0000-0002-8032-9652; Ebner, Andreas/0000-0001-5615-7590	Academy of Finland [126572]; Linz Institute of Technology (LIT) [LIT-2019-7-SEE-113]; government of Upper Austria; Federal Ministry of Education, Science and Research (BMBWF)	Academy of Finland(Academy of Finland); Linz Institute of Technology (LIT); government of Upper Austria; Federal Ministry of Education, Science and Research (BMBWF)	This work was supported by the Academy of Finland (Grant #126572) and by the Linz Institute of Technology (LIT) -project LIT-2019-7-SEE-113, the government of Upper Austria, and the Federal Ministry of Education, Science and Research (BMBWF). The work was carried out under the Academy of Finland's Centers of Excellence Programme (2014-2019).		0	3	3	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100728	10.1016/j.jbc.2021.100728	http://dx.doi.org/10.1016/j.jbc.2021.100728			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933454	gold, Green Published			2022-12-28	WOS:000672866400697
J	Yoblinski, AR; Chung, S; Robinson, SB; Forester, KE; Strahl, BD; Dronamraju, R				Yoblinski, Andrew R.; Chung, Seoyoung; Robinson, Sophie B.; Forester, Kaitlyn E.; Strahl, Brian D.; Dronamraju, Raghuvar			Catalysis-dependent and redundant roles of Dma1 and Dma2 in maintenance of genome stability in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION	DNA double-strand breaks (DSBs) are among the deleterious lesions that are both endogenous and exogenous in origin and are repaired by nonhomologous end joining or homologous recombination. However, the molecular mechanisms responsible for maintaining genome stability remain incompletely understood. Here, we investigate the role of two E3 ligases, Dma1 and Dma2 (homologs of human RNF8), in the maintenance of genome stability in budding yeast. Using yeast spotting assays, chromatin immunoprecipitation and plasmid and chromosomal repair assays, we establish that Dma1 and Dma2 act in a redundant and a catalysis-dependent manner in the maintenance of genome stability, as well as localize to transcribed regions of the genome and increase in abundance upon phleomycin treatment. In addition, Dma1 and Dma2 are required for the normal kinetics of histone H4 acetylation under DNA damage conditions, genetically interact with RAD9 and SAE2, and are in a complex with Rad53 and histones. Taken together, our results demonstrate the requirement of Dma1 and Dma2 in regulating DNA repair pathway choice, preferentially affecting homologous recombination over nonhomologous end joining, and open up the possibility of using these candidates in manipulating the repair pathways toward precision genome editing.	[Yoblinski, Andrew R.; Chung, Seoyoung; Robinson, Sophie B.; Forester, Kaitlyn E.; Strahl, Brian D.; Dronamraju, Raghuvar] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA; [Strahl, Brian D.; Dronamraju, Raghuvar] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Strahl, Brian D.] Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill	Strahl, BD; Dronamraju, R (corresponding author), Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.; Strahl, BD; Dronamraju, R (corresponding author), Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA.; Strahl, BD (corresponding author), Univ N Carolina, Curriculum Genet & Mol Biol, Chapel Hill, NC 27515 USA.	brian_strahl@med.unc.edu; dronamra@email.unc.edu	Strahl, Brian D/C-7601-2012	Strahl, Brian D/0000-0002-4947-6259	National Institutes of Health [GM126900]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grant GM126900 to B. D. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100721	10.1016/j.jbc.2021.100721	http://dx.doi.org/10.1016/j.jbc.2021.100721			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933452	Green Published, gold			2022-12-28	WOS:000672866400691
J	Almubarak, A; Lavy, R; Srnic, N; Hu, YW; Maripuri, DP; Kume, T; Berry, FB				Almubarak, Asra; Lavy, Rotem; Srnic, Nikola; Hu, Yawen; Maripuri, Devi Priyanka; Kume, Tsutomo; Berry, Fred B.			Loss of Foxc1 and Foxc2 function in chondroprogenitor cells disrupts endochondral ossification	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE DIFFERENTIATION; SOX9; GROWTH; SKELETAL; EXPRESSION; MUTATIONS; PROLIFERATION; GENERATION; INDUCTION; DYSPLASIA	Endochondral ossification initiates the growth of the majority of the mammalian skeleton and is tightly controlled through gene regulatory networks. The forkhead box transcription factors Foxc1 and Foxc2 regulate aspects of osteoblast function in the formation of the skeleton, but their roles in chondrocytes to control endochondral ossification are less clear. Here, we demonstrate that Foxc1 expression is directly regulated by the activity of SRY (sex-determining region Y)-box 9, one of the earliest transcription factors to specify the chondrocyte lineage. Moreover, we demonstrate that elevated expression of Foxc1 promotes chondrocyte differentiation in mouse embryonic stem cells and loss of Foxc1 function inhibits chondrogenesis in vitro. Using chondrocyte-targeted deletion of Foxc1 and Foxc2 in mice, we reveal a role for these factors in chondrocyte differentiation in vivo. Loss of both Foxc1 and Foxc2 caused a general skeletal dysplasia predominantly affecting the vertebral column. The long bones of the limbs were smaller, mineralization was reduced, and organization of the growth plate was disrupted; in particular, the stacked columnar organization of the proliferative chondrocyte layer was reduced in size and cell proliferation was decreased. Differential gene expression analysis indicated disrupted expression patterns of chondrogenesis and ossification genes throughout the entire process of endochondral ossification in chondrocyte-specific Foxc1/Foxc2 KO embryos. Our results suggest that Foxc1 and Foxc2 are required for normal chondrocyte differentiation and function, as loss of both genes results in disorganization of the growth plate, reduced chondrocyte proliferation, and delays in chondrocyte hypertrophy that prevents ossification of the skeleton.	[Almubarak, Asra; Hu, Yawen; Maripuri, Devi Priyanka; Berry, Fred B.] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Lavy, Rotem; Srnic, Nikola; Berry, Fred B.] Univ Alberta, Dept Surg, Edmonton, AB, Canada; [Kume, Tsutomo] Northwestern Univ, Feinberg Sch Med, Feinberg Cardiovasc & Renal Res Inst, Dept Med, Chicago, IL 60611 USA	University of Alberta; University of Alberta; Northwestern University; Feinberg School of Medicine	Berry, FB (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.; Berry, FB (corresponding author), Univ Alberta, Dept Surg, Edmonton, AB, Canada.	fberry@ualberta.ca		Srnic, Nikola/0000-0003-0539-7046	Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-05085]; Women and Children's Health Research Institute; Edmonton Civic Employees Charitable Trust; Gilbert K. Winter Fund	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Women and Children's Health Research Institute; Edmonton Civic Employees Charitable Trust; Gilbert K. Winter Fund	This research was supported by grants awarded to F. B. B. from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2019-05085), the Women and Children's Health Research Institute, the Edmonton Civic Employees Charitable Trust, and the Gilbert K. Winter Fund.	Aghajanian P, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0021-z; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Bell DM, 1997, NAT GENET, V16, P174, DOI 10.1038/ng0697-174; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Berry FB, 2005, HUM MOL GENET, V14, P2619, DOI 10.1093/hmg/ddi295; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Caddy JC, 2020, J CELL BIOCHEM, V121, P3266, DOI 10.1002/jcb.29595; Correa-Cerro LS, 2011, SCI REP-UK, V1, DOI 10.1038/srep00167; Dy P, 2012, DEV CELL, V22, P597, DOI 10.1016/j.devcel.2011.12.024; Geister KA, 2015, ANNU REV GENOM HUM G, V16, P199, DOI 10.1146/annurev-genom-090314-045904; Hayashi H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002401; Hiemisch H, 1998, MECH DEVELOP, V73, P129, DOI 10.1016/S0925-4773(98)00039-2; Hong HK, 1999, HUM MOL GENET, V8, P625, DOI 10.1093/hmg/8.4.625; Hopkins A, 2017, MOL CANCER RES, V15, P1341, DOI 10.1158/1541-7786.MCR-17-0185; Hopkins A, 2016, J CELL BIOCHEM, V117, P1707, DOI 10.1002/jcb.25464; Karamboulas K, 2010, J CELL SCI, V123, P2067, DOI 10.1242/jcs.062901; Karp SJ, 2000, DEVELOPMENT, V127, P543; Kawaguchi J, 2005, BONE, V36, P758, DOI 10.1016/j.bone.2004.07.019; Kobayashi T, 2005, J CLIN INVEST, V115, P1734, DOI 10.1172/JCI24397; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Kume T, 1998, CELL, V93, P985, DOI 10.1016/S0092-8674(00)81204-0; Lefebvre V, 2001, OSTEOARTHR CARTILAGE, V9, pS69, DOI 10.1053/joca.2001.0447; Liu CF, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.164459; Liu CF, 2017, SEMIN CELL DEV BIOL, V62, P34, DOI 10.1016/j.semcdb.2016.10.004; Mizuhashi K, 2019, J BONE MINER RES, V34, P1387, DOI 10.1002/jbmr.3719; Murtaugh LC, 1999, GENE DEV, V13, P225, DOI 10.1101/gad.13.2.225; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Ohba S, 2015, CELL REP, V12, P229, DOI 10.1016/j.celrep.2015.06.013; Ono N, 2014, NAT CELL BIOL, V16, P1157, DOI 10.1038/ncb3067; Ornitz DM, 2015, GENE DEV, V29, P1463, DOI 10.1101/gad.266551.115; Ovchinnikov DA, 2000, GENESIS, V26, P145, DOI 10.1002/(SICI)1526-968X(200002)26:2<145::AID-GENE14>3.0.CO;2-C; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Rigueur D, 2014, METHODS MOL BIOL, V1130, P113, DOI 10.1007/978-1-62703-989-5_9; Sasman A, 2012, GENESIS, V50, P766, DOI 10.1002/dvg.22036; SHIANG R, 1994, CELL, V78, P335, DOI 10.1016/0092-8674(94)90302-6; Shih HP, 2015, CELL REP, V13, P326, DOI 10.1016/j.celrep.2015.08.082; Tang L, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0232-1; Terpstra L, 2003, J CELL BIOL, V162, P139, DOI 10.1083/jcb.200302066; WAGNER T, 1994, CELL, V79, P1111, DOI 10.1016/0092-8674(94)90041-8; Winnier GE, 1997, GENE DEV, V11, P926, DOI 10.1101/gad.11.7.926; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yoshida M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7653	42	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101020	10.1016/j.jbc.2021.101020	http://dx.doi.org/10.1016/j.jbc.2021.101020			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34331943	Green Submitted, Green Published, gold			2022-12-28	WOS:000706361700002
J	Bhattacharya, S; Lange, JJ; Levy, M; Florens, L; Washburn, MP; Workman, JL				Bhattacharya, Saikat; Lange, Jeffrey J.; Levy, Michaella; Florens, Laurence; Washburn, Michael P.; Workman, Jerry L.			The disordered regions of the methyltransferase SETD2 govern its function by regulating its proteolysis and phase separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; HISTONE H3K36 TRIMETHYLATION; MISMATCH REPAIR; UBIQUITIN; DEGRADATION; CELL; STABILITY; IDENTIFICATION; MUTATIONS; COMPARTMENTALIZATION	SETD2 is an important methyltransferase that methylates crucial substrates such as histone H3, tubulin, and STAT1 and also physically interacts with transcription and splicing regulators such as Pol II and various hnRNPs. Of note, SETD2 has a functionally uncharacterized extended N-terminal region, the removal of which leads to its stabilization. How this region regulates SETD2 half-life is unclear. Here we show that SETD2 consists of multiple long disordered regions across its length that cumulatively destabilize the protein by facilitating its proteasomal degradation. SETD2 disordered regions can reduce the half-life of the yeast homolog Set2 in mammalian cells as well as in yeast, demonstrating the importance of intrinsic structural features in regulating protein half-life. In addition to the shortened half-life, by performing fluorescence recovery after photobleaching assay we found that SETD2 forms liquid droplets in vivo, another property associated with proteins that contain disordered regions. The phase-separation behavior of SETD2 is exacerbated upon the removal of its N-terminal segment and results in activator-independent histone H3K36 methylation. Our findings reveal that disordered region-facilitated proteolysis is an important mechanism governing SETD2 function.	[Bhattacharya, Saikat; Workman, Jerry L.] Stowers Inst Med Res, Workman Lab, Kansas City, MO 64110 USA; [Lange, Jeffrey J.] Stowers Inst Med Res, Microscopy, Kansas City, MO USA; [Levy, Michaella; Florens, Laurence] Stowers Inst Med Res, Prote, Kansas City, MO USA; [Washburn, Michael P.] Univ Kansas, Med Ctr, Dept Canc Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; Stowers Institute for Medical Research; Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Workman, JL (corresponding author), Stowers Inst Med Res, Workman Lab, Kansas City, MO 64110 USA.	jlw@stowers.org	Bhattacharya, Saikat/AAK-7785-2021	Bhattacharya, Saikat/0000-0001-6028-4840	NIGMS, National Institutes of Health [R35GM118068]; Stowers Institute for Medical Research	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Stowers Institute for Medical Research	This work was supported by funding from the NIGMS, National Institutes of Health (grant no. R35GM118068) and the Stowers Institute for Medical Research to J. L. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al Sarakbi W, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-290; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Bemporad F, 2008, EMBO J, V27, P1525, DOI 10.1038/emboj.2008.82; Bhattacharya S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21663-w; Bhattacharya S, 2020, EPIGENET CHROMATIN, V13, DOI 10.1186/s13072-020-00362-8; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Chiang YC, 2018, CANCER RES, V78, P3135, DOI 10.1158/0008-5472.CAN-17-3460; Choi H, 2015, J PROTEOMICS, V129, P121, DOI 10.1016/j.jprot.2015.07.036; Ciechanover A, 2005, NAT REV MOL CELL BIO, V6, P79, DOI 10.1038/nrm1552; Ciechanover A, 2005, CELL DEATH DIFFER, V12, P1178, DOI 10.1038/sj.cdd.4401692; Cuevas-Velazquez CL, 2018, CURR OPIN PLANT BIOL, V45, P68, DOI 10.1016/j.pbi.2018.05.005; da Fonseca PCA, 2012, MOL CELL, V46, P54, DOI 10.1016/j.molcel.2012.03.026; Dhayalan A, 2010, J BIOL CHEM, V285, P26114, DOI 10.1074/jbc.M109.089433; Dronamraju R, 2018, NUCLEIC ACIDS RES, V46, P1331, DOI 10.1093/nar/gkx1276; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Duns G, 2010, CANCER RES, V70, P4287, DOI 10.1158/0008-5472.CAN-10-0120; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Florens Laurence, 2006, V328, P159; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Fontana Angelo, 2012, Methods Mol Biol, V896, P297, DOI 10.1007/978-1-4614-3704-8_20; Fuchs SM, 2012, J BIOL CHEM, V287, P3249, DOI 10.1074/jbc.M111.273953; Godderz D, 2011, J MOL BIOL, V407, P354, DOI 10.1016/j.jmb.2011.01.051; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hacker KE, 2016, J BIOL CHEM, V291, P21283, DOI 10.1074/jbc.M116.739375; Hahn S, 2018, CELL, V175, P1723, DOI 10.1016/j.cell.2018.11.034; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Huang YP, 2018, J BIOL CHEM, V293, P7811, DOI 10.1074/jbc.RA118.002839; Huang YQ, 2009, J MOL BIOL, V393, P1143, DOI 10.1016/j.jmb.2009.09.010; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lasker K, 2012, P NATL ACAD SCI USA, V109, P1380, DOI 10.1073/pnas.1120559109; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li J, 2016, NEOPLASIA, V18, P339, DOI 10.1016/j.neo.2016.04.005; Luco RF, 2010, SCIENCE, V327, P996, DOI 10.1126/science.1184208; Marchler-Bauer A, 2004, NUCLEIC ACIDS RES, V32, pW327, DOI 10.1093/nar/gkh454; McDonald WH, 2004, RAPID COMMUN MASS SP, V18, P2162, DOI 10.1002/rcm.1603; Melo SP, 2011, J BIOL CHEM, V286, P36559, DOI 10.1074/jbc.M111.274258; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Pfister SX, 2014, CELL REP, V7, P2006, DOI 10.1016/j.celrep.2014.05.026; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Razin SV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P643, DOI [10.31857/S0320972520060019, 10.1134/S0006297920060012]; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Rosenbaum JC, 2011, MOL CELL, V41, P93, DOI 10.1016/j.molcel.2010.12.004; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200; Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Strzyz P, 2018, NAT REV GENET, V19, P534, DOI [10.1038/s41576-018-0037-7, 10.1038/s41580-018-0039-5]; Su XP, 2017, CANCER RES, V77, P4835, DOI 10.1158/0008-5472.CAN-17-0143; Suskiewicz MJ, 2011, PROTEIN SCI, V20, P1285, DOI 10.1002/pro.657; Suzuki S, 2016, NUCLEIC ACIDS RES, V44, P4147, DOI 10.1093/nar/gkw008; Tabb DL, 2002, J PROTEOME RES, V1, P21, DOI 10.1021/pr015504q; Taylor NO, 2019, BIOPHYS J, V117, P1285, DOI 10.1016/j.bpj.2019.08.030; Tompa P, 2008, PROTEINS, V71, P903, DOI 10.1002/prot.21773; Uversky VN, 2017, CURR OPIN STRUC BIOL, V44, P18, DOI 10.1016/j.sbi.2016.10.015; van der Lee R, 2014, CELL REP, V8, P1832, DOI 10.1016/j.celrep.2014.07.055; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Verhoef LGGC, 2009, FASEB J, V23, P123, DOI 10.1096/fj.08-115055; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wang Y, 2015, NUCLEIC ACIDS RES, V43, P4881, DOI 10.1093/nar/gkv393; Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xu T, 2015, J PROTEOMICS, V129, P16, DOI 10.1016/j.jprot.2015.07.001; Yang CZ, 2012, FASEB J, V26, P4506, DOI 10.1096/fj.12-210146; Yen HCS, 2008, SCIENCE, V322, P918, DOI 10.1126/science.1160489; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Yuan HR, 2017, J CLIN INVEST, V127, P3381, DOI 10.1172/JCI94292; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang C, 2019, PROCEEDINGS OF THE TWENTY-EIGHTH INTERNATIONAL JOINT CONFERENCE ON ARTIFICIAL INTELLIGENCE, P4250, DOI [10.1109/IRMMW-THz.2019.8874219, 10.1007/s12083-018-0715-4]; Zhang Y, 2011, ANAL CHEM, V83, P9344, DOI 10.1021/ac201867h; Zhang Y, 2010, ANAL CHEM, V82, P2272, DOI 10.1021/ac9023999; Zhang Y, 2009, ANAL CHEM, V81, P6317, DOI 10.1021/ac9004887; Zhao ML, 2010, J BIOL CHEM, V285, P4771, DOI 10.1074/jbc.M109.060095; Zhu K, 2017, NUCLEIC ACIDS RES, V45, P92, DOI 10.1093/nar/gkw814; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	81	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101075	10.1016/j.jbc.2021.101075	http://dx.doi.org/10.1016/j.jbc.2021.101075			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34391778	Green Published, gold			2022-12-28	WOS:000714635500008
J	Haviland, ZK; Nong, DG; Kuntz, KLV; Starr, TJ; Ma, DB; Tien, M; Anderson, CT; Hancock, WO				Haviland, Zachary K.; Nong, Daguan; Kuntz, Kate L. Vasquez; Starr, Thomas J.; Ma, Dengbo; Tien, Ming; Anderson, Charles T.; Hancock, William O.			Nanoscale dynamics of cellulose digestion by the cellobiohydrolase TrCel7A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULE IMAGING ANALYSIS; MOVEMENT; BINDING; STATE; DISSOCIATION; PROCESSIVITY; HYDROLYSIS; CELLULASES; KINETICS; DOMAINS	Understanding the mechanism by which cellulases from bacteria, fungi, and protozoans catalyze the digestion of lignocellulose is important for developing cost-effective strategies for bioethanol production. Cel7A from the fungus Trichoderma reesei is a model exoglucanase that degrades cellulose strands from their reducing ends by processively cleaving individual cellobiose units. Despite being one of the most studied cellulases, the binding and hydrolysis mechanisms of Cel7A are still debated. Here, we used single-molecule tracking to analyze the dynamics of 11,116 quantum dot-labeled TrCel7A molecules binding to and moving processively along immobilized cellulose. Individual enzyme molecules were localized with a spatial precision of a few nanometers and followed for hundreds of seconds. Most enzyme molecules bound to cellulose in a static state and dissociated without detectable movement, whereas a minority of molecules moved processively for an average distance of 39 nm at an average speed of 3.2 nm/s. These data were integrated into a three-state model in which TrCel7A molecules can bind from solution into either static or processive states and can reversibly switch between states before dissociating. From these results, we conclude that the rate-limiting step for cellulose degradation by Cel7A is the transition out of the static state, either by dissociation from the cellulose surface or by initiation of a processive run. Thus, accelerating the transition of Cel7A out of its static state is a potential avenue for improving cellulase efficiency.	[Haviland, Zachary K.; Nong, Daguan; Hancock, William O.] Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA; [Kuntz, Kate L. Vasquez; Starr, Thomas J.; Anderson, Charles T.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Ma, Dengbo; Tien, Ming] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Hancock, WO (corresponding author), Penn State Univ, Dept Biomed Engn, University Pk, PA 16802 USA.	woh1@psu.edu	Hancock, William/E-7653-2016	Hancock, William/0000-0001-5547-8755; Anderson, Charles/0000-0001-7481-3571	Department of Energy Office of Science [DE-SC0019065, DE-SC0019364]	Department of Energy Office of Science(United States Department of Energy (DOE))	The authors thank Dannielle Gibson for technical assistance, Scott Pflumm for work in establishing the single-molecule assays, and Haw Yang for support. The authors also thank the Penn State CSL Behring Fermentation Facility-University Park, PA for assistance with cellulose preparation. This work was supported by the Department of Energy Office of Science grant number DE-SC0019065 and DE-SC0019364.	Asztalos A, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-55; Bae SO, 2005, APPL MICROBIOL BIOT, V67, P45, DOI 10.1007/s00253-004-1723-2; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Berg, 2018, RANDOM WALKS BIOL; BLOCK SM, 1990, NATURE, V348, P348, DOI 10.1038/348348a0; Brady SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10149; Carpita NC, 2020, J BIOL CHEM, V295, P15144, DOI 10.1074/jbc.REV120.014561; Carroll A, 2009, ANNU REV PLANT BIOL, V60, P165, DOI 10.1146/annurev.arplant.043008.092125; Cruys-Bagger N, 2012, J BIOL CHEM, V287, P18451, DOI 10.1074/jbc.M111.334946; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; DONER LW, 1992, ANAL BIOCHEM, V202, P50, DOI 10.1016/0003-2697(92)90204-K; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; DUCHESNE LC, 1989, BIOSCIENCE, V39, P238, DOI 10.2307/1311160; Fersht A., 1999, STRUCTURE MECH PROTE; Harris D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002897; HESTRIN S, 1954, BIOCHEM J, V58, P345, DOI 10.1042/bj0580345; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Jeoh T, 2017, BIOTECHNOL BIOENG, V114, P1369, DOI 10.1002/bit.26277; Jervis EJ, 1997, J BIOL CHEM, V272, P24016, DOI 10.1074/jbc.272.38.24016; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kongruang S, 2004, APPL BIOCHEM BIOTECH, V113, P213, DOI 10.1385/ABAB:113:1-3:213; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Kuusk S, 2015, J BIOL CHEM, V290, P11678, DOI 10.1074/jbc.M114.635631; Leduc C, 2007, P NATL ACAD SCI USA, V104, P10847, DOI 10.1073/pnas.0701B64104; Mahamdeh M, 2018, J MICROSC-OXFORD, V272, P60, DOI 10.1111/jmi.12744; Mudinoor AR, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-1649-7; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura A, 2016, J BIOL CHEM, V291, P22404, DOI 10.1074/jbc.M116.752048; Nong DG, 2021, BIOMED OPT EXPRESS, V12, P3253, DOI 10.1364/BOE.423798; Park S, 2010, BIOTECHNOL BIOFUELS, V3, DOI 10.1186/1754-6834-3-10; Peri S, 2007, BIOTECHNOL PROGR, V23, P626, DOI 10.1021/bp060322s; Rojel N, 2020, J BIOL CHEM, V295, P1454, DOI 10.1074/jbc.RA119.011420; Ruhnow F, 2011, BIOPHYS J, V100, P2820, DOI 10.1016/j.bpj.2011.04.023; Shang BZ, 2013, J BIOL CHEM, V288, P29081, DOI 10.1074/jbc.M113.497412; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; Simmert S, 2018, OPT EXPRESS, V26, P14499, DOI 10.1364/OE.26.014499; Vermaas JV, 2019, P NATL ACAD SCI USA, V116, P23061, DOI 10.1073/pnas.1913398116; Woody MS, 2016, BIOPHYS J, V111, P273, DOI 10.1016/j.bpj.2016.06.019	40	0	0	0	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101029	10.1016/j.jbc.2021.101029	http://dx.doi.org/10.1016/j.jbc.2021.101029			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339742	gold, Green Published			2022-12-28	WOS:000706408900001
J	Snyder, NA; Silva, GM				Snyder, Nathan A.; Silva, Gustavo M.			Deubiquitinating enzymes (DUBs): Regulation, homeostasis, and oxidative stress response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; CELL-CYCLE PROGRESSION; CARBOXYL-TERMINAL HYDROLASE; PROTEIN CYSTEINE OXIDATION; MACHADO-JOSEPH-DISEASE; TUMOR-SUPPRESSOR CYLD; DNA-DAMAGE-RESPONSE; SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; UBIQUITIN CHAINS	Ubiquitin signaling is a conserved, widespread, and dynamic process in which protein substrates are rapidly modified by ubiquitin to impact protein activity, localization, or stability. To regulate this process, deubiquitinating enzymes (DUBs) counter the signal induced by ubiquitin conjugases and ligases by removing ubiquitin from these substrates. Many DUBs selectively regulate physiological pathways employing conserved mechanisms of ubiquitin bond cleavage. DUB activity is highly regulated in dynamic environments through protein-protein interaction, posttranslational modification, and relocalization. The largest family of DUBs, cysteine pro teases, are also sensitive to regulation by oxidative stress, as reactive oxygen species (ROS) directly modify the catalytic cysteine required for their enzymatic activity. Current research has implicated DUB activity in human diseases, including various cancers and neurodegenerative disorders. Due to their selectivity and functional roles, DUBs have become important targets for therapeutic development to treat these conditions. This review will discuss the main classes of DUBs and their regulatory mechanisms with a particular focus on DUB redox regulation and its physiological impact during oxidative stress.	[Snyder, Nathan A.; Silva, Gustavo M.] Duke Univ, Dept Biol, Durham, NC 27708 USA	Duke University	Silva, GM (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	gustavo.silva@duke.edu		Snyder, Nathan/0000-0001-9204-8420	US National Institutes of Health R35 Award [GM137954]	US National Institutes of Health R35 Award	This work was supported by the US National Institutes of Health R35 Award GM137954 (G. M. S.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe J, 2013, CIRC RES, V112, P1526, DOI 10.1161/CIRCRESAHA.113.301518; Akimov V, 2018, NAT STRUCT MOL BIOL, V25, P631, DOI 10.1038/s41594-018-0084-y; Akutsu M, 2016, J CELL SCI, V129, P875, DOI 10.1242/jcs.183954; Albrecht M, 2004, EUR J BIOCHEM, V271, P3155, DOI 10.1111/j.1432-1033.2004.04245.x; Alexopoulou Z, 2016, P NATL ACAD SCI USA, V113, pE4688, DOI 10.1073/pnas.1523597113; Alvarez V, 2016, SCI REP-UK, V6, DOI 10.1038/srep25513; Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Amer-Sarsour F, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03361-5; Amerik AY, 2004, BBA-MOL CELL RES, V1695, P189, DOI 10.1016/j.bbamcr.2004.10.003; Amm I, 2014, BBA-MOL CELL RES, V1843, P182, DOI 10.1016/j.bbamcr.2013.06.031; An T, 2017, BIOCHEM PHARMACOL, V131, P29, DOI 10.1016/j.bcp.2017.02.011; Angelova PR, 2018, FEBS LETT, V592, P692, DOI 10.1002/1873-3468.12964; Arceci A, 2019, CELL REP, V26, P3076, DOI 10.1016/j.celrep.2019.02.054; Arendt CS, 1999, EMBO J, V18, P3575, DOI 10.1093/emboj/18.13.3575; Aron R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05653-z; Auten RL, 2009, PEDIATR RES, V66, P121, DOI 10.1203/PDR.0b013e3181a9eafb; Back S, 2019, J PROTEOME RES, V18, P309, DOI 10.1021/acs.jproteome.8b00623; BAKER RT, 1991, NUCLEIC ACIDS RES, V19, P1035, DOI 10.1093/nar/19.5.1035; Balut CM, 2011, FASEB J, V25, P3938, DOI 10.1096/fj.11-187005; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Berlin I, 2010, J BIOL CHEM, V285, P34909, DOI 10.1074/jbc.M109.016287; BEYER RE, 1994, J BIOENERG BIOMEMBR, V26, P349, DOI 10.1007/BF00762775; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Blount JR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5638; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; Boudreaux DA, 2010, P NATL ACAD SCI USA, V107, P9117, DOI 10.1073/pnas.0910870107; Brandman O, 2012, CELL, V151, P1042, DOI 10.1016/j.cell.2012.10.044; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Brinkmann K, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00098; Bushman JW, 2021, CELL CHEM BIOL, V28, P78, DOI 10.1016/j.chembiol.2020.09.005; Butterworth MB, 2007, J BIOL CHEM, V282, P37885, DOI 10.1074/jbc.M707989200; Callis Judy, 2014, Arabidopsis Book, V12, pe0174, DOI 10.1199/tab.0174; Chakraborty J, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00535; Chen LH, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/1809592; Chen L, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0196-9; Cheng J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068001; Cho JH, 2021, CELL DEATH DIFFER, V28, P900, DOI 10.1038/s41418-020-00649-z; Chung HS, 2013, CIRC RES, V112, P382, DOI 10.1161/CIRCRESAHA.112.268680; Clague MJ, 2006, TRENDS CELL BIOL, V16, P551, DOI 10.1016/j.tcb.2006.09.002; Clague MJ, 2017, FEBS J, V284, P1753, DOI 10.1111/febs.14007; Clague MJ, 2013, NATURE, V497, P49, DOI 10.1038/497049a; Cohn MA, 2007, MOL CELL, V28, P786, DOI 10.1016/j.molcel.2007.09.031; Cohn MA, 2009, J BIOL CHEM, V284, P5343, DOI 10.1074/jbc.M808430200; Cotto-Rios XM, 2012, CELL REP, V2, P1475, DOI 10.1016/j.celrep.2012.11.011; Cotto-Rios XM, 2011, CELL CYCLE, V10, P4009, DOI 10.4161/cc.10.23.18501; Cui L, 2020, AGING-US, V12, P23082, DOI 10.18632/aging.104067; Cunha-Oliveira T, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/5021694; Cunningham CN, 2015, NAT CELL BIOL, V17, P160, DOI 10.1038/ncb3097; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; Damgaard RB, 2016, CELL, V166, P1215, DOI 10.1016/j.cell.2016.07.019; Das S, 2020, MOL CELLS, V43, P203, DOI 10.14348/molcells.2020.2289; Das T, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114028; Davies CW, 2013, BIOCHEMISTRY-US, V52, P7818, DOI 10.1021/bi401106b; Davies CW, 2011, J MOL BIOL, V413, P416, DOI 10.1016/j.jmb.2011.08.029; de Poot SAH, 2017, J MOL BIOL, V429, P3525, DOI 10.1016/j.jmb.2017.09.015; Defelipe LA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004051; Devarie-Baez NO, 2016, FREE RADICAL RES, V50, P172, DOI 10.3109/10715762.2015.1090571; Dietachmayr M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15059-5; Ding QX, 2001, J NEUROCHEM, V77, P1010, DOI 10.1046/j.1471-4159.2001.00302.x; Dittmar G, 2020, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00915; Doris KS, 2012, MOL CELL BIOL, V32, P4472, DOI 10.1128/MCB.00559-12; Dougherty SE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031151; Durcan TM, 2011, HUM MOL GENET, V20, P141, DOI 10.1093/hmg/ddq452; Edelmann MJ, 2009, BIOCHEM J, V418, P379, DOI 10.1042/BJ20081318; Eletr ZM, 2014, BBA-MOL CELL RES, V1843, P114, DOI 10.1016/j.bbamcr.2013.06.027; Emami S, 2011, CLIN RES HEPATOL GAS, V35, P98, DOI 10.1016/j.gcb.2010.10.002; Enesa K, 2008, J BIOL CHEM, V283, P18582, DOI 10.1074/jbc.M801312200; Ernst R, 2009, MOL CELL, V36, P28, DOI 10.1016/j.molcel.2009.09.016; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Evert BO, 2006, J NEUROSCI, V26, P11474, DOI 10.1523/JNEUROSCI.2053-06.2006; Fan YH, 2011, CELL DEATH DIFFER, V18, P1547, DOI 10.1038/cdd.2011.11; Fang NN, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12907; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Foot N, 2017, PHYSIOL REV, V97, P253, DOI 10.1152/physrev.00012.2016; Forman HJ, 2017, ARCH BIOCHEM BIOPHYS, V617, P26, DOI 10.1016/j.abb.2016.09.013; Fotedar A, 1996, J BIOL CHEM, V271, P31627, DOI 10.1074/jbc.271.49.31627; Fraile JM, 2012, ONCOGENE, V31, P2373, DOI 10.1038/onc.2011.443; Fujita H, 2013, J CELL SCI, V126, P2798, DOI 10.1242/jcs.119909; Garshott DM, 2020, ELIFE, V9, DOI 10.7554/eLife.54023; Ge CM, 2015, P NATL ACAD SCI USA, V112, pE1210, DOI 10.1073/pnas.1418335112; Ge F, 2015, ONCOTARGET, V6, P21369, DOI 10.18632/oncotarget.4128; George AJ, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00029; Gersch M, 2019, MOL CELL, V74, P436, DOI 10.1016/j.molcel.2019.02.030; Gersch M, 2017, NAT STRUCT MOL BIOL, V24, P920, DOI 10.1038/nsmb.3475; Gorrepati KDD, 2018, ISCIENCE, V1, P72, DOI 10.1016/j.isci.2018.02.003; Grou CP, 2015, SCI REP-UK, V5, DOI 10.1038/srep12836; Guevara-Garcia M, 2012, REDOX REP, V17, P84, DOI 10.1179/1351000212Y.0000000005; Guo YY, 2021, CELL MOL IMMUNOL, V18, P1945, DOI 10.1038/s41423-020-00531-5; Gupta V, 2014, BBA-GEN SUBJECTS, V1840, P847, DOI 10.1016/j.bbagen.2013.05.040; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Haglund K, 2005, EMBO J, V24, P3353, DOI 10.1038/sj.emboj.7600808; Hanna J, 2007, CELL, V129, P747, DOI 10.1016/j.cell.2007.03.042; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Harreman MT, 2004, J BIOL CHEM, V279, P20613, DOI 10.1074/jbc.M401720200; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; Hassink GC, 2009, EMBO REP, V10, P755, DOI 10.1038/embor.2009.69; He L, 2017, CELL PHYSIOL BIOCHEM, V44, P532, DOI 10.1159/000485089; He MJ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0127-1; Hendriks IA, 2014, NAT STRUCT MOL BIOL, V21, P927, DOI 10.1038/nsmb.2890; Herhaus L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0441; Heride C, 2016, J CELL SCI, V129, P4001, DOI 10.1242/jcs.188516; Hernandez-Perez S, 2016, MOL ONCOL, V10, P1196, DOI 10.1016/j.molonc.2016.05.008; Herrmann J, 2007, CIRC RES, V100, P1276, DOI 10.1161/01.RES.0000264500.11888.f0; Hodul Molly, 2017, Front Synaptic Neurosci, V9, P16, DOI 10.3389/fnsyn.2017.00016; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Hu HB, 2013, NATURE, V494, P371, DOI 10.1038/nature11831; Hu M, 2002, CELL, V111, P1041, DOI 10.1016/S0092-8674(02)01199-6; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang OW, 2012, NAT STRUCT MOL BIOL, V19, P171, DOI 10.1038/nsmb.2206; Huang TT, 2006, NAT CELL BIOL, V8, P339, DOI 10.1038/ncb1378; Huang XD, 2011, MOL CELL, V42, P511, DOI 10.1016/j.molcel.2011.03.027; Hurley JH, 2011, ANNU REV BIOPHYS, V40, P119, DOI 10.1146/annurev-biophys-042910-155404; Husnjak K, 2012, ANNU REV BIOCHEM, V81, P291, DOI 10.1146/annurev-biochem-051810-094654; Hutti JE, 2009, MOL CELL, V34, P461, DOI 10.1016/j.molcel.2009.04.031; James C, 2018, STEM CELLS, V36, P1170, DOI 10.1002/stem.2830; Jiang XX, 2015, SCI REP-UK, V5, DOI 10.1038/srep13755; Johnston SC, 1999, EMBO J, V18, P3877, DOI 10.1093/emboj/18.14.3877; Johnston SC, 1997, EMBO J, V16, P3787, DOI 10.1093/emboj/16.13.3787; Kahles T, 2021, CELL MOL LIFE SCI, V78, P2169, DOI 10.1007/s00018-020-03625-5; Kapadia B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03028-y; Kapadia BB, 2019, MOL CANCER THER, V18, P1475, DOI 10.1158/1535-7163.MCT-19-0307; Kashiwaba S, 2015, CELL REP, V13, P2072, DOI 10.1016/j.celrep.2015.11.014; Kato K, 2014, MOL CELL, V53, P617, DOI 10.1016/j.molcel.2014.01.030; KAWAGUCHI Y, 1994, NAT GENET, V8, P221, DOI 10.1038/ng1194-221; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Kee Y, 2006, J BIOL CHEM, V281, P36724, DOI 10.1074/jbc.M608756200; Kee Y, 2016, MOL CELL BIOL, V36, P524, DOI 10.1128/MCB.00847-15; Kee Y, 2010, J BIOL CHEM, V285, P11252, DOI 10.1074/jbc.M109.095141; Kessler BM, 2011, CELL BIOCHEM BIOPHYS, V60, P21, DOI 10.1007/s12013-011-9176-6; Khoronenkova SV, 2012, MOL CELL, V45, P801, DOI 10.1016/j.molcel.2012.01.021; Kim W, 2011, MOL CELL, V44, P325, DOI 10.1016/j.molcel.2011.08.025; Kirschner LS, 2000, BIOCHEM BIOPH RES CO, V270, P1106, DOI 10.1006/bbrc.2000.2568; Kliza K, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00021; Kobayashi T, 2015, ONCOGENE, V34, P2251, DOI 10.1038/onc.2014.159; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Komander D, 2010, SUBCELL BIOCHEM, V54, P69, DOI 10.1007/978-1-4419-6676-6_6; Komander D, 2010, MOL CELL, V37, P589, DOI 10.1016/j.molcel.2010.02.017; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Koulich E, 2008, MOL BIOL CELL, V19, P1072, DOI 10.1091/mbc.E07-10-1040; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Kowalski JR, 2012, NEURAL PLAST, V2012, DOI 10.1155/2012/892749; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Krassikova L, 2021, CELL DEATH DIFFER, V28, P1091, DOI 10.1038/s41418-020-00639-1; Kulathu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2567; Kummari E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135531; Kwasna D, 2018, MOL CELL, V70, P150, DOI 10.1016/j.molcel.2018.02.023; Lam MHY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075372; Lanz MC, 2021, EMBO REP, V22, DOI 10.15252/embr.202051121; Larsen CN, 1998, BIOCHEMISTRY-US, V37, P3358, DOI 10.1021/bi972274d; Lee BH, 2010, NATURE, V467, P179, DOI 10.1038/nature09299; Lee JH, 2017, NAT CELL BIOL, V19, P1260, DOI 10.1038/ncb3609; Lee JG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2532; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lee Min Jae, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.R110.003871; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Li H, 2016, MOL CELL, V63, P249, DOI 10.1016/j.molcel.2016.05.031; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Li X, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14866; Li XY, 2018, BIOCHEM BIOPH RES CO, V505, P113, DOI 10.1016/j.bbrc.2018.09.071; Li YH, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/3982906; Li Y, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22030986; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Li ZX, 2018, NUCLEIC ACIDS RES, V46, P823, DOI 10.1093/nar/gkx1226; Liang JR, 2015, EMBO REP, V16, P618, DOI 10.15252/embr.201439820; Liguori I, 2018, CLIN INTERV AGING, V13, P757, DOI 10.2147/CIA.S158513; Lim R, 2019, SCIENCE, V364, P188, DOI 10.1126/science.aat0778; Lin SC, 2008, J MOL BIOL, V376, P526, DOI 10.1016/j.jmb.2007.11.092; Liu B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07510-5; Liu YL, 2009, AM J PATHOL, V174, P1415, DOI 10.2353/ajpath.2009.080861; Livneh I, 2016, CELL RES, V26, P869, DOI 10.1038/cr.2016.86; Lu D, 2018, J AUTOIMMUN, V94, P156, DOI 10.1016/j.jaut.2018.07.019; Lu Y, 2009, MOL CELL BIOL, V29, P547, DOI 10.1128/MCB.00329-08; Luo HK, 2021, ACTA PHYSIOL, V232, DOI 10.1111/apha.13666; Ma JY, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03001-y; Mahboubi H, 2017, BBA-MOL BASIS DIS, V1863, P884, DOI 10.1016/j.bbadis.2016.12.022; Maiti TK, 2011, FEBS J, V278, P4917, DOI 10.1111/j.1742-4658.2011.08393.x; Manohar S, 2019, ANTIOXID REDOX SIGN, V31, P1133, DOI 10.1089/ars.2019.7826; Martins CS, 2020, HORM METAB RES, V52, P117, DOI 10.1055/a-1089-7806; Mashtalir N, 2014, MOL CELL, V54, P392, DOI 10.1016/j.molcel.2014.03.002; Masoomian B, 2018, J CURR OPHTHALMOL, V30, P102, DOI 10.1016/j.joco.2018.02.005; Maurer T, 2016, MOL CELL, V63, P4, DOI 10.1016/j.molcel.2016.06.027; McClellan AJ, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190147; McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073; McCullough J, 2004, J CELL BIOL, V166, P487, DOI 10.1083/jcb.200401141; McDonell LM, 2013, NAT GENET, V45, P556, DOI 10.1038/ng.2602; Meijer IMJ, 2013, CELL SIGNAL, V25, P919, DOI 10.1016/j.cellsig.2013.01.003; Meray RK, 2007, J BIOL CHEM, V282, P10567, DOI 10.1074/jbc.M611153200; Metzger MB, 2014, BBA-MOL CELL RES, V1843, P47, DOI 10.1016/j.bbamcr.2013.05.026; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Meyer C, 2020, MOL CELL, V77, P1193, DOI 10.1016/j.molcel.2019.12.024; Millard SM, 2006, J CELL BIOL, V173, P463, DOI 10.1083/jcb.200602082; Mines MA, 2009, J BIOL CHEM, V284, P5742, DOI 10.1074/jbc.M808507200; Mueller T, 2009, HUM MOL GENET, V18, P3334, DOI 10.1093/hmg/ddp274; Nakae A, 2021, BIOCHEM BIOPH RES CO, V552, P120, DOI 10.1016/j.bbrc.2021.03.049; Nakajima S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084899; Nanao MH, 2004, EMBO REP, V5, P783, DOI 10.1038/sj.embor.7400201; Nijman SMB, 2005, MOL CELL, V17, P331, DOI 10.1016/j.molcel.2005.01.008; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nino CA, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10111548; Nishi R, 2014, NAT CELL BIOL, V16, P1016, DOI 10.1038/ncb3028; Nonhoff U, 2007, MOL BIOL CELL, V18, P1385, DOI 10.1091/mbc.E06-12-1120; Nostramo R, 2016, CURR GENET, V62, P503, DOI 10.1007/s00294-016-0571-9; Obin M, 1998, FASEB J, V12, P561, DOI 10.1096/fasebj.12.7.561; Ohtake F, 2017, J BIOCHEM, V161, P125, DOI 10.1093/jb/mvw088; Okino Y, 2015, J BIOL CHEM, V290, P1580, DOI 10.1074/jbc.M114.609834; Otten EG, 2021, NATURE, V594, P111, DOI 10.1038/s41586-021-03566-4; Paemka L, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005022; Pan YB, 2014, CANCER BIOL THER, V15, P256, DOI 10.4161/cbt.27823; Park CW, 2014, BMB REP, V47, P475, DOI 10.5483/BMBRep.2014.47.9.128; Park SY, 2015, CANCER LETT, V357, P419, DOI 10.1016/j.canlet.2014.12.005; Parsons JL, 2011, MOL CELL, V41, P609, DOI 10.1016/j.molcel.2011.02.016; Peschiaroli A, 2010, ONCOGENE, V29, P1384, DOI 10.1038/onc.2009.430; Pfeiffer A, 2017, EMBO J, V36, P1066, DOI 10.15252/embj.201695151; Pfoh R, 2015, ENDOCR-RELAT CANCER, V22, pT35, DOI 10.1530/ERC-14-0516; PICKART CM, 1985, J BIOL CHEM, V260, P7903; PICKART CM, 1986, J BIOL CHEM, V261, P210; Piper RC, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016808; Pisareva VP, 2011, EMBO J, V30, P1804, DOI 10.1038/emboj.2011.93; Pozhidaeva A, 2019, DNA REPAIR, V76, P30, DOI 10.1016/j.dnarep.2019.02.005; Protter DSW, 2016, TRENDS CELL BIOL, V26, P668, DOI 10.1016/j.tcb.2016.05.004; Pruneda JN, 2019, METHOD ENZYMOL, V618, P321, DOI 10.1016/bs.mie.2019.01.001; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; RECHSTEINER M, 1987, ANNU REV CELL BIOL, V3, P1, DOI 10.1146/annurev.cb.03.110187.000245; REDMAN KL, 1989, NATURE, V338, P438, DOI 10.1038/338438a0; Rehman SAA, 2016, MOL CELL, V63, P146, DOI 10.1016/j.molcel.2016.05.009; Reiley W, 2005, MOL CELL BIOL, V25, P3886, DOI 10.1128/MCB.25.10.3886-3895.2005; Reina CP, 2010, HUM MOL GENET, V19, P235, DOI 10.1093/hmg/ddp482; Renatus M, 2006, STRUCTURE, V14, P1293, DOI 10.1016/j.str.2006.06.012; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Riccio V, 2019, J CELL BIOL, V218, P798, DOI 10.1083/jcb.201804172; Rodrigues AJ, 2010, BBA-MOL CELL RES, V1803, P1154, DOI 10.1016/j.bbamcr.2010.07.004; Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200; Ronau JA, 2016, CELL RES, V26, P441, DOI 10.1038/cr.2016.38; Row PE, 2006, J BIOL CHEM, V281, P12618, DOI 10.1074/jbc.M512615200; Rowinsky EK, 2020, INVEST NEW DRUG, V38, P1448, DOI 10.1007/s10637-020-00915-4; Sadler JBA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40596-5; Sahtoe DD, 2015, TRENDS BIOCHEM SCI, V40, P456, DOI 10.1016/j.tibs.2015.05.002; Santos AL, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/1941285; Sapmaz A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09437-x; Sarkari F, 2010, J MOL BIOL, V402, P825, DOI 10.1016/j.jmb.2010.08.017; Sauer F, 2019, MOL CELL, V74, P421, DOI 10.1016/j.molcel.2019.02.029; Savio MG, 2016, CURR BIOL, V26, P173, DOI 10.1016/j.cub.2015.11.050; Schauer NJ, 2020, J MED CHEM, V63, P2731, DOI 10.1021/acs.jmedchem.9b01138; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Seki T, 2013, J BIOL CHEM, V288, P17145, DOI 10.1074/jbc.M113.463406; Shackleford TJ, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-26; Shan HZ, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0028-3; Shang F, 2011, FREE RADICAL BIO MED, V51, P5, DOI 10.1016/j.freeradbiomed.2011.03.031; Sharma A, 2018, AUTOPHAGY, V14, P1976, DOI 10.1080/15548627.2018.1496877; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shoemaker CJ, 2010, SCIENCE, V330, P369, DOI 10.1126/science.1192430; Shrestha RK, 2014, BIOCHEMISTRY-US, V53, P3199, DOI 10.1021/bi5003162; Silva GM, 2015, NAT STRUCT MOL BIOL, V22, P116, DOI 10.1038/nsmb.2955; Simoes V., 2021, REDOX SENSITIVE E2 R; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stewart MD, 2016, CELL RES, V26, P423, DOI 10.1038/cr.2016.35; Sun SC, 2010, CELL DEATH DIFFER, V17, P25, DOI 10.1038/cdd.2009.43; Suresh HG, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200279; Suzuki M, 2009, ENDOCRINOLOGY, V150, P5230, DOI 10.1210/en.2009-0332; Swatek KN, 2016, CELL RES, V26, P399, DOI 10.1038/cr.2016.39; Takehara Y, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102145; Tanaka K, 2009, P JPN ACAD B-PHYS, V85, P12, DOI [10.2183/pjab.85.12, 10.2183/pjab/85.12]; Tang LJ, 2016, GENE, V578, P92, DOI 10.1016/j.gene.2015.12.006; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tanno H, 2014, J BIOL CHEM, V289, P2415, DOI 10.1074/jbc.M113.528372; Tolay N, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000927; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Trachootham D, 2008, ANTIOXID REDOX SIGN, V10, P1343, DOI 10.1089/ars.2007.1957; Tran HJTT, 2003, BIOCHEMISTRY-US, V42, P11460, DOI 10.1021/bi035033g; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Turell L, 2020, ESSAYS BIOCHEM, V64, P55, DOI 10.1042/EBC20190053; Udeshi ND, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14175-1; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; VanderLinden RT, 2015, MOL CELL, V57, P901, DOI 10.1016/j.molcel.2015.01.016; Ventii KH, 2008, BIOCHEM J, V414, P161, DOI 10.1042/BJ20080798; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Wang B, 2009, GENE DEV, V23, P729, DOI 10.1101/gad.1770309; Wang P, 2020, MOL BIOL CELL, V31, P2139, DOI 10.1091/mbc.E20-03-0168; Wang W, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/2509529; Wang WJ, 2016, MOL CARCINOGEN, V55, P1329, DOI 10.1002/mc.22376; Wang X, 2015, CHEM BIOL DRUG DES, V86, P1036, DOI 10.1111/cbdd.12571; Wang XJ, 2018, MED SCI MONITOR, V24, P1742, DOI 10.12659/MSM.909368; WATSON DC, 1978, NATURE, V276, P196, DOI 10.1038/276196a0; Wickstrom SA, 2010, EMBO J, V29, P131, DOI 10.1038/emboj.2009.317; Winklhofer KF, 2010, BBA-MOL BASIS DIS, V1802, P29, DOI 10.1016/j.bbadis.2009.08.013; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wolberger C, 2014, PROTEIN SCI, V23, P344, DOI 10.1002/pro.2415; Worden EJ, 2017, MOL CELL, V67, P799, DOI 10.1016/j.molcel.2017.07.023; Wu M, 2017, ONCOTARGET, V8, P2197, DOI 10.18632/oncotarget.11116; Wu Q, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100466; Xia YF, 2014, CANCER IMMUNOL RES, V2, P823, DOI 10.1158/2326-6066.CIR-14-0112; Xiao N, 2012, BIOCHEM J, V441, P979, DOI 10.1042/BJ20111358; Xu D, 2015, ELIFE, V4, DOI 10.7554/eLife.10510; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yan KW, 2015, J CELL BIOL, V210, P209, DOI 10.1083/jcb.201503039; Yang J, 2015, J IMMUNOL, V194, P4094, DOI 10.4049/jimmunol.1401451; Yao TT, 2006, NAT CELL BIOL, V8, P994, DOI 10.1038/ncb1460; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Yeh C, 2015, CURR BIOL, V25, P2290, DOI 10.1016/j.cub.2015.07.025; Yin JP, 2015, STRUCTURE, V23, P2043, DOI 10.1016/j.str.2015.08.010; Yu H, 2014, P NATL ACAD SCI USA, V111, P285, DOI 10.1073/pnas.1309085110; Yu H, 2010, MOL CELL BIOL, V30, P5071, DOI 10.1128/MCB.00396-10; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Yun SI, 2015, MOL ONCOL, V9, P1834, DOI 10.1016/j.molonc.2015.06.006; Zhang D, 2006, CELL, V126, P529, DOI 10.1016/j.cell.2006.06.039; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965; Zhang L, 2012, NAT CELL BIOL, V14, P717, DOI 10.1038/ncb2522; Zhang WF, 2011, BIOCHEMISTRY-US, V50, P4775, DOI 10.1021/bi101958h; Zhang XN, 2011, EMBO J, V30, P2177, DOI 10.1038/emboj.2011.125; Zhang ZK, 2020, MOL CELL, V79, P304, DOI 10.1016/j.molcel.2020.06.020; Zheng HY, 2017, CARCINOGENESIS, V38, P1196, DOI 10.1093/carcin/bgx100; Zheng N, 2017, ANNU REV BIOCHEM, V86, P129, DOI 10.1146/annurev-biochem-060815-014922; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708; Zhong XY, 2006, HUM MOL GENET, V15, P2409, DOI 10.1093/hmg/ddl164; Zhou FF, 2016, J BONE MINER RES, V31, P1888, DOI 10.1002/jbmr.2863; Zhou XF, 2019, NAT IMMUNOL, V20, P879, DOI 10.1038/s41590-019-0405-2; Zhou Y, 2020, P NATL ACAD SCI USA, V117, P22157, DOI 10.1073/pnas.2005301117; Zhu P, 2007, MOL CELL, V27, P609, DOI 10.1016/j.molcel.2007.07.024	326	15	16	6	24	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101077	10.1016/j.jbc.2021.101077	http://dx.doi.org/10.1016/j.jbc.2021.101077			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34391779	gold, Green Published			2022-12-28	WOS:000706409200002
J	Smith, EM; Mondragon, A				Smith, Eric M.; Mondragon, Alfonso			Basic residues at the C-gate of DNA gyrase are involved in DNA supercoiling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOPOISOMERASE-II; CRYSTAL-STRUCTURE; STRAND PASSAGE; MECHANISM; TRANSPORT; BINDING; ROLES; STEP	DNA gyrase is a type II topoisomerase that is responsible for maintaining the topological state of bacterial and some archaeal genomes. It uses an ATP-dependent two-gate strand passage mechanism that is shared among all type II topoisomerases. During this process, DNA gyrase creates a transient break in the DNA, the G-segment, to form a cleavage complex. This allows a second DNA duplex, known as the T segment, to pass through the broken G-segment. After the broken strand is religated, the T-segment is able to exit out of the enzyme through a gate called the C-gate. Although many steps of the type II topoisomerase mechanism have been studied extensively, many questions remain about how the T segment ultimately exits out of the C-gate. A recent cryo-EM structure of Streptococcus pneumoniae GyrA shows a putative T-segment in close proximity to the C-gate, suggesting that residues in this region may be important for coordinating DNA exit from the enzyme. Here, we show through site-directed mutagenesis and biochemical characterization that three conserved basic residues in the C-gate of DNA gyrase are important for DNA supercoiling activity, but not for ATPase or cleavage activity. Together with the structural information previously published, our data suggest a model in which these residues cluster to form a positively charged region that facilitates T-segment passage into the cavity formed between the DNA gate and C-gate.	[Smith, Eric M.; Mondragon, Alfonso] Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA	Northwestern University	Mondragon, A (corresponding author), Northwestern Univ, Dept Mol Biosci, Evanston, IL 60208 USA.	a-mondragon@northwestern.edu		Smith, Eric/0000-0002-5385-4558; Mondragon, Alfonso/0000-0002-0423-6323	NIH [R35GM118108]; American Cancer Society Postdoctoral Fellowship [134255-PF-20-041-01-DMC]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society)	This work was supported by the NIH Grant R35GM118108 (to A. M.) and an American Cancer Society Postdoctoral Fellowship (134255-PF-20-041-01-DMC) (to E. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker NM, 2011, NUCLEIC ACIDS RES, V39, P755, DOI 10.1093/nar/gkq799; Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Chen SF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05406-y; Corbett KD, 2007, NAT STRUCT MOL BIOL, V14, P611, DOI 10.1038/nsmb1264; Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396; Fisher L. Mark, 2008, V142, P11, DOI 10.1007/978-1-59745-246-5_2; Gibson EG, 2019, ACS INFECT DIS, V5, P570, DOI 10.1021/acsinfecdis.8b00315; Hearnshaw SJ, 2014, J MOL BIOL, V426, P2023, DOI 10.1016/j.jmb.2014.02.017; Hevener KE, 2018, ACTA PHARM SIN B, V8, P844, DOI 10.1016/j.apsb.2018.07.008; Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414; Lanz MA, 2012, NUCLEIC ACIDS RES, V40, P10893, DOI 10.1093/nar/gks852; Lanz MA, 2011, NUCLEIC ACIDS RES, V39, P9681, DOI 10.1093/nar/gkr680; Laponogov I., 2016, PROTEIN DATA BANK; Lindsley J E, 2001, Methods Mol Biol, V95, P57; MIZUUCHI K, 1978, P NATL ACAD SCI USA, V75, P5960, DOI 10.1073/pnas.75.12.5960; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Olland S, 1999, J BIOL CHEM, V274, P21688, DOI 10.1074/jbc.274.31.21688; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; ROCA J, 1993, J BIOL CHEM, V268, P14250; Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057; ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4; ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T; Rudolph MG, 2013, J MOL BIOL, V425, P2632, DOI 10.1016/j.jmb.2013.04.010; Schmidt BH, 2012, NAT STRUCT MOL BIOL, V19, P1147, DOI 10.1038/nsmb.2388; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Soczek KM, 2018, ELIFE, V7, DOI 10.7554/eLife.41215; Stelljes JT, 2018, NUCLEIC ACIDS RES, V46, P6773, DOI 10.1093/nar/gky470; Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831; Wendorff TJ, 2012, J MOL BIOL, V424, P109, DOI 10.1016/j.jmb.2012.07.014; WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0	33	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101000	10.1016/j.jbc.2021.101000	http://dx.doi.org/10.1016/j.jbc.2021.101000			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34303706	gold, Green Published			2022-12-28	WOS:000690868100012
J	Li, Y; Huang, YJ; Wen, YZ; Wang, D; Liu, HF; Li, YF; Zhao, J; An, LJ; Yu, F; Liu, XY				Li, Yan; Huang, Yujia; Wen, Yunze; Wang, Dan; Liu, Haofeng; Li, Yuanfeng; Zhao, Jun; An, Lijun; Yu, Fei; Liu, Xiayan			The domain of unknown function 4005 (DUF4005) in an Arabidopsis IQD protein functions in microtubule binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELLULOSE SYNTHASE; HELICAL GROWTH; CORTICAL MICROTUBULES; PLASMA-MEMBRANE; CELL ELONGATION; ORGANIZATION; ASSOCIATION; ORIENTATION; INTERACT; ENCODES	The dynamic responses of microtubules (MTs) to internal and external signals are modulated by a plethora of microtubule-associated proteins (MAPs). In higher plants, many plant-specific MAPs have emerged during evolution as advantageous to their sessile lifestyle. Some members of the IQ67 domain (IQD) protein family have been shown to be plant-specific MAPs. However, the mechanisms of interaction between IQD proteins and MTs remain elusive. Here we demonstrate that the domain of unknown function 4005 (DUF4005) of the Arabidopsis IQD family protein ABS6/AtIQD16 is a novel MT-binding domain. Cosedimentation assays showed that the DUF4005 domain binds directly to MTs in vitro. GFP-labeled DUF4005 also decorates all types of MT arrays tested in vivo. Furthermore, we showed that a conserved stretch of 15 amino acid residues within the DUF4005 domain, which shares sequence similarity with the C-terminal MT-binding domain of human MAP Kif18A, is required for the binding to MTs. Transgenic lines overexpressing the DUF4005 domain displayed a spectrum of developmental defects, including spiral growth and stunted growth at the organismal level. At the cellular level, DUF4005 overexpression caused defects in epidermal pavement cell and trichome morphogenesis, as well as abnormal anisotropic cell elongation in the hypocotyls of dark-grown seedlings. These data establish that the DUF4005 domain of ABS6/AtIQD16 is a new MT-binding domain, overexpression of which perturbs MT homeostasis in plants. Our findings provide new insights into the MT-binding mechanisms of plant IQD proteins.	[Li, Yan; Huang, Yujia; Wen, Yunze; Wang, Dan; Liu, Haofeng; Li, Yuanfeng; Zhao, Jun; An, Lijun; Yu, Fei; Liu, Xiayan] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Li, Yan; Huang, Yujia; Wen, Yunze; Wang, Dan; Liu, Haofeng; Li, Yuanfeng; Zhao, Jun; An, Lijun; Yu, Fei; Liu, Xiayan] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Yu, Fei] Northwest A&F Univ, Inst Future Agr, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Liu, XY (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Liu, XY (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.	xyliu@nwafu.edu.cn			National Natural Science Foundation of China [31770205, 31970186, 31870268]; Natural Science Basic Research Program of Shaanxi [2021JC-17]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Basic Research Program of Shaanxi	This work was supported by the National Natural Science Foundation of China (31770205 and 31970186 to X. L. and 31870268 to F. Y.) and Natural Science Basic Research Program of Shaanxi (Program No. 2021JC-17 to X. L.).	Abel S, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-72; Alberico EO, 2017, METHOD CELL BIOL, V141, P115, DOI 10.1016/bs.mcb.2017.06.015; Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2008, MOL PLANT, V1, P950, DOI 10.1093/mp/ssn054; Balkunde R, 2019, J BIOL CHEM, V294, P16374, DOI 10.1074/jbc.RA119.008866; Bichet A, 2001, PLANT J, V25, P137, DOI 10.1046/j.1365-313x.2001.00946.x; Bodakuntla S, 2019, TRENDS CELL BIOL, V29, P804, DOI 10.1016/j.tcb.2019.07.004; Bringmann M, 2012, PLANT CELL, V24, P163, DOI 10.1105/tpc.111.093575; Burstenbinder K, 2017, PLANT PHYSIOL, V173, P1692, DOI 10.1104/pp.16.01743; Burstenbinder K, 2013, J BIOL CHEM, V288, P1871, DOI 10.1074/jbc.M112.396200; Buschmann H, 2004, CURR BIOL, V14, P1515, DOI 10.1016/j.cub.2004.08.033; Buschmann H, 2009, PLANT CELL, V21, P2090, DOI 10.1105/tpc.108.061242; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Duan PG, 2017, MOL PLANT, V10, P685, DOI 10.1016/j.molp.2017.03.009; Elliott A, 2018, PLANT PHYSIOL, V176, P94, DOI 10.1104/pp.17.01329; Fan YW, 2018, CURR BIOL, V28, P987, DOI 10.1016/j.cub.2018.02.014; Furutani I, 2000, DEVELOPMENT, V127, P4443; Galva C, 2014, PLANT CELL, V26, P4409, DOI 10.1105/tpc.114.131482; Gu Y, 2010, P NATL ACAD SCI USA, V107, P12866, DOI 10.1073/pnas.1007092107; Gutierrez R, 2009, NAT CELL BIOL, V11, P797, DOI 10.1038/ncb1886; Hamada T, 2014, INT REV CEL MOL BIO, V312, P1, DOI 10.1016/B978-0-12-800178-3.00001-4; Hamant O, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10207-y; Ishida T, 2007, P NATL ACAD SCI USA, V104, P8544, DOI 10.1073/pnas.0701224104; Kolling M, 2019, J EXP BOT, V70, P387, DOI 10.1093/jxb/ery397; Lazzaro MD, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01766; Lefevre J, 2011, J BIOL CHEM, V286, P3065, DOI 10.1074/jbc.M110.144089; Li YF, 2021, J INTEGR PLANT BIOL, V63, P646, DOI 10.1111/jipb.13003; Liang H, 2018, PLANT PHYSIOL, V177, P1555, DOI 10.1104/pp.18.00558; Lin DS, 2013, CURR BIOL, V23, P290, DOI 10.1016/j.cub.2013.01.022; Lindeboom JJ, 2013, SCIENCE, V342, P1202, DOI 10.1126/science.1245533; Livanos P, 2019, ANNU REV PLANT BIOL, V70, P239, DOI 10.1146/annurev-arplant-050718-100444; Luo DL, 1999, DEVELOPMENT, V126, P5547; Mitra D, 2019, J EXP BOT, V70, P529, DOI 10.1093/jxb/ery395; Nakajima K, 2004, PLANT CELL, V16, P1178, DOI 10.1105/tpc.017830; Nakamura M, 2018, J CELL BIOL, V217, P915, DOI 10.1083/jcb.201708130; Nakamura M, 2009, J CELL SCI, V122, P2208, DOI 10.1242/jcs.044131; Nishiyama T, 2018, CELL, V174, P448, DOI 10.1016/j.cell.2018.06.033; Paredez AR, 2006, SCIENCE, V312, P1491, DOI 10.1126/science.1126551; Schaefer E, 2017, SCIENCE, V356, P186, DOI 10.1126/science.aal3016; Sedbrook JC, 2004, PLANT CELL, V16, P1506, DOI 10.1105/tpc.020644; Shoji T, 2004, PLANT PHYSIOL, V136, P3933, DOI 10.1104/pp.104.051748; Smertenko A, 2017, TRENDS CELL BIOL, V27, P885, DOI 10.1016/j.tcb.2017.08.008; Spittle C, 2000, J BIOL CHEM, V275, P20748, DOI 10.1074/jbc.M002597200; Stumpff J, 2011, MOL CELL, V43, P764, DOI 10.1016/j.molcel.2011.07.022; Sugiyama Y, 2017, CURR BIOL, V27, P2522, DOI 10.1016/j.cub.2017.06.059; Thitamadee S, 2002, NATURE, V417, P193, DOI 10.1038/417193a; Weaver LN, 2011, CURR BIOL, V21, P1500, DOI 10.1016/j.cub.2011.08.005; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wightman R, 2013, CURR BIOL, V23, P1902, DOI 10.1016/j.cub.2013.07.061; Xiao H, 2008, SCIENCE, V319, P1527, DOI 10.1126/science.1153040; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199	51	4	4	2	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100849	10.1016/j.jbc.2021.100849	http://dx.doi.org/10.1016/j.jbc.2021.100849			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058197	Green Published, gold			2022-12-28	WOS:000678068400049
J	Luo, Y; Wang, YR; Huang, Y				Luo, Ying; Wang, Yirong; Huang, Ying			Schizosaccharomyces pombe Ppr10 and Mpa1 together mediate mitochondrial translational initiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PENTATRICOPEPTIDE REPEAT PROTEINS; C-OXIDASE DEFICIENCY; STRUCTURAL BASIS; FISSION YEAST; RNA; LRPPRC; POLYADENYLATION; RECOGNITION; EVOLUTION; EFFICIENT	Pentatricopeptide repeat (PPR) proteins are a large family of proteins that act primarily at different posttranscriptional steps of organellar gene expression. Wehave previously found that the Schizosaccharomyces pombe PPR protein mpal10 interacts with mitochondrial translational activator Mpa1, and both are essential for mitochondrial protein synthesis. However, it is unclear how these two proteins function in mitochondrial protein synthesis in S. pombe. In this study, we further investigated the role of Ppr10 and Mpa1 in mitochondrial protein synthesis. Mitochondrial translational initiation requires two initiation factors, Mti2 and Mti3, which bind to the small subunit of the mitochondrial ribosome (mt-SSU) during the formation of the mitochondrial translational initiation complex. Using sucrose gradient sedimentation analysis, we found that disruption of ppr10, mpa1, or the PPR motifs in Ppr10 impairs the association of Mti2 and Mti3 with the mt-SSU, suggesting that both Ppr10 and Mpa1 may be required for the interaction of Mti2 and Mti3 with the mt-SSU during the assembly of mitochondrial translational initiation complex. Loss of Ppr10 perturbs the association of mitochondrially encoded cytochrome b (cob1) and cytochrome c oxidase subunit 1 (cox1) mRNAs with assembled mitochondrial ribosomes. Proteomic analysis revealed that a fraction of Ppr10 and Mpa1 copurified with a subset of mitoribosomal proteins. The PPR motifs of Ppr10 are necessary for its interaction with Mpa1 and that disruption of these PPR motifs impairs mitochondrial protein synthesis. Our results suggest that Ppr10 and Mpa1 function together to mediate mitochondrial translational initiation.	[Luo, Ying; Wang, Yirong; Huang, Ying] Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Peoples R China	Nanjing Normal University	Huang, Y (corresponding author), Nanjing Normal Univ, Sch Life Sci, Jiangsu Key Lab Microbes & Genom, Nanjing, Peoples R China.	yhuang@njnu.edu.cn			National Natural Science Foundation of China [31470778]; Postgraduate Research & Practice Innovation Program of Jiangsu Province [KYCX20_1186]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postgraduate Research & Practice Innovation Program of Jiangsu Province	This work was supported in part by grants from National Natural Science Foundation of China (31470778 to Y. H.) and Postgraduate Research & Practice Innovation Program of Jiangsu Province (KYCX20_1186 to Y. W.).	Andres-Colas N, 2017, P NATL ACAD SCI USA, V114, P8883, DOI 10.1073/pnas.1705815114; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Ban T, 2013, J BIOL CHEM, V288, P31540, DOI 10.1074/jbc.M113.496828; Barkan A, 2014, ANNU REV PLANT BIOL, V65, P415, DOI 10.1146/annurev-arplant-050213-040159; Chandel NS, 2015, CELL METAB, V22, P204, DOI 10.1016/j.cmet.2015.05.013; Chicherin IV, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64139-5; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; De Silva D, 2017, NUCLEIC ACIDS RES, V45, P6628, DOI 10.1093/nar/gkx426; De Silva D, 2013, CELL METAB, V18, P712, DOI 10.1016/j.cmet.2013.10.007; Derbikova KS, 2018, BIOCHEMISTRY-MOSCOW+, V83, P87, DOI 10.1134/S0006297918020013; Guillaumot D, 2017, P NATL ACAD SCI USA, V114, P8877, DOI 10.1073/pnas.1705780114; Herbert CJ, 2013, RNA BIOL, V10, P1477, DOI 10.4161/rna.25392; Hillman GA, 2019, J BIOL CHEM, V294, P9813, DOI 10.1074/jbc.RA119.008476; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Jones JL, 2019, J BIOL CHEM, V294, P7528, DOI 10.1074/jbc.RA118.005355; Jung SJ, 2015, FEBS LETT, V589, P822, DOI 10.1016/j.febslet.2015.02.015; Ke JY, 2013, NAT STRUCT MOL BIOL, V20, P1377, DOI 10.1038/nsmb.2710; KEENEY JB, 1994, GENETICS, V136, P849; Kuhl I, 2011, NUCLEIC ACIDS RES, V39, P8029, DOI 10.1093/nar/gkr511; Kummer E, 2021, NAT REV MOL CELL BIO, V22, P307, DOI 10.1038/s41580-021-00332-2; Kuzmenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep18749; Kuzmenko A, 2014, BIOCHIMIE, V100, P132, DOI 10.1016/j.biochi.2013.07.024; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; LIAO HX, 1989, J BIOL CHEM, V264, P7518; Lightowlers RN, 2013, RNA BIOL, V10, P1433, DOI 10.4161/rna.24770; Liu Z, 2020, FEMS MICROBIOL LETT; Luo Y, 2019, FEBS J, V286, P4542, DOI 10.1111/febs.15021; Malecki M, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1101-2; Manna S, 2015, BIOCHIMIE, V113, P93, DOI 10.1016/j.biochi.2015.04.004; Metodiev MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004110; Mootha VK, 2003, P NATL ACAD SCI USA, V100, P605, DOI 10.1073/pnas.242716699; MORENO S, 1991, METHOD ENZYMOL, V194, P795; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perks KL, 2018, CELL REP, V23, P127, DOI 10.1016/j.celrep.2018.03.033; Pinker F, 2013, RNA BIOL, V10, P1457, DOI 10.4161/rna.25273; Rackham O, 2012, WIRES RNA, V3, P675, DOI 10.1002/wrna.1128; Rackham O, 2012, BBA-GENE REGUL MECH, V1819, P1008, DOI 10.1016/j.bbagrm.2011.10.007; Richman TR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11884; Ringel R, 2011, NATURE, V478, P269, DOI 10.1038/nature10435; Rudler DL, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay2118; Rutter J, 2015, TRENDS ENDOCRIN MET, V26, P59, DOI 10.1016/j.tem.2014.12.002; Ruzzenente B, 2012, EMBO J, V31, P443, DOI 10.1038/emboj.2011.392; Sasarman F, 2010, MOL BIOL CELL, V21, P1315, DOI 10.1091/mbc.E10-01-0047; SCHAFER B, 1991, MOL GEN GENET, V225, P158; Schmitz-Linneweber C, 2008, TRENDS PLANT SCI, V13, P663, DOI 10.1016/j.tplants.2008.10.001; Siira SJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01221-z; Small ID, 2020, PLANT J, V101, P1040, DOI 10.1111/tpj.14578; Spahr H, 2016, NUCLEIC ACIDS RES, V44, P6868, DOI 10.1093/nar/gkw575; Summer S, 2020, NUCLEIC ACIDS RES, V48, P9762, DOI 10.1093/nar/gkaa148; Vakifahmetoglu-Norberg H, 2017, BIOCHEM BIOPH RES CO, V482, P426, DOI 10.1016/j.bbrc.2016.11.088; Waltz F, 2020, TRENDS BIOCHEM SCI, V45, P149, DOI 10.1016/j.tibs.2019.10.004; Wang YR, 2017, NUCLEIC ACIDS RES, V45, P3323, DOI 10.1093/nar/gkx127; Weraarpachai W, 2009, NAT GENET, V41, P833, DOI 10.1038/ng.390; Wolf D. A, 2017, COLD SPRING HARB PRO; Yin P, 2013, NATURE, V504, P168, DOI 10.1038/nature12651	55	3	3	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1								10.1016/j.jbc.2021.100869	http://dx.doi.org/10.1016/j.jbc.2021.100869			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34119521	Green Published, gold			2022-12-28	WOS:000678068400069
J	Menendez-Arias, L				Menendez-Arias, Luis			Decoding molnupiravir-induced mutagenesis in SARS-CoV-2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Molnupiravir, a prodrug of the nucleoside derivative beta-D-N-4-hydroxycytidine (NHC), is currently in clinical trials for COVID-19 therapy. However, the biochemical mechanisms involved in molnupiravir-induced mutagenesis had not been explored. In a recent study, Gordon et al. demonstrated that NHC can be incorporated into viral RNA and subsequently extended and used as template for RNA-dependent RNA synthesis, proposing a mutagenesis model consistent with available virological evidence. Their study uncovers molecular mechanisms by which molnupiravir drives SARS-CoV-2 into error catastrophe.	[Menendez-Arias, Luis] CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain; [Menendez-Arias, Luis] Univ Autonoma Madrid, Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); Autonomous University of Madrid	Menendez-Arias, L (corresponding author), CSIC, Ctr Biol Mol Severo Ochoa, Madrid, Spain.; Menendez-Arias, L (corresponding author), Univ Autonoma Madrid, Madrid, Spain.	lmenendez@cbm.csic.es	Menendez Arias, Luis/N-7447-2016	Menendez Arias, Luis/0000-0002-1251-6640	Spanish Ministry of Science and Innovation [PID2019-104176RB-I00/AEI/10.13039/50110001 1033]; Fundacion Ramon Areces (Madrid, Spain)	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Fundacion Ramon Areces (Madrid, Spain)	Work in the author's laboratory is supported by the Spanish Ministry of Science and Innovation (grant PID2019-104176RB-I00/AEI/10.13039/50110001 1033), and an institutional grant of Fundacion Ramon Areces (Madrid, Spain).	Agostini ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01348-19; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Gordon CJ, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100770; Hillen HS, 2021, CURR OPIN VIROL, V48, P82, DOI 10.1016/j.coviro.2021.03.010; Ma Y, 2021, CHEM SOC REV, V50, P4514, DOI 10.1039/d0cs01084g; Perales C, 2019, FUTURE MED CHEM, V11, P1645, DOI 10.4155/fmc-2018-0457; Rosenke K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22580-8; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; Zhao JY, 2021, ANTIVIR RES, V190, DOI 10.1016/j.antiviral.2021.105078; Zhou S., 2021, J INFECT DIS, DOI [10.1093/infdis/jiab247, DOI 10.1093/INFDIS/JIAB247]	10	27	28	4	48	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100867	10.1016/j.jbc.2021.100867	http://dx.doi.org/10.1016/j.jbc.2021.100867			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118236	gold, Green Published			2022-12-28	WOS:000678068400067
J	Cardle, II; Jensen, MC; Pun, SH; Sellers, DL				Cardle, Ian I.; Jensen, Michael C.; Pun, Suzie H.; Sellers, Drew L.			Optimized serum stability and specificity of an alpha v beta 6 integrin-binding peptide for tumor targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUTH-DISEASE-VIRUS; IN-VIVO; BETA-6 INTEGRIN; UP-REGULATION; CANCER; EXPRESSION; INTEGRIN-ALPHA(V)BETA(6); ALPHA(V)BETA(6); ACTIVATION; CARCINOMA	The integrin alpha v beta 6 is an antigen expressed at low levels in healthy tissue but upregulated during tumorigenesis, which makes it a promising target for cancer imaging and therapy. A20FMDV2 is a 20-mer peptide derived from the foot-and-mouth disease virus that exhibits nanomolar and selective affinity for alpha v beta 6 versus other integrins. Despite this selectivity, A20FMDV2 has had limited success in imaging and treating alpha v beta 6(+) tumors in vivo because of its poor serum stability. Here, we explore the cyclization and modification of the A20FMDV2 peptide to improve its serum stability without sacrificing its affinity and specificity for alpha v beta 6. Using cysteine amino acid substitutions and cyclization by perfluoroarylation with decafluorobiphenyl, we synthesized six cyclized A20FMDV2 variants and discovered that two retained binding to alpha v beta 6 with modestly improved serum stability. Further D-amino acid substitutions and C-terminal sequence optimization outside the cyclized region greatly prolonged peptide serum stability without reducing binding affinity. While the cyclized A20FMDV2 variants exhibited increased nonspecific integrin binding compared with the original peptide, additional modifications with the non-natural amino acids citrulline, hydroxyproline, and D-alanine were found to restore binding specificity, with some modifications leading to greater alpha v beta 6 integrin selectivity than the original A20FMDV2 peptide. The peptide modifications detailed herein greatly improve the potential of utilizing A20FMDV2 to target alpha v beta 6 in vivo, expanding opportunities for cancer targeting and therapy.	[Cardle, Ian I.; Jensen, Michael C.; Pun, Suzie H.; Sellers, Drew L.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Cardle, Ian I.; Jensen, Michael C.] Seattle Childrens Therapeut, Seattle, WA USA; [Jensen, Michael C.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Jensen, Michael C.] Fred Hutchinson Canc Res Ctr, Program Immunol, 1124 Columbia St, Seattle, WA 98104 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center	Sellers, DL (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.	drewfus@uw.edu		Sellers, Drew/0000-0003-1799-5908; Cardle, Ian/0000-0001-9000-2293	National Institutes of Health [R01NS118247, R21NS099654, R01CA177272]; National Science Foundation Graduate Research Fellowship [DGE-1762114]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This research was supported by the National Institutes of Health under grant nos. R01NS118247 (to D. L. S.), R21NS099654 (to D. L. S.), and R01CA177272 (to S. H. P.), and by a National Science Foundation Graduate Research Fellowship under grant no. DGE-1762114 (to I. I. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and National Science Foundation.	Ahmed N, 2002, J HISTOCHEM CYTOCHEM, V50, P1371, DOI 10.1177/002215540205001010; Annes JP, 2004, J CELL BIOL, V165, P723, DOI 10.1083/jcb.200312172; Bandyopadhyay A, 2009, CURR DRUG TARGETS, V10, P645, DOI 10.2174/138945009788680374; Bates RC, 2005, J CLIN INVEST, V115, P339, DOI 10.1172/JCI200523183; BREUSS JM, 1995, J CELL SCI, V108, P2241; Burman A, 2006, J VIROL, V80, P9798, DOI 10.1128/JVI.00577-06; BUSK M, 1992, J BIOL CHEM, V267, P5790; Desnoyers A GonzAlez, 2020, MOL DIAGN THER, V24, P143; DiCara D, 2008, J VIROL, V82, P1537, DOI 10.1128/JVI.01480-07; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; Elayadi AN, 2007, CANCER RES, V67, P5889, DOI 10.1158/0008-5472.CAN-07-0245; Firer MA, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-70; Foster CC, 2020, J NUCL MED, V61, DOI 10.2967/jnumed.120.255364; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Gu X, 2002, BRIT J CANCER, V87, P348, DOI 10.1038/sj.bjc.6600480; Hamidi Hellyeh, 2018, Nat Rev Cancer, V18, P533, DOI 10.1038/s41568-018-0038-z; Hausner SH, 2007, CANCER RES, V67, P7833, DOI 10.1158/0008-5472.CAN-07-1026; Hausner SH, 2019, CLIN CANCER RES, V25, P1206, DOI 10.1158/1078-0432.CCR-18-2665; Hausner SH, 2015, J NUCL MED, V56, P784, DOI 10.2967/jnumed.114.150680; Hausner SH, 2009, CANCER RES, V69, P5843, DOI 10.1158/0008-5472.CAN-08-4410; Hazelbag S, 2007, J PATHOL, V212, P316, DOI 10.1002/path.2168; Hewish MJ, 2000, J VIROL, V74, P228, DOI 10.1128/JVI.74.1.228-236.2000; Hsiao JR, 2010, HEAD NECK-J SCI SPEC, V32, P160, DOI 10.1002/hed.21166; Hung KY, 2017, EUR J MED CHEM, V136, P154, DOI 10.1016/j.ejmech.2017.05.008; Huttenlocher A, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005074; Keat N, 2018, J NUCL MED TECHNOL, V46, P136, DOI 10.2967/jnmt.117.203547; Khan Z, 2016, CELL TISSUE RES, V365, P657, DOI 10.1007/s00441-016-2474-y; Kimura RH, 2012, CLIN CANCER RES, V18, P839, DOI 10.1158/1078-0432.CCR-11-1116; Kogelberg H, 2008, J MOL BIOL, V382, P385, DOI 10.1016/j.jmb.2008.07.013; Kolodziej A F., 2014, PEPTIDE OPTIMIZATION, P185; Ladner RC, 2004, DRUG DISCOV TODAY, V9, P525, DOI 10.1016/S1359-6446(04)03104-6; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Liu H, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0705-y; Liu H, 2014, AM J NUCL MED MOLEC, V4, P333; LOGAN D, 1993, NATURE, V362, P566, DOI 10.1038/362566a0; Lukey PT, 2020, EUR J NUCL MED MOL I, V47, P967, DOI 10.1007/s00259-019-04586-z; Moore KM, 2020, THERANOSTICS, V10, P2930, DOI 10.7150/thno.38702; Moore KM, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju169; Morgan MR, 2004, J BIOL CHEM, V279, P26533, DOI 10.1074/jbc.M401736200; Munshi HG, 2006, CANCER METAST REV, V25, P45, DOI 10.1007/s10555-006-7888-7; Ngambenjawong C, 2016, BIOCONJUGATE CHEM, V27, P2854, DOI 10.1021/acs.bioconjchem.6b00502; Nieberler M, 2017, CANCERS, V9, DOI 10.3390/cancers9090116; Patsenker E, 2010, J HEPATOL, V52, P362, DOI 10.1016/j.jhep.2009.12.006; Peng ZW, 2016, HEPATOLOGY, V63, P217, DOI 10.1002/hep.28274; Raab-Westphal S, 2017, CANCERS, V9, DOI 10.3390/cancers9090110; Reader CS, 2019, J PATHOL, V249, P332, DOI 10.1002/path.5320; Regezi JA, 2002, ORAL ONCOL, V38, P332, DOI 10.1016/S1368-8375(01)00062-8; Saleem A, 2020, INT J RADIAT ONCOL, V107, P370, DOI 10.1016/j.ijrobp.2020.02.014; Sellers DL, 2019, ACS NANO, V13, P10961, DOI 10.1021/acsnano.9b01515; Shi ML, 2011, NATURE, V474, P343, DOI 10.1038/nature10152; Siegel RL, 2020, CA-CANCER J CLIN, V70, P7, DOI [10.3322/caac.21601, 10.3322/caac.21590]; Slack RJ, 2016, PHARMACOLOGY, V97, P114, DOI 10.1159/000443180; Spokoyny AM, 2013, J AM CHEM SOC, V135, P5946, DOI 10.1021/ja400119t; Sun CC, 2016, AM J THER, V23, pE198, DOI 10.1097/MJT.0000000000000053; Sylvestre M, 2021, J CONTROL RELEASE, V331, P142, DOI 10.1016/j.jconrel.2021.01.015; Thomas GJ, 2002, BRIT J CANCER, V87, P859, DOI 10.1038/sj.bjc.6600545; Thomas GJ, 2001, INT J CANCER, V92, P641, DOI 10.1002/1097-0215(20010601)92:5<641::AID-IJC1243>3.0.CO;2-P; Thomas GJ, 2001, J INVEST DERMATOL, V116, P898, DOI 10.1046/j.1523-1747.2001.01352.x; Tugyi R, 2005, P NATL ACAD SCI USA, V102, P413, DOI 10.1073/pnas.0407677102; Van Aarsen LAK, 2008, CANCER RES, V68, P561, DOI 10.1158/0008-5472.CAN-07-2307; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wagstaff JL, 2012, RSC ADV, V2, P11019, DOI 10.1039/c2ra21655h; Wang Y, 2016, MOL CANCER THER, V15, P232, DOI 10.1158/1535-7163.MCT-15-0544; Weigel LF, 2015, J MED CHEM, V58, P7719, DOI 10.1021/acs.jmedchem.5b00612; Whilding LM, 2017, MOL THER, V25, P259, DOI 10.1016/j.ymthe.2016.10.012; Yan PW, 2018, TRANSL ONCOL, V11, P619, DOI 10.1016/j.tranon.2018.02.013; Yang GY, 2015, WORLD J GASTROENTERO, V21, P7457, DOI 10.3748/wjg.v21.i24.7457; Zhuang ZN, 2013, MED ONCOL, V30, DOI 10.1007/s12032-013-0580-1	68	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100657	10.1016/j.jbc.2021.100657	http://dx.doi.org/10.1016/j.jbc.2021.100657			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857478	Green Published, gold			2022-12-28	WOS:000672866400628
J	Niu, MH; Xu, SZ; Yang, J; Yao, DQ; Li, N; Yan, J; Zhong, GS; Song, GJ				Niu, Minghui; Xu, Shengzhao; Yang, Jie; Yao, Deqiang; Li, Na; Yan, Jie; Zhong, Guisheng; Song, Gaojie			Structural basis for CD97 recognition of the decay-accelerating factor CD55 suggests mechanosensitive activation of adhesion GPCRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; LIGAND CD55; EXPRESSION; DOMAIN; EMR2; LEUKOCYTES; SCATTERING; ARTHRITIS; FEATURES; GPR126	The adhesion G protein-coupled receptor CD97 and its ligand complement decay-accelerating factor CD55 are important binding partners in the human immune system. Dysfunction in this binding has been linked to immune disorders such as multiple sclerosis and rheumatoid arthritis, as well as various cancers. Previous literatures have indicated that the CD97 includes 3 to 5 epidermal growth factor (EGF) domains at its N terminus and these EGF domains can bind to the N-terminal short consensus repeat (SCR) domains of CD55. However, the details of this interaction remain elusive, especially why the CD55 binds with the highest affinity to the shortest isoform of CD97 (EGF(1,2,5)). Herein, we designed a chimeric expression construct with the EGF(1,2,5) domains of CD97 and the SCR1-4 domains of CD55 connected by a flexible linker and determined the complex structure by crystallography. Our data reveal that the two proteins adopt an overall antiparallel binding mode involving the SCR1-3 domains of CD55 and all three EGF domains of CD97. Mutagenesis data confirmed the importance of EGF(5) in the interaction and explained the binding specificity between CD55 and CD97. The architecture of CD55-CD97 binding mode together with kinetics suggests a force-resisting shearing stretch geometry when forces applied to the C termini of both proteins in the circulating environment. The potential of the CD55-CD97 complex to withstand tensile force may provide a basis for the mechanosensing mechanism for activation of adhesion G protein-coupled receptors.	[Niu, Minghui; Xu, Shengzhao; Song, Gaojie] East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China; [Niu, Minghui; Xu, Shengzhao; Song, Gaojie] East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China; [Yang, Jie; Yao, Deqiang; Zhong, Guisheng] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China; [Li, Na] Chinese Acad Sci, Zhangjiang Lab, Shanghai Adv Res Inst, Natl Facil Prot Sci Shanghai, Shanghai, Peoples R China; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore, Singapore	East China Normal University; East China Normal University; ShanghaiTech University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; National University of Singapore	Song, GJ (corresponding author), East China Normal Univ, Inst Biomed Sci, Shanghai Key Lab Regulatory Biol, Shanghai, Peoples R China.; Song, GJ (corresponding author), East China Normal Univ, Sch Life Sci, Shanghai, Peoples R China.	gjsong@bio.ecnu.edu.cn	Yan, Jie/G-2725-2012	Yan, Jie/0000-0002-8555-7291	National Key Research and Development Program of China [2018YFA0507001]; National Nature Science Foundation of China [31770898]	National Key Research and Development Program of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Key Research and Development Program of China (2018YFA0507001) and the National Nature Science Foundation of China Grant 31770898 (to G. S.).	Abbott RJM, 2007, J BIOL CHEM, V282, P22023, DOI 10.1074/jbc.M702588200; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Aust G, 1997, CANCER RES, V57, P1798; Aust G, 2002, AM J CLIN PATHOL, V118, P699; Capasso M, 2006, J IMMUNOL, V177, P1070, DOI 10.4049/jimmunol.177.2.1070; Chen JM, 2013, PROTEIN SCI, V22, P510, DOI 10.1002/pro.2230; de Groot DM, 2009, J IMMUNOL, V183, P4127, DOI 10.4049/jimmunol.0901253; Deinberg I, 2015, BIOCHEM BIOPH RES CO, V464, p743 747; Eichler W, 2000, J LEUKOCYTE BIOL, V68, P561; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; Gray JX, 1996, J IMMUNOL, V157, P5438; Guo SW, 2018, CHEM SCI, V9, P5871, DOI 10.1039/c8sc01319e; Hamann J, 1999, ARTHRITIS RHEUM-US, V42, P650, DOI 10.1002/1529-0131(199904)42:4<650::AID-ANR7>3.0.CO;2-S; Hamann J, 1998, EUR J IMMUNOL, V28, P1701, DOI 10.1002/(SICI)1521-4141(199805)28:05<1701::AID-IMMU1701>3.0.CO;2-2; Hamann J, 1996, J EXP MED, V184, P1185, DOI 10.1084/jem.184.3.1185; Hamann J, 2000, INT IMMUNOL, V12, P439, DOI 10.1093/intimm/12.4.439; Hilbig D, 2018, CELL REP, V24, P1986, DOI 10.1016/j.celrep.2018.07.071; Hoek RM, 2010, ARTHRITIS RHEUM-US, V62, P1036, DOI 10.1002/art.27347; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Irmscher S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10766-0; Jaspars LH, 2001, TISSUE ANTIGENS, V57, P325, DOI 10.1034/j.1399-0039.2001.057004325.x; Karpus ON, 2013, J IMMUNOL, V190, P3740, DOI 10.4049/jimmunol.1202192; Kwakkenbos MJ, 2005, J LEUKOCYTE BIOL, V77, P112, DOI 10.1189/jlb.0704402; Langenhan T, 2020, BASIC CLIN PHARMACOL, V126, P5, DOI 10.1111/bcpt.13223; Langenhan T, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003825; Leemans JC, 2004, J IMMUNOL, V172, P1125, DOI 10.4049/jimmunol.172.2.1125; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lin HH, 2001, J BIOL CHEM, V276, P24160, DOI 10.1074/jbc.M101770200; Lin HH, 2000, GENOMICS, V67, P188, DOI 10.1006/geno.2000.6238; Liu D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039989; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Lukacik P, 2004, P NATL ACAD SCI USA, V101, P1279, DOI 10.1073/pnas.0307200101; Persson BD, 2007, NAT STRUCT MOL BIOL, V14, P164, DOI 10.1038/nsmb1190; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Qian YM, 1999, IMMUNOLOGY, V98, P303; Santiago C, 2010, NAT STRUCT MOL BIOL, V17, P124, DOI 10.1038/nsmb.1726; Scholz N, 2015, CELL REP, V11, P866, DOI 10.1016/j.celrep.2015.04.008; Steinert M, 2002, AM J PATHOL, V161, P1657, DOI 10.1016/S0002-9440(10)64443-4; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; Tria G, 2015, IUCRJ, V2, P207, DOI 10.1107/S205225251500202X; Visser L, 2002, J NEUROIMMUNOL, V132, P156, DOI 10.1016/S0165-5728(02)00306-5; Vizurraga A, 2020, J BIOL CHEM, V295, P14065, DOI 10.1074/jbc.REV120.007423; Wandel E, 2012, J IMMUNOL, V188, P1442, DOI 10.4049/jimmunol.1003944; Wang T, 2005, BLOOD, V105, P2836, DOI 10.1182/blood-2004-07-2878; White JP, 2014, P NATL ACAD SCI USA, V111, P15756, DOI 10.1073/pnas.1417898111; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220; Winter G, 2013, ACTA CRYSTALLOGR D, V69, P1260, DOI 10.1107/S0907444913015308; Yang LY, 2017, ACTA PHARMACOL SIN, V38, P56, DOI 10.1038/aps.2016.89	53	5	5	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100776	10.1016/j.jbc.2021.100776	http://dx.doi.org/10.1016/j.jbc.2021.100776			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33992645	gold, Green Published			2022-12-28	WOS:000672866400742
J	Saibil, HR				Saibil, Helen R.			The PDB and protein homeostasis: From chaperones to degradation and disaggregase machines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CYCLIC-DI-AMP; UNIVERSAL STRESS-PROTEIN; SENSOR KINASE KDPD; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; MOLECULAR-MECHANISMS; STIMULUS PERCEPTION; 2-COMPONENT SYSTEM; NUCLEOTIDE; BINDING	This review contains a personal account of the role played by the PDB in the development of the field of molecular chaperones and protein homeostasis, from the viewpoint of someone who experienced the concurrent advances in the structural biology, electron microscopy, and chaperone fields. The emphasis is on some key structures, including those of Hsp70, GroEL, Hsp90, and small heat shock proteins, that were determined as the molecular chaperone concept and systems for protein quality control were emerging. These structures were pivotal in demonstrating how seemingly nonspecific chaperones could assist the specific folding pathways of a variety of substrates. Moreover, they have provided mechanistic insights into the ATPase machinery of complexes such as GroEL/GroES that promote unfolding and folding and the disaggregases that extract polypeptides from large aggregates and disassemble amyloid fibers. The PDB has provided a framework for the current success in curating, evaluating, and distributing structural biology data, through both the PDB and the EMDB.	[Saibil, Helen R.] Birkbeck Univ London, Inst Struct & Mol Biol, London, England	University of London; Birkbeck University London	Saibil, HR (corresponding author), Birkbeck Univ London, Inst Struct & Mol Biol, London, England.	h.saibil@mail.cryst.bbk.ac.uk						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali MK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00570; Dias DA, 2020, MOLECULES, V25, DOI 10.3390/molecules25102462; [Anonymous], 2019, PLOS PATHOG, V15; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Banerjee A, 2015, J BIOL CHEM, V290, P12731, DOI 10.1074/jbc.M115.644856; Barabote RD, 2006, BBA-BIOMEMBRANES, V1758, P1557, DOI 10.1016/j.bbamem.2006.06.018; Bartoschik T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23154-3; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bowater R, 2015, JOHN WILEY SONS, P9; BRAUN F, 2019, CYCLIC NUCL ARCHAEA, V8, DOI DOI 10.1002/MBO3.829; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Cereija TB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020653118; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; Chi YH, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00750; Choi PH, 2015, MICROBIOLOGYOPEN, V4, P361, DOI 10.1002/mbo3.243; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Commichau FM, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00045-18; Commichau FM, 2018, TRENDS MICROBIOL, V26, P175, DOI 10.1016/j.tim.2017.09.003; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Deng L, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3235-1; Devaux L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007342; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahmi T, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080197; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gandara C, 2015, DNA REPAIR, V27, P1, DOI 10.1016/j.dnarep.2014.12.007; Gibhardt J, 2019, J BIOL CHEM, V294, P16020, DOI 10.1074/jbc.RA119.010046; Gundlach J, 2018, CURR GENET, V64, P191, DOI 10.1007/s00294-017-0734-3; Gundlach J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00804; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Hayes D, 1995, PROGRAM SEDNTERP SED; He J, 2020, NUCLEIC ACIDS RES, V48, P2807, DOI 10.1093/nar/gkaa112; Heermann R, 2003, J BIOL CHEM, V278, P51277, DOI 10.1074/jbc.M303801200; Heermann R, 1998, BBA-BIOMEMBRANES, V1415, P114, DOI 10.1016/S0005-2736(98)00181-3; Heermann R, 2010, FEMS MICROBIOL LETT, V304, P97, DOI 10.1111/j.1574-6968.2010.01906.x; Heermann R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-133; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Jung K, 1998, J BIOL CHEM, V273, P17406, DOI 10.1074/jbc.273.28.17406; Jung K, 2002, J MOL MICROB BIOTECH, V4, P223; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kumar S, 2020, PROTEIN SCI, V29, P2009, DOI 10.1002/pro.3920; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Longo LM, 2020, ELIFE, V9, DOI 10.7554/eLife.64415; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Massa SM, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00307-20; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; O'Connor A, 2017, CURR MED CHEM, V24, P3970, DOI 10.2174/0929867324666170124145543; ObAinowski Z, 1997, METHOD ENZYMOL; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; OToole R, 2003, RES MICROBIOL, V154, P387; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ramesh A, 2015, SEMIN CELL DEV BIOL, V47-48, P3, DOI 10.1016/j.semcdb.2015.10.019; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Rothenbucher MC, 2006, J BACTERIOL, V188, P1950, DOI 10.1128/JB.188.5.1950-1958.2006; Rubin BE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007301; Saveanu C, 2002, PROTEIN SCI, V11, P2551, DOI 10.1110/ps.0217502; Sch-vveikhard E. S., 2010, BIOCHEMISTRY-US, V49, p2194 2204; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schramke H, 2016, CELL REP, V16, P213, DOI 10.1016/j.celrep.2016.05.081; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sokoloski JE, 2011, RNA, V17, P1775, DOI 10.1261/rna.2759911; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Tkaczuk KL, 2013, EVOL APPL, V6, P434, DOI 10.1111/eva.12057; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Xie MQ, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz2970; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; Zhao LP, 2010, INFECT IMMUN, V78, P3506, DOI 10.1128/IAI.00131-10; Zimmann P, 2007, J BACTERIOL, V189, P7326, DOI 10.1128/JB.00976-07; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	93	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100744	10.1016/j.jbc.2021.100744	http://dx.doi.org/10.1016/j.jbc.2021.100744			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957121	Green Accepted, Green Published, gold			2022-12-28	WOS:000672866400713
J	Sali, A				Sali, Andrej			From integrative structural biology to cell biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; SUBSTRATE-BINDING; CHAPERONIN GROEL; ATOMIC-STRUCTURE; PROTEIN; SHOCK; DISAGGREGATION; MECHANISM; REVEALS	Integrative modeling is an increasingly important tool in structural biology, providing structures by combining data from varied experimental methods and prior information. As a result, molecular architectures of large, heterogeneous, and dynamic systems, such as the similar to 52-MDa Nuclear Pore Complex, can be mapped with useful accuracy, precision, and completeness. Key challenges in improving integrative modeling include expanding model representations, increasing the variety of input data and prior information, quantifying a match between input information and a model in a Bayesian fashion, inventing more efficient structural sampling, as well as developing better model validation, analysis, and visualization. In addition, two community-level challenges in integrative modeling are being addressed under the auspices of the Worldwide Protein Data Bank (wwPDB). First, the impact of integrative structures is maximized by PDB-Development, a prototype wwPDB repository for archiving, validating, visualizing, and disseminating integrative structures. Second, the scope of structural biology is expanded by linking the wwPDB resource for integrative structures with archives of data that have not been generally used for structure determination but are increasingly important for computing integrative structures, such as data from various types of mass spectrometry, spectroscopy, optical microscopy, proteomics, and genetics. To address the largest of modeling problems, a type of integrative modeling called metamodeling is being developed; metamodeling combines different types of input models as opposed to different types of data to compute an output model. Collectively, these developments will facilitate the structural biology mindset in cell biology and underpin spatiotemporal mapping of the entire cell.	[Sali, Andrej] Univ Calif San Francisco, Quantitat Biosci Inst QBI, Dept Bioengn & Therapeut Sci, Res Collaboratory Struct Bioinformat Prot Data Ba, San Francisco, CA 94143 USA; [Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sali, A (corresponding author), Univ Calif San Francisco, Quantitat Biosci Inst QBI, Dept Bioengn & Therapeut Sci, Res Collaboratory Struct Bioinformat Prot Data Ba, San Francisco, CA 94143 USA.; Sali, A (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	sali@salilab.org						Ali MMU, 2006, NATURE, V440, P1013, DOI 10.1038/nature04716; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0; Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479; Clare DK, 2012, CELL, V149, P113, DOI 10.1016/j.cell.2012.02.047; Clouser AF, 2019, ELIFE, V8, DOI 10.7554/eLife.50259; de la Pena AH, 2018, SCIENCE, V362, P1018, DOI 10.1126/science.aav0725; Deville C, 2019, CELL REP, V27, P3433, DOI 10.1016/j.celrep.2019.05.075; Dollins DE, 2007, MOL CELL, V28, P41, DOI 10.1016/j.molcel.2007.08.024; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; Fuller SD, 2003, STRUCTURE, V11, P11, DOI 10.1016/S0969-2126(02)00942-5; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0; Hipp MS, 2019, NAT REV MOL CELL BIO, V20, P421, DOI 10.1038/s41580-019-0101-y; Hunt JF, 1996, NATURE, V379, P37, DOI 10.1038/379037a0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kim KK, 1998, NATURE, V394, P595, DOI 10.1038/29106; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Lin Z, 2008, NAT STRUCT MOL BIOL, V15, P303, DOI 10.1038/nsmb.1394; Macklin DN, 2020, SCIENCE, V369, P390, DOI 10.1126/science.aav3751; Mogk A, 2018, MOL CELL, V69, P214, DOI 10.1016/j.molcel.2018.01.004; RITOSSA F, 1962, EXPERIENTIA, V18, P571, DOI 10.1007/BF02172188; Roseman AM, 1996, CELL, V87, P241, DOI 10.1016/S0092-8674(00)81342-2; Rosenzweig R, 2019, NAT REV MOL CELL BIO, V20, P665, DOI 10.1038/s41580-019-0133-3; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; Scheres SHW, 2020, CURR OPIN STRUC BIOL, V64, P17, DOI 10.1016/j.sbi.2020.05.011; Scior A, 2018, EMBO J, V37, P282, DOI 10.15252/embj.201797212; Shiau AK, 2006, CELL, V127, P329, DOI 10.1016/j.cell.2006.09.027; Verba KA, 2016, SCIENCE, V352, P1542, DOI 10.1126/science.aaf5023; Wang R.Y.R., 2020, GR CHAPERONE CYCLE M, DOI [10.1101/2020.11.05.370247, DOI 10.1101/2020.11.05.370247, 10.1101/2020.11,05, 370247]; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	36	19	19	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100743	10.1016/j.jbc.2021.100743	http://dx.doi.org/10.1016/j.jbc.2021.100743			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957123	gold, Green Published			2022-12-28	WOS:000672866400712
J	Taudte, N; Linnert, M; Rahfeld, JU; Piechotta, A; Ramsbeck, D; Buchholz, M; Kolenko, P; Parthier, C; Houston, JA; Veillard, F; Eick, S; Potempa, J; Schilling, S; Demuth, HU; Stubbs, MT				Taudte, Nadine; Linnert, Miriam; Rahfeld, Jens-Ulrich; Piechotta, Anke; Ramsbeck, Daniel; Buchholz, Mirko; Kolenko, Petr; Parthier, Christoph; Houston, John A.; Veillard, Florian; Eick, Sigrun; Potempa, Jan; Schilling, Stephan; Demuth, Hans-Ulrich; Stubbs, Milton T.			Mammalian-like type II glutaminyl cyclases in Porphyromonas gingivalis and other oral pathogenic bacteria as targets for treatment of periodontitis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; CRYSTAL-STRUCTURES; EXPRESSION; VIRULENCE; PH; INHIBITION; CATALYSIS; PLANTS; HEALTH; BRAIN	The development of a targeted therapy would significantly improve the treatment of periodontitis and its associated diseases including Alzheimer's disease, rheumatoid arthritis, and cardiovascular diseases. Glutaminyl cyclases (QCs) from the oral pathogens Porphyromonas gingivalis, Tannerella forsythia, and Prevotella intermedia represent attractive target enzymes for small-molecule inhibitor development, as their action is likely to stabilize essential periplasmic and outer membrane proteins by N-terminal pyroglutamination. In contrast to other microbial QCs that utilize the so-called type I enzymes, these oral pathogens possess sequences corresponding to type II QCs, observed hitherto only in animals. However, whether differences between these bacteroidal QCs and animal QCs are sufficient to enable development of selective inhibitors is not clear. To learn more, we recombinantly expressed all three QCs. They exhibit comparable catalytic efficiencies and are inhibited by metal chelators. Crystal structures of the enzymes from P. gingivalis (PgQC) and T. forsythia (TfQC) reveal a tertiary structure composed of an eight-stranded beta-sheet surrounded by seven a-helices, typical of animal type II QCs. In each case, an active site Zn ion is tetrahedrally coordinated by conserved residues. Nevertheless, significant differences to mammalian enzymes are found around the active site of the bacteroidal enzymes. Application of a PgQC-selective inhibitor described here for the first time results in growth inhibition of two P. gingivalis clinical isolates in a dose-dependent manner. The insights gained by these studies will assist in the development of highly specific small-molecule bacteroidal QC inhibitors, paving the way for alternative therapies against periodontitis and associated diseases.	[Taudte, Nadine; Buchholz, Mirko] Periotrap Pharmaceut GmbH, Halle, Saale, Germany; [Linnert, Miriam; Rahfeld, Jens-Ulrich; Piechotta, Anke; Ramsbeck, Daniel; Buchholz, Mirko; Schilling, Stephan; Demuth, Hans-Ulrich] Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Design & Target Validat, Halle, Saale, Germany; [Kolenko, Petr; Parthier, Christoph; Stubbs, Milton T.] Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, Inst Biochem & Biotechnol, Halle, Saale, Germany; [Houston, John A.; Potempa, Jan] Univ Louisville, Sch Dent, Dept Oral Immunol & Infect Dis, Louisville, KY 40292 USA; [Veillard, Florian; Potempa, Jan] Jagiellonian Univ, Fac Biochem Biophys & Biotechnol, Krakow, Poland; [Eick, Sigrun] Univ Bern, Sch Dent Med, Dept Periodontol, Bern, Switzerland; [Schilling, Stephan] Hsch Anhalt, Angew Biowissensch & Prozesstech, Kothen, Germany; [Stubbs, Milton T.] Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, ZIK HALOmem, Halle, Saale, Germany; [Kolenko, Petr] Czech Acad Sci, Inst Biotechnol, Vvi, Biocev, Vestec, Czech Republic; [Kolenko, Petr] Czech Tech Univ, Dept Solid State Engn, Vvi, Fac Nucl Sci & Phys Engn, Prague, Czech Republic	Fraunhofer Gesellschaft; Martin Luther University Halle Wittenberg; University of Louisville; Jagiellonian University; University of Bern; Martin Luther University Halle Wittenberg; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Czech Technical University Prague	Rahfeld, JU (corresponding author), Fraunhofer Inst Cell Therapy & Immunol, Dept Mol Drug Design & Target Validat, Halle, Saale, Germany.; Stubbs, MT (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, Inst Biochem & Biotechnol, Halle, Saale, Germany.; Stubbs, MT (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Proteinzentrum, ZIK HALOmem, Halle, Saale, Germany.	jens-ulrich.rahfeld@izi.fraunhofer.de; stubbs@biochemtech.uni-halle.de	Ramsbeck, Daniel/AAG-2174-2021; Kolenko, Petr/G-5732-2014	Ramsbeck, Daniel/0000-0002-4966-142X; Veillard, Florian/0000-0003-1248-2396; Kolenko, Petr/0000-0002-4619-9276; Linnert, Miriam/0000-0002-5337-4765; Stubbs, Milton/0000-0003-1278-9013	National Institutes of Health/NIDCR [DE 022597]; EU [306029]	National Institutes of Health/NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); EU(European Commission)	This work was supported in part by National Institutes of Health/NIDCR DE 022597 to J. P. and the EU project "TRIGGER -King of hearts, joints and lungs; periodontal pathogens as etiologic factor in RA, CVD and COPD and their impact on treatment strategies", Grant agreement number 306029 to H.-U. D., J. P., and S. E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahrendt K. A., 2019, World patent, Patent No. [WO/2009/111277, 2009111277]; Baliga Sharmila, 2013, J Indian Soc Periodontol, V17, P461, DOI 10.4103/0972-124X.118317; Bender P, 2019, ARCH ORAL BIOL, V97, P223, DOI 10.1016/j.archoralbio.2018.10.022; Benedyk M, 2019, MOL ORAL MICROBIOL, V34, P237, DOI 10.1111/omi.12268; BICKEL M, 1985, J DENT RES, V64, P1218, DOI 10.1177/00220345850640100801; BICKEL M, 1985, J PERIODONTAL RES, V20, P35, DOI 10.1111/j.1600-0765.1985.tb00408.x; Bochtler M, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00230; Booth RE, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUSBY WH, 1987, J BIOL CHEM, V262, P8532; Carr PD, 2009, PROTEIN PEPTIDE LETT, V16, P1137; Carrillo DR, 2010, BIOL CHEM, V391, P1419, DOI 10.1515/BC.2010.130; Chen YW, 2019, ONCOTARGETS THER, V12, P11131, DOI 10.2147/OTT.S230262; Chevrier B, 1996, EUR J BIOCHEM, V237, P393, DOI 10.1111/j.1432-1033.1996.0393k.x; Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; Darveau RP, 2010, NAT REV MICROBIOL, V8, P481, DOI 10.1038/nrmicro2337; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Duran-Pinedo AE, 2014, INFECT IMMUN, V82, P3374, DOI 10.1128/IAI.01976-14; Ellis TN, 2010, MICROBIOL MOL BIOL R, V74, P81, DOI 10.1128/MMBR.00031-09; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Gorasia DG, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005152; Hajishengallis G, 2011, J ORAL BIOSCI, V53, P233, DOI 10.2330/joralbiosci.53.233; Hajishengallis G, 2012, NAT REV MICROBIOL, V10, P717, DOI 10.1038/nrmicro2873; Hayashi J, 2002, FEMS MICROBIOL LETT, V216, P217, DOI 10.1111/j.1574-6968.2002.tb11438.x; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Huang KF, 2014, ACTA CRYSTALLOGR D, V70, P789, DOI 10.1107/S1399004713033488; Huang KF, 2005, P NATL ACAD SCI USA, V102, P13117, DOI 10.1073/pnas.0504184102; Huang WL, 2010, J MOL BIOL, V401, P374, DOI 10.1016/j.jmb.2010.06.012; Hutcherson JA, 2016, MOL ORAL MICROBIOL, V31, P354, DOI 10.1111/omi.12135; Ide M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151081; Ishida N, 2017, NPJ AGING MECH DIS, V3, DOI 10.1038/s41514-017-0015-x; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamer AR, 2008, J ALZHEIMERS DIS, V13, P437; Kamer AR, 2008, ALZHEIMERS DEMENT, V4, P242, DOI 10.1016/j.jalz.2007.08.004; Klein BA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-578; Kobayashi Tetsuo, 2015, Curr Oral Health Rep, V2, P1; Koch B, 2012, BIOCHEMISTRY-US, V51, P7383, DOI 10.1021/bi300687g; Kovacs-Simon A, 2011, INFECT IMMUN, V79, P548, DOI 10.1128/IAI.00682-10; Kupski O, 2020, BIOCHEMISTRY-US, V59, P2585, DOI 10.1021/acs.biochem.0c00337; Laugisch O, 2016, CLIN ORAL INVEST, V20, P675, DOI 10.1007/s00784-015-1556-7; MARSH PD, 1994, MICROBIOL-UK, V140, P861, DOI 10.1099/00221287-140-4-861; Matthews Debora, 2013, Evid Based Dent, V14, P87, DOI 10.1038/sj.ebd.6400955; MESSER M, 1964, BIOCHIM BIOPHYS ACTA, V92, P409, DOI 10.1016/0926-6569(64)90204-4; Nie R, 2019, J ALZHEIMERS DIS, V72, P479, DOI 10.3233/JAD-190298; Nussbaum JM, 2012, NATURE, V485, P651, DOI 10.1038/nature11060; Patel RM, 2016, J CLIN DIAGN RES, V10, pZC58, DOI 10.7860/JCDR/2016/20973.8182; POHL T, 1991, P NATL ACAD SCI USA, V88, P10059, DOI 10.1073/pnas.88.22.10059; Poole S, 2013, J ALZHEIMERS DIS, V36, P665, DOI 10.3233/JAD-121918; Rajesh K S, 2015, Contemp Clin Dent, V6, P461, DOI 10.4103/0976-237X.169846; Reichert S, 2013, J CLIN PERIODONTOL, V40, P591, DOI 10.1111/jcpe.12102; Ruiz-Carrillo D, 2011, BIOCHEMISTRY-US, V50, P6280, DOI 10.1021/bi200249h; Scheltens P, 2018, ALZHEIMERS RES THER, V10, DOI 10.1186/s13195-018-0431-6; Schilling S, 2003, BIOL CHEM, V384, P1583, DOI 10.1515/BC.2003.175; Schilling S, 2003, J BIOL CHEM, V278, P49773, DOI 10.1074/jbc.M309077200; Schilling S, 2002, ANAL BIOCHEM, V303, P49, DOI 10.1006/abio.2001.5560; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Schilling S, 2008, BIOL CHEM, V389, P983, DOI 10.1515/BC.2008.111; Schwechheimer C, 2015, NAT REV MICROBIOL, V13, P605, DOI 10.1038/nrmicro3525; Smiley CJ, 2015, J AM DENT ASSOC, V146, P508, DOI 10.1016/j.adaj.2015.01.028; Socransky SS, 1998, J CLIN PERIODONTOL, V25, P134, DOI 10.1111/j.1600-051X.1998.tb02419.x; Tonetti MS, 2017, J CLIN PERIODONTOL, V44, P456, DOI 10.1111/jcpe.12732; Totaro MC, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4243; Veith PD, 2013, J PROTEOME RES, V12, P4449, DOI 10.1021/pr400487b; Wilks JC, 2007, J BACTERIOL, V189, P5601, DOI 10.1128/JB.00615-07; Wilson I, 2011, GENOME BIOL, V12, P4; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wintjens R, 2006, J MOL BIOL, V357, P457, DOI 10.1016/j.jmb.2005.12.029; Wu V. W., 2017, MBIO, V8; Wu Z, 2017, BRAIN BEHAV IMMUN, V65, P350, DOI 10.1016/j.bbi.2017.06.002	70	3	3	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100263	10.1016/j.jbc.2021.100263	http://dx.doi.org/10.1016/j.jbc.2021.100263			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837744	gold, Green Published			2022-12-28	WOS:000672866400239
J	Taylor, SS; Wu, J; Bruystens, JGH; Del Rio, JC; Lu, TW; Kornev, AP; Ten Eyck, LF				Taylor, Susan S.; Wu, Jian; Bruystens, Jessica G. H.; Del Rio, Jason C.; Lu, Tsan-Wen; Kornev, Alexandr P.; Ten Eyck, Lynn F.			From structure to the dynamic regulation of a molecular switch: A journey over 3 decades	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-KINASE-A; CATALYTIC SUBUNIT; CRYSTAL-STRUCTURE; CAMP BINDING; STRUCTURE REVEALS; ISOFORM; ALPHA; NUCLEOTIDE; ALLOSTERY; COMPLEX	It is difficult to imagine where the signaling community would be today without the Protein Data Bank. This visionary resource, established in the 1970s, has been an essential partner for sharing information between academics and industry for over 3 decades. We describe here the history of our journey with the protein kinases using cAMP-dependent protein kinase as a prototype. We summarize what we have learned since the first structure, published in 1991, why our journey is still ongoing, and why it has been essential to share our structural information. For regulation of kinase activity, we focus on the cAMP-binding protein kinase regulatory subunits. By exploring full-length macromolecular complexes, we discovered not only allostery but also an essential motif originally attributed to crystal packing. Massive genomic data on disease mutations allows us to now revisit crystal packing as a treasure chest of possible protein:protein interfaces where the biological significance and disease relevance can be validated. It provides a new window into exploring dynamic intrinsically disordered regions that previously were deleted, ignored, or attributed to crystal packing. Merging of crystallography with cryo-electron microscopy, cryo-electron tomography, NMR, and millisecond molecular dynamics simulations is opening a new world for the signaling community where those structure coordinates, deposited in the Protein Data Bank, are just a starting point!	[Taylor, Susan S.; Wu, Jian; Bruystens, Jessica G. H.; Del Rio, Jason C.; Kornev, Alexandr P.] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA; [Taylor, Susan S.; Ten Eyck, Lynn F.] Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92093 USA; [Lu, Tsan-Wen] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA USA; [Ten Eyck, Lynn F.] Univ Calif San Diego, San Diego Supercomp Ctr, San Diego, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco; University of California System; University of California San Diego	Taylor, SS (corresponding author), Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92093 USA.; Taylor, SS (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, San Diego, CA 92093 USA.	staylor@ucsd.edu	Kornev, Alexandr Petrovich/O-7826-2015	Kornev, Alexandr Petrovich/0000-0002-1543-3795				Abu-Abed M, 2007, PROTEINS, V69, P112, DOI 10.1002/prot.21446; Ahuja LG, 2019, P NATL ACAD SCI USA, V116, P15052, DOI 10.1073/pnas.1900163116; Bank P. D., 1971, NATURE-NEW BIOL, V233, P223, DOI [10.1038/newbio233223a0, DOI 10.1038/NEWBIO233223A0, DOI 10.1038/NEWBIO233223B0]; Bao ZQ, 2011, STRUCTURE, V19, P675, DOI 10.1016/j.str.2011.02.016; BEEBE SJ, 1990, MOL ENDOCRINOL, V4, P465, DOI 10.1210/mend-4-3-465; Berman HM, 2005, P NATL ACAD SCI USA, V102, P45, DOI 10.1073/pnas.0408579102; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Bruystens JGH, 2014, STRUCTURE, V22, P59, DOI 10.1016/j.str.2013.10.012; BUBIS J, 1987, J BIOL CHEM, V262, P14961; Cao BH, 2019, STRUCTURE, V27, P816, DOI 10.1016/j.str.2019.03.001; Diller TC, 2001, STRUCTURE, V9, P73, DOI 10.1016/S0969-2126(00)00556-6; Gerlits O, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav0482; Guthrie CR, 1997, J BIOL CHEM, V272, P29560, DOI 10.1074/jbc.272.47.29560; Hao YX, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11930-2; Hao YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11214-z; Haushalter KJ, 2019, AM J PHYSIOL-HEART C, V317, pH1231, DOI 10.1152/ajpheart.00237.2019; Herberg FW, 1999, BIOCHEMISTRY-US, V38, P6352, DOI 10.1021/bi982672w; Honeyman JN, 2014, SCIENCE, V343, P1010, DOI 10.1126/science.1249484; Horvath A, 2010, HUM MUTAT, V31, P369, DOI 10.1002/humu.21178; Hunter Tony, 1994, Seminars in Cell Biology, V5, P367, DOI 10.1006/scel.1994.1044; Iafari N., 2021, P NATL ACAD IN PRESS; Kalman N., 2007, P NATL ACAD SCI USA, V104, p1272 1277; Kennedy EJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004746; Khavrutskii IV, 2009, BIOCHEMISTRY-US, V48, P11532, DOI 10.1021/bi901475g; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; Kim J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1600663; KNIGHTON DR, 1991, SCIENCE, V253, P407, DOI 10.1126/science.1862342; KNIGHTON DR, 1991, SCIENCE, V253, P414, DOI 10.1126/science.1862343; Kornev AP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000056; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kornev AP, 2015, TRENDS BIOCHEM SCI, V40, P628, DOI 10.1016/j.tibs.2015.09.002; Lu TW, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3001018; Lu TW, 2019, P NATL ACAD SCI USA, V116, P16347, DOI 10.1073/pnas.1906036116; Malmstrom RD, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8588; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Masterson LR, 2011, P NATL ACAD SCI USA, V108, P6969, DOI 10.1073/pnas.1102701108; McClendon CL, 2014, P NATL ACAD SCI USA, V111, pE4623, DOI 10.1073/pnas.1418402111; McNicholl ET, 2010, J BIOL CHEM, V285, P15523, DOI 10.1074/jbc.M110.105783; Meharena HS, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001680; Ramakrishnan C, 2002, PROTEIN ENG, V15, P783, DOI 10.1093/protein/15.10.783; RAO ST, 1973, J MOL BIOL, V76, P241, DOI 10.1016/0022-2836(73)90388-4; Rhayem Y, 2015, J BIOL CHEM, V290, P27816, DOI 10.1074/jbc.M115.656553; Singhi AD, 2020, GASTROENTEROLOGY, V158, P573, DOI 10.1053/j.gastro.2019.10.028; Soberg K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181091; SU Y, 1995, SCIENCE, V269, P807, DOI 10.1126/science.7638597; Taylor SS, 2019, IUBMB LIFE, V71, P672, DOI 10.1002/iub.2059; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Taylor SS, 2011, TRENDS BIOCHEM SCI, V36, P65, DOI 10.1016/j.tibs.2010.09.006; Thompson EE, 2009, PROTEIN SCI, V18, P2016, DOI 10.1002/pro.209; UHLER MD, 1986, J BIOL CHEM, V261, P5360; UHLER MD, 1986, P NATL ACAD SCI USA, V83, P1300, DOI 10.1073/pnas.83.5.1300; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Vigil D, 2006, J MOL BIOL, V357, P880, DOI 10.1016/j.jmb.2006.01.006; Vigil D, 2004, J MOL BIOL, V337, P1183, DOI 10.1016/j.jmb.2004.02.028; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Zhang JZ, 2020, CELL, V182, P1531, DOI 10.1016/j.cell.2020.07.043; Zhang P, 2015, STRUCTURE, V23, P1563, DOI 10.1016/j.str.2015.07.007; Zhang P, 2012, SCIENCE, V335, P712, DOI 10.1126/science.1213979; ZHENG JH, 1993, BIOCHEMISTRY-US, V32, P2154, DOI 10.1021/bi00060a005	62	18	18	3	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100746	10.1016/j.jbc.2021.100746	http://dx.doi.org/10.1016/j.jbc.2021.100746			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957122	gold, Green Published			2022-12-28	WOS:000672866400715
J	Wang, T; Xia, DJ; Li, N; Wang, CM; Chen, TY; Wan, T; Chen, GY; Cao, XT				Wang, Tao; Xia, Dajing; Li, Nan; Wang, Chunmei; Chen, Taoyong; Wan, Tao; Chen, Guoyou; Cao, Xuetao			Bone marrow stromal cell-derived growth inhibitor inhibits growth and migration of breast cancer cells via induction of cell cycle arrest and apoptosis (Withdrawal of Vol 296, art no 100756, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Wang CM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100756	1	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100763	10.1016/j.jbc.2021.100763	http://dx.doi.org/10.1016/j.jbc.2021.100763			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237895	gold, Green Published			2022-12-28	WOS:000672866400731
J	Yasuda, K; Nishikawa, M; Okamoto, K; Horibe, K; Mano, H; Yamaguchi, M; Okon, R; Nakagawa, K; Tsugawa, N; Okano, T; Kawagoe, F; Kittaka, A; Ikushiro, S; Sakaki, T				Yasuda, Kaori; Nishikawa, Miyu; Okamoto, Kairi; Horibe, Kyohei; Mano, Hiroki; Yamaguchi, Mana; Okon, Risa; Nakagawa, Kimie; Tsugawa, Naoko; Okano, Toshio; Kawagoe, Fumihiro; Kittaka, Atsushi; Ikushiro, Shinichi; Sakaki, Toshiyuki			Elucidation of metabolic pathways of 25-hydroxyvitamin D3 mediated by CYP24A1 and CYP3A using Cyp24a1 knockout rats generated by CRISPR/Cas9 system	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-D; BIOLOGICAL-ACTIVITY; D-3; SERUM; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; D3-26,23-LACTONE; DERIVATIZATION; MUTATIONS; MICE	CYP24A1-deficient (Cyp24a1 KO) rats were generated using the CRISPER/Cas9 system to investigate CYP24A1-dependent or -independent metabolism of 25(OH)D3, the prohormone of calcitriol. Plasma 25(OH)D3 concentrations in Cyp24a1 KO rats were approximately twofold higher than in wild-type rats. Wild-type rats showed five metabolites of 25(OH)D3 in plasma following oral administration of 25(OH)D3, and these metabolites were not detected in Cyp24a1 KO rats. Among these metabolites, 25(OH)D3-26,23-lactone was identified as the second major metabolite with a significantly higher T-max value than others. When 23S,25(OH)2D3 was administered to Cyp24a1 KO rats, neither 23,25,26(OH)(3)D3 nor 25(OH)D3-26,23-lactone was observed. However, when 23S,25R,26(OH)(3)D3 was administered to Cyp24a1 KO rats, plasma 25(OH)D3-26,23-lactone was detected. These results suggested that CYP24A1 is responsible for the conversion of 25(OH)D3 to 23,25,26(OH)3D3 via 23,25(OH)2D3, but enzyme(s) other than CYP24A1 may be involved in the conversion of 23,25,26(OH)3D3 to 25(OH)D3-26,23-lactone. Enzymatic studies using recombinant human CYP species and the inhibitory effects of ketoconazole suggested that CYP3A plays an essential role in the conversion of 23,25,26(OH)3D3 into 25(OH)D3-26,23-lactone in both rats and humans. Taken together, our data indicate that Cyp24a1 KO rats are valuable for metabolic studies of vitamin D and its analogs. In addition, long-term administration of 25(OH)D3 to Cyp24a1 KO rats at 110 mu g/kg body weight/day resulted in significant weight loss and ectopic calcification. Thus, Cyp24a1 KO rats could represent an important model for studying renal diseases originating from CYP24A1 dysfunction.	[Yasuda, Kaori; Okamoto, Kairi; Horibe, Kyohei; Mano, Hiroki; Yamaguchi, Mana; Okon, Risa; Sakaki, Toshiyuki] Toyama Prefectural Univ, Fac Engn, Dept Pharmaceut Engn, Imizu, Toyama, Japan; [Nishikawa, Miyu; Ikushiro, Shinichi] Toyama Prefectural Univ, Fac Engn, Dept Biotechnol, Imizu, Toyama, Japan; [Nakagawa, Kimie] Kobe Gakuin Univ, Fac Pharmaceut Sci, Lab Hyg Sci, Chuo Ku, Kobe, Hyogo, Japan; [Tsugawa, Naoko] Osaka Shoin Womens Univ, Fac Hlth & Nutr, Dept Hlth & Nutr, Higashiosaka, Osaka, Japan; [Okano, Toshio] Kobe Pharmaceut Univ, Dept Hyg Sci, Higashinada Ku, Kobe, Hyogo, Japan; [Kawagoe, Fumihiro; Kittaka, Atsushi] Teikyo Univ, Fac Pharmaceut Sci, Tokyo, Japan	Toyama Prefectural University; Toyama Prefectural University; Kobe Gakuin University; Kobe Pharmaceutical University; Teikyo University	Sakaki, T (corresponding author), Toyama Prefectural Univ, Fac Engn, Dept Pharmaceut Engn, Imizu, Toyama, Japan.	tsakaki@pu-toyama.ac.jp		Yasuda, Kaori/0000-0003-3495-3216	JSPS KAKENHI [16H04912, 17K15261, 19H02889, 19K05829]; Kato Memorial Bioscience Foundation; Kanamori Foundation	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kato Memorial Bioscience Foundation; Kanamori Foundation	This work was supported by JSPS KAKENHI (16H04912, 17K15261, 19H02889, and 19K05829), Kato Memorial Bioscience Foundation, and Kanamori Foundation.	BOUILLON R, 1995, ENDOCR REV, V16, P200, DOI 10.1210/er.16.2.200; Chatterjee B, 2005, METHOD ENZYMOL, V400, P165, DOI 10.1016/S0076-6879(05)00010-8; Higashi T, 2001, BIOL PHARM BULL, V24, P738, DOI 10.1248/bpb.24.738; ISHIZUKA S, 1987, J BIOL CHEM, V262, P7165; ISHIZUKA S, 1986, J STEROID BIOCHEM, V25, P505; ISHIZUKA S, 1981, FEBS LETT, V134, P207, DOI 10.1016/0014-5793(81)80603-5; ISHIZUKA S, 1982, FEBS LETT, V139, P267, DOI 10.1016/0014-5793(82)80867-3; Jones G, 2012, ARCH BIOCHEM BIOPHYS, V523, P9, DOI 10.1016/j.abb.2011.11.003; Kaufmann M, 2019, J STEROID BIOCHEM, V188, P23, DOI 10.1016/j.jsbmb.2018.12.001; Kaufmann M, 2017, J BONE MINER RES, V32, P1589, DOI 10.1002/jbmr.3135; Kaufmann M, 2015, ENDOCRINOLOGY, V156, P4388, DOI 10.1210/en.2015-1664; Kaufmann M, 2014, J CLIN ENDOCR METAB, V99, P2567, DOI 10.1210/jc.2013-4388; Kawagoe F, 2019, J STEROID BIOCHEM, V186, P161, DOI 10.1016/j.jsbmb.2018.10.010; Kusudo T, 2004, BIOCHEM BIOPH RES CO, V321, P774, DOI 10.1016/j.bbrc.2004.07.040; Masuda S, 2005, ENDOCRINOLOGY, V146, P825, DOI 10.1210/en.2004-1116; Matsunaga T, 2005, BIOL PHARM BULL, V28, P646, DOI 10.1248/bpb.28.646; NAPOLI JL, 1982, J BIOL CHEM, V257, P9634; Nesterova G, 2013, CLIN J AM SOC NEPHRO, V8, P649, DOI 10.2215/CJN.05360512; Nishikawa M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62048-1; Nishikawa M, 2019, J STEROID BIOCHEM, V185, P71, DOI 10.1016/j.jsbmb.2018.07.012; PEDERSEN JI, 1988, BIOCHEM J, V250, P527, DOI 10.1042/bj2500527; Pronicka E, 2017, J APPL GENET, V58, P349, DOI 10.1007/s13353-017-0397-2; Prosser DE, 2007, P NATL ACAD SCI USA, V104, P12673, DOI 10.1073/pnas.0702093104; Qin X, 2019, ACTA PHARM SIN B, V9, P1087, DOI 10.1016/j.apsb.2019.03.005; Roizen JD, 2018, J CLIN INVEST, V128, P1913, DOI 10.1172/JCI98680; Sakaki T, 2000, EUR J BIOCHEM, V267, P6158, DOI 10.1046/j.1432-1327.2000.01680.x; Sakaki T, 2005, FRONT BIOSCI, V10, P119; Schlingmann KP, 2011, NEW ENGL J MED, V365, P410, DOI 10.1056/NEJMoa1103864; St-Arnaud R, 1999, BONE, V25, P127, DOI 10.1016/S8756-3282(99)00118-0; St-Arnaud R, 2000, ENDOCRINOLOGY, V141, P2658, DOI 10.1210/en.141.7.2658; TANAKA Y, 1980, P NATL ACAD SCI-BIOL, V77, P6411, DOI 10.1073/pnas.77.11.6411; Tieu EW, 2014, FEBS J, V281, P3280, DOI 10.1111/febs.12862; Wang ZC, 2014, ENDOCRINOLOGY, V155, P2052, DOI 10.1210/en.2013-2013; Wong T, 2018, DRUG METAB DISPOS, V46, P367, DOI 10.1124/dmd.117.078428; Yasuda K, 2018, J STEROID BIOCHEM, V178, P333, DOI 10.1016/j.jsbmb.2018.02.001	35	8	10	5	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100668	10.1016/j.jbc.2021.100668	http://dx.doi.org/10.1016/j.jbc.2021.100668			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865853	Green Published, gold			2022-12-28	WOS:000672866400639
J	Ding, JJ; Gou, Q; Jia, X; Liu, Q; Jin, JH; Shi, JJ; Hou, YZ				Ding, Jiajun; Gou, Qian; Jia, Xiao; Liu, Qian; Jin, Jianhua; Shi, Juanjuan; Hou, Yongzhong			AMPK phosphorylates PPAR delta to mediate its stabilization, inhibit glucose and glutamine uptake and colon tumor growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED-RECEPTOR-DELTA; ENDOPLASMIC-RETICULUM STRESS; PEROXISOME-PROLIFERATOR; ENDOTHELIAL DYSFUNCTION; LIGAND ACTIVATION; AUTOPHAGY; PROTEINS; PATHWAY; KINASE; IDENTIFICATION	Peroxisome proliferator-activated receptor delta (PPAR delta) is a nuclear receptor transcription factor that plays an important role in the regulation of metabolism, inflammation, and cancer. In addition, the nutrient-sensing kinase 5'AMP-activated protein kinase (AMPK) is a critical regulator of cellular energy in coordination with PPAR delta. However, the molecular mechanism of the AMPK/PPAR delta pathway on cancer progression is still unclear. Here, we found that activated AMPK induced PPAR delta-S50 phosphorylation in cancer cells, whereas the PPAR delta/S50A (nonphosphorylation mimic) mutant reversed this event. Further analysis showed that the PPAR delta/S50E (phosphorylation mimic) but not the PPAR delta/S50A mutant increased PPAR delta protein stability, which led to reduced p62/SQSTM1-mediated degradation of misfolded PPAR delta. Furthermore, PPAR delta-S50 phosphorylation decreased PPAR delta transcription activity and alleviated PPAR delta-mediated uptake of glucose and glutamine in cancer cells. Soft agar and xenograft tumor model analysis showed that the PPAR delta/S50E mutant but not the PPAR delta/S50A mutant inhibited colon cancer cell proliferation and tumor growth, which was associated with inhibition of Glut1 and SLC1A5 transporter protein expression. These findings reveal a new mechanism of AMPK-induced PPAR delta-S50 phosphorylation, accumulation of misfolded PPAR delta protein, and inhibition of PPAR delta transcription activity contributing to the suppression of colon tumor formation.	[Ding, Jiajun; Jia, Xiao; Shi, Juanjuan; Hou, Yongzhong] Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Gou, Qian] Jiangsu Univ, Sch Med, Zhenjiang, Jiangsu, Peoples R China; [Liu, Qian; Jin, Jianhua] Jiangsu Univ, Affiliated Wujin Peoples Hosp, Dept Oncol, Changzhou, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University; Jiangsu University	Shi, JJ; Hou, YZ (corresponding author), Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China.; Shi, JJ; Hou, YZ (corresponding author), Jiangsu Univ, Sch Med, Zhenjiang, Jiangsu, Peoples R China.	sjj@ujs.edu.cn; houyz@ujs.edu.cn		Hou, Yongzhong/0000-0003-2019-8686	National Natural Science Foundation of China [81972618, 81672711, 81872275]; Natural Science Foundation [M2020002]; Changzhou Sci Tech Program [CJ20200004]; Jiangsu Commission of Health	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Changzhou Sci Tech Program; Jiangsu Commission of Health	This article contains supporting information. Acknowledgments-This work was supported by the National Natural Science Foundation of China (81972618, 81672711, 81872275) , Jiangsu Commission of Health, Natural Science Foundation (M2020002) , and Changzhou Sci & Tech Program (Grant No. CJ20200004) .	Aznar N, 2016, ELIFE, V5, DOI 10.7554/eLife.20795; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Boroughs LK, 2015, NAT CELL BIOL, V17, P351, DOI 10.1038/ncb3124; Cheang WS, 2017, DIABETES, V66, P519, DOI 10.2337/db15-1657; Chen L, 2017, CELL REP, V18, P3143, DOI 10.1016/j.celrep.2017.03.010; Choy KW, 2016, BIOCHEM PHARMACOL, V116, P51, DOI 10.1016/j.bcp.2016.07.013; Ding JJ, 2019, EUR J PHARMACOL, V857, DOI 10.1016/j.ejphar.2019.172425; Foreman JE, 2011, MOL CARCINOGEN, V50, P884, DOI 10.1002/mc.20757; Gou Q, 2020, ONCOGENE, V39, P4844, DOI 10.1038/s41388-020-1329-x; Gupta RA, 2004, NAT MED, V10, P245, DOI 10.1038/nm993; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hardie DG, 2015, CLIN CANCER RES, V21, P3836, DOI 10.1158/1078-0432.CCR-14-3300; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Hollingshead HE, 2008, CARCINOGENESIS, V29, P169, DOI 10.1093/carcin/bgm209; Hou Y, 2014, ONCOGENE, V33, P5619, DOI 10.1038/onc.2013.504; Hou YZ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2270; Jeon YJ, 2015, CANCER CELL, V27, P354, DOI 10.1016/j.ccell.2015.02.006; Jeong E, 2014, MOL CARCINOGEN, V53, P926, DOI 10.1002/mc.22144; Jiang XM, 2017, ACTA PHARMACOL SIN, V38, P1512, DOI 10.1038/aps.2017.123; Jiffry J, 2021, CLIN CANCER RES, V27, P865, DOI 10.1158/1078-0432.CCR-20-2385; Jung TW, 2021, ADV MED SCI-POLAND, V66, P155, DOI 10.1016/j.advms.2021.01.007; Jung TW, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0147-5; Kaur J, 2015, NAT REV MOL CELL BIO, V16, P461, DOI 10.1038/nrm4024; Kim YE, 2013, ANNU REV BIOCHEM, V82, P323, DOI 10.1146/annurev-biochem-060208-092442; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kramer DK, 2007, J BIOL CHEM, V282, P19313, DOI 10.1074/jbc.M702329200; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Liu F, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2020.113830; Lo Re AE, 2012, J BIOL CHEM, V287, P25325, DOI 10.1074/jbc.M112.370809; Marin HE, 2006, CANCER RES, V66, P4394, DOI 10.1158/0008-5472.CAN-05-4277; Michalik L, 2004, NAT REV CANCER, V4, P61, DOI 10.1038/nrc1254; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Peters Jeffrey M, 2011, Drug Discov Today Dis Mech, V8, pe85; Schaffer BE, 2015, CELL METAB, V22, P907, DOI 10.1016/j.cmet.2015.09.009; SCHMIDT A, 1992, MOL ENDOCRINOL, V6, P1634, DOI 10.1210/me.6.10.1634; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shin HJR, 2016, NATURE, V534, P553, DOI 10.1038/nature18014; Tang ZJ, 2015, CELL, V160, P729, DOI 10.1016/j.cell.2015.01.028; Wang DZ, 2014, P NATL ACAD SCI USA, V111, P7084, DOI 10.1073/pnas.1324233111; Yang L, 2008, DIS COLON RECTUM, V51, P318, DOI 10.1007/s10350-007-9145-8; Yang L, 2010, ONCOGENE, V29, P516, DOI 10.1038/onc.2009.370; Yang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060715; Yang L, 2011, CLIN CANCER RES, V17, P3760, DOI 10.1158/1078-0432.CCR-10-2779; You ML, 2018, J ONCOL, V2018, DOI 10.1155/2018/6458537; You ML, 2015, CURR PHARM DESIGN, V21, P2956, DOI 10.2174/1381612821666150514104035; Young CD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023205; Zhang Z, 2013, ONKOLOGIE, V36, P598, DOI 10.1159/000355328; Zhao FQ, 2007, CURR GENOMICS, V8, P113, DOI 10.2174/138920207780368187; Zhou DY, 2019, EUR J PHARMACOL, V842, P248, DOI 10.1016/j.ejphar.2018.10.050; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI13505; Zhu B, 2014, ONCOGENE, V33, P5348, DOI 10.1038/onc.2013.477; Zuo XS, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju052; Zuo XS, 2009, JNCI-J NATL CANCER I, V101, P762, DOI 10.1093/jnci/djp078	58	4	4	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100954	10.1016/j.jbc.2021.100954	http://dx.doi.org/10.1016/j.jbc.2021.100954			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34270958	gold, Green Published			2022-12-28	WOS:000706361700004
J	Russo, LC; Tomasin, R; Matos, IA; Manucci, AC; Sowa, ST; Dale, K; Caldecott, KW; Lehtio, L; Schechtman, D; Meotti, FC; Bruni-Cardoso, A; Hoch, NC				Russo, Lilian Cristina; Tomasin, Rebeka; Matos, Isaac Araujo; Manucci, Antonio Carlos; Sowa, Sven T.; Dale, Katie; Caldecott, Keith W.; Lehtio, Lari; Schechtman, Deborah; Meotti, Flavia C.; Bruni-Cardoso, Alexandre; Hoch, Nicolas Carlos			The SARS-CoV-2 Nsp3 macrodomain reverses PARP9/DTX3L-dependent ADP-ribosylation induced by interferon signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INHIBITOR; INDUCTION; TRANSCRIPTION; RESISTANCE; VIRUS; PARP	SARS-CoV-2 nonstructural protein 3 (Nsp3) contains a macrodomain that is essential for coronavirus pathogenesis and is thus an attractive target for drug development. This macrodomain is thought to counteract the host interferon (IFN) response, an important antiviral signalling cascade, via the reversal of protein ADP-ribosylation, a posttranslational modification catalyzed by host poly(ADP-ribose) polymerases (PARPs). However, the main cellular targets of the coronavirus macrodomain that mediate this effect are currently unknown. Here, we use a robust immunofluorescence-based assay to show that activation of the IFN response induces ADP-ribosylation of host proteins and that ectopic expression of the SARS-CoV-2 Nsp3 macrodomain reverses this modification in human cells. We further demonstrate that this assay can be used to screen for on-target and cell-active macrodomain inhibitors. This IFN-induced ADP-ribosylation is dependent on PARP9 and its binding partner DTX3L, but surprisingly the expression of the Nsp3 macrodomain or the deletion of either PARP9 or DTX3L does not impair IFN signaling or the induction of IFN-responsive genes. Our results suggest that PARP9/DTX3Ldependent ADP-ribosylation is a downstream effector of the host IFN response and that the cellular function of the SARS-CoV-2 Nsp3 macrodomain is to hydrolyze this end product of IFN signaling, rather than to suppress the IFN response itself.	[Russo, Lilian Cristina; Tomasin, Rebeka; Matos, Isaac Araujo; Manucci, Antonio Carlos; Schechtman, Deborah; Meotti, Flavia C.; Bruni-Cardoso, Alexandre; Hoch, Nicolas Carlos] Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil; [Sowa, Sven T.; Lehtio, Lari] Univ Oulu, Fac Biochem & Mol Med, Oulu, Finland; [Sowa, Sven T.; Lehtio, Lari] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Dale, Katie; Caldecott, Keith W.] Univ Sussex, Genome Damage & Stabil Ctr, Sch Life Sci, Brighton, E Sussex, England; [Dale, Katie] UCL, UCL Canc Inst, Dept Oncol, London, England	Universidade de Sao Paulo; University of Oulu; University of Oulu; University of Sussex; University of London; University College London	Hoch, NC (corresponding author), Univ Sao Paulo, Inst Chem, Dept Biochem, Sao Paulo, Brazil.	nicolas@iq.usp.br	schechtman, deborah/B-7572-2012; Hoch, Nicolas/J-5288-2012; Araujo Matos, Isaac de/AAX-3846-2021; Matos, Isaac/AAM-2105-2021; Russo, Lilian Cristina/O-7838-2014	Hoch, Nicolas/0000-0002-7610-1305; Araujo Matos, Isaac de/0000-0002-8089-8871; Sowa, Sven/0000-0001-7411-5925; Russo, Lilian Cristina/0000-0002-9846-1352; Meotti, Flavia/0000-0002-7217-3352	FAPESP [2020/53017-6, 2018/18007-5, 2019/26767-2]; Dimensions Sciences short-term fellowship - PNPD/CAPES postdoctoral fellowship; CNPq; FAPESP Young Investigator II Award [2018/14898-2]; FAPESP; Jane and Aatos Erkko Foundation [2019/26767-2]; Academy of Finland [287063, 294085, 319299]	FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Dimensions Sciences short-term fellowship - PNPD/CAPES postdoctoral fellowship; CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP Young Investigator II Award(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Jane and Aatos Erkko Foundation; Academy of Finland(Academy of Finland)	Work in the N. C. H. lab is supported by a COVID19 emergency grant (2020/53017-6) and a Young Investigator Award (2018/18007-5) from FAPESP, L. C. R. is funded by a FAPESP post-doctoral fellowship and held a Dimensions Sciences short-term fellowship, R. T. is funded by a PNPD/CAPES postdoctoral fellowship, A. C. M. and I. A. M. hold PhD scholarships from CNPq, the F. C. M. lab is supported by a FAPESP Young Investigator II Award (2018/14898-2), and work in the A. B.-C. lab is funded by FAPESP grant 2019/26767-2. Work in the L. L. lab was funded by the Jane and Aatos Erkko Foundation and by the Academy of Finland (grant nos. 287063, 294085, and 319299 to L. L.).	Alhammad YMO, 2021, J VIROL, V95, DOI 10.1128/JVI.01969-20; Alhammad YMO, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12040384; Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Brosey CA, 2021, PROG BIOPHYS MOL BIO, V163, P171, DOI 10.1016/j.pbiomolbio.2021.02.002; Caprara G, 2018, J IMMUNOL, V200, P2439, DOI 10.4049/jimmunol.1701117; Daugherty MD, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004403; Fehr AR, 2020, GENE DEV, V34, P341, DOI 10.1101/gad.334425.119; Fehr AR, 2016, MBIO, V7, DOI 10.1128/mBio.01721-16; Fehr AR, 2015, J VIROL, V89, P1523, DOI 10.1128/JVI.02596-14; FIELD AK, 1967, P NATL ACAD SCI USA, V58, P1004, DOI 10.1073/pnas.58.3.1004; Fu YF, 2014, NAT BIOTECHNOL, V32, P279, DOI 10.1038/nbt.2808; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Garcia-Sastre A, 2017, CELL HOST MICROBE, V22, P176, DOI 10.1016/j.chom.2017.07.012; Ghoreschi K, 2011, J IMMUNOL, V186, P4234, DOI 10.4049/jimmunol.1003668; Grunewald ME, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007756; HALLER O, 1979, J EXP MED, V149, P601, DOI 10.1084/jem.149.3.601; Higashi H, 2019, J PROTEOME RES, V18, P1607, DOI 10.1021/acs.jproteome.8b00895; Hoch NC, 2021, BIOCHEM SOC T, V49, P1711, DOI 10.1042/BST20201212; Hoch NC, 2020, GENET MOL BIOL, V43, DOI [10.1590/1678-4685-GMB-2019-0075, 10.1590/1678-4685-gmb-2019-0075]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; HYNES MF, 1989, GENE, V78, P111, DOI 10.1016/0378-1119(89)90319-3; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Iwata H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12849; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Juszczynski P, 2006, MOL CELL BIOL, V26, P5348, DOI 10.1128/MCB.02351-05; Kang S, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e33; Lee AJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02061; Leung AKL, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006864; Li MX, 2021, EMERG MICROBES INFEC, V10, P66, DOI 10.1080/22221751.2020.1865840; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Menear KA, 2008, J MED CHEM, V51, P6581, DOI 10.1021/jm8001263; Michalska K, 2020, IUCRJ, V7, P814, DOI 10.1107/S2052252520009653; Nowak K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18981-w; O'Connor LO, 2016, CANCER RES, V76, P6084, DOI 10.1158/0008-5472.CAN-15-3240; Rack JGM, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.200237; REICH N, 1987, P NATL ACAD SCI USA, V84, P6394, DOI 10.1073/pnas.84.18.6394; Schoggins JW, 2019, ANNU REV VIROL, V6, P567, DOI 10.1146/annurev-virology-092818-015756; Schuller M, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abf8711; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; SHULMAN L, 1980, NATURE, V288, P98, DOI 10.1038/288098a0; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Thorsell AG, 2017, J MED CHEM, V60, P1262, DOI 10.1021/acs.jmedchem.6b00990; Tummino TA, 2021, SCIENCE, V373, P541, DOI 10.1126/science.abi4708; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; WHEELOCK EF, 1965, SCIENCE, V149, P310, DOI 10.1126/science.149.3681.310; Zhang Y, 2015, NAT IMMUNOL, V16, P1215, DOI 10.1038/ni.3279; Zschaler J, 2014, CRIT REV IMMUNOL, V34, P433	47	21	21	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101041	10.1016/j.jbc.2021.101041	http://dx.doi.org/10.1016/j.jbc.2021.101041			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34358560	Green Accepted, Green Published, gold			2022-12-28	WOS:000704369100006
J	Sugiura, S; Nakano, S; Niwa, M; Hasebe, F; Matsui, D; Ito, S				Sugiura, Sayaka; Nakano, Shogo; Niwa, Masazumi; Hasebe, Fumihito; Matsui, Daisuke; Ito, Sohei			Catalytic mechanism of ancestral L-lysine oxidase assigned by sequence data mining	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID OXIDASE; L-ASPARTATE OXIDASE; SP AIU 813; RECOMBINANT EXPRESSION; CRYSTAL-STRUCTURE; ACTIVE-SITE; PROTEIN; RECONSTRUCTION; ENZYME; OXIDASE/MONOOXYGENASE	A large number of protein sequences are registered in public databases such as PubMed. Functionally uncharacterized enzymes are included in these databases, some of which likely have potential for industrial applications. However, assignment of the enzymes remained difficult tasks for now. In this study, we assigned a total of 28 original sequences to uncharacterized enzymes in the FAD-dependent oxidase family expressed in some species of bacteria including Chryseobacterium, Flavobacterium, and Pedobactor. Progenitor sequence of the assigned 28 sequences was generated by ancestral sequence reconstruction, and the generated sequence exhibited L-lysine oxidase activity; thus, we named the enzyme AncLLysO. Crystal structures of ligand-free and ligand-bound forms of AncLLysO were determined, indicating that the enzyme recognizes L-Lys by hydrogen bond formation with R76 and E383. The binding of L-Lys to AncLLysO induced dynamic structural change at a plug loop formed by residues 251 to 254. Biochemical assays of AncLLysO variants revealed the functional importance of these substrate recognition residues and the plug loop. R76A and E383D variants were also observed to lose their activity, and the kcat/Km value of G251P and Y253A mutations were approximately 800- to 1800-fold lower than that of AncLLysO, despite the indirect interaction of the substrates with the mutated residues. Taken together, our data demonstrate that combinational approaches to sequence classification from database and ancestral sequence reconstruction may be effective not only to find new enzymes using databases of unknown sequences but also to elucidate their functions.	[Sugiura, Sayaka; Nakano, Shogo; Niwa, Masazumi; Hasebe, Fumihito; Ito, Sohei] Univ Shizuoka, Grad Div Nutr & Environm Sci, Suruga Ku, Shizuoka, Japan; [Nakano, Shogo] Japan Sci & Technol Agcy, PREST, Kawaguchi, Saitama, Japan; [Matsui, Daisuke] Ritsumeikan Univ, Coll Life Sci, Dept Biotechnol, Kusatsu, Shiga, Japan	University of Shizuoka; Japan Science & Technology Agency (JST); Ritsumeikan University	Nakano, S (corresponding author), Univ Shizuoka, Grad Div Nutr & Environm Sci, Suruga Ku, Shizuoka, Japan.; Nakano, S (corresponding author), Japan Sci & Technol Agcy, PREST, Kawaguchi, Saitama, Japan.	snakano@u-shizuoka-ken.ac.jp	Nakano, Shogo/AAN-1455-2020	Nakano, Shogo/0000-0002-6614-7158; Hasebe, Fumihito/0000-0002-1097-3813; Matsui, Daisuke/0000-0002-2832-5769; Ito, Sohei/0000-0002-9937-3100	JSPS KAKENHI Grant [16K18688, 18K14391]; JST, PRESTO, JSP Grant [JPMJPR20AB]	JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST, PRESTO, JSP Grant	ray data were collected at the synchrotron facilities of the Photon Factory (PF) using beamline BL-5A (2018G006). The authors are grateful to the beamline staff for their assistance with the experiments performed at the Photon Factory. The authors express their appreciation to Prof. M. Yamada and Prof. K. Isobe for providing the Aspergillus carbonarius AIU 205 strain. This work was supported by JSPS KAKENHI Grant Numbers 16K18688 and 18K14391 and by JST, PRESTO, JSP Grant Number JPMJPR20AB.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akanuma S, 2013, P NATL ACAD SCI USA, V110, P11067, DOI 10.1073/pnas.1308215110; Alexandre FR, 2002, TETRAHEDRON LETT, V43, P707, DOI 10.1016/S0040-4039(01)02233-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amano M, 2015, J BIOCHEM, V157, P549, DOI 10.1093/jb/mvv012; Arima J, 2009, FEBS J, V276, P4318, DOI 10.1111/j.1742-4658.2009.07103.x; Ashkenazy H, 2012, NUCLEIC ACIDS RES, V40, pW580, DOI 10.1093/nar/gks498; Baxter S, 2012, J AM CHEM SOC, V134, P19310, DOI 10.1021/ja305438y; Clifton BE, 2016, CELL CHEM BIOL, V23, P236, DOI 10.1016/j.chembiol.2015.12.010; DeLano W.L, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Faust A, 2007, J MOL BIOL, V367, P234, DOI 10.1016/j.jmb.2006.11.071; Fuller JJ, 2016, J BIOL CHEM, V291, P20068, DOI 10.1074/jbc.M116.741561; Furukawa R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72418-4; Gomez D, 2008, APPL MICROBIOL BIOT, V79, P925, DOI 10.1007/s00253-008-1499-x; Gumulya Y, 2017, BIOCHEM J, V474, P1, DOI 10.1042/BCJ20160507; Hahn K, 2017, APPL MICROBIOL BIOT, V101, P2853, DOI 10.1007/s00253-016-8054-y; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Hossain GS, 2014, APPL MICROBIOL BIOT, V98, P1507, DOI 10.1007/s00253-013-5444-2; Im D, 2018, FEBS OPEN BIO, V8, P314, DOI 10.1002/2211-5463.12387; Isobe K, 2019, ANAL BIOCHEM, V584, DOI 10.1016/j.ab.2019.06.006; Jackel C, 2010, J MOL BIOL, V399, P541, DOI 10.1016/j.jmb.2010.04.039; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kameya M, 2013, ANAL BIOCHEM, V438, P124, DOI 10.1016/j.ab.2013.03.024; Khersonsky O, 2010, ANNU REV BIOCHEM, V79, P471, DOI 10.1146/annurev-biochem-030409-143718; Kido K, 2020, ELIFE, V9, DOI [10.7554/elife.54983, 10.7554/eLife.54983]; Kondo H, 2020, PROTEIN SCI, V29, P2213, DOI 10.1002/pro.3946; Matsui D, 2016, ENZYME MICROB TECH, V82, P151, DOI 10.1016/j.enzmictec.2015.10.002; Matsui D, 2014, FEBS OPEN BIO, V4, P220, DOI 10.1016/j.fob.2014.02.002; Mattevi A, 1999, STRUCTURE, V7, P745, DOI 10.1016/S0969-2126(99)80099-9; McDonald CA, 2011, J AM CHEM SOC, V133, P16809, DOI 10.1021/ja2081873; Merkl R, 2016, BIOL CHEM, V397, P1, DOI 10.1515/hsz-2015-0158; Molla G, 2017, BIOTECHNOL ADV, V35, P657, DOI 10.1016/j.biotechadv.2017.07.011; Motoyama T, 2020, BIOCHEMISTRY-US, V59, P3823, DOI 10.1021/acs.biochem.0c00570; Motta P, 2019, BIOCHIMIE, V158, P199, DOI 10.1016/j.biochi.2019.01.010; Moustafa IM, 2006, J MOL BIOL, V364, P991, DOI 10.1016/j.jmb.2006.09.032; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakano S, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-00432-8; Nakano S, 2019, ACS CATAL, V9, P10152, DOI 10.1021/acscatal.9b03418; Nakano S, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00459-19; Nakano S, 2018, BIOCHEMISTRY-US, V57, P3722, DOI 10.1021/acs.biochem.8b00339; NASU S, 1982, J BIOL CHEM, V257, P626; ODEFEY C, 1995, J MOL BIOL, V245, P69, DOI 10.1006/jmbi.1994.0007; Okazaki S, 2013, J BIOCHEM, V154, P233, DOI 10.1093/jb/mvt070; Paradisi F, 2007, J BIOTECHNOL, V128, P408, DOI 10.1016/j.jbiotec.2006.08.008; Parmeggiani F, 2019, ACS CATAL, V9, P3482, DOI 10.1021/acscatal.9b00739; Pollegioni L, 2013, APPL MICROBIOL BIOT, V97, P9323, DOI 10.1007/s00253-013-5230-1; Rosini E, 2017, ADV SYNTH CATAL, V359, P3773, DOI 10.1002/adsc.201700806; Saam J, 2010, J BIOL CHEM, V285, P24439, DOI 10.1074/jbc.M110.131193; Spence MA, 2021, CURR OPIN STRUC BIOL, V69, P131, DOI 10.1016/j.sbi.2021.04.001; Sugawara A, 2014, J BIOSCI BIOENG, V117, P263, DOI 10.1016/j.jbiosc.2013.08.019; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tararina MA, 2020, J MOL BIOL, V432, P3269, DOI 10.1016/j.jmb.2020.03.007; Trisrivirat D, 2020, J BIOL CHEM, V295, P11246, DOI 10.1074/jbc.RA120.014055; Utsumi T, 2012, BIOCHEM BIOPH RES CO, V417, P951, DOI 10.1016/j.bbrc.2011.12.033; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Xue YP, 2018, CHEM SOC REV, V47, P1516, DOI 10.1039/c7cs00253j; Yamada KD, 2016, BIOINFORMATICS, V32, P3246, DOI 10.1093/bioinformatics/btw412; Yamaguchi H, 2018, J BIOCHEM, V164, P359, DOI 10.1093/jb/mvy065; Yang HC, 2005, J EXP BIOL, V208, P3609, DOI 10.1242/jeb.01795	61	4	4	7	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101043	10.1016/j.jbc.2021.101043	http://dx.doi.org/10.1016/j.jbc.2021.101043			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34358565	gold, Green Published			2022-12-28	WOS:000704369100008
J	Woods, EL; Grigorieva, IV; Midgley, AC; Brown, CVM; Lu, YA; Phillips, AO; Bowen, T; Meran, S; Steadman, R				Woods, Emma L.; Grigorieva, Irina, V; Midgley, Adam C.; Brown, Charlotte V. M.; Lu, Yueh-An; Phillips, Aled O.; Bowen, Timothy; Meran, Soma; Steadman, Robert			CD147 mediates the CD44s-dependent differentiation of myofibroblasts driven by transforming growth factor-beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMOOTH-MUSCLE-ACTIN; FACTOR RECEPTOR EGFR; CELL-SURFACE; MECHANICAL TENSION; HYALURONAN; CD44; FIBROSIS; FIBROBLAST; ALPHA; EXPRESSION	Progressive fibrosis leads to loss of organ function and affects many organs as a result of excessive extracellular matrix production. The ubiquitous matrix polysaccharide hyaluronan (HA) is central to this through association with its primary receptor, CD44, which exists as standard CD44 (CD44s) or multiple splice variants. Mediators such as profibrotic transforming growth factor (TGF)-beta 1 and proinflammatory interleukin (IL)-1 beta are widely associated with fibrotic progression. TGF-beta 1 induces myofibroblast differentiation, while IL-1 beta induces a proinflammatory fibroblast phenotype that promotes fibroblast binding to monocyte/macrophages. CD44 expression is essential for both responses. Potential CD44 splice variants involved, however, are unidentified. The TGF-beta 1-activated CD44/ epidermal growth factor receptor complex induces differentiation of metastatic cells through interactions with the matrix metalloproteinase inducer, CD147. This study aimed to determine the CD44 variants involved in TGF-beta 1-and IL-1 beta-medi-ated responses and to investigate the potential profibrotic role of CD147. Using immunocytochemistry and quantitative PCR, standard CD44s were shown to be essential for both TGF-beta 1-induced fibroblast/myofibroblast differentiation and IL-1 beta- induced monocyte binding. Co-immunoprecipitation identified that CD147 associated with CD44s. Using CD147-siRNA and confocal microscopy, we also determined that incorporation of the myofibroblast marker, alpha SMA, into F-actin stress fibers was prevented in the absence of CD147 and myofibroblast-depen-dent collagen gel contraction was inhibited. CD147 did not associate with HA, but removal of HA prevented the association of CD44s with CD147 at points of cell-cell contact. Taken together, our data suggest that CD44s/CD147 colocalization is essential in regulating the mechanical tension required for the alpha SMA incorporation into F-actin stress fibers that regulates myofibroblast phenotype.	[Woods, Emma L.; Grigorieva, Irina, V; Midgley, Adam C.; Brown, Charlotte V. M.; Lu, Yueh-An; Phillips, Aled O.; Bowen, Timothy; Meran, Soma; Steadman, Robert] Cardiff Univ, Coll Biomed & Life Sci, Syst Immun Univ Res Inst, Div Infect & Immun,Wales Kidney Res Unit, Heath Pk, Cardiff, Wales; [Midgley, Adam C.] Nankai Univ, Coll Life Sci, Rongxiang Xu Ctr Regenerat Life Sci, Key Lab Bioact Mat,Minist Educ, Tianjin, Peoples R China	Cardiff University; Nankai University	Woods, EL (corresponding author), Cardiff Univ, Coll Biomed & Life Sci, Syst Immun Univ Res Inst, Div Infect & Immun,Wales Kidney Res Unit, Heath Pk, Cardiff, Wales.	woodse1@cardiff.ac.uk	Midgley, Adam C./P-8108-2019	Midgley, Adam C./0000-0002-7622-0275; Woods, Emma/0000-0002-1896-5527; Lu, Yueh-An/0000-0002-5486-2357	School of Medicine, Cardiff University	School of Medicine, Cardiff University	E. L.W. was funded by the School of Medicine, Cardiff University.	Aghajanian H, 2019, NATURE, V573, P430, DOI 10.1038/s41586-019-1546-z; Bai Y, 2014, INT J MOL SCI, V15, P6356, DOI 10.3390/ijms15046356; Barshishat M, 2002, CLIN EXP METASTAS, V19, P327, DOI 10.1023/A:1015528314970; Barth K, 2006, HISTOCHEM CELL BIOL, V126, P563, DOI 10.1007/s00418-006-0192-3; BISWAS C, 1995, CANCER RES, V55, P434; Bourguignon Lilly Y. W., 1998, Frontiers in Bioscience, V3, pD637; Bourguignon LYW, 2003, J BIOL CHEM, V278, P29420, DOI 10.1074/jbc.M301885200; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Clement S, 2005, J CELL SCI, V118, P1395, DOI 10.1242/jcs.01732; Eddy AA, 2005, ADV CHRONIC KIDNEY D, V12, P353, DOI 10.1053/j.ackd.2005.07.011; FOSSUM S, 1991, EUR J IMMUNOL, V21, P671, DOI 10.1002/eji.1830210320; Gibb AA, 2020, CIRC RES, V127, P427, DOI 10.1161/CIRCRESAHA.120.316958; Glaros T, 2009, FRONT BIOSCI-LANDMRK, V14, P3988, DOI [10.2735/3506, 10.2741/3506]; Govindaraju P, 2019, MATRIX BIOL, V75-76, P314, DOI 10.1016/j.matbio.2018.06.004; Grass GD, 2016, BIOSCIENCE REP, V36, DOI 10.1042/BSR20150256; Grass GD, 2014, ADV CANCER RES, V123, P351, DOI 10.1016/B978-0-12-800092-2.00013-7; Grass GD, 2013, J BIOL CHEM, V288, P26089, DOI 10.1074/jbc.M113.497685; Gross TJ, 2001, NEW ENGL J MED, V345, P517, DOI 10.1056/NEJMra003200; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Hinz B, 2001, AM J PATHOL, V159, P1009, DOI 10.1016/S0002-9440(10)61776-2; Huet E, 2008, FASEB J, V22, P1144, DOI 10.1096/fj.07-8748com; Iida N, 1997, J CELL PHYSIOL, V171, P152, DOI 10.1002/(SICI)1097-4652(199705)171:2<152::AID-JCP5>3.3.CO;2-6; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Joung C, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082990; Kato N, 2011, AM J PATHOL, V178, P572, DOI 10.1016/j.ajpath.2010.10.009; Kim Ju-Young, 2009, Immune Netw, V9, P90, DOI 10.4110/in.2009.9.3.90; Kosugi T, 2015, NEPHROL DIAL TRANSPL, V30, P1097, DOI 10.1093/ndt/gfu302; Lesley J, 2000, J BIOL CHEM, V275, P26967; Liang L, 2002, GENE, V282, P75, DOI 10.1016/S0378-1119(01)00847-2; Liu YJ, 2005, WORLD J GASTROENTERO, V11, P6601, DOI 10.3748/wjg.v11.i42.6601; MACKAY CR, 1994, J CELL BIOL, V124, P71, DOI 10.1083/jcb.124.1.71; Marenzana M, 2015, BEST PRACT RES CL RH, V29, P715, DOI 10.1016/j.berh.2016.02.001; Mauris J, 2014, J CELL SCI, V127, P3141, DOI 10.1242/jcs.148510; Meran S, 2007, J BIOL CHEM, V282, P25687, DOI 10.1074/jbc.M700773200; Meran S, 2013, AM J PATHOL, V182, P2223, DOI 10.1016/j.ajpath.2013.02.038; Meran S, 2011, INT J EXP PATHOL, V92, P158, DOI 10.1111/j.1365-2613.2011.00764.x; Micallef L, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S5; Midgley AC, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aao1822; Midgley AC, 2015, J BIOL CHEM, V290, P11218, DOI 10.1074/jbc.M114.625939; Midgley AC, 2013, J BIOL CHEM, V288, P14824, DOI 10.1074/jbc.M113.451336; Mori L, 2005, EXP CELL RES, V304, P81, DOI 10.1016/j.yexcr.2004.11.011; Murray D, 2004, ANTICANCER RES, V24, P489; Nagaya H, 2014, CLIN EXP NEPHROL, V18, P746, DOI 10.1007/s10157-013-0916-3; Pinnera E, 2017, J ALZHEIMERS DIS, V58, P1137, DOI 10.3233/JAD-161245; Qazi H, 2013, INTEGR BIOL-UK, V5, P1334, DOI 10.1039/c3ib40057c; Quest AFG, 2004, BIOCHEM CELL BIOL, V82, P129, DOI 10.1139/o03-071; Rothenberg ME, 2003, J CLIN INVEST, V111, P1460, DOI 10.1172/JCI200318392; SAMPSON PM, 1992, J CLIN INVEST, V90, P1492, DOI 10.1172/JCI116017; Schuppan D, 2008, LANCET, V371, P838, DOI 10.1016/S0140-6736(08)60383-9; Segura A, 2014, HEART FAIL REV, V19, P173, DOI 10.1007/s10741-012-9365-4; Seiki M, 2002, CURR OPIN CELL BIOL, V14, P624, DOI 10.1016/S0955-0674(02)00363-0; Sier CFM, 2006, INT J CANCER, V118, P2991, DOI 10.1002/ijc.21778; Simpson RML, 2009, AM J PATHOL, V175, P1915, DOI 10.2353/ajpath.2009.090045; Slevin M, 2007, MATRIX BIOL, V26, P58, DOI 10.1016/j.matbio.2006.08.261; Song EW, 2000, CELL IMMUNOL, V204, P19, DOI 10.1006/cimm.2000.1687; Sturhan H, 2015, THROMB RES, V135, P1160, DOI 10.1016/j.thromres.2015.03.022; Sun JX, 2001, CANCER RES, V61, P2276; Suzuki K, 2016, ARTERIOSCL THROM VAS, V36, P636, DOI 10.1161/ATVBAHA.115.306686; Tang W, 2004, MOL BIOL CELL, V15, P4043, DOI 10.1091/mbc.E04-05-0402; Tang W, 2004, J BIOL CHEM, V279, P11112, DOI 10.1074/jbc.M312947200; Thapa R, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2087204; TOLG C, 1993, NUCLEIC ACIDS RES, V21, P1225, DOI 10.1093/nar/21.5.1225; Tomasek JJ, 2013, WOUND REPAIR REGEN, V21, P166, DOI 10.1111/wrr.12001; Vis AN, 2002, J PATHOL, V197, P148, DOI 10.1002/path.1084; [王科雯 Wang Kewen], 2020, [测绘通报, Bulletin of Surveying and Mapping], P1; Webber J, 2009, INT J EXP PATHOL, V90, pA95; Webber J, 2009, J BIOL CHEM, V284, P9083, DOI 10.1074/jbc.M806989200; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Wu HJ, 2020, CELL, V180, P107, DOI 10.1016/j.cell.2019.11.027; Yang CX, 2012, J BIOL CHEM, V287, P43094, DOI 10.1074/jbc.M112.349209; Zhanet DW, 2012, J HEPATOL, V57, P1283, DOI 10.1016/j.jhep.2012.07.042; Zhou SX, 2005, P NATL ACAD SCI USA, V102, P7499, DOI 10.1073/pnas.0502768102; Zhu X, 2014, CURR MED CHEM, V21, P2138, DOI 10.2174/0929867321666131227163352	74	7	7	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100987	10.1016/j.jbc.2021.100987	http://dx.doi.org/10.1016/j.jbc.2021.100987			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34364871	gold, Green Accepted, Green Published			2022-12-28	WOS:000706418900007
J	Ye, X; Mayne, L; Englander, SW				Ye, Xiang; Mayne, Leland; Englander, S. Walter			A conserved strategy for structure change and energy transduction in Hsp104 and other AAA plus protein motors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							HYDROGEN-DEUTERIUM EXCHANGE; MASS-SPECTROMETRY; TRANSLOCATION; COORDINATION; DISAGGREGASE; POTENTIATION; MECHANISM; MACHINES; DYNAMICS; DOMAINS	The superfamily of massively large AAA+ protein molecular machines functions to convert the chemical energy of cytosolic ATP into physicomechanical form and use it to perform an extraordinary number of physical operations on proteins, nucleic acids, and membrane systems. Cryo-EM studies now reveal some aspects of substrate handling at high resolution, but the broader interpretation of AAA+ functional properties is still opaque. This paper integrates recent hydrogen exchange results for the typical AAA+ protein Hsp104 with prior information on several near and distantly related others. The analysis points to a widely conserved functional strategy. Hsp104 cycles through a long-lived loosely-structured energy-input "open" state that releases spent ADP and rebinds cytosolic ATP. ATP-binding energy is transduced by allosteric structure change to poise the protein at a high energy level in a more tightly structured "closed" state. The briefly occupied energy output closed state binds substrate strongly and is catalytically active. ATP hydrolysis permits energetically downhill structural relaxation, which is coupled to drive energy requiring substrate processing. Other AAA+ proteins appear to cycle through states that are analogous functionally if not in structural detail. These results revise the current model for AAA+ function, explain the structural basis of single-molecule optical tweezer kinetic phases, identify the separate energetic roles of ATP binding and hydrolysis, and specify a sequence of structural and energetic events that carry AAA+ proteins unidirectionally around a functional cycle to propel their diverse physical tasks.	[Ye, Xiang] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Mayne, Leland; Englander, S. Walter] Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Mayne, Leland; Englander, S. Walter] Univ Penn, Perelman Sch Med, Johnson Res Fdn, Philadelphia, PA 19104 USA	Texas A&M University System; Texas A&M University College Station; University of Pennsylvania; University of Pennsylvania	Englander, SW (corresponding author), Univ Penn, Perelman Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.; Englander, SW (corresponding author), Univ Penn, Perelman Sch Med, Johnson Res Fdn, Philadelphia, PA 19104 USA.	engl@pennmedicine.upenn.edu		Ye, Xiang/0000-0003-3117-3484	NIH [RO1GM31847]; National Science Foundation [MCB1020649]; Mathers Charitable Foundation; Johnson Research Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Mathers Charitable Foundation; Johnson Research Foundation	This work was supported by research grants to S. W. E. from the NIH (RO1GM31847), National Science Foundation (MCB1020649), and Mathers Charitable Foundation and funds from the Johnson Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Aubin-Tam ME, 2011, CELL, V145, P257, DOI 10.1016/j.cell.2011.03.036; Avellaneda MJ, 2020, NATURE, V578, P317, DOI 10.1038/s41586-020-1964-y; BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110; Bai YW, 1995, METHOD ENZYMOL, V259, P344; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Chistol G, 2012, CELL, V151, P1017, DOI 10.1016/j.cell.2012.10.031; Cooney I, 2019, SCIENCE, V365, P502, DOI 10.1126/science.aax0486; Cordova JC, 2014, CELL, V158, P647, DOI 10.1016/j.cell.2014.05.043; de la Pena AH, 2018, SCIENCE, V362, P1018, DOI 10.1126/science.aav0725; DeSantis ME, 2012, CELL, V151, P778, DOI 10.1016/j.cell.2012.09.038; Doyle SM, 2007, NAT STRUCT MOL BIOL, V14, P114, DOI 10.1038/nsmb1198; Engen JR, 2015, ANNU REV ANAL CHEM, V8, P127, DOI 10.1146/annurev-anchem-062011-143113; Englander JJ, 2003, P NATL ACAD SCI USA, V100, P7057, DOI 10.1073/pnas.1232301100; ENGLANDER JJ, 1985, ANAL BIOCHEM, V147, P234, DOI 10.1016/0003-2697(85)90033-8; Englander SW, 2006, J AM SOC MASS SPECTR, V17, P1481, DOI 10.1016/j.jasms.2006.06.006; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Englander SW, 1996, CURR OPIN STRUC BIOL, V6, P18, DOI 10.1016/S0959-440X(96)80090-X; ENGLANDER SW, 1972, ANNU REV BIOCHEM, V41, P903, DOI 10.1146/annurev.bi.41.070172.004351; Gates SN, 2020, PROTEIN SCI, V29, P407, DOI 10.1002/pro.3743; Gates SN, 2017, SCIENCE, V357, P273, DOI 10.1126/science.aan1052; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Lee J, 2013, P NATL ACAD SCI USA, V110, P8513, DOI 10.1073/pnas.1217988110; Linderstrom-Lang K., 1957, S PROT STRUCT, V9, P23; Lyubimov AY, 2011, CURR OPIN STRUC BIOL, V21, P240, DOI 10.1016/j.sbi.2011.01.002; Maillard RA, 2011, CELL, V145, P459, DOI 10.1016/j.cell.2011.04.010; Majumder P, 2019, P NATL ACAD SCI USA, V116, P534, DOI 10.1073/pnas.1817752116; Mayne L, 2016, METHOD ENZYMOL, V566, P335, DOI 10.1016/bs.mie.2015.06.035; Mayne L, 2011, J AM SOC MASS SPECTR, V22, P1898, DOI 10.1007/s13361-011-0235-4; Milne JS, 1998, PROTEIN SCI, V7, P739, DOI 10.1002/pro.5560070323; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Moffitt JR, 2009, NATURE, V457, P446, DOI 10.1038/nature07637; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Puchades C, 2020, NAT REV MOL CELL BIO, V21, P43, DOI 10.1038/s41580-019-0183-6; Puchades C, 2017, SCIENCE, V358, P609, DOI 10.1126/science.aao0464; Ripstein ZA, 2017, ELIFE, V6, DOI 10.7554/eLife.25754; Rizo AN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10150-y; Rodriguez-Aliaga P, 2016, NAT STRUCT MOL BIOL, V23, P974, DOI 10.1038/nsmb.3298; Rosenzweig R, 2013, SCIENCE, V339, P1080, DOI 10.1126/science.1233066; Ryu JK, 2015, SCIENCE, V347, P1485, DOI 10.1126/science.aaa5267; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Sauer RT, 2011, ANNU REV BIOCHEM, V80, P587, DOI 10.1146/annurev-biochem-060408-172623; Sen M, 2013, CELL, V155, P636, DOI 10.1016/j.cell.2013.09.022; Seraphim TV, 2020, CURR BIOL, V30, pR251, DOI 10.1016/j.cub.2020.01.044; Seyffer F, 2012, NAT STRUCT MOL BIOL, V19, P1347, DOI 10.1038/nsmb.2442; Shorter J, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00085; Skinner JJ, 2012, PROTEIN SCI, V21, P996, DOI 10.1002/pro.2081; Su M, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700325; Tafoya S, 2018, P NATL ACAD SCI USA, V115, P7961, DOI 10.1073/pnas.1802736115; Twomey EC, 2019, SCIENCE, V365, P462, DOI 10.1126/science.aax1033; Ye X, 2020, P NATL ACAD SCI USA, V117, P9384, DOI 10.1073/pnas.1921968117; Ye X, 2019, P NATL ACAD SCI USA, V116, P7333, DOI 10.1073/pnas.1816184116; Ye X, 2019, BIOPHYS J, V116, p484A, DOI 10.1016/j.bpj.2018.11.2612; Yokom AL, 2016, NAT STRUCT MOL BIOL, V23, P830, DOI 10.1038/nsmb.3277; Yu HJ, 2018, P NATL ACAD SCI USA, V115, pE9560, DOI 10.1073/pnas.1810648115; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522	57	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101066	10.1016/j.jbc.2021.101066	http://dx.doi.org/10.1016/j.jbc.2021.101066			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34384781	Green Published, gold			2022-12-28	WOS:000706409400008
J	Fleck, N; Grundner, C				Fleck, Neil; Grundner, Christoph			A Cas12a-based CRISPR interference system for multigene regulation in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CPF1	Mycobacteria are responsible for a heavy global disease burden, but their relative genetic intractability has long frustrated research efforts. The introduction of clustered regularly interspaced short palindromic repeats (CRISPR) interference (CRISPRi) has made gene repression in mycobacteria much more efficient, but limitations of the prototypical Cas9-based platform, for example, in multigene regulation, remain. Here, we introduce an alternative CRISPRi platform for mycobacteria that is based on the minimal type V Cas12a enzyme in combination with synthetic CRISPR arrays. This system is simple, tunable, reversible, can efficiently regulate essential genes and multiple genes simultaneously, and works as efficiently in infected macrophages as it does in vitro. Together, Cas12abased CRISPRi provides a facile tool to probe higher-order genetic interactions in mycobacteria including Mycobacterium tuberculosis (Mtb), which will enable the development of synthetically lethal drug targets and the study of genes conditionally essential during infection.	[Fleck, Neil; Grundner, Christoph] Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA; [Grundner, Christoph] Univ Washington, Dept Pediat, Seattle, WA 98195 USA; [Grundner, Christoph] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	Seattle Children's Hospital; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Grundner, C (corresponding author), Seattle Childrens Res Inst, Ctr Global Infect Dis Res, Seattle, WA 98105 USA.; Grundner, C (corresponding author), Univ Washington, Dept Pediat, Seattle, WA 98195 USA.; Grundner, C (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	christoph.grundner@seattlechildrens.org		Fleck, Neil/0000-0001-8327-4688; Grundner, Christoph/0000-0003-0596-6798	NIH [R01AI117023, R21AI137571, R03AI131223]; American Lung Association	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lung Association	This work was supported by NIH grants R01AI117023, R21AI137571, and R03AI131223 and by a grant by the American Lung Association to C. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Agarwal N, 2020, PLASMID, V110, DOI 10.1016/j.plasmid.2020.102515; Andreu N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010777; Bae S, 2014, BIOINFORMATICS, V30, P1473, DOI 10.1093/bioinformatics/btu048; Choi SY, 2020, ACS SYNTH BIOL, V9, P2351, DOI 10.1021/acssynbio.0c00091; Choudhary E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7267; Ehrt S, 2006, FUTURE MICROBIOL, V1, P177, DOI 10.2217/17460913.1.2.177; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao LY, 2017, NAT BIOTECHNOL, V35, P789, DOI 10.1038/nbt.3900; Kleinstiver BP, 2019, NAT BIOTECHNOL, V37, P276, DOI 10.1038/s41587-018-0011-0; Knoot CJ, 2020, ACS SYNTH BIOL, V9, P132, DOI 10.1021/acssynbio.9b00417; Knott GJ, 2018, SCIENCE, V361, P866, DOI 10.1126/science.aat5011; Lai Y, 2020, CELL SYST, V11, P239, DOI 10.1016/j.cels.2020.08.010; Lakshmanan V, 2015, MBIO, V6, DOI 10.1128/mBio.02330-14; Leenay RT, 2016, MOL CELL, V62, P137, DOI 10.1016/j.molcel.2016.02.031; Li L, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00827-18; Miao CS, 2019, SYN SYST BIOTECHNO, V4, P1, DOI 10.1016/j.synbio.2018.11.002; Pham TT, 2007, MICROBIOL-SGM, V153, P2711, DOI 10.1099/mic.0.2007/008904-0; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Singh AK, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw625; Theus SA, 2004, INFECT IMMUN, V72, P1169, DOI 10.1128/IAI.72.2.1169-1173.2004; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Vignali M, 2011, J CLIN INVEST, V121, P1119, DOI 10.1172/JCI43457; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wei JR, 2011, P NATL ACAD SCI USA, V108, P4176, DOI 10.1073/pnas.1018301108; Zetsche B, 2017, NAT BIOTECHNOL, V35, P31, DOI 10.1038/nbt.3737; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang XC, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.18	29	1	1	4	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100990	10.1016/j.jbc.2021.100990	http://dx.doi.org/10.1016/j.jbc.2021.100990			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298016	gold, Green Published			2022-12-28	WOS:000690868100005
J	Rheinemann, L; Thompson, T; Mercenne, G; Paine, EL; Peterson, FC; Volkman, BF; Alam, SL; Alian, A; Sundquist, WI				Rheinemann, Lara; Thompson, Tuscan; Mercenne, Gaelle; Paine, Elliott L.; Peterson, Francis C.; Volkman, Brian F.; Alam, Steven L.; Alian, Akram; Sundquist, Wesley, I			Interactions between AMOT PPxY motifs and NEDD4L WW domains function in HIV-1 release	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE RECRUITMENT; STRUCTURAL BASIS; PROTEIN; BINDING; NMR; PEPTIDE; ALIX; SPECTROSCOPY; RECOGNITION; ASSIGNMENT	Like most enveloped viruses, HIV must acquire a lipid membrane as it assembles and buds through the plasma mem-brane of infected cells to spread infection. Several sets of host cell machinery facilitate this process, including proteins of the endosomal sorting complexes required for transport pathway, which mediates the membrane fission reaction required to complete viral budding, as well as angiomotin (AMOT) and NEDD4L, which bind one another and promote virion mem-brane envelopment. AMOT and NEDD4L interact through the four NEDD4L WW domains and three different AMOT Pro-Pro-x (any amino acid)-Tyr (PPxY) motifs, but these in-teractions are not yet well defined. Here, we report that individual AMOT PPxY and NEDD4L WW domains interact with the following general affinity hierarchies: AMOT PPxY1>PP-xY2>PPxY3 and NEDD4L WW3>WW2>WW1,--,WW4. The unusually high-affinity of the AMOT PPxY1-NEDD4L WW3 interaction accounts for most of the AMOT-NEDD4L binding and is critical for stimulating HIV-1 release. Comparative structural, binding, and virological analyses reveal that complementary ionic and hydrophobic contacts on both sides of the WW-PPxY core interaction account for the unusually high affinity of the AMOT PPxY1-NEDD4L WW3 interaction. Taken together, our studies reveal how the first AMOT PPxY1 motif binds the third NEDD4L WW domain to stimulate HIV-1 viral envelopment and promote infectivity.	[Rheinemann, Lara; Thompson, Tuscan; Mercenne, Gaelle; Paine, Elliott L.; Alam, Steven L.; Alian, Akram; Sundquist, Wesley, I] Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA; [Peterson, Francis C.; Volkman, Brian F.] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA	Utah System of Higher Education; University of Utah; Medical College of Wisconsin	Alam, SL; Alian, A; Sundquist, WI (corresponding author), Univ Utah, Sch Med, Dept Biochem, Salt Lake City, UT 84112 USA.	Steven.Alam@biofiredx.com; akram.alian@biochem.utah.edu; wes@biochem.utah.edu		Volkman, Brian/0000-0002-6681-5179; Rheinemann, Lara/0000-0002-4314-0172; Paine, Elliott/0000-0001-5575-297X	NIH [R37 AI051174-21]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH R37 AI051174-21 to W. I. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Agromayor M, 2012, STRUCTURE, V20, P414, DOI 10.1016/j.str.2011.12.013; Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Alam SL, 2006, NAT STRUCT MOL BIOL, V13, P1029, DOI 10.1038/nsmb1160; Aragon E, 2012, STRUCTURE, V20, P1726, DOI 10.1016/j.str.2012.07.014; Aragon E, 2011, GENE DEV, V25, P1275, DOI 10.1101/gad.2060811; Bunkoczi G, 2013, ACTA CRYSTALLOGR D, V69, P2276, DOI 10.1107/S0907444913022750; Chung HY, 2008, J VIROL, V82, P4884, DOI 10.1128/JVI.02667-07; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dowlatshahi DP, 2012, DEV CELL, V23, P1247, DOI 10.1016/j.devcel.2012.10.023; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Escobedo A, 2014, STRUCTURE, V22, P1446, DOI 10.1016/j.str.2014.08.016; Fisher RD, 2007, CELL, V128, P841, DOI 10.1016/j.cell.2007.01.035; Goddard T. D., 2001, SPARKY 3; Gottstein D, 2012, J BIOMOL NMR, V52, P351, DOI 10.1007/s10858-012-9615-8; Han ZY, 2020, J BIOL CHEM, V295, P8596, DOI 10.1074/jbc.AC120.013171; Han ZY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008231; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Hurley JH, 2018, BIOCHEM SOC T, V46, P1029, DOI 10.1042/BST20180019; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Kanelis V, 2001, NAT STRUCT BIOL, V8, P407, DOI 10.1038/87562; Kanelis V, 2006, STRUCTURE, V14, P543, DOI 10.1016/j.str.2005.11.018; Keren-Kaplan T, 2013, EMBO J, V32, P538, DOI 10.1038/emboj.2013.4; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lin ZJ, 2019, ELIFE, V8, DOI 10.7554/eLife.49439; Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299; Lippincott-Schwartz J, 2017, ANNU REV VIROL, V4, P309, DOI 10.1146/annurev-virology-101416-041840; MARION D, 1989, J AM CHEM SOC, V111, P1515, DOI 10.1021/ja00186a066; MARION D, 1989, BIOCHEMISTRY-US, V28, P6150, DOI 10.1021/bi00441a004; Martin-Serrano J, 2007, TRAFFIC, V8, P1297, DOI 10.1111/j.1600-0854.2007.00609.x; Mercenne G, 2015, ELIFE, V4, DOI 10.7554/eLife.03778; Nishimura T, 2018, BIOCHEM SOC T, V46, P379, DOI 10.1042/BST20170322; Panwalkar V, 2016, BIOCHEMISTRY-US, V55, P659, DOI 10.1021/acs.biochem.5b01028; Pashkova N, 2013, DEV CELL, V25, P520, DOI 10.1016/j.devcel.2013.04.007; Pei ZF, 2010, VIROLOGY, V397, P155, DOI 10.1016/j.virol.2009.11.002; Qi SQ, 2014, J BIOL CHEM, V289, P4743, DOI 10.1074/jbc.M113.527473; Ray G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11020128; Schubert U, 2000, P NATL ACAD SCI USA, V97, P13057, DOI 10.1073/pnas.97.24.13057; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Slagsvold T, 2005, J BIOL CHEM, V280, P19600, DOI 10.1074/jbc.M501510200; Strack B, 2000, P NATL ACAD SCI USA, V97, P13063, DOI 10.1073/pnas.97.24.13063; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Sundquist WI, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006924; Sundquist WI, 2004, MOL CELL, V13, P783, DOI 10.1016/S1097-2765(04)00129-7; Tedbury PR, 2015, CURR TOP MICROBIOL, V389, P171, DOI 10.1007/82_2015_436; Usami Y, 2008, J VIROL, V82, P4898, DOI 10.1128/JVI.02675-07; Vangone A, 2011, BIOINFORMATICS, V27, P2915, DOI 10.1093/bioinformatics/btr484; Vogt VM, 2000, P NATL ACAD SCI USA, V97, P12945, DOI 10.1073/pnas.97.24.12945; Wang CJ, 2012, BIOCHEM J, V444, P279, DOI 10.1042/BJ20111983; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weiss ER, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001107; Zarrinpar A, 2000, NAT STRUCT BIOL, V7, P611, DOI 10.1038/77891; Zarrinpar Ali, 2003, Sci STKE, V2003, pRE8, DOI 10.1126/stke.2003.179.re8; ZUIDERWEG ERP, 1989, BIOCHEMISTRY-US, V28, P2387, DOI 10.1021/bi00432a008	56	3	3	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100975	10.1016/j.jbc.2021.100975	http://dx.doi.org/10.1016/j.jbc.2021.100975			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34284061	gold, Green Published			2022-12-28	WOS:000690871400017
J	Visser, EA; Moons, SJ; Timmermans, SBPE; de Jong, H; Boltje, TJ; Bull, C				Visser, Eline A.; Moons, Sam J.; Timmermans, Suzanne B. P. E.; de Jong, Heleen; Boltje, Thomas J.; Bull, Christian			Sialic acid O-acetylation: From biosynthesis to roles in health and disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INFLUENZA-C VIRUS; ACUTE LYMPHOBLASTIC-LEUKEMIA; RECEPTOR-DESTROYING ENZYME; N-ACETYLNEURAMINIC ACID; ESCHERICHIA-COLI; 9-O-ACETYL GD3; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL DETERMINATION; POLYSACCHARIDE ANTIGENS; BINDING SPECIFICITIES	Sialic acids are nine-carbon sugars that frequently cap glycans at the cell surface in cells of vertebrates as well as cells of certain types of invertebrates and bacteria. The nine-carbon backbone of sialic acids can undergo extensive enzymatic modification in nature and O-acetylation at the C-4/7/8/9 position in particular is widely observed. In recent years, the detection and analysis of O-acetylated sialic acids have advanced, and sialic acid-specific O-acetyltransferases (SOATs) and O-acetylesterases (SIAEs) that add and remove O-acetyl groups, respectively, have been identified and characterized in mammalian cells, invertebrates, bacteria, and viruses. These advances now allow us to draw a more complete picture of the biosynthetic pathway of the diverse O-acetylated sialic acids to drive the generation of genetically and biochemically engineered model cell lines and organisms with altered expression of O-acetylated sialic acids for dissection of their roles in glycoprotein stability, development, and immune recognition, as well as discovery of novel functions. Furthermore, a growing number of studies associate sialic acid O-acetylation with cancer, autoimmunity, and infection, providing rationale for the development of selective probes and inhibitors of SOATs and SIAEs. Here, we discuss the current insights into the biosynthesis and biological functions of O-acetylated sialic acids and review the evidence linking this modification to disease. Furthermore, we discuss emerging strategies for the design, synthesis, and potential application of unnatural O-acetylated sialic acids and inhibitors of SOATs and SIAEs that may enable therapeutic targeting of this versatile sialic acid modification.	[Visser, Eline A.; Moons, Sam J.; Timmermans, Suzanne B. P. E.; de Jong, Heleen; Boltje, Thomas J.] Radboud Univ Nijmegen, Inst Mol & Mat, Dept Synthet Organ Chem, Nijmegen, Netherlands; [Bull, Christian] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular, Copenhagen, Denmark; [Bull, Christian] Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Copenhagen, Denmark; [Bull, Christian] Hubrecht Inst, Utrecht, Netherlands	Radboud University Nijmegen; University of Copenhagen; University of Copenhagen; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Boltje, TJ (corresponding author), Radboud Univ Nijmegen, Inst Mol & Mat, Dept Synthet Organ Chem, Nijmegen, Netherlands.; Bull, C (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Cellular, Copenhagen, Denmark.; Bull, C (corresponding author), Univ Copenhagen, Fac Hlth Sci, Copenhagen Ctr Glyc, Dept Mol Med, Copenhagen, Denmark.; Bull, C (corresponding author), Hubrecht Inst, Utrecht, Netherlands.	t.boltje@ru.nl; c.bull@sund.ku.dk	Boltje, Thomas/F-9695-2015; Büll, Christian/L-9417-2013; Büll, Christian/AAN-1946-2021	Büll, Christian/0000-0001-7785-2920; Büll, Christian/0000-0001-7785-2920; Moons, Sam/0000-0001-5507-3811; Timmermans, Suzanne B P E/0000-0003-1073-9004	ERC-Stg (GlycoEdit) [758913]; Dutch Scientific Organization (NWO) [VI.202.045]	ERC-Stg (GlycoEdit); Dutch Scientific Organization (NWO)(Netherlands Organization for Scientific Research (NWO))	This work was supported by an ERC-Stg (GlycoEdit, 758913) awarded to T. J. B. and a Veni grant (VI.202.045) from the Dutch Scientific Organization (NWO) awarded to C. B.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Albers M, 2021, GLYCOBIOLOGY, V31, P1176, DOI 10.1093/glycob/cwab034; Alvarez-Rueda N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025220; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; AQUINO D, 1980, FEBS LETT, V112, P195, DOI 10.1016/0014-5793(80)80178-5; ARIGA T, 1995, BIOCHEMISTRY-US, V34, P11500, DOI 10.1021/bi00036a024; Arming S, 2011, GLYCOBIOLOGY, V21, P553, DOI 10.1093/glycob/cwq153; Asha K, 2019, J CLIN MED, V8, DOI 10.3390/jcm8020192; Baker AN, 2020, ACS CENTRAL SCI, V6, P2046, DOI 10.1021/acscentsci.0c00855; Bakkers MJG, 2017, CELL HOST MICROBE, V21, P356, DOI 10.1016/j.chom.2017.02.008; Bakkers MJG, 2016, P NATL ACAD SCI USA, V113, pE3111, DOI 10.1073/pnas.1519881113; Barnard KN, 2020, J VIROL, V94, DOI 10.1128/JVI.01567-19; Barnard KN, 2019, MBIO, V10, DOI 10.1128/mBio.02490-19; Baumann AMT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8673; Bergfeld AK, 2007, J BIOL CHEM, V282, P22217, DOI 10.1074/jbc.M703044200; Bergfeld AK, 2009, J BIOL CHEM, V284, P6, DOI 10.1074/jbc.M807518200; BHATTACHARJEE AK, 1976, CAN J BIOCHEM CELL B, V54, P1, DOI 10.1139/o76-001; BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926; Birks SM, 2011, NEURO-ONCOLOGY, V13, P950, DOI 10.1093/neuonc/nor108; Blix G, 1936, H-S Z PHYSIOL CHEM, V240, P43, DOI 10.1515/bchm2.1936.240.1-2.43; BLUM AS, 1987, P NATL ACAD SCI USA, V84, P8716, DOI 10.1073/pnas.84.23.8716; Brinkman-Van der Linden ECM, 2000, J BIOL CHEM, V275, P8625, DOI 10.1074/jbc.275.12.8625; BROSSMER R, 1993, FEBS LETT, V323, P96, DOI 10.1016/0014-5793(93)81456-A; Bulai T, 2003, FEBS LETT, V534, P185, DOI 10.1016/S0014-5793(02)03838-3; Bull C, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026102118; Bull Christian, 2020, STAR Protoc, V1, P100017, DOI 10.1016/j.xpro.2020.100017; Bull C, 2016, TRENDS BIOCHEM SCI, V41, P519, DOI 10.1016/j.tibs.2016.03.007; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; BUTOR C, 1993, J BIOL CHEM, V268, P10207; BUTOR C, 1993, J BIOL CHEM, V268, P10197; Capon C, 2001, BIOCHEM J, V358, P657, DOI 10.1042/bj3580657; Cariappa A, 2009, J EXP MED, V206, P125, DOI 10.1084/jem.20081399; Carlin AF, 2009, BLOOD, V113, P3333, DOI 10.1182/blood-2008-11-187302; Cavdarli S, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030741; Cavdarli S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010370; Cavdarli S, 2019, GLYCOCONJUGATE J, V36, P79, DOI 10.1007/s10719-018-09856-w; Chammas R, 1996, MOL BIOL CELL, V7, P1691, DOI 10.1091/mbc.7.11.1691; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chang YC, 2014, GLYCOBIOLOGY, V24, P818, DOI 10.1093/glycob/cwu067; Chang YC, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003846; Chatterjee M, 2003, GLYCOBIOLOGY, V13, P351, DOI 10.1093/glycob/cwg027; Chellappa V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053453; Chen HY, 2002, J EXP MED, V196, P1529, DOI 10.1084/jem.20021915; CHERESH DA, 1984, SCIENCE, V225, P844, DOI 10.1126/science.6206564; Cheung NKV, 2013, NAT REV CANCER, V13, P397, DOI 10.1038/nrc3526; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Clarke PA, 2012, ORG BIOMOL CHEM, V10, P529, DOI 10.1039/c1ob06348k; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Cohen M, 2010, OMICS, V14, P455, DOI 10.1089/omi.2009.0148; CORFIELD A P, 1992, Biochemical Society Transactions, V20, p94S; Corfield AP, 2018, MICROORGANISMS, V6, DOI 10.3390/microorganisms6030078; CORFIELD AP, 1986, BIOL CHEM H-S, V367, P433, DOI 10.1515/bchm3.1986.367.1.433; CORFIELD AP, 1992, INFECT IMMUN, V60, P3971, DOI 10.1128/IAI.60.10.3971-3978.1992; Corfield AP, 1999, GLYCOCONJUGATE J, V16, P307, DOI 10.1023/A:1007026314792; CORFIELD AP, 1993, GLYCOCONJUGATE J, V10, P72, DOI 10.1007/BF00731190; Daines DA, 2000, FEMS MICROBIOL LETT, V189, P281, DOI 10.1111/j.1574-6968.2000.tb09244.x; de Vries E, 2020, TRENDS MICROBIOL, V28, P57, DOI 10.1016/j.tim.2019.08.010; DeMaria R, 1997, SCIENCE, V277, P1652, DOI 10.1126/science.277.5332.1652; Deszo EL, 2005, P NATL ACAD SCI USA, V102, P5564, DOI 10.1073/pnas.0407428102; Diaz SL, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.04697; Duan ST, 2020, ANNU REV IMMUNOL, V38, P365, DOI 10.1146/annurev-immunol-102419-035900; Dumermuth E, 2002, J BIOL CHEM, V277, P18687, DOI 10.1074/jbc.M109408200; Erdmann M, 2006, GLYCOCONJUGATE J, V23, P627, DOI 10.1007/s10719-006-9000-5; Fahr C, 2001, J INVEST DERMATOL, V116, P254, DOI 10.1046/j.1523-1747.2001.01237.x; Feuerbaum S, 2018, INT J MED MICROBIOL, V308, P1113, DOI 10.1016/j.ijmm.2018.10.001; Fitz W, 1996, BIOORGAN MED CHEM, V4, P1349, DOI 10.1016/0968-0896(96)00123-X; Fleurence J, 2020, INT J CANCER, V146, P424, DOI 10.1002/ijc.32533; Fleurence J, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/5604891; Forni D, 2017, TRENDS MICROBIOL, V25, P35, DOI 10.1016/j.tim.2016.09.001; Fowler CC, 2017, CURR OPIN MICROBIOL, V35, P70, DOI 10.1016/j.mib.2017.01.012; FRASA H, 1993, J CLIN MICROBIOL, V31, P3174, DOI 10.1128/JCM.31.12.3174-3178.1993; Freeze HH., 2015, ESSENTIALS GLYCOBIOL, P51, DOI DOI 10.1101/GLYCOBIOLOGY.3E.005; Ghosh S, 2005, J CELL BIOCHEM, V95, P206, DOI 10.1002/jcb.20382; Ghosh S, 2005, BRIT J HAEMATOL, V128, P35, DOI 10.1111/j.1365-2141.2004.05256.x; Ghoshal A, 2010, GLYCOBIOLOGY, V20, P553, DOI 10.1093/glycob/cwp207; Giammarioli AM, 2001, FEBS LETT, V506, P45, DOI 10.1016/S0014-5793(01)02776-4; Gocht A, 1998, HISTOCHEM CELL BIOL, V110, P217, DOI 10.1007/s004180050284; GOROG P, 1985, J PATHOL, V146, P205, DOI 10.1002/path.1711460307; Grivennikov SI, 2012, NATURE, V491, P254, DOI 10.1038/nature11465; Groux-Degroote S, 2018, PROG MOL BIOL TRANSL, V156, P197, DOI 10.1016/bs.pmbts.2017.10.003; Guimaraes MJ, 1996, J BIOL CHEM, V271, P13697, DOI 10.1074/jbc.271.23.13697; Hansson GC, 2020, ANNU REV BIOCHEM, V89, P769, DOI [10.1146/annurev-biochem-011520-105053, 10.1146/annurev-biochem-011520105053]; Harduin-Lepers A, 2001, BIOCHIMIE, V83, P727, DOI 10.1016/S0300-9084(01)01301-3; Hashimoto N, 2019, J BIOL CHEM, V294, P10833, DOI 10.1074/jbc.RA118.007083; Heise T, 2018, CELL CHEM BIOL, V25, P1279, DOI 10.1016/j.chembiol.2018.05.018; HERRLER G, 1985, EMBO J, V4, P1503, DOI 10.1002/j.1460-2075.1985.tb03809.x; HERRLER G, 1995, BIOCHEM BIOPH RES CO, V216, P821, DOI 10.1006/bbrc.1995.2695; HERRLER G, 1992, J BIOL CHEM, V267, P12501; HIGA HH, 1988, J BIOL CHEM, V263, P8872; HIGA HH, 1985, VIROLOGY, V144, P279, DOI 10.1016/0042-6822(85)90325-3; Hofling K, 1996, VIROLOGY, V218, P127, DOI 10.1006/viro.1996.0172; Houliston RS, 2006, J BIOL CHEM, V281, P11480, DOI 10.1074/jbc.M512183200; Huang HC, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020397; Huang XC, 2015, J VIROL, V89, P7202, DOI 10.1128/JVI.00854-15; Huang YL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9141; Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116; Hunt KA, 2012, NAT GENET, V44, P3, DOI 10.1038/ng.1037; Hunter CD, 2020, CARBOHYD RES, V497, DOI 10.1016/j.carres.2020.108139; Hunter CD, 2018, ACS CHEM BIOL, V13, P922, DOI 10.1021/acschembio.7b00952; Hurdiss DL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18440-6; HUTCHINS JT, 1988, CANCER RES, V48, P483; IMHOF A, 1988, BIOL CHEM H-S, V369, P841; Iwersen M, 1998, GLYCOCONJUGATE J, V15, P895, DOI 10.1023/A:1006911100081; Janbon G, 2001, MOL MICROBIOL, V42, P453, DOI 10.1046/j.1365-2958.2001.02651.x; Jellusova J, 2010, J IMMUNOL, V184, P3618, DOI 10.4049/jimmunol.0902711; Ji Y, 2021, ACS CHEM BIOL, V16, P1951, DOI 10.1021/acschembio.0c00998; Kahya HF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006263; KAMERLING JP, 1975, CARBOHYD RES, V41, P7, DOI 10.1016/S0008-6215(00)87002-0; KAMERLING JP, 1987, EUR J BIOCHEM, V162, P601, DOI 10.1111/j.1432-1033.1987.tb10681.x; Kanamori A, 1997, P NATL ACAD SCI USA, V94, P2897, DOI 10.1073/pnas.94.7.2897; KELM S, 1994, GLYCOCONJUGATE J, V11, P576, DOI 10.1007/BF00731309; Khedri Z, 2017, ACS CHEM BIOL, V12, P214, DOI 10.1021/acschembio.6b00928; Kinoshita M, 2020, ACS OMEGA, V5, P18608, DOI 10.1021/acsomega.0c00935; Klein A, 1998, BIOCHIMIE, V80, P49, DOI 10.1016/S0300-9084(98)80056-4; KLEIN A, 1994, P NATL ACAD SCI USA, V91, P7782, DOI 10.1073/pnas.91.16.7782; Klenk E, 1941, H-S Z PHYSIOL CHEM, V268, P50, DOI 10.1515/bchm2.1941.268.1-2.50; KNIEP B, 1993, BLOOD, V82, P1776; KNIEP B, 1995, J BIOL CHEM, V270, P30173; Kudelka MR, 2020, NAT REV GASTRO HEPAT, V17, P597, DOI 10.1038/s41575-020-0331-7; Kumari R, 2021, BRIT J CANCER, V124, P1428, DOI 10.1038/s41416-020-01237-1; Langereis MA, 2015, CELL REP, V11, P1966, DOI 10.1016/j.celrep.2015.05.044; Langereis MA, 2009, P NATL ACAD SCI USA, V106, P15897, DOI 10.1073/pnas.0904266106; Larsson JMH, 2009, GLYCOBIOLOGY, V19, P756, DOI 10.1093/glycob/cwp048; Lathem WW, 2002, MOL MICROBIOL, V45, P277, DOI 10.1046/j.1365-2958.2002.02997.x; Lee HJ, 2009, J BIOL CHEM, V284, P24501, DOI 10.1074/jbc.M109.006049; Lewis AL, 2006, J BIOL CHEM, V281, P11186, DOI 10.1074/jbc.M513772200; Lewis AL, 2004, P NATL ACAD SCI USA, V101, P11123, DOI 10.1073/pnas.0403010101; Lewis AL, 2007, J BIOL CHEM, V282, P27562, DOI 10.1074/jbc.M700340200; Lewis AL, 2012, CELL MICROBIOL, V14, P1174, DOI 10.1111/j.1462-5822.2012.01807.x; Lewis AL, 2009, P NATL ACAD SCI USA, V106, P13552, DOI 10.1073/pnas.0902431106; Li RY, 2020, J ORG CHEM, V85, P16157, DOI 10.1021/acs.joc.0c02134; Li WQ, 2020, GLYCOBIOLOGY, V30, P787, DOI 10.1093/glycob/cwaa040; Li WQ, 2017, CARBOHYD RES, V451, P51, DOI 10.1016/j.carres.2017.09.003; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li ZS, 2021, NAT CHEM, V13, P496, DOI 10.1038/s41557-021-00655-9; Lin BX, 2016, APPL MICROBIOL BIOT, V100, P1, DOI 10.1007/s00253-015-7019-x; Liu RX, 2020, VIROLOGY, V545, P16, DOI 10.1016/j.virol.2020.02.007; Lrhorfi LA, 2007, BIOL CHEM, V388, P297, DOI 10.1515/BC.2007.033; Macauley MS, 2014, NAT REV IMMUNOL, V14, P653, DOI 10.1038/nri3737; Mahajan VS, 2019, GLYCOBIOLOGY, V29, P222, DOI 10.1093/glycob/cwy110; Mahajan VS, 2016, CELL REP, V15, P1901, DOI 10.1016/j.celrep.2016.04.080; Malaker SA, 2019, P NATL ACAD SCI USA, V116, P7278, DOI 10.1073/pnas.1813020116; Malisan F, 2002, BBA-MOL CELL BIOL L, V1585, P179, DOI 10.1016/S1388-1981(02)00339-6; Malisan F, 2002, J EXP MED, V196, P1535, DOI 10.1084/jem.20020960; Mandal C, 2012, GLYCOBIOLOGY, V22, P70, DOI 10.1093/glycob/cwr106; Mandal C, 2009, GLYCOCONJUGATE J, V26, P57, DOI 10.1007/s10719-008-9163-3; Mandal C, 2015, TOP CURR CHEM, V366, P1, DOI 10.1007/128_2011_310; Mann B, 1997, INT J CANCER, V72, P258, DOI 10.1002/(SICI)1097-0215(19970717)72:2<258::AID-IJC10>3.3.CO;2-0; Marquina G, 1996, CANCER RES, V56, P5165; Marth JD, 2008, NAT CELL BIOL, V10, P1015, DOI 10.1038/ncb0908-1015; Martin LT, 2002, J BIOL CHEM, V277, P32930, DOI 10.1074/jbc.M203362200; Mather RL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44950-5; Matrosovich M, 2015, TOP CURR CHEM, V367, P1, DOI 10.1007/128_2013_466; Mayr J, 2008, GLYCOCONJUGATE J, V25, P393, DOI 10.1007/s10719-007-9094-4; MCEVER RP, 1995, J BIOL CHEM, V270, P11025, DOI 10.1074/jbc.270.19.11025; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyakoshi LM, 2012, MOL CELL NEUROSCI, V49, P240, DOI 10.1016/j.mcn.2011.08.010; Miyazaki K, 2012, J IMMUNOL, V188, P4690, DOI 10.4049/jimmunol.1100605; Moons SJ, 2019, GLYCOBIOLOGY, V29, P433, DOI 10.1093/glycob/cwz026; MORELL AG, 1971, J BIOL CHEM, V246, P1461; Mukherjee K, 2007, BIOCHEM BIOPH RES CO, V362, P651, DOI 10.1016/j.bbrc.2007.08.048; Mukherjee K, 2009, BIOL CHEM, V390, P325, DOI 10.1515/BC.2009.036; Mukherjee K, 2008, J CELL BIOCHEM, V105, P724, DOI 10.1002/jcb.21867; Narimatsu Y, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100448; Narimatsu Y, 2019, MOL CELL, V75, P394, DOI 10.1016/j.molcel.2019.05.017; Nason R., 2021, NAT COMMUN, V12, P4070; Nguyen T, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008336; Nicoll G, 2003, EUR J IMMUNOL, V33, P1642, DOI 10.1002/eji.200323693; NORIHISA Y, 1994, J IMMUNOL, V152, P485; Ogura K, 1996, BIOCHEM BIOPH RES CO, V225, P932, DOI 10.1006/bbrc.1996.1274; Orizio F, 2015, GLYCOBIOLOGY, V25, P992, DOI 10.1093/glycob/cwv034; ORSKOV F, 1979, J EXP MED, V149, P669, DOI 10.1084/jem.149.3.669; Ou XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15216; Padler-Karavani V, 2014, FASEB J, V28, P1280, DOI 10.1096/fj.13-241497; Pal S, 2004, INT J CANCER, V111, P270, DOI 10.1002/ijc.20246; Parameswaran R, 2013, J EXP MED, V210, P805, DOI 10.1084/jem.20121482; Park SS, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7040171; Pearce OMT, 2016, GLYCOBIOLOGY, V26, P111, DOI 10.1093/glycob/cwv097; Phansopa C, 2015, BIOCHEM J, V472, P157, DOI 10.1042/BJ20150388; Rangarajan ES, 2011, PROTEIN SCI, V20, P1208, DOI 10.1002/pro.649; Rangel A, 2016, J BACTERIOL, V198, P2803, DOI 10.1128/JB.00189-16; Ravasio V, 2017, GLYCOBIOLOGY, V27, P938, DOI 10.1093/glycob/cwx068; Ravindranath MH, 2008, MELANOMA RES, V18, P47, DOI 10.1097/CMR.0b013e3282f43acf; Ribeiro-Resende VT, 2007, NEUROSCIENCE, V147, P97, DOI 10.1016/j.neuroscience.2007.03.046; Rillahan CD, 2011, ANNU REV BIOCHEM, V80, P797, DOI 10.1146/annurev-biochem-061809-152236; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Robbe C, 2003, J BIOL CHEM, V278, P46337, DOI 10.1074/jbc.M302529200; Robinson LS, 2017, J BIOL CHEM, V292, P11861, DOI 10.1074/jbc.M116.769232; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Rosenthal PB, 1998, NATURE, V396, P92, DOI 10.1038/23974; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saile N, 2018, INT J MED MICROBIOL, V308, P459, DOI 10.1016/j.ijmm.2018.03.006; Sait S, 2017, EXPERT REV ANTICANC, V17, P889, DOI 10.1080/14737140.2017.1364995; Schauer R, 2011, ADV EXP MED BIOL, V705, P525, DOI 10.1007/978-1-4419-7877-6_28; Schauer R, 2018, ADV CARBOHYD CHEM BI, V75, P1, DOI 10.1016/bs.accb.2018.09.001; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Schjoldager KT, 2020, NAT REV MOL CELL BIO, V21, P729, DOI 10.1038/s41580-020-00294-x; Schnaar R.L., 2015, ESSENTIALS GLYCOBIOL, P125; Schulz EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017403; Sevdali E, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/1514294; Severi E, 2007, MICROBIOL-SGM, V153, P2817, DOI 10.1099/mic.0.2007/009480-0; Shen YQ, 2004, BIOL CHEM, V385, P145, DOI 10.1515/BC.2004.033; Shen YQ, 2004, EUR J BIOCHEM, V271, P281, DOI 10.1046/j.1432-1033.2003.03927.x; Shi WX, 1996, J BIOL CHEM, V271, P15130, DOI 10.1074/jbc.271.25.15130; Shi WX, 1996, J BIOL CHEM, V271, P31526, DOI 10.1074/jbc.271.49.31526; Shi WX, 1998, GLYCOBIOLOGY, V8, P199, DOI 10.1093/glycob/8.2.199; Sinha D, 1999, LEUKEMIA, V13, P119, DOI 10.1038/sj.leu.2401239; SJOBERG ER, 1994, J CELL BIOL, V126, P549, DOI 10.1083/jcb.126.2.549; SJOBERG ER, 1992, J BIOL CHEM, V267, P16200; Song H, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005411; Song JM, 2013, NATURE, V499, P350, DOI 10.1038/nature12377; Sorensen AL, 2009, BLOOD, V114, P1645, DOI 10.1182/blood-2009-01-199414; Stanley M, 2011, EUR J MED CHEM, V46, P2852, DOI 10.1016/j.ejmech.2011.04.008; Steenbergen SM, 2006, J BACTERIOL, V188, P6195, DOI 10.1128/JB.00466-06; Steenbergen SM, 2009, J BACTERIOL, V191, P7134, DOI 10.1128/JB.01000-09; Stencel-Baerenwald JE, 2014, NAT REV MICROBIOL, V12, P739, DOI 10.1038/nrmicro3346; Stoddart A, 1996, NUCLEIC ACIDS RES, V24, P4003, DOI 10.1093/nar/24.20.4003; Strilic B, 2010, CURR BIOL, V20, P2003, DOI 10.1016/j.cub.2010.09.061; Surolia I, 2010, NATURE, V466, P243, DOI 10.1038/nature09115; Takamiya R, 2013, GLYCOBIOLOGY, V23, P178, DOI 10.1093/glycob/cws139; Takematsu H, 1999, J BIOL CHEM, V274, P25623, DOI 10.1074/jbc.274.36.25623; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Tortorici MA, 2019, NAT STRUCT MOL BIOL, V26, P481, DOI 10.1038/s41594-019-0233-y; Uchiyama S, 2019, P NATL ACAD SCI USA, V116, P7465, DOI 10.1073/pnas.1815572116; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van de Wall S, 2020, TRENDS IMMUNOL, V41, P274, DOI 10.1016/j.it.2020.02.001; VARKI A, 1984, ANAL BIOCHEM, V137, P236, DOI 10.1016/0003-2697(84)90377-4; VARKI A, 1991, CELL, V65, P65, DOI 10.1016/0092-8674(91)90408-Q; VARKI A, 1985, J BIOL CHEM, V260, P6600; Varki A., 2022, ESSENTIALS GLYCOBIOL, V4; Varki A, 2006, CELL, V126, P841, DOI 10.1016/j.cell.2006.08.022; Varki A, 2020, GLYCOBIOLOGY, V30, P132, DOI 10.1093/glycob/cwaa007; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Varki A, 2015, GLYCOBIOLOGY, V25, P1323, DOI 10.1093/glycob/cwv091; Varki A, 2012, ANN NY ACAD SCI, V1253, P16, DOI 10.1111/j.1749-6632.2012.06517.x; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; VLASAK R, 1989, J VIROL, V63, P2056, DOI 10.1128/JVI.63.5.2056-2062.1989; VLASAK R, 1988, J VIROL, V62, P4686, DOI 10.1128/JVI.62.12.4686-4690.1988; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang J, 2019, NAT MED, V25, P656, DOI 10.1038/s41591-019-0374-x; Wasik BR, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00379-16; Wasik BR, 2016, TRENDS MICROBIOL, V24, P991, DOI 10.1016/j.tim.2016.07.005; Weiman S, 2010, BIOCHEM J, V428, P163, DOI 10.1042/BJ20100232; WELTE K, 1987, J IMMUNOL, V139, P1763; Wipfler D, 2011, GLYCOBIOLOGY, V21, P1161, DOI 10.1093/glycob/cwr050; Wu ZG, 2017, SCI REP-UK, V7, DOI 10.1038/srep46206; Yang WH, 2015, P NATL ACAD SCI USA, V112, P13657, DOI 10.1073/pnas.1515464112; Yang YA, 2018, NAT MICROBIOL, V3, P155, DOI 10.1038/s41564-017-0076-4; YE JN, 1992, INT J CANCER, V50, P197, DOI 10.1002/ijc.2910500207; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zeng QH, 2008, P NATL ACAD SCI USA, V105, P9065, DOI 10.1073/pnas.0800502105; Zhang DD, 2015, GENET MOL RES, V14, P14162, DOI 10.4238/2015.October.29.38	253	16	17	7	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100906	10.1016/j.jbc.2021.100906	http://dx.doi.org/10.1016/j.jbc.2021.100906			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34157283	Green Published, gold			2022-12-28	WOS:000690873500018
J	Xu, YQ; Guo, C; Pan, WF; Zhao, C; Ding, YY; Xie, XQ; Wei, ZY; Sun, Y; Yu, C				Xu, Yuqun; Guo, Chen; Pan, Wenfei; Zhao, Chan; Ding, Yanyan; Xie, Xingqiao; Wei, Zhiyi; Sun, Ying; Yu, Cong			Nephrotic-syndrome-associated mutation of KANK2 induces pathologic binding competition with physiological interactor KIF21A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; TRANSFORMATION SUPPRESSOR; STRUCTURAL BASIS; PROTEINS; MECHANISM; FAMILY; PDCD4; MODEL; GENE	Nephrotic syndrome (NS) is a common kidney disorder caused by dysfunction of the glomerular filtration barrier. Some genetic mutations identified in NS patients cause amino acid substitutions of kidney ankyrin repeat-containing (KANK) proteins, which are scaffold proteins that regulate actin polymerization, microtubule targeting, and cell adhesion via binding to various molecules, including the kinesin motor protein KIF21A. However, the mechanisms by which these mutations lead to NS are unclear. Here, we unexpectedly found that the eukaryotic translation initiation factor 4A1 (eIF4A1) interacts with an NS-associated KANK2 mutant (S684F) but not the wildtype protein. Biochemical and structural analyses revealed that the pathological mutation induces abnormal binding of eIF4A1 to KANK2 at the physiological KIF21A-binding site. Competitive binding assays further indicated that eIF4A1 can compete with KIF21A to interact with the S684F mutant of KANK2. In cultured mouse podocytes, this S684F mutant interfered with the KANK2/KIF21A interaction by binding to eIF4A1, and failed to rescue the focal adhesion or cell adhesion that had been reduced or morphologically changed by KANK2 knockout. These structural, biochemical, and cellular results not only provide mechanistic explanations for the podocyte defects caused by the S684F mutation, but also show how a gain-ofbinding mutation can lead to a loss-of-function effect.	[Xu, Yuqun; Guo, Chen; Pan, Wenfei; Zhao, Chan; Ding, Yanyan; Xie, Xingqiao; Wei, Zhiyi; Sun, Ying; Yu, Cong] Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Guangdong, Peoples R China; [Xie, Xingqiao; Wei, Zhiyi; Yu, Cong] Acad Adv Interdisciplinary Studies, Shenzhen, Guangdong, Peoples R China; [Wei, Zhiyi] Southern Univ Sci & Technol, Brain Res Ctr, Shenzhen, Guangdong, Peoples R China; [Sun, Ying; Yu, Cong] Southern Univ Sci & Technol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Guangdong, Peoples R China; [Sun, Ying; Yu, Cong] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen, Guangdong, Peoples R China	Southern University of Science & Technology; Southern University of Science & Technology; Southern University of Science & Technology; Southern University of Science & Technology	Wei, ZY; Sun, Y; Yu, C (corresponding author), Southern Univ Sci & Technol, Sch Life Sci, Dept Biol, Shenzhen, Guangdong, Peoples R China.; Wei, ZY; Yu, C (corresponding author), Acad Adv Interdisciplinary Studies, Shenzhen, Guangdong, Peoples R China.; Wei, ZY (corresponding author), Southern Univ Sci & Technol, Brain Res Ctr, Shenzhen, Guangdong, Peoples R China.; Sun, Y; Yu, C (corresponding author), Southern Univ Sci & Technol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Guangdong, Peoples R China.; Sun, Y; Yu, C (corresponding author), Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Dept Biol, Shenzhen, Guangdong, Peoples R China.	weizy@sustech.edu.cn; suny@sustech.edu.cn; yuc@sustech.edu.cn	ding, yy/HHS-9589-2022; Wei, Zhiyi/N-9995-2019	Wei, Zhiyi/0000-0002-4446-6502	National Natural Science Foundation of China [31770791, 31870757, 31971131, 32000867, 82070728, 81900632, 81772983]; Natural Science Foundation of Guangdong Province [2016A030312016, 2020A1515011305]; Department of Education of Guangdong Province [2020KZDZX1187]; Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Fundamental Research Institutions [2021SHIBS0002]; Shenzhen Innovation Committee of Science and Technology, China [JCYJ20190809141003834, JCYJ20200109141241950, JCYJ20200109141212325]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Department of Education of Guangdong Province(National Natural Science Foundation of Guangdong Province); Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Fundamental Research Institutions; Shenzhen Innovation Committee of Science and Technology, China	We thank Dr Ting Zhang for her suggestions on the experiment design. We thank Drs Ruijun Tian, Wendong Chen, and Lin Lin for their help in MS analysis. We are grateful to Drs Anna Akhmanova, Reinhard Fassler, and Chao Wang for generously providing the plasmids encoding KANK1, KANK2, and the 190-kD isoform of ankyrin-G and Dr Chuanyue Wu for kindly providing the mouse podocyte cells. We thank the assistance of BL19U1 beamline at National Center for Protein Sciences Shanghai and Southern University of Science and Technology Core Research Facilities. This work was supported by the National Natural Science Foundation of China (Grant No. 31770791, 31870757, 31971131, 32000867, 82070728, 81900632, and 81772983), Natural Science Foundation of Guangdong Province (2016A030312016, 2020A1515011305), Department of Education of Guangdong Province (2020KZDZX1187), Shenzhen-Hong Kong Institute of Brain Science, Shenzhen Fundamental Research Institutions (2021SHIBS0002), the Shenzhen Innovation Committee of Science and Technology, China (JCYJ20190809141003834, JCYJ20200109141241950, and JCYJ20200109141212325).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Chang JH, 2009, P NATL ACAD SCI USA, V106, P3148, DOI 10.1073/pnas.0808275106; Chen NP, 2018, CURR OPIN CELL BIOL, V54, P130, DOI 10.1016/j.ceb.2018.05.015; Desai J, 2012, GENE EXPR PATTERNS, V12, P180, DOI 10.1016/j.gep.2012.03.003; Eddy AA, 2003, LANCET, V362, P629, DOI 10.1016/S0140-6736(03)14184-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galicia-Vazquez G, 2012, RNA, V18, P1373, DOI 10.1261/rna.033209.112; Garg P, 2018, AM J NEPHROL, V47, P3, DOI 10.1159/000481633; Gee HY, 2013, J CLIN INVEST, V123, P3243, DOI 10.1172/JCI69134; Kakinuma N, 2009, CELL MOL LIFE SCI, V66, P2651, DOI 10.1007/s00018-009-0038-y; Lerer I, 2005, HUM MOL GENET, V14, P3911, DOI 10.1093/hmg/ddi415; Liu J, 2021, J CELL SCI, V134, DOI 10.1242/jcs.244616; Loh PG, 2009, EMBO J, V28, P274, DOI 10.1038/emboj.2008.278; MUNDEL P, 1995, ANAT EMBRYOL, V192, P387; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305; Orth SR, 1998, NEW ENGL J MED, V338, P1202, DOI 10.1056/NEJM199804233381707; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ramot Y, 2014, J MED GENET, V51, P388, DOI 10.1136/jmedgenet-2014-102346; Rinschen MM, 2018, CELL REP, V23, P2495, DOI 10.1016/j.celrep.2018.04.059; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarkar S, 2002, J BIOL CHEM, V277, P36585, DOI 10.1074/jbc.M204244200; Schroeter CB, 2018, FASEB J, V32, P4696, DOI 10.1096/fj.201701307R; Scott RP, 2015, J CELL BIOL, V209, P199, DOI 10.1083/jcb.201410017; Stefl S, 2013, J MOL BIOL, V425, P3919, DOI 10.1016/j.jmb.2013.07.014; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Sun Y, 2012, J CELL SCI, V125, P4507, DOI 10.1242/jcs.105023; Tsang B, 2020, CELL, V183, P1742, DOI 10.1016/j.cell.2020.11.050; Welsh GI, 2012, NAT REV NEPHROL, V8, P14, DOI 10.1038/nrneph.2011.151; Yang HS, 2003, MOL CELL BIOL, V23, P26, DOI 10.1128/MCB.23.1.26-37.2003; Yang HS, 2001, ONCOGENE, V20, P669, DOI 10.1038/sj.onc.1204137; Yu M, 2019, NANO LETT, V19, P5982, DOI 10.1021/acs.nanolett.9b01732; Zhu Y, 2008, BBA-GEN SUBJECTS, V1780, P128, DOI 10.1016/j.bbagen.2007.09.017	33	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100958	10.1016/j.jbc.2021.100958	http://dx.doi.org/10.1016/j.jbc.2021.100958			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34274317	gold, Green Published			2022-12-28	WOS:000690871400006
J	Egri, SB; Shen, K				Egri, Shawn B.; Shen, Kuang			An interdomain hydrogen bond in the Rag GTPases maintains stable mTORC1 signaling in sensing amino acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; COMPLEX REVEALS; TORC1	Cellular growth and proliferation are primarily dictated by the mechanistic target of rapamycin complex 1 (mTORC1), which balances nutrient availability against the cell's anabolic needs. Central to the activity of mTORC1 is the RagA-RagC GTPase heterodimer, which under favorable conditions recruits the complex to the lysosomal surface to promote its activity. The RagA-RagC heterodimer has a unique architecture in that both subunits are active GTPases. To promote mTORC1 activity, the RagA subunit is loaded with GTP and the RagC subunit is loaded with GDP, while the opposite nucleotide-loading configuration inhibits this signaling pathway. Despite its unique molecular architecture, how the Rag GTPase heterodimer maintains the oppositely loaded nucleotide state remains elusive. Here, we applied structure-function analysis approach to the crystal structures of the Rag GTPase heterodimer and identified a key hydrogen bond that stabilizes the GDP-loaded state of the Rag GTPases. This hydrogen bond is mediated by the backbone carbonyl of Asn30 in the nucleotide-binding domain of RagA or Lys84 of RagC and the hydroxyl group on the side chain of Thr210 in the C-terminal roadblock domain of RagA or Ser266 of RagC, respectively. Eliminating this interdomain hydrogen bond abolishes the ability of the Rag GTPase to maintain its functional state, resulting in a distorted response to amino acid signals. Our results reveal that this long-distance interdomain interaction within the Rag GTPase is required for the maintenance and regulation of the mTORC1 nutrient-sensing pathway.	[Egri, Shawn B.; Shen, Kuang] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Shen, K (corresponding author), Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA 01605 USA.	kuang.Shen@umassmed.edu			NIH [K22CA241362]; 2020 Mello Scholarship of the Program in Molecular Medicine	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); 2020 Mello Scholarship of the Program in Molecular Medicine	This work was supported by a Grant from the NIH (K22CA241362) to K. S. S. B. E. was supported by the 2020 Mello Scholarship of the Program in Molecular Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anandapadamanaban M, 2019, SCIENCE, V366, P203, DOI 10.1126/science.aax3939; Ben-Sahra I, 2017, CURR OPIN CELL BIOL, V45, P72, DOI 10.1016/j.ceb.2017.02.012; Gong R, 2011, GENE DEV, V25, P1668, DOI 10.1101/gad.16968011; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Jeong JH, 2012, J BIOL CHEM, V287, P29648, DOI 10.1074/jbc.C112.384420; Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Rogala KB, 2019, SCIENCE, V366, P468, DOI 10.1126/science.aay0166; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Shen K, 2017, MOL CELL, V68, P552, DOI 10.1016/j.molcel.2017.09.026; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361	12	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100861	10.1016/j.jbc.2021.100861	http://dx.doi.org/10.1016/j.jbc.2021.100861			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34116056	Green Published, gold			2022-12-28	WOS:000678068400061
J	Liew, JJM; El Saudi, IM; Nguyen, SV; Wicht, DK; Dowling, DP				Liew, Jeremy J. M.; El Saudi, Israa M.; Nguyen, Son, V; Wicht, Denyce K.; Dowling, Daniel P.			Structures of the alkanesulfonate monooxygenase MsuD provide insight into C-S bond cleavage, substrate scope, and an unexpected role for the tetramer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REDUCED FLAVIN MONONUCLEOTIDE; CRYSTAL-STRUCTURE; PSEUDOMONAS-PUTIDA; METHANESULFONIC-ACID; ESCHERICHIA-COLI; DIMETHYL SULFIDE; FUNCTIONAL-ROLE; PROTEIN; SULFUR; DIBENZOTHIOPHENE	Bacterial two-component flavin-dependent monooxygenases cleave the stable C-S bond of environmental and anthropogenic organosulfur compounds. The monooxygenase MsuD converts methanesulfonate (MS-) to sulfite, completing the sulfur assimilation process during sulfate starvation, but the mechanism of this conversion remains unclear. To explore the mechanism of C-S bond cleavage, we report a series of crystal structures of MsuD from Pseudomonas fluorescens in different liganded states. This report provides the first crystal structures of an alkanesulfonate monooxygenase with a bound flavin and alkanesulfonate, elucidating the roles of the active site lid, the protein C terminus, and an active site loop in flavin and/or alkanesulfonate binding. These structures position MS- closest to the flavin N5 position, consistent with an N5-(hydro) peroxyflavin mechanism rather than a classical C4a-(hydro) peroxyflavin mechanism. A fully enclosed active site is observed in the ternary complex, mediated by interchain interaction of the C terminus at the tetramer interface. These structures identify an unexpected function of the protein C terminus in this protein family in stabilizing tetramer formation and the alkanesulfonate-binding site. Spurred by interest from the crystal structures, we conducted biochemical assays and molecular docking that redefine MsuD as a small- to medium-chain alkanesulfonate monooxygenase. Functional mutations verify the sulfonate-binding site and reveal the critical importance of the protein C terminus for monooxygenase function. These findings reveal a deeper understanding of MsuD's functionality at the molecular level and consequently how it operates within its role as part of the sulfur assimilation pathway.	[Liew, Jeremy J. M.; El Saudi, Israa M.; Dowling, Daniel P.] Univ Massachusetts, Dept Chem, Boston, MA 02125 USA; [Nguyen, Son, V; Wicht, Denyce K.] Suffolk Univ, Dept Chem & Biochem, Boston, MA 02114 USA; [Nguyen, Son, V] Univ New Hampshire, Dept Chem, Durham, NH 03824 USA	University of Massachusetts System; University of Massachusetts Boston; Suffolk University; University System Of New Hampshire; University of New Hampshire	Dowling, DP (corresponding author), Univ Massachusetts, Dept Chem, Boston, MA 02125 USA.	daniel.dowling@umb.edu		Liew, Jeremy J.M./0000-0002-9190-8772; Dowling, Daniel/0000-0002-2536-0905	National Science Foundation, USA [1807480]; National Institutes of Health (NIH) [2R25GM076321]; Undergraduate Research Funds	National Science Foundation, USA(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Undergraduate Research Funds	This work was supported by the National Science Foundation, USA (1807480 to D. K. W. and D. P. D.). Opinions, findings, and conclusions or recommendations expressed are those of the authors and do not necessarily reflect the views of the National Science Foundation. I. M. E. was supported by a National Institutes of Health (NIH) IMSD grant award (2R25GM076321) and Undergraduate Research Funds. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adak S, 2019, BIOCHEMISTRY-US, V58, P1181, DOI 10.1021/acs.biochem.9b00012; Adak S, 2017, BIOCHEMISTRY-US, V56, P3708, DOI 10.1021/acs.biochem.7b00493; Adak S, 2016, J AM CHEM SOC, V138, P6424, DOI 10.1021/jacs.6b00583; AUTRY AR, 1990, BIOL FERT SOILS, V10, P50; BANNER DW, 1975, NATURE, V255, P609, DOI 10.1038/255609a0; Barnes I, 2006, CHEM REV, V106, P940, DOI 10.1021/cr020529+; Bentley R, 2004, CHEMOSPHERE, V55, P291, DOI 10.1016/j.chemosphere.2003.12.017; Bhandari D, 2017, THESIS TEXAS A M U THESIS TEXAS A M U; Borodina E, 2000, ARCH MICROBIOL, V173, P425, DOI 10.1007/s002030000165; Braymer JJ, 2017, J BIOL CHEM, V292, P12754, DOI 10.1074/jbc.R117.787101; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Campbell ZT, 2009, BIOCHEMISTRY-US, V48, P6085, DOI 10.1021/bi900003t; Cao HY, 2018, ACTA CRYSTALLOGR F, V74, P781, DOI 10.1107/S2053230X18015844; Carpenter RA, 2011, BIOCHEMISTRY-US, V50, P6469, DOI 10.1021/bi200429d; Chenprakhon P, 2014, BIOCHEMISTRY-US, V53, P4084, DOI 10.1021/bi500480n; Clifton M. C., 2011, Protein data bank, DOI 10.2210/pdb3SDO/pdb; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; de Gonzalo G, 2010, CHEMBIOCHEM, V11, P2208, DOI 10.1002/cbic.201000395; Domagalski M. J., 2011, PROTEIN DATA BANK, DOI [10.2210/pdb3RAO, DOI 10.2210/PDB3RAO]; DRAPER RD, 1968, ARCH BIOCHEM BIOPHYS, V125, P802, DOI 10.1016/0003-9861(68)90517-1; Eichhorn E, 1997, J BIOL CHEM, V272, P23031, DOI 10.1074/jbc.272.37.23031; Eichhorn E, 2002, J MOL BIOL, V324, P457, DOI 10.1016/S0022-2836(02)01069-0; Eichhorn E, 1999, J BIOL CHEM, V274, P26639, DOI 10.1074/jbc.274.38.26639; Ellis HR, 2011, BIOORG CHEM, V39, P178, DOI 10.1016/j.bioorg.2011.08.001; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Endoh T, 2005, MOL MICROBIOL, V55, P897, DOI 10.1111/j.1365-2958.2004.04431.x; Endoh T, 2003, MICROBIOL-SGM, V149, P991, DOI 10.1099/mic.0.26031-0; Fisher AJ, 1996, J BIOL CHEM, V271, P21956, DOI 10.1074/jbc.271.36.21956; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; GALLAGHER JR, 1993, FEMS MICROBIOL LETT, V107, P31, DOI 10.1111/j.1574-6968.1993.tb05999.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GIBSON QH, 1962, BIOCHEM J, V83, P368, DOI 10.1042/bj0830368; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Habe H, 2007, MICROBIOL-SGM, V153, P3091, DOI 10.1099/mic.0.2007/008151-0; Higgins TP, 1997, J BACTERIOL, V179, P1974, DOI 10.1128/jb.179.6.1974-1979.1997; Higgins TP, 1996, MICROBIOL-SGM, V142, P251, DOI 10.1099/13500872-142-2-251; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Jun SY, 2016, MOL MICROBIOL, V100, P989, DOI 10.1111/mmi.13363; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KELLY DP, 1990, ADV MICROB ECOL, V11, P345; KELLY DP, 1994, MICROBIOL-SGM, V140, P1419, DOI 10.1099/00221287-140-6-1419; KERTESZ MA, 1993, J BACTERIOL, V175, P1187, DOI 10.1128/JB.175.4.1187-1190.1993; Kertesz MA, 1999, J BACTERIOL, V181, P1464, DOI 10.1128/JB.181.5.1464-1473.1999; Kertesz MA, 2000, FEMS MICROBIOL REV, V24, P135, DOI 10.1016/S0168-6445(99)00033-9; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Li L, 2008, J MOL BIOL, V376, P453, DOI 10.1016/j.jmb.2007.11.069; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Lundgren BR, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00606-18; MASSEY V, 1994, J BIOL CHEM, V269, P22459; Matthews A, 2020, NAT CHEM BIOL, V16, P556, DOI 10.1038/s41589-020-0476-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukherjee T, 2010, J AM CHEM SOC, V132, P5550, DOI 10.1021/ja9107676; Okai M, 2017, PROTEINS, V85, P1171, DOI 10.1002/prot.25267; OMORI T, 1995, BIOSCI BIOTECH BIOCH, V59, P1195, DOI 10.1271/bbb.59.1195; Quadroni M, 1996, EUR J BIOCHEM, V239, P773, DOI 10.1111/j.1432-1033.1996.0773u.x; Nguyen QT, 2017, APPL MICROBIOL BIOT, V101, P2831, DOI 10.1007/s00253-016-8038-y; Robbins JM, 2019, METHOD ENZYMOL, V620, P399, DOI 10.1016/bs.mie.2019.03.018; Robbins JM, 2014, BIOCHEMISTRY-US, V53, P161, DOI 10.1021/bi401234e; Robbins JM, 2012, BIOCHEMISTRY-US, V51, P6378, DOI 10.1021/bi300138d; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Saleem-Batcha R, 2018, P NATL ACAD SCI USA, V115, P4909, DOI 10.1073/pnas.1801189115; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Shelley JC, 2007, J COMPUT AID MOL DES, V21, P681, DOI 10.1007/s10822-007-9133-z; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simo R, 1999, GLOBAL BIOGEOCHEM CY, V13, P1173, DOI 10.1029/1999GB900081; Smart O. S., 2011, GRADE V 1 2 9 GRADE V 1 2 9; Soule J, 2020, BIOCHEM BIOPH RES CO, V522, P107, DOI 10.1016/j.bbrc.2019.11.008; Stein N, 2008, J APPL CRYSTALLOGR, V41, P641, DOI 10.1107/S0021889808006985; Su TT, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00231; Teufel R, 2013, NATURE, V503, P552, DOI 10.1038/nature12643; THYSSE GJE, 1972, ANTON VAN LEE J M S, V38, P53, DOI 10.1007/BF02328077; THYSSE GJE, 1974, A VAN LEEUW J MICROB, V40, P25, DOI 10.1007/BF00394550; van Berkel WJH, 2006, J BIOTECHNOL, V124, P670, DOI 10.1016/j.jbiotec.2006.03.044; Walsh CT, 2013, NAT PROD REP, V30, P175, DOI 10.1039/c2np20069d; Wicht DK, 2016, ARCH BIOCHEM BIOPHYS, V604, P159, DOI 10.1016/j.abb.2016.07.001; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Xiong JY, 2012, BBA-PROTEINS PROTEOM, V1824, P898, DOI 10.1016/j.bbapap.2012.04.005; Zhang R., 2003, Structural Genomics, Crystal Structure of Alkanesulfonate Monooxygenase, protein databank entry, DOI 10.2210/pdb1NQK/pdb	87	2	2	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100823	10.1016/j.jbc.2021.100823	http://dx.doi.org/10.1016/j.jbc.2021.100823			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029591	gold, Green Published			2022-12-28	WOS:000678068400025
J	Pascarelli, S; Merzhakupova, D; Uechi, GI; Laurino, P				Pascarelli, Stefano; Merzhakupova, Dalmira; Uechi, Gen-Ichiro; Laurino, Paola			Binding of single-mutant epidermal growth factor (EGF) ligands alters the stability of the EGF receptor dimer and promotes growth signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECIFICITY-DETERMINING RESIDUES; TIME-RESOLVED FLUORESCENCE; INDUCED APOPTOSIS; A431 CELLS; PROTEIN; KINASE; ACTIVATION; ALGORITHM; SELECTION; MODEL	The epidermal growth factor receptor (EGFR) is a membrane-anchored tyrosine kinase that is able to selectively respond to multiple extracellular stimuli. Previous studies have indicated that the modularity of this system may be caused by ligand-induced differences in the stability of the receptor dimer. However, this hypothesis has not been explored using single-mutant ligands thus far. Herein, we developed a new approach to identify residues responsible for functional divergence by selecting residues in the epidermal growth factor (EGF) ligand that are conserved among orthologs yet divergent between paralogs. Then, we mutated these residues and assessed the mutants' effects on the receptor using a combination of molecular dynamics (MD) and biochemical techniques. Although the EGF mutants had binding affinities for the EGFR comparable with the WT ligand, the EGF mutants showed differential patterns of receptor phosphorylation and cell growth in multiple cell lines. The MD simulations of the EGF mutants indicated that mutations had long-range effects on the receptor dimer interface. This study shows for the first time that a single mutation in the EGF is sufficient to alter the activation of the EGFR signaling pathway at the cellular level. These results also support that biased ligand-receptor signaling in the tyrosine kinase receptor system can lead to differential downstream outcomes and demonstrate a promising new method to study ligand-receptor interactions.	[Pascarelli, Stefano; Merzhakupova, Dalmira; Uechi, Gen-Ichiro; Laurino, Paola] Okinawa Inst Sci & Technol Grad Univ, Prot Engn & Evolut Unit, Onna, Okinawa, Japan	Okinawa Institute of Science & Technology Graduate University	Laurino, P (corresponding author), Okinawa Inst Sci & Technol Grad Univ, Prot Engn & Evolut Unit, Onna, Okinawa, Japan.	paola.laurino@oist.jp			Okinawa Institute of Science and Technology	Okinawa Institute of Science and Technology(Okinawa Institute of Science & Technology Graduate University)	Financial support by the Okinawa Institute of Science and Technology to P. L. is gratefully acknowledged.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ali R, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1034-7; Alvarez-Ponce D, 2017, GENOME BIOL EVOL, V9, P1742, DOI 10.1093/gbe/evx117; Arkhipov A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003742; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bakker J, 2017, J CELL SCI, V130, P4087, DOI 10.1242/jcs.209197; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bjorkelund H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016536; Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Chagoyen M, 2016, BRIEF BIOINFORM, V17, P255, DOI 10.1093/bib/bbv045; Chakrabarti S, 2007, J MOL BIOL, V373, P801, DOI 10.1016/j.jmb.2007.08.036; Colell EA, 2018, NUCLEIC ACIDS RES, V46, pW323, DOI 10.1093/nar/gky419; DELASIERRA IML, 1992, EUR BIOPHYS J BIOPHY, V21, P337, DOI 10.1007/BF00188346; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans BA, 2010, BRIT J PHARMACOL, V159, P1022, DOI 10.1111/j.1476-5381.2009.00602.x; Freed DM, 2017, CELL, V171, P683, DOI 10.1016/j.cell.2017.09.017; GALLAY J, 1993, EUR J BIOCHEM, V211, P213, DOI 10.1111/j.1432-1033.1993.tb19888.x; Gazdar AF, 2009, ONCOGENE, V28, pS24, DOI 10.1038/onc.2009.198; GIARD DJ, 1973, J NATL CANCER I, V51, P1417, DOI 10.1093/jnci/51.5.1417; Gocheva G, 2019, MOL PHARMACEUT, V16, P3293, DOI 10.1021/acs.molpharmaceut.9b00250; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GROENEN LC, 1994, GROWTH FACTORS, V11, P235, DOI 10.3109/08977199409010997; Grudinkin PS, 2007, EUR J CELL BIOL, V86, P591, DOI 10.1016/j.ejcb.2007.05.009; Gulli LF, 1996, CELL GROWTH DIFFER, V7, P173; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; HOMMEL U, 1992, J MOL BIOL, V227, P271, DOI 10.1016/0022-2836(92)90697-I; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Huang YJ, 2016, ELIFE, V5, DOI 10.7554/eLife.14107; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibuka S, 2015, J CELL SCI, V128, P2156, DOI 10.1242/jcs.169060; Kalyaanamoorthy S, 2017, NAT METHODS, V14, P587, DOI [10.1038/nmeth.4285, 10.1038/NMETH.4285]; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Knudsen SLJ, 2014, GROWTH FACTORS, V32, P155, DOI 10.3109/08977194.2014.952410; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044; Laisney JAGC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-27; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Landau M, 2004, STRUCTURE, V12, P2265, DOI 10.1016/j.str.2004.10.006; Lemkul J, 2019, LIVING J COMPUT MOL, V1, P5068, DOI [10.33011/livecoms.1.1.5068, DOI 10.33011/LIVECOMS.1.1.5068]; Lichtarge O, 1996, J MOL BIOL, V257, P342, DOI 10.1006/jmbi.1996.0167; Lindvall C, 2003, CANCER RES, V63, P1743; Liu P, 2012, P NATL ACAD SCI USA, V109, P10861, DOI 10.1073/pnas.1201114109; Macdonald-Obermann JL, 2014, J BIOL CHEM, V289, P26178, DOI 10.1074/jbc.M114.586826; Mehrabi M, 2018, INT J BIOL MACROMOL, V115, P401, DOI 10.1016/j.ijbiomac.2018.04.066; Meng EC, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-339; Mirny LA, 2002, J MOL BIOL, V321, P7, DOI 10.1016/S0022-2836(02)00587-9; Nemoto W, 2013, COMPUT STRUCT BIOTEC, V8, DOI 10.5936/csbj.201308007; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Oda K, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100014; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; Puddicombe SM, 1996, J BIOL CHEM, V271, P30392, DOI 10.1074/jbc.271.48.30392; Puddicombe SM, 1996, J BIOL CHEM, V271, P15367, DOI 10.1074/jbc.271.26.15367; Purba ER, 2017, CELLS-BASEL, V6, DOI 10.3390/cells6020013; Skwark MJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003889; Souriau C, 1999, BIOL CHEM, V380, P451, DOI 10.1515/BC.1999.059; Spielman SJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139047; Strachan L, 2001, J BIOL CHEM, V276, P18265, DOI 10.1074/jbc.M006935200; Teppa E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-235; Turk HF, 2015, METHODS MOL BIOL, V1233, P25, DOI 10.1007/978-1-4939-1789-1_3; Tynan CJ, 2011, MOL CELL BIOL, V31, P2241, DOI 10.1128/MCB.01431-10; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Wiedemann C, 2013, BIOINFORMATICS, V29, P1750, DOI 10.1093/bioinformatics/btt278; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Xie G, 2002, GENOME BIOL, V3; Xu MJ, 2017, CANCER METAST REV, V36, P463, DOI 10.1007/s10555-017-9687-8; Zerbino DR, 2018, NUCLEIC ACIDS RES, V46, pD754, DOI 10.1093/nar/gkx1098; Zhou JQ, 2017, MOL PHYLOGENET EVOL, V113, P126, DOI 10.1016/j.ympev.2017.05.010	72	1	1	4	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100872	10.1016/j.jbc.2021.100872	http://dx.doi.org/10.1016/j.jbc.2021.100872			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34126069	gold, Green Published, Green Submitted			2022-12-28	WOS:000678068400072
J	Eyring, J; Lin, CW; Ngwa, EM; Boilevin, J; Pesciullesi, G; Locher, KP; Darbre, T; Reymond, JL; Aebi, M				Eyring, Jillianne; Lin, Chia-Wei; Ngwa, Elsy Mankah; Boilevin, Jeremy; Pesciullesi, Giorgio; Locher, Kaspar P.; Darbre, Tamis; Reymond, Jean-Louis; Aebi, Markus			Substrate specificities and reaction kinetics of the yeast oligosaccharyltransferase isoforms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-LINKED OLIGOSACCHARIDE; N-GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; OXIDOREDUCTASE ACTIVITY; LECTIN AFFINITY; PROTEIN; SUBUNITS; REVEALS; COMPLEXES; GLYCAN	Oligosaccharyltransferase (OST) catalyzes the central step in N-linked protein glycosylation, the transfer of a preassembled oligosaccharide from its lipid carrier onto asparagine residues of secretory proteins. The prototypic hetero-octameric OST complex from the yeast Saccharomyces cerevisiae exists as two isoforms that contain either Ost3p or Ost6p, both noncatalytic subunits. These two OST complexes have different protein substrate specificities in vivo. However, their detailed biochemical mechanisms and the basis for their different specificities are not clear. The two OST complexes were purified from genetically engineered strains expressing only one isoform. The kinetic properties and substrate specificities were characterized using a quantitative in vitro glycosylation assay with short peptides and different synthetic lipid-linked oligosaccharide (LLO) substrates. We found that the peptide sequence close to the glycosylation sequon affected peptide affinity and turnover rate. The length of the lipid moiety affected LLO affinity, while the lipid double-bond stereochemistry had a greater influence on LLO turnover rates. The two OST complexes had similar affinities for both the peptide and LLO substrates but showed significantly different turnover rates. These data provide the basis for a functional analysis of the Ost3p and Ost6p subunits.	[Eyring, Jillianne; Lin, Chia-Wei; Ngwa, Elsy Mankah; Aebi, Markus] Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, Zurich, Switzerland; [Lin, Chia-Wei] Univ Zurich, Funct Genom Ctr Zurich, ETH Zurich, Zurich, Switzerland; [Boilevin, Jeremy; Pesciullesi, Giorgio; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Locher, Kaspar P.] Swiss Fed Inst Technol, Dept Biol, Inst Mol Biol & Biophys, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Aebi, M (corresponding author), Swiss Fed Inst Technol, Dept Biol, Inst Microbiol, Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021	Lin, Chia-wei/0000-0003-4777-2916	Swiss National Science Foundation [CRSII5_171056, 31003oB_182835]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Swiss National Science Foundation, grant numbers CRSII5_171056 and 31003oB_182835.	Atwood JA, 2006, J PROTEOME RES, V5, P3376, DOI 10.1021/pr060364b; Bai L, 2018, NATURE, V555, P328, DOI 10.1038/nature25755; Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Eichler J, 2017, BBA-MOL CELL BIOL L, V1862, P589, DOI 10.1016/j.bbalip.2017.03.005; FANG XG, 1995, BIOORG MED CHEM LETT, V5, P2701, DOI 10.1016/0960-894X(95)00460-B; GAYNOR EC, 1994, J CELL BIOL, V127, P653, DOI 10.1083/jcb.127.3.653; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Gibbs BS, 1999, BIOORGAN MED CHEM, V7, P441, DOI 10.1016/S0968-0896(98)00268-5; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C, 1991, GUIDE YEAST GENETICS; Hang I, 2015, GLYCOBIOLOGY, V25, P1335, DOI 10.1093/glycob/cwv058; Harada Y, 2013, J BIOL CHEM, V288, P32673, DOI 10.1074/jbc.M113.486985; Harris SL, 1996, J CELL BIOL, V132, P985, DOI 10.1083/jcb.132.6.985; HEESEN ST, 1991, EUR J CELL BIOL, V56, P8; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 1999, BBA-GEN SUBJECTS, V1426, P275, DOI 10.1016/S0304-4165(98)00129-9; Jamaluddin MFB, 2014, MOL CELL PROTEOMICS, V13, P3286, DOI 10.1074/mcp.M114.041178; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jiang LY, 2015, BOT STUD, V56, DOI 10.1186/s40529-015-0111-9; Kelleher DJ, 2007, J CELL BIOL, V177, P29, DOI 10.1083/jcb.200611079; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kelleher DJ, 2003, MOL CELL, V12, P101, DOI 10.1016/S1097-2765(03)00243-0; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Li GT, 2005, J BIOL CHEM, V280, P1864, DOI 10.1074/jbc.M410969200; Lizak C, 2014, J BIOL CHEM, V289, P735, DOI 10.1074/jbc.M113.524751; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Luo QL, 2011, MICROBES INFECT, V13, P1199, DOI 10.1016/j.micinf.2011.08.013; Matsumoto S, 2017, BIOCHEMISTRY-US, V56, P602, DOI 10.1021/acs.biochem.6b01089; Mohorko E, 2014, STRUCTURE, V22, P590, DOI 10.1016/j.str.2014.02.013; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; Mueller S, 2015, MOL BIOL CELL, V26, P2596, DOI 10.1091/mbc.E15-03-0168; Murray AN, 2015, CHEM BIOL, V22, P1052, DOI 10.1016/j.chembiol.2015.06.017; Naegeli A, 2014, J BIOL CHEM, V289, P24521, DOI 10.1074/jbc.M114.579326; NAKAYAMA K, 1992, EMBO J, V11, P2511, DOI 10.1002/j.1460-2075.1992.tb05316.x; Napiorkowska M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34534-0; Napiorkowska M, 2017, NAT STRUCT MOL BIOL, V24, P1100, DOI 10.1038/nsmb.3491; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Poljak K, 2018, MOL CELL PROTEOMICS, V17, P32, DOI 10.1074/mcp.RA117.000096; Ramirez AS, 2019, SCIENCE, V366, P1372, DOI 10.1126/science.aaz3505; Ramirez AS, 2017, GLYCOBIOLOGY, V27, P525, DOI 10.1093/glycob/cwx017; Reiss G, 1996, GLYCOBIOLOGY, V6, P493, DOI 10.1093/glycob/6.5.493; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Samuelson J, 2005, P NATL ACAD SCI USA, V102, P1548, DOI 10.1073/pnas.0409460102; Schulz BL, 2009, P NATL ACAD SCI USA, V106, P11061, DOI 10.1073/pnas.0812515106; Schulz BL, 2009, MOL CELL PROTEOMICS, V8, P357, DOI 10.1074/mcp.M800219-MCP200; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Schwarz M, 2005, FEBS LETT, V579, P6564, DOI 10.1016/j.febslet.2005.10.063; Scott NE, 2012, J BIOL CHEM, V287, P29384, DOI 10.1074/jbc.M112.380212; SHARMA C, 1981, EUR J BIOCHEM, V116, P101, DOI 10.1111/j.1432-1033.1981.tb05306.x; Shrimal S, 2017, J CELL BIOL, V216, P3625, DOI 10.1083/jcb.201702159; Shrimal S, 2013, J CELL BIOL, V201, P81, DOI 10.1083/jcb.201301031; Spirig U, 2005, GLYCOBIOLOGY, V15, P1396, DOI 10.1093/glycob/cwj025; Tai VWF, 2001, J ORG CHEM, V66, P6217, DOI 10.1021/jo0100345; Taxis C, 2006, BIOTECHNIQUES, V40, P73, DOI 10.2144/000112040; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wild R, 2018, SCIENCE, V359, P545, DOI 10.1126/science.aar5140; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wong JP, 2009, J PROTEOME RES, V8, P2388, DOI 10.1021/pr801008c; Xu CC, 2015, NAT REV MOL CELL BIO, V16, P742, DOI 10.1038/nrm4073; Yamasaki T, 2020, J BIOL CHEM, V295, P16072, DOI 10.1074/jbc.RA120.015013; Zacchi LF, 2016, MOL CELL PROTEOMICS, V15, P2435, DOI 10.1074/mcp.M115.056366; Zielinska DF, 2012, MOL CELL, V46, P542, DOI 10.1016/j.molcel.2012.04.031; Zielinska DF, 2010, CELL, V141, P897, DOI 10.1016/j.cell.2010.04.012	69	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100809	10.1016/j.jbc.2021.100809	http://dx.doi.org/10.1016/j.jbc.2021.100809			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34023382	Green Published, gold, Green Accepted			2022-12-28	WOS:000674717300025
J	Landureau, M; Redeker, V; Bellande, T; Eyquem, S; Melki, R				Landureau, Maud; Redeker, Virginie; Bellande, Tracy; Eyquem, Stephanie; Melki, Ronald			The differential solvent exposure of N-terminal residues provides "fingerprints" of alpha-synuclein fibrillar polymorphs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; PROTEIN-STRUCTURE; IDENTIFICATION; SPECIFICITY; DEMENTIA; EXCHANGE; COMPLEX; BINDING	Synucleinopathies are neurodegenerative diseases characterized by the presence of intracellular deposits containing the protein alpha-synuclein (aSYN) within patients' brains. It has been shown that aSYN can form structurally distinct fibrillar assemblies, also termed polymorphs. We previously showed that distinct aSYN polymorphs assembled in vitro, named fibrils, ribbons, and fibrils 91, differentially bind to and seed the aggregation of endogenous aSYN in neuronal cells, which suggests that distinct synucleinopathies may arise from aSYN polymorphs. In order to better understand the differential interactions of aSYN polymorphs with their partner proteins, we mapped aSYN polymorphs surfaces. We used limited proteolysis, hydrogen-deuterium exchange, and differential antibody accessibility to identify amino acids on their surfaces. We showed that the aSYN C-terminal region spanning residues 94 to 140 exhibited similarly high solvent accessibility in these three polymorphs. However, the N-terminal amino acid residues 1 to 38 of fibrils were exposed to the solvent, while only residues 1 to 18 within fibrils 91 were exposed, and no N-terminal residues within ribbons were solvent-exposed. It is likely that these differences in surface accessibility contribute to the differential binding of distinct aSYN polymorphs to partner proteins. We thus posit that the polypeptides exposed on the surface of distinct aSYN fibrillar polymorphs are comparable to fingerprints. Our findings have diagnostic and therapeutic potential, particularly in the prion-like propagation of fibrillar aSYN, as they can facilitate the design of ligands that specifically bind and distinguish between fibrillar polymorphs.	[Landureau, Maud; Redeker, Virginie; Bellande, Tracy; Melki, Ronald] Univ Paris Saclay, Lab Neurodegenerat Dis, Inst Francois Jacob MIRCen, CNRS,CEA, Fontenay Aux Roses, France; [Eyquem, Stephanie] Sanofi R&D, Neurodegenerat Res, Rare & Neurol Dis Res Therapeut Area, Chilly Mazarin, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Sanofi-Aventis; Sanofi France	Redeker, V (corresponding author), Univ Paris Saclay, Lab Neurodegenerat Dis, Inst Francois Jacob MIRCen, CNRS,CEA, Fontenay Aux Roses, France.	virginie.redeker@cnrs.fr	Redeker, Virginie/L-8929-2018	Redeker, Virginie/0000-0003-2694-8388	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Convention Industrielle de Formation par la Recherche (CIFRE) from the Association Nationale de la recherche et de la technologie (ANRT); Fondation pour la Recherche Medicale [DEQ 20160334896, ALZ201912009776]; EU Joint Programme on Neurodegenerative Disease Research; Agence National de la Recherche [PROTEST-70, ANR-17-JPND-0005-01, ANR-17-JPND-0002-02]; European Union [116060, 821522]; Swiss State Secretariat for Education, Research and Innovation (SERI) [17.00038]; Parkinson UK; SANOFI	Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Institut National de la Sante et de la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Convention Industrielle de Formation par la Recherche (CIFRE) from the Association Nationale de la recherche et de la technologie (ANRT)(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); EU Joint Programme on Neurodegenerative Disease Research; Agence National de la Recherche(French National Research Agency (ANR)); European Union(European Commission); Swiss State Secretariat for Education, Research and Innovation (SERI); Parkinson UK(Parkinson's UK); SANOFI	We thank Luc Bousset for assistance in TEM, and the Proteomic-Gif SICaPS platform (I2BC), supported by IBiSA, Ile de France Region, Plan Cancer, CNRS and Paris-Sud University, for allowing us to use their MS equipment and in particular Laila Sago and David Cornu for their assistance. This work was supported by the Centre National de la Recherche Scientifique (CNRS), Institut National de la Sante et de la Recherche Medicale (Inserm), and a Convention Industrielle de Formation par la Recherche (CIFRE) from the Association Nationale de la recherche et de la technologie (ANRT). This work was supported by grants from the Fondation pour la Recherche Medicale (contract DEQ. 20160334896 and ALZ201912009776) and the EU Joint Programme on Neurodegenerative Disease Research and Agence National de la Recherche (contracts PROTEST-70, ANR-17-JPND-0005-01 and Trans-PathND, ANR-17-JPND-0002-02). This work has also received support from the European Union's Horizon 2020 research and innovation program and EFPIA Innovative Medicines Initiative 2 grant agreements No 116060 (IMPRiND) and No. 821522 (PD-MitoQUANT), the Swiss State Secretariat for Education, Research and Innovation (SERI) under contract number 17.00038, Parkinson UK and SANOFI.	Alam P, 2019, J NEUROCHEM, V150, P522, DOI 10.1111/jnc.14808; Bendifallah M, 2020, BIOCHEM BIOPH RES CO, V527, P760, DOI 10.1016/j.bbrc.2020.04.091; Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649; Bousset L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3575; Brundin P, 2010, NAT REV MOL CELL BIO, V11, P301, DOI 10.1038/nrm2873; Burre J, 2015, J PARKINSON DIS, V5, P699, DOI 10.3233/JPD-150642; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; DEMATTOS EP, 2020, NEURON, V10, P369, DOI DOI 10.3233/JPD-191790; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Flavin WP, 2017, ACTA NEUROPATHOL, V134, P629, DOI 10.1007/s00401-017-1722-x; Fontana A, 2004, ACTA BIOCHIM POL, V51, P299; Gallardo J, 2020, ACS CHEM NEUROSCI, V11, P872, DOI 10.1021/acschemneuro.9b00527; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Gath J, 2012, BIOMOL NMR ASSIGN, V6, P51, DOI 10.1007/s12104-011-9324-3; Ghee M, 2005, FEBS J, V272, P4023, DOI 10.1111/j.1742-4658.2005.04776.x; Goedert M, 2001, NAT REV NEUROSCI, V2, P492, DOI 10.1038/35081564; Guerrero-Ferreira R, 2019, ELIFE, V8, DOI 10.7554/eLife.48907; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Hong DP, 2011, FEBS LETT, V585, P561, DOI 10.1016/j.febslet.2011.01.009; Illes-Toth E, 2018, ACS CHEM NEUROSCI, V9, P1469, DOI 10.1021/acschemneuro.8b00052; JAKES R, 1994, FEBS LETT, V345, P27, DOI 10.1016/0014-5793(94)00395-5; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; Li BS, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05971-2; Li YW, 2018, CELL RES, V28, P897, DOI 10.1038/s41422-018-0075-x; Ma L, 2018, BBA-MOL BASIS DIS, V1864, P3714, DOI 10.1016/j.bbadis.2018.10.003; Makky A, 2016, SCI REP-UK, V6, DOI 10.1038/srep37970; McCann Heather, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS62, DOI 10.1016/S1353-8020(13)70017-8; Melki R, 2018, NEUROBIOL DIS, V109, P201, DOI 10.1016/j.nbd.2017.03.011; Oosawa F., 1975, THERMODYNAMICS POLYM; Peelaerts W, 2015, NATURE, V522, P340, DOI 10.1038/nature14547; Perrin RJ, 2003, NEUROSCI LETT, V349, P133, DOI 10.1016/S0304-3940(03)00781-X; de Laureto PP, 2006, BIOCHEMISTRY-US, V45, P11523, DOI 10.1021/bi052614s; Qin Z, 2007, BIOCHEMISTRY-US, V46, P13322, DOI 10.1021/bi7014053; Redeker V, 2007, J MOL BIOL, V369, P1113, DOI 10.1016/j.jmb.2007.04.018; Rey NL, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0859-3; Rodriguez JA, 2015, NATURE, V525, P486, DOI 10.1038/nature15368; Shahnawaz M, 2020, NATURE, V578, P273, DOI 10.1038/s41586-020-1984-7; Shrivastava A.N., 2020, BIOPHYS J, V118, P1; Shrivastava AN, 2017, NEURON, V95, P33, DOI 10.1016/j.neuron.2017.05.026; Shrivastava AN, 2015, EMBO J, V34, P2408, DOI 10.15252/embj.201591397; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Strohaker T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13564-w; Sun YP, 2020, CELL RES, V30, P360, DOI 10.1038/s41422-020-0299-4; Van der Perren A, 2020, ACTA NEUROPATHOL, V139, P977, DOI 10.1007/s00401-020-02157-3; van der Wateren IM, 2018, CHEM SCI, V9, P5506, DOI 10.1039/c8sc01109e; Verasdonck J, 2016, BIOMOL NMR ASSIGN, V10, P5, DOI 10.1007/s12104-015-9628-9; Yamasaki TR, 2019, J BIOL CHEM, V294, P1045, DOI 10.1074/jbc.RA118.004471; ZHANG ZQ, 1993, PROTEIN SCI, V2, P522; Zhao K, 2020, P NATL ACAD SCI USA, V117, P20305, DOI 10.1073/pnas.1922741117; Zhao K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16386-3	52	6	6	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100737	10.1016/j.jbc.2021.100737	http://dx.doi.org/10.1016/j.jbc.2021.100737			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933456	Green Published, gold			2022-12-28	WOS:000672866400706
J	Leka, O; Wu, YF; Li, XD; Kammerer, RA				Leka, Oneda; Wu, Yufan; Li, Xiaodan; Kammerer, Richard A.			Crystal structure of the catalytic domain of botulinum neurotoxin subtype A3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOXIN	Botulinum neurotoxins (BoNTs) are among the most widely used therapeutic proteins; however, only two subtypes within the seven serotypes, BoNT/A1 and BoNT/B1, are currently used for medical and cosmetic applications. Distinct catalytic properties, substrate specificities, and duration of enzymatic activities potentially make other subtypes very attractive candidates to outperform conventional BoNTs in particular therapeutic applications. For example, BoNT/A3 has a significantly shorter duration of action than other BoNT/A subtypes. Notably, BoNT/A3 is the subtype with the least conserved catalytic domain among BoNT/A subtypes. This suggests that the sequence differences, many of which concern the alpha-exosite, contribute to the observed functional differences in toxin persistence by affecting the binding of the substrate SNAP-25 and/or the stability of the catalytic domain fold. To identify the molecular determinants accounting for the differences in the persistence observed for BoNT/A subtypes, we determined the crystal structure of the catalytic domain of BoNT/A3 (LC/A3). The structure of LC/A3 was found to be very similar to that of LC/A1, suggesting that the overall mode of SNAP-25 binding is common between these two proteins. However, circular dichroism (CD) thermal unfolding experiments demonstrated that LC/A3 is significantly less stable than LC/A1, implying that this might contribute to the reduced toxin persistence of BoNT/A3. These findings could be of interest in developing next-generation therapeutic toxins.	[Leka, Oneda; Wu, Yufan; Li, Xiaodan; Kammerer, Richard A.] Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Villigen, Switzerland	Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Kammerer, RA (corresponding author), Paul Scherrer Inst, Div Biol & Chem, Lab Biomol Res, Villigen, Switzerland.	richard.kammerer@psi.ch		li, xiaodan/0000-0001-8647-7317	Swiss National Science Foundation [31003A_163449, 31003A_170028]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by grants 31003A_163449 and 31003A_170028 of the Swiss National Science Foundation to R. A. K. and X. L., respectively.	Ahmed SA, 2001, J PROTEIN CHEM, V20, P221, DOI 10.1023/A:1010952025677; Baldwin MR, 2004, PROTEIN EXPRES PURIF, V37, P187, DOI 10.1016/j.pep.2004.05.009; Breidenbach MA, 2004, NATURE, V432, P925, DOI 10.1038/nature03123; Contreras E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10732-w; Dong M, 2019, ANNU REV BIOCHEM, V88, P811, DOI 10.1146/annurev-biochem-013118-111654; Dressler D, 2012, CURR OPIN MICROBIOL, V15, P325, DOI 10.1016/j.mib.2012.05.012; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Feltrup TM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26764-z; Fernandez-Salas E, 2004, MOVEMENT DISORD, V19, pS23, DOI 10.1002/mds.20006; GILL DM, 1982, MICROBIOL REV, V46, P86, DOI 10.1128/MMBR.46.1.86-94.1982; Henkel JS, 2009, BIOCHEMISTRY-US, V48, P2522, DOI 10.1021/bi801686b; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kammerer RA, 1998, J BIOL CHEM, V273, P10602, DOI 10.1074/jbc.273.17.10602; Lacy DB, 1998, NAT STRUCT BIOL, V5, P898, DOI 10.1038/2338; Niklasson M, 2015, PROTEIN SCI, V24, P2055, DOI 10.1002/pro.2809; Pantano S, 2014, CELL MOL LIFE SCI, V71, P793, DOI 10.1007/s00018-013-1380-7; Peck MW, 2017, TOXINS, V9, DOI 10.3390/toxins9010038; Pellete S, 2015, TOXICON, V107, P37, DOI 10.1016/j.toxicon.2015.06.021; Pellett S, 2018, MBIO, V9, DOI 10.1128/mBio.00089-18; Pier CL, 2011, FEBS LETT, V585, P199, DOI 10.1016/j.febslet.2010.11.045; Pirazzini M, 2017, PHARMACOL REV, V69, P200, DOI 10.1124/pr.116.012658; Rossetto O, 2014, NAT REV MICROBIOL, V12, P535, DOI 10.1038/nrmicro3295; Schiavo G, 2000, PHYSIOL REV, V80, P717, DOI 10.1152/physrev.2000.80.2.717; SCHIAVO G, 1992, J BIOL CHEM, V267, P23479; Segelke B, 2004, P NATL ACAD SCI USA, V101, P6888, DOI 10.1073/pnas.0400584101; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Torii Y, 2011, TOXICON, V57, P93, DOI 10.1016/j.toxicon.2010.10.009; Whitemarsh RCM, 2013, INFECT IMMUN, V81, P3894, DOI 10.1128/IAI.00536-13; Whitemarsh RCM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090252; Zhang SC, 2018, CELL HOST MICROBE, V23, P169, DOI 10.1016/j.chom.2017.12.018; Zhang SC, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14130; Zornetta I, 2016, SCI REP-UK, V6, DOI 10.1038/srep30257	32	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100684	10.1016/j.jbc.2021.100684	http://dx.doi.org/10.1016/j.jbc.2021.100684			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33891946	Green Published, gold			2022-12-28	WOS:000672866400655
J	Matoba, Y; Sato, Y; Oda, K; Hatori, Y; Morimoto, K				Matoba, Yasuyuki; Sato, Yuichiro; Oda, Kosuke; Hatori, Yuta; Morimoto, Kinjiro			Lectins engineered to favor a glycan-binding conformation have enhanced antiviral activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE-BINDING; STRUCTURAL BASIS; GRIFFITHSIN; AGGLUTININ; AGENTS	Homologues of the Oscillatoria agardhii agglutinin (OAA) lectins contain a sequence repeat of similar to 66 amino acids, with the number of tandem repeats varying across family members. OAA homologues bind high-mannose glycans on viral surface proteins, thereby interfering with viral entry into host cells. As such, OAA homologues have potential utility as antiviral agents, but a more detailed understanding of their structure-function relationships would enable us to develop improved constructs. Here, we determined the X-ray crystal structure of free and glycan-bound forms of Pseudomonas taiwanensis lectin (PTL), an OAA-family lectin consisting of two tandem repeats. Like other OAA-family lectins, PTL exhibited a beta-barrel-like structure with two symmetrically positioned glycan-binding sites at the opposite ends of the barrel. Upon glycan binding, the conformation of PTL undergoes a more significant change than expected from previous OAA structural analysis. Moreover, the electron density of the bound glycans suggested that the binding affinities are different at the two binding sites. Next, based on analysis of these structures, we used site-specific mutagenesis to create PTL constructs expected to increase the population with a conformation suitable for glycan binding. The engineered PTLs were examined for their antiviral activity against the influenza virus. Interestingly, some exhibited stronger activity compared with that of the parent PTL. We propose that our approach is effective for the generation of potential microbicides with enhanced antiviral activity.	[Matoba, Yasuyuki; Sato, Yuichiro; Hatori, Yuta; Morimoto, Kinjiro] Yasuda Womens Univ, Fac Pharm, Hiroshima, Japan; [Oda, Kosuke] Hiroshima Univ, Inst Biomed & Hlth Sci, Dept Virol, Hiroshima, Japan	Hiroshima University	Morimoto, K (corresponding author), Yasuda Womens Univ, Fac Pharm, Hiroshima, Japan.	mori-k@yasuda-u.ac.jp	ODA, KOSUKE/ABD-2610-2021	oda, kosuke/0000-0002-1095-548X				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; An YM, 2019, J VIROL, V93, DOI 10.1128/JVI.01693-18; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Balzarini Jan, 2007, Antiviral Chemistry & Chemotherapy, V18, P1; Balzarini J, 2007, NAT REV MICROBIOL, V5, P583, DOI 10.1038/nrmicro1707; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Boyd R., 2003, ANTIVIR RES, V58, P56; BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0; Carneiro MG, 2015, ANGEW CHEM INT EDIT, V54, P6462, DOI 10.1002/anie.201500213; Chen P Y., 2013, ARCH VIROL, V158, p349 358; Coves-Datson EM, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007595; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Francois KO, 2012, MED RES REV, V32, P349, DOI 10.1002/med.20216; Heindel DW, 2020, P NATL ACAD SCI USA, V117, P26926, DOI 10.1073/pnas.2008203117; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Helle F, 2006, J BIOL CHEM, V281, P25177, DOI 10.1074/jbc.M602431200; JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keeffe JR, 2011, P NATL ACAD SCI USA, V108, P14079, DOI 10.1073/pnas.1108777108; Khatri K, 2016, MOL CELL PROTEOMICS, V15, P1895, DOI 10.1074/mcp.M116.058016; Koharudin LMI, 2012, J BIOL CHEM, V287, P33796, DOI 10.1074/jbc.M112.388579; Koharudin LMI, 2011, STRUCTURE, V19, P1170, DOI 10.1016/j.str.2011.05.010; Koharudin LMI, 2011, J BIOL CHEM, V286, P1588, DOI 10.1074/jbc.M110.173278; Mason CP, 2015, MOLECULES, V20, P2229, DOI 10.3390/molecules20022229; Meuleman P, 2011, ANTIMICROB AGENTS CH, V55, P5159, DOI 10.1128/AAC.00633-11; Mitchell CA, 2017, ANTIVIR RES, V142, P37, DOI 10.1016/j.antiviral.2017.03.007; Morimoto K, 2016, VIRUS RES, V223, P64, DOI 10.1016/j.virusres.2016.06.020; O'Keefe BR, 2010, J VIROL, V84, P2511, DOI 10.1128/JVI.02322-09; PEUMANS WJ, 1995, PLANT PHYSIOL, V109, P347, DOI 10.1104/pp.109.2.347; Przybylski M, 2008, J AM SOC MASS SPECTR, V19, p428 444; Rabbani S, 2017, IUCRJ, V4, P7, DOI 10.1107/S2052252516016675; Ritchie G, 2010, VIROLOGY, V399, P257, DOI 10.1016/j.virol.2009.12.020; ROMEO JM, 1986, P NATL ACAD SCI USA, V83, P6332, DOI 10.1073/pnas.83.17.6332; Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331; Sato Y., 2012, PLOS ONE, V7; Sato Y, 2007, J BIOL CHEM, V282, P11021, DOI 10.1074/jbc.M701252200; Sato Y, 2011, J BIOL CHEM, V286, P19446, DOI 10.1074/jbc.M110.216655; Sato Y, 2011, BIOCHEM BIOPH RES CO, V405, P291, DOI 10.1016/j.bbrc.2011.01.031; Thompson AJ, 2020, CELL HOST MICROBE, V27, P725, DOI 10.1016/j.chom.2020.03.009; van der Meer FJUM, 2007, ANTIVIR RES, V76, P21, DOI 10.1016/j.antiviral.2007.04.003; Watanabe Y, 2019, BBA-GEN SUBJECTS, V1863, P1480, DOI 10.1016/j.bbagen.2019.05.012; Watanabe Y, 2018, P NATL ACAD SCI USA, V115, P7320, DOI 10.1073/pnas.1803990115; Watson A., 2020, FRONT IMMUNOL, V11; Whitley MJ, 2013, FEBS J, V280, P2056, DOI 10.1111/febs.12229	46	2	2	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100698	10.1016/j.jbc.2021.100698	http://dx.doi.org/10.1016/j.jbc.2021.100698			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895142	Green Published, gold			2022-12-28	WOS:000672866400669
J	Morales, MM; Pedowitz, NJ; Pratt, MR				Morales, Murielle M.; Pedowitz, Nichole J.; Pratt, Matthew R.			O-GlcNAc modification of MYPT1 modulates lysophosphatidic acid-induced cell contraction in fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEXOSAMINE BIOSYNTHESIS; MYOSIN PHOSPHATASE; CROSS-TALK; GLCNACYLATION; SPHINGOSINE-1-PHOSPHATE; PHOSPHORYLATION; TRANSFERASE; METABOLISM; INSULIN; GLUCOSE	Thousands of proteins have been found to be modified by O-GlcNAc, a common glycosylation modification of serine and threonine residues throughout the cytosol and nucleus. O-GlcNAc is enzymatically added and removed from proteins, making it a potential dynamic regulator of cell signaling. However, compared with other posttranslational modifications like phosphorylation, relatively few O-GlcNAc-regulated pathways have been discovered and biochemically characterized. We previously discovered one such pathway, where O-GlcNAc controls the contraction of fibroblasts initiated by the signaling lipid sphingosine-1-phosphate. Specifically, we found that O-GlcNAc modification of the phosphatase MYPT1 maintains its activity, resulting in dephosphorylation and deactivation of the myosin light chain of the actinomyosin complex. Another signaling lipid that leads to contraction of fibroblasts is lysophosphatidic acid, and this signaling pathway also converges on MYPT1 and actinomyosin. We therefore rationalized that O-GlcNAc would also control this pathway. Here, we used a combination of small molecule inhibitors, 2D and 3D cell cultures, and biochemistry to confirm our hypothesis. Specifically, we found that O-GlcNAc levels control the sensitivity of mouse and primary human dermal fibroblasts to lysophosphatidic acid-induced contraction in culture and the phosphorylation of MLC and that MYPT1 O-GlcNAc modification is responsible. These findings further solidify the importance of O-GlcNAc in regulating the biology of fibroblasts in response to procontractile stimuli.	[Morales, Murielle M.; Pratt, Matthew R.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA; [Pedowitz, Nichole J.; Pratt, Matthew R.] Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA	University of Southern California; University of Southern California	Pratt, MR (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA.; Pratt, MR (corresponding author), Univ Southern Calif, Dept Chem, Los Angeles, CA 90007 USA.	matthew.pratt@usc.edu		Pedowitz, Nichole/0000-0001-6845-2810; Morales, Murielle/0000-0003-2955-2047; Pratt, Matthew/0000-0003-3205-5615	Anton Burg Foundation; NIGMS, National Institutes of Health [R01GM125939, T32GM118289]	Anton Burg Foundation; NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the Anton Burg Foundation and the NIGMS, National Institutes of Health (R01GM125939) to M. R. P. M. M. M. and N. J. P. were supported by NIGMS, National Institutes of Health T32GM118289. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Balana AT, 2021, NAT CHEM, V13, P441, DOI 10.1038/s41557-021-00648-8; Banerjee PS, 2016, MOL ASPECTS MED, V51, P1, DOI 10.1016/j.mam.2016.05.005; Buse MG, 2002, AM J PHYSIOL-ENDOC M, V283, pE241, DOI 10.1152/ajpendo.00060.2002; Chatham JC, 2021, PHYSIOL REV, V101, P427, DOI 10.1152/physrev.00043.2019; Eto Masumi, 2017, J Smooth Muscle Res, V53, P1, DOI 10.1540/jsmr.53.1; Ferrer CM, 2016, J MOL BIOL, V428, P3282, DOI 10.1016/j.jmb.2016.05.028; Gloster TM, 2011, NAT CHEM BIOL, V7, P174, DOI 10.1038/NCHEMBIO.520; Grassie ME, 2012, J BIOL CHEM, V287, P36356, DOI 10.1074/jbc.M112.398479; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Hama K, 2004, J BIOL CHEM, V279, P17634, DOI 10.1074/jbc.M313927200; Hanover JA, 2018, J BIOENERG BIOMEMBR, V50, P155, DOI 10.1007/s10863-018-9751-2; Hardiville S, 2014, CELL METAB, V20, P208, DOI 10.1016/j.cmet.2014.07.014; Hart G. W., 2015, PERSPECT SCI, V6, P49; Hart GW, 2019, J BIOL CHEM, V294, P2211, DOI 10.1074/jbc.AW119.003226; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hartshorne DJ, 2004, J BIOL CHEM, V279, P37211, DOI 10.1074/jbc.R400018200; Heissler Sarah M, 2014, Bioarchitecture, V4, P169, DOI 10.1080/19490992.2015.1054092; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Jiang HM, 2008, FASEB J, V22, P2151, DOI 10.1096/fj.07-097014; Joiner CM, 2019, CURR OPIN STRUC BIOL, V56, P97, DOI 10.1016/j.sbi.2018.12.003; King DT, 2019, CURR OPIN CHEM BIOL, V53, P131, DOI 10.1016/j.cbpa.2019.09.001; Kiss A, 2019, BBA-MOL CELL RES, V1866, P2, DOI 10.1016/j.bbamcr.2018.07.023; Kluk MJ, 2002, BBA-MOL CELL BIOL L, V1582, P72, DOI 10.1016/S1388-1981(02)00139-7; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kreppel LK, 1997, J BIOL CHEM, V272, P9308; Lehman DM, 2005, DIABETES, V54, P1214, DOI 10.2337/diabetes.54.4.1214; Levine ZG, 2016, ANNU REV BIOCHEM, V85, P631, DOI 10.1146/annurev-biochem-060713-035344; Liu CF, 2020, J BIOL CHEM, V295, P7341, DOI 10.1074/jbc.RA119.012401; Liu F, 2004, P NATL ACAD SCI USA, V101, P10804, DOI 10.1073/pnas.0400348101; Liu F, 2009, BRAIN, V132, P1820, DOI 10.1093/brain/awp099; Ma ZY, 2013, AMINO ACIDS, V45, P719, DOI 10.1007/s00726-013-1543-8; MARSHALL S, 1991, J BIOL CHEM, V266, P4706; Mendelson K, 2014, DEVELOPMENT, V141, P5, DOI 10.1242/dev.094805; Ogretmen B, 2018, NAT REV CANCER, V18, P33, DOI 10.1038/nrc.2017.96; Panetti TS, 2001, PROSTAG OTH LIPID M, V64, P93, DOI 10.1016/S0090-6980(01)00102-2; Parizi M, 2000, EXP CELL RES, V254, P210, DOI 10.1006/excr.1999.4754; Pedowitz NJ, 2021, NAT CHEM BIOL, V17, P169, DOI 10.1038/s41589-020-0640-8; Perrakis A, 2014, J LIPID RES, V55, P1010, DOI 10.1194/jlr.R046391; Petrache I., 2016, ANNU REV PHYSIOL, V78, P1; Pinho TS, 2019, BBA-MOL BASIS DIS, V1865, P2048, DOI 10.1016/j.bbadis.2018.10.037; Rhee S, 2007, ADV DRUG DELIVER REV, V59, P1299, DOI 10.1016/j.addr.2007.08.006; Sandbo N, 2016, BIOCHEMISTRY-MOSCOW+, V81, P1698, DOI 10.1134/S0006297916130071; Sheng XY, 2015, DEVELOPMENT, V142, P1390, DOI 10.1242/dev.121723; Shlyonsky V, 2014, PULM CIRC, V4, P471, DOI 10.1086/677362; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takabe K, 2008, PHARMACOL REV, V60, P181, DOI 10.1124/pr.107.07113; TRAXINGER RR, 1991, J BIOL CHEM, V266, P10148; Watterson KR, 2007, WOUND REPAIR REGEN, V15, P607, DOI 10.1111/j.1524-475X.2007.00292.x; Windh RT, 1999, J BIOL CHEM, V274, P27351, DOI 10.1074/jbc.274.39.27351; Wulff-Fuentes E, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00810-4; Yanagida K, 2011, J BIOCHEM, V150, P223, DOI 10.1093/jb/mvr087; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Yee HF, 2001, BIOCHEM BIOPH RES CO, V280, P1340, DOI 10.1006/bbrc.2001.4291; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zachara NE, 2018, FEBS LETT, V592, P3950, DOI 10.1002/1873-3468.13286	56	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100800	10.1016/j.jbc.2021.100800	http://dx.doi.org/10.1016/j.jbc.2021.100800			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019870	Green Published, gold			2022-12-28	WOS:000674717300020
J	Palander, O; Lam, A; Collins, RF; Moraes, TJ; Trimble, WS				Palander, Oliva; Lam, Adam; Collins, Richard F.; Moraes, Theo J.; Trimble, William S.			Nonredundant roles of DIAPHs in primary ciliogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION	Primary cilia are hubs for several signaling pathways, and disruption in cilia function and formation leads to a range of diseases collectively known as ciliopathies. Both ciliogenesis and cilia maintenance depend on vesicle trafficking along a network of microtubules and actin filaments toward the basal body. The DIAPH (Diaphanous-related) family of formins promote both actin polymerization and microtubule (MT) stability. Recently, we showed that the formin DIAPH1 is involved in ciliogenesis. However, the role of other DIAPH family members in ciliogenesis had not been investigated. Here we show that depletion of either DIAPH2 or DIAPH3 also disrupted ciliogenesis and cilia length. DIAPH3 depletion also reduced trafficking within cilia. To specifically examine the role of DIAPH3 at the base, we used fused full-length DIAPH3 to centrin, which targeted DIAPH3 to the basal body, causing increased trafficking to the ciliary base, an increase in cilia length, and formation of bulbs at the tips of cilia. Additionally, we confirmed that the microtubule-stabilizing properties of DIAPH3 are important for its cilia length functions and trafficking. These results indicate the importance of DIAPH proteins in regulating cilia maintenance. Moreover, defects in ciliogenesis caused by DIAPH depletion could only be rescued by expression of the specific family member depleted, indicating nonredundant roles for these proteins.	[Palander, Oliva; Lam, Adam; Collins, Richard F.; Trimble, William S.] Hosp Sick Children, Programs Cell Biol, Toronto, ON, Canada; [Palander, Oliva; Trimble, William S.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Moraes, Theo J.] Hosp Sick Children, Programs Translat Med, Toronto, ON, Canada; [Moraes, Theo J.] Univ Toronto, Dept Paediat, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Trimble, WS (corresponding author), Hosp Sick Children, Programs Cell Biol, Toronto, ON, Canada.; Trimble, WS (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	wtrimble@sickkids.ca	Moraes, Theo/CAJ-3254-2022	Moraes, Theo/0000-0001-9968-6601; Lam, Adam/0000-0002-5518-6901; Trimble, William/0000-0001-9776-5111	CIHR grant [PJT-162194]	CIHR grant(Canadian Institutes of Health Research (CIHR))	This work was supported by funds from CIHR grant PJT-162194 to W. S. T.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100680	10.1016/j.jbc.2021.100680	http://dx.doi.org/10.1016/j.jbc.2021.100680			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872598	gold, Green Published			2022-12-28	WOS:000672866400651
J	Tapryal, N; Shahabi, S; Chakraborty, A; Hosoki, K; Wakamiya, M; Sarkar, G; Sharma, G; Cardenas, VJ; Boldogh, I; Sur, S; Ghosh, G; Hazra, TK				Tapryal, Nisha; Shahabi, Shandy; Chakraborty, Anirban; Hosoki, Koa; Wakamiya, Maki; Sarkar, Gobinda; Sharma, Gulshan; Cardenas, Victor J.; Boldogh, Istvan; Sur, Sanjiv; Ghosh, Gourisankar; Hazra, Tapas K.			Intrapulmonary administration of purified NEIL2 abrogates NF-kappa B-mediated inflammation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Aberrant or constitutive activation of nuclear factor kappa B (NF-kappa B) contributes to various human inflammatory diseases and malignancies via the upregulation of genes involved in cell proliferation, survival, angiogenesis, inflammation, and metastasis. Thus, inhibition of NF-kappa B signaling has potential for therapeutic applications in cancer and inflammatory diseases. We reported previously that Nei-like DNA glycosylase 2 (NEIL2), a mammalian DNA glycosylase, is involved in the preferential repair of oxidized DNA bases from the transcriptionally active sequences via the transcription-coupled base excision repair pathway. We have further shown that Neil2-null mice are highly sensitive to tumor necrosis factor alpha (TNF alpha)and lipopolysaccharide-induced inflammation. Both TNF alpha and lipopolysaccharide are potent activators of NF-kappa B. However, the underlying mechanism of NEIL2's role in the NF-kappa B-mediated inflammation remains elusive. Here, we have documented a noncanonical function of NEIL2 and demonstrated that the expression of genes, such as Cxcl1, Cxcl2, Cxcl10, Il6, and Tnf alpha, involved in inflammation and immune cell migration was significantly higher in both mock- and TNF alpha-treated Neil2-null mice compared with that in the WT mice. NEIL2 blocks NF-kappa B's binding to target gene promoters by directly interacting with the Rel homology region of RelA and represses proinflammatory gene expression as determined by co-immunoprecipitation, chromatin immunoprecipitation, and electrophoretic mobility-shift assays. Remarkably, intrapulmonary administration of purified NEIL2 via a noninvasive nasal route significantly abrogated binding of NF-kappa B to cognate DNA, leading to decreased expression of proinflammatory genes and neutrophil recruitment in Neil2-null as well as WT mouse lungs. Our findings thus highlight the potential of NEIL2 as a biologic for inflammation-associated human diseases.	[Tapryal, Nisha; Chakraborty, Anirban; Hosoki, Koa; Sharma, Gulshan; Cardenas, Victor J.; Sur, Sanjiv; Hazra, Tapas K.] Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA; [Shahabi, Shandy; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Hosoki, Koa; Sur, Sanjiv] Baylor Coll Med, Dept Med Immunol Allergy & Rheumatol, Houston, TX 77030 USA; [Wakamiya, Maki] Univ Texas Med Branch, Dept Biochem, Galveston, TX USA; [Wakamiya, Maki] Univ Texas Med Branch, Dept Mol Biol, Galveston, TX USA; [Sarkar, Gobinda] Mayo Clin & Mayo Fdn, Dept Orthoped, Rochester, MN USA; [Sarkar, Gobinda] Mayo Clin & Mayo Fdn, Dept Expt Pathol, Rochester, MN USA; [Boldogh, Istvan] Univ Texas Med Branch, Dept Microbiol & Immunol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of California System; University of California San Diego; Baylor College of Medicine; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; Mayo Clinic; Mayo Clinic; University of Texas System; University of Texas Medical Branch Galveston	Hazra, TK (corresponding author), Univ Texas Med Branch, Dept Internal Med, Galveston, TX 77555 USA.	tkhazra@utmb.edu		Sarkar, Gobinda/0000-0002-7879-124X; Hosoki, Koa/0000-0003-4228-2176; Cardenas, Victor/0000-0003-2077-9915	National Institutes of Health [R01NS073976, R01HL145477, AI062885, GM085490]; DOD [W81XWH-18-1-0743]; Cellular and Molecular Genetics Training Grant, Center for Molecular Medicine, UCSD	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOD(United States Department of Defense); Cellular and Molecular Genetics Training Grant, Center for Molecular Medicine, UCSD	This project was supported by the National Institutes of Health grants nos. R01NS073976 (to T. K. H), R01HL145477 (to S. S. and T. K. H) and AI062885 (to I. B. and T. K. H), and DOD grant no. W81XWH-18-1-0743 (to S. S.). G. G. was supported by the National Institutes of Health grant no. GM085490. S. S. was supported by the Cellular and Molecular Genetics Training Grant, Center for Molecular Medicine, UCSD. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100723	10.1016/j.jbc.2021.100723	http://dx.doi.org/10.1016/j.jbc.2021.100723			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33932404	gold, Green Published			2022-12-28	WOS:000672866400693
J	Babkoff, A; Cohen-Kfir, E; Aharon, H; Ravid, S				Babkoff, Aryeh; Cohen-Kfir, Einav; Aharon, Hananel; Ravid, Shoshana			Aurora-B phosphorylates the myosin II heavy chain to promote cytokinesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHROMOSOMAL PASSENGER COMPLEX; REGULATORY LIGHT-CHAIN; HUMAN-PLATELET MYOSIN; PROTEIN-KINASE-C; SPINDLE CHECKPOINT; SURVIVIN; LOCALIZATION; INCENP; ISOFORMS; BINDING	Cytokinesis, the final step of mitosis, is mediated by an actomyosin contractile ring, the formation of which is temporally and spatially regulated following anaphase onset. AuroraB is a member of the chromosomal passenger complex, which regulates various processes during mitosis; it is not understood, however, how Aurora-B is involved in cytokinesis. Here, we show that Aurora-B and myosin-IIB form a complex in vivo during telophase. Aurora-B phosphorylates the myosin-IIB rod domain at threonine 1847 (T1847), abrogating the ability of myosin-IIB monomers to form filaments. Furthermore, phosphorylation of myosin-IIB filaments by Aurora-B also promotes filament disassembly. We show that myosin-IIB possessing a phosphomimetic mutation at T1847 was unable to rescue cytokinesis failure caused by myosin-IIB depletion. Cells expressing a phosphoresistant mutation at T1847 had significantly longer intercellular bridges, implying that Aurora-Bmediated phosphorylation of myosin-IIB is important for abscission. We propose that myosin-IIB is a substrate of Aurora-B and reveal a new mechanism of myosin-IIB regulation by Aurora-B in the late stages of mitosis.	[Babkoff, Aryeh; Cohen-Kfir, Einav; Aharon, Hananel; Ravid, Shoshana] Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, Jerusalem, Israel	Hebrew University of Jerusalem	Ravid, S (corresponding author), Hebrew Univ Hadassah Med Sch, Inst Med Res Israel Canada, Dept Biochem & Mol Biol, Jerusalem, Israel.	shoshr@ekmd.huji.ac.il		Ravid, Shoshana/0000-0001-8017-3259				Adriaans IE, 2020, CURR BIOL, V30, P2628, DOI 10.1016/j.cub.2020.04.081; Adriaans IE, 2019, J CELL BIOL, V218, P1250, DOI 10.1083/jcb.201805036; Amaral N, 2016, NAT CELL BIOL, V18, P516, DOI 10.1038/ncb3343; Azzariti A, 2011, BRIT J CANCER, V104, P769, DOI 10.1038/bjc.2011.21; Babkoff A, 2019, J CELL SCI, V132, DOI 10.1242/jcs.233130; Bao JJ, 2005, J BIOL CHEM, V280, P19594, DOI 10.1074/jbc.M501573200; Basant A, 2015, DEV CELL, V33, P204, DOI 10.1016/j.devcel.2015.03.015; Beach JR, 2014, CURR BIOL, V24, P1160, DOI 10.1016/j.cub.2014.03.071; Beach JR, 2009, J BIOL CHEM, V284, P27377, DOI 10.1074/jbc.M109.028316; Bolton MA, 2002, MOL BIOL CELL, V13, P3064, DOI 10.1091/mbc.E02-02-0092; Capalbo L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12507-9; Carlton JG, 2012, SCIENCE, V336, P220, DOI 10.1126/science.1217180; Carmena M, 2012, NAT REV MOL CELL BIO, V13, P789, DOI 10.1038/nrm3474; Clark K, 2008, J MOL BIOL, V378, P790, DOI 10.1016/j.jmb.2008.02.057; Cohen C, 1998, J STRUCT BIOL, V122, P180, DOI 10.1006/jsbi.1998.3983; D'Avino PP, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00221; Dahan I, 2012, MOL BIOL CELL, V23, P591, DOI 10.1091/mbc.E11-01-0015; Delacour-Larose M, 2007, CELL CYCLE, V6, P1878, DOI 10.4161/cc.6.15.4482; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Dulyaninova NG, 2005, BIOCHEMISTRY-US, V44, P6867, DOI 10.1021/bi0500776; EGELHOFF TT, 1993, CELL, V75, P363, DOI 10.1016/0092-8674(93)80077-R; Even-Faitelson L, 2006, MOL BIOL CELL, V17, P2869, DOI 10.1091/mbc.e05-11-1001; Fenix AM, 2016, MOL BIOL CELL, V27, P1465, DOI 10.1091/mbc.E15-10-0725; Field CM, 2019, CURR BIOL, V29, P1999, DOI 10.1016/j.cub.2019.05.016; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Fuller BG, 2008, NATURE, V453, P1132, DOI 10.1038/nature06923; Fung SYS, 2017, CURR BIOL, V27, P78, DOI 10.1016/j.cub.2016.10.042; Gelens L, 2018, TRENDS CELL BIOL, V28, P6, DOI 10.1016/j.tcb.2017.09.005; Gibson DG, 2009, NUCLEIC ACIDS RES, V37, P6984, DOI 10.1093/nar/gkp687; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Gonzalez-Loyola A, 2015, MOL CELL BIOL, V35, P3566, DOI 10.1128/MCB.01286-14; Goto H, 2002, GENES CELLS, V7, P11, DOI 10.1046/j.1356-9597.2001.00498.x; Honda R, 2003, MOL BIOL CELL, V14, P3325, DOI 10.1091/mbc.E02-11-0769; HOSOYA H, 1991, J BIOL CHEM, V266, P22173; Inaba H, 2018, BIOCHEM BIOPH RES CO, V498, P544, DOI 10.1016/j.bbrc.2018.03.016; Jeyaprakash AA, 2007, CELL, V131, P271, DOI 10.1016/j.cell.2007.07.045; Juanes-Garcia A, 2015, J CELL BIOL, V209, P23, DOI 10.1083/jcb.201407059; KATSURAGAWA Y, 1989, EUR J BIOCHEM, V184, P611, DOI 10.1111/j.1432-1033.1989.tb15057.x; KAWAMOTO S, 1989, J BIOL CHEM, V264, P2258; Kitagawa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064826; Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133; Kosako H, 2000, ONCOGENE, V19, P6059, DOI 10.1038/sj.onc.1203987; Landino J, 2017, MOL BIOL CELL, V28, P3634, DOI 10.1091/mbc.E17-06-0399; Landino J, 2016, CURR BIOL, V26, P698, DOI 10.1016/j.cub.2016.01.018; Lens SMA, 2019, NAT REV CANCER, V19, P32, DOI 10.1038/s41568-018-0084-6; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Lin ZZ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-461; Lister IM, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-19; Manukyan A, 2015, J CELL SCI, V128, P50, DOI 10.1242/jcs.151647; Matsumura F, 2011, ARCH BIOCHEM BIOPHYS, V510, P76, DOI 10.1016/j.abb.2011.03.002; Meppelink A, 2015, CELL REP, V11, P508, DOI 10.1016/j.celrep.2015.03.052; Miller AL, 2009, NAT CELL BIOL, V11, P71, DOI 10.1038/ncb1814; Motegi F, 2004, J CELL BIOL, V165, P685, DOI 10.1083/jcb.200402097; Murakami N, 1998, BIOCHEMISTRY-US, V37, P1989, DOI 10.1021/bi971959a; Murakami N, 2000, BIOCHEMISTRY-US, V39, P11441, DOI 10.1021/bi000347e; Murata-Hori M, 2000, J BIOCHEM-TOKYO, V128, P903, DOI 10.1093/oxfordjournals.jbchem.a022840; NIEDERMAN R, 1975, J CELL BIOL, V67, P72, DOI 10.1083/jcb.67.1.72; Nilsson J, 2019, J CELL BIOL, V218, P395, DOI 10.1083/jcb.201809138; Olsen JV, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000475; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Papini D, 2019, J CELL SCI, V132, DOI 10.1242/jcs.234401; Petronczki M, 2007, DEV CELL, V12, P713, DOI 10.1016/j.devcel.2007.03.013; PHILLIPS CL, 1995, J MUSCLE RES CELL M, V16, P379, DOI 10.1007/BF00114503; Pike T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13853; Pinsky BA, 2006, NAT CELL BIOL, V8, P78, DOI 10.1038/ncb1341; Pollard TD, 2020, ADV EXP MED BIOL, V1239, P233, DOI 10.1007/978-3-030-38062-5_11; Pollard TD, 2019, ANNU REV BIOCHEM, V88, P661, DOI 10.1146/annurev-biochem-062917-012530; Ronen D, 2009, J BIOL CHEM, V284, P24948, DOI 10.1074/jbc.M109.023754; Rosenberg M, 2006, MOL BIOL CELL, V17, P1364, DOI 10.1091/mbc.e05-07-0597; Rosenberg M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001496; Rovner AS, 2002, J CELL BIOL, V156, P113, DOI 10.1083/jcb.200107131; Sabry JH, 1997, MOL BIOL CELL, V8, P2605, DOI 10.1091/mbc.8.12.2605; Santaguida S, 2011, EMBO J, V30, P1508, DOI 10.1038/emboj.2011.70; SATTERWHITE LL, 1992, J CELL BIOL, V118, P595, DOI 10.1083/jcb.118.3.595; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Smith SL, 2005, BRIT J CANCER, V93, P719, DOI 10.1038/sj.bjc.6602779; Sohn RL, 1997, J MOL BIOL, V266, P317, DOI 10.1006/jmbi.1996.0790; Straussman R., 2005, THESIS HEBREW U JERU; Straussman R, 2007, J MOL BIOL, V366, P1232, DOI 10.1016/j.jmb.2006.11.083; Terry SJ, 2018, P NATL ACAD SCI USA, V115, P2138, DOI 10.1073/pnas.1722281115; Vicente-Manzanares M, 2009, NAT REV MOL CELL BIO, V10, P778, DOI 10.1038/nrm2786; Wang CW, 2020, GENOM PROTEOM BIOINF, V18, P72, DOI 10.1016/j.gpb.2020.01.001; Wang FW, 2011, CURR BIOL, V21, P1061, DOI 10.1016/j.cub.2011.05.016; Wheatley SP, 2007, CELL CYCLE, V6, P1220, DOI 10.4161/cc.6.10.4179; Wheatley SP, 2004, J BIOL CHEM, V279, P5655, DOI 10.1074/jbc.M311299200; Willems E, 2018, CELL DIV, V13, DOI 10.1186/s13008-018-0040-6; Wu JQ, 2005, SCIENCE, V310, P310, DOI 10.1126/science.1113230; Wu Z, 2018, ANAL CHEM, V90, P9700, DOI 10.1021/acs.analchem.8b02448; Xu ZJ, 2010, J BIOL CHEM, V285, P40163, DOI 10.1074/jbc.M110.181545; Yasui Y, 2004, J BIOL CHEM, V279, P12997, DOI 10.1074/jbc.M311128200; Yuce O, 2005, J CELL BIOL, V170, P571, DOI 10.1083/jcb.200501097; Yumura S, 2005, MOL BIOL CELL, V16, P4256, DOI 10.1091/mbc.E05-03-0219; Zhang DL, 2015, ELIFE, V4, DOI 10.7554/eLife.08898	93	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101024	10.1016/j.jbc.2021.101024	http://dx.doi.org/10.1016/j.jbc.2021.101024			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34343568	gold, Green Published			2022-12-28	WOS:000706408900006
J	Fujimoto, T; Inoue-Mochita, M; Iraha, S; Tanihara, H; Inoue, T				Fujimoto, Tomokazu; Inoue-Mochita, Miyuki; Iraha, Satoshi; Tanihara, Hidenobu; Inoue, Toshihiro			Suberoylanilide hydroxamic acid (SAHA) inhibits transforming growth factor-beta 2-induced increases in aqueous humor outflow resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN TRABECULAR MESHWORK; BONE MORPHOGENETIC PROTEIN-7; TO-MESENCHYMAL TRANSITION; EXTRACELLULAR-MATRIX; MYOFIBROBLAST DIFFERENTIATION; INTRAOCULAR-PRESSURE; LIVER FIBROSIS; GLAUCOMA; TGF-BETA-2; FIBROBLASTS	Transforming growth factor-beta 2 (TGF-beta 2) is highly concentrated in the aqueous humor of primary open-angle glaucoma patients. TGF-beta 2 causes fibrosis of outflow tissues, such as the trabecular meshwork (TM), and increases intraocular pressure by increasing resistance to aqueous humor outflow. Recently, histone deacetylase (HDAC) activity was investigated in fibrosis in various tissues, revealing that HDAC inhibitors suppress tissue fibrosis. However, the effect of HDAC inhibitors on fibrosis in the eye was not determined. Here, we investigated the effect of suberoylanilide hydroxamic acid (SAHA), an HDAC inhibitor, on TGF-beta 2-induced increased resistance to aqueous humor outflow. We found that SAHA suppressed TGF-beta 2-induced outflow resistance in perfused porcine eyes. Moreover, SAHA cotreatment suppressed TGF-beta 2-induced ocular hypertension in rabbits. The permeability of monkey TM (MTM) and Schlemm's canal (MSC) cell monolayers was decreased by TGF-beta 2 treatment. SAHA inhibited the effects of TGF-beta 2 on the permeability of these cells. TGF-beta 2 also increased the expression of extracellular matrix proteins (fibronectin and collagen type I or IV) in MTM, MSC, and human TM (HTM) cells, while SAHA inhibited TGF-beta 2-induced extracellular matrix protein expression in these cells. SAHA also inhibited TGF-beta 2-induced phosphorylation of Akt and ERK, but did not inhibit Smad2/3 phosphorylation, the canonical pathway of TGF-beta signaling. Moreover, SAHA induced the expression of phosphatase and tensin homolog, a PI3K/Akt signaling factor, as well as bone morphogenetic protein 7, an endogenous antagonist of TGF-beta. These results imply that SAHA prevents TGF-beta 2-induced increases in outflow resistance and regulates the non-Smad pathway of TGF-beta signaling in TM and MSC cells.	[Fujimoto, Tomokazu; Iraha, Satoshi; Inoue, Toshihiro] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan; [Inoue-Mochita, Miyuki] Kumamoto Univ, Inst Mol Embryol & Genet, Dept Med Cell Biol, Kumamoto, Japan; [Tanihara, Hidenobu] Kumamoto Univ, Kumamoto Univ Hosp, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Fujimoto, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	tomofuji@kumamoto-u.ac.jp		Inoue, Toshihiro/0000-0003-3769-7609; Fujimoto, Tomokazu/0000-0002-4867-1925	JSPS KAKENHI Grants [16K11289, 19K09934, 17H04351]	JSPS KAKENHI Grants	This work was supported by JSPS KAKENHI Grants 16K11289, 19K09934 (T. F.), and 17H04351 (H. T.). The sponsor and funding organization had no role in the design or conduct of this research.	Acott TS, 2008, EXP EYE RES, V86, P543, DOI 10.1016/j.exer.2008.01.013; Bermudez JY, 2016, INVEST OPHTH VIS SCI, V57, P3698, DOI 10.1167/iovs16-19446; Boon MR, 2011, CYTOKINE GROWTH F R, V22, P221, DOI 10.1016/j.cytogfr.2011.08.001; Cai JW, 2020, MOL VIS, V26, P483; Chansangpetch S, 2018, J OPHTHALMOL, V2018, DOI 10.1155/2018/9171536; Chen KL, 2019, INVEST OPHTH VIS SCI, V60, P1156, DOI 10.1167/iovs.18-24743; Coward WR, 2009, MOL CELL BIOL, V29, P4325, DOI 10.1128/MCB.01776-08; Dolivo DM, 2019, INT J MOL MED, V43, P325, DOI 10.3892/ijmm.2018.3949; Ferreira SM, 2004, AM J OPHTHALMOL, V137, P62, DOI 10.1016/S0002-9394(03)00788-8; Fleenor DL, 2006, INVEST OPHTH VIS SCI, V47, P226, DOI 10.1167/iovs.05-1060; Fuchshofer R, 2007, INVEST OPHTH VIS SCI, V48, P715, DOI 10.1167/iovs.06-0226; Fujimoto T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161332; Fujimoto T, 2012, INVEST OPHTH VIS SCI, V53, P7097, DOI 10.1167/iovs.12-9989; Futakuchi A, 2017, INVEST OPHTH VIS SCI, V58, P2421, DOI 10.1167/iovs.16-21403; Goc A, 2011, J CELL PHYSIOL, V226, P3004, DOI 10.1002/jcp.22648; Gonzalez DM, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005189; Gottanka J, 2004, INVEST OPHTH VIS SCI, V45, P153, DOI 10.1167/iovs.03-0796; Gronkiewicz KM, 2016, VET OPHTHALMOL, V19, P480, DOI 10.1111/vop.12331; Guenter RE, 2019, CANCERS, V11, DOI 10.3390/cancers11060767; Guo T, 2019, BMC OPHTHALMOL, V19, DOI 10.1186/s12886-019-1183-1; Guo WC, 2009, AM J PHYSIOL-LUNG C, V297, pL864, DOI 10.1152/ajplung.00128.2009; HAMARD P, 1994, BRIT J OPHTHALMOL, V78, P449, DOI 10.1136/bjo.78.6.449; Han H, 2011, INVEST OPHTH VIS SCI, V52, P2889, DOI 10.1167/iovs.10-6640; Hu YB, 2006, LUNG, V184, P33, DOI 10.1007/s00408-005-2560-5; Inatani M, 2001, GRAEF ARCH CLIN EXP, V239, P109, DOI 10.1007/s004170000241; Inoue-Mochita M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120774; Jang S, 2017, ONCOTARGET, V8, P70828, DOI 10.18632/oncotarget.19993; Jones PA, 2016, NAT REV GENET, V17, P630, DOI 10.1038/nrg.2016.93; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Liang LL, 2019, MOL MED REP, V20, P2929, DOI 10.3892/mmr.2019.10507; Manson SR, 2014, J UROLOGY, V191, P242, DOI 10.1016/j.juro.2013.06.110; Marumo T, 2010, AM J PHYSIOL-RENAL, V298, pF133, DOI 10.1152/ajprenal.00400.2009; Matsuda A, 2015, INVEST OPHTH VIS SCI, V56, P3801, DOI 10.1167/iovs.14-16008; Matsumura T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242626; McDonnell F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153354; Montecchi-Palmer M, 2017, INVEST OPHTH VIS SCI, V58, DOI 10.1167/iovs.16-19672; Nakamura N, 2021, MOL VIS, V27, P61; Park KC, 2014, BRIT J PHARMACOL, V171, P4820, DOI 10.1111/bph.12590; Pasini A, 2018, BBA-GENE REGUL MECH, V1861, P463, DOI 10.1016/j.bbagrm.2018.03.007; Pattabiraman PP, 2010, AM J PHYSIOL-CELL PH, V298, pC749, DOI 10.1152/ajpcell.00317.2009; Picht G, 2001, GRAEF ARCH CLIN EXP, V239, P199, DOI 10.1007/s004170000252; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Rees JRE, 2006, CANCER RES, V66, P9583, DOI 10.1158/0008-5472.CAN-06-1842; Saito S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186615; Sanders YY, 2014, EUR RESPIR J, V43, P1448, DOI 10.1183/09031936.00095113; Sharma A, 2016, INVEST OPHTH VIS SCI, V57, P3381, DOI 10.1167/iovs.15-18750; Shepard AR, 2010, INVEST OPHTH VIS SCI, V51, P2067, DOI 10.1167/iovs.09-4567; Takahashi E, 2014, EXP EYE RES, V118, P72, DOI 10.1016/j.exer.2013.11.014; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; TRIPATHI RC, 1994, EXP EYE RES, V59, P723, DOI 10.1006/exer.1994.1158; Tung CW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15162-6; Van Veldhuisen PC, 2000, AM J OPHTHALMOL, V130, P429; Wang Z, 2009, EUR RESPIR J, V34, P145, DOI 10.1183/09031936.00084808; Wecker T, 2013, INVEST OPHTH VIS SCI, V54, P6456, DOI 10.1167/iovs.13-12669; Xiao K, 2015, BIOMATERIALS, V67, P183, DOI 10.1016/j.biomaterials.2015.07.033; Xu YN, 2017, MOL MED REP, V16, P5354, DOI 10.3892/mmr.2017.7277; Yang JS, 2020, EUR REV MED PHARMACO, V24, P5726, DOI 10.26355/eurrev_202005_21364; Yao HP, 2019, FASEB J, V33, P3212, DOI 10.1096/fj.201800858RR; Yonemura H, 2019, MOL VIS, V25, P382; Yoshikawa M, 2007, J AM SOC NEPHROL, V18, P58, DOI 10.1681/ASN.2005111187; Yue BYJT, 1996, SURV OPHTHALMOL, V40, P379; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zeisberg M, 2007, J BIOL CHEM, V282, P23337, DOI 10.1074/jbc.M700194200	63	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101070	10.1016/j.jbc.2021.101070	http://dx.doi.org/10.1016/j.jbc.2021.101070			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34389355	Green Published, gold			2022-12-28	WOS:000714635500002
J	Rutbeek, NR; Rezasoltani, H; Patel, TR; Khajehpour, M; Prehna, G				Rutbeek, Nicole R.; Rezasoltani, Hanieh; Patel, Trushar R.; Khajehpour, Mazdak; Prehna, Gerd			Molecular mechanism of quorum sensing inhibition in Streptococcus by the phage protein paratox	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BIOLOGICAL MACROMOLECULES; COMPETENCE; VIRULENCE; PNEUMONIAE; PYOGENES; TRANSFORMATION; SYSTEM; GENES; CLONE	Streptococcus pyogenes, or Group A Streptococcus, is a Grampositive bacterium that can be both a human commensal and a pathogen. Central to this dichotomy are temperate bacteriophages that incorporate into the bacterial genome as prophages. These genetic elements encode both the phage proteins and the toxins harmful to the human host. One such conserved phage protein, paratox (Prx), is always found encoded adjacent to the toxin genes, and this linkage is preserved during all stages of the phage life cycle. Within S. pyogenes, Prx functions to inhibit the quorum-sensing receptor-signal pair ComRS, the master regulator of natural competence, or the ability to uptake endogenous DNA. However, the mechanism by which Prx directly binds and inhibits the receptor ComR is unknown. To understand how Prx inhibits ComR at the molecular level, we pursued an X-ray crystal structure of Prx bound to ComR. The structural data supported by solution X-ray scattering data demonstrate that Prx induces a conformational change in ComR to directly access its DNA-binding domain. Furthermore, electromobility shift assays and competition binding assays reveal that Prx effectively uncouples the interdomain conformational change required for activation of ComR via the signaling molecule XIP. Although to our knowledge the molecular mechanism of quorum-sensing inhibition by Prx is unique, it is analogous to the mechanism employed by the phage protein Aqs1 in Pseudomonas aeruginosa. Together, this demonstrates an example of convergent evolution between Gram-positive and Gram-negative phages to inhibit quorum sensing and highlights the versatility of small phage proteins.	[Rutbeek, Nicole R.; Prehna, Gerd] Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada; [Rezasoltani, Hanieh; Khajehpour, Mazdak] Univ Manitoba, Dept Chem, Winnipeg, MB, Canada; [Patel, Trushar R.] Univ Lethbridge, Dept Chem & Biochem, Lethbridge, AB, Canada	University of Manitoba; University of Manitoba; University of Lethbridge	Prehna, G (corresponding author), Univ Manitoba, Dept Microbiol, Winnipeg, MB, Canada.	gerd.prehna@umanitoba.ca	Patel, Trushar/F-2776-2011	Patel, Trushar/0000-0003-0627-2923; Rezasoltani, Hanieh/0000-0001-5212-3799; Rutbeek, Nicole/0000-0002-6851-8223; Prehna, Gerd/0000-0001-5539-7533; Khajehpour, Mazdak/0000-0002-6080-9333	Natural Sciences and Engineering Research Council of Canada (NSERC) [RGPIN-2018-04968]; Manitoba Medical Service Foundation Operating Grant (MMSF) [8-2020-10]; Canadian Foundation for Innovation award (CFI) [37841]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Manitoba Medical Service Foundation Operating Grant (MMSF); Canadian Foundation for Innovation award (CFI)	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) grant RGPIN-2018-04968 to G. P., a Manitoba Medical Service Foundation Operating Grant (MMSF) 8-2020-10 to G. P., and a Canadian Foundation for Innovation award (CFI) 37841 to G. P. T. R. P. acknowledges Canada Research Chair program.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aggarwal C, 2014, J BIOL CHEM, V289, P22427, DOI 10.1074/jbc.M114.583989; Aziz RK, 2005, J BACTERIOL, V187, P3311, DOI 10.1128/JB.187.10.3311-3318.2005; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Campbell EA, 1998, MOL MICROBIOL, V27, P929, DOI 10.1046/j.1365-2958.1998.00737.x; Capodagli GC, 2020, P NATL ACAD SCI USA, V117, P24494, DOI 10.1073/pnas.2008427117; Chung IY, 2014, P NATL ACAD SCI USA, V111, P11503, DOI 10.1073/pnas.1403537111; Diab J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1428; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Euler CW, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146408; Feigin L.A., 1987, STRUCTURE ANAL SMALL; Fontaine L, 2015, INFECT GENET EVOL, V33, P343, DOI 10.1016/j.meegid.2014.09.010; Fontaine L, 2010, J BACTERIOL, V192, P1444, DOI 10.1128/JB.01251-09; Grant TD, 2018, NAT METHODS, V15, P191, DOI [10.1038/NMETH.4581, 10.1038/nmeth.4581]; Hauser R, 2012, ADV VIRUS RES, V83, P219, DOI 10.1016/B978-0-12-394438-2.00006-2; Imohl M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180757; James NG, 2014, METHODS MOL BIOL, V1076, P29, DOI 10.1007/978-1-62703-649-8_2; Johnston C, 2014, NAT REV MICROBIOL, V12, P181, DOI 10.1038/nrmicro3199; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim DN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13942-4; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Koul A, 2020, BIOPHYS J, V118, P2726, DOI 10.1016/j.bpj.2020.04.025; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; Marks LR, 2014, J INFECT DIS, V210, P25, DOI 10.1093/infdis/jiu058; Mashburn-Warren L, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34816-7; Mashburn-Warren L, 2012, J BACTERIOL, V194, P4589, DOI 10.1128/JB.00830-12; Mashburn-Warren L, 2010, MOL MICROBIOL, V78, P589, DOI 10.1111/j.1365-2958.2010.07361.x; McShan WM, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0059-2018; Meier-Stephenson V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100589; Moon AF, 2016, NUCLEIC ACIDS RES, V44, P3946, DOI 10.1093/nar/gkw143; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Neiditch MB, 2017, ANNU REV GENET, V51, P311, DOI 10.1146/annurev-genet-120116-023507; Norrby-Teglund A, 2000, J MED MICROBIOL, V49, P849, DOI 10.1099/0022-1317-49-10-849; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Panjkovich A, 2018, BIOINFORMATICS, V34, P1944, DOI 10.1093/bioinformatics/btx846; Penades JR, 2015, CURR OPIN MICROBIOL, V23, P171, DOI 10.1016/j.mib.2014.11.019; Peterson S, 2000, J BACTERIOL, V182, P6192, DOI 10.1128/JB.182.21.6192-6202.2000; Peterson SN, 2004, MOL MICROBIOL, V51, P1051, DOI 10.1046/j.1365-2958.2003.03907.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ralph AP, 2013, CURR TOP MICROBIOL, V368, P1, DOI 10.1007/82_2012_280; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Shah MG, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.12.011; Shanker E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005979; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Talagas A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005980; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	48	0	0	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100992	10.1016/j.jbc.2021.100992	http://dx.doi.org/10.1016/j.jbc.2021.100992			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34298018	Green Submitted, gold, Green Published			2022-12-28	WOS:000706418900006
J	Yui, AN; Caaveiro, JMM; Kuroda, D; Nakakido, M; Nagatoishi, S; Goda, S; Maruno, T; Uchiyama, S; Tsumoto, K				Yui, Anna; Caaveiro, Jose M. M.; Kuroda, Daisuke; Nakakido, Makoto; Nagatoishi, Satoru; Goda, Shuichiro; Maruno, Takahiro; Uchiyama, Susumu; Tsumoto, Kouhei			Mechanism of dimerization and structural features of human LI-cadherin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CELL-ADHESION; LIVER-INTESTINE-CADHERIN; CRYSTAL-STRUCTURES; PROTEIN; ULTRACENTRIFUGATION; AGGREGATION; INTERFACE; JUNCTIONS; BINDING	Liver intestine (LI)-cadherin is a member of the cadherin superfamily, which encompasses a group of Ca2+-dependent cell-adhesion proteins. The expression of LI-cadherin is observed on various types of cells in the human body, such as normal small intestine and colon cells, and gastric cancer cells. Because its expression is not observed on normal gastric cells, LI-cadherin is a promising target for gastric cancer imaging. However, because the cell adhesion mechanism of LI-cadherin has remained unknown, rational design of therapeutic molecules targeting this cadherin has been hampered. Here, we have studied the homodimerization mechanism of LI-cadherin. We report the crystal structure of the LI-cadherin homodimer containing its first four extracellular cadherin repeats (EC1-4). The EC1-4 homodimer exhibited a unique architecture different from that of other cadherins reported so far, driven by the interactions between EC2 of one protein chain and EC4 of the second protein chain. The crystal structure also revealed that LI-cadherin possesses a noncanonical calcium ion-free linker between the EC2 and EC3 domains. Various biochemical techniques and molecular dynamics simulations were employed to elucidate the mechanism of homodimerization. We also showed that the formation of the homodimer observed in the crystal structure is necessary for LI-cadherin-dependent cell adhesion by performing cell aggregation assays. Taken together, our data provide structural insights necessary to advance the use of LI-cadherin as a target for imaging gastric cancer.	[Yui, Anna; Caaveiro, Jose M. M.; Kuroda, Daisuke; Nakakido, Makoto; Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan; [Caaveiro, Jose M. M.] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Global Healthcare, Fukuoka, Japan; [Kuroda, Daisuke] Univ Tokyo, Sch Engn, Med Device Dev & Regulat Res Ctr, Tokyo, Japan; [Nagatoishi, Satoru; Tsumoto, Kouhei] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Goda, Shuichiro] Soka Univ, Grad Sch Sci & Engn, Tokyo, Japan; [Maruno, Takahiro; Uchiyama, Susumu] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Osaka, Japan; [Tsumoto, Kouhei] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan	University of Tokyo; Kyushu University; University of Tokyo; University of Tokyo; Soka University; Osaka University; University of Tokyo	Caaveiro, JMM; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Bioengn, Tokyo, Japan.; Caaveiro, JMM (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Global Healthcare, Fukuoka, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Inst Med Sci, Tokyo, Japan.; Tsumoto, K (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan.	jose@phar.kyushu-u.ac.jp; tsumoto@bioeng.t.u-tokyo.ac.jp	Kuroda, Daisuke/AAZ-5672-2020; Satoru, NAGATOISHI/AAY-8198-2021; Uchiyama, Susumu/F-9590-2017; Caaveiro, Jose M.M./J-2790-2013	Kuroda, Daisuke/0000-0003-2390-4785; Satoru, NAGATOISHI/0000-0002-0794-3963; Uchiyama, Susumu/0000-0002-5181-179X; Caaveiro, Jose M.M./0000-0001-5568-2369; Yui, Anna/0000-0001-6765-4306	Japan Society for the Promotion of Science [16H02420, 20H02531, 18J22330]; Ministry of Education, Culture, Sports, Science and Technology [19H05760, 19H05766]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was funded by a Grant-in-Aid for Scientific Research (A) 16H02420 (to K. T.) and a Grant-in-Aid for Scientific Research (B) 20H02531 (to K. T.) from the Japan Society for the Promotion of Science, a Grant-inAid for Scientific Research on Innovative Areas 19H05760 and 19H05766 (to K. T.) from the Ministry of Education, Culture, Sports, Science and Technology, and a Grant-in-Aid for JSPS Fellows 18J22330 (to A. Y.) from the Japan Society for the Promotion of Science.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Araya-Secchi R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13458; BERNDORFF D, 1994, J CELL BIOL, V125, P1353, DOI 10.1083/jcb.125.6.1353; Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559; BOLLER K, 1985, J CELL BIOL, V100, P327, DOI 10.1083/jcb.100.1.327; Brasch J, 2012, TRENDS CELL BIOL, V22, P299, DOI 10.1016/j.tcb.2012.03.004; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Chappuis-Flament S, 2001, J CELL BIOL, V154, P231, DOI 10.1083/jcb.200103143; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Harrison OJ, 2011, STRUCTURE, V19, P244, DOI 10.1016/j.str.2010.11.016; Harrison OJ, 2010, NAT STRUCT MOL BIOL, V17, P348, DOI 10.1038/nsmb.1784; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hinoi T, 2002, GASTROENTEROLOGY, V123, P1565, DOI 10.1053/gast.2002.36598; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Jin XS, 2012, P NATL ACAD SCI USA, V109, pE127, DOI 10.1073/pnas.1117538108; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Jung R, 2004, CELL MOL LIFE SCI, V61, P1157, DOI 10.1007/s00018-004-3470-z; Ko S, 2004, BIOCHEM BIOPH RES CO, V319, P562, DOI 10.1016/j.bbrc.2004.04.197; Kreft B, 1997, J CELL BIOL, V136, P1109, DOI 10.1083/jcb.136.5.1109; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kudo S, 2016, STRUCTURE, V24, P1523, DOI 10.1016/j.str.2016.07.002; Kudo S, 2012, MOL BIOSYST, V8, P2050, DOI 10.1039/c2mb25161b; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Matsusaka K, 2016, ONCOTARGET, V7, P64168, DOI 10.18632/oncotarget.11638; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0; Nicoludis JM, 2016, ELIFE, V5, DOI 10.7554/eLife.18449; Parisini E, 2007, J MOL BIOL, V373, P401, DOI 10.1016/j.jmb.2007.08.011; Petoukhov MV, 2007, J APPL CRYSTALLOGR, V40, pS223, DOI 10.1107/S0021889807002853; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Shimizu N, 2019, AIP CONF PROC, V2054, DOI 10.1063/1.5084672; Shimizu N, 2016, AIP CONF PROC, V1741, DOI 10.1063/1.4952937; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; TAKEICHI M, 1988, DEVELOPMENT, V102, P639; URUSHIHARA H, 1979, DEV BIOL, V70, P206, DOI 10.1016/0012-1606(79)90017-4; URUSHIHARA H, 1976, J CELL SCI, V22, P685; van Roy F, 2014, NAT REV CANCER, V14, P121, DOI 10.1038/nrc3647; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wendeler MW, 2004, EXP CELL RES, V294, P345, DOI 10.1016/j.yexcr.2003.11.022; Weth A, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1285390; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yui A, 2017, J BIOCHEM, V162, P255, DOI 10.1093/jb/mvx050	58	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101054	10.1016/j.jbc.2021.101054	http://dx.doi.org/10.1016/j.jbc.2021.101054			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34364873	Green Published, gold			2022-12-28	WOS:000706409400009
J	Cheng, C; Zheng, EL; Yu, BW; Zhang, Z; Wang, YY; Liu, YB; He, YN				Cheng, Chen; Zheng, Enlin; Yu, Bowen; Zhang, Ze; Wang, Yuanyuan; Liu, Yingbin; He, Yongning			Recognition of lipoproteins by scavenger receptor class A members	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CYSTEINE-RICH DOMAIN; LDL-RECEPTOR; ENDOTHELIAL-CELLS; CRYSTAL-STRUCTURE; SERUM FERRITIN; FOAM CELLS; SR-A; MACROPHAGE; CHOLESTEROL	Scavenger receptor class A (SR-A) proteins are type II transmembrane glycoproteins that form homotrimers on the cell surface. This family has five known members (SCARA1 to 5, or SR-A1 to A5) that recognize a variety of ligands and are involved in multiple biological pathways. Previous reports have shown that some SR-A family members can bind modified low-density lipoproteins (LDLs); however, the mechanisms of the interactions between the SR-A members and these lipoproteins are not fully understood. Here, we systematically characterize the recognition of SR-A receptors with lipoproteins and report that SCARA1 (SR-A1, CD204), MARCO (SCARA2), and SCARA5 recognize acetylated or oxidized LDL and very-low-density lipoprotein in a Ca2+-dependent manner through their C-terminal scavenger receptor cysteine-rich (SRCR) domains. These interactions occur specifically between the SRCR domains and the modified apolipoprotein B component of the lipoproteins, suggesting that they might share a similar mechanism for lipoprotein recognition. Meanwhile, SCARA4, a SR-A member with a carbohydrate recognition domain instead of the SRCR domain at the C terminus, shows low affinity for modified LDL and very-low-density lipoprotein but binds in a Ca2+-independent manner. SCARA3, which does not have a globular domain at the C terminus, was found to have no detectable binding with these lipoproteins. Taken together, these results provide mechanistic insights into the interactions between SR-A family members and lipoproteins that may help us understand the roles of SR-A receptors in lipid transport and related diseases such as atherosclerosis.	[Cheng, Chen; Liu, Yingbin; He, Yongning] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai, Peoples R China; [Cheng, Chen; Liu, Yingbin; He, Yongning] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai, Peoples R China; [Cheng, Chen; Zheng, Enlin; Yu, Bowen; Zhang, Ze; Wang, Yuanyuan; He, Yongning] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China; [Zheng, Enlin; Yu, Bowen; Zhang, Ze; Wang, Yuanyuan; He, Yongning] Univ Chinese Acad Sci, Beijing, Peoples R China; [Liu, Yingbin; He, Yongning] Shanghai Key Lab Biliary Tract Dis, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	He, YN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, State Key Lab Oncogenes & Related Genes,Shanghai, Shanghai, Peoples R China.; He, YN (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Dept Biliary Pancreat Surg, Shanghai, Peoples R China.; He, YN (corresponding author), Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, Shanghai, Peoples R China.; He, YN (corresponding author), Univ Chinese Acad Sci, Beijing, Peoples R China.; He, YN (corresponding author), Shanghai Key Lab Biliary Tract Dis, Shanghai, Peoples R China.	he@sibcb.ac.cn	Lv, Yuanjie/AER-0767-2022; Wang, Yu/GZL-9655-2022; Wang, Yuan/HHC-1520-2022; wangwangwang, yuanyaun/HHN-6432-2022	Ze, Zhang/0000-0001-7029-2086	National Natural Science Foundation of China [91957102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work is supported by the National Natural Science Foundation of China (No. 91957102) to Y. H.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AVIRAM M, 1993, ATHEROSCLEROSIS, V98, P1, DOI 10.1016/0021-9150(93)90217-I; Balla J, 2007, ANTIOXID REDOX SIGN, V9, P2119, DOI 10.1089/ars.2007.1787; BASU SK, 1976, P NATL ACAD SCI USA, V73, P3178, DOI 10.1073/pnas.73.9.3178; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Bowdish DME, 2009, IMMUNOL REV, V227, P19, DOI 10.1111/j.1600-065X.2008.00728.x; Bramucci E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S4-S2; BROWN MS, 1983, ANNU REV BIOCHEM, V52, P223, DOI 10.1146/annurev.bi.52.070183.001255; BROWN MS, 1979, J CELL BIOL, V82, P597, DOI 10.1083/jcb.82.3.597; CAMEJO G, 1982, ADV LIPID RES, V19, P1; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Cavallari JF, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13930; Chappell PE, 2015, STRUCTURE, V23, P1426, DOI 10.1016/j.str.2015.05.019; Cheng C, 2019, J BIOL CHEM, V294, P18881, DOI 10.1074/jbc.RA119.010110; Dai XY, 2012, J MOL CELL CARDIOL, V53, P509, DOI 10.1016/j.yjmcc.2012.07.006; de Winther MPJ, 2000, ARTERIOSCL THROM VAS, V20, P290, DOI 10.1161/01.ATV.20.2.290; Durst R, 2009, GENET TEST MOL BIOMA, V13, P583, DOI 10.1089/gtmb.2009.0048; Edelstein C, 2003, J BIOL CHEM, V278, P52841, DOI 10.1074/jbc.M310425200; ELOVSON J, 1988, J LIPID RES, V29, P1461; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feinberg H, 2007, J BIOL CHEM, V282, P17250, DOI 10.1074/jbc.M701624200; Ginsberg HN, 1998, ENDOCRIN METAB CLIN, V27, P503, DOI 10.1016/S0889-8529(05)70023-2; GOLDSTEIN JL, 1979, P NATL ACAD SCI USA, V76, P333, DOI 10.1073/pnas.76.1.333; Graham SA, 2011, J BIOL CHEM, V286, P24336, DOI 10.1074/jbc.M111.244772; Han HJ, 1998, HUM MOL GENET, V7, P1039, DOI 10.1093/hmg/7.6.1039; Hansson GK, 2001, ARTERIOSCL THROM VAS, V21, P1876, DOI 10.1161/hq1201.100220; Hevonoja T, 2000, BBA-MOL CELL BIOL L, V1488, P189, DOI 10.1016/S1388-1981(00)00123-2; Hohenester E, 1999, NAT STRUCT BIOL, V6, P228, DOI 10.1038/6669; Howell BW, 2001, CURR OPIN NEUROBIOL, V11, P74, DOI 10.1016/S0959-4388(00)00176-8; Ikeda Y, 2006, ENDOCR J, V53, P665, DOI 10.1507/endocrj.K06-010; ILLINGWORTH DR, 1993, AM J KIDNEY DIS, V22, P90, DOI 10.1016/S0272-6386(12)70173-7; Itabe H, 2011, J LIPIDS, V2011, DOI 10.1155/2011/418313; Kattoor AJ, 2019, CURR MED CHEM, V26, P1693, DOI 10.2174/0929867325666180508100950; Kelley JL, 2014, CRIT REV IMMUNOL, V34, P241, DOI 10.1615/CritRevImmunol.2014010267; Khalili A, 2012, J CARDIOVASC THORAC, V4, P1, DOI 10.5681/jcvtr.2012.001; Kiyanagi T, 2011, ATHEROSCLEROSIS, V215, P60, DOI 10.1016/j.atherosclerosis.2010.10.019; KODAMA T, 1990, NATURE, V343, P531, DOI 10.1038/343531a0; KOSTNER GM, 1989, BIOCHEM SOC T, V17, P639, DOI 10.1042/bst0170639; Kruth HS, 2013, CURR PHARM DESIGN, V19, P5865; LANDERS SC, 1993, EXP MOL PATHOL, V59, P38, DOI 10.1006/exmp.1993.1025; LEAKE DS, 1990, BIOCHEM J, V270, P741, DOI 10.1042/bj2700741; Linton MF, 2001, CURR OPIN LIPIDOL, V12, P489, DOI 10.1097/00041433-200110000-00003; Lutomski CA, 2018, ANAL CHEM, V90, P6353, DOI 10.1021/acs.analchem.8b01127; Maguire EM, 2019, VASC PHARMACOL, V112, P54, DOI 10.1016/j.vph.2018.08.002; MAHLEY RW, 1984, J LIPID RES, V25, P1277; Manning-Tobin JJ, 2009, ARTERIOSCL THROM VAS, V29, P19, DOI 10.1161/ATVBAHA.108.176644; MATSUMOTO A, 1990, P NATL ACAD SCI USA, V87, P9133, DOI 10.1073/pnas.87.23.9133; Mccoy AJ, 2017, METHODS MOL BIOL, V1606, P421, DOI 10.1007/978-1-4939-7000-1_18; Michel JB, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186756; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mori K, 2014, BBA-GEN SUBJECTS, V1840, P3345, DOI 10.1016/j.bbagen.2014.08.015; Muczynski V, 2016, BLOOD, V127, P778, DOI 10.1182/blood-2015-05-647032; Nakamura K, 2001, BIOCHEM BIOPH RES CO, V280, P1028, DOI 10.1006/bbrc.2000.4210; Ohtani K, 2001, J BIOL CHEM, V276, P44222, DOI 10.1074/jbc.M103942200; Ojala JRM, 2007, J BIOL CHEM, V282, P16654, DOI 10.1074/jbc.M701750200; Ojo OO, 2018, CHEM PHYS LIPIDS, V217, P51, DOI 10.1016/j.chemphyslip.2018.09.016; Okazaki M, 2005, ARTERIOSCL THROM VAS, V25, P578, DOI 10.1161/01.ATV.0000155017.60171.88; Olofsson SO, 1999, CURR OPIN LIPIDOL, V10, P341, DOI 10.1097/00041433-199908000-00008; Paone S, 2019, CELL MOL LIFE SCI, V76, P1093, DOI 10.1007/s00018-018-2983-9; Park YM, 2014, EXP MOL MED, V46, DOI 10.1038/emm.2014.38; PARTHASARATHY S, 1992, ANNU REV MED, V43, P219, DOI 10.1146/annurev.me.43.020192.001251; Peiser L, 2000, INFECT IMMUN, V68, P1953, DOI 10.1128/IAI.68.4.1953-1963.2000; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Platt N, 2002, INT REV CYTOL, V212, P1; Platt N, 2001, J CLIN INVEST, V108, P649, DOI 10.1172/JCI200113903; PLUMP AS, 1994, P NATL ACAD SCI USA, V91, P9607, DOI 10.1073/pnas.91.20.9607; Pombinho R, 2018, CRIT REV MICROBIOL, V44, P685, DOI 10.1080/1040841X.2018.1493716; PrabhuDas M, 2014, J IMMUNOL, V192, P1997, DOI 10.4049/jimmunol.1490003; PrabhuDas MR, 2017, J IMMUNOL, V198, P3775, DOI 10.4049/jimmunol.1700373; Qin J, 2007, J NEUROSCI RES, V85, P977, DOI 10.1002/jnr.21206; Sahebi R, 2019, J CELL PHYSIOL, V234, P16925, DOI 10.1002/jcp.28393; Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1; Schaftenaar F, 2016, CURR OPIN LIPIDOL, V27, P209, DOI 10.1097/MOL.0000000000000302; Shen WJ, 2018, J LIPID RES, V59, P1114, DOI 10.1194/jlr.R083121; SLOTTE JP, 1987, J BIOL CHEM, V262, P12904; SOUTAR AK, 1990, BRIT MED BULL, V46, P891, DOI 10.1093/oxfordjournals.bmb.a072445; STEINBRECHER UP, 1984, P NATL ACAD SCI-BIOL, V81, P3883, DOI 10.1073/pnas.81.12.3883; Stephen SL, 2010, INT J HYPERTENS, V2010, DOI 10.4061/2010/646929; Strickland DK, 2002, TRENDS ENDOCRIN MET, V13, P66, DOI 10.1016/S1043-2760(01)00526-4; Tamura Y, 2004, J BIOL CHEM, V279, P30938, DOI 10.1074/jbc.M313088200; Taylor ME, 2007, CURR OPIN CELL BIOL, V19, P572, DOI 10.1016/j.ceb.2007.09.004; Torzewski M, 2018, FRONT BIOSCI-LANDMRK, V23, P1257, DOI 10.2741/4642; Trpkovic A, 2015, CRIT REV CL LAB SCI, V52, P70, DOI 10.3109/10408363.2014.992063; Van Berkel TJC, 1998, BIOCHEM J, V331, P29, DOI 10.1042/bj3310029; Wang D, 2015, HUM IMMUNOL, V76, P442, DOI 10.1016/j.humimm.2015.03.012; Whelan FJ, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-227; Wigren M, 2012, CLIN CHIM ACTA, V413, P1562, DOI 10.1016/j.cca.2012.04.031; Xie L, 2018, INT J CHRONIC OBSTR, V13, P1145, DOI 10.2147/COPD.S153326; YAMAMOTO T, 1984, CELL, V39, P27, DOI 10.1016/0092-8674(84)90188-0; Yanyan JY, 2006, J BIOL CHEM, V281, P11834, DOI 10.1074/jbc.M507599200; Yu BW, 2020, J BIOL CHEM, V295, P15727, DOI 10.1074/jbc.RA120.014690; Yu XH, 2013, CLIN CHIM ACTA, V424, P245, DOI 10.1016/j.cca.2013.06.006; Yu XF, 2015, ADV CANCER RES, V128, P309, DOI 10.1016/bs.acr.2015.04.004; Zhang Y, 2017, CANCER RES, V77, P1586, DOI 10.1158/0008-5472.CAN-16-1569	96	3	4	5	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100948	10.1016/j.jbc.2021.100948	http://dx.doi.org/10.1016/j.jbc.2021.100948			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34252459	gold, Green Published			2022-12-28	WOS:000690871000001
J	Fukumoto, Y; Ikeuchi, M; Qu, L; Hoshino, T; Yamaguchi, N; Nakayama, Y; Ogra, Y				Fukumoto, Yasunori; Ikeuchi, Masayoshi; Qu, Liang; Hoshino, Tyuji; Yamaguchi, Naoto; Nakayama, Yuji; Ogra, Yasumitsu			Nuclear translocation promotes proteasomal degradation of human Rad17 protein through the N-terminal destruction boxes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; CELL-CYCLE; MITOTIC EXIT; ATR; CLAMP; CHK1; PROTEOLYSIS; INHIBITOR; REGULATOR; INTERACTS	The ATR pathway is one of the major DNA damage checkpoints, and Rad17 is a DNA-binding protein that is phosphorylated upon DNA damage by ATR kinase. Rad17 recruits the 9-1-1 complex that mediates the checkpoint activation, and proteasomal degradation of Rad17 is important for recovery from the ATR pathway. Here, we identified several Rad17 mutants deficient in nuclear localization and resistant to proteasomal degradation. The nuclear localization signal was identified in the central basic domain of Rad17. Rad17 Delta 230-270 and R240A/L243A mutants that were previously postulated to lack the destruction box, a sequence that is recognized by the ubiquitin ligase/anaphase-promoting complex that mediates degradation of Rad17, also showed cytoplasmic localization. Our data indicate that the nuclear translocation of Rad17 is functionally linked to the proteasomal degradation. The ATP-binding activity of Rad17, but not hydrolysis, is essential for the nuclear translocation, and the ATPase domain orchestrates the nuclear translocation, the proteasomal degradation, as well as the interaction with the 9-1-1 complex. The Rad17 mutant that lacked a nuclear localization signal was proficient in the interaction with the 9-1-1 complex, suggesting cytosolic association of Rad17 and the 9-1-1 complex. Finally, we identified two tandem canonical and noncanonical destruction boxes in the N-terminus of Rad17 as the bona fide destruction box, supporting the role of anaphase-promoting complex in the degradation of Rad17. We propose a model in which Rad17 is activated in the cytoplasm for translocation into the nucleus and continuously degraded in the nucleus even in the absence of exogenous DNA damage.	[Fukumoto, Yasunori; Qu, Liang; Hoshino, Tyuji; Yamaguchi, Naoto; Ogra, Yasumitsu] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan; [Ikeuchi, Masayoshi; Nakayama, Yuji] Kyoto Pharmaceut Univ, Dept Biochem & Mol Biol, Kyoto, Japan	Chiba University; Kyoto Pharmaceutical University	Fukumoto, Y (corresponding author), Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan.	fukumoto@faculty.chiba-u.jp	Ogra, Yasumitsu/A-2747-2017	Ogra, Yasumitsu/0000-0002-8268-1828	Japanese Ministry of Education, Culture, Sports, Science and Technology [15K07920, 16K08253, 18K07138, 19H05772, 19K07079]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grants-in-aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology [15K07920 (Y. F.), 16K08253 (Y. N.), 18K07138 (T. H.), 19H05772 (Y. O.), 19K07079 (Y. F.)].	Alfieri C, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170204; Bao SD, 1998, CELL GROWTH DIFFER, V9, P961; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Clute P, 1999, NAT CELL BIOL, V1, P82, DOI 10.1038/10049; den Elzen N, 2001, J CELL BIOL, V153, P121, DOI 10.1083/jcb.153.1.121; Fukumoto Y, 2019, BIOCHEM BIOPH RES CO, V517, P310, DOI 10.1016/j.bbrc.2019.07.076; Fukumoto Y, 2018, BIOCHEM BIOPH RES CO, V504, P380, DOI 10.1016/j.bbrc.2018.06.038; Fukumoto Y, 2017, BIOCHEM BIOPH RES CO, V490, P1147, DOI 10.1016/j.bbrc.2017.06.159; Fukumoto Y, 2016, BIOCHEM BIOPH RES CO, V477, P982, DOI 10.1016/j.bbrc.2016.07.014; Fukumoto Y, 2010, CYTOTECHNOLOGY, V62, P73, DOI 10.1007/s10616-010-9259-z; He J, 2013, MOL CELL, V50, P649, DOI 10.1016/j.molcel.2013.04.024; Huh J, 2013, MOL CELL BIOL, V33, P213, DOI 10.1128/MCB.00847-12; Ikeuchi M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060871; Laoukili J, 2008, CELL CYCLE, V7, P2720, DOI 10.4161/cc.7.17.6580; Lee J, 2010, MOL BIOL CELL, V21, P926, DOI 10.1091/mbc.E09-11-0958; Leung-Pineda V, 2009, CANCER RES, V69, P2630, DOI 10.1158/0008-5472.CAN-08-3382; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mohni KN, 2013, J VIROL, V87, P531, DOI 10.1128/JVI.02504-12; Neuwald AF, 1999, GENOME RES, V9, P27; Nguyen TB, 2002, J BIOL CHEM, V277, P41960, DOI 10.1074/jbc.M203951200; Post SM, 2003, NUCLEIC ACIDS RES, V31, P5568, DOI 10.1093/nar/gkg765; Puklowski A, 2011, NAT CELL BIOL, V13, P1004, DOI 10.1038/ncb2282; Qi F, 2018, J PHYS CHEM B, V122, P8503, DOI 10.1021/acs.jpcb.8b04800; Rauen M, 2000, J BIOL CHEM, V275, P29767, DOI 10.1074/jbc.M005782200; Saldivar JC, 2017, NAT REV MOL CELL BIO, V18, P622, DOI 10.1038/nrm.2017.67; Salomon-Ferrer R, 2013, WIRES COMPUT MOL SCI, V3, P198, DOI 10.1002/wcms.1121; Song L, 2010, MOL CELL, V38, P369, DOI 10.1016/j.molcel.2010.02.038; Stewart S, 2005, CANCER RES, V65, P8730, DOI 10.1158/0008-5472.CAN-05-1500; Tsao CC, 2004, EMBO J, V23, P4660, DOI 10.1038/sj.emboj.7600463; Venclovas C, 2000, NUCLEIC ACIDS RES, V28, P2481, DOI 10.1093/nar/28.13.2481; Wang QH, 2014, EMBO J, V33, P862, DOI 10.1002/embj.201386064; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wendler P, 2012, BBA-MOL CELL RES, V1823, P2, DOI 10.1016/j.bbamcr.2011.06.014; Xu M, 2009, J BIOL CHEM, V284, P20457, DOI 10.1074/jbc.C109.022384; Zhang LY, 2010, EMBO J, V29, P1726, DOI 10.1038/emboj.2010.55; Zhang YW, 2009, MOL CELL, V35, P442, DOI 10.1016/j.molcel.2009.06.030; Zhang YW, 2005, MOL CELL, V19, P607, DOI 10.1016/j.molcel.2005.07.019; Zhou Y, 2003, J BIOL CHEM, V278, P12530, DOI 10.1074/jbc.M212853200; Zhou Z, 2013, J BIOL CHEM, V288, P18134, DOI 10.1074/jbc.M113.456962; Zou H, 1999, SCIENCE, V285, P418, DOI 10.1126/science.285.5426.418; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302	47	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100831	10.1016/j.jbc.2021.100831	http://dx.doi.org/10.1016/j.jbc.2021.100831			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34174284	Green Published, gold			2022-12-28	WOS:000690873500012
J	Oot, RA; Yao, YQ; Manolson, MF; Wilkens, S				Oot, Rebecca A.; Yao, Yeqi; Manolson, Morris F.; Wilkens, Stephan			Purification of active human vacuolar H+-ATPase in native lipid-containing nanodiscs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON-TRANSLOCATING ATPASE; N-LINKED GLYCOSYLATION; RENAL TUBULAR-ACIDOSIS; INFLUENZA-A VIRUS; V-ATPASE; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; AFFINITY PURIFICATION; STRUCTURAL FEATURES; GOLGI HOMEOSTASIS	Vacuolar H+-ATPases (V-ATPases) are large, multisubunit proton pumps that acidify the lumen of organelles in virtually every eukaryotic cell and in specialized acid-secreting animal cells, the enzyme pumps protons into the extracellular space. In higher organisms, most of the subunits are expressed as multiple isoforms, with some enriched in specific compartments or tissues and others expressed ubiquitously. In mammals, subunit a is expressed as four isoforms (a1-4) that target the enzyme to distinct biological membranes. Mutations in a isoforms are known to give rise to tissue-specific disease, and some a isoforms are upregulated and mislocalized to the plasma membrane in invasive cancers. However, isoform complexity and low abundance greatly complicate purification of active human V-ATPase, a prerequisite for developing isoform-specific therapeutics. Here, we report the purification of an active human V-ATPase in native lipid nanodiscs from a cell line stably expressing affinity-tagged a isoform 4 (a4). We find that exogenous expression of this single subunit in HEK293F cells permits assembly of a functional V-ATPase by incorporation of endogenous subunits. The ATPase activity of the preparation is >95% sensitive to concanamycin A, indicating that the lipid nanodisc-reconstituted enzyme is functionally coupled. Moreover, this strategy permits purification of the enzyme's isolated membrane subcomplex together with biosynthetic assembly factors coiled-coil domain-containing protein 115, transmembrane protein 199, and vacuolar H+-ATPase assembly integral membrane protein 21. Our work thus lays the groundwork for biochemical characterization of active human V-ATPase in an a subunit isoform-specific manner and establishes a platform for the study of the assembly and regulation of the human holoenzyme.	[Oot, Rebecca A.; Wilkens, Stephan] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA; [Yao, Yeqi; Manolson, Morris F.] Univ Toronto, Fac Dent, Toronto, ON, Canada	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; University of Toronto	Wilkens, S (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	wilkenss@upstate.edu			NIH [GM058600, CA228340, PJT-148508]; Canadian Institutes of Health Research	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by NIH Grants GM058600 and CA228340 to S. W. and an Operating Grant PJT-148508 from the Canadian Institutes of Health Research to M. F. M. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbas YM, 2020, SCIENCE, V367, P1240, DOI 10.1126/science.aaz2924; Aoto K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22389-5; ARAI H, 1987, BIOCHEMISTRY-US, V26, P6632, DOI 10.1021/bi00395a011; Bagh MB, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14612; BLAIR HC, 1989, SCIENCE, V245, P855, DOI 10.1126/science.2528207; Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Chitirala P, 2020, J IMMUNOL, V204, P2818, DOI 10.4049/jimmunol.1901536; Civjan NR, 2003, BIOTECHNIQUES, V35, P556, DOI 10.2144/03353rr02; Colacurcio DJ, 2016, AGEING RES REV, V32, P75, DOI 10.1016/j.arr.2016.05.004; Collins MP, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183341; Collins MP, 2020, J BIOL CHEM, V295, P9433, DOI 10.1074/jbc.RA120.013223; Cotter K, 2016, ONCOTARGET, V7, P46142, DOI 10.18632/oncotarget.10063; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Crider BP, 2003, J BIOL CHEM, V278, P44281, DOI 10.1074/jbc.M307372200; Dechant R, 2010, EMBO J, V29, P2515, DOI 10.1038/emboj.2010.138; Eaton AF, 2021, AM J PHYSIOL-CELL PH, V320, pC392, DOI 10.1152/ajpcell.00442.2020; Esmail S, 2018, J CELL BIOCHEM, V119, P861, DOI 10.1002/jcb.26250; Esmail S, 2016, J CELL BIOCHEM, V117, P2757, DOI 10.1002/jcb.25574; Finnigan GC, 2012, J BIOL CHEM, V287, P19487, DOI 10.1074/jbc.M112.343814; Fischer B, 2012, HUM GENET, V131, P1761, DOI 10.1007/s00439-012-1197-8; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Futai M, 2019, P JPN ACAD B-PHYS, V95, P261, DOI 10.2183/pjab.95.018; GLUCK S, 1987, J BIOL CHEM, V262, P15780; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Graham LA, 2003, J BIOENERG BIOMEMBR, V35, P301, DOI 10.1023/A:1025772730586; HILL KJ, 1995, J BIOL CHEM, V270, P22329, DOI 10.1074/jbc.270.38.22329; HILL KJ, 1994, MOL BIOL CELL, V5, P1039, DOI 10.1091/mbc.5.9.1039; Hucthagowder V, 2009, HUM MOL GENET, V18, P2149, DOI 10.1093/hmg/ddp148; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Huss M, 2002, J BIOL CHEM, V277, P40544, DOI 10.1074/jbc.M207345200; Imai-Senga Y, 2002, GENE, V289, P7, DOI 10.1016/S0378-1119(02)00542-5; Inoue H, 1999, BBA-BIOENERGETICS, V1413, P130, DOI 10.1016/S0005-2728(99)00096-1; Jackson DD, 1997, J BIOL CHEM, V272, P25928, DOI 10.1074/jbc.272.41.25928; Jansen JC, 2016, AM J HUM GENET, V98, P322, DOI 10.1016/j.ajhg.2015.12.011; Jansen JC, 2016, AM J HUM GENET, V98, P310, DOI 10.1016/j.ajhg.2015.12.010; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kartner N, 2010, J BIOL CHEM, V285, P37476, DOI 10.1074/jbc.M110.123281; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P17941, DOI 10.1074/jbc.M010790200; Kornak U, 2008, NAT GENET, V40, P32, DOI 10.1038/ng.2007.45; Lafourcade C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002758; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; Lin YC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5767; Lindstrom A, 2018, CHEMMEDCHEM, V13, P2664, DOI 10.1002/cmdc.201800587; Lorente-Canovas B, 2013, DIS MODEL MECH, V6, P434, DOI 10.1242/dmm.010645; Lu XB, 1998, IMMUNITY, V8, P647, DOI 10.1016/S1074-7613(00)80569-5; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; MANOLSON MF, 1992, J BIOL CHEM, V267, P14294; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Marjuki H, 2011, CELL MICROBIOL, V13, P587, DOI 10.1111/j.1462-5822.2010.01556.x; Matsumoto N, 2014, BBA-BIOENERGETICS, V1837, P744, DOI 10.1016/j.bbabio.2014.02.011; MATTSSON JP, 1994, J BIOL CHEM, V269, P24979; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; Merkulova M, 2015, SCI REP-UK, V5, DOI 10.1038/srep14827; Miles AL, 2017, ELIFE, V6, DOI 10.7554/eLife.22693; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Muench SP, 2009, J MOL BIOL, V386, P989, DOI 10.1016/j.jmb.2009.01.014; Nelson N, 2003, J BIOENERG BIOMEMBR, V35, P281, DOI 10.1023/A:1025768529677; NELSON RD, 1992, P NATL ACAD SCI USA, V89, P3541, DOI 10.1073/pnas.89.8.3541; Norgett EE, 2012, P NATL ACAD SCI USA, V109, P13775, DOI 10.1073/pnas.1204257109; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Perreira JM, 2015, CELL REP, V12, P850, DOI 10.1016/j.celrep.2015.06.076; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Roh SH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb9605; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Sharma S, 2019, J BIOL CHEM, V294, P6439, DOI 10.1074/jbc.RA119.007577; Sharma S, 2017, PROTEIN SCI, V26, P1070, DOI 10.1002/pro.3143; Shaw G, 2002, FASEB J, V16, P869, DOI 10.1096/fj.01-0995fje; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Smith AN, 2002, GENE, V297, P169, DOI 10.1016/S0378-1119(02)00884-3; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sreelatha A, 2015, P NATL ACAD SCI USA, V112, P100, DOI 10.1073/pnas.1413764111; Stransky L, 2016, PHYSIOL REV, V96, P1071, DOI 10.1152/physrev.00035.2015; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Sun-Wada GH, 2000, DEV BIOL, V228, P315, DOI 10.1006/dbio.2000.9963; SUPEK F, 1994, J BIOL CHEM, V269, P24102; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Vasanthakumar T, 2020, TRENDS BIOCHEM SCI, V45, P295, DOI 10.1016/j.tibs.2019.12.007; Vasanthakumar T, 2019, P NATL ACAD SCI USA, V116, P7272, DOI 10.1073/pnas.1814818116; Vavassori S, 2014, J CELL BIOL, V205, P7, DOI 10.1083/jcb.201403040; Wagner CA, 2004, PHYSIOL REV, V84, P1263, DOI 10.1152/physrev.00045.2003; Wang Longfei, 2021, STAR Protoc, V2, P100350, DOI 10.1016/j.xpro.2021.100350; Wang LF, 2020, MOL CELL, V80, P501, DOI 10.1016/j.molcel.2020.09.029; Wang R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17762-9; Wilkens S, 1999, J BIOL CHEM, V274, P31804, DOI 10.1074/jbc.274.45.31804; Wilkens S, 2001, J BIOL CHEM, V276, P44064, DOI 10.1074/jbc.M106579200; Wong D, 2011, P NATL ACAD SCI USA, V108, P19371, DOI 10.1073/pnas.1109201108; XIE XS, 1988, J BIOL CHEM, V263, P9859; Xu L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000822; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; ZHANG JM, 1992, J BIOL CHEM, V267, P9773; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	100	2	2	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100964	10.1016/j.jbc.2021.100964	http://dx.doi.org/10.1016/j.jbc.2021.100964			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34270960	Green Published, gold			2022-12-28	WOS:000690871400011
J	Eickelschulte, S; Hartwig, S; Leiser, B; Lehr, S; Joschko, V; Chokkalingam, M; Chadt, A; Al-Hasani, H				Eickelschulte, Samaneh; Hartwig, Sonja; Leiser, Ben; Lehr, Stefan; Joschko, Viola; Chokkalingam, Manopriya; Chadt, Alexandra; Al-Hasani, Hadi			AKT/AMPK-mediated phosphorylation of TBC1D4 disrupts the interaction with insulin-regulated aminopeptidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STIMULATED GLUCOSE-UPTAKE; SKELETAL-MUSCLE; AS160 PHOSPHORYLATION; GLUT4 TRANSLOCATION; DOMAIN FAMILY; EXERCISE; SENSITIVITY; ACTIVATION; INCREASES; TRANSPORT	TBC1D4 is a 160 kDa multidomain Rab GTPase-activating protein (RabGAP) and a downstream target of the insulin- and contraction-activated kinases AKT and AMPK. Phosphorylation of TBC1D4 has been linked to translocation of GLUT4 from storage vesicles (GSVs) to the cell surface. However, its impact on enzymatic activity is not well understood, as previous studies mostly investigated the truncated GAP domain lacking the known phosphorylation sites. In the present study, we expressed and purified recombinant full-length TBC1D4 using a baculovirus system. Size-exclusion chromatography and coimmunoprecipitation experiments revealed that full-length TBC1D4 forms oligomers of similar to 600 kDa. Compared with the truncated GAP domain, full-length TBC1D4 displayed similar substrate specificity, but had a markedly higher specific GAP activity toward Rab10. Using high-resolution mass spectrometry, we mapped 19 Ser/Thr phosphorylation sites in TBC1D4. We determined Michaelis-Menten kinetics using in vitro phosphorylation assays with purified kinases and stable isotopelabeled gamma-[O-18(4)]-ATP. These data revealed that Ser(324) (K-M similar to 6 mu M) and Thr(649) (K-M similar to 25 mu M) were preferential sites for phosphorylation by AKT, whereas Ser(348), Ser(577), Ser(595) (K-M similar to 10 mu M), Ser(711) (K-M similar to 79 mu M), and Ser(764) were found to be preferred targets for AMPK. Phosphorylation of TBC1D4 by AKT or AMPK did not alter the intrinsic RabGAP activity, but did disrupt interaction with insulin-regulated aminopeptidase (IRAP), a resident protein of GSVs implicated in GLUT4 trafficking. These findings provide evidence that insulin and contraction may regulate TBC1D4 function primarily by disrupting the recruitment of the RabGAP to GLUT4 vesicles.	[Eickelschulte, Samaneh; Hartwig, Sonja; Leiser, Ben; Lehr, Stefan; Joschko, Viola; Chokkalingam, Manopriya; Chadt, Alexandra; Al-Hasani, Hadi] Heinrich Heine Univ, Med Fac, Inst Clin Biochem & Pathobiochem, German Diabet Ctr,Leibniz Ctr Diabet Res, Dusseldorf, Germany; [Eickelschulte, Samaneh; Hartwig, Sonja; Lehr, Stefan; Chokkalingam, Manopriya; Chadt, Alexandra; Al-Hasani, Hadi] German Ctr Diabet Res DZD, Partner Dusseldorf, Munich, Germany	Deutsches Diabetes-Zentrum (DDZ); Heinrich Heine University Dusseldorf	Al-Hasani, H (corresponding author), Heinrich Heine Univ, Med Fac, Inst Clin Biochem & Pathobiochem, German Diabet Ctr,Leibniz Ctr Diabet Res, Dusseldorf, Germany.; Al-Hasani, H (corresponding author), German Ctr Diabet Res DZD, Partner Dusseldorf, Munich, Germany.	hadi.al-hasani@ddz.de		Eickelschulte, Samaneh/0000-0002-8040-8393; Leiser, Ben/0000-0001-6470-4750	Deutsche Forschungsgemeinschaft [SFB1116]; EFSD/Novo Nordisk European Diabetes Research Program; DDG Allgemeine Projektforderung 2020	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EFSD/Novo Nordisk European Diabetes Research Program; DDG Allgemeine Projektforderung 2020	This work was supported in part by the Deutsche Forschungsgemeinschaft (SFB1116), the EFSD/Novo Nordisk European Diabetes Research Program (to H. A.), and DDG Allgemeine Projektforderung 2020 (to S. E.).	An D, 2010, DIABETES, V59, P1358, DOI 10.2337/db09-1266; Arias EB, 2007, AM J PHYSIOL-ENDOC M, V292, pE1191, DOI 10.1152/ajpendo.00602.2006; Baer K, 2005, BBA-GEN SUBJECTS, V1725, P340, DOI 10.1016/j.bbagen.2005.04.002; Castorena CM, 2014, DIABETES, V63, P2297, DOI 10.2337/db13-1686; Chen SA, 2008, BIOCHEM J, V409, P449, DOI 10.1042/BJ20071114; Chen SA, 2011, CELL METAB, V13, P68, DOI 10.1016/j.cmet.2010.12.005; Consitt LA, 2013, DIABETES, V62, P3437, DOI 10.2337/db13-0229; Ducommun S, 2012, AM J PHYSIOL-ENDOC M, V302, pE1036, DOI 10.1152/ajpendo.00379.2011; Funai K, 2010, AM J PHYSIOL-ENDOC M, V298, pE999, DOI 10.1152/ajpendo.00758.2009; Geraghty KM, 2007, BIOCHEM J, V407, P231, DOI 10.1042/BJ20070649; Guerra B, 2010, EUR J APPL PHYSIOL, V109, P731, DOI 10.1007/s00421-010-1413-y; Hamada T, 2006, J APPL PHYSIOL, V101, P1368, DOI 10.1152/japplphysiol.00416.2006; Hansen PA, 1998, J APPL PHYSIOL, V85, P1218, DOI 10.1152/jappl.1998.85.4.1218; Hartwig S, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2018.11.009; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Jordens I, 2010, MOL BIOL CELL, V21, P2034, DOI 10.1091/mbc.E10-02-0158; Karunanithi S, 2014, MOL BIOL CELL, V25, P3059, DOI 10.1091/mbc.E14-06-1060; Kido K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65397-z; Kjobsted R, 2019, DIABETES, V68, P1756, DOI 10.2337/db18-0769; Kjobsted R, 2017, DIABETES, V66, P598, DOI 10.2337/db16-0530; Kjobsted R, 2015, DIABETES, V64, P2042, DOI 10.2337/db14-1402; Klip A, 2019, J BIOL CHEM, V294, P11369, DOI 10.1074/jbc.REV119.008351; Koumanov F, 2011, J BIOL CHEM, V286, P16574, DOI 10.1074/jbc.M111.226092; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Lansey MN, 2012, AM J PHYSIOL-ENDOC M, V303, pE1273, DOI 10.1152/ajpendo.00316.2012; Larance M, 2005, J BIOL CHEM, V280, P37803, DOI 10.1074/jbc.M503897200; Mafakheri S, 2018, J BIOL CHEM, V293, P17853, DOI 10.1074/jbc.RA118.005040; Miinea CP, 2005, BIOCHEM J, V391, P87, DOI 10.1042/BJ20050887; Oki K, 2018, APPL PHYSIOL NUTR ME, V43, P795, DOI 10.1139/apnm-2017-0858; Park S, 2012, BMB REP, V45, P360, DOI 10.5483/BMBRep.2012.45.6.030; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Pehmoller C, 2012, DIABETES, V61, P2743, DOI 10.2337/db11-1572; Pencek RR, 2003, DIABETES, V52, P1897, DOI 10.2337/diabetes.52.8.1897; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pfeffer S, 2004, NAT REV MOL CELL BIO, V5, P886, DOI 10.1038/nrm1500; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Ramm G, 2006, J BIOL CHEM, V281, P29174, DOI 10.1074/jbc.M603274200; Roach WG, 2007, BIOCHEM J, V403, P353, DOI 10.1042/BJ20061798; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Sano H, 2007, CELL METAB, V5, P293, DOI 10.1016/j.cmet.2007.03.001; Schweitzer GG, 2012, J APPL PHYSIOL, V113, P1852, DOI 10.1152/japplphysiol.00619.2012; Stockli J, 2008, MOL ENDOCRINOL, V22, P2703, DOI 10.1210/me.2008-0111; Treebak JT, 2009, DIABETOLOGIA, V52, P891, DOI 10.1007/s00125-009-1294-y; Treebak JT, 2014, J PHYSIOL-LONDON, V592, P351, DOI 10.1113/jphysiol.2013.266338; Treebak JT, 2010, AM J PHYSIOL-CELL PH, V298, pC377, DOI 10.1152/ajpcell.00297.2009; Vendelbo MH, 2014, J APPL PHYSIOL, V117, P289, DOI 10.1152/japplphysiol.00044.2014; Vind BF, 2011, DIABETOLOGIA, V54, P157, DOI 10.1007/s00125-010-1924-4; Woo JR, 2017, INT J BIOL MACROMOL, V103, P965, DOI 10.1016/j.ijbiomac.2017.05.119; Zhou Z, 2017, FEBS LETT, V591, P88, DOI 10.1002/1873-3468.12509	49	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100637	10.1016/j.jbc.2021.100637	http://dx.doi.org/10.1016/j.jbc.2021.100637			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872597	Green Published, gold			2022-12-28	WOS:000672866400608
J	Selvan, N; Mehta, N; Venkateswaran, S; Brignol, N; Graziano, M; Sheikh, MO; McAnany, Y; Hung, F; Madrid, M; Krampetz, R; Siano, N; Mehta, A; Brudvig, J; Gotschall, R; Weimer, JM; Do, HV				Selvan, Nithya; Mehta, Nickita; Venkateswaran, Suresh; Brignol, Nastry; Graziano, Matthew; Sheikh, M. Osman; McAnany, Yuliya; Hung, Finn; Madrid, Matthew; Krampetz, Renee; Siano, Nicholas; Mehta, Anuj; Brudvig, Jon; Gotschall, Russell; Weimer, Jill M.; Do, Hung, V			Endolysosomal N-glycan processing is critical to attain the most active form of the enzyme acid alpha-glucosidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANNOSE 6-PHOSPHATE RECEPTOR; GLYCOGEN-STORAGE; SKELETAL-MUSCLE; DISEASE; DEFICIENCY; MILK	Acid alpha-glucosidase (GAA) is a lysosomal glycogen-catabolizing enzyme, the deficiency of which leads to Pompe disease. Pompe disease can be treated with systemic recombinant human GAA (rhGAA) enzyme replacement therapy (ERT), but the current standard of care exhibits poor uptake in skeletal muscles, limiting its clinical efficacy. Furthermore, it is unclear how the specific cellular processing steps of GAA after delivery to lysosomes impact its efficacy. GAA undergoes both proteolytic cleavage and glycan trimming within the endolysosomal pathway, yielding an enzyme that is more efficient in hydrolyzing its natural substrate, glycogen. Here, we developed a tool kit of modified rhGAAs that allowed us to dissect the individual contributions of glycan trimming and proteolysis on maturation-associated increases in glycogen hydrolysis using in vitro and in cellulo enzyme processing, glycopeptide analysis by MS, and high-pH anion-exchange chromatography with pulsed amperometric detection for enzyme kinetics. Chemical modifications of terminal sialic acids on N-glycans blocked sialidase activity in vitro and in cellulo, thereby preventing downstream glycan trimming without affecting proteolysis. This sialidase-resistant rhGAA displayed only partial activation after endolysosomal processing, as evidenced by reduced catalytic efficiency. We also generated enzymatically deglycosylated rhGAA that was shown to be partially activated despite not undergoing proteolytic processing. Taken together, these data suggest that an optimal rhGAA ERT would require both N-glycan and proteolytic processing to attain the most efficient enzyme for glycogen hydrolysis and treatment of Pompe disease. Future studies should examine the amenability of next-generation ERTs to both types of cellular processing.	[Selvan, Nithya; Mehta, Nickita; Venkateswaran, Suresh; Brignol, Nastry; Graziano, Matthew; Sheikh, M. Osman; McAnany, Yuliya; Hung, Finn; Madrid, Matthew; Krampetz, Renee; Siano, Nicholas; Mehta, Anuj; Gotschall, Russell; Weimer, Jill M.; Do, Hung, V] Amicus Therapeut Inc, Discovery Sci Div, Philadelphia, PA 19104 USA; [Brudvig, Jon] Sanford Research, Pediat & Rare Dis Grp, Sioux Falls, SD USA		Do, HV (corresponding author), Amicus Therapeut Inc, Discovery Sci Div, Philadelphia, PA 19104 USA.	hdo@amicusrx.com		Sheikh, Mohammed/0000-0002-9481-8318; Gotschall, Robert Russell/0000-0002-5050-1386	Amicus Therapeutics Inc.	Amicus Therapeutics Inc.	This study was funded by and conducted at Amicus Therapeutics Inc.	[Anonymous], 2018, ONLINE METABOLIC 16; [Anonymous], 1997, N COMP BIOC B; Bijvoet AGA, 1998, HUM MOL GENET, V7, P1815, DOI 10.1093/hmg/7.11.1815; Bonten E, 1996, GENE DEV, V10, P3156, DOI 10.1101/gad.10.24.3156; Bonten EJ, 2009, J BIOL CHEM, V284, P28430, DOI 10.1074/jbc.M109.031419; Cardone Monica, 2008, Pathogenetics, V1, P6, DOI 10.1186/1755-8417-1-6; Case LE, 2012, AM J MED GENET C, V160C, P69, DOI [10.1002/ajmg.c.31321, 10.1002/ajmc.31321]; Choi HY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34438-z; DAHMS NM, 1989, J BIOL CHEM, V264, P11458; Do HV, 2019, ANN TRANSL MED, V7, DOI 10.21037/atm.2019.04.15; Freeze Hudson H, 2008, Curr Protoc Immunol, VChapter 8, DOI [10.1002/0471140864.ps1204s62, 10.1002/0471142727.mb1713as89, 10.1002/0471142735.im0815s83]; Fukuda T, 2006, ANN NEUROL, V59, P700, DOI 10.1002/ana.20807; Garman SC, 2007, ACTA PAEDIATR, V96, P6, DOI 10.1111/j.1651-2227.2007.00198.x; Hermanson GT, 2013, BIOCONJUGATE TECHNIQUES, 3RD EDITION, P1; HERS HG, 1963, BIOCHEM J, V86, P11, DOI 10.1042/bj0860011; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; Jongen SP, 2007, GLYCOBIOLOGY, V17, P600, DOI 10.1093/glycob/cwm015; Kishnani PS, 2006, J PEDIATR-US, V148, P671, DOI 10.1016/j.jpeds.2005.11.033; Maga JA, 2013, J BIOL CHEM, V288, P1428, DOI 10.1074/jbc.M112.438663; Masuko T, 2005, ANAL BIOCHEM, V339, P69, DOI 10.1016/j.ab.2004.12.001; McVie-Wylie AJ, 2008, MOL GENET METAB, V94, P448, DOI 10.1016/j.ymgme.2008.04.009; Meena NK, 2020, MOL THER-METH CLIN D, V18, P199, DOI 10.1016/j.omtm.2020.05.026; Moise A, 2016, J AM SOC MASS SPECTR, V27, P1071, DOI 10.1007/s13361-016-1386-0; Montagnese F, 2016, J NEUROL, V263, P631, DOI 10.1007/s00415-015-7926-x; Moreland RJ, 2005, J BIOL CHEM, V280, P6780, DOI 10.1074/jbc.M404008200; Mozzi A, 2012, PROTEINS, V80, P1123, DOI 10.1002/prot.24013; Park H, 2018, BIOCHEM BIOPH RES CO, V495, P2418, DOI 10.1016/j.bbrc.2017.12.101; Peng SSF, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0446-7; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; PETERS BP, 1979, BIOCHEMISTRY-US, V18, P5505, DOI 10.1021/bi00591a038; Prater SN, 2012, GENET MED, V14, P800, DOI 10.1038/gim.2012.44; Pshezhetsky AV, 1996, J BIOL CHEM, V271, P28359, DOI 10.1074/jbc.271.45.28359; Raben N, 1999, Hum Mutat, V13, P83, DOI 10.1002/(SICI)1098-1004(1999)13:1<83::AID-HUMU13>3.0.CO;2-2; Ramya TNC, 2013, GLYCOBIOLOGY, V23, P211, DOI 10.1093/glycob/cws144; REUSER AJJ, 1984, EXP CELL RES, V155, P178, DOI 10.1016/0014-4827(84)90779-1; REUSER AJJ, 1995, MUSCLE NERVE, pS61; Roig-Zamboni V, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01263-3; Seyrantepe V, 2004, J BIOL CHEM, V279, P37021, DOI 10.1074/jbc.M404531200; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; TONG PY, 1989, J BIOL CHEM, V264, P7962; van den Hout HMP, 2003, PEDIATRICS, V112, P332, DOI 10.1542/peds.112.2.332; VANDERPLOEG AT, 1988, PEDIATR RES, V24, P90, DOI 10.1203/00006450-198807000-00021; VANDERPLOEG AT, 1991, J CLIN INVEST, V87, P513, DOI 10.1172/JCI115025; WISSELAAR HA, 1993, J BIOL CHEM, V268, P2223; Xu S, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.125358; Zeng Y, 2009, NAT METHODS, V6, P207, DOI [10.1038/NMETH.1305, 10.1038/nmeth.1305]; Zhou Q, 2011, BIOCONJUGATE CHEM, V22, P741, DOI 10.1021/bc1005416; Zhu YX, 2009, MOL THER, V17, P954, DOI 10.1038/mt.2009.37; Zhu YX, 2005, BIOCHEM J, V389, P619, DOI 10.1042/BJ20050364; Zhu YX, 2004, J BIOL CHEM, V279, P50336, DOI 10.1074/jbc.M409676200	50	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100769	10.1016/j.jbc.2021.100769	http://dx.doi.org/10.1016/j.jbc.2021.100769			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33971197	gold, Green Published			2022-12-28	WOS:000672866400737
J	Zhao, J; Kim, HJ; Ueda, K; Zhang, K; Montenegro, D; Dunaief, JL; Sparrow, JR				Zhao, Jin; Kim, Hye Jin; Ueda, Keiko; Zhang, Kevin; Montenegro, Diego; Dunaief, Joshua L.; Sparrow, Janet R.			A vicious cycle of bisretinoid formation and oxidation relevant to recessive Stargardt disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							QUANTITATIVE FUNDUS AUTOFLUORESCENCE; RETINAL-PIGMENT EPITHELIUM; CHELATOR DEFERIPRONE PROTECTS; MOUSE MODEL; SHORT-WAVELENGTH; RPE LIPOFUSCIN; IRON; DEGENERATION; HEPCIDIN; A2E	The ability of iron to transfer electrons enables the contribution of this metal to a variety of cellular activities even as the redox properties of iron are also responsible for the generation of hydroxyl radicals ((OH)-O-center dot), the most destructive of the reactive oxygen species. We previously showed that iron can promote the oxidation of bisretinoid by generating highly reactive hydroxyl radical ((OH)-O-center dot). Now we report that preservation of iron regulation in the retina is not sufficient to prevent ironinduced bisretinoid oxidative degradation when blood iron levels are elevated in liver-specific hepcidin knockout mice. We obtained evidence for the perpetuation of Fenton reactions in the presence of the bisretinoid A2E and visible light. On the other hand, iron chelation by deferiprone was not associated with changes in postbleaching recovery of 11-cis-retinal or dark-adapted ERG b-wave amplitudes indicating that the activity of Rpe65, a rate-determining visual cycle protein that carries an iron-binding domain, is not affected. Notably, iron levels were elevated in the neural retina and retinal pigment epithelial (RPE) cells of Abca4(-/-) mice. Consistent with higher iron content, ferritin-L immunostaining was elevated in RPE of a patient diagnosed with ABCA4-associated disease and in RPE and photoreceptor cells of Abca4(-/-) mice. In neural retina of the mutant mice, reduced Tfrc mRNA was also an indicator of retinal iron overload. Thus iron chelation may defend retina when bisretinoid toxicity is implicated in disease processes.	[Zhao, Jin; Kim, Hye Jin; Ueda, Keiko; Montenegro, Diego; Sparrow, Janet R.] Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA; [Zhang, Kevin; Dunaief, Joshua L.] Univ Penn, Dept Ophthalmol, Philadelphia, PA 19104 USA; [Sparrow, Janet R.] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA	Columbia University; University of Pennsylvania; Columbia University	Sparrow, JR (corresponding author), Columbia Univ, Dept Ophthalmol, Med Ctr, New York, NY 10027 USA.; Sparrow, JR (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, New York, NY 10027 USA.	jrs88@columbia.edu	Montenegro, Diego/AAZ-4321-2021	Montenegro, Diego/0000-0001-6892-7492	National Institutes of Health [EY028131, P30EY019007]; Research to Prevent Blindness	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB))	This work was supported in whole or in part by the National Institutes of Health Grant EY028131 and P30EY019007 and by unrestricted funds from Research to Prevent Blindness to the Department of Ophthalmology, Columbia University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumann BH, 2019, AM J PATHOL, V189, P1814, DOI [10.1016/j.ajpath.2019.05.022, 10.1016/j.ajpath.2019.0.5.022]; Burke TR, 2014, INVEST OPHTH VIS SCI, V55, P2841, DOI 10.1167/iovs.13-13624; Chowers I, 2006, INVEST OPHTH VIS SCI, V47, P2135, DOI 10.1167/iovs.05-1135; Crabb JW, 2002, P NATL ACAD SCI USA, V99, P14682, DOI 10.1073/pnas.222551899; Crooks DR, 2018, J BIOL CHEM, V293, P8297, DOI 10.1074/jbc.RA118.001885; Delori F. C., 2007, ATLAS FUNDUS AUTOFLU, P17; Duncker T, 2014, INVEST OPHTH VIS SCI, V55, P8134, DOI 10.1167/iovs.14-14848; EAGLE RC, 1980, OPHTHALMOLOGY, V87, P1189; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Ganz T, 2004, CURR OPIN HEMATOL, V11, P251, DOI 10.1097/00062752-200407000-00004; Gatica E, 2019, PHOTOCHEM PHOTOBIOL, V95, P901, DOI 10.1111/php.13047; Gliem M, 2016, JAMA OPHTHALMOL, V134, P817, DOI 10.1001/jamaophthalmol.2016.1475; Gnana-Prakasam JP, 2008, BIOCHEM J, V411, P79, DOI 10.1042/BJ20071377; Gonzalez AS, 2006, EUR J CLIN NUTR, V60, P802, DOI 10.1038/sj.ejcn.1602384; Hadziahmetovic M, 2011, INVEST OPHTH VIS SCI, V52, P109, DOI 10.1167/iovs.10-6113; Hahn P, 2003, ARCH OPHTHALMOL-CHIC, V121, P1099, DOI 10.1001/archopht.121.8.1099; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Handa JT, 1999, INVEST OPHTH VIS SCI, V40, P775; Hayyan M, 2016, CHEM REV, V116, P3029, DOI 10.1021/acs.chemrev.5b00407; He XN, 2007, PROG RETIN EYE RES, V26, P649, DOI 10.1016/j.preteyeres.2007.07.004; Hirayama T, 2017, J CLIN BIOCHEM NUTR, V60, P39, DOI 10.3164/jcbn.16-70; Kane MA, 2008, ANAL BIOCHEM, V378, P71, DOI 10.1016/j.ab.2008.03.038; Kim HJ, 2018, J LIPID RES, V59, P1620, DOI 10.1194/jlr.M084459; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2008, EXP EYE RES, V86, P975, DOI 10.1016/j.exer.2008.03.016; Kim SR, 2010, VISION RES, V50, P729, DOI 10.1016/j.visres.2009.09.015; Kim SR, 2004, P NATL ACAD SCI USA, V101, P11668, DOI 10.1073/pnas.0403499101; Lakhal-Littleton S, 2016, ELIFE, V5, DOI 10.7554/eLife.19804; de Carvalho JRL, 2020, J BIOL CHEM, V295, P6767, DOI 10.1074/jbc.RA120.012695; Miyazawa M, 2018, RNA, V24, P468, DOI 10.1261/rna.063941.117; Moiseyev G, 2005, P NATL ACAD SCI USA, V102, P12413, DOI 10.1073/pnas.0503460102; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Musallam KM, 2018, CURR MED RES OPIN, V34, P81, DOI 10.1080/03007995.2017.1394833; Namaste SML, 2017, AM J CLIN NUTR, V106, p359S, DOI 10.3945/ajcn.116.141762; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; Obolensky A, 2011, FREE RADICAL BIO MED, V51, P1482, DOI 10.1016/j.freeradbiomed.2011.07.014; Paavo M, 2018, INVEST OPHTH VIS SCI, V59, P2459, DOI 10.1167/iovs.18-24213; Parish CA, 1998, P NATL ACAD SCI USA, V95, P14609, DOI 10.1073/pnas.95.25.14609; Picard E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9030705; Puig S, 2017, METALLOMICS, V9, P1483, DOI 10.1039/c7mt00116a; Radu RA, 2003, P NATL ACAD SCI USA, V100, P4742, DOI 10.1073/pnas.0737855100; Radu RA, 2011, J BIOL CHEM, V286, P18593, DOI 10.1074/jbc.M110.191866; Redmond TM, 2005, P NATL ACAD SCI USA, V102, P13658, DOI 10.1073/pnas.0504167102; Song DL, 2014, INVEST OPHTH VIS SCI, V55, P4525, DOI 10.1167/iovs.14-14568; Song DL, 2012, FREE RADICAL BIO MED, V53, P64, DOI 10.1016/j.freeradbiomed.2012.04.020; Sparrow JR, 2013, INVEST OPHTH VIS SCI, V54, P2812, DOI 10.1167/iovs.12-11490; Sparrow JR, 2012, PROG RETIN EYE RES, V31, P121, DOI 10.1016/j.preteyeres.2011.12.001; Sparrow JR, 2010, PHOTOCH PHOTOBIO SCI, V9, P1480, DOI 10.1039/c0pp00207k; Sun H, 1999, J BIOL CHEM, V274, P8269, DOI 10.1074/jbc.274.12.8269; Timoshnikov VA, 2015, FREE RADICAL BIO MED, V78, P118, DOI 10.1016/j.freeradbiomed.2014.10.513; Trawinski J, 2017, ENVIRON SCI POLLUT R, V24, P1152, DOI 10.1007/s11356-016-7727-5; Ueda K, 2018, P NATL ACAD SCI USA, V115, P4963, DOI 10.1073/pnas.1722601115; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; Winter WE, 2014, LABMEDICINE, V45, P92, DOI 10.1309/LMF28S2GIMXNWHMM; Wolkow N, 2012, AM J PATHOL, V180, P1614, DOI 10.1016/j.ajpath.2011.12.041; Wu L, 2010, ADV EXP MED BIOL, V664, P533, DOI 10.1007/978-1-4419-1399-9_61; Wu YL, 2010, P NATL ACAD SCI USA, V107, P7275, DOI 10.1073/pnas.0913112107; Wu Y, 2009, J BIOL CHEM, V284, P20155, DOI 10.1074/jbc.M109.021345; Xian T, 2019, NANOSCALE RES LETT, V14, DOI 10.1186/s11671-019-3206-5; Yamamoto K, 2011, INVEST OPHTH VIS SCI, V52, P9084, DOI 10.1167/iovs.11-8632; Yoon KD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041309; Yoon KD, 2011, MOL VIS, V17, P1839; Zhao XR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00770-7; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103; Zhou JL, 2015, J BIOL CHEM, V290, P27215, DOI 10.1074/jbc.M115.680363	65	5	5	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100259	10.1016/j.jbc.2021.100259	http://dx.doi.org/10.1016/j.jbc.2021.100259			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837742	gold, Green Published			2022-12-28	WOS:000672866400235
J	He, YM; Jiang, SY; Mao, CY; Zheng, H; Cao, BY; Zhang, ZB; Zhao, J; Zeng, YY; Mao, XL				He, Yuanming; Jiang, Shuoyi; Mao, Chenyu; Zheng, Hui; Cao, Biyin; Zhang, Zubin; Zhao, Jun; Zeng, Yuanying; Mao, Xinliang			The deubiquitinase USP10 restores PTEN activity and inhibits non-small cell lung cancer cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE; REGULATES PTEN; C-MAF; STABILIZATION; LOCALIZATION; 3-KINASE; ROLES	The phosphatase and tensin homolog deleted on chromosome 10 (PTEN) protein is a key player in tumorigenesis of non-small cell lung cancer (NSCLC) and was recently found to be inactivated by tripartite motif containing 25 (TRIM25)-mediated K63-linked polyubiquitination. However, the deubiquitinase (Dub) coordinate TRIM25 in PTEN ubiquitination is still elusive. In the present study, we found that this K63-linked polyubiquitination could be ablated by the ubiquitin-specific protease 10 (USP10) in a screen against a panel of Dubs. We found using coimmununoprecipitation/immunoblotting that USP10 interacted with PTEN and reduced the K63-linked polyubiquitination of PTEN mediated by TRIM25 in NSCLC cells. Moreover, USP10, but not its inactive C424A deubiquitinating mutant or other Dubs, abolished PTEN from K63-linked polyubiquitination mediated by TRIM25. In contrast to TRIM25, USP10 restored PTEN phosphatase activity and reduced the production of the secondary messenger phosphatidylinositol-3,4,5-trisphosphate, thereby inhibiting AKT/mammalian target of rapamycin progrowth signaling transduction in NSCLC cells. Moreover, USP10 was downregulated in NSCLC cell lines and primary tissues, whereas TRIM25 was upregulated. Consistent with its molecular activity, re expression of USP10 suppressed NSCLC cell proliferation and migration, whereas knockout of USP10 promoted NSCLC cell proliferation and migration. In conclusion, the present study demonstrates that USP10 coordinates TRIM25 to modulate PTEN activity. Specifically, USP10 activates PTEN by preventing its K63-linked polyubiquitination mediated by TRIM25 and suppresses the AKT/mammalian target of rapamycin signaling pathway, thereby inhibiting NSCLC proliferation, indicating that it may be a potential drug target for cancer treatment.	[He, Yuanming; Jiang, Shuoyi; Mao, Xinliang] Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangdong Key Lab Vasc Dis,Sch Basic Med Sci, State Key Lab Resp Dis,Affiliated Hosp 2,Guangdon, Guangzhou, Peoples R China; [He, Yuanming; Jiang, Shuoyi; Cao, Biyin; Zhang, Zubin; Mao, Xinliang] Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China; [Mao, Chenyu] Southern Univ Sci & Technol, Sch Med, Shenzhen, Guangdong, Peoples R China; [Zheng, Hui] Soochow Univ, Inst Biomed Sci, Suzhou, Jiangsu, Peoples R China; [Zhao, Jun] Soochow Univ, Affiliated Hosp 1, Dept Thorac Surg, Suzhou, Peoples R China; [Zeng, Yuanying] Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China	Guangzhou Medical University; State Key Laboratory of Respiratory Disease; Soochow University - China; Southern University of Science & Technology; Soochow University - China; Soochow University - China	Mao, XL (corresponding author), Guangzhou Med Univ, Guangzhou Inst Cardiovasc Dis, Guangdong Key Lab Vasc Dis,Sch Basic Med Sci, State Key Lab Resp Dis,Affiliated Hosp 2,Guangdon, Guangzhou, Peoples R China.; Mao, XL (corresponding author), Soochow Univ, Coll Pharmaceut Sci, Dept Pharmacol, Suzhou, Jiangsu, Peoples R China.; Zeng, YY (corresponding author), Suzhou Municipal Hosp, Dept Oncol, Suzhou, Peoples R China.	zengyuanying@163.com; xinliangmao@gzhmu.edu.cn	Zheng, Hui/ABD-6141-2021		National Natural Science Foundation of China [81970194, 81770154]; Suzhou Municipal Science and Technology Project [SYS2020165]; Guangzhou Municipal Science and Technology Project [202002030059]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Municipal Science and Technology Project; Guangzhou Municipal Science and Technology Project	This work was partly sup-ported by the National Natural Science Foundation of China (#81970194 and #81770154 to X. M.) , Suzhou Municipal Science and Technology Project (#SYS2020165 to Y. Z.) , and Guangzhou Municipal Science and Technology Project (#202002030059 to X. M.) .	Bomberger JM, 2009, J BIOL CHEM, V284, P18778, DOI 10.1074/jbc.M109.001685; Chen CY, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00338; Chen GD, 2014, INT J BIOCHEM CELL B, V57, P157, DOI 10.1016/j.biocel.2014.10.024; Draker R, 2011, NUCLEIC ACIDS RES, V39, P3529, DOI 10.1093/nar/gkq1352; Faus H, 2005, MOL CELL ENDOCRINOL, V245, P138, DOI 10.1016/j.mce.2005.11.011; Funamoto S, 2002, CELL, V109, P611, DOI 10.1016/S0092-8674(02)00755-9; Gkountakos A, 2019, CANCERS, V11, DOI 10.3390/cancers11081141; Guo H, 2012, CELL REPORTS, V1, P472, DOI 10.1016/j.celrep.2012.04.008; He YM, 2022, ACTA PHARMACOL SIN, V43, P681, DOI 10.1038/s41401-021-00662-z; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Huang J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1919; Iijima M, 2002, CELL, V109, P599, DOI 10.1016/S0092-8674(02)00745-6; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; Ko A, 2018, CELL DEATH DIFFER, V25, P1050, DOI 10.1038/s41418-018-0072-0; Komander D, 2009, NAT REV MOL CELL BIO, V10, P550, DOI 10.1038/nrm2731; Konermann S, 2015, NATURE, V517, P583, DOI 10.1038/nature14136; Liu JL, 2011, CELL, V147, P223, DOI 10.1016/j.cell.2011.08.037; Lu C, 2018, CANCER LETT, V436, P139, DOI 10.1016/j.canlet.2018.07.032; Marsit CJ, 2005, HUM PATHOL, V36, P768, DOI 10.1016/j.humpath.2005.05.006; Park MK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08481-x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Radu A, 2003, MOL CELL BIOL, V23, P6139, DOI 10.1128/MCB.23.17.6139-6149.2003; Sakoda H, 2003, J BIOL CHEM, V278, P25802, DOI 10.1074/jbc.M301127200; Shi M, 2014, TOXICOL LETT, V228, P133, DOI 10.1016/j.toxlet.2014.05.003; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Sun J, 2018, MOL CELL BIOCHEM, V441, P1, DOI 10.1007/s11010-017-3170-2; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Wang HF, 2012, J BIOL CHEM, V287, P28576, DOI 10.1074/jbc.M111.299990; Wang XY, 2020, CELL DEATH DIFFER, V27, P1747, DOI 10.1038/s41418-019-0458-7; Wang XJ, 2007, CELL, V128, P129, DOI 10.1016/j.cell.2006.11.039; Xu X, 2016, J BIOL CHEM, V291, P9617, DOI 10.1074/jbc.M115.701979; Yuan J, 2010, CELL, V140, P384, DOI 10.1016/j.cell.2009.12.032; Yuan L, 2015, NAT CELL BIOL, V17, P1169, DOI 10.1038/ncb3218; Yuan T, 2020, MOL ONCOL, V14, P197, DOI 10.1002/1878-0261.12596; Zeng YY, 2017, ONCOTARGET, V8, P20103, DOI 10.18632/oncotarget.15384; Zhang JS, 2013, NAT CELL BIOL, V15, P1486, DOI 10.1038/ncb2874; Zhang ZB, 2016, BLOOD, V127, P1676, DOI 10.1182/blood-2015-07-658203; Zhu H, 2020, CANCER RES, V80, P2204, DOI 10.1158/0008-5472.CAN-19-2388; Zhu JY, 2015, DRUG DISCOV TODAY, V20, P988, DOI 10.1016/j.drudis.2015.03.009	39	13	13	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101088	10.1016/j.jbc.2021.101088	http://dx.doi.org/10.1016/j.jbc.2021.101088			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34416231	gold, Green Published			2022-12-28	WOS:000706409200013
J	Nagati, JS; Kobeissy, PH; Nguyen, MQ; Xu, M; Garcia, T; Comerford, SA; Hammer, RE; Garcia, JA				Nagati, Jason S.; Kobeissy, Philippe H.; Nguyen, Minh Q.; Xu, Min; Garcia, Trent; Comerford, Sarah A.; Hammer, Robert E.; Garcia, Joseph A.			Mammalian acetate-dependent acetyl CoA synthetase 2 contains multiple protein destabilization and masking elements	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEGRADATION SIGNALS; CRYSTAL-STRUCTURE; COENZYME; ACTIVATION; DEGRON; DEACETYLATION; SEQUENCES; PATHWAYS; BINDING; ENZYME	Besides contributing to anabolism, cellular metabolites serve as substrates or cofactors for enzymes and may also have signaling functions. Given these roles, multiple control mechanisms likely ensure fidelity of metabolite-generating enzymes. Acetate-dependent acetyl CoA synthetases (ACS) are de novo sources of acetyl CoA, a building block for fatty acids and a substrate for acetyltransferases. Eukaryotic acetate-dependent acetyl CoA synthetase 2 (Acss2) is predominantly cytosolic, but is also found in the nucleus following oxygen or glucose deprivation, or upon acetate exposure. Acss2-generated acetyl CoA is used in acetylation of Hypoxia-Inducible Factor 2 (HIF2), a stress-responsive transcription factor. Mutation of a putative nuclear localization signal in endogenous Acss2 abrogates HIF-2 acetylation and signaling, but surprisingly also results in reduced Acss2 protein levels due to unmasking of two protein destabilization elements (PDE) in the Acss2 hinge region. In the current study, we identify up to four additional PDE in the Acss2 hinge region and determine that a previously identified PDE, the ABC domain, consists of two functional PDE. We show that the ABC domain and other PDE are likely masked by intramolecular interactions with other domains in the Acss2 hinge region. We also characterize mice with a prematurely truncated Acss2 that exposes a putative ABC domain PDE, which exhibits reduced Acss2 protein stability and impaired HIF-2 signaling. Finally, using primary mouse embryonic fi- broblasts, we demonstrate that the reduced stability of select Acss2 mutant proteins is due to a shortened half-life, which is a result of enhanced degradation via a nonproteasome, nonautophagy pathway.	[Nagati, Jason S.; Kobeissy, Philippe H.; Nguyen, Minh Q.; Garcia, Joseph A.] Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA; [Xu, Min; Garcia, Trent] Univ Texas Southwestern Med Ctr Dallas, Dept Med, Dallas, TX 75390 USA; [Comerford, Sarah A.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Genet, Dallas, TX 75390 USA; [Hammer, Robert E.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Garcia, Joseph A.] James J Peters VA Med Ctr, Dept Res, New York, NY 10468 USA	Columbia University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; US Department of Veterans Affairs; Veterans Health Administration (VHA); James J. Peters VA Medical Center	Garcia, JA (corresponding author), Columbia Univ, Dept Med, Med Ctr, New York, NY 10027 USA.; Garcia, JA (corresponding author), James J Peters VA Med Ctr, Dept Res, New York, NY 10468 USA.	jag2369@cumc.columbia.edu		Comerford, Sarah Ann/0000-0002-7452-7759; Garcia, Joseph/0000-0002-5621-7538; Nagati, Jason/0000-0002-4507-6581; Hammer, Robert E./0000-0001-5487-7551	US Department of Veterans Affairs [I01BX000446]; US National Institutes of Health [HL108104, HL130142, P309DK079328]	US Department of Veterans Affairs(US Department of Veterans Affairs); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	These studies were supported by funds provided by the US Department of Veterans Affairs (I01BX000446 -J. A. G.) and the US National Institutes of Health (HL108104, HL130142 -J. A. G.; P309DK079328 -O'Brien Kidney Research Core Center). The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bah A, 2016, J BIOL CHEM, V291, P6696, DOI 10.1074/jbc.R115.695056; Bulusu V, 2017, CELL REP, V18, P647, DOI 10.1016/j.celrep.2016.12.055; Chen R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190241; Chen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116515; Chen R, 2012, J BIOL CHEM, V287, P30800, DOI 10.1074/jbc.M111.244780; Costantini LM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8670; Davey NE, 2019, CURR OPIN STRUC BIOL, V56, P155, DOI 10.1016/j.sbi.2019.03.009; Davey NE, 2016, MOL CELL, V64, P12, DOI 10.1016/j.molcel.2016.09.006; DICE JF, 1990, TRENDS BIOCHEM SCI, V15, P305, DOI 10.1016/0968-0004(90)90019-8; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fortmann KT, 2015, J MOL BIOL, V427, P2748, DOI 10.1016/j.jmb.2015.07.008; Fredrickson EK, 2012, SEMIN CELL DEV BIOL, V23, P530, DOI 10.1016/j.semcdb.2011.12.006; Geffen Y, 2016, MOL CELL, V63, P1055, DOI 10.1016/j.molcel.2016.08.005; Guharoy M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10239; Gulick AM, 2003, BIOCHEMISTRY-US, V42, P2866, DOI 10.1021/bi0271603; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Hu A, 2020, MOL CARCINOGEN, V59, P1280, DOI 10.1002/mc.23256; Im S, 2017, CELL SIGNAL, V36, P127, DOI 10.1016/j.cellsig.2017.05.001; Jogl G, 2004, BIOCHEMISTRY-US, V43, P1425, DOI 10.1021/bi035911a; Li XJ, 2017, MOL CELL, V66, P684, DOI 10.1016/j.molcel.2017.04.026; Luong A, 2000, J BIOL CHEM, V275, P26458, DOI 10.1074/jbc.M004160200; Maurer MJ, 2016, G3-GENES GENOM GENET, V6, P1853, DOI 10.1534/g3.116.027953; Miller KD, 2021, CANCER RES, V81, P1252, DOI 10.1158/0008-5472.CAN-20-1847; Nagati JS, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225105; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; Reger AS, 2007, BIOCHEMISTRY-US, V46, P6536, DOI 10.1021/bi6026506; Sahar S, 2014, J BIOL CHEM, V289, P6091, DOI 10.1074/jbc.M113.537191; Sharma S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152731; Shumway SD, 2004, BIOCHEM J, V380, P173, DOI 10.1042/BJ20031796; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sontag EM, 2014, CURR OPIN CELL BIOL, V26, P139, DOI 10.1016/j.ceb.2013.12.006; Starai VJ, 2005, J BIOL CHEM, V280, P26200, DOI 10.1074/jbc.M504863200; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Stein A, 2019, TRENDS BIOCHEM SCI, V44, P575, DOI 10.1016/j.tibs.2019.01.003; Takasugi T, 2016, J BIOL CHEM, V291, P4649, DOI 10.1074/jbc.M115.692871; Takeuchi J, 2008, BIOCHEM J, V410, P401, DOI 10.1042/BJ20071239; Tao T, 2013, CELL RES, V23, P620, DOI 10.1038/cr.2013.16; Tekirdag K, 2018, J BIOL CHEM, V293, P5414, DOI 10.1074/jbc.R117.818237; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; VARSHAVSKY A, 1991, CELL, V64, P13, DOI 10.1016/0092-8674(91)90202-A; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Xu M, 2014, NAT MED, V20, P1018, DOI 10.1038/nm.3587	49	0	0	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101037	10.1016/j.jbc.2021.101037	http://dx.doi.org/10.1016/j.jbc.2021.101037			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343565	Green Published, gold			2022-12-28	WOS:000704369100013
J	Wilkes, MC; Jung, K; Lee, BE; Saxena, M; Sathianathen, RS; Mercado, JD; Perez, C; Flygare, J; Narla, A; Glader, B; Sakamoto, KM				Wilkes, Mark C.; Jung, Kevin; Lee, Britney E.; Saxena, Mallika; Sathianathen, Ryan S.; Mercado, Jacqueline D.; Perez, Cristina; Flygare, Johan; Narla, Anupama; Glader, Bertil; Sakamoto, Kathleen M.			The active component of ginseng, ginsenoside Rb1, improves erythropoiesis in models of Diamond-Blackfan anemia by targeting Nemo-like kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; CANCER; EXPRESSION; NLK; IDENTIFICATION; EXTRACT	Nemo-like kinase (NLK) is a member of the mitogenactivated protein kinase family of kinases and shares a highly conserved kinase domain with other mitogen-activated protein kinase family members. The activation of NLK contributes to the pathogenesis of Diamond-Blackfan anemia (DBA), reducing c-myb expression and mechanistic target of rapamycin activity, and is therefore a potential therapeutic target. Unlike other anemias, the hematopoietic effects of DBA are largely restricted to the erythroid lineage. Mutations in ribosomal genes induce ribosomal insufficiency and reduced protein translation, dramatically impacting early erythropoiesis in the bone marrow of patients with DBA. We sought to identify compounds that suppress NLK and increases erythropoiesis in ribosomal insufficiency. We report that the active component of ginseng, ginsenoside Rb1, suppresses NLK expression and improves erythropoiesis in in vitro models of DBA. Ginsenoside Rb1-mediated suppression of NLK occurs through the upregulation of miR-208, which binds to the 30-UTR of NLK mRNA and targets it for degradation. We also compare ginsenoside Rb1-mediated upregulation of miR-208 with metformin-mediated upregulation of miR-26. We conclude that targeting NLK expression through miRNA binding of the unique 30-UTR is a viable alternative to the challenges of developing small-molecule inhibitors to target the highly conserved kinase domain of this specific kinase.	[Wilkes, Mark C.; Jung, Kevin; Lee, Britney E.; Saxena, Mallika; Sathianathen, Ryan S.; Mercado, Jacqueline D.; Perez, Cristina; Narla, Anupama; Glader, Bertil; Sakamoto, Kathleen M.] Stanford Univ, Dept Pediat, Div Hematol Oncol, Stanford, CA 94305 USA; [Flygare, Johan] Lund Univ, Lund Stem Cell Ctr, Dept Mol Med & Gene Therapy, Lund, Sweden	Stanford University; Lund University	Sakamoto, KM (corresponding author), Stanford Univ, Dept Pediat, Div Hematol Oncol, Stanford, CA 94305 USA.	kmsakamo@stanford.edu		Narla, Anupama/0000-0003-2325-3388; Jung, Kevin/0000-0002-5578-395X; Sakamoto, Kathleen/0000-0003-0494-8838; Wilkes, Mark/0000-0002-9600-6831	National Institutes of Health [DK098132]; Maternal Child Health Research Institute fellowship [1111239-442-JHACT]; DBA Foundation [138290]; Department of Defense [BM180024]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maternal Child Health Research Institute fellowship; DBA Foundation; Department of Defense(United States Department of Defense)	This work was funded by the National Institutes of Health T32 training grant (DK098132) and Maternal Child Health Research Institute fellowship (1111239-442-JHACT) (to M. C. W.), DBA Foundation (138290) (to K. M. S./M. C. W.), and Department of Defense (BM180024) (to K. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bibikova E, 2014, BLOOD, V124, P3791, DOI 10.1182/blood-2014-06-584656; Bousquet-Antonelli C, 2000, CELL, V102, P765, DOI 10.1016/S0092-8674(00)00065-9; Brott BK, 1998, P NATL ACAD SCI USA, V95, P963, DOI 10.1073/pnas.95.3.963; Chen HW, 2015, TUMOR BIOL, V36, P8447, DOI 10.1007/s13277-015-3609-6; Chen JB, 2015, MOL MED REP, V11, P1181, DOI 10.3892/mmr.2014.2851; Cichocki F, 2011, J IMMUNOL, V187, P6171, DOI 10.4049/jimmunol.1100835; Da Costa Lydie, 2018, F1000Res, V7, DOI 10.12688/f1000research.15542.1; Dong S, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0203-8; Flygare J, 2005, BLOOD, V105, P4627, DOI 10.1182/blood-2004-08-3115; Grosswendt S, 2014, MOL CELL, V54, P1042, DOI 10.1016/j.molcel.2014.03.049; Han Y, 2014, BIOMED PHARMACOTHER, V68, P497, DOI 10.1016/j.biopha.2014.05.003; He XY, 2017, CLIN CANCER RES, V23, P2905, DOI 10.1158/1078-0432.CCR-16-1591; Hwang JW, 2012, AM J CHINESE MED, V40, P187, DOI 10.1142/S0192415X12500152; Jiang SL, 2017, CHIN J INTEGR MED, V23, P331, DOI 10.1007/s11655-015-2146-x; Jin H, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-6; Jin X, 2016, J GINSENG RES, V40, P269, DOI 10.1016/j.jgr.2015.08.007; Lazare SS, 2014, EXP CELL RES, V329, P234, DOI 10.1016/j.yexcr.2014.08.033; Li X, 2012, CELL DEATH DIFFER, V19, P378, DOI 10.1038/cdd.2011.127; Lv LT, 2014, J CELL BIOCHEM, V115, P81, DOI 10.1002/jcb.24635; Narla A, 2011, SEMIN HEMATOL, V48, P117, DOI 10.1053/j.seminhematol.2011.01.004; Shen Q, 2014, CANCER LETT, V344, P204, DOI 10.1016/j.canlet.2013.10.030; Shergis JL, 2013, PHYTOTHER RES, V27, P949, DOI 10.1002/ptr.4832; Tai J, 2015, MOL MED REP, V12, P5619, DOI 10.3892/mmr.2015.4189; Tanno T, 2017, BLOOD ADV, V1, P1107, DOI 10.1182/bloodadvances.2017004705; Ulirsch JC, 2018, AM J HUM GENET, V103, P930, DOI 10.1016/j.ajhg.2018.10.027; Vlachos A, 2010, BLOOD, V116, P3715, DOI 10.1182/blood-2010-02-251090; Wang CZ, 2008, AM J CHINESE MED, V36, P1019, DOI 10.1142/S0192415X08006545; Wilkes MC, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17100-z; Wilkes MC, 2020, EXP HEMATOL, V91, P65, DOI 10.1016/j.exphem.2020.09.187; Wilkes MC, 2017, MOL GENET METAB, V122, P28, DOI 10.1016/j.ymgme.2017.07.008; Yan X, 2016, CELL PHYSIOL BIOCHEM, V39, P1187, DOI 10.1159/000447825; Yasuda J, 2007, P JPN ACAD B-PHYS, V83, P16, DOI 10.2183/pjab.83.16; Zeng X, 2010, J CLIN PHARMACOL, V50, P285, DOI 10.1177/0091270009344334; Zhang HY, 2020, J ETHNOPHARMACOL, V253, DOI 10.1016/j.jep.2020.112658; Zhang L, 2017, ACTA BIOCH BIOPH SIN, V49, P746, DOI 10.1093/abbs/gmx062; Zhang W, 2015, WORLD J GASTROENTERO, V21, P8836, DOI 10.3748/wjg.v21.i29.8836; Zhang XW, 2015, INT J CLIN EXP PATHO, V8, P15086	37	4	4	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100988	10.1016/j.jbc.2021.100988	http://dx.doi.org/10.1016/j.jbc.2021.100988			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34298020	gold, Green Published			2022-12-28	WOS:000706418900005
J	Jenni, A; Kuser, S; Nagar, R; Benninger, M; Hanel, R; Ferguson, MAJ; Roditi, I; Menon, AK; Butikofer, P				Jenni, Aurelio; Kueser, Sebastian; Nagar, Rupa; Benninger, Mattias; Haenel, Robert; Ferguson, Michael A. J.; Roditi, Isabel; Menon, Anant K.; Buetikofer, Peter			Elimination of GPI2 suppresses glycosylphosphatidylinositol GlcNAc transferase activity and alters GPI glycan modification in Trypanosoma brucei	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-ACETYLGLUCOSAMINYL PHOSPHATIDYLINOSITOL; SACCHAROMYCES-CEREVISIAE HOMOLOG; ACIDIC REPETITIVE PROTEIN; PROCYCLIC CULTURE FORMS; 1ST STEP; INITIAL ENZYME; STRUCTURAL-CHARACTERIZATION; DEVELOPMENTAL VARIATION; SURFACE GLYCOPROTEIN; ANCHOR BIOSYNTHESIS	Many eukaryotic cell-surface proteins are post-translationally modified by a glycosylphosphatidylinositol (GPI) moiety that anchors them to the cell membrane. The biosynthesis of GPI anchors is initiated in the endoplasmic reticulum by transfer of GlcNAc from UDP-GlcNAc to phosphatidylinositol. This reaction is catalyzed by GPI GlcNAc transferase, a multisubunit complex comprising the catalytic subunit Gpi3/PIG-A as well as at least five other subunits, including the hydrophobic protein Gpi2, which is essential for the activity of the complex in yeast and mammals, but the function of which is not known. To investigate the role of Gpi2, we exploited Trypanosoma brucei (Tb), an early diverging eukaryote and important model organism that initially provided the first insights into GPI structure and biosynthesis. We generated insect-stage (procyclic) trypanosomes that lack TbGPI2 and found that in TbGPI2-null parasites, (i) GPI GlcNAc transferase activity is reduced, but not lost, in contrast with yeast and human cells, (ii) the GPI GlcNAc transferase complex persists, but its architecture is affected, with loss of at least the TbGPI1 subunit, and (iii) the GPI anchors of procyclins, the major surface proteins, are underglycosylated when compared with their WT counterparts, indicating the importance of TbGPI2 for reactions that occur in the Golgi apparatus. Immunofluorescence microscopy localized TbGPI2 not only to the endoplasmic reticulum but also to the Golgi apparatus, suggesting that in addition to its expected function as a subunit of the GPI GlcNAc transferase complex, TbGPI2 may have an enigmatic noncanonical role in Golgi-localized GPI anchor modification in trypanosomes.	[Jenni, Aurelio; Buetikofer, Peter] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland; [Jenni, Aurelio] Univ Bern, Grad Sch Chem & Biomed Sci, Bern, Switzerland; [Kueser, Sebastian; Benninger, Mattias; Roditi, Isabel] Univ Bern, Inst Cell Biol, Bern, Switzerland; [Nagar, Rupa; Ferguson, Michael A. J.] Univ Dundee, Wellcome Ctr Antilnfect Res, Sch Life Sci, Dundee, Scotland; [Haenel, Robert] Univ Bern, Dept Chem & Biochem, Bern, Switzerland; [Menon, Anant K.] Weill Cornell Med Coll, Dept Biochem, New York, NY USA	University of Bern; University of Bern; University of Bern; University of Dundee; University of Bern; Cornell University	Butikofer, P (corresponding author), Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.	peter.buetikofer@ibmm.unibe.ch	Menon, Anant/AAN-8663-2021	Menon, Anant/0000-0001-6924-2698; Nagar, Rupa/0000-0003-2127-3115; Ferguson, Michael/0000-0003-1321-8714; Jenni, Aurelio/0000-0003-4507-2721	Swiss National Science Foundation Sinergia grant [CRSII5_170923]; Swiss National Science Foundation [310030_184669]; Wellcome Trust [101842/Z13/Z]	Swiss National Science Foundation Sinergia grant(Swiss National Science Foundation (SNSF)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)	The work was supported by the Swiss National Science Foundation Sinergia grant CRSII5_170923 to R. H., A. K. M., and P. B., a Wellcome Trust Investigator Award (101842/Z13/Z) to M. A. J. F., and Swiss National Science Foundation grant 310030_184669 to I. R.	Beneke T, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.170095; Butikofer P, 1997, BIOCHEM J, V326, P415; Butikofer P, 1999, J CELL SCI, V112, P1785; Dean S, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.140197; ENGSTLER M, 1992, MOL BIOCHEM PARASIT, V54, P21, DOI 10.1016/0166-6851(92)90091-W; Farine L, 2015, SCI REP-UK, V5, DOI 10.1038/srep16787; Ferguson M. A. J., 2015, GLYCOSYLPHOSPHATIDYL; FERGUSON MAJ, 1993, BIOCHEM J, V291, P51, DOI 10.1042/bj2910051; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; Field M. C., 1992, LIPID MODIFICATION P, P155; FIELD MC, 1991, EMBO J, V10, P2731, DOI 10.1002/j.1460-2075.1991.tb07821.x; FIELD MC, 1991, J BIOL CHEM, V266, P8392; FIELD MC, 1992, J BIOL CHEM, V267, P5324; Florini F, 2019, NUCLEIC ACIDS RES, V47, P1725, DOI 10.1093/nar/gky1255; Gottier P, 2017, J BIOL CHEM, V292, P1103, DOI 10.1074/jbc.M116.758367; Guther MLS, 2006, MOL BIOL CELL, V17, P5265, DOI 10.1091/mbc.E06-08-0702; Guther MLS, 2009, EUKARYOT CELL, V8, P1407, DOI 10.1128/EC.00178-09; He CY, 2004, J CELL BIOL, V165, P313, DOI 10.1083/jcb.200311076; Hong Y, 1999, J BIOL CHEM, V274, P18582, DOI 10.1074/jbc.274.26.18582; Imhof S, 2015, EUKARYOT CELL, V14, P588, DOI 10.1128/EC.00023-15; Imhoft S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004493; Inoue N, 1996, BIOCHEM BIOPH RES CO, V226, P193, DOI 10.1006/bbrc.1996.1332; Islam ST, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000728; Izquierdo L, 2009, MOL MICROBIOL, V71, P478, DOI 10.1111/j.1365-2958.2008.06542.x; Izquierdo L, 2015, GLYCOBIOLOGY, V25, P438, DOI 10.1093/glycob/cwu131; Ji Z., 2020, PROTEOMIC IDENTIFICA, DOI [10.1101/2020.12.16.423025, DOI 10.1101/2020.12.16.423025]; KAMITANI T, 1993, J BIOL CHEM, V268, P20733; Kinoshita T, 2020, OPEN BIOL, V10, DOI 10.1098/rsob.190290; Kirchner N, 2021, J NAT PROD, V84, P101, DOI 10.1021/acs.jnatprod.0c01174; Kostova Z, 2000, BIOCHEM J, V350, P815, DOI 10.1042/0264-6021:3500815; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEIDICH SD, 1995, J BIOL CHEM, V270, P13029, DOI 10.1074/jbc.270.22.13029; Leidich SD, 1996, J BIOL CHEM, V271, P27829, DOI 10.1074/jbc.271.44.27829; Levin DE, 2009, ENZYMES, V26, P31, DOI 10.1016/S1874-6047(09)26002-1; Madukoma CS, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00184-19; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MAYOR S, 1992, J BIOL CHEM, V267, P754; MazhariTabrizi R, 1996, BIOCHEM J, V316, P853, DOI 10.1042/bj3160853; MENON AK, 1990, J BIOL CHEM, V265, P9033; MENON AK, 1990, EMBO J, V9, P4249, DOI 10.1002/j.1460-2075.1990.tb07873.x; MIYATA T, 1993, SCIENCE, V259, P1318, DOI 10.1126/science.7680492; Montagna G, 2002, EUR J BIOCHEM, V269, P2941, DOI 10.1046/j.1432-1033.2002.02968.x; Montagna GN, 2006, J BIOL CHEM, V281, P33949, DOI 10.1074/jbc.M604951200; Murakami Y, 2005, MOL BIOL CELL, V16, P5236, DOI 10.1091/mbc.E05-08-0743; Nagamune K, 2000, P NATL ACAD SCI USA, V97, P10336, DOI 10.1073/pnas.180230697; Nakanishi M, 2014, PARASITOL INT, V63, P513, DOI 10.1016/j.parint.2014.01.007; Newman HA, 2005, EUKARYOT CELL, V4, P1801, DOI 10.1128/EC.4.11.1801-1807.2005; Orlean P, 2007, J LIPID RES, V48, P993, DOI 10.1194/jlr.R700002-JLR200; Partridge JD, 2013, J BACTERIOL, V195, P909, DOI 10.1128/JB.02063-12; Pottekat A, 2004, J BIOL CHEM, V279, P15743, DOI 10.1074/jbc.M313537200; RODITI I, 1987, NATURE, V325, P272, DOI 10.1038/325272a0; Roditi I, 1998, MOL BIOCHEM PARASIT, V91, P117, DOI 10.1016/S0166-6851(97)00195-3; Sanyat S, 2009, ACS CHEM BIOL, V4, P895, DOI 10.1021/cb900163d; Serricchio M, 2013, MOL MICROBIOL, V87, P569, DOI 10.1111/mmi.12116; Serricchio M, 2012, P NATL ACAD SCI USA, V109, pE954, DOI 10.1073/pnas.1121528109; Shaw S, 2020, BMC RES NOTES, V13, DOI 10.1186/s13104-020-05089-z; Signorell A, 2008, J BIOL CHEM, V283, P20320, DOI 10.1074/jbc.M802430200; Smith TK, 2010, MOL BIOCHEM PARASIT, V172, P66, DOI 10.1016/j.molbiopara.2010.04.001; STEVENS VL, 1991, J BIOL CHEM, V266, P10039; Treumann A, 1997, J MOL BIOL, V269, P529, DOI 10.1006/jmbi.1997.1066; Vassella E, 2000, GENE DEV, V14, P615; Vassella E, 2003, MOL BIOL CELL, V14, P1308, DOI 10.1091/mbc.E02-10-0694; Vassella E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004493; Verchere A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80956-0; VIDUGIRIENE J, 1993, J CELL BIOL, V121, P987, DOI 10.1083/jcb.121.5.987; Vishwakarma RA, 2005, CHEM COMMUN, P453, DOI 10.1039/b413196g; Watanabe R, 2000, EMBO J, V19, P4402, DOI 10.1093/emboj/19.16.4402; Watanabe R, 1998, EMBO J, V17, P877, DOI 10.1093/emboj/17.4.877; Yadav A, 2014, GLYCOCONJUGATE J, V31, P497, DOI 10.1007/s10719-014-9536-8; Yadav B, 2014, J BIOL CHEM, V289, P3365, DOI 10.1074/jbc.M113.528802; Yan BC, 2001, YEAST, V18, P1383, DOI 10.1002/yea.783	72	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100977	10.1016/j.jbc.2021.100977	http://dx.doi.org/10.1016/j.jbc.2021.100977			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34284059	Green Published, gold, Green Submitted			2022-12-28	WOS:000690868100001
J	Jokoji, G; Maeda, S; Oishi, K; Ijuin, T; Nakajima, M; Tawaratsumida, H; Kawamura, I; Tominaga, H; Taketomi, E; Ikegawa, S; Taniguchi, N				Jokoji, Go; Maeda, Shingo; Oishi, Kazuki; Ijuin, Toshiro; Nakajima, Masahiro; Tawaratsumida, Hiroki; Kawamura, Ichiro; Tominaga, Hiroyuki; Taketomi, Eiji; Ikegawa, Shiro; Taniguchi, Noboru			CDC5L promotes early chondrocyte differentiation and proliferation by modulating pre-mRNA splicing of SOX9, COL2A1, and WEE1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTERIOR LONGITUDINAL LIGAMENT; CERVICAL-SPINE; OSSIFICATION; GENE; EXPRESSION; MATURATION; PROTEIN; IDENTIFICATION; REGULATOR; HEDGEHOG	Ossification of the posterior longitudinal ligament (OPLL) of the spine is a common pathological condition that causes intractablemyelopathy and radiculopathy, mainly the result of an endochondral ossification-like process. Our previous genome-wide association study identified six susceptibility loci for OPLL, including the cell division cycle 5-like (CDC5L) gene region. Here, we found CDC5L to be expressed in type II collagen-producing chondrocyte-like fibroblasts in human OPLL specimens, as well as in differentiating ATDC5 chondrocytes. Cdc5l siRNA transfection in murine chondrocytes decreased the expression of the early chondrogenic genes Sox9 and Col2a1, diminished the cartilage matrix production, and enhanced the expression of parathyroid-hormone-related protein (a resting chondrocyte marker). We also showed that Cdc5l shRNA suppressed the growth of cultured murine embryonal metatarsal cartilage rudiments and that Cdc5l knockdown suppressed the growth of ATDC5 cells. Fluorescence-activated cell sorting analysis revealed that the G2/Mcell cycle transition was blocked; our data showed that Cdc5l siRNA transfection enhanced expression of Wee1, an inhibitor of the G2/M transition. Cdc5l siRNA also decreased the pre-mRNA splicing efficiency of Sox9 and Col2a1 genes in both ATDC5 cells and primary chondrocytes; conversely, loss of Cdc5l resulted in enhanced splicing of Wee1 pre-mRNA. Finally, an RNA-binding protein immuno-precipitation assay revealed that Cdc5l bound directly to these target gene transcripts. Overall, we conclude thatCdc5l promotes both early chondrogenesis and cartilage growth and may play a role in the etiology of OPLL, at least in part by fine-tuning the pre-mRNA splicing of chondrogenic genes and Wee1, thus initiating the endochondral ossification process.	[Jokoji, Go; Maeda, Shingo; Ijuin, Toshiro; Tawaratsumida, Hiroki; Taniguchi, Noboru] Kagoshima Univ, Dept Bone & Joint Med, Grad Sch Med & Dent Sci, Kagoshima, Japan; [Jokoji, Go; Oishi, Kazuki; Ijuin, Toshiro; Tawaratsumida, Hiroki; Kawamura, Ichiro; Tominaga, Hiroyuki; Taniguchi, Noboru] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Orthopaed Surg, Kagoshima, Japan; [Nakajima, Masahiro; Ikegawa, Shiro] RIKEN, Ctr Integrat Med Sci, Lab Bone & Joint Dis, Tokyo, Japan; [Taketomi, Eiji] Japanese Red Cross Kagoshima Hosp, Dept Orthopaed Surg, Kagoshima, Japan	Kagoshima University; Kagoshima University; RIKEN	Maeda, S (corresponding author), Kagoshima Univ, Dept Bone & Joint Med, Grad Sch Med & Dent Sci, Kagoshima, Japan.	s-maeda@m3.kufm.kagoshima-u.ac.jp		Maeda, Shingo/0000-0002-2737-3902	Japan Agency for Medical Research and Development [19ek0109223s0403]; Japan Society for the Promotion of Science [18K09111, 17K10933, 20K09482]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Useful suggestions and supports were provided by the Genetic Study Group of the Investigation Committee on the Ossification of Spinal Ligaments. We thank Hui Gao for technical assistance. We thank Eva Lasic, PhD, from Edanz Group (https://jp.edanz.com/ac) for editing a draft of this manuscript. This study was supported by research grants from the Japan Agency for Medical Research and Development (contract no. 19ek0109223s0403) and Japan Society for the Promotion of Science, grant-in-aid for scientific research (C) (contract no. 18K09111, 17K10933, and 20K09482).	Ajuh P, 2000, EMBO J, V19, P6569, DOI 10.1093/emboj/19.23.6569; Akiyama H, 2002, GENE DEV, V16, P2813, DOI 10.1101/gad.1017802; Alvarez J, 2002, DEVELOPMENT, V129, P1913; AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Bernstein HS, 1998, J BIOL CHEM, V273, P4666, DOI 10.1074/jbc.273.8.4666; Boudrez A, 2000, J BIOL CHEM, V275, P25411, DOI 10.1074/jbc.M001676200; Burns CG, 1999, P NATL ACAD SCI USA, V96, P13789, DOI 10.1073/pnas.96.24.13789; Chen YP, 2011, GENE DEV, V25, P701, DOI 10.1101/gad.2002611; Furushima K, 2002, J BONE MINER RES, V17, P128, DOI 10.1359/jbmr.2002.17.1.128; GAUTIER J, 1990, CELL, V60, P487, DOI 10.1016/0092-8674(90)90599-A; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; Grote M, 2010, MOL CELL BIOL, V30, P2105, DOI 10.1128/MCB.01505-09; Hamer PCD, 2011, CLIN CANCER RES, V17, P4200, DOI 10.1158/1078-0432.CCR-10-2537; HASHIZUME Y, 1980, ACTA PATHOL JAPON, V30, P255; Hu JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089352; IGARASHI M, 1991, NATURE, V353, P80, DOI 10.1038/353080a0; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karasugi T, 2013, J BONE MINER METAB, V31, P136, DOI 10.1007/s00774-012-0404-y; Kawamura I, 2012, J BIOL CHEM, V287, P29101, DOI 10.1074/jbc.M112.349415; Kreahling JM, 2012, MOL CANCER THER, V11, P174, DOI 10.1158/1535-7163.MCT-11-0529; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Li J, 2017, CELL PHYSIOL BIOCHEM, V41, P2475, DOI 10.1159/000475916; Li X, 2018, CANCER RES, V78, P4138, DOI 10.1158/0008-5472.CAN-18-0688; Liao CC, 1999, J NEUROSURG, V91, P230, DOI 10.3171/spi.1999.91.2.0230; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lu XY, 2008, MOL CANCER RES, V6, P937, DOI 10.1158/1541-7786.MCR-07-2115; Maeda S, 2001, J BONE MINER RES, V16, P948, DOI 10.1359/jbmr.2001.16.5.948; Maeda S, 2020, OPLL OSSIFICATION PO, P39; Martin JW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095843; Matsunaga S, 2012, SPINE, V37, pE309, DOI 10.1097/BRS.0b013e318241ad33; MCGOWAN CH, 1993, EMBO J, V12, P75, DOI 10.1002/j.1460-2075.1993.tb05633.x; Mizuhashi K, 2018, NATURE, V563, P254, DOI 10.1038/s41586-018-0662-5; Mu R, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.117; Nakajima M, 2016, AM J HUM GENET, V99, P202, DOI 10.1016/j.ajhg.2016.05.018; Nakajima M, 2014, NAT GENET, V46, P1012, DOI 10.1038/ng.3045; O'Brien K, 2008, J BIOL CHEM, V283, P33147, DOI 10.1074/jbc.M805556200; Ohnishi Y, 2001, J HUM GENET, V46, P471, DOI 10.1007/s100380170047; Okawa A, 1998, NAT GENET, V19, P271, DOI 10.1038/956; PARKER LL, 1992, SCIENCE, V257, P1955, DOI 10.1126/science.1384126; Qiu HY, 2016, DIGEST DIS SCI, V61, P795, DOI 10.1007/s10620-015-3937-9; Saito M, 2016, SCI REP-UK, V6, DOI 10.1038/srep20622; Sato R, 2007, J NEUROSURG-SPINE, V7, P174, DOI 10.3171/SPI-07/08/174; Sugita D, 2013, SPINE, V38, pE1388, DOI 10.1097/BRS.0b013e3182a40489; TSUYAMA N, 1984, CLIN ORTHOP RELAT R, P71; Zhang CM, 2020, CANCER MED-US, V9, P3500, DOI 10.1002/cam4.2929; Zhang ZW, 2020, J CANCER, V11, P353, DOI 10.7150/jca.32850	46	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100994	10.1016/j.jbc.2021.100994	http://dx.doi.org/10.1016/j.jbc.2021.100994			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298017	Green Published, gold			2022-12-28	WOS:000690868100007
J	Barrett, CT; Neal, HE; Edmonds, K; Moncman, CL; Thompson, R; Branttie, JM; Boggs, KB; Wu, CY; Leung, DW; Dutch, RE				Barrett, Chelsea T.; Neal, Hadley E.; Edmonds, Kearstin; Moncman, Carole L.; Thompson, Rachel; Branttie, Jean M.; Boggs, Kerri Beth; Wu, Cheng-Yu; Leung, Daisy W.; Dutch, Rebecca E.			Effect of clinical isolate or cleavage site mutations in the SARS-CoV-2 spike protein on protein stability, cleavage, and cell-cell fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPIRATORY SYNDROME CORONAVIRUS; SARS-CORONAVIRUS; CATHEPSIN-L; ENTRY; ACTIVATION; INFLUENZA; PROTEASES; COV; MECHANISMS; INFECTION	The trimeric severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein (S) is the sole viral protein responsible for both viral binding to a host cell and the membrane fusion event needed for cell entry. In addition to facilitating fusion needed for viral entry, S can also drive cell-cell fusion, a pathogenic effect observed in the lungs of SARS-CoV-2-infected patients. While several studies have investigated S requirements involved in viral particle entry, examination of S stability and factors involved in S cell-cell fusion remain limited. A furin cleavage site at the border between the S1 and S2 subunits (S1/S2) has been identified, along with putative cathepsin L and transmembrane serine protease 2 cleavage sites within S2. We demonstrate that S must be processed at the S1/S2 border in order to mediate cell-cell fusion and that mutations at potential cleavage sites within the S2 subunit alter S processing at the S1/S2 border, thus preventing cell-cell fusion. We also identify residues within the internal fusion peptide and the cytoplasmic tail that modulate S-mediated cell-cell fusion. In addition, we examined S stability and protein cleavage kinetics in a variety of mammalian cell lines, including a bat cell line related to the likely reservoir species for SARS-CoV-2, and provide evidence that proteolytic processing alters the stability of the S trimer. This work therefore offers insight into S stability, proteolytic processing, and factors that mediate S cell-cell fusion, all of which help give a more comprehensive understanding of this high-profile therapeutic target.	[Barrett, Chelsea T.; Neal, Hadley E.; Edmonds, Kearstin; Moncman, Carole L.; Thompson, Rachel; Branttie, Jean M.; Boggs, Kerri Beth; Wu, Cheng-Yu; Dutch, Rebecca E.] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA; [Leung, Daisy W.] Washington Univ, Sch Med, Dept Med, Div Infect Dis, St Louis, MO 63110 USA	University of Kentucky; Washington University (WUSTL)	Dutch, RE (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40506 USA.	rdutc2@uky.edu		Wu, Cheng-Yu/0000-0003-4088-6347; Neal, Hadley/0000-0001-8433-593X	CCTS CURE Alliance pilot award from the University of Kentucky; National Institute of Allergy and Infectious Diseases, National Institutes of Health [R01AI051517]; National Institutes of Health [2P20 RR02017]	CCTS CURE Alliance pilot award from the University of Kentucky; National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Financial support was provided by the CCTS CURE Alliance pilot award from the University of Kentucky, National Institute of Allergy and Infectious Diseases, National Institutes of Health grant R01AI051517, and National Institutes of Health grant 2P20 RR02017 to R. E. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Belouzard S, 2012, VIRUSES-BASEL, V4, P1011, DOI 10.3390/v4061011; Belouzard S, 2010, J BIOL CHEM, V285, P22756, DOI 10.1074/jbc.M110.103275; Belouzard S, 2009, P NATL ACAD SCI USA, V106, P5871, DOI 10.1073/pnas.0809524106; Beniac DR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001082; Benton DJ, 2020, NATURE, V588, DOI 10.1038/s41586-020-2772-0; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Biswas NK, 2020, INDIAN J MED RES, V151, P450, DOI 10.4103/ijmr.IJMR_1125_20; Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; Bosch BJ, 2008, J VIROL, V82, P8887, DOI 10.1128/JVI.00415-08; Branttie JM, 2020, J GEN VIROL, V101, P467, DOI 10.1099/jgv.0.001399; Braun E, 2019, CLIN TRANSL IMMUNOL, V8, DOI 10.1002/cti2.1073; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Buonvino S, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-00372-1; Bussani R, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103104; Caldas LA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-73162-5; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Chan CM, 2008, EXP BIOL MED, V233, P1527, DOI 10.3181/0806-RM-197; Cheng YW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108254; Claas ECJ, 1998, LANCET, V351, P472, DOI 10.1016/S0140-6736(97)11212-0; Coutard B, 2020, ANTIVIR RES, V176, DOI 10.1016/j.antiviral.2020.104742; Crameri G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008266; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Davies J, 2020, MOL MED REP, V22, P4221, DOI 10.3892/mmr.2020.11510; El Najjar F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115736; Follis KE, 2006, VIROLOGY, V350, P358, DOI 10.1016/j.virol.2006.02.003; Gallagher TM, 2001, VIROLOGY, V279, P371, DOI 10.1006/viro.2000.0757; Gierer S, 2015, J INFECT DIS, V211, P889, DOI 10.1093/infdis/jiu407; Gierer S, 2013, J VIROL, V87, P5502, DOI 10.1128/JVI.00128-13; Glowacka I, 2011, J VIROL, V85, P4122, DOI 10.1128/JVI.02232-10; Gong YQ, 2020, EPIDEMIOL INFECT, V148, DOI 10.1017/S0950268820000771; Harrison SC, 2015, VIROLOGY, V479, P498, DOI 10.1016/j.virol.2015.03.043; Heald-Sargent T, 2012, VIRUSES-BASEL, V4, P557, DOI 10.3390/v4040557; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hornich B. F., 2020, SARS COV 2 SARS COV, DOI [10. 1101/2020.07.25.221135, DOI 10.1101/2020.07.25.221135]; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; Hulswit RJG, 2016, ADV VIRUS RES, V96, P29, DOI 10.1016/bs.aivir.2016.08.004; Isabel S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70827-z; Islam OK, 2021, TRANSBOUND EMERG DIS, V68, P824, DOI 10.1111/tbed.13748; Izaguirre G, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11090837; Jiang XY, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00392-4; Johnson Bryan A, 2020, bioRxiv, DOI 10.1101/2020.08.26.268854; Kam YW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007870; Kawase M, 2019, J VIROL, V93, DOI 10.1128/JVI.00785-19; Kido H, 2012, BBA-PROTEINS PROTEOM, V1824, P186, DOI 10.1016/j.bbapap.2011.07.001; Korber B, 2020, SPIKE MUTATION PIPEL; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Koyama T, 2020, B WORLD HEALTH ORGAN, V98, P495, DOI 10.2471/BLT.20.253591; Koyama T, 2020, PATHOGENS, V9, DOI 10.3390/pathogens9050324; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Le Coupanec A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005261; Lemmin T, 2020, J STRUCT BIOL-X, V4, DOI 10.1016/j.yjsbx.2020.100038; Li F, 2006, J VIROL, V80, P6794, DOI 10.1128/JVI.02744-05; Li F, 2016, ANNU REV VIROL, V3, P237, DOI 10.1146/annurev-virology-110615-042301; Li W, 2020, BIOPHYS CHEM, V264, DOI 10.1016/j.bpc.2020.106420; Lu GW, 2015, TRENDS MICROBIOL, V23, P468, DOI 10.1016/j.tim.2015.06.003; Mansbach Rachael A, 2020, bioRxiv, DOI 10.1101/2020.07.26.219741; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Menachery VD, 2020, J VIROL, V94, DOI 10.1128/JVI.01774-19; Mercatelli D., 2020, FRONT MICROBIOL, V11, P1, DOI [10.3389/fmicb.2020.01800, DOI 10.3389/fmicb.2020.01800]; Millet JK, 2018, VIROLOGY, V517, P3, DOI 10.1016/j.virol.2017.12.015; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Millet JK, 2014, P NATL ACAD SCI USA, V111, P15214, DOI 10.1073/pnas.1407087111; Nguyen H. T., 2020, SPIKE GLYCOPROTEIN H, DOI 10.22.351569; Ogawa Junko, 2020, bioRxiv, DOI 10.1101/2020.07.21.214932; Oprinca GC, 2021, INT J LEGAL MED, V135, P329, DOI 10.1007/s00414-020-02406-w; Ou T., 2020, HYDROXYCHLOROQUINE M, DOI [10.1101/2020.07.22.216150, DOI 10.1101/2020.07.22.216150]; Papa G., 2020, FURIN CLEAVAGE SARS, DOI 10.1101/2020.08.13.243303; Plante Jessica A, 2020, bioRxiv, DOI 10.1101/2020.09.01.278689; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Seidah NG, 2012, NAT REV DRUG DISCOV, V11, P367, DOI 10.1038/nrd3699; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shulla A, 2011, J VIROL, V85, P873, DOI 10.1128/JVI.02062-10; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; Simmons G, 2011, VIROLOGY, V413, P265, DOI 10.1016/j.virol.2011.02.020; Slaughter KB, 2019, J VIROL, V93, DOI 10.1128/JVI.01069-19; Stadlmann S, 2020, J CLIN PATHOL, V73, P607, DOI 10.1136/jclinpath-2020-206657; Sun XJ, 2010, J VIROL, V84, P8683, DOI 10.1128/JVI.00797-10; Tian SF, 2020, J THORAC ONCOL, V15, P700, DOI 10.1016/j.jtho.2020.02.010; Tortorici MA, 2019, ADV VIRUS RES, V105, P93, DOI 10.1016/bs.aivir.2019.08.002; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Webb S, 2017, J BIOL CHEM, V292, P5685, DOI 10.1074/jbc.M117.777235; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yan RH, 2020, SCIENCE, V367, P1444, DOI 10.1126/science.abb2762; Yang Y, 2015, J VIROL, V89, P9119, DOI 10.1128/JVI.01279-15; Yurkovetskiy Leonid, 2020, bioRxiv, DOI [10.1016/j.cell.2020.09.032, 10.1101/2020.07.04.187757]; Zhang LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19808-4; Zhang Lizhou, 2020, bioRxiv, DOI 10.1101/2020.06.12.148726; Zheng Y, 2018, J VIROL, V92, DOI 10.1128/JVI.01504-18; Zhou H, 2020, CURR BIOL, V30, P2196, DOI 10.1016/j.cub.2020.05.023; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7; Zhu Y., 2020, COLD SPRING HARB SYM, DOI [10.1101/2020.08.25.266775, DOI 10.1101/2020.08.25.266775]	100	10	10	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100902	10.1016/j.jbc.2021.100902	http://dx.doi.org/10.1016/j.jbc.2021.100902			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157282	gold, Green Published			2022-12-28	WOS:000678068400091
J	Nassal, DM; Patel, NJ; Unudurthi, SD; Shaheen, R; Yu, J; Mohler, PJ; Hund, TJ				Nassal, Drew M.; Patel, Nehal J.; Unudurthi, Sathya D.; Shaheen, Rebecca; Yu, Jane; Mohler, Peter J.; Hund, Thomas J.			Ca2+/calmodulin kinase II-dependent regulation of beta(IV)-spectrin modulates cardiac fibroblast gene expression, proliferation, and contractility	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEART-FAILURE; DILATED CARDIOMYOPATHY; HYPERTROPHY; CAMKII; CALCIUM; INHIBITION; CALMODULIN; PHOSPHORYLATION; SPECTRIN; FIBROSIS	Fibrosis is a pronounced feature of heart disease and the result of dysregulated activation of resident cardiac fibroblasts (CFs). Recent work identified stress-induced degradation of the cytoskeletal protein beta(IV)-spectrin as an important step in CF activation and cardiac fibrosis. Furthermore, loss of beta(IV)-spectrin was found to depend on Ca2+/calmodulin-dependent kinase II (CaMKII). Therefore, we sought to determine the mechanism for CaMKII-dependent regulation of beta(IV)-spectrin and CF activity. Computational screening and MS revealed a critical serine residue (S2250 in mouse and S2254 in human) in beta(IV)-spectrin phosphorylated by CaMKII. Disruption of beta(IV)-spectrin/CaMKII interaction or alanine substitution of beta(IV)-spectrin Ser2250 (beta(IV)-S2254A) prevented CaMKII-induced degradation, whereas a phosphomimetic construct (beta(IV)-spectrin with glutamic acid substitution at serine 2254 [beta(IV)-S2254E]) showed accelerated degradation in the absence of CaMKII. To assess the physiological significance of this phosphorylation event, we expressed exogenous beta(IV)-S2254A and beta(IV)-S2254E constructs in beta(IV)-spectrin-deficient CFs, which have increased proliferation and fibrotic gene expression compared with WT CFs. beta(IV)-S2254A but not beta(IV)-S2254E normalized CF proliferation, gene expression, and contractility. Pathophysiological targeting of beta(IV)-spectrin phosphorylation and subsequent degradation was identified in CFs activated with the profibrotic ligand angiotensin II, resulting in increased proliferation and signal transducer and activation of transcription 3 nuclear accumulation. While therapeutic delivery of exogenous WT beta(IV)-spectrin partially reversed these trends, beta(IV)-S2254A completely negated increased CF proliferation and signal transducer and activation of transcription 3 translocation. Moreover, we observed beta(IV)-spectrin phosphorylation and associated loss in total protein within human heart tissue following heart failure. Together, these data illustrate a considerable role for the beta(IV)-spectrin/CaMKII interaction in activating profibrotic signaling.	[Nassal, Drew M.; Patel, Nehal J.; Shaheen, Rebecca; Yu, Jane; Mohler, Peter J.; Hund, Thomas J.] Ohio State Univ, Wexner Med Ctr, Frick Ctr Heart Failure & Arrhythmia, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Nassal, Drew M.; Patel, Nehal J.; Unudurthi, Sathya D.; Shaheen, Rebecca; Yu, Jane; Hund, Thomas J.] Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA; [Mohler, Peter J.] Ohio State Univ, Wexner Med Ctr, Dept Physiol & Cell Biol, Columbus, OH USA; [Mohler, Peter J.; Hund, Thomas J.] Ohio State Univ, Coll Med, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Hund, TJ (corresponding author), Ohio State Univ, Wexner Med Ctr, Frick Ctr Heart Failure & Arrhythmia, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Hund, TJ (corresponding author), Ohio State Univ, Coll Engn, Dept Biomed Engn, Columbus, OH 43210 USA.; Hund, TJ (corresponding author), Ohio State Univ, Coll Med, Dept Internal Med, Wexner Med Ctr, Columbus, OH 43210 USA.	thomas.hund@osumc.edu		Shaheen, Rebecca/0000-0002-5121-8558	National Institutes of Health [HL135096, HL156652, HL134824, HL135754]; Fondation Leducq [TNE 19CVD03]; American Heart Association Post-Doctoral Fellowship [18POST34030245]; Bob and Corrine Frick Center for Heart Failure and Arrhythmia; Dorothy M. Davis Heart and Lung Research Institute; NIH [1S10OD023436-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fondation Leducq(Leducq Foundation); American Heart Association Post-Doctoral Fellowship(American Heart Association); Bob and Corrine Frick Center for Heart Failure and Arrhythmia; Dorothy M. Davis Heart and Lung Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants HL135096 and HL156652 (T. J. H.), HL134824 (T. J. H. and P. J. M.), HL135754 (P. J. M.), the Fondation Leducq (TNE 19CVD03), the American Heart Association Post-Doctoral Fellowship (18POST34030245, D. M. N.), and funding from the Bob and Corrine Frick Center for Heart Failure and Arrhythmia and the Dorothy M. Davis Heart and Lung Research Institute. The MS Fusion Lumos instrument was purchased via an NIH shared instrument grant, 1S10OD023436-01 (Cleveland Clinic). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Baba K, 2020, HISTOCHEM CELL BIOL, V153, P199, DOI 10.1007/s00418-019-01842-z; Backs J, 2008, MOL CELL BIOL, V28, P3437, DOI 10.1128/MCB.01611-07; Backs J, 2009, P NATL ACAD SCI USA, V106, P2342, DOI 10.1073/pnas.0813013106; Bennett V, 2001, PHYSIOL REV, V81, P1353, DOI 10.1152/physrev.2001.81.3.1353; Cao L, 2018, ACTA BIOCH BIOPH SIN, V50, P843, DOI 10.1093/abbs/gmy090; Chen Y, 2017, CARDIOVASC RES, V113, P310, DOI 10.1093/cvr/cvx004; Christensen MD, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000583; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fu X, 2018, J CLIN INVEST, V128, P2127, DOI 10.1172/JCI98215; Glynn P, 2015, CIRCULATION, V132, P567, DOI 10.1161/CIRCULATIONAHA.114.015218; Gourdie RG, 2016, NAT REV DRUG DISCOV, V15, P620, DOI 10.1038/nrd.2016.89; Hardy S, 1997, J VIROL, V71, P1842, DOI 10.1128/JVI.71.3.1842-1849.1997; Hashemi SM, 2009, J MOL CELL CARDIOL, V47, P203, DOI 10.1016/j.yjmcc.2009.04.010; Hegyi B, 2019, J MOL CELL CARDIOL, V127, P246, DOI 10.1016/j.yjmcc.2019.01.001; Hoogenraad CC, 2007, DEV CELL, V12, P587, DOI 10.1016/j.devcel.2007.02.006; Huang CYM, 2017, J NEUROSCI, V37, P11311, DOI 10.1523/JNEUROSCI.2112-17.2017; Hudmon A, 2005, J CELL BIOL, V171, P537, DOI 10.1083/jcb.200505155; Humeres C, 2019, JACC-BASIC TRANSL SC, V4, P449, DOI 10.1016/j.jacbts.2019.02.006; Hund TJ, 2014, CARDIOVASC RES, V102, P166, DOI 10.1093/cvr/cvu008; Hund TJ, 2010, J CLIN INVEST, V120, P3508, DOI 10.1172/JCI43621; Kanarek N, 2012, IMMUNOL REV, V246, P77, DOI 10.1111/j.1600-065X.2012.01098.x; Kanisicak O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12260; Kong P, 2014, CELL MOL LIFE SCI, V71, P549, DOI 10.1007/s00018-013-1349-6; Kreusser MM, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0581-2; Lafontant PJ, 2006, AM J PHYSIOL-CELL PH, V291, pC18, DOI 10.1152/ajpcell.00322.2005; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Ling HY, 2009, J CLIN INVEST, V119, P1230, DOI 10.1172/JCI38022; Lubbers ER, 2019, J BIOL CHEM, V294, P9576, DOI 10.1074/jbc.RA119.007714; Lynch MD, 2018, J CLIN INVEST, V128, P26, DOI 10.1172/JCI93555; Maier LS, 2002, J MOL CELL CARDIOL, V34, P919, DOI 10.1006/jmcc.2002.2038; MARCHESI V. T., 1968, SCIENCE, V159, P203, DOI 10.1126/science.159.3811.203; Mattiazzi A, 2015, AM J PHYSIOL-HEART C, V308, pH1177, DOI 10.1152/ajpheart.00007.2015; Mattiazzi A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00005; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Molkentin JD, 2017, CIRCULATION, V136, P549, DOI 10.1161/CIRCULATIONAHA.116.026238; Mustroph J, 2017, PHARMACOL THERAPEUT, V176, P22, DOI 10.1016/j.pharmthera.2016.10.006; Olson ER, 2008, HYPERTENSION, V51, P704, DOI 10.1161/HYPERTENSIONAHA.107.098459; Parkinson NJ, 2001, NAT GENET, V29, P61, DOI 10.1038/ng710; Patel NJ, 2021, EXPERT OPIN THER TAR, V25, P63, DOI 10.1080/14728222.2021.1849145; Patel NJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.131046; Peng JF, 2002, CIRC RES, V91, P1119, DOI 10.1161/01.RES.0000047090.08299.D5; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Schipper-Krom S, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00056; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stevenson MD, 2010, BIOPHYS J, V99, P19, DOI 10.1016/j.bpj.2010.03.041; Sun B, 2013, HYPERTENSION, V61, P352, DOI 10.1161/HYPERTENSIONAHA.111.00562; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Travers JG, 2016, CIRC RES, V118, P1021, DOI 10.1161/CIRCRESAHA.115.306565; Unudurthi SD, 2018, J CLIN INVEST, V128, P5561, DOI 10.1172/JCI99245; Unudurthi SD, 2018, EXPERT REV CARDIOVAS, V16, P59, DOI 10.1080/14779072.2018.1418664; Unudurthi SD, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002865; Wagner S, 2011, CIRC RES, V108, P555, DOI 10.1161/CIRCRESAHA.110.221911; Westenbrink BD, 2013, EXPERT OPIN THER TAR, V17, P889, DOI 10.1517/14728222.2013.809064; Willeford A, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97054; WITCHER DR, 1991, J BIOL CHEM, V266, P11144; Wu DQ, 2010, TRENDS BIOCHEM SCI, V35, P161, DOI 10.1016/j.tibs.2009.10.002; Xue Y, 2011, PROTEIN ENG DES SEL, V24, P255, DOI 10.1093/protein/gzq094; Zhang R, 2005, NAT MED, V11, P409, DOI 10.1038/nm1215; Zhang T, 2003, CIRC RES, V92, P912, DOI 10.1161/01.RES.0000069686.31472.C5; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhang W, 2010, J CARDIOVASC PHARM, V55, P96, DOI 10.1097/FJC.0b013e3181c9548b; Zhao L, 2016, CIRC RES, V118, P1918, DOI 10.1161/CIRCRESAHA.116.308688	63	1	1	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100893	10.1016/j.jbc.2021.100893	http://dx.doi.org/10.1016/j.jbc.2021.100893			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34153319	gold, Green Published			2022-12-28	WOS:000678068400087
J	Smallwood, TB; Navarro, S; Cristofori-Armstrong, B; Watkins, TS; Tungatt, K; Ryan, RYM; Haigh, OL; Lutzky, VP; Mulvenna, JP; Rosengren, KJ; Loukas, A; Miles, JJ; Clark, RJ				Smallwood, Taylor B.; Navarro, Severine; Cristofori-Armstrong, Ben; Watkins, Thomas S.; Tungatt, Katie; Ryan, Rachael Y. M.; Haigh, Oscar L.; Lutzky, Viviana P.; Mulvenna, Jason P.; Rosengren, K. Johan; Loukas, Alex; Miles, John J.; Clark, Richard J.			Synthetic hookworm-derived peptides are potent modulators of primary human immune cell function that protect against experimental colitis in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENDRITIC CELLS; ANIMAL TOXINS; MOUSE MODEL; SHK TOXIN; SYSTEM; INHIBITOR; THERAPY	The prevalence of autoimmune diseases is on the rise globally. Currently, autoimmunity presents in over 100 different forms and affects around 9% of the world's population. Current treatments available for autoimmune diseases are inadequate, expensive, and tend to focus on symptommanagement rather than cure. Clinical trials have shown that live helminthic therapy can decrease chronic inflammation associated with inflammatory bowel disease and other gastrointestinal autoimmune inflammatory conditions. As an alternative and better controlled approach to live infection, we have identified and characterized two peptides, Acan1 and Nak1, from the excretory/secretory component of parasitic hookworms for their therapeutic activity on experimental colitis. WesynthesizedAcan1 andNak1 peptides fromthe Ancylostoma caninum and Necator americanus hookworms and assessed their structures and protective properties in human cell-based assays and in a mouse model of acute colitis. Acan1 and Nak1 displayed anticolitic properties via significantly reducing weight loss and colon atrophy, edema, ulceration, and necrosis in 2,4,6-trinitrobenzene sulfonic acid-exposed mice. These hookworm peptides prevented mucosal loss of goblet cells and preserved intestinal architecture. Acan1 upregulated genes responsible for the repair and restitution of ulcerated epithelium, whereas Nak1 downregulated genes responsible for epithelial cell migration and apoptotic cell signaling within the colon. These peptides were nontoxic and displayed key immunomodulatory functions in human peripheral blood mononuclear cells by suppressing CD4(+) T cell proliferation and inhibiting IL-2 and TNF production. We conclude that Acan1 and Nak1 warrant further development as therapeutics for the treatment of autoimmunity, particularly gastrointestinal inflammatory conditions.	[Smallwood, Taylor B.; Cristofori-Armstrong, Ben; Rosengren, K. Johan; Clark, Richard J.] Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia; [Navarro, Severine; Watkins, Thomas S.; Tungatt, Katie; Ryan, Rachael Y. M.; Haigh, Oscar L.; Lutzky, Viviana P.; Mulvenna, Jason P.; Miles, John J.] QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia; [Navarro, Severine; Ryan, Rachael Y. M.; Miles, John J.] James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia; [Navarro, Severine] Queensland Univ Technol, Woolworths Ctr Child Nutr Res, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Watkins, Thomas S.; Tungatt, Katie; Ryan, Rachael Y. M.; Loukas, Alex; Miles, John J.] James Cook Univ, Ctr Mol Therapeut, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia; [Tungatt, Katie; Miles, John J.] James Cook Univ, Ctr Trop Bioinformat & Mol Biol, Douglas, Qld, Australia; [Miles, John J.] Cardiff Univ, Univ Hosp, Inst Infect & Immun, Sch Med, Cardiff, Wales	University of Queensland; QIMR Berghofer Medical Research Institute; James Cook University; Queensland University of Technology (QUT); James Cook University; James Cook University; Cardiff University	Clark, RJ (corresponding author), Univ Queensland, Fac Med, Sch Biomed Sci, Brisbane, Qld, Australia.; Miles, JJ (corresponding author), QIMR Berghofer Med Res Inst, Brisbane, Qld, Australia.; Miles, JJ (corresponding author), James Cook Univ, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia.; Miles, JJ (corresponding author), James Cook Univ, Ctr Mol Therapeut, Australian Inst Trop Hlth & Med, Douglas, Qld, Australia.; Miles, JJ (corresponding author), James Cook Univ, Ctr Trop Bioinformat & Mol Biol, Douglas, Qld, Australia.; Miles, JJ (corresponding author), Cardiff Univ, Univ Hosp, Inst Infect & Immun, Sch Med, Cardiff, Wales.	john.miles@jcu.edu.au; richard.clark@uq.edu.au	Clark, Richard J/G-8848-2012; Rosengren, K. Johan/P-4450-2016; Haigh, Oscar/AAD-4324-2022; Navarro, Severine/B-7353-2014	Clark, Richard J/0000-0002-6807-5426; Rosengren, K. Johan/0000-0002-5007-8434; Haigh, Oscar/0000-0001-5022-4692; Smallwood, Taylor/0000-0002-2211-0265; Navarro, Severine/0000-0003-4568-9721; Tungatt, Katie/0000-0002-4088-3501; Cristofori-Armstrong, Ben/0000-0003-0235-2029	Australian Postgraduate Award; Australian Research Council Future Fellowship [FT100100476, FT130100890]; NCI, National Institutes of Health [R01CA155297]; National Health and Medical Research (NHMRC) [1031652, 1051627, 1117504]; Children's Hospital Foundation [RCP10317]; Australian Infectious Disease Research Centre	Australian Postgraduate Award(Australian Government); Australian Research Council Future Fellowship(Australian Research Council); NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Health and Medical Research (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Children's Hospital Foundation; Australian Infectious Disease Research Centre	This work was supported by grants from the Australian Postgraduate Award (T. B. S., B. C. -A., T. S. W., R. Y. M. R.), Australian Research Council Future Fellowship (R. J. C.; grant number FT100100476 and K. J. R.; grant number FT130100890), Australian Infectious Disease Research Centre (R. J. C., J. J. M., and J. P. M.), NCI, National Institutes of Health (J. P. M.; grant number R01CA155297), National Health and Medical Research (NHMRC) Career Development Fellowship (J. J. M. and J. P. M.; grant numbers 1031652 and 1051627), and senior principal research fellowship (A. L.; grant 1117504), and Children's Hospital Foundation (S. N.; RCP10317). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bach JF, 2018, NAT REV IMMUNOL, V18, P105, DOI 10.1038/nri.2017.111; Bogunovic M, 2009, IMMUNITY, V31, P513, DOI 10.1016/j.immuni.2009.08.010; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cantacessi C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000684; CASTANEDA O, 1995, TOXICON, V33, P603, DOI 10.1016/0041-0101(95)00013-C; Chhabra S, 2014, FASEB J, V28, P3952, DOI 10.1096/fj.14-251967; Cristofori-Armstrong B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14763; Croese J, 2006, GUT, V55, P136, DOI 10.1136/gut.2005.079129; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Ferreira I, 2013, INFECT IMMUN, V81, P2104, DOI 10.1128/IAI.00563-12; Ferreira IB, 2017, CLIN TRANSL IMMUNOL, V6, DOI 10.1038/cti.2017.42; Fung-Leung WP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170102; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hansen Lars Koch, 2014, Dan Med J, V61, pB4946; Haugaard-Kedstrom LM, 2018, J BIOL CHEM, V293, P15765, DOI 10.1074/jbc.RA118.002611; Hirota SA, 2011, INFLAMM BOWEL DIS, V17, P1359, DOI 10.1002/ibd.21478; Imam T, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01212; Kazama I, 2015, MED HYPOTHESES, V85, P61, DOI 10.1016/j.mehy.2015.03.023; Keller R., 2004, COMPUTER AIDED RESON, V1; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Lepletier A, 2019, IMMUNOL CELL BIOL, V97, P152, DOI 10.1111/imcb.12205; Levin AD, 2016, J CROHNS COLITIS, V10, P989, DOI 10.1093/ecco-jcc/jjw053; Luo XR, 2016, ANNU REV BIOMED ENG, V18, P181, DOI 10.1146/annurev-bioeng-110315-020137; Marsal J, 2012, J INTERN MED, V272, P411, DOI 10.1111/j.1365-2796.2012.02588.x; Maynard CL, 2009, IMMUNITY, V31, P389, DOI 10.1016/j.immuni.2009.08.012; Mei YY, 2019, INFLAMM BOWEL DIS, V25, pE115, DOI 10.1093/ibd/izz109; Morelli AE, 2007, NAT REV IMMUNOL, V7, P610, DOI 10.1038/nri2132; Mouhat S, 2005, J PEPT SCI, V11, P65, DOI 10.1002/psc.630; Mulvenna J, 2009, MOL CELL PROTEOMICS, V8, P109, DOI 10.1074/mcp.M800206-MCP200; Navarro S, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8807; Norton RS, 2004, CURR MED CHEM, V11, P3041, DOI 10.2174/0929867043363947; Pennington MW, 2015, MAR DRUGS, V13, P529, DOI 10.3390/md13010529; Pennington MW, 1996, BIOCHEM BIOPH RES CO, V219, P696, DOI 10.1006/bbrc.1996.0297; Scheiffele Frank, 2002, Curr Protoc Immunol, VChapter 15, DOI 10.1002/0471142735.im1519s49; Schroeder CI, 2020, METHODS MOL BIOL, V2068, P129, DOI 10.1007/978-1-4939-9845-6_7; Sedda S, 2015, INFLAMM BOWEL DIS, V21, P2921, DOI 10.1097/MIB.0000000000000542; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Shepherd C, 2018, J ETHNOPHARMACOL, V211, P17, DOI 10.1016/j.jep.2017.09.024; Smallwood TB, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00453; Smids C, 2018, J CROHNS COLITIS, V12, P465, DOI 10.1093/ecco-jcc/jjx160; Spadoni I, 2012, MUCOSAL IMMUNOL, V5, P184, DOI 10.1038/mi.2011.64; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Tarcha EJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180762; Tudor JE, 1996, NAT STRUCT BIOL, V3, P317, DOI 10.1038/nsb0496-317; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zaki MH, 2010, IMMUNITY, V32, P379, DOI 10.1016/j.immuni.2010.03.003	49	3	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100834	10.1016/j.jbc.2021.100834	http://dx.doi.org/10.1016/j.jbc.2021.100834			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051231	Green Accepted, gold, Green Published			2022-12-28	WOS:000678068400034
J	Wang, YF; Li, N; Zhang, X; Horng, T				Wang, Yafang; Li, Na; Zhang, Xin; Horng, Tiffany			Mitochondrial metabolism regulates macrophage biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NITRIC-OXIDE; INFLAMMATORY MACROPHAGES; SUCCINATE-DEHYDROGENASE; ALTERNATIVE ACTIVATION; BACTERICIDAL ACTIVITY; MODULATES APOPTOSIS; GLUCOSE-HOMEOSTASIS; CELL-METABOLISM; GENE-EXPRESSION; ITACONATE	Mitochondria are critical for regulation of the activation, differentiation, and survival of macrophages and other immune cells. In response to various extracellular signals, such as microbial or viral infection, changes to mitochondrial metabolism and physiology could underlie the corresponding state of macrophage activation. These changes include alterations of oxidative metabolism, mitochondrial membrane potential, and tricarboxylic acid (TCA) cycling, as well as the release of mitochondrial reactive oxygen species (mtROS) and mitochondrial DNA (mtDNA) and transformation of the mitochondrial ultrastructure. Here, we provide an updated review of how changes in mitochondrial metabolism and various metabolites such as fumarate, succinate, and itaconate coordinate to guide macrophage activation to distinct cellular states, thus clarifying the vital link between mitochondria metabolism and immunity. We also discuss how in disease settings, mitochondrial dysfunction and oxidative stress contribute to dysregulation of the inflammatory response. Therefore, mitochondria are a vital source of dynamic signals that regulate macrophage biology to fine-tune immune responses.	[Wang, Yafang; Li, Na; Zhang, Xin; Horng, Tiffany] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	ShanghaiTech University	Wang, YF; Horng, T (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.	wangyf2@shanghaitech.edu.cn; tsyhorng@shanghaitech.edu			School of Life Sciences and Technology, ShanghaiTech University	School of Life Sciences and Technology, ShanghaiTech University	The authors were supported by the School of Life Sciences and Technology, ShanghaiTech University.	Abuaita BH, 2018, CELL HOST MICROBE, V24, P625, DOI 10.1016/j.chom.2018.10.005; An N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01592; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Artyomov MN, 2020, CELL METAB, V32, P710, DOI 10.1016/j.cmet.2020.09.013; Baardman J, 2015, EPIGENOMICS-UK, V7, P1155, DOI 10.2217/epi.15.71; Bailey JD, 2019, CELL REP, V28, P218, DOI 10.1016/j.celrep.2019.06.018; Bambouskova M, 2018, NATURE, V556, P501, DOI 10.1038/s41586-018-0052-z; Barnes RH, 2020, INT J FOOD MICROBIOL, V324, DOI 10.1016/j.ijfoodmicro.2020.108614; Batista-Gonzalez A, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02993; Bosca L, 2005, TOXICOLOGY, V208, P249, DOI 10.1016/j.tox.2004.11.035; Butcher SK, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00933; Cameron AM, 2019, NAT IMMUNOL, V20, P420, DOI 10.1038/s41590-019-0336-y; Chang HC, 2014, TRENDS ENDOCRIN MET, V25, P138, DOI 10.1016/j.tem.2013.12.001; Chen X, 2015, IMMUNOLOGY, V145, P455, DOI 10.1111/imm.12473; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chu LH, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03409-3; Covarrubias AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.11612; D'Amico D, 2017, TRENDS BIOCHEM SCI, V42, P712, DOI 10.1016/j.tibs.2017.05.002; Degrandi D, 2009, J INTERF CYTOK RES, V29, P55, DOI 10.1089/jir.2008.0013; Dela Cruz CS, 2018, MITOCHONDRION, V41, P37, DOI 10.1016/j.mito.2017.12.001; Di Gioia M, 2020, NAT IMMUNOL, V21, P42, DOI 10.1038/s41590-019-0539-2; Dubouchaud H, 2018, J BIOENERG BIOMEMBR, V50, P367, DOI 10.1007/s10863-018-9767-7; Eisner V, 2018, NAT CELL BIOL, V20, P755, DOI 10.1038/s41556-018-0133-0; Esteban-Martinez L, 2018, AUTOPHAGY, V14, P915, DOI 10.1080/15548627.2017.1332567; Everts B, 2012, BLOOD, V120, P1422, DOI 10.1182/blood-2012-03-419747; Forrester SJ, 2018, CIRC RES, V122, P877, DOI 10.1161/CIRCRESAHA.117.311401; Freigang S, 2016, EUR J IMMUNOL, V46, P1818, DOI 10.1002/eji.201545676; Fuhrmann DC, 2019, REDOX BIOL, V20, P204, DOI 10.1016/j.redox.2018.10.007; Gao ZJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01919-0; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Gu LL, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101307; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hall CJ, 2013, CELL METAB, V18, P265, DOI 10.1016/j.cmet.2013.06.018; He M, 2020, CELL METAB, V31, P580, DOI 10.1016/j.cmet.2020.01.009; Hortelano S, 2003, J IMMUNOL, V171, P6059, DOI 10.4049/jimmunol.171.11.6059; Huang SCC, 2016, IMMUNITY, V45, P817, DOI 10.1016/j.immuni.2016.09.016; Huang SCC, 2014, NAT IMMUNOL, V15, P846, DOI 10.1038/ni.2956; Humphries F, 2020, SCIENCE, V369, P1633, DOI 10.1126/science.abb9818; Infantino V, 2019, CURR MED CHEM, V26, P7104, DOI 10.2174/0929867325666180510124558; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Johnson AR, 2016, MOL METAB, V5, P506, DOI 10.1016/j.molmet.2016.04.005; Jorgensen I, 2015, IMMUNOL REV, V265, P130, DOI 10.1111/imr.12287; Karabay AZ, 2014, IMMUNOPHARM IMMUNOT, V36, P379, DOI 10.3109/08923973.2014.956752; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Kim J, 2017, SCI REP-UK, V7, DOI 10.1038/srep39768; Koivunen P, 2007, J BIOL CHEM, V282, P4524, DOI 10.1074/jbc.M610415200; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Lampropoulou V, 2016, CELL METAB, V24, P158, DOI 10.1016/j.cmet.2016.06.004; Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Lauterbach MA, 2019, IMMUNITY, V51, P997, DOI 10.1016/j.immuni.2019.11.009; Lei WW, 2018, P NATL ACAD SCI USA, V115, P5552, DOI 10.1073/pnas.1720758115; Li DD, 2018, MOL MED REP, V18, P4399, DOI 10.3892/mmr.2018.9427; Li H, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00081; Littlewood-Evans A, 2016, J EXP MED, V213, P1655, DOI 10.1084/jem.20160061; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Michelucci A, 2013, P NATL ACAD SCI USA, V110, P7820, DOI 10.1073/pnas.1218599110; Mills EL, 2018, NATURE, V556, P113, DOI 10.1038/nature25986; Mills EL, 2016, CELL, V167, P457, DOI 10.1016/j.cell.2016.08.064; Mogilenko DA, 2019, CELL, V178, P263, DOI 10.1016/j.cell.2019.06.017; Montava-Garriga L, 2020, J MOL BIOL, V432, P206, DOI 10.1016/j.jmb.2019.06.032; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murphy MP, 2018, CELL, V174, P780, DOI 10.1016/j.cell.2018.07.030; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Natoli G, 2014, IMMUNITY, V40, P175, DOI 10.1016/j.immuni.2014.01.004; Nisbet DJ, 2009, CURR MICROBIOL, V58, P488, DOI 10.1007/s00284-008-9351-1; Noe JT, 2019, J LEUKOCYTE BIOL, V106, P359, DOI 10.1002/JLB.3RU1218-496R; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; O'Neill LAJ, 2019, NAT REV IMMUNOL, V19, P273, DOI 10.1038/s41577-019-0128-5; O'Neill Luke A J, 2011, Biochem J, V438, pe5, DOI 10.1042/BJ20111386; Olagnier D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18764-3; Orecchioni M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01084; PARK MH, 1993, BIOFACTORS, V4, P95; Park S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15489; Pernas L, 2016, ANNU REV PHYSIOL, V78, P505, DOI 10.1146/annurev-physiol-021115-105011; Perocchi F, 2010, NATURE, V467, P291, DOI 10.1038/nature09358; Puleston DJ, 2019, CELL METAB, V30, P352, DOI 10.1016/j.cmet.2019.05.003; Rendra E, 2019, IMMUNOBIOLOGY, V224, P242, DOI 10.1016/j.imbio.2018.11.010; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Salminen A, 2014, AGEING RES REV, V16, P45, DOI 10.1016/j.arr.2014.05.004; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sanchez-Lopez E, 2019, CELL METAB, V29, P1350, DOI 10.1016/j.cmet.2019.03.011; Sanin DE, 2018, IMMUNITY, V49, P1021, DOI 10.1016/j.immuni.2018.10.011; Sarti P, 2003, IUBMB LIFE, V55, P605, DOI 10.1080/15216540310001628726; Shapouri-Moghaddam A, 2018, J CELL PHYSIOL, V233, P6425, DOI 10.1002/jcp.26429; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sloat SR, 2019, MOL BIOL CELL, V30, P2309, DOI 10.1091/mbc.E19-05-0291; Sun KA, 2020, ELIFE, V9, DOI 10.7554/eLife.54877; Tannahill GM, 2013, NATURE, V496, P238, DOI 10.1038/nature11986; Tarhonskaya H, 2017, J MOL BIOL, V429, P2895, DOI 10.1016/j.jmb.2017.08.007; Tur J, 2017, ADV IMMUNOL, V133, P1, DOI 10.1016/bs.ai.2016.12.001; Van den Bossche J, 2016, CELL REP, V17, P684, DOI 10.1016/j.celrep.2016.09.008; Wang Z, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/4063562; Wei HY, 2019, ECOTOX ENVIRON SAFE, V174, P566, DOI 10.1016/j.ecoenv.2019.02.093; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156; West AP, 2011, NATURE, V472, P476, DOI 10.1038/nature09973; Willems PHGM, 2015, CELL METAB, V22, P207, DOI 10.1016/j.cmet.2015.06.006; Williams NC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00141; Wu GN, 2019, J THORAC DIS, V11, P4816, DOI 10.21037/jtd.2019.10.26; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yang XP, 2020, ADIPOCYTE, V9, P484, DOI 10.1080/21623945.2020.1807850; Yu XH, 2019, IMMUNOL CELL BIOL, V97, P134, DOI 10.1111/imcb.12218; Zhang D, 2019, NATURE, V574, P575, DOI 10.1038/s41586-019-1678-1; Zhang HL, 2019, MOL CELL, V76, P110, DOI 10.1016/j.molcel.2019.08.005; Zhang S, 2019, CELL METAB, V29, P443, DOI 10.1016/j.cmet.2018.12.004; Zhao Y, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00128; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zorova LD, 2018, ANAL BIOCHEM, V552, P50, DOI 10.1016/j.ab.2017.07.009	116	23	24	9	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100904	10.1016/j.jbc.2021.100904	http://dx.doi.org/10.1016/j.jbc.2021.100904			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157289	gold, Green Published			2022-12-28	WOS:000678068400093
J	Zhang, A; Venkat, A; Taujale, R; Mull, JL; Ito, A; Kannan, N; Haltiwanger, RS				Zhang, Ao; Venkat, Aarya; Taujale, Rahil; Mull, James L.; Ito, Atsuko; Kannan, Natarajan; Haltiwanger, Robert S.			Peters plus syndrome mutations affect the function and stability of human beta 1,3-glucosyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAMTS-LIKE PROTEINS; O-FUCOSYLATION; QUALITY-CONTROL; SWISS-MODEL; B3GALTL; GLYCOSYLTRANSFERASE; INSIGHTS; DATABASE; FUCOSE; GENE	Peters Plus Syndrome (PTRPLS OMIM #261540) is a severe congenital disorder of glycosylation where patients have multiple structural anomalies, including Peters anomaly of the eye (anterior segment dysgenesis), disproportionate short stature, brachydactyly, dysmorphic facial features, developmental delay, and variable additional abnormalities. PTRPLS patients and some Peters Plus-like (PTRPLS-like) patients (who only have a subset of PTRPLS phenotypes) have mutations in the gene encoding beta 1,3-glucosyltransferase (B3GLCT). B3GLCT catalyzes the transfer of glucose to O-linked fucose on thrombospondin type-1 repeats. Most B3GLCT substrate proteins belong to the ADAMTS superfamily and play critical roles in extracellular matrix. We sought to determine whether the PTRPLS or PTRPLS-like mutations abrogated B3GLCT activity. B3GLCT has two putative active sites, one in the N-terminal region and the other in the C-terminal glycosyl-transferase domain. Using sequence analysis and in vitro activity assays, we demonstrated that the C-terminal domain catalyzes transfer of glucose to O-linked fucose. We also generated a homology model of B3GLCT and identified D421 as the catalytic base. PTRPLS and PTRPLS-like mutations were individually introduced into B3GLCT, and the mutated enzymes were evaluated using in vitro enzyme assays and cell-based functional assays. Our results demonstrated that PTRPLS mutations caused loss of B3GLCT enzymatic activity and/or significantly reduced protein stability. In contrast, B3GLCT with PTRPLS-like mutations retained enzymatic activity, although some showed a minor destabilizing effect. Overall, our data supports the hypothesis that loss of glucose from B3GLCT substrate proteins is responsible for the defects observed in PTRPLS patients, but not for those observed in PTRPLS-like patients.	[Zhang, Ao; Taujale, Rahil; Mull, James L.; Ito, Atsuko; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Zhang, Ao; Venkat, Aarya; Mull, James L.; Kannan, Natarajan; Haltiwanger, Robert S.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Taujale, Rahil; Kannan, Natarajan] Univ Georgia, Inst Bioinformat, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.; Haltiwanger, RS (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	rhalti@uga.edu			NIH [T32 GM107004, P41-GM103311, HD096030, GM130915]; Georgia Research Alliance	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	We thank Dr Bernadette Holdener's group members for their discussion throughout this project, Dr Hisashi Narimatsu for providing the pcDNA3.1(+)-hB3GLCT plasmid, and Dr Kelvin Luther for comments on this article. We thank Dr Nadja Zeltner's group for facility and technical support for protein thermo shift assays. Molecular graphics and analyses NIH performed with UCSF Chimera, developed by the Resource for Biocomputing, Visualization, and Informatics at the University of California, San Francisco, with support from NIH P41-GM103311. Supported by funding from NIH (HD096030 to R. S. H., GM130915 to N. K.) and the Georgia Research Alliance. RT was partially supported by NIH T32 GM107004. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aliferis K, 2010, OPHTHALMIC GENET, V31, P205, DOI 10.3109/13816810.2010.512355; Apte SS, 2009, J BIOL CHEM, V284, P31493, DOI 10.1074/jbc.R109.052340; Benz BA, 2016, DEV BIOL, V416, P111, DOI 10.1016/j.ydbio.2016.05.038; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Dubail J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33974; Dubail J, 2015, MATRIX BIOL, V44-46, P24, DOI 10.1016/j.matbio.2015.03.001; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Haltiwanger RS., 2015, ESSENTIALS GLYCOBIOL, P151; Hao Y., 2020, J BIOL CHEM, V296; Heinonen TYK, 2003, BIOCHEM BIOPH RES CO, V309, P166, DOI 10.1016/S0006-291X(03)01540-7; Hofsteenge J, 2001, J BIOL CHEM, V276, P6485, DOI 10.1074/jbc.M008073200; Holdener BC, 2019, HUM MOL GENET, V28, P4053, DOI 10.1093/hmg/ddz225; Holdener BC, 2019, CURR OPIN STRUC BIOL, V56, P78, DOI 10.1016/j.sbi.2018.12.005; Hubmacher D, 2017, SCI REP-UK, V7, DOI 10.1038/srep41871; Jinek M, 2006, NAT STRUCT MOL BIOL, V13, P945, DOI 10.1038/nsmb1144; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; Kadirvelraj R., 2020, J BIOL CHEM, V296; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kozma K, 2006, J BIOL CHEM, V281, P36742, DOI 10.1074/jbc.M605912200; Le Goff C, 2008, NAT GENET, V40, P1119, DOI 10.1038/ng.199; Leonhard-Melief C, 2010, METHOD ENZYMOL, V480, P401, DOI 10.1016/S0076-6879(10)80018-7; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lu SN, 2020, NUCLEIC ACIDS RES, V48, pD265, DOI 10.1093/nar/gkz991; Luo Y, 2006, J BIOL CHEM, V281, P9385, DOI 10.1074/jbc.M511974200; Luo Y, 2006, J BIOL CHEM, V281, P9393, DOI 10.1074/jbc.M511975200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Neupane S., 2021, GLYCOBIOLOGY; Oberstein SAJL, 2006, AM J HUM GENET, V79, P562, DOI 10.1086/507567; Petit D, 2021, GLYCOBIOLOGY, V31, P243, DOI 10.1093/glycob/cwaa086; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricketts LM, 2007, J BIOL CHEM, V282, P17014, DOI 10.1074/jbc.M700317200; Righino B, 2020, J CHEM INF MODEL, V60, P3145, DOI 10.1021/acs.jcim.0c00281; Sato T, 2006, GLYCOBIOLOGY, V16, P1194, DOI 10.1093/glycob/cwl035; Schneider M, 2017, GLYCOBIOLOGY, V27, P601, DOI 10.1093/glycob/cwx034; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; Taujale R, 2020, ELIFE, V9, DOI 10.7554/eLife.54532; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Vasudevan D, 2015, CURR BIOL, V25, P286, DOI 10.1016/j.cub.2014.11.049; Wang LW, 2007, J BIOL CHEM, V282, P17024, DOI 10.1074/jbc.M701065200; Wang LW, 2009, J BIOL CHEM, V284, P30004, DOI 10.1074/jbc.M109.038059; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Weh E, 2014, CLIN GENET, V86, P142, DOI 10.1111/cge.12241; Zhang AO, 2020, J BIOL CHEM, V295, P15742, DOI 10.1074/jbc.RA120.014557	46	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100843	10.1016/j.jbc.2021.100843	http://dx.doi.org/10.1016/j.jbc.2021.100843			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058199	Green Published, gold			2022-12-28	WOS:000678068400043
J	Kankanamge, D; Ubeysinghe, S; Tennakoon, M; Pantula, PD; Mitra, K; Giri, L; Karunarathne, A				Kankanamge, Dinesh; Ubeysinghe, Sithurandi; Tennakoon, Mithila; Pantula, Priyanka Devi; Mitra, Kishalay; Giri, Lopamudra; Karunarathne, Ajith			Dissociation of the G protein beta gamma from the Gq-PLC beta complex partially attenuates PIP2 hydrolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-BETA; ALPHA-SUBUNIT; QUANTITATIVE PROPERTIES; RECEPTOR RESERVE; GTP-BINDING; ACTIVATION; G(Q); CALCIUM; STIMULATION; TERMINUS	Phospholipase C beta (PLC beta), which is activated by the Gq family of heterotrimeric G proteins, hydrolyzes the inner membrane lipid phosphatidylinositol 4,5-bisphosphate (PIP2), generating diacylglycerol and inositol 1,4,5-triphosphate (IP3). Because Gq and PLC beta regulate many crucial cellular processes and have been identified as major disease drivers, activation and termination of PLC beta signaling by the Gaq subunit have been extensively studied. Gq-coupled receptor activation induces intense and transient PIP2 hydrolysis, which subsequently recovers to a low-intensity steady-state equilibrium. However, the molecular underpinnings of this equilibrium remain unclear. Here, we explored the influence of signaling crosstalk between Gq and Gi/o pathways on PIP2 metabolism in living cells using single-cell and optogenetic approaches to spatially and temporally constrain signaling. Our data suggest that the G beta. complex is a component of the highly efficient lipase Gaq(GTP)-PLC beta-G beta gamma. We found that over time, G beta gamma dissociates from this lipase complex, leaving the less-efficient Gaq(GTP)-PLC beta lipase complex and allowing the significant partial recovery of PIP2 levels. Our findings also indicate that the subtype of the G. subunit in G beta gamma fine-tunes the lipase activity of Gq-PLC beta, in which cells expressing G. with higher plasma membrane interaction show lower PIP2 recovery. Given that G. shows cell- and tissue-specific subtype expression, our findings suggest the existence of tissue-specific distinct Gq-PLC beta signaling paradigms. Furthermore, these results also outline a molecular process that likely safeguards cells from excessive Gq signaling.	[Kankanamge, Dinesh; Ubeysinghe, Sithurandi; Tennakoon, Mithila; Karunarathne, Ajith] Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA; [Pantula, Priyanka Devi; Mitra, Kishalay; Giri, Lopamudra] Indian Inst Technol, Dept Chem Engn, Sangareddy, Telangana, India; [Kankanamge, Dinesh] Washington Univ, Dept Anesthesiol, Sch Med, St Louis, MO 63110 USA	University System of Ohio; University of Toledo; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Hyderabad; Washington University (WUSTL)	Karunarathne, A (corresponding author), Univ Toledo, Dept Chem & Biochem, 2801 W Bancroft St, Toledo, OH 43606 USA.	Ajith.karunarathne@utoledo.edu	Mitra, Kishalay/T-2361-2019	Mitra, Kishalay/0000-0001-5660-6878; Kankanamge, Dinesh/0000-0001-9647-0258	National Institutes of Health-National Institute of General Medical Sciences [1R15GM126455-01A1]; National Institutes of Health, United States	National Institutes of Health-National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institutes of Health, United States(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the National Institutes of Health-National Institute of General Medical Sciences (award number 1R15GM126455-01A1) of the National Institutes of Health, United States. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abell E, 2011, P NATL ACAD SCI USA, V108, P14485, DOI 10.1073/pnas.1018266108; Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; BERRIDGE MJ, 1987, ANNU REV BIOCHEM, V56, P159, DOI 10.1146/annurev.bi.56.070187.001111; BERSTEIN G, 1992, CELL, V70, P411, DOI 10.1016/0092-8674(92)90165-9; Biddlecome GH, 1996, J BIOL CHEM, V271, P7999, DOI 10.1074/jbc.271.14.7999; Bouley RA, 2020, MOL PHARMACOL, V97, P392, DOI 10.1124/mol.119.118661; CAMPS M, 1992, NATURE, V360, P684, DOI 10.1038/360684a0; Caranica C, 2019, YALE J BIOL MED, V92, P169; Carman CV, 2000, J BIOL CHEM, V275, P10443, DOI 10.1074/jbc.275.14.10443; Carman CV, 1999, J BIOL CHEM, V274, P34483, DOI 10.1074/jbc.274.48.34483; Charpentier TH, 2016, J BIOL CHEM, V291, P25608, DOI 10.1074/jbc.M116.740407; Charpentier TH, 2014, J BIOL CHEM, V289, P29545, DOI 10.1074/jbc.M114.586784; Chen X, 2018, BLOOD, V132, DOI 10.1182/blood-2018-99-111385; Chidiac P, 1999, J BIOL CHEM, V274, P19639, DOI 10.1074/jbc.274.28.19639; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; Cook B, 2000, NAT CELL BIOL, V2, P296, DOI 10.1038/35010571; Deng ZJ, 2019, IEEE ACCESS, V7, P49403, DOI 10.1109/ACCESS.2019.2910731; DiBello PR, 1998, J BIOL CHEM, V273, P5780, DOI 10.1074/jbc.273.10.5780; Dickson EJ, 2013, J GEN PHYSIOL, V141, P521, DOI 10.1085/jgp.201210886; Falkenburger BH, 2013, J GEN PHYSIOL, V141, P537, DOI 10.1085/jgp.201210887; Falkenburger BH, 2010, J GEN PHYSIOL, V135, P81, DOI 10.1085/jgp.200910344; Giri L, 2014, BIOPHYS J, V107, P242, DOI 10.1016/j.bpj.2014.05.020; Gresset Aurelie, 2012, Subcell Biochem, V58, P61, DOI 10.1007/978-94-007-3012-0_3; Gurevich VV, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00125; Hepler J.R., 1997, P NATL ACAD SCI USA, V94, p428; Hollins B, 2009, CELL SIGNAL, V21, P1015, DOI 10.1016/j.cellsig.2009.02.017; Horowitz LF, 2005, J GEN PHYSIOL, V126, P243, DOI 10.1085/jgp.200509309; Kadamur G, 2016, J BIOL CHEM, V291, P11394, DOI 10.1074/jbc.M116.723940; Kankanamge D., 2019, CELL SIGNAL, V58, P34; Kankanamge D, 2018, J CELL SCI, V131, DOI 10.1242/jcs.212910; Karunarathne WKA, 2013, P NATL ACAD SCI USA, V110, pE1565, DOI 10.1073/pnas.1220697110; Kim CG, 1996, J BIOL CHEM, V271, P21187, DOI 10.1074/jbc.271.35.21187; Litosch I, 2013, IUBMB LIFE, V65, P936, DOI 10.1002/iub.1218; Loew A, 1998, STRUCT FOLD DES, V6, P1007, DOI 10.1016/S0969-2126(98)00102-6; Lowet E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146443; Guzman-Hernandez ML, 2009, J BIOL CHEM, V284, P18334, DOI 10.1074/jbc.M109.008839; Lyon AM, 2014, TRENDS PHARMACOL SCI, V35, P23, DOI 10.1016/j.tips.2013.10.008; Lyon AM, 2013, MOL PHARMACOL, V84, P488, DOI 10.1124/mol.113.087403; Lyon AM, 2013, NAT STRUCT MOL BIOL, V20, P355, DOI 10.1038/nsmb.2497; McIntire WE, 2009, NEUROSIGNALS, V17, P82, DOI 10.1159/000186692; Mizuno N, 2009, NEUROSIGNALS, V17, P42, DOI 10.1159/000186689; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Mukhopadhyay S, 1999, P NATL ACAD SCI USA, V96, P9539, DOI 10.1073/pnas.96.17.9539; Nakamura Y, 2017, J BIOCHEM, V161, P315, DOI 10.1093/jb/mvw094; Navaratnarajah P, 2017, J BIOL CHEM, V292, P16788, DOI 10.1074/jbc.M117.809673; Nehme R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175642; Oprisan S.A, 2017, INT SCH RES NOTICES, V2017; Peterson YK, 2017, PHARMACOL REV, V69, P256, DOI 10.1124/pr.116.013367; Philip F, 2010, CURR BIOL, V20, P1327, DOI 10.1016/j.cub.2010.06.013; Pitcher JA, 1999, J BIOL CHEM, V274, P34531, DOI 10.1074/jbc.274.49.34531; Quiroga RQ, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.041903; Quitterer U, 1999, P NATL ACAD SCI USA, V96, P10626, DOI 10.1073/pnas.96.19.10626; Rajagopal S, 2017, CELL SIGNAL, V41, P9, DOI 10.1016/j.cellsig.2017.01.024; Rebres RA, 2011, J BIOL CHEM, V286, P942, DOI 10.1074/jbc.M110.198200; Ross EM, 2008, CURR BIOL, V18, pR777, DOI 10.1016/j.cub.2008.07.035; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Sallese M, 2000, MOL PHARMACOL, V57, P826, DOI 10.1124/mol.57.4.826; Samaradivakara S, 2018, BIOCHEM BIOPH RES CO, V503, P165, DOI 10.1016/j.bbrc.2018.05.204; Scarlata S, 2005, BIOPHYS J, V88, P2867, DOI 10.1529/biophysj.104.055715; Schroder S, 1997, FEBS LETT, V401, P243, DOI 10.1016/S0014-5793(96)01483-4; Senarath K, 2018, J BIOL CHEM, V293, P2974, DOI 10.1074/jbc.RA117.000872; Senarath K, 2016, ANAL CHEM, V88, P11450, DOI 10.1021/acs.analchem.6b02512; Senese NB, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00005; Shakeel A, 2020, APPL SCI-BASEL, V10, DOI 10.3390/app10103616; SMRCKA AV, 1993, J BIOL CHEM, V268, P9667; Stauffer TP, 1998, CURR BIOL, V8, P343, DOI 10.1016/S0960-9822(98)70135-6; Sun JF, 2012, COMPUT MATH METHOD M, V2012, DOI 10.1155/2012/239210; Tang W., 2006, J BIOL CHEM, V281, p4746; Tennakoon M, 2019, MOL PHARMACOL, V95, P361, DOI 10.1124/mol.118.114710; Varnai P, 1998, J CELL BIOL, V143, P501, DOI 10.1083/jcb.143.2.501; Waldo GL, 2010, SCIENCE, V330, P974, DOI 10.1126/science.1193438; Wan QW, 2018, J BIOL CHEM, V293, P7466, DOI 10.1074/jbc.RA118.001975; WU DQ, 1993, P NATL ACAD SCI USA, V90, P5297, DOI 10.1073/pnas.90.11.5297; Xu C, 2003, J CELL BIOL, V161, P779, DOI 10.1083/jcb.200301070; Zhao ZQ, 2014, NEURON, V84, P821, DOI 10.1016/j.neuron.2014.10.003; Zhou YX, 2008, BIOCHEMISTRY-US, V47, P4410, DOI 10.1021/bi800044n; Zhu X, 1996, P NATL ACAD SCI USA, V93, P2827, DOI 10.1073/pnas.93.7.2827	79	5	5	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100702	10.1016/j.jbc.2021.100702	http://dx.doi.org/10.1016/j.jbc.2021.100702			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33901492	gold, Green Published			2022-12-28	WOS:000672866400673
J	Luo, JL; Hu, SQ; Fu, ML; Luo, LM; Li, YY; Li, WH; Cai, YT; Dong, RL; Yang, Y; Tu, L; Xu, XZ				Luo, Jinlan; Hu, Shuiqing; Fu, Menglu; Luo, Liman; Li, Yuanyuan; Li, Wenhua; Cai, Yueting; Dong, Ruolan; Yang, Yan; Tu, Ling; Xu, Xizhen			Inhibition of soluble epoxide hydrolase alleviates insulin resistance and hypertension via downregulation of SGLT2 in the mouse kidney	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYSTOLIC BLOOD-PRESSURE; CARDIOVASCULAR OUTCOMES; DIABETES-MELLITUS; KAPPA-B; INFLAMMATION; MECHANISMS; CHANNEL; MODELS; INJURY; CELLS	The epoxyeicosatrienoic acid (EET) exerts beneficial effects on insulin resistance and/or hypertension. EETs could be readily converted to less biological active diols by soluble epoxide hydrolase (sEH). However, whether sEH inhibition can ameliorate the comorbidities of insulin resistance and hypertension and the underlying mechanisms of this relationship are unclear. In this study, C57BL/6 mice were rendered hypertensive and insulin resistant through a high-fat and high-salt (HF-HS) diet. The sEH inhibitor, 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU), was used to treat mice (1 mg/kg/day) for 8 weeks, followed by analysis of metabolic parameters. The expression of sEH and the sodium-glucose cotransporter 2 (SGLT2) was markedly upregulated in the kidneys of mice fed an HF-HS diet. We found that TPPU administration increased kidney EET levels, improved insulin resistance, and reduced hypertension. Furthermore, TPPU treatment prevented upregulation of SGLT2 and the associated increased urine volume and the excretion of urine glucose and urine sodium. Importantly, TPPU alleviated renal inflammation. In vitro, human renal proximal tubule epithelial cells (HK-2 cells) were used to further investigate the underlying mechanism. We observed that 14,15-EET or sEH knockdown or inhibition prevented the upregulation of SGLT2 upon treatment with palmitic acid or NaCl by inhibiting the inhibitory kappa B kinase alpha/beta/NF-kappa B signaling pathway. In conclusion, sEH inhibition by TPPU alleviated insulin resistance and hypertension induced by an HF-HS diet in mice. The increased urine excretion of glucose and sodium was mediated by decreased renal SGLT2 expression because of inactivation of the inhibitory kappa B kinase alpha beta/NF-kappa B-induced inflammatory response.	[Luo, Jinlan; Fu, Menglu; Luo, Liman; Li, Yuanyuan; Li, Wenhua; Tu, Ling] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr Med, Wuhan, Peoples R China; [Luo, Jinlan; Hu, Shuiqing; Cai, Yueting; Xu, Xizhen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China; [Luo, Jinlan; Hu, Shuiqing; Cai, Yueting; Yang, Yan; Xu, Xizhen] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan, Peoples R China; [Dong, Ruolan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Inst Integrated Tradit Chinese & Western Med, Wuhan, Peoples R China; [Yang, Yan] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Endocrinol, Wuhan, Peoples R China; [Tu, Ling; Xu, Xizhen] Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tu, L (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Geriatr Med, Wuhan, Peoples R China.; Xu, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Div Cardiol, Wuhan, Peoples R China.; Xu, XZ (corresponding author), Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Internal Med, Wuhan, Peoples R China.; Tu, L; Xu, XZ (corresponding author), Hubei Key Lab Genet & Mol Mech Cardiol Disorders, Wuhan, Peoples R China.	lingtu@tjh.tjmu.cn; xzxu@tjh.tjmu.edu.cn	fu, meng/GZG-3120-2022; li, yuanyuan/GZA-4435-2022		National Natural Science Foundation of China [81873512, 81471021]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Natural Science Foundation of China (no. 81873512 and no. 81471021).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 2015, Nat Rev Dis Primers, V1, P15039, DOI 10.1038/nrdp.2015.39; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Eaddy MT, 2008, CURR MED RES OPIN, V24, P2501, DOI 10.1185/03007990802297529 ; El-Sherbeni AA, 2014, ARCH TOXICOL, V88, P2013, DOI 10.1007/s00204-014-1371-y; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Fu ML, 2021, MOL CELL ENDOCRINOL, V523, DOI 10.1016/j.mce.2020.111149; Guzik TJ, 2018, ANTIOXID REDOX SIGN, V29, P257, DOI 10.1089/ars.2017.7299; Han HJ, 2005, J CELL PHYSIOL, V202, P246, DOI 10.1002/jcp.20108; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2020, HYPERTENSION, V76, P3, DOI 10.1161/HYPERTENSIONAHA.120.13898; Kabakov Emma, 2006, J Cardiometab Syndr, V1, P95, DOI 10.1111/j.1559-4564.2006.05513.x; Khan MAH, 2013, HYPERTENSION, V62, P905, DOI 10.1161/HYPERTENSIONAHA.113.01949; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; Laethem M, 1993, J BIOL CHEM, V268; Lastra G, 2014, ENDOCRIN METAB CLIN, V43, P103, DOI 10.1016/j.ecl.2013.09.005; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Li R., 2015, AM J PHYSIOL-ENDOC M, V308, pE270; Lu XH, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0903-x; Makita K., 1994, J BIOL CHEM, V94, p2414 2420; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Muntner P, 2018, DIABETES CARE, V41, P2322, DOI 10.2337/dc18-1307; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Rang H., 2011, PROSTAG OTH LIPID M, V98, P93; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Shen HC, 2010, EXPERT OPIN THER PAT, V20, P941, DOI 10.1517/13543776.2010.484804; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Wan EYF, 2018, DIABETES CARE, V41, P1134, DOI 10.2337/dc17-2443; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang HH, 2020, THERANOSTICS, V10, P4749, DOI 10.7150/thno.43108; Yang Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12718; Zelniker TA, 2018, J AM COLL CARDIOL, V72, P1845, DOI 10.1016/j.jacc.2018.06.040; Zhang DH, 2012, CIRC RES, V110, P808, DOI 10.1161/CIRCRESAHA.111.259325; Zhang LN, 2011, EUR J PHARMACOL, V654, P68, DOI 10.1016/j.ejphar.2010.12.016; Zuloaga KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097529	48	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100667	10.1016/j.jbc.2021.100667	http://dx.doi.org/10.1016/j.jbc.2021.100667			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864813	gold, Green Published			2022-12-28	WOS:000672866400638
J	Bai, Y; Parker, EJ				Bai, Yu; Parker, Emily J.			Reciprocal allostery arising from a bienzyme assembly controls aromatic amino acid biosynthesis in Prevotella nigrescens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							3-DEOXY-D-ARABINO-HEPTULOSONATE 7-PHOSPHATE SYNTHASE; CHORISMATE MUTASE; 3-DIMENSIONAL STRUCTURE; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DAHP SYNTHASE; COMPLEX; ENZYME; PURIFICATION	Modular protein assembly has been widely reported as a mechanism for constructing allosteric machinery. Recently, a distinctive allosteric system has been identified in a bienzyme assembly comprising a 3-deoxy-D-arabino heptulosonate-7-phosphate synthase (DAH7PS) and chorismate mutase (CM). These enzymes catalyze the first and branch point reactions of aromatic amino acid biosynthesis in the bacterium Prevotella nigrescens (PniDAH7PS), respectively. The interactions between these two distinct catalytic domains support functional interreliance within this bifunctional enzyme. The binding of prephenate, the product of CM-catalyzed reaction, to the CM domain is associated with a striking rearrangement of overall protein conformation that alters the interdomain interactions and allosterically inhibits the DAH7PS activity. Here, we have further investigated the complex allosteric communication demonstrated by this bifunctional enzyme. We observed allosteric activation of CM activity in the presence of all DAH7PS substrates. Using small-angle X-ray scattering (SAXS) experiments, we show that changes in overall protein conformations and dynamics are associated with the presence of different DAH7PS substrates and the allosteric inhibitor prephenate. Furthermore, we have identified an extended interhelix loop located in CM domain, loopC320-F333, as a crucial segment for the interdomain structural and catalytic communications. Our results suggest that the dual-function enzyme PniDAH7PS contains a reciprocal allosteric system between the two enzymatic moieties as a result of this bidirectional interdomain communication. This arrangement allows for a complex feedback and feedforward system for control of pathway flux by connecting the initiation and branch point of aromatic amino acid biosynthesis.	[Bai, Yu; Parker, Emily J.] Victoria Univ Wellington, Maurice Wilkins Ctr, Ferrier Res Inst, Wellington, New Zealand	Victoria University Wellington	Parker, EJ (corresponding author), Victoria Univ Wellington, Maurice Wilkins Ctr, Ferrier Res Inst, Wellington, New Zealand.	emily.parker@vuw.ac.nz		Parker, Emily/0000-0002-9571-9987	Marsden Fund [VUW1426]	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ))	Marsden Fund VUW1426.	Bai Y, 2019, J BIOL CHEM, V294, P4828, DOI 10.1074/jbc.RA118.005220; Blackmore NJ, 2015, J BIOL CHEM, V290, P18187, DOI 10.1074/jbc.M115.638700; BLACKMORE PF, 1976, FEBS LETT, V64, P222, DOI 10.1016/0014-5793(76)80288-8; Burschowsky D, 2018, BIOCHEMISTRY-US, V57, P557, DOI 10.1021/acs.biochem.7b01018; Cross PJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145187; Cross PJ, 2013, PROTEIN SCI, V22, P1087, DOI 10.1002/pro.2293; Cross PJ, 2013, P NATL ACAD SCI USA, V110, P2111, DOI 10.1073/pnas.1217923110; Cross PJ, 2011, J BIOL CHEM, V286, P10216, DOI 10.1074/jbc.M110.209924; Fan YF, 2018, P NATL ACAD SCI USA, V115, P3006, DOI 10.1073/pnas.1717621115; Furdui C, 2004, J BIOL CHEM, V279, P45618, DOI 10.1074/jbc.M404753200; Goodey NM, 2008, NAT CHEM BIOL, V4, P474, DOI 10.1038/nchembio.98; Helmstaedt K, 2004, ARCH MICROBIOL, V181, P195, DOI 10.1007/s00203-003-0639-z; Huang QJ, 2020, CURR OPIN STRUC BIOL, V62, P175, DOI 10.1016/j.sbi.2020.01.017; HYDE CC, 1988, J BIOL CHEM, V263, P17857; Jiao WT, 2020, CURR OPIN STRUC BIOL, V65, P159, DOI 10.1016/j.sbi.2020.06.015; Jiao WT, 2012, J MOL BIOL, V415, P716, DOI 10.1016/j.jmb.2011.11.037; Kirby N., 2007, AIP C P; Kirby NM, 2013, J APPL CRYSTALLOGR, V46, P1670, DOI 10.1107/S002188981302774X; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lang EJM, 2014, CURR OPIN STRUC BIOL, V29, P102, DOI 10.1016/j.sbi.2014.10.007; Laskowski RA, 2009, FEBS LETT, V583, P1692, DOI 10.1016/j.febslet.2009.03.019; LEE AY, 1995, CHEM BIOL, V2, P195, DOI 10.1016/1074-5521(95)90269-4; LEE AY, 1995, J AM CHEM SOC, V117, P3627, DOI 10.1021/ja00117a038; Lee D., 2005, PDB ID 1YBZ CONSERVE; Light SH, 2013, PROTEIN SCI, V22, P395, DOI 10.1002/pro.2233; Light SH, 2012, PROTEIN SCI, V21, P887, DOI 10.1002/pro.2075; MacBeath G, 1998, BIOCHEMISTRY-US, V37, P10062, DOI 10.1021/bi980449t; Mistry J, 2021, NUCLEIC ACIDS RES, V49, pD412, DOI 10.1093/nar/gkaa913; Nazmi AR, 2016, J BIOL CHEM, V291, P21836, DOI 10.1074/jbc.M116.741637; Nazmi AR, 2014, J MOL BIOL, V426, P656, DOI 10.1016/j.jmb.2013.11.008; Okvist M, 2009, ACTA CRYSTALLOGR F, V65, P1048, DOI 10.1107/S1744309109035878; Palmer T., 2007, ENZYMES BIOCH BIOTEC; Papaleo E, 2016, CHEM REV, V116, P6391, DOI 10.1021/acs.chemrev.5b00623; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Ryan TM, 2018, J APPL CRYSTALLOGR, V51, P97, DOI 10.1107/S1600576717017101; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sasso S, 2005, FEBS J, V272, P375, DOI 10.1111/j.1742-4658.2004.04478.x; Sasso S, 2009, EMBO J, V28, P2128, DOI 10.1038/emboj.2009.165; Schofield LR, 2005, BIOCHEMISTRY-US, V44, P11950, DOI 10.1021/bi050577z; SCHONER R, 1976, J BIOL CHEM, V251, P5440; Shumilin IA, 2004, J MOL BIOL, V341, P455, DOI 10.1016/j.jmb.2004.05.077; Singh H, 2014, P NATL ACAD SCI USA, V111, P3389, DOI 10.1073/pnas.1321621111; Webby CJ, 2010, J BIOL CHEM, V285, P30567, DOI 10.1074/jbc.M110.111856; Webby CJ, 2005, J MOL BIOL, V354, P927, DOI 10.1016/j.jmb.2005.09.093; WILMANNS M, 1992, J MOL BIOL, V223, P477, DOI 10.1016/0022-2836(92)90665-7; Wu J, 2006, J BIOL CHEM, V281, P4042, DOI 10.1074/jbc.M512223200; Xie J, 2020, CURR OPIN STRUC BIOL, V62, P158, DOI 10.1016/j.sbi.2020.01.011; Zhou L, 2012, BIOORG CHEM, V40, P79, DOI 10.1016/j.bioorg.2011.09.002	48	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101038	10.1016/j.jbc.2021.101038	http://dx.doi.org/10.1016/j.jbc.2021.101038			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343567	Green Submitted, gold, Green Published			2022-12-28	WOS:000704369100003
J	Li, HT; Hu, LQ; Cuffee, CW; Mohamed, M; Li, QB; Liu, QD; Zhou, L; Liu, QL				Li, Hongtao; Hu, Liqing; Cuffee, Crist William; Mohamed, Mahetab; Li, Qianbin; Liu, Qingdai; Zhou, Lei; Liu, Qinglian			Interdomain interactions dictate the function of the Candida albicans Hsp110 protein Msi3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE EXCHANGE FACTORS; MOLECULAR CHAPERONE SSE1; POLYPEPTIDE-BINDING SITE; YEAST HSP110; SUBSTRATE-BINDING; HSP70 CHAPERONES; PRION PROPAGATION; CRYSTAL-STRUCTURE; PEPTIDE-BINDING; CELL-GROWTH	Heat shock proteins of 110 kDa (Hsp110s), a unique class of molecular chaperones, are essential for maintaining protein homeostasis. Hsp110s exhibit a strong chaperone activity preventing protein aggregation (the "holdase" activity) and also function as the major nucleotide-exchange factor (NEF) for Hsp70 chaperones. Hsp110s contain two functional domains: a nucleotide-binding domain (NBD) and substrate-binding domain (SBD). ATP binding is essential for Hsp110 function and results in close contacts between the NBD and SBD. However, the molecular mechanism of this ATP-induced allosteric coupling remains poorly defined. In this study, we carried out biochemical analysis on Msi3, the sole Hsp110 in Candida albicans, to dissect the unique allosteric coupling of Hsp110s using three mutations affecting the domain-domain interface. All the mutations abolished both the in vivo and in vitro functions of Msi3. While the ATP-bound state was disrupted in all mutants, only mutation of the NBD-SBD/I interfaces showed significant ATPase activity, suggesting that the full-length Hsp110s have an ATPase that is mainly suppressed by NBD-SBD/I contacts. Moreover, the high-affinity ATP binding unexpectedly appears to require these NBD-SBD contacts. Remarkably, the "holdase" activity was largely intact for all mutants tested while NEF activity was mostly compromised, although both activities strictly depended on the ATP bound state, indicating different requirements for these two activities. Stable peptide substrate binding to Msi3 led to dissociation of the NBD-SBD contacts and compromised interactions with Hsp70. Taken together, our data demonstrate that the exceptionally strong NBD-SBD contacts in Hsp110s dictate the unique allosteric coupling and biochemical activities.	[Li, Hongtao; Hu, Liqing; Cuffee, Crist William; Mohamed, Mahetab; Zhou, Lei; Liu, Qinglian] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA; [Hu, Liqing; Li, Qianbin] Cent South Univ, Xiangya Sch Pharmaceut Sci, Dept Med Chem, Changsha, Hunan, Peoples R China; [Liu, Qingdai] Tianjin Univ Sci & Technol, Key Lab Food Nutr & Safety, Tianjin, Peoples R China	Virginia Commonwealth University; Central South University; Tianjin University Science & Technology	Liu, QL (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23284 USA.	qinglian.liu@vcuhealth.org		Hu, Liqing/0000-0003-3592-488X	NIH [R01GM098592, R21AI140006, R01GM109193]; Virginia Commonwealth University	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia Commonwealth University	This work was supported by NIH (R01GM098592 and R21AI140006 to Qinglian Liu) and VETAR award from the Virginia Commonwealth University (to Qinglian Liu). L. Z. was partially supported by R01GM109193 from NIH. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albanese V, 2006, CELL, V124, P75, DOI 10.1016/j.cell.2005.11.039; Alderson TR, 2016, STRUCTURE, V24, P1014, DOI 10.1016/j.str.2016.05.011; Andreasson C, 2008, P NATL ACAD SCI USA, V105, P16519, DOI 10.1073/pnas.0804187105; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Balchin D, 2016, SCIENCE, V353, DOI 10.1126/science.aac4354; Bertelsen EB, 2009, P NATL ACAD SCI USA, V106, P8471, DOI 10.1073/pnas.0903503106; Bracher A, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00010; BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Cho T, 2003, YEAST, V20, P149, DOI 10.1002/yea.952; Clerico EM, 2015, J MOL BIOL, V427, P1575, DOI 10.1016/j.jmb.2015.02.004; Davis JE, 1999, P NATL ACAD SCI USA, V96, P9269, DOI 10.1073/pnas.96.16.9269; Dragovic Z, 2006, EMBO J, V25, P2519, DOI 10.1038/sj.emboj.7601138; Easton DP, 2000, CELL STRESS CHAPERON, V5, P276, DOI 10.1379/1466-1268(2000)005<0276:THAGSP>2.0.CO;2; Fan Q, 2007, GENETICS, V177, P1583, DOI 10.1534/genetics.107.077982; Fernandez-Fernandez Maria Rosario, 2018, F1000Res, V7, DOI 10.12688/f1000research.15528.1; FLAHERTY KM, 1990, NATURE, V346, P623, DOI 10.1038/346623a0; FLYNN GC, 1989, SCIENCE, V245, P385, DOI 10.1126/science.2756425; Gao XC, 2015, MOL CELL, V59, P781, DOI 10.1016/j.molcel.2015.07.012; Garcia VM, 2017, MOL BIOL CELL, V28, P2066, DOI 10.1091/mbc.E17-01-0070; Goeckeler JL, 2008, FEBS LETT, V582, P2393, DOI 10.1016/j.febslet.2008.05.047; Goeckeler JL, 2002, MOL BIOL CELL, V13, P2760, DOI 10.1091/mbc.02-04-0051; Gozzi GJ, 2020, CELL DEATH DIFFER, V27, P117, DOI 10.1038/s41418-019-0343-4; GRAGEROV A, 1994, J MOL BIOL, V235, P848, DOI 10.1006/jmbi.1994.1043; Gumiero A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13563; Hatayama T, 1998, BIOCHEM BIOPH RES CO, V248, P395, DOI 10.1006/bbrc.1998.8979; Hendrickson WA, 2008, STRUCTURE, V16, P1153, DOI 10.1016/j.str.2008.07.002; Hrizo SL, 2007, J BIOL CHEM, V282, P32665, DOI 10.1074/jbc.M705216200; Kaimal JM, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00027-17; Kandasamy G, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210948; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Kryndushkin D, 2007, MOL BIOL CELL, V18, P2149, DOI 10.1091/mbc.E07-02-0128; Kumar V, 2020, FEBS J, V287, P671, DOI 10.1111/febs.15045; LEEYOON D, 1995, J BIOL CHEM, V270, P15725, DOI 10.1074/jbc.270.26.15725; Li HT, 2020, J BIOL CHEM, V295, P584, DOI 10.1074/jbc.RA119.009686; Liu QL, 2007, CELL, V131, P106, DOI 10.1016/j.cell.2007.08.039; Liu QL, 2020, PROTEIN SCI, V29, P378, DOI 10.1002/pro.3725; Liu XD, 1999, J BIOL CHEM, V274, P26654, DOI 10.1074/jbc.274.38.26654; Mandal AK, 2010, MOL BIOL CELL, V21, P1439, DOI 10.1091/mbc.E09-09-0779; Manjili MH, 2002, CANCER RES, V62, P1737; Mattoo RUH, 2013, J BIOL CHEM, V288, P21399, DOI 10.1074/jbc.M113.479253; Mayer MP, 2019, J BIOL CHEM, V294, P2085, DOI 10.1074/jbc.REV118.002810; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mayer MP, 1999, J MOL BIOL, V289, P1131, DOI 10.1006/jmbi.1999.2844; Moran C, 2013, G3-GENES GENOM GENET, V3, P1409, DOI 10.1534/g3.113.007112; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; MUKAI H, 1993, GENE, V132, P57; Muralidharan V, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2306; Nagao J, 2012, FEMS YEAST RES, V12, P728, DOI 10.1111/j.1567-1364.2012.00822.x; Nitika, 2020, J BIOL CHEM, V295, P10689, DOI 10.1074/jbc.REV120.011666; O'Driscoll J, 2015, J CELL BIOL, V211, P145, DOI 10.1083/jcb.201505104; Oh HJ, 1999, J BIOL CHEM, V274, P15712, DOI 10.1074/jbc.274.22.15712; Oh HJ, 1997, J BIOL CHEM, V272, P31636, DOI 10.1074/jbc.272.50.31636; Pobre KFR, 2019, J BIOL CHEM, V294, P2098, DOI 10.1074/jbc.REV118.002804; Polier S, 2008, CELL, V133, P1068, DOI 10.1016/j.cell.2008.05.022; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rampelt H, 2012, EMBO J, V31, P4221, DOI 10.1038/emboj.2012.264; Ravindran MS, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005086; Raviol H, 2006, FEBS LETT, V580, P168, DOI 10.1016/j.febslet.2005.11.069; Raviol H, 2006, EMBO J, V25, P2510, DOI 10.1038/sj.emboj.7601139; Rudiger S, 1997, NAT STRUCT BIOL, V4, P342, DOI 10.1038/nsb0597-342; Rudiger S, 1997, EMBO J, V16, P1501, DOI 10.1093/emboj/16.7.1501; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Schuermann JP, 2008, MOL CELL, V31, P232, DOI 10.1016/j.molcel.2008.05.006; Shaner L, 2004, J BIOL CHEM, V279, P21992, DOI 10.1074/jbc.M313739200; Shaner L, 2005, J BIOL CHEM, V280, P41262, DOI 10.1074/jbc.M503614200; Shaner L, 2007, CELL STRESS CHAPERON, V12, P1, DOI 10.1379/CSC-245R.1; Shaner L, 2006, BIOCHEMISTRY-US, V45, P15075, DOI 10.1021/bi061279k; Shorter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026319; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Swain JF, 2007, MOL CELL, V26, P27, DOI 10.1016/j.molcel.2007.02.020; Taguchi YV, 2019, P NATL ACAD SCI USA, V116, P24310, DOI 10.1073/pnas.1903268116; Torrente MP, 2013, PRION, V7, P457, DOI 10.4161/pri.27531; Wang XY, 2000, FEBS LETT, V465, P98, DOI 10.1016/S0014-5793(99)01733-0; Wang Y, 2021, CELL STRESS CHAPERON, V26, P695, DOI 10.1007/s12192-021-01213-5; Wegele H, 2003, J CHROMATOGR B, V786, P109, DOI 10.1016/S1570-0232(02)00724-9; Xu XP, 2012, J BIOL CHEM, V287, P5661, DOI 10.1074/jbc.M111.275057; Yakubu UM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100567; Yakubu UM, 2018, BIOL CHEM, V399, P1215, DOI 10.1515/hsz-2018-0209; Yam AYW, 2005, J BIOL CHEM, V280, P41252, DOI 10.1074/jbc.M503615200; Yamagishi N, 2004, J BIOL CHEM, V279, P41727, DOI 10.1074/jbc.M407947200; Yang J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01310-z; Yang J, 2015, STRUCTURE, V23, P2191, DOI 10.1016/j.str.2015.10.012; Young JC, 2010, BIOCHEM CELL BIOL, V88, P291, DOI [10.1139/o09-175, 10.1139/O09-175]; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2011, P NATL ACAD SCI USA, V108, P6987, DOI 10.1073/pnas.1014448108; Zuiderweg ERP, 2017, CELL STRESS CHAPERON, V22, P173, DOI 10.1007/s12192-017-0776-y; Zuo DM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00075	90	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101082	10.1016/j.jbc.2021.101082	http://dx.doi.org/10.1016/j.jbc.2021.101082			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34403698	gold, Green Published			2022-12-28	WOS:000706409200008
J	Spangle, JM; Ghalei, H; Corbett, AH				Spangle, Jennifer M.; Ghalei, Homa; Corbett, Anita H.			Practical advice for mentoring and supporting faculty colleagues in STEM fields: Views from mentor and mentee perspectives	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NTF2; PROTEIN	In 2020, the American Society of Biochemistry and Mo-lecular Biology (ASBMB) Women in Biochemistry and Molecular Biology Committee introduced the ASBMB Lead-ership Awards to recognize individuals with a strong commitment to advancing the careers of women in biochemistry and molecular biology along with demonstrated excellence in research, discovery, and/or service. This inno-vative award recognizes efforts to mentor and support trainees and colleagues at all levels. Such a leadership award provides the opportunity to focus briefly on the important role of mentoring within the STEM disciplines. The goal of this commentary, which brings together perspectives from a senior scientist and recent recipient of the ASBMB Mid-Career Leadership Award as well as two junior faculty, is to highlight approaches for purposeful support of colleagues, with an emphasis on going beyond formal mentoring com-mittees. The commentary primarily focuses on mentoring within the academic arena of extramural funding and publi-cation, highlighting the reality that multiple mentors with diverse expertise and perspectives are critical to support success within STEM careers.	[Spangle, Jennifer M.] Emory Univ, Sch Med, Dept Radiat Oncol, Atlanta, GA USA; [Ghalei, Homa] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Corbett, Anita H.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Corbett, AH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	acorbe2@emory.edu		Ghalei, Homa/0000-0003-0168-4654; Spangle, Jennifer/0000-0002-0181-3244; Corbett, Anita/0000-0002-0461-6895	NIH [1R21CA256456, 5R35GM138123, 5R00CA204601]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work receives financial support from NIH Grants 1R21CA256456 (to A. H. C. and J. M. S.), 5R35GM138123 (to H. G.), and 5R00CA204601 (to J. M. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed T, 2021, FASEB BIOADV, V3, P497, DOI 10.1096/fba.2020-00102; Bayliss R, 2002, EMBO J, V21, P2843, DOI 10.1093/emboj/cdf305; Casad BJ, 2021, J NEUROSCI RES, V99, P13, DOI 10.1002/jnr.24631; Chapman RN, 2018, AM BEHAV SCI, V62, P600, DOI 10.1177/0002764218768859; Clynes M, 2019, NAT REV CANCER, V19, P489, DOI 10.1038/s41568-019-0173-1; Corbett AH, 1996, J BIOL CHEM, V271, P18477, DOI 10.1074/jbc.271.31.18477; Dahlberg M.L., 2019, POLICY GLOBAL AFFAIR; Diggs-Andrews Kelly A, 2021, BMC Proc, V15, P7, DOI 10.1186/s12919-021-00212-9; Eniola-Adefeso O, 2021, SCIENCE, V373, P7, DOI 10.1126/science.abk1976; Javier D, 2021, ETHNIC DIS, V31, P469, DOI 10.18865/ed.31.3.469; Kent HM, 1999, J MOL BIOL, V289, P565, DOI 10.1006/jmbi.1999.2775; Pfund C., 2014, ENTERING MENTORING; Pfund C, 2015, CBE-LIFE SCI EDUC, V14, DOI 10.1187/cbe.14-10-0184; Quimby BB, 2001, J BIOL CHEM, V276, P38820, DOI 10.1074/jbc.M105054200; Ransdell LB, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020432; Roper RL, 2019, MICROBIOL MOL BIOL R, V83, DOI 10.1128/MMBR.00018-19; Segrin C, 2020, COUPLE FAM PSYCHOL, V9, P181, DOI 10.1037/cfp0000143; Sorkness Christine A, 2017, BMC Proc, V11, P22, DOI 10.1186/s12919-017-0083-8; Spence JP, 2018, BMC MED EDUC, V18, DOI 10.1186/s12909-018-1290-3; Spencer KC, 2018, CBE-LIFE SCI EDUC, V17, DOI 10.1187/cbe.18-03-0034; Stewart M, 2000, CELL STRUCT FUNCT, V25, P217, DOI 10.1247/csf.25.217; Strange K, 2008, AM J PHYSIOL-CELL PH, V295, pC567, DOI 10.1152/ajpcell.00208.2008; Willis LM, 2020, ACS CENTRAL SCI, V6, P2294, DOI 10.1021/acscentsci.0c01120; Wong DH, 1997, MOL CELL BIOL, V17, P3755, DOI 10.1128/MCB.17.7.3755	24	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101062	10.1016/j.jbc.2021.101062	http://dx.doi.org/10.1016/j.jbc.2021.101062			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34375642	gold, Green Published			2022-12-28	WOS:000706409400013
J	Tang, DF; Xu, JH; Li, YP; Zhao, P; Kong, XJ; Hu, HL; Liang, SP; Tang, C; Liu, ZH				Tang, Dongfang; Xu, Jiahui; Li, Yinping; Zhao, Piao; Kong, Xiangjin; Hu, Haoliang; Liang, Songping; Tang, Cheng; Liu, Zhonghua			Molecular mechanisms of centipede toxin SsTx-4 inhibition of inwardly rectifying potassium channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-ATP CHANNELS; HIGH-AFFINITY INHIBITOR; ACTIVATING MUTATIONS; RECTIFIER KIR2.1; KIR6.2; BLOCK; CHARYBDOTOXIN; TERTIAPIN; KIR4.1; FORM	Inwardly rectifying potassium channels (Kirs) are important drug targets, with antagonists for the Kir1.1, Kir4.1, and pancreatic Kir6.2/SUR1 channels being potential drug candidates for treating hypertension, depression, and diabetes, respectively. However, few peptide toxins acting on Kirs are identified and their interacting mechanisms remain largely elusive yet. Herein, we showed that the centipede toxin SsTx-4 potently inhibited the Kir1.1, Kir4.1, and Kir6.2/SUR1 channels with nanomolar to submicromolar affinities and intensively studied the molecular bases for toxin-channel interactions using patch-clamp analysis and site-directed mutations. Other Kirs including Kir2.1 to 2.4, Kir4.2, and Kir7.1 were resistant to SsTx4 treatment. Moreover, SsTx-4 inhibited the inward and outward currents of Kirs with different potencies, possibly caused by a K+ "knock-off" effect, suggesting the toxin functions as an out pore blocker physically occluding the K+-conducting pathway. This conclusion was further supported by a mutation analysis showing that M137 located in the outer vestibule of the Kir6.2/ Delta C26 channel was the key residue mediating interaction with SsTx-4. On the other hand, the molecular determinants within SsTx-4 for binding these Kir channels only partially overlapped, with K13 and F44 being the common key residues. Most importantly, K11A, P15A, and Y16A mutant toxins showed improved affinity and/or selectivity toward Kir6.2, while R12A mutant toxin had increased affinity for Kir4.1. To our knowledge, SsTx-4 is the first characterized peptide toxin with Kir4.1 inhibitory activity. This study provides useful insights for engineering a Kir6.2/SUR1 channel-specific antagonist based on the SsTx-4 template molecule and may be useful in developing new antidiabetic drugs.	[Tang, Dongfang; Xu, Jiahui; Li, Yinping; Zhao, Piao; Kong, Xiangjin; Hu, Haoliang; Liang, Songping; Tang, Cheng; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Peoples R China; [Tang, Dongfang] Hunan Univ Sci & Engn, Coll Chem & Bioengn, Yongzhou, Hunan, Peoples R China	Hunan Normal University	Tang, C; Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha, Peoples R China.	chengtang@hunnu.edu.cn; Liuzh@hunnu.edu.cn	xu, jia/GSD-6347-2022	tang, cheng/0000-0002-5848-2458	National Natural Science Foundation of China [31600669, 32071262, 31770832, 31872718]; Science and Technology Innovation Program of Hunan Province [2020RC4023]; Natural Science Foundation of Hunan Province [2018JJ3339]; Research Foundation of the Education Department of Hunan Province [18B015]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Innovation Program of Hunan Province; Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Research Foundation of the Education Department of Hunan Province	This work was supported by the National Natural Science Foundation of China (Grant Nos. 31600669, 32071262, 31770832, and 31872718), the Science and Technology Innovation Program of Hunan Province (2020RC4023), the Natural Science Foundation of Hunan Province (Grant No. 2018JJ3339), and the Research Foundation of the Education Department of Hunan Province (Grant No. 18B015). We thank Professor Shibin Yang (Institute of Biomedical Sciences, Academia Sinica, Taipei, China) for providing us with the SUR1 cDNA.	Arechiga-Figueroa IA, 2017, EUR J PHARMACOL, V815, P56, DOI 10.1016/j.ejphar.2017.10.009; Ashcroft FM, 2013, NAT REV ENDOCRINOL, V9, P660, DOI 10.1038/nrendo.2013.166; Aziz Q, 2014, HYPERTENSION, V64, P523, DOI 10.1161/HYPERTENSIONAHA.114.03116; Babenko AP, 2006, NEW ENGL J MED, V355, P456, DOI 10.1056/NEJMoa055068; Bao L, 2011, CIRC-ARRHYTHMIA ELEC, V4, P926, DOI 10.1161/CIRCEP.111.964643; Baronas VA, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00325; Bhave G, 2011, MOL PHARMACOL, V79, P42, DOI 10.1124/mol.110.066928; Bichet D, 2003, NAT REV NEUROSCI, V4, P957, DOI 10.1038/nrn1244; Bonfanti DH, 2015, CLIN BIOCHEM, V48, P476, DOI 10.1016/j.clinbiochem.2014.12.026; Clement JP, 1997, NEURON, V18, P827, DOI 10.1016/S0896-6273(00)80321-9; Cui YH, 2018, NATURE, V554, P323, DOI 10.1038/nature25752; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; DOUPNIK CA, 1995, CURR OPIN NEUROBIOL, V5, P268, DOI 10.1016/0959-4388(95)80038-7; Doupnik CA, 2017, NEUROPHARMACOLOGY, V127, P161, DOI 10.1016/j.neuropharm.2017.07.011; Du CW, 2019, TOXINS, V11, DOI 10.3390/toxins11020076; Elfert Khaled A, 2020, Am J Case Rep, V21, pe924527, DOI 10.12659/AJCR.924527; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; GOLDSTEIN SAN, 1992, BIOPHYS J, V62, P5, DOI 10.1016/S0006-3495(92)81760-5; GOLDSTEIN SAN, 1993, BIOPHYS J, V65, P1613, DOI 10.1016/S0006-3495(93)81200-1; Gribble FM, 1997, EMBO J, V16, P1145, DOI 10.1093/emboj/16.6.1145; Hattersley AT, 2005, DIABETES, V54, P2503, DOI 10.2337/diabetes.54.9.2503; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; Hibino H, 2010, PHYSIOL REV, V90, P291, DOI 10.1152/physrev.00021.2009; Hu J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067213; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Inagaki N, 1996, NEURON, V16, P1011, DOI 10.1016/S0896-6273(00)80124-5; Isomoto S, 1996, J BIOL CHEM, V271, P24321, DOI 10.1074/jbc.271.40.24321; Ji WZ, 2008, NAT GENET, V40, P592, DOI 10.1038/ng.118; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14286, DOI 10.1021/bi991205r; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; Kharade SV, 2018, MOL PHARMACOL, V94, P926, DOI 10.1124/mol.118.112359; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; Luna-Ramirez K, 2020, BIOCHEM PHARMACOL, V174, DOI 10.1016/j.bcp.2019.113782; Luo L, 2018, P NATL ACAD SCI USA, V115, P1646, DOI 10.1073/pnas.1714760115; MACKINNON R, 1990, NEURON, V5, P767, DOI 10.1016/0896-6273(90)90335-D; Moran-Zendejas R, 2020, BRIT J PHARMACOL, V177, P4548, DOI 10.1111/bph.15214; Nichols CG, 2018, J BIOL CHEM, V293, P18779, DOI 10.1074/jbc.TM118.003344; O'Hare JP, 2015, DIABETIC MED, V32, P1398, DOI 10.1111/dme.12952; Priest BT, 2017, FUTURE MED CHEM, V9, P1963, DOI 10.4155/fmc-2017-0083; Proks P, 2013, DIABETES, V62, P3909, DOI 10.2337/db13-0531; Ramu Y, 2001, BIOCHEMISTRY-US, V40, P3601, DOI 10.1021/bi002584n; Ramu Y, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50688-x; Ramu Y, 2018, J GEN PHYSIOL, V150, P969, DOI 10.1085/jgp.201812017; Remedi MS, 2009, CELL METAB, V9, P140, DOI 10.1016/j.cmet.2008.12.005; Rodriguez-Menchaca AA, 2008, P NATL ACAD SCI USA, V105, P1364, DOI 10.1073/pnas.0708153105; Rodriguez-Menchaca AA, 2016, PHARMACOL REP, V68, P383, DOI 10.1016/j.pharep.2015.10.005; Rorsman P, 2018, PHYSIOL REV, V98, P117, DOI 10.1152/physrev.00008.2017; Sansom MSP, 2002, BBA-BIOMEMBRANES, V1565, P294, DOI 10.1016/S0005-2736(02)00576-X; Swale DR, 2014, CURR OPIN PHARMACOL, V15, P7, DOI 10.1016/j.coph.2013.11.002; Taneja TK, 2009, HUM MOL GENET, V18, P2400, DOI 10.1093/hmg/ddp179; Tinker A, 2018, COMPR PHYSIOL, V8, P1463, DOI 10.1002/cphy.c170048; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Vaxillaire M, 2004, DIABETES, V53, P2719, DOI 10.2337/diabetes.53.10.2719; Xiong ZW, 2019, PHARMACOL BIOCHEM BE, V176, P57, DOI 10.1016/j.pbb.2018.11.010; Yamada M, 1997, J PHYSIOL-LONDON, V499, P715, DOI 10.1113/jphysiol.1997.sp021963; Yan FF, 2007, DIABETES, V56, P2339, DOI 10.2337/db07-0150; Yang YY, 2017, CHANNELS, V11, P636, DOI 10.1080/19336950.2017.1393131; Zhang HX, 2010, J MOL CELL CARDIOL, V48, P71, DOI 10.1016/j.yjmcc.2009.07.002; Zingman LV, 2002, P NATL ACAD SCI USA, V99, P13278, DOI 10.1073/pnas.212315199	60	4	4	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101076	10.1016/j.jbc.2021.101076	http://dx.doi.org/10.1016/j.jbc.2021.101076			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34391777	gold, Green Published			2022-12-28	WOS:000706409200007
J	Kilu, W; Merk, D; Steinhilber, D; Proschak, E; Heering, J				Kilu, Whitney; Merk, Daniel; Steinhilber, Dieter; Proschak, Ewgenij; Heering, Jan			Heterodimer formation with retinoic acid receptor RXR alpha modulates coactivator recruitment by peroxisome proliferator-activated receptor PPAR gamma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RECEPTOR; AGONIST; LIGAND; TARGET	Nuclear receptors (NRs) activate transcription of target genes in response to binding of ligands to their ligand-binding domains (LBDs). Typically, in vitro assays use either gene expression or the recruitment of coactivators to the isolated LBD of the NR of interest to measure NR activation. However, this approach ignores that NRs function as homo- as well as heterodimers and that the LBD harbors the main dimerization interface. Cofactor recruitment is thereby interconnected with oligomerization status as well as ligand occupation of the partnering LBD through allosteric cross talk. Here we present a modular set of homogeneous time-resolved FRET-based assays through which we investigated the activation of PPAR gamma in response to ligands and the formation of heterodimers with its obligatory partner RXR alpha. We introduced mutations into the RXR alpha LBD that prevent coactivator binding but do not interfere with LBD dimerization or ligand binding. This enabled us to specifically detect PPAR gamma coactivator recruitment to PPAR gamma:RXR alpha heterodimers. We found that the RXR alpha agonist SR11237 destabilized the RXR alpha homodimer but promoted formation of the PPAR gamma:RXR alpha heterodimer, while being inactive on PPAR gamma itself. Of interest, incorporation of PPAR gamma into the heterodimer resulted in a substantial gain in affinity for coactivator CBP-1, even in the absence of ligands. Consequently, SR11237 indirectly promoted coactivator binding to PPAR gamma by shifting the oligomerization preference of RXR alpha toward PPAR gamma:RXR alpha heterodimer formation. These results emphasize that investigation of ligand-dependent NR activation should take NR dimerization into account. We envision these assays as the necessary assay tool kit for investigating NRs that partner with RXR alpha.	[Kilu, Whitney; Merk, Daniel; Steinhilber, Dieter; Proschak, Ewgenij] Goethe Univ Frankfurt, Inst Pharmaceut Chem, Frankfurt, Germany; [Steinhilber, Dieter; Proschak, Ewgenij; Heering, Jan] Fraunhofer Inst Translat Med & Pharmacol ITMP, Assay Dev & Screening, Frankfurt, Germany	Goethe University Frankfurt	Heering, J (corresponding author), Fraunhofer Inst Translat Med & Pharmacol ITMP, Assay Dev & Screening, Frankfurt, Germany.	Jan.Heering@itmp.fraunhofer.de		Heering, Jan/0000-0002-4922-1993	Deutsche Forschungsgemeinschaft (DFG) [PR1405/4-2, SFB1039]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	E. P. thanks the Deutsche Forschungsgemeinschaft (DFG; Heisenberg-Professur PR1405/4-2 and SFB1039 A07 and A02) for financial support.	Amoutzias GD, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-34; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Cesario RM, 2001, MOL ENDOCRINOL, V15, P1360, DOI 10.1210/me.15.8.1360; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SS, 2014, BMB REP, V47, P599, DOI 10.5483/BMBRep.2014.47.11.174; Choo J, 2015, J BIOL CHEM, V290, P25609, DOI 10.1074/jbc.M115.673046; Dawson MI, 2012, BBA-MOL CELL BIOL L, V1821, P21, DOI 10.1016/j.bbalip.2011.09.014; Dubuquoy L, 2006, GUT, V55, P1341, DOI 10.1136/gut.2006.093484; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Fadel L, 2020, J BIOL CHEM, V295, P10045, DOI 10.1074/jbc.RA119.011614; Fairhead Michael, 2015, Methods Mol Biol, V1266, P171, DOI 10.1007/978-1-4939-2272-7_12; Gellrich L, 2020, J MED CHEM, V63, P6727, DOI 10.1021/acs.jmedchem.9b02150; Heering J, 2019, METHODS MOL BIOL, V1966, P175, DOI 10.1007/978-1-4939-9195-2_14; Heitel P, 2019, ACS MED CHEM LETT, V10, P203, DOI 10.1021/acsmedchemlett.8b00551; Hirai H, 2010, INT J DEV BIOL, V54, P1589, DOI 10.1387/ijdb.103194hh; Lala DS, 1996, NATURE, V383, P450, DOI 10.1038/383450a0; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Leibowitz MD, 2006, ENDOCRINOLOGY, V147, P1044, DOI 10.1210/en.2005-0690; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Pedelacq JD, 2006, NAT BIOTECHNOL, V24, P79, DOI 10.1038/nbt1172; Perlmann T, 1996, MOL ENDOCRINOL, V10, P958, DOI 10.1210/me.10.8.958; Rastinejad F, 2015, TRENDS BIOCHEM SCI, V40, P16, DOI 10.1016/j.tibs.2014.10.011; Schulman IG, 1998, MOL CELL BIOL, V18, P3483, DOI 10.1128/MCB.18.6.3483; Shulman AI, 2004, CELL, V116, P417, DOI 10.1016/S0092-8674(04)00119-9; Uchimura K, 2001, HEPATOLOGY, V33, P91, DOI 10.1053/jhep.2001.21145; Wang N, 2018, J BIOL CHEM, V293, P18180, DOI 10.1074/jbc.RA118.004652; Willems S, 2020, COMMUN CHEM, V3, DOI 10.1038/s42004-020-0331-0; Wu YF, 2003, J BIOL CHEM, V278, P8637, DOI 10.1074/jbc.M210910200; Zhang HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028253	29	7	7	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100814	10.1016/j.jbc.2021.100814	http://dx.doi.org/10.1016/j.jbc.2021.100814			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34081964	Green Published, gold			2022-12-28	WOS:000678068400017
J	Cao, X; Zhou, ZJ; Tian, Y; Liu, ZZ; Cheng, KO; Chen, XB; Hu, WB; Wong, YM; Li, XF; Zhang, HL; Hu, RG; Huang, PB				Cao, Xu; Zhou, Zijing; Tian, Ye; Liu, Zhengzhao; Cheng, Kar On; Chen, Xibing; Hu, Wenbao; Wong, Yuk Ming; Li, Xiaofen; Zhang, Hailin; Hu, Ronggui; Huang, Pingbo			Opposing roles of E3 ligases TRIM23 and TRIM21 in regulation of ion channel ANO1 protein levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-ACTIVATED CL-CHANNEL; DEPENDENT CYTOKINE EXPRESSION; ANOCTAMIN 1 TMEM16A; NONREDUNDANT ROLE; GENE DISRUPTION; POOR-PROGNOSIS; CANCER CELLS; GROWTH; CONTRIBUTES; BREAST	Anoctamin-1 (ANO1) (TMEM16A) is a calcium-activated chloride channel that plays critical roles in diverse physiological processes, such as sensory transduction and epithelial secretion. ANO1 levels have been shown to be altered under physiological and pathological conditions, although the molecular mechanisms that control ANO1 protein levels remain unclear. The ubiquitin-proteasome system is known to regulate the levels of numerous ion channels, but little information is available regarding whether and how ubiquitination regulates levels of ANO1. Here, we showed that two E3 ligases, TRIM23 and TRIM21, physically interact with the C terminus of ANO1. In vitro and in vivo assays demonstrated that whereas TRIM23 ubiquitinated ANO1 leading to its stabilization, TRIM21 ubiquitinated ANO1 and induced its degradation. Notably, ANO1 regulation by TRIM23 and TRIM21 is involved in chemical-induced pain sensation, salivary secretion, and heart-rate control in mice, and TRIM23 also mediates ANO1 upregulation induced by epidermal growth factor treatment. Our results suggest that these two antagonistic E3 ligases act together to control ANO1 expression and function. Our findings reveal a previously unrecognized mechanism for regulating ANO1 protein levels and identify a potential molecular link between ANO1 regulation, epidermal growth factor, and other signaling pathways.	[Cao, Xu; Zhou, Zijing; Tian, Ye; Liu, Zhengzhao; Cheng, Kar On; Chen, Xibing; Hu, Wenbao; Wong, Yuk Ming; Li, Xiaofen; Huang, Pingbo] Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China; [Liu, Zhengzhao; Hu, Ronggui] Chinese Acad Sci, Ctr Excellence Mol Cell Sci, Shanghai Inst Biochem & Cell Biol, State Key Lab Mol Biol, Shanghai, Peoples R China; [Liu, Zhengzhao] Cent South Univ, Xiangya Hosp, Changsha, Peoples R China; [Zhang, Hailin] Hebei Med Univ, Dept Pharmacol, Shijiazhuang, Hebei, Peoples R China; [Hu, Ronggui] Tongji Univ, Shanghai Peoples Hosp 10, Canc Ctr, Sch Med, Shanghai, Peoples R China; [Hu, Ronggui] Univ Chinese Acad Sci, Sch Life Sci, Hangzhou Inst Adv Study, Hangzhou, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, HKUST Shenzhen Res Inst, Hong Kong, Peoples R China; [Huang, Pingbo] Hong Kong Univ Sci & Technol, Hong Kong Branch, Guangdong Southern Marine Sci & Engn Lab Guangzho, Hong Kong, Peoples R China	Hong Kong University of Science & Technology; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Central South University; Hebei Medical University; Tongji University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology; Hong Kong University of Science & Technology	Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Div Life Sci, Hong Kong, Peoples R China.; Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem & Biol Engn, Hong Kong, Peoples R China.; Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, State Key Lab Mol Neurosci, Hong Kong, Peoples R China.; Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, HKUST Shenzhen Res Inst, Hong Kong, Peoples R China.; Huang, PB (corresponding author), Hong Kong Univ Sci & Technol, Hong Kong Branch, Guangdong Southern Marine Sci & Engn Lab Guangzho, Hong Kong, Peoples R China.	bohuangp@ust.hk	Liu, Zheng-Zhao/ADR-0038-2022	Li, Xiaofen/0000-0002-2079-9038; Huang, Pingbo/0000-0002-4560-8760; Liu, Zheng-Zhao/0000-0003-0659-2775	Hong Kong RGC [GRF16102415, GRF16111616, GRF16102417, GRF16100218]; NSFC-RGC Joint Research Scheme [N_HKUST614/18]; Shenzhen Basic Research Scheme [JCYJ20170818114328332]; Innovation and Technology Commission [ITCPD/17-9];  [SMSEGL20SC01-K]	Hong Kong RGC(Hong Kong Research Grants Council); NSFC-RGC Joint Research Scheme(National Natural Science Foundation of China (NSFC)); Shenzhen Basic Research Scheme; Innovation and Technology Commission; 	This work was supported by Hong Kong RGC GRF16102415, GRF16111616, GRF16102417, and GRF16100218, NSFC-RGC Joint Research Scheme N_HKUST614/18, Shenzhen Basic Research Scheme (JCYJ20170818114328332), and SMSEGL20SC01-K (all to P. H.). This work was supported in part by the Innovation and Technology Commission (ITCPD/17-9)	Arimoto K, 2010, P NATL ACAD SCI USA, V107, P15856, DOI 10.1073/pnas.1004621107; Bill A, 2015, ONCOTARGET, V6, P9173, DOI 10.18632/oncotarget.3277; Britschgi A, 2013, P NATL ACAD SCI USA, V110, pE1026, DOI 10.1073/pnas.1217072110; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Catalan MA, 2015, P NATL ACAD SCI USA, V112, P2263, DOI 10.1073/pnas.1415739112; Cha JY, 2015, P NATL ACAD SCI USA, V112, P9722, DOI 10.1073/pnas.1423827112; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Cheng YF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00891-z; D'Souza A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4775; Dang SY, 2017, NATURE, V552, P426, DOI 10.1038/nature25024; Dickson C, 2018, ELIFE, V7, DOI 10.7554/eLife.32660; Duan DD, 2013, COMPR PHYSIOL, V3, P667, DOI 10.1002/cphy.c110014; Duan YY, 2012, J BIOL CHEM, V287, P40547, DOI 10.1074/jbc.M112.403584; Duran C, 2011, ACTA PHARMACOL SIN, V32, P685, DOI 10.1038/aps.2011.48; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Espinosa A, 2009, J EXP MED, V206, P1661, DOI 10.1084/jem.20090585; Gautam D, 2004, MOL PHARMACOL, V66, P260, DOI 10.1124/mol.66.2.260; Gonzalez EA, 2002, KIDNEY INT, V61, P1627, DOI 10.1046/j.1523-1755.2002.00327.x; Gonzalez L, 2010, J ENDOCRINOL, V204, P299, DOI 10.1677/JOE-09-0372; Hirano A, 2013, CELL, V152, P1106, DOI 10.1016/j.cell.2013.01.054; Hu WB, 2017, ELIFE, V6, DOI 10.7554/eLife.28021; Itou J, 2018, J BIOL CHEM, V293, P6556, DOI 10.1074/jbc.RA117.000245; Jin X., 2010, J BIOL CHEM, V285, P30539; Laurent-Rolle M, 2014, CELL HOST MICROBE, V16, P314, DOI 10.1016/j.chom.2014.07.015; Lazzari E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103609; Lee B, 2014, MOL PAIN, V10, DOI 10.1186/1744-8069-10-5; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Liu W, 2012, CANCER LETT, V326, P41, DOI 10.1016/j.canlet.2012.07.015; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Meza-Carmen V, 2011, P NATL ACAD SCI USA, V108, P10454, DOI 10.1073/pnas.1103867108; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Mroz MS, 2012, J PHYSIOL-LONDON, V590, P1907, DOI 10.1113/jphysiol.2011.226126; Nakamura T, 2004, J PHYSIOL-LONDON, V558, P561, DOI 10.1113/jphysiol.2004.064626; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Ozato K, 2009, J IMMUNOL, V183, P7619, DOI 10.4049/jimmunol.0990103; Pan JA, 2016, MOL CELL, V62, P149, DOI 10.1016/j.molcel.2016.03.015; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Perez-Cornejo P, 2012, P NATL ACAD SCI USA, V109, P10376, DOI 10.1073/pnas.1200174109; Qu ZQ, 2014, CANCER MED-US, V3, P453, DOI 10.1002/cam4.232; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Rotin D., 2011, ARCH EUR J PHYSIOL, V461, P1; SCUDIERI P, 2012, DOWN REGULATION TMEM, V590, P6141, DOI DOI 10.1113/JPHYSIOL.2012.240838; Sjostrand M, 2013, J IMMUNOL, V191, P3753, DOI 10.4049/jimmunol.1202341; Sun Y, 2012, J CELL SCI, V125, P4507, DOI 10.1242/jcs.105023; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Valach J, 2012, INT J CANCER, V131, P2499, DOI 10.1002/ijc.27550; Vichi A., 2005, P NATL ACAD SCI USA, V102, P1945; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wang H, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0720-x; Wang M, 2012, CIRCULATION, V125, P697, DOI 10.1161/CIRCULATIONAHA.111.041806; Watanabe M, 2015, ELIFE, V4, DOI 10.7554/eLife.05615; Wei Z, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06812-y; Xu SH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0525-x; Xue BB, 2018, J VIROL, V92, DOI 10.1128/JVI.00321-18; Yang LT, 2018, J INVEST DERMATOL, V138, P2568, DOI 10.1016/j.jid.2018.05.016; Yao YY, 2018, PATHOL RES PRACT, V214, P2062, DOI 10.1016/j.prp.2018.10.010; Ye Z, 2015, J CELL PHYSIOL, V230, P337, DOI 10.1002/jcp.24709; Yoo SH, 2013, CELL, V152, P1091, DOI 10.1016/j.cell.2013.01.055; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Yu XJ, 2020, P NATL ACAD SCI USA, V117, P29894, DOI 10.1073/pnas.2011147117; Zeng SY, 2017, PROTEIN CELL, V8, P202, DOI 10.1007/s13238-016-0324-z; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhou WB, 2018, CANCER MANAG RES, V10, P3687, DOI 10.2147/CMAR.S175470	64	1	1	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100738	10.1016/j.jbc.2021.100738	http://dx.doi.org/10.1016/j.jbc.2021.100738			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957127	Green Published, gold			2022-12-28	WOS:000672866400707
J	Gierasch, LM; Berman, HM				Gierasch, Lila M.; Berman, Helen M.			How the Protein Data Bank changed biology: An introduction to the JBC Reviews thematic series, part 2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							STRUCTURAL BIOLOGY	In part 1 of this remarkable collection, we told you the story of The Protein Data Bank (PDB) (1), which was founded 50 years ago, and we illustrated the breadth of the science contained within it with ten informative review articles. The second half of this collection is a continuation of our celebrations to mark this momentous anniversary. Part 2 provides eight more superb articles describing how the PDB has influenced biology over the course of the last half-century and how biology has fueled the deposition of impactful structures in the PDB. Here are some brief synopses of the articles you will enjoy in part 2!	[Gierasch, Lila M.] Univ Massachusetts, Dept Biochem Mol Biol & Chem, Amherst, MA 01003 USA; [Berman, Helen M.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Berman, Helen M.] Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA; [Berman, Helen M.] Univ Southern Calif, Bridge Inst, Los Angeles, CA 90007 USA	University of Massachusetts System; University of Massachusetts Amherst; Rutgers State University New Brunswick; University of Southern California; University of Southern California	Gierasch, LM (corresponding author), Univ Massachusetts, Dept Biochem Mol Biol & Chem, Amherst, MA 01003 USA.; Berman, HM (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.; Berman, HM (corresponding author), Univ Southern Calif, Dept Biol Sci, Los Angeles, CA 90007 USA.; Berman, HM (corresponding author), Univ Southern Calif, Bridge Inst, Los Angeles, CA 90007 USA.	berman@rcsb.rutgers.edu; gierasch@biochem.umass.edu		Gierasch, Lila/0000-0002-5706-115X				Berman HM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100608; Michalska K, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100747; Miller MD, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100749; Richardson JS, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100742; Saibil HR, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100744; Sali A, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100743; Taylor SS, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100746; Wilson IA, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100745; Wolberger C, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100741	9	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100748	10.1016/j.jbc.2021.100748	http://dx.doi.org/10.1016/j.jbc.2021.100748			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957128	Green Published, gold			2022-12-28	WOS:000672866400717
J	Kato, T; Tsukamoto, T; Demura, M; Kikukawa, T				Kato, Tomoya; Tsukamoto, Takashi; Demura, Makoto; Kikukawa, Takashi			Real-time identification of two substrate-binding intermediates for the light-driven sodium pump rhodopsin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAMAN-SPECTROSCOPY; NA+ BINDING; HALORHODOPSIN; TEMPERATURE; PHOTOCYCLE	Membrane transport proteins undergo critical conformational changes during substrate uptake and release, as the substrate-binding site is believed to switch its accessibility from one side of the membrane to the other. Thus, at least two substrate-binding intermediates should appear during the process, that is, after uptake and before the release of the substrate. However, this view has not been verified for most transporters because of the difficulty in detecting short-lived intermediates. Here, we report real-time identification of these intermediates for the light-driven outward current-generating Na+-pump rhodopsin. We triggered the transport cycle of Na+-pump rhodopsin using a short laser pulse, and subsequent formation and decay of various intermediates was detected by time-resolved measurements of absorption changes. We used this method to analyze transport reactions and elucidated the sequential formation of the Na+-binding intermediates O1 and O2. Both intermediates exhibited redshifted absorption spectra and generated transient equilibria with short-wavelength intermediates. The equilibria commonly shifted toward O1 and O2 with increasing Na+ concentration, indicating that Na+ is bound to these intermediates. However, these equilibria were formed independently; O1 reached equilibrium with preceding intermediates, indicating Na+ uptake on the cytoplasmic side. In contrast, O2 reached equilibrium with subsequent intermediates, indicating Na+ release on the extracellular side. Thus, there is an irreversible switch in "accessibility" during the O1 to O2 transition, which could represent one of the key processes governing unidirectional Na+ transport.	[Kato, Tomoya] Hokkaido Univ, Global Inst Collaborat Res & Educ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Tsukamoto, Takashi; Demura, Makoto; Kikukawa, Takashi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan; [Tsukamoto, Takashi; Demura, Makoto; Kikukawa, Takashi] Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University	Kikukawa, T (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan.; Kikukawa, T (corresponding author), Hokkaido Univ, Global Inst Collaborat Res & Educ, Global Stn Soft Matter, Sapporo, Hokkaido, Japan.	kikukawa@sci.hokudai.ac.jp	Tsukamoto, Takashi/F-3993-2017; Kikukawa, Takashi/F-5266-2011; Demura, Makoto/F-5272-2011	Tsukamoto, Takashi/0000-0002-6348-6664; Kikukawa, Takashi/0000-0002-6185-7281; Demura, Makoto/0000-0003-0912-9284	Japan Society for the Promotion of Science KAKENHI [17K07326]; Global Station for Soft Matter, a project of the Global Institution for Collaborative Research and Education at Hokkaido University	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Global Station for Soft Matter, a project of the Global Institution for Collaborative Research and Education at Hokkaido University	This work was supported by the Japan Society for the Promotion of Science KAKENHI grant to Takashi Kikukawa (17K07326) and the Global Station for Soft Matter, a project of the Global Institution for Collaborative Research and Education at Hokkaido University.	Asido M, 2019, PHYS CHEM CHEM PHYS, V21, P4461, DOI 10.1039/c8cp07418f; Balashov SP, 2014, BIOCHEMISTRY-US, V53, P7549, DOI 10.1021/bi501064n; Bayburt TH, 2002, NANO LETT, V2, P853, DOI 10.1021/nl025623k; Chen HF, 2018, PHYS CHEM CHEM PHYS, V20, P17694, DOI 10.1039/c8cp02599a; Chizhov I, 1996, BIOPHYS J, V71, P2329, DOI 10.1016/S0006-3495(96)79475-4; Chizhov I, 2001, BIOPHYS J, V81, P1600, DOI 10.1016/S0006-3495(01)75814-6; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Gushchin I, 2015, NAT STRUCT MOL BIOL, V22, P390, DOI 10.1038/nsmb.3002; Hasemi T, 2019, BBA-BIOENERGETICS, V1860, P136, DOI 10.1016/j.bbabio.2018.12.001; Hasemi T, 2016, J BIOL CHEM, V291, P355, DOI 10.1074/jbc.M115.688614; Hontani Y, 2016, PHYS CHEM CHEM PHYS, V18, P24729, DOI 10.1039/c6cp05240a; Iizuka A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47178-5; Inoue K, 2015, ANGEW CHEM INT EDIT, V54, P11536, DOI 10.1002/anie.201504549; Inoue K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2689; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jung K. H., 2012, 244 ACS NAT M EXP 244 ACS NAT M EXP; Kajimoto K, 2017, J PHYS CHEM B, V121, P4431, DOI 10.1021/acs.jpcb.7b02421; Kandori Hideki, 2020, Biophys Rev, V12, P355, DOI 10.1007/s12551-020-00645-0; Kandori H, 2018, CHEM REV, V118, P10646, DOI 10.1021/acs.chemrev.7b00548; Kato HE, 2015, NATURE, V521, P48, DOI 10.1038/nature14322; Kikukawa T, 2015, BBA-BIOENERGETICS, V1847, P748, DOI 10.1016/j.bbabio.2015.05.002; Kovalev K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16032-y; Kovalev K, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aav2671; Moradi M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9393; Murabe K, 2020, J AM CHEM SOC, V142, P16023, DOI 10.1021/jacs.0c07264; Nakamizo Y, 2021, PHYS CHEM CHEM PHYS, V23, P2072, DOI 10.1039/d0cp05652a; Nakamura S, 2016, BBA-BIOENERGETICS, V1857, P1900, DOI 10.1016/j.bbabio.2016.09.006; Nishimura N, 2019, J PHYS CHEM B, V123, P3430, DOI 10.1021/acs.jpcb.9b00928; Otomo A, 2020, BIOCHEMISTRY-US, V59, P520, DOI 10.1021/acs.biochem.9b01062; Sauer DB, 2020, ELIFE, V9, DOI 10.7554/eLife.61350; Shibasaki K, 2013, BIOCHEMISTRY-US, V52, P9257, DOI 10.1021/bi401295e; Shigeta A, 2018, PHYS CHEM CHEM PHYS, V20, P8450, DOI 10.1039/c8cp00626a; Skopintsev P, 2020, NATURE, V583, P314, DOI 10.1038/s41586-020-2307-8	34	2	2	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100792	10.1016/j.jbc.2021.100792	http://dx.doi.org/10.1016/j.jbc.2021.100792			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019877	gold, Green Published			2022-12-28	WOS:000674717300012
J	Michalska, K; Joachimiak, A				Michalska, Karolina; Joachimiak, Andrzej			Structural genomics and the Protein Data Bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BIOLOGY KNOWLEDGEBASE; TARGET SELECTION; DRUG DISCOVERY; DIFFRACTION; VALIDATION; AI	The field of Structural Genomics arose over the last 3 decades to address a large and rapidly growing divergence between microbial genomic, functional, and structural data. Several international programs took advantage of the vast genomic sequence information and evaluated the feasibility of structure determination for expanded and newly discovered protein families. As a consequence, structural genomics has developed structure-determination pipelines and applied them to a wide range of novel, uncharacterized proteins, often from "microbial dark matter," and later to proteins from human pathogens. Advances were especially needed in protein production and rapid de novo structure solution. The experimental three-dimensional models were promptly made public, facilitating structure determination of other members of the family and helping to understand their molecular and biochemical functions. Improvements in experimental methods and databases resulted in fast progress in molecular and structural biology. The Protein Data Bank structure repository played a central role in the coordination of structural genomics efforts and the structural biology community as a whole. It facilitated development of standards and validation tools essential for maintaining high quality of deposited structural data.	[Michalska, Karolina; Joachimiak, Andrzej] Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA; [Michalska, Karolina; Joachimiak, Andrzej] Argonne Natl Lab, Xray Sci Div, Struct Biol Ctr, Lemont, IL 60439 USA; [Joachimiak, Andrzej] Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA	University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago	Joachimiak, A (corresponding author), Univ Chicago, Ctr Struct Genom Infect Dis, Chicago, IL 60637 USA.; Joachimiak, A (corresponding author), Argonne Natl Lab, Xray Sci Div, Struct Biol Ctr, Lemont, IL 60439 USA.; Joachimiak, A (corresponding author), Univ Chicago, Dept Biochem & Mol Biol, 920 E 58Th St, Chicago, IL 60637 USA.	andrzejj@anl.gov		Joachimiak, Andrzej/0000-0003-2535-6209				Adams PD, 2016, STRUCTURE, V24, P502, DOI 10.1016/j.str.2016.02.017; Almo Steven C., 2007, Journal of Structural and Functional Genomics, V8, P121, DOI 10.1007/s10969-007-9036-1; Anderson W. F., 2009, Infectious Disorders - Drug Targets, V9, P507; Arkin AP, 2018, NAT BIOTECHNOL, V36, P566, DOI 10.1038/nbt.4163; Batot G, 2017, NUCLEIC ACIDS RES, V45, P5013, DOI 10.1093/nar/gkx230; Berman HM, 2020, IUCRJ, V7, P630, DOI 10.1107/S205225252000562X; Berman Helen M, 2004, Am J Pharmacogenomics, V4, P247, DOI 10.2165/00129785-200404040-00004; Berman HM, 2013, STRUCTURE, V21, P1485, DOI 10.1016/j.str.2013.07.010; Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790; Berman HM, 2000, NAT STRUCT BIOL, V7, P957, DOI 10.1038/80734; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bluhm WF, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar003; Brzezinski D, 2021, PROTEIN SCI, V30, P115, DOI 10.1002/pro.3959; Burley SK, 2008, STRUCTURE, V16, P5, DOI 10.1016/j.str.2007.12.002; Burley SK, 2017, STRUCTURE, V25, P1317, DOI 10.1016/j.str.2017.08.001; Burley SK, 2017, METHODS MOL BIOL, V1606, P627, DOI 10.1007/978-1-4939-7000-1_26; Callaway E, 2020, NATURE, V588, P203, DOI 10.1038/d41586-020-03348-4; Chance MR, 2002, PROTEIN SCI, V11, P723, DOI 10.1110/ps.4570102; Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300; Chen VB, 2015, J BIOMOL NMR, V63, P77, DOI 10.1007/s10858-015-9969-9; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Gabanyi Margaret J., 2011, Journal of Structural and Functional Genomics, V12, P45, DOI 10.1007/s10969-011-9106-2; Gifford Lida K., 2012, Journal of Structural and Functional Genomics, V13, P57, DOI 10.1007/s10969-012-9133-7; Gore S, 2017, STRUCTURE, V25, P1916, DOI 10.1016/j.str.2017.10.009; Grabowski M, 2019, STRUCT DYN-US, V6, DOI 10.1063/1.5128672; Grabowski M, 2016, ACTA CRYSTALLOGR D, V72, P1181, DOI 10.1107/S2059798316014716; Grabowski Marek, 2016, Journal of Structural and Functional Genomics, V17, P1, DOI 10.1007/s10969-016-9201-5; Grabowski Marek, 2009, Infectious Disorders - Drug Targets, V9, P459, DOI 10.2174/187152609789105704; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Kim Y, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01735-9; Kim Y, 2020, PROTEIN SCI, V29, P1596, DOI 10.1002/pro.3873; Kim Y, 2011, METHODS, V55, P12, DOI 10.1016/j.ymeth.2011.07.010; Koga N, 2012, NATURE, V491, P222, DOI 10.1038/nature11600; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Kryshtafovych A, 2019, PROTEINS, V87, P1011, DOI 10.1002/prot.25823; Lawson CL, 2010, METHOD ENZYMOL, V483, P73, DOI 10.1016/S0076-6879(10)83004-6; Lee D, 2011, BMC STRUCT BIOL, V11, DOI 10.1186/1472-6807-11-2; Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104; Levitt M, 2009, P NATL ACAD SCI USA, V106, P11079, DOI 10.1073/pnas.0905029106; Ludtke SJ, 2011, BIOCOMPUT-PAC SYM, P369; Makowska-Grzyska M, 2014, METHODS MOL BIOL, V1140, P89, DOI 10.1007/978-1-4939-0354-2_7; Mariano G, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.605236; Marsden RL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-86; Marsden Russell L., 2008, V426, P3, DOI 10.1007/978-1-60327-058-8_1; Michalska K, 2020, IUCRJ, V7, P814, DOI 10.1107/S2052252520009653; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Mizianty MJ, 2014, ACTA CRYSTALLOGR D, V70, P2781, DOI 10.1107/S1399004714019427; Osipiuk J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21060-3; Osipiuk Jerzy, 2011, Journal of Structural and Functional Genomics, V12, P21, DOI 10.1007/s10969-011-9107-1; Pearl FMG, 2001, NUCLEIC ACIDS RES, V29, P223, DOI 10.1093/nar/29.1.223; Ponsard R, 2020, J SYNCHROTRON RADIAT, V27, P1297, DOI 10.1107/S1600577520008140; Seiler CY, 2014, NUCLEIC ACIDS RES, V42, pD1253, DOI 10.1093/nar/gkt1060; Service RF, 2020, SCIENCE, V370, P1144, DOI 10.1126/science.370.6521.1144; Sillitoe I, 2021, NUCLEIC ACIDS RES, V49, pD266, DOI 10.1093/nar/gkaa1079; Stevens RC, 2001, SCIENCE, V294, P89, DOI 10.1126/science.1066011; Studer G, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008667; Tan KM, 2002, J CELL BIOL, V159, P373, DOI 10.1083/jcb.200206062; TEPPER J, 1976, CANCER, V37, P1519, DOI 10.1002/1097-0142(197603)37:3<1519::AID-CNCR2820370340>3.0.CO;2-O; Varga J, 2017, NUCLEIC ACIDS RES, V45, pD325, DOI 10.1093/nar/gkw939; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang N, 2018, NAT CHEM BIOL, V14, P730, DOI 10.1038/s41589-018-0061-0; Westbrook J, 2003, NUCLEIC ACIDS RES, V31, P489, DOI 10.1093/nar/gkg068; Wooley J, 2010, ACTA CRYSTALLOGR F, V66; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Yeats C, 2014, METHODS MOL BIOL, V1140, P35, DOI 10.1007/978-1-4939-0354-2_3; Zaucha J, 2020, CHEM COMMUN, V56, P15454, DOI 10.1039/d0cc04383d; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671	69	5	5	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100747	10.1016/j.jbc.2021.100747	http://dx.doi.org/10.1016/j.jbc.2021.100747			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957120	Green Published, gold			2022-12-28	WOS:000672866400716
J	Munoz, SM; Castro-Fernandez, V; Guixe, V				Munoz, Sebastian M.; Castro-Fernandez, Victor; Guixe, Victoria			Structure of an ancestral ADP-dependent kinase with fructose-6P reveals key residues for binding, catalysis, and ligand-induced conformational changes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; PYROCOCCUS-HORIKOSHII; GLUCOKINASE; SPECIFICITY; EVOLUTION; FAMILY; ENZYME	ADP-dependent kinases were first described in archaea, although their presence has also been reported in bacteria and eukaryotes (human and mouse). This enzyme family comprises three substrate specificities; specific phosphofructokinases (ADP-PFKs), specific glucokinases (ADP-GKs), and bifunctional enzymes (ADP-PFK/GK). Although many structures are available for members of this family, none exhibits fructose-6-phosphate (F6P) at the active site. Using an ancestral enzyme, we obtain the first structure of an ADP-dependent kinase (AncMsPFK) with F6P at its active site. Key residues for sugar binding and catalysis were identified by alanine scanning, D36 being a critical residue for F6P binding and catalysis. However, this residue hinders glucose binding because its mutation to alanine converts the AncMsPFK enzyme into a specific ADPGK. Residue K179 is critical for F6P binding, while residues N181 and R212 are also important for this sugar binding, but to a lesser extent. This structure also provides evidence for the requirement of both substrates (sugar and nucleotide) to accomplish the conformational change leading to a closed conformation. This suggests that AncMsPFK mainly populates two states (open and closed) during the catalytic cycle, as reported for specific ADP-PFK. This situation differs from that described for specific ADP-GK enzymes, where each substrate independently causes a sequential domain closure, resulting in three conformational states (open, semiclosed, and closed).	[Munoz, Sebastian M.; Castro-Fernandez, Victor; Guixe, Victoria] Univ Chile, Fac Ciencias, Dept Biol, Lab Bioquim & Biol Mol, Santiago, Chile	Universidad de Chile	Castro-Fernandez, V; Guixe, V (corresponding author), Univ Chile, Fac Ciencias, Dept Biol, Lab Bioquim & Biol Mol, Santiago, Chile.	vcasfe@uchile.cl; vguixe@uchile.cl	Castro-Fernandez, Victor/K-9621-2018; Guixe, Victoria/I-1126-2013	Castro-Fernandez, Victor/0000-0002-4309-6415; Guixe, Victoria/0000-0001-9643-1339; Munoz, Sebastian M./0000-0002-3077-9794	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1191321]; Vicerrectoria de Investigacion y Desarrollo (VID-Universidad de Chile) [UI2018-23]; Fondequip [EQM 120208];  [REDI170497]	Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Vicerrectoria de Investigacion y Desarrollo (VID-Universidad de Chile); Fondequip; 	This work was supported by Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT Grant 1191321), REDI170497, and Vicerrectoria de Investigacion y Desarrollo (VID-Universidad de Chile Grant UI2018-23). The high-throughput ARI crystallization robot was funded by Fondequip EQM 120208.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Rivas-Pardo JA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066687; Carlson JC, 2014, NAT CHEM BIOL, V10, P216, DOI [10.1038/NCHEMBIO.1453, 10.1038/nchembio.1453]; Castro-Fernandez V, 2017, J BIOL CHEM, V292, P21218, DOI 10.1074/jbc.AAC117.001147; Castro-Fernandez V, 2014, FEBS J, V281, P2017, DOI 10.1111/febs.12757; Currie MA, 2009, J BIOL CHEM, V284, P22664, DOI 10.1074/jbc.M109.012401; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Girdlestone C, 2016, J COMPUT BIOL, V23, P21, DOI 10.1089/cmb.2015.0143; Gonzalez-Ordenes F, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01305; Grudnik P, 2018, J BIOL CHEM, V293, P11088, DOI 10.1074/jbc.RA117.001562; Guixe V, 2009, IUBMB LIFE, V61, P753, DOI 10.1002/iub.217; Gumulya Y, 2017, BIOCHEM J, V474, P1, DOI 10.1042/BCJ20160507; Holm L, 2019, BIOINFORMATICS, V35, P5326, DOI 10.1093/bioinformatics/btz536; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Ito S, 2003, J MOL BIOL, V331, P871, DOI 10.1016/S0022-2836(03)00792-7; Ito S, 2001, STRUCTURE, V9, P205, DOI 10.1016/S0969-2126(01)00577-9; Abarca-Lagunas MJ, 2015, FEBS LETT, V589, P3271, DOI 10.1016/j.febslet.2015.09.013; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KENGEN SWM, 1994, J BIOL CHEM, V269, P17537; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Merino F, 2008, FEBS J, V275, P4033, DOI 10.1111/j.1742-4658.2008.06544.x; Richter JP, 2016, J BIOL CHEM, V291, P3694, DOI 10.1074/jbc.M115.679902; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tokarz P, 2018, PROTEIN SCI, V27, P790, DOI 10.1002/pro.3377; Tsuge H, 2002, PROTEIN SCI, V11, P2456, DOI 10.1110/ps.0215602; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Wu MY, 2020, CURR OPIN STRUC BIOL, V64, P9, DOI 10.1016/j.sbi.2020.05.007; Zamora RA, 2017, ARCH BIOCHEM BIOPHYS, V633, P85, DOI 10.1016/j.abb.2017.09.008	32	1	1	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100219	10.1074/jbc.RA120.015376	http://dx.doi.org/10.1074/jbc.RA120.015376			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839685	Green Published, gold			2022-12-28	WOS:000672866400197
J	Schapansky, J; Grinberg, YY; Osiecki, DM; Freeman, EA; Walker, SG; Karran, E; Gopalakrishnan, SM; Talanian, RV				Schapansky, Jason; Grinberg, Yelena Y.; Osiecki, David M.; Freeman, Emily A.; Walker, Stephen G.; Karran, Eric; Gopalakrishnan, Sujatha M.; Talanian, Robert, V			MEK1/2 activity modulates TREM2 cell surface recruitment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NASU-HAKOLA-DISEASE; MOUSE MODEL; MICROGLIA; RECEPTOR; DEFICIENCY; IMPAIRS; ACTIVATION; RESPONSES; VARIANTS; BINDS	Rare sequence variants in the microglial cell surface receptor TREM2 have been shown to increase the risk for Alzheimer's disease (AD). Disease-linked TREM2 mutations seem to confer a partial loss of function, and increasing TREM2 cell surface expression and thereby its function(s) might have therapeutic benefit in AD. However, druggable targets that could modulate microglial TREM2 surface expression are not known. To identify such targets, we conducted a screen of small molecule compounds with known pharmacology using human myeloid cells, searching for those that enhance TREM2 protein at the cell surface. Inhibitors of the kinases MEK1/2 displayed the strongest and most consistent increases in cell surface TREM2 protein, identifying a previously unreported pathway for TREM2 regulation. Unexpectedly, inhibitors of the downstream effector ERK kinases did not have the same effect, suggesting that noncanonical MEK signaling regulates TREM2 trafficking. In addition, siRNA knockdown experiments confirmed that decreased MEK1 and MEK2 were required for this recruitment. In iPSC-derived microglia, MEK inhibition increased cell surface TREM2 only modestly, so various cytokines were used to alter iPSC microglia phenotype, making cells more sensitive to MEK inhibitor-induced TREM2 recruitment. Of those tested, only IFN-gamma priming prior to MEK inhibitor treatment resulted in greater TREM2 recruitment. These data identify the first known mechanisms for increasing surface TREM2 protein and TREM2-regulated function in human myeloid cells and are the first to show a role for MEK1/MEK2 signaling in TREM2 activity.	[Schapansky, Jason; Grinberg, Yelena Y.; Freeman, Emily A.; Karran, Eric; Talanian, Robert, V] AbbVie Inc, Cambridge Res Ctr, Cambridge, MA 02139 USA; [Osiecki, David M.; Walker, Stephen G.; Gopalakrishnan, Sujatha M.] AbbVie Inc, Drug Discovery Sci & Technol, N Chicago, IL USA	AbbVie; AbbVie	Schapansky, J (corresponding author), AbbVie Inc, Cambridge Res Ctr, Cambridge, MA 02139 USA.	jason.schapansky@abbvie.com		Schapansky, Jason/0000-0001-6389-891X; Talanian, Robert/0000-0002-6221-4923; Grinberg, Yelena/0000-0003-4255-5293				Atagi Y, 2015, J BIOL CHEM, V290, P26043, DOI 10.1074/jbc.M115.679043; Bailey CC, 2015, J BIOL CHEM, V290, P26033, DOI 10.1074/jbc.M115.677286; Belanger LF, 2003, MOL CELL BIOL, V23, P4778, DOI 10.1128/MCB.23.14.4778-4787.2003; Bemiller SM, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0216-6; Bianchin MM, 2004, CELL MOL NEUROBIOL, V24, P1, DOI 10.1023/B:CEMN.0000012721.08168.ee; Biber K, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00840; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Caunt CJ, 2015, NAT REV CANCER, V15, P577, DOI 10.1038/nrc4000; Chan G, 2015, NAT NEUROSCI, V18, P1556, DOI 10.1038/nn.4126; Cheng QW, 2018, J BIOL CHEM, V293, P12620, DOI 10.1074/jbc.RA118.001848; Del-Aguila JL, 2015, CURR OPIN GENET DEV, V33, P49, DOI 10.1016/j.gde.2015.07.008; Eblen ST, 2018, ADV CANCER RES, V138, P99, DOI 10.1016/bs.acr.2018.02.004; Frank S, 2008, GLIA, V56, P1438, DOI 10.1002/glia.20710; Galatro TF, 2017, NAT NEUROSCI, V20, P1162, DOI 10.1038/nn.4597; Garcia-Garcia E, 2002, J LEUKOCYTE BIOL, V72, P107; Garcia-Reitboeck P, 2018, CELL REP, V24, P2300, DOI 10.1016/j.celrep.2018.07.094; Gosselin D, 2017, SCIENCE, V356, DOI 10.1126/science.aal3222; Griciuc A, 2019, NEURON, V103, P820, DOI 10.1016/j.neuron.2019.06.010; Guerreiro R, 2013, NEW ENGL J MED, V368, P117, DOI 10.1056/NEJMoa1211851; Haenseler W, 2017, STEM CELL REP, V8, P1727, DOI 10.1016/j.stemcr.2017.05.017; Haney MS, 2018, NAT GENET, V50, P1716, DOI 10.1038/s41588-018-0254-1; Hasselmann J, 2020, GLIA, V68, P721, DOI 10.1002/glia.23781; Jay TR, 2017, J NEUROSCI, V37, P637, DOI [10.1523/JNEUROSCI.2110-16.2017, 10.1523/JNEUROSCI.2110-16.2016]; Jay TR, 2015, J EXP MED, V212, P287, DOI 10.1084/jem.20142322; Jiang T, 2014, NEUROPSYCHOPHARMACOL, V39, P2949, DOI 10.1038/npp.2014.164; Jonsson T, 2013, NEW ENGL J MED, V368, P107, DOI 10.1056/NEJMoa1211103; Kawabori M, 2015, J NEUROSCI, V35, P3384, DOI 10.1523/JNEUROSCI.2620-14.2015; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kleinberger G, 2017, EMBO J, V36, P1837, DOI 10.15252/embj.201796516; Kleinberger G, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009093; Kober DL, 2016, ELIFE, V5, DOI 10.7554/eLife.20391; Korvatska O, 2015, JAMA NEUROL, V72, P920, DOI 10.1001/jamaneurol.2015.0979; Lee CYD, 2018, NEURON, V97, P1032, DOI 10.1016/j.neuron.2018.02.002; Leyns CEG, 2019, NAT NEUROSCI, V22, P1217, DOI 10.1038/s41593-019-0433-0; Mathys H, 2017, CELL REP, V21, P366, DOI 10.1016/j.celrep.2017.09.039; Mazaheri F, 2017, EMBO REP, V18, P1186, DOI 10.15252/embr.201743922; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Nugent AA, 2020, NEURON, V105, P837, DOI 10.1016/j.neuron.2019.12.007; Parhizkar S, 2019, NAT NEUROSCI, V22, P191, DOI 10.1038/s41593-018-0296-9; Park-Min KH, 2009, J IMMUNOL, V183, P2444, DOI 10.4049/jimmunol.0804165; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Prokop S, 2019, ACTA NEUROPATHOL, V138, P613, DOI 10.1007/s00401-019-02048-2; Ren MR, 2018, EXP NEUROL, V302, P205, DOI 10.1016/j.expneurol.2018.01.016; Rosenthal SL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.04.012; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Sankowski R, 2019, NAT NEUROSCI, V22, P2098, DOI 10.1038/s41593-019-0532-y; Sayed FA, 2018, P NATL ACAD SCI USA, V115, P10172, DOI 10.1073/pnas.1811411115; Schlepckow K, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911227; Song WM, 2018, J EXP MED, V215, P745, DOI 10.1084/jem.20171529; Srinivasan K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11295; Takahashi K, 2007, PLOS MED, V4, P675, DOI 10.1371/journal.pmed.0040124; Turnbull IR, 2006, J IMMUNOL, V177, P3520, DOI 10.4049/jimmunol.177.6.3520; Ulland TK, 2017, CELL, V170, P649, DOI 10.1016/j.cell.2017.07.023; Varnum MM, 2017, J BIOL CHEM, V292, P10651, DOI 10.1074/jbc.M116.759159; Wang YM, 2015, CELL, V160, P1061, DOI 10.1016/j.cell.2015.01.049; Xing JJ, 2015, RES REP BIOCHEM, V5, P89, DOI 10.2147/RRBC.S58057; Yeh FL, 2016, NEURON, V91, P328, DOI 10.1016/j.neuron.2016.06.015; Yuan P, 2016, NEURON, V90, P724, DOI 10.1016/j.neuron.2016.05.003; Zhao YJ, 2018, NEURON, V97, P1023, DOI 10.1016/j.neuron.2018.01.031; Zhou YY, 2020, NAT MED, V26, P131, DOI 10.1038/s41591-019-0695-9	61	1	1	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100218	10.1074/jbc.RA120.014352	http://dx.doi.org/10.1074/jbc.RA120.014352			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839686	Green Published, gold			2022-12-28	WOS:000672866400196
J	Ury, B; Potelle, S; Caligiore, F; Whorton, MR; Bommer, GT				Ury, Benoit; Potelle, Sven; Caligiore, Francesco; Whorton, Matthew R.; Bommer, Guido T.			The promiscuous binding pocket of SLC35A1 ensures redundant transport of CDP-ribitol to the Golgi	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIALIC ACID TRANSPORTER; ALPHA-DYSTROGLYCAN; MUSCULAR-DYSTROPHY; O-MANNOSYLATION; MUTATIONS; FAMILY; IDENTIFICATION; GLYCOSYLATION; PHOSPHATE	The glycoprotein alpha-dystroglycan helps to link the intracellular cytoskeleton to the extracellular matrix. A unique glycan structure attached to this protein is required for its interaction with extracellular matrix proteins such as laminin. Up to now, this is the only mammalian glycan known to contain ribitol phosphate groups. Enzymes in the Golgi apparatus use CDP-ribitol to incorporate ribitol phosphate into the glycan chain of alpha-dystroglycan. Since CDP-ribitol is synthesized in the cytoplasm, we hypothesized that an unknown transporter must be required for its import into the Golgi apparatus. We discovered that CDP-ribitol transport relies on the CMP-sialic acid transporter SLC35A1 and the transporter SLC35A4 in a redundant manner. These two transporters are closely related, but bulky residues in the predicted binding pocket of SLC35A4 limit its size. We hypothesized that the large binding pocket SLC35A1 might accommodate the bulky CMP-sialic acid and the smaller CDP-ribitol, whereas SLC35A4 might only accept CDP-ribitol. To test this, we expressed SLC35A1 with mutations in its binding pocket in SLC35A1 KO cell lines. When we restricted the binding site of SLC35A1 by introducing the bulky residues present in SLC35A4, the mutant transporter was unable to support sialylation of proteins in cells but still supported ribitol phosphorylation. This demonstrates that the size of the binding pocket determines the substrate specificity of SLC35A1, allowing a variety of cytosine nucleotide conjugates to be transported. The redundancy with SLC35A4 also explains why patients with SLC35A1 mutations do not show symptoms of alpha-dystroglycan deficiency.	[Ury, Benoit; Potelle, Sven; Caligiore, Francesco; Bommer, Guido T.] UCLouvain, Dept Physiol Chem, de Duve Inst, Brussels, Belgium; [Ury, Benoit; Potelle, Sven; Caligiore, Francesco; Bommer, Guido T.] Walloon Excellence Lifesci & Biotechnol WELBIO, Brussels, Belgium; [Whorton, Matthew R.] Oregon Hlth & Serv Univ OHSU, Vollum Inst, Portland, OR 97239 USA	Universite Catholique Louvain; WELBIO	Bommer, GT (corresponding author), UCLouvain, Dept Physiol Chem, de Duve Inst, Brussels, Belgium.; Bommer, GT (corresponding author), Walloon Excellence Lifesci & Biotechnol WELBIO, Brussels, Belgium.; Whorton, MR (corresponding author), Oregon Hlth & Serv Univ OHSU, Vollum Inst, Portland, OR 97239 USA.	whorton@ohsu.edu; guido.bommer@uclouvain.be	; Bommer, Guido/A-8425-2011	Caligiore, Francesco/0000-0002-4038-3136; Bommer, Guido/0000-0001-6898-4884	Belgian National Fund for Scientific Research (FNRS); Credit de recherche; FRIA fellowship; Charge de Recherche fellowship; WELBIO; E-Rare network EUROGLYCAN, Universite Catholique de Louvain (Fonds Special de Recherche); Fondation MargueriteMarie Delacroix; Prix Professeur Christian Coers; European Research Council within the Horizon 2020 program [771704]; Fonds Maurange	Belgian National Fund for Scientific Research (FNRS)(Fonds de la Recherche Scientifique - FNRS); Credit de recherche; FRIA fellowship(Fonds de la Recherche Scientifique - FNRS); Charge de Recherche fellowship; WELBIO(WELBIO); E-Rare network EUROGLYCAN, Universite Catholique de Louvain (Fonds Special de Recherche); Fondation MargueriteMarie Delacroix; Prix Professeur Christian Coers; European Research Council within the Horizon 2020 program; Fonds Maurange	The authors acknowledge funding from the Belgian National Fund for Scientific Research (FNRS; Credit de recherche to G. T. B.; FRIA fellowship to B. U., Charge de Recherche fellowship to S. P.; and WELBIO to G. T. B.), the E-Rare network EUROGLYCAN, Universite Catholique de Louvain (Fonds Special de Recherche), the Fondation MargueriteMarie Delacroix, the Prix Professeur Christian Coers (to S. P. and B. U.), the European Research Council within the Horizon 2020 program (consolidator grant no. 771704), and the Fonds Maurange.	Ahuja S, 2019, ELIFE, V8, DOI 10.7554/eLife.45221; Bianco G, 2016, PROTEIN SCI, V25, P295, DOI 10.1002/pro.2733; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Coulier L, 2006, ANAL CHEM, V78, P6573, DOI 10.1021/ac0607616; Cubillos-Rojas Monica, 2012, Methods Mol Biol, V869, P205, DOI 10.1007/978-1-61779-821-4_17; Ebert B, 2015, PLANT CELL, V27, P1218, DOI 10.1105/tpc.114.133827; Endo T, 2015, J BIOCHEM, V157, P1, DOI 10.1093/jb/mvu066; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Gerin I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11534; Haan C, 2007, J IMMUNOL METHODS, V318, P11, DOI 10.1016/j.jim.2006.07.027; Hadley B, 2019, COMPUT STRUCT BIOTEC, V17, P1123, DOI 10.1016/j.csbj.2019.08.002; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; HOLM S, 1979, SCAND J STAT, V6, P65; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; Inamori K, 2012, SCIENCE, V335, P93, DOI 10.1126/science.1214115; Jae LT, 2013, SCIENCE, V340, P479, DOI 10.1126/science.1233675; Jordan M, 1996, NUCLEIC ACIDS RES, V24, P596, DOI 10.1093/nar/24.4.596; Kanagawa M, 2016, CELL REP, V14, P2209, DOI 10.1016/j.celrep.2016.02.017; Kauskot A, 2018, HAEMATOLOGICA, V103, pE613, DOI 10.3324/haematol.2018.198028; Khoder-Agha F, 2019, CELL MOL LIFE SCI, V76, P1821, DOI 10.1007/s00018-019-03032-5; Live D, 2013, CHEMBIOCHEM, V14, P2392, DOI 10.1002/cbic.201300417; Ma XL, 2021, HAEMATOLOGICA, V106, P759, DOI 10.3324/haematol.2019.225987; Manya H, 2016, J BIOL CHEM, V291, P24618, DOI 10.1074/jbc.M116.751917; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Mohamed M, 2013, NEUROLOGY, V81, P681, DOI 10.1212/WNL.0b013e3182a08f53; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ng BG, 2017, AM J MED GENET A, V173, P2906, DOI 10.1002/ajmg.a.38412; Ogawa M, 2013, BIOCHEM BIOPH RES CO, V440, P88, DOI 10.1016/j.bbrc.2013.09.022; Parker JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12673-w; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Praissman JL, 2016, ELIFE, V5, DOI 10.7554/eLife.14473; Praissman JL, 2014, ELIFE, V3, DOI 10.7554/eLife.03943; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rautengarten C, 2014, P NATL ACAD SCI USA, V111, P11563, DOI 10.1073/pnas.1406073111; Riemersma M, 2015, HUM MOL GENET, V24, P2241, DOI 10.1093/hmg/ddu742; Schauer R, 2018, ADV CARBOHYD CHEM BI, V75, P1, DOI 10.1016/bs.accb.2018.09.001; Sosicka P, 2017, BBA-MOL CELL RES, V1864, P825, DOI 10.1016/j.bbamcr.2017.02.002; Stevens E, 2013, AM J HUM GENET, V92, P354, DOI 10.1016/j.ajhg.2013.01.016; Veiga-da-Cunha M, 2019, P NATL ACAD SCI USA, V116, P1241, DOI 10.1073/pnas.1816143116; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Willer T, 2014, ELIFE, V3, DOI 10.7554/eLife.03941; Yoshida-Moriguchi T, 2015, GLYCOBIOLOGY, V25, P702, DOI 10.1093/glycob/cwv021; Yoshida-Moriguchi T, 2013, SCIENCE, V341, P896, DOI 10.1126/science.1239951	43	4	4	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100789	10.1016/j.jbc.2021.100789	http://dx.doi.org/10.1016/j.jbc.2021.100789			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34015330	gold, Green Published			2022-12-28	WOS:000674717300010
J	Ye, J; Stefan-Lifshitz, M; Tomer, Y				Ye, Jody; Stefan-Lifshitz, Mihaela; Tomer, Yaron			Genetic and environmental factors regulate the type 1 diabetes gene CTSH via differential DNA methylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; RISK; LOCI	Cathepsin H (CTSH) is a type 1 diabetes (T1D) risk gene; large-scale genetic and epidemiological studies found that T1D genetic risk correlates with high CTSH expression, rapid decline of beta-cell function, and early onset T1D. Counterintuitively, transcriptional downregulation of CTSH by proinflammatory cytokines has been shown to promote beta-cell apoptosis. Here, we potentially explain these observed contrasting effects, describing a new mechanism where proinflammatory cytokines and T1D genetic risk variants regulate CTSH transcription via differential DNA methylation. We show that, in human islets, CTSH downregulation by the proinflammatory cytokine cocktail interleukin 1 beta + tumor necrosis factor alpha + interferon gamma was coupled with DNA hypermethylation in an open chromatin region in CTSH intron 1. A luciferase assay in human embryonic kidney 293 cells revealed that methylation of three key cytosine-phosphateguanine dinucleotide (CpG) residues in intron 1 was responsible for the reduction of promoter activity. We further found that cytokine-induced intron 1 hypermethylation is caused by lowered Tet1/3 activities, suggesting that attenuated active demethylation lowered CTSH transcription. Importantly, individuals who carry the T1D risk variant showed lower methylation variability at the intron 1 CpG residues, presumably making them less sensitive to cytokines, whereas individuals who carry the protective variant showed higher methylation variability, presumably making them more sensitive to cytokines and implying differential responses to environment between the two patient populations. These findings suggest that genetic and environmental influences on a T1D locus are mediated by differential variability and mean of DNA methylation.	[Ye, Jody; Stefan-Lifshitz, Mihaela; Tomer, Yaron] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Ye, J (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10461 USA.	yi.ye@einsteinmed.org	Tomer, Yaron/GWU-8933-2022	Ye, Jody/0000-0003-0926-6107	National Institute of Diabetes and Digestive and Kidney Diseases R01; National Institutes of Health [DK067555]; Diabetes Research and Wellness Foundation UK [N-C/2016/Ye]; US Russell Berrie Foundation New York City Diabetes Fellowship	National Institute of Diabetes and Digestive and Kidney Diseases R01; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Diabetes Research and Wellness Foundation UK; US Russell Berrie Foundation New York City Diabetes Fellowship	This work was supported in part by grant National Institute of Diabetes and Digestive and Kidney Diseases R01, the National Institutes of Health (DK067555 to Y. T.), the Diabetes Research and Wellness Foundation UK nonclinical fellowship (N-C/2016/Ye to J. Y.), and the US Russell Berrie Foundation New York City Diabetes Fellowship (to J. Y.). J. Y. is the guarantor of this work, as such, had full access to all the data in the study, and takes responsibility for the integrity of the data and accuracy of the data analysis. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Teh AL, 2014, GENOME RES, V24, P1064, DOI 10.1101/gr.171439.113; Amouroux R, 2016, NAT CELL BIOL, V18, P225, DOI 10.1038/ncb3296; Arous C, 2015, J BIOL CHEM, V290, P14491, DOI 10.1074/jbc.A114.611111; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Boks MP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006767; Bradfield JP, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002293; Buhling F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026247; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Czamara D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10461-0; Davies NM, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k601; Ecker S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1156-8; Engel N, 2009, EPIGENETICS-US, V4, P98, DOI 10.4161/epi.4.2.7858; Faraco J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003270; Floyel T, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110993; Floyel T, 2014, P NATL ACAD SCI USA, V111, P10305, DOI 10.1073/pnas.1402571111; Inshaw JRJ, 2020, DIABETES CARE, V43, P169, DOI 10.2337/dc19-0803; Kienhofer S, 2015, DIFFERENTIATION, V90, P59, DOI 10.1016/j.diff.2015.10.003; Koskinen MK, 2020, DIABETES, V69, P12, DOI 10.2337/db19-0329; Kundaje A, 2015, NATURE, V518, P317, DOI 10.1038/nature14248; Ling C, 2019, CELL METAB, V29, P1028, DOI 10.1016/j.cmet.2019.03.009; Ma DKK, 2009, CELL CYCLE, V8, P1526, DOI 10.4161/cc.8.10.8500; Nyalwidhe JO, 2020, MICROORGANISMS, V8, DOI 10.3390/microorganisms8020295; Okada R, 2018, INFLAMM RES, V67, P371, DOI 10.1007/s00011-018-1136-9; Onengut-Gumuscu S, 2015, NAT GENET, V47, P381, DOI 10.1038/ng.3245; Paul DS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13555; Rewers M, 2016, LANCET, V387, P2340, DOI 10.1016/S0140-6736(16)30507-4; Rui J., 2020, BIORXIV, DOI [10.110112020.09.01.278028, DOI 10.1101/1010.09.01.278028]; Rui JX, 2016, DIABETOLOGIA, V59, P1021, DOI 10.1007/s00125-016-3897-4; Segerstolpe A, 2016, CELL METAB, V24, P593, DOI 10.1016/j.cmet.2016.08.020; Simeonov DR, 2017, NATURE, V549, P111, DOI 10.1038/nature23875; Smith GD, 2003, INT J EPIDEMIOL, V32, P1, DOI 10.1093/ije/dyg070; Stefan M, 2014, P NATL ACAD SCI USA, V111, P12562, DOI 10.1073/pnas.1408821111; Stefan-Lifshitz M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126663; Turk B, 2012, EMBO J, V31, P1630, DOI 10.1038/emboj.2012.42; Vehik K, 2019, NAT MED, V25, P1865, DOI 10.1038/s41591-019-0667-0; Wallace C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005272; Webster AP, 2018, GENOME MED, V10, DOI 10.1186/s13073-018-0575-9; Wu XJ, 2017, NAT REV GENET, V18, P517, DOI 10.1038/nrg.2017.33; Ye J, 2018, J AUTOIMMUN, V93, P66, DOI 10.1016/j.jaut.2018.06.005	39	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100774	10.1016/j.jbc.2021.100774	http://dx.doi.org/10.1016/j.jbc.2021.100774			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33992646	Green Published, gold			2022-12-28	WOS:000672866400741
J	Kuznetsova, A; Masrati, G; Vigonsky, E; Livnat-Levanon, N; Rose, J; Grupper, M; Baloum, A; Yang, JG; Rees, DC; Ben-Tal, N; Lewinson, O				Kuznetsova, Anastasiya; Masrati, Gal; Vigonsky, Elena; Livnat-Levanon, Nurit; Rose, Jessica; Grupper, Moti; Baloum, Adan; Yang, Janet G.; Rees, Douglas C.; Ben-Tal, Nir; Lewinson, Oded			Titratable transmembrane residues and a hydrophobic plug are essential for manganese import via the Bacillus anthracis ABC transporter MntBC-A	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINE-BINDING PROTEIN; ATP-BINDING; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; STAPHYLOCOCCUS-AUREUS; MALTOSE TRANSPORT; MEMBRANE-PROTEINS; ZINC HOMEOSTASIS; OXIDATIVE STRESS; VIRULENCE	All extant life forms require trace transition metals (e.g., Fe2/3+, Cu1/2+, and Mn2+) to survive. However, as these are environmentally scarce, organisms have evolved sophisticated metal uptake machineries. In bacteria, high-affinity import of transition metals is predominantly mediated by ABC transporters. During bacterial infection, sequestration of metal by the host further limits the availability of these ions, and accordingly, bacterial ABC transporters (importers) of metals are key virulence determinants. However, the structure-function relationships of these metal transporters have not been fully elucidated. Here, we used metal-sensitivity assays, advanced structural modeling, and enzymatic assays to study the ABC transporter MntBC-A, a virulence determinant of the bacterial human pathogen Bacillus anthracis. We find that despite its broad metal-recognition profile, MntBC-A imports only manganese, whereas zinc can function as a high-affinity inhibitor of MntBC-A. Computational analysis shows that the transmembrane metal permeation pathway is lined with six titratable residues that can coordinate the positively charged metal, and mutagenesis studies show that they are essential for manganese transport. Modeling suggests that access to these titratable residues is blocked by a ladder of hydrophobic residues, and ATP-driven conformational changes open and close this hydrophobic seal to permit metal binding and release. The conservation of this arrangement of titratable and hydrophobic residues among ABC transporters of transition metals suggests a common mechanism. These findings advance our understanding of transmembrane metal recognition and permeation and may aid the design and development of novel antibacterial agents.	[Kuznetsova, Anastasiya; Vigonsky, Elena; Livnat-Levanon, Nurit; Rose, Jessica; Baloum, Adan; Lewinson, Oded] Technion Israel Inst Technol, Dept Mol Microbiol, Haifa, Israel; [Kuznetsova, Anastasiya; Vigonsky, Elena; Livnat-Levanon, Nurit; Rose, Jessica; Baloum, Adan; Lewinson, Oded] Technion Israel Inst Technol, Rappaport Inst Med Sci, Haifa, Israel; [Masrati, Gal; Ben-Tal, Nir] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Biochem & Mol Biol, Tel Aviv, Israel; [Grupper, Moti] Infect Dis Unit, Rambam Hlth Care Campus, Haifa, Israel; [Yang, Janet G.] Univ San Francisco, Dept Chem, San Francisco, CA USA; [Rees, Douglas C.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	Technion Israel Institute of Technology; Technion Israel Institute of Technology; Tel Aviv University; Rambam Health Care Campus; University of San Francisco; California Institute of Technology	Lewinson, O (corresponding author), Technion Israel Inst Technol, Dept Mol Microbiol, Haifa, Israel.; Lewinson, O (corresponding author), Technion Israel Inst Technol, Rappaport Inst Med Sci, Haifa, Israel.	lewinson@technion.ac.il			NATO Science for Peace and Security Program [SPS 625, G4622]; US-Israel Binational Science Foundation (BSF) [2015102]; Israel Academy of Sciences and Humanities project [1006/18]	NATO Science for Peace and Security Program; US-Israel Binational Science Foundation (BSF)(US-Israel Binational Science Foundation); Israel Academy of Sciences and Humanities project	This work was supported by grants from the NATO Science for Peace and Security Program (SPS 625 Project G4622, to O. L. and N. B.-T.), the US-Israel Binational Science Foundation (BSF grant 2015102 to O. L. and D. C. R.), and the Israel Academy of Sciences and Humanities project 1006/18 (to O. L.).	AMES GF, 1992, ADV ENZYMOL RAMB, V65, P1; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Ando M, 2003, INFECT IMMUN, V71, P2584, DOI 10.1128/IAI.71.5.2584-2590.2003; Andreini C, 2008, J PROTEOME RES, V7, P209, DOI 10.1021/pr070480u; Andreini C, 2013, NUCLEIC ACIDS RES, V41, pD312, DOI 10.1093/nar/gks1063; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bearden SW, 1999, MOL MICROBIOL, V32, P403, DOI 10.1046/j.1365-2958.1999.01360.x; Becker KW, 2014, FEMS MICROBIOL REV, V38, P1235, DOI 10.1111/1574-6976.12087; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Borths EL, 2005, BIOCHEMISTRY-US, V44, P16301, DOI 10.1021/bi0513103; Britton RA, 2002, J BACTERIOL, V184, P4881, DOI 10.1128/JB.184.17.4881-4890.2002; Colomer-Winter C, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007102; Counago RM, 2014, NAT CHEM BIOL, V10, P35, DOI [10.1038/NCHEMBIO.1382, 10.1038/nchembio.1382]; DAVIDSON AL, 1992, P NATL ACAD SCI USA, V89, P2360, DOI 10.1073/pnas.89.6.2360; Davidson AL, 1996, J BIOL CHEM, V271, P4858; de Boer M, 2019, ELIFE, V8, DOI 10.7554/eLife.44652; Dean M, 2001, J BIOENERG BIOMEMBR, V33, P475, DOI 10.1023/A:1012823120935; Diaz-Ochoa VE, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00002; Dintilhac A, 1997, RES MICROBIOL, V148, P119, DOI 10.1016/S0923-2508(97)87643-7; Doshi R, 2013, J BIOL CHEM, V288, P6801, DOI 10.1074/jbc.M112.430074; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Elazar A, 2016, P NATL ACAD SCI USA, V113, P10340, DOI 10.1073/pnas.1605888113; Gat O, 2005, MOL MICROBIOL, V58, P533, DOI 10.1111/j.1365-2958.2005.04848.x; German N, 2013, FUTURE MICROBIOL, V8, P1257, DOI 10.2217/fmb.13.100; Gouridis G, 2015, NAT STRUCT MOL BIOL, V22, P57, DOI 10.1038/nsmb.2929; Guedon E, 2003, MOL MICROBIOL, V49, P1477, DOI 10.1046/j.1365-2958.2003.03648.x; Harding MM, 2004, ACTA CRYSTALLOGR D, V60, P849, DOI 10.1107/S0907444904004081; Harding MM, 2002, ACTA CRYSTALLOGR D, V58, P872, DOI 10.1107/S0907444902003712; Harding MM, 2001, ACTA CRYSTALLOGR D, V57, P401, DOI 10.1107/S0907444900019168; Helmann JD, 2014, J BIOL CHEM, V289, P28112, DOI 10.1074/jbc.R114.587071; HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435; Holland I. B., 2003, ABC PROTEINS BACTERI; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Horsburgh MJ, 2002, MOL MICROBIOL, V44, P1269, DOI 10.1046/j.1365-2958.2002.02944.x; Hsiao CD, 1996, J MOL BIOL, V262, P225, DOI 10.1006/jmbi.1996.0509; Huang XJ, 2017, MOL MICROBIOL, V103, P253, DOI 10.1111/mmi.13554; IRVING H, 1948, NATURE, V162, P746, DOI 10.1038/162746a0; Jacobsen FE, 2011, METALLOMICS, V3, P38, DOI 10.1039/c0mt00050g; Janulczyk R, 2003, INFECT IMMUN, V71, P2656, DOI 10.1128/IAI.71.5.2656-2664.2003; Juttukonda LJ, 2016, MBIO, V7, DOI 10.1128/mBio.01475-16; Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987; Karpowich NK, 2003, J BIOL CHEM, V278, P8429, DOI 10.1074/jbc.M212239200; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kehl-Fie TE, 2010, CURR OPIN CHEM BIOL, V14, P218, DOI 10.1016/j.cbpa.2009.11.008; Kessel A., 2018, INTRO PROTEINS STRUC, V2nd; Klein JS, 2011, METALLOMICS, V3, P1098, DOI 10.1039/c1mt00073j; Korkhov VM, 2014, NAT STRUCT MOL BIOL, V21, P1097, DOI 10.1038/nsmb.2918; Lewinson O, 2020, FEBS LETT, V594, P3799, DOI 10.1002/1873-3468.13966; Lewinson O, 2017, J MOL BIOL, V429, P606, DOI 10.1016/j.jmb.2017.01.010; Lewinson O, 2009, P NATL ACAD SCI USA, V106, P4677, DOI 10.1073/pnas.0900666106; Lindahl E, 2001, J MOL MODEL, V7, P306, DOI 10.1007/s008940100045; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu CE, 1997, J BIOL CHEM, V272, P21883, DOI 10.1074/jbc.272.35.21883; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Locher KP, 2009, PHILOS T R SOC B, V364, P239, DOI 10.1098/rstb.2008.0125; Marra A, 2002, MICROBIOL-SGM, V148, P1483, DOI 10.1099/00221287-148-5-1483; McDevitt CA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002357; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Nugent T, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-169; Paik S, 2003, J BACTERIOL, V185, P5967, DOI 10.1128/JB.185.20.5967-5975.2003; Pandey R, 2015, MOL MICROBIOL, V98, P1168, DOI 10.1111/mmi.13207; Pattery T, 1999, MOL MICROBIOL, V33, P791, DOI 10.1046/j.1365-2958.1999.01526.x; Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488; Que Q, 2000, MOL MICROBIOL, V35, P1454, DOI 10.1046/j.1365-2958.2000.01811.x; REENSTRA WW, 1980, BIOCHEMISTRY-US, V19, P1, DOI 10.1021/bi00542a001; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Remy L, 2013, MOL MICROBIOL, V87, P730, DOI 10.1111/mmi.12126; Rodriguez GM, 2006, J BACTERIOL, V188, P424, DOI 10.1128/JB.188.2.424-430.2006; Sabrialabed S, 2020, J BIOL CHEM, V295, P5245, DOI 10.1074/jbc.RA119.012063; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Schneider E, 2012, EUR J CELL BIOL, V91, P311, DOI 10.1016/j.ejcb.2011.02.008; SHARFF AJ, 1992, BIOCHEMISTRY-US, V31, P10657, DOI 10.1021/bi00159a003; Sheldon JR, 2019, CURR OPIN IMMUNOL, V60, P1, DOI 10.1016/j.coi.2019.04.002; Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sun YJ, 1998, J MOL BIOL, V278, P219, DOI 10.1006/jmbi.1998.1675; Tal N, 2013, P NATL ACAD SCI USA, V110, P5434, DOI 10.1073/pnas.1209644110; ter Beek J, 2014, J GEN PHYSIOL, V143, P419, DOI 10.1085/jgp.201411164; Tsirigos KD, 2015, NUCLEIC ACIDS RES, V43, pW401, DOI 10.1093/nar/gkv485; Turner AG, 2015, MBIO, V6, DOI 10.1128/mBio.00278-15; Vigonsky E, 2015, METALLOMICS, V7, P1407, DOI [10.1039/c5mt00100e, 10.1039/C5MT00100E]; Vigonsky E, 2013, P NATL ACAD SCI USA, V110, P5440, DOI 10.1073/pnas.1213598110; VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; Yang JG, 2015, J BIOL CHEM, V290, P9135, DOI 10.1074/jbc.M114.603365; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yesilkaya H, 2000, INFECT IMMUN, V68, P2819, DOI 10.1128/IAI.68.5.2819-2826.2000	90	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101087	10.1016/j.jbc.2021.101087	http://dx.doi.org/10.1016/j.jbc.2021.101087			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34416234	Green Published, gold, Green Accepted			2022-12-28	WOS:000755323700004
J	Frkic, LR; Richter, K; Bruning, BJ				Frkic, L. Rebecca; Richter, Katharina; Bruning, B. John			The therapeutic potential of inhibiting PPAR gamma phosphorylation to treat type 2 diabetes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							BETA-OXIDATION PATHWAY; INSULIN SENSITIVITY; ADIPOSE-TISSUE; ACTIVATION; BINDING; LIGAND; MECHANISM; PROMOTES; AGONISTS; ANTAGONIST	A promising approach for treating type 2 diabetes mellitus (T2DM) is to target the Peroxisome Proliferator-Activated Receptor. (PPAR.) transcription factor, which regulates the expression of proteins critical for T2DM. Mechanisms involved in PPAR. signaling are poorly understood, yet globally increasing T2DM prevalence demands improvements in drug design. Synthetic, nonactivating PPAR gamma ligands can abolish the phosphorylation of PPAR. at Ser273, a posttranslational modification correlated with obesity and insulin resistance. It is not understood how these ligands prevent phosphorylation, and the lack of experimental mechanistic information can be attributed to previous ambiguity in the field as well as to limitations in experimental approaches; in silico modeling currently provides the only insight into how ligands block Ser273 phosphorylation. The future availability of experimental evidence is critical for clarifying the mechanism by which ligands prevent phosphorylation and should be the priority of future T2DM-focused research. Following this, the properties of ligands that enable them to block phosphorylation can be improved upon to generate ligands tailored for blocking phosphorylation and therefore restoring insulin sensitivity. This would represent a significant step forward for treating T2DM. This review summarizes current knowledge of the roles of PPAR gamma in T2DM as well as the effects of synthetic ligands on the modulation of these roles. We hypothesize potential factors that contribute to the reduction in recent developments and summarize what has currently been done to shed light on this critical field of research.	[Frkic, L. Rebecca; Bruning, B. John] Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia; [Frkic, L. Rebecca; Bruning, B. John] Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia; [Richter, Katharina] Univ Adelaide, Basil Hetzel Inst Translat Hlth Res, Dept Surg, Richter Lab, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide	Bruning, BJ (corresponding author), Univ Adelaide, Inst Photon & Adv Sensing, Adelaide, SA, Australia.; Bruning, BJ (corresponding author), Univ Adelaide, Sch Biol Sci, Adelaide, SA, Australia.	john.bruning@adelaide.edu.au	Bruning, John/AAW-8567-2020	Bruning, John/0000-0002-6919-1824; Richter, Katharina/0000-0003-2979-8215; Frkic, Rebecca/0000-0003-0071-9018				Achari AE, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18061321; Amato AA, 2012, J BIOL CHEM, V287, P28169, DOI 10.1074/jbc.M111.332106; Banks AS, 2015, NATURE, V517, P391, DOI 10.1038/nature13887; Berger Joel, 2002, Diabetes Technol Ther, V4, P163, DOI 10.1089/15209150260007381; Bodmer M, 2009, DRUG SAFETY, V32, P539, DOI 10.2165/00002018-200932070-00001; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Bruning JB, 2007, STRUCTURE, V15, P1258, DOI 10.1016/j.str.2007.07.014; Brust R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07133-w; Bulynko YA, 2011, BIOCHEMISTRY-US, V50, P313, DOI 10.1021/bi101762x; Burgermeister E, 2008, PPAR RES, V2008, DOI 10.1155/2008/309469; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Capra V, 2013, MED RES REV, V33, P364, DOI 10.1002/med.21251; Chandra M, 2017, PPAR RES, V2017, DOI 10.1155/2017/6404638; Chandra V, 2008, NATURE, V456, P350, DOI 10.1038/nature07413; Chang MR, 2019, ACS CHEM BIOL, V14, P1051, DOI 10.1021/acschembio.9b00236; Chattopadhyay T, 2017, BIOFACTORS, V43, P195, DOI 10.1002/biof.1334; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Choi JH, 2014, GENE DEV, V28, P2361, DOI 10.1101/gad.249367.114; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Choi SS, 2016, DIABETES, V65, P829, DOI 10.2337/db15-1382; Choi SS, 2014, BMB REP, V47, P599, DOI 10.5483/BMBRep.2014.47.11.174; Choi S, 2015, CELL SIGNAL, V27, P2488, DOI 10.1016/j.cellsig.2015.09.009; Czyzyk, 2000, Eur J Intern Med, V11, P245, DOI 10.1016/S0953-6205(00)00106-0; Desterke C, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101611; DREYER C, 1992, CELL, V68, P879, DOI 10.1016/0092-8674(92)90031-7; DREYER C, 1993, BIOL CELL, V77, P67, DOI 10.1016/S0248-4900(05)80176-5; El Ouarrat D, 2020, CELL METAB, V31, P162, DOI 10.1016/j.cmet.2019.10.003; Elzahhar PA, 2019, EUR J MED CHEM, V167, P562, DOI 10.1016/j.ejmech.2019.02.034; Fang L, 2016, PPAR RES, V2016, DOI 10.1155/2016/6042162; Fantuzzi G, 2005, J ALLERGY CLIN IMMUN, V115, P911, DOI 10.1016/j.jaci.2005.02.023; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Frkic R. L., 2018, NUCL RECEPTOR RES, V5; Frkic RL, 2018, ISCIENCE, V5, P69, DOI 10.1016/j.isci.2018.06.012; Goldstein JT, 2017, CANCER RES, V77, P6987, DOI 10.1158/0008-5472.CAN-17-1701; Hall JA, 2020, CELL METAB, V32, P665, DOI 10.1016/j.cmet.2020.08.016; Horita S, 2015, PPAR RES, V2015, DOI 10.1155/2015/646423; Jang JY, 2019, MOLECULES, V24, DOI 10.3390/molecules24193562; Jang JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18274-1; Jang JY, 2017, BBA-PROTEINS PROTEOM, V1865, P674, DOI 10.1016/j.bbapap.2017.03.008; Jepsen K, 2002, J CELL SCI, V115, P689; JugeAubry C, 1997, J BIOL CHEM, V272, P25252, DOI 10.1074/jbc.272.40.25252; Kamenecka T. M., 2010, PROBE REPORTS NIH MO; Kelesidis T, 2010, ANN INTERN MED, V152, P93, DOI 10.7326/0003-4819-152-2-201001190-00008; Khan Mmh, 2006, Asian Pac J Cancer Prev, V7, P253; Komar CM, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-41; Kroker AJ, 2015, PPAR RES, V2015, DOI 10.1155/2015/816856; Laghezza A, 2018, J MED CHEM, V61, P8282, DOI 10.1021/acs.jmedchem.8b00835; Lemkul JA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123984; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; Marciano DP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8443; Montanari R, 2020, J MED CHEM, V63, P4811, DOI 10.1021/acs.jmedchem.0c00048; Motani A, 2009, J MOL BIOL, V386, P1301, DOI 10.1016/j.jmb.2009.01.025; Mottin M, 2015, J PHYS CHEM B, V119, P8330, DOI 10.1021/acs.jpcb.5b04269; Nesto RW, 2004, DIABETES CARE, V27, P256, DOI 10.2337/diacare.27.1.256; Nissen SE, 2010, EUR HEART J, V31, P773, DOI 10.1093/eurheartj/ehq016; Ordan M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30202-5; Ostberg T, 2004, J BIOL CHEM, V279, P41124, DOI 10.1074/jbc.M401552200; Penumetcha M, 2012, PPAR RES, V2012, DOI 10.1155/2012/858352; Pepino MY, 2014, ANNU REV NUTR, V34, P281, DOI 10.1146/annurev-nutr-071812-161220; Ribeiro HV, 2019, J STRUCT BIOL, V207, P317, DOI 10.1016/j.jsb.2019.07.007; Ribeiro HV, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00011; Schiel R, 2006, METHOD FIND EXP CLIN, V28, P169, DOI 10.1358/mf.2006.28.3.985230; Schreiber I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17595-5; Schupp M, 2010, J BIOL CHEM, V285, P40409, DOI 10.1074/jbc.R110.182451; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sime M, 2011, BIOORG MED CHEM LETT, V21, P5568, DOI 10.1016/j.bmcl.2011.06.088; Stechschulte LA, 2016, EBIOMEDICINE, V10, P174, DOI 10.1016/j.ebiom.2016.06.040; Taygerly JP, 2013, BIOORGAN MED CHEM, V21, P979, DOI 10.1016/j.bmc.2012.11.058; Tiacci E, 2013, HAEMATOLOGICA, V98, P635, DOI 10.3324/haematol.2012.078071; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Waku T, 2010, EMBO J, V29, P3395, DOI 10.1038/emboj.2010.197; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang HY, 2019, CHINESE MED J-PEKING, V132, P2612, DOI 10.1097/CM9.0000000000000480; Wang SB, 2016, PHARMACOL RES, V111, P76, DOI 10.1016/j.phrs.2016.02.028; Zheng J, 2018, STRUCTURE, V26, P1431, DOI 10.1016/j.str.2018.07.007; Zheng W, 2013, DIABETOLOGIA, V56, P401, DOI 10.1007/s00125-012-2777-9; ZHU YJ, 1995, P NATL ACAD SCI USA, V92, P7921, DOI 10.1073/pnas.92.17.7921	81	7	7	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101030	10.1016/j.jbc.2021.101030	http://dx.doi.org/10.1016/j.jbc.2021.101030			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34339734	gold, Green Published			2022-12-28	WOS:000704369100009
J	Huang, SC; Vu, LV; Yu, FYH; Nguyen, DT; Benz, EJ				Huang, Shu-Ching; Vu, Long V.; Yu, Faye H.; Nguyen, Dan T.; Benz, Edward J., Jr.			Multifunctional protein 4.1R regulates the asymmetric segregation of Numb during terminal erythroid maturation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC SPINDLE ORIENTATION; CORTICAL DYNEIN; CELL-DIVISION; ISOFORM EXPRESSION; MESSENGER-RNA; STEM-CELLS; NOTCH; BINDS; DIFFERENTIATION; LOCALIZATION	The asymmetric cell division of stem or progenitor cells generates daughter cells with distinct fates that balance proliferation and differentiation. Asymmetric segregation of Notch signaling regulatory protein Numb plays a crucial role in cell diversification. However, the molecular mechanism remains unclear. Here, we examined the unequal distribution of Numb in the daughter cells of murine erythroleukemia cells (MELCs) that undergo DMSO-induced erythroid differentiation. In contrast to the cytoplasmic localization of Numb during uninduced cell division, Numb is concentrated at the cell boundary in interphase, near the one-spindle pole in metaphase, and is unequally distributed to one daughter cell in anaphase in induced cells. The inheritance of Numb guides this daughter cell toward erythroid differentiation while the other cell remains a progenitor cell. Mitotic spindle orientation, critical for distribution of cell fate determinants, requires complex communication between the spindle microtubules and the cell cortex mediated by the NuMA-LGN-dynein/ dynactin complex. Depletion of each individual member of the complex randomizes the position of Numb relative to the mitotic spindle. Gene replacement confirms that multifunctional erythrocyte protein 4.1R (4.1R) functions as a member of the NuMA-LGN-dynein/dynactin complex and is necessary for regulating spindle orientation, in which interaction between 4.1R and NuMA plays an important role. These results suggest that mispositioning of Numb is the result of spindle misorientation. Finally, disruption of the 4.1R-NuMA-LGN complex increases Notch signaling and decreases the erythroblast population. Together, our results identify a critical role for 4.1R in regulating the asymmetric segregation of Numb to mediate erythropoiesis.	[Huang, Shu-Ching; Vu, Long V.; Yu, Faye H.; Nguyen, Dan T.; Benz, Edward J., Jr.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Huang, Shu-Ching; Benz, Edward J., Jr.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Huang, Shu-Ching; Benz, Edward J., Jr.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Benz, Edward J., Jr.] Harvard Med Sch, Dept Pediat & Genet, Boston, MA 02115 USA; [Benz, Edward J., Jr.] Dana Farber Harvard Canc Ctr, Leukemia Program, Boston, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Huang, SC (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Huang, SC (corresponding author), Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA.; Huang, SC (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.	shu-ching_huang@dfci.harvard.edu			NIH [HL44985, HL24385, HL60519]; Claudia Barr Award	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Barr Award	This work was funded by the NIH grants HL44985 and HL24385 (E. J. B., Jr) and HL60519 and Claudia Barr Award (S.-C. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anderson AC, 2005, J IMMUNOL, V174, P890, DOI 10.4049/jimmunol.174.2.890; Bani-Yaghoub M, 2007, DEV DYNAM, V236, P696, DOI 10.1002/dvdy.21072; Bellaiche Y, 2001, CELL, V106, P355, DOI 10.1016/S0092-8674(01)00444-5; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen C, 2016, CURR OPIN CELL BIOL, V43, P1, DOI 10.1016/j.ceb.2016.06.001; Deguillien M, 2001, BLOOD, V98, P3809, DOI 10.1182/blood.V98.13.3809; Dho SE, 2006, MOL BIOL CELL, V17, P4142, DOI 10.1091/mbc.E06-02-0097; di Pietro F, 2016, EMBO REP, V17, P1106, DOI 10.15252/embr.201642292; Du QS, 2004, CELL, V119, P503, DOI 10.1016/j.cell.2004.10.028; Du QS, 2001, NAT CELL BIOL, V3, P1069, DOI 10.1038/ncb1201-1069; Fink J, 2011, NAT CELL BIOL, V13, P771, DOI 10.1038/ncb2269; Gaul L, 2008, J CANCER RES CLIN, V134, P245, DOI 10.1007/s00432-007-0278-x; Geling A, 2002, EMBO REP, V3, P688, DOI 10.1093/embo-reports/kvf124; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Gimm JA, 2002, BIOCHEMISTRY-US, V41, P7275, DOI 10.1021/bi0256330; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Hapak SM, 2018, CELL MOL LIFE SCI, V75, P2735, DOI 10.1007/s00018-018-2828-6; Homem CCF, 2012, DEVELOPMENT, V139, P4297, DOI 10.1242/dev.080515; Huang SC, 2004, J BIOL CHEM, V279, P34595, DOI 10.1074/jbc.M404051200; Huang SC, 2005, MOL BIOL CELL, V16, P117, DOI 10.1091/mbc.E04-05-0426; Huhn SC, 2017, ONCOGENE, V36, P4750, DOI 10.1038/onc.2017.92; Kechad A, 2012, J NEUROSCI, V32, P17197, DOI 10.1523/JNEUROSCI.4127-12.2012; Kiyomitsu T, 2013, CELL, V154, P391, DOI 10.1016/j.cell.2013.06.010; Kodani A, 2013, EMBO J, V32, P597, DOI 10.1038/emboj.2013.3; Kotak S, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9020080; Kotak S, 2012, J CELL BIOL, V199, P97, DOI 10.1083/jcb.201203166; Krauss SW, 2004, J BIOL CHEM, V279, P27591, DOI 10.1074/jbc.M402813200; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Lu YY, 2015, HEPATOLOGY, V62, P1122, DOI 10.1002/hep.27923; Machicoane M, 2014, J CELL BIOL, V205, P791, DOI 10.1083/jcb.201401049; Mattagajasingh SN, 1999, J CELL BIOL, V145, P29, DOI 10.1083/jcb.145.1.29; Mattagajasingh SN, 2009, CTS-CLIN TRANSL SCI, V2, P102, DOI 10.1111/j.1752-8062.2008.00087.x; McGill MA, 2009, J BIOL CHEM, V284, P26427, DOI 10.1074/jbc.M109.014845; Misquitta-Ali CM, 2011, MOL CELL BIOL, V31, P138, DOI 10.1128/MCB.00709-10; MITCHISON TJ, 1992, CELL MOTIL CYTOSKEL, V22, P135, DOI 10.1002/cm.970220207; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nain AS, 2013, CELL CYCLE, V12, P1821, DOI 10.4161/cc.25171; Nguyen-Ngoc T, 2007, NAT CELL BIOL, V9, P1294, DOI 10.1038/ncb1649; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Nteliopoulos G, 2012, STEM CELLS DEV, V21, P2565, DOI 10.1089/scd.2011.0467; Okumura M, 2018, ELIFE, V7, DOI 10.7554/eLife.36559; Pedersen WA, 2002, J NEUROCHEM, V82, P976, DOI 10.1046/j.1471-4159.2002.01036.x; Perry A, 2004, J NEURO-ONCOL, V70, P183, DOI 10.1007/s11060-004-2749-0; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Rajaram V, 2005, MODERN PATHOL, V18, P991, DOI 10.1038/modpathol.3800390; Rajendran D, 2016, ONCOGENE, V35, P5202, DOI 10.1038/onc.2016.69; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Robb VA, 2003, NEUROBIOL DIS, V13, P191, DOI 10.1016/S0969-9961(03)00071-8; Ruiz-Saenz A, 2013, J CELL SCI, V126, P4589, DOI 10.1242/jcs.120840; Seldin L, 2013, MOL BIOL CELL, V24, P3651, DOI 10.1091/mbc.E13-05-0277; Shen Q, 2002, DEVELOPMENT, V129, P4843; Siller KH, 2006, NAT CELL BIOL, V8, P594, DOI 10.1038/ncb1412; Solinet S, 2013, J CELL BIOL, V202, P251, DOI 10.1083/jcb.201304052; Spana EP, 1996, NEURON, V17, P21, DOI 10.1016/S0896-6273(00)80277-9; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Thery M, 2010, J CELL SCI, V123, P4201, DOI 10.1242/jcs.075150; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106; Venkei ZG, 2018, J CELL BIOL, V217, P3785, DOI 10.1083/jcb.201807037; Verdi JM, 1999, P NATL ACAD SCI USA, V96, P10472, DOI 10.1073/pnas.96.18.10472; VOLLOCH V, 1981, CELL, V23, P509, DOI 10.1016/0092-8674(81)90146-X; Williams SE, 2011, NATURE, V470, P353, DOI 10.1038/nature09793; Wong RW, 2006, P NATL ACAD SCI USA, V103, P19783, DOI 10.1073/pnas.0609582104; Woodard GE, 2010, MOL CELL BIOL, V30, P3519, DOI 10.1128/MCB.00394-10; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yang G, 2005, BLOOD, V105, P2146, DOI 10.1182/blood-2004-05-1757; Yang G, 2008, BLOOD, V111, P392, DOI 10.1182/blood-2007-01-068940; Yang YF, 2014, P NATL ACAD SCI USA, V111, P2158, DOI 10.1073/pnas.1319341111; Yoshida T, 2003, DIFFERENTIATION, V71, P486, DOI 10.1046/j.1432-0436.2003.7108006.x; Zheng Z, 2010, J CELL BIOL, V189, P275, DOI 10.1083/jcb.200910021	72	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101051	10.1016/j.jbc.2021.101051	http://dx.doi.org/10.1016/j.jbc.2021.101051			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34364872	gold, Green Published			2022-12-28	WOS:000706361700007
J	Lee, CY; Myong, S				Lee, Chun-Ying; Myong, Sua			Probing steps in DNA transcription using single-molecule methods	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							INDUCED FLUORESCENCE ENHANCEMENT; BACTERIAL RNA-POLYMERASE; REAL-TIME OBSERVATION; ABORTIVE INITIATION; OPTICAL TWEEZERS; PRODUCTIVE INITIATION; OPEN COMPLEX; PROTEIN; ELONGATION; MECHANISM	Transcriptional regulation is one of the key steps in determining gene expression. Diverse single-molecule techniques have been applied to characterize the stepwise progression of transcription, yielding complementary results. These techniques include, but are not limited to, fluorescence-based microscopy with single or multiple colors, force measuring and manipulating microscopy using magnetic field or light, and atomic force microscopy. Here, we summarize and evaluate these current methodologies in studying and resolving individual steps in the transcription reaction, which encompasses RNA polymerase binding, initiation, elongation, mRNA production, and termination. We also describe the advantages and disadvantages of each method for studying transcription.	[Lee, Chun-Ying; Myong, Sua] Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21205 USA; [Myong, Sua] Univ Illinois, Phys Frontier Ctr, Ctr Phys Living Cells, Urbana, IL 61801 USA	Johns Hopkins University; University of Illinois System; University of Illinois Urbana-Champaign	Myong, S (corresponding author), Johns Hopkins Univ, Dept Biophys, Baltimore, MD 21205 USA.; Myong, S (corresponding author), Univ Illinois, Phys Frontier Ctr, Ctr Phys Living Cells, Urbana, IL 61801 USA.	smyong@jhu.edu		Lee, Chun-Ying/0000-0001-6715-5056	NIGMS, National Institutes of Health [1R01GM115631-01A1]; Center for the Physics of Living Cells [0822613]; NCI, National Institutes of Health [R01CA207341]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Center for the Physics of Living Cells; NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the NIGMS, National Institutes of Health (1R01GM115631-01A1) to C.-Y. L. and S. M., National Science Foundation Physics Frontiers Centers Program (0822613) through the Center for the Physics of Living Cells to S. M., and NCI, National Institutes of Health (R01CA207341) to S. M. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbondanzieri EA, 2005, NATURE, V438, P460, DOI 10.1038/nature04268; Alhadid Y, 2017, PROTEIN SCI, V26, P1278, DOI 10.1002/pro.3160; Anand VS, 2006, J BIOL CHEM, V281, P35677, DOI 10.1074/jbc.M608180200; Andrea C., 2021, STUDY VISUALIZE DNA; Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Baek I, 2021, MOL CELL, V81, P3576, DOI 10.1016/j.molcel.2021.07.025; Barnes CO, 2015, MOL CELL, V59, P258, DOI 10.1016/j.molcel.2015.06.034; BERG OG, 1981, BIOCHEMISTRY-US, V20, P6929, DOI 10.1021/bi00527a028; Billingsley DJ, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/2/021001; Browning DF, 2016, NAT REV MICROBIOL, V14, P638, DOI 10.1038/nrmicro.2016.103; Burns CM, 1998, J MOL BIOL, V278, P307, DOI 10.1006/jmbi.1998.1691; Busby SJW, 2019, MICROBIOL-SGM, V165, P386, DOI 10.1099/mic.0.000783; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; Cha J, 2021, J KOREAN PHYS SOC, V78, P442, DOI 10.1007/s40042-020-00031-9; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Chen HM, 2016, GENE DEV, V30, P1796, DOI 10.1101/gad.281725.116; Chen J, 2021, NAT REV MICROBIOL, V19, P95, DOI 10.1038/s41579-020-00450-2; Chen KH, 2015, SCIENCE, V348, DOI 10.1126/science.aaa6090; Cordes T, 2010, BIOCHEMISTRY-US, V49, P9171, DOI 10.1021/bi101184g; Core L, 2019, GENE DEV, V33, P960, DOI 10.1101/gad.325142.119; Coulombre B, 1999, MICROBIOL MOL BIOL R, V63, P457, DOI 10.1128/MMBR.63.2.457-478.1999; Coulon A, 2014, ELIFE, V3, DOI 10.7554/eLife.03939; Cramer P, 2019, NATURE, V573, P45, DOI 10.1038/s41586-019-1517-4; Dangkulwanich M, 2014, CHEM REV, V114, P3203, DOI 10.1021/cr400730x; Dangkulwanich M, 2013, ELIFE, V2, DOI 10.7554/eLife.00971; Davenport RJ, 2000, SCIENCE, V287, P2497, DOI 10.1126/science.287.5462.2497; Davis CA, 2007, P NATL ACAD SCI USA, V104, P7833, DOI 10.1073/pnas.0609888104; Derrington IM, 2015, NAT BIOTECHNOL, V33, P1073, DOI 10.1038/nbt.3357; Deshpande Aishwarya P, 2014, Exp Suppl, V105, P105, DOI 10.1007/978-3-0348-0856-9_6; Dey P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18933-3; Duchi D, 2016, MOL CELL, V63, P939, DOI 10.1016/j.molcel.2016.08.011; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; Eng CHL, 2019, NATURE, V568, P235, DOI 10.1038/s41586-019-1049-y; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; Farge G, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2001; Fazal FM, 2015, NATURE, V525, P274, DOI 10.1038/nature14882; Fitz V, 2016, P NATL ACAD SCI USA, V113, P12733, DOI 10.1073/pnas.1602764113; Forde NR, 2002, P NATL ACAD SCI USA, V99, P11682, DOI 10.1073/pnas.142417799; Frieda KL, 2012, SCIENCE, V338, P397, DOI 10.1126/science.1225722; Friedman LJ, 2013, P NATL ACAD SCI USA, V110, P9740, DOI 10.1073/pnas.1300221110; Friedman LJ, 2012, CELL, V148, P679, DOI 10.1016/j.cell.2012.01.018; Gaertner B, 2014, DEVELOPMENT, V141, P1179, DOI 10.1242/dev.088492; Gardner PP, 2011, NUCLEIC ACIDS RES, V39, P5845, DOI 10.1093/nar/gkr168; Gaspar I, 2015, WIRES DEV BIOL, V4, P135, DOI 10.1002/wdev.170; Gourse RL, 2012, CELL, V148, P635, DOI 10.1016/j.cell.2012.01.042; Greber BJ, 2019, SUBCELL BIOCHEM, V93, P143, DOI 10.1007/978-3-030-28151-9_5; Gross P, 2010, METHOD ENZYMOL, V475, P427, DOI 10.1016/S0076-6879(10)75017-5; Gueroui Z, 2002, P NATL ACAD SCI USA, V99, P6005, DOI 10.1073/pnas.092561399; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0; Hanske J, 2018, CURR OPIN STRUC BIOL, V52, P8, DOI 10.1016/j.sbi.2018.07.002; Heller I, 2014, CHEM REV, V114, P3087, DOI 10.1021/cr4003006; Herbert KM, 2008, ANNU REV BIOCHEM, V77, P149, DOI 10.1146/annurev.biochem.77.073106.100741; Herbert KM, 2006, CELL, V125, P1083, DOI 10.1016/j.cell.2006.04.032; Hua BY, 2018, J AM CHEM SOC, V140, P10067, DOI 10.1021/jacs.8b03784; Hwang H, 2014, CHEM SOC REV, V43, P1221, DOI 10.1039/c3cs60201j; Hwang H, 2011, P NATL ACAD SCI USA, V108, P7414, DOI 10.1073/pnas.1017672108; Izeddin I, 2014, ELIFE, V3, DOI 10.7554/eLife.02230; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kang JY, 2019, J MOL BIOL, V431, P4007, DOI 10.1016/j.jmb.2019.07.017; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2005, MOL CELL, V20, P347, DOI 10.1016/j.molcel.2005.10.012; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Ke RQ, 2013, NAT METHODS, V10, P857, DOI 10.1038/nmeth.2563; Kemmerich FE, 2016, NANO LETT, V16, P381, DOI 10.1021/acs.nanolett.5b03956; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Koh HR, 2018, MOL CELL, V70, P695, DOI 10.1016/j.molcel.2018.04.018; Koh HR, 2017, J AM CHEM SOC, V139, P262, DOI 10.1021/jacs.6b10387; Koh HR, 2014, NUCLEIC ACIDS RES, V42, P8556, DOI 10.1093/nar/gku523; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Koslover DJ, 2012, J MOL BIOL, V423, P664, DOI 10.1016/j.jmb.2012.07.027; Kramm K, 2019, J MOL BIOL, V431, P4116, DOI 10.1016/j.jmb.2019.06.009; Kreig A, 2015, NUCLEIC ACIDS RES, V43, P7961, DOI 10.1093/nar/gkv749; Krieg M, 2019, NAT REV PHYS, V1, P41, DOI 10.1038/s42254-018-0001-7; Larson MH, 2008, CELL, V132, P971, DOI 10.1016/j.cell.2008.01.027; Larson MH, 2012, P NATL ACAD SCI USA, V109, P6555, DOI 10.1073/pnas.1200939109; Larson MH, 2011, MOL CELL, V41, P249, DOI 10.1016/j.molcel.2011.01.008; Lee CY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17176-7; Lee JH, 2014, SCIENCE, V343, P1360, DOI 10.1126/science.1250212; Lerner E, 2018, SCIENCE, V359, P288, DOI 10.1126/science.aan1133; Lerner E, 2017, TRANSCR-AUSTIN, V8, P242, DOI 10.1080/21541264.2017.1308853; Lerner E, 2016, J PHYS CHEM B, V120, P6401, DOI 10.1021/acs.jpcb.6b03692; Levsky JM, 2002, SCIENCE, V297, P836, DOI 10.1126/science.1072241; Lim G, 2020, NUCLEIC ACIDS RES, V48, P9195, DOI 10.1093/nar/gkaa695; Lisica Ana, 2017, BioMolecular Concepts, V8, P1, DOI 10.1515/bmc-2016-0028; Liu CH, 2001, J MOL BIOL, V308, P465, DOI 10.1006/jmbi.2001.4601; Liu X, 2013, BBA-GENE REGUL MECH, V1829, P2, DOI 10.1016/j.bbagrm.2012.09.003; Liu Z, 2018, J CELL BIOL, V217, P1181, DOI 10.1083/jcb.201710038; Luo G, 2007, P NATL ACAD SCI USA, V104, P12610, DOI 10.1073/pnas.0700920104; Ma J, 2013, SCIENCE, V340, P1580, DOI 10.1126/science.1235441; Margeat E, 2006, BIOPHYS J, V90, P1419, DOI 10.1529/biophysj.105.069252; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Mayfield JE, 2016, BBA-PROTEINS PROTEOM, V1864, P372, DOI 10.1016/j.bbapap.2016.01.007; Mazumder A, 2020, P NATL ACAD SCI USA, V117, P15642, DOI 10.1073/pnas.1920427117; MCCLURE WR, 1985, ANNU REV BIOCHEM, V54, P171, DOI 10.1146/annurev.bi.54.070185.001131; Mitra P, 2017, ANNU REV MICROBIOL, V71, P687, DOI 10.1146/annurev-micro-030117-020432; Moffitt JR, 2016, P NATL ACAD SCI USA, V113, P14456, DOI 10.1073/pnas.1617699113; Mukhopadhyay J, 2001, CELL, V106, P453, DOI 10.1016/S0092-8674(01)00464-0; MUNSON LM, 1981, BIOCHEMISTRY-US, V20, P2081, DOI 10.1021/bi00511a003; Nagy J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7161; Neuert G, 2013, SCIENCE, V339, P584, DOI 10.1126/science.1231456; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Neuman KC, 2010, J BIOL CHEM, V285, P18967, DOI 10.1074/jbc.R109.092437; Niaki AG, 2020, MOL CELL, V77, P82, DOI 10.1016/j.molcel.2019.09.022; Nogales E, 2017, ANNU REV BIOPHYS, V46, P59, DOI 10.1146/annurev-biophys-070816-033751; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; Porrua O, 2016, TRENDS GENET, V32, P508, DOI 10.1016/j.tig.2016.05.007; Porrua O, 2015, NAT REV MOL CELL BIO, V16, P190, DOI 10.1038/nrm3943; Qiu YP, 2015, STRUCTURE, V23, P1018, DOI 10.1016/j.str.2015.04.006; Raillon C, 2012, NANO LETT, V12, P1157, DOI 10.1021/nl3002827; Ray-Soni A, 2016, ANNU REV BIOCHEM, V85, P319, DOI 10.1146/annurev-biochem-060815-014844; Revyakin A, 2004, P NATL ACAD SCI USA, V101, P4776, DOI 10.1073/pnas.0307241101; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; Revyakin A, 2012, GENE DEV, V26, P1691, DOI 10.1101/gad.194936.112; Rippe K, 1997, J MOL BIOL, V270, P125, DOI 10.1006/jmbi.1997.1079; Rivetti C, 1999, EMBO J, V18, P4464, DOI 10.1093/emboj/18.16.4464; Roberts JW, 2019, J MOL BIOL, V431, P4030, DOI 10.1016/j.jmb.2019.04.003; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Saba J, 2019, ELIFE, V8, DOI 10.7554/eLife.40981; Saecker RM, 2011, J MOL BIOL, V412, P754, DOI 10.1016/j.jmb.2011.01.018; Sainsbury S, 2015, NAT REV MOL CELL BIO, V16, P129, DOI 10.1038/nrm3952; Santangelo TJ, 2004, MOL CELL, V14, P117, DOI 10.1016/S1097-2765(04)00154-6; Sarkar R, 2016, FRONT PHYS-LAUSANNE, V4, DOI 10.3389/fphy.2016.00048; SCHAFER DA, 1991, NATURE, V352, P444, DOI 10.1038/352444a0; Shaevitz JW, 2003, NATURE, V426, P684, DOI 10.1038/nature02191; Shandilya J, 2012, BBA-GENE REGUL MECH, V1819, P391, DOI 10.1016/j.bbagrm.2012.01.010; Skinner GM, 2004, J BIOL CHEM, V279, P3239, DOI 10.1074/jbc.M310471200; Sorokina M, 2009, J AM CHEM SOC, V131, P9630, DOI 10.1021/ja902861f; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stennett EMS, 2015, J PHYS CHEM LETT, V6, P1819, DOI 10.1021/acs.jpclett.5b00613; Suzuki Y, 2012, FEBS LETT, V586, P3187, DOI 10.1016/j.febslet.2012.06.033; Tang GQ, 2009, P NATL ACAD SCI USA, V106, P22175, DOI 10.1073/pnas.0906979106; Tomko EJ, 2019, METHODS, V159, P35, DOI 10.1016/j.ymeth.2019.03.010; Tomko EJ, 2017, NAT STRUCT MOL BIOL, V24, P1139, DOI 10.1038/nsmb.3500; Tutucci E, 2018, ANNU REV BIOPHYS, V47, P85, DOI 10.1146/annurev-biophys-070317-033037; Vera M, 2016, ANNU REV GENET, V50, P267, DOI 10.1146/annurev-genet-120215-034854; Vishwakarma RK, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao5498; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Wang F, 2013, NAT STRUCT MOL BIOL, V20, P174, DOI 10.1038/nsmb.2472; Wang F, 2011, J MOL BIOL, V412, P814, DOI 10.1016/j.jmb.2011.01.024; Wang S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09560-9; Wang WY, 2018, BIOTECHNOL ADV, V36, P2129, DOI 10.1016/j.biotechadv.2018.10.001; Wang X., 2018, SCIENCE, V361, pAAT5691, DOI [DOI 10.1126/science.aat5691, 10.1126/science.aat5691]; Yakhnin AV, 2016, J BIOL CHEM, V291, P5299, DOI 10.1074/jbc.M115.704189; Yarnell WS, 1999, SCIENCE, V284, P611, DOI 10.1126/science.284.5414.611; Zhang ZJ, 2018, TRANSCR-AUSTIN, V9, P159, DOI 10.1080/21541264.2017.1363017; Zhang ZJ, 2016, GENE DEV, V30, P2106, DOI 10.1101/gad.285395.116; Zhang ZJ, 2014, ELIFE, V3, DOI 10.7554/eLife.01775; Zhou J, 2011, MOL CELL, V44, P635, DOI 10.1016/j.molcel.2011.09.018	150	2	2	10	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101086	10.1016/j.jbc.2021.101086	http://dx.doi.org/10.1016/j.jbc.2021.101086			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34403697	gold, Green Published			2022-12-28	WOS:000706409200012
J	Li, YX; Chen, XY; Nie, YY; Tian, YH; Xiao, X; Yang, F				Li, Yanxin; Chen, Xiaoying; Nie, Yingying; Tian, Yuhua; Xiao, Xian; Yang, Fan			Endocannabinoid activation of the TRPV1 ion channel is distinct from activation by capsaicin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONFORMER GENERATION; STRUCTURAL BASIS; VOLTAGE SENSOR; DESIGN; CONFORMATIONS; VALIDATION; PREDICTION; SYSTEM; LIGAND	Transient receptor potential vanilloid 1 (TRPV1) ion channel serves as the detector for noxious temperature above 42 degrees C, pungent chemicals like capsaicin, and acidic extracellular pH. This channel has also been shown to function as an ionotropic cannabinoid receptor. Despite the solving of high-resolution three-dimensional structures of TRPV1, how endocannabinoids such as anandamide and N-arachidonoyl dopamine bind to and activate this channel remains largely unknown. Here we employed a combination of patch-clamp recording, site directed mutagenesis, and molecular docking techniques to investigate how the endocannabinoids structurally bind to and open the TRPV1 ion channel. We found that these endocannabinoid ligands bind to the vanilloid-binding pocket of TRPV1 in the "tail-up, head-down" configuration, similar to capsaicin; however, there is a unique interaction with TRPV1 Y512 residue critical for endocannabinoid activation of TRPV1 channels. These data suggest that a differential structural mechanism is involved in TRPV1 activation by endocannabinoids compared with the classic agonist capsaicin.	[Li, Yanxin; Nie, Yingying; Tian, Yuhua] Qingdao Univ, Med Coll, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China; [Chen, Xiaoying; Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China; [Chen, Xiaoying; Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China; [Xiao, Xian] Westlake Univ, Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Zhejiang, Peoples R China	Qingdao University; Zhejiang University; Zhejiang University; Westlake University	Tian, YH (corresponding author), Qingdao Univ, Med Coll, Dept Pharmacol, Sch Pharm, Qingdao, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China.; Xiao, X (corresponding author), Westlake Univ, Westlake Inst Adv Study, Inst Basic Med Sci, Hangzhou, Zhejiang, Peoples R China.	yhtian05250@qdu.edu.cn; xiaoxian@westlake.edu.cn; fanyang@zju.edu.cn	Yang, Fan/AAA-6904-2022	Yang, Fan/0000-0002-0520-5254; Tian, Yuhua/0000-0001-8239-6560	National Natural Science Foundation of China [31971040, 31800990]; Zhejiang Provincial Natural Science Foundation of China [LR20C050002, LQ19H090009]; Natural Science Foundation of Shandong Province [ZR2020MH161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (31971040 and 31800990 to F. Y.), Zhejiang Provincial Natural Science Foundation of China (LR20C050002 to F. Y.; LQ19H090009 to X. X.), and Natural Science Foundation of Shandong Province (ZR2020MH161 to Y. T.).	Akopian AN, 2009, TRENDS PHARMACOL SCI, V30, P79, DOI 10.1016/j.tips.2008.10.008; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Di Marzo V, 2002, CURR OPIN NEUROBIOL, V12, P372, DOI 10.1016/S0959-4388(02)00340-9; Dong YW, 2019, BIOCHEM BIOPH RES CO, V516, P365, DOI 10.1016/j.bbrc.2019.06.039; Donvito G, 2018, NEUROPSYCHOPHARMACOL, V43, P52, DOI 10.1038/npp.2017.204; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Gavva N.R., 2009, OPEN DRUG DISCOV J, V1, P1, DOI 10.2174/1877381800901010001; Hawkins PCD, 2012, J CHEM INF MODEL, V52, P2919, DOI 10.1021/ci300314k; Hawkins PCD, 2010, J CHEM INF MODEL, V50, P572, DOI 10.1021/ci100031x; Howlett AC, 2002, PROSTAG OTH LIPID M, V68-9, P619, DOI 10.1016/S0090-6980(02)00060-6; Hughes TET, 2018, NAT STRUCT MOL BIOL, V25, P53, DOI 10.1038/s41594-017-0009-1; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Kaszas K, 2012, J PHARMACOL EXP THER, V340, P152, DOI 10.1124/jpet.111.183053; Kort ME, 2012, PROGR MED CHEM, V51, P57, DOI 10.1016/B978-0-12-396493-9.00002-9; Leaver-Fay A, 2011, METHOD ENZYMOL, P545, DOI [10.1016/S0076-6879(11)87019-9, 10.1016/B978-0-12-381270-4.00019-6]; Lebovitz EE, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-70; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Lishko PV, 2007, NEURON, V54, P905, DOI 10.1016/j.neuron.2007.05.027; Manning BH, 2001, J NEUROSCI, V21, P8238, DOI 10.1523/JNEUROSCI.21-20-08238.2001; Muller C, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00144; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pumroy RA, 2019, ELIFE, V8, DOI 10.7554/eLife.48792; Ranganathan R, 1996, NEURON, V16, P131, DOI 10.1016/S0896-6273(00)80030-6; Singh AK, 2018, NAT STRUCT MOL BIOL, V25, P805, DOI 10.1038/s41594-018-0108-7; Xu LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17582-x; Yang F, 2020, ADV SCI, V7, DOI 10.1002/advs.202000575; Yang F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05339-6; Yang F, 2016, P NATL ACAD SCI USA, V113, pE3657, DOI 10.1073/pnas.1604180113; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Yang SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700810; Yang SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9297; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2006, P NATL ACAD SCI USA, V103, P7292, DOI 10.1073/pnas.0602350103; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Yin Y, 2019, BRIT J PHARMACOL, V176, P3364, DOI 10.1111/bph.14766; Zhang F, 2019, ELIFE, V8, DOI 10.7554/eLife.42756; Zhang F, 2016, ELIFE, V5, DOI 10.7554/eLife.16409; Zhu AQ, 2020, TOXICON, V178, P41, DOI 10.1016/j.toxicon.2020.02.016; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	45	9	9	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101022	10.1016/j.jbc.2021.101022	http://dx.doi.org/10.1016/j.jbc.2021.101022			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34332978	gold, Green Published			2022-12-28	WOS:000706408900010
J	Nassour, H; Hoang, TA; Martin, RD; Dallagnol, JCC; Billard, E; Letourneau, M; Novellino, E; Carotenuto, A; Allen, BG; Tanny, JC; Fournier, A; Hebert, TE; Chatenet, D				Nassour, Hassan; Tuan Anh Hoang; Martin, Ryan D.; Dallagnol, Juliana C. C.; Billard, Etienne; Letourneau, Myriam; Novellino, Ettore; Carotenuto, Alfonso; Allen, Bruce G.; Tanny, Jason C.; Fournier, Alain; Hebert, Terence E.; Chatenet, David			Lipidated peptides derived from intracellular loops 2 and 3 of the urotensin II receptor act as biased allosteric ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; LYSOPHOSPHATIDIC ACID; BINDING-SITES; ACTIVATION; ANTAGONIST; PEPDUCINS; ATHEROSCLEROSIS; INHIBITION; MODULATE; INSIGHT	Over the last decade, the urotensinergic system, composed of one G protein-coupled receptor and two endogenous ligands, has garnered significant attention as a promising new target for the treatment of various cardiovascular diseases. Indeed, this system is associated with various biomarkers of cardiovascular dysfunctions and is involved in changes in cardiac contractility, fibrosis, and hypertrophy contributing, like the angiotensiner-gic system, to the pathogenesis and progression of heart failure. Significant investment has been made toward the development of clinically relevant UT ligands for therapeutic intervention, but with little or no success to date. This system therefore re-mains to be therapeutically exploited. Pepducins and other lipidated peptides have been used as both mechanistic probes and potential therapeutics; therefore, pepducins derived from the human urotensin II receptor might represent unique tools to generate signaling bias and study hUT signaling networks. Two hUT-derived pepducins, derived from the second and the third intracellular loop of the receptor (hUT-Pep2 and [Trp(1), Leu(2)]hUT-Pep3, respectively), were synthesized and pharma-cologically characterized. Our results demonstrated that hUT-Pep2 and [Trp(1), Leu(2)]hUT-Pep3 acted as biased ago-allosteric modulators, triggered ERK1/2 phosphorylation and, to a lesser extent, IP1 production, and stimulated cell proliferation yet were devoid of contractile activity. Interestingly, both hUT-derived pepducins were able to modulate human urotensin II (hUII)-and urotensin II-related peptide (URP)-mediated contraction albeit to different extents. These new derivatives represent unique tools to reveal the intricacies of hUT signaling and also a novel avenue for the design of allosteric ligands selectively targeting hUT signaling potentially.	[Nassour, Hassan; Tuan Anh Hoang; Dallagnol, Juliana C. C.; Billard, Etienne; Letourneau, Myriam; Fournier, Alain; Chatenet, David] Univ Quebec, Inst Natl Rech Sci, Ctr Armand Frappier Sante Biotechnol, Grp Rech Ingn Peptides & Pharmacotherapie GRIPP, Laval, PQ, Canada; [Martin, Ryan D.; Dallagnol, Juliana C. C.; Billard, Etienne; Tanny, Jason C.; Hebert, Terence E.] McGill Univ, Dept Pharmacol & Therapeut, Montreal, PQ, Canada; [Dallagnol, Juliana C. C.; Allen, Bruce G.] Univ Montreal, Montreal Heart Inst, Dept Med, Montreal, PQ, Canada; [Novellino, Ettore; Carotenuto, Alfonso] Univ Naples Federico II, Dept Pharm, Naples, Italy	University of Quebec; Institut national de la recherche scientifique (INRS); McGill University; Universite de Montreal; University of Naples Federico II	Chatenet, D (corresponding author), Univ Quebec, Inst Natl Rech Sci, Ctr Armand Frappier Sante Biotechnol, Grp Rech Ingn Peptides & Pharmacotherapie GRIPP, Laval, PQ, Canada.	david.chatenet@iaf.inrs.ca	Tanny, Jason/AAD-3624-2022; Allen, Bruce/B-4693-2008; Carotenuto, Alfonso/C-8491-2014	Allen, Bruce/0000-0001-9000-9495; Carotenuto, Alfonso/0000-0001-7532-5449	Heart and Stroke Foundation of Canada [G-150008938]; Canadian Institutes of Health Research [PJT-159687, MOP-142184]; Natural Sciences and Engineering Research Council of Canada [RGPIN-2015-04848]; McGill-CIHR Drug Development Training Program; McGill Faculty of Medicine and Health Sciences; Fonds de Recherche en Sante du Quebec; Barbara & Edward Victor award - McGill Faculty of Medicine; Canadian Pacific Chair in Biotechnology	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); McGill-CIHR Drug Development Training Program(Canadian Institutes of Health Research (CIHR)); McGill Faculty of Medicine and Health Sciences; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Barbara & Edward Victor award - McGill Faculty of Medicine; Canadian Pacific Chair in Biotechnology	This work was supported by a grant from the Heart and Stroke Foundation of Canada (G-150008938) and the Canadian Institutes of Health Research (PJT159687) to T. E. H. and J. C. T, a grant from the Canadian Institutes of Health Research to D. C. (MOP-142184) and a grant from the Natural Sciences and Engineering Research Council of Canada (RGPIN-2015-04848) to D. C. R. D. M. was supported by studentships from the McGill-CIHR Drug Development Training Program and the McGill Faculty of Medicine and Health Sciences. H. N. was supported by a fellowship from the Fonds de Recherche en Sante du Quebec. J. C. C. D was supported by the Barbara & Edward Victor award granted by McGill Faculty of Medicine. T. E. H. holds the Canadian Pacific Chair in Biotechnology.	Andersen NH, 1996, FEBS LETT, V399, P47, DOI 10.1016/S0014-5793(96)01279-3; [Anonymous], 2012, Drug Discov Today Technol, V9, pe1, DOI 10.1016/j.ddtec.2011.07.002; Armstrong C.W.D., 2020, NAR CANC, V2, pzcaa012, DOI [10.1093/narcan/zcaa012, DOI 10.1093/NARCAN/ZCAA012]; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Belcheva MM, 2002, NEUROSIGNALS, V11, P34, DOI 10.1159/000057320; Billard E, 2019, PEPTIDE SCI, V111, DOI 10.1002/pep2.24056; Billard E, 2018, J MED CHEM, V61, P8707, DOI 10.1021/acs.jmedchem.8b00789; Billard E, 2017, BIOCHEM PHARMACOL, V144, P100, DOI 10.1016/j.bcp.2017.08.003; Blaukat A, 2000, MOL CELL BIOL, V20, P6837, DOI 10.1128/MCB.20.18.6837-6848.2000; Bousette N, 2006, PEPTIDES, V27, P2919, DOI 10.1016/j.peptides.2006.06.011; Bousette N, 2006, J MOL CELL CARDIOL, V41, P285, DOI 10.1016/j.yjmcc.2006.05.008; Brancaccio D, 2015, J PEPT SCI, V21, P392, DOI 10.1002/psc.2740; BRAUNSCHWEILER L, 1983, J MAGN RESON, V53, P521, DOI 10.1016/0022-2364(83)90226-3; Breton B, 2010, BIOPHYS J, V99, P4037, DOI 10.1016/j.bpj.2010.10.025; Brule C, 2014, FASEB J, V28, P5148, DOI 10.1096/fj.14-249771; Buech TRH, 2008, J BIOL CHEM, V283, P20330, DOI 10.1074/jbc.M800211200; Carr R, 2016, BIOCHEM SOC T, V44, P555, DOI 10.1042/BST20150230; Carr R, 2014, J BIOL CHEM, V289, P35668, DOI 10.1074/jbc.M114.618819; Chatenet D, 2013, BRIT J PHARMACOL, V168, P807, DOI 10.1111/j.1476-5381.2012.02217.x; Chatenet D, 2012, BIOCHEM PHARMACOL, V83, P608, DOI 10.1016/j.bcp.2011.12.009; Chaturvedi M, 2018, TRENDS BIOCHEM SCI, V43, P533, DOI 10.1016/j.tibs.2018.04.003; Colombo F, 2003, J CELL PHYSIOL, V195, P322, DOI 10.1002/jcp.10251; Covic L, 2002, P NATL ACAD SCI USA, V99, P643, DOI 10.1073/pnas.022460899; Covic L, 2002, NAT MED, V8, P1161, DOI 10.1038/nm760; Devost D, 2017, J BIOL CHEM, V292, P5443, DOI 10.1074/jbc.M116.763854; Dimond P, 2011, ANN NY ACAD SCI, V1226, P34, DOI 10.1111/j.1749-6632.2011.06039.x; Doan ND, 2012, BRIT J PHARMACOL, V166, P243, DOI 10.1111/j.1476-5381.2011.01710.x; Doreleijers JF, 1998, J MOL BIOL, V281, P149, DOI 10.1006/jmbi.1998.1808; Douchez A, 2017, J MED CHEM, V60, P9838, DOI 10.1021/acs.jmedchem.7b01525; Dufour-Gallant J, 2015, J MED CHEM, V58, P4624, DOI 10.1021/acs.jmedchem.5b00162; Esposito G, 2011, BASIC RES CARDIOL, V106, P577, DOI 10.1007/s00395-011-0163-2; Fan GH, 1998, EUR J PHARMACOL, V341, P317, DOI 10.1016/S0014-2999(97)01477-5; Gohla A, 1998, J BIOL CHEM, V273, P4653, DOI 10.1074/jbc.273.8.4653; Goldsmith ZG, 2007, ONCOGENE, V26, P3122, DOI 10.1038/sj.onc.1210407; Granier S, 2012, NAT CHEM BIOL, V8, P670, DOI 10.1038/nchembio.1025; Grundmann M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02661-3; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Gurbel PA, 2016, ARTERIOSCL THROM VAS, V36, P189, DOI 10.1161/ATVBAHA.115.306777; Hains MD, 2006, MOL PHARMACOL, V69, P2068, DOI 10.1124/mol.105.017921; Handlogten ME, 2001, J BIOL CHEM, V276, P13941, DOI 10.1074/jbc.M007306200; He Yan-hua, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P505; HWANG TL, 1995, J MAGN RESON SER A, V112, P275, DOI 10.1006/jmra.1995.1047; Jarry M, 2010, BIOCHEM J, V428, P113, DOI 10.1042/BJ20090867; JEENER J, 1979, J CHEM PHYS, V71, P4546, DOI 10.1063/1.438208; Kaneider NC, 2005, NAT MED, V11, P661, DOI 10.1038/nm1245; Kenakin T, 2012, BMC PHARMACOL TOXICO, V13, DOI 10.1186/2050-6511-13-3; Kenakin T, 2011, J PHARMACOL EXP THER, V336, P296, DOI 10.1124/jpet.110.173948; Kim SK, 2010, CHEMMEDCHEM, V5, P1594, DOI 10.1002/cmdc.201000175; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kuliopulos A, 2020, ARTERIOSCL THROM VAS, V40, P2990, DOI 10.1161/ATVBAHA.120.315168; Lee JH, 2016, INT IMMUNOPHARMACOL, V40, P196, DOI 10.1016/j.intimp.2016.09.002; Lukasheva V, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65636-3; Luttrell LM, 2015, MOL PHARMACOL, V88, P579, DOI 10.1124/mol.115.099630; MAPLE JR, 1988, P NATL ACAD SCI USA, V85, P5350, DOI 10.1073/pnas.85.15.5350; Mariggio S, 2006, CELL SIGNAL, V18, P2200, DOI 10.1016/j.cellsig.2006.05.003; MARION D, 1983, BIOCHEM BIOPH RES CO, V113, P967, DOI 10.1016/0006-291X(83)91093-8; Merlino F, 2019, J MED CHEM, V62, P1455, DOI 10.1021/acs.jmedchem.8b01601; Merlino F, 2016, J MED CHEM, V59, P4740, DOI 10.1021/acs.jmedchem.6b00108; Nassour H, 2019, TRENDS PHARMACOL SCI, V40, P725, DOI 10.1016/j.tips.2019.08.005; O'Callaghan K, 2012, J BIOL CHEM, V287, P12787, DOI 10.1074/jbc.R112.355461; Oduori OS, 2020, J CLIN INVEST, V130, P6639, DOI 10.1172/JCI140046; Oh KS, 2017, EUR J PHARMACOL, V799, P94, DOI 10.1016/j.ejphar.2017.02.003; Pehlivan Y, 2014, INFLAMMATION, V37, P1280, DOI 10.1007/s10753-014-9855-8; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; PIANTINI U, 1982, J AM CHEM SOC, V104, P6800, DOI 10.1021/ja00388a062; Prosser HCG, 2008, PEPTIDES, V29, P770, DOI 10.1016/j.peptides.2007.08.013; Quoyer J, 2013, P NATL ACAD SCI USA, V110, pE5088, DOI 10.1073/pnas.1312515110; Sauzeau V, 2001, CIRC RES, V88, P1102, DOI 10.1161/hh1101.092034; Saviello MR, 2010, BIOCHEMISTRY-US, V49, P1477, DOI 10.1021/bi902166d; STATES DJ, 1982, J MAGN RESON, V48, P286, DOI 10.1016/0022-2364(82)90279-7; Strack M, 2017, BIOORG MED CHEM LETT, V27, P3412, DOI 10.1016/j.bmcl.2017.05.088; Tressel SL, 2011, METHODS MOL BIOL, V683, P259, DOI 10.1007/978-1-60761-919-2_19; Tsuji M, 2013, ORG BIOMOL CHEM, V11, P3030, DOI 10.1039/c3ob27445d; Vaudry H, 2015, PHARMACOL REV, V67, P214, DOI 10.1124/pr.114.009480; Wang Y, 2019, CLIN RHEUMATOL, V38, P29, DOI 10.1007/s10067-018-3978-5; Watson AMD, 2013, DIABETOLOGIA, V56, P1155, DOI 10.1007/s00125-013-2837-9; Wu YL, 1998, NEUROREPORT, V9, P99, DOI 10.1097/00001756-199801050-00020; Wuthrich K, 1986, NMR PROTEINS NUCL AC; You ZP, 2012, ARTERIOSCL THROM VAS, V32, P1809, DOI 10.1161/ATVBAHA.112.252973; Zhang P, 2015, J BIOL CHEM, V290, P15785, DOI 10.1074/jbc.M115.636316; Zhang YG, 2008, J HYPERTENS, V26, P1119, DOI 10.1097/HJH.0b013e3282fa1412; Zhang YG, 2007, ACTA PHARMACOL SIN, V28, P36, DOI 10.1111/j.1745-7254.2007.00485.x; Zhao J, 2014, EXP THER MED, V7, P1647, DOI 10.3892/etm.2014.1654; Zhao J, 2013, EXP THER MED, V5, P1765, DOI 10.3892/etm.2013.1052	84	2	2	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101057	10.1016/j.jbc.2021.101057	http://dx.doi.org/10.1016/j.jbc.2021.101057			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34389356	Green Published, gold			2022-12-28	WOS:000706409400005
J	Safren, N; Tank, EM; Malik, AM; Chua, JP; Santoro, N; Barmada, SJ				Safren, Nathaniel; Tank, Elizabeth M.; Malik, Ahmed M.; Chua, Jason P.; Santoro, Nicholas; Barmada, Sami J.			Development of a specific live-cell assay for native autophagic flux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; MOUSE MODEL; HEXANUCLEOTIDE REPEAT; CARGO RECOGNITION; MUTANT HUNTINGTIN; PROTEIN; MUTATIONS; DISEASE; C9ORF72	Autophagy is an evolutionarily conserved pathway mediating the breakdown of cellular proteins and organelles. Emphasizing its pivotal nature, autophagy dysfunction contributes to many diseases; nevertheless, development of effective autophagy modulating drugs is hampered by fundamental deficiencies in available methods for measuring autophagic activity or flux. To overcome these limitations, we introduced the photo convertible protein Dendra2 into the MAP1LC3B locus of human cells via CRISPR/Cas9 genome editing, enabling accurate and sensitive assessments of autophagy in living cells by optical pulse labeling. We used this assay to perform high throughput drug screens of four chemical libraries comprising over 30,000 diverse compounds, identifying several clinically relevant drugs and novel autophagy modulators. A select series of candidate compounds also modulated autophagy flux in human motor neurons modified by CRISPR/Cas9 to express GFP-labeled LC3. Using automated microscopy, we tested the therapeutic potential of autophagy induction in several distinct neuronal models of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD). In doing so, we found that autophagy induction exhibited discordant effects, improving survival in disease models involving the RNA binding protein TDP-43, while exacerbating toxicity in neurons expressing mutant forms of UBQLN2 and C9ORF72 associated with familial ALS/FTD. These studies confirm the utility of the Dendra2-LC3 assay, while illustrating the contradictory effects of autophagy induction in different ALS/FTD subtypes.	[Safren, Nathaniel; Tank, Elizabeth M.; Malik, Ahmed M.; Chua, Jason P.; Barmada, Sami J.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Santoro, Nicholas] Univ Michigan, Ctr Chem Gen, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Barmada, SJ (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	sbarmada@umich.edu		Malik, Ahmed/0000-0002-2625-7483; Safren, Nathaniel/0000-0003-4866-4837; Barmada, Sami/0000-0002-9604-968X	National Institutes of Health National Institute on Aging [P30 AG053760]; National Institute of Neurological Disorders and Stroke [R01-NS097542, R01-NS113943]; University of Michigan Protein Folding Disease Initiative; Center for Chemical Genomics (CCG) at the University of Michigan Life Sciences Institute, Michigan Drug Discovery; Robert Packard Center for ALS Research; Ann Arbor Active Against ALS	National Institutes of Health National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Michigan Protein Folding Disease Initiative; Center for Chemical Genomics (CCG) at the University of Michigan Life Sciences Institute, Michigan Drug Discovery; Robert Packard Center for ALS Research; Ann Arbor Active Against ALS	This article contains supporting information. Acknowledgments-This work was supported by the National Institutes of Health National Institute on Aging P30 AG053760, Na-tional Institute of Neurological Disorders and Stroke R01-NS097542 and R01-NS113943, the University of Michigan Protein Folding Disease Initiative, the Center for Chemical Genomics (CCG) at the University of Michigan Life Sciences Institute, Michigan Drug Discovery, the Robert Packard Center for ALS Research, and Ann Arbor Active Against ALS. We thank Dr Vincent Groppi of Michigan Drug Discovery for his continued support and insights; Dr Lois Weisman and Prof. Tamotsu Yoshimori for RFP-GFP-LC3 HeLa cells; and Dr Paula Gedraitis (Molecular Devices, LLC) for technical assistance. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akar U, 2007, MOL CANCER RES, V5, P241, DOI 10.1158/1541-7786.MCR-06-0229; Alers S, 2012, MOL CELL BIOL, V32, P2, DOI 10.1128/MCB.06159-11; Amick J, 2016, MOL BIOL CELL, V27, P3040, DOI 10.1091/mbc.E16-01-0003; Archbold HC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22858-w; Arrasate M, 2005, P NATL ACAD SCI USA, V102, P3840, DOI 10.1073/pnas.0409777102; Ashkenazi A, 2017, NATURE, V545, P108, DOI 10.1038/nature22078; Awad O, 2015, HUM MOL GENET, V24, P5775, DOI 10.1093/hmg/ddv297; Balgi AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007124; Barmada SJ, 2015, P NATL ACAD SCI USA, V112, P7821, DOI 10.1073/pnas.1509744112; Barmada SJ, 2014, NAT CHEM BIOL, V10, P677, DOI 10.1038/nchembio.1563; Barmada SJ, 2010, J NEUROSCI, V30, P639, DOI 10.1523/JNEUROSCI.4988-09.2010; Boecker CA, 2020, TRAFFIC, V21, P138, DOI 10.1111/tra.12701; Boivin M, 2020, EMBO J, V39, DOI 10.15252/embj.2018100574; Bolognesi B, 2016, CELL REP, V16, P222, DOI 10.1016/j.celrep.2016.05.076; Castillo K, 2013, AUTOPHAGY, V9, P1308, DOI 10.4161/auto.25188; Cerbini T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116032; Chauhan S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9620; CHRISTENSEN E, 1987, HEPATOLOGY, V7, P1346, DOI 10.1002/hep.1840070628; Chudakov DM, 2007, NAT PROTOC, V2, P2024, DOI 10.1038/nprot.2007.291; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; DeBosch BJ, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aac5472; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Deng HX, 2011, NATURE, V477, P211, DOI 10.1038/nature10353; Eguchi Y, 2018, ELIFE, V7, DOI 10.7554/eLife.34595; Evans CS, 2019, NEUROBIOL DIS, V122, P35, DOI 10.1016/j.nbd.2018.07.005; Fernandopulle Michael S, 2018, Curr Protoc Cell Biol, V79, pe51, DOI 10.1002/cpcb.51; Flores BN, 2019, CELL REP, V27, P1133, DOI 10.1016/j.celrep.2019.03.093; Florey O, 2015, AUTOPHAGY, V11, P88, DOI 10.4161/15548627.2014.984277; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Galluzzi L, 2017, NAT REV DRUG DISCOV, V16, P487, DOI 10.1038/nrd.2017.22; Galluzzi L, 2017, NAT REV CLIN ONCOL, V14, P247, DOI 10.1038/nrclinonc.2016.183; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Gijselinck I, 2015, NEUROLOGY, V85, P2116, DOI 10.1212/WNL.0000000000002220; Gijselinck I, 2012, LANCET NEUROL, V11, P54, DOI 10.1016/S1474-4422(11)70261-7; Gorrie GH, 2014, P NATL ACAD SCI USA, V111, P14524, DOI 10.1073/pnas.1405741111; Guo JY, 2013, CELL, V155, P1216, DOI 10.1016/j.cell.2013.11.019; Gupta A, 2010, P NATL ACAD SCI USA, V107, P14333, DOI 10.1073/pnas.1000248107; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hjerpe R, 2016, CELL, V166, P935, DOI 10.1016/j.cell.2016.07.001; Joo JH, 2016, MOL CELL, V62, P491, DOI 10.1016/j.molcel.2016.04.020; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kliosnky D, 2016, AUTOPHAGY, V12, P443, DOI 10.1080/15548627.2016.1147886; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kuoa SY, 2015, P NATL ACAD SCI USA, V112, pE4281, DOI 10.1073/pnas.1512289112; Le Ber I, 2013, JAMA NEUROL, V70, P1403, DOI 10.1001/jamaneurol.2013.3849; Lee EB, 2012, NAT REV NEUROSCI, V13, P38, DOI 10.1038/nrn3121; Lee HJ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0749-9; Leestemaker Y, 2017, CELL CHEM BIOL, V24, P725, DOI 10.1016/j.chembiol.2017.05.010; Liang CC, 2010, J BIOL CHEM, V285, P3499, DOI 10.1074/jbc.M109.072389; Liu QS, 2012, METHODS MOL BIOL, V821, P447, DOI 10.1007/978-1-61779-430-8_29; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Malik AM, 2018, ELIFE, V7, DOI 10.7554/eLife.35977; Martinez-Vicente M, 2010, NAT NEUROSCI, V13, P567, DOI 10.1038/nn.2528; Maruyama H, 2010, NATURE, V465, P223, DOI 10.1038/nature08971; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Meijer AJ, 2015, AMINO ACIDS, V47, P2037, DOI 10.1007/s00726-014-1765-4; Menzies FM, 2017, NEURON, V93, P1015, DOI 10.1016/j.neuron.2017.01.022; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Moriya H, 2015, MOL BIOL CELL, V26, P3932, DOI 10.1091/mbc.E15-07-0512; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nguyen DKH, 2019, NEUROSCI LETT, V697, P34, DOI 10.1016/j.neulet.2018.04.006; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; O'Rourke JG, 2016, SCIENCE, V351, P1324, DOI 10.1126/science.aaf1064; Pickford F, 2008, J CLIN INVEST, V118, P2190, DOI 10.1172/JCI33585; Pottier C, 2015, ACTA NEUROPATHOL, V130, P77, DOI 10.1007/s00401-015-1436-x; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ramirez A, 2006, NAT GENET, V38, P1184, DOI 10.1038/ng1884; Ran FA, 2013, CELL, V154, P1380, DOI 10.1016/j.cell.2013.08.021; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rosenfeldt MT, 2013, NATURE, V504, P296, DOI 10.1038/nature12865; Rudnick ND, 2017, P NATL ACAD SCI USA, V114, pE8294, DOI 10.1073/pnas.1704294114; Sarkar S, 2005, J CELL BIOL, V170, P1101, DOI 10.1083/jcb.200504035; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Sarkar S, 2014, NEUROTOXICOLOGY, V44, P250, DOI 10.1016/j.neuro.2014.07.006; Sellier C, 2016, EMBO J, V35, P1276, DOI 10.15252/embj.201593350; Senturk M, 2019, NAT CELL BIOL, V21, P384, DOI 10.1038/s41556-019-0281-x; Shakeri A, 2019, J CELL PHYSIOL, V234, P5643, DOI 10.1002/jcp.27404; Sharkey LM, 2018, P NATL ACAD SCI USA, V115, pE10495, DOI 10.1073/pnas.1810522115; Shi WY, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.13; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Subach OM, 2011, NAT METHODS, V8, P771, DOI 10.1038/nmeth.1664; Synofzik M, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2012.07.002; Tanaka M, 2004, NAT MED, V10, P148, DOI 10.1038/nm985; Tanik SA, 2013, J BIOL CHEM, V288, P15194, DOI 10.1074/jbc.M113.457408; Teyssou E, 2013, ACTA NEUROPATHOL, V125, P511, DOI 10.1007/s00401-013-1090-0; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tomic T, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.86; Tsvetkov AS, 2010, P NATL ACAD SCI USA, V107, P16982, DOI 10.1073/pnas.1004498107; Ugolino J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006443; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valenzuela V, 2018, AUTOPHAGY, V14, P733, DOI 10.1080/15548627.2018.1432327; Waite AJ, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.016; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Watanabe-Asano T, 2014, BIOCHEM BIOPH RES CO, V445, P334, DOI 10.1016/j.bbrc.2014.01.180; Weskamp K, 2020, J CLIN INVEST, V130, P1139, DOI 10.1172/JCI130988; Weskamp K, 2019, JOVE-J VIS EXP, DOI 10.3791/59036; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Wong E, 2010, NAT NEUROSCI, V13, P805, DOI 10.1038/nn.2575; Wong YC, 2014, J NEUROSCI, V34, P1293, DOI 10.1523/JNEUROSCI.1870-13.2014; Wu JJ, 2020, P NATL ACAD SCI USA, V117, P15230, DOI 10.1073/pnas.1917371117; Xiao SX, 2015, ANN NEUROL, V78, P568, DOI 10.1002/ana.24469; Yang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130953; Yang M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601167; Yoon S, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.501; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang LJ, 2017, MED SCI MONITOR, V23, P801, DOI 10.12659/MSM.898679; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	115	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101003	10.1016/j.jbc.2021.101003	http://dx.doi.org/10.1016/j.jbc.2021.101003			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34303705	Green Published, gold			2022-12-28	WOS:000706361700003
J	Gasparotto, J; Senger, MR; Moreira, ETD; Brum, PO; Kessler, FGC; Peixoto, DO; Panzenhagen, AC; Ong, LK; Soares, MC; Reis, PA; Schirato, GV; Valente, WCG; Montoya, BOA; Silva, FP; Moreira, JCF; Dal-Pizzol, F; Castro-Faria-Neto, HC; Gelain, DP				Gasparotto, Juciano; Senger, Mario Roberto; de Sa Moreira, Emilio Telles; Brum, Pedro Ozorio; Carazza Kessler, Flavio Gabriel; Peixoto, Daniel Oppermann; Panzenhagen, Alana Castro; Ong, Lin Kooi; Soares, Marlene Campos; Reis, Patricia Alves; Schirato, Giuliana Viegas; Goes Valente, Walter Cesar; Araujo Montoya, Bogar Omar; Silva, Floriano P.; Fonseca Moreira, Jose Claudio; Dal-Pizzol, Felipe; Castro-Faria-Neto, Hugo C.; Gelain, Daniel Pens			Neurological impairment caused by Schistosoma mansoni systemic infection exhibits early features of idiopathic neurodegenerative disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; OXIDATIVE STRESS; TAU; NEUROSCHISTOSOMIASIS; PHOSPHORYLATION; PATHOLOGY; MICROGLIA; RECEPTOR; PROTEIN; SEPSIS	Schistosomiasis, a neglected tropical disease caused by trematodes of the Schistosoma genus, affects over 250 million people around the world. This disease has been associated with learning and memory deficits in children, whereas reduced attention levels, impaired work capacity, and cognitive deficits have been observed in adults. Strongly correlated with poverty and lack of basic sanitary conditions, this chronic endemic infection is common in Africa, South America, and parts of Asia and contributes to inhibition of social development and low quality of life in affected areas. Nonetheless, studies on the mechanisms involved in the neurological impairment caused by schistosomiasis are scarce. Here, we used a murine model of infection with Schistosoma mansoni in which parasites do not invade the central nervous system to evaluate the consequences of systemic infection on neurologic function. We observed that systemic infection with S. mansoni led to astrocyte and microglia activation, expression of oxidative stress-induced transcription factor Nrf2, oxidative damage, Tau phosphorylation, and amyloid-beta peptide accumulation in the prefrontal cortex of infected animals. We also found impairment in spatial learning and memory as evaluated by the Morris water maze task. Administration of anthelmintic (praziquantel) and antioxidant (N-acetylcysteine plus deferoxamine) treatments was effective in inhibiting most of these phenotypes, and the combination of both treatments had a synergistic effect to prevent such changes. These data demonstrate new perspectives toward the understanding of the pathology and possible therapeutic approaches to counteract long-term effects of systemic schistosomiasis on brain function.	[Gasparotto, Juciano; Senger, Mario Roberto; Brum, Pedro Ozorio; Carazza Kessler, Flavio Gabriel; Peixoto, Daniel Oppermann; Panzenhagen, Alana Castro; Soares, Marlene Campos; Fonseca Moreira, Jose Claudio; Gelain, Daniel Pens] Univ Fed Rio Grande do Sul, Dept Bioquim, Ctr Estudos Estresse Oxidat, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil; [Senger, Mario Roberto; de Sa Moreira, Emilio Telles; Schirato, Giuliana Viegas; Goes Valente, Walter Cesar; Araujo Montoya, Bogar Omar; Silva, Floriano P.] Fundacao Oswaldo Cruz, Lab Bioquim Expt & Comp Formacos, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Ong, Lin Kooi] Monash Univ Malaysia, Sch Pharm, Bandar Sunway, Selangor, Malaysia; [Ong, Lin Kooi] Univ Newcastle, Sch Biomed Sci & Pharm, Callaghan, NSW, Australia; [Ong, Lin Kooi] Univ Newcastle, Prior Res Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Reis, Patricia Alves; Castro-Faria-Neto, Hugo C.] Fundacao Oswaldo Cruz, Lab Imunofarmacol, Inst Oswaldo Cruz, Rio De Janeiro, RJ, Brazil; [Dal-Pizzol, Felipe] Univ Extremo Sul Catarinense, Lab Fisiopatol Expt, Programa Posgrad Ciencias Saude, Criciuma, SC, Brazil	Universidade Federal do Rio Grande do Sul; Fundacao Oswaldo Cruz; Monash University; Monash University Sunway; University of Newcastle; University of Newcastle; Fundacao Oswaldo Cruz; Universidade do Extremo Sul Catarinense	Gelain, DP (corresponding author), Univ Fed Rio Grande do Sul, Dept Bioquim, Ctr Estudos Estresse Oxidat, Inst Ciencias Basicas Saude, Porto Alegre, RS, Brazil.	daniel.gelain@ufrgs.br	Panzenhagen, Alana Castro/ABG-8126-2021; Reis, Patricia/L-9045-2015; Silva-Jr, Floriano/B-1343-2013; Panzenhagen, Alana Castro/AAA-4545-2021; Panzenhagen, Alana Castro/ABH-2680-2021; Ong, Lin Kooi/H-2797-2012; Gasparotto, Juciano/K-3239-2013; Araujo Montoya, Bogar Omar/G-8545-2019	Panzenhagen, Alana Castro/0000-0002-8844-3468; Reis, Patricia/0000-0003-1861-9517; Silva-Jr, Floriano/0000-0003-4560-1291; Ong, Lin Kooi/0000-0001-8664-0540; , Marlene/0000-0001-6480-7151; Ozorio Brum, Pedro/0000-0002-5858-8017; Gasparotto, Juciano/0000-0003-2545-7288; Araujo Montoya, Bogar Omar/0000-0002-2954-2271	PQ-CNPq fellowship; PDS-CNPq fellowship	PQ-CNPq fellowship; PDS-CNPq fellowship	M. R. S. was a recipient of a PDS-CNPq fellowship, and D. P. G. was a recipient of a PQ-CNPq fellowship.	Alafuzoff I, 2008, BRAIN PATHOL, V18, P484, DOI 10.1111/j.1750-3639.2008.00147.x; Aloe L, 1998, PARASITOL TODAY, V14, P314, DOI 10.1016/S0169-4758(98)01283-6; Bourdenx M, 2017, PROG NEUROBIOL, V155, P171, DOI 10.1016/j.pneurobio.2015.07.003; Bozza FA, 2007, CRIT CARE, V11, DOI 10.1186/cc5783; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Cervellati C, 2020, ANTIOXID REDOX SIGN, V33, P191, DOI 10.1089/ars.2020.8076; Chia R, 2018, LANCET NEUROL, V17, P94, DOI 10.1016/S1474-4422(17)30401-5; Colley DG, 2014, PARASITE IMMUNOL, V36, P347, DOI 10.1111/pim.12087; Colley DG, 2014, LANCET, V383, P2253, DOI 10.1016/S0140-6736(13)61949-2; de Oliveira RB, 2013, INT J PARASITOL, V43, P371, DOI 10.1016/j.ijpara.2012.12.006; Escobedo G, 2009, NEUROIMMUNOMODULAT, V16, P78, DOI 10.1159/000180262; Ezeamama AE, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0005524; Ferrari TCA, 2011, LANCET NEUROL, V10, P853, DOI 10.1016/S1474-4422(11)70170-3; Franklin K.B.J., 2008, MOUSE BRAIN STEREOTA; Gasparotto J, 2018, J BIOL CHEM, V293, P226, DOI 10.1074/jbc.M117.786756; Gasparotto J, 2017, BRAIN BEHAV IMMUN, V62, P124, DOI 10.1016/j.bbi.2017.01.008; Gasparotto J, 2015, BRAIN BEHAV IMMUN, V43, P37, DOI 10.1016/j.bbi.2014.06.204; Gouras GK, 2014, NEURODEGENER DIS, V13, P142, DOI 10.1159/000354776; Guimaraes AG, 2012, N-S ARCH PHARMACOL, V385, P253, DOI 10.1007/s00210-011-0715-x; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Johnson SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep10607; Jukes MCH, 2002, TROP MED INT HEALTH, V7, P104, DOI 10.1046/j.1365-3156.2002.00843.x; Kimura T, 1996, DEMENTIA, V7, P177, DOI 10.1159/000106875; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kongsui R, 2015, NEUROSCIENCE, V310, P629, DOI 10.1016/j.neuroscience.2015.09.061; KVALSVIG JD, 1991, ANN TROP MED PARASIT, V85, P551, DOI 10.1080/00034983.1991.11812608; KVALSVIG JD, 1988, ANN TROP MED PARASIT, V82, P471, DOI 10.1080/00034983.1988.11812278; KVALSVIG JD, 1988, PARASITOL TODAY, V4, P206, DOI 10.1016/0169-4758(88)90158-5; Lambertucci JR, 2014, REV SOC BRAS MED TRO, V47, P251, DOI 10.1590/0037-8682-0083-2013; Magalhaes TNC, 2018, MOL NEUROBIOL, V55, P5689, DOI 10.1007/s12035-017-0795-9; McManus DP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0013-8; Mondragon-Rodriguez S, 2014, NEUROPATH APPL NEURO, V40, P121, DOI 10.1111/nan.12084; Nayak D, 2014, ANNU REV IMMUNOL, V32, P367, DOI 10.1146/annurev-immunol-032713-120240; Nunez Joseph, 2008, J Vis Exp, DOI 10.3791/897; Salminen LE, 2014, REV NEUROSCIENCE, V25, P805, DOI 10.1515/revneuro-2014-0046; Schaffert LN, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10040232; Silva LM, 2002, MEM I OSWALDO CRUZ, V97, P599, DOI 10.1590/S0074-02762002000400028; Steckert AV, 2014, CURR NEUROVASC RES, V11, P83, DOI 10.2174/1567202610666131211111012; Thal DR, 2014, J ALZHEIMERS DIS, V42, pS421, DOI 10.3233/JAD-141461; Vale TC, 2012, NEUROLOGIST, V18, P333, DOI 10.1097/NRL.0b013e3182704d1e; Verjovski-Almeida S, 2004, TRENDS PARASITOL, V20, P304, DOI 10.1016/j.pt.2004.04.012; Wang JZ, 2013, J ALZHEIMERS DIS, V33, pS123, DOI 10.3233/JAD-2012-129031	43	3	3	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100979	10.1016/j.jbc.2021.100979	http://dx.doi.org/10.1016/j.jbc.2021.100979			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34303703	gold, Green Published, Green Accepted			2022-12-28	WOS:000690873500014
J	Mukherjee, R; Bhattacharya, A; Bojkova, D; Mehdipour, AR; Shin, D; Khan, KS; Cheung, HHY; Wong, KB; Ng, WL; Cinatl, J; Geurink, PP; van Noort, GJV; Rajalingam, K; Ciesek, S; Hummer, G; Dikic, I				Mukherjee, Rukmini; Bhattacharya, Anshu; Bojkova, Denisa; Mehdipour, Ahmad Reza; Shin, Donghyuk; Khan, Khadija Shahed; Cheung, Hayley Hei-Yin; Wong, Kam-Bo; Ng, Wai-Lung; Cinatl, Jindrich; Geurink, Paul P.; van Noort, Gerbrand J. van der Heden; Rajalingam, Krishnaraj; Ciesek, Sandra; Hummer, Gerhard; Dikic, Ivan			Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Apart from prevention using vaccinations, the management options for COVID-19 remain limited. In retrospective cohort studies, use of famotidine, a specific oral H2 receptor antagonist (antihistamine), has been associated with reduced risk of intubation and death in patients hospitalized with COVID-19. In a case series, nonhospitalized patients with COVID-19 experienced rapid symptom resolution after taking famotidine, but the molecular basis of these observations remains elusive. Here we show using biochemical, cellular, and functional assays that famotidine has no effect on viral replication or viral protease activity. However, famotidine can affect histamine-induced signaling processes in infected Caco2 cells. Specifically, famotidine treatment inhibits histamine-induced expression of Toll-like receptor 3 (TLR3) in SARS-CoV-2 infected cells and can reduce TLR3-dependent signaling processes that culminate in activation of IRF3 and the NF-kappa B pathway, subsequently controlling antiviral and inflammatory responses. SARS-CoV-2-infected cells treated with famotidine demonstrate reduced expression levels of the inflammatory mediators CCL-2 and IL6, drivers of the cytokine release syndrome that precipitates poor outcome for patients with COVID-19. Given that pharmacokinetic studies indicate that famotidine can reach concentrations in blood that suffice to antagonize histamine H2 receptors expressed in mast cells, neutrophils, and eosinophils, these observations explain how famotidine may contribute to the reduced histamine-induced inflammation and cytokine release, thereby improving the outcome for patients with COVID-19.	[Mukherjee, Rukmini; Bhattacharya, Anshu; Shin, Donghyuk; Dikic, Ivan] Goethe Univ, Fac Med, Inst Biochem 2, Frankfurt, Germany; [Mukherjee, Rukmini; Bhattacharya, Anshu; Shin, Donghyuk; Dikic, Ivan] Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany; [Mukherjee, Rukmini; Dikic, Ivan] Max Planck Inst Biophys, Frankfurt, Germany; [Bojkova, Denisa; Cinatl, Jindrich; Ciesek, Sandra] Univ Hosp Frankfurt, Inst Med Virol, Frankfurt, Germany; [Mehdipour, Ahmad Reza; Hummer, Gerhard] Max Planck Inst Biophys, Dept Theoret Biophys, Frankfurt, Germany; [Shin, Donghyuk] Yonsei Univ, Coll Life Sci & Biotechnol, Dept Syst Biol, Seoul, South Korea; [Khan, Khadija Shahed; Ng, Wai-Lung] Chinese Univ Hong Kong CUHK, Fac Med, Sch Pharm, Hong Kong, Peoples R China; [Wong, Kam-Bo] Chinese Univ Hong Kong CUHK, Sch Life Sci, State Key Lab Agrobiotechnol, Hong Kong, Peoples R China; [Geurink, Paul P.; van Noort, Gerbrand J. van der Heden] Leiden Univ, Med Ctr, Oncode Inst, Leiden, Netherlands; [Geurink, Paul P.; van Noort, Gerbrand J. van der Heden] Leiden Univ, Dept Chem Immunol, Med Ctr, Leiden, Netherlands; [Rajalingam, Krishnaraj] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Cell Biol Biol, Mainz, Germany; [Ciesek, Sandra] Goethe Univ, Inst Pharm Biol, Frankfurt, Germany; [Ciesek, Sandra; Dikic, Ivan] Fraunhofer Inst Mol Biol & Appl Ecol IME, Branch Translat Med & Pharmacol, Frankfurt, Germany; [Hummer, Gerhard] Goethe Univ Frankfurt, Inst Biophys, Frankfurt, Germany	Goethe University Frankfurt; Goethe University Frankfurt; Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Max Planck Society; Yonsei University; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Johannes Gutenberg University of Mainz; Goethe University Frankfurt; Fraunhofer Gesellschaft; Goethe University Frankfurt	Dikic, I (corresponding author), Goethe Univ, Fac Med, Inst Biochem 2, Frankfurt, Germany.; Dikic, I (corresponding author), Goethe Univ, Buchmann Inst Mol Life Sci, Frankfurt, Germany.; Dikic, I (corresponding author), Max Planck Inst Biophys, Frankfurt, Germany.; Dikic, I (corresponding author), Fraunhofer Inst Mol Biol & Appl Ecol IME, Branch Translat Med & Pharmacol, Frankfurt, Germany.	dikic@biochem2.uni-frankfurt.de	Mukherjee, Rukmini/GPX-7606-2022; Wong, Kam-Bo/G-4258-2013; Dikic, Ivan/O-4650-2015; Hummer, Gerhard/A-2546-2013; Mehdipour, Ahmad Reza/AAY-5243-2021; van der Heden van Noort, Gerbrand/J-4636-2017	Mukherjee, Rukmini/0000-0001-7955-6324; Wong, Kam-Bo/0000-0002-6984-5373; Dikic, Ivan/0000-0001-8156-9511; Hummer, Gerhard/0000-0001-7768-746X; van der Heden van Noort, Gerbrand/0000-0001-5955-6431; Bhattacharya, Anshu/0000-0002-7383-3594; Ng, Billy Wai-Lung/0000-0003-2892-6318; Mehdipour, Ahmad Reza/0000-0002-0193-3334	Else Kroener Fresenius Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [259130777 -SFB 1177, LYSFOR2625]; CUHK (Faculty of Medicine); CUHK (PIEF grant); Croucher Foundation; NWO; ZonMw; Max Planck Society; National Research Foundation of Korea (NRF) grant - Korea government (MSIT) [2021R1C1C1003961]; Yonsei University [2021-22-0050]	Else Kroener Fresenius Stiftung; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); CUHK (Faculty of Medicine); CUHK (PIEF grant); Croucher Foundation; NWO(Netherlands Organization for Scientific Research (NWO)); ZonMw(Netherlands Organization for Health Research and Development); Max Planck Society(Max Planck SocietyFoundation CELLEX); National Research Foundation of Korea (NRF) grant - Korea government (MSIT); Yonsei University	I. D. acknowledges funding support from the grants from Else Kroener Fresenius Stiftung; Dr Rolf M. Schwiete Stiftung and the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) Project number 259130777 -SFB 1177, LYSFOR2625 (DFG) to A.B, WLN acknowledges funding support from CUHK (a seed fund from the Faculty of Medicine and a PIEF grant), and W. L. N. from CUHK (a seed fund, "Faculty Innovation Award," from the Faculty of Medicine and a PIEF grant) and Croucher Foundation (start-up fund). G. J. v. d. H. v. N. was funded by NWO (Vidi) and ZonMw (Off-road). A. R. M and G. H. thank the Max Planck Society for support. D. S. was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1C1C1003961) and the Yonsei University Research Fund of 2021 (2021-22-0050).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Afrin LB, 2020, INT J INFECT DIS, V100, P327, DOI 10.1016/j.ijid.2020.09.016; Alonso N, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00045; Bekes M, 2016, MOL CELL, V62, P572, DOI 10.1016/j.molcel.2016.04.016; Chen XJ, 2014, PROTEIN CELL, V5, P369, DOI 10.1007/s13238-014-0026-3; Chuck CP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013197; Conti P, 2020, J BIOL REG HOMEOS AG, V34, P327, DOI 10.23812/CONTI-E; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Freedberg DE, 2020, GASTROENTEROLOGY, V159, P1129, DOI 10.1053/j.gastro.2020.05.053; Grosdidier A, 2011, NUCLEIC ACIDS RES, V39, pW270, DOI 10.1093/nar/gkr366; Gupta A, 2020, ACS COMB SCI, V22, P826, DOI 10.1021/acscombsci.0c00140; Hogan RB, 2020, PULM PHARMACOL THER, V63, DOI 10.1016/j.pupt.2020.101942; Hou YF, 2006, MOL IMMUNOL, V43, P1982, DOI 10.1016/j.molimm.2005.11.013; Iwasaki A, 2020, NAT REV IMMUNOL, V20, P339, DOI 10.1038/s41577-020-0321-6; Janowitz T, 2020, GUT, V69, P1592, DOI 10.1136/gutjnl-2020-321852; Kokic G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20542-0; Kritas SK, 2020, J BIOL REG HOMEOS AG, V34, P9, DOI 10.23812/20-Editorial-Kritas; Loffredo M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84782-w; Ma CL, 2020, CELL RES, V30, P678, DOI 10.1038/s41422-020-0356-z; Malik S, 2013, EUR J MED CHEM, V67, P1, DOI [10.1016/j.ejmech.2013.06.026, 10.1016/j.ejmech.2012.10.053]; Mather JF, 2020, AM J GASTROENTEROL, V115, P1617, DOI 10.14309/ajg.0000000000000832; Matthews K, 2014, VIROL J, V11, DOI 10.1186/s12985-014-0209-9; Neufeldt C.J, 2020, SARS COV 2 INFECT IN, DOI [10.1101/2020.07.21.212639, DOI 10.1161/CIRCRESAHA.120.317134]; Numata T, 2011, J IMMUNOL, V187, P510, DOI 10.4049/jimmunol.1004218; Onofrio L, 2020, FUTUR SCI OA, V6, DOI 10.2144/fsoa-2020-0091; Ortega JT, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10060954; Ratia K, 2008, P NATL ACAD SCI USA, V105, P16119, DOI 10.1073/pnas.0805240105; Roy C. J., 2021, COVID 19 FAMOTIDINE; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Sterling T, 2015, J CHEM INF MODEL, V55, P2324, DOI 10.1021/acs.jcim.5b00559; Theoharides TC, 2021, ANN ALLERG ASTHMA IM, V126, P217, DOI 10.1016/j.anai.2020.11.003; Totura AL, 2015, MBIO, V6, DOI 10.1128/mBio.00638-15; Williamson BN, 2020, NATURE, V585, P273, DOI 10.1038/s41586-020-2423-5; Wu CR, 2020, ACTA PHARM SIN B, V10, P766, DOI 10.1016/j.apsb.2020.02.008; Xie GG, 2018, CELL PHYSIOL BIOCHEM, V46, P2401, DOI 10.1159/000489646; ZHOU YY, 2019, NAT COMMUN, V10, DOI [10.1038/S41467-019-09234-6, DOI 10.1038/s41587-020-0546-8, DOI 10.1038/S41467-019-09234-6]	36	23	24	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100925	10.1016/j.jbc.2021.100925	http://dx.doi.org/10.1016/j.jbc.2021.100925			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34214498	Green Published, gold			2022-12-28	WOS:000690879300015
J	Olivieri, D; Paramanathan, S; Bardet, AF; Hess, D; Smallwood, SA; Elling, U; Betschinger, J				Olivieri, Daniel; Paramanathan, Sujani; Bardet, Anais F.; Hess, Daniel; Smallwood, Sebastien A.; Elling, Ulrich; Betschinger, Joerg			The BTB-domain transcription factor ZBTB2 recruits chromatin remodelers and a histone chaperone during the exit from pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STEM-CELL DIFFERENTIATION; EMBRYONIC-LIKE CELLS; GROUND-STATE; SELF-RENEWAL; H3.3; PROTEIN; NURD; COMPLEXES; QUANTIFICATION; INACTIVATION	Transcription factors (TFs) harboring broad-complex, tramtrack, and bric-a-brac (BTB) domains play important roles in development and disease. These BTB domains are thought to recruit transcriptional modulators to target DNA regions. However, a systematic molecular understanding of the mechanism of action of this TF family is lacking. Here, we identify the zinc finger BTB-TF Zbtb2 from a genetic screen for regulators of exit from pluripotency and demonstrate that its absence perturbs embryonic stem cell differentiation and the gene expression dynamics underlying peri-implantation development. We show that ZBTB2 binds the chromatin remodeler Ep400 to mediate downstream transcription. Independently, the BTB domain directly interacts with nucleosome remodeling and deacetylase and histone chaperone histone regulator A. Nucleosome remodeling and deacetylase recruitment is a common feature of BTB TFs, and based on phylogenetic analysis, we propose that this is a conserved evolutionary property. Binding to UBN2, in contrast, is specific to ZBTB2 and requires a C-terminal extension of the BTB domain. Taken together, this study identifies a BTB-domain TF that recruits chromatin modifiers and a histone chaperone during a developmental cell state transition and defines unique and shared molecular functions of the BTB-domain TF family.	[Olivieri, Daniel; Paramanathan, Sujani; Bardet, Anais F.; Hess, Daniel; Smallwood, Sebastien A.; Betschinger, Joerg] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Bardet, Anais F.] Univ Strasbourg, CNRS, UMR7242, Biotechnol & Cell Signaling, Illkirch Graffenstaden, France; [Elling, Ulrich] Austrian Acad Sci IMBA, Vienna BioCtr VBC, Inst Mol Biotechnol, Vienna, Austria	Friedrich Miescher Institute for Biomedical Research; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA)	Olivieri, D; Betschinger, J (corresponding author), Friedrich Miescher Inst Biomed Res, Basel, Switzerland.	daniel.olivieri@fmi.ch; joerg.betschinger@fmi.ch		Betschinger, Joerg/0000-0002-2627-8479	European Molecular Biology Organization (EMBO) [ALTF 1632-2014]; Marie Curie Actions (LTFCOFUND2013) [GA-2013-609409]; Novartis Research Foundation	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Marie Curie Actions (LTFCOFUND2013); Novartis Research Foundation	D. O. was supported by the European Molecular Biology Organization (EMBO) (ALTF 1632-2014) and Marie Curie Actions (LTFCOFUND2013, GA-2013-609409). Research in the laboratory of J. B. is supported by the Novartis Research Foundation.	Acharya D, 2017, CELL REP, V19, P671, DOI 10.1016/j.celrep.2017.04.001; Betschinger J, 2013, CELL, V153, P335, DOI 10.1016/j.cell.2013.03.012; Bornelov S, 2018, MOL CELL, V71, P56, DOI 10.1016/j.molcel.2018.06.003; Boroviak T, 2015, DEV CELL, V35, P366, DOI 10.1016/j.devcel.2015.10.011; Boskovic A, 2014, GENE DEV, V28, P1042, DOI 10.1101/gad.238881.114; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen PB, 2015, NAT STRUCT MOL BIOL, V22, P999, DOI 10.1038/nsmb.3122; Chevrier S, 2014, IMMUNOL CELL BIOL, V92, P481, DOI 10.1038/icb.2014.20; Collins T, 2001, MOL CELL BIOL, V21, P3609, DOI 10.1128/MCB.21.11.3609-3615.2001; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cox J, 2011, J PROTEOME RES, V10, P1794, DOI 10.1021/pr101065j; Elling U, 2011, CELL STEM CELL, V9, P563, DOI 10.1016/j.stem.2011.10.012; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Gaidatzis D, 2015, BIOINFORMATICS, V31, P1130, DOI 10.1093/bioinformatics/btu781; Galonska C, 2015, CELL STEM CELL, V17, P462, DOI 10.1016/j.stem.2015.07.005; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Gontan C, 2012, NATURE, V485, P386, DOI 10.1038/nature11070; Grover P, 2018, ANNU REV GENET, V52, P109, DOI 10.1146/annurev-genet-120417-031547; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Helleboid PY, 2019, EMBO J, V38, DOI 10.15252/embj.2018101220; Hendrickson PG, 2017, NAT GENET, V49, P925, DOI 10.1038/ng.3844; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Ishiuchi T, 2015, NAT STRUCT MOL BIOL, V22, P662, DOI 10.1038/nsmb.3066; Jin CY, 2007, GENE DEV, V21, P1519, DOI 10.1101/gad.1547707; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kalkan T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0540; Karemaker ID, 2018, EMBO REP, V19, DOI 10.15252/embr.201744993; Kouhara H, 1997, CELL, V89, P693, DOI 10.1016/S0092-8674(00)80252-4; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Leeb M, 2014, CELL STEM CELL, V14, P385, DOI 10.1016/j.stem.2013.12.008; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Li TL, 2015, EMBO J, V34, P1630, DOI 10.15252/embj.201489947; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Luck K, 2020, NATURE, V580, P402, DOI 10.1038/s41586-020-2188-x; Macfarlan TS, 2012, NATURE, V487, P57, DOI 10.1038/nature11244; Macfarlan TS, 2011, GENE DEV, V25, P594, DOI 10.1101/gad.2008511; Maeda T, 2016, INT J HEMATOL, V104, P310, DOI 10.1007/s12185-016-2035-x; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Martello G, 2012, CELL STEM CELL, V11, P491, DOI 10.1016/j.stem.2012.06.008; Masuda T, 2016, SCIENCE, V351, P285, DOI 10.1126/science.aad3312; Masui S, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-45; Mattout A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0760-8; Mena EL, 2018, SCIENCE, V362, P198, DOI 10.1126/science.aap8236; Molotkov A, 2017, DEV CELL, V41, P511, DOI 10.1016/j.devcel.2017.05.004; Olivieri D, 2021, EMBO J, V40, DOI 10.15252/embj.2020106818; Pradhan SK, 2016, MOL CELL, V61, P27, DOI 10.1016/j.molcel.2015.10.039; Qiu DB, 2015, STEM CELL REP, V5, P314, DOI 10.1016/j.stemcr.2015.07.014; Ray-Gallet D, 2011, MOL CELL, V44, P928, DOI 10.1016/j.molcel.2011.12.006; Reynolds N, 2012, CELL STEM CELL, V10, P583, DOI 10.1016/j.stem.2012.02.020; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez-Terrones D, 2018, NAT GENET, V50, P106, DOI 10.1038/s41588-017-0016-5; Sadic D, 2015, EMBO REP, V16, P836, DOI 10.15252/embr.201439937; Sarai N, 2013, EMBO J, V32, P2392, DOI 10.1038/emboj.2013.176; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schnuetgen F, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn603; Scotland KB, 2009, DEV DYNAM, V238, P1863, DOI 10.1002/dvdy.22037; Siggs OM, 2012, CELL CYCLE, V11, P3358, DOI 10.4161/cc.21277; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Stogios PJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r82; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tee WW, 2014, CELL, V156, P678, DOI 10.1016/j.cell.2014.01.009; Thinon E, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5919; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Villegas F, 2019, CELL STEM CELL, V24, P257, DOI 10.1016/j.stem.2018.11.021; Weirauch MT, 2014, CELL, V158, P1431, DOI 10.1016/j.cell.2014.08.009; Wray J, 2011, NAT CELL BIOL, V13, P838, DOI 10.1038/ncb2267; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xiong CY, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0573-9; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Yang SH, 2005, J BIOL CHEM, V280, P18990, DOI 10.1074/jbc.M412917200; Yang SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003112; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Youn HD, 1999, SCIENCE, V286, P790, DOI 10.1126/science.286.5440.790; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	79	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100947	10.1016/j.jbc.2021.100947	http://dx.doi.org/10.1016/j.jbc.2021.100947			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34270961	Green Published, gold			2022-12-28	WOS:000690873500006
J	Absmeier, E; Vester, K; Ghane, T; Burakovskiy, D; Milon, P; Imhof, P; Rodnina, MV; Santos, KF; Wahl, MC				Absmeier, Eva; Vester, Karen; Ghane, Tahereh; Burakovskiy, Dmitry; Milon, Pohl; Imhof, Petra; Rodnina, Marina, V; Santos, Karine F.; Wahl, Markus C.			Long-range allostery mediates cooperative adenine nucleotide binding by the Ski2-like RNA helicase Brr2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEAD BOX HELICASES; CRYO-EM STRUCTURE; STRUCTURAL BASIS; SACCHAROMYCES-CEREVISIAE; KINETIC MECHANISM; TRANSLATION INITIATION; MOLECULAR-DYNAMICS; ANALYSIS REVEALS; IN-VIVO; Q-MOTIF	Brr2 is an essential Ski2-like RNA helicase that exhibits a unique structure among the spliceosomal helicases. Brr2 harbors a catalytically active N-terminal helicase cassette and a structurally similar but enzymatically inactive C-terminal helicase cassette connected by a linker region. Both cassettes contain a nucleotide-binding pocket, but it is unclear whether nucleotide binding in these two pockets is related. Here we use biophysical and computational methods to delineate the functional connectivity between the cassettes and determine whether occupancy of one nucleotide-binding site may influence nucleotide binding at the other cassette. Our results show that Brr2 exhibits high specificity for adenine nucleotides, with both cassettes binding ADP tighter than ATP. Adenine nucleotide affinity for the inactive C-terminal cassette is more than two orders of magnitude higher than that of the active N-terminal cassette, as determined by slow nucleotide release. Mutations at the intercassette surfaces and in the connecting linker diminish the affinity of adenine nucleotides for both cassettes. Moreover, we found that abrogation of nucleotide binding at the C-terminal cassette reduces nucleotide binding at the N-terminal cassette 70 A away. Molecular dynamics simulations identified structural communication lines that likely mediate these long-range allosteric effects, predominantly across the intercassette interface. Together, our results reveal intricate networks of intramolecular interactions in the complex Brr2 RNA helicase, which fine-tune its nucleotide affinities and which could be exploited to regulate enzymatic activity during splicing.	[Absmeier, Eva; Vester, Karen; Santos, Karine F.; Wahl, Markus C.] Free Univ Berlin, Struct Biochem, Berlin, Germany; [Ghane, Tahereh; Imhof, Petra] Free Univ Berlin, Computat Biophys, Berlin, Germany; [Burakovskiy, Dmitry; Rodnina, Marina, V] Max Planck Inst Biophys Chem, Dept Phys Biochem, Gottingen, Germany; [Milon, Pohl] Univ Peruana Ciencias Aplicadas, Hlth Sci Fac, Ctr Res & Innovat, Lima, Peru; [Wahl, Markus C.] Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog, Berlin, Germany; [Absmeier, Eva] MRC Lab Mol Biol, Francis Crick Ave, Cambridge, England; [Burakovskiy, Dmitry] Evotec SE, Hamburg, Germany; [Imhof, Petra] Friedrich Alexander Univ Erlangen Nurnberg, Computat Chem Ctr, Dept Chem & Pharm, Erlangen, Germany; [Santos, Karine F.] 4TEEN4 Pharmaceut GmbH, Hennigsdorf, Germany	Free University of Berlin; Free University of Berlin; Max Planck Society; Universidad Peruana de Ciencias Aplicadas (UPC); Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); MRC Laboratory Molecular Biology; University of Erlangen Nuremberg	Absmeier, E; Santos, KF; Wahl, MC (corresponding author), Free Univ Berlin, Struct Biochem, Berlin, Germany.; Wahl, MC (corresponding author), Helmholtz Zentrum Berlin Mat & Energie, Macromol Crystallog, Berlin, Germany.; Absmeier, E (corresponding author), MRC Lab Mol Biol, Francis Crick Ave, Cambridge, England.; Santos, KF (corresponding author), 4TEEN4 Pharmaceut GmbH, Hennigsdorf, Germany.	absmeier@mrc-linb.cantac.uk; bourgeois@4teen4.de; markus.wahl@fu-berlin.de	Milon, Pohl/ABG-5423-2021; Wahl, Markus/D-6365-2017	Milon, Pohl/0000-0001-6679-5473; Wahl, Markus/0000-0002-2811-5307	Deutsche Forschungsgemeinschaft [TRR186/A15]; Dahlem International Network PostDoc Fellowship from Freie Universitat Berlin	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Dahlem International Network PostDoc Fellowship from Freie Universitat Berlin	This work was funded by grant TRR186/A15 from the Deutsche Forschungsgemeinschaft to M. C. W. K. F. S. was supported by a Dahlem International Network PostDoc Fellowship from Freie Universitat Berlin.	Abraham MJ, 2011, J COMPUT CHEM, V32, P2031, DOI 10.1002/jcc.21773; Absmeier E, 2017, CELL CYCLE, V16, P100, DOI 10.1080/15384101.2016.1255384; Absmeier E, 2015, GENE DEV, V29, P2576, DOI 10.1101/gad.271528.115; Absmeier E, 2015, ACTA CRYSTALLOGR D, V71, P762, DOI 10.1107/S1399004715001005; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Bagga J, 2002, LECT NOTES COMPUT SC, V2265, P459; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Bessonov S, 2008, NATURE, V452, P846, DOI 10.1038/nature06842; Bourgeois CF, 2016, NAT REV MOL CELL BIO, V17, P426, DOI 10.1038/nrm.2016.50; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Buttner K, 2007, NAT STRUCT MOL BIOL, V14, P647, DOI 10.1038/nsmb1246; Bujalowski W, 2000, BIOCHEMISTRY-US, V39, P2106, DOI 10.1021/bi992413m; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen HC, 2013, MOL CELL BIOL, V33, P514, DOI 10.1128/MCB.01093-12; Conrad KS, 2016, EMBO J, V35, P1707, DOI 10.15252/embj.201694327; Dango S, 2011, MOL CELL, V44, P373, DOI 10.1016/j.molcel.2011.08.039; Deckert J, 2006, MOL CELL BIOL, V26, P5528, DOI 10.1128/MCB.00582-06; Dijkstra EW., 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fairman-Williams ME, 2010, CURR OPIN STRUC BIOL, V20, P313, DOI 10.1016/j.sbi.2010.03.011; Fourmann JB, 2013, GENE DEV, V27, P413, DOI 10.1101/gad.207779.112; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Goyal A, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv869; Gromadski KB, 2002, BIOCHEMISTRY-US, V41, P162, DOI 10.1021/bi015712w; Guiraldelli MF, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003383; Guy CP, 2005, NUCLEIC ACIDS RES, V33, P3678, DOI 10.1093/nar/gki685; Hahn D, 2012, GENE DEV, V26, P2408, DOI 10.1101/gad.199307.112; Halbach F, 2012, RNA, V18, P124, DOI 10.1261/rna.029553.111; Hashimoto S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60241-w; He YZ, 2010, EMBO REP, V11, P180, DOI 10.1038/embor.2010.11; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang YH, 2014, MOL CELL BIOL, V34, P210, DOI 10.1128/MCB.00837-13; Johnson SJ, 2013, RNA BIOL, V10, P33, DOI 10.4161/rna.22101; Jung DJ, 2002, MOL CELL BIOL, V22, P5203, DOI 10.1128/MCB.22.14.5203-5211.2002; Juszkiewicz S, 2020, MOL CELL, V79, P603, DOI 10.1016/j.molcel.2020.06.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Khalili M, 2005, J PHYS CHEM B, V109, P13798, DOI 10.1021/jp058007w; Kim DH, 1999, RNA, V5, P959, DOI 10.1017/S135583829999012X; Kudlinzki D, 2012, BIOL CHEM, V393, P1131, DOI 10.1515/hsz-2012-0158; Laggerbauer B, 1998, P NATL ACAD SCI USA, V95, P4188, DOI 10.1073/pnas.95.8.4188; Lauber J, 1996, EMBO J, V15, P4001, DOI 10.1002/j.1460-2075.1996.tb00774.x; Li JQ, 2013, MBIO, V4, DOI 10.1128/mBio.00385-13; Liu SB, 2006, RNA, V12, P1418, DOI 10.1261/rna.55406; Martegani E, 1997, YEAST, V13, P391, DOI 10.1002/(SICI)1097-0061(19970330)13:4<391::AID-YEA92>3.0.CO;2-Q; Matsuo Y, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00188-1; Mayerle M, 2016, RNA, V22, P793, DOI 10.1261/rna.055459.115; Mazina OM, 2004, CELL, V117, P47, DOI 10.1016/S0092-8674(04)00294-6; Milon P, 2007, METHOD ENZYMOL, V430, P1, DOI 10.1016/S0076-6879(07)30001-3; Milon P, 2006, P NATL ACAD SCI USA, V103, P13962, DOI 10.1073/pnas.0606384103; MOORE KJM, 1994, BIOCHEMISTRY-US, V33, P14565, DOI 10.1021/bi00252a024; Mozaffari-Jovin S, 2013, SCIENCE, V341, P80, DOI 10.1126/science.1237515; Mozaffari-Jovin S, 2012, GENE DEV, V26, P2422, DOI 10.1101/gad.200949.112; Noble SM, 1996, EMBO J, V15, P4368, DOI 10.1002/j.1460-2075.1996.tb00810.x; OBRIEN ET, 1989, BIOCHEMISTRY-US, V28, P1413, DOI 10.1021/bi00429a070; Oyama T, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-2; Peck ML, 2003, RNA, V9, P1180, DOI 10.1261/rna.2103703; Pena V, 2009, MOL CELL, V35, P454, DOI 10.1016/j.molcel.2009.08.006; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908; Raghunathan PL, 1998, CURR BIOL, V8, P847, DOI 10.1016/S0960-9822(07)00345-4; Resetar AM, 1995, BIOCHEMISTRY-US, V34, P16039, DOI 10.1021/bi00049a018; Santos KF, 2012, P NATL ACAD SCI USA, V109, P17418, DOI 10.1073/pnas.1208098109; Searfoss A, 2001, MOL CELL BIOL, V21, P4900, DOI 10.1128/MCB.21.15.4900-4908.2001; Semlow DR, 2012, TRENDS BIOCHEM SCI, V37, P263, DOI 10.1016/j.tibs.2012.04.001; Small EC, 2006, MOL CELL, V23, P389, DOI 10.1016/j.molcel.2006.05.043; Sugiyama T, 2019, CELL REP, V26, P3400, DOI 10.1016/j.celrep.2019.02.067; Talavera MA, 2005, BIOCHEMISTRY-US, V44, P959, DOI 10.1021/bi048253i; Tanaka K, 2006, DNA SEQUENCE, V17, P242, DOI 10.1080/10425170600805433; Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296; Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Nguyen THD, 2013, STRUCTURE, V21, P910, DOI 10.1016/j.str.2013.04.017; Toseland CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038270; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Tsai RT, 2007, MOL CELL BIOL, V27, P8027, DOI 10.1128/MCB.01213-07; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; van Nues RW, 2001, GENETICS, V157, P1451; Vester K, 2020, J BIOL CHEM, V295, P2097, DOI 10.1074/jbc.RA119.010964; Walbott H, 2010, EMBO J, V29, P2194, DOI 10.1038/emboj.2010.102; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Weir JR, 2010, P NATL ACAD SCI USA, V107, P12139, DOI 10.1073/pnas.1004953107; Xu DM, 1996, NATURE, V381, P709, DOI 10.1038/381709a0; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Zhang LD, 2015, NUCLEIC ACIDS RES, V43, P3286, DOI 10.1093/nar/gkv062; Zhang LD, 2009, NAT STRUCT MOL BIOL, V16, P731, DOI 10.1038/nsmb.1625	89	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100829	10.1016/j.jbc.2021.100829	http://dx.doi.org/10.1016/j.jbc.2021.100829			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34048711	Green Published, gold			2022-12-28	WOS:000678068400031
J	Grunkemeyer, TJ; Ghosh, S; Patel, AM; Sajja, K; Windak, J; Basrur, V; Kim, Y; Nesvizhskii, AI; Kennedy, RT; Marsh, ENG				Grunkemeyer, Timothy J.; Ghosh, Soumi; Patel, Ayesha M.; Sajja, Keerthi; Windak, James; Basrur, Venkatesha; Kim, Youngsoo; Nesvizhskii, Alexey, I; Kennedy, Robert T.; Marsh, E. Neil G.			The antiviral enzyme viperin inhibits cholesterol biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERFERON-INDUCIBLE PROTEIN; COENZYME-A REDUCTASE; E3 UBIQUITIN LIGASE; C VIRUS-REPLICATION; SQUALENE MONOOXYGENASE; MASS SPECTROMETRY; INFLUENZA-VIRUS; IDENTIFICATION; METABOLISM; EXPRESSION	Many enveloped viruses bud from cholesterol-rich lipid rafts on the cell membrane. Depleting cellular cholesterol impedes this process and results in viral particles with reduced viability. Viperin (Virus Inhibitory Protein, Endoplasmic Reticulum-associated, Interferon iNducible) is an endoplasmic reticulum membrane-associated enzyme that exerts broad-ranging antiviral effects, including inhibiting the budding of some enveloped viruses. However, the relationship between viperin expression and the retarded budding of virus particles from lipid rafts on the cell membrane is unclear. Here, we investigated the effect of viperin expression on cholesterol biosynthesis using transiently expressed genes in the human cell line human embryonic kidney 293T (HEK293T). We found that viperin expression reduces cholesterol levels by 20% to 30% in these cells. Following this observation, a proteomic screen of the viperin interactome identified several cholesterol biosynthetic enzymes among the top hits, including lanosterol synthase (LS) and squalene monooxygenase (SM), which are enzymes that catalyze key steps in establishing the sterol carbon skeleton. Coimmunoprecipitation experiments confirmed that viperin, LS, and SM form a complex at the endoplasmic reticulum membrane. While coexpression of viperin was found to significantly inhibit the specific activity of LS in HEK293T cell lysates, coexpression of viperin had no effect on the specific activity of SM, although did reduce SM protein levels by approximately 30%. Despite these inhibitory effects, the coexpression of neither LS nor SM was able to reverse the viperin-induced depletion of cellular cholesterol levels, possibly because viperin is highly expressed in transfected HEK293T cells. Our results establish a link between viperin expression and downregulation of cholesterol biosynthesis that helps explain viperin's antiviral effects against enveloped viruses.	[Grunkemeyer, Timothy J.; Ghosh, Soumi; Patel, Ayesha M.; Sajja, Keerthi; Windak, James; Kim, Youngsoo; Kennedy, Robert T.; Marsh, E. Neil G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Basrur, Venkatesha; Nesvizhskii, Alexey, I] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Nesvizhskii, Alexey, I] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Marsh, E. Neil G.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Marsh, ENG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Marsh, ENG (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	nmarsh@umich.edu	; Nesvizhskii, Alexey/A-5410-2012; Marsh, Neil/G-7553-2016	Patel, Ayesha/0000-0001-5037-5933; Ghosh, Soumi/0000-0001-6101-0147; Nesvizhskii, Alexey/0000-0002-2806-7819; Marsh, Neil/0000-0003-1713-1683	National Institutes of Health [GM 093088, DK 046960, GM094231]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health grants GM 093088 to E. N. G. M., DK 046960 to R. T. K., and GM094231 to A. I. N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bajimaya S, 2017, VIROLOGY, V510, P234, DOI 10.1016/j.virol.2017.07.024; Bajimaya S, 2017, VIROLOGY, V501, P127, DOI 10.1016/j.virol.2016.11.011; Blattmann P, 2017, CELL SYST, V5, P604, DOI 10.1016/j.cels.2017.11.002; Brown MS, 1997, CELL, V89, P331, DOI 10.1016/S0092-8674(00)80213-5; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cerqueira NMFSA, 2016, BIOCHEMISTRY-US, V55, P5483, DOI 10.1021/acs.biochem.6b00342; Chin KC, 2001, P NATL ACAD SCI USA, V98, P15125, DOI 10.1073/pnas.011593298; Choi H, 2011, NAT METHODS, V8, P70, DOI 10.1038/NMETH.1541; Dukhovny A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26516-z; Dumbrepatil AB, 2020, J BIOL CHEM, V295, P2839, DOI 10.1074/jbc.RA119.011526; Dumbrepatil AB, 2019, J BIOL CHEM, V294, P6888, DOI 10.1074/jbc.RA119.007719; Duschene Kaitlin S, 2012, Biomol Concepts, V3, P255; Duschene KS, 2010, FEBS LETT, V584, P1263, DOI 10.1016/j.febslet.2010.02.041; Ebrahimi KH, 2020, FEBS LETT, V594, P1624, DOI 10.1002/1873-3468.13761; Ebrahimi KH, 2020, FEBS LETT, V594, P1631, DOI 10.1002/1873-3468.13778; Eisele B, 1997, J LIPID RES, V38, P564; Espenshade PJ, 2007, ANNU REV GENET, V41, P401, DOI 10.1146/annurev.genet.41.110306.130315; FAUST JR, 1982, P NATL ACAD SCI-BIOL, V79, P5205, DOI 10.1073/pnas.79.17.5205; Fenwick MK, 2020, BIOCHEMISTRY-US, V59, P652, DOI 10.1021/acs.biochem.9b00741; Fenwick MK, 2017, P NATL ACAD SCI USA, V114, P6806, DOI 10.1073/pnas.1705402114; Fitzgerald KA, 2011, J INTERF CYTOK RES, V31, P131, DOI 10.1089/jir.2010.0127; Foster TL, 2010, J VIROL, V84, P9267, DOI 10.1128/JVI.00616-10; Ghosh S, 2020, J BIOL CHEM, V295, P11513, DOI 10.1074/jbc.REV120.012784; Ghosh S, 2020, BIOCHEMISTRY-US, V59, P780, DOI 10.1021/acs.biochem.9b01090; Gill S, 2011, CELL METAB, V13, P260, DOI 10.1016/j.cmet.2011.01.015; Gizzi AS, 2018, NATURE, V558, P610, DOI 10.1038/s41586-018-0238-4; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; GOLDSTEIN JL, 1990, NATURE, V343, P425, DOI 10.1038/343425a0; Gower TL, 2001, ANTIMICROB AGENTS CH, V45, P1231, DOI 10.1128/AAC.45.4.1231-1237.2001; Haldar S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031797; Helbig KJ, 2014, J MOL BIOL, V426, P1210, DOI 10.1016/j.jmb.2013.10.019; Helbig KJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002178; Helbig KJ, 2011, HEPATOLOGY, V54, P1506, DOI 10.1002/hep.24542; Helbig KJ, 2005, HEPATOLOGY, V42, P702, DOI 10.1002/hep.20844; Hinson ER, 2009, P NATL ACAD SCI USA, V106, P20452, DOI 10.1073/pnas.0911679106; Hinson ER, 2009, J BIOL CHEM, V284, P4705, DOI 10.1074/jbc.M807261200; Howe V, 2015, J BIOL CHEM, V290, P27533, DOI 10.1074/jbc.M115.675181; Incardona JP, 2000, CURR OPIN CELL BIOL, V12, P193, DOI 10.1016/S0955-0674(99)00076-9; Itzhak DN, 2016, ELIFE, V5, DOI 10.7554/eLife.16950; Jiang D, 2010, J VIROL, V84, P8332, DOI 10.1128/JVI.02199-09; Jiang X, 2011, IMMUNITY, V34, P285, DOI 10.1016/j.immuni.2011.03.012; Jumat MR, 2015, ANTIVIR RES, V114, P11, DOI 10.1016/j.antiviral.2014.11.007; Kim JJ, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e33; Li WL, 2020, ANTIVIR RES, V184, DOI 10.1016/j.antiviral.2020.104903; Makins C, 2016, J BIOL CHEM, V291, P26806, DOI 10.1074/jbc.M116.751040; Mattijssen S, 2012, MICROBES INFECT, V14, P419, DOI 10.1016/j.micinf.2011.11.015; McGillivary G, 2013, J INNATE IMMUN, V5, P60, DOI 10.1159/000342473; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mikulecky P, 2018, FEBS LETT, V592, P199, DOI 10.1002/1873-3468.12941; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Mo CQ, 2005, BBA-MOL CELL BIOL L, V1737, P152, DOI 10.1016/j.bbalip.2005.11.002; Nasr N, 2012, BLOOD, V120, P778, DOI 10.1182/blood-2012-01-407395; OSBORNE TF, 1988, J BIOL CHEM, V263, P3380; Padyana AK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07928-x; Panayiotou C, 2018, J VIROL, V92, DOI [10.1128/jvi.02054-17, 10.1128/JVI.02054-17]; Patel AM, 2021, J AM CHEM SOC, V143, P4910, DOI 10.1021/jacs.1c01045; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rabbani MAG, 2016, J VIROL, V90, P11145, DOI 10.1128/JVI.01551-16; RAJAVASHISTH TB, 1989, SCIENCE, V245, P640, DOI 10.1126/science.2562787; Saitoh T, 2011, IMMUNITY, V34, P352, DOI 10.1016/j.immuni.2011.03.010; Seo JY, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003497; Seo JY, 2011, CELL HOST MICROBE, V10, P534, DOI 10.1016/j.chom.2011.11.004; Seo JY, 2011, SCIENCE, V332, P1093, DOI 10.1126/science.1202007; Shaveta G, 2010, BIOCHEM BIOPH RES CO, V391, P1390, DOI 10.1016/j.bbrc.2009.12.070; Simons K, 2002, J CLIN INVEST, V110, P597, DOI 10.1172/JCI200216390; Upadhyay AS, 2017, J BIOL CHEM, V292, P13879, DOI 10.1074/jbc.M117.780122; Van der Hoek KH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04138-1; Vanwalscappel B, 2018, VIROLOGY, V522, P199, DOI 10.1016/j.virol.2018.07.014; Waheed AA, 2007, CELL HOST MICROBE, V2, P71, DOI 10.1016/j.chom.2007.07.005; Wang SS, 2012, J GEN VIROL, V93, P83, DOI 10.1099/vir.0.033860-0; Wang XY, 2007, CELL HOST MICROBE, V2, P96, DOI 10.1016/j.chom.2007.06.009; Wong JMT, 2016, J CHROMATOGR A, V1446, P78, DOI 10.1016/j.chroma.2016.04.006; Xu CM, 2020, J MED VIROL, V92, P149, DOI 10.1002/jmv.25595; Yuan YK, 2020, MOL CELL, V77, P734, DOI 10.1016/j.molcel.2019.11.003; Zelcer N, 2014, MOL CELL BIOL, V34, P1262, DOI 10.1128/MCB.01140-13	75	6	6	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100824	10.1016/j.jbc.2021.100824	http://dx.doi.org/10.1016/j.jbc.2021.100824			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029588	gold, Green Published			2022-12-28	WOS:000678068400026
J	Krumm, CS; Xu, X; Bare, CJ; Holman, CD; Kersten, S; Dow, LE; Lee, AH; Cohen, DE				Krumm, Christopher S.; Xu, Xu; Bare, Curtis J.; Holman, Corey D.; Kersten, Sander; Dow, Lukas E.; Lee, Ann-Hwee; Cohen, David E.			Inducible hepatic expression of CREBH mitigates diet-induced obesity, insulin resistance, and hepatic steatosis in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR 21; TRANSCRIPTION FACTOR CREBH; ELEMENT-BINDING PROTEIN; APOLIPOPROTEIN A-IV; PPAR-ALPHA; FGF21; LIVER; METABOLISM; STRESS; SENSITIVITY	Cyclic AMP-responsive element-binding protein H (CREBH encoded by Creb3l3) is a transcription factor that regulates the expression of genes that control lipid and glucose metabolism as well as inflammation. CREBH is upregulated in the liver under conditions of overnutrition, and mice globally lacking the gene (CREBH-/-) are highly susceptible to diet-induced obesity, insulin resistance, and hepatic steatosis. The net protective effects of CREBH have been attributed in large part to the activities of fibroblast growth factor (Fgf)-21 (Fgf21), a target gene that promotes weight loss, improves glucose homeostasis, and reduces hepatic lipid accumulation. To explore the possibility that activation of the CREBH-Fgf21 axis could ameliorate established effects of high-fat feeding, we generated an inducible transgenic hepatocyte-specific CREBH overexpression mouse model (Tg-rtTA). Acute overexpression of CREBH in livers of Tg-rtTA mice effectively reversed diet-induced obesity, insulin resistance, and hepatic steatosis. These changes were associated with increased activities of thermogenic brown and beige adipose tissues in Tg-rtTA mice, leading to reductions in fat mass, along with enhanced insulin sensitivity and glucose tolerance. Genetically silencing Fgf21 in Tg-rtTA mice abrogated the CREBH-mediated reductions in body weight loss, but only partially reversed the observed improvements in glucose metabolism. These findings reveal that the protective effects of CREBH activation may be leveraged to mitigate diet-induced obesity and associated metabolic abnormalities in both Fgf21-dependent and Fgf21-independent pathways.	[Krumm, Christopher S.; Xu, Xu; Bare, Curtis J.; Holman, Corey D.; Cohen, David E.] Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, New York, NY 10065 USA; [Kersten, Sander] Wageningen Univ, Div Human Nutr & Hlth, Nutr Metab & Genom Grp, Wageningen, Netherlands; [Dow, Lukas E.] Weill Cornell Med Coll, Sandra & Edward Meyer Canc Ctr, Joan & Sanford I Weill Dept Med, Div Hematol & Med Oncol, New York, NY USA; [Lee, Ann-Hwee] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY USA	Cornell University; Wageningen University & Research; Cornell University; Cornell University	Cohen, DE (corresponding author), Weill Cornell Med Coll, Joan & Sanford I Weill Dept Med, Div Gastroenterol & Hepatol, New York, NY 10065 USA.	dcohen@med.cornell.edu	Kersten, Sander/A-1116-2011	Kersten, Sander/0000-0003-4488-7734; Dow, Lukas/0000-0001-7048-1418; Holman, Corey/0000-0003-1111-7442	National Institute of Diabetes and Digestive and Kidney Diseases [R37 DK048873, R01 DK103046, R01 DK056626]; National Institutes of Health (NIH) [T32 DK116970]; Weill Cornell Metabolic Phenotyping Core; NIH/National Cancer Center [P30CA016087]	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Weill Cornell Metabolic Phenotyping Core; NIH/National Cancer Center	This work was supported by the National Institute of Diabetes and Digestive and Kidney Diseases (R37 DK048873, R01 DK103046, and R01 DK056626 to D. E. C.). C. S. K. acknowledges support from the National Institutes of Health (NIH) T32 DK116970 (to D. E. C.). Support from the Weill Cornell Metabolic Phenotyping Core and the NIH/National Cancer Center (P30CA016087 to the Laura and Isaac Perlmutter Cancer Center; New York University Langone Health) is gratefully acknowledged. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Berglund ED, 2009, ENDOCRINOLOGY, V150, P4084, DOI 10.1210/en.2009-0221; BonDurant LD, 2017, CELL METAB, V25, P935, DOI 10.1016/j.cmet.2017.03.005; Chen W, 2011, J BIOL CHEM, V286, P34559, DOI 10.1074/jbc.M111.285965; Cheng DM, 2016, J BIOL CHEM, V291, P23793, DOI 10.1074/jbc.M116.749283; Danno H, 2010, BIOCHEM BIOPH RES CO, V391, P1222, DOI 10.1016/j.bbrc.2009.12.046; Dow LE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095236; Dushay J, 2010, GASTROENTEROLOGY, V139, P456, DOI 10.1053/j.gastro.2010.04.054; Dushay JR, 2015, MOL METAB, V4, P51, DOI 10.1016/j.molmet.2014.09.008; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Henriksson E, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.601349; Inagaki T, 2007, CELL METAB, V5, P415, DOI 10.1016/j.cmet.2007.05.003; Jin X, 2009, J HEPATOL, V50, P1019, DOI 10.1016/j.jhep.2008.10.034; Kang HW, 2013, J BIOL CHEM, V288, P33376, DOI 10.1074/jbc.M113.481408; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim H, 2014, ENDOCRINOLOGY, V155, P769, DOI 10.1210/en.2013-1490; Kwon MM, 2015, CELL REP, V13, P1521, DOI 10.1016/j.celrep.2015.10.021; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Lee JH, 2010, GASTROENTEROLOGY, V139, P653, DOI 10.1053/j.gastro.2010.03.033; Lee MW, 2010, CELL METAB, V11, P331, DOI 10.1016/j.cmet.2010.02.016; Nakagawa Y, 2014, ENDOCRINOLOGY, V155, P4706, DOI 10.1210/en.2014-1113; Park JG, 2016, SCI REP-UK, V6, DOI 10.1038/srep27938; Ruppert PMM, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5563-y; Samms RJ, 2015, CELL REP, V11, P991, DOI 10.1016/j.celrep.2015.04.046; Samuel VT, 2018, CELL METAB, V27, P22, DOI 10.1016/j.cmet.2017.08.002; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Satoh A, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100930; Scapa EF, 2008, FASEB J, V22, P2579, DOI 10.1096/fj.07-105395; Schaap FG, 2013, BIOCHIMIE, V95, P692, DOI 10.1016/j.biochi.2012.10.019; Tan MGK, 2004, J BIOL CHEM, V279, P45235, DOI 10.1074/jbc.M403683200; Tschop MH, 2012, NAT METHODS, V9, P57, DOI [10.1038/NMETH.1806, 10.1038/nmeth.1806]; Vecchi C, 2009, SCIENCE, V325, P877, DOI 10.1126/science.1176639; Veniant MM, 2015, CELL METAB, V21, P731, DOI 10.1016/j.cmet.2015.04.019; Veniant MM, 2012, ENDOCRINOLOGY, V153, P4192, DOI 10.1210/en.2012-1211; Veniant MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040164; Wade H, 2021, MOL NUTR FOOD RES, V65, DOI 10.1002/mnfr.202000771; Wang F, 2012, P NATL ACAD SCI USA, V109, P9641, DOI 10.1073/pnas.1201433109; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Xu J, 2009, AM J PHYSIOL-ENDOC M, V297, pE1105, DOI 10.1152/ajpendo.00348.2009; Xu X, 2015, HEPATOLOGY, V61, P857, DOI 10.1002/hep.27371; Xu X, 2014, J LIPID RES, V55, P850, DOI 10.1194/jlr.M045104; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	45	2	2	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100815	10.1016/j.jbc.2021.100815	http://dx.doi.org/10.1016/j.jbc.2021.100815			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023388	Green Published, gold			2022-12-28	WOS:000678068400018
J	Kulkarni, NN; O'Neill, AM; Dokoshi, T; Luo, EWC; Wong, GCL; Gallo, RL				Kulkarni, Nikhil N.; O'Neill, Alan M.; Dokoshi, Tatsuya; Luo, Elizabeth W. C.; Wong, Gerard C. L.; Gallo, Richard L.			Sequence determinants in the cathelicidin LL-37 that promote inflammation via presentation of RNA to scavenger receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIMICROBIAL PEPTIDE LL-37; DENDRITIC CELLS; ACTIVATION; COMPLEXES; KERATINOCYTES; INHIBITION; LL37	Cathelicidins such as the human 37-amino acid peptide (LL-37) are peptides that not only potently kill microbes but also trigger inflammation by enabling immune recognition of endogenous nucleic acids. Here, a detailed structure-function analysis of LL-37 was performed to understand the details of this process. Alanine scanning of 34-amino acid peptide (LL-34) showed that some variants displayed increased antimicrobial activity against Staphylococcus aureus and group A Streptococcus. In contrast, different substitutions clustered on the hydrophobic face of the LL-34 alpha helix inhibited the ability of those variants to promote type 1 interferon expression in response to U1 RNA or to present U1 to the scavenger receptor (SR) B1 on the keratinocyte cell surface. Small-angle X-ray scattering experiments of the LL-34 variants LL-34, F5A, I24A, and L31A demonstrated that these peptides form cognate supramolecular structures with U1 characterized by inter-dsRNA spacings of approximately 3.5 nm, a range that has been previously shown to activate toll-like receptor 3 by the parent peptide LL-37. Therefore, while alanine substitutions on the hydrophobic face of LL-34 led to loss of binding to SRs and the complete loss of autoinflammatory responses in epithelial and endothelial cells, they did not inhibit the ability to organize with U1 RNA in solution to associate with toll-like receptor 3. These observations advance our understanding of how cathelicidin mediates the process of innate immune self-recognition to enable inert nucleic acids to trigger inflammation. We introduce the term "innate immune vetting" to describe the capacity of peptides such as LL-37 to enable certain nucleic acids to become an inflammatory stimulus through SR binding prior to cell internalization.	[Kulkarni, Nikhil N.; O'Neill, Alan M.; Dokoshi, Tatsuya; Gallo, Richard L.] Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA; [Luo, Elizabeth W. C.; Wong, Gerard C. L.] Univ Calif Los Angeles, Dept Bioengn & Chem, Los Angeles, LA USA	University of California System; University of California San Diego; University of California System; University of California Los Angeles	Gallo, RL (corresponding author), Univ Calif San Diego, Dept Dermatol, La Jolla, CA 92093 USA.	rgallo@ucsd.edu	Dokoshi, Tatsuya/ABY-3443-2022; Gallo, Richard L/A-8931-2009	Gallo, Richard L/0000-0002-1401-7861; Luo, Elizabeth Wei-Chia/0000-0002-8663-0446; Wong, Gerard/0000-0003-0893-6383; O'Neill, Alan/0000-0002-5892-6477	National Institutes of Health [R37AI052453, R01AR076082, R01074302, U01 AI52038, R01AI153185]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant R37AI052453 to R. L. G. and G. C. L. W. R. L. G. also receives support from R01AR076082, R01074302, U01 AI52038, and R01AI153185. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bernard JJ, 2012, NAT MED, V18, P1286, DOI 10.1038/nm.2861; Borkowski AW, 2015, J INVEST DERMATOL, V135, P569, DOI 10.1038/jid.2014.354; Braff MH, 2005, J IMMUNOL, V174, P4271, DOI 10.4049/jimmunol.174.7.4271; Breuer K, 2013, NUCLEIC ACIDS RES, V41, pD1228, DOI 10.1093/nar/gks1147; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Ciornei CD, 2005, ANTIMICROB AGENTS CH, V49, P2845, DOI 10.1128/AAC.49.7.2845-2850.2005; CUNNINGHAM BC, 1989, SCIENCE, V244, P1081, DOI 10.1126/science.2471267; Di Domizio J, 2020, NAT IMMUNOL, V21, P1034, DOI 10.1038/s41590-020-0721-6; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Edfeldt K, 2006, ARTERIOSCL THROM VAS, V26, P1551, DOI 10.1161/01.ATV.0000223901.08459.57; Frasca L, 2018, FRONT IMMUNOL, V9, DOI [10.3389/fimmu.2018.02363, 10.3389/fimmu.2018.01936]; Fuentes-Duculan J, 2017, EXP DERMATOL, V26, P1075, DOI 10.1111/exd.13378; Gunasekera S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00168; Gunasekera S, 2018, CHEMBIOCHEM, V19, P931, DOI 10.1002/cbic.201700599; Haisma EM, 2014, ANTIMICROB AGENTS CH, V58, P4411, DOI 10.1128/AAC.02554-14; Herster F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13756-4; Ilavsky J, 2012, J APPL CRYSTALLOGR, V45, P324, DOI 10.1107/S0021889812004037; Kim SH, 2017, J IMMUNOL, V198, P629, DOI 10.4049/jimmunol.1600886; Kulkarni NN, 2020, J INVEST DERMATOL, V140, P645, DOI 10.1016/j.jid.2019.08.436; Kulkarni NN, 2017, J INVEST DERMATOL, V137, P2417, DOI 10.1016/j.jid.2017.07.814; Kumar A, 2006, IMMUNOLOGY, V117, P11, DOI 10.1111/j.1365-2567.2005.02258.x; Lande R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6621; Lee EY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08868-w; Lee EY, 2017, ACS NANO, V11, P12145, DOI 10.1021/acsnano.7b05234; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lopez-Garcia B, 2005, J INVEST DERMATOL, V125, P108, DOI 10.1111/j.0022-202X.2005.23713.x; Luo XL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00283; Murshid A, 2015, IMMUNOBIOLOGY, V220, P823, DOI 10.1016/j.imbio.2014.12.011; Nagant C, 2012, ANTIMICROB AGENTS CH, V56, P5698, DOI 10.1128/AAC.00918-12; Ong PY, 2002, NEW ENGL J MED, V347, P1151, DOI 10.1056/NEJMoa021481; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Piktel E, 2016, ARCH IMMUNOL THER EX, V64, P33, DOI 10.1007/s00005-015-0359-5; Rico-Mata R, 2013, EXP PARASITOL, V133, P300, DOI 10.1016/j.exppara.2012.12.009; Salvado MD, 2013, ARTERIOSCL THROM VAS, V33, P1965, DOI 10.1161/ATVBAHA.113.301851; Scheenstra MR, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01137; Schmidt NW, 2015, NAT MATER, V14, P696, DOI [10.1038/NMAT4298, 10.1038/nmat4298]; Song Q, 2021, J INVEST DERMATOL, V141, P1428, DOI 10.1016/j.jid.2020.10.027; Sorensen OE, 2001, BLOOD, V97, P3951, DOI 10.1182/blood.V97.12.3951; Takahashi T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22409-3; Tjabringa GS, 2003, J IMMUNOL, V171, P6690, DOI 10.4049/jimmunol.171.12.6690; Tursi SA, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006315; Wang GS, 2019, ADV EXP MED BIOL, V1117, P215, DOI 10.1007/978-981-13-3588-4_12; Xhindoli D, 2016, BBA-BIOMEMBRANES, V1858, P546, DOI 10.1016/j.bbamem.2015.11.003; Yamasaki K, 2007, NAT MED, V13, P975, DOI 10.1038/nm1616; Yu YS, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.100999; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zhang LJ, 2016, IMMUNITY, V45, P119, DOI 10.1016/j.immuni.2016.06.021	49	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100828	10.1016/j.jbc.2021.100828	http://dx.doi.org/10.1016/j.jbc.2021.100828			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34048712	gold, Green Published, Green Submitted			2022-12-28	WOS:000678068400030
J	Light, TP; Gomez-Soler, M; Wang, ZC; Karl, K; Zapata-Mercado, E; Gehring, MP; Lechtenberg, BC; Pogorelov, TV; Hristova, K; Pasquale, EB				Light, Taylor P.; Gomez-Soler, Maricel; Wang, Zichen; Karl, Kelly; Zapata-Mercado, Elmer; Gehring, Marina P.; Lechtenberg, Bernhard C.; Pogorelov, Taras, V; Hristova, Kalina; Pasquale, Elena B.			A cancer mutation promotes EphA4 oligomerization and signaling by altering the conformation of the SAM domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER; FGFR1 AMPLIFICATION; MOLECULAR-DYNAMICS; RECEPTOR DIMERS; PROSTATE-CANCER; DIMERIZATION; EXPRESSION; MIGRATION; DISTINCT; EPHRINS	The Eph receptor tyrosine kinases and their ephrin ligands regulate many physiological and pathological processes. EphA4 plays important roles in nervous system development and adult homeostasis, while aberrant EphA4 signaling has been implicated in neurodegeneration. EphA4 may also affect cancer malignancy, but the regulation and effects of EphA4 signaling in cancer are poorly understood. A correlation between decreased patient survival and high EphA4mRNAexpression inmelanoma tumors that also highly express ephrinAligands suggests that enhancedEphA4 signaling may contribute to melanoma progression. A search for EphA4 gain-of-function mutations in melanoma uncovered a mutation of the highly conserved leucine 920 in the EphA4 sterile alpha motif (SAM) domain. We found that mutation of L920 to phenylalanine (L920F) potentiates EphA4 autophosphorylation and signaling, making it the first documented EphA4 cancer mutation that increases kinase activity. Quantitative Foster resonance energy transfer and fluorescence intensity fluctuation (FIF) analyses revealed that the L920F mutation induces a switch in EphA4 oligomer size, from a dimer to a trimer. We propose this switch in oligomer size as a novel mechanism underlying EphA4-linked tumorigenesis. Molecular dynamics simulations suggest that the L920F mutation alters EphA4 SAM domain conformation, leading to the formation of EphA4 trimers that assemble through two aberrant SAM domain interfaces. Accordingly, EphA4wild-type and the L920Fmutant are affected differently by the SAMdomain and are differentially regulated by ephrin ligand stimulation. The increased EphA4 activation induced by the L920F mutation, through the novel mechanism we uncovered, supports a functional role for EphA4 in promoting pathogenesis.	[Light, Taylor P.; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Inst NanoBioTechnol, Baltimore, MD 21218 USA; [Gomez-Soler, Maricel; Gehring, Marina P.; Lechtenberg, Bernhard C.; Pasquale, Elena B.] Sanford Burnham Prebys Med Discovery Inst, Canc Ctr, La Jolla, CA 92037 USA; [Wang, Zichen; Pogorelov, Taras, V] Univ Illinois, Sch Chem Sci, Beckman Inst Adv Sci & Technol, Dept Chem,Ctr Biophys & Quantitat Biol, Urbana, IL USA; [Wang, Zichen; Pogorelov, Taras, V] Univ Illinois, Sch Chem Sci, Natl Ctr Supercomp Applicat, Urbana, IL USA; [Karl, Kelly; Zapata-Mercado, Elmer; Hristova, Kalina] Johns Hopkins Univ, Inst NanoBioTechnol, Program Mol Biophys, Baltimore, MD 21205 USA; [Lechtenberg, Bernhard C.] Walter & Eliza Hall Inst Med Res, Ubiquitin Signalling Div, Parkville, Vic 3052, Australia; [Lechtenberg, Bernhard C.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia	Johns Hopkins University; Sanford Burnham Prebys Medical Discovery Institute; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; Johns Hopkins University; Walter & Eliza Hall Institute; University of Melbourne	Hristova, K (corresponding author), Johns Hopkins Univ, Dept Mat Sci & Engn, Inst NanoBioTechnol, Baltimore, MD 21218 USA.; Pasquale, EB (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Canc Ctr, La Jolla, CA 92037 USA.; Hristova, K (corresponding author), Johns Hopkins Univ, Inst NanoBioTechnol, Program Mol Biophys, Baltimore, MD 21205 USA.	kalina.hristova@jhu.edu; elenap@sbpdiscovery.org		Wang, Zichen/0000-0003-4759-3053; Karl, Kelly/0000-0002-7810-3179; Zapata-Mercado, Elmer/0000-0002-9766-8124; Pogorelov, Taras/0000-0001-5851-7721	NIH [NS087070, AG062617, GM068619]; NSF [MCB 1712740]; NIH Director's Transformative Research Award [R01 GM123455]; Department of Chemistry; Office of the Vice-Chancellor for Research (RSOCR Award) [4703]; School of Chemical Sciences, University of Illinois at UrbanaChampaign; Extreme Science and Engineering Discovery Environment (XSEDE) - National Science Foundation [TG-MCB130112, ACI-1053575]; Student Pushing Innovation (SPIN) Program of the National Center for Supercomputing Applications (NCSA), University of Illinois at Urbana-Champaign	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NIH Director's Transformative Research Award; Department of Chemistry; Office of the Vice-Chancellor for Research (RSOCR Award); School of Chemical Sciences, University of Illinois at UrbanaChampaign; Extreme Science and Engineering Discovery Environment (XSEDE) - National Science Foundation; Student Pushing Innovation (SPIN) Program of the National Center for Supercomputing Applications (NCSA), University of Illinois at Urbana-Champaign	This work was supported by NIH grants NS087070 and AG062617 (to E. B. P.) as well as NIH GM068619 and NSF MCB 1712740 (to K. H.). In addition, T. V. P. is grateful for support from a NIH Director's Transformative Research Award (R01 GM123455), the Department of Chemistry, the Office of the Vice-Chancellor for Research (RSOCR Award 4703), School of Chemical Sciences, University of Illinois at UrbanaChampaign, and the Extreme Science and Engineering Discovery Environment (XSEDE, Grant TG-MCB130112), which is supported by National Science Foundation Grant ACI-1053575. Z. W. acknowledges support from the Student Pushing Innovation (SPIN) Program of the National Center for Supercomputing Applications (NCSA), University of Illinois at Urbana-Champaign. Part of this research was conducted using computational resources at the Maryland Advanced Research Computing Center (MARCC). The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed F, 2021, BIOPHYS J, V120, P55, DOI 10.1016/j.bpj.2020.11.2262; Ahmed F, 2018, BIOCHEM J, V475, P3669, DOI 10.1042/BCJ20180637; Alford RF, 2017, J CHEM THEORY COMPUT, V13, P3031, DOI 10.1021/acs.jctc.7b00125; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Barquilla A, 2016, MOL BIOL CELL, V27, P2757, DOI 10.1091/mbc.E16-01-0048; Barquilla A, 2015, ANNU REV PHARMACOL, V55, P465, DOI 10.1146/annurev-pharmtox-011112-140226; Batson J, 2014, BIOL OPEN, V3, P453, DOI 10.1242/bio.20146601; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Binns KL, 2000, MOL CELL BIOL, V20, P4791, DOI 10.1128/MCB.20.13.4791-4805.2000; Bisson N, 2007, MOL BIOL CELL, V18, P1030, DOI 10.1091/mbc.E06-04-0294; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Boyd AW, 2014, NAT REV DRUG DISCOV, V13, P39, DOI 10.1038/nrd4175; Browne BC, 2009, CURR CANCER DRUG TAR, V9, P419, DOI 10.2174/156800909788166484; Byrne PO, 2020, J BIOL CHEM, V295, P13353, DOI 10.1074/jbc.RA120.012852; de Marcondes PG, 2017, J CELL BIOCHEM, V118, P442, DOI 10.1002/jcb.25738; Desta IT, 2020, STRUCTURE, V28, P1071, DOI 10.1016/j.str.2020.06.006; Ding LL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317694298; Dionne U, 2018, MOL CELL, V70, P995, DOI 10.1016/j.molcel.2018.05.013; Dong YL, 2018, MOL CELL BIOCHEM, V439, P95, DOI 10.1007/s11010-017-3139-1; Egea J, 2005, NEURON, V47, P515, DOI 10.1016/j.neuron.2005.06.029; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Fawcett JP, 2007, P NATL ACAD SCI USA, V104, P20973, DOI 10.1073/pnas.0710316105; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Gomez-Soler M, 2019, J BIOL CHEM, V294, P8791, DOI 10.1074/jbc.RA119.008213; Hachim IY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14549-9; Hua KT, 2018, CANCER RES, V78, P216, DOI 10.1158/0008-5472.CAN-17-1933; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang YC, 2016, BLOOD, V128, P1578, DOI 10.1182/blood-2016-02-702530; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahimi OA, 2004, HUM MOL GENET, V13, P2313, DOI 10.1093/hmg/ddh235; Ibrahimi OA, 2004, HUM MOL GENET, V13, P69, DOI 10.1093/hmg/ddh011; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Jing XF, 2016, CANCER MED-US, V5, P1214, DOI 10.1002/cam4.670; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kania A, 2016, NAT REV MOL CELL BIO, V17, P240, DOI 10.1038/nrm.2015.16; Kavran JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03772; King C, 2017, J BIOL CHEM, V292, P5291, DOI 10.1074/jbc.M116.764282; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kullander K, 2001, NEURON, V29, P73, DOI 10.1016/S0896-6273(01)00181-7; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Lin CY, 2017, J CANCER, V8, P1089, DOI 10.7150/jca.17471; Lisabeth EM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009159; Liu CL, 2014, ONCOL LETT, V7, P2165, DOI 10.3892/ol.2014.2011; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Nagy P, 2010, P NATL ACAD SCI USA, V107, P16524, DOI 10.1073/pnas.1002642107; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Noberini R, 2012, SEMIN CELL DEV BIOL, V23, P51, DOI 10.1016/j.semcdb.2011.10.023; Park EK, 2004, MOL BIOL CELL, V15, P1647, DOI 10.1091/mbc.E03-09-0674; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Paul MD, 2019, CYTOKINE GROWTH F R, V49, P23, DOI 10.1016/j.cytogfr.2019.10.004; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Qiao Feng, 2005, Sci STKE, V2005, pre7, DOI 10.1126/stke.2862005re7; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Ross JS, 2009, ONCOLOGIST, V14, P320, DOI 10.1634/theoncologist.2008-0230; Saintigny P, 2012, MOL CANCER THER, V11, P2021, DOI 10.1158/1535-7163.MCT-12-0030; Sarabipour S, 2016, J MOL BIOL, V428, P3903, DOI 10.1016/j.jmb.2016.08.026; Sarabipour S, 2016, BBA-BIOMEMBRANES, V1858, P1436, DOI 10.1016/j.bbamem.2016.03.027; Sarabipour S, 2016, ELIFE, V5, DOI 10.7554/eLife.13876; Sarabipour S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10262; Sarabipour S, 2014, ANAL BIOCHEM, V449, P155, DOI 10.1016/j.ab.2013.12.027; Schaupp A, 2014, J CELL BIOL, V204, P409, DOI 10.1083/jcb.201305037; Seiradake E, 2013, NAT STRUCT MOL BIOL, V20, P958, DOI 10.1038/nsmb.2617; Seiradake E, 2010, NAT STRUCT MOL BIOL, V17, P398, DOI 10.1038/nsmb.1782; Seo AN, 2014, VIRCHOWS ARCH, V465, P547, DOI 10.1007/s00428-014-1634-2; Sethi A, 2009, P NATL ACAD SCI USA, V106, P6620, DOI 10.1073/pnas.0810961106; Shi XJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45084; Singh DR, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0017-7; Singh DR, 2017, J MOL BIOL, V429, P2231, DOI 10.1016/j.jmb.2017.05.020; Singh DR, 2017, BBA-MOL CELL RES, V1864, P31, DOI 10.1016/j.bbamcr.2016.10.011; Singh DR, 2016, BBA-GEN SUBJECTS, V1860, P1922, DOI 10.1016/j.bbagen.2016.06.004; Singh DR, 2015, J BIOL CHEM, V290, P27271, DOI 10.1074/jbc.M115.676866; Singh DR, 2015, BIOCHEM J, V471, P101, DOI 10.1042/BJ20150433; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Stapleton D, 1999, NAT STRUCT BIOL, V6, P44; Stoneman MR, 2019, NAT METHODS, V16, P493, DOI 10.1038/s41592-019-0408-9; Thanos CD, 1999, SCIENCE, V283, P833, DOI 10.1126/science.283.5403.833; Turner N, 2010, CANCER RES, V70, P2085, DOI 10.1158/0008-5472.CAN-09-3746; Vincenzi M, 2020, CURR MED CHEM, V27, P450, DOI 10.2174/0929867325666181009114445; Warner N, 2008, FEBS J, V275, P2561, DOI 10.1111/j.1742-4658.2008.06405.x; Xia JF, 2014, MOL CANCER THER, V13, P1918, DOI 10.1158/1535-7163.MCT-13-0804; Xu K, 2013, P NATL ACAD SCI USA, V110, P14634, DOI 10.1073/pnas.1311000110; Yamaguchi Y, 2004, CURR OPIN NEUROBIOL, V14, P288, DOI 10.1016/j.conb.2004.04.003	92	5	5	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100876	10.1016/j.jbc.2021.100876	http://dx.doi.org/10.1016/j.jbc.2021.100876			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34139238	Green Published, gold			2022-12-28	WOS:000678068400076
J	Nielsen, NS; Gadeberg, TAF; Poulsen, ET; Harwood, SL; Weberskov, CE; Pedersen, JS; Andersen, GR; Enghild, JJ				Nielsen, Nadia Sukusu; Gadeberg, Trine A. F.; Poulsen, Ebbe Toftgaard; Harwood, Seandean Lykke; Weberskov, Christian E.; Pedersen, Jan Skov; Andersen, Gregers R.; Enghild, Jan J.			Mutation-induced dimerization of transforming growth factor-beta-induced protein may drive protein aggregation in granular corneal dystrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LATTICE; TGFBIP; IDENTIFICATION; ACCUMULATION; PURIFICATION; PATHOGENESIS; PREVALENCE; SURGERY; MODEL; HTRA1	Protein aggregation in the outermost layers of the cornea, which can lead to cloudy vision and in severe cases blindness, is linked to mutations in the extracellular matrix protein transforming growth factor-beta-induced protein (TGFBIp). Among the most frequent pathogenic mutations are R124H and R555W, both associated with granular corneal dystrophy (GCD) characterized by the early-onset formation of amorphous aggregates. The molecular mechanisms of protein aggregation in GCD are largely unknown. In this study, we determined the crystal structures of R124H, R555W, and the lattice corneal dystrophy-associated A546T. Although there were no changes in the monomeric TGFBIp structure of any mutant that would explain their propensity to aggregate, R124H and R555W demonstrated a new dimer interface in the crystal packing, which is not present in wildtype TGFBIp or A546T. This interface, as seen in both the R124H and R555W structures, involves residue 124 of the first TGFBIp molecule and 555 in the second. The interface is not permitted by the Arg124 and Arg555 residues of wildtype TGFBIp and may play a central role in the aggregation exhibited by R124H and R555W in vivo. Using cross-linking mass spectrometry and inline size exclusion chromatography-small-angle X-ray scattering, we characterized a dimer formed by wildtype and mutant TGFBIps in solution. Dimerization in solution also involves interactions between the N- and C-terminal domains of two TGFBIp molecules but was not identical to the crystal packing dimerization. TGFBIp-targeted interventions that disrupt the R124H/R555W crystal packing dimer interface might offer new therapeutic opportunities to treat patients with GCD.	[Nielsen, Nadia Sukusu; Gadeberg, Trine A. F.; Poulsen, Ebbe Toftgaard; Harwood, Seandean Lykke; Weberskov, Christian E.; Andersen, Gregers R.; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Sci Pk, Aarhus, Denmark; [Pedersen, Jan Skov] Aarhus Univ, Dept Chem, Aarhus, Denmark; [Pedersen, Jan Skov] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus, Denmark	Aarhus University; Aarhus University; Aarhus University	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Sci Pk, Aarhus, Denmark.	jje@mbg.au.dk	Pedersen, Jan Skov/A-8346-2008	Pedersen, Jan Skov/0000-0002-7768-0206; Andersen, Gregers Rom/0000-0001-6292-3319; Toftgaard Poulsen, Ebbe/0000-0002-4416-0431; Harwood, Seandean Lykke/0000-0003-4654-8832; Enghild, Jan Johannes/0000-0001-9292-9172	Lundbeck Foundation (BRAINSTRUC) [R155-2015-2666]; Danish Agency for Science, Technology, and Innovation (DanScatt)	Lundbeck Foundation (BRAINSTRUC); Danish Agency for Science, Technology, and Innovation (DanScatt)	T. A. F. G. and G. R. A. were supported by the Lundbeck Foundation (BRAINSTRUC, grant no. R155-2015-2666) and the Danish Agency for Science, Technology, and Innovation (DanScatt).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andersen RB, 2004, BIOCHEMISTRY-US, V43, P16374, DOI 10.1021/bi048589s; Basaiawmoit RV, 2011, J MOL BIOL, V408, P503, DOI 10.1016/j.jmb.2011.02.052; Brennich ME, 2016, J APPL CRYSTALLOGR, V49, P203, DOI 10.1107/S1600576715024462; BURY AF, 1981, J CHROMATOGR, V213, P491, DOI 10.1016/S0021-9673(00)80500-2; Combe CW, 2015, MOL CELL PROTEOMICS, V14, P1137, DOI 10.1074/mcp.O114.042259; Courtney DG, 2015, INVEST OPHTH VIS SCI, V56, P4653, DOI 10.1167/iovs.15-16922; Courtney DG, 2014, INVEST OPHTH VIS SCI, V55, P977, DOI 10.1167/iovs.13-13279; Dyrlund TF, 2012, J PROTEOME RES, V11, P4231, DOI 10.1021/pr300358k; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Garcia-Castellanos R, 2017, STRUCTURE, V25, P1740, DOI 10.1016/j.str.2017.09.001; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Han KE, 2016, PROG RETIN EYE RES, V50, P67, DOI 10.1016/j.preteyeres.2015.11.002; Harwood SL, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100090; Hedegaard CJ, 2003, MOL VIS, V9, P355; IWAMOTO T, 1975, A GRAEF ARCH KLIN EX, V194, P1, DOI 10.1007/BF00408270; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kannabiran C, 2006, HUM MUTAT, V27, P615, DOI 10.1002/humu.20334; Kao AH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002212; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Karring H, 2013, MOL VIS, V19, P861; Karring H, 2012, EXP EYE RES, V96, P163, DOI 10.1016/j.exer.2011.11.014; Klintworth Gordon K, 2009, Orphanet J Rare Dis, V4, P7, DOI 10.1186/1750-1172-4-7; Klykov O, 2018, NAT PROTOC, V13, P2964, DOI 10.1038/s41596-018-0074-x; Korvatska E, 2000, J BIOL CHEM, V275, P11465, DOI 10.1074/jbc.275.15.11465; Kozin MB, 2001, J APPL CRYSTALLOGR, V34, P33, DOI 10.1107/S0021889800014126; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lakshminarayanan R, 2014, OCUL SURF, V12, P234, DOI 10.1016/j.jtos.2013.12.002; Lee JH, 2010, OPHTHAL EPIDEMIOL, V17, P160, DOI 10.3109/09286581003624939; Lukassen MV, 2020, PROTEOM CLIN APPL, V14, DOI 10.1002/prca.201900072; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nielsen NS, 2020, PROG RETIN EYE RES, V77, DOI 10.1016/j.preteyeres.2020.100843; Nielsen NS, 2017, BIOCHEMISTRY-US, V56, P6470, DOI 10.1021/acs.biochem.7b00668; PEDERSEN JS, 1994, EUR BIOPHYS J BIOPHY, V22, P379, DOI 10.1007/BF00180159; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Poulsen ET, 2019, J BIOL CHEM, V294, P11817, DOI 10.1074/jbc.RA119.009050; Poulsen ET, 2018, FEBS J, V285, P101, DOI 10.1111/febs.14321; Poulsen ET, 2016, PROTEOMICS, V16, P539, DOI 10.1002/pmic.201500287; Poulsen ET, 2014, PROTEOM CLIN APPL, V8, P168, DOI 10.1002/prca.201300058; Runager K, 2013, BIOCHEMISTRY-US, V52, P2821, DOI 10.1021/bi400212m; Runager K, 2011, J BIOL CHEM, V286, P4951, DOI 10.1074/jbc.M110.181099; Runager K, 2009, ACTA CRYSTALLOGR F, V65, P299, DOI 10.1107/S1744309109005016; Song YZ, 2017, J CATARACT REFR SURG, V43, P1489, DOI 10.1016/j.jcrs.2017.07.038; Steiner EM, 2018, PROTEINS, V86, P912, DOI 10.1002/prot.25523; Stenvang M, 2018, J MOL BIOL, V430, P1116, DOI 10.1016/j.jmb.2018.03.001; Taketani Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16308-2; Venkatraman A, 2017, J PROTEOME RES, V16, P2899, DOI 10.1021/acs.jproteome.7b00188	47	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100858	10.1016/j.jbc.2021.100858	http://dx.doi.org/10.1016/j.jbc.2021.100858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097874	Green Published, gold			2022-12-28	WOS:000678068400058
J	Pan, PY; Zhu, JT; Rizvi, A; Zhu, XY; Tanaka, H; Dreyfus, CF				Pan, Ping-Yue; Zhu, Justin; Rizvi, Asma; Zhu, Xinyu; Tanaka, Hikari; Dreyfus, Cheryl F.			Synaptojanin1 deficiency upregulates basal autophagosome formation in astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-SYNUCLEIN; SAC1 DOMAIN; SYNJ1 GENE; MUTATION; METABOLISM; TRANSPORT; NEURON; MTOR; NEURODEGENERATION; COMPARTMENT	Macroautophagy dysregulation is implicated in multiple neurological disorders, such as Parkinson's disease. While autophagy pathways are heavily researched in heterologous cells and neurons, regulation of autophagy in the astrocyte, the most abundant cell type in the mammalian brain, is less well understood. Missense mutations in the Synj1 gene encoding Synaptojanin1 (Synj1), a neuron-enriched lipid phosphatase, have been linked to Parkinsonism with seizures. Our previous study showed that the Synj1 haploinsufficient (Synj1(+/-)) mouse exhibits age-dependent autophagy impairment in multiple brain regions. Here, we used cultured astrocytes from Synj1-deficient mice to investigate its role in astrocyte autophagy. We report that Synj1 is expressed in low levels in astrocytes and represses basal autophagosome formation. We demonstrate using cellular imaging that Synj1-deficient astrocytes exhibit hyperactive autophagosome formation, represented by an increase in the size and number of GFP-microtubule-associated protein 1A/1B-light chain 3 structures. Interestingly, Synj1 deficiency is also associated with an impairment in stress-induced autophagy clearance. We show, for the first time, that the Parkinsonism-associated R839C mutation impacts autophagy in astrocytes. The impact of this mutation on the phosphatase function of Synj1 resulted in elevated basal autophagosome formation that mimics Synj1 deletion. We found that the membrane expression of the astrocyte-specific glucose transporter GluT-1 was reduced in Synj1-deficient astrocytes. Consistently, AMP-activated protein kinase activity was elevated, suggesting altered glucose sensing in Synj1-deficient astrocytes. Expressing exogenous GluT-1 in Synj1-deficient astrocytes reversed the autophagy impairment, supporting a role for Synj1 in regulating astrocyte autophagy via disrupting glucose-sensing pathways. Thus, our work suggests a novel mechanism for Synj1-related Parkinsonism involving astrocyte dysfunction.	[Pan, Ping-Yue; Zhu, Justin; Rizvi, Asma; Zhu, Xinyu; Tanaka, Hikari; Dreyfus, Cheryl F.] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Pan, PY (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, Piscataway, NJ 08854 USA.	pingyue.pan@rutgers.edu		Pan, Pingyue/0000-0002-2805-6810	National Institute of Neurological Disorders and Stroke [R01NS112390]	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was funded by the National Institute of Neurological Disorders and Stroke R01 grant (R01NS112390) to P.-Y. P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Cao MA, 2020, P NATL ACAD SCI USA, V117, P12428, DOI 10.1073/pnas.2004335117; Cao M, 2017, NEURON, V93, P882, DOI 10.1016/j.neuron.2017.01.019; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Cossec JC, 2012, HUM MOL GENET, V21, P3156, DOI 10.1093/hmg/dds142; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; DEVIVO DC, 1991, NEW ENGL J MED, V325, P703, DOI 10.1056/NEJM199109053251006; Di Malta C, 2012, P NATL ACAD SCI USA, V109, pE2334, DOI 10.1073/pnas.1209577109; Dong YM, 2015, ELIFE, V4, DOI 10.7554/eLife.05660; Fasano D, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0410-7; Fulmer CG, 2014, J NEUROSCI, V34, P8186, DOI 10.1523/JNEUROSCI.4267-13.2014; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003; Herrera F, 2009, CELL DEATH DIFFER, V16, P910, DOI 10.1038/cdd.2009.24; Hildebrand MS, 2014, EPILEPSIA, V55, pE18, DOI 10.1111/epi.12519; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kirola L, 2016, PARKINSONISM RELAT D, V31, P124, DOI 10.1016/j.parkreldis.2016.07.014; Kostuk EW, 2019, GLIA, V67, P1542, DOI 10.1002/glia.23627; Krebs CE, 2013, HUM MUTAT, V34, P1200, DOI 10.1002/humu.22372; Lee HJ, 2010, J BIOL CHEM, V285, P9262, DOI 10.1074/jbc.M109.081125; Lee SY, 2004, P NATL ACAD SCI USA, V101, P546, DOI 10.1073/pnas.0307813100; Lieberman OJ, 2020, ELIFE, V9, DOI 10.7554/eLife.50843; Lieberman OJ, 2020, J MOL BIOL, V432, P2589, DOI [10.1016/j.jmb.2019.12, 10.1016/j.jmb.2019.12.028]; Lieberman OJ, 2019, NEUROBIOL DIS, V122, P49, DOI 10.1016/j.nbd.2018.04.017; Lindstrom V, 2017, MOL CELL NEUROSCI, V82, P143, DOI 10.1016/j.mcn.2017.04.009; Maday S, 2016, J NEUROSCI, V36, P5933, DOI 10.1523/JNEUROSCI.4401-15.2016; Mani M, 2007, NEURON, V56, P1004, DOI 10.1016/j.neuron.2007.10.032; McIntire LBJ, 2012, J NEUROSCI, V32, P15271, DOI 10.1523/JNEUROSCI.2034-12.2012; McPherson PS, 1996, NATURE, V379, P353, DOI 10.1038/379353a0; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Micheva KD, 1997, J BIOL CHEM, V272, P27239, DOI 10.1074/jbc.272.43.27239; Moruno-Manchon JF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0599-5; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Nixon RA, 2013, NAT MED, V19, P983, DOI 10.1038/nm.3232; OMALLEY EK, 1992, BRAIN RES, V582, P65, DOI 10.1016/0006-8993(92)90317-3; Pan PY, 2020, HUM MOL GENET, V29, P2300, DOI 10.1093/hmg/ddaa080; Pan PY, 2017, J NEUROSCI, V37, P11366, DOI 10.1523/JNEUROSCI.0964-17.2017; Pan PY, 2012, NAT NEUROSCI, V15, P813, DOI 10.1038/nn.3099; Pinilla Jorge, 2011, Front Biosci (Elite Ed), V3, P1289; Quadri M, 2013, HUM MUTAT, V34, P1208, DOI 10.1002/humu.22373; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schildge S, 2013, JOVE-J VIS EXP, DOI 10.3791/50079; Shinde SR, 2017, CELL REP, V21, P1655, DOI 10.1016/j.celrep.2017.10.053; Smith ED, 2014, J BIOL CHEM, V289, P20615, DOI 10.1074/jbc.M114.568659; Sung K, 2020, J MOL BIOL, V432, P2605, DOI 10.1016/j.jmb.2019.12.041; Taghavi S, 2018, MOL NEUROBIOL, V55, P3477, DOI 10.1007/s12035-017-0535-1; Tremblay ME, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0314-8; Vanhauwaert R, 2017, EMBO J, V36, P1392, DOI 10.15252/embj.201695773; Vijayan V, 2017, J CELL BIOL, V216, P1895, DOI 10.1083/jcb.201611113; Voronov SV, 2008, P NATL ACAD SCI USA, V105, P9415, DOI 10.1073/pnas.0803756105; Wang Q, 2013, JNCI-J NATL CANCER I, V105, P1463, DOI 10.1093/jnci/djt241; Zhu L, 2013, J BIOL CHEM, V288, P32050, DOI 10.1074/jbc.M113.504365	51	6	6	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100873	10.1016/j.jbc.2021.100873	http://dx.doi.org/10.1016/j.jbc.2021.100873			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34126070	Green Published, gold			2022-12-28	WOS:000678068400073
J	Pires, E; Sharma, N; Selemenakis, P; Wu, B; Huang, YX; Alimbetov, DS; Zhao, WX; Wiese, C				Pires, Elena; Sharma, Neelam; Selemenakis, Platon; Wu, Bo; Huang, Yuxin; Alimbetov, Dauren S.; Zhao, Weixing; Wiese, Claudia			RAD51AP1 mediates RAD51 activity through nucleosome interaction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOMOLOGOUS RECOMBINATION; HISTONE OCTAMER; BINDING PROTEIN; DNA-REPAIR; IN-VITRO; CHROMATIN; PROMOTION; RECONSTITUTION; ENHANCEMENT; AFFINITY	RAD51-associated protein 1 (RAD51AP1) is a key protein in the homologous recombination (HR) DNA repair pathway. Loss of RAD51AP1 leads to defective HR, genome instability, and telomere erosion. RAD51AP1 physically interacts with the RAD51 recombinase and promotes RAD51-mediated capture of donor DNA, synaptic complex assembly, and displacement-loop formation when tested with nucleosome-free DNA substrates. In cells, however, DNA is packaged into chromatin, posing an additional barrier to the complexities of the HR reaction. In this study, we show that RAD51AP1 binds to nucleosome core particles (NCPs), the minimum basic unit of chromatin in which approximately two superhelical turns of 147 bp double-stranded DNA are wrapped around one histone octamer with no free DNA ends remaining. We identified a C-terminal region in RAD51AP1, including its previously mapped DNA-binding domain, as critical for mediating the association between RAD51AP1 and both the NCP and the histone octamer. Using in vitro surrogate assays of HR activity, we show that RAD51AP1 is capable of promoting duplex DNA capture and initiating joint-molecule formation with the NCP and chromatinized template DNA, respectively. Together, our results suggest that RAD51AP1 directly assists in the RAD51-mediated search for donor DNA in chromatin. We present a model, in which RAD51AP1 anchors the DNA template through affinity for its nucleosomes to the RAD51-ssDNA nucleoprotein filament.	[Pires, Elena; Sharma, Neelam; Selemenakis, Platon; Wiese, Claudia] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA; [Pires, Elena; Selemenakis, Platon] Colorado State Univ, Cell & Mol Biol Grad Program, Ft Collins, CO 80523 USA; [Wu, Bo; Huang, Yuxin; Alimbetov, Dauren S.; Zhao, Weixing] Univ Texas Hlth San Antonio, Dept Biochem & Struct Biol, San Antonio, TX USA	Colorado State University; Colorado State University; University of Texas System; University of Texas Health San Antonio	Wiese, C (corresponding author), Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA.	cwiese@colostate.edu		Wiese, Claudia/0000-0001-6844-4693; zhao, weixing/0000-0001-5746-3696; Selemenakis, Platon/0000-0002-4507-2249	National Institutes of Health [R01ES021454, R56ES021454, R03ES029206]; V Foundation Scholar Grant; Max & Minnie Tomerlin Voelcker Young Investigator Award [T32OD012201]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); V Foundation Scholar Grant; Max & Minnie Tomerlin Voelcker Young Investigator Award	This work was supported by National Institutes of Health Grants R01ES021454, R56ES021454, R03ES029206 (to C. W.), a V Foundation Scholar Grant and a Max & Minnie Tomerlin Voelcker Young Investigator Award (to W. Z.). E. P. was cosupported by T32OD012201. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexeev A, 2003, NAT STRUCT BIOL, V10, P182, DOI 10.1038/nsb901; Alexiadis V, 2002, GENE DEV, V16, P2767, DOI 10.1101/gad.1032102; Belotserkovskaya R, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14563-y; Bleuyard JY, 2012, EMBO REP, V13, P135, DOI 10.1038/embor.2011.243; Crickard JB, 2019, J BIOL CHEM, V294, P490, DOI 10.1074/jbc.RA118.006146; Daley JM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a017954; Dray E, 2010, NAT STRUCT MOL BIOL, V17, P1255, DOI 10.1038/nsmb.1916; Dray E, 2011, P NATL ACAD SCI USA, V108, P3560, DOI 10.1073/pnas.1016454108; Dunlop MH, 2012, J BIOL CHEM, V287, P12343, DOI 10.1074/jbc.C112.352161; Dunlop MH, 2011, J BIOL CHEM, V286, P37328, DOI 10.1074/jbc.M111.290015; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; FUJIINAKATA T, 1992, J BIOL CHEM, V267, P20980; Gottesfeld JM, 2001, BIOCHEMISTRY-US, V40, P10927, DOI 10.1021/bi0109966; Hammond CM, 2017, NAT REV MOL CELL BIO, V18, P141, DOI 10.1038/nrm.2016.159; Higgs MR, 2018, MOL CELL, V71, P25, DOI 10.1016/j.molcel.2018.05.018; Jaskelioff M, 2003, J BIOL CHEM, V278, P9212, DOI 10.1074/jbc.M211545200; JEONG SW, 1991, J MOL BIOL, V222, P1131, DOI 10.1016/0022-2836(91)90597-Y; Kobayashi W, 2016, SCI REP-UK, V6, DOI 10.1038/srep24228; Kovalenko OV, 2006, NUCLEIC ACIDS RES, V34, P5081, DOI 10.1093/nar/gkl665; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Kulkarni P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800061; Kwon Y, 2007, DNA REPAIR, V6, P1496, DOI 10.1016/j.dnarep.2007.04.012; Kwon YH, 2008, J BIOL CHEM, V283, P10445, DOI 10.1074/jbc.M800082200; Kwon Y, 2017, METHOD ENZYMOL, V591, P307, DOI 10.1016/bs.mie.2017.03.021; Liang FS, 2020, J BIOL CHEM, V295, P8186, DOI 10.1074/jbc.RA120.013714; Liang FS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10408-5; Liang FS, 2016, CELL REP, V15, P2118, DOI 10.1016/j.celrep.2016.05.007; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Lusser A, 2004, NAT METHODS, V1, P19, DOI 10.1038/nmeth709; Maranon DG, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201911049; Mehrotra PV, 2011, MOL CELL, V41, P46, DOI 10.1016/j.molcel.2010.12.008; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Muthurajan UM, 2014, P NATL ACAD SCI USA, V111, P12752, DOI 10.1073/pnas.1405005111; Park YJ, 2006, P NATL ACAD SCI USA, V103, P1248, DOI 10.1073/pnas.0508002103; Parplys AC, 2015, NUCLEIC ACIDS RES, V43, P9817, DOI 10.1093/nar/gkv859; Parplys AC, 2014, DNA REPAIR, V24, P87, DOI 10.1016/j.dnarep.2014.09.007; Pires E, 2017, DNA REPAIR, V59, P76, DOI 10.1016/j.dnarep.2017.09.008; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Raynard S., 2009, COLD SPRING HARB PRO, V2009; Sato K, 2012, EMBO J, V31, P3524, DOI 10.1038/emboj.2012.197; Sharma N, 2008, P NATL ACAD SCI USA, V105, P7959, DOI 10.1073/pnas.0800534105; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Strickfaden H, 2020, CELL, V183, P1772, DOI 10.1016/j.cell.2020.11.027; Tye S, 2021, SEMIN CELL DEV BIOL, V113, P14, DOI 10.1016/j.semcdb.2020.07.004; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wiese C, 2006, NUCLEIC ACIDS RES, V34, P2833, DOI 10.1093/nar/gkl366; Wilson MD, 2017, PHILOS T R SOC B, V372, DOI 10.1098/rstb.2016.0280; Wright WD, 2018, J BIOL CHEM, V293, P10524, DOI 10.1074/jbc.TM118.000372; Zhang ZQ, 2007, NAT STRUCT MOL BIOL, V14, P397, DOI 10.1038/nsmb1223; Zhao WX, 2015, MOL CELL, V59, P176, DOI 10.1016/j.molcel.2015.05.032	50	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100844	10.1016/j.jbc.2021.100844	http://dx.doi.org/10.1016/j.jbc.2021.100844			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058198	Green Submitted, gold, Green Published			2022-12-28	WOS:000678068400044
J	Singh, RR; McNamara, JW; Sadayappan, S				Singh, Rohit R.; McNamara, James W.; Sadayappan, Sakthivel			Mutations in myosin S2 alter cardiac myosin-binding protein-C interaction in hypertrophic cardiomyopathy in a phosphorylation-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPAIRS MYOFILAMENT FUNCTION; MURINE SKINNED MYOCARDIUM; SKELETAL-MUSCLE FIBERS; KINASE-A; TROPONIN-I; FORCE GENERATION; REGULATORY DOMAIN; ATPASE ACTIVITY; ATOMIC MODEL; COILED-COILS	Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disorder primarily caused by mutations in the beta-myosin heavy-chain gene. The proximal subfragment 2 region (S2), 126 amino acids of myosin, binds with the C0-C2 region of cardiac myosin-binding protein-C to regulate cardiac muscle contractility in a manner dependent on PKA-mediated phosphorylation. However, it is unknown if HCM-associated mutations within S2 dysregulate actomyosin dynamics by disrupting its interaction with C0-C2, ultimately leading to HCM. Herein, we study three S2 mutations known to cause HCM: R870H, E924K, and E930 Delta. First, experiments using recombinant proteins, solid-phase binding, and isothermal titrating calorimetry assays independently revealed that mutant S2 proteins displayed significantly reduced binding with C0C2. In addition, CD revealed greater instability of the coiledcoil structure in mutant S2 proteins compared with S2(Wt) proteins. Second, mutant S2 exhibited 5-fold greater affinity for PKA-treated C0-C2 proteins. Third, skinned papillary muscle fibers treated with mutant S2 proteins showed no change in the rate of force redevelopment as a measure of actin-myosin cross-bridge kinetics, whereas S2(Wt) showed increased the rate of force redevelopment. In summary, S2 and C0-C2 interaction mediated by phosphorylation is altered by mutations in S2, which augment the speed and force of contraction observed in HCM. Modulating this interaction could be a potential strategy to treat HCM in the future.	[Singh, Rohit R.; McNamara, James W.; Sadayappan, Sakthivel] Univ Cincinnati, Heart Lung & Vasc Inst, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA; [McNamara, James W.] Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [McNamara, James W.] Univ Melbourne, Sch Biomed Sci, Dept Physiol, Parkville, Vic 3010, Australia	University System of Ohio; University of Cincinnati; Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne	Sadayappan, S (corresponding author), Univ Cincinnati, Heart Lung & Vasc Inst, Dept Internal Med, Div Cardiovasc Hlth & Dis, Cincinnati, OH 45221 USA.	sadayasl@ucmail.uc.edu		McNamara, James/0000-0003-3754-6405; Sadayappan, Sakthivel/0000-0003-2006-7678	NIH [R01 AR078001, R01 HL130356, R01 HL105826, R38 HL155775, R01 HL143490]; American Heart Association Postdoctoral Fellowship [17POST33630095]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Postdoctoral Fellowship(American Heart Association)	S. S. has received support from NIH Grants R01 AR078001, R01 HL130356, R01 HL105826, R38 HL155775, and R01 HL143490. J. W. M. was supported by an American Heart Association Postdoctoral Fellowship (17POST33630095). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adhikari AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10555-9; Adhikari AS, 2016, CELL REP, V17, P2857, DOI 10.1016/j.celrep.2016.11.040; AL-Khayat HA, 2013, P NATL ACAD SCI USA, V110, P318, DOI 10.1073/pnas.1212708110; Armel TZ, 2009, P NATL ACAD SCI USA, V106, P6291, DOI 10.1073/pnas.0900107106; Bardswell SC, 2010, J BIOL CHEM, V285, P5674, DOI 10.1074/jbc.M109.066456; Barefield D, 2010, J MOL CELL CARDIOL, V48, P866, DOI 10.1016/j.yjmcc.2009.11.014; BARNES KP, 1972, J BIOL CHEM, V247, P1708; Blair E, 2002, CIRC RES, V90, P263, DOI 10.1161/hh0302.104532; Bristow MR, 2000, CIRCULATION, V101, P558, DOI 10.1161/01.CIR.101.5.558; Brown JH, 1996, PROTEINS, V26, P134; Brunello E, 2020, P NATL ACAD SCI USA, V117, P8177, DOI 10.1073/pnas.1920632117; Chen PP, 2010, J GEN PHYSIOL, V136, P615, DOI 10.1085/jgp.201010448; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Cuello F, 2011, J BIOL CHEM, V286, P5300, DOI 10.1074/jbc.M110.202713; DAVIS JS, 1987, P NATL ACAD SCI USA, V84, P975, DOI 10.1073/pnas.84.4.975; Desjardins CL, 2012, CIRC-CARDIOVASC IMAG, V5, P127, DOI 10.1161/CIRCIMAGING.111.965772; Dias KA, 2018, J AM COLL CARDIOL, V72, P1157, DOI 10.1016/j.jacc.2018.06.054; Freeman K, 2001, AM J PHYSIOL-HEART C, V280, pH151, DOI 10.1152/ajpheart.2001.280.1.H151; GARVEY JL, 1988, BIOCHEM J, V249, P709, DOI 10.1042/bj2490709; GAUTEL M, 1995, EMBO J, V14, P1952, DOI 10.1002/j.1460-2075.1995.tb07187.x; Giles J, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012782; Gillis TE, 2011, J EXP BIOL, V214, P1989, DOI 10.1242/jeb.052084; Govindan S, 2012, J MUSCLE RES CELL M, V33, P17, DOI 10.1007/s10974-012-9292-y; Gresham KS, 2016, J PHYSIOL-LONDON, V594, P669, DOI 10.1113/JP270959; Gresham KS, 2014, J PHYSIOL-LONDON, V592, P3747, DOI 10.1113/jphysiol.2014.276022; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Gundapaneni D, 2005, J STRUCT BIOL, V149, P117, DOI 10.1016/j.jsb.2004.10.005; Harris SP, 2004, CIRC RES, V95, P930, DOI 10.1161/01.RES.0000147312.02673.56; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Kensler RW, 2011, J STRUCT BIOL, V174, P44, DOI 10.1016/j.jsb.2010.12.003; Kraft T, 2013, J MOL CELL CARDIOL, V57, P13, DOI 10.1016/j.yjmcc.2013.01.001; Marian AJ, 2017, CIRC RES, V121, P749, DOI 10.1161/CIRCRESAHA.117.311059; Maron BJ, 2002, JAMA-J AM MED ASSOC, V287, P1308, DOI 10.1001/jama.287.10.1308; MCKENNA W, 1981, AM J CARDIOL, V47, P532, DOI 10.1016/0002-9149(81)90535-X; McNally EM, 2015, CELL METAB, V21, P174, DOI 10.1016/j.cmet.2015.01.013; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180064; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; Mohamed AS, 1998, ARCH BIOCHEM BIOPHYS, V358, P313, DOI 10.1006/abbi.1998.0857; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Najafi A, 2016, CARDIOVASC RES, V110, P200, DOI 10.1093/cvr/cvw026; Napierski NC, 2020, CIRC RES, V126, P737, DOI 10.1161/CIRCRESAHA.119.315760; OFFER G, 1973, J MOL BIOL, V74, P653, DOI 10.1016/0022-2836(73)90055-7; Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016; Patel JR, 2001, AM J PHYSIOL-HEART C, V280, pH2732, DOI 10.1152/ajpheart.2001.280.6.H2732; Prajapati C, 2018, DIS MODEL MECH, V11, DOI 10.1242/dmm.032896; Previs MJ, 2012, SCIENCE, V337, P1215, DOI 10.1126/science.1223602; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Rao V, 2014, BIOPHYS J, V107, P1196, DOI 10.1016/j.bpj.2014.07.027; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Robinett JC, 2019, J GEN PHYSIOL, V151, P645, DOI 10.1085/jgp.201812200; Root DD, 2006, BIOPHYS J, V90, P2852, DOI 10.1529/biophysj.105.071597; Rosas PC, 2019, JACC-BASIC TRANSL SC, V4, P817, DOI 10.1016/j.jacbts.2019.06.003; Sadayappan S, 2005, CIRC RES, V97, P1156, DOI 10.1161/01.RES.0000190605.79013.4d; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Sadayappan S, 2011, CIRC RES, V109, P141, DOI 10.1161/CIRCRESAHA.111.242560; Sadayappan S, 2009, CIRCULATION, V119, P1253, DOI 10.1161/CIRCULATIONAHA.108.798983; Sarkar SS, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax0069; SCHUMACHER C, 1995, N-S ARCH PHARMACOL, V351, P398; Sequeira V, 2013, CIRC RES, V112, P1491, DOI 10.1161/CIRCRESAHA.111.300436; Singh RR, 2018, DATA BRIEF, V18, P1099, DOI 10.1016/j.dib.2018.04.002; Singh RR, 2018, ARCH BIOCHEM BIOPHYS, V638, P41, DOI 10.1016/j.abb.2017.12.002; Spudich JA, 2015, BIOCHEM SOC T, V43, P64, DOI 10.1042/BST20140324; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, CIRC RES, V99, P884, DOI 10.1161/01.RES.0000245191.34690.66; SUGI H, 1992, P NATL ACAD SCI USA, V89, P6134, DOI 10.1073/pnas.89.13.6134; Tanjore RR, 2006, CLIN GENET, V69, P434, DOI 10.1111/j.1399-0004.2006.00599.x; Toepfer CN, 2020, CIRCULATION, V141, P828, DOI 10.1161/CIRCULATIONAHA.119.042339; Toepfer CN, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aat1199; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Trivedi Darshan V, 2018, Biophys Rev, V10, P27, DOI 10.1007/s12551-017-0274-6; Weisberg A, 1996, P NATL ACAD SCI USA, V93, P8999, DOI 10.1073/pnas.93.17.8999; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Witayavanitkul N, 2014, J BIOL CHEM, V289, P8818, DOI 10.1074/jbc.M113.541128; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Woodhead JL, 2020, ARCH BIOCHEM BIOPHYS, V680, DOI 10.1016/j.abb.2019.108228; Xiao L, 2007, BIOCHEMISTRY-US, V46, P7054, DOI 10.1021/bi700467k; Yang SX, 2020, NATURE, V588, P521, DOI 10.1038/s41586-020-3007-0; YAZAWA Y, 1973, J BIOCHEM-TOKYO, V73, P567, DOI 10.1093/oxfordjournals.jbchem.a130115; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	83	1	1	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100836	10.1016/j.jbc.2021.100836	http://dx.doi.org/10.1016/j.jbc.2021.100836			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051236	Green Published, gold			2022-12-28	WOS:000678068400036
J	Kitai, K; Kawaguchi, K; Tomohiro, T; Morita, M; So, T; Imanaka, T				Kitai, Katsuki; Kawaguchi, Kosuke; Tomohiro, Takenori; Morita, Masashi; So, Takanori; Imanaka, Tsuneo			The lysosomal protein ABCD4 can transport vitamin B-12 across liposomal membranes in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADULT HIPPOCAMPAL NEUROGENESIS; NEURONAL DIFFERENTIATION; EXPRESSION; MATURATION; PHENOTYPES; MODELS; BRAIN	Vitamin B-12 (cobalamin) is an essential micronutrient for human health, and mutation and dysregulation of cobalamin metabolism are associated with serious diseases, such as methylmalonic aciduria and homocystinuria. Mutations in ABCD4 or LMBRD1, which encode the ABC transporter ABCD4 and lysosomal membrane protein LMBD1, respectively, lead to errors in cobalamin metabolism, with the phenotype of a failure to release cobalamin from lysosomes. However, the mechanism of transport of cobalamin across the lysosomal membrane remains unknown. We previously demonstrated that LMBD1 is required for the translocation of ABCD4 from the endoplasmic reticulum to lysosomes. This suggests that ABCD4 performs an important function in lysosomal membrane cobalamin transport. In this study, we expressed human ABCD4 and LMBD1 in methylotrophic yeast and purified them. We prepared ABCD4 and/or LMBD1 containing liposomes loaded with cobalamin and then quantified the release of cobalamin from the liposomes by reverse-phase HPLC. We observed that ABCD4 was able to transport cobalamin from the inside to the outside of liposomes dependent on its ATPase activity and that LMBD1 exhibited no cobalamin transport activity. These results suggest that ABCD4 may be capable of transporting cobalamin from the lysosomal lumen to the cytosol. Furthermore, we examined a series of ABCD4 missense mutations to understand how these alterations impair cobalamin transport. Our findings give insight into the molecular mechanism of cobalamin transport by which ABCD4 involves and its importance in cobalamin deficiency.	[Kitai, Katsuki; Kawaguchi, Kosuke; Tomohiro, Takenori; Morita, Masashi; So, Takanori] Univ Toyama, Grad Sch Med & Pharmaceut Sci, Toyama, Japan; [Imanaka, Tsuneo] Hiroshima Int Univ, Fac Pharmaceut Sci, Kure, Japan	University of Toyama	Kawaguchi, K (corresponding author), Univ Toyama, Grad Sch Med & Pharmaceut Sci, Toyama, Japan.	kkawa@pha.u-toyama.ac.jp	So, Takanori/R-6175-2019	So, Takanori/0000-0003-3004-8526; Kawaguchi, Kosuke/0000-0002-5115-7169; Imanaka, Tsuneo/0000-0003-4677-1356	Ministry of Education, Culture, Sports, Science and Technology of Japan [20K15990]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant-in-aid for early-career scientists (20K15990 to Kosuke Kawaguchi) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and Tamura Science and Technology Foundation (to Kosuke Kawaguchi).	Bonaguidi MA, 2011, CELL, V145, P1142, DOI 10.1016/j.cell.2011.05.024; Brandt MD, 2003, MOL CELL NEUROSCI, V24, P603, DOI 10.1016/S1044-7431(03)00207-0; CRAWLEY JN, 1985, NEUROSCI BIOBEHAV R, V9, P37, DOI 10.1016/0149-7634(85)90030-2; Etkin A, 2006, NEURON, V50, P127, DOI 10.1016/j.neuron.2006.03.013; Furutachi S, 2013, EMBO J, V32, P970, DOI 10.1038/emboj.2013.50; Goncalves JT, 2016, CELL, V167, P897, DOI 10.1016/j.cell.2016.10.021; Hagihara H, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0522-8; Hagihara Hideo, 2019, Neuropsychopharmacology Reports, V39, P78, DOI 10.1002/npr2.12048; Hagihara H, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/318596; Imoto Y, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0288-9; Iwasato T, 2004, GENESIS, V38, P130, DOI 10.1002/gene.20009; Kang EC, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019026; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Knoll B, 2006, NAT NEUROSCI, V9, P195, DOI 10.1038/nn1627; Kobayashi K, 2010, P NATL ACAD SCI USA, V107, P8434, DOI 10.1073/pnas.0912690107; Kobayashi M, 2014, MOL BRAIN, V7, DOI 10.1186/1756-6606-7-12; Mairet-Coello G, 2012, DEVELOPMENT, V139, P475, DOI 10.1242/dev.067314; Nader K, 2019, BRAIN STRUCT FUNCT, V224, P2691, DOI 10.1007/s00429-019-01925-6; Nagashima S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56559-9; Nagashima S, 2011, J BIOL CHEM, V286, P33879, DOI 10.1074/jbc.M111.234997; Oku Y, 2013, J NEUROSCI, V33, P12586, DOI 10.1523/JNEUROSCI.0341-13.2013; Qin QY, 2006, J CELL BIOL, V172, P497, DOI 10.1083/jcb.200505079; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Sahay A, 2011, NATURE, V472, P466, DOI 10.1038/nature09817; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shin R, 2013, BIPOLAR DISORD, V15, P405, DOI 10.1111/bdi.12064; Stritt C, 2010, MOL CELL BIOL, V30, P1828, DOI 10.1128/MCB.01434-09; Takao K, 2013, NEUROPSYCHOPHARMACOL, V38, P1409, DOI 10.1038/npp.2013.38; Terashima M, 2010, J NEUROSCI RES, V88, P1387, DOI 10.1002/jnr.22315; Torashima T, 2008, EMBO REP, V9, P393, DOI 10.1038/embor.2008.31; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Umemori, 2018, MOL BRAIN, V38; von Bohlen und Halbach O, 2007, CELL TISSUE RES, V329, P409, DOI 10.1007/s00441-007-0432-4; Walton NM, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.56; Xu D, 2019, CELL RES, V29, P1039, DOI 10.1038/s41422-019-0222-z; Yamasaki N, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-6; You JC, 2017, NAT MED, V23, P1377, DOI 10.1038/nm.4413; Zhang J, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/727542	38	5	5	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100654	10.1016/j.jbc.2021.100654	http://dx.doi.org/10.1016/j.jbc.2021.100654			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33845046	gold, Green Published			2022-12-28	WOS:000672866400625
J	Muramatsu, M; Osawa, T; Miyamura, Y; Nakagawa, S; Tanaka, T; Kodama, T; Aburatani, H; Sakai, J; Ryeom, S; Minami, T				Muramatsu, Masashi; Osawa, Tsuyoshi; Miyamura, Yuri; Nakagawa, Suguru; Tanaka, Toshiya; Kodama, Tatsuhiko; Aburatani, Hiroyuki; Sakai, Juro; Ryeom, Sandra; Minami, Takashi			Loss of Down syndrome critical region-1 leads to cholesterol metabolic dysfunction that exaggerates hypercholesterolemia in ApoE-null background	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; APOLIPOPROTEIN-E; LIPID-METABOLISM; CALCINEURIN; DSCR1; ATHEROSCLEROSIS; CERULOPLASMIN; ANGIOGENESIS; EXPRESSION; SYNTHASE	Down syndrome critical region (DSCR)-1 functions as a feedback modulator for calcineurin-nuclear factor for activated T cell (NFAT) signals, which are crucial for cell proliferation and inflammation. Stable expression of DSCR-1 inhibits pathological angiogenesis and septic inflammation. DSCR-1 also plays a critical role in vascular wall remodeling associated with aneurysm development that occurs primarily in smooth muscle cells. Besides, Dscr-1 deficiency promotes the M1-to M2-like phenotypic switch in macrophages, which correlates to the reduction of denatured cholesterol uptakes. However, the distinct roles of DSCR-1 in cholesterol and lipid metabolism are not well understood. Here, we show that loss of apolipoprotein (Apo) E in mice with chronic hypercholesterolemia induced Dscr-1 expression in the liver and aortic atheroma. In Dscr-1-null mice fed a high-fat diet, oxidative- and endoplasmic reticulum (ER) stress was induced, and sterol regulatory element-binding protein (SREBP) 2 production in hepatocytes was stimulated. This exaggerated ApoE(-/-)-mediated nonalcoholic fatty liver disease (NAFLD) and subsequent hypercholesterolemia. Genome-wide screening revealed that loss of both ApoE and Dscr-1 resulted in the induction of immune- and leukocyte activation-related genes in the liver compared with ApoE deficiency alone. However, expressions of inflammation-activated markers and levels of monocyte adhesion were suspended upon induction of the Dscr-1 null background in the aortic endothelium. Collectively, our study shows that the combined loss of Dscr-1 and ApoE causes metabolic dysfunction in the liver but reduces atherosclerotic plaques, thereby leading to a dramatic increase in serum cholesterol and the formation of sporadic vasculopathy.	[Muramatsu, Masashi; Miyamura, Yuri; Minami, Takashi] Kumamoto Univ, Div Mol & Vasc Biol, IRDA, Kumamoto, Japan; [Osawa, Tsuyoshi] Univ Tokyo, RCAST, Div Integrat Nutri, Tokyo, Japan; [Nakagawa, Suguru; Aburatani, Hiroyuki] Univ Tokyo, RCAST, Div Genome Sci, Tokyo, Japan; [Tanaka, Toshiya; Kodama, Tatsuhiko] Univ Tokyo, RCAST, Div Syst Biol, Tokyo, Japan; [Sakai, Juro] Univ Tokyo, RCAST, Div Metab Med, Tokyo, Japan; [Sakai, Juro] Tohoku Univ, Grad Sch Med, Div Mol Physiol & Metab, Sendai, Miyagi, Japan; [Ryeom, Sandra] Univ Penn, Dept Canc Biol, Philadelphia, PA USA	Kumamoto University; University of Tokyo; University of Tokyo; University of Tokyo; University of Tokyo; Tohoku University; University of Pennsylvania	Minami, T (corresponding author), Kumamoto Univ, Div Mol & Vasc Biol, IRDA, Kumamoto, Japan.	t-minami@kumamoto-u.ac.jp		Muramatsu, Masashi/0000-0001-6048-1529; Sakai, Juro/0000-0003-4043-1035; Ryeom, Sandra/0000-0002-9869-4455; Tanaka, Toshiya/0000-0003-1224-7898				Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Alfaradhi MZ, 2014, AM J PHYSIOL-REG I, V307, pR26, DOI 10.1152/ajpregu.00049.2014; Bhattacharjee PS, 2009, CURR EYE RES, V34, P99, DOI 10.1080/02713680802647662; Bianchini A, 1999, J BIOL CHEM, V274, P20265, DOI 10.1074/jbc.274.29.20265; Dong B, 2010, J LIPID RES, V51, P1486, DOI 10.1194/jlr.M003566; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Esteban V, 2011, J EXP MED, V208, P2125, DOI 10.1084/jem.20110503; Fuentes JJ, 1997, GENOMICS, V44, P358, DOI 10.1006/geno.1997.4866; Ghigo D, 2006, NITRIC OXIDE-BIOL CH, V15, P148, DOI 10.1016/j.niox.2006.01.002; Han J, 2016, J LIPID RES, V57, P1329, DOI 10.1194/jlr.R067595; Hernandez GL, 2001, J EXP MED, V193, P607, DOI 10.1084/jem.193.5.607; Hesser BA, 2004, BLOOD, V104, P149, DOI 10.1182/blood-2004-01-0273; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; ISHIBASHI S, 1994, P NATL ACAD SCI USA, V91, P4431, DOI 10.1073/pnas.91.10.4431; Liu XJ, 2020, NATURE, V588, P693, DOI 10.1038/s41586-020-2911-7; Maor I, 1997, ARTERIOSCL THROM VAS, V17, P2995, DOI 10.1161/01.ATV.17.11.2995; Mendez-Barbero N, 2013, EMBO MOL MED, V5, P1901, DOI 10.1002/emmm.201302842; Minami T, 2004, J BIOL CHEM, V279, P50537, DOI 10.1074/jbc.M406454200; Minami T, 2014, J BIOCHEM, V155, P217, DOI 10.1093/jb/mvu006; Minami T, 2013, CELL REP, V4, P709, DOI 10.1016/j.celrep.2013.07.021; Minami T, 2009, J CLIN INVEST, V119, P2257, DOI 10.1172/JCI35738; Minami T, 2006, J BIOL CHEM, V281, P20503, DOI 10.1074/jbc.M513112200; Mirshahi F, 2000, THROMB RES, V99, P587, DOI 10.1016/S0049-3848(00)00292-9; Mullard A, 2015, NAT REV DRUG DISCOV, V14, P593, DOI 10.1038/nrd4731; Muramatsu M, 2020, ARTERIOSCL THROM VAS, V40, P2425, DOI 10.1161/ATVBAHA.120.315003; PACHT ER, 1988, J APPL PHYSIOL, V64, P2092, DOI 10.1152/jappl.1988.64.5.2092; Rotter D, 2018, EMBO REP, V19, DOI 10.15252/embr.201744706; Ryeom S, 2008, CANCER CELL, V13, P420, DOI 10.1016/j.ccr.2008.02.018; Shimano H, 2017, NAT REV ENDOCRINOL, V13, P710, DOI 10.1038/nrendo.2017.91; Shiva S, 2006, NAT CHEM BIOL, V2, P486, DOI 10.1038/nchembio813; Suehiro J, 2014, J BIOL CHEM, V289, P29044, DOI 10.1074/jbc.M114.555235; Suzuki H, 1997, NATURE, V386, P292, DOI 10.1038/386292a0; Villahoz S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07071-7; Weber C, 2011, NAT MED, V17, P1410, DOI 10.1038/nm.2538; YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/S0092-8674(05)80095-9	35	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100697	10.1016/j.jbc.2021.100697	http://dx.doi.org/10.1016/j.jbc.2021.100697			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895138	Green Published, gold			2022-12-28	WOS:000672866400668
J	Pedrola, JA; Rudiger, SGD				Pedrola, Julia Aragones; Rudiger, Stefan G. D.			Double J-domain piloting of an Hsp70 substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Heat shock 70 kDa protein (Hsp70) chaperones play a crucial role in the biogenesis of tail-anchored proteins (TAs), starting a downstream cascade to the endoplasmic reticulum (ER) via the guided-entry-of-tail-anchored protein (GET) pathway. J-domain proteins (JDPs) are generally known to assist Hsp70s, but their specific role in TA targeting remains unclear. Cho et al. now identify two separate functions for JDPs in the process, in the initial capture of the TA and the transfer into the GET pathway. These data suggest that several Hsp70 cycles could be involved at distinct steps during protein maturation.	[Pedrola, Julia Aragones; Rudiger, Stefan G. D.] Univ Utrecht, Bijvoet Ctr Biomol Res, Cellular Prot Chem, Utrecht, Netherlands; [Pedrola, Julia Aragones; Rudiger, Stefan G. D.] Univ Utrecht, Sci Life, Utrecht, Netherlands	Utrecht University; Utrecht University	Rudiger, SGD (corresponding author), Univ Utrecht, Bijvoet Ctr Biomol Res, Cellular Prot Chem, Utrecht, Netherlands.; Rudiger, SGD (corresponding author), Univ Utrecht, Sci Life, Utrecht, Netherlands.	s.g.d.rudiger@uu.nl	Rüdiger, Stefan GD/G-4906-2012	Rüdiger, Stefan GD/0000-0002-1807-2972; Aragones Pedrola, Julia/0000-0003-1991-3283	Campaign Team Huntington; Alzheimer Nederland; ZonMw TOP Grant ('Chaperoning axonal transport in neurodegenerative disease') [91215084]	Campaign Team Huntington; Alzheimer Nederland; ZonMw TOP Grant ('Chaperoning axonal transport in neurodegenerative disease')	S. G. D. R. is supported by Campaign Team Huntington, Alzheimer Nederland, and a ZonMw TOP Grant ('Chaperoning axonal transport in neurodegenerative disease'; No. 91215084).	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100717	10.1016/j.jbc.2021.100717	http://dx.doi.org/10.1016/j.jbc.2021.100717			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33930465	Green Published, gold			2022-12-28	WOS:000672866400687
J	Esperante, SA; Varejao, N; Pinheiro, F; Sant'Anna, R; Luque-Ortega, JR; Alfonso, C; Sora, V; Papaleo, E; Rivas, G; Reverter, D; Ventura, S				Esperante, Sebastian A.; Varejao, Nathalia; Pinheiro, Francisca; Sant'Anna, Ricardo; Roman Luque-Ortega, Juan; Alfonso, Carlos; Sora, Valentina; Papaleo, Elena; Rivas, German; Reverter, David; Ventura, Salvador			Disease-associated mutations impacting BC-loop flexibility trigger long-range transthyretin tetramer destabilization and aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL AMYLOID POLYNEUROPATHY; DENATURATION; VARIANT; TAFAMIDIS; PROTEIN; ULTRACENTRIFUGATION; AMYLOIDOGENESIS; STABILIZATION; DISSOCIATION; STABILITY	Hereditary transthyretin amyloidosis (ATTR) is an autosomal dominant disease characterized by the extracellular deposition of the transport protein transthyretin (TTR) as amyloid fibrils. Despite the progress achieved in recent years, understanding why different TTR residue substitutions lead to different clinical manifestations remains elusive. Here, we studied the molecular basis of disease-causing missense mutations affecting residues R34 and K35. R34G and K35T variants cause vitreous amyloidosis, whereas R34T and K35N mutations result in amyloid polyneuropathy and restrictive cardiomyopathy. All variants are more sensitive to pH-induced dissociation and amyloid formation than the wild-type (WT)-TTR counterpart, specifically in the variants deposited in the eyes amyloid formation occurs close to physiological pHs. Chemical denaturation experiments indicate that all the mutants are less stable than WTTTR, with the vitreous amyloidosis variants, R34G and K35T, being highly destabilized. Sequence-induced stabilization of the dimer-dimer interface with T119M rendered tetramers containing R34G or K35T mutations resistant to pH-induced aggregation. Because R34 and K35 are among the residues more distant to the TTR interface, their impact in this region is therefore theorized to occur at long range. The crystal structures of double mutants, R34G/T119M and K35T/T119M, together with molecular dynamics simulations indicate that their strong destabilizing effect is initiated locally at the BC loop, increasing its flexibility in a mutation-dependent manner. Overall, the present findings help us to understand the sequence-dynamic-structural mechanistic details of TTR amyloid aggregation triggered by R34 and K35 variants and to link the degree of mutation-induced conformational flexibility to protein aggregation propensity.	[Esperante, Sebastian A.; Varejao, Nathalia; Pinheiro, Francisca; Sant'Anna, Ricardo; Reverter, David; Ventura, Salvador] Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Barcelona, Spain; [Esperante, Sebastian A.; Varejao, Nathalia; Pinheiro, Francisca; Sant'Anna, Ricardo; Reverter, David; Ventura, Salvador] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain; [Roman Luque-Ortega, Juan] CSIC, Ctr Invest Biol Margarita Salas, Mol Interact Facil, Madrid, Spain; [Alfonso, Carlos; Rivas, German] CSIC, Ctr Invest Biol Margarita Salas, Syst Biochem Bacterial Div Lab, Madrid, Spain; [Sora, Valentina; Papaleo, Elena] Danish Canc Soc Res Ctr, Computat Biol Lab, Copenhagen, Denmark; [Sora, Valentina; Papaleo, Elena] Tech Univ Denmark, Canc Syst Biol Hlth & Technol Dept, Sect Bioinformat, Lyngby, Denmark; [Esperante, Sebastian A.] INFANT Fdn, Buenos Aires, DF, Argentina; [Esperante, Sebastian A.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Autonomous University of Barcelona; Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Danish Cancer Society; Technical University of Denmark; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Esperante, SA; Ventura, S (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, Barcelona, Spain.; Esperante, SA; Ventura, S (corresponding author), Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Barcelona, Spain.; Esperante, SA (corresponding author), INFANT Fdn, Buenos Aires, DF, Argentina.; Esperante, SA (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	sesperante@infant.org.ar; salvador.ventura@uab.es	Rivas, German/AAG-7458-2022; Alfonso, Carlos/K-1316-2014; Ventura, Salvador/C-7021-2008; Ventura, Salvador/AAY-3170-2021; Pinheiro, Francisca/U-1397-2019; Rivas, German/AFL-7528-2022; Reverter, David/H-5360-2015	Rivas, German/0000-0003-3450-7478; Alfonso, Carlos/0000-0001-7165-4800; Ventura, Salvador/0000-0002-9652-6351; Ventura, Salvador/0000-0002-9652-6351; Pinheiro, Francisca/0000-0003-3778-1528; Rivas, German/0000-0003-3450-7478; Reverter, David/0000-0002-5347-0992	Spanish Ministry of Science and Innovation [PID2019-105017RB-100, PID2019-104544GB-I00]; ICREA, ICREA-Academia 2020; Danmarks Grundforsknings-fond [DNRF125]; Carlsbergfondet Distinguished Fellowship [CF18-0314]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ICREA, ICREA-Academia 2020; Danmarks Grundforsknings-fond(Danmarks Grundforskningsfond); Carlsbergfondet Distinguished Fellowship	This work was funded by the Spanish Ministry of Science and Innovation PID2019-105017RB-100 to S. V., PID2019-104544GB-I00 to C. A., and by ICREA, ICREA-Academia 2020 to S. V. and Danmarks Grundforsknings-fond (DNRF125) and Carlsbergfondet Distinguished Fellowship (CF18-0314) to E. P.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALMEIDA MR, 1991, BASIC RES CARDIOL, V86, P567, DOI 10.1007/BF02190707; Almeida MR, 2000, BIOCHEM BIOPH RES CO, V270, P1024, DOI 10.1006/bbrc.2000.2554; Ankarcrona M, 2016, J INTERN MED, V280, P177, DOI 10.1111/joim.12506; Azevedo EPC, 2011, BIOCHEMISTRY-US, V50, P11070, DOI 10.1021/bi201365r; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Bulawa CE, 2012, P NATL ACAD SCI USA, V109, P9629, DOI 10.1073/pnas.1121005109; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Cendron L, 2009, J BIOL CHEM, V284, P25832, DOI 10.1074/jbc.M109.017657; CHRISTMANSON L, 1991, FEBS LETT, V281, P177, DOI 10.1016/0014-5793(91)80387-I; Coelho T, 1996, CURR OPIN NEUROL, V9, P355, DOI 10.1097/00019052-199610000-00007; Coelho T., 1996, NEUROMUSCUL DISORD, V6, pS20, DOI 10.1016/0960-8966(96)88826-2; Coelho T, 2016, NEUROL THER, V5, P1, DOI 10.1007/s40120-016-0040-x; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Dasari AKR, 2020, BIOCHEMISTRY-US, V59, P2319, DOI 10.1021/acs.biochem.0c00079; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Finsterer J, 2019, ACTA NEUROL SCAND, V139, P92, DOI 10.1111/ane.13035; Foss TR, 2005, J MOL BIOL, V347, P841, DOI 10.1016/j.jmb.2005.01.050; HAGEN GA, 1973, J CLIN ENDOCR METAB, V37, P415, DOI 10.1210/jcem-37-3-415; Hammarstrom P, 2003, BIOCHEMISTRY-US, V42, P6656, DOI 10.1021/bi027319b; Hammarstrom P, 2001, SCIENCE, V293, P2459, DOI 10.1126/science.1062245; Hammarstrom P, 2002, P NATL ACAD SCI USA, V99, P16427, DOI 10.1073/pnas.202495199; Hammarstrom P, 2001, BIOCHEMISTRY-US, V40, P11453, DOI 10.1021/bi010673+; Harding S. E., 1992, ANAL ULTRACENTRIFUGA; Jiang X, 2001, P NATL ACAD SCI USA, V98, P14943, DOI 10.1073/pnas.261419998; Jiang X, 2001, BIOCHEMISTRY-US, V40, P11442, DOI 10.1021/bi011194d; Johnson SM, 2012, J MOL BIOL, V421, P185, DOI 10.1016/j.jmb.2011.12.060; Juanhuix J, 2014, J SYNCHROTRON RADIAT, V21, P679, DOI 10.1107/S160057751400825X; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Lai ZH, 1997, BIOCHEMISTRY-US, V36, P10230, DOI 10.1021/bi963195p; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lashuel HA, 1998, BIOCHEMISTRY-US, V37, P17851, DOI 10.1021/bi981876+; Lashuel HA, 1999, BIOCHEMISTRY-US, V38, P13560, DOI 10.1021/bi991021c; Levy J, 2012, AMYLOID, V19, P201, DOI 10.3109/13506129.2012.724035; Long D, 2012, OPHTHALMIC GENET, V33, P28, DOI 10.3109/13816810.2011.599356; Maurer MS, 2018, NEW ENGL J MED, V379, P1007, DOI 10.1056/NEJMoa1805689; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michael J.A., 2014, ENCY NEUROLOGICAL SC, V2; Miller M, 2018, J MED CHEM, V61, P7862, DOI 10.1021/acs.jmedchem.8b00817; Nygaard M, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00078; Palaninathan SK, 2012, CURR MED CHEM, V19, P2324; Palhano FL, 2009, J BIOL CHEM, V284, P1443, DOI 10.1074/jbc.M807100200; Patrosso MC, 1998, AM J MED GENET, V77, P135, DOI 10.1002/(SICI)1096-8628(19980501)77:2<135::AID-AJMG5>3.0.CO;2-R; Penchala SC, 2013, P NATL ACAD SCI USA, V110, P9992, DOI 10.1073/pnas.1300761110; Piana S, 2011, BIOPHYS J, V100, pL47, DOI 10.1016/j.bpj.2011.03.051; Pinheiro F, 2021, FEBS J, V288, P310, DOI 10.1111/febs.15339; REILLY MM, 1995, BRAIN, V118, P849, DOI 10.1093/brain/118.4.849; Sant'Anna R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44709; Sant'Anna R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10787; Sant'Anna R, 2014, J BIOL CHEM, V289, P28324, DOI 10.1074/jbc.M114.563981; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Sekijima Y, 2005, CELL, V121, P73, DOI 10.1016/j.cell.2005.01.018; Sekijima Y, 2006, AMYLOID, V13, P57, DOI 10.1080/13506120600722449; Sekijima Y, 2006, AMYLOID, V13, P236, DOI 10.1080/13506120600960882; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; Srinivasan E, 2020, COMPUT BIOL CHEM, V87, DOI 10.1016/j.compbiolchem.2020.107290; van Holde KE, 2005, PRINCIPLES PHYS BIOC; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	60	2	2	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101039	10.1016/j.jbc.2021.101039	http://dx.doi.org/10.1016/j.jbc.2021.101039			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343569	Green Published, gold			2022-12-28	WOS:000704369100012
J	Pan, CX; Zimmer, A; Shah, M; Huynh, MS; Lai, CCL; Sit, B; Hooda, Y; Curran, DM; Moraes, TF				Pan, Chuxi; Zimmer, Alexandra; Shah, Megha; Minh Sang Huynh; Lai, Christine Chieh-Lin; Sit, Brandon; Hooda, Yogesh; Curran, David M.; Moraes, Trevor F.			Actinobacillus utilizes a binding protein-dependent ABC transporter to acquire the active form of vitamin B-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIQUID-LIQUID-EXTRACTION; IDENTIFICATION; BIOSYNTHESIS; PERFORMANCE; METABOLISM; PYRIDOXINE; SOFTWARE; GENES	Bacteria require high-efficiency uptake systems to survive and proliferate in nutrient-limiting environments, such as those found in host organisms. ABC transporters in the bacterial plasma membrane provide a mechanism for transport of many substrates. In this study, we examine an operon containing a periplasmic binding protein in Actinobacillus for its potential role in nutrient acquisition. The electron density map of 1.76 angstrom resolution obtained from the crystal structure of the periplasmic binding protein was best fit with a molecular model containing a pyridoxal-5'-phosphate (P5P/pyridoxal phosphate/the active form of vitamin B-6) ligand within the protein's binding site. The identity of the P5P bound to this periplasmic binding protein was verified by isothermal titration calorimetry, microscale thermophoresis, and mass spectrometry, leading us to name the protein P5PA and the operon P5PAB. To illustrate the functional utility of this uptake system, we introduced the P5PAB operon from Actinobacillus pleuropneumoniae into an Escherichia coli K-12 strain that was devoid of a key enzyme required for P5P synthesis. The growth of this strain at low levels of P5P supports the functional role of this operon in P5P uptake. This is the first report of a dedicated P5P bacterial uptake system, but through bioinformatics, we discovered homologs mainly within pathogenic representatives of the Pasteurellaceae family, suggesting that this operon exists more widely outside the Actinobacillus genus.	[Pan, Chuxi; Zimmer, Alexandra; Shah, Megha; Minh Sang Huynh; Lai, Christine Chieh-Lin; Sit, Brandon; Hooda, Yogesh; Curran, David M.; Moraes, Trevor F.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	University of Toronto	Moraes, TF (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	trevor.moraes@utoronto.ca	Zimmer, Alexandra/GXF-9297-2022	Huynh, Minh Sang/0000-0002-9541-6441; Curran, David/0000-0003-2749-869X; Sit, Brandon/0000-0003-2378-3039; Zimmer, Alexandra/0000-0002-6047-0923	National Sciences and Engineering Research Council of Canada Undergraduate Student Research Awards studentships	National Sciences and Engineering Research Council of Canada Undergraduate Student Research Awards studentships	B. S. and A. Z. was supported by National Sciences and Engineering Research Council of Canada Undergraduate Student Research Awards studentships, and T. F. M. is a tier II Canada Research Chair in the Structural Biology of Membrane Proteins.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Bojesen AM, 2007, J WILDLIFE DIS, V43, P345, DOI 10.7589/0090-3558-43.3.345; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chiers K, 2010, VET RES, V41, DOI 10.1051/vetres/2010037; Chin N, 1996, FEMS MICROBIOL LETT, V143, P1, DOI 10.1111/j.1574-6968.1996.tb08452.x; Clifford CB, 2012, LABORATORY MOUSE, P481, DOI 10.1016/B978-0-12-382008-2.00020-9; Collins FM., 1996, MED MICROBIOLOGY; Dick T, 2010, MOL MICROBIOL, V78, P980, DOI 10.1111/j.1365-2958.2010.07381.x; El Qaidi S, 2013, J BACTERIOL, V195, P2187, DOI 10.1128/JB.00041-13; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Gautier AL, 2005, J CLIN MICROBIOL, V43, P2307, DOI 10.1128/JCM.43.5.2307-2314.2005; Gholizadeh P, 2017, MICROB PATHOGENESIS, V113, P303, DOI 10.1016/j.micpath.2017.11.001; Grubman A, 2010, MBIO, V1, DOI 10.1128/mBio.00112-10; Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003; Ito T, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.00430-19; Jaehme M, 2015, BBA-GEN SUBJECTS, V1850, P565, DOI 10.1016/j.bbagen.2014.05.006; Jain A, 2015, J CHROMATOGR A, V1422, P60, DOI 10.1016/j.chroma.2015.10.036; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kuhnert P, 2007, INT J SYST EVOL MICR, V57, P625, DOI 10.1099/ijs.0.64659-0; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LAWRENCE JG, 1995, J BACTERIOL, V177, P6371, DOI 10.1128/jb.177.22.6371-6380.1995; Li TT, 2014, BIOMED CHROMATOGR, V28, P648, DOI 10.1002/bmc.3083; Loera-Muro A, 2018, VET MICROBIOL, V217, P66, DOI 10.1016/j.vetmic.2018.02.028; Mendler K, 2019, NUCLEIC ACIDS RES, V47, P4442, DOI 10.1093/nar/gkz246; Mittenhuber G, 2001, J MOL MICROB BIOTECH, V3, P1; Mooney S, 2009, MOLECULES, V14, P329, DOI 10.3390/molecules14010329; MULLIGAN JH, 1977, J BIOL CHEM, V252, P835; Naushad S, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/198560; Nicklas W, 2015, INT J SYST EVOL MICR, V65, P3344, DOI 10.1099/ijsem.0.000417; Norskov-Lauritsen N, 2014, CLIN MICROBIOL REV, V27, P214, DOI 10.1128/CMR.00103-13; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Persson G, 2015, VET RES, V46, DOI 10.1186/s13567-015-0206-z; Rycroft AN, 2000, VET J, V159, P18, DOI 10.1053/tvjl.1999.0403; Sassu EL, 2018, TRANSBOUND EMERG DIS, V65, P72, DOI 10.1111/tbed.12739; Sato K, 2016, APPL ENVIRON MICROB, V82, P3546, DOI 10.1128/AEM.00522-16; Schlosser A, 2000, FEMS MICROBIOL LETT, V184, P187, DOI 10.1016/S0378-1097(00)00045-8; Schlosser A, 1997, J BACTERIOL, V179, P2092, DOI 10.1128/jb.179.6.2092-2095.1997; Sit B, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005107; Tanaka KJ, 2018, BBA-BIOMEMBRANES, V1860, P868, DOI 10.1016/j.bbamem.2017.08.011; Ulrich A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053360; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; van der Ham M, 2012, ANAL CHIM ACTA, V712, P108, DOI 10.1016/j.aca.2011.11.018; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wingfield Paul T, 2014, Curr Protoc Protein Sci, V78, DOI 10.1002/0471140864.ps0602s78; Xie F, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176374; YAMADA R, 1981, J NUTR SCI VITAMINOL, V27, P177; Zhang Z, 2009, ANIMAL, V3, P826, DOI 10.1017/S1751731109004078	51	3	3	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101046	10.1016/j.jbc.2021.101046	http://dx.doi.org/10.1016/j.jbc.2021.101046			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34358566	Green Published, gold			2022-12-28	WOS:000704369100007
J	Patel, KD; Gulick, AM				Patel, Ketan D.; Gulick, Andrew M.			Anti-Zika candidates from a marine fungus with a remarkable biosynthetic repertoire	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RICH	The study of natural products provides exciting opportu-nities for the discovery of novel biologically active molecules and biosynthetic pathways. Recently, Yuan and colleagues described 30 cyclic depsipeptides that are biosynthesized by proteins encoded by three distinct gene clusters in the marine fungus, Beauveria felina. Genetic and biochemical studies confirmed the involvement of nonribosomal peptide synthe-tases in the production of multiple compounds, some of which inhibit Zika virus replication.	[Patel, Ketan D.; Gulick, Andrew M.] Univ Buffalo, Jacobs Sch Med & Biol Sci, Dept Biol Struct, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Gulick, AM (corresponding author), Univ Buffalo, Jacobs Sch Med & Biol Sci, Dept Biol Struct, Buffalo, NY 14260 USA.	amgulick@buffalo.edu	Patel, Ketankumar D/AAB-6158-2021	Patel, Ketankumar D/0000-0003-4254-3145; Gulick, Andrew/0000-0003-4238-7453	National Institutes of General Medical Sciences of the National Institutes of Health [R35GM136235]	National Institutes of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Work in the authors' lab is funded by grant R35GM136235 from the National Institutes of General Medical Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bonhomme S, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.200386; Bozhuyuk KAJ, 2019, NAT CHEM, V11, P653, DOI 10.1038/s41557-019-0276-z; Bozhuyuk KAJ, 2019, CURR OPIN MICROBIOL, V51, P88, DOI 10.1016/j.mib.2019.10.007; Calcott MJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18365-0; Medema MH, 2021, NAT PROD REP, V38, P301, DOI 10.1039/d0np00090f; Mori T, 2018, P NATL ACAD SCI USA, V115, P1718, DOI 10.1073/pnas.1715496115; Musarra-Pizzo M, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13050828; Sivanathan S, 2014, MOLECULES, V19, P12368, DOI 10.3390/molecules190812368; Wang MX, 2016, NAT BIOTECHNOL, V34, P828, DOI 10.1038/nbt.3597; Yuan BCA, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100822	10	0	0	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101047	10.1016/j.jbc.2021.101047	http://dx.doi.org/10.1016/j.jbc.2021.101047			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34358564	Green Published, gold			2022-12-28	WOS:000704369100001
J	Tang, Q; Caglayan, M				Tang, Qun; Caglayan, Melike			The scaffold protein XRCC1 stabilizes the formation of pol beta/gap DNA and ligase III alpha/nick DNA complexes in base excision repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND-BREAK REPAIR; COMPLEMENTING GROUP 1; POLYMERASE-BETA; CANCER-RISK; APRATAXIN DEFICIENCY; INSERTION PRODUCTS; GENE XRCC1; POLYMORPHISMS; DAMAGE; VARIANTS	The base excision repair (BER) pathway involves gap filling by DNA polymerase (pol) beta and subsequent nick sealing by ligase III alpha. X-ray cross-complementing protein 1 (XRCC1), a nonenzymatic scaffold protein, assembles multiprotein complexes, although the mechanism by which XRCC1 orchestrates the final steps of coordinated BER remains incompletely defined. Here, using a combination of biochemical and biophysical approaches, we revealed that the pol beta/XRCC1 complex increases the processivity of BER reactions after correct nucleotide insertion into gaps in DNA and enhances the handoff of nicked repair products to the final ligation step. Moreover, the mutagenic ligation of nicked repair intermediate following pol beta 8-oxodGTP insertion is enhanced in the presence of XRCC1. Our results demonstrated a stabilizing effect of XRCC1 on the formation of pol beta/dNTP/gap DNA and ligase III alpha/ATP/nick DNA catalytic ternary complexes. Real-time monitoring of protein-protein interactions and DNA-binding kinetics showed stronger binding of XRCC1 to pol beta than to ligase III alpha or aprataxin, and higher affinity for nick DNA with undamaged or damaged ends than for one nucleotide gap repair intermediate. Finally, we demonstrated slight differences in stable pol beta/XRCC1 complex formation, pol beta and ligase III alpha protein interaction kinetics, and handoff process as a result of cancer-associated (P161L, R194W, R280H, R399Q, Y576S) and cerebellar ataxia-related (K431N) XRCC1 variants. Overall, our findings provide novel insights into the coordinating role of XRCC1 and the effect of its disease-associated variants on substrate-product channeling in multiprotein/DNA complexes for efficient BER.	[Tang, Qun; Caglayan, Melike] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA	State University System of Florida; University of Florida	Caglayan, M (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA.	caglayanm@ufl.edu	Tang, Qun/AHC-5915-2022	Tang, Qun/0000-0001-8943-0012; CAGLAYAN, MELIKE/0000-0003-1107-1042	National Institutes of Health/National Institute of Environmental Health Sciences [4R00ES026191]; University of Florida Thomas H. Maren Junior Investigator Fund [P0158597]	National Institutes of Health/National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Florida Thomas H. Maren Junior Investigator Fund	This work was supported by the National Institutes of Health/National Institute of Environmental Health Sciences Grant 4R00ES026191 and the University of Florida Thomas H. Maren Junior Investigator Fund P0158597.	Abbotts R, 2017, FREE RADICAL BIO MED, V107, P228, DOI 10.1016/j.freeradbiomed.2016.11.039; Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Ali R, 2018, CANCER RES, V78, P6818, DOI 10.1158/0008-5472.CAN-18-0633; Barbisan G, 2011, EUR J GYNAECOL ONCOL, V32, P274; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Beard WA, 2019, ANNU REV BIOCHEM, V88, P137, DOI 10.1146/annurev-biochem-013118-111315; Beernink PT, 2005, J BIOL CHEM, V280, P30206, DOI 10.1074/jbc.M502155200; Berquist BR, 2010, NUCLEIC ACIDS RES, V38, P5023, DOI 10.1093/nar/gkq193; Brem R, 2005, NUCLEIC ACIDS RES, V33, P2512, DOI 10.1093/nar/gki543; Caglayan M, 2020, DNA REPAIR, V95, DOI 10.1016/j.dnarep.2020.102945; Caglayan M, 2020, NUCLEIC ACIDS RES, V48, P3708, DOI 10.1093/nar/gkaa151; Caglayan M, 2019, J MOL BIOL, V431, P2068, DOI 10.1016/j.jmb.2019.04.028; Caglayan M, 2017, NUCLEIC ACIDS RES, V45, P10079, DOI 10.1093/nar/gkx654; Caglayan M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14045; Caglayan M, 2015, DNA REPAIR, V35, P85, DOI 10.1016/j.dnarep.2015.09.010; Caglayan M, 2015, NUCLEIC ACIDS RES, V43, P2271, DOI 10.1093/nar/gkv079; Caglayan M, 2014, NAT STRUCT MOL BIOL, V21, P497, DOI 10.1038/nsmb.2818; Caldecott KW, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102664; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; Caldecott KW, 2003, DNA REPAIR, V2, P955, DOI 10.1016/S1568-7864(03)00118-6; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; Cappelli E, 1997, J BIOL CHEM, V272, P23970, DOI 10.1074/jbc.272.38.23970; Chandirasekar R, 2011, ENVIRON TOXICOL PHAR, V32, P185, DOI 10.1016/j.etap.2011.05.002; Chatterjee N, 2017, ENVIRON MOL MUTAGEN, V58, P235, DOI 10.1002/em.22087; Chiang FY, 2008, CLIN CANCER RES, V14, P5919, DOI 10.1158/1078-0432.CCR-08-0906; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Dianova II, 2004, NUCLEIC ACIDS RES, V32, P2550, DOI 10.1093/nar/gkh567; Fortini P, 1999, J BIOL CHEM, V274, P15230, DOI 10.1074/jbc.274.21.15230; Ganos C, 2017, MOVEMENT DISORD, V32, P720, DOI 10.1002/mds.26971; Geng J, 2009, UROLOGY, V74, P648, DOI 10.1016/j.urology.2009.02.046; Ginsberg G, 2011, MUTAT RES-REV MUTAT, V727, P1, DOI 10.1016/j.mrrev.2011.02.001; Gryk MR, 2002, STRUCTURE, V10, P1709, DOI 10.1016/S0969-2126(02)00908-5; Halasova E, 2012, INT ARCH OCC ENV HEA, V85, P473, DOI 10.1007/s00420-011-0684-x; Hanssen-Bauer A, 2012, DNA REPAIR, V11, P357, DOI 10.1016/j.dnarep.2012.01.001; Hitomi K, 2007, DNA REPAIR, V6, P410, DOI 10.1016/j.dnarep.2006.10.004; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Horton JK, 2008, CELL RES, V18, P48, DOI 10.1038/cr.2008.7; Horton JK, 2018, DNA REPAIR, V64, P26, DOI 10.1016/j.dnarep.2018.02.004; Horton JK, 2013, DNA REPAIR, V12, P774, DOI 10.1016/j.dnarep.2013.06.004; Jiang Jun, 2009, V471, P305, DOI 10.1007/978-1-59745-416-2_16; Kamble P, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100427; Karahalil B, 2012, HUM EXP TOXICOL, V31, P981, DOI 10.1177/0960327112444476; Kelley MR, 2014, FUTURE ONCOL, V10, P1215, DOI 10.2217/fon.14.60; Kim Yun-Jeong, 2012, Curr Mol Pharmacol, V5, P3; Krokan HE, 2000, FEBS LETT, V476, P73, DOI 10.1016/S0014-5793(00)01674-4; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Kukshal V, 2015, NUCLEIC ACIDS RES, V43, P7021, DOI 10.1093/nar/gkv652; Lee KJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223725; Lindahl T, 2001, PROG NUCLEIC ACID RE, V68, pXVII; Liu YA, 2007, J BIOL CHEM, V282, P13532, DOI 10.1074/jbc.M611295200; London RE, 2015, DNA REPAIR, V30, P90, DOI 10.1016/j.dnarep.2015.02.005; Mani RS, 2019, J BIOL CHEM, V294, P520, DOI 10.1074/jbc.RA118.004262; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Marintchev A, 2003, NUCLEIC ACIDS RES, V31, P580, DOI 10.1093/nar/gkg159; Marintchev A, 1999, NAT STRUCT BIOL, V6, P884; Marintchev A, 2000, NUCLEIC ACIDS RES, V28, P2049, DOI 10.1093/nar/28.10.2049; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Mok MCY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39543-1; Moor NA, 2018, BIOCHEMISTRY-MOSCOW+, V83, P411, DOI 10.1134/S0006297918040120; Moor NA, 2015, NUCLEIC ACIDS RES, V43, P6009, DOI 10.1093/nar/gkv569; Moullan N, 2003, CANCER EPIDEM BIOMAR, V12, P1168; Nelson BC, 2020, MUTAGENESIS, V35, P1, DOI 10.1093/mutage/gez048; Parikh SS, 1997, STRUCTURE, V5, P1543, DOI 10.1016/S0969-2126(97)00303-1; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Prasad R, 2011, MOL BIOL+, V45, P536, DOI 10.1134/S0026893311040091; Prasad R, 2012, NUCLEIC ACIDS RES, V40, P11571, DOI 10.1093/nar/gks898; Prasad R, 2010, J BIOL CHEM, V285, P40479, DOI 10.1074/jbc.M110.155267; Roberts MR, 2011, CARCINOGENESIS, V32, P1223, DOI 10.1093/carcin/bgr096; Roszak A, 2011, INT J BIOL MARKER, V26, P216, DOI 10.5301/JBM.2011.8581; Ryu RA, 2011, J KOREAN MED SCI, V26, P991, DOI 10.3346/jkms.2011.26.8.991; Shen NR, 1998, NUCLEIC ACIDS RES, V26, P1032, DOI 10.1093/nar/26.4.1032; Sizova DV, 2015, DNA REPAIR, V31, P73, DOI 10.1016/j.dnarep.2015.05.005; Srivastava DK, 1998, J BIOL CHEM, V273, P21203, DOI 10.1074/jbc.273.33.21203; Sultana R, 2013, CANCER RES, V73, P1621, DOI 10.1158/0008-5472.CAN-12-2929; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Takanami T, 2005, MUTAT RES-GEN TOX EN, V582, P135, DOI 10.1016/j.mrgentox.2005.01.007; Tang Q, 2020, MUTAGENESIS, V35, P391, DOI 10.1093/mutage/geaa023; Tebbs RS, 2003, DNA REPAIR, V2, P1405, DOI 10.1016/j.dnarep.2003.08.007; Tebbs RS, 1999, DEV BIOL, V208, P513, DOI 10.1006/dbio.1999.9232; THOMPSON LH, 1982, MUTAT RES, V95, P427, DOI 10.1016/0027-5107(82)90276-7; THOMPSON LH, 1990, MOL CELL BIOL, V10, P6160, DOI 10.1128/MCB.10.12.6160; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vodicka P, 2007, CARCINOGENESIS, V28, P657, DOI 10.1093/carcin/bgl187; Wallace SS, 2012, CANCER LETT, V327, P73, DOI 10.1016/j.canlet.2011.12.038; Wei B, 2011, PROSTATE CANCER P D, V14, P225, DOI 10.1038/pcan.2011.26; Whitaker AM, 2018, DNA REPAIR, V71, P93, DOI 10.1016/j.dnarep.2018.08.012; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Wilson SH, 2000, NAT STRUCT BIOL, V7, P176; Wong HK, 2005, J CELL BIOCHEM, V95, P794, DOI 10.1002/jcb.20448; Xue HP, 2011, AM J EPIDEMIOL, V173, P363, DOI 10.1093/aje/kwq378; Yoon Grace, 2018, Handb Clin Neurol, V155, P105, DOI 10.1016/B978-0-444-64189-2.00007-X	95	2	2	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101025	10.1016/j.jbc.2021.101025	http://dx.doi.org/10.1016/j.jbc.2021.101025			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339737	Green Published, gold			2022-12-28	WOS:000706408900013
J	Yang, YY; Lindsey-Boltz, LA; Vaughn, CM; Selby, CP; Cao, XM; Liu, ZX; Hsu, DS; Sancar, A				Yang, Yanyan; Lindsey-Boltz, Laura A.; Vaughn, Courtney M.; Selby, Christopher P.; Cao, Xuemei; Liu, Zhenxing; Hsu, David S.; Sancar, Aziz			Circadian clock, carcinogenesis, chronochemotherapy connections	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CISPLATIN-DNA-DAMAGE; EXCISION-REPAIR; COLORECTAL-CANCER; GENE-EXPRESSION; ADDUCT REPAIR; CRYPTOCHROME; MECHANISMS; TRANSCRIPTION; SENSITIVITY; GENOME	The circadian clock controls the expression of nearly 50% of protein coding genes in mice and most likely in humans as well. Therefore, disruption of the circadian clock is presumed to have serious pathological effects including cancer. However, epidemiological studies on individuals with circadian disruption because of night shift or rotating shift work have produced contradictory data not conducive to scientific consensus as to whether circadian disruption increases the incidence of breast, ovarian, prostate, or colorectal cancers. Similarly, genetically engineered mice with clock disruption do not exhibit spontaneous or radiation-induced cancers at higher incidence than wild-type controls. Because many cellular functions including the cell cycle and cell division are, at least in part, controlled by the molecular clock components (CLOCK, BMAL1, CRYs, PERs), it has also been expected that appropriate timing of chemotherapy may increase the efficacy of chemotherapeutic drugs and ameliorate their side effect. However, empirical attempts at chronochemotherapy have not produced beneficial outcomes. Using mice without and with human tumor xenografts, sites of DNA damage and repair following treatment with the anticancer drug cisplatin have been mapped genome-wide at single nucleotide resolution and as a function of circadian time. The data indicate that mechanism-based studies such as these may provide information necessary for devising rational chronochemotherapy regimens.	[Yang, Yanyan; Lindsey-Boltz, Laura A.; Vaughn, Courtney M.; Selby, Christopher P.; Cao, Xuemei; Liu, Zhenxing; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA; [Hsu, David S.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Duke University	Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.; Hsu, DS (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	shiaowen.hsu@duke.edu; aziz_sancar@med.unc.edu	Liu, Zhenxing/HCH-6877-2022; liu, zhenxing/GWC-9542-2022	Cao, Xuemei/0000-0001-5504-5554; liu, zhenxing/0000-0001-8236-1931; Yang, Yanyan/0000-0001-9943-4279	National Institutes of Health [GM118102]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grant GM118102 to A. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allada R, 2021, NEW ENGL J MED, V384, P550, DOI 10.1056/NEJMra1802337; Altman BJ, 2015, CELL METAB, V22, P1009, DOI 10.1016/j.cmet.2015.09.003; Antoch MP, 2013, CELL CYCLE, V12, P3673, DOI 10.4161/cc.26614; Antoch MP, 2005, CELL CYCLE, V4, P901, DOI 10.4161/cc.4.7.1792; Ballesta A, 2017, PHARMACOL REV, V69, P161, DOI 10.1124/pr.116.013441; Cao XM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021174118; Cavga AD, 2019, FUNCT INTEGR GENOMIC, V19, P729, DOI 10.1007/s10142-019-00680-5; Cederroth CR, 2019, CELL METAB, V30, P238, DOI 10.1016/j.cmet.2019.06.019; Chiou YY, 2016, P NATL ACAD SCI USA, V113, pE6072, DOI 10.1073/pnas.1612917113; Comas M, 2014, CHRONOBIOL INT, V31, P901, DOI 10.3109/07420528.2014.925469; Cox KH, 2019, J MOL ENDOCRINOL, V63, pR93, DOI 10.1530/JME-19-0153; Dakup Panshak P, 2018, Oncotarget, V9, P14524, DOI 10.18632/oncotarget.24539; Dallmann R, 2016, TRENDS MOL MED, V22, P430, DOI 10.1016/j.molmed.2016.03.004; Dubrovsky YV, 2010, AGING-US, V2, P936, DOI 10.18632/aging.100241; Dun AS, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01006; Etchegaray JP, 2009, MOL CELL BIOL, V29, P3853, DOI 10.1128/MCB.00338-09; Farshadi E, 2020, J MOL BIOL, V432, P3515, DOI 10.1016/j.jmb.2020.04.003; Filipski E, 2004, CANCER RES, V64, P7879, DOI 10.1158/0008-5472.CAN-04-0674; Filipski E, 2002, J NATL CANCER I, V94, P690; Finger AM, 2020, FEBS LETT, V594, P2734, DOI 10.1002/1873-3468.13898; Gaddameedhi S, 2011, P NATL ACAD SCI USA, V108, P18790, DOI 10.1073/pnas.1115249108; Gallion HH, 2003, J CLIN ONCOL, V21, P3808, DOI 10.1200/JCO.2003.10.083; Gauger MA, 2005, CANCER RES, V65, P6828, DOI 10.1158/0008-5472.CAN-05-1119; Giacchetti S, 2012, ANN ONCOL, V23, P3110, DOI 10.1093/annonc/mds148; Gorbacheva VY, 2005, P NATL ACAD SCI USA, V102, P3407, DOI 10.1073/pnas.0409897102; Gray MW, 2010, SCIENCE, V330, P920, DOI 10.1126/science.1198594; Green CB, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a030692; HALBERG F, 1960, P SOC EXP BIOL MED, V103, P142; Hamada T, 2014, GENES CELLS, V19, P441, DOI 10.1111/gtc.12144; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hanoun M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034347; Hastings MH, 2003, NAT REV NEUROSCI, V4, P649, DOI 10.1038/nrn1177; HRUSHESKY WJM, 1993, J CLIN ONCOL, V11, P1403, DOI 10.1200/JCO.1993.11.7.1403; HRUSHESKY WJM, 1985, SCIENCE, V228, P73, DOI 10.1126/science.3883493; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Huber AL, 2016, MOL CELL, V64, P774, DOI 10.1016/j.molcel.2016.10.012; Jia M, 2021, ONCOL REP, V45, P1033, DOI 10.3892/or.2020.7914; Kang TH, 2014, NUCLEIC ACIDS RES, V42, P4427, DOI 10.1093/nar/gku094; Kang TH, 2010, P NATL ACAD SCI USA, V107, P4890, DOI 10.1073/pnas.0915085107; Kang TH, 2009, CELL CYCLE, V8, P1665, DOI 10.4161/cc.8.11.8707; Kang TH, 2009, P NATL ACAD SCI USA, V106, P2864, DOI 10.1073/pnas.0812638106; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kinouchi K, 2020, NAT REV CANCER, V20, P645, DOI 10.1038/s41568-020-0291-9; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Kondratov RV, 2003, GENE DEV, V17, P1921, DOI 10.1101/gad.1099503; Kondratov RV, 2006, FASEB J, V20, P530, DOI 10.1096/fj.05-5321fje; Korkmaz T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34433-4; Lee JH, 2013, CANCER RES, V73, P785, DOI 10.1158/0008-5472.CAN-12-1994; Lee Y, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd2645; Lee Y, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000228; LEVI F, 1990, J CLIN ONCOL, V8, P705, DOI 10.1200/JCO.1990.8.4.705; Levi F, 2007, ANNU REV PHARMACOL, V47, P593, DOI 10.1146/annurev.pharmtox.47.120505.105208; Liu ZX, 2020, P NATL ACAD SCI USA, V117, P21609, DOI 10.1073/pnas.2011225117; Lubov JE, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22116112; Miki T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3444; Miyamoto Y, 1999, MOL BRAIN RES, V71, P238, DOI 10.1016/S0169-328X(99)00192-8; Mocellin S, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1010-1; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/S0092-8674(04)01054-2; Narasimamurthy R, 2021, MOL CELL, V81, P1133, DOI 10.1016/j.molcel.2021.01.006; Ozturk N, 2009, P NATL ACAD SCI USA, V106, P2841, DOI 10.1073/pnas.0813028106; Papagiannakopoulos T, 2016, CELL METAB, V24, P324, DOI 10.1016/j.cmet.2016.07.001; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Patel SA, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10020150; Patke A, 2020, NAT REV MOL CELL BIO, V21, P67, DOI 10.1038/s41580-019-0179-2; Peeples L, 2018, NATURE, V556, P290, DOI 10.1038/d41586-018-04600-8; Philpott JM, 2020, ELIFE, V9, DOI 10.7554/eLife.52343; Puram RV, 2016, CELL, V165, P303, DOI 10.1016/j.cell.2016.03.015; Putker M, 2021, EMBO J, V40, DOI 10.15252/embj.2020106745; Relogio A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004338; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Rosbash M, 2021, ANGEW CHEM INT EDIT, V60, P8650, DOI 10.1002/anie.202015199; Ruan W, 2021, NAT REV DRUG DISCOV, V20, P287, DOI 10.1038/s41573-020-00109-w; Sancar A., 2021, COLD SPRING HARB S Q, P20; Sancar A, 2021, SCIENCE, V371, P42, DOI 10.1126/science.abb0738; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Sancar A, 2015, BIOCHEMISTRY-US, V54, P110, DOI 10.1021/bi5007354; Schibler U, 2015, COLD SH Q B, V80, P223, DOI 10.1101/sqb.2015.80.027490; Shafi AA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20513-5; Shostak A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14918; Shostak A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11807; Slat EA, 2017, J BIOL RHYTHM, V32, P121, DOI 10.1177/0748730417696788; Stephenson EM, 2021, ENDOCR-RELAT CANCER, V28, pR95, DOI 10.1530/ERC-20-0475; Stevens RG, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw342; Thresher RJ, 1998, SCIENCE, V282, P1490, DOI 10.1126/science.282.5393.1490; Travis RC, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djw169; Unsal-Kacmaz K, 2005, MOL CELL BIOL, V25, P3109, DOI 10.1128/MCB.25.8.3109-3116.2005; Van Dycke KCG, 2015, CURR BIOL, V25, P1932, DOI 10.1016/j.cub.2015.06.012; Vaughn CM, 2020, J BIOL CHEM, V295, P7584, DOI 10.1074/jbc.RA120.013347; Vitaterna MH, 1999, P NATL ACAD SCI USA, V96, P12114, DOI 10.1073/pnas.96.21.12114; Wagner PM, 2019, MOL NEUROBIOL, V56, P1276, DOI 10.1007/s12035-018-1152-3; Walton ZE, 2018, ANNU REV CANC BIOL, V2, P133, DOI 10.1146/annurev-cancerbio-030617-050216; Xu Y, 2005, NATURE, V434, P640, DOI 10.1038/nature03453; Yan OY, 1998, P NATL ACAD SCI USA, V95, P8660, DOI 10.1073/pnas.95.15.8660; Yang XM, 2009, CHRONOBIOL INT, V26, P1323, DOI 10.3109/07420520903431301; Yang YY, 2019, J BIOL CHEM, V294, P11960, DOI 10.1074/jbc.RA119.009579; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115; Ye R, 2014, GENE DEV, V28, P1989, DOI 10.1101/gad.249417.114; Ye R, 2011, J BIOL CHEM, V286, P25891, DOI 10.1074/jbc.M111.254680; Ye YQ, 2018, CELL SYST, V6, P314, DOI 10.1016/j.cels.2018.01.013; Yimit A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08290-2; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111	105	10	11	3	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101068	10.1016/j.jbc.2021.101068	http://dx.doi.org/10.1016/j.jbc.2021.101068			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34375638	gold, Green Published			2022-12-28	WOS:000714635500003
J	Zhang, D; Robinson, K; Saad, L; Washington, I				Zhang, Dan; Robinson, Kiera; Saad, Leonide; Washington, Ilyas			Vitamin A cycle byproducts impede dark adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETINAL DEGENERATION; A2E; LIPOFUSCIN; PIGMENT; LIGHT; CONSUMPTION; FLUOROPHORE; INHIBITION; MICE	Impaired dark adaptation (DA), a defect in the ability to adjust to dimly lit settings, is a universal hallmark of aging. However, the mechanisms responsible for impaired DA are poorly understood. Vitamin A byproducts, such as vitamin A dimers, are small molecules that form in the retina during the vitamin A cycle. We show that later in life, in the human eye, these byproducts reach levels commensurate with those of vitamin A. In mice, selectively inhibiting the formation of these byproducts, with the investigational drug C20D(3)-vitamin A, results in faster DA. In contrast, acutely increasing these ocular byproducts through exogenous delivery leads to slower DA, with otherwise preserved retinal function and morphology. Our findings reveal that vitamin A cycle byproducts alone are sufficient to cause delays in DA and suggest that they may contribute to universal age-related DA impairment. Our data further indicate that the age-related decline in DA may be tractable to pharmacological intervention by C20D(3)-vitamin A.	[Zhang, Dan; Robinson, Kiera; Saad, Leonide; Washington, Ilyas] Columbia Univ, Med Ctr, New York, NY 10027 USA; [Washington, Ilyas] BiOOrg3 14, Buffalo, WY 82834 USA	Columbia University	Washington, I (corresponding author), Columbia Univ, Med Ctr, New York, NY 10027 USA.; Washington, I (corresponding author), BiOOrg3 14, Buffalo, WY 82834 USA.	publications@bioorg314.com		W, I/0000-0002-2238-7918	US National Institutes of Health, National Eye Institute [1R01EY021207]; Research to Prevent Blindness, Inc, New York, NY	US National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness, Inc, New York, NY(Research to Prevent Blindness (RPB))	The US National Institutes of Health, National Eye Institute (grant number: 1R01EY021207) and Research to Prevent Blindness, Inc, New York, NY, for funding.	Arvanitakis L, 1998, TRENDS ENDOCRIN MET, V9, P27, DOI 10.1016/S1043-2760(98)00007-1; Barja G, 2007, REJUV RES, V10, P215, DOI 10.1089/rej.2006.0516; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Benedetto MM, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00139; Chang B, 2007, VISION RES, V47, P624, DOI 10.1016/j.visres.2006.11.020; Chiu Kin, 2007, J Vis Exp, P313, DOI 10.3791/313; Dong EH, 2017, MOL VIS, V23, P90; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Dugel PU, 2015, RETINA-J RET VIT DIS, V35, P1173, DOI 10.1097/IAE.0000000000000606; ELDRED GE, 1993, NATURE, V361, P724, DOI 10.1038/361724a0; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; FISHMAN GA, 1991, OPHTHALMOLOGY, V98, P957; Gaffney AJ, 2012, OPTOMETRY VISION SCI, V89, P1219, DOI 10.1097/OPX.0b013e318263c6b1; Gliem M, 2016, JAMA OPHTHALMOL, V134, P817, DOI 10.1001/jamaophthalmol.2016.1475; Hecht S, 1940, AM J PHYSIOL, V130, P0651, DOI 10.1152/ajplegacy.1940.130.4.651; Iriyama A, 2008, J BIOL CHEM, V283, P11947, DOI 10.1074/jbc.M708989200; Issa PC, 2015, P NATL ACAD SCI USA, V112, P8415, DOI 10.1073/pnas.1506960112; ITABASHI R, 1993, GRAEF ARCH CLIN EXP, V231, P555, DOI 10.1007/BF00936518; Jackson GR, 1999, VISION RES, V39, P3975, DOI 10.1016/S0042-6989(99)00092-9; Jackson GR, 2014, OPTOMETRY VISION SCI, V91, P925, DOI 10.1097/OPX.0000000000000247; KARPE G, 1948, J PHYSIOL-LONDON, V107, P272, DOI 10.1113/jphysiol.1948.sp004271; Katz ML, 1996, MECH AGEING DEV, V92, P159, DOI 10.1016/S0047-6374(96)01817-9; Kaufman Y, 2011, J BIOL CHEM, V286, P7958, DOI 10.1074/jbc.M110.178640; KOSNIK W, 1988, J GERONTOL, V43, pP63, DOI 10.1093/geronj/43.3.P63; Lains I, 2018, AM J OPHTHALMOL, V190, P113, DOI 10.1016/j.ajo.2018.03.035; Lains I, 2017, OPHTHALMOLOGY, V124, P1340, DOI 10.1016/j.ophtha.2017.03.061; Leibrock CS, 1998, EYE, V12, P511, DOI 10.1038/eye.1998.139; Lem J, 2004, TRENDS MOL MED, V10, P150, DOI 10.1016/j.molmed.2004.02.009; LINSENMEIER RA, 1986, J GEN PHYSIOL, V88, P521, DOI 10.1085/jgp.88.4.521; Ma L, 2011, J BIOL CHEM, V286, P7966, DOI 10.1074/jbc.M110.178657; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; McCaffery P, 1996, P NATL ACAD SCI USA, V93, P12570, DOI 10.1073/pnas.93.22.12570; MCMURDO MET, 1991, GERONTOLOGY, V37, P221; Moe-Nilssen R, 2006, J MOTOR BEHAV, V38, P118, DOI 10.3200/JMBR.38.2.118-125; Moiseyev G, 2010, P NATL ACAD SCI USA, V107, P17551, DOI 10.1073/pnas.1008769107; Mullins RF, 2019, OPHTHALMOLOGY, V126, P591, DOI 10.1016/j.ophtha.2018.10.037; Munch IC, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0273-6; Murdaugh LS, 2011, J MASS SPECTROM, V46, P90, DOI 10.1002/jms.1865; Murdaugh LS, 2010, EXP EYE RES, V90, P564, DOI 10.1016/j.exer.2010.01.014; Noorwez SM, 2008, INVEST OPHTH VIS SCI, V49, P3224, DOI 10.1167/iovs.07-1539; Owsley C, 2016, BMC OPHTHALMOL, V16, DOI 10.1186/s12886-016-0274-5; Owsley C, 2016, OPHTHALMOLOGY, V123, P344, DOI 10.1016/j.ophtha.2015.09.041; Park Paul Shin-Hyun, 2014, Adv Pharmacol, V70, P1, DOI 10.1016/B978-0-12-417197-8.00001-8; Penn J, 2015, DIS MODEL MECH, V8, P131, DOI 10.1242/dmm.017194; Sakai N, 1996, J AM CHEM SOC, V118, P1559, DOI 10.1021/ja953480g; Salin K, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2015.0538; STEFANSSON E, 1988, PEDIATR RES, V23, P5, DOI 10.1203/00006450-198801000-00002; Sung HJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1003; Ueda K, 2016, P NATL ACAD SCI USA, V113, P6904, DOI 10.1073/pnas.1524774113; Wang Z, 2006, PHOTOCHEM PHOTOBIOL, V82, P1251, DOI 10.1562/2006-04-01-RA-864; Washington I, 2005, ANGEW CHEM INT EDIT, V44, P7097, DOI 10.1002/anie.200501346; Washington I., 2007, PHOTOCHEM PHOTOBIOL, V6, P775	52	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101074	10.1016/j.jbc.2021.101074	http://dx.doi.org/10.1016/j.jbc.2021.101074			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34391781	Green Published, gold			2022-12-28	WOS:000714635500001
J	Hutchison, JM; Capone, R; Luu, DD; Shah, KH; Hadziselimovic, A; Van Horn, WD; Sanders, CR				Hutchison, James M.; Capone, Ricardo; Luu, Dustin D.; Shah, Karan H.; Hadziselimovic, Arina; Van Horn, Wade D.; Sanders, Charles R.			Recombinant SARS-CoV-2 envelope protein traffics to the trans-Golgi network following amphipol-mediated delivery into human cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WHEAT-GERM-AGGLUTININ; CORONAVIRUS E-PROTEIN; RESPIRATORY SYNDROME CORONAVIRUS; BRONCHITIS-VIRUS-E; MEMBRANE-PROTEIN; AMPHIPATHIC POLYMERS; COMPLEX; LYSOSOMES; IDENTIFICATION; INVOLVEMENT	The severe acute respiratory syndrome coronavirus 2 envelope protein (S2-E) is a conserved membrane protein that is important for coronavirus (CoV) assembly and budding. Here, we describe the recombinant expression and purification of S2-E in amphipol-class amphipathic polymer solutions, which solubilize and stabilize membrane proteins, but do not disrupt membranes. We found that amphipol delivery of S2-E to preformed planar bilayers results in spontaneous membrane integration and formation of viroporin cation channels. Amphipol delivery of the S2-E protein to human cells results in plasma membrane integration, followed by retrograde trafficking to the trans-Golgi network and accumulation in swollen perinuclear lysosomal-associated membrane protein 1-positive vesicles, likely lysosomes. CoV envelope proteins have previously been proposed to manipulate the luminal pH of the trans-Golgi network, which serves as an accumulation station for progeny CoV particles prior to cellular egress via lysosomes. Delivery of S2-E to cells will enable chemical biological approaches for future studies of severe acute respiratory syndrome coronavirus 2 pathogenesis and possibly even development of "Trojan horse" antiviral therapies. Finally, this work also establishes a paradigm for amphipol-mediated delivery of membrane proteins to cells.	[Hutchison, James M.] Vanderbilt Univ, Chem & Phys Biol Grad Program, 221 Kirkland Hall, Nashville, TN 37235 USA; [Hutchison, James M.; Capone, Ricardo; Hadziselimovic, Arina; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capone, Ricardo; Hadziselimovic, Arina; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Luu, Dustin D.; Shah, Karan H.; Van Horn, Wade D.] Arizona State Univ, Sch Mol Sci, Tempe, AZ 85281 USA; [Luu, Dustin D.; Shah, Karan H.; Van Horn, Wade D.] Arizona State Univ, Biodesign Inst Ctr Personalized Diagnost & Mech E, Tempe, AZ 85281 USA; [Sanders, Charles R.] Arizona State Univ, Dept Med, Tempe, AZ 85281 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe	Sanders, CR (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.; Sanders, CR (corresponding author), Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA.; Van Horn, WD (corresponding author), Arizona State Univ, Sch Mol Sci, Tempe, AZ 85281 USA.; Van Horn, WD (corresponding author), Arizona State Univ, Biodesign Inst Ctr Personalized Diagnost & Mech E, Tempe, AZ 85281 USA.; Sanders, CR (corresponding author), Arizona State Univ, Dept Med, Tempe, AZ 85281 USA.	wade.van.horn@asu.edu; chuck.sanders@vanderbill.edu	Van Horn, Wade/GSN-2667-2022	Van Horn, Wade/0000-0002-2493-5578; Sanders, Charles/0000-0003-2046-2862; Hutchison, James/0000-0002-5529-3248; Luu, Dustin/0000-0003-3464-160X; Shah, Karan/0000-0002-2903-2343	National Institutes of Health (NIH) [RF1 AG056147, R01 GM112077, T32 CA00958229, F31 AG061984, CA68485, DK20593, DK58404, DK59637, EY08126]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) grants RF1 AG056147 (to C. R. S.) and R01 GM112077 (to W. D. V. H.). J. M. H. was supported by NIH T32 CA00958229 and F31 AG061984. The Vanderbilt Cell Imaging Shared Resource is supported by NIH grants CA68485, DK20593, DK58404, DK59637, and EY08126. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Alam I, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00405; ALLEN RD, 1989, J HISTOCHEM CYTOCHEM, V37, P195, DOI 10.1177/37.2.2911005; Almazan F, 2013, MBIO, V4, DOI 10.1128/mBio.00650-13; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Cabrera-Garcia D, 2021, J PHYSIOL-LONDON, V599, P2851, DOI [10.1113/JP281601, 10.1113/JP281037]; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, DOI 10.1101/pdb.prot5623; Cohen JR, 2011, J VIROL, V85, P5794, DOI 10.1128/JVI.00060-11; Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000; Corse E, 2003, VIROLOGY, V312, P25, DOI 10.1016/S0042-6822(03)00175-2; CZAPLA TH, 1990, J ECON ENTOMOL, V83, P2480, DOI 10.1093/jee/83.6.2480; DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06; Demers-Mathieu V, 2021, J PERINATOL, V41, P850, DOI 10.1038/s41372-020-00805-w; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; DUCATELLE R, 1984, ARCH VIROL, V79, P1, DOI 10.1007/BF01314299; Fernandez A, 2014, J MEMBRANE BIOL, V247, P1043, DOI 10.1007/s00232-014-9682-8; FERYFORGUES S, 1993, J PHOTOCH PHOTOBIO A, V70, P229, DOI 10.1016/1010-6030(93)85048-D; Ghosh S, 2020, CELL, V183, P1520, DOI 10.1016/j.cell.2020.10.039; Gorzelle BM, 2002, J AM CHEM SOC, V124, P11594, DOI 10.1021/ja027051b; Jiang Y, 2019, J NEUROSCI, V39, P5255, DOI 10.1523/JNEUROSCI.0578-19.2019; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kanazawa T, 2008, J CELL PHYSIOL, V215, P517, DOI 10.1002/jcp.21328; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; KLUMPERMAN J, 1994, J VIROL, V68, P6523, DOI 10.1128/JVI.68.10.6523-6534.1994; Lim KP, 2001, J BIOL CHEM, V276, P17515, DOI 10.1074/jbc.M009731200; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Lopez LA, 2008, J VIROL, V82, P3000, DOI 10.1128/JVI.01914-07; Mahdy MAA, 2020, FRONT VET SCI, V7, DOI 10.3389/fvets.2020.596391; Maier HJ, 2012, VIRUSES-BASEL, V4, P3440, DOI 10.3390/v4123440; Mandala VS, 2020, NAT STRUCT MOL BIOL, V27, P1202, DOI 10.1038/s41594-020-00536-8; Nagy JK, 2001, FEBS LETT, V501, P115, DOI 10.1016/S0014-5793(01)02627-8; Nieto-Torres JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004077; Parthasarathy K, 2008, BIOPHYS J, V95, pL39, DOI 10.1529/biophysj.108.133041; Parthasarathy K, 2012, PROTEIN EXPRES PURIF, V85, P133, DOI 10.1016/j.pep.2012.07.005; Pavelka M, 2008, HISTOCHEM CELL BIOL, V129, P277, DOI 10.1007/s00418-008-0383-1; Pervushin K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000511; Pielak RM, 2011, BBA-BIOMEMBRANES, V1808, P522, DOI 10.1016/j.bbamem.2010.04.015; Pocanschi CL, 2006, BIOCHEMISTRY-US, V45, P13954, DOI 10.1021/bi0616706; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Popot JL, 2003, CELL MOL LIFE SCI, V60, P1559, DOI 10.1007/s00018-003-3169-6; Prentice E, 2004, J BIOL CHEM, V279, P10136, DOI 10.1074/jbc.M306124200; PUSZTAI A, 1993, BRIT J NUTR, V70, P313, DOI 10.1079/BJN19930124; Raamsman MJB, 2000, J VIROL, V74, P2333, DOI 10.1128/JVI.74.5.2333-2342.2000; Rezgui R, 2016, BBA-BIOMEMBRANES, V1858, P1499, DOI 10.1016/j.bbamem.2016.03.023; Rohn WM, 2000, J CELL SCI, V113, P2093; Satarker S, 2020, ARCH MED RES, V51, P482, DOI 10.1016/j.arcmed.2020.05.012; Schoeman D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.02086; Schoeman D, 2019, VIROL J, V16, DOI 10.1186/s12985-019-1182-0; Surya W, 2018, BBA-BIOMEMBRANES, V1860, P1309, DOI 10.1016/j.bbamem.2018.02.017; Tifrea DF, 2020, VACCINE, V38, P4412, DOI 10.1016/j.vaccine.2020.04.065; Tifrea DF, 2018, VACCINE, V36, P6640, DOI 10.1016/j.vaccine.2018.09.055; To J, 2017, J VIROL, V91, DOI 10.1128/JVI.02158-16; TOOZE J, 1987, J CELL BIOL, V105, P1215, DOI 10.1083/jcb.105.3.1215; Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; Valyaeva AA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74598-5; VELASCO A, 1988, HISTOCHEMISTRY, V89, P177, DOI 10.1007/BF00489921; Venkatagopalan P, 2015, VIROLOGY, V478, P75, DOI 10.1016/j.virol.2015.02.005; Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x; Westerbeck JW, 2019, J VIROL, V93, DOI [10.1128/JVI.00015-19, 10.1128/jvi.00015-19]; Westerbeck JW, 2015, J VIROL, V89, P9313, DOI 10.1128/JVI.01237-15; Wileman T, 2006, SCIENCE, V312, P875, DOI 10.1126/science.1126766; Wilson JM, 2000, MOL BIOL CELL, V11, P2657, DOI 10.1091/mbc.11.8.2657; Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033; Xia BQ, 2021, CELL RES, V31, P847, DOI 10.1038/s41422-021-00519-4; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	66	2	2	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100940	10.1016/j.jbc.2021.100940	http://dx.doi.org/10.1016/j.jbc.2021.100940			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34237302	Green Published, gold			2022-12-28	WOS:000690871000004
J	Lentzsch, AM; Stamos, JL; Yao, J; Russell, R; Lambowitz, AM				Lentzsch, Alfred M.; Stamos, Jennifer L.; Yao, Jun; Russell, Rick; Lambowitz, Alan M.			Structural basis for template switching by a group II intron-encoded non-LTR-retroelement reverse transcriptase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT RNA-POLYMERASE; MITOCHONDRIAL PLASMIDS; DE-NOVO; BACTERIAL RETRONS; CDNA SYNTHESIS; HIV-1 RT; DNA; REPLICATION; RECOMBINATION; RETROTRANSPOSON	Reverse transcriptases (RTs) can switch template strands during complementary DNA synthesis, enabling them to join discontinuous nucleic acid sequences. Template switching (TS) plays crucial roles in retroviral replication and recombination, is used for adapter addition in RNA-Seq, and may contribute to retroelement fitness by increasing evolutionary diversity and enabling continuous complementary DNA synthesis on damaged templates. Here, we determined an X-ray crystal structure of a TS complex of a group II intron RT bound simultaneously to an acceptor RNA and donor RNA template-DNA primer heteroduplex with a 1-nt 3'-DNA overhang. The structure showed that the 3' end of the acceptor RNA binds in a pocket formed by an N-terminal extension present in non-long terminal repeat-retroelement RTs and the RT fingertips loop, with the 3' nucleotide of the acceptor base paired to the 1-nt 3'-DNA overhang and its penultimate nucleotide base paired to the incoming dNTP at the RT active site. Analysis of structure-guided mutations identified amino acids that contribute to acceptor RNA binding and a phenylalanine residue near the RT active site that mediates nontemplated nucleotide addition. Mutation of the latter residue decreased multiple sequential template switches in RNA-Seq. Our results provide new in-sights into the mechanisms of TS and nontemplated nucleotide addition by RTs, suggest how these reactions could be improved for RNA-Seq, and reveal common structural features for TS by non-long terminal repeat-retroelement RTs and viral RNA-dependent RNA polymerases.	[Lambowitz, Alan M.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; Univ Texas Austin, Dept Oncol, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lambowitz, AM (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	lambowitz@austin.utexas.edu		Yao, Jun/0000-0002-1232-1587; Lambowitz, Alan/0000-0001-6036-2423; Lentzsch, Alfred/0000-0002-8150-0511	National Institutes of Health [R35 GM136216, R35 GM131777]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grants R35 GM136216 (to A. M. Lambowitz) and R35 GM131777 (to R. R.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AKINS RA, 1986, CELL, V47, P505, DOI 10.1016/0092-8674(86)90615-X; Appleby TC, 2015, SCIENCE, V347, P771, DOI 10.1126/science.1259210; Arnold JJ, 1999, J BIOL CHEM, V274, P2706, DOI 10.1074/jbc.274.5.2706; Baidyaroy D, 2012, FUNGAL BIOL-UK, V116, P919, DOI 10.1016/j.funbio.2012.06.003; Basu VP, 2008, VIRUS RES, V134, P19, DOI 10.1016/j.virusres.2007.12.017; Bibillo A, 2004, J BIOL CHEM, V279, P14945, DOI 10.1074/jbc.M310450200; Bibillo A, 2002, J MOL BIOL, V316, P459, DOI 10.1006/jmbi.2001.5369; Blocker FJH, 2005, RNA, V11, P14, DOI 10.1261/rna.7181105; Boivin V, 2018, RNA, V24, P950, DOI 10.1261/rna.064493.117; Chen B, 1997, J MOL BIOL, V271, P311, DOI 10.1006/jmbi.1997.1185; Cheng CP, 2005, VIROLOGY, V341, P107, DOI 10.1016/j.virol.2005.06.042; Cheng CP, 2003, J VIROL, V77, P12033, DOI 10.1128/JVI.77.22.12033-12047.2003; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; COFFIN JM, 1979, J GEN VIROL, V42, P1, DOI 10.1099/0022-1317-42-1-1; Das K, 2014, NUCLEIC ACIDS RES, V42, P8125, DOI 10.1093/nar/gku487; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Ferrer-Orta C, 2007, P NATL ACAD SCI USA, V104, P9463, DOI 10.1073/pnas.0700518104; Ferrero D, 2018, SUBCELL BIOCHEM, V88, P39, DOI 10.1007/978-981-10-8456-0_3; Gao GX, 1997, P NATL ACAD SCI USA, V94, P407, DOI 10.1073/pnas.94.2.407; Gao LY, 2020, SCIENCE, V369, P1077, DOI 10.1126/science.aba0372; Golinelli MP, 2002, VIROLOGY, V294, P122, DOI 10.1006/viro.2001.1322; Haack DB, 2019, CELL, V178, P612, DOI 10.1016/j.cell.2019.06.035; Hu WS, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006882; INOUYE S, 1989, CELL, V56, P709, DOI 10.1016/0092-8674(89)90593-X; Jamburuthugoda VK, 2014, NUCLEIC ACIDS RES, V42, P8405, DOI 10.1093/nar/gku514; Johnson KA, 2010, BBA-PROTEINS PROTEOM, V1804, P1041, DOI 10.1016/j.bbapap.2010.01.006; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kojima KK, 2008, MOL BIOL EVOL, V25, P1395, DOI 10.1093/molbev/msn081; KUIPER MTR, 1988, CELL, V55, P693, DOI 10.1016/0092-8674(88)90228-0; LAI MMC, 1992, MICROBIOL REV, V56, P61, DOI 10.1128/MMBR.56.1.61-79.1992; Lambowitz AM, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0050-2014; Lentzsch A. M., 2020, United States Patent Application Publication, Patent No. [US 2020/0255810 A1, 20200255810]; Lentzsch AM, 2019, J BIOL CHEM, V294, P19764, DOI 10.1074/jbc.RA119.011337; Liu MS, 2002, SCIENCE, V295, P2091, DOI 10.1126/science.1067467; Martin-Alonso S, 2021, TRENDS BIOTECHNOL, V39, P194, DOI 10.1016/j.tibtech.2020.06.008; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; Millman A, 2020, CELL, V183, P1551, DOI 10.1016/j.cell.2020.09.065; Mohr S, 2013, RNA, V19, P958, DOI 10.1261/rna.039743.113; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nottingham RM, 2016, RNA, V22, P597, DOI 10.1261/rna.055558.115; Nowak E, 2014, NAT STRUCT MOL BIOL, V21, P389, DOI 10.1038/nsmb.2785; Onafuwa-Nuga A, 2009, MICROBIOL MOL BIOL R, V73, P451, DOI 10.1128/MMBR.00012-09; Oz-Gleenberg I, 2012, FEBS J, V279, P1894, DOI 10.1111/j.1742-4658.2012.08570.x; Oz-Gleenberg I, 2011, NUCLEIC ACIDS RES, V39, P1042, DOI 10.1093/nar/gkq786; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Qin Y, 2016, RNA, V22, P111, DOI 10.1261/rna.054809.115; Qu GS, 2016, NAT STRUCT MOL BIOL, V23, P549, DOI 10.1038/nsmb.3220; Ranjith-Kumar CT, 2004, J VIROL, V78, P12207, DOI 10.1128/JVI.78.22.12207-12217.2004; Mestre MR, 2020, NUCLEIC ACIDS RES, V48, P12632, DOI 10.1093/nar/gkaa1149; Sarafianos SG, 1999, CHEM BIOL, V6, pR137, DOI 10.1016/S1074-5521(99)80071-4; Shaik MM, 2017, PROTEINS, V85, P1435, DOI 10.1002/prot.25304; Shih C, 2018, TRENDS MICROBIOL, V26, P386, DOI 10.1016/j.tim.2018.01.009; Silas S, 2016, SCIENCE, V351, DOI 10.1126/science.aad4234; Stamos JL, 2017, MOL CELL, V68, P926, DOI 10.1016/j.molcel.2017.10.024; Wang DH, 2021, MOL CELL, V81, P2135, DOI 10.1016/j.molcel.2021.02.036; Wang Q, 2020, CELL, V182, P417, DOI 10.1016/j.cell.2020.05.034; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu JQ, 2015, INT J MOL SCI, V16, P12943, DOI 10.3390/ijms160612943; Wulf MG, 2019, J BIOL CHEM, V294, P18220, DOI 10.1074/jbc.RA119.010676; XIONG Y, 1990, EMBO J, V9, P3353, DOI 10.1002/j.1460-2075.1990.tb07536.x; Xu HY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44457-z; Yao J, 2020, ELIFE, V9, DOI 10.7554/eLife.60743; Zhao C, 2018, RNA, V24, P183, DOI 10.1261/rna.063479.117; Zhao C, 2016, NAT STRUCT MOL BIOL, V23, P558, DOI 10.1038/nsmb.3224; Zhu YY, 2001, BIOTECHNIQUES, V30, P892, DOI 10.2144/01304pf02; Zimmerly S, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0058-2014	67	3	4	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100971	10.1016/j.jbc.2021.100971	http://dx.doi.org/10.1016/j.jbc.2021.100971			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34280434	gold, Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000690871400015
J	Espinosa-Vinals, CA; Masin, J; Holubova, J; Stanek, O; Jurnecka, D; Osicka, R; Sebo, P; Bumba, L				Espinosa-Vinals, Carlos Angel; Masin, Jiri; Holubova, Jana; Stanek, Ondrej; Jurnecka, David; Osicka, Radim; Sebo, Peter; Bumba, Ladislav			Almost half of the RTX domain is dispensable for complement receptor 3 binding and cell-invasive activity of the Bordetella adenylate cyclase toxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; TRANSLOCATION; SECRETION; ACYLATION; MEMBRANE; DELIVERY	The whooping cough agent Bordetella pertussis secretes an adenylate cyclase toxin (CyaA) that through its large carboxy-proximal Repeat-in-ToXin (RTX) domain binds the complement receptor 3 (CR3). The RTX domain consists of five blocks (I-V) of characteristic glycine and aspartate-rich nonapeptides that fold into five Ca2+-loaded parallel beta-rolls. Previous work indicated that the CR3-binding structure comprises the interface of beta-rolls II and III. To test if further portions of the RTX domain contribute to CR3 binding, we generated a construct with the RTX block II/III interface (CyaA residues 1132-1294) linked directly to the C-terminal block V fragment bearing the folding scaffold (CyaA residues 1562-1681). Despite deletion of 267 internal residues of the RTX domain, the Ca2+-driven folding of the hybrid block III/V beta-roll still supported formation of the CR3-binding structure at the interface of beta-rolls II and III. Moreover, upon stabilization by N- and C-terminal flanking segments, the block III/V hybrid-comprising constructs competed with CyaA for CR3 binding and induced formation of CyaA toxin-neutralizing antibodies in mice. Finally, a truncated CyaA.1295- 1561 toxin bound and penetrated erythrocytes and CR3-expressing cells, showing that the deleted portions of RTX blocks III, IV, and V (residues 1295-1561) were dispensable for CR3 binding and for toxin translocation across the target cell membrane. This suggests that almost a half of the RTX domain of CyaA is not involved in target cell interaction and rather serves the purpose of toxin secretion.	[Espinosa-Vinals, Carlos Angel; Masin, Jiri; Holubova, Jana; Stanek, Ondrej; Jurnecka, David; Osicka, Radim; Sebo, Peter; Bumba, Ladislav] Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic; [Espinosa-Vinals, Carlos Angel] Univ Chem & Technol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; University of Chemistry & Technology, Prague	Sebo, P; Bumba, L (corresponding author), Acad Sci Czech Republ, Inst Microbiol, Prague, Czech Republic.	sebo@biomed.cas.cz; bumba@biomed.cas.cz	Stanek, Ondrej/J-8407-2014; Osicka, Radim/H-6776-2014; SEBO, Peter/F-7423-2011; Jurnečka, David/ABA-2334-2021; Holubová, Jana/J-6862-2014; Jurnečka, David/L-7246-2017; Bumba, Ladislav/ABC-9943-2020; SEBO, Peter/N-2043-2019; Espinosa Vinals, Carlos Angel/T-2634-2018	Osicka, Radim/0000-0003-2626-5456; SEBO, Peter/0000-0002-9755-7715; Jurnečka, David/0000-0002-1690-8908; Holubová, Jana/0000-0002-0829-0976; Jurnečka, David/0000-0002-1690-8908; Bumba, Ladislav/0000-0001-6659-5447; SEBO, Peter/0000-0002-9755-7715; Espinosa Vinals, Carlos Angel/0000-0002-9622-2331; Masin, Jiri/0000-0001-6258-4599	Grant Agency of the Czech Republic [1915175S, 19-04607S, 19-27630X]; Ministry of Education, Youth and Sports of the Czech Republic [LM2018133]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the project 1915175S, 19-04607S, and 19-27630X of the Grant Agency of the Czech Republic and the research infrastructure project LM2018133 (EATRIS-CZ) of the Ministry of Education, Youth and Sports of the Czech Republic. The SAXS data were collected at the P12 beamline of EMBL (DESY, Hamburg, Germany). We thank Iva Marsikova, Hana Lukeova, and Sona Kozubova for excellent technical help.	Ahmad JN, 2019, MBIO, V10, DOI 10.1128/mBio.01743-19; Basar T, 1999, J BIOL CHEM, V274, P10777, DOI 10.1074/jbc.274.16.10777; Basler M, 2006, INFECT IMMUN, V74, P2207, DOI 10.1128/IAI.74.4.2207-2214.2006; Bauche C, 2006, J BIOL CHEM, V281, P16914, DOI 10.1074/jbc.M601594200; Baumann U, 2019, TOXINS, V11, DOI 10.3390/toxins11110657; BETSOU F, 1995, INFECT IMMUN, V63, P3309, DOI 10.1128/IAI.63.9.3309-3315.1995; BETSOU F, 1993, INFECT IMMUN, V61, P3583, DOI 10.1128/IAI.61.9.3583-3589.1993; Blanchet CE, 2015, J APPL CRYSTALLOGR, V48, P431, DOI 10.1107/S160057671500254X; Bumba L, 2016, MOL CELL, V62, P47, DOI 10.1016/j.molcel.2016.03.018; Bumba L, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000901; Chenal A, 2010, BIOPHYS J, V99, P3744, DOI 10.1016/j.bpj.2010.10.016; EHRMANN IE, 1991, FEBS LETT, V278, P79, DOI 10.1016/0014-5793(91)80088-K; El-Azami-El-Idrissi M, 2003, J BIOL CHEM, V278, P38514, DOI 10.1074/jbc.M304387200; Fedele G, 2017, TOXINS, V9, DOI 10.3390/toxins9100293; Fiser R, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002580; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gray M, 1998, J BIOL CHEM, V273, P18260, DOI 10.1074/jbc.273.29.18260; Guermonprez P, 2001, J EXP MED, V193, P1035, DOI 10.1084/jem.193.9.1035; Guiso N, 2017, TOXINS, V9, DOI 10.3390/toxins9090277; HACKETT M, 1994, SCIENCE, V266, P433, DOI 10.1126/science.7939682; Hasan S, 2015, FEBS LETT, V589, P374, DOI 10.1016/j.febslet.2014.12.023; Holubova J, 2012, INFECT IMMUN, V80, P1181, DOI 10.1128/IAI.05711-11; IWAKI M, 1995, MOL MICROBIOL, V17, P1015, DOI 10.1111/j.1365-2958.1995.mmi_17061015.x; Karimova G, 1998, P NATL ACAD SCI USA, V95, P12532, DOI 10.1073/pnas.95.21.12532; Knapp O, 2020, TOXINS, V12, DOI 10.3390/toxins12030169; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; LADANT D, 1988, J BIOL CHEM, V263, P2612; Masin J, 2020, J BIOL CHEM, V295, P9349, DOI 10.1074/jbc.RA120.013630; Masin J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09575-6; Masin J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29137; Morova J, 2008, P NATL ACAD SCI USA, V105, P5355, DOI 10.1073/pnas.0711400105; Motlova L, 2020, J MOL BIOL, V432, P5696, DOI 10.1016/j.jmb.2020.08.020; Novak J, 2017, TOXINS, V9, DOI 10.3390/toxins9100300; Osicka R, 2015, ELIFE, V4, DOI 10.7554/eLife.10766; Osickova A, 2020, J BIOL CHEM, V295, P9268, DOI 10.1074/jbc.RA120.014122; SAKAMOTO H, 1992, J BIOL CHEM, V267, P13598; Stanek O, 2019, TOXINS, V11, DOI 10.3390/toxins11060336; Subrini O, 2013, J BIOL CHEM, V288, P32585, DOI 10.1074/jbc.M113.508838; Sukova A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183310; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; SZABO G, 1994, J BIOL CHEM, V269, P22496; Voegele A, 2018, PATHOG DIS, V76, DOI 10.1093/femspd/fty085; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wald T, 2014, ANAL BIOCHEM, V450, P57, DOI 10.1016/j.ab.2013.10.039; Wang XZ, 2017, BIOCHEMISTRY-US, V56, P1324, DOI 10.1021/acs.biochem.6b01163; Wang XZ, 2015, J BIOL CHEM, V290, P3576, DOI 10.1074/jbc.M114.585281	46	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100833	10.1016/j.jbc.2021.100833	http://dx.doi.org/10.1016/j.jbc.2021.100833			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051233	Green Published, gold			2022-12-28	WOS:000678068400033
J	Nagashima, S; Maruyama, J; Honda, K; Kondoh, Y; Osada, H; Nawa, M; Nakahama, KI; Ishigami-Yuasa, M; Kagechika, H; Sugimura, H; Iwasa, H; Arimoto-Matsuzaki, K; Nishina, H; Hata, Y				Nagashima, Shunta; Maruyama, Junichi; Honda, Kaori; Kondoh, Yasumitsu; Osada, Hiroyuki; Nawa, Makiko; Nakahama, Ken-Ichi; Ishigami-Yuasa, Mari; Kagechika, Hiroyuki; Sugimura, Haruhiko; Iwasa, Hiroaki; Arimoto-Matsuzaki, Kyoko; Nishina, Hiroshi; Hata, Yutaka			CSE1L promotes nuclear accumulation of transcriptional coactivator TAZ and enhances invasiveness of human cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPORTIN ALPHA; CHROMOSOME SEGREGATION; CENTER STAGE; APOPTOSIS; PROLIFERATION; GENE; EXPRESSION; TRANSPORT; COMPOUND; TARGET	The transcriptional coactivator with PDZ-binding motif (TAZ) (WWTR1) induces epithelial-mesenchymal transition and enhances drug resistance in multiple cancers. TAZ has been shown to interact with transcription factors in the nucleus, but when phosphorylated, translocates to the cytoplasm and is degraded through proteasomes. Here, we identified a compound TAZ inhibitor 4 (TI-4) that shifted TAZ localization to the cytoplasm independently of its phosphorylation. We used affinity beads to ascertain a putative target of TI-4, chromosomal segregation 1 like (CSE1L), which is known to be involved in the recycling of importin alpha and as a biomarker of cancer malignancy. We found that TI-4 suppressed TAZ-mediated transcription in a CSE1L-dependent manner. CSE1L overexpression increased nuclear levels of TAZ, whereas CSE1L silencing delayed its nuclear import. We also found via the in vitro coimmunoprecipitation experiments that TI-4 strengthened the interaction between CSE1L and importin alpha 5 and blocked the binding of importin alpha 5 to TAZ. WWTR1 silencing attenuated CSE1L-promoted colony formation, motility, and invasiveness of human lung cancer and glioblastoma cells. Conversely, CSE1L silencing blocked TAZ-promoted colony formation, motility, and invasiveness in human lung cancer and glioblastoma cells. In human cancer tissues, the expression level of CSE1L was found to correlate with nuclear levels of TAZ. These findings support that CSE1L promotes the nuclear accumulation of TAZ and enhances malignancy in cancer cells.	[Nagashima, Shunta; Maruyama, Junichi; Iwasa, Hiroaki; Arimoto-Matsuzaki, Kyoko; Hata, Yutaka] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo, Japan; [Honda, Kaori; Kondoh, Yasumitsu; Osada, Hiroyuki] RIKEN Ctr Sustainable Resource Sci, Chem Biol Res Grp, Saitama, Japan; [Nawa, Makiko] Tokyo Med & Dent Univ, Lab Cytometry & Proteome Res Nanken Kyoten, Tokyo, Japan; [Nawa, Makiko] Tokyo Med & Dent Univ, RCC, Tokyo, Japan; [Nakahama, Ken-Ichi] Tokyo Med & Dent Univ, Dept Cellular Physiol Chem, Tokyo, Japan; [Ishigami-Yuasa, Mari; Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Chem Biol Screening Ctr, Tokyo, Japan; [Kagechika, Hiroyuki] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka, Japan; [Nishina, Hiroshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Dev & Regenerat Biol, Tokyo, Japan; [Hata, Yutaka] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); RIKEN; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Hamamatsu University School of Medicine; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Maruyama, J; Hata, Y (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Med Biochem, Tokyo, Japan.; Hata, Y (corresponding author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Tokyo, Japan.	jmaruyama.mbc@tmd.ac.jp; yuhammch@tmd.ac.jp	Iwasa, Hiroaki/ABG-9082-2021; Sugimura, Haruhiko/E-9048-2017	Sugimura, Haruhiko/0000-0002-0779-3088; MARUYAMA, Junichi/0000-0002-3665-2700	Japan Society for the Promotion of Sciences DC2	Japan Society for the Promotion of Sciences DC2(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	S. N. is a Research Fellow of the Japan Society for the Promotion of Sciences DC2.	Alnabulsi A, 2012, J PATHOL, V228, P471, DOI 10.1002/path.4031; Behrens P, 2001, ANTICANCER RES, V21, P2413; BRINKMANN U, 1995, P NATL ACAD SCI USA, V92, P10427, DOI 10.1073/pnas.92.22.10427; Chang CC, 2012, ANN DIAGN PATHOL, V16, P362, DOI 10.1016/j.anndiagpath.2012.02.005; Dong Q, 2018, P NATL ACAD SCI USA, V115, pE4013, DOI 10.1073/pnas.1800505115; Elosegui-Artola A, 2017, CELL, V171, P1397, DOI 10.1016/j.cell.2017.10.008; Herold A, 1998, J CELL BIOL, V143, P309, DOI 10.1083/jcb.143.2.309; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; IRNIGER S, 1995, CELL, V81, P269, DOI 10.1016/0092-8674(95)90337-2; Jiang MC, 2016, TUMOR BIOL, V37, P13077, DOI 10.1007/s13277-016-5301-x; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kawano S, 2015, J BIOCHEM, V158, P413, DOI 10.1093/jb/mvv051; Ko fl er M., 2018, NAT COMMUN, V9, P496; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lamar JM, 2018, CANCERS, V10, DOI 10.3390/cancers10070229; Lee WR, 2016, MOL CARCINOGEN, V55, P1542, DOI 10.1002/mc.22407; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Liao CF, 2008, J EXP CLIN CANC RES, V27, DOI 10.1186/1756-9966-27-15; Liu CY, 2010, J BIOL CHEM, V285, P37159, DOI 10.1074/jbc.M110.152942; Lorenzato A, 2012, FASEB J, V26, P2446, DOI 10.1096/fj.11-195982; Nagashima S, 2016, CANCER SCI, V107, P791, DOI 10.1111/cas.12936; Nishio M, 2016, P NATL ACAD SCI USA, V113, pE71, DOI 10.1073/pnas.1517188113; Oka M, 2018, P JPN ACAD B-PHYS, V94, P259, DOI 10.2183/pjab.94.018; Okimoto S, 2015, GENES CELLS, V20, P681, DOI 10.1111/gtc.12262; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Piccolo S, 2013, CLIN CANCER RES, V19, P4925, DOI 10.1158/1078-0432.CCR-12-3172; Suvarna K, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3517; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tsai CSS, 2010, AM J PATHOL, V176, P1619, DOI 10.2353/ajpath.2010.090467; Tung MC, 2009, CANCER EPIDEM BIOMAR, V18, P1570, DOI 10.1158/1055-9965.EPI-08-0948; Wang SM, 2016, J BIOL CHEM, V291, P7926, DOI 10.1074/jbc.M115.700823; Wellmann A, 2001, INT J MOL MED, V7, P489; XIAO ZX, 1993, MOL CELL BIOL, V13, P4691, DOI 10.1128/MCB.13.8.4691; Yang ZY, 2014, MOL CELL BIOL, V34, P1607, DOI 10.1128/MCB.01346-13; Yuksel UM, 2015, TUMORI, V101, P194, DOI 10.5301/tj.5000239; Zhang K, 2015, BIOCHEMISTRY-US, V54, P6555, DOI 10.1021/acs.biochem.5b01014	36	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100803	10.1016/j.jbc.2021.100803	http://dx.doi.org/10.1016/j.jbc.2021.100803			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022224	gold, Green Published			2022-12-28	WOS:000678068400009
J	Andersen, CB; Yoshimura, Y; Nielsen, J; Otzen, DE; Mulder, FAA				Andersen, Camilla B.; Yoshimura, Yuichi; Nielsen, Janni; Otzen, Daniel E.; Mulder, Frans A. A.			How epigallocatechin gallate binds and assembles oligomeric forms of human alpha-synuclein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; TRANSFER DIFFERENCE NMR; AMYLOID FIBRILS; EGCG DIMER; IN-VIVO; AGGREGATION; TOXICITY; DISEASE; FIBRILLATION; STABILITY	The intrinsically disordered human protein alpha-synuclein (alpha SN) can self-associate into oligomers and amyloid fibrils. Several lines of evidence suggest that oligomeric alpha SN is cyto-toxic, making it important to devise strategies to either prevent oligomer formation and/or inhibit the ensuing toxicity. (-)-epigallocatechin gallate (EGCG) has emerged as a molecular modulator of alpha SN self-assembly, as it reduces the flexibility of the C-terminal region of alpha SN in the oligomer and inhibits the oligomer's ability to perturb phospholipid membranes and induce cell death. However, a detailed structural and kinetic characterization of this interaction is still lacking. Here, we use liquid-state NMR spectroscopy to investigate how EGCG interacts with monomeric and oligomeric forms of alpha SN. We find that EGCG can bind to all parts of monomeric alpha SN but exhibits highest affinity for the N-terminal region. Monomeric alpha SN binds similar to 54 molecules of EGCG in total during oligomerization. Furthermore, kinetic data suggest that EGCG dimerization is coupled with the alpha SN association reaction. In contrast, preformed oligomers only bind similar to 7 EGCG molecules per protomer, in agreement with the more compact nature of the oligomer compared with the natively unfolded monomer. In previously conducted cell assays, as little as 0.36 EGCG per alpha SN reduce oligomer toxicity by 50%. Our study thus demonstrates that alpha SN cytotoxicity can be inhibited by small molecules at concentrations at least an order of magnitude below full binding capacity. We speculate this is due to cooperative binding of protein-stabilized EGCG dimers, which in turn implies synergy between protein association and EGCG dimerization.	[Andersen, Camilla B.; Yoshimura, Yuichi; Nielsen, Janni; Otzen, Daniel E.; Mulder, Frans A. A.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [Yoshimura, Yuichi; Mulder, Frans A. A.] Aarhus Univ, Dept Chem, Aarhus C, Denmark; [Otzen, Daniel E.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark; [Andersen, Camilla B.] Univ Southern Denmark, Dept Chem Engn Biotechnol & Environm Technol, Campusvej 55, DK-5230 Odense, Denmark; [Yoshimura, Yuichi] Osaka Univ, Inst Prot Res, Yamada Oka 3-2, Suita, Osaka 5650871, Japan	Aarhus University; Aarhus University; Aarhus University; University of Southern Denmark; Osaka University	Otzen, DE; Mulder, FAA (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.; Mulder, FAA (corresponding author), Aarhus Univ, Dept Chem, Aarhus C, Denmark.; Otzen, DE (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus C, Denmark.	dao@inano.au.dk; fmulder@chem.au.dk	Andersen, Camilla Bertel/Y-6856-2018; Mulder, Frans/C-7158-2017; Yoshimura, Yuichi/G-8924-2019	Andersen, Camilla Bertel/0000-0003-1298-0598; Mulder, Frans/0000-0001-9427-8406; Yoshimura, Yuichi/0000-0002-9905-453X; Otzen, Daniel/0000-0002-2918-8989	Independent Research Fund Denmark|Medical Sciences [4183-00225]	Independent Research Fund Denmark|Medical Sciences	We are grateful for the support from The Independent Research Fund Denmark|Medical Sciences (4183-00225) to D. E. O. for this project.	Ahmed R, 2018, CHEM COMMUN, V54, P4644, DOI 10.1039/c8cc01380b; Bieschke J, 2010, P NATL ACAD SCI USA, V107, P7710, DOI 10.1073/pnas.0910723107; Cawood EE, 2021, BIOPHYS CHEM, V268, DOI 10.1016/j.bpc.2020.106505; Charlton AJ, 2002, J AGR FOOD CHEM, V50, P1593, DOI 10.1021/jf010897z; Danzer KM, 2007, J NEUROSCI, V27, P9220, DOI 10.1523/JNEUROSCI.2617-07.2007; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eaton JD, 2017, BIOSCIENCE REP, V37, DOI 10.1042/BSR20170209; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Ehrnhoefer DE, 2006, HUM MOL GENET, V15, P2743, DOI 10.1093/hmg/ddl210; Fawzi NL, 2011, NATURE, V480, P268, DOI 10.1038/nature10577; Fusco G, 2018, BIOPOLYMERS, V109, DOI 10.1002/bip.23117; Fusco G, 2017, SCIENCE, V358, P1440, DOI 10.1126/science.aan6160; Giehm L, 2011, P NATL ACAD SCI USA, V108, P3246, DOI 10.1073/pnas.1013225108; Hauber I, 2009, P NATL ACAD SCI USA, V106, P9033, DOI 10.1073/pnas.0811827106; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Hudson SA, 2009, J MOL BIOL, V392, P689, DOI 10.1016/j.jmb.2009.07.031; Hyung SJ, 2013, P NATL ACAD SCI USA, V110, P3743, DOI 10.1073/pnas.1220326110; Kaylor J, 2005, J MOL BIOL, V353, P357, DOI 10.1016/j.jmb.2005.08.046; Korshavn KJ, 2017, J BIOL CHEM, V292, P4638, DOI 10.1074/jbc.M116.764092; Kurnik M, 2018, CELL CHEM BIOL, V25, P1389, DOI 10.1016/j.chembiol.2018.08.005; Lashuel HA, 2002, NATURE, V418, P291, DOI 10.1038/418291a; Lee YH, 2019, BBA-PROTEINS PROTEOM, V1867, P529, DOI 10.1016/j.bbapap.2018.11.006; Lokappa SB, 2014, J MOL BIOL, V426, P2130, DOI 10.1016/j.jmb.2014.02.024; Lorenzen N, 2014, J BIOL CHEM, V289, P21299, DOI 10.1074/jbc.M114.554667; Lorenzen N, 2014, J AM CHEM SOC, V136, P3859, DOI 10.1021/ja411577t; Lorenzen N, 2014, FEBS LETT, V588, P497, DOI 10.1016/j.febslet.2013.12.015; Markley JL, 1998, J MOL BIOL, V280, P933, DOI 10.1006/jmbi.1998.1852; Mayer M, 1999, ANGEW CHEM INT EDIT, V38, P1784, DOI 10.1002/(SICI)1521-3773(19990614)38:12<1784::AID-ANIE1784>3.0.CO;2-Q; Mayer M, 2001, J AM CHEM SOC, V123, P6108, DOI 10.1021/ja0100120; Meng FL, 2010, BIOCHEMISTRY-US, V49, P8127, DOI 10.1021/bi100939a; Mulder FAA, 2011, J BIOMOL NMR, V51, P199, DOI 10.1007/s10858-011-9554-9; Nie RZ, 2019, J FUNCT FOODS, V52, P492, DOI 10.1016/j.jff.2018.11.018; Nie RZ, 2017, BIOPHYS CHEM, V230, P1, DOI 10.1016/j.bpc.2017.07.009; Nie RZ, 2016, BIOCHIMIE, V125, P204, DOI 10.1016/j.biochi.2016.03.011; Paslawski W, 2016, METHODS MOL BIOL, V1345, P133, DOI 10.1007/978-1-4939-2978-8_9; Paslawski W, 2014, BIOCHEMISTRY-US, V53, P6252, DOI 10.1021/bi5007833; Paslawski W, 2014, ANGEW CHEM INT EDIT, V53, P7560, DOI 10.1002/anie.201400491; Perissinotto F, 2020, NANOSCALE, V12, P7631, DOI 10.1039/d0nr00287a; Pieri L, 2016, SCI REP-UK, V6, DOI 10.1038/srep24526; Sang SM, 2007, FREE RADICAL BIO MED, V43, P362, DOI 10.1016/j.freeradbiomed.2007.04.008; Sang SM, 2005, J AGR FOOD CHEM, V53, P9478, DOI 10.1021/jf0519055; Sciacca MF, 2020, ACS CHEM NEUROSCI, V11, P4336, DOI 10.1021/acschemneuro.0c00588; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Uversky VN, 2001, J BIOL CHEM, V276, P10737, DOI 10.1074/jbc.M010907200; Venkitakrishnan Rani Parvathy, 2012, Methods Mol Biol, V914, P47, DOI 10.1007/978-1-62703-023-6_4; Viennet T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0049-z; Volles MJ, 2001, BIOCHEMISTRY-US, V40, P7812, DOI 10.1021/bi0102398; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Wroblewski K, 2001, EUR J BIOCHEM, V268, P4384, DOI 10.1046/j.1432-1327.2001.02350.x; Xu ZX, 2017, CHEMPHYSCHEM, V18, P1611, DOI 10.1002/cphc.201700057; Zijlstra N, 2012, ANGEW CHEM INT EDIT, V51, P8821, DOI 10.1002/anie.201200813	52	3	3	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100788	10.1016/j.jbc.2021.100788	http://dx.doi.org/10.1016/j.jbc.2021.100788			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019875	gold, Green Published			2022-12-28	WOS:000674717300009
J	Broadwell, LJ; Smallegan, MJ; Rigby, KM; Navarro-Arriola, JS; Montgomery, RL; Rinn, JL; Leinwand, LA				Broadwell, Lindsey J.; Smallegan, Michael J.; Rigby, Kevin M.; Navarro-Arriola, Jose S.; Montgomery, Rusty L.; Rinn, John L.; Leinwand, Leslie A.			Myosin 7b is a regulatory long noncoding RNA (lncMYH7b) in the human heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHAIN GENE-EXPRESSION; VENTRICULAR HYPERTROPHY; MEF2; ADHESION; TRANSCRIPTION	Myosin heavy chain 7b (MYH7b) is an ancient member of the myosin heavy chain motor protein family that is expressed in striated muscles. In mammalian cardiac muscle, MYH7b RNA is expressed along with two other myosin heavy chains, beta-myosin heavy chain (beta-MyHC) and alpha-myosin heavy chain (alpha-MyHC). However, unlike beta-MyHC and alpha-MyHC, which are maintained in a careful balance at the protein level, the MYH7b locus does not produce a full-length protein in the heart due to a posttranscriptional exon-skipping mechanism that occurs in a tissue-specific manner. Whether this locus has a role in the heart beyond producing its intronic microRNA, miR-499, was unclear. Using cardiomyocytes derived from human induced pluripotent stem cells as a model system, we found that the noncoding exon-skipped RNA (lncMYH7b) affects the transcriptional landscape of human cardiomyocytes, independent of miR-499. Specifically, lncMYH7b regulates the ratio of beta-MyHC to alpha-MyHC, which is crucial for cardiac contractility. We also found that lncMYH7b regulates beat rate and sarcomere formation in cardiomyocytes. This regulation is likely achieved through control of a member of the TEA domain transcription factor family (TEAD3, which is known to regulate beta-MyHC). Therefore, we conclude that this ancient gene has been repurposed by alternative splicing to produce a regulatory long-noncoding RNA in the human heart that affects cardiac myosin composition.	[Broadwell, Lindsey J.; Rinn, John L.] CU Boulder, Dept Biochem, Boulder, CO USA; [Broadwell, Lindsey J.; Smallegan, Michael J.; Rinn, John L.; Leinwand, Leslie A.] CU Boulder, BioFrontiers Inst, Boulder, CO 80309 USA; [Smallegan, Michael J.; Navarro-Arriola, Jose S.; Leinwand, Leslie A.] CU Boulder, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Rigby, Kevin M.; Montgomery, Rusty L.] MiRagen Therapeut Inc, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Leinwand, LA (corresponding author), CU Boulder, BioFrontiers Inst, Boulder, CO 80309 USA.; Leinwand, LA (corresponding author), CU Boulder, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	Leslie.leinwand@colorado.edu	Core, BioFrontiers Advanced Light Microscopy/O-6175-2019	Rinn, John/0000-0002-7231-7539; LEINWAND, LESLIE/0000-0003-1470-4810; Broadwell, Lindsey/0000-0002-7559-3977				Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Ballarino M, 2018, EMBO J, V37, DOI 10.15252/embj.201899697; Bell ML, 2010, MOL CELL BIOL, V30, P1937, DOI 10.1128/MCB.01370-09; Cardoso AC, 2016, STRUCTURE, V24, P1301, DOI 10.1016/j.str.2016.06.003; Chang CP, 2016, BBA-MOL CELL RES, V1863, P1767, DOI 10.1016/j.bbamcr.2016.03.005; Chistiakov DA, 2016, J MOL CELL CARDIOL, V94, P107, DOI 10.1016/j.yjmcc.2016.03.015; Desjardins PR, 2002, MOL BIOL EVOL, V19, P375, DOI 10.1093/oxfordjournals.molbev.a004093; Ewels P. A., 2019, BIORXIV, DOI [10.1101/610741, 10.1101610741, DOI 10.1101/610741]; Fenix AM, 2018, ELIFE, V7, DOI 10.7554/eLife.42144; Han P, 2015, CELL CYCLE, V14, P787, DOI 10.1080/15384101.2015.1010963; Haraksingh RR, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1155; Hasegawa K, 1997, CIRCULATION, V96, P3943; Huebsch N, 2015, TISSUE ENG PART C-ME, V21, P467, DOI [10.1089/ten.tec.2014.0283, 10.1089/ten.TEC.2014.0283]; Jin Y, 2011, TRENDS CARDIOVAS MED, V21, P1, DOI 10.1016/j.tcm.2011.12.009; Karasseva N, 2003, MOL CELL BIOL, V23, P5143, DOI 10.1128/MCB.23.15.5143-5164.2003; Kim NG, 2015, J CELL BIOL, V210, P503, DOI 10.1083/jcb.201501025; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Lee LA, 2019, SKELET MUSCLE, V9, DOI 10.1186/s13395-019-0192-3; Lian XJ, 2012, P NATL ACAD SCI USA, V109, pE1848, DOI 10.1073/pnas.1200250109; Lowes BD, 2002, NEW ENGL J MED, V346, P1357, DOI 10.1056/NEJMoa012630; Miyata S, 2000, CIRC RES, V86, P386, DOI 10.1161/01.RES.86.4.386; Nadruz W, 2005, CARDIOVASC RES, V68, P87, DOI 10.1016/j.cardiores.2005.05.011; Nag S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500511; Nakao K, 1997, J CLIN INVEST, V100, P2362, DOI 10.1172/JCI119776; Nelson BR, 2016, SCIENCE, V351, P271, DOI 10.1126/science.aad4076; Park JH, 2018, MOL CELLS, V41, P83, DOI 10.14348/molcells.2018.2242; Peng X, 2008, P NATL ACAD SCI USA, V105, P6638, DOI 10.1073/pnas.0802319105; Peter AK, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.013318; Potthoff MJ, 2007, DEVELOPMENT, V134, P4131, DOI 10.1242/dev.008367; Rashid F, 2016, GENOM PROTEOM BIOINF, V14, P73, DOI 10.1016/j.gpb.2016.03.005; Rossi AC, 2010, J PHYSIOL-LONDON, V588, P353, DOI 10.1113/jphysiol.2009.181008; Rubio MD, 2011, J NEUROSCI, V31, P1448, DOI 10.1523/JNEUROSCI.3294-10.2011; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Sadayappan S., 2010, PHYSIOLOGY, V119, P1253; Sasaki S, 2014, PLOS ONE, V9; Taniguchi K, 2009, J BIOL CHEM, V284, P29873, DOI 10.1074/jbc.M109.059303; Torsoni AS, 2005, AM J PHYSIOL-HEART C, V289, pH1488, DOI 10.1152/ajpheart.00692.2004; Trcek T, 2013, GENE DEV, V27, P541, DOI 10.1101/gad.209635.112; Ushijima T, 2018, J BIOL CHEM, V293, P148, DOI 10.1074/jbc.M117.813931; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Wales S, 2014, NUCLEIC ACIDS RES, V42, P11349, DOI 10.1093/nar/gku813; Wang ZH, 2016, NAT MED, V22, P1131, DOI 10.1038/nm.4179; Warren CM, 2003, ANAL BIOCHEM, V320, P149, DOI 10.1016/S0003-2697(03)00350-6; Weiss A, 1996, ANNU REV CELL DEV BI, V12, P417, DOI 10.1146/annurev.cellbio.12.1.417; Zhao HX, 2012, VIROLOGY, V424, P115, DOI 10.1016/j.virol.2011.12.006	45	5	5	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100694	10.1016/j.jbc.2021.100694	http://dx.doi.org/10.1016/j.jbc.2021.100694			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895132	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400665
J	Han, JJW; Ho, DV; Kim, HM; Lee, JY; Jeon, YS; Chan, JY				Han, John J. W.; Ho, Daniel, V; Kim, Hyun M.; Lee, Jun Y.; Jeon, Yerin S.; Chan, Jefferson Y.			The deubiquitinating enzyme USP7 regulates the transcription factor Nrf1 by modulating its stability in response to toxic metal exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								The nuclear factor E2-related factor 1 (Nrf1) transcription factor performs a critical role in regulating cellular homeostasis as part of the cellular stress response and drives the expression of antioxidants and detoxification enzymes among many other functions. Ubiquitination plays an important role in controlling the abundance and thus nuclear accumulation of Nrf1 proteins, but the regulatory enzymes that act on Nrf1 are not fully defined. Here, we identified ubiquitin specific protease 7 (USP7), a deubiquitinating enzyme, as a novel regulator of Nrf1 activity. We found that USP7 interacts with Nrf1a and TCF11 -the two long protein isoforms of Nrf1. Expression of wildtype USP7, but not its catalytically defective mutant, resulted in decreased ubiquitination of TCF11 and Nrf1a, leading to their increased stability and increased transactivation of reporter gene expression by TCF11 and Nrf1a. In contrast, knockdown or pharmacologic inhibition of USP7 dramatically increased ubiquitination of TCF11 and Nrf1a and reduction of their steady state levels. Loss of USP7 function attenuated the induction of Nrf1 protein expression in response to treatment with arsenic and other toxic metals, and inhibition of USP7 activity significantly sensitized cells to arsenic treatment. Collectively, these findings suggest that USP7 may act to modulate abundance of Nrf1 protein to induce gene expression in response to toxic metal exposure.	[Han, John J. W.; Ho, Daniel, V; Kim, Hyun M.; Lee, Jun Y.; Jeon, Yerin S.; Chan, Jefferson Y.] Univ Calif Irvine, Dept Lab Med & Pathol, D440 Med Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine	Chan, JY (corresponding author), Univ Calif Irvine, Dept Lab Med & Pathol, D440 Med Sci, Irvine, CA 92697 USA.	jchan@uci.edu			NIEHS, National Institutes of Health [ES029481]	NIEHS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS, National Institutes of Health grant ES029481 (to J. Y. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.		0	4	4	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100732	10.1016/j.jbc.2021.100732	http://dx.doi.org/10.1016/j.jbc.2021.100732			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933455	Green Published, gold			2022-12-28	WOS:000672866400701
J	Kawai, T; Hashimoto, M; Eguchi, N; Nishino, JM; Jinno, Y; Mori-Kreiner, R; Aspaker, M; Chiba, D; Ohtsuka, Y; Kawanabe, A; Nishino, AS; Okamura, Y				Kawai, Takafumi; Hashimoto, Masaki; Eguchi, Natsuki; Nishino, Junko M.; Jinno, Yuka; Mori-Kreiner, Risa; Aspaker, Mans; Chiba, Daijiro; Ohtsuka, Yukio; Kawanabe, Akira; Nishino, Atsuo S.; Okamura, Yasushi			Heterologous functional expression of ascidian Nav1 channels and close relationship with the evolutionary ancestor of vertebrate Nav channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PUTATIVE SODIUM-CHANNEL; AMINO-ACID-SEQUENCE; MOLECULAR EVOLUTION; CIONA-INTESTINALIS; ANKYRIN-G; GENE; PROTEIN; INSIGHTS; CHORDATE; GENOME	Voltage-gated sodium channels (Nav1s) are responsible for the initiation and propagation of action potentials in neurons, muscle, and endocrine cells. Many clinically used drugs such as local anesthetics and antiarrhythmics inhibit Nav1s, and a variety of inherited human disorders are caused by mutations in Nav1 genes. Nav1s consist of the main alpha subunit and several auxiliary beta subunits. Detailed information on the structure-function relationships of Nav1 subunits has been obtained through heterologous expression experiments and analyses of protein structures. The basic properties of Nav1s, including their gating and ion permeation, were classically described in the squid giant axon and other invertebrates. However, heterologous functional expression of Nav1s from marine invertebrates has been unsuccessful. Ascidians belong to the Urochordata, a sister group of vertebrates, and the larval central nervous system of ascidians shows a similar plan to that of vertebrates. Here, we report the biophysical properties of ascidian Ciona Nav1 (CiNav1a) heterologously expressed in Xenopus oocytes. CiNav1a exhibited tetrodotoxin-insensitive sodium currents with rapid gating kinetics of activation and inactivation. Furthermore, consistent with the fact that the Ciona genome lacks orthologous genes to vertebrate beta subunits, the human beta 1 subunit did not influence the gating properties when coexpressed with CiNav1a. Interestingly, CiNav1a contains an ankyrin-binding motif in the II-III linker, which can be targeted to the axon initial segment of mammalian cortical neurons. Our findings provide a platform to gain insight into the evolutionary and biophysical properties of Nav1s, which are important for the development of targeted therapeutics.	[Kawai, Takafumi; Jinno, Yuka; Mori-Kreiner, Risa; Kawanabe, Akira; Okamura, Yasushi] Osaka Univ, Integrat Physiol, Dept Physiol, Grad Sch Med, Suita, Osaka, Japan; [Hashimoto, Masaki; Okamura, Yasushi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan; [Eguchi, Natsuki] Univ Calif Davis, Davis, CA USA; [Nishino, Junko M.; Chiba, Daijiro; Nishino, Atsuo S.] Hirosaki Univ, Fac Agr & Life Sci, Dept Biol, Hirosaki, Aomori, Japan; [Nishino, Junko M.; Nishino, Atsuo S.] Iwate Univ, United Grad Sch Agr Sci, Dept Bioresources Sci, Hirosaki, Aomori, Japan; [Aspaker, Mans] Uppsala Univ, Uppsala, Sweden; [Ohtsuka, Yukio] Natl Inst Adv Ind Sci & Technol, Biomed Res Inst, Tsukuba, Ibaraki, Japan; [Jinno, Yuka] Osaka Univ, Grad Sch Med, Dept Med Biochem, Yamada Oka 2-2, Suita, Osaka, Japan; [Kawanabe, Akira] Kagawa Univ, Fac Med, Mol Physiol & Biophys, Miki, Kagawa, Japan	Osaka University; Osaka University; University of California System; University of California Davis; Hirosaki University; Iwate University; Uppsala University; National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; Kagawa University	Okamura, Y (corresponding author), Osaka Univ, Integrat Physiol, Dept Physiol, Grad Sch Med, Suita, Osaka, Japan.; Okamura, Y (corresponding author), Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka, Japan.	vsop1@me.com	Ohtsuka, Yukio/L-7008-2018; Nishino, Atsuo/F-5393-2013	Ohtsuka, Yukio/0000-0001-9977-9349; Nishino, Atsuo/0000-0003-2818-4377; Eguchi, Natsuki/0000-0002-6412-8295	Japan Society for the Promotion of Science [15K18575, 17K19369, 20K06713, 21229003, 25253016, 19H03401]; Education, Culture, Sports, Science and Technology (Ministry of Education, Culture, Sports, Science and Technology) [15H05901]; Yamada Science Foundation; Sumitomo Foundation; Sekisui Chemical; Center for Medical Research and Education, Graduate School of Medicine, Osaka University; Advanced Medical Frontier Program by Osaka University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Education, Culture, Sports, Science and Technology (Ministry of Education, Culture, Sports, Science and Technology); Yamada Science Foundation; Sumitomo Foundation; Sekisui Chemical; Center for Medical Research and Education, Graduate School of Medicine, Osaka University; Advanced Medical Frontier Program by Osaka University	This work was supported by Grant-in-aid from Japan Society for the Promotion of Science (15K18575 to T. K., 17K19369 and 20K06713 to A. S. N., and 21229003, 25253016, and 19H03401 to Y. O.), Grant-in-aid for Scientific Research on Innovative Areas from Education, Culture, Sports, Science and Technology (Ministry of Education, Culture, Sports, Science and Technology) (15H05901 to Y. O.), and partially by Yamada Science Foundation, The Sumitomo Foundation, and Sekisui Chemical (to A. S. N.). This study was also supported by Center for Medical Research and Education, Graduate School of Medicine, Osaka University. We thank the National BioResource Project implemented by Japan Agency for Medical Research and Development for providing adult Ciona. The activity by M. A. in Osaka University (including Swedish food cooking) provides partial fulfillment of abroad internship of the Medical School of Uppsala University. N. E. was supported by Advanced Medical Frontier Program by Osaka University.	Abitua PB, 2015, NATURE, V524, P462, DOI 10.1038/nature14657; ANDERSON PAV, 1993, P NATL ACAD SCI USA, V90, P7419, DOI 10.1073/pnas.90.15.7419; Benkert P, 2011, BIOINFORMATICS, V27, P343, DOI 10.1093/bioinformatics/btq662; Brunetti R, 2015, J ZOOL SYST EVOL RES, V53, P186, DOI 10.1111/jzs.12101; Cai XJ, 2006, MOL BIOL EVOL, V23, P550, DOI 10.1093/molbev/msj056; Catterall WA, 2017, NAT CHEM BIOL, V13, P455, DOI [10.1038/NCHEMBIO.2353, 10.1038/nchembio.2353]; Catterall WA, 2012, J PHYSIOL-LONDON, V590, P2577, DOI 10.1113/jphysiol.2011.224204; Conklin EG, 1905, J EXP ZOOL, V2, P145, DOI 10.1002/jez.1400020202; Corbin-Leftwich A, 2018, J GEN PHYSIOL, V150, P1583, DOI 10.1085/jgp.201812146; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Dumitrescu AS, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00268; FENG GP, 1995, GENETICS, V139, P1679; Garrido JJ, 2003, SCIENCE, V300, P2091, DOI 10.1126/science.1085167; Geffeney SL, 2019, TOXICON, V170, P77, DOI 10.1016/j.toxicon.2019.09.013; Geffeney SL, 2005, NATURE, V434, P759, DOI 10.1038/nature03444; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Hill AS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000317; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; Horie R, 2018, NATURE, V560, P228, DOI 10.1038/s41586-018-0385-7; Horie T, 2011, NATURE, V469, P525, DOI 10.1038/nature09631; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Inazawa T, 1998, J PHYSIOL-LONDON, V511, P347, DOI 10.1111/j.1469-7793.1998.347bh.x; Jegla T, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006457; Jenkins PM, 2015, P NATL ACAD SCI USA, V112, P957, DOI 10.1073/pnas.1416544112; Jenkins SM, 2002, P NATL ACAD SCI USA, V99, P2303, DOI 10.1073/pnas.042601799; Ji YH, 2018, HANDB EXP PHARMACOL, V246, P187, DOI 10.1007/164_2017_66; Johnston WL, 1996, J NEUROSCI, V16, P1730; Kondo M, 2000, EUR J NEUROSCI, V12, P2812, DOI 10.1046/j.1460-9568.2000.00167.x; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; LOUGHNEY K, 1989, CELL, V58, P1143, DOI 10.1016/0092-8674(89)90512-6; Molinarolo S, 2018, HANDB EXP PHARMACOL, V246, P33, DOI 10.1007/164_2017_75; Molinarolo S, 2018, J BIOL CHEM, V293, P4981, DOI 10.1074/jbc.RA117.000852; Moreau A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00053; Murata Y, 2005, NATURE, V435, P1239, DOI 10.1038/nature03650; Nagahora H, 2000, BIOCHEM BIOPH RES CO, V275, P558, DOI 10.1006/bbrc.2000.3290; Nishino A, 2018, HANDB EXP PHARMACOL, V246, P3, DOI 10.1007/164_2017_70; Nishino A, 2011, P NATL ACAD SCI USA, V108, P2599, DOI 10.1073/pnas.1013547108; Northcutt AJ, 2019, MAR GENOM, V46, P29, DOI 10.1016/j.margen.2019.03.003; Novak AE, 2006, J MOL EVOL, V63, P208, DOI 10.1007/s00239-005-0287-9; Ohno S., 1970, P1; OKAMOTO H, 1976, J PHYSIOL-LONDON, V254, P607, DOI 10.1113/jphysiol.1976.sp011249; OKAMURA Y, 1994, NEURON, V13, P937, DOI 10.1016/0896-6273(94)90259-3; Okamura Y, 2005, PHYSIOL GENOMICS, V22, P269, DOI 10.1152/physiolgenomics.00229.2004; Okamura Y, 2007, PFLUG ARCH EUR J PHY, V454, P361, DOI 10.1007/s00424-007-0222-6; Okamura Yasushi, 1996, P21; Pan XJ, 2019, SCIENCE, V363, P1309, DOI 10.1126/science.aaw2999; Pan XJ, 2018, SCIENCE, V362, DOI 10.1126/science.aau2486; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; QU YS, 1995, J BIOL CHEM, V270, P25696, DOI 10.1074/jbc.270.43.25696; ROSENTHAL JJC, 1993, P NATL ACAD SCI USA, V90, P10026, DOI 10.1073/pnas.90.21.10026; Ryan K, 2016, ELIFE, V5, DOI 10.7554/eLife.16962; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Satou Y, 2019, GENOME BIOL EVOL, V11, P3144, DOI 10.1093/gbe/evz228; Satou Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r152; Soong TW, 2006, TRENDS GENET, V22, P621, DOI 10.1016/j.tig.2006.08.010; Spafford JD, 1998, BIOCHEM BIOPH RES CO, V244, P772, DOI 10.1006/bbrc.1998.8332; TAKAHASH.K, 1971, SCIENCE, V171, P415, DOI 10.1126/science.171.3969.415; TERLAU H, 1991, FEBS LETT, V293, P93, DOI 10.1016/0014-5793(91)81159-6; Tsutsui H, 2000, BIOL BULL, V198, P26, DOI 10.2307/1542800; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; WEST JW, 1992, P NATL ACAD SCI USA, V89, P10910, DOI 10.1073/pnas.89.22.10910; Yan Z, 2017, CELL, V170, P470, DOI 10.1016/j.cell.2017.06.039; Zakon HH, 2017, P ROY SOC B-BIOL SCI, V284, DOI 10.1098/rspb.2017.0824; Zhu WD, 2017, J GEN PHYSIOL, V149, P813, DOI 10.1085/jgp.201711802	66	2	2	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100783	10.1016/j.jbc.2021.100783	http://dx.doi.org/10.1016/j.jbc.2021.100783			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34000300	Green Published, gold			2022-12-28	WOS:000674717300005
J	Vitvitsky, V; Kumar, R; Libiad, M; Maebius, A; Landry, AP; Banerjee, R				Vitvitsky, Victor; Kumar, Roshan; Libiad, Marouane; Maebius, Allison; Landry, Aaron P.; Banerjee, Ruma			The mitochondrial NADH pool is involved in hydrogen sulfide signaling and stimulation of aerobic glycolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Hydrogen sulfide is synthesized by enzymes involved in sulfur metabolism and oxidized via a dedicated mitochondrial pathway that intersects with the electron transport chain at the level of complex III. Studies with H2S are challenging since it is volatile and also reacts with oxidized thiols in the culture medium, forming sulfane sulfur species. The half-life of exogenously added H2S to cultured cells is unknown. In this study, we first examined the half-life of exogenously added H2S to human colonic epithelial cells. In plate cultures, H2S disappeared with a t(1)/2 of 3 to 4 min at 37 degrees C with a small fraction being trapped as sulfane sulfur species. In suspension cultures, the rate of abiotic loss of H2S was slower, and we demonstrated that sulfide stimulated aerobic glycolysis, which was sensitive to the mitochondrial but not the cytoplasmic NADH pool. Oxidation of mitochondrial NADH using the genetically encoded mito-LbNOX tool blunted the cellular sensitivity to sulfide-stimulated aerobic glycolysis and enhanced its oxidation to thiosulfate. In contrast, sulfide did not affect flux through the oxidative pentose phosphate pathway or the TCA cycle. Knockdown of sulfide quinone oxidoreductase, which commits H2S to oxidation, sensitized cells to sulfide-stimulated aerobic glycolysis. Finally, we observed that sulfide decreased ATP levels in cells. The dual potential of H2S to activate oxidative phosphorylation at low concentrations, but inhibit it at high concentrations, suggests that it might play a role in tuning electron flux and, therefore, cellular energy metabolism, particularly during cell proliferation.	[Vitvitsky, Victor; Kumar, Roshan; Libiad, Marouane; Maebius, Allison; Landry, Aaron P.; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Michigan Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Michigan Med, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Vitvitsky, Victor/ABA-2967-2021	Vitvitsky, Victor/0000-0001-6251-6115; Libiad, Marouane/0000-0003-1717-9206; Maebius, Allison/0000-0002-2384-2978	National Institutes of Health [GM130183]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the grants from the National Institutes of Health (GM130183 to R. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.		0	6	7	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100736	10.1016/j.jbc.2021.100736	http://dx.doi.org/10.1016/j.jbc.2021.100736			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933447	gold, Green Published			2022-12-28	WOS:000672866400705
J	Yin, YT; Kovach, A; Hsu, HC; Darwin, KH; Li, HL				Yin, Yanting; Kovach, Amanda; Hsu, Hao-Chi; Darwin, K. Heran; Li, Huilin			The mycobacterial proteasomal ATPase Mpa forms a gapped ring to engage the 20S proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Although many bacterial species do not possess proteasome systems, the actinobacteria, including the human pathogen Mycobacterium tuberculosis, use proteasome systems for targeted protein removal. Previous structural analyses of the mycobacterial proteasome ATPase Mpa revealed a general structural conservation with the archaeal proteasome-activating nucleotidase and eukaryotic proteasomal Rpt1-6 ATPases, such as the N-terminal coiled-coil domain, oligosaccharide-/oligonucleotide-binding domain, and ATPase domain. However, Mpa has a unique beta-grasp domain that in the ADP-bound crystal structure appears to interfere with the docking to the 20S proteasome core particle (CP). Thus, it is unclear how Mpa binds to proteasome CPs. In this report, we show by cryo-EM that the Mpa hexamer in the presence of a degradation substrate and ATP forms a gapped ring, with two of its six ATPase domains being highly flexible. We found that the linkers between the oligonucleotide-binding and ATPase domains undergo conformational changes that are important for function, revealing a previously unappreciated role of the linker region in ATP hydrolysis-driven protein unfolding. We propose that this gapped ring configuration is an intermediate state that helps rearrange its beta-grasp domains and activating C termini to facilitate engagement with proteasome CPs. This work provides new insights into the crucial process of how an ATPase interacts with a bacterial proteasome protease.	[Yin, Yanting; Kovach, Amanda; Hsu, Hao-Chi; Li, Huilin] Van Andel Inst, Dept Struct Biol, Grand Rapids, MI 49503 USA; [Darwin, K. Heran] NYU, Dept Microbiol, Grossman Sch Med, New York, NY 10016 USA	Van Andel Institute; New York University	Li, HL (corresponding author), Van Andel Inst, Dept Struct Biol, Grand Rapids, MI 49503 USA.	Huilin.Li@vai.org		Li, Huilin/0000-0001-8085-8928; Darwin, K Heran/0000-0002-5043-7548; Li, Huilin/0000-0002-8288-7068	US National Institutes of Health [R01 AI070285, R01 AI088075]	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by US National Institutes of Health grants R01 AI070285 (to H. L.) and R01 AI088075 (to K. H. D). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	2	2	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100713	10.1016/j.jbc.2021.100713	http://dx.doi.org/10.1016/j.jbc.2021.100713			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33930464	gold, Green Published			2022-12-28	WOS:000672866400684
J	Zhang, L; Zhang, L; Pan, Y; Gao, JX; Xu, YF; Li, X; Tian, ZJ; Chen, HY; Wang, Y				Zhang, Lin; Zhang, Lu; Pan, Yu; Gao, Junxin; Xu, Yunfei; Li, Xi; Tian, Zhijun; Chen, Hongyan; Wang, Yue			Downregulation of miR-218 by porcine reproductive and respiratory syndrome virus facilitates viral replication via inhibition of type I interferon responses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNE-RESPONSES; STIMULATED GENES; HOST; INFECTION; MICRORNA; MIRNA	Porcine reproductive and respiratory syndrome virus (PRRSV) is a devastating pathogen in the swine industry worldwide. miRNAs are reported to be involved in virus-host interaction. Here, we used high-throughput sequencing and miRNA inhibitors to screen possible miRNAs that can inhibit PRRSV infection on its target cell, porcine alveolar macrophages. We observed that miR-218 was downregulated upon virus infection, and knockdown of miR-218 significantly enhanced PRRSV replication. Overexpression of miR-218 resulted in a decrease in PRRSV replication, and this overexpression did not alter viral genomic RNA levels, but rather increased antiviral interferon signaling. Further analysis revealed that miR-218 regulated PRRSV replication by directly targeting porcine suppressor of cytokine signaling 3 (SOCS3), a JAK2 kinase inhibitor. Knockdown of the endogenous SOCS3 expression led to augmentation of type I interferon genes and resulted in decreased PRRSV replication, and vice versa. During PRRSV infection in vivo and in vitro, cellular miR-218 expression was downregulated and SOCS3 expression was upregulated, further supporting the inverse correlation between miR-218 and SOCS3 expression. The data on SOCS3 depletion in combination with miR-218 inhibition suggested that the antiviral activity of miR-218 required the SOCS3-mediated signaling pathway. Similarly, miR-218 negatively regulated PRRSV replication in Marc-145 cells, as well as the replication of porcine epidemic diarrhea virus and transmissible gastroenteritis virus in Vero and ST cells respectively. Taken together, these results demonstrate that PRRSV-induced miR-218 downregulation serves to inhibit the type I interferon response and may provide a novel therapeutic target for treatment of PRRSV and other viral infections.	[Zhang, Lin; Zhang, Lu; Pan, Yu; Gao, Junxin; Xu, Yunfei; Li, Xi; Tian, Zhijun; Chen, Hongyan; Wang, Yue] Chinese Acad Agr Sci, Natl Poultry Lab Anim Resource Ctr, Harbin Vet Res Inst, State Key Lab Vet Biotechnol,Heilongjiang Prov Ke, Harbin, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS	Wang, Y (corresponding author), Chinese Acad Agr Sci, Natl Poultry Lab Anim Resource Ctr, Harbin Vet Res Inst, State Key Lab Vet Biotechnol,Heilongjiang Prov Ke, Harbin, Peoples R China.	wangyue@caas.cn			National Natural Science Foundation of China [31572497, 31372416]; Heilongjiang province matching grant for national Key RD Program [GX18B052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Heilongjiang province matching grant for national Key RD Program	This research was supported by National Natural Science Foundation of China Grants 31572497 & 31372416, and Heilongjiang province matching grant for national Key R&D Program (GX18B052).	Barbu MG, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00143; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bernier A, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10080440; Brockmeier SL, 2017, VET MICROBIOL, V212, P48, DOI 10.1016/j.vetmic.2017.11.004; Bronevetsky Y, 2013, IMMUNOL REV, V253, P304, DOI 10.1111/imr.12059; Carow B, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00058; Cavanagh D, 1997, ARCH VIROL, V142, P629; Chekulaeva M, 2009, CURR OPIN CELL BIOL, V21, P452, DOI 10.1016/j.ceb.2009.04.009; Chen J, 2017, J VIROL, V91, DOI 10.1128/JVI.01311-16; Chtta B, 2008, J GEN VIROL, V89, P1622; COLLINS JE, 1992, J VET DIAGN INVEST, V4, P117, DOI 10.1177/104063879200400201; Dong HF, 2013, CHEM REV, V113, P6207, DOI 10.1021/cr300362f; Du TF, 2017, TRENDS MICROBIOL, V25, P968, DOI 10.1016/j.tim.2017.06.001; Duan FJ, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000004773; Duan XJ, 2020, POULTRY SCI, V99, P1838, DOI 10.1016/j.psj.2019.11.053; Essandoh K, 2016, SHOCK, V46, P122, DOI 10.1097/SHK.0000000000000604; Eulalio A, 2008, CELL, V132, P9, DOI 10.1016/j.cell.2007.12.024; Fang Y, 2010, VIRUS RES, V154, P61, DOI 10.1016/j.virusres.2010.07.030; Finlay BB, 2006, CELL, V124, P767, DOI 10.1016/j.cell.2006.01.034; Forster SC, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00334; Guo LJ, 2016, J VIROL, V90, P8281, DOI 10.1128/JVI.01091-16; Holla S, 2015, EPIGENOMICS-UK, V7, P1197, DOI 10.2217/epi.15.75; Huang C, 2015, VIRUS RES, V202, P101, DOI 10.1016/j.virusres.2014.12.014; Ke HZ, 2017, VET MICROBIOL, V209, P75, DOI 10.1016/j.vetmic.2017.03.014; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Leite KRM, 2011, UROL ONCOL-SEMIN ORI, V29, P265, DOI 10.1016/j.urolonc.2009.02.002; Li LW, 2015, VIRUS RES, V195, P86, DOI 10.1016/j.virusres.2014.08.012; Li M, 2020, J CELL PHYSIOL, V235, P3362, DOI 10.1002/jcp.29224; Li W, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007578; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo R, 2011, ANTIVIR RES, V91, P99, DOI 10.1016/j.antiviral.2011.04.017; Luo XL, 2017, J VIROL, V91, DOI [10.1128/JVI.00202-17, 10.1128/jvi.00202-17]; McCaskill JL, 2017, MOL THER-NUCL ACIDS, V7, P256, DOI 10.1016/j.omtn.2017.03.008; Mesev EV, 2019, NAT MICROBIOL, V4, P914, DOI 10.1038/s41564-019-0421-x; MEULENBERG JJM, 1993, VIROLOGY, V192, P62, DOI 10.1006/viro.1993.1008; Meulenberg JJM, 2000, VET RES, V31, P11, DOI 10.1051/vetres:2000054; Mohr AM, 2015, SEMIN LIVER DIS, V35, P3, DOI 10.1055/s-0034-1397344; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Nan YC, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01635; Pasternak AO, 2006, J GEN VIROL, V87, P1403, DOI 10.1099/vir.0.81611-0; Pedroso JAB, 2019, HORM-INT J ENDOCRINO, V18, P127, DOI 10.1007/s42000-018-0078-5; Rappe JCF, 2016, VET RES, V47, DOI 10.1186/s13567-016-0399-9; Roy S, 2016, ANTIOXID REDOX SIGN, V25, P795, DOI 10.1089/ars.2016.6728; Roy S, 2011, PHYSIOL GENOMICS, V43, P557, DOI 10.1152/physiolgenomics.00160.2010; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Skalsky RL, 2010, ANNU REV MICROBIOL, V64, P123, DOI 10.1146/annurev.micro.112408.134243; Tian ZJ, 2009, VET MICROBIOL, V138, P34, DOI 10.1016/j.vetmic.2009.03.003; Tie J, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000879; Trobaugh DW, 2017, TRENDS MOL MED, V23, P80, DOI 10.1016/j.molmed.2016.11.003; Vidigal JA, 2015, TRENDS CELL BIOL, V25, P137, DOI 10.1016/j.tcb.2014.11.004; Vu HLX, 2017, VET MICROBIOL, V206, P29, DOI 10.1016/j.vetmic.2016.09.014; Wang XG, 2020, MICROB BIOTECHNOL, V13, P1103, DOI 10.1111/1751-7915.13565; Wong RR, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-019-0614-x; Xu JY, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11100948; Zhang C, 2018, ONCOTARGET, V9, P2175, DOI [10.18632/oncotarget.23299, 10.18632/oncotarget.25667]; Zhang J, 2018, VIROLOGY, V517, P24, DOI 10.1016/j.virol.2018.02.001; Zhang Q, 2018, SCI REP, V8, P15621; Zhang Q, 2016, J IMMUNOL, V196, P2272, DOI 10.4049/jimmunol.1502006	60	12	12	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100683	10.1016/j.jbc.2021.100683	http://dx.doi.org/10.1016/j.jbc.2021.100683			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33887325	Green Published, gold			2022-12-28	WOS:000672866400654
J	Shafer, CM; Tseng, A; Allard, P; McEvoy, MM				Shafer, Catherine M.; Tseng, Ashley; Allard, Patrick; McEvoy, Megan M.			Strength of Cu-efflux response in Escherichia coli coordinates metal resistance in Caenorhabditis elegans and contributes to the severity of environmental toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHELATING-AGENTS; ELEVATED COPPER; DISEASE; GENES; CELLS; SENSITIVITY; MICROBIOME; METABOLISM; GENETICS; UTILITY	Without effective homeostatic systems in place, excess copper (Cu) is universally toxic to organisms. While increased utilization of anthropogenic Cu in the environment has driven the diversification of Cu-resistance systems within enterobacteria, little research has focused on how this change in bacterial architecture impacts host organisms that need to maintain their own Cu homeostasis. Therefore, we utilized a simplified host-microbe system to determine whether the efficiency of one bacterial Cu-resistance system, increasing Cuefflux capacity via the ubiquitous CusRS two-component system, contributes to the availability and subsequent toxicity of Cu in host Caenorhabditis elegans nematode. We found that a fully functional Cu-efflux system in bacteria increased the severity of Cu toxicity in host nematodes without increasing the C. elegans Cu-body burden. Instead, increased Cu toxicity in the host was associated with reduced expression of a protective metal stress-response gene, numr-1, in the posterior pharynx of nematodes where pharyngeal grinding breaks apart ingested bacteria before passing into the digestive tract. The spatial localization of numr-1 transgene activation and loss of bacterially dependent Cu-resistance in nematodes without an effective numr-1 response support the hypothesis that numr-1 is responsive to the bacterial Cu-efflux capacity. We propose that the bacterial Cu-efflux capacity acts as a robust spatial determinant for a host's response to chronic Cu stress.	[Shafer, Catherine M.; Allard, Patrick; McEvoy, Megan M.] Univ Calif Los Angeles, Mol Toxicol Interdept Program, Los Angeles, CA 90095 USA; [Tseng, Ashley; Allard, Patrick; McEvoy, Megan M.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Allard, Patrick; McEvoy, Megan M.] Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA; [McEvoy, Megan M.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Allard, P; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Mol Toxicol Interdept Program, Los Angeles, CA 90095 USA.; Allard, P; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.; Allard, P; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Inst Soc & Genet, Los Angeles, CA 90095 USA.; McEvoy, MM (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	pallard@ucla.edu; mcevoymm@ucla.edu		Tseng, Ashley/0000-0002-3078-3718; Allard, Patrick/0000-0001-7765-1547; McEvoy, Megan/0000-0002-4132-7355	NIEHS [R01 ES027487]; NIEHS T32 training grant "Training in Molecular Toxicology" [T32ES015457]	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS T32 training grant "Training in Molecular Toxicology"	P.A. is supported by NIEHS R01 ES027487. C.M.S. was supported by the NIEHS T32 training grant "Training in Molecular Toxicology" T32ES015457. The con-tent is solely the responsibility of the authors and does not neces-sarily represent the official views of the National Institutes of Environmental Health Sciences.	Affandi T, 2019, BIOCHEM J, V476, P115, DOI 10.1042/BCJ20180577; Affandi T, 2016, BIOCHEMISTRY-US, V55, P5296, DOI 10.1021/acs.biochem.6b00707; Ahmad JU, 2010, ENVIRON MONIT ASSESS, V166, P347, DOI 10.1007/s10661-009-1006-6; Ala A, 2007, LANCET, V369, P397, DOI 10.1016/S0140-6736(07)60196-2; Amrit FRG, 2014, METHODS, V68, P465, DOI 10.1016/j.ymeth.2014.04.002; Anderson GL, 2001, ENVIRON TOXICOL CHEM, V20, P833, DOI [10.1897/1551-5028(2001)020&lt;0833:AOSEFT&gt;2.0.CO;2, 10.1002/etc.5620200419]; Angelo G, 2009, SCIENCE, V326, P954, DOI 10.1126/science.1178343; Boal AK, 2009, CHEM REV, V109, P4760, DOI 10.1021/cr900104z; Bondarczuk K, 2013, CELL BIOL TOXICOL, V29, P397, DOI 10.1007/s10565-013-9262-1; Bourassa MW, 2013, BIOMED SPECTROSC IMA, V2, P129, DOI 10.3233/BSI-130041; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P3049, DOI 10.1897/02-565; Boyd WA, 2003, ENVIRON TOXICOL CHEM, V22, P2768, DOI 10.1897/02-573; BRENNER S, 1974, GENETICS, V77, P71; Brown EG, 2018, CURR GERIATR REP, V7, P81, DOI 10.1007/s13670-018-0240-6; BROWN NL, 1995, MOL MICROBIOL, V17, P1153, DOI 10.1111/j.1365-2958.1995.mmi_17061153.x; Calafato S, 2008, TOXICOL SCI, V106, P384, DOI 10.1093/toxsci/kfn180; Chen JJ, 2004, J NEMATOL, V36, P107; Chun H, 2017, J BIOL CHEM, V292, P1, DOI 10.1074/jbc.M116.760876; Conroy O, 2010, FEMS MICROBIOL LETT, V308, P115, DOI 10.1111/j.1574-6968.2010.02006.x; Djaman O, 2004, J BIOL CHEM, V279, P44590, DOI 10.1074/jbc.M406487200; Dupont CL, 2011, METALLOMICS, V3, P1109, DOI 10.1039/c1mt00107h; Dutta SK, 2019, J NEUROGASTROENTEROL, V25, P363, DOI 10.5056/jnm19044; Ganio K, 2016, ANALYST, V141, P1434, DOI [10.1039/c5an02544c, 10.1039/C5AN02544C]; Geng H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000011743; Govindan JA, 2015, P NATL ACAD SCI USA, V112, P12456, DOI 10.1073/pnas.1517448112; Gudipaty SA, 2012, FEMS MICROBIOL LETT, V330, P30, DOI 10.1111/j.1574-6968.2012.02529.x; Gupte A, 2009, CANCER TREAT REV, V35, P32, DOI 10.1016/j.ctrv.2008.07.004; Harrington JM, 2012, TOXICOL SCI, V129, P49, DOI 10.1093/toxsci/kfs191; Hill-Burns EM, 2017, MOVEMENT DISORD, V32, P739, DOI 10.1002/mds.26942; Javdan B, 2020, CELL, V181, P1661, DOI 10.1016/j.cell.2020.05.001; KHAN FR, 1980, NEMATOLOGICA, V26, P280, DOI 10.1163/187529280X00189; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kishimoto S, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14031; KNOBELOCH L, 1994, ENVIRON HEALTH PERSP, V102, P958; Le Pennec G, 2019, WORLD J MICROB BIOT, V35, DOI 10.1007/s11274-019-2740-8; Malik Ayesha, 2013, BMC Res Notes, V6, P421, DOI 10.1186/1756-0500-6-421; Martinez-Finley EJ, 2011, J TOXICOL-US, V2011, DOI 10.1155/2011/895236; Mashock MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167613; Miller KA, 2019, P NATL ACAD SCI USA, V116, P5955, DOI 10.1073/pnas.1814047116; MILNE L, 1993, ARCH BIOCHEM BIOPHYS, V304, P102, DOI 10.1006/abbi.1993.1327; Moyson S, 2019, J APPL TOXICOL, V39, P282, DOI 10.1002/jat.3718; Petris MJ, 2003, J BIOL CHEM, V278, P9639, DOI 10.1074/jbc.M209455200; Pickett CL, 2013, AGING CELL, V12, P544, DOI 10.1111/acel.12079; Pryor R, 2019, CELL, V178, P1299, DOI 10.1016/j.cell.2019.08.003; Richards AL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006995; Scott TA, 2017, CELL, V169, P442, DOI 10.1016/j.cell.2017.03.040; Segata N, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r42; Shin N, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1007975; Staehlin BM, 2016, GENOME BIOL EVOL, V8, P811, DOI 10.1093/gbe/evw031; Stenhammar L, 1999, Eur J Med Res, V4, P217; Tan MW, 2011, CELL MICROBIOL, V13, P497, DOI 10.1111/j.1462-5822.2011.01570.x; Tvermoes BE, 2010, J CELL SCI, V123, P2123, DOI 10.1242/jcs.065433; Twumasi-Boateng K, 2012, AGING CELL, V11, P659, DOI 10.1111/j.1474-9726.2012.00829.x; Urano H, 2015, MICROBIOL-SGM, V161, P729, DOI 10.1099/mic.0.000026; Vallieres C, 2017, CELL CHEM BIOL, V24, P1228, DOI 10.1016/j.chembiol.2017.08.005; Watson E, 2014, CELL, V156, P759, DOI 10.1016/j.cell.2014.01.047; Wu CW, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0675-z; Xing C, 2020, METALLOMICS, V12, P387, DOI [10.1039/c9mt00273a, 10.1039/C9MT00273A]; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yuan S, 2018, J BIOL CHEM, V293, P10911, DOI 10.1074/jbc.RA118.003503	60	0	0	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101060	10.1016/j.jbc.2021.101060	http://dx.doi.org/10.1016/j.jbc.2021.101060			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34375643	Green Published, gold			2022-12-28	WOS:000706409400002
J	Shizu, R; Nishiguchi, H; Tashiro, S; Sato, T; Sugawara, A; Kanno, Y; Hosaka, T; Sasaki, T; Yoshinari, K				Shizu, Ryota; Nishiguchi, Hikaru; Tashiro, Sarii; Sato, Takumi; Sugawara, Ayaka; Kanno, Yuichiro; Hosaka, Takuomi; Sasaki, Takamitsu; Yoshinari, Kouichi			Helix 12 stabilization contributes to basal transcriptional activity of PXR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREGNANE-X-RECEPTOR; XENOBIOTIC RECEPTOR; LIGAND-BINDING; CRYSTAL-STRUCTURE; NUCLEAR; COMPLEX; RXR; COREGULATORS; RECRUITMENT; METABOLISM	Pregnane X receptor (PXR) plays an important role in xenobiotic metabolism. While ligand binding induces PXRdependent gene transcription, PXR shows constitutive transcriptional activity in the absence of ligands when expressed in cultured cells. This constitutive activity sometimes hampers investigation of PXR activation by compounds of interest. In this study, we investigated the molecular mechanism of PXR activation. In the reported crystal structures of unliganded PXR, helix 12 (H12), including a coactivator binding motif, was stabilized, while it is destabilized in the unliganded structures of other nuclear receptors, suggesting a role for H12 stabilization in the basal activity of PXR. Since Phe420, located in the loop between H11 and H12, is thought to interact with Leu411 and Ile414 to stabilize H12, we substituted alanine at Phe420 (PXR-F420A) and separately inserted three alanine residues directly after Phe420 (PXR-3A) and investigated their influence on PXR-mediated transcription. Reporter gene assays demonstrated that the mutants showed drastically reduced basal activity and enhanced responses to various ligands, which was further enhanced by coexpression of the coactivator peroxisome proliferator-activated receptor gamma coactivator 1 alpha. Mutations of both Leu411 and Ile414 to alanine also suppressed basal activity. Mammalian two-hybrid assays showed that PXR-F420A and PXR-3A bound to corepressors and coactivators in the absence and presence of ligands, respectively. We conclude that the intramolecular interactions of Phe420 with Leu411 and Ile414 stabilize H12 to recruit coactivators even in the absence of ligands, contributing to the basal transcriptional activity of PXR. We propose that the generated mutants might be useful for PXR ligand screening.	[Shizu, Ryota; Nishiguchi, Hikaru; Tashiro, Sarii; Sato, Takumi; Sugawara, Ayaka; Kanno, Yuichiro; Hosaka, Takuomi; Sasaki, Takamitsu; Yoshinari, Kouichi] Univ Shizuoka, Sch Pharmaceut Sci, Lab Mol Toxicol, Shizuoka, Japan	University of Shizuoka	Shizu, R; Yoshinari, K (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Lab Mol Toxicol, Shizuoka, Japan.	r_shizu@u-shizuoka-ken.ac.jp; yoshinari@u-shizuoka-ken.ac.jp	Shizu, Ryota/ACP-9957-2022; Yoshinari, Kouichi/X-8070-2019	Yoshinari, Kouichi/0000-0002-2027-2017; Kanno, Yuichiro/0000-0002-7551-6410; Shizu, Ryota/0000-0002-0465-5077	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [17H07004, 19K16352]	Ministry of Education, Culture, Sports, Sciences, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Sciences, and Technology of Japan [Grant Numbers 17H07004 and 19K16352] .	Banerjee M, 2014, BIOCHEM PHARMACOL, V92, P389, DOI 10.1016/j.bcp.2014.08.025; Bourguet W, 2000, MOL CELL, V5, P289, DOI 10.1016/S1097-2765(00)80424-4; Buchman CD, 2018, EXPERT OPIN DRUG MET, V14, P635, DOI 10.1080/17425255.2018.1476488; Chai SC, 2019, DRUG DISCOV TODAY, V24, P906, DOI 10.1016/j.drudis.2019.01.021; Chen TS, 2008, CURR OPIN CHEM BIOL, V12, P418, DOI 10.1016/j.cbpa.2008.07.001; Chrencik JE, 2005, MOL ENDOCRINOL, V19, P1125, DOI 10.1210/me.2004-0346; de Lera AR, 2007, NAT REV DRUG DISCOV, V6, P811, DOI 10.1038/nrd2398; Delfosse V, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020551118; Dussault I, 2002, MOL CELL BIOL, V22, P5270, DOI 10.1128/MCB.22.15.5270-5280.2002; Eberhardt J, 2019, ACTA CRYSTALLOGR F, V75, P98, DOI 10.1107/S2053230X18018022; Egea PF, 2002, MOL ENDOCRINOL, V16, P987, DOI 10.1210/me.16.5.987; Ellison TI, 2007, J BIOL CHEM, V282, P10953, DOI 10.1074/jbc.M609717200; Gijsbers L, 2011, ANAL BIOCHEM, V414, P77, DOI 10.1016/j.ab.2011.02.032; Hakkola J, 2016, BBA-GENE REGUL MECH, V1859, P1072, DOI 10.1016/j.bbagrm.2016.03.012; Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2; Huber AD, 2021, CELL MOL LIFE SCI, V78, P317, DOI 10.1007/s00018-020-03505-y; Jiang YM, 2019, HEPATOLOGY, V69, P343, DOI 10.1002/hep.30131; Jones SA, 2000, MOL ENDOCRINOL, V14, P27, DOI 10.1210/me.14.1.27; Kanno Y, 2010, J TOXICOL SCI, V35, P515, DOI 10.2131/jts.35.515; Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038; Lin WW, 2018, ADV PROTEIN CHEM STR, V110, P31, DOI 10.1016/bs.apcsb.2017.06.001; Lin WW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00780-5; Liu H, 2004, J BIOL CHEM, V279, P45208, DOI 10.1074/jbc.M408033200; Lonard DM, 2007, ENDOCR REV, V28, P575, DOI 10.1210/er.2007-0012; Lynch C, 2021, BIOCHEM PHARMACOL, V184, DOI 10.1016/j.bcp.2020.114368; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; McKenna NJ, 1999, ENDOCR REV, V20, P321, DOI 10.1210/er.20.3.321; Moore JT, 2000, TOXICOLOGY, V153, P1, DOI 10.1016/S0300-483X(00)00300-0; Motta S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34373-z; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; Narayanan B, 2018, CHEMMEDCHEM, V13, P736, DOI 10.1002/cmdc.201700730; Ngan CH, 2009, BIOCHEMISTRY-US, V48, P11572, DOI 10.1021/bi901578n; Nolte RT, 1998, NATURE, V395, P137, DOI 10.1038/25931; Okamura M, 2019, DRUG METAB PHARMACOK, V34, P272, DOI 10.1016/j.dmpk.2019.04.005; Oladimeji Peter O, 2018, Mol Pharmacol, V93, P119, DOI 10.1124/mol.117.110155; Orans J, 2005, MOL ENDOCRINOL, V19, P2891, DOI 10.1210/me.2005-0156; Pondugula SR, 2013, CANCER LETT, V328, P1, DOI 10.1016/j.canlet.2012.08.030; Saradhi M, 2005, BBA-MOL CELL RES, V1746, P85, DOI 10.1016/j.bbamcr.2005.10.004; Sekiguchi M, 2013, J BIOMOL SCREEN, V18, P1084, DOI 10.1177/1087057113491826; Shizu R, 2021, ARCH TOXICOL, V95, P1089, DOI 10.1007/s00204-020-02955-4; Shizu R, 2020, MOL PHARMACOL, V98, P634, DOI 10.1124/molpharm.120.000103; Sladek FM, 2011, MOL CELL ENDOCRINOL, V334, P3, DOI 10.1016/j.mce.2010.06.018; Squires EJ, 2004, J BIOL CHEM, V279, P49307, DOI 10.1074/jbc.M407281200; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Wallace BD, 2013, J MOL BIOL, V425, P2561, DOI 10.1016/j.jmb.2013.04.012; Wang WY, 2008, PROTEIN ENG DES SEL, V21, P425, DOI 10.1093/protein/gzn017; Wang YM, 2013, TOXICOL APPL PHARM, V272, P96, DOI 10.1016/j.taap.2013.05.014; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Watkins RE, 2003, J MOL BIOL, V331, P815, DOI 10.1016/S0022-2836(03)00795-2; Xu HE, 2002, NATURE, V415, P813, DOI 10.1038/415813a; Xue Y, 2007, MOL ENDOCRINOL, V21, P1028, DOI 10.1210/me.2006-0323	51	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100978	10.1016/j.jbc.2021.100978	http://dx.doi.org/10.1016/j.jbc.2021.100978			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34284062	Green Published, gold			2022-12-28	WOS:000706418900002
J	Okuda, S; Sato, M; Kato, S; Nagashima, S; Inatome, R; Yanagi, S; Fukuda, T				Okuda, Shohei; Sato, Mariko; Kato, Saho; Nagashima, Shun; Inatome, Ryoko; Yanagi, Shigeru; Fukuda, Toshifumi			Oscillation of Cdc20-APC/C-mediated CAMDI stability is critical for cortical neuron migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANAPHASE-PROMOTING COMPLEX; CYTOPLASMIC DILATION; RADIAL MIGRATION; MYOSIN-II; KEN BOX; CENTROSOME; PHOSPHORYLATION; IDENTIFICATION; NUCLEOKINESIS; REVEALS	Radial migration during cortical development is required for formation of the six-layered structure of the mammalian cortex. Defective migration of neurons is linked to several developmental disorders such as autism and schizophrenia. A unique swollen structure called the dilation is formed in migrating neurons and is required for movement of the centrosome and nucleus. However, the detailed molecular mechanism by which this dilation forms is unclear. We report that CAMDI, a gene whose deletion is associated with psychiatric behavior, is degraded by cell division cycle protein 20 (Cdc20)-anaphase-promoting complex/cyclosome (APC/C) cell-cycle machinery after centrosome migration into the dilation in mouse brain development. We also show that CAMDI is restabilized in the dilation until the centrosome enters the dilation, at which point it is once again immediately destabilized. CAMDI degradation is carried out by binding to Cdc20-APC/C via the destruction box degron of CAMDI. CAMDI destruction box mutant overexpression inhibits dilation formation and neuronal cell migration via maintaining the stabilized state of CAMDI. These results indicate that CAMDI is a substrate of the Cdc20-APC/C system and that the oscillatory regulation of CAMDI protein correlates with dilation formation for proper cortical migration.	[Okuda, Shohei; Sato, Mariko; Kato, Saho; Nagashima, Shun; Fukuda, Toshifumi] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan; [Inatome, Ryoko; Yanagi, Shigeru] Gakushuin Univ, Fac Sci, Dept Life Sci, Toshima Ku, Tokyo, Japan	Tokyo University of Pharmacy & Life Sciences; Gakushuin University	Fukuda, T (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Lab Mol Biochem, Hachioji, Tokyo, Japan.	tfukuda@toyaku.ac.jp		Fukuda, Toshifumi/0000-0003-2400-5319	Ministry of Education, Culture, Sports, Science, and Technology; Japan Society for the Promotion of Science; Takeda Science foundation	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science foundation(Takeda Science Foundation (TSF))	This work was supported in part by grants-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology and the Japan Society for the Promotion of Science (to T. F.). T. F. was supported by Takeda Science foundation.	Akbarian S, 1996, ARCH GEN PSYCHIAT, V53, P425; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Beckmann H, 1999, EUR ARCH PSY CLIN N, V249, P44; Bellion A, 2005, J NEUROSCI, V25, P5691, DOI 10.1523/JNEUROSCI.1030-05.2005; Burton JL, 2001, GENE DEV, V15, P2381, DOI 10.1101/gad.917901; Fukuda T, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0224967; Fukuda T, 2017, CELL MOL LIFE SCI, V74, P3533, DOI 10.1007/s00018-017-2539-4; Fukuda T, 2016, EMBO REP, V17, P1785, DOI 10.15252/embr.201642416; Fukuda T, 2010, J BIOL CHEM, V285, P40554, DOI 10.1074/jbc.M110.179481; Harley ME, 2010, EMBO J, V29, P2407, DOI 10.1038/emboj.2010.112; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Huang J, 2016, GENE DEV, V30, P622, DOI 10.1101/gad.274324.115; Hutchins BI, 2016, ENDOCRINOLOGY, V157, P1956, DOI 10.1210/en.2015-1846; Hutsler JJ, 2007, BIOL PSYCHIAT, V61, P449, DOI 10.1016/j.biopsych.2006.01.015; Kim AH, 2009, CELL, V136, P322, DOI 10.1016/j.cell.2008.11.050; KING RW, 1995, CELL, V81, P279, DOI 10.1016/0092-8674(95)90338-0; Konishi Y, 2004, SCIENCE, V303, P1026, DOI 10.1126/science.1093712; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lian GW, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00099; Nadarajah B, 2001, NAT NEUROSCI, V4, P143, DOI 10.1038/83967; Nakajima H, 2003, J BIOL CHEM, V278, P25277, DOI 10.1074/jbc.C300126200; Nishimura YV, 2014, DEVELOPMENT, V141, P3540, DOI 10.1242/dev.111294; Pfleger CM, 2000, GENE DEV, V14, P655; RAKIC P, 1990, EXPERIENTIA, V46, P882, DOI 10.1007/BF01939380; Renaud J, 2008, NAT NEUROSCI, V11, P440, DOI 10.1038/nn2064; Schaar BT, 2005, P NATL ACAD SCI USA, V102, P13652, DOI 10.1073/pnas.0506008102; Schenk J, 2009, P NATL ACAD SCI USA, V106, P16487, DOI 10.1073/pnas.0908928106; Shinohara R, 2012, NAT NEUROSCI, V15, P373, DOI 10.1038/nn.3020; Solecki DJ, 2009, NEURON, V63, P63, DOI 10.1016/j.neuron.2009.05.028; Trivedi N, 2017, NAT COMMUN, V8, P1, DOI 10.1038/ncomms14484; Trivedi N, 2014, NEURAL DEV, V9, DOI 10.1186/1749-8104-9-26; Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934; Tsai LH, 2005, NEURON, V46, P383, DOI 10.1016/j.neuron.2005.04.013; van de Weerdt BCM, 2005, MOL CELL BIOL, V25, P2031, DOI 10.1128/MCB.25.5.2031-2044.2005; van Vugt MATM, 2004, J BIOL CHEM, V279, P36841, DOI 10.1074/jbc.M313681200; Wegiel J, 2010, ACTA NEUROPATHOL, V119, P755, DOI 10.1007/s00401-010-0655-4; Yang T, 2012, CELL REP, V2, P640, DOI 10.1016/j.celrep.2012.08.007; Zachariae W, 1996, SCIENCE, V274, P1201, DOI 10.1126/science.274.5290.1201	38	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100986	10.1016/j.jbc.2021.100986	http://dx.doi.org/10.1016/j.jbc.2021.100986			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298015	gold, Green Published			2022-12-28	WOS:000690868100003
J	Gough, RE; Jones, MC; Zacharchenko, T; Le, S; Yu, M; Jacquemet, G; Muench, S; Yan, J; Humphries, JD; Jorgensen, C; Humphries, MJ; Goult, BT				Gough, Rosemarie E.; Jones, Matthew C.; Zacharchenko, Thomas; Le, Shimin; Yu, Miao; Jacquemet, Guillaume; Muench, Ste P.; Yan, Jie; Humphries, Jonathan D.; Jorgensen, Claus; Humphries, Martin J.; Goult, Benjamin T.			Talin mechanosensitivity is modulated by a direct interaction with cyclin-dependent kinase-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAXILLIN LD MOTIFS; ACTIN-BINDING; EXTRACELLULAR-MATRIX; INTEGRIN ADHESOME; VINCULIN-BINDING; CELL-DIVISION; RECOGNITION; PROTEIN; PHOSPHORYLATION; TRANSDUCTION	Talin (TLN1) is a mechanosensitive component of adhesion complexes that directly couples integrins to the actin cytoskeleton. In response to force, talin undergoes switch-like behavior of its multiple rod domains that modulate interactions with its binding partners. Cyclin-dependent kinase-1 (CDK1) is a key regulator of the cell cycle, exerting its effects through synchronized phosphorylation of a large number of protein targets. CDK1 activity maintains adhesion during interphase, and its inhibition is a prerequisite for the tightly choreographed changes in cell shape and adhesion that are required for successful mitosis. Using a combination of biochemical, structural, and cell biological approaches, we demonstrate a direct interaction between talin and CDK1 that occurs at sites of integrin-mediated adhesion. Mutagenesis demonstrated that CDK1 contains a functional talin-binding LD motif, and the binding site within talin was pinpointed to helical bundle R8. Talin also contains a consensus CDK1 phosphorylation motif centered on S1589, a site shown to be phosphorylated by CDK1 in vitro. A phosphomimetic mutant of this site within talin lowered the binding affinity of the cytoskeletal adaptor KANK and weakened the response of this region to force as measured by single molecule stretching, potentially altering downstream mechanotransduction pathways. The direct binding of the master cell cycle regulator CDK1 to the primary integrin effector talin represents a coupling of cell proliferation and cell adhesion machineries and thereby indicates a mechanism by which the microenvironment can control cell division in multicellular organisms.	[Gough, Rosemarie E.; Goult, Benjamin T.] Univ Kent, Sch Biosci, Canterbury, Kent, England; [Jones, Matthew C.; Zacharchenko, Thomas; Humphries, Jonathan D.; Humphries, Martin J.] Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Manchester, Lancs, England; [Le, Shimin; Yu, Miao; Yan, Jie] Natl Univ Singapore, Mechanobiol Inst, Singapore, Singapore; [Jacquemet, Guillaume] Abo Akad Univ, Fac Sci & Engn, Cell Biol Dept, Turku, Finland; [Jacquemet, Guillaume] Univ Turku, Turku Biosci Ctr, Turku, Finland; [Jacquemet, Guillaume] Abo Akad Univ, Turku, Finland; [Muench, Ste P.] Univ Leeds, Astbury Ctr Struct Biol, Sch Biomed Sci, Leeds, W Yorkshire, England; [Yan, Jie] Natl Univ Singapore, Dept Phys, Singapore, Singapore; [Jorgensen, Claus] Univ Manchester, Canc Res UK Manchester Inst, Manchester, Lancs, England	University of Kent; University of Manchester; National University of Singapore; Abo Akademi University; University of Turku; Abo Akademi University; University of Leeds; National University of Singapore; Cancer Research UK; University of Manchester	Goult, BT (corresponding author), Univ Kent, Sch Biosci, Canterbury, Kent, England.; Humphries, MJ (corresponding author), Univ Manchester, Manchester Acad Hlth Sci Ctr, Fac Biol Med & Hlth, Wellcome Ctr Cell Matrix Res, Manchester, Lancs, England.	martin.humphries@manchester.ac.uk; b.t.goult@kent.ac.uk	Humphries, Jonathan D./AAE-7760-2022; Goult, Benjamin T/B-3127-2009; Yan, Jie/G-2725-2012	Humphries, Jonathan D./0000-0002-8953-7079; Goult, Benjamin T/0000-0002-3438-2807; Yan, Jie/0000-0002-8555-7291; Gough, Rosemarie/0000-0002-5587-4683; Jacquemet, Guillaume/0000-0002-9286-920X; Le, Shimin/0000-0003-2359-1897; Jorgensen, Claus/0000-0002-7841-943X; Jones, Matthew/0000-0003-4723-3277	BBSRC [BB/N007336/1, BB/S007245/1]; HFSP [RGP00001/2016]; Cancer Research UK [C13329/A21671, A25236]; Cancer Research UK Institute Award [A19258]; Rosetrees Trust [M286]; European Research Council [ERC-2017COG 772577]; University of Kent studentship; Wellcome Trust ISSF Research Fellowship [204825/Z/16/Z]; Sigrid Juselius Foundation; Cancer Society of Finland; Abo Akademi University Research Foundation; Drug Discovery and Diagnostics strategic funding	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); HFSP(Human Frontier Science Program); Cancer Research UK(Cancer Research UK); Cancer Research UK Institute Award; Rosetrees Trust(Rosetrees Trust); European Research Council(European Research Council (ERC)European Commission); University of Kent studentship; Wellcome Trust ISSF Research Fellowship(Wellcome Trust); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Society of Finland; Abo Akademi University Research Foundation; Drug Discovery and Diagnostics strategic funding	B. T. G. was funded by BBSRC (BB/N007336/1 and BB/S007245/1) and HFSP (RGP00001/2016). M. J. H. and C. J. were funded by Cancer Research UK (C13329/A21671). C. J. is also funded by a Cancer Research UK Institute Award (A19258), Cancer Research UK (A25236), Rosetrees Trust (M286), and European Research Council (ERC-2017COG 772577). R. E. G. was funded by a University of Kent studentship. T. Z. is funded by a Wellcome Trust ISSF Research Fellowship (204825/Z/16/Z). G. J. was supported by grants from the Sigrid Juselius Foundation, the Cancer Society of Finland, and Abo Akademi University Research Foundation (G. J., CoE CellMech) and by Drug Discovery and Diagnostics strategic funding to Abo Akademi University (G. J.).	Alam T, 2014, BIOCHEM J, V460, P317, DOI 10.1042/BJ20140298; Anthis NJ, 2009, EMBO J, V28, P3623, DOI 10.1038/emboj.2009.287; Assoian RK, 1997, J CELL BIOL, V136, P1, DOI 10.1083/jcb.136.1.1; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Bian YY, 2014, J PROTEOMICS, V96, P253, DOI 10.1016/j.jprot.2013.11.014; Bouchet BP, 2016, ELIFE, V5, DOI 10.7554/eLife.18124; Brown MC, 1998, NAT STRUCT BIOL, V5, P677, DOI 10.1038/1370; Brown NR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7769; Cadart C, 2014, DEV CELL, V29, P159, DOI 10.1016/j.devcel.2014.04.009; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Chang YC, 2014, STRUCTURE, V22, P1810, DOI 10.1016/j.str.2014.09.020; Chastney MR, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.202003038; Chen H, 2011, BIOPHYS J, V100, P517, DOI 10.1016/j.bpj.2010.12.3700; Dao VT, 2009, J CELL SCI, V122, P2996, DOI 10.1242/jcs.041301; DESAI D, 1995, MOL CELL BIOL, V15, P345, DOI 10.1128/MCB.15.1.345; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fededa JP, 2012, NAT CELL BIOL, V14, P440, DOI 10.1038/ncb2482; Frisch SM, 1997, CURR OPIN CELL BIOL, V9, P701, DOI 10.1016/S0955-0674(97)80124-X; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Goedhart J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76603-3; Gough RE, 2018, FEBS LETT, V592, P2108, DOI 10.1002/1873-3468.13081; Goult BT, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.592951; Goult BT, 2018, J CELL BIOL, V217, P3776, DOI 10.1083/jcb.201808061; Goult BT, 2013, J BIOL CHEM, V288, P8238, DOI 10.1074/jbc.M112.438119; Haining AWM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005599; Han S. J., 2021, TALIN VINCULIN PRECO TALIN VINCULIN PRECO; Hemmings L, 1996, J CELL SCI, V109, P2715; Hoellerer MK, 2003, STRUCTURE, V11, P1207, DOI 10.1016/j.str.2003.08.010; Horton ER, 2016, EXP CELL RES, V343, P7, DOI 10.1016/j.yexcr.2015.10.025; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Humphries JD, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000396; Jones MC, 2018, J CELL BIOL, V217, P3203, DOI 10.1083/jcb.201802088; Khan RB, 2021, METHODS MOL BIOL, V2217, P115, DOI 10.1007/978-1-0716-0962-0_9; Kumar A, 2016, J CELL BIOL, V213, P371, DOI 10.1083/jcb.201510012; Kumar M, 2020, NUCLEIC ACIDS RES, V48, pD296, DOI 10.1093/nar/gkz1030; Lancaster OM, 2014, SEMIN CELL DEV BIOL, V34, P109, DOI 10.1016/j.semcdb.2014.02.015; Lancaster OM, 2013, DEV CELL, V25, P270, DOI 10.1016/j.devcel.2013.03.014; Le SM, 2016, METHODS, V94, P13, DOI 10.1016/j.ymeth.2015.08.020; Le SM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv554; Lesman A, 2014, J CELL BIOL, V205, P155, DOI 10.1083/jcb.201309029; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Marchesi S, 2014, DEV CELL, V31, P420, DOI 10.1016/j.devcel.2014.09.009; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McGrath DA, 2013, NAT STRUCT MOL BIOL, V20, P1407, DOI 10.1038/nsmb.2707; MEREDITH JE, 1993, MOL BIOL CELL, V4, P953, DOI 10.1091/mbc.4.9.953; Mertins P, 2016, NATURE, V534, P55, DOI 10.1038/nature18003; Mertins P, 2014, MOL CELL PROTEOMICS, V13, P1690, DOI 10.1074/mcp.M113.036392; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Robertson J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7265; Roux Kyle J, 2018, Curr Protoc Protein Sci, V91, DOI 10.1002/cpps.51; Roux KJ, 2012, J CELL BIOL, V196, P801, DOI 10.1083/jcb.201112098; Skinner SP, 2015, ACTA CRYSTALLOGR D, V71, P154, DOI 10.1107/S1399004714026662; Sun ZQ, 2016, NAT CELL BIOL, V18, P941, DOI 10.1038/ncb3402; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Thery M, 2005, NAT CELL BIOL, V7, P947, DOI 10.1038/ncb1307; Toyoshima F, 2007, J CELL PHYSIOL, V213, P407, DOI 10.1002/jcp.21227; Walker JL, 2005, CANCER METAST REV, V24, P383, DOI 10.1007/s10555-005-5130-7; Whitewood AJ, 2018, FEBS LETT, V592, P1751, DOI 10.1002/1873-3468.13074; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Yan J, 2015, CELL MOL BIOENG, V8, P151, DOI 10.1007/s12195-014-0364-5; Yang J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6880; Yao MX, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11966; Yuan GH, 2017, ANGEW CHEM INT EDIT, V56, P5490, DOI 10.1002/anie.201700411; Zacharchenko T, 2016, STRUCTURE, V24, P1130, DOI 10.1016/j.str.2016.04.016; Zakeri B, 2012, P NATL ACAD SCI USA, V109, pE690, DOI 10.1073/pnas.1115485109; Zhao XD, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa837e	70	12	12	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100837	10.1016/j.jbc.2021.100837	http://dx.doi.org/10.1016/j.jbc.2021.100837			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118235	Green Submitted, gold, Green Accepted, Green Published			2022-12-28	WOS:000678068400037
J	Ji, YC; Nie, ZP; Meng, FL; Hu, CF; Chen, H; Jin, LH; Chen, MQ; Zhang, ML; Zhang, JJ; Liang, M; Wang, M; Guan, MX				Ji, Yanchun; Nie, Zhipeng; Meng, Feilong; Hu, Cuifang; Chen, Hui; Jin, Lihao; Chen, Mengquan; Zhang, Minglian; Zhang, Juanjuan; Liang, Min; Wang, Meng; Guan, Min-Xin			Mechanistic insights into mitochondrial tRNA(Ala) 3 '-end metabolism deficiency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY OPTIC NEUROPATHY; TRANSFER-RNA SYNTHETASE; HAN CHINESE SUBJECTS; 12S RIBOSOMAL-RNA; MUTATION ALTERS; DNA MUTATION; PHENOTYPIC MANIFESTATION; M(1)G37 MODIFICATION; DISCRIMINATOR BASE; OXIDATIVE STRESS	Mitochondrial tRNA 3'-end metabolism is critical for the formation of functional tRNAs. Deficient mitochondrial tRNA 3'-end metabolism is linked to an array of human diseases, including optic neuropathy, but their pathophysiology remains poorly understood. In this report, we investigated the molecular mechanism underlying the Leber's hereditary optic neuropathy (LHON)-associated tRNA(Ala) 5587A>G mutation, which changes a highly conserved adenosine at position 73 (A73) to guanine (G73) on the 3'-end of the tRNA acceptor stem. The m.5587A>G mutation was identified in three Han Chinese families with suggested maternal inheritance of LHON. We hypothesized that the m.5587A>G mutation altered tRNA(Ala) 3'end metabolism and mitochondrial function. In vitro processing experiments showed that the m.5587A>G mutation impaired the 3'-end processing of tRNAAla precursors by RNase Z and inhibited the addition of CCA by tRNA nucleotidyltransferase (TRNT1). Northern blot analysis revealed that the m.5587A>G mutation perturbed tRNA(Ala) aminoacylation, as evidenced by decreased efficiency of aminoacylation and faster electrophoretic mobility of mutated tRNA(Ala) in these cells. The impact of m.5587A>G mutation on tRNA(Ala) function was further supported by increased melting temperature, conformational changes, and reduced levels of this tRNA. Failures in tRNA(Ala) metabolism impaired mitochondrial translation, perturbed assembly and activity of oxidative phosphorylation complexes, diminished ATP production and membrane potential, and increased production of reactive oxygen species. These pleiotropic defects elevated apoptotic cell death and promoted mitophagy in cells carrying the m.5587A>G mutation, thereby contributing to visual impairment. Our findings may provide new insights into the pathophysiology of LHON arising from mitochondrial tRNA 3'-end metabolism deficiency.	[Ji, Yanchun; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Div Med Genet & Genom, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Ji, Yanchun; Meng, Feilong; Wang, Meng; Guan, Min-Xin] Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China; [Ji, Yanchun; Nie, Zhipeng; Meng, Feilong; Hu, Cuifang; Chen, Hui; Jin, Lihao; Wang, Meng; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Hu, Cuifang; Zhang, Juanjuan; Liang, Min] Wenzhou Med Univ, Sch Ophthalmol & Optometry, Wenzhou, Zhejiang, Peoples R China; [Chen, Mengquan] Wenzhou Hosp Tradit Chinese Med, Dept Lab Med, Wenzhou, Zhejiang, Peoples R China; [Zhang, Minglian] Hebei Prov Eye Hosp, Dept Ophthalmol, Xingtai, Hebei, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Ctr Mitochondrial Genet, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Joint Inst Genet & Genome Med, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Univ Toronto, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Wenzhou Medical University; Zhejiang University; Zhejiang University; University of Toronto	Guan, MX (corresponding author), Zhejiang Univ, Div Med Genet & Genom, Childrens Hosp, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Ctr Mitochondrial Genet, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Joint Inst Genet & Genome Med, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Univ Toronto, Hangzhou, Zhejiang, Peoples R China.	gminxin88@zju.edu.cn	Zhang, Juan/GRX-2638-2022		National Natural Science Foundation of China [31970557, 82071007]; National Key research and Development Program [2018YFC1004802]; Zhejiang Provincial Public Welfare Technology Applied Research Projects [LGF21C060001]; Zhejiang Provincial Traditional Chinese Medicine Research Projects [2019ZB072]; Zhejiang Provincial Natural Science Foundation of China [LY19H130005, LY20C060003]; Zhejiang Provincial Health Technology Project Commission [2019RC200]; Wenzhou Science and Technology Bureau [Y20190067]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key research and Development Program; Zhejiang Provincial Public Welfare Technology Applied Research Projects; Zhejiang Provincial Traditional Chinese Medicine Research Projects; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Zhejiang Provincial Health Technology Project Commission; Wenzhou Science and Technology Bureau	This work was supported by grants from the National Natural Science Foundation of China (31970557, 82071007); the National Key research and Development Program (2018YFC1004802), Zhejiang Provincial Public Welfare Technology Applied Research Projects (LGF21C060001) and Zhejiang Provincial Traditional Chinese Medicine Research Projects (2019ZB072), Zhejiang Provincial Natural Science Foundation of China (LY19H130005 and LY20C060003), Zhejiang Provincial Health Technology Project Commission (2019RC200), and Wenzhou Science and Technology Bureau (Y20190067). We thank Ms Jiji Sun's technical assistance.	Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Anding AL, 2017, DEV CELL, V41, P10, DOI 10.1016/j.devcel.2017.02.016; Birch-Machin MA, 2001, METHOD CELL BIOL, V65, P97, DOI 10.1016/S0091-679X(01)65006-4; Bohnsack MT, 2018, CELL MOL LIFE SCI, V75, P241, DOI 10.1007/s00018-017-2598-6; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Chomyn A, 2000, J BIOL CHEM, V275, P19198, DOI 10.1074/jbc.M908734199; Country MW, 2017, BRAIN RES, V1672, P50, DOI 10.1016/j.brainres.2017.07.025; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; Torres AG, 2019, P NATL ACAD SCI USA, V116, P8451, DOI 10.1073/pnas.1821120116; Gamper H, 2018, RNA, V24, P1878, DOI 10.1261/rna.068015.118; Giege R, 1998, NUCLEIC ACIDS RES, V26, P5017, DOI 10.1093/nar/26.22.5017; Gong SS, 2020, J BIOL CHEM, V295, P940, DOI 10.1074/jbc.RA119.010998; Gong SS, 2014, NUCLEIC ACIDS RES, V42, P8039, DOI 10.1093/nar/gku466; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Guan MX, 1998, MOL CELL BIOL, V18, P5868, DOI 10.1128/MCB.18.10.5868; Hou YM, 2010, IUBMB LIFE, V62, P251, DOI 10.1002/iub.301; Ibba M, 2000, ANNU REV BIOCHEM, V69, P617, DOI 10.1146/annurev.biochem.69.1.617; Jha Pooja, 2016, Curr Protoc Mouse Biol, V6, P1, DOI 10.1002/9780470942390.mo150182; Ji YC, 2020, J BIOL CHEM, V295, P13224, DOI 10.1074/jbc.RA120.014603; Ji YC, 2019, HUM MOL GENET, V28, P1515, DOI 10.1093/hmg/ddy450; Ji YC, 2017, MOL MED REP, V16, P8997, DOI 10.3892/mmr.2017.7734; Ji YC, 2016, INVEST OPHTH VIS SCI, V57, P2377, DOI 10.1167/iovs.16-19243; Jia ZD, 2019, NUCLEIC ACIDS RES, V47, P2056, DOI 10.1093/nar/gky1241; Jiang PP, 2016, MOL CELL BIOL, V36, P1920, DOI 10.1128/MCB.00199-16; Jiang PP, 2016, HUM MOL GENET, V25, P584, DOI 10.1093/hmg/ddv498; Jiang PP, 2015, INVEST OPHTH VIS SCI, V56, P4778, DOI 10.1167/iovs.14-16158; Jin X., 2021, J BIOL CHEM, V296; King M P, 1996, Methods Enzymol, V264, P313, DOI 10.1016/S0076-6879(96)64030-0; KING MP, 1993, J BIOL CHEM, V268, P10228; Korolchuk VI, 2009, AUTOPHAGY, V5, P862, DOI 10.4161/auto.8840; Kuhle B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14725-y; Lee J, 2012, BIOCHEM J, V441, P523, DOI 10.1042/BJ20111451; Levinger L, 2004, NUCLEIC ACIDS RES, V32, P5430, DOI 10.1093/nar/gkh884; Levinger L, 2003, NUCLEIC ACIDS RES, V31, P1904, DOI 10.1093/nar/gkg282; Levinger L, 2012, RNA BIOL, V9, P283, DOI 10.4161/rna.19025; Liang M, 2014, INVEST OPHTH VIS SCI, V55, P1321, DOI 10.1167/iovs.13-13011; Lovato MA, 2001, EMBO J, V20, P4846, DOI 10.1093/emboj/20.17.4846; Ma YY, 2013, J CLIN NEUROSCI, V20, P1591, DOI 10.1016/j.jocn.2013.03.034; Mahfouz R, 2009, FERTIL STERIL, V92, P819, DOI 10.1016/j.fertnstert.2008.05.087; Melser S, 2015, BBA-MOL CELL RES, V1853, P2812, DOI 10.1016/j.bbamcr.2015.05.010; Meng FL, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1225; Meng FL, 2018, J BIOL CHEM, V293, P3321, DOI 10.1074/jbc.RA117.000530; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; Miao ZC, 2017, ANNU REV BIOPHYS, V46, P483, DOI 10.1146/annurev-biophys-070816-034125; MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200; Nagan MC, 2000, NUCLEIC ACIDS RES, V28, P2527, DOI 10.1093/nar/28.13.2527; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Pearce SF, 2017, TRENDS BIOCHEM SCI, V42, P625, DOI 10.1016/j.tibs.2017.02.003; Peng GX, 2021, NUCLEIC ACIDS RES, V49, P2816, DOI 10.1093/nar/gkab104; Phizicky EM, 2010, GENE DEV, V24, P1832, DOI 10.1101/gad.1956510; Qu J, 2006, INVEST OPHTH VIS SCI, V47, P475, DOI 10.1167/iovs.05-0665; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Reers M, 1995, METHOD ENZYMOL, V260, P406, DOI 10.1016/0076-6879(95)60154-6; Reinhard L, 2017, NUCLEIC ACIDS RES, V45, P12469, DOI 10.1093/nar/gkx902; Salinas-Giege T, 2015, INT J MOL SCI, V16, P4518, DOI 10.3390/ijms16034518; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Sasarman F, 2015, HUM MOL GENET, V24, P2841, DOI 10.1093/hmg/ddv044; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Scheffler I, 2015, J INHERIT METAB DIS, V38, P405, DOI 10.1007/s10545-014-9768-6; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Slade A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113780; Song LY, 2017, BRAIN RES, V1657, P232, DOI 10.1016/j.brainres.2016.12.019; Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Van Haute L, 2015, J INHERIT METAB DIS, V38, P655, DOI 10.1007/s10545-015-9859-z; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WALLACE DC, 1988, SCIENCE, V242, P1427, DOI 10.1126/science.3201231; Wallace DC, 2017, HANDB EXP PHARMACOL, V240, P339, DOI 10.1007/164_2017_2; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Wang M, 2013, BIOCHEM J, V453, P455, DOI 10.1042/BJ20130294; Wang SW, 2011, CIRC RES, V108, P862, DOI 10.1161/CIRCRESAHA.110.231811; Wedatilake Y, 2016, ORPHANET J RARE DIS, V11, DOI 10.1186/s13023-016-0477-0; Wende S, 2015, NUCLEIC ACIDS RES, V43, P5617, DOI 10.1093/nar/gkv471; Wong A, 2002, HUM MOL GENET, V11, P431, DOI 10.1093/hmg/11.4.431; Wong-Riley M, 2010, EYE BRAIN, V2, P99; Xiao Y, 2020, NUCLEIC ACIDS RES, V48, P11113, DOI 10.1093/nar/gkaa860; Xue L, 2016, MITOCHONDRION, V30, P208, DOI 10.1016/j.mito.2016.08.008; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Youle RJ, 2011, NAT REV MOL CELL BIO, V12, P9, DOI 10.1038/nrm3028; Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965; Zeng QY, 2019, NUCLEIC ACIDS RES, V47, P3072, DOI 10.1093/nar/gkz078; Zhang JJ, 2018, HUM MOL GENET, V27, P1999, DOI 10.1093/hmg/ddy107; Zhang QH, 2021, NUCLEIC ACIDS RES, V49, P4689, DOI 10.1093/nar/gkab228; Zhao XX, 2019, NUCLEIC ACIDS RES, V47, P10340, DOI 10.1093/nar/gkz742; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317; Zhu YS, 2014, METHOD ENZYMOL, V547, P39, DOI 10.1016/B978-0-12-801415-8.00003-5	96	9	9	5	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100816	10.1016/j.jbc.2021.100816	http://dx.doi.org/10.1016/j.jbc.2021.100816			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023389	Green Published, gold			2022-12-28	WOS:000678068400019
J	Strobel, EJ				Strobel, Eric J.			Preparation of E. coli RNA polymerase transcription elongation complexes by selective photoelution from magnetic beads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; IN-VITRO; BACTERIAL; MECHANISM; PROMOTER; DNA; INITIATION; DOMAIN	In vitro studies of transcription frequently require the preparation of defined elongation complexes. Defined transcription elongation complexes (TECs) are typically prepared by constructing an artificial transcription bubble from synthetic oligonucleotides and RNA polymerase. This approach is optimal for diverse applications but is sensitive to nucleic acid length and sequence and is not compatible with systems where promoter-directed initiation or extensive transcription elongation is crucial. To complement scaffold-directed approaches for TEC assembly, I have developed a method for preparing promoter-initiated Escherichia coli TECs using a purification strategy called selective photoelution. This approach combines TEC-dependent sequestration of a biotin-triethylene glycol transcription stall site with photoreversible DNA immobilization to enrich TECs from an in vitro transcription reaction. I show that selective photoelution can be used to purify TECs that contain a 273-bp DNA template and 194-nt structured RNA. Selective photoelution is a straightforward and robust procedure that, in the systems assessed here, generates precisely positioned TECs with >95% purity and >30% yield. TECs prepared by selective photoelution can contain complex nucleic acid sequences and will therefore likely be useful for investigating RNA structure and function in the context of RNA polymerases.	[Strobel, Eric J.] Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Strobel, EJ (corresponding author), Univ Buffalo, Dept Biol Sci, Buffalo, NY 14260 USA.	estrobel@buffalo.edu		Strobel, Eric/0000-0002-7082-2881	University at Buffalo; Arnold O. Beckman postdoctoral fellowship; Cornell University Genomics Innovation Hub Seed Grant	University at Buffalo; Arnold O. Beckman postdoctoral fellowship; Cornell University Genomics Innovation Hub Seed Grant	This work was supported by start-up funding from the University at Buffalo (to E. J. S.), an Arnold O. Beckman postdoctoral fellowship (to E. J. S.), and a Cornell University Genomics Innovation Hub Seed Grant (to John T. Lis and E. J. S.).	Artsimovitch I, 2009, METHODS, V47, P37, DOI 10.1016/j.ymeth.2008.10.006; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; CARPOUSIS AJ, 1980, BIOCHEMISTRY-US, V19, P3245, DOI 10.1021/bi00555a023; DAUBE SS, 1992, SCIENCE, V258, P1320, DOI 10.1126/science.1280856; Estrem ST, 1999, GENE DEV, V13, P2134, DOI 10.1101/gad.13.16.2134; Guo XY, 2018, MOL CELL, V69, P816, DOI 10.1016/j.molcel.2018.02.008; Hein PP, 2014, NAT STRUCT MOL BIOL, V21, P794, DOI 10.1038/nsmb.2867; Henderson KL, 2017, P NATL ACAD SCI USA, V114, pE3032, DOI 10.1073/pnas.1618675114; Johnston D. E., 1976, ABORTIVE INITIATION; Kang JY, 2018, MOL CELL, V69, P802, DOI 10.1016/j.molcel.2018.01.018; Kim PB, 2015, MOL CELL, V57, P317, DOI 10.1016/j.molcel.2015.01.001; Komissarova N, 2003, METHOD ENZYMOL, V371, P233; Krupp F, 2019, MOL CELL, V74, P143, DOI 10.1016/j.molcel.2019.01.016; Kubori T, 1996, J MOL BIOL, V256, P449, DOI 10.1006/jmbi.1996.0100; Makinen JJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21005-w; Mishanina TV, 2017, P NATL ACAD SCI USA, V114, pE5103, DOI 10.1073/pnas.1702383114; OLEJNIK J, 1995, P NATL ACAD SCI USA, V92, P7590, DOI 10.1073/pnas.92.16.7590; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Ruff EF, 2015, J MOL BIOL, V427, P2435, DOI 10.1016/j.jmb.2015.05.024; Said N, 2021, SCIENCE, V371, P44, DOI 10.1126/science.abd1673; Said N, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.62; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Strobel EJ, 2020, J BIOL CHEM, V295, P6401, DOI 10.1074/jbc.RA120.012641; Strobel EJ, 2019, NAT CHEM BIOL, V15, P1067, DOI 10.1038/s41589-019-0382-7; Vassylyev DG, 2007, NATURE, V448, P163, DOI 10.1038/nature05931; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vos SM, 2018, NATURE, V560, P607, DOI 10.1038/s41586-018-0440-4; Vos SM, 2018, NATURE, V560, P601, DOI 10.1038/s41586-018-0442-2; Wang CY, 2020, SCIENCE, V369, P1359, DOI 10.1126/science.abb5317; Widom JR, 2018, MOL CELL, V72, P541, DOI 10.1016/j.molcel.2018.08.046; YARNELL WS, 1992, CELL, V69, P1181, DOI 10.1016/0092-8674(92)90639-T; Yin Z, 2019, P NATL ACAD SCI USA, V116, P18384, DOI 10.1073/pnas.1909801116; Zhang JW, 2016, TRENDS BIOCHEM SCI, V41, P293, DOI 10.1016/j.tibs.2015.12.009; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhang SY, 2021, SCIENCE, V371, P305, DOI 10.1126/science.abf1870	35	5	5	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100812	10.1016/j.jbc.2021.100812	http://dx.doi.org/10.1016/j.jbc.2021.100812			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023383	Green Published, gold			2022-12-28	WOS:000678068400015
J	Telek, E; Karadi, K; Kardos, J; Kengyel, A; Fekete, Z; Halasz, H; Nyitrai, M; Bugyi, B; Lukacs, A				Telek, Elek; Karadi, Kristof; Kardos, Jozsef; Kengyel, Andras; Fekete, Zsuzsanna; Halasz, Henriett; Nyitrai, Miklos; Bugyi, Beata; Lukacs, Andras			The C-terminal tail extension of myosin 16 acts as a molten globule, including intrinsically disordered regions, and interacts with the N-terminal ankyrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL ANTHOLOGY; PROTEIN-STRUCTURE; FLUORESCENCE; PREDICTION; SEQUENCE; STATE; DYNAMICS; SPECTRA; BINDING; DOMAIN	The lesser-known unconventional myosin 16 protein is essential in proper neuronal functioning and has been implicated in cell cycle regulation. Its longer Myo16b isoform contains a C-terminal tail extension (Myo16Tail), which has been shown to play a role in the neuronal phosphoinositide 3-kinase signaling pathway. Myo16Tail mediates the actin cytoskeleton remodeling, downregulates the actin dynamics at the postsynaptic site of dendritic spines, and is involved in the organization of the presynaptic axon terminals. However, the functional and structural features of this C-terminal tail extension are not well known. Here, we report the purification and biophysical characterization of the Myo16Tail by bioinformatics, fluorescence spectroscopy, and CD. Our results revealed that the Myo16Tail is functionally active and interacts with the N-terminal ankyrin domain of myosin 16, suggesting an intramolecular binding between the C and N termini of Myo16 as an autoregulatory mechanism involving backfolding of the motor domain. In addition, the Myo16Tail possesses high structural flexibility and a solvent-exposed hydrophobic core, indicating the largely unstructured, intrinsically disordered nature of this protein region. Some secondary structure elements were also observed, indicating that the Myo16Tail likely adopts a molten globule-like structure. These structural features imply that the Myo16Tail may function as a flexible display site particularly relevant in post-translational modifications, regulatory functions such as backfolding, and phosphoinositide 3-kinase signaling.	[Telek, Elek; Karadi, Kristof; Kengyel, Andras; Fekete, Zsuzsanna; Halasz, Henriett; Nyitrai, Miklos; Bugyi, Beata; Lukacs, Andras] Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary; [Telek, Elek; Kengyel, Andras; Halasz, Henriett; Nyitrai, Miklos; Lukacs, Andras] MTA PTE Nucl Mitochondrial Interact Res Grp, Pecs, Hungary; [Karadi, Kristof; Kengyel, Andras; Nyitrai, Miklos; Bugyi, Beata; Lukacs, Andras] Szentogothai Res Ctr, Pecs, Hungary; [Kardos, Jozsef] Eotvos Lorand Univ, Inst Biol, Dept Biochem, Budapest, Hungary	University of Pecs; Eotvos Lorand University	Bugyi, B; Lukacs, A (corresponding author), Univ Pecs, Med Sch, Dept Biophys, Pecs, Hungary.; Lukacs, A (corresponding author), MTA PTE Nucl Mitochondrial Interact Res Grp, Pecs, Hungary.; Bugyi, B; Lukacs, A (corresponding author), Szentogothai Res Ctr, Pecs, Hungary.	beata.bugyi@aok.pte.hu; andras.lukacs@aok.pte.hu	Kardos, József/J-1035-2017	Kardos, József/0000-0002-2135-2932; Lukacs, Andras/0000-0001-8841-9823; Bugyi, Beata/0000-0003-4181-3633; Telek, Elek/0000-0003-0396-4799	OTKA [K 120391, KH 125597]	OTKA(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA))	J. K. was supported by OTKA K 120391 and KH 125597.	Ball LJ, 2005, ANGEW CHEM INT EDIT, V44, P2852, DOI 10.1002/anie.200400618; Batters C, 2016, TRAFFIC, V17, P860, DOI 10.1111/tra.12400; Batters C, 2016, P NATL ACAD SCI USA, V113, pE1162, DOI 10.1073/pnas.1519435113; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Bodis E, 2013, J PHOTOCH PHOTOBIO B, V129, P108, DOI 10.1016/j.jphotobiol.2013.10.004; Bugyi B, 2020, ADV EXP MED BIOL, V1239, P405, DOI 10.1007/978-3-030-38062-5_18; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Cameron RS, 2007, CELL MOTIL CYTOSKEL, V64, P19, DOI 10.1002/cm.20162; Cilia E, 2014, NUCLEIC ACIDS RES, V42, pW264, DOI 10.1093/nar/gku270; Cilia E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3741; Coluccio L. M, 2020, SERIES ADV EXPT MED, V2nd; CONSLER TG, 1991, BIOCHEMISTRY-US, V30, P1291, DOI 10.1021/bi00219a019; DeForte S, 2016, MOLECULES, V21, DOI 10.3390/molecules21081090; Dijkstra DS, 1997, BIOCHEMISTRY-US, V36, P4860, DOI 10.1021/bi9629081; Dijkstra M, 2018, MOL PHYS, V116, P3173, DOI 10.1080/00268976.2018.1496290; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2018, PROTEIN SCI, V27, P331, DOI 10.1002/pro.3334; Dunker A K, 1998, Pac Symp Biocomput, P473; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Foth BJ, 2006, P NATL ACAD SCI USA, V103, P3681, DOI 10.1073/pnas.0506307103; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Geeves MA, 2005, ADV PROTEIN CHEM, V71, P161, DOI 10.1016/S0065-3233(04)71005-0; GOMORI G, 1955, METHOD ENZYMOL, V1, P138, DOI 10.1016/0076-6879(55)01020-3; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; HARRINGTON WF, 1984, ANNU REV BIOCHEM, V53, P35, DOI 10.1146/annurev.bi.53.070184.000343; Hartman MA, 2011, ANNU REV CELL DEV BI, V27, P133, DOI 10.1146/annurev-cellbio-100809-151502; HEYDUK T, 1990, P NATL ACAD SCI USA, V87, P1744, DOI 10.1073/pnas.87.5.1744; Hild G, 2010, CYTOSKELETON, V67, P609, DOI 10.1002/cm.20473; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Iakoucheva LM, 2004, NUCLEIC ACIDS RES, V32, P1037, DOI 10.1093/nar/gkh253; Judy Eva, 2019, Biophys Rev, V11, P365, DOI 10.1007/s12551-019-00527-0; KABSCH W, 1990, NATURE, V347, P37, DOI 10.1038/347037a0; Kao CF, 2016, INT J NEUROPSYCHOPH, V19, DOI 10.1093/ijnp/pyw064; Kengyel A, 2015, EUR BIOPHYS J BIOPHY, V44, P207, DOI 10.1007/s00249-015-1015-z; Krendel M, 2005, PHYSIOLOGY, V20, P239, DOI 10.1152/physiol.00014.2005; Kriwacki RW, 1996, P NATL ACAD SCI USA, V93, P11504, DOI 10.1073/pnas.93.21.11504; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P954, DOI DOI 10.1007/978-0-387-46312-4; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu YZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116792; Lobato L, 2014, J BIOL CHEM, V289, P26514, DOI 10.1074/jbc.M114.571398; Lucas TG, 2019, METHODS MOL BIOL, V1873, P255, DOI 10.1007/978-1-4939-8820-4_16; Matyus L, 2006, J PHOTOCH PHOTOBIO B, V83, P223, DOI 10.1016/j.jphotobiol.2005.12.017; Mendes L. F. S., 2016, SCI REP-UK, V6, P1; Meszaros B, 2018, NUCLEIC ACIDS RES, V46, pW329, DOI 10.1093/nar/gky384; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Milton DL, 2011, P NATL ACAD SCI USA, V108, P1421, DOI 10.1073/pnas.1011784108; Munton RP, 2004, FEBS LETT, V567, P121, DOI 10.1016/j.febslet.2004.03.121; NAGY B, 1972, ARCH BIOCHEM BIOPHYS, V150, P428, DOI 10.1016/0003-9861(72)90059-8; Neyroz Paolo, 2012, Methods Mol Biol, V896, P197, DOI 10.1007/978-1-4614-3704-8_12; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nyitrai M, 1997, BIOPHYS J, V73, P2023, DOI 10.1016/S0006-3495(97)78232-8; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; Obradovic Z, 2005, PROTEINS, V61, P176, DOI 10.1002/prot.20735; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Patel KG, 2001, J NEUROSCI, V21, P7954; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Pinter R, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.575077; PTITSYN OB, 1994, FEBS LETT, V341, P15, DOI 10.1016/0014-5793(94)80231-9; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Reshetnyak YK, 2001, BIOPHYS J, V81, P1735, DOI 10.1016/S0006-3495(01)75825-0; Rodriguez-Murillo L, 2014, NEUROPSYCHOPHARMACOL, V39, P934, DOI 10.1038/npp.2013.293; Roesler MK, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00330; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; ROSS JBA, 2007, METHODS PROTEIN STRU, P55; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Scholey JM, 2003, NATURE, V422, P746, DOI 10.1038/nature01599; Schulz GE, 1979, MOL MECH BIOL RECOGN, P79; Sellers JR, 2000, BBA-MOL CELL RES, V1496, P3, DOI 10.1016/S0167-4889(00)00005-7; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Smialowski P, 2012, FEBS J, V279, P2192, DOI 10.1111/j.1742-4658.2012.08603.x; Somogyi B., 2007, METHODS PROTEIN STRU, P153; Telek E, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081903; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Toth MA, 2016, J BIOL CHEM, V291, P667, DOI 10.1074/jbc.M115.683904; Turoverov KK, 2003, J FLUORESC, V13, P41, DOI 10.1023/A:1022366816812; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Uversky VN, 2008, ANNU REV BIOPHYS, V37, P215, DOI 10.1146/annurev.biophys.37.032807.125924; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 1996, FOLD DES, V1, P117, DOI 10.1016/S1359-0278(96)00020-X; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; van der Lee R, 2014, CHEM REV, V114, P6589, DOI 10.1021/cr400525m; Vig AT, 2017, J BIOL CHEM, V292, P13566, DOI 10.1074/jbc.M117.799247; Vucetic S, 2007, J PROTEOME RES, V6, P1899, DOI 10.1021/pr060393m; Wang F, 2004, J BIOL CHEM, V279, P2333, DOI 10.1074/jbc.C300488200; Xie HB, 2007, J PROTEOME RES, V6, P1917, DOI 10.1021/pr060394e; XIE X, 1994, NATURE, V368, P306, DOI 10.1038/368306a0; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang Y, 2009, P NATL ACAD SCI USA, V106, P4189, DOI 10.1073/pnas.0808682106; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534; Yokoyama K, 2011, EMBO J, V30, P4739, DOI 10.1038/emboj.2011.348; Yumura S, 2003, INT REV CYTOL, V224, P173, DOI 10.1016/S0074-7696(05)24005-6	95	1	1	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100716	10.1016/j.jbc.2021.100716	http://dx.doi.org/10.1016/j.jbc.2021.100716			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	33930467	gold, Green Published			2022-12-28	WOS:000678068400002
J	Vogt, MS; Nguepbeu, RRN; Mohr, MKF; Albers, SV; Essen, LO; Banerjee, A				Vogt, Marian S.; Nguepbeu, Roi R. Ngouoko; Mohr, Michael K. F.; Albers, Sonja-Verena; Essen, Lars-Oliver; Banerjee, Ankan			The archaeal triphosphate tunnel metalloenzyme SaTTM defines structural determinants for the diverse activities in the CYTH protein family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IV ADENYLYL-CYCLASE; INORGANIC POLYPHOSPHATE; RNA TRIPHOSPHATASE; MECHANISM; SIMILARITIES; SUPERFAMILY; CATALYSIS; GENE	CYTH proteins make up a large superfamily that is conserved in all three domains of life. These enzymes have a triphosphate tunnel metalloenzyme (TTM) fold, which typically results in phosphatase functions, e.g., RNA triphosphatase, inorganic polyphosphatase, or thiamine triphosphatase. Some CYTH orthologs cyclize nucleotide triphosphates to 30,50-cyclic nucleotides. So far, archaeal CYTH proteins have been annotated as adenylyl cyclases, although experimental evidence to support these annotations is lacking. To address this gap, we characterized a CYTH ortholog, SaTTM, from the crenarchaeote Sulfolobus acidocaldarius. Our in silico studies derived ten major subclasses within the CYTH family implying a close relationship between these archaeal CYTH enzymes and class IV adenylyl cyclases. However, initial biochemical characterization reveals inability of SaTTM to produce any cyclic nucleotides. Instead, our structural and functional analyses show a classical TTM behavior, i.e., triphosphatase activity, where pyrophosphate causes product inhibition. The Ca2+-inhibited Michaelis complex indicates a two-metal-ion reaction mechanism analogous to other TTMs. Cocrystal structures of SaTTM further reveal conformational dynamics in SaTTM that suggest feedback inhibition in TTMs due to tunnel closure in the product state. These structural insights combined with further sequence similarity network-based in silico analyses provide a firm molecular basis for distinguishing CYTH orthologs with phosphatase activities from class IV adenylyl cyclases.	[Vogt, Marian S.; Nguepbeu, Roi R. Ngouoko; Essen, Lars-Oliver; Banerjee, Ankan] Philipps Univ Marburg, Dept Chem, Marburg, Germany; [Mohr, Michael K. F.] Albert Ludwigs Univ Freiburg, Inst Pharmaceut Sci, Freiburg, Germany; [Albers, Sonja-Verena] Albert Ludwigs Univ Freiburg, Inst Biol 2, Mol Biol Archaea, Freiburg, Germany; [Essen, Lars-Oliver] Philipps Univ Marburg, Ctr Synthet Microbiol, Marburg, Germany; [Banerjee, Ankan] Philipps Univ Marburg, Dept Genet, Marburg, Germany	Philipps University Marburg; University of Freiburg; University of Freiburg; Philipps University Marburg; Philipps University Marburg	Essen, LO; Banerjee, A (corresponding author), Philipps Univ Marburg, Dept Chem, Marburg, Germany.; Essen, LO (corresponding author), Philipps Univ Marburg, Ctr Synthet Microbiol, Marburg, Germany.; Banerjee, A (corresponding author), Philipps Univ Marburg, Dept Genet, Marburg, Germany.	essen@chemie.uni-marburg.de; banerjee@staff.uni-marburg.de	; /A-5520-2016	Vogt, Marian/0000-0002-9867-3603; Albers, Sonja-Verena/0000-0003-2459-2226; /0000-0002-1791-252X	Volkswagen Foundation [Az96727]; Deutsche Forschungsgemeinschaft [447817670, SFB 987]	Volkswagen Foundation(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft SFB 987 (Collaborative Research Center 987) and Volkswagen Foundation (Az96727) to L.-O. E., M. S. V., and S.-V. A. A. B. was funded by the Deutsche Forschungsgemeinschaft (447817670).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Albers SV, 2003, J BACTERIOL, V185, P3918, DOI 10.1128/JB.185.13.3918-3925.2003; Baumann A, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-21; Bettendorff L, 2013, FEBS J, V280, P6443, DOI 10.1111/febs.12498; Brown MRW, 2004, P NATL ACAD SCI USA, V101, P16085, DOI 10.1073/pnas.0406909101; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Delvaux D, 2013, BBA-GEN SUBJECTS, V1830, P4513, DOI 10.1016/j.bbagen.2013.05.014; Delvaux D, 2011, J BIOL CHEM, V286, P34023, DOI 10.1074/jbc.M111.233585; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gallagher DT, 2006, J MOL BIOL, V362, P114, DOI 10.1016/j.jmb.2006.07.008; Gallagher DT, 2011, J MOL BIOL, V405, P787, DOI 10.1016/j.jmb.2010.11.026; Gerlt JA, 2015, BBA-PROTEINS PROTEOM, V1854, P1019, DOI 10.1016/j.bbapap.2015.04.015; Gong CL, 2006, RNA, V12, P1468, DOI 10.1261/rna.119806; Iyer LM, 2002, BMC GENOMICS, V3, DOI 10.1186/1471-2164-3-33; Jain Ruchi, 2008, J Biol Chem, V283, P31047, DOI 10.1074/jbc.M805392200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Keppetipola N, 2007, J BIOL CHEM, V282, P11941, DOI 10.1074/jbc.M611328200; Khannpnavar B, 2020, CURR OPIN STRUC BIOL, V63, P34, DOI 10.1016/j.sbi.2020.03.003; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEICHTLING BH, 1986, BIOCHEM BIOPH RES CO, V136, P1078, DOI 10.1016/0006-291X(86)90443-2; Li LY, 2007, J PROTEOME RES, V6, P759, DOI 10.1021/pr060383l; Lima CD, 1999, CELL, V99, P533, DOI 10.1016/S0092-8674(00)81541-X; Linder JU, 2006, CELL MOL LIFE SCI, V63, P1736, DOI 10.1007/s00018-006-6072-0; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Martinez J, 2015, J BIOL CHEM, V290, P23348, DOI 10.1074/jbc.M115.674473; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moeder W, 2013, PLANT J, V76, P615, DOI 10.1111/tpj.12325; Orell A, 2012, EXTREMOPHILES, V16, P573, DOI 10.1007/s00792-012-0457-9; Paula FS, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53168-4; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Potterton L, 2018, ACTA CRYSTALLOGR D, V74, P68, DOI 10.1107/S2059798317016035; Rashid MH, 2000, P NATL ACAD SCI USA, V97, P4885, DOI 10.1073/pnas.060030097; Recalde A, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9010193; Remonsellez F, 2006, MICROBIOL-SGM, V152, P59, DOI 10.1099/mic.0.28241-0; SCHERER PA, 1983, CAN J MICROBIOL, V29, P1190, DOI 10.1139/m83-182; Sismeiro O, 1998, J BACTERIOL, V180, P3339, DOI 10.1128/JB.180.13.3339-3344.1998; Steegborn C, 2014, BBA-MOL BASIS DIS, V1842, P2535, DOI 10.1016/j.bbadis.2014.08.012; Swieiawska B, 2014, PLANT PHYSIOL BIOCH, V80, P41, DOI 10.1016/j.plaphy.2014.03.010; Swiezawska B, 2020, FEBS LETT, V594, P1101, DOI 10.1002/1873-3468.13701; Toso DB, 2016, ARCHAEA, V2016, DOI 10.1155/2016/4706532; Toso DB, 2011, ENVIRON MICROBIOL, V13, P2587, DOI 10.1111/j.1462-2920.2011.02531.x; Ung H, 2017, PLANT PHYSIOL, V175, P473, DOI 10.1104/pp.17.00700; Ung H, 2014, PLANT PHYSIOL, V166, P1009, DOI 10.1104/pp.114.248757; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zhang Y, 2017, J BIOL CHEM, V292, P313, DOI 10.1074/jbc.M116.758896	46	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100820	10.1016/j.jbc.2021.100820	http://dx.doi.org/10.1016/j.jbc.2021.100820			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029589	Green Published, gold, Green Submitted			2022-12-28	WOS:000678068400022
J	Zhang, Y; Ding, HT; Jiang, WX; Zhang, X; Cao, HY; Wang, JP; Li, CY; Huang, F; Zhang, XY; Chen, XL; Zhang, YZ; Li, PY				Zhang, Yi; Ding, Hai-Tao; Jiang, Wen-Xin; Zhang, Xia; Cao, Hai-Yan; Wang, Jing-Ping; Li, Chun-Yang; Huang, Feng; Zhang, Xi-Ying; Chen, Xiu-Lan; Zhang, Yu-Zhong; Li, Ping-Yi			Active site architecture of an acetyl xylan esterase indicates a novel cold adaptation strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARBOHYDRATE ESTERASE; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; FAMILY; FLEXIBILITY; PROTEIN; ENZYME; MECHANISM; LIPASE; THERMOSTABILITY	SGNH-type acetyl xylan esterases (AcXEs) play important roles in marine and terrestrial xylan degradation, which are necessary for removing acetyl side groups from xylan. However, only a few cold-adapted AcXEs have been reported, and the underlying mechanisms for their cold adaptation are still unknown because of the lack of structural information. Here, a cold-adapted AcXE, AlAXEase, from the Arctic marine bacterium Arcticibacterium luteifluviistationis SM1504(T) was characterized. AlAXEase could deacetylate xylooligosaccharides and xylan, which, together with its homologs, indicates a novel SGNH-type carbohydrate esterase family. AlAXEase showed the highest activity at 30 degrees C and retained over 70% activity at 0 degrees C but had unusual thermostability with a T-m value of 56 degrees C. To explain the cold adaption mechanism of AlAXEase, we next solved its crystal structure. AlAXEase has similar noncovalent stabilizing interactions to its mesophilic counterpart at the monomer level and forms stable tetramers in solutions, which may explain its high thermostability. However, a long loop containing the catalytic residues Asp200 and His203 in AlAXEase was found to be flexible because of the reduced stabilizing hydrophobic interactions and increased destabilizing asparagine and lysine residues, leading to a highly flexible active site. Structural and enzyme kinetic analyses combined with molecular dynamics simulations at different temperatures revealed that the flexible catalytic loop contributes to the cold adaptation of AlAXEase by modulating the distance between the catalytic His203 in this loop and the nucleophilic Ser32. This study reveals a new cold adaption strategy adopted by the thermostable AlAXEase, shedding light on the cold adaption mechanisms of AcXEs.	[Zhang, Yi; Jiang, Wen-Xin; Cao, Hai-Yan; Wang, Jing-Ping; Huang, Feng; Zhang, Xi-Ying; Chen, Xiu-Lan; Li, Ping-Yi] Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China; [Zhang, Yi; Li, Chun-Yang; Zhang, Yu-Zhong] Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China; [Zhang, Yi; Li, Chun-Yang; Zhang, Yu-Zhong] Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China; [Zhang, Yi; Li, Chun-Yang; Zhang, Yu-Zhong] Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China; [Ding, Hai-Tao] Polar Res Inst China, SOA Key Lab Polar Sci, Shanghai, Peoples R China; [Zhang, Xia] Qingdao Vland Biotech Inc, Dept Mol Biol, Qingdao, Peoples R China; [Zhang, Yu-Zhong] Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Qingdao, Peoples R China	Shandong University; Ocean University of China; Ocean University of China; Qingdao National Laboratory for Marine Science & Technology; Polar Research Institute of China; Shandong University	Li, PY (corresponding author), Shandong Univ, State Key Lab Microbial Technol, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Ocean Univ China, Coll Marine Life Sci, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Ocean Univ China, Frontiers Sci Ctr Deep Ocean Multispheres & Earth, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Pilot Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Qingdao, Peoples R China.; Zhang, YZ (corresponding author), Shandong Univ, Marine Biotechnol Res Ctr, State Key Lab Microbial Technol, Qingdao, Peoples R China.	zhangyz@sdu.edu.cn; lipingyipeace@sdu.edu.cn	WANG, JINGYI/GSJ-1241-2022; wang, jing/GVT-8700-2022; Wang, Jin/GYA-2019-2022; wang, jing/GRS-7509-2022	Li, Chun-Yang/0000-0002-1151-4897	National Key Research and Development Program of China [2018YFC1406700, 2018YFC1406704]; National Natural Science Foundation of China [31630012, U1706207, 91851205, 91751101, 41906195, 41676180]; Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province [2019JZZY010817]; Young Scholars Program of Shandong University [2017WLJH57]; Program of Shandong for Taishan Scholars [tspd20181203]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province; Young Scholars Program of Shandong University; Program of Shandong for Taishan Scholars	We thank the staffs from BL17U1 and BL18U1 beamlines of the National Facility for Protein Science Shanghai and Shanghai Synchrotron Radiation Facility, for assistance during data collection. We would like to thank Jingyao Qu, Jing Zhu, and Zhifeng Li from State Key laboratory of Microbial Technology of Shandong University for help and guidance in dynamic light scattering. This work was supported by the National Key Research and Development Program of China (2018YFC1406700, 2018YFC1406704), the National Natural Science Foundation of China (31630012, U1706207, 91851205, 91751101, 41906195, and 41676180), Major Scientific and Technological Innovation Project (MSTIP) of Shandong Province (2019JZZY010817), the Program of Shandong for Taishan Scholars (tspd20181203), and the Young Scholars Program of Shandong University (2017WLJH57).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adesioye FA, 2016, ENZYME MICROB TECH, V93-94, P79, DOI 10.1016/j.enzmictec.2016.07.001; Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Alalouf O, 2011, J BIOL CHEM, V286, P41993, DOI 10.1074/jbc.M111.301051; Asler IL, 2017, ACS CHEM BIOL, V12, P1928, DOI 10.1021/acschembio.6b01140; Blum DL, 1999, APPL ENVIRON MICROB, V65, P3990; Correia MAS, 2008, J MOL BIOL, V379, P64, DOI 10.1016/j.jmb.2008.03.037; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Komiya D, 2017, APPL ENVIRON MICROB, V83, DOI 10.1128/AEM.01251-17; Koutaniemi S, 2013, J BIOTECHNOL, V168, P684, DOI 10.1016/j.jbiotec.2013.10.009; Kulakova L, 2004, BBA-PROTEINS PROTEOM, V1696, P59, DOI 10.1016/j.bbapap.2003.09.008; Lansky S, 2014, ACTA CRYSTALLOGR D, V70, P261, DOI 10.1107/S139900471302840X; Le LTHL, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01696-x; Lee CW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169540; Leiros HKS, 2007, J BIOL CHEM, V282, P21973, DOI 10.1074/jbc.M610174200; Li DD, 2017, INT J SYST EVOL MICR, V67, P664, DOI 10.1099/ijsem.0.001690; Li J, 2000, NAT STRUCT BIOL, V7, P555; Li PY, 2015, J BIOL CHEM, V290, P11188, DOI 10.1074/jbc.M115.646182; Li PY, 2014, J BIOL CHEM, V289, P19031, DOI 10.1074/jbc.M114.574913; Li Y, 2018, STAND GENOMIC SCI, V13, DOI 10.1186/s40793-018-0335-x; Lian K, 2015, FEBS OPEN BIO, V5, P107, DOI 10.1016/j.fob.2015.01.006; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Martinez L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119264; Martinez-Martinez I, 2008, PROTEINS, V71, P379, DOI 10.1002/prot.21705; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Molgaard A, 2000, STRUCTURE, V8, P373, DOI 10.1016/S0969-2126(00)00118-0; Nagel ZD, 2013, J BIOL CHEM, V288, P14087, DOI 10.1074/jbc.M113.453951; Ogasahara K, 2003, J BIOL CHEM, V278, P8922, DOI 10.1074/jbc.M210893200; Papaleo E, 2006, BBA-PROTEINS PROTEOM, V1764, P1397, DOI 10.1016/j.bbapap.2006.06.005; Park SH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206260; Pfeffer JM, 2013, J BIOL CHEM, V288, P2605, DOI 10.1074/jbc.M112.436352; Razeq FM, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-018-1074-3; Rutkiewicz M, 2019, BBA-PROTEINS PROTEOM, V1867, P776, DOI 10.1016/j.bbapap.2019.06.001; Sanchez-Ruiz JM, 2001, TRENDS BIOTECHNOL, V19, P132, DOI 10.1016/S0167-7799(00)01548-1; Siddiqui KS, 2006, ANNU REV BIOCHEM, V75, P403, DOI 10.1146/annurev.biochem.75.103004.142723; Soni S, 2017, EXTREMOPHILES, V21, P687, DOI 10.1007/s00792-017-0934-2; Struvay C, 2012, INT J MOL SCI, V13, P11643, DOI 10.3390/ijms130911643; Tanaka Y, 2004, J BIOL CHEM, V279, P32957, DOI 10.1074/jbc.M404405200; Tang MAK, 2012, PROTEIN J, V31, P337, DOI 10.1007/s10930-012-9408-7; Tian QQ, 2014, APPL MICROBIOL BIOT, V98, P2081, DOI 10.1007/s00253-013-5056-x; Till M, 2013, PROTEINS, V81, P911, DOI 10.1002/prot.24254; Wang P, 2015, MOL MICROBIOL, V98, P289, DOI 10.1111/mmi.13119; Xie BB, 2009, J BIOL CHEM, V284, P9257, DOI 10.1074/jbc.M808421200; Yang G, 2013, BIOCHIMIE, V95, P1795, DOI 10.1016/j.biochi.2013.06.008; Zhao F, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01029-19	49	5	5	6	27	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100841	10.1016/j.jbc.2021.100841	http://dx.doi.org/10.1016/j.jbc.2021.100841			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058201	Green Published, gold			2022-12-28	WOS:000678068400041
J	Jabeena, CA; Govindaraju, G; Rawat, M; Gopi, S; Sethumadhavan, DV; Jaleel, A; Sasankan, D; Karmodiya, K; Rajavelu, A				Jabeena, C. A.; Govindaraju, Gayathri; Rawat, Mukul; Gopi, Soundhararajan; Sethumadhavan, Devadathan Valiyamangalath; Jaleel, Abdul; Sasankan, Dhakshmi; Karmodiya, Krishanpal; Rajavelu, Arumugam			Dynamic association of the H3K64 trimethylation mark with genes encoding exported proteins in Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARTEMISININ RESISTANCE; COMPARATIVE GENOMICS; CHROMATIN; METHYLATION; EXPRESSION; LANDSCAPE; VIRULENCE	Epigenetic modifications have emerged as critical regulators of virulence genes and stage-specific gene expression in Plasmodium falciparum. However, the specific roles of histone core epigenetic modifications in regulating the stage-specific gene expression are not well understood. In this study, we report an unconventional trimethylation at lysine 64 on histone 3 (H3K64me3) and characterize its functional relevance in P. falciparum. We show that PfSET4 and PfSET5 proteins of P. falciparum methylate H3K64 and that they prefer the nucleosome as a substrate over free histone 3 proteins. Structural analysis of PfSET5 revealed that it interacts with the nucleosome as a dimer. The H3K64me3 mark is dynamic, being enriched in the ring and trophozoite stages and drastically reduced in the schizont stages. Stage-specific global chromatin immunoprecipitation-sequencing analysis of the H3K64me3 mark revealed the selective enrichment of this methyl mark on the genes of exported family proteins in the ring and trophozoite stages and a significant reduction of the same in the schizont stages. Collectively, our data identify a novel epigenetic mark that is associated with the subset of genes encoding for exported proteins, which may regulate their expression in different stages of P. falciparum.	[Jabeena, C. A.; Govindaraju, Gayathri; Sethumadhavan, Devadathan Valiyamangalath; Sasankan, Dhakshmi; Rajavelu, Arumugam] Rajiv Gandhi Ctr Biotechnol RGCB, Pathogen Biol Grp, Thiruvananthapuram, Kerala, India; [Jabeena, C. A.; Govindaraju, Gayathri; Sethumadhavan, Devadathan Valiyamangalath] Manipal Acad Higher Educ MAHE, Manipal, Karnataka, India; [Rawat, Mukul; Karmodiya, Krishanpal] Indian Inst Sci Educ & Res, Dept Biol, Pune, Maharashtra, India; [Gopi, Soundhararajan] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Chennai, Tamil Nadu, India; [Jaleel, Abdul] Rajiv Gandhi Ctr Biotechnol RGCB, Cardiovasc Dis Biol, Thycaud PO, Thiruvananthapuram, Kerala, India	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Manipal Academy of Higher Education (MAHE); Indian Institute of Science Education & Research (IISER) Pune; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB)	Rajavelu, A (corresponding author), Rajiv Gandhi Ctr Biotechnol RGCB, Pathogen Biol Grp, Thiruvananthapuram, Kerala, India.	arajavelu@rgcb.res.in	Naina, Soundhara Rajan G/AAU-8769-2021	Naina, Soundhara Rajan G/0000-0002-7511-2571; Rajavelu, Arumugam/0000-0001-6666-8925; , ABDUL JALEEL/0000-0003-2536-9093; C.A, Jabeena/0000-0003-1629-9556	Department of Science and Technology (DST)-Early Career Research Award [ECR/2015/000117]; DBT-Innovative Young Biotechnologist Award (IYBA) [BT/08/IYBA/2014]; University Grants Commission, Government of India [UGC/Dec 2015/365030, UGC/Dec 2014/371086]; Indian Council for Medical Research; Initiative for Biological Systems Engineering, IIT Madras, India; Genome Engineering Technologies program of the Department of Biotechnology, Government of India [BT/PR25858/GET/119/169/2017]	Department of Science and Technology (DST)-Early Career Research Award(Department of Science & Technology (India)); DBT-Innovative Young Biotechnologist Award (IYBA); University Grants Commission, Government of India(University Grants Commission, India); Indian Council for Medical Research(Indian Council of Medical Research (ICMR)); Initiative for Biological Systems Engineering, IIT Madras, India; Genome Engineering Technologies program of the Department of Biotechnology, Government of India	This work was supported by Department of Science and Technology (DST)-Early Career Research Award (Grant #ECR/2015/000117) and DBT-Innovative Young Biotechnologist Award (IYBA) (Grant #BT/08/IYBA/2014) to A. R. The authors acknowledge University Grants Commission, Government of India, for the senior research fellowship of C. A. J. (UGC/Dec 2015/365030) and D. V. S. (UGC/Dec 2014/371086). G. G. is supported by Senior Research Fellowship from the Indian Council for Medical Research. S. G. acknowledges the Initiative for Biological Systems Engineering, IIT Madras, India, for the IBSE PhD. Studentship. K. K. acknowledges support from the Genome Engineering Technologies program (BT/PR25858/GET/119/169/2017) of the Department of Biotechnology, Government of India.	Adjalley SH, 2016, CELL REP, V14, P2463, DOI 10.1016/j.celrep.2016.02.025; Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Bartfai R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001223; Batugedara G, 2017, TRENDS PARASITOL, V33, P364, DOI 10.1016/j.pt.2016.12.004; Baum J, 2009, NUCLEIC ACIDS RES, V37, P3788, DOI 10.1093/nar/gkp239; Bozdech Z, 1998, MOL BIOCHEM PARASIT, V97, P81, DOI 10.1016/S0166-6851(98)00135-2; Bunnik EM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04295-5; Chaal BK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000737; Choi SW, 2006, MOL BIOCHEM PARASIT, V150, P350, DOI 10.1016/j.molbiopara.2006.07.003; Coetzee N, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00687-7; Cosgrove MS, 2004, NAT STRUCT MOL BIOL, V11, P1037, DOI 10.1038/nsmb851; Cui LW, 2008, INT J PARASITOL, V38, P1083, DOI 10.1016/j.ijpara.2008.01.002; Daujat S, 2009, NAT STRUCT MOL BIOL, V16, P777, DOI 10.1038/nsmb.1629; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Duffy MF, 2012, CELL MICROBIOL, V14, P819, DOI 10.1111/j.1462-5822.2012.01777.x; Duffy T, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000419; Fingerman I. M., 2008, COLD SPRING HARBOR P, V2008; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Fraschka SAK, 2016, SCI REP-UK, V6, DOI 10.1038/srep31965; Gill J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-90; Govindaraju G, 2017, BBA-GENE REGUL MECH, V1860, P1047, DOI 10.1016/j.bbagrm.2017.08.003; Hammam E, 2020, NUCLEIC ACIDS RES, V48, P184, DOI 10.1093/nar/gkz1093; Hoeijmakers WAM, 2012, TRENDS PARASITOL, V28, P486, DOI 10.1016/j.pt.2012.08.006; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; Jabeena CA, 2019, CHEMBIOCHEM, V20, P1225, DOI 10.1002/cbic.201800718; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Karmodiya K, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0029-1; Kensche PR, 2016, NUCLEIC ACIDS RES, V44, P2110, DOI 10.1093/nar/gkv1214; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lange UC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3233; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lu XM, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2214-9; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Merrick CJ, 2010, EUKARYOT CELL, V9, P1150, DOI 10.1128/EC.00093-10; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Ponts N, 2013, CELL HOST MICROBE, V14, P696, DOI 10.1016/j.chom.2013.11.007; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Silberhorn E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006080; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Soulard V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8690; Sullivan WJ, 2006, CELL MICROBIOL, V8, P1850, DOI 10.1111/j.1462-5822.2006.00818.x; Tessarz P, 2014, NAT REV MOL CELL BIO, V15, P703, DOI 10.1038/nrm3890; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Ye T, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1287; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	50	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100614	10.1016/j.jbc.2021.100614	http://dx.doi.org/10.1016/j.jbc.2021.100614			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839154	Green Published, gold			2022-12-28	WOS:000672866400585
J	Pandey, S; Mahanta, P; Berger, BW; Acharya, R				Pandey, Shubhant; Mahanta, Pranjal; Berger, Bryan W.; Acharya, Rudresh			Structural insights into the mechanism of pH-selective substrate specificity of the polysaccharide lyase Smlt1473	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PNEUMONIAE HYALURONATE LYASE; X-RAY-DIFFRACTION; STENOTROPHOMONAS-MALTOPHILIA; MOLECULAR-DYNAMICS; CRYSTALLINE-STRUCTURE; LIGAND DOCKING; ALGINIC ACID; DEGRADATION; CLASSIFICATION; ELECTROSTATICS	Polysaccharide lyases (PLs) are a broad class of microbial enzymes that degrade anionic polysaccharides. Equally broad diversity in their polysaccharide substrates has attracted interest in biotechnological applications such as biomass conversion to value-added chemicals and microbial biofilm removal. Unlike other PLs, Smlt1473 present in the clinically relevant Stenotrophomonas maltophilia strain K279a demonstrates a wide range of pH-dependent substrate specificities toward multiple, diverse polysaccharides: hyaluronic acid (pH 5.0), poly-beta-D-glucuronic (celluronic) acid (pH 7.0), poly-beta-D-mannuronic acid, and poly-alpha-L-guluronate (pH 9.0). To decode the pH-driven multiple substrate specificities and selectivity in this single enzyme, we present the X-ray structures of Smlt1473 determined at multiple pH values in apo and mannuronate-bound states as well as the tetra-hyaluronate-docked structure. Our results indicate that structural flexibility in the binding site and N-terminal loop coupled with specific substrate stereochemistry facilitates distinct modes of entry for substrates having diverse charge densities and chemical structures. Our structural analyses of wild-type apo structures solved at different pH values (5.0-9.0) and pH-trapped (5.0 and 7.0) catalytically relevant wild-type mannuronate complexes (1) indicate that pH modulates the catalytic microenvironment for guiding structurally and chemically diverse polysaccharide substrates, (2) further establish that molecular-level fluctuation in the enzyme catalytic tunnel is preconfigured, and (3) suggest that pH modulates fluctuations resulting in optimal substrate binding and cleavage. Furthermore, our results provide key insight into how strategies to reengineer both flexible loop and regions distal to the active site could be developed to target new and diverse substrates in a wide range of applications.	[Pandey, Shubhant; Mahanta, Pranjal; Acharya, Rudresh] Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India; [Pandey, Shubhant; Acharya, Rudresh] Homi Bhabha Natl Inst, Mumbai, Maharashtra, India; [Berger, Bryan W.] Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA	National Institute of Science Education & Research (NISER); Homi Bhabha National Institute; University of Virginia	Acharya, R (corresponding author), Natl Inst Sci Educ & Res, Sch Biol Sci, Bhubaneswar, Odisha, India.; Acharya, R (corresponding author), Homi Bhabha Natl Inst, Mumbai, Maharashtra, India.; Berger, BW (corresponding author), Univ Virginia, Dept Chem Engn, Charlottesville, VA 22903 USA.	bryan.berger@virginia.edu; rudresh.acharya@niser.ac.in	; Berger, Bryan/D-7985-2014	Pandey, Shubhant/0000-0003-3153-8949; Berger, Bryan/0000-0002-6135-8677	NISER; DBT [BT/PR15324/BRB/10/1482/2016]; National Science Foundation [CBET 1452855]; Center for Innovative Technology, a Research Innovation Award from the University of Virginia School of Engineering and Applied Science	NISER; DBT(Department of Biotechnology (DBT) India); National Science Foundation(National Science Foundation (NSF)); Center for Innovative Technology, a Research Innovation Award from the University of Virginia School of Engineering and Applied Science	S. P., P. M., and R. A: We thank NISER for funding and the NISER X-ray diffraction facility. This work supported in part by DBT BT/PR15324/BRB/10/1482/2016. B. W. B: This work was supported in part by a grant from the Center for Innovative Technology, a Research Innovation Award from the University of Virginia School of Engineering and Applied Science and a grant from the National Science Foundation (CBET 1452855).	ATKINS EDT, 1973, BIOPOLYMERS, V12, P1879, DOI 10.1002/bip.1973.360120814; ATKINS EDT, 1973, BIOPOLYMERS, V12, P1865, DOI 10.1002/bip.1973.360120813; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Braccini I, 1999, CARBOHYD RES, V317, P119, DOI 10.1016/S0008-6215(99)00062-2; Brooke JS, 2012, CLIN MICROBIOL REV, V25, P2, DOI 10.1128/CMR.00019-11; Case D., 2000, J CHEM INF COMP SCI, V222; Case DA, 2005, J COMPUT CHEM, V26, P1668, DOI 10.1002/jcc.20290; Cescutti P, 2011, CARBOHYD RES, V346, P1916, DOI 10.1016/j.carres.2011.05.007; Combs SA, 2013, NAT PROTOC, V8, P1277, DOI 10.1038/nprot.2013.074; Di Bonaventura G, 2004, ANTIMICROB AGENTS CH, V48, P151, DOI 10.1128/AAC.48.1.151-160.2004; Doerr S, 2016, J CHEM THEORY COMPUT, V12, P1845, DOI 10.1021/acs.jctc.6b00049; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Elmabrouk ZH, 2011, PROTEINS, V79, P965, DOI 10.1002/prot.22938; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GACESA P, 1987, FEBS LETT, V212, P199, DOI 10.1016/0014-5793(87)81344-3; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Hynes WL, 2000, FEMS MICROBIOL LETT, V183, P201, DOI 10.1111/j.1574-6968.2000.tb08958.x; Jedrzejas MJ, 2002, J BIOL CHEM, V277, P28287, DOI 10.1074/jbc.M112009200; Kantardjieff KA, 2003, PROTEIN SCI, V12, P1865, DOI 10.1110/ps.0350503; Lemmon G, 2012, METHODS MOL BIOL, V819, P143, DOI 10.1007/978-1-61779-465-0_10; Li SL, 2000, EMBO J, V19, P1228, DOI 10.1093/emboj/19.6.1228; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; MacDonald LC, 2014, J BIOL CHEM, V289, P18022, DOI 10.1074/jbc.M114.571299; MacDonald LC, 2014, J BIOL CHEM, V289, P312, DOI 10.1074/jbc.M113.489195; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mikami B, 2012, ACTA CRYSTALLOGR D, V68, P1207, DOI 10.1107/S090744491202495X; Mongan J, 2004, J COMPUT CHEM, V25, P2038, DOI 10.1002/jcc.20139; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Ogura K, 2009, J BIOL CHEM, V284, P35572, DOI 10.1074/jbc.M109.068056; Ponnuraj K, 2000, J MOL BIOL, V299, P885, DOI 10.1006/jmbi.2000.3817; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; Ryan RP, 2009, NAT REV MICROBIOL, V7, P514, DOI 10.1038/nrmicro2163; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; WARREN L, 1959, J BIOL CHEM, V234, P1971; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; WINTER WT, 1975, J MOL BIOL, V99, P219, DOI 10.1016/S0022-2836(75)80142-2; Wong S, 2019, J PHYS CHEM B, V123, P7123, DOI 10.1021/acs.jpcb.9b04672; Yamasaki M, 2005, J MOL BIOL, V352, P11, DOI 10.1016/j.jmb.2005.06.075	40	2	2	2	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101014	10.1016/j.jbc.2021.101014	http://dx.doi.org/10.1016/j.jbc.2021.101014			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34358563	Green Published, gold			2022-12-28	WOS:000755323700001
J	Boughton, AJ; Liu, L; Lavy, T; Kleifeld, O; Fushman, D				Boughton, Andrew J.; Liu, Leonard; Lavy, Tali; Kleifeld, Oded; Fushman, David			A novel recognition site for polyubiquitin and ubiquitin-like signals in an unexpected region of proteasomal subunit Rpn1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; DI-UBIQUITIN; BINDING PROTEIN; CHAINS; DOMAIN; CONFORMATION; SPECTROSCOPY; RECEPTORS; RESIDUES; DOCKING	The ubiquitin (Ub)-proteasome system is the primary mechanism for maintaining protein homeostasis in eukaryotes, yet the underlying signaling events and specificities of its components are poorly understood. Proteins destined for degradation are tagged with covalently linked polymeric Ub chains and subsequently delivered to the proteasome, often with the assistance of shuttle proteins that contain Ub-like domains. This degradation pathway is riddled with apparent redundancy-in the form of numerous polyubiquitin chains of various lengths and distinct architectures, multiple shuttle proteins, and at least three proteasomal receptors. Moreover, the largest proteasomal receptor, Rpn1, contains one known binding site for polyubiquitin and shuttle proteins, although several studies have recently proposed the existence of an additional uncharacterized site. Here, using a combination of NMR spectroscopy, photocrosslinking, mass spectrometry, and mutagenesis, we show that Rpn1 does indeed contain another recognition site that exhibits affinities and binding preferences for polyubiquitin and Ub-like signals comparable to those of the known binding site in Rpn1. Surprisingly, this novel site is situated in the N-terminal section of Rpn1, a region previously surmised to be devoid of functionality. We identified a stretch of adjacent helices as the location of this previously uncharacterized binding site, whose spatial proximity and similar properties to the known binding site in Rpn1 suggest the possibility of multivalent signal recognition across the solvent exposed surface of Rpn1. These findings offer new mechanistic insights into signal recognition processes that are at the core of the Ub-proteasome system.	[Boughton, Andrew J.; Liu, Leonard; Fushman, David] Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20742 USA; [Lavy, Tali; Kleifeld, Oded] Technion Israel Inst Technol, Fac Biol, Haifa, Israel	University System of Maryland; University of Maryland College Park; Technion Israel Institute of Technology	Fushman, D (corresponding author), Univ Maryland, Ctr Biomol Struct & Org, Dept Chem & Biochem, College Pk, MD 20742 USA.	fushman@umd.edu			National Institutes of Health [GM065334]; National Science Foundation [MCB1818280]; Israel Science Foundation [1623/17, 2167/17]; Ann G. Wylie Dissertation Fellowship through the University of Maryland	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Israel Science Foundation(Israel Science Foundation); Ann G. Wylie Dissertation Fellowship through the University of Maryland	This research was supported by the National Institutes of Health grant GM065334 and the National Science Foundation grant MCB1818280 to D. F. O. K. and T. L. were supported by Israel Science Foundation grants 1623/17 and 2167/17. While writing this article, A. J. B. was supported by the Ann G. Wylie Dissertation Fellowship through the University of Maryland. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Gader A, 2011, BIOINFORMATICS, V27, P1630, DOI 10.1093/bioinformatics/btr234; Beal R, 1996, P NATL ACAD SCI USA, V93, P861, DOI 10.1073/pnas.93.2.861; Bertolaet BL, 2001, NAT STRUCT BIOL, V8, P417, DOI 10.1038/87575; Bohn S, 2010, P NATL ACAD SCI USA, V107, P20992, DOI 10.1073/pnas.1015530107; Boughton AJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100450; Boughton AJ, 2020, STRUCTURE, V28, P29, DOI 10.1016/j.str.2019.10.008; Braxton CN, 2019, BIOCHEMISTRY-US, V58, P883, DOI 10.1021/acs.biochem.8b01089; Bremm A, 2010, NAT STRUCT MOL BIOL, V17, P939, DOI 10.1038/nsmb.1873; Chen X, 2016, STRUCTURE, V24, P1257, DOI 10.1016/j.str.2016.05.018; Chen ZL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11337-z; Chojnacki M, 2017, CELL CHEM BIOL, V24, P443, DOI 10.1016/j.chembiol.2017.02.013; D'Onofrio M, 2012, CHEM-EUR J, V18, P9919, DOI 10.1002/chem.201103778; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; Effantin G, 2009, J MOL BIOL, V386, P1204, DOI 10.1016/j.jmb.2009.01.039; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Elsasser S, 2004, J BIOL CHEM, V279, P26817, DOI 10.1074/jbc.M404020200; Finley D, 2009, ANNU REV BIOCHEM, V78, P477, DOI 10.1146/annurev.biochem.78.081507.101607; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fushman D, 2010, J MOL BIOL, V395, P803, DOI 10.1016/j.jmb.2009.10.039; Goddard T. D., SPARKY 3; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; GRATZER WB, 1969, NATURE, V222, P426, DOI 10.1038/222426a0; Haririnia A, 2007, J MOL BIOL, V368, P753, DOI 10.1016/j.jmb.2007.02.037; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Husnjak K, 2008, NATURE, V453, P481, DOI 10.1038/nature06926; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kajava AV, 2002, J BIOL CHEM, V277, P49791, DOI 10.1074/jbc.M204982200; Klose DP, 2010, BIOINFORMATICS, V26, P2624, DOI 10.1093/bioinformatics/btq480; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; MANAVALAN P, 1987, ANAL BIOCHEM, V167, P76, DOI 10.1016/0003-2697(87)90135-7; Martinez-Fonts K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13906-8; Matiuhin Y, 2008, MOL CELL, V32, P415, DOI 10.1016/j.molcel.2008.10.011; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Nowicka U, 2015, STRUCTURE, V23, P542, DOI 10.1016/j.str.2015.01.010; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peth A, 2009, MOL CELL, V36, P794, DOI 10.1016/j.molcel.2009.11.015; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Popovic D, 2014, NAT MED, V20, P1242, DOI 10.1038/nm.3739; Rosenzweig R, 2012, J BIOL CHEM, V287, P14659, DOI 10.1074/jbc.M111.316323; Ryabov Y, 2006, PROTEINS, V63, P787, DOI 10.1002/prot.20917; Saeki Y, 2002, BIOCHEM BIOPH RES CO, V293, P986, DOI 10.1016/S0006-291X(02)00340-6; Schreiner P, 2008, NATURE, V453, P548, DOI 10.1038/nature06924; Shi Y, 2016, SCIENCE, V351, DOI 10.1126/science.aad9421; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; van Dijk ADJ, 2005, PROTEINS, V60, P367, DOI 10.1002/prot.20476; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Varadan R, 2004, J BIOL CHEM, V279, P7055, DOI 10.1074/jbc.M309184200; Varadan R, 2005, METHOD ENZYMOL, V399, P177, DOI 10.1016/S0076-6879(05)99012-5; Varadan R, 2002, J MOL BIOL, V324, P637, DOI 10.1016/S0022-2836(02)01198-1; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Wickliffe KE, 2011, TRENDS CELL BIOL, V21, P656, DOI 10.1016/j.tcb.2011.08.008; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Yau RG, 2017, CELL, V171, P918, DOI 10.1016/j.cell.2017.09.040; Zhang DN, 2009, MOL CELL, V36, P1018, DOI 10.1016/j.molcel.2009.11.012	59	2	2	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101052	10.1016/j.jbc.2021.101052	http://dx.doi.org/10.1016/j.jbc.2021.101052			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34364874	Green Published, gold			2022-12-28	WOS:000706409400006
J	Chen, E; Reiss, K; Shah, D; Manjula, R; Allen, B; Murphy, EL; Murphy, JW; Batista, VS; Bhandari, V; Lolis, EJ; Lisi, GP				Chen, Emily; Reiss, Krystle; Shah, Dilip; Manjula, Ramu; Allen, Brandon; Murphy, Eva L.; Murphy, James W.; Batista, Victor S.; Bhandari, Vineet; Lolis, Elias J.; Lisi, George P.			A structurally preserved allosteric site in the MIF superfamily affects enzymatic activity and CD74 activation in D-dopachrome tautomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-INHIBITORY FACTOR; CRYSTAL-STRUCTURE; MACROPHAGE; CYTOKINE; HOMOLOG; MODEL; DYNAMICS; DDT	The macrophage migration inhibitory factor (MIF) family of cytokines contains multiple ligand-binding sites and mediates immunomodulatory processes through an undefined mechanism(s). Previously, we reported a dynamic relay connecting the MIF catalytic site to an allosteric site at its solvent channel. Despite structural and functional similarity, the MIF homolog D-dopachrome tautomerase (also called MIF-2) has low sequence identity (35%), prompting the question of whether this dynamic regulatory network is conserved. Here, we establish the structural basis of an allosteric site in MIF-2, showing with solution NMR that dynamic communication is preserved in MIF-2 despite differences in the primary sequence. X-ray crystallography and NMR detail the structural consequences of perturbing residues in this pathway, which include conformational changes surrounding the allosteric site, despite global preservation of the MIF-2 fold. Molecular simulations reveal MIF-2 to contain a comparable hydrogen bond network to that of MIF, which was previously hypothesized to influence catalytic activity by modulating the strength of allosteric coupling. Disruption of the allosteric relay by mutagenesis also attenuates MIF-2 enzymatic activity in vitro and the activation of the cluster of differentiation 74 receptor in vivo , highlighting a conserved point of control for nonoverlapping functions in the MIF superfamily.	[Chen, Emily; Lisi, George P.] Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA; [Reiss, Krystle; Allen, Brandon; Batista, Victor S.] Yale Univ, Dept Chem, New Haven, CT USA; [Shah, Dilip; Bhandari, Vineet] Cooper Univ Hosp, Dept Pediat, Sect Neonatol, Camden, NJ USA; [Manjula, Ramu; Murphy, Eva L.; Murphy, James W.; Lolis, Elias J.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Brown University; Yale University; Cooper University Hospital; Yale University	Lisi, GP (corresponding author), Brown Univ, Dept Mol Biol Cell Biol & Biochem, Providence, RI 02912 USA.; Lolis, EJ (corresponding author), Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA.	elias.lolis@yale.edu; george_lisi@brown.edu		Shah, Dilip/0000-0002-4248-5611; Allen, Brandon/0000-0002-5512-1892; Ramu, Manjula/0000-0002-2237-2599; Lolis, Elias/0000-0002-7902-7868	Rhode Island Foundation [GR5290658]; Office of the Vice President for Research at Brown University; NIH [5R01 GM136815-02]; Respiratory Research Training Grant [T32 HL134625]	Rhode Island Foundation; Office of the Vice President for Research at Brown University; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Respiratory Research Training Grant	This work was supported by Rhode Island Foundation Grant GR5290658 and funds from the Office of the Vice President for Research at Brown University (to G. P. L.) and NIH Grant 5R01 GM136815-02 (to V. S. B.). E. C. was supported by a Respiratory Research Training Grant (T32 HL134625). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AGARWAL RC, 1978, ACTA CRYSTALLOGR A, V34, P791, DOI 10.1107/S0567739478001618; Almrud JJ, 2002, BIOCHEMISTRY-US, V41, P12010, DOI 10.1021/bi020271h; [Anonymous], 1995, INT TABLES CRYSTALLO, VC; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Beswick EJ, 2009, WORLD J GASTROENTERO, V15, P2855, DOI 10.3748/wjg.15.2855; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; CALANDRA T, 1995, NATURE, V377, P68, DOI 10.1038/377068a0; Crichlow GV, 2009, BIOCHEMISTRY-US, V48, P132, DOI 10.1021/bi8014423; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Esumi N, 1998, MAMM GENOME, V9, P753, DOI 10.1007/s003359900858; Fan CP, 2013, P NATL ACAD SCI USA, V110, P10994, DOI 10.1073/pnas.1221817110; Farr L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01273; Fingerle-Rowson G, 2009, MOL CELL BIOL, V29, P1922, DOI 10.1128/MCB.01907-08; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jubb HC, 2017, J MOL BIOL, V429, P365, DOI 10.1016/j.jmb.2016.12.004; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Kneller JM, 2002, J AM CHEM SOC, V124, P1852, DOI 10.1021/ja017461k; Koebernick H, 2002, P NATL ACAD SCI USA, V99, P13681, DOI 10.1073/pnas.212488699; Lai KN, 2003, J PATHOL, V199, P496, DOI 10.1002/path.1291; Lakomek NA, 2012, J BIOMOL NMR, V53, P209, DOI 10.1007/s10858-012-9626-5; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Lubetsky JB, 1999, BIOCHEMISTRY-US, V38, P7346, DOI 10.1021/bi990306m; Magalhaes ES, 2007, EUR J IMMUNOL, V37, P1097, DOI 10.1002/eji.200635968; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meazza C, 2002, ARTHRITIS RHEUM, V46, P232, DOI 10.1002/1529-0131(200201)46:1<232::AID-ART10059>3.0.CO;2-B; Merk M, 2011, P NATL ACAD SCI USA, V108, pE577, DOI 10.1073/pnas.1102941108; Meza-Romero R, 2016, CYTOKINE, V88, P62, DOI 10.1016/j.cyto.2016.08.024; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Negre CFA, 2018, P NATL ACAD SCI USA, V115, pE12201, DOI 10.1073/pnas.1810452115; Pantouris G, 2020, CELL CHEM BIOL, V27, P740, DOI 10.1016/j.chembiol.2020.05.001; Pantouris G, 2018, ANGEW CHEM INT EDIT, V57, P7116, DOI 10.1002/anie.201803191; Pantouris G, 2015, CHEM BIOL, V22, P1197, DOI 10.1016/j.chembiol.2015.08.006; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rajasekaran D, 2014, FASEB J, V28, P4961, DOI 10.1096/fj.14-256636; Rivalta I, 2012, P NATL ACAD SCI USA, V109, pE1428, DOI 10.1073/pnas.1120536109; Rosengren E, 1997, FEBS LETT, V417, P85, DOI 10.1016/S0014-5793(97)01261-1; Rossi AG, 1998, J CLIN INVEST, V101, P2869, DOI 10.1172/JCI1524; Schrodinger LLC, 2015, PYMOL MOL GRAPHICS S, DOI DOI 10.1007/S13398-014-0173-7.2; Shah D, 2019, FASEB J, V33, P13617, DOI 10.1096/fj.201901123R; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Subramanya HS, 1996, BIOCHEMISTRY-US, V35, P792, DOI 10.1021/bi951732k; Sugimoto H, 1999, BIOCHEMISTRY-US, V38, P3268, DOI 10.1021/bi982184o; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Takahashi K, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-33; TENEYCK LF, 1977, ACTA CRYSTALLOGR A, V33, P486, DOI 10.1107/S0567739477001211; Tilstam PV, 2019, J BIOL CHEM, V294, P18522, DOI 10.1074/jbc.RA119.009860; Wang YF, 2016, SCIENCE, V354, DOI 10.1126/science.aad6872; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	55	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101061	10.1016/j.jbc.2021.101061	http://dx.doi.org/10.1016/j.jbc.2021.101061			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34384784	gold, Green Published			2022-12-28	WOS:000706409400012
J	Damle, MS; Singh, AN; Peters, SC; Szalai, VA; Fisher, OS				Damle, Madhura S.; Singh, Aarshi N.; Peters, Stephen C.; Szalai, Veronika A.; Fisher, Oriana S.			The YcnI protein from Bacillus subtilis contains a copper-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PSEUDOMONAS-SYRINGAE; COPC PROTEIN; INSIGHTS; FAMILY; CELLULOSE; CSOR; TRAFFICKING; DEGRADATION; SITE	Bacteria require a precise balance of copper ions to ensure that essential cuproproteins are fully metalated while also avoiding copper-induced toxicity. The Gram-positive bacterium Bacillus subtilis maintains appropriate copper homeostasis in part through the ycn operon. The ycn operon comprises genes encoding three proteins: the putative copper importer YcnJ, the copper-dependent transcriptional repressor YcnK, and the uncharacterized Domain of Unknown Function 1775 (DUF1775) containing YcnI. DUF1775 domains are found across bacterial phylogeny, and bioinformatics analyses indicate that they frequently neighbor domains implicated in copper homeostasis and transport. Here, we investigated whether YcnI can interact with copper and, using electron paramagnetic resonance and inductively coupled plasma-MS, found that this protein can bind a single Cu(II) ion. We determine the structure of both the apo and copper-bound forms of the protein by X-ray crystallography, uncovering a copper-binding site featuring a unique monohistidine brace ligand set that is highly conserved among DUF1775 domains. These data suggest a possible role for YcnI as a copper chaperone and that DUF1775 domains in other bacterial species may also function in copper homeostasis.	[Damle, Madhura S.; Singh, Aarshi N.; Fisher, Oriana S.] Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA; [Peters, Stephen C.] Lehigh Univ, Dept Earth & Environm Sci, Bethlehem, PA 18015 USA; [Szalai, Veronika A.] NIST, Phys Measurement Lab, Gaithersburg, MD 20899 USA	Lehigh University; Lehigh University; National Institute of Standards & Technology (NIST) - USA	Fisher, OS (corresponding author), Lehigh Univ, Dept Chem, Bethlehem, PA 18015 USA.	orf206@lehigh.edu		Szalai, Veronika/0000-0002-1115-2849; Singh, Aarshi/0000-0002-5888-4449; Fisher, Oriana/0000-0003-3215-0831	Lehigh University; National Institute of Standards and Technology	Lehigh University; National Institute of Standards and Technology(National Institute of Standards & Technology (NIST) - USA)	This work was supported by start-up funds and a Class of '68 Award from Lehigh University (to O. S. F.) and by financial support of the National Institute of Standards and Technology (to V. A. S.) .	Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Arnesano F, 2002, STRUCTURE, V10, P1337, DOI 10.1016/S0969-2126(02)00858-4; Banci L, 2003, BIOCHEMISTRY-US, V42, P1939, DOI 10.1021/bi027096p; Beeson WT, 2012, J AM CHEM SOC, V134, P890, DOI 10.1021/ja210657t; CHA JS, 1993, APPL ENVIRON MICROB, V59, P1671, DOI 10.1128/AEM.59.5.1671-1674.1993; Chakravorty DK, 2011, J AM CHEM SOC, V133, P19330, DOI 10.1021/ja208662z; Chaplin AK, 2016, J BIOL CHEM, V291, P12838, DOI 10.1074/jbc.M116.722447; Chen IMA, 2019, NUCLEIC ACIDS RES, V47, pD666, DOI 10.1093/nar/gky901; Chillappagari S, 2009, J BACTERIOL, V191, P2362, DOI 10.1128/JB.01616-08; Ciano L, 2018, NAT CATAL, V1, P571, DOI 10.1038/s41929-018-0110-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fisher OS, 2019, J BIOL CHEM, V294, P16351, DOI 10.1074/jbc.RA119.010093; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Harris PV, 2010, BIOCHEMISTRY-US, V49, P3305, DOI 10.1021/bi100009p; Hart PJ, 1996, PROTEIN SCI, V5, P2175, DOI 10.1002/pro.5560051104; Hausrath AC, 2020, J BIOL CHEM, V295, P11364, DOI 10.1074/jbc.RA120.013907; Helland R, 2008, J BIOL CHEM, V283, P13897, DOI 10.1074/jbc.M800340200; Hemsworth GR, 2014, NAT CHEM BIOL, V10, P122, DOI 10.1038/nchembio.1417; Hemsworth GR, 2013, CURR OPIN STRUC BIOL, V23, P660, DOI 10.1016/j.sbi.2013.05.006; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Hirooka K, 2012, J BACTERIOL, V194, P5675, DOI 10.1128/JB.00919-12; Hodgkinson V, 2012, J BIOL CHEM, V287, P13549, DOI 10.1074/jbc.R111.316406; Hu YH, 2009, J MICROBIOL, V47, P277, DOI 10.1007/s12275-008-0278-9; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P133, DOI 10.1107/S0907444909047374; Karlsen OA, 2011, FEMS MICROBIOL LETT, V323, P97, DOI 10.1111/j.1574-6968.2011.02365.x; Kenney GE, 2016, METALLOMICS, V8, P931, DOI 10.1039/c5mt00289c; Kihlken MA, 2002, BIOCHEM J, V368, P729, DOI 10.1042/BJ20021036; Labourel A, 2020, NAT CHEM BIOL, V16, P345, DOI 10.1038/s41589-019-0438-8; Lawton TJ, 2016, BIOCHEMISTRY-US, V55, P2278, DOI 10.1021/acs.biochem.6b00175; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Loftin IR, 2005, BIOCHEMISTRY-US, V44, P10533, DOI 10.1021/bi050827b; Ma Z, 2009, BIOCHEMISTRY-US, V48, P3325, DOI 10.1021/bi900115w; MELLANO MA, 1988, J BACTERIOL, V170, P2879, DOI 10.1128/jb.170.6.2879-2883.1988; Morosov X, 2018, J BIOL CHEM, V293, P15628, DOI 10.1074/jbc.RA118.004117; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Petrovic DM, 2018, PROTEIN SCI, V27, P1636, DOI 10.1002/pro.3451; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Rademacher C, 2012, MICROBIOL-SGM, V158, P2451, DOI 10.1099/mic.0.058487-0; Radford DS, 2003, FEMS MICROBIOL LETT, V220, P105, DOI 10.1016/S0378-1097(03)00095-8; Ross MO, 2019, SCIENCE, V364, P566, DOI 10.1126/science.aav2572; Samanovic MI, 2012, CELL HOST MICROBE, V11, P106, DOI 10.1016/j.chom.2012.01.009; Serventi F, 2012, J BIOL CHEM, V287, P38812, DOI 10.1074/jbc.M112.406173; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Smaldone GT, 2007, MICROBIOL-SGM, V153, P4123, DOI 10.1099/mic.0.2007/011742-0; Solioz M, 2010, J BIOL INORG CHEM, V15, P3, DOI 10.1007/s00775-009-0588-3; Udagedara SR, 2019, J INORG BIOCHEM, V195, P194, DOI 10.1016/j.jinorgbio.2019.03.007; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7; Wijekoon CJK, 2015, INORG CHEM, V54, P2950, DOI 10.1021/acs.inorgchem.5b00031; Williams CL, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00016; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	53	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101078	10.1016/j.jbc.2021.101078	http://dx.doi.org/10.1016/j.jbc.2021.101078			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34400169	Green Published, Green Submitted, gold			2022-12-28	WOS:000706409200004
J	Kitaoku, Y; Fukamizo, T; Kumsaoad, S; Ubonbal, P; Robinson, RC; Suginta, W				Kitaoku, Yoshihito; Fukamizo, Tamo; Kumsaoad, Sawitree; Ubonbal, Prakayfun; Robinson, Robert C.; Suginta, Wipa			A structural model for (GlcNAc)(2) translocation via a periplasmic chitooligosaccharide-binding protein from marine Vibrio bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHITIN UTILIZATION; MOLECULAR-CLONING; HARVEYI; REFINEMENT; PROGRAM; OLIGOSACCHARIDES; CLASSIFICATION; CATABOLISM; CHITOPORIN; ACCURACY	VhCBP is a periplasmic chitooligosaccharide-binding protein mainly responsible for translocation of the chitooligosaccharide (GlcNAc)(2) across the double membranes of marine bacteria. However, structural and thermodynamic understanding of the sugar-binding/-release processes of VhCBP is relatively less. VhCBP displayed the greatest affinity toward (GlcNAc)(2), with lower affinity for longer-chain chitooligosaccharides [(GlcNAc)(3-4)]. (GlcNAc)(4) partially occupied the closed sugar-binding groove, with two reducing-end GlcNAc units extending beyond the sugar-binding groove and barely characterized by weak electron density. Mutation of three conserved residues (Trp(363), ASp(365), and Trp(513)) to Ala resulted in drastic decreases in the binding affinity toward the preferred substrate (GlcNAc)(2), indicating their significant contributions to sugar binding. The structure of the W513A-(GlcNAc)(2) complex in a 'half-open' conformation unveiled the intermediary step of the (GlcNAc)(2) translocation from the soluble CBP in the periplasm to the inner membrane-transporting components. Isothermal calorimetry data suggested that VhCBP adopts the high-affinity conformation to bind (GlcNAc)(2), while its low-affinity conformation facilitated sugar release. Thus, chitooligosaccharide translocation, conferred by periplasmic VhCBP, is a crucial step in the chitin catabolic pathway, allowing Vibrio bacteria to thrive in oceans where chitin is their major source of nutrients.	[Kitaoku, Yoshihito; Fukamizo, Tamo; Kumsaoad, Sawitree; Ubonbal, Prakayfun; Robinson, Robert C.; Suginta, Wipa] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong, Thailand; [Robinson, Robert C.] Okayama Univ, Res Inst Interdisciplinary Sci RIIS, Okayama, Japan	Vidyasirimedhi Institute of Science & Technology; Okayama University	Fukamizo, T; Robinson, RC; Suginta, W (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn BSE, Rayong, Thailand.; Robinson, RC (corresponding author), Okayama Univ, Res Inst Interdisciplinary Sci RIIS, Okayama, Japan.	tamo0111fuka@gmail.com; br.okayama.u@gmail.com; wipa.s@vistec.ac.th	; robinson, robert/G-9702-2011	Fukamizo, Tamo/0000-0002-4713-0246; robinson, robert/0000-0001-6367-6903; Suginta, Wipa/0000-0001-5927-7192	Vidyasirimedhi Institute of Science and Technology [300/111100/1711111000030]; Thailand Research Fund [BRG610008]; Thailand Science Research and Innovation [PMUB-P5-63-B20PIC_WIS_CHU-PMB010]	Vidyasirimedhi Institute of Science and Technology; Thailand Research Fund(Thailand Research Fund (TRF)); Thailand Science Research and Innovation	We thank Linh Thuy Tran for X-ray data collection and the technical services provided by the Synchrotron Radiation Protein Crystallography Facility of the National Core Facility Program for Biotechnology, Ministry of Science and Technology, and the National Synchrotron Radiation Research Center (NSRRC), Taiwan. We also thank the beamline TPS-05A staff who supported in X-ray diffraction data collection and data processing. We greatly appreciate Dr David Apps, the University of Edinburgh Medical School, U.K., for critical reading and English improvement of the manuscript. This research was supported by Vidyasirimedhi Institute of Science and Technology (300/111100/1711111000030) and Thailand Research Fund through The Basic Research Grant (BRG610008). This grant is partially supported by Thailand Science Research and Innovation through Global Partnership Grant (Contract no: PMUB-P5-63-B20PIC_WIS_CHU-PMB010).	Afonine PV, 2013, ACTA CRYSTALLOGR D, V69, P625, DOI 10.1107/S0907444913000462; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Afonine PV, 2009, J APPL CRYSTALLOGR, V42, P607, DOI 10.1107/S0021889809023528; Aunkham A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02523-y; Austin B, 2006, LETT APPL MICROBIOL, V43, P119, DOI 10.1111/j.1472-765X.2006.01989.x; BASSLER BL, 1991, J BIOL CHEM, V266, P24276; Chitlaru E, 1996, J BIOL CHEM, V271, P33433, DOI 10.1074/jbc.271.52.33433; Chumjan W, 2015, J BIOL CHEM, V290, P19184, DOI 10.1074/jbc.M115.660530; Cuneo MJ, 2009, J BIOL CHEM, V284, P33217, DOI 10.1074/jbc.M109.041624; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERENCI T, 1980, EUR J BIOCHEM, V108, P631, DOI 10.1111/j.1432-1033.1980.tb04758.x; Franca EF, 2008, J CHEM THEORY COMPUT, V4, P2141, DOI 10.1021/ct8002964; Fukamizo T, 2019, INT J BIOL MACROMOL, V128, P985, DOI 10.1016/j.ijbiomac.2019.02.064; Headd JJ, 2012, ACTA CRYSTALLOGR D, V68, P381, DOI 10.1107/S0907444911047834; Kaneko A, 2017, J BIOL CHEM, V292, P15681, DOI 10.1074/jbc.M117.793992; Keyhani NO, 2000, J BIOL CHEM, V275, P33068, DOI 10.1074/jbc.M001041200; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Klancher CA, 2020, P NATL ACAD SCI USA, V117, P20180, DOI 10.1073/pnas.2001768117; Li XB, 2004, P NATL ACAD SCI USA, V101, P627, DOI 10.1073/pnas.0307645100; Li XB, 2007, GLYCOBIOLOGY, V17, P1377, DOI 10.1093/glycob/cwm096; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Maruyama Y, 2015, STRUCTURE, V23, P1643, DOI 10.1016/j.str.2015.06.021; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meibom KL, 2004, P NATL ACAD SCI USA, V101, P2524, DOI 10.1073/pnas.0308707101; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Ohnuma T, 2011, FEBS J, V278, P3991, DOI 10.1111/j.1742-4658.2011.08301.x; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Songsiriritthigul C, 2008, J STRUCT BIOL, V162, P491, DOI 10.1016/j.jsb.2008.03.008; Soysa HSM, 2020, J BIOL CHEM, V295, P9421, DOI 10.1074/jbc.RA120.012921; SPURLINO JC, 1991, J BIOL CHEM, V266, P5202; Suginta W, 2005, FEBS J, V272, P3376, DOI 10.1111/j.1742-4658.2005.04753.x; Suginta W, 2000, J APPL MICROBIOL, V89, P76, DOI 10.1046/j.1365-2672.2000.01076.x; Suginta W, 2018, J BIOL CHEM, V293, P5150, DOI 10.1074/jbc.RA117.001012; Suginta W, 2013, J BIOL CHEM, V288, P11038, DOI 10.1074/jbc.M113.454108; Suginta W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055126; Suginta W, 2010, BMC BIOCHEM, V11, DOI 10.1186/1471-2091-11-40; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Turnbull WB, 2003, J AM CHEM SOC, V125, P14859, DOI 10.1021/ja036166s; vanAalten DMF, 1996, J COMPUT AID MOL DES, V10, P255, DOI 10.1007/BF00355047; Wilkinson A. J., 2003, ABC PROTEINS BACTERI; Zhang XH, 2018, SCI CHINA EARTH SCI, V61, P1357, DOI 10.1007/s11430-017-9229-x	46	0	0	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101071	10.1016/j.jbc.2021.101071	http://dx.doi.org/10.1016/j.jbc.2021.101071			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34400168	gold, Green Published			2022-12-28	WOS:000714635500005
J	Chatterjee, KS; Das, R				Chatterjee, Kiran Sankar; Das, Ranabir			An "up" oriented methionine-aromatic structural motif in SUMO is critical for its stability and activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINEAR CONSTRAINT SOLVER; PARTICLE MESH EWALD; PI-INTERACTIONS; PROTEIN; SUMOYLATION; PHENYLALANINE; OXIDATION; GEOMETRY; SYSTEM; SENP3	Protein structural bioinformatic analyses suggest preferential associations between methionine and aromatic amino acid residues in proteins. Ab initio energy calculations highlight a conformation-dependent stabilizing interaction between the interacting sulfur-aromatic molecular pair. However, the relevance of buried methionine-aromatic motifs to protein folding and function is relatively unexplored. The Small Ubiquitin-Like Modifier (SUMO) is a beta-grasp fold protein and a common posttranslational modifier that affects diverse cellular processes, including transcriptional regulation, chromatin remodeling, metabolic regulation, mitosis, and meiosis. SUMO is a member of the Ubiquitin-Like (UBL) protein family. Herein, we report that a highly conserved and buried methionine-phenylalanine motif is a unique signature of SUMO proteins but absent in other homologous UBL proteins. We also detect that a specific "up" conformation between the methionine-phenylalanine pair of interacting residues in SUMO is critical to its beta-grasp fold. The noncovalent interactions of SUMO with its ligands are dependent on the methionine-phenylalanine pair. MD simulations, NMR, and biophysical and biochemical studies suggest that perturbation of the methionine-aromatic motif disrupts native contacts, modulates noncovalent interactions, and attenuates SUMOylation activity. Our results highlight the importance of conserved orientations of Met-aromatic structural motifs inside a protein core for its structure and function.	[Chatterjee, Kiran Sankar; Das, Ranabir] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, India	Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS)	Das, R (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bengaluru, India.	rana@ncbs.res.in			Department of Atomic Energy, Government of India [RTI 4006]; Tata Institute of Fundamental Research; Department of Biotechnology, B-Life [dbt/pr12422/med/31/287/2014]	Department of Atomic Energy, Government of India(Department of Atomic Energy (DAE)); Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR)); Department of Biotechnology, B-Life	We acknowledge the support of the Department of Atomic Energy, Government of India, under project identification no RTI 4006. The NMR data were acquired at the NCBS-TIFR NMR Facility, supported by the Department of Atomic Energy, Government of India, under project no RTI 4006. The work was supported by intramural grants from the Tata Institute of Fundamental Research. The NMR facility is also partially supported by the Department of Biotechnology, B-Life grant under project number dbt/pr12422/med/31/287/2014. K. S. C. is thankful to Priyesh Mohanty and Aravind Ravichandran for their suggestions with MD simulations. K. S. C. is thankful to Teerna Bhattacharya for her suggestions with bioinformatic analyses. K. S. C. is also thankful to Hitendra Negi, Gajendra Singh, and Vasvi Tripathi for their help with SUMOylation assays.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Azuma Y, 2001, FASEB J, V15, P1825, DOI 10.1096/fj.00-0818fje; Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Cappadocia L, 2015, STRUCTURE, V23, P126, DOI 10.1016/j.str.2014.10.015; CARDAMONE M, 1992, BIOCHEM J, V282, P589, DOI 10.1042/bj2820589; Chakrabarti P, 2007, PROG BIOPHYS MOL BIO, V95, P83, DOI 10.1016/j.pbiomolbio.2007.03.016; Chatterjee KS, 2020, BIOCHEM BIOPH RES CO, V524, P677, DOI 10.1016/j.bbrc.2020.01.144; Chatterjee KS, 2019, J BIOL CHEM, V294, P6772, DOI 10.1074/jbc.RA118.006642; Chu Y, 2011, ONCOGENE, V30, P1108, DOI 10.1038/onc.2010.462; Daeffler KNM, 2012, J AM CHEM SOC, V134, P14890, DOI 10.1021/ja304560x; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Feligioni M, 2013, NEUROMOL MED, V15, P707, DOI 10.1007/s12017-013-8266-6; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Huang C, 2009, EMBO J, V28, P2748, DOI 10.1038/emboj.2009.210; HUNTER CA, 1991, J MOL BIOL, V218, P837, DOI 10.1016/0022-2836(91)90271-7; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kneller D. G., 1993, J CELL BIOCHEM, V53, P239; Knipscheer P, 2007, EMBO J, V26, P2797, DOI 10.1038/sj.emboj.7601711; Kung CCH, 2014, BIOCHEM J, V462, P53, DOI 10.1042/BJ20140521; Lallemand-Breitenbach V, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000661; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lewis AK, 2016, NAT CHEM BIOL, V12, P860, DOI [10.1038/NCHEMBIO.2159, 10.1038/nchembio.2159]; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Okuma T, 1999, BIOCHEM BIOPH RES CO, V254, P693, DOI 10.1006/bbrc.1998.9995; Orabi EA, 2018, PHYS CHEM CHEM PHYS, V20, P23132, DOI 10.1039/c8cp03277g; Orabi EA, 2018, J PHYS CHEM B, V122, P3760, DOI 10.1021/acs.jpcb.8b00089; Pal D, 2001, J BIOMOL STRUCT DYN, V19, P115, DOI 10.1080/07391102.2001.10506725; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pranata J, 1997, BIOORG CHEM, V25, P213, DOI 10.1006/bioo.1997.1064; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; SERRANO L, 1991, J MOL BIOL, V218, P465, DOI 10.1016/0022-2836(91)90725-L; Simpson R. J, 2003, PROTEINS PROTEOMICS, P143; Tatko CD, 2004, PROTEIN SCI, V13, P2515, DOI 10.1110/ps.04820104; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; Welchman RL, 2005, NAT REV MOL CELL BIO, V6, P599, DOI 10.1038/nrm1700; Werner A, 2012, MOL CELL, V46, P287, DOI 10.1016/j.molcel.2012.02.017; Yan S, 2010, EMBO J, V29, P3773, DOI 10.1038/emboj.2010.245; Zauhar RJ, 2000, BIOPOLYMERS, V53, P233, DOI 10.1002/(SICI)1097-0282(200003)53:3<233::AID-BIP3>3.3.CO;2-W	55	0	0	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100970	10.1016/j.jbc.2021.100970	http://dx.doi.org/10.1016/j.jbc.2021.100970			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34274315	gold, Green Published			2022-12-28	WOS:000690871400013
J	Kowalewski, GP; Wildeman, AS; Bogliolo, S; Besold, AN; Bassilana, M; Culotta, VC				Kowalewski, Griffin P.; Wildeman, Asia S.; Bogliolo, Stephanie; Besold, Angelique N.; Bassilana, Martine; Culotta, Valeria C.			Cdc42 regulates reactive oxygen species production in the pathogenic yeast Candida albicans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NADPH-OXIDASE; POLARIZED GROWTH; EXCHANGE FACTOR; GTPASE; RAC; GENERATION; ROLES; IDENTIFICATION; LOCALIZATION; ACTIVATION	Across eukaryotes, Rho GTPases such as Rac and Cdc42 play important roles in establishing cell polarity, which is a key feature of cell growth. In mammals and filamentous fungi, Rac targets large protein complexes containing NADPH oxidases (NOX) that produce reactive oxygen species (ROS). In comparison, Rho GTPases of unicellular eukaryotes were believed to signal cell polarity without ROS, and it was unclear whether Rho GTPases were required for ROS production in these organisms. We document here the first example of Rho GTPase-mediated post-transcriptional control of ROS in a unicellular microbe. Specifically, Cdc42 is required for ROS production by the NOX Fre8 of the opportunistic fungal pathogen Candida albicans. During morphogenesis to a hyphal form, a filamentous growth state, C. albicans FRE8 mRNA is induced, which leads to a burst in ROS. Fre8-ROS is also induced during morphogenesis when FRE8 is driven by an ectopic promoter; hence, Fre8 ROS production is in addition controlled at the post-transcriptional level. Using fluorescently tagged Fre8, we observe that the majority of the protein is associated with the vacuolar system. Interestingly, much of Fre8 in the vacuolar system appears inactive, and Fre8-induced ROS is only produced at sites near the hyphal tip, where Cdc42 is also localized during morphogenesis. We observe that Cdc42 is necessary to activate Fre8-mediated ROS production during morphogenesis. Cdc42 regulation of Fre8 occurs without the large NOX protein complexes typical of higher eukaryotes and therefore represents a novel form of ROS control by Rho GTPases.	[Kowalewski, Griffin P.; Wildeman, Asia S.; Besold, Angelique N.; Culotta, Valeria C.] Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA; [Bogliolo, Stephanie; Bassilana, Martine] Univ Cote dAzur, Inst Biol Valrose iBV, INSERM, CNRS, Parc Valrose, Nice, France	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Culotta, VC (corresponding author), Johns Hopkins Univ, Dept Biochem & Mol Biol, Bloomberg Sch Publ Hlth, Baltimore, MD 21218 USA.	vculott1@jhu.edu	Bassilana, Martine/AAS-5814-2021		National Institutes of Health [R35 GM136644]; CNRS; ANR [ANR-19-CE13-0004-01]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CNRS(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR))	This work was supported by the National Institutes of Health grant R35 GM136644 (to V. C. C.) and by the CNRS and ANR grant ANR-19-CE13-0004-01 (to M. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguirre J, 2005, TRENDS MICROBIOL, V13, P111, DOI 10.1016/j.tim.2005.01.007; Arkowitz Robert A, 2019, F1000Res, V8, DOI 10.12688/f1000research.18546.1; Bassilana M, 2006, EUKARYOT CELL, V5, P321, DOI 10.1128/EC.5.2.321-329.2006; Bassilana M, 2005, EUKARYOT CELL, V4, P588, DOI 10.1128/EC.4.3.588-603.2005; Bassilana M, 2003, EUKARYOT CELL, V2, P9, DOI 10.1128/EC.2.1.9-18.2003; Bassilana M, 2020, CURR OPIN CELL BIOL, V62, P150, DOI 10.1016/j.ceb.2019.11.001; Brand AC, 2014, P NATL ACAD SCI USA, V111, P811, DOI 10.1073/pnas.1307264111; Cano-Dominguez N, 2008, EUKARYOT CELL, V7, P1352, DOI 10.1128/EC.00137-08; Cano-Dominguez N, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01825; Chi MH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149548; Corvest V, 2013, MOL MICROBIOL, V89, P626, DOI 10.1111/mmi.12302; Court H, 2007, MOL BIOL CELL, V18, P265, DOI 10.1091/mbc.E06-05-0411; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; Diebold BA, 2004, J BIOL CHEM, V279, P28136, DOI 10.1074/jbc.M313891200; Diepeveen ET, 2018, GENOME BIOL EVOL, V10, P1765, DOI 10.1093/gbe/evy121; Dingjan I, 2017, J CELL SCI, V130, P1285, DOI 10.1242/jcs.196931; Egan MJ, 2007, P NATL ACAD SCI USA, V104, P11772, DOI 10.1073/pnas.0700574104; Fukai T, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081849; Gratacap RL, 2013, DIS MODEL MECH, V6, P1260, DOI 10.1242/dmm.012039; Hazan I, 2002, EUKARYOT CELL, V1, P856, DOI 10.1128/EC.1.6.856-864.2002; Hope H, 2008, MOL BIOL CELL, V19, P3638, DOI 10.1091/mbc.E07-12-1272; Hu CH, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020437; Johnson DI, 1999, MICROBIOL MOL BIOL R, V63, P54, DOI 10.1128/MMBR.63.1.54-105.1999; Kao YY, 2008, J BIOL CHEM, V283, P12736, DOI 10.1074/jbc.M801010200; Kayano Y, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006840; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; KWONG CH, 1995, J BIOL CHEM, V270, P19868, DOI 10.1074/jbc.270.34.19868; Lacaze I, 2015, MOL MICROBIOL, V95, P1006, DOI 10.1111/mmi.12876; Lalucque H, 2003, TRENDS MICROBIOL, V11, P9, DOI 10.1016/S0966-842X(02)00007-0; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; Nauseef WM, 2008, J BIOL CHEM, V283, P16961, DOI 10.1074/jbc.R700045200; Parascandolo A, 2019, ANTIOXID REDOX SIGN, V30, P443, DOI 10.1089/ars.2017.7268; Peng LP, 2019, FUNGAL GENET BIOL, V133, DOI 10.1016/j.fgb.2019.103282; Pick Edgar, 2014, Small GTPases, V5, pe27952, DOI 10.4161/sgtp.27952; Rinnerthaler M, 2012, P NATL ACAD SCI USA, V109, P8658, DOI 10.1073/pnas.1201629109; Rossi DCP, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006763; Schatzman SS, 2020, J BIOL CHEM, V295, P570, DOI 10.1074/jbc.RA119.011084; Silva PM, 2019, CELL REP, V28, P2231, DOI 10.1016/j.celrep.2019.07.062; SIMON MN, 1995, NATURE, V376, P702, DOI 10.1038/376702a0; Takemoto D, 2007, FUNGAL GENET BIOL, V44, P1065, DOI 10.1016/j.fgb.2007.04.011; Takemoto D, 2011, P NATL ACAD SCI USA, V108, P2861, DOI 10.1073/pnas.1017309108; Tournu H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171145; Ushinsky SC, 2002, EUKARYOT CELL, V1, P95, DOI 10.1128/EC.1.1.95-104.2002; Weber M, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10020322; Wei W, 2016, SCI REP-UK, V6, DOI 10.1038/srep24325; Whiteway M, 2004, CURR OPIN MICROBIOL, V7, P350, DOI 10.1016/j.mib.2004.06.005; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Wong HL, 2007, PLANT CELL, V19, P4022, DOI 10.1105/tpc.107.055624; Yin SN, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00178; Zhang CD, 2010, EUKARYOT CELL, V9, P224, DOI 10.1128/EC.00327-09; Zhang XZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058126	52	1	1	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100917	10.1016/j.jbc.2021.100917	http://dx.doi.org/10.1016/j.jbc.2021.100917			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34181946	gold, Green Published			2022-12-28	WOS:000690879300009
J	Liu, HQ; Lu, ZW; Shi, XF; Liu, LL; Zhang, PS; Golemis, EA; Tu, ZG				Liu, Hanqing; Lu, Ziwen; Shi, Xiaofeng; Liu, Lanlan; Zhang, Peishan; Golemis, Erica A.; Tu, Zhigang			HSP90 inhibition downregulates DNA replication and repair genes via E2F1 repression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANTLE CELL LYMPHOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; POTENT ANTITUMOR-ACTIVITY; MOLECULAR CHAPERONE; GANETESPIB STA-9090; ONCOGENIC RAS; IN-VITRO; EXPRESSION; CANCER; TRANSCRIPTION	Mantle cell lymphoma (MCL) is an especially aggressive and highly heterogeneous mature B-cell lymphoma. Heat shock protein 90 (HSP90) is considered an attractive therapeutic target in a variety of cancers, including MCL, but no HSP90 inhibitors have succeeded in the clinical trials to date. Exploring fine mechanisms of HSP90 inhibition in cancer cells may shed light on novel therapeutic strategies. Here, we found that HSP90 knockdown and continuous inhibition with ganetespib inhibited growth of MCL cells in vitro and in vivo. To our surprise, transient exposure over 12 h was almost as efficient as continuous exposure, and treatment with ganetespib for 12 h efficiently inhibited growth and induced G1 cell cycle arrest and apoptosis of MCL cells. Transcriptome analysis complemented by functional studies was performed to define critical MCL signaling pathways that are exceptionally sensitive to HSP90 inhibition and vital to cell fate. Six genes (cell division cycle 6, cell division cycle 45, minichromosome maintenance 4, minichromosome maintenance 7, RecQ-mediated genome instability 2, and DNA primase polypeptide 1) involved in DNA replication and repair were identified as consistently downregulated in three MCL cell lines after transient ganetespib treatment. E2F1, an important transcription factor essential for cell cycle progression, was identified as a ganetespib target mediating transcriptional downregulation of these six genes, and its stability was also demonstrated to be maintained by HSP90. This study identifies E2F1 as a novel client protein of HSP90 that is very sensitive and worthy of targeting and also finds that HSP90 inhibitors may be useful in combination therapies for MCL.	[Liu, Hanqing; Lu, Ziwen; Zhang, Peishan] Jiangsu Univ, Sch Pharm, Zhenjiang, Jiangsu, Peoples R China; [Shi, Xiaofeng] Jiangsu Univ, Affiliated Hosp, Zhenjiang, Jiangsu, Peoples R China; [Liu, Lanlan; Tu, Zhigang] Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China; [Zhang, Peishan; Golemis, Erica A.] Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Jiangsu University; Jiangsu University; Jiangsu University; Fox Chase Cancer Center	Tu, ZG (corresponding author), Jiangsu Univ, Sch Life Sci, Zhenjiang, Jiangsu, Peoples R China.; Golemis, EA (corresponding author), Fox Chase Canc Ctr, Mol Therapeut Program, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Erica.Golemis@fccc.edu; zhigangtu@ujs.edu.cn			National Natural Science Foundation of China [81672582, 31771521]; Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars [BK20160013]; Natural Science Foundation of Jiangsu Province [BE2016718]; Top Talent of Innovative Research Team of Jiangsu Province; Six Talent Peak Project from Government of Jiangsu Province [2015-SWYY-019, 2016-SWYY-011]; Start-up Scientific Research Fund for the Returned Oversea Scholars from Chinese Ministry of Education [P30 CA006927]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Top Talent of Innovative Research Team of Jiangsu Province; Six Talent Peak Project from Government of Jiangsu Province; Start-up Scientific Research Fund for the Returned Oversea Scholars from Chinese Ministry of Education	The authors and this work were supported by the National Natural Science Foundation of China 81672582 (to H. L.) and 31771521 (to Z. T.); Natural Science Foundation of Jiangsu Province for Distinguished Young Scholars BK20160013 (to H. L.); Natural Science Foundation of Jiangsu Province BE2016718 (to Z. T.); Top Talent of Innovative Research Team of Jiangsu Province (to H. L. and Z. T.); Six Talent Peak Project from Government of Jiangsu Province 2015-SWYY-019 (to H. L.) and 2016-SWYY-011 (to Z. T.); Start-up Scientific Research Fund for the Returned Oversea Scholars from Chinese Ministry of Education (to Z. T.); and P30 CA006927 (to Fox Chase Cancer Center).	Alvarez S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9548; Amin HM, 2003, ARCH PATHOL LAB MED, V127, P424; Braun KA, 2007, MOL BIOL CELL, V18, P1447, DOI 10.1091/mbc.E06-09-0792; Cerchietti LC, 2009, NAT MED, V15, P1369, DOI 10.1038/nm.2059; Chiarle R, 2000, BLOOD, V95, P619, DOI 10.1182/blood.V95.2.619; Chung W, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15081; Dancey J, 2010, NAT REV CLIN ONCOL, V7, P209, DOI 10.1038/nrclinonc.2010.21; Ding H, 2017, LEUKEMIA, V31, P1593, DOI 10.1038/leu.2016.357; Divakar SKA, 2016, LEUKEMIA, V30, P86, DOI 10.1038/leu.2015.185; Dougherty DC, 2005, BIOTECHNIQUES, V39, P203, DOI 10.2144/05392ST02; Drakos E, 2009, LEUKEMIA, V23, P784, DOI 10.1038/leu.2008.348; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkz1031, 10.1093/nar/gkx1132]; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; FERRARINI M, 1992, INT J CANCER, V51, P613, DOI 10.1002/ijc.2910510418; Gabbasov R., 2019, CANCER BIOL THER, V20, P1035, DOI DOI 10.1080/15384047.2019.1595279; Ganji PN, 2013, ANGIOGENESIS, V16, P903, DOI 10.1007/s10456-013-9364-7; Giulino-Roth L, 2017, MOL CANCER THER, V16, P1779, DOI 10.1158/1535-7163.MCT-16-0848; Gopalakrishnan R, 2013, CLIN CANCER RES, V19, P5016, DOI 10.1158/1078-0432.CCR-12-3510; Guan LL, 2020, ONCOTARGETS THER, V13, P2997, DOI 10.2147/OTT.S245813; Hayashi R, 2006, GENE, V367, P126, DOI 10.1016/j.gene.2005.10.002; He SQ, 2014, INVEST NEW DRUG, V32, P577, DOI 10.1007/s10637-014-0095-4; Hertlein E, 2010, BLOOD, V116, P45, DOI 10.1182/blood-2010-01-263756; Hoadley KA, 2012, P NATL ACAD SCI USA, V109, P4437, DOI 10.1073/pnas.1117279109; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson DF, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006483; Jacobson C, 2016, BLOOD, V128, P2517, DOI 10.1182/blood-2016-04-711176; Jares P, 2008, BRIT J HAEMATOL, V142, P149, DOI 10.1111/j.1365-2141.2008.07124.x; Jhaveri K, 2015, ONCOTARGETS THER, V8, DOI 10.2147/OTT.S65804; Jin L, 2011, BRIT J CANCER, V104, P91, DOI 10.1038/sj.bjc.6606007; Kamal A, 2003, NATURE, V425, P407, DOI 10.1038/nature01913; Korz C, 2002, BLOOD, V99, P4554, DOI 10.1182/blood.V99.12.4554; Kotwal A, 2021, EUR J CELL BIOL, V100, DOI 10.1016/j.ejcb.2020.151148; Li J, 2014, CELL METAB, V19, P373, DOI 10.1016/j.cmet.2014.01.001; Li ZL, 2012, CANCER RES, V72, P5014, DOI 10.1158/0008-5472.CAN-12-0635; Lin SF, 2017, ONCOTARGET, V8, P41294, DOI 10.18632/oncotarget.17180; Liu H, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.555; Liu HQ, 2013, CLIN CANCER RES, V19, P5053, DOI 10.1158/1078-0432.CCR-13-1115; Marzec M, 2006, BLOOD, V108, P1744, DOI 10.1182/blood-2006-04-016634; Neckers L, 2012, CLIN CANCER RES, V18, P64, DOI 10.1158/1078-0432.CCR-11-1000; O'Leary B, 2016, NAT REV CLIN ONCOL, V13, P417, DOI 10.1038/nrclinonc.2016.26; Ohtani K, 1999, ONCOGENE, V18, P2299, DOI 10.1038/sj.onc.1202544; Parekh S, 2011, SEMIN CANCER BIOL, V21, P335, DOI 10.1016/j.semcancer.2011.09.008; Perez-Galan P, 2011, BLOOD, V117, P26, DOI 10.1182/blood-2010-04-189977; Pillai RN, 2020, J CLIN ONCOL, V38, P613, DOI 10.1200/JCO.19.00816; Proia DA, 2014, CANCER RES, V74, P1294, DOI 10.1158/0008-5472.CAN-13-3263; Proia DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018552; Roue G, 2011, BLOOD, V117, P1270, DOI 10.1182/blood-2010-04-278853; Shang DS, 2018, CLIN EXP PHARMACOL P, V45, P452, DOI 10.1111/1440-1681.12891; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Sheu YJ, 2016, GENOME RES, V26, P315, DOI 10.1101/gr.195248.115; Shima N, 2007, NAT GENET, V39, P93, DOI 10.1038/ng1936; Shimamura T, 2012, CLIN CANCER RES, V18, P4973, DOI 10.1158/1078-0432.CCR-11-2967; Singh TR, 2008, GENE DEV, V22, P2856, DOI 10.1101/gad.1725108; Smid M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12910; Solier S, 2012, P NATL ACAD SCI USA, V109, P12866, DOI 10.1073/pnas.1203617109; Sun MM, 2018, NUCLEIC ACIDS RES, V46, P6697, DOI 10.1093/nar/gky487; Suzuki M, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00280; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; Tsutsumi S, 2007, CANCER SCI, V98, P1536, DOI 10.1111/j.1349-7006.2007.00561.x; Tu ZG, 2013, MOL CELL BIOL, V33, P1819, DOI 10.1128/MCB.01744-12; Tu ZG, 2011, DEV CELL, V21, P1077, DOI 10.1016/j.devcel.2011.10.010; Valbuena JR, 2005, MODERN PATHOL, V18, P1343, DOI 10.1038/modpathol.3800459; Wang M, 2014, BRIT J HAEMATOL, V165, P510, DOI 10.1111/bjh.12780; Wei CL, 2015, IEEE T BIOMED CIRC S, V9, P105, DOI 10.1109/TBCAS.2014.2315532; Witzig TE, 2011, LEUKEMIA, V25, P341, DOI 10.1038/leu.2010.226; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603; Ying WW, 2012, MOL CANCER THER, V11, P475, DOI 10.1158/1535-7163.MCT-11-0755; Yoshida K, 2004, ONCOGENE, V23, P3802, DOI 10.1038/sj.onc.1207488	69	8	8	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100996	10.1016/j.jbc.2021.100996	http://dx.doi.org/10.1016/j.jbc.2021.100996			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302809	gold, Green Published			2022-12-28	WOS:000690868100013
J	Thackray, AM; Andreoletti, O; Spiropoulos, J; Bujdoso, R				Thackray, Alana M.; Andreoletti, Olivier; Spiropoulos, John; Bujdoso, Raymond			A new model for sensitive detection of zoonotic prions by PrP transgenic Drosophila	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BOVINE SPONGIFORM ENCEPHALOPATHY; NERVOUS-SYSTEM; BSE PRIONS; PROTEIN; MICE; INFECTIVITY; TRANSMISSION; IDENTIFICATION; DIVERSITY; STRAINS	Prions are transmissible protein pathogens most reliably detected by a bioassay in a suitable host, typically mice. However, the mouse bioassay is slow and cumbersome, and relatively insensitive to low titers of prion infectivity. Prions can be detected biochemically in vitro by the protein misfolding cyclic amplification (PMCA) technique, which amplifies diseaseassociated prion protein but does not detect bona fide prion infectivity. Here, we demonstrate that Drosophila transgenic for bovine prion protein (PrP) expression can serve as a model system for the detection of bovine prions significantly more efficiently than either the mouse prion bioassay or PMCA. Strikingly, bovine PrP transgenic Drosophila could detect bovine prion infectivity in the region of a 10-12 dilution of classical bovine spongiform encephalopathy (BSE) inoculum, which is 106-fold more sensitive than that achieved by the bovine PrP mouse bioassay. A similar level of sensitivity was observed in the detection of H-type and L-type atypical BSE and sheep-passaged BSE by bovine PrP transgenic Drosophila. Bioassays of bovine prions in Drosophila were performed within 7 weeks, whereas the mouse prion bioassay required at least a year to assess the same inoculum. In addition, bovine PrP transgenic Drosophila could detect classical BSE at a level 105-fold lower than that achieved by PMCA. These data show that PrP transgenic Drosophila represent a new tractable prion bioassay for the efficient and sensitive detection of mammalian prions, including those of known zoonotic potential.	[Thackray, Alana M.; Bujdoso, Raymond] Univ Cambridge, Dept Vet Med, Cambridge, England; [Andreoletti, Olivier] Ecole Natl Vet Toulouse, UMR INRA ENVT 1225, Hotes Agents Pathogenes, Toulouse, France; [Spiropoulos, John] Anim & Plant Hlth Agcy APHA, Pathol Dept, Addlestone, Surrey, England	University of Cambridge; INRAE; Universite de Toulouse; Ecole Nationale Veterinaire de Toulouse; Animal & Plant Health Agency UK	Bujdoso, R (corresponding author), Univ Cambridge, Dept Vet Med, Cambridge, England.	rb202@cam.ac.uk	Thackray, Alana/S-3658-2017	Thackray, Alana/0000-0002-2752-1127	NC3Rs Skills and Knowledge Transfer Grant [NC/R00093X/1]	NC3Rs Skills and Knowledge Transfer Grant	This work was partly funded by the NC3Rs Skills and Knowledge Transfer Grant (Grant NC/R00093X/1) held by R. B. and A. M. T.	Babelhadj B, 2018, EMERG INFECT DIS, V24, P1029, DOI 10.3201/eid2406.172007; Baron T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015839; Beck KE, 2010, BRAIN PATHOL, V20, P313, DOI 10.1111/j.1750-3639.2009.00273.x; Benestad SL, 2016, VET RES, V47, DOI 10.1186/s13567-016-0375-4; Beringue V, 2007, J NEUROSCI, V27, P6965, DOI 10.1523/JNEUROSCI.0693-07.2007; Biacabe AG, 2004, EMBO REP, V5, P110, DOI 10.1038/sj.embor.7400054; Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104; Bishop MT, 2006, LANCET NEUROL, V5, P393, DOI 10.1016/S1474-4422(06)70413-6; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; Bruce ME, 1997, NATURE, V389, P498, DOI 10.1038/39057; Buschmann A, 2005, J INFECT DIS, V192, P934, DOI 10.1086/431602; Buschmann A, 2000, ARCH VIROL, P75; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Casalone C, 2004, P NATL ACAD SCI USA, V101, P3065, DOI 10.1073/pnas.0305777101; Castilla J, 2003, ARCH VIROL, V148, P677, DOI 10.1007/s00705-002-0958-4; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Green C, 2000, GENETICS, V156, P1117; Groschup MH, 2008, VET RES, V39, DOI 10.1051/vetres:2008008; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hill AF, 1997, NATURE, V389, P448, DOI 10.1038/38925; Jacobs JG, 2007, J CLIN MICROBIOL, V45, P1821, DOI 10.1128/JCM.00160-07; Kaatz M, 2012, AM J PATHOL, V181, P515, DOI 10.1016/j.ajpath.2012.05.001; Katorcha E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004366; Kupfer L, 2007, BBA-MOL BASIS DIS, V1772, P704, DOI 10.1016/j.bbadis.2006.10.009; Lacroux C, 2012, J VIROL, V86, P2056, DOI 10.1128/JVI.06532-11; Lasmezas CI, 1997, SCIENCE, V275, P402, DOI 10.1126/science.275.5298.402; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Marchal I, 2001, BIOL CHEM, V382, P151, DOI 10.1515/BC.2001.023; Marz L., 1995, PROTEIN GLYCOSYLATIO; Miyazawa K, 2011, J CELL BIOCHEM, V112, P3630, DOI 10.1002/jcb.23286; Moremen KW, 2012, NAT REV MOL CELL BIO, V13, P448, DOI 10.1038/nrm3383; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 2004, PRION BIOL DIS; Repnikova E, 2010, J NEUROSCI, V30, P6466, DOI 10.1523/JNEUROSCI.5253-09.2010; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Scott MR, 1997, P NATL ACAD SCI USA, V94, P14279, DOI 10.1073/pnas.94.26.14279; Stimson E, 1999, BIOCHEMISTRY-US, V38, P4885, DOI 10.1021/bi982330q; Thackray AM, 2018, BRAIN, V141, P2700, DOI 10.1093/brain/awy183; Thackray AM, 2016, BIOCHEM J, V473, P4399, DOI 10.1042/BCJ20160417; Wang F, 2010, SCIENCE, V327, P1132, DOI 10.1126/science.1183748; WELLS GAH, 1987, VET REC, V121, P419, DOI 10.1136/vr.121.18.419; Wells GAH, 2005, VET REC, V156, P401, DOI 10.1136/vr.156.13.401; WELLS GAH, 1994, VET REC, V135, P40, DOI 10.1136/vr.135.2.40; White KE, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/fnins.2010.00205; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wilson R, 2012, J GEN VIROL, V93, P1132, DOI 10.1099/vir.0.040030-0; Zeidler M, 2000, REV SCI TECH OIE, V19, P98, DOI 10.20506/rst.19.1.1206	50	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100878	10.1016/j.jbc.2021.100878	http://dx.doi.org/10.1016/j.jbc.2021.100878			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34270959	Green Submitted, Green Published, gold			2022-12-28	WOS:000690873500001
J	Corgiat, EB; List, SM; Rounds, JC; Corbett, AH; Moberg, KH				Corgiat, Edwin B.; List, Sara M.; Rounds, J. Christopher; Corbett, Anita H.; Moberg, Kenneth H.			The RNA-binding protein Nab2 regulates the proteome of the developing Drosophila brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANAR CELL POLARITY; MUSHROOM BODIES; ZC3H14; LOCALIZATION; GENERATION; EXPRESSION; NEURONS; PATHWAY; AXONS	The human ZC3H14 gene, which encodes a ubiquitously expressed polyadenosine zinc finger RNA-binding protein, is mutated in an inherited form of autosomal recessive, non-syndromic intellectual disability. To gain insight into neurological functions of ZC3H14, we previously developed a Drosophila melanogaster model of ZC3H14 loss by deleting the fly ortholog, Nab2. Studies in this invertebrate model revealed that Nab2 controls final patterns of neuron projection within fully developed adult brains, but the role of Nab2 during development of the Drosophila brain is not known. Here, we identify roles for Nab2 in controlling the dynamic growth of axons in the developing brain mushroom bodies, which support olfactory learning and memory, and regulating abundance of a small fraction of the total brain proteome. The group of Nab2-regulated brain proteins, identified by quantitative proteomic analysis, includes the microtubule-binding protein Futsch, the neuronal Ig-family transmembrane protein turtle, the glial:neuron adhesion protein contactin, the Rac GTPase-activating protein tumbleweed, and the planar cell polarity factor Van Gogh, which collectively link Nab2 to the processes of brain morphogenesis, neuroblast proliferation, circadian sleep/wake cycles, and synaptic development. Overall, these data indicate that Nab2 controls the abundance of a subset of brain proteins during the active process of wiring the pupal brain mushroom body and thus provide a window into potentially conserved functions of the Nab2/ZC3H14 RNA-binding proteins in neurodevelopment.	[Corgiat, Edwin B.; Rounds, J. Christopher; Moberg, Kenneth H.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA; [Corgiat, Edwin B.; Rounds, J. Christopher] Emory Univ, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Corgiat, Edwin B.; Rounds, J. Christopher; Corbett, Anita H.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [List, Sara M.] Emory Univ, Grad Program Neurosci, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University; Emory University	Moberg, KH (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.; Corbett, AH (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	acorbe2@emory.edu; kmoberg@emory.edu		Moberg, Kenneth/0000-0002-9820-5543; Rounds, J. Christopher/0000-0001-5287-8454; Corbett, Anita/0000-0002-0461-6895	Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health [5P30NS055077];  [5F31NS110312-02];  [5F31HD088043-03];  [5R01MH10730505]	Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health; ; ; 	Research reported in this publication was also supported in part by the Emory University Integrated Cellular Imaging Microscopy Core of the Emory Neuroscience NINDS, National Institutes of Health, Core Facilities Grant, 5P30NS055077. Financial support is as follows: 5F31NS110312-02, 5F31HD088043-03, and 5R01MH10730505. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal S., 2019, SCI REP-UK, P1; Aibara S, 2017, NUCLEIC ACIDS RES, V45, P1529, DOI 10.1093/nar/gkw1224; Alboukadel K., 2018, GGPUBR GGPLOT2 BASED; Alpert T, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108324; Armstrong JD, 1998, LEARN MEMORY, V5, P102; Axelrod JD, 2002, NAT CELL BIOL, V4, pE6, DOI 10.1038/ncb0102-e6; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Bastock R, 2003, DEVELOPMENT, V130, P3007, DOI 10.1242/dev.00526; Becker R, 1988, COMPUTER SCI SERIES; Bienkowski RS, 2017, CELL REP, V20, P1372, DOI 10.1016/j.celrep.2017.07.038; Butler MT, 2017, NAT REV MOL CELL BIO, V18, P375, DOI 10.1038/nrm.2017.11; Castello A, 2013, TRENDS GENET, V29, P318, DOI 10.1016/j.tig.2013.01.004; Catalanotto C, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101712; Chambers JM., 1992, STAT MODELS S; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Cooper TA, 2009, CELL, V136, P777, DOI 10.1016/j.cell.2009.02.011; Edens BM, 2015, BBA-MOL BASIS DIS, V1852, P685, DOI 10.1016/j.bbadis.2014.07.024; Fasken MB, 2019, PROTEIN SCI, V28, P513, DOI 10.1002/pro.3565; Fenstermaker AG, 2010, J NEUROSCI, V30, P16053, DOI 10.1523/JNEUROSCI.4508-10.2010; Fox J., 2019, R COMPANION APPL REG, V.; Goldstein AYN, 2005, P NATL ACAD SCI USA, V102, P3834, DOI 10.1073/pnas.0500748102; Green DM, 2002, J BIOL CHEM, V277, P7752, DOI 10.1074/jbc.M110053200; Gross C, 2012, NEUROPSYCHOPHARMACOL, V37, P178, DOI 10.1038/npp.2011.137; Guisbert KK, 2005, RNA, V11, P383, DOI 10.1261/rna.7234205; Hakanen J, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00244; He CW, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180116; Hornberg H, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00081; Holt CE, 2019, NAT STRUCT MOL BIOL, V26, P557, DOI 10.1038/s41594-019-0263-5; Jalloh B., 2020, NAB2 RNA BINDING PRO; Jefferis GSXE, 2002, CURR OPIN NEUROBIOL, V12, P80, DOI 10.1016/S0959-4388(02)00293-3; Jones C, 2007, BIOESSAYS, V29, P120, DOI 10.1002/bies.20526; Jones S. K., 2020, POLYADENOSINE RNA BI, DOI 10.08.331827; Jung HS, 2012, NAT REV NEUROSCI, V13, P308, DOI 10.1038/nrn3210; Kang HX, 2019, MOL BRAIN, V12, DOI 10.1186/s13041-019-0472-1; Kelly S. M., 2012, RNA BIOL, V6286, P159; Kelly SM, 2016, DEV NEUROBIOL, V76, P93, DOI 10.1002/dneu.22301; Kelly SM, 2014, RNA, V20, P681, DOI 10.1261/rna.043984.113; Kuleshov MV, 2019, NUCLEIC ACIDS RES, V47, pW183, DOI 10.1093/nar/gkz347; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Kunz T, 2012, DEVELOPMENT, V139, P2510, DOI 10.1242/dev.077883; Kurusu M, 2002, DEVELOPMENT, V129, P409; Lee T, 1999, DEVELOPMENT, V126, P4065; Lee WH, 2020, G3-GENES GENOM GENET, V10, P3575, DOI 10.1534/g3.120.401637; Lepelletier L, 2017, J NEUROSCI, V37, P1685, DOI 10.1523/JNEUROSCI.3016-16.2016; Leung SW, 2009, GENE, V439, P71, DOI 10.1016/j.gene.2009.02.022; Maday S, 2014, NEURON, V84, P292, DOI 10.1016/j.neuron.2014.10.019; Maechler M., 2016, CLUSTER CLUSTERANALY; Mardia K., 1979, MULTIVARIATE ANAL, V15, P518; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Morris KJ, 2018, NUCLEIC ACIDS RES, V46, P6561, DOI 10.1093/nar/gky446; Ng J, 2012, DEVELOPMENT, V139, P165, DOI 10.1242/dev.068668; Pak C, 2011, P NATL ACAD SCI USA, V108, P12390, DOI 10.1073/pnas.1107103108; Ping LY, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.36; Preitner N, 2016, DEVELOPMENT, V143, P2753, DOI 10.1242/dev.128348; R Core Team, 2019, R FDN STAT COMP, DOI DOI 10.1007/978-3-540-74686-7; Rha J, 2017, HUM MOL GENET, V26, P3663, DOI 10.1093/hmg/ddx248; Rounds J. C., 2021, DIS ASS PROTEINS DRO, DOI [10.1101/2021.03.01.433469, DOI 10.1101/2021.03.01.433469]; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Shimizu K, 2011, J NEUROSCI, V31, P4944, DOI 10.1523/JNEUROSCI.0154-11.2011; Soucek S, 2016, MOL CELL BIOL, V36, P2697, DOI 10.1128/MCB.00402-16; Stoeckli ET, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.151415; Strausfeld NJ, 1998, LEARN MEMORY, V5, P11; Taylor J, 1998, GENETICS, V150, P199; Tissir F, 2005, NAT NEUROSCI, V8, P451, DOI 10.1038/nn1428; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; van den Bogaart G, 2009, NAT CELL BIOL, V11, P350, DOI 10.1038/ncb1844; Venables WN., 2002, MODERN APPL STAT S; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Walter W, 2015, BIOINFORMATICS, V31, P2912, DOI 10.1093/bioinformatics/btv300; Wang YS, 2010, DEVELOPMENT, V137, P4091, DOI 10.1242/dev.057455; Welshhans K, 2011, J NEUROSCI, V31, P9800, DOI 10.1523/JNEUROSCI.0166-11.2011; Wigington CP, 2016, J BIOL CHEM, V291, P22442, DOI 10.1074/jbc.M116.754069; WILKINSON GN, 1973, ROY STAT SOC C-APP, V22, P392; Yang YZ, 2015, ANNU REV CELL DEV BI, V31, P623, DOI 10.1146/annurev-cellbio-100814-125315; Zou YM, 2012, CURR TOP DEV BIOL, V101, P141, DOI 10.1016/B978-0-12-394592-1.00009-0; Zou YM, 2004, TRENDS NEUROSCI, V27, P528, DOI 10.1016/j.tins.2004.06.015	77	2	2	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100877	10.1016/j.jbc.2021.100877	http://dx.doi.org/10.1016/j.jbc.2021.100877			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34139237	Green Submitted, Green Published, gold			2022-12-28	WOS:000678068400077
J	Ge, WH; Zhao, Y; Yang, YX; Ding, Z; Xu, X; Weng, D; Wang, SM; Cheng, R; Zhang, JF				Ge, Wenhao; Zhao, Yang; Yang, Yunxia; Ding, Zhao; Xu, Xi; Weng, Dan; Wang, Shiming; Cheng, Rui; Zhang, Jianfa			An insulin-independent mechanism for transcriptional regulation of Foxo1 in type 2 diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-ADENOSYLMETHIONINE; DNA METHYLATION; GENE-EXPRESSION; PLASMA 5'-AMP; HYPERGLYCEMIA; HOMOCYSTEINE; SENSITIVITY; HOMEOSTASIS; METABOLISM; METHIONINE	Hepatic gluconeogenesis is the major contributor to the hyperglycemia observed in both patients and animals with type 2 diabetes. The transcription factor FOXO1 plays a dominant role in stimulating hepatic gluconeogenesis. FOXO1 is mainly regulated by insulin under physiological conditions, but liver-specific disruption of Foxo1 transcription restores normal gluconeogenesis in mice in which insulin signaling has been blocked, suggesting that additional regulatory mechanisms exist. Understanding the transcriptional regulation of Foxo1 may be conducive to the development of insulin-independent strategies for the control of hepatic gluconeogenesis. Here, we found that elevated plasma levels of adenine nucleotide in type 2 diabetes are the major regulators of Foxo1 transcription. We treated lean mice with 5'-AMP and examined their transcriptional profiles using RNA-seq. KEGG analysis revealed that the 5'-AMP treatment led to shifted profiles that were similar to db/db mice. Many of the upregulated genes were in pathways associated with the pathology of type 2 diabetes including Foxo1 signaling. As observed in diabetic db/db mice, lean mice treated with 5'-AMP displayed enhanced Foxo1 transcription, involving an increase in cellular adenosine levels and a decrease in the S-adenosylmethionine to S-adenosylhomocysteine ratio. This reduced methylation potential resulted in declining histone H3K9 methylation in the promoters of Foxo1, G6Pc, and Pepck. In mouse livers and cultured cells, 5'-AMP induced expression of more FOXO1 protein, which was found to be localized in the nucleus, where it could promote gluconeogenesis. Our results revealed that adenine nucleotide-driven Foxo1 transcription is crucial for excessive glucose production in type 2 diabetic mice.	[Ge, Wenhao; Zhao, Yang; Yang, Yunxia; Ding, Zhao; Xu, Xi; Weng, Dan; Wang, Shiming; Cheng, Rui; Zhang, Jianfa] Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China	Nanjing University of Science & Technology	Cheng, R; Zhang, JF (corresponding author), Nanjing Univ Sci & Technol, Ctr Mol Metab, Nanjing, Peoples R China.	chengrui@njust.edu.cn; jfzhang@mail.njust.edu.cn	yang, yx/GZM-0464-2022		National Natural Science Foundation of China [31871178, 31861163004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grant from the National Natural Science Foundation of China (numbers 31871178, 31861163004).	Antonioli L, 2015, NAT REV ENDOCRINOL, V11, P228, DOI 10.1038/nrendo.2015.10; Armoni M, 2006, J BIOL CHEM, V281, P19881, DOI 10.1074/jbc.M600320200; Becker A, 2003, ATHEROSCLEROSIS, V169, P323, DOI 10.1016/S0021-9150(03)00199-0; BRAUNSTEIN M, 1993, GENE DEV, V7, P592, DOI 10.1101/gad.7.4.592; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen JP, 2015, J PHYSIOL BIOCHEM, V71, P405, DOI 10.1007/s13105-015-0420-1; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cuyas E, 2018, ONCOGENE, V37, P963, DOI 10.1038/onc.2017.367; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Friedman B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80244-x; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Haeusler RA, 2010, J BIOL CHEM, V285, P35245, DOI 10.1074/jbc.C110.175851; Hall RK, 2000, J BIOL CHEM, V275, P30169, DOI 10.1074/jbc.M004898200; Hawkins M, 2003, DIABETES, V52, P2748, DOI 10.2337/diabetes.52.11.2748; Kim JJ, 2009, DIABETES, V58, P1275, DOI 10.2337/db08-1001; Kitamura T, 2013, NAT REV ENDOCRINOL, V9, P615, DOI 10.1038/nrendo.2013.157; KNUDSEN TB, 1992, TERATOLOGY, V45, P91, DOI 10.1002/tera.1420450109; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; LEE CC, 1992, BRAIN, V115, P935, DOI 10.1093/brain/115.3.935; LOMBARDINI JB, 1970, MOL PHARMACOL, V6, P481; Lu MJ, 2012, NAT MED, V18, P388, DOI 10.1038/nm.2686; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; Mozzetta C, 2015, NAT REV MOL CELL BIO, V16, P499, DOI 10.1038/nrm4029; Nakae J, 2008, FEBS LETT, V582, P54, DOI 10.1016/j.febslet.2007.11.025; Nakai J, 2002, NAT GENET, V32, P245, DOI 10.1038/ng890; Pastor-Anglada M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00627; Petersen MC, 2017, NAT REV ENDOCRINOL, V13, P572, DOI 10.1038/nrendo.2017.80; Poirier LA, 2001, METABOLISM, V50, P1014, DOI 10.1053/meta.2001.25655; Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667; Qu S, 2006, ENDOCRINOLOGY, V147, P5641, DOI 10.1210/en.2006-0541; Radovic B, 2016, DIABETOLOGIA, V59, P1743, DOI 10.1007/s00125-016-3968-6; Ratnam S, 2006, AM J PHYSIOL-ENDOC M, V290, pE933, DOI 10.1152/ajpendo.00498.2005; Resta R, 1998, IMMUNOL REV, V161, P95, DOI 10.1111/j.1600-065X.1998.tb01574.x; Rhoads TW, 2018, CELL METAB, V27, P677, DOI 10.1016/j.cmet.2018.01.014; Schmoll D, 2000, J BIOL CHEM, V275, P36324, DOI 10.1074/jbc.M003616200; Spencer VA, 2003, METHODS, V31, P67, DOI 10.1016/S1046-2023(03)00089-6; Stewart MD, 2005, MOL CELL BIOL, V25, P2525, DOI 10.1128/MCB.25.7.2525-2538.2005; Valenti L, 2008, DIABETES, V57, P1355, DOI 10.2337/db07-0714; Wu LF, 2006, ACTA PHARMACOL SIN, V27, P477, DOI 10.1111/j.1745-7254.2006.00302.x; Xia L, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118101; Xia L, 2015, J ENDOCRINOL, V224, P225, DOI 10.1530/JOE-14-0501; Yadav H, 2017, J BIOL CHEM, V292, P3420, DOI 10.1074/jbc.M116.764910; Yang X, 2019, DIABETOLOGIA, V62, P2106, DOI 10.1007/s00125-019-04971-1; Yang X, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00497; Yang YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081866; Zhan Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.516; Zhang KB, 2012, ENDOCRINOLOGY, V153, P631, DOI 10.1210/en.2011-1527; Zhang Y, 2012, AM J PHYSIOL-ENDOC M, V302, pE325, DOI 10.1152/ajpendo.00424.2011; Zhou YF, 2018, HEPATOLOGY, V67, P21, DOI 10.1002/hep.29499	50	2	3	3	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100846	10.1016/j.jbc.2021.100846	http://dx.doi.org/10.1016/j.jbc.2021.100846			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058194	gold, Green Published			2022-12-28	WOS:000678068400046
J	Selen, ES; Wolfgang, MJ				Selen, Ebru S.; Wolfgang, Michael J.			mTORC1 activation is not sufficient to suppress hepatic PPAR alpha signaling or ketogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIET-INDUCED OBESITY; LIPID-METABOLISM; INSULIN-RESISTANCE; FUEL METABOLISM	The mechanistic target of rapamycin (mTOR) is often referred to as a master regulator of the cellular metabolism that can integrate the growth factor and nutrient signaling. Fasting suppresses hepatic mTORC1 activity via the activity of the tuberous sclerosis complex (TSC), a negative regulator of mTORC1, to suppress anabolic metabolism. The loss of TSC1 in the liver locks the liver in a constitutively anabolic state even during fasting, which was suggested to regulate peroxisome proliferator-activated receptor alpha (PPAR alpha) signaling and ketogenesis, but the molecular determinants of this regulation are unknown. Here, we examined if the activation of the mTORC1 complex in mice by the liver-specific deletion of TSC1 (TSC1(L-/-)) is sufficient to suppress PPAR alpha signaling and therefore ketogenesis in the fasted state. We found that the activation of mTORC1 in the fasted state is not sufficient to repress PPAR alpha-responsive genes or ketogenesis. Furthermore, we examined whether the activation of the anabolic program mediated by mTORC1 complex activation in the fasted state could suppress the robust catabolic programming and enhanced PPAR alpha transcriptional response of mice with a liver-specific defect in mitochondrial long-chain fatty acid oxidation using carnitine palmitoyltransferase 2 (Cpt2(L-/-)) mice. We generated Cpt2(L-/-); Tsc1(L-/-) double-KO mice and showed that the activation of mTORC1 by deletion of TSC1 could not suppress the catabolic PPAR alpha-mediated phenotype of Cpt2(L-/-) mice. These data demonstrate that the activation of mTORC1 by the deletion of TSC1 is not sufficient to suppress a PPAR alpha transcriptional program or ketogenesis after fasting.	[Selen, Ebru S.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.; Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu			National Institutes of Health [R01DK120530, R01DK116746]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health Grants R01DK120530 and R01DK116746 to M. J. W. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Badman MK, 2007, CELL METAB, V5, P426, DOI 10.1016/j.cmet.2007.05.002; Bowman CE, 2019, CELL REP, V29, P1299, DOI 10.1016/j.celrep.2019.09.053; Cahill GF, 2006, ANNU REV NUTR, V26, P1, DOI 10.1146/annurev.nutr.26.061505.111258; Cappel DA, 2019, CELL METAB, V29, P1291, DOI 10.1016/j.cmet.2019.03.014; Cornu M, 2014, P NATL ACAD SCI USA, V111, P11592, DOI 10.1073/pnas.1412047111; Cotter DG, 2014, J CLIN INVEST, V124, P5175, DOI 10.1172/JCI76388; Iroz A, 2017, CELL REP, V21, P403, DOI 10.1016/j.celrep.2017.09.065; Kenerson HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117000; Kim K, 2012, HEPATOLOGY, V55, P1727, DOI 10.1002/hep.25537; Kucejova B, 2016, CELL REP, V16, P508, DOI 10.1016/j.celrep.2016.06.006; Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525; Lee J, 2017, CELL REP, V20, P655, DOI 10.1016/j.celrep.2017.06.080; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Puchalska P, 2017, CELL METAB, V25, P262, DOI 10.1016/j.cmet.2016.12.022; Quinn WJ, 2017, J CLIN INVEST, V127, P4207, DOI 10.1172/JCI96036; Selen ES, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.135626; Sengupta S, 2010, NATURE, V468, P1100, DOI 10.1038/nature09584; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Yecies JL, 2011, CELL METAB, V14, P21, DOI 10.1016/j.cmet.2011.06.002; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	26	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100884	10.1016/j.jbc.2021.100884	http://dx.doi.org/10.1016/j.jbc.2021.100884			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34146544	Green Published, gold			2022-12-28	WOS:000678068400083
J	Sun, Y; Izadi, S; Callahan, M; Deperalta, G; Wecksler, AT				Sun, Yue; Izadi, Saeed; Callahan, Matthew; Deperalta, Galahad; Wecksler, Aaron T.			Antibody-receptor interactions mediate antibody-dependent cellular cytotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAST PHOTOCHEMICAL OXIDATION; FC-GAMMA-RIII; MOLECULAR-DYNAMICS; MASS-SPECTROMETRY; PROTEINS FPOP; THERAPEUTIC ANTIBODIES; CRYSTAL-STRUCTURE; GLYCOSYLATION; BINDING; PARAMETERS	Binding of antibodies to their receptors is a core component of the innate immune system. Understanding the precise interactions between antibodies and their Fc receptors has led to the engineering of novel mAb biotherapeutics with tailored biological activities. One of the most significant findings is that afucosylated monoclonal antibodies demonstrate increased affinity toward the receptor Fc.RIIIa, with a commensurate increase in antibody-dependent cellular cytotoxicity. Crystal structure analysis has led to the hypothesis that afucosylation in the Fc region results in reduced steric hindrance between antibody-receptor intermolecular glycan interactions, enhancing receptor affinity; however, solution-phase data have yet to corroborate this hypothesis. In addition, recent work has shown that the fragment antigen-binding (Fab) region may directly interact with Fc receptors; however, the biological consequences of these interactions remain unclear. By probing differences in solvent accessibility between native and afucosylated immunoglobulin G1 (IgG1) using hydroxyl radical footprinting-MS, we provide the first solution-phase evidence that an IgG1 bearing an afucosylated Fc region appears to require fewer conformational changes for Fc.RIIIa binding. In addition, we performed extensive molecular dynamics (MD) simulations to understand the molecular mechanism behind the effects of afucosylation. The combination of these techniques provides molecular insight into the steric hindrance from the core Fc fucose in IgG1 and corroborates previously proposed Fab-receptor interactions. Furthermore, MD-guided rational mutagenesis enabled us to demonstrate that Fab-receptor interactions directly contribute to the modulation of antibody-dependent cellular cytotoxicity activity. This work demonstrates that in addition to Fc-polypeptide and glycan-mediated interactions, the Fab provides a third component that influences IgG-Fc receptor biology.	[Sun, Yue; Callahan, Matthew; Deperalta, Galahad; Wecksler, Aaron T.] Genentech Inc, Prot Analyt Chem Dept, San Francisco, CA 94080 USA; [Izadi, Saeed] Genentech Inc, Pharmaceut Dev Dept, San Francisco, CA 94080 USA	Roche Holding; Genentech; Roche Holding; Genentech	Wecksler, AT (corresponding author), Genentech Inc, Prot Analyt Chem Dept, San Francisco, CA 94080 USA.	wecksler.aaron@gene.com		Callahan, Matthew/0000-0002-1854-4212				BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Case D. A., 2016, AMBER 2016; Chan AC, 2010, NAT REV IMMUNOL, V10, P301, DOI 10.1038/nri2761; Charvatova O, 2008, J AM SOC MASS SPECTR, V19, P1692, DOI 10.1016/j.jasms.2008.07.013; Chemical Computing Group ULC, MOL OP ENV MOE 2013 MOL OP ENV MOE 2013; Chen JW, 2012, J AM CHEM SOC, V134, P18724, DOI 10.1021/ja307606f; Chung S, 2012, MABS-AUSTIN, V4, P326, DOI 10.4161/mabs.19941; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Ecker DM, 2015, MABS-AUSTIN, V7, P9, DOI 10.4161/19420862.2015.989042; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Garcia NK, 2020, J AM SOC MASS SPECTR, V31, P1563, DOI 10.1021/jasms.0c00146; Gurjar SA, 2017, J PHARMACEUT BIOMED, V143, P188, DOI 10.1016/j.jpba.2017.06.004; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Houde D, 2010, MOL CELL PROTEOMICS, V9, P1716, DOI 10.1074/mcp.M900540-MCP200; Jefferis R, 2005, ADV EXP MED BIOL, V564, P143; Jefferis R, 2012, ARCH BIOCHEM BIOPHYS, V526, P159, DOI 10.1016/j.abb.2012.03.021; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Jung ST, 2011, CURR OPIN BIOTECH, V22, P858, DOI 10.1016/j.copbio.2011.03.002; Kirschner KN, 2008, J COMPUT CHEM, V29, P622, DOI 10.1002/jcc.20820; Kiselar JG, 2010, J MASS SPECTROM, V45, P1373, DOI 10.1002/jms.1808; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Lin M, 2018, J AM SOC MASS SPECTR, V29, P961, DOI 10.1007/s13361-017-1883-9; Louie S, 2017, BIOTECHNOL BIOENG, V114, P632, DOI 10.1002/bit.26188; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MIZUOCHI T, 1982, J IMMUNOL, V129, P2016; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Rajasekaran N, 2015, IMMUNOTARGETS THER, V4, P91, DOI 10.2147/ITT.S61292; Raju TS, 2008, CURR OPIN IMMUNOL, V20, P471, DOI 10.1016/j.coi.2008.06.007; Reusch D, 2015, MABS-AUSTIN, V7, P167, DOI 10.4161/19420862.2014.986000; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Satoh M, 2006, EXPERT OPIN BIOL TH, V6, P1161, DOI 10.1517/14712598.6.11.1161; Saxena A, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00580; Shi LQ, 2019, BIOCHEMISTRY-US, V58, P1074, DOI 10.1021/acs.biochem.8b01048; Shields RL, 2002, J BIOL CHEM, V277, P26733, DOI 10.1074/jbc.M202069200; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Subedi GP, 2015, STRUCTURE, V23, P1573, DOI 10.1016/j.str.2015.06.015; Subedi GP, 2014, STRUCTURE, V22, P1478, DOI 10.1016/j.str.2014.08.002; Sun Y, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2020.1802135; Tang Y, 2007, J IMMUNOL, V179, P2815, DOI 10.4049/jimmunol.179.5.2815; Woof JM, 2004, NAT REV IMMUNOL, V4, P89, DOI 10.1038/nri1266; Xie B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-04689-3; Yan YT, 2014, J AM SOC MASS SPECTR, V25, P2084, DOI 10.1007/s13361-014-0993-x; Yogo R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-48323-w; Zhang H, 2014, FEBS LETT, V588, P308, DOI 10.1016/j.febslet.2013.11.027; Zhang Y, 2017, J AM SOC MASS SPECTR, V28, P850, DOI 10.1007/s13361-017-1601-7; Zhang Y, 2015, J AM SOC MASS SPECTR, V26, P526, DOI 10.1007/s13361-014-1055-0	51	11	11	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100826	10.1016/j.jbc.2021.100826	http://dx.doi.org/10.1016/j.jbc.2021.100826			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34044019	Green Published, gold			2022-12-28	WOS:000678068400028
J	Valli, J; Garcia-Burgos, A; Rooney, LM; Oliveira, BVDE; Duncan, RR; Rickman, C				Valli, Jessica; Garcia-Burgos, Adrian; Rooney, Liam M.; Oliveira, Beatriz Vale de Melo E.; Duncan, Rory R.; Rickman, Colin			Seeing beyond the limit: A guide to choosing the right super-resolution microscopy technique	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MOLECULE FRET ANALYSIS; STIMULATED-EMISSION; LOCALIZATION MICROSCOPY; SINGLE MOLECULES; RESOLUTION LIMIT; BACKGROUND-FREE; DNA-BINDING; DEPLETION; FLUOROPHORES; PROTEINS	Super-resolution microscopy has become an increasingly popular and robust tool across the life sciences to study minute cellular structures and processes. However, with the increasing number of available super-resolution techniques has come an increased complexity and burden of choice in planning imaging experiments. Choosing the right super-resolution technique to answer a given biological question is vital for understanding and interpreting biological relevance. This is an often-neglected and complex task that should take into account well-defined criteria (e.g., sample type, structure size, imaging requirements). Trade-offs in different imaging capabilities are inevitable; thus, many researchers still find it challenging to select the most suitable technique that will best answer their biological question. This review aims to provide an overview and clarify the concepts underlying the most commonly available super-resolution techniques as well as guide researchers through all aspects that should be considered before opting for a given technique.	[Valli, Jessica; Garcia-Burgos, Adrian; Rooney, Liam M.; Oliveira, Beatriz Vale de Melo E.; Duncan, Rory R.; Rickman, Colin] Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh Super Resolut Imaging Consortium ESRIC, Edinburgh, Midlothian, Scotland	Heriot Watt University	Valli, J; Rickman, C (corresponding author), Heriot Watt Univ, Inst Biol Chem Biophys & Bioengn, Edinburgh Super Resolut Imaging Consortium ESRIC, Edinburgh, Midlothian, Scotland.	j.valli@hw.ac.uk; c.rickman@hw.ac.uk		Valli, Jessica/0000-0003-4346-0317; Vale, Beatriz/0000-0002-7011-4607; Rooney, Liam/0000-0002-2237-501X	Wellcome Trust [215599/Z/19/Z.]; Medical Research Scotland	Wellcome Trust(Wellcome Trust); Medical Research Scotland	J. V. and R. R. D. are supported by the Wellcome Trust, grant 208345/Z/17/Z. L. M. R. and C. R. are supported by the Wellcome Trust, grant 215599/Z/19/Z. A. G.-B. is supported by Medical Research Scotland.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; Abbe E, 1876, P BRISTOL NAT SOC, V1, P200; Ait-Bara Soraya, 2015, Methods Mol Biol, V1259, P349, DOI 10.1007/978-1-4939-2214-7_21; Annibale P, 2010, J PHYS CHEM LETT, V1, P1506, DOI 10.1021/jz1003523; Auer A, 2017, NANO LETT, V17, P6428, DOI 10.1021/acs.nanolett.7b03425; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Balzarotti F, 2017, SCIENCE, V355, P606, DOI 10.1126/science.aak9913; Bannore V, 2009, STUD COMPUT INTELL, V195, P1; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bianchini P, 2012, P NATL ACAD SCI USA, V109, P6390, DOI 10.1073/pnas.1119129109; Carlson GE, 2013, JOVE-J VIS EXP, DOI 10.3791/50604; Carrington G, 2019, MOL BIOL CELL, V30, P2737, DOI 10.1091/mbc.E18-11-0694; Chaurasiya KR, 2018, METHODS MOL BIOL, V1665, P217, DOI 10.1007/978-1-4939-7271-5_12; Cho I, 2018, J MICROSC-OXFORD, V271, P123, DOI 10.1111/jmi.12712; Chozinski TJ, 2014, FEBS LETT, V588, P3603, DOI 10.1016/j.febslet.2014.06.043; Clausen MP, 2015, METHODS, V88, P67, DOI 10.1016/j.ymeth.2015.06.017; Coats JE, 2013, NUCLEIC ACIDS RES, V41, P1372, DOI 10.1093/nar/gks1208; COOHILL TP, 1987, PHOTOCHEM PHOTOBIOL, V46, P1043, DOI 10.1111/j.1751-1097.1987.tb04891.x; Culley S, 2018, NAT METHODS, V15, P263, DOI [10.1038/NMETH.4605, 10.1038/nmeth.4605]; Davidson M, 2014, FLUORESCENT PROTEIN, P97; de Castro MAG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08677-1; Dempsey GT, 2011, NAT METHODS, V8, P1027, DOI [10.1038/nmeth.1768, 10.1038/NMETH.1768]; Dertinger T, 2009, P NATL ACAD SCI USA, V106, P22287, DOI 10.1073/pnas.0907866106; Doshi R, 2014, SCI REP-UK, V4, DOI 10.1038/srep06760; Dunn KW, 2000, BIOTECHNIQUES, V28, P542, DOI 10.2144/00283rr03; Dutta C, 2020, J PHYS CHEM B, V124, P4412, DOI 10.1021/acs.jpcb.0c01807; Dyba M, 2003, APPL OPTICS, V42, P5123, DOI 10.1364/AO.42.005123; Ehrenerg M, SCI BACKGROUND NOBEL; Endesfelder U, 2014, HISTOCHEM CELL BIOL, V141, P629, DOI 10.1007/s00418-014-1192-3; Fish Kenneth N, 2009, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1218s50; Galland R, 2015, NAT METHODS, V12, P641, DOI [10.1038/NMETH.3402, 10.1038/nmeth.3402]; Glushonkov O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27059-z; Gottfert F, 2013, BIOPHYS J, V105, pL1, DOI 10.1016/j.bpj.2013.05.029; Goossen-Schmidt NC, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70335-0; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12471; Gwosch KC, 2020, NAT METHODS, V17, P217, DOI 10.1038/s41592-019-0688-0; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hecht B, 2000, J CHEM PHYS, V112, P7761, DOI 10.1063/1.481382; Heilemann M, 2005, J AM CHEM SOC, V127, P3801, DOI 10.1021/ja044686x; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Hertel F, 2016, CELL REP, V14, P390, DOI 10.1016/j.celrep.2015.12.036; Hooke Robert, 1665, MICROGRAPHIA SOME PH; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hu J, 2017, CHEM COMMUN, V53, P13284, DOI 10.1039/c7cc07752a; Huff J, 2017, NAT METHODS, V14, piv, DOI 10.1038/nmeth.f.404; Huff J, 2015, NAT METHODS, V12, DOI 10.1038/nmeth.f.388; Jardine B, 2009, STUD HIST PHILOS SCI, V40, P382, DOI 10.1016/j.shpsa.2009.10.007; Jiang SR, 2018, PROC SPIE, V10832, DOI 10.1117/12.2506679; Jones SA, 2011, NAT METHODS, V8, P499, DOI [10.1038/NMETH.1605, 10.1038/nmeth.1605]; Juette MF, 2008, NAT METHODS, V5, P527, DOI 10.1038/nmeth.1211; Jungmann R, 2016, NAT METHODS, V13, P439, DOI [10.1038/nmeth.3804, 10.1038/NMETH.3804]; Jungmann R, 2014, NAT METHODS, V11, P313, DOI [10.1038/nmeth.2835, 10.1038/NMETH.2835]; Kang J, 2014, BIOPHYS CHEM, V195, P49, DOI 10.1016/j.bpc.2014.08.004; Kavanagh DM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6774; Khater IM, 2020, PATTERNS, V1, DOI 10.1016/j.patter.2020.100038; Kisley L, 2015, ACS NANO, V9, P9158, DOI 10.1021/acsnano.5b03430; Klar TA, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066613; Klein T, 2011, NAT METHODS, V8, P7, DOI 10.1038/nmeth0111-7b; Kolossov VL, 2018, MICROSC RES TECHNIQ, V81, P115, DOI 10.1002/jemt.22968; Kowaltowski AJ, 2019, FASEB J, V33, P13176, DOI 10.1096/fj.201901136R; Laissue PP, 2017, NAT METHODS, V14, P657, DOI 10.1038/nmeth.4344; Lampe A, 2012, BIOL CELL, V104, P229, DOI 10.1111/boc.201100011; Lee J, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0344-5; Li HL, 2018, CHEM REV, V118, P9412, DOI 10.1021/acs.chemrev.7b00767; Liu Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5443; Lu K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225784; Margineanu A, 2016, SCI REP-UK, V6, DOI 10.1038/srep28186; Martin-Fernandez ML, 2013, J MICROSC-OXFORD, V252, P16, DOI 10.1111/jmi.12070; Masullo LA, 2021, NANO LETT, V21, P840, DOI 10.1021/acs.nanolett.0c04600; Mo GCH, 2017, NAT METHODS, V14, P427, DOI 10.1038/nmeth.4221; Moffitt JR, 2011, OPT EXPRESS, V19, P4242, DOI 10.1364/OE.19.004242; Nahidiazar L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158884; Nickerson A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100589; Nieuwenhuizen RPJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127989; Nieves DJ, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.191268; Oi C, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01188-6; Okamoto K, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2019.04.022; Opazo F, 2012, NAT METHODS, V9, P938, DOI 10.1038/nmeth.2179; Pape JK, 2020, P NATL ACAD SCI USA, V117, P20607, DOI 10.1073/pnas.2009364117; Pawley J. B., 2006, HDB BIOL CONFOCAL MI; Peng SJ, 2017, ANGEW CHEM INT EDIT, V56, P6882, DOI 10.1002/anie.201702731; Puchner EM, 2014, FEBS LETT, V588, P3519, DOI 10.1016/j.febslet.2014.08.020; Rowland CE, 2015, METHODS APPL FLUORES, V3, DOI 10.1088/2050-6120/3/4/042006; Sakon JJ, 2010, NAT METHODS, V7, P203, DOI [10.1038/nmeth.1421, 10.1038/NMETH.1421]; Sapkota K, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19163495; Scarselli M, 2012, J BIOL CHEM, V287, P16768, DOI 10.1074/jbc.M111.329912; Schermelleh L, 2019, NAT CELL BIOL, V21, P72, DOI 10.1038/s41556-018-0251-8; Schermelleh L, 2010, J CELL BIOL, V190, P165, DOI 10.1083/jcb.201002018; Schropp M, 2017, PHOTONICS-BASEL, V4, DOI 10.3390/photonics4020033; Shroff H, 2007, P NATL ACAD SCI USA, V104, P20308, DOI 10.1073/pnas.0710517105; Siemons M, 2020, BIOMED OPT EXPRESS, V11, P735, DOI 10.1364/BOE.382023; Smyth AM, 2013, J BIOL CHEM, V288, P5102, DOI 10.1074/jbc.M112.407585; Sograte-Idrissi S, 2020, NANOSCALE, V12, P10226, DOI 10.1039/d0nr00227e; Steffens H, 2020, METHODS, V174, P42, DOI 10.1016/j.ymeth.2019.05.020; Takasaki K, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00029; Thompson RE, 2002, BIOPHYS J, V82, P2775, DOI 10.1016/S0006-3495(02)75618-X; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Turcottea R, 2019, P NATL ACAD SCI USA, V116, P9586, DOI 10.1073/pnas.1819965116; Valley CC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123941; van de Linde S, 2009, PHOTOCH PHOTOBIO SCI, V8, P465, DOI 10.1039/b822533h; Vaziri A, 2008, P NATL ACAD SCI USA, V105, P20221, DOI 10.1073/pnas.0810636105; Vicidomini G, 2015, NANO LETT, V15, P5912, DOI 10.1021/acs.nanolett.5b02001; Vicidomini G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054421; Vogelsang J, 2008, ANGEW CHEM INT EDIT, V47, P5465, DOI 10.1002/anie.200801518; von Diezmann A, 2017, CHEM REV, V117, P7244, DOI 10.1021/acs.chemrev.6b00629; Waldchen S, 2015, SCI REP-UK, V5, DOI 10.1038/srep15348; Waldchen F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14731-0; Wang S, 2017, BIOMED OPT EXPRESS, V8, P3119, DOI 10.1364/BOE.8.003119; Wasserman MR, 2016, NAT STRUCT MOL BIOL, V23, P333, DOI 10.1038/nsmb.3177; Wegner W, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18640-z; Werbin JL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12257-y; Westphal V, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.143903; Westphal V, 2003, APPL PHYS LETT, V82, P3125, DOI 10.1063/1.1571656; Whelan DR, 2015, SCI REP-UK, V5, DOI 10.1038/srep07924; Willig KI, 2007, NAT METHODS, V4, P915, DOI 10.1038/NMETH1108; Winter FR, 2017, SCI REP-UK, V7, DOI 10.1038/srep46492; Winter PW, 2014, OPTICA, V1, P181, DOI 10.1364/OPTICA.1.000181; WURM C A, 2012, OPTICAL NANOSCOPY, V1, P7, DOI [10.1186/2192-2853-1-7, DOI 10.1186/2192-2853-1-7]; Yasuda R, 1998, CELL, V93, P1117, DOI 10.1016/S0092-8674(00)81456-7; Zhang CY, 2005, NAT MATER, V4, P826, DOI 10.1038/nmat1508; Zhang ML, 2018, ANAL CHEM, V90, P4282, DOI 10.1021/acs.analchem.7b03448; Zhang ZM, 2019, J INNOV OPT HEAL SCI, V12, DOI 10.1142/S1793545819500238	124	20	21	8	33	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100791	10.1016/j.jbc.2021.100791	http://dx.doi.org/10.1016/j.jbc.2021.100791			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34015334	gold, Green Published, Green Accepted			2022-12-28	WOS:000678068400008
J	Weems, JC; Slaughter, BD; Unruh, JR; Weaver, KJ; Miller, BD; Delventhal, KM; Conaway, JW; Conaway, RC				Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Weaver, Kyle J.; Miller, Brandon D.; Delventhal, Kym M.; Conaway, Joan W.; Conaway, Ronald C.			A role for the Cockayne Syndrome B (CSB)-Elongin ubiquitin ligase complex in signal-dependent RNA polymerase II transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COUPLED REPAIR; DNA-DAMAGE; CUL5-RBX2 MODULES; ALPHA-AMANITIN; FACTOR-SIII; ELONGIN; ELONGATION; PROTEIN; DEGRADATION; RECRUITMENT	The Elongin complex was originally identified as an RNA polymerase II (RNAPII) elongation factor and subsequently as the substrate recognition component of a Cullin-RING E3 ubiquitin ligase. More recent evidence indicates that the Elongin ubiquitin ligase assembles with the Cockayne syndrome B helicase (CSB) in response to DNA damage and can target stalled polymerases for ubiquitylation and removal from the genome. In this report, we present evidence that the CSB-Elongin ubiquitin ligase pathway has roles beyond the DNA damage response in the activation of RNAPII-mediated transcription. We observed that assembly of the CSB-Elongin ubiquitin ligase is induced not just by DNA damage, but also by a variety of signals that activate RNAPII-mediated transcription, including endoplasmic reticulum (ER) stress, amino acid starvation, retinoic acid, glucocorticoids, and doxycycline treatment of cells carrying several copies of a doxycycline-inducible reporter. Using glucocorticoid receptor (GR)-regulated genes as a model, we showed that glucocorticoid-induced transcription is accompanied by rapid recruitment of CSB and the Elongin ubiquitin ligase to target genes in a step that depends upon the presence of transcribing RNAPII on those genes. Consistent with the idea that the CSB-Elongin pathway plays a direct role in GR-regulated transcription, mouse cells lacking the Elongin subunit Elongin A exhibit delays in both RNAPII accumulation on and dismissal from target genes following glucocorticoid addition and withdrawal, respectively. Taken together, our findings bring to light a new role for the CSB-Elongin pathway in RNAPII-mediated transcription.	[Weems, Juston C.; Slaughter, Brian D.; Unruh, Jay R.; Weaver, Kyle J.; Miller, Brandon D.; Delventhal, Kym M.; Conaway, Joan W.; Conaway, Ronald C.] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Conaway, Joan W.; Conaway, Ronald C.] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Conaway, JW; Conaway, RC (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.; Conaway, JW; Conaway, RC (corresponding author), Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS 66103 USA.	Joan.Conaway@UTSouthwestern.edu; rcc@stowers.org		Conaway, Joan/0000-0002-2786-0663; Weaver, Kyle/0000-0002-3960-9177	Stowers Institute for Medical Research; Helen Nelson Medical Research Fund at the Greater Kansas City Community Fund	Stowers Institute for Medical Research; Helen Nelson Medical Research Fund at the Greater Kansas City Community Fund	This work was supported by funds from the Stowers Institute for Medical Research and a grant to the Stowers Institute from the Helen Nelson Medical Research Fund at the Greater Kansas City Community Fund.	Ardehali MB, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015877; ASO T, 1995, SCIENCE, V269, P1439, DOI 10.1126/science.7660129; Boetefuer EL, 2018, NUCLEIC ACIDS RES, V46, P7471, DOI 10.1093/nar/gky660; BRADSHER JN, 1993, J BIOL CHEM, V268, P25594; BRADSHER JN, 1993, J BIOL CHEM, V268, P25587; Brinkman EK, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku936; Bushnell DA, 2002, P NATL ACAD SCI USA, V99, P1218, DOI 10.1073/pnas.251664698; CHAFIN DR, 1995, J BIOL CHEM, V270, P19114, DOI 10.1074/jbc.270.32.19114; Connelly JP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40896-w; Droste SK, 2008, ENDOCRINOLOGY, V149, P3244, DOI 10.1210/en.2008-0103; Gressel S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11536-8; Harreman M, 2009, P NATL ACAD SCI USA, V106, P20705, DOI 10.1073/pnas.0907052106; Kamura T, 2004, GENE DEV, V18, P3055, DOI 10.1101/gad.1252404; Kamura T, 2001, J BIOL CHEM, V276, P29748, DOI 10.1074/jbc.M103093200; Lightman SL, 2006, BIOCHEM SOC T, V34, P1117, DOI 10.1042/BST0341117; Lightman S. L., 2002, Archives of Physiology and Biochemistry, V110, P90, DOI 10.1076/apab.110.1.90.899; Mahrour N, 2008, J BIOL CHEM, V283, P8005, DOI 10.1074/jbc.M706987200; Malik S, 2010, NUCLEIC ACIDS RES, V38, P1461, DOI 10.1093/nar/gkp1147; Muller WG, 2001, J CELL BIOL, V154, P33, DOI 10.1083/jcb.200011069; Gonzalez MN, 2021, NAT REV MOL CELL BIO, V22, P3, DOI 10.1038/s41580-020-00308-8; Presman DM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001813; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ribar B, 2007, MOL CELL BIOL, V27, P3211, DOI 10.1128/MCB.00091-07; Ribar B, 2006, MOL CELL BIOL, V26, P3999, DOI 10.1128/MCB.00293-06; Rodriguez J, 2020, ANNU REV BIOCHEM, V89, P189, DOI 10.1146/annurev-biochem-011520-105250; Rudd MD, 1996, J BIOL CHEM, V271, P21549, DOI 10.1074/jbc.271.35.21549; Sarker AH, 2005, MOL CELL, V20, P187, DOI 10.1016/j.molcel.2005.09.022; Selby CP, 1997, P NATL ACAD SCI USA, V94, P11205, DOI 10.1073/pnas.94.21.11205; Stavreva DA, 2004, MOL CELL BIOL, V24, P2682, DOI 10.1128/MCB.24.7.2682-2697.2004; Stavreva DA, 2009, NAT CELL BIOL, V11, P1093, DOI 10.1038/ncb1922; Stevnsner T, 2008, MECH AGEING DEV, V129, P441, DOI 10.1016/j.mad.2008.04.009; Tantin D, 1997, MOL CELL BIOL, V17, P6803, DOI 10.1128/MCB.17.12.6803; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; TROELSTRA C, 1992, CELL, V71, P939, DOI 10.1016/0092-8674(92)90390-X; Tunnacliffe E, 2020, TRENDS GENET, V36, P288, DOI 10.1016/j.tig.2020.01.003; van den Boom V, 2004, J CELL BIOL, V166, P27, DOI 10.1083/jcb.200401056; Van Munster EB, 2005, J MICROSC-OXFORD, V218, P253, DOI 10.1111/j.1365-2818.2005.01483.x; vanderHorst GTJ, 1997, CELL, V89, P425, DOI 10.1016/S0092-8674(00)80223-8; Wang YT, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015876; Wang YM, 2014, P NATL ACAD SCI USA, V111, P14454, DOI 10.1073/pnas.1412569111; Weems JC, 2019, METHODS, V159, P157, DOI 10.1016/j.ymeth.2019.02.015; Weems JC, 2017, J BIOL CHEM, V292, P6431, DOI 10.1074/jbc.C117.777946; Weems JC, 2015, J BIOL CHEM, V290, P15030, DOI 10.1074/jbc.M114.632794; Weidenheim KM, 2009, MECH AGEING DEV, V130, P619, DOI 10.1016/j.mad.2009.07.006; Yasukawa T, 2008, EMBO J, V27, P3256, DOI 10.1038/emboj.2008.249; Young EA, 2004, FRONT NEUROENDOCRIN, V25, P69, DOI 10.1016/j.yfrne.2004.07.001	46	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100862	10.1016/j.jbc.2021.100862	http://dx.doi.org/10.1016/j.jbc.2021.100862			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34116057	Green Published, gold			2022-12-28	WOS:000678068400062
J	Baade, I; Hutten, S; Sternburg, EL; Porschke, M; Hofweber, M; Dormann, D; Kehlenbach, RH				Baade, Imke; Hutten, Saskia; Sternburg, Erin L.; Poerschke, Marius; Hofweber, Mario; Dormann, Dorothee; Kehlenbach, Ralph H.			The RNA-binding protein FUS is chaperoned and imported into the nucleus by a network of import receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOCYTOPLASMIC TRANSPORT; FUNCTIONAL-CHARACTERIZATION; PHASE-TRANSITION; DISTINGUISH FTLD; SPLICING FACTORS; PORE COMPLEX; FET PROTEINS; RS DOMAIN; ALS; DEGENERATION	Fused in sarcoma (FUS) is a predominantly nuclear RNA-binding protein with key functions in RNA processing and DNA damage repair. Defects in nuclear import of FUS have been linked to severe neurodegenerative diseases; hence, it is of great interest to understand this process and how it is dysre-gulated in disease. Transportin-1 (TNPO1) and the closely related transportin-2 have been identified as major nuclear import receptors of FUS. They bind to the C-terminal nuclear localization signal of FUS and mediate the protein's nuclear import and at the same time also suppress aberrant phase transitions of FUS in the cytoplasm. Whether FUS can utilize other nuclear transport receptors for the purpose of import and chaperoning has not been examined so far. Here, we show that FUS directly binds to different import receptors in vitro. FUS formed stable complexes not only with TNPO1 but also with transportin-3, importin beta, importin 7, or the importin beta/7 heterodimer. Binding of these alternative import receptors required arginine residues within FUS-RG/RGG motifs and was weakened by arginine methylation. Interaction with these importins suppressed FUS phase separation and reduced its sequestration into stress granules. In a permeabilized cell system, we further showed that transportin-3 had the capacity to import FUS into the nucleus, albeit with lower efficiency than TNPO1. Our data suggest that aggregation-prone RNA-binding proteins such as FUS may utilize a network of importins for chaperoning and import, similar to histones and ribosomal proteins.	[Baade, Imke; Poerschke, Marius; Kehlenbach, Ralph H.] Georg August Univ Gottingen, Fac Med, Dept Mol Biol, GZMB, Gottingen, Germany; [Hutten, Saskia; Sternburg, Erin L.; Hofweber, Mario; Dormann, Dorothee] Ludwig Maximilians Univ Munchen, BioMed Ctr BMC, Cell Biol, Planegg Martinsried, Germany; [Dormann, Dorothee] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Hutten, Saskia; Sternburg, Erin L.; Dormann, Dorothee] Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Physiol, Mainz, Germany; [Hutten, Saskia; Sternburg, Erin L.; Dormann, Dorothee] Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Biol IMB, Mainz, Germany	University of Gottingen; University of Munich; University of Munich; Johannes Gutenberg University of Mainz; Institute of Molecular Biology (IMB); Johannes Gutenberg University of Mainz	Kehlenbach, RH (corresponding author), Georg August Univ Gottingen, Fac Med, Dept Mol Biol, GZMB, Gottingen, Germany.; Dormann, D (corresponding author), Ludwig Maximilians Univ Munchen, BioMed Ctr BMC, Cell Biol, Planegg Martinsried, Germany.; Dormann, D (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.; Dormann, D (corresponding author), Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Physiol, Mainz, Germany.; Dormann, D (corresponding author), Johannes Gutenberg Univ JGU, Bioctr, Inst Mol Biol IMB, Mainz, Germany.	ddormann@uni-mainz.de; rkehlen@gwdg.de		Kehlenbach, Ralph/0000-0003-4920-9916; Dormann, Dorothee/0000-0002-9260-2775; Porschke, Marius/0000-0003-4129-6058	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [DO 1804/1-1, DO 1804/1-2, DO1804/3-1]; Munich Cluster for Systems Neurology (EXC2145 SyNergy) [390857198]; DFG [KE 660/14-1, SFB860]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Munich Cluster for Systems Neurology (EXC2145 SyNergy); DFG(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) within Emmy Noether Grants DO 1804/1-1 and DO 1804/1-2 as well as research grant DO1804/3-1 (to D. D.). D. D. is additionally supported by the Munich Cluster for Systems Neurology (EXC2145 SyNergy-ID 390857198). R. H. K. was supported by the DFG (KE 660/14-1 and SFB860).	Alberti S, 2016, BIOESSAYS, V38, P959, DOI 10.1002/bies.201600042; Arnold M, 2006, J BIOL CHEM, V281, P5492, DOI 10.1074/jbc.M513281200; Arnold M, 2006, J BIOL CHEM, V281, P20883, DOI 10.1074/jbc.M602189200; Baade I, 2018, MOL CELL PROTEOMICS, V17, P1337, DOI 10.1074/mcp.RA118.000623; Baake M, 2001, EUR J CELL BIOL, V80, P669, DOI 10.1078/0171-9335-00208; Bauerle M, 2002, J BIOL CHEM, V277, P32480, DOI 10.1074/jbc.M202765200; Bogaert E., 2018, CELL REP, V24, P529; Bourgeois B, 2020, P NATL ACAD SCI USA, V117, P8503, DOI 10.1073/pnas.1918944117; Brelstaff J, 2011, ACTA NEUROPATHOL, V122, P591, DOI 10.1007/s00401-011-0863-6; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chook YM, 2011, BBA-MOL CELL RES, V1813, P1593, DOI 10.1016/j.bbamcr.2010.10.014; Davidson YS, 2013, NEUROPATH APPL NEURO, V39, P157, DOI 10.1111/j.1365-2990.2012.01274.x; Devoy A, 2017, BRAIN, V140, P2797, DOI 10.1093/brain/awx248; Dolker N, 2013, STRUCTURE, V21, P1350, DOI 10.1016/j.str.2013.05.015; Dormann D, 2012, EMBO J, V31, P4258, DOI 10.1038/emboj.2012.261; Dormann D, 2011, TRENDS NEUROSCI, V34, P339, DOI 10.1016/j.tins.2011.05.002; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Ederle H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25007-5; Fallini C, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104835; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Frohnert C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088887; Gami-Patel P, 2016, NEUROBIOL AGING, V46, P192, DOI 10.1016/j.neurobiolaging.2016.07.004; Gittings LM, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0673-y; Gonzalez A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83196-y; Gu LL, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-17; Guan TL, 2000, MOL CELL BIOL, V20, P5619, DOI 10.1128/MCB.20.15.5619-5630.2000; Guo L, 2019, TRENDS CELL BIOL, V29, P308, DOI 10.1016/j.tcb.2018.12.004; Hein MY, 2015, CELL, V163, P712, DOI 10.1016/j.cell.2015.09.053; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hu TH, 1996, J CELL BIOL, V134, P589, DOI 10.1083/jcb.134.3.589; Hutten S, 2020, BIO-PROTOCOL, V10, DOI 10.21769/BioProtoc.3846; Hutten S, 2020, SEMIN CELL DEV BIOL, V99, P151, DOI 10.1016/j.semcdb.2019.05.020; Ito D, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5436; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; Jakel S, 1999, EMBO J, V18, P2411, DOI 10.1093/emboj/18.9.2411; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Kataoka N, 1999, J CELL BIOL, V145, P1145, DOI 10.1083/jcb.145.6.1145; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kehlenbach RH, 1999, J CELL BIOL, V145, P645, DOI 10.1083/jcb.145.4.645; Kim HJ, 2017, NEURON, V96, P285, DOI 10.1016/j.neuron.2017.07.029; Kimura M, 2017, ELIFE, V6, DOI 10.7554/eLife.21184; KLEBE C, 1995, BIOCHEMISTRY-US, V34, P639, DOI 10.1021/bi00002a031; Lai MC, 2001, P NATL ACAD SCI USA, V98, P10154, DOI 10.1073/pnas.181354098; Lai MC, 2000, J BIOL CHEM, V275, P7950, DOI 10.1074/jbc.275.11.7950; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Ling SC, 2013, NEURON, V79, P416, DOI 10.1016/j.neuron.2013.07.033; Mackenzie IRA, 2010, LANCET NEUROL, V9, P995, DOI 10.1016/S1474-4422(10)70195-2; Maertens GN, 2014, P NATL ACAD SCI USA, V111, P2728, DOI 10.1073/pnas.1320755111; MELCHIOR F, 1995, METHOD ENZYMOL, V257, P279; Mingot JM, 2001, EMBO J, V20, P3685, DOI 10.1093/emboj/20.14.3685; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Muhlhausser P, 2001, EMBO REP, V2, P690, DOI 10.1093/embo-reports/kve168; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Neumann M, 2012, ACTA NEUROPATHOL, V124, P705, DOI 10.1007/s00401-012-1020-6; Neumann M, 2011, BRAIN, V134, P2595, DOI 10.1093/brain/awr201; Niu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047056; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Port SA, 2015, CELL REP, V13, P690, DOI 10.1016/j.celrep.2015.09.042; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Roloff S, 2013, J BIOL CHEM, V288, P3952, DOI 10.1074/jbc.M112.433243; Scekic-Zahirovic J, 2017, ACTA NEUROPATHOL, V133, P887, DOI 10.1007/s00401-017-1687-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sharma A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10465; Springhower CE, 2020, CURR OPIN CELL BIOL, V64, P112, DOI 10.1016/j.ceb.2020.04.003; Suarez-Calvet M, 2016, ACTA NEUROPATHOL, V131, P587, DOI 10.1007/s00401-016-1544-2; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Taylor JP, 2016, NATURE, V539, P197, DOI 10.1038/nature20413; Waldmann I, 2007, J BIOL CHEM, V282, P27685, DOI 10.1074/jbc.M703301200; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Warda AS, 2016, HUM MOL GENET, V25, P5353, DOI 10.1093/hmg/ddw351; WEIS K, 1995, SCIENCE, V268, P1049, DOI 10.1126/science.7754385; Wlde S., 2012, TRAFFIC, V13, P218; Wohlwend D, 2007, J BIOL CHEM, V282, P10707, DOI 10.1074/jbc.M610409200; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Yun CY, 2003, J BIOL CHEM, V278, P18050, DOI 10.1074/jbc.M211714200; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; ZHANG Y, 2018, CELL, V17, DOI DOI 10.1186/S12943-017-0753-1; Zhang ZC, 2012, P NATL ACAD SCI USA, V109, P12017, DOI 10.1073/pnas.1207247109	78	13	13	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100659	10.1016/j.jbc.2021.100659	http://dx.doi.org/10.1016/j.jbc.2021.100659			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857479	Green Published, gold			2022-12-28	WOS:000672866400630
J	Coates, HW; Capell-Hattam, IM; Brown, AJ				Coates, Hudson W.; Capell-Hattam, Isabelle M.; Brown, Andrew J.			The mammalian cholesterol synthesis enzyme squalene monooxygenase is proteasomally truncated to a constitutively active form	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Squalene monooxygenase (SM, also known as squalene epoxidase) is a rate-limiting enzyme of cholesterol synthesis that converts squalene to monooxidosqualene and is oncogenic in numerous cancer types. SM is subject to feedback regulation via cholesterol-induced proteasomal degradation, which depends on its lipid-sensing N-terminal regulatory domain. We previously identified an endogenous truncated form of SM with a similar abundance to full-length SM, but whether this truncated form is functional or subject to the same regulatory mechanisms as full-length SM is not known. Here, we show that truncated SM differs from full-length SM in two major ways: it is cholesterol resistant and adopts a peripheral rather than integral association with the endoplasmic reticulum membrane. However, truncated SM retains full SM activity and is therefore constitutively active. Truncation of SM occurs during its endoplasmic reticulum-associated degradation and requires the proteasome, which partially degrades the SM N-terminus and disrupts cholesterol-sensing elements within the regulatory domain. Furthermore, truncation relies on a ubiquitin signal that is distinct from that required for cholesterol-induced degradation. Using mutagenesis, we demonstrate that partial proteasomal degradation of SM depends on both an intrinsically disordered region near the truncation site and the stability of the adjacent catalytic domain, which escapes degradation. These findings uncover an additional layer of complexity in the post-translational regulation of cholesterol synthesis and establish SM as the first eukaryotic enzyme found to undergo proteasomal truncation.	[Coates, Hudson W.; Capell-Hattam, Isabelle M.; Brown, Andrew J.] UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia	University of New South Wales Sydney	Brown, AJ (corresponding author), UNSW Sydney, Sch Biotechnol & Biomol Sci, Sydney, NSW, Australia.	aj.brown@unsw.edu.au		Coates, Hudson/0000-0002-6506-5249; Capell-Hattam, Isabelle M/0000-0002-0902-0062	Australian Research Training Program scholarship; UNSW Sydney Scientia PhD Scholarship	Australian Research Training Program scholarship; UNSW Sydney Scientia PhD Scholarship	H. W. C. is a recipient of an Australian Research Training Program scholarship, and I. M. C.-H. is a recipient of a UNSW Sydney Scientia PhD Scholarship.		0	6	6	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100731	10.1016/j.jbc.2021.100731	http://dx.doi.org/10.1016/j.jbc.2021.100731			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933449	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400700
J	Hengge, AC				Hengge, Alvan C.			Plasmodium falciparum finds the winning combination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								After 3 years of laboratory drug pressure in the presence of a picomolar inhibitor, the parasite Plasmodium falciparum developed a combination strategy of gene amplification and mutation to regain viability. The mutation observed led to a dysfunctional enzyme, but new research reveals the clever mechanism behind its success. Not that we needed a reminder of nature's creativity in the time of a pandemic.	[Hengge, Alvan C.] Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA	Utah System of Higher Education; Utah State University	Hengge, AC (corresponding author), Utah State Univ, Dept Chem & Biochem, Logan, UT 84322 USA.	alvan.hengge@usu.edu	Hengge, Alvan/C-8667-2011	Hengge, Alvan/0000-0002-5696-2087				[Anonymous], 2015, GUID TREATM MAL; Cassera MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026916; Ducati RG, 2018, P NATL ACAD SCI USA, V115, P2114, DOI 10.1073/pnas.1525670115; Lewandowicz A, 2004, BIOCHEMISTRY-US, V43, P1458, DOI 10.1021/bi0359123; Minnow Y. V. T., 2021, J BIOL CHEM, V296; Schnick C, 2005, ACTA CRYSTALLOGR D, V61, P1245, DOI 10.1107/S0907444905020251	6	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100526	10.1016/j.jbc.2021.100526	http://dx.doi.org/10.1016/j.jbc.2021.100526			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237898	Green Published, gold			2022-12-28	WOS:000672866400500
J	Kostyak, JC; Mauri, B; Patel, A; Dangelmaier, C; Reddy, H; Kunapuli, SP				Kostyak, John C.; Mauri, Benjamin; Patel, Akruti; Dangelmaier, Carol; Reddy, Haritha; Kunapuli, Satya P.			Phosphorylation of protein kinase C delta Tyr311 positively regulates thromboxane generation in platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Platelets are key mediators of physiological hemostasis and pathological thrombosis, whose function must be carefully balanced by signaling downstream of receptors such as protease-activated receptor (PAR)4. Protein kinase C (PKC) is known to regulate various aspects of platelet function. For instance, PKC delta is known to regulate dense granule secretion, which is important for platelet activation. However, the mechanism by which PKC delta regulates this process as well as other facets of platelet activity is unknown. We speculated that the way PKC delta regulates platelet function may be because of the phosphorylation of tyrosine residues on PKC delta. We investigated phosphorylation of PKC delta following glycoprotein VI-mediated and PAR4-mediated platelet activation and found that Y311 is selectively phosphorylated when PAR4 is activated in human platelets. Therefore, we generated PKC delta Y311F knock-in mice, which are viable and have no gross abnormalities. However, PKC delta Y311F mice have significantly enhanced tail-bleeding times compared with WT littermate controls, which means hemostasis is interrupted. Furthermore, PKC delta Y311F mice exhibit longer time to carotid artery occlusion compared with WT control using a ferric chloride in vivo thrombosis model, indicating that the phosphorylation of PKC delta Y311 is pro-thrombotic. Washed platelets from PKC delta Y311F mice have reduced reactivity after stimulation with a PAR-4 agonist indicating its importance in platelet signaling. The phenotype observed in Y311F mouse platelets is because of reduced thromboxane generation, as an inhibitor of thromboxane generation equalizes the PKC delta Y311F platelet response to that of WT. Therefore, phosphorylation of PKC delta on Y311 is important for regulation of platelet function and specifically thromboxane generation, which reinforces platelet activation.	[Kostyak, John C.; Mauri, Benjamin; Patel, Akruti; Dangelmaier, Carol; Reddy, Haritha; Kunapuli, Satya P.] Temple Univ, Sch Lewis M Katz Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Sch Lewis M Katz Sch Med, Dept Physiol, Philadelphia, PA 19122 USA; [Kunapuli, Satya P.] Temple Univ, Sch Lewis M Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Kunapuli, SP (corresponding author), Temple Univ, Sch Lewis M Katz Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19122 USA.; Kunapuli, SP (corresponding author), Temple Univ, Sch Lewis M Katz Sch Med, Dept Physiol, Philadelphia, PA 19122 USA.; Kunapuli, SP (corresponding author), Temple Univ, Sch Lewis M Katz Sch Med, Dept Pharmacol, Philadelphia, PA 19122 USA.	spk@temple.edu			National Institutes of Health [HL132171, HL93231, HL137207, HL137721]; American Heart Association [17SDG33370020]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by grants HL132171, HL93231, HL137207, HL137721 from the National Institutes of Health (to S. P. K.) and 17SDG33370020 from the American Heart Association (to J. C. K.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji R, 2019, IUBMB LIFE, V'72, P247; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100720	10.1016/j.jbc.2021.100720	http://dx.doi.org/10.1016/j.jbc.2021.100720			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33932405	gold, Green Published			2022-12-28	WOS:000672866400690
J	Mimura, K; Sakamaki, JI; Morishita, H; Kawazu, M; Mano, H; Mizushima, N				Mimura, Kaito; Sakamaki, Jun-Ichi; Morishita, Hideaki; Kawazu, Masahito; Mano, Hiroyuki; Mizushima, Noboru			Genome-wide CRISPR screening reveals nucleotide synthesis negatively regulates autophagy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HOPS COMPLEX; COLON-CANCER; 5-FLUOROURACIL; GROWTH; IDENTIFICATION; CHEMOTHERAPY; METABOLISM; REPRESSION; INHIBITION; RECEPTOR	Macroautophagy (hereafter, autophagy) is a process that directs the degradation of cytoplasmic material in lysosomes. In addition to its homeostatic roles, autophagy undergoes dynamic positive and negative regulation in response to multiple forms of cellular stress, thus enabling the survival of cells. However, the precise mechanisms of autophagy regulation are not fully understood. To identify potential negative regulators of autophagy, we performed a genome-wide CRISPR screen using the quantitative autophagic flux reporter GFP-LC3-RFP. We identified phosphoribosylformylglycinamidine synthase, a component of the de novo purine synthesis pathway, as one such negative regulator of autophagy. Autophagy was activated in cells lacking phosphoribosylformylglycinamidine synthase or phosphoribosyl pyrophosphate amidotransferase, another de novo purine synthesis enzyme, or treated with methotrexate when exogenous levels of purines were insufficient. Purine starvation-induced autophagy activation was concomitant with mammalian target of rapamycin complex 1 (mTORC1) suppression and was profoundly suppressed in cells deficient for tuberous sclerosis complex 2, which negatively regulates mTORC1 through inhibition of Ras homolog enriched in brain, suggesting that purines regulate autophagy through the tuberous sclerosis complex-Ras homolog enriched in brainm-TORC1 signaling axis. Moreover, depletion of the pyrimidine synthesis enzymes carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase and dihydroorotate dehydrogenase activated autophagy as well, although mTORC1 activity was not altered by pyrimidine shortage. These results suggest a different mechanism of autophagy induction between purine and pyrimidine starvation. These findings provide novel insights into the regulation of autophagy by nucleotides and possibly the role of autophagy in nucleotide metabolism, leading to further developing anticancer strategies involving nucleotide synthesis and autophagy.	[Mimura, Kaito; Sakamaki, Jun-Ichi; Morishita, Hideaki; Mizushima, Noboru] Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo, Japan; [Mimura, Kaito; Sakamaki, Jun-Ichi; Morishita, Hideaki; Mizushima, Noboru] Univ Tokyo, Fac Med, Tokyo, Japan; [Kawazu, Masahito; Mano, Hiroyuki] Natl Canc Ctr, Div Cellular Signaling, Tokyo, Japan; [Morishita, Hideaki] Juntendo Univ, Dept Physiol, Grad Sch Med, Tokyo 1138421, Japan	University of Tokyo; University of Tokyo; National Cancer Center - Japan; Juntendo University	Mizushima, N (corresponding author), Univ Tokyo, Grad Sch, Dept Biochem & Mol Biol, Tokyo, Japan.; Mizushima, N (corresponding author), Univ Tokyo, Fac Med, Tokyo, Japan.	nmizu@m.u.tokyo.ac.jp	Kawazu, Masahito/AAE-6143-2022; Mizushima, Noboru/C-3635-2009	Kawazu, Masahito/0000-0003-4146-3629; Mizushima, Noboru/0000-0002-6258-6444; Mimura, Kaito/0000-0002-0053-0218; Sakamaki, Jun-ichi/0000-0003-3361-6314; Morishita, Hideaki/0000-0003-0860-8371	Japan Science and Technology Agency [JPMJER1702]; MD Scientist Training Program, Faculty of Medicine, The University of Tokyo	Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); MD Scientist Training Program, Faculty of Medicine, The University of Tokyo	This work was supported by a grant for Exploratory Research for Advanced Technology from the Japan Science and Technology Agency (JPMJER1702 to N. M.). K. M. was supported by the MD Scientist Training Program, Faculty of Medicine, The University of Tokyo.	Ali ES, 2020, MOL CELL, V78, P1178, DOI 10.1016/j.molcel.2020.05.001; An H, 2020, NATURE, V583, P303, DOI 10.1038/s41586-020-2446-y; An H, 2020, J MOL BIOL, V432, P170, DOI 10.1016/j.jmb.2019.06.001; Bas L, 2018, J CELL BIOL, V217, P3656, DOI 10.1083/jcb.201804028; Boettcher M, 2015, MOL CELL, V58, P575, DOI 10.1016/j.molcel.2015.04.028; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chen SD, 2015, CELL, V160, P1246, DOI 10.1016/j.cell.2015.02.038; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; DeJesus R, 2016, ELIFE, V5, DOI [10.7554/elife.17290, 10.7554/eLife.17290]; Efeyan A, 2014, DEV CELL, V29, P321, DOI 10.1016/j.devcel.2014.03.017; Emmanuel N, 2017, CELL REP, V19, P2665, DOI 10.1016/j.celrep.2017.05.043; Gao JQ, 2018, J CELL BIOL, V217, P3670, DOI 10.1083/jcb.201804039; Gilbert LA, 2014, CELL, V159, P647, DOI 10.1016/j.cell.2014.09.029; Goodwin JM, 2017, CELL REP, V20, P2341, DOI 10.1016/j.celrep.2017.08.034; Guo JY, 2016, GENE DEV, V30, P1704, DOI 10.1101/gad.283416.116; Guo XL, 2012, CANCER LETT, V320, P171, DOI 10.1016/j.canlet.2012.03.002; Hale CM, 2016, AUTOPHAGY, V12, P713, DOI 10.1080/15548627.2016.1147669; HARKNESS R A, 1980, Biochemical Society Transactions, V8, P139; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Houzelstein D, 2002, MOL CELL BIOL, V22, P3794, DOI 10.1128/MCB.22.11.3794-3802.2002; Hoxhaj G, 2017, CELL REP, V21, P1331, DOI 10.1016/j.celrep.2017.10.029; Huang HH, 2015, EMBO J, V34, P154, DOI 10.15252/embj.201489083; Itakura E, 2012, CELL, V151, P1256, DOI 10.1016/j.cell.2012.11.001; Jia R, 2019, ELIFE, V8, DOI 10.7554/eLife.50034; Jiang P, 2014, MOL BIOL CELL, V25, P1327, DOI 10.1091/mbc.E13-08-0447; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Jung J, 2017, ELIFE, V6, DOI [10.7554/eLife.23063, 10.75554/eLife.23063]; Kaizuka T, 2016, MOL CELL, V64, P835, DOI 10.1016/j.molcel.2016.09.037; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kramer NJ, 2018, NAT GENET, V50, P603, DOI 10.1038/s41588-018-0070-7; Kroemer G, 2010, MOL CELL, V40, P280, DOI 10.1016/j.molcel.2010.09.023; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Li J, 2010, EUR J CANCER, V46, P1900, DOI 10.1016/j.ejca.2010.02.021; Li W, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0554-4; Liang JR, 2020, CELL, V180, P1160, DOI 10.1016/j.cell.2020.02.017; Liu KQ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20253-6; Liu YB, 2018, ELIFE, V7, DOI 10.7554/eLife.36588; Matsui T, 2018, J CELL BIOL, V217, P2633, DOI 10.1083/jcb.201712058; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Mizushima N, 2018, NAT CELL BIOL, V20, P521, DOI 10.1038/s41556-018-0092-5; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Moretti F, 2018, EMBO REP, V19, DOI 10.15252/embr.201845889; Morita K, 2018, J CELL BIOL, V217, P3817, DOI 10.1083/jcb.201804132; Orvedahl A, 2011, NATURE, V480, P113, DOI 10.1038/nature10546; Patel SJ, 2017, NATURE, V548, P537, DOI 10.1038/nature23477; Potting C, 2018, P NATL ACAD SCI USA, V115, pE180, DOI 10.1073/pnas.1711023115; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Ropolo A, 2007, J BIOL CHEM, V282, P37124, DOI 10.1074/jbc.M706956200; Saitoh T, 2002, FEBS LETT, V532, P45, DOI 10.1016/S0014-5793(02)03622-0; Sakamaki JI, 2017, MOL CELL, V66, P517, DOI 10.1016/j.molcel.2017.04.027; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Sasaki K, 2012, ANTI-CANCER DRUG, V23, P675, DOI 10.1097/CAD.0b013e328353f8c7; Sasaki K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-370; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shoemaker CJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.2007044; Slobodkin MR, 2013, ESSAYS BIOCHEM, V55, P51, DOI [10.1042/bse0550051, 10.1042/BSE0550051]; Takats S, 2014, MOL BIOL CELL, V25, P1338, DOI 10.1091/mbc.E13-08-0449; Tang JC, 2016, CHINESE MED J-PEKING, V129, P456, DOI 10.4103/0366-6999.176069; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Villa E, 2019, CANCERS, V11, DOI 10.3390/cancers11050688; Wang T, 2014, SCIENCE, V343, P80, DOI 10.1126/science.1246981; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Wyant GA, 2018, SCIENCE, V360, P751, DOI 10.1126/science.aar2663; Zhang R, 2016, NATURE, V535, P164, DOI 10.1038/nature18625; Zhong Y, 2009, NAT CELL BIOL, V11, P468, DOI 10.1038/ncb1854; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	68	4	4	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100780	10.1016/j.jbc.2021.100780	http://dx.doi.org/10.1016/j.jbc.2021.100780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34000301	gold, Green Published			2022-12-28	WOS:000674717300002
J	Poria, DK; Sheshadri, N; Balamurugan, K; Sharan, S; Sterneck, E				Poria, Dipak K.; Sheshadri, Namratha; Balamurugan, Kuppusamy; Sharan, Shikha; Sterneck, Esta			The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTATE-CANCER; ACTIVATION; GLUCONEOGENESIS; AUTOPHAGY; TARGETS	Signal transducer and activator of transcription 3 (STAT3) is an important transcription factor involved in many physiological functions including embryonic development and immune responses and is often activated under pathological conditions such as cancer. Strategies to inactivate STAT3 are being pursued as potential anticancer therapies and have led to the identification of Stattic (6-nitrobenzo[b]thiophene-1, 1-dioxide) as a "specific" STAT3 inhibitor that is often used to interrogate STAT3-mediated gene expression in vitro and in vivo. Here, we show that Stattic exerts many STAT3-independent effects on cancer cells, calling for reassessment of results previously ascribed to STAT3 functions. Studies of the STAT3-deficient prostate cancer cell line PC-3 (PC3) along with STAT3-proficient breast cancer cell lines (MDA-MB-231, SUM149) revealed that Stattic attenuated histone acetylation and neutralized effects of the histone deacetylase (HDAC) inhibitor romidepsin. In PC3 cells, Stattic alone inhibited gene expression of CCL20 and CCL2, but activated expression of TNFA, CEBPD, SOX2, and MYC. In addition, we found that Stattic promoted autophagy and caused cell death. These data point to profound epigenetic effects of Stattic that are independent of its function as a STAT3 inhibitor. Our results demonstrate that Stattic directly or indirectly reduces histone acetylation and suggest reevaluation of Stattic and related compounds as polypharmacological agents through multi-pronged cytotoxic effects on cancer cells.	[Poria, Dipak K.; Sheshadri, Namratha; Balamurugan, Kuppusamy; Sharan, Shikha; Sterneck, Esta] NCI, Lab Cell & Dev Signaling, Ctr Canc Res CCR, NIH, Frederick, MD 21701 USA; [Sheshadri, Namratha] Rutgers State Univ, Ernest Mario Sch Pharm, Susan Lehman Cullman Lab Canc Res, Piscataway, NJ USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Rutgers State University New Brunswick	Sterneck, E (corresponding author), NCI, Lab Cell & Dev Signaling, Ctr Canc Res CCR, NIH, Frederick, MD 21701 USA.	sternecg@nih.org	Kuppusamy, Balamurugan/AAC-6020-2022; Poria, Dipak Kumar/AAM-2084-2021; Sheshadri, Namratha/AAM-7384-2021	Poria, Dipak Kumar/0000-0002-6935-4160; Sheshadri, Namratha/0000-0003-4912-7275; Sharan, Shikha/0000-0001-5885-7304; Sterneck, Esta/0000-0001-7716-8766	Intramural Research Program of the National Institutes of Health, National Cancer Institute [HHSN261200800001E]	Intramural Research Program of the National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, in part with Federal Funds under contract no. HHSN261200800001E. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baell JB, 2016, FUTURE MED CHEM, V8, P1525, DOI 10.4155/fmc-2016-0151; Balamurugan K, 2019, ONCOGENE, V38, P3765, DOI 10.1038/s41388-018-0516-5; Balamurugan K, 2013, INT J BIOL SCI, V9, P917, DOI 10.7150/ijbs.7224; Banerjee K, 2016, INT J CANCER, V138, P2570, DOI 10.1002/ijc.29923; Busker S, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aax7945; Cang SD, 2009, INT J ONCOL, V35, P1417, DOI 10.3892/ijo_00000459; Clark J, 2003, ONCOGENE, V22, P1247, DOI 10.1038/sj.onc.1206247; da Hora CC, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0155-9; Dahlin JL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01657-3; Debnath B, 2012, J MED CHEM, V55, P6645, DOI 10.1021/jm300207s; Hahn YI, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23840-2; Heidelberger S, 2013, BIOORG MED CHEM LETT, V23, P4719, DOI 10.1016/j.bmcl.2013.05.066; Ibrahim SA, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0621-z; Jhaveri K, 2016, CLIN BREAST CANCER, V16, P113, DOI 10.1016/j.clbc.2015.11.006; Kimura K, 2012, DIABETES, V61, P61, DOI 10.2337/db10-1684; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Meares GP, 2014, MOL CELL BIOL, V34, P3911, DOI 10.1128/MCB.00980-14; Nie YZ, 2009, NAT CELL BIOL, V11, P492, DOI 10.1038/ncb1857; Olzscha Heidi, 2015, Critical Reviews in Oncogenesis, V20, P1; Petrich A, 2016, LEUKEMIA LYMPHOMA, V57, P1755, DOI 10.3109/10428194.2016.1160082; Robertson Fredika M, 2013, J Exp Ther Oncol, V10, P219; Sanseverino I, 2012, CHEM BIOL, V19, P1213, DOI 10.1016/j.chembiol.2012.08.021; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Seim I, 2017, G3-GENES GENOM GENET, V7, P1731, DOI 10.1534/g3.117.039909; Shen SS, 2012, MOL CELL, V48, P667, DOI 10.1016/j.molcel.2012.09.013; Shih PC, 2020, LIFE SCI, V242, DOI 10.1016/j.lfs.2019.117241; Simon RP, 2016, J MED CHEM, V59, P1249, DOI 10.1021/acs.jmedchem.5b01502; Uchihara Y, 2019, PHARMACOL REP, V71, P1067, DOI 10.1016/j.pharep.2019.05.021; Wake MS, 2015, FEBS J, V282, P2600, DOI 10.1111/febs.13285; Wright DE, 2018, ANTIOXID REDOX SIGN, V29, P377, DOI 10.1089/ars.2017.7082; Yang CM, 2012, HORM MOL BIOL CLIN I, V10, P241, DOI 10.1515/hmbci-2012-0003; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhuang SG, 2013, CELL SIGNAL, V25, P1924, DOI 10.1016/j.cellsig.2013.05.007	34	4	4	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100220	10.1074/jbc.RA120.016645	http://dx.doi.org/10.1074/jbc.RA120.016645			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839684	Green Published, gold			2022-12-28	WOS:000672866400198
J	Rebbeck, RT; Andrick, AK; Denha, SA; Svensson, B; Guhathakurta, P; Thomas, DD; Hays, TS; Avery, AW				Rebbeck, Robyn T.; Andrick, Anna K.; Denha, Sarah A.; Svensson, Bengt; Guhathakurta, Piyali; Thomas, David D.; Hays, Thomas S.; Avery, Adam W.			Novel drug discovery platform for spinocerebellar ataxia, using fluorescence technology targeting beta-III-spectrin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN-BINDING DOMAIN; HIGH-THROUGHPUT; MUTATIONS; FRET; ALPHA-ACTININ-4; MODULATORS; MECHANISM; DYNAMICS; FILAMIN; SCREENS	Numerous diseases are linked to mutations in the actin-binding domains (ABDs) of conserved cytoskeletal proteins, including beta-III-spectrin, a-actinin, filamin, and dystrophin. A beta-III-spectrin ABD mutation (L253P) linked to spinocerebellar ataxia type 5 (SCA5) causes a dramatic increase in actin binding. Reducing actin binding of L253P is thus a potential therapeutic approach for SCA5 pathogenesis. Here, we validate a high-throughput screening (HTS) assay to discover potential disrupters of the interaction between the mutant beta-III-spectrin ABD and actin in live cells. This assay monitors FRET between fluorescent proteins fused to the mutant ABD and the actin-binding peptide Lifeact, in HEK293-6E cells. Using a specific and high-affinity actin-binding tool compound, swinholide A, we demonstrate HTS compatibility with an excellent Z'-factor of 0.67 +/- 0.03. Screening a library of 1280 pharmacologically active compounds in 1536-well plates to determine assay robustness, we demonstrate high reproducibility across plates and across days. We identified nine Hits that reduced FRET between Lifeact and ABD. Four of those Hits were found to reduce Lifeact cosedimentation with actin, thus establishing the potential of our assay for detection of actin-binding modulators. Concurrent to our primary FRET assay, we also developed a high-throughput compatible counter screen to remove undesirable FRET Hits. Using the FRET Hits, we show that our counter screen is sensitive to undesirable compounds that cause cell toxicity or ABD aggregation. Overall, our FRET-based HTS platform sets the stage to screen large compound libraries for modulators of beta-III-spectrin, or disease-linked spectrin-related proteins, for therapeutic development.	[Rebbeck, Robyn T.; Andrick, Anna K.; Svensson, Bengt; Guhathakurta, Piyali; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA; [Denha, Sarah A.; Avery, Adam W.] Univ Minnesota, Dept Genet Cellular Biol & Dev, Minneapolis, MN 55455 USA; [Hays, Thomas S.; Avery, Adam W.] Oakland Univ, Dept Chem, Rochester, MI 48309 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Oakland University	Avery, AW (corresponding author), Univ Minnesota, Dept Genet Cellular Biol & Dev, Minneapolis, MN 55455 USA.; Avery, AW (corresponding author), Oakland Univ, Dept Chem, Rochester, MI 48309 USA.	awavery@oakland.edu		Rebbeck, Robyn/0000-0003-3840-2286; Avery, Adam/0000-0001-8085-1822; Thomas, David D./0000-0002-8822-2040	NIH [R61NS111075, R33NS111075, R01GM044757, R01HL139065, R37AG026160, R15NS116511]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grants R61NS111075, R33NS111075, and R01GM044757 to T. S. H., R01HL139065 (formerly GM027906) and R37AG026160 to D. D. T., and R15NS116511 to A. W. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akrap N, 2010, ANAL BIOCHEM, V402, P105, DOI 10.1016/j.ab.2010.03.026; Amin Amit Dipak, 2015, Biomark Cancer, V7, P25, DOI 10.4137/BIC.S29326; Avery AW, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01367-w; Avery AW, 2017, P NATL ACAD SCI USA, V114, pE9376, DOI 10.1073/pnas.1707108114; Avery AW, 2016, SCI REP-UK, V6, DOI 10.1038/srep21375; Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e; BUBB MR, 1995, J BIOL CHEM, V270, P3463, DOI 10.1074/jbc.270.8.3463; Burk K, 2004, NEUROLOGY, V62, P327, DOI 10.1212/01.WNL.0000103293.63340.C1; Clark AR, 2009, HUM MOL GENET, V18, P4791, DOI 10.1093/hmg/ddp442; Courtemanche N, 2016, NAT CELL BIOL, V18, P676, DOI 10.1038/ncb3351; Doak AK, 2010, J MED CHEM, V53, P4259, DOI 10.1021/jm100254w; Duff RM, 2011, AM J HUM GENET, V88, P729, DOI 10.1016/j.ajhg.2011.04.021; Ferreira RS, 2010, J MED CHEM, V53, P4891, DOI 10.1021/jm100488w; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Guhathakurta P, 2018, J BIOL CHEM, V293, P12288, DOI 10.1074/jbc.RA118.002702; Henderson DM, 2010, P NATL ACAD SCI USA, V107, P9632, DOI 10.1073/pnas.1001517107; Hughes JP, 2011, BRIT J PHARMACOL, V162, P1239, DOI 10.1111/j.1476-5381.2010.01127.x; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hurley JD, 2017, CELL ADHES MIGR, V11, P80, DOI 10.1080/19336918.2016.1187368; Ikeda Y, 2006, NAT GENET, V38, P184, DOI 10.1038/ng1728; Irwin JJ, 2015, J MED CHEM, V58, P7076, DOI 10.1021/acs.jmedchem.5b01105; Jager V, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-52; Kaplan JM, 2000, NAT GENET, V24, P251, DOI 10.1038/73456; Kumar S, 2009, FREE RADICAL BIO MED, V47, P699, DOI 10.1016/j.freeradbiomed.2009.05.028; Kumari A, 2020, EMBO J, V39, DOI 10.15252/embj.2019104006; Liu LZ, 2016, CHINESE MED J-PEKING, V129, P2516, DOI 10.4103/0366-6999.191834; Lo CH, 2019, ALZHEIMERS DEMENT, V15, P1489, DOI 10.1016/j.jalz.2019.06.4954; Lo CH, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav5637; Lo CH, 2017, SLAS DISCOV, V22, P950, DOI 10.1177/2472555217706478; Loignon M, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-65; Murphy ACH, 2016, FEBS LETT, V590, P685, DOI 10.1002/1873-3468.12101; Ni SS, 2020, EUR J MED CHEM, V185, DOI 10.1016/j.ejmech.2019.111848; Nicita F, 2019, CLIN GENET, V96, P169, DOI 10.1111/cge.13562; Ohara O, 1998, MOL BRAIN RES, V57, P181, DOI 10.1016/S0169-328X(98)00068-0; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Prochniewicz E, 1996, J MOL BIOL, V255, P446, DOI 10.1006/jmbi.1996.0037; Prochniewicz E, 2010, J MOL BIOL, V396, P501, DOI 10.1016/j.jmb.2009.11.063; Rebbeck RT, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58461-1; Rebbeck RT, 2017, SLAS DISCOV, V22, P176, DOI 10.1177/1087057116674312; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sawyer GM, 2009, J MOL BIOL, V390, P1030, DOI 10.1016/j.jmb.2009.06.009; Schaaf TM, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040099; Schaaf TM, 2017, SLAS DISCOV, V22, P262, DOI 10.1177/1087057116680151; Schaaf TM, 2017, SLAS DISCOV, V22, P250, DOI 10.1177/1087057116679637; Shelley MD, 2000, ANTI-CANCER DRUG, V11, P209, DOI 10.1097/00001813-200003000-00009; Sorensen MG, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-250; Stroik DR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29685-z; Terry DR, 1997, J BIOL CHEM, V272, P7841, DOI 10.1074/jbc.272.12.7841; Weins A, 2005, J AM SOC NEPHROL, V16, P3694, DOI 10.1681/ASN.2005070706	49	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100215	10.1074/jbc.RA120.015417	http://dx.doi.org/10.1074/jbc.RA120.015417			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839680	Green Published, gold			2022-12-28	WOS:000672866400193
J	Walbaum, S; Ambrosy, B; Schutz, P; Bachg, AC; Horsthemke, M; Leusen, JHW; Mocsai, A; Hanley, PJ				Walbaum, Stefan; Ambrosy, Benjamin; Schuetz, Paula; Bachg, Anne C.; Horsthemke, Markus; Leusen, Jeanette H. W.; Mocsai, Attila; Hanley, Peter J.			Complement receptor 3 mediates both sinking phagocytosis and phagocytic cup formation via distinct mechanisms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FC-GAMMA RECEPTOR; SYK TYROSINE KINASE; DEFICIENT NEUTROPHILS; MAC-1 CD11B/CD18; MACROPHAGES; ADHESION; MOUSE; REQUIREMENTS; ACTIVATION; ATTACHMENT	A long-standing hypothesis is that complement receptors (CRs), especially CR3, mediate sinking phagocytosis, but evidence is lacking. Alternatively, CRs have been reported to induce membrane ruffles or phagocytic cups, akin to those induced by Fc. receptors (Fc.Rs), but the details of these events are unclear. Here we used real-time 3D imaging and KO mouse models to clarify how particles (human red blood cells) are internalized by resident peritoneal F4/80+ cells (macrophages) via CRs and/or Fc gamma Rs. We first show that Fc.Rs mediate highly efficient, rapid (2-3 min) phagocytic cup formation, which is completely abolished by deletion or mutation of the FcR gamma chain or conditional deletion of the signal transducer Syk. Fc gamma R-mediated phagocytic cups robustly arise from any point of cell-particle contact, including filopodia. In the absence of CR3, Fc.R-mediated phagocytic cups exhibit delayed closure and become aberrantly elongated. Independent of Fc gamma Rs, CR3 mediates sporadic ingestion of complement-opsonized particles by rapid phagocytic cup-like structures, typically emanating from membrane ruffles and largely prevented by deletion of the immunoreceptor tyrosine-based activation motif (ITAM) adaptors FcR. chain and DAP12 or Syk. Deletion of ITAM adaptors or Syk clearly revealed that there is a slow (10-25 min) sinking mode of phagocytosis via a restricted orifice. In summary, we show that (1) CR3 indeed mediates a slow sinking mode of phagocytosis, which is accentuated by deletion of ITAM adaptors or Syk, (2) CR3 induces phagocytic cup-like structures, driven by ITAM adaptors and Syk, and (3) CR3 is involved in forming and closing Fc gamma R-mediated phagocytic cups.	[Walbaum, Stefan; Ambrosy, Benjamin; Schuetz, Paula; Bachg, Anne C.; Horsthemke, Markus; Hanley, Peter J.] Westfalische Wilhems Univ Munster, Inst Mol Zellbiol, Munster, Germany; [Leusen, Jeanette H. W.] Univ Med Ctr Utrecht, Ctr Translat Immunol, Utrecht, Netherlands; [Mocsai, Attila] Semmelweis Univ, Dept Physiol, Sch Med, Budapest, Hungary; [Hanley, Peter J.] Witten Herdecke Univ, Fac Hlth, Sch Med, Dept Physiol Pathophysiol & Toxicol, Witten, Germany; [Hanley, Peter J.] Witten Herdecke Univ, Fac Hlth, Sch Med, ZBAF Ctr Biomed Educ & Res, Witten, Germany	Utrecht University; Utrecht University Medical Center; Semmelweis University	Hanley, PJ (corresponding author), Westfalische Wilhems Univ Munster, Inst Mol Zellbiol, Munster, Germany.; Hanley, PJ (corresponding author), Witten Herdecke Univ, Fac Hlth, Sch Med, Dept Physiol Pathophysiol & Toxicol, Witten, Germany.; Hanley, PJ (corresponding author), Witten Herdecke Univ, Fac Hlth, Sch Med, ZBAF Ctr Biomed Educ & Res, Witten, Germany.	peter.hanley@uni-wh.de		Mocsai, Attila/0000-0002-0512-1157	Deutsche Forschungsgemeinschaft (DFG) [HA 3271/4-1, HA 3271/4-2]; Cells in Motion (CiM) [FF-2016-05, EXC 1003]; Elvonal program of the Hungarian Research, Development, and Innovation Office [KKP_129954]; DFG [FF-2016-05]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cells in Motion (CiM); Elvonal program of the Hungarian Research, Development, and Innovation Office; DFG(German Research Foundation (DFG))	This work was supported by grants HA 3271/4-1 and HA 3271/4-2 from the Deutsche Forschungsgemeinschaft (DFG) and the grant FF-2016-05 from the EXC 1003 (Cluster of Excellence 1003), Cells in Motion (CiM), and DFG (to P. J. H.). This work was also in part funded by the Elvonal program of the Hungarian Research, Development, and Innovation Office (grant No. KKP_129954 to A. M.).	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; Allen LAH, 1996, J EXP MED, V184, P627, DOI 10.1084/jem.184.2.627; Bakker ABH, 2000, IMMUNITY, V13, P345, DOI 10.1016/S1074-7613(00)00034-0; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Blainey P, 2014, NAT METHODS, V11, P879, DOI 10.1038/nmeth.3091; Bohdanowicz M, 2010, J CELL BIOL, V191, P999, DOI 10.1083/jcb.201004005; BROWN EJ, 1988, J CLIN INVEST, V81, P365, DOI 10.1172/JCI113328; Bruhns P, 2012, BLOOD, V119, P5640, DOI 10.1182/blood-2012-01-380121; Clausen BE, 1999, TRANSGENIC RES, V8, P265, DOI 10.1023/A:1008942828960; de Haij S, 2010, CANCER RES, V70, P3209, DOI 10.1158/0008-5472.CAN-09-4109; Dupuy AG, 2008, J CELL SCI, V121, P1773, DOI 10.1242/jcs.018036; El-Brolosy MA, 2019, NATURE, V568, P193, DOI 10.1038/s41586-019-1064-z; Flannagan RS, 2012, ANNU REV PATHOL-MECH, V7, P61, DOI 10.1146/annurev-pathol-011811-132445; Gorgani NN, 2008, J IMMUNOL, V181, P7902, DOI 10.4049/jimmunol.181.11.7902; GRAHAM IL, 1989, J IMMUNOL, V142, P2352; Greenberg S, 1996, P NATL ACAD SCI USA, V93, P1103, DOI 10.1073/pnas.93.3.1103; GRESHAM HD, 1991, J CLIN INVEST, V88, P588, DOI 10.1172/JCI115343; GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Helmy KY, 2006, CELL, V124, P915, DOI 10.1016/j.cell.2005.12.039; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Horsthemke M, 2018, JOVE-J VIS EXP, DOI 10.3791/57566; Horsthemke M, 2017, J BIOL CHEM, V292, P7258, DOI 10.1074/jbc.M116.766923; Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085; Jaumouille V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01097; Jaumouille V, 2019, NAT CELL BIOL, V21, P1357, DOI 10.1038/s41556-019-0414-2; Jongstra-Bilen J, 2003, J BIOL CHEM, V278, P45720, DOI 10.1074/jbc.M303704200; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Konigs V, 2014, J BIOL CHEM, V289, P30772, DOI 10.1074/jbc.M114.563270; KUROSAKI T, 1989, NATURE, V342, P805, DOI 10.1038/342805a0; KUSUNOKI T, 1994, J LEUKOCYTE BIOL, V55, P735, DOI 10.1002/jlb.55.6.735; Lin SY, 2001, SCIENCE, V291, P445, DOI 10.1126/science.291.5503.445; MARTIN BK, 1993, EUR J IMMUNOL, V23, P3037, DOI 10.1002/eji.1830231146; Merle NS, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00257; Metschnikoff E, 1891, Br Med J, V1, P213; Mocsai A, 2003, BLOOD, V101, P4155, DOI 10.1182/blood-2002-07-2346; Mocsai A, 2006, NAT IMMUNOL, V7, P1326, DOI 10.1038/ni1407; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; MUNTHEKAAS AC, 1976, EXP CELL RES, V103, P201, DOI 10.1016/0014-4827(76)90256-1; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; RA C, 1989, NATURE, V341, P752, DOI 10.1038/341752a0; Reversat A, 2020, NATURE, V582, P582, DOI 10.1038/s41586-020-2283-z; Rosales C, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/9042851; Rossi A, 2015, NATURE, V524, P230, DOI 10.1038/nature14580; Saijo K, 2003, NAT IMMUNOL, V4, P274, DOI 10.1038/ni893; Scharffetter-Kochanek K, 1998, J EXP MED, V188, P119, DOI 10.1084/jem.188.1.119; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447; TAKAI T, 1994, CELL, V76, P519, DOI 10.1016/0092-8674(94)90115-5; Tang T, 1997, J EXP MED, V186, P1853, DOI 10.1084/jem.186.11.1853; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Underhill DM, 2012, NAT REV IMMUNOL, V12, P492, DOI 10.1038/nri3244; Uribe-Querol E, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01066; van den Bos E, 2020, J BIOL CHEM, V295, P7726, DOI 10.1074/jbc.RA119.011984; van Spriel AB, 2003, BLOOD, V101, P253, DOI 10.1182/blood.V101.1.253; Wiesmann C, 2006, NATURE, V444, P217, DOI 10.1038/nature05263	56	7	7	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100256	10.1016/j.jbc.2021.100256	http://dx.doi.org/10.1016/j.jbc.2021.100256			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839682	Green Published, gold			2022-12-28	WOS:000672866400232
J	Yu, WJ; Singh, R; Wang, Z; O'Malley, BW; Yi, P				Yu, Wenjuan; Singh, Ramesh; Wang, Zhao; O'Malley, Bert W.; Yi, Ping			The E3 ligase TRAF4 promotes IGF signaling by mediating atypical ubiquitination of IRS-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Insulin-like growth factor (IGF) is a potent mitogen that activates the IGF receptor (IGFR)/insulin receptor substrate (IRS) axis, thus stimulating growth in normal cells and uncontrolled cell proliferation in cancer. Posttranslational modifications of IRS such as ubiquitination tightly control IGF signaling, and we previously identified IRS-1 as a potential substrate for the E3 ubiquitin ligase TRAF4 using an unbiased screen. Here we provide evidence that TRAF4-mediated ubiquitination of IRS-1 is physiologically relevant and crucial for IGF signal transduction. Through site-directed mutagenesis we found that TRAF4 promotes an atypical K29-linked ubiquitination at the C-terminal end of IRS-1. Its depletion abolishes AKT and ERK phosphorylation downstream of IGF-1 and inhibits breast cancer cell proliferation. Overexpression of TRAF4 enhances IGF1-induced IGFR-IRS-1 interaction, IRS-1 tyrosine phosphorylation, and downstream effector protein activation, whereas mutation of IRS-1 ubiquitination sites completely abolishes these effects. Altogether, our studies demonstrate that nonproteolytic ubiquitination of IRS-1 is a key step in conveying IGF-1 stimulation from IGFR to IRS-1.	[Yu, Wenjuan; Wang, Zhao] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Singh, Ramesh; Wang, Zhao; O'Malley, Bert W.; Yi, Ping] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Yu, Wenjuan] Qingdao Univ, Dept Pathol, Affiliated Hosp, Qingdao 266003, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Qingdao University	Yi, P (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	pyi@bcm.edu		Wang, Zhao/0000-0003-4897-9986; Yi, Ping/0000-0001-9433-6805	DOD [W81XWH-15-1-0536]; CPRIT grant [RP150648]; NICHD, National Institutes of Health [HD008818, HD007857]; Robert Welch Foundation [Q-1967-20180324]; Baylor College of Medicine BMB department seed funds; NCI Cancer Center, National Institutes of Health [P30CA125123]	DOD(United States Department of Defense); CPRIT grant; NICHD, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Robert Welch Foundation(The Welch Foundation); Baylor College of Medicine BMB department seed funds; NCI Cancer Center, National Institutes of Health	This work was supported by grants from DOD W81XWH-15-1-0536 to P. Y., CPRIT grant RP150648 to B. W. O. and P. Y., and NICHD, National Institutes of Health grants (HD008818, HD007857) to B. W. O., Robert Welch Foundation Q-1967-20180324 and Baylor College of Medicine BMB department seed funds to Z. W., and NCI Cancer Center, National Institutes of Health Support Grant P30CA125123 (BCM Monoclonal Antibody/recombinant Protein Expression Core Facility). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Becker MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150564; Chan B, 2008, J MAMMARY GLAND BIOL, V13, P415, DOI 10.1007/s10911-008-9101-9; Dearth RK, 2006, MOL CELL BIOL, V26, P9302, DOI 10.1128/MCB.00260-06; Mardilovich K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-14; Rocha RL, 1997, CLIN CANCER RES, V3, P103; Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837	6	2	2	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100739	10.1016/j.jbc.2021.100739	http://dx.doi.org/10.1016/j.jbc.2021.100739			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33991522	Green Published, gold			2022-12-28	WOS:000672866400708
J	Sasaki, S; Tamogami, J; Nishiya, K; Demura, M; Kikukawa, T				Sasaki, Syogo; Tamogami, Jun; Nishiya, Koki; Demura, Makoto; Kikukawa, Takashi			Replaceability of Schiff base proton donors in light-driven proton pump rhodopsins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOCHEMICAL-REACTION CYCLE; VOLUME CHANGES; EXIGUOBACTERIUM-SIBIRICUM; HYDROSTATIC-PRESSURE; ESCHERICHIA-COLI; BACTERIORHODOPSIN; PHOTOCYCLE; MEMBRANE; PROTEIN; EXPRESSION	Many H+-pump rhodopsins conserve "H+ donor" residues in cytoplasmic (CP) half channels to quickly transport H+ from the CP medium to Schiff bases at the center of these proteins. For conventional H+ pumps, the donors are conserved as Asp or Glu but are replaced by Lys in the minority, such as Exi-guobacterium sibiricum rhodopsin (ESR). In dark states, carboxyl donors are protonated, whereas the Lys donor is deprotonated. As a result, carboxyl donors first donate H+ to the Schiff bases and then capture the other H+ from the me-dium, whereas the Lys donor first captures H+ from the me-dium and then donates it to the Schiff base. Thus, carboxyl and Lys-type H+ pumps seem to have different mechanisms, which are probably optimized for their respective H+-transfer re-actions. Here, we examined these differences via replacement of donor residues. For Asp-type deltarhodopsin (DR), the embedded Lys residue distorted the protein conformation and did not act as the H+ donor. In contrast, for Glu-type proteo-rhodopsin (PR) and ESR, the embedded residues functioned well as H+ donors. These differences were further examined by focusing on the activation volumes during the H+-transfer re-actions. The results revealed essential differences between archaeal H+ pump (DR) and eubacterial H+ pumps PR and ESR. Archaeal DR requires significant hydration of the CP channel for the H+-transfer reactions; however, eubacterial PR and ESR require the swing-like motion of the donor residue rather than hydration. Given this common mechanism, donor residues might be replaceable between eubacterial PR and ESR.	[Sasaki, Syogo; Nishiya, Koki] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido, Japan; [Tamogami, Jun] Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime, Japan; [Demura, Makoto; Kikukawa, Takashi] Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Tamogami, J (corresponding author), Matsuyama Univ, Coll Pharmaceut Sci, Matsuyama, Ehime, Japan.; Kikukawa, T (corresponding author), Hokkaido Univ, Fac Adv Life Sci, Sapporo, Hokkaido, Japan.	jtamoga@g.matsuyama-u.ac.jp; kikukawa@sci.hokudai.ac.jp	Kikukawa, Takashi/F-5266-2011; Demura, Makoto/F-5272-2011	Kikukawa, Takashi/0000-0002-6185-7281; Demura, Makoto/0000-0003-0912-9284; TAMOGAMI, JUN/0000-0002-0799-0815	Japan Society for the Promotion of Science KAKENHI [16K18519, 17K07326]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Japan Society for the Promotion of Science KAKENHI granted to J. T. (16K18519) and T. K. (17K07326).	AMES JB, 1990, BIOCHEMISTRY-US, V29, P7181, DOI 10.1021/bi00483a005; Balashov SP, 2013, J BIOL CHEM, V288, P21254, DOI 10.1074/jbc.M113.465138; Balashov SP, 2000, BBA-BIOENERGETICS, V1460, P75, DOI 10.1016/S0005-2728(00)00131-6; Balashov SP, 1999, BIOCHEMISTRY-US, V38, P2026, DOI 10.1021/bi981926a; Beja O, 2000, SCIENCE, V289, P1902, DOI 10.1126/science.289.5486.1902; Beja O, 2013, ENCY BIODIVERSITY, V6, P280; Bieszke JA, 1999, P NATL ACAD SCI USA, V96, P8034, DOI 10.1073/pnas.96.14.8034; CAO Y, 1991, BIOCHEMISTRY-US, V30, P10972, DOI 10.1021/bi00109a023; Dioumaev AK, 2002, BIOCHEMISTRY-US, V41, P5348, DOI 10.1021/bi025563x; Dioumaev AK, 2013, J PHYS CHEM B, V117, P7235, DOI 10.1021/jp402430w; Ernst OP, 2014, CHEM REV, V114, P126, DOI 10.1021/cr4003769; Govorunova EG, 2017, ANNU REV BIOCHEM, V86, P845, DOI 10.1146/annurev-biochem-101910-144233; Gushchin I, 2013, P NATL ACAD SCI USA, V110, P12631, DOI 10.1073/pnas.1221629110; Hasemi T, 2019, BBA-BIOENERGETICS, V1860, P136, DOI 10.1016/j.bbabio.2018.12.001; Hasemi T, 2016, J BIOL CHEM, V291, P355, DOI 10.1074/jbc.M115.688614; Iizuka A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47178-5; Inoue K, 2004, BIOPHYS J, V87, P2587, DOI 10.1529/biophysj.104.043521; Kajimoto K, 2017, J PHYS CHEM B, V121, P4431, DOI 10.1021/acs.jpcb.7b02421; Kamo N, 2006, BIOCHEM BIOPH RES CO, V341, P285, DOI 10.1016/j.bbrc.2005.12.181; Kandori Hideki, 2020, Biophys Rev, V12, P355, DOI 10.1007/s12551-020-00645-0; Kikukawa T, 2008, PHOTOCHEM PHOTOBIOL, V84, P880, DOI 10.1111/j.1751-1097.2008.00318.x; Kikukawa T, 2015, BBA-BIOENERGETICS, V1847, P748, DOI 10.1016/j.bbabio.2015.05.002; Lanyi JK, 2004, ANNU REV PHYSIOL, V66, P665, DOI 10.1146/annurev.physiol.66.032102.150049; Lee KA, 2015, BBA-GEN SUBJECTS, V1850, P1694, DOI 10.1016/j.bbagen.2015.04.002; Murabe K, 2020, J AM CHEM SOC, V142, P16023, DOI 10.1021/jacs.0c07264; Nakamura S, 2016, BBA-BIOENERGETICS, V1857, P1900, DOI 10.1016/j.bbabio.2016.09.006; Nishioku Y, 2002, BIOPHYS J, V83, P1136, DOI 10.1016/S0006-3495(02)75237-5; OESTERHELT D, 1971, NATURE-NEW BIOL, V233, P149, DOI 10.1038/newbio233149a0; OESTERHELT D, 1973, P NATL ACAD SCI USA, V70, P2853, DOI 10.1073/pnas.70.10.2853; OTTO H, 1989, P NATL ACAD SCI USA, V86, P9228, DOI 10.1073/pnas.86.23.9228; Petrovskaya LE, 2015, BIOCHEMISTRY-MOSCOW+, V80, P688, DOI 10.1134/S000629791506005X; Petrovskaya LE, 2010, FEBS LETT, V584, P4193, DOI 10.1016/j.febslet.2010.09.005; SCHULENBERG PJ, 1995, J PHYS CHEM-US, V99, P9617, DOI 10.1021/j100023a046; SCHULENBERG PJ, 1994, BIOPHYS J, V66, P838, DOI 10.1016/S0006-3495(94)80860-4; Tamogami J, 2009, PHOTOCHEM PHOTOBIOL, V85, P578, DOI 10.1111/j.1751-1097.2008.00520.x; Tittor J, 2002, J MOL BIOL, V319, P555, DOI 10.1016/S0022-2836(02)00307-8; VARO G, 1995, BIOCHEMISTRY-US, V34, P12161, DOI 10.1021/bi00038a009; Varo G, 2003, BIOPHYS J, V84, P1202, DOI 10.1016/S0006-3495(03)74934-0; Wickstrand C, 2015, BBA-GEN SUBJECTS, V1850, P536, DOI 10.1016/j.bbagen.2014.05.021; Zscherp C, 1999, P NATL ACAD SCI USA, V96, P5498, DOI 10.1073/pnas.96.10.5498	40	4	5	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101013	10.1016/j.jbc.2021.101013	http://dx.doi.org/10.1016/j.jbc.2021.101013			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34329681	gold, Green Published			2022-12-28	WOS:000706408900007
J	Christie, SM; Hao, J; Tracy, E; Buck, M; Yu, JS; Smith, AW				Christie, Shaun M.; Hao, Jing; Tracy, Erin; Buck, Matthias; Yu, Jennifer S.; Smith, Adam W.			Interactions between semaphorins and plexin-neuropilin receptor complexes in the membranes of live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORRELATION SPECTROSCOPY; GROWTH; EXPRESSION; PROMOTES; SEMA3C; DISRUPTION; MECHANISMS; RESPONSES; SURFACE; ROLES	Signaling of semaphorin ligands via their plexin-neuropilin receptors is involved in tissue patterning in the developing embryo. These proteins play roles in cell migration and adhesion but are also important in disease etiology, including in cancer angiogenesis and metastasis. While some structures of the soluble domains of these receptors have been determined, the conformations of the full-length receptor complexes are just beginning to be elucidated, especially within the context of the plasma membrane. Pulsed-interleaved excitation fluorescence cross-correlation spectroscopy allows direct insight into the formation of protein-protein interactions in the membranes of live cells. Here, we investigated the homodimerization of neuropilin-1 (Nrp1), plexin A2, plexin A4, and plexin D1 using pulsed-interleaved excitation fluorescence crosscorrelation spectroscopy. Consistent with previous studies, we found that Nrp1, plexin A2, and plexin A4 are present as dimers in the absence of exogenous ligand. Plexin D1, on the other hand, was monomeric under similar conditions, which had not been previously reported. We also found that plexin A2 and A4 assemble into a heteromeric complex. Stimulation with semaphorin 3A or semaphorin 3C neither disrupts nor enhances the dimerization of the receptors when expressed alone, suggesting that activation involves a conformational change rather than a shift in the monomer-dimer equilibrium. However, upon stimulation with semaphorin 3C, plexin D1 and Nrp1 form a heteromeric complex. This analysis of interactions provides a complementary approach to the existing structural and biochemical data that will aid in the development of new therapeutic strategies to target these receptors in cancer.	[Christie, Shaun M.; Tracy, Erin; Smith, Adam W.] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Hao, Jing; Yu, Jennifer S.] Cleveland Clin, Dept Canc Biol, Cleveland, OH USA; [Buck, Matthias] Case Western Reserve Univ, Sch Med, Dept Physiol & Biophys, Cleveland, OH 44106 USA; [Yu, Jennifer S.] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH USA; [Yu, Jennifer S.] Cleveland Clin, Cleveland Clin Lerner Coll Med, Cleveland, OH USA	University System of Ohio; University of Akron; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation	Smith, AW (corresponding author), Univ Akron, Dept Chem, Akron, OH 44325 USA.	asmith5@uakron.edu	Smith, Adam/GPS-8322-2022; Smith, Adam/B-7156-2016	Smith, Adam/0000-0001-5216-9017; Hao, Jing/0000-0002-5257-4933	National Institutes of Health [R01EY029169]; National Science Foundation [CHE-1753060]; National Institutes of Health/National Institute of Neurological Disorders and Stroke [R01NS094199, R01NS092641]; VeloSano; Amy Post Foundation; Case Comprehensive Cancer Center; Cleveland Clinic	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Institutes of Health/National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); VeloSano; Amy Post Foundation; Case Comprehensive Cancer Center; Cleveland Clinic	This work was supported with funding from the National Institutes of Health under grant number R01EY029169 (to A. W. S. and M. B.) and the National Science Foundation under grant number CHE-1753060 (to A. W. S.). This work was also supported by the National Institutes of Health/National Institute of Neurological Disorders and Stroke R01NS094199 and R01NS092641, VeloSano, Amy Post Foundation, Case Comprehensive Cancer Center, and the Cleveland Clinic (to J. S. Y.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal PK, 2015, DIABETES, V64, P1743, DOI 10.2337/db14-0719; Alto LT, 2017, METHODS MOL BIOL, V1493, P1, DOI 10.1007/978-1-4939-6448-2_1; Alves CJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38512-y; Antipenko A, 2003, NEURON, V39, P589, DOI 10.1016/S0896-6273(03)00502-6; Aruffo A., 2002, CURR PROTOC MOL BIOL; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bagci T, 2009, ONCOGENE, V28, P3537, DOI 10.1038/onc.2009.204; Behar O, 1996, NATURE, V383, P525, DOI 10.1038/383525a0; Blanc V, 2011, PROSTATE, V71, P649, DOI 10.1002/pros.21281; Briddon SJ, 2018, TRENDS PHARMACOL SCI, V39, P158, DOI 10.1016/j.tips.2017.11.004; Capparuccia L, 2009, J CELL SCI, V122, P1723, DOI 10.1242/jcs.030197; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Casazza A, 2011, ARTERIOSCL THROM VAS, V31, P741, DOI 10.1161/ATVBAHA.110.211920; Chakraborty G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033633; Chen H, 1998, NEURON, V21, P1283, DOI 10.1016/S0896-6273(00)80648-0; Christie S, 2020, ACCOUNTS CHEM RES, V53, P792, DOI 10.1021/acs.accounts.9b00625; Christie SM, 2020, BIOCONJUGATE CHEM, V31, P1362, DOI 10.1021/acs.bioconjchem.0c00105; De Wit J, 2005, MOL CELL NEUROSCI, V29, P40, DOI 10.1016/j.mcn.2004.12.009; Digman MA, 2011, ANNU REV PHYS CHEM, V62, P645, DOI 10.1146/annurev-physchem-032210-103424; Eickholt BJ, 1999, DEVELOPMENT, V126, P2181; Feiner L, 2001, DEVELOPMENT, V128, P3061; Foo Y. H., 2011, SPRINGER SERIES FLUO, V12, P213; Gitler AD, 2004, DEV CELL, V7, P107, DOI 10.1016/j.devcel.2004.06.002; Gu CH, 2013, EXP CELL RES, V319, P1306, DOI 10.1016/j.yexcr.2013.02.003; Herman JG, 2007, INT J ONCOL, V30, P1231; Hota PK, 2012, CELL MOL LIFE SCI, V69, P3765, DOI 10.1007/s00018-012-1019-0; Hu SH, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01236; Janssen BJC, 2012, NAT STRUCT MOL BIOL, V19, P1293, DOI 10.1038/nsmb.2416; Kagoshima M, 2001, GENES CELLS, V6, P559, DOI 10.1046/j.1365-2443.2001.00441.x; Kaliszewski MJ, 2018, METHODS, V140, P40, DOI 10.1016/j.ymeth.2018.02.002; King C, 2018, BBA-BIOMEMBRANES, V1860, P2118, DOI 10.1016/j.bbamem.2018.03.023; Klostermann A, 1998, J BIOL CHEM, V273, P7326, DOI 10.1074/jbc.273.13.7326; Kodo K, 2009, P NATL ACAD SCI USA, V106, P13933, DOI 10.1073/pnas.0904744106; Kong YX, 2016, NEURON, V91, P548, DOI 10.1016/j.neuron.2016.06.018; Kruger RR, 2005, NAT REV MOL CELL BIO, V6, P789, DOI 10.1038/nrm1740; Li ZL, 2021, CELL MOL LIFE SCI, V78, P1101, DOI 10.1007/s00018-020-03571-2; Love CA, 2003, NAT STRUCT BIOL, V10, P843, DOI 10.1038/nsb977; Maione F, 2012, J CLIN INVEST, V122, P1832, DOI 10.1172/JCI58976; Man JH, 2014, CELL REP, V9, P1812, DOI 10.1016/j.celrep.2014.10.055; Marita M, 2015, BIOPHYS J, V109, P1937, DOI 10.1016/j.bpj.2015.04.043; McCormick AM, 2015, ACTA BIOMATER, V28, P33, DOI 10.1016/j.actbio.2015.09.022; Mehta V, 2020, NATURE, V578, P290, DOI 10.1038/s41586-020-1979-4; Miernyk JA, 2008, PLANT J, V53, P597, DOI 10.1111/j.1365-313X.2007.03316.x; Miyato H, 2012, CANCER SCI, V103, P1961, DOI 10.1111/cas.12003; Muller BK, 2005, BIOPHYS J, V89, P3508, DOI 10.1529/biophysj.105.064766; Nakamura F, 1998, NEURON, V21, P1093, DOI 10.1016/S0896-6273(00)80626-1; Pan HJ, 2009, BREAST CANCER RES TR, V118, P197, DOI 10.1007/s10549-008-0179-y; Parker MW, 2012, BIOCHEMISTRY-US, V51, P9437, DOI 10.1021/bi3012143; Peacock JW, 2018, EMBO MOL MED, V10, P219, DOI 10.15252/emmm.201707689; Pellet-Many C, 2008, BIOCHEM J, V411, P211, DOI 10.1042/BJ20071639; Rehman M, 2013, SEMIN CELL DEV BIOL, V24, P179, DOI 10.1016/j.semcdb.2012.10.005; Reidy K, 2011, PEDIATR NEPHROL, V26, P1407, DOI 10.1007/s00467-011-1769-1; Rohm B, 2000, MECH DEVELOP, V93, P95, DOI 10.1016/S0925-4773(00)00269-0; Roodink I, 2005, CANCER RES, V65, P8317, DOI 10.1158/0008-5472.CAN-04-4366; Sabag AD, 2014, J CELL SCI, V127, P5240, DOI 10.1242/jcs.155960; Sharma A, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00028; Smolkin T, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208298; Staton CA, 2011, HISTOPATHOLOGY, V59, P274, DOI 10.1111/j.1365-2559.2011.03922.x; Steup A, 2000, MOL CELL NEUROSCI, V15, P141, DOI 10.1006/mcne.1999.0818; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Suto F, 2003, MECH DEVELOP, V120, P385, DOI 10.1016/S0925-4773(02)00421-5; Takahashi T, 2001, NEURON, V29, P429, DOI 10.1016/S0896-6273(01)00216-1; Takahashi T, 1999, CELL, V99, P59, DOI 10.1016/S0092-8674(00)80062-8; Takahashi T, 1998, NAT NEUROSCI, V1, P487, DOI 10.1038/2203; Taniguchi M, 1997, NEURON, V19, P519, DOI 10.1016/S0896-6273(00)80368-2; Toledano S, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030556; Toyofuku T, 2008, DEV BIOL, V321, P251, DOI 10.1016/j.ydbio.2008.06.028; Usui H, 2003, BIOCHEM BIOPH RES CO, V300, P927, DOI 10.1016/S0006-291X(02)02966-2; Vadivel A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067225; Valdembri D, 2016, CELL ADHES MIGR, V10, P641, DOI 10.1080/19336918.2016.1212805; Wang Z, 2016, ONCOTARGET, V7, P6048, DOI 10.18632/oncotarget.6831; Yang WJ, 2015, EMBO MOL MED, V7, P1267, DOI 10.15252/emmm.201404922; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Zhang LQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121513	75	2	2	1	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100965	10.1016/j.jbc.2021.100965	http://dx.doi.org/10.1016/j.jbc.2021.100965			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34270956	gold, Green Published			2022-12-28	WOS:000690871400004
J	Ereno-Orbea, J; Liu, XL; Sicard, T; Kucharska, I; Li, W; Borovsky, D; Cui, H; Feng, Y; Dimitrov, DS; Julien, JP				Ereno-Orbea, June; Liu, Xianglei; Sicard, Taylor; Kucharska, Iga; Li, Wei; Borovsky, Dorota; Cui, Hong; Feng, Yang; Dimitrov, Dimiter S.; Julien, Jean-Philippe			Structural details of monoclonal antibody m971 recognition of the membrane-proximal domain of CD22	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR T-CELLS; B-ALL; EPITOPE; IDENTIFICATION; THERAPIES; CD19; TCR	Cluster of differentiation-22 (CD22) belongs to the sialic acid-binding immunoglobulin (Ig)-like lectin family of re-ceptors that is expressed on the surface of B cells. It has been classified as an inhibitory coreceptor for the B-cell receptor because of its function in establishing a baseline level of B-cell inhibition. The restricted expression of CD22 on B cells and its inhibitory function make it an attractive target for B-cell depletion in cases of B-cell malignancies. Genetically modified T cells with chimeric antigen receptors (CARs) derived from the m971 antibody have shown promise when used as an immunotherapeutic agent against B-cell acute lymphoblastic leukemia. A key aspect of the efficacy of this CAR-T was its ability to target a membrane-proximal epitope on the CD22 extracellular domain; however, the molecular details of m971 recognition of CD22 have thus far remained elusive. Here, we report the crystal structure of the m971 fragment antigen-binding in complex with the two most membrane-proximal Ig-like domains of CD22 (CD22(d6-d7)). The m971 epitope on CD22 resides at the most proximal Ig domain (d7) to the membrane, and the antibody paratope contains electrostatic surfaces compatible with interactions with phospholipid head groups. Together, our data identify molecular details underly-ing the successful transformation of an antibody epitope on CD22 into an effective CAR immunotherapeutic target.	[Ereno-Orbea, June; Sicard, Taylor; Kucharska, Iga; Cui, Hong; Julien, Jean-Philippe] Hosp Sick Children Res Inst, Program Mol Med, Toronto, ON, Canada; [Ereno-Orbea, June] Ikerbasque, Basque Fdn Sci, Bilbao, Spain; [Liu, Xianglei; Li, Wei; Dimitrov, Dimiter S.] Univ Pittsburgh, Dept Med, Div Infect Dis, Pittsburgh, PA USA; [Sicard, Taylor; Julien, Jean-Philippe] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Borovsky, Dorota; Julien, Jean-Philippe] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Feng, Yang] NIH, Prot Interact Grp, Ctr Canc Res Nanobiol Program, Ctr Canc Res, Frederick, MD USA	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Basque Foundation for Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Julien, JP (corresponding author), Hosp Sick Children Res Inst, Program Mol Med, Toronto, ON, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.; Julien, JP (corresponding author), Univ Toronto, Dept Immunol, Toronto, ON, Canada.	jean-philippe.julien@sickkids.ca	Liu, Xianglei/K-9181-2016		Canadian Institutes of Health Research [PJT-148811]; CIFAR Azrieli Global Scholar program; Ontario Early Researcher Award program; Canada Research Chairs program; Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research [BPF-144483]; Vanier Canada Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIFAR Azrieli Global Scholar program; Ontario Early Researcher Award program(Ministry of Research and Innovation, Ontario); Canada Research Chairs program(Canada Research Chairs); Banting Postdoctoral Fellowship from the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Vanier Canada Graduate Scholarship	This work was supported by operating grant PJT-148811 (to J.-P. J.) from the Canadian Institutes of Health Research, the CIFAR Azrieli Global Scholar program (to J.-P. J.), the Ontario Early Researcher Award program (to J.-P. J.), and the Canada Research Chairs program (to J.-P. J.). J. E.-O. was supported by Banting Postdoctoral Fellowship BPF-144483 from the Canadian Institutes of Health Research. T. S. is a recipient of a Vanier Canada Graduate Scholarship.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Chmielewski M, 2004, J IMMUNOL, V173, P7647, DOI 10.4049/jimmunol.173.12.7647; Dai HR, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00856-8; Davenport AJ, 2018, P NATL ACAD SCI USA, V115, pE2068, DOI 10.1073/pnas.1716266115; Davis SJ, 2006, NAT IMMUNOL, V7, P803, DOI 10.1038/ni1369; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ereno-Orbea J, 2018, J MOL BIOL, V430, P322, DOI 10.1016/j.jmb.2017.12.010; Ereno-Orbea J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00836-6; Fry TJ, 2018, NAT MED, V24, P20, DOI 10.1038/nm.4441; Gardner R, 2016, BLOOD, V127, P2406, DOI 10.1182/blood-2015-08-665547; Gasparrini F, 2016, EMBO J, V35, P258, DOI 10.15252/embj.201593027; Harris DT, 2016, TRENDS PHARMACOL SCI, V37, P220, DOI 10.1016/j.tips.2015.11.004; Haso W, 2013, BLOOD, V121, P1165, DOI 10.1182/blood-2012-06-438002; Hileman RE, 1998, BIOESSAYS, V20, P156, DOI 10.1002/(SICI)1521-1878(199802)20:2<156::AID-BIES8>3.3.CO;2-#; Hughes-Parry HE, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010204; Irimia A, 2016, IMMUNITY, V44, P21, DOI 10.1016/j.immuni.2015.12.001; James ST, 2008, J IMMUNOL, V180, P7028, DOI 10.4049/jimmunol.180.10.7028; Julien JP, 2008, J MOL BIOL, V384, P377, DOI 10.1016/j.jmb.2008.09.024; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kizuka Y, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020025; Labanieh L, 2018, NAT BIOMED ENG, V2, P377, DOI 10.1038/s41551-018-0235-9; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; Morin A, 2013, ELIFE, V2, DOI 10.7554/eLife.01456; Pan J, 2019, LEUKEMIA, V33, P2854, DOI 10.1038/s41375-019-0488-7; Park S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14749-3; Pronker MF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13584; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; Sievers F, 2014, METHODS MOL BIOL, V1079, P105, DOI 10.1007/978-1-62703-646-7_6; Srivastava S, 2015, TRENDS IMMUNOL, V36, P494, DOI 10.1016/j.it.2015.06.004; Stoiber S, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050472; Taniguchi N, 2015, ADV CANCER RES, V126, P11, DOI 10.1016/bs.acr.2014.11.001; Teplyakov A, 2018, PROTEINS, V86, P495, DOI 10.1002/prot.25485; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Walker JA, 2008, IMMUNOLOGY, V123, P314, DOI 10.1111/j.1365-2567.2007.02752.x; Wu L, 2020, CELL MOL IMMUNOL, V17, P600, DOI 10.1038/s41423-020-0470-3; Xiao XD, 2009, MABS-AUSTIN, V1, P297, DOI 10.4161/mabs.1.3.8113; Zhang J, 2020, ADV THER, V37, P3040, DOI 10.1007/s12325-020-01397-9; Zhang ZW, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1711-1; Zhu ZY, 2007, P NATL ACAD SCI USA, V104, P12123, DOI 10.1073/pnas.0701000104	42	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100966	10.1016/j.jbc.2021.100966	http://dx.doi.org/10.1016/j.jbc.2021.100966			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34273351	Green Published, gold			2022-12-28	WOS:000690871400018
J	Kortenoeven, MLA; Esteva-Font, C; Dimke, H; Poulsen, SB; Murali, SK; Fenton, RA				Kortenoeven, Marleen L. A.; Esteva-Font, Cristina; Dimke, Henrik; Poulsen, Soren B.; Murali, Sathish K.; Fenton, Robert A.			High dietary potassium causes ubiquitin-dependent degradation of the kidney sodium-chloride cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CL-COTRANSPORTER; SENSITIVE NACL COTRANSPORTER; FUNCTIONAL EXPRESSION; URINARY SODIUM; BLOOD-PRESSURE; IN-VIVO; PROTEIN; PHOSPHORYLATION; HSP70; HYPERTENSION	The thiazide-sensitive sodium-chloride cotransporter (NCC) in the renal distal convoluted tubule (DCT) plays a critical role in regulating blood pressure (BP) and K+ homeostasis. During hyperkalemia, reduced NCC phosphorylation and total NCC abundance facilitate downstream electrogenic K+ secretion and BP reduction. However, the mechanism for the K+-dependent reduction in total NCC levels is unknown. Here, we show that NCC levels were reduced in ex vivo renal tubules incubated in a high-K+ medium for 24-48 h. This reduction was independent of NCC transcription, but was prevented using inhibitors of the proteasome (MG132) or lysosome (chloroquine). Ex vivo, high K+ increased NCC ubiquitylation, but inhibition of the ubiquitin conjugation pathway prevented the high K+-mediated reduction in NCC protein. In tubules incubated in high K+ media ex vivo or in the renal cortex of mice fed a high K+ diet for 4 days, the abundance and phosphorylation of heat shock protein 70 (Hsp70), a key regulator of ubiquitin-dependent protein degradation and protein folding, were decreased. Conversely, in similar samples the expression of PP1 alpha, known to dephosphorylate Hsp70, was also increased. NCC coimmunoprecipitated with Hsp70 and PP1 alpha, and inhibiting their actions prevented the high K+-mediated reduction in total NCC levels. In conclusion, we show that hyperkalemia drives NCC ubiquitylation and degradation via a PP1 alpha-dependent process facilitated by Hsp70. This mechanism facilitates K+-dependent reductions in NCC to protect plasma K+ homeostasis and potentially reduces BP.	[Kortenoeven, Marleen L. A.; Esteva-Font, Cristina; Poulsen, Soren B.; Murali, Sathish K.; Fenton, Robert A.] Aarhus Univ, Fac Hlth Sci, Dept Biomed, Aarhus, Denmark; [Kortenoeven, Marleen L. A.; Dimke, Henrik] Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark; [Dimke, Henrik] Odense Univ Hosp, Dept Nephrol, Odense, Denmark	Aarhus University; University of Southern Denmark; University of Southern Denmark; Odense University Hospital	Kortenoeven, MLA; Fenton, RA (corresponding author), Aarhus Univ, Fac Hlth Sci, Dept Biomed, Aarhus, Denmark.; Kortenoeven, MLA (corresponding author), Univ Southern Denmark, Inst Mol Med, Dept Cardiovasc & Renal Res, Odense, Denmark.	kortenoeven@health.sdu.dk; Robert.a.fenton@biomed.au.dk	Fenton, Robert/AFR-6983-2022; Kortenoeven, Marleen/B-8565-2014; Fenton, Robert A/ABD-9824-2021; Dimke, Henrik/G-7970-2011	Fenton, Robert/0000-0003-1623-199X; Kortenoeven, Marleen/0000-0001-9962-8276; Poulsen, Soren Brandt/0000-0002-0082-3934; Dimke, Henrik/0000-0002-9170-2168; Murali, Sathish K/0000-0002-7056-9839	Independent Research Fund Denmark [1333-00279, 1331-00738B]; Aarhus University Research Foundation; Helen & Ejnar Bjornows Foundation; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Mindelegat); Lundbeck Foundation; Independent Research Fund Denmark; Leducq Foundation	Independent Research Fund Denmark; Aarhus University Research Foundation; Helen & Ejnar Bjornows Foundation; Novo Nordisk Foundation (Fabrikant Vilhelm Pedersen og Hustrus Mindelegat); Lundbeck Foundation(Lundbeckfonden); Independent Research Fund Denmark; Leducq Foundation(Leducq Foundation)	M. L. K. A. is supported by the Independent Research Fund Denmark (Project No. 1333-00279 and 1331-00738B) and grants from Aarhus University Research Foundation and Helen & Ejnar Bjornows Foundation. The project is further funded by the Leducq Foundation, the Novo Nordisk Foundation (incl. Fabrikant Vilhelm Pedersen og Hustrus Mindelegat), the Lundbeck Foundation and the Independent Research Fund Denmark.	Akita S, 2003, HYPERTENSION, V42, P8, DOI 10.1161/01.HYP.0000074668.08704.6E; Bazua-Valenti S, 2015, J AM SOC NEPHROL, V26, P1781, DOI 10.1681/ASN.2014050470; Chanoux RA, 2012, J BIOL CHEM, V287, P19255, DOI 10.1074/jbc.M112.357756; Cuevas CA, 2017, J AM SOC NEPHROL, V28, P1814, DOI 10.1681/ASN.2016090935; Donnelly BF, 2013, J BIOL CHEM, V288, P13124, DOI 10.1074/jbc.M113.455394; Edkins Adrienne L, 2015, Subcell Biochem, V78, P219, DOI 10.1007/978-3-319-11731-7_11; Ergonul Z, 2006, AM J PHYSIOL-RENAL, V291, pF683, DOI 10.1152/ajprenal.00422.2005; Ferdaus MZ, 2019, AM J PHYSIOL-RENAL, V317, pF825, DOI 10.1152/ajprenal.00216.2019; Flores-Delgado G, 2007, J PROTEOME RES, V6, P1165, DOI 10.1021/pr060504h; Frindt G, 2010, AM J PHYSIOL-RENAL, V299, pF890, DOI 10.1152/ajprenal.00323.2010; Frische S, 2018, AM J PHYSIOL-RENAL, V315, pF429, DOI 10.1152/ajprenal.00539.2017; Goldfarb SB, 2006, P NATL ACAD SCI USA, V103, P5817, DOI 10.1073/pnas.0507903103; GUYTON AC, 1991, SCIENCE, V252, P1813, DOI 10.1126/science.2063193; Hoorn EJ, 2020, PHYSIOL REV, V100, P321, DOI 10.1152/physrev.00044.2018; Kearney PM, 2004, J HYPERTENS, V22, P11, DOI 10.1097/00004872-200401000-00003; Khan MZH, 2012, BIOCHEM BIOPH RES CO, V425, P456, DOI 10.1016/j.bbrc.2012.07.124; Kim GH, 1998, P NATL ACAD SCI USA, V95, P14552, DOI 10.1073/pnas.95.24.14552; Kortenoeven MLA, 2021, AM J PHYSIOL-RENAL, V320, pF908, DOI 10.1152/ajprenal.00064.2021; Marion S, 2014, J BIOL CHEM, V289, P11715, DOI 10.1074/jbc.M113.544312; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; Melikova MS, 2006, CELL BIOL INT, V30, P31, DOI 10.1016/j.cellbi.2005.09.003; Mente A, 2014, NEW ENGL J MED, V371, P601, DOI 10.1056/NEJMoa1311989; Mitsuhashi S, 2001, BIOCHEM BIOPH RES CO, V287, P328, DOI 10.1006/bbrc.2001.5596; Muller P, 2013, ONCOGENE, V32, P3101, DOI 10.1038/onc.2012.314; Needham PG, 2011, J BIOL CHEM, V286, P43611, DOI 10.1074/jbc.M111.288928; O'Donnell M, 2014, NEW ENGL J MED, V371, P612, DOI 10.1056/NEJMoa1311889; Okiyoneda T, 2011, CURR OPIN CELL BIOL, V23, P483, DOI 10.1016/j.ceb.2011.04.012; Arroyo JP, 2011, J AM SOC NEPHROL, V22, P1707, DOI 10.1681/ASN.2011020132; Pedersen NB, 2010, KIDNEY INT, V78, P160, DOI 10.1038/ki.2010.130; Penton D, 2019, J AM SOC NEPHROL, V30, P737, DOI 10.1681/ASN.2018050540; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Picard N, 2014, J AM SOC NEPHROL, V25, P511, DOI 10.1681/ASN.2012121202; PolanowskaGrabowska R, 1997, BLOOD, V90, P1516, DOI 10.1182/blood.V90.4.1516.1516_1516_1526; Rosenbaek LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12819-0; Rosenbaek LL, 2017, AM J PHYSIOL-RENAL, V313, pF495, DOI 10.1152/ajprenal.00088.2017; Rosenbaek LL, 2014, J BIOL CHEM, V289, P13347, DOI 10.1074/jbc.M113.543710; Schultheis PJ, 1998, J BIOL CHEM, V273, P29150, DOI 10.1074/jbc.273.44.29150; Shoda W, 2017, KIDNEY INT, V91, P402, DOI 10.1016/j.kint.2016.09.001; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Sorensen MV, 2013, KIDNEY INT, V83, P811, DOI 10.1038/ki.2013.14; Sorensen MV, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126910; Su XT, 2020, AM J PHYSIOL-RENAL, V319, pF534, DOI 10.1152/ajprenal.00284.2020; Subramanya AR, 2009, J BIOL CHEM, V284, P18471, DOI 10.1074/jbc.M109.008185; Terker AS, 2015, CELL METAB, V21, P39, DOI 10.1016/j.cmet.2014.12.006; Thomson MN, 2020, AM J PHYSIOL-RENAL, V318, pF216, DOI 10.1152/ajprenal.00232.2019; Vallon V, 2009, AM J PHYSIOL-RENAL, V297, pF704, DOI 10.1152/ajprenal.00030.2009; Walsh AH, 1997, FEBS LETT, V416, P230, DOI 10.1016/S0014-5793(97)01210-6; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Wu P, 2019, J AM SOC NEPHROL, V30, P1424, DOI 10.1681/ASN.2019010025; Yang CL, 2003, J CLIN INVEST, V111, P1039, DOI 10.1172/JCI200317443; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568	51	7	8	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100915	10.1016/j.jbc.2021.100915	http://dx.doi.org/10.1016/j.jbc.2021.100915			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34174287	gold, Green Published			2022-12-28	WOS:000690879300006
J	Shi, F; Simandi, Z; Nagy, L; Collins, S				Shi, Fubiao; Simandi, Zoltan; Nagy, Laszlo; Collins, Sheila			Diet-dependent natriuretic peptide receptor C expression in adipose tissue is mediated by PPAR gamma via long-range distal enhancers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLEARANCE RECEPTOR; GENE-EXPRESSION; TRANSCRIPTION; OBESITY; FAT; STIMULATION; ADIPOGENESIS; FIBROBLASTS; KNOCKOUT; INDUCE	The cardiac natriuretic peptides (NPs) are well established as regulators of blood pressure and fluid volume, but they also stimulate adipocyte lipolysis and control the gene program of nonshivering thermogenesis in brown adipose tissue. The NP "clearance" receptor C (NPRC) functions to clear NPs from the circulation via peptide internalization and degradation and thus is an important regulator of NP signaling and adipocyte metabolism. It is well known that the Nprc gene is highly expressed in adipose tissue and dynamically regulated upon nutrition and environmental changes. However, the molecular basis for how Nprc gene expression is regulated is still poorly understood. Here, we identified the nuclear receptor tran-scription factor peroxisome proliferator-activated receptor gamma (PPAR gamma) as a transcriptional regulator of Nprc expression in mouse adipocytes. During 3T3-L1 adipocyte differentiation, levels of Nprc expression increase in parallel with PPAR gamma induction. Rosiglitazone, a classic PPAR gamma agonist, increases, whereas siRNA knockdown of PPAR gamma reduces, Nprc expression in 3T3-L1 adipocytes. By using chromosome conformation capture and luciferase reporter assays, we demonstrate that PPAR gamma controls Nprc gene expression in adipocytes through its long-range distal enhancers. Further-more, the induction of Nprc expression in adipose tissue during high-fat diet feeding is found to be associated with increased PPAR gamma enhancer activity. Our findings define PPAR gamma as a mediator of adipocyte Nprc gene expression and establish a new connection between PPAR gamma and the control of adipocyte NP signaling in obesity.	[Shi, Fubiao; Collins, Sheila] Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Dept Med, Nashville, TN 37235 USA; [Shi, Fubiao; Simandi, Zoltan; Nagy, Laszlo; Collins, Sheila] Sanford Burnham Prebys Med Discovery Inst, Integrat Metab Program, Orlando, FL 32827 USA; [Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21218 USA; [Nagy, Laszlo] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21218 USA; [Nagy, Laszlo] Johns Hopkins All Childrens Hosp, Inst Fundamental Biomed Res, St Petersburg, FL USA; [Collins, Sheila] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Simandi, Zoltan] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA	Vanderbilt University; Sanford Burnham Prebys Medical Discovery Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Medicine; Vanderbilt University; University of Pennsylvania	Collins, S (corresponding author), Vanderbilt Univ, Med Ctr, Div Cardiovasc Med, Dept Med, Nashville, TN 37235 USA.; Collins, S (corresponding author), Sanford Burnham Prebys Med Discovery Inst, Integrat Metab Program, Orlando, FL 32827 USA.; Collins, S (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	sheila.collins@vanderbilt.edu	SIMANDI, Zoltan/A-9619-2012; Nagy, Laszlo/A-3814-2008	SIMANDI, Zoltan/0000-0001-8894-1259; Collins, Sheila/0000-0001-6812-8551; Nagy, Laszlo/0000-0001-6653-2155	NIH [R01 DK103056, R56 DK126890, R01 DK115924]; American Diabetes Association Postdoctoral Fellowship Award [1-18-PDF-110]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association Postdoctoral Fellowship Award(American Diabetes Association)	This work was supported by NIH R01 DK103056 (to S. C.), R56 DK126890 (to S. C.), and R01 DK115924 (to L. N.). F. S. is supported by the American Diabetes Association Postdoctoral Fellowship Award (1-18-PDF-110). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Babaev VR, 2005, ARTERIOSCL THROM VAS, V25, P1647, DOI 10.1161/01.ATV.0000173413.31789.1a; Bordicchia M, 2016, AM J PHYSIOL-REG I, V311, pR104, DOI 10.1152/ajpregu.00499.2015; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Cope Nathan F, 2009, Cold Spring Harb Protoc, V2009, DOI 10.1101/pdb.prot5137; Coue M, 2015, DIABETES, V64, P4033, DOI 10.2337/db15-0305; Daniel B, 2014, GENE DEV, V28, P1562, DOI 10.1101/gad.242685.114; de Andrade EN, 2011, REGUL PEPTIDES, V167, P149, DOI 10.1016/j.regpep.2010.12.009; DEBOLD AJ, 1981, LIFE SCI, V28, P89, DOI 10.1016/0024-3205(81)90370-2; Dessi-Fulgheri P, 1997, J HYPERTENS, V15, P1695, DOI 10.1097/00004872-199715120-00074; Dessi-Fulgheri P, 1998, J NEPHROL, V11, P296; Dixon TM, 2001, J BIOL CHEM, V276, P722, DOI 10.1074/jbc.M008440200; Duan SZ, 2005, CIRC RES, V97, P372, DOI 10.1161/01.RES.0000179226.34112.6d; Fox ER, 2011, CIRCULATION, V124, P1021, DOI 10.1161/CIRCULATIONAHA.110.991943; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Gondor A, 2008, NAT PROTOC, V3, P303, DOI 10.1038/nprot.2007.540; Hagege H, 2007, NAT PROTOC, V2, P1722, DOI 10.1038/nprot.2007.243; Harvell DME, 2006, ENDOCRINOLOGY, V147, P700, DOI 10.1210/en.2005-0617; Hsueh WA, 2004, HYPERTENSION, V43, P297, DOI 10.1161/01.HYP.0000113626.76571.5b; Hu MW, 2021, TRENDS CELL BIOL, V31, P5, DOI 10.1016/j.tcb.2020.10.006; Kilroy G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006940; KISHIMOTO I, 1994, J BIOL CHEM, V269, P28300; Kovacova Z, 2016, OBESITY, V24, P820, DOI 10.1002/oby.21418; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Matsukawa N, 1999, P NATL ACAD SCI USA, V96, P7403, DOI 10.1073/pnas.96.13.7403; Miele A., 2006, CURR PROTOC MOL BIOL; Ogawa T, 1996, CIRCULATION, V93, P2059, DOI 10.1161/01.CIR.93.11.2059; Pan DZ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03554-9; Pennacchio LA, 2013, NAT REV GENET, V14, P288, DOI 10.1038/nrg3458; Pivovarova O, 2012, J CLIN ENDOCR METAB, V97, pE731, DOI 10.1210/jc.2011-2839; Potter LR, 2011, FEBS J, V278, P1808, DOI 10.1111/j.1742-4658.2011.08082.x; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sarzani R, 2004, OBES RES, V12, P351, DOI 10.1038/oby.2004.44; Schlueter N, 2014, PHARMACOL THERAPEUT, V144, P12, DOI 10.1016/j.pharmthera.2014.04.007; Schoenfelder S, 2019, NAT REV GENET, V20, P437, DOI 10.1038/s41576-019-0128-0; Sengenes C, 2002, AM J PHYSIOL-REG I, V283, pR257, DOI 10.1152/ajpregu.00453.2001; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; Shin J, 2009, J ANIM SCI, V87, P3923, DOI 10.2527/jas.2009-2124; Soccio RE, 2017, J CLIN INVEST, V127, P1451, DOI 10.1172/JCI91211; Szanto A, 2010, IMMUNITY, V33, P699, DOI 10.1016/j.immuni.2010.11.009; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Wu W, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aam6870; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Xu HE, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.148pe52; Zhang YX, 2018, P NATL ACAD SCI USA, V115, pE6039, DOI 10.1073/pnas.1806366115	52	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100941	10.1016/j.jbc.2021.100941	http://dx.doi.org/10.1016/j.jbc.2021.100941			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34245781	Green Submitted, Green Published, gold			2022-12-28	WOS:000690871000015
J	Zhang, W; Qian, Y; Jia, GF				Zhang, Wei; Qian, Yang; Jia, Guifang			The detection and functions of RNA modification m(6)A based on m(6)A writers and erasers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							SINGLE-NUCLEOTIDE-RESOLUTION; TUMOR 1-ASSOCIATING PROTEIN; CELL SELF-RENEWAL; STEM-LIKE CELLS; MESSENGER-RNA; NUCLEAR-RNA; FTO GENE; METHYLATED NUCLEOTIDES; ADENOSINE METHYLATION; INNATE IMMUNITY	N-6-methyladenosine (m(6)A) is the most frequent chemical modification in eukaryotic mRNA and is known to participate in a variety of physiological processes, including cancer progression and viral infection. The reversible and dynamic m(6)A modification is installed by m(6)A methyltransferase (writer) enzymes and erased by m(6)A demethylase (eraser) enzymes. m(6)A modification recognized by m(6)A binding proteins (readers) regulates RNA processing and metabolism, leading to downstream biological effects such as promotion of stability and translation or increased degradation. The m(6)A writers and erasers determine the abundance of m(6)A modifications and play decisive roles in its distribution and function. In this review, we focused on m(6)A writers and erasers and present an overview on their known functions and enzymatic molecular mechanisms, showing how they recognize substrates and install or remove m(6)A modifications. We also summarize the current applications of m(6)A writers and erasers for m(6)A detection and highlight the merits and drawbacks of these available methods. Lastly, we describe the biological functions of m(6)A in cancers and viral infection based on research of m(6)A writers and erasers and introduce new assays for m(6)A functionality via programmable m(6)A editing tools.	[Zhang, Wei; Qian, Yang; Jia, Guifang] Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr,Minist Educ, Beijing Natl Lab Mol Sci,Key Lab Bioorgan Chem &, Beijing, Peoples R China	Peking University	Jia, GF (corresponding author), Peking Univ, Coll Chem & Mol Engn, Synthet & Funct Biomol Ctr,Minist Educ, Beijing Natl Lab Mol Sci,Key Lab Bioorgan Chem &, Beijing, Peoples R China.	guifangjia@pku.edu.cn			Beijing Natural Science Foundation [Z200010]; National Natural Science Foundation of China [21822702, 92053109, 21820102008]; National Basic Research Program of China [2019YFA0802201, 2017YFA0505201]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by Beijing Natural Science Foundation (Z200010), the National Natural Science Foundation of China (nos. 21822702, 92053109, and 21820102008), and the National Basic Research Program of China (2019YFA0802201 and 2017YFA0505201).	Alarcon CR, 2015, CELL, V162, P1299, DOI 10.1016/j.cell.2015.08.011; Barbieri I, 2017, NATURE, V552, P126, DOI 10.1038/nature24678; Batista PJ, 2014, CELL STEM CELL, V15, P707, DOI 10.1016/j.stem.2014.09.019; Boissel S, 2009, AM J HUM GENET, V85, P106, DOI 10.1016/j.ajhg.2009.06.002; Bokar JA, 1997, RNA, V3, P1233; BOKAR JA, 1994, J BIOL CHEM, V269, P17697; Chai RC, 2019, AGING-US, V11, P1204, DOI 10.18632/aging.101829; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Chen K., 2015, ANGEW CHEM, V127, P1607; Church C, 2010, NAT GENET, V42, P1086, DOI 10.1038/ng.713; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Cox DBT, 2017, SCIENCE, V358, P1019, DOI 10.1126/science.aaq0180; Dang W, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.00417; Deng WL, 2014, CELL, V158, P849, DOI 10.1016/j.cell.2014.05.050; DESROSIERS R, 1974, P NATL ACAD SCI USA, V71, P3971, DOI 10.1073/pnas.71.10.3971; DIMOCK K, 1977, BIOCHEMISTRY-US, V16, P471, DOI 10.1021/bi00622a021; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Dominguez-Andres J, 2019, CELL METAB, V29, P211, DOI 10.1016/j.cmet.2018.09.003; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Fischer J, 2009, NATURE, V458, P894, DOI 10.1038/nature07848; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Garcia-Campos MA, 2019, CELL, V178, P731, DOI 10.1016/j.cell.2019.06.013; Gerken T, 2007, SCIENCE, V318, P1469, DOI 10.1126/science.1151710; Geula S, 2015, SCIENCE, V347, P1002, DOI 10.1126/science.1261417; Gokhale NS, 2016, CELL HOST MICROBE, V20, P654, DOI 10.1016/j.chom.2016.09.015; Gorbalenya AE, 2020, NAT MICROBIOL, V5, P536, DOI 10.1038/s41564-020-0695-z; Hafner M., 2010, J VIS EXP, V41; Han S, 2020, P NATL ACAD SCI USA, V117, P22068, DOI 10.1073/pnas.2006617117; Han ZF, 2010, NATURE, V464, P1205, DOI 10.1038/nature08921; Hastings MH, 2013, CELL, V155, P740, DOI 10.1016/j.cell.2013.10.028; Haussmann IU, 2016, NATURE, V540, P301, DOI 10.1038/nature20577; He Y, 2018, CELL PHYSIOL BIOCHEM, V48, P838, DOI 10.1159/000491915; HILFIKER A, 1991, ROUX ARCH DEV BIOL, V200, P240, DOI 10.1007/BF00241293; Hongay CF, 2011, P NATL ACAD SCI USA, V108, P14855, DOI 10.1073/pnas.1111577108; Horiuchi K, 2013, J BIOL CHEM, V288, P33292, DOI 10.1074/jbc.M113.500397; Huang Y, 2019, CANCER CELL, V35, P677, DOI 10.1016/j.ccell.2019.03.006; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Imanishi M, 2017, CHEM COMMUN, V53, P12930, DOI 10.1039/c7cc07699a; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Jia GF, 2008, FEBS LETT, V582, P3313, DOI 10.1016/j.febslet.2008.08.019; Jia GF, 2013, TRENDS GENET, V29, P108, DOI 10.1016/j.tig.2012.11.003; Jia GF, 2011, NAT CHEM BIOL, V7, P885, DOI [10.1038/NCHEMBIO.687, 10.1038/nchembio.687]; Jora M, 2019, BBA-GENE REGUL MECH, V1862, P280, DOI 10.1016/j.bbagrm.2018.10.012; Kearns NA, 2015, NAT METHODS, V12, P401, DOI 10.1038/nmeth.3325; Kennedy EM, 2016, CELL HOST MICROBE, V19, P675, DOI 10.1016/j.chom.2016.04.002; Kim GW, 2020, J BIOL CHEM, V295, P13123, DOI 10.1074/jbc.RA120.014260; Knuckles P, 2017, NAT STRUCT MOL BIOL, V24, P561, DOI 10.1038/nsmb.3419; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; KRUG RM, 1976, J VIROL, V20, P45, DOI 10.1128/JVI.20.1.45-53.1976; Lan Q, 2019, CANCER RES, V79, P1285, DOI 10.1158/0008-5472.CAN-18-2965; LAVI S, 1975, P NATL ACAD SCI USA, V72, P2012, DOI 10.1073/pnas.72.6.2012; LEWIS JD, 1992, CELL, V69, P905, DOI 10.1016/0092-8674(92)90610-O; Li EM, 2020, AM J CANCER RES, V10, P1012; Li F, 2019, CYTOGENET GENOME RES, V159, P119, DOI 10.1159/000499062; Li JX, 2020, NUCLEIC ACIDS RES, V48, P5684, DOI 10.1093/nar/gkaa269; Li N, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109091; Li Y, 2012, FUTURE ONCOL, V8, P223, DOI [10.2217/FON.12.1, 10.2217/fon.12.1]; Li Zejuan, 2017, Cancer Cell, V31, P127, DOI 10.1016/j.ccell.2016.11.017; Lichinchi G, 2016, CELL HOST MICROBE, V20, P666, DOI 10.1016/j.chom.2016.10.002; Lichinchi G, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.11, 10.1038/nmicrobiol.2016.11]; Lin Z, 2017, CELL RES, V27, P1216, DOI 10.1038/cr.2017.117; Linder B, 2015, NAT METHODS, V12, P767, DOI [10.1038/nmeth.3453, 10.1038/NMETH.3453]; Little NA, 2000, HUM MOL GENET, V9, P2231, DOI 10.1093/oxfordjournals.hmg.a018914; Liu JZ, 2014, NAT CHEM BIOL, V10, P93, DOI 10.1038/nchembio.1432; Liu J, 2020, SCIENCE, V367, P580, DOI 10.1126/science.aay6018; Liu J, 2018, NAT CELL BIOL, V20, P1074, DOI 10.1038/s41556-018-0174-4; Liu JE, 2021, CELL RES, V31, P404, DOI 10.1038/s41422-020-00465-7; Liu N, 2015, NATURE, V518, P560, DOI 10.1038/nature14234; Liu N, 2013, RNA, V19, P1848, DOI 10.1261/rna.041178.113; Liu XM, 2019, NAT CHEM BIOL, V15, P865, DOI 10.1038/s41589-019-0327-1; Liu Y, 2019, SCIENCE, V365, P1171, DOI 10.1126/science.aax4468; Lu MJ, 2020, NAT MICROBIOL, V5, P584, DOI 10.1038/s41564-019-0653-9; Lu WX, 2018, J BIOL CHEM, V293, P12992, DOI 10.1074/jbc.RA118.004215; Ma JZ, 2017, HEPATOLOGY, V65, P529, DOI 10.1002/hep.28885; Machnicka Magdalena A, 2013, Nucleic Acids Res, V41, pD262, DOI 10.1093/nar/gks1007; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mauer J, 2019, NAT CHEM BIOL, V15, P340, DOI 10.1038/s41589-019-0231-8; Mauer J, 2017, NATURE, V541, P371, DOI 10.1038/nature21022; Merkestein M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7792; Meyer KD, 2012, CELL, V149, P1635, DOI 10.1016/j.cell.2012.05.003; Mo J, 2020, ADV SCI, V7, DOI 10.1002/advs.202001402; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Tran NV, 2019, NUCLEIC ACIDS RES, V47, P7719, DOI 10.1093/nar/gkz619; O'Connell MR, 2014, NATURE, V516, P263, DOI 10.1038/nature13769; O'Neill LAJ, 2019, NAT REV IMMUNOL, V19, P273, DOI 10.1038/s41577-019-0128-5; Patil DP, 2016, NATURE, V537, P369, DOI 10.1038/nature19342; Pellarin I, 2020, ONCOGENE, V39, P4390, DOI 10.1038/s41388-020-1292-6; Pendleton KE, 2017, CELL, V169, P824, DOI 10.1016/j.cell.2017.05.003; Peng W, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1408-4; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Ren WD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12923-x; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Ringeard M, 2019, NATURE, V565, P500, DOI 10.1038/s41586-018-0841-4; ROTTMAN F, 1974, CELL, V3, P197, DOI 10.1016/0092-8674(74)90131-7; Ruzicka K, 2017, NEW PHYTOL, V215, P157, DOI 10.1111/nph.14586; Scholler E, 2018, RNA, V24, P499, DOI 10.1261/rna.064063.117; Schwartz S, 2014, CELL REP, V8, P284, DOI 10.1016/j.celrep.2014.05.048; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Scuteri A, 2007, PLOS GENET, V3, P1200, DOI 10.1371/journal.pgen.0030115; Shen C, 2020, CELL STEM CELL, V27, P64, DOI 10.1016/j.stem.2020.04.009; Shen F, 2015, J CLIN ENDOCR METAB, V100, pE148, DOI 10.1210/jc.2014-1893; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Shima H, 2017, CELL REP, V21, P3354, DOI 10.1016/j.celrep.2017.11.092; Shu X, 2020, NAT CHEM BIOL, V16, P887, DOI 10.1038/s41589-020-0526-9; Sledz P, 2016, ELIFE, V5, DOI 10.7554/eLife.18434; Small TW, 2009, J BIOL CHEM, V284, P24684, DOI 10.1074/jbc.M109.034629; SOMMER S, 1976, NUCLEIC ACIDS RES, V3, P749, DOI 10.1093/nar/3.3.749; Song HP, 2020, CELL CHEM BIOL, V27, P283, DOI 10.1016/j.chembiol.2020.01.002; Tanenbaum ME, 2014, CELL, V159, P635, DOI 10.1016/j.cell.2014.09.039; Tang B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1128-6; Tang C, 2018, P NATL ACAD SCI USA, V115, pE325, DOI 10.1073/pnas.1717794115; Toh JDW, 2020, P NATL ACAD SCI USA, V117, P25284, DOI 10.1073/pnas.2007349117; Visvanathan A, 2018, ONCOGENE, V37, P522, DOI 10.1038/onc.2017.351; Visvanathan A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020141; Vu LP, 2017, NAT MED, V23, P1369, DOI 10.1038/nm.4416; Wang JZ, 2020, CELL STEM CELL, V27, P81, DOI 10.1016/j.stem.2020.04.001; Wang J, 2019, NUCLEIC ACIDS RES, V47, DOI 10.1093/nar/gkz751; Wang L, 2019, SCIENCE, V365, P656, DOI 10.1126/science.aav0758; Wang TY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01204-7; Wang X, 2016, NATURE, V534, P575, DOI 10.1038/nature18298; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang Y, 2004, COLD SPRING HARB SYM, V69, P161, DOI 10.1101/sqb.2004.69.161; Wang Y, 2020, NAT CHEM BIOL, V16, P896, DOI 10.1038/s41589-020-0525-x; Warda AS, 2017, EMBO REP, V18, P2004, DOI 10.15252/embr.201744940; WEI CM, 1977, BIOCHEMISTRY-US, V16, P1672, DOI 10.1021/bi00627a023; WEI CM, 1975, CELL, V4, P379, DOI 10.1016/0092-8674(75)90158-0; WEI CM, 1976, BIOCHEMISTRY-US, V15, P397, DOI 10.1021/bi00647a024; Wei JB, 2018, MOL CELL, V71, P973, DOI 10.1016/j.molcel.2018.08.011; Wen J, 2018, MOL CELL, V69, P1028, DOI 10.1016/j.molcel.2018.02.015; Weng HY, 2018, CELL STEM CELL, V22, P191, DOI 10.1016/j.stem.2017.11.016; WENGLER G, 1993, VIROLOGY, V197, P265, DOI 10.1006/viro.1993.1587; Williams GD, 2019, ANNU REV VIROL, V6, P235, DOI 10.1146/annurev-virology-092818-015559; Wilson C, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0572-6; Xia TF, 2019, PATHOL RES PRACT, V215, DOI 10.1016/j.prp.2019.152666; Xiao W, 2016, MOL CELL, V61, P507, DOI 10.1016/j.molcel.2016.01.012; Xiao Y, 2018, ANGEW CHEM INT EDIT, V57, P15995, DOI 10.1002/anie.201807942; Xu C, 2014, NAT CHEM BIOL, V10, P927, DOI [10.1038/nchembio.1654, 10.1038/NCHEMBIO.1654]; Yang LZ, 2019, MOL CELL, V76, P981, DOI 10.1016/j.molcel.2019.10.024; Ying XL, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01289-0; Yoon KJ, 2017, CELL, V171, P877, DOI 10.1016/j.cell.2017.09.003; Yuan BF, 2017, METHODS MOL BIOL, V1562, P33, DOI 10.1007/978-1-4939-6807-7_3; Yue YA, 2018, CELL DISCOV, V4, DOI 10.1038/s41421-018-0019-0; Yue YN, 2015, GENE DEV, V29, P1343, DOI 10.1101/gad.262766.115; Zhang C, 2018, GENOM PROTEOM BIOINF, V16, P155, DOI 10.1016/j.gpb.2018.03.003; Zhang J, 2019, J PHYSIOL BIOCHEM, V75, P379, DOI 10.1007/s13105-019-00690-8; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhang X, 2019, P NATL ACAD SCI USA, V116, P2919, DOI 10.1073/pnas.1820574116; Zhang ZY, 2010, J BIOL CHEM, V285, P14701, DOI 10.1074/jbc.M110.104711; Zhang Z, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0250; Zhang ZJ, 2020, NAT GENET, V52, P939, DOI 10.1038/s41588-020-0644-z; Zhao J, 2020, SMALL, V16, DOI 10.1002/smll.201907301; Zhao X, 2014, CELL RES, V24, P1403, DOI 10.1038/cr.2014.151; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015; Zheng QL, 2017, NAT IMMUNOL, V18, P1094, DOI 10.1038/ni.3830; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	159	20	20	11	61	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100973	10.1016/j.jbc.2021.100973	http://dx.doi.org/10.1016/j.jbc.2021.100973			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34280435	gold, Green Published			2022-12-28	WOS:000690871400012
J	Goswami, S; Balasubramanian, I; D'Agostino, L; Bandyopadhyay, S; Patel, R; Avasthi, S; Yu, SY; Goldenring, JR; Bonder, EM; Gao, N				Goswami, Sayantani; Balasubramanian, Iyshwarya; D'Agostino, Luca; Bandyopadhyay, Sheila; Patel, Radha; Avasthi, Shail; Yu, Shiyan; Goldenring, James R.; Bonder, Edward M.; Gao, Nan			RAB11A-mediated YAP localization to adherens and tight junctions is essential for colonic epithelial integrity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORGAN SIZE CONTROL; SIGNALING-PATHWAY; CONTACT INHIBITION; HIPPO PATHWAY; TUMOR-SUPPRESSOR; MECHANOTRANSDUCERS YAP; SUBSTRATUM STIFFNESS; WNT/BETA-CATENIN; ALPHA-CATENIN; BETA-CATENIN	Within the intestinal epithelium, regulation of intracellular protein and vesicular trafficking is of utmost importance for barrier maintenance, immune responses, and tissue polarity. RAB11A is a small GTPase that mediates the anterograde transport of protein cargos to the plasma membrane. Loss of RAB11A-dependent trafficking in mature intestinal epithelial cells results in increased epithelial proliferation and nuclear accumulation of Yes-associated protein (YAP), a key Hippo-signaling transducer that senses cell-cell contacts and regulates tissue growth. However, it is unclear how RAB11A regulates YAP intracellular localizations. In this report, we examined the relationship of RAB11A to epithelial junctional complexes, YAP, and the associated consequences on colonic epithelial tissue repair. We found that RAB11A controls the biochemical associations of YAP with multiple components of adherens and tight junctions, including alpha-catenin, beta-catenin, and Merlin, a tumor suppressor. In the absence of RAB11A and Merlin, we observed enhanced YAP-beta-catenin complex formation and nuclear translocation. Upon chemical injury to the intestine, mice deficient in RAB11A were found to have reduced epithelial integrity, decreased YAP localization to adherens and tight junctions, and increased nuclear YAP accumulation in the colon epithelium. Thus, RAB11A-regulated trafficking regulates the Hippo-YAP signaling pathway for rapid reparative response after tissue injury.	[Goswami, Sayantani; Balasubramanian, Iyshwarya; D'Agostino, Luca; Bandyopadhyay, Sheila; Patel, Radha; Avasthi, Shail; Yu, Shiyan; Bonder, Edward M.; Gao, Nan] Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA; [Goldenring, James R.] Vanderbilt Univ, Sch Med, Epithelial Biol Ctr, Dept Surg, Nashville, TN 37212 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Vanderbilt University	Gao, N (corresponding author), Rutgers State Univ, Dept Biol Sci, Newark, NJ 07102 USA.	ngao@rutgers.edu		Goldenring, James/0000-0002-7833-2940; Bonder, Edward/0000-0001-6463-9143; Gao, Nan/0000-0003-4264-7438	National Institutes of Health (NIH) [DK102934, AT010243, DK119198]; National Science Foundation/Division of Biological Infrastructure [1952823]; Rutgers University-Newark Chancellor's Initiative for Multidisciplinary Research Teams award; Rutgers University-Newark School of Arts & Sciences-Newark research funds [DK48370]; New Jersey Commission on Cancer Research fellowships [DFHS16PPC038, DFHS17PPC036]; NIH [F31 DK121428]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation/Division of Biological Infrastructure(National Science Foundation (NSF)); Rutgers University-Newark Chancellor's Initiative for Multidisciplinary Research Teams award; Rutgers University-Newark School of Arts & Sciences-Newark research funds; New Jersey Commission on Cancer Research fellowships; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Yue Liu, Juan Flores, and Brian G. Ayee for their help with experimental procedures. This work was supported by the National Institutes of Health (NIH) grants DK102934, AT010243, DK119198 as well as National Science Foundation/Division of Biological Infrastructure grant 1952823. This work was supported by a Rutgers University-Newark Chancellor's Initiative for Multidisciplinary Research Teams award to N. G.; Rutgers University-Newark School of Arts & Sciences-Newark research funds to E. M. B.; DK48370 to J. R. G.; New Jersey Commission on Cancer Research fellowships DFHS16PPC038 to S. G.; and DFHS17PPC036 to S. B. S. B. is currently supported by an NIH F31 DK121428. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Bosco EE, 2010, ONCOGENE, V29, P2540, DOI 10.1038/onc.2010.20; Cai J, 2010, GENE DEV, V24, P2383, DOI 10.1101/gad.1978810; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; D'Agostino L, 2019, CANCER RES, V79, P4099, DOI 10.1158/0008-5472.CAN-18-4075; Das S, 2015, DEVELOPMENT, V142, P2147, DOI 10.1242/dev.121046; Deng FH, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-017-0244-8; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Dupont S, 2011, NATURE, V474, P179, DOI 10.1038/nature10137; Ehmer U, 2016, MOL CANCER RES, V14, P127, DOI 10.1158/1541-7786.MCR-15-0305; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Fagotto F, 1996, DEV BIOL, V180, P445, DOI 10.1006/dbio.1996.0318; Feng Q, 2017, J CELL SCI, V130, P2491, DOI 10.1242/jcs.201897; Feng Q, 2015, J CELL PHYSIOL, V230, P1170, DOI 10.1002/jcp.24853; Furukawa KT, 2017, CELL REP, V20, P1435, DOI 10.1016/j.celrep.2017.07.032; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Gladden AB, 2010, DEV CELL, V19, P727, DOI 10.1016/j.devcel.2010.10.008; Gumbiner BM, 2014, J CELL SCI, V127, P709, DOI 10.1242/jcs.140103; Halder G, 2012, NAT REV MOL CELL BIO, V13, P591, DOI 10.1038/nrm3416; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Heller B, 2010, J BIOL CHEM, V285, P12308, DOI 10.1074/jbc.M109.096230; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Imajo M, 2015, NAT CELL BIOL, V17, P7, DOI 10.1038/ncb3084; JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534; Kakar-Bhanot R, 2019, HUM REPROD, V34, P519, DOI 10.1093/humrep/dey365; Karaman R, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028753; Kim JH, 2009, P NATL ACAD SCI USA, V106, P11149, DOI 10.1073/pnas.0812651106; Kim M, 2014, BMB REP, V47, P540, DOI 10.5483/BMBRep.2014.47.10.177; Kim NG, 2011, P NATL ACAD SCI USA, V108, P11930, DOI 10.1073/pnas.1103345108; Knowles BC, 2015, J CELL SCI, V128, P1617, DOI 10.1242/jcs.163303; Kwon Y, 2013, SCIENCE, V342, P737, DOI 10.1126/science.1243971; Lapierre LA, 2012, MOL BIOL CELL, V23, P2302, DOI 10.1091/mbc.E11-08-0681; Le J, 2016, SCI REP-UK, V6, DOI 10.1038/srep33014; Li ZQ, 2012, J BIOL CHEM, V287, P13005, DOI 10.1074/jbc.M112.347419; Low BC, 2014, FEBS LETT, V588, P2663, DOI 10.1016/j.febslet.2014.04.012; Madison BB, 2002, J BIOL CHEM, V277, P33275, DOI 10.1074/jbc.M204935200; McClatchey AI, 2012, CURR OPIN CELL BIOL, V24, P685, DOI 10.1016/j.ceb.2012.06.009; McMurray RJ, 2015, J TISSUE ENG REGEN M, V9, P528, DOI 10.1002/term.1957; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Moya IM, 2019, NAT REV MOL CELL BIO, V20, P211, DOI 10.1038/s41580-018-0086-y; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Nardone G, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15321; Nishioka N, 2009, DEV CELL, V16, P398, DOI 10.1016/j.devcel.2009.02.003; Oka T, 2010, BIOCHEM J, V432, P461, DOI 10.1042/BJ20100870; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Paramasivam M, 2011, MOL BIOL CELL, V22, P3725, DOI 10.1091/mbc.E11-04-0300; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Plouffe SW, 2015, TRENDS MOL MED, V21, P212, DOI 10.1016/j.molmed.2015.01.003; Pocaterra A, 2020, J CELL SCI, V133, DOI 10.1242/jcs.230425; Prahallad A, 2016, ONCOGENE, V35, P1073, DOI 10.1038/onc.2015.151; Qiao YT, 2017, CELL REP, V19, P1495, DOI 10.1016/j.celrep.2017.04.075; Radler PD, 2017, MOL CELL ENDOCRINOL, V451, P31, DOI 10.1016/j.mce.2017.04.025; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rausch V, 2020, TRENDS CELL BIOL, V30, P32, DOI 10.1016/j.tcb.2019.10.005; Rosado-Olivieri EA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09404-6; Sato Toshiro, 2013, Methods Mol Biol, V945, P319, DOI 10.1007/978-1-62703-125-7_19; Schlegelmilch K, 2011, CELL, V144, P782, DOI 10.1016/j.cell.2011.02.031; Seo J, 2018, BMB REP, V51, P151, DOI 10.5483/BMBRep.2018.51.3.012; Sobajima T, 2015, BIOL OPEN, V4, P86, DOI 10.1242/bio.20148532; Sorkin A, 2002, NAT REV MOL CELL BIO, V3, P600, DOI 10.1038/nrm883; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Varelas X, 2010, DEV CELL, V19, P831, DOI 10.1016/j.devcel.2010.11.012; Wang WQ, 2011, J BIOL CHEM, V286, P4364, DOI 10.1074/jbc.C110.205401; XU TA, 1995, DEVELOPMENT, V121, P1053; Yan ZB, 2016, ARTERIOSCL THROM VAS, V36, P339, DOI 10.1161/ATVBAHA.115.306549; Yin F, 2013, CELL, V154, P1342, DOI 10.1016/j.cell.2013.08.025; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu FX, 2012, CELL, V150, P780, DOI 10.1016/j.cell.2012.06.037; Yu SY, 2014, EMBO J, V33, P1882, DOI 10.15252/embj.201487888; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zhang Y, 2016, ONCOL REP, V36, P3619, DOI 10.3892/or.2016.5194; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2011, NAT CELL BIOL, V13, P877, DOI 10.1038/ncb2303; Zhao B, 2011, GENE DEV, V25, P51, DOI 10.1101/gad.2000111; Zhao B, 2010, GENE DEV, V24, P862, DOI 10.1101/gad.1909210; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810	81	3	3	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100848	10.1016/j.jbc.2021.100848	http://dx.doi.org/10.1016/j.jbc.2021.100848			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058200	Green Published, gold			2022-12-28	WOS:000678068400048
J	Ilnytska, O; Lai, K; Gorshkov, K; Schultz, ML; Tran, BN; Jeziorek, M; Kunkel, TJ; Azaria, RD; McLoughlin, HS; Waghalter, M; Xu, Y; Schlame, M; Altan-Bonnet, N; Zheng, W; Lieberman, AP; Dobrowolski, R; Storch, J				Ilnytska, Olga; Lai, Kimberly; Gorshkov, Kirill; Schultz, Mark L.; Tran, Bruce Nguyen; Jeziorek, Maciej; Kunkel, Thaddeus J.; Azaria, Ruth D.; McLoughlin, Hayley S.; Waghalter, Miriam; Xu, Yang; Schlame, Michael; Altan-Bonnet, Nihal; Zheng, Wei; Lieberman, Andrew P.; Dobrowolski, Radek; Storch, Judith			Enrichment of NPC1-deficient cells with the lipid LBPA stimulates autophagy, improves lysosomal function, and reduces cholesterol storage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SPHINGOMYELINASE ACTIVITY; LYSOBISPHOSPHATIDIC ACID; IMPAIRED AUTOPHAGY; MEMBRANE-LIPIDS; C2 PROTEIN; TRAFFICKING; DISEASE; NPC1; TRANSPORT; IDENTIFICATION	Niemann-Pick C (NPC) is an autosomal recessive disorder characterized by mutations in the NPC1 or NPC2 genes encoding endolysosomal lipid transport proteins, leading to cholesterol accumulation and autophagy dysfunction. We have previously shown that enrichment of NPC1-deficient cells with the anionic lipid lysobisphosphatidic acid (LBPA; also called bis(monoacylglycerol)phosphate) via treatment with its precursor phosphatidylglycerol (PG) results in a dramatic decrease in cholesterol storage. However, the mechanisms underlying this reduction are unknown. In the present study, we showed using biochemical and imaging approaches in both NPC1-deficient cellular models and an NPC1 mouse model that PG incubation/LBPA enrichment significantly improved the compromised autophagic flux associated with NPC1 disease, providing a route for NPC1-independent endolysosomal cholesterol mobilization. PG/LBPA enrichment specifically enhanced the late stages of autophagy, and effects were mediated by activation of the lysosomal enzyme acid sphingomyelinase. PG incubation also led to robust and specific increases in LBPA species with polyunsaturated acyl chains, potentially increasing the propensity for membrane fusion events, which are critical for late-stage autophagy progression. Finally, we demonstrated that PG/LBPA treatment efficiently cleared cholesterol and toxic protein aggregates in Purkinje neurons of the NPC1(I1061T) mouse model. Collectively, these findings provide a mechanistic basis supporting cellular LBPA as a potential new target for therapeutic intervention in NPC disease.	[Ilnytska, Olga; Lai, Kimberly; Waghalter, Miriam; Storch, Judith] Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA; [Ilnytska, Olga; Dobrowolski, Radek; Storch, Judith] Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA; [Gorshkov, Kirill; Tran, Bruce Nguyen; Zheng, Wei] Natl Ctr Adv Translat Sci, NIH, Bethesda, MD USA; [Schultz, Mark L.; Kunkel, Thaddeus J.; Azaria, Ruth D.; Lieberman, Andrew P.] Univ Michigan, Dept Pathol, Med Sch, Ann Arbor, MI 48109 USA; [Jeziorek, Maciej; Dobrowolski, Radek] Rutgers State Univ, Dept Biol Sci, Newark, NJ USA; [McLoughlin, Hayley S.] Univ Michigan, Dept Neurol, Med Sch, Ann Arbor, MI USA; [Xu, Yang; Schlame, Michael] NYU, Sch Med, Dept Anesthesiol, New York, NY 10016 USA; [Xu, Yang; Schlame, Michael] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Altan-Bonnet, Nihal] NHLBI, Lab Host Pathogen Dynam, Bldg 10, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); University of Michigan System; University of Michigan; Rutgers State University Newark; Rutgers State University New Brunswick; University of Michigan System; University of Michigan; New York University; New York University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Ilnytska, O; Storch, J (corresponding author), Rutgers State Univ, Dept Nutr Sci, New Brunswick, NJ 08901 USA.; Ilnytska, O; Storch, J (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Brunswick, NJ 08901 USA.	ilnytska@sebs.rutgers.edu; storch@sebs.rutgers.edu	Zheng, Wei/GQQ-8951-2022; Zheng, Wei/GOE-5990-2022; Gorshkov, Kirill/W-2188-2019; Zheng, Wei/J-8889-2014	Gorshkov, Kirill/0000-0002-4652-8818; Zheng, Wei/0000-0003-1034-0757; Azaria, Ruth/0000-0002-1686-2591; Ilnytska, Olga/0000-0003-0807-9158; Nguyen Tran, Bruce/0000-0002-8786-1481; Schultz, Mark/0000-0002-3149-4424; McLoughlin, Hayley/0000-0003-4279-2758	Ara Parseghian Medical Research Foundation; American Heart Association [14GRNT19990014, 18CDA34110230]; Niemann-Pick Canada; U.S. National Institutes of Health [R01 NS063967, R01 AG062475, R56 AG061040, R01 GM1125866]	Ara Parseghian Medical Research Foundation; American Heart Association(American Heart Association); Niemann-Pick Canada; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by funds from the Ara Parseghian Medical Research Foundation to O. I., an American Heart Association career development grant 18CDA34110230 to O. I., an American Heart Association Grant-inAid 14GRNT19990014 to J. S., Niemann-Pick Canada to M. L. S., Hope for Marian to M. L. S., and U.S. National Institutes of Health R01 NS063967 to A. P. L., R01 AG062475 and R56 AG061040 to R. D. and R01 GM1125866 to J. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdul-Hammed M, 2010, J LIPID RES, V51, P1747, DOI 10.1194/jlr.M003822; Bedia C, 2010, J LIPID RES, V51, P3542, DOI 10.1194/jlr.D010033; Bissig C, 2013, DEV CELL, V25, P364, DOI 10.1016/j.devcel.2013.04.003; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Borbon IA, 2011, J APPL GENET, V52, P213, DOI 10.1007/s13353-010-0021-1; BROTHERUS J, 1977, J LIPID RES, V18, P191; Carriere F, 2020, BIOCHIMIE, V179, P237, DOI 10.1016/j.biochi.2020.05.013; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Chan RB, 2012, J BIOL CHEM, V287, P2678, DOI 10.1074/jbc.M111.274142; Chapuy-Regaud S, 2013, BIOCHIMIE, V95, P1677, DOI 10.1016/j.biochi.2013.05.019; Cheruku SR, 2006, J BIOL CHEM, V281, P31594, DOI 10.1074/jbc.M602765200; Chevallier J, 2008, J BIOL CHEM, V283, P27871, DOI 10.1074/jbc.M801463200; Chu BB, 2015, CELL, V161, P291, DOI 10.1016/j.cell.2015.02.019; Corcelle-Termeau E, 2016, AUTOPHAGY, V12, P833, DOI 10.1080/15548627.2016.1159378; Dai S, 2017, AUTOPHAGY, V13, P1435, DOI 10.1080/15548627.2017.1329081; Dai S, 2016, J BIOMOL SCREEN, V21, P1112, DOI 10.1177/1087057116670068; Dany M, 2016, BLOOD, V128, P1944, DOI 10.1182/blood-2016-04-708750; Devlin C, 2010, TRAFFIC, V11, P601, DOI 10.1111/j.1600-0854.2010.01046.x; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Elrick MJ, 2012, HUM MOL GENET, V21, P4876, DOI 10.1093/hmg/dds324; Falguieres T, 2009, EXP CELL RES, V315, P1567, DOI 10.1016/j.yexcr.2008.12.006; Gabande-Rodriguez E, 2014, CELL DEATH DIFFER, V21, P864, DOI 10.1038/cdd.2014.4; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Guan ZQ, 2007, BIOCHEMISTRY-US, V46, P14500, DOI 10.1021/bi701907g; Hoglinger D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12152-2; Hsu FF, 2004, J AM SOC MASS SPECTR, V15, P1, DOI 10.1016/j.jasms.2003.08.006; Ikonen E, 2008, NAT REV MOL CELL BIO, V9, P125, DOI 10.1038/nrm2336; Ilnytska O, 2021, BBA-MOL CELL BIOL L, V1866, DOI 10.1016/j.bbalip.2021.158916; Infante RE, 2008, P NATL ACAD SCI USA, V105, P15287, DOI 10.1073/pnas.0807328105; Infante RE, 2017, ELIFE, V6, DOI 10.7554/eLife.25466; Jenkins RW, 2011, J BIOL CHEM, V286, P3777, DOI 10.1074/jbc.M110.155234; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Ko DC, 2005, PLOS GENET, V1, P81, DOI 10.1371/journal.pgen.0010007; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; Kwon HJ, 2009, CELL, V137, P1213, DOI 10.1016/j.cell.2009.03.049; Le Blanc I, 2005, NAT CELL BIOL, V7, P653, DOI 10.1038/ncb1269; Lee H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6514; Li J, 2017, METHODS MOL BIOL, V1583, P85, DOI 10.1007/978-1-4939-6875-6_8; Li J, 2016, ELIFE, V5, DOI 10.7554/eLife.21635; Li X, 2014, J MOL MED, V92, P473, DOI 10.1007/s00109-014-1120-y; Li XC, 2016, P NATL ACAD SCI USA, V113, P10079, DOI 10.1073/pnas.1611956113; Li XC, 2016, P NATL ACAD SCI USA, V113, P8212, DOI 10.1073/pnas.1607795113; Lim CY, 2019, NAT CELL BIOL, V21, P1206, DOI 10.1038/s41556-019-0391-5; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Maekawa M, 2015, J CELL SCI, V128, P1422, DOI 10.1242/jcs.164715; Maetzel D, 2014, STEM CELL REP, V2, P866, DOI 10.1016/j.stemcr.2014.03.014; Manni MM, 2018, ELIFE, V7, DOI 10.7554/eLife.34394; Matsuo H, 2004, SCIENCE, V303, P531, DOI 10.1126/science.1092425; McCauliff LA, 2019, ELIFE, V8, DOI 10.7554/eLife.50832; McCauliff LA, 2015, J BIOL CHEM, V290, P27321, DOI 10.1074/jbc.M115.667469; McCauliff LA, 2011, BIOCHEMISTRY-US, V50, P7341, DOI 10.1021/bi200574f; McLoughlin HS, 2018, ANN NEUROL, V84, P64, DOI 10.1002/ana.25264; Meneses-Salas E, 2020, CELL MOL LIFE SCI, V77, P2839, DOI 10.1007/s00018-019-03330-y; Mizushima N, 1998, NATURE, V395, P395, DOI 10.1038/26506; Mobius W, 2003, TRAFFIC, V4, P222; Moreau D, 2019, EMBO REP, V20, DOI 10.15252/embr.201847055; Naureckiene S, 2000, SCIENCE, V290, P2298, DOI 10.1126/science.290.5500.2298; Nesslauer AM, 2019, LIPIDS HEALTH DIS, V18, DOI 10.1186/s12944-019-1088-2; Oninla VO, 2014, J LIPID RES, V55, P2606, DOI 10.1194/jlr.M054528; Ordonez YF, 2019, J AM CHEM SOC, V141, P7736, DOI 10.1021/jacs.8b11687; Pacheco CD, 2007, HUM MOL GENET, V16, P1495, DOI 10.1093/hmg/ddm100; Park H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093369; Pasqual G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002232; Pfeffer SR, 2019, J BIOL CHEM, V294, P1706, DOI 10.1074/jbc.TM118.004165; Pfisterer SG, 2016, CURR OPIN LIPIDOL, V27, P282, DOI 10.1097/MOL.0000000000000292; Pfrieger FW, 2018, J LIPID RES, V59, P2255, DOI 10.1194/jlr.R084210; Piazza GJ, 2007, J AM OIL CHEM SOC, V84, P645, DOI 10.1007/s11746-007-1081-1; Pinot M, 2014, SCIENCE, V345, P693, DOI 10.1126/science.1255288; Pipalia NH, 2019, FASEB J, V33; Praggastis M, 2015, J NEUROSCI, V35, P8091, DOI 10.1523/JNEUROSCI.4173-14.2015; Reagan JM, 2000, J BIOL CHEM, V275, P38104, DOI 10.1074/jbc.M005296200; Riethmuller J, 2009, CELL PHYSIOL BIOCHEM, V24, P65, DOI 10.1159/000227814; Rosato AS, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13572-w; Sanman LE, 2016, CELL CHEM BIOL, V23, P793, DOI 10.1016/j.chembiol.2016.05.019; Sarkar S, 2013, CELL REP, V5, P1302, DOI 10.1016/j.celrep.2013.10.042; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Shen DB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1735; STANACEV NZ, 1967, J BIOL CHEM, V242, P3018; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Sun G, 2008, ANAL CHEM, V80, P7576, DOI 10.1021/ac801200w; THORNBURG T, 1991, J BIOL CHEM, V266, P6834; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Vanier MT, 2015, J INHERIT METAB DIS, V38, P187, DOI 10.1007/s10545-014-9794-4; Varnai P, 2002, J BIOL CHEM, V277, P27412, DOI 10.1074/jbc.M109672200; Vats S, 2019, MOL BIOL CELL, V30, P2283, DOI 10.1091/mbc.E18-08-0482; Vihervaara T, 2011, CELL MOL LIFE SCI, V68, P537, DOI 10.1007/s00018-010-0470-z; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Walkley SU, 2009, BBA-MOL CELL RES, V1793, P726, DOI 10.1016/j.bbamcr.2008.11.014; Wang H, 2019, MOL CELL, V73, P458, DOI 10.1016/j.molcel.2018.11.014; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Ward S, 2010, PEDIATR RES, V68, P52, DOI [10.1203/PDR.0b013e3181df4623, 10.1203/00006450-201011001-00099]; Wheeler S, 2019, NEUROBIOL DIS, V127, P242, DOI 10.1016/j.nbd.2019.03.005; Wijdeven RH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11808; Wojtanik KM, 2003, J BIOL CHEM, V278, P14850, DOI 10.1074/jbc.M300488200; Xu M, 2016, FRONT BIOSCI-LANDMRK, V21, P696, DOI 10.2741/4415; Xu Z, 2008, BIOCHEMISTRY-US, V47, P11134, DOI 10.1021/bi801328u; Yu DZ, 2014, J BIOMOL SCREEN, V19, P1164, DOI 10.1177/1087057114537378; Zaitseva E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001131; Zhang XL, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000252	104	9	8	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100813	10.1016/j.jbc.2021.100813	http://dx.doi.org/10.1016/j.jbc.2021.100813			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023384	Green Published, gold			2022-12-28	WOS:000678068400016
J	Cooper, JM; Lathuiliere, A; Migliorini, M; Arai, AL; Wani, MM; Dujardin, S; Muratoglu, SC; Hyman, BT; Strickland, DK				Cooper, Joanna M.; Lathuiliere, Aurelien; Migliorini, Mary; Arai, Allison L.; Wani, Mashhood M.; Dujardin, Simon; Muratoglu, Selen C.; Hyman, Bradley T.; Strickland, Dudley K.			Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN; HIGH-AFFINITY BINDING; AMYLOID PRECURSOR PROTEIN; PAIRED HELICAL FILAMENTS; CELL-SURFACE RECEPTORS; ALPHA-2-MACROGLOBULIN RECEPTOR; APOLIPOPROTEIN-E; ENDOGENOUS TAU; MOUSE MODEL; BETA	In Alzheimer's disease (AD), pathological forms of tau are transferred from cell to cell and "seed" aggregation of cytoplasmic tau. Phosphorylation of tau plays a key role in neuro-degenerative tauopathies. In addition, apolipoprotein E (apoE), a major component of lipoproteins in the brain, is a genetic risk determinant for AD. The identification of the apoE receptor, low-density lipoprotein receptor-related protein 1 (LRP1), as an endocytic receptor for tau raises several questions about the role of LRP1 in tauopathies: is internalized tau, like other LRP1 ligands, delivered to lysosomes for degradation, and does LRP1 internalize pathological tau leading to cytosolic seeding? We found that LRP1 rapidly internalizes 125I-labeled tau, which is then efficiently degraded in lysosomal compartments. Surface plasmon resonance experiments confirm high affinity binding of tau and the tau microtubule-binding domain to LRP1. Interestingly, phosphorylated forms of recombinant tau bind weakly to LRP1 and are less efficiently internalized by LRP1. LRP1-mediated uptake of tau is inhibited by apoE, with the apoE4 isoform being the most potent inhibitor, likely because of its higher affinity for LRP1. Employing post-translationally-modified tau derived from brain lysates of human AD brain tissue, we found that LRP1-expressing cells, but not LRP1-deficient cells, promote cytosolic tau seeding in a process enhanced by apoE. These studies identify LRP1 as an endocytic receptor that binds and processes monomeric forms of tau leading to its degradation and promotes seeding by pathological forms of tau. The balance of these processes may be fundamental to the spread of neuropathology across the brain in AD.	[Cooper, Joanna M.; Migliorini, Mary; Arai, Allison L.; Wani, Mashhood M.; Muratoglu, Selen C.; Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Lathuiliere, Aurelien; Dujardin, Simon; Hyman, Bradley T.] Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit, Charlestown, MA 02129 USA; [Lathuiliere, Aurelien; Dujardin, Simon; Hyman, Bradley T.] Harvard Med Sch, Charlestown, MA 02129 USA; [Muratoglu, Selen C.; Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA; [Muratoglu, Selen C.] NHLBI, Vasc Biol & Hypertens Branch, Div Cardiovasc Sci, 6705 Rockledge Dr, Bethesda, MD 20892 USA	University System of Maryland; University of Maryland Baltimore; Harvard University; Massachusetts General Hospital; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Strickland, DK (corresponding author), Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA.; Hyman, BT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Alzheimer Res Unit, Charlestown, MA 02129 USA.; Hyman, BT (corresponding author), Harvard Med Sch, Charlestown, MA 02129 USA.; Strickland, DK (corresponding author), Univ Maryland, Sch Med, Dept Physiol, Baltimore, MD 21201 USA.; Strickland, DK (corresponding author), Univ Maryland, Sch Med, Dept Surg, Baltimore, MD 21201 USA.	bhyman@mgh.harvard.edu; dstrickland@som.umaryland.edu	Lathuiliere, Aurelien/N-8586-2019	Lathuiliere, Aurelien/0000-0002-5191-5214; Wani, Mashhood/0000-0002-1951-9078	National Heart, Lung, and Blood Institute, National Institutes of Health [R35 HL135743]; Rainwater Trust; JPB Foundation; National Institute on Aging, National Institutes of Health [R56AG061196]; National Heart, Lung, and Blood Institute [T32 HL007698, F30 HL145952]; Swiss National Science Foundation [P2ELP3_184403]; Alzheimer's Association [AACSF-19-617308]; Professor Dr Max Cloetta Foundation; Uniscientia Foundation, Vaduz; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant [839098]	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Rainwater Trust; JPB Foundation; National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Alzheimer's Association(Alzheimer's Association); Professor Dr Max Cloetta Foundation; Uniscientia Foundation, Vaduz; European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant	This work was supported by grants R35 HL135743 (D. K. S.) from the National Heart, Lung, and Blood Institute, National Institutes of Health and from the Rainwater Trust (B. T. H.), the JPB Foundation (B. T. H.) and National Institute on Aging, National Institutes of Health R56AG061196 (B. T. H.). J. M. C., M. M. W., and A. L. A. were supported by T32 HL007698, whereas A. L. A. was supported by F30 HL145952 from the National Heart, Lung, and Blood Institute. A. L. was supported by the Swiss National Science Foundation (P2ELP3_184403), the Alzheimer's Association (AACSF-19-617308), the Professor Dr Max Cloetta Foundation and Uniscientia Foundation, Vaduz and European Union's Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant agreement #839098. S. C. M. contributed to this article as an employee of the University of Maryland, Baltimore. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arai AL, 2020, BIOCHEMISTRY-US, V59, P2922, DOI 10.1021/acs.biochem.0c00442; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arboleda-Velasquez JF, 2019, NAT MED, V25, P1680, DOI 10.1038/s41591-019-0611-3; ASHCOM JD, 1990, J CELL BIOL, V110, P1041, DOI 10.1083/jcb.110.4.1041; BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Chai XY, 2012, NEUROBIOL DIS, V48, P356, DOI 10.1016/j.nbd.2012.05.021; CHAPPELL DA, 1994, J BIOL CHEM, V269, P18001; Chen Y, 2010, P NATL ACAD SCI USA, V107, P12011, DOI 10.1073/pnas.0914984107; Corder E. H., 2008, SCIENCE, V261, P921; de Calignon A, 2012, NEURON, V73, P685, DOI 10.1016/j.neuron.2011.11.033; DeVos SL, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00267; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Dujardin S, 2020, NAT MED, V26, P1256, DOI 10.1038/s41591-020-0938-9; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Evans L., 2020, BIORXIV, DOI [10.7143/jhep,47.248, DOI 10.7143/JHEP]; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; FITZGERALD DJ, 1995, J CELL BIOL, V129, P1533, DOI 10.1083/jcb.129.6.1533; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; Furman JL, 2015, JOVE-J VIS EXP, DOI 10.3791/53205; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanger DP, 2007, J BIOL CHEM, V282, P23645, DOI 10.1074/jbc.M703269200; Harris J A., 2012, PLOS ONE, V7, pe45881; Harrison TM, 2019, ANN NEUROL, V85, P229, DOI 10.1002/ana.25406; Herz J., 1991, J BIOL CHEM, V266, P21232; Holmes BB, 2014, P NATL ACAD SCI USA, V111, pE4376, DOI 10.1073/pnas.1411649111; Holmes BB, 2013, P NATL ACAD SCI USA, V110, pE3138, DOI 10.1073/pnas.1301440110; Huijbers W, 2019, J NEUROSCI, V39, P548, DOI 10.1523/JNEUROSCI.1397-18.2018; HYMAN BT, 1984, SCIENCE, V225, P1168, DOI 10.1126/science.6474172; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; IQBAL K, 1989, P NATL ACAD SCI USA, V86, P5646, DOI 10.1073/pnas.86.14.5646; Jarosz-Griffiths HH, 2016, J BIOL CHEM, V291, P3174, DOI 10.1074/jbc.R115.702704; Kaufman SK, 2018, ACTA NEUROPATHOL, V136, P57, DOI 10.1007/s00401-018-1855-6; KOUNNAS MZ, 1995, CELL, V82, P331, DOI 10.1016/0092-8674(95)90320-8; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; KOUNNAS MZ, 1992, J BIOL CHEM, V267, P12420; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; LALAZAR A, 1988, J BIOL CHEM, V263, P3542; Liu L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031302; MAHLEY RW, 1977, J BIOL CHEM, V252, P7279; Mair W, 2016, ANAL CHEM, V88, P3704, DOI 10.1021/acs.analchem.5b04509; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Medina M., 2014, FRONT CELL NEUROSCI, V8, P1; Merezhko M, 2018, CELL REP, V25, P2027, DOI 10.1016/j.celrep.2018.10.078; Migliorini M, 2020, J BIOL CHEM, V295, P212, DOI 10.1074/jbc.RA119.010449; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Muratoglu SC, 2010, J BIOL CHEM, V285, P14308, DOI 10.1074/jbc.M109.046672; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Nizynski B, 2017, PROTEIN SCI, V26, P2126, DOI 10.1002/pro.3275; Obermoeller-McCormick LM, 2001, J CELL SCI, V114, P899; Pietrzik CU, 2002, EMBO J, V21, P5691, DOI 10.1093/emboj/cdf568; Polydoro M, 2013, J NEUROSCI, V33, P13300, DOI 10.1523/JNEUROSCI.0881-13.2013; Pooler AM, 2013, EMBO REP, V14, P389, DOI 10.1038/embor.2013.15; Prasad H, 2018, P NATL ACAD SCI USA, V115, pE6640, DOI 10.1073/pnas.1801612115; Prasad JM, 2016, J BIOL CHEM, V291, P18430, DOI 10.1074/jbc.M116.744904; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Rauch JN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-24904-z; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Sagare A, 2007, NAT MED, V13, P1029, DOI 10.1038/nm1635; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P1182, DOI 10.1097/NEN.0000000000000016; Shi Y, 2017, NATURE, V549, P523, DOI 10.1038/nature24016; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Simic G, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010006; Stopschinski BE, 2018, J BIOL CHEM, V293, P10826, DOI 10.1074/jbc.RA117.000378; Storck SE, 2016, J CLIN INVEST, V126, P123, DOI 10.1172/JCI81108; STRICKLAND DK, 1990, J BIOL CHEM, V265, P17401; STRITTMATTER WJ, 1993, P NATL ACAD SCI USA, V90, P1977, DOI 10.1073/pnas.90.5.1977; Swanson E, 2017, J ALZHEIMERS DIS, V58, P803, DOI 10.3233/JAD-170168; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Tepper K, 2014, J BIOL CHEM, V289, P34389, DOI 10.1074/jbc.M114.611368; Ulery PG, 2000, J BIOL CHEM, V275, P7410, DOI 10.1074/jbc.275.10.7410; Van Gool B, 2019, MOL NEUROBIOL, V56, P7234, DOI 10.1007/s12035-019-1594-2; Waldron E, 2008, NEUROBIOL DIS, V31, P188, DOI 10.1016/j.nbd.2008.04.006; Wegmann S, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6404; WEISGRABER KH, 1978, J BIOL CHEM, V253, P9053; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Yamada K, 2011, J NEUROSCI, V31, P13110, DOI 10.1523/JNEUROSCI.2569-11.2011; Young PA, 2016, J BIOL CHEM, V291, P26035, DOI 10.1074/jbc.M116.754622; Zdanovsky AG, 1996, J BIOL CHEM, V271, P6122, DOI 10.1074/jbc.271.11.6122	83	15	15	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100715	10.1016/j.jbc.2021.100715	http://dx.doi.org/10.1016/j.jbc.2021.100715			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33930462	Green Published, gold			2022-12-28	WOS:000672866400686
J	Duran, EC; Walter, NG				Duran, Elizabeth C.; Walter, Nils G.			Sisyphus observed: Unraveling the high ATP usage of an RNA chaperone	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEAD-BOX PROTEIN; CYT-19; HELIX	DEAD-box proteins are nonprocessive RNA helicases that can function as RNA chaperones by coupling ATP binding and hydrolysis to structural reorganization of RNA. Here, Jarmoskaite et al. quantify the ATP utilization of an RNA chaperone during refolding of a misfolded ribozyme substrate. Strikingly, 100 ATP hydrolysis events are needed per successfully refolded ribozyme, suggesting that each round of unfolding requires ten ATP molecules, since 90% of substrate unfolding cycles only lead back to the kinetically favored misfolded state. This near-Sisyphean effort reveals a potentially conserved model for RNA reorganization by RNA chaperones.	[Duran, Elizabeth C.; Walter, Nils G.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Duran, Elizabeth C.; Walter, Nils G.] Univ Michigan, Ctr RNA Biomed, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Walter, NG (corresponding author), Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA.; Walter, NG (corresponding author), Univ Michigan, Ctr RNA Biomed, Ann Arbor, MI 48109 USA.	nwalter@umich.edu	Walter, Nils/G-7504-2016	Walter, Nils/0000-0002-7301-1275; Duran, Elizabeth C./0000-0002-3988-5091	NIH [GM131922]; NIH IRACDA fellowship [K12 GM111725]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH IRACDA fellowship(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant GM131922 to N. G. W. and an NIH IRACDA fellowship on grant K12 GM111725 to E. C. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhaskaran H, 2007, NATURE, V449, P1014, DOI 10.1038/nature06235; Gilman B, 2017, BIOCHEM SOC T, V45, P1313, DOI 10.1042/BST20170095; Henn A, 2012, ANNU REV BIOPHYS, V41, P247, DOI 10.1146/annurev-biophys-050511-102243; Jarmoskaite I., 2021, J BIOL CHEM, V296; Jarmoskaite I, 2014, P NATL ACAD SCI USA, V111, pE2928, DOI 10.1073/pnas.1404307111; Liu YC, 2015, J BIOMED SCI, V22, DOI 10.1186/s12929-015-0161-z; Mitchell D, 2013, J MOL BIOL, V425, P2670, DOI 10.1016/j.jmb.2013.05.008; Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7; Russell R, 2006, J MOL BIOL, V363, P531, DOI 10.1016/j.jmb.2006.08.024; Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103	10	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100265	10.1016/j.jbc.2021.100265	http://dx.doi.org/10.1016/j.jbc.2021.100265			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837746	Green Published, gold			2022-12-28	WOS:000672866400241
J	Elko, EA; Manuel, AM; White, S; Zito, E; van Der Vliet, A; Anathy, V; Janssen-Heininger, YMW				Elko, Evan A.; Manuel, Allison M.; White, Sheryl; Zito, Ester; van Der Vliet, Albert; Anathy, Vikas; Janssen-Heininger, Yvonne M. W.			Oxidation of peroxiredoxin-4 induces oligomerization and promotes interaction with proteins governing protein folding and endoplasmic reticulum stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2-CYS PEROXIREDOXINS; CRYSTAL-STRUCTURE; HYPEROXIDATION; PRDX4; IV	Peroxiredoxins (PRDXs) catalyze the reduction of hydrogen peroxide (H2O2). PRDX4 is the only peroxiredoxin located within the endoplasmic reticulum (ER) and is the most highly expressed H2O2 scavenger in the ER. PRDX4 has emerged as an important player in numerous diseases, such as fibrosis and metabolic syndromes, and its overoxidation is a potential indicator of ER redox stress. It is unclear how overoxidation of PRDX4 governs its oligomerization state and interacting partners. Herein, we addressed these questions via non-reducing Western blots, mass spectrometry, and site-directed mutagenesis. We report that the oxidation of PRDX4 in lung epithelial cells treated with tertbutyl hydroperoxide caused a shift of PRDX4 from monomer/dimer to high molecular weight (HMW) species, which contain PRDX4 modified with sulfonic acid residues (PRDX4-SO3), as well as of a complement of ER-associated proteins, including protein disulfide isomerases important in protein folding, thioredoxin domain-containing protein 5, and heat shock protein A5, a key regulator of the ER stress response. Mutation of any of the four cysteines in PRDX4 altered the HMW species in response to tertbutyl hydroperoxide as well as the secretion of PRDX4. We also demonstrate that the expression of ER oxidoreductase 1 alpha, which generates H2O2 in the ER, increased PRDX4 HMW formation and secretion. These results suggest a link between SO3 modification in the formation of HMW PRDX4 complexes in cells, whereas the association of key regulators of ER homeostasis with HMW oxidized PRDX4 point to a putative role of PRDX4 in regulating ER stress responses.	[Elko, Evan A.; Manuel, Allison M.; van Der Vliet, Albert; Anathy, Vikas; Janssen-Heininger, Yvonne M. W.] Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA; [White, Sheryl] Univ Vermont, Dept Neurol Sci, Burlington, VT USA; [Zito, Ester] Ist Ric Farmacol Mario Negri IRCCS, Dept Biochem & Mol Pharmacol, Milan, Italy	University of Vermont; University of Vermont; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Janssen-Heininger, YMW (corresponding author), Univ Vermont, Dept Pathol & Lab Med, Burlington, VT 05405 USA.	Yvonne.janssen@med.uvm.edu		Elko, Evan/0000-0001-6472-3169	National Institutes of Health [R35HL135828, R01HL137268, R01HL085646, R01HL138708, R21AG055325, F31HL144051, R01HL122383, R01HL141364, RO1HL136917]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health: R35HL135828 (Y.-J. H.), R01HL137268, R01HL085646, R01HL138708, R21AG055325 (A. v. d. V.), F31HL144051 (E. E.), and R01HL122383, R01HL141364, and RO1HL136917 (V. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abbasi A, 2012, J AM HEART ASSOC, V1, DOI 10.1161/JAHA.112.002956; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Bolduc JA, 2018, J BIOL CHEM, V293, P11901, DOI 10.1074/jbc.RA117.001690; Burman A, 2018, MATRIX BIOL, V68-69, P355, DOI 10.1016/j.matbio.2018.03.015; Chang TS, 2002, J BIOL CHEM, V277, P25370, DOI 10.1074/jbc.M110432200; Cox AG, 2009, BIOCHEM J, V421, P51, DOI 10.1042/BJ20090242; Cunniff B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127310; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; El Eter E, 2015, BRAZ J MED BIOL RES, V48, P465, DOI 10.1590/1414-431X20144142; Gerrits EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089719; Hampton MB, 2016, MOL CELLS, V39, P72, DOI 10.14348/molcells.2016.2351; Hanaka T, 2019, BMC PULM MED, V19, DOI 10.1186/s12890-019-1032-2; Haynes AC, 2013, J BIOL CHEM, V288, P29714, DOI 10.1074/jbc.M113.473470; Ikeda Y, 2011, J BIOCHEM, V149, P443, DOI 10.1093/jb/mvq156; Ishida YI, 2014, FEBS OPEN BIO, V4, P848, DOI 10.1016/j.fob.2014.10.003; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Kakihana T, 2013, J BIOL CHEM, V288, P29586, DOI 10.1074/jbc.M113.467845; Kakihana T, 2012, ANTIOXID REDOX SIGN, V16, P763, DOI 10.1089/ars.2011.4238; Kam MK, 2019, CELL BIOL TOXICOL, V35, P573, DOI 10.1007/s10565-019-09477-5; Konno T, 2015, J CELL BIOL, V211, P253, DOI 10.1083/jcb.201506123; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; Lipinski S, 2019, EMBO J, V38, DOI 10.15252/embj.2018101266; Loberg MA, 2019, CHEM RES TOXICOL, V32, P474, DOI 10.1021/acs.chemrestox.8b00346; Malkinson AM, 1997, TOXICOLOGY, V123, P53, DOI 10.1016/S0300-483X(97)00108-X; Matsumoto A, 1999, FEBS LETT, V443, P246, DOI 10.1016/S0014-5793(98)01736-0; Mullen I., 2015, MOL MED, V21, P108; Nelson KJ, 2018, ANTIOXID REDOX SIGN, V28, P521, DOI 10.1089/ars.2016.6922; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Okado-Matsumoto A, 2000, J BIOCHEM, V127, P493, DOI 10.1093/oxfordjournals.jbchem.a022632; Pastor-Flores D, 2020, P NATL ACAD SCI USA, V117, P16313, DOI 10.1073/pnas.1915275117; Peskin AV, 2013, J BIOL CHEM, V288, P14170, DOI 10.1074/jbc.M113.460881; Rhee SG, 2016, MOL CELLS, V39, P1, DOI 10.14348/molcells.2016.2368; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Schulte J, 2011, SHOCK, V35, P460, DOI 10.1097/SHK.0b013e3182115f40; Sobotta MC, 2015, NAT CHEM BIOL, V11, P64, DOI 10.1038/nchembio.1695; Stocker S, 2018, NAT CHEM BIOL, V14, P148, DOI 10.1038/nchembio.2536; Tairum CA, 2016, SCI REP-UK, V6, DOI 10.1038/srep33133; Tavender TJ, 2010, EMBO J, V29, P4185, DOI 10.1038/emboj.2010.273; Toledano MB, 2016, MOL CELLS, V39, P31, DOI 10.14348/molcells.2016.2326; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2002, BIOCHEMISTRY-US, V41, P5493, DOI 10.1021/bi012173m; Yamada S, 2018, PATHOL INT, V68, P91, DOI 10.1111/pin.12634; Yang K, 2016, STRUCTURE, V24, P1755, DOI 10.1016/j.str.2016.08.002; Zhang J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092509; Zito E, 2013, ANTIOXID REDOX SIGN, V18, P1666, DOI 10.1089/ars.2012.4966; Zito E, 2010, MOL CELL, V40, P787, DOI 10.1016/j.molcel.2010.11.010	46	9	9	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100665	10.1016/j.jbc.2021.100665	http://dx.doi.org/10.1016/j.jbc.2021.100665			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895140	Green Published, gold			2022-12-28	WOS:000672866400636
J	Exterkate, M; de Kok, NAW; Andringa, RLH; Wolbert, NHJ; Minnaard, AJ; Driessen, AJM				Exterkate, Marten; de Kok, Niels A. W.; Andringa, Ruben L. H.; Wolbert, Niels H. J.; Minnaard, Adriaan J.; Driessen, Arnold J. M.			A promiscuous archaeal cardiolipin synthase enables construction of diverse natural and unnatural phospholipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLAR LIPIDS; METHANOSPIRILLUM-HUNGATEI; TETRAETHER LIPIDS; ESCHERICHIA-COLI; BIOSYNTHESIS; MEMBRANE; DOMAINS; IDENTIFICATION; PROLINE; GLYCINE	Cardiolipins (CL) are a class of lipids involved in the structural organization of membranes, enzyme functioning, and osmoregulation. Biosynthesis of CLs has been studied in eukaryotes and bacteria, but has been barely explored in archaea. Unlike the common fatty acyl chain-based ester phospholipids, archaeal membranes are made up of the structurally different isoprenoid-based ether phospholipids, possibly involving a different cardiolipin biosynthesis mechanism. Here, we identified a phospholipase D motif-containing cardiolipin synthase (MhCls) from the methanogen Methanospirillum hungatei. The enzyme was overexpressed in Escherichia coli, purified, and its activity was characterized by LC-MS analysis of substrates/products. MhCls utilizes two archaetidylglycerol (AG) molecules in a transesterification reaction to synthesize glycerol-di-archaetidyl-cardiolipin (Gro-DACL) and glycerol. The enzyme is nonselective to the stereochemistry of the glycerol backbone and the nature of the lipid tail, as it also accepts phosphatidylglycerol (PG) to generate glycerol-diphosphatidyl-cardiolipin (Gro-DPCL). Remarkably, in the presence of AG and PG, MhCls formed glycerol-archaetidyl-phosphatidyl-cardiolipin (Gro-APCL), an archaeal-bacterial hybrid cardiolipin species that so far has not been observed in nature. Due to the reversibility of the transesterification, in the presence of glycerol, Gro-DPCL can be converted back into two PG molecules. In the presence of other compounds that contain primary hydroxyl groups (e.g., alcohols, water, sugars), various natural and unique unnatural phospholipid species could be synthesized, including multiple di-phosphatidyl-cardiolipin species. Moreover, MhCls can utilize a glycolipid in the presence of phosphatidylglycerol to form a glycosyl-mono-phosphatidyl-cardiolipin species, emphasizing the promiscuity of this cardiolipin synthase that could be of interest for bio-catalytic purposes.	[Exterkate, Marten; de Kok, Niels A. W.; Wolbert, Niels H. J.; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Groningen, Netherlands; [Exterkate, Marten; de Kok, Niels A. W.; Wolbert, Niels H. J.; Driessen, Arnold J. M.] Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands; [Andringa, Ruben L. H.; Minnaard, Adriaan J.] Univ Groningen, Stratingh Inst Chem, Dept Chem Biol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, Groningen, Netherlands.; Driessen, AJM (corresponding author), Univ Groningen, Zernike Inst Adv Mat, Groningen, Netherlands.	a.j.m.driessen@rug.nl	Andringa, Ruben/AAC-1641-2022	Andringa, Ruben/0000-0003-3226-6463; de Kok, Niels/0000-0002-0306-892X; Driessen, Arnold J.M./0000-0001-9258-9104; Minnaard, Adriaan/0000-0002-5966-1300; Exterkate, Marten/0000-0003-2204-8008				Alcaraz ML, 1996, J ORG CHEM, V61, P192, DOI 10.1021/jo951350k; Arias-Cartin R, 2011, P NATL ACAD SCI USA, V108, P7781, DOI 10.1073/pnas.1010427108; Aspinall HC, 1997, TETRAHEDRON LETT, V38, P4679, DOI 10.1016/S0040-4039(97)00965-9; Ball WB, 2018, FEBS LETT, V592, P1273, DOI 10.1002/1873-3468.12887; Bogdanov Mikhail, 2008, V49, P197, DOI 10.1007/978-1-4020-8831-5_8; Caforio A, 2018, P NATL ACAD SCI USA, V115, P3704, DOI 10.1073/pnas.1721604115; Caforio A, 2017, BBA-MOL CELL BIOL L, V1862, P1325, DOI 10.1016/j.bbalip.2016.12.006; Corcelli A, 2007, BIOCHEM BIOPH RES CO, V354, P795, DOI 10.1016/j.bbrc.2007.01.060; Corcelli A, 2009, BBA-BIOMEMBRANES, V1788, P2101, DOI 10.1016/j.bbamem.2009.05.010; Dowhan W, 2008, N COMP BIOC, P1, DOI 10.1016/B978-044453219-0.50003-9; Exterkate M., 2019, ACS OMEGA, V4, P5293; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; Hidalgo-Ahumada CAP, 2018, ENVIRON MICROBIOL, V20, P4503, DOI 10.1111/1462-2920.14388; HIRAOKA S, 1993, FEBS LETT, V336, P221, DOI 10.1016/0014-5793(93)80807-7; Ikon N, 2017, BBA-BIOMEMBRANES, V1859, P1156, DOI 10.1016/j.bbamem.2017.03.013; Iwashita M, 2009, J MED CHEM, V52, P5837, DOI 10.1021/jm900598m; Jacob J, 1999, BIOPHYS J, V76, P1367, DOI 10.1016/S0006-3495(99)77298-X; Jain S, 2014, CHEM BIOL, V21, P1392, DOI 10.1016/j.chembiol.2014.07.022; Jeucken A, 2018, BBA-MOL CELL BIOL L, V1863, P1345, DOI 10.1016/j.bbalip.2018.06.017; Kawai F, 2004, J BACTERIOL, V186, P1475, DOI 10.1128/JB.186.5.1475-1483.2004; Keith DJ, 2019, J AM CHEM SOC, V141, P12939, DOI 10.1021/jacs.9b06830; Koga Y, 2007, MICROBIOL MOL BIOL R, V71, P97, DOI 10.1128/MMBR.00033-06; Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i; KUSHWAHA SC, 1981, BIOCHIM BIOPHYS ACTA, V664, P156, DOI 10.1016/0005-2760(81)90038-2; Lewis RNAH, 2009, BBA-BIOMEMBRANES, V1788, P2069, DOI 10.1016/j.bbamem.2009.03.014; Li CJ, 2016, J BIOL CHEM, V291, P25144, DOI 10.1074/jbc.M116.762070; Lobasso S, 2003, J LIPID RES, V44, P2120, DOI 10.1194/jlr.M300212-JLR200; Lopalco P, 2004, J LIPID RES, V45, P194, DOI 10.1194/jlr.M300329-JLR200; Luevano-Martinez LA, 2015, ARCH BIOCHEM BIOPHYS, V585, P90, DOI 10.1016/j.abb.2015.09.015; Matsumi R, 2011, RES MICROBIOL, V162, P39, DOI 10.1016/j.resmic.2010.10.003; Mileykovskaya E, 2000, J BACTERIOL, V182, P1172, DOI 10.1128/JB.182.4.1172-1175.2000; Mileykovskaya E, 2009, BBA-BIOMEMBRANES, V1788, P2084, DOI 10.1016/j.bbamem.2009.04.003; Musatov A, 2017, BIOCHIMIE, V142, P102, DOI 10.1016/j.biochi.2017.08.013; NISHIHARA M, 1987, J BIOCHEM-TOKYO, V101, P997, DOI 10.1093/oxfordjournals.jbchem.a121969; Noguchi F, 2016, MOL PHYLOGENET EVOL, V101, P133, DOI 10.1016/j.ympev.2016.05.011; Pereto J, 2004, TRENDS BIOCHEM SCI, V29, P469, DOI 10.1016/j.tibs.2004.07.002; Ponting CP, 1996, PROTEIN SCI, V5, P914; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Reinink P, 2019, J EXP MED, V216, P757, DOI 10.1084/jem.20181812; Romantsov T, 2018, MOL MICROBIOL, V107, P623, DOI 10.1111/mmi.13904; Romantsov T, 2009, BBA-BIOMEMBRANES, V1788, P2092, DOI 10.1016/j.bbamem.2009.06.010; Sandoval-Calderon M, 2009, J BIOL CHEM, V284, P17383, DOI 10.1074/jbc.M109.006072; Schaus SE, 2002, J AM CHEM SOC, V124, P1307, DOI 10.1021/ja016737l; Schlame M, 2017, BBA-MOL CELL BIOL L, V1862, P3, DOI 10.1016/j.bbalip.2016.08.010; Sciara G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5068; SHIBUYA I, 1985, J BACTERIOL, V161, P473, DOI 10.1128/JB.161.2.473-477.1985; SITA LR, 1993, J ORG CHEM, V58, P5285, DOI 10.1021/jo00071a049; Smith AB, 2002, ORG LETT, V4, P635, DOI 10.1021/ol017271e; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; Sprott GD, 2003, BBA-MOL CELL BIOL L, V1633, P179, DOI 10.1016/j.bbalip.2003.08.001; SPROTT GD, 1994, BBA-LIPID LIPID MET, V1214, P234, DOI 10.1016/0005-2760(94)90069-8; Sung'hwa F, 2006, CARBOHYD RES, V341, P846, DOI 10.1016/j.carres.2006.02.005; Tan BK, 2012, P NATL ACAD SCI USA, V109, P16504, DOI 10.1073/pnas.1212797109; Tian HF, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-32; Tropp BE, 1997, BBA-LIPID LIPID MET, V1348, P192, DOI 10.1016/S0005-2760(97)00100-8; Wood JM, 2018, CURR GENET, V64, P795, DOI 10.1007/s00294-018-0811-2; Yeh EAH, 2013, J AM CHEM SOC, V135, P1577, DOI 10.1021/ja311606u; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	58	4	4	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100691	10.1016/j.jbc.2021.100691	http://dx.doi.org/10.1016/j.jbc.2021.100691			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33894204	Green Published, gold			2022-12-28	WOS:000672866400662
J	Fukuda, K; Lu, F; Qin, J				Fukuda, Koichi; Lu, Fan; Qin, Jun			Molecular basis for Ras suppressor-1 binding to PINCH-1 in focal adhesion assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUCINE-RICH REPEAT; INTEGRIN ADHESOME; STRUCTURAL BASIS; PROTEINS; COMPLEX; ILK; LOCALIZATION; ACTIVATION; EXPRESSION; REGIONS	Ras suppressor-1 (Rsu-1) is a leucine-rich repeat (LRR)-containing protein that is crucial for regulating cell adhesion and is involved in such physiological and pathological processes as focal adhesion assembly and tumor metastasis. Rsu-1 interacts with zinc-finger type multi-LIM domain-containing adaptor protein PINCH-1, known to be involved in the integrin-mediated consensus adhesome, but not with its highly homologous family member PINCH-2. However, the structural basis for and regulatory mechanisms of this specific interaction remain unclear. Here, we determined the crystal structures of Rsu-1 and its complex with the PINCH-1 LIM4-5 domains. Rsu-1 displays an arc-shaped solenoid architecture, with eight LRRs shielded by N- and C-terminal capping modules. We showed that the conserved concave surface of the Rsu-1 LRR domain binds and stabilizes the PINCH-1 LIM5 domain via salt bridge and hydrophobic interactions, while the C-terminal non-LIM region of PINCH-2 sterically disfavors Rsu-1 binding. We also showed that Rsu-1 can be assembled, via PINCH-1-binding, into a heteropentamer complex comprising Rsu-1, PINCH-1, ILK, Parvin, and Kindlin-2, which constitute a major consensus integrin adhesome crucial for focal adhesion assembly. Our mutagenesis and cell biological data emphasize the significance of the Rsu-1/PINCH-1 interaction in focal adhesion assembly and cell spreading, providing crucial molecular insights into Rsu-1-mediated cell adhesion with implications for disease development.	[Fukuda, Koichi; Lu, Fan; Qin, Jun] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Lu, Fan; Qin, Jun] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Case Western Reserve University	Qin, J (corresponding author), Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA.; Qin, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA.	qinj@ccf.org			National Institutes of Health [5R01HL058758]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (5R01HL058758: J. Q.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Bellizzi JJ, 1999, STRUCTURE, V7, pR263, DOI 10.1016/S0969-2126(00)80020-9; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Chiswell BP, 2008, P NATL ACAD SCI USA, V105, P20677, DOI 10.1073/pnas.0811415106; Choy MS, 2019, P NATL ACAD SCI USA, V116, P20472, DOI 10.1073/pnas.1908718116; CUTLER ML, 1992, MOL CELL BIOL, V12, P3750, DOI 10.1128/MCB.12.9.3750; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dougherty GW, 2005, EXP CELL RES, V306, P168, DOI 10.1016/j.yexcr.2005.01.025; Elias MC, 2012, J CELL SCI, V125, P3185, DOI 10.1242/jcs.101386; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fan QR, 2005, NATURE, V433, P269, DOI 10.1038/nature03206; Favre B, 2001, J BIOL CHEM, V276, P32427, DOI 10.1074/jbc.M011005200; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fukuda K, 2014, J BIOL CHEM, V289, P28363, DOI 10.1074/jbc.M114.596692; Fukuda K, 2009, MOL CELL, V36, P819, DOI 10.1016/j.molcel.2009.11.028; Fukuda T, 2003, J BIOL CHEM, V278, P51324, DOI 10.1074/jbc.M309122200; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hamidi Hellyeh, 2018, Nat Rev Cancer, V18, P533, DOI 10.1038/s41568-018-0038-z; Heroes E, 2019, STRUCTURE, V27, P507, DOI 10.1016/j.str.2018.12.002; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Huizinga EG, 2002, SCIENCE, V297, P1176, DOI 10.1126/science.107355; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito S, 2010, MOL BIOL CELL, V21, P4120, DOI 10.1091/mbc.E10-05-0459; Kadrmas JL, 2004, J CELL BIOL, V167, P1019, DOI 10.1083/jcb.200408090; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kim YC, 2015, CELL ADHES MIGR, V9, P227, DOI 10.4161/19336918.2014.972775; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Masuelli L, 1996, MOL CELL BIOL, V16, P5466; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Miras I, 2015, ACTA CRYSTALLOGR D, V71, P1351, DOI 10.1107/S139900471500704X; Montanez E, 2012, J CELL SCI, V125, P5233, DOI 10.1242/jcs.112029; Morgan J, 2019, BLOOD ADV, V3, P1450, DOI 10.1182/bloodadvances.2018027011; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ng ACY, 2011, P NATL ACAD SCI USA, V108, P4631, DOI 10.1073/pnas.1000093107; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Peggie MW, 2002, J CELL SCI, V115, P195; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Pronovost SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003406; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sebe-Pedros A, 2010, P NATL ACAD SCI USA, V107, P10142, DOI 10.1073/pnas.1002257107; Seiradake E, 2011, EMBO J, V30, P4479, DOI 10.1038/emboj.2011.346; Sheldrick GM, 2010, ACTA CRYSTALLOGR D, V66, P479, DOI 10.1107/S0907444909038360; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Simpson KJ, 2008, NAT CELL BIOL, V10, P1027, DOI 10.1038/ncb1762; Tan S, 2001, ESCHERICHIA COLI PRO, V21, P224; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Varjosalo M, 2013, NAT METHODS, V10, P307, DOI [10.1038/NMETH.2400, 10.1038/nmeth.2400]; Vaynberg J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06906-7; Wiechmann S, 2020, J BIOL CHEM, V295, P4526, DOI 10.1074/jbc.RA119.011025; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858; Zhang YJ, 2002, J CELL SCI, V115, P4777, DOI 10.1242/jcs.00166; Zhang YJ, 2002, J BIOL CHEM, V277, P38328, DOI 10.1074/jbc.M205576200	68	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100685	10.1016/j.jbc.2021.100685	http://dx.doi.org/10.1016/j.jbc.2021.100685			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33891945	gold, Green Published			2022-12-28	WOS:000672866400656
J	Ghodke, PP; Mali, JR; Patra, A; Rizzo, CJ; Guengerich, FP; Egli, M				Ghodke, Pratibha P.; Mali, Jyotirling R.; Patra, Amritraj; Rizzo, Carmelo J.; Guengerich, F. Peter; Egli, Martin			Enzymatic bypass and the structural basis of miscoding opposite the DNA adduct 1,N-2-ethenodeoxyguanosine by human DNA translesion polymerase eta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ERROR-FREE BYPASS; Y-FAMILY; 1,N-2-ETHENOGUANINE; MECHANISM; SITE; 1,N2-ETHENODEOXYGUANOSINE; N2,3-ETHENOGUANINE; 1,N2-ETHENOGUANINE; OLIGONUCLEOTIDES; MISINCORPORATION	Etheno (epsilon)-adducts, e.g., 1,N-2-epsilon-guanine (1,N-2-epsilon-G) and 1,N-6-epsilon-adenine (1,N-6-epsilon-A), are formed through the reaction of DNA with metabolites of vinyl compounds or with lipid peroxidation products. These lesions are known to be mutagenic, but it is unknown how they lead to errors in DNA replication that are bypassed by DNA polymerases. Here we report the structural basis of misincorporation frequencies across from 1,N-2-epsilon-G by human DNA polymerase (hpol) eta. In single-nucleotide insertions opposite the adduct 1,N-2-epsilon-G, hpol. preferentially inserted dGTP, followed by dATP, dTTP, and dCTP. This preference for purines was also seen in the first extension step. Analysis of full-length extension products by LC-MS/MS revealed that G accounted for 85% of nucleotides inserted opposite 1,N-2-epsilon-G in single base insertion, and 63% of bases inserted in the first extension step. Extension from the correct nucleotide pair (C) was not observed, but the primer with A paired opposite 1,N-2-epsilon-G was readily extended. Crystal structures of ternary hpol. insertion-stage complexes with nonhydrolyzable nucleotides dAMPnPP or dCMPnPP showed a syn orientation of the adduct, with the incoming A staggered between adducted base and the 5'-adjacent T, while the incoming C and adducted base were roughly coplanar. The formation of a bifurcated H-bond between incoming dAMPnPP and 1,N-2-epsilon-G and T, compared with the single Hbond formed between incoming dCMPnPP and 1,N-2-epsilon-G, may account for the observed facilitated insertion of dGTP and dATP. Thus, preferential insertion of purines by hpol. across from etheno adducts contributes to distinct outcomes in errorprone DNA replication.	[Ghodke, Pratibha P.; Patra, Amritraj; Rizzo, Carmelo J.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA; [Mali, Jyotirling R.; Rizzo, Carmelo J.] Vanderbilt Univ, Dept Chem, Coll Arts & Sci, Nashville, TN USA; [Rizzo, Carmelo J.; Guengerich, F. Peter; Egli, Martin] Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University	Egli, M (corresponding author), Vanderbilt Univ, Sch Med, Dept Biochem, Nashville, TN 37212 USA.; Egli, M (corresponding author), Vanderbilt Ingram Canc Ctr, Nashville, TN 37232 USA.	martin.egli@vanderbilt.edu		Ghodke, Pratibha P./0000-0002-8402-3933	National Institutes of Health [R01 ES026955, R01 ES010546, P01 CA160032]; Vanderbilt-Ingram Cancer Center [P30 CA-068485]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES026955 (to F. P. G. and M. E.), R01 ES010546 (to F. P. G.), P01 CA160032 (to M. E. and C. J. R.), and Vanderbilt-Ingram Cancer Center (P30 CA-068485). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akasaka S, 1999, CHEM RES TOXICOL, V12, P501, DOI 10.1021/tx980259j; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barbin A, 2000, MUTAT RES, V462, P69; Bartsch H, 1997, EUR J CANCER PREV, V6, P529, DOI 10.1097/00008469-199712000-00007; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Boudsocq F, 2001, NUCLEIC ACIDS RES, V29, P4607, DOI 10.1093/nar/29.22.4607; Chen HJC, 2005, CHEM RES TOXICOL, V18, P1593, DOI 10.1021/tx050145p; Choi JY, 2006, CHEM RES TOXICOL, V19, P879, DOI 10.1021/tx060051v; Chowdhury Goutam, 2011, Curr Protoc Nucleic Acid Chem, VChapter 7, DOI 10.1002/0471142700.nc0716s47; Cruet-Hennequart S, 2010, SUBCELL BIOCHEM, V50, P189, DOI 10.1007/978-90-481-3471-7_10; Dechakhamphu S, 2008, CANCER EPIDEM BIOMAR, V17, P1658, DOI 10.1158/1055-9965.EPI-08-0191; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghodke PP, 2020, J BIOL CHEM, V295, P6092, DOI 10.1074/jbc.RA120.012829; Goodenough AK, 2005, CHEM RES TOXICOL, V18, P1701, DOI 10.1021/tx050141k; Guengerich F, 2018, MOL LIFE SCI ENCY RE, P379; Guengerich F. P, 2010, CHEM BIOL DNA DAMAGE, P299; GUENGERICH FP, 1993, CHEM RES TOXICOL, V6, P635, DOI 10.1021/tx00035a008; GUENGERICH FP, 1991, CHEM RES TOXICOL, V4, P168, DOI 10.1021/tx00020a008; HECHT SS, 1992, CHEM RES TOXICOL, V5, P706, DOI 10.1021/tx00029a018; Jahnz-Wechmann Z, 2016, FRONT CHEM, V4, DOI 10.3389/fchem.2016.00019; JANCARIK J, 1991, J APPL CRYSTALLOGR, V24, P409, DOI 10.1107/S0021889891004430; KRONBERG L, 1992, CHEM RES TOXICOL, V5, P852, DOI 10.1021/tx00030a019; Langouet S, 1998, BIOCHEMISTRY-US, V37, P5184, DOI 10.1021/bi972327r; Langouet S, 1997, BIOCHEMISTRY-US, V36, P6069, DOI 10.1021/bi962526v; Lee SH, 2005, CHEM RES TOXICOL, V18, P780, DOI 10.1021/tx0497088; Linhart KB, 2015, HEPATOL SURG NUTR, V4, P117, DOI 10.3978/j.issn.2304-3881.2015.01.14; Morinello EJ, 2001, CHEM RES TOXICOL, V14, P327, DOI 10.1021/tx0002076; Nair J, 1999, MUTAT RES-FUND MOL M, V424, P59, DOI 10.1016/S0027-5107(99)00008-1; Njuma OJ, 2019, J BIOL CHEM, V294, P10253, DOI 10.1074/jbc.RA119.008986; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; OTlaherty D K., 2016, CHEM SCI, V7, p4896 ; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patra A, 2016, J BIOL CHEM, V291, P24304, DOI 10.1074/jbc.M116.755462; Patra A, 2015, J BIOL CHEM, V290, P8028, DOI 10.1074/jbc.M115.637561; Patra A, 2016, CHEMBIOCHEM, V17, P2033, DOI 10.1002/cbic.201600420; Patra A, 2016, J BIOL CHEM, V291, P14134, DOI 10.1074/jbc.M116.732487; Patra A, 2015, J AM CHEM SOC, V137, P7011, DOI 10.1021/jacs.5b02701; Patra A, 2014, J BIOL CHEM, V289, P16867, DOI 10.1074/jbc.M114.551820; Petrova KV, 2007, CHEM RES TOXICOL, V20, P1685, DOI 10.1021/tx7001433; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Saparbaev M, 2002, J BIOL CHEM, V277, P26987, DOI 10.1074/jbc.M111100200; SATTSANGI PD, 1977, J ORG CHEM, V42, P3292, DOI 10.1021/jo00440a020; Shanmugam G, 2007, CHEM RES TOXICOL, V20, P1601, DOI 10.1021/tx7001788; Singer B., 1999, EXOCYCLIC DNA ADDUCT; SODUM RS, 1988, CANCER RES, V48, P320; Su Y, 2015, J BIOL CHEM, V290, P15921, DOI 10.1074/jbc.M115.653691; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; Vaisman A, 2017, CRIT REV BIOCHEM MOL, V52, P274, DOI 10.1080/10409238.2017.1291576; VanderVeen LA, 2005, BIOCHEMISTRY-US, V44, P5024, DOI 10.1021/bi0472898; Yang IY, 2003, J BIOL CHEM, V278, P13989, DOI 10.1074/jbc.M212535200; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zang H, 2006, J BIOL CHEM, V281, P2358, DOI 10.1074/jbc.M510889200; Zang H, 2005, J BIOL CHEM, V280, P29750, DOI 10.1074/jbc.M504756200	56	1	1	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100642	10.1016/j.jbc.2021.100642	http://dx.doi.org/10.1016/j.jbc.2021.100642			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839151	Green Published, gold			2022-12-28	WOS:000672866400613
J	Jaskolka, MC; Tarsio, M; Smardon, AM; Khan, MM; Kane, PM				Jaskolka, Michael C.; Tarsio, Maureen; Smardon, Anne M.; Khan, Md Murad; Kane, Patricia M.			Defining steps in RAVE-catalyzed V-ATPase assembly using purified RAVE and V-ATPase subcomplexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CRYSTAL-STRUCTURE; GLUCOSE; ASSOCIATION; COMPLEXES; CELLS	The vacuolar H+-ATPase (V-ATPase) is a highly conserved proton pump responsible for the acidification of intracellular organelles in virtually all eukaryotic cells. V-ATPases are regulated by the rapid and reversible disassembly of the peripheral V-1 domain from the integral membrane V-o domain, accompanied by release of the V-1 C subunit from both domains. Efficient reassembly of V-ATPases requires the Regulator of the H+-ATPase of Vacuoles and Endosomes (RAVE) complex in yeast. Although a number of pairwise interactions between RAVE and V-ATPase subunits have been mapped, the low endogenous levels of the RAVE complex and lethality of constitutive RAV1 overexpression have hindered biochemical characterization of the intact RAVE complex. We describe a novel inducible overexpression system that allows purification of native RAVE and RAVE-V1 complexes. Both purified RAVE and RAVE-V1 contain substoichiometric levels of subunit C. RAVE-V1 binds tightly to expressed subunit C in vitro, but binding of subunit C to RAVE alone is weak. Neither RAVE nor RAVE-V1 interacts with the N-terminal domain of V-o subunit Vph1 in vitro. RAVE-V1 complexes, like isolated V-1, have no MgATPase activity, suggesting that RAVE cannot reverse V1 inhibition generated by rotation of subunit H and entrapment of MgADP that occur upon disassembly. However, purified RAVE can accelerate reassembly of V-1 carrying a mutant subunit H incapable of inhibition with V-o complexes reconstituted into lipid nanodiscs, consistent with its catalytic activity in vivo. These results provide new insights into the possible order of events in V-ATPase reassembly and the roles of the RAVE complex in each event.	[Jaskolka, Michael C.; Tarsio, Maureen; Smardon, Anne M.; Khan, Md Murad; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	kanepm@upstate.edu		Khan, Md. Murad/0000-0002-7371-2995; Jaskolka, Michael/0000-0003-2341-0750	National Institutes of Health (NIH) [R01 GM127364]; NIH [R01 GM058600]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Institutes of Health (NIH) R01 GM127364 to P. M. K. Md. M. K. was supported by NIH R01 GM058600 to Stephan Wilkens. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Banerjee S, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00510; Bodzeta A, 2017, CELL REP, V20, P1348, DOI 10.1016/j.celrep.2017.07.040; Bowman EJ, 2004, J BIOL CHEM, V279, P33131, DOI 10.1074/jbc.M404638200; Brace EJ, 2006, EUKARYOT CELL, V5, P2104, DOI 10.1128/EC.00347-05; Breker M, 2014, NUCLEIC ACIDS RES, V42, pD726, DOI 10.1093/nar/gkt933; Cotter K, 2015, TRENDS BIOCHEM SCI, V40, P611, DOI 10.1016/j.tibs.2015.08.005; Couoh-Cardel S, 2015, J BIOL CHEM, V290, P27959, DOI 10.1074/jbc.M115.662494; Diab H, 2009, J BIOL CHEM, V284, P13316, DOI 10.1074/jbc.M900475200; Jaskolka MC, 2020, J BIOL CHEM, V295, P2259, DOI 10.1074/jbc.RA119.011522; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Liberman R, 2014, J BIOL CHEM, V289, P1355, DOI 10.1074/jbc.M113.524561; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; McGuire CM, 2018, J BIOL CHEM, V293, P9113, DOI 10.1074/jbc.RA117.001327; Oot RA, 2017, PROTEIN SCI, V26, P896, DOI 10.1002/pro.3147; Oot RA, 2016, EMBO J, V35, P1694, DOI 10.15252/embj.201593447; Oot RA, 2012, STRUCTURE, V20, P1881, DOI 10.1016/j.str.2012.08.020; Oot RA, 2012, J BIOL CHEM, V287, P13396, DOI 10.1074/jbc.M112.343962; Oot RA, 2010, J BIOL CHEM, V285, P24654, DOI 10.1074/jbc.M110.136960; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Rein J, 2008, AM J PHYSIOL-CELL PH, V294, pC56, DOI 10.1152/ajpcell.00041.2007; Roh SH, 2018, MOL CELL, V69, P993, DOI 10.1016/j.molcel.2018.02.006; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Seol JH, 2001, NAT CELL BIOL, V3, P384, DOI 10.1038/35070067; Sharma S, 2019, J BIOL CHEM, V294, P6439, DOI 10.1074/jbc.RA119.007577; Sharma S, 2018, J BIOL CHEM, V293, P10718, DOI 10.1074/jbc.RA118.002951; Sharma S, 2017, PROTEIN SCI, V26, P1070, DOI 10.1002/pro.3143; Smardon AM, 2002, J BIOL CHEM, V277, P13831, DOI 10.1074/jbc.M200682200; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Smardon AM, 2015, J BIOL CHEM, V290, P27511, DOI 10.1074/jbc.M115.667634; Smardon AM, 2014, MOL BIOL CELL, V25, P356, DOI 10.1091/mbc.E13-05-0231; Stransky LA, 2015, J BIOL CHEM, V290, P27360, DOI 10.1074/jbc.M115.659128; SUMNER JP, 1995, J BIOL CHEM, V270, P5649, DOI 10.1074/jbc.270.10.5649; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Vitavska O, 2003, J BIOL CHEM, V278, P18499, DOI 10.1074/jbc.M212844200; Vitayska O, 2005, J BIOL CHEM, V280, P1070; WEST RW, 1984, MOL CELL BIOL, V4, P2467, DOI 10.1128/MCB.4.11.2467; Zhang ZY, 2008, J BIOL CHEM, V283, P35983, DOI 10.1074/jbc.M805345200; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	40	4	4	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100703	10.1016/j.jbc.2021.100703	http://dx.doi.org/10.1016/j.jbc.2021.100703			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895134	gold, Green Published			2022-12-28	WOS:000672866400674
J	Krepl, M; Dendooven, T; Luisi, B; Sponer, J				Krepl, Miroslav; Dendooven, Tom; Luisi, Ben F.; Sponer, Jiri			MD simulations reveal the basis for dynamic assembly of Hfq-RNA complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; SIDE-CHAIN; STACKING; IDENTIFICATION; RECOGNITION; PARAMETERS; BACKBONE; NMR	The conserved protein Hfq is a key factor in the RNA-mediated control of gene expression in most known bacteria. The transient intermediates Hfq forms with RNA support intricate and robust regulatory networks. In Pseudomonas, Hfq recognizes repeats of adenine-purine-any nucleotide (ARN) in target mRNAs via its distal binding side, and together with the catabolite repression control (Crc) protein, assembles into a translation-repression complex. Earlier experiments yielded static, ensemble-averaged structures of the complex, but details of its interface dynamics and assembly pathway remained elusive. Using explicit solvent atomistic molecular dynamics simulations, we modeled the extensive dynamics of the Hfq-RNA interface and found implications for the assembly of the complex. We predict that syn/anti flips of the adenine nucleotides in each ARN repeat contribute to a dynamic recognition mechanism between the Hfq distal side and mRNA targets. We identify a previously unknown binding pocket that can accept any nucleotide and propose that it may serve as a 'status quo' staging point, providing nonspecific binding affinity, until Crc engages the Hfq-RNA binary complex. The dynamical components of the Hfq-RNA recognition can speed up screening of the pool of the surrounding RNAs, participate in rapid accommodation of the RNA on the protein surface, and facilitate competition among different RNAs. The register of Crc in the ternary assembly could be defined by the recognition of a guanine-specific base-phosphate interaction between the first and last ARN repeats of the bound RNA. This dynamic substrate recognition provides structural rationale for the stepwise assembly of multicomponent ribonucleoprotein complexes nucleated by Hfq-RNA binding.	[Krepl, Miroslav; Sponer, Jiri] Czech Acad Sci, Inst Biophys, Brno, Czech Republic; [Dendooven, Tom; Luisi, Ben F.] Univ Cambridge, Dept Biochem, Cambridge, England; [Dendooven, Tom] MRC LMB, Cambridge, England	Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Cambridge; MRC Laboratory Molecular Biology	Krepl, M (corresponding author), Czech Acad Sci, Inst Biophys, Brno, Czech Republic.	krepl@seznam.cz	Sponer, Jiri/D-9467-2012; Krepl, Miroslav/F-3868-2019	Dendooven, Tom/0000-0002-9847-0910; Sponer, Jiri/0000-0001-6558-6186; Krepl, Miroslav/0000-0002-9833-4281	Czech Science Foundation [20-16554S]; Praemium Academiae; AstraZeneca; Wellcome Trust [200873/Z/16/Z]	Czech Science Foundation(Grant Agency of the Czech Republic); Praemium Academiae(Czech Academy of Sciences); AstraZeneca(AstraZeneca); Wellcome Trust(Wellcome Trust)	This work was supported by the Czech Science Foundation [Grant number 20-16554S to M. K. and J. S.]; Praemium Academiae to J. S.; AstraZeneca studentship to T. D.; and Wellcome Trust Investigator award [Grant number 200873/Z/16/Z to B. F. L.].	Atakisi H, 2018, ACTA CRYSTALLOGR D, V74, P264, DOI 10.1107/S2059798318000207; Azam MS, 2018, NUCLEIC ACIDS RES, V46, P2585, DOI 10.1093/nar/gkx1286; Banas P, 2012, J CHEM THEORY COMPUT, V8, P2448, DOI 10.1021/ct3001238; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bergonzo C, 2015, RNA, V21, P1578, DOI 10.1261/rna.051102.115; Bergonzo C, 2014, J CHEM THEORY COMPUT, V10, P492, DOI 10.1021/ct400862k; Borisek J, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100633; Borkar AN, 2016, P NATL ACAD SCI USA, V113, P7171, DOI 10.1073/pnas.1521349113; Bottaro S, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar8521; Brennan RG, 2007, CURR OPIN MICROBIOL, V10, P125, DOI 10.1016/j.mib.2007.03.015; Campagne S, 2019, METHOD ENZYMOL, V614, P393, DOI 10.1016/bs.mie.2018.09.002; Casalino L, 2018, P NATL ACAD SCI USA, V115, P6584, DOI 10.1073/pnas.1802963115; Case I.Y.B-S.D.A, 2018, AMBER 18; Chou FC, 2013, NAT METHODS, V10, P74, DOI [10.1038/NMETH.2262, 10.1038/nmeth.2262]; Condon DE, 2015, J CHEM THEORY COMPUT, V11, P2729, DOI 10.1021/ct501025q; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Daubner GM, 2012, EMBO J, V31, P162, DOI 10.1038/emboj.2011.367; Fender A, 2010, GENE DEV, V24, P2621, DOI 10.1101/gad.591310; Ganser LR, 2019, NAT REV MOL CELL BIO, V20, P474, DOI 10.1038/s41580-019-0136-0; Gorecka KM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11900-8; Hoekzema M, 2019, EMBO J, V38, DOI 10.15252/embj.2018101199; Hopkins CW, 2015, J CHEM THEORY COMPUT, V11, P1864, DOI 10.1021/ct5010406; Horstmann N, 2012, NUCLEIC ACIDS RES, V40, P11023, DOI 10.1093/nar/gks809; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kligun E, 2015, RNA BIOL, V12, P720, DOI 10.1080/15476286.2015.1040977; Krepl M, 2015, J CHEM THEORY COMPUT, V11, P1220, DOI 10.1021/ct5008108; Krepl M, 2018, NUCLEIC ACIDS RES, V46, P6528, DOI 10.1093/nar/gky490; Krepl M, 2017, NUCLEIC ACIDS RES, V45, P8046, DOI 10.1093/nar/gkx418; Krepl M, 2016, NUCLEIC ACIDS RES, V44, P6452, DOI 10.1093/nar/gkw438; Kuhrova P, 2019, J CHEM THEORY COMPUT, V15, P3288, DOI 10.1021/acs.jctc.8b00955; Kuhrova P, 2016, J CHEM THEORY COMPUT, V12, P4534, DOI 10.1021/acs.jctc.6b00300; Kwiatkowska J, 2018, RNA, V24, P1761, DOI 10.1261/rna.067777.118; Le Grand S, 2013, COMPUT PHYS COMMUN, V184, P374, DOI 10.1016/j.cpc.2012.09.022; Link TM, 2009, P NATL ACAD SCI USA, V106, P19286, DOI 10.1073/pnas.0908744106; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Mikulecky P.J., 2004, NAT STRUCT MOL BIOL, V11, P1206; Milojevic T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064609; Mlynsky V, 2020, J CHEM THEORY COMPUT, V16, P3936, DOI 10.1021/acs.jctc.0c00228; Nerenberg PS, 2018, CURR OPIN STRUC BIOL, V49, P129, DOI 10.1016/j.sbi.2018.02.002; Nikulin A, 2005, ACTA CRYSTALLOGR D, V61, P141, DOI 10.1107/S0907444904030008; Noel JK, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004794; Palermo G, 2019, J STRUCT BIOL, V206, P267, DOI 10.1016/j.jsb.2019.03.004; Pei XY, 2019, ELIFE, V8, DOI 10.7554/eLife.43158; Richardson JS, 2008, RNA, V14, P465, DOI 10.1261/rna.657708; Ripin N, 2019, P NATL ACAD SCI USA, V116, P2935, DOI 10.1073/pnas.1808696116; Robinson KE, 2014, NUCLEIC ACIDS RES, V42, P2736, DOI 10.1093/nar/gkt1171; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Santiago-Frangos A, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1475; Santiago-Frangos A, 2016, P NATL ACAD SCI USA, V113, pE6089, DOI 10.1073/pnas.1613053113; Schulz EC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10085-8; Schumacher MA, 2002, EMBO J, V21, P3546, DOI 10.1093/emboj/cdf322; Sharma I\, 2017, SCI REP, V7; Sharma M, 2019, NUCLEIC ACIDS RES, V47, P10564, DOI 10.1093/nar/gkz877; Sonnleitner E, 2018, NUCLEIC ACIDS RES, V46, P1470, DOI 10.1093/nar/gkx1245; Sonnleitner E, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004440; Sonnleitner E, 2009, P NATL ACAD SCI USA, V106, P21866, DOI 10.1073/pnas.pnas.0910308106; Sponer J, 2006, CHEM-EUR J, V12, P2854, DOI 10.1002/chem.200501239; Sponer J, 1996, J PHYS CHEM-US, V100, P5590, DOI 10.1021/jp953306e; Sponer J, 2008, PHYS CHEM CHEM PHYS, V10, P2595, DOI 10.1039/b719370j; Sponer J, 2018, CHEM REV, V118, P4177, DOI 10.1021/acs.chemrev.7b00427; Sponer J, 2017, WIRES RNA, V8, DOI 10.1002/wrna.1405; Sponer J, 2013, BIOPOLYMERS, V99, P978, DOI 10.1002/bip.22322; Szabla R, 2016, J PHYS CHEM B, V120, P10635, DOI 10.1021/acs.jpcb.6b07551; Van den Bossche A, 2014, J PROTEOME RES, V13, P4446, DOI 10.1021/pr500796n; Vecerek B, 2005, RNA, V11, P976, DOI 10.1261/rna.2360205; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wagner EGH, 2013, RNA BIOL, V10, P619, DOI 10.4161/rna.24044; Wang LJ, 2015, NUCLEIC ACIDS RES, V43, P2400, DOI 10.1093/nar/gkv072; Wen B, 2017, PHYS CHEM CHEM PHYS, V19, P21152, DOI 10.1039/c7cp01044c; Wlodawer A, 2008, FEBS J, V275, P1, DOI 10.1111/j.1742-4658.2007.06178.x; WOLFF JA, 1991, J BACTERIOL, V173, P4700, DOI 10.1128/jb.173.15.4700-4706.1991; Zgarbova M, 2011, J CHEM THEORY COMPUT, V7, P2886, DOI 10.1021/ct200162x; Zirbel CL, 2009, NUCLEIC ACIDS RES, V37, P4898, DOI 10.1093/nar/gkp468	77	3	3	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100656	10.1016/j.jbc.2021.100656	http://dx.doi.org/10.1016/j.jbc.2021.100656			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857481	Green Published, gold			2022-12-28	WOS:000672866400627
J	Lebeau, PF; Platko, K; Byun, JH; Austin, RC				Lebeau, Paul F.; Platko, Khrystyna; Byun, Jae Hyun; Austin, Richard C.			Calcium as a reliable marker for the quantitative assessment of endoplasmic reticulum stress in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ER STRESS; BINDING CHAPERONES; GLYCOSYLATION; HOMEOSTASIS; INHIBITION; RETENTION; GRP78	Calcium (Ca2+) is an essential mineral of endoplasmic reticulum (ER) luminal biochemistry because of the Ca2+ dependence of ER-resident chaperones charged with folding de novo proteins that transit this cellular compartment. ER Ca2+ depletion reduces the ability of chaperones to properly fold the proteins entering the ER, thus leading to an accumulation of misfolded proteins and the onset of a state known as ER stress. However, not all conditions that cause ER stress do so in a manner dependent on ER Ca2+ depletion. Agents such as tunicamycin inhibit the glycosylation of de novo polypeptides, a key step in the maturation process of newly synthesized proteins. Despite this established effect of tunicamycin, our understanding of how such conditions modulate ER Ca2+ levels is still limited. In the present study, we report that a variety of ER stress-inducing agents that have not been known to directly alter ER Ca2+ homeostasis can also cause a marked reduction in ER Ca2+ levels. Consistent with these observations, protecting against ER stress using small chemical chaperones, such as 4-phenylbutyrate and tauroursodeoxycholic acid, also attenuated ER Ca2+ depletion caused by these agents. We also describe a novel highthroughput and low-cost assay for the rapid quantification of ER stress using ER Ca2+ levels as a surrogate marker. This report builds on our understanding of ER Ca2+ levels in the context of ER stress and also provides the scientific community with a new, reliable tool to study this important cellular process in vitro.	[Lebeau, Paul F.; Platko, Khrystyna; Byun, Jae Hyun; Austin, Richard C.] McMaster Univ, Dept Med, Div Nephrol, Res Inst St Joes Hamilton, Hamilton, ON, Canada; [Lebeau, Paul F.; Platko, Khrystyna; Byun, Jae Hyun; Austin, Richard C.] Hamilton Ctr Kidney Res, Hamilton, ON, Canada	McMaster University	Austin, RC (corresponding author), McMaster Univ, Dept Med, Div Nephrol, Res Inst St Joes Hamilton, Hamilton, ON, Canada.	austinr@taari.ca		Byun, Jae Hyun/0000-0002-1231-511X	Heart and Stroke Foundation of Canada [G-13-0003064, G-15-0009389]; Canadian Institutes of Health Research [74477, 173520]	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by research grants to R. C. A. from the Heart and Stroke Foundation of Canada (G-13-0003064, G-15-0009389) and the Canadian Institutes of Health Research (74477, 173520). R. C. A. is a career investigator of the Heart and Stroke Foundation of Ontario and holds the Amgen Canada Research Chair in the Division of Nephrology at St. Joseph's Healthcare and McMaster University.	Al-Harbi AL, 2011, PROCEEDINGS OF THE FOURTH INTERNATIONAL C* CONFERENCE ON COMPUTER SCIENCE AND SOFTWARE ENGINEERING 2011 (C3S2E '11), P1; Arnaudeau S, 2002, J BIOL CHEM, V277, P46696, DOI 10.1074/jbc.M202395200; Asahi J, 2010, LIFE SCI, V87, P431, DOI 10.1016/j.lfs.2010.08.007; Austin RC, 2009, ANTIOXID REDOX SIGN, V11, P2279, DOI [10.1089/ars.2009.2686, 10.1089/ARS.2009.2686]; Basseri S, 2009, J LIPID RES, V50, P2486, DOI 10.1194/jlr.M900216-JLR200; CALLEA F, 1992, LIVER, V12, P357; Chen Q, 2017, TRANSL RES, V190, P40, DOI 10.1016/j.trsl.2017.09.003; Chen WQ, 2014, NAT MED, V20, P184, DOI 10.1038/nm.3440; CHENG TC, 1994, BIOCHEM J, V301, P563, DOI 10.1042/bj3010563; Coe H, 2009, GEN PHYSIOL BIOPHYS, V28, pF96; Corbett EF, 1999, J BIOL CHEM, V274, P6203, DOI 10.1074/jbc.274.10.6203; Corbett EF, 2000, TRENDS BIOCHEM SCI, V25, P307, DOI 10.1016/S0968-0004(00)01588-7; Dai FY, 2017, P NATL ACAD SCI USA, V114, P3192, DOI 10.1073/pnas.1619588114; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Kang S, 2016, J BIOL CHEM, V291, P5185, DOI 10.1074/jbc.M115.705012; Krebs J, 2015, BIOCHEM BIOPH RES CO, V460, P114, DOI 10.1016/j.bbrc.2015.02.004; Lamb HK, 2006, J BIOL CHEM, V281, P8796, DOI 10.1074/jbc.M503964200; Larsen AH, 2001, BMC BIOCHEM, V2; Lebeau P, 2017, J BIOL CHEM, V292, P1510, DOI 10.1074/jbc.M116.744235; LI JK, 1992, J FERMENT BIOENG, V74, P104, DOI 10.1016/0922-338X(92)80010-G; Lin JY, 2017, NEOPLASIA, V19, P43, DOI 10.1016/j.neo.2016.11.007; Lin L, 2001, J BIOL CHEM, V276, P33893, DOI 10.1074/jbc.M105226200; Maity S, 2016, CELL REP, V16, P851, DOI 10.1016/j.celrep.2016.06.025; MERLIE JP, 1982, J BIOL CHEM, V257, P2694; Michalak M, 2002, CELL CALCIUM, V32, P269, DOI 10.1016/S0143416002001884; Mimnaugh EG, 2006, MOL CANCER RES, V4, P667, DOI 10.1158/1541-7786.MCR-06-0019; Oslowski CM, 2011, METHOD ENZYMOL, V490, P71, DOI 10.1016/B978-0-12-385114-7.00004-0; Paredes RM, 2008, METHODS, V46, P143, DOI 10.1016/j.ymeth.2008.09.025; Paris S, 2005, FEBS LETT, V579, P105, DOI 10.1016/j.febslet.2004.11.055; Platko K, 2019, MOL METAB, V27, P62, DOI 10.1016/j.molmet.2019.06.021; Prins D, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004069; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Ruiz A, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.31; Samali Afshin, 2010, Int J Cell Biol, V2010, P830307, DOI 10.1155/2010/830307; Sano R, 2013, BBA-MOL CELL RES, V1833, P3460, DOI 10.1016/j.bbamcr.2013.06.028; Santos CXC, 2009, ANTIOXID REDOX SIGN, V11, P2409, DOI 10.1089/ARS.2009.2625; Schauble N, 2012, EMBO J, V31, P3282, DOI 10.1038/emboj.2012.189; SUZUKI CK, 1991, J CELL BIOL, V114, P189, DOI 10.1083/jcb.114.2.189; Tharmalingam T, 2008, MOL BIOTECHNOL, V39, P167, DOI 10.1007/s12033-008-9045-8; Uppala JK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03940-1; Vitadello M, 2003, FASEB J, V17, P923, DOI 10.1096/fj.02-0644fje; Waning DL, 2015, NAT MED, V21, P1262, DOI 10.1038/nm.3961; Werstuck GH, 2001, J CLIN INVEST, V107, P1263, DOI 10.1172/JCI11596; Yamamoto WR, 2019, J BIOL CHEM, V294, P168, DOI 10.1074/jbc.RA118.005683; Yan Zhongyu, 2011, Open Neuroendocrinol J, V4, P136	47	7	7	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100779	10.1016/j.jbc.2021.100779	http://dx.doi.org/10.1016/j.jbc.2021.100779			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34000299	gold, Green Published			2022-12-28	WOS:000674717300001
J	Mercaldi, GF; Andrade, MD; Zanella, JD; Cordeiro, AT; Benedetti, CE				Mercaldi, Gustavo Fernando; Andrade, Maxuel de Oliveira; Zanella, Jackeline de Lima; Cordeiro, Artur Torres; Benedetti, Celso Eduardo			Molecular basis for diaryldiamine selectivity and competition with tRNA in a type 2 methionyl-tRNA synthetase from a Gram-negative bacterium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIBACTERIAL ACTIVITY; ISOLEUCYL ADENYLATES; XANTHOMONAS-CITRI; ANTIFUNGAL AGENT; STRUCTURAL BASIS; INHIBITORS; ANALOGS; RECOGNITION; BINDING; AMINOACYLATION	Gram-negative bacteria are responsible for a variety of human, animal, and plant diseases. The spread of multidrug-resistant Gram-negative bacteria poses a challenge to disease control and highlights the need for novel antimicrobials. Owing to their critical role in protein synthesis, aminoacyl-tRNA synthetases, including the methionyl-tRNA synthetases MetRS1 and MetRS2, are attractive drug targets. MetRS1 has long been exploited as a drug target in Gram-positive bacteria and protozoan parasites. However, MetRS1 inhibitors have limited action upon Gram-negative pathogens or on Gram-positive bacteria that produce MetRS2 enzymes. The underlying mechanism by which MetRS2 enzymes are insensitive to MetRS1 inhibitors is presently unknown. Herein, we report the first structures of MetRS2 from a multidrug-resistant Gram-negative bacterium in its ligand-free state and bound to its substrate or MetRS1 inhibitors. The structures reveal the binding mode of two diaryldiamine MetRS1 inhibitors that occupy the amino acid-binding site and a surrounding auxiliary pocket implicated in tRNA acceptor arm binding. The structural features associated with amino acid polymorphisms found in the methionine and auxiliary pockets reveal the molecular basis for diaryldiamine binding and selectivity between MetRS1 and MetRS2 enzymes. Moreover, we show that mutations in key polymorphic residues in the methionine and auxiliary pockets not only altered inhibitor binding affinity but also significantly reduced enzyme function. Our findings thus reinforce the tRNA acceptor arm binding site as a druggable pocket in class I aminoacyl-tRNA synthetases and provide a structural basis for optimization of MetRS2 inhibitors for the development of new antimicrobials against Gram-negative pathogens.	[Mercaldi, Gustavo Fernando; Andrade, Maxuel de Oliveira; Zanella, Jackeline de Lima; Cordeiro, Artur Torres; Benedetti, Celso Eduardo] Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil		Mercaldi, GF; Benedetti, CE (corresponding author), Brazilian Ctr Res Energy & Mat CNPEM, Brazilian Biosci Natl Lab LNBio, Campinas, SP, Brazil.	gustavo.mercaldi@lnbio.cnpem.br; celso.benedetti@lnbio.cnpem.br	Mercaldi, Gustavo Fernando/AGB-3253-2022	Mercaldi, Gustavo Fernando/0000-0003-1445-6060; cordeiro, artur/0000-0002-5676-2456	National Institutes of Health [R01NS118247, R21NS099654, R01CA177272]; National Science Foundation Graduate Research Fellowship [DGE-1762114]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This research was supported by the National Institutes of Health under grant nos. R01NS118247 (to D. L. S.), R21NS099654 (to D. L. S.), and R01CA177272 (to S. H. P.), and by a National Science Foundation Graduate Research Fellowship under grant no. DGE-1762114 (to I. I. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health and National Science Foundation.	Abe VY, 2016, MOL PLANT PATHOL, V17, P1223, DOI 10.1111/mpp.12359; Baker SJ, 2006, J MED CHEM, V49, P4447, DOI 10.1021/jm0603724; Brown JR, 2003, EMBO REP, V4, P692, DOI 10.1038/sj.embor.embor881; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Buckner FS, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02061-18; CASSIO D, 1971, EUR J BIOCHEM, V20, P283, DOI 10.1111/j.1432-1033.1971.tb01393.x; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho H.Y., 2017, 5GL7 PROT DAT BANK, V5GI, P7; Crepin T, 2004, BIOCHEMISTRY-US, V43, P2635, DOI 10.1021/bi0356247; Crepin T, 2003, J MOL BIOL, V332, P59, DOI 10.1016/S0022-2836(03)00917-3; Crepin T, 2002, BIOCHEMISTRY-US, V41, P13003, DOI 10.1021/bi026343m; Critchley IA, 2005, ANTIMICROB AGENTS CH, V49, P4247, DOI 10.1128/AAC.49.10.4247-4252.2005; Critchley IA, 2009, J ANTIMICROB CHEMOTH, V63, P954, DOI 10.1093/jac/dkp041; De Oliveira DMP, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00181-19; Devine WG, 2017, ACS INFECT DIS, V3, P225, DOI 10.1021/acsinfecdis.6b00202; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Faghih O, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.00999-17; Fang PF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7402; First EA, 2017, METHODS, V113, P3, DOI 10.1016/j.ymeth.2016.10.010; First EA, 2015, ANAL BIOCHEM, V483, P34, DOI 10.1016/j.ab.2015.04.032; Gentry DR, 2003, ANTIMICROB AGENTS CH, V47, P1784, DOI 10.1128/AAC.47.6.1784-1789.2003; Gholami D, 2018, IRAN J FISH SCI, V17, P162; Gomez MAR, 2020, RNA, V26, P910, DOI 10.1261/rna.071720.119; Green LS, 2009, ANTIMICROB AGENTS CH, V53, P86, DOI 10.1128/AAC.00275-08; Huang WL, 2017, BIOORG MED CHEM LETT, V27, P2702, DOI 10.1016/j.bmcl.2017.04.048; Huang WL, 2016, EUR J MED CHEM, V124, P1081, DOI 10.1016/j.ejmech.2016.10.024; Hurdle JG, 2005, ANTIMICROB AGENTS CH, V49, P4821, DOI 10.1128/AAC.49.12.4821-4833.2005; Jarvest RL, 2004, BIOORG MED CHEM LETT, V14, P3937, DOI 10.1016/j.bmcl.2004.05.070; Jarvest RL, 2003, BIOORG MED CHEM LETT, V13, P1265, DOI 10.1016/S0960-894X(03)00093-3; Jarvest RL, 2003, BIOORG MED CHEM LETT, V13, P665, DOI 10.1016/S0960-894X(02)01027-2; Jarvest RL, 2002, J MED CHEM, V45, P1959, DOI 10.1021/jm025502x; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim SE, 2005, BIOORG MED CHEM LETT, V15, P3389, DOI 10.1016/j.bmcl.2005.05.035; Koh C.Y., 2012, 4EGA PROT DAT BANK; Koh CY, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002775; Koh CY, 2012, STRUCTURE, V20, P1681, DOI 10.1016/j.str.2012.07.011; KOZAK M, 1983, MICROBIOL REV, V47, P1; Lee J, 1998, BIOORG MED CHEM LETT, V8, P3511, DOI 10.1016/S0960-894X(98)00642-8; Lee J, 2003, BIOORG MED CHEM LETT, V13, P1087, DOI 10.1016/S0960-894X(03)00020-9; Lee J, 2001, BIOORG MED CHEM LETT, V11, P961, DOI 10.1016/S0960-894X(01)00095-6; Li X., 2015, 4QRD PROT DAT BANK; Lv PC, 2012, CURR MED CHEM, V19, P3550, DOI 10.2174/092986712801323199; Mansfield J, 2012, MOL PLANT PATHOL, V13, P614, DOI 10.1111/j.1364-3703.2012.00804.x; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McElwain TF, 2017, REV SCI TECH OIE, V36, P423, DOI 10.20506/rst.36.2.2663; Mechulam Y, 1999, J MOL BIOL, V294, P1287, DOI 10.1006/jmbi.1999.3339; MEINNEL T, 1988, NUCLEIC ACIDS RES, V16, P8095, DOI 10.1093/nar/16.16.8095; Michaels SA, 2020, J ANTIMICROB CHEMOTH, V75, P1218, DOI 10.1093/jac/dkz567; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakama T, 2001, J BIOL CHEM, V276, P47387, DOI 10.1074/jbc.M109089200; Nakanishi K, 2005, NAT STRUCT MOL BIOL, V12, P931, DOI 10.1038/nsmb988; Nakanishi K., 2005, 2CSX PROT DAT BANK; Nakanishi K., 2005, 2CT8 PROT DAT BANK, V2; Nayak SU, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02760-16; Nureki O., 2000, 1QQT PROT DAT BANK, V1QQT; Ochsner UA, 2005, ANTIMICROB AGENTS CH, V49, P4253, DOI 10.1128/AAC.49.10.4253-4262.2005; Ojo KK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163641; Organization WH, 2017, PRIOR PATH GUID DISC; Palencia A., 2012, 4AQ7 PROT DAT BANK, V4A07; Palencia A, 2012, NAT STRUCT MOL BIOL, V19, P677, DOI 10.1038/nsmb.2317; Pham JS, 2014, INT J PARASITOL-DRUG, V4, P1, DOI 10.1016/j.ijpddr.2013.10.001; Ranade RM, 2015, ANTIMICROB AGENTS CH, V59, P7128, DOI 10.1128/AAC.01573-15; RICH A, 1976, ANNU REV BIOCHEM, V45, P805, DOI 10.1146/annurev.bi.45.070176.004105; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Robies S, 2017, CURR DRUG DISCOV TEC, V14, P156; Rock FL, 2007, SCIENCE, V316, P1759, DOI 10.1126/science.1142189; Ryan RP, 2011, NAT REV MICROBIOL, V9, P344, DOI 10.1038/nrmicro2558; Seattle Structural Genomics Center for Infectious Disease (SSGCID), 2016, 5K0S PROT DAT BANK; Serre L, 2001, J MOL BIOL, V306, P863, DOI 10.1006/jmbi.2001.4408; Shibata S, 2012, J MED CHEM, V55, P6342, DOI 10.1021/jm300303e; Shibata S, 2011, ANTIMICROB AGENTS CH, V55, P1982, DOI 10.1128/AAC.01796-10; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Silvian LF, 1999, SCIENCE, V285, P1074, DOI 10.1126/science.285.5430.1074; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tacconelli E, 2018, LANCET INFECT DIS, V18, P318, DOI [10.1016/S1473-3099(17)30753-3, 10.1016/s1473-3099(17)30753-3]; Timilsina S, 2020, NAT REV MICROBIOL, V18, P415, DOI 10.1038/s41579-020-0361-8; Torrie LS, 2017, ACS INFECT DIS, V3, P718, DOI 10.1021/acsinfecdis.7b00047; Van Boeckel TP, 2015, P NATL ACAD SCI USA, V112, P5649, DOI 10.1073/pnas.1503141112; Vondenhoff GHM, 2011, EUR J MED CHEM, V46, P5227, DOI 10.1016/j.ejmech.2011.08.049; Wang W, 2018, IUCRJ, V5, P478, DOI 10.1107/S2052252518008217; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419; Zhang Z, 2016, ACS INFECT DIS, V2, P399, DOI 10.1021/acsinfecdis.6b00036; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774	86	3	3	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100658	10.1016/j.jbc.2021.100658	http://dx.doi.org/10.1016/j.jbc.2021.100658			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33857480	gold, Green Published			2022-12-28	WOS:000672866400629
J	Portela, PC; Silva, MA; Teixeira, LR; Salgueiro, CA				Portela, Pilar C.; Silva, Marta A.; Teixeira, Liliana R.; Salgueiro, Carlos A.			A unique aromatic residue modulates the redox range of a periplasmic multiheme cytochrome from Geobacter metallireducens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SULFURREDUCENS; REDUCTION; PHYSIOLOGY; INSIGHTS; IRON; C(7)	Geobacter bacteria are able to transfer electrons to the exterior of the cell and reduce extracellular electron acceptors including toxic/radioactive metals and electrode surfaces, with potential applications in bioremediation or electricity harvesting. The triheme c-type cytochrome PpcA from Geobacter metallireducens plays a crucial role in bridging the electron transfer from the inner to the outer membrane, ensuring an effective extracellular electron transfer. This cytochrome shares 80% identity with PpcA from Geobacter sulfurreducens, but their redox properties are markedly different, thus determining the distinctive working redox potential ranges in the two bacteria. PpcA from G. metallireducens possesses two extra aromatic amino acids (Phe-6 and Trp-45) in its hydrophobic heme core, whereas PpcA from G. sulfurreducens has a leucine and a methionine in the equivalent positions. Given the different nature of these residues in the two cytochromes, we have hypothesized that the extra aromatic amino acids could be partially responsible for the observed functional differences. In this work, we have replaced Phe-6 and Trp-45 residues by their nonaromatic counterparts in PpcA from G. sulfurreducens. Using redox titrations followed by UV-visible and NMR spectroscopy we observed that residue Trp-45 shifted the redox potential range 33% toward that of PpcA from G. sulfurreducens, whereas Phe-6 produced a negligible effect. For the first time, it is shown that the inclusion of an aromatic residue at the heme core can modulate the working redox range in abundant periplasmic proteins, paving the way to engineer bacterial strains for optimal microbial bioelectrochemical applications.	[Portela, Pilar C.; Silva, Marta A.; Teixeira, Liliana R.; Salgueiro, Carlos A.] Univ NOVA Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO Requimte, Campus Caparica, Caparica, Portugal	Universidade Nova de Lisboa	Salgueiro, CA (corresponding author), Univ NOVA Lisboa, Fac Ciencias & Tecnol, Dept Quim, UCIBIO Requimte, Campus Caparica, Caparica, Portugal.	csalgueiro@fct.unl.pt	Salgueiro, Carlos/A-4522-2013	Salgueiro, Carlos/0000-0003-1136-809X; C. Portela, Pilar/0000-0003-1619-5036; Silva, Marta A./0000-0002-4994-5473	Fundacao para a Ciencia e Tecnologia (FCT, Portugal) [PTDC/BIA-BQM/31981/2017, 2020.04717.BD]; Applied Molecular Biosciences Unit-UCIBIO - FCT [UIDP/04378/2020, UIDB/04378/2020]; FCT-MCTES - FEDER through COMPETE 2020, Operational Program of Science and Innovation (Programa Operacional Ciencia e Inovacao) [ROTEIRO/0031/2013-PINFRA/22161/2016]; FCT-MCTES - FEDER through COMPETE 2020, Operational Regional Program of Lisbon (Programa Operacional Regional de Lisboa) [ROTEIRO/0031/2013-PINFRA/22161/2016]; FCT through Central Administration Program of Investement and Development Expenses (Programa de Investimentos e Despesas de Desenvolvimento da Administracao Central)	Fundacao para a Ciencia e Tecnologia (FCT, Portugal)(Portuguese Foundation for Science and Technology); Applied Molecular Biosciences Unit-UCIBIO - FCT(Portuguese Foundation for Science and Technology); FCT-MCTES - FEDER through COMPETE 2020, Operational Program of Science and Innovation (Programa Operacional Ciencia e Inovacao); FCT-MCTES - FEDER through COMPETE 2020, Operational Regional Program of Lisbon (Programa Operacional Regional de Lisboa); FCT through Central Administration Program of Investement and Development Expenses (Programa de Investimentos e Despesas de Desenvolvimento da Administracao Central)	This work was supported by Fundacao para a Ciencia e Tecnologia (FCT, Portugal) through the following grants: PTDC/BIA-BQM/31981/2017 (to C. A. S.) and 2020.04717.BD (to P. C. P.). This work was also supported by the Applied Molecular Biosciences Unit-UCIBIO, which is financed by national funds from FCT (UIDP/04378/2020 and UIDB/04378/2020). The NMR spectrometers at FCT NOVA are part of the National NMR Network (Portuguese Nuclear Magnetic Resonance Network) and are supported by FCT-MCTES (ROTEIRO/0031/2013-PINFRA/22161/2016) cofunded by FEDER through COMPETE 2020, Operational Program of Science and Innovation (Programa Operacional Ciencia e Inovacao), and Operational Regional Program of Lisbon (Programa Operacional Regional de Lisboa) and FCT through Central Administration Program of Investement and Development Expenses (Programa de Investimentos e Despesas de Desenvolvimento da Administracao Central).	Aklujkar M, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-109; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bender K. S., 2014, BROCK BIOL MICROORGA; Butler JE, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-40; Dantas JM, 2019, J PHYS CHEM B, V123, P3050, DOI 10.1021/acs.jpcb.9b01214; Dantas JM, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00752; Fernandes TM, 2018, BIOCHEM J, V475, P2861, DOI 10.1042/BCJ20180457; Ferreira MR, 2018, FEBS OPEN BIO, V8, P1897, DOI 10.1002/2211-5463.12505; Levar CE, 2014, MBIO, V5, DOI 10.1128/mBio.02034-14; Liu GF, 2013, APPL MICROBIOL BIOT, V97, P7935, DOI 10.1007/s00253-012-4545-7; Liu YM, 2014, ENV MICROBIOL REP, V6, P776, DOI 10.1111/1758-2229.12204; Lloyd JR, 2000, APPL ENVIRON MICROB, V66, P3743, DOI 10.1128/AEM.66.9.3743-3749.2000; Londer YY, 2002, BBA-BIOENERGETICS, V1554, P202, DOI 10.1016/S0005-2728(02)00244-X; Lovley DR, 2011, ADV MICROB PHYSIOL, V59, P1, DOI 10.1016/B978-0-12-387661-4.00004-5; LOVLEY DR, 1995, ADV AGRON, V54, P175, DOI 10.1016/S0065-2113(08)60900-1; LOVLEY DR, 1986, APPL ENVIRON MICROB, V51, P683, DOI 10.1128/AEM.51.4.683-689.1986; Morgado L, 2008, BBA-BIOENERGETICS, V1777, P1157, DOI 10.1016/j.bbabio.2008.04.043; Morgado L, 2010, BIOPHYS J, V99, P293, DOI 10.1016/j.bpj.2010.04.017; Ortiz-Bernad I, 2004, APPL ENVIRON MICROB, V70, P3091, DOI 10.1128/AEM.70.5.3091-3095.2004; Pawluk A, 2019, CELL, V177, P16, DOI 10.1016/j.cell.2019.02.047; Pessanha M, 2004, BIOCHEMISTRY-US, V43, P9909, DOI 10.1021/bi0492859; Pessanha M, 2006, BIOCHEMISTRY-US, V45, P13910, DOI 10.1021/bi061394v; Portela PC, 2018, ARCH BIOCHEM BIOPHYS, V644, P8, DOI 10.1016/j.abb.2018.02.017; Reguera G, 2019, ADV MICROB PHYSIOL, V74, P1, DOI 10.1016/bs.ampbs.2019.02.007; Salgueiro CA., 2016, MULTIHEME CYTOCHROME, P1, DOI DOI 10.1007/978-3-642-44961-1_1; Santoro C, 2017, J POWER SOURCES, V356, P225, DOI 10.1016/j.jpowsour.2017.03.109; Schumann FH, 2007, J BIOMOL NMR, V39, P275, DOI 10.1007/s10858-007-9197-z; Tan Y, 2017, MBIO, V8, DOI 10.1128/mBio.02203-16; Tremblay PL, 2012, ENV MICROBIOL REP, V4, P82, DOI 10.1111/j.1758-2229.2011.00305.x; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Yalcin SE, 2020, NAT CHEM BIOL, V16, P1136, DOI 10.1038/s41589-020-0623-9; Zacharoff L, 2016, BIOELECTROCHEMISTRY, V107, P7, DOI 10.1016/j.bioelechem.2015.08.003	32	0	0	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100711	10.1016/j.jbc.2021.100711	http://dx.doi.org/10.1016/j.jbc.2021.100711			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33915126	gold, Green Published			2022-12-28	WOS:000672866400682
J	Struwe, MA; Kalimuthu, P; Luo, ZY; Zhong, QF; Ellis, D; Yang, J; Khadanand, KC; Harmer, JR; Kirk, ML; McEwan, AG; Clement, B; Bernhardt, PV; Kobe, B; Kappler, U				Struwe, Michel A.; Kalimuthu, Palraj; Luo, Zhenyao; Zhong, Qifeng; Ellis, Daniel; Yang, Jing; Khadanand, K. C.; Harmer, Jeffrey R.; Kirk, Martin L.; McEwan, Alastair G.; Clement, Bernd; Bernhardt, Paul, V; Kobe, Bostjan; Kappler, Ulrike			Active site architecture reveals coordination sphere flexibility and specificity determinants in a group of closely related molybdoenzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIMETHYL-SULFOXIDE REDUCTASE; N-OXIDE REDUCTASE; DENSITY-FUNCTIONAL CALCULATIONS; ORDER REGULAR APPROXIMATION; SULFITE-OXIDIZING ENZYMES; RHODOBACTER-CAPSULATUS; DIMETHYLSULFOXIDE REDUCTASE; CRYSTAL-STRUCTURE; DMSO REDUCTASE; HAEMOPHILUS-INFLUENZAE	MtsZ is a molybdenum-containing methionine sulfoxide reductase that supports virulence in the human respiratory pathogen Haemophilus influenzae (Hi). HiMtsZ belongs to a group of structurally and spectroscopically uncharacterized S-/N-oxide reductases, all of which are found in bacterial pathogens. Here, we have solved the crystal structure of HiMtsZ, which reveals that the HiMtsZ substrate-binding site encompasses a previously unrecognized part that accommodates the methionine sulfoxide side chain via interaction with His182 and Arg166. Charge and amino acid composition of this side chain-binding region vary and, as indicated by electrochemical, kinetic, and docking studies, could explain the diverse substrate specificity seen in closely related enzymes of this type. The HiMtsZ Mo active site has an underlying structural flexibility, where dissociation of the central Ser187 ligand affected catalysis at low pH. Unexpectedly, the two main HiMtsZ electron paramagnetic resonance (EPR) species resembled not only a related dimethyl sulfoxide reductase but also a structurally unrelated nitrate reductase that possesses an Asp-Mo ligand. This suggests that contrary to current views, the geometry of the Mo center and its primary ligands, rather than the specific amino acid environment, is the main determinant of the EPR properties of mononuclear Mo enzymes. The flexibility in the electronic structure of the Mo centers is also apparent in two of three HiMtsZ EPR-active Mo(V) species being catalytically incompetent off-pathway forms that could not be fully oxidized.	[Struwe, Michel A.; Luo, Zhenyao; Zhong, Qifeng; Ellis, Daniel; McEwan, Alastair G.; Kobe, Bostjan; Kappler, Ulrike] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Struwe, Michel A.; Clement, Bernd] Christian Albrechts Univ Kiel, Pharmazeut Inst, Kiel, Germany; [Kalimuthu, Palraj; Bernhardt, Paul, V] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Luo, Zhenyao; Kirk, Martin L.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Yang, Jing; Khadanand, K. C.] Univ New Mexico, Dept Chem & Chem Biol, Albuquerque, NM 87131 USA; [Harmer, Jeffrey R.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia; [Struwe, Michel A.] Christian Albrechts Univ Kiel, Zool Inst, Strukturbiol, D-24118 Kiel, Germany	University of Queensland; University of Kiel; University of Queensland; University of Queensland; University of New Mexico; University of Queensland; University of Kiel	Kappler, U (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld, Australia.	u.kappler@uq.edu.au	Kappler, Ulrike/A-9483-2013; Ellis, Daniel/GWN-0700-2022	Kappler, Ulrike/0000-0002-2642-1319; Zhong, Qifeng/0000-0002-6664-3581; Struwe, Michel/0000-0001-6931-1841; Ellis, Daniel/0000-0002-6934-4923	Australian Research Council [DP190103158, FL180100109]; National Health and Medical Research Council [GNT1158451, 1180826]; National Institutes of Health [R01-GM057378]; Studienstiftung des Deutschen Volkes; Bayer Science and Education Foundation	Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Studienstiftung des Deutschen Volkes; Bayer Science and Education Foundation	This work was supported by Australian Research Council Discovery Grant DP190103158 to P. V. B., National Health and Medical Research Council Project Grant GNT1158451 to U. K. and A. G. M., and National Health and Medical Research Council Ideas Grant 1180826 to B. K. B. K. is an Australian Research Council Laureate Fellow (FL180100109). M. L. K. acknowledges the National Institutes of Health (R01-GM057378) for continued financial support. M. A. S. is a recipient of a scholarship funded by the Studienstiftung des Deutschen Volkes and received a travel grant from the Bayer Science and Education Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABO M, 1994, BIOSCI BIOTECH BIOCH, V58, P596, DOI 10.1271/bbb.58.596; Adams B, 1999, BIOCHEMISTRY-US, V38, P8501, DOI 10.1021/bi9902034; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Assmann G, 2016, J APPL CRYSTALLOGR, V49, P1021, DOI 10.1107/S1600576716005471; Ausubet F. M., 2003, CURRENT PROTOCOLS MO, V2003; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bard A.J., 2006, ELECTROCHEMICAL METH; BASTIAN NR, 1991, J BIOL CHEM, V266, P45; BENNETT B, 1994, EUR J BIOCHEM, V225, P321, DOI 10.1111/j.1432-1033.1994.00321.x; BENSON N, 1992, FEBS LETT, V307, P169, DOI 10.1016/0014-5793(92)80760-E; Bentley R, 2005, BIOCHEM MOL BIOL EDU, V33, P274, DOI 10.1002/bmb.2005.49403304274; Bernhardt PV, 2006, J BIOL INORG CHEM, V11, P930, DOI 10.1007/s00775-006-0148-z; BERNHARDT PV, 1991, INORG CHEM, V30, P942, DOI 10.1021/ic00005a013; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Cobb N, 2005, J BIOL CHEM, V280, P11007, DOI 10.1074/jbc.M412050200; Czjzek M, 1998, J MOL BIOL, V284, P435, DOI 10.1006/jmbi.1998.2156; Denkel LA, 2013, MICROBIOL-SGM, V159, P1447, DOI 10.1099/mic.0.067256-0; Dhouib R, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01743; Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dos Santos JP, 1998, J MOL BIOL, V284, P421, DOI 10.1006/jmbi.1998.2155; Emesh S, 2009, BIOCHEMISTRY-US, V48, P2156, DOI 10.1021/bi801553q; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Enemark JH, 2006, DALTON T, P3501, DOI 10.1039/b602919a; Ezraty B, 2005, J BACTERIOL, V187, P231, DOI 10.1128/JB.187.1.231-237.2005; Farne H, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00432; FINNEGAN MG, 1993, INORG CHEM, V32, P2616, DOI 10.1021/ic00064a005; Friesner RA, 2006, J MED CHEM, V49, P6177, DOI 10.1021/jm051256o; Gennaris A, 2015, NATURE, V528, P409, DOI 10.1038/nature15764; George GN, 1996, J AM CHEM SOC, V118, P1113, DOI 10.1021/ja953317l; George GN, 1999, J AM CHEM SOC, V121, P1256, DOI 10.1021/ja982843k; Gon S, 2000, J BACTERIOL, V182, P5779, DOI 10.1128/JB.182.20.5779-5786.2000; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; He FMC, 2017, J BIOL INORG CHEM, V22, P775, DOI 10.1007/s00775-016-1427-y; Hille R, 2014, CHEM REV, V114, P3963, DOI 10.1021/cr400443z; Hilton JC, 1999, J BIOL CHEM, V274, P8428, DOI 10.1074/jbc.274.13.8428; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Holm Liisa, 2006, Curr Protoc Bioinformatics, VChapter 5, DOI 10.1002/0471250953.bi0505s14; Ingersol LJ, 2020, J AM CHEM SOC, V142, P2721, DOI 10.1021/jacs.9b11762; IobbiNivol C, 1996, BBA-PROTEIN STRUCT M, V1294, P77, DOI 10.1016/0167-4838(95)00271-5; Johnson KE, 2001, J BIOL CHEM, V276, P13178, DOI 10.1074/jbc.M010965200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kalimuthu P, 2017, CHEMELECTROCHEM, V4, P947; Kalimuthu P, 2015, J PHYS CHEM B, V119, P3456, DOI 10.1021/jp512562k; Kalimuthu P, 2014, BBA-BIOENERGETICS, V1837, P112, DOI 10.1016/j.bbabio.2013.07.010; Kappler U, 2005, J BIOL CHEM, V280, P24999, DOI 10.1074/jbc.M503237200; Kappler U, 2019, ADV MICROB PHYSIOL, V75, P1, DOI 10.1016/bs.ampbs.2019.05.001; Kappler U, 2014, METAL IONS LIFE SCI, V14, P279, DOI 10.1007/978-94-017-9269-1_11; Kaufmann P, 2018, BIOCHEMISTRY-US, V57, P1130, DOI 10.1021/acs.biochem.7b01108; King P, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-10; Kirk Martin L, 2020, Met Ions Life Sci, V20, DOI 10.1515/9783110589757-015; Kirk ML, 2017, RSC METALLOBIO SER, V7, P13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lansbury L, 2020, J INFECTION, V81, P266, DOI 10.1016/j.jinf.2020.05.046; Larosa V, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20171492; Li HK, 2000, J AM CHEM SOC, V122, P7673, DOI 10.1021/ja000643e; Long F, 2008, ACTA CRYSTALLOGR D, V64, P125, DOI 10.1107/S0907444907050172; Loschi L, 2004, J BIOL CHEM, V279, P50391, DOI 10.1074/jbc.M408876200; Magalon A, 1998, BIOCHEMISTRY-US, V37, P7363, DOI 10.1021/bi972858f; Maia LB, 2016, J AM CHEM SOC, V138, P8834, DOI 10.1021/jacs.6b03941; Miralles-Robledillo JM, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133349; McAlpine AS, 1997, J BIOL INORG CHEM, V2, P690, DOI 10.1007/s007750050185; MCEWAN AG, 1991, BIOCHEM J, V274, P305, DOI 10.1042/bj2740305; MELVILLE DB, 1954, J BIOL CHEM, V208, P503; MELVILLE DB, 1954, J BIOL CHEM, V208, P495; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mtei RP, 2011, J AM CHEM SOC, V133, P9762, DOI 10.1021/ja109178q; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; Pollock V. V, 2005, DENITRIFCANS ARCH BI, V318, P322; Pollock VV, 2000, J BIOL CHEM, V275, P35086, DOI 10.1074/jbc.M006872200; Pollock VV, 1997, J BIOL CHEM, V272, P3355, DOI 10.1074/jbc.272.6.3355; Rendon J, 2017, INORG CHEM, V56, P4422, DOI 10.1021/acs.inorgchem.6b03129; Ridge JP, 2002, BIOCHEMISTRY-US, V41, P15762, DOI 10.1021/bi0266582; Roman F, 2004, J CLIN MICROBIOL, V42, P1450, DOI 10.1128/JCM.42.4.1450-1459.2004; Rothery RA, 2008, BBA-BIOMEMBRANES, V1778, P1897, DOI 10.1016/j.bbamem.2007.09.002; Rothery RA, 2012, P NATL ACAD SCI USA, V109, P14773, DOI 10.1073/pnas.1200671109; Sastry GM, 2013, J COMPUT AID MOL DES, V27, P221, DOI 10.1007/s10822-013-9644-8; Schindelin H, 1996, SCIENCE, V272, P1615, DOI 10.1126/science.272.5268.1615; Schneider F, 1996, J MOL BIOL, V263, P53, DOI 10.1006/jmbi.1996.0555; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Temple CA, 2000, BIOCHEMISTRY-US, V39, P4046, DOI 10.1021/bi9921541; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P61, DOI 10.1107/S090744490705024X; Van Eldere J, 2014, LANCET INFECT DIS, V14, P1281, DOI 10.1016/S1473-3099(14)70734-0; van Lenthe E, 1998, J CHEM PHYS, V108, P4783, DOI 10.1063/1.475889; vanLenthe E, 1997, J CHEM PHYS, V107, P2488, DOI 10.1063/1.474590; VINCENT SP, 1978, BIOCHEM J, V171, P639, DOI 10.1042/bj1710639; WATANABE T, 1982, J PHYS CHEM-US, V86, P2617, DOI 10.1021/j100211a014; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; Wootton DG, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38090-5; Zhong QF, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.615860	91	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100672	10.1016/j.jbc.2021.100672	http://dx.doi.org/10.1016/j.jbc.2021.100672			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33887324	gold, Green Published			2022-12-28	WOS:000672866400643
J	Zhekova, HR; Pushkin, A; Kayik, G; Kao, LY; Azimov, R; Abuladze, N; Kurtz, D; Damergi, M; Noskov, SY; Kurtz, I				Zhekova, Hristina R.; Pushkin, Alexander; Kayik, Gulru; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Kurtz, Debra; Damergi, Mirna; Noskov, Sergei Yu; Kurtz, Ira			Identification of multiple substrate binding sites in SLC4 transporters in the outward-facing conformation: Insights into the transport mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Solute carrier family 4 (SLC4) transporters mediate the transmembrane transport of HCO3-, CO32-, and Cl- necessary for pH regulation, transepithelial H+/base transport, and ion homeostasis. Substrate transport with varying stoichiometry and specificity is achieved through an exchange mechanism and/or through coupling of the uptake of anionic substrates to typically co-transported Na+. Recently solved outward-facing structures of two SLC4 members (human anion exchanger 1 [hAE1] and human electrogenic sodium bicarbonate cotransporter 1 [hNBCe1]) with different transport modes (Cl-/HCO3- exchange versus Na+-CO32- symport) revealed highly conserved three-dimensional organization of their transmembrane domains. However, the exact location of the ion binding sites and their protein-ion coordination motifs are still unclear. In the present work, we combined site identification by ligand competitive saturation mapping and extensive molecular dynamics sampling with functional mutagenesis studies which led to the identification of two substrate binding sites (entry and central) in the outward-facing states of hAE1 and hNBCe1. Mutation of residues in the identified binding sites led to impaired transport in both proteins. We also showed that R730 in hAE1 is crucial for anion binding in both entry and central sites, whereas in hNBCe1, a Na+ acts as an anchor for CO32- binding to the central site. Additionally, protonation of the central acidic residues (E681 in hAE1 and D754 in hNBCe1) alters the ion dynamics in the permeation cavity and may contribute to the transport mode differences in SLC4 proteins. These results provide a basis for understanding the functional differences between hAE1 and hNBCe1 and may facilitate potential drug development for diseases such as proximal and distal renal tubular acidosis.	[Zhekova, Hristina R.; Kayik, Gulru; Damergi, Mirna; Noskov, Sergei Yu] Univ Calgary, Ctr Mol Simulat, Dept Biol Sci, Calgary, AB, Canada; [Pushkin, Alexander; Kao, Liyo; Azimov, Rustam; Abuladze, Natalia; Kurtz, Debra; Kurtz, Ira] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90095 USA; [Kurtz, Ira] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Noskov, SY (corresponding author), Univ Calgary, Ctr Mol Simulat, Dept Biol Sci, Calgary, AB, Canada.; Kurtz, I (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Nephrol, Los Angeles, CA 90095 USA.; Kurtz, I (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	snoskov@ucalgary.ca; ikurtz@mednet.ucla.edu		Zhekova, Hristina/0000-0002-7022-2034; Noskov, Sergei/0000-0001-7769-335X	NIH [R01 DK077162]; Allan Smidt Charitable Fund; Ralph Block Family Foundation; Kleeman Family Fund; Factor Family Foundation; Alberta Innovates Health Solution Post-Doctoral Fellowship; Canada Foundation for Innovation; West-Grid/Compute Canada clusters	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Allan Smidt Charitable Fund; Ralph Block Family Foundation; Kleeman Family Fund; Factor Family Foundation; Alberta Innovates Health Solution Post-Doctoral Fellowship; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); West-Grid/Compute Canada clusters	I. K. was supported by funds from the NIH (R01 DK077162), the Allan Smidt Charitable Fund, the Ralph Block Family Foundation, the Kleeman Family Fund, and the Factor Family Foundation. H. Z. was supported by the Alberta Innovates Health Solution Post-Doctoral Fellowship and NIH (R01 DK077162). MD simulations were performed on the Canada Foundation for Innovation supported GladOS cluster at the University of Calgary and on the West-Grid/Compute Canada clusters under Research Allocation Award to S. Y. N. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100724	10.1016/j.jbc.2021.100724	http://dx.doi.org/10.1016/j.jbc.2021.100724			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33932403	Green Published, gold			2022-12-28	WOS:000672866400694
J	Ambroggio, EE; Navarro, GSC; Socas, LBP; Bagatolli, LA; Gamarnik, AV				Ambroggio, Ernesto E.; Costa Navarro, Guadalupe S.; Perez Socas, Luis Benito; Bagatolli, Luis A.; Gamarnik, Andrea, V			Dengue and Zika virus capsid proteins bind to membranes and self-assemble into liquid droplets with nucleic acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROBE	Dengue virus (DENV) and Zika virus (ZIKV) capsid proteins efficiently recruit and surround the viral RNA at the endoplasmic reticulum (ER) membrane to yield nascent viral particles. However, little is known either about the molecular mechanisms by which multiple copies of capsid proteins assemble into nucleocapsids (NCs) or how the NC is recruited and wrapped by the ER membrane during particle morphogenesis. Here, we measured relevant interactions concerning this viral process using purified DENV and ZIKV capsid proteins, membranes mimicking the ER lipid composition, and nucleic acids in in vitro conditions to understand the biophysical properties of the RNA genome encapsidation process. We found that both ZIKV and DENV capsid proteins bound to liposomes at liquid-disordered phase regions, docked exogenous membranes, and RNA molecules. Liquid-liquid phase separation is prone to occur when positively charged proteins interact with nucleic acids, which is indeed the case for the studied capsids. We characterized these liquid condensates by measuring nucleic acid partition constants and the extent of water dipolar relaxation, observing a cooperative process for the formation of the new phase that involves a distinct water organization. Our data support a new model in which capsid-RNA complexes directly bind the ER membrane, seeding the process of RNA recruitment for viral particle assembly. These results contribute to our understanding of the viral NC formation as a stable liquid-liquid phase transition, which could be relevant for dengue and Zika gemmation, opening new avenues for antiviral intervention.	[Ambroggio, Ernesto E.; Perez Socas, Luis Benito] Univ Nacl Cordoba, CONICET, CIQUIBIC, Dept Quim Biol Ranwel Caputto,Fac Ciencias Quim, Cordoba, Argentina; [Costa Navarro, Guadalupe S.; Gamarnik, Andrea, V] Fdn Inst Leloir CONICET, Buenos Aires, DF, Argentina; [Bagatolli, Luis A.] INIMEC CONICET, Inst Invest Med Mercedes & Martin Ferreyra, Cordoba, Argentina; [Bagatolli, Luis A.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba	Ambroggio, EE (corresponding author), Univ Nacl Cordoba, CONICET, CIQUIBIC, Dept Quim Biol Ranwel Caputto,Fac Ciencias Quim, Cordoba, Argentina.; Gamarnik, AV (corresponding author), Fdn Inst Leloir CONICET, Buenos Aires, DF, Argentina.	eambroggio@unc.edu.ar; agamarnik@leloir.org.ar		Socas, Luis/0000-0003-2392-4663; Costa Navarro, Guadalupe Soledad/0000-0002-4051-4749	National Agency for Research and Innovation of Argentina from National Institute of Allergy and Infectious Diseases, National Institutes of Health [PICT-2015-2575, PICT-2018-3204, PICT-2019-02869, R01.AI095175]; CONICET	National Agency for Research and Innovation of Argentina from National Institute of Allergy and Infectious Diseases, National Institutes of Health; CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET))	This work was supported by grants from the National Agency for Research and Innovation of Argentina PICT-2015-2575 and PICT-2018-3204 to E. E. A. and PICT-2019-02869 to A. V. G., and R01.AI095175 from National Institute of Allergy and Infectious Diseases, National Institutes of Health, to A. V. G., L. B. P. S., and G. S. C. N. are supported by CONICET fellowships. E. E. A., L. A. B., and A. V. G. are CONICET Investigators. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Ambadipudi S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00480-0; Bagatolli LA, 2016, SPRINGER SER FLUORES, V17, P197, DOI 10.1007/4243_2016_7; Baumgart T, 2007, BBA-BIOMEMBRANES, V1768, P2182, DOI 10.1016/j.bbamem.2007.05.012; Byk LA, 2016, ANNU REV VIROL, V3, P263, DOI 10.1146/annurev-virology-110615-042334; Cabre EJ, 2012, BBA-BIOMEMBRANES, V1818, P1717, DOI 10.1016/j.bbamem.2012.03.008; Cai SD, 2018, ANALYST, V143, P5317, DOI 10.1039/c8an01467a; Clausell A, 2006, J PHYS CHEM B, V110, P4465, DOI 10.1021/jp0551972; de Jong H. G. B., 1932, PROTOPLASMA, V15, P110; Ding BB, 2016, WIRES RNA, V7, P213, DOI 10.1002/wrna.1326; Feng Z, 2019, J BIOL CHEM, V294, P14823, DOI 10.1074/jbc.REV119.007895; FUOSS RM, 1949, SCIENCE, V110, P552, DOI 10.1126/science.110.2865.552; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8; Ilinskaya ON, 2014, MOL BIOL+, V48, P615, DOI 10.1134/S0026893314040050; Jameson D. M., 2014, INTRO FLUORESCENCE; KEENAN TW, 1970, BIOCHEMISTRY-US, V9, P19, DOI 10.1021/bi00803a003; Kostyuchenko VA, 2016, NATURE, V533, P425, DOI 10.1038/nature17994; Kuhn RJ, 2002, CELL, V108, P717, DOI 10.1016/S0092-8674(02)00660-8; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, P954, DOI DOI 10.1007/978-0-387-46312-4; Langmuir I, 1918, J AM CHEM SOC, V40, P1361, DOI 10.1021/ja02242a004; Lehninger A., 2005, LEHNINGER PRINCIPLES; Ling Gilbert N., 2003, Physiological Chemistry and Physics and Medical NMR, V35, P91; Socas LBP, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183421; Prasad VM, 2017, NAT STRUCT MOL BIOL, V24, P184, DOI 10.1038/nsmb.3352; Rhine K, 2020, ANNU REV BIOPHYS, V49, P247, DOI 10.1146/annurev-biophys-052118-115508; Sing CE, 2020, SOFT MATTER, V16, P2885, DOI 10.1039/d0sm00001a; STRUCK DK, 1981, BIOCHEMISTRY-US, V20, P4093, DOI 10.1021/bi00517a023; Tan TY, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008542; Tan TY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14647-9; Uversky VN, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9120842; WEBER G, 1979, BIOCHEMISTRY-US, V18, P3075, DOI 10.1021/bi00581a025; Weinberger A, 2013, BIOPHYS J, V105, P154, DOI 10.1016/j.bpj.2013.05.024; Zhou YY, 2020, NUCLEIC ACIDS RES, V48, DOI 10.1093/nar/gkz1124	34	4	4	4	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101059	10.1016/j.jbc.2021.101059	http://dx.doi.org/10.1016/j.jbc.2021.101059			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34375636	gold, Green Submitted, Green Published			2022-12-28	WOS:000706409400003
J	Pan, H; Kaur, P; Barnes, R; Detwiler, AC; Sanford, SL; Liu, M; Xu, PN; Mahn, C; Tang, QY; Hao, PY; Bhattaram, D; You, CJ; Gu, XY; Lu, W; Piehler, J; Xu, GZ; Weninger, K; Riehn, R; Opresko, PL; Wang, H				Pan, Hai; Kaur, Parminder; Barnes, Ryan; Detwiler, Ariana C.; Sanford, Samantha Lynn; Liu, Ming; Xu, Pengning; Mahn, Chelsea; Tang, Qingyu; Hao, Pengyu; Bhattaram, Dhruv; You, Changjiang; Gu, Xinyun; Lu, Warren; Piehler, Jacob; Xu, Guozhou; Weninger, Keith; Riehn, Robert; Opresko, Patricia L.; Wang, Hong			Structure, dynamics, and regulation of TRF1-TIN2-mediated trans- and cis-interactions on telomeric DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-MOLECULE; PROTEIN TIN2; LENGTH REGULATOR; BINDING PROTEIN; TRF1; SHELTERIN; COMPLEX; END; PROTECTION; MECHANISM	TIN2 is a core component of the shelterin complex linking double-stranded telomeric DNA-binding proteins (TRF1 and TRF2) and single-strand overhang-binding proteins (TPP1-POT1). In vivo, the large majority of TRF1 and TRF2 exist in complexes containing TIN2 but lacking TPP1/POT1; however, the role of TRF1-TIN2 interactions in mediating interactions with telomeric DNA is unclear. Here, we investigated DNA molecular structures promoted by TRF1-TIN2 interaction using atomic force microscopy (AFM), total internal reflection fluo-rescence microscopy (TIRFM), and the DNA tightrope assay. We demonstrate that the short (TIN2S) and long (TIN2L) isoforms of TIN2 facilitate TRF1-mediated DNA compaction (cis-in-teractions) and DNA-DNA bridging (trans-interactions) in a telomeric sequence-and length-dependent manner. On the short telomeric DNA substrate (six TTAGGG repeats), the ma-jority of TRF1-mediated telomeric DNA-DNA bridging events are transient with a lifetime of similar to 1.95 s. On longer DNA substrates (270 TTAGGG repeats), TIN2 forms multiprotein complexes with TRF1 and stabilizes TRF1-mediated DNA-DNA bridging events that last on the order of minutes. Preincubation of TRF1 with its regulator protein Tankyrase 1 and the cofactor NAD+ significantly reduced TRF1-TIN2 mediated DNA-DNA bridging, whereas TIN2 protected the disassembly of TRF1-TIN2 mediated DNA-DNA bridging upon Tankyrase 1 addition. Furthermore, we showed that TPP1 inhibits TRF1-TIN2L-mediated DNA-DNA bridging. Our study, together with previous findings, supports a molecular model in which protein assemblies at telomeres are heterogeneous with distinct subcomplexes and full shelterin complexes playing distinct roles in telomere protection and elongation.	[Pan, Hai; Kaur, Parminder; Liu, Ming; Xu, Pengning; Mahn, Chelsea; Hao, Pengyu; Weninger, Keith; Riehn, Robert; Wang, Hong] North Carolina State Univ, Phys Dept, Raleigh, NC 27695 USA; [Kaur, Parminder; Wang, Hong] North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA; [Barnes, Ryan; Detwiler, Ariana C.; Sanford, Samantha Lynn; Opresko, Patricia L.] Univ Pittsburgh, UPMC Hillman Canc Ctr, Dept Environm & Occupat Hlth, Pittsburgh, PA USA; [Tang, Qingyu; Xu, Guozhou] North Carolina State Univ, Dept Mol & Struct Biochem, Raleigh, NC USA; [Bhattaram, Dhruv] Georgia Inst Technol, Dept Biomed Engn, Atlanta, GA 30332 USA; [Bhattaram, Dhruv] Emory Univ Med, Atlanta, GA 30332 USA; [You, Changjiang; Piehler, Jacob] Univ Osnabruck, Dept Biol Chem, Osnabruck, Germany; [Gu, Xinyun] NYU, Coll Art & Sci, New York, NY USA; [Lu, Warren] NYU, NYU Grossman Sch Med, Dept Pathol, New York, NY USA; [Opresko, Patricia L.] Carnegie Mellon Univ, Mol Biophys & Struct Biol Grad Program, Pittsburgh, PA 15213 USA; [Opresko, Patricia L.] Univ Pittsburgh, Pittsburgh, PA USA; [Wang, Hong] North Carolina State Univ, Toxicol Program, Raleigh, NC 27695 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; North Carolina State University; University System of Georgia; Georgia Institute of Technology; Emory University; University Osnabruck; New York University; New York University; Carnegie Mellon University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of North Carolina; North Carolina State University	Wang, H (corresponding author), North Carolina State Univ, Phys Dept, Raleigh, NC 27695 USA.; Wang, H (corresponding author), North Carolina State Univ, Ctr Human Hlth & Environm, Raleigh, NC 27695 USA.; Wang, H (corresponding author), North Carolina State Univ, Toxicol Program, Raleigh, NC 27695 USA.	hong_wang@ncsu.edu	Tang, Qingyu/W-4530-2018; Riehn, Robert/A-7195-2011; Barnes, Ryan/V-8232-2017; Wang, Hong/F-3164-2014	Tang, Qingyu/0000-0002-5554-6540; Pan, Hai/0000-0001-6660-9052; Riehn, Robert/0000-0002-4408-3560; Barnes, Ryan/0000-0003-0122-5773; Sanford, Samantha/0000-0002-6517-3557; Wang, Hong/0000-0003-0165-3559; Detwiler, Ariana/0000-0002-9311-5899; Piehler, Jacob/0000-0002-2143-2270	National Institutes of Health [R01GM107559, R01GM123246, P30 ES025128, R01CA207342, R01GM132263]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (R01GM107559 to H. W., R. R., R01GM123246 to H. W., R. R., and P. L. O, P30 ES025128 Pilot Project Grant to H. W. and P. K. through the Center for Human Health and the Environment at NCSU, R01CA207342 to P.L.O., and R01GM132263 to K.W.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bandaria JN, 2016, CELL, V164, P735, DOI 10.1016/j.cell.2016.01.036; Benarroch-Popivker D, 2016, MOL CELL, V61, P274, DOI 10.1016/j.molcel.2015.12.009; Bianchi A, 1999, EMBO J, V18, P5735, DOI 10.1093/emboj/18.20.5735; Bisht KK, 2013, J CELL SCI, V126, P3493, DOI 10.1242/jcs.130872; Broccoli D, 1997, HUM MOL GENET, V6, P69, DOI 10.1093/hmg/6.1.69; Broccoli D, 1997, NAT GENET, V17, P231, DOI 10.1038/ng1097-231; Canudas S, 2007, EMBO J, V26, P4867, DOI 10.1038/sj.emboj.7601903; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Cech TR, 2004, CELL, V116, P273, DOI 10.1016/S0092-8674(04)00038-8; Chandradoss SD, 2014, JOVE-J VIS EXP, DOI 10.3791/50549; Chen Y, 2008, SCIENCE, V319, P1092, DOI 10.1126/science.1151804; Chiang YJ, 2004, MOL CELL BIOL, V24, P6631, DOI 10.1128/mcb.24.15.6631-6634.2004; CHUNG SH, 1991, J NEUROSCI METH, V40, P71, DOI 10.1016/0165-0270(91)90118-J; Countryman P, 2018, J BIOL CHEM, V293, P1054, DOI 10.1074/jbc.M117.806406; de Lange T, 2018, ANNU REV GENET, V52, P223, DOI 10.1146/annurev-genet-032918-021921; di Fagagna FD, 2003, NATURE, V426, P194, DOI 10.1038/nature02118; Doksani Y, 2013, CELL, V155, P345, DOI 10.1016/j.cell.2013.09.048; Dunn AR, 2011, NUCLEIC ACIDS RES, V39, P7487, DOI 10.1093/nar/gkr459; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Erdel F, 2017, CELL REP, V18, P41, DOI 10.1016/j.celrep.2016.12.005; Erie DA, 2014, DNA REPAIR, V20, P71, DOI 10.1016/j.dnarep.2014.03.007; Frescas D, 2014, J BIOL CHEM, V289, P24180, DOI 10.1074/jbc.M114.592592; Gauer JW, 2016, METHOD ENZYMOL, V581, P285, DOI 10.1016/bs.mie.2016.08.012; Giraud-Panis MJ, 2010, FEBS LETT, V584, P3785, DOI 10.1016/j.febslet.2010.08.004; Griffith J, 1998, J MOL BIOL, V278, P79, DOI 10.1006/jmbi.1998.1686; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; HANISH JP, 1994, P NATL ACAD SCI USA, V91, P8861, DOI 10.1073/pnas.91.19.8861; Houghtaling BR, 2004, CURR BIOL, V14, P1621, DOI 10.1016/j.cub.2004.08.052; Hu CY, 2017, CELL RES, V27, P1485, DOI 10.1038/cr.2017.144; Hughes CD, 2013, NUCLEIC ACIDS RES, V41, P4901, DOI 10.1093/nar/gkt177; Hwang H, 2012, STRUCTURE, V20, P1872, DOI 10.1016/j.str.2012.08.018; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Kad NM, 2010, MOL CELL, V37, P702, DOI 10.1016/j.molcel.2010.02.003; Kaminker PG, 2009, CELL CYCLE, V8, P931, DOI 10.4161/cc.8.6.7941; Kaur P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20513; Kim S, 2004, J BIOL CHEM, V279, P43799, DOI 10.1074/jbc.M408650200; Kim SH, 2008, J CELL BIOL, V181, P447, DOI 10.1083/jcb.200710028; Kim SH, 1999, NAT GENET, V23, P405, DOI 10.1038/70508; Kim SH, 2003, EMBO REP, V4, P685, DOI 10.1038/sj.embor.embor872; Kocak H, 2014, GENE DEV, V28, P2090, DOI 10.1101/gad.248567.114; LeBlanc SJ, 2018, NUCLEIC ACIDS RES, V46, P10782, DOI 10.1093/nar/gky865; Li B, 2016, ACTA CRYSTALLOGR F, V72, P320, DOI 10.1107/S2053230X16004131; Lim CJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01313-w; Lin JG, 2016, NUCLEIC ACIDS RES, V44, P6363, DOI 10.1093/nar/gkw518; Lin JG, 2014, NUCLEIC ACIDS RES, V42, P2493, DOI 10.1093/nar/gkt1132; Muraki K, 2012, FRONT ONCOL, V2, DOI 10.3389/fonc.2012.00135; Nelson ND, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00025-18; O'Connor MS, 2006, P NATL ACAD SCI USA, V103, P11874, DOI 10.1073/pnas.0605303103; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Palm W, 2008, ANNU REV GENET, V42, P301, DOI 10.1146/annurev.genet.41.110306.130350; Pan H, 2020, NUCLEIC ACIDS RES, V48, P5639, DOI 10.1093/nar/gkaa284; Pan H, 2017, NUCLEIC ACIDS RES, V45, P9164, DOI 10.1093/nar/gkx548; Pan H, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/4/045006; Pike AM, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00593-18; Poulet A, 2012, NUCLEIC ACIDS RES, V40, P2566, DOI 10.1093/nar/gkr1116; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sanford SL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19115-y; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Smith S, 1998, SCIENCE, V282, P1484, DOI 10.1126/science.282.5393.1484; Smith S, 2009, CELL CYCLE, V8, P797, DOI 10.4161/cc.8.6.8337; Sowd G, 2009, J BIOL CHEM, V284, P34682, DOI 10.1074/jbc.M109.049031; Takai KK, 2011, MOL CELL, V44, P647, DOI 10.1016/j.molcel.2011.08.043; Takai KK, 2010, J BIOL CHEM, V285, P1457, DOI 10.1074/jbc.M109.038026; Timashev LA, 2017, GENE DEV, V31, P578, DOI 10.1101/gad.294108.116; Van Ly D, 2018, MOL CELL, V71, P510, DOI 10.1016/j.molcel.2018.06.025; Vancevska A, 2017, GENE DEV, V31, P567, DOI 10.1101/gad.294082.116; Verdun RE, 2007, NATURE, V447, P924, DOI 10.1038/nature05976; Walne AJ, 2008, BLOOD, V112, P3594, DOI 10.1182/blood-2008-05-153445; Wang F, 2007, NATURE, V445, P506, DOI 10.1038/nature05454; Wang H., 2007, PROTEIN INTERACTIONS, P39; Wang H, 2006, J BIOL CHEM, V281, P15227, DOI 10.1074/jbc.M601476200; Wang H, 2011, J BIOL CHEM, V286, P7479, DOI 10.1074/jbc.M110.205641; Wright WE, 1997, GENE DEV, V11, P2801, DOI 10.1101/gad.11.21.2801; Yang Y, 2003, METHODS, V29, P175, DOI 10.1016/S1046-2023(02)00308-0; Ye JZS, 2004, J BIOL CHEM, V279, P47264, DOI 10.1074/jbc.M409047200; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Ye JZS, 2004, NAT GENET, V36, P618, DOI 10.1038/ng1360; Zhou SY, 2006, CRIT REV EUKAR GENE, V16, P103, DOI 10.1615/CritRevEukarGeneExpr.v16.i2.10	79	2	2	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101080	10.1016/j.jbc.2021.101080	http://dx.doi.org/10.1016/j.jbc.2021.101080			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34403696	Green Published, gold			2022-12-28	WOS:000706409200005
J	Zhang, HL; Zhao, B; Han, W; Sun, YB; Yang, P; Chen, YJ; Ni, D; Zhang, J; Yin, DM				Zhang, Hai-Long; Zhao, Bing; Han, Wei; Sun, Yi-Bei; Yang, Pin; Chen, Yongjun; Ni, Duan; Zhang, Jian; Yin, Dong-Min			Acetylation of calmodulin regulates synaptic plasticity and fear learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; HISTONE ACETYLATION; NMDA RECEPTORS; INDUCED LTP; PHOSPHORYLATION; KINASE; MECHANISMS; CAMKII; MEMORY; ACTIVATION	Synaptic plasticity is critical for brain function, including learning and memory. It is regulated by gene transcription and protein synthesis as well as posttranslational modifications at synapses. Although protein acetylation has been shown to be involved in the regulation of synaptic plasticity, this was mainly for histone protein acetylation. To investigate whether acetylation of nonhistone proteins is important for synaptic plasticity, we analyzed mouse brain acetylome and found that calmodulin (CaM), a ubiquitous Ca2+ sensor, was acetylated on three lysine residues, which were conserved across species. NMDA receptor-dependent long-term potentiation (LTP) is considered the most compelling form of synaptic plasticity. During LTP induction, activation of NMDA receptor triggers Ca2+ influx, and the Ca2+ binds with CaM and activates calcium/calmodulin-dependent protein kinase II alpha (CaMKII alpha), which is essential for LTP induction. By using home-generated and site-specific antibodies against acetylated CaM, we show that CaM acetylation is upregulated by neural activities in an NMDA receptor-dependent manner. Moreover, mutation of acetyllysines in CaM1 proteins disrupts synaptic plasticity and fear learning in a mouse model. We further demonstrate that acetylation of CaM reduces the binding free energy and increases the binding affinity toward CaMKII alpha, a protein kinase pivotal to synaptic plasticity and learning. Taken together, our results demonstrate importance of CaM acetylation in regulating synaptic plasticity and learning.	[Zhang, Hai-Long; Zhao, Bing; Han, Wei; Sun, Yi-Bei; Yang, Pin; Yin, Dong-Min] East China Normal Univ, Sch Life Sci, Minist Educ & Shanghai, Key Lab Brain Funct Genom, Shanghai, Peoples R China; [Zhang, Hai-Long] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [Zhang, Hai-Long] Soochow Univ, Inst Neurosci, Suzhou, Peoples R China; [Chen, Yongjun] Guangzhou Univ Chinese Med, Med Coll Acu Moxi & Rehabil, Guangzhou, Peoples R China; [Ni, Duan; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Dept Pharm, Key Lab Cell Differentiat & Apoptosis Chinese,Min, Shanghai, Peoples R China; [Ni, Duan; Zhang, Jian] Shanghai Jiao Tong Univ, Sch Med SJTU SM, Fundamental Res Ctr, Renji Hosp, Shanghai, Peoples R China	East China Normal University; Soochow University - China; Soochow University - China; Guangzhou University of Chinese Medicine; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Yin, DM (corresponding author), East China Normal Univ, Sch Life Sci, Minist Educ & Shanghai, Key Lab Brain Funct Genom, Shanghai, Peoples R China.	dmyin@brain.ecnu.edu.cn	Zhang, Jian/GXA-1303-2022	Zhang, Jian/0000-0002-6558-791X; Yin, Dongmin/0000-0001-9329-050X; Ni, Duan/0000-0002-3902-2843; Zhang, Hai-Long/0000-0002-8720-2734				Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; BIBER A, 1984, EXP BRAIN RES, V56, P323; Biever A, 2019, CURR OPIN NEUROBIOL, V57, P141, DOI 10.1016/j.conb.2019.02.008; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BROSE N, 1992, SCIENCE, V256, P1021, DOI 10.1126/science.1589771; CHEUNG WY, 1980, SCIENCE, V207, P19, DOI 10.1126/science.6243188; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Coba MP, 2019, CURR OPIN STRUC BIOL, V54, P86, DOI 10.1016/j.sbi.2019.01.003; Ehlers MD, 1996, CELL, V84, P745, DOI 10.1016/S0092-8674(00)81052-1; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; GHOSH A, 1995, SCIENCE, V268, P239, DOI 10.1126/science.7716515; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Grunwald ME, 1999, P NATL ACAD SCI USA, V96, P13444, DOI 10.1073/pnas.96.23.13444; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hansen BK, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09024-0; Huganir RL, 2013, NEURON, V80, P704, DOI 10.1016/j.neuron.2013.10.025; Kameyama K, 1998, NEURON, V21, P1163, DOI 10.1016/S0896-6273(00)80633-9; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kim WB, 2017, NEURON, V95, P1129, DOI 10.1016/j.neuron.2017.08.004; Kitchen P, 2020, CELL, V181, P784, DOI 10.1016/j.cell.2020.03.037; KLEE CB, 1980, ANNU REV BIOCHEM, V49, P489, DOI 10.1146/annurev.bi.49.070180.002421; Kouvaros S, 2016, HIPPOCAMPUS, V26, P1542, DOI 10.1002/hipo.22655; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lee SJR, 2009, NATURE, V458, P299, DOI 10.1038/nature07842; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Marks CR, 2018, MOL PHARMACOL, V94, P1352, DOI 10.1124/mol.118.113142; MARUTA H, 1986, J CELL BIOL, V103, P571, DOI 10.1083/jcb.103.2.571; MEANS AR, 1980, NATURE, V285, P73, DOI 10.1038/285073a0; Mielcarek M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080849; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Parra V, 2017, J MOL CELL CARDIOL, V103, P121, DOI 10.1016/j.yjmcc.2016.12.006; PATTON BL, 1993, MOL BIOL CELL, V4, P159, DOI 10.1091/mbc.4.2.159; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Perfitt TL, 2020, J NEUROSCI, V40, P2000, DOI 10.1523/JNEUROSCI.0893-19.2020; Quinn JJ, 2005, HIPPOCAMPUS, V15, P665, DOI 10.1002/hipo.20088; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Saimi Y, 2002, ANNU REV PHYSIOL, V64, P289, DOI 10.1146/annurev.physiol.64.100301.111649; Saito K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009935; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Saunders A, 2018, CELL, V174, P1015, DOI 10.1016/j.cell.2018.07.028; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811; Shonesy BC, 2014, PROG MOL BIOL TRANSL, V122, P61, DOI 10.1016/B978-0-12-420170-5.00003-9; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Strack S, 2000, J BIOL CHEM, V275, P23798, DOI 10.1074/jbc.M001471200; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Takemoto K, 2017, NAT BIOTECHNOL, V35, P38, DOI 10.1038/nbt.3710; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wang G, 2017, CELL REP, V20, P1335, DOI 10.1016/j.celrep.2017.07.030; WATTERSON DM, 1980, J BIOL CHEM, V255, P962; West PJ, 2014, EPILEPSIA, V55, P214, DOI 10.1111/epi.12524; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Yao X, 2018, DEV CELL, V45, P526, DOI 10.1016/j.devcel.2018.04.021; Yu Y, 2021, FRONT MOL NEUROSCI, V14, DOI 10.3389/fnmol.2021.594332; Zhang HL, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101044; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689; Zuhlke RD, 1999, NATURE, V399, P159, DOI 10.1038/20200	76	4	4	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101034	10.1016/j.jbc.2021.101034	http://dx.doi.org/10.1016/j.jbc.2021.101034			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34339735	gold, Green Published			2022-12-28	WOS:000706361700008
J	Amaya, C; Cameron, CJF; Devarkar, SC; Seager, SJH; Gerstein, MB; Xiong, Y; Schlieker, C				Amaya, Catherine; Cameron, Christopher J. F.; Devarkar, Swapnil C.; Seager, Sebastian J. H.; Gerstein, Mark B.; Xiong, Yong; Schlieker, Christian			Nodal modulator (NOMO) is required to sustain endoplasmic reticulum morphology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEINS; ATLASTIN GTPASES; LIVING CELLS; NICALIN; DOMAIN; ROLES; TRANSPORTER; COMPONENT; NETWORK; PATHWAY	The endoplasmic reticulum (ER) is a membrane-bound organelle responsible for protein folding, lipid synthesis, and calcium homeostasis. Maintenance of ER structural integrity is crucial for proper function, but much remains to be learned about the molecular players involved. To identify proteins that support the structure of the ER, we performed a proteomic screen and identified nodal modulator (NOMO), a widely conserved type I transmembrane protein of unknown function, with three nearly identical orthologs specified in the human genome. We found that overexpression of NOMO1 imposes a sheet morphology on the ER, whereas depletion of NOMO1 and its orthologs causes a collapse of ER morphology concomitant with the formation of membrane-delineated holes in the ER network positive for the lysosomal marker lysosomal-associated protein 1. In addition, the levels of key players of autophagy including microtubule-associated protein light chain 3 and autophagy cargo receptor p62/sequestosome 1 strongly increase upon NOMO depletion. In vitro reconstitution of NOMO1 revealed a "beads on a string" structure likely representing consecutive immunoglobulin-like domains. Extending NOMO1 by insertion of additional immunoglobulin folds results in a correlative increase in the ER intermembrane distance. Based on these observations and a genetic epistasis analysis including the known ER-shaping proteins Atlastin2 and Climp63, we propose a role for NOMO1 in the functional network of ER-shaping proteins.	[Amaya, Catherine; Cameron, Christopher J. F.; Devarkar, Swapnil C.; Seager, Sebastian J. H.; Gerstein, Mark B.; Xiong, Yong; Schlieker, Christian] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Gerstein, Mark B.] Yale Univ, Dept Comp Sci, POB 2158, New Haven, CT 06520 USA; [Gerstein, Mark B.] Yale Univ, Dept Stat & Data Sci, New Haven, CT USA; [Schlieker, Christian] Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA	Yale University; Yale University; Yale University; Yale University; Yale University	Schlieker, C (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Schlieker, C (corresponding author), Yale Sch Med, Dept Cell Biol, New Haven, CT 06510 USA.	christian.schlieker@yale.edu		Cameron, Christopher/0000-0003-4088-0957; Devarkar, Swapnil Chandrakant/0000-0002-9271-243X	National Institutes of Health [R01GM114401, GM126835]; CMB TG [T32GM007223]; National Science Foundation Graduate Research Fellowship [DGE1752134]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CMB TG; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF))	This work is supported by National Institutes of Health Grants R01GM114401 and GM126835 (to C. S.), CMB TG T32GM007223 (to C. A.), and the National Science Foundation Graduate Research Fellowship DGE1752134 (to C. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028; Berardi MJ, 1999, STRUCT FOLD DES, V7, P1247, DOI 10.1016/S0969-2126(00)80058-1; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Blackstone C, 2011, NAT REV NEUROSCI, V12, P31, DOI 10.1038/nrn2946; Chen XQ, 2010, PROTEOMICS, V10, P4040, DOI 10.1002/pmic.201000234; Chen XQ, 2010, J PROTEOME RES, V9, P885, DOI 10.1021/pr900784c; Chitwood PJ, 2020, NATURE, V584, P630, DOI 10.1038/s41586-020-2624-y; Chiurchiu V, 2014, NEUROMOL MED, V16, P3, DOI 10.1007/s12017-013-8271-9; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; de Araujo MEG, 2020, TRAFFIC, V21, P60, DOI 10.1111/tra.12714; Dettmer U, 2010, J BIOL CHEM, V285, P26174, DOI 10.1074/jbc.M110.132548; Echelman DJ, 2016, P NATL ACAD SCI USA, V113, P2490, DOI 10.1073/pnas.1522946113; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Grumati P, 2017, ELIFE, V6, DOI 10.7554/eLife.25555; Haffner C, 2004, EMBO J, V23, P3041, DOI 10.1038/sj.emboj.7600307; Haffner C, 2007, J BIOL CHEM, V282, P10632, DOI 10.1074/jbc.M611033200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025; Hung V, 2016, NAT PROTOC, V11, P456, DOI 10.1038/nprot.2016.018; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Jozsef L, 2014, J BIOL CHEM, V289, P9380, DOI 10.1074/jbc.M114.548602; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lee SY, 2016, CELL REP, V15, P1837, DOI 10.1016/j.celrep.2016.04.064; Liu N, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202012091; Ma YJ, 2001, CELL, V107, P827, DOI 10.1016/S0092-8674(01)00623-7; Malhotra V, 2015, ANNU REV CELL DEV BI, V31, P109, DOI 10.1146/annurev-cellbio-100913-013002; Matlack KES, 1998, CELL, V92, P381, DOI 10.1016/S0092-8674(00)80930-7; McGilvray PT, 2020, ELIFE, V9, DOI 10.7554/eLife.56889; Meldolesi J, 1998, TRENDS BIOCHEM SCI, V23, P10, DOI 10.1016/S0968-0004(97)01143-2; Miller OK, 2018, PROTEIN SCI, V27, P1651, DOI 10.1002/pro.3478; Morin-Leisk J, 2011, J CELL BIOL, V195, P605, DOI 10.1083/jcb.201105006; PALADE GEORGE E., 1956, JOUR BIOPHYS AND BIOCHEM CYTOL, V2, P85, DOI 10.1083/jcb.2.4.85; Park SH, 2010, J CLIN INVEST, V120, P1097, DOI 10.1172/JCI40979; Pawar S, 2017, ELIFE, V6, DOI 10.7554/eLife.28202; Powers RE, 2017, NATURE, V543, P257, DOI 10.1038/nature21387; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046; Sakai K, 2009, PROTEOMICS, V9, P3036, DOI 10.1002/pmic.200800803; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schroeder LK, 2019, J CELL BIOL, V218, P83, DOI 10.1083/jcb.201809107; Schweitzer Y, 2015, BIOPHYS J, V109, P564, DOI 10.1016/j.bpj.2015.06.001; Shen BR, 2019, ISCIENCE, V22, P70, DOI 10.1016/j.isci.2019.10.067; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Shibata Y, 2010, CELL, V143, P774, DOI 10.1016/j.cell.2010.11.007; Slotboom DJ, 2008, METHODS, V46, P73, DOI 10.1016/j.ymeth.2008.06.012; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Upla P, 2017, STRUCTURE, V25, P434, DOI 10.1016/j.str.2017.01.006; Vedrenne C, 2005, MOL BIOL CELL, V16, P1928, DOI 10.1091/mbc.E04-07-0554; Veesler D, 2009, ANAL BIOCHEM, V388, P115, DOI 10.1016/j.ab.2009.02.018; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wu MJ, 2014, CELL MICROBIOL, V16, P1603, DOI 10.1111/cmi.12318; Yates A. D., 2019, NUCLEIC ACIDS RES, V48; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Yuniati L, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107664; Zhao GH, 2016, EXP CELL RES, V349, P32, DOI 10.1016/j.yexcr.2016.09.015; Zhao JH, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00500	60	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100937	10.1016/j.jbc.2021.100937	http://dx.doi.org/10.1016/j.jbc.2021.100937			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34224731	gold, Green Published			2022-12-28	WOS:000690871000009
J	Dahlin, HR; Zheng, N; Scott, JD				Dahlin, Heather R.; Zheng, Ning; Scott, John D.			Beyond PKA: Evolutionary and structural insights that define a docking and dimerization domain superfamily	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; REGULATORY SUBUNIT RII; ANCHORING PROTEIN; AKAP SPECIFICITY; MOLECULAR-BASIS; FIBROUS SHEATH; CLONING; BINDING; LOCALIZATION; PHOSPHORYLATION	Protein-interaction domains can create unique macromolecular complexes that drive evolutionary innovation. By combining bioinformatic and phylogenetic analyses with structural approaches, we have discovered that the docking and dimerization (D/D) domain of the PKA regulatory subunit is an ancient and conserved protein fold. An archetypal function of this module is to interact with A-kinase-anchoring proteins (AKAPs) that facilitate compartmentalization of this key cellsignaling enzyme. Homology searching reveals that D/D domain proteins comprise a superfamily with 18 members that function in a variety of molecular and cellular contexts. Further in silico analyses indicate that D/D domains segregate into subgroups on the basis of their similarity to type I or type II PKA regulatory subunits. The sperm autoantigenic protein 17 (SPA17) is a prototype of the type II or R2D2 subgroup that is conserved across metazoan phyla. We determined the crystal structure of an extended D/D domain from SPA17 (amino acids 1-75) at 1.72 A resolution. This revealed a four-helix bundle-like configuration featuring terminal beta-strands that can mediate higher order oligomerization. In solution, SPA17 forms both homodimers and tetramers and displays a weak affinity for AKAP18. Quantitative approaches reveal that AKAP18 binding occurs at nanomolar affinity when SPA17 heterodimerizes with the ropporin-1-like D/D protein. These findings expand the role of the D/D fold as a versatile proteininteraction element that maintains the integrity of macromolecular architectures within organelles such as motile cilia.	[Dahlin, Heather R.; Zheng, Ning; Scott, John D.] Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA; [Zheng, Ning] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Zheng, N; Scott, JD (corresponding author), Univ Washington, Dept Pharmacol, Seattle, WA 98195 USA.; Zheng, N (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	nzheng@uw.edu; scottjdw@uw.edu			NIH [T32GM007750, R01 DK119192]; Howard Hughes Medical Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	The research is supported by NIH T32GM007750 (to H. R. D.) and R01 DK119192 (to J. D. S.). N. Z. is supported by the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alto NM, 2003, P NATL ACAD SCI USA, V100, P4445, DOI 10.1073/pnas.0330734100; Bardeci NG, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107732; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bieluszewska A, 2018, FEBS J, V285, P947, DOI 10.1111/febs.14378; Burns-Hamuro LL, 2003, P NATL ACAD SCI USA, V100, P4072, DOI 10.1073/pnas.2628038100; CANNON JF, 1987, MOL CELL BIOL, V7, P2653, DOI 10.1128/MCB.7.8.2653; Carlson CR, 2006, J BIOL CHEM, V281, P21535, DOI 10.1074/jbc.M603223200; CARR DW, 1992, J BIOL CHEM, V267, P13376; Carr DW, 2001, J BIOL CHEM, V276, P17332, DOI 10.1074/jbc.M011252200; CARR DW, 1991, J BIOL CHEM, V266, P14188; COGHLAN VM, 1994, J BIOL CHEM, V269, P7658; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Hoang DT, 2018, MOL BIOL EVOL, V35, P518, DOI 10.1093/molbev/msx281; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Eide T, 1998, EXP CELL RES, V238, P305, DOI 10.1006/excr.1997.3855; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fiedler SE, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105262; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Fujita A, 2000, J CELL SCI, V113, P103; Gaillard AR, 2001, J CELL BIOL, V153, P443, DOI 10.1083/jcb.153.2.443; Gotz F, 2016, BIOCHEM J, V473, P1881, DOI 10.1042/BCJ20160242; Gold MG, 2006, MOL CELL, V24, P383, DOI 10.1016/j.molcel.2006.09.006; Gold MG, 2013, J BIOL CHEM, V288, P17111, DOI 10.1074/jbc.M112.447326; Grossman-Haham I, 2021, NAT STRUCT MOL BIOL, V28, DOI 10.1038/s41594-020-00519-9; Gui M, 2021, NAT STRUCT MOL BIOL, V28, DOI 10.1038/s41594-020-00530-0; HAUSKEN ZE, 1994, J BIOL CHEM, V269, P24245; HSU DR, 1994, GENETICS, V137, P999; Hsu PL, 2018, CELL, V174, P1106, DOI 10.1016/j.cell.2018.06.038; Hu J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13347; Huang LJS, 1997, J BIOL CHEM, V272, P8057, DOI 10.1074/jbc.272.12.8057; Hundsrucker C, 2006, BIOCHEM J, V396, P297, DOI 10.1042/BJ20051970; Kennedy EJ, 2015, METHODS MOL BIOL, V1294, P137, DOI 10.1007/978-1-4939-2537-7_11; Keryer G, 1998, J BIOL CHEM, V273, P34594, DOI 10.1074/jbc.273.51.34594; Kozlov AM, 2019, BIOINFORMATICS, V35, P4453, DOI 10.1093/bioinformatics/btz305; KREBS EG, 1985, BIOCHEM SOC T, V13, P813, DOI 10.1042/bst0130813; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Nguyen LT, 2015, MOL BIOL EVOL, V32, P268, DOI 10.1093/molbev/msu300; Langeberg LK, 2015, NAT REV MOL CELL BIO, V16, P232, DOI 10.1038/nrm3966; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li W, 2020, NAT CELL BIOL, V22, P960, DOI 10.1038/s41556-020-0550-8; Li YF, 2011, ASIAN J ANDROL, V13, P266, DOI 10.1038/aja.2010.149; LOHMANN SM, 1984, P NATL ACAD SCI-BIOL, V81, P6723, DOI 10.1073/pnas.81.21.6723; Miller MA., 2010, GAT COMP ENV WORKSH, P1, DOI DOI 10.1109/GCE.2010.5676129; Newell AEH, 2008, CELL MOTIL CYTOSKEL, V65, P539, DOI 10.1002/cm.20279; Newlon MG, 1999, NAT STRUCT BIOL, V6, P222; Newlon MG, 2001, EMBO J, V20, P1651, DOI 10.1093/emboj/20.7.1651; Omar MH, 2020, TRENDS PHARMACOL SCI, V41, P933, DOI 10.1016/j.tips.2020.09.007; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peng M, 2015, J PROTEOME RES, V14, P2976, DOI 10.1021/acs.jproteome.5b00370; Pigino Gaia, 2012, Bioarchitecture, V2, P50; Rinaldi J, 2010, STRUCTURE, V18, P1471, DOI 10.1016/j.str.2010.08.013; Sarma GN, 2010, STRUCTURE, V18, P155, DOI 10.1016/j.str.2009.12.012; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Smith FD, 2017, SCIENCE, V356, P1288, DOI 10.1126/science.aaj1669; Smith FD, 2013, ELIFE, V2, DOI 10.7554/eLife.01319; South PF, 2010, J BIOL CHEM, V285, P595, DOI 10.1074/jbc.M109.042697; SUTHERLAND EW, 1955, NATURE, V175, P169, DOI 10.1038/175169a0; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; TODA T, 1987, MOL CELL BIOL, V7, P1371, DOI 10.1128/MCB.7.4.1371; Turnham RE, 2016, GENE, V577, P101, DOI 10.1016/j.gene.2015.11.052; Vardanyan A, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-68; Vijayaraghavan S, 1997, J BIOL CHEM, V272, P4747, DOI 10.1074/jbc.272.8.4747; Wang XP, 2009, J MOL BIOL, V390, P530, DOI 10.1016/j.jmb.2009.05.061; Wen Y, 2001, BIOCHEM J, V357, P25, DOI 10.1042/0264-6021:3570025; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Young SAM, 2016, J CELL SCI, V129, P4379, DOI 10.1242/jcs.193151; Zhu XY, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a028126	69	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100927	10.1016/j.jbc.2021.100927	http://dx.doi.org/10.1016/j.jbc.2021.100927			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34256050	gold, Green Published			2022-12-28	WOS:000690879300005
J	Frost, J; Rocha, S; Ciulli, A				Frost, Julianty; Rocha, Sonia; Ciulli, Alessio			Von Hippel-Lindau (VHL) small-molecule inhibitor binding increases stability and intracellular levels of VHL protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; HIF-ALPHA; HYPOXIA; GENE; EXPRESSION; COMPLEX; OPTIMIZATION; DEGRADATION; THERAPY; PRODUCT	Von Hippel-Lindau (VHL) disease is characterized by frequent mutation of VHL protein, a tumor suppressor that functions as the substrate recognition subunit of a Cullin2 RING E3 ligase complex (CRL2(VHL)). CRL2(VHL) plays important roles in oxygen sensing by targeting hypoxia-inducible factor-alpha (HIF-alpha) subunits for ubiquitination and degradation. VHL is also commonly hijacked by bifunctional molecules such as proteolysis-targeting chimeras to induce degradation of target molecules. We previously reported the design and characterization of VHL inhibitors VH032 and VH298 that block the VHL:HIF-alpha interaction, activate the HIF transcription factor, and induce a hypoxic response, which can be beneficial to treat anemia and mitochondrial diseases. How these compounds affect the global cellular proteome remains unknown. Here, we use unbiased quantitative MS to identify the proteomic changes elicited by the VHL inhibitor compared with hypoxia or the broad-spectrum prolyl-hydroxylase domain enzyme inhibitor IOX2. Our results demonstrate that VHL inhibitors selectively activate the HIF response similar to the changes induced in hypoxia and IOX2 treatment. Interestingly, VHL inhibitors were found to specifically upregulate VHL itself. Our analysis revealed that this occurs via protein stabilization of VHL isoforms and not via changes in transcript levels. Increased VHL levels upon VH298 treatment resulted in turn in reduced levels of HIF-1 alpha protein. This work demon-strates the specificity of VHL inhibitors and reveals different antagonistic effects upon their acute versus prolonged treatment in cells. These findings suggest that therapeutic use of VHL inhibitors may not produce overt side effects from HIF stabilization as previously thought.	[Frost, Julianty; Ciulli, Alessio] Div Biol Chem & Drug Discovery, Dundee, Scotland; [Frost, Julianty; Rocha, Sonia] Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland; [Frost, Julianty; Rocha, Sonia] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol Physiol & Cell Signalling, Liverpool, Merseyside, England	University of Dundee; University of Liverpool	Ciulli, A (corresponding author), Div Biol Chem & Drug Discovery, Dundee, Scotland.; Rocha, S (corresponding author), Univ Dundee, Ctr Gene Regulat & Express, Sch Life Sci, Dundee, Scotland.; Rocha, S (corresponding author), Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol Physiol & Cell Signalling, Liverpool, Merseyside, England.	srocha@liverpool.ac.uk; a.ciulli@dundee.ac.uk	Ciulli, Alessio/A-6279-2011	Ciulli, Alessio/0000-0002-8654-1670; Frost, Julianty/0000-0001-8209-2575	Wellcome Trust [102398]; European Research Council [ERC-2012-StG-311460]; Cancer Research UK [C99667/A12918]	Wellcome Trust(Wellcome TrustEuropean Commission); European Research Council(European Research Council (ERC)European Commission); Cancer Research UK(Cancer Research UK)	This work was supported by the Wellcome Trust through a PhD Studentship to J. F. (102398), the European Research Council through a Starting Grant to A. C. (ERC-2012-StG-311460 DrugE3CRLs), and Cancer Research UK through a Senior Fellowship to S. R. (C99667/A12918).	Batie M, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6020047; Bondeson DP, 2015, NAT CHEM BIOL, V11, P611, DOI [10.1038/NCHEMBIO.1858, 10.1038/nchembio.1858]; BORST P, 1991, ACTA ONCOL, V30, P87, DOI 10.3109/02841869109091819; Cardote TAF, 2017, STRUCTURE, V25, P901, DOI 10.1016/j.str.2017.04.009; Chakrabarty A, 2012, P NATL ACAD SCI USA, V109, P2718, DOI 10.1073/pnas.1018001108; Ferreira JV, 2015, SCI REP-UK, V5, DOI 10.1038/srep10210; Frost Julianty, 2019, Wellcome Open Res, V4, P17, DOI 10.12688/wellcomeopenres.15044.1; Frost J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13312; Gadd MS, 2017, NAT CHEM BIOL, V13, P514, DOI [10.1038/nchembio.2329, 10.1038/NCHEMBIO.2329]; Galdeano C, 2014, J MED CHEM, V57, P8657, DOI 10.1021/jm5011258; Ginouves A, 2008, P NATL ACAD SCI USA, V105, P4745, DOI 10.1073/pnas.0705680105; Girardini M, 2019, BIOORGAN MED CHEM, V27, P2466, DOI 10.1016/j.bmc.2019.02.048; Hasanov E, 2017, ONCOGENE, V36, P3450, DOI 10.1038/onc.2016.495; Hasegawa S, 2018, CURR OPIN NEPHROL HY, V27, P331, DOI 10.1097/MNH.0000000000000431; Hsu T, 2012, ONCOGENE, V31, P2247, DOI 10.1038/onc.2011.442; Huang HT, 2018, CELL CHEM BIOL, V25, P88, DOI 10.1016/j.chembiol.2017.10.005; Iliopoulos O, 1998, P NATL ACAD SCI USA, V95, P11661, DOI 10.1073/pnas.95.20.11661; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Iskar M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000925; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jain IH, 2016, SCIENCE, V352, P54, DOI 10.1126/science.aad9642; Kamura T, 1999, SCIENCE, V284, P657, DOI 10.1126/science.284.5414.657; Kenneth NS, 2008, BIOCHEM J, V414, P19, DOI 10.1042/BJ20081055; Khan S, 2019, NAT MED, V25, P1938, DOI 10.1038/s41591-019-0668-z; Kitchens ME, 1999, J BIOL CHEM, V274, P12544, DOI 10.1074/jbc.274.18.12544; Labrousse-Arias D, 2017, J CELL BIOL, V216, P835, DOI 10.1083/jcb.201608024; Lai YL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016975; Lee DC, 2015, CELL, V161, P595, DOI 10.1016/j.cell.2015.03.011; Maher ER, 1997, MEDICINE, V76, P381, DOI 10.1097/00005792-199711000-00001; Maniaci C, 2019, CURR OPIN CHEM BIOL, V52, P145, DOI 10.1016/j.cbpa.2019.07.003; Maniaci C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00954-1; Mayer-Kuckuk P, 2002, P NATL ACAD SCI USA, V99, P3400, DOI 10.1073/pnas.062036899; Michalski A, 2011, J PROTEOME RES, V10, P1785, DOI 10.1021/pr101060v; Morais C, 2011, INT J BIOCHEM CELL B, V43, P1537, DOI 10.1016/j.biocel.2011.08.003; Pettersson Mariell, 2019, Drug Discov Today Technol, V31, P15, DOI 10.1016/j.ddtec.2019.01.002; Qiu S, 2019, J DIABETES RES, V2019, DOI 10.1155/2019/1897174; Qiu S, 2018, BIOCHEM BIOPH RES CO, V505, P1063, DOI 10.1016/j.bbrc.2018.09.172; Raina K, 2016, P NATL ACAD SCI USA, V113, P7124, DOI 10.1073/pnas.1521738113; Rubio S, 2014, J PLANT PHYSIOL, V171, P373, DOI 10.1016/j.jplph.2013.11.009; Schoenfeld A, 1998, P NATL ACAD SCI USA, V95, P8817, DOI 10.1073/pnas.95.15.8817; Shenoy N, 2016, ANN ONCOL, V27, P1685, DOI 10.1093/annonc/mdw241; Soares P, 2018, J MED CHEM, V61, P599, DOI 10.1021/acs.jmedchem.7b00675; Tovell H, 2019, ACS CHEM BIOL, V14, P2024, DOI 10.1021/acschembio.9b00505; Van Molle I, 2012, CHEM BIOL, V19, P1300, DOI 10.1016/j.chembiol.2012.08.015; Varshney N, 2017, J KIDNEY CANCER VHL, V4, P20, DOI 10.15586/jkcvhl.2017.88; Verma R, 2020, MOL CELL, V77, P446, DOI 10.1016/j.molcel.2020.01.010; Wang YX, 2016, CANCER LETT, V383, P1, DOI 10.1016/j.canlet.2016.09.009; Zengerle M, 2015, ACS CHEM BIOL, V10, P1770, DOI 10.1021/acschembio.5b00216; Zhang J, 2018, SCIENCE, V361, P290, DOI 10.1126/science.aap8411; Zhang J, 2018, BIOMEDICINES, V6, DOI 10.3390/biomedicines6010035	51	2	2	1	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100910	10.1016/j.jbc.2021.100910	http://dx.doi.org/10.1016/j.jbc.2021.100910			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34174286	gold, Green Published			2022-12-28	WOS:000690873500007
J	Parrot, C; Moulinier, L; Bernard, F; Hashem, Y; Dupuy, D; Sissler, M				Parrot, Camila; Moulinier, Luc; Bernard, Florian; Hashem, Yaser; Dupuy, Denis; Sissler, Marie			Peculiarities of aminoacyl-tRNA synthetases from trypanosomatids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTAMINYL-TRANSFER-RNA; CRYSTAL-STRUCTURE; SEQUENCE; BINDING; BRUCEI; DOMAIN; ATP	Trypanosomatid parasites are responsible for various human diseases, such as sleeping sickness, animal trypanosomiasis, or cutaneous and visceral leishmaniases. The few available drugs to fight related parasitic infections are often toxic and present poor efficiency and specificity, and thus, finding new molecular targets is imperative. Aminoacyl-tRNA synthetases (aaRSs) are essential components of the translational machinery as they catalyze the specific attachment of an amino acid onto cognate tRNA(s). In trypanosomatids, one gene encodes both cytosolicand mitochondrial-targeted aaRSs, with only three exceptions. We identify here a unique specific feature of aaRSs from trypanosomatids, which is that most of them harbor distinct insertion and/or extension sequences. Among the 26 identified aaRSs in the trypanosome Leishmania tarentolae, 14 contain an additional domain or a terminal extension, confirmed in mature mRNAs by direct cDNA nanopore sequencing. Moreover, these RNA-Seq data led us to address the question of aaRS dual localization and to determine splice-site locations and the 50-UTR lengths for each mature aaRS-encoding mRNA. Altogether, our results provided evidence for at least one specific mechanism responsible for mitochondrial addressing of some L. tarentolae aaRSs. We propose that these newly identified features of trypanosomatid aaRSs could be developed as relevant drug targets to combat the diseases caused by these parasites.	[Parrot, Camila; Bernard, Florian; Hashem, Yaser; Dupuy, Denis; Sissler, Marie] Univ Bordeaux, IECB, U1212 INSERM, ARNA,UMR5320,CNRS, Pessac, France; [Moulinier, Luc] Univ Strasbourg, CNRS, ICube Lab, CSTB Complex Syst & Translat Bioinformat, Strasbourg, France; [Moulinier, Luc] Univ Strasbourg, CNRS, Strasbourg Federat Translat Med FMTS, Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Sissler, M (corresponding author), Univ Bordeaux, IECB, U1212 INSERM, ARNA,UMR5320,CNRS, Pessac, France.	m.sissler@iecb.u-bordeaux.fr		SISSLER, Marie/0000-0001-8594-5238; Bernard, Florian/0000-0003-2691-3871; Parrot, Camila/0000-0002-9495-2015	University of Bordeaux and F. B. by the international PhD Idex program from the University of Bordeaux	University of Bordeaux and F. B. by the international PhD Idex program from the University of Bordeaux	C. P. was supported by the University of Bordeaux and F. B. by the international PhD Idex program from the University of Bordeaux.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BEDOUELLE H, 1993, BIOCHIMIE, V75, P1099, DOI 10.1016/0300-9084(93)90009-H; Bullwinkle TJ, 2014, TOP CURR CHEM, V344, P43, DOI 10.1007/128_2013_423; Cestari I, 2013, MOL CELL BIOL, V33, P4872, DOI 10.1128/MCB.00711-13; Chadha S, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006575; Chung S, 2020, MOL CELLS, V43, P350, DOI 10.14348/molcells.2020.2287; Claros MG, 1996, EUR J BIOCHEM, V241, P779, DOI 10.1111/j.1432-1033.1996.00779.x; CUSACK S, 1990, NATURE, V347, P249, DOI 10.1038/347249a0; ERIANI G, 1990, NATURE, V347, P203, DOI 10.1038/347203a0; Francin M, 2002, J BIOL CHEM, V277, P1762, DOI 10.1074/jbc.M109759200; Frechin M, 2009, RNA BIOL, V6, P31, DOI 10.4161/rna.6.1.7564; Frugier M, 2000, EMBO J, V19, P2371, DOI 10.1093/emboj/19.10.2371; Geslain R, 2006, J BIOL CHEM, V281, P38217, DOI 10.1074/jbc.M607862200; Gianchecchi E, 2020, EXPERT REV ANTI-INFE, V18, P563, DOI 10.1080/14787210.2020.1751611; Grant TD, 2012, NUCLEIC ACIDS RES, V40, P3723, DOI 10.1093/nar/gkr1223; Guo M, 2014, TOP CURR CHEM, V344, P89, DOI 10.1007/128_2013_424; Guo M, 2013, NAT CHEM BIOL, V9, P145, DOI [10.1038/nchembio.1158, 10.1038/NCHEMBIO.1158]; Guo M, 2010, NAT REV MOL CELL BIO, V11, P668, DOI 10.1038/nrm2956; Guo M, 2010, FEBS LETT, V584, P434, DOI 10.1016/j.febslet.2009.11.064; Hamilton V, 2014, EUKARYOT CELL, V13, P539, DOI 10.1128/EC.00312-13; HANCOCK K, 1990, J BIOL CHEM, V265, P19208; Kaser S, 2018, MOL BIOCHEM PARASIT, V221, P52, DOI 10.1016/j.molbiopara.2018.03.004; Kalidas S, 2014, EUKARYOT CELL, V13, P504, DOI 10.1128/EC.00017-14; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kelly P, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0007983; Kim HS, 2014, FEBS LETT, V588, P2328, DOI 10.1016/j.febslet.2014.05.027; Kim T, 2000, J BIOL CHEM, V275, P21768, DOI 10.1074/jbc.M002404200; Koh CY, 2015, ACTA CRYSTALLOGR D, V71, P1684, DOI 10.1107/S1399004715007683; Kwon NH, 2019, NAT REV DRUG DISCOV, V18, P629, DOI 10.1038/s41573-019-0026-3; Larson ET, 2011, J MOL BIOL, V409, P159, DOI 10.1016/j.jmb.2011.03.026; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lefort V, 2015, MOL BIOL EVOL, V32, P2798, DOI 10.1093/molbev/msv150; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; McLachlan G., 2000, WILEY SER PROB STAT; Mekonnen G, 2018, PLOS NEGLECT TROP D, V12, DOI 10.1371/journal.pntd.0006790; Moulinier L, 2017, HUM MUTAT, V38, P1316, DOI 10.1002/humu.23277; Ognjenovic J, 2016, NUCLEIC ACIDS RES, V44, P3420, DOI 10.1093/nar/gkw082; Park JS, 2018, INT J BIOL MACROMOL, V120, P835, DOI 10.1016/j.ijbiomac.2018.08.171; Pettersen EF, 2021, PROTEIN SCI, V30, P70, DOI 10.1002/pro.3943; Raymond F, 2012, NUCLEIC ACIDS RES, V40, P1131, DOI 10.1093/nar/gkr834; Rinehart J, 2004, J BIOL CHEM, V279, P1161, DOI 10.1074/jbc.M310100200; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Ruan BF, 2005, J BIOL CHEM, V280, P25887, DOI 10.1074/jbc.M502174200; Siegel TN, 2010, NUCLEIC ACIDS RES, V38, P4946, DOI 10.1093/nar/gkq237; SIMPSON AM, 1989, NUCLEIC ACIDS RES, V17, P5427, DOI 10.1093/nar/17.14.5427; Simpson L, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003841; Thompson JD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-318; Tolkunova E, 2000, J BIOL CHEM, V275, P35063, DOI 10.1074/jbc.M006265200; Torres-Larios A, 2003, J MOL BIOL, V331, P201, DOI 10.1016/S0022-2836(03)00719-8; Torrie LS, 2020, ACS INFECT DIS, V6, P1044, DOI 10.1021/acsinfecdis.9b00453; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wicker N, 2002, NUCLEIC ACIDS RES, V30, P3992, DOI 10.1093/nar/gkf511; Xu XL, 2018, RNA BIOL, V15, P649, DOI 10.1080/15476286.2017.1377868; Yang XL, 2003, P NATL ACAD SCI USA, V100, P15376, DOI 10.1073/pnas.2136794100; Zhang ZS, 2020, RSC MED CHEM, V11, P885, DOI 10.1039/d0md00057d; Zhou HH, 2013, NATURE, V494, P121, DOI 10.1038/nature11774; Zikova A, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006679; 2006, P NATL ACAD SCI USA, V103, P6847	62	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100913	10.1016/j.jbc.2021.100913	http://dx.doi.org/10.1016/j.jbc.2021.100913			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34175310	Green Published, gold			2022-12-28	WOS:000690879300014
J	Separovich, RJ; Wilkins, MR				Separovich, Ryan J.; Wilkins, Marc R.			Ready, SET, Go: Post-translational regulation of the histone lysine methylation network in budding yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RNA-POLYMERASE-II; PROTEOME-WIDE ANALYSIS; SENSITIVE PHOSPHOPROTEOME REVEALS; CHARGE-BASED INTERACTION; CELL-CYCLE PROGRESSION; H3 LYS(36) METHYLATION; SACCHAROMYCES-CEREVISIAE; H3K36 METHYLATION; H2B UBIQUITYLATION; DNA-DAMAGE	Histone lysine methylation is a key epigenetic modification that regulates eukaryotic transcription. Here, we comprehensively review the function and regulation of the histone methylation network in the budding yeast and model eukaryote, Saccharomyces cerevisiae. First, we outline the lysine methylation sites that are found on histone proteins in yeast (H3K4me1/2/3, H3K36me1/2/3, H3K79me1/2/3, and H4K5/8/ 12me1) and discuss their biological and cellular roles. Next, we detail the reduced but evolutionarily conserved suite of methyltransferase (Set1p, Set2p, Dot1p, and Set5p) and demethylase (Jhd1p, Jhd2p, Rph1p, and Gis1p) enzymes that are known to control histone lysine methylation in budding yeast cells. Specifically, we illustrate the domain architecture of the methylation enzymes and highlight the structural features that are required for their respective functions and molecular interactions. Finally, we discuss the prevalence of post-translational modifications on yeast histone methylation enzymes and how phosphorylation, acetylation, and ubiquitination in particular are emerging as key regulators of enzyme function. We note that it will be possible to completely connect the histone methylation network to the cell's signaling system, given that all methylation sites and cognate enzymes are known, most phosphosites on the enzymes are known, and the mapping of kinases to phosphosites is tractable owing to the modest set of protein kinases in yeast. Moving forward, we expect that the rich variety of post-translational modifications that decorates the histone methylation machinery will explain many of the unresolved questions surrounding the function and dynamics of this intricate epigenetic network.	[Separovich, Ryan J.; Wilkins, Marc R.] Univ New South Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia	University of New South Wales Sydney	Wilkins, MR (corresponding author), Univ New South Wales, Sch Biotechnol & Biomol Sci, Syst Biol Initiat, Sydney, NSW, Australia.	m.wilkins@unsw.edu.au		Separovich, Ryan/0000-0001-6310-8463; Wilkins, Marc/0000-0002-5700-5684	Australian Research Training Program Scholarship; Australian Research Council [DP170100108, DP200100129]	Australian Research Training Program Scholarship; Australian Research Council(Australian Research Council)	R. J. S. was the recipient of an Australian Research Training Program Scholarship. This work was supported by Australian Research Council Grants DP170100108 and DP200100129 to M. R. W.	Agapite J, 2020, NUCLEIC ACIDS RES, V48, pD650, DOI 10.1093/nar/gkz813; Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Allard S, 1999, EMBO J, V18, P5108, DOI 10.1093/emboj/18.18.5108; ALLFREY VG, 1964, SCIENCE, V144, P559, DOI 10.1126/science.144.3618.559; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Altaf M, 2007, MOL CELL, V28, P1002, DOI 10.1016/j.molcel.2007.12.002; Nguyen AT, 2011, GENE DEV, V25, P1345, DOI 10.1101/gad.2057811; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Ardito F, 2017, INT J MOL MED, V40, P271, DOI 10.3892/ijmm.2017.3036; Bae HJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16082-2; Balciunas D, 1999, MOL GEN GENET, V262, P589; Batta K, 2011, GENE DEV, V25, P2254, DOI 10.1101/gad.177238.111; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Beilharz TH, 2017, GENETICS, V205, P185, DOI 10.1534/genetics.116.194852; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Beltrao P, 2012, CELL, V150, P413, DOI 10.1016/j.cell.2012.05.036; Bernard A, 2015, CURR BIOL, V25, P546, DOI 10.1016/j.cub.2014.12.049; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bhaumik SR, 2007, NAT STRUCT MOL BIOL, V14, P1008, DOI 10.1038/nsmb1337; Bilokapic S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11726-4; Bird AW, 2002, NATURE, V419, P411, DOI 10.1038/nature01035; Black JC, 2012, MOL CELL, V48, P491, DOI 10.1016/j.molcel.2012.11.006; Blair LP, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501662; Boa S, 2003, YEAST, V20, P827, DOI 10.1002/yea.995; Bodenmiller B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001182; Bontron S, 2013, CELL REP, V3, P16, DOI 10.1016/j.celrep.2012.11.025; Bostelman LJ, 2007, DNA REPAIR, V6, P383, DOI 10.1016/j.dnarep.2006.12.010; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Briggs SD, 2001, GENE DEV, V15, P3286, DOI 10.1101/gad.940201; Calpena E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134106; Cameroni E, 2004, CELL CYCLE, V3, P462; Carlson SM, 2015, J BIOL CHEM, V290, P12040, DOI 10.1074/jbc.M115.641530; Carmen AA, 2002, J BIOL CHEM, V277, P4778, DOI 10.1074/jbc.M110532200; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Carvalho S, 2013, NUCLEIC ACIDS RES, V41, P2881, DOI 10.1093/nar/gks1472; Chang YY, 2011, BIOCHEM J, V433, P295, DOI 10.1042/BJ20101418; Chen SH, 2010, J BIOL CHEM, V285, P12803, DOI 10.1074/jbc.M110.106989; Cheng XD, 2005, ANNU REV BIOPH BIOM, V34, P267, DOI 10.1146/annurev.biophys.34.040204.144452; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Chong SY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14595-4; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Choudhury R, 2019, GENE DEV, V33, P550, DOI 10.1101/gad.322222.118; Chu Y, 2007, EMBO J, V26, P4646, DOI 10.1038/sj.emboj.7601887; Chu YY, 2006, MOL CELL BIOL, V26, P3029, DOI 10.1128/MCB.26.8.3029-3038.2006; Clarke AS, 1999, MOL CELL BIOL, V19, P2515; Corda Y, 1999, NAT GENET, V21, P204, DOI 10.1038/5991; CORDEN JL, 1990, TRENDS BIOCHEM SCI, V15, P383, DOI 10.1016/0968-0004(90)90236-5; Croken MM, 2012, TRENDS PARASITOL, V28, P202, DOI 10.1016/j.pt.2012.02.009; De Vos D, 2011, EMBO REP, V12, P956, DOI 10.1038/embor.2011.131; Dehe PM, 2006, BIOCHEM CELL BIOL, V84, P536, DOI 10.1139/O06-081; Dehe PM, 2006, J BIOL CHEM, V281, P35404, DOI 10.1074/jbc.M603099200; Dion MF, 2005, P NATL ACAD SCI USA, V102, P5501, DOI 10.1073/pnas.0500136102; Donaldson-Collier MC, 2019, NAT GENET, V51, P517, DOI 10.1038/s41588-018-0338-y; Dover J, 2002, J BIOL CHEM, V277, P28368, DOI 10.1074/jbc.C200348200; Drazic A, 2016, BBA-PROTEINS PROTEOM, V1864, P1372, DOI 10.1016/j.bbapap.2016.06.007; Dronamraju R, 2018, NUCLEIC ACIDS RES, V46, P1331, DOI 10.1093/nar/gkx1276; Du HN, 2008, GENE DEV, V22, P2786, DOI 10.1101/gad.1700008; Du HN, 2010, J BIOL CHEM, V285, P11704, DOI 10.1074/jbc.M109.085043; Eapen VV, 2017, P NATL ACAD SCI USA, V114, pE1158, DOI 10.1073/pnas.1614364114; Emery-Corbin SJ, 2021, INT J PARASITOL, V51, P225, DOI 10.1016/j.ijpara.2020.09.006; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Faber PW, 1998, HUM MOL GENET, V7, P1463, DOI 10.1093/hmg/7.9.1463; Fahrenkrog B, 2016, MICROB CELL, V3, P1, DOI 10.15698/mic2016.01.472; Fang J, 2007, MOL CELL BIOL, V27, P5055, DOI 10.1128/MCB.00127-07; Farooq Z, 2016, MUTAT RES-REV MUTAT, V768, P46, DOI 10.1016/j.mrrev.2016.03.005; Faucher D, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001082; Feng Q, 2002, CURR BIOL, V12, P1052, DOI 10.1016/S0960-9822(02)00901-6; Fingerman IM, 2007, GENE DEV, V21, P2018, DOI 10.1101/gad.1560607; Fingerman IM, 2005, J BIOL CHEM, V280, P28761, DOI 10.1074/jbc.C500097200; Fraga MF, 2005, NAT GENET, V37, P391, DOI 10.1038/ng1531; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Fu HQ, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003542; Fuchs J, 2006, TRENDS PLANT SCI, V11, P199, DOI 10.1016/j.tplants.2006.02.008; Fuchs SM, 2012, J BIOL CHEM, V287, P3249, DOI 10.1074/jbc.M111.273953; Gao YG, 2014, STRUCTURE, V22, P378, DOI 10.1016/j.str.2013.12.005; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Gilbert TM, 2014, MOL CELL PROTEOMICS, V13, P2883, DOI 10.1074/mcp.M114.038224; Gnad F, 2009, PROTEOMICS, V9, P4642, DOI 10.1002/pmic.200900144; GOLDKNOPF IL, 1975, J BIOL CHEM, V250, P7182; Gong FD, 2019, MUTAT RES-REV MUTAT, V780, P37, DOI 10.1016/j.mrrev.2017.09.003; Gong XYJ, 2020, BBA-GENE REGUL MECH, V1863, DOI 10.1016/j.bbagrm.2020.194603; Gopalakrishnan R, 2019, NUCLEIC ACIDS RES, V47, P3888, DOI 10.1093/nar/gkz119; Govind CK, 2010, MOL CELL, V39, P234, DOI 10.1016/j.molcel.2010.07.003; Green EM, 2012, NUCLEUS-PHILA, V3, P335, DOI 10.4161/nucl.20695; Green EM, 2012, NAT STRUCT MOL BIOL, V19, P361, DOI 10.1038/nsmb.2252; Greer EL, 2012, NAT REV GENET, V13, P343, DOI 10.1038/nrg3173; Guillemette B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001354; Guo HB, 2007, P NATL ACAD SCI USA, V104, P8797, DOI 10.1073/pnas.0702981104; GUTIERRE.RM, 1967, SCIENCE, V157, P1324, DOI 10.1126/science.157.3794.1324; Ha SD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12077-w; Hacker KE, 2016, J BIOL CHEM, V291, P21283, DOI 10.1074/jbc.M116.739375; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hamamoto R, 2004, NAT CELL BIOL, V6, P731, DOI 10.1038/ncb1151; Hamamoto R, 2006, CANCER SCI, V97, P113, DOI 10.1111/j.1349-7006.2006.00146.x; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Helbig AO, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-685; Henriksen P, 2012, MOL CELL PROTEOMICS, V11, P1510, DOI 10.1074/mcp.M112.017251; Herissant L, 2014, BIOL CELL, V106, P126, DOI 10.1111/boc.201400003; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hicke L, 1999, TRENDS CELL BIOL, V9, P107, DOI 10.1016/S0962-8924(98)01491-3; Hojfeldt JW, 2013, NAT REV DRUG DISCOV, V12, P917, DOI 10.1038/nrd4154; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hsu PL, 2018, CELL, V174, P1106, DOI 10.1016/j.cell.2018.06.038; Huang F, 2015, J BIOL CHEM, V290, P28760, DOI 10.1074/jbc.M115.693085; Huang F, 2010, J BIOL CHEM, V285, P24548, DOI 10.1074/jbc.M110.117333; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Huber LC, 2007, ARTHRITIS RHEUM-US, V56, P3523, DOI 10.1002/art.22948; Husmann D, 2019, NAT STRUCT MOL BIOL, V26, P880, DOI 10.1038/s41594-019-0298-7; Huyen Y, 2004, NATURE, V432, P406, DOI 10.1038/nature03114; Hyun K, 2017, EXP MOL MED, V49, DOI 10.1038/emm.2017.11; Iesmantavicius V, 2014, MOL CELL PROTEOMICS, V13, P1979, DOI 10.1074/mcp.O113.035683; Ingvarsdottir K, 2007, MOL CELL BIOL, V27, P7856, DOI 10.1128/MCB.00801-07; Ismail MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096648; Jaiswal D, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00341-19; Jaiswal D, 2017, J MOL BIOL, V429, P1946, DOI 10.1016/j.jmb.2016.10.018; Jang YK, 1999, MOL CELL BIOL, V19, P7630; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Jeon J, 2018, NUCLEIC ACIDS RES, V46, P11129, DOI 10.1093/nar/gky920; Jezek M, 2017, EPIGENETICS-US, V12, P93, DOI 10.1080/15592294.2016.1265712; Jha DK, 2014, NAT STRUCT MOL BIOL, V21, P655, DOI 10.1038/nsmb.2866; Jha DK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4965; Jiang LB, 2013, NATURE, V499, P223, DOI 10.1038/nature12361; Jones B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000190; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Kim J, 2013, MOL CELL, V49, P1121, DOI 10.1016/j.molcel.2013.01.034; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kim T, 2007, J BIOL CHEM, V282, P20827, DOI 10.1074/jbc.M703034200; Kim T, 2009, CELL, V137, P259, DOI 10.1016/j.cell.2009.02.045; Kim W, 2014, CELL CYCLE, V13, P726, DOI 10.4161/cc.28104; Kirmizis A, 2007, NATURE, V449, P928, DOI 10.1038/nature06160; Kitada T, 2012, GENE DEV, V26, P2443, DOI 10.1101/gad.201095.112; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; KLEINSMI.LJ, 1966, P NATL ACAD SCI USA, V55, P1182, DOI 10.1073/pnas.55.5.1182; Klose RJ, 2007, MOL CELL BIOL, V27, P3951, DOI 10.1128/MCB.02180-06; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Klose RJ, 2006, NATURE, V442, P312, DOI 10.1038/nature04853; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; KORNBERG RD, 1974, SCIENCE, V184, P868, DOI 10.1126/science.184.4139.868; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Krogan NJ, 2002, J BIOL CHEM, V277, P10753, DOI 10.1074/jbc.C200023200; Kwon DW, 2011, BIOCHEM BIOPH RES CO, V410, P614, DOI 10.1016/j.bbrc.2011.06.039; Kwon T, 2003, EMBO J, V22, P292, DOI 10.1093/emboj/cdg025; Lacoste N, 2002, J BIOL CHEM, V277, P30421, DOI 10.1074/jbc.C200366200; Lal S, 2018, NUCLEIC ACIDS RES, V46, P215, DOI 10.1093/nar/gkx1051; Lamour J, 2019, FEMS YEAST RES, V19, DOI 10.1093/femsyr/foz035; Lanouette S, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134974; Lanz MC, 2021, EMBO REP, V22, DOI 10.15252/embr.202051121; Lazzaro F, 2008, EMBO J, V27, P1502, DOI 10.1038/emboj.2008.81; Ledesma L, 2018, DATABASE-OXFORD, DOI 10.1093/database/bax099; Lee CH, 2013, MOL CELL, V52, P255, DOI 10.1016/j.molcel.2013.08.024; Lee JS, 2007, CELL, V131, P1084, DOI 10.1016/j.cell.2007.09.046; Lee KY, 2018, G3-GENES GENOM GENET, V8, P3411, DOI 10.1534/g3.118.200589; Lee KY, 2018, G3-GENES GENOM GENET, V8, P1829, DOI 10.1534/g3.118.200151; Lee S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02759-8; Lerner AM, 2020, GENOME RES, V30, P1605, DOI 10.1101/gr.264283.120; Leung CS, 2019, CELL REP, V27, P3760, DOI 10.1016/j.celrep.2019.05.100; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li B, 2009, J BIOL CHEM, V284, P7970, DOI 10.1074/jbc.M808220200; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li F, 2017, NUCLEIC ACIDS RES, V45, P5183, DOI 10.1093/nar/gkx129; Li JM, 2019, CELL REP, V29, P2092, DOI 10.1016/j.celrep.2019.10.034; Li J, 2019, CELL MOL LIFE SCI, V76, P2899, DOI 10.1007/s00018-019-03144-y; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Liang CY, 2013, MOL BIOL CELL, V24, P3251, DOI 10.1091/mbc.E12-11-0820; Liang CY, 2011, NUCLEIC ACIDS RES, V39, P4151, DOI 10.1093/nar/gkr040; Liang G, 2007, NAT STRUCT MOL BIOL, V14, P243, DOI 10.1038/nsmb1204; Licatalosi DD, 2002, MOL CELL, V9, P1101, DOI 10.1016/S1097-2765(02)00518-X; Lickwar CR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004886; Liu W, 2017, BIOMED REP, V7, P153, DOI 10.3892/br.2017.941; Liu YL, 2014, PHARMACOL THERAPEUT, V143, P275, DOI 10.1016/j.pharmthera.2014.03.007; Liu YY, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00261-6; Luciano P, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.40; Ma XJ, 1998, P NATL ACAD SCI USA, V95, P6693, DOI 10.1073/pnas.95.12.6693; Macias MJ, 2000, NAT STRUCT BIOL, V7, P375, DOI 10.1038/75144; Malik S, 2010, FEBS J, V277, P1805, DOI 10.1111/j.1742-4658.2010.07607.x; Maltby VE, 2012, P NATL ACAD SCI USA, V109, P18505, DOI 10.1073/pnas.1202070109; Maltby VE, 2012, MOL CELL BIOL, V32, P3479, DOI 10.1128/MCB.00389-12; Margaritis T, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002952; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin BJE, 2017, GENETICS, V205, P1113, DOI 10.1534/genetics.116.199422; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Martin GM, 2014, EPIGENETICS-US, V9, P513, DOI 10.4161/epi.27645; Mas-y-Mas S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165139; Mazur PK, 2014, NATURE, V510, P283, DOI 10.1038/nature13320; McCauley BS, 2014, BBA-GENE REGUL MECH, V1839, P1454, DOI 10.1016/j.bbagrm.2014.05.008; McDaniel SL, 2017, CELL MOL LIFE SCI, V74, P3317, DOI 10.1007/s00018-017-2517-x; McDaniel SL, 2017, CELL REP, V19, P2371, DOI 10.1016/j.celrep.2017.05.057; McGrath J, 2015, PHARMACOL THERAPEUT, V150, P1, DOI 10.1016/j.pharmthera.2015.01.002; Mersman DP, 2012, J BIOL CHEM, V287, P2652, DOI 10.1074/jbc.M111.280867; Mersman DP, 2009, GENE DEV, V23, P951, DOI 10.1101/gad.1769209; Michaels KK, 2020, NUCLEIC ACIDS RES, V48, P5407, DOI 10.1093/nar/gkaa292; Mikheyeva IV, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004740; Millar CB, 2004, COLD SPRING HARB SYM, V69, P193, DOI 10.1101/sqb.2004.69.193; Miller T, 2001, P NATL ACAD SCI USA, V98, P12902, DOI 10.1073/pnas.231473398; Mohammad K, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19030860; Morera L, 2016, CLIN EPIGENETICS, V8, DOI 10.1186/s13148-016-0223-4; Morris SA, 2007, J BIOL CHEM, V282, P7632, DOI 10.1074/jbc.M607909200; Morselli M, 2015, ELIFE, V4, DOI 10.7554/eLife.06205; MURRAY K, 1964, BIOCHEMISTRY-US, V3, P10, DOI 10.1021/bi00889a003; Nadal-Ribelles M, 2015, NUCLEIC ACIDS RES, V43, P4937, DOI 10.1093/nar/gkv220; Nakanishi S, 2008, NAT STRUCT MOL BIOL, V15, P881, DOI 10.1038/nsmb.1454; Narita T, 2019, NAT REV MOL CELL BIO, V20, P156, DOI 10.1038/s41580-018-0081-3; Nelson CJ, 2006, CELL, V126, P905, DOI 10.1016/j.cell.2006.07.026; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, P NATL ACAD SCI USA, V100, P1820, DOI 10.1073/pnas.0437846100; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Ng HH, 2002, GENE DEV, V16, P1518, DOI 10.1101/gad.1001502; Nielsen ML, 2008, NAT METHODS, V5, P459, DOI 10.1038/nmeth0608-459; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Nislow C, 1997, MOL BIOL CELL, V8, P2421, DOI 10.1091/mbc.8.12.2421; Nordberg N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095078; Norris A, 2010, GENE DEV, V24, P115, DOI 10.1101/gad.1865510; Oh S, 2010, BIOCHEM BIOPH RES CO, V399, P512, DOI 10.1016/j.bbrc.2010.07.100; Olia AS, 2015, ACS CHEM BIOL, V10, P2034, DOI 10.1021/acschembio.5b00342; Onishi M, 2007, MOL CELL, V28, P1015, DOI 10.1016/j.molcel.2007.12.004; Ontoso D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003262; Osborne EA, 2009, NAT GENET, V41, P800, DOI 10.1038/ng.402; Oshiro J, 2003, J BIOL CHEM, V278, P31495, DOI 10.1074/jbc.M305452200; Pai CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5091; Patnaik D, 2004, J BIOL CHEM, V279, P53248, DOI 10.1074/jbc.M409604200; Pedruzzi I, 2000, EMBO J, V19, P2569, DOI 10.1093/emboj/19.11.2569; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Pryde F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005882; Qu QH, 2018, CELL, V174, P1117, DOI 10.1016/j.cell.2018.07.020; Quan ZZ, 2011, MICROBIOL-SGM, V157, P2694, DOI 10.1099/mic.0.048199-0; Ramasamy SK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13601; Rando OJ, 2007, CURR OPIN GENET DEV, V17, P94, DOI 10.1016/j.gde.2007.02.006; Rando OJ, 2012, GENETICS, V190, P351, DOI 10.1534/genetics.111.132266; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Roguev A, 2003, J BIOL CHEM, V278, P8487, DOI 10.1074/jbc.M209562200; Roguev A, 2001, EMBO J, V20, P7137, DOI 10.1093/emboj/20.24.7137; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Ryu HY, 2014, BMC BIOL, V12, DOI 10.1186/s12915-014-0075-3; Ryu HY, 2014, BIOCHEM BIOPH RES CO, V446, P113, DOI 10.1016/j.bbrc.2014.02.061; Sadowski I, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat026; San-Segundo PA, 2000, MOL BIOL CELL, V11, P3601, DOI 10.1091/mbc.11.10.3601; Sawada K, 2004, J BIOL CHEM, V279, P43296, DOI 10.1074/jbc.M405902200; Schaft D, 2003, NUCLEIC ACIDS RES, V31, P2475, DOI 10.1093/nar/gkg372; Schlichter A, 2005, EMBO J, V24, P1222, DOI 10.1038/sj.emboj.7600607; Schmahling S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.163808; Schneider J, 2005, MOL CELL, V19, P849, DOI 10.1016/j.molcel.2005.07.024; Schramke V, 2001, GENE DEV, V15, P1845, DOI 10.1101/gad.193901; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Schulze JM, 2009, MOL CELL, V35, P626, DOI 10.1016/j.molcel.2009.07.017; Sein H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120200; Sen P, 2015, GENE DEV, V29, P1362, DOI 10.1101/gad.263707.115; Separovich RJ, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015995; Separovich RJ, 2020, TRENDS BIOCHEM SCI, V45, P1035, DOI 10.1016/j.tibs.2020.08.004; Seward DJ, 2007, NAT STRUCT MOL BIOL, V14, P240, DOI 10.1038/nsmb1200; Shahbazian MD, 2005, MOL CELL, V19, P271, DOI 10.1016/j.molcel.2005.06.010; Shanower GA, 2005, GENETICS, V169, P173, DOI 10.1534/genetics.104.033191; Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shi Y, 2007, MOL CELL, V25, P1, DOI 10.1016/j.molcel.2006.12.010; Shi YJ, 2005, MOL CELL, V19, P857, DOI 10.1016/j.molcel.2005.08.027; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Shilatifard A, 2012, ANNU REV BIOCHEM, V81, P65, DOI 10.1146/annurev-biochem-051710-134100; Sims RJ, 2006, GENE DEV, V20, P2779, DOI 10.1101/gad.1468206; Singer MS, 1998, GENETICS, V150, P613; Singh V, 2017, PROTEIN J, V36, P1, DOI 10.1007/s10930-017-9696-z; Smolka MB, 2007, P NATL ACAD SCI USA, V104, P10364, DOI 10.1073/pnas.0701622104; Smolle M, 2012, NAT STRUCT MOL BIOL, V19, P884, DOI 10.1038/nsmb.2312; Soares LM, 2017, MOL CELL, V68, P773, DOI 10.1016/j.molcel.2017.10.013; Soares LM, 2014, CELL REP, V6, P961, DOI 10.1016/j.celrep.2014.02.017; Soares LM, 2012, J BIOL CHEM, V287, P15219, DOI 10.1074/jbc.M112.341412; Song YC, 2016, J HEMATOL ONCOL, V9, DOI 10.1186/s13045-016-0279-9; Sorenson MR, 2016, RNA BIOL, V13, P412, DOI 10.1080/15476286.2016.1144009; Soulard A, 2010, MOL BIOL CELL, V21, P3475, DOI 10.1091/mbc.E10-03-0182; South PF, 2013, P NATL ACAD SCI USA, V110, pE1016, DOI 10.1073/pnas.1215768110; Spellmon N, 2015, INT J MOL SCI, V16, P1406, DOI 10.3390/ijms16011406; Steunou AL, 2016, MOL CELL BIOL, V36, P2768, DOI 10.1128/MCB.00112-16; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Stulemeijer IJE, 2015, SCI REP-UK, V5, DOI 10.1038/srep09824; Sun ZW, 2002, NATURE, V418, P104, DOI 10.1038/nature00883; Swaney DL, 2013, NAT METHODS, V10, P676, DOI [10.1038/NMETH.2519, 10.1038/nmeth.2519]; Takahashi Y, 2011, P NATL ACAD SCI USA, V108, P20526, DOI 10.1073/pnas.1109360108; Takahashi YH, 2010, ADV ENZYME REGUL, V50, P104, DOI 10.1016/j.advenzreg.2009.12.005; Tatum D, 2011, J BIOL CHEM, V286, P17530, DOI 10.1074/jbc.M111.241570; Thornton JL, 2014, GENE DEV, V28, P115, DOI 10.1101/gad.232215.113; Tong ZT, 2014, MOL CELL PROTEOMICS, V13, P2871, DOI 10.1074/mcp.M114.040774; Tresaugues L, 2006, J MOL BIOL, V359, P1170, DOI 10.1016/j.jmb.2006.04.050; Tronnersjo S, 2007, MOL GENET GENOMICS, V277, P57, DOI 10.1007/s00438-006-0171-3; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Tu SJ, 2007, J BIOL CHEM, V282, P14262, DOI 10.1074/jbc.M609900200; Unal E, 2011, COLD SH Q B, V76, P73, DOI 10.1101/sqb.2011.76.011379; Valencia-Sanchez MI, 2021, SCIENCE, V371, P363, DOI 10.1126/science.abc6663; Van Aller GS, 2012, EPIGENETICS-US, V7, P340, DOI 10.4161/epi.19506; van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6; van Welsem T, 2008, MOL CELL BIOL, V28, P3861, DOI 10.1128/MCB.02050-07; van Welsem T, 2018, NUCLEIC ACIDS RES, V46, P11251, DOI 10.1093/nar/gky801; Venkatesh S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13610; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Venters BJ, 2011, MOL CELL, V41, P480, DOI 10.1016/j.molcel.2011.01.015; Verzijlbergen KF, 2012, MOL CELL, V48, P489, DOI 10.1016/j.molcel.2012.11.014; Vlaming H, 2019, EMBO J, V38, DOI 10.15252/embj.2019101564; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; Wagner EJ, 2012, NAT REV MOL CELL BIO, V13, P115, DOI 10.1038/nrm3274; Walter D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004095; Wang SS, 2011, MOL CELL BIOL, V31, P3171, DOI 10.1128/MCB.05017-11; Wang SZ, 2008, BMB REP, V41, P294, DOI 10.5483/BMBRep.2008.41.4.294; Wang Y, 2015, NUCLEIC ACIDS RES, V43, P4881, DOI 10.1093/nar/gkv393; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Weiner A, 2015, MOL CELL, V58, P371, DOI 10.1016/j.molcel.2015.02.002; Weiner A, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001369; Weinert BT, 2014, MOL SYST BIOL, V10, DOI 10.1002/msb.134766; Westholm JO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031577; Wilkinson AW, 2019, NATURE, V565, P372, DOI 10.1038/s41586-018-0821-8; Winter DL, 2018, J MOL BIOL, V430, P102, DOI 10.1016/j.jmb.2017.11.009; Woo YH, 2012, MOL BIOL EVOL, V29, P1757, DOI 10.1093/molbev/mss022; Wozniak GG, 2014, BBA-GENE REGUL MECH, V1839, P1353, DOI 10.1016/j.bbagrm.2014.03.002; Wu M, 2008, MOL CELL BIOL, V28, P7337, DOI 10.1128/MCB.00976-08; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xie LQ, 2011, EMBO J, V30, P1473, DOI 10.1038/emboj.2011.91; Xu MS, 2012, DEV CELL, V23, P1059, DOI 10.1016/j.devcel.2012.10.005; Ye CQ, 2019, MOL CELL, V73, P1115, DOI 10.1016/j.molcel.2019.01.012; Youdell ML, 2008, MOL CELL BIOL, V28, P4915, DOI 10.1128/MCB.00001-08; Young NL, 2010, CELL MOL LIFE SCI, V67, P3983, DOI 10.1007/s00018-010-0475-7; Yu Y, 2010, FEMS YEAST RES, V10, P793, DOI 10.1111/j.1567-1364.2010.00680.x; Zhang K, 2005, CELL, V122, P723, DOI 10.1016/j.cell.2005.06.021; Zhang L, 2005, EMBO J, V24, P2379, DOI 10.1038/sj.emboj.7600711; Zhang MM, 2015, BIOTECHNOL J, V10, P1903, DOI 10.1002/biot.201500508; Zhang NS, 2009, MICROBIOL-SGM, V155, P1690, DOI 10.1099/mic.0.026377-0; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao YM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a025064; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025	347	3	4	4	9	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100939	10.1016/j.jbc.2021.100939	http://dx.doi.org/10.1016/j.jbc.2021.100939			29	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34224729	gold, Green Published			2022-12-28	WOS:000690871000005
J	Valverde, A; Dunys, J; Lorivel, T; Debayle, D; Gay, AS; Caillava, C; Chami, M; Checler, F				Valverde, Audrey; Dunys, Julie; Lorivel, Thomas; Debayle, Delphine; Gay, Anne-Sophie; Caillava, Celine; Chami, Mounia; Checler, Frederic			Dipeptidyl peptidase 4 contributes to Alzheimer's disease-like defects in a mouse model and is increased in sporadic Alzheimer's disease brains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; BETA-DEGRADING ENZYMES; PYROGLUTAMATE-A-BETA; APATHY-LIKE BEHAVIOR; 1ST HIGHLY POTENT; GLUTAMINYL CYCLASE; INTRANEURONAL ACCUMULATION; LYSOSOMAL DYSFUNCTION; COGNITIVE DEFICITS; C99	The amyloid cascade hypothesis, which proposes a promi-nent role for full-length amyloid beta peptides in Alzheimer's disease, is currently being questioned. In addition to full-length amyloid beta peptide, several N-terminally truncated fragments of amyloid beta peptide could well contribute to Alzheimer's disease setting and/or progression. Among them, pyroGlu3-amyloid beta peptide appears to be one of the main components of early anatomical lesions in Alzheimer's disease-affected brains. Little is known about the proteolytic activities that could ac-count for the N-terminal truncations of full-length amyloid beta, but they appear as the rate-limiting enzymes yielding the Glu3-amyloid beta peptide sequence that undergoes subsequent cyclization by glutaminyl cyclase, thereby yielding pyroGlu3- amyloid beta. Here, we investigated the contribution of dipeptidyl peptidase 4 in Glu3-amyloid beta peptide formation and the functional influence of its genetic depletion or pharmacological blockade on spine maturation as well as on pyroGlu3-amyloid beta peptide and amyloid beta 42-positive plaques and amyloid beta 42 load in the triple transgenic Alzheimer's disease mouse model. Furthermore, we examined whether reduction of dipeptidyl peptidase 4 could rescue learning and memory deficits displayed by these mice. Our data establish that dipeptidyl peptidase 4 reduction alleviates anatomical, biochemical, and behavioral Alzheimer's disease-related defects. Furthermore, we demonstrate that dipeptidyl peptidase 4 activity is increased early in sporadic Alzheimer's disease brains. Thus, our data demonstrate that dipeptidyl peptidase 4 participates in pyro-Glu3-amyloid beta peptide formation and that targeting this peptidase could be considered as an alternative strategy to interfere with Alzheimer's disease progression.	[Valverde, Audrey; Dunys, Julie; Lorivel, Thomas; Debayle, Delphine; Gay, Anne-Sophie; Caillava, Celine; Chami, Mounia; Checler, Frederic] Univ Cote dAzur, INSERM, Team Labeled Lab Excellence LABEX Distalz, CNRS,IPMC, Valbonne, France; [Caillava, Celine] Genbiotech, Antibes, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur	Checler, F (corresponding author), Univ Cote dAzur, INSERM, Team Labeled Lab Excellence LABEX Distalz, CNRS,IPMC, Valbonne, France.	checler@ipmc.cnrs.fr	Valverde, Audrey/AAZ-4106-2021; Checler, Frederic/C-1241-2009	Checler, Frederic/0000-0003-2098-1750; Valverde, Audrey/0000-0002-6060-3503	LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); Hospital University Federation (FHU) OncoAge; Fondation Plan Alzheimer	LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); Hospital University Federation (FHU) OncoAge; Fondation Plan Alzheimer	The authors thank Dr La Ferla for initial supply of 3xTg-AD mice. This work was supported through the LABEX (excellence laboratory, program investment for the future) DISTALZ (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease), the Hospital University Federation (FHU) OncoAge, and the Fondation Plan Alzheimer. The authors greatly thank Frederic Brau and Sophie Abelanet at Imaging and Cytometry platform (Cote d'Azur, MICA). The authors thank Dr Luc Buee (UMR 837 Inserm-UDSL-CHRU, Centre de Recherche Jean-Pierre Aubert, Lille) for helpful discussions.	Alexandru A, 2011, J NEUROSCI, V31, P12790, DOI 10.1523/JNEUROSCI.1794-11.2011; Angelopoulou E, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.41; Antonyan A, 2018, NEUROCHEM INT, V113, P112, DOI 10.1016/j.neuint.2017.12.001; Barelli HL, 1997, MOL MED, V3, P695, DOI 10.1007/BF03401708; Bergman A, 2007, BIOPHARM DRUG DISPOS, V28, P315, DOI 10.1002/bdd.560; Bernstein HG, 2018, NEUROCHEM INT, V114, P55, DOI 10.1016/j.neuint.2018.01.005; Bourgeois A, 2018, NEUROBIOL AGING, V71, P21, DOI 10.1016/j.neurobiolaging.2018.06.038; Brothers HM, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00118; Bussiere R, 2017, J BIOL CHEM, V292, P10153, DOI 10.1074/jbc.M116.743070; Castellani Rudy J, 2006, Am J Alzheimers Dis Other Demen, V21, P126, DOI 10.1177/153331750602100213; Cavanagh C, 2013, J ALZHEIMERS DIS, V36, P233, DOI 10.3233/JAD-122131; CHECLER F, 1995, J NEUROCHEM, V65, P1431; Checler F., 1993, TEC BEHAV N 2, P375; Chen HX, 1999, BIOORG MED CHEM LETT, V9, P1511; Chen SY, 2019, NEUROPHARMACOLOGY, V157, DOI 10.1016/j.neuropharm.2019.107668; Cheng Q, 2020, PHARMACOL THERAPEUT, V212, DOI 10.1016/j.pharmthera.2020.107559; Cisse M, 2017, MOL PSYCHIATR, V22, P1562, DOI 10.1038/mp.2016.152; Cynis H, 2008, BIOCHEMISTRY-US, V47, P7405, DOI 10.1021/bi800250p; D'Amico M, 2010, EXP GERONTOL, V45, P202, DOI 10.1016/j.exger.2009.12.004; DAUCH P, 1993, PEPTIDES, V14, P593, DOI 10.1016/0196-9781(93)90150-F; David C, 1999, J MED CHEM, V42, P5197, DOI 10.1021/jm9903040; Dunys J, 2018, J BIOL CHEM, V293, P15419, DOI 10.1074/jbc.R118.003999; Gilbert MP, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00178; Goutagny R, 2013, EUR J NEUROSCI, V37, P1896, DOI 10.1111/ejn.12233; Green Brian D, 2006, Diab Vasc Dis Res, V3, P159, DOI 10.3132/dvdr.2006.024; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Huang YM, 2019, J AM GERIATR SOC, V67, P841, DOI 10.1111/jgs.15830; ICHAI C, 1994, J NEUROCHEM, V62, P645; Jawhar S, 2011, J BIOL CHEM, V286, P4454, DOI 10.1074/jbc.M110.185819; Kaur G, 2017, MOL PSYCHIATR, V22, P981, DOI 10.1038/mp.2016.189; Kim DS, 2017, CELL TRANSPLANT, V26, P1560, DOI 10.1177/0963689717721234; Kosaraju J, 2017, MOL NEUROBIOL, V54, P6074, DOI 10.1007/s12035-016-0125-7; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lauritzen L, 2019, CURR ALZHEIMER RES, V16, P453, DOI 10.2174/1567205016666190325092841; Lena I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49392-7; Miners JS, 2008, BRAIN PATHOL, V18, P240, DOI 10.1111/j.1750-3639.2008.00132.x; Miners JS, 2011, J NEUROPATH EXP NEUR, V70, P944, DOI 10.1097/NEN.0b013e3182345e46; Mondragon-Rodriguez S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00121; Nalivaeva N N, 2012, Int J Alzheimers Dis, V2012, P383796, DOI 10.1155/2012/383796; Nixon RA, 2017, FASEB J, V31, P2729, DOI 10.1096/fj.201700359; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Panza F, 2019, NAT REV NEUROL, V15, P73, DOI 10.1038/s41582-018-0116-6; Pardossi-Piquard R, 2016, CURR ALZHEIMER RES, V13, P942, DOI 10.2174/1567205013666160404120106; Portelius E, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-2; Pospisilik JA, 2002, DIABETES, V51, P943, DOI 10.2337/diabetes.51.4.943; Pulina MV, 2020, ALZHEIMERS DEMENT, V16, P273, DOI 10.1016/j.jalz.2019.09.002; Qiao H, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8056370; RAHFELD J, 1991, BIOL CHEM H-S, V372, P313, DOI 10.1515/bchm3.1991.372.1.313; Risher WC, 2014, ELIFE, V3, DOI 10.7554/eLife.04047; Schilling S, 2008, NAT MED, V14, P1106, DOI 10.1038/nm.1872; Sevalle J, 2009, J NEUROCHEM, V109, P248, DOI 10.1111/j.1471-4159.2009.05950.x; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Stover KR, 2015, BEHAV BRAIN RES, V289, P29, DOI 10.1016/j.bbr.2015.04.012; Valverde A, 2021, ACTA NEUROPATHOL, V141, P823, DOI 10.1007/s00401-021-02308-0; Wittnam JL, 2012, J BIOL CHEM, V287, P8154, DOI 10.1074/jbc.M111.308601; Yuan XY, 2017, REV NEUROSCIENCE, V28, P715, DOI 10.1515/revneuro-2017-0016	59	7	7	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100963	10.1016/j.jbc.2021.100963	http://dx.doi.org/10.1016/j.jbc.2021.100963			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34265307	gold, Green Published			2022-12-28	WOS:000690873500017
J	Guerrero-Santoro, J; Khor, JM; Acikbas, AH; Jaynes, JB; Ettensohn, CA				Guerrero-Santoro, Jennifer; Khor, Jian Ming; Acikbas, Ayse Haruka; Jaynes, James B.; Ettensohn, Charles A.			Analysis of the DNA-binding properties of Alx1, an evolutionarily conserved regulator of skeletogenesis in echinoderms	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CLASS HOMEODOMAIN PROTEINS; PAIRED-LIKE HOMEOPROTEIN; GENETIC INTERACTIONS; FUNCTIONAL DOMAINS; TRANSCRIPTION; CART1; NETWORK; DIMERIZATION; SPECIFICITY; MUTANT	Alx1, a homeodomain-containing transcription factor, is a highly conserved regulator of skeletogenesis in echinoderms. In sea urchins, Alx1 plays a central role in the differentiation of embryonic primary mesenchyme cells (PMCs) and positively regulates the transcription of most biomineralization genes expressed by these cells. The alx1 gene arose via duplication and acquired a skeletogenic function distinct from its paralog (alx4) through the exonization of a 41-amino acid motif (the D2 domain). Alx1 and Alx4 contain glutamine-50 paired-type homeodomains, which interact preferentially with palindromic binding sites in vitro. Chromatin immunoprecipitation sequencing (ChIP-seq) studies have shown, however, that Alx1 binds both to palindromic and half sites in vivo. To address this apparent discrepancy and explore the function of the D2 domain, we used an endogenous cis-regulatory module associated with Sp-mtmmpb, a gene that encodes a PMC-specific metalloprotease, to analyze the DNA-binding properties of Alx1. We find that Alx1 forms dimeric complexes on TAAT-containing half sites by a mechanism distinct from the well-known mechanism of dimerization on palindromic sites. We used transgenic reporter assays to analyze the functional roles of half sites in vivo and demonstrate that two sites with partially redundant functions are essential for the PMC-specific activity of the Sp-mtmmpb cis-regulatory module. Finally, we show that the D2 domain influences the DNA-binding properties of Alx1 in vitro, suggesting that the exonization of this motif may have facilitated the acquisition of new transcriptional targets and consequently a novel developmental function.	[Guerrero-Santoro, Jennifer; Khor, Jian Ming; Acikbas, Ayse Haruka; Ettensohn, Charles A.] Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA; [Jaynes, James B.] Thomas Jefferson Univ, Dept Biochem & Mol Biol, Philadelphia, PA 19107 USA	Carnegie Mellon University; Jefferson University	Ettensohn, CA (corresponding author), Carnegie Mellon Univ, Dept Biol Sci, 4400 5th Ave, Pittsburgh, PA 15213 USA.	jsantoro@andrew.cmu.edu; ettensohn@cmu.edu		Khor, Jian Ming/0000-0002-1428-6770; Oshima Acikbas, Ayse Haruka/0000-0001-9581-4506	National Science Foundation [IOS-1354973]; National Institutes of Health [R24-OD023046, R01-GM117458]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by grants from the National Science Foundation (IOS-1354973, to C. A. E.) and the National Institutes of Health (R24-OD023046 to C. A. E. and R01-GM117458 to J. B. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altschuler Sarah E, 2013, J Nucleic Acids Investig, V4, P19; Arnone MI, 2004, METHOD CELL BIOL, V74, P621; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bertola DR, 2013, AM J MED GENET A, V161A, P600, DOI 10.1002/ajmg.a.35762; Beverdam A, 2001, DEVELOPMENT, V128, P3975; Bobola N, 2017, CURR OPIN GENET DEV, V43, P1, DOI 10.1016/j.gde.2016.09.008; Cai RL, 1998, BIOCHEM BIOPH RES CO, V250, P305, DOI 10.1006/bbrc.1998.9257; Capellini TD, 2010, DEVELOPMENT, V137, P2559, DOI 10.1242/dev.048819; Crocker J, 2015, CELL, V160, P191, DOI 10.1016/j.cell.2014.11.041; Czarkwiani A, 2013, GENE EXPR PATTERNS, V13, P464, DOI 10.1016/j.gep.2013.09.002; Dee CT, 2013, HUM MOL GENET, V22, P239, DOI 10.1093/hmg/dds423; El-Ruby M, 2018, AM J MED GENET A, V176, P1190, DOI 10.1002/ajmg.a.38655; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Erkenbrack EM, 2015, P NATL ACAD SCI USA, V112, pE4075, DOI 10.1073/pnas.1509845112; Ettensohn CA, 2003, DEVELOPMENT, V130, P2917, DOI 10.1242/dev.00511; Farley EK, 2016, P NATL ACAD SCI USA, V113, P6508, DOI 10.1073/pnas.1605085113; Furukawa K, 2002, GENES CELLS, V7, P1135, DOI 10.1046/j.1365-2443.2002.00587.x; Galliot B, 1999, DEV GENES EVOL, V209, P186, DOI 10.1007/s004270050243; Gao F, 2008, P NATL ACAD SCI USA, V105, P6091, DOI 10.1073/pnas.0801201105; Gao F, 2015, DEV BIOL, V400, P148, DOI 10.1016/j.ydbio.2015.01.017; Hughes AEO, 2018, GENOME RES, V28, P1520, DOI 10.1101/gr.231886.117; Iioka T, 2003, J BONE MINER RES, V18, P1419, DOI 10.1359/jbmr.2003.18.8.1419; Khor JM, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.569314; Khor JM, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.180653; Khor JM, 2017, ELIFE, V6, DOI 10.7554/eLife.32728; Koga H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149067; Kuijper S, 2005, DEVELOPMENT, V132, P1601, DOI 10.1242/dev.01735; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Lynch VJ, 2008, EVOLUTION, V62, P2131, DOI 10.1111/j.1558-5646.2008.00440.x; Matsumoto T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068774; McCauley BS, 2012, EVODEVO, V3, DOI 10.1186/2041-9139-3-17; Merabet S, 2016, TRENDS GENET, V32, P334, DOI 10.1016/j.tig.2016.03.004; Mirasierra M, 2006, MOL ENDOCRINOL, V20, P2876, DOI 10.1210/me.2005-0472; Perez-Villamil B, 2004, J BIOL CHEM, V279, P38062, DOI 10.1074/jbc.M400800200; Qu SM, 1999, DEVELOPMENT, V126, P359; Rafiq K, 2014, DEVELOPMENT, V141, P950, DOI 10.1242/dev.105585; Rafiq K, 2012, DEVELOPMENT, V139, P579, DOI 10.1242/dev.073049; Shashikant T, 2018, GENESIS, V56, DOI 10.1002/dvg.23253; Tucker SC, 1999, J BIOL CHEM, V274, P32325, DOI 10.1074/jbc.274.45.32325; Twigg SRF, 2009, AM J HUM GENET, V84, P698, DOI 10.1016/j.ajhg.2009.04.009; Ullah A, 2017, CLIN GENET, V91, P494, DOI 10.1111/cge.12822; Uz E, 2010, AM J HUM GENET, V86, P789, DOI 10.1016/j.ajhg.2010.04.002; WILSON D, 1993, GENE DEV, V7, P2120, DOI 10.1101/gad.7.11.2120; WILSON DS, 1995, CELL, V82, P709, DOI 10.1016/0092-8674(95)90468-9; Zhao Q, 1996, NAT GENET, V13, P275, DOI 10.1038/ng0796-275	45	2	2	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100901	10.1016/j.jbc.2021.100901	http://dx.doi.org/10.1016/j.jbc.2021.100901			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157281	Green Published, gold			2022-12-28	WOS:000678068400090
J	Harwood, SL; Nielsen, NS; Diep, K; Jensen, KT; Nielsen, PK; Yamamoto, K; Enghild, JJ				Harwood, Seandean Lykke; Nielsen, Nadia Sukusu; Diep, Khang; Jensen, Kathrine Tejlgard; Nielsen, Peter Kresten; Yamamoto, Kazuhiro; Enghild, Jan J.			Development of selective protease inhibitors via engineering of the bait region of human alpha(2)-macroglobulin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MATRIX-METALLOPROTEINASE INHIBITORS; HUMAN ALPHA-2-MACROGLOBULIN; STRUCTURAL BASIS; PROTEOLYTIC ACTIVITIES; SUBSTRATE RECOGNITION; CRYSTAL-STRUCTURE; CLEAVAGE SITES; COMPONENT C4; HUMAN PLASMA; FAST FORMS	Human alpha(2)-macroglobulin (A2M) is an abundant protease inhibitor in plasma, which regulates many proteolytic processes and is involved in innate immunity. A2M's unique protease-trapping mechanism of inhibition is initiated when a protease cleaves within the exposed and highly susceptible "bait region." As the wild-type bait region is permissive to cleavage by most human proteases, A2M is accordingly a broad-spectrum protease inhibitor. In this study, we extensively modified the bait region in order to identify any potential functionally important elements in the bait region sequence and to engineer A2M proteins with restrictive bait regions, which more selectively inhibit a target protease. A2M in which the bait region was entirely replaced by glycine-serine repeats remained fully functional and was not cleaved by any tested protease. Therefore, this bait region was designated as the "tabula rasa" bait region and used as the starting point for further bait region engineering. Cleavage of the tabula rasa bait region by specific proteases was conveyed by the insertion of appropriate substrate sequences, e.g., basic residues for trypsin. Screening and optimization of tabula rasa bait regions incorporating matrix metalloprotease 2 (MMP2) substrate sequences produced an A2M that was specifically cleaved by MMPs and inhibited MMP2 cleavage activity as efficiently as wild-type A2M. We propose that this approach can be used to develop A2M-based protease inhibitors, which selectively inhibit target proteases, which might be applied toward the clinical inhibition of dys-regulated proteolysis as occurs in arthritis and many types of cancer.	[Harwood, Seandean Lykke; Nielsen, Nadia Sukusu; Diep, Khang; Jensen, Kathrine Tejlgard; Enghild, Jan J.] Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark; [Harwood, Seandean Lykke; Nielsen, Peter Kresten] Novo Nordisk AS, Global Res Technol, Malov, Denmark; [Yamamoto, Kazuhiro] Univ Liverpool, Inst Life Course & Med Sci, Liverpool, Merseyside, England	Aarhus University; Novo Nordisk; University of Liverpool	Enghild, JJ (corresponding author), Aarhus Univ, Dept Mol Biol & Genet, Aarhus, Denmark.	jje@mbg.au.dk		Enghild, Jan Johannes/0000-0001-9292-9172; Harwood, Seandean Lykke/0000-0003-4654-8832	Velux Fonden [00014557]; Danish Council for Independent Research-Medical Science [DFF-4004-00471]; LEO Foundation; Novo Nordisk Foundation (BIO-MS); Versus Arthritis Career Development Fellowship [21447]	Velux Fonden(Velux Fonden); Danish Council for Independent Research-Medical Science(Det Frie Forskningsrad (DFF)); LEO Foundation(LEO Pharma); Novo Nordisk Foundation (BIO-MS); Versus Arthritis Career Development Fellowship	J. J. E. is supported by the Velux Fonden (00014557), the Danish Council for Independent Research-Medical Science (DFF-4004-00471), the LEO Foundation, and the Novo Nordisk Foundation (BIO-MS). K. Y. is supported by Versus Arthritis Career Development Fellowship (Grant 21447).	Aleshin AE, 2012, J BIOL CHEM, V287, P19642, DOI 10.1074/jbc.M112.361121; Arandjelovic S, 2005, ARCH BIOCHEM BIOPHYS, V438, P29, DOI 10.1016/j.abb.2005.03.019; Arbelaez LF, 1997, ARCH BIOCHEM BIOPHYS, V347, P62, DOI 10.1006/abbi.1997.0309; BARRETT AJ, 1979, BIOCHEM J, V181, P401, DOI 10.1042/bj1810401; BOISSET N, 1993, J MOL BIOL, V232, P522, DOI 10.1006/jmbi.1993.1408; Bond JS, 2019, J BIOL CHEM, V294, P1643, DOI 10.1074/jbc.TM118.004156; BORTH W, 1994, ANN NY ACAD SCI, V737, P267, DOI 10.1111/j.1749-6632.1994.tb44317.x; Bowen ME, 1998, J BIOL CHEM, V273, P1825, DOI 10.1074/jbc.273.3.1825; BRETAUDIERE JP, 1988, P NATL ACAD SCI USA, V85, P1437, DOI 10.1073/pnas.85.5.1437; Cathcart J, 2015, GENES DIS, V2, P26, DOI 10.1016/j.gendis.2014.12.002; Chen EI, 2002, J BIOL CHEM, V277, P4485, DOI 10.1074/jbc.M109469200; CHRISTENSEN U, 1984, BIOCHEMISTRY-US, V23, P6619, DOI 10.1021/bi00321a052; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; Coussens LM, 2002, SCIENCE, V295, P2387, DOI 10.1126/science.1067100; Crawley JTB, 2011, BLOOD, V118, P3212, DOI 10.1182/blood-2011-02-306597; DEUTSCH DG, 1970, SCIENCE, V170, P1095, DOI 10.1126/science.170.3962.1095; Doan N, 2007, BIOCHEM J, V407, P23, DOI 10.1042/BJ20070764; Dong JF, 2002, BLOOD, V100, P4033, DOI 10.1182/blood-2002-05-1401; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; ELLIS V, 1982, BIOCHIM BIOPHYS ACTA, V701, P24; ENGHILD JJ, 1989, J BIOL CHEM, V264, P11428; ENGHILD JJ, 1989, J BIOL CHEM, V264, P8779; Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625; Fredslund F, 2006, J MOL BIOL, V361, P115, DOI 10.1016/j.jmb.2006.06.009; Gendron C, 2007, J BIOL CHEM, V282, P18294, DOI 10.1074/jbc.M701523200; GETTINS P, 1986, BIOCHEMISTRY-US, V25, P5011, DOI 10.1021/bi00366a007; Gron H, 1997, J PERIODONTAL RES, V32, P61, DOI 10.1111/j.1600-0765.1997.tb01383.x; HALL PK, 1981, BIOCHEM BIOPH RES CO, V100, P8, DOI 10.1016/S0006-291X(81)80055-1; HARPEL PC, 1970, J EXP MED, V132, P329, DOI 10.1084/jem.132.2.329; Harwood SL, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1016/j.mcpro.2021.100090; Harwood SL, 2020, BIOCHEMISTRY-US, V59, P4799, DOI 10.1021/acs.biochem.0c00803; Harwood SL, 2020, J BIOL CHEM, V295, P16732, DOI 10.1074/jbc.RA120.015694; HOWELL JB, 1983, ARCH BIOCHEM BIOPHYS, V221, P261, DOI 10.1016/0003-9861(83)90143-1; Ikai A, 1999, CYTOTECHNOLOGY, V31, P53, DOI 10.1023/A:1008011919876; IMBER MJ, 1981, J BIOL CHEM, V256, P8134; Janssen BJC, 2006, NATURE, V444, P213, DOI 10.1038/nature05172; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kashiwagi M, 2004, J BIOL CHEM, V279, P10109, DOI 10.1074/jbc.M312123200; Keil B., 1971, ENZYMES, V3, P249, DOI [10.1016/S1874-6047(08)60399-6., 10.1021/bi00843a047, DOI 10.1021/BI00843A047]; Kidmose RT, 2012, P NATL ACAD SCI USA, V109, P15425, DOI 10.1073/pnas.1208031109; Kuno K, 1999, J BIOL CHEM, V274, P18821, DOI 10.1074/jbc.274.26.18821; Laronha H, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10050717; Levin M, 2017, BBA-MOL CELL RES, V1864, P1927, DOI 10.1016/j.bbamcr.2017.06.009; Marrero A, 2012, ANGEW CHEM INT EDIT, V51, P3340, DOI 10.1002/anie.201108015; MEIER UC, 1991, BIOL CHEM H-S, V372, P1051, DOI 10.1515/bchm3.1991.372.2.1051; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; Mortensen S, 2015, J IMMUNOL, V194, P5488, DOI 10.4049/jimmunol.1500087; NAGASE H, 1983, J BIOL CHEM, V258, P7490; Overall CM, 2006, NAT REV CANCER, V6, P227, DOI 10.1038/nrc1821; Pelman GR, 2005, J BIOL CHEM, V280, P2370, DOI 10.1074/jbc.M409603200; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Ratnikov BI, 2014, P NATL ACAD SCI USA, V111, pE4148, DOI 10.1073/pnas.1406134111; Raymond WW, 2009, J IMMUNOL, V182, P5770, DOI 10.4049/jimmunol.0900127; Razai AS, 2020, J BIOL CHEM, V295, P2464, DOI 10.1074/jbc.RA119.011712; ROCHE PA, 1987, BIOCHEMISTRY-US, V26, P486, DOI 10.1021/bi00376a021; Romanelli R, 1999, INFECT IMMUN, V67, P2319, DOI 10.1128/IAI.67.5.2319-2326.1999; SALVESEN G, 1993, METHOD ENZYMOL, V223, P121; SALVESEN GS, 1981, BIOCHEM J, V195, P453, DOI 10.1042/bj1950453; SALVESEN GS, 1980, BIOCHEM J, V187, P695, DOI 10.1042/bj1870695; SOTTRUPJENSEN L, 1983, ANN NY ACAD SCI, V421, P188, DOI 10.1111/j.1749-6632.1983.tb18109.x; SOTTRUPJENSEN L, 1989, J BIOL CHEM, V264, P15781; SOTTRUPJENSEN L, 1985, P NATL ACAD SCI USA, V82, P9, DOI 10.1073/pnas.82.1.9; VANLEUVEN F, 1988, J BIOL CHEM, V263, P468; VANROMPAEY L, 1995, BIOCHEM J, V312, P191, DOI 10.1042/bj3120191; VanRompaey L, 1997, BIOCHEM J, V326, P507; VIRCA GD, 1984, J BIOL CHEM, V259, P8870; Yu ZX, 2012, J BIOL CHEM, V287, P22988, DOI 10.1074/jbc.M112.348979; Zhang Y, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1363-4	68	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100879	10.1016/j.jbc.2021.100879	http://dx.doi.org/10.1016/j.jbc.2021.100879			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34139236	gold, Green Published			2022-12-28	WOS:000678068400078
J	Srivastav, MK; Agarwal, N; Poonia, P; Natarajan, K				Srivastav, Manjit Kumar; Agarwal, Neha; Poonia, Poonam; Natarajan, Krishnamurthy			Interplay between transcriptional regulators and the SAGA chromatin modifying complex fine-tune iron homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CCAAT-BINDING FACTOR; HISTONE ACETYLTRANSFERASE COMPLEXES; CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; FACTOR CBF; GENE; SUBUNIT; ROLES; ACTIVATION; COMMENSALISM	The human fungal pathogen Candida albicans responds to iron deprivation by a global transcriptome reconfiguration known to be controlled by the transcriptional regulators Hap43 (also known as Cap2), Sef1, and the trimeric Hap2-Hap3-Hap5 complex. However, the relative roles of these regulators are not known. To dissect this system, we focused on the FRP1 and ACO1 genes, which are induced and repressed, respectively, under iron deprivation conditions. Chromatin immunoprecipitation assays showed that the trimeric HAP complex and Sef1 are recruited to both FRP1 and ACO1 promoters. While the HAP complex occupancy at the FRP1 promoter was Sef1-dependent, occupancy of Sef1 was not dependent on the HAP complex. Furthermore, iron deprivation elicited histone H3-Lys9 hyperacetylation and Pol II recruitment mediated by the trimeric HAP complex and Sef1 at the FRP1 promoter. In contrast, at the ACO1 promoter, the HAP trimeric complex and Hap43 promoted histone deacetylation and also limited Pol II recruitment under iron deprivation conditions. Mutational analysis showed that the SAGA subunits Gcn5, Spt7, and Spt20 are required for C. albicans growth in iron-deficient medium and for H3-K9 acetylation and transcription from the FRP1 promoter. Thus, the trimeric HAP complex promotes FRP1 transcription by stimulating H3K9Ac and Pol II recruitment and, along with Hap43, functions as a repressor of ACO1 by maintaining a deacetylated promoter under iron-deficient conditions. Thus, a regulatory network involving iron-responsive transcriptional regulators and the SAGA histone modifying complex functions as a molecular switch to fine-tune tight control of iron homeostasis gene expression in C. albicans.	[Srivastav, Manjit Kumar; Agarwal, Neha; Poonia, Poonam; Natarajan, Krishnamurthy] Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi, India	Jawaharlal Nehru University, New Delhi	Natarajan, K (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, Lab Eukaryot Gene Regulat, New Delhi, India.	nat0200@mail.jnu.ac.in	Srivastav, Manjit Kumar/S-7734-2019	Srivastav, Manjit Kumar/0000-0001-7235-7621	UGC; CSIR	UGC(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	N. A. was supported by research fellowship from UGC, and M. K. S. and P. P. were supported by Junior and Senior Research Fellowships from CSIR.	Almeida RS, 2009, FEMS YEAST RES, V9, P1000, DOI 10.1111/j.1567-1364.2009.00570.x; Baek YU, 2008, EUKARYOT CELL, V7, P1168, DOI 10.1128/EC.00108-08; Baptista T, 2017, MOL CELL, V68, P130, DOI 10.1016/j.molcel.2017.08.016; Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948; Bhaumik SR, 2004, GENE DEV, V18, P333, DOI 10.1101/gad.1148404; Blankenship JR, 2011, CELL HOST MICROBE, V10, P93, DOI 10.1016/j.chom.2011.08.001; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Brown CE, 2001, SCIENCE, V292, P2333, DOI 10.1126/science.1060214; Chakravarti A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170649; Chang P, 2015, FUNGAL GENET BIOL, V81, P132, DOI 10.1016/j.fgb.2015.01.011; Chen CB, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002956; Chen CB, 2011, CELL HOST MICROBE, V10, P118, DOI 10.1016/j.chom.2011.07.005; Coustry F, 1996, J BIOL CHEM, V271, P14485, DOI 10.1074/jbc.271.24.14485; Drysdale CM, 1998, MOL CELL BIOL, V18, P1711, DOI 10.1128/MCB.18.3.1711; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; Gola S, 2003, YEAST, V20, P1339, DOI 10.1002/yea.1044; Grant PA, 2021, BBA-GENE REGUL MECH, V1864, DOI 10.1016/j.bbagrm.2020.194669; Gupta M, 2020, CURR OPIN CHEM BIOL, V55, P189, DOI 10.1016/j.cbpa.2020.02.008; Hameed S, 2008, FEMS YEAST RES, V8, P744, DOI 10.1111/j.1567-1364.2008.00394.x; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Helmlinger D, 2017, TRENDS BIOCHEM SCI, V42, P850, DOI 10.1016/j.tibs.2017.09.001; Homann OR, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000783; Hortschansky P, 2007, EMBO J, V26, P3157, DOI 10.1038/sj.emboj.7601752; Hsu PC, 2013, EUKARYOT CELL, V12, P804, DOI 10.1128/EC.00014-13; Hsu PC, 2011, EUKARYOT CELL, V10, P207, DOI 10.1128/EC.00158-10; Johnson DC, 2005, EUKARYOT CELL, V4, P1662, DOI 10.1128/EC.4.10.1662-1676.2005; Keaveney M, 1998, MOL CELL, V1, P917, DOI 10.1016/S1097-2765(00)80091-X; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; Lan CY, 2004, MOL MICROBIOL, V53, P1451, DOI 10.1111/j.1365-2958.2004.04214.x; Laprade L, 2002, GENETICS, V161, P509; Lee KK, 2007, NAT REV MOL CELL BIO, V8, P284, DOI 10.1038/nrm2145; Lee KK, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.40; Lenstra TL, 2011, MOL CELL, V42, P536, DOI 10.1016/j.molcel.2011.03.026; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mao YH, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01645; Mayer FL, 2013, VIRULENCE, V4, P119, DOI 10.4161/viru.22913; MOEHLE CM, 1991, MOL CELL BIOL, V11, P2723, DOI 10.1128/MCB.11.5.2723; Murad AMA, 2000, YEAST, V16, P325, DOI 10.1002/1097-0061(20000315)16:4&lt;325::AID-YEA538&gt;3.0.CO;2-#; Natarajan K, 1998, MOL CELL, V2, P683, DOI 10.1016/S1097-2765(00)80166-5; Noble SM, 2005, EUKARYOT CELL, V4, P298, DOI 10.1128/EC.4.2.298-309.2005; Noble SM, 2013, CURR OPIN MICROBIOL, V16, P708, DOI 10.1016/j.mib.2013.09.006; PARR RM, 1964, BIOCHEM J, V91, P424, DOI 10.1042/bj0910424; Puri S, 2014, MOL MICROBIOL, V93, P291, DOI 10.1111/mmi.12659; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Sellam A, 2009, MOL BIOL CELL, V20, P2389, DOI 10.1091/mbc.E08-11-1093; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; Sharma S, 2014, ANTIMICROB AGENTS CH, V58, P2409, DOI 10.1128/AAC.02130-13; Singh RP, 2011, J BIOL CHEM, V286, P25154, DOI 10.1074/jbc.M111.233569; Sinha I, 2017, J BIOL CHEM, V292, P6047, DOI 10.1074/jbc.C116.768549; Sinha S, 1996, MOL CELL BIOL, V16, P328; SINHA S, 1995, P NATL ACAD SCI USA, V92, P1624, DOI 10.1073/pnas.92.5.1624; Skrahina V, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02388; Soffers JHM, 2020, GENE DEV, V34, P1287, DOI 10.1101/gad.341156.120; Spedale G, 2012, GENE DEV, V26, P527, DOI 10.1101/gad.184705.111; Srivastav M. K., 2017, CANDIDA ALBICANS CEL, P347; Srivastav MK, 2018, MSPHERE, V3, DOI 10.1128/mSphere.00370-18; Tan XJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094468; Uhl MA, 2001, MICROBIOL-SGM, V147, P1189, DOI 10.1099/00221287-147-5-1189; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Wu PYJ, 2004, MOL CELL, V15, P199, DOI 10.1016/j.molcel.2004.06.005	61	2	2	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100727	10.1016/j.jbc.2021.100727	http://dx.doi.org/10.1016/j.jbc.2021.100727			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	33933457	gold, Green Published			2022-12-28	WOS:000678068400003
J	Qian, TT; Li, CL; He, RY; Wan, C; Liu, YH; Yu, HJ				Qian, Tiantian; Li, Chenlu; He, Ruyue; Wan, Chun; Liu, Yinghui; Yu, Haijia			Calcium-dependent and -independent lipid transfer mediated by tricalbins in yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Membrane contact sites (MCSs) formed between the endoplasmic reticulum (ER) and the plasma membrane (PM) provide a platform for nonvesicular lipid exchange. The ER-anchored tricalbins (Tcb1, Tcb2, and Tcb3) are critical tethering factors at ER-PM MCSs in yeast. Tricalbins possess a synaptotagmin-like mitochondrial-lipid-binding protein (SMP) domain and multiple Ca2+-binding C2 domains. Although tricalbins have been suggested to be involved in lipid exchange at the ER-PM MCSs, it remains unclear whether they directly mediate lipid transport. Here, using in vitro lipid transfer assays, we discovered that tricalbins are capable of transferring phospholipids between membranes. Unexpectedly, while its lipid transfer activity was markedly elevated by Ca2+, Tcb3 constitutively transferred lipids even in the absence of Ca2+. The stimulatory activity of Ca2+ on Tcb3 required intact Ca2+-binding sites on both the C2C and C2D domains of Tcb3, while Ca2+-independent lipid transport was mediated by the SMP domain that transferred lipids via direct interactions with phosphatidylserine and other negatively charged lipid molecules. These findings establish tricalbins as lipid transfer proteins, and reveal Ca2+-dependent and -independent lipid transfer activities mediated by these tricalbins, providing new insights into their mechanism in maintaining PM integrity at ER-PM MCSs.	[Qian, Tiantian; Li, Chenlu; He, Ruyue; Liu, Yinghui; Yu, Haijia] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China; [Wan, Chun] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	Nanjing Normal University; University of Colorado System; University of Colorado Boulder	Liu, YH; Yu, HJ (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China.	yinghuiliu@njnu.edu.cn; yuhaijia@njnu.edu.cn	Yu, Haijia/GXV-5159-2022	Yu, Haijia/0000-0002-7193-8034	National Natural Science Foundation of China (NSFC) [91854117, 31871425]; Natural Science Foundation of Jiangsu Province [BK20200036]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talent Peaks Project in Jiangsu Province; Jiangsu Distinguished Professor Fund	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Six Talent Peaks Project in Jiangsu Province; Jiangsu Distinguished Professor Fund	We thank Dr Jingshi Shen for insightful discussions and Xiaojun Wang for technical assistance. This work was supported by the National Natural Science Foundation of China (NSFC) grants (Nos. 91854117 and 31871425), Natural Science Foundation of Jiangsu Province (BK20200036), the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), Six Talent Peaks Project in Jiangsu Province, and Jiangsu Distinguished Professor Funding.		0	10	10	2	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100729	10.1016/j.jbc.2021.100729	http://dx.doi.org/10.1016/j.jbc.2021.100729			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933446	gold, Green Published			2022-12-28	WOS:000672866400698
J	Blumenthal, DK; Cheng, XL; Fajer, M; Ho, KY; Rohrer, J; Gerlits, O; Taylor, P; Juneja, P; Kovalevsky, A; Radic, Z				Blumenthal, Donald K.; Cheng, Xiaolin; Fajer, Mikolai; Ho, Kwok-Yiu; Rohrer, Jacqueline; Gerlits, Oksana; Taylor, Palmer; Juneja, Puneet; Kovalevsky, Andrey; Radic, Zoran			Covalent inhibition of hAChE by organophosphates causes homodimer dissociation through long-range allosteric effects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; ACETYLCHOLINESTERASE INHIBITION; INTERACTION KINETICS; TORPEDO-CALIFORNICA; PROTEIN; COMPLEX; BUTYRYLCHOLINESTERASE; EXPRESSION; LANGEVIN; SYSTEM	Acetylcholinesterase (EC 3.1.1.7), a key acetylcholine hydrolyzing enzyme in cholinergic neurotransmission, is present in a variety of states in situ, including monomers, C-terminally disulfide-linked homodimers, homotetramers, and up to three tetramers covalently attached to structural subunits. Could oligomerization that ensures high local concentrations of catalytic sites necessary for efficient neurotransmission be affected by environmental factors? Using small-angle X-ray scattering (SAXS) and cryo-EM, we demonstrate that homodimerization of recombinant monomeric human acetylcholinesterase (hAChE) in solution occurs through a C-terminal four-helix bundle at micromolar concentrations. We show that diethylphosphorylation of the active serine in the catalytic gorge or isopropylmethylphosphonylation by the RP enantiomer of sarin promotes a 10-fold increase in homodimer dissociation. We also demonstrate the dissociation of organophosphate (OP)-conjugated dimers is reversed by structurally diverse oximes 2PAM, HI6, or RS194B, as demonstrated by SAXS of diethylphosphoryl-hAChE. However, binding of oximes to the native ligand-free hAChE, binding of high-affinity reversible ligands, or formation of an SP-sarin-hAChE conjugate had no effect on homodimerization. Dissociation monitored by time-resolved SAXS occurs in milliseconds, consistent with rates of hAChE covalent inhibition. OP-induced dissociation was not observed in the SAXS profiles of the double mutant Y337A/F338A, where the active center gorge volume is larger than in wildtype hAChE. These observations suggest a key role of the tightly packed acyl pocket in allosterically triggered OP-induced dimer dissociation, with the potential for local reduction of acetylcholine-hydrolytic power in situ. Computational models predict allosteric correlated motions extending from the acyl pocket toward the four-helix bundle dimerization interface 25 angstrom away.	[Blumenthal, Donald K.] Univ Utah, Dept Pharmacol & Toxicol, 112 Skaggs Hall, Salt Lake City, UT 84112 USA; [Cheng, Xiaolin; Fajer, Mikolai] Ohio State Univ, Coll Pharm, Div Med Chem & Pharmacognosy, 500 W 12Th Ave, Columbus, OH 43210 USA; [Ho, Kwok-Yiu; Rohrer, Jacqueline; Taylor, Palmer; Radic, Zoran] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Gerlits, Oksana] Tennessee Wesleyan Univ, Dept Nat Sci, Athens, TN USA; [Juneja, Puneet] Iowa State Univ, CryoEM Facil, Ames, IA USA; [Kovalevsky, Andrey] Oak Ridge Natl Lab, Neutron Scattering Div, Oak Ridge, TN USA	Utah System of Higher Education; University of Utah; University System of Ohio; Ohio State University; University of California System; University of California San Diego; Iowa State University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Radic, Z (corresponding author), Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA.	zradic@ucsd.edu	Juneja, Puneet/HHC-1232-2022	Juneja, Puneet/0000-0002-6774-2821; Cheng, Xiaolin/0000-0002-7396-3225; Blumenthal, Donald/0000-0002-8614-1167; Rohrer, Jacqueline/0000-0002-6436-161X; Kovalevsky, Andrey/0000-0003-4459-9142; Juneja, Puneet/0000-0002-8934-4509	US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; NIH; NIGMS, National Institutes of Health [P41GM103393]; CounterACT Program; National Institute of Neurological Disorders and Stroke (NINDS) [U01 NS083451, R21 NS098998]; UCSD Academic Senate [BG084144]; National Institutes of Health Office of the Director (NIH OD)	US Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CounterACT Program; National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); UCSD Academic Senate; National Institutes of Health Office of the Director (NIH OD)	The highly professional and creative assistance of the Stanford Synchrotron Radiation Lightsource (SSRL) BioSAXS beamline (BL 4-2) scientists Dr Thomas Weiss, Dr Tsutomu Matsui, and Dr Ivan Rajkovic is highly appreciated. Use of the Stanford Synchrotron Radiation Lightsource, SLAC National Accelerator Laboratory, is supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract No. DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research, and by the NIH and the NIGMS, National Institutes of Health (P41GM103393). We are grateful to Dr Jonah Cheung, NYSBC, New York, for providing us with atomic coordinates of PDB ID 5HF5 well before their deposition to the PDB. We thank Dina Schneidman-Duhovny (dina@salilab.org) for her assistance in using MultiFoXS. This research was supported by the CounterACT Program, National Institutes of Health Office of the Director (NIH OD), the National Institute of Neurological Disorders and Stroke (NINDS) (grant numbers U01 NS083451 and R21 NS098998), and the UCSD Academic Senate grant BG084144. The contents of this publication are solely the responsibility of the authors and do not necessarily represent the official views of the National Institute of General Medical Sciences or National Institutes of Health.	Arac D, 2007, NEURON, V56, P992, DOI 10.1016/j.neuron.2007.12.002; AUGUSTINSSON KB, 1949, SCIENCE, V110, P98, DOI 10.1126/science.110.2847.98; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bester SM, 2019, PROTEIN SCI, V28, P1106, DOI 10.1002/pro.3625; Bester SM, 2018, CHEM RES TOXICOL, V31, P1405, DOI 10.1021/acs.chemrestox.8b00294; Blotnick-Rubin E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00123; Bourne Y, 2003, EMBO J, V22, P1, DOI 10.1093/emboj/cdg005; Cheung J, 2012, J MED CHEM, V55, P10282, DOI 10.1021/jm300871x; Cochran R, 2011, J BIOL CHEM, V286, P29718, DOI 10.1074/jbc.M111.264739; Coscia F, 2020, NATURE, V578, P627, DOI 10.1038/s41586-020-1995-4; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Fabrichny IP, 2007, NEURON, V56, P979, DOI 10.1016/j.neuron.2007.11.013; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Franklin MC, 2016, PROTEINS, V84, P1246, DOI 10.1002/prot.25073; Frisch M.J., 2016, GAUSSIAN 16; Gerlits O, 2019, CHEM-BIOL INTERACT, V309, DOI 10.1016/j.cbi.2019.06.011; Gerlits O, 2019, J BIOL CHEM, V294, P10607, DOI 10.1074/jbc.RA119.008725; Gorecki L, 2020, J BIOL CHEM, V295, P4079, DOI 10.1074/jbc.RA119.012400; Hajizadeh NR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25355-2; Kikhney AG, 2020, PROTEIN SCI, V29, P66, DOI 10.1002/pro.3731; Kousba AA, 2004, TOXICOL SCI, V80, P239, DOI 10.1093/toxsci/kfh163; MAULET Y, 1990, NEURON, V4, P289, DOI 10.1016/0896-6273(90)90103-M; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; PASTOR RW, 1988, MOL PHYS, V65, P1409, DOI 10.1080/00268978800101881; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; RADIC Z, 1992, BIOCHEMISTRY-US, V31, P9760, DOI 10.1021/bi00155a032; Radic Z, 2001, J BIOL CHEM, V276, P4622, DOI 10.1074/jbc.M006855200; RADIC Z, 1993, BIOCHEMISTRY-US, V32, P12074, DOI 10.1021/bi00096a018; Radic Z., 2006, TOXICOLOGY ORGANOPHO, P161; Radic Z, 2010, CHEM-BIOL INTERACT, V187, P163, DOI 10.1016/j.cbi.2010.04.014; Rosenfeld CA, 2006, TOXICOL SCI, V90, P460, DOI 10.1093/toxsci/kfj094; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2011, J STRUCT BIOL, V173, P461, DOI 10.1016/j.jsb.2010.09.023; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; TAYLOR P, 1991, J BIOL CHEM, V266, P4025; TAYLOR P, 1993, CHEM-BIOL INTERACT, V87, P199, DOI 10.1016/0009-2797(93)90043-X; Taylor P., 2009, ENCY NEUROSCIENCE, P5, DOI [10.1016/B978-008045046-9.01132-3, DOI 10.1016/B978-008045046-9.01132-3]; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; VELLOM DC, 1993, BIOCHEMISTRY-US, V32, P12, DOI 10.1021/bi00052a003; Wang XF, 2010, J BIOL CHEM, V285, P17564, DOI 10.1074/jbc.M110.111641; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	51	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101007	10.1016/j.jbc.2021.101007	http://dx.doi.org/10.1016/j.jbc.2021.101007			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34324828	Green Published, gold			2022-12-28	WOS:000706418900009
J	Pant, J; Giovinazzo, JA; Tuka, LS; Pena, D; Raper, J; Thomson, R				Pant, Jyoti; Giovinazzo, Joseph A.; Tuka, Lilit S.; Pena, Darwin; Raper, Jayne; Thomson, Russell			Apolipoproteins L1-6 share key cation channel-regulating residues but have different membrane insertion and ion conductance properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; TRYPANOSOME LYTIC FACTOR; L GENE-CLUSTER; INNATE IMMUNITY; KIDNEY-DISEASE; PLASMA-MEMBRANE; FACTOR APOL1; CELL-DEATH; VARIANTS	The human apolipoprotein L gene family encodes the apolipoprotein L1-6 (APOL1-6) proteins, which are effectors of the innate immune response to viruses, bacteria and protozoan parasites. Due to a high degree of similarity between APOL proteins, it is often assumed that they have similar functions to APOL1, which forms cation channels in planar lipid bilayers and membranes resulting in cytolytic activity. However, the channel properties of the remaining APOL proteins have not been reported. Here, we used transient overexpression and a planar lipid bilayer system to study the function of APOL proteins. By measuring lactate dehydrogenase release, we found that APOL1, APOL3, and APOL6 were cytolytic, whereas APOL2, APOL4, and APOL5 were not. Cells expressing APOL1 or APOL3, but not APOL6, developed a distinctive swollen morphology. In planar lipid bilayers, recombinant APOL1 and APOL2 required an acidic environment for the insertion of each protein into the membrane bilayer to form an ion conductance channel. In contrast, recombinant APOL3, APOL4, and APOL5 readily inserted into bilayers to form ion conductance at neutral pH, but required a positive voltage on the side of insertion. Despite these differences in membrane insertion properties, the ion conductances formed by APOL1-4 were similarly pH-dependent and cation-selective, consistent with conservation of the pore-lining region in each protein. Thus, despite structural conservation, the APOL proteins are functionally different. We propose that these proteins interact with different membranes and under different voltage and pH conditions within a cell to effect innate immunity to different microbial pathogens.	[Pant, Jyoti; Giovinazzo, Joseph A.; Tuka, Lilit S.; Pena, Darwin; Raper, Jayne; Thomson, Russell] CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA; [Giovinazzo, Joseph A.] Univ Colorado, Dept Biochem & Mol Genet, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Raper, Jayne] CUNY, PhD Program Biochem, Grad Ctr, New York, NY USA	City University of New York (CUNY) System; Hunter College (CUNY); University of Colorado System; University of Colorado Anschutz Medical Campus; City University of New York (CUNY) System	Pant, J; Thomson, R (corresponding author), CUNY Hunter Coll, Dept Biol Sci, 695 Pk Ave, New York, NY 10021 USA.	jpanta@genectr.hunter.cuny.edu; rthomson@genectr.hunter.cuny.edu		Pant, Jyoti/0000-0003-0490-3170; Raper, Jayne/0000-0002-8723-9748	NSF [IOS-1249166]	NSF(National Science Foundation (NSF))	This study was supported by NSF IOS-1249166 to J. R.	Abbas W, 2014, BBA-BIOMEMBRANES, V1838, P1132, DOI 10.1016/j.bbamem.2013.06.020; Ahmad L, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00155; Andreu-Fernandez V, 2016, J BIOL CHEM, V291, P25207, DOI 10.1074/jbc.M116.733634; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Choi Y, 2018, NAT REV MICROBIOL, V16, P340, DOI 10.1038/s41579-018-0003-6; Datta S, 2020, J AM SOC NEPHROL, V31, P2083, DOI 10.1681/ASN.2020010079; de Araujo LS, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01586; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Friedman DJ, 2011, J AM SOC NEPHROL, V22, P2098, DOI 10.1681/ASN.2011050519; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Giovinazzo JA, 2020, ELIFE, V9, DOI 10.7554/eLife.51185; Gupta N, 2020, J AM SOC NEPHROL, V31, P2065, DOI 10.1681/ASN.2019080830; Hikita H., 2018, LIVER RES, V2, P120, DOI [10.1016/j.livres.2018.09.003, DOI 10.1016/J.LIVRES.2018.09.003]; Hitomi JI, 2008, CELL, V135, P1311, DOI 10.1016/j.cell.2008.10.044; Ho J, 2020, J INFECTION, V81, P72, DOI 10.1016/j.jinf.2020.03.066; Hofmann K., 1993, BIOL CHEM H-S, V374, P166, DOI DOI 10.1515/BCHM3.1993.374.1-6.143; Hsu NY, 2010, CELL, V141, P799, DOI 10.1016/j.cell.2010.03.050; Jakes KS, 1999, Q REV BIOPHYS, V32, P189, DOI 10.1017/S0033583599003492; Kall L, 2007, NUCLEIC ACIDS RES, V35, pW429, DOI 10.1093/nar/gkm256; KAGAWA Y, 1966, J BIOL CHEM, V241, P2461; Kalai M, 2002, CELL DEATH DIFFER, V9, P981, DOI 10.1038/sj.cdd.4401051; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Khatua AK, 2015, AM J PHYSIOL-CELL PH, V309, pC22, DOI 10.1152/ajpcell.00384.2014; Kumar P, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8010004; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Lannon H, 2019, KIDNEY INT, V96, P1303, DOI 10.1016/j.kint.2019.07.010; Lebreton A, 2011, SCIENCE, V331, P1319, DOI 10.1126/science.1200120; Liu ZH, 2005, MOL CANCER RES, V3, P21; Lugli EB, 2004, MOL BIOCHEM PARASIT, V138, P9, DOI 10.1016/j.molbiopara.2004.07.004; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maulucci G, 2015, AUTOPHAGY, V11, P1905, DOI 10.1080/15548627.2015.1084455; Min HJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45282; Molina-Portela MP, 2008, J EXP MED, V205, P1721, DOI 10.1084/jem.20071463; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Rad MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25083-7; Raper J, 1999, INFECT IMMUN, V67, P1910; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; Robinson M, 2018, CELL MOL LIFE SCI, V75, P3693, DOI 10.1007/s00018-018-2882-0; Robinson R.A., 1965, ELECTROLYTE SOLUTION, V2nd; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; Sana TR, 2005, CYTOKINE, V29, P256, DOI 10.1016/j.cyto.2004.11.003; Scales SJ, 2020, J AM SOC NEPHROL, V31, P2044, DOI 10.1681/ASN.2019080829; Schaub C, 2020, J BIOL CHEM, V295, P13138, DOI 10.1074/jbc.RA120.014201; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Scorrano L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09253-3; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Taylor HE, 2014, J VIROL, V88, P592, DOI 10.1128/JVI.02828-13; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Tzur S, 2010, HUM GENET, V128, P345, DOI 10.1007/s00439-010-0861-0; Uzureau S, 2020, CELL REP, V30, P3821, DOI 10.1016/j.celrep.2020.02.064; Zhaorigetu S, 2011, J BIOL CHEM, V286, P27389, DOI 10.1074/jbc.M110.210245	61	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100951	10.1016/j.jbc.2021.100951	http://dx.doi.org/10.1016/j.jbc.2021.100951			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34252458	Green Published, gold			2022-12-28	WOS:000690871000003
J	Priyanka, P; Sharma, M; Das, S; Saxena, S				Priyanka, Priyanka; Sharma, Madhur; Das, Sanjeev; Saxena, Sandeep			The lncRNA HMS recruits RNA-binding protein HuR to stabilize the 3 '-UTR of HOXC10 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OSTEOSARCOMA CELL-LINES; NONCODING RNA; EXPRESSION; IDENTIFICATION; TRANSCRIPTION; METASTASIS; CHROMATIN; CYCLIN; FAMILY; GROWTH	YLong noncoding RNAs (lncRNAs) have been reported to drive key cancer pathways but the functions of majority of lncRNAs are unknown making a case for comprehensive functional evaluation of lncRNAs. With an aim to identify lncRNAs dysregulated in human cancers, we analyzed the cancer patient database of lung adenocarcinoma (LUAD), which revealed an upregulated lncRNA, LINC02381 (renamed HOXC10 mRNA stabilizing factor or HMS in this study), whose depletion results in proliferation defects and inhibition of colony formation of human cancer cells. In order to identify the binding targets of HMS, we screened for cis-genes and discovered that HOXC10, an oncogene, is downregulated in the absence of HMS. Depletion of HMS does not affect the HOXC10 promoter activity but inhibits the HOXC10 30-UTR-linked luciferase reporter activity. Since lncRNAs have been known to associate with RNA-binding proteins (RBPs) to stabilize mRNA transcripts, we screened for different RBPs and discovered that HuR, an ELAV family protein, stabilizes HOXC10 mRNA. Using RNA pull-down and deletion mapping experiments, we show that HuR physically interacts with the cytosine-rich stretch of HMS and HOXC10 30-UTR to stabilize HOXC10 mRNA. HOXC10 is overexpressed in many human cancers, and our discovery highlights that lncRNA HMS sustains the HOXC10 mRNA levels to maintain the invasive phenotypes of cancer cells.	[Priyanka, Priyanka; Das, Sanjeev; Saxena, Sandeep] Natl Inst Immunol, DNA Replicat & Cell Cycle Lab, New Delhi, India; [Sharma, Madhur] UDSC, Dept Biochem, New Delhi, India; [Saxena, Sandeep] JNU, Dept Biotechnol, New Delhi, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi	Saxena, S (corresponding author), Natl Inst Immunol, DNA Replicat & Cell Cycle Lab, New Delhi, India.; Saxena, S (corresponding author), JNU, Dept Biotechnol, New Delhi, India.	sandeepsaxena@mail.jnu.ac.in		Priyanka, Fnu/0000-0001-7933-3809; Das, Sanjeev/0000-0002-3594-1033	Government of India [BT/PR22824/BRB/10/1578/2016, EMR/2016/001702]	Government of India	We thank Bharti Sharma, Ritu Shekhar, Ananya Kar, and Sunder Bisht for helping in various parts of this paper. This study was partly funded by project numbers BT/PR22824/BRB/10/1578/2016 and EMR/2016/001702 from Government of India.	Bhatlekar S, 2014, J MOL MED, V92, P811, DOI 10.1007/s00109-014-1181-y; Bian X, 2021, BIOCHEM BIOPH RES CO, V548, P112, DOI 10.1016/j.bbrc.2021.02.072; BOTHWELL ALM, 1991, J BIOL CHEM, V266, P24657; Cao LM, 2017, ELIFE, V6, DOI 10.7554/eLife.30433; Carlson MRJ, 2001, DEV BIOL, V229, P396, DOI 10.1006/dbio.2000.0104; Chen CYA, 2002, MOL CELL BIOL, V22, P7268, DOI 10.1128/MCB.22.20.7268-7278.2002; Chen XH, 2020, CANCER MANAG RES, V12, P3971, DOI 10.2147/CMAR.S237285; Ciarlo E, 2013, DIS MODEL MECH, V6, P424, DOI 10.1242/dmm.009761; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dong D, 2019, BIOMED PHARMACOTHER, V111, P917, DOI 10.1016/j.biopha.2018.12.143; Fan XHC, 1998, EMBO J, V17, P3448, DOI 10.1093/emboj/17.12.3448; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Ghosh T, 2017, J BIOL CHEM, V292, P21264, DOI 10.1074/jbc.M117.808287; Guerra SL, 2020, CANCER CELL, V37, P705, DOI 10.1016/j.ccell.2020.03.004; Hostikka SL, 2009, INT J BIOL SCI, V5, P397; Huang JG, 2016, NUCLEIC ACIDS RES, V44, P3059, DOI 10.1093/nar/gkv1353; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Jafarzadeh M, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.562253; Jafarzadeh M, 2020, BIOCHIMIE, V171, P63, DOI 10.1016/j.biochi.2020.02.009; Kawasaki Y, 2016, CELL REP, V16, P2554, DOI 10.1016/j.celrep.2016.08.015; Kim J, 2016, NUCLEIC ACIDS RES, V44, P2378, DOI 10.1093/nar/gkw017; Kornienko AE, 2013, BMC BIOL, V11, DOI 10.1186/1741-7007-11-59; Lauvrak SU, 2013, BRIT J CANCER, V109, P2228, DOI 10.1038/bjc.2013.549; Lee YS, 2012, P NATL ACAD SCI USA, V109, P15520, DOI 10.1073/pnas.1116224109; Li BZ, 2019, STEM CELLS, V37, P247, DOI 10.1002/stem.2925; Li DF, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04072-4; Li J, 2015, CANCER RES, V75, P3728, DOI 10.1158/0008-5472.CAN-15-0273; Li LL, 2019, CANCER LETT, V450, P14, DOI 10.1016/j.canlet.2019.02.036; Long B, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03205-2; Lv XJ, 2019, EUR REV MED PHARMACO, V23, P1947, DOI 10.26355/eurrev_201903_17233; Maamar H, 2013, GENE DEV, V27, P1260, DOI 10.1101/gad.217018.113; Militello G, 2017, BRIEF BIOINFORM, V18, P780, DOI 10.1093/bib/bbw053; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Niknafs YS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12791; Pautke C, 2004, ANTICANCER RES, V24, P3743; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Sadik H, 2016, CANCER RES, V76, P4443, DOI 10.1158/0008-5472.CAN-16-0774; Shekhar R, 2019, J BIOL CHEM, V294, P4381, DOI 10.1074/jbc.RA118.005778; Shi HS, 2018, J EXP CLIN CANC RES, V37, DOI 10.1186/s13046-018-0840-1; Simion V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19664-2; Tripathi V, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003368; Wang CF, 2019, P NATL ACAD SCI USA, V116, P14620, DOI 10.1073/pnas.1903432116; Wang J, 2020, CELL TRANSPLANT, V29, DOI 10.1177/0963689720938023; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang LJ, 2015, CELL RES, V25, P335, DOI 10.1038/cr.2015.21; Wang XH, 2019, MOL MED REP, V20, P640, DOI 10.3892/mmr.2019.10292; Wu BL, 2021, ENVIRON TOXICOL, V36, P840, DOI 10.1002/tox.23087; Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Yang JH, 2020, NUCLEIC ACIDS RES, V48, P12943, DOI 10.1093/nar/gkaa1151; Yang JL, 2014, THORAC CANCER, V5, P149, DOI 10.1111/1759-7714.12074; YAO KM, 1993, J NEUROBIOL, V24, P723, DOI 10.1002/neu.480240604; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yeap BB, 2002, J BIOL CHEM, V277, P27183, DOI 10.1074/jbc.M202883200; Yoon JH, 2013, J MOL BIOL, V425, P3723, DOI 10.1016/j.jmb.2012.11.024; Zhang GH, 2019, J CELL PHYSIOL, V234, P5163, DOI 10.1002/jcp.27320	57	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100997	10.1016/j.jbc.2021.100997	http://dx.doi.org/10.1016/j.jbc.2021.100997			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302808	gold, Green Published			2022-12-28	WOS:000690868100006
J	Denisov, SS; Ippel, JH; Castoldi, E; Mans, B; Hackeng, TM; Dijkgraaf, I				Denisov, Stepan S.; Ippel, Johannes H.; Castoldi, Elisabetta; Mans, Ben J.; Hackeng, Tilman M.; Dijkgraaf, Ingrid			Molecular basis of anticoagulant and anticomplement activity of the tick salivary protein Salp14 and its homologs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIDERMAL-GROWTH-FACTOR; LECTIN PATHWAY; FACTOR-V; ORNITHODOROS-SAVIGNYI; BORNE DISEASES; C-TERMINUS; XPLOR-NIH; INHIBITOR; ACTIVATION; SEQUENCE	During feeding, a tick's mouthpart penetrates the host's skin and damages tissues and small blood vessels, triggering the extrinsic coagulation and lectin complement pathways. To elude these defense mechanisms, ticks secrete multiple anticoagulant proteins and complement system inhibitors in their saliva. Here, we characterized the inhibitory activities of the homologous tick salivary proteins tick salivary lectin pathway inhibitor, Salp14, and Salp9Pac from Ixodes scapularis in the coagulation cascade and the lectin complement pathway. All three proteins inhibited binding ofmannan-binding lectin to the polysaccharide mannan, preventing the activation of the lectin complement pathway. In contrast, only Salp14 showed an appreciable effect on coagulation by prolonging the lag timeof thrombin generation. We found that the anticoagulant properties of Salp14 are governed by its basic tail region, which resembles the C terminus of tissue factor pathway inhibitor alpha and blocks the assembly and/or activity of the prothrombinase complex in the same way. Moreover, the Salp14 protein tail contributes to the inhibition of the lectin complement pathway via interaction with mannan binding lectin-associated serine proteases. Furthermore, we identified BaSO4-adsorbing protein 1 isolated from the tick Ornithodoros savignyi as a distant homolog of tick salivary lectin pathway inhibitor/Salp14 proteins and showed that it inhibits the lectin complement pathway but not coagulation. The structure of BaSO4-adsorbing protein 1, solved here usingNMR spectroscopy, indicated that this protein adopts a noncanonical epidermal growth factor domain-like structural fold, the first such report for tick salivary proteins. These data support a mechanism by which tick saliva proteins simultaneously inhibit both the host coagulation cascade and the lectin complement pathway.	[Denisov, Stepan S.; Ippel, Johannes H.; Castoldi, Elisabetta; Hackeng, Tilman M.; Dijkgraaf, Ingrid] Univ Maastricht, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands; [Mans, Ben J.] Agr Res Council, Onderstepoort Vet Inst, Epidemiol Parasites & Vectors, Onderstepoort, South Africa; [Mans, Ben J.] Univ South Africa, Dept Life & Consumer Sci, Pretoria, South Africa; [Mans, Ben J.] Univ Pretoria, Dept Vet Trop Dis, Pretoria, South Africa	Maastricht University; Agricultural Research Council of South Africa; Onderstepoort Veterinary Institute, Agricultural Research Council; University of South Africa; University of Pretoria	Dijkgraaf, I (corresponding author), Univ Maastricht, Cardiovasc Res Inst Maastricht CARIM, Dept Biochem, Maastricht, Netherlands.	i.dijkgraaf@maastrichtuniversity.nl	Mans, Ben J./M-2427-2017	Mans, Ben J./0000-0002-0177-0029; Ippel, Hans/0000-0001-6589-6678; Denisov, Stepan S./0000-0001-5460-940X; Hackeng, Tilman/0000-0003-0142-0843; Dijkgraaf, Ingrid/0000-0003-4586-3646	Netherlands Organisation for Scientific Research [Aspasia 015.010.005, ECHO 711.018.005]; Maastricht UMC+ Kootstra Talent Fellowship	Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Maastricht UMC+ Kootstra Talent Fellowship	This work was supported by the Netherlands Organisation for Scientific Research grant Aspasia 015.010.005 and ECHO 711.018.005 to I. D. and Maastricht UMC+ Kootstra Talent Fellowship to S. S. D.	Assumpcao TC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22780-1; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bersch B, 1998, BIOCHEMISTRY-US, V37, P1204, DOI 10.1021/bi971851v; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Bhattacharya S, 2020, ADV PROTEIN CHEM STR, V119, P1, DOI 10.1016/bs.apcsb.2019.09.003; Bunce MW, 2013, J BIOL CHEM, V288, P30151, DOI 10.1074/jbc.M113.506840; Dantas-Torres F, 2012, TRENDS PARASITOL, V28, P437, DOI 10.1016/j.pt.2012.07.003; Denisov SS, 2019, J BIOL CHEM, V294, P12370, DOI 10.1074/jbc.RA119.008902; Denisov SS, 2019, CHEM COMMUN, V55, P1374, DOI 10.1039/c8cc08777f; Dzik S, 2019, TRANSFUS MED REV, V33, P199, DOI 10.1016/j.tmrv.2019.08.004; Ehebauer MT, 2002, EXP PARASITOL, V101, P138, DOI 10.1016/S0014-4894(02)00102-9; Garred P, 2016, IMMUNOL REV, V274, P74, DOI 10.1111/imr.12468; Gingras AR, 2011, STRUCTURE, V19, P1635, DOI 10.1016/j.str.2011.08.014; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Horak IG, 2002, EXP APPL ACAROL, V28, P27, DOI 10.1023/A:1025381712339; KARCZEWSKI J, 1994, J BIOL CHEM, V269, P6702; Kazimirova M, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00043; Keizer MP, 2015, EUR J IMMUNOL, V45, P544, DOI 10.1002/eji.201445070; Kjaer TR, 2013, MOL IMMUNOL, V56, P413, DOI 10.1016/j.molimm.2013.05.007; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lu HS, 2001, J BIOL CHEM, V276, P34913, DOI 10.1074/jbc.M102874200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mans BJ, 2004, INSECT BIOCHEM MOLEC, V34, P1, DOI 10.1016/j.ibmb.2003.09.002; Mans BJ, 2002, J BIOL CHEM, V277, P21371, DOI 10.1074/jbc.M112060200; Narasimhan S, 2004, P NATL ACAD SCI USA, V101, P1141, DOI 10.1073/pnas.0307669100; Narasimhan S, 2002, INSECT MOL BIOL, V11, P641, DOI 10.1046/j.1365-2583.2002.00375.x; Nijhof AM, 2010, INT J PARASITOL, V40, P1587, DOI 10.1016/j.ijpara.2010.06.003; Ogden NH, 2016, TRENDS PARASITOL, V32, P646, DOI 10.1016/j.pt.2016.04.015; Presanis JS, 2004, MOL IMMUNOL, V40, P921, DOI 10.1016/j.molimm.2003.10.013; Reichhardt MP, 2020, P NATL ACAD SCI USA, V117, P362, DOI 10.1073/pnas.1909973116; Ribeiro J. M. C, 2020, FRONT CELL INFECT MI, V10, P1; Schuijt TJ, 2013, CIRCULATION, V128, P254, DOI 10.1161/CIRCULATIONAHA.113.003191; Schuijt TJ, 2011, CELL HOST MICROBE, V10, P136, DOI 10.1016/j.chom.2011.06.010; Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Tian Y, 2017, J BIOMOL NMR, V67, P35, DOI 10.1007/s10858-016-0082-5; Tirloni L, 2020, J PROTEOMICS, V229, DOI 10.1016/j.jprot.2020.103899; Tombling BJ, 2020, ANGEW CHEM INT EDIT, V59, P11218, DOI 10.1002/anie.201913809; van Doorn P, 2017, J THROMB HAEMOST, V15, P140, DOI 10.1111/jth.13559; van Doorn P, 2020, THROMB HAEMOSTASIS, V120, P55, DOI 10.1055/s-0039-1700516; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wood JP, 2013, P NATL ACAD SCI USA, V110, P17838, DOI 10.1073/pnas.1310444110	43	3	3	2	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100865	10.1016/j.jbc.2021.100865	http://dx.doi.org/10.1016/j.jbc.2021.100865			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118237	Green Published, gold			2022-12-28	WOS:000678068400065
J	Dutta, A; Batish, M; Parashar, V				Dutta, Anirudha; Batish, Mona; Parashar, Vijay			Structural basis of KdpD histidine kinase binding to the second messenger c-di-AMP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNIVERSAL STRESS-PROTEIN; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; STIMULUS PERCEPTION; 2-COMPONENT SYSTEM; NUCLEOTIDE; GMP; EXPRESSION; POTASSIUM; ULTRACENTRIFUGATION	The KdpDE two-component system regulates potassium homeostasis and virulence in various bacterial species. The KdpD histidine kinases (HK) of this system contain a universal stress protein (USP) domain which binds to the second messenger cyclic-di-adenosine monophosphate (c-di-AMP) for regulating transcriptional output from this two-component system in Firmicutes such as Staphylococcus aureus. However, the structural basis of c-di-AMP specificity within the KdpD-USP domain is not well understood. Here, we resolved a 2.3 angstrom crystal structure of the S. aureus KdpD-USP domain (USPSa) complexed with c-di-AMP. Binding affinity analyses of USPSa mutants targeting the observed USPSa:c-di-AMP structural interface enabled the identification of the sequence residues that are required for c-di-AMP specificity. Based on the conservation of these residues in other Firmicutes, we identified the binding motif, (A/G/C)XSXSX2N(Y/F), which allowed us to predict c-di-AMP binding in other KdpD HKs. Further-more, we found that the USPSa domain contains structural features distinct from the canonical standalone USPs that bind ATP as a preferred ligand. These features include inwardfacing conformations of its beta 1-alpha 1 and beta 4-alpha 4 loops, a short alpha 2 helix, the absence of a triphosphate-binding Walker A motif, and a unique dual phospho-ligand binding mode. It is therefore likely that USPSa-like domains in KdpD HKs represent a novel subfamily of the USPs.	[Dutta, Anirudha; Batish, Mona; Parashar, Vijay] Univ Delaware, Dept Med & Mol Sci, Newark, DE 19716 USA	University of Delaware	Parashar, V (corresponding author), Univ Delaware, Dept Med & Mol Sci, Newark, DE 19716 USA.	parashar@udel.edu	Batish, Mona/AAG-8296-2019	Batish, Mona/0000-0001-9039-6149; Parashar, Vijay/0000-0002-7518-0400	National Institutes of Health [R35GM119504]; University of Delaware Research Foundation [SI19A00244]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Delaware Research Foundation	This research was supported by National Institutes of Health Grant R35GM119504 to V. P. and the University of Delaware Research Foundation SI19A00244 to M. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ali MK, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00570; Dias DA, 2020, MOLECULES, V25, DOI 10.3390/molecules25102462; [Anonymous], 2019, PLOS PATHOG, V15; Bai YL, 2014, J BACTERIOL, V196, P614, DOI 10.1128/JB.01041-13; Bai YL, 2013, J BACTERIOL, V195, P5123, DOI 10.1128/JB.00769-13; Bai YL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035206; Banerjee A, 2015, J BIOL CHEM, V290, P12731, DOI 10.1074/jbc.M115.644856; Barabote RD, 2006, BBA-BIOMEMBRANES, V1758, P1557, DOI 10.1016/j.bbamem.2006.06.018; Bartoschik T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23154-3; Bendezu FO, 2009, EMBO J, V28, P193, DOI 10.1038/emboj.2008.264; Bowater R, 2015, ELS JOHN WILEY SONS, P9; Braun F, 2019, MICROBIOLOGYOPEN, V8, DOI 10.1002/mbo3.829; Brautigam CA, 2015, METHOD ENZYMOL, V562, P109, DOI 10.1016/bs.mie.2015.05.001; Cereija TB, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020653118; Cheng H, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003926; Chi YH, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00750; Choi PH, 2015, MICROBIOLOGYOPEN, V4, P361, DOI 10.1002/mbo3.243; Chou SH, 2016, J BACTERIOL, V198, P32, DOI 10.1128/JB.00333-15; Commichau FM, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00045-18; Commichau FM, 2018, TRENDS MICROBIOL, V26, P175, DOI 10.1016/j.tim.2017.09.003; Commichau FM, 2015, MOL MICROBIOL, V97, P189, DOI 10.1111/mmi.13026; Corrigan RM, 2013, NAT REV MICROBIOL, V11, P513, DOI 10.1038/nrmicro3069; Corrigan RM, 2013, P NATL ACAD SCI USA, V110, P9084, DOI 10.1073/pnas.1300595110; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Deng L, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3235-1; Devaux L, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007342; Drumm JE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000460; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fahmi T, 2017, GENES-BASEL, V8, DOI 10.3390/genes8080197; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Galperin MY, 2010, CURR OPIN MICROBIOL, V13, P150, DOI 10.1016/j.mib.2010.01.005; Gandara C, 2015, DNA REPAIR, V27, P1, DOI 10.1016/j.dnarep.2014.12.007; Gibhardt J, 2019, J BIOL CHEM, V294, P16020, DOI 10.1074/jbc.RA119.010046; Gundlach J, 2018, CURR GENET, V64, P191, DOI 10.1007/s00294-017-0734-3; Gundlach J, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00804; Gundlach J, 2015, J BACTERIOL, V197, P3265, DOI 10.1128/JB.00564-15; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Hayes D, 1995, PROGRAM SEDNTERP SED; He J, 2020, NUCLEIC ACIDS RES, V48, P2807, DOI 10.1093/nar/gkaa112; Heermann R, 2003, J BIOL CHEM, V278, P51277, DOI 10.1074/jbc.M303801200; Heermann R, 1998, BBA-BIOMEMBRANES, V1415, P114, DOI 10.1016/S0005-2736(98)00181-3; Heermann R, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-133; Hengge R, 2016, J BACTERIOL, V198, P15, DOI 10.1128/JB.00331-15; Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; Jung K, 1998, J BIOL CHEM, V273, P17406, DOI 10.1074/jbc.273.28.17406; Jung K, 2002, J MOL MICROB BIOTECH, V4, P223; Kalia D, 2013, CHEM SOC REV, V42, P305, DOI 10.1039/c2cs35206k; Krissinel E, 2010, J COMPUT CHEM, V31, P133, DOI 10.1002/jcc.21303; Kumar S, 2020, PROTEIN SCI, V29, P2009, DOI 10.1002/pro.3920; Kvint K, 2003, CURR OPIN MICROBIOL, V6, P140, DOI 10.1016/S1369-5274(03)00025-0; leermann R., 2010, FEMS MICROBIOL LETT, V304, P106; Lo MC, 2004, ANAL BIOCHEM, V332, P153, DOI 10.1016/j.ab.2004.04.031; Longo LM, 2020, ELIFE, V9, DOI 10.7554/eLife.64415; Lori C, 2015, NATURE, V523, P236, DOI 10.1038/nature14473; Luo Y, 2012, MOL MICROBIOL, V83, P623, DOI 10.1111/j.1365-2958.2011.07953.x; Mascher T, 2006, MICROBIOL MOL BIOL R, V70, P910, DOI 10.1128/MMBR.00020-06; Maslennikov I, 2010, P NATL ACAD SCI USA, V107, P10902, DOI 10.1073/pnas.1001656107; Massa SM, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00307-20; Mehne FMP, 2013, J BIOL CHEM, V288, P2004, DOI 10.1074/jbc.M112.395491; Moscoso JA, 2016, J BACTERIOL, V198, P98, DOI 10.1128/JB.00480-15; NYSTROM T, 1994, MOL MICROBIOL, V11, P537, DOI 10.1111/j.1365-2958.1994.tb00334.x; O'Connor A, 2017, CURR MED CHEM, V24, P3970, DOI 10.2174/0929867324666170124145543; O'Toole R, 2003, RES MICROBIOL, V154, P387, DOI 10.1016/S0923-2508(03)00081-0; ObAinowski Z, 1997, METHOD ENZYMOL; Ortega A, 2011, BIOPHYS J, V101, P892, DOI 10.1016/j.bpj.2011.06.046; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Ramesh A, 2015, SEMIN CELL DEV BIOL, V47-48, P3, DOI 10.1016/j.semcdb.2015.10.019; Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; Rothenbucher MC, 2006, J BACTERIOL, V188, P1950, DOI 10.1128/JB.188.5.1950-1958.2006; Rubin BE, 2018, PLOS GENET, V14, DOI 10.1371/journal.pgen.1007301; Saveanu C, 2002, PROTEIN SCI, V11, P2551, DOI 10.1110/ps.0217502; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Schramke H, 2016, CELL REP, V16, P213, DOI 10.1016/j.celrep.2016.05.081; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Schweikhard ES, 2010, BIOCHEMISTRY-US, V49, P2194, DOI 10.1021/bi9017522; SEMISOTNOV GV, 1991, BIOPOLYMERS, V31, P119, DOI 10.1002/bip.360310111; Sokoloski JE, 2011, RNA, V17, P1775, DOI 10.1261/rna.2759911; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Studier FW, 2014, METHODS MOL BIOL, V1091, P17, DOI 10.1007/978-1-62703-691-7_2; Tkaczuk KL, 2013, EVOL APPL, V6, P434, DOI 10.1111/eva.12057; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Witte CE, 2013, MBIO, V4, DOI 10.1128/mBio.00282-13; Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020; Xie MQ, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aaz2970; Xue T, 2011, INFECT IMMUN, V79, P2154, DOI 10.1128/IAI.01180-10; Yang J, 2014, MOL MICROBIOL, V93, P65, DOI 10.1111/mmi.12641; Zarembinski TI, 1998, P NATL ACAD SCI USA, V95, P15189, DOI 10.1073/pnas.95.26.15189; Zhao LP, 2010, INFECT IMMUN, V78, P3506, DOI 10.1128/IAI.00131-10; Zimmann P, 2007, J BACTERIOL, V189, P7326, DOI 10.1128/JB.00976-07; Zschiedrich CP, 2016, J MOL BIOL, V428, P3752, DOI 10.1016/j.jmb.2016.08.003	93	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100771	10.1016/j.jbc.2021.100771	http://dx.doi.org/10.1016/j.jbc.2021.100771			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33989637	Green Published, gold			2022-12-28	WOS:000672866400738
J	Furey, IM; Mehta, SC; Sankaran, B; Hu, LY; Prasad, BVV; Palzkill, T				Furey, Ian M.; Mehta, Shrenik C.; Sankaran, Banumathi; Hu, Liya; Prasad, B. V. Venkataram; Palzkill, Timothy			Local interactions with the Glu166 base and the conformation of an active site loop play key roles in carbapenem hydrolysis by the KPC-2 beta-lactamase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI STRAIN; SUBSTRATE PROFILE; CRYSTAL-STRUCTURE; ENZYME; SUBSTITUTIONS; ANTIBIOTICS; INHIBITION; EVOLUTION; INSIGHTS; ACID	The Klebsiella pneumoniae carbapenemase-2 (KPC-2) is a common source of antibiotic resistance in Gram-negative bacterial infections. KPC-2 is a class A beta-lactamase that exhibits a broad substrate profile and hydrolyzes most beta-lactam antibiotics including carbapenems owing to rapid deacylation of the covalent acyl-enzyme intermediate. However, the features that allow KPC-2 to deacylate substrates more rapidly than non-carbapenemase enzymes are not clear. The active-site residues in KPC-2 are largely conserved in sequence and structure compared with non-carbapenemases, suggesting that subtle alterations may collectively facilitate hydrolysis of carbapenems. We utilized a nonbiased genetic approach to identify mutants deficient in carbapenem hydrolysis but competent for ampicillin hydrolysis. Subsequent pre-steady-state enzyme kinetics analyses showed that the substitutions slow the rate of deacylation of carbapenems. Structure determination via X-ray diffraction indicated that a F72Y mutant forms a hydrogen bond between the tyrosine hydroxyl group and Glu166, which may lower basicity and impair the activation of the catalytic water for deacylation, whereas several mutants impact the structure of the Q214-R220 active site loop. A T215P substitution lowers the deacylation rate and drastically alters the conformation of the loop, thereby disrupting interactions between the enzyme and the carbapenem acyl-enzyme intermediate. Thus, the environment of the Glu166 general base and the precise placement and conformational stability of the Q214-R220 loop are critical for efficient deacylation of carbapenems by the KPC-2 enzyme. Therefore, the design of carbapenem antibiotics that interact with Glu166 or alter the Q214-R220 loop conformation may disrupt enzyme function and overcome resistance.	[Furey, Ian M.; Mehta, Shrenik C.; Palzkill, Timothy] Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA; [Sankaran, Banumathi] Lawrence Berkeley Natl Lab, Dept Mol Biophys & Integrated Bioimaging, Berkeley Ctr Struct Biol, Berkeley, CA USA; [Hu, Liya; Prasad, B. V. Venkataram; Palzkill, Timothy] Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Baylor College of Medicine; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Baylor College of Medicine	Palzkill, T (corresponding author), Baylor Coll Med, Dept Pharmacol & Chem Biol, Houston, TX 77030 USA.; Palzkill, T (corresponding author), Baylor Coll Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA.	timothyp@bcm.edu		Mehta, Shrenik/0000-0003-3302-7069	NIH [R01 AI32956, T32 AI055449]; Welch Foundation [Q1279]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation)	This work was supported by NIH R01 AI32956 to T. P., NIH T32 AI055449 to I. M. F., and Welch Foundation Q1279 to B. V. V. P. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMANN E, 1988, GENE, V69, P301, DOI 10.1016/0378-1119(88)90440-4; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; Bonomo Robert A, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025239; Brown CA, 2020, J BIOL CHEM, V295, P7376, DOI 10.1074/jbc.RA119.012489; BULLOCK WO, 1987, BIOTECHNIQUES, V5, P376; BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058; Bush K, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01076-18; Bush K, 2010, CURR OPIN MICROBIOL, V13, P558, DOI 10.1016/j.mib.2010.09.006; CDC, 2013, ANTIBIOTIC RESISTANC, DOI [DOI 10.15620/CDC:82532, 10.15620/cdc:82532]; CHARNAS RL, 1981, BIOCHEMISTRY-US, V20, P2732, DOI 10.1021/bi00513a005; Dellus-Gur E, 2015, J MOL BIOL, V427, P2396, DOI 10.1016/j.jmb.2015.05.011; Dellus-Gur E, 2013, J MOL BIOL, V425, P2609, DOI 10.1016/j.jmb.2013.03.033; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Galleni Moreno, 2007, P195; Hart KM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12965; HOLLAWAY MR, 1969, FEBS LETT, V4, P299, DOI 10.1016/0014-5793(69)80261-9; Kalp M, 2008, BIOCHEMISTRY-US, V47, P11830, DOI 10.1021/bi800833u; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; Ke W, 2012, ANTIMICROB AGENTS CH, V56, P2713, DOI 10.1128/AAC.06099-11; Krishnan NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136813; Livermore DM, 2006, TRENDS MICROBIOL, V14, P413, DOI 10.1016/j.tim.2006.07.008; Logan LK, 2017, J INFECT DIS, V215, pS28, DOI 10.1093/infdis/jiw282; Lohans CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-49264-0; Long SW, 2017, MBIO, V8, DOI [10.1128/mBio.00489-17, 10.1128/mbio.00489-17]; Majiduddin FK, 2005, ANTIMICROB AGENTS CH, V49, P3421, DOI 10.1128/AAC.49.8.3421-3427.2005; Malabanan MM, 2013, J AM CHEM SOC, V135, P5978, DOI 10.1021/ja401504w; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Mehta S. C., 2020, J BIOL CHEM, V296; Mehta SC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004949; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; PALZKILL T, 1994, MOL MICROBIOL, V12, P217, DOI 10.1111/j.1365-2958.1994.tb01011.x; Palzkill T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00016; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Papp-Wallace KM, 2010, ANTIMICROB AGENTS CH, V54, P2867, DOI 10.1128/AAC.00197-10; Patel MP, 2018, J BIOL CHEM, V293, P17971, DOI 10.1074/jbc.RA118.003792; Patel MP, 2017, BIOCHEMISTRY-US, V56, P3443, DOI 10.1021/acs.biochem.7b00176; Pemberton OA, 2017, J MED CHEM, V60, P3525, DOI 10.1021/acs.jmedchem.7b00158; Petrella S, 2008, ANTIMICROB AGENTS CH, V52, P3725, DOI 10.1128/AAC.00163-08; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pozzi C, 2016, ANTIMICROB AGENTS CH, V60, P7189, DOI 10.1128/AAC.00936-16; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Radisky ES, 2006, P NATL ACAD SCI USA, V103, P6835, DOI 10.1073/pnas.0601910103; Radisky ES, 2002, P NATL ACAD SCI USA, V99, P10316, DOI 10.1073/pnas.112332899; Richard JP, 2016, BIOCHEMISTRY-US, V55, P3036, DOI 10.1021/acs.biochem.6b00311; Schneider KD, 2009, BIOCHEMISTRY-US, V48, P11840, DOI 10.1021/bi901690r; Soeung V, 2020, J BIOL CHEM, V295, P18239, DOI 10.1074/jbc.RA120.016103; Stewart NK, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02191-18; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; Tremblay LW, 2010, BIOCHEMISTRY-US, V49, P3766, DOI 10.1021/bi100232q; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vakulenko SB, 1999, J BIOL CHEM, V274, P23052, DOI 10.1074/jbc.274.33.23052; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; World Health Organization, 2016, ANTIMICROBIAL RESIST; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; ZAFARALLA G, 1992, J AM CHEM SOC, V114, P1505, DOI 10.1021/ja00030a070; Zhai X, 2018, J AM CHEM SOC, V140, P8277, DOI 10.1021/jacs.8b04367	64	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100799	10.1016/j.jbc.2021.100799	http://dx.doi.org/10.1016/j.jbc.2021.100799			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022225	gold, Green Published			2022-12-28	WOS:000674717300019
J	Gardner, AI; Wu, YQ; Verhaegh, R; Liu, YJ; Wilker, B; Soddemann, M; Keitsch, S; Edwards, MJ; Haq, IJ; Kamler, M; Becker, KA; Brodlie, M; Gulbins, E				Gardner, Aaron Ions; Wu, Yuqing; Verhaegh, Rabea; Liu, Yongjie; Wilker, Barbara; Soddemann, Matthias; Keitsch, Simone; Edwards, Michael J.; Haq, Iram J.; Kamler, Markus; Becker, Katrin Anne; Brodlie, Malcolm; Gulbins, Erich			Interferon regulatory factor 8 regulates expression of acid ceramidase and infection susceptibility in cystic fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS; INFLAMMATION; IDENTIFICATION; SPHINGOSINE; BASES; GENE	Most patients with cystic fibrosis (CF) suffer from acute and chronic pulmonary infections with bacterial pathogens, which often determine their life quality and expectancy. Previous studies have demonstrated a downregulation of the acid ceramidase in CF epithelial cells resulting in an increase of ceramide and a decrease of sphingosine. Sphingosine kills many bacterial pathogens, and the downregulation of sphingosine seems to determine the infection susceptibility of cystic fibrosis mice and patients. It is presently unknown how deficiency of the cystic fibrosis transmembrane conductance regulator (CFTR) connects to a marked downregulation of the acid ceramidase in human and murine CF epithelial cells. Here, we employed quantitative PCR, western blot analysis, and enzyme activity measurements to study the role of IRF8 for acid ceramidase regulation. We report that genetic deficiency or functional inhibition of CFTR/Cftr results in an upregulation of interferon regulatory factor 8 (IRF8) and a concomitant downregulation of acid ceramidase expression with CF and an increase of ceramide and a reduction of sphingosine levels in tracheal and bronchial epithelial cells from both human individuals or mice. CRISPR/Cas9- or siRNA-mediated downregulation of IRF8 prevented changes of acid ceramidase, ceramide, and sphingosine in CF epithelial cells and restored resistance to Pseudomonas aeruginosa infections, which is one of the most important and common pathogens in lung infection of patients with CF. These studies indicate that CFTR deficiency causes a downregulation of acid ceramidase via upregulation of IRF8, which is a central pathway to control infection susceptibility of CF cells.	[Gardner, Aaron Ions; Haq, Iram J.; Brodlie, Malcolm] Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England; [Wu, Yuqing; Verhaegh, Rabea; Liu, Yongjie; Wilker, Barbara; Soddemann, Matthias; Keitsch, Simone; Becker, Katrin Anne] Univ Duisburg Essen, Univ Hosp Essen, Dept Mol Biol, Essen, Germany; [Verhaegh, Rabea; Kamler, Markus; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany; [Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA; [Haq, Iram J.; Brodlie, Malcolm] Great North Childrens Hosp, Pediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; University of Duisburg Essen; University of Duisburg Essen; University System of Ohio; University of Cincinnati	Brodlie, M (corresponding author), Newcastle Univ, Fac Med Sci, Translat & Clin Res Inst, Newcastle Upon Tyne, Tyne & Wear, England.; Gulbins, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Essen, Germany.; Gulbins, E (corresponding author), Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH 45221 USA.; Brodlie, M (corresponding author), Great North Childrens Hosp, Pediat Resp Med, Newcastle Upon Tyne, Tyne & Wear, England.	malcolm.brodlie@ncl.ac.uk; erich.gulbins@uni-due.de		Kamler, Markus/0000-0001-6608-8496; Haq, Iram/0000-0002-5795-0440; Liu, Yongjie/0000-0001-7259-9495; Brodlie, Malcolm/0000-0003-4591-8299	DFG [Gu-335-35/1]; Medical Research Council Clinician Scientist Fellowship [MR/M008797/1]	DFG(German Research Foundation (DFG)); Medical Research Council Clinician Scientist Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The study was supported by DFG grant Gu-335-35/1 to E. G. M. B. and A. I. G. were supported by a Medical Research Council Clinician Scientist Fellowship to M. B. (MR/M008797/1).	Azuma MM, 2018, BIOCHEM BIOPH RES CO, V495, P2383, DOI 10.1016/j.bbrc.2017.12.137; Becker KA, 2021, INFECT IMMUN, V89, DOI 10.1128/IAI.00677-20; Becker KA, 2012, J MOL MED, V90, P1011, DOI 10.1007/s00109-012-0867-2; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Bhagirath AY, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0339-5; BIBEL DJ, 1992, J INVEST DERMATOL, V98, P269, DOI 10.1111/1523-1747.ep12497842; Bodas M, 2011, J IMMUNOL, V186, P602, DOI 10.4049/jimmunol.1002850; Brodlie M, 2010, AM J RESP CRIT CARE, V182, P369, DOI 10.1164/rccm.200905-0799OC; Caretti A, 2014, BBA-GEN SUBJECTS, V1840, P586, DOI 10.1016/j.bbagen.2013.10.018; Carstens Henning, 2019, Cell Physiol Biochem, V53, P1015, DOI 10.33594/000000194; Charizopoulou N, 2006, BMC GENET, V7, DOI 10.1186/1471-2156-7-18; Charizopoulou N, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-6; CI' Foundation, 2019, PAT REG ANN REP; Dechecchi MC, 2011, AM J RESP CELL MOL, V45, P825, DOI 10.1165/rcmb.2010-0457OC; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Elborn JS, 2016, LANCET, V388, P2519, DOI 10.1016/S0140-6736(16)00576-6; Fischer CL, 2013, SKIN PHARMACOL PHYS, V26, P36, DOI 10.1159/000343175; Gardner AI, 2020, AM J RESP CRIT CARE, V202, P1133, DOI 10.1164/rccm.202001-0180OC; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grassme H, 2017, CELL HOST MICROBE, V21, P707, DOI 10.1016/j.chom.2017.05.001; Haq IJ, 2021, AM J PHYSIOL-LUNG C, V320, pL288, DOI 10.1152/ajplung.00137.2020; Hu XL, 2011, CANCER RES, V71, P2882, DOI 10.1158/0008-5472.CAN-10-2493; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; Kormann MSD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183526; Kreiselmeier NE, 2003, AM J PHYSIOL-LUNG C, V285, pL1286, DOI 10.1152/ajplung.00127.2003; Liessi N, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138722; Loberto N, 2020, GLYCOCONJUGATE J, V37, P623, DOI 10.1007/s10719-020-09935-x; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Nelson N, 1996, J IMMUNOL, V156, P3711; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; RIORDAN JR, 1989, SCIENCE, V245, P1066; Seitz AP, 2019, J MOL MED, V97, P1195, DOI 10.1007/s00109-019-01800-1; Tabazavareh ST, 2016, CELL PHYSIOL BIOCHEM, V38, P2094, DOI 10.1159/000445567; Teichgraber V, 2008, NAT MED, V14, P382, DOI 10.1038/nm1748; Ulrich M, 2010, J CYST FIBROS, V9, P217, DOI 10.1016/j.jcf.2010.03.001; Verhaegh R, 2020, J BIOL CHEM, V295, P7686, DOI 10.1074/jbc.RA119.012325; Xiong HB, 2005, J BIOL CHEM, V280, P23531, DOI 10.1074/jbc.M414296200; Zhang Y., 2009, J IMMUNOL, V184, P5104	39	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100650	10.1016/j.jbc.2021.100650	http://dx.doi.org/10.1016/j.jbc.2021.100650			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839155	gold, Green Published			2022-12-28	WOS:000672866400621
J	Gether, U; Sitte, HH				Gether, Ulrik; Sitte, Harald H.			It takes two-or more-to tango: Revisiting the role of dopamine transporter oligomerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								The dopamine transporter utilizes the transmembrane sodium gradient to mediate reuptake of dopamine from the extracellular space. The dopamine transporter can form dimers and possibly also higher order structures in the plasma membrane, and this oligomerization has been implicated in both trafficking and transport. However, we still do not fully understand its biological importance. A study by Sorkina et al. now describes a series of small molecules that link transporter conformation to oligomerization and endocytosis, providing an interesting step forward in an intricate dance.	[Gether, Ulrik] Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Maersk Tower 7-5, Copenhagen, Denmark; [Sitte, Harald H.] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria	University of Copenhagen; Medical University of Vienna	Gether, U (corresponding author), Univ Copenhagen, Fac Hlth & Med Sci, Dept Neurosci, Maersk Tower 7-5, Copenhagen, Denmark.	gether@sund.ku.dk	Sitte, Harald/N-2681-2013	Sitte, Harald/0000-0002-1339-7444; Gether, Ulrik/0000-0002-0020-3807	Lundbeck Foundation [R266-2017-4331, R276-2018-792]; Independent Research Fund Denmark-Medical Sciences [7016-00325B]; Austrian Science Fund/FWF [W1232]; WWTF [CS15-033]	Lundbeck Foundation(Lundbeckfonden); Independent Research Fund Denmark-Medical Sciences; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); WWTF	The work was supported by the Lundbeck Foundation grants R266-2017-4331 (U. G.), R2762018-792 (U. G.), Independent Research Fund Denmark-Medical Sciences (U. G. 7016-00325B), and by the Austrian Science Fund/FWF grant W1232 (MolTag; H. H. S.), grant doc.fund DOC 33 (H. H. S.) and the WWTF (grant CS15-033) (H. H. S.).	Anderluh A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14089; Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; Broer S, 2012, BRIT J PHARMACOL, V167, P256, DOI 10.1111/j.1476-5381.2012.01975.x; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Das AK, 2019, J BIOL CHEM, V294, P5632, DOI 10.1074/jbc.RA118.006178; Jayaraman K, 2021, J NEUROCHEM, V157, P919, DOI 10.1111/jnc.15145; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Seidel S, 2005, MOL PHARMACOL, V67, P140, DOI 10.1124/mol.67.1.140; Sorkina T, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100430; Sorkina T, 2018, ELIFE, V7, DOI 10.7554/eLife.32293	10	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100629	10.1016/j.jbc.2021.100629	http://dx.doi.org/10.1016/j.jbc.2021.100629			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237901	Green Published, gold			2022-12-28	WOS:000672866400600
J	Ghosh, G; Sharma, PV; Kumar, A; Jain, S; Sen, R				Ghosh, Gairika; Sharma, Pankaj, V; Kumar, Amit; Jain, Sriyans; Sen, Ranjan			Design of novel peptide inhibitors against the conserved bacterial transcription terminator, Rho	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT TERMINATION; DEFECTIVE-MUTANTS; STRUCTURAL BASIS; PROTEIN; RNA; ANTITERMINATION; POLARITY; REVERSE; NUSA	The transcription terminator Rho regulates many physiological processes in bacteria, such as antibiotic sensitivity, DNA repair, RNA remodeling, and so forth, and hence, is a potential antimicrobial target, which is unexplored. The bacteriophage P4 capsid protein, Psu, moonlights as a natural Rho antagonist. Here, we report the design of novel peptides based on the C-terminal region of Psu using phenotypic screening methods. The resultant 38-mer peptides, in addition to containing mutagenized Psu sequences, also contained plasmid sequences, fused to their C termini. Expression of these peptides inhibited the growth of Escherichia coli and specifically inhibited Rhodependent termination in vivo. Peptides 16 and 33 exhibited the best Rho-inhibitory properties in vivo. Direct high-affinity binding of these two peptides to Rho also inhibited the latter's RNA-dependent ATPase and transcription termination functions in vitro. These two peptides remained functional even if eight to ten amino acids were deleted from their C termini. In silico modeling and genetic and biochemical evidence revealed that these two peptides bind to the primary RNA-binding site of the Rho hexamer near its subunit interfaces. In addition, the gene expression profiles of these peptides and Psu overlapped significantly. These peptides also inhibited the growth of Mycobacteria and inhibited the activities of Rho proteins from Mycobacterium tuberculosis, Xanthomonas, Vibrio cholerae, and Salmonella enterica. Our results showed that these novel anti-Rho peptides mimic the Rho-inhibition function of the similar to 42-kDa dimeric bacteriophage P4 capsid protein, Psu. We conclude that these peptides and their C-terminal deletion derivatives could provide a basis on which to design novel antimicrobial peptides.	[Ghosh, Gairika; Sharma, Pankaj, V; Kumar, Amit; Jain, Sriyans; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Lab Transcript, Hyderabad, India; [Ghosh, Gairika; Sharma, Pankaj, V] Manipal Inst Higher Educ, Grad Studies, Manipal, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Lab Transcript, Hyderabad, India.	rsen@cdfd.org.in		Jain, Sriyans/0000-0002-8707-9991; Sen, Ranjan/0000-0001-5693-787X	Department of Science and Technology-Science and Engineering Research Board, India (DST-SERB) [EMR/2015/001620]; Indian Council of Medical Research, India (ICMR) [AMR/INDO/GER/219/2019-ECD-II]	Department of Science and Technology-Science and Engineering Research Board, India (DST-SERB); Indian Council of Medical Research, India (ICMR)(Indian Council of Medical Research (ICMR))	This work is supported by the Department of Science and Technology-Science and Engineering Research Board, India (DST-SERB) Grant EMR/2015/001620 and Indian Council of Medical Research, India (ICMR) Grant AMR/INDO/GER/219/2019-ECD-II to R. S.	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; Banerjee R, 2012, J BIOL CHEM, V287, P44667, DOI 10.1074/jbc.M112.423202; Banerjee S, 2006, J MICROBIOL, V44, P11; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chen YH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44305; Cukuroglu E, 2012, NUCLEIC ACIDS RES, V40, pD829, DOI 10.1093/nar/gkr929; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Drago-Serrano ME, 2018, CURR PHARM DESIGN, V24, P1067, DOI 10.2174/1381612824666180327155929; Ghosh G, 2018, J BACTERIOL, V200, DOI [10.1128/JB.00380-17, 10.1128/jb.00380-17]; Goude R., 2008, J VISUALIZED EXPT, V15, P761, DOI [10.3791/761, DOI 10.3791/761]; Gutierrrez P, 2007, J BIOL CHEM, V282, P23348, DOI 10.1074/jbc.M702010200; Haas David W, 2005, Top HIV Med, V13, P90; Hafeezunnisa M, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.605305; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Ibrahim HR, 2011, J AGR FOOD CHEM, V59, P10336, DOI 10.1021/jf2020396; Ippel JH, 2009, J BIOL CHEM, V284, P12363, DOI 10.1074/jbc.M808179200; Jain S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09146-5; Kalarickal NC, 2010, J MOL BIOL, V395, P966, DOI 10.1016/j.jmb.2009.12.022; Kalyani BS, 2011, J MOL BIOL, V413, P548, DOI 10.1016/j.jmb.2011.08.053; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kurnaresan V, 2015, MOL IMMUNOL B, V68, P421; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin CH, 2014, PHYTOPATHOLOGY, V104, P340, DOI 10.1094/PHYTO-09-13-0252-R; LINDEROTH NA, 1991, J BACTERIOL, V173, P6722, DOI 10.1128/jb.173.21.6722-6731.1991; Linderoth NA, 1997, VIROLOGY, V227, P131, DOI 10.1006/viro.1996.8325; London N, 2010, STRUCTURE, V18, P188, DOI 10.1016/j.str.2009.11.012; Mitra P, 2017, ANNU REV MICROBIOL, V71, P687, DOI 10.1146/annurev-micro-030117-020432; Pal K, 2019, J MOL BIOL, V431, p4749 4766; Pani B, 2006, J BIOL CHEM, V281, P26491, DOI 10.1074/jbc.M603982200; Pani B, 2009, J MOL BIOL, V389, P647, DOI 10.1016/j.jmb.2009.04.052; Parikh A, 2013, APPL ENVIRON MICROB, V79, P1718, DOI 10.1128/AEM.03695-12; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2009, P NATL ACAD SCI USA, V106, P15406, DOI 10.1073/pnas.0903846106; Qayyum MZ, 2016, J BIOL CHEM, V291, P8090, DOI 10.1074/jbc.M115.701268; Rabhi M, 2011, EMBO J, V30, P2805, DOI 10.1038/emboj.2011.192; Ranjan A, 2013, NUCLEIC ACIDS RES, V41, P6839, DOI 10.1093/nar/gkt336; Richardson JP, 2003, CELL, V114, P157, DOI 10.1016/S0092-8674(03)00554-3; Richardson JP, 2002, BBA-GENE STRUCT EXPR, V1577, P251, DOI 10.1016/S0167-4781(02)00456-6; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Thandar M, 2016, ANTIMICROB AGENTS CH, V60, P2671, DOI 10.1128/AAC.02972-15; Thomsen ND, 2009, CELL, V139, P523, DOI 10.1016/j.cell.2009.08.043; Valabhoju V, 2016, J BIOL CHEM, V291, P22386, DOI 10.1074/jbc.M116.745364; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Vasilchenko AS, 2017, J PEPT SCI, V23, P855, DOI 10.1002/psc.3049; Veldkamp AI, 1999, J CHROMATOGR B, V736, P123, DOI 10.1016/S0378-4347(99)00457-0; Wang QY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020600; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; YANG JT, 1986, METHOD ENZYMOL, V130, P208; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhu XL, 2011, PROTEINS, V79, P2671, DOI 10.1002/prot.23094; ZWIEFKA A, 1993, BIOCHEMISTRY-US, V32, P3564, DOI 10.1021/bi00065a007	55	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100653	10.1016/j.jbc.2021.100653	http://dx.doi.org/10.1016/j.jbc.2021.100653			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33845047	Green Published, gold			2022-12-28	WOS:000672866400624
J	Ma, JQ; Ayres, CM; Hellman, LM; Devlin, JR; Baker, BM				Ma, Jiaqi; Ayres, Cory M.; Hellman, Lance M.; Devlin, Jason R.; Baker, Brian M.			Dynamic allostery controls the peptide sensitivity of the Ly49C natural killer receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; STRUCTURAL BASIS; I MOLECULES; MHC; COMPLEX; BINDING; RECOGNITION; SIMULATIONS; REVEALS; AMBER	Using a variety of activating and inhibitory receptors, natural killer (NK) cells protect against disease by eliminating cells that have downregulated class I major histocompatibility complex (MHC) proteins, such as in response to cell transformation or viral infection. The inhibitory murine NK receptor Ly49C specifically recognizes the class I MHC protein H-2K(b). Unusual among NK receptors, Ly49C exhibits a peptide-dependent sensitivity to H-2K(b) recognition, which has not been explained despite detailed structural studies. To gain further insight into Ly49C peptide sensitivity, we examined Ly49C recognition biochemically and through the lens of dynamic allostery. We found that the peptide sensitivity of Ly49C arises through small differences in H-2K(b)-binding affinity. Although molecular dynamics simulations supported a role for peptide-dependent protein dynamics in producing these differences in binding affinity, calorimetric measurements indicated an enthalpically as opposed to entropically driven process. A quantitative linkage analysis showed that this emerges from peptide-dependent dynamic tuning of electrostatic interactions across the Ly49C-H-2K(b) interface. We propose a model whereby different peptides alter the flexibility of H-2K(b), which in turn changes the strength of electrostatic interactions across the protein-protein interface. Our results provide a quantitative assessment of how peptides alter Ly49C-binding affinity, suggest the underlying mechanism, and demonstrate peptide-driven allostery at work in class I MHC proteins. Lastly, our model provides a solution for how dynamic allostery could impact binding of some, but not all, class I MHC partners depending on the structural and chemical composition of the interfaces.	[Ma, Jiaqi; Ayres, Cory M.; Devlin, Jason R.; Baker, Brian M.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Ma, Jiaqi; Ayres, Cory M.; Devlin, Jason R.; Baker, Brian M.] Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA; [Hellman, Lance M.] Nevada State Coll, Dept Phys & Life Sci, Henderson, NV USA	University of Notre Dame; University of Notre Dame; Nevada System of Higher Education (NSHE); Nevada State College	Baker, BM (corresponding author), Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA.; Baker, BM (corresponding author), Univ Notre Dame, Harper Canc Res Inst, Notre Dame, IN 46556 USA.	brian-baker@nd.edu		Devlin, Jason/0000-0001-9184-8741	NIH [R35GM118166, S10OD028553]; I-CTSI by NIH [UL1TR002529]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); I-CTSI by NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Supported by NIH grants R35GM118166 and S10OD028553 to B. M. B. J.R. D was supported by a fellowship from the I-CTSI, supported by NIH grant UL1TR002529.	Andreatta M, 2016, BIOINFORMATICS, V32, P511, DOI 10.1093/bioinformatics/btv639; Ayres CM, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00966; Ayres CM, 2017, J CHEM INF MODEL, V57, P1990, DOI 10.1021/acs.jcim.7b00118; Bailey A, 2015, SCI REP-UK, V5, DOI 10.1038/srep14928; Beerbaum M, 2013, J BIOMOL NMR, V57, P167, DOI 10.1007/s10858-013-9777-z; Blevins SJ, 2017, FRONT MOL BIOSCI, V4, DOI 10.3389/fmolb.2017.00002; Borbulevych OY, 2009, IMMUNITY, V31, P885, DOI 10.1016/j.immuni.2009.11.003; Brown PH, 2006, BIOPHYS J, V90, P4651, DOI 10.1529/biophysj.106.081372; COOPER A, 1984, EUR BIOPHYS J BIOPHY, V11, P103, DOI 10.1007/BF00276625; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Dam J, 2003, NAT IMMUNOL, V4, P1213, DOI 10.1038/ni1006; Deng L, 2008, J BIOL CHEM, V283, P16840, DOI 10.1074/jbc.M801526200; Fleri W, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00278; Franksson L, 1999, EUR J IMMUNOL, V29, P2748, DOI 10.1002/(SICI)1521-4141(199909)29:09<2748::AID-IMMU2748>3.0.CO;2-C; FREMONT DH, 1992, SCIENCE, V257, P919, DOI 10.1126/science.1323877; FREMONT DH, 1995, P NATL ACAD SCI USA, V92, P2479, DOI 10.1073/pnas.92.7.2479; Garstka MA, 2011, FASEB J, V25, P3989, DOI 10.1096/fj.11-190249; Gotz AW, 2012, J CHEM THEORY COMPUT, V8, P1542, DOI 10.1021/ct200909j; Hanke T, 1999, IMMUNITY, V11, P67, DOI 10.1016/S1074-7613(00)80082-5; Hawse WF, 2013, J BIOL CHEM, V288, P24372, DOI 10.1074/jbc.M113.490664; Hawse WF, 2012, J IMMUNOL, V188, P5819, DOI 10.4049/jimmunol.1200952; Hellman LM, 2016, J IMMUNOL METHODS, V432, P95, DOI 10.1016/j.jim.2016.02.016; Hertig S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004746; Hillig RC, 2004, J BIOL CHEM, V279, P652, DOI 10.1074/jbc.M307457200; Hilser VJ, 2012, ANNU REV BIOPHYS, V41, P585, DOI 10.1146/annurev-biophys-050511-102319; Hopkins JR, 2020, FEBS J, V287, P3777, DOI 10.1111/febs.15278; Iluang j, 2007, J IMMUNOL, V1'79; Insaidoo FK, 2011, J BIOL CHEM, V286, P40163, DOI 10.1074/jbc.M111.283564; Kane K, 2015, PLOS ONE, V10; Kern PS, 1998, IMMUNITY, V9, P519, DOI 10.1016/S1074-7613(00)80635-4; Kumawat A, 2017, P NATL ACAD SCI USA, V114, pE5825, DOI 10.1073/pnas.1705311114; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; Li YL, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00123; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; Matsumoto N, 2001, J IMMUNOL, V166, P4422, DOI 10.4049/jimmunol.166.7.4422; Morgan CS, 1997, PROTEIN SCI, V6, P1771, DOI 10.1002/pro.5560060819; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Natarajan K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15260; Pegram HJ, 2011, IMMUNOL CELL BIOL, V89, P216, DOI 10.1038/icb.2010.78; Rangarajan S, 2018, J BIOL CHEM, V293, P15991, DOI 10.1074/jbc.RA118.003832; RECORD MT, 1978, Q REV BIOPHYS, V11, P103, DOI 10.1017/S003358350000202X; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Shiroishi M, 2006, P NATL ACAD SCI USA, V103, P16412, DOI 10.1073/pnas.0605228103; Singh Nishant K, 2020, Biochemistry, V59, P4163, DOI 10.1021/acs.biochem.0c00689; Smock RG, 2009, SCIENCE, V324, P198, DOI 10.1126/science.1169377; Sullivan LC, 2016, J BIOL CHEM, V291, P18740, DOI 10.1074/jbc.M116.737130; van Hateren A, 2017, J BIOL CHEM, V292, P20255, DOI 10.1074/jbc.M117.809624; van Hateren Andy, 2017, F1000Res, V6, P158, DOI 10.12688/f1000research.10474.1; Wang R, 2009, J IMMUNOL, V183, P2554, DOI 10.4049/jimmunol.0901276; Willcox BE, 2003, NAT IMMUNOL, V4, P913, DOI 10.1038/ni961; Yanaka S, 2014, J BIOL CHEM	52	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100686	10.1016/j.jbc.2021.100686	http://dx.doi.org/10.1016/j.jbc.2021.100686			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33891944	gold, Green Published			2022-12-28	WOS:000672866400657
J	Mizsei, R; Li, XL; Chen, WN; Szabo, M; Wang, JH; Wagner, G; Reinherz, EL; Mallis, RJ				Mizsei, Reka; Li, Xiaolong; Chen, Wan-Na; Szabo, Monika; Wang, Jia-Huai; Wagner, Gerhard; Reinherz, Ellis L.; Mallis, Robert J.			A general chemical crosslinking strategy for structural analyses of weakly interacting proteins applied to preTCR-pMHC complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							T-CELL-RECEPTOR; ALPHA-BETA; THYMIC SELECTION; TCR-BETA; PEPTIDE; RECOGNITION; MECHANISMS; ECTODOMAIN; LIGAND; MECHANOTRANSDUCTION	T lymphocytes discriminate between healthy and infected or cancerous cells via T-cell receptor-mediated recognition of peptides bound and presented by cell-surface-expressed major histocompatibility complex molecules (MHCs). Pre-T-cell receptors (preTCRs) on thymocytes foster development of alpha beta T lymphocytes through their beta chain interaction with MHC displaying self-peptides on thymic epithelia. The specific binding of a preTCR with a peptide-MHC complex (pMHC) has been identified previously as forming a weak affinity complex with a distinct interface from that of mature alpha beta TCR. However, a lack of appropriate tools has limited prior efforts to investigate this unique interface. Here we designed a small-scale linkage screening protocol using bismaleimide linkers for determining residue-specific distance constraints between transiently interacting protein pairs in solution. Employing linkage distance restraint-guided molecular modeling, we report the oriented solution docking geometry of a preTCR beta-pMHC interaction. The linkage model of preTCR beta-pMHC complex was independently verified with paramagnetic pseudocontact chemical shift (PCS) NMR of the unlinked protein mixtures. Using linkage screens, we show that the preTCR binds with differing affinities to peptides presented by MHC in solution. Moreover, the C-terminal peptide segment is a key determinant in preTCR-pMHC recognition. We also describe the process for future large-scale production and purification of the linked constructs for NMR, X-ray crystallography, and single-molecule electron microscopy studies.	[Mizsei, Reka; Li, Xiaolong; Wang, Jia-Huai; Reinherz, Ellis L.; Mallis, Robert J.] Dana Farber Canc Inst, Lab Immunobiol, Boston, MA 02115 USA; [Li, Xiaolong; Wang, Jia-Huai; Reinherz, Ellis L.; Mallis, Robert J.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Wang, Jia-Huai] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Mizsei, Reka] Semmelweis Univ, Dept Biochem, Budapest, Hungary; [Li, Xiaolong; Reinherz, Ellis L.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Chen, Wan-Na; Wang, Jia-Huai; Wagner, Gerhard; Mallis, Robert J.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Wang, Jia-Huai] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Mallis, Robert J.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Szabo, Monika] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic, Australia	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Semmelweis University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Monash University	Reinherz, EL; Mallis, RJ (corresponding author), Dana Farber Canc Inst, Lab Immunobiol, Boston, MA 02115 USA.; Reinherz, EL; Mallis, RJ (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.; Reinherz, EL (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Mallis, RJ (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Mallis, RJ (corresponding author), Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA.	ellis_reinherz@dfci.harvard.edu; robert_mallis@hms.harvard.edu	Li, Xiaolong/AAG-7297-2019; Mizsei, Réka/ABB-7079-2020	Li, Xiaolong/0000-0001-6549-4089; Mizsei, Réka/0000-0003-4519-4307	NIH [PO1 AI143565, P41 GM132079]; NIH R01 grant [AI115698, GM129026, AI0037581]; Claudia Adams Barr award; European National Talent Program [NTP-NFTO-P-15-0693, NTP-NFTO-P-17-C-0139, NTP-NFTO-P-19-B-0270]; Rosztoczy Foundation Scholarship; Semmelweis University [EFOP-3.6.3-VEKOP-16-2017-00009]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Claudia Adams Barr award; European National Talent Program; Rosztoczy Foundation Scholarship; Semmelweis University	This work was supported by NIH PO1 AI143565 to R. J. M., J. H. W., G. W., and E. L. R.; NIH R01 grants AI115698 to E. L. R., GM129026 and AI0037581 to G. W.; NIH P41 GM132079 to G. W.; Claudia Adams Barr award to J.H. W; European National Talent Program (NTP-NFTO-P-15-0693, NTP-NFTO-P-17-C-0139 and NTP-NFTO-P-19-B-0270), Rosztoczy Foundation Scholarship, and Semmelweis University EFOP-3.6.3-VEKOP-16-2017-00009 scholarship to R. M. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bonvin AMJJ, 2018, NAT PROTOC, V13, P1503, DOI 10.1038/s41596-018-0017-6; BRAGG L, 1950, PROC R SOC LON SER-A, V203, P321, DOI 10.1098/rspa.1950.0142; Brazin KN, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00441; Bullock JMA, 2018, BIOINFORMATICS, V34, P3584, DOI 10.1093/bioinformatics/bty366; Chakraborty AK, 2014, NAT IMMUNOL, V15, P798, DOI 10.1038/ni.2940; Chen WN, 2014, FEBS LETT, V588, P2206, DOI 10.1016/j.febslet.2014.05.018; Chen XY, 2013, ADV DRUG DELIVER REV, V65, P1357, DOI 10.1016/j.addr.2012.09.039; Das DK, 2016, J BIOL CHEM, V291, P25292, DOI 10.1074/jbc.M116.752865; Das DK, 2015, P NATL ACAD SCI USA, V112, P1517, DOI 10.1073/pnas.1424829112; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dong D, 2019, NATURE, V573, P546, DOI 10.1038/s41586-019-1537-0; Feng YN, 2018, TRENDS IMMUNOL, V39, P596, DOI 10.1016/j.it.2018.05.005; Ghendler Y, 1998, P NATL ACAD SCI USA, V95, P10061, DOI 10.1073/pnas.95.17.10061; Graham B, 2011, BIOCONJUGATE CHEM, V22, P2118, DOI 10.1021/bc200353c; Hare BJ, 1999, NAT STRUCT BIOL, V6, P574; Hennecke J, 2000, EMBO J, V19, P5611, DOI 10.1093/emboj/19.21.5611; Hwang W, 2020, P NATL ACAD SCI USA, V117, P21336, DOI 10.1073/pnas.2005899117; Kahraman A, 2011, BIOINFORMATICS, V27, P2163, DOI 10.1093/bioinformatics/btr348; Keller R., 2004, COMPUTER AIDED RESON, V1; Klein L, 2014, NAT REV IMMUNOL, V14, P377, DOI 10.1038/nri3667; Koehler J, 2011, PROG NUCL MAG RES SP, V59, P360, DOI 10.1016/j.pnmrs.2011.05.001; KUNZ D, 1983, COLLOID POLYM SCI, V261, P635, DOI 10.1007/BF01415033; La Gruta NL, 2018, NAT REV IMMUNOL, V18, P467, DOI 10.1038/s41577-018-0007-5; Li XL, 2021, SCIENCE, V371, P181, DOI 10.1126/science.abe0918; Mallis RJ, 2018, J BIOL CHEM, V293, P754, DOI 10.1074/jbc.M117.813493; Mallis RJ, 2016, BIOMOL NMR ASSIGN, V10, P35, DOI 10.1007/s12104-015-9632-0; Mallis RJ, 2015, P NATL ACAD SCI USA, V112, P8373, DOI 10.1073/pnas.1504971112; Ming QQ, 2019, EXP BIOL MED, V244, P1559, DOI 10.1177/1535370219855401; Natarajan K, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01657; Orton HW, 2020, MAGN RESON, V1, P1, DOI [10.5194/mr-1-1-2020, DOI 10.5194/MR-1-1-2020]; PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205; Piehler J, 2005, CURR OPIN STRUC BIOL, V15, P4, DOI 10.1016/j.sbi.2005.01.008; Rossjohn J, 2015, ANNU REV IMMUNOL, V33, P169, DOI 10.1146/annurev-immunol-032414-112334; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658; Saio T, 2009, J BIOMOL NMR, V45, P335, DOI 10.1007/s10858-009-9370-7; Sasada T, 2001, J EXP MED, V194, P883, DOI 10.1084/jem.194.7.883; Sasada T, 2000, EUR J IMMUNOL, V30, P1281, DOI 10.1002/(SICI)1521-4141(200005)30:5<1281::AID-IMMU1281>3.3.CO;2-4; Sibener LV, 2018, CELL, V174, P672, DOI 10.1016/j.cell.2018.06.017; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Sun ZYJ, 2004, P NATL ACAD SCI USA, V101, P16867, DOI 10.1073/pnas.0407576101; Sun ZYJ, 2001, CELL, V105, P913, DOI 10.1016/S0092-8674(01)00395-6; Takaba H, 2017, TRENDS IMMUNOL, V38, P805, DOI 10.1016/j.it.2017.07.010; Teng MK, 1998, CURR BIOL, V8, P409, DOI 10.1016/S0960-9822(98)70160-5; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; von Boehmer H, 1998, IMMUNOL REV, V165, P111; Wang JH, 2012, IMMUNOL REV, V250, P102, DOI 10.1111/j.1600-065X.2012.01161.x; Wieczorek M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00292; Zhou B, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00005	49	1	1	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100255	10.1016/j.jbc.2021.100255	http://dx.doi.org/10.1016/j.jbc.2021.100255			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837736	Green Published, gold			2022-12-28	WOS:000672866400231
J	Oldach, L				Oldach, Laurel			The paper that found a third form of fat cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BROWN ADIPOSE-TISSUE; ADIPOCYTES; DISTINCT		[Oldach, Laurel] Albert Einstein Coll Med, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine	Oldach, L (corresponding author), Albert Einstein Coll Med, Bronx, NY 10467 USA.	loldach@asbmb.org		Oldach, Laurel/0000-0003-1491-608X				Berry DC, 2017, CELL METAB, V25, P166, DOI 10.1016/j.cmet.2016.10.023; Cinti S, 2009, AM J PHYSIOL-ENDOC M, V297, pE977, DOI 10.1152/ajpendo.00183.2009; de Jong JMA, 2019, NAT METAB, V1, P830, DOI 10.1038/s42255-019-0101-4; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Pan RP, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00185; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Wang WS, 2019, CELL METAB, V30, P174, DOI 10.1016/j.cmet.2019.05.005; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100817	10.1016/j.jbc.2021.100817	http://dx.doi.org/10.1016/j.jbc.2021.100817			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34023386	Green Published, gold			2022-12-28	WOS:000674717300026
J	Osman, S; Mohammad, E; Lidschreiber, M; Stuetzer, A; Bazso, FL; Maier, KC; Urlaub, H; Cramer, P				Osman, Sara; Mohammad, Eusra; Lidschreiber, Michael; Stuetzer, Alexandra; Bazso, Fanni Laura; Maier, Kerstin C.; Urlaub, Henning; Cramer, Patrick			The Cdk8 kinase module regulates interaction of the mediator complex with RNA polymerase II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								The Cdk8 kinase module (CKM) is a dissociable part of the coactivator complex mediator, which regulates gene transcription by RNA polymerase II. The CKM has both negative and positive functions in gene transcription that remain poorly understood at the mechanistic level. In order to reconstitute the role of the CKM in transcription initiation, we prepared recombinant CKM from the yeast Saccharomyces cerevisiae. We showed that CKM bound to the core mediator (cMed) complex, sterically inhibiting cMed from binding to the polymerase II preinitiation complex (PIC) in vitro. We further showed that the Cdk8 kinase activity of the CKM weakened CKM-cMed interaction, thereby facilitating dissociation of the CKM and enabling mediator to bind the PIC in order to stimulate transcription initiation. Finally, we report that the kinase activity of Cdk8 is required for gene activation during the stressful condition of heat shock in vivo but not under steady-state growth conditions. Based on these results, we propose a model in which the CKM negatively regulates mediator function at upstream-activating sequences by preventing mediator binding to the PIC at the gene promoter. However, during gene activation in response to stress, the Cdk8 kinase activity of the CKM may release mediator and allow its binding to the PIC, thereby accounting for the positive function of CKM. This may impart improved adaptability to stress by allowing a rapid transcriptional response to environmental changes, and we speculate that a similar mechanism in metazoans may allow the precise timing of developmental transcription programs.	[Osman, Sara; Mohammad, Eusra; Lidschreiber, Michael; Maier, Kerstin C.; Cramer, Patrick] Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany; [Stuetzer, Alexandra; Bazso, Fanni Laura; Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Dept Cellular Biochem, Gottingen, Germany; [Stuetzer, Alexandra; Urlaub, Henning] Univ Med Ctr, Bioanalyt Res Grp, Inst Clin Chem, Gottingen, Germany	Max Planck Society; Max Planck Society; University of Gottingen	Cramer, P (corresponding author), Max Planck Inst Biophys Chem, Dept Mol Biol, Gottingen, Germany.	patrick.cramer@mpibpc.mpg.de			Deutsche Forschungsgemeinschaft [EXC 2067/1-390729940]; European Research Council Advanced Investigator grant CHROMATRANS [882357]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Research Council Advanced Investigator grant CHROMATRANS	P. C. was supported by the Deutsche Forschungsgemeinschaft (EXC 2067/1-390729940) and the European Research Council Advanced Investigator grant CHROMATRANS (grant agreement no: 882357).		0	11	11	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100734	10.1016/j.jbc.2021.100734	http://dx.doi.org/10.1016/j.jbc.2021.100734			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933450	gold, Green Published			2022-12-28	WOS:000672866400703
J	Qian, SW; Tang, Y; Tang, QQ				Qian, Shuwen; Tang, Yan; Tang, Qi-Qun			Adipose tissue plasticity and the pleiotropic roles of BMP signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TUMOR-NECROSIS-FACTOR; ALTERNATIVELY ACTIVATED MACROPHAGES; FACTOR-ALPHA; BROWN-FAT; TGF-BETA; GROWTH-FACTOR; STEM-CELLS; RESIDENT MACROPHAGES; ADIPOCYTE APOPTOSIS; INSULIN-RESISTANCE	Adipose tissues, including white, beige, and brown adipose tissue, have evolved to be highly dynamic organs. Adipose tissues undergo profound changes during development and regeneration and readily undergo remodeling to meet the demands of an everchanging metabolic landscape. The dynamics are determined by the high plasticity of adipose tissues, which contain various cell types: adipocytes, immune cells, endothelial cells, nerves, and fibroblasts. There are numerous proteins that participate in regulating the plasticity of adipose tissues. Among these, bone morphogenetic proteins (BMPs) were initially found to regulate the differentiation of adipocytes, and they are being reported to have pleiotropic functions by emerging studies. Here, in the first half of the article, we summarize the plasticity of adipocytes and macrophages, which are two groups of cells targeted by BMP signaling in adipose tissues. We then review how BMPs regulate the differentiation, death, and lipid metabolism of adipocytes. In addition, the potential role of BMPs in regulating adipose tissue macrophages is considered. Finally, the expression of BMPs in adipose tissues and their metabolic relevance are discussed.	[Qian, Shuwen; Tang, Yan; Tang, Qi-Qun] Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China; [Qian, Shuwen; Tang, Yan; Tang, Qi-Qun] Fudan Univ, Dept Endocrinol & Metab, Zhongshan Hosp, Shanghai, Peoples R China	Fudan University; Fudan University	Tang, QQ (corresponding author), Fudan Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Key Lab Metab & Mol Med,Minist Educ, Shanghai, Peoples R China.; Tang, QQ (corresponding author), Fudan Univ, Dept Endocrinol & Metab, Zhongshan Hosp, Shanghai, Peoples R China.	qqtang@shmu.edu.cn		Qian, Shuwen/0000-0002-5667-8908	National Natural Science Foundation (NSFC) [81730021, 31670787, 81200621]	National Natural Science Foundation (NSFC)(National Natural Science Foundation of China (NSFC))	The works in our lab mentioned in the article were supported by the National Natural Science Foundation (NSFC) Grants 81730021 to Q. -Q. T. and 31670787 and 81200621 to S. Q.	AHRENS M, 1993, DNA CELL BIOL, V12, P871, DOI 10.1089/dna.1993.12.871; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Alkhouri N, 2010, J BIOL CHEM, V285, P3428, DOI 10.1074/jbc.M109.074252; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Arner E, 2010, DIABETES, V59, P105, DOI 10.2337/db09-0942; Arner Peter, 2018, Nestle Nutr Inst Workshop Ser, V89, P37, DOI 10.1159/000486491; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; BERSE B, 1992, MOL BIOL CELL, V3, P211, DOI 10.1091/mbc.3.2.211; Bertrand JY, 2005, BLOOD, V106, P3004, DOI 10.1182/blood-2005-02-0461; Billon N, 2007, DEVELOPMENT, V134, P2283, DOI 10.1242/dev.002642; Blackwell KA, 2009, PROSTAG OTH LIPID M, V90, P76, DOI 10.1016/j.prostaglandins.2009.08.005; Boon MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074083; Bordicchia M, 2012, J CLIN INVEST, V122, P1022, DOI 10.1172/JCI59701; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boulter L, 2012, NAT MED, V18, P572, DOI 10.1038/nm.2667; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Brykczynska U, 2020, CELL REP, V30, P1627, DOI 10.1016/j.celrep.2020.01.005; Camell C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075147; Carmean CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067807; Caron-Debarle M, 2010, CURR PHARM DESIGN, V16, P3352, DOI 10.2174/138161210793563446; Carreira AC, 2014, ARCH BIOCHEM BIOPHYS, V561, P64, DOI 10.1016/j.abb.2014.07.011; Cartier A, 2010, CLIN ENDOCRINOL, V72, P349, DOI 10.1111/j.1365-2265.2009.03671.x; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Chen YW, 2015, P NATL ACAD SCI USA, V112, pE4556, DOI 10.1073/pnas.1506954112; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Chujo S, 2009, J CELL PHYSIOL, V220, P189, DOI 10.1002/jcp.21750; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; CINTI S, 1989, BIOL CELL, V67, P359, DOI 10.1016/0248-4900(89)90075-0; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cros J, 2010, IMMUNITY, V33, P375, DOI 10.1016/j.immuni.2010.08.012; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Oliveira SHDD, 2014, MICROB PATHOGENESIS, V67-68, P41, DOI 10.1016/j.micpath.2014.02.004; Domingo P, 1999, AIDS, V13, P2261, DOI 10.1097/00002030-199911120-00008; Domingo P, 2005, EUR J CLIN INVEST, V35, P771, DOI 10.1111/j.1365-2362.2005.01576.x; Elias I, 2012, DIABETES, V61, P1801, DOI 10.2337/db11-0832; Elsen M, 2014, AM J PHYSIOL-CELL PH, V306, pC431, DOI 10.1152/ajpcell.00290.2013; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Rafols ME, 2014, ENDOCRINOL NUTR, V61, P100, DOI 10.1016/j.endonu.2013.03.011; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Fischer K, 2017, NAT MED, V23, P623, DOI 10.1038/nm.4316; Fisher FM, 2012, GENE DEV, V26, P271, DOI 10.1101/gad.177857.111; Fong D, 2013, CELL SIGNAL, V25, P717, DOI 10.1016/j.cellsig.2012.12.003; Gao ZG, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.155861; Garg K, 2013, BIOMATERIALS, V34, P4439, DOI 10.1016/j.biomaterials.2013.02.065; Gavin KM, 2016, FASEB J, V30, P1096, DOI 10.1096/fj.15-278994; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giordano A, 2013, J LIPID RES, V54, P2423, DOI 10.1194/jlr.M038638; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gordon S, 2016, IMMUNITY, V44, P463, DOI 10.1016/j.immuni.2016.02.026; Grefhorst A, 2015, BIOL SEX DIFFER, V6, DOI 10.1186/s13293-015-0025-y; Guiu-Jurado E, 2016, OBESITY, V24, P2092, DOI 10.1002/oby.21571; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Gustafson B, 2012, DIABETES, V61, P1217, DOI 10.2337/db11-1419; Gyorki DE, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2353; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Harada K, 2003, AM J PHYSIOL-ENDOC M, V285, pE1182, DOI 10.1152/ajpendo.00259.2003; Harman-Boehm I, 2007, J CLIN ENDOCR METAB, V92, P2240, DOI 10.1210/jc.2006-1811; Hausman GJ, 2004, J ANIM SCI, V82, P925; Hegarty SV, 2013, PROG NEUROBIOL, V109, P28, DOI 10.1016/j.pneurobio.2013.07.002; Heinecke K, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-59; Hino J, 2017, INT J OBESITY, V41, P483, DOI 10.1038/ijo.2017.15; Hino J, 2012, INT J OBESITY, V36, P725, DOI 10.1038/ijo.2011.124; Hinoi E, 2014, DIABETES, V63, P162, DOI 10.2337/db13-0808; Hong JH, 2009, IMMUNOLOGY, V128, pe442, DOI 10.1111/j.1365-2567.2008.02998.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huang HY, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002691; Huang HY, 2009, P NATL ACAD SCI USA, V106, P12670, DOI 10.1073/pnas.0906266106; Huber J, 2008, J CLIN ENDOCR METAB, V93, P3215, DOI 10.1210/jc.2007-2630; Hui XY, 2015, CELL METAB, V22, P279, DOI 10.1016/j.cmet.2015.06.004; Itoh K, 2001, ENDOCRINOLOGY, V142, P3656, DOI 10.1210/en.142.8.3656; Jenkins SJ, 2013, J EXP MED, V210, P2477, DOI 10.1084/jem.20121999; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; Jespersen NZ, 2013, CELL METAB, V17, P798, DOI 10.1016/j.cmet.2013.04.011; Ji YW, 2012, J BIOL CHEM, V287, P24378, DOI 10.1074/jbc.M112.371807; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Jo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000324; Johnson JA, 2004, AM J PHYSIOL-ENDOC M, V286, pE261, DOI 10.1152/ajpendo.00056.2003; Kamei N, 2006, J BIOL CHEM, V281, P26602, DOI 10.1074/jbc.M601284200; Kang K, 2008, CELL METAB, V7, P485, DOI 10.1016/j.cmet.2008.04.002; Keophiphath M, 2010, ARTERIOSCL THROM VAS, V30, P39, DOI 10.1161/ATVBAHA.109.197442; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; KERN PA, 1995, J CLIN INVEST, V95, P2111, DOI 10.1172/JCI117899; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Kierdorf K, 2013, NAT NEUROSCI, V16, P273, DOI 10.1038/nn.3318; Kleemann R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008817; Kochan Z, 1997, METABOLISM, V46, P10, DOI 10.1016/S0026-0495(97)90160-8; Koga M, 2013, J INFLAMM-LOND, V10, DOI 10.1186/1476-9255-10-32; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Koza RA, 2006, PLOS GENET, V2, P769, DOI 10.1371/journal.pgen.0020081; Kuroda E, 2009, J IMMUNOL, V183, P3652, DOI 10.4049/jimmunol.0900864; Kwon SJ, 2009, IMMUNOLOGY, V128, pe758, DOI 10.1111/j.1365-2567.2009.03079.x; Lee GT, 2011, MOL IMMUNOL, V48, P1540, DOI 10.1016/j.molimm.2011.04.019; Lee MW, 2015, CELL, V160, P74, DOI 10.1016/j.cell.2014.12.011; Lee YH, 2015, FASEB J, V29, P286, DOI 10.1096/fj.14-263038; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Lepper C, 2010, GENESIS, V48, P424, DOI 10.1002/dvg.20630; Li JP, 2002, AM J PHYSIOL-ENDOC M, V282, pE1334, DOI 10.1152/ajpendo.00516.2001; Li ZT, 2014, EUR J IMMUNOL, V44, P3283, DOI 10.1002/eji.201344287; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lijnen HR, 2008, CARDIOVASC RES, V78, P286, DOI 10.1093/cvr/cvm007; Liu ZH, 2018, DIABETES, V67, P2397, DOI 10.2337/db18-0684; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; lyengar P., 2005, NAT MED, V11, p797 803; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Mawrie D, 2019, CELL TISSUE RES, V378, P531, DOI 10.1007/s00441-019-03072-0; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Merrick D, 2019, SCIENCE, V364, P353, DOI 10.1126/science.aav2501; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Modica S, 2016, CELL REP, V16, P2243, DOI 10.1016/j.celrep.2016.07.048; MODOLELL M, 1995, EUR J IMMUNOL, V25, P1101, DOI 10.1002/eji.1830250436; Moreno-Miralles I, 2009, CURR OPIN HEMATOL, V16, P195, DOI 10.1097/MOH.0b013e32832a07d6; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Morrell NW, 2016, NAT REV CARDIOL, V13, P106, DOI 10.1038/nrcardio.2015.156; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mullen AC, 2011, CELL, V147, P565, DOI 10.1016/j.cell.2011.08.050; Munder M, 1999, J IMMUNOL, V163, P3771; Murano I, 2008, J LIPID RES, V49, P1562, DOI 10.1194/jlr.M800019-JLR200; Neill DR, 2010, NATURE, V464, P1367, DOI 10.1038/nature08900; Ng SF, 2014, FASEB J, V28, P1830, DOI 10.1096/fj.13-244046; Nguyen KD, 2011, NATURE, V480, P104, DOI 10.1038/nature10653; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Nickel J, 2005, J MOL BIOL, V349, P933, DOI 10.1016/j.jmb.2005.04.015; Nickel J, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121579; Nishinakamura R, 2014, PEDIATR NEPHROL, V29, P681, DOI 10.1007/s00467-013-2671-9; Nisoli E, 2000, P NATL ACAD SCI USA, V97, P8033, DOI 10.1073/pnas.97.14.8033; Odegaard JI, 2007, NATURE, V447, P1116, DOI 10.1038/nature05894; Oguri Y, 2020, CELL, V182, P563, DOI 10.1016/j.cell.2020.06.021; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Palis J, 1999, DEVELOPMENT, V126, P5073; Palmer AK, 2015, DIABETES, V64, P2289, DOI 10.2337/db14-1820; Pei Z, 2014, ARCH BIOCHEM BIOPHYS, V560, P27, DOI 10.1016/j.abb.2014.07.025; Peirce V, 2014, NATURE, V510, P76, DOI 10.1038/nature13477; Peiser L, 2002, CURR OPIN IMMUNOL, V14, P123, DOI 10.1016/S0952-7915(01)00307-7; Phillips KJ, 2019, BIOLOGY-BASEL, V8, DOI 10.3390/biology8030057; Plubell DL, 2017, MOL CELL PROTEOMICS, V16, P873, DOI 10.1074/mcp.M116.065524; POISSONNET CM, 1984, EARLY HUM DEV, V10, P1, DOI 10.1016/0378-3782(84)90106-3; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Prasad MS, 2019, GENESIS, V57, DOI 10.1002/dvg.23276; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Qian SW, 2019, J MOL CELL BIOL, V11, P14, DOI 10.1093/jmcb/mjy011; Qian SW, 2016, EBIOMEDICINE, V11, P91, DOI 10.1016/j.ebiom.2016.07.034; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Qian SW, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0928-y; Qiu YF, 2014, CELL, V157, P1292, DOI 10.1016/j.cell.2014.03.066; Rajala MW, 2003, ENDOCRINOLOGY, V144, P3765, DOI 10.1210/en.2003-0580; Rao RR, 2014, CELL, V157, P1279, DOI 10.1016/j.cell.2014.03.065; RAPPOLEE DA, 1988, SCIENCE, V241, P708, DOI 10.1126/science.3041594; RICQUIER D, 1982, J CLIN ENDOCR METAB, V54, P803; RICQUIER D, 1976, BIOCHEM BIOPH RES CO, V73, P577, DOI 10.1016/0006-291X(76)90849-4; Robinson N, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101239; Rocher C, 2012, CAN J PHYSIOL PHARM, V90, P947, DOI [10.1139/Y2012-102, 10.1139/y2012-102]; Rodriguez A, 2012, DIABETOLOGIA, V55, P3038, DOI 10.1007/s00125-012-2671-5; Ross S, 2006, EMBO J, V25, P4490, DOI 10.1038/sj.emboj.7601332; Rothhammer T, 2007, ONCOGENE, V26, P4158, DOI 10.1038/sj.onc.1210182; Ryden M, 2015, CELL METAB, V22, P408, DOI 10.1016/j.cmet.2015.06.011; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Salazar VS, 2016, NAT REV ENDOCRINOL, V12, P203, DOI 10.1038/nrendo.2016.12; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schreiber I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17595-5; Schulz TJ, 2013, NATURE, V495, P379, DOI 10.1038/nature11943; Schwalie PC, 2018, NATURE, V559, P103, DOI 10.1038/s41586-018-0226-8; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sebo ZL, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.166801; Sekiya M, 2004, J BIOL CHEM, V279, P15084, DOI 10.1074/jbc.M310985200; Shan TZ, 2013, J LIPID RES, V54, P2214, DOI 10.1194/jlr.M038711; Shao M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03196-x; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092608; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; Shinoda K, 2015, NAT MED, V21, P389, DOI 10.1038/nm.3819; Sindrilaru A, 2011, J CLIN INVEST, V121, P985, DOI 10.1172/JCI44490; Smallie T, 2010, J EXP MED, V207, P2081, DOI 10.1084/jem.20100414; Soula HA, 2015, J THEOR BIOL, V364, P189, DOI 10.1016/j.jtbi.2014.08.046; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Spiller KL, 2014, BIOMATERIALS, V35, P4477, DOI 10.1016/j.biomaterials.2014.02.012; Stabile H, 2007, BLOOD, V109, P1834, DOI 10.1182/blood-2006-06-032276; Stafeev IS, 2017, INT J ENDOCRINOL, V2017, DOI 10.1155/2017/5076732; Stappenbeck TS, 2009, SCIENCE, V324, P1666, DOI 10.1126/science.1172687; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun CY, 2020, CELL STEM CELL, V26, P707, DOI 10.1016/j.stem.2020.03.004; Tam CS, 2012, J CLIN ENDOCR METAB, V97, P1320, DOI 10.1210/jc.2011-2806; Tamai M, 2017, LAB INVEST, V97, P228, DOI 10.1038/labinvest.2016.124; Tang QQ, 2012, ANNU REV BIOCHEM, V81, P715, DOI 10.1146/annurev-biochem-052110-115718; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang SS, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/238150; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tang Y, 2016, J MOL CELL BIOL, V8, P302, DOI 10.1093/jmcb/mjw019; Timmons JA, 2007, P NATL ACAD SCI USA, V104, P4401, DOI 10.1073/pnas.0610615104; Townsend KL, 2013, ANTIOXID REDOX SIGN, V19, P243, DOI 10.1089/ars.2012.4536; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Tzanavari T, 2010, CURR DIR AUTOIMMUN, V11, P145, DOI 10.1159/000289203; Velickovic K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23267-9; Villarroya F, 2007, INT J OBESITY, V31, P1763, DOI 10.1038/sj.ijo.0803698; Viola A, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01462; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vishvanath L, 2016, CELL METAB, V23, P350, DOI 10.1016/j.cmet.2015.10.018; Vukicevic S, 2009, CYTOKINE GROWTH F R, V20, P441, DOI 10.1016/j.cytogfr.2009.10.020; Walden TB, 2009, J CELL PHYSIOL, V218, P444, DOI 10.1002/jcp.21621; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wang RN, 2014, GENES DIS, V1, P87, DOI 10.1016/j.gendis.2014.07.005; Warne JP, 2003, J ENDOCRINOL, V177, P351, DOI 10.1677/joe.0.1770351; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wentworth JM, 2010, DIABETES, V59, P1648, DOI 10.2337/db09-0287; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Willenborg S, 2012, BLOOD, V120, P613, DOI 10.1182/blood-2012-01-403386; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Xi QR, 2011, CELL, V147, P1511, DOI 10.1016/j.cell.2011.11.032; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xue RD, 2014, AM J PHYSIOL-ENDOC M, V306, pE363, DOI 10.1152/ajpendo.00119.2013; Xue YS, 2019, TRENDS IMMUNOL, V40, P1035, DOI 10.1016/j.it.2019.09.005; Yao YC, 2009, CIRC RES, V105, P575, DOI 10.1161/CIRCRESAHA.109.202333; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zou Y, 2020, J LIPID RES, V61, P1589, DOI 10.1194/jlr.RA120000869	229	5	5	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100678	10.1016/j.jbc.2021.100678	http://dx.doi.org/10.1016/j.jbc.2021.100678			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872596	Green Published, gold			2022-12-28	WOS:000672866400649
J	Diszhazi, G; Magyar, ZE; Lisztes, E; Toth-Molnar, E; Nanasi, PP; Vennekens, R; Toth, BI; Almassy, J				Diszhazi, Gyula; Magyar, Zsuzsanna E.; Lisztes, Erika; Toth-Molnar, Edit; Nanasi, Peter P.; Vennekens, Rudi; Toth, Balazs, I; Almassy, Janos			TRPM4 links calcium signaling to membrane potential in pancreatic acinar cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+ RELEASE; RYANODINE-RECEPTORS; CYTOSOLIC CALCIUM; WAVE-PROPAGATION; CHANNEL TRPM4; OSCILLATIONS; CA-2+; ENTRY; ACETYLCHOLINE; ACTIVATION	Transient receptor potential cation channel subfamily M member 4 (TRPM4) is a Ca2+-activated nonselective cation channel that mediates membrane depolarization. Although, a current with the hallmarks of a TRPM4-mediated current has been previously reported in pancreatic acinar cells (PACs), the role of TRPM4 in the regulation of acinar cell function has not yet been explored. In the present study, we identify this TRPM4 current and describe its role in context of Ca2+ signaling of PACs using pharmacological tools and TRPM4-deficient mice. We found a significant Ca2+-activated cation current in PACs that was sensitive to the TRPM4 inhibitors 9-phenanthrol and 4-chloro-2-[[2-(2-chlorophenoxy)acetyl]amino]benzoic acid (CBA). We demonstrated that the CBA-sensitive current was responsible for a Ca2+-dependent depolarization of PACs from a resting membrane potential of -44.4 +/- 2.9 to -27.7 +/- 3 mV. Furthermore, we showed that Ca2+ influx was higher in the TRPM4 KO-and CBA-treated PACs than in control cells. As hormone-induced repetitive Ca2+ transients partially rely on Ca2+ influx in PACs, the role of TRPM4 was also assessed on Ca2+ oscillations elicited by physiologically relevant concentrations of the cholecystokinin analog cerulein. These data show that the amplitude of Ca2+ signals was significantly higher in TRPM4 KO than in control PACs. Our results suggest that PACs are depolarized by TRPM4 currents to an extent that results in a significant reduction of the inward driving force for Ca2+. In conclusion, TRPM4 links intracellular Ca2+ signaling to membrane potential as a negative feedback regulator of Ca2+ entry in PACs.	[Diszhazi, Gyula; Magyar, Zsuzsanna E.; Lisztes, Erika; Nanasi, Peter P.; Toth, Balazs, I; Almassy, Janos] Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary; [Toth-Molnar, Edit] Univ Szeged, Dept Ophthalmol, Szeged, Hungary; [Vennekens, Rudi] Katholieke Univ Leuven, VIB Ctr Brain & Dis Res, Fac Med, Lab Ion Channel Res,Dept Cellular & Mol Med,TRP R, Leuven, Belgium	University of Debrecen; Szeged University; Flanders Institute for Biotechnology (VIB); KU Leuven	Almassy, J (corresponding author), Univ Debrecen, Fac Med, Dept Physiol, Debrecen, Hungary.	almassy.janos@med.unideb.hu	vennekens, rudi/AHD-0495-2022	Vennekens, Rudi/0000-0002-2564-5150; Toth, Balazs Istvan/0000-0002-4103-4333	Lajos Szodoray Scholarship of the Faculty of Medicine, University of Debrecen; New National Excellence Program of the Ministry for Innovation and Technology [UNKP-20-5-DE-422]; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences; FWO-Vlaanderen; KU Leuven BOF	Lajos Szodoray Scholarship of the Faculty of Medicine, University of Debrecen; New National Excellence Program of the Ministry for Innovation and Technology; Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences(Hungarian Academy of Sciences); FWO-Vlaanderen(FWO); KU Leuven BOF	J. A. is a recipient of the Lajos Szodoray Scholarship of the Faculty of Medicine, University of Debrecen. B. I. T. was supported by the New National Excellence Program of the Ministry for Innovation and Technology (UNKP-20-5-DE-422) and the Janos Bolyai Research Scholarship of the Hungarian Academy of Sciences. R. V. is supported by grants from the FWO-Vlaanderen and KU Leuven BOF (TRPLe: TRP Research Platform Leuven).	[Anonymous], 2015, PANCREAPEDIA EXOCRIN, DOI DOI 10.3998/PANC.2015.24; Burris SK, 2015, BRIT J PHARMACOL, V172, P2459, DOI 10.1111/bph.13077; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Colsoul B, 2010, P NATL ACAD SCI USA, V107, P5208, DOI 10.1073/pnas.0913107107; Criddle DN, 2009, AM J PHYSIOL-GASTR L, V297, pG1085, DOI 10.1152/ajpgi.00119.2009; Earley S, 2004, CIRC RES, V95, P922, DOI 10.1161/01.RES.0000147311.54833.03; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Edelstein Arthur D, 2014, J Biol Methods, V1; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Gerasimenko JV, 2014, J PHYSIOL-LONDON, V592, P269, DOI 10.1113/jphysiol.2013.261784; Gerasimenko JV, 2013, P NATL ACAD SCI USA, V110, P13186, DOI 10.1073/pnas.1300910110; Gerasimenko JV, 2009, P NATL ACAD SCI USA, V106, P10758, DOI 10.1073/pnas.0904818106; Geyer N, 2015, CELL CALCIUM, V58, P160, DOI 10.1016/j.ceca.2015.03.009; Huang F, 2009, P NATL ACAD SCI USA, V106, P21413, DOI 10.1073/pnas.0911935106; Ito K, 1997, EMBO J, V16, P242, DOI 10.1093/emboj/16.2.242; IWATSUKI N, 1977, J PHYSIOL-LONDON, V269, P723, DOI 10.1113/jphysiol.1977.sp011925; KASAI H, 1993, CELL, V74, P669, DOI 10.1016/0092-8674(93)90514-Q; KASAI H, 1990, NATURE, V348, P735, DOI 10.1038/348735a0; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Launay P, 2004, SCIENCE, V306, P1374, DOI 10.1126/science.1098845; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Markovics A, 2019, J CELL MOL MED, V23, P6203, DOI 10.1111/jcmm.14505; MARUYAMA Y, 1993, EMBO J, V12, P3017, DOI 10.1002/j.1460-2075.1993.tb05970.x; MARUYAMA Y, 1982, NATURE, V300, P61, DOI 10.1038/300061a0; MCCANDLESS M, 1981, J PHYSIOL-LONDON, V318, P57; Mignen O, 2008, J PHYSIOL-LONDON, V586, P185, DOI 10.1113/jphysiol.2007.146258; Mogami H, 1997, CELL, V88, P49, DOI 10.1016/S0092-8674(00)81857-7; NATHANSON MH, 1992, J BIOL CHEM, V267, P18118; NATHANSON MH, 1994, J BIOL CHEM, V269, P4693; Nilius B, 2006, EMBO J, V25, P467, DOI 10.1038/sj.emboj.7600963; Orabi AI, 2010, AM J PHYSIOL-GASTR L, V299, pG196, DOI 10.1152/ajpgi.00498.2009; OSIPCHUK YV, 1990, EMBO J, V9, P697, DOI 10.1002/j.1460-2075.1990.tb08162.x; Ousingsawat J, 2009, J BIOL CHEM, V284, P28698, DOI 10.1074/jbc.M109.012120; Ozhathil LC, 2018, BRIT J PHARMACOL, V175, P2504, DOI 10.1111/bph.14220; Pace RW, 2007, J PHYSIOL-LONDON, V582, P113, DOI 10.1113/jphysiol.2007.133660; Park JY, 2008, BIOCHEM BIOPH RES CO, V368, P677, DOI 10.1016/j.bbrc.2008.01.153; Park MK, 2000, EMBO J, V19, P5729, DOI 10.1093/emboj/19.21.5729; PETERSEN OH, 1991, CELL CALCIUM, V12, P135, DOI 10.1016/0143-4160(91)90015-7; PETERSEN OH, 1983, PFLUG ARCH EUR J PHY, V396, P82, DOI 10.1007/BF00584703; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PRALONG WF, 1988, FEBS LETT, V242, P79, DOI 10.1016/0014-5793(88)80989-X; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; PUTNEY JW, 1990, CELL CALCIUM, V11, P611, DOI 10.1016/0143-4160(90)90016-N; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Shuttleworth TJ, 1996, BIOCHEM J, V316, P819, DOI 10.1042/bj3160819; Shuttleworth TJ, 1996, J BIOL CHEM, V271, P21720, DOI 10.1074/jbc.271.36.21720; SJODIN L, 1991, J PHYSIOL-LONDON, V444, P763; Straub SV, 2000, J GEN PHYSIOL, V116, P547, DOI 10.1085/jgp.116.4.547; STREB H, 1983, NATURE, V306, P67, DOI 10.1038/306067a0; STREB H, 1985, J BIOL CHEM, V260, P7309; TEPIKIN AV, 1992, J BIOL CHEM, V267, P3569; TEPIKIN AV, 1992, J BIOL CHEM, V267, P14073; THORN P, 1993, CELL, V74, P661, DOI 10.1016/0092-8674(93)90513-P; TOESCU EC, 1992, EMBO J, V11, P1623, DOI 10.1002/j.1460-2075.1992.tb05208.x; TSUNODA Y, 1990, AM J PHYSIOL, V258, pC147, DOI 10.1152/ajpcell.1990.258.1.C147; Vennekens R, 2007, NAT IMMUNOL, V8, P312, DOI 10.1038/ni1441; WARD JB, 1995, LANCET, V346, P1016, DOI 10.1016/S0140-6736(95)91695-4; Wen L, 2015, GASTROENTEROLOGY, V149, P481, DOI 10.1053/j.gastro.2015.04.015; Won JH, 2007, AM J PHYSIOL-GASTR L, V293, pG1166, DOI 10.1152/ajpgi.00352.2007; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; YULE DI, 1988, FEBS LETT, V239, P358, DOI 10.1016/0014-5793(88)80951-7; Yule DI, 1997, J BIOL CHEM, V272, P9093; YULE DI, 1991, CELL CALCIUM, V12, P145, DOI 10.1016/0143-4160(91)90016-8	63	7	7	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101015	10.1016/j.jbc.2021.101015	http://dx.doi.org/10.1016/j.jbc.2021.101015			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34329682	Green Published, Green Accepted, gold			2022-12-28	WOS:000706408900003
J	Dultz, G; Srikakulam, SK; Konetschnik, M; Shimakami, T; Doncheva, NT; Dietz, J; Sarrazin, C; Biondi, RM; Zeuzem, S; Tampe, R; Kalinina, OV; Welsch, C				Dultz, Georg; Srikakulam, Sanjay K.; Konetschnik, Michael; Shimakami, Tetsuro; Doncheva, Nadezhda T.; Dietz, Julia; Sarrazin, Christoph; Biondi, Ricardo M.; Zeuzem, Stefan; Tampe, Robert; Kalinina, Olga, V; Welsch, Christoph			Epistatic interactions promote persistence of NS3-Q80K in HCV infection by compensating for protein folding instability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADAPTER PROTEIN; INHIBITORS; HELICASE; FITNESS; REPLICATION; RESISTANCE; SIMEPREVIR; STABILITY; SEQUENCE; NETWORKS	The Q80K polymorphism in the NS3-4A protease of the hepatitis C virus is associated with treatment failure of direct acting antiviral agents. This polymorphism is highly prevalent in genotype 1a infections and stably transmitted between hosts. Here, we investigated the underlying molecular mechanisms of evolutionarily conserved coevolving amino acids in NS3-Q80K and revealed potential implications of epistatic interactions in immune escape and variants persistence. Using purified protein, we characterized the impact of epistatic amino acid substitutions on the physicochemical properties and peptide cleavage kinetics of the NS3-Q80K protease. We found that Q80K destabilized the protease protein fold (p < 0.0001). Although NS3-Q80K showed reduced peptide substrate turnover (p < 0.0002), replicative fitness in an H77S.3 cell culture model of infection was not significantly inferior to the WT virus. Epistatic substitutions at residues 91 and 174 in NS3Q80K stabilized the protein fold (p < 0.0001) and leveraged the WT protease stability. However, changes in protease stability inversely correlated with enzymatic activity. In infectious cell culture, these secondary substitutions were not associated with a gain of replicative fitness in NS3-Q80K variants. Using molecular dynamics, we observed that the total number of residue contacts in NS3-Q80K mutants correlated with protein folding stability. Changes in the number of contacts reflected the compensatory effect on protein folding instability by epistatic substitutions. In summary, epistatic substitutions in NS3-Q80K contribute to viral fitness by mechanisms not directly related to RNA replication. By compensating for protein-folding instability, epistatic interactions likely protect NS3-Q80K variants from immune cell recognition.	[Dultz, Georg; Konetschnik, Michael; Dietz, Julia; Sarrazin, Christoph; Zeuzem, Stefan; Welsch, Christoph] Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany; [Srikakulam, Sanjay K.; Kalinina, Olga, V] Helmholtz Ctr Infect Res, Helmholtz Inst Pharmaceut Res Saarland HIPS, Saarland Univ Campus, Saarbrucken, Germany; [Srikakulam, Sanjay K.] Saarland Univ, Grad Sch Comp Sci, Saarbrucken, Germany; [Srikakulam, Sanjay K.] Saarland Univ, Interdisciplinary Grad Sch Nat Prod Res, Saarbrucken, Germany; [Shimakami, Tetsuro] Kanazawa Univ Hosp, Dept Gastroenterol, Kanazawa, Ishikawa, Japan; [Doncheva, Nadezhda T.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Prot Res, Copenhagen, Denmark; [Biondi, Ricardo M.] Max Planck Gesell, Mol Targeting, Partner Inst, Inst Invest Biomed Buenos Aires IBioBA,CONICET, Buenos Aires, DF, Argentina; [Zeuzem, Stefan; Welsch, Christoph] Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany; [Tampe, Robert] Goethe Univ Frankfurt, Bioctr, Inst Biochem, Frankfurt, Germany; [Kalinina, Olga, V] Saarland Univ, Med Fac, Homburg, Germany; [Kalinina, Olga, V] Saarland Informat Campus, Ctr Bioinformat, Saarbrucken, Germany; [Sarrazin, Christoph] St Josef Hosp Wiesbaden, Internal Med 2, Wiesbaden, Germany	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Helmholtz Association; Helmholtz-Center for Infection Research; Saarland University; Saarland University; Saarland University; Kanazawa University; Novo Nordisk Foundation; University of Copenhagen; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Max Planck Society; Goethe University Frankfurt; Goethe University Frankfurt Hospital; Goethe University Frankfurt; Universitatsklinikum des Saarlandes	Welsch, C (corresponding author), Goethe Univ Hosp Frankfurt, Dept Internal Med 1, Frankfurt, Germany.; Welsch, C (corresponding author), Univ Hosp Frankfurt, Univ Ctr Infect Dis, Frankfurt, Germany.	christoph.welsch@kgu.de	Tampe, Robert/H-2953-2015	Tampe, Robert/0000-0002-0403-2160; Dultz, Georg/0000-0003-0775-0907; Doncheva, Nadezhda T./0000-0002-8806-6850; Srikakulam, Sanjay Kumar/0000-0002-1752-5060; Biondi, Ricardo/0000-0002-8873-7167	German Research Foundation grant entitled "Molecular escape mechanisms due to patterns of resistance-associated amino acid variants in the hepatitis C virus NS3 protease" [WE 4388/6-1]; Deutscher Akademischer Austauschdienst-Japan Society for the Promotion of Science Joint Research Program grant entitled "Molecular mechanisms for hep-atitis C virus NS3 variant selection" [PPP 57155496]; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation, ResearchTraining Group Translational Research Innovation-Pharma TRIP; DZIF German Center for Infection Research grant entitled "Geno-& phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" [TTU 05.902]	German Research Foundation grant entitled "Molecular escape mechanisms due to patterns of resistance-associated amino acid variants in the hepatitis C virus NS3 protease"; Deutscher Akademischer Austauschdienst-Japan Society for the Promotion of Science Joint Research Program grant entitled "Molecular mechanisms for hep-atitis C virus NS3 variant selection"; Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen; Research Center for Translational Medicine and Pharmacology TMP; Else Kroner-Fresenius Foundation, ResearchTraining Group Translational Research Innovation-Pharma TRIP; DZIF German Center for Infection Research grant entitled "Geno-& phenotypic NS3, NS5A and NS5B inhibitor resistance analysis"	C. W. was supported by the German Research Foundation grant entitled "Molecular escape mechanisms due to patterns of resistance-associated amino acid variants in the hepatitis C virus NS3 protease" (WE 4388/6-1) . T. S. and C. W. acknowledge support by the Deutscher Akademischer Austauschdienst-Japan Society for the Promotion of Science Joint Research Program grant entitled "Molecular mechanisms for hep-atitis C virus NS3 variant selection" (PPP 57155496) . C. W. and S. Z. acknowledge support by the Landes-Offensive zur Entwicklung Wissenschaftlich-okonomischer Exzellenz of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP, and the Else Kroner-Fresenius Foundation, ResearchTraining Group Translational Research Innovation-Pharma TRIP. C. S. was supported by a DZIF German Center for Infection Research grant entitled "Geno-& phenotypic NS3, NS5A and NS5B inhibitor resistance analysis" (TTU 05.902) .	Bartenschlager R, 2013, NAT REV MICROBIOL, V11, P482, DOI 10.1038/nrmicro3046; Beran RKF, 2008, J BIOL CHEM, V283, P29929, DOI 10.1074/jbc.M804065200; Bigman LS, 2020, CURR OPIN STRUC BIOL, V60, P50, DOI 10.1016/j.sbi.2019.11.005; Bigman LS, 2018, J PHYS CHEM B, V122, P11450, DOI 10.1021/acs.jpcb.8b07379; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Dietz J, 2018, GASTROENTEROLOGY, V154, P976, DOI 10.1053/j.gastro.2017.11.007; Domingo E, 2012, MICROBIOL MOL BIOL R, V76, P159, DOI 10.1128/MMBR.05023-11; Doncheva NT, 2019, J MOL BIOL, V431, P2354, DOI 10.1016/j.jmb.2019.04.034; Doncheva NT, 2011, TRENDS BIOCHEM SCI, V36, P179, DOI 10.1016/j.tibs.2011.01.002; Dultz G, 2020, J BIOL CHEM, V295, P13862, DOI 10.1074/jbc.RA120.013898; Engler OB, 2004, VACCINE, V23, P58, DOI 10.1016/j.vaccine.2004.05.009; Frick DN, 2007, CURR ISSUES MOL BIOL, V9, P1; Gotte M., 2017, HDB ANTIMICROBIAL RE, V1st; Gouy M, 2010, MOL BIOL EVOL, V27, P221, DOI 10.1093/molbev/msp259; Guedj J, 2010, J THEOR BIOL, V267, P330, DOI 10.1016/j.jtbi.2010.08.036; Harrington PR, 2018, HEPATOLOGY, V67, P2430, DOI 10.1002/hep.29693; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Joung IS, 2008, J PHYS CHEM B, V112, P9020, DOI 10.1021/jp8001614; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Klein EY, 2018, MSPHERE, V3, DOI 10.1128/mSphereDirect.00554-17; Lenz O, 2015, J HEPATOL, V62, P1008, DOI 10.1016/j.jhep.2014.11.032; Ma YH, 2008, J VIROL, V82, P7624, DOI 10.1128/JVI.00724-08; Martin-Garcia F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121114; McCloskey RM, 2015, J INFECT DIS, V211, P1288, DOI 10.1093/infdis/jiu613; McGivern DR, 2015, J VIROL, V89, P5362, DOI 10.1128/JVI.03188-14; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Miton CM, 2020, METHOD ENZYMOL, V643, P243, DOI 10.1016/bs.mie.2020.07.012; Murai K, 2018, ANTIMICROB AGENTS CH, V62, DOI [10.1128/AAC.02601-17, 10.1128/aac.02601-17]; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peres-da-Silva A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080691; Pham LV, 2019, J HEPATOL, V70, P388, DOI 10.1016/j.jhep.2018.10.031; Raab M, 2018, ACS CHEM BIOL, V13, P1921, DOI 10.1021/acschembio.7b01078; Romano KP, 2010, P NATL ACAD SCI USA, V107, P20986, DOI 10.1073/pnas.1006370107; Rong LB, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000544; Sampath A, 2009, ANTIVIR RES, V81, P6, DOI 10.1016/j.antiviral.2008.08.004; Sarrazin C, 2015, ANTIVIR RES, V116, P10, DOI 10.1016/j.antiviral.2015.01.003; Scheiblhofer S, 2017, EXPERT REV VACCINES, V16, P479, DOI 10.1080/14760584.2017.1306441; Schmidt J, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003042; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sheldon J, 2014, J VIROL, V88, P12098, DOI 10.1128/JVI.01860-14; Shimakami T, 2011, GASTROENTEROLOGY, V140, P667, DOI 10.1053/j.gastro.2010.10.056; Soderholm J, 2006, GUT, V55, P266, DOI 10.1136/gut.2005.072231; Taremi SS, 1998, PROTEIN SCI, V7, P2143, DOI 10.1002/pro.5560071011; Vallet S, 2005, J MED VIROL, V75, P528, DOI 10.1002/jmv.20302; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; Van Gunsteren WF, 1988, MOL SIMULAT, V1, P173, DOI 10.1080/08927028808080941; VanderWeele TJ, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1517; Verbinnen T, 2015, ANTIMICROB AGENTS CH, V59, P7548, DOI 10.1128/AAC.01444-15; Welsch C, 2015, J HEPATOL, V62, P779, DOI 10.1016/j.jhep.2014.11.009; Welsch C, 2012, GASTROENTEROLOGY, V142, P654, DOI 10.1053/j.gastro.2011.11.035; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yao NH, 1999, STRUCTURE, V7, P1353, DOI 10.1016/S0969-2126(00)80025-8; Yi M, 2006, P NATL ACAD SCI USA, V103, P2310, DOI 10.1073/pnas.0510727103; Yi MK, 2006, J BIOL CHEM, V281, P8205, DOI 10.1074/jbc.M510246200; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104; Zerihun MB, 2017, BIOCHEM SOC T, V45, P1253, DOI 10.1042/BST20170063	62	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101031	10.1016/j.jbc.2021.101031	http://dx.doi.org/10.1016/j.jbc.2021.101031			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34339738	Green Published, gold			2022-12-28	WOS:000704369100015
J	Igarashi, K; Nishizawa, H; Saiki, Y; Matsumoto, M				Igarashi, Kazuhiko; Nishizawa, Hironari; Saiki, Yuriko; Matsumoto, Mitsuyo			The transcription factor BACH1 at the crossroads of cancer biology: From epithelial-mesenchymal transition to ferroptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							OXIDATIVE STRESS-RESPONSE; REPRESSES E-CADHERIN; PANCREATIC-CANCER; CELLULAR SENESCENCE; GENE-EXPRESSION; HEME-BINDING; BETA-GLOBIN; IN-VITRO; NUCLEAR EXPORT; STEM-CELLS	The progression of cancer involves not only the gradual evolution of cells by mutations in DNA but also alterations in the gene expression induced by those mutations and input from the surrounding microenvironment. Such alterations contribute to cancer cells' abilities to reprogram metabolic pathways and undergo epithelial-to-mesenchymal transition (EMT), which facilitate the survival of cancer cells and their metastasis to other organs. Recently, BTB and CNC homology 1 (BACH1), a hemeregulated transcription factor that represses genes involved in iron and heme metabolism in normal cells, was shown to shape the metabolism and metastatic potential of cancer cells. The growing list of BACH1 target genes in cancer cells reveals that BACH1 promotes metastasis by regulating various sets of genes beyond iron metabolism. BACH1 represses the expression of genes that mediate cell-cell adhesion and oxidative phosphorylation but activates the expression of genes required for glycolysis, cell motility, and matrix protein degradation. Furthermore, BACH1 represses FOXA1 gene encoding an activator of epithelial genes and activates SNAI2 encoding a repressor of epithelial genes, forming a feedforward loop of EMT. By synthesizing these observations, we propose a "two-faced BACH1 model", which accounts for the dynamic switching between metastasis and stress resistance along with cancer progression. We discuss here the possibility that BACH1mediated promotion of cancer also brings increased sensitivity to iron-dependent cell death (ferroptosis) through crosstalk of BACH1 target genes, imposing programmed vulnerability upon cancer cells. We also discuss the future directions of this field, including the dynamics and plasticity of EMT.	[Igarashi, Kazuhiko; Nishizawa, Hironari; Matsumoto, Mitsuyo] Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi, Japan; [Igarashi, Kazuhiko; Matsumoto, Mitsuyo] Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan; [Saiki, Yuriko] Tohoku Univ, Grad Sch Med, Dept Invest Pathol, Sendai, Miyagi, Japan	Tohoku University; Tohoku University; Tohoku University	Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Dept Biochem, Sendai, Miyagi, Japan.; Igarashi, K (corresponding author), Tohoku Univ, Grad Sch Med, Ctr Regulatory Epigenome & Dis, Sendai, Miyagi, Japan.	igarashi@med.tohoku.ac.jp	Nishizawa, Hironari/GQP-8164-2022	Nishizawa, Hironari/0000-0001-7024-9942; Saiki, Yuriko/0000-0002-0663-2792; Igarashi, Kazuhiko/0000-0002-2470-2475; Matsumoto, Mitsuyo/0000-0002-2918-9893	Japan Society for the Promotion of Science [20KK0176, 18H04021, 20K16296, 19K23738, 20K07386, 19K07680, 16K07108]; Tohoku University Graduate School of Medicine; Gonryo Medical Foundation; Takeda Science Foundation; Natural Sciences from the Mitsubishi Foundation	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tohoku University Graduate School of Medicine; Gonryo Medical Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF)); Natural Sciences from the Mitsubishi Foundation	Investigation by the authors has been supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (20KK0176 and 18H04021 to K. I., 20K16296 and 19K23738 to H. N., 20K07386 to Y. S., and 19K07680 and 16K07108 to M. M.) , Grant-in-Aid for Joint Research by Young Researchers from Tohoku University Graduate School of Medicine (to H. N.) , Gonryo Medical Foundation (to H. N.) , Takeda Science Foundation (to H. N.) , and research grant in the Natural Sciences from the Mitsubishi Foundation (to K. I.) .	Adams EJ, 2019, NATURE, V571, P408, DOI 10.1038/s41586-019-1318-9; Adams PD, 2009, MOL CELL, V36, P2, DOI 10.1016/j.molcel.2009.09.021; Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Aletaha M, 2017, BIOMED PHARMACOTHER, V88, P34, DOI 10.1016/j.biopha.2017.01.030; Alon U, 2007, INTRO SYSTEMS BIOL D; Amoutzias GD, 2007, MOL BIOL EVOL, V24, P827, DOI 10.1093/molbev/msl211; Nieto MA, 2016, CELL, V166, P21, DOI 10.1016/j.cell.2016.06.028; Arensman MD, 2019, P NATL ACAD SCI USA, V116, P9533, DOI 10.1073/pnas.1814932116; Avula LR, 2020, CANCER METAST REV, V39, P1223, DOI 10.1007/s10555-020-09924-4; Badgley MA, 2020, SCIENCE, V368, P85, DOI 10.1126/science.aaw9872; Bean TL, 1997, NUCLEIC ACIDS RES, V25, P2509, DOI 10.1093/nar/25.12.2509; Beck B, 2015, CELL STEM CELL, V16, P67, DOI 10.1016/j.stem.2014.12.002; Bejjani F, 2019, BBA-REV CANCER, V1872, P11, DOI 10.1016/j.bbcan.2019.04.003; Bierie B, 2017, P NATL ACAD SCI USA, V114, pE2337, DOI 10.1073/pnas.1618298114; Bolos V, 2003, J CELL SCI, V116, P499, DOI 10.1242/jcs.00224; Brand M, 2004, NAT STRUCT MOL BIOL, V11, P73, DOI 10.1038/nsmb713; Bushweller JH, 2019, NAT REV CANCER, V19, P611, DOI 10.1038/s41568-019-0196-7; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen X, 2021, NAT REV CLIN ONCOL, V18, P280, DOI 10.1038/s41571-020-00462-0; Cohen B, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000666; Collado M, 2010, NAT REV CANCER, V10, P51, DOI 10.1038/nrc2772; Cook DP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16066-2; Daher B, 2019, CANCER RES, V79, P3877, DOI 10.1158/0008-5472.CAN-18-3855; Darwin J., 1860, ORIGIN SPECIES MEANS; David CJ, 2018, NAT REV MOL CELL BIO, V19, P419, DOI 10.1038/s41580-018-0007-0; Davudian Sadaf, 2016, Biomed Pharmacother, V84, P191, DOI 10.1016/j.biopha.2016.09.021; Dirac-Svejstrup AB, 2020, MOL CELL, V79, P332, DOI 10.1016/j.molcel.2020.05.035; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dohi Y, 2008, NAT STRUCT MOL BIOL, V15, P1246, DOI 10.1038/nsmb.1516; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Dunsch AK, 2012, J CELL BIOL, V198, P1039, DOI 10.1083/jcb.201202112; Fang MG, 2016, P NATL ACAD SCI USA, V113, P1250, DOI 10.1073/pnas.1525619113; Fang MG, 2014, MOL CELL, V55, P904, DOI 10.1016/j.molcel.2014.08.010; Fischer KR, 2015, NATURE, V527, P472, DOI 10.1038/nature15748; Fricker LD, 2020, ANNU REV PHARMACOL, V60, P457, DOI 10.1146/annurev-pharmtox-010919-023603; Fu XY, 2019, P NATL ACAD SCI USA, V116, P26823, DOI 10.1073/pnas.1911584116; Fujimoto M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01807-7; Gell DA, 2018, BLOOD CELL MOL DIS, V70, P13, DOI 10.1016/j.bcmd.2017.10.006; Gillespie MA, 2020, MOL CELL, V78, P960, DOI 10.1016/j.molcel.2020.03.031; Hajra KM, 2002, CANCER RES, V62, P1613; Hamazaki J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103683; Han WY, 2019, CANCER LETT, V445, P45, DOI 10.1016/j.canlet.2019.01.003; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Hernandez L, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr3074; Hintze KJ, 2007, J BIOL CHEM, V282, P34365, DOI 10.1074/jbc.M700254200; Hira S, 2007, IUBMB LIFE, V59, P542, DOI 10.1080/15216540701225941; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Huang XD, 2018, THERANOSTICS, V8, P3366, DOI 10.7150/thno.23978; Iemura K, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202006116; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Igarashi K, 2017, NAT REV IMMUNOL, V17, P437, DOI 10.1038/nri.2017.26; Igarashi K, 2014, TOHOKU J EXP MED, V232, P229, DOI 10.1620/tjem.232.229; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jagle S, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1007109; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jiang L, 2020, EBIOMEDICINE, V51, DOI 10.1016/j.ebiom.2019.102617; Jiang L, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2143875; Jiang L, 2015, CIRC RES, V117, P364, DOI 10.1161/CIRCRESAHA.115.306829; Jiang TY, 2021, CANCER LETT, V501, P187, DOI 10.1016/j.canlet.2020.11.016; Jiang TY, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay0152; Jiang XJ, 2021, NAT REV MOL CELL BIO, V22, P266, DOI 10.1038/s41580-020-00324-8; Kanezaki R, 2001, J BIOL CHEM, V276, P7278, DOI 10.1074/jbc.M004227200; Kaspar JW, 2010, J BIOL CHEM, V285, P153, DOI 10.1074/jbc.M109.040022; KATAOKA K, 1994, MOL CELL BIOL, V14, P700, DOI 10.1128/MCB.14.1.700; Kim HM, 2016, GENE, V584, P17, DOI 10.1016/j.gene.2016.03.002; Kim S, 2013, TUMOR BIOL, V34, P1699, DOI 10.1007/s13277-013-0707-1; Kitamura H, 2018, CANCER SCI, V109, P900, DOI 10.1111/cas.13537; Kitamuro T, 2003, J BIOL CHEM, V278, P9125, DOI 10.1074/jbc.M209939200; Kobayashi A, 2020, CANCERS, V12, DOI 10.3390/cancers12092681; Kobayashi M, 2017, HAEMATOLOGICA, V102, P454, DOI 10.3324/haematol.2016.151043; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Kuraku S, 2009, INT J DEV BIOL, V53, P765, DOI 10.1387/ijdb.072533km; Kuwahara M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12596; Lambert SA, 2018, CELL, V172, P650, DOI 10.1016/j.cell.2018.01.029; Lazar SB, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00224-20; Lee J, 2019, NATURE, V568, P254, DOI 10.1038/s41586-019-1005-x; Lee J, 2014, P NATL ACAD SCI USA, V111, pE364, DOI 10.1073/pnas.1304840111; Li J, 2018, BIOCHEM J, V475, P981, DOI 10.1042/BCJ20170520; Li J, 2012, FEBS LETT, V586, P448, DOI 10.1016/j.febslet.2012.01.028; Liang YJ, 2012, J BIOL CHEM, V287, P33533, DOI 10.1074/jbc.M112.392332; Lignitto L, 2019, CELL, V178, P316, DOI 10.1016/j.cell.2019.06.003; Lin XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067496; Loboda A, 2009, ANTIOXID REDOX SIGN, V11, P1501, DOI [10.1089/ars.2008.2211, 10.1089/ARS.2008.2211]; Luengo A, 2021, MOL CELL, V81, P691, DOI 10.1016/j.molcel.2020.12.012; Makohon-Moore A, 2016, NAT REV CANCER, V16, P553, DOI 10.1038/nrc.2016.66; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marro S, 2010, HAEMATOL-HEMATOL J, V95, P1261, DOI 10.3324/haematol.2009.020123; MATSUMURA T, 1979, J GERONTOL, V34, P323, DOI 10.1093/geronj/34.3.323; Meng D, 2010, TOXICOL APPL PHARM, V244, P291, DOI 10.1016/j.taap.2010.01.004; Mohammadzadeh R, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317695925; MOHLER J, 1991, MECH DEVELOP, V34, P3, DOI 10.1016/0925-4773(91)90086-L; Moon EJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24631-6; Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Muto A, 1998, EMBO J, V17, P5734, DOI 10.1093/emboj/17.19.5734; Nakanome A, 2013, ONCOGENE, V32, P3231, DOI 10.1038/onc.2012.336; Nie D, 2016, ONCOGENE, V35, P3626, DOI 10.1038/onc.2015.428; Nie E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39743; Nishizawa H, 2020, J BIOL CHEM, V295, P69, DOI 10.1074/jbc.RA119.009548; Nishizawa H, 2012, CANCER SCI, V103, P897, DOI 10.1111/j.1349-7006.2012.02244.x; Niu C, 2021, NUCLEIC ACIDS RES, V49, P1972, DOI 10.1093/nar/gkab034; Ogawa K, 2001, EMBO J, V20, P2835, DOI 10.1093/emboj/20.11.2835; Okita Y, 2013, J BIOL CHEM, V288, P20658, DOI 10.1074/jbc.M113.450478; Ota K, 2011, ANTIOXID REDOX SIGN, V14, P2441, DOI 10.1089/ars.2010.3574; Otsuki A, 2020, ARCH PHARM RES, V43, P275, DOI 10.1007/s12272-019-01193-2; Otsuki A, 2016, FREE RADICAL BIO MED, V91, P45, DOI 10.1016/j.freeradbiomed.2015.12.005; Ou XQ, 2019, J CANCER RES THER, V15, P1597, DOI 10.4103/jcrt.JCRT_282_19; Oyake T, 1996, MOL CELL BIOL, V16, P6083; Padilla J, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10030634; Parolia A, 2019, NATURE, V571, P413, DOI 10.1038/s41586-019-1347-4; Pastushenko I, 2018, NATURE, V556, P463, DOI 10.1038/s41586-018-0040-3; Petrocca F, 2013, CANCER CELL, V24, P182, DOI 10.1016/j.ccr.2013.07.008; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Prieur A, 2008, CURR OPIN CELL BIOL, V20, P150, DOI 10.1016/j.ceb.2008.01.007; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Riedelberger M, 2020, CELL HOST MICROBE, V27, P454, DOI 10.1016/j.chom.2020.01.023; Rilo-Alvarez H, 2021, DRUG DELIV TRANSL RE, V11, P426, DOI 10.1007/s13346-021-00931-8; Robertson H, 2020, CANCERS, V12, DOI 10.3390/cancers12123609; Roe JS, 2017, CELL, V170, P875, DOI 10.1016/j.cell.2017.07.007; Roychoudhuri R, 2016, NAT IMMUNOL, V17, P851, DOI 10.1038/ni.3441; Roychoudhuri R, 2013, NATURE, V498, P506, DOI 10.1038/nature12199; Sato M, 2020, INT J CANCER, V147, P3224, DOI 10.1002/ijc.33262; Sato M, 2020, CANCER RES, V80, P1279, DOI 10.1158/0008-5472.CAN-18-4099; Segawa K, 2019, EUR BIOPHYS J BIOPHY, V48, P361, DOI 10.1007/s00249-019-01364-5; Segawa K, 2019, TOHOKU J EXP MED, V247, P153, DOI 10.1620/tjem.247.153; Sekine H, 2018, MOL CELL BIOL, V38, DOI 10.1128/MCB.00252-18; Semenza GL, 2019, ANNU REV PHARMACOL, V59, P379, DOI 10.1146/annurev-pharmtox-010818-021637; Shaffer SM, 2020, CELL, V182, P947, DOI 10.1016/j.cell.2020.07.003; Shajari N, 2018, ARTIF CELL NANOMED B, V46, P1495, DOI 10.1080/21691401.2017.1374284; Shimizu T, 2019, CHEM SOC REV, V48, P5624, DOI 10.1039/c9cs00268e; Shinke G, 2018, CANCER SCI, V109, P2520, DOI 10.1111/cas.13700; Singh A, 2010, ONCOGENE, V29, P4741, DOI 10.1038/onc.2010.215; Slabicki M, 2020, NATURE, V588, P164, DOI 10.1038/s41586-020-2925-1; Slater SC, 2018, MOL THER, V26, P2823, DOI 10.1016/j.ymthe.2018.08.020; Song Y, 2010, CANCER RES, V70, P2115, DOI 10.1158/0008-5472.CAN-09-2979; Steckel M, 2012, CELL RES, V22, P1227, DOI 10.1038/cr.2012.82; Stemmler MP, 2019, NAT CELL BIOL, V21, P102, DOI 10.1038/s41556-018-0196-y; Stockwell BR, 2020, TRENDS CELL BIOL, V30, P478, DOI 10.1016/j.tcb.2020.02.009; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021; Suenaga T, 2016, J BIOCHEM, V160, P291, DOI 10.1093/jb/mvw035; Sun JY, 2004, P NATL ACAD SCI USA, V101, P1461, DOI 10.1073/pnas.0308083100; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Taguchi K, 2021, CANCERS, V13, DOI 10.3390/cancers13010046; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka H, 2016, J BIOL CHEM, V291, P6316, DOI 10.1074/jbc.M116.713842; Taniguchi S, 2020, SCIENCE, V369, P269, DOI 10.1126/science.aay1813; Toyokuni S, 2020, CANCER SCI, V111, P2665, DOI 10.1111/cas.14496; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Urbano AM, 2021, BBA-MOL BASIS DIS, V1867, DOI 10.1016/j.bbadis.2020.165965; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Vesuna F, 2009, NEOPLASIA, V11, P1318, DOI 10.1593/neo.91084; Visciano C, 2015, ONCOGENE, V34, P5175, DOI 10.1038/onc.2014.441; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; von Burstin J, 2009, GASTROENTEROLOGY, V137, P361, DOI 10.1053/j.gastro.2009.04.004; Voss TC, 2014, NAT REV GENET, V15, P69, DOI 10.1038/nrg3623; Wagner V, 2020, ONCOGENE, V39, P5165, DOI 10.1038/s41388-020-1354-9; Waku T, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00010-20; Waku T, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00597-19; Wang P, 2020, ADV EXP MED BIOL, V1217, P211, DOI 10.1007/978-981-15-1025-0_13; Wang Q, 2021, EXP CELL RES, V399, DOI 10.1016/j.yexcr.2020.112453; Wang WM, 2019, NATURE, V569, P270, DOI 10.1038/s41586-019-1170-y; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Watanabe-Matsui M, 2015, ARCH BIOCHEM BIOPHYS, V565, P25, DOI 10.1016/j.abb.2014.11.005; Watanabe-Matsui M, 2011, BLOOD, V117, P5438, DOI 10.1182/blood-2010-07-296483; Weber JD, 1999, NAT CELL BIOL, V1, P20, DOI 10.1038/8991; Wei S, 2020, BMC PULM MED, V20, DOI 10.1186/s12890-020-1112-3; Wei XX, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau7887; Wiel C, 2019, CELL, V178, P330, DOI 10.1016/j.cell.2019.06.005; Wu C, 2012, NAT GENET, V44, P62, DOI 10.1038/ng.1020; Wu J, 2019, NATURE, V572, P402, DOI 10.1038/s41586-019-1426-6; Xiang Z, 2017, ONCOGENE, V36, P5122, DOI 10.1038/onc.2017.108; Yamamoto M, 2018, PHYSIOL REV, V98, P1169, DOI 10.1152/physrev.00023.2017; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yesilkanal AE, 2021, ELIFE, V10, DOI 10.7554/eLife.59696; Ying Y, 2020, ONCOGENE, V39, P1004, DOI 10.1038/s41388-019-1013-1; Yoshida C, 1999, GENES CELLS, V4, P643, DOI 10.1046/j.1365-2443.1999.00291.x; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Yusoff FM, 2021, MICROVASC RES, V134, DOI 10.1016/j.mvr.2020.104126; Zeitlinger J, 2020, CURR OPIN SYST BIOL, V23, P22, DOI 10.1016/j.coisb.2020.08.002; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304; Zhang N, 2019, CELL DEATH DIFFER, V26, P843, DOI 10.1038/s41418-018-0158-8; Zhang Y, 2019, CELL CHEM BIOL, V26, P623, DOI 10.1016/j.chembiol.2019.01.008; Zhao Y, 2021, CANCER MED-US, V10, P3413, DOI 10.1002/cam4.3884; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064; Zhou WH, 2019, J CELL SCI, V132, DOI 10.1242/jcs.235127; Zhu GD, 2018, BIOCHEM BIOPH RES CO, V499, P120, DOI 10.1016/j.bbrc.2018.02.178; Zhu JH, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/8810785	196	18	18	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101032	10.1016/j.jbc.2021.101032	http://dx.doi.org/10.1016/j.jbc.2021.101032			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34339740	gold, Green Published			2022-12-28	WOS:000704369100017
J	Solanki, AK; Arif, E; Srivastava, P; Furchtl, CM; Rahman, B; Wen, P; Singh, A; Holzman, LB; Fitzgibbon, WR; Budisavljevic, MN; Lobo, GP; Kwon, SH; Han, Z; Lazzara, MJ; Lipschutz, JH; Nihalani, D				Solanki, Ashish K.; Arif, Ehtesham; Srivastava, Pankaj; Furchtl, Christopher M.; Rahman, Bushra; Wen, Pei; Singh, Avinash; Holzman, Lawrence B.; Fitzgibbon, Wayne R.; Budisavljevic, Milos N.; Lobo, Glenn P.; Kwon, Sang-Ho; Han, Zhe; Lazzara, Matthew J.; Lipschutz, Joshua H.; Nihalani, Deepak			Phosphorylation of slit diaphragm proteins NEPHRIN and NEPH1 upon binding of HGF promotes podocyte repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE GROWTH-FACTOR; RECEPTOR TYROSINE KINASE; NEPHROTIC SYNDROME; MET; SHP2; PHOSPHATASE; ACTIVATION; INJURY; ACTIN; INHIBITOR	Phosphorylation (activation) and dephosphorylation (deactivation) of the slit diaphragm proteins NEPHRIN and NEPH1 are critical for maintaining the kidney epithelial podocyte actin cytoskeleton and, therefore, proper glomerular filtration. However, the mechanisms underlying these events remain largely unknown. Here we show that NEPHRIN and NEPH1 are novel receptor proteins for hepatocyte growth factor (HGF) and can be phosphorylated independently of the mesenchymal epithelial transition receptor in a ligand-dependent fashion through engagement of their extracellular domains by HGF. Furthermore, we demonstrate SH2 domain-containing protein tyrosine phosphatase-2-dependent dephosphorylation of these proteins. To establish HGF as a ligand, purified baculovirus-expressed NEPHRIN and NEPH1 recombinant proteins were used in surface plasma resonance binding experiments. We report high affinity interactions of NEPHRIN and NEPH1 with HGF, although NEPHRIN binding was 20-fold higher than that of NEPH1. In addition, using molecular modeling we constructed peptides that were used to map specific HGF-binding regions in the extracellular domains of NEPHRIN and NEPH1. Finally, using an in vitro model of cultured podocytes and an ex vivo model of Drosophila nephrocytes, as well as chemically induced injury models, we demonstrated that HGF-induced phosphorylation of NEPHRIN and NEPH1 is centrally involved in podocyte repair. Taken together, this is the first study demonstrating a receptor-based function for NEPHRIN and NEPH1. This has important biological and clinical implications for the repair of injured podocytes and the maintenance of podocyte integrity.	[Solanki, Ashish K.; Arif, Ehtesham; Rahman, Bushra; Singh, Avinash; Fitzgibbon, Wayne R.; Budisavljevic, Milos N.; Lobo, Glenn P.; Lipschutz, Joshua H.] Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA; [Srivastava, Pankaj] Univ Colorado, Dept Biochem & Mol Genet, Anschutz Med Campus, Aurora, CO USA; [Furchtl, Christopher M.] Univ Penn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA; [Wen, Pei; Han, Zhe] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Holzman, Lawrence B.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Kwon, Sang-Ho] Augusta Univ, Dept Cellular Biol & Anat, Augusta, GA USA; [Lazzara, Matthew J.] Univ Virginia, Dept Chem Engn, Charlottesville, VA USA; [Lipschutz, Joshua H.] Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA; [Nihalani, Deepak] NIH, Div Kidney Urol & Hematol Dis, Bldg 10, Bethesda, MD 20892 USA	Medical University of South Carolina; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Pennsylvania; University System of Maryland; University of Maryland Baltimore; University of Pennsylvania; University System of Georgia; Augusta University; University of Virginia; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; National Institutes of Health (NIH) - USA	Lipschutz, JH (corresponding author), Med Univ South Carolina, Dept Med, Charleston, SC 29425 USA.; Lipschutz, JH (corresponding author), Ralph H Johnson Vet Affairs Med Ctr, Dept Med, Charleston, SC 29401 USA.	Lipschut@musc.edu	Solanki, Ashish K/F-5210-2017	Solanki, Ashish K/0000-0002-5043-1699; Furcht, Christopher/0000-0002-5403-4914; Fitzgibbon, Wayne/0000-0001-7295-4178; Kwon, Sang-Ho/0000-0001-9074-4641	Veterans Affairs [I01 BX000820]; NIH [R01 DK087956, R56 DK116887, P30DK074038, RO3 TR003038]; NSF [CBET 1714588]; American Heart Association [17CSA33590067]; Dialysis Clinic, Inc.	Veterans Affairs(US Department of Veterans Affairs); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); American Heart Association(American Heart Association); Dialysis Clinic, Inc.	This work was supported in part by grants from the Veterans Affairs (Merit Award I01 BX000820 to J. H. L.) , NIH (R01 DK087956 and R56 DK116887 to D. N., P30DK074038 to J. H. L., and RO3 TR003038 to E. A.) , NSF (CBET 1714588 to M. J. L.) , American Heart Association (17CSA33590067 to J. H. L.) , and Dialysis Clinic, Inc (to J. H. L.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arif E, 2011, MOL CELL BIOL, V31, P2134, DOI 10.1128/MCB.05051-11; Arif E, 2019, KIDNEY INT, V96, P656, DOI 10.1016/j.kint.2019.03.023; Arif E, 2019, KIDNEY INT, V96, P139, DOI 10.1016/j.kint.2019.02.014; Arif E, 2016, MOL CELL BIOL, V36, P1639, DOI 10.1128/MCB.00020-16; Arif E, 2014, J BIOL CHEM, V289, P9502, DOI 10.1074/jbc.M113.505743; Ayoub NM, 2017, ONCOTARGETS THER, V10, P4869, DOI 10.2147/OTT.S148604; Basilico C, 2008, J BIOL CHEM, V283, P21267, DOI 10.1074/jbc.M800727200; Benzing T, 2004, J AM SOC NEPHROL, V15, P1382, DOI 10.1097/01.ASN.0000130167.30769.55; Dai CS, 2010, KIDNEY INT, V77, P962, DOI 10.1038/ki.2010.40; Donoviel DB, 2001, MOL CELL BIOL, V21, P4829, DOI 10.1128/MCB.21.14.4829-4836.2001; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Furcht CM, 2014, J CELL SCI, V127, P3555, DOI 10.1242/jcs.150862; Furge KA, 2000, ONCOGENE, V19, P5582, DOI 10.1038/sj.onc.1203859; Garg P, 2007, MOL CELL BIOL, V27, P8698, DOI 10.1128/MCB.00948-07; Grahammer F, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.86177; Hanafusa H, 2004, J BIOL CHEM, V279, P22992, DOI 10.1074/jbc.M312498200; Harita Y, 2008, J BIOL CHEM, V283, P9177, DOI 10.1074/jbc.M707247200; Hermle T, 2017, J AM SOC NEPHROL, V28, P1521, DOI 10.1681/ASN.2016050517; Hochapfel F, 2017, CELL MOL LIFE SCI, V74, P4573, DOI 10.1007/s00018-017-2593-y; Hou B, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109744; Hsu MF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00564-3; Huber TB, 2005, CURR OPIN NEPHROL HY, V14, P211, DOI 10.1097/01.mnh.0000165885.85803.a8; Hulkko J, 2014, NEPHRON EXTRA, V4, P146, DOI 10.1159/000365091; Kato T, 2017, BIOMED REP, V7, P495, DOI 10.3892/br.2017.1001; Kato T, 2011, NEPHROLOGY, V16, P310, DOI 10.1111/j.1440-1797.2010.01392.x; Li J, 2009, EXP CELL RES, V315, P2284, DOI 10.1016/j.yexcr.2009.04.011; Mallik L, 2012, J BIOL CHEM, V287, P9441, DOI 10.1074/jbc.M111.284927; Maroun CR, 2000, MOL CELL BIOL, V20, P8513, DOI 10.1128/MCB.20.22.8513-8525.2000; Martin CE, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00302; Matsumoto K, 2014, BIOMEDICINES, V2, P275, DOI 10.3390/biomedicines2040275; Nejak-Bowen K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059836; Nihalani D, 2019, J BIOL CHEM, V294, P10104, DOI 10.1074/jbc.RA119.008362; Okamoto T, 2001, BONE MARROW TRANSPL, V28, P197, DOI 10.1038/sj.bmt.1703095; Patrakka J, 2007, TRENDS MOL MED, V13, P396, DOI 10.1016/j.molmed.2007.06.006; Rampino T, 2005, NEPHROL DIAL TRANSPL, V20, P1066, DOI 10.1093/ndt/gfh740; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rantanen M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000016142.29721.22; Sagar A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12134-8; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Solanki AK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010274; Solanki AK, 2019, KIDNEY INT, V96, P883, DOI 10.1016/j.kint.2019.06.016; Solanki AK, 2014, J BIOL CHEM, V289, P34780, DOI 10.1074/jbc.M114.563486; Srivastava P, 2019, KIDNEY INT, V95, P708, DOI 10.1016/j.kint.2018.10.030; Stewart N, 2013, AM J PHYSIOL-RENAL, V304, pF625, DOI 10.1152/ajprenal.00504.2012; Timmerman I, 2012, MOL BIOL CELL, V23, P4212, DOI 10.1091/mbc.E12-01-0038; Tryggvason K, 2006, CELL, V125, P221, DOI 10.1016/j.cell.2006.04.002; Venkatareddy M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028710; Verma R, 2006, J CLIN INVEST, V116, P1346, DOI 10.1172/JCI27414; Verma R, 2003, J BIOL CHEM, V278, P20716, DOI 10.1074/jbc.M301689200; Verma R, 2016, MOL CELL BIOL, V36, P596, DOI 10.1128/MCB.00956-15; Wagner MC, 2008, J BIOL CHEM, V283, P35579, DOI 10.1074/jbc.M805507200; Yamagamim H, 2002, CANCER, V95, P824, DOI 10.1002/cncr.10732; Zhou D, 2013, KIDNEY INT, V84, P509, DOI 10.1038/ki.2013.102; Zhuang SF, 2009, DEVELOPMENT, V136, P2335, DOI 10.1242/dev.031609	55	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101079	10.1016/j.jbc.2021.101079	http://dx.doi.org/10.1016/j.jbc.2021.101079			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34391780	gold, Green Published			2022-12-28	WOS:000706409200011
J	Yin, T; Yao, W; Norris, KA; D'Adamio, L				Yin, Tao; Yao, Wen; Norris, Kelly A.; D'Adamio, Luciano			A familial Danish dementia rat shows impaired presynaptic and postsynaptic glutamatergic transmission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-PRECURSOR PROTEIN; KNOCK-IN MICE; MEMORY DEFICITS; TAU-GENE; SYNAPTIC PLASTICITY; MUTATION; BRITISH; MOUSE; APP; EXPRESSION	Familial British dementia and familial Danish dementia are neurodegenerative disorders caused by mutations in the gene integral membrane protein 2B (ITM2b) encoding BRI2, which tunes excitatory synaptic transmission at both presynaptic and postsynaptic termini. In addition, BRI2 interacts with and modulates proteolytic processing of amyloid-beta precursor protein (APP), whose mutations cause familial forms of Alzheimer's disease (AD) (familial AD). To study the pathogenic mechanisms triggered by the Danish mutation, we generated rats carrying the Danish mutation in the rat Itm2b gene (Itm2b(D) rats). Given the BRI2/APP interaction and the widely accepted relevance of human amyloid beta (A beta), a proteolytic product of APP, to AD, Itm2b(D) rats were engineered to express two humanized App alleles and produce human A beta. Here, we studied young Itm2b(D) rats to investigate early pathogenic changes in these diseases. We found that periadolescent Itm2b(D) rats not only present subtle changes in human A beta levels along with decreased spontaneous glutamate release and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepro pionic acid receptor-mediated responses but also had increased short-term synaptic facilitation in the hippocampal Schaeffer-collateral pathway. These alterations in excitatory interneuronal communication can impair learning and memory processes and were akin to those observed in adult mice producing rodent A beta and carrying either the Danish or British mutations in the mouse Itm2b gene. Collectively, the data show that the pathogenic Danish mutation alters the physiological function of BRI2 at glutamatergic synapses across species and early in life. Future studies will determine whether this phenomenon represents an early pathogenic event in human dementia.	[Yin, Tao; Yao, Wen; Norris, Kelly A.; D'Adamio, Luciano] Rutgers State Univ, Brain Hlth Inst, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA; [Yao, Wen] Southern Med Univ, Biomed Res Ctr, 1023 South Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China	Rutgers State University Newark; Rutgers State University New Brunswick; Southern Medical University - China	D'Adamio, L (corresponding author), Rutgers State Univ, Brain Hlth Inst, Dept Pharmacol Physiol & Neurosci, Newark, NJ 07103 USA.	luciano.dadamio@rutgers.edu		Yin, Tao/0000-0003-0524-8075	NIH/NIA [R01AG063407, RF1AG064821, 1R01AG033007]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	L. D. was funded by the NIH/NIA R01AG063407, RF1AG064821, 1R01AG033007. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreadis A, 2005, BBA-MOL BASIS DIS, V1739, P91, DOI 10.1016/j.bbadis.2004.08.010; Barbagallo APM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018006; Barbagallo APM, 2011, J BIOL CHEM, V286, P8717, DOI 10.1074/jbc.C111.219873; Barbagallo APM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015503; Bartelle BB, 2016, J NEUROSCI, V36, P4139, DOI 10.1523/JNEUROSCI.4050-15.2016; Biundo F, 2016, ONCOTARGET, V7, P11923, DOI 10.18632/oncotarget.7389; Choi SI, 2003, FASEB J, V17, P373, DOI 10.1096/fj.03-0730fje; Deacon RMJ, 2006, NAT PROTOC, V1, P936, DOI 10.1038/nprot.2006.120; Del Prete D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108576; Fanutza T, 2015, ELIFE, V4, DOI 10.7554/eLife.09743; Foote AL, 2007, CURR BIOL, V17, P551, DOI 10.1016/j.cub.2007.01.061; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Garringer HJ, 2010, BRAIN STRUCT FUNCT, V214, P235, DOI 10.1007/s00429-009-0221-9; Giliberto L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007900; Goedert M, 1998, NEURON, V21, P955, DOI 10.1016/S0896-6273(00)80615-7; Grover A, 2003, EXP NEUROL, V184, P131, DOI 10.1016/S0014-4886(03)00393-5; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hanes J, 2009, J NEUROCHEM, V108, P1167, DOI 10.1111/j.1471-4159.2009.05869.x; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Janke C, 1999, MOL BRAIN RES, V68, P119, DOI 10.1016/S0169-328X(99)00079-0; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kepecs A, 2008, NATURE, V455, P227, DOI 10.1038/nature07200; Kowalska Anna, 2002, Journal of Applied Genetics, V43, P535; Leuzy A, 2014, AMYLOID, V21, P143, DOI 10.3109/13506129.2014.926267; Lombino F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057120; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Matsuda S, 2011, J ALZHEIMERS DIS, V27, P385, DOI 10.3233/JAD-2011-110785; Matsuda S, 2011, NEUROBIOL AGING, V32, P1400, DOI 10.1016/j.neurobiolaging.2009.08.005; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Ren SQ, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016395; Ren SQ, 2020, ELIFE, V9, DOI 10.7554/eLife.57513; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Spillantini MG, 1998, TRENDS NEUROSCI, V21, P428, DOI 10.1016/S0166-2236(98)01337-X; Stanford PM, 2003, BRAIN, V126, P814, DOI 10.1093/brain/awg090; Tamayev R, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-19; Tamayev R, 2012, J NEUROSCI, V32, P5481, DOI 10.1523/JNEUROSCI.5193-11.2012; Tamayev R, 2012, EMBO MOL MED, V4, P171, DOI 10.1002/emmm.201100195; Tamayev R, 2011, EMBO J, V30, P2501, DOI 10.1038/emboj.2011.161; Tamayev R, 2010, P NATL ACAD SCI USA, V107, P20822, DOI 10.1073/pnas.1011689107; Tamayev R, 2010, J NEUROSCI, V30, P14915, DOI 10.1523/JNEUROSCI.3917-10.2010; Tambini MD, 2020, J BIOL CHEM, V295, P7442, DOI 10.1074/jbc.RA120.012542; Tambini MD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60800-1; Tambini MD, 2020, ELIFE, V9, DOI 10.7554/eLife.52612; Tambini MD, 2019, AGING CELL, V18, DOI 10.1111/acel.13033; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Whishaw IQ, 2001, DEV PSYCHOBIOL, V39, P151, DOI 10.1002/dev.1041; Yao W, 2019, J NEUROSCI, V39, P6992, DOI 10.1523/JNEUROSCI.0207-19.2019; Yao W, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41340-9; Yasuda M, 2000, ANN NEUROL, V47, P422, DOI 10.1002/1531-8249(200004)47:4<422::AID-ANA4>3.0.CO;2-G; Yin T, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.015679; Zimmer ER, 2014, CAN J NEUROL SCI, V41, P547, DOI 10.1017/cjn.2014.15; Zimmer ER, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-6; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	56	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101089	10.1016/j.jbc.2021.101089	http://dx.doi.org/10.1016/j.jbc.2021.101089			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34416235	Green Published, gold			2022-12-28	WOS:000706409200009
J	Hou, SR; Lee, JM; Myint, W; Matsuo, H; Yilmaz, NK; Schiffer, CA				Hou, Shurong; Lee, Jeong Min; Myint, Wazo; Matsuo, Hiroshi; Yilmaz, Nese Kurt; Schiffer, Celia A.			Structural basis of substrate specificity in human cytidine deaminase family APOBEC3s	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; CRISPR-CAS9 NUCLEASES; CYTOSINE DEAMINATION; DRUG-RESISTANCE; DNA; BINDING; MUTAGENESIS; DETERMINANTS; RESTRICTION	The human cytidine deaminase family of APOBEC3s (A3s) plays critical roles in both innate immunity and the development of cancers. A3s comprise seven functionally overlapping but distinct members that can be exploited as nucleotide base editors for treating genetic diseases. Although overall structurally similar, A3s have vastly varying deamination activity and substrate preferences. Recent crystal structures of ssDNAbound A3s together with experimental studies have provided some insights into distinct substrate specificities among the family members. However, the molecular interactions responsible for their distinct biological functions and how structure regulates substrate specificity are not clear. In this study, we identified the structural basis of substrate specificities in three catalytically active A3 domains whose crystal structures have been previously characterized: A3A, A3B- CTD, and A3GCTD. Through molecular modeling and dynamic simulations, we found an interdependency between ssDNA substrate binding conformation and nucleotide sequence specificity. In addition to the U-shaped conformation seen in the crystal structure with the CTC0 motif, A3A can accommodate the CCC0 motif when ssDNA is in a more linear (L) conformation. A3B can also bind both U- and L-shaped ssDNA, unlike A3G, which can stably recognize only linear ssDNA. These varied conformations are stabilized by sequence-specific interactions with active site loops 1 and 7, which are highly variable among A3s. Our results explain the molecular basis of previously observed substrate specificities in A3s and have implications for designing A3-specific inhibitors for cancer therapy as well as engineering base-editing systems for gene therapy.	[Hou, Shurong; Lee, Jeong Min; Yilmaz, Nese Kurt; Schiffer, Celia A.] Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA; [Myint, Wazo; Matsuo, Hiroshi] Frederick Natl Lab Canc Res, Basic Res Lab, Frederick, MD USA	University of Massachusetts System; University of Massachusetts Worcester; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yilmaz, NK; Schiffer, CA (corresponding author), Univ Massachusetts, Med Sch, Dept Biochem & Mol Pharmacol, Worcester, MA 01605 USA.	Nese.KurtYilmaz@umassmed.edu; Celia.Schiffer@umassmed.edu		Myint, Wazo/0000-0002-2055-5180; Schiffer, Celia/0000-0003-2270-6613	NIH office of intramural training and education's Intramural AIDS Research Fellowship; National Cancer Institute, National Institutes of Health [HHSN26120080001E]	NIH office of intramural training and education's Intramural AIDS Research Fellowship; National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	W. M. is supported in part by the NIH office of intramural training and education's Intramural AIDS Research Fellowship. For W. M. and H.M., this project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under contract HHSN26120080001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does it mention of trade names,commercial products, or organizations imply endorsement by the US Government. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Autore F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011515; Beale RCL, 2004, J MOL BIOL, V337, P585, DOI 10.1016/j.jmb.2004.01.046; BETTS L, 1994, J MOL BIOL, V235, P635, DOI 10.1006/jmbi.1994.1018; Bogerd HP, 2006, NUCLEIC ACIDS RES, V34, P89, DOI 10.1093/nar/gkj416; Bohn MF, 2015, STRUCTURE, V23, P903, DOI 10.1016/j.str.2015.03.016; Bohn MF, 2013, STRUCTURE, V21, P1042, DOI 10.1016/j.str.2013.04.010; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Byeon IJL, 2016, BIOCHEMISTRY-US, V55, P2944, DOI 10.1021/acs.biochem.6b00382; Byeon IJL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2883; CACCIAMANI T, 1991, ARCH BIOCHEM BIOPHYS, V290, P285, DOI 10.1016/0003-9861(91)90543-R; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chelico L, 2008, J BIOL CHEM, V283, P13780, DOI 10.1074/jbc.M801004200; Chelico L, 2010, J BIOL CHEM, V285, P16195, DOI 10.1074/jbc.M110.107987; Chen KM, 2008, NATURE, V452, P116, DOI 10.1038/nature06638; Conticello SG, 2005, MOL BIOL EVOL, V22, P367, DOI 10.1093/molbev/msi026; Cortez LM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008545; Dang Y, 2008, J BIOL CHEM, V283, P11606, DOI 10.1074/jbc.M707586200; Dang Y, 2006, J VIROL, V80, P10522, DOI 10.1128/JVI.01123-06; Furukawa A, 2009, EMBO J, V28, P440, DOI 10.1038/emboj.2008.290; Harjes E, 2009, J MOL BIOL, V389, P819, DOI 10.1016/j.jmb.2009.04.031; Harjes S, 2013, J VIROL, V87, P7008, DOI 10.1128/JVI.03173-12; Henes M, 2019, ACS CHEM BIOL, V14, P2441, DOI 10.1021/acschembio.9b00370; Holden LG, 2008, NATURE, V456, P121, DOI 10.1038/nature07357; Hou SR, 2019, J CHEM THEORY COMPUT, V15, P637, DOI 10.1021/acs.jctc.8b00545; Ito F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21955-0; Ito F, 2017, J MOL BIOL, V429, P1787, DOI 10.1016/j.jmb.2017.04.021; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kim E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14500; Kitamura S, 2012, NAT STRUCT MOL BIOL, V19, P1005, DOI 10.1038/nsmb.2378; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kleinstiver BP, 2015, NATURE, V523, P481, DOI 10.1038/nature14592; Komor AC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.aao4774; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kouno T, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15024; Kouno T, 2015, NAT STRUCT MOL BIOL, V22, P485, DOI 10.1038/nsmb.3033; Langlois MA, 2005, NUCLEIC ACIDS RES, V33, P1913, DOI 10.1093/nar/gki343; Larue RS, 2009, J VIROL, V83, P494, DOI 10.1128/JVI.01976-08; Lee CM, 2016, MOL THER, V24, P645, DOI 10.1038/mt.2016.8; Li M, 2012, ACS CHEM BIOL, V7, P506, DOI 10.1021/cb200440y; Lu XX, 2015, J BIOL CHEM, V290, P4010, DOI 10.1074/jbc.M114.624262; Maiti A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04872-8; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; Matsumoto T, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44407-9; Mitra M, 2014, NUCLEIC ACIDS RES, V42, P1095, DOI 10.1093/nar/gkt945; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Ng JCF, 2020, CURR RES STRUCT BIOL, V2, P130, DOI 10.1016/j.crstbi.2020.07.001; Nishida K, 2016, SCIENCE, V353, DOI 10.1126/science.aaf8729; Ozen A, 2014, P NATL ACAD SCI USA, V111, P15993, DOI 10.1073/pnas.1414063111; Paulsen JL, 2017, J CHEM THEORY COMPUT, V13, P2300, DOI 10.1021/acs.jctc.6b01262; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; Pham P, 2003, NATURE, V424, P103, DOI 10.1038/nature01760; Ran FA, 2015, NATURE, V520, P186, DOI 10.1038/nature14299; Rathore A, 2013, J MOL BIOL, V425, P4442, DOI 10.1016/j.jmb.2013.07.040; Rees HA, 2018, NAT REV GENET, V19, P770, DOI 10.1038/s41576-018-0059-1; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Shaban NM, 2016, J MOL BIOL, V428, P2307, DOI 10.1016/j.jmb.2016.04.026; Shandilya SMD, 2014, VIROLOGY, V471, P105, DOI 10.1016/j.virol.2014.09.023; Shandilya SMD, 2010, STRUCTURE, V18, P28, DOI 10.1016/j.str.2009.10.016; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Shi K, 2020, FASEB BIOADV, V2, P49, DOI 10.1096/fba.2019-00068; Shi K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17694-3; Shi K, 2017, NAT STRUCT MOL BIOL, V24, P131, DOI 10.1038/nsmb.3344; Shi K, 2015, J BIOL CHEM, V290, P28120, DOI 10.1074/jbc.M115.679951; Silvas TV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25881-z; Siu KK, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3593; Solomon WC, 2019, NUCLEIC ACIDS RES, V47, P7676, DOI 10.1093/nar/gkz550; Soumana DI, 2016, J AM CHEM SOC, V138, P11850, DOI 10.1021/jacs.6b06454; Starrett GJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12918; Suspene R, 2004, NUCLEIC ACIDS RES, V32, P2421, DOI 10.1093/nar/gkh554; Wagner JR, 2019, J CHEM INF MODEL, V59, P2264, DOI 10.1021/acs.jcim.8b00427; Wedekind JE, 2003, TRENDS GENET, V19, P207, DOI 10.1016/S0168-9525(03)00054-4; Xiao X, 2017, NUCLEIC ACIDS RES, V45, P7494, DOI 10.1093/nar/gkx362; Xiao X, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12193; Yu Q, 2004, NAT STRUCT MOL BIOL, V11, P435, DOI 10.1038/nsmb758; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2003, NATURE, V424, P94, DOI 10.1038/nature01707; Zheng YH, 2004, J VIROL, V78, P6073, DOI 10.1128/JVI.78.11.6073-6076.2004	79	3	3	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100909	10.1016/j.jbc.2021.100909	http://dx.doi.org/10.1016/j.jbc.2021.100909			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34171358	Green Published, gold			2022-12-28	WOS:000690873500002
J	Sychantha, D; Rotondo, CM; Tehrani, KHME; Martin, NI; Wright, GD				Sychantha, David; Rotondo, Caitlyn M.; Tehrani, Kamaleddin H. M. E.; Martin, Nathaniel, I; Wright, Gerard D.			Aspergillomarasmine A inhibits metallo-beta-lactamases by selectively sequestering Zn2+	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; BINDING; INSIGHTS; AFFINITY; ENZYME; IONS	Class B metallo-beta-lactamases (MBLs) are Zn2+-dependent enzymes that catalyze the hydrolysis of beta-lactam antibiotics to confer resistance in bacteria. Several problematic groups of MBLs belong to subclass B1, including the binuclear New Delhi MBL (NDM), Verona integrin-encoded MBL, and imipenemase-type enzymes, which are responsible for widespread antibiotic resistance. Aspergillomarasmine A (AMA) is a natural aminopolycarboxylic acid that functions as an effective inhibitor of class B1 MBLs. The precise mechanism of action of AMA is not thoroughly understood, but it is known to inactivate MBLs by removing one catalytic Zn2+ cofactor. We investigated the kinetics of MBL inactivation in detail and report that AMA is a selective Zn2+ scavenger that indirectly inactivates NDM-1 by encouraging the dissociation of a metal cofactor. To further investigate the mechanism in living bacteria, we used an active site probe and showed that AMA causes the loss of a Zn2+ ion from a low-affinity binding site of NDM1. Zn2+-depleted NDM-1 is rapidly degraded, contributing to the efficacy of AMA as a beta-lactam potentiator. However, MBLs with higher metal affinity and stability such as NDM-6 and imipenemase-7 exhibit greater tolerance to AMA. These results indicate that the mechanism of AMA is broadly applicable to diverse Zn2+ chelators and highlight that leveraging Zn2+ availability can influence the survival of MBL-producing bacteria when they are exposed to beta-lactam antibiotics.	[Sychantha, David; Rotondo, Caitlyn M.; Wright, Gerard D.] McMaster Univ, David Braley Ctr Antibiot Discovery, Hamilton, ON, Canada; [Sychantha, David; Rotondo, Caitlyn M.; Wright, Gerard D.] McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada; [Sychantha, David; Rotondo, Caitlyn M.; Wright, Gerard D.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Tehrani, Kamaleddin H. M. E.; Martin, Nathaniel, I] Leiden Univ, Inst Biol Leiden, Biol Chem Grp, Leiden, Netherlands	McMaster University; McMaster University; McMaster University; Leiden University; Leiden University - Excl LUMC	Wright, GD (corresponding author), McMaster Univ, David Braley Ctr Antibiot Discovery, Hamilton, ON, Canada.; Wright, GD (corresponding author), McMaster Univ, MG DeGroote Inst Infect Dis Res, Hamilton, ON, Canada.; Wright, GD (corresponding author), McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.	wrightge@mcmaster.ca	Wright, G/ABB-7666-2021		Canadian Institutes of Health Research Fellowship award [FRN-148463]; Ontario Graduate Scholarship; Queen Elizabeth II Graduate Scholarship; Canada Research Chair in Antibiotic Biochemistry	Canadian Institutes of Health Research Fellowship award(Canadian Institutes of Health Research (CIHR)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Queen Elizabeth II Graduate Scholarship; Canada Research Chair in Antibiotic Biochemistry(Canada Research Chairs)	This work was supported by a Canadian Institutes of Health Research Fellowship award (to D. S. and FRN-148463 to G. D. W.), an Ontario Graduate Scholarship and Queen Elizabeth II Graduate Scholarship (to C. M. R.), and a Canada Research Chair in Antibiotic Biochemistry (to G. D. W.).	Aitha M, 2014, BIOCHEMISTRY-US, V53, P7321, DOI 10.1021/bi500916y; Albu SA, 2016, ANGEW CHEM INT EDIT, V55, P13259, DOI 10.1002/anie.201606657; AULD DS, 1995, METHOD ENZYMOL, V248, P228; Bahr G, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01849-17; Bergstrom A, 2018, ACS INFECT DIS, V4, P135, DOI 10.1021/acsinfecdis.7b00106; Cheng ZS, 2018, J BIOL CHEM, V293, P12606, DOI 10.1074/jbc.RA118.003835; Fu HG, 2018, NAT CATAL, V1, P186, DOI 10.1038/s41929-018-0029-1; Gonzalez LJ, 2016, NAT CHEM BIOL, V12, P516, DOI [10.1038/nchembio.2083, 10.1038/NCHEMBIO.2083]; Griffin DH, 2011, BIOCHEMISTRY-US, V50, P9125, DOI 10.1021/bi200839h; Guo QQ, 2020, ACS CATAL, V10, P6291, DOI 10.1021/acscatal.0c01187; Jacquin O, 2009, J MOL BIOL, V392, P1278, DOI 10.1016/j.jmb.2009.07.092; Ju LC, 2018, TRENDS PHARMACOL SCI, V39, P635, DOI 10.1016/j.tips.2018.03.007; Kastritis PL, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0835; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; King AM, 2014, NATURE, V510, P503, DOI 10.1038/nature13445; King D, 2011, PROTEIN SCI, V20, P1484, DOI 10.1002/pro.697; King DT, 2012, J AM CHEM SOC, V134, P11362, DOI 10.1021/ja303579d; Kocyla A, 2015, J INORG BIOCHEM, V152, P82, DOI 10.1016/j.jinorgbio.2015.08.024; Kontoghiorghes GJ, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9061456; Koteva K., 2015, ANGEW CHEM INT ED EN, V128, P2250; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Liao D., 2015, ANGEW CHEM INT ED EN, V128, P4363; Lisa MN, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00601-9; Marszalek I, 2016, J INORG BIOCHEM, V161, P107, DOI 10.1016/j.jinorgbio.2016.05.009; Marty MT, 2015, ANAL CHEM, V87, P4370, DOI 10.1021/acs.analchem.5b00140; Meini MR, 2015, FEBS LETT, V589, P3419, DOI 10.1016/j.febslet.2015.08.015; Mojica MF, 2016, CURR DRUG TARGETS, V17, P1029, DOI 10.2174/1389450116666151001105622; Murphy TA, 2006, J MOL BIOL, V357, P890, DOI 10.1016/j.jmb.2006.01.003; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Rasia RM, 2002, BIOCHEMISTRY-US, V41, P1853, DOI 10.1021/bi010933n; Rotondo CM, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01386-19; Rotondo CM, 2017, CURR OPIN MICROBIOL, V39, P96, DOI 10.1016/j.mib.2017.10.026; Tehrani KHME, 2020, CHEM COMMUN, V56, P3047, DOI 10.1039/d0cc00356e; Wu WJ, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00115-18; Yamaguchi Y, 2011, CHEMBIOCHEM, V12, P1979, DOI 10.1002/cbic.201100342; Zhang J, 2017, J ORG CHEM, V82, P13643, DOI 10.1021/acs.joc.7b02342	37	9	9	3	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100918	10.1016/j.jbc.2021.100918	http://dx.doi.org/10.1016/j.jbc.2021.100918			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34181945	Green Published, gold			2022-12-28	WOS:000690879300010
J	Zielinski, M; Roder, C; Schroder, GF				Zielinski, Mara; Roeder, Christine; Schroeder, Gunnar F.			Challenges in sample preparation and structure determination of amyloids by cryo-EM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							AUTOMATED PARTICLE PICKING; NEAR-ATOMIC RESOLUTION; ALZHEIMERS-DISEASE; CRYOELECTRON MICROSCOPY; ELECTRON-MICROSCOPY; FIBRIL FORMATION; GRID PREPARATION; X-RAY; MOLECULAR-MECHANISMS; HELICAL FILAMENTS	Amyloids share a common architecture but play disparate biological roles in processes ranging from bacterial defense mechanisms to protein misfolding diseases. Their structures are highly polymorphic, which makes them difficult to study by X-ray diffraction or NMR spectroscopy. Our understanding of amyloid structures is due in large part to recent advances in the field of cryo-EM, which allows for determining the polymorphs separately. In this review, we highlight the main stepping stones leading to the substantial number of high-resolution amyloid fibril structures known today as well as recent developments regarding automation and software in cryo-EM. We discuss that sample preparation should move closer to physiological conditions to understand how amyloid aggregation and disease are linked. We further highlight new approaches to address heterogeneity and polymorphism of amyloid fibrils in EM image processing and give an outlook to the upcoming challenges in researching the structural biology of amyloids.	[Zielinski, Mara; Roeder, Christine; Schroeder, Gunnar F.] Forschungszentrum Julich, Inst Biol Informat Proc, Struct Biochem IBI 7, Julich Ctr Struct Biol, Julich, Germany; [Zielinski, Mara; Roeder, Christine; Schroeder, Gunnar F.] Forschungszentrum Julich, JuStruct, Julich Ctr Struct Biol, Julich, Germany; [Roeder, Christine] Heinrich Heine Univ Dusseldorf, Inst Phys Biol, Dusseldorf, Germany; [Schroeder, Gunnar F.] Heinrich Heine Univ Dusseldorf, Phys Dept, Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Schroder, GF (corresponding author), Forschungszentrum Julich, Inst Biol Informat Proc, Struct Biochem IBI 7, Julich Ctr Struct Biol, Julich, Germany.; Schroder, GF (corresponding author), Forschungszentrum Julich, JuStruct, Julich Ctr Struct Biol, Julich, Germany.; Schroder, GF (corresponding author), Heinrich Heine Univ Dusseldorf, Phys Dept, Dusseldorf, Germany.	gu.schroeder@fz-juelich.de	Schröder, Gunnar F/H-5261-2013	Schröder, Gunnar F/0000-0003-1803-5431; Zielinski, Mara/0000-0001-7443-917X				Adler-Abramovich L, 2012, NAT CHEM BIOL, V8, P701, DOI [10.1038/NCHEMBIO.1002, 10.1038/nchembio.1002]; Alam P, 2019, J NEUROCHEM, V150, P522, DOI 10.1111/jnc.14808; Alexandrescu AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056467; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Annamalai K, 2017, ANGEW CHEM INT EDIT, V56, P7510, DOI 10.1002/anie.201701761; Annamalai K, 2016, ANGEW CHEM INT EDIT, V55, P4822, DOI 10.1002/anie.201511524; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Armstrong M, 2020, BIOPHYS J, V118, P708, DOI 10.1016/j.bpj.2019.12.017; Arnold SA, 2017, J STRUCT BIOL, V197, P220, DOI 10.1016/j.jsb.2016.11.002; Arnold SA, 2016, ACS NANO, V10, P4981, DOI 10.1021/acsnano.6b01328; Astbury WT, 1932, PHILOS T R SOC LOND, V230, P75, DOI 10.1098/rsta.1932.0003; Bauerlein FJB, 2017, CELL, V171, P179, DOI 10.1016/j.cell.2017.08.009; Baker Kelty R, 2012, Methodist Debakey Cardiovasc J, V8, P3; Bansal A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21129-z; Benilova I, 2012, NAT NEUROSCI, V15, P349, DOI 10.1038/nn.3028; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; BERRIMAN J, 1994, ULTRAMICROSCOPY, V56, P241, DOI 10.1016/0304-3991(94)90012-4; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BRENNER S, 1959, BIOCHIM BIOPHYS ACTA, V34, P103, DOI 10.1016/0006-3002(59)90237-9; Bu XL, 2019, NEUROSCI BULL, V35, P1113, DOI 10.1007/s12264-019-00382-9; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Buell AK, 2014, P NATL ACAD SCI USA, V111, P7671, DOI 10.1073/pnas.1315346111; Campioni S, 2014, J AM CHEM SOC, V136, P2866, DOI 10.1021/ja412105t; Cao Q, 2020, NAT STRUCT MOL BIOL, V27, P653, DOI 10.1038/s41594-020-0435-3; Cendrowska U, 2020, P NATL ACAD SCI USA, V117, P6866, DOI 10.1073/pnas.1916176117; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Cline EN, 2018, J ALZHEIMERS DIS, V64, pS567, DOI 10.3233/JAD-179941; COCHRAN W, 1952, ACTA CRYSTALLOGR, V5, P581, DOI 10.1107/S0365110X52001635; Cohen A. S., 1986, AMYLOIDOSIS, P3; Dandey V. P., 2017, ACTA CRYSTALLOGR FOU, V73, pC1295; Dandey VP, 2020, NAT METHODS, V17, P897, DOI 10.1038/s41592-020-0925-6; Dandey VP, 2018, J STRUCT BIOL, V202, P161, DOI 10.1016/j.jsb.2018.01.002; Dear AJ, 2020, CHEM SCI, V11, P6236, DOI 10.1039/c9sc06501f; Dear AJ, 2020, P NATL ACAD SCI USA, V117, P12087, DOI 10.1073/pnas.1922267117; DEROSIER DJ, 1968, NATURE, V217, P130, DOI 10.1038/217130a0; DEROSIER DJ, 1970, J MOL BIOL, V52, P355, DOI 10.1016/0022-2836(70)90036-7; Desfosses A, 2014, J STRUCT BIOL, V185, P15, DOI 10.1016/j.jsb.2013.11.003; Diaz R, 2010, METHOD ENZYMOL, V482, P131, DOI 10.1016/S0076-6879(10)82005-1; Drummond E, 2017, ACTA NEUROPATHOL, V133, P933, DOI 10.1007/s00401-017-1691-0; DUBOCHET J, 1982, J MICROSC-OXFORD, V128, P219, DOI 10.1111/j.1365-2818.1982.tb04625.x; Edgren G, 2016, ANN INTERN MED, V165, P316, DOI 10.7326/M15-2421; Egelman EH, 2020, BIOPHYS J, V118, P1238, DOI 10.1016/j.bpj.2020.01.026; Egelman EH, 2010, METHOD ENZYMOL, V482, P167, DOI 10.1016/S0076-6879(10)82006-3; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; Ehrnhoefer DE, 2008, NAT STRUCT MOL BIOL, V15, P558, DOI 10.1038/nsmb.1437; Eisenberg D, 2012, CELL, V148, P1188, DOI 10.1016/j.cell.2012.02.022; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, ACTA NEUROPATHOL, V136, P699, DOI 10.1007/s00401-018-1914-z; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Faruqi AR, 2007, CURR OPIN STRUC BIOL, V17, P549, DOI 10.1016/j.sbi.2007.08.014; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Fitzpatrick AWP, 2013, P NATL ACAD SCI USA, V110, P5468, DOI 10.1073/pnas.1219476110; Fowler DM, 2006, PLOS BIOL, V4, P100, DOI 10.1371/journal.pbio.0040006; Fowler DM, 2007, TRENDS BIOCHEM SCI, V32, P217, DOI 10.1016/j.tibs.2007.03.003; Frank J, 2006, 3 DIMENSIONAL ELECT; Frederik PM, 2005, METHOD ENZYMOL, V391, P431, DOI 10.1016/S0076-6879(05)91024-0; Friedreich N., 1859, VIRCHOWS ARCH PATHOL, V16, P50, DOI DOI 10.1007/BF01945246; Galkin VE, 2015, STRUCTURE, V23, P173, DOI 10.1016/j.str.2014.11.006; Galkin VE, 2012, CURR BIOL, V22, pR96, DOI 10.1016/j.cub.2011.12.010; Gallardo R, 2020, NAT STRUCT MOL BIOL, V27, P1048, DOI 10.1038/s41594-020-0496-3; Galvagnion C, 2015, NAT CHEM BIOL, V11, P229, DOI [10.1038/NCHEMBIO.1750, 10.1038/nchembio.1750]; GEDDES AJ, 1968, J MOL BIOL, V32, P343, DOI 10.1016/0022-2836(68)90014-4; Ghosh U, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2023089118; Glynn C, 2020, NAT STRUCT MOL BIOL, V27, P417, DOI 10.1038/s41594-020-0403-y; Gorbenko G, 2015, SOFT MATTER, V11, P6223, DOI 10.1039/c5sm00183h; Gremer L, 2017, SCIENCE, V358, P116, DOI 10.1126/science.aao2825; Guijarro JI, 1998, P NATL ACAD SCI USA, V95, P4224, DOI 10.1073/pnas.95.8.4224; Guo Q, 2018, CELL, V172, P696, DOI 10.1016/j.cell.2017.12.030; Haataja L, 2008, ENDOCR REV, V29, P303, DOI 10.1210/er.2007-0037; Hasecke F, 2018, CHEM SCI, V9, P5937, DOI 10.1039/c8sc01479e; He S., 2018, THESIS U CAMBRIDGE; Hirota-Nakaoka N, 2003, J BIOCHEM, V134, P159, DOI 10.1093/jb/mvg124; Horvath I, 2016, P NATL ACAD SCI USA, V113, P12473, DOI 10.1073/pnas.1610371113; Hu RD, 2015, ACS CHEM NEUROSCI, V6, P1759, DOI 10.1021/acschemneuro.5b00192; Huang Z, 2004, J STRUCT BIOL, V145, P29, DOI 10.1016/j.jsb.2003.11.004; Huber ST, 2018, J STRUCT BIOL, V202, P1, DOI 10.1016/j.jsb.2017.11.013; Iadanza MG, 2018, NAT REV MOL CELL BIO, V19, P755, DOI 10.1038/s41580-018-0060-8; Jain T, 2012, J STRUCT BIOL, V179, P68, DOI 10.1016/j.jsb.2012.04.020; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Jaunmuktane Z, 2018, ACTA NEUROPATHOL, V135, P671, DOI 10.1007/s00401-018-1822-2; JOHNSON KH, 1989, NEW ENGL J MED, V321, P513; Ke PC, 2020, CHEM SOC REV, V49, P5473, DOI 10.1039/c9cs00199a; Klebl DP, 2020, STRUCTURE, V28, P1238, DOI 10.1016/j.str.2020.07.018; Klebl DP, 2020, ACTA CRYSTALLOGR D, V76, P340, DOI 10.1107/S2059798320002958; KLUG A, 1958, ACTA CRYSTALLOGR, V11, P199, DOI 10.1107/S0365110X58000517; Knowles TP, 2007, SCIENCE, V318, P1900, DOI 10.1126/science.1150057; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Kontziampasis D, 2019, IUCRJ, V6, P1024, DOI 10.1107/S2052252519011345; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P911, DOI 10.1007/s00401-016-1565-x; Lawson CL, 2018, J STRUCT BIOL, V204, P523, DOI 10.1016/j.jsb.2018.10.004; Li D, 2020, BIOCHEMISTRY-US, V59, P639, DOI 10.1021/acs.biochem.9b01069; Li GH, 2012, MED RES REV, V32, P999, DOI 10.1002/med.20231; Li SM, 2020, J NEUROCHEM, V154, pCP5, DOI 10.1111/jnc.15007; Li YL, 2020, STRUCTURE, V28, P858, DOI 10.1016/j.str.2020.03.008; Liberta F, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09033-z; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Loquet A, 2018, J MOL BIOL, V430, P3629, DOI 10.1016/j.jmb.2018.07.024; Lovestam S, 2021, FEBS OPEN BIO, V11, P999, DOI 10.1002/2211-5463.13110; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Maeots ME, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17230-4; Makin OS, 2005, P NATL ACAD SCI USA, V102, P315, DOI 10.1073/pnas.0406847102; McMullan G, 2016, METHOD ENZYMOL, V579, P1, DOI 10.1016/bs.mie.2016.05.056; Mehta D, 2017, EXPERT OPIN INV DRUG, V26, P735, DOI 10.1080/13543784.2017.1323868; Michaels TCT, 2020, NAT CHEM, V12, P445, DOI 10.1038/s41557-020-0452-1; Michaels TCT, 2018, ANNU REV PHYS CHEM, V69, P273, DOI 10.1146/annurev-physchem-050317-021322; MISSMAHL HP, 1953, VIRCHOWS ARCH A, V324, P489, DOI 10.1007/BF00954791; Miti T, 2015, BIOMACROMOLECULES, V16, P326, DOI 10.1021/bm501521r; Modler AJ, 2003, J MOL BIOL, V325, P135, DOI 10.1016/S0022-2836(02)01175-0; Morales R, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003537; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Moriya T, 2017, JOVE-J VIS EXP, DOI 10.3791/55448; Morris KL, 2012, METHODS MOL BIOL, V849, P121, DOI 10.1007/978-1-61779-551-0_9; Murphy MP, 2010, J ALZHEIMERS DIS, V19, P311, DOI [10.3233/JAD-2009-1221, 10.3233/JAD-2010-1221]; Nakane T, 2020, NATURE, V587, P152, DOI 10.1038/s41586-020-2829-0; Ohashi M, 2019, PHYS REV E, V100, DOI 10.1103/PhysRevE.100.042411; Ono K, 2009, P NATL ACAD SCI USA, V106, P14745, DOI 10.1073/pnas.0905127106; Ow SY, 2013, SOFT MATTER, V9, P9692, DOI 10.1039/c3sm51671g; Oxford Alexandra E, 2020, Int J Alzheimers Dis, V2020, P5380346, DOI 10.1155/2020/5380346; Page LJ, 2005, EMBO J, V24, P4124, DOI 10.1038/sj.emboj.7600872; Paravastu AK, 2009, P NATL ACAD SCI USA, V106, P7443, DOI 10.1073/pnas.0812033106; Peduzzo A, 2020, ACS CHEM NEUROSCI, V11, P909, DOI 10.1021/acschemneuro.9b00594; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499; Pham CLL, 2014, ESSAYS BIOCHEM, V56, P207, DOI [10.1042/bse0560207, 10.1042/BSE0560207]; Picotti P, 2007, J MOL BIOL, V367, P1237, DOI 10.1016/j.jmb.2007.01.072; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Pothula KR, 2021, PROG BIOPHYS MOL BIO, V160, P16, DOI 10.1016/j.pbiomolbio.2020.11.007; Pothula KR, 2019, ULTRAMICROSCOPY, V203, P132, DOI 10.1016/j.ultramic.2018.12.009; PUCHTLER H, 1962, J HISTOCHEM CYTOCHEM, V10, P355, DOI 10.1177/10.3.355; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Purro SA, 2018, NATURE, V564, P415, DOI 10.1038/s41586-018-0790-y; Radamaker L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21126-2; Ramakrishnan C, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-84; Ravelli RBG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16392-5; Redmon J, 2016, PROC CVPR IEEE, P779, DOI 10.1109/CVPR.2016.91; Riek R, 2016, NATURE, V539, P227, DOI 10.1038/nature20416; Roder C, 2020, NAT STRUCT MOL BIOL, V27, P660, DOI 10.1038/s41594-020-0442-4; Roder C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11320-8; Roseman AM, 2004, J STRUCT BIOL, V145, P91, DOI 10.1016/j.jsb.2003.11.007; Rubinstein JL, 2019, ACTA CRYSTALLOGR D, V75, P1063, DOI 10.1107/S2059798319014372; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Santiago JA, 2014, NEUROBIOL DIS, V72, P84, DOI 10.1016/j.nbd.2014.03.019; Scheres SHW, 2020, ACTA CRYSTALLOGR D, V76, P94, DOI 10.1107/S2059798319016577; Scheres SHW, 2015, J STRUCT BIOL, V189, P114, DOI 10.1016/j.jsb.2014.11.010; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Schmidli C, 2019, P NATL ACAD SCI USA, V116, P15007, DOI 10.1073/pnas.1907214116; Schmidt M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13038-z; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schuster J, 2016, J ALZHEIMERS DIS, V53, P53, DOI 10.3233/JAD-151029; Schutzmann M. P., 2020, ENDOLYSOSOMAL ASS CO, DOI [10.1101/2020.06.28.175885, DOI 10.1101/2020.06.28.175885]; Schweighauser M, 2020, NATURE, V585, P464, DOI 10.1038/s41586-020-2317-6; Serrano-Pozo A, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a006189; Sipe JD, 2016, AMYLOID, V23, P209, DOI 10.1080/13506129.2016.1257986; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; Strohaker T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13564-w; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; Swuec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09133-w; TAYLOR KA, 1974, SCIENCE, V186, P1036, DOI 10.1126/science.186.4168.1036; TAYLOR KA, 1976, J ULTRA MOL STRUCT R, V55, P448, DOI 10.1016/S0022-5320(76)80099-8; Thurber KR, 2021, J STRUCT BIOL, V213, DOI 10.1016/j.jsb.2021.107736; Tornquist M, 2020, P NATL ACAD SCI USA, V117, P11265, DOI 10.1073/pnas.1918481117; Tornquist M, 2018, CHEM COMMUN, V54, P8667, DOI 10.1039/c8cc02204f; Treusch S, 2009, CELL CYCLE, V8, P1668, DOI 10.4161/cc.8.11.8503; van Groen T, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16565-1; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; Vettore N, 2019, PHYS CHEM CHEM PHYS, V21, P26184, DOI 10.1039/c9cp04524d; Virchow R, 1854, VIRCHOWS ARCH PATHOL, V6, P135, DOI [10.1007/BF01930815, DOI 10.1007/BF01930815]; Virchow R., 1854, ARCH PATHOL ANAT PHY, V6, P268; Volkmann N, 2004, J STRUCT BIOL, V145, P152, DOI 10.1016/j.jsb.2003.11.026; von der Ecken J, 2016, NATURE, V534, P724, DOI 10.1038/nature18295; Wagner T, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0790-y; Wagner T, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0437-z; Wang F, 2016, J STRUCT BIOL, V195, P325, DOI 10.1016/j.jsb.2016.07.006; Weber M, 2020, J MICROSC-OXFORD, V277, P12, DOI 10.1111/jmi.12858; Wei H., 2019, MICROSC MICROANAL, V25, P1010, DOI [10.1017/S1431927619005786, DOI 10.1017/S1431927619005786]; Wei H, 2017, MICROSC MICROANAL, V23, P848; Wei H, 2018, J STRUCT BIOL, V202, P170, DOI 10.1016/j.jsb.2018.01.001; Weirich F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161243; Weissenberger G., 2020, MICROSC MICROANAL, V26, P1; Wiltzius JJW, 2009, NAT STRUCT MOL BIOL, V16, P973, DOI 10.1038/nsmb.1643; Wlodawer A, 2017, ACTA CRYSTALLOGR D, V73, P379, DOI 10.1107/S205979831700225X; Wu SP, 2012, STRUCTURE, V20, P582, DOI 10.1016/j.str.2012.02.017; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Xuong NH, 2004, PROC SPIE, V5301, P242, DOI 10.1117/12.526021; Yip KM, 2020, NATURE, V587, P157, DOI 10.1038/s41586-020-2833-4; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105; Zhang YX, 2021, J MATER CHEM B, V9, P3300, DOI 10.1039/d0tb02958k; Zhu YN, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1757-y; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166; Zraika S, 2010, DIABETOLOGIA, V53, P1046, DOI 10.1007/s00125-010-1671-6; Zurdo J, 2001, J MOL BIOL, V311, P325, DOI 10.1006/jmbi.2001.4858	196	4	4	5	22	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100938	10.1016/j.jbc.2021.100938	http://dx.doi.org/10.1016/j.jbc.2021.100938			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34224730	Green Published, gold			2022-12-28	WOS:000690871000008
J	Matsumoto, N; Nemoto-Sasaki, Y; Oka, S; Arai, S; Wada, I; Yamashita, A				Matsumoto, Naoki; Nemoto-Sasaki, Yoko; Oka, Saori; Arai, Seisuke; Wada, Ikuo; Yamashita, Atsushi			Phosphorylation of human phospholipase A1 DDHD1 at newly identified phosphosites affects its subcellular localization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN SEC23P-INTERACTING PROTEIN; HEREDITARY SPASTIC PARAPARESIS; ACID; A(1); LYSOPHOSPHATIDYLINOSITOL; METABOLISM; MUTATIONS; KINASE; BRAIN; PURIFICATION	Phospholipase A1 (PLA1) hydrolyzes the fatty acids of glycerophospholipids, which are structural components of the cellular membrane. Genetic mutations in DDHD1, an intracellular PLA1, result in hereditary spastic paraplegia (HSP) in humans. However, the regulation of DDHD1 activity has not yet been elucidated in detail. In the present study, we examined the phosphorylation of DDHD1 and identified the responsible protein kinases. We performed MALDI-TOF MS/MS analysis and Phos-tag SDS-PAGE in alanine-substitution mutants in HEK293 cells and revealed multiple phosphorylation sites in human DDHD1, primarily Ser8, Ser11, Ser723, and Ser727. The treatment of cells with a protein phosphatase inhibitor induced the hyperphosphorylation of DDHD1, suggesting that multisite phosphorylation occurred not only at these major, but also at minor sites. Site-specific kinase-substrate prediction algorithms and in vitro kinase analyses indicated that cyclin-dependent kinase CDK1/cyclin A2 phosphorylated Ser8, Ser11, and Ser727 in DDHD1 with a preference for Ser11 and that CDK5/p35 also phosphorylated Ser11 and Ser727 with a preference for Ser11. In addition, casein kinase CK2a1 was found to phosphorylate Ser104, although this was not a major phosphorylation site in cultivated HEK293 cells. The evaluation of the effects of phosphorylation revealed that the phosphorylation mimic mutants S11/727E exhibit only 20% reduction in PLA1 activity. However, the phosphorylation mimics were mainly localized to focal adhesions, whereas the phosphorylation-resistant mutants S11/727A were not. This suggested that phosphorylation alters the subcellular localization of DDHD1 without greatly affecting its PLA1 activity.	[Matsumoto, Naoki; Nemoto-Sasaki, Yoko; Oka, Saori; Yamashita, Atsushi] Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo, Japan; [Arai, Seisuke; Wada, Ikuo] Fukushima Med Univ, Inst Biomed Sci, Dept Cell Sci, Sch Med, Fukushima, Fukushima, Japan	Teikyo University; Fukushima Medical University	Yamashita, A (corresponding author), Teikyo Univ, Fac Pharma Sci, Itabashi Ku, Tokyo, Japan.	ayamashi@pharm.teikyo-u.ac.jp		Yamashita, Atsushi/0000-0002-2544-2134	Japan Society for the Promotion of Science [15K07946, 19K07088, 17K07311]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was partly supported by Grants-in-Aid for Scientific Research (15K07946 (A. Y.), 19K07088 (A. Y.), and 17K07311 (I. W.)) from the Japan Society for the Promotion of Science.	Aoki J, 2007, BIOCHIMIE, V89, P197, DOI 10.1016/j.biochi.2006.09.021; Baba T, 2014, J BIOL CHEM, V289, P11497, DOI 10.1074/jbc.M113.531921; Breitkopf S. B., 2012, CURR PROTOC MOL BIOL, V98; COBB MH, 1995, J BIOL CHEM, V270, P14843, DOI 10.1074/jbc.270.25.14843; Dajani R, 2001, CELL, V105, P721, DOI 10.1016/S0092-8674(01)00374-9; Dard R, 2017, EUR J MED GENET, V60, P639, DOI 10.1016/j.ejmg.2017.08.015; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Gotzke H, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12301-7; Han MH, 2001, J BIOL CHEM, V276, P27698, DOI 10.1074/jbc.M101983200; Higgs HN, 1998, J BIOL CHEM, V273, P5468, DOI 10.1074/jbc.273.10.5468; Higgs HN, 1996, J BIOL CHEM, V271, P10874, DOI 10.1074/jbc.271.18.10874; HIGGS HN, 1994, P NATL ACAD SCI USA, V91, P9574, DOI 10.1073/pnas.91.20.9574; Hiramatsu T, 2003, J BIOL CHEM, V278, P49438, DOI 10.1074/jbc.M213018200; Inoue N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9858; Kato A, 2007, BIOPOLYMERS, V85, P12, DOI 10.1002/bip.20596; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Kinoshita E, 2012, PROTEOMICS, V12, P192, DOI 10.1002/pmic.201100524; Lev S, 2004, EXP CELL RES, V297, P1, DOI 10.1016/j.yexcr.2004.02.033; Liguori R, 2014, J NEUROL, V261, P1789, DOI 10.1007/s00415-014-7418-4; Lo Giudice T, 2014, EXP NEUROL, V261, P518, DOI 10.1016/j.expneurol.2014.06.011; Mazaki Y, 1998, J BIOL CHEM, V273, P22435, DOI 10.1074/jbc.273.35.22435; McNiven MA, 2013, TRENDS CELL BIOL, V23, P16, DOI 10.1016/j.tcb.2012.08.009; Mignarri A, 2016, J NEUROL SCI, V362, P287, DOI 10.1016/j.jns.2016.02.007; Miura S, 2016, EUR J MED GENET, V59, P413, DOI 10.1016/j.ejmg.2016.05.010; Nakajima K, 2002, J BIOL CHEM, V277, P11329, DOI 10.1074/jbc.M111092200; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Oka S, 2010, J BIOCHEM, V147, P671, DOI 10.1093/jb/mvp208; Oka S, 2009, J BIOCHEM, V145, P13, DOI 10.1093/jb/mvn136; PETE MJ, 1994, J BIOL CHEM, V269, P19494; Richter KN, 2018, EMBO J, V37, P139, DOI 10.15252/embj.201695709; Sato T, 1997, J BIOL CHEM, V272, P2192; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sonoda H, 2002, J BIOL CHEM, V277, P34254, DOI 10.1074/jbc.M201659200; Suzuki T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037551; Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505; Tesson C, 2012, AM J HUM GENET, V91, P1051, DOI 10.1016/j.ajhg.2012.11.001; TURNER CE, 1990, J CELL BIOL, V111, P1059, DOI 10.1083/jcb.111.3.1059; Waite M., 1987, PHOSPHOLIPASES HDB L, V5, P1; Yamashita A, 2014, PROG LIPID RES, V53, P18, DOI 10.1016/j.plipres.2013.10.001; Yamashita A, 2013, PROSTAG OTH LIPID M, V107, P103, DOI 10.1016/j.prostaglandins.2013.05.004; Yamashita A, 2010, BBA-MOL CELL BIOL L, V1801, P711, DOI 10.1016/j.bbalip.2010.03.012	43	5	5	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100851	10.1016/j.jbc.2021.100851	http://dx.doi.org/10.1016/j.jbc.2021.100851			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34089703	Green Published, gold			2022-12-28	WOS:000678068400051
J	Abreha, MH; Ojelade, S; Dammer, EB; McEachin, ZT; Duong, DM; Gearing, M; Bassell, GJ; Lah, JJ; Levey, AI; Shulman, JM; Seyfried, NT				Abreha, Measho H.; Ojelade, Shamsideen; Dammer, Eric B.; McEachin, Zachary T.; Duong, Duc M.; Gearing, Marla; Bassell, Gary J.; Lah, James J.; Levey, Allan, I; Shulman, Joshua M.; Seyfried, Nicholas T.			TBK1 interacts with tau and enhances neurodegeneration in tauopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABNORMALLY PHOSPHORYLATED-TAU; DEPENDENT PROTEIN-KINASE; NEUROFIBRILLARY TANGLES; IKK-EPSILON; ACTIVATION; HYPERPHOSPHORYLATION; LOCALIZATION; INHIBITOR; SEVERITY	One of the defining pathological features of Alzheimer's disease (AD) is the deposition of neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau in the brain. Aberrant activation of kinases in AD has been suggested to enhance phosphorylation and toxicity of tau, making the responsible tau kinases attractive therapeutic targets. The full complement of tau-interacting kinases in AD brain and their activity in disease remains incompletely defined. Here, immunoaffinity enrichment coupled with mass spectrometry (MS) identified TANK-binding kinase 1 (TBK1) as a tau-interacting partner in human AD cortical brain tissues. We validated this interaction in human AD, familial frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) caused by mutations in MAPT (R406W & P301L) and corticobasal degeneration (CBD) postmortem brain tissues as well as human cell lines. Further, we document increased TBK1 activation in both AD and FTDP-17 and map TBK1 phosphorylation sites on tau based on in vitro kinase assays coupled to MS. Lastly, in a Drosophila tauopathy model, activating expression of a conserved TBK1 ortholog triggers tau hyperphosphorylation and enhanced neurodegeneration, whereas knockdown had the reciprocal effect, suppressing tau toxicity. Collectively, our findings suggest that increased TBK1 activation may promote tau hyperphosphorylation and neuronal loss in AD and related tauopathies.	[Abreha, Measho H.; Dammer, Eric B.; Duong, Duc M.; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Abreha, Measho H.; Dammer, Eric B.; McEachin, Zachary T.; Duong, Duc M.; Gearing, Marla; Bassell, Gary J.; Lah, James J.; Levey, Allan, I; Seyfried, Nicholas T.] Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA; [Ojelade, Shamsideen; Shulman, Joshua M.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Ojelade, Shamsideen; Shulman, Joshua M.] Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA; [Dammer, Eric B.; Duong, Duc M.; Gearing, Marla] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [McEachin, Zachary T.; Bassell, Gary J.] Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA USA; [Gearing, Marla; Lah, James J.; Levey, Allan, I; Seyfried, Nicholas T.] Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Shulman, Joshua M.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA	Emory University; Emory University; Baylor College of Medicine; Baylor College of Medicine; Emory University; Emory University; Emory University; Baylor College of Medicine; Baylor College of Medicine	Seyfried, NT (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Seyfried, NT (corresponding author), Emory Univ, Sch Med, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA.; Shulman, JM (corresponding author), Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA.; Shulman, JM (corresponding author), Texas Childrens Hosp, Jan & Dan Duncan Neurol Res Inst, Houston, TX 77030 USA.; Seyfried, NT (corresponding author), Emory Univ, Sch Med, Dept Neurol, Atlanta, GA 30322 USA.; Shulman, JM (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.; Shulman, JM (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	Joshua.Shulman@bcm.edu; nseyfri@emory.edu	Levey, Allan/F-2104-2011; Dammer, Eric B/V-8652-2019	Levey, Allan/0000-0002-3153-502X; Dammer, Eric B/0000-0003-2947-7606	NIH [R01 CA027607, R01 CA238029, R01 CA027607-37S1, R01 AA025204-01A1, R21 AA025470-01A1, P50 AA11999]; W. M. Keck Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation(W.M. Keck Foundation)	This work is supported by NIH grants (R01 CA027607, R01 CA238029) to A. S. L., R01 CA027607-37S1 to A. J. C. and A. S. L., NIH grants (R01 AA025204-01A1, R21 AA025470-01A1, and P50 AA11999) to K. M., and a pilot grant from a gift by the W. M. Keck Foundation to support COVID-19 research to A. S. L., K. M, and P. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abreha MH, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201800108; Ahmad L, 2016, TRENDS MOL MED, V22, P511, DOI 10.1016/j.molmed.2016.04.006; Alonso AD, 1996, NAT MED, V2, P783, DOI 10.1038/nm0796-783; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2001, P NATL ACAD SCI USA, V98, P6923, DOI 10.1073/pnas.121119298; ARRIAGADA PV, 1992, NEUROLOGY, V42, P631, DOI 10.1212/WNL.42.3.631; Augustinack JC, 2002, ACTA NEUROPATHOL, V103, P26, DOI 10.1007/s004010100423; Awadalla MS, 2015, AM J OPHTHALMOL, V159, P124, DOI 10.1016/j.ajo.2014.09.044; Bai LY, 2015, EUR J PHARMACOL, V769, P287, DOI 10.1016/j.ejphar.2015.11.032; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; BANCHER C, 1989, BRAIN RES, V477, P90, DOI 10.1016/0006-8993(89)91396-6; Bierer I., 1995, ARCH NEUROL-CHICAGO; Borghero G, 2016, NEUROBIOL AGING, V43, DOI 10.1016/j.neurobiolaging.2016.03.028; BRANDT R, 1994, J BIOL CHEM, V269, P11776; Brenner D, 2019, J EXP MED, V216, P267, DOI 10.1084/jem.20180729; Cavallini A, 2013, J BIOL CHEM, V288, P23331, DOI 10.1074/jbc.M113.463984; Chouhan AK, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0333-4; Chun J, 2004, MOL CELLS, V18, P360; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dammer EB, 2015, PROTEOMICS, V15, P508, DOI 10.1002/pmic.201400189; Dolan PJ, 2010, CURR OPIN DRUG DISC, V13, P595; Drummond E, 2020, BRAIN, V143, P2803, DOI 10.1093/brain/awaa223; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Freischmidt A, 2017, JAMA NEUROL, V74, P110, DOI 10.1001/jamaneurol.2016.3712; Freischmidt A, 2015, NAT NEUROSCI, V18, P631, DOI 10.1038/nn.4000; Gerhino V., 2020, NEURON, V106; Gfiselinck I., 2015, NEUROLOGY, V85, p2116 2125; Giacomini C, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0539-8; Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; GONG CX, 1995, J NEUROCHEM, V65, P732, DOI 10.1046/j.1471-4159.1995.65020732.x; Hasan M, 2016, PHARMACOL RES, V111, P336, DOI 10.1016/j.phrs.2016.04.008; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; He L, 2017, NEUROSCI BULL, V33, P354, DOI 10.1007/s12264-017-0116-3; Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hsieh YC, 2019, CELL REP, V29, P301, DOI 10.1016/j.celrep.2019.08.104; Hu YH, 2021, NUCLEIC ACIDS RES, V49, pD908, DOI 10.1093/nar/gkaa936; KOPKE E, 1993, J BIOL CHEM, V268, P24374; Koriath Carolin A M, 2017, Alzheimers Dement (Amst), V6, P75, DOI 10.1016/j.dadm.2016.10.003; Kouri N, 2014, ACTA NEUROPATHOL, V127, P271, DOI 10.1007/s00401-013-1193-7; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Lauro C, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00493; liackladi M., 2016, BIOCH GENET, V54, P61; Lindquist SG, 2008, EUR J NEUROL, V15, P377, DOI 10.1111/j.1468-1331.2008.02069.x; LINDWALL G, 1984, J BIOL CHEM, V259, P5301; Litersky JM, 1996, BIOCHEM J, V316, P655, DOI 10.1042/bj3160655; Liu SJ, 2003, J NEUROCHEM, V87, P1333, DOI 10.1046/j.1471-4159.2003.02070.x; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Martin L, 2013, AGEING RES REV, V12, P289, DOI 10.1016/j.arr.2012.06.003; Matsumoto G, 2015, HUM MOL GENET, V24, P4429, DOI 10.1093/hmg/ddv179; Meier S, 2016, J NEUROSCI, V36, P1001, DOI 10.1523/JNEUROSCI.3029-15.2016; Meier S, 2015, J ALZHEIMERS DIS, V48, P687, DOI 10.3233/JAD-150298; Oakes JA, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0287-x; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Park S, 2018, BMB REP, V51, P265, DOI 10.5483/BMBRep.2018.51.6.077; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Pillai S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10072; Pilli M, 2012, IMMUNITY, V37, P223, DOI 10.1016/j.immuni.2012.04.015; Ping L., 2020, SCI DATA, V7, P1; Ping LY, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00650-8; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Ritch R, 2014, JAMA OPHTHALMOL, V132, P544, DOI 10.1001/jamaophthalmol.2014.104; Seyfried NT, 2017, CELL SYST, V4, P60, DOI 10.1016/j.cels.2016.11.006; Steinhilb ML, 2007, J NEUROSCI RES, V85, P1271, DOI 10.1002/jnr.21232; Takeda S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9490; Tanaka Y, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002521; Weidberg H, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002355; Wesseling H, 2020, CELL, V183, P1699, DOI 10.1016/j.cell.2020.10.029; Williams KL, 2015, NEUROBIOL AGING, V36, DOI 10.1016/j.neurobiolaging.2015.08.013; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Xu DC, 2018, CELL, V174, P1477, DOI 10.1016/j.cell.2018.07.041; Yoshida H, 2006, J NEUROCHEM, V99, P154, DOI 10.1111/j.1471-4159.2006.04052.x; YU T, 2012, MEDIAT INFLAMM, V2012, DOI DOI 10.1155/2012/979105; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007	80	5	5	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100760	10.1016/j.jbc.2021.100760	http://dx.doi.org/10.1016/j.jbc.2021.100760			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33965374	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400728
J	Allu, PKR; Paulo, E; Bertholet, AM; Situ, G; Lee, SH; Wu, YX; Gleason, CE; Saha, B; Chawla, A; Wang, BA; Pearce, D				Allu, Prasanna K. R.; Paulo, Esther; Bertholet, Ambre M.; Situ, Gavin; Lee, Seung-Hwan; Wu, Yixuan; Gleason, Catherine E.; Saha, Bidisha; Chawla, Ajay; Wang, Biao; Pearce, David			Role of mTORC2 in biphasic regulation of brown fat metabolism in response to mild and severe cold	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADIPOSE-TISSUE; BEIGE FAT; THERMOGENESIS; OBESITY; WHITE; SENSITIVITY; ADIPOCYTES; ACTIVATION; LIPOLYSIS; ENERGY	Nonshivering thermogenesis is essential for mammals to maintain body temperature. According to the canonical view, temperature is sensed by cutaneous thermoreceptors and nerve impulses transmitted to the hypothalamus, which generates sympathetic signals to beta-adrenergic receptors in brown adipocytes. The energy for heat generation is primarily provided by the oxidation of fatty acids derived from triglyceride hydrolysis and cellular uptake. Fatty acids also activate the uncoupling protein, UCP1, which creates a proton leak that uncouples mitochondrial oxidative phosphorylation from ATP production, resulting in energy dissipation as heat. Recent evidence supports the idea that in response to mild cold, beta-adrenergic signals stimulate not only lipolysis and fatty acid oxidation, but also act through the mTORC2-Akt signaling module to stimulate de novo lipogenesis. This opposing anabolic effect is thought to maintain lipid fuel stores during increased catabolism. We show here, using brown fat-specific Gs-alpha knockout mice and cultured adipocytes that, unlike mild cold, severe cold directly cools brown fat and bypasses beta-adrenergic signaling to inhibit mTORC2. This cell-autonomous effect both inhibits lipogenesis and augments UCP1 expression to enhance thermogenesis. These findings suggest a novel mechanism for overriding beta-adrenergic-stimulated anabolic activities while augmenting catabolic activities to resolve the homeostatic crisis presented by severe cold.	[Allu, Prasanna K. R.; Situ, Gavin; Gleason, Catherine E.; Saha, Bidisha; Pearce, David] Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA; [Paulo, Esther; Lee, Seung-Hwan; Wu, Yixuan; Chawla, Ajay; Wang, Biao; Pearce, David] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Bertholet, Ambre M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Allu, Prasanna K. R.] Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA; [Lee, Seung-Hwan] Catholic Univ Korea, Seoul St Marys Hosp, Coll Med, Div Endocrinol & Metab,Dept Internal Med, Seoul, South Korea; [Situ, Gavin] Circle Pharma, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Catholic University of Korea; Seoul St. Mary's Hospital	Allu, PKR; Pearce, D (corresponding author), Univ Calif San Francisco, Dept Med, Div Nephrol, San Francisco, CA 94143 USA.; Pearce, D (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.; Allu, PKR (corresponding author), Harvard Med Sch, Joslin Diabet Ctr, Boston, MA 02115 USA.	Prasanna.allu@joslin.harvard.edu; david.pearce@ucsf.edu	Wu, Yixuan/GXG-9879-2022; Paulo Mirasol, Esther/C-8607-2017	Wu, Yixuan/0000-0001-9637-9219; Paulo Mirasol, Esther/0000-0002-8108-3957	James Hilton Manning and Emma Austin Manning Foundation; NIH [DK094641, DK101064, R01-DK56695, P30DK063720, P30DK098722, DK105175]; American Heart Association; Larry Hillblom Foundation	James Hilton Manning and Emma Austin Manning Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Larry Hillblom Foundation	The authors gratefully acknowledge support from the James Hilton Manning and Emma Austin Manning Foundation (D. P.). The authors also acknowledge grant support from NIH DK094641 and DK101064 (A. C.); R01-DK56695 (D. P.); P30DK063720, P30DK098722, and DK105175 (B. W.). P. K. R. A. is supported by a postdoctoral fellowship grant from American Heart Association. E. P, is supported by a fellowship grant from Larry Hillblom Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Albert V, 2016, EMBO MOL MED, V8, P232, DOI 10.15252/emmm.201505610; Bachman ES, 2002, SCIENCE, V297, P843, DOI 10.1126/science.1073160; Calejman CM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14430-w; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; COUSIN B, 1992, J CELL SCI, V103, P931; Fei ZL, 2011, J BIOL CHEM, V286, P27761, DOI 10.1074/jbc.M111.248435; Gasparetti AL, 2005, PFLUG ARCH EUR J PHY, V449, P537, DOI 10.1007/s00424-004-1359-1; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hung CM, 2014, CELL REP, V8, P256, DOI 10.1016/j.celrep.2014.06.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Klein J, 1999, J BIOL CHEM, V274, P34795, DOI 10.1074/jbc.274.49.34795; Li YQ, 2016, P NATL ACAD SCI USA, V113, P446, DOI 10.1073/pnas.1517142113; Liu DX, 2016, J CLIN INVEST, V126, P1704, DOI 10.1172/JCI83532; LONCAR D, 1991, CELL TISSUE RES, V266, P149, DOI 10.1007/BF00678721; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Misra UK, 2012, J CELL BIOCHEM, V113, P1488, DOI 10.1002/jcb.24018; Morrison S, 2015, ADIPOCYTE, V4, P295, DOI 10.1080/21623945.2015.1040612; Mottillo EP, 2014, J LIPID RES, V55, P2276, DOI 10.1194/jlr.M050005; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Oehler-Janne C, 2008, BIOCHEM BIOPH RES CO, V375, P399, DOI 10.1016/j.bbrc.2008.08.035; Paulo E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29333-6; Sanchez-Gurmaches j., 2018, CELL METAB, P27; Sidossis L, 2015, J CLIN INVEST, V125, P478, DOI 10.1172/JCI78362; Sun WP, 2016, EMBO REP, V17, P383, DOI 10.15252/embr.201540819; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Ye L, 2013, P NATL ACAD SCI USA, V110, P12480, DOI 10.1073/pnas.1310261110; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Zechner R, 2012, CELL METAB, V15, P279, DOI 10.1016/j.cmet.2011.12.018	29	6	6	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100632	10.1016/j.jbc.2021.100632	http://dx.doi.org/10.1016/j.jbc.2021.100632			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865855	Green Published, gold			2022-12-28	WOS:000672866400603
J	Chen, PF; Ma, XF; Sun, LF; Tian, Y; Fan, YZ; Li, PW; Xiao, ZH; Zhu, MX; Guo, CR; Li, CZ; Yu, Y; Wang, J				Chen, Ping-Fang; Ma, Xue-Fei; Sun, Liang-Fei; Tian, Yun; Fan, Ying-Zhe; Li, Peiwang; Xiao, Zhihong; Zhu, Michael X.; Guo, Chang-Run; Li, Changzhu; Yu, Ye; Wang, Jin			A conserved residue in the P2X4 receptor has a nonconserved function in ATP recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE EPOXIDE HYDROLASE; SYSTOLIC BLOOD-PRESSURE; SODIUM-CHANNEL ACTIVITY; CARDIOVASCULAR OUTCOMES; DIABETES-MELLITUS; KAPPA-B; HYPERTENSION; KIDNEY; INFLAMMATION; INHIBITORS	Highly conserved amino acids are generally anticipated to have similar functions across a protein superfamily, including that of the P2X ion channels, which are gated by extracellular ATP. However, whether and how these functions are conserved becomes less clear when neighboring amino acids are not conserved. Here, we investigate one such case, focused on the highly conserved residue from P2X4, E118 (rat P2X4 numbering, rP2X4), a P2X subtype associated with human neuropathic pain. When we compared the crystal structures of P2X4 with those of other P2X subtypes, including P2X3, P2X7, and AmP2X, we observed a slightly altered side-chain orientation of E118. We used protein chimeras, double-mutant cycle analysis, and molecular modeling to reveal that E118 forms specific contacts with amino acids in the "beak" region, which facilitates ATP binding to rP2X4. These contacts are not present in other subtypes because of sequence variance in the beak region, resulting in decoupling of this conserved residue from ATP recognition and/or channel gating of P2X receptors. Our study provides an example of a conserved residue with a specific role in functional proteins enabled by adjacent non-conserved residues. The unique role established by the E118-beak region contact provides a blueprint for the development of subtype-specific inhibitors of P2X4.	[Chen, Ping-Fang; Sun, Liang-Fei; Yu, Ye] Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, Shanghai, Peoples R China; [Ma, Xue-Fei; Guo, Chang-Run; Yu, Ye; Wang, Jin] China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China; [Ma, Xue-Fei; Tian, Yun] Hunan Agr Univ, Coll Biosci & Biotechnol, Changsha, Peoples R China; [Fan, Ying-Zhe] Shanghai Univ Chinese Tradit Med, Putuo Hosp, Shanghai, Peoples R China; [Li, Peiwang; Xiao, Zhihong; Li, Changzhu] Hunan Acad Forestry, State Key Lab Utilizat Woody Oil Resource, Changsha, Peoples R China; [Zhu, Michael X.] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, McGovern Med Sch, Houston, TX 77030 USA; [Yu, Ye] Guangxi Normal Univ, Sch Chem & Pharmaceut Sci, Collaborat Innovat Ctr Guangxi Ethn Med, State Key Lab Chem & Mol Engn Med Resources, Guilin, Peoples R China	Shanghai Jiao Tong University; China Pharmaceutical University; Hunan Agricultural University; Shanghai University of Traditional Chinese Medicine; University of Texas System; University of Texas Health Science Center Houston; Guangxi Normal University	Yu, Y (corresponding author), Shanghai Jiao Tong Univ, Inst Med Sci, Dept Pharmacol & Chem Biol, Sch Med, Shanghai, Peoples R China.; Yu, Y; Wang, J (corresponding author), China Pharmaceut Univ, Sch Basic Med & Clin Pharm, Nanjing, Peoples R China.; Li, CZ (corresponding author), Hunan Acad Forestry, State Key Lab Utilizat Woody Oil Resource, Changsha, Peoples R China.; Yu, Y (corresponding author), Guangxi Normal Univ, Sch Chem & Pharmaceut Sci, Collaborat Innovat Ctr Guangxi Ethn Med, State Key Lab Chem & Mol Engn Med Resources, Guilin, Peoples R China.	lichangzhu2013@aliyun.com; yuye@shsmu.edu.cn; wangjin@cpu.edu.cn		Zhu, Michael/0000-0002-5676-841X; Tian, Yun/0000-0002-0906-3919	National Natural Science Foundation of China [32000869, 31570832, 31971146, 81603409, 31971042]; Natural Science Foundation of Jiangsu Province [BK20202002]; Innovation and Entrepreneurship Talent Program of Jiangsu Province; Open Project of State Key Laboratory of Natural Medicines [SKLNMZZRC201801]; Hunan Provincial Natural Science Foundation of China [2018JJ1012]; Guangxi Funds for Distinguished Experts; State Key Laboratory of Utilization of Woody Oil Resource [2019XK2002]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Innovation and Entrepreneurship Talent Program of Jiangsu Province; Open Project of State Key Laboratory of Natural Medicines; Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); Guangxi Funds for Distinguished Experts; State Key Laboratory of Utilization of Woody Oil Resource	This study was supported with funds from the National Natural Science Foundation of China with grant number 32000869 (J. W.), 31570832 (Y. Y.), 31971146 (Y. Y.), 81603409 (Y.-Z. F.), and 31971042 (Y. T.), Natural Science Foundation of Jiangsu Province (BK20202002 to Y. Y.), Innovation and Entrepreneurship Talent Program of Jiangsu Province (Y. Y. and J. W.), Open Project of State Key Laboratory of Natural Medicines (SKLNMZZRC201801 to Y. Y.), Hunan Provincial Natural Science Foundation of China (2018JJ1012 to Y. T.), Guangxi Funds for Distinguished Experts (Y. Y.), and State Key Laboratory of Utilization of Woody Oil Resource with grant number 2019XK2002 (C. L.).	Adler AI, 2000, BMJ-BRIT MED J, V321, P412, DOI 10.1136/bmj.321.7258.412; [Anonymous], 2015, Nat Rev Dis Primers, V1, P15039, DOI 10.1038/nrdp.2015.39; Baker RG, 2011, CELL METAB, V13, P11, DOI 10.1016/j.cmet.2010.12.008; Capdevila JH, 2014, J BIOL CHEM, V289, P4377, DOI 10.1074/jbc.M113.508416; Chen GM, 2011, HYPERTENSION, V57, P891, DOI 10.1161/HYPERTENSIONAHA.110.162446; Eaddy MT, 2008, CURR MED RES OPIN, V24, P2501, DOI 10.1185/03007990802297529 ; El-Sherbeni AA, 2014, ARCH TOXICOL, V88, P2013, DOI 10.1007/s00204-014-1371-y; Ferrannini E, 2012, LANCET, V380, P601, DOI 10.1016/S0140-6736(12)60987-8; Fu ML, 2021, MOL CELL ENDOCRINOL, V523, DOI 10.1016/j.mce.2020.111149; Guzik TJ, 2018, ANTIOXID REDOX SIGN, V29, P257, DOI 10.1089/ars.2017.7299; Han HJ, 2005, J CELL PHYSIOL, V202, P246, DOI 10.1002/jcp.20108; Heerspink HJL, 2016, CIRCULATION, V134, P752, DOI 10.1161/CIRCULATIONAHA.116.021887; Hummel CS, 2011, AM J PHYSIOL-CELL PH, V300, pC14, DOI 10.1152/ajpcell.00388.2010; Imig JD, 2005, HYPERTENSION, V46, P975, DOI 10.1161/01.HYP.0000176237.74820.75; Imig JD, 2020, HYPERTENSION, V76, P3, DOI 10.1161/HYPERTENSIONAHA.120.13898; Kabakov Emma, 2006, J Cardiometab Syndr, V1, P95, DOI 10.1111/j.1559-4564.2006.05513.x; Khan MAH, 2013, HYPERTENSION, V62, P905, DOI 10.1161/HYPERTENSIONAHA.113.01949; Koepsell H, 2017, PHARMACOL THERAPEUT, V170, P148, DOI 10.1016/j.pharmthera.2016.10.017; LAETHEM RM, 1993, J BIOL CHEM, V268, P12912; Lastra G, 2014, ENDOCRIN METAB CLIN, V43, P103, DOI 10.1016/j.ecl.2013.09.005; Lee YJ, 2007, AM J PHYSIOL-RENAL, V293, pF1036, DOI 10.1152/ajprenal.00034.2007; Li R, 2015, AM J PHYSIOL-ENDOC M, V308, pE270, DOI 10.1152/ajpendo.00118.2014; Lu XH, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0903-x; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; Merkel MJ, 2010, AM J PHYSIOL-HEART C, V298, pH679, DOI 10.1152/ajpheart.00533.2009; Muntner P, 2018, DIABETES CARE, V41, P2322, DOI 10.2337/dc18-1307; Olearczyk JJ, 2009, CLIN SCI, V116, P61, DOI 10.1042/CS20080039; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Pavlov TS, 2011, AM J PHYSIOL-RENAL, V301, pF672, DOI 10.1152/ajprenal.00597.2010; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Rahmoune H, 2005, DIABETES, V54, P3427, DOI 10.2337/diabetes.54.12.3427; Rang H., 2011, PROSTAG OTH LIPID M, V98, P93; Sabolic I, 2012, AM J PHYSIOL-CELL PH, V302, pC1174, DOI 10.1152/ajpcell.00450.2011; Shen HC, 2010, EXPERT OPIN THER PAT, V20, P941, DOI 10.1517/13543776.2010.484804; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Tornatore L, 2012, TRENDS CELL BIOL, V22, P557, DOI 10.1016/j.tcb.2012.08.001; Vallon V, 2015, ANNU REV MED, V66, P255, DOI 10.1146/annurev-med-051013-110046; Vallon V, 2012, ANNU REV PHYSIOL, V74, P351, DOI 10.1146/annurev-physiol-020911-153333; Wan EYF, 2018, DIABETES CARE, V41, P1134, DOI 10.2337/dc17-2443; Wei Y, 2004, J GEN PHYSIOL, V124, P719, DOI 10.1085/jgp.200409140; Wright EM, 2004, PFLUG ARCH EUR J PHY, V447, P510, DOI 10.1007/s00424-003-1063-6; Xu XZ, 2010, DIABETES, V59, P997, DOI 10.2337/db09-1241; Yang HH, 2020, THERANOSTICS, V10, P4749, DOI 10.7150/thno.43108; Yang Y, 2018, AGING CELL, V17, DOI 10.1111/acel.12718; Zelniker TA, 2018, J AM COLL CARDIOL, V72, P1845, DOI 10.1016/j.jacc.2018.06.040; Zhang DH, 2012, CIRC RES, V110, P808, DOI 10.1161/CIRCRESAHA.111.259325; Zhang LN, 2011, EUR J PHARMACOL, V654, P68, DOI 10.1016/j.ejphar.2010.12.016; Zuloaga KL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097529	48	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100655	10.1016/j.jbc.2021.100655	http://dx.doi.org/10.1016/j.jbc.2021.100655			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33901491	gold, Green Published			2022-12-28	WOS:000672866400626
J	Joswig, JO; Anders, J; Zhang, HX; Rademacher, C; Keller, BG				Joswig, Jan-O; Anders, Jennifer; Zhang, Hengxi; Rademacher, Christoph; Keller, Bettina G.			The molecular basis for the pH-dependent calcium affinity of the pattern recognition receptor langerin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	The C-type lectin receptor langerin plays a vital role in the mammalian defense against invading pathogens. Langerin requires a Ca2+ cofactor, the binding affinity of which is regulated by pH. Thus, Ca2+ is bound when langerin is on the membrane but released when langerin and its pathogen substrate traffic to the acidic endosome, allowing the substrate to be degraded. The change in pH is sensed by protonation of the allosteric pH sensor histidine H294. However, the mechanism by which Ca2+ is released from the buried binding site is not clear. We studied the structural consequences of protonating H294 by molecular dynamics simulations (total simulation time: about 120 mu s) and Markov models. We discovered a relay mechanism in which a proton is moved into the vicinity of the Ca2+-binding site without transferring the initial proton from H294. Protonation of H294 unlocks a conformation in which a protonated lysine side chain forms a hydrogen bond with a Ca2+-coordinating aspartic acid. This destabilizes Ca2+ in the binding pocket, which we probed by steered molecular dynamics. After Ca2+ release, the proton is likely transferred to the aspartic acid and stabilized by a dyad with a nearby glutamic acid, triggering a conformational transition and thus preventing Ca2+ rebinding. These results show how pH regulation of a buried orthosteric binding site from a solvent-exposed allosteric pH sensor can be realized by information transfer through a specific chain of conformational arrangements.	[Joswig, Jan-O; Anders, Jennifer; Zhang, Hengxi; Rademacher, Christoph; Keller, Bettina G.] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Zhang, Hengxi; Rademacher, Christoph] Max Planck Inst Colloids & Interfaces, Dept Biomol Syst, Potsdam, Germany; [Zhang, Hengxi; Rademacher, Christoph] Univ Vienna, Dept Pharmaceut Chem, Vienna, Austria; [Zhang, Hengxi; Rademacher, Christoph] Univ Vienna, Dept Microbiol & Immunobiol, Max F Perutz Labs, Vienna, Austria	Free University of Berlin; Max Planck Society; University of Vienna; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	Keller, BG (corresponding author), Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany.	bettina.keller@fu-berlin.de	Rademacher, Christoph/H-3101-2012; Keller, Bettina G./B-7834-2011	Rademacher, Christoph/0000-0001-7082-7239; Keller, Bettina G./0000-0002-7051-0888; Anders, Jennifer/0000-0001-6941-2001; Kapp-Joswig, Jan-Oliver/0000-0003-1492-3757	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [390540038, CRC 765, DFG RA1944/6-1]; Max Planck Society	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); Max Planck Society(Max Planck SocietyFoundation CELLEX)	Funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy -EXC 2008 -390540038 -UniSysCat. The authors thank the North-German Supercomputing Alliance (HLRN), the Paderborn Center for Parallel Computing PC2, and the ZEDAT of the FU Berlin for computing time. Also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) through CRC 765, and DFG RA1944/6-1. We thank the Max Planck Society for support.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	4	3	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100718	10.1016/j.jbc.2021.100718	http://dx.doi.org/10.1016/j.jbc.2021.100718			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33989634	gold, Green Published			2022-12-28	WOS:000672866400688
J	Kodera, N; Abe, H; Nguyen, PDN; Ono, S				Kodera, Noriyuki; Abe, Hiroshi; Nguyen, Phuong Doan N.; Ono, Shoichiro			Native cyclase-associated protein and actin from Xenopus laevis oocytes form a unique 4:4 complex with a tripartite structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENYLATE-CYCLASE; COFILIN; MECHANISM; DYNAMICS; DOMAIN; CAP2; TURNOVER; SRV2/CAP; MONOMERS	Cyclase-associated protein (CAP) is a conserved actinbinding protein that regulates multiple aspects of actin dynamics, including polymerization, depolymerization, filament severing, and nucleotide exchange. CAP has been isolated from different cells and tissues in an equimolar complex with actin, and previous studies have shown that a CAP-actin complex contains six molecules each of CAP and actin. Intriguingly, here, we successfully isolated a complex of Xenopus cyclaseassociated protein 1 (XCAP1) with actin from oocyte extracts, which contained only four molecules each of XCAP1 and actin. This XCAP1-actin complex remained stable as a single population of 340 kDa species during hydrodynamic analyses using gel filtration or analytical ultracentrifugation. Examination of the XCAP1-actin complex by high-speed atomic force microscopy revealed a tripartite structure: one middle globular domain and two globular arms. The two arms were observed in high and low states. The arms at the high state were spontaneously converted to the low state by dissociation of actin from the complex. However, when extra Gactin was added, the arms at the low state were converted to the high state. Based on the known structures of the N-terminal helical-folded domain and C-terminal CARP domain, we hypothesize that the middle globular domain corresponds to a tetramer of the N-terminal helical-folded domain of XCAP1 and that each arm in the high state corresponds to a heterotetramer containing a dimer of the C-terminal CARP domain of XCAP1 and two G-actin molecules. This novel configuration of a CAP-actin complex should help to understand how CAP promotes actin filament disassembly.	[Kodera, Noriyuki; Nguyen, Phuong Doan N.] Kanazawa Univ, WPI Nano Life Sci Inst, Kanazawa, Ishikawa, Japan; [Abe, Hiroshi] Chiba Univ, Grad Sch Sci, Dept Biol, Chiba, Japan; [Ono, Shoichiro] Emory Univ, Sch Med, Dept Pathol & Cell Biol, Atlanta, GA 30322 USA; [Ono, Shoichiro] Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Kanazawa University; Chiba University; Emory University; Emory University	Ono, S (corresponding author), Emory Univ, Sch Med, Dept Pathol & Cell Biol, Atlanta, GA 30322 USA.; Ono, S (corresponding author), Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA.	sono@emory.edu	Kodera, Noriyuki/AAJ-1797-2020; Ono, Shoichiro/A-6475-2015; Kodera, Noriyuki/E-6569-2015	Ono, Shoichiro/0000-0002-4763-0398; Kodera, Noriyuki/0000-0003-4880-8423	JST CREST [JPMJCR1762]; JSPS KAKENHI Grant [20H00327]; National Institutes of Health [R01AR048615]; JSPS Bridge Award	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); JSPS KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JSPS Bridge Award	This work was supported by grants from JST CREST (JPMJCR1762) to N. K., JSPS KAKENHI Grant (20H00327) to N. K., and the National Institutes of Health (R01AR048615) to S. O. S. O. is a recipient of a JSPS Bridge Award. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898; Ando T, 2008, PROG SURF SCI, V83, P337, DOI 10.1016/j.progsurf.2008.09.001; ANKENBAUER T, 1988, J CELL BIOL, V107, P1489, DOI 10.1083/jcb.107.4.1489; Aspit L, 2019, J MED GENET, V56, P228, DOI 10.1136/jmedgenet-2018-105498; Balcer HI, 2003, CURR BIOL, V13, P2159, DOI 10.1016/S0960-9822(03)00907-2; Bertling E, 2007, J CELL SCI, V120, P1225, DOI 10.1242/jcs.000158; Chaudhry F, 2013, MOL BIOL CELL, V24, P31, DOI 10.1091/mbc.E12-08-0589; Chaudhry F, 2010, CYTOSKELETON, V67, P120, DOI 10.1002/cm.20429; Demeler Borries, 2010, Curr Protoc Protein Sci, VChapter 7, DOI 10.1002/0471140864.ps0713s60; Dodatko T, 2004, BIOCHEMISTRY-US, V43, P10628, DOI 10.1021/bi049071r; FEDORCHAIKEN M, 1990, CELL, V61, P329, DOI 10.1016/0092-8674(90)90813-T; FIELD J, 1990, CELL, V61, P319, DOI 10.1016/0092-8674(90)90812-S; Field J, 2015, SCI REP-UK, V5, DOI 10.1038/srep17256; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; FREEMAN NL, 1995, J BIOL CHEM, V270, P5680, DOI 10.1074/jbc.270.10.5680; Freeman NL, 1996, MOL CELL BIOL, V16, P548; GIESELMANN R, 1992, FEBS LETT, V298, P149, DOI 10.1016/0014-5793(92)80043-G; Hilton DM, 2018, J MOL BIOL, V430, P3323, DOI 10.1016/j.jmb.2018.06.025; Iwase S, 2017, CYTOSKELETON, V74, P343, DOI 10.1002/cm.21385; Iwase S, 2016, BIOCHEM J, V473, P4427, DOI 10.1042/BCJ20160329; Jansen S, 2014, J BIOL CHEM, V289, P30732, DOI 10.1074/jbc.M114.601765; Johnston AB, 2015, NAT CELL BIOL, V17, P1504, DOI 10.1038/ncb3252; Kepser LJ, 2019, P NATL ACAD SCI USA, V116, P8397, DOI 10.1073/pnas.1813351116; KhosrowShahian F, 2002, MECH DEVELOP, V113, P211, DOI 10.1016/S0925-4773(02)00033-3; Kotila T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13213-2; Kotila T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04231-7; Lila T, 1997, MOL BIOL CELL, V8, P367, DOI 10.1091/mbc.8.2.367; Makkonen M, 2013, J BIOL CHEM, V288, P984, DOI 10.1074/jbc.M112.435719; Mattila PK, 2004, MOL BIOL CELL, V15, P5158, DOI 10.1091/mbc.E04-06-0444; Moriyama K, 2002, J CELL SCI, V115, P1591; Mu A, 2020, P NATL ACAD SCI USA, V117, P439, DOI 10.1073/pnas.1914072117; Mu A, 2019, NAT CELL BIOL, V21, P592, DOI 10.1038/s41556-019-0307-4; Ngo KX, 2015, ELIFE, V4, DOI 10.7554/eLife.04806; Nomura K, 2013, BIOCHEM J, V453, P249, DOI 10.1042/BJ20130491; Nomura K, 2012, J CELL SCI, V125, P4077, DOI 10.1242/jcs.104950; Normoyle KPM, 2012, J BIOL CHEM, V287, P35722, DOI 10.1074/jbc.M112.396051; Okada K, 1999, J CELL SCI, V112, P1553; Ono S, 2013, J CELL SCI, V126, P3249, DOI 10.1242/jcs.128231; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Peche V, 2007, CELL MOL LIFE SCI, V64, P2702, DOI 10.1007/s00018-007-7316-3; POLLARD TD, 1992, J BIOL CHEM, V267, P20339; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Purde V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225647; Quintero-Monzon O, 2009, J BIOL CHEM, V284, P10923, DOI 10.1074/jbc.M808760200; Rust MB, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.586631; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shekhar S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13268-1; Shibata M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01466-8; Uchihashi T, 2012, NAT PROTOC, V7, P1193, DOI 10.1038/nprot.2012.047; Wloclawer A., 2005, PROTEINS, V58, P262; Yusof AM, 2006, J MOL BIOL, V362, P1072, DOI 10.1016/j.jmb.2006.08.008; Zhang HT, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00282-19; Zhou GL, 2014, J CELL SCI, V127, P5052, DOI 10.1242/jcs.156059	53	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100649	10.1016/j.jbc.2021.100649	http://dx.doi.org/10.1016/j.jbc.2021.100649			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839148	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400620
J	Sato, K; Watamura, N; Fujioka, R; Mihira, N; Sekiguchi, M; Nagata, K; Ohshima, T; Saito, T; Saido, TC; Sasaguri, H				Sato, Kaori; Watamura, Naoto; Fujioka, Ryo; Mihira, Naomi; Sekiguchi, Misaki; Nagata, Kenichi; Ohshima, Toshio; Saito, Takashi; Saido, Takaomi C.; Sasaguri, Hiroki			A third-generation mouse model of Alzheimer's disease shows early and increased cored plaque pathology composed of wild-type human amyloid beta peptide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A-BETA; TRANSMEMBRANE DOMAIN; PRECURSOR PROTEIN; APP; DEPOSITION; CLEAVAGE; MUTATION; BRAIN; HYPOTHESIS; MECHANISM	We previously developed single App knock-in mouse models of Alzheimer's disease (AD) harboring the Swedish and Beyreuther/Iberian mutations with or without the Arctic mutation (AppNL-G-F and AppNL-F mice, respectively). These models showed AP pathology, neuroinflammation, and cognitive impairment in an age-dependent manner. The former model exhibits extensive pathology as early as 6 months, but is unsuitable for investigating AP metabolism and clearance because the Arctic mutation renders AP resistant to proteolytic degradation and prone to aggregation. In particular, it is inapplicable to preclinical immunotherapy studies due to its discrete affinity for anti-AP antibodies. The latter model may take as long as 18 months for the pathology to become prominent, which leaves an unfulfilled need for an Alzheimer's disease animal model that is both swift to show pathology and useful for antibody therapy. We thus utilized mutant Psen1 knock-in mice into which a pathogenic mutation (P117L) had been introduced to generate a new model that exhibits early deposition of wild-type human AP by crossbreeding the AppNL-F line with the Psen1P117L/WT line. We show that the effects of the pathogenic mutations in the App and Psen1 genes are additive or synergistic. This new third-generation mouse model showed more cored plaque pathology and neuroinflammation than AppNL-G-F mice and will help accelerate the development of disease-modifying therapies to treat preclinical AD.	[Sato, Kaori; Watamura, Naoto; Fujioka, Ryo; Mihira, Naomi; Sekiguchi, Misaki; Saido, Takaomi C.; Sasaguri, Hiroki] RIKEN Ctr Brain Sci, Lab Proteolyt Neurosci, Wako, Saitama, Japan; [Sato, Kaori; Ohshima, Toshio] Waseda Univ, Dept Life Sci & Med Biosci, Lab Mol Brain Sci, Shinjuku Ku, Tokyo, Japan; [Nagata, Kenichi] Nagoya Univ, Grad Sch Med, Dept Funct Anat & Neurosci, Nagoya, Aichi, Japan; [Saito, Takashi] Nagoya City Univ, Grad Sch Med Sci, Inst Brain Sci, Dept Neurocognit Sci, Nagoya, Aichi, Japan	RIKEN; Waseda University; Nagoya University; Nagoya City University	Saido, TC; Sasaguri, H (corresponding author), RIKEN Ctr Brain Sci, Lab Proteolyt Neurosci, Wako, Saitama, Japan.	takaomi.saido@riken.jp; hiroki.sasaguri@riken.jp	; Saido, Takaomi/N-5472-2015; Saito, Takashi/G-2563-2015	Nagata, Kenichi/0000-0001-8377-7197; Saido, Takaomi/0000-0003-1970-6903; Watamura, Naoto/0000-0001-7971-7378; Saito, Takashi/0000-0002-9659-9251	AMED [JP20dm0207001]; JSPS KAKENHI [JP18K07402]	AMED; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by AMED under Grant Number JP20dm0207001 (Brain Mapping by Integrated Neurotechnologies for Disease Studies (Brain/MINDS)) (T. C. S.) and JSPS KAKENHI Grant Number JP18K07402 (H. S.).	Boon BDC, 2020, ACTA NEUROPATHOL, V140, P811, DOI 10.1007/s00401-020-02198-8; Chen WT, 2020, CELL, V182, P976, DOI 10.1016/j.cell.2020.06.038; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; Enya M, 1999, AM J PATHOL, V154, P271, DOI 10.1016/S0002-9440(10)65273-X; Flood DG, 2002, NEUROBIOL AGING, V23, P335, DOI 10.1016/S0197-4580(01)00330-X; Fukumoto H, 1996, AM J PATHOL, V148, P259; Gamache J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10428-1; Hashimoto S, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10278-x; Hashimoto S, 2018, J BIOL CHEM, V293, P3118, DOI 10.1074/jbc.M117.811315; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; Higuchi M, 2012, FASEB J, V26, P1204, DOI 10.1096/fj.11-187740; Hongo N, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00307; IWATSUBO T, 1994, NEURON, V13, P45, DOI 10.1016/0896-6273(94)90458-8; Jun H, 2020, NEURON, V107, P1095, DOI 10.1016/j.neuron.2020.06.023; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Kwart D, 2019, NEURON, V104, P256, DOI 10.1016/j.neuron.2019.07.010; Lewcock JW, 2020, NEURON, V108, P801, DOI 10.1016/j.neuron.2020.09.029; Li HM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-28; Lichtenthaler SF, 1999, P NATL ACAD SCI USA, V96, P3053, DOI 10.1073/pnas.96.6.3053; Morishima-Kawashima M, 2000, AM J PATHOL, V157, P2093, DOI 10.1016/S0002-9440(10)64847-X; Nalivaeva NN, 2014, FRONT AGING NEUROSCI, V6, DOI [10.3389/tnagi.2014.00235, 10.3389/fnagi.2014.00235]; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; Nortley R, 2019, SCIENCE, V365, P250, DOI 10.1126/science.aav9518; Podlesny-Drabiniok A, 2020, TRENDS NEUROSCI, V43, P965, DOI 10.1016/j.tins.2020.10.002; Qi-Takahara Y, 2005, J NEUROSCI, V25, P436, DOI 10.1523/JNEUROSCI.1575-04.2005; Qin Q, 2021, MECH AGEING DEV, V195, DOI 10.1016/j.mad.2021.111438; Ruiz-Riquelme A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-021-01187-6; Saido TC, 2006, NEUROSCI RES, V54, P235, DOI 10.1016/j.neures.2005.12.015; SAIDO TC, 1994, J BIOL CHEM, V269, P15253; Saito T, 2005, NAT MED, V11, P434, DOI 10.1038/nm1206; Saito T, 2019, J BIOL CHEM, V294, P12754, DOI 10.1074/jbc.RA119.009487; Saito T, 2016, J NEUROSCI, V36, P9933, DOI 10.1523/JNEUROSCI.1907-16.2016; Saito T, 2011, NAT NEUROSCI, V14, P1023, DOI 10.1038/nn.2858; Sasaguri H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05262-w; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Sato K, 2004, EUR J MED CHEM, V39, P573, DOI 10.1016/j.ejmech.2004.02.013; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Shimojo M, 2008, J BIOL CHEM, V283, P16488, DOI 10.1074/jbc.M801279200; Shirotani K, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43535-6; Sobue A, 2021, ACTA NEUROPATHOL COM, V9, DOI 10.1186/s40478-020-01099-x; Sutoko S, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102198; Takami M, 2009, J NEUROSCI, V29, P13042, DOI 10.1523/JNEUROSCI.2362-09.2009; Thal DR, 2002, NEUROLOGY, V58, P1791, DOI 10.1212/WNL.58.12.1791; Tsubuki S, 2003, LANCET, V361, P1957, DOI 10.1016/S0140-6736(03)13555-6; Uruno A, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00467-19	50	7	7	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101004	10.1016/j.jbc.2021.101004	http://dx.doi.org/10.1016/j.jbc.2021.101004			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34329683	Green Published, gold			2022-12-28	WOS:000706418900011
J	Guengerich, FP; McCarty, KD; Chapman, JG; Tateishi, Y				Guengerich, F. Peter; McCarty, Kevin D.; Chapman, Jesse G.; Tateishi, Yasuhiro			Stepwise binding of inhibitors to human cytochrome P450 17A1 and rapid kinetics of inhibition of androgen biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESISTANT PROSTATE-CANCER; ORTERONEL TAK-700; INDUCED-FIT; 17,20-LYASE INHIBITOR; DANSYL HYDRAZINE; KETOCONAZOLE; CASTRATION; MECHANISM; STEROIDS; THERAPY	Cytochrome P450 (P450) 17A1 catalyzes the 17 alpha-hydroxyl-ation of progesterone and pregnenolone as well as the subse-quent lyase cleavage of both products to generate androgens. However, the selective inhibition of the lyase reactions, particularly with 17 alpha-hydroxy pregnenolone, remains a challenge for the treatment of prostate cancer. Here, we considered the mechanisms of inhibition of drugs that have been devel-oped to inhibit P450 17A1, including ketoconazole, seviteronel, orteronel, and abiraterone, the only approved inhibitor used for prostate cancer therapy, as well as clotrimazole, known to inhibit P450 17A1. All five compounds bound to P450 17A1 in a multistep process, as observed spectrally, over a period of 10 to 30 s. However, no lags were observed for the onset of inhibition in rapid-quench experiments with any of these five compounds. Furthermore, the addition of substrate to inhibitor-P450 17A1 complexes led to an immediate formation of product, without a lag that could be attributed to conformational changes. Although abiraterone has been previously described as showing slow-onset inhibition (t(1/2) = 30 min), we observed rapid and strong inhibition. These results are in contrast to inhibitors of P450 3A4, an enzyme with a larger active site in which complete inhibition is not observed with ketoconazole and clotrimazole until the changes are completed. Overall, our results indicate that both P450 17A1 reactions-17 alpha-hydroxylation and lyase activity-are inhibited by the initial binding of any of these inhibitors, even though subsequent conformational changes occur.	[Guengerich, F. Peter; McCarty, Kevin D.; Chapman, Jesse G.; Tateishi, Yasuhiro] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu		McCarty, Kevin/0000-0003-0027-9120; Tateishi, Yasuhiro/0000-0003-1884-014X; Chapman, Jesse G/0000-0002-3104-1310	National Institutes of Health [R01 GM118122]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the National Institutes of Health grant R01 GM118122 (F. P. G.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Appelblad P, 1997, ANAL CHEM, V69, P4905, DOI 10.1021/ac9702958; Auchus R. J., 2015, CYTOCHROME P450 STRU, P851; Auchus RJ, 2017, J STEROID BIOCHEM, V165, P71, DOI 10.1016/j.jsbmb.2016.02.002; AYUB M, 1989, J STEROID BIOCHEM, V32, P515, DOI 10.1016/0022-4731(89)90384-1; Bird IM, 2016, J STEROID BIOCHEM, V163, P136, DOI 10.1016/j.jsbmb.2016.04.021; Boxenbaum H, 1999, J PHARM PHARM SCI, V2, P47; BROWN MW, 1985, CLIN PHARMACOL THER, V37, P290, DOI 10.1038/clpt.1985.42; Burris-Hiday SD, 2021, MOL CELL ENDOCRINOL, V528, DOI 10.1016/j.mce.2021.111261; CHAYEN R, 1971, ANAL BIOCHEM, V42, P283, DOI 10.1016/0003-2697(71)90037-6; Cheong EJY, 2020, J PHARMACOL EXP THER, V374, P438, DOI 10.1124/jpet.120.265868; Child SA, 2020, J MED CHEM, V63, P6513, DOI 10.1021/acs.jmedchem.9b01849; DECOSTER R, 1986, CLIN ENDOCRINOL, V24, P657; DeVore NM, 2012, NATURE, V482, P116, DOI 10.1038/nature10743; Ekroos M, 2006, P NATL ACAD SCI USA, V103, P13682, DOI 10.1073/pnas.0603236103; Eng H, 2021, DRUG METAB DISPOS, V49, P442, DOI 10.1124/dmd.121.000356; Estrada DF, 2014, J BIOL CHEM, V289, P14310, DOI 10.1074/jbc.M114.560144; Fehl C, 2018, J MED CHEM, V61, P4946, DOI 10.1021/acs.jmedchem.8b00419; Fizazi K, 2015, J CLIN ONCOL, V33, P723, DOI 10.1200/JCO.2014.56.5119; Garrido M, 2014, J STEROID BIOCHEM, V143, P1, DOI 10.1016/j.jsbmb.2014.01.013; Geller DH, 1999, MOL ENDOCRINOL, V13, P167, DOI 10.1210/me.13.1.167; Gianni S, 2014, BIOPHYS CHEM, V189, P33, DOI 10.1016/j.bpc.2014.03.003; Gonzalez E, 2017, J BIOL CHEM, V292, P13168, DOI 10.1074/jbc.M117.794917; Guengerich F. P, 2020, J BIOL CHEM, V296; Guengerich F.P., 2015, CYTOCHROME P450 STRU, P523, DOI [10.1007/978-3-319-12108-6, DOI 10.1007/978-3-319-12108-6]; Guengerich FP, 2021, ACS CATAL, V11, P639, DOI 10.1021/acscatal.0c04455; Guengerich FP, 2020, ACS CATAL, V10, P5008, DOI 10.1021/acscatal.0c00677; Guengerich FP, 2019, DRUG METAB DISPOS, V47, P1232, DOI 10.1124/dmd.119.088732; Guengerich FP, 2019, J BIOL CHEM, V294, P10928, DOI 10.1074/jbc.RA119.009305; Guengerich FP, 2019, J BIOL CHEM, V294, P10028, DOI 10.1074/jbc.RA119.008860; Guengerich FP, 2014, HAYES' PRINCIPLES AND METHODS OF TOXICOLOGY, 6TH EDITION, P1905; Guengerich FP, 2005, ARCH BIOCHEM BIOPHYS, V440, P204, DOI 10.1016/j.abb.2005.06.019; Hanna IH, 1998, ARCH BIOCHEM BIOPHYS, V350, P324, DOI 10.1006/abbi.1997.0534; HONIG PK, 1993, JAMA-J AM MED ASSOC, V269, P1513, DOI 10.1001/jama.269.12.1513; Huggins C, 1940, J UROLOGY, V43, P705, DOI 10.1016/S0022-5347(17)71453-X; Isin EM, 2007, J BIOL CHEM, V282, P6863, DOI 10.1074/jbc.M610346200; Jarman M, 1998, J MED CHEM, V41, P5375, DOI 10.1021/jm981017j; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Kaku T, 2011, BIOORGAN MED CHEM, V19, P6383, DOI 10.1016/j.bmc.2011.08.066; Kim D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100571; Krug SJ, 2013, J STEROID BIOCHEM, V134, P75, DOI 10.1016/j.jsbmb.2012.10.019; Madan RA, 2020, CLIN GENITOURIN CANC, V18, P258, DOI 10.1016/j.clgc.2019.11.002; Munkboel CH, 2019, TOXICOLOGY, V425, DOI 10.1016/j.tox.2019.152247; Petrunak EM, 2017, DRUG METAB DISPOS, V45, P635, DOI 10.1124/dmd.117.075317; Petrunak EM, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.610998; PONT A, 1982, ANN INTERN MED, V97, P370, DOI 10.7326/0003-4819-97-3-370; Rice MA, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00801; SCHENKMAN JB, 1967, MOL PHARMACOL, V3, P113; Segel I.H., 1975, ENZYME KINETICS; Sevrioukova IF, 2015, BIOCHEMISTRY-US, V54, P4083, DOI 10.1021/acs.biochem.5b00510; Sevrioukova IF, 2012, ARCH BIOCHEM BIOPHYS, V520, P108, DOI 10.1016/j.abb.2012.02.018; SILVERMAN RB, 1995, METHOD ENZYMOL, V249, P240; SONINO N, 1987, NEW ENGL J MED, V317, P812, DOI 10.1056/NEJM198709243171307; Visser SAG, 2000, J CHROMATOGR B, V745, P357, DOI 10.1016/S0378-4347(00)00296-6; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Williams PA, 2004, SCIENCE, V305, P683, DOI 10.1126/science.1099736; Yamaoka M, 2012, J STEROID BIOCHEM, V129, P115, DOI 10.1016/j.jsbmb.2012.01.001; Yano JK, 2004, J BIOL CHEM, V279, P38091, DOI 10.1074/jbc.C400293200; Yoshimoto FK, 2016, J BIOL CHEM, V291, P17143, DOI 10.1074/jbc.M116.732966; YUN CH, 1993, DRUG METAB DISPOS, V21, P403; Zimmerlin A, 2011, DRUG METAB DISPOS, V39, P1039, DOI 10.1124/dmd.110.037911	60	2	2	1	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100969	10.1016/j.jbc.2021.100969	http://dx.doi.org/10.1016/j.jbc.2021.100969			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34273352	gold, Green Published			2022-12-28	WOS:000690871400007
J	Heitmann, ASB; Zanjani, AAH; Klenow, MB; Mularski, A; Sonder, SL; Lund, FW; Boye, TL; Dias, C; Bendix, PM; Simonsen, AC; Khandelia, H; Nylandsted, J				Heitmann, Anne Sofie Busk; Zanjani, Ali Asghar Hakami; Klenow, Martin Berg; Mularski, Anna; Sonder, Stine Lauritzen; Lund, Frederik Wendelboe; Boye, Theresa Louise; Dias, Catarina; Bendix, Poul Martin; Simonsen, Adam Cohen; Khandelia, Himanshu; Nylandsted, Jesper			Phenothiazines alter plasma membrane properties and sensitize cancer cells to injury by inhibiting annexin-mediated repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID-BILAYER; CHARMM; GUI; TRIFLUOPERAZINE; PHOSPHATIDYLCHOLINE; PHARMACOKINETICS; PROCHLORPERAZINE; SIMULATIONS; CALCIUM; GROMACS	Repair of damaged plasma membrane in eukaryotic cells is largely dependent on the binding of annexin repair proteins to phospholipids. Changing the biophysical properties of the plasma membrane may provide means to compromise annexinmediated repair and sensitize cells to injury. Since, cancer cells experience heightened membrane stress and are more dependent on efficient plasma membrane repair, inhibiting repair may provide approaches to sensitize cancer cells to plasma membrane damage and cell death. Here, we show that derivatives of phenothiazines, which have widespread use in the fields of psychiatry and allergy treatment, strongly sensitize cancer cells to mechanical-, chemical-, and heat-induced injury by inhibiting annexin-mediated plasma membrane repair. Using a combination of cell biology, biophysics, and computer simulations, we show that trifluoperazine acts by thinning the membrane bilayer, making it more fragile and prone to ruptures. Secondly, it decreases annexin binding by compromising the lateral diffusion of phosphatidylserine, inhibiting the ability of annexins to curve and shape membranes, which is essential for their function in plasma membrane repair. Our results reveal a novel avenue to target cancer cells by compromising plasma membrane repair in combination with noninvasive approaches that induce membrane injuries.	[Heitmann, Anne Sofie Busk; Sonder, Stine Lauritzen; Boye, Theresa Louise; Dias, Catarina; Nylandsted, Jesper] Danish Canc Soc, Membrane Integr, Res Ctr, Copenhagen, Denmark; [Zanjani, Ali Asghar Hakami; Klenow, Martin Berg; Mularski, Anna; Lund, Frederik Wendelboe; Simonsen, Adam Cohen; Khandelia, Himanshu] Univ Southern Denmark, PHYLIFE Phys Life Sci, Dept Phys Chem & Pharm, Odense M, Denmark; [Bendix, Poul Martin] Univ Copenhagen, Fac Hlth Sci, Niels Bohr Inst, Copenhagen, Denmark; [Nylandsted, Jesper] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark	Danish Cancer Society; University of Southern Denmark; University of Copenhagen; Niels Bohr Institute; University of Copenhagen	Nylandsted, J (corresponding author), Danish Canc Soc, Membrane Integr, Res Ctr, Copenhagen, Denmark.; Nylandsted, J (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen, Denmark.	jnl@cancer.dk	Nylandsted, Jesper/ABE-7192-2021	Hakami Zanjani, Ali Asghar/0000-0002-0206-9074; Khandelia, Himanshu/0000-0001-9913-6394; Simonsen, Adam Cohen/0000-0003-1937-8524; Nylandsted, Jesper/0000-0001-6474-5093; Boye, Theresa Louise/0000-0001-6260-6954; Berg Klenow, Martin/0000-0002-2045-8583; Lauritzen Sonder, Stine/0000-0001-5551-4461; Dias, Catarina/0000-0002-1746-4384	Novo Nordisk Foundation Interdisciplinary Synergy Grant [NNF18OC0034936]; Danish Council for Independent Research Natural Sciences [9040-00252B]; Scientific Committee Danish Cancer Society [R90-A5847-14-S2]; PRACE project [2016153468]; PRACE aisbl; Novo Nordisk Foundation	Novo Nordisk Foundation Interdisciplinary Synergy Grant; Danish Council for Independent Research Natural Sciences(Det Frie Forskningsrad (DFF)); Scientific Committee Danish Cancer Society; PRACE project; PRACE aisbl; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	This study was supported by the Novo Nordisk Foundation Interdisciplinary Synergy Grant (NNF18OC0034936), the Danish Council for Independent Research Natural Sciences (9040-00252B), and Scientific Committee Danish Cancer Society (R90-A5847-14-S2). The simulations were carried out on the Danish e-Infrastructure Cooperation National HPC Center, on ABACUS 2.0 at the University of Southern Denmark, SDU, and on computing resources on the Swiss cluster Piz Daint as part of a PRACE project (grant number 2016153468). We also acknowledge that the results of this research have been achieved using the DECI resource Kay based in Ireland at ICHEC with support from the PRACE aisbl. Part of the computations was carried out on the ROBUST resource for Biomolecular simulations with support from the Novo Nordisk Foundation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Anand A, 2019, MOL CANCER THER, V18, P1602, DOI 10.1158/1535-7163.MCT-18-1406; Andrews NW, 2014, TRENDS CELL BIOL, V24, P734, DOI 10.1016/j.tcb.2014.07.008; Bendix PM, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9041029; BERENDSEN HJC, 1995, COMPUT PHYS COMMUN, V91, P43, DOI 10.1016/0010-4655(95)00042-E; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BLACKWOOD RA, 1995, J LEUKOCYTE BIOL, V58, P114, DOI 10.1002/jlb.58.1.114; Bouter A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1270; Boye TL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28481-z; Boye TL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01743-6; Braga C, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2013227; Broniec A, 2007, LANGMUIR, V23, P694, DOI 10.1021/la061628b; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chamoun-Emanuelli AM, 2013, ANTIMICROB AGENTS CH, V57, P2571, DOI 10.1128/AAC.02593-12; Deng SS, 2013, ONCOL LETT, V5, P107, DOI 10.3892/ol.2012.959; Doktorova M, 2019, BIOPHYS J, V116, P487, DOI 10.1016/j.bpj.2018.12.016; Dornier E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06351-6; Drucker P, 2013, J BIOL CHEM, V288, P24764, DOI 10.1074/jbc.M113.474023; Duncan R, 2008, BRIT J CANCER, V98, P426, DOI 10.1038/sj.bjc.6604128; Ellegaard AM, 2016, EBIOMEDICINE, V9, P130, DOI 10.1016/j.ebiom.2016.06.013; Erejuwa OO, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/931251; Feng ZZ, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1046-3; Florentsen CD, 2021, SOFT MATTER, V17, P308, DOI 10.1039/d0sm00241k; FRENZEL J, 1978, BIOCHIM BIOPHYS ACTA, V507, P185, DOI 10.1016/0005-2736(78)90415-7; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Grek CL, 2010, CURR OPIN PHARMACOL, V10, P362, DOI 10.1016/j.coph.2010.05.003; Hakobyan D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185440; Hendrich AB, 2001, BBA-BIOMEMBRANES, V1510, P414, DOI 10.1016/S0005-2736(00)00373-4; Izadifar Z, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020460; Jaiswal JK, 2015, CELL CYCLE, V14, P502, DOI 10.1080/15384101.2014.995495; Jaiswal JK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4795; Jaszczyszyn A, 2012, PHARMACOL REP, V64, P16, DOI 10.1016/S1734-1140(12)70726-0; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000880; Jo S, 2009, BIOPHYS J, V97, P50, DOI 10.1016/j.bpj.2009.04.013; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Kok HP, 2020, INT J HYPERTHER, V37, P711, DOI 10.1080/02656736.2020.1779357; Kopec W, 2013, FEBS J, V280, P2785, DOI 10.1111/febs.12286; Lauritzen SP, 2015, SEMIN CELL DEV BIOL, V45, P32, DOI 10.1016/j.semcdb.2015.10.028; Lee J, 2019, J CHEM THEORY COMPUT, V15, P775, DOI 10.1021/acs.jctc.8b01066; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Li AM, 2020, FEBS OPEN BIO, V10, P2097, DOI 10.1002/2211-5463.12960; Liu L, 1997, ARCH BIOCHEM BIOPHYS, V342, P322, DOI 10.1006/abbi.1997.0140; Liu XY, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0392-y; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; Michalak K, 2006, CURR DRUG TARGETS, V7, P1095, DOI 10.2174/138945006778226570; Morgan RJ, 2001, CANCER CHEMOTH PHARM, V47, P327, DOI 10.1007/s002800000232; Mussunoor S, 2008, J PATHOL, V216, P131, DOI 10.1002/path.2400; NAHATA MC, 1992, J CLIN PHARM THER, V17, P121, DOI 10.1111/j.1365-2710.1992.tb01279.x; Ohlow MJ, 2011, DRUG DISCOV TODAY, V16, P119, DOI 10.1016/j.drudis.2011.01.001; PARRINELLO M, 1980, PHYS REV LETT, V45, P1196, DOI 10.1103/PhysRevLett.45.1196; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pavlova NN, 2016, CELL METAB, V23, P27, DOI 10.1016/j.cmet.2015.12.006; Perez-Isidoro R, 2020, CHEM PHYS LIPIDS, V229, DOI 10.1016/j.chemphyslip.2020.104913; Petersen NHT, 2013, CANCER CELL, V24, P379, DOI 10.1016/j.ccr.2013.08.003; Pezeshkian W, 2016, SOFT MATTER, V12, P5164, DOI 10.1039/c6sm00464d; Pezeshkian W, 2017, FEBS OPEN BIO, V7, P1638, DOI 10.1002/2211-5463.12321; Pulkoski-Gross A, 2015, MOL PHARMACOL, V87, P501, DOI 10.1124/mol.114.096941; Qi HB, 2015, ONCOL LETT, V10, P1947, DOI 10.3892/ol.2015.3498; Shao CH, 2006, J BIOL CHEM, V281, P31689, DOI 10.1074/jbc.M604502200; Sonder SL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43143-4; Stewart MP, 2018, CHEM REV, V118, P7409, DOI 10.1021/acs.chemrev.7b00678; Swaminathan V, 2011, CANCER RES, V71, P5075, DOI 10.1158/0008-5472.CAN-11-0247; Tang SKY, 2017, SCIENCE, V356, P1022, DOI 10.1126/science.aam6496; Wesolowska O., 2011, MOL MEMBR BIOL, V28, P103, DOI DOI 10.3109/09687688.2010.533706; Wu EL, 2014, J COMPUT CHEM, V35, P1997, DOI 10.1002/jcc.23702; Zhelev Z, 2004, CANCER CHEMOTH PHARM, V53, P267, DOI 10.1007/s00280-003-0738-1	69	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101012	10.1016/j.jbc.2021.101012	http://dx.doi.org/10.1016/j.jbc.2021.101012			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34324830	Green Published, gold			2022-12-28	WOS:000690868100004
J	Tooley, AS; Kazyken, D; Bodur, C; Gonzalez, IE; Fingar, DC				Tooley, Aaron Seth; Kazyken, Dubek; Bodur, Cagri; Gonzalez, Ian E.; Fingar, Diane C.			The innate immune kinase TBK1 directly increases mTORC2 activity and downstream signaling to Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-EPSILON; BINDING PARTNER; CELL-GROWTH; RAPAMYCIN; ACTIVATION; RICTOR; PHOSPHORYLATION; INHIBITION; COMPLEX; RAPTOR	TBK1 responds to microbes to initiate cellular responses critical for host innate immune defense. We found previously that TBK1 phosphorylates mTOR (mechanistic target of rapamycin) on S2159 to increase mTOR complex 1 (mTORC1) signaling in response to the growth factor EGF and the viral dsRNA mimetic poly(I:C). mTORC1 and the less well studied mTORC2 respond to diverse cues to control cellular metabolism, proliferation, and survival. Although TBK1 has been linked to Akt phosphorylation, a direct relationship between TBK1 and mTORC2, an Akt kinase, has not been described. By studying MEFs lacking TBK1, as well as MEFs, macrophages, and mice bearing an Mtor S2159A knock-in allele (MtorA/A) using in vitro kinase assays and cell-based approaches, we demonstrate here that TBK1 activates mTOR complex 2 (mTORC2) directly to increase Akt phosphorylation. We find that TBK1 and mTOR S2159 phosphorylation promotes mTOR-dependent phosphorylation of Akt in response to several growth factors and poly(I:C). Mechanistically, TBK1 coimmunoprecipitates with mTORC2 and phosphorylates mTOR S2159 within mTORC2 in cells. Kinase assays demonstrate that TBK1 and mTOR S2159 phosphorylation increase mTORC2 intrinsic catalytic activity. Growth factors failed to activate TBK1 or increase mTOR S2159 phosphorylation in MEFs. Thus, basal TBK1 activity cooperates with growth factors in parallel to increase mTORC2 (and mTORC1) signaling. Collectively, these results reveal cross talk between TBK1 and mTOR, key regulatory nodes within two major signaling networks. As TBK1 and mTOR contribute to tumorigenesis and metabolic disorders, these kinases may work together in a direct manner in a variety of physiological and pathological settings.	[Tooley, Aaron Seth; Kazyken, Dubek; Bodur, Cagri; Gonzalez, Ian E.; Fingar, Diane C.] Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Fingar, DC (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Med Sch, Ann Arbor, MI 48109 USA.	dfingar@umich.edu		Gonzalez, Ian/0000-0002-4571-909X	NIH [R01-DK-103877, R01-GM-137577]; American Diabetes Association (ADA) (Basic Science Grant) [1-12-BS-49]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association (ADA) (Basic Science Grant)	This work was supported by grants to D. C. F. from the NIH (R01-DK-103877; R01-GM-137577) and from the American Diabetes Association (ADA) (Basic Science Grant #1-12-BS-49). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Barbie TU, 2014, J CLIN INVEST, V124, P5411, DOI 10.1172/JCI75661; Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002; Bodur C, 2018, EMBO J, V37, P19, DOI 10.15252/embj.201696164; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Chimin P, 2017, J LIPID RES, V58, P1797, DOI 10.1194/jlr.M074518; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Clement JF, 2008, CELL RES, V18, P889, DOI 10.1038/cr.2008.273; Cooper JM, 2017, CANCER RES, V77, P5077, DOI 10.1158/0008-5472.CAN-17-0829; Dong LQ, 2005, AM J PHYSIOL-ENDOC M, V289, pE187, DOI 10.1152/ajpendo.00011.2005; Durand JK, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7090139; Ekim B, 2011, MOL CELL BIOL, V31, P2787, DOI 10.1128/MCB.05437-11; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637; Goncalves A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023971; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Helgason E, 2013, FEBS LETT, V587, P1230, DOI 10.1016/j.febslet.2013.01.059; Hoxhaj G, 2020, NAT REV CANCER, V20, P74, DOI 10.1038/s41568-019-0216-7; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Hsu PP, 2011, SCIENCE, V332, P1317, DOI 10.1126/science.1199498; Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08; Huh JY, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.10.010; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Joung SM, 2011, J IMMUNOL, V186, P499, DOI 10.4049/jimmunol.0903534; Kazyken D, 2019, SCI SIGNAL, V12, DOI 10.1126/scisignal.aav3249; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Kim J, 2019, NAT CELL BIOL, V21, P63, DOI 10.1038/s41556-018-0205-1; Kowalsky AH, 2020, J BIOL CHEM, V295, P1769, DOI 10.1074/jbc.RA119.010857; Lamming DW, 2012, SCIENCE, V335, P1638, DOI 10.1126/science.1215135; Lawrence RE, 2019, NAT CELL BIOL, V21, P133, DOI 10.1038/s41556-018-0244-7; Lee PL, 2017, TRENDS ENDOCRIN MET, V28, P319, DOI 10.1016/j.tem.2017.01.004; Lee PL, 2016, MOL METAB, V5, P422, DOI 10.1016/j.molmet.2016.04.001; Liu GY, 2020, NAT REV MOL CELL BIO, V21, P183, DOI 10.1038/s41580-019-0199-y; Liu LH, 2010, DEV CELL, V19, P845, DOI 10.1016/j.devcel.2010.11.004; Liu PD, 2015, CANCER DISCOV, V5, P1194, DOI 10.1158/2159-8290.CD-15-0460; Ma XL, 2012, P NATL ACAD SCI USA, V109, P9378, DOI 10.1073/pnas.1121552109; Manning BD, 2017, CELL, V169, P381, DOI 10.1016/j.cell.2017.04.001; Mogensen TH, 2009, CLIN MICROBIOL REV, V22, P240, DOI 10.1128/CMR.00046-08; Mostoslavsky G, 2006, P NATL ACAD SCI USA, V103, P16406, DOI 10.1073/pnas.0608130103; Mowers J, 2013, ELIFE, V2, DOI 10.7554/eLife.01119; Nguyen Thu P, 2017, Cell Logist, V7, pe1378794, DOI 10.1080/21592799.2017.1378794; Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006; Ou YH, 2011, MOL CELL, V41, P458, DOI 10.1016/j.molcel.2011.01.019; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Revach OY, 2020, EXPERT OPIN THER TAR, V24, P1065, DOI 10.1080/14728222.2020.1826929; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Sancak Y, 2009, BIOCHEM SOC T, V37, P289, DOI 10.1042/BST0370289; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Shimobayashi M, 2016, CELL RES, V26, P7, DOI 10.1038/cr.2015.146; Soliman GA, 2010, J BIOL CHEM, V285, P7866, DOI 10.1074/jbc.M109.096222; Szwed A, 2021, PHYSIOL REV, V101, P1371, DOI 10.1152/physrev.00026.2020; Tang YF, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11365; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tu DQ, 2013, CELL REP, V3, P747, DOI 10.1016/j.celrep.2013.01.033; Uhm M, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aah5085; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Valvezan AJ, 2019, NAT METAB, V1, P321, DOI 10.1038/s42255-019-0038-7; Wolfson RL, 2017, CELL METAB, V26, P301, DOI 10.1016/j.cmet.2017.07.001; Xie XD, 2011, P NATL ACAD SCI USA, V108, P6474, DOI 10.1073/pnas.1016132108; Xu Jianming, 2005, Curr Protoc Mol Biol, VChapter 28, DOI 10.1002/0471142727.mb2801s70; Yu T, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/979105; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zhang DH, 2010, J CLIN INVEST, V120, P2805, DOI 10.1172/JCI43008; Zhao CY, 2019, EXPERT OPIN THER TAR, V23, P437, DOI 10.1080/14728222.2019.1601702; Zhao P, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.592949; Zhao P, 2018, CELL, V172, P731, DOI 10.1016/j.cell.2018.01.007; Zhou RY, 2020, ACTA BIOCH BIOPH SIN, V52, P757, DOI 10.1093/abbs/gmaa051; Zhu LL, 2019, NAT CELL BIOL, V21, P1604, DOI 10.1038/s41556-019-0429-8; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	77	5	5	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100942	10.1016/j.jbc.2021.100942	http://dx.doi.org/10.1016/j.jbc.2021.100942			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34245780	gold, Green Published, Green Submitted			2022-12-28	WOS:000690871000013
J	Suay-Corredera, C; Pricolo, MR; Herrero-Galan, E; Velazquez-Carreras, D; Sanchez-Ortiz, D; Garcia-Giustiniani, D; Delgado, J; Galano-Frutos, JJ; Garcia-Cebollada, H; Vilches, S; Dominguez, F; Molina, MS; Barriales-Villa, R; Frisso, G; Sancho, J; Serrano, L; Garcia-Pavia, P; Monserrat, L; Alegre-Cebollada, J				Suay-Corredera, Carmen; Rosaria Pricolo, Maria; Herrero-Galan, Elias; Velazquez-Carreras, Diana; Sanchez-Ortiz, David; Garcia-Giustiniani, Diego; Delgado, Javier; Jose Galano-Frutos, Juan; Garcia-Cebollada, Helena; Vilches, Silvia; Dominguez, Fernando; Sabater Molina, Maria; Barriales-Villa, Roberto; Frisso, Giulia; Sancho, Javier; Serrano, Luis; Garcia-Pavia, Pablo; Monserrat, Lorenzo; Alegre-Cebollada, Jorge			Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN-BINDING; CARDIAC MYOSIN; C GENE; MOLECULAR DIAGNOSIS; CIRCULAR-DICHROISM; SEQUENCE VARIANTS; SITE MUTATION; DOMAIN; IDENTIFICATION; GUIDELINES	Hypertrophic cardiomyopathy (HCM) is the most common inherited cardiac disease. Variants in MYBPC3, the gene encoding cardiac myosin-binding protein C (cMyBP-C), are the leading cause of HCM. However, the pathogenicity status of hundreds of MYBPC3 variants found in patients remains unknown, as a consequence of our incomplete understanding of the pathomechanisms triggered by HCM-causing variants. Here, we examined 44 nontruncating MYBPC3 variants that we classified as HCM-linked or nonpathogenic according to cosegregation and population genetics criteria. We found that around half of the HCM-linked variants showed alterations in RNA splicing or protein stability, both of which can lead to cMyBP-C haploinsufficiency. These protein haploinsufficiency drivers associated with HCM pathogenicity with 100% and 94% specificity, respectively. Furthermore, we uncovered that 11% of nontruncating MYBPC3 variants currently classified as of uncertain significance in ClinVar induced one of these molecular phenotypes. Our strategy, which can be applied to other conditions induced by protein loss of function, supports the idea that cMyBP-C haploinsufficiency is a fundamental pathomechanism in HCM.	[Suay-Corredera, Carmen; Rosaria Pricolo, Maria; Herrero-Galan, Elias; Velazquez-Carreras, Diana; Sanchez-Ortiz, David; Dominguez, Fernando; Alegre-Cebollada, Jorge] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain; [Rosaria Pricolo, Maria; Frisso, Giulia] Univ Napoli Federico II, Dipartimento Med Mol & Biotecnol Med, Naples, Italy; [Garcia-Giustiniani, Diego; Monserrat, Lorenzo] Hlth Code A, La Coruna, Spain; [Delgado, Javier; Serrano, Luis] Barcelona Inst Sci & Technol, Ctr Genom Regulat CRG, EMBL CRG Syst Biol Res Unit, Barcelona, Spain; [Jose Galano-Frutos, Juan; Garcia-Cebollada, Helena; Sancho, Javier] Univ Zaragoza, Dept Bioquim & Biol Mol & Celular, Fac Ciencias, Zaragoza, Spain; [Jose Galano-Frutos, Juan; Garcia-Cebollada, Helena; Sancho, Javier] Univ Zaragoza, Biocomputat & Complex Syst Phys Inst BIFI, Joint Units BIFI IQFR CSIC & GBs CSIC, Madrid, Spain; [Vilches, Silvia; Dominguez, Fernando; Garcia-Pavia, Pablo] Hosp Univ Puerta Hierro, Dept Cardiol, Heart Failure & Inherited Cardiac Dis Unit, Madrid, Spain; [Vilches, Silvia; Dominguez, Fernando; Sabater Molina, Maria; Garcia-Pavia, Pablo] European Reference Network Rare & Low Prevalence, Murcia, Spain; [Dominguez, Fernando; Barriales-Villa, Roberto; Garcia-Pavia, Pablo] Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Madrid, Spain; [Sabater Molina, Maria] Hosp C Univ Virgen Arrixaca, Murcia, Spain; [Barriales-Villa, Roberto] Univ A Coruna, Serv Galego Saude SERGAS, Unidad Cardiopatias Familiares,Serv Galego Saude, Inst Invest Biomed Coruna INIBIC,Complexo Hosp Un, La Coruna, Spain; [Frisso, Giulia] Scarl, CEINGE Biotecnol Avanzate, Zaragoza, Spain; [Sancho, Javier] Aragon Hlth Res Inst IIS Aragon, Zaragoza, Spain; [Serrano, Luis] Inst Catalana Recerca & Estudis Avancats ICREA, Madrid, Spain; [Serrano, Luis] Univ Pompeu Fabra UPF, Barcelona, Spain; [Garcia-Pavia, Pablo] Univ Francisco Vitoria UFV, Madrid, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); University of Naples Federico II; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Zaragoza; University of Zaragoza; Hospital Puerta de Hierro-Majadahonda; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); ICREA; Pompeu Fabra University; Universidad Francisco de Vitoria	Alegre-Cebollada, J (corresponding author), Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain.	jalegre@cnic.es	Pricolo, Maria Rosaria/T-9200-2019; Galano-Frutos, Juan José/J-4337-2015; Alegre-Cebollada, Jorge/I-4301-2014; Herrero-Galán, Elías/L-1207-2014; Sancho, javier/AAA-1225-2019; Frisso, Giulia/A-5675-2014; Sabater-Molina, Maria/I-2722-2015	Pricolo, Maria Rosaria/0000-0002-6362-780X; Galano-Frutos, Juan José/0000-0002-1896-7805; Alegre-Cebollada, Jorge/0000-0003-0542-0170; Herrero-Galán, Elías/0000-0003-1916-6185; Sancho, javier/0000-0002-2879-9200; Garcia-Cebollada, Helena/0000-0002-9590-7371; Vilches-Soria, Silvia/0000-0001-8080-3329; Barriales-Villa, Roberto/0000-0002-6721-3487; Velazquez Carreras, Diana/0000-0002-0671-2549; Monserrat, Lorenzo/0000-0001-5776-0623; Sanchez-Ortiz, David/0000-0002-3551-6416; Sabater-Molina, Maria/0000-0003-1352-1748; Suay-Corredera, Carmen/0000-0003-2100-4847; Dominguez, Fernando/0000-0001-8408-363X	Ministerio de Ciencia e Innovacion (MCIN) [BIO2014-54768-P, BIO2017-83640-P, EIN2019-102966, RYC-2014-16604]; European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR) [AC16/00045]; Comunidad de Madrid [S2018/NMT-4443]; ISCIII; Pro CNIC Foundation; Severo Ochoa Center of Excellence [SEV2015-0505]; ISCIII to the Centro de Investigacion Biomedica en Red [CB16/11/00425]; MCIN [BFU2015-63571-P, FPU16/04232]; Gobierno de Aragon [E45_17R]; ERDF-InterregV-A POCTEFA, Spain [PIREPREDEFA086/15, BES-2016-076638]; Italian Ministry of Education, Universities and Research, Italy; AEI [PID2019-107293GB-I00]	Ministerio de Ciencia e Innovacion (MCIN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR); Comunidad de Madrid(Comunidad de Madrid); ISCIII(Instituto de Salud Carlos III); Pro CNIC Foundation; Severo Ochoa Center of Excellence(Spanish Government); ISCIII to the Centro de Investigacion Biomedica en Red; MCIN; Gobierno de Aragon(Gobierno de Aragon); ERDF-InterregV-A POCTEFA, Spain; Italian Ministry of Education, Universities and Research, Italy; AEI	J. A.-C. acknowledges funding from the Ministerio de Ciencia e Innovacion (MCIN) through grants BIO2014-54768-P; BIO2017-83640-P/MINECO/AEI/FEDER, UE; EIN2019-102966 and RYC-2014-16604, the European Research Area Network on Cardiovascular Diseases (ERA-CVD/ISCIII, Spain MINOTAUR, AC16/00045), and the Comunidad de Madrid (consortium Tec4Bio-CM, S2018/NMT-4443, FEDER). The CNIC is supported by the ISCIII, MCIN, and the Pro CNIC Foundation and was a Severo Ochoa Center of Excellence (SEV2015-0505). We acknowledge funding from ISCIII to the Centro de Investigacion Biomedica en Red (CB16/11/00425). L. S. acknowledges funding from MCIN (BFU2015-63571-P). J. S. acknowledges funding from AEI (PID2019-107293GB-I00), Gobierno de Aragon (E45_17R), and ERDF-InterregV-A POCTEFA, Spain (PIREPREDEFA086/15). C. S.-C. is the recipient of an FPI-SO predoctoral fellowship BES-2016-076638. M. R. P. was the recipient of a PhD fellowship from the Italian Ministry of Education, Universities and Research, Italy. H. G.-C. is the recipient of an FPU16/04232 doctoral contract from MCIN.	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; Alegre-Cebollada J, 2020, NANOMECHANICAL PHENO NANOMECHANICAL PHENO; Allali-Hassani A, 2009, BIOCHEM J, V424, P15, DOI 10.1042/BJ20090723; Amato F, 2012, J MOL DIAGN, V14, P81, DOI 10.1016/j.jmoldx.2011.09.001; Andersen PS, 2004, EUR J HUM GENET, V12, P673, DOI 10.1038/sj.ejhg.5201190; Ashley EA, 2018, J AM COLL CARDIOL, V72, P430, DOI 10.1016/j.jacc.2018.05.029; Bagnall RD, 2018, J AM COLL CARDIOL, V72, P419, DOI 10.1016/j.jacc.2018.04.078; Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bezold KL, 2013, J BIOL CHEM, V288, P21496, DOI 10.1074/jbc.M113.474346; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Braunwald E., 2015, HYPERTROPHIC CARDIOM, P1; Carrier L, 1997, CIRC RES, V80, P427, DOI 10.1161/01.res.0000435859.24609.b3; Cerny J., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/716945; Crehalet H, 2012, CARDIOGENETICS, V2, P26, DOI 10.4081/cardiogenetics.2012.e6; D'Argenio V, 2014, J MOL DIAGN, V16, P32, DOI 10.1016/j.jmoldx.2013.07.008; Da'as SI, 2018, BIOCHEM J, V475, P3933, DOI 10.1042/BCJ20180685; Doh CY, 2019, BBA-MOL BASIS DIS, V1865, P661, DOI 10.1016/j.bbadis.2019.01.007; Erdmann J, 2001, J AM COLL CARDIOL, V38, P322, DOI 10.1016/S0735-1097(01)01387-0; Frisso G, 2009, CLIN GENET, V76, P91, DOI 10.1111/j.1399-0004.2009.01190.x; Frisso G, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111883; Galano-Frutos JJ, 2021, BRIEF BIOINFORM, V22, P3, DOI 10.1093/bib/bbz146; Glazier AA, 2019, PFLUG ARCH EUR J PHY, V471, P781, DOI 10.1007/s00424-018-2226-9; Glazier AA, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99319; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Harper AR, 2021, NAT GENET, V53, P135, DOI 10.1038/s41588-020-00764-0; Harris SP, 2011, CIRC RES, V108, P751, DOI 10.1161/CIRCRESAHA.110.231670; Helms AS, 2020, CIRC-GENOM PRECIS ME, V13, P396, DOI 10.1161/CIRCGEN.120.002929; Helms AS, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.133782; Helms AS, 2014, CIRC-CARDIOVASC GENE, V7, P434, DOI 10.1161/CIRCGENETICS.113.000448; Hohfeld J, 2001, EMBO REP, V2, P885, DOI 10.1093/embo-reports/kve206; Holliday M., 2021, CIRC-GENOM PRECIS ME, V14; Homburger JR, 2016, P NATL ACAD SCI USA, V113, P6701, DOI 10.1073/pnas.1606950113; Houdayer C, 2012, HUM MUTAT, V33, P1228, DOI 10.1002/humu.22101; Ito K, 2017, P NATL ACAD SCI USA, V114, P7689, DOI 10.1073/pnas.1707741114; Jaaskelainen P, 2002, J MOL MED-JMM, V80, P412, DOI 10.1007/s00109-002-0323-9; Jordan DM, 2011, AM J HUM GENET, V88, P183, DOI 10.1016/j.ajhg.2011.01.011; Galano-Frutos JJ, 2019, J CHEM INF MODEL, V59, P4350, DOI 10.1021/acs.jcim.9b00430; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Kobayashi Y, 2017, GENOME MED, V9, DOI 10.1186/s13073-017-0403-7; Lappalainen T, 2019, CELL, V177, P70, DOI 10.1016/j.cell.2019.02.032; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lin J, 2010, CAN J CARDIOL, V26, P518, DOI 10.1016/S0828-282X(10)70464-5; Lopes LR, 2020, CIRC-GENOM PRECIS ME, V13, P165, DOI 10.1161/CIRCGEN.120.002905; Lv WJ, 2018, CIRCULATION, V138, P2852, DOI 10.1161/CIRCULATIONAHA.118.035028; MacArthur DG, 2014, NATURE, V508, P469, DOI 10.1038/nature13127; Maron BJ, 2012, J AM COLL CARDIOL, V60, P705, DOI 10.1016/j.jacc.2012.02.068; Marston S, 2012, J MUSCLE RES CELL M, V33, P75, DOI 10.1007/s10974-011-9268-3; Marston S, 2009, CIRC RES, V105, P219, DOI 10.1161/CIRCRESAHA.109.202440; McNally EM, 2015, TRENDS CARDIOVAS MED, V25, P646, DOI 10.1016/j.tcm.2015.02.013; Moolman-Smook J, 2002, CIRC RES, V91, P704, DOI 10.1161/01.RES.0000036750.81083.83; Nag S, 2021, ELIFE, V10, DOI 10.7554/eLife.63703; O'Leary TS, 2019, J MOL CELL CARDIOL, V127, P165, DOI 10.1016/j.yjmcc.2018.12.003; Page SP, 2012, CIRC-CARDIOVASC GENE, V5, P156, DOI 10.1161/CIRCGENETICS.111.960831; Pimenta-Lopes C, 2019, COMMUN PHYS-UK, V2, DOI 10.1038/s42005-019-0192-y; Porebski BT, 2015, PROTEIN ENG DES SEL, V28, P67, DOI 10.1093/protein/gzv002; Pricolo MR, 2020, J CARDIOVASC TRANSL, V13, P867, DOI 10.1007/s12265-020-09959-6; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Redwood CS, 1999, CARDIOVASC RES, V44, P20, DOI 10.1016/S0008-6363(99)00213-8; Rees M, 2021, ACTA NEUROPATHOL, V141, P431, DOI 10.1007/s00401-020-02257-0; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Rosano GL, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00172; Rottbauer W, 1997, J CLIN INVEST, V100, P475, DOI 10.1172/JCI119555; Sadayappan S, 2014, PFLUG ARCH EUR J PHY, V466, P195, DOI 10.1007/s00424-013-1396-8; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schuldt M, 2021, CIRC-HEART FAIL, V14, P39, DOI 10.1161/CIRCHEARTFAILURE.120.007022; Semsarian C., 2015, HYPERTROPHIC CARDIOM; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Singer ES, 2019, CIRC-GENOM PRECIS ME, V12, DOI 10.1161/CIRCGEN.118.002368; Smelter DF, 2018, AM J PHYSIOL-HEART C, V314, pH1179, DOI 10.1152/ajpheart.00686.2017; Thompson A. D., 2021, GENET MED; van der Velden J, 2015, CARDIOVASC RES, V105, P449, DOI 10.1093/cvr/cvv019; van Dijk SJ, 2016, ARCH BIOCHEM BIOPHYS, V601, P133, DOI 10.1016/j.abb.2016.01.006; van Dijk SJ, 2009, CIRCULATION, V119, P1473, DOI 10.1161/CIRCULATIONAHA.108.838672; Vignier N, 2009, CIRC RES, V105, P239, DOI 10.1161/CIRCRESAHA.109.201251; Walsh R, 2019, GENOME MED, V11, DOI 10.1186/s13073-019-0616-z; Walsh R, 2017, GENET MED, V19, P192, DOI 10.1038/gim.2016.90; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Xiong HY, 2015, SCIENCE, V347, DOI 10.1126/science.1254806; Yang LL, 2017, PEERJ, V5, DOI 10.7717/peerj.3550; Yotti R, 2019, ANNU REV GENOM HUM G, V20, P129, DOI 10.1146/annurev-genom-083118-015306; Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020; Zhang MZ, 2016, SCI REP-UK, V6, DOI 10.1038/srep33340; Zhang XL, 2014, BIOCHEMISTRY-US, V53, P5332, DOI 10.1021/bi500784g	86	6	6	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100854	10.1016/j.jbc.2021.100854	http://dx.doi.org/10.1016/j.jbc.2021.100854			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097875	gold, Green Published			2022-12-28	WOS:000678068400054
J	Beeg, M; Battocchio, E; De Luigi, A; Colombo, L; Natale, C; Cagnotto, A; Corbelli, A; Fiordaliso, F; Diomede, L; Salmona, M; Gobbi, M				Beeg, Marten; Battocchio, Elisabetta; De Luigi, Ada; Colombo, Laura; Natale, Carmina; Cagnotto, Alfredo; Corbelli, Alessandro; Fiordaliso, Fabio; Diomede, Luisa; Salmona, Mario; Gobbi, Marco			Nonphosphorylated tau slows down A beta(1-42) aggregation, binds to A beta(1-42) oligomers, and reduces A beta(1-42) toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID-BETA OLIGOMERS; A-BETA; ALZHEIMERS-DISEASE; PROTEIN; MECHANISMS; MUTATIONS; TANGLES; BRAIN	The formation of neurofibrillary tangles and amyloid plaques accompanies the progression of Alzheimer's disease. Tangles are made of fibrillar aggregates formed by the microtubule-associated protein tau, whereas plaques comprise fibrillar forms of amyloid-beta (A beta). Both form toxic oligomers during aggregation and are thought to interact synergistically to each promote the accumulation of the other. Recent in vitro studies have suggested that the monomeric nonphosphorylated full-length tau protein hinders the aggregation of A beta(1-40) peptide, but whether the same is true for the more aggregationprone A beta(1-42) was not determined. We used in vitro and in vivo techniques to explore this question. We have monitored the aggregation kinetics of A beta(1-42) by thioflavine T fluorescence in the presence or the absence of different concentrations of nonphosphorylated tau. We observed that elongation of A beta(1-42) fibrils was inhibited by tau in a dose-dependent manner. Interestingly, the fibrils were structurally different in the presence of tau but did not incorporate tau. Surface plasmon resonance indicated that tau monomers bound to A beta(1-42) oligomers (but not monomers) and hindered their interaction with the anti-A beta antibody 4G8, suggesting that tau binds to the hydrophobic central core of A beta recognized by 4G8. Tau monomers also antagonized the toxic effects of A beta oligomers in Caenorhabditis elegans. This suggests that nonphosphorylated tau might have a neuroprotective effect by binding A beta(1-42) oligomers formed during the aggregation and shielding their hydrophobic patches.	[Beeg, Marten; Battocchio, Elisabetta; De Luigi, Ada; Colombo, Laura; Natale, Carmina; Cagnotto, Alfredo; Diomede, Luisa; Salmona, Mario; Gobbi, Marco] Ist Ric Farmacol Mario Negri IRCCS, Dept Mol Biochem & Pharmacol, Milan, Italy; [Corbelli, Alessandro; Fiordaliso, Fabio] Ist Ric Farmacol Mario Negri IRCCS, Dept Cardiovasc Med, Milan, Italy	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Gobbi, M (corresponding author), Ist Ric Farmacol Mario Negri IRCCS, Dept Mol Biochem & Pharmacol, Milan, Italy.	marco.gobbi@marionegri.it	Natale, Carmina/ABE-4340-2021; Natale, Carmina/HHN-5820-2022; Gobbi, Marco/J-2638-2016	Natale, Carmina/0000-0001-8552-9875; Natale, Carmina/0000-0001-8552-9875; Gobbi, Marco/0000-0003-1014-6225; salmona, mario/0000-0002-9098-9873; Battocchio, Elisabetta/0000-0001-7431-2224; De Luigi, Ada/0000-0001-7907-7139	Fondazione Mariani; Banca Intesa-San Paolo; Fondazione Regionale per la Ricerca Biomedica [Care4NeuroRare CP_20/2018]	Fondazione Mariani; Banca Intesa-San Paolo; Fondazione Regionale per la Ricerca Biomedica	This work was partially supported by Fondazione Mariani with a grant to M. S. and Banca Intesa-San Paolo (grant 2014-2015) and Fondazione Regionale per la Ricerca Biomedica (Care4NeuroRare CP_20/2018) to L. D.	Aisen PS, 2019, JPAD-J PREV ALZHEIM, V6, P150, DOI 10.14283/jpad.2019.23; Balducci C, 2010, P NATL ACAD SCI USA, V107, P2295, DOI 10.1073/pnas.0911829107; Beeg M, 2016, J BIOL CHEM, V291, P6958, DOI 10.1074/jbc.M115.689539; Beeg M, 2013, CURR OPIN PHARMACOL, V13, P797, DOI 10.1016/j.coph.2013.05.010; Beeg M, 2011, ANAL BIOCHEM, V411, P297, DOI 10.1016/j.ab.2010.12.032; BUSCIGLIO J, 1995, NEURON, V14, P879, DOI 10.1016/0896-6273(95)90232-5; Calafate S, 2015, CELL REP, V11, P1176, DOI 10.1016/j.celrep.2015.04.043; Chen DL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10355-1; Cohen SIA, 2015, NAT STRUCT MOL BIOL, V22, P207, DOI 10.1038/nsmb.2971; Cohen SIA, 2013, P NATL ACAD SCI USA, V110, P9758, DOI 10.1073/pnas.1218402110; Cohen SIA, 2012, J MOL BIOL, V421, P160, DOI 10.1016/j.jmb.2012.02.031; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608917; Congdon EE, 2018, NAT REV NEUROL, V14, P399, DOI 10.1038/s41582-018-0013-z; Dawson HN, 2010, NEUROSCIENCE, V169, P516, DOI 10.1016/j.neuroscience.2010.04.037; Diomede L, 2014, BLOOD, V123, P3543, DOI 10.1182/blood-2013-10-525634; Do TD, 2014, J PHYS CHEM B, V118, P11220, DOI 10.1021/jp506258g; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; Giorgino T, 2019, BBA-MOL BASIS DIS, V1865, P648, DOI 10.1016/j.bbadis.2019.01.010; Goedert M, 2004, SEMIN CELL DEV BIOL, V15, P45, DOI 10.1016/j.semcdb.2003.12.015; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Guo JP, 2006, P NATL ACAD SCI USA, V103, P1953, DOI 10.1073/pnas.0509386103; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Han PC, 2017, J NEUROPATH EXP NEUR, V76, P44, DOI 10.1093/jnen/nlw105; Hasegawa M, 1997, J BIOL CHEM, V272, P33118, DOI 10.1074/jbc.272.52.33118; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hatami A, 2014, J BIOL CHEM, V289, P32131, DOI 10.1074/jbc.M114.594846; Hoglund K, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2016.252; Holtzman DM, 2011, NEUROBIOL AGING, V32, pS4, DOI 10.1016/j.neurobiolaging.2011.09.003; Knopman DS, 2019, NEW ENGL J MED, V380, P1476, DOI 10.1056/NEJMe1903193; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kollmer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12683-8; Luo JH, 2016, J BIOL CHEM, V291, P16485, DOI 10.1074/jbc.R116.714576; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Meisl G, 2019, ADV EXP MED BIOL, V1174, P1, DOI 10.1007/978-981-13-9791-2_1; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Miller Y, 2011, BIOCHEMISTRY-US, V50, P5172, DOI 10.1021/bi200400u; Moreno-Gonzalez I, 2017, MOL PSYCHIATR, V22, P1327, DOI 10.1038/mp.2016.230; Mullane K, 2013, BIOCHEM PHARMACOL, V85, P289, DOI 10.1016/j.bcp.2012.11.014; Naini SMA, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/151979; Neddens J, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0557-6; Petersen RC, 2018, NEUROLOGY, V90, P126, DOI 10.1212/WNL.0000000000004826; PRICE JL, 1991, NEUROBIOL AGING, V12, P295, DOI 10.1016/0197-4580(91)90006-6; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Romeo M, 2017, J ALZHEIMERS DIS, V57, P857, DOI 10.3233/JAD-160951; Rossi G, 2014, NEUROBIOL AGING, V35, P408, DOI 10.1016/j.neurobiolaging.2013.08.004; Stravalaci M, 2016, J ALZHEIMERS DIS, V53, P1485, DOI 10.3233/JAD-150882; Stravalaci M, 2012, J BIOL CHEM, V287, P27796, DOI 10.1074/jbc.M111.334979; Trambauer J, 2020, CURR OPIN NEUROBIOL, V61, P73, DOI 10.1016/j.conb.2020.01.011; Vasconcelos B, 2016, ACTA NEUROPATHOL, V131, P549, DOI 10.1007/s00401-015-1525-x; Wallin C, 2018, J AM CHEM SOC, V140, P8138, DOI 10.1021/jacs.7b13623; Yuksel M, 2019, EUR J PHARMACOL, V856, DOI 10.1016/j.ejphar.2019.172415; Zeinolabediny Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10875-0; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691	54	2	2	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100664	10.1016/j.jbc.2021.100664	http://dx.doi.org/10.1016/j.jbc.2021.100664			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865852	gold, Green Published			2022-12-28	WOS:000672866400635
J	Cresswell, P				Cresswell, Peter			CR3 ruffles Fc gamma R's claim over phagocytic cups	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							RECEPTORS	Phagocytosis plays diverse roles in biology, but our understanding of the purpose, interplay, and cell signaling mechanisms associated with different modes of phagocytosis is limited, without being able to capture and visualize each step in this rapid process from the beginning to end. A new study by Walbaum et al. uses stunning time-lapse 3D imaging of the engulfment of erythrocytes by macrophages via sinking, ruffling, and cup formation, unequivocally confirming a visionary 44-year-old theory derived from still electron microscopy photos that phagocytosis mediated by complement receptor CR3 occurs via a sinking mechanism and antibody-mediated phagocytosis occurs via phagocytic cup formation. The article also challenges the dogma, showing that phagocytic cup formation is not unique to antibody receptor phagocytosis, rather CR3 plays a complex role in different modes of phagocytosis. For example, inhibition of antibody-mediated phagocytosis leads to a compensatory upregulation of CR3-mediated sinking phagocytosis. These findings animate, in vivid colors, processes previously only captured as stills, exposing interactions between different phagocytic mechanisms and altering our basic understanding of this important process.	[Cresswell, Peter] Vet Greater Los Angeles HealthCare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA 90073 USA; [Cresswell, Peter] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Cresswell, Peter] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	Geriatric Research Education & Clinical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Cresswell, P (corresponding author), Vet Greater Los Angeles HealthCare Syst, Geriatr Res Educ & Clin Ctr, Los Angeles, CA 90073 USA.; Cresswell, P (corresponding author), Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA.; Cresswell, P (corresponding author), Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA.				VA MERIT [BX003485, R01AGAG066212, AZ140160 W81XWH-15-1-0422]; Paul G Allen Foundation	VA MERIT(US Department of Veterans Affairs); Paul G Allen Foundation	VA MERIT BX003485, R01AGAG066212, AZ140160 W81XWH-15-1-0422 (DOD/CDMRP), Paul G Allen Foundation.	Crowley MT, 1997, J EXP MED, V186, P1027, DOI 10.1084/jem.186.7.1027; Griciuc A, 2021, CURR OPIN NEUROL, V34, P228, DOI 10.1097/WCO.0000000000000911; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Jaumouille V, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01097; KAPLAN G, 1977, SCAND J IMMUNOL, V6, P797, DOI 10.1111/j.1365-3083.1977.tb02153.x; Ling GS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4039; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; Patel PC, 2008, MOL BIOL CELL, V19, P4628, DOI 10.1091/mbc.E08-02-0223; Uribe-Querol E, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01368; Walbaum S., 2021, J BIOL CHEM, V296	10	0	0	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100801	10.1016/j.jbc.2021.100801	http://dx.doi.org/10.1016/j.jbc.2021.100801			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019878	Green Published, gold			2022-12-28	WOS:000674717300021
J	Horsfall, AJ; Vandborg, BA; Kowalczyk, W; Chav, T; Scanlon, DB; Abell, AD; Bruning, JB				Horsfall, Aimee J.; Vandborg, Beth A.; Kowalczyk, Wioleta; Chav, Theresa; Scanlon, Denis B.; Abell, Andrew D.; Bruning, John B.			Unlocking the PIP-box: A peptide library reveals interactions that drive high-affinity binding to human PCNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; CRYSTALLOGRAPHY; INHIBITOR; COMPLEXES; SEQUENCE; CLAMP; P21	The human sliding clamp, Proliferating Cell Nuclear Antigen (hPCNA), interacts with over 200 proteins through a conserved binding motif, the PIP-box, to orchestrate DNA replication and repair. It is not clear how changes to the features of a PIP-box modulate protein binding and thus how they fine-tune downstream processes. Here, we present a systematic study of each position within the PIP-box to reveal how hPCNA-interacting peptides bind with drastically varied affinities. We synthesized a series of 27 peptides derived from the native protein p21 with small PIP-box modifications and another series of 19 peptides containing PIP-box binding motifs from other proteins. The hPCNA-binding affinity of all peptides, characterized as K-D values determined by surface plasmon resonance, spanned a 4000-fold range, from 1.83 nM to 7.59 mu M. The hPCNA-bound peptide structures determined by X-ray crystallography and modeled computationally revealed intermolecular and intramolecular interaction networks that correlate with high hPCNA affinity. These data informed rational design of three new PIP-box sequences, testing of which revealed the highest affinity hPCNA-binding partner to date, with a K-D value of 1.12 nM, from a peptide with PIP-box QTRITEYF. This work showcases the sequence-specific nuances within the PIP-box that are responsible for high-affinity hPCNA binding, which underpins our understanding of how nature tunes hPCNA affinity to regulate DNA replication and repair processes. In addition, these insights will be useful to future design of hPCNA inhibitors.	[Horsfall, Aimee J.; Chav, Theresa; Scanlon, Denis B.; Abell, Andrew D.] Univ Adelaide, ARC Ctr Excellence Nanoscale BioPhoton, Sch Phys Sci, Inst Photon & Adv Sensing, Adelaide, SA, Australia; [Vandborg, Beth A.; Bruning, John B.] Univ Adelaide, Sch Biol Sci, Inst Photon & Adv Sensing, Adelaide, SA, Australia; [Kowalczyk, Wioleta] CSIRO Mfg, Clayton, Vic, Australia	University of Adelaide; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Abell, AD (corresponding author), Univ Adelaide, ARC Ctr Excellence Nanoscale BioPhoton, Sch Phys Sci, Inst Photon & Adv Sensing, Adelaide, SA, Australia.; Bruning, JB (corresponding author), Univ Adelaide, Sch Biol Sci, Inst Photon & Adv Sensing, Adelaide, SA, Australia.	andrew.abell@adelaide.edu.au; john.bruning@adelaide.edu.au	Bruning, John/AAW-8567-2020	Bruning, John/0000-0002-6919-1824; Vandborg, Bethiney/0000-0002-3234-3089; Kowalczyk, Wioleta/0000-0001-5180-594X; Horsfall, Aimee/0000-0003-1276-2742	Australian Government Research Training Program Stipends (RTPS)	Australian Government Research Training Program Stipends (RTPS)(Australian Government)	A. J. H. and B. A. V. are supported by Australian Government Research Training Program Stipends (RTPS).	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; [Anonymous], 2015, PYMOL MOL GRAPH SYST; Anthis NJ, 2013, PROTEIN SCI, V22, P851, DOI 10.1002/pro.2253; Boehm EM, 2016, ENZYMES, V39, P231, DOI 10.1016/bs.enz.2016.03.003; Boehm EM, 2016, BIOESSAYS, V38, P1117, DOI 10.1002/bies.201600116; Bruning JB, 2004, STRUCTURE, V12, P2209, DOI 10.1016/j.str.2004.09.018; Choe KN, 2017, MOL CELL, V65, P380, DOI 10.1016/j.molcel.2016.12.020; Cowieson NP, 2015, J SYNCHROTRON RADIAT, V22, P187, DOI 10.1107/S1600577514021717; De Biasio A, 2013, ADV PROTEIN CHEM STR, V91, P1, DOI 10.1016/B978-0-12-411637-5.00001-9; De March M, 2018, NUCLEIC ACIDS RES, V46, P9816, DOI 10.1093/nar/gky723; De March M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms13935; Duffy CM, 2016, J MOL BIOL, V428, P1023, DOI 10.1016/j.jmb.2015.11.029; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Frkic R. I., 2018, NUCL RECEPTORS RES, V5; Gonzalez-Magana A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040570; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Hayashi A, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800238; Hishiki A, 2009, J BIOL CHEM, V284, P10552, DOI 10.1074/jbc.M809745200; Horsfall AJ, 2020, CHEMBIOCHEM, V21, P442, DOI 10.1002/cbic.201900275; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaufmann T, 2017, NUCLEIC ACIDS RES, V45, P9741, DOI 10.1093/nar/gkx604; Kontopidis G, 2005, P NATL ACAD SCI USA, V102, P1871, DOI 10.1073/pnas.0406540102; Kroker AJ, 2015, BIOCHEMISTRY-US, V54, P3483, DOI 10.1021/acs.biochem.5b00241; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Majka J, 2004, PROG NUCLEIC ACID RE, V78, P227, DOI 10.1016/S0079-6603(04)78006-X; Marshall AC, 2017, FEBS J, V284, P985, DOI 10.1111/febs.14035; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Pederick JL, 2020, J BIOL CHEM, V295, P7894, DOI 10.1074/jbc.RA120.012936; Piovesan D, 2016, NUCLEIC ACIDS RES, V44, pW367, DOI 10.1093/nar/gkw315; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Prestel A, 2019, CELL MOL LIFE SCI, V76, P4923, DOI 10.1007/s00018-019-03150-0; Stierand K, 2006, BIOINFORMATICS, V22, P1710, DOI 10.1093/bioinformatics/btl150; Stolimenov I, 2009, BIOCHEM SOC T, V37, P605, DOI 10.1042/BST0370605; Tsurimoto Toshiki, 1999, Frontiers in Bioscience, V4, pd849, DOI 10.2741/Tsurimoto; Warbrick E, 2006, ONCOGENE, V25, P2850, DOI 10.1038/sj.onc.1209320; Warbrick E, 1998, BIOESSAYS, V20, P195, DOI 10.1002/(SICI)1521-1878(199803)20:3<195::AID-BIES2>3.0.CO;2-R; WARBRICK E, 1995, CURR BIOL, V5, P275, DOI 10.1016/S0960-9822(95)00058-3; Wegener KL, 2018, CHEM-EUR J, V24, P11325, DOI 10.1002/chem.201801734; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wlodawer A, 2013, FEBS J, V280, P5705, DOI 10.1111/febs.12495; Zheleva DI, 2000, BIOCHEMISTRY-US, V39, P7388, DOI 10.1021/bi992498r	47	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100773	10.1016/j.jbc.2021.100773	http://dx.doi.org/10.1016/j.jbc.2021.100773			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33984330	Green Published, gold			2022-12-28	WOS:000672866400740
J	Khater, M; Bryant, CN; Wu, GY				Khater, Mostafa; Bryant, Christian N.; Wu, Guangyu			G beta gamma translocation to the Golgi apparatus activates ARF1 to spatiotemporally regulate G protein-coupled receptor signaling to MAPK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP-RIBOSYLATION FACTOR; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE SYNTHESIS; PHOSPHOLIPASE-D ACTIVATION; PLASMA-MEMBRANE; ENDOPLASMIC-RETICULUM; ANGIOTENSIN-II; CHOLERA-TOXIN; GROWTH-FACTOR; CELL-SURFACE; KINASE	After activation of G protein-coupled receptors, G protein beta gamma dimers may translocate from the plasma membrane to the Golgi apparatus (GA). We recently report that this translocation activates extracellular signal-regulated protein kinases 1 and 2 (ERK1/2) via PI3K gamma; however, how G beta gamma-PI3K gamma activates the ERK1/2 pathway is unclear. Here, we demonstrate that chemokine receptor CXCR4 activates ADP-ribosylation factor 1 (ARF1), a small GTPase important for vesicle-mediated membrane trafficking. This activation is blocked by CRISPR-Cas9-mediated knockout of the GA-translocating G gamma 9 subunit. Inducible targeting of different G beta gamma dimers to the GA can directly activate ARF1. CXCR4 activation and constitutive G beta gamma recruitment to the GA also enhance ARF1 translocation to the GA. We further demonstrate that pharmacological inhibition and CRISPR-Cas9-mediated knockout of PI3K gamma markedly inhibit CXCR4-mediated and G beta gamma translocation-mediated ARF1 activation. We also show that depletion of ARF1 by siRNA and CRISPR-Cas9 and inhibition of GA-localized ARF1 activation abolish ERK1/2 activation by CXCR4 and G beta gamma translocation to the GA and suppress prostate cancer PC3 cell migration and invasion. Collectively, our data reveal a novel function for G beta gamma translocation to the GA to activate ARF1 and identify GA-localized ARF1 as an effector acting downstream of G beta gamma-PI3K gamma to spatiotemporally regulate G protein-coupled receptor signaling to mitogen-activated protein kinases.	[Khater, Mostafa; Bryant, Christian N.; Wu, Guangyu] Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Wu, GY (corresponding author), Augusta Univ, Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA.	guwu@augusta.edu		Bryant, Christian/0000-0002-3379-5837; Khater, Mostafa/0000-0001-7080-6534	National Institute of General Medical Sciences of the National Institutes of Health [R35GM136397, R01GM118915]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Sciences of the National Institutes of Health under award numbers R35GM136397 and R01GM118915 (to G. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akgoz M, 2004, J BIOL CHEM, V279, P51541, DOI 10.1074/jbc.M410639200; Akgoz M, 2006, CELL SIGNAL, V18, P1758, DOI 10.1016/j.cellsig.2006.01.016; Boal F, 2010, TRAFFIC, V11, P1537, DOI 10.1111/j.1600-0854.2010.01122.x; Boulay PL, 2011, ONCOGENE, V30, P3846, DOI 10.1038/onc.2011.100; Boulay PL, 2008, J BIOL CHEM, V283, P36425, DOI 10.1074/jbc.M803603200; BROWN HA, 1993, CELL, V75, P1137, DOI 10.1016/0092-8674(93)90323-I; Casalou C, 2020, FRONT CELL DEV BIOL, V8, DOI 10.3389/fcell.2020.00217; Chatterjee S, 2014, ADV CANCER RES, V124, P31, DOI 10.1016/B978-0-12-411638-2.00002-1; Chisari M, 2009, PLOS ONE, V4, pA181, DOI 10.1371/journal.pone.0007797; COCKCROFT S, 1994, SCIENCE, V263, P523, DOI 10.1126/science.8290961; CRESPO P, 1994, NATURE, V369, P418, DOI 10.1038/369418a0; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Davis JE, 2016, ONCOTARGET, V7, P39834, DOI 10.18632/oncotarget.9405; Dell'Angelica EC, 2000, J CELL BIOL, V149, P81, DOI 10.1083/jcb.149.1.81; Donaldson JG, 2011, NAT REV MOL CELL BIO, V12, P362, DOI 10.1038/nrm3117; Dong CM, 2011, J BIOL CHEM, V286, P43361, DOI 10.1074/jbc.M111.267286; Feng Y, 2004, EMBO REP, V5, P596, DOI 10.1038/sj.embor.7400152; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Haines E, 2014, J BIOL CHEM, V289, P5687, DOI 10.1074/jbc.M113.516047; Irannejad R, 2010, J BIOL CHEM, V285, P32393, DOI 10.1074/jbc.M110.154963; Jamora C, 1999, CELL, V98, P59, DOI 10.1016/S0092-8674(00)80606-6; Jensen DD, 2016, J BIOL CHEM, V291, P11285, DOI 10.1074/jbc.M115.710681; Jones DH, 2000, J BIOL CHEM, V275, P13962, DOI 10.1074/jbc.C901019199; Karnam P, 1997, J BIOL CHEM, V272, P6136, DOI 10.1074/jbc.272.10.6136; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Klayman LM, 2017, J BIOL CHEM, V292, P1773, DOI 10.1074/jbc.M116.750430; KOCH WJ, 1994, P NATL ACAD SCI USA, V91, P12706, DOI 10.1073/pnas.91.26.12706; Lewis-Saravalli S, 2013, CELL SIGNAL, V25, P1813, DOI 10.1016/j.cellsig.2013.05.011; Li CM, 2017, CELL REP, V21, P1089, DOI 10.1016/j.celrep.2017.10.011; Li CM, 2012, J BIOL CHEM, V287, P42784, DOI 10.1074/jbc.M112.410936; LopezIlasaca M, 1997, SCIENCE, V275, P394, DOI 10.1126/science.275.5298.394; Madukwe JC, 2018, J BIOL CHEM, V293, P6387, DOI 10.1074/jbc.RA118.002354; Malik S, 2015, MOL BIOL CELL, V26, P1188, DOI 10.1091/mbc.E14-10-1476; MASSENBURG D, 1994, P NATL ACAD SCI USA, V91, P11718, DOI 10.1073/pnas.91.24.11718; Mazaki Y, 2012, MOL BIOL CELL, V23, P2457, DOI 10.1091/mbc.E12-01-0062; McCulloch DA, 2001, MOL PHARMACOL, V59, P1523, DOI 10.1124/mol.59.6.1523; Mitchell R, 2003, J BIOL CHEM, V278, P33818, DOI 10.1074/jbc.M305825200; Mitchell R, 1998, NATURE, V392, P411, DOI 10.1038/32937; O'Neill PR, 2012, P NATL ACAD SCI USA, V109, pE3568, DOI 10.1073/pnas.1205345109; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Roth MG, 2008, TRAFFIC, V9, P1233, DOI 10.1111/j.1600-0854.2008.00742.x; Saenz JB, 2009, NAT CHEM BIOL, V5, P157, DOI 10.1038/nchembio.144; Saini DK, 2007, J BIOL CHEM, V282, P24099, DOI 10.1074/jbc.M701191200; Saini DK, 2010, P NATL ACAD SCI USA, V107, P11417, DOI 10.1073/pnas.1003042107; Schlienger S, 2014, MOL BIOL CELL, V25, P17, DOI 10.1091/mbc.E13-06-0335; Senarath K, 2018, J BIOL CHEM, V293, P2974, DOI 10.1074/jbc.RA117.000872; Shome K, 2000, ENDOCRINOLOGY, V141, P2200, DOI 10.1210/en.141.6.2200; Skippen A, 2002, J BIOL CHEM, V277, P5823, DOI 10.1074/jbc.M110274200; Taichman RS, 2002, CANCER RES, V62, P1832; Vasudevan C, 1998, J CELL SCI, V111, P1277; Wei Z., 2021, J BIOL CHEM, V296; Wei Z, 2019, CELL REP, V28, P554, DOI 10.1016/j.celrep.2019.05.033; Weis WI, 2018, ANNU REV BIOCHEM, V87, P897, DOI 10.1146/annurev-biochem-060614-033910; Wu GY, 2003, J BIOL CHEM, V278, P47062, DOI 10.1074/jbc.M305707200; ZHANG GF, 1995, J BIOL CHEM, V270, P21, DOI 10.1074/jbc.270.1.21; Zhou FG, 2015, CELL SIGNAL, V27, P2035, DOI 10.1016/j.cellsig.2015.06.007	56	5	5	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100805	10.1016/j.jbc.2021.100805	http://dx.doi.org/10.1016/j.jbc.2021.100805			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022220	Green Published, gold			2022-12-28	WOS:000674717300023
J	Pourfarjam, Y; Ma, ZJ; Kurinov, I; Moss, J; Kim, IK				Pourfarjam, Yasin; Ma, Zhijun; Kurinov, Igor; Moss, Joel; Kim, In-Kwon			Structural and biochemical analysis of human ADP-ribosyl-acceptor hydrolase 3 reveals the basis of metal selectivity and different roles for the two magnesium ions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLY(ADP-RIBOSE); BINDING; FAMILY; REPAIR	ADP-ribosylation is a reversible and site-specific posttranslational modification that regulates a wide array of cellular signaling pathways. Regulation of ADP-ribosylation is vital for maintaining genomic integrity, and uncontrolled accumulation of poly(ADP-ribosyl)ation triggers a poly(ADP-ribose) (PAR)-dependent release of apoptosis-inducing factor from mitochondria, leading to cell death. ADP-ribosylacceptor hydrolase 3 (ARH3) cleaves PAR and mono(ADP-ribosyl)ation at serine following DNA damage. ARH3 is also a metalloenzyme with strong metal selectivity. While coordination of two magnesium ions (Mg-A and Mg-B) significantly enhances its catalytic efficiency, calcium binding suppresses its function. However, how the coordination of different metal ions affects its catalysis has not been defined. Here, we report a new crystal structure of ARH3 complexed with its product ADP-ribose and calcium. This structure shows that calcium coordination significantly distorts the binuclear metal center of ARH3, which results in decreased binding affinity to ADP-ribose, and suboptimal substrate alignment, leading to impaired hydrolysis of PAR and mono(ADP-ribosyl)ated serines. Furthermore, combined structural and mutational analysis of the metal-coordinating acidic residues revealed that Mg-A is crucial for optimal substrate positioning for catalysis, whereas Mg-B plays a key role in substrate binding. Our collective data provide novel insights into the different roles of these metal ions and the basis of metal selectivity of ARH3 and contribute to understanding the dynamic regulation of cellular ADP-ribosylations during the DNA damage response.	[Pourfarjam, Yasin; Ma, Zhijun; Kim, In-Kwon] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Kurinov, Igor] Cornell Univ, NE CAT APS, Dept Chem & Chem Biol, Argonne, IL USA; [Moss, Joel] NHLBI, Pulm Branch, NIH, Bldg 10, Bethesda, MD 20892 USA	University System of Ohio; University of Cincinnati; Cornell University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Kim, IK (corresponding author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.	kimiw@ucmail.uc.edu		Pourfarjam, Yasin/0000-0002-2836-0214; Kim, In-Kwon/0000-0002-2779-9735				Abplanalp J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02253-1; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Andrabi SA, 2006, P NATL ACAD SCI USA, V103, P18308, DOI 10.1073/pnas.0606526103; Barkauskaite E, 2015, MOL CELL, V58, P935, DOI 10.1016/j.molcel.2015.05.007; Barkauskaite E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3164; Beneke Sascha, 2012, Frontiers in Genetics, V3, P169, DOI 10.3389/fgene.2012.00169; Bock FJ, 2015, MOL CELL, V58, P959, DOI 10.1016/j.molcel.2015.01.037; Bonfiglio JJ, 2017, MOL CELL, V65; BROCHU G, 1994, BBA-GENE STRUCT EXPR, V1219, P342, DOI 10.1016/0167-4781(94)90058-2; Chaudhuri AR, 2017, NAT REV MOL CELL BIO, V18, P610, DOI 10.1038/nrm.2017.53; Danhauser K, 2018, AM J HUM GENET, V103, P817, DOI 10.1016/j.ajhg.2018.10.005; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FALKE JJ, 1994, Q REV BIOPHYS, V27, P219, DOI 10.1017/S0033583500003012; GLUSKER JP, 1991, ADV PROTEIN CHEM, V42, P1; GROSSHANS CA, 1989, BIOCHEMISTRY-US, V28, P6888, DOI 10.1021/bi00443a017; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Hassa PO, 2006, MICROBIOL MOL BIOL R, V70, P789, DOI 10.1128/MMBR.00040-05; Kasamatsu A, 2011, J BIOL CHEM, V286, P21110, DOI 10.1074/jbc.M111.237636; Kim IK, 2015, J BIOL CHEM, V290, P3775, DOI 10.1074/jbc.M114.624718; Kim IK, 2012, NAT STRUCT MOL BIOL, V19, P653, DOI 10.1038/nsmb.2305; Kraus WL, 2013, MOL ASPECTS MED, V34, P1109, DOI 10.1016/j.mam.2013.01.005; Langelier MF, 2018, CURR OPIN STRUC BIOL, V53, P187, DOI 10.1016/j.sbi.2018.11.002; Luo X, 2012, GENE DEV, V26, P417, DOI 10.1101/gad.183509.111; Mashimo M, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124519; Mashimo M, 2018, METHODS MOL BIOL, V1813, P187, DOI 10.1007/978-1-4939-8588-3_12; Mashimo M, 2013, P NATL ACAD SCI USA, V110, P18964, DOI 10.1073/pnas.1312783110; Mordasini T, 2003, J BIOL CHEM, V278, P4381, DOI 10.1074/jbc.C200664200; Mueller-Dieckmann C, 2006, P NATL ACAD SCI USA, V103, P15026, DOI 10.1073/pnas.0606762103; O'Sullivan J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08859-x; Oka S, 2006, J BIOL CHEM, V281, P705, DOI 10.1074/jbc.M510290200; Ono T, 2006, P NATL ACAD SCI USA, V103, P16687, DOI 10.1073/pnas.0607911103; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Palazzo L, 2018, ELIFE, V7, DOI 10.7554/eLife.34334; Palazzo L, 2017, FEBS J, V284, P2932, DOI 10.1111/febs.14078; Pascal JM, 2015, DNA REPAIR, V32, P10, DOI 10.1016/j.dnarep.2015.04.008; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; Pourfarjam Y, 2020, BIOCHEM BIOPH RES CO, V527, P818, DOI 10.1016/j.bbrc.2020.04.120; Pourfarjam Y, 2018, J BIOL CHEM, V293, P12350, DOI 10.1074/jbc.RA118.003586; Rack GM., 2018, CELL CHEM BIOL, V25; Slade D, 2011, NATURE, V477, P616, DOI 10.1038/nature10404; Stevens LA, 2019, ACS CHEM BIOL, V14, P2576, DOI 10.1021/acschembio.9b00429; Suskiewicz MJ, 2020, NATURE, V579, P598, DOI 10.1038/s41586-020-2013-6; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vyas S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3240; Wang MX, 2018, J BIOL CHEM, V293, P14470, DOI 10.1074/jbc.RA118.004284; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	46	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100692	10.1016/j.jbc.2021.100692	http://dx.doi.org/10.1016/j.jbc.2021.100692			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33894202	Green Published, gold			2022-12-28	WOS:000672866400663
J	Liu, LH; Akkoyunlu, M				Liu, Lunhua; Akkoyunlu, Mustafa			Circulating CD138 enhances disease progression by augmenting autoreactive antibody production in a mouse model of systemic lupus erythematosus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPARAN-SULFATE PROTEOGLYCANS; FIBROBLAST-GROWTH-FACTOR; B-CELL-RECEPTOR; SOLUBLE SYNDECAN-1; SERUM SYNDECAN-1; EXPRESSION; SURVIVAL; APRIL; BAFF; TACI	Systemic lupus erythematosus (SLE) is a progressive autoim-mune disease characterized by high levels of antibodies directed against nuclear antigens. Elevated serum CD138, a heparan sulfate-bearing proteoglycan, correlates with increased disease activity in patients with SLE, but the contribution of CD138 to lupus disease is not known. Corroborating patient data, we detected an increase in serum CD138 in MRL/MpJ-Faslpr/J (MRL/Lpr) mice (a model for SLE disease) parallel to disease activity. Although T-cell receptor beta (TCR beta)+CD138+ T cells typically expand in MRL/Lpr mice as the disease progresses, surprisingly, TCR beta+CD138- cells were the primary source of circulating CD138, as the transfer of TCR beta+CD138- cells, but not TCR beta+CD138+ cells, to young MRL/Lpr mice resulted in higher serum CD138 in the recipients. We found that trypsin was able to cleave CD138 from TCR beta+CD138+ cells, and that trypsin was highly expressed in TCR beta+CD138- cells. Moreover, trypsin inhibitors, the "defined trypsin inhibitor" and leupeptin, increased CD138 expression on TCR beta+CD138- cells, suggesting a contribution of cleaved CD138 to the increase in blood CD138 levels. Furthermore, soluble CD138 was able to bind "a proliferation-inducing ligand" (APRIL) and enhance APRIL-mediated plasma cell generation and autoreactive antibody production through the phosphorylation of extracellular signal- regulated kinase in B cells. The APRIL receptor "trans-membrane activator, calcium modulator, and cyclophilin ligand interactor" was involved in the enhancement of APRIL activity by CD138, as the synergistic effect of APRIL and CD138 was ablated in transmembrane activator, calcium modulator, and cyclophilin ligand interactor-deficient B cells. These findings indicate a regulatory role for soluble CD138 in B-cell differen-tiation and autoreactive antibody production in SLE disease.	[Liu, Lunhua; Akkoyunlu, Mustafa] US FDA, Lab Bacterial Polysaccharides, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Akkoyunlu, M (corresponding author), US FDA, Lab Bacterial Polysaccharides, Div Bacterial Parasit & Allergen Prod, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Mustafa.Akkoyunlu@fda.hhs.gov						Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Biajoux V, 2016, CELL REP, V17, P193, DOI 10.1016/j.celrep.2016.08.068; Bischof D, 2006, BLOOD, V107, P3235, DOI 10.1182/blood-2005-01-0256; Bossen C, 2008, BLOOD, V111, P1004, DOI 10.1182/blood-2007-09-110874; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Couchman JR, 2003, NAT REV MOL CELL BIO, V4, P926, DOI 10.1038/nrm1257; Dhodapkar MV, 1998, BLOOD, V91, P2679, DOI 10.1182/blood.V91.8.2679.2679_2679_2688; Ding K, 2005, J CELL BIOL, V171, P729, DOI 10.1083/jcb.200508010; Elenius V, 2004, J BIOL CHEM, V279, P41928, DOI 10.1074/jbc.M404506200; Endo K, 2003, J BIOL CHEM, V278, P40764, DOI 10.1074/jbc.M306736200; Fitzgerald ML, 2000, J CELL BIOL, V148, P811, DOI 10.1083/jcb.148.4.811; Hahn BH, 2013, NEW ENGL J MED, V368, P1528, DOI 10.1056/NEJMct1207259; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Ingold K, 2005, J EXP MED, V201, P1375, DOI 10.1084/jem.20042309; Joensuu H, 2002, CANCER RES, V62, P5210; Jung O, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.5; Kato M, 1998, NAT MED, V4, P691, DOI 10.1038/nm0698-691; KIM CW, 1994, MOL BIOL CELL, V5, P797, DOI 10.1091/mbc.5.7.797; Kim KJ, 2015, J RHEUMATOL, V42, P202, DOI 10.3899/jrheum.140568; Koshikawa N, 1998, AM J PATHOL, V153, P937, DOI 10.1016/S0002-9440(10)65635-0; Kyrtsonis MC, 2004, EUR J HAEMATOL, V72, P252, DOI 10.1046/j.0902-4441.2003.00205.x; Li W, 2017, CURR OPIN RHEUMATOL, V29, P434, DOI 10.1097/BOR.0000000000000412; Liu LH, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01569; Liu LH, 2018, DIABETES, V67, P1589, DOI 10.2337/db17-1089; Liu LH, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19827-8; Mackay F, 2009, NAT REV IMMUNOL, V9, P491, DOI 10.1038/nri2572; Mahtouk K, 2006, ONCOGENE, V25, P7180, DOI 10.1038/sj.onc.1209699; MALI M, 1994, J BIOL CHEM, V269, P27795; Manon-Jensen T, 2010, FEBS J, V277, P3876, DOI 10.1111/j.1742-4658.2010.07798.x; McCarron MJ, 2017, BLOOD, V129, P2749, DOI 10.1182/blood-2017-01-761643; Minowa K, 2011, AUTOIMMUNITY, V44, P357, DOI 10.3109/08916934.2010.545846; Moreaux J, 2009, EUR J HAEMATOL, V83, P119, DOI 10.1111/j.1600-0609.2009.01262.x; Nikolova V, 2009, CARCINOGENESIS, V30, P397, DOI 10.1093/carcin/bgp001; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Owen JL, 2003, J IMMUNOL, V171, P4340, DOI 10.4049/jimmunol.171.8.4340; Palaiologou M, 2014, HISTOL HISTOPATHOL, V29, P177, DOI 10.14670/HH-29.177; Purushothaman A, 2008, J BIOL CHEM, V283, P32628, DOI 10.1074/jbc.M806266200; Purushothaman A, 2010, BLOOD, V115, P2449, DOI 10.1182/blood-2009-07-234757; Richard ML, 2018, LUPUS SCI MED, V5, DOI 10.1136/lupus-2016-000199; Rui LX, 2006, J IMMUNOL, V177, P5337, DOI 10.4049/jimmunol.177.8.5337; Sakai J, 2017, CLIN MICROBIOL REV, V30, P991, DOI 10.1128/CMR.00046-17; Salazar-Camarena DC, 2019, CYTOKINE, V114, P115, DOI 10.1016/j.cyto.2018.11.008; Schneider P, 2005, CURR OPIN IMMUNOL, V17, P282, DOI 10.1016/j.coi.2005.04.005; Schweighoffer E, 2018, CURR OPIN CELL BIOL, V51, P8, DOI 10.1016/j.ceb.2017.10.002; Seidel C, 2000, BLOOD, V95, P388, DOI 10.1182/blood.V95.2.388; Subramanian SV, 1997, J BIOL CHEM, V272, P14713, DOI 10.1074/jbc.272.23.14713; Theocharis AD, 2010, FEBS J, V277, P3904, DOI 10.1111/j.1742-4658.2010.07800.x; Tsokos GC, 2011, NEW ENGL J MED, V365, P2110, DOI 10.1056/NEJMra1100359; Uslu K, 2014, J IMMUNOL, V192, P3582, DOI 10.4049/jimmunol.1203468; Yang Y, 2002, BLOOD, V100, P610, DOI 10.1182/blood.V100.2.610; Yasuda T, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001592	52	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101053	10.1016/j.jbc.2021.101053	http://dx.doi.org/10.1016/j.jbc.2021.101053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34364875	Green Published, gold			2022-12-28	WOS:000706409400007
J	Teramoto, T; Koyasu, T; Adachi, N; Kawasaki, M; Moriya, T; Numata, T; Senda, T; Kakuta, Y				Teramoto, Takamasa; Koyasu, Takeshi; Adachi, Naruhiko; Kawasaki, Masato; Moriya, Toshio; Numata, Tomoyuki; Senda, Toshiya; Kakuta, Yoshimitsu			Minimal protein-only RNase P structure reveals insights into tRNA precursor recognition and catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX; DOMAIN; VALIDATION; MATURATION; MECHANISM; PROVIDES; TOOLS; MODEL	Ribonuclease P (RNase P) is an endoribonuclease that catalyzes the processing of the 5' leader sequence of precursor tRNA (pre-tRNA). Ribonucleoprotein RNase P and protein only RNase P (PRORP) in eukaryotes have been extensively studied, but the mechanism by which a prokaryotic nuclease recognizes and cleaves pre-tRNA is unclear. To gain insights into this mechanism, we studied homologs of Aquifex RNase P (HARPs), thought to be enzymes of approximately 23 kDa comprising only this nuclease domain. We determined the cryo-EM structure of Aq880, the first identified HARP enzyme. The structure unexpectedly revealed that Aq880 consists of both the nuclease and protruding helical (PrH) domains. Aq880 monomers assemble into a dimer via the PrH domain. Six dimers form a dodecamer with a left-handed one-turn superhelical structure. The structure also revealed that the active site of Aq880 is analogous to that of eukaryotic PRORPs. The pre-tRNA docking model demonstrated that 5' processing of pre-tRNAs is achieved by two adjacent dimers within the dodecamer. One dimer is responsible for catalysis, and the PrH domains of the other dimer are responsible for pre-tRNA elbow recognition. Our study suggests that HARPs measure an invariant distance from the pre-tRNA elbow to cleave the 5' leader sequence, which is analogous to the mechanism of eukaryotic PRORPs and the ribonucleoprotein RNase P. Collectively, these findings shed light on how different types of RNase P enzymes utilize the same pre-tRNA processing.	[Teramoto, Takamasa; Koyasu, Takeshi; Kakuta, Yoshimitsu] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Biophys Chem,Nishi Ku, Fukuoka, Japan; [Adachi, Naruhiko; Kawasaki, Masato; Moriya, Toshio; Senda, Toshiya] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Struct Biol Res Ctr, Tsukuba, Ibaraki, Japan; [Kawasaki, Masato; Senda, Toshiya] Grad Univ Adv Studies Soken Dai, Sch High Energy Accelerator Sci, Dept Mat Struct Sci, Tsukuba, Ibaraki, Japan; [Numata, Tomoyuki] Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Biochem,Nishi Ku, Fukuoka, Japan	Kyushu University; High Energy Accelerator Research Organization (KEK); Graduate University for Advanced Studies - Japan; Kyushu University	Teramoto, T; Kakuta, Y (corresponding author), Kyushu Univ, Fac Agr, Dept Biosci & Biotechnol, Lab Biophys Chem,Nishi Ku, Fukuoka, Japan.	teramotot@agr.kyushu-u.ac.jp; kakuta@agr.kyushu-u.ac.jp		Senda, Toshiya/0000-0002-5153-928X; Kawasaki, Masato/0000-0002-8319-2102; Teramoto, Takamasa/0000-0003-1555-5394; Moriya, Toshio/0000-0001-7226-5487	JSPS KAKENHI [21K06032]; Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (AMED) [JP21am0101071, 3051]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Grant-in-aid for scientific research by JSPS KAKENHI (grant number 21K06032) and the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research [BINDS]) from the Japan Agency for Medical Research and Development (AMED) (grant number JP21am0101071) (supporting no. 3051).	Abbott JA, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00158; Afonine PV, 2018, ACTA CRYSTALLOGR D, V74, P814, DOI 10.1107/S2059798318009324; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Daniels CJ, 2019, RNA, V25, P286, DOI 10.1261/rna.068379.118; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Feyh R, 2021, ELIFE, V10, DOI 10.7554/eLife.70160; Gobert A, 2019, IUBMB LIFE, V71, P1117, DOI 10.1002/iub.2062; Gobert A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2358; Gobert A, 2010, NAT STRUCT MOL BIOL, V17, P740, DOI 10.1038/nsmb.1812; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; Howard MJ, 2012, P NATL ACAD SCI USA, V109, P16149, DOI 10.1073/pnas.1209062109; Itoh Y, 2013, SCIENCE, V340, P75, DOI 10.1126/science.1229521; Karasik A, 2016, J MOL BIOL, V428, P26, DOI 10.1016/j.jmb.2015.11.025; Lan PF, 2018, SCIENCE, V362, P657, DOI 10.1126/science.aat6678; Lechner M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-522; Li FZ, 2015, SCI REP-UK, V5, DOI 10.1038/srep09878; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Matelska D, 2017, NUCLEIC ACIDS RES, V45, P6995, DOI 10.1093/nar/gkx494; Mukherjee A, 2017, ENVIRON MICROBIOL, V19, P2831, DOI 10.1111/1462-2920.13808; Nickel AI, 2017, P NATL ACAD SCI USA, V114, P11121, DOI 10.1073/pnas.1707862114; Pellegrini O, 2012, STRUCTURE, V20, P1769, DOI 10.1016/j.str.2012.08.002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pinker F, 2017, J BIOL CHEM, V292, P13904, DOI 10.1074/jbc.M117.782078; Reinhard L, 2015, NUCLEIC ACIDS RES, V43, P5664, DOI 10.1093/nar/gkv481; Reiter NJ, 2010, NATURE, V468, P784, DOI 10.1038/nature09516; Schaffer AE, 2019, ANNU REV GENOM HUM G, V20, P359, DOI 10.1146/annurev-genom-083118-015334; Schwarz TS, 2019, IUBMB LIFE, V71, P1109, DOI 10.1002/iub.2122; Teramoto T, 2020, NUCLEIC ACIDS RES, V48, P11815, DOI 10.1093/nar/gkaa627; Wan FT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10496-3; Wu J, 2018, CELL, V175, P1393, DOI 10.1016/j.cell.2018.10.003; Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711; Zhang JW, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6020018; Zhang JW, 2013, NATURE, V500, P363, DOI 10.1038/nature12440; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	36	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101028	10.1016/j.jbc.2021.101028	http://dx.doi.org/10.1016/j.jbc.2021.101028			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339732	gold, Green Published			2022-12-28	WOS:000706408900008
J	Yamaguchi, K; Itakura, M; Kitazawa, R; Lim, SY; Nagata, K; Shibata, T; Akagawa, M; Uchida, K				Yamaguchi, Kosuke; Itakura, Masanori; Kitazawa, Roma; Lim, Sei-Young; Nagata, Koji; Shibata, Takahiro; Akagawa, Mitsugu; Uchida, Koji			Oxidative deamination of lysine residues by polyphenols generates an equilibrium of aldehyde and 2-piperidinol products	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSYL OXIDASE; GREEN TEA; IDENTIFICATION; SEMIALDEHYDES; COMPLEXES; MECHANISM; PROTEINS; EPITOPES	Polyphenols, especially catechol-type polyphenols, exhibit lysyl oxidase-like activity and mediate oxidative deamination of lysine residues in proteins. Previous studies have shown that polyphenol-mediated oxidative deamination of lysine residues can be associated with altered electrical properties of proteins and increased crossreactivity with natural immunoglobulin M antibodies. This interaction suggested that oxidized proteins could act as innate antigens and elicit an innate immune response. However, the structural basis for oxidatively deaminated lysine residues remains unclear. In the present study, to establish the chemistry of lysine oxidation, we characterized oxidation products obtained via incubation of the lysine analog N-biotinyl-5-aminopentylamine with eggshell membranes containing lysyl oxidase and identified a unique six-membered ring 2-piperidinol derivative equilibrated with a ring-open product (aldehyde) as the major product. By monitoring these aldehyde-2-piperidinol products, we evaluated the lysyl oxidase-like activity of polyphenols. We also observed that this reaction was mediated by some polyphenols, especially o-diphenolic-type polyphenols, in the presence of copper ions. Interestingly, the natural immunoglobulin M monoclonal antibody recognized these aldehyde-2-piperidinol products as an innate epitope. These findings establish the existence of a dynamic equilibrium of oxidized lysine and provide important insights into the chemopreventive function of dietary polyphenols for chronic diseases.	[Yamaguchi, Kosuke; Itakura, Masanori; Kitazawa, Roma; Lim, Sei-Young; Nagata, Koji; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Shibata, Takahiro] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Akagawa, Mitsugu] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Sakai, Osaka, Japan; [Uchida, Koji] Japan Agcy Med Res & Dev, CREST, Tokyo, Japan	University of Tokyo; Nagoya University; Osaka Metropolitan University; Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), Japan Agcy Med Res & Dev, CREST, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp	Shibata, Takahiro/I-6872-2014	Shibata, Takahiro/0000-0003-3194-607X; Nagata, Koji/0000-0002-4704-0603	Ministry of Education, Sciences, Sports, Technology, Japan [JP17H06170];  [JP20gm0910013]	Ministry of Education, Sciences, Sports, Technology, Japan; 	This study was supported in part by a Grant-in-aid for Scientific Research (S) (no. JP17H06170) (to K. U.) from the Ministry of Education, Sciences, Sports, Technology, Japan. This research was also supported by AMED-CREST from AMED (JP20gm0910013) (to K. U.).	Akagawa M, 2005, J AGR FOOD CHEM, V53, P8019, DOI 10.1021/jf050843f; Akagawa M, 2001, EUR J BIOCHEM, V268, P1953, DOI 10.1046/j.1432-1327.2001.02068.x; Akagawa M, 1999, BBA-PROTEIN STRUCT M, V1434, P151, DOI 10.1016/S0167-4838(99)00169-7; Akagawa M, 2016, BIOSCI BIOTECH BIOCH, V80, P13, DOI 10.1080/09168451.2015.1062715; Akagawa M, 2006, CHEM RES TOXICOL, V19, P1059, DOI 10.1021/tx060026p; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Charron CL, 2018, AUST J CHEM, V71, P697, DOI 10.1071/CH18198; Furuhashi M, 2017, BIOCHEMISTRY-US, V56, P4701, DOI 10.1021/acs.biochem.7b00409; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; HARRIS ED, 1980, SCIENCE, V208, P55, DOI 10.1126/science.6102412; Hatasa Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153002; Hawkins CL, 2019, J BIOL CHEM, V294, P19683, DOI 10.1074/jbc.REV119.006217; Ishii T, 2008, FREE RADICAL BIO MED, V45, P1384, DOI 10.1016/j.freeradbiomed.2008.07.023; Ishii T, 2010, BIOORGAN MED CHEM, V18, P4892, DOI 10.1016/j.bmc.2010.06.021; KAGAN HM, 1991, AM J RESP CELL MOL, V5, P206, DOI 10.1165/ajrcmb/5.3.206; Kaveri SV, 2012, J IMMUNOL, V188, P939, DOI 10.4049/jimmunol.1102107; Kijewska M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28798-9; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; Lin H, 2017, FREE RADICAL BIO MED, V104, P20, DOI 10.1016/j.freeradbiomed.2017.01.006; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Lutz HU, 2007, J AUTOIMMUN, V29, P287, DOI 10.1016/j.jaut.2007.07.007; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Schmelzer CEH, 2020, IUBMB LIFE, V72, P842, DOI 10.1002/iub.2213; SHAH MA, 1992, BIOCHIM BIOPHYS ACTA, V1159, P311, DOI 10.1016/0167-4838(92)90061-H; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; STAHMANN MA, 1977, BIOPOLYMERS, V16, P1299, DOI 10.1002/bip.1977.360160610; SUZUKI S, 1988, INORG CHEM, V27, P591, DOI 10.1021/ic00277a001	27	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101035	10.1016/j.jbc.2021.101035	http://dx.doi.org/10.1016/j.jbc.2021.101035			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34339739	Green Published, gold			2022-12-28	WOS:000704369100005
J	Du Truong, C; Craig, TA; Cui, GF; Botuyan, MV; Serkasevich, RA; Chan, KY; Mer, G; Chiu, PL; Kumar, R				Du Truong, Chloe; Craig, Theodore A.; Cui, Gaofeng; Botuyan, Maria Victoria; Serkasevich, Rachel A.; Chan, Ka-Yi; Mer, Georges; Chiu, Po-Lin; Kumar, Rajiv			Cryo-EM reveals conformational flexibility in apo DNA polymerase zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST REV1; TRANSLESION SYNTHESIS; COMPLEX-FORMATION; STATISTICAL-MODEL; PROTEIN-KINASE; SUBUNIT; BYPASS; DELTA; VISUALIZATION; MUTAGENESIS	The translesion synthesis (TLS) DNA polymerases Rev1 and Pol zeta function together in DNA lesion bypass during DNA replication, acting as nucleotide inserter and extender polymerases, respectively. While the structural characterization of the Saccharomyces cerevisiae Pol zeta in its DNA-bound state has illuminated how this enzyme synthesizes DNA, a mechanistic understanding of TLS also requires probing conformational changes associated with DNA-and Rev1 binding. Here, we used single-particle cryo-electron microscopy to determine the structure of the apo Pol zeta holoenzyme. We show that compared with its DNA-bound state, apo Pol zeta displays enhanced flexibility that correlates with concerted motions associated with expansion of the Pol zeta DNA-binding channel upon DNA binding. We also identified a lysine residue that obstructs the DNA-binding channel in apo Pol zeta, suggesting a gating mechanism. The Pol zeta subunit Rev7 is a hub protein that directly binds Rev1 and is a component of several other protein complexes such as the shieldin DNA double-strand break repair complex. We analyzed the molecular interactions of budding yeast Rev7 in the context of Pol zeta and those of human Rev7 in the context of shieldin using a crystal structure of Rev7 bound to a fragment of the shieldin-3 protein. Overall, our study provides new insights into Pol zeta mechanism of action and the manner in which Rev7 recognizes partner proteins.	[Du Truong, Chloe; Chan, Ka-Yi; Chiu, Po-Lin] Arizona State Univ, Biodesign Inst, Sch Mol Sci, Tempe, AZ 85281 USA; [Craig, Theodore A.; Serkasevich, Rachel A.; Kumar, Rajiv] Mayo Clin, Dept Med, Div Hypertens & Nephrol, Nephrol & Hypertens Res, Rochester, MN 55901 USA; [Cui, Gaofeng; Botuyan, Maria Victoria; Mer, Georges; Kumar, Rajiv] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA; [Mer, Georges] Mayo Clin, Dept Canc Biol, Rochester, MN 55901 USA; [Chiu, Po-Lin] Arizona State Univ, Biodesign Ctr Struct Appl Discovery, Tempe, AZ 85281 USA	Arizona State University; Arizona State University-Tempe; Mayo Clinic; Mayo Clinic; Mayo Clinic; Arizona State University; Arizona State University-Tempe	Chiu, PL (corresponding author), Arizona State Univ, Biodesign Inst, Sch Mol Sci, Tempe, AZ 85281 USA.; Kumar, R (corresponding author), Mayo Clin, Dept Med, Div Hypertens & Nephrol, Nephrol & Hypertens Res, Rochester, MN 55901 USA.; Mer, G; Kumar, R (corresponding author), Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55901 USA.; Mer, G (corresponding author), Mayo Clin, Dept Canc Biol, Rochester, MN 55901 USA.; Chiu, PL (corresponding author), Arizona State Univ, Biodesign Ctr Struct Appl Discovery, Tempe, AZ 85281 USA.	mer.georges@mayo.edu; plchiu@asu.edu; rkumar@mayo.edu	Chiu, Po-Lin/ABB-7848-2021; Chiu, Po-Lin/GWV-6758-2022; Mer, Georges/AAT-4946-2021	Chiu, Po-Lin/0000-0001-8608-7650; Chiu, Po-Lin/0000-0001-8608-7650; Mer, Georges/0000-0002-1900-1578; Botuyan, Maria Victoria/0000-0002-6466-7432	Arizona State University (ASU); NVIDIA GPU Grant Program	Arizona State University (ASU); NVIDIA GPU Grant Program	This research was also supported by Arizona State University (ASU) startup funds to P.-L. C. We thank the GPU device support by the NVIDIA GPU Grant Program to P.-L. C.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baynton K, 2000, TRENDS BIOCHEM SCI, V25, P74, DOI 10.1016/S0968-0004(99)01524-8; Bepler T, 2019, NAT METHODS, V16, P1153, DOI 10.1038/s41592-019-0575-8; Bezalel-Buch R, 2020, NUCLEIC ACIDS RES, V48, P8461, DOI 10.1093/nar/gkaa580; Brandao LN, 2014, GENETICS, V197, P1111, DOI 10.1534/genetics.114.165308; Cardone G, 2013, J STRUCT BIOL, V184, P226, DOI 10.1016/j.jsb.2013.08.002; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Chatterjee N, 2020, P NATL ACAD SCI USA, V117, P28918, DOI 10.1073/pnas.2016064117; Cheng AC, 2018, J STRUCT BIOL, V204, P270, DOI 10.1016/j.jsb.2018.07.015; Chiu PL, 2015, J STRUCT BIOL, V192, P163, DOI 10.1016/j.jsb.2015.08.015; Cui GF, 2018, J MOL BIOL, V430, P2042, DOI 10.1016/j.jmb.2018.05.017; Dai YX, 2020, J BIOL CHEM, V295, P250, DOI 10.1074/jbc.RA119.011464; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fattah FJ, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004419; Ghezraoui H, 2018, NATURE, V560, P122, DOI 10.1038/s41586-018-0362-1; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gomez-Llorente Y, 2013, CELL REP, V5, P79, DOI 10.1016/j.celrep.2013.08.046; Goodman MF, 2002, ANNU REV BIOCHEM, V71, P17, DOI 10.1146/annurev.biochem.71.083101.124707; Goodman MF, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a010363; Guo CX, 2003, EMBO J, V22, P6621, DOI 10.1093/emboj/cdg626; Guo DY, 2004, NUCLEIC ACIDS RES, V32, P1122, DOI 10.1093/nar/gkh279; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Hara K, 2010, J BIOL CHEM, V285, P12299, DOI 10.1074/jbc.M109.092403; Jain R, 2019, NAT STRUCT MOL BIOL, V26, P955, DOI 10.1038/s41594-019-0305-z; Johnson RE, 2012, P NATL ACAD SCI USA, V109, P12455, DOI 10.1073/pnas.1206052109; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kunz BA, 2000, MUTAT RES-FUND MOL M, V451, P169, DOI 10.1016/S0027-5107(00)00048-8; Lawrence CW, 2004, ADV PROTEIN CHEM, V69, P167; LEMONTT JF, 1971, GENETICS, V68, P21; Leung W, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010010; Liang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15879-5; Makarova AV, 2015, DNA REPAIR, V29, P47, DOI 10.1016/j.dnarep.2015.02.012; Makarova AV, 2012, NUCLEIC ACIDS RES, V40, P11618, DOI 10.1093/nar/gks948; Malik R, 2020, NAT STRUCT MOL BIOL, V27, P913, DOI 10.1038/s41594-020-0476-7; Marians KJ, 2018, ANNU REV BIOCHEM, V87, P217, DOI 10.1146/annurev-biochem-062917-011921; Martin SK, 2019, NUCLEIC ACIDS RES, V47, P8348, DOI 10.1093/nar/gkz705; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Masuda Y, 2003, J BIOL CHEM, V278, P12356, DOI 10.1074/jbc.M211765200; Miniowitz-Shemtov S, 2015, P NATL ACAD SCI USA, V112, P11536, DOI 10.1073/pnas.1515358112; MORRISON A, 1989, J BACTERIOL, V171, P5659, DOI 10.1128/jb.171.10.5659-5667.1989; Murakumo Y, 2000, J BIOL CHEM, V275, P4391, DOI 10.1074/jbc.275.6.4391; Murakumo Y, 2001, J BIOL CHEM, V276, P35644, DOI 10.1074/jbc.M102051200; Nair DT, 2005, SCIENCE, V309, P2219, DOI 10.1126/science.1116336; Nakane T, 2018, ELIFE, V7, DOI [10.7554/elife.36861, 10.7554/eLife.36861]; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Nelson JR, 1996, SCIENCE, V272, P1646, DOI 10.1126/science.272.5268.1646; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Netz DJA, 2012, NAT CHEM BIOL, V8, P125, DOI 10.1038/nchembio.721; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pintilie GD, 2010, J STRUCT BIOL, V170, P427, DOI 10.1016/j.jsb.2010.03.007; Prakash S, 2005, ANNU REV BIOCHEM, V74, P317, DOI 10.1146/annurev.biochem.74.082803.133250; Punjani A, 2020, NAT METHODS, V17, P1214, DOI 10.1038/s41592-020-00990-8; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rizzo AA, 2019, ENZYMES, V45, P139, DOI 10.1016/bs.enz.2019.07.001; Rizzo AA, 2018, P NATL ACAD SCI USA, V115, pEB191, DOI 10.1073/pnas.1801149115; Rosenberg SC, 2015, J CELL BIOL, V211, P745, DOI 10.1083/jcb.201509076; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Tan YZ, 2017, NAT METHODS, V14, P793, DOI [10.1038/NMETH.4347, 10.1038/nmeth.4347]; Taniguchi T, 2019, MOL CELL, V75, P419, DOI 10.1016/j.molcel.2019.07.012; Waters LS, 2009, MICROBIOL MOL BIOL R, V73, P134, DOI 10.1128/MMBR.00034-08; Wojtaszek JL, 2019, CELL, V178, P152, DOI 10.1016/j.cell.2019.05.028; Xie W, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2024512118; Yamanaka K, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006842; Zhang L, 2007, MOL CELL BIOL, V27, P2861, DOI 10.1128/MCB.02276-06; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	73	2	2	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100912	10.1016/j.jbc.2021.100912	http://dx.doi.org/10.1016/j.jbc.2021.100912			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34174285	Green Published, gold			2022-12-28	WOS:000690879300013
J	He, QF; He, X; Xiao, Y; Zhao, Q; Ye, ZZ; Cui, LM; Chen, Y; Guan, MX				He, Qiufen; He, Xiao; Xiao, Yun; Zhao, Qiong; Ye, Zhenzhen; Cui, Limei; Chen, Ye; Guan, Min-Xin			Tissue-specific expression atlas of murine mitochondrial tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA; M(1)G37 MODIFICATION; MUTATION; AMINOACYLATION; BIOSYNTHESIS; ORGANIZATION; BIOGENESIS; SEQUENCE; MODEL	Mammalian mitochondrial tRNA (mt-tRNA) plays a central role in the synthesis of the 13 subunits of the oxidative phosphorylation complex system (OXPHOS). However, many aspects of the context-dependent expression of mt-tRNAs in mammals remain unknown. To investigate the tissue-specific effects of mt-tRNAs, we performed a comprehensive analysis of mitochondrial tRNA expression across five mice tissues (brain, heart, liver, skeletal muscle, and kidney) using Northern blot analysis. Striking differences in the tissue-specific expression of 22 mt-tRNAs were observed, in some cases differing by as much as tenfold from lowest to highest expression levels among these five tissues. Overall, the heart exhibited the highest levels of mt-tRNAs, while the liver displayed markedly lower levels. Variations in the levels of mt-tRNAs showed significant correlations with total mitochondrial DNA (mtDNA) contents in these tissues. However, there were no significant differences observed in the 2-thiouridylation levels of tRNALys, tRNAGlu, and tRNAGln among these tissues. A wide range of aminoacylation levels for 15 mt-tRNAs occurred among these five tissues, with skeletal muscle and kidneys most notably displaying the highest and lowest tRNA aminoacylation levels, respectively. Among these tissues, there was a negative correlation between variations in mt-tRNA aminoacylation levels and corresponding variations in mitochondrial tRNA synthetases (mt-aaRS) expression levels. Furthermore, the variable levels of OXPHOS subunits, as encoded by mtDNA or nuclear genes, may reflect differences in relative functional emphasis for mitochondria in each tissue. Our findings provide new insight into the mechanism of mt-tRNA tissue-specific effects on oxidative phosphorylation.	[He, Qiufen; He, Xiao; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Childrens Hosp, Div Med Genet & Genom, Sch Med, Hangzhou, Zhejiang, Peoples R China; [He, Qiufen; He, Xiao; Chen, Ye; Guan, Min-Xin] Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China; [He, Qiufen; He, Xiao; Xiao, Yun; Zhao, Qiong; Ye, Zhenzhen; Cui, Limei; Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Chen, Ye; Guan, Min-Xin] Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ, Ctr Mitochondrial Genet, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou, Zhejiang, Peoples R China; [Guan, Min-Xin] Zhejiang Univ Univ Toronto Joint Inst Genet & Gen, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Chen, Y; Guan, MX (corresponding author), Zhejiang Univ, Childrens Hosp, Div Med Genet & Genom, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, Y; Guan, MX (corresponding author), Natl Clin Res Ctr Child Hlth, Hangzhou, Zhejiang, Peoples R China.; Chen, Y; Guan, MX (corresponding author), Zhejiang Univ, Inst Genet, Sch Med, Hangzhou, Zhejiang, Peoples R China.; Chen, Y; Guan, MX (corresponding author), Zhejiang Univ, Zhejiang Prov Key Lab Genet & Dev Disorders, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ, Ctr Mitochondrial Genet, Key Lab Reprod Genet, Minist Educ PRC, Hangzhou, Zhejiang, Peoples R China.; Guan, MX (corresponding author), Zhejiang Univ Univ Toronto Joint Inst Genet & Gen, Div Mitochondrial Biomed, Hangzhou, Zhejiang, Peoples R China.	yechency@zju.edu.cn; gminxin88@zju.edu.cn	; Chen, Ye/D-1164-2015	He, Qiufen/0000-0002-1175-1913; Chen, Ye/0000-0003-3671-2504; Guan, Min-Xin/0000-0001-5067-6736	Ministry of Science and Technology of Zhejiang Province [2018C03026]; Ministry of Science and Technology of China [2018YFC1004802]; National Natural Science Foundation of China [82030028, 31671305]	Ministry of Science and Technology of Zhejiang Province; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research was supported by grants from Grant 2018C03026 from Ministry of Science and Technology of Zhejiang Province, the National Key Technologies R&D Program Grant 2018YFC1004802 from the Ministry of Science and Technology of China (to M.-X. G.), 82030028 (M.-X. G.), and 31671305 (Y. C.) from the National Natural Science Foundation of China.	Agnew T, 2018, CELL REP, V25, P3315, DOI 10.1016/j.celrep.2018.11.080; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Barazzoni R, 2000, J BIOL CHEM, V275, P3343, DOI 10.1074/jbc.275.5.3343; Bayona-Bafaluy MP, 2003, NUCLEIC ACIDS RES, V31, P5349, DOI 10.1093/nar/gkg739; BIBB MJ, 1981, CELL, V26, P167, DOI 10.1016/0092-8674(81)90300-7; Brzezniak LK, 2011, RNA BIOL, V8, P616, DOI 10.4161/rna.8.4.15393; Dittmar KA, 2006, PLOS GENET, V2, P2107, DOI 10.1371/journal.pgen.0020221; Dogan SA, 2014, CELL METAB, V19, P458, DOI 10.1016/j.cmet.2014.02.004; El Yacoubi B, 2012, ANNU REV GENET, V46, P69, DOI 10.1146/annurev-genet-110711-155641; Enriquez J A, 1996, Methods Enzymol, V264, P183, DOI 10.1016/S0076-6879(96)64019-1; ENRIQUEZ JA, 1995, NAT GENET, V10, P47, DOI 10.1038/ng0595-47; Fernandez-Vizarra E, 2011, MITOCHONDRION, V11, P207, DOI 10.1016/j.mito.2010.09.011; Torres AG, 2019, P NATL ACAD SCI USA, V116, P8451, DOI 10.1073/pnas.1821120116; Guan MX, 2006, AM J HUM GENET, V79, P291, DOI 10.1086/506389; Herbers E, 2019, MITOCHONDRION, V44, P85, DOI 10.1016/j.mito.2018.01.004; Holzmann J, 2008, CELL, V135, P462, DOI 10.1016/j.cell.2008.09.013; Hou YM, 2010, IUBMB LIFE, V62, P251, DOI 10.1002/iub.301; Huttlin EL, 2010, CELL, V143, P1174, DOI 10.1016/j.cell.2010.12.001; Ji YC, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100816; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC689, DOI 10.1152/ajpcell.00108.2006; Juhling F, 2009, NUCLEIC ACIDS RES, V37, pD159, DOI 10.1093/nar/gkn772; KING MP, 1993, J BIOL CHEM, V268, P10228; Kirchner S, 2015, NAT REV GENET, V16, P98, DOI 10.1038/nrg3861; Lant JT, 2019, J BIOL CHEM, V294, P5294, DOI 10.1074/jbc.REV118.002982; Magalhaes PJ, 1998, MOL BIOL CELL, V9, P2375, DOI 10.1091/mbc.9.9.2375; Masuyama M, 2005, BBA-GEN SUBJECTS, V1723, P302, DOI 10.1016/j.bbagen.2005.03.001; Maute RL, 2013, P NATL ACAD SCI USA, V110, P1404, DOI 10.1073/pnas.1206761110; McFarland MR, 2020, NUCLEIC ACIDS RES, V48, P3071, DOI 10.1093/nar/gkaa055; McManus MJ, 2019, CELL METAB, V29, P78, DOI 10.1016/j.cmet.2018.08.002; Meng FL, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1225; Meng FL, 2017, J BIOL CHEM, V292, P2881, DOI 10.1074/jbc.M116.749374; Mercer TR, 2011, CELL, V146, P645, DOI 10.1016/j.cell.2011.06.051; MONTOYA J, 1983, CELL, V34, P151, DOI 10.1016/0092-8674(83)90145-9; Muir R, 2016, BIOESSAYS, V38, P150, DOI 10.1002/bies.201500105; OJALA D, 1981, NATURE, V290, P470, DOI 10.1038/290470a0; Sanchez MIGL, 2011, CELL CYCLE, V10, P2904, DOI 10.4161/cc.10.17.17060; Scarpulla RC, 2008, PHYSIOL REV, V88, P611, DOI 10.1152/physrev.00025.2007; Sissler M, 2017, TRENDS MOL MED, V23, P693, DOI 10.1016/j.molmed.2017.06.002; Suzuki T, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18068-6; Suzuki T, 2011, ANNU REV GENET, V45, P299, DOI 10.1146/annurev-genet-110410-132531; Umeda N, 2005, J BIOL CHEM, V280, P1613, DOI 10.1074/jbc.M409306200; Wallace DC, 2013, J CLIN INVEST, V123, P1405, DOI 10.1172/JCI61398; Wang M, 2016, NUCLEIC ACIDS RES, V44, P10974, DOI 10.1093/nar/gkw726; Wang M, 2016, J BIOL CHEM, V291, P21029, DOI 10.1074/jbc.M116.739482; Xiao Y, 2020, NUCLEIC ACIDS RES, V48, P11113, DOI 10.1093/nar/gkaa860; Yu JL, 2020, J CLIN INVEST, V130, P4935, DOI 10.1172/JCI134965; Zhang JW, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1600; Zhang QH, 2018, NUCLEIC ACIDS RES, V46, P10930, DOI 10.1093/nar/gky758; Zhao XX, 2019, NUCLEIC ACIDS RES, V47, P10340, DOI 10.1093/nar/gkz742; Zhou M, 2018, J BIOL CHEM, V293, P1425, DOI 10.1074/jbc.RA117.000317	50	3	3	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100960	10.1016/j.jbc.2021.100960	http://dx.doi.org/10.1016/j.jbc.2021.100960			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265302	Green Published, gold			2022-12-28	WOS:000690871400019
J	Kayed, R				Kayed, Rakez			Infectious etiology and amyloidosis in Alzheimer's disease: The puzzle continues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							HERPES; NEUROINFLAMMATION; BRAIN	Recent studies have renewed the debate on infectious etiology in late-onset Alzheimer's disease. Bocharova et al. reported that abundant expression of human beta amyloid (A beta) in the mouse brain (5XFAD animals) failed to protect against acute herpes simplex virus type 1 infection relative to control mice. While this study does not confirm the antiviral actions of A beta, it neither supports nor disproves the hypothesis that infection with microbial pathogens is the major cause of Alzheimer's disease.	[Kayed, Rakez] Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Dept Neurol, Galveston, TX 77555 USA; [Kayed, Rakez] Univ Texas Med Branch, Dept Neurosci, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA; [Kayed, Rakez] Univ Texas Med Branch, Dept Cell Biol, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston; University of Texas System; University of Texas Medical Branch Galveston	Kayed, R (corresponding author), Univ Texas Med Branch, Mitchell Ctr Neurodegenerat Dis, Dept Neurol, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Neurosci, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA.; Kayed, R (corresponding author), Univ Texas Med Branch, Dept Cell Biol, Mitchell Ctr Neurodegenerat Dis, Galveston, TX 77555 USA.	rakayed@utmb.edu		Kayed, Rakez/0000-0001-6216-8640	Mitchell Center for Neurodegenerative Diseases; National Institutes of Health [R01AG054025, R01NS094557, RFA1AG055771, R01AG060718]	Mitchell Center for Neurodegenerative Diseases; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Work in the author's laboratory is supported by Mitchell Center for Neurodegenerative Diseases and National Institutes of Health grants: R01AG054025, R01NS094557, RFA1AG055771, and R01AG060718. The author is grateful to Drs Sagar Gaikwad and Urmi Sengupta for preparing the schematic and for the helpful suggestions. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bocharova O, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100845; Dasgupta G, 2011, VACCINE, V29, P5824, DOI 10.1016/j.vaccine.2011.06.083; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Ismail R, 2020, J NEUROINFLAMM, V17, DOI 10.1186/s12974-020-01820-6; Itzhaki RF, 2016, J ALZHEIMERS DIS, V54, P1273, DOI 10.3233/JAD-160607; Itzhaki RF, 2016, J ALZHEIMERS DIS, V51, P979, DOI 10.3233/JAD-160152; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Miklossy J, 2011, EXPERT REV MOL MED, V13, DOI 10.1017/S1462399411002006; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Wozniak MA, 2005, J MED VIROL, V75, P300, DOI 10.1002/jmv.20271	10	3	3	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100936	10.1016/j.jbc.2021.100936	http://dx.doi.org/10.1016/j.jbc.2021.100936			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34217702	Green Published, gold			2022-12-28	WOS:000690871000014
J	Kirstein, AS; Kehr, S; Nebe, M; Hanschkow, M; Barth, LAG; Lorenz, J; Penke, M; Breitfeld, J; Le Duc, D; Landgraf, K; Korner, A; Kovacs, P; Stadler, PF; Kiess, W; Garten, A				Kirstein, Anna S.; Kehr, Stephanie; Nebe, Michele; Hanschkow, Martha; Barth, Lisa A. G.; Lorenz, Judith; Penke, Melanie; Breitfeld, Jana; Le Duc, Diana; Landgraf, Kathrin; Korner, Antje; Kovacs, Peter; Stadler, Peter F.; Kiess, Wieland; Garten, Antje			PTEN regulates adipose progenitor cell growth, differentiation, and replicative aging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INSULIN-RECEPTOR; GENE-EXPRESSION; FAT; TISSUE; ADIPOCYTES; BINDING; ADIPOGENESIS; INTEGRATION; METABOLISM; IMPACT	The tumor suppressor phosphatase and tensin homolog (PTEN) negatively regulates the insulin signaling pathway. Germline PTEN pathogenic variants cause PTEN hamartoma tumor syndrome (PHTS), associated with lipoma development in children. Adipose progenitor cells (APCs) lose their capacity to differentiate into adipocytes during continuous culture, whereas APCs from lipomas of patients with PHTS retain their adipogenic potential over a prolonged period. It remains unclear which mechanisms trigger this aberrant adipose tissue growth. To investigate the role of PTEN in adipose tissue development, we performed functional assays and RNA-Seq of control and PTEN knockdown APCs. Reduction of PTEN levels using siRNA or CRISPR led to enhanced proliferation and differentiation of APCs. Forkhead box protein O1 (FOXO1) transcriptional activity is known to be regulated by insulin signaling, and FOXO1 was downregulated at the mRNA level while its inactivation through phosphorylation increased. FOXO1 phosphorylation initiates the expression of the lipogenesis-activating transcription factor sterol regulatory element-binding protein 1 (SREBP1). SREBP1 levels were higher after PTEN knockdown and may account for the observed enhanced adipogenesis. To validate this, we overexpressed constitutively active FOXO1 in PTEN CRISPR cells and found reduced adipogenesis, accompanied by SREBP1 downregulation. We observed that PTEN CRISPR cells showed less senescence compared with controls and the senescence marker CDKN1A (p21) was downregulated in PTEN knockdown cells. Cellular senescence was the most significantly enriched pathway found in RNA-Seq of PTEN knockdown versus control cells. These results provide evidence that PTEN is involved in the regulation of APC proliferation, differentiation, and senescence, thereby contributing to aberrant adipose tissue growth in patients with PHTS.	[Kirstein, Anna S.; Nebe, Michele; Hanschkow, Martha; Barth, Lisa A. G.; Lorenz, Judith; Penke, Melanie; Landgraf, Kathrin; Korner, Antje; Kiess, Wieland; Garten, Antje] Univ Leipzig, Ctr Pediat Res, Univ Hosp Children & Adolescents, Leipzig, Germany; [Kehr, Stephanie; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, Bioinformat Grp, Leipzig, Germany; [Kehr, Stephanie; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, Leipzig, Germany; [Breitfeld, Jana; Kovacs, Peter] Univ Leipzig, Med Dept Endocrinol Nephrol Rheumatol 3, Med Ctr, Leipzig, Germany; [Le Duc, Diana] Univ Leipzig, Inst Human Genet, Med Ctr, Leipzig, Germany; [Le Duc, Diana] Max Planck Inst Evolutionary Anthropol, Dept Evolutionary Genet, Leipzig, Germany; [Stadler, Peter F.] Max Planck Inst Math Sci, Leipzig, Germany; [Garten, Antje] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England	Leipzig University; Leipzig University; Leipzig University; Leipzig University; Leipzig University; Max Planck Society; Max Planck Society; University of Birmingham	Kirstein, AS (corresponding author), Univ Leipzig, Ctr Pediat Res, Univ Hosp Children & Adolescents, Leipzig, Germany.	anna.Kirstein@medizin.uni-leipzig.de	Kirstein, Anna/GPX-6631-2022; Körner, Antje/B-3988-2015; Landgraf, Kathrin/J-4937-2016	Kirstein, Anna/0000-0002-3554-1902; Körner, Antje/0000-0001-6001-0356; Landgraf, Kathrin/0000-0002-6878-6033; Kehr, Stephanie/0000-0001-8461-5763; Kovacs, Peter/0000-0002-0290-5423	Clinician Scientist Program, Medizinische Fakultat der Universitat Leipzig; ESPE Early Career Scientific Development Grant; Federal Ministry of Education and Research (BMBF), Germany [FKZ: 01EO1501]	Clinician Scientist Program, Medizinische Fakultat der Universitat Leipzig; ESPE Early Career Scientific Development Grant; Federal Ministry of Education and Research (BMBF), Germany(Federal Ministry of Education & Research (BMBF))	D. L. D. is funded through "Clinician Scientist Program, Medizinische Fakultat der Universitat Leipzig." M. H. was supported through the ESPE Early Career Scientific Development Grant. K. L. and A. K. were supported by the Federal Ministry of Education and Research (BMBF), Germany, (FKZ: 01EO1501, IFB AdiposityDiseases). P. F. S. is also affiliated with the Institute of Theoretical Chemistry of the University of Vienna, Austria, the National University of Colombia, and the Santa Fe Institute.	Afgan E, 2018, NUCLEIC ACIDS RES, V46, pW537, DOI 10.1093/nar/gky379; Bartke A, 2008, AGING CELL, V7, P285, DOI 10.1111/j.1474-9726.2008.00387.x; Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29; Berniakovich I, 2008, J BIOL CHEM, V283, P34283, DOI 10.1074/jbc.M804362200; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Breitfeld J, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00138; Cartwright MJ, 2007, EXP GERONTOL, V42, P463, DOI 10.1016/j.exger.2007.03.003; Choudhery MS, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-8; Chu CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036474; Cignarelli A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030759; Deng X, 2012, J BIOL CHEM, V287, P20132, DOI 10.1074/jbc.M112.347211; Eckel-Mahan K, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9040863; Esteve D, 2015, STEM CELLS, V33, P1277, DOI 10.1002/stem.1916; Fagerberg L, 2014, MOL CELL PROTEOMICS, V13, P397, DOI 10.1074/mcp.M113.035600; Feng YY, 2017, ONCOTARGET, V8, P20452, DOI 10.18632/oncotarget.14723; Filtz EA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136729; Fischer-Posovszky P, 2008, OBESITY FACTS, V1, P184, DOI 10.1159/000145784; Garcia Z, 2006, EMBO J, V25, P655, DOI 10.1038/sj.emboj.7600967; HAUNER H, 1989, J CLIN INVEST, V84, P1663, DOI 10.1172/JCI114345; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Hsieh SC, 2009, MOL CARCINOGEN, V48, P545, DOI 10.1002/mc.20491; Huang W, 2019, MOL METAB, V30, P48, DOI 10.1016/j.molmet.2019.09.008; Igarashi M, 2019, AGING CELL, V18, DOI 10.1111/acel.12935; Kassner F, 2020, ADIPOCYTE, V9, P290, DOI 10.1080/21623945.2020.1785083; Kassner F, 2018, INT J MOL MED, V41, P3691, DOI 10.3892/ijmm.2018.3568; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kirkland JL, 2002, EXP GERONTOL, V37, P757, DOI 10.1016/S0531-5565(02)00014-1; Kirstein AS, 2019, CANCERS, V11, DOI 10.3390/cancers11101586; Klingelhutz AJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19024-z; Le Duc D., 2020, INT J OBES LOND, V45, P565; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luo WJ, 2013, BIOINFORMATICS, V29, P1830, DOI 10.1093/bioinformatics/btt285; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Pal A, 2012, NEW ENGL J MED, V367, P1002, DOI 10.1056/NEJMoa1113966; Ramaswamy S, 1999, P NATL ACAD SCI USA, V96, P2110, DOI 10.1073/pnas.96.5.2110; Sanchez-Gurmaches J, 2012, CELL METAB, V16, P348, DOI 10.1016/j.cmet.2012.08.003; Sanjabi S, 2005, GENE DEV, V19, P2138, DOI 10.1101/gad.1329805; Saxton RA, 2017, CELL, V168, P960, DOI [10.1016/j.cell.2017.03.035, 10.1016/j.cell.2017.02.004]; Schaum N, 2020, NATURE, V583, P596, DOI 10.1038/s41586-020-2499-y; Schmid GL, 2014, PEDIATR RES, V75, P527, DOI 10.1038/pr.2013.246; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schumacher B, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000161; Simpson L, 2001, EXP CELL RES, V264, P29, DOI 10.1006/excr.2000.5130; Stephens M, 2017, BIOSTATISTICS, V18, P275, DOI 10.1093/biostatistics/kxw041; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang ED, 1999, J BIOL CHEM, V274, P16741, DOI 10.1074/jbc.274.24.16741; Tchkonia T, 2010, AGING CELL, V9, P667, DOI 10.1111/j.1474-9726.2010.00608.x; Tsai CA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng052; Tu Q, 2018, ONCOGENE, V37, P128, DOI 10.1038/onc.2017.316; Wabitsch M, 2001, INT J OBESITY, V25, P8, DOI 10.1038/sj.ijo.0801520; YKIJARVINEN H, 1986, ACTA ENDOCRINOL-COP, V113, P88, DOI 10.1530/acta.0.1130088; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014	53	6	6	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100968	10.1016/j.jbc.2021.100968	http://dx.doi.org/10.1016/j.jbc.2021.100968			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34273354	Green Published, gold			2022-12-28	WOS:000690871400001
J	Sridhar, A; Lummis, SCR; Pasini, D; Mehregan, A; Brams, M; Kambara, K; Bertrand, D; Lindahl, E; Howard, RJ; Ulens, C				Sridhar, Akshay; Lummis, Sarah C. R.; Pasini, Diletta; Mehregan, Aujan; Brams, Marijke; Kambara, Kumiko; Bertrand, Daniel; Lindahl, Erik; Howard, Rebecca J.; Ulens, Chris			Regulation of a pentameric ligand-gated ion channel by a semiconserved cationic lipid-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; PROTEIN INTERACTIONS; GENERAL-ANESTHETICS; STRUCTURAL BASIS; SOFTWARE NEWS; K+ CHANNEL; RECEPTOR; DYNAMICS; ACTIVATION; MECHANISM	Pentameric ligand-gated ion channels (pLGICs) are crucial mediators of electrochemical signal transduction in various organisms from bacteria to humans. Lipids play an important role in regulating pLGIC function, yet the structural bases for specific pLGIC-lipid interactions remain poorly understood. The bacterial channel ELIC recapitulates several properties of eukaryotic pLGICs, including activation by the neurotransmitter GABA and binding and modulation by lipids, offering a simplified model system for structure-function relationship studies. In this study, functional effects of noncanonical amino acid substitution of a potential lipid-interacting residue (W206) at the top of the M1-helix, combined with detergent interactions observed in recent X-ray structures, are consistent with this region being the location of a lipid-binding site on the outward face of the ELIC transmembrane domain. Coarse grained and atomistic molecular dynamics simulations revealed preferential binding of lipids containing a positive charge, particularly involving interactions with residue W206, consistent with cation-pi binding. Polar contacts from other regions of the protein, particularly M3 residue Q264, further support lipid binding via headgroup ester linkages. Aromatic residues were identified at analogous sites in a handful of eukaryotic family members, including the human GABA(A) receptor epsilon subunit, suggesting conservation of relevant interactions in other evolutionary branches. Further mutagenesis experiments indicated that mutations at this site in epsilon-containing GABA(A) receptors can change the apparent affinity of the agonist response to GAB(A), suggesting a potential role of this site in channel gating. In conclusion, this work details type-specific lipid interactions, which adds to our growing understanding of how lipids modulate pLGICs.	[Sridhar, Akshay; Lindahl, Erik] KTH Royal Inst Technol, Dept Appl Phys, Sci Life Lab, Solna, Sweden; [Lummis, Sarah C. R.] Univ Cambridge, Dept Biochem, Cambridge, England; [Pasini, Diletta; Mehregan, Aujan; Brams, Marijke; Ulens, Chris] Katholieke Univ Leuven, Lab Struct Neurobiol, Dept Cellular & Mol Med, Fac Med, Leuven, Belgium; [Kambara, Kumiko; Bertrand, Daniel] HiQScreen Sarl, Geneva, Switzerland; [Lindahl, Erik; Howard, Rebecca J.] Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden	Royal Institute of Technology; University of Cambridge; KU Leuven; Stockholm University	Ulens, C (corresponding author), Katholieke Univ Leuven, Lab Struct Neurobiol, Dept Cellular & Mol Med, Fac Med, Leuven, Belgium.; Howard, RJ (corresponding author), Stockholm Univ, Dept Biochem & Biophys, Sci Life Lab, Solna, Sweden.	ecca.noward@scilifelab.se; chris.ulens@kuleuven.be		Ulens, Chris/0000-0002-8202-5281	Marie Sklodowska-Curie grant [898762]; Swedish Research Council [2017-04641, 2019-02433]; Swedish e-Science Research Center; MRC [MR/L021676]; FWO-Vlaanderen [G0C9717N, G0C1319N]; KU Leuven [C3/19/023, C14/17/093]	Marie Sklodowska-Curie grant; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish e-Science Research Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); FWO-Vlaanderen(FWO); KU Leuven(KU Leuven)	A. S. was supported by Marie Sklodowska-Curie grant 898762, and E. L./R. J. H. by grants from the Swedish Research Council (2017-04641, 2019-02433) and Swedish e-Science Research Center. S. C. R. L. was supported by the MRC grant MR/L021676. C. U. was supported by grants from FWO-Vlaanderen (G0C9717N, G0C1319N) and KU Leuven (C3/19/023, C14/17/093).	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Althoff T, 2014, NATURE, V512, P333, DOI 10.1038/nature13669; Arcario MJ, 2017, J BIOL CHEM, V292, P9480, DOI 10.1074/jbc.M117.780197; Barrantes FJ, 2002, MOL MEMBR BIOL, V19, P277, DOI 10.1080/09687680210166226; Basak S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02997-4; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Chen Q, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06361-4; Dacosta CJB, 2013, NAT CHEM BIOL, V9, P701, DOI [10.1038/NCHEMBIO.1338, 10.1038/nchembio.1338]; Dawaliby R, 2016, NAT CHEM BIOL, V12, P35, DOI [10.1038/NCHEMBIO.1960, 10.1038/nchembio.1960]; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; Du J, 2015, NATURE, V526, P224, DOI 10.1038/nature14853; Dumas F, 1999, FEBS LETT, V458, P271, DOI 10.1016/S0014-5793(99)01148-5; Duncan AL, 2020, ANNU REV PHARMACOL, V60, P31, DOI 10.1146/annurev-pharmtox-010919-023411; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Gharpure A, 2019, NEURON, V104, P501, DOI 10.1016/j.neuron.2019.07.030; Hansen SB, 2011, NATURE, V477, P495, DOI 10.1038/nature10370; Hassaine G, 2014, NATURE, V512, P276, DOI 10.1038/nature13552; Henault CM, 2019, NAT CHEM BIOL, V15, P1156, DOI 10.1038/s41589-019-0369-4; Henault CM, 2015, J BIOL CHEM, V290, P25118, DOI 10.1074/jbc.M115.676833; Hess B, 2008, J CHEM THEORY COMPUT, V4, P116, DOI 10.1021/ct700200b; Hibbs RE, 2011, NATURE, V474, P54, DOI 10.1038/nature10139; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Huang K, 2005, CURR OPIN NEUROBIOL, V15, P527, DOI 10.1016/j.conb.2005.08.001; Huang X, 2015, NATURE, V526, P277, DOI 10.1038/nature14972; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Keller CA, 2004, J NEUROSCI, V24, P5881, DOI 10.1523/JNEUROSCI.1037-04.2004; Khan HM, 2020, J CHEM THEORY COMPUT, V16, P2550, DOI 10.1021/acs.jctc.9b01194; Khan HM, 2019, J CHEM THEORY COMPUT, V15, P7, DOI 10.1021/acs.jctc.8b00839; Killian JA, 2000, TRENDS BIOCHEM SCI, V25, P429, DOI 10.1016/S0968-0004(00)01626-1; Kim JJ, 2020, NATURE, V585, P303, DOI 10.1038/s41586-020-2654-5; Knoflach F, 2018, JOVE-J VIS EXP, DOI 10.3791/57842; Lacin E, 2017, J GEN PHYSIOL, V149, P799, DOI 10.1085/jgp.201711801; Laganowsky A, 2014, NATURE, V510, P172, DOI 10.1038/nature13419; Laverty D, 2019, NATURE, V565, P516, DOI 10.1038/s41586-018-0833-4; Laverty D, 2017, NAT STRUCT MOL BIOL, V24, P977, DOI 10.1038/nsmb.3477; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Martens C, 2016, NAT STRUCT MOL BIOL, V23, P744, DOI 10.1038/nsmb.3262; Masiulis S, 2019, NATURE, V565, P454, DOI 10.1038/s41586-018-0832-5; McGibbon RT, 2015, BIOPHYS J, V109, P1528, DOI 10.1016/j.bpj.2015.08.015; Michaud-Agrawal N, 2011, J COMPUT CHEM, V32, P2319, DOI 10.1002/jcc.21787; Miller PS, 2017, NAT STRUCT MOL BIOL, V24, P986, DOI 10.1038/nsmb.3484; Miller PS, 2014, NATURE, V512, P270, DOI 10.1038/nature13293; Morales-Perez CL, 2016, NATURE, V538, P411, DOI 10.1038/nature19785; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; MOURITSEN OG, 1984, BIOPHYS J, V46, P141, DOI 10.1016/S0006-3495(84)84007-2; Muller MP, 2019, CHEM REV, V119, P6086, DOI 10.1021/acs.chemrev.8b00608; Norimatsu Y, 2017, NATURE, V545, P193, DOI 10.1038/nature22357; Nowak MW, 1998, METHOD ENZYMOL, V293, P504; Nury H, 2011, NATURE, V469, P428, DOI 10.1038/nature09647; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Phulera S, 2018, ELIFE, V7, DOI 10.7554/eLife.39383; Polovinkin L, 2018, NATURE, V563, P275, DOI 10.1038/s41586-018-0672-3; Price KL, 2005, J NEUROSCI METH, V149, P172, DOI 10.1016/j.jneumeth.2005.05.014; Qi YF, 2015, J CHEM THEORY COMPUT, V11, P4486, DOI 10.1021/acs.jctc.5b00513; Rahman MM, 2020, NEURON, V106, P952, DOI 10.1016/j.neuron.2020.03.012; Robinson CV, 2019, TRENDS BIOCHEM SCI, V44, P795, DOI 10.1016/j.tibs.2019.04.001; Rupakheti CR, 2018, THEOR CHEM ACC, V137, DOI 10.1007/s00214-018-2376-z; Sands ZA, 2007, STRUCTURE, V15, P235, DOI 10.1016/j.str.2007.01.004; Schmidt D, 2006, NATURE, V444, P775, DOI 10.1038/nature05416; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Tong AL, 2019, ELIFE, V8, DOI 10.7554/eLife.50766; Walsh RM, 2018, NATURE, V557, P261, DOI 10.1038/s41586-018-0081-7; Wassenaar TA, 2014, J CHEM THEORY COMPUT, V10, P676, DOI 10.1021/ct400617g; Wu HX, 2014, SCIENCE, V344, P58, DOI 10.1126/science.1249489; Yesylevskyy SO, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000810; Zheng H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1254; Zhu ST, 2018, NATURE, V559, P67, DOI 10.1038/s41586-018-0255-3	72	8	8	2	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100899	10.1016/j.jbc.2021.100899	http://dx.doi.org/10.1016/j.jbc.2021.100899			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34157288	Green Published, gold			2022-12-28	WOS:000690873500003
J	Stojanovski, BM; Di Cera, E				Stojanovski, Bosko M.; Di Cera, Enrico			Role of sequence and position of the cleavage sites in prothrombin activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; SINGLE-MOLECULE; ACTIVE-SITE; EXOSITE-I; SUBSTRATE; THROMBIN; BINDING; CONFORMATIONS; COAGULATION; SPECIFICITY	In the penultimate step of the coagulation cascade, the multidomain vitamin-K-dependent zymogen prothrombin is converted to thrombin by the prothrombinase complex composed of factor Xa, cofactor Va, and phospholipids. Activation of prothrombin requires cleavage at two residues, R271 and R320, along two possible pathways generating either the intermediate prethrombin-2 (following initial cleavage at R271) or meizothrombin (following initial cleavage at R320). The former pathway is preferred in the absence of and the latter in the presence of cofactor Va. Several mechanisms have been proposed to explain this preference, but the role of the sequence and position of the sites of cleavage has not been thoroughly investigated. In this study, we engineered constructs where the sequences (261)DEDSDRAIEGRTATSEYQT(279) and (310)RELLESYIDGRIVEGSDAE(328) were swapped between the R271 and R320 sites. We found that in the absence of cofactor Va, the wild-type sequence at the R271 site is cleaved preferentially regardless of its position at the R271 or R320 site, whereas in the presence of cofactor Va, the R320 site is cleaved preferentially regardless of its sequence. Additional single molecule FRET measurements revealed that the environment of R271 changes significantly upon cleavage at R320 due to the conformational transition from the closed form of prothrombin to the open form of meizothrombin. Detailed kinetics of cleavage at the R271 site were monitored by a newly developed assay based on loss of FRET. These findings show how sequence and position of the cleavage sites at R271 and R320 dictate the preferred pathway of prothrombin activation.	[Stojanovski, Bosko M.; Di Cera, Enrico] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA	Saint Louis University	Di Cera, E (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	enrico@slu.edu			National Institutes of Health Research [HL049413, HL139554, HL147821]	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by the National Institutes of Health Research grants HL049413, HL139554, and HL147821 (E. D. C.).	Acquasaliente L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42524-z; Anderson PJ, 2003, J BIOL CHEM, V278, P44489, DOI 10.1074/jbc.M306916200; Backes BJ, 2000, NAT BIOTECHNOL, V18, P187, DOI 10.1038/72642; Bianchini EP, 2005, P NATL ACAD SCI USA, V102, P10099, DOI 10.1073/pnas.0504704102; Brufatto N, 2003, J BIOL CHEM, V278, P6755, DOI 10.1074/jbc.M206413200; Chakraborty P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21728-9; Chen Q, 1997, BIOCHEMISTRY-US, V36, P4701, DOI 10.1021/bi961441r; Chen ZW, 2010, P NATL ACAD SCI USA, V107, P19278, DOI 10.1073/pnas.1010262107; Chinnaraj M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21304-1; DAVIE EW, 1991, BIOCHEMISTRY-US, V30, P10363, DOI 10.1021/bi00107a001; DeAngelis JP, 2011, THROMB RES, V128, P470, DOI 10.1016/j.thromres.2011.03.007; Di Cera E, 1998, ADV PROTEIN CHEM, V51, P59; Haynes LM, 2012, J BIOL CHEM, V287, P38647, DOI 10.1074/jbc.M112.407791; HUBER R, 1978, ACCOUNTS CHEM RES, V11, P114, DOI 10.1021/ar50123a006; Kim PY, 2007, J BIOL CHEM, V282, P32568, DOI 10.1074/jbc.M701781200; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kroh HK, 2007, J BIOL CHEM, V282, P16095, DOI 10.1074/jbc.M610577200; Kroh HK, 2011, J BIOL CHEM, V286, P23345, DOI 10.1074/jbc.M111.230292; Lee CJ, 2010, BIOPHYS CHEM, V149, P28, DOI 10.1016/j.bpc.2010.03.011; Lentz BR, 2003, PROG LIPID RES, V42, P423, DOI 10.1016/S0163-7827(03)00025-0; Mann KG, 2003, CHEST, V124, p4S, DOI 10.1378/chest.124.3_suppl.4S; Martin PD, 1997, STRUCTURE, V5, P1681, DOI 10.1016/S0969-2126(97)00314-6; Nomura S, 2015, J INTENSIVE CARE, V3, DOI 10.1186/s40560-014-0066-z; Orcutt SJ, 2004, J BIOL CHEM, V279, P54927, DOI 10.1074/jbc.M410866200; Orcutt SJ, 2002, J BIOL CHEM, V277, P46191, DOI 10.1074/jbc.M208677200; Papaconstantinou ME, 2008, CELL MOL LIFE SCI, V65, P3688, DOI 10.1007/s00018-008-8502-7; Pozzi N, 2016, J BIOL CHEM, V291, P18107, DOI 10.1074/jbc.M116.738310; Pozzi N, 2016, J BIOL CHEM, V291, P6071, DOI 10.1074/jbc.M115.700401; Pozzi N, 2014, P NATL ACAD SCI USA, V111, P7630, DOI 10.1073/pnas.1403779111; Pozzi N, 2013, J BIOL CHEM, V288, P22734, DOI 10.1074/jbc.M113.466946; Ruben EA, 2021, BLOOD, V137, P3137, DOI 10.1182/blood.2021010684; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schrimpf W, 2018, BIOPHYS J, V114, P1518, DOI 10.1016/j.bpj.2018.02.035; Stojanovski BM, 2020, J BIOL CHEM, V295, P15236, DOI 10.1074/jbc.RA120.014789; Stojanovski Bosko M., 2018, BioMolecular Concepts, V9, P169, DOI 10.1515/bmc-2018-0016; TANS G, 1991, J BIOL CHEM, V266, P21864; Varfaj F, 2007, J BIOL CHEM, V282, P20264, DOI 10.1074/jbc.M701327200; Vindigni A, 1997, NAT BIOTECHNOL, V15, P891, DOI 10.1038/nbt0997-891; Whelihan MF, 2012, BLOOD, V120, P3837, DOI 10.1182/blood-2012-05-427856; Wood JP, 2011, BLOOD, V117, P1710, DOI 10.1182/blood-2010-09-311035; Xu H, 2005, J BIOL CHEM, V280, P7956, DOI 10.1074/jbc.M412869200	41	5	5	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100955	10.1016/j.jbc.2021.100955	http://dx.doi.org/10.1016/j.jbc.2021.100955			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265300	gold, Green Published			2022-12-28	WOS:000690871400002
J	Zemskov, EA; Wu, XM; Aggarwal, S; Yegambaram, M; Gross, C; Lu, Q; Wang, H; Tang, HY; Wang, T; Black, SM				Zemskov, Evgeny A.; Wu, Xiaomin; Aggarwal, Saurabh; Yegambaram, Mannivannan; Gross, Christine; Lu, Qing; Wang, Hui; Tang, Haiyang; Wang, Ting; Black, Stephen M.			Nitration of protein kinase G-I alpha modulates cyclic nucleotide crosstalk via phosphodiesterase 3A: Implications for acute lung injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLUBLE GUANYLYL CYCLASE; MOLECULAR-MECHANISMS; CAMP; ACTIVATION; CGMP; PHOSPHATASE; PKA; VASORELAXATION; ISOFORMS; RECEPTOR	Phosphodiesterase 3A (PDE3A) selectively cleaves the phosphodiester bond of cAMP and is inhibited by cGMP, making it an important regulator of cAMP-cGMP signaling crosstalk in the pulmonary vasculature. In addition, the nitric oxide-cGMP axis is known to play an important role in maintaining endothelial barrier function. However, the potential role of protein kinase G-I alpha (PKG-I alpha) in this protective process is unresolved and was the focus of our study. We describe here a novel mechanism regulating PDE3A activity, which involves a PKG-I alpha-dependent inhibitory phosphorylation of PDE3A at serine 654. We also show that this phosphorylation is critical for maintaining intracellular cAMP levels in the pulmonary endothelium and endothelial barrier integrity. In an animal model of acute lung injury (ALI) induced by challenging mice with lipopolysaccharide (LPS), an increase in PDE3 activity and a decrease in cAMP levels in lung tissue was associated with reduced PKG activity upon PKG-I alpha nitration at tyrosine 247. The peroxynitrite scavenger manganese (III) tetrakis(1-methyl-4-pyridyl)porphyrin prevented this increase in PDE3 activity in LPS-exposed lungs. In addition, site-directed mutagenesis of PDE3A to replace serine 654 with alanine yielded a mutant protein that was insensitive to PKG-dependent regulation. Taken together, our data demonstrate a novel functional link between nitrosative stress induced by LPS during ALI and the downregulation of barrier-protective intracellular cAMP levels. Our data also provide new evidence that PKG-I alpha is critical for endothelial barrier maintenance and that preservation of its catalytic activity may be efficacious in ALI therapy.	[Zemskov, Evgeny A.; Wu, Xiaomin; Yegambaram, Mannivannan; Lu, Qing; Wang, Hui; Tang, Haiyang] Univ Arizona Hlth Sci, Dept Med, Tucson, AZ USA; [Aggarwal, Saurabh; Gross, Christine] Augusta Univ, Vasc Biol Ctr, Augusta, GA USA; [Wang, Hui; Tang, Haiyang] Northwest A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Tang, Haiyang; Wang, Ting; Black, Stephen M.] Florida Int Univ, Ctr Translat Sci, Port St Lucie, FL 34987 USA; [Wang, Ting] Univ Arizona, Dept Internal Med, Phoenix, AZ USA; [Wang, Ting; Black, Stephen M.] Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Environm Hlth Sci, Miami, FL 33199 USA; [Black, Stephen M.] Florida Int Univ, Herbert Wertheim Coll Med, Cellular Biol & Pharmacol, Miami, FL 33199 USA; [Aggarwal, Saurabh] Univ Alabama Birmingham, Dept Anesthesiol, Birmingham, AL USA; [Gross, Christine] Broward Hlth Med Ctr, Dept Med, Ft Lauderdale, FL USA	University of Arizona; University of Arizona Health Sciences; University System of Georgia; Augusta University; Northwest A&F University - China; State University System of Florida; Florida International University; University of Arizona; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of Alabama System; University of Alabama Birmingham	Black, SM (corresponding author), Florida Int Univ, Ctr Translat Sci, Port St Lucie, FL 34987 USA.; Black, SM (corresponding author), Florida Int Univ, Robert Stempel Coll Publ Hlth & Social Work, Dept Environm Hlth Sci, Miami, FL 33199 USA.; Black, SM (corresponding author), Florida Int Univ, Herbert Wertheim Coll Med, Cellular Biol & Pharmacol, Miami, FL 33199 USA.	stblack@fiu.edu			Interdisciplinary Training in Cardiovascular Research [HL60190, HL137282, HL134610, HL142212, HL146369]; National Heart, Lung, and Blood Institute, Bethesda, MD, USA [T32 HL007249]	Interdisciplinary Training in Cardiovascular Research; National Heart, Lung, and Blood Institute, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by HL60190 (S. M. B.), HL137282 (S. M. B.), HL134610 (S. M. B.), HL142212 (S. M. B./E. A. Z.), HL146369 (S. M. B.), and the Interdisciplinary Training in Cardiovascular Research T32 HL007249 (X. W.), all from the National Heart, Lung, and Blood Institute, Bethesda, MD, USA.	Adderley SP, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00010; Aggarwal S, 2014, J BIOL CHEM, V289, P7948, DOI 10.1074/jbc.M113.534313; Aggarwal S, 2011, J CELL PHYSIOL, V226, P3104, DOI 10.1002/jcp.22692; Aslam M, 2010, CARDIOVASC RES, V87, P375, DOI 10.1093/cvr/cvq065; Baillie GS, 2009, FEBS J, V276, P1790, DOI 10.1111/j.1742-4658.2009.06926.x; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V299, pL652, DOI 10.1152/ajplung.00202.2009; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Chung KF, 2006, EUR J PHARMACOL, V533, P110, DOI 10.1016/j.ejphar.2005.12.059; Davel AP, 2015, LIFE SCI, V125, P49, DOI 10.1016/j.lfs.2015.01.018; Garcia-Morales V, 2014, VASC PHARMACOL, V60, P95, DOI 10.1016/j.vph.2014.01.004; Geoffroy V, 1999, EUR J BIOCHEM, V259, P892, DOI 10.1046/j.1432-1327.1999.00123.x; Goeckeler ZM, 2005, J BIOL CHEM, V280, P33083, DOI 10.1074/jbc.M503173200; Gonzales JN, 2014, AM J PHYSIOL-LUNG C, V306, pL497, DOI 10.1152/ajplung.00086.2013; Guinzberg R, 2017, FEBS J, V284, P258, DOI 10.1111/febs.13969; Hambleton R, 2005, J BIOL CHEM, V280, P39168, DOI 10.1074/jbc.M506760200; Horai S, 2013, CELL MOL NEUROBIOL, V33, P291, DOI 10.1007/s10571-012-9896-1; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; Hwang TL, 2012, TOXICOL APPL PHARM, V260, P193, DOI 10.1016/j.taap.2012.02.011; Joshi CN, 2011, J PHARMACOL EXP THER, V339, P394, DOI 10.1124/jpet.111.183400; Kellner M, 2017, ADV EXP MED BIOL, V967, P105, DOI 10.1007/978-3-319-63245-2_8; Kumar S, 2017, FREE RADICAL BIO MED, V102, P217, DOI 10.1016/j.freeradbiomed.2016.11.008; Lincoln TM, 2006, FRONT BIOSCI-LANDMRK, V11, P356, DOI 10.2741/1803; Liu H, 2015, INT IMMUNOPHARMACOL, V29, P937, DOI 10.1016/j.intimp.2015.10.010; Liu S, 2012, J NEUROL SCI, V320, P45, DOI 10.1016/j.jns.2012.06.005; Lubomirov LT, 2018, ACTA PHYSIOL, V224, DOI 10.1111/apha.13079; Lynch MJ, 2007, BIOCHEM SOC T, V35, P938, DOI 10.1042/BST0350938; Masciarelli S, 2004, J CLIN INVEST, V114, P196, DOI 10.1172/JCI2004210804; Maurice DH, 2005, FRONT BIOSCI, V10, P1221, DOI 10.2741/1614; Murthy KS, 2002, AM J PHYSIOL-CELL PH, V282, pC508, DOI 10.1152/ajpcell.00373.2001; Nakane M, 2003, CLIN CHEM LAB MED, V41, P865, DOI 10.1515/CCLM.2003.131; Palmer D, 2007, J BIOL CHEM, V282, P9411, DOI 10.1074/jbc.M606936200; Pavlaki N, 2018, J CARDIOVASC DEV DIS, V5, DOI 10.3390/jcdd5010004; Pooladanda V, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-018-1247-9; Rafikov R, 2014, J BIOL CHEM, V289, P4710, DOI 10.1074/jbc.M114.547596; Ramos-Espiritu LS, 2011, J PHARMACOL EXP THER, V338, P925, DOI 10.1124/jpet.111.184135; Ricciardolo FLM, 2015, RESPIRATION, V89, P572, DOI 10.1159/000381905; Samuel S, 2017, CELL PHYSIOL BIOCHEM, V41, P1894, DOI 10.1159/000471938; Schlegel N, 2009, CRIT CARE MED, V37, P1735, DOI 10.1097/CCM.0b013e31819deb6a; Schlegel N, 2009, MICROCIRCULATION, V16, P521, DOI 10.1080/10739680902967427; Seifert R, 2015, TRENDS BIOCHEM SCI, V40, P8, DOI 10.1016/j.tibs.2014.10.008; Sharma S, 2008, AM J PHYSIOL-LUNG C, V294, pL46, DOI 10.1152/ajplung.00247.2007; Sharma S, 2010, VASC PHARMACOL, V52, P182, DOI 10.1016/j.vph.2009.11.010; Sheehe JL, 2018, J BIOL CHEM, V293, P16791, DOI 10.1074/jbc.RA118.004363; SILVER P J, 1985, Reviews in Clinical and Basic Pharmacology, V5, P341; Song P, 2007, CIRCULATION, V116, P1585, DOI 10.1161/CIRCULATIONAHA.107.716498; Stangherlin A, 2012, AM J PHYSIOL-HEART C, V302, pH379, DOI 10.1152/ajpheart.00766.2011; Stehlik Josef, 2006, Expert Opin Investig Drugs, V15, P733, DOI 10.1517/13543784.15.7.733; Sud N, 2007, AM J PHYSIOL-LUNG C, V293, pL1444, DOI 10.1152/ajplung.00175.2007; Takagi T, 2014, CURR NEUROVASC RES, V11, P302, DOI 10.2174/1567202611666140912113152; Umapathy NS, 2010, VASC PHARMACOL, V52, P199, DOI 10.1016/j.vph.2009.12.008; Umapathy NS, 2010, J CELL PHYSIOL, V223, P215, DOI 10.1002/jcp.22029; Vandeput F, 2013, P NATL ACAD SCI USA, V110, P19778, DOI 10.1073/pnas.1305427110; Vogel SM, 2012, COMPR PHYSIOL, V2, P449, DOI 10.1002/cphy.c100006; Waschke J, 2004, AM J PHYSIOL-HEART C, V287, pH2427, DOI 10.1152/ajpheart.00556.2004; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zemskov Evgeny, 2011, J Cardiovasc Dis Res, V2, P14, DOI 10.4103/0975-3583.78582; Zhao YDD, 2012, AM J PATHOL, V180, P2268, DOI 10.1016/j.ajpath.2012.02.016; Zuo HX, 2018, BRIT J PHARMACOL, V175, P2988, DOI 10.1111/bph.14347	59	1	1	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100946	10.1016/j.jbc.2021.100946	http://dx.doi.org/10.1016/j.jbc.2021.100946			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34252457	Green Published, gold			2022-12-28	WOS:000690871000011
J	Bocharova, O; Pandit, NP; Molesworth, K; Fisher, A; Mychko, O; Makarava, N; Baskakov, IV				Bocharova, Olga; Pandit, Narayan P.; Molesworth, Kara; Fisher, Aidan; Mychko, Olga; Makarava, Natallia; Baskakov, Ilia, V			Alzheimer's disease-associated beta-amyloid does not protect against herpes simplex virus 1 infection in the mouse brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLAMYDIA-PNEUMONIAE; MICROGLIA; TYPE-1; COLOCALIZATION; ACTIVATION; RECEPTORS; NEURONS; MICE	Alzheimer's disease (AD) is a devastating fatal neurodegenerative disease. An alternative to the amyloid cascade hypothesis is that a viral infection is key to the etiology of late-onset AD, with beta-amyloid (A beta) peptides playing a protective role. In the current study, young 5XFAD mice that overexpress mutant human amyloid precursor protein with the Swedish, Florida, and London familial AD mutations were infected with one of two strains of herpes simplex virus 1 (HSV-1), 17syn+ and McKrae, at three different doses. Contrary to previous work, 5XFAD genotype failed to protect mice against HSV-1 infection. The region- and cell-specific tropisms of HSV-1 were not affected by the 5XFAD genotype, indicating that host-pathogen interactions were not altered. Seven- to ten-month-old 5XFAD animals in which extracellular A beta aggregates were abundant showed slightly better survival rate relative to their wild-type (WT) littermates, although the difference was not statistically significant. In these 5XFAD mice, HSV-1 replication centers were partially excluded from the brain areas with high densities of A beta aggregates. A beta aggregates were free of HSV-1 viral particles, and the limited viral invasion to areas with a high density of A beta aggregates was attributed to phagocytic activity of reactive microglia. In the oldest mice (12-15 months old), the survival rate did not differ between 5XFAD and WT littermates. While the current study questions the antiviral role of A beta, it neither supports nor refutes the viral etiology hypothesis of late-onset AD.	[Bocharova, Olga; Pandit, Narayan P.; Molesworth, Kara; Fisher, Aidan; Mychko, Olga; Makarava, Natallia; Baskakov, Ilia, V] Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA; [Bocharova, Olga; Pandit, Narayan P.; Molesworth, Kara; Fisher, Aidan; Mychko, Olga; Makarava, Natallia; Baskakov, Ilia, V] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Ctr Biomed Engn & Technol, Baltimore, MD 21201 USA.; Baskakov, IV (corresponding author), Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA.	Baskakov@som.umaryland.edu	Bocharova, Olga V./J-8284-2018	Bocharova, Olga V./0000-0002-5056-1506; Fisher, Aidan/0000-0002-5706-537X	NIH [R01 NS045585]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the NIH Supplemental award for R01 NS045585 to I. V. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Allnutt MA, 2020, NEURON, V105, P1027, DOI 10.1016/j.neuron.2019.12.031; Baik SH, 2016, GLIA, V64, P2274, DOI 10.1002/glia.23074; Bello-Morales R, 2018, J VIROL, V92, DOI 10.1128/JVI.00088-18; Braun E, 2006, J GEN VIROL, V87, P2827, DOI 10.1099/vir.0.81850-0; Cairns DM, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aay8828; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Cymerys J, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/2302835; De Chiara G, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007617; De Chiara G, 2012, MOL NEUROBIOL, V46, P614, DOI 10.1007/s12035-012-8320-7; Drayman N, 2019, ELIFE, V8, DOI 10.7554/eLife.46339; Duarte LF, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00046; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Eimer WA, 2018, NEURON, V99, P56, DOI 10.1016/j.neuron.2018.06.030; Ezzat K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10192-2; Fekete R, 2018, ACTA NEUROPATHOL, V136, P461, DOI 10.1007/s00401-018-1885-0; Fricker M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-196; Gerard HC, 2005, MICROB PATHOGENESIS, V39, P19, DOI 10.1016/j.micpath.2005.05.002; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Hammond CJ, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-121; Harris SA, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00048; Hatton CF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02656; Haynes SE, 2006, NAT NEUROSCI, V9, P1512, DOI 10.1038/nn1805; Hidetoshi T.-S., 2012, WIRES MEMBR TRANSP S, V1, P493, DOI [10.1002/wmts.46, DOI 10.1002/WMTS.46]; Hogestyn JM, 2018, NEURAL REGEN RES, V13, P211, DOI 10.4103/1673-5374.226380; Itzhaki RE, 2004, NEUROBIOL AGING, V25, P619, DOI 10.1016/j.neurobiolaging.2003.12.021; Itzhaki RF, 2018, FRONT AGING NEUROSCI, V10, DOI 10.3389/fnagi.2018.00324; Janda E, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00144; Jeong HH, 2019, NEURON, V104, P1034, DOI 10.1016/j.neuron.2019.11.009; Kollias CM, 2015, J NEUROVIROL, V21, P8, DOI 10.1007/s13365-014-0302-2; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Little CS, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00304; Little CS, 2004, NEUROBIOL AGING, V25, P419, DOI 10.1016/S0197-4580(03)00127-1; Makarava N, 2020, NEUROBIOL DIS, V137, DOI 10.1016/j.nbd.2020.104783; Miklossy J, 2006, NEUROBIOL AGING, V27, P228, DOI 10.1016/j.neurobiolaging.2005.01.018; Miklossy J, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00046; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Piacentini R, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00097; Readhead B, 2018, NEURON, V99, P64, DOI 10.1016/j.neuron.2018.05.023; Reinert LS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13348; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Sawtell NM, 1998, J VIROL, V72, P5343, DOI 10.1128/JVI.72.7.5343-5350.1998; SAWTELL NM, 1992, J VIROL, V66, P2150, DOI 10.1128/JVI.66.4.2150-2156.1992; Spangenberg E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11674-z; Spangenberg EE, 2016, BRAIN, V139, P1265, DOI 10.1093/brain/aww016; Szpara ML, 2014, J VIROL, V88, P1209, DOI 10.1128/JVI.01987-13; Theriault P, 2016, CURR BIOL, V26, pR772, DOI 10.1016/j.cub.2016.06.066; Tsai MC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188490; Villalba M, 2012, MED MICROBIOL IMMUN, V201, P371, DOI 10.1007/s00430-012-0247-0; Wang H, 2013, VIRUS RES, V173, P436, DOI 10.1016/j.virusres.2013.01.001; Webre JM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/612316; Yanguas-Casas N, 2020, AGING CELL, V19, DOI 10.1111/acel.13182	55	12	12	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100845	10.1016/j.jbc.2021.100845	http://dx.doi.org/10.1016/j.jbc.2021.100845			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34052228	gold, Green Published, Green Submitted			2022-12-28	WOS:000678068400045
J	Cho, Y; Tachibana, S; Lam, K; Arita, Y; Khosrowjerdi, S; Zhang, O; Liang, AL; Li, RX; Andreyev, A; Murphy, AN; Ross, RS				Cho, Yoshitake; Tachibana, Shizuko; Lam, Kayla; Arita, Yoh; Khosrowjerdi, Shamim; Zhang, Oliver; Liang, Alex; Li, Ruixia; Andreyev, Aleksander; Murphy, Anne N.; Ross, Robert S.			Perm1 promotes cardiomyocyte mitochondrial biogenesis and protects against hypoxia/reoxygenation-induced damage in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATIVE CAPACITY; DILATED CARDIOMYOPATHY; HEART-FAILURE; ERR-ALPHA; METABOLISM; COACTIVATOR; TRANSCRIPTION; HYPERTROPHY; TRANSLATION; GENE	Normal contractile function of the heart depends on a constant and reliable production of ATP by cardiomyocytes. Dysregulation of cardiac energy metabolism can result in immature heart development and disrupt the ability of the adult myocardium to adapt to stress, potentially leading to heart failure. Further, restoration of abnormal mitochondrial function can have beneficial effects on cardiac dysfunction. Previously, we identified a novel protein termed Perm1 (PGC- 1 and estrogen-related receptor (ERR)-induced regulator, muscle 1) that is enriched in skeletal and cardiac-muscle mitochondria and transcriptionally regulated by PGC-1 (peroxisome proliferator-activated receptor gamma coactivator 1) and ERR. The role of Perm1 in the heart is poorly understood and is studied here. We utilized cell culture, mouse models, and human tissue, to study its expression and transcriptional control, as well as its role in transcription of other factors. Critically, we tested Perm1's role in cardiomyocyte mitochondrial function and its ability to protect myocytes from stress-induced damage. Our studies show that Perm1 expression increases throughout mouse cardiogenesis, demonstrate that Perm1 interacts with PGC- 1a and enhances activation of PGC-1 and ERR, increases mitochondrial DNA copy number, and augments oxidative capacity in cultured neonatal mouse cardiomyocytes. Moreover, we found that Perm1 reduced cellular damage produced as a result of hypoxia and reoxygenation-induced stress and mitigated cell death of cardiomyocytes. Taken together, our results show that Perm1 promotes mitochondrial biogenesis in mouse cardiomyocytes. Future studies can assess the potential of Perm1 to be used as a novel therapeutic to restore cardiac dysfunction induced by ischemic injury.	[Cho, Yoshitake; Tachibana, Shizuko; Lam, Kayla; Khosrowjerdi, Shamim; Zhang, Oliver; Liang, Alex; Li, Ruixia; Andreyev, Aleksander; Ross, Robert S.] Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA; [Cho, Yoshitake; Liang, Alex; Li, Ruixia; Ross, Robert S.] Vet Adm Healthcare, Dept Med Cardiol, San Diego, CA 92161 USA; [Arita, Yoh; Murphy, Anne N.] Univ Calif San Diego, Dept Pharmacol, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Murphy, Anne N.] Cytokinetics Inc, San Francisco, CA USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Cho, Y (corresponding author), Univ Calif San Diego, Dept Med, Div Cardiovasc Med, La Jolla, CA 92093 USA.; Cho, Y (corresponding author), Vet Adm Healthcare, Dept Med Cardiol, San Diego, CA 92161 USA.	cyoshitake@health.ucsd.edu		Andreyev, Alexander Y./0000-0002-9246-9943; Zhang, Oliver/0000-0001-9710-9843; Ross, Robert/0000-0003-2195-8982	NHLBI, National Institute of Health (NIH) [R01HL151239]; Veterans Administration [I01 BX004897]; Tobacco-Related Disease Research Program (TRDRP) [T31IP1606]	NHLBI, National Institute of Health (NIH); Veterans Administration(US Department of Veterans Affairs); Tobacco-Related Disease Research Program (TRDRP)(University of California System)	This work is supported by NHLBI, National Institute of Health (NIH) Grant R01HL151239 (to Y. C. and R. S. R.). R. S. R was also funded by the Veterans Administration (I01 BX004897), and Y. C. was also funded by Tobacco-Related Disease Research Program (TRDRP) T31IP1606. The content is solely the responsibility of the authors and does not represent official views of the National Institute of Health.	Alaynick WA, 2007, CELL METAB, V6, P13, DOI 10.1016/j.cmet.2007.06.007; Anderson ME, 2011, J MOL CELL CARDIOL, V51, P468, DOI 10.1016/j.yjmcc.2011.01.012; Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103; Aravamudhan S, 2021, J MOL CELL CARDIOL, V154, P41, DOI 10.1016/j.yjmcc.2021.01.010; Arita Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5552; Camara AKS, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00013; Chen Q, 2006, J PHARMACOL EXP THER, V319, P1405, DOI 10.1124/jpet.106.110262; Cho Y, 2019, MOL METAB, V23, P88, DOI 10.1016/j.molmet.2019.02.009; Cho Y, 2016, FASEB J, V30, P674, DOI 10.1096/fj.15-276360; Cho Y, 2013, J BIOL CHEM, V288, P25207, DOI 10.1074/jbc.M113.489674; Cho Y, 2009, MOL PHARMACOL, V76, P1360, DOI 10.1124/mol.109.057000; Deacon DC, 2019, NAT BIOMED ENG, V3, P147, DOI 10.1038/s41551-019-0348-9; Gantner ML, 2014, P NATL ACAD SCI USA, V111, P11870, DOI 10.1073/pnas.1406638111; Garnier A, 2003, J PHYSIOL-LONDON, V551, P491, DOI 10.1113/jphysiol.2003.045104; Ghosh S, 2019, IUBMB LIFE, V71, P791, DOI 10.1002/iub.2018; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Hom JR, 2011, DEV CELL, V21, P469, DOI 10.1016/j.devcel.2011.08.008; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Ikeda M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119687; Ikeuchi M, 2005, CIRCULATION, V112, P683, DOI 10.1161/CIRCULATIONAHA.104.524835; Imahashi K, 2005, CIRC RES, V97, P916, DOI 10.1161/01.RES.0000187456.06162.cb; Karamanlidis G, 2010, CIRC RES, V106, P1541, DOI 10.1161/CIRCRESAHA.109.212753; Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; KOZAK M, 1984, NATURE, V308, P241, DOI 10.1038/308241a0; Lai L, 2008, GENE DEV, V22, P1948, DOI 10.1101/gad.1661708; Leone TC, 2011, COLD SH Q B, V76, P175, DOI 10.1101/sqb.2011.76.011965; Lerin C, 2006, CELL METAB, V3, P429, DOI 10.1016/j.cmet.2006.04.013; Lesnefsky EJ, 2017, ANNU REV PHARMACOL, V57, P535, DOI 10.1146/annurev-pharmtox-010715-103335; Lesnefsky EJ, 1997, AM J PHYSIOL-HEART C, V273, pH1544, DOI 10.1152/ajpheart.1997.273.3.H1544; LIN FT, 1993, P NATL ACAD SCI USA, V90, P9606, DOI 10.1073/pnas.90.20.9606; LIU CC, 1984, NATURE, V309, P82, DOI 10.1038/309082a0; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Manso AM, 2013, J BIOL CHEM, V288, P4252, DOI 10.1074/jbc.M112.427484; McDermott-Roe C, 2011, NATURE, V478, P114, DOI 10.1038/nature10490; Mettauer B, 2006, PFLUG ARCH EUR J PHY, V452, P653, DOI 10.1007/s00424-006-0072-7; Oka S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234913; Papadopoulou-Legbelou K, 2017, INDIAN PEDIATR, V54, P667, DOI 10.1007/s13312-017-1131-1; Paradies G, 2018, AM J PHYSIOL-HEART C, V315, pH1341, DOI 10.1152/ajpheart.00028.2018; Park CB, 2011, J CELL BIOL, V193, P809, DOI 10.1083/jcb.201010024; Piquereau J, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00959; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; ROCKMAN HA, 1991, P NATL ACAD SCI USA, V88, P8277, DOI 10.1073/pnas.88.18.8277; Rose AJ, 2003, J PHYSIOL-LONDON, V553, P303, DOI 10.1113/jphysiol.2003.054171; Sharov VG, 1998, J MOL CELL CARDIOL, V30, P1757, DOI 10.1006/jmcc.1998.0739; Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266; Sihag S, 2009, J MOL CELL CARDIOL, V46, P201, DOI 10.1016/j.yjmcc.2008.10.025; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Tachibana S, 2019, JOVE-J VIS EXP, DOI 10.3791/59052; Taegtmeyer H, 2016, CIRC RES, V118, P1659, DOI 10.1161/RES.0000000000000097; de Carvalho AETS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15656-3; Vasquez-Trincado C, 2016, J PHYSIOL-LONDON, V594, P509, DOI 10.1113/JP271301; Ventura-Clapier R, 2004, J PHYSIOL-LONDON, V555, P1, DOI 10.1113/jphysiol.2003.055095; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang JM, 1999, NAT GENET, V21, P133, DOI 10.1038/5089; Wende AR, 2017, AM J PHYSIOL-HEART C, V313, pH1098, DOI 10.1152/ajpheart.00101.2017; Xiong W, 2001, NUCLEIC ACIDS RES, V29, P3087, DOI 10.1093/nar/29.14.3087; Yeh CH, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000508; Zhang T, 2002, J BIOL CHEM, V277, P1261, DOI 10.1074/jbc.M108525200; Zhou B, 2018, J CLIN INVEST, V128, P3716, DOI 10.1172/JCI120849	62	4	4	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100825	10.1016/j.jbc.2021.100825	http://dx.doi.org/10.1016/j.jbc.2021.100825			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029594	Green Published, gold			2022-12-28	WOS:000678068400027
J	Guo, CX; Fordjour, FK; Tsai, SJ; Morrell, JC; Gould, SJ				Guo, Chenxu; Fordjour, Francis K.; Tsai, Shang Jui; Morrell, James C.; Gould, Stephen J.			Choice of selectable marker affects recombinant protein expression in cells and exosomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSGENE EXPRESSION; LENTIVIRAL VECTORS; SLEEPING-BEAUTY; GENE; RESISTANCE; ENHANCER; CLONING; VIRUS; ELEMENT	Transgenic mammalian cells are used for numerous research, pharmaceutical, industrial, and clinical purposes, and dominant selectable markers are often used to enable the selection of transgenic cell lines. Using HEK293 cells, we show here that the choice of selectable marker gene has a significant impact on both the level of recombinant protein expression and the cell-to-cell variability in recombinant protein expression. Specifically, we observed that cell lines generated with the NeoR or BsdR selectable markers and selected in the antibiotics G418 or blasticidin, respectively, displayed the lowest level of recombinant protein expression as well as the greatest cell-to-cell variability in transgene expression. In contrast, cell lines generated with the BleoR marker and selected in zeocin yielded cell lines that expressed the highest levels of linked recombinant protein, approximately 10-fold higher than those selected using the NeoR or BsdR markers, as well as the lowest cell-tocell variability in recombinant protein expression. Intermediate yet still-high levels of expression were observed in cells generated with the PuroR- or HygR-based vectors and that were selected in puromycin or hygromycin, respectively. Similar results were observed in the African green monkey cell line COS7. These data indicate that each combination of selectable marker and antibiotic establishes a threshold below which no cell can survive and that these thresholds vary significantly between different selectable markers. Moreover, we show that choice of selectable marker also affects recombinant protein expression in cell-derived exosomes, consistent with the hypothesis that exosome protein budding is a stochastic rather than determinative process.	[Guo, Chenxu; Fordjour, Francis K.; Tsai, Shang Jui; Morrell, James C.; Gould, Stephen J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.	sgould@jhmi.edu		Guo, Chenxu/0000-0002-9651-4203; Tsai, Shang-Jui/0000-0002-9602-2823	National Institutes of Health [5U19CA179563]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Gould lab and the Department of Biological Chemistry for their suggestions during the course of this study and particularly Dr Michael Caterina. We thank Zhaolin Chen and Yiyan Lin for expert technical assistance, Hao Zhang for flow cytometric analysis, and Nazar Filonov and Nadia Filonov for assistance with NTA analysis. This work was supported, in part, by the National Institutes of Health (grant number 5U19CA179563). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachurski D, 2019, J EXTRACELL VESICLES, V8, DOI 10.1080/20013078.2019.1596016; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; CANAANI D, 1982, P NATL ACAD SCI-BIOL, V79, P5166, DOI 10.1073/pnas.79.17.5166; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Chen ZY, 2004, GENE THER, V11, P856, DOI 10.1038/sj.gt.3302231; Di Matteo Mario, 2012, Methods Mol Biol, V859, P241, DOI 10.1007/978-1-61779-603-6_14; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fonseca JP, 2019, ACS SYNTH BIOL, V8, P2593, DOI 10.1021/acssynbio.9b00322; Gaspar V, 2015, EXPERT OPIN BIOL TH, V15, P353, DOI 10.1517/14712598.2015.996544; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; GILLIES SD, 1983, CELL, V33, P717, DOI 10.1016/0092-8674(83)90014-4; GRUSS P, 1979, P NATL ACAD SCI USA, V76, P4317, DOI 10.1073/pnas.76.9.4317; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; HUMPHRIES RK, 1982, CELL, V30, P173; Hunter Molly, 2019, Curr Protoc Protein Sci, V95, pe77, DOI 10.1002/cpps.77; Ivics Z, 1997, CELL, V91, P501, DOI 10.1016/S0092-8674(00)80436-5; JOYNER A, 1982, P NATL ACAD SCI-BIOL, V79, P1573, DOI 10.1073/pnas.79.5.1573; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KASTER KR, 1983, NUCLEIC ACIDS RES, V11, P6895, DOI 10.1093/nar/11.19.6895; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Li MJ, 2012, JOVE-J VIS EXP, DOI 10.3791/4031; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; MULSANT P, 1988, SOMAT CELL MOLEC GEN, V14, P243, DOI 10.1007/BF01534585; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Shaner NC, 2013, NAT METHODS, V10, P407, DOI [10.1038/nmeth.2413, 10.1038/NMETH.2413]; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Stokowa-Soltys K, 2019, J INORG BIOCHEM, V195, P71, DOI 10.1016/j.jinorgbio.2019.03.010; Szymczak AL, 2005, EXPERT OPIN BIOL TH, V5, P627, DOI 10.1517/14712598.5.5.627; Tipanee J, 2017, HUM GENE THER, V28, P1087, DOI 10.1089/hum.2017.128; Trastoy MO, 2005, MUTAGENESIS, V20, P111, DOI 10.1093/mutage/gei016; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; VARA J, 1985, GENE, V33, P197, DOI 10.1016/0378-1119(85)90094-0; Vernia M, 2003, ANN NY ACAD SCI, V983, P170, DOI 10.1111/j.1749-6632.2003.tb05972.x; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814	42	3	3	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100838	10.1016/j.jbc.2021.100838	http://dx.doi.org/10.1016/j.jbc.2021.100838			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051235	Green Published, gold			2022-12-28	WOS:000678068400038
J	Larson-Casey, JL; Gu, LL; Kang, J; Dhyani, A; Carter, AB				Larson-Casey, Jennifer L.; Gu, Linlin; Kang, Jungsoon; Dhyani, Ashish; Carter, A. Brent			NOX4 regulates macrophage apoptosis resistance to induce fibrotic progression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PULMONARY-FIBROSIS; NADPH OXIDASE; ALTERNATIVE ACTIVATION; LUNG FIBROBLASTS; EXPRESSION; MICE; INHIBITION; SURVIVAL; STRESS; CELLS	Pulmonary fibrosis is a progressive lung disease often occurring secondary to environmental exposure. Asbestos exposure is an important environmental mediator of lung fibrosis and remains a significant cause of disease despite strict regulations to limit exposure. Lung macrophages play an integral role in the pathogenesis of fibrosis induced by asbestos (asbestosis), in part by generating reactive oxygen species (ROS) and promoting resistance to apoptosis. However, the mechanism by which macrophages acquire apoptosis resistance is not known. Here, we confirm that macrophages isolated from asbestosis subjects are resistant to apoptosis and show they are associated with enhanced mitochondrial content of NADPH oxidase 4 (NOX4), which generates mitochondrial ROS generation. Similar results were seen in chrysotile-exposed WT mice, while macrophages from Nox4(-/-) mice showed increased apoptosis. NOX4 regulated apoptosis resistance by activating Akt1-mediated Bcl-2-associated death phosphorylation. Demonstrating the importance of NOX4-mediated apoptosis resistance in fibrotic remodeling, mice harboring a conditional deletion of Nox4 in monocyte-derived macrophages exhibited increased apoptosis and were protected from pulmonary fibrosis. Moreover, resolution occurred when Nox4 was deleted in monocyte-derived macrophages in mice with established fibrosis. These observations suggest that NOX4 regulates apoptosis resistance in monocyte-derived macrophages and contributes to the pathogenesis of pulmonary fibrosis. Targeting NOX4-mediated apoptosis resistance in monocyte-derived macrophages may provide a novel therapeutic target to protect against the development and/or progression of pulmonary fibrosis.	[Larson-Casey, Jennifer L.; Gu, Linlin; Kang, Jungsoon; Dhyani, Ashish; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Carter, A. Brent] Birmingham Vet Adm Med Ctr, Birmingham, AL 35233 USA	University of Alabama System; University of Alabama Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA.; Carter, AB (corresponding author), Birmingham Vet Adm Med Ctr, Birmingham, AL 35233 USA.	bcarter1@uab.edu		Carter, A. Brent/0000-0001-6002-4715; Larson-Casey, Jennifer L./0000-0001-7238-7986	National Institutes of Health [2R01 ES015981-13, P42 ES027723-2]; Department of Veteran Affairs Merit Review [1 I01 CX001715-2]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veteran Affairs Merit Review(US Department of Veterans Affairs)	Research reported in this publication was supported by the National Institutes of Health grants 2R01 ES015981-13 and P42 ES027723-2 and Department of Veteran Affairs Merit Review 1 I01 CX001715-2 to A. B. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Attfield M. D., 2004, Morbidity and Mortality Weekly Report, V53, P627; Bernard K, 2017, J BIOL CHEM, V292, P3029, DOI 10.1074/jbc.M116.752261; Campa CC, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07698-6; Carnesecchi S, 2011, ANTIOXID REDOX SIGN, V15, P607, DOI 10.1089/ars.2010.3829; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Cucoranu I, 2005, CIRC RES, V97, P900, DOI 10.1161/01.RES.0000187457.24338.3D; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Gorin Y, 2003, AM J PHYSIOL-RENAL, V285, pF219, DOI 10.1152/ajprenal.00414.2002; Gu LL, 2019, REDOX BIOL, V26, DOI 10.1016/j.redox.2019.101307; Guidotti TL, 2004, AM J RESP CRIT CARE, V170, P691, DOI 10.1164/rccm.200310-1436ST; Hagimoto N, 1997, AM J RESP CELL MOL, V17, P272, DOI 10.1165/ajrcmb.17.3.2893; HAMILTON RF, 1995, AM J PHYSIOL-LUNG C, V269, pL318, DOI 10.1152/ajplung.1995.269.3.L318; He C, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126551; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Jacobsen K, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00450-6; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Larson-Casey JL, 2019, J CLIN INVEST, V129, P4962, DOI [10.1172/JCl127959, 10.1172/JCI127959]; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Lawson WE, 2011, P NATL ACAD SCI USA, V108, P10562, DOI 10.1073/pnas.1107559108; Masamune A, 2008, AM J PHYSIOL-GASTR L, V294, pG99, DOI 10.1152/ajpgi.00272.2007; McCubbrey AL, 2018, AM J RESP CELL MOL, V58, P66, DOI 10.1165/rcmb.2017-0154OC; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Nisimoto Y, 2014, BIOCHEMISTRY-US, V53, P5111, DOI 10.1021/bi500331y; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Palmieri M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14338; Plataki M, 2005, CHEST, V127, P266, DOI 10.1378/chest.127.1.266; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Sancho P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045285; Sedeek M, 2010, AM J PHYSIOL-RENAL, V299, pF1348, DOI 10.1152/ajprenal.00028.2010; Spadoni T, 2015, ARTHRITIS RHEUMATOL, V67, P1611, DOI 10.1002/art.39084; Tanaka T, 2002, EUR RESPIR J, V20, P359, DOI 10.1183/09031936.02.00252602; von Harsdorf R, 1999, CIRCULATION, V99, P2934, DOI 10.1161/01.CIR.99.22.2934; Wang LY, 2006, AM J PHYSIOL-LUNG C, V290, pL695, DOI 10.1152/ajplung.00245.2005; Xia H, 2008, J EXP MED, V205, P1659, DOI 10.1084/jem.20080001; Xu Y, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.90558; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.551; YANG E, 1995, CELL, V80, P285, DOI 10.1016/0092-8674(95)90411-5; Yang M, 2020, THORAX, V75, P798, DOI 10.1136/thoraxjnl-2020-214822; Zhao QD, 2015, CIRCULATION, V131, P643, DOI 10.1161/CIRCULATIONAHA.114.011079; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	47	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100810	10.1016/j.jbc.2021.100810	http://dx.doi.org/10.1016/j.jbc.2021.100810			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023385	gold, Green Published			2022-12-28	WOS:000678068400013
J	Yoon, JH; Basu, D; Choudhury, JR; Prakash, S; Prakash, L				Yoon, Jung-Hoon; Basu, Debashree; Choudhury, Jayati Roy; Prakash, Satya; Prakash, Louise			DNA polymerase lambda promotes error-free replication through Watson-Crick impairing N1-methyl-deoxyadenosine adduct in conjunction with DNA polymerase zeta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; STRUCTURAL BASIS; DAMAGE TOLERANCE; THYMINE DIMER; BYPASS; ETA; IOTA; DUPLEX; YEAST; PHOTOPRODUCT	In a previous study, we showed that replication through the N1-methyl-deoxyadenosine (1-MeA) adduct in human cells is mediated via three different Pol tau/Pol theta, Pol zeta, and Pol.-dependent pathways. Based on biochemical studies with these Pols, in the Pol tau/Pol theta pathway, we inferred a role for Pol theta in the insertion of a nucleotide (nt) opposite 1-MeA and of Pol theta in extension of synthesis from the inserted nt; in the Pol eta pathway, we inferred that this Pol alone would replicate through 1-MeA; in the Pol zeta pathway, however, the Pol required for inserting an nt opposite 1-MeA had remained unidentified. In this study, we provide biochemical and genetic evidence for a role for Pol lambda in inserting the correct nt T opposite 1-MeA, from which Pol zeta would extend synthesis. The high proficiency of purified Pol lambda for inserting a T opposite 1-MeA implicates a role for Pol lambda-which normally uses W-C base pairing for DNA synthesis-in accommodating 1-MeA in a syn confirmation and forming a Hoogsteen base pair with T. The potential of Pol. to replicate through DNA lesions by Hoogsteen base pairing adds another novel aspect to Pol lambda's role in translesion synthesis in addition to its role as a scaffolding component of Pol zeta. We discuss how the action mechanisms of Pol lambda and Pol lambda could be restrained to inserting a T opposite 1-MeA and extending synthesis thereafter, respectively.	[Yoon, Jung-Hoon; Basu, Debashree; Choudhury, Jayati Roy; Prakash, Satya; Prakash, Louise] Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Prakash, L (corresponding author), Univ Texas Med Branch, Dept Biochem & Mol Biol, Galveston, TX 77555 USA.	loprakash@utmb.edu		Prakash, Louise/0000-0001-9143-6261; Prakash, Satya/0000-0001-7228-1444	National Institutes of Health [R01 GM126087]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (R01 GM126087). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acharya N, 2006, MOL CELL BIOL, V26, P9555, DOI 10.1128/MCB.01671-06; Baynton K, 1998, MOL CELL BIOL, V18, P960, DOI 10.1128/MCB.18.2.960; Biertumpfel C, 2010, NATURE, V465, P1044, DOI 10.1038/nature09196; Conde J, 2015, J BIOL CHEM, V290, P29794, DOI 10.1074/jbc.M115.693010; Doles J, 2010, P NATL ACAD SCI USA, V107, P20786, DOI 10.1073/pnas.1011409107; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Gibbs PEM, 2005, GENETICS, V169, P575, DOI 10.1534/genetics.104.034611; Jain RK, 2017, SCI REP-UK, V7, DOI 10.1038/srep43904; Johnson RE, 2000, NATURE, V406, P1015, DOI 10.1038/35023030; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Johnson RE, 1999, SCIENCE, V285, P263, DOI 10.1126/science.285.5425.263; Johnson RE, 2005, P NATL ACAD SCI USA, V102, P12359, DOI 10.1073/pnas.0504380102; Johnson RE, 2000, J BIOL CHEM, V275, P7447, DOI 10.1074/jbc.275.11.7447; Johnson RE, 2001, MOL CELL BIOL, V21, P3558, DOI 10.1128/MCB.21.10.3558-3563.2001; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; KEMMINK J, 1987, NUCLEIC ACIDS RES, V15, P4645, DOI 10.1093/nar/15.11.4645; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Lee JH, 1999, P NATL ACAD SCI USA, V96, P6632, DOI 10.1073/pnas.96.12.6632; Malik R, 2020, NAT STRUCT MOL BIOL, V27, P913, DOI 10.1038/s41594-020-0476-7; Masutani C, 1999, NATURE, V399, P700, DOI 10.1038/21447; Nair Deepak T, 2006, Nat Struct Mol Biol, V13, P619, DOI 10.1038/nsmb1118; Nair DT, 2006, STRUCTURE, V14, P749, DOI 10.1016/j.str.2006.01.010; Nair DT, 2005, STRUCTURE, V13, P1569, DOI 10.1016/j.str.2005.08.010; Nair DT, 2004, NATURE, V430, P377, DOI 10.1038/nature02692; Nelson JR, 2000, MOL MICROBIOL, V37, P549, DOI 10.1046/j.1365-2958.2000.01997.x; Ringvoll J, 2006, EMBO J, V25, P2189, DOI 10.1038/sj.emboj.7601109; Silverstein TD, 2010, NATURE, V465, P1039, DOI 10.1038/nature09104; Ummat A, 2012, NAT STRUCT MOL BIOL, V19, P628, DOI 10.1038/nsmb.2295; Washington MT, 2003, MOL CELL BIOL, V23, P5107, DOI 10.1128/MCB.23.14.5107-5112.2003; Xie K, 2010, P NATL ACAD SCI USA, V107, P20792, DOI 10.1073/pnas.1011412107; Yoon JH, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000900; Yoon JH, 2019, GENE DEV, V33, P282, DOI 10.1101/gad.320531.118; Yoon JH, 2019, CELL, V176, P1295, DOI 10.1016/j.cell.2019.01.023; Yoon JH, 2018, J BIOL CHEM, V293, P2949, DOI 10.1074/jbc.RA117.000962; Yoon JH, 2017, J BIOL CHEM, V292, P18682, DOI 10.1074/jbc.M117.808659; Yoon JH, 2015, GENE DEV, V29, P2588, DOI 10.1101/gad.272229.115; Yoon JH, 2010, P NATL ACAD SCI USA, V107, P14116, DOI 10.1073/pnas.1007795107; Yoon JH, 2010, GENE DEV, V24, P123, DOI 10.1101/gad.1872810; Yoon JH, 2009, P NATL ACAD SCI USA, V106, P18219, DOI 10.1073/pnas.0910121106; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	41	0	0	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100868	10.1016/j.jbc.2021.100868	http://dx.doi.org/10.1016/j.jbc.2021.100868			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34119520	Green Published, gold			2022-12-28	WOS:000678068400068
J	Brown, RDR; Veerman, BP; Oh, J; Tate, RJ; Torta, F; Cunningham, MR; Adams, DR; Pyne, S; Pyne, NJ				Brown, Ryan D. R.; Veerman, Ben E. P.; Oh, Jeongah; Tate, Rothwelle J.; Torta, Federico; Cunningham, Margaret R.; Adams, David R.; Pyne, Susan; Pyne, Nigel J.			A new model for regulation of sphingosine kinase 1 translocation to the plasma membrane in breast cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							1-PHOSPHATE RECEPTORS; EXPRESSION; ACTIVATION; ALPHA; STIMULATION	The translocation of sphingosine kinase 1 (SK1) to the plasma membrane (PM) is crucial in promoting oncogenesis. We have previously proposed that SK1 exists as both a monomer and dimer in equilibrium, although it is unclear whether these species translocate to the PM via the same or different mechanisms. We therefore investigated the structural determinants involved to better understand how translocation might potentially be targeted for therapeutic intervention. We report here that monomeric WT mouse SK1 (GFP-mSK1) translocates to the PM of MCF-7L cells stimulated with carbachol or phorbol 12-myristate 13-acetate, whereas the dimer translocates to the PM in response to sphingosine-1-phosphate; thus, the equilibrium between the monomer and dimer is sensitive to cellular stimulus. In addition, carbachol and phorbol 12-myristate 13-acetate induced translocation of monomeric GFP-mSK1 to lamellipodia, whereas sphingosine1-phosphate induced translocation of dimeric GFP-mSK1 to filopodia, suggesting that SK1 regulates different cell biological processes dependent on dimerization. GFP-mSK1 mutants designed to modulate dimerization confirmed this difference in localization. Regulation by the C-terminal tail of SK1 was investigated using GFP-mSK1 truncations. Removal of the last five amino acids (PPEEP) prevented translocation of the enzyme to the PM, whereas removal of the last ten amino acids restored translocation. This suggests that the penultimate five amino acids (SRRGP) function as a translocation brake, which can be released by sequestration of the PPEEP sequence. We propose that these determinants alter the arrangement of N-terminal and C-terminal domains in SK1, leading to unique surfaces that promote differential translocation to the PM.	[Brown, Ryan D. R.; Veerman, Ben E. P.; Tate, Rothwelle J.; Cunningham, Margaret R.; Pyne, Susan; Pyne, Nigel J.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland; [Oh, Jeongah; Torta, Federico] Natl Univ Singapore, SLING, Life Sci Inst, Singapore Lipid Incubator, Singapore, Singapore; [Oh, Jeongah; Torta, Federico] Natl Univ Singapore, Dept Biochem, YLL Sch Med, Singapore, Singapore; [Adams, David R.] Heriot Watt Univ, Sch Engn & Phys Sci, Edinburgh, Midlothian, Scotland	University of Strathclyde; National University of Singapore; National University of Singapore; Heriot Watt University	Pyne, NJ (corresponding author), Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland.	n.j.pyne@strath.ac.uk		Brown, Ryan/0000-0003-2880-0301; Cunningham, Margaret/0000-0001-6454-8671; Torta, Federico/0000-0001-7545-7484; Veerman, Ben/0000-0002-0734-5920	University of Strathclyde; NRF [2019-NRF-ISF003-3172]	University of Strathclyde; NRF	R. D. R. B. acknowledges the University of Strathclyde for a scholarship award. J. O. was supported by the NRF 2019-NRF-ISF003-3172 grant.	Adams DR, 2016, TRENDS BIOCHEM SCI, V41, P395, DOI 10.1016/j.tibs.2016.02.007; Barr RK, 2008, J BIOL CHEM, V283, P34994, DOI 10.1074/jbc.M804658200; Brizuela L, 2007, J LIPID RES, V48, P2264, DOI 10.1194/jlr.M700291-JLR200; Delon C, 2004, J BIOL CHEM, V279, P44763, DOI 10.1074/jbc.M405771200; Fiszman GL, 2007, CANCER BIOL THER, V6, P1106, DOI 10.4161/cbt.6.7.4330; Gustin DJ, 2013, BIOORG MED CHEM LETT, V23, P4608, DOI 10.1016/j.bmcl.2013.06.030; HAWORTH NL, 2015, RSC ADV, V5, P8630, DOI DOI 10.1039/C5RA10672A; Hengst JA, 2010, ARCH BIOCHEM BIOPHYS, V494, P23, DOI 10.1016/j.abb.2009.11.006; Hengst JA, 2009, ARCH BIOCHEM BIOPHYS, V492, P62, DOI 10.1016/j.abb.2009.09.013; Huwiler A, 2006, BBA-MOL CELL BIOL L, V1761, P367, DOI 10.1016/j.bbalip.2006.02.007; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Kiss Z, 1998, BBA-LIPID LIPID MET, V1392, P109, DOI 10.1016/S0005-2760(98)00030-7; Lee MD, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aar4411; Lim KG, 2011, J BIOL CHEM, V286, P18633, DOI 10.1074/jbc.M111.220756; Long JS, 2010, MOL CELL BIOL, V30, P3827, DOI 10.1128/MCB.01133-09; Maczis Melissa, 2015, Advances in Biological Regulation, V60, P160, DOI 10.1016/j.jbior.2015.09.006; Narayanaswamy P, 2014, ANAL CHEM, V86, P3043, DOI 10.1021/ac4039652; Ohotski J, 2013, INT J CANCER, V132, P605, DOI 10.1002/ijc.27692; Olivera A, 1996, J CELL BIOCHEM, V60, P529, DOI 10.1002/(SICI)1097-4644(19960315)60:4<529::AID-JCB9>3.0.CO;2-U; Pham DH, 2014, ONCOGENE, V33, P5559, DOI 10.1038/onc.2013.502; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pulkoski-Gross MJ, 2018, J LIPID RES, V59, P462, DOI 10.1194/jlr.M081307; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Pyne S, 2016, PROG LIPID RES, V62, P93, DOI 10.1016/j.plipres.2016.03.001; SCHMIDT M, 1994, EUR J BIOCHEM, V225, P667, DOI 10.1111/j.1432-1033.1994.00667.x; Shen HY, 2014, NAT CELL BIOL, V16, P652, DOI 10.1038/ncb2987; Stahelin RV, 2005, J BIOL CHEM, V280, P43030, DOI 10.1074/jbc.M507574200; Stanislaus D, 1997, MOL ENDOCRINOL, V11, P738, DOI 10.1210/me.11.6.738; ter Braak M, 2009, BBA-MOL CELL BIOL L, V1791, P357, DOI 10.1016/j.bbalip.2009.01.019; Wang J, 2014, ACS MED CHEM LETT, V5, P1329, DOI 10.1021/ml5004074; Wang QS, 2014, TUMOR BIOL, V35, P363, DOI 10.1007/s13277-013-1051-1; Wang Z, 2013, STRUCTURE, V21, P798, DOI 10.1016/j.str.2013.02.025; Watson C, 2010, AM J PATHOL, V177, P2205, DOI 10.2353/ajpath.2010.100220; Wilson C, 2020, METABOLISM, V111, DOI 10.1016/j.metabol.2020.154340; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200	37	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100674	10.1016/j.jbc.2021.100674	http://dx.doi.org/10.1016/j.jbc.2021.100674			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865856	Green Published, Green Accepted, gold			2022-12-28	WOS:000672866400645
J	Cirilo, JA; Yengo, CM				Cirilo, Joseph A., Jr.; Yengo, Christopher M.			A dynamic Dab2 keeps myosin VI stably on track	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Myosins are actin-based motor proteins known to perform a variety of different mechanical tasks in cells including transporting cargo, generating tension, and linking the cytoskeleton and membrane. Myosins that function as transporters often form complexes with adaptor proteins and vesicular membranes, making it unclear how they transport their cargo through the actin cytoskeletal network. Rai et al. now use single-molecule kinetics, FRET, and DNA origami scaffolds that mimic motor-adaptor complexes to reveal that the myosin VI-Dab2 complex, which is held together weakly and turns over rapidly, can facilitate processive transport without disruption of the cytoskeleton.	[Cirilo, Joseph A., Jr.; Yengo, Christopher M.] Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Yengo, CM (corresponding author), Penn State Coll Med, Dept Cellular & Mol Physiol, Hershey, PA 17033 USA.	cmy11@psu.edu		Yengo, Christopher/0000-0003-3987-9019; Cirilo, Joseph/0000-0003-2135-5831	NIH [HL127699, HL150953, HL150953-01S1]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The work was supported by NIH grants to C. M. Y. (HL127699, HL150953) and a research supplement to J. A. C. (HL150953-01S1). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	De la Cruz EM, 2001, J BIOL CHEM, V276, P32373, DOI 10.1074/jbc.M104136200; Mishra SK, 2002, EMBO J, V21, P4915, DOI 10.1093/emboj/cdf487; Olenick MA, 2019, J CELL SCI, V132, DOI 10.1242/jcs.227132; Rai A, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.012703; Reymann AC, 2012, SCIENCE, V336, P1310, DOI 10.1126/science.1221708; Svitkina TM, 2020, TRENDS CELL BIOL, V30, P556, DOI 10.1016/j.tcb.2020.03.005; Triclin S, 2021, NAT MATER, V20, P883, DOI 10.1038/s41563-020-00905-0; Twelvetrees A, 2019, J CELL SCI, V132, DOI 10.1242/jcs.215822; Van Gele M, 2009, PIGM CELL MELANOMA R, V22, P268, DOI 10.1111/j.1755-148X.2009.00558.x; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	10	0	0	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100640	10.1016/j.jbc.2021.100640	http://dx.doi.org/10.1016/j.jbc.2021.100640			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237899	Green Published, gold			2022-12-28	WOS:000672866400611
J	Gurung, C; Fendereski, M; Sapkota, K; Guo, J; Huang, FQ; Guo, YL				Gurung, Chandan; Fendereski, Mona; Sapkota, Krishna; Guo, Jason; Huang, Faqing; Guo, Yan-Lin			Dicer represses the interferon response and the double-stranded RNA-activated protein kinase pathway in mouse embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL MECHANISMS; INNATE IMMUNITY; DEFICIENT; DIFFERENTIATION; PKR; PROLIFERATION; PLURIPOTENCY; EXPRESSION; RECEPTORS; ELEMENTS	Recent studies have demonstrated that embryonic stem cells (ESCs) are deficient in expressing type I interferons (IFN), the cytokines that play key roles in antiviral responses. However, the underlying molecular mechanisms and biological implications of this finding are poorly understood. In this study, we developed a synthetic RNA-based assay that can simultaneously assess multiple forms of antiviral responses. Dicer is an enzyme essential for RNA interference (RNAi), which is used as a major antiviral mechanism in invertebrates. RNAi activity is detected in wild-type ESCs but is abolished in Dicer knockout ESCs (D-/-ESCs) as expected. Surprisingly, D-/-ESCs have gained the ability to express IFN, which is otherwise deficient in wild-type ESCs. Furthermore, D-/-ESCs have constitutively active double-stranded RNA (dsRNA)-activated protein kinase (PKR), an enzyme that is also involved in antiviral response. D-/-ESCs show increased sensitivity to the cytotoxicity resulting from RNA transfection. The effects of dsRNA can be partly replicated with a synthetic B2RNA corresponding to the retrotransposon B2 short interspersed nuclear element. B2RNA has secondary structure features of dsRNA and accumulates in D-/-ESCs, suggesting that B2RNA could be a cellular RNA that activates PKR and contributes to the decreased cell proliferation and viability of D-/-ESCs. Treatment of D-/-ESCs with a PKR inhibitor and IFN beta-neutralizing antibodies increased cell proliferation rate and cell viability. Based on these findings, we propose that, in ESCs, Dicer acts as a repressor of antiviral responses and plays a key role in the maintenance of proliferation, viability, and pluripotency of ESCs.	[Gurung, Chandan; Fendereski, Mona; Guo, Jason; Guo, Yan-Lin] Univ Southern Mississippi, Dept Cell & Mol Biol, Hattiesburg, MS 39406 USA; [Sapkota, Krishna; Huang, Faqing] Univ Southern Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA; [Guo, Yan-Lin] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA	University of Southern Mississippi; University of Southern Mississippi; Johns Hopkins University	Guo, YL (corresponding author), Univ Southern Mississippi, Dept Cell & Mol Biol, Hattiesburg, MS 39406 USA.; Guo, YL (corresponding author), Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA.	yanlin.guo@usm.edu			National Institute of General Medical Sciences [R15GM128196]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part supported by the National Institute of General Medical Sciences (R15GM128196).	Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; Bodak M, 2017, FEBS OPEN BIO, V7, P204, DOI 10.1002/2211-5463.12174; Bogerd HP, 2014, RNA, V20, P923, DOI 10.1261/rna.044545.114; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Chiappinelli KB, 2012, MOL CANCER RES, V10, P316, DOI 10.1158/1541-7786.MCR-11-0520; Coleman TM, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh007; Cullen BR, 2013, CELL HOST MICROBE, V14, P374, DOI 10.1016/j.chom.2013.09.011; D'Angelo W, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1033-8; D'Angelo W, 2016, STEM CELLS DEV, V25, P648, DOI 10.1089/scd.2015.0377; Eggenberger J, 2019, P NATL ACAD SCI USA, V116, P1384, DOI 10.1073/pnas.1812449116; Espinoza CA, 2007, RNA, V13, P583, DOI 10.1261/rna.310307; Garcia MA, 2007, BIOCHIMIE, V89, P799, DOI 10.1016/j.biochi.2007.03.001; Guo YL, 2007, DEV DYNAM, V236, P3383, DOI 10.1002/dvdy.21374; Guo YL, 2019, AM J REPROD IMMUNOL, V81, DOI 10.1111/aji.13089; Guo YL, 2017, IMMUNOL CELL BIOL, V95, P17, DOI 10.1038/icb.2016.70; Guo YL, 2015, STEM CELLS, V33, P3165, DOI 10.1002/stem.2079; HERTZOG PJ, 1994, MOL REPROD DEV, V39, P226; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Huang FQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183974; Hutchins AP, 2015, SCI BULL, V60, P1722, DOI 10.1007/s11434-015-0905-x; Kaneko H, 2011, NATURE, V471, P325, DOI 10.1038/nature09830; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kim BM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039239; Kim Y, 2014, GENE DEV, V28, P1310, DOI 10.1101/gad.242644.114; KOZAK M, 1987, J MOL BIOL, V196, P947, DOI 10.1016/0022-2836(87)90418-9; Kumar H, 2009, BIOCHEM BIOPH RES CO, V388, P621, DOI 10.1016/j.bbrc.2009.08.062; Li N, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni036; Luningschror P, 2012, STEM CELLS, V30, P655, DOI 10.1002/stem.1033; Maillard PV, 2013, SCIENCE, V342, P235, DOI 10.1126/science.1241930; Maillard PV, 2016, EMBO J, V35, P2505, DOI 10.15252/embj.201695086; Mens MMJ, 2018, STEM CELL REV REP, V14, P309, DOI 10.1007/s12015-018-9808-y; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nallagatla SR, 2011, CURR OPIN STRUC BIOL, V21, P119, DOI 10.1016/j.sbi.2010.11.003; Napetschnig J, 2013, ANNU REV BIOPHYS, V42, P443, DOI 10.1146/annurev-biophys-083012-130338; Pare JM, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003865; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shen T, 2012, ANTI-CANCER AGENT ME, V12, P631, DOI 10.2174/187152012800617678; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Tiscornia G, 2010, GENE DEV, V24, P2732, DOI 10.1101/gad.1982910; Walters RD, 2009, IUBMB LIFE, V61, P831, DOI 10.1002/iub.227; Wang QQ, 2004, MICROBIOL MOL BIOL R, V68, P432, DOI 10.1128/MMBR.68.3.432-452.2004; Wang RX, 2014, J BIOL CHEM, V289, P25186, DOI 10.1074/jbc.M113.537746; Wang RX, 2014, STEM CELLS DEV, V23, P594, DOI 10.1089/scd.2013.0417; Wang RX, 2013, J BIOL CHEM, V288, P15926, DOI 10.1074/jbc.M112.421438; White E, 2014, NAT STRUCT MOL BIOL, V21, P552, DOI 10.1038/nsmb.2827; Williams BRG, 1999, ONCOGENE, V18, P6112, DOI 10.1038/sj.onc.1203127; Witteveldt J, 2019, ELIFE, V8, DOI 10.7554/eLife.44171; Wu XF, 2018, CELL, V172, P423, DOI 10.1016/j.cell.2017.11.018; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229	55	8	8	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100264	10.1016/j.jbc.2021.100264	http://dx.doi.org/10.1016/j.jbc.2021.100264			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837743	Green Published, gold			2022-12-28	WOS:000672866400240
J	Konovalov, KA; Wang, W; Wang, G; Goonetilleke, EC; Gao, X; Wang, D; Huang, XH				Konovalov, Kirill A.; Wang, Wei; Wang, Guo; Goonetilleke, Eshani C.; Gao, Xin; Wang, Dong; Huang, Xuhui			A comprehensive mechanism for 5-carboxylcytosine-induced transcriptional pausing revealed by Markov state models	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								RNA polymerase II (Pol II) surveils the genome, pausing as it encounters DNA lesions and base modifications and initiating signals for DNA repair among other important regulatory events. Recent work suggests that Pol II pauses at 5-carboxycytosine (5caC), an epigenetic modification of cytosine, because of a specific hydrogen bond between the carboxyl group of 5caC and a specific residue in fork loop 3 of Pol II. This hydrogen bond compromises productive NTP binding and slows down elongation. Apart from this specific interaction, the carboxyl group of 5caC can potentially interact with numerous charged residues in the cleft of Pol II. However, it is not clear how other interactions between Pol II and 5caC contribute to pausing. In this study, we use Markov state models (a type of kinetic network models) built from extensive molecular dynamics simulations to comprehensively study the impact of 5caC on Pol II translocation. We describe two translocation intermediates with specific interactions that prevent the template base from loading into the Pol II active site. In addition to the previously observed state with 5caC constrained by fork loop 3, we discovered a new intermediate state with a hydrogen bond between 5caC and fork loop 2. Surprisingly, we find that 5caC may curb translocation by suppressing kinking of the helix bordering the active site (the bridge helix) because its high flexibility is critical to translocation. Our work provides new insights into how epigenetic modifications of genomic DNA can modulate Pol II translocation, inducing pauses in transcription.	[Konovalov, Kirill A.; Wang, Wei; Wang, Guo; Goonetilleke, Eshani C.; Huang, Xuhui] Hong Kong Univ Sci & Technol, Dept Chem, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China; [Konovalov, Kirill A.; Goonetilleke, Eshani C.; Huang, Xuhui] Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China; [Gao, Xin] King Abdullah Univ Sci & Technol KAUST, Comp Elect & Math Sci & Engn Div, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Wang, Dong] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, Div Pharmaceut Sci, La Jolla, CA 92093 USA	Hong Kong University of Science & Technology; King Abdullah University of Science & Technology; University of California System; University of California San Diego; University of California System; University of California San Diego	Huang, XH (corresponding author), Hong Kong Univ Sci & Technol, Dept Chem, State Key Lab Mol Neurosci, Kowloon, Hong Kong, Peoples R China.; Huang, XH (corresponding author), Hong Kong Ctr Neurodegenerat Dis, Hong Kong Sci Pk, Hong Kong, Peoples R China.	xuhuihuang@ust.hk	Huang, Xuhui/ABE-3207-2021; Gao, Xin/D-5487-2013	Huang, Xuhui/0000-0002-7119-9358; Goonetilleke, Eshani C/0000-0002-5476-3260; Gao, Xin/0000-0002-7108-3574	Hong Kong Research Grant Council [16302214, 16307718, 16303919, T13-605/18-W, AoE/M-09/12, AoE/P705/16, PF16-06144]; Innovation and Technology Commission [ITCPD/17-9, ITC-CNERC14SC01]; University of California San Diego; King Abdullah University of Science and Technology Office of Sponsored Research [FCC/1/1976-23, FCC/1/1976-26, URF/1/4098-01-01, REI/1/0018-01-01]; Hong Kong Research Grant Council Collaborative Research Fund [C6021-19EF]	Hong Kong Research Grant Council(Hong Kong Research Grants Council); Innovation and Technology Commission; University of California San Diego(University of California System); King Abdullah University of Science and Technology Office of Sponsored Research(King Abdullah University of Science & Technology); Hong Kong Research Grant Council Collaborative Research Fund	This work was supported by Hong Kong Research Grant Council (Grant numbers: 16302214, 16307718, 16303919, T13-605/18-W, AoE/M-09/12, and AoE/P705/16 to X. H. and PF16-06144 to K. A. K.); Innovation and Technology Commission (Grant numbers: ITCPD/17-9 and ITC-CNERC14SC01 to X.H.); University of California San Diego start-up fund to D. W.; King Abdullah University of Science and Technology Office of Sponsored Research (Grant numbers: FCC/1/1976-23, FCC/1/1976-26, URF/1/4098-01-01, and REI/1/0018-01-01 to X.G.); Hong Kong Research Grant Council Collaborative Research Fund: (C6021-19EF to X. H.).		0	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100735	10.1016/j.jbc.2021.100735	http://dx.doi.org/10.1016/j.jbc.2021.100735			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33991521	gold, Green Published			2022-12-28	WOS:000672866400704
J	Kuatsjah, E; Chan, ACK; Katahira, R; Haugen, SJ; Beckham, GT; Murphy, MEP; Eltis, LD				Kuatsjah, Eugene; Chan, Anson C. K.; Katahira, Rui; Haugen, Stefan J.; Beckham, Gregg T.; Murphy, Michael E. P.; Eltis, Lindsay D.			Structural and functional analysis of lignostilbene dioxygenases from Sphingobium sp. SYK-6	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGNIN-DERIVED BIARYL; CAROTENOID CLEAVAGE; PURIFICATION; ENZYME; CATABOLISM; CHEMICALS; PATHWAY; CLONING; MODEL	Lignostilbene-alpha,beta-dioxygenases (LSDs) are iron-dependent oxygenases involved in the catabolism of lignin-derived stilbenes. Sphingobium sp. SYK-6 contains eight LSD homologs with undetermined physiological roles. To investigate which homologs are involved in the catabolism of dehydrodiconiferyl alcohol (DCA), derived from beta-5 linked lignin subunits, we heterologously produced the enzymes and screened their activities in lysates. The seven soluble enzymes all cleaved lignostilbene, but only LSD2, LSD3, and LSD4 exhibited high specific activity for 3-(4-hydroxy-3-(4-hydroxy-3-methoxystyryl)-5-methoxyphenyl) acrylate (DCA-S) relative to lignostilbene. LSD4 catalyzed the cleavage of DCA-S to 5-formylferulate and vanillin and cleaved lignostilbene and DCA-S (similar to 10(6) M-1 s(-1)) with tenfold greater specificity than pterostilbene and resveratrol. X-ray crystal structures of native LSD4 and the catalytically inactive cobalt-substituted Co-LSD4 at 1.45 angstrom resolution revealed the same fold, metal ion coordination, and edge-to-edge dimeric structure as observed in related enzymes. Key catalytic residues, Phe-59, Tyr-101, and Lys-134, were also conserved. Structures of Co-LSD4.vanillin, Co-LSD4.lignostilbene, and Co-LSD4.DCA-S complexes revealed that Ser-283 forms a hydrogen bond with the hydroxyl group of the ferulyl portion of DCA-S. This residue is conserved in LSD2 and LSD4 but is alanine in LSD3. Substitution of Ser-283 with Ala minimally affected the specificity of LSD4 for either lignostilbene or DCA-S. By contrast, substitution with phenylalanine, as occurs in LSD5 and LSD6, reduced the specificity of the enzyme for both substrates by an order of magnitude. This study expands our understanding of an LSD critical to DCA catabolism as well as the physiological roles of other LSDs and their determinants of substrate specificity.	[Kuatsjah, Eugene; Chan, Anson C. K.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Kuatsjah, Eugene; Katahira, Rui; Haugen, Stefan J.; Beckham, Gregg T.] Natl Renewable Energy Lab, Renewable Resources & Enabling Sci Ctr, Golden, CO USA; [Kuatsjah, Eugene; Beckham, Gregg T.] Oak Ridge Natl Lab, Ctr Bioenergy Innovat, Oak Ridge, TN USA; [Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, BioProd Inst, Vancouver, BC, Canada	University of British Columbia; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; United States Department of Energy (DOE); Oak Ridge National Laboratory; University of British Columbia	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada.; Eltis, LD (corresponding author), Univ British Columbia, BioProd Inst, Vancouver, BC, Canada.	leltis@mail.ubc.ca	Kuatsjah, Eugene/GLN-5085-2022; Eltis, Lindsay/J-8272-2015	Eltis, Lindsay/0000-0002-6774-8158; Kuatsjah, Eugene/0000-0002-8793-2331	Natural Sciences and Engineering Research Council of Canada (NSERC) [171359]; NSERC [04802]; U.S. Department of Energy (DOE) [DE-AC36-08GO28308]; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office; Center for Bioenergy Innovation, a U.S. Department of Energy Research Center - Office of Biological and Environmental Research in the DOE Office of Science; Canada Research Chair	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office(United States Department of Energy (DOE)); Center for Bioenergy Innovation, a U.S. Department of Energy Research Center - Office of Biological and Environmental Research in the DOE Office of Science(United States Department of Energy (DOE)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs)	This research was supported by Discovery Grant 171359 from the Natural Sciences and Engineering Research Council of Canada (NSERC) to L. D. E. and NSERC Discovery Grant 04802 to M. E. P. M. L. D. E. is the recipient of a Canada Research Chair. This work was authored in part by the National Renewable Energy Laboratory, operated by Alliance for Sustainable Energy, LLC, for the U.S. Department of Energy (DOE) under Contract No. DE-AC36-08GO28308. Funding was provided to R. K., S. J. H., and G. T. B. by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office. E. K. and G. T. B. also acknowledges funding from The Center for Bioenergy Innovation, a U.S. Department of Energy Research Center supported by the Office of Biological and Environmental Research in the DOE Office of Science. The views expressed in the article do not necessarily represent the views of the DOE or the US Government. The US Government retains and the publisher, by accepting the article for publication, acknowledges that the US Government retains a nonexclusive, paidup, irrevocable, worldwide license to publish or reproduce the published form of this work, or allow others to do so, for US Government purposes.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ausibel F. M., 2002, SHORT PROTOCOLS MOL; Becker J, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.016; Beckham GT, 2016, CURR OPIN BIOTECH, V42, P40, DOI 10.1016/j.copbio.2016.02.030; Brefort T, 2011, FUNGAL GENET BIOL, V48, P132, DOI 10.1016/j.fgb.2010.10.009; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; Daruwalla A, 2019, BIOCH BIOPHYS ACTA M, V1865; Eltis L.D., 2018, LIGNIN VALORIZATION, P290, DOI [10.1039/9781788010351-00290, DOI 10.1039/9781788010351-00290]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; HAIGLER BE, 1990, J BACTERIOL, V172, P457, DOI 10.1128/JB.172.1.457-464.1990; Harada A, 2017, FEBS J, V284, P1855, DOI 10.1111/febs.14085; Harrison PJ, 2014, ARCH BIOCHEM BIOPHYS, V544, P105, DOI 10.1016/j.abb.2013.10.005; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; Johnson CW, 2019, JOULE, V3, P1523, DOI 10.1016/j.joule.2019.05.011; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamimura N, 2021, INT BIODETER BIODEGR, V159, DOI 10.1016/j.ibiod.2021.105208; Kamimura N, 2017, ENV MICROBIOL REP, V9, P679, DOI 10.1111/1758-2229.12597; Kamoda S, 2003, BIOSCI BIOTECH BIOCH, V67, P1394, DOI 10.1271/bbb.67.1394; Kamoda S, 1997, BIOSCI BIOTECH BIOCH, V61, P1575, DOI 10.1271/bbb.61.1575; Kamoda S., 1009, AGR BIOL CHEM TOKYO, V53, p2757 2761; Kamoda S., 1009, BIOSCI BIOTECH BIOCH, V57, p931 934; KATAYAMA Y, 1987, MOKUZAI GAKKAISHI, V33, P77; Khadka N, 2019, J BIOL CHEM, V294, P10596, DOI 10.1074/jbc.RA119.007535; Kiser PD, 2012, P NATL ACAD SCI USA, V109, pE2747, DOI 10.1073/pnas.1212025109; KISHI K, 1991, AGR BIOL CHEM TOKYO, V55, P1319, DOI 10.1080/00021369.1991.10870761; Kuatsjah E, 2019, J BIOL CHEM, V294, P12911, DOI 10.1074/jbc.RA119.009428; Kurt Z, 2018, APPL ENVIRON MICROB, V84, DOI 10.1128/AEM.00104-18; McAndrew RP, 2016, P NATL ACAD SCI USA, V113, P14324, DOI 10.1073/pnas.1608917113; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Presley GN, 2021, METAB ENG, V65, P1, DOI 10.1016/j.ymben.2021.02.003; Ragauskas AJ, 2014, SCIENCE, V344, P709, DOI 10.1126/science.1246843; Schutyser W, 2018, CHEM SOC REV, V47, P852, DOI 10.1039/c7cs00566k; Seaton S. C., 2018, LIGNIN VALORIZATION, P252; Shiel AE, 2012, GEOCHIM COSMOCHIM AC, V76, P175, DOI 10.1016/j.gca.2011.10.005; Sonoki T, 2018, ACS SUSTAIN CHEM ENG, V6, P1256, DOI 10.1021/acssuschemeng.7b03597; Sui XW, 2018, J BIOL INORG CHEM, V23, P887, DOI 10.1007/s00775-018-1586-0; Sui XW, 2017, BIOCHEMISTRY-US, V56, P2836, DOI 10.1021/acs.biochem.7b00251; Sui XW, 2016, J BIOL CHEM, V291, P19401, DOI 10.1074/jbc.M116.744912; Sui XW, 2013, ARCH BIOCHEM BIOPHYS, V539, P203, DOI 10.1016/j.abb.2013.06.012; Suzuki Y, 2020, J BIOSCI BIOENG, V130, P71, DOI 10.1016/j.jbiosc.2020.02.002; Takahashi K, 2018, ENVIRON MICROBIOL, V20, P1739, DOI 10.1111/1462-2920.14099; Takahashi K, 2015, APPL ENVIRON MICROB, V81, P8022, DOI 10.1128/AEM.02391-15; Takahashi K, 2014, BIODEGRADATION, V25, P735, DOI 10.1007/s10532-014-9695-0; Varman AM, 2016, P NATL ACAD SCI USA, V113, pE5802, DOI 10.1073/pnas.1606043113; Yamada M, 2007, ARCH MICROBIOL, V187, P511, DOI 10.1007/s00203-007-0218-9; Yu RQ, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.02154-18	47	3	3	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100758	10.1016/j.jbc.2021.100758	http://dx.doi.org/10.1016/j.jbc.2021.100758			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33965373	Green Published, gold			2022-12-28	WOS:000672866400726
J	Li, SX; Isiorho, EA; Owens, VL; Donnan, PH; Odili, CL; Mansoorabadi, SO				Li, Shuxin; Isiorho, Eta A.; Owens, Victoria L.; Donnan, Patrick H.; Odili, Chidinma L.; Mansoorabadi, Steven O.			A noncanonical heme oxygenase specific for the degradation of c-type heme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS ISDG; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; IRON-ABSORPTION; PRODUCT; ENZYME; HUTZ; GENE; CLASSIFICATION; METABOLISM	Heme oxygenases (HOs) play a critical role in recouping iron from the labile heme pool. The acquisition and liberation of heme iron are especially important for the survival of pathogenic bacteria. All characterized HOs, including those belonging to the HugZ superfamily, preferentially cleave free b-type heme. Another common form of heme found in nature is c-type heme, which is covalently linked to proteinaceous cysteine residues. However, mechanisms for direct iron acquisition from the c-type heme pool are unknown. Here we identify a HugZ homolog from the oligopeptide permease (opp) gene cluster of Paracoccus denitrificans that lacks any observable reactivity with heme b and show that it instead rapidly degrades c-type hemopeptides. This c-type heme oxygenase catalyzes the oxidative cleavage of the model substrate microperoxidase-11 at the beta- and/or delta-meso position(s), yielding the corresponding peptide-linked biliverdin, CO, and free iron. X-ray crystallographic analysis suggests that the switch in substrate specificity from b-to c-type heme involves loss of the N-terminal alpha/beta domain and C-terminal loop containing the coordinating histidine residue characteristic of HugZ homologs, thereby accommodating a larger substrate that provides its own iron ligand. These structural features are also absent in certain heme utilization/storage proteins from human pathogens that exhibit low or no HO activity with free heme. This study thus expands the scope of known iron acquisition strategies to include direct oxidative cleavage of heme-containing proteolytic fragments of c-type cytochromes and helps to explain why certain oligopeptide permeases show specificity for the import of heme in addition to peptides.	[Li, Shuxin; Isiorho, Eta A.; Owens, Victoria L.; Donnan, Patrick H.; Odili, Chidinma L.; Mansoorabadi, Steven O.] Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA; [Isiorho, Eta A.] CUNY, Adv Sci Res Ctr, New York, NY 10021 USA	Auburn University System; Auburn University; City University of New York (CUNY) System	Mansoorabadi, SO (corresponding author), Auburn Univ, Dept Chem & Biochem, Auburn, AL 36849 USA.	som@auburn.edu		Donnan, Patrick H./0000-0002-8076-2683	National Science Foundation (NSF), Division of Chemistry under CAREER Award [CHE-1555138]; U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) [DE-SC0018043]	National Science Foundation (NSF), Division of Chemistry under CAREER Award(National Science Foundation (NSF)); U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES)(United States Department of Energy (DOE))	Work by S. L. and V. L. O. was supported by the National Science Foundation (NSF), Division of Chemistry under CAREER Award CHE-1555138. Work by E. A. I. was supported by the U.S. Department of Energy (DOE), Office of Science, Basic Energy Sciences (BES) under DOE Early Career Award DE-SC0018043.	Acharya G, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1033-6; Ahmed FH, 2015, J MOL BIOL, V427, P3554, DOI 10.1016/j.jmb.2015.09.021; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baker SC, 1998, MICROBIOL MOL BIOL R, V62, P1046, DOI 10.1128/MMBR.62.4.1046-1078.1998; Bowman SEJ, 2008, NAT PROD REP, V25, P1118, DOI 10.1039/b717196j; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; FERGUSON SJ, 1991, BIOCHIM BIOPHYS ACTA, V1058, P17, DOI 10.1016/S0005-2728(05)80259-2; Frankenberg-Dinkel N, 2004, ANTIOXID REDOX SIGN, V6, P825, DOI 10.1089/ars.2004.6.825; Guo Y, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-226; Hooda J, 2014, NUTRIENTS, V6, P1080, DOI 10.3390/nu6031080; Hu YL, 2011, J BIOL CHEM, V286, P1537, DOI 10.1074/jbc.M110.172007; Joosten RP, 2014, IUCRJ, V1, P213, DOI 10.1107/S2052252514009324; KUTTY RK, 1982, J BIOL CHEM, V257, P9944; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Liu XH, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-23; Lyles KV, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00198; Matsui T, 2013, BIOCHEMISTRY-US, V52, P3025, DOI 10.1021/bi400382p; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nambu S, 2013, J BIOL CHEM, V288, P10101, DOI 10.1074/jbc.M112.448399; Onzuka M, 2017, BBA-GEN SUBJECTS, V1861, P1870, DOI 10.1016/j.bbagen.2017.04.003; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellet YH, 2016, J INORG BIOCHEM, V154, P103, DOI 10.1016/j.jinorgbio.2015.11.002; Przybyszewska J, 2014, PRZ GASTROENTEROL, V9, P208, DOI 10.5114/pg.2014.45102; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; Reniere ML, 2010, MOL MICROBIOL, V75, P1529, DOI 10.1111/j.1365-2958.2010.07076.x; Sachla AJ, 2016, BIOMETALS, V29, P593, DOI 10.1007/s10534-016-9937-1; Schalk IJ, 2013, AMINO ACIDS, V44, P1267, DOI 10.1007/s00726-013-1468-2; Scheepers GH, 2016, FEBS LETT, V590, P4393, DOI 10.1002/1873-3468.12445; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Schneider S, 2006, J BIOL CHEM, V281, P32606, DOI 10.1074/jbc.M607516200; Slamti L, 2019, RES MICROBIOL, V170, P338, DOI 10.1016/j.resmic.2019.07.004; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Tanaka KJ, 2019, J BIOL CHEM, V294, P1070, DOI 10.1074/jbc.RA118.004479; TENHUNEN R, 1969, J BIOL CHEM, V244, P6388; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Tong Y, 2009, ARCH BIOCHEM BIOPHYS, V481, P1, DOI 10.1016/j.abb.2008.10.013; Traore ES, 2021, MOLECULES, V26, DOI 10.3390/molecules26030549; TU AT, 1968, EXPERIENTIA, V24, P219, DOI 10.1007/BF02152778; Uchida T, 2017, DALTON T, V46, P8104, DOI 10.1039/c7dt01562c; Uchida T, 2017, BIOCHEMISTRY-US, V56, P2723, DOI 10.1021/acs.biochem.7b00152; Uchida T, 2012, CHEM COMMUN, V48, P6741, DOI 10.1039/c2cc31147j; Vagin AA, 2004, ACTA CRYSTALLOGR D, V60, P2184, DOI 10.1107/S0907444904023510; West AR, 2008, WORLD J GASTROENTERO, V14, P4101, DOI 10.3748/wjg.14.4101; Wilks A, 2014, ARCH BIOCHEM BIOPHYS, V544, P87, DOI 10.1016/j.abb.2013.10.013; Wilson BR, 2016, TRENDS MOL MED, V22, P1077, DOI 10.1016/j.molmed.2016.10.005; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu RY, 2005, J BIOL CHEM, V280, P2840, DOI 10.1074/jbc.M409526200; YOSHINAGA T, 1982, J BIOL CHEM, V257, P7803; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	50	2	2	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100666	10.1016/j.jbc.2021.100666	http://dx.doi.org/10.1016/j.jbc.2021.100666			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862082	gold, Green Published			2022-12-28	WOS:000672866400637
J	Okada, M; Unno, H; Emi, KI; Matsumoto, M; Hemmi, H				Okada, Miyako; Unno, Hideaki; Emi, Koh-Ichi; Matsumoto, Mayuko; Hemmi, Hisashi			A versatile cis-prenyltransferase from Methanosarcina mazei catalyzes both C- and O-prenylations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Polyprenyl groups, products of isoprenoid metabolism, are utilized in peptidoglycan biosynthesis, protein N-glycosylation, and other processes. These groups are formed by cis-prenyltransferases, which use allylic prenyl pyrophosphates as prenyldonors to catalyze the C-prenylation of the general acceptor substrate, isopentenyl pyrophosphate. Repetition of this reaction forms (Z,E-mixed)-polyprenyl pyrophosphates, which are converted later into glycosyl carrier lipids, such as undecaprenyl phosphate and dolichyl phosphate. MM_0014 from the methanogenic archaeon Methanosarcina mazei is known as a versatile cis-prenyltransferase that accepts both isopentenyl pyrophosphate and dimethylallyl pyrophosphate as acceptor substrates. To learn more about this enzyme's catalytic activity, we determined the X-ray crystal structures of MM_0014 in the presence or absence of these substrates. Surprisingly, one structure revealed a complex with O-prenylglycerol, suggesting that the enzyme catalyzed the prenylation of glycerol contained in the crystallization buffer. Further analyses confirmed that the enzyme could catalyze the O-prenylation of small alcohols, such as 2-propanol, expanding our understanding of the catalytic ability of cis-prenyltransferases.	[Okada, Miyako; Emi, Koh-Ichi; Matsumoto, Mayuko; Hemmi, Hisashi] Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan; [Unno, Hideaki] Nagasaki Univ, Grad Sch Engn, Nagasaki, Japan; [Unno, Hideaki] Nagasaki Univ, Org Marine Sci & Technol, Nagasaki, Japan	Nagoya University; Nagasaki University; Nagasaki University	Hemmi, H (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Nagoya, Aichi, Japan.	hhemmi@agr.nagoya-u.ac.jp	Hemmi, Hisashi/I-6868-2014	Hemmi, Hisashi/0000-0002-9538-809X; Unno, Hideaki/0000-0001-5917-269X	JSPS KAKENHI [17H05437, 18K19170, 19H04651, 20H02899]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Numbers 17H05437, 18K19170, 19H04651, and 20H02899 for H. H.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	1	1	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100679	10.1016/j.jbc.2021.100679	http://dx.doi.org/10.1016/j.jbc.2021.100679			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33872599	Green Published, gold			2022-12-28	WOS:000672866400650
J	Caval, V; Suspene, R; Khal, P; Gaillard, J; Caignard, G; Vitour, D; Roingeard, P; Vartanian, JP; Wain-Hobson, S				Caval, Vincent; Suspene, Rodolphe; Khal, Pierre; Gaillard, Julien; Caignard, Gregory; Vitour, Damien; Roingeard, Philippe; Vartanian, Jean-Pierre; Wain-Hobson, Simon			Frame-shifted APOBEC3A encodes two alternative proapoptotic proteins that target the mitochondrial network	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUG INITIATOR CODON; MUTATIONAL PROCESSES; CYTIDINE DEAMINASES; READING FRAMES; NUCLEAR-DNA; VIRUS; GENE; HYPERMUTATION; SEQUENCE; CANCER	The human APOBEC3A (A3A) cytidine deaminase is a powerful DNA mutator enzyme recognized as a major source of somatic mutations in tumor cell genomes. However, there is a discrepancy between APOBEC3A mRNA levels after interferon stimulation in myeloid cells and A3A detection at the protein level. To understand this difference, we investigated the expression of two novel alternative "A3Alt" proteins encoded in the +1-shifted reading frame of the APOBEC3A gene. A3Alt-L and its shorter isoform A3Alt-S appear to be transmembrane proteins targeted to the mitochondrial compartment that induce membrane depolarization and apoptosis. Thus, the APOBEC3A gene represents a new example wherein a single gene encodes two proapoptotic proteins, A3A cytidine deaminases that target the genome and A3Alt proteins that target mitochondria.	[Caval, Vincent; Suspene, Rodolphe; Khal, Pierre; Vartanian, Jean-Pierre; Wain-Hobson, Simon] Inst Pasteur, Mol Retrovirol Unit, Paris, France; [Khal, Pierre] Sorbonne Univ, ED515, Paris, France; [Gaillard, Julien; Roingeard, Philippe] Morphogenese & Antigenicite VIH & Virus Hepatites, INSERM, U1259, MAVIVH, Tours, France; [Gaillard, Julien; Roingeard, Philippe] Univ Tours, PPF ASB, Plate Forme IBiSA Microscopies, Tours, France; [Gaillard, Julien; Roingeard, Philippe] CHRU Tours, Tours, France; [Caignard, Gregory; Vitour, Damien] Univ Paris Est, Ecole Natl Vet Alfort, Lab Sante Anim Alfort, INRAE,Anses,UMR Virol, Maisons Alfort, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours; CHU Tours; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Ecole Nationale Veterinaire d'Alfort (ENVA); INRAE	Caval, V (corresponding author), Inst Pasteur, Mol Retrovirol Unit, Paris, France.	vincent.caval@pasteur.fr		Vitour, Damien/0000-0002-2205-2624; Caval, vincent/0000-0002-5458-6081; Caignard, Gregory/0000-0001-7021-0749	La Ligue contre le Cancer	La Ligue contre le Cancer(Ligue nationale contre le cancer)	P. K. was supported by La Ligue contre le Cancer. The funding bodies had no role in the design of the study or collection, analysis, and interpretation of the data, or the writing of the manuscript.	Aarreberg LD, 2019, MOL CELL, V74, P801, DOI 10.1016/j.molcel.2019.02.038; Abramowitz J, 2004, P NATL ACAD SCI USA, V101, P8366, DOI 10.1073/pnas.0308758101; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Armenteros JJA, 2017, BIOINFORMATICS, V33, P3387, DOI 10.1093/bioinformatics/btx431; Aynaud MM, 2012, J BIOL CHEM, V287, P39182, DOI 10.1074/jbc.M112.372722; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bergeron D, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.472654; Bogerd HP, 2006, P NATL ACAD SCI USA, V103, P8780, DOI 10.1073/pnas.0603313103; Brunet MA, 2019, NUCLEIC ACIDS RES, V47, pD403, DOI 10.1093/nar/gky936; Buchan DWA, 2019, NUCLEIC ACIDS RES, V47, pW402, DOI 10.1093/nar/gkz297; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Caval V, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6129; Chan K, 2015, NAT GENET, V47, P1067, DOI 10.1038/ng.3378; Chen H, 2006, CURR BIOL, V16, P480, DOI 10.1016/j.cub.2006.01.031; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cortez LM, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008545; Garcia EI, 2018, J VIROL, V92, DOI 10.1128/JVI.00971-18; Green AM, 2016, CELL CYCLE, V15, P998, DOI 10.1080/15384101.2016.1152426; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Huttlin EL, 2017, NATURE, V545, P505, DOI 10.1038/nature22366; Jarmuz A, 2002, GENOMICS, V79, P285, DOI 10.1006/geno.2002.6718; Kidd JM, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030063; Klemke M, 2001, EMBO J, V20, P3849, DOI 10.1093/emboj/20.14.3849; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P3873, DOI 10.1093/nar/12.9.3873; Kozak M, 2002, GENE, V299, P1, DOI 10.1016/S0378-1119(02)01056-9; KOZAK M, 1981, NUCLEIC ACIDS RES, V9, P5233, DOI 10.1093/nar/9.20.5233; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; Lamy P, 2016, CANCER RES, V76, P5894, DOI 10.1158/0008-5472.CAN-16-0436; Landry S, 2011, EMBO REP, V12, P444, DOI 10.1038/embor.2011.46; Lecossier D, 2003, SCIENCE, V300, P1112, DOI 10.1126/science.1083338; Mangeat B, 2003, NATURE, V424, P99, DOI 10.1038/nature01709; McFadden N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002413; Mossmann D, 2012, BBA-GENE REGUL MECH, V1819, P1098, DOI 10.1016/j.bbagrm.2011.11.007; Muckenfuss H, 2006, J BIOL CHEM, V281, P22161, DOI 10.1074/jbc.M601716200; Mussil B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39245-8; Mussil B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073641; Nik-Zainal S, 2014, NAT GENET, V46, P487, DOI 10.1038/ng.2955; Nik-Zainal S, 2012, CELL, V149, P979, DOI 10.1016/j.cell.2012.04.024; Niocel M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40941-8; NOTEBORN MHM, 1994, J VIROL, V68, P346, DOI 10.1128/JVI.68.1.346-351.1994; Petljak M, 2019, CELL, V176, P1282, DOI 10.1016/j.cell.2019.02.012; QUELLE DE, 1995, CELL, V83, P993; Refsland EW, 2010, NUCLEIC ACIDS RES, V38, P4274, DOI 10.1093/nar/gkq174; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Roper N, 2019, CELL REP, V26, P2651, DOI 10.1016/j.celrep.2019.02.028; Savojardo C, 2014, BIOINFORMATICS, V30, P2973, DOI 10.1093/bioinformatics/btu411; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Stephens PJ, 2012, NATURE, V486, P400, DOI 10.1038/nature11017; Suspene R, 2005, J GEN VIROL, V86, P125, DOI 10.1099/vir.0.80426-0; Suspene R, 2017, NUCLEIC ACIDS RES, V45, P3231, DOI 10.1093/nar/gkx001; Suspene R, 2011, J VIROL, V85, P7594, DOI 10.1128/JVI.00290-11; Suspene R, 2011, P NATL ACAD SCI USA, V108, P4858, DOI 10.1073/pnas.1009687108; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Vanderperre B, 2011, FASEB J, V25, P2373, DOI 10.1096/fj.10-173815; Vartanian JP, 2008, SCIENCE, V320, P230, DOI 10.1126/science.1153201	55	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101081	10.1016/j.jbc.2021.101081	http://dx.doi.org/10.1016/j.jbc.2021.101081			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34403699	Green Published, gold			2022-12-28	WOS:000706361700010
J	Chirasani, VR; Pasek, DA; Meissner, G				Chirasani, Venkat R.; Pasek, Daniel A.; Meissner, Gerhard			Structural and functional interactions between the Ca2+-, ATP-, and caffeine-binding sites of skeletal muscle ryanodine receptor (RyR1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-RELEASE CHANNEL; GENERAL FORCE-FIELD; SARCOPLASMIC-RETICULUM; CHARMM; ACTIVATION; EFFICIENT; INSIGHTS; DOMAINS; CA-2+; GUI	Ryanodine receptor type 1 (RyR1) releases Ca2+ ions from the sarcoplasmic reticulum of skeletal muscle cells to initiate muscle contraction. Multiple endogenous and exogenous effectors regulate RyR1, such as ATP, Ca2+, caffeine (Caf), and ryanodine. Cryo-EM identified binding sites for the three coactivators Ca2+, ATP, and Caf. However, the mechanism of coregulation and synergy between these activators remains to be determined. Here, we used [H-3]ryanodine ligand-binding assays and molecular dynamics simulations to test the hypothesis that both the ATP-and Caf-binding sites communicate with the Ca2+-binding site to sensitize RyR1 to Ca2+. We report that either phosphomethylphosphonic acid adenylate ester (AMPPCP), a nonhydrolyzable ATP analog, or Caf can activate RyR1 in the absence or the presence of Ca2+. However, enhanced RyR1 activation occurred in the presence of Ca2+, AMPPCP, and Caf. In the absence of Ca2+, Na+ inhibited [H-3] ryanodine binding without impairing RyR1 activation by AMPPCP and Caf. Computational analysis suggested that Ca2+-, ATP-, and Caf-binding sites modulate RyR1 protein stability through interactions with the carboxyterminal domain and other domains in the activation core. In the presence of ATP and Caf but the absence of Ca2+, Na+ is predicted to inhibit RyR1 by interacting with the Ca2+-binding site. Our data suggested that ATP and Caf binding affected the conformation of the Ca2+-binding site, and conversely, Ca2+ binding affected the conformation of the ATP-and Caf-binding sites. We conclude that Ca2+, ATP, and Caf regulate RyR1 through a network of allosteric interactions involving the Ca2+-, ATP-, and Caf-binding sites.	[Chirasani, Venkat R.; Pasek, Daniel A.; Meissner, Gerhard] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA	University of North Carolina; University of North Carolina Chapel Hill	Chirasani, VR (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27515 USA.	venkatr@med.unc.edu	Chirasani, Venkata Reddy/ABB-4967-2021; Chirasani, Venkata Reddy/AFN-6812-2022	Chirasani, Venkata Reddy/0000-0003-1416-0438; Chirasani, Venkata Reddy/0000-0003-1416-0438; Meissner, Gerhard/0000-0001-5185-4389	National Institutes of Health [AR018687]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Dr Naohiro Yamaguchi, Medical University of South Carolina, for critical comments and helpful insights. Support by National Institutes of Health grant AR018687 is gratefully acknowledged.	Bai XC, 2016, CELL RES, V26, P995, DOI 10.1038/cr.2016.89; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; BLOCK BA, 1988, J CELL BIOL, V107, P2587, DOI 10.1083/jcb.107.6.2587; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chirasani VR, 2019, AM J PHYSIOL-CELL PH, V317, pC358, DOI 10.1152/ajpcell.00052.2019; Dashti A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18403-x; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dhindwal S, 2017, SCI SIGNAL, V10, DOI 10.1126/scisignal.aai8842; Efremov RG, 2015, NATURE, V517, P39, DOI 10.1038/nature13916; EISENHABER F, 1995, J COMPUT CHEM, V16, P273, DOI 10.1002/jcc.540160303; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Franzini-Armstrong C, 2018, J GEN PHYSIOL, V150, P189, DOI 10.1085/jgp.201711889; Gong DS, 2019, NATURE, V572, P347, DOI 10.1038/s41586-019-1377-y; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; Iyer KA, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb2964; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Lanner JT, 2012, ADV EXP MED BIOL, V740, P217, DOI 10.1007/978-94-007-2888-2_9; Lee J, 2016, J CHEM THEORY COMPUT, V12, P405, DOI 10.1021/acs.jctc.5b00935; Lindsay C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33328-8; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; Ludtke SJ, 2005, STRUCTURE, V13, P1203, DOI 10.1016/j.str.2005.06.005; Ma RF, 2020, NAT CHEM BIOL, V16, P1246, DOI 10.1038/s41589-020-0627-5; Meissner G, 1997, J BIOL CHEM, V272, P1628, DOI 10.1074/jbc.272.3.1628; Meissner G, 2017, J GEN PHYSIOL, V149, P1065, DOI 10.1085/jgp.201711878; Murayama T, 2018, COMMUN BIOL, V1, DOI 10.1038/s42003-018-0103-x; Nelson BR, 2013, P NATL ACAD SCI USA, V110, P11881, DOI 10.1073/pnas.1310571110; Nelson Thomas E., 2002, Current Molecular Medicine (Hilversum), V2, P347, DOI 10.2174/1566524023362429; OGAWA Y, 1990, J BIOCHEM-TOKYO, V107, P894, DOI 10.1093/oxfordjournals.jbchem.a123144; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Rebbeck RT, 2014, INT J BIOCHEM CELL B, V48, P28, DOI 10.1016/j.biocel.2013.12.001; Rios E, 2018, J GEN PHYSIOL, V150, P521, DOI 10.1085/jgp.201711959; Rosenberg H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0310-1; ROUSSEAU E, 1988, ARCH BIOCHEM BIOPHYS, V267, P75, DOI 10.1016/0003-9861(88)90010-0; Samso M, 2005, NAT STRUCT MOL BIOL, V12, P539, DOI 10.1038/nsmb938; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Schrodinger LLC, 2017, PYMOL MOL GRAPHICS S; SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1; SMITH JS, 1986, J GEN PHYSIOL, V88, P573, DOI 10.1085/jgp.88.5.573; Sutko JL, 1997, PHARMACOL REV, V49, P53; Vanommeslaeghe K, 2012, J CHEM INF MODEL, V52, P3144, DOI 10.1021/ci300363c; Vanommeslaeghe K, 2010, J COMPUT CHEM, V31, P671, DOI 10.1002/jcc.21367; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Webb Benjamin, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi0506s47; Weiss RG, 2004, AM J PHYSIOL-CELL PH, V287, pC1094, DOI 10.1152/ajpcell.00173.2004; Willegems K, 2018, STRUCTURE, V26, P1303, DOI 10.1016/j.str.2018.06.010; Woll KA, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21141-3; Xu L, 2020, CELL CALCIUM, V87, DOI 10.1016/j.ceca.2020.102182; Xu L, 2018, J BIOL CHEM, V293, P19501, DOI 10.1074/jbc.RA118.004453; Xu L, 2018, J BIOL CHEM, V293, P2015, DOI 10.1074/jbc.M117.803247; Yan Z, 2015, NATURE, V517, P50, DOI 10.1038/nature14063; Yuchi ZG, 2016, CELL CALCIUM, V59, P209, DOI 10.1016/j.ceca.2016.04.003	54	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101040	10.1016/j.jbc.2021.101040	http://dx.doi.org/10.1016/j.jbc.2021.101040			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34352272	Green Published, gold			2022-12-28	WOS:000704369100002
J	Hoang, HM; Johnson, HE; Heo, J				Hanh My Hoang; Johnson, Hope Elizabeth; Heo, Jongyun			Rac-dependent feedforward autoactivation of NOX2 leads to oxidative burst	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GUANINE-NUCLEOTIDE EXCHANGE; NADPH OXIDASE ACTIVITY; CELL-FREE SYSTEM; NEUTROPHIL CYTOCHROME-B; RESPIRATORY BURST; INSERT REGION; SUPEROXIDE-PRODUCTION; MOLECULAR-MECHANISMS; EFFECTOR REGION; RHO-GTPASES	NADPH oxidase 2 (NOX2) produces the superoxide anion radical (O-2(-)), which has functions in both cell signaling and immune defense. NOX2 is a multimeric-protein complex consisting of several protein subunits including the GTPase Rac. NOX2 uniquely facilitates an oxidative burst, which is described by initially slow O-2(-) production, which increases over time. The NOX2 oxidative burst is considered critical to immune defense because it enables expedited O-2(-) production in response to infections. However, the mechanism of the initiation and progression of this oxidative burst and its implications for regulation of NOX2 have not been clarified. In this study, we show that the NOX2 oxidative burst is a result of autoactivation of NOX2 coupled with the redox function of Rac. NOX2 autoactivation begins when active Rac triggers NOX2 activation and the subsequent production of O-2(-), which in turn activates redox-sensitive Rac. This activated Rac further activates NOX2, amplifying the feedforward cycle and resulting in a NOX2-mediated oxidative burst. Using mutagenesis-based kinetic and cell analyses, we show that enzymatic activation of Rac is exclusively responsible for production of the active Rac trigger that initiates NOX2 autoactivation, whereas redox-mediated Rac activation is the main driving force of NOX2 autoactivation and contributes to generation of similar to 98% of the active NOX2 in cells. The results of this study provide insight into the regulation of NOX2 function, which could be used to develop therapeutics to control immune responses associated with dysregulated NOX2 oxidative bursts.	[Hanh My Hoang; Johnson, Hope Elizabeth; Heo, Jongyun] Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA	University of Texas System; University of Texas Arlington	Heo, J (corresponding author), Univ Texas Arlington, Dept Chem & Biochem, Arlington, TX 76019 USA.	jheo@uta.edu			National Institutes of Health [1R15AI096146-01A1]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health grant 1R15AI096146-01A1 to J. H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe K, 2000, J BIOL CHEM, V275, P10141, DOI 10.1074/jbc.275.14.10141; ABO A, 1992, J BIOL CHEM, V267, P16767; Azadmanesh J, 2018, ANTIOXIDANTS-BASEL, V7, DOI 10.3390/antiox7020025; Bertagnolo V, 2008, J PROTEOME RES, V7, P3729, DOI 10.1021/pr7008719; Bindoli A, 2008, ANTIOXID REDOX SIGN, V10, P1549, DOI 10.1089/ars.2008.2063; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brandes RP, 2005, CARDIOVASC RES, V65, P16, DOI 10.1016/j.cardiores.2004.08.007; Chhatriwala MK, 2007, J MOL BIOL, V368, P1307, DOI 10.1016/j.jmb.2007.02.060; Cifuentes-Pagano E, 2014, ANTIOXID REDOX SIGN, V20, P2741, DOI 10.1089/ars.2013.5620; Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13; Cross AR, 1999, BIOCHEM J, V338, P229, DOI 10.1042/0264-6021:3380229; Dahlgren C, 1999, J IMMUNOL METHODS, V232, P3, DOI 10.1016/S0022-1759(99)00146-5; Dang PMC, 2003, BIOCHEMISTRY-US, V42, P4520, DOI 10.1021/bi0205754; Dang PMC, 2002, P NATL ACAD SCI USA, V99, P4262, DOI 10.1073/pnas.072345299; Dang PMC, 2001, P NATL ACAD SCI USA, V98, P3001, DOI 10.1073/pnas.061029698; Dang PMC, 2000, BIOCHEMISTRY-US, V39, P3069, DOI 10.1021/bi9919807; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Diebold BA, 2001, NAT IMMUNOL, V2, P211, DOI 10.1038/85259; DINAUER MC, 1990, J CLIN INVEST, V86, P1729, DOI 10.1172/JCI114898; Doncic A, 2013, MOL CELL, V50, P856, DOI 10.1016/j.molcel.2013.04.014; Fisher AB, 2009, ANTIOXID REDOX SIGN, V11, P1349, DOI [10.1089/ars.2008.2378, 10.1089/ARS.2008.2378]; Forbes LV, 1999, FEBS LETT, V449, P225, DOI 10.1016/S0014-5793(99)00444-5; Freeman JL, 1996, J BIOL CHEM, V271, P19794, DOI 10.1074/jbc.271.33.19794; FREEMAN JLR, 1994, BIOCHEMISTRY-US, V33, P13431, DOI 10.1021/bi00249a031; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; Geyer M, 1997, CURR OPIN STRUC BIOL, V7, P786, DOI 10.1016/S0959-440X(97)80147-9; Gureasko J, 2008, NAT STRUCT MOL BIOL, V15, P452, DOI 10.1038/nsmb.1418; Han CH, 1998, J BIOL CHEM, V273, P16663, DOI 10.1074/jbc.273.27.16663; Hawkins BJ, 2007, MOL BIOL CELL, V18, P2002, DOI 10.1091/mbc.E06-09-0830; Heo J, 2005, BIOCHEMISTRY-US, V44, P6573, DOI 10.1021/bi047443q; Heo J, 2001, P NATL ACAD SCI USA, V98, P7690, DOI 10.1073/pnas.141230698; Heo J, 2005, J BIOL CHEM, V280, P31003, DOI 10.1074/jbc.M504768200; Heo JY, 2006, BIOCHEMISTRY-US, V45, P14481, DOI 10.1021/bi0610101; Heo J, 2011, BIOCHEMISTRY-US, V50, P5731, DOI 10.1021/bi200347y; Heo JY, 2011, ANTIOXID REDOX SIGN, V14, P689, DOI 10.1089/ars.2009.2984; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P261, DOI 10.1091/mbc.4.3.261; HEYWORTH PG, 1993, MOL BIOL CELL, V4, P1217, DOI 10.1091/mbc.4.11.1217; Hoang Hanh My, 2021, Small GTPases, V12, P44, DOI 10.1080/21541248.2019.1601954; Hoyal CR, 2003, P NATL ACAD SCI USA, V100, P5130, DOI 10.1073/pnas.1031526100; Koga H, 1999, J BIOL CHEM, V274, P25051, DOI 10.1074/jbc.274.35.25051; KURGANOV BI, 1976, J THEOR BIOL, V60, P247, DOI 10.1016/0022-5193(76)90059-X; Kutys Matthew L, 2015, Small GTPases, V6, P16, DOI 10.4161/21541248.2014.989792; KWONG CH, 1995, J BIOL CHEM, V270, P19868, DOI 10.1074/jbc.270.34.19868; LAMARCHE N, 1994, TRENDS GENET, V10, P436, DOI 10.1016/0168-9525(94)90114-7; Lapouge K, 2000, MOL CELL, V6, P899, DOI 10.1016/S1097-2765(00)00087-3; LENZEN C, 1995, METHOD ENZYMOL, V255, P95; LEVY R, 1994, BBA-MOL CELL RES, V1220, P253, DOI 10.1016/0167-4889(94)90146-5; Matono R, 2014, J BIOL CHEM, V289, P24874, DOI 10.1074/jbc.M114.581785; Miyano K, 2009, BIOCHEM J, V422, P373, DOI 10.1042/BJ20082182; Mumbengegwi DR, 2008, MOL CELL BIOL, V28, P3700, DOI 10.1128/MCB.02038-07; Neet K E, 1980, Methods Enzymol, V64, P139; Negishi Manabu, 2006, Tanpakushitsu Kakusan Koso, V51, P693; Nisimoto Y, 1997, J BIOL CHEM, V272, P18834, DOI 10.1074/jbc.272.30.18834; Panday A, 2015, CELL MOL IMMUNOL, V12, DOI 10.1038/cmi.2014.89; PARKOS CA, 1989, BLOOD, V73, P1416; Parvez S, 2018, CHEM REV, V118, P8798, DOI 10.1021/acs.chemrev.7b00698; Perry JJP, 2010, BBA-PROTEINS PROTEOM, V1804, P245, DOI 10.1016/j.bbapap.2009.11.004; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; Pick Edgar, 2014, Small GTPases, V5, pe27952, DOI 10.4161/sgtp.27952; Pomerening JR, 2003, NAT CELL BIOL, V5, P346, DOI 10.1038/ncb954; Price MO, 2002, J BIOL CHEM, V277, P19220, DOI 10.1074/jbc.M200061200; Qian H, 2008, BIOPHYS J, V95, P10, DOI 10.1529/biophysj.108.131771; Roy K, 2015, CLIN SCI, V128, P863, DOI 10.1042/CS20140542; Sarfstein R, 2004, J BIOL CHEM, V279, P16007, DOI 10.1074/jbc.M312394200; Seitz PM, 2010, J BIOMOL SCREEN, V15, P388, DOI 10.1177/1087057109359687; Sha W, 2003, P NATL ACAD SCI USA, V100, P975, DOI 10.1073/pnas.0235349100; Shin JY, 2016, J BIOL CHEM, V291, P13699, DOI 10.1074/jbc.M115.694422; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Sigal N, 2003, J BIOL CHEM, V278, P4854, DOI 10.1074/jbc.M211011200; Streeter J, 2013, CARDIOVASC THER, V31, P125, DOI 10.1111/j.1755-5922.2011.00310.x; Tasseff R, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14523-5; Teufelhofer O, 2003, TOXICOL SCI, V76, P376, DOI 10.1093/toxsci/kfg234; Thomas DC, 2017, IMMUNOL LETT, V192, P88, DOI 10.1016/j.imlet.2017.08.016; Umutesi HG, 2020, J BIOL CHEM, V295, P13651, DOI 10.1074/jbc.RA120.013275; Wang HB, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020040; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wey M, 2016, BIOCHEMISTRY-US, V55, P543, DOI 10.1021/acs.biochem.5b00902; Wey M, 2013, BIOCHEMISTRY-US, V52, P8465, DOI 10.1021/bi400679q; ZHEN L, 1993, P NATL ACAD SCI USA, V90, P9832, DOI 10.1073/pnas.90.21.9832; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693	80	5	5	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100982	10.1016/j.jbc.2021.100982	http://dx.doi.org/10.1016/j.jbc.2021.100982			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34293347	gold, Green Published			2022-12-28	WOS:000690868100015
J	He, XT; Gao, F; Hou, JJ; Li, TJ; Tan, J; Wang, CY; Liu, XY; Wang, MQ; Liu, H; Chen, YQ; Yu, ZY; Yang, M				He, Xueting; Gao, Fei; Hou, Jiaojiao; Li, Tingjie; Tan, Jiang; Wang, Chunyu; Liu, Xiaoyan; Wang, Maoqi; Liu, Hui; Chen, Yuqin; Yu, Zhuoyuan; Yang, Mei			Metformin inhibits MAPK signaling and rescues pancreatic aquaporin 7 expression to induce insulin secretion in type 2 diabetes mellitus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ISLET BETA-CELLS; GLYCEROL KINASE; P38 MAPK; RAT; APOPTOSIS; GLUCOSE; PROTEIN; MODEL; GENE; JNK	Metformin is the first-line antidiabetic agent for type 2 diabetes mellitus (T2DM) treatment. Although accumulated evidence has shed light on the consequences of metformin action, the precise mechanisms of its action, especially in the pancreas, are not fully understood. Aquaporin 7 (AQP7) acts as a critical regulator of intraislet glycerol content, which is necessary for insulin production and secretion. The aim of this study was to investigate the effects of different doses of metformin on AQP7 expression and explore the possible mechanism of its protective effects in the pancreatic islets. We used an in vivo model of high-fat diet in streptozocin-induced diabetic rats and an in vitro model of rat pancreatic beta-cells (INS1 cells) damaged by hyperglycemia and hyperlipidemia. Our data showed that AQP7 expression levels were decreased, whereas p38 and JNK mitogen-activated protein kinases (MAPKs) were activated in vivo and in vitro in response to hyperglycemia and hyperlipidemia. T2DM rats treated with metformin demonstrated a reduction in blood glucose levels and increased regeneration of pancreatic beta-cells. In addition, metformin upregulated AQP7 expression as well as inhibited activation of p38 and JNK MAPKs both in vivo and in vitro. Overexpression of AQP7 increased glycerol influx into INS-1 cells, whereas inhibition of AQP7 reduced glycerol influx, thereby decreasing subsequent insulin secretion. Our findings demonstrate a new mechanism by which metformin suppresses the p38 and JNK pathways, thereby upregulating pancreatic AQP7 expression and promoting glycerol influx into pancreatic beta Psi-cells and subsequent insulin secretion in T2DM.	[He, Xueting; Hou, Jiaojiao; Li, Tingjie; Tan, Jiang; Wang, Chunyu; Liu, Xiaoyan; Wang, Maoqi; Liu, Hui; Yang, Mei] Chongqing Med Univ, Coll Basic Med, Dept Anat, Chongqing, Peoples R China; [Gao, Fei; Yu, Zhuoyuan] Chongqing Med Univ, Affiliated Hosp 1, Dept Urol, Chongqing, Peoples R China; [Chen, Yuqin] Chongqing Med Univ, Coll Basic Med, Inst Neurosci, Chongqing, Peoples R China	Chongqing Medical University; Chongqing Medical University; Chongqing Medical University	Yang, M (corresponding author), Chongqing Med Univ, Coll Basic Med, Dept Anat, Chongqing, Peoples R China.	yangmei503@cqmu.edu.cn	Liu, XiaoYan/GQA-7216-2022		National Natural Science Foundation of China [81971230, 81671312, 81672893]; Science and technology research project of Chongqing Education Commission [KJQN201800428]; Senior Young-middle-aged Medical Talents Program of Chongqing Health Committee [204216qn]; Chongqing Science and Health Joint Project [2020GDRC007]; Reserve Talents Program for academic Leaders of the First Affiliated Hospital of Chongqing Medical University [XKTS070]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and technology research project of Chongqing Education Commission; Senior Young-middle-aged Medical Talents Program of Chongqing Health Committee; Chongqing Science and Health Joint Project; Reserve Talents Program for academic Leaders of the First Affiliated Hospital of Chongqing Medical University	Funding from the National Natural Science Foundation of China (81971230 and 81671312), Science and technology research project of Chongqing Education Commission (KJQN201800428) to M. Y.; National Natural Science Foundation of China (81672893), Senior Young-middle-aged Medical Talents Program of Chongqing Health Committee (No.204216qn), Chongqing Science and Health Joint Project (2020GDRC007) and Reserve Talents Program for academic Leaders of the First Affiliated Hospital of Chongqing Medical University (No.XKTS070) to F. G.	Arima H, 2003, J BIOL CHEM, V278, P44525, DOI 10.1074/jbc.M304368200; Baidwan S, 2017, APOPTOSIS, V22, P1380, DOI 10.1007/s10495-017-1409-8; Bailey CJ, 1996, NEW ENGL J MED, V334, P574, DOI 10.1056/NEJM199602293340906; Dai YL, 2015, INT J BIOL SCI, V11, P1272, DOI 10.7150/ijbs.12108; de Gonzalo-Calvo D, 2016, SCI REP-UK, V6, DOI 10.1038/srep37354; Galant D, 2016, CELLS-BASEL, V5, DOI 10.3390/cells5020021; Goldsworthy M, 2016, DIABETES, V65, P1434, DOI 10.2337/db15-1276; Grether-Beck S, 2012, J INVEST DERMATOL, V132, P1561, DOI 10.1038/jid.2012.42; Guo LX, 2017, EUR J PHARM SCI, V110, P70, DOI 10.1016/j.ejps.2017.03.038; Hansen JS, 2016, METABOLISM, V65, P1731, DOI 10.1016/j.metabol.2016.09.004; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Kaneto H, 2004, NAT MED, V10, P1128, DOI 10.1038/nm1111; Kirpichnikov D, 2002, ANN INTERN MED, V137, P25, DOI 10.7326/0003-4819-137-1-200207020-00009; Kong CS, 2011, J NUTR BIOCHEM, V22, P276, DOI 10.1016/j.jnutbio.2010.02.005; Lawrence MC, 2015, MOL ENDOCRINOL, V29, P274, DOI 10.1210/me.2014-1066; Li FX, 2015, WORLD J GASTROENTERO, V21, P4547, DOI 10.3748/wjg.v21.i15.4547; Li QX, 2019, FOOD SCI NUTR, V7, P1695, DOI 10.1002/fsn3.1006; Li WB, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03218-x; Li ZH, 2018, MOL CELL PROTEOMICS, V17, P2119, DOI 10.1074/mcp.RA118.000698; Makeeva N, 2006, BIOCHEM J, V393, P129, DOI 10.1042/BJ20050814; Mansor LS, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-136; Matsumura K, 2007, MOL CELL BIOL, V27, P6026, DOI 10.1128/MCB.00384-07; Matthaei S, 2000, ENDOCR REV, V21, P585, DOI 10.1210/er.21.6.585; Miyauchi T, 2015, FEBS LETT, V589, P608, DOI 10.1016/j.febslet.2015.01.025; Moon JS, 2017, J DIABETES COMPLICAT, V31, P21, DOI 10.1016/j.jdiacomp.2016.09.001; Noel RJ, 1997, J BIOL CHEM, V272, P18621, DOI 10.1074/jbc.272.30.18621; Prudente S, 2007, DIABETES, V56, P1468, DOI 10.2337/db06-1389; Reed MJ, 2000, METABOLISM, V49, P1390, DOI 10.1053/meta.2000.17721; Rodriguez A, 2011, CELL CYCLE, V10, P1548, DOI 10.4161/cc.10.10.15672; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Sidarala V, 2016, RECENT PATENTS ENDOC, V10, P76, DOI 10.2174/1872214810666161020154905; Skelly RH, 2001, DIABETES, V50, P1791, DOI 10.2337/diabetes.50.8.1791; Srinivasan K, 2005, PHARMACOL RES, V52, P313, DOI 10.1016/j.phrs.2005.05.004; Tan YJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep17741; Tang XL, 2014, INDIAN J MED RES, V140, P744; Tian JY, 2006, CHINESE MED J-PEKING, V119, P574, DOI 10.1097/00029330-200604010-00010; Veroux M, 2019, BMC SURG, V18, DOI 10.1186/s12893-018-0452-x; Wang CY, 2015, BIOCHEM BIOPH RES CO, V460, P205, DOI 10.1016/j.bbrc.2015.03.009; Wei XY, 2015, J MOL HISTOL, V46, P273, DOI 10.1007/s10735-015-9618-3; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yang X, 2017, BBA-MOL BASIS DIS, V1863, P1984, DOI 10.1016/j.bbadis.2016.09.019; Zhang EM, 2019, CELL METAB, V29, P64, DOI 10.1016/j.cmet.2018.09.008; Zhang XJ, 2015, VASC PHARMACOL, V73, P86, DOI 10.1016/j.vph.2015.04.003	43	7	8	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101002	10.1016/j.jbc.2021.101002	http://dx.doi.org/10.1016/j.jbc.2021.101002			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34303707	gold, Green Published			2022-12-28	WOS:000690868100002
J	Pimviriyakul, P; Jaruwat, A; Chitnumsub, P; Chaiyen, P				Pimviriyakul, Panu; Jaruwat, Aritsara; Chitnumsub, Penchit; Chaiyen, Pimchai			Structural insights into a flavin-dependent dehalogenase HadA explain catalysis and substrate inhibition via quadruple pi-stacking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLOROPHENOL 4-MONOOXYGENASE TFTD; SITE-DIRECTED MUTAGENESIS; DEGRADATION GENE-CLUSTER; OXYGENASE COMPONENT; HYDROXYPHENYLACETATE 3-HYDROXYLASE; OXIDOREDUCTASE TFTC; MONOOXYGENASE; HYDROXYLASE; MECHANISM; 2,4,6-TRICHLOROPHENOL	HadA is a flavin-dependent monooxygenase catalyzing hydroxylation plus dehalogenation/denitration, which is useful for biodetoxification and biodetection. In this study, the X-ray structure of wild-type HadA (HadA(WT)) co-complexed with reduced FAD (FADH(-)) and 4-nitrophenol (4NP) (HadA(WT)-FADH(-)-4NP) was solved at 2.3-angstrom resolution, providing the first full package (with flavin and substrate bound) structure of a monooxygenase of this type. Residues Arg101, Gln158, Arg161, Thr193, Asp254, Arg233, and Arg439 constitute a flavin-binding pocket, whereas the 4NP-binding pocket contains the aromatic side chain of Phe206, which provides pi-pi stacking and also is a part of the hydrophobic pocket formed by Phe155, Phe286, Thr449, and Leu457. Based on site-directed mutagenesis and stopped-flow experiments, Thr193, Asp254, and His290 are important for C4a-hydroperoxyflavin formation with His290, also serving as a catalytic base for hydroxylation. We also identified a novel structural motif of quadruple p-stacking (pi-pi-pi-pi) provided by two 4NP and two Phe441 from two subunits. This motif promotes 4NP binding in a nonproductive dead-end complex, which prevents C4a-hydroperoxy-FAD formation when HadA is premixed with aromatic substrates. We also solved the structure of the HadA(Phe441Val)-FADH(-)-4NP complex at 2.3-angstrom resolution. Although 4NP can still bind to this variant, the quadruple pi-stacking motif was disrupted. All HadA(Phe441) variants lack substrate inhibition behavior, confirming that quadruple pi-stacking is a main cause of dead-end complex formation. Moreover, the activities of these HadA(Phe441) variants were improved by 20%, suggesting that insights gained from the flavin-dependent monooxygenases illustrated here should be useful for future improvement of HadA's biocatalytic applications.	[Pimviriyakul, Panu] Kasetsart Univ, Fac Sci, Dept Biochem, Bangkok, Thailand; [Jaruwat, Aritsara; Chitnumsub, Penchit] Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand; [Chaiyen, Pimchai] Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand	Kasetsart University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Vidyasirimedhi Institute of Science & Technology	Chitnumsub, P (corresponding author), Natl Ctr Genet Engn & Biotechnol, Pathum Thani, Thailand.; Chaiyen, P (corresponding author), Vidyasirimedhi Inst Sci & Technol VISTEC, Sch Biomol Sci & Engn, Rayong, Thailand.	penchit@biotec.or.th; pimchai.chaiyen@vistec.ac.th		Pimviriyakul, Panu/0000-0002-0410-0610	Thailand Research Fund [MRG6280185]; National Center for Genetic Engineering and Biotechnology (BIOTEC) platform [P16-52034]; National Science and Technology Development Agency (NSTDA) through NSTDA Technology Development Group [P20-50077]; Global Partnership from PMU-B, Royal Academy of Engineering; Vidyasirimedhi Institute of Science and Technology (VISTEC)	Thailand Research Fund(Thailand Research Fund (TRF)); National Center for Genetic Engineering and Biotechnology (BIOTEC) platform; National Science and Technology Development Agency (NSTDA) through NSTDA Technology Development Group; Global Partnership from PMU-B, Royal Academy of Engineering; Vidyasirimedhi Institute of Science and Technology (VISTEC)	This research was financially supported by The Thailand Research Fund through a grant MRG6280185 (to P. P.), grants from National Center for Genetic Engineering and Biotechnology (BIOTEC) platform P16-52034 and National Science and Technology Development Agency (NSTDA) through NSTDA Technology Development Group P20-50077 (to P. Chitnumsub), grants from Global Partnership from PMU-B, Royal Academy of Engineering, and Vidyasirimedhi Institute of Science and Technology (VISTEC) (to P. Chaiyen).	ABUSOUD HM, 1993, J BIOL CHEM, V268, P7699; Agarwal V, 2017, CHEM REV, V117, P5619, DOI 10.1021/acs.chemrev.6b00571; Alfieri A, 2007, P NATL ACAD SCI USA, V104, P1177, DOI 10.1073/pnas.0608381104; Chaiyen P, 2001, EUR J BIOCHEM, V268, P5550, DOI 10.1046/j.1432-1033.2001.02490.x; Chaiyen P, 2012, TRENDS BIOCHEM SCI, V37, P373, DOI 10.1016/j.tibs.2012.06.005; Chakraborty S, 2010, BIOCHEMISTRY-US, V49, P372, DOI 10.1021/bi901454u; Chen T, 2018, CRYST GROWTH DES, V18, P2765, DOI 10.1021/acs.cgd.7b01503; Chenprakhon P, 2019, PROTEIN SCI, V28, P8, DOI 10.1002/pro.3525; Chenprakhon P, 2017, ARCH BIOCHEM BIOPHYS, V620, P1, DOI 10.1016/j.abb.2017.03.004; Cho SY, 2017, BIORESOURCE TECHNOL, V245, P1800, DOI 10.1016/j.biortech.2017.05.006; CHOI H, 1995, J BIOL CHEM, V270, P16813, DOI 10.1074/jbc.270.28.16813; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Deng YF, 2020, CHEMBIOCHEM, V21, P163, DOI 10.1002/cbic.201900277; Dhammaraj T, 2016, ACS CHEM BIOL, V11, P2889, DOI 10.1021/acschembio.6b00402; Dhammaraj T, 2015, ACS CATAL, V5, P4492, DOI 10.1021/acscatal.5b00439; Dockrey SAB, 2019, TETRAHEDRON, V75, P1115, DOI 10.1016/j.tet.2019.01.008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fang LC, 2019, J AGR FOOD CHEM, V67, P2245, DOI 10.1021/acs.jafc.9b00173; FRANCISCO WA, 1993, J BIOL CHEM, V268, P24734; Gisi MR, 2003, J BACTERIOL, V185, P2786, DOI 10.1128/JB.185.9.2786-2792.2003; Hatta T, 2012, BIOSCI BIOTECH BIOCH, V76, P892, DOI 10.1271/bbb.110843; Hayes RP, 2012, INT J MOL SCI, V13, P9769, DOI 10.3390/ijms13089769; Heine T, 2018, BIOLOGY-BASEL, V7, DOI 10.3390/biology7030042; Hlouchova K, 2012, BIOCHEMISTRY-US, V51, P3848, DOI 10.1021/bi300261p; Huijbers MME, 2014, ARCH BIOCHEM BIOPHYS, V544, P2, DOI 10.1016/j.abb.2013.12.005; Kim SH, 2007, J BIOL CHEM, V282, P33107, DOI 10.1074/jbc.M703440200; Kirchner U, 2003, J BIOL CHEM, V278, P47545, DOI 10.1074/jbc.M307397200; Kitagawa W, 2004, J BACTERIOL, V186, P4894, DOI 10.1128/JB.186.15.4894-4902.2004; KIYOHARA H, 1992, APPL ENVIRON MICROB, V58, P1276, DOI 10.1128/AEM.58.4.1276-1283.1992; Li YW, 2015, RSC ADV, V5, P13871, DOI 10.1039/c4ra16165c; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Min J, 2020, ENVIRON POLLUT, V258, DOI 10.1016/j.envpol.2019.113703; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nakamura T, 2004, BBA-PROTEINS PROTEOM, V1700, P151, DOI 10.1016/j.bbapap.2004.04.008; Nakamura T, 2003, CHEM PHARM BULL, V51, P1293, DOI 10.1248/cpb.51.1293; Olaniran AO, 2011, CHEMOSPHERE, V83, P1297, DOI 10.1016/j.chemosphere.2011.04.009; Perry LL, 2007, J BACTERIOL, V189, P7563, DOI 10.1128/JB.01849-06; Phintha A, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.016004; Pimviriyakul Panu, 2020, Enzymes, V47, P365, DOI 10.1016/bs.enz.2020.05.010; Pimviriyakul P, 2020, MICROB BIOTECHNOL, V13, P67, DOI 10.1111/1751-7915.13488; Pimviriyakul P, 2018, CHEM SCI, V9, DOI 10.1039/c8sc01482e; Pimviriyakul P, 2018, J BIOL CHEM, V293, P18525, DOI 10.1074/jbc.RA118.005538; Pimviriyakul P, 2017, J BIOL CHEM, V292, P4818, DOI 10.1074/jbc.M116.774448; Pongpamorn P, 2019, CHEMBIOCHEM, V20, P3020, DOI 10.1002/cbic.201900413; Romero E, 2018, CHEM REV, V118, P1742, DOI 10.1021/acs.chemrev.7b00650; Shen XL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43577-w; Suadee C, 2007, J BIOCHEM, V142, P539, DOI 10.1093/jb/mvm155; Sucharitakul J, 2007, BIOCHEMISTRY-US, V46, P8611, DOI 10.1021/bi7006614; Sucharitakul J, 2006, J BIOL CHEM, V281, P17044, DOI 10.1074/jbc.M512385200; Tararina MA, 2021, BIOCHEMISTRY-US, V60, P259, DOI 10.1021/acs.biochem.0c00855; Thakuria R, 2019, CRYST GROWTH DES, V19, P523, DOI 10.1021/acs.cgd.8b01630; Thotsaporn K, 2004, BBA-GENE STRUCT EXPR, V1680, P60, DOI 10.1016/j.bbaexp.2004.08.003; Thotsaporn K, 2011, J BIOL CHEM, V286, P28170, DOI 10.1074/jbc.M111.241836; Tinikul R, 2016, ADV BIOCHEM ENG BIOT, V154, P47, DOI 10.1007/10_2014_281; Tongsook C, 2011, J BIOL CHEM, V286, P44491, DOI 10.1074/jbc.M111.284463; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Watthaisong P, 2019, ANGEW CHEM INT EDIT, V58, P13254, DOI 10.1002/anie.201904923; Webb BN, 2010, J BIOL CHEM, V285, P2014, DOI 10.1074/jbc.M109.056135; Xun LY, 2004, J BIOL CHEM, V279, P6696, DOI 10.1074/jbc.M312072200; Yamamoto K, 2011, J BIOSCI BIOENG, V111, P687, DOI 10.1016/j.jbiosc.2011.01.016; Yeh E, 2006, BIOCHEMISTRY-US, V45, P7904, DOI 10.1021/bi060607d; Zhang H, 2018, J AGR FOOD CHEM, V66, P12217, DOI 10.1021/acs.jafc.8b05382	62	3	3	7	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100952	10.1016/j.jbc.2021.100952	http://dx.doi.org/10.1016/j.jbc.2021.100952			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34252455	gold, Green Published			2022-12-28	WOS:000690871000017
J	Bunch, TA; Guhathakurta, P; Lepak, VC; Thompson, AR; Kanassatega, RS; Wilson, A; Thomas, DD; Colson, BA				Bunch, Thomas A.; Guhathakurta, Piyali; Lepak, Victoria C.; Thompson, Andrew R.; Kanassatega, Rhye-Samuel; Wilson, Anna; Thomas, David D.; Colson, Brett A.			Cardiac myosin-binding protein C interaction with actin is inhibited by compounds identified in a high-throughput fluorescence lifetime screen	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; REGULATORY DOMAIN; PHOSPHORYLATION; FRET; ACTIVATION; MODULATORS; MUTATIONS; MOTILITY	Cardiac myosin-binding protein C (cMyBP-C) interacts with actin and myosin to modulate cardiac muscle contractility. These interactions are disfavored by cMyBP-C phosphorylation. Heart failure patients often display decreased cMyBP-C phosphorylation, and phosphorylation in model systems has been shown to be cardioprotective against heart failure. Therefore, cMyBP-C is a potential target for heart failure drugs that mimic phosphorylation or perturb its interactions with actin/myosin. Here we have used a novel fluorescence lifetime-based assay to identify small-molecule inhibitors of actin-cMyBP-C binding. Actin was labeled with a fluorescent dye (Alexa Fluor 568, AF568) near its cMyBP-C binding sites; when combined with the cMyBP-C N-terminal fragment, C0-C2, the fluorescence lifetime of AF568-actin decreases. Using this reduction in lifetime as a readout of actin binding, a high-throughput screen of a 1280-compound library identified three reproducible hit compounds (suramin, NF023, and aurintricarboxylic acid) that reduced C0C2 binding to actin in the micromolar range. Binding of phosphorylated C0-C2 was also blocked by these compounds. That they specifically block binding was confirmed by an actin-C0-C2 time-resolved FRET (TR-FRET) binding assay. Isothermal titration calorimetry (ITC) and transient phosphorescence anisotropy (TPA) confirmed that these compounds bind to cMyBP-C, but not to actin. TPA results were also consistent with these compounds inhibiting C0-C2 binding to actin. We conclude that the actin-cMyBP-C fluorescence lifetime assay permits detection of pharmacologically active compounds that affect cMyBP-C-actin binding. We now have, for the first time, a validated high-throughput screen focused on cMyBP-C, a regulator of cardiac muscle contractility and known key factor in heart failure.	[Bunch, Thomas A.; Lepak, Victoria C.; Kanassatega, Rhye-Samuel; Colson, Brett A.] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA; [Guhathakurta, Piyali; Thompson, Andrew R.; Wilson, Anna; Thomas, David D.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN USA	University of Arizona; University of Minnesota System; University of Minnesota Twin Cities	Colson, BA (corresponding author), Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ 85721 USA.	bcolson@arizona.edu		Kanassatega, Rhye-Samuel/0000-0001-9007-6524; Thompson, Andrew/0000-0001-8537-6776; Thomas, David D./0000-0002-8822-2040	National Institutes of Health [R37 AG26160, R01 HL141564]; University of Arizona Sarver Heart Center "Novel Research Project Award in the Area of Cardiovascular Disease and Medicine"	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arizona Sarver Heart Center "Novel Research Project Award in the Area of Cardiovascular Disease and Medicine"	This work was supported by National Institutes of Health grants R37 AG26160 (to D. D. T.) and R01 HL141564 (to B. A. C.) and a University of Arizona Sarver Heart Center "Novel Research Project Award in the Area of Cardiovascular Disease and Medicine" (to B. A. C). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Arimura T, 2011, HUM MUTAT, V32, P1481, DOI 10.1002/humu.21603; Bunch TA, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012707; Bunch TA, 2019, J BIOL CHEM, V294, P16228, DOI 10.1074/jbc.RA119.009543; Bunch TA, 2018, J MOL CELL CARDIOL, V125, P140, DOI 10.1016/j.yjmcc.2018.10.009; Colson B. A., 2012, P NATL ACAD SCI USA; Colson BA, 2016, P NATL ACAD SCI USA, V113, P3233, DOI 10.1073/pnas.1521281113; Copeland O, 2010, J MOL CELL CARDIOL, V49, P1003, DOI 10.1016/j.yjmcc.2010.09.007; Cornea RL, 2013, J BIOMOL SCREEN, V18, P97, DOI 10.1177/1087057112456878; Goutelle S, 2008, FUND CLIN PHARMACOL, V22, P633, DOI 10.1111/j.1472-8206.2008.00633.x; Green EM, 2016, SCIENCE, V351, P617, DOI 10.1126/science.aad3456; Gruber SJ, 2014, J BIOMOL SCREEN, V19, P215, DOI 10.1177/1087057113510740; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Guhathakurta P, 2018, J BIOL CHEM, V293, P12288, DOI 10.1074/jbc.RA118.002702; Hershberger RE, 2013, NAT REV CARDIOL, V10, P531, DOI 10.1038/nrcardio.2013.105; Jacques AM, 2008, J MOL CELL CARDIOL, V45, P209, DOI 10.1016/j.yjmcc.2008.05.020; Malik FI, 2011, SCIENCE, V331, P1439, DOI 10.1126/science.1200113; McNamara JW, 2019, P NATL ACAD SCI USA, V116, P11731, DOI 10.1073/pnas.1821660116; McNamara JW, 2016, J MOL CELL CARDIOL, V94, P65, DOI 10.1016/j.yjmcc.2016.03.009; Mun JY, 2014, P NATL ACAD SCI USA, V111, P2170, DOI 10.1073/pnas.1316001111; Nag S, 2017, NAT STRUCT MOL BIOL, V24, P525, DOI 10.1038/nsmb.3408; Pohlmann L, 2007, CIRC RES, V101, P928, DOI 10.1161/CIRCRESAHA.107.158774; Previs MJ, 2016, P NATL ACAD SCI USA, V113, P3239, DOI 10.1073/pnas.1522236113; Previs MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400205; Prochniewicz E, 2004, BIOCHEMISTRY-US, V43, P10642, DOI 10.1021/bi049914e; Rebbeck RT, 2017, SLAS DISCOV, V22, P176, DOI 10.1177/1087057116674312; Risi C, 2018, STRUCTURE, V26, P1604, DOI 10.1016/j.str.2018.08.007; Robinett JC, 2019, J GEN PHYSIOL, V151, P645, DOI 10.1085/jgp.201812200; Rosas PC, 2015, CIRC-HEART FAIL, V8, P582, DOI 10.1161/CIRCHEARTFAILURE.114.001550; Schaaf T. M., 2018, BIOSENSORS-BASEL, P8; Schaaf TM, 2017, SLAS DISCOV, V22, P262, DOI 10.1177/1087057116680151; Shaffer JF, 2009, J BIOL CHEM, V284, P12318, DOI 10.1074/jbc.M808850200; Simeonov A, 2008, J MED CHEM, V51, P2363, DOI 10.1021/jm701301m; Spudich JA, 2019, PFLUG ARCH EUR J PHY, V471, P701, DOI 10.1007/s00424-019-02259-2; Walcott S, 2015, BIOPHYS J, V108, P10, DOI 10.1016/j.bpj.2014.11.1852; Wang C, 2016, J MOL CELL CARDIOL, V96, P2, DOI 10.1016/j.yjmcc.2015.10.007; Weith A, 2012, J MOL CELL CARDIOL, V52, P219, DOI 10.1016/j.yjmcc.2011.09.019; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	38	2	2	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100840	10.1016/j.jbc.2021.100840	http://dx.doi.org/10.1016/j.jbc.2021.100840			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34052227	Green Published, gold			2022-12-28	WOS:000678068400040
J	Breslauer, KJ				Breslauer, Kenneth J.			The shaping of a molecular linguist: How a career studying DNA energetics revealed the language of molecular communication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRIPLE-HELIX; THERMODYNAMIC CHARACTERIZATION; VOLUMETRIC PROPERTIES; DOMAINS IMPLICATIONS; SECONDARY STRUCTURE; ENERGY LANDSCAPES; HYDRATION CHANGES; MELTING BEHAVIOR; COIL TRANSITION; ABASIC LESION	My personal and professional journeys have been far from predictable based on my early childhood. Owing to a range of serendipitous influences, I miraculously transitioned from a rebellious, apathetic teenage street urchin who did poorly in school to a highly motivated, disciplined, and ambitious academic honors student. I was the proverbial "late bloomer." Ultimately, I earned my PhD in biophysical chemistry at Yale, followed by a postdoc fellowship at Berkeley. These two meccas of thermodynamics, coupled with my deep fascination with biology, instilled in me a passion to pursue an academic career focused on mapping the energy landscapes of biological systems. I viewed differential energetics as the language of molecular communication that would dictate and control biological structures, as well as modulate the modes of action associated with biological functions. I wanted to be a "molecular linguist." For the next 50 years, my group and I used a combination of spectroscopic and calorimetric techniques to characterize the energy profiles of the polymorphic conformational space of DNA molecules, their differential ligand-binding properties, and the energy landscapes associated with mutagenic DNA damage recognition, repair, and replication. As elaborated below, the resultant energy databases have enabled the development of quantitative molecular biology through the rational design of primers, probes, and arrays for diagnostic, therapeutic, and molecular-profiling protocols, which collectively have contributed to a myriad of biomedical assays. Such profiling is further justified by yielding unique energy-based insights that complement and expand elegant, structure-based understandings of biological processes.	[Breslauer, Kenneth J.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Breslauer, Kenneth J.] Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey	Breslauer, KJ (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.; Breslauer, KJ (corresponding author), Rutgers Canc Inst New Jersey, New Brunswick, NJ 08901 USA.	kjbdna@rutgers.edu			NIH (United States) [23509, 34469, 47995]	NIH (United States)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the NIH (United States) to K.J.B.: General Medicine 23509 and 34469 and NIH (United States): Cancer 47995. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABOULELA F, 1985, NUCLEIC ACIDS RES, V13, P4811, DOI 10.1093/nar/13.13.4811; Akbari M, 2008, MECH AGEING DEV, V129, P353, DOI 10.1016/j.mad.2008.01.007; Ashley CT, 1995, ANNU REV GENET, V29, P703, DOI 10.1146/annurev.ge.29.120195.003415; Bacolla A, 2006, DNA REPAIR, V5, P1161, DOI 10.1016/j.dnarep.2006.05.032; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berman HM, 2016, CURR OPIN STRUC BIOL, V40, P17, DOI 10.1016/j.sbi.2016.06.018; Bloomfield V. A., 1974, PHYS CHEM NUCL ACIDS; BOOTHMAN DA, 1987, CANCER RES, V47, P5361; BOOTHMAN DA, 1994, RADIAT RES, V138, pS121, DOI 10.2307/3578778; Braunlin W, 2013, BIOPOLYMERS, V99, P408, DOI 10.1002/bip.22213; Breslauer KJ, 2007, BIOPHYS CHEM, V126, P9, DOI 10.1016/j.bpc.2006.03.016; BRESLAUER KJ, 1987, P NATL ACAD SCI USA, V84, P8922, DOI 10.1073/pnas.84.24.8922; BRESLAUER KJ, 1986, P NATL ACAD SCI USA, V83, P3746, DOI 10.1073/pnas.83.11.3746; BRESLAUER KJ, 1975, J MOL BIOL, V99, P549, DOI 10.1016/S0022-2836(75)80171-9; Burdak-Rothkamm S, 2020, TRENDS CANCER, V6, P974, DOI 10.1016/j.trecan.2020.05.011; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; Cathomen T, 2005, GENE THER, V12, P1415, DOI 10.1038/sj.gt.3302572; Chaires J. B., 2018, DNA TARGETING MOL TH, V7, P74; Chaires JB, 2008, ANNU REV BIOPHYS, V37, P135, DOI 10.1146/annurev.biophys.36.040306.132812; Chalikian TV, 2008, J PHYS CHEM B, V112, P911, DOI 10.1021/jp709578u; CHALIKIAN TV, 1994, BIOCHEMISTRY-US, V33, P8629, DOI 10.1021/bi00195a003; Chalikian TV, 1998, BIOPOLYMERS, V48, P264, DOI 10.1002/(SICI)1097-0282(1998)48:4<264::AID-BIP6>3.3.CO;2-#; Chalikian TV, 1996, P NATL ACAD SCI USA, V93, P1012, DOI 10.1073/pnas.93.3.1012; Chalikian TV, 2003, ANNU REV BIOPH BIOM, V32, P207, DOI 10.1146/annurev.biophys.32.110601.141709; Chalikian TV, 1999, P NATL ACAD SCI USA, V96, P7853, DOI 10.1073/pnas.96.14.7853; Chalikian TV, 1996, BIOPOLYMERS, V39, P619, DOI 10.1002/(SICI)1097-0282(199611)39:5<619::AID-BIP1>3.0.CO;2-Z; Ciulli Alessio, 2013, Methods Mol Biol, V1008, P357, DOI 10.1007/978-1-62703-398-5_13; Cooper DN, 2011, HUM MUTAT, V32, P1075, DOI 10.1002/humu.21557; Crooke ST, 2004, ANNU REV MED, V55, P61, DOI 10.1146/annurev.med.55.091902.104408; Crooke ST, 2021, BIOCHEM PHARMACOL, V189, DOI 10.1016/j.bcp.2020.114196; Cummings CJ, 2000, ANNU REV GENOM HUM G, V1, P281, DOI 10.1146/annurev.genom.1.1.281; Datta K, 2009, J BIOL CHEM, V284, P17180, DOI 10.1074/jbc.M109.007641; DELCOURT SG, 1991, J BIOL CHEM, V266, P15160; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; DOKTYCZ MJ, 1992, BIOPOLYMERS, V32, P849, DOI 10.1002/bip.360320712; Esadze A, 2017, BIOCHEMISTRY-US, V56, P1974, DOI 10.1021/acs.biochem.7b00017; Fleming AM, 2020, J AM CHEM SOC, V142, P1115, DOI 10.1021/jacs.9b11050; Freire E, 2008, DRUG DISCOV TODAY, V13, P869, DOI 10.1016/j.drudis.2008.07.005; Fulroth B, 2017, CHEM BIO, V1, P58; Garbett NC, 2008, METHOD CELL BIOL, V84, P3, DOI 10.1016/S0091-679X(07)84001-5; Garbett NC, 2012, EXPERT OPIN DRUG DIS, V7, P299, DOI 10.1517/17460441.2012.666235; Gavande NS, 2016, DNA REPAIR IN CANCER THERAPY: MOLECULAR TARGETS AND CLINICAL APPLICATIONS, 2ND EDITION, P135, DOI 10.1016/B978-0-12-803582-5.00005-X; Gelfand CA, 1998, BIOCHEMISTRY-US, V37, P7321, DOI 10.1021/bi9803372; Gelfand CA, 1996, BIOPOLYMERS, V38, P439; Ghosal K, 2020, MINI-REV MED CHEM, V20, P779, DOI 10.2174/1389557520666200103114556; Ghosh S, 2020, P NATL ACAD SCI USA, V117, P14194, DOI 10.1073/pnas.1920886117; Goodsell DS, 2013, BIOPOLYMERS, V99, P817, DOI 10.1002/bip.22338; GOTOH O, 1981, BIOPOLYMERS, V20, P1043, DOI 10.1002/bip.1981.360200514; GRALLA J, 1973, J MOL BIOL, V78, P301, DOI 10.1016/0022-2836(73)90118-6; Halpin-Healy TS, 2020, NATURE, V577, P271, DOI 10.1038/s41586-019-1849-0; Han FX, 2005, BIOCHEMISTRY-US, V44, P9785, DOI 10.1021/bi047374f; Hansen WK, 2000, J PHARMACOL EXP THER, V295, P1; Haq I, 2001, METHOD ENZYMOL, V340, P109; Haq I, 2000, METHOD ENZYMOL, V323, P373; Hegde ML, 2010, J BIOL CHEM, V285, P28812, DOI 10.1074/jbc.M110.126664; Henry CM, 2001, CHEM ENG NEWS, V79, P69, DOI 10.1021/cen-v079n023.p069; Hevener KE, 2018, METHOD ENZYMOL, V610, P265, DOI 10.1016/bs.mie.2018.09.022; Holbrook JA, 1999, BIOCHEMISTRY-US, V38, P8409, DOI 10.1021/bi990043w; Holdgate Geoffrey, 2013, Methods Mol Biol, V1008, P327, DOI 10.1007/978-1-62703-398-5_12; Huang A, 2020, NAT REV DRUG DISCOV, V19, P23, DOI 10.1038/s41573-019-0046-z; Huguet JM, 2010, P NATL ACAD SCI USA, V107, P15431, DOI 10.1073/pnas.1001454107; Jelesarov I, 1999, J MOL BIOL, V294, P981, DOI 10.1006/jmbi.1999.3284; Jin Q, 2013, BIOCHEMISTRY-US, V52, P7870, DOI 10.1021/bi4009825; JIN R, 1990, SCIENCE, V250, P543, DOI 10.1126/science.2237404; JIN RZ, 1992, P NATL ACAD SCI USA, V89, P8832, DOI 10.1073/pnas.89.18.8832; JIN RZ, 1993, P NATL ACAD SCI USA, V90, P10568, DOI 10.1073/pnas.90.22.10568; Kawasaki Y, 2011, DRUG DISCOV TODAY, V16, P985, DOI 10.1016/j.drudis.2011.07.010; Khristich AN, 2020, J BIOL CHEM, V295, P4134, DOI 10.1074/jbc.REV119.007678; Kibbe WA, 2007, NUCLEIC ACIDS RES, V35, pW43, DOI 10.1093/nar/gkm234; Klinakis A, 2020, CELL MOL LIFE SCI, V77, P677, DOI 10.1007/s00018-019-03299-8; Klump HH, 2020, Q REV BIOPHYS, V53, DOI 10.1017/S0033583520000098; Lai YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12465; Lan X, 2012, CURR BIOINFORM, V7, P447, DOI 10.2174/157489312803900947; Lane AN, 2008, NUCLEIC ACIDS RES, V36, P5482, DOI 10.1093/nar/gkn517; Lane AN, 2012, BIOCHIMIE, V94, P277, DOI 10.1016/j.biochi.2011.08.004; Lee BJ, 2007, BIOCHEMISTRY-US, V46, P10756, DOI 10.1021/bi7005674; Lenglet G, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/290935; Li MX, 2014, J MOL BIOL, V426, P2183, DOI 10.1016/j.jmb.2014.03.014; Liang JJ, 2008, CLIN CANCER RES, V14, P7043, DOI 10.1158/1078-0432.CCR-08-0381; Limp-Foster M, 2000, ENVIRON MOL MUTAGEN, V35, P71, DOI 10.1002/(SICI)1098-2280(2000)35:2<71::AID-EM1>3.0.CO;2-P; Liu Y, 2009, J BIOL CHEM, V284, P28352, DOI 10.1074/jbc.M109.050286; Ma XL, 2020, ENVIRON MOL MUTAGEN, V61, P680, DOI 10.1002/em.22359; Maher L J 3rd, 1991, Antisense Res Dev, V1, P277; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Matson Robert S., 2007, V381, P279; McMurray CT, 1999, P NATL ACAD SCI USA, V96, P1823, DOI 10.1073/pnas.96.5.1823; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Minetti CASA, 2003, J MOL BIOL, V328, P1047, DOI 10.1016/S0022-2836(03)00365-6; Minetti CASA, 2003, P NATL ACAD SCI USA, V100, P14719, DOI 10.1073/pnas.2336142100; Minetti CA, 2018, BIOPOLYMERS, V109, DOI 10.1002/bip.23098; Minetti CASA, 2015, BIOPOLYMERS, V103, P491, DOI 10.1002/bip.22680; Minetti CASA, 2010, BIOPOLYMERS, V93, P370, DOI 10.1002/bip.21355; Minetti CASA, 2010, NUCLEIC ACIDS RES, V38, P97, DOI 10.1093/nar/gkp1036; MULLIS KB, 1994, ANGEW CHEM INT EDIT, V33, P1209, DOI 10.1002/anie.199412091; Nestorova GG, 2016, SENSOR ACTUAT B-CHEM, V225, P174, DOI 10.1016/j.snb.2015.11.032; Nohmi T, 2016, THRESHOLDS OF GENOTOXIC CARCINOGENS: FROM MECHANISMS TO REGULATION, P49, DOI 10.1016/B978-0-12-801663-3.00004-2; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Owczarzy R, 1997, BIOPOLYMERS, V44, P217, DOI 10.1002/(SICI)1097-0282(1997)44:3<217::AID-BIP3>3.0.CO;2-Y; Panjkovich A, 2005, BIOINFORMATICS, V21, P711, DOI 10.1093/bioinformatics/bti066; Panjkovich A, 2005, NUCLEIC ACIDS RES, V33, pW570, DOI 10.1093/nar/gki379; PILCH DS, 1995, CURR OPIN STRUC BIOL, V5, P334, DOI 10.1016/0959-440X(95)80095-6; Pilzecker B, 2019, NUCLEIC ACIDS RES, V47, P7163, DOI 10.1093/nar/gkz531; PLUM GE, 1992, BIOCHEMISTRY-US, V31, P12096, DOI 10.1021/bi00163a019; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; PLUM GE, 1990, P NATL ACAD SCI USA, V87, P9436, DOI 10.1073/pnas.87.23.9436; PLUM GE, 1995, J MOL BIOL, V248, P679; PLUM GE, 1994, ANN NY ACAD SCI, V726, P45, DOI 10.1111/j.1749-6632.1994.tb52796.x; Polyzos AA, 2017, DNA REPAIR, V56, P144, DOI 10.1016/j.dnarep.2017.06.017; Qu XG, 2001, J AM CHEM SOC, V123, P1, DOI 10.1021/ja002793v; Redstone SCJ, 2019, CHEM RES TOXICOL, V32, P437, DOI 10.1021/acs.chemrestox.8b00332; Rosenquist TA, 2003, DNA REPAIR, V2, P581, DOI 10.1016/S1568-7864(03)00025-9; Rouzina I, 1999, BIOPHYS J, V77, P3242, DOI 10.1016/S0006-3495(99)77155-9; Rouzina I, 1999, BIOPHYS J, V77, P3252, DOI 10.1016/S0006-3495(99)77156-0; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; SantaLucia J, 1998, P NATL ACAD SCI USA, V95, P1460, DOI 10.1073/pnas.95.4.1460; SHIBUTANI S, 1993, BIOCHEMISTRY-US, V32, P4615, DOI 10.1021/bi00068a019; Shigi N, 2017, MOLECULES, V22, DOI 10.3390/molecules22101586; Silvestri R, 2019, MUTAGENESIS, V34, P363, DOI 10.1093/mutage/gez031; Son I, 2014, J AM CHEM SOC, V136, P4040, DOI 10.1021/ja5004137; Spasic A, 2018, NUCLEIC ACIDS RES, V46, P4883, DOI 10.1093/nar/gky270; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; STREISINGER G, 1985, GENETICS, V109, P633; Sugimoto N, 2014, INT REV CEL MOL BIO, V307, P205, DOI 10.1016/B978-0-12-800046-5.00008-4; Sun JS, 1996, CURR OPIN STRUC BIOL, V6, P327, DOI 10.1016/S0959-440X(96)80051-0; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; Suzuki N, 2002, BIOCHEMISTRY-US, V41, P6100, DOI 10.1021/bi020049c; Szczesny B, 2010, MECH AGEING DEV, V131, P330, DOI 10.1016/j.mad.2010.03.009; TINOCO I, 1973, NATURE-NEW BIOL, V246, P40, DOI 10.1038/newbio246040a0; Tinoco I, 2015, BIOPOLYMERS, V103, P424, DOI 10.1002/bip.22568; Tinoco I, 2014, ANNU REV BIOPHYS, V43, P1, DOI 10.1146/annurev-biophys-051013-022708; TURNER DH, 1988, ANNU REV BIOPHYS BIO, V17, P167; Turner DH, 2010, NUCLEIC ACIDS RES, V38, pD280, DOI 10.1093/nar/gkp892; VESNAVER G, 1989, P NATL ACAD SCI USA, V86, P3614, DOI 10.1073/pnas.86.10.3614; Volker J, 2014, BIOPOLYMERS, V101, P1, DOI 10.1002/bip.22236; Volker J, 2012, J AM CHEM SOC, V134, P6033, DOI 10.1021/ja3010896; Volker J, 2008, P NATL ACAD SCI USA, V105, P18326, DOI 10.1073/pnas.0810376105; VOLKER J, 1994, BIOCHEMISTRY-US, V33, P13502, DOI 10.1021/bi00249a039; Volker J, 2002, P NATL ACAD SCI USA, V99, P14700, DOI 10.1073/pnas.222519799; Volker J, 2007, J AM CHEM SOC, V129, P5272, DOI 10.1021/ja070258q; Volker J, 2020, J PHYS CHEM B, V124, P5614, DOI 10.1021/acs.jpcb.0c04065; Volker J, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9110709; VOLOGODSKII AV, 1984, J BIOMOL STRUCT DYN, V2, P131, DOI 10.1080/07391102.1984.10507552; Wells RD, 2009, J BIOL CHEM, V284, P8997, DOI 10.1074/jbc.X800010200; Young JY, 2018, DATABASE-OXFORD, DOI 10.1093/database/bay002; Yu HJ, 2008, J MED CHEM, V51, P5909, DOI 10.1021/jm800826y; Yuan BF, 2010, CHEM RES TOXICOL, V23, P11, DOI 10.1021/tx9004264; Yudkina AV, 2019, CRYSTALS, V9, DOI 10.3390/cryst9050269; Zhao JH, 2010, CELL MOL LIFE SCI, V67, P43, DOI 10.1007/s00018-009-0131-2; Zharkov DO, 2003, DNA REPAIR, V2, P839, DOI 10.1016/S1568-7864(03)00084-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	151	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100522	10.1016/j.jbc.2021.100522	http://dx.doi.org/10.1016/j.jbc.2021.100522			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237886	Green Published, gold			2022-12-28	WOS:000672866400496
J	Cheng, CL; Wong, MK; Li, YJ; Hochstrasser, M				Cheng, Chin Leng; Wong, Michael K.; Li, Yanjie; Hochstrasser, Mark			Conserved proline residues in the coiled coil-OB domain linkers of Rpt proteins facilitate eukaryotic proteasome base assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS PEPTIDE-BONDS; REGULATORY PARTICLE; STRUCTURAL INSIGHTS; 20S PROTEASOME; 26S PROTEASOME; PATHWAY; SUBSTRATE; TRANSLOCATION; BINDING; SEM1	The proteasome is a large protease complex that degrades many different cellular proteins. In eukaryotes, the 26S proteasome contains six different subunits of the ATPases associated with diverse cellular activities family, Rpt1-Rpt6, which form a hexameric ring as part of the base subcomplex that drives unfolding and translocation of substrates into the proteasome core. Archaeal proteasomes contain only a single Rpt-like ATPases associated with diverse cellular activities ATPase, the proteasome-activating nucleotidase, which forms a trimer of dimers. A key proteasome-activating nucleotidase proline residue (P91) forms cis- and trans-peptide bonds in successive subunits around the ring, allowing efficient dimerization through upstream coiled coils. However, the importance of the equivalent Rpt prolines for eukaryotic proteasome assembly was unknown. Here we showed that the equivalent proline is highly conserved in Rpt2, Rpt3, and Rpt5, and loosely conserved in Rpt1, in deeply divergent eukaryotes. Although in no case was a single Pro-to-Ala substitution in budding yeast strongly deleterious to growth, the rpt5-P76A mutation decreased levels of the protein and induced a mild proteasome assembly defect. Moreover, the rpt2-P103A, rpt3-P93A, andrpt5-P76Amutations all caused synthetic defects when combined with deletions of specific proteasome base assembly chaperones. The rpt2-P103A rpt5-P76A double mutant had uniquely strong growth defects attributable to defects in proteasome base formation. Several Rpt subunits in this mutant formed aggregates thatwere cleared, at least in part, byHsp42 chaperone-mediated protein quality control. We propose that the conserved Rpt linker prolines promote efficient 26S proteasome base assembly by facilitating specific ATPase heterodimerization.	[Cheng, Chin Leng; Wong, Michael K.; Li, Yanjie; Hochstrasser, Mark] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Hochstrasser, Mark] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA	Yale University; Yale University	Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Hochstrasser, M (corresponding author), Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06520 USA.	mark.hochstrasser@yale.edu		Wong, Michael/0000-0002-0645-9061; Hochstrasser, Mark/0000-0002-1131-5484	National Institutes of Health [GM083050, GM136325]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health Grants (GM083050 and GM136325) to M. H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	[Anonymous], 2004, FRONT BIOSCI, V9, p2420 2446; [Anonymous], 2018, ANNU REV BIOCHEM, V82, P415; Bard JAM, 2018, ANNU REV BIOCHEM, V87, P697, DOI 10.1146/annurev-biochem-062917-011931; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; BRANDTS JF, 1975, BIOCHEMISTRY-US, V14, P4953, DOI 10.1021/bi00693a026; Budenholzer L, 2017, J MOL BIOL, V429, P3500, DOI 10.1016/j.jmb.2017.05.027; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Djuranovic S, 2009, MOL CELL, V34, P580, DOI 10.1016/j.molcel.2009.04.030; Fu XY, 2018, P NATL ACAD SCI USA, V115, P13246, DOI 10.1073/pnas.1805353115; Funakoshi M, 2004, J CELL SCI, V117, P6447, DOI 10.1242/jcs.01575; Funakoshi M, 2009, CELL, V137, P887, DOI 10.1016/j.cell.2009.04.061; Geng FQ, 2008, MOL BIOL CELL, V19, P3616, DOI 10.1091/mbc.E08-01-0050; Guthrie, 2002, METHOD ENZYMOL, V194, P933; Hanssum A, 2014, MOL CELL, V55, P566, DOI 10.1016/j.molcel.2014.06.017; Hurt E, 2009, J CELL BIOL, V184, p833 S46; Kaneko T, 2009, CELL, V137, P914, DOI 10.1016/j.cell.2009.05.008; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Kusmierczyk AR, 2008, NAT STRUCT MOL BIOL, V15, P237, DOI 10.1038/nsmb.1389; Le Tallec B, 2009, MOL CELL, V33, P389, DOI 10.1016/j.molcel.2009.01.010; Li Y., 2015, CURR PROTOC CELL BIO, V67; Mannhaupt G, 1999, FEBS LETT, V450, P27, DOI 10.1016/S0014-5793(99)00467-6; Pal D, 1999, J MOL BIOL, V294, P271, DOI 10.1006/jmbi.1999.3217; Panasenko OO, 2019, NAT STRUCT MOL BIOL, V26, P110, DOI 10.1038/s41594-018-0179-5; Paraskevopoulos K, 2014, MOL CELL, V56, P453, DOI 10.1016/j.molcel.2014.09.008; Peters LZ, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005178; Roelofs J, 2009, NATURE, V459, P861, DOI 10.1038/nature08063; Rousseau A, 2016, NATURE, V536, P184, DOI 10.1038/nature18943; Saeki Y, 2009, CELL, V137, P900, DOI 10.1016/j.cell.2009.05.005; Satoh T, 2014, STRUCTURE, V22, P731, DOI 10.1016/j.str.2014.02.014; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith DM, 2007, MOL CELL, V27, P731, DOI 10.1016/j.molcel.2007.06.033; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; STEWART DE, 1990, J MOL BIOL, V214, P253, DOI 10.1016/0022-2836(90)90159-J; Tomko RJ, 2014, MOL CELL, V53, P433, DOI 10.1016/j.molcel.2013.12.009; Tomko RJ, 2011, MOL CELL, V44, P907, DOI 10.1016/j.molcel.2011.11.020; Tomko RJ, 2010, MOL CELL, V38, P393, DOI 10.1016/j.molcel.2010.02.035; Velichutina I, 2004, EMBO J, V23, P500, DOI 10.1038/sj.emboj.7600059; Wedemeyer WJ, 2002, BIOCHEMISTRY-US, V41, P14637, DOI 10.1021/bi020574b; Wehmer M, 2017, P NATL ACAD SCI USA, V114, P1305, DOI 10.1073/pnas.1621129114; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Zhang F, 2009, MOL CELL, V34, P473, DOI 10.1016/j.molcel.2009.04.021; Zhang F, 2009, MOL CELL, V34, P485, DOI 10.1016/j.molcel.2009.04.022; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008	45	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100660	10.1016/j.jbc.2021.100660	http://dx.doi.org/10.1016/j.jbc.2021.100660			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862083	gold, Green Published			2022-12-28	WOS:000672866400631
J	Tohda, R; Tanaka, H; Mutoh, R; Zhang, XH; Lee, YH; Konuma, T; Ikegami, T; Migita, CT; Kurisu, G				Tohda, Rei; Tanaka, Hideaki; Mutoh, Risa; Zhang, Xuhong; Lee, Young-Ho; Konuma, Tsuyoshi; Ikegami, Takahisa; Migita, Catharina T.; Kurisu, Genji			Crystal structure of higher plant heme oxygenase-1 and its mechanism of interaction with ferredoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHYTOCHROME-CHROMOPHORE BIOSYNTHESIS; SYNECHOCYSTIS SP PCC-6803; ELECTRON-TRANSFER COMPLEX; GRAM-NEGATIVE BACTERIA; RAT HEME; GENE; EXPRESSION; PRODUCT; BINDING; MUTANT	Heme oxygenase (HO) converts heme to carbon monoxide, biliverdin, and free iron, products that are essential in cellular redox signaling and iron recycling. In higher plants, HO is also involved in the biosynthesis of photoreceptor pigment precursors. Despite many common enzymatic reactions, the amino acid sequence identity between plant-type and other HOs is exceptionally low (similar to 19.5%), and amino acids that are catalytically important in mammalian HO are not conserved in plant-type HOs. Structural characterization of plant-type HO is limited to spectroscopic characterization by electron spin resonance, and it remains unclear how the structure of plant-type HO differs from that of other HOs. Here, we have solved the crystal structure of Glycine max (soybean) HO-1 (GmHO-1) at a resolution of 1.06 angstrom and carried out the isothermal titration calorimetry measurements and NMR spectroscopic studies of its interaction with ferredoxin, the plant-specific electron donor. The high-resolution X-ray structure of GmHO-1 reveals several novel structural components: an additional irregularly structured region, a new water tunnel from the active site to the surface, and a hydrogenbonding network unique to plant-type HOs. Structurally important features in other HOs, such as His ligation to the bound heme, are conserved in GmHO-1. Based on combined data from X-ray crystallography, isothermal titration calorimetry, and NMR measurements, we propose the evolutionary fine-tuning of plant-type HOs for ferredoxin dependency in order to allow adaptation to dynamic pH changes on the stroma side of the thylakoid membrane in chloroplast without losing enzymatic activity under conditions of fluctuating light.	[Tohda, Rei; Tanaka, Hideaki; Mutoh, Risa; Kurisu, Genji] Osaka Univ, Inst Prot Res, Suita, Osaka, Japan; [Tohda, Rei; Tanaka, Hideaki; Kurisu, Genji] Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka, Japan; [Zhang, Xuhong] Yamagata Univ, Grad Sch Med Sci, Yamagata, Yamagata, Japan; [Lee, Young-Ho] Korea Basic Sci Inst, Res Ctr Bioconvergence Anal, Cheongju, Chungbuk, South Korea; [Lee, Young-Ho] Chungnam Natl Univ, Grad Sch Analyt Sci & Technol, Daejeon, South Korea; [Lee, Young-Ho] Korea Brain Res Inst, Res Headquarters, Daegu, South Korea; [Lee, Young-Ho] Univ Sci & Technol, Bioanalyt Sci, Daejeon, South Korea; [Konuma, Tsuyoshi; Ikegami, Takahisa] Yokohama City Univ, Grad Sch Med Life Sci, Tsurumi Ku, Yokohama, Kanagawa, Japan; [Migita, Catharina T.] Yamaguchi Univ, Dept Biol Chem, Yoshida, Yamaguchi, Japan; [Mutoh, Risa] Fukuoka Univ, Fac Sci, Jonan, Fukuoka 8140180, Japan	Osaka University; Osaka University; Yamagata University; Korea Basic Science Institute (KBSI); Chungnam National University; Korea Brain Research Institute (KBRI); University of Science & Technology (UST); Yokohama City University; Yamaguchi University; Fukuoka University	Kurisu, G (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka, Japan.; Kurisu, G (corresponding author), Osaka Univ, Dept Macromol Sci, Toyonaka, Osaka, Japan.	gkurisu@protein.osaka-u.ac.jp	KURISU, GENJI/ABA-5960-2020; KURISU, GENJI/AAD-7109-2022; Tanaka, Hideaki/AGY-8426-2022; Ikegami, Takahisa/I-9626-2017	KURISU, GENJI/0000-0002-5354-0807; KURISU, GENJI/0000-0002-5354-0807; Ikegami, Takahisa/0000-0002-1429-1844; Konuma, Tsuyoshi/0000-0002-4412-2849; TOHDA, REI/0000-0001-5644-1399	National Research Foundation of Korea - Korean government [16H06560];  [2018K1A3A1A39088040];  [2019R1A2C1004954]	National Research Foundation of Korea - Korean government(National Research Foundation of KoreaKorean Government); ; 	This work was supported by a Grant-in-Aid for Scientific Research (16H06560 to G. K.), National Research Foundation of Korea grants funded by the Korean government (2018K1A3A1A39088040 and 2019R1A2C1004954 to Y.-H. L.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Balestrasse KB, 2008, BIOMETALS, V21, P433, DOI 10.1007/s10534-008-9132-0; BAX A, 1994, CURR OPIN STRUC BIOL, V4, P738, DOI 10.1016/S0959-440X(94)90173-2; BEALE SI, 1984, ARCH BIOCHEM BIOPHYS, V235, P371, DOI 10.1016/0003-9861(84)90210-8; BEALE SI, 1993, CHEM REV, V93, P785, DOI 10.1021/cr00018a008; Bianchetti CM, 2007, J BIOL CHEM, V282, P37624, DOI 10.1074/jbc.M707396200; Brewitz HH, 2017, BBA-GEN SUBJECTS, V1861, P683, DOI 10.1016/j.bbagen.2016.12.021; Cornejo J, 1998, PLANT J, V15, P99, DOI 10.1046/j.1365-313X.1998.00186.x; Davis SJ, 1999, P NATL ACAD SCI USA, V96, P6541, DOI 10.1073/pnas.96.11.6541; Davis SJ, 2001, PLANT PHYSIOL, V126, P656, DOI 10.1104/pp.126.2.656; De Montellano PRO, 1998, ACCOUNTS CHEM RES, V31, P543; de Montellano PRO, 2000, CURR OPIN CHEM BIOL, V4, P221; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Friedman J, 2004, BIOCHEMISTRY-US, V43, P5239, DOI 10.1021/bi049687g; Gohya T, 2008, BIOCHEM BIOPH RES CO, V376, P293, DOI 10.1016/j.bbrc.2008.08.141; Gohya T, 2006, FEBS J, V273, P5384, DOI 10.1111/j.1742-4658.2006.05531.x; Harada E, 2015, BIOCHEMISTRY-US, V54, P340, DOI 10.1021/bi5009694; HASE T, 1991, PLANT PHYSIOL, V97, P1395, DOI 10.1104/pp.97.4.1395; Hirotsu S, 2004, J BIOL CHEM, V279, P11937, DOI 10.1074/jbc.M311631200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kim JY, 2016, J BIOCHEM, V160, P101, DOI 10.1093/jb/mvw016; Kinoshita M, 2017, BIOCHEM BIOPH RES CO, V482, P909, DOI 10.1016/j.bbrc.2016.11.132; Kobayashi N, 2012, J BIOMOL NMR, V53, P311, DOI 10.1007/s10858-012-9641-6; Kurisu G, 2001, NAT STRUCT BIOL, V8, P117, DOI 10.1038/84097; Lad L, 2003, J MOL BIOL, V330, P527, DOI 10.1016/S0022-2836(03)00578-3; Lad L, 2003, J BIOL CHEM, V278, P7834, DOI 10.1074/jbc.M211450200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Lightning LK, 2001, J BIOL CHEM, V276, P10612, DOI 10.1074/jbc.M010349200; Linley PJ, 2006, FEBS J, V273, P2594, DOI 10.1111/j.1742-4658.2006.05264.x; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Micsonai A, 2015, P NATL ACAD SCI USA, V112, pE3095, DOI 10.1073/pnas.1500851112; Muramoto T, 2002, PLANT PHYSIOL, V130, P1958, DOI 10.1104/pp.008128; Muramoto T, 1999, PLANT CELL, V11, P335, DOI 10.1105/tpc.11.3.335; Noriega GO, 2004, BIOCHEM BIOPH RES CO, V323, P1003, DOI 10.1016/j.bbrc.2004.08.199; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ozen M, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00084; Ratliff M, 2001, J BACTERIOL, V183, P6394, DOI 10.1128/JB.183.21.6394-6403.2001; RHIE GE, 1992, J BIOL CHEM, V267, P16088; Schmitt MP, 1997, J BACTERIOL, V179, P838, DOI 10.1128/jb.179.3.838-845.1997; Schuller DJ, 1999, NAT STRUCT BIOL, V6, P860; Schuller DJ, 2001, BIOCHEMISTRY-US, V40, P11552, DOI 10.1021/bi0110239; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Shekhawat GS, 2010, J EXP BOT, V61, P2255, DOI 10.1093/jxb/erq074; Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930]; Shinohara F, 2017, PHOTOSYNTH RES, V134, P281, DOI 10.1007/s11120-016-0331-1; Smith H, 2000, NATURE, V407, P585, DOI 10.1038/35036500; Sugishima M, 2000, FEBS LETT, V471, P61, DOI 10.1016/S0014-5793(00)01353-3; Sugishima M, 2005, BIOCHEMISTRY-US, V44, P4257, DOI 10.1021/bi0480483; Sugishima M, 2004, EUR J BIOCHEM, V271, P4517, DOI 10.1111/j.1432-1033.2004.04411.x; Sugishima M, 2003, BIOCHEMISTRY-US, V42, P9898, DOI 10.1021/bi027268i; Sugishima M, 2002, BIOCHEMISTRY-US, V41, P7293, DOI 10.1021/bi025662a; Sugishima M, 2019, FEBS LETT, V593, P868, DOI 10.1002/1873-3468.13360; Sugishima M, 2014, P NATL ACAD SCI USA, V111, P2524, DOI 10.1073/pnas.1322034111; TENHUNEN R, 1968, P NATL ACAD SCI USA, V61, P748, DOI 10.1073/pnas.61.2.748; Terwilliger TC, 2009, ACTA CRYSTALLOGR D, V65, P582, DOI 10.1107/S0907444909012098; TROXLER RF, 1979, J BIOL CHEM, V254, P3411; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Wang JL, 2006, BIOCHEMISTRY-US, V45, P61, DOI 10.1021/bi051645k; Wang JL, 2005, J BIOL CHEM, V280, P2797, DOI 10.1074/jbc.M411229200; YOSHIDA T, 1979, J BIOL CHEM, V254, P4487; Zhou H, 2000, J AM CHEM SOC, V122, P8311, DOI 10.1021/ja0002868; Zhu WM, 2000, J BACTERIOL, V182, P6783, DOI 10.1128/JB.182.23.6783-6790.2000	66	4	4	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100217	10.1074/jbc.RA120.016271	http://dx.doi.org/10.1074/jbc.RA120.016271			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839679	gold, Green Published			2022-12-28	WOS:000672866400195
J	Jacob, RA; Edgar, CR; Prevost, J; Trothen, SM; Lurie, A; Mumby, MJ; Galbraith, A; Kirchhoff, F; Haeryfar, SMM; Finzi, A; Dikeakos, JD				Jacob, Rajesh Abraham; Edgar, Cassandra R.; Prevost, Jeremie; Trothen, Steven M.; Lurie, Antony; Mumby, Mitchell J.; Galbraith, Alexa; Kirchhoff, Frank; Haeryfar, S. M. Mansour; Finzi, Andres; Dikeakos, Jimmy D.			The HIV-1 accessory protein Nef increases surface expression of the checkpoint receptor Tim-3 in infected CD4(+) T cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENTATION BIFC ANALYSIS; MUCIN DOMAIN 3; INHIBITORY RECEPTORS; PD-1 EXPRESSION; DOWN-MODULATION; UP-REGULATION; SOLUBLE FORM; EXHAUSTION; LYMPHOCYTES; VPU	Prolonged immune activation drives the upregulation of multiple checkpoint receptors on the surface of virus-specific T cells, inducing their exhaustion. Reversing HIV-1-induced T cell exhaustion is imperative for efficient virus clearance; however, viral mediators of checkpoint receptor upregulation remain largely unknown. The enrichment of checkpoint receptors on T cells upon HIV-1 infection severely constrains the generation of an efficient immune response. Herein, we examined the role of HIV-1 Nef in mediating the upregulation of checkpoint receptors on peripheral blood mononuclear cells. We demonstrate that the HIV-1 accessory protein Nef upregulates cell surface levels of the checkpoint receptor T-cell immunoglobulin mucin domain-3 (Tim-3) and that this is dependent on Nef's dileucine motif LL164/165. Furthermore, we used a bimolecular fluorescence complementation assay to demonstrate that Nef and Tim-3 form a complex within cells that is abrogated upon mutation of the Nef dileucine motif. We also provide evidence that Nef moderately promotes Tim-3 shedding from the cell surface in a dileucine motif- dependent manner. Treating HIV-1-infected CD4(+) T cells with a matrix metalloprotease inhibitor enhanced cell surface Tim-3 levels and reduced Tim-3 shedding. Finally, Tim-3 expressing CD4(+) T cells displayed a higher propensity to release the proinflammatory cytokine interferon-gamma. Collectively, our findings uncover a novel mechanism by which HIV-1 directly increases the levels of a checkpoint receptor on the surface of infected CD4(+) T cells.	[Jacob, Rajesh Abraham; Edgar, Cassandra R.; Trothen, Steven M.; Lurie, Antony; Mumby, Mitchell J.; Galbraith, Alexa; Haeryfar, S. M. Mansour; Dikeakos, Jimmy D.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada; [Prevost, Jeremie; Finzi, Andres] Ctr Rech CHUM, Montreal, PQ, Canada; [Prevost, Jeremie; Finzi, Andres] Univ Montreal, Dept Microbiol Infectiol & Immunol, Montreal, PQ, Canada; [Kirchhoff, Frank] Ulm Univ, Inst Mol Virol, Med Ctr, Uim, Germany; [Finzi, Andres] McGill Univ, Dept Microbiol & Immunol, Montreal, PQ, Canada; [Jacob, Rajesh Abraham] McMaster Univ, McMaster Immunol Res Ctr, Hamilton, ON, Canada	Western University (University of Western Ontario); Universite de Montreal; Universite de Montreal; Ulm University; McGill University; McMaster University	Dikeakos, JD (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Microbiol & Immunol, London, ON, Canada.	Jimmy.Dikeakos@uwo.ca	Haeryfar, S.M. Mansour/L-6845-2015	Haeryfar, S.M. Mansour/0000-0002-1125-8176; Prevost, Jeremie/0000-0002-5260-5154	Canadian Institutes of Health Research (CIHR) [389413]; Canadian Foundation for Innovation [36287]; CIHR foundation [352417]; NIH [R01 AI148379]; Canada Research Chair on Retroviral Entry [RCHS0235 950-232424]; Canadian Institutes of Health Research Canada Graduate Scholarships; RGE Murray Scholarship from the University of Western Ontario; Ontario Graduate Scholarships from the Ontario Government; DFG priority program [SPP1923]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation); CIHR foundation(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canada Research Chair on Retroviral Entry; Canadian Institutes of Health Research Canada Graduate Scholarships(Canadian Institutes of Health Research (CIHR)); RGE Murray Scholarship from the University of Western Ontario; Ontario Graduate Scholarships from the Ontario Government; DFG priority program(German Research Foundation (DFG))	This work was supported by a Project Grant to J. D. D. from the Canadian Institutes of Health Research (CIHR project grant 389413) and by an Infrastructure Grant from the Canadian Foundation for Innovation for the Im-aging Pathogens for Knowledge Translation (ImPaKT) facility (#36287 to J. D. D.; co-PI) . This work was also supported by a CIHR foundation grant #352417 and by NIH R01 AI148379 to A. F., who is the recipient of a Canada Research Chair on Retroviral Entry #RCHS0235 950-232424. C. R. E. and J. P. are recipients of Canadian Institutes of Health Research Canada Graduate Scholarships. S. M. T. is a recipient of an RGE Murray Scholarship from the University of Western Ontario. A. L. and M. J. M. are recipients of Ontario Graduate Scholarships from the Ontario Government. F. K. is supported by the DFG priority program SPP1923. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Anderson AC, 2016, IMMUNITY, V44, P989, DOI 10.1016/j.immuni.2016.05.001; Anderson AC, 2014, CANCER IMMUNOL RES, V2, P393, DOI 10.1158/2326-6066.CIR-14-0039; Apps R, 2016, CELL HOST MICROBE, V19, P686, DOI 10.1016/j.chom.2016.04.005; Avery L, 2018, P NATL ACAD SCI USA, V115, P2455, DOI 10.1073/pnas.1712107115; Bar KJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002721; Barker E, 2016, CELL HOST MICROBE, V19, P570, DOI 10.1016/j.chom.2016.04.023; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blagoveshchenskaya AD, 2002, CELL, V111, P853, DOI 10.1016/S0092-8674(02)01162-5; Butte MJ, 2007, IMMUNITY, V27, P111, DOI 10.1016/j.immuni.2007.05.016; Cao EH, 2007, IMMUNITY, V26, P311, DOI 10.1016/j.immuni.2007.01.016; Chiba S, 2012, NAT IMMUNOL, V13, P832, DOI 10.1038/ni.2376; Clayton KL, 2015, J VIROL, V89, P3723, DOI 10.1128/JVI.00006-15; Craig HM, 1998, P NATL ACAD SCI USA, V95, P11229, DOI 10.1073/pnas.95.19.11229; Das M, 2017, IMMUNOL REV, V276, P97, DOI 10.1111/imr.12520; Das SR, 2005, INDIAN J MED RES, V121, P315; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DeKruyff RH, 2010, J IMMUNOL, V184, P1918, DOI 10.4049/jimmunol.0903059; Dikeakos JD, 2012, MOL BIOL CELL, V23, P2184, DOI 10.1091/mbc.E11-11-0928; Dirk BS, 2016, SCI REP-UK, V6, DOI 10.1038/srep37021; Dirk BS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125619; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Dutton RW, 1998, ANNU REV IMMUNOL, V16, P201, DOI 10.1146/annurev.immunol.16.1.201; Fenton-May AE, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-146; Fenwick C, 2019, IMMUNOL REV, V292, P149, DOI 10.1111/imr.12823; Ferris RL, 2014, J IMMUNOL, V193, P1525, DOI 10.4049/jimmunol.1400557; Freeman GJ, 2010, IMMUNOL REV, V235, P172, DOI 10.1111/j.0105-2896.2010.00903.x; Gallimore A, 1998, J EXP MED, V187, P1383, DOI 10.1084/jem.187.9.1383; Geng H, 2006, J IMMUNOL, V176, P1411, DOI 10.4049/jimmunol.176.3.1411; Gerlach H, 2010, NAT CHEM BIOL, V6, P46, DOI [10.1038/NCHEMBIO.268, 10.1038/nchembio.268]; Goepfert PA, 2000, J VIROL, V74, P10249, DOI 10.1128/JVI.74.21.10249-10255.2000; Gruener NH, 2001, J VIROL, V75, P5550, DOI 10.1128/JVI.75.12.5550-5558.2001; Haller C, 2014, J VIROL, V88, P14241, DOI 10.1128/JVI.02333-14; Hansen JA, 2013, BIOL BLOOD MARROW TR, V19, P1323, DOI 10.1016/j.bbmt.2013.06.011; Heigele A, 2016, CELL HOST MICROBE, V20, P381, DOI 10.1016/j.chom.2016.08.004; Hoffmann M, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005661; Huang YH, 2015, NATURE, V517, P386, DOI 10.1038/nature13848; Jacob RA, 2017, VIROLOGY, V509, P1, DOI 10.1016/j.virol.2017.05.018; Jafari M, 2014, J VIROL, V88, P5062, DOI 10.1128/JVI.03472-13; Johnson AL, 2016, MSPHERE, V1, DOI 10.1128/mSphere.00288-16; Jones RB, 2008, J EXP MED, V205, P2763, DOI 10.1084/jem.20081398; Kahan SM, 2015, VIROLOGY, V479, P180, DOI 10.1016/j.virol.2014.12.033; Kassu A, 2010, J IMMUNOL, V185, P3007, DOI 10.4049/jimmunol.1000156; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kmiec D, 2016, MBIO, V7, DOI 10.1128/mBio.00934-16; Lalvani A, 1997, J EXP MED, V186, P859, DOI 10.1084/jem.186.6.859; Latchman Y, 2001, NAT IMMUNOL, V2, P261, DOI 10.1038/85330; Lee JH, 2018, EBIOMEDICINE, V28, P151, DOI 10.1016/j.ebiom.2018.01.004; Lee J, 2011, MOL CELL BIOL, V31, P3963, DOI 10.1128/MCB.05297-11; Lee JH, 2016, EBIOMEDICINE, V6, P103, DOI 10.1016/j.ebiom.2016.03.004; Lee JH, 2013, MOL CELL, V49, P668, DOI 10.1016/j.molcel.2012.12.004; Li F, 2018, CANCER MANAG RES, V10, P941, DOI 10.2147/CMAR.S162478; Li MH, 2019, P NATL ACAD SCI USA, V116, P5705, DOI 10.1073/pnas.1819475116; Li MH, 2014, P NATL ACAD SCI USA, V111, pE3699, DOI 10.1073/pnas.1404851111; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; McMahan RH, 2010, J CLIN INVEST, V120, P4546, DOI 10.1172/JCI43127; Miller KE, 2015, J MOL BIOL, V427, P2039, DOI 10.1016/j.jmb.2015.03.005; Mitchell RS, 2008, J VIROL, V82, P7758, DOI 10.1128/JVI.02668-07; Moller-Hackbarth K, 2013, J BIOL CHEM, V288, P34529, DOI 10.1074/jbc.M113.488478; Mumby MJ, 2021, J VIROL, V95, DOI 10.1128/JVI.00588-21; Ochsenbauer C, 2012, J VIROL, V86, P2715, DOI 10.1128/JVI.06157-11; Ostalecki C, 2016, EBIOMEDICINE, V13, P294, DOI 10.1016/j.ebiom.2016.10.027; Pardons M, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007619; Parrish NF, 2013, P NATL ACAD SCI USA, V110, P6626, DOI 10.1073/pnas.1304288110; Pawlak EN, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0388-3; Pawlak EN, 2015, BBA-GEN SUBJECTS, V1850, P733, DOI 10.1016/j.bbagen.2015.01.003; Pereira EA, 2016, TRAFFIC, V17, P976, DOI 10.1111/tra.12412; Piguet V, 2000, NAT CELL BIOL, V2, P163, DOI 10.1038/35004038; Prevost J, 2020, J VIROL, V94, DOI 10.1128/JVI.01999-19; Radziewicz H, 2007, J VIROL, V81, P2545, DOI 10.1128/JVI.02021-06; Reiss K, 2009, SEMIN CELL DEV BIOL, V20, P126, DOI 10.1016/j.semcdb.2008.11.002; Ren XF, 2014, ELIFE, V3, DOI 10.7554/eLife.01754; Rhein BA, 2016, J VIROL, V90, P6097, DOI 10.1128/JVI.00100-16; Richard J, 2015, P NATL ACAD SCI USA, V112, pE2687, DOI 10.1073/pnas.1506755112; Roeth JF, 2004, J CELL BIOL, V167, P903, DOI 10.1083/jcb.200407031; Sakuishi K, 2010, J EXP MED, V207, P2187, DOI 10.1084/jem.20100643; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Sanz M, 2021, J VIROL, V95, DOI 10.1128/JVI.02214-20; Sauter D, 2015, CELL REP, V10, P586, DOI 10.1016/j.celrep.2014.12.047; Schwartz O, 1996, NAT MED, V2, P338, DOI 10.1038/nm0396-338; Silva IG, 2017, EBIOMEDICINE, V22, P44, DOI 10.1016/j.ebiom.2017.07.018; Sugden SM, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8030067; Tang DL, 2012, NAT IMMUNOL, V13, P808, DOI 10.1038/ni.2396; Tang RH, 2019, SEMIN IMMUNOL, V42, DOI 10.1016/j.smim.2019.101302; Tian XL, 2015, J IMMUNOL, V194, P3873, DOI 10.4049/jimmunol.1402176; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; Usami Y, 2015, NATURE, V526, P218, DOI 10.1038/nature15400; Veillette M, 2015, J VIROL, V89, P545, DOI 10.1128/JVI.02868-14; Veillette M, 2014, J VIROL, V88, P2633, DOI 10.1128/JVI.03230-13; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Wildurn S, 2006, J VIROL, V80, P8047, DOI 10.1128/JVI.00252-06; Wu W, 2012, EUR J IMMUNOL, V42, P1180, DOI 10.1002/eji.201141852; Zajac AJ, 1998, J EXP MED, V188, P2205, DOI 10.1084/jem.188.12.2205; Zhu C, 2005, NAT IMMUNOL, V6, P1245, DOI 10.1038/ni1271	96	9	9	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101042	10.1016/j.jbc.2021.101042	http://dx.doi.org/10.1016/j.jbc.2021.101042			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34358561	Green Published, gold			2022-12-28	WOS:000704369100016
J	Zaharias, S; Zhang, ZH; Davis, K; Fargason, T; Cashman, D; Yu, T; Zhang, J				Zaharias, Steve; Zhang, Zihan; Davis, Kenneth; Fargason, Talia; Cashman, Derek; Yu, Tao; Zhang, Jun			Intrinsically disordered electronegative clusters improve stability and binding specificity of RNA-binding proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; MECHANISMS; ROLES; CHAPERONES; PROTEOMES; SEQUENCE; RESIDUES; FEATURES	RNA-binding proteins play crucial roles in various cellular functions and contain abundant disordered protein regions. The disordered regions in RNA-binding proteins are rich in repetitive sequences, such as poly-K/R, poly-N/Q, poly-A, and poly-G residues. Our bioinformatic analysis identified a largely neglected repetitive sequence family we define as electronegative clusters (ENCs) that contain acidic residues and/or phosphorylation sites. The abundance and length of ENCs exceed other known repetitive sequences. Despite their abundance, the functions of ENCs in RNA-binding proteins are still elusive. To investigate the impacts of ENCs on protein stability, RNAbinding affinity, and specificity, we selected one RNA-binding protein, the ribosomal biogenesis factor 15 (Nop15), as a model. We found that the Nop15 ENC increases protein stability and inhibits nonspecific RNA binding, but minimally interferes with specific RNA binding. To investigate the effect of ENCs on sequence specificity of RNA binding, we grafted an ENC to another RNA-binding protein, Ser/Arg-rich splicing factor 3. Using RNA Bind-n-Seq, we found that the engineered ENC inhibits disparate RNA motifs differently, instead of weakening all RNA motifs to the same extent. The motif site directly involved in electrostatic interaction is more susceptible to the ENC inhibition. These results suggest that one of functions of ENCs is to regulate RNA binding via electrostatic interaction. This is consistent with our finding that ENCs are also overrepresented in DNA-binding proteins, whereas underrepresented in halophiles, in which nonspecific nucleic acid binding is inhibited by high concentrations of salts.	[Zaharias, Steve; Zhang, Zihan; Davis, Kenneth; Fargason, Talia; Zhang, Jun] Univ Alabama Birmingham, Coll Arts & Sci, Dept Chem, Birmingham, AL 35294 USA; [Cashman, Derek] Tennessee Technol Univ, Dept Chem, Cookeville, TN 38505 USA; [Yu, Tao] Univ North Dakota, Dept Chem, Grand Forks, ND USA	University of Alabama System; University of Alabama Birmingham; Tennessee Technological University; University of North Dakota Grand Forks	Zhang, J (corresponding author), Univ Alabama Birmingham, Coll Arts & Sci, Dept Chem, Birmingham, AL 35294 USA.	zhanguab@uab.edu	; Zhang, Jun/R-1502-2016	Zhang, Zihan/0000-0003-1362-4229; Zaharias, Steve/0000-0003-0339-8096; Zhang, Jun/0000-0002-5842-7424; Cashman, Derek/0000-0002-6041-8922	United States National Science Foundation [MCB 2024964]	United States National Science Foundation(National Science Foundation (NSF))	This work was supported by the United States National Science Foundation (MCB 2024964 to J. Z.).	Anko ML, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r17; ANDERSEN HC, 1983, J COMPUT PHYS, V52, P24, DOI 10.1016/0021-9991(83)90014-1; Apweiler R, 2004, NUCLEIC ACIDS RES, V32, pD115, DOI 10.1093/nar/gkh131; Arakawa T, 2016, CURR PROTEIN PEPT SC, V18, P65, DOI 10.2174/1389203717666160617111140; Bitencourt-Ferreira G, 2019, METHODS MOL BIOL, V2053, P109, DOI 10.1007/978-1-4939-9752-7_8; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; Busa VF, 2017, BIOCHEMISTRY-US, V56, P3571, DOI 10.1021/acs.biochem.7b00362; CALNAN BJ, 1991, GENE DEV, V5, P201, DOI 10.1101/gad.5.2.201; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Cavaloc Y, 1999, RNA, V5, P468, DOI 10.1017/S1355838299981967; Chou CC, 2015, MOL BIOSYST, V11, P2144, DOI 10.1039/c5mb00206k; Clore GM, 2004, J AM CHEM SOC, V126, P2923, DOI 10.1021/ja0386804; Conicella AE, 2016, STRUCTURE, V24, P1537, DOI 10.1016/j.str.2016.07.007; Cossee M, 2011, AM J MED GENET A, V155A, P98, DOI 10.1002/ajmg.a.33785; Csizmok V, 2018, CURR OPIN STRUC BIOL, V48, P58, DOI 10.1016/j.sbi.2017.10.013; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Darling AL, 2017, MOLECULES, V22, DOI 10.3390/molecules22122027; Davis KB, 2018, ANAL BIOCHEM, V557, P142, DOI 10.1016/j.ab.2018.07.022; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Doetsch M, 2011, NUCLEIC ACIDS RES, V39, P4405, DOI 10.1093/nar/gkq1339; Dominski Z, 2002, MOL CELL BIOL, V22, P6648, DOI 10.1128/MCB.22.18.6648-6660.2002; El-Gebali S, 2019, NUCLEIC ACIDS RES, V47, pD427, DOI 10.1093/nar/gky995; Fukuchi S, 2003, J MOL BIOL, V327, P347, DOI 10.1016/S0022-2836(03)00150-5; Granneman S, 2011, EMBO J, V30, P4006, DOI 10.1038/emboj.2011.256; Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472; HEINRICHS V, 1995, EMBO J, V14, P3987, DOI 10.1002/j.1460-2075.1995.tb00070.x; Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Karlin S, 2002, P NATL ACAD SCI USA, V99, P333, DOI 10.1073/pnas.012608599; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Koculi E, 2006, J MOL BIOL, V359, P446, DOI 10.1016/j.jmb.2006.03.031; Kosugi S, 2009, J BIOL CHEM, V284, P478, DOI 10.1074/jbc.M807017200; Krois AS, 2018, P NATL ACAD SCI USA, V115, pE11302, DOI 10.1073/pnas.1814051115; Lambert N, 2014, MOL CELL, V54, P887, DOI 10.1016/j.molcel.2014.04.016; Letunic I, 2018, NUCLEIC ACIDS RES, V46, pD493, DOI 10.1093/nar/gkx922; Luque I, 2002, ANNU REV BIOPH BIOM, V31, P235, DOI 10.1146/annurev.biophys.31.082901.134215; Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041; Nagi AD, 1997, FOLD DES, V2, P67, DOI 10.1016/S1359-0278(97)00007-2; Oeffinger M, 2003, EMBO J, V22, P6573, DOI 10.1093/emboj/cdg616; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P1989, DOI 10.1021/bi047993o; OLLIVIER B, 1994, MICROBIOL REV, V58, P27, DOI 10.1128/MMBR.58.1.27-38.1994; OOI T, 1987, P NATL ACAD SCI USA, V84, P3086, DOI 10.1073/pnas.84.10.3086; Panja S, 2015, J MOL BIOL, V427, P3491, DOI 10.1016/j.jmb.2015.07.010; Renaux A, 2018, NUCLEIC ACIDS RES, V46, P2699, DOI 10.1093/nar/gky092; Santiago-Frangos A, 2017, ELIFE, V6, DOI 10.7554/eLife.27049; Santiago-Frangos A, 2016, P NATL ACAD SCI USA, V113, pE6089, DOI 10.1073/pnas.1613053113; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Shibata A, 2016, MUTAGENESIS, V31, P61, DOI 10.1093/mutage/gev057; Sigrist CJA, 2013, NUCLEIC ACIDS RES, V41, pE344, DOI 10.1093/nar/gks1067; Tang C, 2006, J BIOMOL NMR, V36, P37, DOI 10.1007/s10858-006-9065-2; Tompa P, 2010, BIOCHEM CELL BIOL, V88, P167, DOI [10.1139/O09-163, 10.1139/o09-163]; Uversky VN, 2015, FEBS LETT, V589, P2498, DOI 10.1016/j.febslet.2015.06.004; Vo MN, 2009, J MOL BIOL, V386, P789, DOI 10.1016/j.jmb.2008.12.070; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Wright PE, 2015, NAT REV MOL CELL BIO, V16, P18, DOI 10.1038/nrm3920; Wu S, 2016, NATURE, V534, P133, DOI 10.1038/nature17942; Xue B, 2012, J BIOMOL STRUCT DYN, V30, P137, DOI 10.1080/07391102.2012.675145; Zhang J, 2017, NUCLEIC ACIDS RES, V45, P2829, DOI 10.1093/nar/gkw961; Zhang J, 2014, P NATL ACAD SCI USA, V111, pE2937, DOI 10.1073/pnas.1406381111	62	3	3	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100945	10.1016/j.jbc.2021.100945	http://dx.doi.org/10.1016/j.jbc.2021.100945			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34246632	Green Published, gold			2022-12-28	WOS:000690871000010
J	Amdare, N; Purcell, AW; DiLorenzo, TP				Amdare, Nitin; Purcell, Anthony W.; DiLorenzo, Teresa P.			Noncontiguous T cell epitopes in autoimmune diabetes: From mice to men and back again	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GLUTAMIC-ACID DECARBOXYLASE; ISLET AMYLOID POLYPEPTIDE; NOD MICE; BETA-CELLS; POSTTRANSLATIONAL MODIFICATION; IMMUNE RECOGNITION; HIGH-EFFICIENCY; MURINE INSULIN; CHROMOGRANIN-A; TARGET ANTIGEN	Type 1 diabetes (T1D) is a T cell-mediated autoimmune disease that affects the insulin-producing beta cells of the pancreatic islets. The nonobese diabetic mouse is a widely studied spontaneous model of the disease that has contributed greatly to our understanding of T1D pathogenesis. This is especially true in the case of antigen discovery. Upon review of existing knowledge concerning the antigens and peptide epitopes that are recognized by T cells in this model, good concordance is observed between mouse and human antigens. A fascinating recent illustration of the contribution of the nonobese diabetic mouse in the area of epitope identification is the discovery of noncontiguous CD4(+) T cell epitopes. This novel epitope class is characterized by the linkage of an insulin-derived peptide to, most commonly, a fragment of a natural cleavage product of another beta cell secretory granule constituent. These so-called hybrid insulin peptides are also recognized by T cells in patients with T1D, although the precise mechanism for their generation has yet to be defined and is the subject of active investigation. Although evidence from the tumor immunology arena documented the existence of noncontiguous CD8(+) T cell epitopes, generated by proteasome-mediated peptide splicing involving transpeptidation, such CD8(+) T cell epitopes were thought to be a rare immunological curiosity. However, recent advances in bioinformatics and mass spectrometry have challenged this view. These developments, coupled with the discovery of hybrid insulin peptides, have spurred a search for noncontiguous CD8(+) T cell epitopes in T1D, an exciting frontier area still in its infancy.	[Amdare, Nitin; DiLorenzo, Teresa P.] Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA; [Purcell, Anthony W.] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Purcell, Anthony W.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Div Endocrinol, Dept Med, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Einstein Mt Sinai Diabet Res Ctr, Bronx, NY 10467 USA; [DiLorenzo, Teresa P.] Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Monash University; Monash University; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	DiLorenzo, TP (corresponding author), Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10467 USA.; DiLorenzo, TP (corresponding author), Albert Einstein Coll Med, Div Endocrinol, Dept Med, Bronx, NY 10467 USA.; DiLorenzo, TP (corresponding author), Albert Einstein Coll Med, Einstein Mt Sinai Diabet Res Ctr, Bronx, NY 10467 USA.; DiLorenzo, TP (corresponding author), Albert Einstein Coll Med, Fleischer Inst Diabet & Metab, Bronx, NY 10467 USA.	teresa.dilorenzo@einsteinmed.org		DiLorenzo, Teresa/0000-0003-4337-3598; Amdare, Nitin/0000-0001-9030-630X; Purcell, Anthony/0000-0003-0532-8331	NIAID, National Institutes of Health [R01 AI123730]; NIDDK, National Institutes of Health [R01 DK120420]; National Health and Medical Research Council Principal Research Fellowship [1137739]; Juvenile Diabetes Foundation [1-SRA-2019-806-SB]	NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Health and Medical Research Council Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Juvenile Diabetes Foundation(Juvenile Diabetes Research Foundation)	Work in the laboratory of T. P. D. is supported by the NIAID, National Institutes of Health (R01 AI123730) and the NIDDK, National Institutes of Health (R01 DK120420). T. P. D. is the Diane Belfer, Cypres & Endelson Families Faculty Scholar in Diabetes Research. A. W. P. is supported by a National Health and Medical Research Council Principal Research Fellowship (1137739) and aspects of this work in his laboratory are funded by the Juvenile Diabetes Foundation (1-SRA-2019-806-SB). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abiru N, 2000, J AUTOIMMUN, V14, P231, DOI 10.1006/jaut.2000.0369; Arai T, 2010, CLIN IMMUNOL, V136, P74, DOI 10.1016/j.clim.2010.02.016; Arif S, 2004, J CLIN INVEST, V113, P451, DOI 10.1172/JCI200419585; Arribas-Layton D, 2020, DIABETES, V69, P1492, DOI 10.2337/db19-0620; Azoury ME, 2020, DIABETES, V69, P2678, DOI 10.2337/db20-0013; Babon JAB, 2016, NAT MED, V22, P1482, DOI 10.1038/nm.4203; Baker RL, 2019, DIABETES, V68, P1830, DOI 10.2337/db19-0128; Baker RL, 2018, DIABETES, V67, P1836, DOI 10.2337/db18-0200; Baker RL, 2013, J IMMUNOL, V191, P3990, DOI 10.4049/jimmunol.1301480; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; Berkers CR, 2015, J IMMUNOL, V195, P4085, DOI 10.4049/jimmunol.1402455; Berkers CR, 2009, INT J BIOCHEM CELL B, V41, P66, DOI 10.1016/j.biocel.2008.08.036; Birk OS, 1996, J AUTOIMMUN, V9, P159, DOI 10.1006/jaut.1996.0019; Blum JS, 2013, ANNU REV IMMUNOL, V31, P443, DOI 10.1146/annurev-immunol-032712-095910; Bockova J, 1997, J AUTOIMMUN, V10, P323, DOI 10.1006/jaut.1997.0150; Bowie L, 1999, J IMMUNOL METHODS, V228, P87, DOI 10.1016/S0022-1759(99)00106-4; Buitinga M, 2018, DIABETES, V67, P2337, DOI 10.2337/db18-0295; Busick RY, 2007, CLIN IMMUNOL, V122, P298, DOI 10.1016/j.clim.2006.10.008; Chao CC, 1997, IMMUNOGENETICS, V46, P29, DOI 10.1007/s002510050238; Chao CC, 1999, P NATL ACAD SCI USA, V96, P9299, DOI 10.1073/pnas.96.16.9299; Chen C, 2003, J IMMUNOL, V171, P733, DOI 10.4049/jimmunol.171.2.733; Chen GJ, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0007034, 10.1371/journal.pone.0007804]; Chen W, 2001, J IMMUNOL, V167, P4926, DOI 10.4049/jimmunol.167.9.4926; Chen YY, 2018, FRONT PLANT SCI, V9, DOI [10.3389/fpls.2018.00779, 10.3389/fendo.2018.00051]; Culina S, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao4013; Dalet A, 2011, P NATL ACAD SCI USA, V108, pE323, DOI 10.1073/pnas.1101892108; Dalet A, 2010, J IMMUNOL, V184, P3016, DOI 10.4049/jimmunol.0901277; DANIEL D, 1995, EUR J IMMUNOL, V25, P1056, DOI 10.1002/eji.1830250430; Daniel D, 1996, P NATL ACAD SCI USA, V93, P956, DOI 10.1073/pnas.93.2.956; Darrah E, 2018, CURR OPIN RHEUMATOL, V30, P72, DOI 10.1097/BOR.0000000000000452; Debug T, 2011, DIABETES, V60, P2325, DOI 10.2337/db11-0288; Dedrick S, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00078; Delong T, 2016, SCIENCE, V351, P711, DOI 10.1126/science.aad2791; Delong T, 2012, DIABETES, V61, P3239, DOI 10.2337/db12-0112; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Di Lorenzo TP, 2007, CLIN EXP IMMUNOL, V148, P1, DOI 10.1111/j.1365-2249.2006.03244.x; Driver John P, 2012, Rev Diabet Stud, V9, P169, DOI 10.1900/RDS.2012.9.169; Dudek NL, 2006, DIABETES, V55, P2412, DOI 10.2337/db06-0109; Ebstein F, 2016, SCI REP-UK, V6, DOI 10.1038/srep24032; Ejrnaes M, 2005, J IMMUNOL, V174, P2746, DOI 10.4049/jimmunol.174.5.2746; Erhard F, 2020, CANCER IMMUNOL RES, V8, P1018, DOI 10.1158/2326-6066.CIR-19-0886; Faridi P, 2020, CANCER IMMUNOL RES, V8, P1322, DOI 10.1158/2326-6066.CIR-19-0894; Faridi P, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aar3947; Faridi P, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700464; Gonzalez-Duque S, 2018, CELL METAB, V28, P946, DOI 10.1016/j.cmet.2018.07.007; Graser RT, 2000, J IMMUNOL, V164, P3913, DOI 10.4049/jimmunol.164.7.3913; Gurr W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069464; Halbout P, 2002, J IMMUNOL, V169, P2436, DOI 10.4049/jimmunol.169.5.2436; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Han GC, 2005, J IMMUNOL, V174, P4516, DOI 10.4049/jimmunol.174.8.4516; Hanada K, 2004, NATURE, V427, P252, DOI 10.1038/nature02240; Haskins K, 2005, ADV IMMUNOL, V87, P123, DOI 10.1016/S0065-2776(05)87004-X; Hattori M, 1999, J IMMUNOL, V163, P1721; Heath VL, 1999, DIABETES, V48, P2157, DOI 10.2337/diabetes.48.11.2157; Howson JMM, 2009, DIABETES OBES METAB, V11, P31, DOI 10.1111/j.1463-1326.2008.01001.x; Inoue K, 2004, DIABETOLOGIA, V47, P739, DOI 10.1007/s00125-004-1370-2; Ireland JM, 2011, J EXP MED, V208, P2625, DOI 10.1084/jem.20110640; James EA, 2020, DIABETES, V69, P1311, DOI 10.2337/dbi19-0022; James EA, 2018, DIABETES, V67, P1035, DOI 10.2337/dbi17-0030; Jamison BL, 2019, J IMMUNOL, V203, P48, DOI 10.4049/jimmunol.1900127; Karges W, 1997, DIABETES, V46, P1548, DOI 10.2337/diabetes.46.10.1548; Katsarou Anastasia, 2017, Nat Rev Dis Primers, V3, P17016, DOI 10.1038/nrdp.2017.16; KAUFMAN DL, 1993, NATURE, V366, P69, DOI 10.1038/366069a0; Kelemen K, 2001, DIABETES, V50, P1729, DOI 10.2337/diabetes.50.8.1729; Kracht MJL, 2017, NAT MED, V23, P501, DOI 10.1038/nm.4289; Kudva YC, 2001, HUM IMMUNOL, V62, P1099, DOI 10.1016/S0198-8859(01)00308-1; Lamont D, 2014, J IMMUNOL, V193, P2135, DOI 10.4049/jimmunol.1400997; Levisetti MG, 2008, DIABETES, V57, P1852, DOI 10.2337/db08-0068; Li L, 2008, DIABETES, V57, P2099, DOI 10.2337/db08-0383; Lieberman SM, 2003, P NATL ACAD SCI USA, V100, P8384, DOI 10.1073/pnas.0932778100; Lieberman SM, 2004, J IMMUNOL, V173, P6727, DOI 10.4049/jimmunol.173.11.6727; Liepe J, 2019, CANCER IMMUNOL RES, V7, P62, DOI 10.1158/2326-6066.CIR-18-0424; Liepe J, 2016, SCIENCE, V354, P354, DOI 10.1126/science.aaf4384; Liu CP, 2000, P NATL ACAD SCI USA, V97, P14596, DOI 10.1073/pnas.250390997; Lowe CE, 2007, NAT GENET, V39, P1074, DOI 10.1038/ng2102; Makino S, 1980, Jikken Dobutsu, V29, P1; MAKINO S, 1986, EXP ANIM TOKYO, V35, P495, DOI 10.1538/expanim1978.35.4_495; Mannering SI, 2005, J EXP MED, V202, P1191, DOI 10.1084/jem.20051251; Marino E, 2012, DIABETES, V61, P2893, DOI 10.2337/db12-0006; Marre ML, 2018, DIABETES, V67, P1356, DOI 10.2337/db17-1166; Martin S, 2001, NEW ENGL J MED, V345, P1036, DOI 10.1056/NEJMoa010465; Martinez NR, 2003, J CLIN INVEST, V111, P1365, DOI 10.1172/JCI200317166; Martini S, 2020, IMMUNOGENETICS, V72, P57, DOI 10.1007/s00251-019-01137-6; Maupin-Furlow J, 2012, NAT REV MICROBIOL, V10, P100, DOI 10.1038/nrmicro2696; McGinty JW, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0657-7; McGinty JW, 2014, DIABETES, V63, P3033, DOI 10.2337/db13-1952; McKenzie MD, 2006, INT IMMUNOL, V18, P837, DOI 10.1093/intimm/dxl020; McLaughlin RJ, 2016, CLIN EXP IMMUNOL, V185, P133, DOI 10.1111/cei.12775; Michaux A, 2014, J IMMUNOL, V192, P1962, DOI 10.4049/jimmunol.1302032; Michels AW, 2011, J IMMUNOL, V187, P5921, DOI 10.4049/jimmunol.1100746; MILLER BJ, 1988, J IMMUNOL, V140, P52; Mishto M, 2017, TRENDS IMMUNOL, V38, P904, DOI 10.1016/j.it.2017.07.011; Mitchell AM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2019129118; Mukherjee G, 2015, IMMUNOLOGY, V144, P631, DOI 10.1111/imm.12415; Mukherjee R, 2005, J IMMUNOL, V174, P5306, DOI 10.4049/jimmunol.174.9.5306; Murray JS, 2007, CHEM BIOL DRUG DES, V70, P227, DOI 10.1111/j.1747-0285.2007.00552.x; Mylonas R, 2018, MOL CELL PROTEOMICS, V17, P2347, DOI 10.1074/mcp.RA118.000877; Nayak DK, 2014, DIABETES, V63, P3438, DOI 10.2337/db13-1882; Nejentsev S, 2007, NATURE, V450, P887, DOI 10.1038/nature06406; Nikoopour E, 2016, CLIN EXP IMMUNOL, V185, P292, DOI 10.1111/cei.12811; Nikoopour E, 2014, EUR J IMMUNOL, V44, P1170, DOI 10.1002/eji.201343986; Ogino T, 2000, IMMUNOGENETICS, V51, P538, DOI 10.1007/s002510000173; Ouspenskaia T., 2020, BIORXIV2020021294584 1000 NOVEL UNANNOTAT, DOI [10.1101/2020.02.12.945840, DOI 10.1101/2020.02.12.945840]; Paes W, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.563800; Paes W, 2019, P NATL ACAD SCI USA, V116, P24748, DOI 10.1073/pnas.1911622116; Platteel ACM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01441; Platteel ACM, 2017, CELL REP, V20, P1242, DOI 10.1016/j.celrep.2017.07.026; Platteel ACM, 2016, EUR J IMMUNOL, V46, P1109, DOI 10.1002/eji.201545989; Pomerleau DP, 2005, DIABETES, V54, P1603, DOI 10.2337/diabetes.54.5.1603; Postigo-Fernandez J, 2019, J AUTOIMMUN, V98, P13, DOI 10.1016/j.jaut.2018.11.003; Pugliese A, 2017, J CLIN INVEST, V127, P2881, DOI 10.1172/JCI94549; Purcell AW, 2019, NAT PROTOC, V14, P1687, DOI 10.1038/s41596-019-0133-y; Qin OY, 2006, DIABETES, V55, P3068, DOI 10.2337/db06-0065; Quinn A, 2001, J IMMUNOL, V166, P2982, DOI 10.4049/jimmunol.166.5.2982; Quinn A, 2001, J IMMUNOL, V167, P1748, DOI 10.4049/jimmunol.167.3.1748; Rammensee HG, 1997, MOL B INT U, P1; Ravanan R, 2007, CLIN EXP IMMUNOL, V148, P368, DOI 10.1111/j.1365-2249.2007.03358.x; Redondo MJ, 2018, PEDIATR DIABETES, V19, P346, DOI 10.1111/pedi.12597; Reed B, 2021, J EXP MED, V218, DOI 10.1084/jem.20192135; Reed JC, 2015, NAT REV ENDOCRINOL, V11, P308, DOI 10.1038/nrendo.2014.236; Rolfs Z, 2019, J PROTEOME RES, V18, P349, DOI 10.1021/acs.jproteome.8b00651; Rondas Dieter, 2015, Diabetes, V64, P573, DOI 10.2337/db14-0621; Scotto M, 2012, DIABETES, V61, P2546, DOI 10.2337/db12-0136; Severe S, 2007, MOL IMMUNOL, V44, P2950, DOI 10.1016/j.molimm.2007.01.008; Smith EL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00392; Sollid LM, 2017, IMMUNOGENETICS, V69, P605, DOI 10.1007/s00251-017-0985-7; Spence A, 2018, P NATL ACAD SCI USA, V115, P5265, DOI 10.1073/pnas.1715590115; Stadinski BD, 2010, NAT IMMUNOL, V11, P225, DOI 10.1038/ni.1844; Suri A, 2005, J CLIN INVEST, V115, P2268, DOI 10.1172/JCI25350; Suri A, 2008, J IMMUNOL, V180, P3849, DOI 10.4049/jimmunol.180.6.3849; Thebault-Baumont K, 2003, J CLIN INVEST, V111, P851, DOI 10.1172/JCI200316584; Tisch R, 1999, J IMMUNOL, V163, P1178; Tsai S, 2008, ADV IMMUNOL, V100, P79, DOI 10.1016/S0065-2776(08)00804-3; Tsui H, 2008, DIABETES, V57, P918, DOI 10.2337/db07-0226; Ueda H, 2003, NATURE, V423, P506, DOI 10.1038/nature01621; Unger WW, 2011, J AUTOIMMUN, V37, P151, DOI 10.1016/j.jaut.2011.05.012; van Lummel M, 2014, DIABETES, V63, P237, DOI 10.2337/db12-1214; Vella A, 2005, AM J HUM GENET, V76, P773, DOI 10.1086/429843; Verchere CB, 1996, J BIOL CHEM, V271, P27475, DOI 10.1074/jbc.271.44.27475; Videbaek N, 2003, J AUTOIMMUN, V20, P97, DOI 10.1016/S0896-8411(03)00003-9; Vigneron N, 2004, SCIENCE, V304, P587, DOI 10.1126/science.1095522; Vigneron N, 2019, MOL IMMUNOL, V113, P93, DOI 10.1016/j.molimm.2018.03.030; Vomund AN, 2021, J EXP MED, V218, DOI 10.1084/jem.20202530; Vomund AN, 2015, P NATL ACAD SCI USA, V112, pE5496, DOI 10.1073/pnas.1515954112; Wan XX, 2020, NAT IMMUNOL, V21, P455, DOI 10.1038/s41590-020-0623-7; Wan X, 2018, NATURE, V560, P107, DOI 10.1038/s41586-018-0341-6; Warren EH, 2006, SCIENCE, V313, P1444, DOI 10.1126/science.1130660; Whitworth HS, 2013, METHODS, V61, P52, DOI 10.1016/j.ymeth.2012.12.012; Wiles TA, 2019, J PROTEOME RES, V18, P814, DOI 10.1021/acs.jproteome.8b00875; Wiles TA, 2017, J AUTOIMMUN, V78, P11, DOI 10.1016/j.jaut.2016.10.007; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465; Xu XJ, 1999, DIABETOLOGIA, V42, P560, DOI 10.1007/s001250051195; Yamanouchi J, 2007, NAT GENET, V39, P329, DOI 10.1038/ng1958; Yang T, 2013, IMMUNOL RES, V55, P91, DOI 10.1007/s12026-012-8368-5; Yu C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/9083103; Zechel MA, 1998, J AUTOIMMUN, V11, P83, DOI 10.1006/jaut.1997.0178; Zekzer D, 1998, J CLIN INVEST, V101, P68, DOI 10.1172/JCI119878; Ziegler AG, 2013, JAMA-J AM MED ASSOC, V309, P2473, DOI 10.1001/jama.2013.6285; Zinselmeyer BH, 2018, DIABETOLOGIA, V61, P1374, DOI 10.1007/s00125-018-4592-4	160	2	2	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100827	10.1016/j.jbc.2021.100827	http://dx.doi.org/10.1016/j.jbc.2021.100827			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34044020	Green Published, gold			2022-12-28	WOS:000678068400029
J	Esendir, E; Burtscher, V; Coleman, JA; Zhu, R; Gouaux, E; Freissmuth, M; Sandtner, W				Esendir, Eray; Burtscher, Verena; Coleman, Jonathan A.; Zhu, Rong; Gouaux, Eric; Freissmuth, Michael; Sandtner, Walter			Extracellular loops of the serotonin transporter act as a selectivity filter for drug binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY STRUCTURES; INDUCED FIT; IBOGAINE; ANTIDEPRESSANTS; INHIBITION; MECHANISM; DOPAMINE; STATE	The serotonin transporter (SERT) shapes serotonergic neurotransmission by retrieving its eponymous substrate from the synaptic cleft. Ligands that discriminate between SERT and its close relative, the dopamine transporter DAT, differ in their association rate constant rather than their dissociation rate. The structural basis for this phenomenon is not known. Here we examined the hypothesis that the extracellular loops 2 (EL2) and 4 (EL4) limit access to the ligand-binding site of SERT. We employed an antibody directed against EL4 (residues 388-400) and the antibody fragments 8B6 scFv (directed against EL2 and EL4) and 15B8 Fab (directed against EL2) and analyzed their effects on the transport cycle of and inhibitor binding to SERT. Electrophysiological recordings showed that the EL4 antibody and 8B6 scFv impeded the initial substrate-induced transition from the outward to the inward-facing conformation but not the forward cycling mode of SERT. In contrast, binding of radiolabeled inhibitors to SERT was enhanced by either EL4or EL2-directed antibodies. We confirmed this observation by determining the association and dissociation rate of the DAT-selective inhibitor methylphenidate via electrophysiological recordings; occupancy of EL2 with 15B8 Fab enhanced the affinity of SERT for methylphenidate by accelerating its binding. Based on these observations, we conclude that (i) EL4 undergoes a major movement during the transition from the outward to the inward-facing state, and (ii) EL2 and EL4 limit access of inhibitors to the binding of SERT, thus acting as a selectivity filter. This insight has repercussions for drug development.	[Esendir, Eray; Burtscher, Verena; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria; [Esendir, Eray; Burtscher, Verena; Freissmuth, Michael; Sandtner, Walter] Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Exploratory Drug Dev, Vienna, Austria; [Coleman, Jonathan A.; Gouaux, Eric] Oregon Hlth & Sci Univ, Vollum Inst, L474, Portland, OR 97201 USA; [Zhu, Rong] Johannes Kepler Univ Linz, Inst Biophys, Linz, Austria; [Gouaux, Eric] Oregon Hlth & Sci Univ, Howard Hughes Med Inst, Portland, OR 97201 USA; [Coleman, Jonathan A.] Univ Pittsburgh, Dept Struct Biol, Pittsburgh, PA USA	Medical University of Vienna; Medical University of Vienna; Oregon Health & Science University; Johannes Kepler University Linz; Howard Hughes Medical Institute; Oregon Health & Science University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Inst Pharmacol, Vienna, Austria.; Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Physiol & Pharmacol, Gaston H Glock Res Labs Exploratory Drug Dev, Vienna, Austria.	michael.freissmuth@meduniwien.ac.at		Sandtner, Walter/0000-0003-3637-260X; Burtscher, Verena/0000-0002-0464-0799	doctoral program CCHD (Cell Communication In Health and Disease) - Austrian Science Fund/FWF [W1205]; Medical University of Vienna; Vienna Science and Technology Fund/WWTF [LSC17-026]; Austrian Science Fund/FWF [P31599]; National Institutes of Health [5R37MH070039]	doctoral program CCHD (Cell Communication In Health and Disease) - Austrian Science Fund/FWF; Medical University of Vienna; Vienna Science and Technology Fund/WWTF; Austrian Science Fund/FWF(Austrian Science Fund (FWF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the doctoral program CCHD (Cell Communication In Health and Disease) funded by a grant from the Austrian Science Fund/FWF (W1205) and by the Medical University of Vienna, by grants from the Vienna Science and Technology Fund/WWTF (LSC17-026 to M. F.), from the Austrian Science Fund/FWF (P31599 to W. S. and R. Z.), and from the National Institutes of Health (5R37MH070039 to E. G.). E. G. is an investigator with the Howard Hughes Medical Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bhat S, 2019, BIOCHEM SOC T, V47, P861, DOI 10.1042/BST20180512; Bhat S, 2017, J BIOL CHEM, V292, P16773, DOI 10.1074/jbc.M117.794081; Bulling S, 2012, J BIOL CHEM, V287, P18524, DOI 10.1074/jbc.M112.343681; Burtscher V., 2019, BIO-PROTOCOL, V9, P1; Burtscher V, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215365; Burtscher V, 2018, ELIFE, V7, DOI 10.7554/eLife.34944; Cesar-Razquin A, 2015, CELL, V162, P478, DOI 10.1016/j.cell.2015.07.022; Chakraborty P, 2017, BIOCHEMISTRY-US, V56, P2853, DOI 10.1021/acs.biochem.7b00340; Coleman JA, 2019, NATURE, V569, P141, DOI 10.1038/s41586-019-1135-1; Coleman JA, 2018, NAT STRUCT MOL BIOL, V25, P170, DOI 10.1038/s41594-018-0026-8; Coleman JA, 2016, NATURE, V532, P334, DOI 10.1038/nature17629; Freissmuth M, 2018, HANDB EXP PHARMACOL, V245, P249, DOI 10.1007/164_2017_71; Hasenhuetl PS, 2018, J GEN PHYSIOL, V150, P431, DOI 10.1085/jgp.201711915; Hasenhuetl PS, 2016, J BIOL CHEM, V291, P25864, DOI 10.1074/jbc.M116.753319; Hasenhuetl PS, 2015, MOL PHARMACOL, V88, P12, DOI 10.1124/mol.115.099036; Jacobs MT, 2007, J BIOL CHEM, V282, P29441, DOI 10.1074/jbc.M704456200; KOSHLAND DE, 1959, J CELL COMPAR PHYSL, V54, P245, DOI 10.1002/jcp.1030540420; Krishnamurthy H, 2012, NATURE, V481, P469, DOI 10.1038/nature10737; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Navratna V, 2019, CURR OPIN STRUC BIOL, V54, P161, DOI 10.1016/j.sbi.2019.03.011; PLENGE P, 1991, EUR J PHARM-MOLEC PH, V206, P243, DOI 10.1016/S0922-4106(05)80025-2; Plenge P, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15292-y; Plenge P, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.371765; Rannversson H, 2015, J BIOL CHEM, V290, P14582, DOI 10.1074/jbc.M114.629071; Rothman RB, 2012, J PHARMACOL EXP THER, V341, P251, DOI 10.1124/jpet.111.188946; Sandtner W, 2016, MOL PHARMACOL, V89, P165, DOI 10.1124/mol.115.101394; Sarker S, 2010, MOL PHARMACOL, V78, P1026, DOI 10.1124/mol.110.067538; Schicker K, 2012, J BIOL CHEM, V287, P438, DOI 10.1074/jbc.M111.304261; Schmidt H, 2006, BIOINFORMATICS, V22, P514, DOI 10.1093/bioinformatics/bti799; Sitte HH, 2015, TRENDS PHARMACOL SCI, V36, P41, DOI 10.1016/j.tips.2014.11.006; Smicun Y, 1999, J BIOL CHEM, V274, P36058, DOI 10.1074/jbc.274.51.36058; Vogt AD, 2012, BIOCHEMISTRY-US, V51, P5894, DOI 10.1021/bi3006913; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhu R, 2016, ANGEW CHEM INT EDIT, V55, P1719, DOI 10.1002/anie.201508755	36	3	3	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100863	10.1016/j.jbc.2021.100863	http://dx.doi.org/10.1016/j.jbc.2021.100863			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118233	Green Published, gold			2022-12-28	WOS:000678068400063
J	Gordon, CJ; Tchesnokov, EP; Schinazi, RF; Gotte, M				Gordon, Calvin J.; Tchesnokov, Egor P.; Schinazi, Raymond F.; Gotte, Matthias			Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS; BETA-D-N-4-HYDROXYCYTIDINE; INHIBITION; RIBAVIRIN; ANALOGS	The RNA-dependent RNA polymerase of the severe acute respiratory syndrome coronavirus 2 is an important target in current drug development efforts for the treatment of coronavirus disease 2019. Molnupiravir is a broad-spectrum antiviral that is an orally bioavailable prodrug of the nucleoside analogue beta-D-N-4-hydroxycytidine (NHC). Molnupiravir or NHC can increase G to A and C to U transition mutations in replicating coronaviruses. These increases in mutation frequencies can be linked to increases in antiviral effects; however, biochemical data of molnupiravir-induced mutagenesis have not been reported. Here we studied the effects of the active compound NHC 5'-triphosphate (NHC-TP) against the purified severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase complex. The efficiency of incorporation of natural nucleotides over the efficiency of incorporation of NHC-TP into model RNA substrates followed the order GTP (12,841) > ATP (424) > UTP (171) > CTP (30), indicating that NHC-TP competes predominantly with CTP for incorporation. No significant inhibition of RNA synthesis was noted as a result of the incorporated monophosphate in the RNA primer strand. When embedded in the template strand, NHC-monophosphate supported the formation of both NHC:G and NHC:A base pairs with similar efficiencies. The extension of the NHC:G product was modestly inhibited, but higher nucleotide concentrations could overcome this blockage. In contrast, the NHC:A base pair led to the observed G to A (G:NHC:A) or C to U (C:G:NHC:A:U) mutations. Together, these biochemical data support a mechanism of action of molnupiravir that is primarily based on RNA mutagenesis mediated via the template strand.	[Gordon, Calvin J.; Tchesnokov, Egor P.; Gotte, Matthias] Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada; [Schinazi, Raymond F.] Emory Univ, Ctr AIDS Res, Dept Pediat, Lab Biochem Pharmacol,Sch Med, Atlanta, GA USA; [Schinazi, Raymond F.] Childrens Healthcare Atlanta, Atlanta, GA USA; [Gotte, Matthias] Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada	University of Alberta; Emory University; Children's Healthcare of Atlanta (CHOA); University of Alberta	Gotte, M (corresponding author), Univ Alberta, Dept Med Microbiol & Immunol, Edmonton, AB, Canada.; Gotte, M (corresponding author), Univ Alberta, Li Ka Shing Inst Virol, Edmonton, AB, Canada.	jotte@ualberta.ca		Tchesnokov, Egor Petrovitch/0000-0003-1698-2961; Gordon, Calvin/0000-0002-8259-6201	Canadian Institutes of Health Research (CIHR) [170343]; Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR -One Health Consortium; NIH CFAR grant [P30AI050409]; NSF [2032273]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR -One Health Consortium; NIH CFAR grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF))	This study was supported by grants to M. G. from the Canadian Institutes of Health Research (CIHR, grant number 170343), and from the Alberta Ministry of Economic Development, Trade and Tourism by the Major Innovation Fund Program for the AMR -One Health Consortium. R. F. S. is supported by NIH CFAR grant P30AI050409 and NSF award #2032273. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agostini ML, 2019, J VIROL, V93, DOI 10.1128/JVI.01348-19; Costantini VP, 2012, ANTIVIR THER, V17, P981, DOI 10.3851/IMP2229; Cox RM, 2021, NAT MICROBIOL, V6, P11, DOI 10.1038/s41564-020-00835-2; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Deval J, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004995; Ehteshami M, 2017, ANTIMICROB AGENTS CH, V61, DOI 10.1128/AAC.02395-16; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Fung A, 2014, ANTIMICROB AGENTS CH, V58, P3636, DOI 10.1128/AAC.02666-14; Gordon CJ, 2020, J BIOL CHEM, V295, P6785, DOI 10.1074/jbc.RA120.013679; Gordon CJ, 2020, J BIOL CHEM, V295, P4773, DOI 10.1074/jbc.AC120.013056; Hernandez-Santiago BI, 2004, ANTIMICROB AGENTS CH, V48, P4636, DOI 10.1128/AAC.48.12.4636-4642.2004; JANION C, 1979, ACTA BIOCHIM POL, V26, P171; JANION C, 1980, MUTAT RES, V72, P43, DOI 10.1016/0027-5107(80)90218-3; Jena NR, 2020, PHYS CHEM CHEM PHYS, V22, P28115, DOI 10.1039/d0cp05297c; Painter WP, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.02428-20; Reynard O, 2015, VIRUSES-BASEL, V7, P6233, DOI 10.3390/v7122934; Rosenke K, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22580-8; Shannon A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18463-z; Sheahan TP, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.abb5883; SLEDZIEWSKA E, 1980, MUTAT RES, V70, P11, DOI 10.1016/0027-5107(80)90053-6; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003565; Sticher ZM, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.01719-19; Stuyver LJ, 2003, ANTIMICROB AGENTS CH, V47, P244, DOI 10.1128/AAC.47.1.244-254.2003; Tchesnokov EP, 2020, J BIOL CHEM, V295, P16156, DOI 10.1074/jbc.AC120.015720; Tchesnokov EP, 2020, PLOS NEGLECT TROP D, V14, DOI 10.1371/journal.pntd.0008283; Tchesnokov EP, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040326; Tchesnokov EP, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22328-3; Toots M, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aax5866; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tvarogova J, 2019, J VIROL, V93, DOI 10.1128/JVI.00291-19; U.S. Food and Drug Administration, 2020, CLEVE CLIN J MED; Urakova N, 2018, J VIROL, V92, DOI 10.1128/JVI.01965-17; Vasudevan N, 2020, CHEM COMMUN, V56, P13363, DOI 10.1039/d0cc05944g; Wahl A, 2021, NATURE, V591, P451, DOI 10.1038/s41586-021-03312-w; Xie XP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19055-7; Yoon Jeong-Joong, 2018, Antimicrob Agents Chemother, V62, DOI [10.1128/aac.00766-18, 10.1128/AAC.00766-18]; Zhou ST, 2021, J INFECT DIS, V224, P415, DOI 10.1093/infdis/jiab247	37	100	103	13	57	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100770	10.1016/j.jbc.2021.100770	http://dx.doi.org/10.1016/j.jbc.2021.100770			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	33989635	Green Published, gold			2022-12-28	WOS:000678068400004
J	Niemi, NM; Pagliarini, DJ				Niemi, Natalie M.; Pagliarini, David J.			The extensive and functionally uncharacterized mitochondrial phosphoproteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PROTEIN-PHOSPHORYLATION; PHOSPHATASE; REVEALS; ACID; ACETYLATION; DISEASE; COMPLEX; CELLS	More than half a century ago, reversible protein phosphorylation was linked to mitochondrial metabolism through the regulation of pyruvate dehydrogenase. Since this discovery, the number of identified mitochondrial protein phosphorylation sites has increased by orders of magnitude, driven largely by technological advances in mass spectrometry-based phospho-proteomics. However, the majority of these modifications remain uncharacterized, rendering their function and relevance unclear. Nonetheless, recent studies have shown that disruption of resident mitochondrial protein phosphatases causes substantial metabolic dysfunction across organisms, suggesting that proper management of mitochondrial phosphorylation is vital for organellar and organismal homeostasis. While these data suggest that phosphorylation within mitochondria is of critical importance, significant gaps remain in our knowledge of how these modifications influence organellar function. Here, we curate publicly available datasets to map the extent of protein phosphorylation within mammalian mitochondria and to highlight the known functions of mitochondrial-resident phosphatases. We further propose models by which phosphorylation may affect mitochondrial enzyme activities, protein import and processing, and overall organellar homeostasis.	[Niemi, Natalie M.; Pagliarini, David J.] Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Pagliarini, David J.] Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pagliarini, David J.] Washington Univ, Dept Genet, St Louis, MO 63110 USA; [Pagliarini, David J.] Morgridge Inst Res, Madison, WI 53715 USA; [Pagliarini, David J.] Univ Madison Wisconsin, Dept Biochem, Madison, WI 53706 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.	Pagliarini, DJ (corresponding author), Washington Univ, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Dept Genet, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.; Pagliarini, DJ (corresponding author), Univ Madison Wisconsin, Dept Biochem, Madison, WI 53706 USA.	pagliarini@wustl.edu	Niemi, Natalie/AAH-6963-2021	Niemi, Natalie/0000-0002-5174-4005; Pagliarini, David J./0000-0002-0001-0087	BJC Investigator funds; Diabetes Research Center through Washington University in St. Louis, MO, USA [P30DK020579];  [R01DK098672]	BJC Investigator funds; Diabetes Research Center through Washington University in St. Louis, MO, USA; 	This work was supported by R01DK098672 and BJC Investigator funds (to D. J. P.) and the Diabetes Research Center (P30DK020579 Pilot and Feasibility funds to N. M. N.) through Washington University in St. Louis, MO, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Amer YO, 2018, BBA-BIOENERGETICS, V1859, P868, DOI 10.1016/j.bbabio.2018.04.005; Antonicka H, 2020, CELL METAB, V32, P479, DOI 10.1016/j.cmet.2020.07.017; Aponte AM, 2009, METHOD ENZYMOL, V457, P63, DOI 10.1016/S0076-6879(09)05004-6; Baeza J, 2016, TRENDS BIOCHEM SCI, V41, P231, DOI 10.1016/j.tibs.2015.12.006; Bertolin G, 2018, ELIFE, V7, DOI 10.7554/eLife.38111; Boerner JL, 2004, MOL CELL BIOL, V24, P7059, DOI 10.1128/MCB.24.16.7059-7071.2004; BURNETT G, 1954, J BIOL CHEM, V211, P969; Calvo SE, 2016, NUCLEIC ACIDS RES, V44, pD1251, DOI 10.1093/nar/gkv1003; Carithers LJ, 2015, BIOPRESERV BIOBANK, V13, P311, DOI 10.1089/bio.2015.0032; Cohen P, 2002, NAT CELL BIOL, V4, pE127, DOI 10.1038/ncb0502-e127; Deng N, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000117; Dickinson ME, 2016, NATURE, V537, P508, DOI 10.1038/nature19356; FISCHER EH, 1955, J BIOL CHEM, V216, P121; Frankovsky J, 2021, MITOCHONDRION, V57, P148, DOI 10.1016/j.mito.2020.12.016; FRIEDKIN M, 1949, J BIOL CHEM, V177, P775; Grimsrud PA, 2012, CELL METAB, V16, P672, DOI 10.1016/j.cmet.2012.10.004; Guo X, 2017, J BIOL CHEM, V292, P11751, DOI 10.1074/jbc.M117.787341; Guo X, 2017, CELL REP, V18, P307, DOI 10.1016/j.celrep.2016.12.049; Harris RA, 2002, ADV ENZYME REGUL, V42, P249, DOI 10.1016/S0065-2571(01)00061-9; Hebert-Chatelain E, 2016, NATURE, V539, P555, DOI 10.1038/nature20127; Hebert-Chatelain E, 2012, BBA-BIOENERGETICS, V1817, P718, DOI 10.1016/j.bbabio.2012.01.014; Hornbeck PV, 2015, NUCLEIC ACIDS RES, V43, pD512, DOI 10.1093/nar/gku1267; Hung V, 2017, ELIFE, V6, DOI 10.7554/eLife.24463; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Johnson SC, 2013, SCIENCE, V342, P1524, DOI 10.1126/science.1244360; Kolitsida P, 2019, P NATL ACAD SCI USA, V116, P20517, DOI 10.1073/pnas.1901759116; Lefkimmiatis K, 2013, J CELL BIOL, V202, P453, DOI 10.1083/jcb.201303159; LINN TC, 1969, P NATL ACAD SCI USA, V62, P234, DOI 10.1073/pnas.62.1.234; Lu G, 2009, J CLIN INVEST, V119, P1678, DOI 10.1172/JCI38151; Lu W, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5930; Lu ZM, 2018, TRENDS BIOCHEM SCI, V43, P301, DOI 10.1016/j.tibs.2018.01.006; Martin-Perez M, 2020, NAT METAB, V2, DOI 10.1038/s42255-020-00319-x; Niemi NM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11047-6; Osman C, 2010, EMBO J, V29, P1976, DOI 10.1038/emboj.2010.98; Pagliarini DJ, 2008, CELL, V134, P112, DOI 10.1016/j.cell.2008.06.016; Panda S, 2016, MOL CELL, V63, P457, DOI 10.1016/j.molcel.2016.06.021; Phillips D, 2011, BIOCHEMISTRY-US, V50, P2515, DOI 10.1021/bi101434x; Prus G, 2019, TRENDS BIOCHEM SCI, V44, P943, DOI 10.1016/j.tibs.2019.06.003; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Reidenbach AG, 2018, CELL CHEM BIOL, V25, P154, DOI 10.1016/j.chembiol.2017.11.001; Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Stefely JA, 2016, MOL CELL, V63, P608, DOI 10.1016/j.molcel.2016.06.030; Stefely JA, 2015, MOL CELL, V57, P83, DOI 10.1016/j.molcel.2014.11.002; Waegemann K, 1996, J BIOL CHEM, V271, P6545, DOI 10.1074/jbc.271.11.6545; Weinert BT, 2015, EMBO J, V34, P2620, DOI 10.15252/embj.201591271; White PJ, 2018, CELL METAB, V27, P1281, DOI 10.1016/j.cmet.2018.04.015; WIELAND O, 1970, P NATL ACAD SCI USA, V65, P947, DOI 10.1073/pnas.65.4.947; Wu RH, 2011, NAT METHODS, V8, P677, DOI [10.1038/nmeth.1636, 10.1038/NMETH.1636]; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Zaninello M, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17821-1; Zhao XL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000299	53	4	4	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100880	10.1016/j.jbc.2021.100880	http://dx.doi.org/10.1016/j.jbc.2021.100880			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144036	gold, Green Published			2022-12-28	WOS:000678068400079
J	Zhang, BC; Lapenta, K; Wang, Q; Nam, JH; Chung, DJ; Robert, ME; Nathanson, MH; Yang, XY				Zhang, Bichen; Lapenta, Kalina; Wang, Qi; Nam, Jin Hyun; Chung, Dongjun; Robert, Marie E.; Nathanson, Michael H.; Yang, Xiaoyong			Trefoil factor 2 secreted from damaged hepatocytes activates hepatic stellate cells to induce fibrogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-GLCNAC TRANSFERASE; LIVER; EXPRESSION; MOUSE; ACID; IDENTIFICATION; PROLIFERATION; PEPTIDES; FIBROSIS; CANCER	Liver fibrosis is a common characteristic of chronic liver diseases. The activation of hepatic stellate cells (HSCs) plays a key role in fibrogenesis in response to liver injury, yet the mechanism by which damaged hepatocytes modulate the activation of HSCs is poorly understood. Our previous studies have established that liver-specific deletion of O-GlcNAc transferase (OGT)leads to hepatocyte necroptosis and spontaneous fibrosis. Here, we report that OGT-deficient hepatocytes secrete trefoil factor 2 (TFF2) that activates HSCs and contributes to the fibrogenic process. The expression and secretion of TFF2 are induced in OGT-deficient hepatocytes but not in WT hepatocytes. TFF2 activates the platelet-derived growth factor receptor beta signaling pathway that promotes the proliferation and migration of primary HSCs. TFF2 protein expression is elevated in mice with carbon tetrachloride-induced liver injury. These findings identify TFF2 as a novel factor that mediates intercellular signaling between hepatocytes and HSCs and suggest a role of the hepatic OGT-TFF2 axis in the process of fibrogenesis.	[Zhang, Bichen; Wang, Qi; Yang, Xiaoyong] Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Lapenta, Kalina; Yang, Xiaoyong] Yale Univ, Dept Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, Sch Med, New Haven, CT 06520 USA; [Nam, Jin Hyun] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Chung, Dongjun] Ohio State Univ, Coll Med, Dept Biomed Informat, Columbus, OH USA; [Robert, Marie E.] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Nathanson, Michael H.] Yale Univ, Dept Internal Med, Sect Digest Dis, Sch Med, New Haven, CT USA	Yale University; Yale University; Medical University of South Carolina; University System of Ohio; Ohio State University; Yale University; Yale University	Yang, XY (corresponding author), Yale Univ, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.; Yang, XY (corresponding author), Yale Univ, Dept Comparat Med, Program Integrat Cell Signaling & Neurobiol Metab, Sch Med, New Haven, CT 06520 USA.	xiaoyong.yang@yale.edu		Yang, Xiaoyong/0000-0002-5315-7285; Nam, Jin Hyun/0000-0003-2165-5287; Robert, Marie/0000-0002-6385-4578; Chung, Dongjun/0000-0002-8072-5671; Nathanson, Michael/0000-0001-9964-0160	National Institutes of Health [R01DK089098, R01DK102648, P01DK57751]; Yale Liver Center [P30DK34989]; American Diabetes Association [1-19-IBS-119]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Yale Liver Center; American Diabetes Association(American Diabetes Association)	This work was supported by the National Institutes of Health (R01DK089098, R01DK102648), Yale Liver Center (P30DK34989), and American Diabetes Association (1-19-IBS-119) to X. Y., the National Institutes of Health (P01DK57751) to M. E. R., M. H. N., and X. Y. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aihara E, 2017, ANNU REV PHYSIOL, V79, P357, DOI 10.1146/annurev-physiol-021115-105447; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; Asrani SK, 2019, J HEPATOL, V70, P151, DOI 10.1016/j.jhep.2018.09.014; Baldini SF, 2016, J MOL BIOL, V428, P3295, DOI 10.1016/j.jmb.2016.04.035; Bujak M, 2018, CELL PHYSIOL BIOCHEM, V47, P827, DOI 10.1159/000490039; Clark PM, 2008, J AM CHEM SOC, V130, P11576, DOI 10.1021/ja8030467; Dhar DK, 2003, LAB INVEST, V83, P1343, DOI 10.1097/01.LAB.0000085190.99749.15; Dubeykovskaya Z, 2009, J BIOL CHEM, V284, P3650, DOI 10.1074/jbc.M804935200; Emidio NB, 2019, TRENDS BIOCHEM SCI, V44, P387, DOI 10.1016/j.tibs.2019.01.004; Friedman SL, 2008, PHYSIOL REV, V88, P125, DOI 10.1152/physrev.00013.2007; Guinez C, 2011, DIABETES, V60, P1399, DOI 10.2337/db10-0452; Hagerstrand D, 2006, ONCOGENE, V25, P4913, DOI 10.1038/sj.onc.1209497; Hahne H, 2013, J PROTEOME RES, V12, P927, DOI 10.1021/pr300967y; Hautekeete ML, 1997, VIRCHOWS ARCH, V430, P195, DOI 10.1007/BF01324802; Hayashi Y, 2018, BIOCHEM BIOPH RES CO, V506, P12, DOI 10.1016/j.bbrc.2018.10.023; Hertel SC, 2004, PEPTIDES, V25, P755, DOI 10.1016/j.peptides.2003.11.021; Higashi T, 2017, ADV DRUG DELIVER REV, V121, P27, DOI 10.1016/j.addr.2017.05.007; Hoffmann W, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21124535; Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200; Huang H, 2021, J CELL PHYSIOL, V236, P7491, DOI 10.1002/jcp.30385; Ikeda K, 1999, HEPATOLOGY, V29, P1760, DOI 10.1002/hep.510290640; Kendall TJ, 2009, HEPATOLOGY, V49, P901, DOI 10.1002/hep.22701; Khoury Thaer, 2005, Int J Gastrointest Cancer, V35, P171, DOI 10.1385/IJGC:35:3:171; Kocabayoglu P, 2015, J HEPATOL, V63, P141, DOI 10.1016/j.jhep.2015.01.036; Krizhanovsky V, 2008, CELL, V134, P657, DOI 10.1016/j.cell.2008.06.049; Li MD, 2013, CELL METAB, V17, P303, DOI 10.1016/j.cmet.2012.12.015; Ma JF, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-8; Mederacke I, 2015, NAT PROTOC, V10, P305, DOI 10.1038/nprot.2015.017; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; O'Rourke JM, 2018, WORLD J GASTROENTERO, V24, P4436, DOI 10.3748/wjg.v24.i39.4436; Ochiai Y, 2020, HEPATOLOGY, V72, P503, DOI 10.1002/hep.31039; Ong QX, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00599; Orime K, 2013, ENDOCRINOLOGY, V154, P54, DOI 10.1210/en.2012-1814; Ramachandran P, 2019, NATURE, V575, P512, DOI 10.1038/s41586-019-1631-3; Ruan HB, 2017, GENE DEV, V31, P1655, DOI 10.1101/gad.305441.117; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Sasaki M, 2003, LAB INVEST, V83, P1403, DOI 10.1097/01.LAB.0000092230.59485.9E; Sciaccaluga M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073426; Tan EP, 2017, J BIOL CHEM, V292, P14940, DOI 10.1074/jbc.M117.797944; THIM L, 1989, FEBS LETT, V250, P85, DOI 10.1016/0014-5793(89)80690-8; Tsuchida T, 2018, J HEPATOL, V69, P385, DOI 10.1016/j.jhep.2018.03.011; WAKE K, 1971, AM J ANAT, V132, P429, DOI 10.1002/aja.1001320404; Wake K, 2006, P JPN ACAD B-PHYS, V82, P155, DOI 10.2183/pjab.82.155; Wederell ED, 2008, NUCLEIC ACIDS RES, V36, P4549, DOI 10.1093/nar/gkn382; Wei W, 2021, NAT CHEM BIOL, V17, P326, DOI 10.1038/s41589-020-00698-y; Wu XJ, 2019, AM J PHYSIOL-ENDOC M, V317, pE436, DOI 10.1152/ajpendo.00454.2018; Xu L, 2005, GUT, V54, P142, DOI 10.1136/gut.2004.042127; Xu WQ, 2017, J HEPATOL, V67, P310, DOI 10.1016/j.jhep.2017.03.017; Xue Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075240; Yang XY, 2008, NATURE, V451, P964, DOI 10.1038/nature06668; Yang XY, 2017, NAT REV MOL CELL BIO, V18, P452, DOI 10.1038/nrm.2017.22; Zhang BC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.127709; Zhao M, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708736; Zhu Y, 2017, DIABETES, V66, P2789, DOI 10.2337/db17-0323	54	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100887	10.1016/j.jbc.2021.100887	http://dx.doi.org/10.1016/j.jbc.2021.100887			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34146542	Green Published, gold			2022-12-28	WOS:000678068400085
J	Adamus, K; Reboul, C; Voss, J; Huang, C; Schittenhelm, RB; Le, SN; Ellisdon, AM; Elmlund, H; Boudes, M; Elmlund, D				Adamus, Klaudia; Reboul, Cyril; Voss, Jarrod; Huang, Cheng; Schittenhelm, Ralf B.; Le, Sarah N.; Ellisdon, Andrew M.; Elmlund, Hans; Boudes, Marion; Elmlund, Dominika			SAGA and SAGA-like SLIK transcriptional coactivators are structurally and biochemically equivalent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H2B DEUBIQUITINATION; SACCHAROMYCES-CEREVISIAE; ACETYLATED HISTONES; COMPLEX; BINDING; PROTEIN; SPT3; RECRUITMENT; ACTIVATION; COMPONENTS	The SAGA-like complex SLIK is a modified version of the Spt-Ada-Gcn5-Acetyltransferase (SAGA) complex. SLIK is formed through C-terminal truncation of the Spt7 SAGAsubunit, causing loss of Spt8, one of the subunits that interacts with the TATA-binding protein (TBP). SLIK and SAGA are both coactivators of RNA polymerase II transcription in yeast, and both SAGA and SLIK perform chromatin modifications. The two complexes have been speculated to uniquely contribute to transcriptional regulation, but their respective contributions are not clear. To investigate, we assayed the chromatinmodifying functions of SAGA and SLIK, revealing identical kinetics on minimal substrates in vitro. We also examined the binding of SAGA and SLIK to TBP and concluded that interestingly, both protein complexes have similar affinity for TBP. Additionally, despite the loss of Spt8 and C-terminus of Spt7 in SLIK, TBPprebound to SLIKis not released in the presence of TATA-box DNA, just like TBP prebound to SAGA. Furthermore, we determined a low-resolution cryo-EM structure of SLIK, revealing a modular architecture identical to SAGA. Finally, we performed a comprehensive study of DNA-binding properties of both coactivators. Purified SAGA and SLIK both associate with ssDNA and dsDNA with high affinity (K-D = 10-17 nM), and the binding is sequence-independent. In conclusion, our study shows that the cleavage of Spt7 and the absence of the Spt8 subunit in SLIK neither drive any major conformational differences in its structure comparedwith SAGA, nor significantly affect HAT, DUB, or DNA-binding activities in vitro.	[Adamus, Klaudia; Reboul, Cyril; Voss, Jarrod; Le, Sarah N.; Ellisdon, Andrew M.; Elmlund, Hans; Boudes, Marion; Elmlund, Dominika] Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia; [Huang, Cheng; Schittenhelm, Ralf B.] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Monash Prote & Metabol Facil, Clayton, Vic, Australia; [Elmlund, Dominika] FB Rice, 33-477 Collins St, Melbourne, Vic 3000, Australia; [Le, Sarah N.] Harvard Univ, Harvard Med Sch, Boston, MA 02115 USA	Monash University; Monash University; Harvard University; Harvard Medical School	Boudes, M; Elmlund, D (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Biomed Discovery Inst, Clayton, Vic, Australia.; Elmlund, D (corresponding author), FB Rice, 33-477 Collins St, Melbourne, Vic 3000, Australia.	marion.boudes@monash.edu; dominika.elmlund@monash.edu		Boudes, Marion/0000-0003-2577-710X; LE, SARAH/0000-0003-1156-2597; Reboul, Cyril/0000-0002-6258-2697; Schittenhelm, Ralf/0000-0001-8738-1878	Australian Research Council [DP170101850]; National Health and Medical Research Council, Australia [APP1125909, APP1122769]	Australian Research Council(Australian Research Council); National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	H. E. acknowledges the Australian Research Council grant DP170101850 and the National Health and Medical Research Council, Australia, grant APP1125909. C. R. acknowledges Early Career Fellowship (APP1122769).	Aakio T, 2020, J CELL SCI, V133; Adamus K, 2019, J STRUCT BIOL, V207, P327, DOI 10.1016/j.jsb.2019.07.004; Baptista T, 2017, MOL CELL, V68, P130, DOI 10.1016/j.molcel.2017.08.016; Belotserkovskaya R, 2000, MOL CELL BIOL, V20, P634, DOI 10.1128/MCB.20.2.634-647.2000; Bhaumik SR, 2001, GENE DEV, V15, P1935, DOI 10.1101/gad.911401; Bian CB, 2011, EMBO J, V30, P2829, DOI 10.1038/emboj.2011.193; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Cieniewicz AM, 2014, MOL CELL PROTEOMICS, V13, P2896, DOI 10.1074/mcp.M114.038174; Clouaire T, 2018, MOL CELL, V72, P250, DOI 10.1016/j.molcel.2018.08.020; Diaz-Santin LM, 2017, ELIFE, V6, DOI 10.7554/eLife.28384; Doriczew R, 2020, LIFE, V9, P28; Dudley AM, 1999, GENE DEV, V13, P2940, DOI 10.1101/gad.13.22.2940; EISENMANN DM, 1994, GENETICS, V137, P647; Eopytova D, 2018, CELL CYCLE, V17, P1870; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9; Han Y, 2014, EMBO J, V33, P2534, DOI 10.15252/embj.201488638; Hassan AH, 2007, BIOCHEM J, V402, P125, DOI 10.1042/BJ20060907; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Hoke Stephen Mt, 2007, BMC Biochemistry, V8, P16, DOI 10.1186/1471-2091-8-16; Ikeda K, 1999, MOL CELL BIOL, V19, P855; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Koehler C, 2014, J BIOL CHEM, V289, P8989, DOI 10.1074/jbc.M113.500868; Laprade L, 2007, GENETICS, V177, P2007, DOI 10.1534/genetics.107.081976; Lim S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3641; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mittal C, 2018, J BIOL CHEM, V293, P13736, DOI 10.1074/jbc.RA118.004487; Mohan RD, 2014, GENE DEV, V28, P259, DOI 10.1101/gad.225151.113; Morari F, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00314; Morgan MT, 2016, SCIENCE, V351, P725, DOI 10.1126/science.aac5681; Papai G, 2020, NATURE, V577, P711, DOI 10.1038/s41586-020-1944-2; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pray-Grant MG, 2002, MOL CELL BIOL, V22, P8774, DOI 10.1128/MCB.22.24.8774-8786.2002; Ramachandran S, 2016, CELL REP, V15, P1554, DOI 10.1016/j.celrep.2016.04.041; Reboul CF, 2018, PROTEIN SCI, V27, P51, DOI 10.1002/pro.3266; Reboul CF, 2016, STRUCTURE, V24, P988, DOI 10.1016/j.str.2016.04.006; Ringel AE, 2015, P NATL ACAD SCI USA, V112, pE5461, DOI 10.1073/pnas.1508449112; Roberts SM, 1997, GENETICS, V147, P451; Samara NL, 2012, STRUCTURE, V20, P1414, DOI 10.1016/j.str.2012.05.015; Samara NL, 2010, SCIENCE, V328, P1025, DOI 10.1126/science.1190049; Setiaputra D, 2015, J BIOL CHEM, V290, P10057, DOI 10.1074/jbc.M114.624684; Sharif H, 2017, P NATL ACAD SCI USA, V114, P7367, DOI 10.1073/pnas.1707386114; Sharov G, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01564-7; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Spedale G, 2010, J BIOL CHEM, V285, P22791, DOI 10.1074/jbc.M110.108787; Stark H, 2010, METHOD ENZYMOL, V481, P109, DOI 10.1016/S0076-6879(10)81005-5; Sterner DE, 2002, P NATL ACAD SCI USA, V99, P11622, DOI 10.1073/pnas.182021199; Strahl BD, 2021, BBA-GENE REGUL MECH, V1864, DOI 10.1016/j.bbagrm.2020.194600; Sun J, 2018, P NATL ACAD SCI USA, V115, P10010, DOI 10.1073/pnas.1805343115; Utley RT, 1998, NATURE, V394, P498, DOI 10.1038/28886; Vignali M, 2000, EMBO J, V19, P2629, DOI 10.1093/emboj/19.11.2629; Wang HB, 2020, NATURE, V577, P717, DOI 10.1038/s41586-020-1933-5; Wang YL, 2008, J BIOL CHEM, V283, P33808, DOI 10.1074/jbc.M806936200; Warfield L, 2004, GENE DEV, V18, P1022, DOI 10.1101/gad.1192204; Weake VM, 2011, GENE DEV, V25, P1499, DOI 10.1101/gad.2046211; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	58	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100671	10.1016/j.jbc.2021.100671	http://dx.doi.org/10.1016/j.jbc.2021.100671			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864814	Green Published, gold			2022-12-28	WOS:000672866400642
J	Guo, X; Ramirez, I; Garcia, YA; Velasquez, EF; Gholkar, AA; Cohn, W; Whitelegge, JP; Tofig, B; Damoiseaux, R; Torres, JZ				Guo, Xiao; Ramirez, Ivan; Garcia, Yenni A.; Velasquez, Erick F.; Gholkar, Ankur A.; Cohn, Whitaker; Whitelegge, Julian P.; Tofig, Bobby; Damoiseaux, Robert; Torres, Jorge Z.			DUSP7 regulates the activity of ERK2 to promote proper chromosome alignment during cell division	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE ASSEMBLY CHECKPOINT; ACTIVATED PROTEIN-KINASE; MAP KINASE; PHOSPHATASES; CYCLE; PHOSPHORYLATION; IDENTIFICATION; PROTEOMICS; PEPTIDES; PATHWAY	Human cell division is a highly regulated process that relies on the accurate capture and movement of chromosomes to the metaphase plate. Errors in the fidelity of chromosome congression and alignment can lead to improper chromosome segregation, which is correlated with aneuploidy and tumorigenesis. These processes are known to be regulated by extracellular signal-regulated kinase 2 (ERK2) in other species, but the role of ERK2 in mitosis in mammals remains unclear. Here, we have identified the dual-specificity phosphatase 7 (DUSP7), known to display selectivity for ERK2, as important in regulating chromosome alignment. During mitosis, DUSP7 bound to ERK2 and regulated the abundance of active phospho-ERK2 through its phosphatase activity. Overexpression of DUSP7, but not catalytically inactive mutants, led to a decrease in the levels of phospho-ERK2 and mitotic chromosome misalignment, while knockdown of DUSP7 also led to defective chromosome congression that resulted in a prolonged mitosis. Consistently, knockdown or chemical inhibition of ERK2 or chemical inhibition of the MEK kinase that phosphorylates ERK2 led to chromosome alignment defects. Our results support a model wherein MEK-mediated phosphorylation and DUSP7-mediated dephosphorylation regulate the levels of active phospho-ERK2 to promote proper cell division.	[Guo, Xiao; Ramirez, Ivan; Garcia, Yenni A.; Velasquez, Erick F.; Gholkar, Ankur A.; Torres, Jorge Z.] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cohn, Whitaker; Whitelegge, Julian P.] Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Pasarow Mass Spectrometry Lab, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.; Torres, Jorge Z.] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Whitelegge, Julian P.; Torres, Jorge Z.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Tofig, Bobby; Damoiseaux, Robert] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA USA; [Damoiseaux, Robert] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Torres, JZ (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Jane & Terry Semel Inst Neurosci & Human Behav, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.; Torres, JZ (corresponding author), Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA.	torres@chem.ucla.edu	; Damoiseaux, Robert/F-1086-2011	Torres, Jorge/0000-0002-2158-889X; Gholkar, Ankur/0000-0002-3490-234X; Whitelegge, Julian/0000-0003-2763-7733; Damoiseaux, Robert/0000-0002-7611-7534	NIH-NIGMS [R35GM139539, R01GM117475]; USHHS [T32CA009056]; HHMI through the James H. Gilliam Fellowships for Advanced Study Program; HHMI through the MBI Whitcome Fellowship; NIH [P30DK063491]; NCI [P30CA016042]	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); USHHS; HHMI through the James H. Gilliam Fellowships for Advanced Study Program; HHMI through the MBI Whitcome Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Work was supported by NIH-NIGMS R35GM139539, R01GM117475 (J. Z. T.); USHHS T32CA009056 (Y. A. G.); a grant to the University of California, Los Angeles from the HHMI through the James H. Gilliam Fellowships for Advanced Study Program and an MBI Whitcome Fellowship (E. F. V); NIH P30DK063491 (J. P. W.) and NCI P30CA016042 (R. D.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bradley M, 2016, JOVE-J VIS EXP, DOI 10.3791/54870; Bryja V, 2017, CRIT REV BIOCHEM MOL, V52, P614, DOI 10.1080/10409238.2017.1350135; Caunt CJ, 2008, J BIOL CHEM, V283, P26612, DOI 10.1074/jbc.M801500200; Chen PL, 2001, J BIOL CHEM, V276, P29440, DOI 10.1074/jbc.M103463200; Cheung K, 2016, MOL CELL PROTEOMICS, V15, P1658, DOI 10.1074/mcp.M115.056465; Combes G, 2017, ONCOGENE, V36, P4819, DOI 10.1038/onc.2017.113; Cuyas E, 2014, METHODS MOL BIOL, V1170, P113, DOI 10.1007/978-1-4939-0888-2_7; DENU JM, 1995, P NATL ACAD SCI USA, V92, P5910, DOI 10.1073/pnas.92.13.5910; Dowd S, 1998, J CELL SCI, V111, P3389; Duncia JV, 1998, BIOORG MED CHEM LETT, V8, P2839, DOI 10.1016/S0960-894X(98)00522-8; Eblen ST, 2018, ADV CANCER RES, V138, P99, DOI 10.1016/bs.acr.2018.02.004; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Franz M, 2016, BIOINFORMATICS, V32, P309, DOI 10.1093/bioinformatics/btv557; Gholkar AA, 2016, CELL REP, V14, P180, DOI 10.1016/j.celrep.2015.12.035; Giurgiu M, 2019, NUCLEIC ACIDS RES, V47, pD559, DOI 10.1093/nar/gky973; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; HAYSTEAD TAJ, 1992, FEBS LETT, V306, P17, DOI 10.1016/0014-5793(92)80828-5; Heim A, 2017, ADV EXP MED BIOL, V953, P83, DOI 10.1007/978-3-319-46095-6_3; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Keyse SM, 2008, CANCER METAST REV, V27, P253, DOI 10.1007/s10555-008-9123-1; Kim DI, 2016, MOL BIOL CELL, V27, P1188, DOI 10.1091/mbc.E15-12-0844; Kim HS, 2016, MOL CELLS, V39, P654, DOI 10.14348/molcells.2016.0214; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magnaghi-Jaulin L, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9010028; Meloche S, 2007, ONCOGENE, V26, P3227, DOI 10.1038/sj.onc.1210414; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Nichols A, 2000, J BIOL CHEM, V275, P24613, DOI 10.1074/jbc.M001515200; Ohori M, 2005, BIOCHEM BIOPH RES CO, V336, P357, DOI 10.1016/j.bbrc.2005.08.082; Ong JY, 2020, CYTOSKELETON, V77, P558, DOI 10.1002/cm.21649; Owens DM, 2007, ONCOGENE, V26, P3203, DOI 10.1038/sj.onc.1210412; Patananan AN, 2014, J BIOL CHEM, V289, P16936, DOI 10.1074/jbc.M114.564385; Patterson KI, 2009, BIOCHEM J, V418, P475, DOI 10.1042/BJ20082234; PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x; Pfender S, 2015, NATURE, V524, P239, DOI 10.1038/nature14568; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Saurin AT, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00062; Seternes OM, 2019, BBA-MOL CELL RES, V1866, P124, DOI 10.1016/j.bbamcr.2018.09.002; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shinohara M, 2006, MOL BIOL CELL, V17, P5227, DOI 10.1091/mbc.E06-04-0284; Slack DN, 2001, J BIOL CHEM, V276, P16491, DOI 10.1074/jbc.M010966200; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Takenaka K, 1997, J CELL BIOL, V136, P1091, DOI 10.1083/jcb.136.5.1091; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Tighe A, 2004, J CELL SCI, V117, P6339, DOI 10.1242/jcs.01556; Tischer T, 2016, CELL REP, V17, P1426, DOI 10.1016/j.celrep.2016.10.007; Torres JZ, 2011, CELL, V147, P1309, DOI 10.1016/j.cell.2011.11.020; Torres JZ, 2009, PROTEOMICS, V9, P2888, DOI 10.1002/pmic.200800873; Wang XM, 1997, J CELL BIOL, V137, P433, DOI 10.1083/jcb.137.2.433; ZHANG ZY, 1994, BIOCHEMISTRY-US, V33, P15266, DOI 10.1021/bi00255a007	51	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100676	10.1016/j.jbc.2021.100676	http://dx.doi.org/10.1016/j.jbc.2021.100676			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865857	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400647
J	Hamilton, J; Brustovetsky, T; Brustovetsky, N				Hamilton, James; Brustovetsky, Tatiana; Brustovetsky, Nickolay			The effect of mitochondrial calcium uniporter and cyclophilin D knockout on resistance of brain mitochondria to Ca2+-induced damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERMEABILITY TRANSITION PORE; CHAIN FATTY-ACIDS; CYCLOSPORINE-A; UPTAKE CAPACITY; INNER MEMBRANE; HEART-MITOCHONDRIA; CYTOCHROME-C; CA2+ RELEASE; MOUSE MODEL; LIVER	The mitochondrial calcium uniporter (MCU) and cyclophilin D (CyD) are key players in induction of the permeability transition pore (PTP), which leads to mitochondrial depolarization and swelling, the major signs of Ca2+-induced mitochondrial damage. Mitochondrial depolarization inhibits ATP production, whereas swelling results in the release of mitochondrial pro-apoptotic proteins. The extent to which simultaneous deletion of MCU and CyD inhibits PTP induction and prevents damage of brain mitochondria is not clear. Here, we investigated the effects of MCU and CyD deletion on the propensity for PTP induction using mitochondria isolated from the brains of MCU-KO, CyD-KO, and newly created MCU/CyD-double knockout (DKO) mice. Neither deletion of MCU nor of CyD affected respiration or membrane potential in mitochondria isolated from the brains of these mice. Mitochondria from MCU-KO and MCU/CyD-DKO mice displayed reduced Ca2+ uptake and diminished extent of PTP induction. The Ca2+ uptake by mitochondria from CyD-KO mice was increased compared with mitochondria from WT mice. Deletion of CyD prevented mitochondrial swelling and resulted in transient depolarization in response to Ca2+, but it did not prevent Ca2+-induced delayed mitochondrial depolarization. Mitochondria from MCU/CyD-DKO mice did not swell in response to Ca2+, but they did exhibit mild sustained depolarization. Dibucaine, an inhibitor of the Ca2+-activated mitochondrial phospholipase A2, attenuated and bovine serum albumin completely eliminated the sustained depolarization. This suggests the involvement of phospholipase A2 and free fatty acids. Thus, in addition to induction of the classical PTP, alternative deleterious mechanisms may contribute to mitochondrial damage following exposure to elevated Ca2+.	[Hamilton, James; Brustovetsky, Tatiana; Brustovetsky, Nickolay] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Brustovetsky, Nickolay] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Brustovetsky, N (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Brustovetsky, N (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	nbrous@iu.edu		Brustovetsky, Nickolay/0000-0002-6564-2560	National Institutes of Health NINDS [R01 NS098772]	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by a the National Institutes of Health NINDS grant R01 NS098772 to N. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANDREYEV AY, 1989, EUR J BIOCHEM, V182, P585, DOI 10.1111/j.1432-1033.1989.tb14867.x; Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Bambrick LL, 2006, J BIOENERG BIOMEMBR, V38, P43, DOI 10.1007/s10863-006-9004-7; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; Bernardi P, 2002, VITAM HORM, V65, P97, DOI 10.1016/S0083-6729(02)65061-7; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bernardi P, 2020, P NATL ACAD SCI USA, V117, P2743, DOI 10.1073/pnas.1921035117; Bernardi P, 2015, J MOL CELL CARDIOL, V78, P100, DOI 10.1016/j.yjmcc.2014.09.023; Bernardi P, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00095; Bertholet A.M., 2019, ARCH BIOCHEM BIOPHYS, V571, p515; Beutner G, 2001, J BIOL CHEM, V276, P21482, DOI 10.1074/jbc.M101486200; Bisbach CM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-72708-x; BJORNTORP P, 1964, J BIOL CHEM, V239, P339; BROEKEMEIER KM, 1985, J BIOL CHEM, V260, P105; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2017, NEUROMETHODS, V123, P199, DOI 10.1007/978-1-4939-6890-9_10; Brustovetsky T, 2005, J NEUROCHEM, V94, P980, DOI 10.1111/j.1471-4159.2005.03248.x; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Chalmers S, 2003, J BIOL CHEM, V278, P19062, DOI 10.1074/jbc.M212661200; Chaudhuri D, 2013, ELIFE, V2, DOI 10.7554/eLife.00704; COX DA, 1993, TRENDS PHARMACOL SCI, V14, P408, DOI 10.1016/0165-6147(93)90063-P; CROMPTON M, 1988, BIOCHEM J, V255, P357; CROMPTON M, 1992, BIOCHIM BIOPHYS ACTA, V1101, P214, DOI 10.1016/0005-2728(92)90228-T; Csordas G, 2013, CELL METAB, V17, P976, DOI 10.1016/j.cmet.2013.04.020; De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Denton RM, 2009, BBA-BIOENERGETICS, V1787, P1309, DOI 10.1016/j.bbabio.2009.01.005; FOURNIER N, 1987, J BIOENERG BIOMEMBR, V19, P297, DOI 10.1007/BF00762419; Gadd ME, 2006, J BIOL CHEM, V281, P6931, DOI 10.1074/jbc.M510845200; HALESTRAP AP, 1990, BIOCHEM J, V268, P153, DOI 10.1042/bj2680153; Hamilton J, 2018, J BIOL CHEM, V293, P15652, DOI 10.1074/jbc.RA118.002926; HANSFORD RG, 1991, J BIOENERG BIOMEMBR, V23, P823, DOI 10.1007/BF00786004; Jakob R, 2014, NEUROSCI LETT, V575, P7, DOI 10.1016/j.neulet.2014.05.026; KAMO N, 1979, J MEMBRANE BIOL, V49, P105, DOI 10.1007/BF01868720; Kannurpatti SS, 2017, J CEREBR BLOOD F MET, V37, P381, DOI 10.1177/0271678X16680637; KRONER H, 1986, ARCH BIOCHEM BIOPHYS, V251, P525, DOI 10.1016/0003-9861(86)90360-7; Lai J.C.K., 1989, NEUROMETHODS, P43; Li T, 2010, BBA-BIOENERGETICS, V1797, P52, DOI 10.1016/j.bbabio.2009.07.012; Li V, 2009, EXP NEUROL, V218, P171, DOI 10.1016/j.expneurol.2009.02.007; Mallilankaraman K, 2012, NAT CELL BIOL, V14, P1336, DOI 10.1038/ncb2622; Moon SH, 2012, J BIOL CHEM, V287, P14880, DOI 10.1074/jbc.M111.336776; Murphy AN, 1996, P NATL ACAD SCI USA, V93, P9893, DOI 10.1073/pnas.93.18.9893; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Nicholls DG, 2017, NEUROCHEM INT, V109, P5, DOI 10.1016/j.neuint.2016.12.018; Nichols M, 2017, J CEREBR BLOOD F MET, V37, P3027, DOI 10.1177/0271678X16682250; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; NISHIDA T, 1989, J BIOCHEM-TOKYO, V106, P533, DOI 10.1093/oxfordjournals.jbchem.a122887; Pan X, 2013, NAT CELL BIOL, V15, P1464, DOI 10.1038/ncb2868; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Pellman JJ, 2015, J NEUROCHEM, V134, P652, DOI 10.1111/jnc.13165; Penzo D, 2002, BBA-BIOENERGETICS, V1555, P160, DOI 10.1016/S0005-2728(02)00272-4; Perry GM, 2010, HUM MOL GENET, V19, P3354, DOI 10.1093/hmg/ddq247; Plovanich M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055785; Raffaello A, 2013, EMBO J, V32, P2362, DOI 10.1038/emboj.2013.157; Rustenbeck I, 1996, BBA-LIPID LIPID MET, V1304, P129, DOI 10.1016/S0005-2760(96)00113-0; Sancak Y, 2013, SCIENCE, V342, P1379, DOI 10.1126/science.1242993; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; SCHONFELD P, 1989, BIOCHIM BIOPHYS ACTA, V977, P266, DOI 10.1016/S0005-2728(89)80080-5; Shalbuyeva N, 2006, J BIOL CHEM, V281, P37547, DOI 10.1074/jbc.M607263200; SKULACHEV VP, 1991, FEBS LETT, V294, P158, DOI 10.1016/0014-5793(91)80658-P; SPECTOR AA, 1969, J LIPID RES, V10, P56; Sultan A, 2001, ARCH BIOCHEM BIOPHYS, V386, P37, DOI 10.1006/abbi.2000.2194; VODYANOY I, 1993, BIOPHYS J, V65, P2097, DOI 10.1016/S0006-3495(93)81245-1; Williams GSB, 2013, P NATL ACAD SCI USA, V110, P10479, DOI 10.1073/pnas.1300410110; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; ZURINI M, 1981, EUR J BIOCHEM, V119, P517, DOI 10.1111/j.1432-1033.1981.tb05638.x	67	2	2	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100669	10.1016/j.jbc.2021.100669	http://dx.doi.org/10.1016/j.jbc.2021.100669			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864812	Green Published, gold			2022-12-28	WOS:000672866400640
J	Ricci, D; Tutton, S; Marrocco, I; Ying, MJ; Blumenthal, D; Eletto, D; Vargas, J; Boyle, S; Fazelinia, H; Qian, L; Suresh, K; Taylor, D; Paton, JC; Paton, AW; Tang, CHA; Hu, CCA; Radhakrishnan, R; Gidalevitz, T; Argon, Y				Ricci, Daniela; Tutton, Stephen; Marrocco, Ilaria; Ying, Mingjie; Blumenthal, Daniel; Eletto, Daniela; Vargas, Jade; Boyle, Sarah; Fazelinia, Hossein; Qian, Lei; Suresh, Krishna; Taylor, Deanne; Paton, James C.; Paton, Adrienne W.; Tang, Chih-Hang Anthony; Hu, Chih-Chi Andrew; Radhakrishnan, Ravi; Gidalevitz, Tali; Argon, Yair			An interdomain helix in IRE1 alpha mediates the conformational change required for the sensor's activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM STRESS; ALLOSTERIC INHIBITION; KINASE; IRE1; PATHWAY; SIGNALS; DOMAIN; SITE; DIFFERENTIATION	The unfolded protein response plays an evolutionarily conserved role in homeostasis, and its dysregulation often leads to human disease, including diabetes and cancer. IRE1 alpha is a major transducer that conveys endoplasmic reticulum stress via biochemical signals, yet major gaps persist in our understanding of how the detection of stress is converted to one of several molecular outcomes. It is known that, upon sensing unfolded proteins via its endoplasmic reticulum luminal domain, IRE1 alpha dimerizes and then oligomerizes (often visualized as clustering). Once assembled, the kinase domain trans-autophosphorylates a neighboring IRE1 alpha, inducing a conformational change that activates the RNase effector domain. However, the full details of how the signal is transmitted are not known. Here, we describe a previously unrecognized role for helix aK, located between the kinase and RNase domains of IRE1 alpha, in conveying this critical conformational change. Using constructs containing mutations within this interdomain helix, we show that distinct substitutions affect oligomerization, kinase activity, and the RNase activity of IRE1 alpha differentially. Furthermore, using both biochemical and computational methods, we found that different residues at position 827 specify distinct conformations at distal sites of the protein, such as in the RNase domain. Of importance, an RNase-inactive mutant, L827P, can still dimerize with wildtype monomers, but this mutation inactivates the wildtype molecule and renders leukemic cells more susceptible to stress. We surmise that helix aK is a conduit for the activation of IRE1 alpha in response to stress.	[Ricci, Daniela; Tutton, Stephen; Marrocco, Ilaria; Blumenthal, Daniel; Eletto, Daniela; Vargas, Jade; Boyle, Sarah; Argon, Yair] Childrens Hosp Philadelphia, Div Cell Pathol, Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Ricci, Daniela; Tutton, Stephen; Marrocco, Ilaria; Blumenthal, Daniel; Eletto, Daniela; Vargas, Jade; Boyle, Sarah; Argon, Yair] Univ Penn, Civ Ctr Blvd, Philadelphia, PA 19104 USA; [Ying, Mingjie; Gidalevitz, Tali] Drexel Univ, Dept Biol, Philadelphia, PA 19104 USA; [Fazelinia, Hossein; Qian, Lei; Taylor, Deanne] Childrens Hosp Philadelphia, Dept Biomed & Hlth Informat, Philadelphia, PA 19104 USA; [Suresh, Krishna; Radhakrishnan, Ravi] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Paton, James C.; Paton, Adrienne W.] Univ Adelaide, Res Ctr Infect Dis, Dept Mol & Biomed Sci, Adelaide, SA, Australia; [Tang, Chih-Hang Anthony; Hu, Chih-Chi Andrew] Wistar Inst Anat & Biol, 3601 Spruce St, Philadelphia, PA 19104 USA; [Marrocco, Ilaria] Weizmann Inst Sci, Dept Biol Regulat, Rehovot, Israel; [Eletto, Daniela] Univ Salerno, Salerno, Italy; [Vargas, Jade] Fordham Univ, New York, NY 10023 USA; [Boyle, Sarah] Temple Univ, Philadelphia, PA 19122 USA; [Tang, Chih-Hang Anthony] Methodist Hosp Res Inst, Houston, TX USA; [Tang, Chih-Hang Anthony] Houston Methodist Canc Ctr, Houston, TX USA; [Radhakrishnan, Ravi] Methodist Hosp Res Inst, Houston Methodist Canc Ctr, Ctr Translat Res Hematol Malignancies, Houston, TX USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Drexel University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Adelaide; The Wistar Institute; Weizmann Institute of Science; University of Salerno; Fordham University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital Research Institute	Argon, Y (corresponding author), Childrens Hosp Philadelphia, Div Cell Pathol, Civ Ctr Blvd, Philadelphia, PA 19104 USA.; Argon, Y (corresponding author), Univ Penn, Civ Ctr Blvd, Philadelphia, PA 19104 USA.	yargon@pennmedicine.upenn.edu		Tang, Chih-hang/0000-0002-5097-5709; Vargas, Jade/0000-0001-6536-775X; Hu, Chih-Chi/0000-0001-9024-2932; Qian, Lei/0000-0003-4054-4267; MARROCCO, ILARIA/0000-0002-8225-2177	National Institutes of Health (NIH) [AG18001, GM077480, AG063029]; Italian-American Cancer Foundation; NIH [R21 AI32828, 5 T32 HL 795418]; NCI, NIH [R01CA163910]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Italian-American Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by National Institutes of Health (NIH) grants AG18001 and GM077480 to Y. A., and AG063029 to T. G. D. E. was supported by a postdoctoral fellowship from the Italian-American Cancer Foundation. D. R. was supported by NIH training grant 5 T32 HL 795418. D. B. was supported by NIH grant R21 AI32828. C.-H. A. T. and C.-C. A. H. were supported by NCI, NIH grant R01CA163910. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Ali MMU, 2011, EMBO J, V30, P894, DOI 10.1038/emboj.2011.18; Amin-Wetzel N, 2017, CELL, V171, P1625, DOI 10.1016/j.cell.2017.10.040; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Concha NO, 2015, MOL PHARMACOL, V88, P1011, DOI 10.1124/mol.115.100917; Feldman HC, 2016, ACS CHEM BIOL, V11, P2195, DOI 10.1021/acschembio.5b00940; Gardner BM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013169; Gass JN, 2002, J BIOL CHEM, V277, P49047, DOI 10.1074/jbc.M205011200; Ghosh R, 2014, CELL, V158, P534, DOI 10.1016/j.cell.2014.07.002; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Jiang DD, 2016, MOL CANCER THER, V15, P2055, DOI 10.1158/1535-7163.MCT-15-1023; Jiang DD, 2015, SEMIN CANCER BIOL, V33, P48, DOI 10.1016/j.semcancer.2015.04.010; Jiang H, 2015, CLIN EXP MED, V15, P85, DOI 10.1007/s10238-013-0269-y; Jordan EJ, 2019, CELL MOL LIFE SCI, V76, P2663, DOI 10.1007/s00018-019-03097-2; Kellogg EH, 2011, PROTEINS, V79, P830, DOI 10.1002/prot.22921; Korennykh AV, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-48; Korennykh AV, 2009, NATURE, V457, P687, DOI 10.1038/nature07661; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; Li H, 2010, P NATL ACAD SCI USA, V107, P16113, DOI 10.1073/pnas.1010580107; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Liu CY, 2003, J BIOL CHEM, V278, P17680, DOI 10.1074/jbc.M300418200; Luo J, 2002, P NATL ACAD SCI USA, V99, P16597, DOI 10.1073/pnas.262667599; Molinari A, 2005, CURR TOP MICROBIOL, V300, P1; Ohtsuki T, 1989, Hum Cell, V2, P297; Pandurangan AP, 2017, NUCLEIC ACIDS RES, V45, pW229, DOI 10.1093/nar/gkx439; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Paton AW, 2006, NATURE, V443, P548, DOI 10.1038/nature05124; Pincus D, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000415; Prischi F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4554; Ri M, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.26; Ricci D, 2019, FASEB J, V33, P9811, DOI 10.1096/fj.201801240RR; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Sanches M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5202; Shamu CE, 1996, EMBO J, V15, P3028, DOI 10.1002/j.1460-2075.1996.tb00666.x; Sidrauski C, 1997, CELL, V90, P1031, DOI 10.1016/S0092-8674(00)80369-4; Tam AB, 2014, CELL REP, V9, P850, DOI 10.1016/j.celrep.2014.09.016; Tang CHA, 2018, J CELL BIOL, V217, P1739, DOI 10.1083/jcb.201709137; Tang CHA, 2014, J CLIN INVEST, V124, P2585, DOI 10.1172/JCI73448; Vincenz L, 2013, MOL CANCER THER, V12, P831, DOI 10.1158/1535-7163.MCT-12-0782; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang LK, 2012, NAT CHEM BIOL, V8, P982, DOI [10.1038/NCHEMBIO.1094, 10.1038/nchembio.1094]; Wiseman RL, 2010, MOL CELL, V38, P291, DOI 10.1016/j.molcel.2010.04.001; Xue Z, 2011, J BIOL CHEM, V286, P30859, DOI 10.1074/jbc.M111.273714; Zhou JH, 2006, P NATL ACAD SCI USA, V103, P14343, DOI 10.1073/pnas.0606480103	46	2	2	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100781	10.1016/j.jbc.2021.100781	http://dx.doi.org/10.1016/j.jbc.2021.100781			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34000298	Green Published, gold			2022-12-28	WOS:000674717300003
J	Zhong, ZDA; Michalski, MN; Stevens, PD; Sall, EA; Williams, BO				Zhong, Zhendong A.; Michalski, Megan N.; Stevens, Payton D.; Sall, Emily A.; Williams, Bart O.			Regulation of Wnt receptor activity: Implications for therapeutic development in colon cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							APC TUMOR-SUPPRESSOR; ADVANCED COLORECTAL-CANCER; DROSOPHILA APC2; OVERLAPPING ROLES; NUCLEAR EXPORT; ACTIVATE; ENDOCYTOSIS; MANAGEMENT; PATHWAY; GROWTH	Hyperactivation of Wnt/beta-catenin (canonical) signaling in colorectal cancers (CRCs) was identified in the 1990s. Most CRC patients have mutations in genes that encode components of the Wnt pathway. Inactivating mutations in the adenomatous polyposis coli (APC) gene, which encodes a protein necessary for beta-catenin degradation, are by far the most prevalent. Other Wnt signaling components are mutated in a smaller proportion of CRCs; these include a FZD-specific ubiquitin E3 ligase known as ring finger protein 43 that removes FZDs from the cell membrane. Our understanding of the genetic and epigenetic landscape of CRC has grown exponentially because of contributions from high-throughput sequencing projects such as The Cancer Genome Atlas. Despite this, no Wnt modulators have been successfully developed for CRC-targeted therapies. In this review, we will focus on the Wnt receptor complex, and speculate on recent discoveries about ring finger protein 43regulating Wnt receptors in CRCs. We then review the current debate on a new APC-Wnt receptor interaction model with therapeutic implications.	[Zhong, Zhendong A.; Michalski, Megan N.; Stevens, Payton D.; Sall, Emily A.; Williams, Bart O.] Van Andel Inst, Dept Cell Biol, Grand Rapids, MI 49503 USA	Van Andel Institute	Williams, BO (corresponding author), Van Andel Inst, Dept Cell Biol, Grand Rapids, MI 49503 USA.	bart.williams@vai.org			American Cancer Society	American Cancer Society(American Cancer Society)	P. D. S. is supported by a postdoctoral fellowship from the American Cancer Society.	Ahmed Y, 2002, DEVELOPMENT, V129, P1751; Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777; Akong K, 2002, DEV BIOL, V250, P91, DOI 10.1006/dbio.2002.0776; Alok A, 2017, J CELL SCI, V130, P1532, DOI 10.1242/jcs.198093; Baehs S, 2009, CANCER LETT, V276, P152, DOI 10.1016/j.canlet.2008.11.003; Beta M, 2015, CURR EYE RES, V40, P719, DOI 10.3109/02713683.2014.954673; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Brunt L, 2018, CELL MOL LIFE SCI, V75, P785, DOI 10.1007/s00018-017-2654-2; Brynczka C, 2008, DIFFERENTIATION, V76, P795, DOI 10.1111/j.1432-0436.2007.00261.x; Cabel CR, 2019, DEV CELL, V49, P827, DOI 10.1016/j.devcel.2019.05.039; Cersosimo RJ, 2013, AM J HEALTH-SYST PH, V70, P491, DOI 10.2146/ajhp110532b; Cersosimo RJ, 2013, AM J HEALTH-SYST PH, V70, P395, DOI 10.2146/ajhp110532; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Chee YC, 2018, DEV CELL, V46, P681, DOI 10.1016/j.devcel.2018.07.023; Chen MR, 2019, DEV CELL, V49, P825, DOI 10.1016/j.devcel.2019.05.013; Coombs GS, 2010, J CELL SCI, V123, P3357, DOI 10.1242/jcs.072132; Daly CS, 2017, ONCOGENE, V36, P1793, DOI 10.1038/onc.2016.342; de Lau W, 2014, GENE DEV, V28, P305, DOI 10.1101/gad.235473.113; Fenderico M., 2020, RNF43 TRUNCATING MUT; Flanagan DJ, 2019, CANCER RES, V79, P970, DOI 10.1158/0008-5472.CAN-18-2095; Ganesh S, 2018, MOL THER, V26, P2567, DOI 10.1016/j.ymthe.2018.09.005; Geisinger JM, 2020, NUCLEIC ACIDS RES, V48, P9067, DOI 10.1093/nar/gkaa603; Giannakis M, 2014, NAT GENET, V46, P1264, DOI 10.1038/ng.3127; Greicius G, 2018, P NATL ACAD SCI USA, V115, pE3173, DOI 10.1073/pnas.1713510115; Grumolato L, 2010, GENE DEV, V24, P2517, DOI 10.1101/gad.1957710; Haack F, 2020, J CELL SCI, V133, DOI 10.1242/jcs.243675; Hankey William, 2018, Oncotarget, V9, P31214, DOI 10.18632/oncotarget.25781; Hankey W, 2018, CANCER RES, V78, P617, DOI 10.1158/0008-5472.CAN-17-1357; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; He Y, 2018, DIS MARKERS, V2018, DOI 10.1155/2018/8619462; Henderson BR, 2000, NAT CELL BIOL, V2, P653, DOI 10.1038/35023605; Herr P, 2012, TRENDS MOL MED, V18, P483, DOI 10.1016/j.molmed.2012.06.008; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jo YS, 2015, HUM PATHOL, V46, P1640, DOI 10.1016/j.humpath.2015.07.004; Johnston AD, 2020, CRISPR J, V3, P188, DOI 10.1089/crispr.2019.0077; Kabiri Z, 2014, DEVELOPMENT, V141, P2206, DOI 10.1242/dev.104976; Kleeman SO, 2020, GUT, V69, P1092, DOI 10.1136/gutjnl-2019-319126; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Koo BK, 2015, P NATL ACAD SCI USA, V112, P7548, DOI 10.1073/pnas.1508113112; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lee KH, 2010, P NATL ACAD SCI USA, V107, P69, DOI 10.1073/pnas.0909734107; Li S, 2020, ONCOGENE, V39, P3458, DOI 10.1038/s41388-020-1232-5; Li VSW, 2012, CELL, V149, P1245, DOI 10.1016/j.cell.2012.05.002; Li YQ, 2020, PROTEIN CELL, V11, P292, DOI 10.1007/s13238-020-00691-0; Lorenowicz MJ, 2009, EXP CELL RES, V315, P2683, DOI 10.1016/j.yexcr.2009.06.015; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Madan B, 2016, ONCOGENE, V35, P2197, DOI 10.1038/onc.2015.280; Madan B, 2018, J CLIN INVEST, V128, P5620, DOI 10.1172/JCI122383; Madan B, 2018, BONE RES, V6, DOI 10.1038/s41413-018-0017-8; Masramon L, 2006, J CELL SCI, V119, P1477, DOI 10.1242/jcs.02871; McCartney BM, 1999, J CELL BIOL, V146, P1303, DOI 10.1083/jcb.146.6.1303; McGough IJ, 2018, DEV CELL, V44, P535, DOI 10.1016/j.devcel.2018.02.018; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mohamed NE, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5867-y; Montagnani F, 2011, COLORECTAL DIS, V13, P846, DOI 10.1111/j.1463-1318.2010.02206.x; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Parker TW, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-59899-z; Prosperi JR, 2009, J CELL PHYSIOL, V220, P319, DOI 10.1002/jcp.21766; Qiu WM, 2011, BIOCHEM BIOPH RES CO, V413, P98, DOI 10.1016/j.bbrc.2011.08.061; Rim EY, 2020, MOL BIOL CELL, V31, P1425, DOI 10.1091/mbc.E20-02-0114; Ring L, 2014, CELL SIGNAL, V26, P260, DOI 10.1016/j.cellsig.2013.11.021; Rosin-Arbesfeld R, 2000, NATURE, V406, P1009, DOI 10.1038/35023016; Rosin-Arbesfeld R, 2003, EMBO J, V22, P1101, DOI 10.1093/emboj/cdg105; Saito-Diaz K, 2018, DEV CELL, V44, P566, DOI 10.1016/j.devcel.2018.02.013; Samowitz WS, 1999, CANCER RES, V59, P1442; Schaum N, 2018, NATURE, V562, P367, DOI 10.1038/s41586-018-0590-4; Schell MJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11743; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Steinhart Z, 2017, NAT MED, V23, P60, DOI 10.1038/nm.4219; Suzuki H, 2004, NAT GENET, V36, P417, DOI 10.1038/ng1330; Taelman VF, 2010, CELL, V143, P1136, DOI 10.1016/j.cell.2010.11.034; Tsukiyama T, 2015, MOL CELL BIOL, V35, P2007, DOI 10.1128/MCB.00159-15; Tu JH, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54931-3; van Amerongen R, 2012, DEV BIOL, V369, P101, DOI 10.1016/j.ydbio.2012.06.020; Van Cutsem E, 2014, ANN ONCOL, V25, P1, DOI 10.1093/annonc/mdu260; van Es JH, 1999, CURR BIOL, V9, P105, DOI 10.1016/S0960-9822(99)80024-4; Vera R, 2015, CANCER CHEMOTH PHARM, V76, P659, DOI 10.1007/s00280-015-2808-6; Voloshanenko O, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20641-5; Voloshanenko O, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3610; Wellenstein MD, 2019, NATURE, V572, P538, DOI 10.1038/s41586-019-1450-6; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Xie YH, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0116-z; Xue JL, 2019, BIOMED PHARMACOTHER, V115, DOI 10.1016/j.biopha.2019.108921; Young MA, 2018, STEM CELLS, V36, P114, DOI 10.1002/stem.2712; Zeineldin M, 2013, BBA-REV CANCER, V1836, P80, DOI 10.1016/j.bbcan.2013.01.001	88	6	6	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100782	10.1016/j.jbc.2021.100782	http://dx.doi.org/10.1016/j.jbc.2021.100782			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34000297	gold, Green Published			2022-12-28	WOS:000674717300004
J	Zolov, SN; Imai, H; Losiewicz, MK; Singh, RSJ; Fort, PE; Gardner, TW				Zolov, Sergey N.; Imai, Hisanori; Losiewicz, Mandy K.; Singh, Ravi S. J.; Fort, Patrice E.; Gardner, Thomas W.			Insulin-like growth factor-2 regulates basal retinal insulin receptor activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	The retinal insulin receptor (IR) exhibits basal kinase activity equivalent to that of the liver of fed animals, but unlike the liver, does not fluctuate with feeding and fasting; it also declines rapidly after the onset of insulin-deficient diabetes. The ligand(s) that determine basal IR activity in the retina has not been identified. Using a highly sensitive insulin assay, we found that retinal insulin concentrations remain constant in fed versus fasted rats and in diabetic versus control rats; vitreous fluid insulin levels were undetectable. Neutralizing antibodies against insulin-like growth factor 2 (IGF-2), but not insulin-like growth factor 1 (IGF-1) or insulin, decreased IR kinase activity in normal rat retinas, and depletion of IGF-2 from serum specifically reduced IR phosphorylation in retinal cells. Immunoprecipitation studies demonstrated that IGF-2 induced greater phosphorylation of the retinal IR than the IGF-1 receptor. Retinal IGF-2 mRNA content was 10-fold higher in adults than pups and orders of magnitude higher than in liver. Diabetes reduced retinal IGF-2, but not IGF-1 or IR, mRNA levels, and reduced IGF-2 and IGF-1 content in vitreous fluid. Finally, intravitreal administration of IGF-2 (mature and pro-forms) increased retinal IR and Akt kinase activity in diabetic rats. Collectively, these data reveal that IGF-2 is the primary ligand that defines basal retinal IR activity and suggest that reduced ocular IGF-2 may contribute to reduced IR activity in response to diabetes. These findings may have importance for understanding the regulation of metabolic and prosurvival signaling in the retina.	[Zolov, Sergey N.; Losiewicz, Mandy K.; Fort, Patrice E.; Gardner, Thomas W.] Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA; [Zolov, Sergey N.; Gardner, Thomas W.] Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Zolov, Sergey N.] Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Imai, Hisanori] Kobe Univ, Dept Ophthalmol, Med Sch, Kobe, Hyogo, Japan; [Singh, Ravi S. J.] Retina Associates, Kansas City, MO USA; [Fort, Patrice E.; Gardner, Thomas W.] Univ Michigan, Dept Mol & Integrat Physiol, Sch Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Kobe University; University of Michigan System; University of Michigan	Zolov, SN (corresponding author), Univ Michigan, Sch Med, Dept Ophthalmol & Visual Sci, Ann Arbor, MI 48109 USA.; Zolov, SN (corresponding author), Univ Michigan, Sch Med, Dept Internal Med, Ann Arbor, MI 48109 USA.; Zolov, SN (corresponding author), Univ Michigan, Sch Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA.	zolov@med.umich.edu			JDRF Center of Excellence at the University of Michigan; A. Alfred Taubman Medical Research Institute; Research to Prevent Blindness [R01EY20582, R24DK082841, P30EY007003]	JDRF Center of Excellence at the University of Michigan; A. Alfred Taubman Medical Research Institute; Research to Prevent Blindness(Research to Prevent Blindness (RPB))	The study was supported by the JDRF Center of Excellence at the University of Michigan, The A. Alfred Taubman Medical Research Institute, and an Unrestricted Grant from Research to Prevent Blindness, R01EY20582 and R24DK082841 (T. W. G. and P. E. F.), and P30EY007003.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100712	10.1016/j.jbc.2021.100712	http://dx.doi.org/10.1016/j.jbc.2021.100712			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33915127	Green Published, gold			2022-12-28	WOS:000672866400683
J	Madland, E; Forsberg, Z; Wang, Y; Lindorff-Larsen, K; Niebisch, A; Modregger, J; Eijsink, VGH; Aachmann, FL; Courtade, G				Madland, Eva; Forsberg, Zarah; Wang, Yong; Lindorff-Larsen, Kresten; Niebisch, Axel; Modregger, Jan; Eijsink, Vincent G. H.; Aachmann, Finn L.; Courtade, Gaston			Structural and functional variation of chitin-binding domains of a lytic polysaccharide monooxygenase from Cellvibrio japonicus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERRATIA-MARCESCENS; CRYSTAL-STRUCTURE; ENDOGLUCANASE Z; MOLECULAR-BASIS; CELLULOSE; CLEAVAGE; FORCE; DEGRADATION; FAMILY; DETERMINANTS	Among the extensive repertoire of carbohydrate-active enzymes, lytic polysaccharide monooxygenases (LPMOs) have a key role in recalcitrant biomass degradation. LPMOs are copper-dependent enzymes that catalyze oxidative cleavage of glycosidic bonds in polysaccharides such as cellulose and chitin. Several LPMOs contain carbohydrate-binding modules (CBMs) that are known to promote LPMO efficiency. However, structural and functional properties of some CBMs remain unknown, and it is not clear why some LPMOs, like CjLPMO10A from the soil bacterium Cellvibrio japonicus, have multiple CBMs (CjCBM5 and CjCBM73). Here, we studied substrate binding by these two CBMs to shine light on their functional variation and determined the solution structures of both by NMR, which constitutes the first structure of a member of the CBM73 family. Chitin-binding experiments and molecular dynamics simulations showed that, while both CBMs bind crystalline chitin with Kd values in the micromolar range, CjCBM73 has higher affinity for chitin than CjCBM5. Furthermore, NMR titration experiments showed that CjCBM5 binds soluble chitohexaose, whereas no binding of CjCBM73 to this chitooligosaccharide was detected. These functional differences correlate with distinctly different arrangements of three conserved aromatic amino acids involved in substrate binding. In CjCBM5, these residues show a linear arrangement that seems compatible with the experimentally observed affinity for single chitin chains. On the other hand, the arrangement of these residues in CjCBM73 suggests a wider binding surface that may interact with several chitin chains. Taken together, these results provide insight into natural variation among related chitin-binding CBMs and the possible functional implications of such variation.	[Madland, Eva; Aachmann, Finn L.; Courtade, Gaston] NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Norwegian Biopolymer Lab NOBIPOL, Trondheim, Norway; [Forsberg, Zarah; Eijsink, Vincent G. H.] Norwegian Univ Life Sci NMBU, Fac Chem Biotechnol & Food Sci, As, Norway; [Wang, Yong; Lindorff-Larsen, Kresten] Univ Copenhagen, Linderstrom Lang Ctr Prot Sci, Dept Biol, Struct Biol & NMR Lab, Copenhagen, Denmark; [Niebisch, Axel; Modregger, Jan] Eucodis Biosci GmbH, Vienna, Austria	Norwegian University of Science & Technology (NTNU); Norwegian University of Life Sciences; University of Copenhagen	Courtade, G (corresponding author), NTNU Norwegian Univ Sci & Technol, Dept Biotechnol & Food Sci, Norwegian Biopolymer Lab NOBIPOL, Trondheim, Norway.	gaston.courtade@ntnu.no	Wang, Yong/J-3990-2012; Lindorff-Larsen, Kresten/K-6469-2014	Wang, Yong/0000-0001-9156-0377; Forsberg, Zarah/0000-0002-8236-7986; Modregger, Jan/0000-0001-6209-5891; Lindorff-Larsen, Kresten/0000-0002-4750-6039; Eijsink, Vincent/0000-0002-9220-8743; Courtade, Gaston/0000-0002-1644-3223	Novo Nordisk Foundation [NNF18OC0055736, NNF18OC0032242]; BRAINSTRUC structural biology initiative from the Lundbeck Foundation	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); BRAINSTRUC structural biology initiative from the Lundbeck Foundation	This work was funded by The Novo Nordisk Foundation, project numbers NNF18OC0055736 (to Z. F.) and NNF18OC0032242 (to G. C.). Y. W. and K. L.-L. were supported by the BRAINSTRUC structural biology initiative from the Lundbeck Foundation.	Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Agger JW, 2014, P NATL ACAD SCI USA, V111, P6287, DOI 10.1073/pnas.1323629111; Akagi K, 2006, J BIOCHEM, V139, P483, DOI 10.1093/jb/mvj062; Barducci A, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.020603; Bayer EA, 1998, CURR OPIN STRUC BIOL, V8, P548, DOI 10.1016/S0959-440X(98)80143-7; Bayer EA, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P578, DOI 10.1007/0-387-30742-7_19; Bissaro B, 2017, NAT CHEM BIOL, V13, P1123, DOI [10.1038/NCHEMBIO.2470, 10.1038/nchembio.2470]; Bonomi M, 2019, NAT METHODS, V16, P670, DOI 10.1038/s41592-019-0506-8; Bonomi M, 2009, COMPUT PHYS COMMUN, V180, P1961, DOI 10.1016/j.cpc.2009.05.011; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brun E, 1997, BIOCHEMISTRY-US, V36, P16074, DOI 10.1021/bi9718494; Brunecky R, 2013, SCIENCE, V342, P1513, DOI 10.1126/science.1244273; BRURBERG MB, 1994, FEMS MICROBIOL LETT, V124, P399, DOI 10.1016/0378-1097(94)00462-5; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; Carrard G, 2000, P NATL ACAD SCI USA, V97, P10342, DOI 10.1073/pnas.160216697; Chalak A, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1548-y; Courtade G, 2018, J BIOL CHEM, V293, P13006, DOI 10.1074/jbc.RA118.004269; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; de Jong DH, 2013, J CHEM THEORY COMPUT, V9, P687, DOI 10.1021/ct300646g; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Eibinger M, 2014, J BIOL CHEM, V289, P35929, DOI 10.1074/jbc.M114.602227; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; FLYVBJERG H, 1989, J CHEM PHYS, V91, P461, DOI 10.1063/1.457480; Forsberg Z, 2018, J BIOL CHEM, V293, P1397, DOI 10.1074/jbc.M117.817130; Forsberg Z, 2016, J BIOL CHEM, V291, P7300, DOI 10.1074/jbc.M115.700161; Forsberg Z, 2011, PROTEIN SCI, V20, P1479, DOI 10.1002/pro.689; Frandsen KEH, 2016, NAT CHEM BIOL, V12, P298, DOI [10.1038/NCHEMBIO.2029, 10.1038/nchembio.2029]; Gilbert HJ, 2013, CURR OPIN STRUC BIOL, V23, P669, DOI 10.1016/j.sbi.2013.05.005; GOODAY GW, 1990, ADV MICROB ECOL, V11, P387; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Hara M, 2013, J BIOCHEM, V154, P185, DOI 10.1093/jb/mvt043; Hemsworth GR, 2013, J AM CHEM SOC, V135, P6069, DOI 10.1021/ja402106e; Heuts DPHM, 2008, BIOCHEM J, V413, P175, DOI 10.1042/BJ20071591; Hudson KL, 2015, J AM CHEM SOC, V137, P15152, DOI 10.1021/jacs.5b08424; Hult EL, 2005, BIOCHEM J, V388, P851, DOI 10.1042/BJ20050090; Huynh Kathy, 2015, Curr Protoc Protein Sci, V79, DOI 10.1002/0471140864.ps2809s79; Igarashi K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4975; Ikegami T, 2000, J BIOL CHEM, V275, P13654, DOI 10.1074/jbc.275.18.13654; Isaksen T, 2014, J BIOL CHEM, V289, P2632, DOI 10.1074/jbc.M113.530196; Itoh Y, 2002, BIOSCI BIOTECH BIOCH, V66, P1084, DOI 10.1271/bbb.66.1084; Keller R., 2004, COMPUTER AIDED RESON, V1; Kikkawa Y, 2008, BIOMACROMOLECULES, V9, P2126, DOI 10.1021/bm800162x; Kittl R, 2012, BIOTECHNOL BIOFUELS, V5, DOI 10.1186/1754-6834-5-79; Kracher D, 2018, J BIOL CHEM, V293, P1676, DOI 10.1074/jbc.RA117.000109; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Larsen AH, 2020, PLOS COMPUT BIOL, V16, DOI [10.1371/journal.pcbi.1007870, 10.1371/journal.pcbi.1007870.r001, 10.1371/journal.pcbi.1007870.r002, 10.1371/journal.pcbi.1007870.r003, 10.1371/journal.pcbi.1007870.r004]; Lehtio J, 2003, P NATL ACAD SCI USA, V100, P484, DOI 10.1073/pnas.212651999; Lescop E, 2007, J MAGN RESON, V187, P163, DOI 10.1016/j.jmr.2007.04.002; Levasseur A, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-41; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Loose JSM, 2014, FEBS LETT, V588, P3435, DOI 10.1016/j.febslet.2014.07.036; Malecki PH, 2013, ACTA CRYSTALLOGR D, V69, P821, DOI 10.1107/S0907444913002011; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; Mattinen ML, 1997, PROTEIN SCI, V6, P294; Mekasha S, 2020, J BIOL CHEM, V295, P9134, DOI 10.1074/jbc.RA120.013040; Mine S, 2014, J BIOCHEM, V155, P115, DOI 10.1093/jb/mvt104; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Mulder FAA, 1999, J MOL BIOL, V292, P111, DOI 10.1006/jmbi.1999.3034; Mutahir Z, 2018, FEBS LETT, V592, P2562, DOI 10.1002/1873-3468.13189; Nagy T, 1998, FEBS LETT, V429, P312, DOI 10.1016/S0014-5793(98)00625-5; Nakagawa YS, 2013, J AGR FOOD CHEM, V61, P11061, DOI 10.1021/jf402743e; Pall S, 2013, COMPUT PHYS COMMUN, V184, P2641, DOI 10.1016/j.cpc.2013.06.003; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Periole X, 2009, J CHEM THEORY COMPUT, V5, P2531, DOI 10.1021/ct9002114; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips CM, 2011, ACS CHEM BIOL, V6, P1399, DOI 10.1021/cb200351y; Quinlan RJ, 2011, P NATL ACAD SCI USA, V108, P15079, DOI 10.1073/pnas.1105776108; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sikorski P, 2009, BIOMACROMOLECULES, V10, P1100, DOI 10.1021/bm801251e; Simpson HD, 1999, J BACTERIOL, V181, P4611, DOI 10.1128/JB.181.15.4611-4616.1999; Stepnov AA, 2021, BIOTECHNOL BIOFUELS, V14, DOI 10.1186/s13068-021-01879-0; Tiwary P, 2015, J PHYS CHEM B, V119, P736, DOI 10.1021/jp504920s; Tormo J, 1996, EMBO J, V15, P5739, DOI 10.1002/j.1460-2075.1996.tb00960.x; Tribello GA, 2014, COMPUT PHYS COMMUN, V185, P604, DOI 10.1016/j.cpc.2013.09.018; Tuveng TR, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01834-5; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P28492, DOI 10.1074/jbc.M504468200; Vaaje-Kolstad G, 2005, J BIOL CHEM, V280, P11313, DOI 10.1074/jbc.M407175200; Vaaje-Kolstad G, 2017, CURR OPIN STRUC BIOL, V44, P67, DOI 10.1016/j.sbi.2016.12.012; Vaaje-Kolstad G, 2013, FEBS J, V280, P3028, DOI 10.1111/febs.12181; Vaaje-Kolstad G, 2010, SCIENCE, V330, P219, DOI 10.1126/science.1192231; van Aalten DMF, 2000, P NATL ACAD SCI USA, V97, P5842, DOI 10.1073/pnas.97.11.5842; Vermaas JV, 2015, J PHYS CHEM B, V119, P6129, DOI 10.1021/acs.jpcb.5b00778; Vickery ON, 2021, J CHEM THEORY COMPUT, V17, P6472, DOI 10.1021/acs.jctc.1c00295; Vu VV, 2014, P NATL ACAD SCI USA, V111, P13822, DOI 10.1073/pnas.1408090111; XU GY, 1995, BIOCHEMISTRY-US, V34, P6993, DOI 10.1021/bi00021a011; Yu ZC, 2015, J MOL MODEL, V21, DOI 10.1007/s00894-015-2670-9; Zhang HY, 2003, J BIOMOL NMR, V25, P173, DOI 10.1023/A:1022836027055	91	0	0	7	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101084	10.1016/j.jbc.2021.101084	http://dx.doi.org/10.1016/j.jbc.2021.101084			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	YZ2PR	34411561	gold, Green Published			2022-12-28	WOS:000755323700003
J	Anikeeva, N; Panteleev, S; Mazzanti, NW; Terai, M; Sato, T; Sykulev, Y				Anikeeva, Nadia; Panteleev, Sergey; Mazzanti, Nicholas W.; Terai, Mizue; Sato, Takami; Sykulev, Yuri			Efficient killing of tumor cells by CAR-T cells requires greater number of engaged CARs than TCRs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYTOLYTIC ACTIVITY; TARGET-CELL; ANTIGEN; RECEPTOR; MECHANISMS; AFFINITY; PROTEIN; IMMUNOTHERAPY; GRANULES; KINETICS	Although CAR-T cells are widely used to treat cancer, efficiency of CAR-T cell cytolytic responses has not been carefully examined. We engineered CAR specific for HMW-MAA (high molecular-weight melanoma-associated antigen) and evaluated potency of CD8+ CAR-T cells to release cytolytic granules and to kill tissue-derived melanoma cells, which express different levels of HMW-MAA. CAR-T cells efficiently killed melanoma cells expressing high level of HMW-MAA, but not melanoma cells with lower levels of HMW-MAA. The same melanoma cells presenting significantly lower level of stimulatory peptideMHC ligand were readily lysed by T cells transduced with genes encoding alpha,beta-TCR specific for the peptide-MHC ligand. The data suggest that higher level of targeted molecules is required to engage a larger number of CARs than TCRs to induce efficient cytolytic granule release and destruction of melanoma cells. Understanding the difference in molecular mechanisms controlling activation thresholds of CAR- versus TCR-mediated responses will contribute to improving efficiency of CAR T cells required to eliminate solid tumors presenting low levels of targeted molecules.	[Anikeeva, Nadia; Panteleev, Sergey; Mazzanti, Nicholas W.; Sykulev, Yuri] Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA; [Terai, Mizue; Sato, Takami; Sykulev, Yuri] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Sato, Takami; Sykulev, Yuri] Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Jefferson University; Jefferson University; Jefferson University	Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.; Sykulev, Y (corresponding author), Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA.; Sykulev, Y (corresponding author), Thomas Jefferson Univ, Sidney Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	Yuri.Sykulev@Jefferson.edu	Terai, Mizue/GOG-8566-2022	Terai, Mizue/0000-0003-2672-9468; Anikeeva, Nadia/0000-0003-1494-6270; Sykulev, Yuri/0000-0002-9685-0223	Dean's Transformational Science Award Grant (Thomas Jefferson University, United States); Hasumi International Research Foundation (Japan)	Dean's Transformational Science Award Grant (Thomas Jefferson University, United States); Hasumi International Research Foundation (Japan)	This work was supported by The Dean's Transformational Science Award Grant (Thomas Jefferson University, United States) to T. S. and Y. S. and by the grant from Hasumi International Research Foundation (Japan) to T. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amara S, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030650; Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Anikeeva N, 2003, BIOCHEMISTRY-US, V42, P4709, DOI 10.1021/bi026864+; Anikeeva N, 2006, P NATL ACAD SCI USA, V103, P16846, DOI 10.1073/pnas.0607771103; Anikeeva N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041466; Anikeeva N, 2011, IMMUNOL RES, V51, P183, DOI 10.1007/s12026-011-8252-8; Beal AM, 2008, J IMMUNOL, V181, P4815, DOI 10.4049/jimmunol.181.7.4815; Beal AM, 2009, IMMUNITY, V31, P632, DOI 10.1016/j.immuni.2009.09.004; Cabrera T, 2003, CANCER IMMUNOL IMMUN, V52, P1, DOI 10.1007/s00262-002-0332-0; Caramalho I, 2009, J CELL MOL MED, V13, P3834, DOI 10.1111/j.1582-4934.2008.00586.x; Chang CC, 2004, ANN NY ACAD SCI, V1028, P340, DOI 10.1196/annals.1322.040; Combs J, 2006, P NATL ACAD SCI USA, V103, P14883, DOI 10.1073/pnas.0600914103; Davenport AJ, 2018, P NATL ACAD SCI USA, V115, pE2068, DOI 10.1073/pnas.1716266115; Engels B, 2012, MOL THER, V20, P652, DOI 10.1038/mt.2011.286; Feins S, 2019, AM J HEMATOL, V94, pS3, DOI 10.1002/ajh.25418; Gakamsky DM, 2000, BIOCHEMISTRY-US, V39, P11163, DOI 10.1021/bi000763z; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Gudipati V, 2020, NAT IMMUNOL, V21, P848, DOI 10.1038/s41590-020-0719-0; Harris DT, 2018, J IMMUNOL, V200, P1088, DOI 10.4049/jimmunol.1700236; Hay KA, 2017, DRUGS, V77, P237, DOI 10.1007/s40265-017-0690-8; HENKART PA, 1984, J EXP MED, V160, P75, DOI 10.1084/jem.160.1.75; Ioannidou K, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02115; Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4; Linette GP, 2013, BLOOD, V122, P863, DOI 10.1182/blood-2013-03-490565; Ma S, 2019, INT J BIOL SCI, V15, P2548, DOI 10.7150/ijbs.34213; Martinez M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00128; Morgan RA, 2010, MOL THER, V18, P843, DOI 10.1038/mt.2010.24; Pillai V, 2019, BLOOD ADV, V3, P3539, DOI 10.1182/bloodadvances.2019000692; Ruiz-Cabello F, 2002, SEMIN CANCER BIOL, V12, P15, DOI 10.1006/scbi.2001.0406; Scarfo I, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0230-9; Schreiber RD, 2011, SCIENCE, V331, P1565, DOI 10.1126/science.1203486; Schuster SJ, 2017, NEW ENGL J MED, V377, P2545, DOI 10.1056/NEJMoa1708566; Scotto M, 2012, DIABETES, V61, P2546, DOI 10.2337/db12-0136; Seliger B, 2002, SEMIN CANCER BIOL, V12, P3, DOI 10.1006/scbi.2001.0404; Sidney J, 1997, HUM IMMUNOL, V58, P12, DOI 10.1016/S0198-8859(97)00206-1; Steblyanko M, 2015, J BIOL CHEM, V290, P11833, DOI 10.1074/jbc.M114.614719; Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071; Stone JD, 2015, CURR OPIN IMMUNOL, V33, P16, DOI 10.1016/j.coi.2015.01.003; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Sykulev Y, 1995, P NATL ACAD SCI USA, V92, P11990, DOI 10.1073/pnas.92.26.11990; SYKULEV Y, 1994, IMMUNITY, V1, P15, DOI 10.1016/1074-7613(94)90005-1; Sykulev Y, 1998, IMMUNITY, V9, P475, DOI 10.1016/S1074-7613(00)80631-7; Sykulev Y, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3153pe50; TSOMIDES TJ, 1991, P NATL ACAD SCI USA, V88, P11276, DOI 10.1073/pnas.88.24.11276; Vesely MD, 2013, ANN NY ACAD SCI, V1284, P1, DOI 10.1111/nyas.12105; Wang X., 2010, International Bureau of World Intellectual Property Organization, Patent No. [WO 2010/045495 A2, 2010045495]; Wang XH, 2011, CANCER RES, V71, P7410, DOI 10.1158/0008-5472.CAN-10-1134; Wei SC, 2018, CANCER DISCOV, V8, P1069, DOI 10.1158/2159-8290.CD-18-0367; Zhang C, 2017, BIOMARK RES, V5, DOI 10.1186/s40364-017-0102-y	50	3	3	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101033	10.1016/j.jbc.2021.101033	http://dx.doi.org/10.1016/j.jbc.2021.101033			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34371020	Green Published, gold			2022-12-28	WOS:000704369100004
J	Arshad, H; Patel, Z; Mehrabian, M; Bourkas, MEC; Al-Azzawi, ZAM; Schmitt-Ulms, G; Watts, JC				Arshad, Hamza; Patel, Zeel; Mehrabian, Mohadeseh; Bourkas, Matthew E. C.; Al-Azzawi, Zaid A. M.; Schmitt-Ulms, Gerold; Watts, Joel C.			The aminoglycoside G418 hinders de novo prion infection in cultured cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CREUTZFELDT-JAKOB-DISEASE; CHRONIC WASTING DISEASE; SPONGIFORM ENCEPHALOPATHY; SCRAPIE INFECTION; PROTEIN; LINE; PROPAGATION; STRAINS; THERAPEUTICS; RESISTANCE	The study of prions and the discovery of candidate therapeutics for prion disease have been facilitated by the ability of prions to replicate in cultured cells. Paradigms in which prion proteins from different species are expressed in cells with low or no expression of endogenous prion protein (PrP) have expanded the range of prion strains that can be propagated. In these systems, cells stably expressing a PrP of interest are typically generated via coexpression of a selectable marker and treatment with an antibiotic. Here, we report the unexpected discovery that the aminoglycoside G418 (Geneticin) interferes with the ability of stably transfected cultured cells to become infected with prions. In G418-resistant lines of N2a or CAD5 cells, the presence of G418 reduced levels of protease-resistant PrP following challenge with the RAIL or 22L strains of mouse prions. G418 also interfered with the infection of cells expressing hamster PrP with the 263K strain of hamster prions. Interestingly, G418 had minimal to no effect on proteaseresistant PrP levels in cells with established prion infection, arguing that G418 selectively interferes with de novo prion infection. As G418 treatment had no discernible effect on cellular PrP levels or its localization, this suggests that G418 may specifically target prion assemblies or processes involved in the earliest stages of prion infection.	[Arshad, Hamza; Patel, Zeel; Mehrabian, Mohadeseh; Bourkas, Matthew E. C.; Al-Azzawi, Zaid A. M.; Schmitt-Ulms, Gerold; Watts, Joel C.] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Arshad, Hamza; Bourkas, Matthew E. C.; Al-Azzawi, Zaid A. M.; Watts, Joel C.] Univ Toronto, Dept Biochem, Toronto, ON, Canada; [Mehrabian, Mohadeseh; Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Mehrabian, Mohadeseh] Sangamo Therapeut, Brisbane, CA USA	University of Toronto; University of Toronto; University of Toronto	Watts, JC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada.; Watts, JC (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	joel.watts@utoronto.ca		Schmitt-Ulms, Gerold/0000-0001-6962-0919; Watts, Joel/0000-0002-2604-2925	NSERC	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	Z. P. and Z. A. M. A.-A. were supported by NSERC undergraduate student research awards.	Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Arosio P, 2015, PHYS CHEM CHEM PHYS, V17, P7606, DOI 10.1039/c4cp05563b; Avar M, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000814; Berry DB, 2013, P NATL ACAD SCI USA, V110, pE4160, DOI 10.1073/pnas.1317164110; Bian JF, 2010, J VIROL, V84, P8322, DOI 10.1128/JVI.00633-10; Biasini E, 2013, J NEUROSCI, V33, P2408, DOI 10.1523/JNEUROSCI.3406-12.2013; Bidou L, 2012, TRENDS MOL MED, V18, P679, DOI 10.1016/j.molmed.2012.09.008; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; Bosque PJ, 2000, J VIROL, V74, P4377, DOI 10.1128/JVI.74.9.4377-4386.2000; Bourkas MEC, 2019, J BIOL CHEM, V294, P4911, DOI 10.1074/jbc.RA118.007135; Brandner S, 2017, ACTA NEUROPATHOL, V133, P197, DOI 10.1007/s00401-017-1670-5; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; Colby DW, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a006833; Courageot MP, 2008, J GEN VIROL, V89, P341, DOI 10.1099/vir.0.83344-0; De Luigi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001888; Demaimay R, 1997, J VIROL, V71, P9685, DOI 10.1128/JVI.71.12.9685-9689.1997; Duesberg P, 2000, P NATL ACAD SCI USA, V97, P14295, DOI 10.1073/pnas.97.26.14295; Fang C, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005623; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Forloni G, 2002, P NATL ACAD SCI USA, V99, P10849, DOI 10.1073/pnas.162195499; Ghaemmaghami S, 2007, P NATL ACAD SCI USA, V104, P17971, DOI 10.1073/pnas.0708372104; Ghaemmaghami S, 2010, J VIROL, V84, P3408, DOI 10.1128/JVI.02145-09; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Giles K, 2016, J PHARMACOL EXP THER, V358, P537, DOI 10.1124/jpet.116.235556; Giles K, 2015, J PHARMACOL EXP THER, V355, P2, DOI 10.1124/jpet.115.224659; Gousset K, 2009, NAT CELL BIOL, V11, P328, DOI 10.1038/ncb1841; Grassmann A, 2013, VIRUSES-BASEL, V5, P374, DOI 10.3390/v5010374; Haik S, 2014, LANCET NEUROL, V13, P150, DOI 10.1016/S1474-4422(13)70307-7; Hatin Isabelle, 2001, Cellular and Molecular Biology Online Papers, V47, pOL23; Herbst A, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003755; Imberdis T, 2016, J BIOL CHEM, V291, P26164, DOI 10.1074/jbc.M116.745612; JIMENEZ A, 1980, NATURE, V287, P869, DOI 10.1038/287869a0; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Krance SH, 2020, J NEUROCHEM, V153, P150, DOI 10.1111/jnc.14956; Kung M, 1997, FEBS LETT, V409, P333, DOI 10.1016/S0014-5793(97)00452-3; Li JL, 2010, SCIENCE, V327, P869, DOI 10.1126/science.1183218; Liang JJ, 2012, PRION, V6, DOI 10.4161/pri.22511; Lu D, 2013, J PHARMACOL EXP THER, V347, P325, DOI 10.1124/jpet.113.205799; Maas E, 2007, J BIOL CHEM, V282, P18702, DOI 10.1074/jbc.M701309200; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; Mange A, 2000, J VIROL, V74, P3135, DOI 10.1128/JVI.74.7.3135-3140.2000; Marshall KE, 2017, J VIROL, V91, DOI 10.1128/JVI.01686-16; Massignan T, 2010, J BIOL CHEM, V285, P7752, DOI 10.1074/jbc.M109.064949; MASULLO C, 1992, J INFECT DIS, V165, P784, DOI 10.1093/infdis/165.4.784; MCKENZIE D, 1994, J VIROL, V68, P7534, DOI 10.1128/JVI.68.11.7534-7536.1994; Mehrabian M, 2016, ASN NEURO, V8, DOI 10.1177/1759091416679074; Mehrabian M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114594; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nishida N, 2000, J VIROL, V74, P320, DOI 10.1128/JVI.74.1.320-325.2000; Oelschlegel AM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003158; Oelschlegel AM, 2012, J VIROL, V86, P5297, DOI 10.1128/JVI.00181-12; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; Orru CD, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8050140; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Polymenidou M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003872; Poncet-Montange G, 2011, J BIOL CHEM, V286, P27718, DOI 10.1074/jbc.M111.234393; Prokhorova I, 2017, P NATL ACAD SCI USA, V114, pE10899, DOI 10.1073/pnas.1715501114; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Qi YP, 1997, J NEUROSCI, V17, P1217; RACE RE, 1987, J GEN VIROL, V68, P1391, DOI 10.1099/0022-1317-68-5-1391; Raymond GJ, 2006, J VIROL, V80, P596, DOI 10.1128/JVI.80.2.596-604.2006; Reidenbach AG, 2020, J BIOL CHEM, V295, P13516, DOI 10.1074/jbc.RA120.014905; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Safar JG, 2005, P NATL ACAD SCI USA, V102, P3501, DOI 10.1073/pnas.0409651102; Safar JG, 2002, NAT BIOTECHNOL, V20, P1147, DOI 10.1038/nbt748; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Sandberg MK, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5347; Sandberg MK, 2011, NATURE, V470, P540, DOI 10.1038/nature09768; Schatzl HM, 1997, J VIROL, V71, P8821; Scheckel C, 2018, NAT REV GENET, V19, P405, DOI 10.1038/s41576-018-0011-4; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Solomon IH, 2010, J BIOL CHEM, V285, P26719, DOI 10.1074/jbc.M110.134619; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SURI C, 1993, J NEUROSCI, V13, P1280; TARABOULOS A, 1990, J CELL BIOL, V110, P2117, DOI 10.1083/jcb.110.6.2117; Tark D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115939; Trevitt CR, 2006, BRAIN, V129, P2241, DOI 10.1093/brain/awl150; Varges D, 2017, J NEUROL NEUROSUR PS, V88, P119, DOI 10.1136/jnnp-2016-313541; Vilette D, 2001, P NATL ACAD SCI USA, V98, P4055, DOI 10.1073/pnas.061337998; Vorberg I, 2004, J INFECT DIS, V189, P431, DOI 10.1086/381166; Walia R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47629-z; Wangen JR, 2020, ELIFE, V9, DOI 10.7554/eLife.52611; Watts JC, 2018, ACTA NEUROPATHOL, V135, P159, DOI 10.1007/s00401-017-1790-y; Watts JC, 2014, J BIOL CHEM, V289, P19841, DOI 10.1074/jbc.R114.550707; Westergard L, 2011, J BIOL CHEM, V286, P44234, DOI 10.1074/jbc.M111.286195; Wilham JM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001217; Wille H, 2009, P NATL ACAD SCI USA, V106, P16990, DOI 10.1073/pnas.0909006106; Williamson RA, 1998, J VIROL, V72, P9413, DOI 10.1128/JVI.72.11.9413-9418.1998	90	2	2	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101073	10.1016/j.jbc.2021.101073	http://dx.doi.org/10.1016/j.jbc.2021.101073			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34390689	gold, Green Published			2022-12-28	WOS:000714635500004
J	Shi, S; Ma, B; Sun, FD; Qu, C; An, HL				Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; An, Hailong			Theaflavin binds to a druggable pocket of TMEM16A channel and inhibits lung adenocarcinoma cell viability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHLORIDE CHANNELS; SWISS-MODEL; CONTRIBUTES	As a calcium-activated chloride channel regulated by the intracellular Ca2+ concentration and membrane potential, TMEM16A has attracted considerable attention and has been proposed as a novel anticancer drug target. We have previously reported that the pocket above the ion conductance pore could be a nonselective inhibitor-binding pocket. However, whether this pocket is druggable remains unexplored. In this study, we performed virtual screening to target the presumed inhibitor binding pocket and identified a highly effective TMEM16A inhibitor, theaflavin (TF: a tea polyphenol in black tea). Molecular dynamics simulations revealed that theaflavin adopts a "wedge insertion mode" to block the ion conduction pore and induces pore closure. Moreover, the binding mode showed that the TF pedestal plays an important role in pore blockade, and R515, R535, T539, K603, E623, and E633 were determined to be most likely to interact directly with the pedestal. Mutagenesis experiment results corroborated the mechanism through which TF binds to this pocket. Combined with the quantitative calculation results, our data indicated that the three hydroxyl groups on the pedestal may be the most crucial pharmacophores for TMEM16A inhibition by TF. Finally, antitumor experiments revealed that TF could target TMEM16A to inhibit the proliferation and migration of LA795 cells, indicating the potential therapeutic effect of TF on the growth of lung adenocarcinoma with high TMEM16A expression. The successful application of drug screening strategies based on this binding pocket highlights new directions for discovering superior modulators and contributes to the development of novel therapeutics for lung adenocarcinoma.	[Shi, Sai; Ma, Biao; Qu, Chang; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Qu, Chang; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China; [Shi, Sai; Ma, Biao; Sun, Fude; Qu, Chang; An, Hailong] Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Peoples R China	Hebei University of Technology; Hebei University of Technology; Hebei University of Technology	An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, State Key Lab Reliabil & Intelligence Elect Equip, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Electromagnet Field & Elect Apparat Relia, Tianjin, Peoples R China.; An, HL (corresponding author), Hebei Univ Technol, Sch Sci, Inst Biophys, Key Lab Mol Biophys, Tianjin, Peoples R China.	hailong_an@163.com			National Natural Science Foundation of China [81830061]; Natural Science Foundation of Tianjin of China [19JCYBJC28300]; Natural Science Foundation of Hebei Province of China [H2020202005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Tianjin of China(Natural Science Foundation of Tianjin); Natural Science Foundation of Hebei Province of China(Natural Science Foundation of Hebei Province)	This work was supported by the National Natural Science Foundation of China (Grant No. 81830061 to H. A.), the Natural Science Foundation of Tianjin of China (Grant No. 19JCYBJC28300 to H. A.), the Natural Science Foundation of Hebei Province of China (Grant No. H2020202005 to H. A.).	Ben Chorin A, 2020, PROTEIN SCI, V29, P258, DOI 10.1002/pro.3779; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Bienert S, 2017, NUCLEIC ACIDS RES, V45, pD313, DOI 10.1093/nar/gkw1132; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Bushell KSR, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11753-1; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; Case D. A., 2016, AMBER 2016; Cosconati S, 2010, EXPERT OPIN DRUG DIS, V5, P597, DOI 10.1517/17460441.2010.484460; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Luis JAD, 2021, MINI-REV MED CHEM, V21, P2655, DOI 10.2174/1389557520666200730161549; Falzone ME, 2019, ELIFE, V8, DOI 10.7554/eLife.43229; Fraga CG, 2019, FOOD FUNCT, V10, P514, DOI [10.1039/C8FO01997E, 10.1039/c8fo01997e]; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Guex N, 2009, ELECTROPHORESIS, V30, pS162, DOI 10.1002/elps.200900140; Guo S, 2020, PHARMACOL RES, V155, DOI 10.1016/j.phrs.2020.104721; Guo S, 2019, J CELL PHYSIOL, V234, P8698, DOI 10.1002/jcp.27529; Huang F, 2012, PHARMACOL REV, V64, P1, DOI 10.1124/pr.111.005009; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ji QS, 2019, J CELL PHYSIOL, V234, P7856, DOI 10.1002/jcp.27865; Jia LH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136584; Joung IS, 2009, J PHYS CHEM B, V113, P13279, DOI 10.1021/jp902584c; Kalienkova V, 2019, ELIFE, V8, DOI 10.7554/eLife.44364; Liu F, 2015, ONCOTARGET, V6, P11585, DOI 10.18632/oncotarget.3412; Lu T, 2012, J COMPUT CHEM, V33, P580, DOI 10.1002/jcc.22885; Oh U, 2016, PFLUG ARCH EUR J PHY, V468, P443, DOI 10.1007/s00424-016-1790-0; Paulino C, 2017, NATURE, V552, P421, DOI 10.1038/nature24652; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; Shi S, 2020, ARCH BIOCHEM BIOPHYS, V695, DOI 10.1016/j.abb.2020.108650; Shi S, 2020, COMPUT STRUCT BIOTEC, V18, P714, DOI 10.1016/j.csbj.2020.03.015; Sliwoski G, 2014, PHARMACOL REV, V66, P334, DOI 10.1124/pr.112.007336; Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X; Studer G, 2014, BIOINFORMATICS, V30, pI505, DOI 10.1093/bioinformatics/btu457; Sui YJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115443; Tan QY, 2019, J AGR FOOD CHEM, V67, P159, DOI 10.1021/acs.jafc.8b05369; Tao WQ, 2016, J PHARMACEUT BIOMED, V131, P140, DOI 10.1016/j.jpba.2016.08.020; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Wu YY, 2011, J ZHEJIANG UNIV-SC B, V12, P744, DOI 10.1631/jzus.B1100041; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang X, 2017, BRIT J PHARMACOL, V174, P2334, DOI 10.1111/bph.13841	42	6	6	5	20	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101016	10.1016/j.jbc.2021.101016	http://dx.doi.org/10.1016/j.jbc.2021.101016			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34329684	Green Published, gold			2022-12-28	WOS:000706408900005
J	Shimada, A; Hara, F; Shinzawa-Itoh, K; Kanehisa, N; Yamashita, E; Muramoto, K; Tsukihara, T; Yoshikawa, S				Shimada, Atsuhiro; Hara, Fumiyoshi; Shinzawa-Itoh, Kyoko; Kanehisa, Nobuko; Yamashita, Eiki; Muramoto, Kazumasa; Tsukihara, Tomitake; Yoshikawa, Shinya			Critical roles of the Cu-B site in efficient proton pumping as revealed by crystal structures of mammalian cytochrome c oxidase catalytic intermediates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-2 REDUCTION; ACTIVATION; RESOLUTION; MECHANISM; PROVIDE; PATHWAY; FORMS; WATER; CYCLE	Mammalian cytochrome c oxidase (CcO) reduces O-2 to water in a bimetallic site including Fe-a3 and Cu-B giving intermediate molecules, termed A-, P-, F-, O-, E-, and R-forms. From the P-form on, each reaction step is driven by single electron donations from cytochrome c coupled with the pumping of a single proton through the H-pathway, a proton conducting pathway composed of a hydrogen-bond network and a water channel. The proton-gradient formed is utilized for ATP production by F-ATPase. For elucidation of the proton pumping mechanism, crystal structural determination of these intermediate forms is necessary. Here we report X-ray crystallographic analysis at similar to 1.8 angstrom resolution of fully reduced CcO crystals treated with O-2 for three different time periods. Our disentanglement of intermediate forms from crystals that were composed of multiple forms determined that these three crystallographic data sets contained similar to 45% of the O-form structure, similar to 45% of the E-form structure, and similar to 20% of an oxymyoglobin-type structure consistent with the A-form, respectively. The O- and E-forms exhibit an unusually long Cu-B(2+)-OH- distance and CuB1+-H2O structure keeping Fe-a3(3+)- OH- state, respectively, suggesting that the O-and E-forms have high electron affinities that cause the O -> E and E -> R transitions to be essentially irreversible and thus enable tightly coupled proton pumping. The water channel of the H-pathway is closed in the O- and E-forms and partially open in the R form. These structures, together with those of the recently reported P- and F-forms, indicate that closure of the H-pathway water channel avoids back-leaking of protons for facilitating the effective proton pumping.	[Shimada, Atsuhiro; Hara, Fumiyoshi; Shinzawa-Itoh, Kyoko; Tsukihara, Tomitake; Yoshikawa, Shinya] Univ Hyogo, Picobiol Inst, Grad Sch Life Sci, Akoh, Hyogo, Japan; [Hara, Fumiyoshi; Muramoto, Kazumasa; Yoshikawa, Shinya] Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Akoh, Hyogo, Japan; [Kanehisa, Nobuko] Osaka Univ, Grad Sch Engn, Dept Appl Chem, Suita, Osaka, Japan; [Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, Suita, Osaka, Japan; [Shimada, Atsuhiro] Gifu Univ, Fac Appl Biol Sci, Dept Appl Life Sci, 1-1 Yanagido, Gifu 5011193, Japan	University of Hyogo; University of Hyogo; Osaka University; Osaka University; Gifu University	Tsukihara, T; Yoshikawa, S (corresponding author), Univ Hyogo, Picobiol Inst, Grad Sch Life Sci, Akoh, Hyogo, Japan.; Muramoto, K; Yoshikawa, S (corresponding author), Univ Hyogo, Grad Sch Life Sci, Dept Life Sci, Akoh, Hyogo, Japan.; Tsukihara, T (corresponding author), Osaka Univ, Inst Prot Res, Suita, Osaka, Japan.	muramoto@sci.u-hyogo.ac.jp; tsuki@protein.osaka-u.ac.jp; yoshi@sci.u-hyogo.ac.jp		Shimada, Atsuhiro/0000-0002-7208-7315	Japanese Ministry of Education, Culture, Sports, Science and Technology [2247012]; Photon and Quantum Basic Research Coordinated Development Program by the Japanese Ministry of Education, Culture, Sports, Science and Technology; JSPS KAKENHI GRANT [22370060, 26291033, 15K18493, 18K14635, 18K06092]; JST, CREST; Targeted Proteins Research Program [12101577]; SPring-8 [2015A1095]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Photon and Quantum Basic Research Coordinated Development Program by the Japanese Ministry of Education, Culture, Sports, Science and Technology; JSPS KAKENHI GRANT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST, CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); SPring-8(SPring-8)	This work was supported by a Grant-in-Aid for the Global Center of Excellence Program (to S. Y.), for Scientific Research (A) 2247012 (to S. Y.), and the Photon and Quantum Basic Research Coordinated Development Program (to T. T., S. Y., and K. S.-I.), each provided by the Japanese Ministry of Education, Culture, Sports, Science and Technology. Support was also provided by JSPS KAKENHI GRANT 22370060 (to K. M.), 26291033 (to S. Y.), 15K18493, 18K14635 (to A. S.), and 18K06092 (to T. T.), by JST, CREST and the Targeted Proteins Research Program 12101577 (to T. T.), and by SPring-8 2015A1095 (to T. T.).	Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Bloch D, 2004, P NATL ACAD SCI USA, V101, P529, DOI 10.1073/pnas.0306036101; BRICOGNE G, 1974, ACTA CRYSTALLOGR A, VA 30, P395, DOI 10.1107/S0567739474010722; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Dai YF, 2009, ACTA CRYSTALLOGR E, V65, pM1001, DOI 10.1107/S1600536809029559; Einarsdottir O, 2002, J INORG BIOCHEM, V91, P87, DOI 10.1016/S0162-0134(02)00377-X; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/NMETH.2962, 10.1038/nmeth.2962]; Ishigami I, 2019, P NATL ACAD SCI USA, V116, P3572, DOI 10.1073/pnas.1814526116; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Lepp H, 2008, BBA-BIOENERGETICS, V1777, P897, DOI 10.1016/j.bbabio.2008.04.013; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Moody AJ, 1996, BBA-BIOENERGETICS, V1276, P6; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; OGURA T, 1993, J AM CHEM SOC, V115, P8527, DOI 10.1021/ja00072a002; OLMSTEAD MM, 1982, TRANSIT METAL CHEM, V7, P140, DOI 10.1007/BF01035827; Proshlyakov DA, 2000, SCIENCE, V290, P1588, DOI 10.1126/science.290.5496.1588; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Sakaguchi M, 2010, J BIOENERG BIOMEMBR, V42, P241, DOI 10.1007/s10863-010-9282-y; Shimada A, 2020, J BIOL CHEM, V295, P5818, DOI 10.1074/jbc.RA119.009596; Shimada A, 2018, J BIOL CHEM, V293, P14868, DOI 10.1074/jbc.RA118.003123; Shimada A, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603042; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Stepnicka P, 2013, DALTON T, V42, P3373, DOI 10.1039/c2dt32511j; Tosha T, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01702-1; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; Vojtechovsky J, 1999, BIOPHYS J, V77, P2153, DOI 10.1016/S0006-3495(99)77056-6; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Wiertz FGM, 2007, J BIOL CHEM, V282, P31580, DOI 10.1074/jbc.M705520200; Wikstrom M, 2018, CHEM REV, V118, P2469, DOI 10.1021/acs.chemrev.7b00664; Wikstrom M, 2012, BBA-BIOENERGETICS, V1817, P468, DOI 10.1016/j.bbabio.2011.10.010; Yano N, 2016, J BIOL CHEM, V291, P23882, DOI 10.1074/jbc.M115.711770; Yoshikawa S, 1998, SCIENCE, V280, P1723, DOI 10.1126/science.280.5370.1723; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a; Yu MA, 2012, J AM CHEM SOC, V134, P4753, DOI 10.1021/ja210535w	39	7	7	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100967	10.1016/j.jbc.2021.100967	http://dx.doi.org/10.1016/j.jbc.2021.100967			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34274318	gold, Green Published			2022-12-28	WOS:000706361700006
J	Bugatti, A; Caccuri, F; Filippini, F; Ravelli, C; Caruso, A				Bugatti, Antonella; Caccuri, Francesca; Filippini, Federica; Ravelli, Cosetta; Caruso, Arnaldo			Binding to PI(4,5)P-2 is indispensable for secretion of B-cell clonogenic HIV-1 matrix protein p17 variants	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS; MEMBRANE-BINDING; GAG; PROMOTES; LYMPHANGIOGENESIS; REPLICATION; MECHANISMS; INHIBITOR; INCREASES; LYMPHOMA	HIV-1 matrix protein p17 variants (vp17s) derived from non-Hodgkin's lymphoma (NHL) tissues of HIV-1-seropositive (HIV+) patients promote B-cell growth by activating the Akt signaling pathway. It is fundamental to understand the role played by vp17s in producing a microenvironment that fosters lymphoma development and progression. Therefore, we asked whether vp17s could be secreted from infected cells in their biologically active form. In this study, we show that two B-cell growth-promoting vp17s, NHL-a101 and NHL-a102, characterized by amino acid insertions at position 117 to 118 (Ala-Ala) or 125 to 126 (Gly-Asn), respectively, are secreted from HIV-1-infected Jurkat T cells during the active phase of viral replication. Secretion of biologically active vp17s also occurred in HeLa cells nucleofected with a plasmid expressing the entire Gag gene, following proteolytic cleavage of the Gag precursor polyprotein (Pr55(Gag)) by cellular aspartyl proteases. Binding of Pr55(Gag) to phosphatidylinositol-(4,5)-bisphosphate was indispensable for allowing the unconventional secretion of both wildtype p17 and vp17s. Indeed, here we demonstrate that inhibition of Pr55(Gag) binding to phosphatidylinositol-(4,5)-bisphosphate by using neomycin, or its enzymatic depletion achieved by overexpression of 5ptaseIV, significantly impair the secretion of p17s. We also demonstrated that heparan sulfate proteoglycans were involved in tethering p17s at the cell surface. This finding opens up an interesting way for investigating whether tethered p17s on the surface of HIV-1 reservoirs may represent a likely target for immune-mediated killing.	[Bugatti, Antonella; Caccuri, Francesca; Filippini, Federica; Caruso, Arnaldo] Univ Brescia, Dept Mol & Translat Med, Med Sch, Sect Microbiol, Brescia, Italy; [Ravelli, Cosetta] Univ Brescia, Dept Mol & Translat Med, Med Sch, Sect Expt Oncol & Immunol, Brescia, Italy	University of Brescia; University of Brescia	Caruso, A (corresponding author), Univ Brescia, Dept Mol & Translat Med, Med Sch, Sect Microbiol, Brescia, Italy.	arnaldo.caruso@unibs.it	Caccuri, Francesca/AAC-1281-2022	Caccuri, Francesca/0000-0002-1923-9033	Associazione Italiana per la Ricerca sul Cancro [20108]	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	This study was supported in part by Associazione Italiana per la Ricerca sul Cancro grant 20108 (to A. C.).	Alefantis T, 2005, J BIOL CHEM, V280, P17353, DOI 10.1074/jbc.M409851200; Basta D, 2015, PATHOG DIS, V73, DOI 10.1093/femspd/ftv062; Bugatti A, 2013, J BIOL CHEM, V288, P1150, DOI 10.1074/jbc.M112.400077; Caccuri F, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021366118; Caccuri F, 2016, SCI REP-UK, V6, DOI 10.1038/srep38027; Caccuri F, 2014, J VIROL, V88, P5706, DOI 10.1128/JVI.03142-13; Caccuri F, 2014, ARTERIOSCL THROM VAS, V34, P846, DOI 10.1161/ATVBAHA.113.302478; Caccuri F, 2012, P NATL ACAD SCI USA, V109, P14580, DOI 10.1073/pnas.1206605109; Chukkapalli V, 2008, J VIROL, V82, P2405, DOI 10.1128/JVI.01614-07; Chukkapalli V, 2010, P NATL ACAD SCI USA, V107, P1600, DOI 10.1073/pnas.0908661107; Cote TR, 1997, INT J CANCER, V73, P645, DOI 10.1002/(SICI)1097-0215(19971127)73:5&lt;645::AID-IJC6&gt;3.0.CO;2-X; De Francesco MA, 1998, AIDS, V12, P245, DOI 10.1097/00002030-199803000-00001; De Francesco MA, 2002, P NATL ACAD SCI USA, V99, P9972, DOI 10.1073/pnas.142274699; Deeks SG, 2012, NATURE, V487, P439, DOI 10.1038/487439a; Dolcetti R, 2015, P NATL ACAD SCI USA, V112, P14331, DOI 10.1073/pnas.1514748112; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Fiorentini S, 2006, NEW MICROBIOL, V29, P1; Fiorentini S, 2008, VACCINE, V26, P4758, DOI 10.1016/j.vaccine.2008.06.082; Fiorentini S, 2008, P NATL ACAD SCI USA, V105, P3867, DOI 10.1073/pnas.0800370105; GABEV E, 1989, BIOCHIM BIOPHYS ACTA, V979, P105, DOI 10.1016/0005-2736(89)90529-4; Giagulli C, 2021, CANCER GENE THER, V28, P649, DOI 10.1038/s41417-020-00246-9; Giagulli C, 2012, BLOOD, V119, P2274, DOI 10.1182/blood-2011-06-364083; Giagulli C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017831; He WX, 2019, BBA-GEN SUBJECTS, V1863, P13, DOI 10.1016/j.bbagen.2018.09.016; Iaria ML, 2014, VACCINE, V32, P1072, DOI 10.1016/j.vaccine.2013.12.051; Imamichi H, 2020, P NATL ACAD SCI USA, V117, P3704, DOI 10.1073/pnas.1917876117; Isaguliants M, 2021, CANCERS, V13, DOI 10.3390/cancers13020305; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Kisseleva MV, 2002, J BIOL CHEM, V277, P6266, DOI 10.1074/jbc.M105969200; Knowles DM, 2003, HEMATOL ONCOL CLIN N, V17, P785, DOI 10.1016/S0889-8588(03)00050-9; Marciniszyn K., 1997, ADV EXP MED BIOL, V95, P199; Marini E, 2008, CELL MICROBIOL, V10, P655, DOI 10.1111/j.1462-5822.2007.01073.x; Martorelli D, 2015, INT J CANCER, V137, P1374, DOI 10.1002/ijc.29494; Mazzuca P, 2017, J VIROL, V91, DOI 10.1128/JVI.00801-17; Mori T, 2008, ARCH VIROL, V153, P1191, DOI 10.1007/s00705-008-0094-x; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Pepper MS, 2003, CELL TISSUE RES, V314, P167, DOI 10.1007/s00441-003-0748-7; Popovic M, 2005, P NATL ACAD SCI USA, V102, P14807, DOI 10.1073/pnas.0506857102; Rusnati M, 2001, J BIOL CHEM, V276, P22420, DOI 10.1074/jbc.M010779200; Rusnati M, 2009, CURR PHARM DESIGN, V15, P2946, DOI 10.2174/138161209789058156; Saad JS, 2006, P NATL ACAD SCI USA, V103, P11364, DOI 10.1073/pnas.0602818103; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shkriabai N, 2006, BIOCHEMISTRY-US, V45, P4077, DOI 10.1021/bi052308e; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Taylor JG, 2015, BIOMARK MED, V9, P473, DOI 10.2217/bmm.15.13; Tewari D, 2003, J GENE MED, V5, P182, DOI 10.1002/jgm.336; Vandenhende MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129550; Vandergeeten C, 2007, BIOCHEM PHARMACOL, V73, P1738, DOI 10.1016/j.bcp.2007.02.011; Vitale M, 2003, BRIT J HAEMATOL, V120, P337, DOI 10.1046/j.1365-2141.2003.04053.x; Zentner I, 2013, CHEMMEDCHEM, V8, P426, DOI 10.1002/cmdc.201200577; Zhou WJ, 1996, J VIROL, V70, P8540, DOI 10.1128/JVI.70.12.8540-8548.1996	52	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100934	10.1016/j.jbc.2021.100934	http://dx.doi.org/10.1016/j.jbc.2021.100934			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34273353	Green Published, gold			2022-12-28	WOS:000690871000018
J	Guo, B; Shi, XR; Ma, Z; Ji, MX; Tang, C; Wang, F				Guo, Bin; Shi, Xiaorui; Ma, Zhe; Ji, Moxuan; Tang, Chu; Wang, Fu			A ratiometric dual luciferase reporter for quantitative monitoring of pre-mRNA splicing efficiency in vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPLICEOSOME	Precursor messenger RNA (pre-mRNA) splicing is critical for cell growth and development, and errors in RNA splicing frequently cause cellular dysfunction, abnormal gene expression, and a variety of human diseases. However, there is currently a lack of reliable systems to noninvasively monitor the mRNA splicing efficiency in cells and animals. Here, we described the design of a genetically engineered ratiometric dual luciferase reporter to continuously quantify the changes in mRNA splice variants in vivo. This reporter system is encoded within a single polypeptide but on separate exons, thus generating two distinct luciferase signals derived from spliced and unspliced mRNAs. With this reporter, the two kinds of luciferase in the same individual can minimize the influence of indirect factors on splicing, and the ratio of these two luciferase intensities represents the dynamic splicing efficiency of premRNA. Our study offers a convenient and robust tool for the screening and identification of small molecules or trans-acting factors that affect the efficiency of specific splicing reactions.	[Guo, Bin; Shi, Xiaorui; Ji, Moxuan; Tang, Chu; Wang, Fu] Xidian Univ, Engn Res Ctr Mol & Neuro Imaging, Sch Life Sci & Technol, Minist Educ, Xian, Peoples R China; [Ma, Zhe; Wang, Fu] Xi An Jiao Tong Univ, Sch Basic Med Sci, Inst Med Engn, Xian, Peoples R China; [Wang, Fu] Shaanxi Inst Int Trade & Commerce, Sch Pharm, Xian, Peoples R China	Xidian University; Xi'an Jiaotong University	Wang, F (corresponding author), Xidian Univ, Engn Res Ctr Mol & Neuro Imaging, Sch Life Sci & Technol, Minist Educ, Xian, Peoples R China.; Wang, F (corresponding author), Xi An Jiao Tong Univ, Sch Basic Med Sci, Inst Med Engn, Xian, Peoples R China.; Wang, F (corresponding author), Shaanxi Inst Int Trade & Commerce, Sch Pharm, Xian, Peoples R China.	wangfu@xjtu.edu.cn	Wang, Fu/S-7955-2017	Wang, Fu/0000-0001-9222-0833	National Natural Science Foundation of China [81772010]; National Key Research and Development Program of China (973 Program) [2017YFA0205202]; "Young Talent Support Plan" of Xi'an Jiaotong University; Natural Science Foundation of Shaanxi Province [2021JM-540, 2019JQ-924]; Key breeding program by Collaborative innovation center of green manufacturing technology for traditional Chinese medicine in Shaanxi province [2019XT-1-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China (973 Program)(National Basic Research Program of China); "Young Talent Support Plan" of Xi'an Jiaotong University; Natural Science Foundation of Shaanxi Province(Natural Science Foundation of Shaanxi Province); Key breeding program by Collaborative innovation center of green manufacturing technology for traditional Chinese medicine in Shaanxi province	This work was supported by National Natural Science Foundation of China (No. 81772010), The National Key Research and Development Program of China (973 Program) (Grant No. 2017YFA0205202), "Young Talent Support Plan" of Xi'an Jiaotong University, Natural Science Foundation of Shaanxi Province (No. 2021JM-540, 2019JQ-924), and Key breeding program by Collaborative innovation center of green manufacturing technology for traditional Chinese medicine in Shaanxi province (2019XT-1-05).	Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; de Klerk E, 2015, TRENDS GENET, V31, P128, DOI 10.1016/j.tig.2015.01.001; Fica SM, 2020, CURR OPIN STRUC BIOL, V65, P139, DOI 10.1016/j.sbi.2020.06.018; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Hoskins AA, 2012, TRENDS BIOCHEM SCI, V37, P179, DOI 10.1016/j.tibs.2012.02.009; Jacob AG, 2017, HUM GENET, V136, P1043, DOI 10.1007/s00439-017-1791-x; Jiang W, 2021, COMPUT STRUCT BIOTEC, V19, P183, DOI 10.1016/j.csbj.2020.12.009; Kotake Y., 2007, SPLICING FACTOR SF3B; Kotake Y, 2007, NAT CHEM BIOL, V3, P570, DOI 10.1038/nchembio.2007.16; Martin RM, 2013, CELL REP, V4, P1144, DOI 10.1016/j.celrep.2013.08.013; Monteuuis G, 2019, NUCLEIC ACIDS RES, V47, P11497, DOI 10.1093/nar/gkz1068; Parker R M, 1999, Methods Mol Biol, V106, P247; Poverennaya IV, 2020, BIOCHEMISTRY-MOSCOW+, V85, P725, DOI 10.1134/S0006297920070019; Prediger E A, 2001, Methods Mol Biol, V160, P495; Shi YR, 2018, BIOMED OPT EXPRESS, V9, P518, DOI 10.1364/BOE.9.000518; Somarelli JA, 2013, RNA, V19, P116, DOI 10.1261/rna.035097.112; Vaz-Drago R, 2017, HUM GENET, V136, P1093, DOI 10.1007/s00439-017-1809-4; Wong ML, 2005, BIOTECHNIQUES, V39, P75, DOI 10.2144/05391RV01; Xie JR, 2020, MOL THER-METH CLIN D, V17, P904, DOI 10.1016/j.omtm.2020.04.007; Younis I, 2010, MOL CELL BIOL, V30, P1718, DOI 10.1128/MCB.01301-09; Zheng HF, 2019, ANAL CHEM, V91, P12392, DOI 10.1021/acs.analchem.9b02935	21	1	1	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100933	10.1016/j.jbc.2021.100933	http://dx.doi.org/10.1016/j.jbc.2021.100933			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34216622	Green Published, gold			2022-12-28	WOS:000690873500008
J	Piper, IM; Struyvenberg, SA; Valgardson, JD; Johnson, DA; Gao, M; Johnston, K; Svendsen, JE; Kodama, HM; Hvorecny, KL; Antos, JM; Amacher, JF				Piper, Isabel M.; Struyvenberg, Sarah A.; Valgardson, Jordan D.; Johnson, D. Alex; Gao, Melody; Johnston, Katherine; Svendsen, Justin E.; Kodama, Hanna M.; Hvorecny, Kelli L.; Antos, John M.; Amacher, Jeanine F.			Sequence variation in the beta 7-beta 8 loop of bacterial class A sortase enzymes alters substrate selectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAPHYLOCOCCUS-AUREUS SORTASE; SURFACE-PROTEINS; EVOLUTIONARY CONSERVATION; SORTING SIGNAL; CELL-WALL; SPECIFICITY; TRANSPEPTIDASE; ALIGNMENT; RECOGNITION; LIGATION	Gram-positive bacteria contain sortase enzymes on their cell surfaces that catalyze transpeptidation reactions critical for proper cellular function. In vitro, sortases are used in sortase-mediated ligation (SML) reactions for a variety of protein engineering applications. Historically, sortase A from Staphylococcus aureus (saSrtA) has been the enzyme of choice to catalyze SML reactions. However, the stringent specificity of saSrtA for the LPXTG sequence motif limits its uses. Here, we describe the impact on substrate selectivity of a structur-ally conserved loop with a high degree of sequence variability in all classes of sortases. We investigate the contribution of this beta 7-beta 8 loop by designing and testing chimeric sortase enzymes. Our chimeras utilize natural sequence variation of class A sortases from eight species engineered into the SrtA sequence from Streptococcus pneumoniae. While some of these chimeric enzymes mimic the activity and selectivity of the WT protein from which the loop sequence was derived (e.g., that of saSrtA), others results in chimeric Streptococcus pneumoniae SrtA enzymes that are able to accommodate a range of residues in the final position of the substrate motif (LPXTX). Using mutagenesis, structural comparisons, and sequence analyses, we identify three interactions facilitated by beta 7-beta 8 loop residues that appear to be broadly conserved or converged upon in class A sortase enzymes. These studies provide the foundation for a deeper understanding of sortase target selectivity and can expand the sortase toolbox for future SML applications.	[Piper, Isabel M.; Struyvenberg, Sarah A.; Valgardson, Jordan D.; Johnson, D. Alex; Gao, Melody; Johnston, Katherine; Svendsen, Justin E.; Kodama, Hanna M.; Antos, John M.; Amacher, Jeanine F.] Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA; [Hvorecny, Kelli L.] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Valgardson, Jordan D.] Stanford Univ, Dept Chem Syst Biol, Palo Alto, CA 94304 USA	Western Washington University; University of Washington; University of Washington Seattle; Stanford University	Antos, JM; Amacher, JF (corresponding author), Western Washington Univ, Dept Chem, Bellingham, WA 98225 USA.	antosj@wwu.edu; amachej@wwu.edu		Svendsen, Justin/0000-0002-5873-5339; Gao, Melody/0000-0003-2902-7517; Johnson, David/0000-0001-5675-685X	NSF [CHE-1904711]; Cottrell Scholar Award from the Research Corporation for Science Advancement; NIAID, National Institutes of Health [F32AI145111]; Elwha Undergraduate Summer Research Award; Joseph and Karen Morse Student Research in Chemistry Fellowship	NSF(National Science Foundation (NSF)); Cottrell Scholar Award from the Research Corporation for Science Advancement; NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Elwha Undergraduate Summer Research Award; Joseph and Karen Morse Student Research in Chemistry Fellowship	J. F. A. was funded by NSF CHE-1904711 and J. M. A. was funded by a Cottrell Scholar Award from the Research Corporation for Science Advancement. K. L. H. was supported by the NIAID, National Institutes of Health, Award Number F32AI145111. In addition, I. M. P. received an Elwha Undergraduate Summer Research Award and D. A. J. received a Joseph and Karen Morse Student Research in Chemistry Fellowship to fund summer research. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Antos JM, 2016, CURR OPIN STRUC BIOL, V38, P111, DOI 10.1016/j.sbi.2016.05.021; Antos JM, 2009, J AM CHEM SOC, V131, P10800, DOI 10.1021/ja902681k; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Bennett NR, 2019, BIOMACROMOLECULES, V20, P4370, DOI 10.1021/acs.biomac.9b01049; Bentley ML, 2008, J BIOL CHEM, V283, P14762, DOI 10.1074/jbc.M800974200; Bentley ML, 2007, J BIOL CHEM, V282, P6571, DOI 10.1074/jbc.M610519200; Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197; Bradshaw WJ, 2015, FEBS J, V282, P2097, DOI 10.1111/febs.13288; Chan AH, 2015, J BIOL CHEM, V290, P25461, DOI 10.1074/jbc.M115.670984; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clancy KW, 2010, BIOPOLYMERS, V94, P385, DOI 10.1002/bip.21472; Coordinators NR., 2017, NUCLEIC ACIDS RES, V45, pD12, DOI 10.1093/nar/gkw1071; Di Girolamo S, 2019, BIOCHEM J, V476, P665, DOI 10.1042/BCJ20180885; Dorr BM, 2014, P NATL ACAD SCI USA, V111, P13343, DOI 10.1073/pnas.1411179111; Freund C, 2021, CHEMBIOCHEM, V22, P1347, DOI 10.1002/cbic.202000745; Guimaraes CP, 2013, NAT PROTOC, V8, P1787, DOI 10.1038/nprot.2013.101; Hess GT, 2013, ACS SYNTH BIOL, V2, P490, DOI 10.1021/sb400019s; Jacobitz AW, 2017, ADV PROTEIN CHEM STR, V109, P223, DOI 10.1016/bs.apcsb.2017.04.008; Johanning K, 1998, J BIOL CHEM, V273, P22672, DOI 10.1074/jbc.273.35.22672; Kang CY, 2020, J BIOL CHEM, V295, P3734, DOI 10.1074/jbc.RA119.011322; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Kruger RG, 2004, ANAL BIOCHEM, V326, P42, DOI 10.1016/j.ab.2003.10.023; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Li J, 2020, J BIOL CHEM, V295, P2664, DOI 10.1074/jbc.RA119.012039; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Mazmanian SK, 1999, SCIENCE, V285, P760, DOI 10.1126/science.285.5428.760; Nikghalb KD, 2018, CHEMBIOCHEM, V19, P185, DOI 10.1002/cbic.201700517; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; Piotukh K, 2011, J AM CHEM SOC, V133, P17536, DOI 10.1021/ja205630g; Podracky CJ, 2021, NAT CHEM BIOL, V17, P317, DOI 10.1038/s41589-020-00706-1; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Race PR, 2009, J BIOL CHEM, V284, P6924, DOI 10.1074/jbc.M805406200; Raeeszadeh-Sarmazdeh M, 2015, COLLOID SURFACE B, V128, P457, DOI 10.1016/j.colsurfb.2015.02.044; Schmohl L, 2017, BIOORGAN MED CHEM, V25, P5002, DOI 10.1016/j.bmc.2017.06.033; Schmohl L, 2017, J PEPT SCI, V23, P631, DOI 10.1002/psc.2980; Spirig T, 2011, MOL MICROBIOL, V82, P1044, DOI 10.1111/j.1365-2958.2011.07887.x; Suree N, 2009, J BIOL CHEM, V284, P24465, DOI 10.1074/jbc.M109.022624; Ton-That H, 2002, J BIOL CHEM, V277, P7447, DOI 10.1074/jbc.M109945200; Valgardson J, 2019, PROTEIN SCI, V28, P2127, DOI 10.1002/pro.3741; Wojcik M, 2020, PROTEINS, V88, P1394, DOI 10.1002/prot.25958; Wuethrich I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109883; Zou Z, 2020, BIOCONJUGATE CHEM, V31, P2476, DOI 10.1021/acs.bioconjchem.0c00486	50	4	4	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100981	10.1016/j.jbc.2021.100981	http://dx.doi.org/10.1016/j.jbc.2021.100981			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302812	gold, Green Published			2022-12-28	WOS:000690868100011
J	Kritsiligkou, P; Shen, TK; Dick, TP				Kritsiligkou, Paraskevi; Shen, Tzu Keng; Dick, Tobias P.			A comparison of Prx- and OxyR-based H2O2 probes expressed in S. cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; INDICATOR	Genetically encoded fluorescent H2O2 probes continue to advance the field of redox biology. Here, we compare the previously established peroxiredoxin-based H2O2 probe roGFP2-Tsa2 Delta CR with the newly described OxyR-based H2O2 probe HyPer7, using yeast as the model system. Although not as sensitive as roGFP2-Tsa2 Delta CR, HyPer7 is much improved relative to earlier HyPer versions, most notably by ratiometric pH stability. The most striking difference between the two probes is the dynamics of intracellular probe reduction. HyPer7 is rapidly reduced, predominantly by the thioredoxin system, whereas roGFP2-Tsa2 Delta CR is reduced more slowly, predominantly by the glutathione system. We discuss the pros and cons of each probe and suggest that future side-by-side measurements with both probes may provide information on the relative activity of the two major cellular reducing systems.	[Kritsiligkou, Paraskevi; Shen, Tzu Keng; Dick, Tobias P.] DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany; [Dick, Tobias P.] Heidelberg Univ, Fac Biosci, Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Dick, TP (corresponding author), DKFZ ZMBH Alliance, German Canc Res Ctr DKFZ, Heidelberg, Germany.; Dick, TP (corresponding author), Heidelberg Univ, Fac Biosci, Heidelberg, Germany.	t.dick@dkfz.de	Kritsiligkou, Paraskevi/W-9399-2019	Kritsiligkou, Paraskevi/0000-0003-2452-141X; SHEN, TZU-KENG/0000-0001-5026-4600	CNV Foundation; European Commission	CNV Foundation; European Commission(European CommissionEuropean Commission Joint Research Centre)	P. K. acknowledges support by the CNV Foundation. This work has been supported by the European Commission (to T. P. D.).	Belousov VV, 2006, NAT METHODS, V3, P281, DOI 10.1038/NMETH866; Bilan DS, 2013, ACS CHEM BIOL, V8, P535, DOI 10.1021/cb300625g; Breckwoldt MO, 2016, SCI REP-UK, V6, DOI 10.1038/srep23251; Carmona M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12475-0; Dalla Tiezza M, 2020, REDOX BIOL, V34, DOI 10.1016/j.redox.2020.101540; de Cubas L, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050731; Demaurex N, 2009, BBA-BIOENERGETICS, V1787, P1383, DOI 10.1016/j.bbabio.2008.12.012; Domenech A, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0523-6; Entian KD, 1999, MOL GEN GENET, V262, P683, DOI 10.1007/PL00013817; Ezerina D, 2014, J MOL CELL CARDIOL, V73, P43, DOI 10.1016/j.yjmcc.2013.12.023; Gutsche M, 2009, J BIOL CHEM, V284, P31532, DOI 10.1074/jbc.M109.059246; Gutscher M, 2008, NAT METHODS, V5, P553, DOI 10.1038/NMETH.1212; Kostyuk AI, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21218164; Lee CJ, 2004, NAT STRUCT MOL BIOL, V11, P1179, DOI 10.1038/nsmb856; Markvicheva KN, 2011, BIOORGAN MED CHEM, V19, P1079, DOI 10.1016/j.bmc.2010.07.014; Matlashov ME, 2015, BBA-GEN SUBJECTS, V1850, P2318, DOI 10.1016/j.bbagen.2015.08.002; Meyer AJ, 2010, ANTIOXID REDOX SIGN, V13, P621, DOI 10.1089/ars.2009.2948; Morgan B, 2016, NAT CHEM BIOL, V12, P437, DOI [10.1038/NCHEMBIO.2067, 10.1038/nchembio.2067]; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pak VV, 2020, CELL METAB, V31, P642, DOI 10.1016/j.cmet.2020.02.003; Pastor-Flores D, 2020, P NATL ACAD SCI USA, V117, P16313, DOI 10.1073/pnas.1915275117; Pedre B, 2018, P NATL ACAD SCI USA, V115, pE11623, DOI 10.1073/pnas.1807954115; Poburko D, 2011, J BIOL CHEM, V286, P11672, DOI 10.1074/jbc.M110.159962; Roma LP, 2018, ANTIOXID REDOX SIGN, V29, P552, DOI 10.1089/ars.2017.7449; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwarzlander M, 2016, ANTIOXID REDOX SIGN, V24, P680, DOI 10.1089/ars.2015.6266; Schwarzlander M, 2014, NATURE, V514, pE12, DOI 10.1038/nature13858; Ugalde J. M., 2021, PLANT PHYSIOL; Wei Q, 2012, NUCLEIC ACIDS RES, V40, P4320, DOI 10.1093/nar/gks017; Zheng M, 1998, SCIENCE, V279, P1718, DOI 10.1126/science.279.5357.1718	31	4	4	4	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100866	10.1016/j.jbc.2021.100866	http://dx.doi.org/10.1016/j.jbc.2021.100866			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34118234	gold, Green Published			2022-12-28	WOS:000678068400066
J	Endo, R; Uchiyama, K; Lim, SY; Itakura, M; Adachi, T; Uchida, K				Endo, Ryunosuke; Uchiyama, Kazuki; Lim, Sei-Young; Itakura, Masanori; Adachi, Takahiro; Uchida, Koji			Recognition of acrolein-specific epitopes by B cell receptors triggers an innate immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXIDATION-SPECIFIC EPITOPES; NATURAL ANTIBODIES; B-1A; IMMUNOGLOBULIN; REPERTOIRES; GENERATION; PRODUCTS; MARKERS; RANGE	Natural antibodies, predominantly immunoglobulin M (IgM), play an important role in the defense against pathogens and in maintaining homeostasis against oxidized molecules known as oxidation-specific epitopes, such as those contained in oxidized low-density lipoproteins. However, owing to the complexity of the oxidized products, very few individual epitopes have been characterized in detail. In the present study, to identify endogenous sources of oxidation-specific epitopes, we stimulated mouse spleen and peritoneal cavity (PerC) cells in vitro with bovine serum albumin modified with a variety of lipid peroxidation-related carbonyl compounds and identified the acrolein-modified bovine serum albumin as the most efficient trigger studied for the production of IgM in PerC cells. The acrolein-specific epitopes accelerated the differentiation of B-1a cells, a fetal-derived B cell lineage, to plasma cells. In addition, acrolein-modified bovine serum albumin was specifically bound to B-1a cells, suggesting the presence of an acrolein-specific IgM-B cell receptor (BCR). A hybridoma, REG25, producing an acrolein-specific IgM, was established from the PerC cells and was indeed identified as a population of B cells expressing a specific IgM-BCR. In addition, we analyzed the BCR repertoire of acrolein-specific B cells and identified the most frequent IgM heavy chain gene segments of the B cells. These data established the presence of innate B cells expressing the acrolein-specific BCR and suggested that in addition to our understanding of acrolein as a toxic aldehyde, it may play a role as a trigger of the innate immune response.	[Endo, Ryunosuke; Uchiyama, Kazuki; Lim, Sei-Young; Itakura, Masanori; Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan; [Adachi, Takahiro] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Tokyo, Japan; [Uchida, Koji] CREST, Japan Agcy Med Res & Dev, Tokyo, Japan	University of Tokyo; Tokyo Medical & Dental University (TMDU); Japan Science & Technology Agency (JST)	Uchida, K (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan.; Uchida, K (corresponding author), CREST, Japan Agcy Med Res & Dev, Tokyo, Japan.	a-uchida@g.ecc.u-tokyo.ac.jp			Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [JP17H06170];  [JP20gm0910013]	Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; 	This study was supported in part by a Grant-in-Aid for Scientific Research (S) (JP17H06170) (K. U.) from the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan. This research was also supported by AMED-CREST from AMED (JP20gm0910013) (K. U.).	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; Anderson MM, 1997, J CLIN INVEST, V99, P424, DOI 10.1172/JCI119176; Baumgarth N, 2000, J EXP MED, V192, P271, DOI 10.1084/jem.192.2.271; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Binder CJ, 2005, SPRINGER SEMIN IMMUN, V26, P385, DOI 10.1007/s00281-004-0185-z; Cascalho M, 1996, SCIENCE, V272, P1649, DOI 10.1126/science.272.5268.1649; Chou MY, 2009, J CLIN INVEST, V119, P1335, DOI 10.1172/JCI36800; DEMONTARBY L, 1988, TETRAHEDRON LETT, V29, P3937, DOI 10.1016/S0040-4039(00)80387-1; Faderl M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00016; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Furuhata A, 2003, J BIOL CHEM, V278, P48658, DOI 10.1074/jbc.M309401200; Gronwall C, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00066; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Hara Y, 2013, ANAL CHIM ACTA, V793, P107, DOI 10.1016/j.aca.2013.07.024; Kantor AB, 1997, J IMMUNOL, V158, P1175; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Maeshima T, 2012, CHEM RES TOXICOL, V25, P1384, DOI 10.1021/tx3000818; MIAN IS, 1991, J MOL BIOL, V217, P133, DOI 10.1016/0022-2836(91)90617-F; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Papac-Milicevic NR, 2010, ADV IMMUNOL, V131, P1; Rickert RC, 1997, NUCLEIC ACIDS RES, V25, P1317, DOI 10.1093/nar/25.6.1317; Shao BH, 2005, J BIOL CHEM, V280, P36386, DOI 10.1074/jbc.M508169200; Sun MJ, 2002, J ORG CHEM, V67, P3575, DOI 10.1021/jo0105383; Tomitori H, 2005, STROKE, V36, P2609, DOI 10.1161/01.STR.0000190004.36793.2d; TORNBERG UC, 1995, EMBO J, V14, P1680, DOI 10.1002/j.1460-2075.1995.tb07157.x; Tsiantoulas D, 2014, CIRC RES, V114, P1743, DOI 10.1161/CIRCRESAHA.113.301145; Uchida K, 1998, J BIOL CHEM, V273, P16058, DOI 10.1074/jbc.273.26.16058; Uchida K, 1998, P NATL ACAD SCI USA, V95, P4882, DOI 10.1073/pnas.95.9.4882; Uchida K, 1999, TRENDS CARDIOVAS MED, V9, P109, DOI 10.1016/S1050-1738(99)00016-X; Uchida K, 2013, REDOX BIOL, V1, P94, DOI 10.1016/j.redox.2012.12.005; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Yoshikawa S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18738; Zemlin M, 2003, J MOL BIOL, V334, P733, DOI 10.1016/j.jmb.2003.10.007	34	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100648	10.1016/j.jbc.2021.100648	http://dx.doi.org/10.1016/j.jbc.2021.100648			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839149	gold, Green Published			2022-12-28	WOS:000672866400619
J	Li, N; Wang, CM; Wu, YA; Liu, XG; Cao, XT				Li, Nan; Wang, Chunmei; Wu, Yanan; Liu, Xingguang; Cao, Xuetao			Ca2+/calmodulin-dependent protein kinase II promotes cell cycle progression by directly activating MEK1 and subsequently modulating p27 phosphorylation (Withdrawal of Vol 284, Pg 3021, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Li N, 2009, J BIOL CHEM, V284, P3021, DOI 10.1074/jbc.M805483200	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100766	10.1016/j.jbc.2021.100766	http://dx.doi.org/10.1016/j.jbc.2021.100766			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237889	Green Published, gold			2022-12-28	WOS:000672866400734
J	Miller, MD; Phillips, GN				Miller, Mitchell D.; Phillips, George N., Jr.			Moving beyond static snapshots: Protein dynamics and the Protein Data Bank	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ADENYLATE KINASE; ENERGY LANDSCAPES; LIGAND-BINDING; CONFORMATIONAL TRANSITIONS; 3-DIMENSIONAL STRUCTURE; CRYSTAL-STRUCTURES; DISTAL HISTIDINE; CARBON-MONOXIDE; HIGH-RESOLUTION; MYOGLOBIN	Proteins are the molecular machines of living systems. Their dynamics are an intrinsic part of their evolutionary selection in carrying out their biological functions. Although the dynamics are more difficult to observe than a static, average structure, we are beginning to observe these dynamics and form sound mechanistic connections between structure, dynamics, and function. This progress is highlighted in case studies from myoglobin and adenylate kinase to the ribosome and molecular motors where these molecules are being probed with a multitude of techniques across many timescales. New approaches to time-resolved crystallography are allowing simple "movies" to be taken of proteins in action, and new methods of mapping the variations in cryo-electron microscopy are emerging to reveal a more complete description of life's machines. The results of these new methods are aided in their dissemination by continual improvements in curation and distribution by the Protein Data Bank and their partners around the world.	[Miller, Mitchell D.; Phillips, George N., Jr.] Rice Univ, Dept Biosci, Houston, TX 77005 USA; [Phillips, George N., Jr.] Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University; Rice University	Phillips, GN (corresponding author), Rice Univ, Dept Biosci, Houston, TX 77005 USA.; Phillips, GN (corresponding author), Rice Univ, Dept Chem, Houston, TX 77005 USA.	georgep@rice.edu	Phillips, George/M-6217-2013	Phillips, George/0000-0002-4171-4603; Miller, Mitchell/0000-0003-1626-4943				Abbott Sanja, 2018, Curr Protoc Bioinformatics, V61, DOI 10.1002/cpbi.48; Adams PD, 2019, ACTA CRYSTALLOGR D, V75, P451, DOI 10.1107/S2059798319004522; Adkar BV, 2011, J PHYS CHEM A, V115, P3691, DOI 10.1021/jp104787s; Agarwal PK, 2005, J AM CHEM SOC, V127, P15248, DOI 10.1021/ja055251s; Aguiar j. A., 2020, EUR RESPIR J; Andrews BK, 1998, STRUCTURE, V6, P587, DOI 10.1016/S0969-2126(98)00060-4; Aranda R, 2006, ACTA CRYSTALLOGR D, V62, P776, DOI 10.1107/S0907444906017318; Assalauova D, 2020, IUCRJ, V7, P1102, DOI 10.1107/S2052252520012798; Astumian RD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11402-7; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Ayyer K, 2019, OPT EXPRESS, V27, P37816, DOI 10.1364/OE.27.037816; Bae E, 2006, P NATL ACAD SCI USA, V103, P2132, DOI 10.1073/pnas.0507527103; Balsera MA, 1996, J PHYS CHEM-US, V100, P2567, DOI 10.1021/jp9536920; Barends TRM, 2015, SCIENCE, V350, P445, DOI 10.1126/science.aac5492; Belyy V, 2014, FEBS LETT, V588, P3520, DOI 10.1016/j.febslet.2014.05.040; Berger R., 2011, PLOS ONE, V6; Berman HM, 2019, STRUCTURE, V27, P1745, DOI 10.1016/j.str.2019.11.002; Berman HM, 2012, STRUCTURE, V20, P391, DOI 10.1016/j.str.2012.01.010; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Berry MB, 2006, PROTEINS, V62, P555, DOI 10.1002/prot.20699; Brown MT, 2011, CURR OPIN MICROBIOL, V14, P734, DOI 10.1016/j.mib.2011.09.009; Bryden A, 2012, IEEE T VIS COMPUT GR, V18, P132, DOI 10.1109/TVCG.2010.250; CARLSON ML, 1994, BIOCHEMISTRY-US, V33, P10597, DOI 10.1021/bi00201a005; Chandrasekaran SN, 2016, STRUCT DYNAM-US, V3, DOI 10.1063/1.4941599; Chapman HN, 2011, NATURE, V470, P73, DOI 10.1038/nature09750; Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1478-3975/2/4/S12; Chu H, 2018, J BIOL CHEM, V293, P11709, DOI 10.1074/jbc.RA118.001897; Criswell AR, 2003, J MOL BIOL, V330, P1087, DOI 10.1016/S0022-2836(03)00655-7; Cutting JE, 2002, PERCEPTION, V31, P1165, DOI 10.1068/p3318; Daily MD, 2012, CHEM PHYS, V396, P84, DOI 10.1016/j.chemphys.2011.08.015; Daily MD, 2010, J MOL BIOL, V400, P618, DOI 10.1016/j.jmb.2010.05.015; Dashti A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18403-x; Dashti A, 2014, P NATL ACAD SCI USA, V111, P17492, DOI 10.1073/pnas.1419276111; Delgado M, 2017, ACS CATAL, V7, P3190, DOI 10.1021/acscatal.7b00201; Deshpande N, 2005, NUCLEIC ACIDS RES, V33, pD233; Echols N, 2003, NUCLEIC ACIDS RES, V31, P478, DOI 10.1093/nar/gkg104; Falahati K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06615-1; Feng YP, 2009, PROTEINS, V77, P551, DOI 10.1002/prot.22467; Ferber DM, 1997, GENE, V185, P239, DOI 10.1016/S0378-1119(96)00651-8; Flores SC, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-215; Frank J, 2016, METHODS, V100, P61, DOI 10.1016/j.ymeth.2016.02.007; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Frauenfelder H, 2003, P NATL ACAD SCI USA, V100, P8615, DOI 10.1073/pnas.1633688100; FRIEDMAN JM, 1985, SCIENCE, V229, P187, DOI 10.1126/science.4012316; Gennerich A, 2009, CURR OPIN CELL BIOL, V21, P59, DOI 10.1016/j.ceb.2008.12.002; GIBSON QH, 1992, J BIOL CHEM, V267, P22022; Gonzalez-Gronow M, 2009, ANTIOXID REDOX SIGN, V11, P2299, DOI [10.1089/ars.2009.2568, 10.1089/ARS.2009.2568]; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Ha DP, 2020, J INFECTION, V81, P478, DOI 10.1016/j.jinf.2020.06.017; Hardy B, 2008, BIOCHEM PHARMACOL, V75, P891, DOI 10.1016/j.bcp.2007.10.008; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hildebrand PW, 2019, TRENDS BIOCHEM SCI, V44, P902, DOI 10.1016/j.tibs.2019.06.004; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ibrahim M, 2020, P NATL ACAD SCI USA, V117, P12624, DOI 10.1073/pnas.2000529117; JOHNSON KA, 1989, J MOL BIOL, V207, P459, DOI 10.1016/0022-2836(89)90269-6; Kapustina M, 2006, J MOL BIOL, V362, P1159, DOI 10.1016/j.jmb.2006.06.078; KENDREW JC, 1960, NATURE, V185, P422, DOI 10.1038/185422a0; KENDREW JC, 1958, NATURE, V181, P662, DOI 10.1038/181662a0; Kerns SJ, 2015, NAT STRUCT MOL BIOL, V22, P124, DOI 10.1038/nsmb.2941; Khongwichit S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79803-z; KHOO JC, 1970, J BIOL CHEM, V245, P4163; Kondrashov DA, 2008, PROTEINS, V70, P353, DOI 10.1002/prot.21499; Kondrashov DA, 2007, STRUCTURE, V15, P169, DOI 10.1016/j.str.2006.12.006; KOSHLAND DE, 1958, P NATL ACAD SCI USA, V44, P98, DOI 10.1073/pnas.44.2.98; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; Krebs WG, 2000, NUCLEIC ACIDS RES, V28, P1665, DOI 10.1093/nar/28.8.1665; Krishnamurthy H, 2009, BIOCHEMISTRY-US, V48, P2723, DOI 10.1021/bi802001w; Kupitz C, 2014, NATURE, V513, P261, DOI 10.1038/nature13453; LAI HH, 1995, PROTEINS, V22, P322, DOI 10.1002/prot.340220404; LANGE S, 1994, MOL BIOCHEM PARASIT, V66, P297, DOI 10.1016/0166-6851(94)90156-2; Levinthal C., 1969, MOSSBAUER SPECTROSC, P22; Li DC, 2015, BIOPHYS J, V109, P647, DOI 10.1016/j.bpj.2015.06.059; Lin CY, 2013, J PHYS CHEM B, V117, P13947, DOI 10.1021/jp4019537; Liu R, 2013, CLIN CANCER RES, V19, P6802, DOI 10.1158/1078-0432.CCR-13-1106; Lubchenko V, 2005, J PHYS CHEM B, V109, P7488, DOI 10.1021/jp045205z; Luo B, 2013, ONCOGENE, V32, P805, DOI 10.1038/onc.2012.130; Maia FRNC, 2012, NAT METHODS, V9, P854, DOI 10.1038/nmeth.2110; Markley JL, 2008, J BIOMOL NMR, V40, P153, DOI 10.1007/s10858-008-9221-y; Martin-Garcia JM, 2016, ARCH BIOCHEM BIOPHYS, V602, P32, DOI 10.1016/j.abb.2016.03.036; Mccoy JG, 2007, J MOL BIOL, V366, P830, DOI 10.1016/j.jmb.2006.11.059; Mehrabi P, 2019, SCIENCE, V365, P1167, DOI 10.1126/science.aaw9904; Meuwly M, 2002, BIOPHYS CHEM, V98, P183, DOI 10.1016/S0301-4622(02)00093-5; Miller C, 2010, BIOPHYS J, V99, P887, DOI 10.1016/j.bpj.2010.04.076; Miron S, 2004, BIOCHEMISTRY-US, V43, P67, DOI 10.1021/bi0355995; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Nain M, 2017, J VIROL, V91, DOI [10.1128/jvi.02274-16, 10.1128/JVI.02274-16]; Nango E, 2016, SCIENCE, V354, P1552, DOI 10.1126/science.aah3497; Ni M, 2011, BIOCHEM J, V434, P181, DOI 10.1042/BJ20101569; NIENHAUS GU, 1992, P NATL ACAD SCI USA, V89, P2902, DOI 10.1073/pnas.89.7.2902; NIENHAUS GU, 1994, BIOCHEMISTRY-US, V33, P13413, DOI 10.1021/bi00249a030; Nienhaus K, 2005, BIOCHEMISTRY-US, V44, P5095, DOI 10.1021/bi047513t; Nienhaus K, 2003, BIOCHEMISTRY-US, V42, P9647, DOI 10.1021/bi034788k; Olmos JL, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0524-5; Olsson U, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1106; Ostermann A, 2000, NATURE, V404, P205, DOI 10.1038/35004622; Panneels V, 2015, STRUCT DYNAM-US, V2, DOI 10.1063/1.4922774; Park JK, 2013, B MATH BIOL, V75, P124, DOI 10.1007/s11538-012-9797-y; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Phillips GN, 1999, J PHYS CHEM B, V103, P8817, DOI 10.1021/jp9918205; PHILLIPS GN, 1995, PROTEIN SCI, V4, P149; PHILLIPS GN, 1990, BIOPHYS J, V57, P381, DOI 10.1016/S0006-3495(90)82540-6; Pisliakov AV, 2009, P NATL ACAD SCI USA, V106, P17359, DOI 10.1073/pnas.0909150106; QUILLIN ML, 1993, J MOL BIOL, V234, P140, DOI 10.1006/jmbi.1993.1569; Rayner JO, 2020, BIOCHEM PHARMACOL, V182, DOI 10.1016/j.bcp.2020.114227; Reid SP, 2014, ANTIVIR RES, V109, P171, DOI 10.1016/j.antiviral.2014.07.004; Ren Z, 2013, ACTA CRYSTALLOGR D, V69, P946, DOI 10.1107/S0907444913003454; RHOADS DG, 1968, J BIOL CHEM, V243, P3963; Riccardi D, 2009, BIOPHYS J, V96, P464, DOI 10.1016/j.bpj.2008.l0.010; Roberts JL, 2015, J CELL PHYSIOL, V230, P2552, DOI 10.1002/jcp.25014; Rogne P, 2016, BIOPHYS J, V111, P1385, DOI 10.1016/j.bpj.2016.08.028; Rose PW, 2013, NUCLEIC ACIDS RES, V41, pD475, DOI 10.1093/nar/gks1200; Saavedra HG, 2018, NATURE, V558, P324, DOI 10.1038/s41586-018-0183-2; Sabirli R, 2021, LIFE SCI, V265, DOI 10.1016/j.lfs.2020.118781; Sato M, 2010, ADV GENET, V69, P97, DOI 10.1016/S0065-2660(10)69006-2; Schotte F, 2004, J STRUCT BIOL, V147, P235, DOI 10.1016/j.jsb.2004.06.009; Schotte F, 2003, SCIENCE, V300, P1944, DOI 10.1126/science.1078797; Schotte F, 2012, P NATL ACAD SCI USA, V109, P19256, DOI 10.1073/pnas.1210938109; Schrank TP, 2009, P NATL ACAD SCI USA, V106, P16984, DOI 10.1073/pnas.0906510106; Schrodinger L., 2020, PYMOL MOL GRAPHICS S; SCHULZ GE, 1986, EUR J BIOCHEM, V161, P127, DOI 10.1111/j.1432-1033.1986.tb10132.x; SCHULZ GE, 1974, NATURE, V250, P120, DOI 10.1038/250120a0; Schwander P, 2010, NEW J PHYS, V12, DOI 10.1088/1367-2630/12/3/035007; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Sehnal D, 2018, WORKSH MOL GRAPH VIS, P29, DOI [/10.5555/3293503.3293509, DOI 10.5555/3293503.3293509]; Sellers JR, 2020, ADV EXP MED BIOL, V1239, P153, DOI 10.1007/978-3-030-38062-5_8; Shibanuma Y, 2020, J BIOCHEM, V168, P223, DOI 10.1093/jb/mvaa043; Shimamura AP, 2002, HIST PHOTOGR, V26, P341, DOI 10.1080/03087298.2002.10443307; Sladewski TE, 2014, RNA BIOL, V11, P986, DOI 10.4161/rna.29947; SMITH J, 1990, P NATL ACAD SCI USA, V87, P1601, DOI 10.1073/pnas.87.4.1601; Spirin AS, 2009, J BIOL CHEM, V284, P21103, DOI 10.1074/jbc.X109.001552; Srajer V, 1996, SCIENCE, V274, P1726, DOI 10.1126/science.274.5293.1726; Srajer V, 2001, BIOCHEMISTRY-US, V40, P13802, DOI 10.1021/bi010715u; Suhre K, 2004, NUCLEIC ACIDS RES, V32, pW610, DOI 10.1093/nar/gkh368; Taniguchi Y, 2007, BIOSYSTEMS, V88, P283, DOI 10.1016/j.biosystems.2006.08.016; Taylor JN, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5016487; Thomas DR, 2006, J BACTERIOL, V188, P7039, DOI 10.1128/JB.00552-06; TOYOSHIMA YY, 1987, NATURE, V328, P536, DOI 10.1038/328536a0; Tsai YL, 2018, P NATL ACAD SCI USA, V115, pE4245, DOI 10.1073/pnas.1714866115; Tsai YL, 2015, J BIOL CHEM, V290, P8049, DOI 10.1074/jbc.M114.618736; Tseng CC, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900377; Turonova B, 2020, SCIENCE, V370, P203, DOI 10.1126/science.abd5223; Vale R D, 1990, Adv Biophys, V26, P97, DOI 10.1016/0065-227X(90)90009-I; Van Krieken R, 2019, J BIOL CHEM, V294, P7755, DOI 10.1074/jbc.RA118.006939; Wang Y, 2013, J CHEM THEORY COMPUT, V9, P84, DOI 10.1021/ct300720s; Wang YJ, 2018, PROTEINS, V86, P332, DOI 10.1002/prot.25443; Weikl TR, 2014, PROTEIN SCI, V23, P1508, DOI 10.1002/pro.2539; Whitford PC, 2008, J BIOL CHEM, V283, P2042, DOI 10.1074/jbc.M707632200; Wriggers W, 1997, PROTEINS, V29, P1; Wu SP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012643; Yang F, 1996, J MOL BIOL, V256, P762, DOI 10.1006/jmbi.1996.0123; Yang XJ, 2011, NATURE, V479, P428, DOI 10.1038/nature10506; Yorke BA, 2014, NAT METHODS, V11, P1131, DOI [10.1038/NMETH.3139, 10.1038/nmeth.3139]; Young JY, 2017, STRUCTURE, V25, P536, DOI 10.1016/j.str.2017.01.004; Zimmermann MT, 2014, RNA, V20, P792, DOI 10.1261/rna.041269.113	157	10	10	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100749	10.1016/j.jbc.2021.100749	http://dx.doi.org/10.1016/j.jbc.2021.100749			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33961840	gold, Green Published			2022-12-28	WOS:000672866400718
J	Usher, ET; Sabri, N; Rohac, R; Boal, AK; Mittag, T; Showalter, SA				Usher, Emery T.; Sabri, Nafiseh; Rohac, Roman; Boal, Amie K.; Mittag, Tanja; Showalter, Scott A.			Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; NMR; PCIF1; GENE; IDENTIFICATION; TUMORIGENESIS; DEGRADATION; PROSTATE; MUTANTS; DRIVES	Speckle-type POZ protein (SPOP) is a ubiquitin ligase adaptor that binds substrate proteins and facilitates their proteasomal degradation. Most SPOP substrates present multiple SPOP-binding (SB) motifs and undergo liquid-liquid phase separation with SPOP. Pancreatic and duodenal homeobox 1 (Pdx1), an insulin transcription factor, is downregulated by interaction with SPOP. Unlike other substrates, only one SB motif has previously been reported within the Pdx1 C-terminal intrinsically disordered region (Pdx1-C). Given this difference, we aimed to determine the specific mode of interaction of Pdx1 with SPOP and how it is similar or different to that of other SPOP substrates. Here, we identify a second SB motif in Pdx1-C, but still find that the resulting moderate valency is insufficient to support phase separation with SPOP in cells. Although Pdx1 does not phase separate with SPOP, Pdx1 and SPOP interaction prompts SPOP relocalization from nuclear speckles to the diffuse nucleoplasm. Accordingly, we find that SPOP-mediated ubiquitination activity of Pdx1 occurs in the nucleoplasm and that highly efficient Pdx1 turnover requires both SB motifs. Our results suggest that the subnuclear localization of SPOP-substrate interactions and substrate ubiquitination may be directed by the properties of the substrate itself.	[Usher, Emery T.; Boal, Amie K.; Showalter, Scott A.] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Sabri, Nafiseh; Mittag, Tanja] St Jude Childrens Res Hosp, Dept Struct Biol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Rohac, Roman; Boal, Amie K.; Showalter, Scott A.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; St Jude Children's Research Hospital; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Showalter, SA (corresponding author), Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA.; Showalter, SA (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sas76@psu.edu		Rohac, Roman/0000-0002-5954-0998; Usher, Emery/0000-0002-8303-9992; Mittag, Tanja/0000-0002-1827-3811				Ahlgren U, 1998, GENE DEV, V12, P1763, DOI 10.1101/gad.12.12.1763; Blattner M, 2017, CANCER CELL, V31, P436, DOI 10.1016/j.ccell.2017.02.004; BOAM DSW, 1989, BIOCHEM J, V264, P233, DOI 10.1042/bj2640233; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Bouchard JJ, 2018, MOL CELL, V72, P19, DOI 10.1016/j.molcel.2018.08.027; Boysen G, 2015, ELIFE, V4, DOI 10.7554/eLife.09207; Claiborn KC, 2010, J CLIN INVEST, V120, P3713, DOI 10.1172/JCI40440; Cook EC, 2019, J PHYS CHEM B, V123, P106, DOI 10.1021/acs.jpcb.8b10051; Cook EC, 2018, METHOD ENZYMOL, V611, P81, DOI 10.1016/bs.mie.2018.08.025; Cuneo MJ, 2019, FEBS J, V286, P3946, DOI 10.1111/febs.15056; Dai XP, 2017, NAT MED, V23, DOI 10.1038/nm.4378; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Errington WJ, 2012, STRUCTURE, V20, P1141, DOI 10.1016/j.str.2012.04.009; Gao K, 2015, AM J CANCER RES, V5, P3210; Gibbs EB, 2017, ARCH BIOCHEM BIOPHYS, V628, P57, DOI 10.1016/j.abb.2017.05.008; Goddard T D, 2008, SPARKY 3; Habener JF, 2005, ENDOCRINOLOGY, V146, P1025, DOI 10.1210/en.2004-1576; Harmon TC, 2017, ELIFE, V6, DOI 10.7554/eLife.22537; Ilik IA, 2020, ELIFE, V9, DOI 10.7554/eLife.60579; Janouskova H, 2017, NAT MED, V23, P1046, DOI 10.1038/nm.4372; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kim MS, 2013, APMIS, V121, P626, DOI 10.1111/apm.12030; Klein P, 2003, CURR BIOL, V13, P1669, DOI 10.1016/j.cub.2003.09.027; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Lee W, 2015, BIOINFORMATICS, V31, P1325, DOI 10.1093/bioinformatics/btu830; Li GQ, 2014, CANCER CELL, V25, P455, DOI 10.1016/j.ccr.2014.02.007; Li H, 2000, MOL CELL BIOL, V20, P1784, DOI 10.1128/MCB.20.5.1784-1796.2000; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu AH, 2004, MOL CELL BIOL, V24, P4372, DOI 10.1128/MCB.24.10.4372-4383.2004; Liu AH, 2006, FEBS LETT, V580, P6701, DOI 10.1016/j.febslet.2006.11.021; Macfarlane WM, 1999, J CLIN INVEST, V104, pR33, DOI 10.1172/JCI7449; MACFARLANE WM, 1994, BIOCHEM J, V303, P625, DOI 10.1042/bj3030625; Marshak S, 1996, P NATL ACAD SCI USA, V93, P15057, DOI 10.1073/pnas.93.26.15057; Marzahn MR, 2016, EMBO J, V35, P1254, DOI 10.15252/embj.201593169; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MILLER CP, 1994, EMBO J, V13, P1145, DOI 10.1002/j.1460-2075.1994.tb06363.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagai Y, 1997, FEBS LETT, V418, P23, DOI 10.1016/S0014-5793(97)01340-9; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; OHLSSON H, 1993, EMBO J, V12, P4251, DOI 10.1002/j.1460-2075.1993.tb06109.x; Ohta T, 1999, MOL CELL, V3, P535, DOI 10.1016/S1097-2765(00)80482-7; Ostertag MS, 2019, J MOL BIOL, V431, P2213, DOI 10.1016/j.jmb.2019.04.017; Ostertag MS, 2019, STRUCTURE, V27, P327, DOI 10.1016/j.str.2018.10.005; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pierce WK, 2016, J MOL BIOL, V428, P1256, DOI 10.1016/j.jmb.2015.10.002; Roehrl MHA, 2004, BIOCHEMISTRY-US, V43, P16056, DOI 10.1021/bi048233g; Sahu D, 2014, ANAL BIOCHEM, V449, P17, DOI 10.1016/j.ab.2013.12.005; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmit JD, 2020, J AM CHEM SOC, V142, P874, DOI 10.1021/jacs.9b10066; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Wilding L, 2004, DIABETES-METAB RES, V20, P114, DOI 10.1002/dmrr.429; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	59	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100693	10.1016/j.jbc.2021.100693	http://dx.doi.org/10.1016/j.jbc.2021.100693			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33894201	gold, Green Published			2022-12-28	WOS:000672866400664
J	Yang, LJ; Li, N; Wang, CM; Yu, YZ; Yuan, L; Zhang, MH; Cao, XT				Yang, Lianjun; Li, Nan; Wang, Chunmei; Yu, Yizhi; Yuan, Liang; Zhang, Minghui; Cao, Xuetao			Cyclin L2, a novel RNA polymerase II-associated cyclin, is involved in pre-mRNA splicing and induces apoptosis of human hepatocellular carcinoma cells (Withdrawal of Vol 279, Pg 11639, 2004)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal													yu, yizhi/ADP-7854-2022					Yang LJ, 2004, J BIOL CHEM, V279, P11639, DOI 10.1074/jbc.M312895200	1	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100762	10.1016/j.jbc.2021.100762	http://dx.doi.org/10.1016/j.jbc.2021.100762			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237909	gold, Green Published			2022-12-28	WOS:000672866400730
J	Schaub, C; Lee, P; Racho-Jansen, A; Giovinazzo, J; Terra, N; Raper, J; Thomson, R				Schaub, Charles; Lee, Penny; Racho-Jansen, Alisha; Giovinazzo, Joseph; Terra, Nada; Raper, Jayne; Thomson, Russell			Coiled-coil binding of the leucine zipper domains of APOL1 is necessary for the open cation channel conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRYPANOSOME LYTIC FACTOR; HIGH-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-L; KIDNEY-DISEASE; INNATE IMMUNITY; RISK VARIANTS; PROTEIN; BRUCEI; MEMBRANE; SERUM	Apolipoprotein L-I (APOL1) is a channel-forming effector of innate immunity. The common human APOL1 variant G0 provides protection against infection with certain Trypano-soma and Leishmania parasite species, but it cannot protect against the trypanosomes responsible for human African trypanosomiasis. Human APOL1 variants G1 and G2 protect against human-infective trypanosomes but also confer a higher risk of developing chronic kidney disease. Trypanosome-killing activity is dependent on the ability of APOL1 to insert into membranes at acidic pH and form pH-gated cation channels. We previously mapped the channel's pore-lining region to the C-terminal domain (residues 332-398) and identified a membrane-insertion domain (MID, residues 177-228) that facilitates acidic pH-dependent membrane insertion. In this article, we further investigate structural determinants of cation channel formation by APOL1. Using a combination of site-directed mutagenesis and targeted chemical modification, our data indicate that the C-terminal heptad-repeat sequence (residues 368-395) is a bona fide leucine zipper domain (ZIP) that is required for cation channel formation as well as lysis of trypanosomes and mammalian cells. Using protein-wide cysteine-scanning mutagenesis, coupled with the substituted cysteine accessibility method, we determined that, in the open channel state, both the N-terminal domain and the C-terminal ZIP domain are exposed on the intralumenal/extracellular side of the membrane and provide evidence that each APOL1 monomer contributes four transmembrane domains to the open cation channel conformation. Based on these data, we propose an oligomeric topology model in which the open APOL1 cation channel is assembled from the coiled-coil as-sociation of C-terminal ZIP domains.	[Schaub, Charles; Lee, Penny; Racho-Jansen, Alisha; Giovinazzo, Joseph; Terra, Nada; Raper, Jayne; Thomson, Russell] CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA; [Schaub, Charles; Raper, Jayne] CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10021 USA; [Schaub, Charles] Vanderbilt Univ, 221 Kirkland Hall, Nashville, TN 37235 USA; [Lee, Penny] CUNY, John Jay Coll, New York, NY 10021 USA; [Giovinazzo, Joseph] Univ Colorado, Sch Med, Aurora, CO USA; [Terra, Nada] Icahn Sch Med Mt Sinai, New York, NY 10029 USA	City University of New York (CUNY) System; Hunter College (CUNY); City University of New York (CUNY) System; Vanderbilt University; City University of New York (CUNY) System; University of Colorado System; University of Colorado Anschutz Medical Campus; Icahn School of Medicine at Mount Sinai	Raper, J; Thomson, R (corresponding author), CUNY Hunter Coll, Dept Biol Sci, New York, NY 10021 USA.; Raper, J (corresponding author), CUNY, Grad Ctr, PhD Program Biochem, New York, NY 10021 USA.	raper@genectr.hunter.cuny.edu; rthomson@genectr.hunter.cuny.edu		Terra, Nada/0000-0003-2181-695X; Schaub, Charles/0000-0002-3251-3455; Raper, Jayne/0000-0002-8723-9748	NSF [IOS-1249166]	NSF(National Science Foundation (NSF))	J. R. received fund NSF IOS-1249166.	Akabas MH, 2015, ADV EXP MED BIOL, V869, P25, DOI 10.1007/978-1-4939-2845-3_3; Beckerman P, 2017, NAT MED, V23, P429, DOI 10.1038/nm.4287; Bruno J, 2021, J BIOL CHEM, V296, DOI 10.1074/jbc.RA120.013943; Chun J, 2019, P NATL ACAD SCI USA, V116, P3712, DOI 10.1073/pnas.1820414116; Cooper A, 2017, ELIFE, V6, DOI [10.7554/eLife.25461, 10.7554/elife.25461]; Currier RB, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006855; Datta S, 2020, J AM SOC NEPHROL, V31, P2083, DOI 10.1681/ASN.2020010079; DeJesus E, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003317; Duchateau PN, 2001, J LIPID RES, V42, P620; Duchateau PN, 1997, J BIOL CHEM, V272, P25576, DOI 10.1074/jbc.272.41.25576; Dummer PD, 2015, SEMIN NEPHROL, V35, P222, DOI 10.1016/j.semnephrol.2015.04.008; Friedman DJ, 2021, J AM SOC NEPHROL, V32, P1, DOI 10.1681/ASN.2020111629; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Giovinazzo JA, 2020, ELIFE, V9, DOI 10.7554/eLife.51185; Grigoryan G, 2008, CURR OPIN STRUC BIOL, V18, P477, DOI 10.1016/j.sbi.2008.04.008; Gupta N, 2020, J AM SOC NEPHROL, V31, P2065, DOI 10.1681/ASN.2019080830; HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779; HIRUMI H, 1989, J PARASITOL, V75, P985, DOI 10.2307/3282883; HU JC, 1993, PROTEIN SCI, V2, P1072, DOI 10.1002/pro.5560020701; Jha A, 2020, FEBS J, V287, P2000, DOI 10.1111/febs.15133; Johnstone DB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051546; Lan XQ, 2014, AM J PHYSIOL-RENAL, V307, pF326, DOI 10.1152/ajprenal.00647.2013; Lannon H, 2019, KIDNEY INT, V96, P1303, DOI 10.1016/j.kint.2019.07.010; Lecordier L, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000685; Madhavan SM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.92581; Molina-Portela MP, 2008, J EXP MED, V205, P1721, DOI 10.1084/jem.20071463; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Mony L, 2020, P NATL ACAD SCI USA, V117, P20898, DOI 10.1073/pnas.2010032117; Musset B, 2011, NATURE, V480, P273, DOI 10.1038/nature10557; Nichols B, 2015, KIDNEY INT, V87, P332, DOI 10.1038/ki.2014.270; O'Toole JF, 2018, J AM SOC NEPHROL, V29, P869, DOI 10.1681/ASN.2016121322; Olabisi OA, 2016, P NATL ACAD SCI USA, V113, P830, DOI 10.1073/pnas.1522913113; Omasits U, 2014, BIOINFORMATICS, V30, P884, DOI 10.1093/bioinformatics/btt607; Oshaben KM, 2012, BIOCHEMISTRY-US, V51, P9581, DOI 10.1021/bi301132k; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; Raper J, 1999, INFECT IMMUN, V67, P1910; RIFKIN MR, 1984, EXP PARASITOL, V58, P81, DOI 10.1016/0014-4894(84)90023-7; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; Scales SJ, 2020, J AM SOC NEPHROL, V31, P2044, DOI 10.1681/ASN.2019080829; Schaub C, 2020, J BIOL CHEM, V295, P13138, DOI 10.1074/jbc.RA120.014201; Shah SS, 2019, J AM SOC NEPHROL, V30, P2355, DOI 10.1681/ASN.2019020114; Sharma AK, 2016, FEBS J, V283, P1846, DOI 10.1111/febs.13706; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Smith EE, 2009, GENOME RES, V19, P850, DOI 10.1101/gr.085647.108; Spencer RK, 2017, BIOCHEMISTRY-US, V56, P5300, DOI 10.1021/acs.biochem.7b00756; Stephens NA, 2011, EUKARYOT CELL, V10, P1023, DOI 10.1128/EC.05112-11; Thomson R, 2015, P NATL ACAD SCI USA, V112, P2894, DOI 10.1073/pnas.1421953112; Thomson R, 2014, P NATL ACAD SCI USA, V111, pE2130, DOI 10.1073/pnas.1400699111; Thomson R, 2009, P NATL ACAD SCI USA, V106, P19509, DOI 10.1073/pnas.0905669106; Ultsch M, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02387-5; Uzureau P, 2013, NATURE, V501, P430, DOI 10.1038/nature12516; Uzureau S, 2020, CELL REP, V30, P3821, DOI 10.1016/j.celrep.2020.02.064; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2006, NEW ENGL J MED, V355, P2752, DOI 10.1056/NEJMoa063265; Vanwalleghem G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9078; Verdi J, 2020, CELL HOST MICROBE, V28, P79, DOI 10.1016/j.chom.2020.04.012; Verdi J, 2020, METHODS MOL BIOL, V2116, P463, DOI 10.1007/978-1-0716-0294-2_28	59	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101009	10.1016/j.jbc.2021.101009	http://dx.doi.org/10.1016/j.jbc.2021.101009			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34331942	gold, Green Published			2022-12-28	WOS:000706418900013
J	Schoeps, B; Eckfeld, C; Fluter, L; Keppler, S; Mishrat, R; Knolle, P; Bayer, F; Bottcher, J; Hermann, CD; Haussler, D; Kruger, A				Schoeps, Benjamin; Eckfeld, Celina; Flueter, Laura; Keppler, Selina; Mishrat, Ritu; Knolle, Percy; Bayer, Felix; Boettcher, Jan; Hermann, Chris D.; Haeussler, Daniel; Krueger, Achim			Identification of invariant chain CD74 as a functional receptor of tissue inhibitor of metalloproteinases-1 (TIMP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PREMETASTATIC NICHE; TERMINAL DOMAIN; CELLS; CD63; DIFFERENTIATION	Multifunctionality of tissue inhibitor of metalloproteinases-1 (TIMP-1) comprising antiproteolytic as well as cytokinic activity has been attributed to its N-terminal and C-terminal domains, respectively. The molecular basis of the emerging proinflammatory cytokinic activity of TIMP-1 is still not completely understood. The cytokine receptor invariant chain (CD74) is involved in many inflammation-associated diseases and is highly expressed by immune cells. CD74 triggers zeta chain-associated protein kinase-70 (ZAP-70) signaling-associated activation upon interaction with its only known ligand, the macrophage migration inhibitory factor. Here, we demonstrate TIMP-1-CD74 interaction by coimmunoprecipitation and confocal microscopy in cells engineered to overexpress CD74. In silico docking in HADDOCK predicted regions of the N-terminal domain of TIMP-1 (N-TIMP-1) to interact with CD74. This was experimentally confirmed by confocal microscopy demonstrating that recombinant N-TIMP-1 lacking the entire C-terminal domain was sufficient to bind CD74. Interaction of TIMP-1 with endogenously expressed CD74 was demonstrated in the Namalwa B lymphoma cell line by dot blot binding assays as well as confocal microscopy. Functionally, we demonstrated that TIMP-1-CD74 interaction triggered intracellular ZAP-70 activation. N-TIMP-1 was sufficient to induce ZAP-70 activation and interference with the cytokine-binding site of CD74 using a synthetic peptide-abrogated TIMP-1-mediated ZAP-70 activation. Altogether, we here identified CD74 as a receptor and mediator of cytokinic TIMP-1 activity and revealed TIMP-1 as moonlighting protein harboring both cytokinic and antiproteolytic activity within its N-terminal domain. Recognition of this functional TIMP-1-CD74 interaction may shed new light on clinical attempts to therapeutically target ligand-induced CD74 activity in cancer and other inflammatory diseases.	[Schoeps, Benjamin; Eckfeld, Celina; Flueter, Laura; Knolle, Percy; Bayer, Felix; Boettcher, Jan; Hermann, Chris D.; Haeussler, Daniel; Krueger, Achim] Tech Univ Munich, Inst Mol Immunol, Sch Med, Munich, Germany; [Schoeps, Benjamin; Eckfeld, Celina; Flueter, Laura; Knolle, Percy; Bayer, Felix; Boettcher, Jan; Hermann, Chris D.; Haeussler, Daniel; Krueger, Achim] Tech Univ Munich, Inst Expt Oncol, Sch Med, Munich, Germany; [Keppler, Selina; Mishrat, Ritu] Tech Univ Munich, Sch Med, Inst Clin Chem & Pathobiochem, Munich, Germany; [Keppler, Selina; Mishrat, Ritu] Tech Univ Munich, Ctr Translat Canc Res, TranslaTUM, Munich, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Technical University of Munich	Kruger, A (corresponding author), Tech Univ Munich, Inst Mol Immunol, Sch Med, Munich, Germany.; Kruger, A (corresponding author), Tech Univ Munich, Inst Expt Oncol, Sch Med, Munich, Germany.	achim.krueger@tum.de		Hermann, Chris D./0000-0002-2269-5259; Keppler, Selina Jessica/0000-0002-9010-8044; Schoeps, Benjamin/0000-0003-3934-0849; Haussler, Daniel/0000-0003-0658-3262; Eckfeld, Celina/0000-0002-2807-5368	Deutsche Forschungsgemeinschaft, Bonn, Germany [KR2047/1-3, KR2047/8-1]; Wilhelm Sander-Stiftung, Munich, Germany [2016.124.1, 2016.124.2]	Deutsche Forschungsgemeinschaft, Bonn, Germany(German Research Foundation (DFG)); Wilhelm Sander-Stiftung, Munich, Germany	This work was supported by grants to A. K. from the Deutsche Forschungsgemeinschaft, Bonn, Germany (KR2047/1-3, and KR2047/8-1) and the Wilhelm Sander-Stiftung, Munich, Germany (2016.124.1 and 2016.124.2). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Borghese F, 2011, EXPERT OPIN THER TAR, V15, P237, DOI 10.1517/14728222.2011.550879; CHESLER L, 1995, BLOOD, V86, P4506, DOI 10.1182/blood.V86.12.4506.bloodjournal86124506; Cui H, 2015, ONCOGENE, V34, P3640, DOI 10.1038/onc.2014.300; de Vries SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017695; DOCHERTY AJP, 1985, NATURE, V318, P66, DOI 10.1038/318066a0; Eckfeld C, 2019, CANCER METAST REV, V38, P469, DOI 10.1007/s10555-019-09812-6; Farr L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01273; Figueiredo CR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01132; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Grunwald B, 2016, GASTROENTEROLOGY, V151, P1011, DOI 10.1053/j.gastro.2016.07.043; Grunwald B, 2019, TRENDS CELL BIOL, V29, P6, DOI 10.1016/j.tcb.2018.08.006; Guedez L, 2005, BLOOD, V105, P1660, DOI 10.1182/blood-2004-04-1385; Guedez L, 2001, BLOOD, V97, P1796, DOI 10.1182/blood.V97.6.1796; Guedez L, 1998, J CLIN INVEST, V102, P2002, DOI 10.1172/JCI2881; Huang W, 1996, FEBS LETT, V384, P155, DOI 10.1016/0014-5793(96)00304-3; Huberts DHEW, 2010, BBA-MOL CELL RES, V1803, P520, DOI 10.1016/j.bbamcr.2010.01.022; Jasanoff A, 1998, EMBO J, V17, P6812, DOI 10.1093/emboj/17.23.6812; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Klasen C, 2014, J IMMUNOL, V192, P5273, DOI 10.4049/jimmunol.1302209; Kobuch J, 2015, HAEMATOLOGICA, V100, P1005, DOI 10.3324/haematol.2014.121590; KOCH N, 1982, NATURE, V299, P644, DOI 10.1038/299644a0; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094318; Martin P, 2015, LEUKEMIA LYMPHOMA, V56, P3065, DOI 10.3109/10428194.2015.1028052; Melo R, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17081215; Meza-Romero R, 2016, METAB BRAIN DIS, V31, P249, DOI 10.1007/s11011-016-9798-x; Moreira IS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08321-2; Moreira JM, 2015, CANCER RES, V75, DOI 10.1158/1538-7445.SABCS14-P5-07-08; MURPHY G, 1991, BIOCHEMISTRY-US, V30, P8097, DOI 10.1021/bi00247a001; Murphy G, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-233; Nukarinen E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161480; Raeeszadeh-Sarmazdeh M, 2019, J BIOL CHEM, V294, P9476, DOI 10.1074/jbc.RA119.008321; Rapti M, 2008, BIOCHEM J, V411, P433, DOI 10.1042/BJ20071430; ROCHE PA, 1991, NATURE, V354, P392, DOI 10.1038/354392a0; Schoeps B, 2021, CANCER RES, V81, P3568, DOI 10.1158/0008-5472.CAN-20-4125; Schroder B, 2016, BBA-MOL CELL RES, V1863, P1269, DOI 10.1016/j.bbamcr.2016.03.026; Seubert B, 2015, HEPATOLOGY, V61, P238, DOI 10.1002/hep.27378; Shachar I, 1996, SCIENCE, V274, P106, DOI 10.1126/science.274.5284.106; Stein R, 2007, CLIN CANCER RES, V13, p5556S, DOI 10.1158/1078-0432.CCR-07-1167; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; Thevenard J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103839; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; Vandenbark AA, 2020, CELL IMMUNOL, V354, DOI 10.1016/j.cellimm.2020.104153; Verzeaux L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05039-z; Warner RB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58964-x; WOOLLEY DE, 1975, BIOCHEM BIOPH RES CO, V66, P747, DOI 10.1016/0006-291X(75)90573-2	47	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101072	10.1016/j.jbc.2021.101072	http://dx.doi.org/10.1016/j.jbc.2021.101072			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34391782	Green Published, gold			2022-12-28	WOS:000714635500006
J	Suresh, P; Miller, WT; London, E				Suresh, Pavana; Miller, W. Todd; London, Erwin			Phospholipid exchange shows insulin receptor activity is supported by both the propensity to form wide bilayers and ordered raft domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE PHOSPHATASES; DETERGENT-RESISTANT MEMBRANES; THERMOTROPIC PHASE-BEHAVIOR; LIPID RAFTS; MODEL MEMBRANES; COORDINATED ACTION; CHOLESTEROL; CAVEOLAE; CELLS; PHOSPHATIDYLCHOLINES	Insulin receptor (IR) is a membrane tyrosine kinase that mediates the response of cells to insulin. IR activity has been shown to be modulated by changes in plasma membrane lipid composition, but the properties and structural determinants of lipids mediating IR activity are poorly understood. Here, using efficient methyl-alpha-cyclodextrin mediated lipid exchange, we studied the effect of altering plasma membrane outer leaflet phospholipid composition upon the activity of IR in mammalian cells. After substitution of endogenous lipids with lipids having an ability to form liquid ordered (Lo) domains (sphingomyelins) or liquid disordered (Ld) domains (unsaturated phosphatidylcholines (PCs)), we found that the propensity of lipids to form ordered domains is required for high IR activity. Additional substitution experiments using a series of saturated PCs showed that IR activity increased substantially with increasing acyl chain length, which increases both bilayer width and the propensity to form ordered domains. Incorporating purified IR into alkyl maltoside micelles with increasing hydrocarbon lengths also increased IR activity, but more modestly than by increasing lipid acyl chain length in cells. These results suggest that the ability to form Lo domains as well as wide bilayer width contributes to increased IR activity. Inhibition of phosphatases showed that some of the lipid dependence of IR activity upon lipid structure reflected protection from phosphatases by lipids that support Lo domain formation. These results are consistent with a model in which a combination of bilayer width and ordered domain formation modulates IR activity via IR conformation and accessibility to phosphatases.	[Suresh, Pavana; London, Erwin] SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA; [Miller, W. Todd] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA; [Miller, W. Todd] Dept Vet Affairs Med Ctr, Northport, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	London, E (corresponding author), SUNY Stony Brook, Dept Biochem & Cell Biol, Stony Brook, NY 11794 USA.	Erwin.london@stonybrook.edu		Suresh, Pavana/0000-0003-1597-6818	NIH [GM 122493]; Department of Veterans Affairs Merit Review Grant [BX002292]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs Merit Review Grant(US Department of Veterans Affairs)	This work was supported by NIH grant GM 122493 (to E. L.) and Department of Veterans Affairs Merit Review Grant BX002292 (to W. T. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amoui M, 2001, J ENDOCRINOL, V171, P153, DOI 10.1677/joe.0.1710153; Arsov Z, 2018, CHEM PHYS LIPIDS, V213, P102, DOI 10.1016/j.chemphyslip.2018.03.003; Asante-Appiah E, 2003, AM J PHYSIOL-ENDOC M, V284, pE663, DOI 10.1152/ajpendo.00462.2002; BARON CB, 1984, J LIQ CHROMATOGR, V7, P2793, DOI 10.1080/01483918408067046; Bickel PE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1, DOI 10.1152/ajpendo.2002.282.1.E1; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown DA, 1998, ANNU REV CELL DEV BI, V14, P111, DOI 10.1146/annurev.cellbio.14.1.111; Brown DA, 1998, J MEMBRANE BIOL, V164, P103, DOI 10.1007/s002329900397; Brown DA, 2006, PHYSIOLOGY, V21, P430, DOI 10.1152/physiol.00032.2006; Caselli A, 2002, BIOCHEM BIOPH RES CO, V296, P692, DOI 10.1016/S0006-291X(02)00928-2; Cheng A, 2002, EUR J BIOCHEM, V269, P1050, DOI 10.1046/j.0014-2956.2002.02756.x; Cheng HT, 2009, J BIOL CHEM, V284, P6079, DOI 10.1074/jbc.M806077200; Delle Bovi RJ, 2019, BBA-BIOMEMBRANES, V1861, P819, DOI 10.1016/j.bbamem.2019.01.009; Delle Bovi RJ, 2017, ANAL BIOCHEM, V536, P69, DOI 10.1016/j.ab.2017.08.011; Diaz-Rohrer BB, 2014, P NATL ACAD SCI USA, V111, P8500, DOI 10.1073/pnas.1404582111; Elchebly M, 1999, SCIENCE, V283, P1544, DOI 10.1126/science.283.5407.1544; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gustavsson J, 1999, FASEB J, V13, P1961, DOI 10.1096/fasebj.13.14.1961; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Heberle FA, 2020, P NATL ACAD SCI USA, V117, P19943, DOI 10.1073/pnas.2002200117; Heberle FA, 2013, J AM CHEM SOC, V135, P6853, DOI 10.1021/ja3113615; Hissa B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082988; Karlsson M, 2004, EUR J BIOCHEM, V271, P2471, DOI 10.1111/j.1432-1033.2004.04177.x; Khatibzadeh N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057147; Kim J, 2015, LIPIDS, V50, P721, DOI 10.1007/s11745-015-4007-y; Koynova R, 1998, BBA-REV BIOMEMBRANES, V1376, P91, DOI 10.1016/S0304-4157(98)00006-9; Krishnakumar SS, 2007, J MOL BIOL, V374, P671, DOI 10.1016/j.jmb.2007.09.037; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; LEWIS RNAH, 1987, BIOCHEMISTRY-US, V26, P6118, DOI 10.1021/bi00393a026; LEWIS RNAH, 1988, BIOCHEMISTRY-US, V27, P880, DOI 10.1021/bi00403a007; Li GT, 2020, J LIPID RES, V61, P758, DOI 10.1194/jlr.RA119000565; Li GT, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0223572; Li GT, 2016, P NATL ACAD SCI USA, V113, P14025, DOI 10.1073/pnas.1610705113; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lin CY, 2015, BBA-BIOMEMBRANES, V1848, P886, DOI 10.1016/j.bbamem.2014.12.019; Lin QQ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087903; Lin QQ, 2013, J BIOL CHEM, V288, P1340, DOI 10.1074/jbc.M112.415596; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; London E, 2005, BBA-MOL CELL RES, V1746, P203, DOI 10.1016/j.bbamcr.2005.09.002; MCINTOSH TJ, 1992, BIOCHEMISTRY-US, V31, P2012, DOI 10.1021/bi00122a017; Mihailescu M, 2011, BIOPHYS J, V100, P1455, DOI 10.1016/j.bpj.2011.01.035; Oliver RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062488; Oshikawa J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010189; Park JW, 2013, HEPATOLOGY, V57, P525, DOI 10.1002/hep.26015; Parpal S, 2001, J BIOL CHEM, V276, P9670, DOI 10.1074/jbc.M007454200; Pike LJ, 2005, BBA-MOL CELL RES, V1746, P260, DOI 10.1016/j.bbamcr.2005.05.005; Sanchez-Wandelmer J, 2009, BBA-BIOMEMBRANES, V1788, P1731, DOI 10.1016/j.bbamem.2009.05.002; Stone MB, 2017, ELIFE, V6, DOI 10.7554/eLife.19891; Su XL, 2016, SCIENCE, V352, P595, DOI 10.1126/science.aad9964; SUN H, 1994, TRENDS BIOCHEM SCI, V19, P480, DOI 10.1016/0968-0004(94)90134-1; Symons JL, 2021, SOFT MATTER, V17, P288, DOI 10.1039/d0sm00404a; Tada K, 2009, BBA-BIOMEMBRANES, V1788, P1056, DOI 10.1016/j.bbamem.2009.02.008; Uchikawa E, 2019, ELIFE, V8, DOI 10.7554/eLife.48630; Vainio S, 2005, BIOCHEM J, V391, P465, DOI 10.1042/BJ20050460; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Varshney P, 2016, IMMUNOLOGY, V149, P13, DOI 10.1111/imm.12617; Wang Q, 2018, BIOPHYS J, V115, P664, DOI 10.1016/j.bpj.2018.07.011; Young RM, 2003, J BIOL CHEM, V278, P20746, DOI 10.1074/jbc.M211402200; Zhang L, 2019, FRONT CHEM SCI ENG, V13, P98, DOI 10.1007/s11705-018-1775-y	61	4	4	2	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101010	10.1016/j.jbc.2021.101010	http://dx.doi.org/10.1016/j.jbc.2021.101010			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34324831	Green Published, gold			2022-12-28	WOS:000706408900012
J	Bate, N; Lodge, J; Brindle, NPJ				Bate, Neil; Lodge, James; Brindle, Nicholas P. J.			Intrinsic differences in the mechanisms of Tie2 binding to angiopoietins exploited by directed evolution to create an Ang2-selective ligand trap	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; RECEPTOR; DOMAINS	Angiopoietins Ang1 and Ang2 are secreted ligands for the endothelial receptor tyrosine kinase Tie2 essential for vascular development and maintenance. Ang1 acts as an agonist to maintain normal vessel function, whereas Ang2 acts as a Tie2 antagonist. Ang2 is increased in macular edema, sepsis, and other conditions, in which it blocks Ang1-mediated signaling, causing vascular dysfunction and contributing to disease pathology. Therefore, Ang2 is an attractive therapeutic target. Previously, we reported a Tie2 ectodomain variant that selectively binds Ang2 and acts as soluble ligand trap to sequester Ang2; however, the mechanism of Ang2-binding selectivity is unknown. In the present study, we used directed protein evolution to enhance Ang2-binding affinity of this Tie2 ectodomain trap. We examined contributions of individual residues in the ligand-binding interface of Tie2 to Ang1 and Ang2 binding. Surprisingly, different combinations of Tie2 residues were found to bind each ligand, with hydrophobic residues binding both ligands and polar residues contributing selectively to either Ang1 or Ang2 binding. Our analysis also identified a single Tie2 residue, His168, with a pivotal role in both Ang1 and Ang2 binding, enabling competition between binding ligands. In summary, this study reports an enhanced-affinity Ang2-selective ligand trap with potential for therapeutic development and reveals the mechanism behind its selectivity. It also provides the first analysis of contributions of individual Tie2 residues to Ang1 and Ang2 binding and identifies selectivity-determining residues that could be targeted in the future design of small molecule and other inhibitors of Ang2 for the treatment of vascular dysfunction.	[Brindle, Nicholas P. J.] Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England; Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England	University of Leicester; University of Leicester	Brindle, NPJ (corresponding author), Univ Leicester, Dept Mol & Cell Biol, Leicester, Leics, England.	npjb1@le.ac.uk		Lodge, James/0000-0003-0663-6264; Brindle, Nicholas/0000-0002-4221-677X	British Heart Foundation [PG/19/27/34305, PG/15/65/31707]	British Heart Foundation(British Heart Foundation)	This work was supported by funding from the British Heart Foundation (PG/19/27/34305 and PG/15/65/31707).	Arakawa H, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm616; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Barton WA, 2006, NAT STRUCT MOL BIOL, V13, P524, DOI 10.1038/nsmb1101; Brindle NPJ, 2013, J BIOL CHEM, V288, P33205, DOI 10.1074/jbc.M113.510578; Brindle NPJ, 2006, CIRC RES, V98, P1014, DOI 10.1161/01.RES.0000218275.54089.12; Davis S, 1996, CELL, V87, P1161, DOI 10.1016/S0092-8674(00)81812-7; DUMONT DJ, 1992, ONCOGENE, V7, P1471; Economides AN, 2003, NAT MED, V9, P47, DOI 10.1038/nm811; Fiedler U, 2003, J BIOL CHEM, V278, P1721, DOI 10.1074/jbc.M208550200; Huang CC, 2009, CURR OPIN BIOTECH, V20, P692, DOI 10.1016/j.copbio.2009.10.010; Ji P, 2020, J CLIN PHARMACOL, V60, P1275, DOI 10.1002/jcph.1729; Kim KT, 2005, J BIOL CHEM, V280, P20126, DOI 10.1074/jbc.M500292200; Lee SJ, 2018, J CLIN INVEST, V128, P5018, DOI 10.1172/JCI99659; Macdonald PR, 2006, J BIOL CHEM, V281, P28408, DOI 10.1074/jbc.M605219200; Maisonpierre PC, 1997, SCIENCE, V277, P55, DOI 10.1126/science.277.5322.55; PARTANEN J, 1992, MOL CELL BIOL, V12, P1698, DOI 10.1128/MCB.12.4.1698; Peters KG, 2004, RECENT PROG HORM RES, V59, P51, DOI 10.1210/rp.59.1.51; Procopio WN, 1999, J BIOL CHEM, V274, P30196, DOI 10.1074/jbc.274.42.30196; RUNTING AS, 1993, GROWTH FACTORS, V9, P99; Sacconi R., 2019, F1000RES; Saharinen P, 2017, NAT REV DRUG DISCOV, V16, P635, DOI 10.1038/nrd.2016.278; Tabruyn SP, 2010, AM J PATHOL, V177, P3233, DOI 10.2353/ajpath.2010.100059; Watson PJ, 2012, NATURE, V481, P335, DOI 10.1038/nature10728; Yu XH, 2013, P NATL ACAD SCI USA, V110, P7205, DOI 10.1073/pnas.1216890110; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	25	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100888	10.1016/j.jbc.2021.100888	http://dx.doi.org/10.1016/j.jbc.2021.100888			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34153320	gold, Green Published			2022-12-28	WOS:000690873500015
J	Buck, M				Buck, Matthias			Letting go: Deep computational modeling insights into pH-dependent calcium affinity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Calcium and other cofactors can feature as key additions to a molecular interface, to the extent that the cofactor is completely buried in the bound state. How can such an interaction be regulated then? The answer: By facilitating a switch through an allosteric network. Although a number of unbinding mechanisms are being characterized, an extensive computational study by Joswig et al. reveals a detailed model for the pattern recognition receptor langerin.	[Buck, Matthias] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Case Western Reserve University	Buck, M (corresponding author), Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA.	Matthias.Buck@case.edu			NEI, National Institutes of Health [R01EY029169]	NEI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	M. B. thanks Jan-O Joswig and Bettina Keller for critical reading. This work was supported by NEI, National Institutes of Health, Grant R01EY029169. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Chen TY, 2018, ACCOUNTS CHEM RES, V51, P860, DOI 10.1021/acs.accounts.7b00541; Feinberg H, 2010, J BIOL CHEM, V285, P13285, DOI 10.1074/jbc.M109.086058; Hanske J, 2016, J AM CHEM SOC, V138, P12176, DOI 10.1021/jacs.6b05458; Joswig JO, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100718; Keller BG, 2020, CURR OPIN STRUC BIOL, V62, P31, DOI 10.1016/j.sbi.2019.11.003; Li ZL, 2017, STRUCTURE, V25, P679, DOI 10.1016/j.str.2017.02.007; Mack ET, 2012, J AM CHEM SOC, V134, P333, DOI 10.1021/ja2073033; Ribeiro JML, 2019, BIOCHEMISTRY-US, V58, P156, DOI 10.1021/acs.biochem.8b00977; Rosenzweig R, 2016, J AM CHEM SOC, V138, P1466, DOI 10.1021/jacs.5b11346; Zhang LQ, 2016, BIOPHYS J, V110, P877, DOI 10.1016/j.bpj.2015.12.036	10	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100974	10.1016/j.jbc.2021.100974	http://dx.doi.org/10.1016/j.jbc.2021.100974			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34280436	gold, Green Published			2022-12-28	WOS:000690871400020
J	Chen, ZG; Eggerman, TL; Bocharov, AV; Baranova, IN; Vishnyakova, TG; Patterson, AP				Chen, Zhigang; Eggerman, Thomas L.; Bocharov, Alexander, V; Baranova, Irina N.; Vishnyakova, Tatyana G.; Patterson, Amy P.			APOBEC3-induced mutation of the hepatitis virus B DNA genome occurs during its viral RNA reverse transcription into (-)-DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOBEC3 CYTIDINE DEAMINASES; HYPERMUTATION; MUTAGENESIS; OVEREXPRESSION; HETEROGENEITY; REPLICATION; EVOLUTION; PROTEINS	APOBEC3s are innate single-stranded DNA cytidine-touridine deaminases that catalyze mutations in both pathogen and human genomes with significant roles in human disease. However, how APOBEC3s mutate a single-stranded DNA that is available momentarily during DNA transcription or replication in vivo remains relatively unknown. In this study, utilizing hepatitis B virus (HBV) viral mutations, we evaluated the mutational characteristics of individual APOBEC3s with reference to the HBV replication process through HBV whole single-strand (-)-DNA genome mutation analyses. We found that APOBEC3s induced C-to-T mutations from the HBV reverse transcription start site continuing through the whole (-)-DNA transcript to the termination site with variable effi-ciency, in an order of A3B >> A3G > A3H-II or A3C. A3B had a 3-fold higher mutation efficiency than A3H-II or A3C with up to 65% of all HBV genomic cytidines being converted into uridines in a single mutation event, consistent with the A3B localized hypermutation signature in cancer, namely, kataegis. On the other hand, A3C expression led to a 3-fold higher number of mutation-positive HBV genome clones, although each individual clone had a lower number of C-to-T mutations. Like A3B, A3C preferred both 50-TC and 50-CC sequences, but to a lesser degree. The APOBEC3-induced HBV mutations were predominantly detected in the HBV rcDNA but were not detectable in other intermediates including HBV cccDNA and pgRNA by primer extension of their PCR amplification products. These data demonstrate that APOBEC3-induced HBV genome mutations occur predominantly when the HBV RNA genome was reversely transcribed into (-)-DNA in the viral capsid.	[Chen, Zhigang; Eggerman, Thomas L.; Bocharov, Alexander, V; Baranova, Irina N.; Vishnyakova, Tatyana G.; Patterson, Amy P.] Clin Ctr, Dept Lab Med, Bethesda, MD 20892 USA; [Eggerman, Thomas L.] NIDDK, Div Diabet Endocrinol & Metab Dis, Bethesda, MD 20892 USA; [Patterson, Amy P.] NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Patterson, AP (corresponding author), Clin Ctr, Dept Lab Med, Bethesda, MD 20892 USA.; Patterson, AP (corresponding author), NHLBI, NIH, Bldg 10, Bethesda, MD 20892 USA.	amy.patterson@nih.gov			National Institute of Health; NIAID; NIDDK	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research is supported by the intramural program of the National Institute of Health with funds from NIAID and NIDDK. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Health.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alves BM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9120392; Anderson M, 2018, GENES-BASEL, V9, DOI 10.3390/genes9090453; Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; Burns MB, 2013, NAT GENET, V45, P977, DOI 10.1038/ng.2701; Burns MB, 2013, NATURE, V494, P366, DOI 10.1038/nature11881; Chelico L, 2006, NAT STRUCT MOL BIOL, V13, P392, DOI 10.1038/nsmb1086; Chen JL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16459; Chen YM, 2018, ANTIVIR RES, V149, P16, DOI 10.1016/j.antiviral.2017.11.006; Chen ZG, 2017, J BIOL CHEM, V292, P13459, DOI 10.1074/jbc.M116.760637; Chen ZG, 2012, J MOL BIOL, V418, P65, DOI 10.1016/j.jmb.2012.02.005; Chen ZG, 2010, RNA, V16, P1040, DOI 10.1261/rna.1863010; Desimmie BA, 2016, NUCLEIC ACIDS RES, V44, P7848, DOI 10.1093/nar/gkw653; Doehle BP, 2005, VIROLOGY, V339, P281, DOI 10.1016/j.virol.2005.06.005; Glebe D, 2013, SEMIN LIVER DIS, V33, P103, DOI 10.1055/s-0033-1345717; Green AM, 2019, DNA REPAIR, V83, DOI 10.1016/j.dnarep.2019.102700; Gunther S, 1997, VIROLOGY, V238, P363, DOI 10.1006/viro.1997.8863; GUNTHER S, 1995, J VIROL, V69, P5437; Harari A, 2009, J VIROL, V83, P295, DOI 10.1128/JVI.01665-08; Harris RS, 2015, VIROLOGY, V479, P131, DOI 10.1016/j.virol.2015.03.012; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kanagaraj A, 2019, BIOCHEM BIOPH RES CO, V518, P26, DOI 10.1016/j.bbrc.2019.08.003; Kitamura K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003361; Kock J, 2008, J GEN VIROL, V89, P1184, DOI 10.1099/vir.0.83507-0; Lam AM, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.00680-17, 10.1128/aac.00680-17]; Law EK, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601737; Li XL, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060139; Nair S, 2018, J VIROL, V92, DOI 10.1128/JVI.02190-17; Ng JCF, 2019, NUCLEIC ACIDS RES, V47, P1178, DOI 10.1093/nar/gky1316; Nikkila J, 2017, BRIT J CANCER, V117, P113, DOI 10.1038/bjc.2017.133; Nowarski R, 2008, NAT STRUCT MOL BIOL, V15, P1059, DOI 10.1038/nsmb.1495; Olson ME, 2018, CELL CHEM BIOL, V25, P36, DOI 10.1016/j.chembiol.2017.10.007; Pak V, 2011, J VIROL, V85, P8538, DOI 10.1128/JVI.02645-10; Rawson JMO, 2018, NUCLEIC ACIDS RES, V46, P10535, DOI 10.1093/nar/gky910; Roberts SA, 2013, NAT GENET, V45, P970, DOI 10.1038/ng.2702; Roper N, 2019, CELL REP, V26, P2651, DOI 10.1016/j.celrep.2019.02.028; Serebrenik AA, 2020, CLIN CANCER RES, V26, P3397, DOI 10.1158/1078-0432.CCR-19-2786; Silvas TV, 2019, PROTEIN SCI, V28, P1552, DOI 10.1002/pro.3670; Suspene R, 2005, P NATL ACAD SCI USA, V102, P8321, DOI 10.1073/pnas.0408223102; Suspene R, 2016, RETROVIROLOGY, V13, DOI 10.1186/s12977-016-0318-1; Vartanian JP, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000928; Wang JCY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002919; Wissing S, 2010, MOL ASPECTS MED, V31, P383, DOI 10.1016/j.mam.2010.06.001; WU HL, 1991, J VIROL, V65, P1680, DOI 10.1128/JVI.65.4.1680-1686.1991; Yang ZT, 2015, J CLIN MICROBIOL, V53, P2203, DOI 10.1128/JCM.00068-15; Zhou HL, 2017, VIRUS RES, V235, P86, DOI 10.1016/j.virusres.2017.03.021; Zhu B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14730-1; Zou J, 2017, CELL BIOSCI, V7, DOI 10.1186/s13578-017-0156-4	49	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100889	10.1016/j.jbc.2021.100889	http://dx.doi.org/10.1016/j.jbc.2021.100889			26	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34181944	gold, Green Published			2022-12-28	WOS:000690873500013
J	Rajagopal, S; Poddar, R; Paul, S				Rajagopal, Sathyanarayanan; Poddar, Ranjana; Paul, Surojit			Tyrosine phosphatase STEP is a key regulator of glutamate-induced prostaglandin E-2 release from neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; CYTOSOLIC PHOSPHOLIPASE A(2); FACTOR-KAPPA-B; SPECIFICITY SEQUENCE; SIGNALING PATHWAY; PTP-SL; CYCLOOXYGENASE-2; PHOSPHORYLATION; INACTIVATION; RECEPTORS	The neuron-specific tyrosine phosphatase striatal-enriched phosphatase (STEP) is emerging as a key regulator of excitotoxicity, which is involved in the pathogenesis of both acute and chronic neurological diseases. However, the intracellular mechanisms that are regulated by STEP to confer neuroprotection against excitotoxic insults are not well understood. The present study investigates the role of STEP in regulating neuronal release of the proinflammatory prostanoid prostaglandin E-2 (PGE(2)), which is associated with a wide range of pathological conditions. The findings show that glutamate-mediated activation of the N-methyl-D-aspartic acid receptor in STEP-deficient neurons leads to rapid and sustained increase in the phosphorylation of p38 mitogen-activated protein kinase (p38 MAPK), a signaling molecule involved in the production of inflammatory mediators. Such sustained p38 MAPK activation increases the activity of cytosolic phospholipase A(2), which catalyzes the release of arachidonic acid, the initial substrate for PGE(2) biosynthesis. Sustained p38 MAPK activation also induces nuclear factor-kappa B-mediated increase in expression of cyclooxygenase-2 that is involved in the conversion of arachidonic acid to prostanoids, resulting in enhanced biosynthesis and release of PGE(2) from neurons. Restoration of STEP function with a STEP mimetic (TAT-STEP-myc peptide) significantly decreases the activation of p38 MAPK-mediated cytosolic phospholipase A(2)/cyclooxygenase-2/PGE(2) signaling cascade. This study identifies an important mechanism involved in the neuronal release of the proinflammatory mediator PGE(2) after excitotoxic insult and highlights for the first time the immunomodulatory ability of a neuronal tyrosine phosphatase.	[Rajagopal, Sathyanarayanan; Poddar, Ranjana; Paul, Surojit] Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA	University of New Mexico; University of New Mexico's Health Sciences Center	Paul, S (corresponding author), Univ New Mexico, Hlth Sci Ctr, Dept Neurol, Albuquerque, NM 87131 USA.	spaul@salud.unm.edu			National Institutes of Health [NS059962, NS083914]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health Grant numbers NS059962 (to S. P.) and NS083914 (to R. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ackerman WE, 2008, BIOL REPROD, V78, P68, DOI 10.1095/biolreprod.107.061663; Ainslie PN, 2008, J PHYSIOL-LONDON, V586, P4005, DOI 10.1113/jphysiol.2008.158279; BOULANGER LM, 1995, J NEUROSCI, V15, P1532; Bult A, 1996, J NEUROSCI, V16, P7821; Candelario-Jalil E, 2021, EXP NEUROL, V335, DOI 10.1016/j.expneurol.2020.113494; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; de Vis JB, 2015, HUM BRAIN MAPP, V36, P3973, DOI 10.1002/hbm.22891; Deb I, 2013, J NEUROSCI, V33, P17814, DOI 10.1523/JNEUROSCI.2346-12.2013; Deb I, 2011, J NEUROCHEM, V116, P1097, DOI 10.1111/j.1471-4159.2010.07165.x; Dong P, 2014, NEUROSCIENCE, V275, P2, DOI 10.1016/j.neuroscience.2014.05.064; Graeber MB, 2011, FEBS LETT, V585, P3798, DOI 10.1016/j.febslet.2011.08.033; Guo RM, 2013, MOL MED REP, V8, P603, DOI 10.3892/mmr.2013.1554; He JY, 2018, TRANSL NEUROSCI, V9, P147, DOI 10.1515/tnsci-2018-0022; Ji RR, 2007, MOL PAIN, V3, DOI 10.1186/1744-8069-3-33; Kaltschmidt B, 2002, BMC MOL BIOL, V3, DOI 10.1186/1471-2199-3-16; Kaltschmidt B, 2005, BBA-MOL CELL RES, V1745, P287, DOI 10.1016/j.bbamcr.2005.05.009; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kim EK, 2015, ARCH TOXICOL, V89, P867, DOI 10.1007/s00204-015-1472-2; Kramer RM, 1996, J BIOL CHEM, V271, P27723, DOI 10.1074/jbc.271.44.27723; Krementsov DN, 2013, MOL CELL BIOL, V33, P3728, DOI 10.1128/MCB.00688-13; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lasa M, 2000, MOL CELL BIOL, V20, P4265, DOI 10.1128/MCB.20.12.4265-4274.2000; Legos JJ, 2002, EUR J PHARMACOL, V447, P37, DOI 10.1016/S0014-2999(02)01890-3; Lewerenz J, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00469; LIN LL, 1993, CELL, V72, P269, DOI 10.1016/0092-8674(93)90666-E; Lodge D, 2009, NEUROPHARMACOLOGY, V56, P6, DOI 10.1016/j.neuropharm.2008.08.006; LOMBROSO PJ, 1993, J NEUROSCI, V13, P3064; Lynch DR, 2002, J PHARMACOL EXP THER, V300, P717, DOI 10.1124/jpet.300.3.717; Macri MA, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-14; Mattson MP, 2006, NAT REV NEUROSCI, V7, P278, DOI 10.1038/nrn1886; Minghetti L, 2004, J NEUROPATH EXP NEUR, V63, P901, DOI 10.1093/jnen/63.9.901; Mukherjee S, 2011, BIOCHEM J, V440, P115, DOI 10.1042/BJ20110240; Munoz JJ, 2003, BIOCHEM J, V372, P193, DOI 10.1042/BJ20021941; Munoz L, 2010, NEUROPHARMACOLOGY, V58, P561, DOI 10.1016/j.neuropharm.2009.11.010; Nguyen TH, 1999, J NEUROCHEM, V73, P1995; Olney J W, 1986, Adv Exp Med Biol, V203, P631; Ostergaard L, 2016, J CEREBR BLOOD F MET, V36, P302, DOI 10.1177/0271678X15606723; Paul S, 2003, NAT NEUROSCI, V6, P34, DOI 10.1038/nn989; Paul S, 2000, J NEUROSCI, V20, P5630, DOI 10.1523/JNEUROSCI.20-15-05630.2000; Poddar R, 2019, J CEREBR BLOOD F MET, V39, P1069, DOI 10.1177/0271678X17747193; Poddar R, 2016, J BIOL CHEM, V291, P813, DOI 10.1074/jbc.M115.663468; Poddar R, 2010, J NEUROCHEM, V115, P1350, DOI 10.1111/j.1471-4159.2010.07035.x; Prinz M, 2017, NAT NEUROSCI, V20, P136, DOI 10.1038/nn.4475; Rajagopal S, 2021, BRAIN BEHAV IMMUN, V93, P141, DOI 10.1016/j.bbi.2020.12.034; Rajagopal S, 2019, J NEUROCHEM, V150, P44, DOI 10.1111/jnc.14775; Rajagopal S, 2016, NEUROBIOL AGING, V41, P25, DOI 10.1016/j.neurobiolaging.2016.02.004; Shelat PB, 2008, J NEUROCHEM, V106, P45, DOI 10.1111/j.1471-4159.2008.05347.x; Shen Y, 2007, P NATL ACAD SCI USA, V104, P6078, DOI 10.1073/pnas.0605427104; Shi G, 2015, AM J TRANSL RES, V7, P1612; Spooren W, 2010, CURR TOP BEHAV NEURO, V2, P391, DOI 10.1007/7854_2010_36; Strauss KI, 2002, J NEUROTRAUM, V19, P627, DOI 10.1089/089771502753754091; Svensson CI, 2003, NEUROREPORT, V14, P1153, DOI 10.1097/00001756-200306110-00010; Torres JES, 2006, NEUROSCI LETT, V403, P233, DOI 10.1016/j.neulet.2006.04.063; Waxman EA, 2005, J BIOL CHEM, V280, P29322, DOI 10.1074/jbc.M502080200; Yamamoto K, 1995, J BIOL CHEM, V270, P31315, DOI 10.1074/jbc.270.52.31315; Zuniga A, 1999, J BIOL CHEM, V274, P21900, DOI 10.1074/jbc.274.31.21900	56	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100944	10.1016/j.jbc.2021.100944	http://dx.doi.org/10.1016/j.jbc.2021.100944			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34246631	Green Published, gold			2022-12-28	WOS:000690871000007
J	Ehrencrona, E; van der Post, S; Gallego, P; Recktenwald, CV; Rodriguez-Pineiro, AM; Garcia-Bonete, MJ; Trillo-Muyo, S; Backstrom, M; Hansson, GC; Johansson, MEV				Ehrencrona, Erik; van der Post, Sjoerd; Gallego, Pablo; Recktenwald, Christian, V; Rodriguez-Pineiro, Ana M.; Garcia-Bonete, Maria-Jose; Trillo-Muyo, Sergio; Backstrom, Malin; Hansson, Gunnar C.; Johansson, Malin E., V			The IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRE-ALPHA-INHIBITOR; COVALENTLY CROSS-LINKS; VON-WILLEBRAND-FACTOR; MUC2 MUCIN; HEAVY-CHAIN; AUTOCATALYTIC CLEAVAGE; LOW PH; IDENTIFICATION; LAYERS; CELLS	Mucus forms an important protective barrier that minimizes bacterial contact with the colonic epithelium. Intestinal mucus is organized in a complex network with several specific proteins, including the mucin-2 (MUC2) and the abundant IgGFc-binding protein, FCGBP. FCGBP is expressed in all intestinal goblet cells and is secreted into the mucus. It is comprised of repeated von Willebrand D (vWD) domain assemblies, most of which have a GDPH amino acid sequence that can be autocatalytically cleaved, as previously observed in the mucins MUC2 and mucin-5AC. However, the functions of FCGBP in the mucus are not understood. We show that all vWD domains of FCGBP with a GDPH sequence are cleaved and that these cleavages occur early during biosynthesis in the endoplasmic reticulum. All cleaved fragments, however, remain connected via a disulfide bond within each vWD domain. This cleavage generates a C-terminal-reactive Asp-anhydride that could react with other molecules, such as MUC2, but this was not observed. Quantitative analyses by MS showed that FCGBP was mainly soluble in chaotropic solutions, whereas MUC2 was insoluble, and most of the secreted FCGBP was not covalently bound to MUC2. Although FCGBP has been suggested to bind immunoglobulin G, we were unable to reproduce this binding in vitro using purified proteins. In conclusion, while the function of FCGBP is still unknown, our results suggest that it does not contribute to covalent crosslinking in the mucus, nor incorporate immunoglobulin G into mucus, instead the single disulfide bond linking each fragment could mediate controlled dissociation.	[Ehrencrona, Erik; van der Post, Sjoerd; Gallego, Pablo; Recktenwald, Christian, V; Rodriguez-Pineiro, Ana M.; Garcia-Bonete, Maria-Jose; Trillo-Muyo, Sergio; Backstrom, Malin; Hansson, Gunnar C.; Johansson, Malin E., V] Univ Gothenburg, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden	University of Gothenburg	Johansson, MEV (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem, Gothenburg, Sweden.	malin.johansson@medkem.gu.se	Johansson, Malin E. V./HCH-7451-2022; Garcia-Bonete, Maria Jose/AAE-8902-2021; Hansson, Gunnar C./A-1236-2009	Garcia-Bonete, Maria Jose/0000-0002-8832-4338; Johansson, Malin E. V./0000-0002-4237-6677; van der Post, Sjoerd/0000-0002-7965-5311; Recktenwald, Christian Viktor/0000-0003-1710-1863; Trillo-Muyo, Sergio/0000-0002-3135-9134; Hansson, Gunnar C./0000-0002-1900-1869	Swedish Research Council [201503047, 2017-00958, 2019-01134]; Swedish Cancer Foundation [CAN2016/487, 2017/360]; Knut and Alice Wallenberg Foundation [2017-0028]; National Institute of Allergy and Infectious Diseases [U01AI095473]; European Research Council (ERC) [694181]; IngaBritt and Arne Lundberg Foundation [2015-070, 2018-0117]; Sahlgrenska University Hospital [ALFGBG-724681, ALFGBG-440741]; Sahlgrenska Academy	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); European Research Council (ERC)(European Research Council (ERC)European Commission); IngaBritt and Arne Lundberg Foundation; Sahlgrenska University Hospital; Sahlgrenska Academy	We thank the Mammalian Protein Expression Core Facility and the Centre for Cellular Imaging at the Sahlgrenska Academy for their assistance. We are thankful for all technical assistance and help from Frida Svensson and Joakim Bergstrom. This work was supported by the Swedish Research Council (201503047, 2017-00958, 2019-01134), the Swedish Cancer Foundation (CAN2016/487, 2017/360), the Knut and Alice Wallenberg Foundation (2017-0028), National Institute of Allergy and Infectious Diseases (U01AI095473), European Research Council (ERC) (694181), IngaBritt and Arne Lundberg Foundation (2015-070, 2018-0117), Sahlgrenska University Hospital (ALFGBG-724681, ALFGBG-440741), and the Sahlgrenska Academy.	Adkins JN, 2002, MOL CELL PROTEOMICS, V1, P947, DOI 10.1074/mcp.M200066-MCP200; Albert TK, 2010, J PROTEOME RES, V9, P3108, DOI 10.1021/pr100020c; Armenteros JJA, 2019, NAT BIOTECHNOL, V37, P420, DOI 10.1038/s41587-019-0036-z; Axelsson MAB, 1998, J BIOL CHEM, V273, P18864, DOI 10.1074/jbc.273.30.18864; Bell CH, 2013, SCIENCE, V341, P77, DOI 10.1126/science.1232322; Blom AM, 1997, BIOCHEM J, V328, P185; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Dong XC, 2019, BLOOD, V133, P1523, DOI 10.1182/blood-2018-10-876300; ENGHILD JJ, 1991, J BIOL CHEM, V266, P747; Erickson NA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131991; Espey MG, 2013, FREE RADICAL BIO MED, V55, P130, DOI 10.1016/j.freeradbiomed.2012.10.554; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Harada N, 1997, J BIOL CHEM, V272, P15232, DOI 10.1074/jbc.272.24.15232; Herrmann A, 1999, J BIOL CHEM, V274, P15828, DOI 10.1074/jbc.274.22.15828; Javitt G, 2020, CELL, V183, P717, DOI 10.1016/j.cell.2020.09.021; Johansson MEV, 2015, CELL HOST MICROBE, V18, P582, DOI 10.1016/j.chom.2015.10.007; Johansson MEV, 2009, J PROTEOME RES, V8, P3549, DOI 10.1021/pr9002504; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kaczmarczyk A, 2002, J BIOL CHEM, V277, P13578, DOI 10.1074/jbc.M200288200; Kobayashi K, 2002, GUT, V51, P169, DOI 10.1136/gut.51.2.169; KOBAYASHI K, 1989, J IMMUNOL, V143, P2567; KOBAYASHI K, 1991, J IMMUNOL, V146, P68; Lang TG, 2016, MOL BIOL EVOL, V33, P1921, DOI 10.1093/molbev/msw066; Lidell ME, 2006, BIOCHEM J, V399, P121, DOI 10.1042/BJ20060443; Lidell ME, 2003, J BIOL CHEM, V278, P13944, DOI 10.1074/jbc.M210069200; Lockhart-Cairns MP, 2019, MATRIX BIOL, V77, P73, DOI 10.1016/j.matbio.2018.08.006; MORELLE W, 1994, EUR J BIOCHEM, V221, P881, DOI 10.1111/j.1432-1033.1994.tb18803.x; Nystrom EEL, 2018, EBIOMEDICINE, V33, P134, DOI 10.1016/j.ebiom.2018.05.031; Osicka R, 2004, J BIOL CHEM, V279, P24944, DOI 10.1074/jbc.M314013200; Patrick ME, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20153814; PISZKIEW.D, 1970, BIOCHEM BIOPH RES CO, V40, P1173, DOI 10.1016/0006-291X(70)90918-6; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Recktenwald CV, 2016, J BIOL CHEM, V291, P13580, DOI 10.1074/jbc.M116.726406; Reese AT, 2018, ELIFE, V7, DOI 10.7554/eLife.35987; Rodriguez-Pineiro AM, 2013, AM J PHYSIOL-GASTR L, V305, pG348, DOI 10.1152/ajpgi.00047.2013; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Schirrmeister J, 2011, J BACTERIOL, V193, P3733, DOI 10.1128/JB.00437-11; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Schwartz Jacquelyn L, 2014, Open AIDS J, V8, P21, DOI 10.2174/1874613601408010021; Serpe M, 2008, DEV CELL, V14, P940, DOI 10.1016/j.devcel.2008.03.023; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Soto P, 2006, J CELL BIOCHEM, V97, P1267, DOI 10.1002/jcb.20718; Springer TA, 2014, BLOOD, V124, P1412, DOI 10.1182/blood-2014-05-378638; Thuveson M, 2000, J BIOL CHEM, V275, P30996, DOI 10.1074/jbc.M002399200; Thuveson M, 1999, J BIOL CHEM, V274, P6741, DOI 10.1074/jbc.274.10.6741; van der Post S, 2019, GUT, V68, P2142, DOI 10.1136/gutjnl-2018-317571; van der Post S, 2013, J BIOL CHEM, V288, P14636, DOI 10.1074/jbc.M113.459479; Velcich A, 2002, SCIENCE, V295, P1726, DOI 10.1126/science.1069094; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Zhou YF, 2012, BLOOD, V120, P449, DOI 10.1182/blood-2012-01-405134	54	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100871	10.1016/j.jbc.2021.100871	http://dx.doi.org/10.1016/j.jbc.2021.100871			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34126068	gold, Green Submitted, Green Published			2022-12-28	WOS:000678068400071
J	Marakasova, E; Olivares, P; Karnaukhova, E; Chun, H; Hernandez, NE; Kurasawa, JH; Hassink, GU; Shestopal, SA; Strickland, DK; Sarafanov, AG				Marakasova, Ekaterina; Olivares, Philip; Karnaukhova, Elena; Chun, Haarin; Hernandez, Nancy E.; Kurasawa, James H.; Hassink, Gabriela U.; Shestopal, Svetlana A.; Strickland, Dudley K.; Sarafanov, Andrey G.			Molecular chaperone RAP interacts with LRP1 in a dynamic bivalent mode and enhances folding of ligand-binding regions of other LDLR family receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DENSITY-LIPOPROTEIN RECEPTOR; HIGH-AFFINITY BINDING; CONSERVED ACIDIC RESIDUE; PROTEIN-PROTEIN DOCKING; CIRCULAR-DICHROISM; VLDL RECEPTOR; I-TASSER; RECOGNITION; COMPLEX; EXPRESSION	The low-density lipoprotein receptor (LDLR) family of receptors are cell-surface receptors that internalize numerous ligands and play crucial role in various processes, such as lipoprotein metabolism, hemostasis, fetal development, etc. Previously, receptor-associated protein (RAP) was described as a molecular chaperone for LDLR-related protein 1 (LRP1), a prominent member of the LDLR family. We aimed to verify this role of RAP for LRP1 and two other LDLR family receptors, LDLR and vLDLR, and to investigate the mechanisms of respective interactions using a cell culture model system, purified system, and in silico modelling. Upon coexpression of RAP with clusters of the ligand-binding complement repeats (CRs) of the receptors in secreted form in insect cells culture, the isolated proteins had increased yield, enhanced folding, and improved binding properties compared with proteins expressed without RAP, as determined by circular dichroism and surface plasmon resonance. Within LRP1 CR-clusters II and IV, we identified multiple sites comprised of adjacent CR doublets, which provide alternative bivalent binding combinations with specific pairs of lysines on RAP. Mutational analysis of these lysines within each of isolated RAP D1/D2 and D3 domains having high affinity to LRP1 and of conserved tryptophans on selected CR-doublets of LRP1, as well as in silico docking of a model LRP1 CR-triplet with RAP, indicated a universal role for these residues in interaction of RAP and LRP1. Consequently, we propose a new model of RAP interaction with LDLR family receptors based on switching of the bivalent contacts between molecules over time in a dynamic mode.	[Marakasova, Ekaterina; Olivares, Philip; Karnaukhova, Elena; Chun, Haarin; Hernandez, Nancy E.; Kurasawa, James H.; Hassink, Gabriela U.; Shestopal, Svetlana A.; Sarafanov, Andrey G.] US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA; [Strickland, Dudley K.] Univ Maryland, Sch Med, Ctr Vasc & Inflammatory Dis, Baltimore, MD 21201 USA; [Marakasova, Ekaterina] US FDA, Ctr Devices & Radiol Hlth, Silver Spring, MD USA; [Kurasawa, James H.] AstraZeneca, R&D, Antibody Discovery & Prot Engn, Gaithersburg, MD USA; [Hassink, Gabriela U.] GSK Slaoui Ctr Vaccines Res, Rockville, MD USA	US Food & Drug Administration (FDA); University System of Maryland; University of Maryland Baltimore; US Food & Drug Administration (FDA); AstraZeneca	Sarafanov, AG (corresponding author), US FDA, Ctr Biol Evaluat & Res, Silver Spring, MD 20993 USA.	Andrey.Sarafanov@fda.hhs.gov		Marakasova, Ekaterina/0000-0002-6505-4726; Sarafanov, Andrey/0000-0001-6124-9713; Hernandez, Nancy/0000-0002-8307-4704; Shestopal, Svetlana/0000-0003-0725-5885; Olivares, Philip/0000-0003-3182-5884; Chun, Haarin/0000-0002-2668-6296	Center for Biologics Evaluation and Research of the US Food and Drug Administration	Center for Biologics Evaluation and Research of the US Food and Drug Administration	This work was supported by funds from the Center for Biologics Evaluation and Research of the US Food and Drug Administration by appointments to the research program administered by the Oak Ridge Institute for Science and Education through an interagency agreement with the US Department of Energy. This study used the computational resources of the High Performance Computing clusters of the FDA, Center for Devices and Radiological Health. The authors are thankful to Dr. Rong Fong Shen and Dr. Wells Wu (US FDA), who contributed to protein characterization. These contributions are an informal communication and represent the best judgment of the authors and do not bind or obligate the US Food and Drug Administration.	Dato VA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061780; Andersen OM, 2000, J BIOL CHEM, V275, P21017, DOI 10.1074/jbc.M000507200; Andersen OM, 2001, BIOCHEMISTRY-US, V40, P15408, DOI 10.1021/bi0110692; Au DT, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8356537; Bajari TM, 1998, BIOL CHEM, V379, P1053, DOI 10.1515/bchm.1998.379.8-9.1053; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Chagas R, 2018, FOOD CHEM, V259, P166, DOI 10.1016/j.foodchem.2018.03.115; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Cooper JM, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100715; De Nardis C, 2017, J BIOL CHEM, V292, P912, DOI 10.1074/jbc.M116.758862; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Dlugosz P, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19103090; Dolmer K, 2013, J BIOL CHEM, V288, P24081, DOI 10.1074/jbc.M113.473728; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Gent J, 2004, CELL MOL LIFE SCI, V61, P2461, DOI 10.1007/s00018-004-4090-3; Gettins PGW, 2012, BIOCHEM J, V443, P65, DOI 10.1042/BJ20111867; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Guo Y, 2004, J BIOL CHEM, V279, P16629, DOI 10.1074/jbc.M400157200; HERZ J, 1991, J BIOL CHEM, V266, P21232; HIDER RC, 1988, BIOPHYS CHEM, V31, P45, DOI 10.1016/0301-4622(88)80007-3; HIDER RC, 1988, BIOPOLYMERS, V27, P113, DOI 10.1002/bip.360270109; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jensen GA, 2006, J MOL BIOL, V362, P700, DOI 10.1016/j.jmb.2006.07.013; Jensen JK, 2009, BIOCHEM J, V421, P273, DOI 10.1042/BJ20090175; Katz AK, 1996, J AM CHEM SOC, V118, P5752, DOI 10.1021/ja953943i; Kelly SM, 2000, CURR PROTEIN PEPT SC, V1, P349, DOI 10.2174/1389203003381315; Khalili M, 2004, PROTEIN SCI, V13, P2725, DOI 10.1110/ps.04878904; Kurasawa JH, 2015, BIOCHEMISTRY-US, V54, P481, DOI 10.1021/bi5011688; Kurasawa JH, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.468108; Lane-Donovan C, 2014, NEURON, V83, P771, DOI 10.1016/j.neuron.2014.08.005; Martinez-Olivan J, 2015, FEBS LETT, V589, P3534, DOI 10.1016/j.febslet.2015.10.014; Marze NA, 2017, PROTEINS, V85, P479, DOI 10.1002/prot.25168; MEDH JD, 1995, J BIOL CHEM, V270, P536, DOI 10.1074/jbc.270.2.536; Meijer AB, 2007, BBA-PROTEINS PROTEOM, V1774, P714, DOI 10.1016/j.bbapap.2007.04.003; Migliorini M, 2020, J BIOL CHEM, V295, P212, DOI 10.1074/jbc.RA119.010449; Migliorini MM, 2003, J BIOL CHEM, V278, P17986, DOI 10.1074/jbc.M212592200; Mikhailenko I, 2001, J BIOL CHEM, V276, P39484, DOI 10.1074/jbc.M104382200; Neels JG, 1999, J BIOL CHEM, V274, P31305, DOI 10.1074/jbc.274.44.31305; Obermoeller LM, 1997, J BIOL CHEM, V272, P10761; Prasad JM, 2016, J BIOL CHEM, V291, P18430, DOI 10.1074/jbc.M116.744904; Raab David, 2010, Syst Synth Biol, V4, P215, DOI 10.1007/s11693-010-9062-3; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Sarafanov A, 2004, ANAL BIOCHEM, V328, P98, DOI 10.1016/j.ab.2003.11.028; Sarafanov AG, 2006, BIOCHEMISTRY-US, V45, P1829, DOI 10.1021/bi0520380; Sarafanov AG, 2007, THROMB HAEMOSTASIS, V98, P1170, DOI 10.1160/TH07-05-0353; Sato A, 1999, BIOCHEM J, V341, P377, DOI 10.1042/0264-6021:3410377; Schasfoort R, 2008, HANDBOOK OF SURFACE PLASMON RESONANCE, pX, DOI 10.1039/9781847558220-FP010; Sreerama N, 2004, METHOD ENZYMOL, V383, P318; Tang N, 2016, J AGR FOOD CHEM, V64, P4376, DOI 10.1021/acs.jafc.6b01534; van den Biggelaar M, 2011, INT J BIOCHEM CELL B, V43, P431, DOI 10.1016/j.biocel.2010.11.017; Verdaguer N, 2004, NAT STRUCT MOL BIOL, V11, P429, DOI 10.1038/nsmb753; Wang C, 2005, PROTEIN SCI, V14, P1328, DOI 10.1110/ps.041222905; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; WILLIAMS SE, 1992, J BIOL CHEM, V267, P9035; Willnow TE, 1996, EMBO J, V15, P2632, DOI 10.1002/j.1460-2075.1996.tb00623.x; WILLNOW TE, 1995, P NATL ACAD SCI USA, V92, P4537, DOI 10.1073/pnas.92.10.4537; WOODY RW, 1994, EUR BIOPHYS J BIOPHY, V23, P253, DOI 10.1007/BF00213575; Yakovlev S, 2017, BIOCHEMISTRY-US, V56, P2518, DOI 10.1021/acs.biochem.7b00087; Yamamoto T, 2008, ANAL BIOCHEM, V372, P222, DOI 10.1016/j.ab.2007.09.005; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yasui N, 2010, STRUCTURE, V18, P320, DOI 10.1016/j.str.2010.01.010; Young PA, 2016, J BIOL CHEM, V291, P26035, DOI 10.1074/jbc.M116.754622	67	2	2	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100842	10.1016/j.jbc.2021.100842	http://dx.doi.org/10.1016/j.jbc.2021.100842			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058195	Green Submitted, gold, Green Published			2022-12-28	WOS:000678068400042
J	Shen, QT; Wang, YFE; Palazzo, AF				Shen, Qingtang; Wang, Yifan E.; Palazzo, Alexander F.			Crosstalk between nucleocytoplasmic trafficking and the innate immune response to viral infection	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NUCLEAR-PORE COMPLEX; MESSENGER-RNA EXPORT; VESICULAR STOMATITIS-VIRUS; NF-KAPPA-B; CYCLIC GMP-AMP; HIV-1 MATRIX PROTEIN; IMPORTIN-BETA; NS1 PROTEIN; LOCALIZATION SIGNAL; INFLUENZA-VIRUS	The nuclear pore complex is the sole gateway connecting the nucleoplasm and cytoplasm. In humans, the nuclear pore complex is one of the largest multiprotein assemblies in the cell, with a molecular mass of similar to 110 MDa and consisting of 8 to 64 copies of about 34 different nuclear pore proteins, termed nucleoporins, for a total of 1000 subunits per pore. Trafficking events across the nuclear pore are mediated by nuclear transport receptors and are highly regulated. The nuclear pore complex is also used by several RNA viruses and almost all DNA viruses to access the host cell nucleoplasm for replication. Viruses hijack the nuclear pore complex, and nuclear transport receptors, to access the nucleoplasm where they replicate. In addition, the nuclear pore complex is used by the cell innate immune system, a network of signal transduction pathways that coordinates the first response to foreign invaders, including viruses and other pathogens. Several branches of this response depend on dynamic signaling events that involve the nuclear translocation of downstream signal transducers. Mounting evidence has shown that these signaling cascades, especially those steps that involve nucleocytoplasmic trafficking events, are targeted by viruses so that they can evade the innate immune system. This review summarizes how nuclear pore proteins and nuclear transport receptors contribute to the innate immune response and highlights how viruses manipulate this cellular machinery to favor infection. A comprehensive understanding of nuclear pore proteins in antiviral innate immunity will likely contribute to the development of new antiviral therapeutic strategies.	[Shen, Qingtang] Fujian Med Univ, Sch Basic Med Sci, Fuzhou, Peoples R China; [Wang, Yifan E.; Palazzo, Alexander F.] Univ Toronto, Dept Biochem, Toronto, ON, Canada	Fujian Medical University; University of Toronto	Shen, QT (corresponding author), Fujian Med Univ, Sch Basic Med Sci, Fuzhou, Peoples R China.; Palazzo, AF (corresponding author), Univ Toronto, Dept Biochem, Toronto, ON, Canada.	qtshen1983@hotmail.com; alex.palazzo@utoronto.ca	; Palazzo, Alexander/B-1270-2013	SHEN, QINGTANG/0000-0001-5520-8480; Wang, Yifan E./0000-0001-7784-3856; Palazzo, Alexander/0000-0002-9700-1995	Canadian Institutes of Health Research [FRN 102725]; startup grant for Highlevel Talents of Fujian Medical University [XRCZX2019019]; Natural Science Foundation of Fujian Province, China [2020J01604]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); startup grant for Highlevel Talents of Fujian Medical University; Natural Science Foundation of Fujian Province, China(Natural Science Foundation of Fujian Province)	information-The authors acknowledge financial support for this work from a Canadian Institutes of Health Research grant to A. F. P. (FRN 102725), a startup grant for Highlevel Talents of Fujian Medical University (XRCZX2019019) and a Natural Science Foundation of Fujian Province, China (no. 2020J01604) to Q. S.	Addetia A, 2021, MBIO, V12, DOI 10.1128/mBio.00065-21; De Jesus-Gonzalez LA, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060583; Ahmed M, 1998, J VIROL, V72, P8413, DOI 10.1128/JVI.72.10.8413-8419.1998; Ahmed M, 2003, J VIROL, V77, P4646, DOI 10.1128/JVI.77.8.4646-4657.2003; AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1; Aksenova V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18266-2; Alcazar-Roman AR, 2006, NAT CELL BIOL, V8, P711, DOI 10.1038/ncb1427; Ao ZJ, 2007, J BIOL CHEM, V282, P13456, DOI 10.1074/jbc.M610546200; Ao ZJ, 2012, J BIOL CHEM, V287, P10544, DOI 10.1074/jbc.M111.317057; Ao ZJ, 2010, J VIROL, V84, P8650, DOI 10.1128/JVI.00508-10; Arts GJ, 1998, EMBO J, V17, P7430, DOI 10.1093/emboj/17.24.7430; Banninger G, 2004, J BIOL CHEM, V279, P39199, DOI 10.1074/jbc.M400815200; Barrows NJ, 2016, CELL HOST MICROBE, V20, P259, DOI 10.1016/j.chom.2016.07.004; Beck M, 2017, NAT REV MOL CELL BIO, V18, P73, DOI 10.1038/nrm.2016.147; Belov GA, 2000, VIROLOGY, V275, P244, DOI 10.1006/viro.2000.0427; Belov GA, 2004, J VIROL, V78, P10166, DOI 10.1128/JVI.78.18.10166-10177.2004; BISCHOFF FR, 1991, NATURE, V354, P80, DOI 10.1038/354080a0; BISCHOFF FR, 1994, P NATL ACAD SCI USA, V91, P2587, DOI 10.1073/pnas.91.7.2587; Bischoff FR, 1997, FEBS LETT, V419, P249, DOI 10.1016/S0014-5793(97)01467-1; Bjork P, 2017, CELL MOL LIFE SCI, V74, P2875, DOI 10.1007/s00018-017-2503-3; BLACK BL, 1992, J VIROL, V66, P4058, DOI 10.1128/JVI.66.7.4058-4064.1992; Blanchette P, 2008, J VIROL, V82, P2642, DOI 10.1128/JVI.02309-07; Bock JO, 2020, AGING-US, V12, P11277, DOI 10.18632/aging.103524; Bogerd HP, 1998, J VIROL, V72, P8627, DOI 10.1128/JVI.72.11.8627-8635.1998; BONNER WM, 1975, J CELL BIOL, V64, P431, DOI 10.1083/jcb.64.2.431; Bouvier NM, 2008, VACCINE, V26, pD49, DOI 10.1016/j.vaccine.2008.07.039; Bouyac-Bertoia M, 2001, MOL CELL, V7, P1025, DOI 10.1016/S1097-2765(01)00240-4; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Boyne JR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000194; Bridgeman A, 2015, SCIENCE, V349, P1228, DOI 10.1126/science.aab3632; BUKRINSKY MI, 1993, NATURE, V365, P666, DOI 10.1038/365666a0; Canton J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006838; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Cautain B, 2015, FEBS J, V282, P445, DOI 10.1111/febs.13163; Chang CW, 2015, J VIROL, V89, P1703, DOI 10.1128/JVI.02880-14; Chang CW, 2012, J VIROL, V86, P8072, DOI 10.1128/JVI.01058-12; Chase GP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002187; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; Chen JJ, 2010, J GEN VIROL, V91, P2474, DOI 10.1099/vir.0.022681-0; Chen ZY, 1999, EMBO J, V18, P2273, DOI 10.1093/emboj/18.8.2273; Christ F, 2008, CURR BIOL, V18, P1192, DOI 10.1016/j.cub.2008.07.079; Connor JH, 2002, J VIROL, V76, P10177, DOI 10.1128/JVI.76.20.10177-10187.2002; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Copeland AM, 2009, J VIROL, V83, P1660, DOI 10.1128/JVI.01139-08; Corman VM, 2018, ADV VIRUS RES, V100, P163, DOI 10.1016/bs.aivir.2018.01.001; Cortese M, 2017, CELL REP, V18, P2113, DOI 10.1016/j.celrep.2017.02.014; Darshan MS, 2004, J VIROL, V78, P12179, DOI 10.1128/JVI.78.22.12179-12188.2004; de Groot RJ, 2013, J VIROL, V87, P7790, DOI 10.1128/JVI.01244-13; Di Nunzio F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046037; Dickmanns A, 2015, INT REV CEL MOL BIO, V320, P171, DOI 10.1016/bs.ircmb.2015.07.010; DINGWALL C, 1982, CELL, V30, P449, DOI 10.1016/0092-8674(82)90242-2; Dingwall C, 1998, CURR BIOL, V8, pR922, DOI 10.1016/S0960-9822(98)00010-4; Dobbs N, 2015, CELL HOST MICROBE, V18, P157, DOI 10.1016/j.chom.2015.07.001; DOORBAR J, 1987, J VIROL, V61, P2793, DOI 10.1128/JVI.61.9.2793-2799.1987; Doye V, 1997, CURR OPIN CELL BIOL, V9, P401, DOI 10.1016/S0955-0674(97)80014-2; Drosten C, 2003, NEW ENGL J MED, V348, P1967, DOI 10.1056/NEJMoa030747; Dultz E, 2010, J CELL BIOL, V191, P15, DOI 10.1083/jcb.201007076; Ebina H, 2004, MICROBES INFECT, V6, P715, DOI 10.1016/j.micinf.2004.04.002; Fagerlund R, 2005, J BIOL CHEM, V280, P15942, DOI 10.1074/jbc.M500814200; Fagerlund R, 2002, J BIOL CHEM, V277, P30072, DOI 10.1074/jbc.M202943200; Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Faza MB, 2009, J CELL BIOL, V184, P833, DOI 10.1083/jcb.200810059; Feldmann H, 2011, LANCET, V377, P849, DOI 10.1016/S0140-6736(10)60667-8; Fernandez-Martinez J, 2016, CELL, V167, P1215, DOI 10.1016/j.cell.2016.10.028; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001; Gagne B, 2017, TRAFFIC, V18, P362, DOI 10.1111/tra.12480; Gallay P, 1996, J VIROL, V70, P1027, DOI 10.1128/JVI.70.2.1027-1032.1996; Gallay P, 1997, P NATL ACAD SCI USA, V94, P9825, DOI 10.1073/pnas.94.18.9825; Gao DX, 2013, SCIENCE, V341, P903, DOI 10.1126/science.1240933; Gao P, 2013, CELL, V154, P748, DOI 10.1016/j.cell.2013.07.023; Ge WL, 2019, EXP CELL RES, V377, P17, DOI 10.1016/j.yexcr.2019.02.021; Gentili M, 2015, SCIENCE, V349, P1232, DOI 10.1126/science.aab3628; Germain MA, 2014, MOL CELL PROTEOMICS, V13, P184, DOI 10.1074/mcp.M113.030155; Ghildyal R, 2009, J VIROL, V83, P7349, DOI 10.1128/JVI.01748-08; Ghosh R, 2020, AM J CASE REP, V21, DOI 10.12659/AJCR.925641; Gillespie LK, 2010, J VIROL, V84, P10438, DOI 10.1128/JVI.00986-10; Gordon DE, 2020, NATURE, V583, P459, DOI 10.1038/s41586-020-2286-9; GORLICH D, 1995, CURR BIOL, V5, P383, DOI 10.1016/S0960-9822(95)00079-0; Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x; Grossman E, 2012, ANNU REV BIOPHYS, V41, P557, DOI [10.1146/annurev-biophys-050511-102328, 10.1146/annurev-biophys-850511-102328]; Gurtler C, 2013, TRENDS MICROBIOL, V21, P413, DOI 10.1016/j.tim.2013.04.004; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Haffar OK, 2000, J MOL BIOL, V299, P359, DOI 10.1006/jmbi.2000.3768; Hampoelz B, 2019, ANNU REV BIOPHYS, V48, P515, DOI 10.1146/annurev-biophys-052118-115308; Haspel RL, 1996, EMBO J, V15, P6262, DOI 10.1002/j.1460-2075.1996.tb01016.x; Henderson BR, 1997, J MOL BIOL, V274, P693, DOI 10.1006/jmbi.1997.1420; Her LS, 1997, SCIENCE, V276, P1845, DOI 10.1126/science.276.5320.1845; Herold A, 2000, MOL CELL BIOL, V20, P8996, DOI 10.1128/MCB.20.23.8996-9008.2000; Hirano T, 2020, IMMUNITY, V52, P731, DOI 10.1016/j.immuni.2020.04.003; Hiriart E, 2003, J BIOL CHEM, V278, P37790, DOI 10.1074/jbc.M305925200; Hoelz A, 2011, ANNU REV BIOCHEM, V80, P613, DOI 10.1146/annurev-biochem-060109-151030; Hou FJ, 2011, CELL, V146, P448, DOI 10.1016/j.cell.2011.06.041; Huffman JB, 2017, J VIROL, V91, DOI 10.1128/JVI.00641-17; Hutten S, 2009, J CELL SCI, V122, P1100, DOI 10.1242/jcs.040154; Ishikawa H, 2009, NATURE, V461, P788, DOI 10.1038/nature08476; Izaurralde E, 1997, EMBO J, V16, P6535, DOI 10.1093/emboj/16.21.6535; IZAURRALDE E, 1995, NATURE, V376, P709, DOI 10.1038/376709a0; Jakel S, 1998, EMBO J, V17, P4491, DOI 10.1093/emboj/17.15.4491; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Jani D, 2014, NUCLEIC ACIDS RES, V42, P6686, DOI 10.1093/nar/gku252; Jayappa Kallesh Danappa, 2012, Int J Biochem Mol Biol, V3, P70; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; Johnson LA, 2009, J VIROL, V83, P6335, DOI 10.1128/JVI.00375-09; Johnson LA, 2009, J VIROL, V83, P1184, DOI 10.1128/JVI.02010-08; Jorquera PA, 2019, J VIROL, V93, DOI 10.1128/JVI.01684-18; Jovasevic V, 2008, J VIROL, V82, P3311, DOI 10.1128/JVI.01919-07; Jureka AS, 2020, J BIOL CHEM, V295, P1153, DOI 10.1074/jbc.RA119.011410; Jureka AS, 2015, STRUCTURE, V23, P2001, DOI 10.1016/j.str.2015.08.007; Kabachinski G, 2015, J CELL SCI, V128, P423, DOI 10.1242/jcs.083246; Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; Kann M, 1999, J CELL BIOL, V145, P45, DOI 10.1083/jcb.145.1.45; Katahira J, 1999, EMBO J, V18, P2593, DOI 10.1093/emboj/18.9.2593; Katahira J, 2015, GENES-BASEL, V6, P163, DOI 10.3390/genes6020163; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Keminer O, 1999, BIOPHYS J, V77, P217, DOI 10.1016/S0006-3495(99)76883-9; Khuperkar D, 2017, VIROLOGY, V512, P151, DOI 10.1016/j.virol.2017.09.012; Koffa MD, 2001, EMBO J, V20, P5769, DOI 10.1093/emboj/20.20.5769; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; Kosinski J, 2016, SCIENCE, V352, P363, DOI 10.1126/science.aaf0643; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Lazarte-Rantes C, 2021, CUREUS J MED SCIENCE, V13, DOI 10.7759/cureus.15018; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Sage V, 2013, VIRUSES-BASEL, V5, P2019, DOI 10.3390/v5082019; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee ES, 2020, NUCLEIC ACIDS RES, V48, P11645, DOI 10.1093/nar/gkaa919; Lee JG, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00568-7; Leuzinger H, 2005, J VIROL, V79, P13047, DOI 10.1128/JVI.79.20.13047-13059.2005; Levin A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114629; Levine JM, 2020, MULT SCLER RELAT DIS, V43, DOI 10.1016/j.msard.2020.102194; Li JJ, 2021, MED-CAMBRIDGE, V2, P99, DOI 10.1016/j.medj.2020.07.002; Li X., 2020, LANCET, V395, p497, DOI [DOI 10.1016/S0140-6736(20)30183-5, 10.1016/S0140-6736(20)30183-5]; Li XD, 2013, SCIENCE, V341, P1390, DOI 10.1126/science.1244040; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Lin DH, 2019, ANNU REV BIOCHEM, V88, P725, DOI 10.1146/annurev-biochem-062917-011901; Lin DH, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1015; Lischka P, 2006, MOL CELL BIOL, V26, P1631, DOI 10.1128/MCB.26.5.1631-1643.2006; Liu D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091658; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; Liu Y, 2020, MOL CELL PROTEOMICS, V19, DOI 10.1074/mcp.RA120.002316; Liu YG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037636; Lopez-Garcia P, 2006, BIOESSAYS, V28, P525, DOI 10.1002/bies.20413; Lund MK, 2005, MOL CELL, V20, P645, DOI 10.1016/j.molcel.2005.10.005; Lund N, 2012, NUCLEIC ACIDS RES, V40, P3663, DOI 10.1093/nar/gkr1238; Lundberg L, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005122; Lundberg L, 2013, ANTIVIR RES, V100, P662, DOI 10.1016/j.antiviral.2013.10.004; Mahajan R, 1997, CELL, V88, P97, DOI 10.1016/S0092-8674(00)81862-0; Mahanty S, 2004, LANCET INFECT DIS, V4, P487, DOI 10.1016/S1473-3099(04)01103-X; Malik P, 2012, J BIOL CHEM, V287, P12277, DOI 10.1074/jbc.M111.331777; Marfori M, 2011, BBA-MOL CELL RES, V1813, P1562, DOI 10.1016/j.bbamcr.2010.10.013; Marg A, 2004, J CELL BIOL, V165, P823, DOI 10.1083/jcb.200403057; Marrugal-Lorenzo JA, 2018, ANTIVIR RES, V159, P77, DOI 10.1016/j.antiviral.2018.09.011; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; MartinezMoczygemba M, 1997, J BIOL CHEM, V272, P20070, DOI 10.1074/jbc.272.32.20070; Mateo M, 2010, J VIROL, V84, P1169, DOI 10.1128/JVI.01372-09; MAUL GG, 1972, J CELL BIOL, V55, P433, DOI 10.1083/jcb.55.2.433; McBride KM, 2000, EMBO J, V19, P6196, DOI 10.1093/emboj/19.22.6196; McBride KM, 2002, EMBO J, V21, P1754, DOI 10.1093/emboj/21.7.1754; Meng W, 2019, CRIT REV MICROBIOL, V45, P495, DOI 10.1080/1040841X.2018.1553848; Meyer T, 2004, EUR J BIOCHEM, V271, P4606, DOI 10.1111/j.1432-1033.2004.04423.x; Meyer T, 2002, EXP CELL RES, V272, P45, DOI 10.1006/excr.2001.5405; Meyer T, 2007, EXPERT OPIN THER TAR, V11, P1355, DOI 10.1517/14728222.11.10.1355; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Mitchell SF, 2014, MOL CELL, V54, P547, DOI 10.1016/j.molcel.2014.04.033; Monette A, 2009, J BIOL CHEM, V284, P31350, DOI 10.1074/jbc.M109.048736; Moore MS, 1998, J BIOL CHEM, V273, P22857, DOI 10.1074/jbc.273.36.22857; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Moroianu J, 1997, P NATL ACAD SCI USA, V94, P9699, DOI 10.1073/pnas.94.18.9699; MOROIANU J, 1995, P NATL ACAD SCI USA, V92, P6532, DOI 10.1073/pnas.92.14.6532; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Nardozzi J, 2010, J MOL BIOL, V402, P83, DOI 10.1016/j.jmb.2010.07.013; Neilson DE, 2009, AM J HUM GENET, V84, P44, DOI 10.1016/j.ajhg.2008.12.009; Nelson LM, 2003, VIROLOGY, V306, P162, DOI 10.1016/S0042-6822(02)00025-9; Nemeroff ME, 1998, MOL CELL, V1, P991, DOI 10.1016/S1097-2765(00)80099-4; Neufeldt CJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003744; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; Nitahara-Kasahara Y, 2007, J VIROL, V81, P5284, DOI 10.1128/JVI.01928-06; Ohno M, 2000, CELL, V101, P187, DOI 10.1016/S0092-8674(00)80829-6; Ote I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007882; Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105; Palazzo AF, 2016, BIOESSAYS, V38, P744, DOI 10.1002/bies.201600038; Palazzo AF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004351; Palazzo AF, 2012, BBA-GENE REGUL MECH, V1819, P566, DOI 10.1016/j.bbagrm.2011.12.012; Pallett MA, 2019, J VIROL, V93, DOI 10.1128/JVI.00051-19; Pan MM, 2016, FRONT MED-PRC, V10, P410, DOI 10.1007/s11684-016-0489-0; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Park N, 2010, J BIOL CHEM, V285, P28796, DOI 10.1074/jbc.M110.143404; Pasdeloup D, 2009, J VIROL, V83, P6610, DOI 10.1128/JVI.02655-08; Perwitasari O, 2014, J VIROL, V88, P10228, DOI 10.1128/JVI.01774-14; Popov S, 1998, EMBO J, V17, P909, DOI 10.1093/emboj/17.4.909; Porter FW, 2006, P NATL ACAD SCI USA, V103, P12417, DOI 10.1073/pnas.0605375103; Porter FW, 2009, J VIROL, V83, P1941, DOI 10.1128/JVI.01752-08; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Preston VG, 2008, J VIROL, V82, P6654, DOI 10.1128/JVI.00257-08; Pumroy RA, 2015, BIOCHEM J, V466, P13, DOI 10.1042/BJ20141186; Puntener D, 2011, J VIROL, V85, P481, DOI 10.1128/JVI.01571-10; Qin C, 2020, CLIN INFECT DIS, V71, P762, DOI 10.1093/cid/ciaa248; QIU Y, 1995, RNA, V1, P304; Rabe B, 2003, P NATL ACAD SCI USA, V100, P9849, DOI 10.1073/pnas.1730940100; Rajani KR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002929; Rasaiyaah J, 2013, NATURE, V503, P402, DOI 10.1038/nature12769; Ray N, 2004, J VIROL, V78, P3489, DOI 10.1128/JVI.78.7.3489-3501.2004; Reid SP, 2007, J VIROL, V81, P13469, DOI 10.1128/JVI.01097-07; Reid SP, 2006, J VIROL, V80, P5156, DOI 10.1128/JVI.02349-05; Ribbeck K, 1998, EMBO J, V17, P6587, DOI 10.1093/emboj/17.22.6587; Ricour C, 2009, J GEN VIROL, V90, P177, DOI 10.1099/vir.0.005678-0; ROBBINS J, 1991, CELL, V64, P615, DOI 10.1016/0092-8674(91)90245-T; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Rogers RS, 2003, J BIOL CHEM, V278, P30091, DOI 10.1074/jbc.M301344200; Saito S, 2016, MOL CELL BIOL, V36, P1820, DOI 10.1128/MCB.00158-16; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Scherer J, 2011, VIRUSES-BASEL, V3, P1417, DOI 10.3390/v3081417; Schmid M, 2012, J VIROL, V86, P2282, DOI 10.1128/JVI.06275-11; Schmidt HB, 2016, TRENDS BIOCHEM SCI, V41, P46, DOI 10.1016/j.tibs.2015.11.001; Schmitz A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000741; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schwartz TU, 2016, J MOL BIOL, V428, P1986, DOI 10.1016/j.jmb.2016.03.015; Seki T, 1996, J BIOCHEM, V120, P207; Shen QT, 2021, PLOS GENET, V17, DOI 10.1371/journal.pgen.1009378; Singh U., 2020, OVEREX PRESSED NUP88, DOI [10.1101/ 2020.04.27.063057, DOI 10.1101/2020.04.27.063057]; Siomi MC, 1997, J CELL BIOL, V138, P1181, DOI 10.1083/jcb.138.6.1181; Sivan G, 2013, P NATL ACAD SCI USA, V110, P3519, DOI 10.1073/pnas.1300708110; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Song L, 2006, BLOOD, V108, P3237, DOI 10.1182/blood-2006-04-020271; Stark GR, 2012, IMMUNITY, V36, P503, DOI 10.1016/j.immuni.2012.03.013; Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; Strunze S, 2011, CELL HOST MICROBE, V10, P210, DOI 10.1016/j.chom.2011.08.010; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Suomalainen M, 2013, CURR OPIN VIROL, V3, P27, DOI 10.1016/j.coviro.2012.12.004; Takeda A, 2010, J BIOL CHEM, V285, P16248, DOI 10.1074/jbc.M109.048785; Tan MK, 2020, IMMUNOLOGY, V160, P261, DOI 10.1111/imm.13223; Tan XJ, 2018, ANNU REV MICROBIOL, V72, P447, DOI 10.1146/annurev-micro-102215-095605; Taylor SL, 2009, J VIROL, V83, P1271, DOI 10.1128/JVI.00986-08; ten Hoeve J, 2002, MOL CELL BIOL, V22, P5662, DOI 10.1128/MCB.22.16.5662-5668.2002; Tessier TM, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8060559; Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464; Tolonen N, 2001, MOL BIOL CELL, V12, P2031, DOI 10.1091/mbc.12.7.2031; Tomko RP, 1997, P NATL ACAD SCI USA, V94, P3352, DOI 10.1073/pnas.94.7.3352; Truant R, 1999, MOL CELL BIOL, V19, P1210; Twyffels L, 2014, FEBS LETT, V588, P1857, DOI 10.1016/j.febslet.2014.04.023; Umlauf D, 2013, J CELL SCI, V126, P2656, DOI 10.1242/jcs.118000; Varadarajan P, 2005, MOL BIOL CELL, V16, P1823, DOI 10.1091/mbc.E04-07-0583; Varghese FS, 2016, ANTIVIR RES, V126, P117, DOI 10.1016/j.antiviral.2015.12.012; Vetter IR, 1999, CELL, V97, P635, DOI 10.1016/S0092-8674(00)80774-6; Virhammar J, 2020, NEUROLOGY, V95, P445, DOI 10.1212/WNL.0000000000010250; von Kobbe C, 2000, MOL CELL, V6, P1243, DOI 10.1016/S1097-2765(00)00120-9; Wagstaff KM, 2012, BIOCHEM J, V443, P851, DOI 10.1042/BJ20120150; Walker EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071316; Wang H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000986; Weirich CS, 2006, NAT CELL BIOL, V8, P668, DOI 10.1038/ncb1424; Welsch S, 2009, CELL HOST MICROBE, V5, P365, DOI 10.1016/j.chom.2009.03.007; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wickramasinghe VO, 2014, NUCLEIC ACIDS RES, V42, P5059, DOI 10.1093/nar/gku095; Widman DG, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200043; Williams BJL, 2005, BIOCHEM J, V387, P295, DOI 10.1042/BJ20041223; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Wong PMC, 2003, J BIOMED SCI, V10, P468, DOI 10.1159/000072374; Wong RW, 2015, CHEM BIOL, V22, P1285, DOI 10.1016/j.chembiol.2015.10.001; Woo JL, 2007, J VIROL, V81, P575, DOI 10.1128/JVI.01725-06; Woo PCY, 2012, J VIROL, V86, P3995, DOI 10.1128/JVI.06540-11; Woo PCY, 2009, EXP BIOL MED, V234, P1117, DOI 10.3181/0903-MR-94; Woodward CL, 2009, J VIROL, V83, P6522, DOI 10.1128/JVI.02061-08; Wu B, 2013, CELL, V152, P276, DOI 10.1016/j.cell.2012.11.048; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Wu TR, 2002, J BIOL CHEM, V277, P47572, DOI 10.1074/jbc.M207536200; Wu WWH, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-49; Xu DR, 2012, MOL BIOL CELL, V23, P3677, DOI 10.1091/mbc.E12-01-0046; Xu ST, 2016, CELL HOST MICROBE, V20, P443, DOI 10.1016/j.chom.2016.09.003; Xu W, 2014, CELL HOST MICROBE, V16, P187, DOI 10.1016/j.chom.2014.07.008; Xu Zhe, 2020, Lancet Respir Med, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Xylourgidis N, 2006, J CELL SCI, V119, P4409, DOI 10.1242/jcs.03201; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang LP, 2018, J VIROL, V92, DOI [10.1128/JVI.00072-18, 10.1128/jvi.00072-18]; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Yarbrough ML, 2014, TRAFFIC, V15, P127, DOI 10.1111/tra.12137; Yatherajam G, 2011, J VIROL, V85, P1429, DOI 10.1128/JVI.02108-10; Ye J, 2017, J VIROL, V91, DOI [10.1128/JVI.00039-17, 10.1128/jvi.00039-17]; Yi S, 2012, INT J MOL MED, V30, P877, DOI 10.3892/ijmm.2012.1067; Yuan H, 1998, VIROLOGY, V251, P383, DOI 10.1006/viro.1998.9413; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721; Zhang K, 2019, NAT MICROBIOL, V4, P1671, DOI 10.1038/s41564-019-0482-x; Zhang L, 2012, J CELL BIOL, V196, P315, DOI 10.1083/jcb.201107058; Zhang YQ, 2020, CELL RES, V30, P532, DOI 10.1038/s41422-020-0320-y; Zolotukhin AS, 1999, J VIROL, V73, P120, DOI 10.1128/JVI.73.1.120-127.1999; Zuckerman B, 2020, MOL CELL, V79, P251, DOI 10.1016/j.molcel.2020.05.013; zur Hausen H, 2000, JNCI-J NATL CANCER I, V92, P690, DOI 10.1093/jnci/92.9.690	300	13	13	5	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100856	10.1016/j.jbc.2021.100856	http://dx.doi.org/10.1016/j.jbc.2021.100856			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097873	gold, Green Published			2022-12-28	WOS:000678068400056
J	Chapman, JM; Muday, GK				Chapman, Jordan M.; Muday, Gloria K.			Flavonols modulate lateral root emergence by scavenging reactive oxygen species in Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPARENT-TESTA MUTANTS; NADPH OXIDASE ATRBOHD; AUXIN TRANSPORT; DIHYDROETHIDIUM FLUORESCENCE; CELL-DEATH; REDOX; ACCUMULATION; SUPEROXIDE; RESPONSES; PROTEINS	Flavonoids are a class of specialized metabolites with subclasses including flavonols and anthocyanins, which have unique properties as antioxidants. Flavonoids modulate plant development, but whether and how they impact lateral root development is unclear. We examined potential roles for flavonols in this process using Arabidopsis thaliana mutants with defects in genes encoding key enzymes in flavonoid biosynthesis. We observed the tt4 and fls1 mutants, which produce no flavonols, have increased lateral root emergence. The tt4 root phenotype was reversed by genetic and chemical complementation. To more specifically define the flavonoids involved, we tested an array of flavonoid biosynthetic mutants, eliminating roles for anthocyanins and the flavonols quercetin and isorhamnetin in modulating lateral root development. Instead, two tt7 mutant alleles, with defects in a branchpoint enzyme blocking quercetin biosynthesis, formed reduced numbers of lateral roots and tt7-2 had elevated levels of kaempferol. Using a flavonol-specific dye, we observed that in the tt7-2 mutant, kaempferol accumulated within lateral root primordia at higher levels than wild-type. These data are consistent with kaempferol, or downstream derivatives, acting as a negative regulator of lateral root emergence. We examined ROS accumulation using ROS-responsive probes and found reduced fluorescence of a superoxide-selective probe within the primordia of tt7-2 compared with wild-type, but not in the tt4 mutant, consistent with opposite effects of these mutants on lateral root emergence. These results support a model in which increased level of kaempferol in the lateral root primordia of tt7-2 reduces superoxide concentration and ROS-stimulated lateral root emergence.	[Chapman, Jordan M.; Muday, Gloria K.] Wake Forest Univ, Biol Dept, Winston Salem, NC 27109 USA	Wake Forest University	Muday, GK (corresponding author), Wake Forest Univ, Biol Dept, Winston Salem, NC 27109 USA.	muday@wfu.edu		Chapman, Jordan/0000-0001-6755-9341; Muday, Gloria/0000-0002-0377-4517	National Science Foundation [IOS-1558046]; National Institutes of Health [T32 GM127261]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by National Science Foundation IOS-1558046 to G. K. M. and a National Institutes of Health T32 GM127261 fellowship to J. M. C. The content is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health.	Agati G, 2012, PLANT SCI, V196, P67, DOI 10.1016/j.plantsci.2012.07.014; Bennett T, 2006, CURR BIOL, V16, P553, DOI 10.1016/j.cub.2006.01.058; Bhalerao RP, 2002, PLANT J, V29, P325, DOI 10.1046/j.0960-7412.2001.01217.x; Brown DE, 2001, PLANT PHYSIOL, V126, P524, DOI 10.1104/pp.126.2.524; Buer CS, 2007, PLANT PHYSIOL, V145, P478, DOI 10.1104/pp.107.101824; Buer CS, 2013, PLANTA, V238, P171, DOI 10.1007/s00425-013-1883-3; Buer CS, 2008, PLANT SIGNAL BEHAV, V3, P415, DOI 10.4161/psb.3.6.5440; Buer CS, 2009, J EXP BOT, V60, P751, DOI 10.1093/jxb/ern323; Buer CS, 2006, PLANT PHYSIOL, V140, P1384, DOI 10.1104/pp.105.075671; Burko Y, 2020, PLANT COMMUN, V1, DOI 10.1016/j.xplc.2020.100078; CABELLI DE, 1983, J PHYS CHEM-US, V87, P1809, DOI 10.1021/j100233a031; Caverzan A, 2012, GENET MOL BIOL, V35, P1011, DOI 10.1590/S1415-47572012000600016; Chapman JM, 2019, CHEM RES TOXICOL, V32, P370, DOI 10.1021/acs.chemrestox.9b00028; Chen J, 2013, ANN BIOMED ENG, V41, P327, DOI 10.1007/s10439-012-0653-x; Csepregi K, 2018, PHYTOCHEM ANALYSIS, V29, P129, DOI 10.1002/pca.2720; Ditengou FA, 2008, P NATL ACAD SCI USA, V105, P18818, DOI 10.1073/pnas.0807814105; Du YJ, 2018, J EXP BOT, V69, P155, DOI 10.1093/jxb/erx223; Ezerina D, 2018, CELL CHEM BIOL, V25, P447, DOI 10.1016/j.chembiol.2018.01.011; Foreman J, 2003, NATURE, V422, P442, DOI 10.1038/nature01485; Foyer CH, 2020, ANNU REV PLANT BIOL, V71, P157, DOI 10.1146/annurev-arplant-050718-095955; Gayomba SR, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.185819; Geisler M, 2005, PLANT J, V44, P179, DOI 10.1111/j.1365-313X.2005.02519.x; Goujon T, 2003, PLANT MOL BIOL, V51, P973, DOI 10.1023/A:1023022825098; Grierson Claire, 2014, Arabidopsis Book, V12, pe0172, DOI 10.1199/tab.0172; Heim KE, 2002, J NUTR BIOCHEM, V13, P572, DOI 10.1016/S0955-2863(02)00208-5; Jang JY, 2012, PLANT SIGNAL BEHAV, V7, P1180, DOI 10.4161/psb.21178; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Joo JH, 2005, PLANT CELL, V17, P957, DOI 10.1105/tpc.104.029603; Kapoor D., 2019, PLANT GENE, V19, P100182, DOI [DOI 10.1016/J.PLGENE.2019.100182, 10.1016/j.plgene.2019.100182]; Kaya H, 2014, PLANT CELL, V26, P1069, DOI 10.1105/tpc.113.120642; Kim HJ, 2008, PLANT SIGNAL BEHAV, V3, P1119, DOI 10.4161/psb.3.12.7039; Krieger G, 2016, PLANT PHYSIOL, V172, P1209, DOI 10.1104/pp.16.00660; Kudla, 2019, ROS PRODUCTION LOCAL; Kuhn BM, 2011, PLANT PHYSIOL, V156, P585, DOI 10.1104/pp.111.175976; Kwak JM, 2003, EMBO J, V22, P2623, DOI 10.1093/emboj/cdg277; Laskowski M, 2008, PLOS BIOL, V6, P2721, DOI 10.1371/journal.pbio.0060307; Lee Y, 2013, CELL, V153, P402, DOI 10.1016/j.cell.2013.02.045; Lewis DR, 2013, PLANT CELL, V25, P3329, DOI 10.1105/tpc.113.114868; Lewis DR, 2011, PLANT PHYSIOL, V156, P144, DOI 10.1104/pp.111.172502; Li N, 2015, PLANTA, V241, P591, DOI 10.1007/s00425-014-2204-1; Liu B, 2017, PLANT CELL REP, V36, P947, DOI 10.1007/s00299-017-2128-x; Liu P, 2014, PROTEOMICS, V14, P750, DOI 10.1002/pmic.201300307; Liu XH, 2019, INT J MOL MED, V43, P199, DOI 10.3892/ijmm.2018.3962; LYNCH J, 1995, PLANT PHYSIOL, V109, P7, DOI 10.1104/pp.109.1.7; Lynch JP, 2018, J EXP BOT, V69, P3279, DOI 10.1093/jxb/ery048; Ma LY, 2012, J EXP BOT, V63, P305, DOI 10.1093/jxb/err280; Mabuchi K, 2018, P NATL ACAD SCI USA, V115, pE4710, DOI 10.1073/pnas.1804233115; Malamy JE, 1997, DEVELOPMENT, V124, P33; Maloney GS, 2014, PLANT PHYSIOL, V166, P614, DOI 10.1104/pp.114.240507; Manzano C, 2014, PLANT PHYSIOL, V165, P1105, DOI 10.1104/pp.114.238873; Mendez-Bravo A, 2010, PLANT CELL PHYSIOL, V51, P1612, DOI 10.1093/pcp/pcq117; Mhamdi A, 2010, J EXP BOT, V61, P4197, DOI 10.1093/jxb/erq282; Muhlemann JK, 2018, P NATL ACAD SCI USA, V115, pE11188, DOI 10.1073/pnas.1811492115; Munne-Bosch S, 2013, PLANT PHYSIOL, V161, P5, DOI 10.1104/pp.112.205690; Nadarajah KK, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155208; Nakabayashi R, 2014, PLANT J, V77, P367, DOI 10.1111/tpj.12388; Okuma E, 2011, J PLANT PHYSIOL, V168, P2048, DOI 10.1016/j.jplph.2011.06.002; Orman-Ligeza B, 2016, DEVELOPMENT, V143, P3328, DOI 10.1242/dev.136465; Owens DK, 2008, PLANT PHYSIOL, V147, P1046, DOI 10.1104/pp.108.117457; Panche AN, 2016, J NUTR SCI, V5, DOI 10.1017/jns.2016.41; Passaia G, 2015, PLANT SCI, V234, P22, DOI 10.1016/j.plantsci.2015.01.017; Peer WA, 2004, PLANT CELL, V16, P1898, DOI 10.1105/tpc.021501; Peshavariya HM, 2007, FREE RADICAL RES, V41, P699, DOI 10.1080/10715760701297354; Pietta PG, 2000, J NAT PROD, V63, P1035, DOI 10.1021/np9904509; Poole LB, 2015, FREE RADICAL BIO MED, V80, P148, DOI 10.1016/j.freeradbiomed.2014.11.013; Porco S, 2016, DEVELOPMENT, V143, P3340, DOI 10.1242/dev.136283; Potocky M, 2007, NEW PHYTOL, V174, P742, DOI 10.1111/j.1469-8137.2007.02042.x; Preuss A, 2009, FEBS LETT, V583, P1981, DOI 10.1016/j.febslet.2009.05.006; Quideauessor S, 2017, RECENT ADV POLYPHENO, P143, DOI DOI 10.1002/9781118883303.CH7; Reed RC, 1998, PLANT PHYSIOL, V118, P1369, DOI 10.1104/pp.118.4.1369; Richter GL, 2009, PLANT PHYSIOL, V151, P1855, DOI 10.1104/pp.109.142448; Ringli C, 2008, PLANT CELL, V20, P1470, DOI 10.1105/tpc.107.053249; Rounds CM, 2011, PLANT PHYSIOL, V157, P175, DOI 10.1104/pp.111.182196; Saito K, 2013, PLANT PHYSIOL BIOCH, V72, P21, DOI 10.1016/j.plaphy.2013.02.001; Schopfer P, 1996, PLANTA, V199, P43, DOI 10.1007/BF00196879; SHEAHAN JJ, 1992, BIOTECHNIQUES, V13, P880; Sibout R, 2006, PLOS GENET, V2, P1898, DOI 10.1371/journal.pgen.0020202; Silva-Navas J, 2016, PLANT CELL, V28, P1372, DOI 10.1105/tpc.15.00857; Soubeyrand E, 2018, PLANT CELL, V30, P2910, DOI 10.1105/tpc.18.00688; Suzuki N, 2011, CURR OPIN PLANT BIOL, V14, P691, DOI 10.1016/j.pbi.2011.07.014; Swarup K, 2008, NAT CELL BIOL, V10, P946, DOI 10.1038/ncb1754; Teixeira JAS, 2019, MOL PLANT, V12, P784, DOI 10.1016/j.molp.2019.03.015; Tognetti VB, 2012, PLANT CELL ENVIRON, V35, P321, DOI 10.1111/j.1365-3040.2011.02324.x; Tsukagoshi H, 2010, CELL, V143, P606, DOI 10.1016/j.cell.2010.10.020; Tuominen H, 2019, CELL DEATH CELLS OVE; Ursache R, 2018, PLANT J, V93, P399, DOI 10.1111/tpj.13784; Watkins JM, 2017, PLANT PHYSIOL, V175, P1807, DOI 10.1104/pp.17.01010; Watkins JM, 2014, PLANT PHYSIOL, V164, P1707, DOI 10.1104/pp.113.233528; Winkel-Shirley B, 2001, PLANT PHYSIOL, V126, P485, DOI 10.1104/pp.126.2.485; Winterbourn CC, 2014, BBA-GEN SUBJECTS, V1840, P730, DOI 10.1016/j.bbagen.2013.05.004; Xie HT, 2014, PLANT CELL, V26, P2007, DOI 10.1105/tpc.114.125427; Xu F, 2018, MOL PLANT, V11, P523, DOI 10.1016/j.molp.2017.12.003; Yonekura-Sakakibara K, 2008, PLANT CELL, V20, P2160, DOI 10.1105/tpc.108.058040	93	13	13	4	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100222	10.1074/jbc.RA120.014543	http://dx.doi.org/10.1074/jbc.RA120.014543			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839683	gold, Green Published, Green Submitted			2022-12-28	WOS:000672866400200
J	Daniel, PV; Dogra, S; Rawat, P; Choubey, A; Khan, AS; Rajak, S; Kamthan, M; Mondal, P				Daniel, P. Vineeth; Dogra, Surbhi; Rawat, Priya; Choubey, Abhinav; Khan, Aiysha Siddiq; Rajak, Sangam; Kamthan, Mohan; Mondal, Prosenjit			NF-kappa B p65 regulates hepatic lipogenesis by promoting nuclear entry of ChREBP in response to a high carbohydrate diet	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Overconsumption of sucrose and other sugars has been associated with nonalcoholic fatty liver disease (NAFLD). Reports suggest hepatic de novo lipogenesis (DNL) as an important contributor to and regulator of carbohydrate-induced hepatic lipid accumulation in NAFLD. The mechanisms responsible for the increase in hepatic DNL due to over-consumption of carbohydrate diet are less than clear; however, literatures suggest high carbohydrate diet to activate the lipogenic transcription factor carbohydrate response element-binding protein (ChREBP), which further transcribes genes involved in DNL. Here, we provide an evidence of an unknown link between nuclear factor kappa-light chain enhancer of activated B cells (NF-kappa B) activation and increased DNL. Our data indicates high carbohydrate diet to enforce nuclear shuttling of hepatic NF-kappa B p65 and repress transcript levels of sorcin, a cytosolic interacting partner of ChREBP. Reduced sorcin levels, further prompted ChREBP nuclear translocation, leading to enhanced DNL and intrahepatic lipid accumulation both in vivo and in vitro. We further report that pharmacological inhibition of NF-kappa B abrogated high carbohydrate diet-mediated sorcin repression and thereby prevented ChREBP nuclear translocation and this, in turn, attenuated hepatic lipid accumulation both in in vitro and in vivo. Additionally, sorcin knockdown blunted the lipid-lowering ability of the NF-kappa B inhibitor in vitro. Together, these data suggest a heretofore unknown role for NF-kappa B in regulating ChREBP nuclear localization and activation, in response to high carbohydrate diet, for further explorations in lines of NAFLD therapeutics.	[Daniel, P. Vineeth; Dogra, Surbhi; Rawat, Priya; Choubey, Abhinav; Mondal, Prosenjit] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Khan, Aiysha Siddiq; Kamthan, Mohan] Jamia Hamdard, Dept Biochem, Sch Chem & Life Sci, New Delhi, India; [Rajak, Sangam] Sanjay Gandhi Post Grad Inst Med Sci, Dept Endocrinol, Lucknow, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Jamia Hamdard University; Sanjay Gandhi Postgraduate Institute of Medical Sciences	Mondal, P (corresponding author), Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India.; Kamthan, M (corresponding author), Jamia Hamdard, Dept Biochem, Sch Chem & Life Sci, New Delhi, India.	kamthan.mohan@gmail.com; prosenjit@iitmandi.ac.in		Kamthan, Mohan/0000-0001-8859-4699; Choubey, Abhinav/0000-0002-6025-6820; Daniel, P Vineeth/0000-0002-2612-9043; RAJAK, SANGAM/0000-0001-7529-6174	SERB [CRG/2019/004006]	SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	This work was supported by SERB (CRG/2019/004006) to P. M. and M. K.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	6	6	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100714	10.1016/j.jbc.2021.100714	http://dx.doi.org/10.1016/j.jbc.2021.100714			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33930463	Green Published, gold			2022-12-28	WOS:000672866400685
J	Frenster, JD; Stephan, G; Ravn-Boess, N; Bready, D; Wilcox, J; Kieslich, B; Wilde, C; Straeter, N; Wiggin, GR; Liebscher, I; Schoeneberg, T; Placantonakis, DG				Frenster, Joshua D.; Stephan, Gabriele; Ravn-Boess, Niklas; Bready, Devin; Wilcox, Jordan; Kieslich, Bjoern; Wilde, Caroline; Straeter, Norbert; Wiggin, Giselle R.; Liebscher, Ines; Schoeneberg, Torsten; Placantonakis, Dimitris G.			Functional impact of intramolecular cleavage and dissociation of adhesion G protein-coupled receptor GPR133 (ADGRD1) on canonical signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-LATROTOXIN CIRL; CONSTITUTIVE ACTIVITY; ACTIVATION MECHANISM; PROTEOLYTIC CLEAVAGE; TETHERED AGONISM; ANGIOGENESIS; BINDING; DOMAIN; VASCULOSTATIN; MIGRATION	GPR133 (ADGRD1), an adhesion G protein-coupled receptor (GPCR) whose canonical signaling activates GaS-mediated generation of cytosolic cAMP, has been shown to be necessary for the growth of glioblastoma (GBM), a brain malignancy. The extracellular N terminus of GPR133 is thought to be autoproteolytically cleaved into N-terminal and C-terminal fragments (NTF and CTF, respectively). However, the role of this cleavage in receptor activation remains unclear. Here, we used subcellular fractionation and immunoprecipitation approaches to show that the WT GPR133 receptor is cleaved shortly after protein synthesis and generates significantly more canonical signaling than an uncleavable point mutant GPR133 (H543R) in patient-derived GBM cultures and HEK293T cells. After cleavage, the resulting NTF and CTF remain noncovalently bound to each other until the receptor is trafficked to the plasma membrane, where we demonstrated NTF-CTF dissociation occurs. Using a fusion of the CTF of GPR133 and the N terminus of thrombin-activated human protease-activated receptor 1 as a controllable proxy system to test the effect of intramolecular cleavage and dissociation, we also showed that thrombin-induced cleavage and shedding of the human protease-activated receptor 1 NTF increased intracellular cAMP levels. These results support a model wherein dissociation of the NTF from the CTF at the plasma membrane promotes GPR133 activation and downstream signaling. These findings add depth to our understanding of the molecular life cycle and mechanism of action of GPR133 and provide critical insights that will inform therapeutic targeting of GPR133 in GBM.	[Frenster, Joshua D.; Stephan, Gabriele; Ravn-Boess, Niklas; Bready, Devin; Wilcox, Jordan; Placantonakis, Dimitris G.] NYU, Dept Neurosurg, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA; [Frenster, Joshua D.; Placantonakis, Dimitris G.] NYU, Kimmel Ctr Stem Cell Biol, Grossman Sch Med, New York, NY 10003 USA; [Kieslich, Bjoern; Straeter, Norbert] Univ Leipzig, Ctr Biotechnol & Biomed, Inst Bioanalyt Chem, Leipzig, Germany; [Wilde, Caroline; Liebscher, Ines; Schoeneberg, Torsten] Univ Leipzig, Med Fac, Rudolf Schonheimer Inst Biochem, Leipzig, Germany; [Wiggin, Giselle R.] Heptares Therapeut Ltd, Cambridge, England; [Placantonakis, Dimitris G.] NYU, Laura & Isaac Perlmutter Canc Ctr, Grossman Sch Med, New York, NY 10003 USA; [Placantonakis, Dimitris G.] NYU, Brain & Spine Tumor Ctr, Grossman Sch Med, New York, NY 10003 USA; [Placantonakis, Dimitris G.] NYU, Grossman Sch Med, Neurosci Inst, New York, NY 10003 USA	New York University; New York University; Leipzig University; Leipzig University; Heptares Therapeutics Ltd.; New York University; New York University; New York University	Placantonakis, DG (corresponding author), NYU, Dept Neurosurg, Grossman Sch Med, 550 1St Ave, New York, NY 10016 USA.; Placantonakis, DG (corresponding author), NYU, Kimmel Ctr Stem Cell Biol, Grossman Sch Med, New York, NY 10003 USA.; Placantonakis, DG (corresponding author), NYU, Laura & Isaac Perlmutter Canc Ctr, Grossman Sch Med, New York, NY 10003 USA.; Placantonakis, DG (corresponding author), NYU, Brain & Spine Tumor Ctr, Grossman Sch Med, New York, NY 10003 USA.; Placantonakis, DG (corresponding author), NYU, Grossman Sch Med, Neurosci Inst, New York, NY 10003 USA.	dimitris.placantonakis@nyulangone.org		Wilde, Caroline/0000-0003-4548-1760; Frenster, Joshua/0000-0003-2401-1575; Wiggin, Giselle/0000-0003-4436-9208; Placantonakis, Dimitris/0000-0003-1950-2978	NYSTEM Stem Cell Biology training grant [C322560GG]; DFG postdoctoral fellowship [STE 2843/1-1]; T32 Cell Biology training Grant [T32GM136542]; DFG [266022790 P4, 209933838 B6, 421152132]; NIH/NINDS [R01 NS102665]; NYSTEM (NY State Stem Cell Science) [IIRP C32595GG]; NIH/NIBIB [R01 EB028774]; DFG (German Research Foundation) FOR2149; NYU Perlmutter Cancer Center Support Grant [P30CA016087]; NYU Grossman School of Medicine	NYSTEM Stem Cell Biology training grant; DFG postdoctoral fellowship(German Research Foundation (DFG)); T32 Cell Biology training Grant; DFG(German Research Foundation (DFG)); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NYSTEM (NY State Stem Cell Science); NIH/NIBIB(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); DFG (German Research Foundation) FOR2149(German Research Foundation (DFG)); NYU Perlmutter Cancer Center Support Grant; NYU Grossman School of Medicine	J. D. F. was supported by a NYSTEM Stem Cell Biology training grant to NYU Grossman School of Medicine (#C322560GG). G. S. was supported by a DFG postdoctoral fellowship (STE 2843/1-1). N. R. -B. was supported by a T32 Cell Biology training Grant (T32GM136542) to NYU Grossman School of Medicine. I. L. and T. S. were supported by DFG FOR2149 (project numbers 266022790 P4 to T. S. and P5 to I. L.), CRC1052 (project number 209933838 B6), and CRC1423 (project number 421152132). D. G. P. was supported by NIH/NINDS R01 NS102665, NYSTEM (NY State Stem Cell Science) IIRP C32595GG, NIH/NIBIB R01 EB028774 (to Dr Steven Baete at NYU Grossman School of Medicine), NYU Grossman School of Medicine, and DFG (German Research Foundation) FOR2149 as a Mercator fellow. The NYU Microscopy Core facility was supported by the NYU Perlmutter Cancer Center Support Grant P30CA016087. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abe J, 2002, J BIOL CHEM, V277, P23391, DOI 10.1074/jbc.M110877200; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Bayin NS, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.63; Bayin NS, 2017, ONCOTARGET, V8, P64932, DOI 10.18632/oncotarget.18117; Bohnekamp J, 2011, J BIOL CHEM, V286, P41912, DOI 10.1074/jbc.C111.265934; Bruser A, 2016, J BIOL CHEM, V291, P508, DOI 10.1074/jbc.M115.701102; Cork SM, 2012, ONCOGENE, V31, P5144, DOI 10.1038/onc.2012.1; Frenster J. D., 2020, NEUROONCOL ADV, V2; Frenster JD, 2018, METHODS MOL BIOL, V1741, P63, DOI 10.1007/978-1-4939-7659-1_4; Frenster JD, 2017, NEUROSURGERY, V64, P177, DOI 10.1093/neuros/nyx227; Gray JX, 1996, J IMMUNOL, V157, P5438; Hovelson DH, 2015, NEOPLASIA, V17, P385, DOI 10.1016/j.neo.2015.03.004; Hsiao CC, 2015, INT J BIOCHEM CELL B, V65, P197, DOI 10.1016/j.biocel.2015.06.007; Hsiao CC, 2011, FEBS LETT, V585, P313, DOI 10.1016/j.febslet.2010.12.005; Hsiao CC, 2009, FEBS LETT, V583, P3285, DOI 10.1016/j.febslet.2009.09.001; Huang YS, 2012, MOL CELL BIOL, V32, P1408, DOI 10.1128/MCB.06557-11; Iguchi T, 2008, J BIOL CHEM, V283, P14469, DOI 10.1074/jbc.M708919200; Kaur B, 2005, ONCOGENE, V24, P3632, DOI 10.1038/sj.onc.1208317; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kishore A, 2016, J BIOL CHEM, V291, P3385, DOI 10.1074/jbc.M115.689349; Krasnoperov V, 2002, J BIOL CHEM, V277, P46518, DOI 10.1074/jbc.M206415200; Krasnoperov V, 1999, J BIOL CHEM, V274, P3590, DOI 10.1074/jbc.274.6.3590; Langenhan T, 2020, BASIC CLIN PHARMACOL, V126, P5, DOI 10.1111/bcpt.13223; LEFKOWITZ RJ, 1993, TRENDS PHARMACOL SCI, V14, P303, DOI 10.1016/0165-6147(93)90048-O; Liebscher I, 2016, HANDB EXP PHARMACOL, V234, P111, DOI 10.1007/978-3-319-41523-9_6; Liebscher I, 2014, CELL REP, V9, P2018, DOI 10.1016/j.celrep.2014.11.036; Lin HH, 2010, ADV EXP MED BIOL, V706, P49; Maser RL, 2020, CELL SIGNAL, V72, DOI 10.1016/j.cellsig.2020.109637; Mathiasen S, 2020, NAT CHEM BIOL, V16, P1343, DOI 10.1038/s41589-020-0617-7; Mehrotra M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181968; Morgan RK, 2019, ANN NY ACAD SCI, V1456, P5, DOI 10.1111/nyas.14094; Moriguchi T, 2004, GENES CELLS, V9, P549, DOI 10.1111/j.1356-9597.2004.00743.x; Okajima D, 2010, J RECEPT SIG TRANSD, V30, P143, DOI 10.3109/10799891003671139; Paavola KJ, 2011, J BIOL CHEM, V286, P28914, DOI 10.1074/jbc.M111.247973; Patra C, 2013, P NATL ACAD SCI USA, V110, P16898, DOI 10.1073/pnas.1304837110; Petersen SC, 2015, NEURON, V85, P755, DOI 10.1016/j.neuron.2014.12.057; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Salzman GS, 2017, P NATL ACAD SCI USA, V114, P10095, DOI 10.1073/pnas.1708810114; Schoneberg T, 2016, PHARMACOL RES, V108, P9, DOI 10.1016/j.phrs.2016.03.027; Scholz N, 2016, HANDB EXP PHARMACOL, V234, P221, DOI 10.1007/978-3-319-41523-9_10; Schulze A, 2020, FASEB J, V34, P11243, DOI 10.1096/fj.202000100R; Stoveken HM, 2015, P NATL ACAD SCI USA, V112, P6194, DOI 10.1073/pnas.1421785112; Vallon M, 2006, J BIOL CHEM, V281, P34179, DOI 10.1074/jbc.M605291200; Volynski KE, 2004, EMBO J, V23, P4423, DOI 10.1038/sj.emboj.7600443; Wilde C, 2016, FASEB J, V30, P666, DOI 10.1096/fj.15-276220; Yang LY, 2017, ACTA PHARMACOL SIN, V38, P56, DOI 10.1038/aps.2016.89; Zhu BK, 2019, J BIOL CHEM, V294, P19246, DOI 10.1074/jbc.RA119.008234	48	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100798	10.1016/j.jbc.2021.100798	http://dx.doi.org/10.1016/j.jbc.2021.100798			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022221	Green Published, gold			2022-12-28	WOS:000674717300018
J	Harris, LD; Le Pen, J; Scholz, N; Mieszczanek, J; Vaughan, N; Davis, S; Berridge, G; Kessler, BM; Bienz, M; Licchesi, JDF				Harris, Lee D.; Le Pen, Janic; Scholz, Nico; Mieszczanek, Juliusz; Vaughan, Natalie; Davis, Simon; Berridge, Georgina; Kessler, Benedikt M.; Bienz, Mariann; Licchesi, Julien D. F.			The deubiquitinase TRABID stabilizes the K29/K48-specific E3 ubiquitin ligase HECTD1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPECTROMETRY ENABLES CHARACTERIZATION; AFFINITY PURIFICATION; MULTIUBIQUITIN CHAIN; POLYUBIQUITIN; PROTEIN; REVEALS; AUTOUBIQUITINATION; DEGRADATION; SPECIFICITY; PROTEASOME	Ubiquitin is a versatile posttranslational modification, which is covalently attached to protein targets either as a single moiety or as a ubiquitin chain. In contrast to K48 and K63-linked chains, which have been extensively studied, the regulation and function of most atypical ubiquitin chains are only starting to emerge. The deubiquitinase TRABID/ZRANB1 is tuned for the recognition and cleavage of K29 and K33-linked chains. Yet, substrates of TRABID and the cellular functions of these atypical ubiquitin signals remain unclear. We determined the interactome of two TRABID constructs rendered catalytic dead either through a point mutation in the catalytic cysteine residue or through removal of the OTU catalytic domain. We identified 50 proteins trapped by both constructs and which therefore represent candidate substrates of TRABID. The E3 ubiquitin ligase HECTD1 was then validated as a substrate of TRABID and used UbiCREST and Ub-AQUA proteomics to show that HECTD1 preferentially assembles K29- and K48-linked ubiquitin chains. Further in vitro autoubiquitination assays using ubiquitin mutants established that while HECTD1 can assemble short homotypic K29 and K48-linked chains, it requires branching at K29/K48 in order to achieve its full ubiquitin ligase activity. We next used transient knockdown and genetic knockout of TRABID in mammalian cells in order to determine the functional relationship between TRABID and HECTD1. This revealed that upon TRABID depletion, HECTD1 is readily degraded. Thus, this study identifies HECTD1 as a mammalian E3 ligase that assembles branched K29/K48 chains and also establishes TRABID-HECTD1 as a DUB/E3 pair regulating K29 linkages.	[Harris, Lee D.; Scholz, Nico; Vaughan, Natalie; Licchesi, Julien D. F.] Univ Bath, Dept Biol & Biochem, Bath, Avon, England; [Le Pen, Janic; Mieszczanek, Juliusz; Bienz, Mariann] Cambridge Biomed Campus, MRC Lab Mol Biol, Cambridge, England; [Davis, Simon; Berridge, Georgina; Kessler, Benedikt M.] Univ Oxford, Target Discovery Inst, Nuffield Dept Med, Oxford, England	University of Bath; MRC Laboratory Molecular Biology; University of Oxford	Licchesi, JDF (corresponding author), Univ Bath, Dept Biol & Biochem, Bath, Avon, England.	j.licchesi@bath.ac.uk	Kessler, Benedikt/AAY-8614-2021	Kessler, Benedikt/0000-0002-8160-2446; Licchesi, Julien/0000-0003-3786-3013; Davis, Simon/0000-0001-7840-2411	Royal Society [RG130469]; Alzheimer's Research UK pilot grant [ARUK-PPG2015A-16]; Alzheimer's Research UK [ARUK-PhD2017-28]; ARUK network grants and travel awards; University of Bath; Cancer Research UK [C7379/A15291]; Medical Research Council [U105192713]; University of Bath Research Studentship; MRC GW4 BioMed Doctoral Training Partnership; MRC [MC_U105192713, 2110681] Funding Source: UKRI	Royal Society(Royal Society of London); Alzheimer's Research UK pilot grant; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); ARUK network grants and travel awards; University of Bath; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Bath Research Studentship; MRC GW4 BioMed Doctoral Training Partnership; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by a Royal Society Grant to J. D. F. L. (RG130469), an Alzheimer's Research UK pilot grant to J. D. F. L. (ARUK-PPG2015A-16), an Alzheimer's Research UK PhD studentship to L. D. H./J. D. F. L. (ARUK-PhD2017-28), ARUK network grants and travel awards to J. D. F. L., a start-up grant from the University of Bath to J. D. F. L., Cancer Research UK (Grant C7379/A15291 to M. B.), and the Medical Research Council (Grant U105192713, to M. B.). N. V. was funded through a University of Bath Research Studentship and N. S. by a studentship from the MRC GW4 BioMed Doctoral Training Partnership.	Akutsu M, 2011, P NATL ACAD SCI USA, V108, P2228, DOI 10.1073/pnas.1015287108; Alam SL, 2004, EMBO J, V23, P1411, DOI 10.1038/sj.emboj.7600114; Amemiya Y, 2008, MOL CANCER RES, V6, P1385, DOI 10.1158/1541-7786.MCR-08-0094; Baldridge RD, 2016, CELL, V166, P394, DOI 10.1016/j.cell.2016.05.048; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Bhogaraju S, 2016, CELL, V167, P1636, DOI 10.1016/j.cell.2016.11.019; Bingol B, 2014, NATURE, V510, P370, DOI 10.1038/nature13418; Broix L, 2016, NAT GENET, V48, P1349, DOI 10.1038/ng.3676; Byrne R, 2017, CHEMBIOCHEM, V18, P1415, DOI 10.1002/cbic.201700006; Chastagner P, 2006, EMBO REP, V7, P1147, DOI 10.1038/sj.embor.7400822; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; CIECHANOVER A, 1980, P NATL ACAD SCI-BIOL, V77, P1365, DOI 10.1073/pnas.77.3.1365; CIECHANOVER A, 1982, J BIOL CHEM, V257, P2537; Crosas B, 2006, CELL, V127, P1401, DOI 10.1016/j.cell.2006.09.051; Crowe SO, 2017, ANAL CHEM, V89, P4428, DOI 10.1021/acs.analchem.6b03675; Deol KK, 2020, MOL CELL, V80, DOI 10.1016/j.molcel.2020.10.017; Duhamel S, 2018, CELL REP, V22, P1016, DOI 10.1016/j.celrep.2017.12.096; Evans PC, 2003, J BIOL CHEM, V278, P23180, DOI 10.1074/jbc.M301863200; Fei C, 2013, MOL CELL BIOL, V33, P4095, DOI 10.1128/MCB.00418-13; Feng X, 2019, AUTOPHAGY, V15, P1130, DOI 10.1080/15548627.2019.1570063; Fernando MDA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004117; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Goudreault M, 2009, MOL CELL PROTEOMICS, V8, P157, DOI 10.1074/mcp.M800266-MCP200; Haakonsen DL, 2019, TRENDS CELL BIOL, V29, P704, DOI 10.1016/j.tcb.2019.06.003; HERSHKO A, 1983, J BIOL CHEM, V258, P8206; HERSHKO A, 1979, P NATL ACAD SCI USA, V76, P3107, DOI 10.1073/pnas.76.7.3107; Tran H, 2013, J BIOL CHEM, V288, P3753, DOI 10.1074/jbc.M112.415240; HOCHSTRASSER M, 1991, P NATL ACAD SCI USA, V88, P4606, DOI 10.1073/pnas.88.11.4606; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hofmann RM, 1999, CELL, V96, P645, DOI 10.1016/S0092-8674(00)80575-9; Hospenthal MK, 2015, NAT PROTOC, V10, P349, DOI 10.1038/nprot.2015.018; Hu M, 2005, EMBO J, V24, P3747, DOI 10.1038/sj.emboj.7600832; Huang FT, 2013, P NATL ACAD SCI USA, V110, P15722, DOI 10.1073/pnas.1308014110; Huguenin-Dezot N, 2016, CELL REP, V16, P1180, DOI 10.1016/j.celrep.2016.06.064; Jin J, 2016, NAT IMMUNOL, V17, P259, DOI 10.1038/ni.3347; Jin LY, 2008, CELL, V133, P653, DOI 10.1016/j.cell.2008.04.012; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kee Y, 2005, EMBO J, V24, P2414, DOI 10.1038/sj.emboj.7600710; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kirkpatrick DS, 2006, NAT CELL BIOL, V8, P700, DOI 10.1038/ncb1436; Koegl M, 1999, CELL, V96, P635, DOI 10.1016/S0092-8674(00)80574-7; Komander D, 2009, BIOCHEM SOC T, V37, P937, DOI 10.1042/BST0370937; Komander D, 2009, EMBO REP, V10, P466, DOI 10.1038/embor.2009.55; Kristariyanto YA, 2015, MOL CELL, V58, P83, DOI 10.1016/j.molcel.2015.01.041; Kristariyanto YA, 2015, BIOCHEM J, V467, P345, DOI 10.1042/BJ20141502; Kulathu Y, 2012, NAT REV MOL CELL BIO, V13, P508, DOI 10.1038/nrm3394; Lam YA, 1997, NATURE, V385, P737, DOI 10.1038/385737a0; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee Min Jae, 2011, Mol Cell Proteomics, V10, DOI 10.1074/mcp.R110.003871; Leto DE, 2019, MOL CELL, V73, P377, DOI 10.1016/j.molcel.2018.11.015; Li WB, 2015, MOL CELL, V59, P188, DOI 10.1016/j.molcel.2015.06.002; Li ZB, 2002, J BIOL CHEM, V277, P4656, DOI 10.1074/jbc.M108269200; Licchesi JDF, 2012, NAT STRUCT MOL BIOL, V19, P62, DOI 10.1038/nsmb.2169; Lindsten K, 2002, J CELL BIOL, V157, P417, DOI 10.1083/jcb.200111034; Lips C, 2020, EMBO J, V39, DOI 10.15252/embj.2020104863; Liu C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14274; Liu XL, 2016, FEBS LETT, V590, P4213, DOI 10.1002/1873-3468.12471; Longworth J., 1977, METHODS MOL BIOL, P36; Mansour W, 2015, J BIOL CHEM, V290, P4688, DOI 10.1074/jbc.M114.568295; Mastrandrea LD, 1999, J BIOL CHEM, V274, P27299, DOI 10.1074/jbc.274.38.27299; McDowell GS, 2013, INT J BIOCHEM CELL B, V45, P1833, DOI 10.1016/j.biocel.2013.05.026; McGouran JF, 2013, CHEM BIOL, V20, P1447, DOI 10.1016/j.chembiol.2013.10.012; Mevissen TET, 2013, CELL, V154, P169, DOI 10.1016/j.cell.2013.05.046; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Michel MA, 2015, MOL CELL, V58, P95, DOI 10.1016/j.molcel.2015.01.042; Mukhopadhyay D, 2007, SCIENCE, V315, P201, DOI 10.1126/science.1127085; Nuber U, 1998, EUR J BIOCHEM, V254, P643, DOI 10.1046/j.1432-1327.1998.2540643.x; Ohtake F, 2016, MOL CELL, V64, P251, DOI 10.1016/j.molcel.2016.09.014; Pao KC, 2016, NAT CHEM BIOL, V12, P324, DOI [10.1038/nchembio.2045, 10.1038/NCHEMBIO.2045]; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Phu LL, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.003756; PICKART CM, 1985, J BIOL CHEM, V260, P1573; Pickart CM, 2005, METHOD ENZYMOL, V399, P21, DOI 10.1016/S0076-6879(05)99002-2; Rape M, 2006, CELL, V124, P89, DOI 10.1016/j.cell.2005.10.032; Ritorto MS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5763; Sarkar AA, 2012, J CELL BIOL, V196, P789, DOI 10.1083/jcb.201105101; Schubert OT, 2015, NAT PROTOC, V10, DOI 10.1038/nprot.2015.015; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Segref A, 2014, CELL METAB, V19, P642, DOI 10.1016/j.cmet.2014.01.016; Sheng Y, 2012, MOL CELL PROTEOMICS, V11, P329, DOI 10.1074/mcp.O111.013706; Shi Tong, 2012, BMC Chemical Biology, V12, P4, DOI 10.1186/1472-6769-12-4; Sowa ME, 2009, CELL, V138, P389, DOI 10.1016/j.cell.2009.04.042; Swatek KN, 2019, NATURE, V572, P533, DOI 10.1038/s41586-019-1482-y; TAKESHIGE K, 1992, J CELL BIOL, V119, P301, DOI 10.1083/jcb.119.2.301; Terrell J, 1998, MOL CELL, V1, P193, DOI 10.1016/S1097-2765(00)80020-9; Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208; Tsuchiya H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-02869-x; Tsuchiya H, 2017, MOL CELL, V66, P488, DOI 10.1016/j.molcel.2017.04.024; Valkevich EM, 2014, BIOCHEMISTRY-US, V53, P4979, DOI 10.1021/bi5006305; van Tienen LM, 2017, ELIFE, V6, DOI [10.7554/eLife.20882.001, 10.7554/eLife.20882]; Virdee S, 2010, NAT CHEM BIOL, V6, P750, DOI [10.1038/NCHEMBIO.426, 10.1038/nchembio.426]; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wenzel DM, 2011, NATURE, V474, P105, DOI 10.1038/nature09966; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Williamson A, 2009, P NATL ACAD SCI USA, V106, P18213, DOI 10.1073/pnas.0907887106; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yau R, 2016, NAT CELL BIOL, V18, P579, DOI 10.1038/ncb3358; You JX, 2001, J BIOL CHEM, V276, P19871, DOI 10.1074/jbc.M100034200; Zhang PJ, 2018, CELL REP, V23, P823, DOI 10.1016/j.celrep.2018.03.078; Zhu YK, 2019, CELL DEATH DIFFER, V26, P306, DOI 10.1038/s41418-018-0119-2	107	8	8	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100246	10.1074/jbc.RA120.015162	http://dx.doi.org/10.1074/jbc.RA120.015162			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33853758	Green Published, gold			2022-12-28	WOS:000672866400223
J	Kuliyev, E; Zhang, C; Sui, DX; Hu, J				Kuliyev, Eziz; Zhang, Chi; Sui, Dexin; Hu, Jian			Zinc transporter mutations linked to acrodermatitis enteropathica disrupt function and cause mistrafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE; SLC39A4; CFTR; ROLES; ZIP4; COLOCALIZATION; IDENTIFICATION; DEFICIENCY; STABILITY; MANGANESE	ZIP4 is a representative member of the Zrt-/Irt-like protein (ZIP) transporter family and responsible for zinc uptake from diet. Loss-of-function mutations of human ZIP4 (hZIP4) drastically reduce zinc absorption, causing a life-threatening autosomal recessive disorder, acrodermatitis enteropathica (AE). These mutations occur not only in the conserved trans-membrane zinc transport machinery, but also in the extracellular domain (ECD) of hZIP4, which is only present in a fraction of mammalian ZIPs. How these AE-causing ECD mutations lead to ZIP4 malfunction has not be fully clarified. In this work, we characterized all seven confirmed AE-causing missense mutations in hZIP4-ECD and found that the variants exhibited completely abolished zinc transport activity in a cell-based transport assay. Although the variants were able to be expressed in HEK293T cells, they failed to traffic to the cell surface and were largely retained in the ER with immature glycosylation. When the corresponding mutations were introduced in the ECD of ZIP4 from Pteropus Alecto, a close homolog of hZIP4, the variants exhibited structural defects or reduced thermal stability, which likely accounts for intracellular mistrafficking of the AE-associated variants and as such a total loss of zinc uptake activity. This work provides a molecular pathogenic mechanism for AE.	[Kuliyev, Eziz; Hu, Jian] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Zhang, Chi; Sui, Dexin; Hu, Jian] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA	Michigan State University; Michigan State University	Hu, J (corresponding author), Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA.; Hu, J (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	hujian1@msu.edu			National Institutes of Health [GM115373, GM129004]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by National Institutes of Health GM115373 and GM129004 (to J. H.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Andreini C, 2006, J PROTEOME RES, V5, P196, DOI 10.1021/pr050361j; Bin BH, 2014, EMBO MOL MED, V6, P1028, DOI 10.15252/emmm.201303809; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Boycott KM, 2015, AM J HUM GENET, V97, P886, DOI 10.1016/j.ajhg.2015.11.002; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Choi EK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21464-0; Chowanadisai W, 2013, P NATL ACAD SCI USA, V110, P9903, DOI 10.1073/pnas.1222142110; Dufner-Beattie J, 2003, J BIOL CHEM, V278, P33474, DOI 10.1074/jbc.M305000200; Dufner-Beattie J, 2007, HUM MOL GENET, V16, P1391, DOI 10.1093/hmg/ddm088; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; FISCHER PWF, 1984, AM J CLIN NUTR, V40, P743, DOI 10.1093/ajcn/40.4.743; Fukada T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003642; Gaither LA, 2001, J BIOL CHEM, V276, P22258, DOI 10.1074/jbc.M101772200; Geiser J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002766; Hara T, 2017, J PHYSIOL SCI, V67, P283, DOI 10.1007/s12576-017-0521-4; Hoch E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030734; HOOGENRAAD TU, 1985, SCI TOTAL ENVIRON, V42, P37, DOI 10.1016/0048-9697(85)90005-1; Hu J, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7010004; Jeong J, 2013, MOL ASPECTS MED, V34, P612, DOI 10.1016/j.mam.2012.05.011; Jeong J, 2012, P NATL ACAD SCI USA, V109, pE3530, DOI 10.1073/pnas.1211775110; Jung AG, 2011, J DTSCH DERMATOL GES, V9, P999, DOI 10.1111/j.1610-0387.2011.07742.x; Kambe T, 2004, CELL MOL LIFE SCI, V61, P49, DOI 10.1007/s00018-003-3148-y; Kambe T, 2015, PHYSIOL REV, V95, P749, DOI 10.1152/physrev.00035.2014; Kambe T, 2014, CELL MOL LIFE SCI, V71, P3281, DOI 10.1007/s00018-014-1617-0; Kury S, 2002, NAT GENET, V31, P239, DOI 10.1038/ng913; Kury S., 2012, EUR J HUM GENET, V20; Kury Sebastien, 2003, Hum Mutat, V22, P337, DOI 10.1002/humu.9178; Legardinier S, 2009, J MOL BIOL, V389, P546, DOI 10.1016/j.jmb.2009.04.025; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liu FY, 2019, SCIENCE, V364, P1184, DOI 10.1126/science.aaw7611; Liu FY, 2017, CELL, V169, P85, DOI 10.1016/j.cell.2017.02.024; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Lukacs GL, 2012, TRENDS MOL MED, V18, P81, DOI 10.1016/j.molmed.2011.10.003; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; Maret W, 2006, J TRACE ELEM MED BIO, V20, P3, DOI 10.1016/j.jtemb.2006.01.006; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; McCall KA, 2000, J NUTR, V130, p1437S, DOI 10.1093/jn/130.5.1437S; Nakano A, 2003, J INVEST DERMATOL, V120, P963, DOI 10.1046/j.1523-1747.2003.12243.x; Park JH, 2015, AM J HUM GENET, V97, P894, DOI 10.1016/j.ajhg.2015.11.003; Perafan-Riveros C, 2002, PEDIATR DERMATOL, V19, P426, DOI 10.1046/j.1525-1470.2002.00200.x; Pinilla-Tenas JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC862, DOI 10.1152/ajpcell.00479.2010; Prasad AS, 2003, BMJ-BRIT MED J, V326, P409, DOI 10.1136/bmj.326.7386.409; Schmitt S, 2009, HUM MUTAT, V30, P926, DOI 10.1002/humu.20988; Spiro RG, 2002, GLYCOBIOLOGY, V12, p43R, DOI 10.1093/glycob/12.4.43R; Taylor-Cousar JL, 2017, NEW ENGL J MED, V377, P2013, DOI 10.1056/NEJMoa1709846; Wang FD, 2004, HUM MOL GENET, V13, P563, DOI 10.1093/hmg/ddh049; Wang K, 2002, AM J HUM GENET, V71, P66, DOI 10.1086/341125; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zhang C, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107582; Zhang T, 2020, FASEB J, V34, P237, DOI 10.1096/fj.201902043R; Zhang T, 2019, BIOCHEM J, V476, P1791, DOI 10.1042/BCJ20190108; Zhang T, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700344; Zhang T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11979; ZHOU NE, 1992, J BIOL CHEM, V267, P2664	55	5	5	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100269	10.1016/j.jbc.2021.100269	http://dx.doi.org/10.1016/j.jbc.2021.100269			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837739	gold, Green Published			2022-12-28	WOS:000672866400245
J	Liao, ZJ; Gingras, AR; Lagarrigue, F; Ginsberg, MH; Shattil, SJ				Liao, Zhongji; Gingras, Alexandre R.; Lagarrigue, Frederic; Ginsberg, Mark H.; Shattil, Sanford J.			Optogenetics-based localization of talin to the plasma membrane promotes activation of beta 3 integrins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRUCTURAL BASIS; PLATELET; PROTEIN; DOMAIN; BINDING; RIAM; AGGREGATION; RECOGNITION; COMPLEX; HEAD	Interaction of talin with the cytoplasmic tails of integrin beta triggers integrin activation, leading to an increase of integrin affinity/avidity for extracellular ligands. In talin KO mice, loss of talin interaction with platelet integrin alpha IIb beta 3 causes a severe hemostatic defect, and loss of talin interaction with endothelial cell integrin alpha V beta 3 affects angiogenesis. In normal cells, talin is autoinhibited and localized in the cytoplasm. Here, we used an optogenetic platform to assess whether recruitment of fulllength talin to the plasma membrane was sufficient to induce integrin activation. A dimerization module (Arabidopsis cryptochrome 2 fused to the N terminus of talin; N-terminal of cryptochrome-interacting basic helix-loop-helix domain ended with a CAAX box protein [C: cysteine; A: aliphatic amino acid; X: any C-terminal amino acid]) responsive to 450 nm (blue) light was inserted into Chinese hamster ovary cells and endothelial cells also expressing alpha IIb beta 3 or alpha V beta 3, respectively. Thus, exposure of the cells to blue light caused a rapid and reversible recruitment of Arabidopsis cryptochrome 2-talin to the N-terminal of cryptochrome-interacting basic helix-loop-helix domain ended with a CAAX box protein [C: cysteine; A: aliphatic amino acid; X: any C-terminal amino acid]-decorated plasma membrane. This resulted in beta 3 integrin activation in both cell types, as well as increasing migration of the endothelial cells. However, membrane recruitment of talin was not sufficient for integrin activation, as membraneassociated Ras-related protein 1 (Rap1)-GTP was also required. Moreover, talin mutations that interfered with its direct binding to Rap1 abrogated beta 3 integrin activation. Altogether, these results define a role for the plasma membrane recruitment of talin in beta 3 integrin activation, and they suggest a nuanced sequence of events thereafter involving Rap1-GTP.	[Liao, Zhongji; Gingras, Alexandre R.; Lagarrigue, Frederic; Ginsberg, Mark H.; Shattil, Sanford J.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Liao, ZJ; Shattil, SJ (corresponding author), Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.	zhliao@health.ucsd.edu; sshattil@health.ucsd.edu		Liao, Zhongji/0000-0003-2180-5329; Lagarrigue, Frederic/0000-0002-4660-8666	University of Strathclyde; NRF [2019-NRF-ISF003-3172]	University of Strathclyde; NRF	R. D. R. B. acknowledges the University of Strathclyde for a scholarship award. J. O. was supported by the NRF 2019-NRF-ISF003-3172 grant.	ABRAMS C, 1994, J BIOL CHEM, V269, P18781; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; BECKERLE MC, 1989, J CELL BIOL, V109, P3333, DOI 10.1083/jcb.109.6.3333; Bennett JS, 2015, BIOPOLYMERS, V104, P323, DOI 10.1002/bip.22679; Bromberger T, 2018, BLOOD, V132, P2754, DOI 10.1182/blood-2018-04-846766; Calderwood DA, 2002, J BIOL CHEM, V277, P21749, DOI 10.1074/jbc.M111996200; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Camp D, 2018, J CELL SCI, V131, DOI 10.1242/jcs.225144; Chinthalapudi K, 2018, P NATL ACAD SCI USA, V115, P10339, DOI 10.1073/pnas.1806275115; Coller BS, 2015, J THROMB HAEMOST, V13, pS17, DOI 10.1111/jth.12915; Critchley DR, 2009, ANNU REV BIOPHYS, V38, P235, DOI 10.1146/annurev.biophys.050708.133744; Crittenden JR, 2004, NAT MED, V10, P982, DOI 10.1038/nm1098; Dedden D, 2019, CELL, V179, P120, DOI 10.1016/j.cell.2019.08.034; Elliott PR, 2010, STRUCTURE, V18, P1289, DOI 10.1016/j.str.2010.07.011; Eto K, 2002, P NATL ACAD SCI USA, V99, P12819, DOI 10.1073/pnas.202380099; FROJMOVIC MM, 1991, BLOOD, V78, P369; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2019, J CELL BIOL, V218, P1799, DOI 10.1083/jcb.201810061; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; HANCOCK JF, 1990, CELL, V63, P133, DOI 10.1016/0092-8674(90)90294-O; Hato T, 1998, J CELL BIOL, V141, P1685, DOI 10.1083/jcb.141.7.1685; Haydari Z, 2020, BIOPHYS J, V118, P1977, DOI 10.1016/j.bpj.2020.02.023; Hynes RO, 2002, COLD SPRING HARB SYM, V67, P143, DOI 10.1101/sqb.2002.67.143; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kahner BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034056; KAWATA M, 1990, P NATL ACAD SCI USA, V87, P8960, DOI 10.1073/pnas.87.22.8960; Kennedy MJ, 2010, NAT METHODS, V7, P973, DOI 10.1038/NMETH.1524; Klapproth S, 2015, BLOOD, V126, P2592, DOI 10.1182/blood-2015-04-639310; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lagarrigue F, 2020, BLOOD, V136, P1180, DOI 10.1182/blood.2020005348; Lagarrigue F, 2018, BLOOD ADV, V2, P2358, DOI 10.1182/bloodadvances.2018020487; Lagarrigue F, 2016, BLOOD, V128, P479, DOI 10.1182/blood-2015-12-638700; Li HD, 2017, P NATL ACAD SCI USA, V114, P9349, DOI 10.1073/pnas.1703064114; Liao ZJ, 2017, J CELL SCI, V130, P3532, DOI 10.1242/jcs.205203; Liao ZJ, 2015, BLOOD, V125, P1995, DOI 10.1182/blood-2014-09-603035; OTOOLE TE, 1994, J CELL BIOL, V124, P1047, DOI 10.1083/jcb.124.6.1047; Park H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00060-2; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Peurois F, 2019, BIOCHEM SOC T, V47, P13, DOI 10.1042/BST20170525; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rangarajan ES, 2020, J BIOL CHEM, V295, P12885, DOI 10.1074/jbc.RA119.010789; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Stalker Timothy J, 2012, Handb Exp Pharmacol, P59, DOI 10.1007/978-3-642-29423-5_3; Stefanini L, 2018, BLOOD, V132, P1951, DOI 10.1182/blood-2018-03-838714; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Su WJ, 2015, BLOOD, V126, P2695, DOI 10.1182/blood-2015-05-644104; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Watanabe N, 2008, J CELL BIOL, V181, P1211, DOI 10.1083/jcb.200803094; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Ye F, 2013, CURR BIOL, V23, P2288, DOI 10.1016/j.cub.2013.09.050; Zhang PF, 2020, P NATL ACAD SCI USA, V117, P32402, DOI 10.1073/pnas.2014583117; Zhu L, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01822-8	54	3	3	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100675	10.1016/j.jbc.2021.100675	http://dx.doi.org/10.1016/j.jbc.2021.100675			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865854	Green Published, gold			2022-12-28	WOS:000672866400646
J	Cook, AD; Roberts, AJ; Atherton, J; Tewari, R; Topf, M; Moores, CA				Cook, Alexander D.; Roberts, Anthony J.; Atherton, Joseph; Tewari, Rita; Topf, Maya; Moores, Carolyn A.			Cryo-EM structure of a microtubule-bound parasite kinesin motor and implications for its mechanism and inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; PLASMODIUM-FALCIPARUM; ARTEMISININ RESISTANCE; EG5; PREDICTION; VISUALIZATION; REFINEMENT; TRANSPORT; MOTILITY; REGIONS	Plasmodium parasites cause malaria and are responsible annually for hundreds of thousands of deaths. Kinesins are a superfamily of microtubule-dependent ATPases that play important roles in the parasite replicative machinery, which is a potential target for antiparasite drugs. Kinesin-5, a molecular motor that cross-links microtubules, is an established antimitotic target in other disease contexts, but its mechanism in Plasmodium falciparum is unclear. Here, we characterized P. falciparum kinesin-5 (PfK5) using cryo-EM to determine the motor's nucleotide-dependent microtubule-bound structure and introduced 3D classification of individual motors into our microtubule image processing pipeline to maximize our structural insights. Despite sequence divergence in PfK5, the motor exhibits classical kinesin mechanochemistry, including ATP-induced subdomain rearrangement and cover neck bundle formation, consistent with its plus-ended directed motility. We also observed that an insertion in loop5 of the PfK5 motor domain creates a different environment in the well-characterized human kinesin-5 drug-binding site. Our data reveal the possibility for selective inhibition of PfK5 and can be used to inform future exploration of Plasmodium kinesins as antiparasite targets.	[Cook, Alexander D.; Roberts, Anthony J.; Atherton, Joseph; Topf, Maya; Moores, Carolyn A.] Birkbeck Univ London, Inst Struct & Mol Biol, Dept Biol Sci, London, England; [Tewari, Rita] Univ Nottingham, Sch Life Sci, Nottingham, England; [Cook, Alexander D.] Univ Oxford, Dept Biochem, Oxford, England; [Atherton, Joseph] Kings Coll London, Randall Ctr Cell & Mol Biophys, London, England	University of London; Birkbeck University London; University of Nottingham; University of Oxford; University of London; King's College London	Moores, CA (corresponding author), Birkbeck Univ London, Inst Struct & Mol Biol, Dept Biol Sci, London, England.	c.moores@mail.cryst.bbk.ac.uk		Tewari, Rita/0000-0003-3943-1847; Cook, Alex/0000-0003-1283-1541; Topf, Maya/0000-0002-8185-1215; Moores, Carolyn/0000-0001-5686-6290	Medical Research Council, UK [MR/J003867/1, MR/R000352/1]; Wellcome Trust [101311-10, 085945/Z/08/Z, 104196/Z/14/Z, 217186/Z/19/Z, 209250/Z/17/Z, 208398/Z/17/Z]; Biotechnology and Biological Sciences Research Council, UK [BB/N017609/1]	Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	A. D. C. was supported by PhD studentships from the Medical Research Council, UK (MR/J003867/1) and funds from the Wellcome Trust (101311-10). This work was also supported by funds from the Wellcome Trust (085945/Z/08/Z) to C. A. M., A. J. R (104196/Z/14/Z and 217186/Z/19/Z) and M. T. (209250/Z/17/Z and 208398/Z/17/Z) and the Medical Research Council, UK to C. A. M. (MR/R000352/1). R. T. was supported by the Biotechnology and Biological Sciences Research Council, UK (BB/N017609/1).	Acar S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2348; Aleshnick M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008181; Amos LA, 1997, CURR OPIN CELL BIOL, V9, P4, DOI 10.1016/S0955-0674(97)80145-7; Atherton J, 2017, ELIFE, V6, DOI 10.7554/eLife.27793; Atherton J, 2014, ELIFE, V3, DOI 10.7554/eLife.03680; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkh121, 10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Behnke-Parks WM, 2011, J BIOL CHEM, V286, P5242, DOI 10.1074/jbc.M110.192930; Bell KM, 2017, J BIOL CHEM, V292, P14680, DOI 10.1074/jbc.M117.797662; Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322; Birnbaum J, 2020, SCIENCE, V367, P51, DOI 10.1126/science.aax4735; Cahu J, 2009, J CELL SCI, V122, P1295, DOI 10.1242/jcs.044248; Cao LY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6364; Chua PR, 2007, MOL MICROBIOL, V65, P347, DOI 10.1111/j.1365-2958.2007.05787.x; Cochran JC, 2004, J BIOL CHEM, V279, P38861, DOI 10.1074/jbc.M404203200; Cook AD, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.10.004; Cowman AF, 2016, CELL, V167, P610, DOI 10.1016/j.cell.2016.07.055; Cross RA, 2014, NAT REV MOL CELL BIO, V15, P257, DOI 10.1038/nrm3768; Davies HM, 2017, FEMS MICROBIOL REV, V41, P923, DOI 10.1093/femsre/fux046; DeBonis S, 2004, MOL CANCER THER, V3, P1079; Debs GE, 2020, P NATL ACAD SCI USA, V117, P16976, DOI 10.1073/pnas.2001546117; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Dowling DP, 2010, BIOCHEMISTRY-US, V49, P5600, DOI 10.1021/bi100390z; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Farabella I, 2015, J APPL CRYSTALLOGR, V48, P1314, DOI 10.1107/S1600576715010092; Gibson DG, 2009, NAT METHODS, V6, P343, DOI [10.1038/NMETH.1318, 10.1038/nmeth.1318]; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Goulet A, 2014, P NATL ACAD SCI USA, V111, P1837, DOI 10.1073/pnas.1319848111; Heffernan R, 2017, BIOINFORMATICS, V33, P2842, DOI 10.1093/bioinformatics/btx218; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hwang W, 2008, STRUCTURE, V16, P62, DOI 10.1016/j.str.2007.11.008; HYMAN AA, 1991, J CELL SCI, P125; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Joseph AP, 2016, METHODS, V100, P42, DOI 10.1016/j.ymeth.2016.03.007; Kaan HYK, 2010, BIOCHEM J, V425, P55, DOI 10.1042/BJ20091207; Kapitein LC, 2005, NATURE, V435, P114, DOI 10.1038/nature03503; Kapitein LC, 2008, J CELL BIOL, V182, P421, DOI 10.1083/jcb.200801145; Kaseda K, 2008, EMBO REP, V9, P761, DOI 10.1038/embor.2008.96; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kikkawa M, 2006, EMBO J, V25, P4187, DOI 10.1038/sj.emboj.7601299; Klausen MS, 2019, PROTEINS, V87, P520, DOI 10.1002/prot.25674; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lacey SE, 2019, ELIFE, V8, DOI 10.7554/eLife.47145; Larson AG, 2010, BIOPHYS J, V98, P2619, DOI 10.1016/j.bpj.2010.03.014; Liu LQ, 2014, J BIOL CHEM, V289, P16601, DOI 10.1074/jbc.M114.551408; Liu LQ, 2011, J BIOL CHEM, V286, P6201, DOI 10.1074/jbc.M110.154989; Lockhart A, 1996, BIOCHEMISTRY-US, V35, P2365, DOI 10.1021/bi952318n; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Manka SW, 2018, ESSAYS BIOCHEM, V62, P737, DOI 10.1042/EBC20180031; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Murata JM, 2013, J BIOL CHEM, V288, P34839, DOI 10.1074/jbc.M113.518845; Myers SM, 2016, FUTURE MED CHEM, V8, P463, DOI 10.4155/fmc.16.5; Parke CL, 2010, J BIOL CHEM, V285, P5859, DOI 10.1074/jbc.M109.071233; Pena A, 2020, STRUCTURE, V28, P450, DOI 10.1016/j.str.2020.01.013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pizzi E, 2001, GENOME RES, V11, P218, DOI 10.1101/gr.GR-1522R; Rai A, 2020, NAT MATER, V19, P355, DOI 10.1038/s41563-019-0546-6; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shang ZG, 2014, ELIFE, V3, DOI 10.7554/eLife.04686; Shimamoto Y, 2015, DEV CELL, V34, P669, DOI 10.1016/j.devcel.2015.08.017; Sindelar CV, 2010, P NATL ACAD SCI USA, V107, P4111, DOI 10.1073/pnas.0911208107; Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016; Toropova K, 2017, NAT STRUCT MOL BIOL, V24, P461, DOI 10.1038/nsmb.3391; Vale RD, 2000, SCIENCE, V288, P88, DOI 10.1126/science.288.5463.88; Vale RD, 1996, J CELL BIOL, V135, P291, DOI 10.1083/jcb.135.2.291; VALE RD, 1994, J BIOL CHEM, V269, P23769; van Vuuren RJ, 2015, CANCER CHEMOTH PHARM, V76, P1101, DOI 10.1007/s00280-015-2903-8; van Zundert GCP, 2016, J MOL BIOL, V428, P720, DOI 10.1016/j.jmb.2015.09.014; von Loeffelholz O, 2019, J STRUCT BIOL, V207, P312, DOI 10.1016/j.jsb.2019.07.003; von Loeffelholz O, 2019, J MOL BIOL, V431, P864, DOI 10.1016/j.jmb.2019.01.011; Waitzman JS, 2011, BIOPHYS J, V101, P2760, DOI 10.1016/j.bpj.2011.10.032; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang RYR, 2016, ELIFE, V5, DOI 10.7554/eLife.17219; Wang S., 2015, SCI REPORTS, V6, P1, DOI DOI 10.3390/nano6010003; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wickstead B, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-110; Wojcik EJ, 2013, GENE, V531, P133, DOI 10.1016/j.gene.2013.08.004; Yahiya S, 2019, CURR OPIN CHEM BIOL, V50, P1, DOI 10.1016/j.cbpa.2019.01.029; Yan RX, 2013, SCI REP-UK, V3, DOI 10.1038/srep02619; Yan YW, 2004, J MOL BIOL, V335, P547, DOI 10.1016/j.jmb.2003.10.074; Zeeshan M, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.583812; Zhang A. M., 2018, SCIENCE, V360, P1; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang R, 2015, CELL, V162, P849, DOI 10.1016/j.cell.2015.07.012; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007; Zivanov J, 2020, IUCRJ, V7, P253, DOI 10.1107/S2052252520000081; Zivanov J, 2018, ELIFE, V7, DOI 10.7554/eLife.42166	89	6	6	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV	2021	297	5							101063	10.1016/j.jbc.2021.101063	http://dx.doi.org/10.1016/j.jbc.2021.101063			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	XD9SD	34375637	Green Published, gold, Green Accepted			2022-12-28	WOS:000723038700013
J	Matsuzawa, T; Morita, M; Shimane, A; Otsuka, R; Mei, Y; Irie, F; Yamaguchi, Y; Yanai, K; Yoshikawa, T				Matsuzawa, Takuro; Morita, Masanobu; Shimane, Ai; Otsuka, Rina; Mei, Yu; Irie, Fumitoshi; Yamaguchi, Yu; Yanai, Kazuhiko; Yoshikawa, Takeo			Heparan sulfate promotes differentiation of white adipocytes to maintain insulin sensitivity and glucose homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENOME-WIDE ASSOCIATION; CELL-SURFACE; PPAR-GAMMA; ADIPOSE; ADIPOGENESIS; RECEPTOR; TARGET; FAT; ACTIVATION; ENZYME	Heparan sulfate (HS), a highly sulfated linear polysaccharide, is involved in diverse biological functions in various tissues. Although previous studies have suggested a possible contribution of HS to the differentiation of white adipocytes, there has been no direct evidence supporting this. Here, we inhibited the synthesis of HS chains in 3T3-L1 cells using CRISPR-Cas9 technology, resulting in impaired differentiation of adipocytes with attenuated bone morphogenetic protein 4 (BMP4)- fibroblast growth factor 1 (FGF1) signaling pathways. HS reduction resulted in reduced glucose uptake and decreased insulin-dependent intracellular signaling. We then made heterozygous mutant mice for the Ext1 gene, which encodes an enzyme essential for the HS biosynthesis, specifically in the visceral white adipose tissue (Fabp4-Cre(+)::Ext1(flox/WT) mice, hereafter called Ext1(Delta/WT)) to confirm the importance of HS in vivo. The expression levels of transcription factors that control adipocyte differentiation, such as peroxisome proliferator-activated receptor gamma, were reduced in Ext1(Delta/WT) adipocytes, which contained smaller, unilocular lipid droplets, reduced levels of enzymes involved in lipid synthesis, and altered expression of BMP4-FGF1 signaling molecules. Furthermore, we examined the impact of HS reduction in visceral white adipose tissue on systemic glucose homeostasis. We observed that Ext1(Delta/WT) mice showed glucose intolerance because of insulin resistance. Our results demonstrate that HS plays a crucial role in the differentiation of white adipocytes through BMP4-FGF1 signaling pathways, thereby contributing to insulin sensitivity and glucose homeostasis.	[Matsuzawa, Takuro; Shimane, Ai; Otsuka, Rina; Mei, Yu; Yanai, Kazuhiko; Yoshikawa, Takeo] Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan; [Morita, Masanobu] Tohoku Univ, Grad Sch Med, Dept Environm Med & Mol Toxicol, Sendai, Miyagi, Japan; [Irie, Fumitoshi; Yamaguchi, Yu] Sanford Burnham Prebys Med Discovery Inst, Human Genet Program, La Jolla, CA USA	Tohoku University; Tohoku University; Sanford Burnham Prebys Medical Discovery Institute	Yoshikawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Pharmacol, Sendai, Miyagi, Japan.	tyoshikawa@med.tohoku.ac.jp	Yoshikawa, Takeo/U-1823-2019	Yoshikawa, Takeo/0000-0002-7056-6021; Yamaguchi, Yu/0000-0003-0098-281X	Japan Society for the Promotion of Science KAKENHI [JP20J11179]; Nishinomiya Basic Research Fund, Japan; Anzai Diabetes Memorial Research Fund, Japan; National Institutes of Health, USA [R01 AR055670]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nishinomiya Basic Research Fund, Japan; Anzai Diabetes Memorial Research Fund, Japan; National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by Japan Society for the Promotion of Science KAKENHI grant number JP20J11179 (to T. M.); Nishinomiya Basic Research Fund (to T. M.), Japan; Anzai Diabetes Memorial Research Fund, Japan (to T. Y.); and National Institutes of Health grant R01 AR055670 (to Y. Y.), USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	BOURDON MA, 1987, P NATL ACAD SCI USA, V84, P3194, DOI 10.1073/pnas.84.10.3194; Chang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095045; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Choy L, 2000, J CELL BIOL, V149, P667, DOI 10.1083/jcb.149.3.667; Clarke AJ, 2018, J EXP MED, V215, P399, DOI 10.1084/jem.20170771; De Boer J, 2004, TISSUE ENG, V10, P393, DOI 10.1089/107632704323061753; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fellgett SW, 2015, J CELL SCI, V128, P1408, DOI 10.1242/jcs.164467; Foster MT, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.15; Foster MT, 2011, PHYSIOL BEHAV, V104, P845, DOI 10.1016/j.physbeh.2011.04.064; FROST SC, 1985, J BIOL CHEM, V260, P2646; Garin-Shkolnik T, 2014, DIABETES, V63, P900, DOI 10.2337/db13-0436; Greenall SA, 2016, MABS-AUSTIN, V8, P246, DOI 10.1080/19420862.2015.1122149; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; Hammarstedt A, 2013, P NATL ACAD SCI USA, V110, P2563, DOI 10.1073/pnas.1211255110; Harmon AW, 2004, AM J PHYSIOL-ENDOC M, V287, pE758, DOI 10.1152/ajpendo.00581.2003; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hoffmann JM, 2017, CELL REP, V20, P1038, DOI 10.1016/j.celrep.2017.07.020; Hutley LJ, 2011, MOL CELL ENDOCRINOL, V339, P165, DOI 10.1016/j.mce.2011.04.012; Iida T, 2015, GLIA, V63, P1213, DOI 10.1002/glia.22812; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Inubushi T, 2018, J BONE MINER RES, V33, P658, DOI 10.1002/jbmr.3341; Irie F, 2012, P NATL ACAD SCI USA, V109, P5052, DOI 10.1073/pnas.1117881109; Jeffery E, 2014, ADIPOCYTE, V3, P206, DOI 10.4161/adip.29674; Jonker JW, 2012, NATURE, V485, P391, DOI 10.1038/nature10998; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Lee MJ, 2019, DIABETES, V68, P587, DOI 10.2337/db18-0955; Lin X, 2000, DEV BIOL, V224, P299, DOI 10.1006/dbio.2000.9798; Lubura M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037026; Martinez L, 2010, BIOCHEM PHARMACOL, V79, P1300, DOI 10.1016/j.bcp.2009.12.013; Matsumoto Y, 2010, J BIOL CHEM, V285, P19227, DOI 10.1074/jbc.M110.105338; Matsuzawa T, 2018, BIOCHEM BIOPH RES CO, V499, P688, DOI 10.1016/j.bbrc.2018.03.213; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Miller SG, 1996, P NATL ACAD SCI USA, V93, P5507, DOI 10.1073/pnas.93.11.5507; Moens SJB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115662; Moore AF, 2008, DIABETES, V57, P2503, DOI 10.2337/db08-0284; Mullican SE, 2013, MOL ENDOCRINOL, V27, P127, DOI 10.1210/me.2012-1267; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Ross SE, 2000, SCIENCE, V289, P950, DOI 10.1126/science.289.5481.950; Sarjeant K, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008417; Satoh M, 2008, EUR J CLIN INVEST, V38, P97, DOI 10.1111/j.1365-2362.2007.01912.x; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seip M, 1996, ACTA PAEDIATR, V85, P2, DOI 10.1111/j.1651-2227.1996.tb14262.x; Serafini S, 2017, DIAGN PATHOL, V12, DOI 10.1186/s13000-017-0673-9; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Suenaga M, 2013, CYTOKINE, V64, P138, DOI 10.1016/j.cyto.2013.07.011; Suh JM, 2014, NATURE, V513, P436, DOI 10.1038/nature13540; Takahashi M, 2008, FEBS LETT, V582, P573, DOI 10.1016/j.febslet.2008.01.023; Tran TH, 2012, J BIOL CHEM, V287, P32651, DOI 10.1074/jbc.M112.353243; van Wijk XMR, 2014, ANGIOGENESIS, V17, P443, DOI 10.1007/s10456-013-9401-6; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Wilsie Larissa C, 2005, Lipids Health Dis, V4, P2, DOI 10.1186/1476-511X-4-2; Yamada Y, 2020, NEUROPHARMACOLOGY, V175, DOI 10.1016/j.neuropharm.2020.108179; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; Yokoyama M, 2020, BBA-GEN SUBJECTS, V1864, DOI 10.1016/j.bbagen.2020.129707; Yue F, 2014, NATURE, V515, P355, DOI 10.1038/nature13992; Zhang P, 2018, CELL, V174, P1450, DOI 10.1016/j.cell.2018.07.002; Zhang XH, 2015, MOL THER-NUCL ACIDS, V4, DOI 10.1038/mtna.2015.37	61	4	4	1	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101006	10.1016/j.jbc.2021.101006	http://dx.doi.org/10.1016/j.jbc.2021.101006			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34310946	Green Published, gold			2022-12-28	WOS:000706418900003
J	Patterson-Orazem, AC; Qerqez, AN; Azouz, LR; Ma, MT; Hill, SE; Ku, YM; Schildmeyer, LA; Maynard, JA; Lieberman, RL				Patterson-Orazem, Athena C.; Qerqez, Ahlam N.; Azouz, Laura R.; Ma, Minh Thu; Hill, Shannon E.; Ku, Yemo; Schildmeyer, Lisa A.; Maynard, Jennifer A.; Lieberman, Raquel L.			Recombinant antibodies recognize conformation-dependent epitopes of the leucine zipper of misfolding-prone myocilin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRABECULAR MESHWORK CELLS; OPEN-ANGLE GLAUCOMA; OLFACTOMEDIN DOMAIN; MONOCLONAL-ANTIBODIES; VARIABLE DOMAINS; IN-VITRO; CLEAVAGE; GENE; IDENTIFICATION; GENERATION	Recombinant antibodies with well-characterized epitopes and known conformational specificities are critical reagents to support robust interpretation and reproducibility of immunoassays across biomedical research. For myocilin, a protein prone to misfolding that is associated with glaucoma and an emerging player in other human diseases, currently available antibodies are unable to differentiate among the numerous disease-associated protein states. This fundamentally constrains efforts to understand the connection between myocilin structure, function, and disease. To address this concern, we used protein engineering methods to develop new recombinant antibodies that detect the N-terminal leucine zipper structural domain of myocilin and that are cross-reactive for human and mouse myocilin. After harvesting spleens from immunized mice and in vitro library panning, we identified two antibodies, 2A4 and 1G12. 2A4 specifically recognizes a folded epitope while 1G12 recognizes a range of conformations. We matured antibody 2A4 for improved biophysical properties, resulting in variant 2H2. In a human IgG1 format, 2A4, 1G12, and 2H2 immunoprecipitate full-length folded myocilin present in the spent media of human trabecular meshwork (TM) cells, and 2H2 can visualize myocilin in fixed human TM cells using fluorescence microscopy. These new antibodies should find broad application in glaucoma and other research across multiple species platforms.	[Patterson-Orazem, Athena C.; Ma, Minh Thu; Hill, Shannon E.; Ku, Yemo; Schildmeyer, Lisa A.; Lieberman, Raquel L.] Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA; [Qerqez, Ahlam N.; Azouz, Laura R.; Maynard, Jennifer A.] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA; [Maynard, Jennifer A.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA	University System of Georgia; Georgia Institute of Technology; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Lieberman, RL (corresponding author), Georgia Inst Technol, Sch Chem & Biochem, Atlanta, GA 30332 USA.; Maynard, JA (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.; Maynard, JA (corresponding author), Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA.	maynard@che.utexas.edu; raquel.lieberman@chemistry.gatech.edu		Azouz, Laura/0000-0002-9423-6000; Ku, Yemo/0000-0002-7994-2636	Brightfocus Foundation [G2016027]; National Institutes of Health, National Eye Institute [R01EY021205, T32007092, R21EY031093]; Welch Foundation [F-1767]; NSF GRFP Fellowship	Brightfocus Foundation(BrightFocus Foundation); National Institutes of Health, National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Welch Foundation(The Welch Foundation); NSF GRFP Fellowship(National Science Foundation (NSF)NSF - Office of the Director (OD))	This work was supported by the Brightfocus Foundation (G2016027 to R. L. L.), National Institutes of Health, National Eye Institute (R01EY021205 to R. L. L., T32007092 to M. T. M., and R21EY031093 to R. L. L. and J. A. M.), Welch Foundation (F-1767 to J. A. M.) and an NSF GRFP Fellowship (A. N. Q.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	AbdulHameed MDM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112193; Alexander GC, 2021, JAMA-J AM MED ASSOC, V325, P1717, DOI 10.1001/jama.2021.3854; Aroca-Aguilar JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054385; Aroca-Aguilar JD, 2010, INVEST OPHTH VIS SCI, V51, P72, DOI 10.1167/iovs.09-4118; Bradbury A, 2015, NATURE, V518, P27, DOI 10.1038/518027a; Bradbury AR, 2015, PROTEIN ENG DES SEL, V28, P303, DOI 10.1093/protein/gzv051; Covell DJ, 2017, NEUROPATH APPL NEURO, V43, P604, DOI 10.1111/nan.12402; De Genst E, 2014, BBA-PROTEINS PROTEOM, V1844, P1907, DOI 10.1016/j.bbapap.2014.08.016; Desai AA, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100508; Eshed Y, 2007, J CELL BIOL, V177, P551, DOI 10.1083/jcb.200612139; Fantini J, 2020, PROTEIN SCI, V29, P1748, DOI 10.1002/pro.3906; Fautsch MP, 2004, MOL VIS, V10, P417; Fellouse FA, 2004, P NATL ACAD SCI USA, V101, P12467, DOI 10.1073/pnas.0401786101; Fingert JH, 2002, SURV OPHTHALMOL, V47, P547, DOI 10.1016/S0039-6257(02)00353-3; Fingert JH, 1998, GENOME RES, V8, P377, DOI 10.1101/gr.8.4.377; Furlong ST, 2002, BIOORGAN MED CHEM, V10, P3637, DOI 10.1016/S0968-0896(02)00174-8; Gobeil S, 2004, INVEST OPHTH VIS SCI, V45, P3560, DOI 10.1167/iovs.04-0300; Goldwich A, 2005, KIDNEY INT, V67, P140, DOI 10.1111/j.1523-1755.2005.00064.x; Goyal A, 2014, CURR EYE RES, V39, P823, DOI 10.3109/02713683.2011.556299; Henderson MX, 2020, NEUROBIOL DIS, V136, DOI 10.1016/j.nbd.2019.104712; Hill SE, 2017, STRUCTURE, V25, P1697, DOI 10.1016/j.str.2017.09.008; Hill SE, 2014, J MOL BIOL, V426, P921, DOI 10.1016/j.jmb.2013.12.002; Hjelm B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045817; Ionescu RM, 2008, J PHARM SCI-US, V97, P1414, DOI 10.1002/jps.21104; Judge SM, 2020, CANCER RES, V80, P1861, DOI 10.1158/0008-5472.CAN-19-1558; Julian MC, 2019, J BIOL CHEM, V294, P8438, DOI 10.1074/jbc.RA118.004731; Kapetanakis VV, 2016, BRIT J OPHTHALMOL, V100, P86, DOI 10.1136/bjophthalmol-2015-307223; Keller KE, 2018, EXP EYE RES, V171, P164, DOI 10.1016/j.exer.2018.03.001; Krebber A, 1997, J IMMUNOL METHODS, V201, P35, DOI 10.1016/S0022-1759(96)00208-6; Kumar A, 2020, BIOCHEM BIOPH RES CO, V529, P411, DOI 10.1016/j.bbrc.2020.05.225; Kwon YH, 2009, NEW ENGL J MED, V360, P1113, DOI 10.1056/NEJMra0804630; Laber JR, 2017, MOL PHARMACEUT, V14, P3269, DOI 10.1021/acs.molpharmaceut.7b00322; Labrijn AF, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02823-9; Lieberman RL, 2021, ACCOUNTS CHEM RES, V54, P2205, DOI 10.1021/acs.accounts.1c00060; Lou WJ, 2021, BIOTECHNOL BIOENG, V118, P797, DOI 10.1002/bit.27610; Maertens B, 2007, J BIOL CHEM, V282, P10647, DOI 10.1074/jbc.M611339200; Majsterek I, 2011, EXP MOL PATHOL, V90, P231, DOI 10.1016/j.yexmp.2011.01.001; Martin MD, 2021, EXP EYE RES, V211, DOI 10.1016/j.exer.2021.108729; Maynard J, 2005, J IMMUNOL METHODS, V306, P51, DOI 10.1016/j.jim.2005.07.022; Maynard JA, 2002, NAT BIOTECHNOL, V20, P597, DOI 10.1038/nbt0602-597; Meliopoulos VA, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006701; Milewska M, 2019, J CELL PHYSIOL, V234, P19675, DOI 10.1002/jcp.28568; Nguyen TD, 1998, J BIOL CHEM, V273, P6341, DOI 10.1074/jbc.273.11.6341; Orwig SD, 2012, J MOL BIOL, V421, P242, DOI 10.1016/j.jmb.2011.12.016; PACK P, 1995, J MOL BIOL, V246, P28, DOI 10.1006/jmbi.1994.0062; Patterson-Orazem AC, 2018, EXP EYE RES, V173, P109, DOI 10.1016/j.exer.2018.05.002; Pei JM, 2014, METHODS MOL BIOL, V1079, P263, DOI 10.1007/978-1-62703-646-7_17; Perchiacca JM, 2012, P NATL ACAD SCI USA, V109, P84, DOI 10.1073/pnas.1111232108; Polansky JR, 1997, OPHTHALMOLOGICA, V211, P126, DOI 10.1159/000310780; Saeed AFUH, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00495; Schilling O, 2011, BIOL CHEM, V392, P1031, DOI 10.1515/BC.2011.158; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Silva JP, 2009, J BIOL CHEM, V284, P6495, DOI 10.1074/jbc.M806979200; Smith K, 2009, NAT PROTOC, V4, P372, DOI 10.1038/nprot.2009.3; Snider EJ, 2018, J TISSUE ENG REGEN M, V12, P695, DOI 10.1002/term.2488; Snuderl M, 2013, CELL, V152, P1065, DOI 10.1016/j.cell.2013.01.036; Stamer WD, 2006, EXP EYE RES, V83, P1386, DOI 10.1016/j.exer.2006.07.018; Stamer WD, 2017, EXP EYE RES, V158, P112, DOI 10.1016/j.exer.2016.07.009; STAMER WD, 1995, CURR EYE RES, V14, P611, DOI 10.3109/02713689508998409; Stamer WD, 2000, CURR EYE RES, V20, P347, DOI 10.1076/0271-3683(200005)20:5;1-1;FT347; Stefani M, 2012, PROG NEUROBIOL, V99, P226, DOI 10.1016/j.pneurobio.2012.03.002; Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668; Stone JD, 2001, BIOPHYS J, V81, P2547, DOI 10.1016/S0006-3495(01)75899-7; Surendran S, 2005, NEUROSCI LETT, V382, P323, DOI 10.1016/j.neulet.2005.03.030; Tamm ER, 1999, INVEST OPHTH VIS SCI, V40, P2577; Tian YI, 2020, ADV BIOSYST, V4, DOI 10.1002/adbi.202000004; Ukaji T, 2021, CANCER SCI, V112, P2299, DOI 10.1111/cas.14891; Vaikath NN, 2015, NEUROBIOL DIS, V79, P81, DOI 10.1016/j.nbd.2015.04.009; Wang Wenyan, 2021, Transl Vis Sci Technol, V10, P27, DOI 10.1167/tvst.10.6.27; Westernberg L, 2016, J ALLERGY CLIN IMMUN, V138, P571, DOI 10.1016/j.jaci.2015.11.034; Yang DL, 2016, ANAL BIOCHEM, V508, P78, DOI 10.1016/j.ab.2016.06.024; Zhou Y, 2020, FASEB J, V34, P7160, DOI 10.1096/fj.201902326R	72	0	0	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101067	10.1016/j.jbc.2021.101067	http://dx.doi.org/10.1016/j.jbc.2021.101067			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34384785	Green Published, gold			2022-12-28	WOS:000706361700005
J	Weismiller, HA; Holub, TJ; Krzesinski, BJ; Margittai, M				Weismiller, Hilary A.; Holub, Tyler J.; Krzesinski, Brad J.; Margittai, Martin			A thiol-based intramolecular redox switch in four-repeat tau controls fibril assembly and disassembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYO-EM STRUCTURES; PROTEIN-TAU; STRUCTURAL-CHARACTERIZATION; HEPARIN-BINDING; DISULFIDE BONDS; SEEDING BARRIER; FILAMENTS; AGGREGATION; MECHANISMS; CYSTEINE-322	Oxidative stress has been implicated in the pathogenesis and progression of several tauopathies, including Alzheimer's dis-ease. The deposition of fibrillar inclusions made of tau protein is one of the pathological hallmarks of these disorders. Although it is becoming increasingly evident that the specific fibril structure may vary from one tauopathy to another and it is recognized that different types of isoforms (three-repeat and four-repeat tau) can be selectively deposited, little is known about the role oxidation may play in aggregation. Four-repeat tau contains two cysteines that can form an intramolecular disulfide bond, resulting in a structurally restrained compact monomer. There is discrepancy as to whether this monomer can aggregate or not. Using isolated four-repeat tau monomers (htau40) with intramolecular disulfide bonds, we demonstrate that these proteins form fibrils. The fibrils are less stable than fibrils formed under reducing conditions but are highly effec-tive in seeding oxidized tau monomers. Conversely, a strong seeding barrier prevents incorporation of reduced tau mono-mers, tau mimics in which the cysteines have been replaced by alanines or serines, and three-repeat tau (htau23), a single-cysteine isoform. The barrier also holds true when seed and monomer types are reversed, indicating that oxidized and reduced tau are incompatible with each other. Surprisingly, fibrils composed of compact tau disaggregate upon reduction, highlighting the importance of the intramolecular disulfide bond for fibril stability. The findings uncover a novel binary redox switch that controls the aggregation and disaggregation of these fibrils and extend the conformational spectrum of tau aggregates.	[Weismiller, Hilary A.; Holub, Tyler J.; Krzesinski, Brad J.; Margittai, Martin] Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA	University of Denver	Margittai, M (corresponding author), Univ Denver, Dept Chem & Biochem, Denver, CO 80208 USA.	martin.margittai@du.edu	Margittai, Martin/D-5039-2014	Margittai, Martin/0000-0003-1903-5927	NIH [RF1AG061566]; Ted Puck Endowed Chair position	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ted Puck Endowed Chair position	This work was funded by the NIH grant RF1AG061566 (to M. M.). The work was also supported by the Ted Puck Endowed Chair position (to M. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aoyagi H, 2007, J BIOL CHEM, V282, P20309, DOI 10.1074/jbc.M611876200; Arakhamia T, 2020, CELL, V180, P633, DOI 10.1016/j.cell.2020.01.027; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; BERLINER LJ, 1982, ANAL BIOCHEM, V119, P450, DOI 10.1016/0003-2697(82)90612-1; BETZ SF, 1993, PROTEIN SCI, V2, P1551, DOI 10.1002/pro.5560021002; Bhattacharya K, 2001, BIOCHEM BIOPH RES CO, V285, P20, DOI 10.1006/bbrc.2001.5116; Braakman M. J., 2018, ROYAL SOC CHEM, P1, DOI DOI 10.1039/9781788013253-00001; Brunello CA, 2020, CELL MOL LIFE SCI, V77, P1721, DOI 10.1007/s00018-019-03349-1; Cereghetti G, 2018, CELL CYCLE, V17, P1545, DOI 10.1080/15384101.2018.1480220; Crowe A, 2013, J BIOL CHEM, V288, P11024, DOI 10.1074/jbc.M112.436006; Dinkel PD, 2015, BIOCHEMISTRY-US, V54, P4731, DOI 10.1021/acs.biochem.5b00453; Dinkel PD, 2011, BIOCHEMISTRY-US, V50, P4330, DOI 10.1021/bi2004685; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Falcon B, 2018, NATURE, V561, P137, DOI 10.1038/s41586-018-0454-y; Fichou Y, 2018, P NATL ACAD SCI USA, V115, P13234, DOI 10.1073/pnas.1810058115; Fichou Y, 2018, CHEM COMMUN, V54, P4573, DOI 10.1039/c8cc01355a; Fitzpatrick AWP, 2017, NATURE, V547, P185, DOI 10.1038/nature23002; FLORY PJ, 1956, J AM CHEM SOC, V78, P5222, DOI 10.1021/ja01601a025; Furukawa Y, 2011, J BIOL CHEM, V286, P27236, DOI 10.1074/jbc.M111.248963; Gibbons GS, 2019, JAMA NEUROL, V76, P101, DOI 10.1001/jamaneurol.2018.2505; Go YM, 2008, BBA-GEN SUBJECTS, V1780, P1271, DOI 10.1016/j.bbagen.2008.01.011; Goedert M, 1996, NATURE, V383, P550, DOI 10.1038/383550a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Goedert M, 2017, ANNU REV NEUROSCI, V40, P189, DOI 10.1146/annurev-neuro-072116-031153; Gotz J, 2019, ANNU REV PATHOL-MECH, V14, P239, DOI 10.1146/annurev-pathmechdis-012418-012936; Hou YJ, 2019, NAT REV NEUROL, V15, P565, DOI 10.1038/s41582-019-0244-7; Hughson AG., 2021, STRUCTURE INFECTIOUS, DOI [10.1101/2021.02.14.431014, DOI 10.1101/2021.02.14.431014]; Iadanza MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06761-6; Jacob C, 2004, ORG BIOMOL CHEM, V2, P1953, DOI 10.1039/b406180b; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kovacs GG, 2015, NEUROPATH APPL NEURO, V41, P3, DOI 10.1111/nan.12208; Lee YM, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-020-03355-3; Maji SK, 2009, SCIENCE, V325, P328, DOI 10.1126/science.1173155; Margittai M, 2004, P NATL ACAD SCI USA, V101, P10278, DOI 10.1073/pnas.0401911101; Margittai M, 2006, METHOD ENZYMOL, V413, P122, DOI 10.1016/S0076-6879(06)13007-4; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; Meyer V, 2014, BIOCHEMISTRY-US, V53, P5804, DOI 10.1021/bi501050g; Meyer V, 2014, ANGEW CHEM INT EDIT, V53, P1590, DOI 10.1002/anie.201308473; Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200; Nachman E, 2020, J BIOL CHEM, V295, P9676, DOI 10.1074/jbc.RA120.013478; Nespovitaya N, 2016, J AM CHEM SOC, V138, P846, DOI 10.1021/jacs.5b08694; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; PACE CN, 1988, J BIOL CHEM, V263, P11820; POLAND DC, 1965, BIOPOLYMERS, V3, P379, DOI 10.1002/bip.1965.360030404; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Radamaker L, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21126-2; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; Sbodio JI, 2019, ANTIOXID REDOX SIGN, V30, P1450, DOI 10.1089/ars.2017.7321; SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230; Scheres SHW, 2020, CURR OPIN STRUC BIOL, V64, P17, DOI 10.1016/j.sbi.2020.05.011; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o; Siddiqua A, 2010, J BIOL CHEM, V285, P37920, DOI 10.1074/jbc.M110.185728; Siddiqua A, 2012, J AM CHEM SOC, V134, P10271, DOI 10.1021/ja303498q; Sies H, 2017, ANNU REV BIOCHEM, V86, P715, DOI 10.1146/annurev-biochem-061516-045037; Soragni A, 2008, BIOCHEMISTRY-US, V47, P10841, DOI 10.1021/bi8008856; Spillantini MG, 2013, LANCET NEUROL, V12, P609, DOI 10.1016/S1474-4422(13)70090-5; Strang KH, 2019, LAB INVEST, V99, P912, DOI 10.1038/s41374-019-0197-x; Strang KH, 2018, J BIOL CHEM, V293, P2408, DOI 10.1074/jbc.M117.815357; Swuec P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09133-w; Tonnies E, 2017, J ALZHEIMERS DIS, V57, P1105, DOI 10.3233/JAD-161088; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Wang LQ, 2020, NAT STRUCT MOL BIOL, V27, P598, DOI 10.1038/s41594-020-0441-5; Wegmann S, 2013, P NATL ACAD SCI USA, V110, pE313, DOI 10.1073/pnas.1212100110; Weismiller HA, 2018, J BIOL CHEM, V293, P17336, DOI 10.1074/jbc.RA118.005316; WISCHIK CM, 1988, P NATL ACAD SCI USA, V85, P4884, DOI 10.1073/pnas.85.13.4884; Zhang WJ, 2019, ELIFE, V8, DOI 10.7554/eLife.43584; Zhang WJ, 2020, NATURE, V580, P283, DOI 10.1038/s41586-020-2043-0; Zhao J, 2017, BIOPHYS J, V112, P921, DOI 10.1016/j.bpj.2017.01.024; Zhu HL, 2010, J BIOL CHEM, V285, P3592, DOI 10.1074/jbc.M109.035691; Zubcic K, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.572308	72	2	2	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101021	10.1016/j.jbc.2021.101021	http://dx.doi.org/10.1016/j.jbc.2021.101021			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339733	Green Published, gold			2022-12-28	WOS:000706408900004
J	Welch, N; Singh, SS; Kumar, A; Dhruba, SR; Mishra, S; Sekar, J; Bellar, A; Attaway, AH; Chelluboyina, A; Willard, BB; Li, L; Huo, ZG; Karnik, SS; Esser, K; Longworth, MS; Shah, YM; Davuluri, G; Pal, R; Dasarathy, S				Welch, Nicole; Singh, Shashi Shekhar; Kumar, Avinash; Dhruba, Saugato Rahman; Mishra, Saurabh; Sekar, Jinendiran; Bellar, Annette; Attaway, Amy H.; Chelluboyina, Aruna; Willard, Belinda B.; Li, Ling; Huo, Zhiguang; Karnik, Sadashiva S.; Esser, Karyn; Longworth, Michelle S.; Shah, Yatrik M.; Davuluri, Gangarao; Pal, Ranadip; Dasarathy, Srinivasan			Integrated multiomics analysis identifies molecular landscape perturbations during hyperammonemia in skeletal muscle and myotubes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-SEQ EXPERIMENTS; AMMONIA METABOLISM; SYSTEMS BIOLOGY; TRANSCRIPTIONAL REGULATION; EXPRESSION ANALYSIS; SENESCENCE; QUANTIFICATION; GLYCOSYLATION; SARCOPENIA; CIRRHOSIS	Ammonia is a cytotoxic molecule generated during normal cellular functions. Dysregulated ammonia metabolism, which is evident in many chronic diseases such as liver cirrhosis, heart failure, and chronic obstructive pulmonary disease, initiates a hyperammonemic stress response in tissues including skeletal muscle and in myotubes. Perturbations in levels of specific regulatory molecules have been reported, but the global responses to hyperammonemia are unclear. In this study, we used a multiomics approach to vertically integrate unbiased data generated using an assay for transposase-accessible chromatin with high-throughput sequencing, RNA-Seq, and proteomics. We then horizontally integrated these data across different models of hyperammonemia, including myotubes and mouse and human muscle tissues. Changes in chromatin accessibility and/or expression of genes resulted in distinct clusters of temporal molecular changes including transient, persistent, and delayed responses during hyperammonemia in myotubes. Known responses to hyperammonemia, including mitochondrial and oxidative dysfunction, protein homeostasis disruption, and oxidative stress pathway activation, were enriched in our datasets. During hyperammonemia, pathways that impact skeletal muscle structure and function that were consistently enriched were those that contribute to mitochondrial dysfunction, oxidative stress, and senescence. We made several novel observations, including an enrichment in antiapoptotic B-cell leukemia/lymphoma 2 family protein expression, increased calcium flux, and increased protein glycosylation in myotubes and muscle tissue upon hyperammonemia. Critical molecules in these pathways were validated experimentally. Human skeletal muscle from patients with cirrhosis displayed similar responses, establishing translational relevance. These data demonstrate complex molecular interactions during adaptive and maladaptive responses during the cellular stress response to hyperammonemia.	[Welch, Nicole; Singh, Shashi Shekhar; Kumar, Avinash; Mishra, Saurabh; Sekar, Jinendiran; Bellar, Annette; Attaway, Amy H.; Chelluboyina, Aruna; Longworth, Michelle S.; Dasarathy, Srinivasan] Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA; [Welch, Nicole; Dasarathy, Srinivasan] Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA; [Dhruba, Saugato Rahman; Pal, Ranadip] Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA; [Attaway, Amy H.] Cleveland Clin, Lerner Res Inst, Dept Pulm Med, Cleveland, OH 44106 USA; [Willard, Belinda B.; Li, Ling] Cleveland Clin, Lerner Res Inst, Prote Res Core Serv, Cleveland, OH 44106 USA; [Huo, Zhiguang] Univ Florida, Coll Publ Hlth & Hlth Profess, Dept Biostat, Gainesville, FL USA; [Karnik, Sadashiva S.] Cleveland Clin, Lerner Res Inst, Dept Cardiovasc & Metab Sci, Cleveland, OH 44106 USA; [Esser, Karyn] Univ Florida, Coll Med, Dept Physiol & Funct Genom, Gainesville, FL USA; [Shah, Yatrik M.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Shah, Yatrik M.] Univ Michigan, Dept Gastroenterol, Ann Arbor, MI 48109 USA; [Davuluri, Gangarao] Pennington Biomed Res Ctr, Integrated Physiol & Mol Metab, 6400 Perkins Rd, Baton Rouge, LA 70808 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Texas Tech University System; Texas Tech University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; State University System of Florida; University of Florida; Cleveland Clinic Foundation; State University System of Florida; University of Florida; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Dasarathy, S (corresponding author), Cleveland Clin, Dept Inflammat & Immun, Lerner Res Inst, Cleveland, OH 44106 USA.; Dasarathy, S (corresponding author), Cleveland Clin, Dept Gastroenterol & Hepatol, Cleveland, OH 44106 USA.; Pal, R (corresponding author), Texas Tech Univ, Dept Elect & Comp Engn, Lubbock, TX 79409 USA.	Ranadip.pal@ttu.edu; dasaras@ccf.org	CHELLUBOYINA, ARUNA KUMAR/GXG-8165-2022; Sekar, Jinendiran/AEJ-5723-2022; Singh, Shashi Shekhar/AAD-7584-2021; CHELLUBOYINA, ARUNA KUMAR/GZL-7536-2022; longworth, michelle/S-8456-2019	CHELLUBOYINA, ARUNA KUMAR/0000-0001-7201-3810; Sekar, Jinendiran/0000-0002-8044-1628; Singh, Shashi Shekhar/0000-0002-9294-4855; CHELLUBOYINA, ARUNA KUMAR/0000-0001-7201-3810; Dhruba, Saugato Rahman/0000-0001-5947-6757	National Institutes of Health (NIH) [RO1 GM119174, RO1 DK113196, P50 AA024333, RO1 AA021890, 3U01AA026976-03S1, UO1 AA 026976, R56HL141744, UO1 DK061732, 5U01 DK062470-17S2, R21 AR 071046]; Howard and Helen Trevey Endowment; American College of Gastroenterology Clinical Research Award; Velosano grant; Department of Defense [PR150084]; Cure for IBD; NIH [K08 AA028794, 1S10OD023436-01, R21AI153780];  [K12 HL141952];  [R01CA148828];  [R01DK095201];  [R01CA245546]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard and Helen Trevey Endowment; American College of Gastroenterology Clinical Research Award; Velosano grant; Department of Defense(United States Department of Defense); Cure for IBD; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; ; 	S. D. is partially supported by the National Institutes of Health (NIH) RO1 GM119174; RO1 DK113196; P50 AA024333; RO1 AA021890; 3U01AA026976-03S1; UO1 AA 026976; R56HL141744;UO1 DK061732; 5U01 DK062470-17S2; R21 AR 071046 (also G. D. is supported); and the Howard and Helen Trevey Endowment. N. W. is partially supported by the NIH K08 AA028794 and the American College of Gastroenterology Clinical Research Award. The proteomics core is partially supported by the NIH shared instrument grant 1S10OD023436-01. A. H. A. and N. W. were supported by K12 HL141952. M. S. L. was supported by the NIH R21AI153780, Velosano grant, Department of Defense grant no. PR150084, and by Cure for IBD. Y. S. S. was supported by R01CA148828, R01DK095201, and R01CA245546. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.	Adeva MM, 2012, METABOLISM, V61, P1495, DOI 10.1016/j.metabol.2012.07.007; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ballance LT, 2006, PROG OCEANOGR, V69, P360, DOI 10.1016/j.pocean.2006.03.013; BORYS MC, 1994, BIOTECHNOL BIOENG, V43, P505, DOI 10.1002/bit.260430611; Cavalcante RG, 2017, BIOINFORMATICS, V33, P2381, DOI 10.1093/bioinformatics/btx183; Chen G, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00317; Cisek K, 2016, NEPHROL DIAL TRANSPL, V31, P2003, DOI 10.1093/ndt/gfv364; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dam G, 2013, METAB BRAIN DIS, V28, P217, DOI 10.1007/s11011-013-9377-3; Damink SWMO, 2002, NEUROCHEM INT, V41, P177, DOI 10.1016/S0197-0186(02)00040-2; Dasarathy S, 2018, CURR OPIN CLIN NUTR, V21, P30, DOI 10.1097/MCO.0000000000000426; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; Dasarathy S, 2011, J HEPATOL, V54, P915, DOI 10.1016/j.jhep.2010.08.032; Davuluri G, 2019, MOL CELL BIOL, V39, DOI 10.1128/MCB.00451-18; Davuluri G, 2016, J PHYSIOL-LONDON, V594, P7341, DOI 10.1113/JP272796; Davuluri G, 2016, J HEPATOL, V65, P929, DOI 10.1016/j.jhep.2016.06.004; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Draghici S, 2007, GENOME RES, V17, P1537, DOI 10.1101/gr.6202607; EVANS MJ, 1990, GENE DEV, V4, P1023, DOI 10.1101/gad.4.6.1023; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Galili T, 2015, BIOINFORMATICS, V31, P3718, DOI 10.1093/bioinformatics/btv428; GANDA OP, 1976, METABOLISM, V25, P427, DOI 10.1016/0026-0495(76)90075-5; Ghazalpour A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001393; Gleyzer N, 2005, MOL CELL BIOL, V25, P1354, DOI 10.1128/MCB.25.4.1354-1366.2005; Gorg B, 2015, GLIA, V63, P37, DOI 10.1002/glia.22731; Holecek M, 2019, AMINO ACIDS, V51, P1667, DOI 10.1007/s00726-019-02803-5; Jayakumar AR, 2009, J NEUROCHEM, V109, P252, DOI 10.1111/j.1471-4159.2009.05842.x; Kant S, 2019, J BIOL CHEM, V294, P7231, DOI 10.1074/jbc.RA118.005411; Kappler M, 2017, CLIN ORAL INVEST, V21, P211, DOI 10.1007/s00784-016-1780-9; Kelly RT, 2020, MOL CELL PROTEOMICS, V19, P1739, DOI 10.1074/mcp.R120.002234; Khan A, 2018, NUCLEIC ACIDS RES, V46, pD260, DOI 10.1093/nar/gkx1126; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kitajima S, 2017, ONCOTARGET, V8, P114481, DOI 10.18632/oncotarget.23010; Klemann CJHM, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0015-3; Koster J, 2018, BIOINFORMATICS, V34, P3600, DOI 10.1093/bioinformatics/bty350; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kumar A, 2019, FREE RADICAL BIO MED, V145, P284, DOI 10.1016/j.freeradbiomed.2019.09.031; Kumar A, 2017, HEPATOLOGY, V65, P2045, DOI 10.1002/hep.29107; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lau E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02467-3; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; LOCKWOOD AH, 1979, J CLIN INVEST, V63, P449, DOI 10.1172/JCI109322; Love JT, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07669-x; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Neph S, 2012, BIOINFORMATICS, V28, P1919, DOI 10.1093/bioinformatics/bts277; Norenberg MD, 2009, METAB BRAIN DIS, V24, P103, DOI 10.1007/s11011-008-9113-6; Orchard P, 2020, CELL SYST, V10, P298, DOI 10.1016/j.cels.2020.02.009; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Raudvere U, 2019, NUCLEIC ACIDS RES, V47, pW191, DOI 10.1093/nar/gkz369; Rimland CA, 2021, HEPATOLOGY, V73, P247, DOI 10.1002/hep.31252; Robinson SW, 2014, COMPUT STRUCT BIOTEC, V11, P35, DOI 10.1016/j.csbj.2014.08.007; Sapieha P, 2018, TRENDS CELL BIOL, V28, P595, DOI 10.1016/j.tcb.2018.03.003; Schlotter F, 2018, CIRCULATION, V138, P377, DOI 10.1161/CIRCULATIONAHA.117.032291; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrattenholz A, 2010, METHODS MOL BIOL, V662, P29, DOI 10.1007/978-1-60761-800-3_2; Seliger B, 2009, PROTEOMICS, V9, P1567, DOI 10.1002/pmic.200700288; Singh KD, 2019, J CHEM INF MODEL, V59, P373, DOI 10.1021/acs.jcim.8b00583; Singh Shashi Shekhar, 2021, Cell Physiol Biochem, V55, P91, DOI 10.33594/000000327; Suzuki H, 2002, AM J PHYSIOL-GASTR L, V283, pG986, DOI 10.1152/ajpgi.00482.2001; Tchoukalova YD, 2010, P NATL ACAD SCI USA, V107, P18226, DOI 10.1073/pnas.1005259107; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tsien C, 2015, HEPATOLOGY, V61, P2018, DOI 10.1002/hep.27717; von Zglinicki T, 2021, ANTIOXID REDOX SIGN, V34, P308, DOI 10.1089/ars.2020.8048; Walker V, 2014, ADV CLIN CHEM, V67, P73, DOI 10.1016/bs.acc.2014.09.002; Wang DG, 2008, COMPUT BIOL CHEM, V32, P462, DOI 10.1016/j.compbiolchem.2008.07.014; Wang FG, 2018, MUTAGENESIS, V33, P291, DOI 10.1093/mutage/gey023; Wang RS, 2015, WIRES SYST BIOL MED, V7, P141, DOI 10.1002/wsbm.1297; Wang Y, 2015, MOL CELL, V58, P598, DOI 10.1016/j.molcel.2015.05.005; Welch N, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020659; Yang M, 2000, BIOTECHNOL PROGR, V16, P751, DOI 10.1021/bp000090b; Yuan GC, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1218-y; Zhang B, 2013, GENOME RES, V23, P1522, DOI 10.1101/gr.156539.113; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.414	84	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101023	10.1016/j.jbc.2021.101023	http://dx.doi.org/10.1016/j.jbc.2021.101023			24	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34343564	gold, Green Published			2022-12-28	WOS:000706408900011
J	Ch, NPL; Sivagnanam, A; Raja, S; Mahalingam, S				Ch, Naga Padma Lakshmi; Sivagnanam, Ananthi; Raja, Sebastian; Mahalingam, Sundarasamy			Molecular basis for RASSF10/NPM/RNF2 feedback cascade-mediated regulation of gastric cancer cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR GENE; CYCLE ARREST; NUCLEAR IMPORT; NUCLEOPHOSMIN; APOPTOSIS; PROTEIN; P53; DEGRADATION; PATHWAY; GADD45	Ras-association domain family (RASSF) proteins are encoded by numerous tumor suppressor genes that frequently become silenced in human cancers. RASSF10 is downregulated by promoter hypermethylation in cancers and has been shown to inhibit cell proliferation; however, the molecular mechanism(s) remains poorly understood. Here, we demonstrate for the first time that RASSF10 inhibits Cdk1/cyclin-B kinase complex formation to maintain stable levels of cyclin-B for inducing mitotic arrest during cell cycle. Using LC-MS/MS, live cell imaging, and biochemical approaches, we identify Nucleophosmin (NPM) as a novel functional target of RASSF10 and revealed that RASSF10 expression promoted the nuclear accumulation of GADD45a and knockdown of either NPM or GADD45a, resulting in impairment of RASSF10-mediated G2/M phase arrest. Furthermore, we demonstrate that RASSF10 is a substrate for the E3 ligase ring finger protein 2 (RNF2) and show that an NPM-dependent downregulation of RNF2 expression is critical to maintain stable RASSF10 levels in cells for efficient mitotic arrest. Interestingly, the Kaplan-Meier plot analysis shows a positive correlation of RASSF10 and NPM expression with greater gastric cancer patient survival and the reverse with expression of RNF2, suggesting that they may have a role in cancer progression. Finally, our findings provide insights into the mode of action of the RASSF10/NPM/RNF2 signaling cascade on controlling cell proliferation and may represent a novel therapeutic avenue for the prevention of gastric cancer metastasis.	[Ch, Naga Padma Lakshmi; Sivagnanam, Ananthi; Raja, Sebastian; Mahalingam, Sundarasamy] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Natl Canc Tissue Biobank, Dept Biotechnol,Lab Mol Cell Biol, Chennai, Tamil Nadu, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Mahalingam, S (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Natl Canc Tissue Biobank, Dept Biotechnol,Lab Mol Cell Biol, Chennai, Tamil Nadu, India.	mahalingam@iitm.ac.in		Sivagnanam, Ananthi/0000-0002-4777-587X	Department of Biotechnology, Government of India [BT/PR28626/BRB/10/1672/2018]; Council of Scientific and Industrial Research, Government of India	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported by grants from the Department of Biotechnology [BT/PR28626/BRB/10/1672/2018], Government of India, to S. M. and graduate fellowship from the Council of Scientific and Industrial Research, Government of India, to N. P. L. C.	Afonso O, 2019, ELIFE, V8, DOI 10.7554/eLife.47646; Ananthi S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-19937-3; BOSTOCK CJ, 1971, EXP CELL RES, V68, P163, DOI 10.1016/0014-4827(71)90599-4; Box JK, 2016, BMC MOL BIOL, V17, DOI 10.1186/s12867-016-0073-9; Burger AM, 2004, EUR J CANCER, V40, P2217, DOI 10.1016/j.ejca.2004.07.006; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chen Y, 2018, AM J PHYSIOL-CELL PH, V315, pC225, DOI 10.1152/ajpcell.00283.2017; Cheng K, 2010, BLOOD, V115, P3341, DOI 10.1182/blood-2009-03-208587; Choi JA, 2001, INT J ONCOL, V19, P837; Colombo E, 2011, ONCOGENE, V30, P2595, DOI 10.1038/onc.2010.646; Datta D, 2015, J BIOL CHEM, V290, P21536, DOI 10.1074/jbc.M115.637280; Dong TH, 2015, DISCOV MED, V20, P261; Fagotto F, 1998, CURR BIOL, V8, P181, DOI 10.1016/S0960-9822(98)70082-X; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Falini B, 2020, BLOOD, V136, P1707, DOI 10.1182/blood.2019004226; Gadad SS, 2011, J MOL BIOL, V410, P997, DOI 10.1016/j.jmb.2011.04.009; Gao H, 2005, J BIOL CHEM, V280, P10988, DOI 10.1074/jbc.M412720200; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guo J, 2015, ONCOTARGET, V6, P4202, DOI 10.18632/oncotarget.2866; Hagting A, 1999, CURR BIOL, V9, P680, DOI 10.1016/S0960-9822(99)80308-X; Hill VK, 2011, ONCOGENE, V30, P978, DOI 10.1038/onc.2010.471; Hu XL, 2010, BIOCHEM BIOPH RES CO, V398, P62, DOI 10.1016/j.bbrc.2010.06.033; Hu Y., 2019, J INT MED RES, V47, P2890, DOI DOI 10.1177/0300060519848924; Jin Yongshuai, 2015, Genes Cancer, V6, P231; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627; Li JM, 1999, EUR HEART J, V20, P406, DOI 10.1053/euhj.1998.1308; Li X, 2016, ONCOGENE, V35, P2453, DOI 10.1038/onc.2015.300; Li X.-Q., 2016, ONCOTARGET, DOI [10.18632/oncotarget.8975, DOI 10.18632/ONCOTARGET.8975]; Liu W, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.24; Liu XJ, 2012, J BIOL CHEM, V287, P19599, DOI 10.1074/jbc.M112.363622; Martin-Renedo J, 2008, J PINEAL RES, V45, P532, DOI 10.1111/j.1600-079X.2008.00641.x; Mi HY, 2009, METHODS MOL BIOL, V563, P123, DOI 10.1007/978-1-60761-175-2_7; Nagy A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27521-y; Perez EA, 2009, MOL CANCER THER, V8, P2086, DOI 10.1158/1535-7163.MCT-09-0366; Qu C, 2017, ONCOTARGET, V8, P3144, DOI 10.18632/oncotarget.13673; Radivojac P, 2010, PROTEINS, V78, P365, DOI 10.1002/prot.22555; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Richburg JH, 2014, SEMIN CELL DEV BIOL, V30, P27, DOI 10.1016/j.semcdb.2014.03.001; Sportoletti P, 2008, BLOOD, V111, P3859, DOI 10.1182/blood-2007-06-098251; Su WJ, 2013, P NATL ACAD SCI USA, V110, P1720, DOI 10.1073/pnas.1211604110; Suryadinata R, 2010, BIOSCIENCE REP, V30, P243, DOI 10.1042/BSR20090171; Takizawa CG, 2000, CURR OPIN CELL BIOL, V12, P658, DOI 10.1016/S0955-0674(00)00149-6; Tamura RE, 2012, CURR MOL MED, V12, P634; Thoompumkal IJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135845; Toyoshima-Morimoto F, 2001, NATURE, V410, P215, DOI 10.1038/35065617; Underhill-Day N, 2011, EPIGENETICS-US, V6, P284, DOI 10.4161/epi.6.3.14108; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Volodko N, 2014, FEBS LETT, V588, P2671, DOI 10.1016/j.febslet.2014.02.041; Vorlaufer E, 1998, MOL BIOL CELL, V9, P1817, DOI 10.1091/mbc.9.7.1817; Wan Q, 2015, DATABASE-OXFORD, DOI 10.1093/database/bav019; Wang XW, 1999, P NATL ACAD SCI USA, V96, P3706, DOI 10.1073/pnas.96.7.3706; Wen W, 2014, ONCOGENE, V33, P421, DOI 10.1038/onc.2012.605; Wu XC, 2016, SCI REP-UK, V6, DOI 10.1038/srep19000; Xia PY, 2014, CELL RES, V24, P943, DOI 10.1038/cr.2014.85; Xue WJ, 2016, TUMOR BIOL, V37, P11249, DOI 10.1007/s13277-016-5001-6; Yang Shaozhe, 2017, Curr Protoc Chem Biol, V9, P147, DOI 10.1002/cpch.25; Zhan QM, 1999, ONCOGENE, V18, P2892, DOI 10.1038/sj.onc.1202667; Zhang JF, 2017, ONCOL LETT, V13, P3817, DOI 10.3892/ol.2017.5868; Zhang XY, 2014, J CANCER RES THER, V10, pC108, DOI 10.4103/0973-1482.145811	61	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100935	10.1016/j.jbc.2021.100935	http://dx.doi.org/10.1016/j.jbc.2021.100935			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34224728	gold, Green Published			2022-12-28	WOS:000690871000012
J	Jackson, JT; Mulazzani, E; Nutt, SL; Masters, SL				Jackson, Jacob T.; Mulazzani, Elisabeth; Nutt, Stephen L.; Masters, Seth L.			The role of PLC gamma 2 in immunological disorders, cancer, and neurodegeneration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							B-CELL RECEPTOR; PHOSPHOLIPASE-C-GAMMA; PROTEIN-TYROSINE KINASE; CHRONIC LYMPHOCYTIC-LEUKEMIA; PHOSPHATIDYLINOSITOL 3-KINASE; ANTIGEN RECEPTOR; SIGNAL-TRANSDUCTION; MEDIATED ACTIVATION; ALTERNATE PATHWAY; INNATE IMMUNITY	Phosphatidylinositol-specific phospholipase C gamma 2 (PLC gamma 2) is a critical signaling molecule activated downstream from a variety of cell surface receptors that contain an intracellular immunoreceptor tyrosine-based activation motif. These receptors recruit kinases such as Syk, BTK, and BLNK to phosphorylate and activate PLC gamma 2, which then generates 1Dmyo-inositol 1,4,5-trisphosphate and diacylglycerol. These well-known second messengers are required for diverse membrane functionality including cellular proliferation, endocytosis, and calcium flux. As a result, PLC gamma 2 dysfunction is associated with a variety of diseases including cancer, neurodegeneration, and immune disorders. The diverse pathologies associated with PLC gamma 2 are exemplified by distinct genetic variants. Inherited mutations at this locus cause PLC gamma 2-associated antibody deficiency and immune dysregulation, in some cases with autoinflammation. Acquired mutations at this locus, which often arise as a result of BTK inhibition to treat chronic lymphocytic leukemia, result in constitutive downstream signaling and lymphocyte proliferation. Finally, a third group of PLC gamma 2 variants actually has a protective effect in a variety of neurodegenerative disorders, presumably by increased uptake and degradation of deleterious neurological aggregates. Therefore, manipulating PLC gamma 2 activity either up or down could have therapeutic benefit; however, we require a better understanding of the signaling pathways propagated by these variants before such clinical utility can be realized. Here, we review the signaling roles of PLC gamma 2 in hematopoietic cells to help understand the effect of mutations driving immune disorders and cancer and extrapolate from this to roles which may relate to protection against neurodegeneration.	[Jackson, Jacob T.; Nutt, Stephen L.] Immunol Div, Parkville, Vic, Australia; [Jackson, Jacob T.; Mulazzani, Elisabeth; Masters, Seth L.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Mulazzani, Elisabeth; Nutt, Stephen L.; Masters, Seth L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Masters, Seth L.] Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Paediat, Immunol Lab, Guangzhou, Guangdong, Peoples R China	Walter & Eliza Hall Institute; University of Melbourne	Masters, SL (corresponding author), Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia.; Masters, SL (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.; Masters, SL (corresponding author), Guangzhou Women & Childrens Med Ctr, Guangzhou Inst Paediat, Immunol Lab, Guangzhou, Guangdong, Peoples R China.	masters@wehi.edu.au	; Nutt, Stephen/C-9256-2013	Mulazzani, Elisabeth/0000-0003-0721-8072; Jackson, Jacob/0000-0002-6396-2739; Nutt, Stephen/0000-0002-0020-6637	German Research Foundation (DFG) [SCHU 3126/3-1]; National Health and Medical Research Council [1155342, 2003159]; Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship	German Research Foundation (DFG)(German Research Foundation (DFG)); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Sylvia and Charles Viertel Foundation; Howard Hughes Medical Institute-Wellcome International Research Scholarship	E. M. is funded by the German Research Foundation (DFG, reference no. SCHU 3126/3-1). S. L. M. acknowledges funding from National Health and Medical Research Council Grant (2003159), The Sylvia and Charles Viertel Foundation, and Howard Hughes Medical Institute-Wellcome International Research Scholarship. S. L. M. is a scientific advisor for IFM therapeutics. S. L. N. acknowledges funding from National Health and Medical Research Council Grant (1155342).	Abe K, 2011, ARTHRITIS RHEUM-US, V63, P1301, DOI 10.1002/art.30280; Aderibigbe OM, 2015, JAMA DERMATOL, V151, P627, DOI 10.1001/jamadermatol.2014.5641; Afroz S, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00074; Ahn IE, 2017, BLOOD, V129, P1469, DOI 10.1182/blood-2016-06-719294; Aiba Y, 2004, P NATL ACAD SCI USA, V101, P16612, DOI 10.1073/pnas.0407468101; Aki D, 2008, GENES CELLS, V13, P199, DOI 10.1111/j.1365-2443.2007.01159.x; Aman MJ, 2000, CURR BIOL, V10, P393, DOI 10.1016/S0960-9822(00)00415-2; Andrade MVM, 2004, J IMMUNOL, V172, P7254, DOI 10.4049/jimmunol.172.12.7254; Andreae S, 2003, BLOOD, V102, P2130, DOI 10.1182/blood-2003-01-0273; Andreone BJ, 2020, NAT NEUROSCI, V23, P927, DOI 10.1038/s41593-020-0650-6; Bai L, 2007, MOL CELL BIOL, V27, P5957, DOI 10.1128/MCB.02273-06; Barbu EA, 2012, J IMMUNOL, V188, P6278, DOI 10.4049/jimmunol.1102660; Benschop RJ, 2001, J IMMUNOL, V167, P4172, DOI 10.4049/jimmunol.167.8.4172; Bergholdt R, 2012, DIABETES, V61, P954, DOI 10.2337/db11-1263; Bernal-Quiros M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059842; BERRIDGE MJ, 1993, NATURE, V361, P315, DOI 10.1038/361315a0; Bogaert DJA, 2016, J MED GENET, V53, P575, DOI 10.1136/jmedgenet-2015-103690; Bonilla FA, 2000, P NATL ACAD SCI USA, V97, P1725, DOI 10.1073/pnas.040543597; Bourette RP, 1997, EMBO J, V16, P5880, DOI 10.1093/emboj/16.19.5880; Bourgin-Hierle C, 2008, LEUKEMIA, V22, P161, DOI 10.1038/sj.leu.2404986; Brooks SR, 2000, J IMMUNOL, V164, P3123, DOI 10.4049/jimmunol.164.6.3123; Brooks SR, 2004, J IMMUNOL, V172, P7556, DOI 10.4049/jimmunol.172.12.7556; Bunney TD, 2009, MOL CELL, V34, P223, DOI 10.1016/j.molcel.2009.02.023; Burger JA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11589; Caraux A, 2006, BLOOD, V107, P994, DOI 10.1182/blood-2005-06-2428; Dalmasso MC, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0394-9; Castillo E, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17999-3; Chae JJ, 2015, ARTHRITIS RHEUMATOL, V67, P563, DOI 10.1002/art.38961; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Cheng D, 2017, NAT IMMUNOL, V18, P205, DOI 10.1038/ni.3642; Chiang CY, 2012, J BIOL CHEM, V287, P3704, DOI 10.1074/jbc.C111.328559; Conway OJ, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0289-x; Cremasco V, 2008, ARTHRITIS RHEUM-US, V58, P2712, DOI 10.1002/art.23757; Dai XZ, 2006, MOL CELL BIOL, V26, P88, DOI 10.1128/MCB.26.1.88-99.2006; Dai YM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-77; de Castro RO, 2012, J BIOL CHEM, V287, P8194, DOI 10.1074/jbc.M111.326850; de Gorter DJJ, 2007, J IMMUNOL, V178, P1405, DOI 10.4049/jimmunol.178.3.1405; Dye JR, 2007, J IMMUNOL, V179, P229, DOI 10.4049/jimmunol.179.1.229; ElHillal O, 1997, P NATL ACAD SCI USA, V94, P1919, DOI 10.1073/pnas.94.5.1919; Engelke M, 2013, J IMMUNOL, V191, P5354, DOI 10.4049/jimmunol.1301326; Engels N, 2001, J EXP MED, V194, P255, DOI 10.1084/jem.194.3.255; Epple H, 2008, MOL CELL BIOL, V28, P3610, DOI 10.1128/MCB.00259-08; Everett KL, 2011, MOL CELL BIOL, V31, P1240, DOI 10.1128/MCB.01408-10; Feng AL, 2016, ONCOTARGET, V7, P20507, DOI 10.18632/oncotarget.7050; Fernandes MJG, 2005, J LEUKOCYTE BIOL, V78, P524, DOI 10.1189/jlb.0804479; Follo MY, 2019, LEUKEMIA, V33, P2276, DOI 10.1038/s41375-019-0416-x; Fu GP, 2012, J IMMUNOL, V189, P2326, DOI 10.4049/jimmunol.1103458; Fu GP, 2010, J EXP MED, V207, P309, DOI 10.1084/jem.20090880; Gango A, 2020, INT J CANCER, V146, P85, DOI 10.1002/ijc.32502; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Giannelou A, 2014, CURR OPIN ALLERGY CL, V14, P491, DOI 10.1097/ACI.0000000000000117; Gorjestani S, 2011, J BIOL CHEM, V286, P43651, DOI 10.1074/jbc.M111.307389; Gossmann J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150411; Graham DB, 2007, J CLIN INVEST, V117, P3445, DOI 10.1172/JCI32729; Guo BC, 2005, J IMMUNOL, V174, P5375, DOI 10.4049/jimmunol.174.9.5375; Gyanchandani R, 2013, MOL CANCER RES, V11, P1585, DOI 10.1158/1541-7786.MCR-13-0358; Hashimoto A, 2000, J IMMUNOL, V165, P1738, DOI 10.4049/jimmunol.165.4.1738; Hashimoto A, 1998, J EXP MED, V188, P1287, DOI 10.1084/jem.188.7.1287; HERNANDEZ D, 1994, GENOMICS, V23, P504, DOI 10.1006/geno.1994.1533; Hibbs M. L., 2002, SUSTAINED J BIOL CHE, V297; Hikida M, 2003, J EXP MED, V198, P581, DOI 10.1084/jem.20030280; Hitomi T, 1999, FEBS LETT, V445, P371, DOI 10.1016/S0014-5793(99)00153-2; Hong J, 2010, CANCER RES, V70, P1247, DOI 10.1158/0008-5472.CAN-09-2774; Huynh MQ, 2015, LEUKEMIA LYMPHOMA, V56, P1088, DOI 10.3109/10428194.2014.941832; Irie N, 2009, J BIOL CHEM, V284, P14637, DOI 10.1074/jbc.M807598200; Jack GD, 2009, BLOOD, V114, P2172, DOI 10.1182/blood-2008-11-191536; Jackson JK, 2000, J RHEUMATOL, V27, P2877; Jacobi AM, 2008, ANN RHEUM DIS, V67, P450, DOI 10.1136/ard.2007.075762; Jakus Z, 2009, J EXP MED, V206, P577, DOI 10.1084/jem.20081859; Janz S, 2003, GENE CHROMOSOME CANC, V36, P211, DOI 10.1002/gcc.10178; Jones D, 2017, LEUKEMIA, V31, P1645, DOI 10.1038/leu.2017.110; Kadri S, 2017, BLOOD ADV, V1, P715, DOI 10.1182/bloodadvances.2016003632; Kanagal-Shamanna R, 2019, CANCER-AM CANCER SOC, V125, P559, DOI 10.1002/cncr.31831; Kaymaz Y, 2017, MOL CANCER RES, V15, P563, DOI 10.1158/1541-7786.MCR-16-0305; Kim YJ, 2004, MOL CELL BIOL, V24, P9986, DOI 10.1128/MCB.24.22.9986-9999.2004; Kin NW, 2006, J IMMUNOL, V176, P6727, DOI 10.4049/jimmunol.176.11.6727; Kitaura Y, 2007, IMMUNITY, V26, P567, DOI 10.1016/j.immuni.2007.03.015; Koss H, 2014, TRENDS BIOCHEM SCI, V39, P603, DOI 10.1016/j.tibs.2014.09.004; Kozyrev SV, 2008, NAT GENET, V40, P484, DOI 10.1038/ng0408-484; Krepischi ACV, 2016, MOL CYTOGENET, V9, DOI 10.1186/s13039-016-0227-y; Kuang ZX, 2017, MOL MED REP, V16, P4685, DOI 10.3892/mmr.2017.7158; Lampson BL, 2018, EXPERT REV HEMATOL, V11, P185, DOI 10.1080/17474086.2018.1435268; Landau DA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02329-y; Lang ML, 2002, BIOCHEM J, V364, P517, DOI 10.1042/BJ20011696; Leon CMMP, 2011, J CELL PHYSIOL, V226, P1780, DOI 10.1002/jcp.22507; Li WQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068999; Lin MQ, 2002, INFECT IMMUN, V70, P889, DOI 10.1128/IAI.70.2.889-898.2002; Lindstrom S, 2019, BLOOD, V134, P1645, DOI 10.1182/blood.2019000435; Liu TM, 2015, BLOOD, V126, P61, DOI 10.1182/blood-2015-02-626846; Lo Vasco VR, 2014, J CELL COMMUN SIGNAL, V8, P219, DOI 10.1007/s12079-014-0235-9; Lo Vasco VR, 2014, ANTICANCER RES, V34, P4069; Lucas CR, 2013, J IMMUNOL, V190, P723, DOI 10.4049/jimmunol.1201646; Maddocks KJ, 2015, JAMA ONCOL, V1, P80, DOI 10.1001/jamaoncol.2014.218; Magno L, 2019, ALZHEIMERS RES THER, V11, DOI 10.1186/s13195-019-0469-0; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Martin-Nalda A, 2020, J CLIN IMMUNOL, V40, P987, DOI 10.1007/s10875-020-00794-7; Maschietto M, 2008, ONCOLOGY-BASEL, V75, P81, DOI 10.1159/000155210; Mikosik A, 2016, ONCOTARGET, V7, P76479, DOI 10.18632/oncotarget.13259; Milner JD, 2015, J CLIN IMMUNOL, V35, P527, DOI 10.1007/s10875-015-0177-x; Mizuno K, 2005, EUR J IMMUNOL, V35, P644, DOI 10.1002/eji.200425465; Mizuno K, 2002, J IMMUNOL, V169, P778, DOI 10.4049/jimmunol.169.2.778; Moens L, 2016, IMMUNOL CELL BIOL, V94, P774, DOI 10.1038/icb.2016.41; Moreno-Garcia ME, 2005, J IMMUNOL, V174, P2687, DOI 10.4049/jimmunol.174.5.2687; Mueller H, 2010, BLOOD, V115, P3118, DOI 10.1182/blood-2009-11-254185; Nakamura-Ishizu A, 2015, J EXP MED, V212, P2133, DOI 10.1084/jem.20150057; Nera KP, 2006, EUR J IMMUNOL, V36, P516, DOI 10.1002/eji.200535418; Neves JF, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02863; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Obba S, 2015, AUTOPHAGY, V11, P1114, DOI 10.1080/15548627.2015.1034406; Oh-Hora M, 2003, J EXP MED, V198, P1841, DOI 10.1084/jem.20031547; Ombrello MJ, 2012, NEW ENGL J MED, V366, P330, DOI 10.1056/NEJMoa1102140; Ozdener F, 2002, MOL PHARMACOL, V62, P672, DOI 10.1124/mol.62.3.672; Palmbos PL, 2002, J ORTHOP RES, V20, P483, DOI 10.1016/S0736-0266(01)00147-4; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Park WY, 2002, ONCOGENE, V21, P8521, DOI 10.1038/sj.onc.1205977; Paroha R, 2019, J CELL BIOCHEM, V120, P5062, DOI 10.1002/jcb.27783; Pisegna S, 2002, J IMMUNOL, V169, P68, DOI 10.4049/jimmunol.169.1.68; Qi F, 2019, ONCOL LETT, V17, P2905, DOI 10.3892/ol.2019.9884; Quinquenel A, 2019, BLOOD, V134, P641, DOI 10.1182/blood.2019000854; Regunathan J, 2006, J IMMUNOL, V177, P5365, DOI 10.4049/jimmunol.177.8.5365; Roes J, 2003, P NATL ACAD SCI USA, V100, P7241, DOI 10.1073/pnas.0731875100; Rossaint J, 2011, KIDNEY INT, V80, P493, DOI 10.1038/ki.2011.125; Rudolph A, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0625-9; Rudolph A, 2013, ENDOCR-RELAT CANCER, V20, P875, DOI 10.1530/ERC-13-0349; Rueda B, 2010, ANN RHEUM DIS, V69, P700, DOI 10.1136/ard.2009.118174; Schade A, 2016, CELL SIGNAL, V28, P1237, DOI 10.1016/j.cellsig.2016.05.010; Sieger N, 2013, ARTHRITIS RHEUM-US, V65, P770, DOI 10.1002/art.37818; Sierksma A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201910606; Sims R, 2017, NAT GENET, V49, P1373, DOI 10.1038/ng.3916; Sohn HW, 2003, J EXP MED, V197, P1511, DOI 10.1084/jem.20021686; Song HF, 2007, J IMMUNOL, V178, P926, DOI 10.4049/jimmunol.178.2.926; Song ZB, 2010, CLIN CANCER RES, V16, P587, DOI 10.1158/1078-0432.CCR-09-1519; Spurrell DR, 2009, J IMMUNOL, V183, P310, DOI 10.4049/jimmunol.0802096; Stanislaus A, 2012, CANCER CELL INT, V12, DOI 10.1186/1475-2867-12-30; Stork B, 2007, EMBO J, V26, P1140, DOI 10.1038/sj.emboj.7601557; Sun L, 2015, MOL MED REP, V12, P4266, DOI 10.3892/mmr.2015.3958; Taguchi T, 2004, IMMUNOLOGY, V112, P575, DOI 10.1111/j.1365-2567.2004.01918.x; Tassi I, 2005, J IMMUNOL, V175, P749, DOI 10.4049/jimmunol.175.2.749; Tesi N, 2019, EUR J HUM GENET, V27, P244, DOI 10.1038/s41431-018-0273-5; Tokuda Yuichi, 2014, BMC Res Notes, V7, P780, DOI 10.1186/1756-0500-7-780; van der Lee SJ, 2019, ACTA NEUROPATHOL, V138, P237, DOI 10.1007/s00401-019-02026-8; Vendel AC, 2009, J IMMUNOL, V182, P1509, DOI 10.4049/jimmunol.182.3.1509; Venkataraman C, 1998, J IMMUNOL, V160, P3322; Walliser C, 2008, J BIOL CHEM, V283, P30351, DOI 10.1074/jbc.M803316200; Walliser C, 2016, J BIOL CHEM, V291, P22136, DOI 10.1074/jbc.M116.746842; Walliser C, 2015, J BIOL CHEM, V290, P17056, DOI 10.1074/jbc.M115.645739; Wang DM, 2000, IMMUNITY, V13, P25, DOI 10.1016/S1074-7613(00)00005-4; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Wang J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005392; Watanabe D, 2001, J BIOL CHEM, V276, P38595, DOI 10.1074/jbc.M103675200; Weber M, 2008, J EXP MED, V205, P853, DOI 10.1084/jem.20072619; Wen RR, 2006, MOL CELL BIOL, V26, P9364, DOI 10.1128/MCB.00839-06; Wen RR, 2003, J BIOL CHEM, V278, P43654, DOI 10.1074/jbc.M307318200; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Xu SL, 2006, J IMMUNOL, V176, P4690, DOI 10.4049/jimmunol.176.8.4690; Xu S, 2009, J BIOL CHEM, V284, P7038, DOI 10.1074/jbc.M806650200; Yang C, 2008, LEUKEMIA, V22, P1755, DOI 10.1038/leu.2008.163; Yang Y, 2013, ONCOL REP, V30, P596, DOI 10.3892/or.2013.2514; Yao YL, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00965; Yasuda T, 2000, J EXP MED, V191, P641, DOI 10.1084/jem.191.4.641; Yasuda T, 2002, J EXP MED, V196, P51, DOI 10.1084/jem.20020068; Ying HY, 2011, IMMUNOBIOLOGY, V216, P566, DOI 10.1016/j.imbio.2010.09.016; Yokozeki T, 2003, J IMMUNOL, V171, P1328, DOI 10.4049/jimmunol.171.3.1328; Yu P, 2005, IMMUNITY, V22, P451, DOI 10.1016/j.immuni.2005.01.018; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zhou Q, 2012, AM J HUM GENET, V91, P713, DOI 10.1016/j.ajhg.2012.08.006	167	8	8	5	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100905	10.1016/j.jbc.2021.100905	http://dx.doi.org/10.1016/j.jbc.2021.100905			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34157287	Green Published, gold			2022-12-28	WOS:000690873500011
J	Rashid, I; Hammel, M; Sverzhinsky, A; Tsai, MS; Pascal, JM; Tainer, JA; Tomkinson, AE				Rashid, Ishtiaque; Hammel, Michal; Sverzhinsky, Aleksandr; Tsai, Miaw-Sheue; Pascal, John M.; Tainer, John A.; Tomkinson, Alan E.			Direct interaction of DNA repair protein tyrosyl DNA phosphodiesterase 1 and the DNA ligase III catalytic domain is regulated by phosphorylation of its flexible N-terminus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; STRUCTURAL BASIS; SPINOCEREBELLAR ATAXIA; POLYMERASE BETA; BRCT DOMAIN; XRCC1; TDP1; NUCLEAR; ALPHA; SAXS	Tyrosyl DNA phosphodiesterase 1 (TDP1) and DNA Ligase III alpha (LigIII alpha) are key enzymes in single-strand break (SSB) repair. TDP1 removes 3'-tyrosine residues remaining after degradation of DNA topoisomerase (TOP) 1 cleavage complexes trapped by either DNA lesions or TOP1 inhibitors. It is not known how TDP1 is linked to subsequent processing and LigIII alpha-catalyzed joining of the SSB. Here we define a direct interaction between the TDP1 catalytic domain and the LigIII DNA-binding domain (DBD) regulated by conformational changes in the unstructured TDP1 N-terminal region induced by phosphorylation and/or alterations in amino acid sequence. Full-length and N-terminally truncated TDP1 are more effective at correcting SSB repair defects in TDP1 null cells compared with full-length TDP1 with amino acid substitutions of an N-terminal serine residue phosphorylated in response to DNA damage. TDP1 forms a stable complex with LigIII(170-755), as well as full-length LigIII alpha alone or in complex with the DNA repair scaffold protein XRCC1. Small-angle X-ray scattering and negative stain electron microscopy combined with mapping of the interacting regions identified a TDP1/LigIII alpha compact dimer of heterodimers in which the two LigIII catalytic cores are positioned in the center, whereas the two TDP1 molecules are located at the edges of the core complex flanked by highly flexible regions that can interact with other repair proteins and SSBs. As TDP1and LigIII alpha together repair adducts caused by TOP1 cancer chemotherapy inhibitors, the defined interaction architecture and regulation of this enzyme complex provide insights into a key repair pathway in nonmalignant and cancer cells.	[Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA; [Rashid, Ishtiaque; Tomkinson, Alan E.] Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87131 USA; [Hammel, Michal; Tsai, Miaw-Sheue] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA USA; [Sverzhinsky, Aleksandr; Pascal, John M.] Univ Montreal, Dept Biochem & Mol Med, Montreal, PQ, Canada; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA; [Tainer, John A.] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA	University of New Mexico; University of New Mexico; University of New Mexico; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Universite de Montreal; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Tomkinson, AE (corresponding author), Univ New Mexico, Dept Internal Med, Albuquerque, NM 87131 USA.; Tomkinson, AE (corresponding author), Univ New Mexico, Dept Mol Genet & Microbiol, Albuquerque, NM 87131 USA.; Tomkinson, AE (corresponding author), Univ New Mexico, Comprehens Canc Ctr, Albuquerque, NM 87131 USA.; Tainer, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.; Tainer, JA (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA.	jatainer@gmail.com; atomkinson@salud.unm.edu	Tainer, John/GWQ-4878-2022	Tainer, John/0000-0003-1659-2429; Hammel, Michal/0000-0002-5610-9289; Sverzhinsky, Aleksandr/0000-0003-1405-925X; Tsai, Miaw-Sheue/0000-0003-3239-5724	National Institutes of Health (NIH) [R01 ES012512, R35 CA220430]; Structural Cell Biology of DNA Repair Program [P01 CA092584]; National Science and Engineering Research Council of Canada [RGPIN-2015-05776]; Cancer Prevention Research Institute of Texas (CPRIT) grant [RP180813]; Robert A. Welch Chemistry Chair; Office of Science, U.S. Department of Energy [DE-AC02-05BH11231]; Office of Biological and Environmental Research, U.S. Department of Energy [DE-AC02-05BH11231]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Structural Cell Biology of DNA Repair Program; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Cancer Prevention Research Institute of Texas (CPRIT) grant; Robert A. Welch Chemistry Chair; Office of Science, U.S. Department of Energy(United States Department of Energy (DOE)); Office of Biological and Environmental Research, U.S. Department of Energy(United States Department of Energy (DOE))	This work was supported in part by National Institutes of Health (NIH) grants R01 ES012512 (A. E. T.), R35 CA220430 (J. A. T.), and the Structural Cell Biology of DNA Repair Program (P01 CA092584, A. E. T., J. M. P., J. A. T.) and a Discovery grant RGPIN-2015-05776 from the National Science and Engineering Research Council of Canada (J. M. P.). This content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. J. A. T. is also supported by Cancer Prevention Research Institute of Texas (CPRIT) grant RP180813, and a Robert A. Welch Chemistry Chair. Funding for the SIBYLS beamline at the Advanced Light Source was provided in part by the Offices of Science and Biological and Environmental Research, U.S. Department of Energy, under Contract DE-AC02-05BH11231.	Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Breslin C, 2015, NUCLEIC ACIDS RES, V43, P6934, DOI 10.1093/nar/gkv623; Brosey CA, 2019, CURR OPIN STRUC BIOL, V58, P197, DOI 10.1016/j.sbi.2019.04.004; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Caldecott KW, 2008, NAT REV GENET, V9, P619, DOI 10.1038/nrg2380; Caldecott KW, 1996, NUCLEIC ACIDS RES, V24, P4387, DOI 10.1093/nar/24.22.4387; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Caldecott KW, 1995, NUCLEIC ACIDS RES, V23, P4836, DOI 10.1093/nar/23.23.4836; Cannan WJ, 2016, J CELL PHYSIOL, V231, P3, DOI 10.1002/jcp.25048; Chiang SC, 2010, CELL CYCLE, V9, P588, DOI 10.4161/cc.9.3.10598; Classen S, 2013, J APPL CRYSTALLOGR, V46, P1, DOI 10.1107/S0021889812048698; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; Cotner-Gohara E, 2010, BIOCHEMISTRY-US, V49, P6165, DOI 10.1021/bi100503w; Cuneo MJ, 2011, NUCLEIC ACIDS RES, V39, P7816, DOI 10.1093/nar/gkr419; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Davies DR, 2002, STRUCTURE, V10, P237, DOI 10.1016/S0969-2126(02)00707-4; De Ioannes P, 2012, CELL REP, V2, P1505, DOI 10.1016/j.celrep.2012.11.004; de la Rosa-Trevin JM, 2016, J STRUCT BIOL, V195, P93, DOI 10.1016/j.jsb.2016.04.010; Della-Maria J, 2011, J BIOL CHEM, V286, P33845, DOI 10.1074/jbc.M111.274159; Dutta A, 2017, NUCLEIC ACIDS RES, V45, P2585, DOI 10.1093/nar/gkw1262; Dyer KN, 2014, METHODS MOL BIOL, V1091, P245, DOI 10.1007/978-1-62703-691-7_18; Eckelmann Bradley J, 2020, NAR Cancer, V2, pzcaa013, DOI 10.1093/narcan/zcaa013; El-Khamisy SF, 2005, NATURE, V434, P108, DOI 10.1038/nature03314; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Flett FJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02530-z; Gao YK, 2011, NATURE, V471, P240, DOI 10.1038/nature09773; Guinier A., 1955, SMALL ANGLE SCATTERI; Hammel M, 2021, PROTEIN SCI, V30, P1735, DOI 10.1002/pro.4133; Hammel M, 2021, NUCLEIC ACIDS RES, V49, P306, DOI 10.1093/nar/gkaa1188; Hammel M, 2016, J BIOL CHEM, V291, P26987, DOI 10.1074/jbc.M116.751867; Hanzlikova H, 2018, MOL CELL, V71, P319, DOI 10.1016/j.molcel.2018.06.004; Heideker J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001320; Hoch NC, 2017, NATURE, V541, P87, DOI 10.1038/nature20790; Huang SYN, 2013, NUCLEIC ACIDS RES, V41, P7793, DOI 10.1093/nar/gkt483; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kubota Y, 1996, EMBO J, V15, P6662, DOI 10.1002/j.1460-2075.1996.tb01056.x; Lakshmipathy U, 2000, NUCLEIC ACIDS RES, V28, P3880, DOI 10.1093/nar/28.20.3880; Lakshmipathy U, 1999, MOL CELL BIOL, V19, P3869; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Lieber MR, 2010, ANNU REV BIOCHEM, V79, P181, DOI 10.1146/annurev.biochem.052308.093131; Mackey ZB, 1997, MOL CELL BIOL, V17, P989, DOI 10.1128/MCB.17.2.989; Mani RS, 2004, BIOCHEMISTRY-US, V43, P16505, DOI 10.1021/bi048615m; Mastronarde DN, 2005, J STRUCT BIOL, V152, P36, DOI 10.1016/j.jsb.2005.07.007; Montecucco A, 1998, EMBO J, V17, P3786, DOI 10.1093/emboj/17.13.3786; Moreira MC, 2001, NAT GENET, V29, P189, DOI 10.1038/ng1001-189; Nash RA, 1997, BIOCHEMISTRY-US, V36, P5207, DOI 10.1021/bi962281m; Okano S, 2005, NUCLEIC ACIDS RES, V33, P422, DOI 10.1093/nar/gki190; Okano S, 2003, MOL CELL BIOL, V23, P3974, DOI 10.1128/MCB.23.11.3974-3981.2003; Olive PL, 1998, RADIAT RES, V150, pS42, DOI 10.2307/3579807; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2018, DNA REPAIR, V71, P177, DOI 10.1016/j.dnarep.2018.08.022; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plo I, 2003, DNA REPAIR, V2, P1087, DOI 10.1016/S1568-7864(03)00116-2; Polo LM, 2019, CELL REP, V26, P573, DOI 10.1016/j.celrep.2018.12.082; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2013, ACS CHEM BIOL, V8, P82, DOI 10.1021/cb300648v; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Putnam CD, 2007, Q REV BIOPHYS, V40, P191, DOI 10.1017/S0033583507004635; Rambo RP, 2013, NATURE, V496, P477, DOI 10.1038/nature12070; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; Rossi MN, 2009, J BIOL CHEM, V284, P31616, DOI 10.1074/jbc.M109.025882; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Scheres SHW, 2012, NAT METHODS, V9, P853, DOI 10.1038/nmeth.2115; Schneidman-Duhovny D, 2018, METHODS MOL BIOL, V1764, P449, DOI 10.1007/978-1-4939-7759-8_29; Schneidman-Duhovny D, 2016, NUCLEIC ACIDS RES, V44, pW424, DOI 10.1093/nar/gkw389; Schneidman-Duhovny D, 2013, BIOPHYS J, V105, P962, DOI 10.1016/j.bpj.2013.07.020; Schneidman-Duhovny D, 2010, NUCLEIC ACIDS RES, V38, pW540, DOI 10.1093/nar/gkq461; Shen J, 2010, NAT GENET, V42, P245, DOI 10.1038/ng.526; Shi K, 2012, NAT STRUCT MOL BIOL, V19, P1372, DOI 10.1038/nsmb.2423; Simsek D, 2011, NATURE, V471, P245, DOI 10.1038/nature09794; Sorzano COS, 2010, J STRUCT BIOL, V171, P197, DOI 10.1016/j.jsb.2010.03.011; Szczesny B, 2014, NUCLEIC ACIDS RES, V42, P13161, DOI 10.1093/nar/gku1089; Takashima H, 2002, NAT GENET, V32, P267, DOI 10.1038/ng987; Taylor RM, 1998, CURR BIOL, V8, P877, DOI 10.1016/S0960-9822(07)00350-8; Vidal AE, 2001, EMBO J, V20, P6530, DOI 10.1093/emboj/20.22.6530; Vilenchik MM, 2003, P NATL ACAD SCI USA, V100, P12871, DOI 10.1073/pnas.2135498100; Whitehouse CJ, 2001, CELL, V104, P107, DOI 10.1016/S0092-8674(01)00195-7; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009	85	1	1	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100921	10.1016/j.jbc.2021.100921	http://dx.doi.org/10.1016/j.jbc.2021.100921			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34181949	Green Published, gold			2022-12-28	WOS:000690879300007
J	Buonvicino, D; Ranieri, G; Pittelli, M; Lapucci, A; Bragliola, S; Chiarugi, A				Buonvicino, Daniela; Ranieri, Giuseppe; Pittelli, Maria; Lapucci, Andrea; Bragliola, Stefania; Chiarugi, Alberto			SIRT1-dependent restoration of NAD plus homeostasis after increased extracellular NAD plus exposure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINAMIDE MONONUCLEOTIDE; CELL-DEATH; POLY(ADP-RIBOSE) POLYMERASE; EXOGENOUS NAD; MITOCHONDRIAL; METABOLISM; INHIBITOR; RIBOSIDE; BIOSYNTHESIS; PROTEIN	In the last several years, NAD+ supplementation has emerged as an innovative and safe therapeutic strategy for a wide spectrum of disorders, including diabetes and neuropathy. However, critical questions remain as to how NAD+ and its precursors are taken up by cells, as well as the effects of long-lasting intracellular NAD+ (iNAD+) increases. Here, we investigated the kinetics of iNAD+ levels in different cell types challenged with prolonged exposure to extracellular NAD+ (eNAD+). Surprisingly, we found that after the initial increase, iNAD+ contents decreased back to control levels (iNAD+ resetting). Focusing our attention on HeLa cells, we found that oxygen and ATP consumption occurred with similar temporal kinetics after eNAD+ exposure. Using [H-3]NAD+ and [C-14] NAD+, we determined that NAD+ resetting was not due to increased dinucleotide extrusion but rather due to reduced uptake of cleaved NAD+ products. Indeed, eNAD+ exposure reduced the expression of the ecto-50 -nucleotidase CD73, the nicotinamide adenine mononucleotide transporter solute carrier family 12 member 8, and the nicotinamide riboside kinase. Interestingly, silencing the NAD+-sensor enzyme sirtuin 1 prevented eNAD+-dependent transcriptional repression of ecto-50 -nucleotidase, solute carrier family 12 member 8, and nicotinamide riboside kinase, as well as iNAD+ resetting. Our findings provide the first evidence for a sirtuin 1-mediated homeostatic response aimed at maintaining physiological iNAD+ levels in conditions of excess eNAD+ availability. These data may be of relevance for therapies designed to support the NAD+ metabolome via extracellular supplementation of the dinucleotide or its precursors.	[Buonvicino, Daniela; Ranieri, Giuseppe; Lapucci, Andrea; Bragliola, Stefania; Chiarugi, Alberto] Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy; [Pittelli, Maria] Chiesi Farmaceut SpA, Corp Preclin R&D, Parma, Italy	University of Florence; Chiesi Pharmaceuticals Inc	Buonvicino, D (corresponding author), Univ Florence, Dept Hlth Sci, Sect Clin Pharmacol & Oncol, Florence, Italy.	aniela.buonvicino@unifi.it	Buonvicino, Daniela/AAC-4978-2022; Ranieri, Giuseppe/AAC-4942-2022	Ranieri, Giuseppe/0000-0001-8875-4250; buonvicino, daniela/0000-0003-0435-8475	AIRC; Fondazione CR Firenze under IG [20451]	AIRC(Fondazione AIRC per la ricerca sul cancro); Fondazione CR Firenze under IG	This work was supported by Grant AIRC and Fondazione CR Firenze under IG 2017 - ID. 20451 project (Principal Investigator, A. C.).	Airhart SE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186459; Alano CC, 2004, J BIOL CHEM, V279, P18895, DOI 10.1074/jbc.M313329200; Aleo MF, 2001, J CELL BIOCHEM, V80, P360, DOI 10.1002/1097-4644(20010301)80:3<360::AID-JCB90>3.0.CO;2-X; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Audrito V, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01720; Beauparlant P, 2009, ANTI-CANCER DRUG, V20, P346, DOI 10.1097/CAD.0b013e3283287c20; Belenky P, 2007, TRENDS BIOCHEM SCI, V32, P12, DOI 10.1016/j.tibs.2006.11.006; Bieganowski P, 2004, CELL, V117, P495, DOI 10.1016/S0092-8674(04)00416-7; Billington RA, 2008, J BIOL CHEM, V283, P6367, DOI 10.1074/jbc.M706204200; Bortell R, 2001, J IMMUNOL, V167, P2049, DOI 10.4049/jimmunol.167.4.2049; Buonvicino D, 2018, PAIN, V159, P1980, DOI 10.1097/j.pain.0000000000001291; Buonvicino D, 2018, CELL CHEM BIOL, V25, P471, DOI 10.1016/j.chembiol.2018.01.012; Buonvicino D, 2013, J BIOL CHEM, V288, P36530, DOI 10.1074/jbc.M113.506378; BURGER RM, 1970, J BIOL CHEM, V245, P6274; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Canto C, 2015, CELL METAB, V22, P31, DOI 10.1016/j.cmet.2015.05.023; Chiarugi A, 2002, TRENDS PHARMACOL SCI, V23, P122, DOI 10.1016/S0165-6147(00)01902-7; Chiarugi A, 2012, NAT REV CANCER, V12, P741, DOI 10.1038/nrc3340; Chini EN, 2009, CURR PHARM DESIGN, V15, P57, DOI 10.2174/138161209787185788; Di Stefano M, 2015, CELL DEATH DIFFER, V22, P731, DOI 10.1038/cdd.2014.164; Diguet N, 2018, CIRCULATION, V137, P2256, DOI 10.1161/CIRCULATIONAHA.116.026099; Drevs J, 2003, ANTICANCER RES, V23, P4853; Escande C, 2013, DIABETES, V62, P1084, DOI 10.2337/db12-1139; Essuman K, 2018, CURR BIOL, V28, P421, DOI 10.1016/j.cub.2017.12.024; Felici R, 2015, MOL PHARMACOL, V87, P965, DOI 10.1124/mol.114.097204; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gardell SJ, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11078-z; Gearing LJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215495; Goldfarb RD, 2002, CRIT CARE MED, V30, P974, DOI 10.1097/00003246-200205000-00004; Gomes AP, 2013, CELL, V155, P1624, DOI 10.1016/j.cell.2013.11.037; Gong B, 2013, NEUROBIOL AGING, V34, P1581, DOI 10.1016/j.neurobiolaging.2012.12.005; Grant R, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00257; Grozio A, 2019, NAT METAB, V1, P47, DOI 10.1038/s42255-018-0009-4; Grozio A, 2013, J BIOL CHEM, V288, P25938, DOI 10.1074/jbc.M113.470435; Haferkamp I, 2004, NATURE, V432, P622, DOI 10.1038/nature03131; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Heilbronn L., 2019, NUTR HEAL AGING, V5, P71; Holen K, 2008, INVEST NEW DRUG, V26, P45, DOI 10.1007/s10637-007-9083-2; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kang BE, 2020, EUR J CLIN INVEST, V50, DOI 10.1111/eci.13334; Khan NA, 2014, EMBO MOL MED, V6, P721, DOI 10.1002/emmm.201403943; Kulikova V, 2019, METABOLITES, V9, DOI 10.3390/metabo9120293; Lautrup S, 2019, CELL METAB, V30, P630, DOI 10.1016/j.cmet.2019.09.001; Liu L, 2014, FUND CLIN PHARMACOL, V28, P180, DOI 10.1111/fcp.12016; Luongo TS, 2020, NATURE, V588, P174, DOI 10.1038/s41586-020-2741-7; Martens CR, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03421-7; Mills KF, 2016, CELL METAB, V24, P795, DOI 10.1016/j.cmet.2016.09.013; Park JH, 2016, NEUROBIOL DIS, V95, P102, DOI 10.1016/j.nbd.2016.07.018; Pillai VB, 2010, J BIOL CHEM, V285, P3133, DOI 10.1074/jbc.M109.077271; Pittelli M, 2011, MOL PHARMACOL, V80, P1136, DOI 10.1124/mol.111.073916; Pittelli M, 2010, J BIOL CHEM, V285, P34106, DOI 10.1074/jbc.M110.136739; Ratajczak J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13103; Robson Simon C, 2006, Purinergic Signal, V2, P409, DOI 10.1007/s11302-006-9003-5; Roh E, 2018, METABOLISM, V88, P51, DOI 10.1016/j.metabol.2018.08.005; Ryu D, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf5504; Sauve AA, 1998, BIOCHEMISTRY-US, V37, P13239, DOI 10.1021/bi981248s; Schmidt MS, 2019, NAT METAB, V1, P660, DOI 10.1038/s42255-019-0085-0; Todisco S, 2006, J BIOL CHEM, V281, P1524, DOI 10.1074/jbc.M510425200; Trammell SAJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12948; Trammell SAJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep26933; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; von Heideman A, 2010, CANCER CHEMOTH PHARM, V65, P1165, DOI 10.1007/s00280-009-1125-3; Wang G, 2014, CELL, V158, P1324, DOI 10.1016/j.cell.2014.07.040; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; WELTIN D, 1994, ONCOL RES, V6, P399; Yang T, 2007, J MED CHEM, V50, P6458, DOI 10.1021/jm701001c; Ying WH, 2003, BIOCHEM BIOPH RES CO, V308, P809, DOI 10.1016/S0006-291X(03)01483-9; Yoshino J, 2018, CELL METAB, V27, P513, DOI 10.1016/j.cmet.2017.11.002; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Zhang HB, 2016, SCIENCE, V352, P1436, DOI 10.1126/science.aaf2693; ZOCCHI E, 1993, BIOCHEM BIOPH RES CO, V196, P1459, DOI 10.1006/bbrc.1993.2416	71	4	4	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100855	10.1016/j.jbc.2021.100855	http://dx.doi.org/10.1016/j.jbc.2021.100855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097876	gold, Green Published			2022-12-28	WOS:000678068400055
J	Evans, JP; Liu, SL				Evans, John P.; Liu, Shan-Lu			Role of host factors in SARS-CoV-2 entry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESPIRATORY SYNDROME CORONAVIRUS; SPIKE PROTEIN; DC-SIGN; SIALIC-ACID; CYCLOSPORINE-A; CELL ENTRY; PHOSPHATIDYLSERINE RECEPTORS; FUNCTIONAL RECEPTOR; HEPARAN-SULFATE; VIRUS ENTRY	The zoonotic transmission of highly pathogenic coronaviruses into the human population is a pressing concern highlighted by the ongoing SARS-CoV-2 pandemic. Recent work has helped to illuminate much about the mechanisms of SARS-CoV-2 entry into the cell, which determines host- and tissue-specific tropism, pathogenicity, and zoonotic transmission. Here we discuss current findings on the factors governing SARS-CoV-2 entry. We first reviewed key features of the viral spike protein (S) mediating fusion of the viral envelope and host cell membrane through binding to the SARS-CoV-2 receptor, angiotensin-converting enzyme 2. We then examined the roles of host proteases including transmembrane protease serine 2 and cathepsins in processing S for virus entry and the impact of this processing on endosomal and plasma membrane virus entry routes. We further discussed recent work on several host cofactors that enhance SARS-CoV-2 entry including Neuropilin-1, CD147, phosphatidylserine receptors, heparan sulfate proteoglycans, sialic acids, and C-type lectins. Finally, we discussed two key host restriction factors, i.e., interferon-induced transmembrane proteins and lymphocyte antigen 6 complex locus E, which can disrupt SARS-CoV-2 entry. The features of SARS-CoV-2 are presented in the context of other human coronaviruses, highlighting unique aspects. In addition, we identify the gaps in understanding of SARS-CoV-2 entry that will need to be addressed by future studies.	[Evans, John P.; Liu, Shan-Lu] Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA; [Evans, John P.; Liu, Shan-Lu] Ohio State Univ, Dept Vet Biosci, Infect Dis Inst, Columbus, OH 43210 USA; [Evans, John P.] Ohio State Univ, Mol Cellular & Dev Biol Program, Infect Dis Inst, Columbus, OH 43210 USA; [Liu, Shan-Lu] Ohio State Univ, Dept Microbial Infect & Immun, Infect Dis Inst, Columbus, OH 43210 USA; [Liu, Shan-Lu] Ohio State Univ, Viruses & Emerging Pathogens Program, Infect Dis Inst, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Liu, SL (corresponding author), Ohio State Univ, Ctr Retrovirus Res, Columbus, OH 43210 USA.; Liu, SL (corresponding author), Ohio State Univ, Dept Vet Biosci, Infect Dis Inst, Columbus, OH 43210 USA.; Liu, SL (corresponding author), Ohio State Univ, Dept Microbial Infect & Immun, Infect Dis Inst, Columbus, OH 43210 USA.; Liu, SL (corresponding author), Ohio State Univ, Viruses & Emerging Pathogens Program, Infect Dis Inst, Columbus, OH 43210 USA.	liu.6244@osu.edu		Evans, John/0000-0001-8644-5825	Glenn Barber Fellowship; NIH [R01 AI150473]; National Cancer Institute of the NIH [U54CA260582]	Glenn Barber Fellowship; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J. P. E. was supported by Glenn Barber Fellowship. S.-L. L. was supported in part by a fund provided by an anonymous private donor to OSU, as well as by NIH grant R01 AI150473 and by the National Cancer Institute of the NIH under award no. U54CA260582. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Amraei Razie, 2021, ACS Cent Sci, V7, P1156, DOI [10.1101/2020.06.22.165803, 10.1021/acscentsci.0c01537]; Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020; Bertram S, 2013, J VIROL, V87, P6150, DOI 10.1128/JVI.03372-12; Bertram S, 2011, J VIROL, V85, P13363, DOI 10.1128/JVI.05300-11; Bozzo C.P, 2020, BIORXIV, DOI [DOI 10.1038/nrendo.2016.30, 10.1101/2020.08.18.255935]; Brufsky A, 2020, J MED VIROL, V92, P1386, DOI [10.1002/jmv.25902, 10.1002/jmv.25980]; Brunton B, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0006983; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Cagno V, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11070596; Cambi A, 2004, J CELL BIOL, V164, P145, DOI 10.1083/jcb.200306112; Cantuti-Castelvetri L, 2020, SCIENCE, V370, P856, DOI 10.1126/science.abd2985; Carbajo-Lozoya J, 2014, VIRUS RES, V184, P44, DOI 10.1016/j.virusres.2014.02.010; Chan CM, 2009, J VIROL, V83, P1026, DOI 10.1128/JVI.01387-08; Chan JFW, 2020, EMERG MICROBES INFEC, V9, P221, DOI 10.1080/22221751.2020.1719902; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chen ZN, 2005, J INFECT DIS, V191, P755, DOI 10.1086/427811; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; COLLINS AR, 1994, IMMUNOL INVEST, V23, P313, DOI 10.3109/08820139409066826; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; Daly JL, 2020, SCIENCE, V370, P861, DOI 10.1126/science.abd3072; Daugherty MD, 2012, ANNU REV GENET, V46, P677, DOI 10.1146/annurev-genet-110711-155522; Davidson AD, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00763-0; de Haan CAM, 2005, J VIROL, V79, P14451, DOI 10.1128/JVI.79.22.14451-14456.2005; de Wilde AH, 2013, J GEN VIROL, V94, P1749, DOI 10.1099/vir.0.052910-0; de Wilde AH, 2011, J GEN VIROL, V92, P2542, DOI 10.1099/vir.0.034983-0; Dragovich MA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36449-2; Duggal NK, 2012, NAT REV IMMUNOL, V12, P687, DOI 10.1038/nri3295; Evans JP, 2020, TRENDS MICROBIOL, V28, P224, DOI 10.1016/j.tim.2019.10.004; Fehr AR, 2015, METHODS MOL BIOL, V1282, P1, DOI 10.1007/978-1-4939-2438-7_1; Gui M, 2017, CELL RES, V27, P119, DOI 10.1038/cr.2016.152; Han DP, 2007, J VIROL, V81, P12029, DOI 10.1128/JVI.00315-07; Hao Wei, 2021, Sci Bull (Beijing), V66, P1205, DOI 10.1016/j.scib.2021.01.010; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hofmann H, 2005, P NATL ACAD SCI USA, V102, P7988, DOI 10.1073/pnas.0409465102; Hofmann H, 2006, J VIROL, V80, P8639, DOI 10.1128/JVI.00560-06; Hofmann-Winkler Heike, 2020, Crit Care Explor, V2, pe0284, DOI 10.1097/CCE.0000000000000284; Huang IC, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001258; Huang XC, 2015, J VIROL, V89, P7202, DOI 10.1128/JVI.00854-15; Hulswit RJG, 2019, P NATL ACAD SCI USA, V116, P2681, DOI 10.1073/pnas.1809667116; Jeffers SA, 2006, ADV EXP MED BIOL, V581, P265; Jemielity S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003232; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Kawase M, 2009, J VIROL, V83, P712, DOI 10.1128/JVI.01933-08; Kim SY, 2020, ANTIVIR RES, V181, DOI 10.1016/j.antiviral.2020.104873; Kleine-Weber H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34859-w; Kluge SF, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.019; Kwon PS, 2020, CELL DISCOV, V6, DOI 10.1038/s41421-020-00192-8; Lang JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023710; Li K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003124; Li MH, 2019, P NATL ACAD SCI USA, V116, P5705, DOI 10.1073/pnas.1819475116; Li MH, 2014, P NATL ACAD SCI USA, V111, pE3699, DOI 10.1073/pnas.1404851111; Li WT, 2017, P NATL ACAD SCI USA, V114, pE8508, DOI 10.1073/pnas.1712592114; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; Li X., 2020, SARS COV 2 SPIKE PRO, DOI [10.1101/2020.05.10.087288, DOI 10.1101/2020.05.10.087288]; Liu BM, 2014, J VIROL, V88, P13821, DOI 10.1128/JVI.02505-14; Liu Chenglong, 2020, Med Drug Discov, V7, P100056, DOI 10.1016/j.medidd.2020.100056; Liu Z, 2020, J VIROL, V94, DOI 10.1128/JVI.00790-20; Lozach PY, 2004, J BIOL CHEM, V279, P32035, DOI 10.1074/jbc.M402296200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Mar KB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06000-y; Marzi A, 2004, J VIROL, V78, P12090, DOI 10.1128/JVI.78.21.12090-12095.2004; Matsuyama S, 2005, P NATL ACAD SCI USA, V102, P12543, DOI 10.1073/pnas.0503203102; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Milewska A, 2014, J VIROL, V88, P13221, DOI 10.1128/JVI.02078-14; Millet JK, 2015, VIRUS RES, V202, P120, DOI 10.1016/j.virusres.2014.11.021; Moller-Tank S, 2014, VIROLOGY, V468, P565, DOI 10.1016/j.virol.2014.09.009; Moller-Tank S, 2014, J VIROL, V88, P6702, DOI 10.1128/JVI.00300-14; Moller-Tank S, 2013, J VIROL, V87, P8327, DOI 10.1128/JVI.01025-13; Mori Yutaro, 2022, medRxiv, DOI 10.1101/2020.09.16.20190694; Morizono K, 2014, J VIROL, V88, P4275, DOI 10.1128/JVI.03287-13; Mycroft-West C., 2020, BIORXIV, DOI [10.1101/2020.02.29.971093, 10]; Neu U, 2011, CURR OPIN STRUC BIOL, V21, P610, DOI 10.1016/j.sbi.2011.08.009; Ogando NS, 2020, J GEN VIROL, V101, P925, DOI 10.1099/jgv.0.001453; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Park YJ, 2019, NAT STRUCT MOL BIOL, V26, P1151, DOI 10.1038/s41594-019-0334-7; Pfaender S, 2020, NAT MICROBIOL, V5, P1330, DOI [10.1038/s41564-020-0769-y, 10.1101/2020.03.05.979260]; Pfefferle S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002331; Pushkarsky T, 2001, P NATL ACAD SCI USA, V98, P6360, DOI 10.1073/pnas.111583198; Qian ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076469; Raj VS, 2013, NATURE, V495, P251, DOI 10.1038/nature12005; Raony I, 2020, DIABETES RES CLIN PR, V165, DOI 10.1016/j.diabres.2020.108280; Sasaki M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009233; SCHULTZE B, 1991, J VIROL, V65, P6232, DOI 10.1128/JVI.65.11.6232-6237.1991; Schwegmann-Wessels C, 2006, GLYCOCONJUGATE J, V23, P51, DOI 10.1007/s10719-006-5437-9; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shang J, 2020, NATURE, V581, P221, DOI 10.1038/s41586-020-2179-y; Shi GL, 2021, EMBO J, V40, DOI [10.1101/2020.08.11.246678, 10.15252/embj.2020106501]; Shirato K, 2018, VIROLOGY, V517, P9, DOI 10.1016/j.virol.2017.11.012; Shirato K, 2013, J VIROL, V87, P12552, DOI 10.1128/JVI.01890-13; Shriver Zachary, 2012, Handb Exp Pharmacol, P159, DOI 10.1007/978-3-642-23056-1_8; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Szczepanski A, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040328; Tai WB, 2020, CELL MOL IMMUNOL, V17, P613, DOI 10.1038/s41423-020-0400-4; Tanaka Y, 2017, J GEN VIROL, V98, P190, DOI 10.1099/jgv.0.000663; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Teesalu T, 2009, P NATL ACAD SCI USA, V106, P16157, DOI 10.1073/pnas.0908201106; Thepaut M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009576; Ulrich H, 2020, STEM CELL REV REP, V16, P434, DOI 10.1007/s12015-020-09976-7; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6; Vanarsdall AL, 2018, MBIO, V9, DOI 10.1128/mBio.00781-18; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; von Brunn A, 2015, CURR OPIN VIROL, V14, P56, DOI 10.1016/j.coviro.2015.08.004; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang HL, 2008, CELL RES, V18, P290, DOI 10.1038/cr.2008.15; Wang K, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-00426-x; Wang SM, 2019, J MED VIROL, V91, P1743, DOI 10.1002/jmv.25518; Wang S, 2021, CELL RES, V31, P126, DOI 10.1038/s41422-020-00460-y; Watanabe A, 2010, J VIROL, V84, P4183, DOI 10.1128/JVI.02168-09; Weiss SR, 2020, J EXP MED, V217, DOI 10.1084/jem.20200537; Wong LYR, 2016, VIROL SIN, V31, P12, DOI 10.1007/s12250-015-3683-3; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Wrensch F, 2014, VIRUSES-BASEL, V6, P3683, DOI 10.3390/v6093683; Wrobel AG, 2020, NAT STRUCT MOL BIOL, V27, P763, DOI 10.1038/s41594-020-0468-7; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yang ZY, 2004, J VIROL, V78, P5642, DOI 10.1128/JVI.78.11.5642-5650.2004; Ye ZW, 2020, INT J BIOL SCI, V16, P1686, DOI 10.7150/ijbs.45472; YEAGER CL, 1992, NATURE, V357, P420, DOI 10.1038/357420a0; Yu JY, 2019, J VIROL, V93, DOI 10.1128/JVI.01866-18; Yu JY, 2017, J BIOL CHEM, V292, P4674, DOI 10.1074/jbc.M116.755819; Yurchenko V, 2006, IMMUNOLOGY, V117, P301, DOI 10.1111/j.1365-2567.2005.02316.x; Zhang Qi, 2020, bioRxiv, DOI 10.1101/2020.07.14.202549; Zhao XS, 2020, J VIROL, V94, DOI 10.1128/JVI.00562-20; Zhao XS, 2019, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.03228; Zhao XS, 2018, J VIROL, V92, DOI 10.1128/JVI.01535-17; Zhao XS, 2014, P NATL ACAD SCI USA, V111, P6756, DOI 10.1073/pnas.1320856111; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	130	29	29	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100847	10.1016/j.jbc.2021.100847	http://dx.doi.org/10.1016/j.jbc.2021.100847			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34058196	gold, Green Published			2022-12-28	WOS:000678068400047
J	Kamps, J; Lin, YH; Oliva, R; Bader, V; Winter, R; Winklhofer, KF; Tatzelt, J				Kamps, Janine; Lin, Yu-Hsuan; Oliva, Rosario; Bader, Verian; Winter, Roland; Winklhofer, Konstanze F.; Tatzelt, Joerg			The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the A beta-binding domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COACERVATION; IMPAIRMENT; DISEASE; COPPER; PRPC; PI	Formation of biomolecular condensates through liquid-liquid phase separation (LLPS) has been described for several pathogenic proteins linked to neurodegenerative diseases and is discussed as an early step in the formation of protein aggregates with neurotoxic properties. In prion diseases, neurodegeneration and formation of infectious prions is caused by aberrant folding of the cellular prion protein (PrPC). PrPC is characterized by a large intrinsically disordered N-terminal domain and a structured C-terminal globular domain. A significant fraction of mature PrPC is proteolytically processed in vivo into an entirely unstructured fragment, designated N1, and the corresponding C-terminal fragment C1 harboring the globular domain. Notably, N1 contains a polybasic motif that serves as a binding site for neurotoxic A beta oligomers. PrP can undergo LLPS; however, nothing is known how phase separation of PrP is triggered on a molecular scale. Here, we show that the intrinsically disordered N1 domain is necessary and sufficient for LLPS of PrP. Similar to full-length PrP, the N1 fragment formed highly dynamic liquid-like droplets. Remarkably, a slightly shorter unstructured fragment, designated N2, which lacks the A beta-binding domain and is generated under stress conditions, failed to form liquid-like droplets and instead formed amorphous assemblies of irregular structures. Through a mutational analysis, we identified three positively charged lysines in the postoctarepeat region as essential drivers of condensate formation, presumably largely via cation-pi interactions. These findings provide insights into the molecular basis of LLPS of the mammalian prion protein and reveal a crucial role of the A beta-binding domain in this process.	[Kamps, Janine; Lin, Yu-Hsuan; Tatzelt, Joerg] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, Bochum, Germany; [Kamps, Janine; Winter, Roland; Winklhofer, Konstanze F.; Tatzelt, Joerg] Ruhr Univ Bochum, Cluster Excellence RESOLV, Bochum, Germany; [Oliva, Rosario; Winter, Roland] TU Dortmund Univ, Fac Chem & Chem Biol, Div Phys Chem Biophys Chem 1, Dortmund, Germany; [Bader, Verian; Winklhofer, Konstanze F.] Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Mol Cell Biol, Bochum, Germany	Ruhr University Bochum; Ruhr University Bochum; Dortmund University of Technology; Ruhr University Bochum	Tatzelt, J (corresponding author), Ruhr Univ Bochum, Inst Biochem & Pathobiochem, Dept Biochem Neurodegenerat Dis, Bochum, Germany.; Tatzelt, J (corresponding author), Ruhr Univ Bochum, Cluster Excellence RESOLV, Bochum, Germany.	joerg.Tatzelt@rub.de		Winklhofer, Konstanze/0000-0002-7256-8231; Kamps, Janine/0000-0002-4930-3868; Tatzelt, Jorg/0000-0001-5017-5528	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [2033-390677874-RESOLV, TA 167/6-3, TA 167/11-1, WI/2111-6]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work was funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy-EXC 2033-390677874-RESOLV; TA 167/6-3 and TA 167/11-1 (to J. T.); and WI/2111-6 (to K. F. W.).	Ahlers J, 2021, BIOPHYS J, V120, P1266, DOI 10.1016/j.bpj.2021.01.019; Alberti S, 2019, ANNU REV GENET, V53, P171, DOI 10.1146/annurev-genet-112618-043527; Altmeppen Hermann C, 2012, Am J Neurodegener Dis, V1, P15; Babinchak WM, 2020, J MOL BIOL, V432, P1910, DOI 10.1016/j.jmb.2020.03.004; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Banjade S, 2014, ELIFE, V3, DOI 10.7554/eLife.04123; Beland M, 2012, J NEUROCHEM, V120, P853, DOI 10.1111/j.1471-4159.2011.07613.x; Brandner S, 1996, NATURE, V379, P339, DOI 10.1038/379339a0; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; CHEN SG, 1995, J BIOL CHEM, V270, P19173, DOI 10.1074/jbc.270.32.19173; Chen SG, 2010, J BIOL CHEM, V285, P26377, DOI 10.1074/jbc.M110.145516; Chesebro B, 2005, SCIENCE, V308, P1435, DOI 10.1126/science.1110837; Darling AL, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.118984; Darling AL, 2018, PROTEOMICS, V18, DOI 10.1002/pmic.201700193; Das S, 2020, P NATL ACAD SCI USA, V117, P28795, DOI 10.1073/pnas.2008122117; Eigenbrod S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188989; Ferreira DG, 2017, NAT NEUROSCI, V20, P1569, DOI 10.1038/nn.4648; HARRIS DA, 1993, BIOCHEMISTRY-US, V32, P1009, DOI 10.1021/bi00055a003; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Huang JJ, 2020, J MOL BIOL, V432, P828, DOI 10.1016/j.jmb.2019.11.020; Iraci N, 2015, VIRUS RES, V207, P62, DOI 10.1016/j.virusres.2014.10.015; Kang J, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000327; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; Kelly SM, 2005, BBA-PROTEINS PROTEOM, V1751, P119, DOI 10.1016/j.bbapap.2005.06.005; Kim S, 2016, P NATL ACAD SCI USA, V113, pE847, DOI 10.1073/pnas.1521521113; Konig A. S., 2021, J BIOL CHEM, V296; Kostylev MA, 2018, MOL CELL, V72, P426, DOI 10.1016/j.molcel.2018.10.009; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Li PL, 2012, NATURE, V483, P336, DOI 10.1038/nature10879; Lin YH, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.178101; Mallucci G, 2003, SCIENCE, V302, P871, DOI 10.1126/science.1090187; Mange A, 2004, BIOL CELL, V96, P125, DOI 10.1016/j.biolcel.2003.11.007; Matos CO, 2020, FASEB J, V34, P365, DOI 10.1096/fj.201901897R; Millhauser GL, 2007, ANNU REV PHYS CHEM, V58, P299, DOI 10.1146/annurev.physchem.58.032806.104657; Nguyen XTA, 2019, MOL NEUROBIOL, V56, P6121, DOI 10.1007/s12035-019-1510-9; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Nygaard HB, 2009, ARCH NEUROL-CHICAGO, V66, P1325, DOI 10.1001/archneurol.2009.223; O'Flynn BG, 2021, CURR OPIN CELL BIOL, V69, P70, DOI 10.1016/j.ceb.2020.12.012; Ondrejcak T, 2018, J NEUROSCI, V38, P10595, DOI 10.1523/JNEUROSCI.1700-18.2018; Pak CW, 2016, MOL CELL, V63, P72, DOI 10.1016/j.molcel.2016.05.042; Passos YM, 2021, INT J BIOL MACROMOL, V173, P34, DOI 10.1016/j.ijbiomac.2021.01.097; Pierce WK, 2016, J MOL BIOL, V428, P1256, DOI 10.1016/j.jmb.2015.10.002; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purro SA, 2018, BIOL PSYCHIAT, V83, P358, DOI 10.1016/j.biopsych.2017.11.020; Rambold AS, 2008, EMBO J, V27, P1974, DOI 10.1038/emboj.2008.122; Resenberger UK, 2011, TOP CURR CHEM, V305, P101, DOI 10.1007/128_2011_160; Resenberger UK, 2011, EMBO J, V30, P2057, DOI 10.1038/emboj.2011.86; Sherrill CD, 2013, ACCOUNTS CHEM RES, V46, P1020, DOI 10.1021/ar3001124; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Smith LM, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024075; Tange H., 2021, J BIOL CHEM, V296; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Winklhofer KF, 2003, TRAFFIC, V4, P313, DOI 10.1034/j.1600-0854.2003.00088.x; Yeo GC, 2011, ADV COLLOID INTERFAC, V167, P94, DOI 10.1016/j.cis.2010.10.003; Zbinden A, 2020, DEV CELL, V55, P45, DOI 10.1016/j.devcel.2020.09.014; Zondlo NJ, 2013, ACCOUNTS CHEM RES, V46, P1039, DOI 10.1021/ar300087y	57	8	8	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100860	10.1016/j.jbc.2021.100860	http://dx.doi.org/10.1016/j.jbc.2021.100860			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34102212	gold, Green Published			2022-12-28	WOS:000678068400060
J	Maitra, D; Pinsky, BM; Soherawardy, A; Zheng, HY; Banerjee, R; Omary, MB				Maitra, Dhiman; Pinsky, Benjamin M.; Soherawardy, Amenah; Zheng, Haiyan; Banerjee, Ruma; Omary, M. Bishr			Protein-aggregating ability of different protoporphyrin-IX nanostructures is dependent on their oxidation and protein-binding capacity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN SERUM; SUBCELLULAR-LOCALIZATION; LIGAND-BINDING; SINGLET OXYGEN; PORPHYRIN NANOSTRUCTURES; SCLEROSING CHOLANGITIS; QUANTUM YIELD; MECHANISM; ALBUMIN; MODEL	Porphyrias are rare blood disorders caused by genetic defects in the heme biosynthetic pathway and are associated with the accumulation of high levels of porphyrins that become cytotoxic. Porphyrins, due to their amphipathic nature, spontaneously associate into different nanostructures, but very little is known about the cytotoxic effects of these porphyrin nanostructures. Previously, we demonstrated the unique ability of fluorescent biological porphyrins, including protoporphyrin-IX (PP-IX), to cause organelle-selective protein aggregation, which we posited to be a major mechanism by which fluorescent porphyrins exerts their cytotoxic effect. Herein, we tested the hypothesis that PP-IX-mediated protein aggregation is modulated by different PP-IX nanostructures via a mechanism that depends on their oxidizing potential and protein-binding ability. UV-visible spectrophotometry showed pH-mediated reversible transformations of PP-IX nanostructures. Biochemical analysis showed that PP-IX nanostructure size modulated PP-IX-induced protein oxidation and protein aggregation. Furthermore, albumin, the most abundant serum protein, preferentially binds PP-IX dimers and enhances their oxidizing ability. PP-IX binding quenched albumin intrinsic fluorescence and oxidized His-91 residue to Asn/Asp, likely via a previously described photo-oxidation mechanism for other proteins. Extracellular albumin protected from intracellular porphyrinogenic stress and protein aggregation by acting as a PP-IX sponge. This work highlights the importance of PP-IX nanostructures in the context of porphyrias and offers insights into potential novel therapeutic approaches.	[Maitra, Dhiman; Soherawardy, Amenah; Zheng, Haiyan; Omary, M. Bishr] Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Pinsky, Benjamin M.; Banerjee, Ruma; Omary, M. Bishr] Univ Michigan, Med Sch, Ann Arbor, MI 48109 USA; [Banerjee, Ruma] Dept Biol Chem, Ann Arbor, MI USA	Rutgers State University New Brunswick; University of Michigan System; University of Michigan	Maitra, D (corresponding author), Rutgers State Univ, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA.	dm1401@cabm.rutgers.edu		Zheng, Haiyan/0000-0003-1955-1817; , dhiman/0000-0002-8775-2963	National Institutes of Health [DK116548, GM130183]; Honors Summer Fellowship (College of Literature, Science, and the Arts); Summer Undergraduate Research Fellowship (Department of Molecular and Integrative Physiology) at the University of Michigan	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Honors Summer Fellowship (College of Literature, Science, and the Arts); Summer Undergraduate Research Fellowship (Department of Molecular and Integrative Physiology) at the University of Michigan	This work was supported by National Institutes of Health R01 grants DK116548 (M. B. O.) and GM130183 (R. B.); an Honors Summer Fellowship (College of Literature, Science, and the Arts), and a Summer Undergraduate Research Fellowship (Department of Molecular and Integrative Physiology) at the University of Michigan (B. M. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ajioka RS, 2006, BBA-MOL CELL RES, V1763, P723, DOI 10.1016/j.bbamcr.2006.05.005; Badminton M. N., 2014, CLIN BIOCH METABOLIC, P533; Baral A, 2017, NEW J CHEM, V41, P8130, DOI 10.1039/c7nj01227f; Belcher J, 2009, J PHYS CHEM B, V113, P6020, DOI 10.1021/jp900957d; Bissell DM., 2015, ROSENBERGS MOL GENET, V5th, P731, DOI DOI 10.1016/B978-0-12-410529-4.00066-8; Brancaleon L, 2002, BIOPHYS CHEM, V96, P77, DOI 10.1016/S0301-4622(02)00035-2; BRUN A, 1991, J PHOTOCH PHOTOBIO B, V10, P285, DOI 10.1016/1011-1344(91)80015-A; Camilloni C, 2008, BIOPHYS J, V94, P4654, DOI 10.1529/biophysj.107.125799; Carter EL, 2017, J BIOL CHEM, V292, P11280, DOI 10.1074/jbc.M117.783118; Chen YZ, 2014, NANOSCALE, V6, P978, DOI 10.1039/c3nr04908f; Constantin C, 2010, NANOMEDICINE-UK, V5, P307, DOI 10.2217/NNM.09.111; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Cunha JB, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88668-9; Davies MJ, 2003, BIOCHEM BIOPH RES CO, V305, P761, DOI 10.1016/S0006-291X(03)00817-9; Dayan FE, 2011, AM SCI, V99, P236, DOI 10.1511/2011.90.236; Dini F, 2009, NANOTECHNOLOGY, V20, DOI 10.1088/0957-4484/20/5/055502; La DD, 2017, PHOTOCH PHOTOBIO SCI, V16, P151, DOI 10.1039/c6pp00335d; Elemans JAAW, 2006, ADV MATER, V18, P1251, DOI 10.1002/adma.200502498; Elenbaas JS, 2016, FASEB J, V30, P1798, DOI 10.1096/fj.201500111R; Evans TW, 2002, ALIMENT PHARM THER, V16, P6, DOI 10.1046/j.1365-2036.16.s5.2.x; Ezzeddine R, 2013, J BIOL CHEM, V288, P36579, DOI 10.1074/jbc.M113.511642; Fasano M, 2005, IUBMB LIFE, V57, P787, DOI 10.1080/15216540500404093; Fernandez NF, 2008, J PHYS CHEM B, V112, P7592, DOI 10.1021/jp710249d; Fickert P, 2007, AM J PATHOL, V171, P525, DOI 10.2353/ajpath.2007.061133; FOOTE CS, 1991, PHOTOCHEM PHOTOBIOL, V54, P659, DOI 10.1111/j.1751-1097.1991.tb02071.x; Gotardo F, 2017, CHEM PHYS LETT, V674, P48, DOI 10.1016/j.cplett.2017.02.055; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; GUNDRY RL, 2007, CLIN PROTEOMICS DIAG, P263, DOI DOI 10.1002/9783527622153.CH18; Hasobe T, 2005, J AM CHEM SOC, V127, P1216, DOI 10.1021/ja047768u; Hsieh YJ, 2003, J CELL PHYSIOL, V194, P363, DOI 10.1002/jcp.10273; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; Imahori H, 2004, ADV FUNCT MATER, V14, P525, DOI 10.1002/adfm.200305172; INAMURA I, 1991, B CHEM SOC JPN, V64, P2005, DOI 10.1246/bcsj.64.2005; Jin CS, 2014, ADV HEALTHC MATER, V3, P1240, DOI 10.1002/adhm.201300651; Jin CS, 2013, ACS NANO, V7, P2541, DOI 10.1021/nn3058642; Kawakami A, 2006, FEBS J, V273, P3346, DOI 10.1111/j.1742-4658.2006.05341.x; Kim S, 2014, J AM CHEM SOC, V136, P11707, DOI 10.1021/ja504279r; LEHN JM, 1993, SCIENCE, V260, P1762, DOI 10.1126/science.8511582; Liu Z, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09563-w; Lyoumi S, 2011, GASTROENTEROLOGY, V141, P1509, DOI 10.1053/j.gastro.2011.06.078; Magna G, 2019, MOLECULES, V24, DOI 10.3390/molecules24234307; Maitra D, 2019, CELL MOL GASTROENTER, V8, P535, DOI 10.1016/j.jcmgh.2019.06.006; Maitra D, 2019, CELL MOL GASTROENTER, V8, P659, DOI 10.1016/j.jcmgh.2019.05.010; Maitra D, 2015, J BIOL CHEM, V290, P23711, DOI 10.1074/jbc.M114.636001; MARGALIT R, 1983, BIOCHEM J, V209, P547, DOI 10.1042/bj2090547; Medforth CJ, 2009, CHEM COMMUN, P7261, DOI 10.1039/b914432c; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Puy H, 2010, LANCET, V375, P924, DOI 10.1016/S0140-6736(09)61925-5; Quinlan GJ, 2005, HEPATOLOGY, V41, P1211, DOI 10.1002/hep.20720; Rabbani G, 2019, INT J BIOL MACROMOL, V123, P979, DOI 10.1016/j.ijbiomac.2018.11.053; Saggi H, 2019, J HEPATOL, V70, P108, DOI 10.1016/j.jhep.2018.09.023; Sansaloni-Pastor S, 2019, PHARMACEUTICALS-BASE, V12, DOI 10.3390/ph12040148; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Scolaro LM, 2002, J PHYS CHEM B, V106, P2453, DOI 10.1021/jp013155h; Sen P, 2009, SPECTROCHIM ACTA A, V74, P94, DOI 10.1016/j.saa.2009.05.010; Seo J, 2016, J AM CHEM SOC, V138, P16315, DOI 10.1021/jacs.6b08700; Shaw AK, 2008, J PHOTOCH PHOTOBIO B, V90, P187, DOI 10.1016/j.jphotobiol.2008.01.001; Singla A, 2013, J CELL SCI, V126, P3105, DOI 10.1242/jcs.123026; Sulkowski L, 2016, MOLECULES, V21, DOI 10.3390/molecules21111519; Sullivan DJ, 1996, P NATL ACAD SCI USA, V93, P11865, DOI 10.1073/pnas.93.21.11865; Sullivan DJ, 1998, J BIOL CHEM, V273, P31103, DOI 10.1074/jbc.273.47.31103; Takeshita K, 2004, J INVEST DERMATOL, V122, P1463, DOI 10.1111/j.0022-202X.2004.22601.x; Tanielian C, 2001, FREE RADICAL BIO MED, V30, P208, DOI 10.1016/S0891-5849(00)00460-3; Teiten MH, 2003, BRIT J CANCER, V88, P146, DOI 10.1038/sj.bjc.6600664; Tene KW, 2019, J PHYS CHEM B, V123, P5832, DOI 10.1021/acs.jpcb.9b01913; TOMITA M, 1969, BIOCHEMISTRY-US, V8, P5149, DOI 10.1021/bi00840a069; TSAI CS, 1985, BIOCHEM J, V225, P203, DOI 10.1042/bj2250203; Walter MG, 2010, J PORPHYR PHTHALOCYA, V14, P759, DOI 10.1142/S1088424610002689; Wang M, 2009, ANTIOXID REDOX SIGN, V11, P2307, DOI [10.1089/ars.2009.2485, 10.1089/ARS.2009.2485]; Wang ZC, 2004, J AM CHEM SOC, V126, P15954, DOI 10.1021/ja045068j; Wang ZC, 2006, ADV MATER, V18, P2557, DOI 10.1002/adma.200600539; WOODBURN KW, 1991, PHOTOCHEM PHOTOBIOL, V54, P725, DOI 10.1111/j.1751-1097.1991.tb02081.x; Wurthner F, 2011, ANGEW CHEM INT EDIT, V50, P3376, DOI 10.1002/anie.201002307; Zhang HB, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aac5418; Zhang N, 2018, NANO LETT, V18, P560, DOI 10.1021/acs.nanolett.7b04701; Zhou J, 2017, BIOMATERIALS, V129, P1, DOI 10.1016/j.biomaterials.2017.03.014	76	3	3	3	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100778	10.1016/j.jbc.2021.100778	http://dx.doi.org/10.1016/j.jbc.2021.100778			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023387	Green Submitted, Green Published, gold			2022-12-28	WOS:000678068400006
J	White, CJ; Ellis, JM; Wolfgang, MJ				White, Cory J.; Ellis, Jessica M.; Wolfgang, Michael J.			The role of ethanolamine phosphate phospholyase in regulation of astrocyte lipid homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSLATIONAL PROFILING APPROACH; FATTY-ACID-METABOLISM; GENE-EXPRESSION; MESSENGER-RNA; DOCOSAHEXAENOIC ACID; ARACHIDONIC-ACID; BETA-OXIDATION; INBORN-ERRORS; BRAIN UPTAKE; PHOSPHOETHANOLAMINE	Dietary lipid composition has been shown to impact brain morphology, brain development, and neurologic function. However, how diet uniquely regulates brain lipid homeostasis compared with lipid homeostasis in peripheral tissues remains largely uncharacterized. To evaluate the lipid response to dietary changes in the brain, we assessed actively translating mRNAs in astrocytes and neurons across multiple diets. From this data, ethanolamine phosphate phospholyase (Etnppl) was identified as an astrocyte-specific fasting-induced gene. Etnppl catabolizes phosphoethanolamine (PEtN), a prominent headgroup precursor in phosphatidylethanolamine (PE) also found in other classes of neurologically relevant lipid species. Altered Etnppl expression has also previously been associated with humans with mood disorders. We evaluated the relevance of Etnppl in maintaining brain lipid homeostasis by characterizing Etnppl across development and in coregulation with PEtN-relevant genes, as well as determining the impact to the brain lipidome after Etnppl loss. We found that Etnppl expression dramatically increased during a critical window of early brain development in mice and was also induced by glucocorticoids. Using a constitutive knockout of Etnppl (Etnppl(KO)), we did not observe robust changes in expression of PEtN-related genes. However, loss of Etnppl altered the phospholipid profile in the brain, resulting in increased total abundance of PE and in polyunsaturated fatty acids within PE and phosphatidylcholine species in the brain. Together, these data suggest that brain phospholipids are regulated by the phospholyase action of the enzyme Etnppl, which is induced by dietary fasting in astrocytes.	[White, Cory J.; Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA; [Ellis, Jessica M.] East Carolina Univ, East Carolina Diabet & Obes Inst, Dept Physiol, Greenville, NC 27858 USA; [Wolfgang, Michael J.] Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA	Johns Hopkins University; University of North Carolina; East Carolina University; Johns Hopkins University	Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biol Chem, Baltimore, MD 21205 USA.; Wolfgang, MJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	mwolfga1@jhmi.edu		White, Cory/0000-0003-3350-2835	National Institutes of Health (NIH) [R01NS072241, R01DK116746, R01DK125812, F31NS102151, F99NS118713]; NIH [T32GM007445]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported in part by National Institutes of Health (NIH) grants R01NS072241 and R01DK116746 to M. J. W., R01DK125812 to J. M. E., as well as F31NS102151 and F99NS118713 to C. J. W. C. J. W. was additionally supported by the NIH T32GM007445 training grant to the Biochemistry, Cellular and Molecular Biology Graduate Program at Johns Hopkins School of Medicine. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aguado-Llera D, 2011, NEUROCHEM INT, V58, P22, DOI 10.1016/j.neuint.2010.10.005; Ahmed AT, 2020, J AFFECT DISORDERS, V264, P90, DOI 10.1016/j.jad.2019.11.122; Ahmed MY, 2017, BRAIN, V140, P547, DOI 10.1093/brain/aww318; Ao MRB, 2008, AUST NZ J PSYCHIAT, V42, P995, DOI 10.1080/00048670802512073; Barone R, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00636; Borowsky AD, 2012, J LIPID RES, V53, P1920, DOI 10.1194/jlr.M028084; Boukouris AE, 2016, TRENDS BIOCHEM SCI, V41, P712, DOI 10.1016/j.tibs.2016.05.013; Brenna JT, 2007, PROSTAG LEUKOTR ESS, V77, P247, DOI 10.1016/j.plefa.2007.10.016; Brenna JT, 2014, J HUM EVOL, V77, P99, DOI 10.1016/j.jhevol.2014.02.017; Carter BS, 2012, PHYSIOL GENOMICS, V44, P1188, DOI 10.1152/physiolgenomics.00097.2012; Cho K. H., 2017, CLIN GENET, V113, P1; Clark-Taylor T, 2004, MED HYPOTHESES, V62, P970, DOI 10.1016/j.mehy.2004.01.011; Clarke LE, 2018, P NATL ACAD SCI USA, V115, pE1896, DOI 10.1073/pnas.1800165115; Clarke LE, 2013, NAT REV NEUROSCI, V14, P311, DOI 10.1038/nrn3484; Crawford M. A., 2008, NOVARTIS FOUND S, P267, DOI [10.1002/9780470719862.ch16, DOI 10.1002/9780470719862.CH16]; Davis-Bruno K, 2011, BIRTH DEFECTS RES B, V92, P240, DOI 10.1002/bdrb.20311; Ding QS, 2016, J CLIN PATHOL, V69, P215, DOI 10.1136/jclinpath-2015-203042; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; Dowhan W, 1997, ANNU REV BIOCHEM, V66, P199, DOI 10.1146/annurev.biochem.66.1.199; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Dutta DJ, 2018, P NATL ACAD SCI USA, V115, P11832, DOI 10.1073/pnas.1811013115; Dyall SC, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00052; Eckel-Mahan KL, 2012, P NATL ACAD SCI USA, V109, P5541, DOI 10.1073/pnas.1118726109; Ellis JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116587; Ellis JM, 2013, MOL CELL BIOL, V33, P1869, DOI 10.1128/MCB.01548-12; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Fleshood H. L., 2016, ARCH BIOCHEM BIOPHYS, V141, P423; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gohil VM, 2013, J BIOL CHEM, V288, P35387, DOI 10.1074/jbc.M113.489237; Hamilton JA, 2007, J MOL NEUROSCI, V33, P2, DOI 10.1007/s12031-007-0060-1; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Heiman M, 2014, NAT PROTOC, V9, P1282, DOI 10.1038/nprot.2014.085; Horibata Y, 2018, J LIPID RES, V59, P1015, DOI 10.1194/jlr.P081620; Huigen MCDG, 2015, MOL GENET METAB, V114, P51, DOI 10.1016/j.ymgme.2014.10.016; Iannotti FA, 2016, PROG LIPID RES, V62, P107, DOI 10.1016/j.plipres.2016.02.002; Jemberg JN, 2017, J NEUROCHEM, V142, P407, DOI 10.1111/jnc.14072; Kadmiel M, 2013, TRENDS PHARMACOL SCI, V34, P518, DOI 10.1016/j.tips.2013.07.003; KENNEDY EP, 1956, J BIOL CHEM, V222, P193; Kroll JR, 2013, J COMP NEUROL, V521, P3500, DOI 10.1002/cne.23364; Lamari F, 2015, J INHERIT METAB DIS, V38, P3, DOI 10.1007/s10545-014-9764-x; Lee J, 2016, CELL REP, V16, P201, DOI 10.1016/j.celrep.2016.05.062; Lee J, 2012, BMC BIOCHEM, V13, DOI 10.1186/1471-2091-13-23; Leishman E, 2016, BBA-MOL CELL BIOL L, V1861, P491, DOI 10.1016/j.bbalip.2016.03.003; Leventoux N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62145-1; Lin LE, 2015, J LIPID RES, V56, P390, DOI 10.1194/jlr.M055590; Magomedova L, 2016, HANDB EXP PHARMACOL, V233, P73, DOI 10.1007/164_2015_1; McMahon HT, 2015, J CELL SCI, V128, P1065, DOI 10.1242/jcs.114454; McQuillin A, 2007, PHARMACOGENET GENOM, V17, P605, DOI 10.1097/FPC.0b013e328011b5b2; Merritt JL, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.10.57; Mitchell RW, 2011, PROSTAG LEUKOTR ESS, V85, P293, DOI 10.1016/j.plefa.2011.04.007; Murphy Robert C, 2011, Biochim Biophys Acta, V1811, P635, DOI 10.1016/j.bbalip.2011.09.003; Norton WT., 1984, MYELIN, P147, DOI DOI 10.1007/978-1-4757-1830-0_5; PAVLIDIS P, 1994, CELL, V79, P23, DOI 10.1016/0092-8674(94)90397-2; Pavlovic Z, 2013, INT J MOL SCI, V14, P2529, DOI 10.3390/ijms14022529; Roberts SJ, 2004, BIOCHEM J, V382, P59, DOI 10.1042/BJ20040511; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136; Salvati S, 2000, DEV NEUROSCI-BASEL, V22, P481, DOI 10.1159/000017479; Schiroli D, 2015, BBA-PROTEINS PROTEOM, V1854, P1200, DOI 10.1016/j.bbapap.2015.02.023; Schiroli D, 2015, FEBS J, V282, P183, DOI 10.1111/febs.13122; Schiroli D, 2013, IUBMB LIFE, V65, P645, DOI 10.1002/iub.1178; Schmitt S, 2015, BBA-MOL CELL BIOL L, V1851, P999, DOI 10.1016/j.bbalip.2014.12.016; Schroeder FA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071323; Schuurs-Hoeijmakers JHM, 2012, AM J HUM GENET, V91, P1073, DOI 10.1016/j.ajhg.2012.10.017; Shao L, 2008, BIOL PSYCHIAT, V64, P89, DOI 10.1016/j.biopsych.2007.11.010; Sibille E, 2004, NEUROPSYCHOPHARMACOL, V29, P351, DOI 10.1038/sj.npp.1300335; Stankiewicz AM, 2014, BMC NEUROSCI, V15, DOI 10.1186/s12868-014-0130-6; Tasseva G, 2013, J BIOL CHEM, V288, P4158, DOI 10.1074/jbc.M112.434183; Tsuboi K, 2007, CHEM BIODIVERS, V4, P1914, DOI 10.1002/cbdv.200790159; Tyni T, 1999, ACTA PAEDIATR, V88, P237, DOI 10.1080/08035259950169954; Tyni T, 1997, J PEDIATR-US, V130, P67, DOI 10.1016/S0022-3476(97)70312-3; Vasconcelos AR, 2016, FRONT ENDOCRINOL, V7, DOI 10.3389/fendo.2016.00009; Vaz FM, 2019, BRAIN, V142, P3382, DOI 10.1093/brain/awz291; Veiga-da-Cunha M, 2012, J BIOL CHEM, V287, P7246, DOI 10.1074/jbc.M111.323485; Watkins PA, 2001, J MOL NEUROSCI, V16, P87, DOI 10.1385/JMN:16:2-3:87; White CJ, 2020, MOL CELL BIOL, V40, DOI 10.1128/MCB.00037-20; Xie ZG, 2016, CELL REP, V14, P991, DOI 10.1016/j.celrep.2016.01.004; Zhang Y, 2014, J NEUROSCI, V34, P11929, DOI [10.1523/JNEUROSCI.1860-14.2014, 10.11772/j.issn.1001-9081.2014.07.1929]; Zheng L, 2019, ADV NUTR, V10, P1163, DOI 10.1093/advances/nmz051; Zuchero JB, 2015, DEVELOPMENT, V142, P3805, DOI 10.1242/dev.129304	81	3	3	2	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100830	10.1016/j.jbc.2021.100830	http://dx.doi.org/10.1016/j.jbc.2021.100830			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology	TQ1SY	34048714	Green Published, gold			2022-12-28	WOS:000678068400032
J	Barile, A; Battista, T; Fiorillo, A; di Salvo, ML; Malatesta, F; Tramonti, A; Ilari, A; Contestabile, R				Barile, Anna; Battista, Theo; Fiorillo, Annarita; di Salvo, Martino Luigi; Malatesta, Francesco; Tramonti, Angela; Ilari, Andrea; Contestabile, Roberto			Identification and characterization of the pyridoxal 5 '-phosphate allosteric site in Escherichia coli pyridoxine 5 '-phosphate oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-STRUCTURE; BIOSYNTHESIS; BINDING	Pyridoxal 5'-phosphate (PLP), the catalytically active form of vitamin B6, plays a pivotal role in metabolism as an enzyme cofactor. PLP is a very reactive molecule and can be very toxic unless its intracellular concentration is finely regulated. In Escherichia coli, PLP formation is catalyzed by pyridoxine 5'-phosphate oxidase (PNPO), a homodimeric FMN-dependent enzyme that is responsible for the last step of PLP biosynthesis and is also involved in the PLP salvage pathway. We have recently observed that E. coli PNPO undergoes an allosteric feedback inhibition by PLP, caused by a strong allosteric coupling between PLP binding at the allosteric site and substrate binding at the active site. Here we report the crystallo-graphic identification of the PLP allosteric site, located at the interface between the enzyme subunits and mainly circum-scribed by three arginine residues (Arg23, Arg24, and Arg215) that form an "arginine cage" and efficiently trap PLP. The crystal structure of the PNPO-PLP complex, characterized by a marked structural asymmetry, presents only one PLP molecule bound at the allosteric site of one monomer and sheds light on the allosteric inhibition mechanism that makes the enzyme-substrate-PLP ternary complex catalytically incompetent. Site-directed mutagenesis studies focused on the arginine cage validate the identity of the allosteric site and provide an effective means to modulate the allosteric properties of the enzyme, from the loosening of the allosteric coupling (in the R23L/R24L and R23L/R215L variants) to the complete loss of allosteric properties (in the R23L/R24L/R21L variant).	[Barile, Anna; Battista, Theo; Fiorillo, Annarita; Tramonti, Angela; Ilari, Andrea] CNR, Ist Biol & Patol Mol, Rome, Italy; [Barile, Anna; Battista, Theo; Fiorillo, Annarita; di Salvo, Martino Luigi; Malatesta, Francesco; Tramonti, Angela; Contestabile, Roberto] Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); Fondazione Cenci Bolognetti; Sapienza University Rome	Contestabile, R (corresponding author), Sapienza Univ Roma, Dipartimento Sci Biochim A Rossi Fanelli, Ist Pasteur Italia, Fdn Cenci Bolognetti, Rome, Italy.	roberto.contestabile@uniroma1.it	Battista, Theo/GSN-8769-2022; Ilari, Andrea/AAC-7670-2022; Tramonti, Angela/K-5325-2019	Ilari, Andrea/0000-0002-7754-399X; Tramonti, Angela/0000-0002-5625-1170; FIORILLO, Annarita/0000-0002-8966-8554; Contestabile, Roberto/0000-0002-5235-9993; Barile, Anna/0000-0002-0929-3378	Istituto Pasteur Italia -Fondazione Cenci Bolognetti; Sapienza Universita di Roma [RM11916B51484C08, RM120172A76E4B78]; CNR Italy-Russia bilateral project [CUPB86C17000270001]	Istituto Pasteur Italia -Fondazione Cenci Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Sapienza Universita di Roma; CNR Italy-Russia bilateral project	This research was supported by grants from Istituto Pasteur Italia -Fondazione Cenci Bolognetti (Research Grant "Anna Tramontano" 2018 to R. C.), from Sapienza Universita di Roma (RM11916B51484C08 and RM120172A76E4B78 to R. C.), and the CNR Italy-Russia bilateral project (Grant CUPB86C17000270001 to A. T.).	Barile A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70598-7; Barile A, 2019, J BIOL CHEM, V294, P15593, DOI 10.1074/jbc.RA119.009697; Battista T., 2020, PROTEIN DATA BANK; Battista T., 2020, PROTEIN DATA BANK; Denesyuk AI, 2002, J MOL BIOL, V316, P155, DOI 10.1006/jmbi.2001.5310; Di Salvo M, 1998, PROTEIN EXPRES PURIF, V13, P349, DOI 10.1006/prep.1998.0904; di Salvo ML, 2017, MOL GENET METAB, V122, P135, DOI 10.1016/j.ymgme.2017.08.003; di Salvo ML, 2011, BBA-PROTEINS PROTEOM, V1814, P1597, DOI 10.1016/j.bbapap.2010.12.006; di Salvo ML, 2002, J MOL BIOL, V315, P385, DOI 10.1006/jmbi.2001.5254; Fitzpatrick TB, 2007, BIOCHEM J, V407, P1, DOI 10.1042/BJ20070765; Ito T, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00056-20; KWON O, 1991, J BIOL CHEM, V266, P22136; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; Percudani R, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-273; PETERSON EA, 1954, J AM CHEM SOC, V76, P169, DOI 10.1021/ja01630a045; Safo MK, 2000, STRUCTURE, V8, P751, DOI 10.1016/S0969-2126(00)00162-3; Safo MK, 2001, J MOL BIOL, V310, P817, DOI 10.1006/jmbi.2001.4734; Yang ES, 2000, ARCH BIOCHEM BIOPHYS, V377, P109, DOI 10.1006/abbi.2000.1737; Yang Y, 1998, J BACTERIOL, V180, P1814, DOI 10.1128/JB.180.7.1814-1821.1998; ZHAO GS, 1995, J BACTERIOL, V177, P883, DOI 10.1128/jb.177.4.883-891.1995	20	1	1	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100795	10.1016/j.jbc.2021.100795	http://dx.doi.org/10.1016/j.jbc.2021.100795			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019876	Green Published, gold			2022-12-28	WOS:000674717300015
J	Cheng, S; Bo, ZY; Hollenberg, P; Osawa, Y; Zhang, HM				Cheng, Shen; Bo, Zhiyuan; Hollenberg, Paul; Osawa, Yoichi; Zhang, Haoming			Amphipol-facilitated elucidation of the functional tetrameric complex of full-length cytochrome P450 CYP2B4 and NADPH-cytochrome P450 oxidoreductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P-450 REDUCTASE; LIVER-MICROSOMES; NANODISCS; PROTEINS; ENZYME; SYSTEM	Interactions of membrane-bound mammalian cytochromes P450 (CYPs) with NADPH-cytochrome P450 oxidoreductase (POR), which are required for metabolism of xenobiotics, are facilitated by membrane lipids. A variety of membrane mimetics, such as phospholipid liposomes and nanodiscs, have been used to simulate the membrane to form catalytically active CYP:POR complexes. However, the exact mechanism(s) of these interactions are unclear because of the absence of structural information of full-length mammalian CYP:POR complexes in membranes. Herein, we report the use of amphipols (APols) to form a fully functional, soluble, homogeneous preparation of full-length CYP:POR complexes amenable to biochemical and structural study. Incorporation of CYP2B4 and POR into APols resulted in a CYP2B4:POR complex with a stoichiometry of 1:1, which was fully functional in demethylating benzphetamine at a turnover rate of 37.7 +/- 2.2 min(-1), with a coupling efficiency of 40%. Interestingly, the stable complex had a molecular weight (M-w) of 338 +/- 22 kDa determined by multiangle light scattering, suggestive of a tetrameric complex of 2CYP2B4:2POR embedded in one APol nanoparticle. Moreover, negative stain electron microscopy (EM) validated the homogeneity of the complex and allowed us to generate a three-dimensional EM map and model consistent with the tetramer observed in solution. This first report of the full-length mammalian CYP:POR complex by transmission EM not only reveals the architecture that facilitates electron transfer but also highlights a potential use of APols in biochemical and structural studies of functional CYP complexes with redox partners.	[Cheng, Shen; Bo, Zhiyuan; Hollenberg, Paul; Osawa, Yoichi; Zhang, Haoming] Univ Michigan, Dept Pharmacol, Med Sch, Ann Arbor, MI 48109 USA; [Cheng, Shen] Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA	University of Michigan System; University of Michigan; University of Minnesota System; University of Minnesota Twin Cities	Zhang, HM (corresponding author), Univ Michigan, Dept Pharmacol, Med Sch, Ann Arbor, MI 48109 USA.	haom@umich.edu	Cheng, Shen/GWQ-6903-2022; Zhang, Haoming/AAE-3749-2020; Hollenberg, Paul F/A-7538-2009	Cheng, Shen/0000-0002-7493-4784; Zhang, Haoming/0000-0002-8765-4394; Bo, Zhiyuan/0000-0001-8759-1349	National Institutes of Health [GM077430, ES030791]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful for technical assistance from the staff scientists, Drs. Min Su, Amy Bondy, and Laura Koepping, at the Microscopy Core Facilities of Life Sciences Institute to acquire EM images. This work was supported by grants from the National Institutes of Health (GM077430 and ES030791). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bayburt TH, 2002, P NATL ACAD SCI USA, V99, P6725, DOI 10.1073/pnas.062565599; BLACK SD, 1979, BIOCHEM BIOPH RES CO, V91, P1528, DOI 10.1016/0006-291X(79)91238-5; Bridges A, 1998, J BIOL CHEM, V273, P17036, DOI 10.1074/jbc.273.27.17036; Denisov IG, 2004, J AM CHEM SOC, V126, P3477, DOI 10.1021/ja0393574; Denisov IG, 2011, BBA-PROTEINS PROTEOM, V1814, P223, DOI 10.1016/j.bbapap.2010.05.017; Duan JJ, 2018, P NATL ACAD SCI USA, V115, pEB201, DOI 10.1073/pnas.1810719115; Gohon Y, 2006, LANGMUIR, V22, P1281, DOI 10.1021/la052243g; GRIFFITH IP, 1972, BIOCHEM J, V126, P553, DOI 10.1042/bj1260553; GRUENKE LD, 1995, J BIOL CHEM, V270, P24707, DOI 10.1074/jbc.270.42.24707; Guengerich F. P., 1995, CYTOCHROME P, P473; Hamdane D, 2009, J BIOL CHEM, V284, P11374, DOI 10.1074/jbc.M807868200; Hulse RE, 2018, ELIFE, V7, DOI 10.7554/eLife.36931; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Laursen T, 2013, BIOTECHNOL APPL BIOC, V60, P119, DOI 10.1002/bab.1092; LU AYH, 1969, J BIOL CHEM, V244, P3714; Mahajan M, 2019, CHEM COMMUN, V55, P5777, DOI 10.1039/c9cc01630a; Martinez SE, 2019, DRUG METAB DISPOS, V47, P1314, DOI 10.1124/dmd.119.088070; Mukherjee G, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-020-01568-y; OMURA T, 1964, J BIOL CHEM, V239, P2370; OMURA T, 1962, J BIOL CHEM, V237, P1375; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; Pearl NM, 2016, BIOCHEMISTRY-US, V55, P6558, DOI 10.1021/acs.biochem.6b00996; PETERSON JA, 1976, J BIOL CHEM, V251, P4010; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Popot JL, 2010, ANNU REV BIOCHEM, V79, P737, DOI 10.1146/annurev.biochem.052208.114057; Prade E, 2018, ANGEW CHEM INT EDIT, V57, P8458, DOI 10.1002/anie.201802210; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Sellner M, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031023; SHEN AL, 1989, J BIOL CHEM, V264, P7584; Su M, 2020, J BIOL CHEM, V295, P1637, DOI 10.1074/jbc.RA119.011305; Tribet C, 1996, P NATL ACAD SCI USA, V93, P15047, DOI 10.1073/pnas.93.26.15047; VERMILION JL, 1978, J BIOL CHEM, V253, P2694; Zhang HM, 2007, J BIOL CHEM, V282, P29766, DOI 10.1074/jbc.M703845200; Zhang HM, 2018, J BIOL CHEM, V293, P7727, DOI 10.1074/jbc.RA117.000600; Zhang HM, 2003, BIOCHEMISTRY-US, V42, P11594, DOI 10.1021/bi034968u; Zhang M, 2016, ANGEW CHEM INT EDIT, V55, P4497, DOI 10.1002/anie.201600073	36	1	1	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100645	10.1016/j.jbc.2021.100645	http://dx.doi.org/10.1016/j.jbc.2021.100645			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839156	gold, Green Published			2022-12-28	WOS:000672866400616
J	Lee, YS; Herrera-Tequia, A; Silwal, J; Geiger, JH; Grotewold, E				Lee, Yun Sun; Herrera-Tequia, Andres; Silwal, Jagannath; Geiger, James H.; Grotewold, Erich			A hydrophobic residue stabilizes dimers of regulatory ACT-like domains in plant basic helix-loop-helix transcription factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								About a third of the plant basic helix-loop-helix (bHLH) transcription factors harbor a C-terminal aspartate kinase, chorismate mutase, and TyrA (ACT)-like domain, which was originally identified in the maize R regulator of anthocyanin biosynthesis, where it modulates the ability of the bHLH to dimerize and bind DNA. Characterization of other bHLH ACT-like domains, such as the one in the Arabidopsis R ortholog, GL3, has not definitively confirmed dimerization, raising the question of the overall role of this potential regulatory domain. To learn more, we compared the dimerization of the ACT-like domains of R(R-ACT) and GL3 (GL3(ACT)). Weshow that R-ACT dimerizes with a dissociation constant around 100 nM, over an order of magnitude stronger than GL3(ACT). Structural predictions combined with mutational analyses demonstrated that V568, located in a hydrophobic pocket in R-ACT, is important: when mutated to the Ser residue present in GL3(ACT), dimerization affinity dropped by almost an order of magnitude. The converse S595V mutation in GL3(ACT) significantly increased the dimerization strength. We cloned and assayed dimerization for all identified maize ACT-like domains and determined that 12 of 42 formed heterodimers in yeast two-hybrid assays, irrespective of whether they harbored V568, which was often replaced by other aliphatic amino acids. Moreover, we determined that the presence of polar residues at that position occurs only in a small subset of anthocyanin regulators. The combined results provide new insights into possibly regulatory mechanisms and suggest that many of the other plant ACT-like domains associate to modulate fundamental cellular processes.	[Lee, Yun Sun; Herrera-Tequia, Andres; Silwal, Jagannath; Grotewold, Erich] Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA; [Geiger, James H.] Michigan State Univ, Dept Chem, E Lansing, MI 48824 USA; [Silwal, Jagannath] Zoetis Inc, Vet Med Res & Dev, Kalamazoo, MI USA	Michigan State University; Michigan State University; Zoetis	Grotewold, E (corresponding author), Michigan State Univ, Dept Biochem & Mol Biol, E Lansing, MI 48824 USA.	grotewol@msu.edu		Herrera-Tequia, Andres/0000-0002-3503-5516; Grotewold, Erich/0000-0002-4720-7290	National Science Foundation [MCB-1513807, MCB-1822343]	National Science Foundation(National Science Foundation (NSF))	We acknowledge the assistance of Dr Lim Heo in the Feig laboratory for assistance with modeling and advice. We thank members of the Grotewold laboratory, Kaillathe (Pappan) Padmanabhan, and Herve Begue for assistance and helpful discussions. This research was supported by National Science Foundation grants MCB-1513807 and MCB-1822343.		0	4	4	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100708	10.1016/j.jbc.2021.100708	http://dx.doi.org/10.1016/j.jbc.2021.100708			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33901489	gold, Green Published			2022-12-28	WOS:000672866400679
J	Otzen, DE				Otzen, Daniel E.			Driving forces in amyloidosis: How does a light chain make a heavy heart?	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Light-chain amyloidosis (AL) is a fatal disorder wherein the immunoglobulin light chain misfolds and aggregates, leading to amyloid plaques in various organs. Patient-specific mutations in the light chain variable domain (V-L) are tightly linked to amyloidosis, but how these mutations drive AL is unknown. In recent work, Rottenaicher et al. analyze fivemutations found in the V-L of a patient with cardiac AL. Their data suggest that decreased V-L stability and increased flexibility in the core of the V-L, causedby mutations outside of this core, could be key to aggregation and highlight the delicate balancing act required for antibody maturation to enable antigen recognition while not altering protein biophysics.	[Otzen, Daniel E.] Aarhus Univ, iNANO, Aarhus C, Denmark	Aarhus University	Otzen, DE (corresponding author), Aarhus Univ, iNANO, Aarhus C, Denmark.	dao@inano.au.dk		Otzen, Daniel/0000-0002-2918-8989				Annamalai K, 2017, ANGEW CHEM INT EDIT, V56, P7510, DOI 10.1002/anie.201701761; Gertz MA, 2018, AM J HEMATOL, V93, P1169, DOI 10.1002/ajh.25149; Lecoq L, 2019, CHEMBIOCHEM, V20, P1027, DOI 10.1002/cbic.201800732; Merlini G, 2017, HEMATOL-AM SOC HEMAT, P1, DOI 10.1182/asheducation-2017.1.1; Morgan GJ, 2016, J MOL BIOL, V428, P4280, DOI 10.1016/j.jmb.2016.08.021; Pradhan T, 2020, J BIOL CHEM, V295, P18474, DOI 10.1074/jbc.RA120.016006; Radamaker L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09032-0; Rottenaicher GJ, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100334	8	1	1	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100785	10.1016/j.jbc.2021.100785	http://dx.doi.org/10.1016/j.jbc.2021.100785			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019874	Green Published, gold			2022-12-28	WOS:000674717300007
J	Ren, JP; Wu, Y; Wang, Y; Zhao, YQ; Li, YH; Hao, SL; Lin, LX; Zhang, SY; Xu, XZ; Wang, HL				Ren, Jianping; Wu, Yan; Wang, Ya; Zhao, Yuqin; Li, Youhang; Hao, Shuailin; Lin, Lixiu; Zhang, Shuyuan; Xu, Xingzhi; Wang, Hailong			CtIP suppresses primary microRNA maturation and promotes metastasis of colon cancer cells in a xenograft mouse model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNAS	miRNAs are important regulators of eukaryotic gene expression. The post-transcriptional maturation of miRNAs is controlled by the Drosha-DiGeorge syndrome critical region gene 8 (DGCR8) microprocessor. Dysregulation of miRNA biogenesis has been implicated in the pathogenesis of human diseases, including cancers. C-terminal-binding protein-interacting protein (CtIP) is a well-known DNA repair factor that promotes the processing of DNA double-strand break (DSB) to initiate homologous recombination-mediated DSB repair. However, it was unclear whether CtIP has other unknown cellular functions. Here, we aimed to uncover the roles of CtIP in miRNA maturation and cancer cell metastasis. We found that CtIP is a potential regulatory factor that suppresses the processing of miRNA primary transcripts (pri-miRNA). CtIP directly bound to both DGCR8 and pri-miRNAs through a conserved Sae2-like domain, reduced the binding of Drosha to DGCR8 and pri-miRNA substrate, and inhibited processing activity of Drosha complex. CtIP depletion significantly increased the expression levels of a subset of mature miRNAs, including miR-302 family members that are associated with tumor progression and metastasis in several cancer types. We also found that CtIP-inhibited miRNAs, such as miR-302 family members, are not crucial for DSB repair. However, increase of miR-302b levels or loss of CtIP function severely suppressed human colon cancer cell line tumor cell metastasis in a mouse xenograft model. These studies reveal a previously unrecognized mechanism of CtIP in miRNA processing and tumor metastasis that represents a new function of CtIP in cancer.	[Ren, Jianping; Wu, Yan; Wang, Ya; Zhao, Yuqin; Li, Youhang; Hao, Shuailin; Lin, Lixiu; Zhang, Shuyuan; Wang, Hailong] Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing, Peoples R China; [Ren, Jianping; Wu, Yan; Wang, Ya; Zhao, Yuqin; Li, Youhang; Hao, Shuailin; Lin, Lixiu; Zhang, Shuyuan; Wang, Hailong] Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China; [Xu, Xingzhi] China Shenzhen Univ, Sch Med, Guangdong Key Lab Genome Stabil & Dis Prevent, Shenzhen, Guangdong, Peoples R China; [Xu, Xingzhi] China Shenzhen Univ, Sch Med, Carson Int Canc Ctr, Marshall Lab Biomed Engn, Shenzhen, Guangdong, Peoples R China	Capital Normal University; Capital Normal University	Wang, HL (corresponding author), Capital Normal Univ, Beijing Key Lab DNA Damage Response, Beijing, Peoples R China.; Wang, HL (corresponding author), Capital Normal Univ, Coll Life Sci, Beijing, Peoples R China.	Hailwang@cnu.edu.cn		jianping, ren/0000-0002-5239-7367	National Natural Science Foundation of China [31761133012, 31530016]; Beijing Natural Science Foundation [5182003]; National Basic Research Program of China [2017YFA0503900]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (grant numbers: 31971221 and 31370841) and the Beijing Natural Science Foundation (grant number: 5182003) awarded to H. W. and the National Natural Science Foundation of China (grant numbers: 31761133012 and 31530016) and the National Basic Research Program of China (grant number: 2017YFA0503900) to X. X.	Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; Kim VN, 2009, NAT REV MOL CELL BIO, V10, P126, DOI 10.1038/nrm2632; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385	7	4	4	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100707	10.1016/j.jbc.2021.100707	http://dx.doi.org/10.1016/j.jbc.2021.100707			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33901493	gold, Green Published			2022-12-28	WOS:000672866400678
J	Rollen, K; Granzin, J; Remeeva, A; Davari, MD; Gensch, T; Nazarenko, VV; Kovalev, K; Bogorodskiy, A; Borshchevskiy, V; Hemmer, S; Schwaneberg, U; Gordeliy, V; Jaeger, KE; Batra-Safferling, R; Gushchin, I; Krauss, U				Roellen, Katrin; Granzin, Joachim; Remeeva, Alina; Davari, Mehdi D.; Gensch, Thomas; Nazarenko, Vera V.; Kovalev, Kirill; Bogorodskiy, Andrey; Borshchevskiy, Valentin; Hemmer, Stefanie; Schwaneberg, Ulrich; Gordeliy, Valentin; Jaeger, Karl-Erich; Batra-Safferling, Renu; Gushchin, Ivan; Krauss, Ulrich			The molecular basis of spectral tuning in blue- and red-shifted flavin-binding fluorescent proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REPORTER PROTEINS; ILOV; PHOTOPHYSICS; SIMULATION; GENERATION; LIBRARIES; TOOLS; MODEL; FBFP	Photoactive biological systems modify the optical properties of their chromophores, known as spectral tuning. Determining the molecular origin of spectral tuning is instrumental for understanding the function and developing applications of these biomolecules. Spectral tuning in flavin-binding fluorescent proteins (FbFPs), an emerging class of fluorescent reporters, is limited by their dependency on protein-bound flavins, whose structure and hence electronic properties cannot be altered by mutation. A blue-shifted variant of the plant-derived improved light, oxygen, voltage FbFP has been created by introducing a lysine within the flavin-binding pocket, but the molecular basis of this shift remains unconfirmed. We here structurally characterize the blue-shifted improved light, oxygen, voltage variant and construct a new blue-shifted CagFbFP protein by introducing an analogous mutation. X-ray structures of both proteins reveal displacement of the lysine away from the chromophore and opening up of the structure as instrumental for the blue shift. Site saturation mutagenesis and high-throughput screening yielded a red-shifted variant, and structural analysis revealed that the lysine side chain of the blue-shifted variant is stabilized close to the flavin by a secondary mutation, accounting for the red shift. Thus, a single additional mutation in a blue-shifted variant is sufficient to generate a red-shifted FbFP. Using spectroscopy, X-ray crystallography, and quantum mechanics molecular mechanics calculations, we provide a firm structural and functional understanding of spectral tuning in FbFPs. We also show that the identified blue- and red-shifted variants allow for two-color microscopy based on spectral separation. In summary, the generated blue- and red-shifted variants represent promising new tools for application in life sciences.	[Roellen, Katrin; Hemmer, Stefanie; Jaeger, Karl-Erich; Krauss, Ulrich] Heinrich Heine Univ Dusseldorf, Inst Mol Enzymtechnol, Dusseldorf, Germany; [Granzin, Joachim; Kovalev, Kirill; Borshchevskiy, Valentin; Gordeliy, Valentin; Batra-Safferling, Renu] Forschungszentrum Julich, IBI 7 Struct Biochem, Julich, Germany; [Granzin, Joachim; Kovalev, Kirill; Borshchevskiy, Valentin; Gordeliy, Valentin; Batra-Safferling, Renu] Forschungszentrum Julich, JuStruct Julich Ctr Struct Biol, Julich, Germany; [Remeeva, Alina; Nazarenko, Vera V.; Kovalev, Kirill; Bogorodskiy, Andrey; Borshchevskiy, Valentin; Gordeliy, Valentin; Gushchin, Ivan] Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia; [Davari, Mehdi D.; Schwaneberg, Ulrich] Rhein Westfal TH Aachen, Inst Biotechnol, Aachen, Germany; [Gensch, Thomas] Forschungszentrum Julich, IBI 1 Mol & Cellular Physiol, Julich, Germany; [Kovalev, Kirill; Gordeliy, Valentin] Univ Grenoble Alpes, CNRS, Commissariat Energie Atom & Energies Alternat, Inst Biol Struct Jean Pierre Ebel, Grenoble, France; [Kovalev, Kirill] Rhein Westfal TH Aachen, Inst Crystallog, Aachen, Germany; [Hemmer, Stefanie; Jaeger, Karl-Erich; Krauss, Ulrich] Forschungszentrum Julich, IBG 1 Biotechnol, Julich, Germany; [Schwaneberg, Ulrich] DWI Leibniz Inst Interact Mat, Aachen, Germany	Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Helmholtz Association; Research Center Julich; Moscow Institute of Physics & Technology; RWTH Aachen University; Helmholtz Association; Research Center Julich; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); RWTH Aachen University; Helmholtz Association; Research Center Julich; DWI Leibniz Institute for Interactive Materials	Krauss, U (corresponding author), Heinrich Heine Univ Dusseldorf, Inst Mol Enzymtechnol, Dusseldorf, Germany.; Gushchin, I (corresponding author), Moscow Inst Phys & Technol, Res Ctr Mol Mech Aging & Age Related Dis, Dolgoprudnyi, Russia.; Krauss, U (corresponding author), Forschungszentrum Julich, IBG 1 Biotechnol, Julich, Germany.	ivan.gushchin@phystech.edu; u.krauss@fz-juelich.de	Bogorodskiy, Andrey/R-7690-2016; Remeeva, Alina/F-2772-2018; Borshchevskiy, Valentin I./F-2287-2014; Batra-Safferling, Renu/G-2918-2013; Schwaneberg, Ulrich/E-7234-2014; Nazarenko, Vera/F-5649-2017	Bogorodskiy, Andrey/0000-0002-7589-7823; Borshchevskiy, Valentin I./0000-0003-4398-9712; Batra-Safferling, Renu/0000-0002-8597-4335; Schwaneberg, Ulrich/0000-0003-4026-701X; Kovalev, Kirill/0000-0002-2229-181X; Remeeva, Alina/0000-0003-3977-3679; Hemmer, Stefanie/0000-0001-6539-0562; Nazarenko, Vera/0000-0001-8966-9146; Gensch, Thomas/0000-0002-3903-4705	Deutsche Forschungsgemeinschaft (DFG) Training Group 1166 "BioNoCo" (Biocatalysis in Non-conventional Media); Julich Aachen Research Alliance for High Performance Computing (JARA-HPC) from RWTH Aachen University [JARA0065]	Deutsche Forschungsgemeinschaft (DFG) Training Group 1166 "BioNoCo" (Biocatalysis in Non-conventional Media)(German Research Foundation (DFG)); Julich Aachen Research Alliance for High Performance Computing (JARA-HPC) from RWTH Aachen University	M. D. D. thanks Deutsche Forschungsgemeinschaft (DFG) Training Group 1166 "BioNoCo" (Biocatalysis in Non-conventional Media) for the financial support and computing resources granted by the Julich Aachen Research Alliance for High Performance Computing (JARA-HPC) from RWTH Aachen University under project JARA0065.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ahlrichs R., 1989, TURBOMOLE V6 2 2010; Autour A, 2017, MICROMACHINES-BASEL, V8, DOI 10.3390/mi8040128; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; Becker W, 2005, ADV TIME CORRELATED; Bourenkov GP, 2010, ACTA CRYSTALLOGR D, V66, P409, DOI 10.1107/S0907444909054961; Bunzel HA, 2018, CURR OPIN STRUC BIOL, V48, P149, DOI 10.1016/j.sbi.2017.12.010; Case D., 2015, AMBER, V14; Chapman S, 2008, P NATL ACAD SCI USA, V105, P20038, DOI 10.1073/pnas.0807551105; Choi CH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018499; Christie JM, 2012, J BIOL CHEM, V287, P22295, DOI 10.1074/jbc.M111.318881; Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4; Copp JN, 2014, METHODS MOL BIOL, V1179, P3, DOI 10.1007/978-1-4939-1053-3_1; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Davari MD, 2016, J PHYS CHEM B, V120, P3344, DOI 10.1021/acs.jpcb.6b01512; de Sanctis D, 2012, J SYNCHROTRON RADIAT, V19, P455, DOI 10.1107/S0909049512009715; de Vries AH, 1999, J PHYS CHEM B, V103, P6133, DOI 10.1021/jp9913012; Dennig A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026222; Drepper T, 2007, NAT BIOTECHNOL, V25, P443, DOI 10.1038/nbt1293; Drepper T, 2010, APPL ENVIRON MICROB, V76, P5990, DOI 10.1128/AEM.00701-10; Drummond DA, 2005, J MOL BIOL, V350, P806, DOI 10.1016/j.jmb.2005.05.023; Edelheit O, 2009, BMC BIOTECHNOL, V9, DOI 10.1186/1472-6750-9-61; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Endres S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33291-4; Ferrer FJA, 2013, J CHEM THEORY COMPUT, V9, P2072, DOI 10.1021/ct301107m; Geiger A, 2012, BIOPHYS J, V102, P2401, DOI 10.1016/j.bpj.2012.03.065; Hilgers F, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184608; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kastner J, 2009, J PHYS CHEM A, V113, P11856, DOI 10.1021/jp9028968; Khrenova MG, 2017, J PHYS CHEM B, V121, P10018, DOI 10.1021/acs.jpcb.7b07533; Khrenova MG, 2015, J PHYS CHEM B, V119, P5176, DOI 10.1021/acs.jpcb.5b01299; Klaumunzer B, 2010, J PHYS CHEM B, V114, P10826, DOI 10.1021/jp100642c; Kopka B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13420-1; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Li DY, 2020, METHOD ENZYMOL, V643, P225, DOI 10.1016/bs.mie.2020.04.055; Lin JY, 2013, NEURON, V79, P241, DOI 10.1016/j.neuron.2013.05.022; Lobo LA, 2011, FEMS MICROBIOL LETT, V317, P67, DOI 10.1111/j.1574-6968.2011.02212.x; Losi A, 2018, CHEM REV, V118, P10659, DOI 10.1021/acs.chemrev.8b00163; Mathes T, 2009, J MOL BIOL, V385, P1511, DOI 10.1016/j.jmb.2008.11.001; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nazarenko VV, 2019, PHOTOCH PHOTOBIO SCI, V18, P1793, DOI 10.1039/c9pp00067d; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Potzkei J, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-28; Ravikumar Y, 2017, ANAL BIOCHEM, V525, P38, DOI 10.1016/j.ab.2017.02.012; Remeeva A, 2021, PROTEINS, V89, P1005, DOI 10.1002/prot.26078; Rupprecht C, 2017, J BIOTECHNOL, V258, P25, DOI 10.1016/j.jbiotec.2017.05.006; Shaner NC, 2007, J CELL SCI, V120, P4247, DOI 10.1242/jcs.005801; Shcherbakova DM, 2015, ANNU REV BIOCHEM, V84, P519, DOI 10.1146/annurev-biochem-060614-034411; Shin H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097817; Shu XK, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001041; Smith W, 2006, MOL SIMULAT, V32, P935, DOI 10.1080/08927020600939830; STEPHENSON RC, 1989, J BIOL CHEM, V264, P6164; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Tickle I.J., 2018, STARANISO; TYLERCROSS R, 1991, J BIOL CHEM, V266, P22549; VOSKO SH, 1980, CAN J PHYS, V58, P1200, DOI 10.1139/p80-159; Walter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043921; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Wingen M, 2014, PHOTOCH PHOTOBIO SCI, V13, P875, DOI 10.1039/c3pp50414j; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhang LC, 2013, RES MICROBIOL, V164, P710, DOI 10.1016/j.resmic.2013.05.004	64	5	5	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100662	10.1016/j.jbc.2021.100662	http://dx.doi.org/10.1016/j.jbc.2021.100662			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862085	Green Published, gold			2022-12-28	WOS:000672866400633
J	Anzmann, AF; Sniezek, OL; Pado, A; Busa, V; Vaz, FM; Kreimer, SD; DeVine, LR; Cole, RN; Le, A; Kirsch, BJ; Claypool, SM; Vernon, HJ				Anzmann, Arianna F.; Sniezek, Olivia L.; Pado, Alexandra; Busa, Veronica; Vaz, Frederic M.; Kreimer, Simion D.; DeVine, Lauren R.; Cole, Robert N.; Le, Anne; Kirsch, Brian J.; Claypool, Steven M.; Vernon, Hilary J.			Diverse mitochondrial abnormalities in a new cellular model of TAFFAZZIN deficiency are remediated by cardiolipin-interacting small molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHOMBOID PROTEASE PARL; BARTH-SYNDROME; RESPIRATORY-CHAIN; COMPLEX-I; MASS-SPECTROMETRY; DYSFUNCTION; MUTATIONS; MITOPHAGY; APOPTOSIS; AUTOPHAGY	Barth syndrome (BTHS) is an X-linked disorder of mito-chondrial phospholipid metabolism caused by pathogenic variants in TAFFAZIN, which results in abnormal cardiolipin (CL) content in the inner mitochondrial membrane. To identify unappreciated pathways of mitochondrial dysfunction in BTHS, we utilized an unbiased proteomics strategy and iden-tified that complex I (CI) of the mitochondrial respiratory chain and the mitochondrial quality control protease presenilin-associated rhomboid-like protein (PARL) are altered in a new HEK293-based tafazzin-deficiency model. Follow-up studies confirmed decreased steady state levels of specific CI subunits and an assembly factor in the absence of tafazzin; this decrease is in part based on decreased transcription and results in reduced CI assembly and function. PARL, a rhomboid pro-tease associated with the inner mitochondrial membrane with a role in the mitochondrial response to stress, such as mito-chondrial membrane depolarization, is increased in tafazzin-deficient cells. The increased abundance of PARL correlates with augmented processing of a downstream target, phospho-glycerate mutase 5, at baseline and in response to mitochon-drial depolarization. To clarify the relationship between abnormal CL content, CI levels, and increased PARL expres-sion that occurs when tafazzin is missing, we used blue-native PAGE and gene expression analysis to determine that these defects are remediated by SS-31 and bromoenol lactone, pharmacologic agents that bind CL or inhibit CL deacylation, respectively. These findings have the potential to enhance our understanding of the cardiac pathology of BTHS, where defective mitochondrial quality control and CI dysfunction have well-recognized roles in the pathology of diverse forms of cardiac dysfunction.	[Anzmann, Arianna F.; Sniezek, Olivia L.; Pado, Alexandra; Busa, Veronica; Vernon, Hilary J.] Johns Hopkins Univ, Sch Med, Dept Genet Med, Baltimore, MD 21218 USA; [Vaz, Frederic M.] Acad Med Ctr, Dept Clin Chem & Pediat, Amsterdam, Netherlands; [Kreimer, Simion D.; DeVine, Lauren R.; Cole, Robert N.] Johns Hopkins Univ, Sch Med, Dept Biol Chem, Mass Spectrometry & Prote Facil, Baltimore, MD 21205 USA; [Le, Anne; Kirsch, Brian J.] Johns Hopkins Univ, Sch Med, Dept Pathol & Oncol, Baltimore, MD USA; [Claypool, Steven M.] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA	Johns Hopkins University; University of Amsterdam; Academic Medical Center Amsterdam; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Vernon, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Dept Genet Med, Baltimore, MD 21218 USA.	hvernon1@jhmi.edu		Anzmann, Arianna/0000-0002-7368-6918; Le, Anne/0000-0002-2958-8149; Pado, Alexandra/0000-0003-2018-0662; Kirsch, Brian/0000-0001-9984-4438; Sniezek, Olivia/0000-0002-6435-2852	Johns Hopkins University School of Medicine Core Coins Program; National Heart, Lung, and Blood Institute of the National Institutes of Health [F31HL147454]	Johns Hopkins University School of Medicine Core Coins Program; National Heart, Lung, and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Proteomics analysis was supported by the Johns Hopkins University School of Medicine Core Coins Program to H. J. V. Research reported in this publication was supported by the National Heart, Lung, and Blood Institute of the National Institutes of Health under Award Number F31HL147454 to A. F. A. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anzmann AF, 2019, HANDBOOK OF MITOCHONDRIAL DYSFUNCTION, P61; BARTH PG, 1983, J NEUROL SCI, V62, P327, DOI 10.1016/0022-510X(83)90209-5; Birk AV, 2014, BRIT J PHARMACOL, V171, P2017, DOI 10.1111/bph.12468; Chatzispyrou IA, 2018, BBA-MOL BASIS DIS, V1864, P3650, DOI 10.1016/j.bbadis.2018.08.041; Chavez JD, 2020, P NATL ACAD SCI USA, V117, P15363, DOI 10.1073/pnas.2002250117; Chicco AJ, 2007, AM J PHYSIOL-CELL PH, V292, pC33, DOI 10.1152/ajpcell.00243.2006; Clarke SLN, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-23; Claypool SM, 2008, J CELL BIOL, V182, P937, DOI 10.1083/jcb.200801152; Claypool SM, 2012, TRENDS BIOCHEM SCI, V37, P32, DOI 10.1016/j.tibs.2011.09.003; Claypool SM, 2009, BBA-BIOMEMBRANES, V1788, P2059, DOI 10.1016/j.bbamem.2009.04.020; Cole LK, 2016, DIABETES, V65, P3289, DOI 10.2337/db16-0114; Dorn GW, 2015, EMBO MOL MED, V7, P865, DOI 10.15252/emmm.201404575; Elgogary A, 2016, P NATL ACAD SCI USA, V113, pE5328, DOI 10.1073/pnas.1611406113; Fassone E, 2011, J MED GENET, V48, P691, DOI 10.1136/jmedgenet-2011-100340; Ferreira C., 1993, GENEREVIEWS R; Galluzzi L, 2016, IMMUNITY, V44, P221, DOI 10.1016/j.immuni.2016.01.020; Gonzalez IL, 2005, AM J MED GENET A, V134A, P409, DOI 10.1002/ajmg.a.30661; Gonzalvez F, 2013, BBA-MOL BASIS DIS, V1832, P1194, DOI 10.1016/j.bbadis.2013.03.005; Guerrero-Castillo S, 2017, CELL METAB, V25, P128, DOI 10.1016/j.cmet.2016.09.002; Herbrich SM, 2013, J PROTEOME RES, V12, P594, DOI 10.1021/pr300624g; Houtkooper RH, 2009, ANAL BIOCHEM, V387, P230, DOI 10.1016/j.ab.2009.01.032; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Kulik W, 2008, CLIN CHEM, V54, P371, DOI 10.1373/clinchem.2007.095711; Lavandero S, 2015, J CLIN INVEST, V125, P55, DOI 10.1172/JCI73943; Lee E, 2014, AUTOPHAGY, V10, P572, DOI 10.4161/auto.27649; Lesnefsky EJ, 2016, CIRC RES, V118, P1593, DOI 10.1161/CIRCRESAHA.116.307505; Lu YW, 2016, HUM MOL GENET, V25, P1754, DOI 10.1093/hmg/ddw046; Lu YW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00003; Lysyk L, 2020, J MOL BIOL, V432, P5052, DOI 10.1016/j.jmb.2020.04.006; Ma KL, 2020, CELL DEATH DIFFER, V27, P1036, DOI 10.1038/s41418-019-0396-4; Malhotra A, 2009, P NATL ACAD SCI USA, V106, P2337, DOI 10.1073/pnas.0811224106; McKenzie M, 2006, J MOL BIOL, V361, P462, DOI 10.1016/j.jmb.2006.06.057; Miliara X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09089-x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Potting C, 2013, CELL METAB, V18, P287, DOI 10.1016/j.cmet.2013.07.008; R Core Team, 2015, R LANGUAGE ENV STAT; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Roberts AE, 2012, AM J MED GENET A, V158A, P2726, DOI 10.1002/ajmg.a.35609; Saric A, 2016, FRONT GENET, V6, DOI 10.3389/fgene.2015.00359; Scheubel RJ, 2002, J AM COLL CARDIOL, V40, P2174, DOI 10.1016/S0735-1097(02)02600-1; Sekine S, 2012, J BIOL CHEM, V287, P34635, DOI 10.1074/jbc.M112.357509; Shi G, 2017, CELL REP, V18, P1458, DOI 10.1016/j.celrep.2017.01.029; Shires SE, 2018, CIRC RES, V122, P649, DOI 10.1161/CIRCRESAHA.118.312655; Spinazzi M, 2016, SEMIN CELL DEV BIOL, V60, P19, DOI 10.1016/j.semcdb.2016.07.034; Stiburek L, 2007, J MOL BIOL, V374, P506, DOI 10.1016/j.jmb.2007.09.044; Szeto HH, 2014, BRIT J PHARMACOL, V171, P2029, DOI 10.1111/bph.12461; Tang JX, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113820; Thompson WR, 2016, GENET MED, V18, P1001, DOI 10.1038/gim.2015.204; Nguyen T, 2019, CELL REP, V27, P491, DOI 10.1016/j.celrep.2019.03.036; Vogel RO, 2005, FEBS J, V272, P5317, DOI 10.1111/j.1742-4658.2005.04928.x; Wai T, 2016, EMBO REP, V17, P1844, DOI 10.15252/embr.201642698; Wang B, 2018, CIRC RES, V122, P712, DOI 10.1161/CIRCRESAHA.117.312317; Wu WX, 2016, EMBO J, V35, P1368, DOI 10.15252/embj.201593102; Xu Y, 2006, J BIOL CHEM, V281, P39217, DOI 10.1074/jbc.M606100200; Yang C, 2017, IN VITRO CELL DEV-AN, V53, P248, DOI 10.1007/s11626-016-0105-2; Younossi Z, 2018, NAT REV GASTRO HEPAT, V15, P11, DOI 10.1038/nrgastro.2017.109; Zhang M, 2002, J BIOL CHEM, V277, P43553, DOI 10.1074/jbc.C200551200	58	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101005	10.1016/j.jbc.2021.101005	http://dx.doi.org/10.1016/j.jbc.2021.101005			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34314685	Green Published, gold			2022-12-28	WOS:000706418900008
J	Sanderson, MR; Fahlman, RP; Wevrick, R				Sanderson, Matthea R.; Fahlman, Richard P.; Wevrick, Rachel			The N-terminal domain of the Schaaf-Yang syndrome protein MAGEL2 likely has a role in RNA metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PRADER-WILLI-SYNDROME; MESSENGER-RNA; AFFINITY PURIFICATION; TRUNCATING MUTATIONS; BINDING-PROTEINS; SMC5/6 COMPLEX; MOUSE MODEL; GENE; FAMILY; TRANSLATION	MAGEL2 encodes the L2 member of the melanoma associated antigen gene (MAGE) protein family, truncating mutations of which can cause Schaaf-Yang syndrome, an autism spectrum disorder. MAGEL2 is also inactivated in Prader-Willi syndrome, which overlaps clinically and mechanistically with Schaaf-Yang syndrome. Studies to date have only investigated the C-terminal portion of the MAGEL2 protein, containing the MAGE homology domain that interacts with RING-E3 ubiquitin ligases and deubiquitinases to form protein complexes that modify protein ubiquitination. In contrast, the N-terminal portion of the MAGEL2 protein has never been studied. Here, we find that MAGEL2 has a low complexity intrinsically disordered N-terminus rich in Pro-X-n-Gly motifs that is predicted to mediate liquid-liquid phase separation to form biomolecular condensates. We used proximity-dependent biotin identification (BioID) and liquid chromatography-tandem mass spectrometry to identify MAGEL2-proximal proteins, then clustered these proteins into functional networks. We determined that coding mutations analogous to disruptive mutations in other MAGE proteins alter these networks in biologically relevant ways. Proteins identified as proximal to the N-terminal portion of MAGEL2 are primarily involved in mRNA metabolic processes and include three mRNA N 6-methyladenosine (m(6)A)-binding YTHDF proteins and two RNA interference-mediating TNRC6 proteins. We found that YTHDF2 coimmunoprecipitates with MAGEL2, and coexpression of MAGEL2 reduces the nuclear accumulation of YTHDF2 after heat shock. We suggest that the N-terminal region of MAGEL2 may have a role in RNA metabolism and in particular the regulation of mRNAs modified by m(6)A methylation. These results provide mechanistic insight into pathogenic MAGEL2 mutations associated with Schaaf-Yang syndrome and related disorders.	[Sanderson, Matthea R.; Wevrick, Rachel] Univ Alberta, Dept Med Genet, Edmonton, AB, Canada; [Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB, Canada; [Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB, Canada	University of Alberta; University of Alberta; University of Alberta	Wevrick, R (corresponding author), Univ Alberta, Dept Med Genet, Edmonton, AB, Canada.	rwevrick@ualberta.ca		Wevrick, Rachel/0000-0002-3343-5794	Foundation for Prader-Willi Research	Foundation for Prader-Willi Research	We thank Jack Moore and the Alberta Proteomics and Mass Spectrometry Facility, Adam Casey for assistance with MATLB scripts and Jocelyn Bischof for technical assistance. We gratefully acknowledge operating funding from the Foundation for Prader-Willi Research.	Aumais JP, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0002.2001; Baillat D, 2009, MOL CELL BIOL, V29, P4144, DOI 10.1128/MCB.00380-09; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; BANDZIULIS RJ, 1989, GENE DEV, V3, P431, DOI 10.1101/gad.3.4.431; Baraghithy S, 2019, J BONE MINER RES, V34, P93, DOI 10.1002/jbmr.3591; Bayat A, 2018, EUR J MED GENET, V61, P627, DOI 10.1016/j.ejmg.2018.04.007; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Birge RB, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-13; Bischof JM, 2007, HUM MOL GENET, V16, P2713, DOI 10.1093/hmg/ddm225; Boccaccio I, 1999, HUM MOL GENET, V8, P2497, DOI 10.1093/hmg/8.13.2497; Buers I, 2020, CLIN GENET, V97, P209, DOI 10.1111/cge.13639; Bush JR, 2008, DIFFERENTIATION, V76, P994, DOI 10.1111/j.1432-0436.2008.00281.x; Carias KV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230874; Chen H, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.138576; Cho HJ, 2014, EMBO J, V33, P2314, DOI 10.15252/embj.201487807; Chomez P, 2001, CANCER RES, V61, P5544; Couzens AL, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004712; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; Crutcher E, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52287-2; Decker CJ, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012286; Devos Julia, 2011, J Circadian Rhythms, V9, P12, DOI 10.1186/1740-3391-9-12; Doyle JM, 2010, MOL CELL, V39, P963, DOI 10.1016/j.molcel.2010.08.029; Enya T, 2018, AM J MED GENET A, V176, P707, DOI 10.1002/ajmg.a.38606; Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x; Fei QL, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000664; Feng Y, 2011, PROTEIN CELL, V2, P7, DOI 10.1007/s13238-011-1002-9; Gee RRF, 2020, J BIOL CHEM, V295, P16121, DOI 10.1074/jbc.REV120.008029; Fountain MD, 2017, GENES BRAIN BEHAV, V16, P592, DOI 10.1111/gbb.12378; Fountain Michael D, 2016, Diseases, V4, DOI 10.3390/diseases4010002; Fountain MD, 2017, GENET MED, V19, P45, DOI 10.1038/gim.2016.53; Fu Y, 2020, NAT CHEM BIOL, V16, P955, DOI 10.1038/s41589-020-0524-y; Goldstrohm AC, 2018, TRENDS GENET, V34, P972, DOI 10.1016/j.tig.2018.09.006; Goss DJ, 2013, WIRES RNA, V4, P167, DOI 10.1002/wrna.1151; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Guo W, 2019, SCI CHINA LIFE SCI, V62, P886, DOI 10.1007/s11427-019-9541-0; Gupta GD, 2015, CELL, V163, P1484, DOI 10.1016/j.cell.2015.10.065; Gur I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099503; GURUPRASAD K, 1990, PROTEIN ENG, V4, P155, DOI 10.1093/protein/4.2.155; Habelhah H, 2001, NAT CELL BIOL, V3, P325, DOI 10.1038/35060131; Hanson J, 2019, GENOM PROTEOM BIOINF, V17, P645, DOI 10.1016/j.gpb.2019.01.004; Hao H, 2015, MOL CELL, V59, P956, DOI 10.1016/j.molcel.2015.07.033; Hao YH, 2013, CELL, V152, P1051, DOI 10.1016/j.cell.2013.01.051; Haque N, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03326-5; Haspula D, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00558; He PC, 2021, EMBO J, V40, DOI 10.15252/embj.2020105977; Huang CY, 2020, CELL DEATH DIFFER, V27, P227, DOI 10.1038/s41418-019-0350-5; Huntzinger E, 2010, EMBO J, V29, P4146, DOI 10.1038/emboj.2010.274; Jobling R, 2018, J MED GENET, V55, P316, DOI 10.1136/jmedgenet-2017-105222; Kamaludin AA, 2016, HUM MOL GENET, V25, P3798, DOI 10.1093/hmg/ddw225; Karas M, 2001, ENDOCRINOLOGY, V142, P1835, DOI 10.1210/en.142.5.1835; Kim DI, 2014, P NATL ACAD SCI USA, V111, pE2453, DOI 10.1073/pnas.1406459111; Kim J, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002510; Kleinendorst L, 2018, AM J MED GENET A, V176, P2456, DOI 10.1002/ajmg.a.40486; Koval AP, 1998, J BIOL CHEM, V273, P14780, DOI 10.1074/jbc.273.24.14780; Kozakova L, 2015, CELL CYCLE, V14, P920, DOI 10.1080/15384101.2014.1000112; Kozlov SV, 2007, NAT GENET, V39, P1266, DOI 10.1038/ng2114; Kuwako K, 2004, J BIOL CHEM, V279, P1703, DOI 10.1074/jbc.M308454200; Laghmani K, 2016, NEW ENGL J MED, V374, P1853, DOI 10.1056/NEJMoa1507629; Lambert JP, 2015, J PROTEOMICS, V118, P81, DOI 10.1016/j.jprot.2014.09.011; Lancaster AK, 2014, BIOINFORMATICS, V30, P2501, DOI 10.1093/bioinformatics/btu310; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lee AK, 2017, J MOL BIOL, V429, P1114, DOI 10.1016/j.jmb.2017.03.005; Lee S, 2000, HUM MOL GENET, V9, P1813, DOI 10.1093/hmg/9.12.1813; Lee S, 2005, HUM MOL GENET, V14, P627, DOI 10.1093/hmg/ddi059; Lee YJ, 2014, FEBS J, V281, P352, DOI 10.1111/febs.12606; Li X, 2015, CANCER GENET-NY, V208, P25, DOI 10.1016/j.cancergen.2014.11.005; Lim J, 2014, CELL, V159, P1365, DOI 10.1016/j.cell.2014.10.055; Lo Giacco D, 2014, J MED GENET, V51, P340, DOI 10.1136/jmedgenet-2013-101988; Luck C, 2016, BEHAV NEUROSCI, V130, P448, DOI 10.1037/bne0000150; Ludwig A, 2016, MEM I OSWALDO CRUZ, V111, P765, DOI 10.1590/0074-02760160224; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Matuszewska KE, 2018, CLIN DYSMORPHOL, V27, P49, DOI 10.1097/MCD.0000000000000212; McCarthy J, 2018, AM J MED GENET A, V176, P2564, DOI 10.1002/ajmg.a.40650; Mejlachowicz D, 2015, AM J HUM GENET, V97, P616, DOI 10.1016/j.ajhg.2015.08.010; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Mercer RE, 2009, AM J MED GENET B, V150B, P1085, DOI 10.1002/ajmg.b.30934; Mercer RE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004291; Merte J, 2010, NAT CELL BIOL, V12, P41, DOI 10.1038/ncb2002; Meziane H, 2015, BIOL PSYCHIAT, V78, P85, DOI 10.1016/j.biopsych.2014.11.010; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Modelska A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.542; O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200; Okutman O, 2017, J ASSIST REPROD GEN, V34, P683, DOI 10.1007/s10815-017-0900-z; Oncul M, 2018, HUM MOL GENET, V27, P3129, DOI 10.1093/hmg/ddy216; Oughtred R, 2021, PROTEIN SCI, V30, P187, DOI 10.1002/pro.3978; Palecek JJ, 2015, STRUCTURE, V23, P2183, DOI 10.1016/j.str.2015.10.004; Patil DP, 2018, TRENDS CELL BIOL, V28, P113, DOI 10.1016/j.tcb.2017.10.001; Piao H, 2017, SCI REP-UK, V7, DOI 10.1038/srep39887; Pineda CT, 2015, AUTOPHAGY, V11, P844, DOI 10.1080/15548627.2015.1034420; Pravdivyi I, 2015, HUM MOL GENET, V24, P4276, DOI 10.1093/hmg/ddv159; Quesnel-Vallieres M, 2019, NAT REV GENET, V20, P51, DOI 10.1038/s41576-018-0066-2; Quiroz FG, 2015, NAT MATER, V14, P1164, DOI [10.1038/nmat4418, 10.1038/NMAT4418]; Ries RJ, 2019, NATURE, V571, P424, DOI 10.1038/s41586-019-1374-1; Roux Kyle J, 2013, Curr Protoc Protein Sci, V74, DOI 10.1002/0471140864.ps1923s74; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sanderson MR, 2020, HUM GENET, V139, P1513, DOI 10.1007/s00439-020-02193-9; Schaaf CP, 2013, NAT GENET, V45, P1405, DOI 10.1038/ng.2776; Schaller F, 2010, HUM MOL GENET, V19, P4895, DOI 10.1093/hmg/ddq424; Shahbazian D, 2010, CELL CYCLE, V9, P4106, DOI 10.4161/cc.9.20.13630; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Soden SE, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010076; Soto-Rifo R, 2013, NUCLEIC ACIDS RES, V41, P6286, DOI 10.1093/nar/gkt306; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Suzuki Keiko, 2010, BMC Res Notes, V3, P294, DOI 10.1186/1756-0500-3-294; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tacer KF, 2017, BIOCHEM J, V474, P2177, DOI 10.1042/BCJ20160616; Tang MK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059477; Tennese AA, 2011, ENDOCRINOLOGY, V152, P967, DOI 10.1210/en.2010-0709; Tong WJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23503-2; Troshin PV, 2018, BIOINFORMATICS, V34, P1939, DOI 10.1093/bioinformatics/bty045; Tsang B, 2020, CELL, V183, P1742, DOI 10.1016/j.cell.2020.11.050; Tsang YH, 2020, ELIFE, V9, DOI 10.7554/eLife.48963; Urreizti R, 2017, SCI REP-UK, V7, DOI 10.1038/srep44138; Valentin-Vega YA, 2016, SCI REP-UK, V6, DOI 10.1038/srep25996; van der Crabben SN, 2016, J CLIN INVEST, V126, P2881, DOI 10.1172/JCI82890; Vernon RM, 2018, ELIFE, V7, DOI 10.7554/eLife.31486; Wang H, 2009, J BIOL CHEM, V284, P32116, DOI 10.1074/jbc.M109.006726; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Weidensdorfer D, 2009, RNA, V15, P104, DOI 10.1261/rna.1175909; Weon JL, 2015, CURR OPIN CELL BIOL, V37, P1, DOI 10.1016/j.ceb.2015.08.002; Wevrick R, 2020, PHYSIOL BEHAV, V219, DOI 10.1016/j.physbeh.2020.112864; Wijesuriya TM, 2017, HUM MOL GENET, V26, P4215, DOI 10.1093/hmg/ddx311; Wood JD, 1998, MOL CELL NEUROSCI, V11, P149, DOI 10.1006/mcne.1998.0677; Wu R, 2019, CELL RES, V29, P23, DOI 10.1038/s41422-018-0113-8; Xiao B, 2019, MOL SYNDROMOL, V10, P286, DOI 10.1159/000501376; Yang JS, 2020, CELL MOL LIFE SCI, V77, P305, DOI 10.1007/s00018-019-03278-z; Ye JQ, 2015, P NATL ACAD SCI USA, V112, pE3020, DOI 10.1073/pnas.1508461112; Youn JY, 2018, MOL CELL, V69, P517, DOI 10.1016/j.molcel.2017.12.020; Zabrady K, 2016, NUCLEIC ACIDS RES, V44, P1064, DOI 10.1093/nar/gkv1021; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zheng CS, 2015, CELL SIGNAL, V27, P2343, DOI 10.1016/j.cellsig.2015.08.018; Zhou HY, 2005, J BIOL CHEM, V280, P13841, DOI 10.1074/jbc.M411065200; Zhou J, 2015, NATURE, V526, P591, DOI 10.1038/nature15377	134	2	2	2	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100959	10.1016/j.jbc.2021.100959	http://dx.doi.org/10.1016/j.jbc.2021.100959			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265304	Green Published, gold			2022-12-28	WOS:000690871400010
J	Trastoy, B; Du, JJ; Li, C; Garcia-Alija, M; Klontz, EH; Roberts, BR; Donahue, TC; Wang, LX; Sundberg, EJ; Guerin, ME				Trastoy, Beatriz; Du, Jonathan J.; Li, Chao; Garcia-Alija, Mikel; Klontz, Erik H.; Roberts, Blaine R.; Donahue, Thomas C.; Wang, Lai-Xi; Sundberg, Eric J.; Guerin, Marcelo E.			GH18 endo-beta-N-acetylglucosaminidases use distinct mechanisms to process hybrid-type N-linked glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTRATE-ASSISTED CATALYSIS; TRANSGLYCOSYLATION ACTIVITY; PLANT POLYSACCHARIDES; GLYCOSYLATION; SPECIFICITY; BACTEROIDES; FERMENTATION; ANTIBODIES; INSIGHTS; STARCH	N-glycosylation is one of the most abundant post-translational modifications of proteins, essential for many physiological processes, including protein folding, protein stability, oligomerization and aggregation, and molecular recognition events. Defects in the N-glycosylation pathway cause diseases that are classified as congenital disorders of glycosylation. The ability to manipulate protein N-glycosylation is critical not only to our fundamental understanding of biology but also for the development of new drugs for a wide range of human diseases. Chemoenzymatic synthesis using engineered endo-beta-N-acetylglucosaminidases (ENGases) has been used extensively to modulate the chemistry of N-glycosylated proteins. However, defining the molecular mechanisms by which ENGases specifically recognize and process N-glycans remains a major challenge. Here we present the X-ray crystal structure of the ENGase EndoBT-3987 from Bacteroides thetaiotaomicron in complex with a hybrid-type glycan product. In combination with alanine scanning mutagenesis, molecular docking calculations and enzymatic activity measurements conducted on a chemically engineered monoclonal antibody substrate unveil two mechanisms for hybrid-type recognition and processing by paradigmatic ENGases. Altogether, the experimental data provide pivotal insight into the molecular mechanism of substrate recognition and specificity for GH18 ENGases and further advance our understanding of chemoenzymatic synthesis and remodeling of homogeneous N-glycan glycoproteins.	[Trastoy, Beatriz; Garcia-Alija, Mikel; Guerin, Marcelo E.] Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Struct Glycobiol Lab, Basque Res & Technol Alliance BRTA, Bizkaia, Derio, Spain; [Trastoy, Beatriz; Garcia-Alija, Mikel; Guerin, Marcelo E.] IIS Biocruces Bizkaia, Struct Glycobiol Lab, Baracaldo, Bizkaia, Spain; [Du, Jonathan J.; Roberts, Blaine R.; Sundberg, Eric J.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Li, Chao; Donahue, Thomas C.; Wang, Lai-Xi] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA; [Klontz, Erik H.] Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA; [Klontz, Erik H.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Guerin, Marcelo E.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain	CIC bioGUNE; Emory University; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Basque Foundation for Science	Trastoy, B; Guerin, ME (corresponding author), Ctr Cooperat Res Biosci CIC bioGUNE, Struct Biol Unit, Struct Glycobiol Lab, Basque Res & Technol Alliance BRTA, Bizkaia, Derio, Spain.; Trastoy, B; Guerin, ME (corresponding author), IIS Biocruces Bizkaia, Struct Glycobiol Lab, Baracaldo, Bizkaia, Spain.; Sundberg, EJ (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.; Guerin, ME (corresponding author), Basque Fdn Sci, Ikerbasque, Bilbao, Spain.	beatriz.trastoy@gmail.com; eric.sundberg@emory.edu; mrcguerin@gmail.com	Du, Jonathan/AAW-5098-2021; Trastoy, Beatriz/F-3692-2016; Li, Chao/E-5253-2013	Du, Jonathan/0000-0002-7750-4413; Trastoy, Beatriz/0000-0002-2178-732X; Li, Chao/0000-0002-8090-2017	MINECO/FEDER EU [BFU2016-77427-C2-2-R, BFU2017-92223-EXP, PID2019-105649RB-I00]; Severo Ochoa Excellence Accreditation [SEV-2016-0644]; Basque Government [KK-2019/00076]; NIH [R01AI149297, R01GM080374]; European Union Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant [844905]; La Caixa Foundation [100010434, LCF/BQ/DR19/11740011]	MINECO/FEDER EU(Spanish Government); Severo Ochoa Excellence Accreditation; Basque Government(Basque Government); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union Horizon 2020 Research and Innovation Program under the Marie Sklodowska-Curie grant; La Caixa Foundation(La Caixa Foundation)	This work was supported by the MINECO/FEDER EU contracts BFU2016-77427-C2-2-R, BFU2017-92223-EXP, PID2019-105649RB-I00 and Severo Ochoa Excellence Accreditation SEV-2016-0644; the Basque Government contract KK-2019/00076 (to M. E. G.) and NIH R01AI149297 (to E. J. S., M. E. G., L.-X. W.), and R01GM080374 (to L.-X. W.). This project was supported by the European Union Horizon 2020 Research and Innovation Program under the Marie SklodowskaCurie grant agreement No. 844905 (to B. T.) and from La Caixa Foundation (ID 100010434) grant LCF/BQ/DR19/11740011 (to M. G.-A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Arnold JN, 2007, ANNU REV IMMUNOL, V25, P21, DOI 10.1146/annurev.immunol.25.022106.141702; Chacko BK, 2011, J BIOL CHEM, V286, P38738, DOI 10.1074/jbc.M111.247981; Chen L, 2014, ACTA CRYSTALLOGR D, V70, P932, DOI 10.1107/S1399004713033841; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cho KH, 2001, J BACTERIOL, V183, P7224, DOI 10.1128/JB.183.24.7224-7230.2001; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Cuskin F, 2015, NATURE, V517, P165, DOI 10.1038/nature13995; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Davies GJ, 1997, BIOCHEM J, V321, P557, DOI 10.1042/bj3210557; Della JN, 1996, J BACTERIOL, V178, P7180; Du JJ, 2020, GLYCOBIOLOGY, V30, P268, DOI 10.1093/glycob/cwz042; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fadel F, 2015, ACTA CRYSTALLOGR D, V71, P1455, DOI 10.1107/S139900471500783X; Fairbanks AJ, 2017, CHEM SOC REV, V46, P5128, DOI 10.1039/c6cs00897f; Fairbanks AJ, 2013, PURE APPL CHEM, V85, P1847, DOI 10.1351/PAC-CON-12-09-10; Forster SC, 2019, NAT BIOTECHNOL, V37, P186, DOI 10.1038/s41587-018-0009-7; Fujita K, 2001, BIOSCI BIOTECH BIOCH, V65, P1542, DOI 10.1271/bbb.65.1542; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Huang W, 2012, J AM CHEM SOC, V134, P12308, DOI 10.1021/ja3051266; Jefferis R, 2009, NAT REV DRUG DISCOV, V8, P226, DOI 10.1038/nrd2804; Jitonnom J, 2011, BIOCHEMISTRY-US, V50, P4697, DOI 10.1021/bi101362g; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Klontz EH, 2019, ACS CENTRAL SCI, V5, P524, DOI 10.1021/acscentsci.8b00917; Koropatkin NM, 2012, NAT REV MICROBIOL, V10, P323, DOI 10.1038/nrmicro2746; Krapp S, 2003, J MOL BIOL, V325, P979, DOI 10.1016/S0022-2836(02)01250-0; KUMAR R, 1990, P NATL ACAD SCI USA, V87, P9948, DOI 10.1073/pnas.87.24.9948; Lapebie P, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10068-5; Lee KH, 2018, MABS-AUSTIN, V10, P380, DOI 10.1080/19420862.2018.1433976; Li C, 2018, CHEM REV, V118, P8359, DOI 10.1021/acs.chemrev.8b00238; Li TZ, 2016, J BIOL CHEM, V291, P16508, DOI 10.1074/jbc.M116.738765; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Mackenzie LF, 1998, J AM CHEM SOC, V120, P5583, DOI 10.1021/ja980833d; Majewska NI, 2020, ANNU REV CHEM BIOMOL, V11, P311, DOI 10.1146/annurev-chembioeng-102419-010001; Martens EC, 2008, CELL HOST MICROBE, V4, P447, DOI 10.1016/j.chom.2008.09.007; Martens EC, 2009, J BIOL CHEM, V284, P24673, DOI 10.1074/jbc.R109.022848; Mastrangeli R, 2020, TRENDS BIOTECHNOL, V38, P1154, DOI 10.1016/j.tibtech.2020.05.009; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nimmerjahn F, 2008, NAT REV IMMUNOL, V8, P34, DOI 10.1038/nri2206; Noguchi M, 2009, J ORG CHEM, V74, P2210, DOI 10.1021/jo8024708; Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69; Parodi AJ, 2000, BIOCHEM J, V348, P1, DOI 10.1042/0264-6021:3480001; Parry S, 2006, GLYCOBIOLOGY, V16, P623, DOI 10.1093/glycob/cwj110; Peanne R, 2018, EUR J MED GENET, V61, P643, DOI 10.1016/j.ejmg.2017.10.012; Pereira NA, 2018, MABS-AUSTIN, V10, P693, DOI 10.1080/19420862.2018.1466767; Petrescu AJ, 2006, CURR OPIN STRUC BIOL, V16, P600, DOI 10.1016/j.sbi.2006.08.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quast I, 2017, CELL MOL LIFE SCI, V74, P837, DOI 10.1007/s00018-016-2366-z; Reily C, 2019, NAT REV NEPHROL, V15, P346, DOI 10.1038/s41581-019-0129-4; Rymen D, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003989; SALYERS AA, 1977, APPL ENVIRON MICROB, V34, P529, DOI 10.1128/AEM.34.5.529-533.1977; SALYERS AA, 1977, APPL ENVIRON MICROB, V33, P319, DOI 10.1128/AEM.33.2.319-322.1977; Seki H, 2019, J BIOL CHEM, V294, P17143, DOI 10.1074/jbc.RA119.010842; Sjogren J, 2020, GLYCOBIOLOGY, V30, P254, DOI 10.1093/glycob/cwz085; Stanley P, 2017, ESSENTIALS GLYCOBIOL, P99; Tamura K, 2021, CURR OPIN STRUC BIOL, V68, P26, DOI 10.1016/j.sbi.2020.11.001; Trastoy B, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14754-7; Trastoy B, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04300-x; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; van Aalten DMF, 2001, P NATL ACAD SCI USA, V98, P8979, DOI 10.1073/pnas.151103798; Varki A, 2017, GLYCOBIOLOGY, V27, P3, DOI 10.1093/glycob/cww086; Wang LX, 2011, TRENDS GLYCOSCI GLYC, V23, P33, DOI 10.4052/tigg.23.33; White A, 1997, CURR OPIN STRUC BIOL, V7, P645, DOI 10.1016/S0959-440X(97)80073-5; Williams SJ, 2002, J BIOL CHEM, V277, P40055, DOI 10.1074/jbc.M206481200; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Yu H, 2006, ANGEW CHEM INT EDIT, V45, P3938, DOI 10.1002/anie.200600572; Zhang XY, 2016, J MOL BIOL, V428, P3183, DOI 10.1016/j.jmb.2016.02.030	68	1	1	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							101011	10.1016/j.jbc.2021.101011	http://dx.doi.org/10.1016/j.jbc.2021.101011			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34324829	Green Published, gold			2022-12-28	WOS:000690868100014
J	Kim, SH; Wu, CG; Jia, WY; Xing, YN; Tibbetts, RS				Kim, Sang Hwa; Wu, Cheng-Guo; Jia, Weiyan; Xing, Yongna; Tibbetts, Randal S.			Roles of constitutive and signal-dependent protein phosphatase 2A docking motifs in burst attenuation of the cyclic AMP response element-binding protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVITY; CREB PHOSPHORYLATION; CAMP; KINASE; CBP; COACTIVATION; RECOGNITION; ACTIVATION; MECHANISM; COMPLEX	The cAMP response element-binding protein (CREB) is an important regulator of cell growth, metabolism, and synaptic plasticity. CREB is activated through phosphorylation of an evolutionarily conserved Ser residue (S133) within its intrinsically disordered kinase-inducible domain (KID). Phosphorylation of S133 in response to cAMP, Ca2+, and other stimuli triggers an association of the KID with the KID-interacting (KIX) domain of the CREB-binding protein (CBP), a histone acetyl transferase (HAT) that promotes transcriptional activation. Here we addressed the mechanisms of CREB attenuation following bursts in CREB phosphorylation. We show that phosphorylation of S133 is reversed by protein phosphatase 2A (PP2A), which is recruited to CREB through its B56 regulatory subunits. We found that a B56-binding site located at the carboxyl-terminal boundary of the KID (BS2) mediates highaffinity B56 binding, while a second binding site (BS1) located near the amino terminus of the KID mediates low affinity binding enhanced by phosphorylation of adjacent casein kinase (CK) phosphosites. Mutations that diminished B56 binding to BS2 elevated both basal and stimulus-induced phosphorylation of S133, increased CBP interaction with CREB, and potentiated the expression of CREB-dependent reporter genes. Cells from mice harboring a homozygous CrebE153D mutation that disrupts BS2 exhibited increased S133 phosphorylation stoichiometry and elevated transcriptional bursts to cAMP. These findings provide insights into substrate targeting by PP2A holoenzymes and establish a new mechanism of CREB attenuation that has implications for understanding CREB signaling in cell growth, metabolism, synaptic plasticity, and other physiologic contexts.	[Kim, Sang Hwa; Jia, Weiyan; Tibbetts, Randal S.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53726 USA; [Wu, Cheng-Guo; Xing, Yongna] Univ Wisconsin, Sch Med & Publ Hlth, Dept Oncol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Human Oncol, Madison, WI 53726 USA.	rstibbetts@wisc.edu	Jia, Weiyan/AFQ-4316-2022; JIA, WEIYAN/ABG-6750-2021	JIA, WEIYAN/0000-0003-0899-0697	National Cancer Institute [CA180765-01]; National Institute for Neurological Disorders and Stroke [NS118792-01]; National Institute for General Medicine [R01 GM096060-01]; Jordan's Guardian Angels Foundation [A19-33765007]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute for Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute for General Medicine; Jordan's Guardian Angels Foundation	This work was supported by the National Cancer Institute [CA180765-01 to R. S. T.], National Institute for Neurological Disorders and Stroke [NS118792-01 to R. S. T.], National Institute for General Medicine [R01 GM096060-01 to Y. X.], and Jordan's Guardian Angels Foundation [A19-33765007 to Y. X.].	Altarejos JY, 2011, NAT REV MOL CELL BIO, V12, P141, DOI 10.1038/nrm3072; Arthur JSC, 2000, FEBS LETT, V482, P44, DOI 10.1016/S0014-5793(00)02031-7; Bittinger MA, 2004, CURR BIOL, V14, P2156, DOI 10.1016/j.cub.2004.11.002; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Conkright MD, 2003, MOL CELL, V12, P413, DOI 10.1016/j.molcel.2003.08.013; Cundell MJ, 2016, J CELL BIOL, V214, P539, DOI 10.1083/jcb.201606033; Druker BJ, 1996, NAT MED, V2, P561, DOI 10.1038/nm0596-561; Du KY, 2000, MOL CELL BIOL, V20, P4320, DOI 10.1128/MCB.20.12.4320-4327.2000; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Grimes CA, 2001, J NEUROCHEM, V78, P1219, DOI 10.1046/j.1471-4159.2001.00495.x; Hertz EPT, 2016, MOL CELL, V63, P686, DOI 10.1016/j.molcel.2016.06.024; Iourgenko V, 2003, P NATL ACAD SCI USA, V100, P12147, DOI 10.1073/pnas.1932773100; Kandel ER, 2012, MOL BRAIN, V5, DOI 10.1186/1756-6606-5-14; Kim SH, 2016, NUCLEIC ACIDS RES, V44, P9667, DOI 10.1093/nar/gkw643; Luo Q, 2012, P NATL ACAD SCI USA, V109, P20865, DOI 10.1073/pnas.1219028109; MATTHEWS RP, 1994, MOL CELL BIOL, V14, P6107, DOI 10.1128/MCB.14.9.6107; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Naqvi S, 2014, BIOCHEM J, V458, P469, DOI 10.1042/BJ20131115; Parker D, 1998, MOL CELL, V2, P353, DOI 10.1016/S1097-2765(00)80279-8; Radhakrishnan I, 1997, CELL, V91, P741, DOI 10.1016/S0092-8674(00)80463-8; Ravnskjaer K, 2007, EMBO J, V26, P2880, DOI 10.1038/sj.emboj.7601715; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shanware NP, 2007, J BIOL CHEM, V282, P6283, DOI 10.1074/jbc.M610674200; Shanware NP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012173; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shi YL, 2004, P NATL ACAD SCI USA, V101, P5898, DOI 10.1073/pnas.0307718101; Shnitkind S, 2018, BIOCHEMISTRY-US, V57, P6964, DOI 10.1021/acs.biochem.8b01092; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Wang J, 2016, PROTEIN CELL, V7, P516, DOI 10.1007/s13238-016-0283-4; Wang J, 2010, DEV CELL, V18, P114, DOI 10.1016/j.devcel.2009.10.023; Wang XR, 2020, ELIFE, V9, DOI 10.7554/eLife.55966; Wang XR, 2016, STRUCTURE, V24, P2174, DOI 10.1016/j.str.2016.09.010; Wiggin GR, 2002, MOL CELL BIOL, V22, P2871, DOI 10.1128/MCB.22.8.2871-2881.2002; Wlodarchak N, 2013, CELL RES, V23, P931, DOI 10.1038/cr.2013.77; Wu CG, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.27; Xing Y, 2006, CELL, V127, P341, DOI 10.1016/j.cell.2006.09.025; Xu W, 2007, EMBO J, V26, P2890, DOI 10.1038/sj.emboj.7601734; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0	44	1	1	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100908	10.1016/j.jbc.2021.100908	http://dx.doi.org/10.1016/j.jbc.2021.100908			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34171357	Green Published, gold			2022-12-28	WOS:000678068400095
J	Gravdal, A; Xiao, XJ; Cnop, M; El Jellas, K; Johansson, S; Njolstad, PR; Lowe, ME; Johansson, BB; Molven, A; Fjeld, K				Gravdal, Anny; Xiao, Xunjun; Cnop, Miriam; El Jellas, Khadija; Johansson, Stefan; Njolstad, Pal R.; Lowe, Mark E.; Johansson, Bente B.; Molven, Anders; Fjeld, Karianne			The position of single-base deletions in the VNTR sequence of the carboxyl ester lipase (CEL) gene determines proteotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALT-STIMULATED LIPASE; TANDEM REPEATS; PROTEIN; GLYCOSYLATION; EXPRESSION; NUMBER; RISK; POLYMORPHISMS; PANCREATITIS; VARIANTS	Variable number of tandem repeat (VNTR) sequences in the genome can have functional consequences that contribute to human disease. This is the case for the CEL gene, which is specifically expressed in pancreatic acinar cells and encodes the digestive enzyme carboxyl ester lipase. Rare single-base deletions (DELs) within the first (DEL1) or fourth (DEL4) VNTR segment of CEL cause maturity-onset diabetes of the young, type 8 (MODY8), an inherited disorder characterized by exocrine pancreatic dysfunction and diabetes. Studies on the DEL1 variant have suggested that MODY8 is initiated by CEL protein misfolding and aggregation. However, it is unclear how the position of single-base deletions within the CEL VNTR affects pathogenic properties of the protein. Here, we investigated four naturally occurring CEL variants, arising from single-base deletions in different VNTR segments (DEL1, DEL4, DEL9, and DEL13). When the four variants were expressed in human embryonic kidney 293 cells, only DEL1 and DEL4 led to significantly reduced secretion, increased intracellular aggregation, and increased endoplasmic reticulum stress compared with normal CEL protein. The level of Oglycosylation was affected in all DEL variants. Moreover, all variants had enzymatic activity comparable with that of normal CEL. We conclude that the longest aberrant protein tails, resulting from single-base deletions in the proximal VNTR segments, have highest pathogenic potential, explaining why DEL1 and DEL4 but not DEL9 and DEL13 have been observed in patients with MODY8. These findings further support the view that CEL mutations cause pancreatic disease through protein misfolding and proteotoxicity, leading to endoplasmic reticulum stress and activation of the unfolded protein response.	[Gravdal, Anny; El Jellas, Khadija; Molven, Anders; Fjeld, Karianne] Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway; [Gravdal, Anny; El Jellas, Khadija; Johansson, Stefan; Njolstad, Pal R.; Johansson, Bente B.; Molven, Anders; Fjeld, Karianne] Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway; [Gravdal, Anny; Johansson, Stefan; Fjeld, Karianne] Haukeland Hosp, Dept Med Genet, Bergen, Norway; [Xiao, Xunjun; Lowe, Mark E.] Washington Univ, Sch Med, Dept Pediat, Div Gastroenterol Hepatol & Nutr, St Louis, MO 63110 USA; [Cnop, Miriam] Univ Libre Bruxelles, ULB Erasmus Hosp, ULB Ctr Diabet Res, Brussels, Belgium; [Cnop, Miriam] Univ Libre Bruxelles, ULB Erasmus Hosp, Div Endocrinol, Brussels, Belgium; [Njolstad, Pal R.; Johansson, Bente B.] Haukeland Hosp, Dept Pediat & Adolescent Med, Bergen, Norway; [Molven, Anders] Haukeland Hosp, Dept Pathol, Bergen, Norway	University of Bergen; University of Bergen; University of Bergen; Haukeland University Hospital; Washington University (WUSTL); Universite Libre de Bruxelles; Universite Libre de Bruxelles; University of Bergen; Haukeland University Hospital; University of Bergen; Haukeland University Hospital	Molven, A (corresponding author), Univ Bergen, Dept Clin Med, Gade Lab Pathol, Bergen, Norway.; Molven, A (corresponding author), Univ Bergen, Ctr Diabet Res, Dept Clin Sci, Bergen, Norway.; Molven, A (corresponding author), Haukeland Hosp, Dept Pathol, Bergen, Norway.	anders.molven@uib.no	Johansson, Stefan/C-4394-2011; Johansson, Bente Berg/AAE-7666-2022; Fjeld, Karianne/Q-7122-2018	Johansson, Stefan/0000-0002-2298-7008; Fjeld, Karianne/0000-0003-0441-1475; El Jellas, Khadija/0000-0003-4473-1422; Molven, Anders/0000-0003-1847-3079; Lowe, Mark/0000-0002-5116-3841	University of Bergen; Western Norway Regional Health Authority [Helse Vest 912057]; Research Council of Norway [289534]; Translational Medical Center grant from Stiftelsen Kristian Gerhard Jebsen; NIH/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK124415]; Fonds National de la Recherche Scientifique (FNRS); Brussels Region Innoviris project DiaType; Fonds Erasme for Medical Research	University of Bergen; Western Norway Regional Health Authority; Research Council of Norway(Research Council of Norway); Translational Medical Center grant from Stiftelsen Kristian Gerhard Jebsen; NIH/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fonds National de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); Brussels Region Innoviris project DiaType; Fonds Erasme for Medical Research	This research was funded by a PhD fellowship to A. G. from the University of Bergen and by grants to A. M. from Western Norway Regional Health Authority (Helse Vest 912057) and the Research Council of Norway (FRIMEDBIO program 289534). This research was also supported by a Translational Medical Center grant from Stiftelsen Kristian Gerhard Jebsen to P. R. N., by a grant to M. E. L. from the NIH/National Institute of Diabetes and Digestive and Kidney Diseases (R01DK124415), and by grants from the Fonds National de la Recherche Scientifique (FNRS), the Brussels Region Innoviris project DiaType, and the Fonds Erasme for Medical Research to M. C. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABOUAKIL N, 1993, J BIOL CHEM, V268, P25755; Amarasinghe C, 2015, PROTEIN PEPTIDE LETT, V22, P885, DOI 10.2174/0929866522666150728115307; [Anonymous], 2015, NAT GENET; BLACKBERG L, 1995, EUR J BIOCHEM, V228, P817, DOI 10.1111/j.1432-1033.1995.tb20327.x; Brookes KJ, 2013, GENOMICS, V101, P273, DOI 10.1016/j.ygeno.2013.03.003; Bruneau N, 1997, J BIOL CHEM, V272, P27353, DOI 10.1074/jbc.272.43.27353; BRUNEAU N, 1995, J BIOL CHEM, V270, P13524, DOI 10.1074/jbc.270.22.13524; Cai CQ, 2011, DIABETES, V60, P336, DOI 10.2337/db10-0255; Cassidy BM, 2020, HUM MUTAT, V41, P1967, DOI 10.1002/humu.24105; Dalva M, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010244; Dalva M, 2017, PANCREATOLOGY, V17, P83, DOI 10.1016/j.pan.2016.10.006; DOWNS D, 1994, BIOCHEMISTRY-US, V33, P7979, DOI 10.1021/bi00192a001; El Jellas K, 2018, J BIOL CHEM, V293, P19476, DOI 10.1074/jbc.RA118.001934; Fjeld K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165567; Hegyi E, 2019, GUT, V68, P301, DOI 10.1136/gutjnl-2018-315994; Hetz C, 2018, MOL CELL, V69, P169, DOI 10.1016/j.molcel.2017.06.017; Higuchi S, 2002, J HUM GENET, V47, P213, DOI 10.1007/s100380200027; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; Johansson BB, 2018, PANCREATOLOGY, V18, P12, DOI 10.1016/j.pan.2017.12.001; Johansson BB, 2011, J BIOL CHEM, V286, P34593, DOI 10.1074/jbc.M111.222679; Ju TZ, 2008, J CELL BIOL, V182, P531, DOI 10.1083/jcb.200711151; Kereszturi E, 2009, HUM MUTAT, V30, P575, DOI 10.1002/humu.20853; Kosobokova EN, 2016, BIOCHEMISTRY-MOSCOW+, V81, P187, DOI 10.1134/S0006297916030019; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Lindquist S, 2002, EUR J BIOCHEM, V269, P759, DOI 10.1046/j.0014-2956.2001.02666.x; Loomes KM, 1999, EUR J BIOCHEM, V266, P105, DOI 10.1046/j.1432-1327.1999.00824.x; Mayerle J, 2019, GASTROENTEROLOGY, V156, P1951, DOI 10.1053/j.gastro.2018.11.081; Pandol SJ, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00008; Rabdano SO, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10574-w; Raeder H, 2006, NAT GENET, V38, P54, DOI 10.1038/ng1708; Raeder H, 2014, DIABETES, V63, P259, DOI 10.2337/db13-1012; Ragvin A, 2013, PANCREATOLOGY, V13, P29, DOI 10.1016/j.pan.2012.12.059; Sahin-Toth M, 2017, CURR OPIN GASTROEN, V33, P390, DOI 10.1097/MOG.0000000000000380; Simpson J, 2010, AM J MED GENET B, V153B, P1228, DOI 10.1002/ajmg.b.31084; Steentoft C, 2013, EMBO J, V32, P1478, DOI 10.1038/emboj.2013.79; Terzyan S, 2000, PROTEIN SCI, V9, P1783, DOI 10.1110/ps.9.9.1783; Torsvik J, 2014, J BIOL CHEM, V289, P29097, DOI 10.1074/jbc.M114.574244; Torsvik J, 2010, HUM GENET, V127, P55, DOI 10.1007/s00439-009-0740-8; Vesterhus M, 2010, PANCREATOLOGY, V10, P467, DOI 10.1159/000266284; WANG CS, 1995, BIOCHEMISTRY-US, V34, P10639, DOI 10.1021/bi00033a039; Xiao XJ, 2016, J BIOL CHEM, V291, P23224, DOI 10.1074/jbc.M116.734384	41	5	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100661	10.1016/j.jbc.2021.100661	http://dx.doi.org/10.1016/j.jbc.2021.100661			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862081	Green Published, gold			2022-12-28	WOS:000672866400632
J	Hemmann, JL; Bruhwiler, MR; Bortfeld-Miller, M; Vorholt, JA				Hemmann, Jethro L.; Bruehwiler, Manuel R.; Bortfeld-Miller, Miriam; Vorholt, Julia A.			Structural diversity of the coenzyme methylofuran and identification of enzymes for the biosynthesis of its polyglutamate side chain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Methylofuran (MYFR) is a formyl-carrying coenzyme essential for the oxidation of formaldehyde in most methylotrophic bacteria. In Methylorubrum extorquens, MYFR contains a large and branched polyglutamate side chain of up to 24 glutamates. These glutamates play an essential role in interfacing the coenzyme with the formyltransferase/hydrolase complex, an enzyme that generates formate. To date, MYFR has not been identified in other methylotrophs, and it is unknown whether its structural features are conserved. Here, we examined nine bacterial strains for the presence and structure of MYFR using high-resolution liquid chromatography-mass spectrometry (LC-MS). Two of the strains produced MYFR as present in M. extorquens, while a modified MYFR containing tyramine instead of tyrosine in its core structure was detected in six strains. When M. extorquens was grown in the presence of tyramine, the compound was readily incorporated into MYFR, indicating that the biosynthetic enzymes are unable to discriminate tyrosine from tyramine. Using gene deletions in combination with LC-MS analyses, we identified three genes, orf5, orfY, and orf17 that are essential for MYFR biosynthesis. Notably, the orfY and orf5 mutants accumulated short MYFR intermediates with only one and two glutamates, respectively, suggesting that these enzymes catalyze glutamate addition. Upon homologous overexpression of orf5, a drastic increase in the number of glutamates in MYFR was observed (up to 40 glutamates), further corroborating the function of Orf5 as a glutamate ligase. We thus renamed OrfY and Orf5 to MyfA and MyfB to highlight that these enzymes are specifically involved in MYFR biosynthesis.	[Hemmann, Jethro L.; Bruehwiler, Manuel R.; Bortfeld-Miller, Miriam; Vorholt, Julia A.] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	ETH Zurich	Vorholt, JA (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	jvorholt@ethz.ch	Hemmann, Jethro L/GPP-3825-2022; Vorholt, Julia A./K-3514-2016	Hemmann, Jethro L/0000-0003-4687-5577; Vorholt, Julia A./0000-0002-6011-4910	Swiss National Science Foundation [31003A-173094]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	We thank Dr Ludmila Chistoserdova (University of Washington, Seattle, WA, USA) for providing the Delta orf5 M. extorquens AM1 and Delta orf Y M. flagellatus KT mutants. We also thank the Blockcourse students Viktoria Brunner, Rafael Ruch, Jacob Hanimann, and Timothy Bradley for their help with cloning and characterization of MyfB. We further appreciate the support of Philipp Christen with LC-MS measurements and acknowledge the Functional Genomics Center, Zurich, for the identification of proteins.; This work was supported by Swiss National Science Foundation Grants 31003A-173094 and by ETH Zurich.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100682	10.1016/j.jbc.2021.100682	http://dx.doi.org/10.1016/j.jbc.2021.100682			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33894199	gold, Green Published			2022-12-28	WOS:000672866400653
J	Neijssen, J; Cardoso, RMF; Chevalier, KM; Wiegman, L; Valerius, T; Anderson, GM; Moores, SL; Schuurman, J; Parren, PWHI; Strohl, WR; Chiu, ML				Neijssen, Joost; Cardoso, Rosa M. F.; Chevalier, Kristen M.; Wiegman, Luus; Valerius, Thomas; Anderson, G. Mark; Moores, Sheri L.; Schuurman, Janine; Parren, Paul W. H., I; Strohl, William R.; Chiu, Mark L.			Discovery of amivantamab (JNJ-61186372), a bispecific antibody targeting EGFR and MET	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PHASE-III; ONARTUZUMAB; RESISTANCE; ERLOTINIB; INVASION; DOMAIN	A bispecific antibody (BsAb) targeting the epidermal growth factor receptor (EGFR) and mesenchymal-epithelial transition factor (MET) pathways represents a novel approach to overcome resistance to targeted therapies in patients with nonsmall cell lung cancer. In this study, we sequentially screened a panel of BsAbs in a combinatorial approach to select the optimal bispecific molecule. The BsAbs were derived from different EGFR and MET parental monoclonal antibodies. Initially, molecules were screened for EGFR and MET binding on tumor cell lines and lack of agonistic activity toward MET. Hits were identified and further screened based on their potential to induce untoward cell proliferation and crossphosphorylation of EGFR by MET via receptor colocalization in the absence of ligand. After the final step, we selected the EGFR and MET arms for the lead BsAb and added low fucose Fc engineering to generate amivantamab (JNJ-61186372). The crystal structure of the anti-MET Fab of amivantamab bound to MET was solved, and the interaction between the two molecules in atomic details was elucidated. Amivantamab antagonized the hepatocyte growth factor (HGF)-induced signaling by binding to MET Sema domain and thereby blocking HGF beta-chain-Sema engagement. The amivantamab EGFR epitope was mapped to EGFR domain III and residues K443, K465, I467, and S468. Furthermore, amivantamab showed superior antitumor activity over small molecule EGFR and MET inhibitors in the HCC827-HGF in vivo model. Based on its unique mode of action, amivantamab may provide benefit to patients with malignancies associated with aberrant EGFR and MET signaling.	[Neijssen, Joost; Wiegman, Luus; Schuurman, Janine; Parren, Paul W. H., I] Genmab, Utrecht, Netherlands; [Cardoso, Rosa M. F.; Chevalier, Kristen M.; Anderson, G. Mark; Moores, Sheri L.; Strohl, William R.; Chiu, Mark L.] Janssen Res & Dev, Spring House, PA 19477 USA; [Valerius, Thomas] Univ Kiel, Sect Stem Cell Transplantat & Immunotherapy, Dept Med 2, Kiel, Germany; [Valerius, Thomas] Univ Hosp Schleswig Holstein, Kiel, Germany; [Anderson, G. Mark] Genome Profiling LLC, Wayne, PA USA; [Parren, Paul W. H., I] Lava Therapeut, Utrecht, Netherlands; [Strohl, William R.] BiStro Biotech Consulting LLC, Bridgewater, NJ USA; [Chiu, Mark L.] Tavotek Biotherapeut, Spring House, PA 19477 USA	Genmab; Johnson & Johnson; Janssen Pharmaceuticals; University of Kiel; University of Kiel; Schleswig Holstein University Hospital	Chiu, ML (corresponding author), Janssen Res & Dev, Spring House, PA 19477 USA.; Chiu, ML (corresponding author), Tavotek Biotherapeut, Spring House, PA 19477 USA.	markchiu03@gmail.com	Valerius, Thomas/A-3086-2011	Parren, Paul/0000-0002-4365-3859; Valerius, Thomas/0000-0001-9181-8067; Neijssen, Joost/0000-0001-6697-4324	Janssen Research and Development, LLC	Janssen Research and Development, LLC	The study was funded by Janssen Research and Development, LLC.	Agarwal S, 2009, BRIT J CANCER, V100, P941, DOI 10.1038/sj.bjc.6604937; Arrieta O, 2015, J THORAC ONCOL, V10, P838, DOI 10.1097/JTO.0000000000000481; Bean J, 2007, P NATL ACAD SCI USA, V104, P20932, DOI 10.1073/pnas.0710370104; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Chemical Computing Group ULC, 2021, MOL OP ENV MOE 2019; Cochran JR, 2004, J IMMUNOL METHODS, V287, P147, DOI 10.1016/j.jim.2004.01.024; Dulak AM, 2011, ONCOGENE, V30, P3625, DOI 10.1038/onc.2011.84; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; Gonzalez A, 2016, INT J CANCER, V139, P1851, DOI 10.1002/ijc.30174; Grugan KD, 2017, MABS-AUSTIN, V9, P114, DOI 10.1080/19420862.2016.1249079; Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105; Haura EB, 2019, J CLIN ONCOL, V37; Husain B, 2018, BIODRUGS, V32, P441, DOI 10.1007/s40259-018-0299-9; Jo MJ, 2000, J BIOL CHEM, V275, P8806, DOI 10.1074/jbc.275.12.8806; Labrijn AF, 2014, NAT PROTOC, V9, P2450, DOI 10.1038/nprot.2014.169; Labrijn AF, 2013, P NATL ACAD SCI USA, V110, P5145, DOI 10.1073/pnas.1220145110; Lee BS, 2016, ANN SURG ONCOL, V23, P2046, DOI 10.1245/s10434-015-5084-0; Lee DH, 2015, IMMUNOTARGETS THER, V4, P35, DOI 10.2147/ITT.S37409; Lee JM, 2016, ONCOGENE, V35, P4437, DOI 10.1038/onc.2015.514; Li SQ, 2005, CANCER CELL, V7, P301, DOI 10.1016/j.ccr.2005.03.003; Liu L, 2014, CLIN CANCER RES, V20, P6059, DOI 10.1158/1078-0432.CCR-14-0543; Liu XD, 2008, EXPERT OPIN INV DRUG, V17, P997, DOI [10.1517/13543784.17.7.997, 10.1517/13543784.17.7.997 ]; Lobo ED, 2004, J PHARM SCI-US, V93, P2645, DOI 10.1002/jps.20178; Luraghi P, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00164; Merchant M, 2013, P NATL ACAD SCI USA, V110, pE2987, DOI 10.1073/pnas.1302725110; Moores SL, 2016, CANCER RES, V76, P3942, DOI 10.1158/0008-5472.CAN-15-2833; Niemann HH, 2007, CELL, V130, P235, DOI 10.1016/j.cell.2007.05.037; Niemann HH, 2013, BBA-PROTEINS PROTEOM, V1834, P2195, DOI 10.1016/j.bbapap.2012.10.012; Oxnard GR, 2018, JAMA ONCOL, V4, P1527, DOI 10.1001/jamaoncol.2018.2969; Patnaik A, 2018, CANCER CHEMOTH PHARM, V82, P407, DOI 10.1007/s00280-018-3623-7; Puri Neelu, 2008, J Carcinog, V7, P9; Scagliotti GV, 2018, J THORAC ONCOL, V13, P849, DOI 10.1016/j.jtho.2017.12.009; Scagliotti GV, 2017, J CLIN ONCOL, V35, DOI 10.1200/JCO.2017.35.15_suppl.9019; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Soria JC, 2018, NEW ENGL J MED, V378, P113, DOI 10.1056/NEJMoa1713137; Spigel DR, 2017, J CLIN ONCOL, V35, P412, DOI 10.1200/JCO.2016.69.2160; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Stamos J, 2004, EMBO J, V23, P2325, DOI 10.1038/sj.emboj.7600243; Surati M, 2011, EXPERT OPIN BIOL TH, V11, P1655, DOI 10.1517/14712598.2011.626762; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; van Bueren JJL, 2008, P NATL ACAD SCI USA, V105, P6109, DOI 10.1073/pnas.0709477105; Vijayaraghavan S, 2020, MOL CANCER THER, V19, P2044, DOI 10.1158/1535-7163.MCT-20-0071; Voigt M, 2012, NEOPLASIA, V14, P1023, DOI 10.1593/neo.121242; Xiang H, 2013, CLIN CANCER RES, V19, P5068, DOI 10.1158/1078-0432.CCR-13-0260; Yano S, 2011, J THORAC ONCOL, V6, P2011, DOI 10.1097/JTO.0b013e31823ab0dd; Yu HA, 2013, CLIN CANCER RES, V19, P2240, DOI 10.1158/1078-0432.CCR-12-2246; Yun J, 2020, CANCER DISCOV, V10, P1194, DOI 10.1158/2159-8290.CD-20-0116	48	41	41	9	26	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100641	10.1016/j.jbc.2021.100641	http://dx.doi.org/10.1016/j.jbc.2021.100641			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839159	Green Published, Green Submitted, gold			2022-12-28	WOS:000672866400612
J	Wang, XX; Zhang, S; Dong, PP; Li, YH; Zhang, L; Shi, SH; Yu, ZQ; Chen, S				Wang, Xiao-Xiao; Zhang, Si; Dong, Ping-Ping; Li, Yao-Hua; Zhang, Li; Shi, Song-Hai; Yu, Zhi-Qiang; Chen, She			MRCK beta links Dasm1 to actin rearrangements to promote dendrite development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Proper dendrite morphogenesis and synapse formation are essential for neuronal development and function. Dasm1, a member of the immunoglobulin superfamily, is known to promote dendrite outgrowth and excitatory synapse maturation in vitro. However, the in vivo function of Dasm1 in neuronal development and the underlying mechanisms are not well understood. To learn more, Dasm1 knockout mice were constructed and employed to confirm that Dasm1 regulates dendrite arborization and spine formation in vivo. We performed a yeast two-hybrid screen using Dasm1, revealing MRCK beta as a putative partner; additional lines of evidence confirmed this interaction and identified cytoplasmic proline-rich region (823-947 aa) of Dasm1 and MRCK beta self-activated kinase domain (CC1, 410-744 aa) as necessary and sufficient for binding. Using co-immunoprecipitation assay, autophosphorylation assay, and BS3 cross-linking assay, we show that Dasm1 binding triggers a change in MRCK beta's conformation and subsequent dimerization, resulting in autophosphorylation and activation. Activated MRCK beta in turn phosphorylates a class 2 regulatory myosin light chain, which leads to enhanced actin rearrangement, causing the dendrite outgrowth and spine formation observed before. Removal of Dasm1 in mice leads to behavioral abnormalities. Together, these results reveal a crucial molecular pathway mediating cell surface and intracellular signaling communication to regulate actin dynamics and neuronal development in the mammalian brain.	[Wang, Xiao-Xiao; Zhang, Si; Li, Yao-Hua; Zhang, Li; Chen, She] Fudan Univ, NHC Key Lab Glycoconjugate Res, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai, Peoples R China; [Wang, Xiao-Xiao; Dong, Ping-Ping] Fudan Univ, Zhongshan Hosp, Shanghai Inst Liver Dis, Dept Gastroenterol & Hepatol, Shanghai, Peoples R China; [Dong, Ping-Ping] Univ Hong Kong, Fac Med, Ctr Canc Res, Dept Surg, Hong Kong, Peoples R China; [Shi, Song-Hai] Tsinghua Univ, IDG McGovern Inst Brain Res, Tsinghua Peking Ctr Life Sci,Sch Life Sci, Beijing Frontier Res Ctr Biol Struct,Beijing Adv, Beijing, Peoples R China; [Shi, Song-Hai] Mem Sloan Kettering Canc Ctr, Dev Biol Program, Sloan Kettering Inst, 1275 York Ave, New York, NY 10021 USA; [Yu, Zhi-Qiang] Chinese Acad Med Sci, NHC Key Lab Myopia, Shanghai, Peoples R China; [Yu, Zhi-Qiang] Fudan Univ, Eye & ENT Hosp, Eye Dept, Shanghai, Peoples R China	Fudan University; Fudan University; University of Hong Kong; Tsinghua University; Memorial Sloan Kettering Cancer Center; Chinese Academy of Medical Sciences - Peking Union Medical College; Fudan University	Chen, S (corresponding author), Fudan Univ, NHC Key Lab Glycoconjugate Res, Dept Biochem & Mol Biol, Sch Basic Med Sci, Shanghai, Peoples R China.; Yu, ZQ (corresponding author), Chinese Acad Med Sci, NHC Key Lab Myopia, Shanghai, Peoples R China.; Yu, ZQ (corresponding author), Fudan Univ, Eye & ENT Hosp, Eye Dept, Shanghai, Peoples R China.	zhiqiang.yu@fdeent.org; shechen@fudan.edu.cn		zhang, Si/0000-0002-5682-4995	National Natural Science Foundation of China [81772615, 81573423, 81770137]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We greatly appreciate Professor Mingjie Zhang from Hong Kong University of Science and Technology for providing MRCK ss cDNAs, Professor Ivan Tan from National University of Singapore for providing MRCKa cDNAs. This work was supported by grants from the National Natural Science Foundation of China (81772615, 81573423, and 81770137).		0	1	1	1	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100730	10.1016/j.jbc.2021.100730	http://dx.doi.org/10.1016/j.jbc.2021.100730			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933448	Green Published, gold			2022-12-28	WOS:000672866400699
J	Kondo, K; Izumi, M; Inabe, K; Yoshida, K; Imashimizu, M; Suzuki, T; Hisabori, T				Kondo, Kumiko; Izumi, Masayuki; Inabe, Kosuke; Yoshida, Keisuke; Imashimizu, Mari; Suzuki, Toshiharu; Hisabori, Toru			The phototroph-specific beta-hairpin structure of the gamma subunit of FoF1-ATP synthase is important for efficient ATP synthesis of cyanobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTON MOTIVE FORCE; ELECTRON-TRANSPORT; ESCHERICHIA-COLI; ROTARY MOTOR; C-RING; PHOTOSYNTHESIS; STOICHIOMETRY; CHLOROPLASTS; HOMEOSTASIS; ACTIVATION	The F(o)F(1)synthase produces ATP from ADP and inorganic phosphate. The gamma subunit of FoF1 ATP synthase in photosynthetic organisms, which is the rotor subunit of this enzyme, contains a characteristic beta-hairpin structure. This structure is formed from an insertion sequence that has been conserved only in phototrophs. Using recombinant subcomplexes, we previously demonstrated that this region plays an essential role in the regulation of ATP hydrolysis activity, thereby functioning in controlling intracellular ATP levels in response to changes in the light environment. However, the role of this region in ATP synthesis has long remained an open question because its analysis requires the preparation of the whole FoF1 complex and a transmembrane proton-motive force. In this study, we successfully prepared proteoliposomes containing the entire FoF1 ATP synthase from a cyanobacterium, Synechocystis sp. PCC 6803, and measured ATP synthesis/hydrolysis and proton-translocating activities. The relatively simple genetic manipulation of Synechocystis enabled the biochemical investigation of the role of the beta-hairpin structure of FoF1 ATP synthase and its activities. We further performed physiological analyses of Synechocystis mutant strains lacking the beta-hairpin structure, which provided novel insights into the regulatory mechanisms of FoF1 ATP synthase in cyanobacteria via the phototroph-specific region of the gamma subunit. Our results indicated that this structure critically contributes to ATP synthesis and suppresses ATP hydrolysis.	[Kondo, Kumiko; Izumi, Masayuki; Inabe, Kosuke; Yoshida, Keisuke; Imashimizu, Mari; Suzuki, Toshiharu; Hisabori, Toru] Tokyo Inst Technol, Lab Chem & Life Sci, Midori Ku, Yokohama, Kanagawa, Japan; [Inabe, Kosuke] Kobe Univ, Grad Sch Sci Technol & Innovat, Nada Ku, 1-1 Rokkodai, Kobe, Hyogo 6578501, Japan	Tokyo Institute of Technology; Kobe University	Hisabori, T (corresponding author), Tokyo Inst Technol, Lab Chem & Life Sci, Midori Ku, Yokohama, Kanagawa, Japan.	thisabor@res.titech.ac.jp	Yoshida, Keisuke/E-5231-2014; Hisabori, Toru/E-5205-2014	Yoshida, Keisuke/0000-0001-6542-6254; Hisabori, Toru/0000-0003-2046-0277	JSPS KAKENHI [16H06556]; Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials	This study was supported by JSPS KAKENHI Grant Number 16H06556 (to T. H.) and by Dynamic Alliance for Open Innovation Bridging Human, Environment and Materials.	Akiyama K, 2019, BIOCHEM J, V476, P1771, DOI 10.1042/BCJ20190242; Arisaka S, 2019, ALGAL RES, V41, DOI 10.1016/j.algal.2019.101565; Armbruster U, 2017, CURR OPIN PLANT BIOL, V37, P56, DOI 10.1016/j.pbi.2017.03.012; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; Doello S, 2021, CURR BIOL, V31, P1606, DOI 10.1016/j.cub.2021.01.065; Doello S, 2018, PLANT PHYSIOL, V177, P594, DOI 10.1104/pp.18.00297; Falcon LI, 2010, ISME J, V4, P777, DOI 10.1038/ismej.2010.2; Fischer S, 1999, FEBS LETT, V457, P327, DOI 10.1016/S0014-5793(99)01060-1; Fujikawa M, 2012, J BIOL CHEM, V287, P18781, DOI 10.1074/jbc.M112.345793; Hahn A, 2018, SCIENCE, V360, P620, DOI 10.1126/science.aat4318; Hisabori T, 2013, ANTIOXID REDOX SIGN, V19, P1846, DOI 10.1089/ars.2012.5044; Imashimizu M, 2011, J BIOL CHEM, V286, P26595, DOI 10.1074/jbc.M111.234138; Inabe K, 2019, J BIOL CHEM, V294, P10094, DOI 10.1074/jbc.RA118.007131; Jault JM, 1996, J BIOL CHEM, V271, P28818, DOI 10.1074/jbc.271.46.28818; Jiang WP, 2001, P NATL ACAD SCI USA, V98, P4966, DOI 10.1073/pnas.081424898; JUNESCH U, 1987, BIOCHIM BIOPHYS ACTA, V893, P275, DOI 10.1016/0005-2728(87)90049-1; Junge W, 2015, ANNU REV BIOCHEM, V84, P631, DOI 10.1146/annurev-biochem-060614-034124; Kondo K, 2018, BBA-BIOENERGETICS, V1859, P319, DOI 10.1016/j.bbabio.2018.02.004; Konno H, 2012, PLANT CELL PHYSIOL, V53, P626, DOI 10.1093/pcp/pcs018; Konno H, 2011, J BIOL CHEM, V286, P13423, DOI 10.1074/jbc.M110.155986; KRAMER DM, 1990, PHOTOSYNTH RES, V26, P213, DOI 10.1007/BF00033134; Kramer DM, 2003, TRENDS PLANT SCI, V8, P27, DOI 10.1016/S1360-1385(02)00010-9; KRAMER DM, 1989, BIOCHIM BIOPHYS ACTA, V976, P28, DOI 10.1016/S0005-2728(89)80186-0; Kuhlbrandt W, 2019, ANNU REV BIOCHEM, V88, P515, DOI 10.1146/annurev-biochem-013118-110903; LANDT O, 1990, GENE, V96, P125, DOI 10.1016/0378-1119(90)90351-Q; Luan GD, 2019, BIOTECHNOL ADV, V37, P771, DOI 10.1016/j.biotechadv.2019.04.005; MIKI J, 1988, FEBS LETT, V232, P221, DOI 10.1016/0014-5793(88)80421-6; Mitome N, 2004, P NATL ACAD SCI USA, V101, P12159, DOI 10.1073/pnas.0403545101; Mnatsakanyan N, 2009, J BIOL CHEM, V284, P11336, DOI 10.1074/jbc.M900374200; Muller DJ, 2001, FEBS LETT, V504, P219, DOI 10.1016/S0014-5793(01)02708-9; Murakami S, 2018, BIOCHEM J, V475, P2925, DOI 10.1042/BCJ20180481; Nakamura J, 2013, BIOSCIENCE REP, V33, P735, DOI 10.1042/BSR20130078; Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517; Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Shikanai T, 2017, MOL PLANT, V10, P20, DOI 10.1016/j.molp.2016.08.004; Soga N, 2017, P NATL ACAD SCI USA, V114, P4960, DOI 10.1073/pnas.1700801114; Soga N, 2011, FEBS J, V278, P2647, DOI 10.1111/j.1742-4658.2011.08191.x; Stahlberg H, 2001, EMBO REP, V2, P229, DOI 10.1093/embo-reports/kve047; Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700; Suhai T, 2008, BBA-BIOMEMBRANES, V1778, P1131, DOI 10.1016/j.bbamem.2007.12.017; Sunamura EI, 2010, PLANT CELL PHYSIOL, V51, P855, DOI 10.1093/pcp/pcq061; Suzuki T, 2002, J BIOL CHEM, V277, P13281, DOI 10.1074/jbc.M111210200; Suzuki T, 2007, P NATL ACAD SCI USA, V104, P20776, DOI 10.1073/pnas.0708075105; Tikhonov AN, 2013, PHOTOSYNTH RES, V116, P511, DOI 10.1007/s11120-013-9845-y; Usukura E, 2012, J BIOL CHEM, V287, P1884, DOI 10.1074/jbc.M111.305938; Watanabe R, 2015, BIOPHYS J, V108, P1144, DOI 10.1016/j.bpj.2015.01.017; Watt IN, 2010, P NATL ACAD SCI USA, V107, P16823, DOI 10.1073/pnas.1011099107; WILLIAMS JGK, 1988, METHOD ENZYMOL, V167, P766; Yang JH, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01221-8; Yoshida K, 2013, PLANT CELL PHYSIOL, V54, P875, DOI 10.1093/pcp/pct037; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509	53	1	1	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101027	10.1016/j.jbc.2021.101027	http://dx.doi.org/10.1016/j.jbc.2021.101027			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339736	Green Published, gold			2022-12-28	WOS:000706408900015
J	Kondo, T; Kichijo, M; Maruta, A; Nakaya, M; Takenaka, S; Arakawa, T; Fushinobu, S; Sakamoto, T				Kondo, Tatsuya; Kichijo, Miyu; Maruta, Akiho; Nakaya, Makoto; Takenaka, Shigeo; Arakawa, Takatoshi; Fushinobu, Shinya; Sakamoto, Tatsuji			Structural and functional analysis of gum arabic L-rhamnose-alpha-1,4-D-glucuronate lyase establishes a novel polysaccharide lyase family	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUBSTITUTION POSITIONS; FUSARIUM-OXYSPORUM; CRYSTAL-STRUCTURE; ARABINOGALACTAN; ENZYMES; LARCH; EXO-BETA-1,3-D-GALACTANASE; RHAMNOGALACTURONAN; CLASSIFICATION; IDENTIFICATION	Gum arabic (GA) is widely used as an emulsion stabilizer and coating in several industrial applications, such as foods and pharmaceuticals. GA contains a complex carbohydrate moiety, and the nonreducing ends of the side chains are often capped with L-rhamnose; thus, enzymes that can remove these caps are promising tools for the structural analysis of the carbohydrates comprising GA. In this study, GA-specific L-rhamnose-alpha-1,4-D- glucuronate lyase from the fungus Fusarium oxysporum 12S (FoRham1) was cloned and characterized. FoRham1 showed the highest amino acid sequence similarity with enzymes belonging to the glycoside hydrolase family 145; however, the catalytic residue on the posterior pocket of the fl-propeller fold protein was not conserved. The catalytic residues of FoRham1 were instead conserved with ulvan lyases belonging to polysaccharide lyase family 24. Kinetic analysis showed that FoRham1 has the highest catalytic efficiency for the substrate alpha-L-rhamnose-(1-4)-D-glucuronic acid. The crystal structures of ligand-free and alpha-L-rhamnose-(1-4)-D-glucuronic acid -bound FoRham1 were determined, and the active site was identified on the anterior side of the fl-propeller. The three-dimensional structure of the active site and mutagenesis analysis revealed the detailed catalytic mechanism of FoRham1. Our findings offer a new enzymatic tool for the further analysis of the GA carbohydrate structure and for elucidating its physiological functions in plants. Based on these results, we renamed glycoside hydrolase family 145 as a new polysaccharide lyase family 42, in which FoRham1 is included.	[Kondo, Tatsuya; Kichijo, Miyu; Maruta, Akiho; Sakamoto, Tatsuji] Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Org Res Promot, Osaka, Japan; [Nakaya, Makoto] Osaka Prefecture Univ, Ctr Res & Dev Bioresources, Org Res Promot, Osaka, Japan; [Nakaya, Makoto] Otemae Coll Nutr & Confectionery, Dept Nutr, Osaka, Japan; [Takenaka, Shigeo] Osaka Prefecture Univ, Grad Sch Comprehens Rehabil, Osaka, Japan; [Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Dept Biotechnol, Tokyo, Japan; [Arakawa, Takatoshi; Fushinobu, Shinya] Univ Tokyo, Collaborat Res Inst Innovat Microbiol, Tokyo, Japan; [Kondo, Tatsuya] Kyoto Univ, Res Inst Sustainable Humanosphere RISH, Uji, Kyoto 6110011, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; University of Tokyo; University of Tokyo; Kyoto University	Sakamoto, T (corresponding author), Osaka Prefecture Univ, Grad Sch Life & Environm Sci, Org Res Promot, Osaka, Japan.	sakamoto@biochem.osakafu-u.ac.jp	Nakaya, Makoto/F-6731-2015	Nakaya, Makoto/0000-0002-5890-2272	Osaka Prefecture University [4020101]	Osaka Prefecture University	Funding was provided by Osaka Prefecture University (grant No 4020101). The funder had no role in the study design; data collection, analysis, or interpretation; manuscript writing; or the decision to submit the article for publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bazin HG, 1998, CARBOHYD RES, V309, P135, DOI 10.1016/S0008-6215(98)00118-9; CREMER D, 1975, J AM CHEM SOC, V97, P1354, DOI 10.1021/ja00839a011; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Garron ML, 2014, CURR OPIN STRUC BIOL, V28, P87, DOI 10.1016/j.sbi.2014.07.012; Garron ML, 2010, GLYCOBIOLOGY, V20, P1547, DOI 10.1093/glycob/cwq122; Haque A, 2005, BIOSCI BIOTECH BIOCH, V69, P2170, DOI 10.1271/bbb.69.2170; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Ishida T, 2009, J BIOL CHEM, V284, P10100, DOI 10.1074/jbc.M808122200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KNOX JP, 1995, FASEB J, V9, P1004, DOI 10.1096/fasebj.9.11.7544308; KOGA H, 1988, PHYSIOL MOL PLANT P, V32, P395, DOI 10.1016/S0885-5765(88)80033-X; Kondo K, 2011, INT J BIOL MACROMOL, V48, P256, DOI 10.1016/j.ijbiomac.2010.11.009; Kondo T, 2021, FEBS J, V288, P4918, DOI 10.1111/febs.15795; Kondo T, 2020, APPL MICROBIOL BIOT, V104, P1135, DOI 10.1007/s00253-019-10299-y; Konishi T, 2008, CARBOHYD RES, V343, P1191, DOI 10.1016/j.carres.2008.03.004; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Lombard V, 2010, BIOCHEM J, V432, P437, DOI 10.1042/BJ20101185; Maruta A, 2017, ENZYME MICROB TECH, V103, P25, DOI 10.1016/j.enzmictec.2017.04.006; Matsumoto S, 2017, ENZYME MICROB TECH, V98, P76, DOI 10.1016/j.enzmictec.2016.12.008; Munoz-Munoz J, 2017, J BIOL CHEM, V292, P13271, DOI 10.1074/jbc.M117.794578; Munoz-Munoz J, 2017, P NATL ACAD SCI USA, V114, P4936, DOI 10.1073/pnas.1701130114; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Nie SP, 2013, FOOD HYDROCOLLOID, V31, P42, DOI 10.1016/j.foodhyd.2012.09.014; Okawa M, 2013, APPL MICROBIOL BIOT, V97, P9685, DOI 10.1007/s00253-013-4759-3; Panteloglou AG, 2010, FOOD CHEM, V122, P972, DOI 10.1016/j.foodchem.2010.02.037; Poidevin L, 2013, APPL ENVIRON MICROB, V79, P4220, DOI 10.1128/AEM.00327-13; Ponder GR, 1997, CARBOHYD POLYM, V34, P251, DOI 10.1016/S0144-8617(97)00099-4; Qin LX, 2017, PLANT J, V89, P957, DOI 10.1111/tpj.13434; Rojas AL, 2004, J MOL BIOL, V343, P1281, DOI 10.1016/j.jmb.2004.09.012; Sakamoto T, 2007, APPL ENVIRON MICROB, V73, P3109, DOI 10.1128/AEM.02101-06; Sakamoto T, 2011, APPL MICROBIOL BIOT, V90, P1701, DOI 10.1007/s00253-011-3219-1; Sakamoto T, 2010, APPL MICROBIOL BIOT, V86, P1115, DOI 10.1007/s00253-009-2344-6; Singh A, 2016, CAN J CHEM, V94, P927, DOI 10.1139/cjc-2015-0606; Sogabe Y, 2011, ACTA CRYSTALLOGR D, V67, P415, DOI 10.1107/S0907444911006299; STREET CA, 1983, TALANTA, V30, P887, DOI 10.1016/0039-9140(83)80206-9; Suzuki K, 2014, PROTEINS, V82, P2857, DOI 10.1002/prot.24649; Takeda K, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01692-19; Ulaganathan T, 2018, J BIOL CHEM, V293, P4026, DOI 10.1074/jbc.RA117.001642; Ulaganathan T, 2017, ACS CHEM BIOL, V12, P1269, DOI 10.1021/acschembio.7b00126; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Vuillemin ME, 2019, FOOD HYDROCOLLOID, V96, P463, DOI 10.1016/j.foodhyd.2019.05.048; Wende FJ, 2017, CARBOHYD POLYM, V157, P1525, DOI 10.1016/j.carbpol.2016.11.029; Wende FJ, 2016, CARBOHYD POLYM, V136, P1348, DOI 10.1016/j.carbpol.2015.09.112; Xu K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048742	46	1	1	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101001	10.1016/j.jbc.2021.101001	http://dx.doi.org/10.1016/j.jbc.2021.101001			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34303708	gold, Green Published			2022-12-28	WOS:000706418900014
J	Safari, MS; King, MR; Brangwynne, CP; Petry, S				Safari, Mohammad S.; King, Matthew R.; Brangwynne, Clifford P.; Petry, Sabine			Interaction of spindle assembly factor TPX2 with importins-alpha/beta inhibits protein phase separation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROTUBULE NUCLEATION; BINDING; RAN; CENTROSOME; RECEPTORS; TARGET; FUS	The microtubule-based mitotic spindle is responsible for equally partitioning the genome during each cell division, and its assembly is executed via several microtubule nucleation pathways. Targeting Protein for XKlp2 (TPX2) stimulates the branching microtubule nucleation pathway, where new microtubules are nucleated from preexisting ones within mitotic or meiotic spindles. TPX2, like other spindle assembly factors, is sequestered by binding to nuclear importins-alpha/beta until the onset of mitosis, yet the molecular nature of this regulation remains unclear. Here we demonstrate that TPX2 interacts with importins-alpha/beta with nanomolar affinity in a 1:1:1 mono dispersed trimer. We also identify a new nuclear localization sequence in TPX2 that contributes to its high-affinity interaction with importin-alpha. In addition, we establish that TPX2 interacts with importin-beta via dispersed, weak interactions. We show that interactions of both importin-alpha and -beta with TPX2 inhibit its ability to undergo phase separation, which was recently shown to enhance the kinetics of branching microtubule nucleation. In summary, our study informs how importins regulate TPX2 to facilitate spindle assembly, and provides novel insight into the functional regulation of protein phase separation.	[Safari, Mohammad S.; King, Matthew R.; Petry, Sabine] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Brangwynne, Clifford P.] Princeton Univ, Dept Chem & Biol Engn, Princeton, NJ 08544 USA; [Brangwynne, Clifford P.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA	Princeton University; Princeton University; Howard Hughes Medical Institute; Princeton University	Petry, S (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	spetry@princeton.edu		King, Matthew/0000-0002-8533-3589	NIGMS, National Institutes of Health [T32GM007388]; NIGMS, National Institutes of Health; Pew Scholars Program in the Biomedical Sciences; David and Lucile Packard Foundation	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Pew Scholars Program in the Biomedical Sciences; David and Lucile Packard Foundation(The David & Lucile Packard Foundation)	This work was supported by PhD training grant T32GM007388 by NIGMS, National Institutes of Health (to M. R. K.), as well as the New Innovator Award of NIGMS, National Institutes of Health (DP2), the Pew Scholars Program in the Biomedical Sciences, and the David and Lucile Packard Foundation (all to S. P.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfaro-Aco R, 2020, ELIFE, V9, DOI 10.7554/eLife.49797; Alfaro-Aco R, 2017, J CELL BIOL, V216, P983, DOI 10.1083/jcb.201607060; Brangwynne CP, 2015, NAT PHYS, V11, P899, DOI [10.1038/NPHYS3532, 10.1038/nphys3532]; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Cavazza T, 2016, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00082; Chang CC, 2017, J CELL BIOL, V216, P3453, DOI 10.1083/jcb.201705168; Christie M, 2016, J MOL BIOL, V428, P2060, DOI 10.1016/j.jmb.2015.10.023; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Das RK, 2013, P NATL ACAD SCI USA, V110, P13392, DOI 10.1073/pnas.1304749110; Decker F, 2018, ELIFE, V7, DOI 10.7554/eLife.31149; Eibes S, 2018, CURR BIOL, V28, P121, DOI 10.1016/j.cub.2017.11.046; Forbes DJ, 2015, CURR OPIN CELL BIOL, V35, P78, DOI 10.1016/j.ceb.2015.04.012; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Giesecke A, 2010, J BIOL CHEM, V285, P17628, DOI 10.1074/jbc.M110.102343; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; GORLICH D, 1994, CELL, V79, P767, DOI 10.1016/0092-8674(94)90067-1; Gruss OJ, 2001, CELL, V104, P83, DOI 10.1016/S0092-8674(01)00193-3; Guo L, 2018, CELL, V173, P677, DOI 10.1016/j.cell.2018.03.002; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Heald R, 1996, NATURE, V382, P420, DOI 10.1038/382420a0; Heald R, 2015, J CELL BIOL, V211, P1103, DOI 10.1083/jcb.201510015; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hulme EC, 2010, BRIT J PHARMACOL, V161, P1219, DOI 10.1111/j.1476-5381.2009.00604.x; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; Jakel S, 2002, EMBO J, V21, P377, DOI 10.1093/emboj/21.3.377; Jiang H, 2015, CELL, V163, P108, DOI 10.1016/j.cell.2015.08.010; King MR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14087-0; Loughlin R, 2010, J CELL BIOL, V191, P1239, DOI 10.1083/jcb.201006076; Miyatake H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115995; Monterroso B, 2019, EMBO REP, V20, DOI 10.15252/embr.201845946; Mothilal M, SPR NONLINEAR KINETI; Nachury MV, 2001, CELL, V104, P95, DOI 10.1016/S0092-8674(01)00194-5; Pan WC, 2007, BIOPHYS J, V92, P267, DOI 10.1529/biophysj.106.094854; Pan WC, 2010, J PHYS CHEM B, V114, P7620, DOI 10.1021/jp100617w; Petry S, 2016, ANNU REV BIOCHEM, V85, P659, DOI 10.1146/annurev-biochem-060815-014528; Petry S, 2013, CELL, V152, P768, DOI 10.1016/j.cell.2012.12.044; Roostalu J, 2015, NAT CELL BIOL, V17, P1422, DOI 10.1038/ncb3241; Schatz CA, 2003, EMBO J, V22, P2060, DOI 10.1093/emboj/cdg195; Shin Y, 2017, SCIENCE, V357, DOI 10.1126/science.aaf4382; Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114; Tan S, 2005, PROTEIN EXPRES PURIF, V40, P385, DOI 10.1016/j.pep.2004.12.002; Thawani A, 2019, ELIFE, V8, DOI 10.7554/eLife.43890; Thawani A, 2018, NAT CELL BIOL, V20, P575, DOI 10.1038/s41556-018-0091-6; Trieselmann N, 2003, J CELL SCI, V116, P4791, DOI 10.1242/jcs.00798; Verma V, 2019, J CELL BIOL, V218, P2829, DOI 10.1083/jcb.201904114; Wang J, 2018, CELL, V174, P688, DOI 10.1016/j.cell.2018.06.006; Wittmann T, 2000, J CELL BIOL, V149, P1405, DOI 10.1083/jcb.149.7.1405; Woodruff JB, 2017, CELL, V169, P1066, DOI 10.1016/j.cell.2017.05.028; Wuhr M, 2015, CURR BIOL, V25, P2663, DOI 10.1016/j.cub.2015.08.047; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Zhang R, 2017, ELIFE, V6, DOI 10.7554/eLife.30959	51	4	4	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100998	10.1016/j.jbc.2021.100998	http://dx.doi.org/10.1016/j.jbc.2021.100998			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34302807	gold, Green Published			2022-12-28	WOS:000706418900010
J	Yaghootfam, C; Gehrig, B; Sylvester, M; Gieselmann, V; Matzner, U				Yaghootfam, Claudia; Gehrig, Bernd; Sylvester, Marc; Gieselmann, Volkmar; Matzner, Ulrich			Deletion of fatty acid amide hydrolase reduces lyso-sulfatide levels but exacerbates metachromatic leukodystrophy in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOUSE MODEL; CEREBROSIDE SULFOTRANSFERASE; HUMAN-CELLS; ANANDAMIDE; QUANTIFICATION; PROLIFERATION; METABOLISM; HYPOTHESIS; APOPTOSIS; PATHOLOGY	An inherited deficiency of arylsulfatase A (ASA) causes the lysosomal storage disease metachromatic leukodystrophy (MLD) characterized by massive intralysosomal storage of the acidic glycosphingolipid sulfatide and progressive demyelin-ation. Lyso-sulfatide, which differs from sulfatide by the lack of the N-linked fatty acid, also accumulates in MLD and is considered a key driver of pathology although its concentra-tions are far below sulfatide levels. However, the metabolic origin of lyso-sulfatide is unknown. We show here that ASA -deficient murine macrophages and microglial cells express an endo-N-deacylase that cleaves the N-linked fatty acid from sulfatide. An ASA-deficient astrocytoma cell line devoid of this activity was used to identify the enzyme by overexpressing 13 deacylases with potentially matching substrate specificities. Hydrolysis of sulfatide was detected only in cells over-expressing the enzyme fatty acid amide hydrolase (FAAH). A cell-free assay with recombinant FAAH confirmed the novel role of this enzyme in sulfatide hydrolysis. Consistent with the in vitro data, deletion of FAAH lowered lyso-sulfatide levels in a mouse model of MLD. Regardless of the established cyto-toxicity of lyso-sulfatide and the anti-inflammatory effects of FAAH inhibition seen in mouse models of several neurological diseases, genetic inactivation of FAAH did not mitigate, but rather exacerbated the disease phenotype of MLD mice. This unexpected finding was reflected by worsening of rotarod performance, increase of anxiety-related exploratory activity, aggravation of peripheral neuropathy, and reduced life expec-tancy. Thus, we conclude that FAAH has a protective function in MLD and may represent a novel therapeutic target for treatment of this fatal condition.	[Yaghootfam, Claudia; Gieselmann, Volkmar; Matzner, Ulrich] Univ Bonn, Med Fac, Bonn, Germany; [Gehrig, Bernd; Sylvester, Marc] Univ Bonn, Med Fac, Core Facil Mass Spectrometry, Inst Biochem & Mol Biol, Bonn, Germany	University of Bonn; University of Bonn	Matzner, U (corresponding author), Univ Bonn, Med Fac, Bonn, Germany.	matzner@uni-bonn.de		Sylvester, Marc/0000-0002-4275-0200				Baillie G, 2002, J LIPID RES, V43, P69; Bala Usman, 2014, BMC Res Notes, V7, P714, DOI 10.1186/1756-0500-7-714; Bartoll A, 2020, EMBO MOL MED, V12, DOI 10.15252/emmm.201911776; Breiden B, 2020, BIOL CHEM, V401, P31, DOI 10.1515/hsz-2019-0270; Breiden B, 2019, ANNU REV BIOCHEM, V88, P461, DOI 10.1146/annurev-biochem-013118-111518; Chen J, 2009, CHROMATOGRAPHIA, V69, P1, DOI 10.1365/s10337-008-0841-x; Di Marzo V, 1999, EUR J BIOCHEM, V264, P258, DOI 10.1046/j.1432-1327.1999.00631.x; Elleder M, 2006, J INHERIT METAB DIS, V29, P707, DOI 10.1007/s10545-006-0411-z; Furusato M, 2002, J BIOL CHEM, V277, P17300, DOI 10.1074/jbc.m110688200; Habetha M, 2001, NEUROSCI RES COMMUN, V29, P69, DOI 10.1002/nrc.1028; HANNUN YA, 1987, SCIENCE, V235, P670, DOI 10.1126/science.3101176; Hans M, 2009, NEUROCHEM RES, V34, P508, DOI 10.1007/s11064-008-9813-7; Henne WM, 2017, ADV EXP MED BIOL, V997, P135, DOI 10.1007/978-981-10-4567-7_10; Kaminski D, 2020, HUM MOL GENET, V29, P3807, DOI 10.1093/hmg/ddaa277; Lang WS, 1999, J MED CHEM, V42, P896, DOI 10.1021/jm980461j; LIN YN, 1982, INT J BIOCHEM, V14, P831, DOI 10.1016/0020-711X(82)90105-7; Lu HC, 2016, BIOL PSYCHIAT, V79, P516, DOI 10.1016/j.biopsych.2015.07.028; Lubke T, 2009, BBA-MOL CELL RES, V1793, P625, DOI 10.1016/j.bbamcr.2008.09.018; Maccarrone M, 2000, J BIOL CHEM, V275, P31938, DOI 10.1074/jbc.M005722200; Maccarrone M, 1998, J BIOL CHEM, V273, P32332, DOI 10.1074/jbc.273.48.32332; Matthes F, 2012, HUM MOL GENET, V21, P2599, DOI 10.1093/hmg/dds086; Matzner U, 2005, HUM MOL GENET, V14, P1139, DOI 10.1093/hmg/ddi126; McKinney MK, 2005, ANNU REV BIOCHEM, V74, P411, DOI 10.1146/annurev.biochem.74.082803.133450; Mirzaian M, 2015, J LIPID RES, V56, P936, DOI 10.1194/jlr.M057232; MONTI E, 1992, BIOCHIM BIOPHYS ACTA, V1124, P80, DOI 10.1016/0005-2760(92)90129-J; Pino LK, 2020, MASS SPECTROM REV, V39, P229, DOI 10.1002/mas.21540; Pohl A, 2002, BIOCHEM J, V365, P259, DOI 10.1042/BJ20011880; POLTEN A, 1991, NEW ENGL J MED, V324, P18, DOI 10.1056/NEJM199101033240104; Ramakrishnan H, 2007, J NEUROSCI, V27, P9482, DOI 10.1523/JNEUROSCI.2287-07.2007; Ramarao MK, 2005, ANAL BIOCHEM, V343, P143, DOI 10.1016/j.ab.2005.04.032; Ren SY, 2020, ACTA PHARMACOL SIN, V41, P1263, DOI 10.1038/s41401-020-0385-7; Schulze H, 2014, BBA-MOL CELL BIOL L, V1841, P799, DOI 10.1016/j.bbalip.2013.10.015; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Schwarzmann G, 2018, METHODS MOL BIOL, V1804, P323, DOI 10.1007/978-1-4939-8552-4_16; Stein A, 2015, MOL THER, V23, P1160, DOI 10.1038/mt.2015.69; Stella N, 2009, NEUROPHARMACOLOGY, V56, P244, DOI 10.1016/j.neuropharm.2008.07.037; SUNDARAM SK, 1995, J BIOL CHEM, V270, P10187, DOI 10.1074/jbc.270.17.10187; Suzuki K, 1998, NEUROCHEM RES, V23, P251, DOI 10.1023/A:1022436928925; Tanaka M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8050491; TEMPESTA MC, 1994, BIOCHEM J, V297, P479, DOI 10.1042/bj2970479; TODA K, 1989, BIOCHEM BIOPH RES CO, V159, P605, DOI 10.1016/0006-291X(89)90037-5; van Eijk M, 2020, ESSAYS BIOCHEM, V64, P565, DOI 10.1042/EBC20190090; VONFIGURA K, 2001, METABOLIC MOL BASES, P3695; Yaghootfam A, 2007, BIOCHEMISTRY-US, V46, P9260, DOI 10.1021/bi700014q; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	45	1	1	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101064	10.1016/j.jbc.2021.101064	http://dx.doi.org/10.1016/j.jbc.2021.101064			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34375644	Green Published, gold			2022-12-28	WOS:000706361700001
J	Gado, JE; Harrison, BE; Sandgren, M; Stahlberg, J; Beckham, GT; Payne, CM				Gado, Japheth E.; Harrison, Brent E.; Sandgren, Mats; Stahlberg, Jerry; Beckham, Gregg T.; Payne, Christina M.			Machine learning reveals sequence-function relationships in family 7 glycoside hydrolases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRICHODERMA-REESEI CELLOBIOHYDROLASE; CARBOHYDRATE-BINDING MODULE; CRYSTAL-STRUCTURE; CELLULOSE-BINDING; PHANEROCHAETE-CHRYSOSPORIUM; ANGSTROM RESOLUTION; PROTEIN-SEQUENCE; ENDOGLUCANASE I; THERMOSTABLE CELLOBIOHYDROLASE; ENZYMATIC-HYDROLYSIS	Family 7 glycoside hydrolases (GH7) are among the principal enzymes for cellulose degradation in nature and industrially. These enzymes are often bimodular, including a catalytic domain and carbohydrate-binding module (CBM) attached via a flexible linker, and exhibit an active site that binds cello-oligomers of up to ten glucosyl moieties. GH7 cellulases consist of two major subtypes: cellobiohydrolases (CBH) and endoglucanases (EG). Despite the critical importance of GH7 enzymes, there remain gaps in our understanding of how GH7 sequence and structure relate to function. Here, we employed machine learning to gain data-driven insights into relation-ships between sequence, structure, and function across the GH7 family. Machine-learning models, trained only on the number of residues in the active-site loops as features, were able to discriminate GH7 CBHs and EGs with up to 99% ac-curacy, demonstrating that the lengths of loops A4, B2, B3, and B4 strongly correlate with functional subtype across the GH7 family. Classification rules were derived such that specific residues at 42 different sequence positions each predicted the functional subtype with accuracies surpassing 87%. A random forest model trained on residues at 19 positions in the catalytic domain predicted the presence of a CBM with 89.5% accuracy. Our machine learning results recapitulate, as top-performing features, a substantial number of the sequence positions determined by previous experimental studies to play vital roles in GH7 activity. We surmise that the yet-to-be-explored sequence positions among the top-performing features also contribute to GH7 functional variation and may be exploited to understand and manipulate function.	[Gado, Japheth E.; Payne, Christina M.] Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA; [Gado, Japheth E.; Beckham, Gregg T.] Natl Renewable Energy Lab, Renewable Resources & Enabling Sci Ctr, Golden, CO USA; [Harrison, Brent E.] Univ Kentucky, Dept Comp Sci, Lexington, KY USA; [Sandgren, Mats; Stahlberg, Jerry] Swedish Univ Agr Sci, Dept Mol Sci, Uppsala, Sweden	University of Kentucky; United States Department of Energy (DOE); National Renewable Energy Laboratory - USA; University of Kentucky; Swedish University of Agricultural Sciences	Payne, CM (corresponding author), Univ Kentucky, Dept Chem & Mat Engn, Lexington, KY 40506 USA.	christy.payne@uky.edu	; Stahlberg, Jerry/D-4163-2013; Payne, Christina/C-7338-2011	Sandgren, Mats/0000-0002-2358-4534; Gado, Japheth/0000-0002-0024-2531; Harrison, Brent/0000-0002-1301-5928; Stahlberg, Jerry/0000-0003-4059-8580; Payne, Christina/0000-0001-5264-0964	National Science Foundation [CBET-1552355]; U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office; NSF	National Science Foundation(National Science Foundation (NSF)); U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF))	This work was supported in part by the National Science Foundation (CBET-1552355 to C. M. P. in support of J. E. G.). Funding was provided to G. T. B. by the U.S. Department of Energy Office of Energy Efficiency and Renewable Energy Bioenergy Technologies Office. This material is also based upon work supported by (while CMP is serving at) the NSF. Any opinion, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the NSF.	Alpaydin E, 2014, ADAPT COMPUT MACH LE, P1; Amore A, 2017, P NATL ACAD SCI USA, V114, P13667, DOI 10.1073/pnas.1714249114; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Archer KJ, 2008, COMPUT STAT DATA AN, V52, P2249, DOI 10.1016/j.csda.2007.08.015; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Beckham GT, 2014, CURR OPIN BIOTECH, V27, P96, DOI 10.1016/j.copbio.2013.12.002; Beckham GT, 2010, BIOPHYS J, V99, P3773, DOI 10.1016/j.bpj.2010.10.032; Beckham GT, 2010, J PHYS CHEM B, V114, P1447, DOI 10.1021/jp908810a; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Borisova AS, 2018, BIOTECHNOL BIOFUELS, V11, DOI 10.1186/s13068-017-1006-7; Borisova AS, 2015, FEBS J, V282, P4515, DOI 10.1111/febs.13509; Breiman L., 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Bu LT, 2012, J BIOL CHEM, V287, P24807, DOI 10.1074/jbc.M112.365510; Bu LT, 2011, J BIOL CHEM, V286, P18161, DOI 10.1074/jbc.M110.212076; Chen X, 2012, GENOMICS, V99, P323, DOI 10.1016/j.ygeno.2012.04.003; Chicco D, 2017, BIODATA MIN, V10, DOI 10.1186/s13040-017-0155-3; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Colussi F, 2015, J BIOL CHEM, V290, P2444, DOI 10.1074/jbc.M114.624163; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; De Fonzo V, 2007, CURR BIOINFORM, V2, P49, DOI 10.2174/157489307779314348; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; DIVNE C, 1994, SCIENCE, V265, P524, DOI 10.1126/science.8036495; Doolittle R. F, 1996, COMPUTER METHODS MAC; Drummond C, 2003, P WORKSH LEARN IMB D, P1; Eddy S., 2003, HMMER USERS GUIDE BI; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; GhattyVenkataKrishna PK, 2013, BIOPHYS J, V104, P904, DOI 10.1016/j.bpj.2012.12.052; Han PF, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-8; Hannenhalli SS, 2000, J MOL BIOL, V303, P61, DOI 10.1006/jmbi.2000.4036; Harrison MJ, 1998, EUR J BIOCHEM, V256, P119, DOI 10.1046/j.1432-1327.1998.2560119.x; He HB, 2009, IEEE T KNOWL DATA EN, V21, P1263, DOI 10.1109/TKDE.2008.239; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Hobdey SE, 2016, APPL ENVIRON MICROB, V82, P3395, DOI 10.1128/AEM.00163-16; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; Huysmans J, 2011, DECIS SUPPORT SYST, V51, P141, DOI 10.1016/j.dss.2010.12.003; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Kadowaki MAS, 2018, FEBS J, V285, P559, DOI 10.1111/febs.14356; Kari J, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.604264; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kern M, 2013, P NATL ACAD SCI USA, V110, P10189, DOI 10.1073/pnas.1301502110; Kim JH, 2009, COMPUT STAT DATA AN, V53, P3735, DOI 10.1016/j.csda.2009.04.009; Kleywegt GJ, 1997, J MOL BIOL, V272, P383, DOI 10.1006/jmbi.1997.1243; Knott BC, 2014, J AM CHEM SOC, V136, P8810, DOI 10.1021/ja504074g; Knott BC, 2014, J AM CHEM SOC, V136, P321, DOI 10.1021/ja410291u; Kurasin M, 2011, J BIOL CHEM, V286, P169, DOI 10.1074/jbc.M110.161059; Le Costaouec T, 2013, BIORESOURCE TECHNOL, V143, P196, DOI 10.1016/j.biortech.2013.05.079; Lin CT, 2005, INT J NEURAL SYST, V15, P71, DOI 10.1142/S0129065705000116; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Luque A, 2019, PATTERN RECOGN, V91, P216, DOI 10.1016/j.patcog.2019.02.023; Lynd LR, 2002, MICROBIOL MOL BIOL R, V66, P506, DOI 10.1128/MMBR.66.3.506-577.2002; Mackenzie LF, 1998, BIOCHEM J, V335, P409, DOI 10.1042/bj3350409; Martinez D, 2008, NAT BIOTECHNOL, V26, P553, DOI 10.1038/nbt1403; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; Mitsuzawa S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16434-x; Momeni MH, 2014, ACTA CRYSTALLOGR D, V70, P2356, DOI 10.1107/S1399004714013844; Momeni MH, 2013, J BIOL CHEM, V288, P5861, DOI 10.1074/jbc.M112.440891; Moroz OV, 2015, ACTA CRYSTALLOGR F, V71, P114, DOI 10.1107/S2053230X14027307; Mulakala C, 2005, PROTEINS, V60, P598, DOI 10.1002/prot.20547; Munoz IG, 2001, J MOL BIOL, V314, P1097, DOI 10.1006/jmbi.2000.5180; Murphy L, 2012, J BIOL CHEM, V287, P1252, DOI 10.1074/jbc.M111.276485; Nakamura A, 2013, J BIOL CHEM, V288, P13503, DOI 10.1074/jbc.M113.452623; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Parkkinen T, 2008, PROTEIN SCI, V17, P1383, DOI 10.1110/ps.034488.108; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, J AM CHEM SOC, V135, P18831, DOI 10.1021/ja407287f; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; Payne CM, 2012, J BIOL CHEM, V287, P36322, DOI 10.1074/jbc.M112.402149; Pechenizkiy M, 2006, COMP MED SY, P708, DOI 10.1109/CBMS.2006.65; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; REINIKAINEN T, 1992, PROTEINS, V14, P475, DOI 10.1002/prot.340140408; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Sammond DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048615; Schiano-di-Cola C, 2020, FEBS J, V287, P2577, DOI 10.1111/febs.15151; Schiano-di-Cola C, 2019, J BIOL CHEM, V294, P1807, DOI 10.1074/jbc.RA118.006699; Silveira RL, 2018, PHYS CHEM CHEM PHYS, V20, P7498, DOI 10.1039/c8cp00101d; Sonoda MT, 2019, BBA-GEN SUBJECTS, V1863, P1015, DOI 10.1016/j.bbagen.2019.03.013; Sorensen TH, 2017, BIOTECHNOL BIOENG, V114, P53, DOI 10.1002/bit.26050; Srisodsuk M, 1997, J BIOTECHNOL, V57, P49, DOI 10.1016/S0168-1656(97)00088-6; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sulzenbacher G, 1997, BIOCHEMISTRY-US, V36, P5902, DOI 10.1021/bi962963+; Takashima S, 2007, FEBS LETT, V581, P5891, DOI 10.1016/j.febslet.2007.11.068; Taylor CB, 2013, J PHYS CHEM B, V117, P4924, DOI 10.1021/jp401410h; Taylor LE, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03501-8; Textor LC, 2013, FEBS J, V280, P56, DOI 10.1111/febs.12049; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Ubhayasekera W, 2005, FEBS J, V272, P1952, DOI 10.1111/j.1742-4658.2005.04625.x; VANTILBEURGH H, 1986, FEBS LETT, V204, P223, DOI 10.1016/0014-5793(86)80816-X; Vinzant TB, 2001, APPL BIOCHEM BIOTECH, V91-3, P99, DOI 10.1385/ABAB:91-93:1-9:99; von Ossowski I, 2003, J MOL BIOL, V333, P817, DOI 10.1016/S0022-2836(03)00881-7; Wang YF, 2016, BIOTECHNOL BIOENG, V113, P1873, DOI 10.1002/bit.25970; Whisstock JC, 2003, Q REV BIOPHYS, V36, P307, DOI 10.1017/S0033583503003901; Zhang YHP, 2004, BIOTECHNOL BIOENG, V88, P797, DOI 10.1002/bit.20282; Zhang Y, 2013, J PHYS CHEM B, V117, P8714, DOI 10.1021/jp403999s; Zhu XQ, 2004, ARTIF INTELL REV, V22, P177, DOI 10.1007/s10462-004-0751-8; Zong ZY, 2019, J AM CHEM SOC, V141, P14451, DOI 10.1021/jacs.9b08477	97	4	5	8	32	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100931	10.1016/j.jbc.2021.100931	http://dx.doi.org/10.1016/j.jbc.2021.100931			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34216620	Green Submitted, Green Published, gold			2022-12-28	WOS:000690879300001
J	Lopez-Soldado, I; Guinovart, JJ; Duran, J				Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi			Increased liver glycogen levels enhance exercise capacity in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEVATED MUSCLE GLYCOGEN; GLUCOSE-METABOLISM; INTRACELLULAR-DISTRIBUTION; HEPATIC GLYCOGENOLYSIS; EXHAUSTIVE EXERCISE; RUNNING ENDURANCE; ENERGY-STATE; FOOD-INTAKE; SYNTHASE; GLUCONEOGENESIS	Muscle glycogen depletion has been proposed as one of the main causes of fatigue during exercise. However, few studies have addressed the contribution of liver glycogen to exercise performance. Using a low-intensity running protocol, here, we analyzed exercise capacity in mice overexpressing protein targeting to glycogen (PTG) specifically in the liver (PTG(OE) mice), which show a high concentration of glycogen in this organ. PTG(OE) mice showed improved exercise capacity, as determined by the distance covered and time ran in an extenuating endurance exercise, compared with control mice. Moreover, fasting decreased exercise capacity in control mice but not in PTG(OE) mice. After exercise, liver glycogen stores were totally depleted in control mice, but PTG(OE) mice maintained significant glycogen levels even in fasting conditions. In addition, PTG(OE) mice displayed an increased hepatic energy state after exercise compared with control mice. Exercise caused a reduction in the blood glucose concentration in control mice that was less pronounced in PTG(OE) mice. No changes were found in the levels of blood lactate, plasma free fatty acids, or beta-hydroxybutyrate. Plasma glucagon was elevated after exercise in control mice, but not in PTG(OE) mice. Exercise-induced changes in skeletal muscle were similar in both genotypes. These results identify hepatic glycogen as a key regulator of endurance capacity in mice, an effect that may be exerted through the maintenance of blood glucose levels.	[Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi] Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain; [Lopez-Soldado, Iliana; Guinovart, Joan J.; Duran, Jordi] Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain; [Guinovart, Joan J.] Univ Barcelona, Dept Biochem & Mol Biomed, Barcelona, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; University of Barcelona	Lopez-Soldado, I (corresponding author), Barcelona Inst Sci & Technol, Inst Res Biomed IRB Barcelona, Barcelona, Spain.; Lopez-Soldado, I (corresponding author), Ctr Invest Biomed Red Diabet & Enfermedades Metab, Madrid, Spain.	iliana.lopez@irbbarcelona.org	Duran, Jordi/AGP-2068-2022; Duran, Jordi/J-7298-2017	Duran, Jordi/0000-0002-8342-4882; 	MINECO [BFU2017-84345-P]; CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion)	MINECO(Spanish Government); CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion)	This study was supported by a grant BFU2017-84345-P from MINECO to J. G. and J. D. and the CIBER de Diabetes y Enfermedades Metabolicas Asociadas (ISCIII, Ministerio de Ciencia e Innovacion).	Ament W, 2009, SPORTS MED, V39, P389, DOI 10.2165/00007256-200939050-00005; Auge E, 2018, GLIA, V66, P2094, DOI 10.1002/glia.23463; BANGSBO J, 1992, J PHYSIOL-LONDON, V451, P205, DOI 10.1113/jphysiol.1992.sp019161; Banzet S, 2009, J APPL PHYSIOL, V107, P1830, DOI 10.1152/japplphysiol.00739.2009; Berglund ED, 2009, J CLIN INVEST, V119, P2412, DOI 10.1172/JCI38650; Berman HK, 1998, J BIOL CHEM, V273, P26421, DOI 10.1074/jbc.273.41.26421; Camacho RC, 2006, AM J PHYSIOL-ENDOC M, V290, pE405, DOI 10.1152/ajpendo.00385.2005; Cermak NM, 2013, SPORTS MED, V43, P1139, DOI 10.1007/s40279-013-0079-0; Duran J, 2014, HUM MOL GENET, V23, P3147, DOI 10.1093/hmg/ddu024; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Evans M, 2017, J PHYSIOL-LONDON, V595, P2857, DOI 10.1113/JP273185; Fan WW, 2017, CELL METAB, V25, P1186, DOI 10.1016/j.cmet.2017.04.006; FELIG P, 1972, NEW ENGL J MED, V287, P184, DOI 10.1056/NEJM197207272870412; Frayn KN, 2010, ACTA PHYSIOL, V199, P509, DOI 10.1111/j.1748-1716.2010.02128.x; Garcia-Rocha M, 2001, BIOCHEM J, V357, P17, DOI 10.1042/0264-6021:3570017; Gasa R, 2000, J BIOL CHEM, V275, P26396, DOI 10.1074/jbc.M002427200; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P421, DOI 10.1152/jappl.1972.33.4.421; Gonzalez JT, 2016, AM J PHYSIOL-ENDOC M, V311, pE543, DOI 10.1152/ajpendo.00232.2016; GORSKI J, 1988, EUR J APPL PHYSIOL, V57, P554, DOI 10.1007/BF00418461; HERMANSE.L, 1967, ACTA PHYSIOL SCAND, V71, P129, DOI 10.1111/j.1748-1716.1967.tb03719.x; Herring JA, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8111373; Hoene M, 2009, J PHYSIOL-LONDON, V587, P241, DOI 10.1113/jphysiol.2008.160275; Holness MJ, 2003, BIOCHEM J, V369, P687, DOI 10.1042/BJ20021509; Irimia JM, 2010, J BIOL CHEM, V285, P12851, DOI 10.1074/jbc.M110.106534; Jensen J, 2011, FRONT PHYSIOL, V2, DOI 10.3389/fphys.2011.00112; JOHNALDER HB, 1986, AM J PHYSIOL, V251, pR137, DOI 10.1152/ajpregu.1986.251.1.R137; KASLOW HR, 1985, J BIOL CHEM, V260, P9953; KASLOW HR, 1984, FEBS LETT, V172, P294, DOI 10.1016/0014-5793(84)81144-8; Knudsen JG, 2015, MOL CELL BIOCHEM, V403, P209, DOI 10.1007/s11010-015-2351-0; Li LO, 2015, DIABETES, V64, P23, DOI 10.2337/db13-1070; Lopez-Soldado I, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100498; Lopez-Soldado I, 2020, FEBS LETT, V594, P1698, DOI 10.1002/1873-3468.13770; Lopez-Soldado I, 2017, DIABETOLOGIA, V60, P1076, DOI 10.1007/s00125-017-4240-4; Lopez-Soldado I, 2015, DIABETES, V64, P796, DOI 10.2337/db14-0728; Mir-Coll J, 2016, DIABETOLOGIA, V59, P1012, DOI 10.1007/s00125-016-3871-1; Nezhad FY, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00262; Pederson BA, 2005, DIABETES, V54, P3466, DOI 10.2337/diabetes.54.12.3466; Pederson BA, 2005, J BIOL CHEM, V280, P17260, DOI 10.1074/jbc.M410448200; Pederson BA, 2005, BIOCHEM BIOPH RES CO, V331, P491, DOI 10.1016/j.bbrc.2005.03.206; Pei LM, 2006, NAT MED, V12, P1048, DOI 10.1038/nm1471; Pei LM, 2005, J BIOL CHEM, V280, P29256, DOI 10.1074/jbc.M502606200; PERNOW B, 1971, J APPL PHYSIOL, V31, P416, DOI 10.1152/jappl.1971.31.3.416; Petersen KF, 2004, J CLIN ENDOCR METAB, V89, P4656, DOI 10.1210/jc.2004-0408; Pillon NJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13869-w; ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380, DOI 10.1152/ajpendo.1993.265.3.E380; Ros S, 2010, J BIOL CHEM, V285, P37170, DOI 10.1074/jbc.M110.157396; Ros S, 2009, J BIOL CHEM, V284, P6370, DOI 10.1074/jbc.M808576200; SALMON DMW, 1985, INT J OBESITY, V9, P443; Shulman RG, 2001, P NATL ACAD SCI USA, V98, P457, DOI 10.1073/pnas.98.2.457; Stevenson EJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE1140, DOI 10.1152/ajpendo.90788.2008; Trefts E, 2015, PROG MOL BIOL TRANSL, V135, P203, DOI 10.1016/bs.pmbts.2015.07.010; van Loon LJC, 2001, J PHYSIOL-LONDON, V536, P295, DOI 10.1111/j.1469-7793.2001.00295.x; von Wilamowitz-Moellendorff A, 2013, DIABETES, V62, P4070, DOI 10.2337/db13-0880; WAHREN J, 1971, J CLIN INVEST, V50, P2715, DOI 10.1172/JCI106772; Wahren J, 2007, ANNU REV NUTR, V27, P329, DOI 10.1146/annurev.nutr.27.061406.093806; Wasserman DH, 2009, AM J PHYSIOL-ENDOC M, V296, pE11, DOI 10.1152/ajpendo.90563.2008; WASSERMAN DH, 1989, AM J PHYSIOL, V257, pE108, DOI 10.1152/ajpendo.1989.257.1.E108; Winoto A, 2002, CELL, V109, pS57, DOI 10.1016/S0092-8674(02)00710-9; WOLFE RR, 1986, J CLIN INVEST, V77, P900, DOI 10.1172/JCI112388; Xirouchaki CE, 2016, MOL METAB, V5, P221, DOI 10.1016/j.molmet.2016.01.004; Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050; Zhu AP, 2009, ANAL BIOCHEM, V388, P97, DOI 10.1016/j.ab.2009.02.009	62	8	8	2	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100976	10.1016/j.jbc.2021.100976	http://dx.doi.org/10.1016/j.jbc.2021.100976			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34284060	Green Published, gold			2022-12-28	WOS:000690873500004
J	Najarzadeh, Z; Zaman, M; Sereikaite, V; Stromgaard, K; Andreasen, M; Otzen, DE				Najarzadeh, Zahra; Zaman, Masihuz; Sereikaite, Vita; Stromgaard, Kristian; Andreasen, Maria; Otzen, Daniel E.			Heparin promotes fibrillation of most phenol-soluble modulin virulence peptides from Staphylococcus aureus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES; AMYLOID-AGGREGATION; PROTEIN; DETERMINANTS; GLYCOSAMINOGLYCANS; ALZHEIMERS; FIBRILS	Phenol-soluble modulins (PSMs), such as alpha-PSMs, beta-PSMs, and 8-toxin, are virulence peptides secreted by different Staphylococcus aureus strains. PSMs are able to form amyloid fibrils, which may strengthen the biofilm matrix that promotes bacterial colonization of and extended growth on surfaces (e.g., cell tissue) and increases antibiotic resistance. Many components contribute to biofilm formation, including the human produced highly sulfated glycosaminoglycan heparin. Although heparin promotes S. aureus infection, the molecular basis for this is unclear. Given that heparin is known to induce fibrillation of a wide range of proteins, we hypothesized that heparin aids bacterial colonization by promoting PSM fibril-lation. Here, we address this hypothesis using a combination of thioflavin T-fluorescence kinetic studies, CD, FTIR, electron microscopy, and peptide microarrays to investigate the mechanism of aggregation, the structure of the fibrils, and identify possible binding regions. We found that heparin accelerates fibrillation of all alpha-PSMs (except PSM alpha 2) and 8-toxin but inhibits beta-PSM fibrillation by blocking nucleation or reducing fibrillation levels. Given that S. aureus secretes higher levels of alpha-PSM than beta-PSM peptides, heparin is therefore likely to promote fibrillation overall. Heparin binding is driven by multiple positively charged lysine residues in alpha-PSMs and 8 toxins, the removal of which strongly reduced binding affinity. Binding of heparin did not affect the structure of the resulting fibrils, that is, the outcome of the aggregation process. Rather, heparin provided a scaffold to catalyze or inhibit fibrillation. Based on our findings, we speculate that heparin may strengthen the bacterial biofilm and therefore enhance colonization via increased PSM fibrillation.	[Najarzadeh, Zahra; Otzen, Daniel E.] Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark; [Zaman, Masihuz; Andreasen, Maria] Aarhus Univ, Dept Biomed, Aarhus C, Denmark; [Sereikaite, Vita; Stromgaard, Kristian] Univ Copenhagen, Dept Drug Design & Pharmacol, Copenhagen O, Denmark	Aarhus University; Aarhus University; University of Copenhagen	Otzen, DE (corresponding author), Aarhus Univ, Interdisciplinary Nanosci Ctr iNANO, Aarhus C, Denmark.; Andreasen, M (corresponding author), Aarhus Univ, Dept Biomed, Aarhus C, Denmark.	mariaj@biomed.au.dk; dao@inano.au.dk		Najarzadeh, Zahra/0000-0002-0044-7537; Otzen, Daniel/0000-0002-2918-8989; Andreasen, Maria/0000-0002-6096-2995; Stromgaard, Kristian/0000-0003-2206-4737; Sereikaite, Vita/0000-0001-7497-4965	Independent Research Foundation Denmark| Technical Sciences [6111-00241B]; Independent Research Foundation Denmark|Natural Sciences [802100208B]; Aarhus University Research Foundation	Independent Research Foundation Denmark| Technical Sciences; Independent Research Foundation Denmark|Natural Sciences; Aarhus University Research Foundation	D. E. O. gratefully acknowledges support by the Independent Research Foundation Denmark| Technical Sciences (grant no. 6111-00241B) and the Independent Research Foundation Denmark|Natural Sciences (grant no. 802100208B). M. A. gratefully acknowledges support by Aarhus University Research Foundation.	Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bleem A, 2018, J MOL BIOL, V430, P3751, DOI 10.1016/j.jmb.2018.06.043; Bourgault S, 2011, BIOCHEMISTRY-US, V50, P1001, DOI 10.1021/bi101822y; Capila I, 2002, ANGEW CHEM INT EDIT, V41, P391; CARDIN AD, 1989, ARTERIOSCLEROSIS, V9, P21, DOI 10.1161/01.ATV.9.1.21; Carlson RP, 2008, J BIOMAT SCI-POLYM E, V19, P1035, DOI 10.1163/156856208784909372; Chapman MR, 2002, SCIENCE, V295, P851, DOI 10.1126/science.1067484; Cheung GYC, 2014, FEMS MICROBIOL REV, V38, P698, DOI 10.1111/1574-6976.12057; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cohlberg JA, 2002, BIOCHEMISTRY-US, V41, P1502, DOI 10.1021/bi011711s; Dueholm MS, 2010, MOL MICROBIOL, V77, P1009, DOI 10.1111/j.1365-2958.2010.07269.x; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; Forson AM, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69084-x; Hirsh J, 2001, ARTERIOSCL THROM VAS, V21, P1094, DOI 10.1161/hq0701.093686; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hryszko T, 2013, INT UROL NEPHROL, V45, P825, DOI 10.1007/s11255-012-0151-y; Jha NN, 2013, BIOCHEMISTRY-US, V52, P8800, DOI 10.1021/bi401398k; Jones CJ, 2011, ANNU REV ANAL CHEM, V4, P439, DOI 10.1146/annurev-anchem-061010-113911; Klajnert B, 2006, BIOCHEM BIOPH RES CO, V339, P577, DOI 10.1016/j.bbrc.2005.11.053; Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327; LEVINE H, 1993, PROTEIN SCI, V2, P404, DOI 10.1002/pro.5560020312; Mansson C, 2014, J BIOL CHEM, V289, P31066, DOI 10.1074/jbc.M114.595124; Marinelli P, 2016, SCI REP-UK, V6, DOI 10.1038/srep34552; McLaurin J, 1999, EUR J BIOCHEM, V266, P1101, DOI 10.1046/j.1432-1327.1999.00957.x; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Meisl G, 2016, NAT PROTOC, V11, P252, DOI 10.1038/nprot.2016.010; Michaels TCT, 2020, P NATL ACAD SCI USA, V117, P24251, DOI 10.1073/pnas.2006684117; Mishra S, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00135-17; Motamedi-Shad N, 2012, NAT STRUCT MOL BIOL, V19, P547, DOI 10.1038/nsmb.2286; Motamedi-Shad N, 2009, J BIOCHEM, V146, P805, DOI 10.1093/jb/mvp128; Munke A, 2017, P NATL ACAD SCI USA, V114, P6444, DOI 10.1073/pnas.1700407114; Najarzadeh Z, 2019, BBA-PROTEINS PROTEOM, V1867, DOI 10.1016/j.bbapap.2019.140263; Nielsen SB, 2012, J MOL BIOL, V421, P601, DOI 10.1016/j.jmb.2012.01.050; Nitani A, 2017, J BIOL CHEM, V292, P21219, DOI 10.1074/jbc.M117.813097; Noborn F, 2011, P NATL ACAD SCI USA, V108, P5584, DOI 10.1073/pnas.1101194108; Otto Michael, 2018, Microbiol Spectr, V6, DOI 10.1128/microbiolspec.GPP3-0023-2018; Otzen D, 2019, CSH PERSPECT BIOL, V11, DOI 10.1101/cshperspect.a033860; Otzen D, 2011, BBA-PROTEINS PROTEOM, V1814, P562, DOI 10.1016/j.bbapap.2011.03.003; Potter KJ, 2015, AM J TRANSPLANT, V15, P1519, DOI 10.1111/ajt.13134; Relini A, 2008, J BIOL CHEM, V283, P4912, DOI 10.1074/jbc.M702712200; Romero D, 2010, P NATL ACAD SCI USA, V107, P2230, DOI 10.1073/pnas.0910560107; Schwartz K, 2016, MOL MICROBIOL, V99, P123, DOI 10.1111/mmi.13219; Schwartz K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002744; Shanks RMQ, 2005, INFECT IMMUN, V73, P4596, DOI 10.1128/IAI.73.8.4596-4606.2005; Shi SF, 2016, INT J NANOMED, V11, P6499, DOI 10.2147/IJN.S41371; So M, 2017, PROTEIN SCI, V26, P1024, DOI 10.1002/pro.3149; Surewaard BGJ, 2013, CELL MICROBIOL, V15, P1427, DOI 10.1111/cmi.12130; Tayeb-Fligelman E, 2020, STRUCTURE, V28, P301, DOI 10.1016/j.str.2019.12.006; Tayeb-Fligelman E, 2017, SCIENCE, V355, P831, DOI 10.1126/science.aaf4901; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853; Zaman M, 2020, ELIFE, V9, DOI 10.7554/eLife.59776	54	4	5	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100953	10.1016/j.jbc.2021.100953	http://dx.doi.org/10.1016/j.jbc.2021.100953			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34270957	Green Published, gold			2022-12-28	WOS:000690871400005
J	Prussia, GA; Shisler, KA; Zadvornyy, OA; Streit, BR; DuBois, JL; Peters, JW				Prussia, Gregory A.; Shisler, Krista A.; Zadvornyy, Oleg A.; Streit, Bennett R.; DuBois, Jennifer L.; Peters, John W.			The unique Phe-His dyad of 2-ketopropyl coenzyme M oxidoreductase/carboxylase selectively promotes carboxylation and S-C bond cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; DISULFIDE OXIDOREDUCTASE; CATALYTIC MECHANISM; FAMILY	The 2-ketopropyl-coenzyme M oxidoreductase/carboxylase (2-KPCC) enzyme is the only member of the disulfide oxido-reductase (DSOR) family of enzymes, which are important for reductively cleaving S-S bonds, to have carboxylation activity. 2-KPCC catalyzes the conversion of 2-ketopropyl-coenzyme M to acetoacetate, which is used as a carbon source, in a controlled reaction to exclude protons. A conserved His-Glu motif present in DSORs is key in the protonation step; however, in 2-KPCC, the dyad is substituted by Phe-His. Here, we propose that this difference is important for coupling carboxylation with C-S bond cleavage. We substituted the Phe-His dyad in 2-KPCC to be more DSOR like, replacing the phenyl-alanine with histidine (F501H) and the histidine with glutamate (H506E), and solved crystal structures of F501H and the double variant F501H_H506E. We found that F501 protects the enolacetone intermediate from protons and that the F501H variant strongly promotes protonation. We also provided evidence for the involvement of the H506 residue in stabilizing the developing charge during the formation of acetoacetate, which acts as a product inhibitor in the WT but not the H506E variant enzymes. Finally, we determined that the F501H substitution promotes a DSOR-like charge transfer interaction with flavin adenine dinucleotide, eliminating the need for cysteine as an internal base. Taken together, these results indicate that the 2-KPCC dyad is responsible for selectively promoting carboxylation and inhibiting protonation in the formation of acetoacetate.	[Prussia, Gregory A.; Shisler, Krista A.; Zadvornyy, Oleg A.; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA; [Streit, Bennett R.; DuBois, Jennifer L.] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA	Washington State University; Montana State University System; Montana State University Bozeman	Peters, JW (corresponding author), Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA.	jw.peters@wsu.edu		Streit, Bennett/0000-0001-9174-7019	US DOE, Office of Science, Office of Basic Energy Sciences [DE-SC0018143]; United States Department of Agriculture National Institute of Food and Agriculture, Hatch umbrella project [1015621]	US DOE, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); United States Department of Agriculture National Institute of Food and Agriculture, Hatch umbrella project	This work was supported by the US DOE, Office of Science, Office of Basic Energy Sciences under award DE-SC0018143 to J. W. P. and J. L. D. Partial salary support for J. W. P. was supported by the United States Department of Agriculture National Institute of Food and Agriculture, Hatch umbrella project #1015621. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding agencies.	Argyrou A, 2004, PROG NUCLEIC ACID RE, V78, P89, DOI 10.1016/S0079-6603(04)78003-4; Boyd JM, 2010, J BIOL CHEM, V285, P25232, DOI 10.1074/jbc.M110.144410; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; DeLano W.L, PYMOL MOL GRAPHICS S; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; Deponte M, 2013, BBA-GEN SUBJECTS, V1830, P3217, DOI 10.1016/j.bbagen.2012.09.018; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ensign SA, 2003, ANNU REV BIOCHEM, V72, P55, DOI 10.1146/annurev.biochem.72.121801.161820; Frey P. A., 2007, ENZYMATIC REACTION M, P387; GHISLA S, 1989, EUR J BIOCHEM, V181, P1, DOI 10.1111/j.1432-1033.1989.tb14688.x; Glueck SM, 2010, CHEM SOC REV, V39, P313, DOI 10.1039/b807875k; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KARPLUS PA, 1989, J MOL BIOL, V210, P163, DOI 10.1016/0022-2836(89)90298-2; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nocek B, 2002, BIOCHEMISTRY-US, V41, P12907, DOI 10.1021/bi026580p; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAI EF, 1983, J BIOL CHEM, V258, P1752; Pai EF, 1991, CURR OPIN STRUC BIOL, V1, P796, DOI 10.1016/0959-440X(91)90181-R; Pandey AS, 2011, FEBS LETT, V585, P459, DOI 10.1016/j.febslet.2010.12.035; Pandey AS, 2006, BIOCHEMISTRY-US, V45, P113, DOI 10.1021/bi051518o; Prussia GA, 2016, FEBS LETT, V590, P2991, DOI 10.1002/1873-3468.12325; RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043; SCHULZ GE, 1978, NATURE, V273, P120, DOI 10.1038/273120a0; Streit BR, 2019, J BIOL CHEM, V294, P5137, DOI 10.1074/jbc.RA118.005554; Williams Jr C. H., 1992, CHEM BIOCH FLAVOENZY, P121	27	1	1	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100961	10.1016/j.jbc.2021.100961	http://dx.doi.org/10.1016/j.jbc.2021.100961			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265301	gold, Green Published			2022-12-28	WOS:000690871400014
J	Conley, JM; Sun, HM; Ayers, KL; Zhu, H; Chen, R; Shen, M; Hall, MD; Ren, HX				Conley, Jason M.; Sun, Hongmao; Ayers, Kristin L.; Zhu, Hu; Chen, Rong; Shen, Min; Hall, Matthew D.; Ren, Hongxia			Human GPR17 missense variants identified in metabolic disease patients have distinct downstream signaling profiles	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-GAMMA-SUBUNITS; ORPHAN RECEPTOR; AGRP NEURONS; GPCR; EXPRESSION; GENOME; INTERROGATION; OBESITY; SWITCH; FOXO1	GPR17 is a G-protein-coupled receptor (GPCR) implicated in the regulation of glucose metabolism and energy homeostasis. Such evidence is primarily drawn from mouse knockout studies and suggests GPR17 as a potential novel therapeutic target for the treatment of metabolic diseases. However, links between human GPR17 genetic variants, downstream cellular signaling, and metabolic diseases have yet to be reported. Here, we analyzed GPR17 coding sequences from control and disease cohorts consisting of individuals with adverse clinical metabolic deficits including severe insulin resistance, hypercholesterolemia, and obesity. We identified 18 nonsynonymous GPR17 variants, including eight variants that were exclusive to the disease cohort. We characterized the protein expression levels, membrane localization, and downstream signaling profiles of nine GPR17 variants (F43L, V96M, V103M, D105N, A131T, G136S, R248Q, R301H, and G354V). These nine GPR17 variants had similar protein expression and subcellular localization as wild-type GPR17; however, they showed diverse downstream signaling profiles. GPR17-G136S lost the capacity for agonist-mediated cAMP, Ca2+, and beta-arrestin signaling. GPR17-V96M retained cAMP inhibition similar to GPR17-WT, but showed impaired Ca2+ and beta-arrestin signaling. GPR17-D105N displayed impaired cAMP and Ca2+ signaling, but unaffected agonist-stimulated beta-arrestin recruitment. The identification and functional profiling of naturally occurring human GPR17 variants from individuals with metabolic diseases revealed receptor variants with diverse signaling profiles, including differential signaling perturbations that resulted in GPCR signaling bias. Our findings provide a framework for structure-function relationship studies of GPR17 signaling and metabolic disease.	[Conley, Jason M.; Ren, Hongxia] Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA; [Conley, Jason M.; Ren, Hongxia] Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA; [Sun, Hongmao; Zhu, Hu; Shen, Min; Hall, Matthew D.] NIH, Natl Ctr Adv Translat Sci, Rockville, MD USA; [Ayers, Kristin L.; Chen, Rong] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, Dept Genet & Genom Sci, New York, NY 10029 USA; [Ayers, Kristin L.; Chen, Rong] Mt Sinai Venture, Sema4, Stamford, CT USA; [Ren, Hongxia] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA; [Ren, Hongxia] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Ren, Hongxia] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Ren, Hongxia] Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); Icahn School of Medicine at Mount Sinai; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington	Ren, HX (corresponding author), Indiana Univ Sch Med, Herman B Wells Ctr Pediat Res, Dept Pediat, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Ctr Diabet & Metab Dis, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA.; Ren, HX (corresponding author), Indiana Univ Sch Med, Dept Anat Cell Biol & Physiol, Indianapolis, IN 46202 USA.	renh@iu.edu	zhu, hu/GQQ-8365-2022	Ren, Hongxia/0000-0003-2909-4365; Conley, Jason/0000-0003-4201-4112; Ayers, Kristin/0000-0002-4984-5229; Shen, Min/0000-0002-8218-0433	NIH [R00DK098294, R01DK120772]; CSCTR Early Career Development Award from Central Society for Clinical and Translational Research; Wells Center for Pediatric Research Support for Clinical/Translational Research from Riley Children's Foundation (RCF); Diabetes and Obesity Research Training award [T32DK064466]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CSCTR Early Career Development Award from Central Society for Clinical and Translational Research; Wells Center for Pediatric Research Support for Clinical/Translational Research from Riley Children's Foundation (RCF); Diabetes and Obesity Research Training award	This work was supported by funding from NIH R00DK098294 (H. R.), NIH R01DK120772 (H. R.), CSCTR Early Career Development Award from Central Society for Clinical and Translational Research (H. R.), Wells Center for Pediatric Research Support for Clinical/Translational Research from Riley Children's Foundation (RCF) (H. R.), and Diabetes and Obesity Research Training award T32DK064466 (J. M. C.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdullah N, 2016, CELL REP, V17, P2966, DOI 10.1016/j.celrep.2016.11.050; Attie AD, 2017, CURR OPIN ENDOCRINOL, V24, P83, DOI 10.1097/MED.0000000000000321; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baqi Y, 2018, J MED CHEM, V61, P8136, DOI 10.1021/acs.jmedchem.7b01768; Barnea G, 2008, P NATL ACAD SCI USA, V105, P64, DOI 10.1073/pnas.0710487105; Barroso I, 2019, CELL, V177, P146, DOI 10.1016/j.cell.2019.02.024; Benned-Jensen T, 2010, BRIT J PHARMACOL, V159, P1092, DOI 10.1111/j.1476-5381.2009.00633.x; Blasius R, 1998, J NEUROCHEM, V70, P1357; Bonde MM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014135; Cheng RKY, 2017, NATURE, V545, P112, DOI 10.1038/nature22309; Ciana P, 2006, EMBO J, V25, P4615, DOI 10.1038/sj.emboj.7601341; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Fenalti G, 2014, NATURE, V506, P191, DOI 10.1038/nature12944; Flock T, 2017, NATURE, V545, P317, DOI 10.1038/nature22070; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Glukhova A, 2018, ACS PHARMACOL TRANSL, V1, P73, DOI 10.1021/acsptsci.8b00026; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Gusach A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13348-2; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Hennen S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004350; HUNYADY L, 1994, J BIOL CHEM, V269, P24798; Husted AS, 2017, CELL METAB, V25, P777, DOI 10.1016/j.cmet.2017.03.008; Inoue A, 2019, CELL, V177, P1933, DOI 10.1016/j.cell.2019.04.044; Isberg V, 2015, TRENDS PHARMACOL SCI, V36, P22, DOI 10.1016/j.tips.2014.11.001; Katritch V, 2014, TRENDS BIOCHEM SCI, V39, P233, DOI 10.1016/j.tibs.2014.03.002; Khan SM, 2013, PHARMACOL REV, V65, P545, DOI 10.1124/pr.111.005603; Komolov KE, 2017, CELL SIGNAL, V41, P17, DOI 10.1016/j.cellsig.2017.07.004; Kroeze WK, 2015, NAT STRUCT MOL BIOL, V22, P362, DOI 10.1038/nsmb.3014; Lee Y, 2020, NATURE, V583, P862, DOI 10.1038/s41586-020-2419-1; Liu XM, 2016, HUM MUTAT, V37, P235, DOI 10.1002/humu.22932; Lotta LA, 2019, CELL, V177, P597, DOI 10.1016/j.cell.2019.03.044; Luginina A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax2518; Marschallinger J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9466; Mastaitis J, 2015, P NATL ACAD SCI USA, V112, P1845, DOI 10.1073/pnas.1424968112; Oprea TI, 2018, NAT REV DRUG DISCOV, V17, P317, DOI [10.1038/nrd.2018.14, 10.1038/nrd.2018.52]; Ou ZM, 2019, CELL REP, V26, P2984, DOI 10.1016/j.celrep.2019.02.060; Pfeil EM, 2020, MOL CELL, V80, P940, DOI 10.1016/j.molcel.2020.10.027; Reilly AM, 2019, NUTR DIABETES, V9, DOI 10.1038/s41387-019-0096-7; Ren HX, 2015, DIABETES, V64, P3670, DOI 10.2337/db15-0390; Ren HX, 2013, DIABETES, V62, P3373, DOI 10.2337/db13-0597; Ren HX, 2012, CELL, V149, P1314, DOI 10.1016/j.cell.2012.04.032; Roth BL, 2015, J BIOL CHEM, V290, P19471, DOI 10.1074/jbc.R115.654764; Santos R, 2017, NAT REV DRUG DISCOV, V16, P19, DOI 10.1038/nrd.2016.230; Savova V, 2016, NAT GENET, V48, P231, DOI 10.1038/ng.3493; Savova V, 2013, CURR OPIN GENET DEV, V23, P642, DOI 10.1016/j.gde.2013.09.001; Simon K, 2017, MOL PHARMACOL, V91, P518, DOI 10.1124/mol.116.107904; Sloop KW, 2018, BRIT J PHARMACOL, V175, P4060, DOI 10.1111/bph.14157; Smrcka AV, 2008, CELL MOL LIFE SCI, V65, P2191, DOI 10.1007/s00018-008-8006-5; Wang YC, 2011, LANCET, V378, P815, DOI 10.1016/S0140-6736(11)60814-3; Zarzycka B, 2019, PHARMACOL REV, V71, P571, DOI 10.1124/pr.119.017863; Zhang C, 2012, NATURE, V492, P387, DOI 10.1038/nature11701; Zhou QT, 2019, ELIFE, V8, DOI 10.7554/eLife.50279; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8	53	3	3	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100881	10.1016/j.jbc.2021.100881	http://dx.doi.org/10.1016/j.jbc.2021.100881			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144038	gold, Green Published			2022-12-28	WOS:000678068400080
J	Pearce, R; Zhang, Y				Pearce, Robin; Zhang, Yang			Toward the solution of the protein structure prediction problem	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							RESIDUE-RESIDUE CONTACTS; META-THREADING-SERVER; FORCE-FIELD; STRUCTURE REFINEMENT; DRUG DISCOVERY; MACROMOLECULAR ENERGY; HOMOLOGY DETECTION; COUPLING ANALYSIS; STABILITY CHANGES; FOLD-RECOGNITION	Since Anfinsen demonstrated that the information encoded in a protein's amino acid sequence determines its structure in 1973, solving the protein structure prediction problem has been the Holy Grail of structural biology. The goal of protein structure prediction approaches is to utilize computational modeling to determine the spatial location of every atom in a protein molecule starting from only its amino acid sequence. Depending on whether homologous structures can be found in the Protein Data Bank (PDB), structure prediction methods have been historically categorized as template-based modeling (TBM) or template-free modeling (FM) approaches. Until recently, TBM has been the most reliable approach to predicting protein structures, and in the absence of reliable templates, the modeling accuracy sharply declines. Nevertheless, the results of the most recent community-wide assessment of protein structure prediction experiment (CASP14) have demonstrated that the protein structure prediction problem can be largely solved through the use of end-to-end deep machine learning techniques, where correct folds could be built for nearly all single-domain proteins without using the PDB templates. Critically, the model quality exhibited little correlation with the quality of available template structures, as well as the number of sequence homologs detected for a given target protein. Thus, the implementation of deep-learning techniques has essentially broken through the 50-year-old modeling border between TBM and FM approaches and has made the success of high-resolution structure prediction significantly less dependent on template availability in the PDB library.	[Pearce, Robin; Zhang, Yang] Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA; [Zhang, Yang] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Zhang, Y (corresponding author), Univ Michigan, Dept Computat Med & Bioinformat, Ann Arbor, MI 48109 USA.; Zhang, Y (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	zhng@umich.edu			National Institute of General Medical Sciences [GM136422, S10OD026825]; National Institute of Allergy and Infectious Diseases [AI134678]; National Science Foundation [IIS1901191, DBI2030790, MTM2025426]	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF))	We thank Dr Chengxin Zhang for helpful discussions and his input on the manuscript. This work was supported in part by the National Institute of General Medical Sciences (GM136422, S10OD026825), the National Institute of Allergy and Infectious Diseases (AI134678), and the National Science Foundation (IIS1901191, DBI2030790, MTM2025426).	Abriata LA, 2019, PROTEINS, V87, P1100, DOI 10.1002/prot.25787; AlQuraishi M, 2019, CELL SYST, V8, P292, DOI 10.1016/j.cels.2019.03.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659; Baker H, 2020, 14 M CRIT ASS TECHN, P30; Baldassi C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092721; Barth P, 2009, P NATL ACAD SCI USA, V106, P1409, DOI 10.1073/pnas.0808323106; Beauchamp KA, 2012, J CHEM THEORY COMPUT, V8, P1409, DOI 10.1021/ct2007814; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bhattacharya S., 2020, DISC DIST OR BAS COV, DOI [10.1101/2020.01.31.923409, DOI 10.1101/2020.01.31.923409]; BOWIE JU, 1991, SCIENCE, V253, P164, DOI 10.1126/science.1853201; BOWIE JU, 1994, P NATL ACAD SCI USA, V91, P4436, DOI 10.1073/pnas.91.10.4436; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; BROWNE WJ, 1969, J MOL BIOL, V42, P65, DOI 10.1016/0022-2836(69)90487-2; Buchan DWA, 2017, BIOINFORMATICS, V33, P2684, DOI 10.1093/bioinformatics/btx217; Callaway E, 2020, NATURE, V588, P203, DOI 10.1038/d41586-020-03348-4; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Chan WKB, 2020, J MOL BIOL, V432, P4872, DOI 10.1016/j.jmb.2020.07.003; Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347; Choudhary S, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01664; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Deiana A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217889; Di Lena P, 2012, BIOINFORMATICS, V28, P2449, DOI 10.1093/bioinformatics/bts475; Ding WZ, 2020, ADV SCI, V7, DOI 10.1002/advs.202001314; Drews J, 2000, SCIENCE, V287, P1960, DOI 10.1126/science.287.5460.1960; Duan Y, 1998, SCIENCE, V282, P740, DOI 10.1126/science.282.5389.740; Dunbrack R, 2014, 11 COMMUNITY WIDE EX; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Eickholt J, 2012, BIOINFORMATICS, V28, P3066, DOI 10.1093/bioinformatics/bts598; Ekeberg M, 2013, PHYS REV E, V87, DOI 10.1103/PhysRevE.87.012707; Ekins S, 2007, BRIT J PHARMACOL, V152, P21, DOI 10.1038/sj.bjp.0707306; Elmlund D, 2017, CURR OPIN STRUC BIOL, V46, P1, DOI 10.1016/j.sbi.2017.03.003; Evers A, 2005, J MED CHEM, V48, P1088, DOI 10.1021/jm0491804; Evers A, 2004, J MED CHEM, V47, P5381, DOI 10.1021/jm0311487; Fariselli P, 2001, PROTEIN ENG, V14, P835, DOI 10.1093/protein/14.11.835; Fariselli P, 1999, PROTEIN ENG, V12, P15, DOI 10.1093/protein/12.1.15; Fischer D, 1997, P NATL ACAD SCI USA, V94, P11929, DOI 10.1073/pnas.94.22.11929; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Glusker J P, 1994, Methods Biochem Anal, V37, P1; GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402; Greener JG, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11994-0; Han X, 2019, J MED CHEM, V62, P941, DOI 10.1021/acs.jmedchem.8b01631; Hanson J, 2018, BIOINFORMATICS, V34, P4039, DOI 10.1093/bioinformatics/bty481; He BJ, 2017, BIOINFORMATICS, V33, P2296, DOI 10.1093/bioinformatics/btx164; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Heo L, 2018, P NATL ACAD SCI USA, V115, P13276, DOI 10.1073/pnas.1811364115; Heo L, 2013, NUCLEIC ACIDS RES, V41, pW384, DOI 10.1093/nar/gkt458; Huang J, 2020, 14 COMMUNITY WIDE EX, P272; Huang J, 2017, NAT METHODS, V14, P71, DOI [10.1038/NMETH.4067, 10.1038/nmeth.4067]; Ingraham J., 2019, INT C LEARN REPR; Jones DT, 2015, BIOINFORMATICS, V31, P999, DOI 10.1093/bioinformatics/btu791; Jones DT, 2012, BIOINFORMATICS, V28, P184, DOI 10.1093/bioinformatics/btr638; Jones DT, 2001, PROTEINS, P127; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001; Kallberg M, 2012, NAT PROTOC, V7, P1511, DOI 10.1038/nprot.2012.085; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Kandathil SM, 2019, PROTEINS, V87, P1092, DOI 10.1002/prot.25779; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; Klebe G, 2006, DRUG DISCOV TODAY, V11, P580, DOI 10.1016/j.drudis.2006.05.012; Kolniski, 2010, MULTISCALE APPROACHE, P810; KROGH A, 1994, J MOL BIOL, V235, P1501, DOI 10.1006/jmbi.1994.1104; Kryshtafovych A, 2019, PROTEINS, V87, P1011, DOI 10.1002/prot.25823; Kryshtafovych A, 2018, PROTEINS, V86, P321, DOI 10.1002/prot.25425; KUNTZ ID, 1992, SCIENCE, V257, P1078, DOI 10.1126/science.257.5073.1078; Lange OF, 2010, BIOPHYS J, V99, P647, DOI 10.1016/j.bpj.2010.04.062; LEVITT M, 1969, J MOL BIOL, V46, P269, DOI 10.1016/0022-2836(69)90421-5; LEVITT M, 1975, NATURE, V253, P694, DOI 10.1038/253694a0; LEWIS PN, 1971, P NATL ACAD SCI USA, V68, P2293, DOI 10.1073/pnas.68.9.2293; Li Y, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008865; Li Y, 2019, PROTEINS, V87, P1082, DOI 10.1002/prot.25798; Li Y, 2019, BIOINFORMATICS, V35, P4647, DOI 10.1093/bioinformatics/btz291; Lindorff-Larsen K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032131; Lindorff-Larsen K, 2011, SCIENCE, V334, P517, DOI 10.1126/science.1208351; Liu Y, 2018, CELL SYST, V6, P65, DOI 10.1016/j.cels.2017.11.014; Loewenstein Y, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-2-207; Ma JZ, 2015, BIOINFORMATICS, V31, P3506, DOI 10.1093/bioinformatics/btv472; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Malmstrom L, 2007, PLOS BIOL, V5, P758, DOI 10.1371/journal.pbio.0050076; MCCAMMON JA, 1977, NATURE, V267, P585, DOI 10.1038/267585a0; Metzker Michael L, 2010, Nat Rev Genet, V11, P31, DOI 10.1038/nrg2626; Mittal J, 2010, BIOPHYS J, V99, pL26, DOI 10.1016/j.bpj.2010.05.005; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; MOULT J, 1995, PROTEINS, V23, pR2, DOI 10.1002/prot.340230303; Moult J, 2016, PROTEINS, V84, P4, DOI 10.1002/prot.25064; Moult J, 2014, PROTEINS, V82, P1, DOI 10.1002/prot.24452; NEEDLEMAN SB, 1970, J MOL BIOL, V48, P443, DOI 10.1016/0022-2836(70)90057-4; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Palmer A. G., 1996, PROTEIN NMR SPECTROS; Park H, 2015, STRUCTURE, V23, P1123, DOI 10.1016/j.str.2015.03.022; Pearce R, 2021, CURR OPIN STRUC BIOL, V68, P194, DOI 10.1016/j.sbi.2021.01.007; Pires DEV, 2014, BIOINFORMATICS, V30, P335, DOI 10.1093/bioinformatics/btt691; Porta-Pardo E, 2016, CANCER IMMUNOL RES, V4, P789, DOI 10.1158/2326-6066.CIR-15-0233; Porta-Pardo E, 2015, NUCLEIC ACIDS RES, V43, pD968, DOI 10.1093/nar/gku1140; Quan LJ, 2016, BIOINFORMATICS, V32, P2936, DOI 10.1093/bioinformatics/btw361; Radivojac P, 2013, NAT METHODS, V10, P221, DOI [10.1038/NMETH.2340, 10.1038/nmeth.2340]; Remmert M, 2012, NAT METHODS, V9, P173, DOI [10.1038/NMETH.1818, 10.1038/nmeth.1818]; Rives A., 2019, BIORXIV, DOI 10.1101/622803https://www.biorxiv.org/content/10.1101/622803v3.; Rives R, MSA TRANSFORMER, DOI [10.1101/2021.02.12.430858, DOI 10.1101/2021.02.12.430858]; Robustelli P, 2018, P NATL ACAD SCI USA, V115, pE4758, DOI 10.1073/pnas.1800690115; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; RomeraParedes, 2020, 14 COMMUNITY WIDE EX, P22; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Roy A, 2012, STRUCTURE, V20, P987, DOI 10.1016/j.str.2012.03.009; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Sanchez R, 1997, PROTEINS, P50; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD94, DOI 10.1093/nar/gky989; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott WRP, 1999, J PHYS CHEM A, V103, P3596, DOI 10.1021/jp984217f; Seemayer S, 2014, BIOINFORMATICS, V30, P3128, DOI 10.1093/bioinformatics/btu500; Senior AW, 2020, NATURE, V577, P706, DOI 10.1038/s41586-019-1923-7; Senior AW, 2019, PROTEINS, V87, P1141, DOI 10.1002/prot.25834; Shan YB, 2011, J AM CHEM SOC, V133, P9181, DOI 10.1021/ja202726y; Shaw DE, 2008, COMMUN ACM, V51, P91, DOI 10.1145/1364782.1364802; Shaw DE, 2014, INT CONF HIGH PERFOR, P41, DOI 10.1109/SC.2014.9; Shaw DE, 2010, SCIENCE, V330, P341, DOI 10.1126/science.1187409; Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959; SKOLNICK J, 1990, SCIENCE, V250, P1121, DOI 10.1126/science.250.4984.1121; Skolnick J, 2017, J PHYS CHEM B, V121, P3546, DOI 10.1021/acs.jpcb.6b09517; Skwark MJ, 2013, BIOINFORMATICS, V29, P1815, DOI 10.1093/bioinformatics/btt259; Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125; Song YF, 2013, STRUCTURE, V21, P1735, DOI 10.1016/j.str.2013.08.005; Sun HP, 2015, PROTEINS, V83, P485, DOI 10.1002/prot.24744; Sundaram L, 2018, NAT GENET, V50, P1161, DOI 10.1038/s41588-018-0167-z; Tegge AN, 2009, NUCLEIC ACIDS RES, V37, pW515, DOI 10.1093/nar/gkp305; Thomas DJ, 1996, PROTEIN ENG, V9, P941, DOI 10.1093/protein/9.11.941; Tokuriki N, 2009, CURR OPIN STRUC BIOL, V19, P596, DOI 10.1016/j.sbi.2009.08.003; Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543; Tseng YY, 2009, J MOL BIOL, V387, P451, DOI 10.1016/j.jmb.2008.12.072; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Vaidehi N, 2002, P NATL ACAD SCI USA, V99, P12622, DOI 10.1073/pnas.122357199; Vajda S, 2006, CURR OPIN DRUG DISC, V9, P354; Vaswani A, 2017, ADV NEUR IN, V30; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Walsh I, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-5; Wang S, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005324; Wang Y, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1823-z; Wang Z, 2010, BIOINFORMATICS, V26, P882, DOI 10.1093/bioinformatics/btq058; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051; Woodard J, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166840; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Wu Q, 2020, BIOINFORMATICS, V36, P41, DOI 10.1093/bioinformatics/btz477; Wu ST, 2008, PROTEINS, V72, P547, DOI 10.1002/prot.21945; Wu S, 2008, BIOINFORMATICS, V24, P924, DOI 10.1093/bioinformatics/btn069; Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17; Wu ST, 2007, NUCLEIC ACIDS RES, V35, P3375, DOI 10.1093/nar/gkm251; Wu ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003400; Xu D, 2013, SCI REP-UK, V3, DOI 10.1038/srep01895; Xu D, 2013, PROTEINS, V81, P229, DOI 10.1002/prot.24179; Xu D, 2012, PROTEINS, V80, P1715, DOI 10.1002/prot.24065; Xu JB, 2019, P NATL ACAD SCI USA, V116, P16856, DOI 10.1073/pnas.1821309116; Xu JR, 2010, BIOINFORMATICS, V26, P889, DOI 10.1093/bioinformatics/btq066; Xue B, 2009, PROTEINS, V76, P176, DOI 10.1002/prot.22329; Yang JY, 2020, P NATL ACAD SCI USA, V117, P1496, DOI 10.1073/pnas.1914677117; Yang JY, 2015, NAT METHODS, V12, P7, DOI 10.1038/nmeth.3213; Yang YD, 2008, PROTEINS, V72, P793, DOI 10.1002/prot.21968; Yang YD, 2011, BIOINFORMATICS, V27, P2076, DOI 10.1093/bioinformatics/btr350; Zhang C, 2020, 14 COMM WIDE EXP CRI, P339; Zhang C, 2020, 14 COMMUNITY WIDE EX, P72; Zhang CX, 2021, J PROTEOME RES, V20, P1178, DOI 10.1021/acs.jproteome.0c00359; Zhang CX, 2020, J PROTEOME RES, V19, P1351, DOI 10.1021/acs.jproteome.0c00129; Zhang CX, 2020, BIOINFORMATICS, V36, P2105, DOI 10.1093/bioinformatics/btz863; Zhang J, 2015, STRUCTURE, V23, P1538, DOI 10.1016/j.str.2015.06.007; Zhang J, 2011, STRUCTURE, V19, P1784, DOI 10.1016/j.str.2011.09.022; Zhang J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015386; Zhang Y, 2005, P NATL ACAD SCI USA, V102, P1029, DOI 10.1073/pnas.0407152101; Zhang Y, 2004, P NATL ACAD SCI USA, V101, P7594, DOI 10.1073/pnas.0305695101; Zhang Y, 2003, BIOPHYS J, V85, P1145, DOI 10.1016/S0006-3495(03)74551-2; Zhang Y, 2002, PROTEINS, V48, P192, DOI 10.1002/prot.10141; Zhang Y., 2020, 14 M CRIT ASS TECHN, P220; Zhang Y., 2021, DEC MICR PROT FAM LI, DOI [10.1101/2021.04.15.440088, DOI 10.1101/2021.04.15.440088]; Zhang Y, 2008, CURR OPIN STRUC BIOL, V18, P342, DOI 10.1016/j.sbi.2008.02.004; Zhang Y, 2009, SCIENCE, V325, P1544, DOI 10.1126/science.1174671; Zheng W, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007411; Zheng W, 2019, PROTEINS, V87, P1149, DOI 10.1002/prot.25792; Zheng W, 2019, NUCLEIC ACIDS RES, V47, pW429, DOI 10.1093/nar/gkz384; Zhou HY, 2012, MOL PHARMACEUT, V9, P1775, DOI 10.1021/mp3000716; Zhou HY, 2011, BIOPHYS J, V101, P2043, DOI 10.1016/j.bpj.2011.09.012; Zhu JW, 2018, BIOINFORMATICS, V34, P263, DOI 10.1093/bioinformatics/bty278	195	21	21	14	42	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100870	10.1016/j.jbc.2021.100870	http://dx.doi.org/10.1016/j.jbc.2021.100870			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34119522	gold, Green Published			2022-12-28	WOS:000678068400070
J	Capone, R; Tiwari, A; Hadziselimovic, A; Peskova, Y; Hutchison, JM; Sanders, CR; Kenworthy, AK				Capone, Ricardo; Tiwari, Ajit; Hadziselimovic, Arina; Peskova, Yelena; Hutchison, James M.; Sanders, Charles R.; Kenworthy, Anne K.			The C99 domain of the amyloid precursor protein resides in the disordered membrane phase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE ACTIVITY; DETERGENT-RESISTANT MEMBRANES; LIPID RAFT COMPOSITION; PLASMA-MEMBRANE; ALZHEIMERS-DISEASE; TRANSMEMBRANE DOMAIN; ALPHA-SECRETASE; BETA-PROTEIN; STRUCTURAL DETERMINANTS; CHOLESTEROL BINDING	Processing of the amyloid precursor protein (APP) via the amyloidogenic pathway is associated with the etiology of Alzheimer's disease. The cleavage of APP by beta-secretase to generate the transmembrane 99-residue C-terminal fragment (C99) and subsequent processing of C99 by alpha-secretase to yield amyloid-beta (A beta) peptides are essential steps in this pathway. Biochemical evidence suggests that amyloidogenic processing of C99 occurs in cholesterol- and sphingolipid-enriched liquidordered phase membrane rafts. However, direct evidence that C99 preferentially associates with these rafts has remained elusive. Here, we tested this by quantifying the affinity of C99GFP for raft domains in cell-derived giant plasma membrane vesicles (GPMVs). We found that C99 was essentially excluded from ordered domains in vesicles from HeLa cells, undifferentiated SH-SY5Y cells, or SH-SY5Y-derived neurons; instead, similar to 90% of C99 partitioned into disordered domains. The strong association of C99 with disordered domains occurred independently of its cholesterol-binding activity or homodimerization, or of the presence of the familial Alzheimer disease Arctic mutation (APP E693G). Finally, through biochemical studies we confirmed previous results, which showed that C99 is processed in the plasma membrane by alpha-secretase, in addition to the well-known alpha-secretase. These findings suggest that C99 itself lacks an intrinsic affinity for raft domains, implying that either i) amyloidogenic processing of the protein occurs in disordered regions of the membrane, ii) processing involves a marginal subpopulation of C99 found in rafts, or iii) as-yetunidentified protein-protein interactions with C99 in living cells drive this protein into membrane rafts to promote its cleavage therein.	[Capone, Ricardo; Hadziselimovic, Arina; Hutchison, James M.; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Capone, Ricardo; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Capone, Ricardo; Tiwari, Ajit; Kenworthy, Anne K.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Tiwari, Ajit; Peskova, Yelena; Kenworthy, Anne K.] Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22903 USA; [Sanders, Charles R.] Vanderbilt Univ, Med Ctr, Dept Med, Nashville, TN USA; [Tiwari, Ajit; Kenworthy, Anne K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; University of Virginia; Vanderbilt University; University of Virginia	Kenworthy, AK (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.; Kenworthy, AK (corresponding author), Univ Virginia, Ctr Membrane & Cell Physiol, Charlottesville, VA 22903 USA.; Kenworthy, AK (corresponding author), Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22903 USA.	akk7hp@virginia.edu		Hutchison, James/0000-0002-5529-3248; Sanders, Charles/0000-0003-2046-2862; Kenworthy, Anne/0000-0001-6567-9059	NIH [T32 CA00958229, F31 AG061984, CA68485, DK20593, DK58404, DK59637, EY08126, 1RF1 AG056147]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The CISR is supported by NIH grants CA68485, DK20593, DK58404, DK59637, and EY08126. This work was supported by NIH 1RF1 AG056147 to A. K. K. and C. R. S. J. M. H. was supported by NIH T32 CA00958229 and by F31 AG061984. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramowski D, 2008, J PHARMACOL EXP THER, V327, P411, DOI 10.1124/jpet.108.140327; Andrew RJ, 2017, P NATL ACAD SCI USA, V114, pE9665, DOI 10.1073/pnas.1708568114; Andrew RJ, 2016, J BIOL CHEM, V291, P19235, DOI 10.1074/jbc.R116.746032; Araki W, 2015, FRONT BIOSCI-LANDMRK, V20, P314, DOI 10.2741/4311; Audagnotto M, 2016, J PHYS CHEM LETT, V7, P3572, DOI 10.1021/acs.jpclett.6b01721; Barnes NY, 1998, J NEUROSCI, V18, P5869; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Barros M, 2020, LANGMUIR, V36, P6569, DOI 10.1021/acs.langmuir.0c01178; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Beel AJ, 2010, BBA-MOL CELL BIOL L, V1801, P975, DOI 10.1016/j.bbalip.2010.03.008; Bell N, 2013, BBA-MOL CELL RES, V1833, P643, DOI 10.1016/j.bbamcr.2012.11.025; Bhattacharyya R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0166400; Bhattacharyya R, 2013, J NEUROSCI, V33, P11169, DOI 10.1523/JNEUROSCI.4704-12.2013; Bouillot C, 1996, J BIOL CHEM, V271, P7640, DOI 10.1074/jbc.271.13.7640; Bredesen DE, 2010, J ALZHEIMERS DIS, V22, P57, DOI 10.3233/JAD-2010-100537; Calsolaro V, 2016, ALZHEIMERS DEMENT, V12, P719, DOI 10.1016/j.jalz.2016.02.010; Castro MA, 2019, PROTEIN SCI, V28, P1177, DOI 10.1002/pro.3606; Chen AC, 2015, J CELL BIOL, V211, P1157, DOI 10.1083/jcb.201502001; Chen TY, 2006, BIOCHEM BIOPH RES CO, V342, P266, DOI 10.1016/j.bbrc.2006.01.156; Chen WL, 2014, ACS SYM SER, V1174, P5; Cheng HP, 2009, J BIOL CHEM, V284, P1373, DOI 10.1074/jbc.M806380200; Cordy JM, 2006, MOL MEMBR BIOL, V23, P111, DOI 10.1080/09687860500496417; Cunningham O, 2003, EMBO J, V22, P5994, DOI 10.1093/emboj/cdg588; DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5; Dominguez L, 2016, P NATL ACAD SCI USA, V113, pE5281, DOI 10.1073/pnas.1606482113; Dominguez L, 2014, J AM CHEM SOC, V136, P9619, DOI 10.1021/ja503150x; Eckert GP, 2009, BIOCHEM BIOPH RES CO, V382, P673, DOI 10.1016/j.bbrc.2009.03.070; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Fabiani C, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00309; Florean C, 2008, BBA-MOL CELL RES, V1783, P1551, DOI 10.1016/j.bbamcr.2008.03.012; Gersbacher MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069363; Gerstle Z, 2018, METHOD ENZYMOL, V603, P129, DOI 10.1016/bs.mie.2018.02.007; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Gotz A, 2019, BIOPHYS J, V116, P2103, DOI 10.1016/j.bpj.2019.04.030; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Grabowski TJ, 2001, ANN NEUROL, V49, P697, DOI 10.1002/ana.1009; Grimm MOW, 2006, ACTA NEUROL SCAND, V114, P27, DOI 10.1111/j.1600-0404.2006.00682.x; Grimm MOW, 2008, J BIOL CHEM, V283, P11302, DOI 10.1074/jbc.M801520200; Grimm MOW, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00063; Guardia-Laguarta C, 2009, J NEUROCHEM, V110, P220, DOI 10.1111/j.1471-4159.2009.06126.x; Gutierrez E, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.201900521; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Heberle FA, 2020, P NATL ACAD SCI USA, V117, P19943, DOI 10.1073/pnas.2002200117; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Huang H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121777; Hur JY, 2008, FEBS J, V275, P1174, DOI 10.1111/j.1742-4658.2008.06278.x; Hutchison JM, 2020, J AM CHEM SOC, V142, P12715, DOI 10.1021/jacs.0c04669; Itkin A, 2017, ACS OMEGA, V2, P6525, DOI 10.1021/acsomega.7b00619; Jager S, 2009, J NEUROCHEM, V111, P1369, DOI 10.1111/j.1471-4159.2009.06420.x; Jayne T, 2016, J ALZHEIMERS DIS, V52, P781, DOI 10.3233/JAD-151186; Johnson SA, 2010, BBA-BIOMEMBRANES, V1798, P1427, DOI 10.1016/j.bbamem.2010.03.009; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kaether C, 2002, J CELL BIOL, V158, P551, DOI 10.1083/jcb.200201123; KAMINO K, 1992, AM J HUM GENET, V51, P998; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 2004, J CELL BIOL, V165, P735, DOI 10.1083/jcb.200312170; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; Klymchenko AS, 2014, CHEM BIOL, V21, P97, DOI 10.1016/j.chembiol.2013.11.009; Kochetov AV, 2008, FEBS LETT, V582, P1293, DOI 10.1016/j.febslet.2008.03.014; Kojro E, 2001, P NATL ACAD SCI USA, V98, P5815, DOI 10.1073/pnas.081612998; Kovalevich J, 2013, METHODS MOL BIOL, V1078, P9, DOI 10.1007/978-1-62703-640-5_2; Kraft ML, 2013, MOL BIOL CELL, V24, P2765, DOI 10.1091/mbc.E13-03-0165; Kuhn PH, 2010, EMBO J, V29, P3020, DOI 10.1038/emboj.2010.167; Kusumi A, 2020, TRAFFIC, V21, P106, DOI 10.1111/tra.12718; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Lee SJ, 1998, NAT MED, V4, P730, DOI 10.1038/nm0698-730; Lemmin T, 2014, J BIOL CHEM, V289, P6763, DOI 10.1074/jbc.M113.470781; Levental I, 2020, TRENDS CELL BIOL, V30, P341, DOI 10.1016/j.tcb.2020.01.009; Levental I, 2010, P NATL ACAD SCI USA, V107, P22050, DOI 10.1073/pnas.1016184107; Levental KR, 2015, METHODS MOL BIOL, V1232, P65, DOI 10.1007/978-1-4939-1752-5_6; Levental KR, 2015, CURR TOP MEMBR, V75, P25, DOI 10.1016/bs.ctm.2015.03.009; LEVY E, 1990, SCIENCE, V248, P1124, DOI 10.1126/science.2111584; Li CD, 2019, J CHEM INF MODEL, V59, P339, DOI 10.1021/acs.jcim.8b00559; Li GT, 2020, J LIPID RES, V61, P758, DOI 10.1194/jlr.RA119000565; Li S, 2017, ACS CHEM NEUROSCI, V8, P1279, DOI 10.1021/acschemneuro.6b00425; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Lorent JH, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01328-3; Lorent JH, 2015, CHEM PHYS LIPIDS, V192, P23, DOI 10.1016/j.chemphyslip.2015.07.022; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Mahammad S, 2008, BBA-BIOMEMBRANES, V1778, P1251, DOI 10.1016/j.bbamem.2008.02.010; Marinko JT, 2020, P NATL ACAD SCI USA, V117, P14168, DOI 10.1073/pnas.2000508117; Matsumura N, 2014, J BIOL CHEM, V289, P5109, DOI 10.1074/jbc.M113.510131; Miravalle L, 2000, J BIOL CHEM, V275, P27110; Miyashita N, 2009, J AM CHEM SOC, V131, P3438, DOI 10.1021/ja809227c; Montesinos J, 2020, EMBO J, V39, DOI 10.15252/embj.2019103791; Motoki K, 2012, BRAIN BEHAV, V2, P270, DOI 10.1002/brb3.52; Mouilleron H, 2016, NUCLEIC ACIDS RES, V44, P14, DOI 10.1093/nar/gkv1218; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; Nadezhdin KD, 2012, FEBS LETT, V586, P1687, DOI 10.1016/j.febslet.2012.04.062; Nelson LD, 2008, J BIOL CHEM, V283, P4632, DOI 10.1074/jbc.M709483200; Nierzwicki L, 2015, J PHYS CHEM LETT, V6, P784, DOI 10.1021/acs.jpclett.5b00197; Nilsberth C, 2001, NAT NEUROSCI, V4, P887, DOI 10.1038/nn0901-887; O'Brien RJ, 2011, ANNU REV NEUROSCI, V34, P185, DOI 10.1146/annurev-neuro-061010-113613; Panahi A, 2016, J PHYS CHEM LETT, V7, P3535, DOI 10.1021/acs.jpclett.6b01624; Parkin ET, 1999, BIOCHEM J, V344, P23, DOI 10.1042/0264-6021:3440023; Parkin ET, 1997, J NEUROCHEM, V69, P2179; Pierrot N, 2013, EMBO MOL MED, V5, P608, DOI 10.1002/emmm.201202215; Raghunathan K, 2018, INFECT IMMUN, V86, DOI 10.1128/IAI.00872-17; Raghunathan K, 2016, BIOPHYS J, V111, P2547, DOI 10.1016/j.bpj.2016.11.008; Riddell DR, 2001, CURR BIOL, V11, P1288, DOI 10.1016/S0960-9822(01)00394-3; Rivera-Dictter A, 2013, PLOS ONE, V8; Rushworth Jo V, 2010, Int J Alzheimers Dis, V2011, P603052, DOI 10.4061/2011/603052; Sakurai T, 2008, J CELL BIOL, V183, P339, DOI 10.1083/jcb.200804075; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schlebach JP, 2016, BIOCHEMISTRY-US, V55, P985, DOI 10.1021/acs.biochem.5b01154; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Sengupta P, 2019, NAT CELL BIOL, V21, P452, DOI 10.1038/s41556-019-0300-y; Seno K, 2017, J BIOL CHEM, V292, P15321, DOI 10.1074/jbc.M117.804880; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Sezgin E, 2012, BBA-BIOMEMBRANES, V1818, P1777, DOI 10.1016/j.bbamem.2012.03.007; Sezgin E, 2012, NAT PROTOC, V7, P1042, DOI 10.1038/nprot.2012.059; Simons M, 1998, P NATL ACAD SCI USA, V95, P6460, DOI 10.1073/pnas.95.11.6460; Skinkle AD, 2020, BIOPHYS J, V118, P1292, DOI 10.1016/j.bpj.2019.12.040; Song YL, 2014, J AM CHEM SOC, V136, P4093, DOI 10.1021/ja4114374; Song YL, 2014, PROTEIN SCI, V23, P1, DOI 10.1002/pro.2385; Song YL, 2013, BIOCHEMISTRY-US, V52, P5051, DOI 10.1021/bi400735x; Stone MB, 2017, ELIFE, V6, DOI 10.7554/eLife.19891; Sun FD, 2017, J CHEM INF MODEL, V57, P1375, DOI 10.1021/acs.jcim.7b00196; Tan JZA, 2019, J BIOL CHEM, V294, P1618, DOI 10.1074/jbc.RA118.005222; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Veatch SL, 2005, BBA-MOL CELL RES, V1746, P172, DOI 10.1016/j.bbamcr.2005.06.010; Vetrivel KS, 2004, J BIOL CHEM, V279, P44945, DOI 10.1074/jbc.M407986200; Vetrivel KS, 2005, J BIOL CHEM, V280, P25892, DOI 10.1074/jbc.M503570200; Vetrivel KS, 2010, BBA-MOL CELL BIOL L, V1801, P860, DOI 10.1016/j.bbalip.2010.03.007; Vetrivel KS, 2009, J BIOL CHEM, V284, P3793, DOI 10.1074/jbc.M808920200; Vivas MG, 2015, RSC ADV, V5, P74531, DOI 10.1039/c5ra10719a; von Stetten D, 2012, ACTA CRYSTALLOGR F, V68, P878, DOI 10.1107/S1744309112028667; Wahrle S, 2002, NEUROBIOL DIS, V9, P11, DOI 10.1006/nbdi.2001.0470; Wang C, 2019, ADV EXP MED BIOL, V1135, P67, DOI 10.1007/978-3-030-14265-0_4; Wang H, 2011, J MOL BIOL, V408, P879, DOI 10.1016/j.jmb.2011.03.028; Wang X, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00294; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Winkler E, 2015, BIOCHEMISTRY-US, V54, P6149, DOI 10.1021/acs.biochem.5b00986; Wolfe MS, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.07.004; Yan Y, 2017, J BIOL CHEM, V292, P15826, DOI 10.1074/jbc.M117.789669; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang M, 2006, FASEB J, V20, P1176, DOI 10.1096/fj.05-5531fje; Zhang YW, 2011, MOL BRAIN, V4, DOI 10.1186/1756-6606-4-3; Zhou Y, 2013, J BIOL CHEM, V288, P35660, DOI 10.1074/jbc.M113.519116; Zidovetzki R, 2007, BBA-BIOMEMBRANES, V1768, P1311, DOI 10.1016/j.bbamem.2007.03.026; Zor T, 1996, ANAL BIOCHEM, V236, P302, DOI 10.1006/abio.1996.0171	145	3	3	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100652	10.1016/j.jbc.2021.100652	http://dx.doi.org/10.1016/j.jbc.2021.100652			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839158	gold, Green Submitted, Green Published			2022-12-28	WOS:000672866400623
J	Chen, W; Li, N; Chen, TY; Han, YM; Li, CF; Wang, YZ; He, WG; Zhang, LH; Wan, T; Cao, XT				Chen, Wei; Li, Nan; Chen, Taoyong; Han, Yanmei; Li, Changfei; Wang, Yuzhen; He, Weigang; Zhang, Lihuang; Wan, Tao; Cao, Xuetao			The lysosome-associated apoptosis-inducing protein containing the pleckstrin homology (PH) and FYVE domains (LAPF), representative of a novel family of PH and FYVE domain-containing proteins, induces caspase-independent apoptosis via the lysosomal-mitochondrial pathway (Withdrawal of Vol 280, Pg 40985, 2005)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal																		Chen W, 2005, J BIOL CHEM, V280, P40985, DOI 10.1074/jbc.M502190200	1	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100764	10.1016/j.jbc.2021.100764	http://dx.doi.org/10.1016/j.jbc.2021.100764			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237888	gold, Green Published			2022-12-28	WOS:000672866400732
J	Hartmann, AM; Fu, LF; Ziegler, C; Winklhofer, M; Nothwang, HG				Hartmann, Anna-Maria; Fu, Lifei; Ziegler, Christine; Winklhofer, Michael; Nothwang, Hans Gerd			Structural changes in the extracellular loop 2 of the murine KCC2 potassium chloride cotransporter modulate ion transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K-CL COTRANSPORTER; CRYO-EM STRUCTURES; PHYSIOLOGY; HYPEREXCITABILITY; IDENTIFICATION; DISRUPTION; MECHANISM; TERMINUS; ISOFORM; BRAIN	K+-Cl- cotransporters (KCCs) play important roles in physiological processes such as inhibitory neurotransmission and cell-volume regulation. KCCs exhibit significant variations in K+ affinities, yet recent atomic structures demonstrated that K+- and Cl--binding sites are highly conserved, raising the question of whether additional structural elements may contribute to ion coordination. The termini and the large extracellular domain (ECD) of KCCs exhibit only low sequence identity and were already discussed as modulators of transport activity. Here, we used the extracellular loop 2 (EL2) that links transmembrane helices (TMs) 3 and 4, as a mechanism to modulate ECD folding. We compared consequences of point mutations in the K+-binding site on the function of WT KCC2 and in a KCC2 variant, in which EL2 was structurally altered by insertion of a IFYPYDVPDYAGYPYDVPDYAGSY-PYDVPDYAAHAAA (3xHA) tag (36 amino acids). In WT KCC2, individual mutations of five residues in the K+-binding site resulted in a 2- to 3-fold decreased transport rate. However, the same mutations in the KCC2 variant with EL2 structurally altered by insertion of a 3xHA tag had no effect on transport activity. Homology models of mouse KCC2 with the 3xHA tag inserted into EL2 using ab initio prediction were generated. The models suggest subtle conformational changes occur in the ECD upon EL2 modification. These data suggest that a conformational change in the ECD, for example, by interaction with EL2, might be an elegant way to modulate the K+ affinity of the different isoforms in the KCC subfamily.	[Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Div Neurogenet, Sch Med & Hlth Sci, Oldenburg, Germany; [Hartmann, Anna-Maria; Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany; [Fu, Lifei; Ziegler, Christine] Univ Regensburg, Fac Biol & Preclin Med, Biophys 2, Biophys 2 Struct Biol, Regensburg, Germany; [Winklhofer, Michael] Carl von Ossietzky Univ Oldenburg, Inst Biol & Environm Sci, IBU, Oldenburg, Germany; [Nothwang, Hans Gerd] Carl von Ossietzky Univ Oldenburg, Ctr Excellence Hearing4all, Oldenburg, Germany	Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg; University of Regensburg; Carl von Ossietzky Universitat Oldenburg; Carl von Ossietzky Universitat Oldenburg	Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Div Neurogenet, Sch Med & Hlth Sci, Oldenburg, Germany.; Hartmann, AM (corresponding author), Carl von Ossietzky Univ Oldenburg, Res Ctr Neurosensory Sci, Oldenburg, Germany.	anna.maria.hartmann@uol.de	Winklhofer, Michael/B-7349-2009	Winklhofer, Michael/0000-0003-1352-9723; Ziegler, Christine Maria/0000-0003-3439-7213; Nothwang, Hans Gerd/0000-0001-7695-6437	Deutsche Forschungsgemeinschaft [HA 6338/2-1, NO428/14-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (Grants HA 6338/2-1 to A. -M. H. and NO428/14-1 to H. G. N.).	Abramson J, 2009, CURR OPIN STRUC BIOL, V19, P425, DOI 10.1016/j.sbi.2009.06.002; Acton BA, 2012, J NEUROSCI, V32, P8746, DOI 10.1523/JNEUROSCI.6089-11.2012; Adragna NC, 2004, J MEMBRANE BIOL, V201, P109, DOI 10.1007/s00232-004-0695-6; Benjamini Y., 1995, J R STAT SOC B, V57, P289, DOI DOI 10.1111/J.2517-6161.1995.TB02031.X; Bergeron MJ, 2006, J BIOL CHEM, V281, P15959, DOI 10.1074/jbc.M600015200; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Boulenguez P, 2010, NAT MED, V16, P302, DOI 10.1038/nm.2107; Chew TA, 2019, NATURE, V572, P488, DOI 10.1038/s41586-019-1438-2; Chi X., 2020, MOLECULAR BASIS REGU, DOI [10.1101/2020.02.22.960815, DOI 10.1101/2020.02.22.960815]; Clapcote SJ, 2009, P NATL ACAD SCI USA, V106, P14085, DOI 10.1073/pnas.0904817106; Cordshagen A, 2018, J BIOL CHEM, V293, P16984, DOI 10.1074/jbc.RA118.004349; Coull JAM, 2003, NATURE, V424, P938, DOI 10.1038/nature01868; Delpire E, 2000, NEWS PHYSIOL SCI, V15, P309, DOI 10.1152/physiologyonline.2000.15.6.309; Delpire E, 2020, AM J PHYSIOL-CELL PH, V318, pC225, DOI 10.1152/ajpcell.00465.2019; Di Fulvio M, 2009, PHYSIOLOGY AND PATHOLOGY OF CHLORIDE TRANSPORTERS AND CHANNELS IN THE NERVOUS SYSTEM: FROM MOLECULES TO DISEASES, P169; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Gagnon KB, 2013, AM J PHYSIOL-CELL PH, V304, pC693, DOI 10.1152/ajpcell.00350.2012; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Gerelsaikhan T, 2000, J BIOL CHEM, V275, P40471, DOI 10.1074/jbc.M007751200; Gillen CM, 1996, J BIOL CHEM, V271, P16237, DOI 10.1074/jbc.271.27.16237; Hartmann AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179968; Hartmann AM, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00470; Hartmann AM, 2010, J BIOL CHEM, V285, P23994, DOI 10.1074/jbc.M110.144063; Hediger MA, 2013, MOL ASPECTS MED, V34, P95, DOI 10.1016/j.mam.2012.12.009; Hoglund PJ, 2011, MOL BIOL EVOL, V28, P1531, DOI 10.1093/molbev/msq350; Huberfeld G, 2007, J NEUROSCI, V27, P9866, DOI 10.1523/JNEUROSCI.2761-07.2007; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Kahle KT, 2008, NAT CLIN PRACT NEURO, V4, P490, DOI 10.1038/ncpneuro0883; Kahle KT, 2014, EMBO REP, V15, P766, DOI 10.15252/embr.201438840; Kaila K, 2014, NAT REV NEUROSCI, V15, P637, DOI 10.1038/nrn3819; Kim JY, 2012, CELL, V148, P1051, DOI 10.1016/j.cell.2011.12.037; Kowalczyk L, 2011, P NATL ACAD SCI USA, V108, P3935, DOI 10.1073/pnas.1018081108; Krishnamurthy H, 2009, NATURE, V459, P347, DOI 10.1038/nature08143; Liu S, 2019, SCIENCE, V366, P505, DOI 10.1126/science.aay3129; Markkanen M, 2014, J COMP NEUROL, V522, P1897, DOI 10.1002/cne.23510; Mercado A, 2006, J BIOL CHEM, V281, P1016, DOI 10.1074/jbc.M509972200; Merner ND, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00386; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Papp E, 2008, NEUROSCIENCE, V154, P677, DOI 10.1016/j.neuroscience.2008.03.072; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Payne JA, 1997, AM J PHYSIOL-CELL PH, V273, pC1516, DOI 10.1152/ajpcell.1997.273.5.C1516; Payne JA, 2003, TRENDS NEUROSCI, V26, P199, DOI 10.1016/S0166-2236(03)00068-7; Puskarjov M., 2014, NEUROPHARMACOLOGY, V32, P11356; R Development Core Team, 2009, R LANG ENV STAT COMP; Race JE, 1999, AM J PHYSIOL-CELL PH, V277, pC1210, DOI 10.1152/ajpcell.1999.277.6.C1210; Reid MS, 2020, ELIFE, V9, DOI 10.7554/eLife.52505; Rivera C, 2002, J CELL BIOL, V159, P747, DOI 10.1083/jcb.200209011; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Tyzio R, 2014, SCIENCE, V343, P675, DOI 10.1126/science.1247190; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Weber M, 2014, J BIOL CHEM, V289, P18668, DOI 10.1074/jbc.M114.567834; WELCH BL, 1947, BIOMETRIKA, V34, P28, DOI 10.2307/2332510; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Xie Y, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5883; Yang X., 2020, NAT COMMUN, V11, P1; Zhang S., 2021, COMMUN BIOL, V4, P1; Zhao BB, 2008, CELL SIGNAL, V20, P1769, DOI 10.1016/j.cellsig.2008.06.011; Zhao Y., 2020, BIORXIV, P1, DOI [10.1101/2020.07.26.221770, DOI 10.1101/2020.07.26.221770]	59	1	1	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100793	10.1016/j.jbc.2021.100793	http://dx.doi.org/10.1016/j.jbc.2021.100793			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019872	gold, Green Published			2022-12-28	WOS:000674717300013
J	Kamm, DR; Pyles, KD; Sharpe, MC; Healy, LN; Colca, JR; McCommis, KS				Kamm, Dakota R.; Pyles, Kelly D.; Sharpe, Martin C.; Healy, Laura N.; Colca, Jerry R.; McCommis, Kyle S.			Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL PYRUVATE CARRIER; PANCREATIC BETA-CELL; NONALCOHOLIC STEATOHEPATITIS; MOUSE MODEL; PPAR-GAMMA; PIOGLITAZONE; GLUCOSE; METABOLISM; SECRETION; THIAZOLIDINEDIONES	Insulin sensitizers and incretin mimetics are antidiabetic agents with vastly different mechanisms of action. Thiazolidinedione (TZD) insulin sensitizers are associated with weight gain, whereas glucagon-like peptide-1 receptor agonists can induce weight loss. We hypothesized that combination of a TZD insulin sensitizer and the glucagon-like peptide-1 receptor agonist liraglutide would more significantly improve mouse models of diabetes and nonalcoholic steatohepatitis (NASH). Diabetic db/db and MS-NASH mice were treated with the TZD MSDC-0602K by oral gavage, liraglutide (Lira) by s.c. injection, or combination 0602K+Lira. Lira slightly reduced body weight and modestly improved glycemia in db/db mice. Comparatively, 0602K-treated and 0602K+Lira-treated mice exhibited slight weight gain but completely corrected glycemia and improved glucose tolerance. 0602K reduced plasma insulin, whereas Lira further increased the hyperinsulinemia of db/db mice. Surprisingly, 0602K+Lira treatment reduced plasma insulin and C-peptide to the same extent as mice treated with 0602K alone. 0602K did not reduce glucose-stimulated insulin secretion in vivo, or in isolated islets, indicating the reduced insulinemia was likely compensatory to improved insulin sensitivity. In MS-NASH mice, both 0602K or Lira alone improved plasma alanine aminotransferase and aspartate aminotransferase, as well as liver histology, but more significant improvements were observed with 0602K+Lira treatment. 0602K or 0602K+Lira also increased pancreatic insulin content in both db/db and MS-NASH mice. In conclusion, MSDC-0602K corrected glycemia and reduced insulinemia when given alone, or in combination with Lira. However, 0602K+Lira combination more significantly improved glucose tolerance and liver histology, suggesting that this combination treatment may be an effective therapeutic strategy for diabetes and NASH.	[Kamm, Dakota R.; Pyles, Kelly D.; Sharpe, Martin C.; McCommis, Kyle S.] St Louis Univ, Sch Med, Biochem & Mol Biol, St Louis, MO 63104 USA; [Healy, Laura N.] LNH Tox Path Consulting LLC, Newbury Pk, CA USA; [Colca, Jerry R.] Cirius Therapeut, Kalamazoo, MI USA; [Colca, Jerry R.] Cirius Therapeut, San Diego, CA USA	Saint Louis University	McCommis, KS (corresponding author), St Louis Univ, Sch Med, Biochem & Mol Biol, St Louis, MO 63104 USA.	kyle.mccommis@health.slu.edu		Colca, Jerry/0000-0003-3933-8626; Pyles, Kelly/0000-0001-9478-3365; Kamm, Dakota/0000-0003-3096-8429; McCommis, Kyle/0000-0003-2381-1589	NIH [R00 HL136658]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K. S. M. is supported by NIH R00 HL136658. The db/db study and analyses received no specific grant funding from any public or commercial agency. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abdulreda MH, 2016, CELL METAB, V23, P541, DOI 10.1016/j.cmet.2016.01.009; Adams MD, 1998, BIOCHEM PHARMACOL, V55, P1915, DOI 10.1016/S0006-2952(98)00052-5; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Buganova M, 2017, J ENDOCRINOL, V233, P93, DOI 10.1530/JOE-16-0478; Campbell IW, 2007, DIABETES RES CLIN PR, V76, P163, DOI 10.1016/j.diabres.2006.08.015; Chareyron I, 2020, DIABETOLOGIA, V63, P2628, DOI 10.1007/s00125-020-05275-5; Chen ZJ, 2012, J BIOL CHEM, V287, P23537, DOI 10.1074/jbc.M112.363960; Colca JR, 2013, CLIN PHARMACOL THER, V93, P352, DOI 10.1038/clpt.2013.10; Colca JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061551; Cusi K, 2016, ANN INTERN MED, V165, P305, DOI 10.7326/M15-1774; Diani AR, 2004, AM J PHYSIOL-ENDOC M, V286, pE116, DOI 10.1152/ajpendo.00331.2003; Divakaruni AS, 2013, P NATL ACAD SCI USA, V110, P5422, DOI 10.1073/pnas.1303360110; Donath MY, 2005, DIABETES, V54, pS108, DOI 10.2337/diabetes.54.suppl_2.S108; Duparc T, 2019, AM J PHYSIOL-GASTR L, V317, pG508, DOI 10.1152/ajpgi.00139.2019; Eguchi Y, 2015, HEPATOL RES, V45, P269, DOI 10.1111/hepr.12351; Fukunaga T, 2015, J BONE MINER RES, V30, P508, DOI 10.1002/jbmr.2364; Harrison SA, 2020, J HEPATOL, V72, P613, DOI 10.1016/j.jhep.2019.10.023; Kalavalapalli S, 2018, AM J PHYSIOL-ENDOC M, V315, pE163, DOI 10.1152/ajpendo.00023.2018; Kimura T, 2015, MOL CELL ENDOCRINOL, V400, P78, DOI 10.1016/j.mce.2014.11.018; Lamontagne J, 2013, DIABETES, V62, P2122, DOI 10.2337/db12-0428; Lamontagne J, 2009, ENDOCRINOLOGY, V150, P3465, DOI 10.1210/en.2008-1557; Larsen PJ, 2008, DIABETES OBES METAB, V10, P301, DOI 10.1111/j.1463-1326.2008.00865.x; Matsui J, 2004, DIABETES, V53, P2844, DOI 10.2337/diabetes.53.11.2844; McCommis KS, 2017, HEPATOLOGY, V65, P1543, DOI 10.1002/hep.29025; McCommis KS, 2016, MOL METAB, V5, P602, DOI 10.1016/j.molmet.2016.06.016; McCommis KS, 2015, CELL METAB, V22, P682, DOI 10.1016/j.cmet.2015.07.028; Miyazaki Y, 2002, DIABETES CARE, V25, P517, DOI 10.2337/diacare.25.3.517; Musso G, 2017, JAMA INTERN MED, V177, P633, DOI 10.1001/jamainternmed.2016.9607; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, V8th; Neuschwander-Tetri BA, 2003, HEPATOLOGY, V38, P1008, DOI 10.1053/jhep.2003.50420; Newsome PN, 2021, NEW ENGL J MED, V384, P1113, DOI 10.1056/NEJMoa2028395; Patterson JN, 2014, J BIOL CHEM, V289, P13335, DOI 10.1074/jbc.M113.521666; Qian X, 2018, DIABETES THER, V9, P815, DOI 10.1007/s13300-018-0401-9; Raman P, 2000, EUR J PHARMACOL, V409, P19, DOI 10.1016/S0014-2999(00)00806-2; Raman P, 1998, LIFE SCI, V62, pPL89, DOI 10.1016/S0024-3205(97)01177-6; Rohatgi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062012; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Secher A, 2014, J CLIN INVEST, V124, P4473, DOI 10.1172/JCI75276; Somm E, 2021, TRANSL RES, V227, P75, DOI 10.1016/j.trsl.2020.07.008; Suzuki Y, 2001, MOL CELL BIOL, V21, P2683, DOI 10.1128/MCB.21.8.2683-2694.2001; Talchai C, 2012, CELL, V150, P1223, DOI 10.1016/j.cell.2012.07.029; Tozzo E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126642; Vigueira PA, 2014, CELL REP, V7, P2042, DOI 10.1016/j.celrep.2014.05.017; Vilsboll T, 2007, DIABETES CARE, V30, P1608, DOI 10.2337/dc06-2593	44	9	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100807	10.1016/j.jbc.2021.100807	http://dx.doi.org/10.1016/j.jbc.2021.100807			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022222	gold, Green Published			2022-12-28	WOS:000674717300024
J	Marinko, JT; Wright, MT; Schlebach, JP; Clowes, KR; Heintzman, DR; Plate, L; Sanders, CR				Marinko, Justin T.; Wright, Madison T.; Schlebach, Jonathan P.; Clowes, Katherine R.; Heintzman, Darren R.; Plate, Lars; Sanders, Charles R.			Glycosylation limits forward trafficking of the tetraspan membrane protein PMP22	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MARIE-TOOTH DISEASE; QUALITY-CONTROL; TRANSPORT RECEPTOR; N-GLYCOSYLATION; MYELIN; MUTATIONS; TREMBLER; CALNEXIN; GENE; GLYCAN	Peripheral myelin protein 22 (PMP22) folds and trafficks inefficiently, with only 20% of newly expressed protein trafficking to the cell surface. This behavior is exacerbated in many of the mutants associated with Charcot-Marie-Tooth disease, motivating further study. Here we characterized the role of N-glycosylation in limiting PMP22 trafficking. We first eliminated N-glycosylation using an N41Q mutation, which resulted in an almost 3-fold increase in trafficking efficiency of wildtype (WT) PMP22 and a 10-fold increase for the severely unstable L16P disease mutant in HEK293 cells, with similar results in Schwann cells. Total cellular levels were also much higher for the WT/N41Q mutant, although not for the L16P/N41Q form. Depletion of oligosaccharyltransferase OST-A and OST-B subunits revealed that WT PMP22 is N-glycosylated post-translationally by OST-B, whereas L16P is cotranslationally glycosylated by OST-A. Quantitative proteomic screens revealed similarities and differences in the interactome for WT, glycosylation-deficient, and unstable mutant forms of PMP22 and also suggested that L16P is sequestered at earlier stages of endoplasmic reticulum quality control. CRISPR knockout studies revealed a role for retention in endoplasmic reticulum sorting receptor 1 (RER1) in limiting the trafficking of all three forms, for UDP-glucose glycoprotein glucosyltransferase 1 (UGGT1) in limiting the trafficking of WT and L16P but not N41Q, and calnexin (CNX) in limiting the trafficking of WT and N41Q but not L16P. This work shows that N-glycosylation is a limiting factor to forward trafficking PMP22 and sheds light on the proteins involved in its quality control.	[Marinko, Justin T.; Clowes, Katherine R.; Sanders, Charles R.] Vanderbilt Univ, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37235 USA; [Marinko, Justin T.; Clowes, Katherine R.; Sanders, Charles R.] Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Wright, Madison T.; Plate, Lars] Vanderbilt Univ, Dept Chem, 221 Kirkland Hall, Nashville, TN 37235 USA; [Schlebach, Jonathan P.] Indiana Univ, Dept Chem, Bloomington, IN USA; [Heintzman, Darren R.] Vanderbilt Univ, Dept Pathol Microbiol & Immunol, 221 Kirkland Hall, Nashville, TN 37235 USA; [Plate, Lars] Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Indiana University System; Indiana University Bloomington; Vanderbilt University; Vanderbilt University	Sanders, CR (corresponding author), Vanderbilt Univ, Dept Biochem, 221 Kirkland Hall, Nashville, TN 37235 USA.; Sanders, CR (corresponding author), Vanderbilt Univ, Ctr Struct Biol, 221 Kirkland Hall, Nashville, TN 37235 USA.	chuck.sanders@vanderbilt.edu		Plate, Lars/0000-0003-4363-6116; Clowes, Katherine/0000-0002-5147-8392; Heintzman, Darren/0000-0002-4903-758X; Wright, Madison/0000-0002-2274-7856; Sanders, Charles/0000-0003-2046-2862	National Institutes of Health [R01 NS095989, R35 GM133552, F31 NS113494, T32 NS00749, T32 GM065086]; Vanderbilt Institute of Chemical Biology Fellowship; National Science Foundation Graduate Research Fellowship Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Institute of Chemical Biology Fellowship; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF))	This work was supported by National Institutes of Health Grants R01 NS095989 (to C. R. S.) and R35 GM133552 (to L. P.). J. T. M. was supported by National Institutes of Health Fellowship F31 NS113494 and National Institutes of Health Training Grant T32 NS00749. K. R. W. was supported by National Institute of Health Training Grant T32 GM065086. M. T. W. was supported by National Institutes of Health Training Grant T32 GM065086, the Vanderbilt Institute of Chemical Biology Fellowship, and the National Science Foundation Graduate Research Fellowship Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aebi M, 2013, BBA-MOL CELL RES, V1833, P2430, DOI 10.1016/j.bbamcr.2013.04.001; Appenzeller C, 1999, NAT CELL BIOL, V1, P330, DOI 10.1038/14020; Barlowe C, 2016, ANNU REV CELL DEV BI, V32, P197, DOI 10.1146/annurev-cellbio-111315-125016; Barlowe CK, 2013, GENETICS, V193, P383, DOI 10.1534/genetics.112.142810; Bridges RJ, 2018, HANDB EXP PHARMACOL, V245, P385, DOI 10.1007/164_2018_103; Cherepanova N, 2016, CURR OPIN CELL BIOL, V41, P57, DOI 10.1016/j.ceb.2016.03.021; Cherepanova NA, 2019, J CELL BIOL, V218, P2782, DOI 10.1083/jcb.201904004; Cherepanova NA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20946; Cherepanova NA, 2014, J CELL BIOL, V206, P525, DOI 10.1083/jcb.201404083; Chitwood P. L, 2018, CELL, V175, pe1516; Colby J, 2000, NEUROBIOL DIS, V7, P561, DOI 10.1006/nbdi.2000.0323; Conti BJ, 2015, MOL CELL, V58, P269, DOI 10.1016/j.molcel.2015.02.018; Dickson KM, 2002, P NATL ACAD SCI USA, V99, P9852, DOI 10.1073/pnas.152621799; DiVincenzo C, 2014, MOL GENET GENOM MED, V2, P522, DOI 10.1002/mgg3.106; Egea PF, 2010, P NATL ACAD SCI USA, V107, P17182, DOI 10.1073/pnas.1012556107; El-Abassi R, 2014, PM&R, V6, P342, DOI 10.1016/j.pmrj.2013.08.611; Eregno I., 2019, CRIT REV BIOCHEM MOL, V54, P153; Ferris SP, 2013, MOL BIOL CELL, V24, P2597, DOI 10.1091/mbc.E13-02-0101; Fonslow BR, 2012, J PROTEOME RES, V11, P2697, DOI 10.1021/pr300200x; Fontanini A, 2005, J BIOL CHEM, V280, P2378, DOI 10.1074/jbc.M405104200; Fu YL, 2019, BIOCHEM BIOPH RES CO, V511, P356, DOI 10.1016/j.bbrc.2019.02.053; Gogala M, 2014, NATURE, V506, P107, DOI 10.1038/nature12950; Guo JS, 2014, ANN NEUROL, V75, P255, DOI 10.1002/ana.24086; Hara T, 2014, SCI REP-UK, V4, DOI 10.1038/srep06992; Hasse B, 2004, MOL CELL NEUROSCI, V27, P370, DOI 10.1016/j.mcn.2004.06.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huang H, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aar2631; Jung J, 2011, FASEB J, V25, P3929, DOI 10.1096/fj.11-184911; Kozlov G, 2020, FEBS J, V287, P4322, DOI 10.1111/febs.15330; Kozlov G, 2017, STRUCTURE, V25, P1415, DOI 10.1016/j.str.2017.07.010; Lamriben L, 2016, TRAFFIC, V17, P308, DOI 10.1111/tra.12358; Lee S, 2014, J NEUROSCI, V34, P16140, DOI 10.1523/JNEUROSCI.1908-14.2014; Li J, 2013, MOL NEUROBIOL, V47, P673, DOI 10.1007/s12035-012-8370-x; Liu N, 2004, NEUROBIOL DIS, V17, P300, DOI 10.1016/j.nbd.2004.07.010; Lopez-Sambrooks C, 2016, NAT CHEM BIOL, V12, P1023, DOI 10.1038/nchembio.2194; Marinko JT, 2020, J BIOL CHEM, V295, P11963, DOI 10.1074/jbc.AC120.014940; Marinko JT, 2020, P NATL ACAD SCI USA, V117, P14168, DOI 10.1073/pnas.2000508117; Marinko JT, 2019, CHEM REV, V119, P5537, DOI 10.1021/acs.chemrev.8b00532; McCaffrey K, 2016, ESSAYS BIOCHEM, V60, P227, DOI 10.1042/EBC20160003; Mittendorf KF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700220; Mittendorf KF, 2014, BIOCHEMISTRY-US, V53, P6139, DOI 10.1021/bi500809t; Morena J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20143419; Myers JK, 2008, BIOCHEMISTRY-US, V47, P10620, DOI 10.1021/bi801157p; Naef R, 1999, NEUROBIOL DIS, V6, P1, DOI 10.1006/nbdi.1998.0227; Naef R, 1997, MOL CELL NEUROSCI, V9, P13, DOI 10.1006/mcne.1997.0604; Notterpek L, 1999, NEUROBIOL DIS, V6, P450, DOI 10.1006/nbdi.1999.0274; Notterpek L, 2001, P NATL ACAD SCI USA, V98, P14404, DOI 10.1073/pnas.251548398; Nyfeler B, 2008, J CELL BIOL, V180, P705, DOI 10.1083/jcb.200709100; PAREEK S, 1993, J BIOL CHEM, V268, P10372; Pareek S, 1997, J NEUROSCI, V17, P7754; Pareyson D, 2017, CURR OPIN NEUROL, V30, P471, DOI 10.1097/WCO.0000000000000474; Pearse BR, 2010, BBA-MOL CELL RES, V1803, P684, DOI 10.1016/j.bbamcr.2009.10.008; Pfeffer S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9403; Plate L, 2019, CELL CHEM BIOL, V26, P913, DOI 10.1016/j.chembiol.2019.04.001; Plate L, 2016, ELIFE, V5, DOI 10.7554/eLife.15550; POPOT JL, 1987, J MOL BIOL, V198, P655, DOI 10.1016/0022-2836(87)90208-7; Ramirez AS, 2019, SCIENCE, V366, P1372, DOI 10.1126/science.aaz3505; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rinis N, 2018, CELL CHEM BIOL, V25, P1231, DOI 10.1016/j.chembiol.2018.07.005; Roux KJ, 2005, MOL BIOL CELL, V16, P1142, DOI 10.1091/mbc.E04-07-0551; Ruiz-Canada C, 2009, CELL, V136, P272, DOI 10.1016/j.cell.2008.11.047; Ryan MC, 2000, J NEUROCHEM, V75, P1465, DOI 10.1046/j.1471-4159.2000.0751465.x; Sahenk Z, 1999, ANN NEUROL, V45, P16, DOI 10.1002/1531-8249(199901)45:1<16::AID-ART5>3.0.CO;2-F; Sakakura M, 2011, STRUCTURE, V19, P1160, DOI 10.1016/j.str.2011.05.009; Schlebach JP, 2015, J AM CHEM SOC, V137, P8758, DOI 10.1021/jacs.5b03743; Schlebach JP, 2015, Q REV BIOPHYS, V48, P1, DOI 10.1017/S0033583514000110; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Scurry AN, 2016, J NEUROPATH EXP NEUR, V75, P334, DOI 10.1093/jnen/nlw004; Shames I, 2003, J NEUROPATH EXP NEUR, V62, P751, DOI 10.1093/jnen/62.7.751; Shrimal S, 2013, HUM MOL GENET, V22, P4638, DOI 10.1093/hmg/ddt312; Shurtleffn MJ, 2018, ELIFE, V7, DOI 10.7554/eLife.37018; SNIPES GJ, 1992, J CELL BIOL, V117, P225, DOI 10.1083/jcb.117.1.225; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sun ZH, 2019, J CELL BIOL, V218, P3171, DOI 10.1083/jcb.201906047; Tanese N, 1997, METHODS, V12, P224, DOI 10.1006/meth.1997.0475; Tannous A, 2015, SEMIN CELL DEV BIOL, V41, P79, DOI 10.1016/j.semcdb.2014.12.001; Tobler AR, 1999, J NEUROSCI, V19, P2027; Vanoye CG, 2019, J BIOL CHEM, V294, P12054, DOI 10.1074/jbc.RA118.006248; Voorhees RM, 2014, CELL, V157, P1632, DOI 10.1016/j.cell.2014.05.024; WELCHER AA, 1992, PROG BRAIN RES, V94, P163; Wright MT, 2021, MOL CELL PROTEOMICS, V20, DOI 10.1074/mcp.RA120.002168; Zhou Y, 2019, J NEUROSCI, V39, P5404, DOI 10.1523/JNEUROSCI.2942-18.2019	83	3	3	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100719	10.1016/j.jbc.2021.100719	http://dx.doi.org/10.1016/j.jbc.2021.100719			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33933451	Green Published, gold, Green Submitted			2022-12-28	WOS:000672866400689
J	Vali, SW; Haja, DK; Brand, RA; Adams, MWW; Lindahl, PA				Vali, Shaik Waseem; Haja, Dominik K.; Brand, Richard A.; Adams, Michael W. W.; Lindahl, Paul A.			The Pyrococcus furiosus ironome is dominated by [Fe4S4](2+) clusters or thioferrate-like iron depending on the availability of elemental sulfur	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Pyrococcus furiosus is a hyperthermophilic anaerobic archaeon whose metabolism depends on whether elemental sulfur is (+S-0) or is not (-S-0) included in growth medium. Under +S-0 conditions, expression of respiratory hydrogenase declines while respiratory membrane-bound sulfane reductase and the putative iron-storage protein IssA increase. Our objective was to investigate the iron content of WT and Delta IssA cells under these growth conditions using Mossbauer spectroscopy. WT-S-0 cells contained similar to 1 mMFe, with similar to 85% present as two spectroscopically distinct forms of S = 0 [Fe4S4](2+) clusters; the remainder was mainly high-spin Fe-II. WT+S-0 cells contained 5 to 9 mM Fe, with 75 to 90% present as magnetically ordered thioferrate-like (TFL) iron nanoparticles. TFL iron was similar to chemically defined thioferrates; both consisted of Fe-III ions coordinated by an S-4 environment, and both exhibited strong coupling between particles causing high applied fields to have little spectral effect. At high temperatures with magnetic hyperfine interactions abolished, TFL iron exhibited two doublets overlapping those of [Fe4S4](2+) clusters in -S-0 cells. This coincidence arose because of similar coordination environments of TFL iron and cluster iron. The TFL structure was more heterogeneous in the presence of IssA. Presented data suggest that IssA may coordinate insoluble iron sulfides as TFL iron, formed as a byproduct of anaerobic sulfur respiration under high iron conditions, which thereby reduces its toxicity to the cell. This was the first Mossbauer characterization of the ironome of an archaeon, and it illustrates differences relative to the iron content of better-studied bacteria such as Escherichia coli.	[Vali, Shaik Waseem; Lindahl, Paul A.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Haja, Dominik K.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Brand, Richard A.] Univ Duisburg Essen, Fac Phys, Duisburg, Germany; [Brand, Richard A.] Karlsruhe Inst Technol, Inst Nanotechnol, Eggenstein Leopoldshafen, Germany; [Lindahl, Paul A.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; University System of Georgia; University of Georgia; University of Duisburg Essen; Helmholtz Association; Karlsruhe Institute of Technology; Texas A&M University System; Texas A&M University College Station	Lindahl, PA (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.; Lindahl, PA (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.	lindahl@chem.tamu.edu		Brand, Richard/0000-0001-6009-8634	National Institutes of Health [GM127021]; National Science Foundation; Robert A. Welch Foundation [A1170]; Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy [DE-FG02-95ER20175]; Welch Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Robert A. Welch Foundation(The Welch Foundation); Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy; Welch Foundation(The Welch Foundation)	This work was supported by the National Institutes of Health (GM127021 to P. A. L.), the National Science Foundation (MCB-1817389), the Robert A. Welch Foundation (A1170), and the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the Department of Energy (DE-FG02-95ER20175 to M. W. W. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the National Science Foundation, the Welch Foundation or the Department of Energy.		0	2	2	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100710	10.1016/j.jbc.2021.100710	http://dx.doi.org/10.1016/j.jbc.2021.100710			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33930466	Green Published, gold			2022-12-28	WOS:000672866400681
J	Aggarwal, G; May-Zhang, LS; Yermalitsky, V; Dikalov, S; Voynov, MA; Amarnath, V; Kon, V; Linton, MF; Vickers, KC; Davies, SS				Aggarwal, Geetika; May-Zhang, Linda S.; Yermalitsky, Valery; Dikalov, Sergey; Voynov, Maxim A.; Amarnath, Venkataraman; Kon, Valentina; Linton, MacRae F.; Vickers, Kasey C.; Davies, Sean S.			Myeloperoxidase-induced modification of HDL by isolevuglandins inhibits paraoxonase-1 activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; APOLIPOPROTEIN-A-I; LIPID-PEROXIDATION; LACTONASE ACTIVITY; GAMMA-KETOALDEHYDES; PON1; ASSOCIATION; SITES; ATHEROSCLEROSIS	Reduced activity of paraoxonase 1 (PON1), a high-density lipoprotein (HDL)-associated enzyme, has been implicated in the development of atherosclerosis. Post-translational modifi- cations of PON1 may represent important mechanisms leading to reduced PON1 activity. Under atherosclerotic conditions, myeloperoxidase (MPO) is known to associate with HDL. MPO generates the oxidants hypochlorous acid and nitrogen dioxide, which can lead to post-translational modification of PON1, including tyrosine modifications that inhibit PON1 activity. Nitrogen dioxide also drives lipid peroxidation, leading to the formation of reactive lipid dicarbonyls such as malondialde-hyde and isolevuglandins, which modify HDL and could inhibit PON1 activity. Because isolevuglandins are more reactive than malondialdehyde, we used in vitro models containing HDL, PON1, and MPO to test the hypothesis that IsoLG formation by MPO and its subsequent modification of HDL contributes to MPO-mediated reductions in PON1 activity. Incubation of MPO with HDL led to modification of HDL proteins, including PON1, by IsoLG. Incubation of HDL with IsoLG reduced PON1 lactonase and antiperoxidation activities. IsoLG modi-fication of recombinant PON1 markedly inhibited its activity, while irreversible IsoLG modification of HDL before adding recombinant PON1 only slightly inhibited the ability of HDL to enhance the catalytic activity of recombinant PON1. Together, these studies support the notion that association of MPO with HDL leads to lower PON1 activity in part via IsoLG-mediated modification of PON1, so that IsoLG modification of PON1 could contribute to increased risk for atherosclerosis, and blocking this modification might prove beneficial to reduce atherosclerosis.	[Aggarwal, Geetika; May-Zhang, Linda S.; Yermalitsky, Valery; Linton, MacRae F.; Davies, Sean S.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA; [Dikalov, Sergey; Amarnath, Venkataraman; Davies, Sean S.] Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA; [Voynov, Maxim A.] North Carolina State Univ, Dept Chem, Raleigh, NC USA; [Kon, Valentina] Vanderbilt Univ, Med Ctr, Dept Pediat, Div Nephrol & Hypertens, Nashville, TN 37232 USA; [Linton, MacRae F.; Vickers, Kasey C.] Vanderbilt Univ, Med Ctr, Dept Med, Atherosclerosis Res Unit,Div Cardiovasc Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University; University of North Carolina; North Carolina State University; Vanderbilt University; Vanderbilt University	Davies, SS (corresponding author), Vanderbilt Univ, Dept Pharmacol, Nashville, TN 37235 USA.; Davies, SS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Clin Pharmacol, Nashville, TN 37235 USA.	sean.davies@vanderbilt.edu	Aggarwal, Geetika/ABD-8696-2021	Aggarwal, Geetika/0000-0002-1848-5056; Voynov, Maxim/0000-0002-5565-5843; Dikalov, Sergey/0000-0003-2976-6184	NIH/National Heart, Lung, and Blood Institute [PO1 HL116263]	NIH/National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a program project grant from the NIH/National Heart, Lung, and Blood Institute (PO1 HL116263). The authors are grateful to Dr Keri Tallman for the synthesis of IsoLG and Dr Dan S. Tawfik (Weizmann Institute of Science, Rehovot, Israel) for kindly providing recombinant paraoxonase 1 plasmid. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aggarwal G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147999; Aharoni A, 2005, NAT GENET, V37, P73, DOI 10.1038/ng1482; Amarnath V, 2005, SYNTHETIC COMMUN, V35, P397, DOI 10.1081/SCC-200048945; Atwa ET, 2020, MOL BIOL REP, V47, P4255, DOI 10.1007/s11033-020-05558-5; Aviram M, 2000, CIRCULATION, V101, P2510, DOI 10.1161/01.CIR.101.21.2510; Bajaj P, 2013, PROTEIN SCI, V22, P1799, DOI 10.1002/pro.2380; Bi WZ, 2016, CHEM RES TOXICOL, V29, P1628, DOI 10.1021/acs.chemrestox.6b00141; Billeclke S, 2000, DRUG METAB DISPOS, V28, P1335; Brame CJ, 1999, J BIOL CHEM, V274, P13139, DOI 10.1074/jbc.274.19.13139; Brennan M, 2003, NEW ENGL J MED, V349, P1595, DOI 10.1056/NEJMoa035003; Connelly PW, 2004, J LIPID RES, V45, P561, DOI 10.1194/jlr.M300464-JLR200; Davies SS, 2006, BIOCHEMISTRY-US, V45, P15756, DOI 10.1021/bi061860g; Dikalov SI, 2018, ANTIOXID REDOX SIGN, V28, P1433, DOI 10.1089/ars.2017.7396; Draganov DI, 2000, J BIOL CHEM, V275, P33435, DOI 10.1074/jbc.M004543200; Draganov DI, 2005, J LIPID RES, V46, P1239, DOI 10.1194/jlr.M400511-JLR200; Enkisch C, 2009, EUR J ORG CHEM, V2009, P5549, DOI 10.1002/ejoc.200900787; Fuhrman B, 2010, NUTRITION, V26, P359, DOI 10.1016/j.nut.2009.05.003; Gaidukov L, 2005, BIOCHEMISTRY-US, V44, P11843, DOI 10.1021/bi050862i; Gaidukov L, 2007, J LIPID RES, V48, P1637, DOI 10.1194/jlr.D600045-JLR200; Godbole Charuta, 2021, Future Cardiol, V17, P119, DOI 10.2217/fca-2020-0028; Graner M, 2006, J AM COLL CARDIOL, V47, P2429, DOI 10.1016/j.jacc.2006.01.074; Hernandez-Diaz Y, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000005298; Huang JS, 2020, NUTRIENTS, V12, DOI 10.3390/nu12071937; Huang Y, 2013, J CLIN INVEST, V123, P3815, DOI 10.1172/JCI67478; James RW, 2000, CIRCULATION, V101, P2252, DOI 10.1161/01.CIR.101.19.2252; Kato Y, 2016, J CLIN BIOCHEM NUTR, V58, P99, DOI 10.3164/jcbn.15-104; Khersonsky O, 2006, J BIOL CHEM, V281, P7649, DOI 10.1074/jbc.M512594200; Khersonsky O, 2006, CHEMBIOCHEM, V7, P49, DOI 10.1002/cbic.200500334; Khersonsky O, 2005, BIOCHEMISTRY-US, V44, P6371, DOI 10.1021/bi047440d; Kraemer T, 2004, BIOL CHEM, V385, P809, DOI 10.1515/BC.2004.106; Li C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42518-x; Liu T, 2014, EUR J CLIN NUTR, V68, P1029, DOI 10.1038/ejcn.2014.105; Mackness B, 2000, EUR J CLIN INVEST, V30, P4; Mackness B, 2001, ARTERIOSCL THROM VAS, V21, P1451, DOI 10.1161/hq0901.094247; Mackness B, 2006, ARTERIOSCL THROM VAS, V26, P1545, DOI 10.1161/01.ATV.0000222924.62641.aa; Mackness Michael I, 2004, Am J Cardiovasc Drugs, V4, P211, DOI 10.2165/00129784-200404040-00002; May-Zhang LS, 2019, J BIOL CHEM, V294, P19022, DOI 10.1074/jbc.RA119.009424; May-Zhang LS, 2018, J BIOL CHEM, V293, P9176, DOI 10.1074/jbc.RA117.001099; Mohammed CJ, 2019, J CLIN MED, V8, DOI 10.3390/jcm8071034; Mont S, 2016, SCI REP-UK, V6, DOI 10.1038/srep24919; Murillo-Gonzalez FE, 2020, CLIN CHIM ACTA, V500, P47, DOI 10.1016/j.cca.2019.09.016; Poliakov E, 2003, FASEB J, V17, P2209, DOI 10.1096/fj.03-0086com; Shih DM, 2000, J BIOL CHEM, V275, P17527, DOI 10.1074/jbc.M910376199; Tao H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17915-w; Tomas M, 2004, REV ESP CARDIOL, V57, P557, DOI 10.1157/13062921; Undurti A, 2009, J BIOL CHEM, V284, P30825, DOI 10.1074/jbc.M109.047605; Zagol-Ikapite I, 2015, J LIPID RES, V56, P2196, DOI 10.1194/jlr.P063271; Zhang C, 2010, GENE THER, V17, P626, DOI 10.1038/gt.2010.11; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810; Zhang WH, 2003, CHEM RES TOXICOL, V16, P512, DOI 10.1021/tx020105a; Zhao Y, 2012, MOL GENET METAB, V105, P141, DOI 10.1016/j.ymgme.2011.09.018; Zheng L, 2005, J BIOL CHEM, V280, P38, DOI 10.1074/jbc.M407019200; Zheng LM, 2004, J CLIN INVEST, V114, P529, DOI 10.1172/JCI200421109	54	5	5	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101019	10.1016/j.jbc.2021.101019	http://dx.doi.org/10.1016/j.jbc.2021.101019			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34331945	gold, Green Published			2022-12-28	WOS:000706408900009
J	Williamson, DB; Sohn, CJ; Ito, A; Haltiwanger, RS				Williamson, Daniel B.; Sohn, Camron J.; Ito, Atsuko; Haltiwanger, Robert S.			POGLUT2 and POGLUT3 O-glucosylate multiple EGF repeats in fibrillin-1,-2, and LTBP1 and promote secretion of fibrillin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALCIUM-BINDING; MARFAN-SYNDROME; NOTCH; PROTEIN; GLYCOSYLATION; MICROFIBRILS; EXPRESSION; RESIDUES; DOMAIN; SITES	Fibrillin-1 (FBN1) is the major component of extracellular matrix microfibrils, which are required for proper development of elastic tissues, including the heart and lungs. Through protein-protein interactions with latent transforming growth factor (TGF) beta-binding protein 1 (LTBP1), microfibrils regulate TGF-beta signaling. Mutations within the 47 epidermal growth factor-like (EGF) repeats of FBN1 cause autosomal dominant disorders including Marfan Syndrome, which is characterized by disrupted TGF-beta signaling. We recently identified two novel protein O-glucosyltransferases, Protein O-glucosyltransferase 2 (POGLUT2) and 3 (POGLUT3), that modify a small fraction of EGF repeats on Notch. Here, using mass spectral analysis, we show that POGLUT2 and POGLUT3 also modify over half of the EGF repeats on FBN1, fibrillin-2 (FBN2), and LTBP1. While most sites are modified by both enzymes, some sites show a preference for either POGLUT2 or POGLUT3. POGLUT2 and POGLUT3 are homologs of POGLUT1, which stabilizes Notch proteins by addition of O-glucose to Notch EGF repeats. Like POGLUT1, POGLUT2 and 3 can discern a folded versus unfolded EGF repeat, suggesting POGLUT2 and 3 are involved in a protein folding pathway. In vitro secretion assays using the N-terminal portion of recombinant FBN1 revealed reduced FBN1 secretion in POGLUT2 knockout, POGLUT3 knockout, and POGLUT2 and 3 double-knockout HEK293T cells compared with wild type. These results illustrate that POGLUT2 and 3 function together to O-glucosylate protein substrates and that these modifications play a role in the secretion of substrate proteins. It will be interesting to see how disease variants in these proteins affect their O-glucosylation.	[Williamson, Daniel B.; Sohn, Camron J.; Ito, Atsuko; Haltiwanger, Robert S.] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Williamson, Daniel B.; Sohn, Camron J.; Ito, Atsuko; Haltiwanger, Robert S.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia	Haltiwanger, RS (corresponding author), Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA.; Haltiwanger, RS (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.	rhalti@uga.edu		Haltiwanger, Robert/0000-0001-7439-9577	NIH [T32 GM107004]; Georgia Research Alliance	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Georgia Research Alliance	Supported by funding from NIH (GM061126 to R. S. H.) and the Georgia Research Alliance. D. B. W. was partially supported by NIH T32 GM107004. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acar M, 2008, CELL, V132, P247, DOI 10.1016/j.cell.2007.12.016; Bern MW, 2011, J PROTEOME RES, V10, P5296, DOI 10.1021/pr200780j; Braakman I, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013201; BRUNNER AM, 1989, J BIOL CHEM, V264, P13660; Cardy CM, 1998, J MOL BIOL, V276, P855, DOI 10.1006/jmbi.1997.1593; Chaudhry SS, 2007, J CELL BIOL, V176, P355, DOI 10.1083/jcb.200608167; Doyle JJ, 2012, FEBS LETT, V586, P2003, DOI 10.1016/j.febslet.2012.05.027; Fernandez-Valdivia R, 2011, DEVELOPMENT, V138, P1925, DOI 10.1242/dev.060020; GLANVILLE RW, 1994, J BIOL CHEM, V269, P26630; Godwin ARF, 2019, MATRIX BIOL, V84, P17, DOI 10.1016/j.matbio.2019.06.006; HANDFORD PA, 1991, NATURE, V353, P395, DOI 10.1038/353395a0; Handford PA, 2000, BBA-MOL CELL RES, V1498, P84, DOI 10.1016/S0167-4889(00)00085-9; HANDFORD PA, 1991, NATURE, V351, P164, DOI 10.1038/351164a0; Harvey BM, 2016, J BIOL CHEM, V291, P16348, DOI 10.1074/jbc.M116.732537; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Jensen SA, 2016, BIOCHEM J, V473, P827, DOI 10.1042/BJ20151108; Jensen SA, 2015, HUM MOL GENET, V24, P4454, DOI 10.1093/hmg/ddv181; Kakuda S, 2020, J BIOL CHEM, V295, P14710, DOI 10.1074/jbc.RA120.014407; Kakuda S, 2017, DEV CELL, V40, P193, DOI 10.1016/j.devcel.2016.12.013; Kettle S, 1999, J MOL BIOL, V285, P1277, DOI 10.1006/jmbi.1998.2368; Kirschner R, 2011, J BIOL CHEM, V286, P32810, DOI 10.1074/jbc.M111.221804; Li ZJ, 2017, NAT CHEM BIOL, V13, P757, DOI 10.1038/nchembio.2381; Lin GQ, 2002, J BIOL CHEM, V277, P50795, DOI 10.1074/jbc.M210611200; Luca VC, 2017, SCIENCE, V355, P1320, DOI 10.1126/science.aaf9739; Luca VC, 2015, SCIENCE, V347, P847, DOI 10.1126/science.1261093; Massam-Wu T, 2010, J CELL SCI, V123, P3006, DOI 10.1242/jcs.073437; Matsumoto K, 2021, MOL ASPECTS MED, V79, DOI 10.1016/j.mam.2020.100938; Matsuura A, 2008, J BIOL CHEM, V283, P35486, DOI 10.1074/jbc.M806202200; MIYAZONO K, 1991, EMBO J, V10, P1091, DOI 10.1002/j.1460-2075.1991.tb08049.x; Moloney DJ, 2000, J BIOL CHEM, V275, P9604, DOI 10.1074/jbc.275.13.9604; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Ono RN, 2009, J BIOL CHEM, V284, P16872, DOI 10.1074/jbc.M809348200; Pandey A, 2021, GLYCOBIOLOGY, V31, P8, DOI 10.1093/glycob/cwaa049; Pecori F, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79666-4; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Rana NA, 2011, J BIOL CHEM, V286, P31623, DOI 10.1074/jbc.M111.268243; REES DJG, 1988, EMBO J, V7, P2053, DOI 10.1002/j.1460-2075.1988.tb03045.x; Reinhardt DP, 2000, J BIOL CHEM, V275, P12339, DOI 10.1074/jbc.275.16.12339; Reinhardt DP, 1996, J MOL BIOL, V258, P104, DOI 10.1006/jmbi.1996.0237; Saiki W, 2021, BIOMOLECULES, V11, DOI 10.3390/biom11020309; Sengle G, 2015, MATRIX BIOL, V47, P3, DOI 10.1016/j.matbio.2015.05.002; Sengle G, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002425; Shao L, 2002, GLYCOBIOLOGY, V12, P763, DOI 10.1093/glycob/cwf085; Shi SL, 2003, P NATL ACAD SCI USA, V100, P5234, DOI 10.1073/pnas.0831126100; Stahl M, 2008, J BIOL CHEM, V283, P13638, DOI 10.1074/jbc.M802027200; Stanley P, 2020, FASEB J, V34, DOI 10.1096/fasebj.2020.34.s1.00181; STENFLO J, 1988, J BIOL CHEM, V263, P21; Takeuchi H, 2018, P NATL ACAD SCI USA, V115, pE8395, DOI 10.1073/pnas.1804005115; Takeuchi H, 2017, J BIOL CHEM, V292, P15964, DOI 10.1074/jbc.M117.800102; Unsold C, 2001, J CELL SCI, V114, P187; Wang Y, 2001, J BIOL CHEM, V276, P40338, DOI 10.1074/jbc.M107849200; Wipff PJ, 2008, EUR J CELL BIOL, V87, P601, DOI 10.1016/j.ejcb.2008.01.012; Zhang AO, 2020, J BIOL CHEM, V295, P15742, DOI 10.1074/jbc.RA120.014557; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165	54	2	2	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101055	10.1016/j.jbc.2021.101055	http://dx.doi.org/10.1016/j.jbc.2021.101055			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34411563	Green Published, gold			2022-12-28	WOS:000706409400011
J	Rondelli, CM; Perfetto, M; Danoff, A; Bergonia, H; Gillis, S; O'Neill, L; Jackson, L; Nicolas, G; Puy, H; West, R; Phillips, JD; Yien, YY				Rondelli, Catherine M.; Perfetto, Mark; Danoff, Aidan; Bergonia, Hector; Gillis, Samantha; O'Neill, Leah; Jackson, Laurie; Nicolas, Gael; Puy, Herve; West, Richard; Phillips, John D.; Yien, Yvette Y.			The ubiquitous mitochondrial protein unfoldase CLPX regulates erythroid heme synthesis by control of iron utilization and heme synthesis enzyme activation and turnover	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DELTA-AMINOLEVULINATE SYNTHASE; PROTOPORPHYRIN-IX; GLOBIN; PRESEQUENCE; DEGRADATION; EXPRESSION; TRANSPORT; EKLF/KLF1; BINDING; CELLS	Heme plays a critical role in catalyzing life-essential redox reactions in all cells, and its synthesis must be tightly balanced with cellular requirements. Heme synthesis in eukaryotes is tightly regulated by the mitochondrial AAA+ unfoldase CLPX (caseinolytic mitochondrial matrix peptidase chaperone subunit X), which promotes heme synthesis by activation of delta-amino-levulinate synthase (ALAS/Hem1) in yeast and regulates turnover of ALAS1 in human cells. However, the specific mechanisms by which CLPX regulates heme synthesis are unclear. In this study, we interrogated the mechanisms by which CLPX regulates heme synthesis in erythroid cells. Quantitation of enzyme activity and protein degradation showed that ALAS2 stability and activity were both increased in the absence of CLPX, suggesting that CLPX primarily regulates ALAS2 by control of its turnover, rather than its activation. However, we also showed that CLPX is required for PPOX (protoporphyrinogen IX oxidase) activity and maintenance of FECH (ferrochelatase) levels, which are the terminal enzymes in heme synthesis, likely accounting for the heme deficiency and porphyrin accumulation observed in Clpx(-/-) cells. Lastly, CLPX is required for iron utilization for hemoglobin synthesis during erythroid differentiation. Collectively, our data show that the role of CLPX in yeast ALAS/Hem1 activation is not conserved in vertebrates as vertebrates rely on CLPX to regulate ALAS turnover as well as PPOX and FECH activity. Our studies reveal that CLPX mutations may cause anemia and porphyria via dysregulation of ALAS, FECH, and PPOX activities, as well as of iron metabolism.	[Rondelli, Catherine M.; Perfetto, Mark; Danoff, Aidan; Gillis, Samantha; O'Neill, Leah; Yien, Yvette Y.] Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA; [Perfetto, Mark; Yien, Yvette Y.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Perfetto, Mark; Yien, Yvette Y.] Univ Pittsburgh, Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA 15260 USA; [Bergonia, Hector; Jackson, Laurie; Phillips, John D.] Univ Utah, Div Hematol, Sch Med, Salt Lake City, UT USA; [Nicolas, Gael; Puy, Herve] Univ Paris Diderot, Ctr Rech Sur Inflammat, Sorbonne Paris Cite, Site Bichat, Paris, France; [Puy, Herve] Hop Louis Mourier, APHP, Ctr Francais Porphyries, Colombes, France; [West, Richard] Univ Delaware, Delaware Biotechnol Inst, Delaware, OH USA	University of Delaware; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Utah System of Higher Education; University of Utah; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Delaware	Yien, YY (corresponding author), Univ Delaware, Dept Biol Sci, Newark, DE 19716 USA.; Yien, YY (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.; Yien, YY (corresponding author), Univ Pittsburgh, Pittsburgh Heart Lung & Blood Vasc Med Inst, Pittsburgh, PA 15260 USA.	yieny@pitt.edu	NICOLAS, Gaël/D-7611-2013	NICOLAS, Gaël/0000-0002-1671-8274; Perfetto, Mark/0000-0001-8546-0839; Rondelli, Catherine/0000-0002-5264-6714; West, Richard/0000-0003-1459-0825	Cooley's Anemia Foundation; National Institutes of Health [K01 DK106156, R03 DK118307, P01 HL032262, P20GM104316, R35 GM1133560]; U. Utah CIHD pilot grant [U54 DK083909]	Cooley's Anemia Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U. Utah CIHD pilot grant	This work was supported by the Cooley's Anemia Foundation (Y. Y. Y.) and National Institutes of Health grants K01 DK106156, R03 DK118307, P01 HL032262, P20GM104316, R35 GM1133560 and a U. Utah CIHD pilot grant (Y. Y. Y.), and U54 DK083909 (J. D. P). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baker TA, 2012, BBA-MOL CELL RES, V1823, P15, DOI 10.1016/j.bbamcr.2011.06.007; Chen CY, 2013, CELL METAB, V17, P343, DOI 10.1016/j.cmet.2013.01.013; Chen CY, 2012, BBA-MOL CELL RES, V1823, P1459, DOI 10.1016/j.bbamcr.2012.01.003; Cheong A, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.188714; Christenson ET, 2018, J BIOL CHEM, V293, P3819, DOI 10.1074/jbc.M117.817478; Chung J, 2017, ELIFE, V6, DOI 10.7554/eLife.24767; Feng D, 2012, MOL CELL, V47, P158, DOI 10.1016/j.molcel.2012.06.026; Fischer F, 2015, SCI REP-UK, V5, DOI 10.1038/srep18375; Ganis JJ, 2012, DEV BIOL, V366, P185, DOI 10.1016/j.ydbio.2012.03.021; Girvan HM, 2013, J BIOL CHEM, V288, P13194, DOI 10.1074/jbc.R112.422642; Gispert S, 2013, HUM MOL GENET, V22, P4871, DOI 10.1093/hmg/ddt338; Goodfellow BJ, 2001, FEBS LETT, V505, P325, DOI 10.1016/S0014-5793(01)02818-6; Grillo AS, 2017, SCIENCE, V356, P608, DOI 10.1126/science.aah3862; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Hildick-Smith GJ, 2013, AM J HUM GENET, V93, P906, DOI 10.1016/j.ajhg.2013.09.011; Jenkinson EM, 2013, AM J HUM GENET, V92, P605, DOI 10.1016/j.ajhg.2013.02.013; Kardon JR, 2020, ELIFE, V9, DOI 10.7554/eLife.54387; Kardon JR, 2015, CELL, V161, P858, DOI 10.1016/j.cell.2015.04.017; Kobayashi M, 2017, HAEMATOLOGICA, V102, P454, DOI 10.3324/haematol.2016.151043; Kubota Y, 2016, J BIOL CHEM, V291, P20516, DOI 10.1074/jbc.M116.719161; Martinkova M, 2013, J BIOL CHEM, V288, P27702, DOI 10.1074/jbc.R113.473249; Munakata H, 2004, J BIOCHEM, V136, P233, DOI 10.1093/jb/mvh112; Olivares AO, 2016, NAT REV MICROBIOL, V14, P33, DOI 10.1038/nrmicro.2015.4; POULSON R, 1975, J BIOL CHEM, V250, P1269; Quadrini KJ, 2006, FEBS LETT, V580, P2285, DOI 10.1016/j.febslet.2006.03.039; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Seo JH, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002507; Shah DI, 2012, NATURE, V491, P608, DOI 10.1038/nature11536; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; SRIVASTAVA G, 1983, BIOCHEM BIOPH RES CO, V117, P344, DOI 10.1016/0006-291X(83)91582-6; Sun SJ, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.273; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Tahara T, 2004, J BIOL CHEM, V279, P5480, DOI 10.1074/jbc.M302733200; VOLLAND C, 1988, J BIOL CHEM, V263, P8294; Wang TR, 2018, AGING CELL, V17, DOI 10.1111/acel.12784; YAMAUCHI K, 1980, J BIOL CHEM, V255, P1746; Yien YY, 2018, J BIOL CHEM, V293, P19797, DOI 10.1074/jbc.RA118.002742; Yien YY, 2017, P NATL ACAD SCI USA, V114, pE8045, DOI 10.1073/pnas.1700632114; Yien YY, 2012, J BIOL CHEM, V287, P15193, DOI 10.1074/jbc.M112.350496; Zenke-Kawasaki Y, 2007, MOL CELL BIOL, V27, P6962, DOI 10.1128/MCB.02415-06; Zhang J, 2003, BLOOD, V102, P3938, DOI 10.1182/blood-2003-05-1479	41	7	7	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100972	10.1016/j.jbc.2021.100972	http://dx.doi.org/10.1016/j.jbc.2021.100972			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34280433	gold, Green Published			2022-12-28	WOS:000690871400008
J	Amiar, S; Husby, ML; Wijesinghe, KJ; Angel, S; Bhattarai, N; Gerstman, BS; Chapagain, PP; Li, S; Stahelin, RV				Amiar, Souad; Husby, Monica L.; Wijesinghe, Kaveesha J.; Angel, Stephanie; Bhattarai, Nisha; Gerstman, Bernard S.; Chapagain, Prem P.; Li, Sheng; Stahelin, Robert, V			Lipid-specific oligomerization of the Marburg virus matrix protein VP40 is regulated by two distinct interfaces for virion assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EBOLA-VIRUS; PLASMA-MEMBRANE; BINDING PROPERTIES; CELLS; DYNAMICS; BRIGHTNESS; MICROSCOPY; VESICLES; NUMBER; DOMAIN	Marburg virus (MARV) is a lipid-enveloped virus harboring a negative-sense RNA genome, which has caused sporadic outbreaks of viral hemorrhagic fever in sub-Saharan Africa. MARV assembles and buds from the host cell plasma membrane where MARV matrix protein (mVP40) dimers associate with anionic lipids at the plasma membrane inner leaflet and undergo a dynamic and extensive self-oligomerization into the structural matrix layer. The MARV matrix layer confers the virion filamentous shape and stability but how host lipids modulate mVP40 oligomerization is mostly unknown. Using in vitro and cellular techniques, we present a mVP40 assembly model highlighting two distinct oligomerization interfaces: the (N-terminal domain [NTD] and C-terminal domain [CTD]) in mVP40. Cellular studies of NTD and CTD oligomerization interface mutants demonstrate the importance of each interface in matrix assembly. The assembly steps include protein trafficking to the plasma membrane, homo-multimerization that induced protein enrichment, plasma membrane fluidity changes, and elongations at the plasma membrane. An ascorbate peroxidase derivative (APEX)-transmission electron microscopy method was employed to closely assess the ultrastructural localization and formation of viral particles for wildtype mVP40 and NTD and CTD oligomerization interface mutants. Taken together, these studies present a mechanistic model of mVP40 oligomerization and assembly at the plasma membrane during virion assembly that requires interactions with phosphatidylserine for NTD-NTD interactions and phosphatidylinositol-4,5-bisphosphate for proper CTD-CTD interactions. These findings have broader implications in understanding budding of lipid-enveloped viruses from the host cell plasma membrane and potential strategies to target protein-protein or lipid-protein interactions to inhibit virus budding.	[Amiar, Souad; Husby, Monica L.; Wijesinghe, Kaveesha J.; Angel, Stephanie; Stahelin, Robert, V] Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA; [Wijesinghe, Kaveesha J.] Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA; [Bhattarai, Nisha; Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Dept Phys, Miami, FL 33199 USA; [Gerstman, Bernard S.; Chapagain, Prem P.] Florida Int Univ, Biomol Sci Inst, Miami, FL 33199 USA; [Li, Sheng] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Notre Dame; State University System of Florida; Florida International University; State University System of Florida; Florida International University; University of California System; University of California San Diego	Stahelin, RV (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, W Lafayette, IN 47907 USA.	rstaheli@purdue.edu		Stahelin, Robert/0000-0001-5443-7863; Chapagain, Prem/0000-0002-0999-4975	NIH [AI081077, GM020501, GM121964, AI117905, NS070899, T32 GM075762]; Purdue Pharmacy Live Cell Imaging Facility [NIH OD027034]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Purdue Pharmacy Live Cell Imaging Facility	These studies were supported by the NIH AI081077 to R. V. S., NIH GM020501, GM121964, AI117905, NS070899 to S. L., NIH T32 GM075762 to M. L. H. and K. J. W., and the Purdue Pharmacy Live Cell Imaging Facility (NIH OD027034 R. V. S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adu-Gyamfi E, 2015, J VIROL, V89, P9440, DOI 10.1128/JVI.01087-15; Adu-Gyamfi E, 2013, J BIOL CHEM, V288, P5779, DOI 10.1074/jbc.M112.443960; Adu-Gyamfi E, 2012, BIOPHYS J, V103, pL41, DOI 10.1016/j.bpj.2012.09.026; Adu-Gyamfi E, 2012, BIOPHYS J, V102, P2517, DOI 10.1016/j.bpj.2012.04.022; [Anonymous], 2019, EB VIR DIS DEM REP C; Ariotti N, 2015, DEV CELL, V35, P513, DOI 10.1016/j.devcel.2015.10.016; Bagatolli LA, 2003, METHOD ENZYMOL, V360, P481; Beer B, 1999, NATURWISSENSCHAFTEN, V86, P8, DOI 10.1007/s001140050562; Bharat TAM, 2012, P NATL ACAD SCI USA, V109, P4275, DOI 10.1073/pnas.1120453109; Bobone S, 2017, J VIROL, V91, DOI 10.1128/JVI.00267-17; Bornholdt ZA, 2013, CELL, V154, P763, DOI 10.1016/j.cell.2013.07.015; Bray M, 2005, INT J BIOCHEM CELL B, V37, P1560, DOI 10.1016/j.biocel.2005.02.018; Breman JG, 2016, J INFECT DIS, V214, pS93, DOI 10.1093/infdis/jiw207; DARSZON A, 1980, P NATL ACAD SCI-BIOL, V77, P239, DOI 10.1073/pnas.77.1.239; de Armas-Rillo L, 2016, REV MED VIROL, V26, P146, DOI 10.1002/rmv.1872; Del Vecchio K, 2018, J BIOL CHEM, V293, P3335, DOI 10.1074/jbc.M117.816280; Digman MA, 2008, BIOPHYS J, V94, P2320, DOI 10.1529/biophysj.107.114645; Feldmann H, 1993, Arch Virol Suppl, V7, P81; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Gc JB, 2016, PHYS CHEM CHEM PHYS, V18, P28409, DOI 10.1039/c6cp03776c; Harty RN, 2000, P NATL ACAD SCI USA, V97, P13871, DOI 10.1073/pnas.250277297; Harty RN, 2018, METHODS MOL BIOL, V1604, P209, DOI 10.1007/978-1-4939-6981-4_15; Heaton NS, 2011, TRENDS MICROBIOL, V19, P368, DOI 10.1016/j.tim.2011.03.007; Hilsch M, 2014, BIOPHYS J, V107, P912, DOI 10.1016/j.bpj.2014.06.042; Hoenen T, 2010, J VIROL, V84, P7053, DOI 10.1128/JVI.00737-10; Hogue IB, 2011, J VIROL, V85, P9749, DOI 10.1128/JVI.00743-11; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jasenosky LD, 2001, J VIROL, V75, P5205, DOI 10.1128/JVI.75.11.5205-5214.2001; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Johnson KA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19125; Julkowska Magdalena M, 2013, Methods Mol Biol, V1009, P261, DOI 10.1007/978-1-62703-401-2_24; Ketter E, 2019, ANNU REV VIROL, V6, P319, DOI 10.1146/annurev-virology-092818-015748; Koehler A, 2018, J GEN VIROL, V99, P1614, DOI 10.1099/jgv.0.001169; Kolesnikova L, 2004, J VIROL, V78, P12277, DOI 10.1128/JVI.78.22.12277-12287.2004; Kolesnikova L, 2004, J VIROL, V78, P2382, DOI 10.1128/JVI.78.5.2382-2393.2004; Kolesnikova L, 2002, J VIROL, V76, P1825, DOI 10.1128/JVI.76.4.1825-1838.2002; Kolesnikova L, 2007, J INFECT DIS, V196, pS232, DOI 10.1086/520584; Krementsov DN, 2010, TRAFFIC, V11, P1401, DOI 10.1111/j.1600-0854.2010.01111.x; Leroy EM, 2011, CLIN MICROBIOL INFEC, V17, P964, DOI 10.1111/j.1469-0691.2011.03535.x; Liu YL, 2010, J VIROL, V84, P2294, DOI 10.1128/JVI.02034-09; Lu JH, 2013, J VIROL, V87, P7777, DOI 10.1128/JVI.00470-13; Madsen JJ, 2018, P NATL ACAD SCI USA, V115, pE8595, DOI 10.1073/pnas.1805443115; Makino A, 2011, J INFECT DIS, V204, pS871, DOI 10.1093/infdis/jir309; Mucksch F, 2017, ELIFE, V6, DOI 10.7554/eLife.25287; Nakai K, 2006, J VIROL, V80, P11265, DOI 10.1128/JVI.01203-06; Noda T, 2002, J VIROL, V76, P4855, DOI 10.1128/JVI.76.10.4855-4865.2002; Oda S, 2016, J VIROL, V90, P1839, DOI 10.1128/JVI.01597-15; Owen DM, 2012, NAT PROTOC, V7, P24, DOI 10.1038/nprot.2011.419; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rasband, 2015, IMAGEJ SOFTWARE; REEVES JP, 1969, J CELL PHYSIOL, V73, P49, DOI 10.1002/jcp.1040730108; Ruigrok RWH, 2000, J MOL BIOL, V300, P103, DOI 10.1006/jmbi.2000.3822; Slenczka W, 2007, J INFECT DIS, V196, pS131, DOI 10.1086/520551; Suzuki Y, 1997, MOL BIOL EVOL, V14, P800, DOI 10.1093/oxfordjournals.molbev.a025820; Timmins J, 2003, J MOL BIOL, V326, P493, DOI 10.1016/S0022-2836(02)01406-7; Wan W, 2020, ELIFE, V9, DOI 10.7554/eLife.59225; Wijesinghe KJ, 2017, J BIOL CHEM, V292, P6108, DOI 10.1074/jbc.M116.758300; Wijesinghe KJ, 2016, J VIROL, V90, P3074, DOI 10.1128/JVI.02607-15; Yamashita Y, 2002, BBA-BIOMEMBRANES, V1561, P129, DOI 10.1016/S0005-2736(02)00338-3; You CJ, 2014, ANAL BIOANAL CHEM, V406, P3345, DOI 10.1007/s00216-014-7803-y; Youker RT, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.9.090801	63	3	3	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100796	10.1016/j.jbc.2021.100796	http://dx.doi.org/10.1016/j.jbc.2021.100796			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019871	Green Published, gold			2022-12-28	WOS:000674717300016
J	Castellano, S; Claxton, DP; Ficici, E; Kusakizako, T; Stix, R; Zhou, WC; Nureki, O; Mchaourab, HS; Faraldo-Gomez, JD				Castellano, Steven; Claxton, Derek P.; Ficici, Emel; Kusakizako, Tsukasa; Stix, Robyn; Zhou, Wenchang; Nureki, Osamu; Mchaourab, Hassane S.; Faraldo-Gomez, Jose D.			Conserved binding site in the N-lobe of prokaryotic MATE transporters suggests a role for Na+ in ion-coupled drug efflux	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT ALTERNATING ACCESS; MEMBRANE-PROTEIN STRUCTURE; MULTIDRUG-RESISTANCE; CONFORMATIONAL DYNAMICS; MOLECULAR-DYNAMICS; NA+/CA2+ EXCHANGER; EXTRUSION; PUMPS; MECHANISM; NORM	In both prokaryotes and eukaryotes, multidrug and toxic-compound extrusion (MATE) transporters catalyze the efflux of a broad range of cytotoxic compounds, including human-made antibiotics and anticancer drugs. MATEs are secondary-active antiporters, i.e., their drug-efflux activity is coupled to, and powered by, the uptake of ions down a preexisting transmembrane electrochemical gradient. Key aspects of this mechanism, however, remain to be delineated, such as its ion specificity and stoichiometry. We previously revealed the existence of a Na+-binding site in a MATE transporter from Pyroccocus furiosus (PfMATE) and hypothesized that this site might be broadly conserved among prokaryotic MATEs. Here, we evaluate this hypothesis by analyzing VcmN and ClbM, which along with PfMATE are the only three prokaryotic MATEs whose molecular structures have been determined at atomic resolution, i.e. better than 3 A. Reinterpretation of existing crystallographic data and molecular dynamics simulations indeed reveal an occupied Na+-binding site in the N-terminal lobe of both structures, analogous to that identified in PfMATE. We likewise find this site to be strongly selective against K+, suggesting it is mechanistically significant. Consistent with these computational results, DEER spectroscopy measurements for multiple doubly-spin-labeled VcmN constructs demonstrate Na+-dependent changes in protein conformation. The existence of this binding site in three MATE orthologs implicates Na+ in the ion-coupled drug-efflux mechanisms of this class of transporters. These results also imply that observations of H+-dependent activity likely stem either from a site elsewhere in the structure, or from H+ displacing Na+ under certain laboratory conditions, as has been noted for other Na+-driven transport systems.	[Castellano, Steven; Ficici, Emel; Stix, Robyn; Zhou, Wenchang; Faraldo-Gomez, Jose D.] NHLBI, Theoret Mol Biophys Lab, NIH, Bldg 10, Bethesda, MD 20892 USA; [Claxton, Derek P.; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Kusakizako, Tsukasa; Nureki, Osamu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Bunkyo Ku, Tokyo, Japan	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Vanderbilt University; University of Tokyo	Faraldo-Gomez, JD (corresponding author), NHLBI, Theoret Mol Biophys Lab, NIH, Bldg 10, Bethesda, MD 20892 USA.; Claxton, DP (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	derek.p.claxton@vanderbilt.edu; jose.faraldo@nih.gov		Claxton, Derek P/0000-0002-1374-7176	Division of Intramural Research of the National Heart, Lung and Blood Institute of the National Institutes of Health; National Institutes of Health [R01 GM077659]	Division of Intramural Research of the National Heart, Lung and Blood Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported with funds from the Division of Intramural Research of the National Heart, Lung and Blood Institute of the National Institutes of Health (S. C., E. F., R. S., W. Z., J. D. F.-G.) and from National Institutes of Health with grant number R01 GM077659 (D. P. C. and H. S. M.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Afonine PV, 2012, ACTA CRYSTALLOGR D, V68, P352, DOI 10.1107/S0907444912001308; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Chen J, 2002, J BACTERIOL, V184, P572, DOI 10.1128/JB.184.2.572-576.2002; Clavel F, 2004, NEW ENGL J MED, V350, P1023, DOI 10.1056/NEJM2ra025195; Claxton DP, 2018, P NATL ACAD SCI USA, V115, pE6182, DOI 10.1073/pnas.1802417115; Claxton DP, 2015, METHOD ENZYMOL, V564, P349, DOI 10.1016/bs.mie.2015.07.026; Dastvan R, 2019, SCIENCE, V364, P689, DOI 10.1126/science.aav9406; Dastvan R, 2016, P NATL ACAD SCI USA, V113, P1220, DOI 10.1073/pnas.1520431113; Debruycker V, 2020, NAT STRUCT MOL BIOL, V27, P829, DOI 10.1038/s41594-020-0464-y; Duraes F, 2018, CURR MED CHEM, V25, P6030, DOI 10.2174/0929867325666180209142612; Eicher T, 2014, ELIFE, V3, DOI 10.7554/eLife.03145; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ficici E, 2018, P NATL ACAD SCI USA, V115, pE6172, DOI 10.1073/pnas.1802080115; Guskov A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13420; Hariharan P, 2017, J GEN PHYSIOL, V149, P1029, DOI 10.1085/jgp.201711788; Hashimoto K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059525; He XA, 2010, NATURE, V467, P991, DOI 10.1038/nature09408; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Huda MN, 2001, FEMS MICROBIOL LETT, V203, P235, DOI 10.1111/j.1574-6968.2001.tb10847.x; Hustedt EJ, 2018, BIOPHYS J, V115, P1200, DOI 10.1016/j.bpj.2018.08.008; Jagessar KL, 2020, P NATL ACAD SCI USA, V117, P4732, DOI 10.1073/pnas.1917139117; JARDETZK.O, 1966, NATURE, V211, P969, DOI 10.1038/211969a0; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jin Y, 2014, J BIOL CHEM, V289, P14624, DOI 10.1074/jbc.M113.546770; Kazmier K, 2017, CURR OPIN STRUC BIOL, V45, P100, DOI 10.1016/j.sbi.2016.12.006; Kazmier K, 2014, P NATL ACAD SCI USA, V111, P14752, DOI 10.1073/pnas.1410431111; Kazmier K, 2014, NAT STRUCT MOL BIOL, V21, P472, DOI 10.1038/nsmb.2816; Klauda JB, 2010, J PHYS CHEM B, V114, P7830, DOI 10.1021/jp101759q; Krah A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.183137; Krah A, 2010, BBA-BIOENERGETICS, V1797, P763, DOI 10.1016/j.bbabio.2010.04.014; Krah A, 2010, J MOL BIOL, V395, P20, DOI 10.1016/j.jmb.2009.10.059; Kuk ACY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09658-0; Kuroda T, 2009, BBA-PROTEINS PROTEOM, V1794, P763, DOI 10.1016/j.bbapap.2008.11.012; Kusakizako T, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2019.183154; Kusakizako T, 2019, STRUCTURE, V27, P293, DOI 10.1016/j.str.2018.10.004; Leone V, 2015, P NATL ACAD SCI USA, V112, pE1057, DOI 10.1073/pnas.1421202112; Long F, 2008, ANTIMICROB AGENTS CH, V52, P3052, DOI 10.1128/AAC.00475-08; Lu M, 2016, CHANNELS, V10, P88, DOI 10.1080/19336950.2015.1106654; Lu M, 2013, NAT STRUCT MOL BIOL, V20, P1310, DOI 10.1038/nsmb.2687; Lu M, 2013, P NATL ACAD SCI USA, V110, P2099, DOI 10.1073/pnas.1219901110; Luoto HH, 2013, P NATL ACAD SCI USA, V110, P1255, DOI 10.1073/pnas.1217816110; Marinelli F, 2014, P NATL ACAD SCI USA, V111, pE5354, DOI 10.1073/pnas.1415751111; Masureel M, 2014, NAT CHEM BIOL, V10, P149, DOI 10.1038/nchembio.1408; Matthies D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6286; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Meier T, 2009, J MOL BIOL, V391, P498, DOI 10.1016/j.jmb.2009.05.082; Miyauchi H, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01541-0; Morita Y, 2000, J BACTERIOL, V182, P6694, DOI 10.1128/JB.182.23.6694-6697.2000; Mousa JJ, 2017, BIOCHEM BIOPH RES CO, V482, P1233, DOI 10.1016/j.bbrc.2016.12.018; Mousa JJ, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2015.9, 10.1038/nmicrobiol.2015.9]; Nayal M, 1996, J MOL BIOL, V256, P228, DOI 10.1006/jmbi.1996.0081; Nie LY, 2016, J BIOL CHEM, V291, P15503, DOI 10.1074/jbc.M116.728618; Nikaido H, 2009, ANNU REV BIOCHEM, V78, P119, DOI 10.1146/annurev.biochem.78.082907.145923; Nina M, 1997, J PHYS CHEM B, V101, P5239, DOI 10.1021/jp970736r; Omote H, 2006, TRENDS PHARMACOL SCI, V27, P587, DOI 10.1016/j.tips.2006.09.001; Paz A, 2018, P NATL ACAD SCI USA, V115, pE2742, DOI 10.1073/pnas.1718451115; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Picollo A, 2012, NAT STRUCT MOL BIOL, V19, P525, DOI 10.1038/nsmb.2277; Piddock LJV, 2006, NAT REV MICROBIOL, V4, P629, DOI 10.1038/nrmicro1464; Poole K, 2007, ANN MED, V39, P162, DOI 10.1080/07853890701195262; Putman M, 2000, MICROBIOL MOL BIOL R, V64, P672, DOI 10.1128/MMBR.64.4.672-693.2000; Radchenko M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8995; Schlegel K, 2012, P NATL ACAD SCI USA, V109, P947, DOI 10.1073/pnas.1115796109; Schulz S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001596; Shlosman I, 2018, J GEN PHYSIOL, V150, P51, DOI 10.1085/jgp.201711897; Spellberg B, 2008, CLIN INFECT DIS, V46, P155, DOI 10.1086/524891; Staritzbichler R, 2011, J CHEM THEORY COMPUT, V7, P1167, DOI 10.1021/ct100576m; Stein RA, 2015, METHOD ENZYMOL, V563, P531, DOI 10.1016/bs.mie.2015.07.031; Tanaka Y, 2017, STRUCTURE, V25, P1455, DOI 10.1016/j.str.2017.07.009; Tanaka Y, 2013, NATURE, V496, P247, DOI 10.1038/nature12014; Xu XJ, 2003, MICROBIOL IMMUNOL, V47, P937, DOI 10.1111/j.1348-0421.2003.tb03467.x; Zakrzewska S, 2019, P NATL ACAD SCI USA, V116, P12275, DOI 10.1073/pnas.1904210116	74	4	4	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100262	10.1016/j.jbc.2021.100262	http://dx.doi.org/10.1016/j.jbc.2021.100262			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33837745	gold, Green Published			2022-12-28	WOS:000672866400238
J	Deng, ZH; Zeng, QY; Tang, J; Zhang, B; Chai, JW; Andersen, JF; Chen, X; Xu, XQ				Deng, Zhenhui; Zeng, Qingye; Tang, Jie; Zhang, Bei; Chai, Jinwei; Andersen, John F.; Chen, Xin; Xu, Xueqing			Anti-inflammatory effects of FS48, the first potassium channel inhibitor from the salivary glands of the flea Xenopsylla cheopis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+ CHANNEL; ANIMAL TOXINS; KV1.3; MACROPHAGES; ALPHA; INFLAMMATION; ACTIVATION; DOCKING	The voltage-gated potassium (Kv) 1.3 channel plays a crucial role in the immune responsiveness of T-lymphocytes and macrophages, presenting a potential target for treatment of immune- and inflammation related-diseases. FS48, a protein from the rodent flea Xenopsylla cheopis, shares the three disulfide bond feature of scorpion toxins. However, its threedimensional structure and biological function are still unclear. In the present study, the structure of FS48 was evaluated by circular dichroism and homology modeling. We also described its in vitro ion channel activity using patch clamp recording and investigated its anti-inflammatory activity in LPS-induced Raw 264.7 macrophage cells and carrageenaninduced paw edema in mice. FS48 was found to adopt a common alpha beta beta structure and contain an atypical dyad motif. It dose-dependently exhibited the Kv1.3 channel in Raw 264.7 and HEK 293T cells, and its ability to block the channel pore was demonstrated by the kinetics of activation and competition binding with tetraethylammonium. FS48 also downregulated the secretion of proinflammatory molecules NO, IL-1 beta, TNF-alpha, and IL-6 by Raw 264.7 cells in a manner dependent on Kv1.3 channel blockage and the subsequent inactivation of the MAPK/NF-kappa B pathways. Finally, we observed that FS48 inhibited the paw edema formation, tissue myeloperoxidase activity, and inflammatory cell infiltrations in carrageenantreated mice. We therefore conclude that FS48 identified from the flea saliva is a novel potassium channel inhibitor displaying anti-inflammatory activity. This discovery will promote understanding of the bloodsucking mechanism of the flea and provide a new template molecule for the design of Kv1.3 channel blockers.	[Deng, Zhenhui; Chen, Xin] Zhujiang Hosp, Dept Pulm & Crit Care Med, Guangzhou, Peoples R China; [Deng, Zhenhui; Zeng, Qingye; Zhang, Bei; Chai, Jinwei; Xu, Xueqing] Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Peoples R China; [Tang, Jie] Southern Med Univ, Sch Basic Med Sci, Dept Physiol, Guangzhou, Peoples R China; [Andersen, John F.] NIAID, Lab Malaria & Vector Res, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Chen, X (corresponding author), Zhujiang Hosp, Dept Pulm & Crit Care Med, Guangzhou, Peoples R China.; Xu, XQ (corresponding author), Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Peoples R China.	chen_xin1020@163.com; xu2003@smu.edu.cn	Tang, Jie/GNW-2318-2022	Tang, Jie/0000-0001-7882-4462	National Natural Science Foundation of China [31370782, 31861143050, 82070038, 31772476, 31911530077]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded in part by the National Natural Science Foundation of China (No. 31370782, 31861143050, 82070038, 31772476, and 31911530077).	Andersen JF, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-102; Blunck R, 2001, J IMMUNOL, V166, P1009, DOI 10.4049/jimmunol.166.2.1009; Chen PC, 2009, BIOPHYS J, V96, P2577, DOI 10.1016/j.bpj.2008.12.3952; Chen R, 2003, PROTEINS, V52, P80, DOI 10.1002/prot.10389; Dan A, 1999, J MED ENTOMOL, V36, P875, DOI 10.1093/jmedent/36.6.875; Dauplais M, 1997, J BIOL CHEM, V272, P4302, DOI 10.1074/jbc.272.7.4302; de la Vega RCR, 2004, TOXICON, V43, P865, DOI 10.1016/j.toxicon.2004.03.022; Deng ZH, 2019, INT J BIOL MACROMOL, V129, P1155, DOI 10.1016/j.ijbiomac.2019.01.073; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; Fajloun Z, 2000, J BIOL CHEM, V275, P39394, DOI 10.1074/jbc.M006810200; Gulbins E, 2010, BBA-BIOENERGETICS, V1797, P1251, DOI 10.1016/j.bbabio.2010.01.018; Jouirou B, 2004, BIOCHEM J, V377, P37, DOI 10.1042/BJ20030977; Kan XH, 2016, ARCH BIOCHEM BIOPHYS, V591, P150, DOI 10.1016/j.abb.2015.12.013; Kim DE, 2004, NUCLEIC ACIDS RES, V32, pW526, DOI 10.1093/nar/gkh468; LAMBERT P, 1990, BIOCHEM BIOPH RES CO, V170, P684, DOI 10.1016/0006-291X(90)92145-P; Leanza L, 2012, CURR MED CHEM, V19, P5394, DOI 10.2174/092986712803833281; Leanza L, 2012, EMBO MOL MED, V4, P577, DOI 10.1002/emmm.201200235; Li WF, 2013, EUR J PHARMACOL, V715, P62, DOI 10.1016/j.ejphar.2013.06.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loram LC, 2007, J PAIN, V8, P127, DOI 10.1016/j.jpain.2006.06.010; Mans BJ, 2011, J INNATE IMMUN, V3, P41, DOI 10.1159/000321599; Matzner N, 2008, J IMMUNOL, V181, P6803, DOI 10.4049/jimmunol.181.10.6803; Mouhat S, 2004, BIOCHEM J, V378, P717, DOI 10.1042/BJ20031860; Mouhat S, 2004, BIOCHEM J, V377, P25, DOI 10.1042/BJ20030115; Nguyen T, 2020, BIOMED PHARMACOTHER, V123, DOI 10.1016/j.biopha.2019.109753; Norton RS, 2017, NEUROPHARMACOLOGY, V127, P124, DOI 10.1016/j.neuropharm.2017.07.002; Paesen GC, 2009, J MOL BIOL, V389, P734, DOI 10.1016/j.jmb.2009.04.045; Ribeiro JMC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044612; Roome T, 2008, J ETHNOPHARMACOL, V120, P248, DOI 10.1016/j.jep.2008.08.025; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Serrano-Albarras A, 2018, EXPERT OPIN THER TAR, V22, P101, DOI 10.1080/14728222.2017.1420170; Stehling EG, 2012, BIOCHEMISTRY-US, V51, P1885, DOI 10.1021/bi201713z; Takac P, 2006, J EXP BIOL, V209, P343, DOI 10.1242/jeb.02003; Tytgat J, 1999, TRENDS PHARMACOL SCI, V20, P444, DOI 10.1016/S0165-6147(99)01398-X; Vicente R, 2003, J BIOL CHEM, V278, P46307, DOI 10.1074/jbc.M304388200; Vicente R, 2008, J BIOL CHEM, V283, P8756, DOI 10.1074/jbc.M708223200; Villalonga N, 2007, BIOCHEM BIOPH RES CO, V352, P913, DOI 10.1016/j.bbrc.2006.11.120; Villalonga N, 2010, J GEN PHYSIOL, V135, P135, DOI 10.1085/jgp.200910334; VINEGAR R, 1969, J PHARMACOL EXP THER, V166, P96; Wu BM, 2020, INT J MOL MED, V45, P103, DOI 10.3892/ijmm.2019.4395; Wulff H, 2009, NAT REV DRUG DISCOV, V8, P982, DOI 10.1038/nrd2983; Xu XQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep36574; Zeng BS, 2018, J MED CHEM, V61, P10709, DOI 10.1021/acs.jmedchem.8b01358; Zhang B, 2018, ANTI-CANCER DRUG, V29, P880, DOI 10.1097/CAD.0000000000000662; Zhou QL, 2018, INT IMMUNOPHARMACOL, V63, P110, DOI 10.1016/j.intimp.2018.07.009; Zhu H, 2015, SCI CHINA LIFE SCI, V58, P867, DOI 10.1007/s11427-015-4915-3	46	3	3	7	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100670	10.1016/j.jbc.2021.100670	http://dx.doi.org/10.1016/j.jbc.2021.100670			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33864815	Green Published, gold			2022-12-28	WOS:000672866400641
J	Ingram, SM; Rana, T; Manson, AM; Yayah, FM; Jackson, EGB; Anderson, C; Davids, BO; Goodwin, JS				Ingram, Shalonda M.; Rana, Tanu; Manson, Ashley M.; Yayah, Faisal M.; Jackson, Evan G. B.; Anderson, Christopher; Davids, Benem-Orom; Goodwin, J. Shawn			Optogenetically-induced multimerization of the dopamine transporter increases uptake and trafficking to the plasma membrane	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARABIDOPSIS CRYPTOCHROMES; CIRCADIAN CLOCK; CROSS-LINKING; COCAINE; AMPHETAMINE; METHAMPHETAMINE; OLIGOMERIZATION; MECHANISM; LIGHT; NEURONS	The dopamine transporter (DAT) is essential for the reup-take of the released neurotransmitter dopamine (DA) in the brain. Psychostimulants, methamphetamine and cocaine, have been reported to induce the formation of DAT multimeric complexes in vivo and in vitro. The interpretation of DAT multimer function has been primarily in the context of compounds that induce structural and functional modifications of the DAT, complicating the understanding of the significance of DAT multimers. To examine multimerization in the absence of DAT ligands as well as in their presence, we developed a novel, optogenetic fusion chimera of cryptochrome 2 and DAT with an mCherry fluorescent reporter (Cry2-DAT). Using blue light to induce Cry2-DAT multimeric protein complex formation, we were able to simultaneously test the functional contributions of DAT multimerization in the absence or presence of substrates or inhibitors with high spatiotemporal precision. We found that blue light-stimulated Cry2-DAT multimers significantly increased IDT307 uptake and MFZ 9-18 binding in the absence of ligands as well as after methamphetamine and nomifensine treatment. Blue light-induced Cry2-DAT multimerization increased colocalization with recycling endosomal marker Rab11 and had decreased presence in Rab5-positive early endosomes and Rab7-positive late endosomes. Our data suggest that the increased uptake and binding results from induced and rapid trafficking of DAT multimers to the plasma membrane. Our data suggest that DAT multimers may function to help maintain DA homeostasis.	[Ingram, Shalonda M.; Rana, Tanu; Manson, Ashley M.; Yayah, Faisal M.; Jackson, Evan G. B.; Anderson, Christopher; Davids, Benem-Orom; Goodwin, J. Shawn] Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA	Meharry Medical College	Goodwin, JS (corresponding author), Meharry Med Coll, Sch Med, Dept Biochem Canc Biol Neurosci & Pharmacol, Nashville, TN 37208 USA.	jgoodwin@mmc.edu			NIH [DA036420, GM059994]; HRSA Grant [D34HP16299-10-00]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HRSA Grant	This work was funded by NIH Grants DA036420 (to J. S. G. and T. R.) and GM059994 (to S. M. I. and B.-O. D.), and HRSA Grant D34HP16299-10-00 (to A. M. M., F. M. Y., C. A., and E. G. B. J.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baucum AJ, 2004, J NEUROSCI, V24, P3436, DOI 10.1523/JNEUROSCI.0387-04.2004; Bayer N, 1998, J VIROL, V72, P9645, DOI 10.1128/JVI.72.12.9645-9655.1998; Beuming T, 2008, NAT NEUROSCI, V11, P780, DOI 10.1038/nn.2146; Burney S, 2009, FEBS LETT, V583, P1427, DOI 10.1016/j.febslet.2009.03.040; Butler B, 2015, J BIOL CHEM, V290, P29542, DOI 10.1074/jbc.M115.691592; Cervinski MA, 2005, J BIOL CHEM, V280, P40442, DOI 10.1074/jbc.M501969200; Chang JC, 2012, J NEUROSCI, V32, P8919, DOI 10.1523/JNEUROSCI.0048-12.2012; Chen NH, 2008, J NEUROCHEM, V105, P910, DOI 10.1111/j.1471-4159.2007.05195.x; Chen R, 2009, J PHARMACOL EXP THER, V328, P912, DOI 10.1124/jpet.108.147959; Cheng MH, 2017, J BIOL CHEM, V292, P12471, DOI 10.1074/jbc.M116.763565; Chi LM, 2003, J PHARMACOL EXP THER, V307, P729, DOI 10.1124/jpet.103.055095; Das AK, 2019, J BIOL CHEM, V294, P5632, DOI 10.1074/jbc.RA118.006178; Daws LC, 2002, BIOCHEM BIOPH RES CO, V290, P1545, DOI 10.1006/bbrc.2002.6384; Devlin PF, 2000, PLANT CELL, V12, P2499, DOI 10.1105/tpc.12.12.2499; Duan HC, 2015, DRUG METAB DISPOS, V43, P1773, DOI 10.1124/dmd.115.064824; Engel S, 2011, J VIROL, V85, P4198, DOI 10.1128/JVI.02179-10; Eriksen J, 2010, J BIOL CHEM, V285, P27289, DOI 10.1074/jbc.M110.131003; Eriksen J, 2009, J NEUROSCI, V29, P6794, DOI 10.1523/JNEUROSCI.4177-08.2009; Ferrer JV, 1998, P NATL ACAD SCI USA, V95, P9238, DOI 10.1073/pnas.95.16.9238; Fleckenstein AE, 1997, J PHARMACOL EXP THER, V282, P834; Furman CA, 2009, NEUROSCI LETT, V463, P78, DOI 10.1016/j.neulet.2009.07.049; Furman CA, 2009, J NEUROSCI, V29, P3328, DOI 10.1523/JNEUROSCI.5386-08.2009; Gabriel LR, 2013, J NEUROSCI, V33, P17836, DOI 10.1523/JNEUROSCI.3284-13.2013; German CL, 2012, J NEUROCHEM, V123, P288, DOI 10.1111/j.1471-4159.2012.07875.x; Giros B, 1996, NATURE, V379, P606, DOI 10.1038/379606a0; Goodwin JS, 2009, J BIOL CHEM, V284, P2978, DOI 10.1074/jbc.M805298200; Goodwin JS, 2005, METHODS, V37, P154, DOI 10.1016/j.ymeth.2005.05.013; Goodwin JS, 2005, BIOPHYS J, V89, P1398, DOI 10.1529/biophysj.104.055640; Gulley JM, 2003, EUR J PHARMACOL, V479, P139, DOI 10.1016/j.ejphar.2003.08.064; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Hastrup H, 2003, J BIOL CHEM, V278, P45045, DOI 10.1074/jbc.C300349200; Hastrup H, 2001, P NATL ACAD SCI USA, V98, P10055, DOI 10.1073/pnas.181344298; Hong WMC, 2013, FASEB J, V27, P2995, DOI 10.1096/fj.12-218727; Johnson LA, 2005, NEUROPHARMACOLOGY, V49, P750, DOI 10.1016/j.neuropharm.2005.08.018; Jones SR, 1998, P NATL ACAD SCI USA, V95, P4029, DOI 10.1073/pnas.95.7.4029; Kahlig KM, 2004, J BIOL CHEM, V279, P8966, DOI 10.1074/jbc.M303976200; Karpowicz RJ, 2013, ACS CHEM NEUROSCI, V4, P858, DOI 10.1021/cn400038u; Kristensen AS, 2011, PHARMACOL REV, V63, P585, DOI 10.1124/pr.108.000869; Lebowitz JJ, 2019, J BIOL CHEM, V294, P6957, DOI 10.1074/jbc.RA119.007441; Li Y, 2010, J NEUROCHEM, V114, P873, DOI 10.1111/j.1471-4159.2010.06818.x; Little KY, 2002, MOL PHARMACOL, V61, P436, DOI 10.1124/mol.61.2.436; Liu HT, 2011, TRENDS PLANT SCI, V16, P684, DOI 10.1016/j.tplants.2011.09.002; Loder MK, 2003, J BIOL CHEM, V278, P22168, DOI 10.1074/jbc.M301845200; MOLLENHAUER HH, 1990, BIOCHIM BIOPHYS ACTA, V1031, P225, DOI 10.1016/0304-4157(90)90008-Z; Muhlhauser WWD, 2017, BBA-MOL CELL RES, V1864, P280, DOI 10.1016/j.bbamcr.2016.11.009; Partch CL, 2005, BIOCHEMISTRY-US, V44, P3795, DOI 10.1021/bi047545g; Rothman RB, 2003, EUR J PHARMACOL, V479, P23, DOI 10.1016/j.ejphar.2003.08.054; Saunders C, 2000, P NATL ACAD SCI USA, V97, P6850, DOI 10.1073/pnas.110035297; Schmitt KC, 2010, ANN NY ACAD SCI, V1187, P316, DOI 10.1111/j.1749-6632.2009.05148.x; Shipley MM, 2016, JOVE-J VIS EXP, DOI 10.3791/53193; Siciliano CA, 2018, J NEUROSCI, V38, P484, DOI 10.1523/JNEUROSCI.2604-17.2017; Somers DE, 1998, SCIENCE, V282, P1488, DOI 10.1126/science.282.5393.1488; Sorkina T, 2003, J BIOL CHEM, V278, P28274, DOI 10.1074/jbc.M210652200; Sorkina T, 2018, ELIFE, V7, DOI 10.7554/eLife.32293; Swant J, 2011, J BIOL CHEM, V286, P43933, DOI 10.1074/jbc.M111.241232; Taslimi A, 2016, NAT CHEM BIOL, V12, P425, DOI [10.1038/nchembio.2063, 10.1038/NCHEMBIO.2063]; Taslimi A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5925; Torres GE, 2006, J NEUROCHEM, V97, P3, DOI 10.1111/j.1471-4159.2006.03719.x; Torres GE, 2003, J BIOL CHEM, V278, P2731, DOI 10.1074/jbc.M201926200; Volz TJ, 2007, ADDICTION, V102, P44, DOI 10.1111/j.1360-0443.2007.01771.x; Wu SJ, 2017, J NEUROSCI, V37, P9438, DOI 10.1523/JNEUROSCI.3885-16.2017; Wu S, 2015, P NATL ACAD SCI USA, V112, P15480, DOI 10.1073/pnas.1512957112; Xie ZH, 2009, J PHARMACOL EXP THER, V330, P316, DOI 10.1124/jpet.109.153775; Yang HQ, 2001, PLANT CELL, V13, P2573, DOI 10.1105/tpc.13.12.2573; Yang HQ, 2000, CELL, V103, P815, DOI 10.1016/S0092-8674(00)00184-7; Yang YJ, 2008, MOL PLANT, V1, P167, DOI 10.1093/mp/ssm018; Yanovsky MJ, 2001, J BIOL RHYTHM, V16, P523, DOI 10.1177/074873001129002213; Yorgason JT, 2011, NEUROSCIENCE, V182, P125, DOI 10.1016/j.neuroscience.2011.03.017; Zhen J, 2018, J NEUROCHEM, V144, P162, DOI 10.1111/jnc.14259; Zhen J, 2015, J NEUROCHEM, V133, P167, DOI 10.1111/jnc.13025; Zhu J, 2008, CNS NEUROL DISORD-DR, V7, P393, DOI 10.2174/187152708786927877	71	0	0	2	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100787	10.1016/j.jbc.2021.100787	http://dx.doi.org/10.1016/j.jbc.2021.100787			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34015332	gold, Green Published			2022-12-28	WOS:000674717300008
J	Siswanto, FM; Oguro, A; Imaoka, S				Siswanto, Ferbian Milas; Oguro, Ami; Imaoka, Susumu			Sp1 is a substrate of Keap1 and regulates the activity of CRL4A(WDR23) ubiquitin ligase toward Nrf2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MECHANISM	Nuclear factor erythroid 2-related factor 2 (Nrf2) is a critical transcription factor that orchestrates cellular responses to oxidative stress. Because the dysregulation of Nrf2 has been implicated in many diseases, precise regulation of its protein level is crucial for maintaining homeostasis. Kelch-like-ECH-associated protein 1 (Keap1) and WD40 repeat protein 23 (WDR23) directly regulate Nrf2 levels via similar but distinct proteasome-dependent pathways. WDR23 forms a part of the WDR23-Cullin 4A-RING ubiquitin ligase complex (CRL4A(WDR23)), whereas Keap1 serves as a substrate adaptor for the Cullin 3-containing ubiquitin ligase complex. However, the mechanisms underlying crosstalk between these Keap1 and WDR23 pathways for the regulation of Nrf2 levels have not been investigated. Here, we showed that knockdown (KD) of Keap1 upregulated the expression of Cullin4A (CUL4A) in a specificity protein 1 (Sp1)-dependent manner. We also revealed that Sp1 interacted with Keap1, leading to ubiquitination of Sp1. Increases in Sp1 by Keap1 KD triggered Sp1 binding to the fourth Sp1 binding site (Sp1_M4) within the -230/+50 region of the CUL4A gene. We also demonstrated that the overexpression and KD of Sp1 reduced and increased Nrf2 protein levels, respectively. These effects were abrogated by the WDR23 KD, suggesting that Sp1 also regulates Nrf2 levels via the ubiquitin ligase complex CRL4A(WDR23). In conclusion, we discovered Sp1 as a novel substrate of Keap1 and provided evidence that Sp1 regulates the expression of CUL4A. We revealed a novel role for Sp1 in mediating cross-talk between two independent regulators of Nrf2 protein levels.	[Siswanto, Ferbian Milas; Oguro, Ami; Imaoka, Susumu] Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Sanda, Japan; [Oguro, Ami] Hiroshima Univ, Grad Sch Integrated Sci Life, Program Biomed Sci, Hiroshima, Japan	Kwansei Gakuin University; Hiroshima University	Imaoka, S (corresponding author), Kwansei Gakuin Univ, Sch Sci & Technol, Dept Biomed Chem, Sanda, Japan.	imaoka@kwansei.ac.jp		Siswanto, Ferbian/0000-0001-5034-1514	JSPS KAKENHI [17K08581]; Kwansei Gakuin University	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Kwansei Gakuin University(Kwansei Gakuin University)	This study was partially supported by a JSPS KAKENHI Grant (17K08581). It was also partially supported by a Grant-in-Aid from Kwansei Gakuin University.	Baba K, 2013, J BIOL CHEM, V288, P18393, DOI 10.1074/jbc.M112.438762; Beishline K, 2015, FEBS J, V282, P224, DOI 10.1111/febs.13148; Burger Angelika M, 2010, Open Cancer J, V3, P116; Deniaud E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007035; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Ge WJ, 2017, CANCER CELL, V32, P561, DOI 10.1016/j.ccell.2017.09.008; Guo D, 2012, BIOCHEM BIOPH RES CO, V428, P80, DOI 10.1016/j.bbrc.2012.10.010; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Li Chao, 2018, Cell Physiol Biochem, V51, P2829, DOI 10.1159/000496013; Li WC, 2010, METHODS MOL BIOL, V633, P185, DOI 10.1007/978-1-59745-019-5_13; Safe S, 2018, CANCER PREV RES, V11, P371, DOI 10.1158/1940-6207.CAPR-17-0407; Sharma P, 2014, OPEN BIOL, V4, DOI 10.1098/rsob.130217; Suzuki T, 2019, CELL REP, V28, P746, DOI 10.1016/j.celrep.2019.06.047; Vizcaino C, 2015, PHARMACOL THERAPEUT, V152, P124; Wang YT, 2009, FASEB J, V23; Wang YT, 2011, J MOL BIOL, V414, P1, DOI 10.1016/j.jmb.2011.09.027; Wei S, 2009, MOL PHARMACOL, V76, P47, DOI 10.1124/mol.109.055376; Yeh SH, 2011, NUCLEIC ACIDS RES, V39, P5412, DOI 10.1093/nar/gkr161	18	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100704	10.1016/j.jbc.2021.100704	http://dx.doi.org/10.1016/j.jbc.2021.100704			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895141	gold, Green Published			2022-12-28	WOS:000672866400675
J	Takatani, T; Shirakawa, J; Shibue, K; Gupta, MK; Kim, H; Lu, SS; Hu, J; White, MF; Kennedy, RT; Kulkarni, RN				Takatani, Tomozumi; Shirakawa, Jun; Shibue, Kimitaka; Gupta, Manoj K.; Kim, Hyunki; Lu, Shusheng; Hu, Jiang; White, Morris F.; Kennedy, Robert T.; Kulkarni, Rohit N.			Insulin receptor substrate 1, but not IRS2, plays a dominant role in regulating pancreatic alpha cell function in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; BETA-CELLS; CRYSTAL-STRUCTURE; GLUCAGON-SECRETION; B30.2 DOMAIN; ISLETS; PHOSPHOANTIGENS; RESTRICTION; KINASE	Dysregulated glucagon secretion deteriorates glycemic control in type 1 and type 2 diabetes. Although insulin is known to regulate glucagon secretion via its cognate receptor (insulin receptor, INSR) in pancreatic alpha cells, the role of downstream proteins and signaling pathways underlying insulin's activities are not fully defined. Using in vivo (knockout) and in vitro (knockdown) studies targeting insulin receptor substrate (IRS) proteins, we compared the relative roles of IRS1 and IRS2 in regulating alpha cell function. Alpha cell-specific IRS1-knockout mice exhibited glucose intolerance and inappropriate glucagon suppression during glucose tolerance tests. In contrast, alpha cell-specific IRS2-knockout animals manifested normal glucose tolerance and suppression of glucagon secretion after glucose administration. Alpha cell lines with stable IRS1 knockdown could not repress glucagon mRNA expression and exhibited a reduction in phosphorylation of AKT Ser/Thr kinase (AKT, at Ser-473 and Thr-308). AlphaIRS1KD cells also displayed suppressed global protein translation, including reduced glucagon expression, impaired cytoplasmic Ca2+ response, and mitochondrial dysfunction. This was supported by the identification of novel IRS1-specific downstream target genes, Trpc3 and Cartpt, that are associated with glucagon regulation in alpha cells. These results provide evidence that IRS1, rather than IRS2, is a dominant regulator of pancreatic alpha cell function.	[Takatani, Tomozumi; Shibue, Kimitaka; Gupta, Manoj K.; Kim, Hyunki; Hu, Jiang; Kulkarni, Rohit N.] Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA; [Takatani, Tomozumi] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan; [Shirakawa, Jun] Gunma Univ, Inst Mol & Cellular Regulat IMCR, Lab Diabet & Metab Disorders, Gunma, Japan; [Gupta, Manoj K.] Takeda Pharmaceut, Cell Therapy Translat Engine Cite, Cambridge, MA USA; [Lu, Shusheng; Kennedy, Robert T.] Univ Michigan, Dept Chem, Ann Arbor, MI 48109 USA; [Lu, Shusheng; Kennedy, Robert T.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA; [White, Morris F.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA 02115 USA; [Kulkarni, Rohit N.] Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Joslin Diabetes Center, Inc.; Chiba University; Gunma University; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School	Kulkarni, RN (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Joslin Diabet Ctr, Islet Cell & Regenerat Biol,Dept Med, Boston, MA 02115 USA.; Kulkarni, RN (corresponding author), Harvard Med Sch, Harvard Stem Cell Inst, Boston, MA 02115 USA.	rohit.kulkarni@joslin.harvard.edu		Kulkarni, Rohit/0000-0001-5029-6119; Shirakawa, Jun/0000-0002-0822-8750	National Institutes of Health [R01 DK67536, R01 DK103215, R01 DK046960]; Manpei Suzuki Diabetes Foundation; Iacocca Foundation; Japan Society for the Promotion of Science; Uehara Memorial Foundation; MSD Life Science Foundation; JDRF advanced postdoctoral fellowship grant [3-APF-2017-393-A-N]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manpei Suzuki Diabetes Foundation; Iacocca Foundation; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Uehara Memorial Foundation(Uehara Memorial Foundation); MSD Life Science Foundation; JDRF advanced postdoctoral fellowship grant	This work was supported by grants from the National Institutes of Health R01 DK67536 and in part from R01 DK103215 (R. N. K.) and R01 DK046960 (R. T. K.). T. T. was supported by Manpei Suzuki Diabetes Foundation and the Iacocca Foundation. J. S. is supported by the Japan Society for the Promotion of Science and Uehara Memorial Foundation. K. S. was supported by MSD Life Science Foundation. M. K. G. is supported by JDRF advanced postdoctoral fellowship grant 3-APF-2017-393-A-N.	Abels M, 2016, DIABETOLOGIA, V59, P1928, DOI 10.1007/s00125-016-4020-6; Allister EM, 2013, DIABETES, V62, P1623, DOI 10.2337/db12-0981; Araujo EP, 2002, FEBS LETT, V531, P437, DOI 10.1016/S0014-5793(02)03580-9; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Aspinwall CA, 2000, J BIOL CHEM, V275, P22331, DOI 10.1074/jbc.M909647199; Bozadjieva N, 2017, J CLIN INVEST, V127, P4379, DOI 10.1172/JCI90004; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; Cryer PE, 2012, ENDOCRINOLOGY, V153, P1039, DOI 10.1210/en.2011-1499; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Dong XC, 2008, CELL METAB, V8, P65, DOI 10.1016/j.cmet.2008.06.006; Edlund A, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-87; Gazit N, 2016, NEURON, V89, P583, DOI 10.1016/j.neuron.2015.12.034; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Herrera PL, 2000, DEVELOPMENT, V127, P2317; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Kim MS, 2009, GASTROENTEROLOGY, V137, P1509, DOI 10.1053/j.gastro.2009.07.042; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kulkarni RN, 1999, CELL, V96, P329, DOI 10.1016/S0092-8674(00)80546-2; Kusminski CM, 2016, DIABETES, V65, P1534, DOI 10.2337/db15-1323; Le Marchand SJ, 2010, J BIOL CHEM, V285, P14389, DOI 10.1074/jbc.M109.069195; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Liew CW, 2014, P NATL ACAD SCI USA, V111, pE2319, DOI 10.1073/pnas.1323066111; Lin XY, 2004, J CLIN INVEST, V114, P908, DOI [10.1172/JCI22217, 10.1172/JCI200422217]; Liu SM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007983; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Nishiki Y, 2013, MOL ENDOCRINOL, V27, P336, DOI 10.1210/me.2012-1230; Okada T, 2007, P NATL ACAD SCI USA, V104, P8977, DOI 10.1073/pnas.0608703104; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Ozoe A, 2013, FEBS LETT, V587, P2319, DOI 10.1016/j.febslet.2013.05.066; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Park K, 2013, MOL CELL BIOL, V33, P3227, DOI 10.1128/MCB.00506-13; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Riehle C, 2014, MOL CELL BIOL, V34, P3450, DOI 10.1128/MCB.00426-14; Rorsman P, 2012, CELL CALCIUM, V51, P300, DOI 10.1016/j.ceca.2011.11.006; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Shen XX, 2012, ENDOCR RES, V37, P12, DOI 10.3109/07435800.2011.610855; Shiota C, 2017, DIABETOLOGIA, V60, P2399, DOI 10.1007/s00125-017-4425-x; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tang CY, 2017, MOL CELLS, V40, P123, DOI 10.14348/molcells.2017.2228; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Vergari E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08193-8; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Xavier GD, 2011, DIABETOLOGIA, V54, P819, DOI 10.1007/s00125-010-2010-7; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhang Q, 2013, CELL METAB, V18, P871, DOI 10.1016/j.cmet.2013.10.014; Zhou A, 2014, DIABETOLOGIA, V57, P801, DOI 10.1007/s00125-013-3148-x; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	74	4	4	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100646	10.1016/j.jbc.2021.100646	http://dx.doi.org/10.1016/j.jbc.2021.100646			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839150	gold, Green Published			2022-12-28	WOS:000672866400617
J	Wilson, IA; Stanfield, RL				Wilson, Ian A.; Stanfield, Robyn L.			50 Years of structural immunology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							GAMMA-GLUTAMYLMETHYLAMIDE SYNTHETASE; GLUTAMINE-SYNTHETASE; MARINE-BACTERIA; NITROGEN-SOURCE; METHYLAMINE; GENE; IDENTIFICATION; PURIFICATION; METABOLISM; EXPRESSION	Fifty years ago, the first landmark structures of antibodies heralded the dawn of structural immunology. Momentum then started to build toward understanding how antibodies could recognize the vast universe of potential antigens and how antibody-combining sites could be tailored to engage antigens with high specificity and affinity through recombination of germline genes (V, D, J) and somatic mutation. Equivalent groundbreaking structures in the cellular immune system appeared some 15 to 20 years later and illustrated how processed protein antigens in the form of peptides are presented by MHC molecules to T cell receptors. Structures of antigen receptors in the innate immune system then explained their inherent specificity for particular microbial antigens including lipids, carbohydrates, nucleic acids, small molecules, and specific proteins. These two sides of the immune system act immediately (innate) to particular microbial antigens or evolve (adaptive) to attain high specificity and affinity to a much wider range of antigens. We also include examples of other key receptors in the immune system (cytokine receptors) that regulate immunity and inflammation. Furthermore, these antigen receptors use a limited set of protein folds to accomplish their various immunological roles. The other main players are the antigens themselves. We focus on surface glycoproteins in enveloped viruses including SARS-CoV-2 that enable entry and egress into host cells and are targets for the antibody response. This review covers what we have learned over the past half century about the structural basis of the immune response to microbial pathogens and how that information can be utilized to design vaccines and therapeutics.	[Wilson, Ian A.; Stanfield, Robyn L.] Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA; [Wilson, Ian A.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Wilson, IA (corresponding author), Scripps Res Inst, Dept Integrat Struct & Computat Biol, La Jolla, CA 92037 USA.; Wilson, IA (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.	wilson@scripps.edu						Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; ALMASSY RJ, 1986, NATURE, V323, P304, DOI 10.1038/323304a0; BROWN JR, 1994, J MOL EVOL, V38, P566; Carpenter LJ, 2012, CHEM SOC REV, V41, P6473, DOI 10.1039/c2cs35121h; Chen Y, 2012, ENVIRON MICROBIOL, V14, P2308, DOI 10.1111/j.1462-2920.2012.02765.x; Chen Y, 2011, P NATL ACAD SCI USA, V108, P17791, DOI 10.1073/pnas.1112928108; Chen Y, 2010, APPL ENVIRON MICROB, V76, P4530, DOI 10.1128/AEM.00739-10; Chen Y, 2010, APPL ENVIRON MICROB, V76, P4102, DOI 10.1128/AEM.00469-10; CHISTOSERDOV AY, 1994, J BACTERIOL, V176, P4052, DOI 10.1128/JB.176.13.4052-4065.1994; Eisenberg D, 2000, BBA-PROTEIN STRUCT M, V1477, P122, DOI 10.1016/S0167-4838(99)00270-8; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gibb SW, 1999, DEEP-SEA RES PT II, V46, P593, DOI 10.1016/S0967-0645(98)00119-2; Gonzalez JM, 1997, APPL ENVIRON MICROB, V63, P4237; HUSAIN M, 1987, J BACTERIOL, V169, P1712, DOI 10.1128/jb.169.4.1712-1717.1987; Kamini Sharma, 2018, APPL ENVIRON MICROB, V84; KIMURA T, 1992, BIOSCI BIOTECH BIOCH, V56, P708, DOI 10.1271/bbb.56.708; Krajewski WW, 2005, P NATL ACAD SCI USA, V102, P10499, DOI 10.1073/pnas.0502248102; KUMADA Y, 1993, P NATL ACAD SCI USA, V90, P3009, DOI 10.1073/pnas.90.7.3009; Latypova E, 2010, MOL MICROBIOL, V75, P426, DOI 10.1111/j.1365-2958.2009.06989.x; LIAW SH, 1995, PROTEIN SCI, V4, P2358, DOI 10.1002/pro.5560041114; Lidbury E. A., 2015, ISME J; Lidbury I, 2017, ISME J, V11, P1592, DOI 10.1038/ismej.2017.31; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Murray DS, 2013, J BIOL CHEM, V288, P35801, DOI 10.1074/jbc.M113.519496; Poste AE, 2014, SCI TOTAL ENVIRON, V481, P274, DOI 10.1016/j.scitotenv.2014.02.066; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; Stein LY, 2017, ENVIRON MICROBIOL, V19, P2117, DOI 10.1111/1462-2920.13716; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taubert M, 2017, ENVIRON MICROBIOL, V19, P2246, DOI 10.1111/1462-2920.13709; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; van Rooyen JM, 2011, STRUCTURE, V19, P471, DOI 10.1016/j.str.2011.02.001; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wischer D, 2015, ISME J, V9, P195, DOI 10.1038/ismej.2014.102; WOODS DR, 1993, FEMS MICROBIOL REV, V11, P273, DOI 10.1111/j.1574-6976.1993.tb00001.x; Yamamoto S, 2008, BIOSCI BIOTECH BIOCH, V72, P101, DOI 10.1271/bbb.70462; Yamamoto S, 2007, BIOSCI BIOTECH BIOCH, V71, P545, DOI 10.1271/bbb.60590; Yang SY, 2020, J MICROBIOL BIOTECHN, V30, P785, DOI 10.4014/jmb.1910.10044; ZHANG XP, 1993, J BACTERIOL, V175, P5617, DOI 10.1128/JB.175.17.5617-5627.1993; Zhuang GC, 2018, ENVIRON MICROBIOL, V20, P4543, DOI 10.1111/1462-2920.14406	39	7	7	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100745	10.1016/j.jbc.2021.100745	http://dx.doi.org/10.1016/j.jbc.2021.100745			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957119	Green Published, gold			2022-12-28	WOS:000672866400714
J	Xie, W; Chen, MZ; Zhai, ZD; Li, HJ; Song, T; Zhu, YG; Dong, D; Zhou, P; Duan, LW; Zhang, Y; Li, DW; Liu, XQ; Zhou, J; Liu, M				Xie, Wei; Chen, Mingzhen; Zhai, Zhaodong; Li, Hongjie; Song, Ting; Zhu, Yigao; Dong, Dan; Zhou, Peng; Duan, Liangwei; Zhang, You; Li, Dengwen; Liu, Xinqi; Zhou, Jun; Liu, Min			HIV-1 exposure promotes PKG1-mediated phosphorylation and degradation of stathmin to increase epithelial barrier permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; MICROTUBULES; INFECTION; AUTOPHAGY; JUNCTIONS; CYLD	Exposure of mucosal epithelial cells to the human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120 is known to disrupt epithelial cell junctions by impairing stathmin-mediated microtubule depolymerization. However, the pathological significance of this process and its underlying molecular mechanism remain unclear. Here we show that treatment of epithelial cells with pseudotyped HIV-1 viral particles or recombinant gp120 protein results in the activation of protein kinase G 1 (PKG1). Examination of epithelial cells by immunofluorescence microscopy reveals that PKG1 activation mediates the epithelial barrier damage upon HIV-1 exposure. Immunoprecipitation experiments show that PKG1 interacts with stathmin and phosphorylates stathmin at serine 63 in the presence of gp120. Immunoprecipitation and immunofluorescence microscopy further demonstrate that PKG1-mediated phosphorylation of stathmin promotes its autophagic degradation by enhancing the interaction between stathmin and the autophagy adaptor protein p62. Collectively, these results suggest that HIV-1 exposure exploits the PKG1/stathmin axis to affect the microtubule cytoskeleton and thereby perturbs epithelial cell junctions. Our findings reveal a novel molecular mechanism by which exposure to HIV-1 increases epithelial permeability, which has implications for the development of effective strategies to prevent mucosal HIV-1 transmission.	[Xie, Wei; Chen, Mingzhen; Zhai, Zhaodong; Li, Hongjie; Song, Ting; Zhu, Yigao; Dong, Dan; Zhou, Peng; Zhou, Jun; Liu, Min] Shandong Normal Univ, Coll Life Sci, Inst Biomed Sci, Shandong Prov Key Lab Anim Resistance Biol,Collab, Jinan, Shandong, Peoples R China; [Duan, Liangwei; Zhang, You; Li, Dengwen; Liu, Xinqi; Zhou, Jun] Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China	Shandong Normal University; Nankai University	Zhou, J; Liu, M (corresponding author), Shandong Normal Univ, Coll Life Sci, Inst Biomed Sci, Shandong Prov Key Lab Anim Resistance Biol,Collab, Jinan, Shandong, Peoples R China.; Zhou, J (corresponding author), Nankai Univ, Coll Life Sci, State Key Lab Med Chem Biol, Tianjin, Peoples R China.	junzhou@sdnu.edu.cn; minliu@sdnu.edu.cn	Zhang, You/GYU-9078-2022	Zhang, You/0000-0002-5401-4593	National Key R&D Program of China [2018YFA0107001]; National Natural Science Foundation of China [31701209, 31471262]	National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the National Key R&D Program of China [2018YFA0107001] and the National Natural Science Foundation of China [31701209 and 31471262].	Angulo-Urarte A, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183316; Basu R, 2017, J BIOL CHEM, V292, P14747, DOI 10.1074/jbc.M117.786491; Beena Vt, 2013, J Oral Maxillofac Pathol, V17, P76, DOI 10.4103/0973-029X.110741; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BUTT E, 1994, EUR J PHARM-MOLEC PH, V269, P265, DOI 10.1016/0922-4106(94)90095-7; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Chen M, 2021, SCI CHINA LIFE SCI, V64, P575, DOI 10.1007/s11427-020-1765-6; Chen PW, 2010, J BIOL CHEM, V285, P10053, DOI 10.1074/jbc.M109.044420; Cicala C, 2016, CURR DRUG TARGETS, V17, P122, DOI 10.2174/1389450116666150825120735; De Clercq E, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00276; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Dong D, 2020, THORAC CANCER, V11, P519, DOI 10.1111/1759-7714.13344; Duan LW, 2017, SCI REP-UK, V7, DOI 10.1038/srep46733; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Espert L, 2006, J CLIN INVEST, V116, P2161, DOI 10.1172/JCI26185; France MM, 2017, J CELL SCI, V130, P307, DOI 10.1242/jcs.193482; Garcia MA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029181; Gavilan MP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002087; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hu Z, 2017, FRONT NEUROSCI, V11, P150; Li J, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00921; Lin X., 2016, CANCER BIOTHER RADI, V31, P37; Liu M, 2018, PHARMACOL THERAPEUT, V182, P28, DOI 10.1016/j.pharmthera.2017.08.013; Lu Nu T, 2018, J Cell Death, V11, p1179066018785141, DOI 10.1177/1179066018785141; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Melar M, 2007, J VIROL, V81, P1773, DOI 10.1128/JVI.01316-06; Meng W, 2008, CELL, V135, P948, DOI 10.1016/j.cell.2008.09.040; Nazli A, 2013, J IMMUNOL, V191, P4246, DOI 10.4049/jimmunol.1301482; Nazli A, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000852; Odenwald MA, 2017, J CELL SCI, V130, P243, DOI 10.1242/jcs.188185; Paschoud S, 2014, TISSUE BARRIERS, V2, DOI 10.4161/tisb.28755; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; RAN JX, 2020, DEV CELL, V53, DOI DOI 10.1088/1361-6463/AB9A9B; Ranek MJ, 2019, NATURE, V566, P264, DOI 10.1038/s41586-019-0895-y; Shaik MM, 2019, NATURE, V565, P318, DOI 10.1038/s41586-018-0804-9; Sun S, 2020, ACTA PHARMACOL SIN, V41, P1310, DOI 10.1038/s41401-020-0470-y; Tugizov S, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1159276; Vasileva E, 2018, TISSUE BARRIERS, V6, DOI 10.1080/21688370.2018.1539596; Xie W, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0175-1; Xie W, 2018, BIOL LETTERS, V14, DOI 10.1098/rsbl.2017.0540; Xie W, 2017, J GENET GENOMICS, V44, P343, DOI 10.1016/j.jgg.2017.06.002; Xu KW, 2015, J BIOL CHEM, V290, P19245, DOI 10.1074/jbc.M115.639625; Yang Y, 2021, SCI BULL, V66, P727, DOI 10.1016/j.scib.2020.10.014; Yang YF, 2016, J CELL SCI, V129, P2289, DOI 10.1242/jcs.183319; Yano T, 2013, J CELL BIOL, V203, P605, DOI 10.1083/jcb.201304194; Yip YY, 2014, J BIOL CHEM, V289, P2157, DOI 10.1074/jbc.M113.470682; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhang Y, 2018, VIROLOGY, V518, P293, DOI 10.1016/j.virol.2018.02.003	52	1	1	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100644	10.1016/j.jbc.2021.100644	http://dx.doi.org/10.1016/j.jbc.2021.100644			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839152	gold, Green Published			2022-12-28	WOS:000672866400615
J	Yokoyama, T; Niinae, T; Tsumagari, K; Imami, K; Ishihama, Y; Hizukuri, Y; Akiyama, Y				Yokoyama, Tatsuhiko; Niinae, Tomoya; Tsumagari, Kazuya; Imami, Koshi; Ishihama, Yasushi; Hizukuri, Yohei; Akiyama, Yoshinori			The Escherichia coli S2P intramembrane protease RseP regulates ferric citrate uptake by cleaving the sigma factor regulator FecR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSPORT-SYSTEM; TRANSCRIPTIONAL REGULATION; DICITRATE-TRANSPORT; STRESS-RESPONSE; GENE; PROTEOLYSIS; YAEL; BACTERIA; ACTIVATION; CLEAVAGE	Escherichia coli RseP, a member of the site-2 protease family of intramembrane proteases, is involved in the activation of the sE extracytoplasmic stress response and elimination of signal peptides from the cytoplasmic membrane. However, whether RseP has additional cellular functions is unclear. In this study, we used mass spectrometry-based quantitative proteomic analysis to search for new substrates that might reveal unknown physiological roles for RseP. Our data showed that the levels of several Fec system proteins encoded by the fecABCDE operon (fec operon) were significantly decreased in an RsePdeficient strain. The Fec system is responsible for the uptake of ferric citrate, and the transcription of the fec operon is controlled by FecI, an alternative sigma factor, and its regulator FecR, a single-pass transmembrane protein. Assays with a fec operon expression reporter demonstrated that the proteolytic activity of RseP is essential for the ferric citrate-dependent upregulation of the fec operon. Analysis using the FecR protein and FecR-derived model proteins showed that FecR undergoes sequential processing at the membrane and that RseP participates in the last step of this sequential processing to generate the N-terminal cytoplasmic fragment of FecR that participates in the transcription of the fec operon with FecI. A shortened FecR construct was not dependent on RseP for activation, confirming this cleavage step is the essential and sufficient role of RseP. Our study unveiled that E. coli RseP performs the intramembrane proteolysis of FecR, a novel physiological role that is essential for regulating iron uptake by the ferric citrate transport system.	[Yokoyama, Tatsuhiko; Hizukuri, Yohei; Akiyama, Yoshinori] Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan; [Niinae, Tomoya; Tsumagari, Kazuya; Imami, Koshi; Ishihama, Yasushi] Kyoto Univ, Grad Sch Pharmaceut Sci, Kyoto, Japan	Kyoto University; Kyoto University	Hizukuri, Y; Akiyama, Y (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Kyoto, Japan.	yhizukur@infront.kyoto-u.ac.jp; yakiyama@infront.kyoto-u.ac.jp	Ishihama, Yasushi/B-3101-2016	Ishihama, Yasushi/0000-0001-7714-203X; Imami, Koshi/0000-0002-7451-4982; YOKOYAMA, Tatsuhiko/0000-0003-3122-6822; Tsumagari, Kazuya/0000-0001-8464-7829	JSPS KAKENHI [JP21J15841, JP18K14674, JP20H03241, JP20H04844, JP17H05667, JP17K15091, JP19K06562, JP18H02404]; JST Strategic Basic Research Program CREST [18070870]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JST Strategic Basic Research Program CREST	This work was supported by JSPS KAKENHI Grant Numbers JP21J15841 (to T. Y.), JP18K14674, JP20H03241, JP20H04844 (to K. I.), JP17H05667 (to Y. I.), JP17K15091, JP19K06562 (to Y. H.), JP18H02404 (to Y. A.) and by JST Strategic Basic Research Program CREST (No. 18070870) to Y. I.	Ades SE, 2008, CURR OPIN MICROBIOL, V11, P535, DOI 10.1016/j.mib.2008.10.004; Akiyama K, 2015, ELIFE, V4, DOI 10.7554/eLife.08928; Akiyama Y, 2004, EMBO J, V23, P4434, DOI 10.1038/sj.emboj.7600449; Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902; ANGERER A, 1995, MOL MICROBIOL, V18, P163, DOI 10.1111/j.1365-2958.1995.mmi_18010163.x; Arends J, 2016, PROTEOMICS, V16, P3161, DOI 10.1002/pmic.201600316; Bastiaansen KC, 2015, ENVIRON MICROBIOL, V17, P3263, DOI 10.1111/1462-2920.12776; Bastiaansen KC, 2014, ENVIRON MICROBIOL, V16, P2433, DOI 10.1111/1462-2920.12371; Beard HA, 2019, ACS CHEM BIOL, V14, P2372, DOI 10.1021/acschembio.9b00404; Began J, 2020, EMBO J, V39, DOI 10.15252/embj.2019102935; Braun V, 2005, FEMS MICROBIOL REV, V29, P673, DOI 10.1016/j.femsre.2004.10.001; Braun V, 2003, CURR OPIN MICROBIOL, V6, P173, DOI 10.1016/S1369-5274(03)00022-5; Braun V, 2020, J BACTERIOL, V202, DOI 10.1128/JB.00058-20; Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Delgado C, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00215-18; Deu E, 2017, FEBS J, V284, P2604, DOI 10.1111/febs.14130; Draper RC, 2011, MOL MICROBIOL, V82, P1444, DOI 10.1111/j.1365-2958.2011.07901.x; Dunny GM, 2013, ANNU REV GENET, V47, P457, DOI 10.1146/annurev-genet-111212-133449; ENZ S, 1995, GENE, V163, P13, DOI 10.1016/0378-1119(95)00380-O; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Grass G, 2005, J BACTERIOL, V187, P1604, DOI 10.1128/JB.187.5.1604-1611.2005; Grass G, 2002, J BACTERIOL, V184, P864, DOI 10.1128/JB.184.3.864-866.2002; HARLE C, 1995, EMBO J, V14, P1430, DOI 10.1002/j.1460-2075.1995.tb07129.x; Hizukuri Y, 2014, STRUCTURE, V22, P326, DOI 10.1016/j.str.2013.12.003; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Inaba K, 2008, J BIOL CHEM, V283, P35042, DOI 10.1074/jbc.M806603200; Kanehara K, 2001, GENE, V281, P71, DOI 10.1016/S0378-1119(01)00823-X; Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302; King-Lyons ND, 2007, J BACTERIOL, V189, P6266, DOI 10.1128/JB.00629-07; Koide K, 2007, J BIOL CHEM, V282, P4553, DOI 10.1074/jbc.M607339200; Konovalova A, 2014, FEMS MICROBIOL REV, V38, P493, DOI 10.1111/1574-6976.12050; Kroos L, 2013, BIOCHIM BIOPHYS ACTA, V1828, P2873; Kuhnle N, 2019, J CELL SCI, V132, DOI 10.1242/jcs.217745; Li XC, 2009, P NATL ACAD SCI USA, V106, P14837, DOI 10.1073/pnas.0903289106; Miyake T, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.607381; Muller C, 2009, MOL MICROBIOL, V71, P1228, DOI 10.1111/j.1365-2958.2009.06597.x; OCHS M, 1995, MOL MICROBIOL, V15, P119, DOI 10.1111/j.1365-2958.1995.tb02226.x; Ochs M, 1996, MOL GEN GENET, V250, P455; Otero-Asman JR, 2019, ENVIRON MICROBIOL, V21, P4629, DOI 10.1111/1462-2920.14773; Pennetzdorfer N, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00214; Saha R, 2013, J BASIC MICROB, V53, P303, DOI 10.1002/jobm.201100552; SAIKI K, 1993, J BIOL CHEM, V268, P26041; SAIKI K, 1992, BIOCHEM BIOPH RES CO, V189, P1491, DOI 10.1016/0006-291X(92)90243-E; Saito A, 2011, P NATL ACAD SCI USA, V108, P13740, DOI 10.1073/pnas.1108376108; Salta S., 2017, NAT CELL BIOL, V19, P318; Schneider JS, 2013, BBA-BIOMEMBRANES, V1828, P2808, DOI 10.1016/j.bbamem.2013.04.019; Soupene E, 1998, P NATL ACAD SCI USA, V95, P7030, DOI 10.1073/pnas.95.12.7030; Sun LF, 2016, CURR OPIN STRUC BIOL, V37, P97, DOI 10.1016/j.sbi.2015.12.008; Tsumagari K, 2017, GENES CELLS, V22, P237, DOI 10.1111/gtc.12466; VANHOVE B, 1990, J BACTERIOL, V172, P6749, DOI 10.1128/jb.172.12.6749-6758.1990; WAGEGG W, 1981, J BACTERIOL, V145, P156, DOI 10.1128/JB.145.1.156-163.1981; Welz D, 1998, J BACTERIOL, V180, P2387, DOI 10.1128/JB.180.9.2387-2394.1998; Wolfe MS, 2009, CHEM REV, V109, P1599, DOI 10.1021/cr8004197; Yu YTN, 2000, J BACTERIOL, V182, P3305, DOI 10.1128/JB.182.11.3305-3309.2000	55	3	3	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100673	10.1016/j.jbc.2021.100673	http://dx.doi.org/10.1016/j.jbc.2021.100673			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33865858	Green Submitted, Green Published, gold			2022-12-28	WOS:000672866400644
J	Artan, M; Barratt, S; Flynn, SM; Begum, F; Skehel, M; Nicolas, A; de Bono, M				Artan, Murat; Barratt, Stephen; Flynn, Sean M.; Begum, Farida; Skehel, Mark; Nicolas, Armel; de Bono, Mario			Interactome analysis of Caenorhabditis elegans synapses by TurboID-based proximity labeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT BIOTINYLATION; EXPRESSION; ORGANIZATION; ADAPTATION; NEIGHBORS; PROTEINS; VESICLES; PARTNERS; SENTRYN	Proximity labeling provides a powerful in vivo tool to characterize the proteome of subcellular structures and the interactome of specific proteins. The nematode Caenorhabditis elegans is one of the most intensely studied organisms in biology, offering many advantages for biochemistry. Using the highly active biotin ligase TurboID, we optimize here a proximity labeling protocol for C. elegans. An advantage of TurboID is that biotin's high affinity for streptavidin means biotin-labeled proteins can be affinity purified under harsh denaturing conditions. By combining extensive sonication with aggressive denaturation using SDS and urea, we achieved near-complete solubilization of worm proteins. We then used this protocol to characterize the proteomes of the worm gut, muscle, skin, and nervous system. Neurons are among the smallest C. elegans cells. To probe the method's sensitivity, we expressed TurboID exclusively in the two AFD neurons and showed that the protocol could identify known and previously unknown proteins expressed selectively in AFD. The active zones of synapses are composed of a protein matrix that is difficult to solubilize and purify. To test if our protocol could solubilize active zone proteins, we knocked TurboID into the endogenous elks-1 gene, which encodes a presynaptic active zone protein. We identified many known ELKS-1-interacting active zone proteins, as well as previously uncharacterized synaptic proteins. Versatile vectors and the inherent advantages of using C. elegans, including fast growth and the ability to rapidly make and functionally test knock-ins, make proximity labeling a valuable addition to the armory of this model organism.	[Artan, Murat; Barratt, Stephen; Nicolas, Armel; de Bono, Mario] IST Austria, Klosterneuburg, Austria; [Flynn, Sean M.; Begum, Farida; Skehel, Mark] Med Res Council Lab Mol Biol, Cell Biol Div, Cambridge, England; [Artan, Murat; Barratt, Stephen; Nicolas, Armel; de Bono, Mario] IST Austria, Klosterneuburg, Austria; [Flynn, Sean M.] Univ Cambridge, Cambridge Inst, Canc Res UK, Li Ka Shing Ctr, Cambridge, England	Institute of Science & Technology - Austria; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC); Institute of Science & Technology - Austria; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	de Bono, M (corresponding author), IST Austria, Klosterneuburg, Austria.; de Bono, M (corresponding author), IST Austria, Klosterneuburg, Austria.	mdebono@ist.ac.at		Begum, Farida/0000-0002-7983-3317; de Bono, Mario/0000-0001-8347-0443	Advanced ERC Grant [269058]; Wellcome Investigator Award [209504/Z/17/Z]; ISTplus Fellowship [754411]	Advanced ERC Grant; Wellcome Investigator Award; ISTplus Fellowship	This work was supported by an Advanced ERC Grant (269058 ACMO) and a Wellcome Investigator Award (209504/Z/17/Z) to M. d. B. and an ISTplus Fellowship to M. A. (Marie Sklodowska-Curie agreement No 754411) .	Aburaya S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70692-w; Angeles-Albores D, 2016, BMC BIOINFORMATICS, V17, DOI 10.1186/s12859-016-1229-9; Bacaj T, 2007, GENETICS, V176, P2651, DOI 10.1534/genetics.107.074369; Branon TC, 2018, NAT BIOTECHNOL, V36, P880, DOI 10.1038/nbt.4201; BRENNER S, 1974, GENETICS, V77, P71; Carbonell AU, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11437-w; Chen CL, 2015, P NATL ACAD SCI USA, V112, P12093, DOI 10.1073/pnas.1515623112; Dingar D, 2015, J PROTEOMICS, V118, P95, DOI 10.1016/j.jprot.2014.09.029; Edwards SL, 2018, GENETICS, V210, P947, DOI 10.1534/genetics.118.301466; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Ge MH, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101567; Gingras AC, 2019, CURR OPIN CHEM BIOL, V48, P44, DOI 10.1016/j.cbpa.2018.10.017; Jacob AL, 2010, J COMP NEUROL, V518, P3221, DOI 10.1002/cne.22394; Jordan BA, 2007, NAT NEUROSCI, V10, P427, DOI 10.1038/nn1867; Kim DI, 2016, TRENDS CELL BIOL, V26, P804, DOI 10.1016/j.tcb.2016.09.004; Lobingier BT, 2017, CELL, V169, P350, DOI 10.1016/j.cell.2017.03.022; Lockhead D, 2016, MOL BIOL CELL, V27, P3717, DOI 10.1091/mbc.E16-06-0473; Lorenzo R, 2020, NUCLEIC ACIDS RES, V48, P7119, DOI 10.1093/nar/gkaa486; Loveless T, 2017, MOL BIOL CELL, V28, P3621, DOI 10.1091/mbc.E16-06-0455; Mannix KM, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176644; May DG, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9051070; Morrison LM, 2018, GENETICS, V210, P925, DOI 10.1534/genetics.118.300847; Nance J, 2019, GENETICS, V212, P959, DOI 10.1534/genetics.119.301506; Ortega-Cuellar D, 2010, J NUTRIGENET NUTRIGE, V3, P18, DOI 10.1159/000318054; Packer JS, 2019, SCIENCE, V365, P1265, DOI 10.1126/science.aax1971; Qin W, 2021, NAT METHODS, V18, P133, DOI 10.1038/s41592-020-01010-5; Redemann S, 2011, NAT METHODS, V8, P250, DOI 10.1038/NMETH.1565; Rees JS, 2015, MOL CELL PROTEOMICS, V14, P2848, DOI 10.1074/mcp.R115.052902; Reinke AW, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602426; Reinke AW, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14023; Samavarchi-Tehrani P, 2020, MOL CELL PROTEOMICS, V19, P757, DOI 10.1074/mcp.R120.001941; Sanchez A. D., 2020, PROXIMITY LABELING N; Schaffer U, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1178; Sudhof TC, 2012, NEURON, V75, P11, DOI 10.1016/j.neuron.2012.06.012; Taylor S. R., 2019, EXPRESSION PROFILING, DOI [10.1101/737577, DOI 10.1101/737577]; Trinkle-Mulcahy Laura, 2019, F1000Res, V8, DOI 10.12688/f1000research.16903.1; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Uezu A, 2016, SCIENCE, V353, P1123, DOI 10.1126/science.aag0821; Varnaite R, 2016, PROTEOMICS, V16, P2503, DOI 10.1002/pmic.201600123; Waaijers S, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0286-x; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Xu YF, 2021, CELL BIOSCI, V11, DOI 10.1186/s13578-021-00542-3; Yuet KP, 2015, P NATL ACAD SCI USA, V112, P2705, DOI 10.1073/pnas.1421567112	43	5	6	7	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101094	10.1016/j.jbc.2021.101094	http://dx.doi.org/10.1016/j.jbc.2021.101094			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34416233	Green Published, gold			2022-12-28	WOS:000706409200006
J	Cavac, E; Ramirez-Tapia, LE; Martin, CT				Cavac, Elvan; Ramirez-Tapia, Luis E.; Martin, Craig T.			High-salt transcription of DNA cotethered with T7 RNA polymerase to beads generates increased yields of highly pure RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO TRANSCRIPTION; DOUBLE-STRANDED-RNA; MESSENGER-RNA; PURIFICATION; MECHANISM; RECOGNITION; BINDING; PROTEIN; ELONGATION; ACTIVATION	High yields of RNA are routinely prepared following the two-step approach of high-yield in vitro transcription using T7 RNA polymerase followed by extensive purification using gel separation or chromatographic methods. We recently demonstrated that in high-yield transcription reactions, as RNA accumulates in solution, T7 RNA polymerase rebinds and extends the encoded RNA (using the RNA as a template), resulting in a product pool contaminated with longer-than desired, (partially) double-stranded impurities. Current purifi- cation methods often fail to fully eliminate these impurities, which, if present in therapeutics, can stimulate the innate immune response with potentially fatal consequences. In this work, we introduce a novel in vitro transcription method that generates high yields of encoded RNA without double-stranded impurities, reducing the need for further purification. Transcription is carried out at high-salt conditions to eliminate RNA product rebinding, while promoter DNA and T7 RNA polymerase are cotethered in close proximity on magnetic beads to drive promoter binding and transcription initiation, resulting in an increase in overall yield and purity of only the encoded RNA. A more complete elimination of double stranded RNA during synthesis will not only reduce overall production costs, but also should ultimately enable therapies and technologies that are currently being hampered by those impurities.	[Cavac, Elvan; Martin, Craig T.] Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA; [Ramirez-Tapia, Luis E.; Martin, Craig T.] Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst	Martin, CT (corresponding author), Univ Massachusetts, Dept Chem, Amherst, MA 01003 USA.; Martin, CT (corresponding author), Univ Massachusetts, Grad Program Mol & Cellular Biol, Amherst, MA 01003 USA.	cmartin@chem.umass.edu	Martin, Craig/L-3596-2013	Martin, Craig/0000-0003-1029-5239	National Science Foundation [MCB-1516896]; National Institutes of Health [1R01GM134042]	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Science Foundation [MCB-1516896] and by the National Institutes of Health [1R01GM134042]. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Arnaud-Barbe N, 1998, NUCLEIC ACIDS RES, V26, P3550, DOI 10.1093/nar/26.15.3550; Baiersdorfer M, 2019, MOL THER-NUCL ACIDS, V15, P26, DOI 10.1016/j.omtn.2019.02.018; Bandwar RP, 2002, J MOL BIOL, V324, P63, DOI 10.1016/S0022-2836(02)01034-3; Baumschlager A, 2017, ACS SYNTH BIOL, V6, P2157, DOI 10.1021/acssynbio.7b00169; BROWNLEE GG, 1995, NUCLEIC ACIDS RES, V23, P2641, DOI 10.1093/nar/23.14.2641; Burgess K, 2000, CHEM REV, V100, P2047, DOI 10.1021/cr990045m; CAZENAVE C, 1994, P NATL ACAD SCI USA, V91, P6972, DOI 10.1073/pnas.91.15.6972; CHAPMAN KA, 1987, NUCLEIC ACIDS RES, V15, P5413, DOI 10.1093/nar/15.13.5413; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Davis Robert H., 1995, Current Opinion in Biotechnology, V6, P213, DOI 10.1016/0958-1669(95)80035-2; Easton LE, 2010, RNA, V16, P647, DOI 10.1261/rna.1862210; Esposito EA, 2004, J BIOL CHEM, V279, P44270, DOI 10.1074/jbc.M407688200; Gholamalipour Y, 2018, NUCLEIC ACIDS RES, V46, P9253, DOI 10.1093/nar/gky796; Gong P, 2004, J BIOL CHEM, V279, P44277, DOI 10.1074/jbc.M409118200; GUREVICH VV, 1991, ANAL BIOCHEM, V195, P207, DOI 10.1016/0003-2697(91)90318-N; Hartmann G, 2017, ADV IMMUNOL, V133, P121, DOI 10.1016/bs.ai.2016.11.001; Jia YP, 1997, BIOCHEMISTRY-US, V36, P4223, DOI 10.1021/bi9630467; Jia YP, 1996, J BIOL CHEM, V271, P30451, DOI 10.1074/jbc.271.48.30451; Kao C, 1999, RNA, V5, P1268, DOI 10.1017/S1355838299991033; Kariko K, 2004, J BIOL CHEM, V279, P12542, DOI 10.1074/jbc.M310175200; Kariko K, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr695; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; KONARSKA MM, 1989, CELL, V57, P423, DOI 10.1016/0092-8674(89)90917-3; KRUPP G, 1989, NUCLEIC ACIDS RES, V17, P3023, DOI 10.1093/nar/17.8.3023; KRUPP G, 1988, GENE, V72, P75, DOI 10.1016/0378-1119(88)90129-1; Kukarin A, 2003, J BIOL CHEM, V278, P2419, DOI 10.1074/jbc.M210058200; Lebedev AV, 2001, NUCLEOS NUCLEOT NUCL, V20, P1403, DOI 10.1081/NCN-100002565; Lemaire PA, 2008, J MOL BIOL, V381, P351, DOI 10.1016/j.jmb.2008.05.056; Liu XQ, 2009, J BIOL CHEM, V284, P36262, DOI 10.1074/jbc.M109.056820; Lukavsky PJ, 2004, RNA, V10, P889, DOI 10.1261/rna.5264804; MARTIN CT, 1988, BIOCHEMISTRY-US, V27, P3966, DOI 10.1021/bi00411a012; Martins R, 2014, J CHROMATOGR A, V1355, P1, DOI 10.1016/j.chroma.2014.05.075; MCALLISTER WT, 1993, CELL MOL BIOL RES, V39, P385; MCALLISTER WT, 1980, NUCLEIC ACIDS RES, V8, P4821, DOI 10.1093/nar/8.20.4821; McKenna SA, 2007, NAT PROTOC, V2, P3270, DOI 10.1038/nprot.2007.480; MELLITS KH, 1990, NUCLEIC ACIDS RES, V18, P5401, DOI 10.1093/nar/18.18.5401; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Nacheva GA, 2003, EUR J BIOCHEM, V270, P1458, DOI 10.1046/j.1432-1033.2003.03510.x; Nayak D, 2009, J BIOL CHEM, V284, P13641, DOI 10.1074/jbc.M900718200; OSTRANDER EA, 1990, SCIENCE, V249, P1261, DOI 10.1126/science.2399463; Petrov A, 2013, METHOD ENZYMOL, V530, P315, DOI 10.1016/B978-0-12-420037-1.00017-8; POKROVSKAYA ID, 1994, ANAL BIOCHEM, V220, P420, DOI 10.1006/abio.1994.1360; Ramirez-Tapia LE, 2012, J BIOL CHEM, V287, P37352, DOI 10.1074/jbc.M112.370643; Rong M, 1998, J BIOL CHEM, V273, P10253, DOI 10.1074/jbc.273.17.10253; Sarcar SN, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32231-6; SCHENBORN ET, 1985, NUCLEIC ACIDS RES, V13, P6223, DOI 10.1093/nar/13.17.6223; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sousa R., 2013, ENCY BIOL CHEM, P355; Steitz TA, 2009, CURR OPIN STRUC BIOL, V19, P683, DOI 10.1016/j.sbi.2009.09.001; Tahirov TH, 2002, NATURE, V420, P43, DOI 10.1038/nature01129; Tatematsu M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2857; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; TRIANAALONSO FJ, 1995, J BIOL CHEM, V270, P6298, DOI 10.1074/jbc.270.11.6298; Ujvari A, 1996, BIOCHEMISTRY-US, V35, P14574, DOI 10.1021/bi961165g; Ujvari A, 1997, J MOL BIOL, V273, P775, DOI 10.1006/jmbi.1997.1350; Weissman Drew, 2013, Methods Mol Biol, V969, P43, DOI 10.1007/978-1-62703-260-5_3; Yeliseev A, 2017, PROTEIN EXPRES PURIF, V131, P109, DOI 10.1016/j.pep.2016.11.006; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5; Zaher HS, 2004, BIOCHEMISTRY-US, V43, P7873, DOI 10.1021/bi0497300	63	3	3	6	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100999	10.1016/j.jbc.2021.100999	http://dx.doi.org/10.1016/j.jbc.2021.100999			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34303704	Green Published, gold			2022-12-28	WOS:000706418900004
J	Markham, KJ; Tikhonova, EB; Scarpa, AC; Hariharan, P; Katsube, S; Guan, L				Markham, Kelsey J.; Tikhonova, Elena B.; Scarpa, Aaron C.; Hariharan, Parameswaran; Katsube, Satoshi; Guan, Lan			Complete cysteine-scanning mutagenesis of the Salmonella typhimurium melibiose permease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CONFORMATIONAL-CHANGES; MEMBRANE-SPANNING SEGMENTS; ESCHERICHIA-COLI; INDIVIDUAL RESIDUES; CYTOPLASMIC LOOP; ACIDIC RESIDUES; CARRIER; NA+; TRANSPORT; MECHANISM	The melibiose permease of Salmonella typhimurium (MelBSt) catalyzes the stoichiometric symport of galactopyranoside with a cation (H+, Li+, or Na+) and is a prototype for Na+-coupled major facilitator superfamily (MFS) transporters presenting from bacteria to mammals. X-ray crystal structures of MelBSt have revealed the molecular recognition mechanism for sugar binding; however, understanding of the cation site and symport mechanism is still vague. To further investigate the transport mechanism and conformational dynamics of MelBSt, we generated a complete single-Cys library containing 476 unique mutants by placing a Cys at each position on a functional Cysless background. Surprisingly, 105 mutants (22%) exhibit poor transport activities (<15% of Cys-less transport), although the expression levels of most mutants were comparable to that of the control. The affected positions are distributed throughout the protein. Helices I and X and transmembrane residues Asp and Tyr are most affected by cysteine replacement, while helix IX, the cytoplasmic middle-loop, and C-terminal tail are least affected. Single-Cys replacements at the major sugar-binding positions (K18, D19, D124, W128, R149, and W342) or at positions important for cation binding (D55, N58, D59, and T121) abolished the Na+-coupled active transport, as expected. We mapped 50 loss-of-function mutants outside of these substrate binding sites that suffered from defects in protein expression/ stability or conformational dynamics. This complete Cysscanning mutagenesis study indicates that MelBSt is highly susceptible to single-Cys mutations, and this library will be a useful tool for further structural and functional studies to gain insights into the cation-coupled symport mechanism for Na+-coupled MFS transporters.	[Markham, Kelsey J.; Tikhonova, Elena B.; Scarpa, Aaron C.; Hariharan, Parameswaran; Katsube, Satoshi; Guan, Lan] Texas Tech Univ, Ctr Membrane Prot Res, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys,Sch Med, Lubbock, TX 79430 USA; [Tikhonova, Elena B.] Texas Tech Univ, Sch Med, Dept Cell Biol & Biochem, Hlth Sci Ctr, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center; Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Guan, L (corresponding author), Texas Tech Univ, Ctr Membrane Prot Res, Hlth Sci Ctr, Dept Cell Physiol & Mol Biophys,Sch Med, Lubbock, TX 79430 USA.	Lan.Guan@ttuhsc.edu	Parameswaran, Hariharan/P-2496-2015; Tikhonova, Elena/P-2515-2015	Parameswaran, Hariharan/0000-0002-6020-1547; Tikhonova, Elena/0000-0002-7892-9173; Guan, Lan/0000-0002-2274-361X; katsube, satoshi/0000-0002-3312-7476	National Institutes of Health [R01GM122759, R21NS105863]; National Science Foundation [MCB1158085]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Institutes of Health (grants R01GM122759 and R21NS105863) and the National Science Foundation (grant MCB1158085) to L. G. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Amin A, 2014, J BACTERIOL, V196, P3134, DOI 10.1128/JB.01868-14; Anzai T, 2019, BIOCHEM BIOPH RES CO, V520, P566, DOI 10.1016/j.bbrc.2019.10.070; Cater RJ, 2021, NATURE, V595, P315, DOI 10.1038/s41586-021-03650-9; Chae PS, 2010, NAT METHODS, V7, P1003, DOI 10.1038/NMETH.1526; DAMIANOFORANO E, 1986, J BIOL CHEM, V261, P6893; Dayem MA, 2003, J BIOL CHEM, V278, P1518, DOI 10.1074/jbc.M210053200; Ding PZ, 2004, BBA-BIOMEMBRANES, V1660, P106, DOI 10.1016/j.bbamem.2003.11.005; Ding PZ, 2000, J MEMBRANE BIOL, V174, P135, DOI 10.1007/s002320001038; Ding PZ, 2000, BIOCHEM BIOPH RES CO, V268, P409, DOI 10.1006/bbrc.2000.2149; Ding PZ, 2001, J MEMBRANE BIOL, V183, P33, DOI 10.1007/s00232-001-0053-x; Ding PZ, 2001, BIOCHEMISTRY-US, V40, P5506, DOI 10.1021/bi002761k; Dumas F, 2000, BIOCHEMISTRY-US, V39, P4846, DOI 10.1021/bi992634s; Ethayathulla AS, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4009; Frillingos S, 1998, FASEB J, V12, P1281, DOI 10.1096/fasebj.12.13.1281; Ganea C, 2001, BIOCHEMISTRY-US, V40, P13744, DOI 10.1021/bi011223k; Garcia-Celma JJ, 2008, LANGMUIR, V24, P8119, DOI 10.1021/la800428h; Granell M, 2010, P NATL ACAD SCI USA, V107, P22078, DOI 10.1073/pnas.1008649107; Guan L., 2020, ENCY BIOCH, V3rd; Guan L., 2018, EUROPEAN BIOPHYSICAL, V2nd; Guan L, 2006, ANNU REV BIOPH BIOM, V35, P67, DOI 10.1146/annurev.biophys.35.040405.102005; Guan L, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02462-x; Guan L, 2011, J BIOL CHEM, V286, P6367, DOI 10.1074/jbc.M110.206227; HAMA H, 1994, J BIOL CHEM, V269, P1063; Hariharan P, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012710; Hariharan P, 2018, BMC BIOL, V16, DOI 10.1186/s12915-018-0553-0; Hariharan P, 2017, J GEN PHYSIOL, V149, P1029, DOI 10.1085/jgp.201711788; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Jakkula SV, 2012, J BACTERIOL, V194, P5538, DOI 10.1128/JB.01206-12; Kaback HR, 2019, J GEN PHYSIOL, V151, P878, DOI 10.1085/jgp.201912377; Kaback HR, 2001, NAT REV MOL CELL BIO, V2, P610, DOI 10.1038/35085077; LEBLANC G, 1993, SOC GEN PHY, V48, P213; Lee J, 2016, FRONT MOL BIOSCI, V3, DOI 10.3389/fmolb.2016.00021; Leon X, 2005, BIOCHEMISTRY-US, V44, P3506, DOI 10.1021/bi048301z; LOPILATO J, 1978, J BACTERIOL, V134, P147, DOI 10.1128/JB.134.1.147-156.1978; Maehrel C, 1998, J BIOL CHEM, V273, P33192, DOI 10.1074/jbc.273.50.33192; MUSVETEAU I, 1995, BIOCHEMISTRY-US, V34, P6775, DOI 10.1021/bi00020a024; Nguyen LN, 2014, NATURE, V509, P503, DOI 10.1038/nature13241; Nomura N, 2015, NATURE, V526, P397, DOI 10.1038/nature14909; Poolman B, 1996, MOL MICROBIOL, V19, P911, DOI 10.1046/j.1365-2958.1996.397949.x; POURCHER T, 1993, J BIOL CHEM, V268, P3209; POURCHER T, 1995, BIOCHEMISTRY-US, V34, P4412, DOI 10.1021/bi00013a033; Pourcher T, 1996, BIOCHEMISTRY-US, V35, P4161, DOI 10.1021/bi9527496; Smirnova I, 2011, BIOCHEMISTRY-US, V50, P9684, DOI 10.1021/bi2014294; Tikhonova EB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08070; Trevino SR, 2007, J MOL BIOL, V373, P211, DOI 10.1016/j.jmb.2007.07.061; Wilson TH, 2001, BBA-BIOENERGETICS, V1505, P121, DOI 10.1016/S0005-2728(00)00282-6; Yan N, 2015, ANNU REV BIOPHYS, V44, P257, DOI 10.1146/annurev-biophys-060414-033901; Yasunaga M, 2019, CANCER SCI, V110, P761, DOI 10.1111/cas.13907; Yousef MS, 2009, P NATL ACAD SCI USA, V106, P15291, DOI 10.1073/pnas.0905516106; ZANI ML, 1993, J BIOL CHEM, V268, P3216; ZANI ML, 1994, J BIOL CHEM, V269, P24883	52	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101090	10.1016/j.jbc.2021.101090	http://dx.doi.org/10.1016/j.jbc.2021.101090			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34416232	gold, Green Published			2022-12-28	WOS:000706409200010
J	Zhang, HL; Han, W; Du, YQ; Zhao, B; Yang, P; Yin, DM				Zhang, Hai-Long; Han, Wei; Du, Yin-Quan; Zhao, Bing; Yang, Pin; Yin, Dong-Min			SRC3 acetylates calmodulin in the mouse brain to regulate synaptic plasticity and fear learning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER CELL-PROLIFERATION; HISTONE DEACETYLASE; COACTIVATOR; PHOSPHORYLATION; KINASE; LTP; MECHANISMS; MEMORY; CONTRIBUTES; ACTIVATION	Protein acetylation is a reversible posttranslational modifi- cation, which is regulated by lysine acetyltransferase (KAT) and lysine deacetyltransferase (KDAC). Although protein acetylation has been shown to regulate synaptic plasticity, this was mainly for histone protein acetylation. The function and regulation of nonhistone protein acetylation in synaptic plasticity and learning remain largely unknown. Calmodulin (CaM), a ubiquitous Ca2+ sensor, plays critical roles in synaptic plasticity such as long-term potentiation (LTP). During LTP induction, activation of NMDA receptor triggers Ca2+ influx, and the Ca2+ binds with CaM and activates calcium/ calmodulin-dependent protein kinase II alpha (CaMKII alpha). In our previous study, we demonstrated that acetylation of CaM was important for synaptic plasticity and fear learning in mice. However, the KAT responsible for CaM acetylation is currently unknown. Here, following an HEK293 cell-based screen of candidate KATs, steroid receptor coactivator 3 (SRC3) is identified as the most active KAT for CaM. We further demonstrate that SRC3 interacts with and acetylates CaM in a Ca2+ and NMDA receptor-dependent manner. We also show that pharmacological inhibition or genetic downregulation of SRC3 impairs CaM acetylation, synaptic plasticity, and contextual fear learning in mice. Moreover, the effects of SRC3 inhibition on synaptic plasticity and fear learning could be rescued by 3KQ-CaM, a mutant form of CaM, which mimics acetylation. Together, these observations demonstrate that SRC3 acetylates CaM and regulates synaptic plasticity and learning in mice.	[Zhang, Hai-Long; Han, Wei; Du, Yin-Quan; Zhao, Bing; Yang, Pin; Yin, Dong-Min] East China Normal Univ, Sch Life Sci, Key Lab Brain Funct Genom, Minist Educ & Shanghai, Shanghai, Peoples R China; [Zhang, Hai-Long] Soochow Univ, Jiangsu Key Lab Neuropsychiat Dis, Suzhou, Peoples R China; [Zhang, Hai-Long] Soochow Univ, Inst Neurosci, Suzhou, Peoples R China	East China Normal University; Soochow University - China; Soochow University - China	Yin, DM (corresponding author), East China Normal Univ, Sch Life Sci, Key Lab Brain Funct Genom, Minist Educ & Shanghai, Shanghai, Peoples R China.	dmyin@brain.ecnu.edu.cn		Yin, Dongmin/0000-0001-9329-050X; Zhang, Hai-Long/0000-0002-8720-2734	National Natural Science of China [31970900]; Fundamental Research Funds for the Central Universities; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	National Natural Science of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning	This work was supported by grants from National Natural Science of China (No. 31970900), the Fundamental Research Funds for the Central Universities, the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning. We thank Dr Jiemin Wong (ECNU, China) for providing the TIP60 and SRC3 constructs.	Alarcon JM, 2004, NEURON, V42, P947, DOI 10.1016/j.neuron.2004.05.021; ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; Allis CD, 2007, CELL, V131, P633, DOI 10.1016/j.cell.2007.10.039; Barria A, 1997, SCIENCE, V276, P2042, DOI 10.1126/science.276.5321.2042; Chen HW, 1997, CELL, V90, P569, DOI 10.1016/S0092-8674(00)80516-4; Chen WB, 2017, J IMMUNOL, V198, P1606, DOI 10.4049/jimmunol.1600300; Chen XA, 2010, MOL ENDOCRINOL, V24, P1917, DOI 10.1210/me.2010-0201; Chin D, 2000, TRENDS CELL BIOL, V10, P322, DOI 10.1016/S0962-8924(00)01800-6; Coba MP, 2019, CURR OPIN STRUC BIOL, V54, P86, DOI 10.1016/j.sbi.2019.01.003; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Hsieh J, 2005, CURR OPIN CELL BIOL, V17, P664, DOI 10.1016/j.ceb.2005.09.002; Kim WB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15121-2; Kim WB, 2017, NEURON, V95, P1129, DOI 10.1016/j.neuron.2017.08.004; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Liu ZL, 2008, INT J BIOL SCI, V4, P202; Louie MC, 2004, MOL CELL BIOL, V24, P5157, DOI 10.1128/MCB.24.12.5157-5171.2004; Ma H, 2014, CELL, V159, P281, DOI 10.1016/j.cell.2014.09.019; Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012; Mammen AL, 1997, J BIOL CHEM, V272, P32528, DOI 10.1074/jbc.272.51.32528; Maren S, 2013, NAT REV NEUROSCI, V14, P417, DOI 10.1038/nrn3492; Min SW, 2010, NEURON, V67, P953, DOI 10.1016/j.neuron.2010.08.044; Nishihara E, 2003, J NEUROSCI, V23, P213; Otmakhov N, 2004, J NEUROPHYSIOL, V91, P1955, DOI 10.1152/jn.00941.2003; Pang ZP, 2010, J NEUROSCI, V30, P4132, DOI 10.1523/JNEUROSCI.3129-09.2010; Parra V, 2017, J MOL CELL CARDIOL, V103, P121, DOI 10.1016/j.yjmcc.2016.12.006; PATTON BL, 1993, MOL BIOL CELL, V4, P159, DOI 10.1091/mbc.4.2.159; Penn AC, 2017, NATURE, V549, P384, DOI 10.1038/nature23658; Sebti S, 2014, P NATL ACAD SCI USA, V111, P4115, DOI 10.1073/pnas.1313618111; Soderling TR, 2000, TRENDS NEUROSCI, V23, P75, DOI 10.1016/S0166-2236(99)01490-3; Song XZ, 2016, P NATL ACAD SCI USA, V113, P4970, DOI 10.1073/pnas.1604274113; Stashi E, 2013, MOL ENDOCRINOL, V27, P1776, DOI 10.1210/me.2013-1192; Storchel PH, 2015, EMBO J, V34, P2237, DOI 10.15252/embj.201490643; Swaminathan PD, 2012, CIRC RES, V110, P1661, DOI 10.1161/CIRCRESAHA.111.243956; Takemoto K, 2017, NAT BIOTECHNOL, V35, P38, DOI 10.1038/nbt.3710; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Wu D, 2017, NATURE, V544, P316, DOI 10.1038/nature21720; Wu ZT, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.373092; Xia ZG, 2005, NAT REV NEUROSCI, V6, P267, DOI 10.1038/nrn1647; Xu JM, 2009, NAT REV CANCER, V9, P615, DOI 10.1038/nrc2695; Xu JM, 2000, P NATL ACAD SCI USA, V97, P6379, DOI 10.1073/pnas.120166297; Yore MA, 2010, NEUROSCIENCE, V169, P1017, DOI 10.1016/j.neuroscience.2010.05.053; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang HL, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101034; Zhou HJ, 2005, CANCER RES, V65, P7976, DOI 10.1158/0008-5472.CAN-04-4076; Zhou XE, 2010, J BIOL CHEM, V285, P9161, DOI 10.1074/jbc.M109.085779	47	4	4	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101044	10.1016/j.jbc.2021.101044	http://dx.doi.org/10.1016/j.jbc.2021.101044			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34358562	Green Published, gold			2022-12-28	WOS:000704369100011
J	Dong, HJ; Ma, JC; Chen, QY; Chen, B; Liang, LJ; Liao, YL; Song, YL; Wang, HH; Cronan, JE				Dong, Huijuan; Ma, Jincheng; Chen, Qunyi; Chen, Bo; Liang, Lujie; Liao, Yuling; Song, Yulu; Wang, Haihong; Cronan, John E.			A cryptic long-chain 3-ketoacyl-ACP synthase in the Pseudomonas putida F1 unsaturated fatty acid synthesis pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; THERMAL REGULATION; IDENTIFICATION; SEQUENCE	The Pseudomonas putida F1 genome contains five genes annotated as encoding 3-ketoacyl-acyl carrier protein (ACP) synthases. Four are annotated as encoding FabF (3-ketoacylACP synthase II) proteins, and the fifth is annotated as encoding a FabB (3-ketoacyl-ACP synthase I) protein. Expression of one of the FabF proteins, FabF2, is cryptic in the native host and becomes physiologically important only when the repressor controlling fabF2 transcription is inactivated. When derepressed, FabF2 can functionally replace FabB, and when expressed from a foreign promoter, had weak FabF activity. Complementation of Escherichia coli fabB and fabF mutant strains with high expression showed that P. putida fabF1 restored E. coli fabF function, whereas fabB restored E. coli fabB function and fabF2 restored the functions of both E. coli fabF and fabB. The P. putida AfabF1 deletion strain was almost entirely defective in synthesis of cis-vaccenic acid, whereas the AfabB strain is an unsaturated fatty acid (UFA) auxotroph that accumulated high levels of spontaneous suppressors in the absence of UFA supplementation. This was due to increased expression of fabF2 that bypasses loss of fabB because of the inactivation of the regulator, Pput_2425, encoded in the same operon as fabF2. Spontaneous suppressor accumulation was decreased by high levels of UFA supplementation, whereas competition by the P. putida n-oxidation pathway gave increased accumulation. The AfabB Delta fabF2 strain is a stable UFA auxotroph indicating that suppressor accumulation requires FabF2 function. However, at low concentrations of UFA supplementation, the AfabF2 APput_2425 double mutant strain still accumulated suppressors at low UFA concentrations.	[Dong, Huijuan; Ma, Jincheng; Chen, Qunyi; Chen, Bo; Liang, Lujie; Liao, Yuling; Song, Yulu; Wang, Haihong] South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China; [Dong, Huijuan; Cronan, John E.] Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA; [Cronan, John E.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	South China Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Wang, HH (corresponding author), South China Agr Univ, Coll Life Sci, Guangdong Prov Key Lab Prot Funct & Regulat Agr O, Guangzhou, Guangdong, Peoples R China.; Cronan, JE (corresponding author), Univ Illinois, Dept Microbiol, Urbana, IL 61801 USA.; Cronan, JE (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	wanghh36@scau.edu.cn; jecronan@illinois.edu			National Natural Science Foundation of China [31671987, 31972232]; NIH from the National Institute of Allergy and Infectious Diseases, National Institutes of Health [AI15650]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH from the National Institute of Allergy and Infectious Diseases, National Institutes of Health	This work was supported by grants from the National Natural Science Foundation of China (Grant number: 31671987 and 31972232) and by NIH grant AI15650 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Campbell JW, 2001, ANNU REV MICROBIOL, V55, P305, DOI 10.1146/annurev.micro.55.1.305; Cheng JL, 2012, APPL ENVIRON MICROB, V78, P1563, DOI 10.1128/AEM.07335-11; DEMENDOZA D, 1983, J BIOL CHEM, V258, P2098; dos Santos VAPM, 2004, ENVIRON MICROBIOL, V6, P1264, DOI 10.1111/j.1462-2920.2004.00734.x; GARWIN JL, 1980, J BIOL CHEM, V255, P3263; Hume AR, 2009, J BACTERIOL, V191, P7554, DOI 10.1128/JB.01016-09; Kang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013557; KAUPPINEN S, 1988, CARLSBERG RES COMMUN, V53, P357, DOI 10.1007/BF02983311; Kondakova T, 2019, ENVIRON MICROBIOL, V21, P1659, DOI 10.1111/1462-2920.14546; Lai CY, 2003, J BIOL CHEM, V278, P51494, DOI 10.1074/jbc.M308638200; Li M, 2016, J BACTERIOL, V198, P3060, DOI 10.1128/JB.00463-16; Luo QX, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00327; Nelson KE, 2002, ENVIRON MICROBIOL, V4, P799, DOI 10.1046/j.1462-2920.2002.00366.x; OBERHOFER TR, 1979, J CLIN MICROBIOL, V10, P800, DOI 10.1128/JCM.10.6.800-804.1979; Overhage J, 2007, J BACTERIOL, V189, P2164, DOI 10.1128/JB.01623-06; Parsons JB, 2013, PROG LIPID RES, V52, P249, DOI 10.1016/j.plipres.2013.02.002; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Ruth K, 2008, BIOMACROMOLECULES, V9, P1652, DOI 10.1021/bm8001655; Schmitz S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00284; SPECTOR AA, 1985, J LIPID RES, V26, P1015; Subramanian C, 2010, J BACTERIOL, V192, P280, DOI 10.1128/JB.00404-09; Timmis KN, 2002, ENVIRON MICROBIOL, V4, P779, DOI 10.1046/j.1462-2920.2002.00365.x; ULRICH AK, 1983, J BACTERIOL, V154, P221, DOI 10.1128/JB.154.1.221-230.1983; Wang HH, 2003, J BACTERIOL, V185, P4930, DOI 10.1128/JB.185.16.4930-4937.2003; Wang K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09479-1; Yuan YQ, 2012, J BACTERIOL, V194, P5185, DOI 10.1128/JB.00860-12; Zarzycki-Siek J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064554; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhu K, 2006, MOL MICROBIOL, V60, P260, DOI 10.1111/j.1365-2958.2006.05088.x; Zhu L, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-119	30	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100920	10.1016/j.jbc.2021.100920	http://dx.doi.org/10.1016/j.jbc.2021.100920			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34181948	gold, Green Published			2022-12-28	WOS:000690879300016
J	Matsuda, S; Yuzaki, M				Matsuda, Shinji; Yuzaki, Michisuke			Subunit-dependent and subunit-independent rules of AMPA receptor trafficking during chemical long-term depression in hippocampal neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNAPTIC PLASTICITY; PHOSPHORYLATION; REQUIRES; TARP; GLUR2; GLUA1; PKA; ENDOCYTOSIS; EXPRESSION; SYNAPSES	Long-term potentiation (LTP) and long-term depression (LTD) of excitatory neurotransmission are believed to be the neuronal basis of learning and memory. Both processes are primarily mediated by neuronal activity-induced transport of postsynaptic AMPA-type glutamate receptors (AMPARs). While AMPAR subunits and their specific phosphorylation sites mediate differential AMPAR trafficking, LTP and LTD could also occur in a subunit-independent manner. Thus, it remains unclear whether and how certain AMPAR subunits with phosphorylation sites are preferentially recruited to or removed from synapses during LTP and LTD. Using immunoblot and immunocytochemical analysis, we show that phosphomimetic mutations of the membrane-proximal region (MPR) in GluA1 AMPAR subunits affect the subunit dependent endosomal transport of AMPARs during chemical LTD. AP-2 and AP-3, adaptor protein complexes necessary for clathrin-mediated endocytosis and late endosomal/lysosomal trafficking, respectively, are reported to be recruited to AMPARs by binding to the AMPAR auxiliary subunit, stargazin (STG), in an AMPAR subunit-independent manner. However, the association of AP-3, but not AP-2, with STG was indirectly inhibited by the phosphomimetic mutation in the MPR of GluA1. Thus, although AMPARs containing the phosphomimetic mutation at the MPR of GluA1 were endocytosed by a chemical LTD-inducing stimulus, they were quickly recycled back to the cell surface in hippocampal neurons. These results could explain how the phosphorylation status of GluA1-MPR plays a dominant role in subunit independent STG-mediated AMPAR trafficking during LTD.	[Matsuda, Shinji] Univ Electrocommun, Dept Engn Sci, Grad Sch Informat & Engn, Tokyo, Japan; [Matsuda, Shinji] Univ Electrocommun, Ctr Neurosci & Biomed Engn CNBE, Tokyo, Japan; [Matsuda, Shinji; Yuzaki, Michisuke] Keio Univ, Dept Physiol, Sch Med, Tokyo, Japan	University of Electro-Communications - Japan; University of Electro-Communications - Japan; Keio University	Matsuda, S (corresponding author), Univ Electrocommun, Dept Engn Sci, Grad Sch Informat & Engn, Tokyo, Japan.; Matsuda, S (corresponding author), Univ Electrocommun, Ctr Neurosci & Biomed Engn CNBE, Tokyo, Japan.; Matsuda, S; Yuzaki, M (corresponding author), Keio Univ, Dept Physiol, Sch Med, Tokyo, Japan.	smatsuda@uec.ac.jp; myuzaki@keio.jp	Matsuda, Shinji/L-4727-2013; Matsuda, Shinji/GRR-5226-2022; Yuzaki, Michisuke/K-5328-2013	Yuzaki, Michisuke/0000-0002-5750-3544	CREST from JST; MEXT [16H06461, 15H05772, 17K07048]	CREST from JST(Core Research for Evolutional Science and Technology (CREST)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by the CREST from JST (S. M. and M. Y.) and MEXT (16H06461 and 15H05772 to M. Y. and 17K07048 to S. M.).	Boehm J, 2006, NEURON, V51, P213, DOI 10.1016/j.neuron.2006.06.013; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Chung HJ, 2003, SCIENCE, V300, P1751, DOI 10.1126/science.1082915; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Diering GH, 2018, NEURON, V100, P314, DOI 10.1016/j.neuron.2018.10.018; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Fernandez-Monreal M, 2012, J NEUROSCI, V32, P13200, DOI 10.1523/JNEUROSCI.0061-12.2012; Fiuza M, 2017, J CELL BIOL, V216, P3323, DOI 10.1083/jcb.201701034; Granger Adam J, 2014, Front Synaptic Neurosci, V6, P15, DOI 10.3389/fnsyn.2014.00015; Granger AJ, 2013, NATURE, V493, P495, DOI 10.1038/nature11775; Groc L, 2020, SCIENCE, V368, P1204, DOI 10.1126/science.aay4631; Jenkins MA, 2014, MOL PHARMACOL, V85, P618, DOI 10.1124/mol.113.091488; Kastning K, 2007, P NATL ACAD SCI USA, V104, P2991, DOI 10.1073/pnas.0611170104; Lee HK, 2003, CELL, V112, P631, DOI 10.1016/S0092-8674(03)00122-3; Lee HK, 2000, NATURE, V405, P955, DOI 10.1038/35016089; Lee SH, 2004, NEURON, V43, P221, DOI 10.1016/j.neuron.2004.06.015; Lin DT, 2009, NAT NEUROSCI, V12, P879, DOI 10.1038/nn.2351; Lu W, 2012, CURR OPIN NEUROBIOL, V22, P470, DOI 10.1016/j.conb.2011.09.008; Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027; Luscher C, 2000, NAT NEUROSCI, V3, P545, DOI 10.1038/75714; Matsuda S, 2000, EMBO J, V19, P2765, DOI 10.1093/emboj/19.12.2765; Matsuda S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3759; Nicoll RA, 2006, SCIENCE, V311, P1253, DOI 10.1126/science.1123339; Nicoll RA, 2017, NEURON, V93, P281, DOI 10.1016/j.neuron.2016.12.015; Nomura T, 2012, EUR J NEUROSCI, V35, P402, DOI 10.1111/j.1460-9568.2011.07963.x; Nooh MM, 2014, J BIOL CHEM, V289, P2277, DOI 10.1074/jbc.M113.513481; Park M, 2004, SCIENCE, V305, P1972, DOI 10.1126/science.1102026; Rouach N, 2005, NAT NEUROSCI, V8, P1525, DOI 10.1038/nn1551; Sanderson JL, 2016, NEURON, V89, P1000, DOI 10.1016/j.neuron.2016.01.043; Seidenman KJ, 2003, J NEUROSCI, V23, P9220; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Steinberg JP, 2006, NEURON, V49, P845, DOI 10.1016/j.neuron.2006.02.025; Sumioka A, 2010, NEURON, V66, P755, DOI 10.1016/j.neuron.2010.04.035; Summers KC, 2019, J BIOL CHEM, V294, P5521, DOI 10.1074/jbc.RA118.004340; Takamiya K, 2008, J NEUROSCI, V28, P5752, DOI 10.1523/JNEUROSCI.0654-08.2008; Tian M, 2015, NEUROPHARMACOLOGY, V89, P43, DOI 10.1016/j.neuropharm.2014.09.006; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; Tomita S, 2005, NEURON, V45, P269, DOI 10.1016/j.neuron.2005.01.009; Unoki T, 2012, NEURON, V73, P135, DOI 10.1016/j.neuron.2011.09.034; Xia J, 2000, NEURON, V28, P499, DOI 10.1016/S0896-6273(00)00128-8; Yamasaki M, 2016, J NEUROSCI, V36, P4296, DOI 10.1523/JNEUROSCI.4178-15.2016; Zhao Y, 2019, SCIENCE, V364, P355, DOI 10.1126/science.aaw8250; Zhou ZK, 2018, NAT NEUROSCI, V21, P50, DOI 10.1038/s41593-017-0030-z	43	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100949	10.1016/j.jbc.2021.100949	http://dx.doi.org/10.1016/j.jbc.2021.100949			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34252460	gold, Green Published			2022-12-28	WOS:000690871000016
J	Pokorny, D; Truebestein, L; Fleming, KD; Burke, JE; Leonard, TA				Pokorny, Daniel; Truebestein, Linda; Fleming, Kaelin D.; Burke, John E.; Leonard, Thomas A.			In vitro reconstitution of Sgk3 activation by phosphatidylinositol 3-phosphate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOX HOMOLOGY DOMAIN; PROTEIN-KINASE-C; PHOSPHOINOSITIDE 3-KINASE; STRUCTURAL BASIS; AKT; SERUM; PI3K; PHOSPHORYLATION; INHIBITOR; PATHWAY	Serum-and glucocorticoid-regulated kinase 3 (Sgk3) is a serine/threonine protein kinase activated by the phospholipid phosphatidylinositol 3-phosphate (PI3P) downstream of growth factor signaling via class I phosphatidylinositol 3-kinase (PI3K) signaling and by class III PI3K/Vps34-mediated PI3P production on endosomes. Upregulation of Sgk3 activity has recently been linked to a number of human cancers; however, the precise mechanism of activation of Sgk3 is unknown. Here, we use a wide range of cell biological, biochemical, and biophysical techniques, including hydrogen-deuterium exchange mass spectrometry, to investigate the mechanism of activation of Sgk3 by PI3P. We show that Sgk3 is regulated by a combination of phosphorylation and allosteric activation. We demonstrate that binding of Sgk3 to PI3P via its regulatory phox homology (PX) domain induces large conformational changes in Sgk3 associated with its activation and that the PI3P-binding pocket of the PX domain of Sgk3 is sequestered in its inactive conformation. Finally, we reconstitute Sgk3 activation via Vps34-mediated PI3P synthesis on phosphatidylinositol liposomes in vitro. In addition to identifying the mechanism of Sgk3 activation by PI3P, our findings open up potential therapeutic avenues in allosteric inhibitor development to target Sgk3 in cancer.	[Pokorny, Daniel; Truebestein, Linda; Leonard, Thomas A.] Max Perutz Labs, Dept Struct & Computat Biol, Vienna, Austria; [Pokorny, Daniel; Truebestein, Linda; Leonard, Thomas A.] Med Univ Vienna, Dept Med Biochem, Vienna, Austria; [Fleming, Kaelin D.; Burke, John E.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC, Canada; [Burke, John E.] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC, Canada	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); Medical University of Vienna; University of Victoria; University of British Columbia	Leonard, TA (corresponding author), Max Perutz Labs, Dept Struct & Computat Biol, Vienna, Austria.; Leonard, TA (corresponding author), Med Univ Vienna, Dept Med Biochem, Vienna, Austria.	thomas.leonard@meduniwien.ac.at	Burke, John/H-3922-2019; Leonard, Thomas/A-5143-2013	Burke, John/0000-0001-7904-9859; Leonard, Thomas/0000-0001-6853-666X; Pokorny, Daniel/0000-0002-0343-0466; Fleming, Kaelin/0000-0003-3063-7865	Austrian Science Fund (FWF) [P28135, P30584, P33066, W1261]; Hertha Firnberg Postdoctoral Fellowship from the Austrian Science Fund [FWF T915]; Michael Smith Foundation for Health Research (MSFHR) Scholar award [17686]; Cancer Research Society [CRS-24368]	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Hertha Firnberg Postdoctoral Fellowship from the Austrian Science Fund; Michael Smith Foundation for Health Research (MSFHR) Scholar award(Michael Smith Foundation for Health Research); Cancer Research Society	This work was supported by the Austrian Science Fund (FWF) grants P28135, P30584, P33066, and W1261 to T. A. L. L. T. was supported by a Hertha Firnberg Postdoctoral Fellowship from the Austrian Science Fund (FWF T915). J. E. B. was supported by a Michael Smith Foundation for Health Research (MSFHR) Scholar award (17686) and an operating grant from the Cancer Research Society (CRS-24368).	Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Backer JM, 2008, BIOCHEM J, V410, P1, DOI 10.1042/BJ20071427; Backer JM, 2016, BIOCHEM J, V473, P2251, DOI 10.1042/BCJ20160170; Bago R, 2016, EMBO J, V35, P1902, DOI 10.15252/embj.201693929; Bago R, 2014, BIOCHEM J, V463, P413, DOI 10.1042/BJ20140889; Bieniossek Christoph, 2008, Curr Protoc Protein Sci, VChapter 5, DOI 10.1002/0471140864.ps0520s51; Chan TO, 2011, P NATL ACAD SCI USA, V108, pE1120, DOI 10.1073/pnas.1109879108; Chandra M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09355-y; Chen W, 2009, J BIOL CHEM, V284, P3453, DOI 10.1074/jbc.M807502200; Dai FY, 2002, BIOCHEM BIOPH RES CO, V293, P1191, DOI 10.1016/S0006-291X(02)00349-2; Ebner M, 2017, MOL CELL, V65, P416, DOI 10.1016/j.molcel.2016.12.028; Elsner DJ, 2019, J BIOL CHEM, V294, P14422, DOI 10.1074/jbc.RA119.008713; Endicott JA, 2012, ANNU REV BIOCHEM, V81, P587, DOI 10.1146/annurev-biochem-052410-090317; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fruman DA, 2017, CELL, V170, P605, DOI 10.1016/j.cell.2017.07.029; Fruman DA, 2014, NAT REV DRUG DISCOV, V13, P140, DOI 10.1038/nrd4204; Gasser JA, 2014, MOL CELL, V56, P595, DOI 10.1016/j.molcel.2014.09.023; Gewinner C, 2009, CANCER CELL, V16, P115, DOI 10.1016/j.ccr.2009.06.006; Goulden BD, 2019, J CELL BIOL, V218, P1066, DOI 10.1083/jcb.201809026; Hastie CJ, 2006, NAT PROTOC, V1, P968, DOI 10.1038/nprot.2006.149; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Hurley JH, 2017, ANNU REV BIOCHEM, V86, P225, DOI 10.1146/annurev-biochem-061516-044820; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Ivetac I, 2005, MOL BIOL CELL, V16, P2218, DOI 10.1091/mbc.e04-09-0799; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Kobayashi T, 1999, BIOCHEM J, V339, P319, DOI 10.1042/0264-6021:3390319; Landel I, 2020, ACS MED CHEM LETT, V11, P225, DOI 10.1021/acsmedchemlett.9b00548; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lapierre JM, 2016, J MED CHEM, V59, P6455, DOI 10.1021/acs.jmedchem.6b00619; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Leonard TA, 2011, CELL, V144, P55, DOI 10.1016/j.cell.2010.12.013; Lin K, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002618; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Liu SL, 2018, MOL CELL, V71, P1092, DOI 10.1016/j.molcel.2018.07.035; Lucic I, 2018, P NATL ACAD SCI USA, V115, pE3940, DOI 10.1073/pnas.1716109115; Lucic I, 2016, J MOL BIOL, V428, P121, DOI 10.1016/j.jmb.2015.11.001; Malik N, 2018, BIOCHEM J, V475, P117, DOI 10.1042/BCJ20170650; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003; Martini M, 2014, ANN MED, V46, P372, DOI 10.3109/07853890.2014.912836; Masson GR, 2019, NAT METHODS, V16, P595, DOI 10.1038/s41592-019-0459-y; Oancea E, 1998, CELL, V95, P307, DOI 10.1016/S0092-8674(00)81763-8; Oh WJ, 2010, EMBO J, V29, P3939, DOI 10.1038/emboj.2010.271; Pao AC, 2007, AM J PHYSIOL-RENAL, V292, pF1741, DOI 10.1152/ajprenal.00027.2007; Sawa-Makarska J, 2020, SCIENCE, V369, P1206, DOI 10.1126/science.aaz7714; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Tessier M, 2006, J BIOL CHEM, V281, P23978, DOI 10.1074/jbc.M604333200; Theile CS, 2013, NAT PROTOC, V8, P1800, DOI 10.1038/nprot.2013.102; Vasudevan KM, 2009, CANCER CELL, V16, P21, DOI 10.1016/j.ccr.2009.04.012; Virbasius JV, 2001, P NATL ACAD SCI USA, V98, P12908, DOI 10.1073/pnas.221352898; Wang YZ, 2017, P NATL ACAD SCI USA, V114, pE1500, DOI 10.1073/pnas.1612991114; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Weisner J, 2019, CANCER RES, V79, P2367, DOI 10.1158/0008-5472.CAN-18-2861; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111	55	3	3	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100919	10.1016/j.jbc.2021.100919	http://dx.doi.org/10.1016/j.jbc.2021.100919			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34181950	Green Submitted, gold, Green Published			2022-12-28	WOS:000690879300002
J	Carman, GM				Carman, George M.			Lipid metabolism has been good to me	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; CDP-DIACYLGLYCEROL SYNTHASE; PHOSPHATIDATE PHOSPHATASE-ACTIVITY; PHOSPHATIDYLSERINE SYNTHASE; PHOSPHOLIPID-SYNTHESIS; CTP SYNTHETASE; PHOSPHATIDYLINOSITOL SYNTHASE; PYROPHOSPHATE PHOSPHATASE; PARTIAL-PURIFICATION; ESCHERICHIA-COLI	My career in research has flourished through hard work, supportive mentors, and outstanding mentees and collaborators. The Carman laboratory has contributed to the understanding of lipid metabolism through the isolation and characterization of key lipid biosynthetic enzymes as well as through the identification of the enzyme-encoding genes. Our findings from yeast have proven to be invaluable to understand regulatory mechanisms of human lipid metabolism. Several rewarding aspects of my career have been my service to the Journal of Biological Chemistry as an editorial board member and Associate Editor, the National Institutes of Health as a member of study sections, and national and international scientific meetings as an organizer. I advise early career scientists to not assume anything, acknowledge others' accomplishments, and pay it forward.	[Carman, George M.] Rutgers State Univ, Dept Food Sci, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08854 USA; [Carman, George M.] Rutgers State Univ, Rutgers Ctr Lipid Res, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Carman, GM (corresponding author), Rutgers State Univ, Dept Food Sci, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08854 USA.; Carman, GM (corresponding author), Rutgers State Univ, Rutgers Ctr Lipid Res, New Jersey Inst Food Nutr & Hlth, New Brunswick, NJ 08854 USA.	gcarman@rutgers.edu			NIH [GM028140, GM035655, GM050679, GM136128]; National Science Foundation [DCB9204588]; New Jersey Agricultural Experiment Station	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); New Jersey Agricultural Experiment Station	I am grateful to my official and unofficial mentors who saw in me the potential of becoming a successful scientist; without them, I would not be the person I am today. I am fortunate to have had the opportunity to mentor so many talented and hardworking students and postdoctoral associates who are the essence of the Carman laboratory (Fig. 5). The research would not be possible without financial support from the NIH (GM028140, GM035655, GM050679, and GM136128), National Science Foundation (DCB9204588), and the New Jersey Agricultural Experiment Station. I acknowledge the Department of Food Science, School of Environmental and Biological Sciences, Rutgers University for supporting my career. I acknowledge my wife Maureen, who endured my anxieties in getting grants and publishing papers and allowing me to spend so much time with my service activities. I am also grateful for the support of my children, Jennifer, Michael, and Peter, understanding when they were young that I had to go to work to make money. I thank Peter Carman, Terrance Cooper, Gil-Soo Han, and Judy Storch for their comments during the preparation of this manuscript. Finally, I thank Herb Tabor for inviting me to write this article; I regret that he did not have the opportunity to read it. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ANGUS WW, 1972, ARCH BIOCHEM BIOPHYS, V151, P483, DOI 10.1016/0003-9861(72)90525-5; ATKINSON K, 1980, J BIOL CHEM, V255, P6653; ATKINSON KD, 1980, J BACTERIOL, V141, P558, DOI 10.1128/JB.141.2.558-564.1980; BAELEE MS, 1984, J BIOL CHEM, V259, P857; BAILIS AM, 1987, MOL CELL BIOL, V7, P167, DOI 10.1128/MCB.7.1.167; Barbosa AD, 2015, MOL BIOL CELL, V26, P3641, DOI 10.1091/mbc.E15-03-0173; Barneda D, 2015, ELIFE, V4, DOI 10.7554/eLife.07485; BECKER GW, 1977, J BIOL CHEM, V252, P8684; Carman GM, 2007, J BIOL CHEM, V282, P37293, DOI 10.1074/jbc.R700038200; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; Carman GM, 2019, J LIPID RES, V60, P2, DOI 10.1194/jlr.S087452; Carman GM, 2019, J BIOL CHEM, V294, P1681, DOI 10.1074/jbc.TM118.004159; Carman George M, 2011, Front Biol (Beijing), V6, P172; Carman GM, 2011, ANNU REV BIOCHEM, V80, P859, DOI 10.1146/annurev-biochem-060409-092229; CARMAN GM, 1982, APPL ENVIRON MICROB, V43, P81, DOI 10.1128/AEM.43.1.81-85.1982; CARMAN GM, 1981, CAN J MICROBIOL, V27, P1140, DOI 10.1139/m81-179; CARMAN GM, 1981, J FOOD BIOCHEM, V5, P185, DOI 10.1111/j.1745-4514.1981.tb00672.x; Carman GM, 1999, PROG LIPID RES, V38, P361, DOI 10.1016/S0163-7827(99)00010-7; CARMAN GM, 1991, METHOD ENZYMOL, V197, P548; CARMAN GM, 1979, J BIOL CHEM, V254, P8391; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; CARMAN GM, 1980, J BACTERIOL, V142, P262, DOI 10.1128/JB.142.1.262-267.1980; CARMAN GM, 1984, J FOOD BIOCHEM, V8, P321, DOI 10.1111/j.1745-4514.1984.tb00331.x; CARMAN GM, 1980, J FOOD BIOCHEM, V4, P147, DOI 10.1111/j.1745-4514.1980.tb00652.x; CARMAN GM, 1980, J FOOD BIOCHEM, V4, P153, DOI 10.1111/j.1745-4514.1980.tb00653.x; CARMAN GM, 1980, J FOOD BIOCHEM, V3, P89, DOI 10.1111/j.1745-4514.1980.tb00638.x; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; CARMAN GM, 1980, J FOOD BIOCHEM, V4, P261, DOI 10.1111/j.1745-4514.1980.tb00785.x; CARMAN GM, 1977, APPL ENVIRON MICROB, V33, P192, DOI 10.1128/AEM.33.1.192-198.1977; CARMAN GM, 1978, J LIPID RES, V19, P519; Chang YF, 2008, PROG LIPID RES, V47, P333, DOI 10.1016/j.plipres.2008.03.004; Choi HS, 2011, J BIOL CHEM, V286, P1486, DOI 10.1074/jbc.M110.155598; COUSMINER JJ, 1982, J BACTERIOL, V151, P1372, DOI 10.1128/JB.151.3.1372-1379.1982; COUSMINER JJ, 1981, CAN J MICROBIOL, V27, P544, DOI 10.1139/m81-080; Covey S.R., 1989, 7 HABITS HIGHLY EFFE; DEEMS RA, 1975, J BIOL CHEM, V250, P9013; Dennis EA, 2016, J BIOL CHEM, V291, P24431, DOI 10.1074/jbc.X116.723791; Dey P, 2020, J LIPID RES, V61, P1556, DOI 10.1194/jlr.R120001092; Donkor J, 2007, J BIOL CHEM, V282, P3450, DOI 10.1074/jbc.M610745200; DOWHAN W, 1974, J BIOL CHEM, V249, P3079; DOWHAN W, 1970, J BIOL CHEM, V245, P4629; Dowhan W, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.666203; Dowhan W, 2017, J BIOL CHEM, V292, P10755, DOI 10.1074/jbc.X117.794891; DUTT A, 1985, BIOCHEMISTRY-US, V24, P1074, DOI 10.1021/bi00326a001; Fernandez F, 2001, J BIOL CHEM, V276, P41455, DOI 10.1074/jbc.M105544200; FERNANDEZ S, 1986, J BACTERIOL, V166, P779, DOI 10.1128/jb.166.3.779-786.1986; FISCHL AS, 1986, J BIOL CHEM, V261, P3178; FISCHL AS, 1983, J BACTERIOL, V154, P304, DOI 10.1128/JB.154.1.304-311.1983; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Goldfine H, 2020, J BIOL CHEM, V295, P4124, DOI 10.1074/jbc.X120.013022; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han GS, 2008, J BIOL CHEM, V283, P20443, DOI 10.1074/jbc.M802866200; Han GS, 2008, J BIOL CHEM, V283, P20433, DOI 10.1074/jbc.M802903200; Han GS, 2007, J BIOL CHEM, V282, P37026, DOI 10.1074/jbc.M705777200; Han GS, 2017, J BIOL CHEM, V292, P13230, DOI 10.1074/jbc.M117.801720; Han GS, 2010, J BIOL CHEM, V285, P14628, DOI 10.1074/jbc.M110.117747; Han GS, 2006, J BIOL CHEM, V281, P9210, DOI 10.1074/jbc.M600425200; Han GS, 2002, J BIOL CHEM, V277, P47709, DOI 10.1074/jbc.M207996200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Havriluk T, 2008, ANAL BIOCHEM, V373, P392, DOI 10.1016/j.ab.2007.08.037; Henry S. A., 1986, P CNRS INSERM INT S, P623; Henry SA, 1998, PROG NUCLEIC ACID RE, V61, P133, DOI 10.1016/S0079-6603(08)60826-0; Henry SA, 2012, GENETICS, V190, P317, DOI 10.1534/genetics.111.130286; HIRABAYASHI T, 1976, BIOCHEMISTRY-US, V15, P5205, DOI 10.1021/bi00669a002; Hirschberg CB, 2018, J BIOL CHEM, V293, P12653, DOI 10.1074/jbc.X118.004819; HOMANN MJ, 1985, J BACTERIOL, V163, P1265, DOI 10.1128/JB.163.3.1265-1266.1985; HOMANN MJ, 1987, J BACTERIOL, V169, P3276, DOI 10.1128/jb.169.7.3276-3280.1987; HROMY JM, 1986, J BIOL CHEM, V261, P5572; Hsieh LS, 2015, J BIOL CHEM, V290, P11467, DOI 10.1074/jbc.M115.648659; IRIE K, 1993, MOL GEN GENET, V236, P283, DOI 10.1007/BF00277124; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Johnston C. N., 2002, THESIS RUTGERS U THESIS RUTGERS U; KANFER J, 1964, J BIOL CHEM, V239, P1720; Karanasios E, 2013, MOL BIOL CELL, V24, P2124, DOI 10.1091/mbc.E13-01-0021; Karanasios E, 2010, P NATL ACAD SCI USA, V107, P17539, DOI 10.1073/pnas.1007974107; KELLEY MJ, 1988, J BIOL CHEM, V263, P18078; KELLEY MJ, 1987, J BIOL CHEM, V262, P14563; Kennedy E. P., 1986, LIPIDS MEMBRANES PRE, P171; Kennedy EP, 2001, J BIOL CHEM, V276, P42619, DOI 10.1074/jbc.R100051200; KENNEDY EUGENE P., 1962, HARVEY LECTURES, V57, P143; Kersting MC, 2006, J BIOL CHEM, V281, P13110, DOI 10.1074/jbc.M601612200; Khayyo VI, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15124-z; Kim KH, 1998, J BIOL CHEM, V273, P6844, DOI 10.1074/jbc.273.12.6844; Kim KS, 1999, J BIOL CHEM, V274, P14857, DOI 10.1074/jbc.274.21.14857; KINNEY AJ, 1988, P NATL ACAD SCI USA, V85, P7962, DOI 10.1073/pnas.85.21.7962; KINNEY AJ, 1990, J BACTERIOL, V172, P1133, DOI 10.1128/jb.172.2.1133-1136.1990; KLIG LS, 1985, J BACTERIOL, V162, P1135, DOI 10.1128/JB.162.3.1135-1141.1985; KLIG LS, 1988, J BACTERIOL, V170, P1878, DOI 10.1128/jb.170.4.1878-1886.1988; Kwiatek JM, 2020, BBA-MOL CELL BIOL L, V1865, DOI 10.1016/j.bbalip.2019.03.006; LANGNER CA, 1989, J BIOL CHEM, V264, P7994; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P974, DOI 10.1021/bi00650a005; LARSON TJ, 1976, BIOCHEMISTRY-US, V15, P5212, DOI 10.1021/bi00669a003; LETTS VA, 1983, P NATL ACAD SCI-BIOL, V80, P7279, DOI 10.1073/pnas.80.23.7279; LIN YP, 1989, J BIOL CHEM, V264, P8641; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; Mandala SM, 1998, P NATL ACAD SCI USA, V95, P150, DOI 10.1073/pnas.95.1.150; Mao CG, 1997, J BIOL CHEM, V272, P28690, DOI 10.1074/jbc.272.45.28690; Munnik T, 1996, J BIOL CHEM, V271, P15708, DOI 10.1074/jbc.271.26.15708; NASMYTH KA, 1980, P NATL ACAD SCI-BIOL, V77, P2119, DOI 10.1073/pnas.77.4.2119; NICKELS JT, 1993, J BIOL CHEM, V268, P24083; NICKELS JT, 1992, J BIOL CHEM, V267, P16297; O'Hara L, 2006, J BIOL CHEM, V281, P34537, DOI 10.1074/jbc.M606654200; Pappas A, 1998, J BIOL CHEM, V273, P15954, DOI 10.1074/jbc.273.26.15954; Pascual F, 2013, J BIOL CHEM, V288, P35781, DOI 10.1074/jbc.M113.525766; PAULUS H, 1960, J BIOL CHEM, V235, P1303; Peterfy M, 2001, NAT GENET, V27, P121, DOI 10.1038/83685; Phan J, 2005, CELL METAB, V1, P73, DOI 10.1016/j.cmet.2004.12.002; Qie LX, 1997, J BIOL CHEM, V272, P16110, DOI 10.1074/jbc.272.26.16110; Qiu YX, 2013, J BIOL CHEM, V288, P29124, DOI 10.1074/jbc.M113.507392; RAETZ CRH, 1976, J BACTERIOL, V125, P855, DOI 10.1128/JB.125.3.855-863.1976; Reue K, 2019, J LIPID RES, V60, P728, DOI 10.1194/jlr.S091769; Rhee SG, 2019, J BIOL CHEM, V294, P5169, DOI 10.1074/jbc.X119.007975; ROBINSON ML, 1982, PLANT PHYSIOL, V69, P146, DOI 10.1104/pp.69.1.146; Russell DW, 2018, J BIOL CHEM, V293, P18804, DOI 10.1074/jbc.X118.005918; Sembongi H, 2013, J BIOL CHEM, V288, P34502, DOI 10.1074/jbc.M113.488445; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; SMITH SW, 1957, J BIOL CHEM, V228, P915; Smith WL, 2019, J BIOL CHEM, V294, P1779, DOI 10.1074/jbc.X118.006184; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Soto-Cardalda A, 2012, J BIOL CHEM, V287, P968, DOI 10.1074/jbc.M111.313130; Sreenivas A, 2001, J BIOL CHEM, V276, P29915, DOI 10.1074/jbc.M105147200; STEINER MR, 1972, BIOCHIM BIOPHYS ACTA, V260, P222, DOI 10.1016/0005-2760(72)90035-5; STEINER MR, 1970, BIOCHEMISTRY-US, V9, P63, DOI 10.1021/bi00803a009; Stukey J, 1997, PROTEIN SCI, V6, P469; Su WM, 2014, J BIOL CHEM, V289, P18818, DOI 10.1074/jbc.M114.581462; TALWALKAR RT, 1974, BIOCHIM BIOPHYS ACTA, V360, P306, DOI 10.1016/0005-2760(74)90060-5; Temprano A, 2016, DIABETOLOGIA, V59, P1985, DOI 10.1007/s00125-016-4018-0; Toke DA, 1998, J BIOL CHEM, V273, P3278, DOI 10.1074/jbc.273.6.3278; Toke DA, 1998, J BIOL CHEM, V273, P14331, DOI 10.1074/jbc.273.23.14331; Toke DA, 1999, BIOCHEMISTRY-US, V38, P14606, DOI 10.1021/bi991472x; Vance DE, 2017, J BIOL CHEM, V292, P17169, DOI 10.1074/jbc.X117.815100; WAECHTER CJ, 1973, ARCH BIOCHEM BIOPHYS, V158, P401, DOI 10.1016/0003-9861(73)90637-1; WAECHTER CJ, 1971, J BACTERIOL, V105, P837, DOI 10.1128/JB.105.3.837-843.1971; WISSING JB, 1993, PLANT PHYSIOL, V102, P1243, DOI 10.1104/pp.102.4.1243; WISSING JB, 1993, FEBS LETT, V315, P95, DOI 10.1016/0014-5793(93)81141-L; Wu WI, 1996, J BIOL CHEM, V271, P1868, DOI 10.1074/jbc.271.4.1868; WU WI, 1994, J BIOL CHEM, V269, P29495; WU WI, 1993, J BIOL CHEM, V268, P13830; Wu WI, 1996, BIOCHEMISTRY-US, V35, P3790, DOI 10.1021/bi952808f; Yang WL, 1996, J BIOL CHEM, V271, P28777, DOI 10.1074/jbc.271.46.28777; Yang WL, 1996, J BIOL CHEM, V271, P11113, DOI 10.1074/jbc.271.19.11113; YANG WL, 1994, BIOCHEMISTRY-US, V33, P10785, DOI 10.1021/bi00201a028; YANG WL, 1995, J BIOL CHEM, V270, P14983, DOI 10.1074/jbc.270.25.14983	144	3	3	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100786	10.1016/j.jbc.2021.100786	http://dx.doi.org/10.1016/j.jbc.2021.100786			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34015333	Green Published, gold			2022-12-28	WOS:000678068400007
J	Chevalier, C; Leymarie, O; Sedano, L; Da Costa, B; Richard, CA; Maisonnasse, P; Refregiers, M; Jamme, F; Le Goffic, R				Chevalier, Christophe; Leymarie, Olivier; Sedano, Laura; Da Costa, Bruno; Richard, Charles-Adrien; Maisonnasse, Pauline; Refregiers, Matthieu; Jamme, Frederic; Le Goffic, Ronan			PB1-F2 amyloid-like fibers correlate with proinflammatory signaling and respiratory distress in influenza-infected mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							A VIRUS PROTEIN; ELECTROCHEMICAL DETECTION; CELLS; OLIGOMERIZATION; PLETHYSMOGRAPHY; SPECTROSCOPY; PATHOGENESIS; CONTRIBUTES; EXPRESSION; MICROSCOPY	PB1-F2 is a virulence factor of influenza A virus known to increase viral pathogenicity in mammalian hosts. PB1-F2 is an intrinsically disordered protein displaying a propensity to form amyloid-like fibers. However, the correlation between PB1-F2 structures and the resulting inflammatory response is unknown. Here, we used synchrotron-coupled Fourier transform-IR and deep UV microscopies to determine the presence of PB1-F2 fibers in influenza A virus-infected mice. In order to study the correlation between PB1-F2 structure and the inflammatory response, transgenic mice expressing luciferase under the control of an NF-kappa B promotor, allowing in vivo monitoring of inflammation, were intranasally instilled with monomeric, fibrillated, or truncated forms of recombinant PB1-F2. Our intravital NF-kappa B imaging, supported by cytokine quantification, clearly shows the proinflammatory effect of PB1-F2 fibers compared with N-terminal region of PB1-F2 unable to fibrillate. It is noteworthy that instillation of monomeric PB1-F2 of H5N1 virus induced a stronger inflammatory response when compared with prefibrillated PB1-F2 of H1N1 virus, suggesting mechanisms of virulence depending on PB1-F2 sequence. Finally, using whole-body plethysmography to measure volume changes in the lungs, we quantified the effects of the different forms of PB1-F2 on respiratory parameters. Thus, we conclude that PB1-F2-induced inflammation and respiratory distress are tightly correlated with sequence polymorphism and oligomerization status of the protein.	[Chevalier, Christophe; Leymarie, Olivier; Sedano, Laura; Da Costa, Bruno; Richard, Charles-Adrien; Maisonnasse, Pauline; Le Goffic, Ronan] Univ Paris Saclay, UVSQ, INRAE, VIM, Jouy En Josas, France; [Refregiers, Matthieu; Jamme, Frederic] Synchrotron SOLEIL, Gif Sur Yvette, France	INRAE; UDICE-French Research Universities; Universite Paris Saclay; SOLEIL Synchrotron	Chevalier, C; Le Goffic, R (corresponding author), Univ Paris Saclay, UVSQ, INRAE, VIM, Jouy En Josas, France.	christophe.chevalier@inrae.fr; ronan.le-goffic@inrae.fr	LE GOFFIC, Ronan/B-7649-2008; LE GOFFIC, Ronan/M-3099-2019; Réfrégiers, Matthieu/AAE-2075-2022; Chevalier, Christophe/C-2575-2009	LE GOFFIC, Ronan/0000-0002-2012-0064; LE GOFFIC, Ronan/0000-0002-2012-0064; Refregiers, Matthieu/0000-0002-3281-2308; Chevalier, Christophe/0000-0003-3231-9027; Maisonnasse, Pauline/0000-0002-0555-207X; RICHARD, Charles-Adrien/0000-0001-5306-2297	Region Ile-de-France (SESAME); REACTIV ANR project [ANR-17-CE35-0007]	Region Ile-de-France (SESAME)(Region Ile-de-France); REACTIV ANR project	We thank Gwladys Meesemaecker, Laetitia Guedeville, Mathilde Bauducel, Marlene Hery, Charline Pontlevoy, Andre Tiffoche, and Jerome Pottier (Unite Experimentale Animalerie Rongeurs, INRAE, Jouy-en-Josas) for technical assistance with animal experiments. We thank Pr. Richard Flavell (Howard Hughes Medical Institute, Yale University School of Medicine) for his gift of NF-kappa B luciferase transgenic mice. This work has benefited from the facilities and expertise of the protein purification platform under the direction of Dr Mohammed Moudjou (VIM, INRAE, Jouy-en-Josas). We are grateful to the MIMA2 platform for access to the TEM (Christine Pechoux) and IVIS200 (Stephane Biacchesi), which was financed by the Region Ile-de-France (SESAME). We thank Jean Millet (VIM, INRAE, Jouy-en-Josas) for critical reading of the article. This work was supported by the REACTIV ANR project (ANR-17-CE35-0007). We acknowledge SOLEIL for provision of synchrotron beamtime (proposals no. 20121092).	Ajjaji D, 2016, BIOCHEM BIOPH RES CO, V477, P27, DOI 10.1016/j.bbrc.2016.06.016; Alymova IV, 2014, J VIROL, V88, P503, DOI 10.1128/JVI.01373-13; Alymova IV, 2011, J VIROL, V85, P12324, DOI 10.1128/JVI.05872-11; Barth A, 2007, BBA-BIOENERGETICS, V1767, P1073, DOI 10.1016/j.bbabio.2007.06.004; Barthelemy A, 2017, MUCOSAL IMMUNOL, V10, P460, DOI 10.1038/mi.2016.49; Bottomly D, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0547-7; Brandes M, 2013, CELL, V154, P197, DOI 10.1016/j.cell.2013.06.013; Bruns K, 2007, J BIOL CHEM, V282, P353, DOI 10.1074/jbc.M606494200; Cassel SL, 2009, SEMIN IMMUNOL, V21, P194, DOI 10.1016/j.smim.2009.05.002; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Chevalier C, 2016, J BIOL CHEM, V291, P9060, DOI 10.1074/jbc.M115.710533; Chevalier C, 2010, J BIOL CHEM, V285, P13233, DOI 10.1074/jbc.M109.067710; Conenello GM, 2007, PLOS PATHOG, V3, P1414, DOI 10.1371/journal.ppat.0030141; Da Costa B, 2015, J VIROL, V89, P6376, DOI 10.1128/JVI.00589-15; Dou D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01581; Edelstein Arthur, 2010, Curr Protoc Mol Biol, VChapter 14, DOI 10.1002/0471142727.mb1420s92; Fischer H, 2006, J MEMBRANE BIOL, V211, P139, DOI 10.1007/s00232-006-0861-0; Giuliani A, 2009, J SYNCHROTRON RADIAT, V16, P835, DOI 10.1107/S0909049509034049; Goormaghtigh E, 2006, BIOPHYS J, V90, P2946, DOI 10.1529/biophysj.105.072017; Hoffmann E, 2002, VACCINE, V20, P3165, DOI 10.1016/S0264-410X(02)00268-2; James J, 2016, J GEN VIROL, V97, P2516, DOI 10.1099/jgv.0.000584; Jamme F, 2013, BIOL CELL, V105, P277, DOI 10.1111/boc.201200075; Jamme F, 2010, MICROSC MICROANAL, V16, P507, DOI 10.1017/S1431927610093852; Julander JG, 2014, ANTIVIR RES, V108, P10, DOI 10.1016/j.antiviral.2014.05.002; Kash JC, 2015, AM J PATHOL, V185, P1528, DOI 10.1016/j.ajpath.2014.08.030; Kocer ZA, 2015, EMERG MICROBES INFEC, V4, DOI 10.1038/emi.2015.40; Kozlowski LP, 2017, NUCLEIC ACIDS RES, V45, pD1112, DOI 10.1093/nar/gkw978; Le Goffic R, 2006, PLOS PATHOG, V2, P526, DOI 10.1371/journal.ppat.0020053; Le Goffic R, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002202; Le Goffic R, 2010, J IMMUNOL, V185, P4812, DOI 10.4049/jimmunol.0903952; Leymarie O, 2017, J GEN VIROL, V98, P1196, DOI 10.1099/jgv.0.000782; Leymarie O, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100679; Leymarie O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057894; Lomask M, 2006, EXP TOXICOL PATHOL, V57, P13, DOI 10.1016/j.etp.2006.02.014; Marjuki H, 2010, ARCH VIROL, V155, P925, DOI 10.1007/s00705-010-0666-4; McAuley JL, 2007, CELL HOST MICROBE, V2, P240, DOI 10.1016/j.chom.2007.09.001; McAuley JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003392; McAuley JL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001014; Menachery VD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131451; Miodek A, 2014, ANAL CHEM, V86, P9098, DOI 10.1021/ac5018056; Miodek A, 2014, BIOSENS BIOELECTRON, V59, P6, DOI 10.1016/j.bios.2014.02.037; Mitzner D, 2009, CELL MICROBIOL, V11, P1502, DOI 10.1111/j.1462-5822.2009.01343.x; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Pinar A, 2017, J BIOL CHEM, V292, P826, DOI 10.1074/jbc.M116.756379; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8183; Sanders CJ, 2013, AM J PHYSIOL-LUNG C, V304, pL481, DOI 10.1152/ajplung.00343.2012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Solbak SMO, 2013, BBA-PROTEINS PROTEOM, V1834, P568, DOI 10.1016/j.bbapap.2012.11.009; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Van Hoecke L, 2017, JOVE-J VIS EXP, DOI 10.3791/55398; Vidic J., 2013, J ANAL BIOANAL TECH, V4, P169; Vidic J, 2016, J BIOL CHEM, V291, P739, DOI 10.1074/jbc.M115.652917; VidicJ Chevalier C., 2013, J JOURNALOF ANALYTIC, VS7, P6; Vidy A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165361; Yoshizumi T, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5713; Zamarin D, 2006, J VIROL, V80, P7976, DOI 10.1128/JVI.00415-06; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904	57	1	1	5	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100885	10.1016/j.jbc.2021.100885	http://dx.doi.org/10.1016/j.jbc.2021.100885			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34146545	gold, Green Published			2022-12-28	WOS:000678068400084
J	Gaborit, B; Govers, R; Altie, A; Brunel, JM; Morange, P; Peiretti, F				Gaborit, Benedicte; Govers, Roland; Altie, Alexandre; Brunel, Jean Michel; Morange, Pierre; Peiretti, Franck			The aminosterol Claramine inhibits beta-secretase 1-mediated insulin receptor cleavage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; AMYLOID PRECURSOR PROTEIN; ALZHEIMERS-DISEASE; GOLGI NETWORK; UBIQUITIN; DEGRADATION; AUTOPHAGY; PROTEASOME; BACE1; SENSITIVITY	The cleavage of the insulin receptor by beta-secretase 1 (BACE1) in the liver increases during diabetes, which contributes to reduce insulin receptor levels and impair insulin signaling. However, the precise signaling events that lead to this increased cleavage are unclear. We showed that BACE1 cleaves the insulin receptor in the early secretory pathway. Indeed, coimmunoprecipitation experiments reveal the interaction of the proforms of the two proteins. Moreover, fragments of insulin receptor are detected in the early secretory pathway and a mutated form of BACE1 that retains its prodomain cleaves an early secretory pathway-resident form of the insulin receptor. We showed that BACE1 proform levels are regulated by proteasome and/or lysosome-dependent degradation systems whose efficiencies are dependent on the O-GlcNacylation process. Our results showed that enhanced O-GlcNacylation reduces the efficiency of intracellular protein degradation systems, leading to the accumulation of the proform of BACE1 in the early secretory pathway where it cleaves the precursor of the insulin receptor. All these dysregulations are found in the livers of diabetic mice. In addition, we performed a screen of molecules according to their ability to increase levels of the insulin receptor at the surface of BACE1-overexpressing cells. This approach identified the aminosterol Claramine, which accelerated intracellular trafficking of the proform of BACE1 and increased autophagy. Both of these effects likely contribute to the reduced amount of the proform of BACE1 in the early secretory pathway, thereby reducing insulin receptor cleavage. These newly described properties of Claramine are consistent with its insulin sensitizing effect.	[Gaborit, Benedicte; Govers, Roland; Altie, Alexandre; Morange, Pierre; Peiretti, Franck] Aix Marseille Univ, C2VN, INRAE, INSERM, Marseille, France; [Gaborit, Benedicte] AP HM, Endocrinol Metab Dis & Nutr Dept, Marseille, France; [Brunel, Jean Michel] Aix Marseille Univ, MCT, SSA, INSERM, Marseille, France; [Morange, Pierre] La Timone Hosp, AP HM, Hematol Lab, Marseille, France	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Peiretti, F (corresponding author), Aix Marseille Univ, C2VN, INRAE, INSERM, Marseille, France.	franck.peiretti@univ-amu.fr	GABORIT, Bénédicte/AAK-3842-2020; Peiretti, Franck/GLV-3378-2022; peiretti, franck/L-2718-2017; Morange, Pierre/T-9070-2019; Govers, Roland/O-5782-2016	GABORIT, Bénédicte/0000-0002-4180-158X; Peiretti, Franck/0000-0001-7198-0534; peiretti, franck/0000-0001-7198-0534; Morange, Pierre/0000-0002-9065-722X; Govers, Roland/0000-0003-1359-5333	Institut National de la Sante et la Recherche Medicale (Inserm)	Institut National de la Sante et la Recherche Medicale (Inserm)(Institut National de la Sante et de la Recherche Medicale (Inserm))	We thank J.F. Landrier, J. Astier, and C. Couturier for providing mouse liver samples. Funding was obtained from Institut National de la Sante et la Recherche Medicale (Inserm).	Bao J, 2018, P NATL ACAD SCI USA, V115, P3954, DOI 10.1073/pnas.1800498115; Baulac S, 2003, NEUROBIOL DIS, V14, P194, DOI 10.1016/S0969-9961(03)00123-2; Beckman M, 2006, BIOCHEMISTRY-US, V45, P6703, DOI 10.1021/bi052498t; Benjannet S, 2001, J BIOL CHEM, V276, P10879, DOI 10.1074/jbc.M009899200; Blanchet M, 2018, CHEMMEDCHEM, V13, P1018, DOI 10.1002/cmdc.201800073; Blanquart C, 2005, MOL PHARMACOL, V68, P885, DOI 10.1124/mol.105.013151; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Boucher J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009191; Cao JQ, 2019, NEUROSCI LETT, V703, P68, DOI 10.1016/j.neulet.2019.03.016; Choi E, 2016, CELL, V166, P567, DOI 10.1016/j.cell.2016.05.074; Clague MJ, 2010, CELL, V143, P682, DOI 10.1016/j.cell.2010.11.012; Costantini C, 2007, BIOCHEM J, V407, P383, DOI 10.1042/BJ20070040; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Dev R, 2018, ANN ONCOL, V29, P18, DOI 10.1093/annonc/mdx815; Ding WX, 2007, J BIOL CHEM, V282, P4702, DOI 10.1074/jbc.M609267200; Dodd GT, 2019, CELL REP, V28, P2905, DOI 10.1016/j.celrep.2019.08.019; Erales J, 2014, BBA-MOL CELL RES, V1843, P216, DOI 10.1016/j.bbamcr.2013.05.008; Fregno I, 2019, CRIT REV BIOCHEM MOL, V54, P153, DOI 10.1080/10409238.2019.1610351; Fujita E, 2007, HUM MOL GENET, V16, P618, DOI 10.1093/hmg/ddm002; Haeusler RA, 2018, NAT REV MOL CELL BIO, V19, P31, DOI 10.1038/nrm.2017.89; Huse JT, 2002, J BIOL CHEM, V277, P16278, DOI 10.1074/jbc.M111141200; Kang EL, 2012, J BIOL CHEM, V287, P42867, DOI 10.1074/jbc.M112.407072; Kang EL, 2010, J BIOL CHEM, V285, P24108, DOI 10.1074/jbc.M109.092742; Kara I, 2015, J BIOL CHEM, V290, P2812, DOI 10.1074/jbc.M114.592543; Keembiyehetty CN, 2011, J CELL SCI, V124, P2851, DOI 10.1242/jcs.083287; Kocaturk NM, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00128; Koh YH, 2005, J BIOL CHEM, V280, P32499, DOI 10.1074/jbc.M506199200; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Kou XJ, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090927; Krishnan N, 2018, J BIOL CHEM, V293, P1517, DOI 10.1074/jbc.C117.819110; Lane CA, 2018, EUR J NEUROL, V25, P59, DOI 10.1111/ene.13439; Meakin PJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03755-2; Nagarajan A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12639; Neth BJ, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00345; Opoku-Nsiah KA, 2018, TRANSL RES, V198, P48, DOI 10.1016/j.trsl.2018.05.002; Ortiz-Meoz RF, 2015, ACS CHEM BIOL, V10, P1392, DOI 10.1021/acschembio.5b00004; Otoda T, 2013, DIABETES, V62, P811, DOI 10.2337/db11-1652; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pomytkin I, 2018, CNS NEUROSCI THER, V24, P763, DOI 10.1111/cns.12866; Qin ZH, 2015, BIOCHEM BIOPH RES CO, V458, P21, DOI 10.1016/j.bbrc.2015.01.040; Qing H, 2004, FASEB J, V18, P1571, DOI 10.1096/fj.04-1994fje; Rahman MA, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/6279313; Ruan HB, 2012, CELL METAB, V16, P226, DOI 10.1016/j.cmet.2012.07.006; Schmidt V, 2016, J CLIN INVEST, V126, P2706, DOI 10.1172/JCI84708; Singh AK, 2015, AGING CELL, V14, P595, DOI 10.1111/acel.12335; Song RS, 2013, NATURE, V494, P375, DOI 10.1038/nature11834; Vella V, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19113615; Vieira MNN, 2017, FRONT AGING NEUROSCI, V9, DOI [10.3389/fnagi.2077.00007, 10.3389/fnagi.2017.00007]; Wang YC, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.124945; Wani WY, 2017, MOL BRAIN, V10, DOI 10.1186/s13041-017-0311-1; Westmeyer GG, 2004, J BIOL CHEM, V279, P53205, DOI 10.1074/jbc.M410378200; Yamagishi N, 2012, BIOCHEM BIOPH RES CO, V417, P364, DOI 10.1016/j.bbrc.2011.11.118; Yamamoto S, 2018, CELL REP, V23, P3286, DOI 10.1016/j.celrep.2018.05.032; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Zhang FX, 2003, CELL, V115, P715, DOI 10.1016/S0092-8674(03)00974-7; Zhang KZ, 2018, DIABETES, V67, P180, DOI 10.2337/dbi17-0048; Zhang L, 2013, J LIPID RES, V54, P1410, DOI 10.1194/jlr.M035774; Zhang MM, 2012, J NEUROCHEM, V120, P1129, DOI 10.1111/j.1471-4159.2011.07644.x	58	2	2	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100818	10.1016/j.jbc.2021.100818	http://dx.doi.org/10.1016/j.jbc.2021.100818			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029592	gold, Green Published, Green Submitted			2022-12-28	WOS:000678068400020
J	Kumari, P; Sundaram, R; Manohar, K; Vasudevan, D; Acharya, N				Kumari, Premlata; Sundaram, Rajivgandhi; Manohar, Kodavati; Vasudevan, Dileep; Acharya, Narottam			Interdomain connecting loop and J loop structures determine cross-species compatibility of PCNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; DNA-POLYMERASE-ETA; TRANSLESION SYNTHESIS; MUTATIONAL ANALYSIS; COMPLEX-FORMATION; YEAST REV1; PROTEIN	Eukaryotic proliferating cell nuclear antigen (PCNA) plays an essential role in orchestrating the assembly of the replisome complex, stimulating processive DNA synthesis, and recruiting other regulatory proteins during the DNA damage response. PCNA and its binding partner network are relatively conserved in eukaryotes, and it exhibits extraordinary structural similarity across species. However, despite this structural similarity, the PCNA of a given species is rarely functional in heterologous systems. In this report, we determined the X-ray crystal structure of Neurospora crassa PCNA (NcPCNA) and compared its structure-function relationship with other available PCNA studies to understand this cross-species incompatibility. We found two regions, the interdomain connecting loop (IDCL) and J loop structures, vary significantly among PCNAs. In particular, the J loop deviates in NcPCNA from that in Saccharomyces cerevisiae PCNA (ScPCNA) by 7 A. Differences in the IDCL structures result in varied binding affinities of PCNAs for the subunit Pol32 of DNA polymerase delta and for T2-amino alcohol, a small-molecule inhibitor of human PCNA. To validate that these structural differences are accountable for functional incompatibility in S. cerevisiae, we generated NcPCNA mutants mimicking IDCL and J loop structures of ScPCNA. Our genetic analyses suggested that NcPCNA mutants are fully functional in S. cerevisiae. The susceptibility of the strains harboring ScPCNA mimics of NcPCNA to various genotoxic agents was similar to that in yeast cells expressing ScPCNA. Taken together, we conclude that in addition to the overall architecture of PCNA, structures of the IDCL and J loop of PCNA are critical determinants of interspecies functional compatibility.	[Kumari, Premlata; Manohar, Kodavati; Acharya, Narottam] Inst Life Sci, Lab Genom Instabil & Dis, Dept Infect Dis Biol, Bhubaneswar, India; [Kumari, Premlata] Reg Ctr Biotechnol, Faridabad, India; [Sundaram, Rajivgandhi; Vasudevan, Dileep] Inst Life Sci, Dept Infect Dis Biol, Lab Macromol Crystallog, Bhubaneswar, India; [Sundaram, Rajivgandhi] Manipal Acad Higher Educ, Manipal, India; [Manohar, Kodavati] Houston Methodist Res Inst, Ctr Neuroregenerat, Dept Neurosurg, Houston, TX 77030 USA	Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Department of Biotechnology (DBT) India; Regional Centre for Biotechnology; Department of Biotechnology (DBT) India; Institute of Life Sciences India (ILS); Manipal Academy of Higher Education (MAHE); The Methodist Hospital System; The Methodist Hospital - Houston	Acharya, N (corresponding author), Inst Life Sci, Lab Genom Instabil & Dis, Dept Infect Dis Biol, Bhubaneswar, India.; Vasudevan, D (corresponding author), Inst Life Sci, Dept Infect Dis Biol, Lab Macromol Crystallog, Bhubaneswar, India.	dileepvasudevan@gmail.com; narottam_acharya@ils.res.in	KUMARI, PREMLATA/HHS-0881-2022; kodavati, manohar/V-5200-2019; sundaram, Rajivgandhi/GOK-2864-2022	kodavati, manohar/0000-0003-3939-7351; sundaram, Rajivgandhi/0000-0001-5424-1908; Acharya, Narottam/0000-0001-8858-5418; Vasudevan, Dileep/0000-0001-5568-628X	Department of Biotechnology, Government of India; Institute of Life Sciences; DBT; SERB	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Institute of Life Sciences; DBT(Department of Biotechnology (DBT) India); SERB(Department of Science & Technology (India)Science Engineering Research Board (SERB), India)	The research fellowship from the Department of Biotechnology, Government of India, to R. S. and the intramural and extramural supports from the Institute of Life Sciences, DBT, and SERB at different times of the study to D. V. and N. A. are greatly acknowledged.	Acharya N, 2005, MOL CELL BIOL, V25, P9734, DOI 10.1128/MCB.25.21.9734-9740.2005; Acharya N, 2002, J MOL BIOL, V321, P579, DOI 10.1016/S0022-2836(02)00654-X; Acharya N, 2007, MOL CELL BIOL, V27, P7266, DOI 10.1128/MCB.01196-07; Acharya N, 2020, BIOCHEM SOC T, V48, P2811, DOI 10.1042/BST20200678; Acharya N, 2020, CURR GENET, V66, P635, DOI 10.1007/s00294-020-01071-1; Acharya N, 2019, CURR GENET, V65, P649, DOI 10.1007/s00294-018-0918-5; Acharya N, 2011, P NATL ACAD SCI USA, V108, P17927, DOI 10.1073/pnas.1109981108; Acharya N, 2009, P NATL ACAD SCI USA, V106, P9631, DOI 10.1073/pnas.0902175106; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arroyo MP, 1996, J BIOL CHEM, V271, P15971, DOI 10.1074/jbc.271.27.15971; AYYAGARI R, 1995, MOL CELL BIOL, V15, P4420; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Dieckman LM, 2013, DNA REPAIR, V12, P367, DOI 10.1016/j.dnarep.2013.02.007; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Freudenthal BD, 2008, BIOCHEMISTRY-US, V47, P13354, DOI 10.1021/bi8017762; Gibbs E, 1997, J BIOL CHEM, V272, P2373; Gohain D, 2019, MOL MICROBIOL, V111, P1510, DOI 10.1111/mmi.14234; Gonzalez-Magana A, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040570; Johnson RE, 2006, METHOD ENZYMOL, V408, P390, DOI 10.1016/S0076-6879(06)08024-4; Khandagale P, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200602; Khandagale P, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900323; KRISHNA TSR, 1994, CELL, V79, P1233, DOI 10.1016/0092-8674(94)90014-0; KRISHNA TSR, 1994, J MOL BIOL, V241, P265, DOI 10.1006/jmbi.1994.1495; Kumar A, 2016, J SYNCHROTRON RADIAT, V23, P629, DOI 10.1107/S160057751600076X; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Manohar K, 2018, MOL MICROBIOL, V110, P707, DOI 10.1111/mmi.14004; Manohar K, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0582-6; Marshall AC, 2017, FEBS J, V284, P985, DOI 10.1111/febs.14035; NG L, 1990, J BIOL CHEM, V265, P11948; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Sundaram R, 2021, FEBS LETT, V595, P1328, DOI 10.1002/1873-3468.14055; Unni S, 2011, J COMPUT CHEM, V32, P1488, DOI 10.1002/jcc.21720; Zamir L, 2012, P NATL ACAD SCI USA, V109, pE406, DOI 10.1073/pnas.1108633109	35	4	4	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100911	10.1016/j.jbc.2021.100911	http://dx.doi.org/10.1016/j.jbc.2021.100911			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34175309	Green Published, gold			2022-12-28	WOS:000678068400096
J	Nie, YY; Li, YX; Liu, L; Ren, SY; Tian, YH; Yang, F				Nie, Yingying; Li, Yanxin; Liu, Lei; Ren, Shouyan; Tian, Yuhua; Yang, Fan			Molecular mechanism underlying modulation of TRPV1 heat activation by polyols	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPSAICIN-RECEPTOR; ION-CHANNEL; THERMAL-STABILITY; PORE TURRET; TEMPERATURE; THERMOSENSATION; FRAMEWORK; RESPONSES; SOLUTES; DOMAIN	Sensing noxiously high temperatures is crucial for living organisms to avoid heat-induced injury. The TRPV1 channel has long been known as a sensor for noxious heat. However, the mechanism of how this channel is activated by heat remains elusive. Here we found that a series of polyols including sucrose, sorbitol, and hyaluronan significantly elevate the heat activation threshold temperature of TRPV1. The modulatory effects of these polyols were only observed when they were perfused extracellularly. Interestingly, mutation of residues E601 and E649 in the outer pore region of TRPV1 largely abolished the effects of these polyols. We further observed that intraplantar injection of polyols into the hind paws of rats reduced their heat-induced pain response. Our observations not only suggest that the extracellular regions of TRPV1 are critical for the modulation of heat activation by polyols, but also indicate a potential role of polyols in reducing heat-induced pain sensation.	[Nie, Yingying; Li, Yanxin; Liu, Lei; Tian, Yuhua] Qingdao Univ, Sch Pharm, Dept Pharmacol, Med Coll, Qingdao, Peoples R China; [Ren, Shouyan] Qingdao Univ, Dept Otorhinolaryngol, Affiliated Hosp, Qingdao, Shandong, Peoples R China; [Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China; [Yang, Fan] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China	Qingdao University; Qingdao University; Zhejiang University; Zhejiang University	Tian, YH (corresponding author), Qingdao Univ, Sch Pharm, Dept Pharmacol, Med Coll, Qingdao, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Biophys, Hangzhou, Zhejiang, Peoples R China.; Yang, F (corresponding author), Zhejiang Univ, Affiliated Hosp 1, Sch Med, Kidney Dis Ctr, Hangzhou, Zhejiang, Peoples R China.	yhtian05250@qdu.edu.cn; fanyanga@zju.edu.cn	Yang, Fan/AAA-6904-2022	Yang, Fan/0000-0002-0520-5254; Tian, Yuhua/0000-0001-8239-6560	National Natural Science Foundation of China [31971040, 31800990]; Zhejiang Provincial Natural Science Foundation of China [LR20C050002]; Natural Science Foundation of Shandong Province [ZR2020MH161]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	This study was supported by National Natural Science Foundation of China (31971040 and 31800990 to F. Y.), Zhejiang Provincial Natural Science Foundation of China (LR20C050002 to F. Y.), and Natural Science Foundation of Shandong Province (ZR2020MH161 to Y. T.).	Ahern GP, 2005, J NEUROSCI, V25, P5109, DOI 10.1523/JNEUROSCI.0237-05.2005; Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; BACK JF, 1979, BIOCHEMISTRY-US, V18, P5191, DOI 10.1021/bi00590a025; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Caires R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9095; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Cao X, 2014, J GEN PHYSIOL, V143, P75, DOI 10.1085/jgp.201311025; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chowdhury S, 2014, CELL, V158, P1148, DOI 10.1016/j.cell.2014.07.026; Clapham DE, 2011, P NATL ACAD SCI USA, V108, P19492, DOI 10.1073/pnas.1117485108; Clapham DE, 2003, NATURE, V426, P517, DOI 10.1038/nature02196; Cui YY, 2012, J GEN PHYSIOL, V139, P273, DOI 10.1085/jgp.201110724; Davis-Searles PR, 2001, ANNU REV BIOPH BIOM, V30, P271, DOI 10.1146/annurev.biophys.30.1.271; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Du GX, 2020, J BIOL CHEM, V295, P9641, DOI 10.1074/jbc.RA120.013037; Feng Q, 2014, CURR TOP MEMBR, V74, P19, DOI 10.1016/B978-0-12-800181-3.00002-6; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Grandl J, 2010, NAT NEUROSCI, V13, P708, DOI 10.1038/nn.2552; Jara-Oseguera A, 2016, ELIFE, V5, DOI 10.7554/eLife.13356; Jordt SE, 2000, P NATL ACAD SCI USA, V97, P8134, DOI 10.1073/pnas.100129497; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; Lee SL, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1917745; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Liao YH, 2002, PHARM RES-DORDR, V19, P1847, DOI 10.1023/A:1021445608807; Liu FF, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3453713; Nolden AA, 2019, PHYSIOL BEHAV, V208, DOI 10.1016/j.physbeh.2019.05.018; O'Connor TF, 2004, J AM CHEM SOC, V126, P11794, DOI 10.1021/ja0481777; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Pozo MA, 1997, EXP BRAIN RES, V116, P3, DOI 10.1007/PL00005742; Trevisani M, 2002, NAT NEUROSCI, V5, P546, DOI 10.1038/nn852; Vay L, 2012, BRIT J PHARMACOL, V165, P787, DOI 10.1111/j.1476-5381.2011.01601.x; Vlachova V, 2003, J NEUROSCI, V23, P1340, DOI 10.1523/JNEUROSCI.23-04-01340.2003; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Vriens J, 2014, NAT REV NEUROSCI, V15, P573, DOI 10.1038/nrn3784; Vriens J, 2011, NEURON, V70, P482, DOI 10.1016/j.neuron.2011.02.051; Vyklicky L, 1999, J PHYSIOL-LONDON, V517, P181, DOI 10.1111/j.1469-7793.1999.0181z.x; Welch JM, 2000, P NATL ACAD SCI USA, V97, P13889, DOI 10.1073/pnas.230146497; Xu LZ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17582-x; Yang F, 2020, ADV SCI, V7, DOI 10.1002/advs.202000575; Yang F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05339-6; Yang F, 2015, NAT CHEM BIOL, V11, P518, DOI [10.1038/NCHEMBIO.1835, 10.1038/nchembio.1835]; Yang F, 2014, J GEN PHYSIOL, V143, P91, DOI 10.1085/jgp.201311024; Yang F, 2010, P NATL ACAD SCI USA, V107, P7083, DOI 10.1073/pnas.1000357107; Yang S., 2020, P NATL ACAD SCI USA, V117, P22714; Yang SL, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1700810; Yang SL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9297; Yao J, 2011, P NATL ACAD SCI USA, V108, P11109, DOI 10.1073/pnas.1105196108; Zhu AQ, 2020, TOXICON, V178, P41, DOI 10.1016/j.toxicon.2020.02.016	51	3	3	5	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100806	10.1016/j.jbc.2021.100806	http://dx.doi.org/10.1016/j.jbc.2021.100806			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022223	gold, Green Published			2022-12-28	WOS:000678068400011
J	Moller, MS; El Bouaballati, S; Henrissat, B; Svensson, B				Moller, Marie Sofie; El Bouaballati, Souad; Henrissat, Bernard; Svensson, Birte			Functional diversity of three tandem C-terminal carbohydrate-binding modules of a beta-mannanase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENS SUBSP CELLULOSA; STRUCTURAL-CHARACTERIZATION; PSEUDOMONAS XYLANASE; BETA-1,4-MANNANASE; SEQUENCE; CLONING; DOMAIN; DEGRADATION; STABILITY; BACTERIUM	Carbohydrate active enzymes, such as those involved in plant cell wall and storage polysaccharide biosynthesis and deconstruction, often contain repeating noncatalytic carbohydrate-binding modules (CBMs) to compensate for low-affinity binding typical of protein-carbohydrate interactions. The bacterium Saccharophagus degradans produces an endo-beta-mannanase of glycoside hydrolase family 5 subfamily 8 with three phylogenetically distinct family 10 CBMs located C-terminally from the catalytic domain (SdGH5_8-CBM10x3). However, the functional roles and cooperativity of these CBM domains in polysaccharide binding are not clear. To learn more, we studied the full-length enzyme, three stepwise CBM family 10 (CBM10) truncations, and GFP fusions of the individual CBM10s and all three domains together by pull-down assays, affinity gel electrophoresis, and activity assays. Only the C-terminal CBM10-3 was found to bind strongly to microcrystalline cellulose (dissociation constant, K-d = 1.48 mu M). CBM10-3 and CBM10-2 bound galactomannan with similar affinity (K-d = 0.2-0.4 mg/ml), but CBM10-1 had 20-fold lower affinity for this substrate. CBM10 truncations barely affected specific activity on carob galactomannan and konjac glucomannan. Full-length SdGH5_8-CBM10x3 was twofold more active on the highly galactose-decorated viscous guar gum galactomannan and crystalline ivory nut mannan at high enzyme concentrations, but the specific activity was fourfold to ninefold reduced at low enzyme and substrate concentrations compared with the enzyme lacking CBM10-2 and CBM10-3. Comparison of activity and binding data for the different enzyme forms indicates unproductive and productive polysaccharide binding to occur. We conclude that the C-terminal most CBM10-3 secures firm binding, with contribution from CBM10-2, which with CBM10-1 also provides spatial flexibility.	[Moller, Marie Sofie; El Bouaballati, Souad; Svensson, Birte] Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark; [Henrissat, Bernard] Aix Marseille Univ, CNRS, Architecture & Fonct Macromol Biol, Marseille, France; [Henrissat, Bernard] King Abdulaziz Univ, Dept Biol Sci, Jeddah, Saudi Arabia	Technical University of Denmark; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; King Abdulaziz University	Moller, MS (corresponding author), Tech Univ Denmark, Dept Biotechnol & Biomed, Lyngby, Denmark.	msmo@dtu.dk	Møller, Marie Sofie/GRE-9135-2022; Henrissat, Bernard/J-2475-2012	Henrissat, Bernard/0000-0002-3434-8588; Svensson, Birte/0000-0002-2993-8196; Moller, Marie Sofie/0000-0001-9017-3367	Independent Research Fund Denmark|Natural Sciences (FNU) [6108-00476B]	Independent Research Fund Denmark|Natural Sciences (FNU)	We thank Karina Jansen (Technical University of Denmark) for technical assistance. We also thank Prof Jens Preben Morth (Technical University of Denmark) for introduction to the JASCO FP-8500 Fluorescence Spectrometer. This work was supported by Independent Research Fund Denmark|Natural Sciences (FNU) by a grant to the project "Roles and structural determinants of low-affinity carbohydrate-protein interactions" (grant no. 6108-00476B).	ARCAND N, 1993, BIOCHEM J, V290, P857, DOI 10.1042/bj2900857; Attia M, 2016, FEBS J, V283, P1701, DOI 10.1111/febs.13696; Blake AW, 2006, J BIOL CHEM, V281, P29321, DOI 10.1074/jbc.M605903200; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Cockburn D., 2017, METHONDS MOL BIOL 15, V1; Conway JM, 2018, AICHE J, V64, P4218, DOI 10.1002/aic.16354; Crouch LI, 2016, J BIOL CHEM, V291, P7439, DOI 10.1074/jbc.M115.702365; DEY PM, 1978, ADV CARBOHYD CHEM BI, V35, P341; Dilokpimol A, 2011, BBA-PROTEINS PROTEOM, V1814, P1720, DOI 10.1016/j.bbapap.2011.08.003; Duan CJ, 2017, APPL MICROBIOL BIOT, V101, P5723, DOI 10.1007/s00253-017-8320-7; Ebringerova A, 2006, MACROMOL SYMP, V232, P1, DOI 10.1002/masy.200551401; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekborg NA, 2007, APPL ENVIRON MICROB, V73, P7785, DOI 10.1128/AEM.00876-07; FERREIRA LMA, 1991, BIOCHEM J, V279, P793, DOI 10.1042/bj2790793; Gardner JG, 2014, MOL MICROBIOL, V94, P1121, DOI 10.1111/mmi.12821; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GILBERT HJ, 1990, MOL MICROBIOL, V4, P759, DOI 10.1111/j.1365-2958.1990.tb00646.x; Gill J, 1999, BIOCHEM J, V342, P473, DOI 10.1042/0264-6021:3420473; HALL J, 1995, BIOCHEM J, V309, P749, DOI 10.1042/bj3090749; Herve C, 2010, P NATL ACAD SCI USA, V107, P15293, DOI 10.1073/pnas.1005732107; Heux L, 2005, BIOMACROMOLECULES, V6, P324, DOI 10.1021/bm0495349; Hogg D, 2003, BIOCHEM J, V371, P1027, DOI 10.1042/BJ20021860; Hori R, 2007, CARBOHYD POLYM, V70, P298, DOI 10.1016/j.carbpol.2007.04.011; Huson DH, 2012, SYST BIOL, V61, P1061, DOI 10.1093/sysbio/sys062; Hutcheson SW, 2011, MAR DRUGS, V9, P645, DOI 10.3390/md9040645; Jin Y, 2016, ACS CENTRAL SCI, V2, P896, DOI 10.1021/acscentsci.6b00232; Kari J, 2018, ACS CATAL, V8, P11966, DOI 10.1021/acscatal.8b03547; Kari J, 2017, ACS CATAL, V7, P4904, DOI 10.1021/acscatal.7b00838; Kim DY, 2011, BIORESOURCE TECHNOL, V102, P9185, DOI 10.1016/j.biortech.2011.06.073; Krska D, 2020, BIOTECHNOL BIOFUELS, V13, DOI 10.1186/s13068-020-01709-9; Ktunagai Y, 2013, BIOCHEM BIOPH RES CO, V301, P307; Liu HX, 2015, PROCESS BIOCHEM, V50, P712, DOI 10.1016/j.procbio.2015.02.011; Lombard V, 2014, NUCLEIC ACIDS RES, V42, pD490, DOI 10.1093/nar/gkt1178; Low KE, 2021, GLYCOBIOLOGY, V31, P681, DOI 10.1093/glycob/cwaa050; MCCLEARY BV, 1985, CARBOHYD RES, V139, P237; MILLWARDSADLER SJ, 1995, BIOCHEM J, V312, P39, DOI 10.1042/bj3120039; Morrill J, 2018, APPL MICROBIOL BIOT, V102, P5149, DOI 10.1007/s00253-018-8997-2; Morrill J, 2015, BMC BIOCHEM, V16, DOI 10.1186/s12858-015-0055-4; O'Connor RM, 2014, P NATL ACAD SCI USA, V111, pE5096, DOI 10.1073/pnas.1413110111; Park SR, 2002, BIOCHEM BIOPH RES CO, V291, P425, DOI 10.1006/bbrc.2002.6437; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pires VMR, 2017, J BIOL CHEM, V292, P4847, DOI 10.1074/jbc.M116.767541; Ponyi T, 2000, BIOCHEMISTRY-US, V39, P985, DOI 10.1021/bi9921642; Raghothama S, 2000, BIOCHEMISTRY-US, V39, P978, DOI 10.1021/bi992163+; Sakai K, 2018, J BIOSCI BIOENG, V125, P287, DOI 10.1016/j.jbiosc.2017.10.009; Shi PJ, 2011, J IND MICROBIOL BIOT, V38, P451, DOI 10.1007/s10295-010-0789-3; TAKEO K, 1972, ARCH BIOCHEM BIOPHYS, V153, P1, DOI 10.1016/0003-9861(72)90413-4; Tamaru Y, 1997, J FERMENT BIOENG, V83, P201, DOI 10.1016/S0922-338X(97)83584-2; Von Ereiesleben P., 2018, BIOTECHNOL BIOFUELS, V11, P194; Wang YJ, 2009, BIORESOURCE TECHNOL, V100, P345, DOI 10.1016/j.biortech.2008.06.001; Watson BJ, 2009, J BACTERIOL, V191, P5697, DOI 10.1128/JB.00481-09; Wei XY, 2020, FOOD CHEM, V329, DOI 10.1016/j.foodchem.2020.127179; Xu CL, 2010, CARBOHYD RES, V345, P810, DOI 10.1016/j.carres.2010.01.007; Zhao D, 2020, INT J BIOL MACROMOL, V154, P826, DOI 10.1016/j.ijbiomac.2020.03.157; Zimmermann L, 2018, J MOL BIOL, V430, P2237, DOI 10.1016/j.jmb.2017.12.007	55	2	2	3	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100638	10.1016/j.jbc.2021.100638	http://dx.doi.org/10.1016/j.jbc.2021.100638			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33838183	Green Published, gold			2022-12-28	WOS:000672866400609
J	Richardson, JS; Richardson, DC; Goodsell, DS				Richardson, Jane S.; Richardson, David C.; Goodsell, David S.			Seeing the PDB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							VIBRIO-VULNIFICUS; RTX TOXIN; RHO-GTPASES; ACTIVATION; INACTIVATION; EXPRESSION; INFECTION; VIRULENCE; INSIGHTS; DOMAIN	Ever since the first structures of proteins were determined in the 1960s, structural biologists have required methods to visualize biomolecular structures, both as an essential tool for their research and also to promote 3D comprehension of structural results by a wide audience of researchers, students, and the general public. In this review to celebrate the 50th anniversary of the Protein Data Bank, we present our own experiences in developing and applying methods of visualization and analysis to the ever-expanding archive of protein and nucleic acid structures in the worldwide Protein Data Bank. Across that timespan, Jane and David Richardson have concentrated on the organization inside and between the macromolecules, with ribbons to show the overall backbone "fold" and contact dots to show how the all-atom details fit together locally. David Goodsell has explored surface-based representations to present and explore biological subjects that range from molecules to cells. This review concludes with some ideas about the current challenges being addressed by the field of biomolecular visualization.	[Richardson, Jane S.; Richardson, David C.] Duke Univ, Dept Biochem, Durham, NC 27708 USA; [Goodsell, David S.] Scripps Res Inst, Dept Integrat & Computat Biol, La Jolla, CA 92037 USA; [Goodsell, David S.] Rutgers State Univ, Res Collaboratory Struct Bioinformat Prot Data Ba, Piscataway, NJ 08901 USA	Duke University; Scripps Research Institute; Rutgers State University New Brunswick	Richardson, JS (corresponding author), Duke Univ, Dept Biochem, Durham, NC 27708 USA.; Goodsell, DS (corresponding author), Scripps Res Inst, Dept Integrat & Computat Biol, La Jolla, CA 92037 USA.; Goodsell, DS (corresponding author), Rutgers State Univ, Res Collaboratory Struct Bioinformat Prot Data Ba, Piscataway, NJ 08901 USA.	jsr@kinemage.biochem.duke.edu; goodsell@scripps.edu	; Richardson, Jane/E-2660-2016	Richardson, David/0000-0001-5069-343X; Richardson, Jane/0000-0002-3311-2944				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarwal S, 2015, CELL MICROBIOL, V17, P1494, DOI 10.1111/cmi.12451; Agarwal S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9745; Ahrens S, 2013, J BIOL CHEM, V288, P1397, DOI 10.1074/jbc.M112.396309; Baker-Austin C, 2018, ENVIRON MICROBIOL, V20, P423, DOI 10.1111/1462-2920.13955; Baker-Austin C, 2017, TRENDS MICROBIOL, V25, P76, DOI 10.1016/j.tim.2016.09.008; BIOSCA EG, 1993, INFECT IMMUN, V61, P1611, DOI 10.1128/IAI.61.5.1611-1618.1993; Bisharat N, 1996, LANCET, V348, P1585, DOI 10.1016/S0140-6736(05)66199-5; Diard M, 2017, FEMS MICROBIOL REV, V41, P679, DOI 10.1093/femsre/fux023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froelich BA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0209; Froelich BA, 2014, APPL ENVIRON MICROB, V80, P7454, DOI 10.1128/AEM.02042-14; Gavin HE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006119; Hernandez-Cabanyero C, 2020, ENVIRON MICROBIOL, V22, P4133, DOI 10.1111/1462-2920.15137; Hori M., 2017, JMM CASE REP, V4; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kim BS, 2020, TOXINS, V12, DOI 10.3390/toxins12090544; Kim BS, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00659-20; Kim BS, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00272-17; Kim BS, 2016, CELL MICROBIOL, V18, P1078, DOI 10.1111/cmi.12568; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; King M, 2019, ANN INTERN MED, V171, P520, DOI 10.7326/L19-0133; Koton Y, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00803; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kwon SY, 2005, PLASMID, V53, P274, DOI 10.1016/j.plasmid.2004.11.006; Lee Y, 2019, P NATL ACAD SCI USA, V116, P18031, DOI 10.1073/pnas.1905095116; Lo HR, 2011, J INFECT DIS, V203, P1866, DOI 10.1093/infdis/jir070; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Mikonranta L, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0447-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Raz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114576; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Vezzulli L, 2016, P NATL ACAD SCI USA, V113, pE5062, DOI 10.1073/pnas.1609157113; Woida PJ, 2018, MOL MICROBIOL, V107, P133, DOI 10.1111/mmi.13875; Zaidenstein R, 2008, EMERG INFECT DIS, V14, P1875, DOI 10.3201/eid1412.080499; Zhou Y, 2017, SCIENCE, V358, P528, DOI 10.1126/science.aam8659; Ziolo KJ, 2014, INFECT IMMUN, V82, P2148, DOI 10.1128/IAI.00017-14	45	10	10	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100742	10.1016/j.jbc.2021.100742	http://dx.doi.org/10.1016/j.jbc.2021.100742			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957126	Green Published, gold			2022-12-28	WOS:000672866400711
J	Ficko-Blean, E				Ficko-Blean, Elizabeth			A fresh trim provides a new look at the human mannose receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							CARBOHYDRATE-RECOGNITION; BINDING; DOMAIN	The human mannose receptor plays an important role in scavenging a variety of glycans and glycoconjugates, which contributes to both innate and adaptive immunity. However, the fine details of its ligand specificity, and specifically that of carbohydrate-recognition domain 4, the most functionally relevant C-type lectin domain within the receptor, are not completely understood. Feinberg et al. use glycan arrays, crystallography, and a newly trimmed version of carbohydrate-recognition domain 4 to elucidate the molecular mechanisms driving binding specificity. These data contribute to our molecular understanding of Ca2+-mediated binding promiscuity in the human mannose receptor and the scavenging role of the receptor itself and highlight unexpected interactions that should inspire further study.	[Ficko-Blean, Elizabeth] CNRS, Stn Biol Roscoff, Lab Integrat Biol Marine Models LBI2M, Roscoff, France; [Ficko-Blean, Elizabeth] Sorbonne Univ, Roscoff, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Sorbonne Universite	Ficko-Blean, E (corresponding author), CNRS, Stn Biol Roscoff, Lab Integrat Biol Marine Models LBI2M, Roscoff, France.; Ficko-Blean, E (corresponding author), Sorbonne Univ, Roscoff, France.	efickoblean@sb-roscoff.fr		Ficko-Blean, Elizabeth/0000-0002-3915-4715				Feinberg H, 2000, J BIOL CHEM, V275, P21539, DOI 10.1074/jbc.M002366200; Feinberg H., 2021, J BIOL CHEM, V296; Hu ZZ, 2019, J STRUCT BIOL, V208, DOI 10.1016/j.jsb.2019.09.001; Hu ZZ, 2018, STRUCTURE, V26, P60, DOI 10.1016/j.str.2017.11.006; Liu Y, 2001, J MOL BIOL, V305, P481, DOI 10.1006/jmbi.2000.4326; Napper CE, 2006, BIOCHEM J, V395, P579, DOI 10.1042/BJ20052027; Napper CE, 2001, J BIOL CHEM, V276, P14759, DOI 10.1074/jbc.M100425200; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; TAYLOR ME, 1992, J BIOL CHEM, V267, P1719; TAYLOR ME, 1993, J BIOL CHEM, V268, P399	10	0	0	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100922	10.1016/j.jbc.2021.100922	http://dx.doi.org/10.1016/j.jbc.2021.100922			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34181947	Green Published, gold			2022-12-28	WOS:000678068400097
J	Kearns, S; Mason, FM; Rathmell, WK; Park, IY; Walker, C; Verhey, KJ; Cianfrocco, MA				Kearns, Sarah; Mason, Frank M.; Rathmell, W. Kimryn; Park, In Young; Walker, Cheryl; Verhey, Kristen J.; Cianfrocco, Michael A.			Molecular determinants for alpha-tubulin methylation by SETD2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE H3K36 METHYLATION; C-TERMINAL DOMAIN; SRI DOMAIN; ACETYLATION; MUTATIONS; REVEALS; DETYROSINATION; IDENTIFICATION; RECOGNITION; HYPB/SETD2	Post-translational modifications to tubulin are important for many microtubule-based functions inside cells. It was recently shown that methylation of tubulin by the histone methyltransferase SETD2 occurs on mitotic spindle microtubules during cell division, with its absence resulting in mitotic defects. However, the catalytic mechanism of methyl addition to tubulin is unclear. We used a truncated version of human wild type SETD2 (tSETD2) containing the catalytic SET and C-terminal Set2-Rpb1-interacting (SRI) domains to investigate the biochemical mechanism of tubulin methylation. We found that recombinant tSETD2 had a higher activity toward tubulin dimers than polymerized microtubules. Using recombinant single-isotype tubulin, we demonstrated that methylation was restricted to lysine 40 of alpha-tubulin. We then introduced pathogenic mutations into tSETD2 to probe the recognition of histone and tubulin substrates. A mutation in the catalytic domain (R1625C) allowed tSETD2 to bind to tubulin but not methylate it, whereas a mutation in the SRI domain (R2510H) caused loss of both tubulin binding and methylation. Further investigation of the role of the SRI domain in substrate binding found that mutations within this region had differential effects on the ability of tSETD2 to bind to tubulin versus the binding partner RNA polymerase II for methylating histones in vivo, suggesting distinct mechanisms for tubulin and histone methylation by SETD2. Finally, we found that substrate recognition also requires the negatively charged C-terminal tail of alpha-tubulin. Together, this study provides a framework for understanding how SETD2 serves as a dual methyltransferase for both histone and tubulin methylation.	[Kearns, Sarah] Univ Michigan, Program Chem Biol, Ann Arbor, MI USA; [Kearns, Sarah; Cianfrocco, Michael A.] Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA; [Mason, Frank M.; Rathmell, W. Kimryn] Vanderbilt Univ, Dept Med, Div Hematol & Oncol, Med Ctr, Nashville, TN USA; [Mason, Frank M.; Rathmell, W. Kimryn] Vanderbilt Univ, Dept Genet, Nashville, TN USA; [Park, In Young; Walker, Cheryl] Baylor Coll Med, Ctr Precis Environm Hlth, Houston, TX USA; [Verhey, Kristen J.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI USA; [Cianfrocco, Michael A.] Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Vanderbilt University; Vanderbilt University; Baylor College of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Cianfrocco, MA (corresponding author), Univ Michigan, Life Sci Inst, Ann Arbor, MI 48109 USA.; Cianfrocco, MA (corresponding author), Univ Michigan, Dept Biol Chem, Ann Arbor, MI 48109 USA.	mcianfro@umich.edu			NIH [P200A150164, 5T32GM008597-22, R01GM070862, R35GM131744]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S. K. is funded by Graduate Assistance in Areas of National Need (P200A150164) and the Chemical Biology Interface Training Grant from the NIH (5T32GM008597-22). This work was supported by NIH Grants R01GM070862 and R35GM131744 to K. J. V. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Barisic M, 2015, SCIENCE, V348, P799, DOI 10.1126/science.aaa5175; Boggs AE, 2015, CANCER RES, V75, P203, DOI 10.1158/0008-5472.CAN-13-3563; Cermakova K, 2019, BIORXIV; Chen K, 2017, CELL, V170, P492, DOI 10.1016/j.cell.2017.06.042; Chiang YC, 2018, CANCER RES, V78, P3135, DOI 10.1158/0008-5472.CAN-17-3460; Chin HG, 2020, J BIOL CHEM, V295, P4748, DOI 10.1074/jbc.RA119.010951; Coombes C, 2016, P NATL ACAD SCI USA, V113, pE7176, DOI 10.1073/pnas.1605397113; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Davenport AM, 2014, J MOL BIOL, V426, P2605, DOI 10.1016/j.jmb.2014.05.009; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Eram MS, 2015, BBA-GEN SUBJECTS, V1850, P1842, DOI 10.1016/j.bbagen.2015.05.013; Eshun-Wilson L, 2019, P NATL ACAD SCI USA, V116, P10366, DOI 10.1073/pnas.1900441116; Ferreira LT, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201910064; Fontebasso AM, 2013, ACTA NEUROPATHOL, V125, P659, DOI 10.1007/s00401-013-1095-8; Gadadhar S, 2017, J CELL SCI, V130, P1347, DOI 10.1242/jcs.199471; Garnham CP, 2015, CELL, V161, P1112, DOI 10.1016/j.cell.2015.04.003; Hacker KE, 2016, J BIOL CHEM, V291, P21283, DOI 10.1074/jbc.M116.739375; Hakimi AA, 2013, EUR UROL, V63, P848, DOI 10.1016/j.eururo.2012.09.005; Ho TH, 2014, J CLIN ONCOL, V32, DOI 10.1200/jco.2014.32.15_suppl.4583; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; JORDAN MA, 1992, J CELL SCI, V102, P401; Kanu N, 2015, ONCOGENE, V34, P5699, DOI 10.1038/onc.2015.24; Kim IK, 2019, ONCOGENE, V38, P180, DOI 10.1038/s41388-018-0429-3; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kormendi V, 2012, J BIOL CHEM, V287, P41569, DOI 10.1074/jbc.C112.421222; Le V. H, 2018, WORLD J UROL, V36, P1899; Leandro-Garcia LJ, 2010, CYTOSKELETON, V67, P214, DOI 10.1002/cm.20436; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P5720, DOI 10.1073/pnas.84.16.5720; Lee CC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-35392-6; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Li CL, 2020, J CELL BIOCHEM, V121, P797, DOI 10.1002/jcb.29325; Li CL, 2019, J CELL PHYSIOL, V234, P661, DOI 10.1002/jcp.26836; Li FX, 2020, ELIFE, V9, DOI 10.7554/eLife.58157; Li FX, 2019, NAT STRUCT MOL BIOL, V26, P583, DOI 10.1038/s41594-019-0242-x; Li J, 2016, ONCOTARGET, V7, P50719, DOI 10.18632/oncotarget.9368; Li L, 2015, CELL MOL LIFE SCI, V72, P4237, DOI 10.1007/s00018-015-2000-5; Li M, 2005, P NATL ACAD SCI USA, V102, P17636, DOI 10.1073/pnas.0506350102; Liao SH, 2019, CELL RES, V29, P533, DOI 10.1038/s41422-019-0187-y; Liu L, 2017, BIOSCI TRENDS, V11, P214, DOI 10.5582/bst.2016.01228; Liu WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002004; Liu X, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0133-7; Ly N., 2016, SCI REP-UK, V6, P1; Mar BG, 2017, BLOOD, V130, P2631, DOI 10.1182/blood-2017-03-775569; Ojima I, 1999, P NATL ACAD SCI USA, V96, P4256, DOI 10.1073/pnas.96.8.4256; Park IY, 2016, CELL, V166, P950, DOI 10.1016/j.cell.2016.07.005; Peris L, 2009, J CELL BIOL, V185, P1159, DOI 10.1083/jcb.200902142; Prota AE, 2013, J CELL BIOL, V200, P259, DOI 10.1083/jcb.201211017; Rebehmed J, 2014, FEBS LETT, V588, P4431, DOI 10.1016/j.febslet.2014.10.014; Roll-Mecak A, 2019, CURR OPIN CELL BIOL, V56, P102, DOI 10.1016/j.ceb.2018.10.009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seervai RNH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abb7854; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Soppina V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048204; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Szyk A, 2014, CELL, V157, P1405, DOI 10.1016/j.cell.2014.03.061; Szyk A, 2011, NAT STRUCT MOL BIOL, V18, P1250, DOI 10.1038/nsmb.2148; Ti SC., 2020, STAR PROTOC, V1; Ti SC, 2018, DEV CELL, V47, P175, DOI 10.1016/j.devcel.2018.08.014; Verhey KJ, 2007, CELL CYCLE, V6, P2152, DOI 10.4161/cc.6.17.4633; Vojnic E, 2006, J BIOL CHEM, V281, P13, DOI 10.1074/jbc.C500423200; Yoh SM, 2007, GENE DEV, V21, P160, DOI 10.1101/gad.1503107; Yu N, 2016, CURR BIOL, V26, P1728, DOI 10.1016/j.cub.2016.04.069; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193; Zheng WH, 2012, J AM CHEM SOC, V134, P18004, DOI 10.1021/ja307060p; Zhu XF, 2014, NAT GENET, V46, P287, DOI 10.1038/ng.2894	66	5	5	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100898	10.1016/j.jbc.2021.100898	http://dx.doi.org/10.1016/j.jbc.2021.100898			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157286	Green Submitted, Green Published, gold			2022-12-28	WOS:000678068400088
J	Prajapati, M; Conboy, HL; Hojyo, S; Fukada, T; Budnik, B; Bartnikas, TB				Prajapati, Milankumar; Conboy, Heather L.; Hojyo, Shintaro; Fukada, Toshiyuki; Budnik, Bogdan; Bartnikas, Thomas B.			Biliary excretion of excess iron in mice requires hepatocyte iron import by Slc39a14	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EFFLUX TRANSPORTER SLC30A10; TRANSFERRIN-BOUND IRON; RADIOACTIVE IRON; BILE; OVERLOAD; FERRITIN; LIVER; PLASMA; HYPOTHYROIDISM; DEFICIENCY	Iron is essential for erythropoiesis and other biological processes, but is toxic in excess. Dietary absorption of iron is a highly regulated process and is a major determinant of body iron levels. Iron excretion, however, is considered a passive, unregulated process, and the underlying pathways are unknown. Here we investigated the role of metal transporters SLC39A14 and SLC30A10 in biliary iron excretion. While SLC39A14 imports manganese into the liver and other organs under physiological conditions, it imports iron under conditions of iron excess. SLC30A10 exports manganese from hepatocytes into the bile. We hypothesized that biliary excretion of excess iron would be impaired by SLC39A14 and SLC30A10 deficiency. We therefore analyzed biliary iron excretion in Slc39a14-and Slc30a10-deficient mice raised on iron-sufficient and -rich diets. Bile was collected surgically from the mice, then analyzed with nonheme iron assays, mass spectrometry, ELISAs, and an electrophoretic assay for iron-loaded ferritin. Our results support a model in which biliary excretion of excess iron requires iron import into hepatocytes by SLC39A14, followed by iron export into the bile predominantly as ferritin, with iron export occurring independently of SLC30A10. To our knowledge, this is the first report of a molecular determinant of mammalian iron excretion and can serve as basis for future investigations into mechanisms of iron excretion and relevance to iron homeostasis.	[Prajapati, Milankumar; Conboy, Heather L.; Bartnikas, Thomas B.] Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA; [Hojyo, Shintaro] Hokkaido Univ, Grad Sch Med, Inst Genet Med, Div Mol Psychoimmunol, Sapporo, Hokkaido, Japan; [Fukada, Toshiyuki] Tokushima Bunri Univ, Fac Pharmaceut Sci, Dept Mol & Cellular Physiol, Tokushima, Japan; [Budnik, Bogdan] Harvard Univ, Fac Arts & Sci, Div Sci, Mass Spectrometry & Prote Resource Lab, Cambridge, MA 02138 USA; [Conboy, Heather L.] Akebia Therapeut, Cambridge, MA USA	Brown University; Hokkaido University; Tokushima Bunri University; Harvard University	Bartnikas, TB (corresponding author), Brown Univ, Dept Pathol & Lab Med, Providence, RI 02912 USA.	thomas_bartnikas@brown.edu	Budnik, Bogdan/AGG-8824-2022	Budnik, Bogdan/0000-0003-3622-2003; Prajapati, Milankumar/0000-0003-3399-3697	NIH [DK11049]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DK11049 (T. B. B.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anagianni S, 2019, CURR NEUROL NEUROSCI, V19, DOI 10.1007/s11910-019-0942-y; Arosio P, 2017, IUBMB LIFE, V69, P414, DOI 10.1002/iub.1621; Aydemir TB, 2020, AM J PHYSIOL-GASTR L, V318, pG673, DOI 10.1152/ajpgi.00301.2019; Aydemir TB, 2017, J NEUROSCI, V37, P5996, DOI 10.1523/JNEUROSCI.0285-17.2017; Boyer JL, 2013, COMPR PHYSIOL, V3, P1035, DOI 10.1002/cphy.c120027; BRADFORD WD, 1969, AM J PATHOL, V56, P201; BRISSOT P, 1994, AM J PHYSIOL, V267, pG135, DOI 10.1152/ajpgi.1994.267.1.G135; BRISSOT P, 1994, ADV EXP MED BIOL, V356, P277; Brissot P, 1997, HEPATOLOGY, V25, P1457, DOI 10.1002/hep.510250625; CHAM BE, 1985, ANAL BIOCHEM, V151, P561, DOI 10.1016/0003-2697(85)90220-9; CLETON MI, 1986, HEPATOLOGY, V6, P30, DOI 10.1002/hep.1840060107; Corradini E, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100896; Fini A, 1997, J INORG BIOCHEM, V68, P251, DOI 10.1016/S0162-0134(97)00093-7; Hahn PF, 1939, J EXP MED, V70, P443, DOI 10.1084/jem.70.5.443; Hawkins WB, 1944, J EXP MED, V80, P31, DOI 10.1084/jem.80.1.31; Hojyo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018059; HULTCRANTZ R, 1989, GASTROENTEROLOGY, V96, P1539, DOI 10.1016/0016-5085(89)90524-6; HULTCRANTZ R, 1982, LAB INVEST, V46, P383; Hutchens S, 2017, J BIOL CHEM, V292, P9760, DOI 10.1074/jbc.M117.783605; IANCU TC, 1985, J HEPATOL, V1, P261, DOI 10.1016/S0168-8278(85)80054-4; JACOBS A, 1970, GUT, V11, P732, DOI 10.1136/gut.11.9.732; Jenkitkasemwong S, 2018, P NATL ACAD SCI USA, V115, pE1769, DOI 10.1073/pnas.1720739115; Jenkitkasemwong S, 2015, CELL METAB, V22, P138, DOI 10.1016/j.cmet.2015.05.002; Jonker JW, 2002, P NATL ACAD SCI USA, V99, P15649, DOI 10.1073/pnas.202607599; Kall L, 2008, BIOINFORMATICS, V24, pI42, DOI 10.1093/bioinformatics/btn294; Katsarou A, 2020, MOL ASPECTS MED, V75, DOI 10.1016/j.mam.2020.100866; Knutson MD, 2017, J BIOL CHEM, V292, P12735, DOI 10.1074/jbc.R117.786632; LESAGE GD, 1986, J CLIN INVEST, V77, P90, DOI 10.1172/JCI112307; LEVY P, 1991, GASTROENTEROLOGY, V101, P1673, DOI 10.1016/0016-5085(91)90407-C; Liu CY, 2017, J BIOL CHEM, V292, P16605, DOI 10.1074/jbc.M117.804989; Mercadante CJ, 2019, J CLIN INVEST, V129, P5442, DOI 10.1172/JCI129710; Mercadante CJ, 2019, HAEMATOLOGICA, V104, P678, DOI 10.3324/haematol.2018.198382; REGOECZI E, 1994, HEPATOLOGY, V19, P1476, DOI 10.1002/hep.1840190624; REGOECZI E, 1995, HEPATOLOGY, V21, P1063, DOI 10.1016/0270-9139(95)90256-2; Santana-Codina N, 2018, PHARMACEUTICALS-BASE, V11, DOI 10.3390/ph11040114; Scheiber IF, 2019, J BIOL CHEM, V294, P9147, DOI 10.1074/jbc.RA119.008762; SCHUMANN K, 1986, RES EXP MED, V186, P215, DOI 10.1007/BF01852047; Taylor CA, 2019, J BIOL CHEM, V294, P1860, DOI 10.1074/jbc.RA118.005628; Vinchi F, 2014, GASTROENTEROLOGY, V146, P1325, DOI 10.1053/j.gastro.2014.01.053; Wang PC, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aaw6127; Winslow JWW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21093304; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xia ZD, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006892; Xin YJ, 2017, CELL DISCOV, V3, DOI 10.1038/celldisc.2017.25; YU SG, 1992, BIOL TRACE ELEM RES, V35, P73, DOI 10.1007/BF02786239; Yu YY, 2020, BLOOD, V136, P726, DOI 10.1182/blood.2019002907; ZUYDERHOUDT FMJ, 1985, BIOCHIM BIOPHYS ACTA, V838, P381, DOI 10.1016/0304-4165(85)90238-7	47	6	6	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100835	10.1016/j.jbc.2021.100835	http://dx.doi.org/10.1016/j.jbc.2021.100835			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34051234	gold, Green Published			2022-12-28	WOS:000678068400035
J	Singh, A; Kumar, A; Kumar, P; Nayak, N; Bhardwaj, T; Giri, R; Garg, N				Singh, Ashutosh; Kumar, Ankur; Kumar, Prateek; Nayak, Namyashree; Bhardwaj, Taniya; Giri, Rajanish; Garg, Neha			A novel inhibitor L755507 efficiently blocks c-Myc-MAX heterodimerization and induces apoptosis in cancer cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; SMALL-MOLECULE INHIBITORS; BINDING-SITES; ONCOPROTEIN; GROWTH; DISRUPTION; EXPRESSION; TARGETS; DNA	c-Myc is a transcription factor that plays a crucial role in cellular homeostasis, and its deregulation is associated with highly aggressive and chemotherapy-resistant cancers. After binding with partner MAX, the c-Myc-MAX heterodimer regulates the expression of several genes, leading to an oncogenic phenotype. Although considered a crucial therapeutic target, no clinically approved c-Myc-targeted therapy has yet been discovered. Here, we report the discovery via computer-aided drug discovery of a small molecule, L755507, which functions as a c-Myc inhibitor to efficiently restrict the growth of diverse Myc-expressing cells with low micromolar IC50 values. L755507 successfully disrupts the c-Myc-MAX heterodimer, resulting in decreased expression of c-Myc target genes. Spectroscopic and computational experiments demonstrated that L755507 binds to the c-Myc peptide and thereby stabilizes the helix-loop-helix conformation of the c-Myc transcription factor. Taken together, this study suggests that L755507 effectively inhibits the c-Myc-MAX heterodimerization and may be used for further optimization to develop a cMyc-targeted antineoplastic drug.	[Singh, Ashutosh; Kumar, Ankur; Kumar, Prateek; Nayak, Namyashree; Bhardwaj, Taniya; Giri, Rajanish] Indian Inst Technol Mandi, Sch Basic Sci, Mandi, Himachal Prades, India; [Singh, Ashutosh; Kumar, Ankur; Kumar, Prateek; Nayak, Namyashree; Bhardwaj, Taniya; Giri, Rajanish] Indian Inst Technol Mandi, Adv Mat Res Ctr, Mandi, Himachal Prades, India; [Garg, Neha] Banaras Hindu Univ, Inst Med Sci, Dept Med Chem, Varanasi, Uttar Pradesh, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Mandi; Banaras Hindu University (BHU)	Garg, N (corresponding author), Banaras Hindu Univ, Inst Med Sci, Dept Med Chem, Varanasi, Uttar Pradesh, India.	nehagarg@bhu.ac.in	Garg, Neha/AAG-5180-2020; Singh, Ashutosh/T-7221-2018	Garg, Neha/0000-0003-2227-8292; Kumar, Prateek/0000-0001-7392-5045; Singh, Ashutosh/0000-0003-0193-9346; Nayak, Namyashree/0000-0002-8513-9401; Bhardwaj, Taniya/0000-0002-7226-6348	University Grants Commission, India; Ministry of Human Resource Development, India; Department of Science and Technology, India [BT/11/IYBA/2018/06]; Science and Engineering Research Board Grant, India [SB/S2/RJN-072/2015, ECR/2017/00092]; Institute of Eminence Scheme, BHU	University Grants Commission, India(University Grants Commission, India); Ministry of Human Resource Development, India(Ministry of Higher Education & Scientific Research (MHESR)); Department of Science and Technology, India(Department of Science & Technology (India)); Science and Engineering Research Board Grant, India; Institute of Eminence Scheme, BHU	A. S. acknowledges University Grants Commission, India, and A. K. acknowledges the Ministry of Human Resource Development, India, for Doctoral Research Fellowship. R. G. is thankful to the Department of Science and Technology, India (BT/11/IYBA/2018/06), and N. G. acknowledges the Science and Engineering Research Board Grant, India (SB/S2/RJN-072/2015), (ECR/2017/00092), and the seed grant under the Institute of Eminence Scheme, BHU for financial support.	Allen-Petersen BL, 2019, BIODRUGS, V33, P539, DOI 10.1007/s40259-019-00370-5; Amati B, 2001, BBA-REV CANCER, V1471, pM135, DOI 10.1016/S0304-419X(01)00020-8; Bahuguna A, 2020, COMPUT BIOL MED, V116, DOI 10.1016/j.compbiomed.2019.103574; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Bhat J, 2017, ACS OMEGA, V2, P4382, DOI 10.1021/acsomega.6b00531; Cang SD, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0224-3; Carabet LA, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010120; Chen H, 2018, SIGNAL TRANSDUCT TAR, V3, DOI 10.1038/s41392-018-0008-7; Choi SH, 2017, ACS CHEM BIOL, V12, P2715, DOI 10.1021/acschembio.7b00799; Conacci-Sorrell M, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014357; Coude MM, 2015, ONCOTARGET, V6, P17698, DOI 10.18632/oncotarget.4131; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 2012, CELL, V149, P22, DOI 10.1016/j.cell.2012.03.003; Dang CV, 1999, MOL CELL BIOL, V19, P1; Fletcher S, 2015, BBA-GENE REGUL MECH, V1849, P525, DOI 10.1016/j.bbagrm.2014.03.005; Follis AV, 2008, CHEM BIOL, V15, P1149, DOI 10.1016/j.chembiol.2008.09.011; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Greenwood JR, 2010, J COMPUT AID MOL DES, V24, P591, DOI 10.1007/s10822-010-9349-1; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hammoudeh DI, 2009, J AM CHEM SOC, V131, P7390, DOI 10.1021/ja900616b; Han HY, 2019, CANCER CELL, V36, P483, DOI 10.1016/j.ccell.2019.10.001; Handoko L, 2018, EPIGENETICS-US, V13, P410, DOI 10.1080/15592294.2018.1469891; Hao Huang, 2008, J Exp Clin Cancer Res, V27, P27, DOI 10.1186/1756-9966-27-27; Hart JR, 2014, P NATL ACAD SCI USA, V111, P12556, DOI 10.1073/pnas.1319488111; Ivanov AA, 2013, TRENDS PHARMACOL SCI, V34, P393, DOI 10.1016/j.tips.2013.04.007; Jeong KC, 2010, MOL BIOSYST, V6, P1503, DOI 10.1039/c002534h; Jin F, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003249; Jung KY, 2015, J MED CHEM, V58, P3002, DOI 10.1021/jm501440q; Kalkat M, 2017, GENES-BASEL, V8, DOI 10.3390/genes8060151; Kumar P, 2020, J BIOMOL STRUCT DYN, V38, P4997, DOI 10.1080/07391102.2019.1696231; Lakowicz J. R., 2013, PRINCIPLES FLUORESCE, P383; Li B, 2013, CLIN CANCER RES, V19, P5835, DOI 10.1158/1078-0432.CCR-12-3629; Loregian A, 2005, J CELL PHYSIOL, V204, P750, DOI 10.1002/jcp.20356; McKeown MR, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a014266; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mo H, 2006, P NATL ACAD SCI USA, V103, P6344, DOI 10.1073/pnas.0601418103; Nair SK, 2003, CELL, V112, P193, DOI 10.1016/S0092-8674(02)01284-9; Nieddu E, 2005, FASEB J, V19, P632, DOI 10.1096/fj.04-2369fje; Parmee ER, 1998, BIOORG MED CHEM LETT, V8, P1107, DOI 10.1016/S0960-894X(98)00170-X; Poole CJ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8050142; Rahl PB, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a020990; Robinson K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005951; Sander T, 2015, J CHEM INF MODEL, V55, P460, DOI 10.1021/ci500588j; Sengupta P, 2018, NUCLEIC ACIDS RES, V46, P9932, DOI 10.1093/nar/gky824; Shamsi A, 2020, J BIOMOL STRUCT DYN, V38, P1094, DOI 10.1080/07391102.2019.1595728; Sidorova JM, 2008, CELL CYCLE, V7, P796, DOI 10.4161/cc.7.6.5566; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Souers AJ, 2013, NAT MED, V19, P202, DOI 10.1038/nm.3048; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Wang YH, 2005, BREAST CANCER RES, V7, pR220, DOI 10.1186/bcr975; Whitfield JR, 2017, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00010; Yang AM, 2017, CANCER RES, V77, P6641, DOI 10.1158/0008-5472.CAN-16-3452; Yao R., 2018, BIOSCIENCE REP, V38, P1; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641; Yu C, 2016, SCI REP-UK, V6, DOI 10.1038/srep22298; Yu C, 2015, CELL STEM CELL, V16, P142, DOI 10.1016/j.stem.2015.01.003; Zhang HL, 2019, ONCOL LETT, V17, P4487, DOI 10.3892/ol.2019.10081	57	7	7	7	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100903	10.1016/j.jbc.2021.100903	http://dx.doi.org/10.1016/j.jbc.2021.100903			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157284	Green Published, gold			2022-12-28	WOS:000678068400092
J	Alabi, SB; Crews, CM				Alabi, Shanique B.; Crews, Craig M.			Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Of late, targeted protein degradation (TPD) has surfaced as a novel and innovative chemical tool and therapeutic modality. By co-opting protein degradation pathways, TPD facilitates complete removal of the protein molecules from within or outside the cell. While the pioneering Proteolysis-Targeting Chimera (PROTAC) technology and molecular glues hijack the ubiquitin-proteasome system, newer modalities co-opt autophagy or the endo-lysosomal pathway. Using this mechanism, TPD is posited to largely expand the druggable space far beyond small-molecule inhibitors. In this review, we discuss the major advances in TPD, highlight our current understanding, and explore outstanding questions in the field.	[Alabi, Shanique B.; Crews, Craig M.] Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Mol Cellular & Dev Biol, New Haven, CT 06520 USA; [Crews, Craig M.] Yale Univ, Dept Chem, New Haven, CT 06520 USA	Yale University; Yale University; Yale University	Crews, CM (corresponding author), Yale Univ, Dept Pharmacol, New Haven, CT 06520 USA.; Crews, CM (corresponding author), Yale Univ, Mol Cellular & Dev Biol, New Haven, CT 06520 USA.; Crews, CM (corresponding author), Yale Univ, Dept Chem, New Haven, CT 06520 USA.	craig.crews@yale.edu			Howard Hughes Medical Institute Gilliam Fellowship	Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute)	S. B. A. is supported by the Howard Hughes Medical Institute Gilliam Fellowship. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	46	47	23	83	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100647	10.1016/j.jbc.2021.100647	http://dx.doi.org/10.1016/j.jbc.2021.100647			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33839157	gold, Green Published			2022-12-28	WOS:000672866400618
J	Fukui, N; Yamamoto, H; Miyabe, M; Aoyama, Y; Hongo, K; Mizobata, T; Kawahata, I; Yabuki, Y; Shinoda, Y; Fukunaga, K; Kawata, Y				Fukui, Naoya; Yamamoto, Hanae; Miyabe, Moe; Aoyama, Yuki; Hongo, Kunihiro; Mizobata, Tomohiro; Kawahata, Ichiro; Yabuki, Yasushi; Shinoda, Yasuharu; Fukunaga, Kohji; Kawata, Yasushi			An alpha-synuclein decoy peptide prevents cytotoxic alpha-synuclein aggregation caused by fatty acid binding protein 3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARKINSONS-DISEASE; LEWY BODIES; DEMENTIA; OLIGOMERS; INCLUSIONS; TOXICITY; MUTANTS	alpha-synuclein (alpha Syn) is a protein known to form intracellular aggregates during the manifestation of Parkinson's disease. Previously, it was shown that aSyn aggregation was strongly suppressed in the midbrain region of mice that did not possess the gene encoding the lipid transport protein fatty acid binding protein 3 (FABP3). An interaction between these two proteins was detected in vitro, suggesting that FABP3 may play a role in the aggregation and deposition of aSyn in neurons. To characterize the molecular mechanisms that underlie the interactions between FABP3 and aSyn that modulate the cellular accumulation of the latter, in this report, we used in vitro fluorescence assays combined with fluorescence microscopy, transmission electron microscopy, and quartz crystal microbalance assays to characterize in detail the process and consequences of FABP3-alpha Syn interaction. We demonstrated that binding of FABP3 to aSyn results in changes in the aggregation mechanism of the latter; specifically, a suppression of fibrillar forms of alpha Syn and also the production of aggregates with an enhanced cytotoxicity toward mice neuro2A cells. Because this interaction involved the C-terminal sequence region of alpha Syn, we tested a peptide derived from this region of alpha Syn (alpha SynP130-140) as a decoy to prevent the FABP3-alpha Syn interaction. We observed that the peptide competitively inhibited binding of alpha Syn to FABP3 in vitro and in cultured cells. We propose that administration of alpha SynP130-140 might be used to prevent the accumulation of toxic FABP3-alpha Syn oligomers in cells, thereby preventing the progression of Parkinson's disease.	[Fukui, Naoya; Yamamoto, Hanae; Miyabe, Moe; Aoyama, Yuki; Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Dept Chem & Biotechnol, Fac Engn, Grad Sch Engn, Tottori, Japan; [Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori, Japan; [Hongo, Kunihiro; Mizobata, Tomohiro; Kawata, Yasushi] Tottori Univ, Ctr Res Green Sustainable Chem, Tottori, Japan; [Kawahata, Ichiro; Yabuki, Yasushi; Shinoda, Yasuharu; Fukunaga, Kohji] Tohoku Univ, Grad Sch Pharmaceut Sci, Dept Pharmacol, Sendai, Miyagi, Japan	Tottori University; Tottori University; Tottori University; Tohoku University	Kawata, Y (corresponding author), Tottori Univ, Dept Chem & Biotechnol, Fac Engn, Grad Sch Engn, Tottori, Japan.; Kawata, Y (corresponding author), Tottori Univ, Dept Biomed Sci, Inst Regenerat Med & Biofunct, Grad Sch Med Sci, Tottori, Japan.; Kawata, Y (corresponding author), Tottori Univ, Ctr Res Green Sustainable Chem, Tottori, Japan.	kawata@tottori-u.ac.jp	Kawata, Yasushi/ABA-9608-2021; Kawahata, Ichiro/N-4414-2019; Shinoda, Yasuharu/AAE-6135-2019; Fukunaga, Kohji/AAI-8811-2021	Kawahata, Ichiro/0000-0002-5916-7847; Shinoda, Yasuharu/0000-0001-9910-048X; Mizobata, Tomohiro/0000-0002-7808-2099; Kawata, Yasushi/0000-0002-2744-1506	Japan Agency for Medical Research and Development, AMED [JP20dm0107073, JP20dm0107071]; Joint Usage/Research Center for Developmental Medicine, IMEG, Kumamoto University	Japan Agency for Medical Research and Development, AMED(Japan Agency for Medical Research and Development (AMED)); Joint Usage/Research Center for Developmental Medicine, IMEG, Kumamoto University	This study was supported by the Strategic Research Program for Brain Sciences from Japan Agency for Medical Research and Development, AMED (Grant No. JP20dm0107073 to Y. K. and JP20dm0107071 to K. F.) and partially supported by funding from the Joint Usage/Research Center for Developmental Medicine, IMEG, Kumamoto University.	Albertazzi L, 2009, PHOTOCHEM PHOTOBIOL, V85, P287, DOI 10.1111/j.1751-1097.2008.00435.x; Baba M, 1998, AM J PATHOL, V152, P879; Basmaciyan L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187756; Blum D, 2001, PROG NEUROBIOL, V65, P135, DOI 10.1016/S0301-0082(01)00003-X; Cheng A, 2019, BRAIN RES, V1707, P190, DOI 10.1016/j.brainres.2018.11.036; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Dasari AKR, 2019, BIOCHEMISTRY-US, V58, P2814, DOI 10.1021/acs.biochem.9b00215; GLATZ JFC, 1993, PROSTAG LEUKOTR ESS, V48, P33, DOI 10.1016/0952-3278(93)90007-J; HAN HY, 1995, CHEM BIOL, V2, P163, DOI 10.1016/1074-5521(95)90071-3; Hanhoff T, 2002, MOL CELL BIOCHEM, V239, P45, DOI 10.1023/A:1020502624234; Hashimoto M, 1998, BRAIN RES, V799, P301, DOI 10.1016/S0006-8993(98)00514-9; Hirose M, 2013, J SYNCHROTRON RADIAT, V20, P923, DOI 10.1107/S0909049513021298; Hoyer W, 2002, J MOL BIOL, V322, P383, DOI 10.1016/S0022-2836(02)00775-1; Izawa Y, 2012, BRAIN BEHAV, V2, P595, DOI 10.1002/brb3.86; Kameda H, 2017, J BIOCHEM, V161, P55, DOI 10.1093/jb/mvw052; Karube H, 2008, FEBS LETT, V582, P3693, DOI 10.1016/j.febslet.2008.10.001; Kawahata I, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9010049; Kawahata I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215358; Liu RZ, 2010, INT J DEV BIOL, V54, P1229, DOI 10.1387/ijdb.092976rl; Liu RZ, 2008, GENOMICS, V92, P436, DOI 10.1016/j.ygeno.2008.08.003; Matsuo K, 2021, BRAIN RES, V1760, DOI 10.1016/j.brainres.2021.147383; Matsuo K, 2019, NEUROPHARMACOLOGY, V150, P164, DOI 10.1016/j.neuropharm.2019.03.029; Matsuoka S, 2015, ANGEW CHEM INT EDIT, V54, P1508, DOI 10.1002/anie.201409830; Menke T, 2003, BIOFACTORS, V18, P65, DOI 10.1002/biof.5520180208; Micsonai A, 2018, NUCLEIC ACIDS RES, V46, pW315, DOI 10.1093/nar/gky497; Nishiwaki H, 2020, MOVEMENT DISORD, V35, P1626, DOI 10.1002/mds.28119; Okochi M, 2000, J BIOL CHEM, V275, P390, DOI 10.1074/jbc.275.1.390; Owada Y, 1996, J CHEM NEUROANAT, V12, P113, DOI 10.1016/S0891-0618(96)00192-5; Paleologou KE, 2009, BRAIN, V132, P1093, DOI 10.1093/brain/awn349; PAPADOPOULOS NG, 1994, J IMMUNOL METHODS, V177, P101, DOI 10.1016/0022-1759(94)90147-3; Prinsen CFM, 1996, BIOCHEM J, V314, P253, DOI 10.1042/bj3140253; Rauch JN, 2020, NATURE, V580, P381, DOI 10.1038/s41586-020-2156-5; Remple Krissy, 2011, J Vis Exp, DOI 10.3791/3659; Rivers RC, 2008, PROTEIN SCI, V17, P887, DOI 10.1110/ps.073181508; Roberts HL, 2015, BIOMOLECULES, V5, P282, DOI 10.3390/biom5020282; Sharon R, 2001, P NATL ACAD SCI USA, V98, P9110, DOI 10.1073/pnas.171300598; Sharon R, 2003, NEURON, V37, P583, DOI 10.1016/S0896-6273(03)00024-2; Sharon R, 2003, J BIOL CHEM, V278, P49874, DOI 10.1074/jbc.M309127200; Shioda N, 2014, J BIOL CHEM, V289, P18957, DOI 10.1074/jbc.M113.527341; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Sorrentino ZA, 2020, J BIOL CHEM, V295, P10224, DOI 10.1074/jbc.REV120.011743; Sorrentino ZA, 2018, J BIOL CHEM, V293, P18914, DOI 10.1074/jbc.RA118.005603; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Spillantini MG, 1998, NEUROSCI LETT, V251, P205, DOI 10.1016/s0304-3940(98)00504-7; Tan MC, 2014, BIOORGAN MED CHEM, V22, P1804, DOI 10.1016/j.bmc.2014.02.001; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; UEDA K, 1993, P NATL ACAD SCI USA, V90, P11282, DOI 10.1073/pnas.90.23.11282; Uversky VN, 2001, J BIOL CHEM, V276, P44284, DOI 10.1074/jbc.M105343200; van der Wateren IM, 2018, CHEM SCI, V9, P5506, DOI 10.1039/c8sc01109e; Wada-Isoe K, 2008, J NEUROL SCI, V266, P20, DOI 10.1016/j.jns.2007.08.018; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Winner B, 2011, P NATL ACAD SCI USA, V108, P4194, DOI 10.1073/pnas.1100976108; Xin W, 2015, BIOMOLECULES, V5, P1634, DOI 10.3390/biom5031634; Yabuki Y, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21062230; Yagi H, 2005, J BIOL CHEM, V280, P38609, DOI 10.1074/jbc.M508623200; Yamamoto H, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010047; Yamamoto T, 2009, BIOTECHNOL LETT, V31, P1695, DOI 10.1007/s10529-009-0065-7; ZANOTTI G, 1992, J BIOL CHEM, V267, P18541; Zimmerman AW, 1999, BIOCHEM J, V344, P495, DOI 10.1042/0264-6021:3440495	60	3	3	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100663	10.1016/j.jbc.2021.100663	http://dx.doi.org/10.1016/j.jbc.2021.100663			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862084	Green Published, gold			2022-12-28	WOS:000672866400634
J	Gerber, AN; Newton, R; Sasse, SK				Gerber, Anthony N.; Newton, Robert; Sasse, Sarah K.			Repression of transcription by the glucocorticoid receptor: A parsimonious model for the genomics era	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NF-KAPPA-B; DNA-BINDING; MEDIATED REPRESSION; REGULATORY ELEMENTS; NEGATIVE REGULATION; RESPONSE UNIT; GENE; HORMONE; MECHANISMS; TRANSACTIVATION	Glucocorticoids are potent anti-inflammatory drugs that are used to treat an extraordinary range of human disease, including COVID-19, underscoring the ongoing importance of understanding their molecular mechanisms. Early studies of GR signaling led to broad acceptance of models in which glucocorticoid receptor (GR) monomers tether repressively to inflammatory transcription factors, thus abrogating inflammatory gene expression. However, newer data challenge this core concept and present an exciting opportunity to reframe our understanding of GR signaling. Here, we present an alternate, two-part model for transcriptional repression by glucocorticoids. First, widespread GR-mediated induction of transcription results in rapid, primary repression of inflammatory gene transcription and associated enhancers through competition-based mechanisms. Second, a subset of GR-induced genes, including targets that are regulated in coordination with inflammatory transcription factors such as NF-kappa B, exerts secondary repressive effects on inflammatory gene expression. Within this framework, emerging data indicate that the gene set regulated through the cooperative convergence of GR and NF-kappa B signaling is central to the broad clinical effectiveness of glucocorticoids in terminating inflammation and promoting tissue repair.	[Gerber, Anthony N.; Sasse, Sarah K.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Gerber, Anthony N.] Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO 80206 USA; [Gerber, Anthony N.] Univ Colorado, Dept Med, Aurora, CO 80045 USA; [Newton, Robert] Univ Calgary, Cumming Sch Med, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Newton, Robert] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Calgary, AB, Canada	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Calgary; University of Calgary	Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.; Gerber, AN (corresponding author), Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO 80206 USA.; Gerber, AN (corresponding author), Univ Colorado, Dept Med, Aurora, CO 80045 USA.	gerbera@njhealth.org	Newton, Robert/C-6814-2012	Newton, Robert/0000-0002-4919-8498; Gerber, Anthony/0000-0002-5280-8218	NIH-NHLBI [R01HL109557]; Canadian Institutes for Health Research (CIHR) [MOP 125918, PJT 156310]; Natural Sciences and Engineering Research Council (NSERC) [RGPIN-2016-04549]	NIH-NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by NIH-NHLBI R01HL109557 (A. N. G), Canadian Institutes for Health Research (CIHR) project grants (MOP 125918, PJT 156310), and Natural Sciences and Engineering Research Council (NSERC) Discovery Grant RGPIN-2016-04549 (R. N.).	Abraham SM, 2006, J EXP MED, V203, P1883, DOI 10.1084/jem.20060336; Arango-Lievano M, 2015, ADV EXP MED BIOL, V872, P33, DOI 10.1007/978-1-4939-2895-8_2; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Ayroldi E, 2001, BLOOD, V98, P743, DOI 10.1182/blood.V98.3.743; Azouz Nurit P, 2021, Pathog Immun, V6, P55, DOI 10.20411/pai.v6i1.408; Barish GD, 2012, CELL METAB, V15, P554, DOI 10.1016/j.cmet.2012.02.012; Barnes PJ, 2017, HANDB EXP PHARMACOL, V237, P93, DOI 10.1007/164_2016_62; BARNES PJ, 1995, ANN MED, V27, P531, DOI 10.3109/07853899509002464; BAXTER JD, 1972, P NATL ACAD SCI USA, V69, P1892, DOI 10.1073/pnas.69.7.1892; BEATO M, 1989, J STEROID BIOCHEM, V32, P737, DOI 10.1016/0022-4731(89)90521-9; Becker M, 2002, EMBO REP, V3, P1188, DOI 10.1093/embo-reports/kvf244; Bledsoe RK, 2002, CELL, V110, P93, DOI 10.1016/S0092-8674(02)00817-6; Bodine SC, 2015, ADV EXP MED BIOL, V872, P145, DOI 10.1007/978-1-4939-2895-8_7; Boija A, 2018, CELL, V175, P1842, DOI 10.1016/j.cell.2018.10.042; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Bracken MB, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001046.pub2; CALDENHOVEN E, 1995, MOL ENDOCRINOL, V9, P401, DOI 10.1210/me.9.4.401; CHROUSOS GP, 1993, ANN INTERN MED, V119, P1113, DOI 10.7326/0003-4819-119-11-199312010-00009; Clark AR, 2007, MOL CELL ENDOCRINOL, V275, P79, DOI 10.1016/j.mce.2007.04.013; Cohen DM, 2017, TRENDS ENDOCRIN MET, V28, P531, DOI 10.1016/j.tem.2017.04.001; Cook PR, 2018, NUCLEIC ACIDS RES, V46, P9895, DOI 10.1093/nar/gky763; De Bosscher K, 2008, EUR J PHARMACOL, V583, P290, DOI 10.1016/j.ejphar.2007.11.076; de Loyola MB, 2021, REV MED VIROL, V31, DOI 10.1002/rmv.2157; Del Valle DM, 2020, NAT MED, V26, P1636, DOI [10.1038/s41591-020-1051-9, 10.1101/2020.05.28.20115758]; Devine JH, 1999, MOL CELL ENDOCRINOL, V151, P49, DOI 10.1016/S0303-7207(99)00013-1; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; Dickensheets H, 2007, GENES IMMUN, V8, P21, DOI 10.1038/sj.gene.6364352; Dobosz E, 2016, J INNATE IMMUN, V8, P564, DOI 10.1159/000448038; Dostert A, 2004, CURR PHARM DESIGN, V10, P2807; Escoter-Torres L, 2020, NUCLEIC ACIDS RES, V48, P8393, DOI 10.1093/nar/gkaa565; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Frenkel B, 2015, ADV EXP MED BIOL, V872, P179, DOI 10.1007/978-1-4939-2895-8_8; Frijters R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-359; Garcia DA, 2021, NUCLEIC ACIDS RES, V49, P6605, DOI 10.1093/nar/gkab072; GELFAND ML, 1951, NEW ENGL J MED, V245, P293, DOI 10.1056/NEJM195108232450804; Gerber AN, 2015, ADV EXP MED BIOL, V872, P279, DOI 10.1007/978-1-4939-2895-8_12; Granner DK, 2015, ADV EXP MED BIOL, V872, P3, DOI 10.1007/978-1-4939-2895-8_1; GUERTIN M, 1983, BIOCHEMISTRY-US, V22, P4296, DOI 10.1021/bi00287a021; Guertin MJ, 2014, MOL ENDOCRINOL, V28, P1522, DOI 10.1210/me.2014-1130; Hah N, 2011, CELL, V145, P622, DOI 10.1016/j.cell.2011.03.042; HECK S, 1994, EMBO J, V13, P4087, DOI 10.1002/j.1460-2075.1994.tb06726.x; HOECK W, 1992, J STEROID BIOCHEM, V41, P283, DOI 10.1016/0960-0760(92)90353-K; Hong H, 1997, MOL CELL BIOL, V17, P2735, DOI 10.1128/MCB.17.5.2735; Horby P, 2021, NEW ENGL J MED, V384, P693, DOI [10.1056/NEJMoa2021436, 10.1056/NEJMoa2022926]; Hu GQ, 2019, P NATL ACAD SCI USA, V116, P14191, DOI 10.1073/pnas.1908258116; Hua GQ, 2016, P NATL ACAD SCI USA, V113, pE635, DOI 10.1073/pnas.1522826113; IMAI E, 1990, MOL CELL BIOL, V10, P4712, DOI 10.1128/MCB.10.9.4712; Ito K, 2001, J BIOL CHEM, V276, P30208, DOI 10.1074/jbc.M103604200; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; Joanny E, 2012, BRIT J PHARMACOL, V165, P1124, DOI 10.1111/j.1476-5381.2011.01574.x; Johnson TA, 2018, NUCLEIC ACIDS RES, V46, P203, DOI 10.1093/nar/gkx1044; Kadiyala V, 2016, J BIOL CHEM, V291, P12673, DOI 10.1074/jbc.M116.721217; Kermani TA, 2018, RHEUMATOLOGY, V57, P1513, DOI 10.1093/rheumatology/kex385; King EM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053936; King EM, 2009, J BIOL CHEM, V284, P26803, DOI 10.1074/jbc.M109.028381; Kunadharaju R, 2020, CLIN CHEST MED, V41, P439, DOI 10.1016/j.ccm.2020.06.008; Kuo T, 2015, ADV EXP MED BIOL, V872, P99, DOI 10.1007/978-1-4939-2895-8_5; Kurimoto T, 2021, EUR J PHARMACOL, V895, DOI 10.1016/j.ejphar.2021.173880; Kuroda MI, 2020, ANNU REV BIOCHEM, V89, P235, DOI 10.1146/annurev-biochem-120219-103641; Kushner P J, 2000, Novartis Found Symp, V230, P20, DOI 10.1002/0470870818.ch3; LABAER J, 1994, J MOL BIOL, V239, P664, DOI 10.1006/jmbi.1994.1405; Langlais D, 2012, MOL CELL, V47, P38, DOI 10.1016/j.molcel.2012.04.021; Larkin JD, 2013, J CELL SCI, V126, P2052, DOI 10.1242/jcs.123653; Lasa M, 2002, MOL CELL BIOL, V22, P7802, DOI 10.1128/MCB.22.22.7802-7811.2002; Li AQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063578; Lower KM, 2009, P NATL ACAD SCI USA, V106, P21771, DOI 10.1073/pnas.0909331106; Lu XQ, 2008, BLOOD, V112, P4098, DOI 10.1182/blood-2008-03-148726; Magomedova L, 2016, HANDB EXP PHARMACOL, V233, P73, DOI 10.1007/164_2015_1; Makarov SS, 2001, ARTHRITIS RES, V3, P200, DOI 10.1186/ar300; Martin F, 2011, NAT GENET, V43, P822, DOI 10.1038/ng.916; McDowell IC, 2018, GENOME RES, V28, P1272, DOI 10.1101/gr.233346.117; MCEWAN IJ, 1994, J BIOL CHEM, V269, P25629; McNally JG, 2000, SCIENCE, V287, P1262, DOI 10.1126/science.287.5456.1262; Meijsing SH, 2015, ADV EXP MED BIOL, V872, P59, DOI 10.1007/978-1-4939-2895-8_3; Mendelson CR, 2000, ANNU REV PHYSIOL, V62, P875, DOI 10.1146/annurev.physiol.62.1.875; MEYER ME, 1989, CELL, V57, P433, DOI 10.1016/0092-8674(89)90918-5; MIESFELD RL, 1990, AM REV RESPIR DIS, V141, pS11; Miyata M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7062; Morand EF, 2000, CURR OPIN RHEUMATOL, V12, P171, DOI 10.1097/00002281-200005000-00002; Nakamura Yutaka, 2005, Current Drug Targets - Inflammation and Allergy, V4, P267, DOI 10.2174/1568010053586273; Newton R, 2007, MOL PHARMACOL, V72, P799, DOI 10.1124/mol.107.038794; Newton R, 2017, J BIOL CHEM, V292, P7163, DOI 10.1074/jbc.R117.777318; Ngo KA, 2020, CELL REP, V30, P2758, DOI 10.1016/j.celrep.2020.01.108; Nicolaides NC, 2000, ENDOTEXT; NITSCH D, 1993, P NATL ACAD SCI USA, V90, P5479, DOI 10.1073/pnas.90.12.5479; Oakley RH, 2013, J ALLERGY CLIN IMMUN, V132, P1033, DOI 10.1016/j.jaci.2013.09.007; ORO AE, 1988, CELL, V55, P1109, DOI 10.1016/0092-8674(88)90255-3; Osborne CS, 2004, NAT GENET, V36, P1065, DOI 10.1038/ng1423; Paakinaho V, 2019, GENOME RES, V29, P1223, DOI 10.1101/gr.244814.118; de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012; Ramos YFM, 2010, NUCLEIC ACIDS RES, V38, P5396, DOI 10.1093/nar/gkq184; RANDOLPH TG, 1950, J ALLERGY, V21, P288, DOI 10.1016/0021-8707(50)90060-8; Rao NAS, 2011, GENOME RES, V21, P1404, DOI 10.1101/gr.118042.110; RAY A, 1990, MOL CELL BIOL, V10, P5736, DOI 10.1128/MCB.10.11.5736; RAY A, 1994, P NATL ACAD SCI USA, V91, P752, DOI 10.1073/pnas.91.2.752; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Reichardt HM, 1998, CELL, V93, P531, DOI 10.1016/S0092-8674(00)81183-6; Rodrigue-Gervais IG, 2014, CELL HOST MICROBE, V15, P23, DOI 10.1016/j.chom.2013.12.003; Roesler WJ, 1998, MOL CELL BIOCHEM, V178, P1, DOI 10.1023/A:1006886421795; Rogatsky I, 2003, P NATL ACAD SCI USA, V100, P13845, DOI 10.1073/pnas.2336092100; Rogatsky I, 2002, P NATL ACAD SCI USA, V99, P16701, DOI 10.1073/pnas.262671599; Rogliani Paola, 2020, J Exp Pharmacol, V12, P233, DOI 10.2147/JEP.S237480; Ronchetti S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19124090; Rose AJ, 2013, MOL CELL ENDOCRINOL, V380, P65, DOI 10.1016/j.mce.2013.03.007; RUSCONI S, 1987, EMBO J, V6, P1309, DOI 10.1002/j.1460-2075.1987.tb02369.x; Russell G, 2019, NAT REV ENDOCRINOL, V15, P525, DOI 10.1038/s41574-019-0228-0; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; Saliba DG, 2014, CELL REP, V8, P1308, DOI 10.1016/j.celrep.2014.07.034; Sasse SK, 2019, GENOME RES, V29, P1753, DOI 10.1101/gr.248187.119; Sasse SK, 2017, AM J RESP CELL MOL, V57, P226, DOI 10.1165/rcmb.2016-0357OC; Schaecke H, 2007, MOL CELL ENDOCRINOL, V275, P109, DOI 10.1016/j.mce.2007.05.014; SCHEINMAN RI, 1995, SCIENCE, V270, P283, DOI 10.1126/science.270.5234.283; Schiller BJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0418-y; Schmidt SF, 2016, BIOESSAYS, V38, P618, DOI 10.1002/bies.201600034; Schmidt SF, 2015, GENOME RES, V25, P1281, DOI 10.1101/gr.188300.114; Sellares J, 2020, CURR OPIN PULM MED, V26, P591, DOI 10.1097/MCP.0000000000000720; Shen MW, 2018, NATURE, V563, P646, DOI 10.1038/s41586-018-0686-x; Shirazi SN, 2015, ADV EXP MED BIOL, V872, P235, DOI 10.1007/978-1-4939-2895-8_10; Shrinivas K, 2019, MOL CELL, V75, P549, DOI 10.1016/j.molcel.2019.07.009; So AYL, 2007, PLOS GENET, V3, P927, DOI 10.1371/journal.pgen.0030094; Starick SR, 2015, GENOME RES, V25, P825, DOI 10.1101/gr.185157.114; Takei Y, 2016, HANDBOOK OF HORMONES: COMPARATIVE ENDOCRINOLOGY FOR BASIC AND CLINICAL RESEARCH, P1; Tapscott SJ, 2005, DEVELOPMENT, V132, P2685, DOI 10.1242/dev.01874; Tsang AH, 2016, J ENDOCRINOL, V230, pR1, DOI 10.1530/JOE-16-0051; Tuckermann JP, 1999, J CELL BIOL, V147, P1365, DOI 10.1083/jcb.147.7.1365; Uhlenhaut NH, 2013, MOL CELL, V49, P158, DOI 10.1016/j.molcel.2012.10.013; Van Moortel L, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.559673; VANDESTOLPE A, 1993, AM J RESP CELL MOL, V8, P340, DOI 10.1165/ajrcmb/8.3.340; Vandewalle J, 2018, TRENDS ENDOCRIN MET, V29, P42, DOI 10.1016/j.tem.2017.10.010; Verstrepen L, 2014, ADV EXP MED BIOL, V809, P13; Vettorazzi S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8796; Vitousek MN, 2019, INTEGR COMP BIOL, V59, P251, DOI 10.1093/icb/icz087; Vollmer TR, 2012, J BIOL CHEM, V287, P35212, DOI 10.1074/jbc.M112.400671; Voss TC, 2011, CELL, V146, P544, DOI 10.1016/j.cell.2011.07.006; Wang JC, 1999, MOL ENDOCRINOL, V13, P604, DOI 10.1210/me.13.4.604; Whirledge S, 2018, ENDOCRINOLOGY, V159, P46, DOI 10.1210/en.2017-00728; WIELAND S, 1991, EMBO J, V10, P2513, DOI 10.1002/j.1460-2075.1991.tb07791.x; Yamamoto K R, 1995, Harvey Lect, V91, P1; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; YU FL, 1971, P NATL ACAD SCI USA, V68, P2177, DOI 10.1073/pnas.68.9.2177; Zhao MM, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2006347	142	13	13	2	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100687	10.1016/j.jbc.2021.100687	http://dx.doi.org/10.1016/j.jbc.2021.100687			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33891947	Green Published, gold			2022-12-28	WOS:000672866400658
J	Kentache, T; Thabault, L; Deumer, G; Haufroid, V; Frederick, R; Linster, CL; Peracchi, A; Veiga-da-Cunha, M; Bommer, GT; Van Schaftingen, E				Kentache, Takfarinas; Thabault, Leopold; Deumer, Gladys; Haufroid, Vincent; Frederick, Raphael; Linster, Carole L.; Peracchi, Alessio; Veiga-da-Cunha, Maria; Bommer, Guido T.; Van Schaftingen, Emile			The metalloprotein YhcH is an anomerase providing N-acetylneuraminate aldolase with the open form of its substrate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; SIALIC-ACID; CRYSTAL-STRUCTURE; LYASE; SPECIFICITY; DIVERSITY; PH	N-acetylneuraminate (Neu5Ac), an abundant sugar present in glycans in vertebrates and some bacteria, can be used as an energy source by several prokaryotes, including Escherichia coli. In solution, more than 99% of Neu5Ac is in cyclic form (approximate to 92% beta-anomer and approximate to 7% alpha-anomer), whereas <0.5% is in the open form. The aldolase that initiates Neu5Ac metabolism in E. coli, NanA, has been reported to act on the alpha-anomer. Surprisingly, when we performed this reaction at pH 6 to minimize spontaneous anomerization, we found NanA and its human homolog NPL preferentially metabolize the open form of this substrate. We tested whether the E. coli Neu5Ac anomerase NanM could promote turnover, finding it stimulated the utilization of both beta and alpha-anomers by NanA in vitro. However, NanM is localized in the periplasmic space and cannot facilitate Neu5Ac metabolism by NanA in the cytoplasm in vivo. We discovered that YhcH, a cytoplasmic protein encoded by many Neu5Ac catabolic operons and belonging to a protein family of unknown function (DUF386), also facilitated Neu5Ac utilization by NanA and NPL and displayed Neu5Ac anomerase activity in vitro. YhcH contains Zn, and its accelerating effect on the aldolase reaction was inhibited by metal chelators. Remarkably, several transition metals accelerated Neu5Ac anomerization in the absence of enzyme. Experiments with E. coli mutants indicated that YhcH expression provides a selective advantage for growth on Neu5Ac. In conclusion, YhcH plays the unprecedented role of providing an aldolase with the preferred unstable open form of its substrate.	[Kentache, Takfarinas; Veiga-da-Cunha, Maria; Bommer, Guido T.; Van Schaftingen, Emile] UCLouvain, de Duve Inst, Lab Physiol Chem, Brussels, Belgium; [Thabault, Leopold; Frederick, Raphael] UCLouvain, Louvain Drug Res Inst LDRI, Med Chem Res Grp CMFA, Brussels, Belgium; [Deumer, Gladys; Haufroid, Vincent] UCLouvain, Louvain Ctr Toxicol & Appl Pharmacol, Brussels, Belgium; [Linster, Carole L.] Univ Luxembourg, Luxembourg Ctr Syst Biomed, Luxembourg, Luxembourg; [Peracchi, Alessio] Univ Parma, Dept Chem Life Sci & Environm Sustainabil, Parma, Italy; [Bommer, Guido T.] UCLouvain, Walloon Excellence Life Sci & Biotechnol WELBIO, Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; University of Luxembourg; University of Parma; Universite Catholique Louvain; WELBIO	Van Schaftingen, E (corresponding author), UCLouvain, de Duve Inst, Lab Physiol Chem, Brussels, Belgium.	emile.vanschaftingen@uclouvain.be	Peracchi, Alessio/Q-5173-2019; Bommer, Guido/A-8425-2011	Peracchi, Alessio/0000-0003-3254-4099; Veiga-da-Cunha, Maria/0000-0002-2968-7374; Bommer, Guido/0000-0001-6898-4884; KENTACHE, TAKFARINAS/0000-0002-5855-8301; Linster, Carole/0000-0001-7143-0719; Thabault, Leopold/0000-0001-9501-6563				Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Barbosa JARG, 2000, J MOL BIOL, V303, P405, DOI 10.1006/jmbi.2000.4138; BAUMANN W, 1989, BIOL CHEM H-S, V370, P141, DOI 10.1515/bchm3.1989.370.1.141; Bell A, 2020, J BIOL CHEM, V295, P13724, DOI 10.1074/jbc.RA120.014454; BLACKLOW SC, 1988, BIOCHEMISTRY-US, V27, P1158, DOI 10.1021/bi00404a013; Chan J, 2011, ORG BIOMOL CHEM, V9, P4818, DOI 10.1039/c1ob05079f; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi KH, 2004, J AM CHEM SOC, V126, P3402, DOI 10.1021/ja038540u; COMB DG, 1960, J BIOL CHEM, V235, P2529; DABROWSKI U, 1979, TETRAHEDRON LETT, P4637; DEIJL CM, 1983, BIOCHEM BIOPH RES CO, V111, P668, DOI 10.1016/0006-291X(83)90358-3; Ellens KW, 2017, NUCLEIC ACIDS RES, V45, P11495, DOI 10.1093/nar/gkx937; Haase H, 2013, BIOMETALS, V26, P167, DOI 10.1007/s10534-012-9604-0; Haines-Menges BL, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MBP-0005-2014; Hopkins AP, 2013, FEMS MICROBIOL LETT, V347, P14, DOI 10.1111/1574-6968.12213; HOWARD SM, 1965, ARCH BIOCHEM BIOPHYS, V110, P395, DOI 10.1016/0003-9861(65)90140-2; JAQUES LW, 1977, J BIOL CHEM, V252, P4533; KALIVODA KA, 2003, ESCHERICHIA COLI J B, V185, P4806, DOI DOI 10.1128/JB.185.16.4806-4815.2003; Kentache T, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20200927; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Klepach T, 2008, J AM CHEM SOC, V130, P11892, DOI 10.1021/ja077565g; Lorentzen E, 2005, BIOCHEMISTRY-US, V44, P4222, DOI 10.1021/bi048192o; MIDELFORT CF, 1977, J BIOL CHEM, V252, P3486; North RA, 2016, FEBS LETT, V590, P4414, DOI 10.1002/1873-3468.12462; OLSON JA, 1959, ARCH BIOCHEM BIOPHYS, V85, P225, DOI 10.1016/0003-9861(59)90465-5; Ooi HC, 2000, AUST J CHEM, V53, P171, DOI 10.1071/CH99140; Park D, 2007, GLYCOBIOLOGY, V17, P955, DOI 10.1093/glycob/cwm066; Plumbridge J, 1999, J BACTERIOL, V181, P47, DOI 10.1128/JB.181.1.47-54.1999; Richardson JS, 2008, J BACTERIOL, V190, P2903, DOI 10.1128/JB.01120-07; Ryu KS, 2005, J MOL BIOL, V349, P153, DOI 10.1016/j.jmb.2005.03.047; Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200; SLONCZEWSKI JL, 1981, P NATL ACAD SCI-BIOL, V78, P6271, DOI 10.1073/pnas.78.10.6271; Tailford LE, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8624; Teplyakov A, 2005, J BACTERIOL, V187, P5520, DOI 10.1128/JB.187.16.5520-5527.2005; Thoden JB, 2002, J BIOL CHEM, V277, P20854, DOI 10.1074/jbc.M201415200; UCHIDA Y, 1984, J BIOCHEM-TOKYO, V96, P507, DOI 10.1093/oxfordjournals.jbchem.a134863; Vallese F, 2015, FEBS J, V282, P3311, DOI 10.1111/febs.13344; VIEIRA MM, 1979, PULLULARIA PULLUALAN, V138, P55; VIMR ER, 1985, J BACTERIOL, V164, P845, DOI 10.1128/JB.164.2.845-853.1985; Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004; Watanabe S, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36774-6; ZILBERSTEIN D, 1984, J BACTERIOL, V158, P246, DOI 10.1128/JB.158.1.246-252.1984	42	3	3	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100699	10.1016/j.jbc.2021.100699	http://dx.doi.org/10.1016/j.jbc.2021.100699			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895133	gold, Green Published			2022-12-28	WOS:000672866400670
J	Pundir, S; Ge, XL; Sanyal, S				Pundir, Shreya; Ge, Xueliang; Sanyal, Suparna			GGQ methylation enhances both speed and accuracy of stop codon recognition by bacterial class-I release factors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Accurate translation termination in bacteria requires correct recognition of the stop codons by the class-I release factors (RFs) RF1 and RF2, which release the nascent peptide from the peptidyl tRNA after undergoing a "compact to open" conformational transition. These RFs possess a conserved Gly-Gly-Gln (GGQ) peptide release motif, of which the Q residue is posttranslationally methylated. GGQ-methylated RFs have been shown to be faster in peptide release than the unmethylated ones, but it was unknown whether this modification had additional roles. Using a fluorescence-based real-time in vitro translation termination assay in a stopped-flow instrument, we demonstrate that methylated RF1 and RF2 are two- to four-fold more accurate in the cognate stop codon recognition than their unmethylated variants. Using pH titration, we show that the lack of GGQ methylation facilitates the "compact to open" transition, which results in compromised accuracy of the unmethylated RFs. Furthermore, thermal melting studies using circular dichroism and SYPRO-orange fluorescence demonstrate that GGQ methylation increases overall stability of the RF proteins. This increased stability, we suspect, is the basis for the more controlled conformational change of the methylated RFs upon codon recognition, which enhances both their speed and accuracy. This GGQ methylation-based modulation of the accuracy of RFs can be a tool for regulating translational termination in vivo.	[Pundir, Shreya; Ge, Xueliang; Sanyal, Suparna] Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden	Uppsala University	Sanyal, S (corresponding author), Uppsala Univ, Biomed Ctr, Dept Cell & Mol Biol, Uppsala, Sweden.	suparna.sanyal@icm.uu.se		Ge, Xueliang/0000-0001-7954-3195	Swedish Research Council [2016-06264, 2018-05946, 2018-05498]; Knut and Alice Wallenberg Foundation [KAW 2017.0055]; Carl Trygger Foundation [CTS 18:338, CTS 19:806]; WennerGren Stiftelserna [UPD2017:0238]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Carl Trygger Foundation; WennerGren Stiftelserna	This work is supported by the grants from Swedish Research Council (grant numbers 2016-06264, 2018-05946 and 2018-05498), Knut and Alice Wallenberg Foundation (grant number KAW 2017.0055), Carl Trygger Foundation (grant numbers CTS 18:338 and CTS 19:806), and WennerGren Stiftelserna (UPD2017:0238) to S. S.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	43	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100681	10.1016/j.jbc.2021.100681	http://dx.doi.org/10.1016/j.jbc.2021.100681			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33887323	Green Published, gold			2022-12-28	WOS:000672866400652
J	Davis, SE; Roth, JR; Aljabi, Q; Hakim, AR; Savell, KE; Day, JJ; Arrant, AE				Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Savell, Katherine E.; Day, Jeremy J.; Arrant, Andrew E.			Delivering progranulin to neuronal lysosomes protects against excitotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FRONTOTEMPORAL LOBAR DEGENERATION; TRAUMATIC BRAIN-INJURY; ACTIVATED MICROGLIA; NEURITE OUTGROWTH; TNF RECEPTORS; HOST-DEFENSE; MOUSE MODEL; AUTOPHAGY; DEMENTIA; DEATH	Loss-of-function mutations in progranulin (GRN) are a major genetic cause of frontotemporal dementia (FTD), possibly due to loss of progranulin's neurotrophic and antiinflammatory effects. Progranulin promotes neuronal growth and protects against excitotoxicity and other forms of injury. It is unclear if these neurotrophic effects are mediated through cellular signaling or through promotion of lysosomal function. Progranulin is a secreted proprotein that may activate neurotrophic signaling through cell-surface receptors. However, progranulin is efficiently trafficked to lysosomes and is necessary for maintaining lysosomal function. To determine which of these mechanisms mediates progranulin's protection against excitotoxicity, we generated lentiviral vectors expressing progranulin (PGRN) or lysosome-targeted progranulin (L-PGRN). L-PGRN was generated by fusing the LAMP-1 transmembrane and cytosolic domains to the C-terminus of progranulin. L-PGRN exhibited no detectable secretion, but was delivered to lysosomes and processed into granulins. PGRN and L-PGRN protected against NMDA excitotoxicity in rat primary cortical neurons, but L-PGRN had more consistent protective effects than PGRN. L-PGRN's protective effects were likely mediated through the autophagy-lysosomal pathway. In control neurons, an excitotoxic dose of NMDA stimulated autophagy, and inhibiting autophagy with 3-methyladenine reduced excitotoxic cell death. L-PGRN blunted the autophagic response to NMDA and occluded the protective effect of 3-methyladenine. This was not due to a general impairment of autophagy, as L-PGRN increased basal autophagy and did not alter autophagy after nutrient starvation. These data show that progranulin's protection against excitotoxicity does not require extracellular progranulin, but is mediated through lysosomes, providing a mechanistic link between progranulin's lysosomal and neurotrophic effects.	[Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Arrant, Andrew E.] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA; [Davis, Skylar E.; Roth, Jonathan R.; Aljabi, Qays; Hakim, Ahmad R.; Savell, Katherine E.; Day, Jeremy J.; Arrant, Andrew E.] Univ Alabama Birmingham, Alzheimers Dis Ctr, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA; [Savell, Katherine E.; Day, Jeremy J.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Savell, Katherine E.] NIDA, Behav Neurosci Branch, Intramural Res Program, NIH, Baltimore, MD 20852 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); NIH National Institute on Drug Abuse (NIDA)	Arrant, AE (corresponding author), Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA.; Arrant, AE (corresponding author), Univ Alabama Birmingham, Alzheimers Dis Ctr, Evelyn F McKnight Brain Inst, Birmingham, AL 35294 USA.	andrewarrant@uabmc.edu		Day, Jeremy/0000-0002-7361-3399	Association for Frontotemporal Degeneration (Basic Science Pilot Grant); National Institute on Aging [F31 AG064868, R00 AG056597, R21 AG068658]; UAB Alzheimer's Disease Center [P20 AG068024]; National Institute on Drug Abuse [F31 DA042514]; National Institute of Mental Health [R01 MH114990]	Association for Frontotemporal Degeneration (Basic Science Pilot Grant); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); UAB Alzheimer's Disease Center; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by funding from The Association for Frontotemporal Degeneration (Basic Science Pilot Grant) to A. E. A., from the National Institute on Aging to J. R. R. (F31 AG064868), A. E. A. (R00 AG056597 and R21 AG068658), and the UAB Alzheimer's Disease Center (P20 AG068024), from the National Institute on Drug Abuse to K. E. S. (F31 DA042514), and from the National Institute of Mental Health to J. J. D. (R01 MH114990). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abu-Remaileh M, 2017, SCIENCE, V358, P807, DOI 10.1126/science.aan6298; Almeida MR, 2016, NEUROBIOL AGING, V41, DOI 10.1016/j.neurobiolaging.2016.02.019; Altmann C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0132-1; Altmann C, 2016, NEUROBIOL DIS, V96, P294, DOI 10.1016/j.nbd.2016.09.010; Arrant AE, 2020, ANN CLIN TRANSL NEUR, V7, P2433, DOI 10.1002/acn3.51242; Arrant AE, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0872-6; Arrant AE, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0264-6; Arrant AE, 2018, J NEUROSCI, V38, P2341, DOI 10.1523/JNEUROSCI.3081-17.2018; Arrant AE, 2017, BRAIN, V140, P1447, DOI 10.1093/brain/awx060; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 1998, J ENDOCRINOL, V158, P145, DOI 10.1677/joe.0.1580145; Beel S, 2017, HUM MOL GENET, V26, P2850, DOI 10.1093/hmg/ddx162; Borsello T, 2003, EUR J NEUROSCI, V18, P473, DOI 10.1046/j.1460-9568.2003.02757.x; Butler VJ, 2019, PLOS GENET, V15, DOI 10.1371/journal.pgen.1008295; Butler VJ, 2019, BIOCHEMISTRY-US, V58, P2670, DOI 10.1021/acs.biochem.9b00275; Butlers VJ, 2019, J MOL BIOL, V431, P1038, DOI 10.1016/j.jmb.2019.01.027; Cenik B, 2012, J BIOL CHEM, V287, P32298, DOI 10.1074/jbc.R112.399170; Chang MC, 2017, J EXP MED, V214, P2611, DOI 10.1084/jem.20160999; Chen X, 2013, J NEUROSCI, V33, P9202, DOI 10.1523/JNEUROSCI.5336-12.2013; Chen YH, 2018, J MOL MED, V96, P1359, DOI 10.1007/s00109-018-1703-0; Chitramuthu BP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174784; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P581, DOI 10.1001/archneurol.2010.350; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; De Muynck L, 2013, NEUROBIOL AGING, V34, P2541, DOI 10.1016/j.neurobiolaging.2013.04.022; Descloux C, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0916-z; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Eriksen JL, 2008, J NEUROCHEM, V104, P287, DOI 10.1111/j.1471-4159.2007.04968.x; Finch N, 2011, NEUROLOGY, V76, P467, DOI 10.1212/WNL.0b013e31820a0e3b; Finch N, 2009, BRAIN, V132, P583, DOI 10.1093/brain/awn352; Gao X, 2010, PROTEIN CELL, V1, P552, DOI 10.1007/s13238-010-0067-1; Gass J, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-33; Ghidoni R, 2008, NEUROLOGY, V71, P1235, DOI 10.1212/01.wnl.0000325058.10218.fc; Ginet V, 2014, AUTOPHAGY, V10, P846, DOI 10.4161/auto.28264; Gotzl JK, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0281-5; Gotzl JK, 2014, ACTA NEUROPATHOL, V127, P845, DOI 10.1007/s00401-014-1262-6; GUARNIERI FG, 1993, J BIOL CHEM, V268, P1941; Guo A, 2010, BRAIN RES, V1366, P1, DOI 10.1016/j.brainres.2010.09.099; Hensley SE, 2009, SCIENCE, V326, P734, DOI 10.1126/science.1178258; Holler CJ, 2017, ENEURO, V4, DOI 10.1523/ENEURO.0100-17.2017; Hu FH, 2010, NEURON, V68, P654, DOI 10.1016/j.neuron.2010.09.034; Huin V, 2020, BRAIN, V143, P303, DOI 10.1093/brain/awz377; Hyung S, 2019, GLIA, V67, P360, DOI 10.1002/glia.23547; Kanazawa M, 2015, BRAIN, V138, P1932, DOI 10.1093/brain/awv079; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kleinberger G, 2016, NEUROBIOL AGING, V39, DOI 10.1016/j.neurobiolaging.2015.12.014; Klionsky DJ, 2021, AUTOPHAGY, V17, P1, DOI 10.1080/15548627.2020.1797280; Krabbe G, 2017, P NATL ACAD SCI USA, V114, P5029, DOI 10.1073/pnas.1700477114; Laird AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013368; Lee CW, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0196-6; Lui HS, 2016, CELL, V165, P921, DOI 10.1016/j.cell.2016.04.001; Martens LH, 2012, J CLIN INVEST, V122, P3955, DOI 10.1172/JCI63113; Menzel L, 2017, GLIA, V65, P278, DOI 10.1002/glia.23091; Menzies FM, 2015, NAT REV NEUROSCI, V16, P345, DOI 10.1038/nrn3961; Mikulka CR, 2020, P NATL ACAD SCI USA, V117, P9032, DOI 10.1073/pnas.1917675117; Minami SS, 2014, NAT MED, V20, P1157, DOI 10.1038/nm.3672; Neill T, 2016, J CELL BIOL, V215, P687, DOI 10.1083/jcb.201603079; Nguyen AD, 2013, TRENDS ENDOCRIN MET, V24, P597, DOI 10.1016/j.tem.2013.08.003; Nicholson AM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11992; Puyal J, 2012, NEUROSCIENTIST, V18, P224, DOI 10.1177/1073858411404948; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ryan CL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-130; Sadasivan S, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-21; Salazar DA, 2015, J NEUROSCI, V35, P9315, DOI 10.1523/JNEUROSCI.4808-14.2015; Savell KE, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3348; Savell KE, 2019, ENEURO, V6, DOI 10.1523/ENEURO.0495-18.2019; Schmitz K, 2020, CELL MOL IMMUNOL, V17, P1077, DOI 10.1038/s41423-019-0274-5; Shacka JJ, 2007, NEUROSCI LETT, V414, P57, DOI 10.1016/j.neulet.2006.12.025; Shankaran SS, 2008, J BIOL CHEM, V283, P1744, DOI 10.1074/jbc.M705115200; Sheng JH, 2014, GENE, V542, P141, DOI 10.1016/j.gene.2014.03.041; Smith KR, 2012, AM J HUM GENET, V90, P1102, DOI 10.1016/j.ajhg.2012.04.021; St Martin JL, 2007, J NEUROCHEM, V100, P1449, DOI 10.1111/j.1471-4159.2006.04310.x; Suh HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035115; Tanaka Y, 2013, NEUROSCIENCE, V250, P8, DOI 10.1016/j.neuroscience.2013.06.049; Tanaka Y, 2013, NEUROSCIENCE, V231, P49, DOI 10.1016/j.neuroscience.2012.11.032; Tanaka Y, 2017, HUM MOL GENET, V26, P969, DOI 10.1093/hmg/ddx011; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Valdez C, 2020, HUM MOL GENET, V29, P716, DOI 10.1093/hmg/ddz229; Valdez C, 2017, HUM MOL GENET, V26, P4861, DOI 10.1093/hmg/ddx364; Van Damme P, 2008, J CELL BIOL, V181, P37, DOI 10.1083/jcb.200712039; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; van der Zee J, 2011, BRAIN, V134, P808, DOI 10.1093/brain/awr007; Voskobiynyk Y, 2020, ELIFE, V9, DOI 10.7554/eLife.57354; Wang C, 2018, CURR OPIN NEUROBIOL, V48, P52, DOI 10.1016/j.conb.2017.09.005; Wang WZ, 2011, BRAIN RES, V1389, P61, DOI 10.1016/j.brainres.2011.02.083; Wang Y, 2008, AUTOPHAGY, V4, P214, DOI 10.4161/auto.5369; Wang Y, 2009, EUR J NEUROSCI, V30, P2258, DOI 10.1111/j.1460-9568.2009.07025.x; Ward ME, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5642; WILLIAMS MA, 1990, J CELL BIOL, V111, P955, DOI 10.1083/jcb.111.3.955; Xu JD, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2011.06.017; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang JS, 2020, NATURE, V588, P459, DOI 10.1038/s41586-020-2709-7; Zhang YJ, 2007, J NEUROSCI, V27, P10530, DOI 10.1523/JNEUROSCI.3421-07.2007; Zhou XL, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212382; Zhou XL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0205-9; Zhou XL, 2017, ACTA NEUROPATHOL, V134, P151, DOI 10.1007/s00401-017-1719-5; Zhou XL, 2015, J CELL BIOL, V210, P991, DOI 10.1083/jcb.201502029; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	97	5	5	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100993	10.1016/j.jbc.2021.100993	http://dx.doi.org/10.1016/j.jbc.2021.100993			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF5RS	34298019	gold, Green Published			2022-12-28	WOS:000706361700009
J	Littler, DR; Mohanty, B; Lowery, SA; Colson, RN; Gully, BS; Perlman, S; Scanlon, MJ; Rossjohn, J				Littler, Dene R.; Mohanty, Biswaranjan; Lowery, Shea A.; Colson, Rhys N.; Gully, Benjamin S.; Perlman, Stanley; Scanlon, Martin J.; Rossjohn, Jamie			Binding of a pyrimidine RNA base-mimic to SARS-CoV-2 nonstructural protein 9	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORONAVIRUS; REPLICATION; NSP9	The coronaviral nonstructural protein 9 (Nsp9) is essential for viral replication; it is the primary substrate of Nsp12's pseudokinase domain within the viral replication transcription complex, an association that also recruits other components during different stages of RNA reproduction. In the unmodified state, Nsp9 forms an obligate homodimer via an essential GxxxG protein-interaction motif, but its ssRNA-binding mechanism remains unknown. Using structural biological techniques, here we show that a base-mimicking compound identified from a small molecule fragment screen engages Nsp9 via a tetrameric Pi-Pi stacking interaction that induces the formation of a parallel trimer-of-dimers. This oligomerization mechanism allows an interchange of "latching" N-termini, the charges of which contribute to a series of electropositive channels that suggests a potential interface for viral RNA. The identified pyrrolo-pyrimidine compound may also serve as a potential starting point for the development of compounds seeking to probe Nsp9's role within SARS-CoV-2 replication.	[Littler, Dene R.; Colson, Rhys N.; Gully, Benjamin S.; Rossjohn, Jamie] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia; [Mohanty, Biswaranjan] Univ Sydney, Sydney Analyt Core Res Facil, Sydney, NSW, Australia; [Mohanty, Biswaranjan; Scanlon, Martin J.] Monash Univ, Monash Inst Pharmaceut Sci, ARC Ctr Fragment Based Design, Parkville, Vic, Australia; [Lowery, Shea A.; Perlman, Stanley] Univ Iowa, Dept Microbiol & Immunol, Iowa City, IA USA; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, Wales	Monash University; Monash University; University of Sydney; Monash University; University of Iowa; Cardiff University	Littler, DR; Rossjohn, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Infect & Immun Program, Clayton, Vic, Australia.; Scanlon, MJ (corresponding author), Monash Univ, Monash Inst Pharmaceut Sci, Med Chem, Parkville, Vic, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Cardiff, Wales.	dene.littler@monash.edu; martin.scanlon@monash.edu; jamie.rossjohn@monash.edu	Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Scanlon, Martin/0000-0002-9230-7506; Gully, Benjamin/0000-0002-8197-0871; Littler, Dene/0000-0001-5904-1905	Australian Research Council Centre of Excellence for Advanced Molecular Imaging; Australian Research Council Centre for Fragment-Based Design	Australian Research Council Centre of Excellence for Advanced Molecular Imaging(Australian Research Council); Australian Research Council Centre for Fragment-Based Design(Australian Research Council)	Funding for the work originated from the Australian Research Council Centre of Excellence for Advanced Molecular Imaging and the Centre for Fragment-Based Design. This research was undertaken in part using the MX2 beamline at the Australian Synchrotron, part of ANSTO, and made use of the Australian Cancer Research Foundation (ACRF) detector. Additionally, we thank Dr Geoffrey Kong of the Monash Molecular Crystallisation Facility for his assistance with crystallographic screening and optimization. We thank A. RiboldiTunnicliffe and R. Williamson for assistance with data collection.	Aragao D, 2018, J SYNCHROTRON RADIAT, V25, P885, DOI 10.1107/S1600577518003120; Banerjee AK, 2020, CELL, V183, P1325, DOI 10.1016/j.cell.2020.10.004; Brockway SM, 2003, J VIROL, V77, P10515, DOI 10.1128/JVI.77.19.10515-10527.2003; Casanal A, 2020, PROTEIN SCI, V29, P1069, DOI 10.1002/pro.3791; Chen J, 2020, CELL, V182, P1560, DOI 10.1016/j.cell.2020.07.033; Chen JP, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.00853; Egloff MP, 2004, P NATL ACAD SCI USA, V101, P3792, DOI 10.1073/pnas.0307877101; El-Kamand S, 2022, PROTEINS, V90, P176, DOI 10.1002/prot.26205; Dudas EF, 2021, BIOMOL NMR ASSIGN, V15, P235, DOI 10.1007/s12104-021-10011-0; Fehr AR, 2020, METHODS MOL BIOL, V2099, P53, DOI 10.1007/978-1-0716-0211-9_5; Frieman M, 2012, J VIROL, V86, P884, DOI 10.1128/JVI.05957-11; Glanzer JG, 2016, J ANTIMICROB CHEMOTH, V71, P3432, DOI 10.1093/jac/dkw340; Ivanov KA, 2004, J VIROL, V78, P5619, DOI 10.1128/JVI.78.11.5619-5632.2004; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kirchdoerfer RN, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10280-3; Lehmann KC, 2015, NUCLEIC ACIDS RES, V43, P8416, DOI 10.1093/nar/gkv838; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Littler DR, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101258; Lu D, 2010, P NATL ACAD SCI USA, V107, P633, DOI 10.1073/pnas.0909191107; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Miknis ZJ, 2009, J VIROL, V83, P3007, DOI 10.1128/JVI.01505-08; Nebl S, 2020, J BIOMOL NMR, V74, P595, DOI 10.1007/s10858-020-00339-5; Ponnusamy R, 2008, J MOL BIOL, V383, P1081, DOI 10.1016/j.jmb.2008.07.071; Sawicki S G, 1995, Adv Exp Med Biol, V380, P499; Slanina H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2022310118; Smith EC, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003760; Snijder EJ, 2016, ADV VIRUS RES, V96, P59, DOI 10.1016/bs.aivir.2016.08.008; Snijder EJ, 2006, J VIROL, V80, P5927, DOI 10.1128/JVI.02501-05; Sola I, 2015, ANNU REV VIROL, V2, P265, DOI 10.1146/annurev-virology-100114-055218; Sutton G, 2004, STRUCTURE, V12, P341, DOI 10.1016/j.str.2004.01.016; Taylor A, 2018, METHOD ENZYMOL, V610, P97, DOI 10.1016/bs.mie.2018.09.018; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Yan LM, 2021, CELL, V184, P3474, DOI 10.1016/j.cell.2021.05.033; Yan LM, 2021, CELL, V184, P184, DOI 10.1016/j.cell.2020.11.016; Yin WC, 2020, SCIENCE, V368, P1499, DOI 10.1126/science.abc1560; Zeng Z, 2018, J VIROL, V92, DOI 10.1128/JVI.00692-18; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	38	5	5	3	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101018	10.1016/j.jbc.2021.101018	http://dx.doi.org/10.1016/j.jbc.2021.101018			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34331944	Green Accepted, Green Published, gold			2022-12-28	WOS:000706408900014
J	Perdigao, C; Barata, MA; Burrinha, T; Almeida, CG				Perdigao, Catarina; Barata, Mariana A.; Burrinha, Tatiana; Almeida, Claudia Guimas			Alzheimer's disease BIN1 coding variants increase intracellular A beta levels by interfering with BACE1 recycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYLOID PRECURSOR PROTEIN; SECRETASE CLEAVAGE; AMPHIPHYSIN FAMILY; CRYSTAL-STRUCTURE; SH3 DOMAIN; ENDOCYTOSIS; IDENTIFICATION; ACCUMULATION; LOCI; BIN1/AMPHIPHYSIN-II	Genetic studies have identified BIN1 as the second most important risk locus associated with late-onset Alzheimer's disease (LOAD). However, it is unclear how mutation of this locus mechanistically promotes Alzheimer's disease (AD) pathology. Here we show the consequences of two coding variants in BIN1 (rs754834233 and rs138047593), both in terms of intracellular beta-amyloid (iAbeta) accumulation and early endosome enlargement, two interrelated early cytopathological AD phenotypes, supporting their association with LOAD risk. We previously found that Bin1 deficiency potentiates iAbeta production by enabling BACE1 cleavage of the amyloid precursor protein in enlarged early endosomes due to decreased BACE1 recycling. Here, we discovered that the expression of the two LOAD mutant forms of Bin1 does not rescue the iAbeta accumulation and early endosome enlargement induced by Bin1 knockdown and recovered by wild-type Bin1. Moreover, the overexpression of Bin1 mutants, but not wild-type Bin1, increased the iAbeta42 fragment by reducing the recycling of BACE1, which accumulated in early endosomes, recapitulating the phenotype of Bin1 knockdown. We showed that the mutations in Bin1 reduced its interaction with BACE1. The endocytic recycling of transferrin was similarly affected, indicating that Bin1 is a general regulator of endocytic recycling. These data demonstrate that the LOAD-coding variants in Bin1 lead to a loss of function in endocytic recycling, which may be an early causal mechanism of LOAD.	[Perdigao, Catarina; Barata, Mariana A.; Burrinha, Tatiana; Almeida, Claudia Guimas] Univ Nova Lisboa, NOVA Med Sch, NMS, CEDOC,iNOVA4Hlth, Lisbon, Portugal	Universidade Nova de Lisboa	Almeida, CG (corresponding author), Univ Nova Lisboa, NOVA Med Sch, NMS, CEDOC,iNOVA4Hlth, Lisbon, Portugal.	claudia.almeida@nms.unl.pt	Barata, Mariana/AAN-9261-2020; Burrinha, Tatiana/GQP-1961-2022	Burrinha, Tatiana/0000-0003-0166-6552; Guimas Almeida, Claudia/0000-0001-9384-2896; Perdigao, Catarina/0000-0002-8528-078X	Maratona da Saude; FCT (Portugal) [CEECIND/00410/2017]; Alzheimer's Association [ALZ AARG-19-618007]; European Union [811087]; FCT [PD/BD/128374/2017, SFRH/BD/131513/2017, 2020.06758.BD]	Maratona da Saude; FCT (Portugal)(Portuguese Foundation for Science and TechnologyEuropean Commission); Alzheimer's Association(Alzheimer's Association); European Union(European Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	C. G. A. has obtained funding from Maratona da Saude 2016; CEECIND/00410/2017 financed by FCT (Portugal) ; ALZ AARG-19-618007 (Alzheimer's Association) ; the European Union's Horizon 2020 research and innovation pro-gram under grant agreement No 811087 (Lysocil) . C. B. P. was the recipient of an FCT doctoral fellowship (PD/BD/128374/2017) . T. B. is the recipient of an FCT doctoral fellowship (SFRH/BD/131513/2017) . M. A. B. is the recipient of an FCT doctoral fellowship (2020.06758.BD) .	Almeida CG, 2006, J NEUROSCI, V26, P4277, DOI 10.1523/JNEUROSCI.5078-05.2006; Andrew RJ, 2019, J BIOL CHEM, V294, P4477, DOI 10.1074/jbc.RA118.006379; Barral S, 2012, NEUROLOGY, V78, P1464, DOI 10.1212/WNL.0b013e3182553c48; Betts M.J., 2007, BIOINFORMATICS GENET, DOI [10.1002/9780470059180.ch13, DOI 10.1002/0470867302.CH14]; Burrinha T, 2021, J CELL SCI, V134, DOI 10.1242/jcs.255752; Butler MH, 1997, J CELL BIOL, V137, P1355, DOI 10.1083/jcb.137.6.1355; Cai T, 2020, J BIOCHEM, V167, P463, DOI 10.1093/jb/mvz110; Calafate S, 2016, CELL REP, V17, P931, DOI 10.1016/j.celrep.2016.09.063; Casal E, 2006, BIOCHEMISTRY-US, V45, P12917, DOI 10.1021/bi060717k; Cataldo AM, 2000, AM J PATHOL, V157, P277, DOI 10.1016/S0002-9440(10)64538-5; Chapuis J, 2013, MOL PSYCHIATR, V18, P1225, DOI 10.1038/mp.2013.1; Chia PZC, 2013, TRAFFIC, V14, P997, DOI 10.1111/tra.12088; Cirrito JR, 2008, NEURON, V58, P42, DOI 10.1016/j.neuron.2008.02.003; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; de Chaumont F, 2012, NAT METHODS, V9, P690, DOI [10.1038/NMETH.2075, 10.1038/nmeth.2075]; De Rossi P, 2019, BRAIN PATHOL, V29, P485, DOI 10.1111/bpa.12687; De Rossi P, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0124-1; Edgar JR, 2015, J CELL SCI, V128, P2520, DOI 10.1242/jcs.170233; Evergren E, 2004, TRAFFIC, V5, P514, DOI 10.1111/j.1398-9219.2004.00198.x; Almeida JFF, 2018, J MOL NEUROSCI, V64, P471, DOI 10.1007/s12031-018-1045-y; Glennon EB, 2020, BRAIN COMMUN, V2, DOI 10.1093/braincomms/fcaa011; Glennon EBC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078806; Gouras GK, 2000, AM J PATHOL, V156, P15, DOI 10.1016/S0002-9440(10)64700-1; Gouras GK, 2012, LIFE SCI, V91, P1153, DOI 10.1016/j.lfs.2012.06.004; Holler CJ, 2014, J ALZHEIMERS DIS, V42, P1221, DOI 10.3233/JAD-132450; Hu XL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016616; Iizuka T, 1996, BIOCHEM BIOPH RES CO, V218, P238, DOI 10.1006/bbrc.1996.0042; Jin LW, 2004, AM J PATHOL, V164, P975, DOI 10.1016/S0002-9440(10)63185-9; Kamboh MI, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.45; Karch CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050976; Kim NY, 2017, ALZHEIMERS RES THER, V9, DOI 10.1186/s13195-016-0232-8; Knobloch M, 2007, NEUROBIOL AGING, V28, P1297, DOI 10.1016/j.neurobiolaging.2006.06.019; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lee JH, 2011, ARCH NEUROL-CHICAGO, V68, P320, DOI 10.1001/archneurol.2010.292; Leprince C, 2003, J CELL SCI, V116, P1937, DOI 10.1242/jcs.00403; Leprince C, 1997, J BIOL CHEM, V272, P15101, DOI 10.1074/jbc.272.24.15101; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MAYER BJ, 1995, CURR BIOL, V5, P364, DOI 10.1016/S0960-9822(95)00073-X; Miyagawa T, 2016, HUM MOL GENET, V25, P2948, DOI 10.1093/hmg/ddw146; Morais VA, 2008, FEBS LETT, V582, P427, DOI 10.1016/j.febslet.2008.01.003; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Muller AJ, 2003, MOL CELL BIOL, V23, P4295, DOI 10.1128/MCB.23.12.4295-4306.2003; Nicot AS, 2007, NAT GENET, V39, P1134, DOI 10.1038/ng2086; Owen DJ, 1998, EMBO J, V17, P5273, DOI 10.1093/emboj/17.18.5273; Pant S, 2009, NAT CELL BIOL, V11, P1399, DOI 10.1038/ncb1986; Peter BJ, 2004, SCIENCE, V303, P495, DOI 10.1126/science.1092586; Rajendran L, 2008, SCIENCE, V320, P520, DOI 10.1126/science.1156609; Ramjaun AR, 1997, J BIOL CHEM, V272, P16700, DOI 10.1074/jbc.272.26.16700; Ramjaun AR, 1998, J NEUROCHEM, V70, P2369; REFOLO LM, 1995, J NEUROSCI RES, V40, P694, DOI 10.1002/jnr.490400515; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Safari F, 2012, MEMBRANES, V2, DOI 10.3390/membranes2010091; Sakane H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093509; Sannerud R, 2016, CELL, V166, P193, DOI 10.1016/j.cell.2016.05.020; Sannerud R, 2011, P NATL ACAD SCI USA, V108, pE559, DOI 10.1073/pnas.1100745108; Sartori M, 2019, ACTA NEUROPATHOL, V138, P631, DOI 10.1007/s00401-019-02017-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Takahashi RH, 2004, J NEUROSCI, V24, P3592, DOI 10.1523/JNEUROSCI.5167-03.2004; Tan MS, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.01.151; Tan MS, 2013, TRENDS MOL MED, V19, P594, DOI 10.1016/j.molmed.2013.06.004; Toh WH, 2018, MOL BIOL CELL, V29, P191, DOI 10.1091/mbc.E17-05-0270; Traer CJ, 2007, NAT CELL BIOL, V9, P1370, DOI 10.1038/ncb1656; Ubelmann F, 2017, BIO-PROTOCOL, V7, DOI 10.21769/BioProtoc.2635; Ubelmann F, 2017, EMBO REP, V18, P102, DOI 10.15252/embr.201642738; URMONEIT B, 1995, J MOL NEUROSCI, V6, P23, DOI 10.1007/BF02736756; Vardarajan BN, 2015, ANN NEUROL, V78, P487, DOI 10.1002/ana.24466; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Wigge P, 1997, MOL BIOL CELL, V8, P2003, DOI 10.1091/mbc.8.10.2003; Wigge P, 1998, TRENDS NEUROSCI, V21, P339, DOI 10.1016/S0166-2236(98)01264-8; Wijsman EM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001308; Wolfe MS, 2019, NEUROCHEM RES, V44, P5, DOI 10.1007/s11064-018-2511-1; WU XD, 1995, STRUCTURE, V3, P215, DOI 10.1016/S0969-2126(01)00151-4; Yang AJ, 1998, J NEUROSCI RES, V52, P691, DOI 10.1002/(SICI)1097-4547(19980615)52:6<691::AID-JNR8>3.0.CO;2-3; Zhao YQ, 2008, TRAFFIC, V9, P2253, DOI 10.1111/j.1600-0854.2008.00819.x; Zou L, 2007, CELL RES, V17, P389, DOI 10.1038/cr.2007.5	78	3	3	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101056	10.1016/j.jbc.2021.101056	http://dx.doi.org/10.1016/j.jbc.2021.101056			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34375641	gold, Green Published			2022-12-28	WOS:000706409400001
J	Srivastava, P; Garg, A; Misra, RC; Chanotiya, CS; Ghosh, S				Srivastava, Payal; Garg, Anchal; Misra, Rajesh Chandra; Chanotiya, Chandan Singh; Ghosh, Sumit			UGT86C11 is a novel plant UDP-glycosyltransferase involved in labdane diterpene biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANDROGRAPHIS-PANICULATA; BIOACTIVE DITERPENOIDS; DIPHOSPHATE SYNTHASE; IN-VITRO; METABOLISM; ACID; GLUCOSYLTRANSFERASE; NEOANDROGRAPHOLIDE; RESISTANCE; GLYCOSYLATION	Glycosyltransferases constitute a large family of enzymes across all domains of life, but knowledge of their biochemical function remains largely incomplete, particularly in the context of plant specialized metabolism. The labdane diterpenes represent a large class of phytochemicals with many pharmacological benefits, such as anti-inflammatory, hepatoprotective, and anticarcinogenic. The medicinal plant kalmegh (Andrographis paniculata) pro-duces bioactive labdane diterpenes; notably, the C19-hydroxyl diterpene (andrograpanin) is predominantly found as C19-O-glucoside (neoandrographolide), whereas diterpenes having additional hydroxylation(s) at C3 (14-deoxy-11,12-didehydroan-drographolide) or C3 and C14 (andrographolide) are primarily detected as aglycones, signifying scaffold-selective C19-O-gluco-sylation of diterpenes in planta. Here, we analyzed UDP-glycosyltransferase (UGT) activity and diterpene levels across various developmental stages and tissues and found an apparent correlation of UGT activity with the spatiotemporal accumulation of neoandrographolide, the major diterpene C19-O-glucoside. The biochemical analysis of recombinant UGTs preferentially expressed in neoandrographolide-accumulating tissues identified a previously uncharacterized UGT86 member (ApUGT12/ UGT86C11) that catalyzes C19-O-glucosylation of diterpenes with strict scaffold selectivity. ApUGT12 localized to the cyto-plasm and catalyzed diterpene C19-O-glucosylation in planta. The substrate selectivity demonstrated by the recombinant ApUGT12 expressed in plant and bacterium hosts was comparable to native UGT activity. Recombinant ApUGT12 showed signifi- cantly higher catalytic efficiency using andrograpanin compared with 14-deoxy-11,12-didehydroandrographolide and trivial ac-tivity using andrographolide. Moreover, ApUGT12 silencing in plants led to a drastic reduction in neoandrographolide content and increased levels of andrograpanin. These data suggest the involvement of ApUGT12 in scaffold-selective C19-O-glucosyla-tion of labdane diterpenes in plants. This knowledge of UGT86 function might help in developing plant chemotypes and synthesis of pharmacologically relevant diterpenes.	[Srivastava, Payal; Garg, Anchal; Misra, Rajesh Chandra; Ghosh, Sumit] Council Sci & Ind Res Cent Inst Med & Aromat Plan, Plant Biotechnol Div, Lucknow, Uttar Pradesh, India; [Srivastava, Payal; Ghosh, Sumit] Acad Sci & Innovat Res AcSIR, Ghaziabad, India; [Chanotiya, Chandan Singh] Council Sci & Ind Res Cent Inst Med & Aromat Plan, Phytochem Div, Lucknow, Uttar Pradesh, India; [Misra, Rajesh Chandra] John Innes Ctr, Biochem & Metab Dept, Norwich, Norfolk, England	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); Academy of Scientific & Innovative Research (AcSIR); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Institute of Medicinal & Aromatic Plants (CIMAP); UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Ghosh, S (corresponding author), Council Sci & Ind Res Cent Inst Med & Aromat Plan, Plant Biotechnol Div, Lucknow, Uttar Pradesh, India.; Ghosh, S (corresponding author), Acad Sci & Innovat Res AcSIR, Ghaziabad, India.	sumitg80@gmail.com	Misra, Rajesh Chandra/AAS-7119-2020	Misra, Rajesh Chandra/0000-0001-9594-3789; GARG, ANCHAL/0000-0002-1546-6810; Chanotiya, Dr CS/0000-0001-9802-0162	Indian National Science Academy [SP/YSP/126/2016/217]; Council of Scientific and Industrial Research [HCP-10]; CSIR	Indian National Science Academy; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	S. G. received research grants from the Indian National Science Academy (SP/YSP/126/2016/217) and the Council of Scientific and Industrial Research (HCP-10). P. S. acknowledges the CSIR for research fellowship.	Adiji OA, 2021, PLANT PHYSIOL, V185, P1617, DOI 10.1093/plphys/kiab016; Batkhuu J, 2002, BIOL PHARM BULL, V25, P1169, DOI 10.1248/bpb.25.1169; Baulcombe DC, 2004, TRENDS BIOCHEM SCI, V29, P279, DOI 10.1016/j.tibs.2004.04.007; Bowles D, 2006, ANNU REV PLANT BIOL, V57, P567, DOI 10.1146/annurev.arplant.57.032905.105429; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazier-Hicks M, 2007, P NATL ACAD SCI USA, V104, P20238, DOI 10.1073/pnas.0706421104; Burgos RA, 2021, MOLECULES, V26, DOI 10.3390/molecules26010005; Cai JH, 2021, MOL PLANT, V14, P440, DOI 10.1016/j.molp.2020.12.018; Chae L, 2014, SCIENCE, V344, P510, DOI 10.1126/science.1252076; Cherukupalli N, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01203; Ding Y, 2019, NAT PLANTS, V5, P1043, DOI 10.1038/s41477-019-0509-6; Erb M, 2020, PLANT PHYSIOL, V184, P39, DOI 10.1104/pp.20.00433; Fellenberg C, 2020, PLANT J, V102, P99, DOI 10.1111/tpj.14615; Fernie AR, 2017, ANNU REV GENET, V51, P287, DOI 10.1146/annurev-genet-120116-024640; Gachon CMM, 2005, TRENDS PLANT SCI, V10, P542, DOI 10.1016/j.tplants.2005.09.007; Garg A, 2021, PROTOPLASMA, V258, P1155, DOI 10.1007/s00709-021-01631-3; Garg A, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1864-y; Haroth S, 2019, J BIOL CHEM, V294, P9858, DOI 10.1074/jbc.RA119.007600; He Y, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.574775; Heiling S, 2021, PLANT CELL, V33, P1748, DOI 10.1093/plcell/koab048; Heskes AM, 2018, PLANT J, V93, P943, DOI 10.1111/tpj.13822; Jackson RG, 2001, J BIOL CHEM, V276, P4350, DOI 10.1074/jbc.M006185200; Jiang MY, 2021, J ETHNOPHARMACOL, V272, DOI 10.1016/j.jep.2021.113954; Jing TT, 2020, J EXP BOT, V71, P7018, DOI 10.1093/jxb/eraa373; KAPIL A, 1993, BIOCHEM PHARMACOL, V46, P182, DOI 10.1016/0006-2952(93)90364-3; Kim MJ, 2019, PLANT BIOTECHNOL J, V17, P1037, DOI 10.1111/pbi.13035; Kumar A, 2021, PLANT J, V107, P1403, DOI 10.1111/tpj.15388; Kumar S, 2014, J CHROMATOGR SCI, V52, P1043, DOI 10.1093/chromsci/bmt157; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Lacchini E, 2020, ANNU REV CELL DEV BI, V36, P291, DOI 10.1146/annurev-cellbio-011620-031429; Lairson LL, 2008, ANNU REV BIOCHEM, V77, P521, DOI 10.1146/annurev.biochem.76.061005.092322; Li YJ, 2015, PLANT SCI, V236, P157, DOI 10.1016/j.plantsci.2015.04.002; Li Y, 2018, ORG LETT, V20, P5999, DOI 10.1021/acs.orglett.8b02146; Liang ZT, 2009, J FOOD DRUG ANAL, V17, P69; Lim EK, 2004, EMBO J, V23, P2915, DOI 10.1038/sj.emboj.7600295; Liu J, 2008, INT IMMUNOPHARMACOL, V8, P951, DOI 10.1016/j.intimp.2007.12.014; Liu J, 2007, AM J CHINESE MED, V35, P317, DOI 10.1142/S0192415X07004849; Liu YL, 2002, PLANT J, V30, P415, DOI 10.1046/j.1365-313X.2002.01297.x; Lo CW, 2021, TOXICOL APPL PHARM, V410, DOI 10.1016/j.taap.2020.115341; Louveau T, 2018, PLANT CELL, V30, P3038, DOI 10.1105/tpc.18.00641; Lu R, 2003, METHODS, V30, P296, DOI 10.1016/S1046-2023(03)00037-9; Mageroy MH, 2017, PLANT PHYSIOL, V175, P641, DOI 10.1104/pp.17.00611; Majumdar M, 2020, WORLD J MICROB BIOT, V36, DOI 10.1007/s11274-020-02919-x; Misra RC, 2017, NEW PHYTOL, V214, P706, DOI 10.1111/nph.14412; Misra RC, 2015, PLANT SCI, V240, P50, DOI 10.1016/j.plantsci.2015.08.016; Misra RC, 2014, PLANT PHYSIOL, V164, P1028, DOI 10.1104/pp.113.232884; Nagatoshi M, 2011, J BIOL CHEM, V286, P32866, DOI 10.1074/jbc.M111.242586; Nakagawa T, 2007, BIOSCI BIOTECH BIOCH, V71, P2095, DOI 10.1271/bbb.70216; Nantajit D, 2017, RADIAT RES, V188, P66, DOI 10.1667/RR14698.1; Owatworakit A, 2013, J BIOL CHEM, V288, P3696, DOI 10.1074/jbc.M112.426155; Peters RJ, 2010, NAT PROD REP, V27, P1521, DOI 10.1039/c0np00019a; Pfisterer PH, 2010, PLANTA MED, V76, P1698, DOI 10.1055/s-0030-1249876; Pichersky E, 2018, NEW PHYTOL, V220, P692, DOI 10.1111/nph.14178; Rao YK, 2004, PHYTOCHEMISTRY, V65, P2317, DOI 10.1016/j.phytochem.2004.05.008; Richman A, 2005, PLANT J, V41, P56, DOI 10.1111/j.1365-313X.2004.02275.x; Sandeep, 2019, NEW PHYTOL, V222, P408, DOI 10.1111/nph.15606; Seki H, 2015, PLANT CELL PHYSIOL, V56, P1463, DOI 10.1093/pcp/pcv062; Shah SA, 2008, J CHROMATOGR SCI, V46, P735, DOI 10.1093/chromsci/46.8.735; Shao H, 2005, PLANT CELL, V17, P3141, DOI 10.1105/tpc.105.035055; Shu Y., 2020, PLANTA MED INT, V7, pE45; Srivastava G, 2020, PLANT SCI, V292, DOI 10.1016/j.plantsci.2019.110382; Stucky DF, 2015, J EXP BOT, V66, P189, DOI 10.1093/jxb/eru410; Sun GX, 2020, PLANT PHYSIOL, V184, P1744, DOI 10.1104/pp.20.00953; Sun W, 2019, PLANT J, V97, P841, DOI 10.1111/tpj.14162; Sun YW, 2018, MOL PLANT, V11, P1308, DOI 10.1016/j.molp.2018.05.010; Tiwari P, 2016, BIOTECHNOL ADV, V34, P714, DOI 10.1016/j.biotechadv.2016.03.006; Tognetti VB, 2010, PLANT CELL, V22, P2660, DOI 10.1105/tpc.109.071316; Valdiani A, 2017, CRIT REV BIOTECHNOL, V37, P803, DOI 10.1080/07388551.2016.1260525; Wang HX, 2018, J EXP BOT, V69, P5445, DOI 10.1093/jxb/ery305; Weigel D, 2006, CSH PROTOC, V2006, P4666, DOI DOI 10.1093/mp/sst004; Wiart C, 2005, PHYTOTHER RES, V19, P1069, DOI 10.1002/ptr.1765; Wilson AE, 2019, PLANT J, V100, P1273, DOI 10.1111/tpj.14514; Wu BP, 2019, J EXP BOT, V70, P925, DOI 10.1093/jxb/ery419; Yang T, 2013, PHYTOTHER RES, V27, P618, DOI 10.1002/ptr.4771; Yonekura-Sakakibara K, 2011, PLANT J, V66, P182, DOI 10.1111/j.1365-313X.2011.04493.x; Zerbe P, 2015, PLANT J, V83, P783, DOI 10.1111/tpj.12925; Zi JC, 2014, ANNU REV PLANT BIOL, V65, P259, DOI 10.1146/annurev-arplant-050213-035705	77	5	5	9	23	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101045	10.1016/j.jbc.2021.101045	http://dx.doi.org/10.1016/j.jbc.2021.101045			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34363833	Green Published, gold			2022-12-28	WOS:000704369100010
J	Zhang, XN; Li, X; Jia, HT; An, GS; Ni, JH				Zhang, Xinning; Li, Xin; Jia, Hongti; An, Guoshun; Ni, Juhua			The m6A methyltransferase METTL3 modifies PGC-1 alpha mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PGC-1 COACTIVATORS; DIFFERENTIATION; EXPRESSION; RECEPTORS; BLOOD	Mitochondrial biogenesis and energy metabolism are essential for regulating the inflammatory state of monocytes. This state is partially controlled by peroxisome proliferatoractivated receptor gamma coactivator 1-alpha (PGC-1 alpha), a coactivator that regulates mitochondrial biogenesis and energy metabolism. Disruption of these processes can also contribute to the initiation of chronic inflammatory diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis. Methyltransferase-like 3 (METTL3)-dependent N6-methyl adenosine (m6A) methylation has recently been shown to regulate a variety of inflammatory processes. However, the role of m6A mRNA methylation in affecting mitochondrial metabolism in monocytes under inflammation is unclear, nor is there an established relationship between m6A methylation and PGC-1 alpha. In this study, we identified a novel mechanism by which METTL3 acts during oxidized low-density lipoprotein (oxLDL)-induced monocyte inflammation, where METTL3 and YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) cooperatively modify PGC-1 alpha mRNA, mediating its degradation, decreasing PGC-1 alpha protein levels, and thereby enhancing the inflammatory response. METTL3 coordinated with YTHDF2 to suppress the expression of PGC-1 alpha, as well as that of cytochrome c (CYCS) and NADH:ubiquinone oxidoreductase subunit C2 (NDUFC2) and reduced ATP production and oxygen consumption rate (OCR). This subsequently increased the accumulation of cellular and mitochondrial reactive oxygen species (ROS) and the levels of proinflammatory cytokines in inflammatory monocytes. These data may provide new insights into the role of METTL3-dependent m6A modification of PGC1 alpha mRNA in the monocyte inflammation response. These data also contribute to a more comprehensive understanding of the pathogenesis of monocyte-macrophage inflammation -associated diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis.	[Zhang, Xinning; Li, Xin; Jia, Hongti; An, Guoshun; Ni, Juhua] Peking Univ, Sch Basic Med Sci, Dept Biochem & Biophys, Beijing, Peoples R China	Peking University	Ni, JH (corresponding author), Peking Univ, Sch Basic Med Sci, Dept Biochem & Biophys, Beijing, Peoples R China.	juhuani@bjmu.edu.cn	Ni, jh/HDN-6081-2022	Zhang, Xinning/0000-0002-3617-3582	National Natural Science Foundation of China [81571368]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We would like to thank Guohui Dang for providing THP-1 cells. This work was supported by the National Natural Science Foundation of China (grant 81571368).	Arena G, 2018, MOL CELL, V69, P594, DOI 10.1016/j.molcel.2018.01.023; Auffray C, 2009, ANNU REV IMMUNOL, V27, P669, DOI 10.1146/annurev.immunol.021908.132557; BERLINER JA, 1990, J CLIN INVEST, V85, P1260, DOI 10.1172/JCI114562; Chen JC, 2019, GENOM PROTEOM BIOINF, V17, P154, DOI 10.1016/j.gpb.2018.12.007; Chen YL, 2019, CIRC RES, V125, P1087, DOI 10.1161/CIRCRESAHA.119.315833; Chimen M, 2020, HAEMATOLOGICA, V105, P1248, DOI 10.3324/haematol.2018.215145; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dorn GW, 2015, CIRC RES, V116, P167, DOI 10.1161/CIRCRESAHA.116.303554; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Duffield JS, 2010, SEMIN NEPHROL, V30, P234, DOI 10.1016/j.semnephrol.2010.03.003; EVANS MJ, 1989, J BIOL CHEM, V264, P14361; Feng ZH, 2018, J CELL MOL MED, V22, P2558, DOI 10.1111/jcmm.13491; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; FROSTEGARD J, 1990, P NATL ACAD SCI USA, V87, P904, DOI 10.1073/pnas.87.3.904; FROSTEGARD J, 1992, ARTERIOSCLER THROMB, V12, P461, DOI 10.1161/01.ATV.12.4.461; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Hnasko TS, 2015, METHODS MOL BIOL, V1318, P87, DOI 10.1007/978-1-4939-2742-5_9; Katschke KJ, 2001, ARTHRITIS RHEUM, V44, P1022, DOI 10.1002/1529-0131(200105)44:5<1022::AID-ANR181>3.3.CO;2-E; Li XB, 2017, P NATL ACAD SCI USA, V114, pE9655, DOI 10.1073/pnas.1712465114; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Liu L, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1119-7; Liu TF, 2012, J BIOL CHEM, V287, P25758, DOI 10.1074/jbc.M112.362343; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Scarpulla RC, 2011, BBA-MOL CELL RES, V1813, P1269, DOI 10.1016/j.bbamcr.2010.09.019; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Soyal S, 2006, DIABETOLOGIA, V49, P1477, DOI 10.1007/s00125-006-0268-6; Villena JA, 2015, FEBS J, V282, P647, DOI 10.1111/febs.13175; Vu LP, 2019, CANCER DISCOV, V9, P25, DOI 10.1158/2159-8290.CD-18-0959; Wang HM, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09903-6; Wang X, 2014, NATURE, V505, P117, DOI 10.1038/nature12730; Wang XB, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.122; Woollard KJ, 2010, NAT REV CARDIOL, V7, P77, DOI 10.1038/nrcardio.2009.228; Xu K, 2017, CELL RES, V27, P1100, DOI 10.1038/cr.2017.100; Zhang CY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00922; Zhang YW, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010199; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132; Zhou Y, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkw104; Zong X, 2019, J IMMUNOL, V202, P567, DOI 10.4049/jimmunol.1801151; Zuo H, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9010005; Zuroff L, 2017, CELL MOL LIFE SCI, V74, P2167, DOI 10.1007/s00018-017-2463-7	41	21	20	4	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101058	10.1016/j.jbc.2021.101058	http://dx.doi.org/10.1016/j.jbc.2021.101058			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34375639	Green Published, gold			2022-12-28	WOS:000706409400010
J	Franco, ML; Nadezhdin, KD; Light, TP; Goncharuk, SA; Soler-Lopez, A; Ahmed, F; Mineev, KS; Hristova, K; Arseniev, AS; Vilar, M				Franco, Maria L.; Nadezhdin, Kirill D.; Light, Taylor P.; Goncharuk, Sergey A.; Soler-Lopez, Andrea; Ahmed, Fozia; Mineev, Konstantin S.; Hristova, Kalina; Arseniev, Alexander S.; Vilar, Marcal			Interaction between the transmembrane domains of neurotrophin receptors p75 and TrkA mediates their reciprocal activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-AFFINITY NGF; FUNCTIONAL INTERACTIONS; INTRACELLULAR DOMAIN; STRUCTURAL BASIS; SENSORY NEURONS; IN-VIVO; DIMERIZATION; EXPRESSION; BINDING; ASSOCIATION	The neurotrophin receptors p75 and tyrosine protein kinase receptor A (TrkA) play important roles in the development and survival of the nervous system. Biochemical data suggest that p75 and TrkA reciprocally regulate the activities of each other. For instance, p75 is able to regulate the response of TrkA to lower concentrations of nerve growth factor (NGF), and TrkA promotes shedding of the extracellular domain of p75 by alpha-secretases in a ligand-dependent manner. The current model suggests that p75 and TrkA are regulated by means of a direct physical interaction; however, the nature of such interaction has been elusive thus far. Here, using NMR in micelles, multiscale molecular dynamics, FRET, and functional studies, we identified and characterized the direct interaction between TrkA and p75 through their respective transmembrane domains (TMDs). Molecular dynamics of p75-TMD mutants suggests that although the interaction between TrkA and p75 TMDs is maintained upon mutation, a specific protein interface is required to facilitate TrkA active homodimerization in the presence of NGF. The same mutations in the TMD protein interface of p75 reduced the activation of TrkA by NGF as well as reducing cell differentiation. In summary, we provide a structural model of the p75-TrkA receptor complex necessary for neuronal development stabilized by TMD interactions.	[Franco, Maria L.; Soler-Lopez, Andrea; Vilar, Marcal] Inst Biomed CSIC, Unit Mol Basis Neurodegenerat, Valencia, Spain; [Nadezhdin, Kirill D.; Goncharuk, Sergey A.; Mineev, Konstantin S.; Arseniev, Alexander S.] Russian Acad Sci, Dept Struct Biol, Lab NMR Spect, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia; [Light, Taylor P.; Ahmed, Fozia; Hristova, Kalina] Johns Hopkins Univ, Dept Mat Sci & Engn, Baltimore, MD 21218 USA; [Goncharuk, Sergey A.; Mineev, Konstantin S.] Moscow Inst Phys & Technol, Phystech Sch Biol & Med Phys, Moscow, Russia	Consejo Superior de Investigaciones Cientificas (CSIC); Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Johns Hopkins University; Moscow Institute of Physics & Technology	Vilar, M (corresponding author), Inst Biomed CSIC, Unit Mol Basis Neurodegenerat, Valencia, Spain.; Arseniev, AS (corresponding author), Russian Acad Sci, Dept Struct Biol, Lab NMR Spect, Shemyakin Ovchinnikov Inst Bioorgan Chem, Moscow, Russia.	aars@nmr.ru; mvilar@ibv.csic.es	Mineev, Konstantin S/Q-3948-2018; Vilar, Marcal/B-4581-2016	Mineev, Konstantin S/0000-0002-2418-9421; Nadezhdin, Kirill/0000-0002-7140-0779; Vilar, Marcal/0000-0002-9376-6544	Spanish Ministry of Economy and Competitiveness [BFU2013-42746-P, SAF2017-84096-R]; Generalitat Valenciana Prometeo grant [2018/055]; National Institutes of Health [GM068619]; Russian Science Foundation [19-74-30014]	Spanish Ministry of Economy and Competitiveness(Spanish Government); Generalitat Valenciana Prometeo grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Spanish Ministry of Economy and Competitiveness (project BFU2013-42746-P and SAF2017-84096-R), the Generalitat Valenciana Prometeo grant 2018/055 (to M. V.), and the National Institutes of Health GM068619 (to K. H.). NMR studies of TRKATM and p75-TM were supported by the Russian Science Foundation (grant no. 19-74-30014 to A. S. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ahmed F, 2020, BIOCHEM J, V477, P4515, DOI 10.1042/BCJ20200671; Ahmed F, 2018, BIOCHEM J, V475, P3669, DOI 10.1042/BCJ20180637; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Bibel M, 1999, EMBO J, V18, P616, DOI 10.1093/emboj/18.3.616; Biener G, 2014, INT J MOL SCI, V15, P261, DOI 10.3390/ijms15010261; Bothwell M, 2014, Handb Exp Pharmacol, V220, P3, DOI 10.1007/978-3-642-45106-5_1; BOTHWELL M, 1995, ANNU REV NEUROSCI, V18, P223, DOI 10.1146/annurev.neuro.18.1.223; Ceni Claire, 2014, Handb Exp Pharmacol, V220, P193, DOI 10.1007/978-3-642-45106-5_8; Chang MS, 2004, J NEUROSCI RES, V78, P186, DOI 10.1002/jnr.20262; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; CHAO MV, 1995, TRENDS NEUROSCI, V18, P321, DOI 10.1016/0166-2236(95)93922-K; Chavent M, 2014, BIOCHEMISTRY-US, V53, P6641, DOI 10.1021/bi500800x; Chen LR, 2010, J AM CHEM SOC, V132, P3628, DOI 10.1021/ja910692u; Chill JH, 2006, J BIOMOL NMR, V36, P123, DOI 10.1007/s10858-006-9071-4; DAVIES AM, 1993, NEURON, V11, P565, DOI 10.1016/0896-6273(93)90069-4; Deinhardt Katrin, 2014, Handb Exp Pharmacol, V220, P103, DOI 10.1007/978-3-642-45106-5_5; Esposito D, 2001, J BIOL CHEM, V276, P32687, DOI 10.1074/jbc.M011674200; Lacaruso MF, 2011, J MOL BIOL, V414, P681, DOI 10.1016/j.jmb.2011.09.022; Franco ML, 2020, J BIOL CHEM, V295, P275, DOI 10.1074/jbc.RA119.011312; Franco ML, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000844; Friedman WJ, 1999, EXP CELL RES, V253, P131, DOI 10.1006/excr.1999.4705; Hempstead B L, 2014, Handb Exp Pharmacol, V220, P17, DOI 10.1007/978-3-642-45106-5_2; HEMPSTEAD BL, 1991, NATURE, V350, P678, DOI 10.1038/350678a0; HOLTZMAN DM, 1995, J NEUROSCI, V15, P1567; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; HUBER LJ, 1995, J NEUROSCI RES, V40, P557, DOI 10.1002/jnr.490400415; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jung KM, 2003, J BIOL CHEM, V278, P42161, DOI 10.1074/jbc.M306028200; Kai L, 2012, METHODS MOL BIOL, V800, P201, DOI 10.1007/978-1-61779-349-3_14; Kanning KC, 2003, J NEUROSCI, V23, P5425, DOI 10.1523/jneurosci.23-13-05425.2003; King C, 2017, J BIOL CHEM, V292, P5291, DOI 10.1074/jbc.M116.764282; King C, 2016, INTEGR BIOL-UK, V8, P216, DOI 10.1039/c5ib00202h; Kot EF, 2020, BBA-BIOMEMBRANES, V1862, DOI 10.1016/j.bbamem.2020.183380; Kraemer B R, 2014, Handb Exp Pharmacol, V220, P121, DOI 10.1007/978-3-642-45106-5_6; LEE KF, 1992, CELL, V69, P737, DOI 10.1016/0092-8674(92)90286-L; LEE KF, 1994, DEVELOPMENT, V120, P1027; Lesovoy DM, 2017, J BIOMOL NMR, V69, P165, DOI 10.1007/s10858-017-0146-1; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Lukat G, 2013, J CHEM INF MODEL, V53, P2908, DOI 10.1021/ci400172g; MAHADEO D, 1994, J BIOL CHEM, V269, P6884; Majdan M, 1999, INT J DEV NEUROSCI, V17, P153, DOI 10.1016/S0736-5748(99)00016-7; Majdan M, 2001, J CELL BIOL, V155, P1275, DOI 10.1083/jcb.200110017; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Nadezhdin KD, 2016, J BIOL CHEM, V291, P12346, DOI 10.1074/jbc.M116.723585; Nykjaer A, 2004, NATURE, V427, P843, DOI 10.1038/nature02319; Paul MD, 2020, J BIOL CHEM, V295, P9917, DOI 10.1074/jbc.RA120.013639; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Raicu V, 2009, NAT PHOTONICS, V3, P107, DOI 10.1038/NPHOTON.2008.291; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rifkin JT, 2000, DEV BIOL, V227, P465, DOI 10.1006/dbio.2000.9841; Ross AH, 1996, J CELL BIOL, V132, P945, DOI 10.1083/jcb.132.5.945; Sarabipour S, 2014, ANAL BIOCHEM, V449, P155, DOI 10.1016/j.ab.2013.12.027; Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426; Shahane G, 2019, J MOL MODEL, V25, DOI 10.1007/s00894-019-3964-0; Sinha B, 2011, CELL, V144, P402, DOI 10.1016/j.cell.2010.12.031; Skeldal S, 2012, J BIOL CHEM, V287, P43798, DOI 10.1074/jbc.M112.374710; Sykes AM, 2012, J BIOL CHEM, V287, P43810, DOI 10.1074/jbc.M112.382903; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VERGE VMK, 1992, J NEUROSCI, V12, P4011; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wehrman T, 2007, NEURON, V53, P25, DOI 10.1016/j.neuron.2006.09.034; White FA, 1996, J NEUROSCI, V16, P4662; WOLF DE, 1995, J BIOL CHEM, V270, P2133, DOI 10.1074/jbc.270.5.2133; Yano H, 2000, Pharm Acta Helv, V74, P253, DOI 10.1016/S0031-6865(99)00036-9; Yoon SO, 1998, J NEUROSCI, V18, P3273; Zampieri N, 2006, BIOCHEM SOC T, V34, P607, DOI 10.1042/BST0340607	67	3	3	1	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100926	10.1016/j.jbc.2021.100926	http://dx.doi.org/10.1016/j.jbc.2021.100926			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34216618	Green Published, gold			2022-12-28	WOS:000690879300008
J	Gupta, R; Mittal, A; Agrawal, V; Gupta, S; Gupta, K; Jain, RR; Garg, P; Mohanty, SK; Sogani, R; Chhabra, HS; Gautam, V; Mishra, T; Sengupta, D; Ahuja, G				Gupta, Ria; Mittal, Aayushi; Agrawal, Vishesh; Gupta, Sushant; Gupta, Krishan; Jain, Rishi Raj; Garg, Prakriti; Mohanty, Sanjay Kumar; Sogani, Riya; Chhabra, Harshit Singh; Gautam, Vishakha; Mishra, Tripti; Sengupta, Debarka; Ahuja, Gaurav			OdoriFy: A conglomerate of artificial intelligence-driven prediction engines for olfactory decoding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ODORANT RECEPTORS; EVOLUTION; PROTEIN; HUMANS; GENES	The molecular mechanisms of olfaction, or the sense of smell, are relatively underexplored compared with other sensory systems, primarily because of its underlying molecular complexity and the limited availability of dedicated predictive computational tools. Odorant receptors (ORs) allow the detection and discrimination of a myriad of odorant molecules and therefore mediate the first step of the olfactory signaling cascade. To date, odorant (or agonist) information for the majority of these receptors is still unknown, limiting our understanding of their functional relevance in odor-induced behavioral responses. In this study, we introduce OdoriFy, a Web server featuring powerful deep neural network-based prediction engines. OdoriFy enables (1) identification of odorant molecules for wildtype or mutant human ORs (Odor Finder); (2) classification of user-provided chemicals as odorants/nonodorants (Odorant Predictor); (3) identification of responsive ORs for a query odorant (OR Finder); and (4) interaction validation using Odorant-OR Pair Analysis. In addition, OdoriFy provides the rationale behind every prediction it makes by leveraging explainable artificial intelligence. This module highlights the basis of the prediction of odorants/ nonodorants at atomic resolution and for the ORs at amino acid levels. A key distinguishing feature of OdoriFy is that it is built on a comprehensive repertoire of manually curated information of human ORs with their known agonists and nonagonists, making it a highly interactive and resource-enriched Web server. Moreover, comparative analysis of OdoriFy predictions with an alternative structure-based ligand interaction method revealed comparable results. OdoriFy is available freely as a web service at https://odorify.ahujalab.iiitd.edu.in/olfy/.	[Gupta, Ria; Mittal, Aayushi; Agrawal, Vishesh; Gupta, Sushant; Garg, Prakriti; Mohanty, Sanjay Kumar; Sogani, Riya; Gautam, Vishakha; Sengupta, Debarka; Ahuja, Gaurav] Indraprastha Inst Informat Technol Delhi IIIT Del, Dept Computat Biol, New Delhi, India; [Gupta, Krishan; Chhabra, Harshit Singh; Sengupta, Debarka] Indraprastha Inst Informat Technol Delhi IIIT Del, Dept Comp Sci & Engn, New Delhi, India; [Jain, Rishi Raj] Indraprastha Inst Informat Technol Delhi IIIT Del, Dept Comp Sci & Design, New Delhi, India; [Mishra, Tripti] Pathfinder Res & Training Fdn, Greater Noida, Uttar Pradesh, India; [Sengupta, Debarka] Indraprastha Inst Informat Technol, Ctr Artificial Intelligence, New Delhi, India; [Sengupta, Debarka] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia	Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi; Indraprastha Institute of Information Technology Delhi; Queensland University of Technology (QUT)	Ahuja, G (corresponding author), Indraprastha Inst Informat Technol Delhi IIIT Del, Dept Computat Biol, New Delhi, India.	gaurav.ahuja@iiitd.ac.in		Gupta, Krishan/0000-0002-3390-9494; Agrawal, Vishesh/0000-0002-7760-5628; Gupta, Ria/0000-0001-7120-042X; Mohanty, Sanjay/0000-0002-1375-2223	Department of Biotechnology, Ministry of Science & Technology, Government of India [BT/HRD/35/02/2006]; Science and Engineering Research Board [SRG/2020/000232]; Indraprastha Institute of Information Technology-Delhi; INSPIRE faculty grant from the Department of Science & Technology, India	Department of Biotechnology, Ministry of Science & Technology, Government of India(Department of Biotechnology (DBT) India); Science and Engineering Research Board; Indraprastha Institute of Information Technology-Delhi; INSPIRE faculty grant from the Department of Science & Technology, India	The Ahuja laboratory is supported by the Ramalingaswami Re-entry Fellowship (BT/HRD/35/02/2006), a re-entry scheme of the Department of Biotechnology, Ministry of Science & Technology, Government of India, Start-Up Research Grant (SRG/2020/000232) from the Science and Engineering Research Board, and an intramural start-up grant from Indraprastha Institute of Information Technology-Delhi. The Sengupta laboratory is funded by the INSPIRE faculty grant from the Department of Science & Technology, India.	Abaffy T, 2018, FRONT ONCOL, V8, DOI 10.3389/fonc.2018.00162; Abraham Mark James, 2015, SoftwareX, V1-2, P19, DOI 10.1016/j.softx.2015.06.001; Ahuja Gaurav, 2014, Commun Integr Biol, V7, DOI 10.4161/19420889.2014.970501; Ahuja G, 2014, SCI REP-UK, V4, DOI 10.1038/srep04037; Ahuja G, 2013, SCI REP-UK, V3, DOI 10.1038/srep02063; Bach S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130140; Baker N, 2017, ARXIV PREPRINT ARXIV; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Boesveldt S, 2021, CELL TISSUE RES, V383, P559, DOI 10.1007/s00441-020-03367-7; Boillat M, 2021, CELL TISSUE RES, V383, P387, DOI 10.1007/s00441-020-03393-5; BROWER KR, 1975, J CHEM EDUC, V52, P538, DOI 10.1021/ed052p538; Bushdid C, 2018, J PHYS CHEM LETT, V9, P2235, DOI 10.1021/acs.jpclett.8b00633; Bushdid C, 2014, SCIENCE, V343, P1370, DOI 10.1126/science.1249168; Bushdid C, 2018, METHODS MOL BIOL, V1820, P77, DOI 10.1007/978-1-4939-8609-5_7; Cao Y, 2008, BIOINFORMATICS, V24, P1733, DOI 10.1093/bioinformatics/btn307; Dagan-Wiener A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12359-7; Dibattista M, 2017, CHANNELS, V11, P399, DOI 10.1080/19336950.2017.1307489; Durante MA, 2020, NAT NEUROSCI, V23, P323, DOI 10.1038/s41593-020-0587-9; Feinstein P, 2004, CELL, V117, P833, DOI 10.1016/j.cell.2004.05.013; Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121; Flegel C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055368; Fuchs T, 2001, HUM GENET, V108, P1, DOI 10.1007/s004390000436; Gaillard I, 2004, CELL MOL LIFE SCI, V61, P456, DOI 10.1007/s00018-003-3273-7; Gelis L, 2017, EXP DERMATOL, V26, P569, DOI 10.1111/exd.13316; Gelis L, 2016, J BIOL CHEM, V291, P17772, DOI 10.1074/jbc.M116.734517; Gerkin RC, 2015, ELIFE, V4, DOI 10.7554/eLife.08127; Go Y, 2008, MOL BIOL EVOL, V25, P1897, DOI 10.1093/molbev/msn135; Grus WE, 2008, MOL BIOL EVOL, V25, P1593, DOI 10.1093/molbev/msn107; Gupta A., 2021, BIOINFORMATICS; Gupta K, 2021, BRIEF BIOINFORM, V22, P873, DOI 10.1093/bib/bbaa168; Hashiguchi Y, 2007, MOL BIOL EVOL, V24, P2099, DOI 10.1093/molbev/msm140; Huang WK, 2016, SCI REP-UK, V6, DOI 10.1038/srep23450; Hughes NK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013114; Hussain A, 2013, P NATL ACAD SCI USA, V110, P19579, DOI 10.1073/pnas.1318596110; Ihara Sayoko, 2018, Clin Calcium, V28, P1124, DOI CliCa180811241129; Jimenez-Luna J, 2020, NAT MACH INTELL, V2, P573, DOI 10.1038/s42256-020-00236-4; Johnson BA, 2005, J COMP NEUROL, V483, P192, DOI 10.1002/cne.20415; Joussain Pauline, 2011, Commun Integr Biol, V4, P563, DOI 10.4161/cib.4.5.15811; Jovancevic N, 2017, FRONT PHYSIOL, V8, DOI 10.3389/fphys.2017.00888; K?pf, 2019, ADV NEURAL INFORM PR, V32, P8024, DOI DOI 10.5555/3454287.3455008; Kalra S, 2021, FEBS J, V288, P4230, DOI 10.1111/febs.15606; Kalra S, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01232-5; Karpov P, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00423-w; Keller A, 2017, SCIENCE, V355, P820, DOI 10.1126/science.aal2014; Krishnan SR, 2021, J CHEM INF MODEL, V61, P621, DOI 10.1021/acs.jcim.0c01060; Lee SJ, 2019, NAT REV DRUG DISCOV, V18, P116, DOI 10.1038/s41573-018-0002-3; Licon CC, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006945; Liu XY, 2011, BIOINFORMATICS, V27, P2302, DOI 10.1093/bioinformatics/btr385; Lowe DM, 2011, J CHEM INF MODEL, V51, P739, DOI 10.1021/ci100384d; Lusci A, 2013, J CHEM INF MODEL, V53, P1563, DOI 10.1021/ci400187y; Malki A, 2015, J LEUKOCYTE BIOL, V97, P533, DOI 10.1189/jlb.2A0714-331RR; Malnic B, 2004, P NATL ACAD SCI USA, V101, P2584, DOI 10.1073/pnas.0307882100; Maresh A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002640; Mayhew E. J., 2020, DRAWING BORDERS OLFA, DOI [10. 1101/2020.12.04.412254, DOI 10.1101/2020.12.04.412254]; Meister M, 2015, ELIFE, V4, DOI 10.7554/eLife.07865; Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2; MORAN DT, 1982, J NEUROCYTOL, V11, P721, DOI 10.1007/BF01153516; MORAN DT, 1982, BRAIN RES, V253, P39, DOI 10.1016/0006-8993(82)90671-0; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; NAKAMURA T, 1987, NATURE, V325, P442, DOI 10.1038/325442a0; Niimura Y, 2003, P NATL ACAD SCI USA, V100, P12235, DOI 10.1073/pnas.1635157100; Oka Y, 2004, EMBO J, V23, P120, DOI 10.1038/sj.emboj.7600032; PACE U, 1986, P NATL ACAD SCI USA, V83, P4947, DOI 10.1073/pnas.83.13.4947; PACE U, 1985, NATURE, V316, P255, DOI 10.1038/316255a0; Pfister P, 2020, CURR BIOL, V30, P2574, DOI 10.1016/j.cub.2020.04.086; Poivet E, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aao6086; Precone V, 2020, EUR REV MED PHARMACO, V24, P2140, DOI 10.26355/eurrev_202002_20394; Raman B, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-212; Reblitz-Richardson O., 2020, ARXIV PREPRINT ARXIV; Saito H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000016; Sanz G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085110; Sarafoleanu C, 2009, J Med Life, V2, P196; Saraiva LR, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax0396; Schild D, 1998, PHYSIOL REV, V78, P429, DOI 10.1152/physrev.1998.78.2.429; Serizawa SU, 2004, TRENDS GENET, V20, P648, DOI 10.1016/j.tig.2004.09.006; Sharma A, 2022, IEEE ACM T COMPUT BI, V19, P418, DOI 10.1109/TCBB.2020.3002154; Sundararajan M, 2017, PR MACH LEARN RES, V70; Tan LZ, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156639; Tetko IV, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00475-y; Vannier B, 1999, P NATL ACAD SCI USA, V96, P2060, DOI 10.1073/pnas.96.5.2060	80	5	5	1	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100956	10.1016/j.jbc.2021.100956	http://dx.doi.org/10.1016/j.jbc.2021.100956			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265305	gold, Green Published			2022-12-28	WOS:000690871400003
J	Tseng, YJ; Sandwith, SN; Green, KM; Chambers, AE; Krans, A; Raimer, HM; Sharlow, ME; Reisinger, MA; Richardson, AE; Routh, ED; Smaldino, MA; Wang, YH; Vaughn, JP; Todd, PK; Smaldino, PJ				Tseng, Yi-Ju; Sandwith, Siara N.; Green, Katelyn M.; Chambers, Antonio E.; Krans, Amy; Raimer, Heather M.; Sharlow, Meredith E.; Reisinger, Michael A.; Richardson, Adam E.; Routh, Eric D.; Smaldino, Melissa A.; Wang, Yuh-Hwa; Vaughn, James P.; Todd, Peter K.; Smaldino, Philip J.			The RNA helicase DHX36-G4R1 modulates C9orf72 GGGGCC hexanucleotide repeat-associated translation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							G-QUADRUPLEX STRUCTURES; NON-AUG TRANSLATION; TETRAMOLECULAR QUADRUPLEX; RESOLVING ACTIVITY; SMALL MOLECULES; MAJOR SOURCE; CGG REPEATS; IN-VITRO; DNA; EXPANSION	GGGGCC (G4C2) hexanucleotide repeat expansions in the endosomal trafficking gene C9orf72 are the most common genetic cause of ALS and frontotemporal dementia. Repeat-associated non-AUG (RAN) translation of this expansion through near-cognate initiation codon usage and internal ri-bosomal entry generates toxic proteins that accumulate in patients' brains and contribute to disease pathogenesis. The helicase protein DEAH-box helicase 36 (DHX36-G4R1) plays active roles in RNA and DNA G-quadruplex (G4) resolution in cells. As G4C2 repeats are known to form G4 structures in vitro, we sought to determine the impact of manipulating DHX36 expression on repeat transcription and RAN translation. Using a series of luciferase reporter assays both in cells and in vitro, we found that DHX36 depletion suppresses RAN translation in a repeat length-dependent manner, whereas overexpression of DHX36 enhances RAN translation from G4C2 reporter RNAs. Moreover, upregulation of RAN translation that is typically triggered by integrated stress response activation is prevented by loss of DHX36. These results suggest that DHX36 is active in regulating G(4)C(2) repeat translation, providing potential impli-cations for therapeutic development in nucleotide repeat expansion disorders.	[Tseng, Yi-Ju; Green, Katelyn M.; Krans, Amy; Todd, Peter K.] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Tseng, Yi-Ju] Univ Michigan, Cellular & Mol Biol Grad Program, Ann Arbor, MI 48109 USA; [Sandwith, Siara N.; Chambers, Antonio E.; Sharlow, Meredith E.; Reisinger, Michael A.; Richardson, Adam E.; Smaldino, Melissa A.; Smaldino, Philip J.] Ball State Univ, Dept Biol, Muncie, IN 47306 USA; [Raimer, Heather M.; Wang, Yuh-Hwa] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA; [Routh, Eric D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27515 USA; [Vaughn, James P.] NanoMedica LLC, Div Canc Biol, Winston Salem, NC USA; [Todd, Peter K.] Ann Arbor VA Med Ctr, Dept Neurol, Ann Arbor, MI 48105 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ball State University; University of Virginia; University of North Carolina; University of North Carolina Chapel Hill	Todd, PK (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.; Smaldino, PJ (corresponding author), Ball State Univ, Dept Biol, Muncie, IN 47306 USA.; Todd, PK (corresponding author), Ann Arbor VA Med Ctr, Dept Neurol, Ann Arbor, MI 48105 USA.	petertod@med.umich.edu; pjsmaldino@bsu.edu		Routh, Eric/0000-0002-7371-1802; Tseng, Yi-Ju/0000-0002-2242-6200; Raimer Young, Heather/0000-0002-7415-6011	National Institutes of Health [R15 AG067291, T32GM008136, RO1GM101192, P50HD104463, R01NS099280, R01NS086810, BLRD BX004842, BX003231]; University of Michigan; Ball State University; Amyotrophic Lateral Sclerosis Association [18-IIA-406]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Michigan(University of Michigan System); Ball State University; Amyotrophic Lateral Sclerosis Association	This work was funded by the National Institutes of Health (R15 AG067291 to P. J. S., T32GM008136 to H. M. R., RO1GM101192 to Y.-H. W., P50HD104463, R01NS099280, and R01NS086810 to P. K. T.), VA (BLRD BX004842 and BX003231 to P. K. T.), the University of Michigan (Cellular and Molecular Biology Graduate program and the Chia-Lun Lo Fellowship to Y.-J. T.), Ball State University (Startup Funds and Junior Faculty ASPIRE grant to P. J. S., Graduate Student ASPIRE grant to A. E. R.), and Amyotrophic Lateral Sclerosis Association grant 18-IIA-406 to P. J. S. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Almeida S, 2019, ACTA NEUROPATHOL, V138, P1099, DOI 10.1007/s00401-019-02083-z; Asamitsu S, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abd9440; Bedrat A, 2016, NUCLEIC ACIDS RES, V44, P1746, DOI 10.1093/nar/gkw006; Biffi G, 2013, NAT CHEM, V5, P182, DOI [10.1038/NCHEM.1548, 10.1038/nchem.1548]; Booy EP, 2012, NUCLEIC ACIDS RES, V40, P4110, DOI 10.1093/nar/gkr1306; Booy EP, 2016, J BIOL CHEM, V291, P5355, DOI 10.1074/jbc.M115.711499; Booy Evan P, 2015, Methods Mol Biol, V1259, P125, DOI 10.1007/978-1-4939-2214-7_9; Booy EP, 2014, NUCLEIC ACIDS RES, V42, P3346, DOI 10.1093/nar/gkt1340; Brunelle JL, 2013, METHOD ENZYMOL, V530, P101, DOI 10.1016/B978-0-12-420037-1.00005-1; Buijsen RAM, 2016, HUM REPROD, V31, P158, DOI 10.1093/humrep/dev280; Buijsen RAM, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0162-2; Byrd AK, 2016, J BIOL CHEM, V291, P18041, DOI 10.1074/jbc.M116.718478; Byrne S, 2014, AMYOTROPH LAT SCL FR, V15, P148, DOI 10.3109/21678421.2013.838586; Chalupnikova K, 2008, J BIOL CHEM, V283, P35186, DOI 10.1074/jbc.M804857200; Chambers VS, 2015, NAT BIOTECHNOL, V33, P877, DOI 10.1038/nbt.3295; Chen MC, 2018, NATURE, V558, P465, DOI 10.1038/s41586-018-0209-9; Cheng WW, 2019, NEURON, V104, P885, DOI 10.1016/j.neuron.2019.09.003; Cheng WW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02495-z; Conlon EG, 2016, ELIFE, V5, DOI 10.7554/eLife.17820; Creacy SD, 2008, J BIOL CHEM, V283, P34626, DOI 10.1074/jbc.M806277200; DeJesus-Hernandez M, 2011, NEURON, V72, P245, DOI 10.1016/j.neuron.2011.09.011; Donnelly CJ, 2013, NEURON, V80, P415, DOI 10.1016/j.neuron.2013.10.015; Fratta P, 2012, SCI REP-UK, V2, DOI 10.1038/srep01016; FRY M, 1994, P NATL ACAD SCI USA, V91, P4950, DOI 10.1073/pnas.91.11.4950; Giri B, 2011, NUCLEIC ACIDS RES, V39, P7161, DOI 10.1093/nar/gkr234; Goodman LD, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0711-9; Green KM, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02200-0; Haeusler AR, 2014, NATURE, V507, P195, DOI 10.1038/nature13124; Hansel-Hertsch R, 2016, NAT GENET, V48, P1267, DOI 10.1038/ng.3662; Henderson A, 2014, NUCLEIC ACIDS RES, V42, P860, DOI 10.1093/nar/gkt957; Hinnebusch AG, 2016, SCIENCE, V352, P1413, DOI 10.1126/science.aad9868; Huang WW, 2012, NUCLEIC ACIDS RES, V40, P1033, DOI 10.1093/nar/gkr849; Hukema RK, 2015, HUM MOL GENET, V24, P4948, DOI 10.1093/hmg/ddv216; Huppert JL, 2005, NUCLEIC ACIDS RES, V33, P2908, DOI 10.1093/nar/gki609; Huppert JL, 2007, NUCLEIC ACIDS RES, V35, P406, DOI 10.1093/nar/gkl1057; Iwamoto F, 2008, EXP CELL RES, V314, P1378, DOI 10.1016/j.yexcr.2008.01.006; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kearse MG, 2016, MOL CELL, V62, P314, DOI 10.1016/j.molcel.2016.02.034; KETTANI A, 1995, J MOL BIOL, V254, P638, DOI 10.1006/jmbi.1995.0644; Kim HN, 2011, J BONE MINER RES, V26, P2161, DOI 10.1002/jbmr.426; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; Krans A, 2016, ANN NEUROL, V80, P871, DOI 10.1002/ana.24800; Linsalata AE, 2019, EMBO REP, V20, DOI 10.15252/embr.201847498; Liu HH, 2021, J AM CHEM SOC, V143, P7368, DOI 10.1021/jacs.1c00131; Maizels N, 2015, EMBO REP, V16, P910, DOI 10.15252/embr.201540607; Maltby CJ, 2020, NUCLEIC ACIDS RES, V48, P9822, DOI 10.1093/nar/gkaa699; Mcrae EKS, 2017, NUCLEIC ACIDS RES, V45, P6656, DOI 10.1093/nar/gkx380; Mendoza O, 2016, NUCLEIC ACIDS RES, V44, P1989, DOI 10.1093/nar/gkw079; Murat P, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1602-2; Nie JW, 2015, CELL REP, V13, P723, DOI 10.1016/j.celrep.2015.09.043; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Rhodes D, 2015, NUCLEIC ACIDS RES, V43, P8627, DOI 10.1093/nar/gkv862; Rodriguez CM, 2019, NEUROBIOL DIS, V130, DOI 10.1016/j.nbd.2019.104515; Sauer M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10432-5; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schofield JPR, 2015, BIOCHEM SOC T, V43, P338, DOI 10.1042/BST20150053; Schult P, 2021, BIOL CHEM, V402, P581, DOI 10.1515/hsz-2020-0292; Sellier C, 2017, NEURON, V93, P331, DOI 10.1016/j.neuron.2016.12.016; Sexton AN, 2011, MOL CELL BIOL, V31, P736, DOI 10.1128/MCB.01033-10; Shi KY, 2017, P NATL ACAD SCI USA, V114, pE1111, DOI 10.1073/pnas.1620293114; Shi YX, 2018, NAT MED, V24, P313, DOI 10.1038/nm.4490; Simone R, 2018, EMBO MOL MED, V10, P22, DOI 10.15252/emmm.201707850; Simone R, 2015, FEBS LETT, V589, P1653, DOI 10.1016/j.febslet.2015.05.003; Smaldino PJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132668; Sonobe Y, 2018, NEUROBIOL DIS, V116, P155, DOI 10.1016/j.nbd.2018.05.009; Starck SR, 2016, SCIENCE, V351, DOI 10.1126/science.aad3867; Su ZM, 2014, NEURON, V83, P1043, DOI 10.1016/j.neuron.2014.07.041; Tabet R, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-017-02643-5; Taylor JP, 2017, P NATL ACAD SCI USA, V114, P1445, DOI 10.1073/pnas.1621085114; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Umoh ME, 2016, NEUROLOGY, V87, P1024, DOI 10.1212/WNL.0000000000003067; USDIN K, 1995, NUCLEIC ACIDS RES, V23, P4202, DOI 10.1093/nar/23.20.4202; Van Mossevelde S, 2017, CURR OPIN GENET DEV, V44, P117, DOI 10.1016/j.gde.2017.02.008; Vaughn JP, 2005, J BIOL CHEM, V280, P38117, DOI 10.1074/jbc.C500348200; Vester K, 2019, BIOCHEM BIOPH RES CO, V508, P756, DOI 10.1016/j.bbrc.2018.11.186; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Westergard T, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201809423; Westergard T, 2016, CELL REP, V17, P645, DOI 10.1016/j.celrep.2016.09.032; Yamada SB, 2019, NAT NEUROSCI, V22, P1383, DOI 10.1038/s41593-019-0455-7; Yoo JS, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004012; Young SK, 2016, J BIOL CHEM, V291, P10824, DOI 10.1074/jbc.M116.722256; Zamiri B, 2014, J BIOL CHEM, V289, P4653, DOI 10.1074/jbc.C113.502336; Zhou B, 2015, SCI REP-UK, V5, DOI 10.1038/srep16673; Zu T, 2020, P NATL ACAD SCI USA, V117, P18591, DOI 10.1073/pnas.2005748117; Zu T, 2013, P NATL ACAD SCI USA, V110, pE4968, DOI 10.1073/pnas.1315438110	85	5	5	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100914	10.1016/j.jbc.2021.100914	http://dx.doi.org/10.1016/j.jbc.2021.100914			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34174288	gold, Green Published			2022-12-28	WOS:000690879300011
J	Pastore, AJ; Teo, RD; Montoya, A; Burg, MJ; Twahir, UT; Bruner, SD; Beratan, DN; Angerhofer, A				Pastore, Anthony J.; Teo, Ruijie D.; Montoya, Alvaro; Burg, Matthew J.; Twahir, Umar T.; Bruner, Steven D.; Beratan, David N.; Angerhofer, Alexander			Oxalate decarboxylase uses electron hole hopping for catalysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACILLUS-SUBTILIS YVRK; ACTIVE-SITE; SPECIFICITY SWITCH; CALCIUM-OXALATE; CHARGE-TRANSFER; SIGMA-FACTOR; TRYPTOPHAN; MANGANESE; PROTEINS; ACID	The hexameric low-pH stress response enzyme oxalate decarboxylase catalyzes the decarboxylation of the oxalate mono-anion in the soil bacterium Bacillus subtilis. A single protein subunit contains two Mn-binding cupin domains, and catalysis depends on Mn(III) at the N-terminal site. The present study suggests a mechanistic function for the C-terminal Mn as an electron hole donor for the N-terminal Mn. The resulting spatial separation of the radical intermediates directs the chemistry toward decarboxylation of the substrate. A pi-stacked tryptophan pair (W96/W274) links two neighboring protein subunits together, thus reducing the Mn-to-Mn distance from 25.9 angstrom (intrasubunit) to 21.5 angstrom (intersubunit). Here, we used theoretical analysis of electron hole-hopping paths through redox-active sites in the enzyme combined with site-directed mutagenesis and X-ray crystallography to demonstrate that this tryptophan pair supports effective electron hole hopping between the C-terminal Mn of one subunit and the N-terminal Mn of the other subunit through two short hops of similar to 8.5 angstrom. Replacement of W96, W274, or both with phenylalanine led to a large reduction in catalytic efficiency, whereas replacement with tyrosine led to recovery of most of this activity. W96F and W96Y mutants share the wildtype tertiary structure. Two additional hole-hopping networks were identified leading from the Mn ions to the protein surface, potentially protecting the enzyme from high Mn oxidation states during turnover. Our findings strongly suggest that multistep hole-hopping transport between the two Mn ions is required for enzymatic function, adding to the growing examples of proteins that employ aromatic residues as hopping stations.	[Pastore, Anthony J.; Montoya, Alvaro; Burg, Matthew J.; Twahir, Umar T.; Bruner, Steven D.; Angerhofer, Alexander] Univ Florida, Dept Chem, Gainesville, FL 32611 USA; [Teo, Ruijie D.; Beratan, David N.] Duke Univ, Dept Chem, Durham, NC 27706 USA	State University System of Florida; University of Florida; Duke University	Angerhofer, A (corresponding author), Univ Florida, Dept Chem, Gainesville, FL 32611 USA.; Beratan, DN (corresponding author), Duke Univ, Dept Chem, Durham, NC 27706 USA.	david.beratan@duke.edu; alex@chem.ufl.edu	Pastore, Anthony/GQZ-4544-2022		National Science Foundation [CHE-2002950]; NIH [GM-48043]	National Science Foundation(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by the National Science Foundation (Grant CHE-2002950 to A. A.) and the NIH (Grant GM-48043 to D. N. B. and R. D. T.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the National Science Foundation.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Albert A, 2017, J ENZYM INHIB MED CH, V32, P426, DOI 10.1080/14756366.2016.1256884; Anand R, 2002, BIOCHEMISTRY-US, V41, P7659, DOI 10.1021/bi0200965; Angerhofer A., 2017, RCSB PDB 5VG3 STRUCT, DOI [10.2210/pdb5VG3/pdb, DOI 10.2210/PDB5VG3/PDB]; [Anonymous], 2020, PYMOL MOL GRAPHICS S; Barry BA, 2015, BBA-BIOENERGETICS, V1847, P46, DOI 10.1016/j.bbabio.2014.09.003; Beratan DN, 2015, ACCOUNTS CHEM RES, V48, P474, DOI 10.1021/ar500271d; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burg M. J., 2018, STRUCTURE OXALATE DE, DOI [10.1101/426874, DOI 10.1101/426874]; Burrell MR, 2007, BIOCHEMISTRY-US, V46, P12327, DOI 10.1021/bi700947s; Byrdin M, 2003, P NATL ACAD SCI USA, V100, P8676, DOI 10.1073/pnas.1531645100; Campomanes P, 2014, J AM CHEM SOC, V136, P2313, DOI 10.1021/ja408138f; Capobianco A, 2015, J PHYS CHEM B, V119, P5462, DOI 10.1021/acs.jpcb.5b02940; Chang CH, 2004, J BIOL CHEM, V279, P52840, DOI 10.1074/jbc.M402345200; Conter C, 2019, IUBMB LIFE, V71, P917, DOI 10.1002/iub.2027; Cowley AB, 2010, INT J TOXICOL, V29, P20, DOI 10.1177/1091581809353611; Davidson VL, 2012, BBA-PROTEINS PROTEOM, V1824, P1299, DOI 10.1016/j.bbapap.2012.01.008; Dempsey JL, 2010, CHEM REV, V110, P7024, DOI 10.1021/cr100182b; DUNNING TH, 1971, J CHEM PHYS, V55, P716, DOI 10.1063/1.1676139; Dutton MV, 1996, CAN J MICROBIOL, V42, P881, DOI 10.1139/m96-114; EMILIANI E, 1968, BIOCHIM BIOPHYS ACTA, V167, P414, DOI 10.1016/0005-2744(68)90221-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ener ME, 2017, BIOCHEMISTRY-US, V56, P3531, DOI 10.1021/acs.biochem.7b00432; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Glover SD, 2018, J AM CHEM SOC, V140, P185, DOI 10.1021/jacs.7b08032; Gray HB, 2018, ACCOUNTS CHEM RES, V51, P1850, DOI 10.1021/acs.accounts.8b00245; Gray HB, 2015, P NATL ACAD SCI USA, V112, P10920, DOI 10.1073/pnas.1512704112; Gray HB, 2005, P NATL ACAD SCI USA, V102, P3534, DOI 10.1073/pnas.0408029102; HAGLER L, 1973, AM J CLIN NUTR, V26, P758; HAGLER L, 1973, AM J CLIN NUTR, V26, P882, DOI 10.1093/ajcn/26.8.882; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Ichiye T, 2013, ENCY BIOPHYSICS, P614; JAKOBY WB, 1956, J BIOL CHEM, V222, P435; Jiang N, 2013, J PHYS CHEM B, V117, P9129, DOI 10.1021/jp401551t; JOHNSON DA, 1995, INORG CHEM, V34, P5666, DOI 10.1021/ic00126a041; Junge W, 2019, Q REV BIOPHYS, V52, DOI 10.1017/S0033583518000112; Just VJ, 2007, BIOCHEM J, V407, P397, DOI 10.1042/BJ20070708; Just VJ, 2004, J BIOL CHEM, V279, P19867, DOI 10.1074/jbc.M313820200; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kozlov YN, 2004, PHYS CHEM CHEM PHYS, V6, P4905, DOI 10.1039/b406569g; Kumar V, 2019, PHYTOCHEMISTRY, V158, P103, DOI 10.1016/j.phytochem.2018.10.029; Lubitz W, 2019, PHOTOSYNTH RES, V142, P105, DOI 10.1007/s11120-019-00648-3; MacLellan SR, 2008, MOL MICROBIOL, V69, P954, DOI 10.1111/j.1365-2958.2008.06331.x; MacLellan SR, 2009, J BACTERIOL, V191, P931, DOI 10.1128/JB.01435-08; Mahmoudi L, 2016, BIOCHEMISTRY-US, V55, P2849, DOI 10.1021/acs.biochem.6b00019; MARCUS RA, 1985, BIOCHIM BIOPHYS ACTA, V811, P265, DOI 10.1016/0304-4173(85)90014-X; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MEHTA A, 1991, J BIOL CHEM, V266, P23548; Melin F, 2020, CHEM REV, V120, P10244, DOI 10.1021/acs.chemrev.0c00249; Migliore A, 2014, CHEM REV, V114, P3381, DOI 10.1021/cr4006654; Moghadam SA, 2020, BIOSYSTEMS, V195, DOI 10.1016/j.biosystems.2020.104148; Moomaw EW, 2009, BIOCHEMISTRY-US, V48, P6116, DOI 10.1021/bi801856k; Neese F, 2020, J CHEM PHYS, V152, DOI 10.1063/5.0004608; Neese F, 2018, WIRES COMPUT MOL SCI, V8, DOI 10.1002/wcms.1327; Neese F, 2012, WIRES COMPUT MOL SCI, V2, P73, DOI 10.1002/wcms.81; ONUCHIC JN, 1992, ANNU REV BIOPH BIOM, V21, P349, DOI 10.1146/annurev.biophys.21.1.349; Paul E, 2018, MICROBIOL RES, V215, P65, DOI 10.1016/j.micres.2018.06.009; Polizzi NF, 2015, P NATL ACAD SCI USA, V112, P10821, DOI 10.1073/pnas.1513520112; Qi ZQ, 2017, PLANT SCI, V265, P51, DOI 10.1016/j.plantsci.2017.09.014; Reece SY, 2006, PHILOS T R SOC B, V361, P1351, DOI 10.1098/rstb.2006.1874; Reinhardt LA, 2003, J AM CHEM SOC, V125, P1244, DOI 10.1021/ja0286977; Rosso KM, 2004, J PHYS CHEM A, V108, P5242, DOI 10.1021/jp037470a; Roy A, 2018, J PHYS CHEM B, V122, P3723, DOI 10.1021/acs.jpcb.7b11762; Ru XY, 2019, J PHYS CHEM B, V123, P5035, DOI 10.1021/acs.jpcb.9b01086; SAITO I, 1995, J AM CHEM SOC, V117, P6406, DOI 10.1021/ja00128a050; Saylor BT, 2012, BIOCHEMISTRY-US, V51, P2911, DOI 10.1021/bi300001q; Shen YH, 2008, J MICROBIOL BIOTECHN, V18, P1245; Sjode A, 2008, ENZYME MICROB TECH, V43, P78, DOI 10.1016/j.enzmictec.2007.11.014; Strobel BW, 2001, GEODERMA, V99, P169, DOI 10.1016/S0016-7061(00)00102-6; Svedruzic D, 2007, ARCH BIOCHEM BIOPHYS, V464, P36, DOI 10.1016/j.abb.2007.03.016; Tabares LC, 2009, J PHYS CHEM B, V113, P9016, DOI 10.1021/jp9021807; Tanner A, 2000, J BACTERIOL, V182, P5271, DOI 10.1128/JB.182.18.5271-5273.2000; Tanner A, 2001, J BIOL CHEM, V276, P43627, DOI 10.1074/jbc.M107202200; Teo RD, 2019, PHYS CHEM CHEM PHYS, V21, P22869, DOI 10.1039/c9cp04805g; Teo RD, 2018, PHYS CHEM CHEM PHYS, V20, P26063, DOI 10.1039/c8cp04816a; Twahir UT, 2016, BIOCHEMISTRY-US, V55, P6505, DOI 10.1021/acs.biochem.6b00891; Twahir UT, 2015, FREE RADICAL BIO MED, V80, P59, DOI 10.1016/j.freeradbiomed.2014.12.012; Uren NC, 2018, SOIL RES, V56, P443, DOI 10.1071/SR17244; Warren JJ, 2010, CHEM REV, V110, P6961, DOI 10.1021/cr100085k; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Winestrand S, 2012, J CHEM TECHNOL BIOT, V87, P1600, DOI 10.1002/jctb.3801; Winkler JR, 2015, Q REV BIOPHYS, V48, P411, DOI 10.1017/S0033583515000062; Winkler JR, 2015, PHILOS T R SOC A, V373, DOI 10.1098/rsta.2014.0178; Winkler JR, 2014, CHEM REV, V114, P3369, DOI 10.1021/cr4004715; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Zanetti-Polzi L, 2019, J PHYS CHEM LETT, V10, P1450, DOI 10.1021/acs.jpclett.9b00403; Zhao CM, 2018, UROLOGY, V113, DOI 10.1016/j.urology.2017.11.038; Zhu W, 2018, BIOCHEMISTRY-US, V57, P3425, DOI 10.1021/acs.biochem.8b00214; Zhu W, 2017, ESSAYS BIOCHEM, V61, P259, DOI 10.1042/EBC20160070; Zhu W, 2016, BIOCHEMISTRY-US, V55, P2163, DOI 10.1021/acs.biochem.6b00043; Zhu W, 2016, BIOCHEMISTRY-US, V55, P429, DOI 10.1021/acs.biochem.5b01340	97	3	3	2	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100857	10.1016/j.jbc.2021.100857	http://dx.doi.org/10.1016/j.jbc.2021.100857			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097877	Green Published, gold			2022-12-28	WOS:000678068400057
J	Wu, KL; Wu, HZ; Lyu, W; Kim, Y; Furdui, CM; Anderson, KS; Koleske, AJ				Wu, Kuanlin; Wu, Hanzhi; Lyu, Wanqing; Kim, Youngjoo; Furdui, Cristina M.; Anderson, Karen S.; Koleske, Anthony J.			Platelet-derived growth factor receptor beta activates Abl2 via direct binding and phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE-ACTIVITY; DNA-DAMAGE RESPONSE; C-ABL; FAMILY KINASES; SRC FAMILY; ARG; DOMAIN; CORTACTIN; PATHWAYS; ADHESION	Abl family kinases are nonreceptor tyrosine kinases activated by diverse cellular stimuli that regulate cytoskeleton organization, morphogenesis, and adhesion. The catalytic activity of Abl family kinases is tightly regulated in cells by a complex set of intramolecular and intermolecular interactions and post-translational modifications. For example, the platelet-derived growth factor receptor beta (PDGFR beta), important for cell proliferation and chemotaxis, is a potent activator of Abl family kinases. However, the molecular mechanism by which PDGFR beta engages and activates Abl family kinases is not known. We show here that the Abl2 Src homology 2 domain directly binds to phosphotyrosine Y771 in the PDGFR beta cytoplasmic domain. PDGFR beta directly phosphorylates multiple novel sites on the N-terminal half of Abl2, including Y116, Y139, and Y161 within the Src homology 3 domain, and Y299, Y303, and Y310 on the kinase domain. Y116, Y161, Y272, and Y310 are all located at or near the Src homology 3/Src homology 2-kinase linker interface, which helps maintain Abl family kinases in an autoinhibited conformation. We also found that PDGFR beta-mediated phosphorylation of Abl2 in vitro activates Abl2 kinase activity, but mutation of these four tyrosines (Y116, Y161, Y272, and Y310) to phenylalanine abrogated PDGFR beta-mediated activation of Abl2. These findings reveal how PDGFR beta engages and phosphorylates Abl2 leading to activation of the kinase, providing a framework to understand how growth factor receptors engage and activate Abl family kinases.	[Wu, Kuanlin; Lyu, Wanqing; Anderson, Karen S.; Koleske, Anthony J.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA; [Wu, Hanzhi; Furdui, Cristina M.] Wake Forest Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC USA; [Kim, Youngjoo; Anderson, Karen S.] Yale Univ, Dept Pharmacol, New Haven, CT USA; [Koleske, Anthony J.] Yale Univ, Dept Neurosci, New Haven, CT 06520 USA	Yale University; Wake Forest University; Yale University; Yale University	Koleske, AJ (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA.; Koleske, AJ (corresponding author), Yale Univ, Dept Neurosci, New Haven, CT 06520 USA.	anthony.koleske@yale.edu		Furdui, Cristina M./0000-0003-3771-7999	American Heart Association; National Institutes of Healthgrants [MH115939, NS105640, NS112121, CA12197]	American Heart Association(American Heart Association); National Institutes of Healthgrants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	K. W. was supported by a predoctoral fellowship from the American Heart Association. This work was supported by the National Institutes of Healthgrants MH115939, NS105640, NS112121 (A. J. K.) and CA12197 (C. M. F.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barila D, 1998, NAT GENET, V18, P280, DOI 10.1038/ng0398-280; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Boyle SN, 2007, CURR BIOL, V17, P445, DOI 10.1016/j.cub.2007.01.057; Bradley WD, 2006, MOL BIOL CELL, V17, P4827, DOI 10.1091/mbc.E06-02-0132; Bradley WD, 2009, J CELL SCI, V122, P3441, DOI 10.1242/jcs.039859; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Chen S, 2008, J MOL BIOL, V383, P414, DOI 10.1016/j.jmb.2008.08.040; Chen SG, 2007, PROTEIN SCI, V16, P572, DOI 10.1110/ps.062631007; Colicelli J, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3139re6; Ekman S, 2002, ONCOGENE, V21, P1870, DOI 10.1038/sj.onc.1205210; Ganguly SS, 2012, ONCOGENE, V31, P1804, DOI 10.1038/onc.2011.361; Ganguly Sourik S, 2012, Genes Cancer, V3, P414, DOI 10.1177/1947601912458586; Greuber EK, 2013, NAT REV CANCER, V13, P559, DOI 10.1038/nrc3563; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Hantschel O., 2006, ABL FAMILY KINASES D, P1; Heldin CH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009100; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Hu YH, 2019, J CELL BIOL, V218, P3986, DOI 10.1083/jcb.201812144; Jacob M, 2009, CELL SIGNAL, V21, P1308, DOI 10.1016/j.cellsig.2009.03.016; KAZLAUSKAS A, 1992, MOL CELL BIOL, V12, P2534, DOI 10.1128/MCB.12.6.2534; Khatri A, 2016, J CELL SCI, V129, P9, DOI 10.1242/jcs.175521; Koleske AJ, 1998, NEURON, V21, P1259, DOI 10.1016/S0896-6273(00)80646-7; KYPTA RM, 1990, CELL, V62, P481, DOI 10.1016/0092-8674(90)90013-5; Lapetina S, 2009, J CELL BIOL, V185, P503, DOI 10.1083/jcb.200809085; Lewis JM, 1996, P NATL ACAD SCI USA, V93, P15174, DOI 10.1073/pnas.93.26.15174; MacGrath SM, 2012, BIOCHEMISTRY-US, V51, P6644, DOI 10.1021/bi300722t; Maiani E, 2011, BIOCHEM PHARMACOL, V82, P1269, DOI 10.1016/j.bcp.2011.07.001; MAYER BJ, 1994, MOL CELL BIOL, V14, P2883, DOI 10.1128/MCB.14.5.2883; Meltser V, 2011, CELL DEATH DIFFER, V18, P2, DOI 10.1038/cdd.2010.132; Mero B, 2019, J BIOL CHEM, V294, P4608, DOI 10.1074/jbc.RA118.004732; Nagar B, 2006, MOL CELL, V21, P787, DOI 10.1016/j.molcel.2006.01.035; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; Peacock JG, 2010, CYTOSKELETON, V67, P666, DOI 10.1002/cm.20479; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pisabarro MT, 1998, J MOL BIOL, V281, P513, DOI 10.1006/jmbi.1998.1932; Plattner R, 2004, MOL CELL BIOL, V24, P2573, DOI 10.1128/mcb.24.6.2573-2583.2004; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; Plattner R, 2003, NAT CELL BIOL, V5, P309, DOI 10.1038/ncb949; Qiu ZZ, 2010, P NATL ACAD SCI USA, V107, P1136, DOI 10.1073/pnas.0913131107; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shaul Y, 2005, CELL RES, V15, P33, DOI 10.1038/sj.cr.7290261; Simpson MA, 2015, J BIOL CHEM, V290, P8360, DOI 10.1074/jbc.M115.638874; Srinivasan D, 2006, CANCER RES, V66, P5648, DOI 10.1158/0008-5472.CAN-06-0734; Srinivasan D, 2009, CELL SIGNAL, V21, P1143, DOI 10.1016/j.cellsig.2009.03.003; Tanis KQ, 2003, MOL CELL BIOL, V23, P3884, DOI 10.1128/MCB.23.11.3884-3896.2003; Tanos B, 2006, J BIOL CHEM, V281, P32714, DOI 10.1074/jbc.M603126200; Tanos BE, 2007, CELL SIGNAL, V19, P1602, DOI 10.1016/j.cellsig.2007.02.008; VALIUS M, 1993, MOL CELL BIOL, V13, P133, DOI 10.1128/MCB.13.1.133; Weigel MT, 2013, ANN ONCOL, V24, P126, DOI 10.1093/annonc/mds240; Wetzel DM, 2016, J CELL SCI, V129, P3130, DOI 10.1242/jcs.185595; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Xie T, 2020, SCIENCE, V370, P189, DOI 10.1126/science.abc2754; Zipfel PA, 2004, CURR BIOL, V14, P1222, DOI 10.1016/j.cub.2004.07.021	53	0	0	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100883	10.1016/j.jbc.2021.100883	http://dx.doi.org/10.1016/j.jbc.2021.100883			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144039	gold, Green Published			2022-12-28	WOS:000678068400082
J	Al-Mohanna, T; Nejat, N; Iannetta, AA; Hicks, LM; Popescu, GV; Popescu, SC				Al-Mohanna, Thualfeqar; Nejat, Najmeh; Iannetta, Anthony A.; Hicks, Leslie M.; Popescu, George, V; Popescu, Sorina C.			Arabidopsis thimet oligopeptidases are redox-sensitive enzymes active in the local and systemic plant immune response	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SALICYLIC-ACID; THIOREDOXIN REDUCTASE; FUNCTIONAL-ANALYSIS; MASS-SPECTROMETRY; OXIDATIVE BURST; DISULFIDE BOND; GENE FAMILY; THALIANA; PROTEIN; RESISTANCE	Upon pathogen infection, receptors in plants will activate a localized immune response, the effector-triggered immunity (ETI), and a systemic immune response, the systemic acquired response (SAR). Infection also induces oscillations in the redox environment of plant cells, triggering response mechanisms involving sensitive cysteine residues that subsequently alter protein function. Arabidopsis thaliana thimet oligopeptidases TOP1 and TOP2 are required for plant defense against pathogens and the oxidative stress response. Herein, we evaluated the biochemical attributes of TOP isoforms to determine their redox sensitivity using ex vivo Escherichia coli cultures and recombinant proteins. Moreover, we explored the link between their redox regulation and plant immunity in wild-type and mutant Arabidopsis lines. These analyses revealed that redox regulation of TOPs occurs through two mechanisms: (1) oxidative dimerization of full-length TOP1 via intermolecular disulfides engaging cysteines in the N-terminal signal peptide, and (2) oxidative activation of all TOPs via cysteines that are unique and conserved. Further, we detected increased TOP activity in wild-type plants undergoing ETI or SAR following inoculation with Pseudomonas syringae strains. Mutants unable to express the chloroplast NADPH-dependent thioredoxin reductase C (NTRC) showed elevated TOP activity under unstressed conditions and were SAR-incompetent. A top1top2 knockout mutant challenged with P. syringae exhibited misregulation of ROS-induced gene expression in pathogen-inoculated and distal tissues. Furthermore, TOP1 and TOP2 could cleave a peptide derived from the immune component ROC1 with distinct efficiencies at common and specific sites. We propose that Arabidopsis TOPs are thiol-regulated peptidases active in redox-mediated signaling of local and systemic immunity.	[Al-Mohanna, Thualfeqar; Nejat, Najmeh; Popescu, Sorina C.] Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA; [Iannetta, Anthony A.; Hicks, Leslie M.] Univ N Carolina, Dept Chem, Chapel Hill, NC 27515 USA; [Popescu, George, V] Mississippi State Univ, Inst Genom Biocomp & Biotechnol, Mississippi State, MS 39762 USA	Mississippi State University; University of North Carolina; University of North Carolina Chapel Hill; Mississippi State University	Popescu, SC (corresponding author), Mississippi State Univ, Dept Biochem Mol Biol Entomol & Plant Pathol, Mississippi State, MS 39762 USA.	scp319@msstate.edu	Almohanna, Thualfeqar/M-1597-2015; Popescu, Sorina Claudia/AFT-2361-2022; Popescu, George/N-2193-2019; Hicks, Leslie/E-8015-2010	Almohanna, Thualfeqar/0000-0001-7952-0786; Popescu, Sorina Claudia/0000-0001-5780-8252; Popescu, George/0000-0002-7580-6792; Hicks, Leslie/0000-0002-8008-3998				Akhtar A, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20092156; Alvarez C, 2012, NEW PHYTOL, V193, P165, DOI 10.1111/j.1469-8137.2011.03889.x; Alvarez ME, 1998, CELL, V92, P773, DOI 10.1016/S0092-8674(00)81405-1; Axtell MJ, 2003, CELL, V112, P369, DOI 10.1016/S0092-8674(03)00036-9; Baerenfaller K, 2008, SCIENCE, V320, P938, DOI 10.1126/science.1157956; Baier M, 2005, J EXP BOT, V56, P1449, DOI 10.1093/jxb/eri161; Bernsdorff F, 2016, PLANT CELL, V28, P102, DOI 10.1105/tpc.15.00496; Chambers MC, 2012, NAT BIOTECHNOL, V30, P918, DOI 10.1038/nbt.2377; CHEN ZX, 1993, SCIENCE, V262, P1883, DOI 10.1126/science.8266079; Chib R, 2015, J LUMIN, V168, P62, DOI 10.1016/j.jlumin.2015.07.030; Chou IT, 1997, PLANT MOL BIOL, V35, P873, DOI 10.1023/A:1005930024796; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Conrath U, 2006, MOL PLANT MICROBE IN, V19, P1062, DOI 10.1094/MPMI-19-1062; CORNISHBOWDEN A, 1975, BIOCHEM J, V149, P305, DOI 10.1042/bj1490305; Czarnocka W, 2018, FREE RADICAL BIO MED, V122, P4, DOI 10.1016/j.freeradbiomed.2018.01.011; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; Dietz KJ, 2016, PLANT PHYSIOL, V171, P1535, DOI 10.1104/pp.16.00938; Dietz KJ, 2003, INT REV CYTOL, V228, P141, DOI 10.1016/S0074-7696(03)28004-9; Doke N, 1987, JPN J PHYTOPATHOL, V53, p585 590; Dumont S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204530; Durrant WE, 2004, ANNU REV PHYTOPATHOL, V42, P185, DOI 10.1146/annurev.phyto.42.040803.140421; El-Shetehy M, 2015, PLANT SIGNAL BEHAV, V10, DOI 10.1080/15592324.2014.998544; Elmore JM, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014555; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Fukasawa Kayoko M, 2011, J Amino Acids, V2011, P574816, DOI 10.4061/2011/574816; Gadjev I, 2006, PLANT PHYSIOL, V141, P436, DOI 10.1104/pp.106.078717; GAFFNEY T, 1993, SCIENCE, V261, P754, DOI 10.1126/science.261.5122.754; Gaupels F, 2017, NEW PHYTOL, V214, p554 560; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Grant M, 2006, CURR OPIN PLANT BIOL, V9, P414, DOI 10.1016/j.pbi.2006.05.013; Grasso G, 2014, J INORG BIOCHEM, V130, P92, DOI 10.1016/j.jinorgbio.2013.09.021; HAMMERSCHMIDT R, 1982, PHYSIOL PLANT PATHOL, V20, P73, DOI 10.1016/0048-4059(82)90025-X; Helm S, 2018, METHODS MOL BIOL, V1696, P235, DOI 10.1007/978-1-4939-7411-5_16; Hicks LM, 2007, PLANT CELL, V19, P2653, DOI 10.1105/tpc.107.052597; Hirasawa M, 1999, BIOCHEMISTRY-US, V38, P5200, DOI 10.1021/bi982783v; Hochmal AK, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11847; Holbrook K, 2016, MOL PLANT, V9, P1286, DOI 10.1016/j.molp.2016.06.004; Iannetta AA, 2021, PLANT J, V106, P336, DOI 10.1111/tpj.15165; Ishiga Y, 2016, PEERJ, V4, DOI 10.7717/peerj.1938; Ito J, 2011, J PROTEOME RES, V10, P1571, DOI 10.1021/pr1009433; Kall L, 2007, NAT METHODS, V4, P923, DOI 10.1038/NMETH1113; Kiffin R, 2004, MOL BIOL CELL, V15, P4829, DOI 10.1091/mbc.E04-06-0477; Kmiec B, 2014, TRENDS PLANT SCI, V19, P771, DOI 10.1016/j.tplants.2014.09.004; Kmiec B, 2013, P NATL ACAD SCI USA, V110, pE3761, DOI 10.1073/pnas.1307637110; Kuki Y, 2020, PLANT PHYSIOL BIOCH, V150, P71, DOI 10.1016/j.plaphy.2020.02.029; Kuzniak E, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.572686; Lamb C, 1997, ANNU REV PLANT PHYS, V48, P251, DOI 10.1146/annurev.arplant.48.1.251; Lamberti G, 2011, PLANT SIGNAL BEHAV, V6, P1918, DOI 10.4161/psb.6.12.18127; Lee SJ, 2018, ARCH PHARM RES, V41, P583, DOI 10.1007/s12272-018-1036-0; Lepisto A, 2009, PLANT PHYSIOL, V149, P1261, DOI 10.1104/pp.108.133777; Li M, 2014, CELL HOST MICROBE, V16, P473, DOI 10.1016/j.chom.2014.09.007; Liebthal M, 2018, ANTIOXID REDOX SIGN, V28, P609, DOI 10.1089/ars.2017.7164; Lindsey BE, 2017, JOVE-J VIS EXP, DOI 10.3791/56587; Lu WP, 2003, ANAL BIOCHEM, V316, P58, DOI 10.1016/S0003-2697(03)00034-4; Majsec K, 2017, PLANT CELL, V29, P2687, DOI 10.1105/tpc.17.00481; Malvezzi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039408; Perez-Ruiz JM, 2017, P NATL ACAD SCI USA, V114, P12069, DOI 10.1073/pnas.1706003114; Marmagne A, 2007, MOL CELL PROTEOMICS, V6, P1980, DOI 10.1074/mcp.M700099-MCP200; Mata-Perez C, 2019, PLANT SCI, V279, P27, DOI 10.1016/j.plantsci.2018.05.001; McConnell EW, 2019, PLANT PHYSIOL, V179, P1248, DOI 10.1104/pp.18.01194; Michalska J, 2009, P NATL ACAD SCI USA, V106, P9908, DOI 10.1073/pnas.0903559106; Miller G, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000448; Monroe JD, 2018, PLANT SCI, V276, P163, DOI 10.1016/j.plantsci.2018.08.016; Morales J, 2016, J EXP BOT, V67, P1663, DOI 10.1093/jxb/erv558; Moreau M, 2013, PLANT J, V76, P603, DOI 10.1111/tpj.12320; Nampoothiri KM, 2005, LETT APPL MICROBIOL, V41, P498, DOI 10.1111/j.1472-765X.2005.01789.x; Navarathna CM, 2019, J ENVIRON MANAGE, V250, DOI 10.1016/j.jenvman.2019.109429; Nguyen-Kim H, 2016, PROTEOMICS, V16, P491, DOI 10.1002/pmic.201500129; Noctor G., 2006, PLANT CELL ENVIRON, V29, P425; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; Olp MD, 2020, BMC BIOINFORMATICS, V21, DOI 10.1186/s12859-020-3513-y; Paige C., 2009, J BIOL CHEM, V284, P35412; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pitzschke A, 2009, MOL PLANT, V2, P120, DOI 10.1093/mp/ssn079; Pulido P, 2010, J EXP BOT, V61, P4043, DOI 10.1093/jxb/erq218; Qiu JL, 2008, EMBO J, V27, P2214, DOI 10.1038/emboj.2008.147; Reniere ML, 2018, J BACTERIOL, V200, DOI 10.1128/JB.00128-18; Rentel MC, 2004, NATURE, V427, P858, DOI 10.1038/nature02353; Rosenwasser S, 2013, PLANT PHYSIOL, V163, P1071, DOI 10.1104/pp.113.218206; SALVEMINI D, 1993, P NATL ACAD SCI USA, V90, P7240, DOI 10.1073/pnas.90.15.7240; Samant RS, 2018, NATURE, V563, P407, DOI 10.1038/s41586-018-0678-x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwarzlander M, 2016, ANTIOXID REDOX SIGN, V24, P680, DOI 10.1089/ars.2015.6266; Senkler J, 2017, PLANT J, V89, P1079, DOI 10.1111/tpj.13448; Smirnova GV, 2000, FREE RADICAL BIO MED, V28, P1009, DOI 10.1016/S0891-5849(99)00256-7; Suhm T, 2018, CELL METAB, V27, P1309, DOI 10.1016/j.cmet.2018.04.011; Tada Y, 2008, SCIENCE, V321, P952, DOI 10.1126/science.1156970; TISLJAR U, 1993, BIOL CHEM H-S, V374, P91; Toivola J, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00389; Tossounian MA, 2018, BBA-GEN SUBJECTS, V1862, P775, DOI 10.1016/j.bbagen.2017.10.007; van Bentem SD, 2008, J PROTEOME RES, V7, P2458, DOI 10.1021/pr8000173; VILLAFRANCA JE, 1987, BIOCHEMISTRY-US, V26, P2182, DOI 10.1021/bi00382a017; Wang RY, 2014, ACTA CRYSTALLOGR F, V70, P555, DOI 10.1107/S2053230X14006128; Wang YM, 2018, PLANT CELL, V30, P2480, DOI 10.1105/tpc.18.00547; Waszczak C, 2014, P NATL ACAD SCI USA, V111, P11545, DOI 10.1073/pnas.1411607111; Westlake TJ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00327; Zannini F, 2017, METHODS MOL BIOL, V1653, P51, DOI 10.1007/978-1-4939-7225-8_4	98	3	3	4	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100695	10.1016/j.jbc.2021.100695	http://dx.doi.org/10.1016/j.jbc.2021.100695			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33894200	gold, Green Published			2022-12-28	WOS:000672866400666
J	Vollmers, AC; Mekonen, HE; Campos, S; Carpenter, S; Vollmers, C				Vollmers, Apple Cortez; Mekonen, Honey E.; Campos, Sophia; Carpenter, Susan; Vollmers, Christopher			Generation of an isoform-level transcriptome atlas of macrophage activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-SEQ; ANNOTATION; PANTHER; GENCODE	RNA-seq is routinely used to measure gene expression changes in response to cell perturbation. Genes upregulated or downregulated following some perturbation are designated as genes of interest, and their most expressed isoform(s) would then be selected for follow-up experimentation. However, because of its need to fragment RNA molecules, RNA-seq is limited in its ability to capture gene isoforms and their expression patterns. This lack of isoform-specific data means that isoforms would be selected based on annotation databases that are incomplete, not tissue specific, or do not provide key information on expression levels. As a result, minority or nonexistent isoforms might be selected for follow-up, leading to loss in valuable resources and time. There is therefore a great need to comprehensively identify gene isoforms along with their corresponding levels of expression. Using the long-read nanopore-based R2C2 method, which does not fragment RNA molecules, we generated an Isoform-level transcriptome Atlas of Macrophage Activation that identifies full-length isoforms in primary human monocyte-derived macrophages. Macrophages are critical innate immune cells important for recognizing pathogens through binding of pathogen-associated molecular patterns to toll-like receptors, culminating in the initiation of host defense pathways. We characterized isoforms for most moderately-to-highly expressed genes in resting and toll-like receptor-activated monocyte-derived macrophages, identified isoforms differentially expressed between conditions, and validated these isoforms by RT-qPCR. We compiled these data into a user-friendly data portal within the UCSC Genome Browser (https://genome.ucsc.edu/s/ vollmers/IAMA). Our atlas represents a valuable resource for innate immune research, providing unprecedented isoform information for primary human macrophages.	[Vollmers, Apple Cortez; Carpenter, Susan] Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA; [Mekonen, Honey E.; Campos, Sophia; Vollmers, Christopher] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz	Carpenter, S (corresponding author), Univ Calif Santa Cruz, Dept Mol Cellular & Dev Biol, Santa Cruz, CA 95064 USA.; Vollmers, C (corresponding author), Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA.	sucarpen@ucsc.edu; vollmers@ucsc.edu		Vollmers, Apple/0000-0003-2787-0797	National Institute of General Medical Sciences/National Institutes of Health [1R35GM133569, R35GM137801]; NIH [T32GM008646]; Ford Predoctoral Fellowship; Howard Hughes Medical Institute Gilliam Fellowship	National Institute of General Medical Sciences/National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Predoctoral Fellowship; Howard Hughes Medical Institute Gilliam Fellowship(Howard Hughes Medical Institute)	We acknowledge funding by the National Institute of General Medical Sciences/National Institutes of Health Grant 1R35GM133569 (to C. V.) and R35GM137801 (to Susan Carpenter), NIH Predoctoral Training Grant (T32GM008646), Ford Predoctoral Fellowship, and the Howard Hughes Medical Institute Gilliam Fellowship (to A. C. V.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Byrne A, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00643; Byrne A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16027; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Cole C, 2020, GENOME RES, V30, P589, DOI 10.1101/gr.257188.119; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Gao Y., 2020, ABPOA SIMD BASES C L, DOI [10.1101/2020.05.07.083196, DOI 10.1101/2020.05.07.083196]; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Gupta I, 2018, NAT BIOTECHNOL, V36, P1197, DOI 10.1038/nbt.4259; Harris CR, 2020, NATURE, V585, P357, DOI 10.1038/s41586-020-2649-2; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Kawai T, 2008, ANN NY ACAD SCI, V1143, P1, DOI 10.1196/annals.1443.020; Lebrigand K, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17800-6; Li H, 2018, BIOINFORMATICS, V34, P3094, DOI 10.1093/bioinformatics/bty191; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Medzhitov R, 2009, NAT REV IMMUNOL, V9, P692, DOI 10.1038/nri2634; Mi HY, 2010, NUCLEIC ACIDS RES, V38, pD204, DOI 10.1093/nar/gkp1019; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Picelli S, 2014, GENOME RES, V24, P2033, DOI 10.1101/gr.177881.114; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Robinson E. K., 2020, INFLAMMATION DRIVES, DOI [10.1101/2020.07.06.190330, DOI 10.1101/2020.07.06.190330]; Shafin K, 2020, NAT BIOTECHNOL, V38, P1044, DOI 10.1038/s41587-020-0503-6; Tardaguila M, 2018, GENOME RES, V28, P396, DOI 10.1101/gr.222976.117; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Vaser R, 2017, GENOME RES, V27, P737, DOI 10.1101/gr.214270.116; Virtanen P, 2020, NAT METHODS, V17, P261, DOI 10.1038/s41592-019-0686-2; Volden R., 2020, COLD SPRING HARB SYM, DOI [10.1101/2020.01.10.902361, DOI 10.1101/2020.01.10.902361]; Volden R, 2018, P NATL ACAD SCI USA, V115, P9726, DOI 10.1073/pnas.1806447115; Workman RE, 2019, NAT METHODS, V16, P1297, DOI 10.1038/s41592-019-0617-2; Wyman D., 2020, TECHNOLOGY AGNOSTIC, DOI [10.1101/672931, DOI 10.1101/672931, DOI 10.1093/jac/dkw397]	35	2	2	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100784	10.1016/j.jbc.2021.100784	http://dx.doi.org/10.1016/j.jbc.2021.100784			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34000296	gold, Green Published			2022-12-28	WOS:000674717300006
J	Wang, C; Chen, TY; Zhang, N; Yang, MJ; Li, B; Lu, X; Cao, XT; Ling, CQ				Wang, Chen; Chen, Taoyong; Zhang, Ning; Yang, Mingjin; Li, Bai; Lu, Xiang; Cao, Xuetao; Ling, Changquan			Melittin, a major component of bee venom, sensitizes human hepatocellular carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by activating CaMKII-TAK1-JNK/p38 and inhibiting I kappa B alpha kinase-NF kappa B (Withdrawal of Vol 284, Pg 3804, 2009)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Item Withdrawal													li, bai/GRJ-4913-2022; li, bz/GVR-7133-2022					Wang C, 2009, J BIOL CHEM, V284, P3804, DOI 10.1074/jbc.M807191200	1	0	0	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100767	10.1016/j.jbc.2021.100767	http://dx.doi.org/10.1016/j.jbc.2021.100767			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	34237896	Green Published, gold			2022-12-28	WOS:000672866400735
J	Nguyen, PQ; Conesa, C; Rabut, E; Bragagnolo, G; Gouzerh, C; Fernandez-Tornero, C; Lesage, P; Reguera, J; Acker, J				Phong Quoc Nguyen; Conesa, Christine; Rabut, Elise; Bragagnolo, Gabriel; Gouzerh, Celia; Fernandez-Tornero, Carlos; Lesage, Pascale; Reguera, Juan; Acker, Joel			Ty1 integrase is composed of an active N-terminal domain and a large disordered C-terminal module dispensable for its activity in vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-LOCALIZATION SIGNAL; REVERSE TRANSCRIPTION; RETROTRANSPOSON TY1; TRANSPOSABLE ELEMENTS; HIV-1 INTEGRASE; STRAND TRANSFER; PROTEIN; PURIFICATION; POLYMERASE; INHIBITION	Long-terminal repeat (LTR) retrotransposons are genetic elements that, like retroviruses, replicate by reverse transcription of an RNA intermediate into a complementary DNA (cDNA) that is next integrated into the host genome by their own integrase. The Ty1 LTR retrotransposon has proven to be a reliable working model to investigate retroelement integration site preference. However, the low yield of recombinant Ty1 integrase production reported so far has been a major obstacle for structural studies. Here we analyze the biophysical and biochemical properties of a stable and functional recombinant Ty1 integrase highly expressed in E.coli. The recombinant protein is monomeric and has an elongated shape harboring the three-domain structure common to all retroviral integrases at the N-terminal half, an extra folded region, and a large intrinsically disordered region at the C-terminal half. Recombinant Ty1 integrase efficiently catalyzes concerted integration in vitro, and the N-terminal domain displays similar activity. These studies that will facilitate structural analyses may allow elucidating the molecular mechanisms governing Ty1 specific integration into safe places in the genome.	[Phong Quoc Nguyen; Bragagnolo, Gabriel; Reguera, Juan] Aix Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France; [Conesa, Christine; Rabut, Elise; Gouzerh, Celia; Acker, Joel] Univ Paris Saclay, CNRS, CEA, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France; [Fernandez-Tornero, Carlos] CSIC, Ctr Invest Biol Margarita Salas, Madrid, Spain; [Lesage, Pascale] Univ Paris, Hop St Louis, Genomes & Cell Biol Dis Unit, Inst Rech St Louis,INSERM U944,CNRS UMR 7212, Paris, France; [Reguera, Juan] INSERM, AFMB UMR7257, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Reguera, J (corresponding author), Aix Marseille Univ, CNRS, AFMB UMR 7257, Marseille, France.; Acker, J (corresponding author), Univ Paris Saclay, CNRS, CEA, Inst Integrat Biol Cell I2BC, Gif Sur Yvette, France.; Reguera, J (corresponding author), INSERM, AFMB UMR7257, Marseille, France.	juan.reguera@inserm.fr; joel.acker@cea.fr	Fernandez-Tornero, Carlos/I-6888-2015; Acker, Joël/F-5138-2010; Reguera, Juan/A-7551-2017	Fernandez-Tornero, Carlos/0000-0001-5097-731X; Acker, Joël/0000-0002-0855-875X; Nguyen, Phong Quoc/0000-0001-5968-9170; Reguera, Juan/0000-0003-4977-7948; LESAGE, Pascale/0000-0002-4221-8038	ARC Foundation	ARC Foundation(Australian Research Council)	P. Q. N. was supported by the ARC Foundation with a fourth-year PhD fellowship.	Amartely H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25246-6; Asif-Laidin A, 2020, EMBO J, V39, DOI 10.15252/embj.2019104337; Ballandras-Colas A, 2016, NATURE, V530, P358, DOI 10.1038/nature16955; Baller JA, 2012, GENOME RES, V22, P704, DOI 10.1101/gr.129585.111; Bhatt V, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16963-6; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; BOEKE JD, 1985, CELL, V40, P491, DOI 10.1016/0092-8674(85)90197-7; Bolton EC, 2002, MOL CELL, V9, P879, DOI 10.1016/S1097-2765(02)00495-1; BRAITERMAN LT, 1994, MOL CELL BIOL, V14, P5719, DOI 10.1128/MCB.14.9.5719; Bridier-Nahmias A, 2015, SCIENCE, V348, P585, DOI 10.1126/science.1259114; Bujacz G, 1996, STRUCTURE, V4, P89, DOI 10.1016/S0969-2126(96)00012-3; Carr M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050978; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Costa SJ, 2013, PROTEIN EXPRES PURIF, V92, P163, DOI 10.1016/j.pep.2013.09.013; Curcio MJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0053-2014; Cyert MS, 2013, GENETICS, V193, P677, DOI 10.1534/genetics.112.147207; Delelis O, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-114; Deprez E, 2000, BIOCHEMISTRY-US, V39, P9275, DOI 10.1021/bi000397j; Devine SE, 1996, GENE DEV, V10, P620, DOI 10.1101/gad.10.5.620; Eide DJ, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-9-r77; Engel SR, 2014, G3-GENES GENOM GENET, V4, P389, DOI 10.1534/g3.113.008995; Engelman AN, 2017, CURR OPIN STRUC BIOL, V47, P23, DOI 10.1016/j.sbi.2017.04.005; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Friedl AA, 2010, MOL GENET GENOMICS, V284, P231, DOI 10.1007/s00438-010-0561-4; Gabler Felix, 2020, Curr Protoc Bioinformatics, V72, pe108, DOI 10.1002/cpbi.108; Goffeau A, 1996, SCIENCE, V274, P546, DOI 10.1126/science.274.5287.546; Hare S, 2010, P NATL ACAD SCI USA, V107, P20057, DOI 10.1073/pnas.1010246107; Hare S, 2010, NATURE, V464, P232, DOI 10.1038/nature08784; Hopkins JB, 2017, J APPL CRYSTALLOGR, V50, P1545, DOI 10.1107/S1600576717011438; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; JI H, 1993, CELL, V73, P1007, DOI 10.1016/0092-8674(93)90278-X; Kenna MA, 1998, MOL CELL BIOL, V18, P1115, DOI 10.1128/MCB.18.2.1115; Kim JM, 1998, GENOME RES, V8, P464, DOI 10.1101/gr.8.5.464; Kirchner J, 1996, J VIROL, V70, P4737, DOI 10.1128/JVI.70.7.4737-4747.1996; LAPINSKAS PJ, 1995, MOL CELL BIOL, V15, P1382; Lesage P, 2005, CYTOGENET GENOME RES, V110, P70, DOI 10.1159/000084940; Li M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105078; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Manalastas-Cantos K, 2021, J APPL CRYSTALLOGR, V54, P343, DOI 10.1107/S1600576720013412; Moore SP, 2009, J VIROL, V83, P9502, DOI 10.1128/JVI.00159-09; MOORE SP, 1994, P NATL ACAD SCI USA, V91, P1843, DOI 10.1073/pnas.91.5.1843; Moore SP, 2000, J VIROL, V74, P11522, DOI 10.1128/JVI.74.24.11522-11530.2000; MOORE SP, 1995, J VIROL, V69, P4683, DOI 10.1128/JVI.69.8.4683-4692.1995; Moore SP, 1998, MOL CELL BIOL, V18, P1105, DOI 10.1128/MCB.18.2.1105; Mularoni L, 2012, GENOME RES, V22, P693, DOI 10.1101/gr.129460.111; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Pandey KK, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-01855-2; Passos DO, 2017, SCIENCE, V355, P89, DOI 10.1126/science.aah5163; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Qi XJ, 2012, J BIOL CHEM, V287, P18589, DOI 10.1074/jbc.M111.326025; Reguera J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005636; Sayers JR, 1996, ANAL BIOCHEM, V241, P186, DOI 10.1006/abio.1996.0397; Schramm A, 2019, ARCH BIOCHEM BIOPHYS, V676, DOI 10.1016/j.abb.2019.07.020; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Wilhelm FX, 2005, CYTOGENET GENOME RES, V110, P269, DOI 10.1159/000084960; Wilhelm M, 2000, BIOCHEM J, V348, P337, DOI 10.1042/0264-6021:3480337; Wilhelm M, 2005, EUKARYOT CELL, V4, P1057, DOI 10.1128/EC.4.6.1057-1065.2005; Wilhelm M, 2006, EUKARYOT CELL, V5, P1760, DOI 10.1128/EC.00159-06; Yin ZQ, 2016, NATURE, V530, P362, DOI 10.1038/nature16950; Yu DN, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-623	65	0	0	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT	2021	297	4							101093	10.1016/j.jbc.2021.101093	http://dx.doi.org/10.1016/j.jbc.2021.101093			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WP2YV	34416236	Green Published, gold			2022-12-28	WOS:000713004000012
J	Chaurasia, P; Nguyen, THO; Rowntree, LC; Juno, JA; Wheatley, AK; Kent, SJ; Kedzierska, K; Rossjohn, J; Petersen, J				Chaurasia, Priyanka; Nguyen, Thi H. O.; Rowntree, Louise C.; Juno, Jennifer A.; Wheatley, Adam K.; Kent, Stephen J.; Kedzierska, Katherine; Rossjohn, Jamie; Petersen, Jan			Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								CD8(+) T cells play an important role in vaccination and immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Although numerous SARS-CoV-2 CD8+ T cell epitopes have been identified, the molecular basis underpinning T cell receptor (TCR) recognition of SARSCoV-2-specific T cells remains unknown. The T cell response directed toward SARS-CoV-2 spike protein-derived S269-277 peptide presented by the human leukocyte antigen (HLA)A*02:01 allomorph (hereafter the HLA-A2S(269-277) epitope) is, to date, the most immunodominant SARS-CoV-2 epitope found in individuals bearing this allele. As HLA-A2S(269-277)- specific CD8(+) T cells utilize biased TRAV12 gene usage within the TCR alpha-chain, we sought to understand the molecular basis underpinning this TRAV12 dominance. We expressed four TRAV12(+) TCRs which bound the HLA-A2S(269-277) complex with low micromolar affinity and determined the crystal structure of the HLA-A2S(269-277) binary complex, and subsequently a ternary structure of the TRAV12(+) TCR complexed to HLA-A2S(269-277). We found that the TCR made extensive contacts along the entire length of the S269-277 peptide, suggesting that the TRAV12(+) TCRs would be sensitive to sequence variation within this epitope. To examine this, we investigated cross-reactivity toward analogous peptides from existing SARSCoV-2 variants and closely related coronaviruses. We show via surface plasmon resonance and tetramer studies that the TRAV12(+) T cell repertoire cross-reacts poorly with these analogous epitopes. Overall, we defined the structural basis underpinning biased TCR recognition of CD8(+) T cells directed at an immunodominant epitope and provide a framework for understanding TCR cross-reactivity toward viral variants within the S269-277 peptide.	[Chaurasia, Priyanka; Rossjohn, Jamie; Petersen, Jan] Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia; [Chaurasia, Priyanka; Rossjohn, Jamie; Petersen, Jan] Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Nguyen, Thi H. O.; Rowntree, Louise C.; Juno, Jennifer A.; Wheatley, Adam K.; Kent, Stephen J.; Kedzierska, Katherine] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia; [Wheatley, Adam K.; Kent, Stephen J.] Univ Melbourne, Australian Res Council Ctr Excellence Convergent, Melbourne, Vic, Australia; [Rossjohn, Jamie; Petersen, Jan] Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia; [Rossjohn, Jamie] Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff, Wales	Monash University; Monash University; University of Melbourne; University of Melbourne; Monash University; Cardiff University	Rossjohn, J; Petersen, J (corresponding author), Monash Univ, Biomed Discovery Inst, Infect & Immun Program, Clayton, Vic, Australia.; Rossjohn, J; Petersen, J (corresponding author), Monash Univ, Biomed Discovery Inst, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Kedzierska, K (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Melbourne, Vic, Australia.; Rossjohn, J; Petersen, J (corresponding author), Monash Univ, Australian Res Council Ctr Excellence Adv Mol Ima, Clayton, Vic, Australia.; Rossjohn, J (corresponding author), Cardiff Univ, Inst Infect & Immun, Sch Med, Heath Pk, Cardiff, Wales.	kkedz@unimelb.edu.au; Jamie.rossjohn@monash.edu; jan.petersen@monasn.edu	Rowntree, Louise/HHZ-1437-2022; Rossjohn, Jamie/F-9032-2013	Rossjohn, Jamie/0000-0002-2020-7522; Rowntree, Louise/0000-0002-0649-5089; Kent, Stephen/0000-0002-8539-4891	NHMRC Leadership Investigator Grant [1173871]; NHMRC Emerging Leadership Level 1 Investigator Grant [1194036]; Research Grants Council of the Hong Kong Special Administrative Region, China [T11-712/19-N]; Emerging Leadership 1 Investigator Grant [1173433]; NHMRC Early Career Fellowship (ECF) [1123673]; NHMRC Senior Principal Research Fellowship [1136322]; ARC Laureate fellowship; MRFF Award [2005544]	NHMRC Leadership Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Emerging Leadership Level 1 Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); Research Grants Council of the Hong Kong Special Administrative Region, China(Hong Kong Research Grants Council); Emerging Leadership 1 Investigator Grant; NHMRC Early Career Fellowship (ECF)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Laureate fellowship(Australian Research Council); MRFF Award(Medical Research Future Fund (MRFF))	This work was supported by the NHMRC Leadership Investigator Grant to K. K. (1173871), NHMRC Emerging Leadership Level 1 Investigator Grant to T. H. O. N. (#1194036), Research Grants Council of the Hong Kong Special Administrative Region, China (#T11-712/19-N) to K. K., and MRFF Award (#2005544) to K. K., S. J. K., A. K. W., and J. A. J. A. K. W. are supported by Emerging Leadership 1 Investigator Grant (#1173433), J. A. J. by an NHMRC Early Career Fellowship (ECF) (#1123673), and S. J. K. by NHMRC Senior Principal Research Fellowship (#1136322). J. R. is supported by an ARC Laureate fellowship.	Adamo S., 2020, LYMPHOPENIA INDUCED; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bonifacius A, 2021, IMMUNITY, V54, P340, DOI 10.1016/j.immuni.2021.01.008; Clements CS, 2002, ACTA CRYSTALLOGR D, V58, P2131, DOI 10.1107/S0907444902015482; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Diao B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00827; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferretti AP, 2020, IMMUNITY, V53, P1095, DOI 10.1016/j.immuni.2020.10.006; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Habel JR, 2020, P NATL ACAD SCI USA, V117, P24384, DOI 10.1073/pnas.2015486117; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kared H, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI145476; Koutsakos M, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100208; Koutsakos M, 2019, NAT IMMUNOL, V20, P613, DOI 10.1038/s41590-019-0320-6; Le Bert N, 2021, J EXP MED, V218, DOI 10.1084/jem.20202617; Lefranc MP, 2009, NUCLEIC ACIDS RES, V37, pD1006, DOI 10.1093/nar/gkn838; Lineburg KE, 2021, IMMUNITY, V54, P1055, DOI 10.1016/j.immuni.2021.04.006; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Nguyen THO, 2021, IMMUNITY, V54, P1066, DOI 10.1016/j.immuni.2021.04.009; Peng Y, 2020, NAT IMMUNOL, P1, DOI DOI 10.1038/s41590-020-0782-6; Petersen J, 2020, NAT STRUCT MOL BIOL, V27, P49, DOI 10.1038/s41594-019-0353-4; Saini SK, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf7550; Sattler A, 2020, J CLIN INVEST, V130, DOI 10.1172/JCI140965; Schulien I, 2021, NAT MED, V27, P78, DOI 10.1038/s41591-020-01143-2; Shomuradova AS, 2020, IMMUNITY, V53, P1245, DOI 10.1016/j.immuni.2020.11.004; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Thevarajan I, 2020, NAT MED, V26, P453, DOI 10.1038/s41591-020-0819-2; Valkenburg SA, 2016, P NATL ACAD SCI USA, V113, P4440, DOI 10.1073/pnas.1603106113; Weiskopf D, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abd2071; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zheng HY, 2020, CELL MOL IMMUNOL, V17, P541, DOI 10.1038/s41423-020-0401-3	31	6	6	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101065	10.1016/j.jbc.2021.101065	http://dx.doi.org/10.1016/j.jbc.2021.101065			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34384783	Green Published, Green Accepted, gold			2022-12-28	WOS:000706409400014
J	Jia, WY; Kim, SH; Scalf, MA; Tonzi, P; Millikin, RJ; Guns, WM; Liu, L; Mastrocola, AS; Smith, LM; Huang, TT; Tibbetts, RS				Jia, Weiyan; Kim, Sang Hwa; Scalf, Mark A.; Tonzi, Peter; Millikin, Robert J.; Guns, William M.; Liu, Lu; Mastrocola, Adam S.; Smith, Lloyd M.; Huang, Tony T.; Tibbetts, Randal S.			Fused in sarcoma regulates DNA replication timing and kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-BINDING PROTEIN; PRO-ONCOPROTEIN TLS/FUS; NUCLEAR IMPORT RECEPTOR; CELL-FREE FORMATION; PHASE-SEPARATION; POLYMERASE-II; TRANSCRIPTIONAL ACTIVATION; TERMINAL DOMAIN; TET FAMILY; RIF1	Fused in sarcoma (FUS) encodes an RNA-binding protein with diverse roles in transcriptional activation and RNA splicing. While oncogenic fusions of FUS and transcription factor DNA-binding domains are associated with soft tissue sarcomas, dominant mutations in FUS can cause amyotrophic lateral sclerosis. FUS has also been implicated in genome maintenance. However, the underlying mechanisms of its actions in genome stability are unknown. Here, we applied gene editing, functional reconstitution, and integrated proteomics and transcriptomics to illuminate roles for FUS in DNA replication and repair. Consistent with a supportive role in DNA double-strand break repair, FUS-deficient cells exhibited subtle alterations in the recruitment and retention of double strand break-associated factors, including 53BP1 and BRCA1. FUS-/- cells also exhibited reduced proliferative potential that correlated with reduced speed of replication fork progression, diminished loading of prereplication complexes, enhanced micronucleus formation, and attenuated expression and splicing of S-phase-associated genes. Finally, FUSdeficient cells exhibited genome-wide alterations in DNA replication timing that were reversed upon re-expression of FUS complementary DNA. We also showed that FUSdependent replication domains were enriched in transcriptionally active chromatin and that FUS was required for the timely replication of transcriptionally active DNA. These findings suggest that alterations in DNA replication kinetics and programming contribute to genome instability and functional defects in FUS-deficient cells.	[Jia, Weiyan; Kim, Sang Hwa; Guns, William M.; Mastrocola, Adam S.; Tibbetts, Randal S.] Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA; [Scalf, Mark A.; Millikin, Robert J.; Smith, Lloyd M.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Tonzi, Peter; Huang, Tony T.] New York Univ Langone Hlth, Dept Biochem & Mol Pharmacol, New York, NY USA; [Liu, Lu] Univ Wisconsin, Dept Biostat & Med Informat, Sch Med & Publ Hlth, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; New York University; University of Wisconsin System; University of Wisconsin Madison	Tibbetts, RS (corresponding author), Univ Wisconsin, Dept Human Oncol, Sch Med & Publ Hlth, Madison, WI 53706 USA.	rstibbetts@wisc.edu	Jia, Weiyan/AFQ-4316-2022; JIA, WEIYAN/ABG-6750-2021	JIA, WEIYAN/0000-0003-0899-0697	National Cancer Institute [R01CA180765-01]; National Institute of Neurological Disorders and Stroke [1R21NS090313-01A1]; National Institute of Environmental Health Sciences [R01ES025166]; University of Wisconsin Carbone Cancer Center support grant [P30CA014520]; National Institutes of Health Shared Instrumentation Grants [1S10RR025483-01]; National Institute of General Medical Sciences [R35GM126914]; National Human Genome Research Institute [5T32HG002760]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Wisconsin Carbone Cancer Center support grant; National Institutes of Health Shared Instrumentation Grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work was supported by the National Cancer Institute (R01CA180765-01 to R. S. T.); National Institute of Neurological Disorders and Stroke (1R21NS090313-01A1 to R. S. T.); National Institute of Environmental Health Sciences (R01ES025166 to T. T. H.); University of Wisconsin Carbone Cancer Center support grant (P30CA014520); National Institutes of Health Shared Instrumentation Grants (1S10RR025483-01); National Institute of General Medical Sciences (R35GM126914 to L. M. S.); National Human Genome Research Institute training grant to the Genomic Sciences Training Program (5T32HG002760 to R. J. M.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Antonescu CR, 2006, CLIN CANCER RES, V12, P5356, DOI 10.1158/1078-0432.CCR-05-2811; Baechtold H, 1999, J BIOL CHEM, V274, P34337, DOI 10.1074/jbc.274.48.34337; BAILLY RA, 1994, MOL CELL BIOL, V14, P3230, DOI 10.1128/MCB.14.5.3230; Bertolotti A, 1999, ONCOGENE, V18, P8000, DOI 10.1038/sj.onc.1203207; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Bertrand P, 1999, ONCOGENE, V18, P4515, DOI 10.1038/sj.onc.1203048; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Buonomo SBC, 2017, ADV EXP MED BIOL, V1042, P259, DOI 10.1007/978-981-10-6955-0_12; Burgers PMJ, 2017, ANNU REV BIOCHEM, V86, P417, DOI 10.1146/annurev-biochem-061516-044709; Burke KA, 2015, MOL CELL, V60, P231, DOI 10.1016/j.molcel.2015.09.006; Chan RCW, 2018, BIOINFORMATICS, V34, P669, DOI 10.1093/bioinformatics/btx603; Chen DL, 2010, NATURE, V464, P624, DOI 10.1038/nature08820; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Cho WK, 2018, SCIENCE, V361, P412, DOI 10.1126/science.aar4199; Chong SS, 2018, SCIENCE, V361, DOI 10.1126/science.aar2555; Cornacchia D, 2012, EMBO J, V31, P3678, DOI 10.1038/emboj.2012.214; Corrado L, 2010, J MED GENET, V47, P190, DOI 10.1136/jmg.2009.071027; CROZAT A, 1993, NATURE, V363, P640, DOI 10.1038/363640a0; Deng QD, 2014, J NEUROSCI, V34, P7802, DOI 10.1523/JNEUROSCI.0172-14.2014; Dev H, 2018, NAT CELL BIOL, V20, P954, DOI 10.1038/s41556-018-0140-1; Dileep V, 2015, GENOME RES, V25, P1104, DOI 10.1101/gr.183699.114; Dimitrova DS, 2002, J CELL SCI, V115, P4037, DOI 10.1242/jcs.00087; Dimitrova DS, 1999, MOL CELL, V4, P983, DOI 10.1016/S1097-2765(00)80227-0; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dormann D, 2010, EMBO J, V29, P2841, DOI 10.1038/emboj.2010.143; Dungrawala H, 2015, METHODS MOL BIOL, V1228, P123, DOI 10.1007/978-1-4939-1680-1_10; Escribano-Diaz C, 2013, MOL CELL, V49, P872, DOI 10.1016/j.molcel.2013.01.001; Foti R, 2016, MOL CELL, V61, P260, DOI 10.1016/j.molcel.2015.12.001; Fragkos M, 2015, NAT REV MOL CELL BIO, V16, P360, DOI 10.1038/nrm4002; Gao YZ, 2017, GENES-BASEL, V8, DOI 10.3390/genes8020064; Gardiner M, 2008, BIOCHEM J, V415, P297, DOI 10.1042/BJ20081135; Gudjonsson T, 2012, CELL, V150, P697, DOI 10.1016/j.cell.2012.06.039; Guipaud O, 2006, PROTEOMICS, V6, P5962, DOI 10.1002/pmic.200600259; Gupta R, 2018, CELL, V173, P972, DOI 10.1016/j.cell.2018.03.050; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Hansen RK, 2016, NAT CELL BIOL, V18, P1357, DOI 10.1038/ncb3436; Hanzlikova H, 2018, MOL CELL, V71, P319, DOI 10.1016/j.molcel.2018.06.004; Hayano M, 2012, GENE DEV, V26, P137, DOI 10.1101/gad.178491.111; Hicks GG, 2000, NAT GENET, V24, P175, DOI 10.1038/72842; Hill SJ, 2016, P NATL ACAD SCI USA, V113, pE7701, DOI 10.1073/pnas.1611673113; Hiratani I, 2010, GENOME RES, V20, P155, DOI 10.1101/gr.099796.109; Hiratani I, 2008, PLOS BIOL, V6, P2220, DOI 10.1371/journal.pbio.0060245; Hoffelder DR, 2004, CHROMOSOMA, V112, P389, DOI 10.1007/s00412-004-0284-6; Hoffman MM, 2012, NAT METHODS, V9, P473, DOI [10.1038/nmeth.1937, 10.1038/NMETH.1937]; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Isobe SY, 2017, CELL REP, V20, P297, DOI 10.1016/j.celrep.2017.06.056; Jungmichel S, 2013, MOL CELL, V52, P272, DOI 10.1016/j.molcel.2013.08.026; Kaaij LJT, 2018, CELL REP, V24, P1, DOI 10.1016/j.celrep.2018.06.003; Kamelgarn M, 2018, P NATL ACAD SCI USA, V115, pE11904, DOI 10.1073/pnas.1810413115; Kanoh Y, 2015, NAT STRUCT MOL BIOL, V22, P889, DOI 10.1038/nsmb.3102; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kawaguchi T, 2020, J PROTEOME RES, V19, P360, DOI 10.1021/acs.jproteome.9b00575; Kim SH, 2018, HUM MOL GENET, V27, P322, DOI 10.1093/hmg/ddx403; Kim SH, 2016, NUCLEIC ACIDS RES, V44, P9667, DOI 10.1093/nar/gkw643; Koren A, 2012, AM J HUM GENET, V91, P1033, DOI 10.1016/j.ajhg.2012.10.018; Kuroda M, 2000, EMBO J, V19, P453, DOI 10.1093/emboj/19.3.453; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Kwon I, 2013, CELL, V155, P1049, DOI 10.1016/j.cell.2013.10.033; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Levone BR, 2021, J CELL BIOL, V220, DOI 10.1083/jcb.202008030; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Ling SC, 2019, ELIFE, V8, DOI 10.7554/eLife.40811; Liu F, 2016, BIOINFORMATICS, V32, P641, DOI 10.1093/bioinformatics/btv643; Lopez-Contreras AJ, 2013, CELL REP, V3, P1105, DOI 10.1016/j.celrep.2013.03.009; Lopez-Erauskin J, 2018, NEURON, V100, P816, DOI 10.1016/j.neuron.2018.09.044; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Marchal C, 2018, NAT PROTOC, V13, P819, DOI 10.1038/nprot.2017.148; Martinez-Macias MI, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800222; Mastrocola AS, 2013, J BIOL CHEM, V288, P24731, DOI 10.1074/jbc.M113.497974; Mattarocci S, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00045; MAY WA, 1993, MOL CELL BIOL, V13, P7393, DOI 10.1128/MCB.13.12.7393; McQuin C, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2005970; Millikin RJ, 2020, J PROTEOME RES, V19, P1975, DOI 10.1021/acs.jproteome.9b00796; Millikin RJ, 2018, J PROTEOME RES, V17, P386, DOI 10.1021/acs.jproteome.7b00608; Mirman Z, 2018, NATURE, V560, P112, DOI 10.1038/s41586-018-0324-7; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Noordermeer SM, 2018, NATURE, V560, P117, DOI 10.1038/s41586-018-0340-7; Ou JH, 2019, NAT METHODS, V16, P453, DOI 10.1038/s41592-019-0430-y; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; RABBITTS TH, 1993, NAT GENET, V4, P175, DOI 10.1038/ng0693-175; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rivera-Mulia JC, 2015, GENOME RES, V25, P1091, DOI 10.1101/gr.187989.114; Rulten SL, 2014, NUCLEIC ACIDS RES, V42, P307, DOI 10.1093/nar/gkt835; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; SANCHEZGARCIA I, 1994, P NATL ACAD SCI USA, V91, P7869, DOI 10.1073/pnas.91.17.7869; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schwartz JC, 2013, CELL REP, V5, P918, DOI 10.1016/j.celrep.2013.11.017; Schwartz JC, 2012, GENE DEV, V26, P2690, DOI 10.1101/gad.204602.112; Sergushichev A., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shang YL, 2016, BRAIN RES, V1647, P65, DOI 10.1016/j.brainres.2016.03.036; Shortreed MR, 2015, J PROTEOME RES, V14, P4714, DOI 10.1021/acs.jproteome.5b00599; Siefert JC, 2017, GENOME RES, V27, P1406, DOI 10.1101/gr.218602.116; Silverman J, 2004, GENE DEV, V18, P2108, DOI 10.1101/gad.1216004; Sima J, 2019, CELL, V176, P816, DOI 10.1016/j.cell.2018.11.036; Singatulina AS, 2019, CELL REP, V27, P1809, DOI 10.1016/j.celrep.2019.04.031; Sirbu BM, 2011, GENE DEV, V25, P1320, DOI 10.1101/gad.2053211; Solntsev SK, 2018, J PROTEOME RES, V17, P1844, DOI 10.1021/acs.jproteome.7b00873; Splinter J, 2010, MUTAGENESIS, V25, P289, DOI 10.1093/mutage/geq005; Sun SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7171; Sun ZH, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1000614; Tan AY, 2009, J MOL CELL BIOL, V1, P82, DOI 10.1093/jmcb/mjp025; Therizols P, 2014, SCIENCE, V346, P1238, DOI 10.1126/science.1259587; Tonzi P, 2018, ELIFE, V7, DOI 10.7554/eLife.41426; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; Vaquero-Garcia J, 2016, ELIFE, V5, DOI 10.7554/eLife.11752; Wang HB, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06111-6; Wang WY, 2013, NAT NEUROSCI, V16, P1383, DOI 10.1038/nn.3514; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xu DY, 2010, EMBO J, V29, P3140, DOI 10.1038/emboj.2010.186; Yamazaki S, 2012, EMBO J, V31, P3667, DOI 10.1038/emboj.2012.180; Yoshizawa T, 2018, CELL, V173, P693, DOI 10.1016/j.cell.2018.03.003; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6; ZINSZNER H, 1994, GENE DEV, V8, P2513, DOI 10.1101/gad.8.21.2513	116	2	2	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101049	10.1016/j.jbc.2021.101049	http://dx.doi.org/10.1016/j.jbc.2021.101049			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JL	34375640	gold, Green Published			2022-12-28	WOS:000706409400004
J	Li, DY; Mukhopadhyay, S				Li, Danyang; Mukhopadhyay, Somshuvra			A three-pocket model for substrate coordination and selectivity by the nucleotide sugar transporters SLC35A1 and SLC35A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CMP-SIALIC ACID; UDP-GALACTOSE; SHIGA TOXIN; GLYCOSYLATION; GOLGI; RECOGNITION; MECHANISMS; IDENTIFICATION; TRANSMEMBRANE; TRAFFICKING	The CMP-sialic acid transporter SLC35A1 and UDP-galactose transporter SLC35A2 are two well-characterized nucleotide sugar transporters with distinctive substrate specificities. Mutations in either induce congenital disorders of glycosylation. Despite the biomedical relevance, mechanisms of substrate specificity are unclear. To address this critical issue, we utilized a structure-guided mutagenesis strategy and assayed a series of SLC35A2 and SLC35A1 mutants using a rescue approach. Our results suggest that three pockets in the central cavity of each transporter provide substrate specificity. The pockets comprise (1) nucleobase (residues E52, K55, and Y214 of SLC35A1; E75, K78, N235, and G239 of SLC35A2); (2) middle (residues Q101, N102, and T260 of SLC35A1; Q125, N126, Q129, Y130, and Q278 of SLC35A2); and (3) sugar (residues K124, T128, S188, and K272 of SLC35A1; K148, T152, S213, and K297 of SLC35A2) pockets. Within these pockets, two components appear to be especially critical for substrate specificity. Y214 (for SLC35A1) and G239 (for SLC35A2) in the nucleobase pocket appear to discriminate cytosine from uracil. Furthermore, Q129 and Q278 of SLC35A2 in the middle pocket appear to interact specifically with the beta-phosphate of UDP while the corresponding A105 and A253 residues in SLC35A1 do not interact with CMP, which lacks a beta-phosphate. Overall, our findings contribute to a molecular understanding of substrate specificity and coordination in SLC35A1 and SLC35A2 and have important implications for the understanding and treatment of diseases associated with mutations or dysregulations of these two transporters.	[Mukhopadhyay, Somshuvra] Univ Texas Austin, Div Pharmacol & Toxicol, Coll Pharm, Inst Cellular & Mol Biol, Austin, TX 78712 USA; Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin	Mukhopadhyay, S (corresponding author), Univ Texas Austin, Div Pharmacol & Toxicol, Coll Pharm, Inst Cellular & Mol Biol, Austin, TX 78712 USA.	som@austin.utexas.edu		Li, Danyang/0000-0002-1895-3534	National Institutes of Health/National Institute of Allergy and Infectious Diseases [R21-AI123608]; UT Austin	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UT Austin	Supported in part by the National Institutes of Health/National Institute of Allergy and Infectious Diseases grant R21-AI123608 and funds from UT Austin to S. M.	Toscanini MA, 2019, J BIOL CHEM, V294, P10042, DOI 10.1074/jbc.RA119.008827; Ahuja S, 2019, ELIFE, V8, DOI 10.7554/eLife.45221; Aoki K, 2003, J BIOL CHEM, V278, P22887, DOI 10.1074/jbc.M302620200; Aoki K, 2001, J BIOL CHEM, V276, P21555, DOI 10.1074/jbc.M101462200; Baldassari S, 2019, ACTA NEUROPATHOL, V138, P885, DOI 10.1007/s00401-019-02061-5; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Chan KF, 2010, GLYCOBIOLOGY, V20, P689, DOI 10.1093/glycob/cwq016; Eckhardt M, 1999, J BIOL CHEM, V274, P8779, DOI 10.1074/jbc.274.13.8779; Evers C, 2017, MOL GENET METAB, V121, P297, DOI 10.1016/j.ymgme.2017.06.014; Freeze HH, 2012, LANCET NEUROL, V11, P453, DOI 10.1016/S1474-4422(12)70040-6; Gupta N, 2014, ACS MED CHEM LETT, V5, P94, DOI 10.1021/ml400457j; Hadley B, 2014, COMPUT STRUCT BIOTEC, V10, P23, DOI 10.1016/j.csbj.2014.05.003; HALL ET, 1994, J BIOL CHEM, V269, P14355; Han J, 2018, CELL REP, V23, P596, DOI 10.1016/j.celrep.2018.03.045; HARVEY BE, 1993, BIOCHEM BIOPH RES CO, V190, P571, DOI 10.1006/bbrc.1993.1086; Hong KJ, 2000, BIOCHEMISTRY-US, V39, P2013, DOI 10.1021/bi992363l; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Li DY, 2020, TOXINS, V12, DOI 10.3390/toxins12050342; Li DY, 2019, GLYCOBIOLOGY, V29, P490, DOI 10.1093/glycob/cwz016; Lim SF, 2008, GLYCOBIOLOGY, V18, P851, DOI 10.1093/glycob/cwn080; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maggioni A, 2013, CHEMBIOCHEM, V14, P1936, DOI 10.1002/cbic.201300298; Mohamed M, 2013, NEUROLOGY, V81, P681, DOI 10.1212/WNL.0b013e3182a08f53; Mukhopadhyay S, 2013, J MOL MED, V91, P1131, DOI 10.1007/s00109-013-1048-7; Mukhopadhyay S, 2012, SCIENCE, V335, P332, DOI 10.1126/science.1215930; Ng BG, 2019, HUM MUTAT, V40, P908, DOI 10.1002/humu.23731; Nji E, 2019, NAT STRUCT MOL BIOL, V26, P415, DOI 10.1038/s41594-019-0225-y; Noel R, 2013, J MED CHEM, V56, P3404, DOI 10.1021/jm4002346; Obrig TG, 2010, TOXINS, V2, P2769, DOI 10.3390/toxins2122769; Oelmann S, 2001, J BIOL CHEM, V276, P26291, DOI 10.1074/jbc.M011124200; Parker JL, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12673-w; Parker JL, 2019, CURR OPIN STRUC BIOL, V57, P127, DOI 10.1016/j.sbi.2019.03.019; Parker JL, 2017, NATURE, V551, P521, DOI 10.1038/nature24464; Quelhas D, 2021, MOL GENET METAB REP, V26, DOI 10.1016/j.ymgmr.2021.100717; Rodrigues E, 2018, CANCERS, V10, DOI 10.3390/cancers10060207; Saenz JB, 2007, INFECT IMMUN, V75, P4552, DOI 10.1128/IAI.00442-07; Scott H, 2014, GLYCOBIOLOGY, V24, P407, DOI 10.1093/glycob/cwu015; Selyunin AS, 2021, TOXINS, V13, DOI 10.3390/toxins13060424; Selyunin AS, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201900439; Selyunin AS, 2017, J CELL BIOL, V216, P3249, DOI 10.1083/jcb.201704015; Selyunin AS, 2015, TRAFFIC, V16, P1270, DOI 10.1111/tra.12338; Sim NS, 2018, NEUROL-GENET, V4, DOI 10.1212/NXG.0000000000000294; Song ZW, 2013, MOL ASPECTS MED, V34, P590, DOI 10.1016/j.mam.2012.12.004; Stechmann B, 2010, CELL, V141, P231, DOI 10.1016/j.cell.2010.01.043; Takeshima-Futagami T, 2012, GLYCOBIOLOGY, V22, P1731, DOI 10.1093/glycob/cws116; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Yates TM, 2018, EUR J PAEDIATR NEURO, V22, P1095, DOI 10.1016/j.ejpn.2018.08.002; Zhao W, 2006, J BIOL CHEM, V281, P31106, DOI 10.1074/jbc.M605564200; Zogzas CE, 2018, METALLOMICS, V10, DOI 10.1039/c8mt00115d; Zogzas CE, 2016, J BIOL CHEM, V291, P15940, DOI 10.1074/jbc.M116.726935	51	2	2	1	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101069	10.1016/j.jbc.2021.101069	http://dx.doi.org/10.1016/j.jbc.2021.101069			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WR6VH	34384782	gold, Green Published			2022-12-28	WOS:000714635500007
J	Schuck, PL; Ball, LE; Stewart, JA				Schuck, P. Logan; Ball, Lauren E.; Stewart, Jason A.			The DNA-binding protein CST associates with the cohesin complex and promotes chromosome cohesion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SISTER-CHROMATID COHESION; REPLICATION FORKS; ROLES; CHECKPOINT; CTF4; WAPL	Sister chromatid cohesion (SCC), the pairing of sister chro-matids after DNA replication until mitosis, is established by loading of the cohesin complex on newly replicated chroma-tids. Cohesin must then be maintained until mitosis to prevent segregation defects and aneuploidy. However, how SCC is established and maintained until mitosis remains incompletely understood, and emerging evidence suggests that replication stress may lead to premature SCC loss. Here, we report that the ssDNA-binding protein CTC1-STN1-TEN1 (CST) aids in SCC. CST primarily functions in telomere length regulation but also has known roles in replication restart and DNA repair. After depletion of CST subunits, we observed an increase in the complete loss of SCC. In addition, we determined that CST associates with the cohesin complex. Unexpectedly, we did not find evidence of altered cohesin loading or mitotic progression in the absence of CST; however, we did find that treatment with various replication inhibitors increased the association between CST and cohesin. Because replication stress was recently shown to induce SCC loss, we hypothesized that CST may be required to maintain or remodel SCC after DNA replication fork stalling. In agreement with this idea, SCC loss was greatly increased in CST-depleted cells after exogenous replication stress. Based on our findings, we propose that CST aids in the maintenance of SCC at stalled replication forks to prevent premature cohesion loss.	[Schuck, P. Logan; Stewart, Jason A.] Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA; [Ball, Lauren E.] Med Univ South Carolina, Dept Cell & Mol Pharmacol, Charleston, SC 29425 USA	University of South Carolina System; University of South Carolina Columbia; Medical University of South Carolina	Stewart, JA (corresponding author), Univ South Carolina, Dept Biol Sci, Columbia, SC 29208 USA.	jason.stewart@sc.edu		Ball, Lauren/0000-0001-6780-1679	NIH [K99 GM104409, R00 GM104409]; University of South Carolina; SPARC grant from the University of South Carolina	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of South Carolina; SPARC grant from the University of South Carolina	This work was supported by funds from the NIH (K99 GM104409 and R00 GM104409 to J. A. S.) and by startup funds from the University of South Carolina. P. L. S. was supported in part by a SPARC grant from the University of South Carolina. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health or the University of South Carolina.	Ackerson SM, 2020, CELL CYCLE, V19, P3491, DOI 10.1080/15384101.2020.1849979; Alam Muhammad S, 2018, Curr Protoc Immunol, V123, pe58, DOI 10.1002/cpim.58; Benedict B, 2020, DEV CELL, V52, P683, DOI 10.1016/j.devcel.2020.01.024; Canudas S, 2009, J CELL BIOL, V187, P165, DOI 10.1083/jcb.200903096; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Chastain M, 2016, CELL REP, V16, P2048, DOI 10.1016/j.celrep.2016.08.008; Chen LY, 2013, GENE DEV, V27, P2099, DOI 10.1101/gad.222893.113; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Dynek JN, 2004, SCIENCE, V304, P97, DOI 10.1126/science.1094754; Errico A, 2009, EMBO J, V28, P3681, DOI 10.1038/emboj.2009.304; Feng XY, 2017, NUCLEIC ACIDS RES, V45, P4281, DOI 10.1093/nar/gkx125; Ganduri S, 2017, NUCLEIC ACIDS RES, V45, P9455, DOI 10.1093/nar/gkx621; Gerlich D, 2006, CURR BIOL, V16, P1571, DOI 10.1016/j.cub.2006.06.068; GOULIAN M, 1990, J BIOL CHEM, V265, P13221; Haarhuis JHI, 2014, DEV CELL, V31, P7, DOI 10.1016/j.devcel.2014.09.010; Hubner NC, 2010, CHROMOSOMA, V119, P149, DOI 10.1007/s00412-009-0244-2; Ivanov MP, 2018, EMBO J, V37, DOI 10.15252/embj.201797150; Kasbek C, 2013, J BIOL CHEM, V288, P30139, DOI 10.1074/jbc.M113.493478; Kim BJ, 2010, J BIOL CHEM, V285, P22782, DOI 10.1074/jbc.M110.134577; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Leylek TR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57530-9; Lim CJ, 2021, NAT REV MOL CELL BIO, V22, P283, DOI 10.1038/s41580-021-00328-y; Litwin I, 2018, GENES-BASEL, V9, DOI 10.3390/genes9120581; Makrantoni V, 2018, CURR BIOL, V28, pR688, DOI 10.1016/j.cub.2018.05.019; Masamsetti VP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12255-w; Megason Sean G., 2009, V546, P317, DOI 10.1007/978-1-60327-977-2_19; Minamino M, 2018, CURR BIOL, V28, P2665, DOI 10.1016/j.cub.2018.06.037; Mirkovic M, 2015, CELL REP, V13, P469, DOI 10.1016/j.celrep.2015.09.020; Morales C, 2020, J BIOL CHEM, V295, P146, DOI 10.1074/jbc.RA119.011099; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Peters JM, 2008, GENE DEV, V22, P3089, DOI 10.1101/gad.1724308; Roy S, 2018, J CELL BIOL, V217, P1521, DOI 10.1083/jcb.201709121; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Schuck PL, 2019, METHODS MOL BIOL, V1999, P335, DOI 10.1007/978-1-4939-9500-4_24; Setiaputra D, 2019, EMBO REP, V20, DOI 10.15252/embr.201847560; Sigoillot FD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025511; Silva RD, 2018, CURR BIOL, V28, P2837, DOI 10.1016/j.cub.2018.06.062; Song JH, 2012, J BIOL CHEM, V287, P34325, DOI 10.1074/jbc.M112.400192; Stewart JA, 2018, FRONT BIOSCI-LANDMRK, V23, P1564, DOI 10.2741/4661; Stewart JA, 2012, EMBO J, V31, P3537, DOI 10.1038/emboj.2012.215; Terret ME, 2009, NATURE, V462, P231, DOI 10.1038/nature08550; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Uhlmann F, 1998, CURR BIOL, V8, P1095, DOI 10.1016/S0960-9822(98)70463-4; Villa F, 2016, MOL CELL, V63, P385, DOI 10.1016/j.molcel.2016.06.009; Wang YL, 2019, LIFE SCI ALLIANCE, V2, DOI 10.26508/lsa.201800270; Wutz G, 2017, EMBO J, V36, P3573, DOI 10.15252/embj.201798004; Yoshizawa-Sugata N, 2009, J BIOL CHEM, V284, P20718, DOI 10.1074/jbc.M806711200; Zhang MM, 2019, NUCLEIC ACIDS RES, V47, P5243, DOI 10.1093/nar/gkz264; Zheng G, 2018, ELIFE, V7, DOI 10.7554/eLife.33920	50	4	4	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101026	10.1016/j.jbc.2021.101026	http://dx.doi.org/10.1016/j.jbc.2021.101026			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JI	34339741	gold, Green Published			2022-12-28	WOS:000706408900002
J	Spiteri, VA; Goodall, M; Doutch, J; Rambo, RP; Gor, J; Perkins, SJ				Spiteri, Valentina A.; Goodall, Margaret; Doutch, James; Rambo, Robert P.; Gor, Jayesh; Perkins, Stephen J.			Solution structures of human myeloma IgG3 antibody reveal extended Fab and Fc regions relative to the other IgG subclasses	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; X-RAY; NEUTRON-SCATTERING; FORCE-FIELD; PROTEIN-A; SEDIMENTATION; COMPLEMENT; SIMULATION; HYDRATION; PACKAGE	Human immunoglobulin G subclass 3 (IgG3) possesses a uniquely long hinge region that separates its Fab antigen binding and Fc receptor-binding regions. Owing to this hinge length, the molecular structure of full-length IgG3 remains elusive, and the role of the two conserved Fc glycosylation sites are unknown. To address these issues, we subjected glycosylated and deglycosylated human myeloma IgG3 to multidisciplinary solution structure studies. Using analytical ultracentrifugation, the elongated structure of IgG3 was determined from the reduced sedimentation coefficients s(20,w)(0) of 5.82 to 6.29 S for both glycosylated and deglycosylated IgG3. X-ray and neutron scattering showed that the Guinier RG values were 6.95 nm for glycosylated IgG3 and were unchanged after deglycosylation, again indicating an elongated structure. The distance distribution function P(r) showed a maximum length of 25 to 28 nm and three distinct maxima. The molecular structure of IgG3 was determined using atomistic modeling based on molecular dynamics simulations of the IgG3 hinge and Monte Carlo simulations to identify physically realistic arrangements of the Fab and Fc regions. This resulted in libraries containing 135,135 and 73,905 glycosylated and deglycosylated IgG3 structures, respectively. Comparisons with the X-ray and neutron scattering curves gave 100 best -fit models for each form of IgG3 that accounted for the experimental scattering curves. These models revealed the first molecular structures for full-length IgG3. The structures exhibited relatively restricted Fab and Fc conformations joined by an extended semirigid hinge, which explains the potent effector functions of IgG3 relative to the other subclasses IgG1, IgG2, and IgG4.	[Spiteri, Valentina A.; Gor, Jayesh; Perkins, Stephen J.] UCL, Dept Struct & Mol Biol, Div Biosci, London, England; [Goodall, Margaret] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England; [Doutch, James] STFC Rutherford Appleton Lab, ISIS Facil, Harwell Campus, Didcot, Oxon, England; [Rambo, Robert P.] Diamond Light Source Ltd, Harwell Sci & Innovat Campus, Didcot, Oxon, England	University of London; University College London; University of Birmingham; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory; Diamond Light Source	Perkins, SJ (corresponding author), UCL, Dept Struct & Mol Biol, Div Biosci, London, England.	s.perkins@ucl.ac.uk		Spiteri, Valentina/0000-0002-5002-4989; Perkins, Stephen/0000-0001-9218-9805; Gor, Jayesh/0000-0002-1654-1392; Doutch, James/0000-0003-0747-8368	EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies [EP/L015218/1]; Diamond Light Source Ltd. [STU0174]; ISIS neutron facility joint PhD studentship; EPSRC [EP/K039121/1]; NSF [CHE01265821]	EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Diamond Light Source Ltd.; ISIS neutron facility joint PhD studentship; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NSF(National Science Foundation (NSF))	V. A. S. was supported by an EPSRC Centre for Doctoral Training in Emergent Macromolecular Therapies (EP/L015218/1), Diamond Light Source Ltd. (STU0174), and ISIS neutron facility joint PhD studentship. S. J. P. was supported by a joint EPSRC (EP/K039121/1) and NSF (CHE01265821) grant for CCP-SAS.	Appeltshauser L, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000817; Arnold O, 2014, NUCL INSTRUM METH A, V764, P156, DOI 10.1016/j.nima.2014.07.029; Basham M, 2015, J SYNCHROTRON RADIAT, V22, P853, DOI 10.1107/S1600577515002283; Best RB, 2012, J CHEM THEORY COMPUT, V8, P3257, DOI 10.1021/ct300400x; Bogdanos DP, 2005, HEPATOLOGY, V42, P458, DOI 10.1002/hep.20788; Bondza S, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.609941; Bonner A, 2009, MUCOSAL IMMUNOL, V2, P74, DOI 10.1038/mi.2008.68; BRADY RL, 1992, J MOL BIOL, V227, P253, DOI 10.1016/0022-2836(92)90695-G; Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287; Cowieson NP, 2020, J SYNCHROTRON RADIAT, V27, P1438, DOI 10.1107/S1600577520009960; Damelang T, 2019, TRENDS IMMUNOL, V40, P197, DOI 10.1016/j.it.2019.01.005; David CC, 2014, METHODS MOL BIOL, V1084, P193, DOI 10.1007/978-1-62703-658-0_11; Davies AM, 2014, J MOL BIOL, V426, P630, DOI 10.1016/j.jmb.2013.10.039; de Taeye SW, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00740; DEISENHOFER J, 1981, BIOCHEMISTRY-US, V20, P2361, DOI 10.1021/bi00512a001; Diebolder CA, 2014, SCIENCE, V343, P1260, DOI 10.1126/science.1248943; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Fleming PJ, 2018, BIOPHYS J, V114, P856, DOI 10.1016/j.bpj.2018.01.002; Glatter O., 1982, SMALL ANGLE XRAY SCA; Goujon M, 2010, NUCLEIC ACIDS RES, V38, pW695, DOI 10.1093/nar/gkq313; Grant BJ, 2006, BIOINFORMATICS, V22, P2695, DOI 10.1093/bioinformatics/btl461; GREGORY L, 1987, MOL IMMUNOL, V24, P821, DOI 10.1016/0161-5890(87)90184-2; Guvench O, 2009, J CHEM THEORY COMPUT, V5, P2353, DOI 10.1021/ct900242e; Heenan R. K., 2011, NEUTRON NEWS, V22, P19, DOI DOI 10.1080/10448632.2011.569531; Huang J, 2013, J COMPUT CHEM, V34, P2135, DOI 10.1002/jcc.23354; Hui GK, 2019, J BIOL CHEM, V294, P10789, DOI 10.1074/jbc.RA118.007134; Hui GK, 2015, BIOCHEM J, V471, P167, DOI 10.1042/BJ20150612; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jefferis R, 2007, EXPERT OPIN BIOL TH, V7, P1401, DOI 10.1517/14712598.7.9.1401; Jo S, 2008, J COMPUT CHEM, V29, P1859, DOI 10.1002/jcc.20945; Jo S, 2017, J COMPUT CHEM, V38, P1114, DOI 10.1002/jcc.24660; Jo S, 2011, J COMPUT CHEM, V32, P3135, DOI 10.1002/jcc.21886; Liu XB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12097-6; Lu YL, 2007, BIOPHYS J, V93, P3733, DOI 10.1529/biophysj.107.108993; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Miller BT, 2008, J CHEM INF MODEL, V48, P1920, DOI 10.1021/ci800133b; Park SJ, 2019, GLYCOBIOLOGY, V29, P320, DOI 10.1093/glycob/cwz003; PERKINS SJ, 1986, EUR J BIOCHEM, V157, P169, DOI 10.1111/j.1432-1033.1986.tb09653.x; Perkins SJ, 2001, BIOPHYS CHEM, V93, P129, DOI 10.1016/S0301-4622(01)00216-2; Perkins SJ, 2008, METHOD CELL BIOL, V84, P375, DOI 10.1016/S0091-679X(07)84013-1; Perkins SJ, 2016, J APPL CRYSTALLOGR, V49, P1861, DOI 10.1107/S160057671601517X; Perkins SJ, 2009, J R SOC INTERFACE, V6, pS679, DOI 10.1098/rsif.2009.0164.focus; Pernot P, 2013, J SYNCHROTRON RADIAT, V20, P660, DOI 10.1107/S0909049513010431; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PILZ I, 1970, BIOCHEMISTRY-US, V9, P211, DOI 10.1021/bi00804a004; Plomp R, 2015, MOL CELL PROTEOMICS, V14, P1373, DOI 10.1074/mcp.M114.047381; PLUMMER TH, 1984, J BIOL CHEM, V259, P700; PUMPHREY RSH, 1986, IMMUNOL TODAY, V7, P206, DOI 10.1016/0167-5699(86)90106-4; Raman EP, 2010, J PHYS CHEM B, V114, P12981, DOI 10.1021/jp105758h; Rayner LE, 2015, J BIOL CHEM, V290, P8420, DOI 10.1074/jbc.M114.631002; Rayner LE, 2014, J BIOL CHEM, V289, P20740, DOI 10.1074/jbc.M114.572404; Receveur-Brechot V, 2012, CURR PROTEIN PEPT SC, V13, P55, DOI 10.2174/138920312799277901; Richardson SI, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1008064; Round A, 2015, ACTA CRYSTALLOGR D, V71, P67, DOI 10.1107/S1399004714026959; Schuck P, 1998, BIOPHYS J, V75, P1503, DOI 10.1016/S0006-3495(98)74069-X; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; SEMENYUK AV, 1991, J APPL CRYSTALLOGR, V24, P537, DOI 10.1107/S002188989100081X; Shah IS, 2017, MOL IMMUNOL, V92, P28, DOI 10.1016/j.molimm.2017.10.001; Shaw A, 2019, NAT NANOTECHNOL, V14, P184, DOI 10.1038/s41565-018-0336-3; Spiteri V. A., 2021, THESIS U COLL LONDON; Spiteri VA, 2021, BIOPHYS J, V120, P1814, DOI 10.1016/j.bpj.2021.02.038; Stapleton NM, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1608; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Strasser J, 2019, NANO LETT, V19, P4787, DOI 10.1021/acs.nanolett.9b02220; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267; VANLOGHEM E, 1982, SCAND J IMMUNOL, V15, P275; WALKER MR, 1989, BIOCHEM J, V259, P347, DOI 10.1042/bj2590347; Wang B, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1690959; Watson MC, 2013, J APPL CRYSTALLOGR, V46, P1171, DOI 10.1107/S002188981301666X; Wright DW, 2019, BIOPHYS J, V117, P2101, DOI 10.1016/j.bpj.2019.10.024; Wright DW, 2015, J APPL CRYSTALLOGR, V48, P953, DOI 10.1107/S1600576715007062; Wuhrer M, 2007, PROTEOMICS, V7, P4070, DOI 10.1002/pmic.200700289; Zhang HZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000387; Zhang WH, 2017, J MOL GRAPH MODEL, V73, P179, DOI 10.1016/j.jmgm.2017.02.010; Zheng W., 2020, EXP THER MED, V21, P1	79	2	2	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							100995	10.1016/j.jbc.2021.100995	http://dx.doi.org/10.1016/j.jbc.2021.100995			23	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6NA	34302810	Green Published, gold			2022-12-28	WOS:000706418900012
J	Huang, LW; So, PK; Chen, YW; Leung, YC; Yao, ZP				Huang, Liwen; So, Pui-Kin; Chen, Yu Wai; Leung, Yun-Chung; Yao, Zhong-Ping			Interdomain flexibility and interfacial integrity of beta-lactamase inhibitory protein (BLIP) modulate its binding to class A beta 3-lactamases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROGEN-DEUTERIUM EXCHANGE; DYNAMICS; SIMULATIONS; CHALLENGES; AFFINITY; POTENT; STATE; TEM-1	beta-Lactamase inhibitory protein (BLIP) consists of a tandem repeat of alpha beta domains conjugated by an interdomain loop and can effectively bind and inactivate class A beta-lactamases, which are responsible for resistance of bacteria to beta-lactam antibiotics. The varied ability of BLIP to bind different beta-lactamases and the structural determinants for significant enhancement of BLIP variants with a point mutation are poorly understood. Here, we investigated the conformational dynamics of BLIP upon binding to three clinically prevalent class A beta-lactamases (TEM1, SHV1, and PC1) with dissociation constants between subnanomolar and micromolar. Hydrogen deuterium exchange mass spectrometry revealed that the flexibility of the interdomain region was significantly suppressed upon strong binding to TEM1, but was not significantly changed upon weak binding to SHV1 or PC1. E73M and K74G mutations in the interdomain region improved binding affinity toward SHV1 and PC1, respectively, showing significantly increased flexibility of the interdomain region compared to the wild-type and favorable conformational changes upon binding. In contrast, more rigidity of the interfacial loop 135-145 was observed in these BLIP mutants in both free and bound states. Consistently, molecular dynamics simulations of BLIP exhibited drastic changes in the flexibility of the loop 135-145 in all complexes. Our results indicated for the first time that higher flexibility of the interdomain linker, as well as more rigidity of the interfacial loop 135-145, could be desirable determinants for enhancing inhibition of BLIP to class A beta-lactamases. Together, these findings provide unique insights into the design of enhanced inhibitors.	[Huang, Liwen; So, Pui-Kin; Chen, Yu Wai; Leung, Yun-Chung; Yao, Zhong-Ping] Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Res Inst Future Food, Hung Hom,Kowloon, Hong Kong, Peoples R China; [Huang, Liwen; So, Pui-Kin; Chen, Yu Wai; Leung, Yun-Chung; Yao, Zhong-Ping] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom, Kowloon, Hong Kong, Peoples R China; [Huang, Liwen; Yao, Zhong-Ping] Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol Incubat, Shenzhen, Peoples R China; [Huang, Liwen; Yao, Zhong-Ping] Hong Kong Polytech Univ, Shenzhen Key Lab Food Biol Safety Control, Shenzhen Res Inst, Shenzhen, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong Polytechnic University; Hong Kong Polytechnic University	Yao, ZP (corresponding author), Hong Kong Polytech Univ, State Key Lab Chem Biol & Drug Discovery, Res Inst Future Food, Hung Hom,Kowloon, Hong Kong, Peoples R China.; Yao, ZP (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hung Hom, Kowloon, Hong Kong, Peoples R China.; Yao, ZP (corresponding author), Hong Kong Polytech Univ, State Key Lab Chinese Med & Mol Pharmacol Incubat, Shenzhen, Peoples R China.; Yao, ZP (corresponding author), Hong Kong Polytech Univ, Shenzhen Key Lab Food Biol Safety Control, Shenzhen Res Inst, Shenzhen, Peoples R China.	zhongping.yao@polyu.edu.hk	Chen, Yu Wai/AAJ-8037-2020; Yao, Zhong-Ping/K-2117-2014	Chen, Yu Wai/0000-0001-7833-7533; Yao, Zhong-Ping/0000-0003-3555-9632	Hong Kong Research Grants Council [153040/15P, 153348/16P, 153041/17P, 15304020, R5013-19F, C5031-14E, C4002-17G, R4005-18]; Natural Science Foundation of China [81874306]; China Resources Life Sciences Group Limited	Hong Kong Research Grants Council(Hong Kong Research Grants Council); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Resources Life Sciences Group Limited	This work was supported by Hong Kong Research Grants Council (Grant Nos. 153040/15P, 153348/16P, 153041/17P, 15304020, R5013-19F, C5031-14E, C4002-17G, and R4005-18), Natural Science Foundation of China (Grant No. 81874306), and China Resources Life Sciences Group Limited. We thank Prof Lars Konermann (Western Ontario University) for his support in the MD simulation, and The University Research Facility in Chemical and Environmental Analysis and The University Research Facility in Life Sciences of The Hong Kong Polytechnic University for their technical supports.	Bonomo Robert A, 2017, Cold Spring Harb Perspect Med, V7, DOI 10.1101/cshperspect.a025239; Brown KA, 2017, ANALYST, V142, P2874, DOI 10.1039/c7an00662d; Brown TD, 2020, NAT REV MATER, V5, P127, DOI 10.1038/s41578-019-0156-6; Bruix M, 2008, BIOPHYS J, V94, P2297, DOI 10.1529/biophysj.107.122952; Bush K, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a025247; Calabrese AN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15702-1; Craig PO, 2011, J AM CHEM SOC, V133, P17463, DOI 10.1021/ja207506z; Guttman M, 2013, J AM SOC MASS SPECTR, V24, P1906, DOI 10.1007/s13361-013-0727-5; Hamuro Y, 2018, J AM SOC MASS SPECTR, V29, P623, DOI 10.1007/s13361-017-1860-3; Hanes MS, 2011, PROTEINS, V79, P1267, DOI 10.1002/prot.22961; Hanes MS, 2009, BIOCHEMISTRY-US, V48, P9185, DOI 10.1021/bi9007963; Harrison RA, 2016, CURR OPIN STRUC BIOL, V41, P187, DOI 10.1016/j.sbi.2016.08.003; Hoofnagle AN, 2003, ANNU REV BIOPH BIOM, V32, P1, DOI 10.1146/annurev.biophys.32.110601.142417; Huang LW, 2020, J AM CHEM SOC, V142, P13756, DOI 10.1021/jacs.0c04088; Huang LW, 2019, RAPID COMMUN MASS SP, V33, P83, DOI 10.1002/rcm.8307; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Konermann L, 2011, CHEM SOC REV, V40, P1224, DOI 10.1039/c0cs00113a; Maragakis P, 2008, J PHYS CHEM B, V112, P6155, DOI 10.1021/jp077018h; Martens C, 2019, NAT PROTOC, V14, P3183, DOI 10.1038/s41596-019-0219-6; Masson GR, 2017, EXPERT OPIN DRUG DIS, V12, P981, DOI 10.1080/17460441.2017.1363734; McAllister RG, 2015, BIOCHEMISTRY-US, V54, P2683, DOI 10.1021/acs.biochem.5b00215; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Reynolds KA, 2008, J MOL BIOL, V382, P1265, DOI 10.1016/j.jmb.2008.05.051; Reynolds KA, 2006, J BIOL CHEM, V281, P26745, DOI 10.1074/jbc.M603878200; Skinner JJ, 2014, P NATL ACAD SCI USA, V111, P15975, DOI 10.1073/pnas.1404213111; STRYNADKA NCJ, 1994, NATURE, V368, P657, DOI 10.1038/368657a0; Strynadka NCJ, 1996, NAT STRUCT BIOL, V3, P290, DOI 10.1038/nsb0396-290; Tooke CL, 2019, J MOL BIOL, V431, P3472, DOI 10.1016/j.jmb.2019.04.002; Trabjerg E, 2018, TRAC-TREND ANAL CHEM, V106, P125, DOI 10.1016/j.trac.2018.06.008; Vendruscolo M, 2003, J AM CHEM SOC, V125, P15686, DOI 10.1021/ja036523z; Wang JH, 2007, J BIOL CHEM, V282, P17676, DOI 10.1074/jbc.M611548200; Wang W, 2009, J AM CHEM SOC, V131, P787, DOI 10.1021/ja8076022; Yao ZP, 2006, J MOL BIOL, V363, P673, DOI 10.1016/j.jmb.2006.08.032; Ye X, 2019, P NATL ACAD SCI USA, V116, P7333, DOI 10.1073/pnas.1816184116; Yuan J, 2011, J MOL BIOL, V406, P730, DOI 10.1016/j.jmb.2011.01.014; Zhang Z, 2003, J BIOL CHEM, V278, P45706, DOI 10.1074/jbc.M308572200; Zhu SL, 2017, BIOCHEMISTRY-US, V56, P4127, DOI 10.1021/acs.biochem.7b00193	38	0	0	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100980	10.1016/j.jbc.2021.100980	http://dx.doi.org/10.1016/j.jbc.2021.100980			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34302811	gold, Green Published			2022-12-28	WOS:000690868100009
J	Kumar, S; Chinnaraj, M; Planer, W; Zuo, XB; Macor, P; Tedesco, F; Pozzi, N				Kumar, Suresh; Chinnaraj, Mathivanan; Planer, William; Zuo, Xiaobing; Macor, Paolo; Tedesco, Francesco; Pozzi, Nicola			An allosteric redox switch in domain V of beta 2-glycoprotein I controls membrane binding and anti-domain I autoantibody recognition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA(2)-GLYCOPROTEIN I; ANTIPHOSPHOLIPID SYNDROME; PHOSPHOLIPID-BINDING; OXIDATIVE STRESS; FACTOR-XII; ANTIBODIES; ACTIVATION; HEPARIN; PROTEIN; FLUORESCENCE	beta(2)-glycoprotein I (beta(2)GPI) is an abundant multidomain plasma protein that plays various roles in the clotting and complement cascades. It is also the main target of antiphospholipid antibodies (aPL) in the acquired coagulopathy known as antiphospholipid syndrome (APS). Previous studies have shown that beta(2)GPI adopts two interconvertible biochemical conformations, oxidized and reduced, depending on the integrity of the disulfide bonds. However, the precise contribution of the disulfide bonds to beta(2)GPI structure and function is unknown. Here, we substituted cysteine residues with serine to investigate how the disulfide bonds C32-C60 in domain I (DI) and C288-C326 in domain V (DV) regulate beta(2)GPI's structure and function. Results of our biophysical and biochemical studies support the hypothesis that the C32-C60 disulfide bond plays a structural role, whereas the disulfide bond C288-C326 is allosteric. We demonstrate that absence of the C288-C326 bond, unlike absence of the C32-C60 bond, diminishes membrane binding without affecting the thermodynamic stability and overall structure of the protein, which remains elongated in solution. We also document that, while absence of the C32-C60 bond directly impairs recognition of beta(2)GPI by pathogenic anti-DI antibodies, absence of the C288-C326 disulfide bond is sufficient to abolish complex formation in the presence of anionic phospholipids. We conclude that the disulfide bond C288-C326 operates as a molecular switch capable of regulating beta(2)GPI's physiological functions in a redox-dependent manner. We propose that in APS patients with anti-DI antibodies, selective rupture of the C288-C326 disulfide bond may be a valid strategy to lower the pathogenic potential of aPL.	[Kumar, Suresh; Chinnaraj, Mathivanan; Planer, William; Pozzi, Nicola] St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Zuo, Xiaobing] Argonne Natl Lab, Xray Sci Div, Lemont, IL USA; [Macor, Paolo] Univ Trieste, Dept Life Sci, Trieste, Italy; [Tedesco, Francesco] IRCCS, Ist Auxol Italiano, Lab Immunorheumatol, Milan, Italy	Saint Louis University; United States Department of Energy (DOE); Argonne National Laboratory; University of Trieste; IRCCS Istituto Auxologico Italiano	Pozzi, N (corresponding author), St Louis Univ, Sch Med, Edward A Doisy Dept Biochem & Mol Biol, St Louis, MO 63104 USA.	nicola.pozzi@health.slu.edu		Chinnaraj, Mathivanan/0000-0002-7749-7364; Pozzi, Nicola/0000-0003-2309-7100; Tedesco, Francesco/0000-0003-2462-0493; Planer, William/0000-0003-2860-4343; Macor, Paolo/0000-0003-3079-4019	National Heart, Lung, and Blood Institute [R01 HL150146]	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by a grant R01 HL150146 (N. P.) from the National Heart, Lung, and Blood Institute.	Agar C, 2011, BLOOD, V117, P6939, DOI 10.1182/blood-2010-12-325951; Agar C, 2010, BLOOD, V116, P1336, DOI 10.1182/blood-2009-12-260976; Agostinis C, 2014, BLOOD, V123, P3478, DOI 10.1182/blood-2013-11-537704; Agostinis C, 2011, BLOOD, V118, P4231, DOI 10.1182/blood-2011-01-333617; Baerenfaenger M, 2019, BBA-PROTEINS PROTEOM, V1867, P556, DOI 10.1016/j.bbapap.2019.03.007; Banzato A, 2011, THROMB RES, V128, P583, DOI 10.1016/j.thromres.2011.04.021; Bouma B, 1999, EMBO J, V18, P5166, DOI 10.1093/emboj/18.19.5166; Buchholz I, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-84021-2; Butera D, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19295-7; Butera D, 2018, SCI ADV, V4, DOI 10.1126/sciadv.aaq1477; Chaturvedi S, 2020, BLOOD, V135, P239, DOI 10.1182/blood.2019003863; Chen Y, 1998, BIOCHEMISTRY-US, V37, P9976, DOI 10.1021/bi980274n; Chinnaraj M, 2021, CHEMBIOCHEM, V22, P134, DOI 10.1002/cbic.202000537; Chinnaraj M, 2019, BLOOD ADV, V3, P1738, DOI 10.1182/bloodadvances.2019030932; Chiu J, 2019, J BIOL CHEM, V294, P2949, DOI 10.1074/jbc.REV118.005604; de Groot PG, 2011, J THROMB HAEMOST, V9, P1275, DOI 10.1111/j.1538-7836.2011.04327.x; de Groot PG, 2012, BLOOD, V120, P266, DOI 10.1182/blood-2012-03-378646; de Laat B, 2006, BLOOD, V107, P1916, DOI 10.1182/blood-2005-05-1943; de Laat B, 2005, BLOOD, V105, P1540, DOI 10.1182/blood-2004-09-3387; de Laat B, 2011, ARTHRITIS RHEUM-US, V63, P3960, DOI 10.1002/art.30633; Durigutto P, 2020, J IMMUNOL, V205, P1385, DOI 10.4049/jimmunol.2000570; EFTINK MR, 1994, BIOPHYS J, V66, P482, DOI 10.1016/S0006-3495(94)80799-4; Essex DW, 2003, BIOCHEMISTRY-US, V42, P129, DOI 10.1021/bi0205045; Forneris F, 2016, EMBO J, V35, P1133, DOI 10.15252/embj.201593673; Franke D, 2017, J APPL CRYSTALLOGR, V50, P1212, DOI 10.1107/S1600576717007786; GALLI M, 1990, LANCET, V335, P1544, DOI 10.1016/0140-6736(90)91374-J; Giannakopoulos B, 2013, NEW ENGL J MED, V368, P1033, DOI 10.1056/NEJMra1112830; Giles IP, 2003, ARTHRITIS RHEUM-US, V48, P2111, DOI 10.1002/art.11101; Guerin J, 2002, J BIOL CHEM, V277, P2644, DOI 10.1074/jbc.M110176200; Hammel M, 2002, J MOL BIOL, V321, P85, DOI 10.1016/S0022-2836(02)00621-6; Hulstein JJJ, 2007, BLOOD, V110, P1483, DOI 10.1182/blood-2006-10-053199; HUNT J, 1994, J IMMUNOL, V152, P653; Ioannou Y, 2011, ARTHRITIS RHEUM-US, V63, P2774, DOI 10.1002/art.30383; Ioannou Y, 2010, BLOOD, V116, P1961, DOI 10.1182/blood-2009-04-215335; Iverson GM, 1998, P NATL ACAD SCI USA, V95, P15542, DOI 10.1073/pnas.95.26.15542; Li J, 2019, CIRCULATION, V139, P1300, DOI 10.1161/CIRCULATIONAHA.118.036323; Meroni PL, 2011, NAT REV RHEUMATOL, V7, P330, DOI 10.1038/nrrheum.2011.52; Morrissey JH, 2012, BLOOD, V119, P5972, DOI 10.1182/blood-2012-03-306605; Muller-Calleja N, 2018, BLOOD ADV, V2, P979, DOI 10.1182/bloodadvances.2018017095; PACE CN, 1990, TRENDS BIOTECHNOL, V8, P93, DOI 10.1016/0167-7799(90)90146-O; Passam FH, 2011, J THROMB HAEMOST, V9, P275, DOI 10.1111/j.1538-7836.2011.04301.x; Passam FH, 2010, J THROMB HAEMOST, V8, P1754, DOI 10.1111/j.1538-7836.2010.03944.x; Passam FH, 2010, BLOOD, V116, P1995, DOI 10.1182/blood-2010-02-271494; PIXLEY RA, 1991, THROMB HAEMOSTASIS, V66, P540; Pozzi N, 2013, J THROMB HAEMOST, V11, P1093, DOI 10.1111/jth.12238; Pozzi N, 2010, PROTEIN SCI, V19, P1065, DOI 10.1002/pro.387; Proulle V, 2014, BLOOD, V124, P611, DOI 10.1182/blood-2014-02-554980; Raimondo MG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186513; Rand JH, 2008, BLOOD, V112, P1687, DOI 10.1182/blood-2008-03-144204; Ruben E, 2020, J BIOL CHEM, V295, P10794, DOI 10.1074/jbc.RA120.013939; SCHOUSBOE I, 1985, BLOOD, V66, P1086; Schwarzenbacher R, 1999, EMBO J, V18, P6228, DOI 10.1093/emboj/18.22.6228; Shaw AW, 2007, J BIOL CHEM, V282, P6556, DOI 10.1074/jbc.M607973200; SILVERBERG M, 1987, BIOCHEM J, V248, P715, DOI 10.1042/bj2480715; Soares D. C., 2005, STRUCTURAL BIOL COMP, V1st; Stopa JD, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.89373; Subang R, 2000, J AUTOIMMUN, V15, P21, DOI 10.1006/jaut.2000.0382; Weaver JC, 2020, ARTERIOSCL THROM VAS, V40, P2794, DOI 10.1161/ATVBAHA.120.315156; Zhang JY, 2017, AM J TRANSL RES, V9, P3935; Zhou SJ, 2017, LIPIDS HEALTH DIS, V16, DOI 10.1186/s12944-017-0555-x	60	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100890	10.1016/j.jbc.2021.100890	http://dx.doi.org/10.1016/j.jbc.2021.100890			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34197876	gold, Green Published			2022-12-28	WOS:000690873500019
J	Shepard, A; Hoxha, S; Troutman, S; Harbaugh, D; Kareta, MS; Kissil, JL				Shepard, Alyssa; Hoxha, Sany; Troutman, Scott; Harbaugh, David; Kareta, Michael S.; Kissil, Joseph L.			Transcriptional regulation of miR-30a by YAP impacts PTPN13 and KLF9 levels and Schwann cell proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIPPO SIGNALING PATHWAY; HEPATOCELLULAR-CARCINOMA; BANTAM MICRORNA; ORGAN SIZE; EXPRESSION; YAP/TAZ; BIOGENESIS; SUPPRESSES; CROSSTALK; APOPTOSIS	The Hippo pathway is a key regulatory pathway that is tightly regulated by mechanical cues such as tension, pressure, and contact with the extracellular matrix and other cells. At the distal end of the pathway is the yes-associated protein (YAP), a well-characterized transcriptional regulator. Through binding to transcription factors such as the TEA Domain TFs (TEADs) YAP regulates expression of several genes involved in cell fate, proliferation and death decisions. While the function of YAP as direct transcriptional regulator has been extensively characterized, only a small number of studies examined YAP function as a regulator of gene expression via microRNAs. We utilized bioinformatic approaches, including chromatin immunoprecipitation sequencing and RNA-Seq, to identify potential new targets of YAP regulation and identified miR-30a as a YAP target gene in Schwann cells. We find that YAP binds to the promoter and regulates the expression of miR-30a. Moreover, we identify several YAP-regulated genes that are putative miR30a targets and focus on two of these, protein tyrosine pohosphatase non-receptor type 13 (PTPN13) and Kruppel like factor 9. We find that YAP regulation of Schwann cell proliferation and death is mediated, to a significant extent, through miR-30a regulation of PTPN13 in Schwann cells. These find-ings identify a new regulatory function by YAP, mediated by miR-30a, to downregulate expression of PTPN13 and Kruppel like factor 9. These studies expand our understanding of YAP function as a regulator of miRNAs and illustrate the complexity of YAP transcriptional functions.	[Shepard, Alyssa; Hoxha, Sany; Troutman, Scott; Harbaugh, David; Kissil, Joseph L.] Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA; [Troutman, Scott; Kissil, Joseph L.] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA; [Kareta, Michael S.] Sanford Res, Genet & Genom Grp, Sioux Falls, SD USA	Scripps Research Institute; H Lee Moffitt Cancer Center & Research Institute; Sanford Health	Kissil, JL (corresponding author), Scripps Res Inst, Dept Mol Med, Jupiter, FL 33458 USA.; Kissil, JL (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA.	Joseph.Kissil@Moffitt.org		Kareta, Michael/0000-0002-6980-9065	NIH NIGMS Center for Pediatric Research [5P20GM103620]; NIH NCI/NIGMS [R01CA233661]; NINDS/NIH [NS117926]	NIH NIGMS Center for Pediatric Research; NIH NCI/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Institute of General Medical Sciences (NIGMS)); NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The work was supported by NS117926 (NINDS/NIH) to J. L. K. M. S. K. is supported by the NIH NIGMS Center for Pediatric Research 5P20GM103620 and the NIH NCI/NIGMS Grant R01CA233661 for research support. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Beyer TA, 2013, CELL REP, V5, P1611, DOI 10.1016/j.celrep.2013.11.021; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Brown AR, 2015, CARCINOGENESIS, V36, P946, DOI 10.1093/carcin/bgv104; Chaulk SG, 2014, J BIOL CHEM, V289, P1886, DOI 10.1074/jbc.C113.529362; Dromard M, 2007, CANCER RES, V67, P6806, DOI 10.1158/0008-5472.CAN-07-0513; Fishilevich S, 2017, DATABASE-OXFORD, DOI 10.1093/database/bax028; Freiss G, 2011, ANTI-CANCER AGENT ME, V11, P78, DOI 10.2174/187152011794941262; Guan YW, 2018, ONCOTARGET, V9, P4924, DOI 10.18632/oncotarget.23529; Guerrant W, 2016, CANCER RES, V76, P3507, DOI 10.1158/0008-5472.CAN-15-1144; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hong WJ, 2012, SEMIN CELL DEV BIOL, V23, P785, DOI 10.1016/j.semcdb.2012.05.004; Hoxha S, 2020, CANCER RES, V80, P2512, DOI 10.1158/0008-5472.CAN-19-2415; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kim M, 2015, CELL REP, V11, P270, DOI 10.1016/j.celrep.2015.03.015; Lee H, 2016, BBA-GENE REGUL MECH, V1859, P599, DOI 10.1016/j.bbagrm.2016.02.010; Lei YH, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/7267816; Li NS, 2017, FEBS J, V284, P1045, DOI 10.1111/febs.13985; Lin KC, 2017, TRENDS BIOCHEM SCI, V42, P862, DOI 10.1016/j.tibs.2017.09.003; Lo Sardo F, 2017, CARCINOGENESIS, V38, P64, DOI 10.1093/carcin/bgw110; Long QZ, 2020, EXP CELL RES, V396, DOI 10.1016/j.yexcr.2020.112286; Ma SH, 2019, ANNU REV BIOCHEM, V88, P577, DOI 10.1146/annurev-biochem-013118-111829; Martin M., 2011, LAB INVEST, V96, P1105; Mori M, 2014, CELL, V156, P893, DOI 10.1016/j.cell.2013.12.043; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Pan DJ, 2010, DEV CELL, V19, P491, DOI 10.1016/j.devcel.2010.09.011; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Piccolo S, 2014, PHYSIOL REV, V94, P1287, DOI 10.1152/physrev.00005.2014; Shen SY, 2015, CELL RES, V25, P997, DOI 10.1038/cr.2015.98; Sun JB, 2014, CANCER LETT, V355, P25, DOI 10.1016/j.canlet.2014.09.022; Tan CY, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/5251236; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Torres-Martin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065868; Tumaneng K, 2012, NAT CELL BIOL, V14, P1322, DOI 10.1038/ncb2615; Yang YF, 2015, CIRC RES, V117, P891, DOI 10.1161/CIRCRESAHA.115.306624; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Yu N, 2019, MOL ONCOL, V13, P1356, DOI 10.1002/1878-0261.12478; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zanconato F, 2015, NAT CELL BIOL, V17, P1218, DOI 10.1038/ncb3216; Zhan H, 2016, TUMOR BIOL, V37, P9691, DOI 10.1007/s13277-016-4843-2; Zhang W, 2013, BIOL OPEN, V2, P822, DOI 10.1242/bio.20134317; Zheng YG, 2019, DEV CELL, V50, P264, DOI 10.1016/j.devcel.2019.06.003; Zhong ZW, 2018, ONCOL REP, V40, P3852, DOI 10.3892/or.2018.6760; Zhu JH, 2008, ONCOGENE, V27, P2525, DOI 10.1038/sj.onc.1210922	44	1	1	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100962	10.1016/j.jbc.2021.100962	http://dx.doi.org/10.1016/j.jbc.2021.100962			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TF	34265306	gold, Green Published			2022-12-28	WOS:000690871400009
J	Guo, WT; Wei, JH; Estillore, JP; Zhang, L; Wang, RW; Sun, B; Chen, SRW				Guo, Wenting; Wei, Jinhong; Estillore, John Paul; Zhang, Lin; Wang, Ruiwu; Sun, Bo; Chen, S. R. Wayne			RyR2 disease mutations at the C-terminal domain intersubunit interface alter closed-state stability and channel activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC RYANODINE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; SUDDEN UNEXPLAINED DEATH; INDUCED CA2+ RELEASE; EXON 3 DELETION; SARCOPLASMIC-RETICULUM; MOLECULAR-BASIS; COMMON DEFECT; MUSCLE; THRESHOLD	Ryanodine receptors (RyRs) are ion channels that mediate the release of Ca2+ from the sarcoplasmic reticulum/endoplasmic reticulum, mutations of which are implicated in a number of human diseases. The adjacent C-terminal domains (CTDs) of cardiac RyR (RyR2) interact with each other to form a ring-like tetrameric structure with the intersubunit interface undergoing dynamic changes during channel gating. This mobile CTD intersubunit interface harbors many disease-associated mutations. However, the mechanisms of action of these mutations and the role of CTD in channel function are not well understood. Here, we assessed the impact of CTD disease-associated mutations P4902S, P4902L, E4950K, and G4955E on Ca2+- and caffeine-mediated activation of RyR2. The G4955E mutation dramatically increased both the Ca2+-independent basal activity and Ca2+-dependent activation of [H-3]ryanodine binding to RyR2. The P4902S and E4950K mutations also increased Ca2+ activation but had no effect on the basal activity of RyR2. All four disease mutations increased caffeine-mediated activation of RyR2 and reduced the threshold for activation and termination of spontaneous Ca2+ release. G4955D dramatically increased the basal activity of RyR2, whereas G4955K mutation markedly suppressed channel activity. Similarly, substitution of P4902 with a negatively charged residue (P4902D), but not a positively charged residue (P4902K), also dramatically increased the basal activity of RyR2. These data suggest that electrostatic interactions are involved in stabilizing the CTD intersubunit interface and that the G4955E disease mutation disrupts this interface, and thus the stability of the closed state. Our studies shed new insights into the mechanisms of action of RyR2 CTD disease mutations.	[Guo, Wenting; Wei, Jinhong; Estillore, John Paul; Zhang, Lin; Wang, Ruiwu; Sun, Bo; Chen, S. R. Wayne] Univ Calgary, Libin Cardiovasc Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Sun, Bo] Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China	Libin Cardiovascular Institute Of Alberta; University of Calgary; Kunming University of Science & Technology	Sun, B; Chen, SRW (corresponding author), Univ Calgary, Libin Cardiovasc Inst, Dept Physiol & Pharmacol, Calgary, AB, Canada.; Sun, B (corresponding author), Kunming Univ Sci & Technol, Med Sch, Kunming, Yunnan, Peoples R China.	sunbo1025@hotmail.com; swchen@ucalgary.ca	Wei, Jinhong/GWV-0561-2022	Wei, Jinhong/0000-0002-5251-9192	Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada; Heart and Stroke Foundation Chair in Cardiovascular Research	Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of CanadaCanadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation Chair in Cardiovascular Research	This work was supported by research grants from the Canadian Institutes of Health Research, Heart and Stroke Foundation of Canada, and Heart and Stroke Foundation Chair in Cardiovascular Research (to S. R. W. C.).	Aiba I, 2016, P NATL ACAD SCI USA, V113, pE4895, DOI 10.1073/pnas.1605216113; Alkon DL, 1998, TRENDS NEUROSCI, V21, P529, DOI 10.1016/S0166-2236(98)01277-6; Alvarado FJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126544; Bauce B, 2002, J AM COLL CARDIOL, V40, P341, DOI 10.1016/S0735-1097(02)01946-0; Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Bers DM, 2008, ANNU REV PHYSIOL, V70, P23, DOI 10.1146/annurev.physiol.70.113006.100455; Bers DM, 2014, ANNU REV PHYSIOL, V76, P107, DOI 10.1146/annurev-physiol-020911-153308; Bhuiyan ZA, 2007, CIRCULATION, V116, P1569, DOI 10.1161/CIRCULATIONAHA.107.711606; Bogdanov KY, 2001, CIRC RES, V88, P1254, DOI 10.1161/hh1201.092095; Campbell MJ, 2015, AM J MED GENET A, V167, P2197, DOI 10.1002/ajmg.a.37140; Chen SRW, 2002, BIOPHYS J, V82, P2436, DOI 10.1016/S0006-3495(02)75587-2; Chi XM, 2019, P NATL ACAD SCI USA, V116, P25575, DOI 10.1073/pnas.1914451116; d'Amati G, 2005, HUM PATHOL, V36, P761, DOI 10.1016/j.humpath.2005.04.019; Denniss A, 2018, INT J BIOCHEM CELL B, V101, P49, DOI 10.1016/j.biocel.2018.05.004; des Georges A, 2016, CELL, V167, P145, DOI 10.1016/j.cell.2016.08.075; Dharmawan T, 2019, ANN NONINVAS ELECTRO, V24, DOI 10.1111/anec.12623; Du GG, 1998, J BIOL CHEM, V273, P31867, DOI 10.1074/jbc.273.48.31867; FABIATO A, 1979, J PHYSIOL-PARIS, V75, P463; Fill M, 2002, PHYSIOL REV, V82, P893, DOI 10.1152/physrev.00013.2002; Fokstuen S, 2016, HUM GENOMICS, V10, DOI 10.1186/s40246-016-0080-4; Fujii Y, 2017, HEART RHYTHM, V14, P98, DOI 10.1016/j.hrthm.2016.10.015; Fujino N, 2006, CIRCULATION, V114, P165; FURUICHI T, 1994, J NEUROSCI, V14, P4794; GIANNINI G, 1995, MED RES REV, V15, P313, DOI 10.1002/med.2610150405; Gong DS, 2019, NATURE, V572, P347, DOI 10.1038/s41586-019-1377-y; Guo WT, 2020, J BIOL CHEM, V295, P15622, DOI 10.1074/jbc.RA120.013512; Guo WT, 2016, J BIOL CHEM, V291, P2150, DOI 10.1074/jbc.M115.693325; Hamdan FF, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004772; Hata Y, 2016, HEART RHYTHM, V13, P1544, DOI 10.1016/j.hrthm.2016.03.038; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; INUI M, 1987, J BIOL CHEM, V262, P15637; Jiang DW, 2004, P NATL ACAD SCI USA, V101, P13062, DOI 10.1073/pnas.0402388101; Jiang DW, 2002, CIRC RES, V91, P218, DOI 10.1161/01.RES.0000028455.36940.5E; Jiang DW, 2005, CIRC RES, V97, P1173, DOI 10.1161/01.RES.0000192146.85173.4b; Jones PP, 2008, BIOCHEM J, V412, P171, DOI 10.1042/BJ20071287; Kawamura M, 2013, CIRC J, V77, P1705, DOI 10.1253/circj.CJ-12-1460; Kimlicka L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2501; Kohli U, 2019, PACE, V42, P1146, DOI 10.1111/pace.13668; Kong H, 2008, BIOCHEM J, V414, P441, DOI 10.1042/BJ20080489; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Laitinen PJ, 2003, EUR J HUM GENET, V11, P888, DOI 10.1038/sj.ejhg.5201061; Lehnart SE, 2008, J CLIN INVEST, V118, P2230, DOI 10.1172/JCI35346; Li P, 2001, J GEN PHYSIOL, V118, P33, DOI 10.1085/jgp.118.1.33; Lieve KV, 2016, CIRC J, V80, P1285, DOI 10.1253/circj.CJ-16-0326; Lieve KVV, 2019, HEART RHYTHM, V16, P220, DOI 10.1016/j.hrthm.2018.08.025; Liu YJ, 2015, J BIOL CHEM, V290, P7736, DOI 10.1074/jbc.M114.618827; Lobo PA, 2009, STRUCTURE, V17, P1505, DOI 10.1016/j.str.2009.08.016; MacLennan DH, 2009, J PHYSIOL-LONDON, V587, P3113, DOI 10.1113/jphysiol.2009.172155; Mandikian D, 2014, J COMP NEUROL, V522, P3555, DOI 10.1002/cne.23641; Marjamaa A, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-12; Medeiros-Domingo A, 2009, J AM COLL CARDIOL, V54, P2065, DOI 10.1016/j.jacc.2009.08.022; Murayama T, 1996, J BIOL CHEM, V271, P5079; Napolitano C, 2007, HEART RHYTHM, V4, P675, DOI 10.1016/j.hrthm.2006.12.048; NELSON MT, 1995, SCIENCE, V270, P633, DOI 10.1126/science.270.5236.633; Nishio H, 2006, CIRC J, V70, P1402, DOI 10.1253/circj.70.1402; Ohno S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131517; Ohno S, 2014, EUROPACE, V16, P1646, DOI 10.1093/europace/eut382; Palmer AE, 2004, P NATL ACAD SCI USA, V101, P17404, DOI 10.1073/pnas.0408030101; Peng W, 2016, SCIENCE, V354, DOI 10.1126/science.aah5324; Postma AV, 2005, J MED GENET, V42, P863, DOI 10.1136/jmg.2004.028993; Priori SG, 2002, CIRCULATION, V106, P69, DOI 10.1161/01.CIR.0000020013.73106.D8; Priori SG, 2001, CIRCULATION, V103, P196; Priori SG, 2011, CIRC RES, V108, P871, DOI 10.1161/CIRCRESAHA.110.226845; Roston TM, 2017, J ELECTROCARDIOL, V50, P227, DOI 10.1016/j.jelectrocard.2016.09.006; ROUSSEAU E, 1989, AM J PHYSIOL, V256, pH328, DOI 10.1152/ajpheart.1989.256.2.H328; Sun B, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aba7287; Szentpali Z, 2013, CIRCULATION, V127, P1165, DOI 10.1161/CIRCULATIONAHA.112.144949; Tang YJ, 2012, CIRC RES, V110, P968, DOI 10.1161/CIRCRESAHA.111.256560; Tester DJ, 2004, MAYO CLIN PROC, V79, P1380, DOI 10.4065/79.11.1380; Thomas LN, 2004, CARDIOVASC RES, V64, P52, DOI 10.1016/j.cardiores.2004.06.009; Tiso N, 2001, HUM MOL GENET, V10, P189, DOI 10.1093/hmg/10.3.189; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; van der Werf C, 2012, CIRC-ARRHYTHMIA ELEC, V5, P748, DOI 10.1161/CIRCEP.112.970517; Van Petegem F, 2012, J BIOL CHEM, V287, P31624, DOI 10.1074/jbc.R112.349068; Wang RW, 2003, J BIOL CHEM, V278, P51557, DOI 10.1074/jbc.M306788200; Ware JS, 2013, J CARDIOVASC TRANSL, V6, P94, DOI 10.1007/s12265-012-9401-8; Xiao ZC, 2016, J BIOL CHEM, V291, P24528, DOI 10.1074/jbc.M116.756528; Yao JJ, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108169; Yap SM, 2019, SEIZURE-EUR J EPILEP, V67, P11, DOI 10.1016/j.seizure.2019.02.017	79	5	5	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100808	10.1016/j.jbc.2021.100808	http://dx.doi.org/10.1016/j.jbc.2021.100808			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022226	gold, Green Published			2022-12-28	WOS:000678068400012
J	Meng, ZY; Xu, R; Xie, LX; Wu, YT; He, Q; Gao, P; He, XH; Chen, Q; Xie, Q; Zhang, JQ; Yang, QW				Meng, Zhaoyou; Xu, Rui; Xie, Lexing; Wu, Yutong; He, Qian; Gao, Pan; He, Xiaohui; Chen, Qiong; Xie, Qi; Zhang, Jiqiang; Yang, Qingwu			A20/Nrdp1 interaction alters the inflammatory signaling profile by mediating K48-and K63-linked polyubiquitination of effectors MyD88 and TBK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; QUANTITATIVE PROTEOMICS REVEALS; NEGATIVE REGULATION; A20; UBIQUITINATION; DEGRADATION; TNFAIP3; INJURY; GENE; INHIBITION	A20 is a potent anti-inflammatory protein that mediates both inflammation and ubiquitination in mammals, but the related mechanisms are not clear. In this study, we performed mass spectrometry (MS) screening, gene ontology (GO) analysis, and coimmunoprecipitation (co-IP) in a lipopolysaccharide (LPS)-induced inflammatory cell model to identify novel A20-interacting proteins. We confirmed that the E3 ubiquitin ligase Nrdp1, also known as ring finger protein 41 (RNF41), interacted with A20 in LPS-stimulated cells. Further co-IP analysis demonstrated that when A20 was knocked out, degradation-inducing K48-linked ubiquitination of inflammatory effector MyD88 was decreased, but protein interaction-mediating K63-linked ubiquitination of another inflammatory effector TBK1 was increased. Moreover, western blot experiments showed that A20 inhibition induced an increase in levels of MyD88 and phosphorylation of downstream effector proteins as well as of TBK1 and a downstream effector, while Nrdp1 inhibition induced an increase in MyD88 but a decrease in TBK1 levels. When A20 and Nrdp1 were coinhibited, no further change in MyD88 was observed, but TBK1 levels were significantly decreased compared with those upon A20 inhibition alone. Gain- and loss-of-function analyses revealed that the ZnF4 domain of A20 is required for Nrdp1 polyubiquitination. Upon LPS stimulation, the inhibition of Nrdp1 alone increased the secretion of IL-6 and TNF-alpha but decreased IFN-beta secretion, as observed in other studies, suggesting that Nrdp1 preferentially promotes the production of IFN-beta. Taken together, these results demonstrated that A20/Nrdp1 interaction is important for A20 anti-inflammation, thus revealing a novel mechanism for the anti-inflammatory effects of A20.	[Meng, Zhaoyou; Xu, Rui; Xie, Lexing; Wu, Yutong; He, Qian; Gao, Pan; He, Xiaohui; Chen, Qiong; Xie, Qi; Yang, Qingwu] Army Med Univ, Xinqiao Hosp, Dept Neurol, Mil Med Univ 3, Chongqing, Peoples R China; [Meng, Zhaoyou; Zhang, Jiqiang] Army Med Univ, Dept Neurobiol, Mil Med Univ 3, Chongqing, Peoples R China	Army Medical University; Army Medical University	Xie, Q; Yang, QW (corresponding author), Army Med Univ, Xinqiao Hosp, Dept Neurol, Mil Med Univ 3, Chongqing, Peoples R China.; Zhang, JQ (corresponding author), Army Med Univ, Dept Neurobiol, Mil Med Univ 3, Chongqing, Peoples R China.	xieqi.tmmu@gmail.com; zhangjiqiang@tmmu.edu.cn; yangqwmlys@163.com			National Natural Science Foundation of China [81701548]; China Postdoctoral Science Foundation [2019M653976]; Chongqing Natural Science Foundation [cstc2019jcyj-msxmX0255]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Chongqing Natural Science Foundation(Natural Science Foundation of Chongqing)	This study was supported by the National Natural Science Foundation of China (81701548), China Postdoctoral Science Foundation Grant (2019M653976), and Chongqing Natural Science Foundation (cstc2019jcyj-msxmX0255).	Adrianto I, 2011, NAT GENET, V43, P253, DOI 10.1038/ng.766; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Bosanac I, 2010, MOL CELL, V40, P548, DOI 10.1016/j.molcel.2010.10.009; Catrysse L, 2014, TRENDS IMMUNOL, V35, P22, DOI 10.1016/j.it.2013.10.005; Chi H, 2018, NAT BIOTECHNOL, V36, P1059, DOI 10.1038/nbt.4236; Duwel M, 2009, J IMMUNOL, V182, P7718, DOI 10.4049/jimmunol.0803313; Duong BH, 2015, IMMUNITY, V42, P55, DOI 10.1016/j.immuni.2014.12.031; Hamerman JA, 2016, IMMUNOL REV, V269, P212, DOI 10.1111/imr.12381; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iha H, 2008, EMBO J, V27, P629, DOI 10.1038/emboj.2008.5; Kanayama M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6779; Kinsella S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1143-3; Lassot I, 2018, CELL REP, V25, P2484, DOI 10.1016/j.celrep.2018.11.002; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Li ZP, 2019, BRAIN BEHAV IMMUN, V79, P228, DOI 10.1016/j.bbi.2019.02.005; Liu T, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.23; Martens A, 2020, NAT IMMUNOL, V21, P381, DOI 10.1038/s41590-020-0621-9; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Mauro C, 2006, J BIOL CHEM, V281, P18482, DOI 10.1074/jbc.M601502200; Meng ZY, 2017, J IMMUNOL, V198, P820, DOI 10.4049/jimmunol.1600334; Moll HP, 2014, J BIOL CHEM, V289, P30912, DOI 10.1074/jbc.M114.591966; Nakamura BN, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195893; Parvatiyar K, 2010, J BIOL CHEM, V285, P14999, DOI 10.1074/jbc.M110.109819; Ping LY, 2013, J PROTEOME RES, V12, P5978, DOI 10.1021/pr400775w; Priem D, 2020, TRENDS IMMUNOL, V41, P421, DOI 10.1016/j.it.2020.03.001; Qiu XB, 2002, P NATL ACAD SCI USA, V99, P14843, DOI 10.1073/pnas.232580999; Qiu XB, 2004, EMBO J, V23, P800, DOI 10.1038/sj.emboj.7600075; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Schmitz R, 2009, J EXP MED, V206, P981, DOI 10.1084/jem.20090528; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2012, CELL MOL IMMUNOL, V9, P123, DOI 10.1038/cmi.2011.59; Shembade N, 2010, SCIENCE, V327, P1135, DOI 10.1126/science.1182364; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Song GH, 2016, NAT IMMUNOL, V17, P1342, DOI 10.1038/ni.3588; Turer EE, 2008, J EXP MED, V205, P451, DOI 10.1084/jem.20071108; Vetters J, 2019, J EXP MED, V216, P2010, DOI 10.1084/jem.20182164; Wang C, 2009, NAT IMMUNOL, V10, P744, DOI 10.1038/ni.1742; Wang YC, 2014, ANN NEUROL, V75, P876, DOI 10.1002/ana.24159; Wauman J, 2011, J CELL SCI, V124, P921, DOI 10.1242/jcs.078055; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Xie Q, 2017, SCI REP-UK, V7, DOI 10.1038/srep41089; Xiong XY, 2016, CIRCULATION, V134, P1025, DOI 10.1161/CIRCULATIONAHA.116.021881; Xu P, 2012, J PROTEOME RES, V11, P4403, DOI 10.1021/pr300613c; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Zhao W, 2013, FEBS LETT, V587, P542, DOI 10.1016/j.febslet.2013.01.052; Zhong L, 2005, J BIOL CHEM, V280, P9425, DOI 10.1074/jbc.M408955200; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	52	1	1	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100811	10.1016/j.jbc.2021.100811	http://dx.doi.org/10.1016/j.jbc.2021.100811			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34023381	gold, Green Published			2022-12-28	WOS:000678068400014
J	Rao, Y; Gammon, ST; Sutton, MN; Zacharias, NM; Bhattacharya, P; Piwnica-Worms, D				Rao, Yi; Gammon, Seth T.; Sutton, Margie N.; Zacharias, Niki M.; Bhattacharya, Pratip; Piwnica-Worms, David			Excess exogenous pyruvate inhibits lactate dehydrogenase activity in live cells in an MCT1-dependent manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MONOCARBOXYLATE TRANSPORTERS; BRAIN METABOLISM; METABOLOMICS; SUBSTRATE	Cellular pyruvate is an essential metabolite at the crossroads of glycolysis and oxidative phosphorylation, capable of supporting fermentative glycolysis by reduction to lactate mediated by lactate dehydrogenase (LDH) among other functions. Several inherited diseases of mitochondrial metabolism impact extracellular (plasma) pyruvate concentrations, and [1-C-13]pyruvate infusion is used in isotope-labeled metabolic tracing studies, including hyperpolarized magnetic resonance spectroscopic imaging. However, how these extracellular pyruvate sources impact intracellular metabolism is not clear. Herein, we examined the effects of excess exogenous pyruvate on intracellular LDH activity, extracellular acidification rates (ECARs) as a measure of lactate production, and hyperpolarized [1-C-13]pyruvate-to-[1-C-13]lactate conversion rates across a panel of tumor and normal cells. Combined LDH activity and LDHB/LDHA expression analysis intimated various heterotetrameric isoforms comprising LDHA and LDHB in tumor cells, not only canonical LDHA. Millimolar concentrations of exogenous pyruvate induced substrate inhibition of LDH activity in both enzymatic assays ex vivo and in live cells, abrogated glycolytic ECAR, and inhibited hyperpolarized [1-C-13]pyruvate-to-[1-C-13]lactate conversion rates in cellulo. Of importance, the extent of exogenous pyruvate-induced inhibition of LDH and glycolytic ECAR in live cells was highly dependent on pyruvate influx, functionally mediated by monocarboxylate transporter-1 localized to the plasma membrane. These data provided evidence that highly concentrated bolus injections of pyruvate in vivo may transiently inhibit LDH activity in a tissue type- and monocarboxylate transporter-1-dependent manner. Maintaining plasma pyruvate at submillimolar concentrations could potentially minimize transient metabolic perturbations, improve pyruvate therapy, and enhance quantification of metabolic studies, including hyperpolarized [1-C-13]pyruvate magnetic resonance spectroscopic imaging and stable isotope tracer experiments.	[Rao, Yi; Gammon, Seth T.; Sutton, Margie N.; Bhattacharya, Pratip; Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA; [Zacharias, Niki M.] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Piwnica-Worms, D (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, Houston, TX 77030 USA.	dpiwnica-worms@mdanderson.org		Piwnica-Worms, David/0000-0002-2120-7217	National Institutes of Health [P50 CA94056]; Gerald Dewey Dodd, Jr, Endowed Distinguished Chair of the University of Texas MD Anderson Cancer Center, a faculty UT STARs Award; University of Texas MD Anderson Cancer Center Independent Research Grant (MDACC IRG); Erickson Kidney Cancer Research Foundation; NCI Cancer Center Support Grant [P30 CA016672, P50 CA221707, U01 CA214263]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gerald Dewey Dodd, Jr, Endowed Distinguished Chair of the University of Texas MD Anderson Cancer Center, a faculty UT STARs Award; University of Texas MD Anderson Cancer Center Independent Research Grant (MDACC IRG); Erickson Kidney Cancer Research Foundation; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded by the National Institutes of Health grant P50 CA94056 to the MD Anderson Cancer Center-Washington University Inter-Institutional Molecular Imaging Center, the Gerald Dewey Dodd, Jr, Endowed Distinguished Chair of the University of Texas MD Anderson Cancer Center, a faculty UT STARs Award, a University of Texas MD Anderson Cancer Center Independent Research Grant (MDACC IRG), and the Erickson Kidney Cancer Research Foundation. We would like to thank the Biostatistics Resource and the Small Animal Imaging Facility (SAIF) of MDACC for animal imaging assistance, especially Charles Kingsley, which obtain support from an NCI Cancer Center Support Grant (P30 CA016672). Financial support was also obtained from P50 CA221707 and U01 CA214263. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Ardenkjaer-Larsen JH, 2003, P NATL ACAD SCI USA, V100, P10158, DOI 10.1073/pnas.1733835100; Bhattacharya P, 2009, EXP BIOL MED, V234, P1395, DOI 10.3181/0904-MR-135; Brindle KM, 2011, MAGN RESON MED, V66, P505, DOI 10.1002/mrm.22999; Chokkathukalam A, 2014, BIOANALYSIS, V6, P511, DOI 10.4155/bio.13.348; Doherty JR, 2013, J CLIN INVEST, V123, P3685, DOI 10.1172/JCI69741; Dutta P, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040340; Feng YB, 2018, CANCER MED-US, V7, P6124, DOI 10.1002/cam4.1820; Fernandez-Garcia J, 2020, TRENDS BIOCHEM SCI, V45, P185, DOI 10.1016/j.tibs.2019.12.002; Fujii T, 2014, MOL GENET METAB, V112, P133, DOI 10.1016/j.ymgme.2014.04.008; Gammon ST, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8121487; Ganapathy V, 2008, AAPS J, V10, P193, DOI 10.1208/s12248-008-9022-y; Guglielmetti C, 2017, P NATL ACAD SCI USA, V114, pE6982, DOI 10.1073/pnas.1613345114; GUTFREUND H, 1968, BIOCHEM J, V106, P683, DOI 10.1042/bj1060683; Jang C, 2018, CELL, V173, P822, DOI 10.1016/j.cell.2018.03.055; Jin L, 2017, ONCOGENE, V36, P3797, DOI 10.1038/onc.2017.6; Kirk P, 2000, EMBO J, V19, P3896, DOI 10.1093/emboj/19.15.3896; Kurhanewicz J, 2019, NEOPLASIA, V21, P1, DOI 10.1016/j.neo.2018.09.006; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Ma EH, 2019, IMMUNITY, V51, P856, DOI 10.1016/j.immuni.2019.09.003; Marsac C, 1997, HUM GENET, V99, P785, DOI 10.1007/s004390050449; Miloushev VZ, 2018, CANCER RES, V78, P3755, DOI 10.1158/0008-5472.CAN-18-0221; Miloushev VZ, 2017, J MAGN RESON, V275, P120, DOI 10.1016/j.jmr.2016.12.009; Moreno KX, 2010, AM J PHYSIOL-HEART C, V298, pH1556, DOI 10.1152/ajpheart.00656.2009; Nelson SJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006070; Park I, 2018, MAGN RESON MED, V80, P864, DOI 10.1002/mrm.27077; Perez-Escuredo J, 2016, BBA-MOL CELL RES, V1863, P2481, DOI 10.1016/j.bbamcr.2016.03.013; Rao Y, 2020, P NATL ACAD SCI USA, V117, P22378, DOI 10.1073/pnas.2003537117; Rodrigues TB, 2014, NAT MED, V20, P93, DOI 10.1038/nm.3416; Saito K, 2012, MAGN RESON MED, V67, P801, DOI 10.1002/mrm.23065; Sattlar UGA, 2007, LAB INVEST, V87, P84, DOI 10.1038/labinvest.3700493; Serrao EM, 2016, FRONT ONCOL, V6, DOI 10.3389/fonc.2016.00059; STAMBAUGH R, 1966, J BIOL CHEM, V241, P1462; Valvona CJ, 2016, BRAIN PATHOL, V26, P3, DOI 10.1111/bpa.12299; WANG CS, 1977, EUR J BIOCHEM, V78, P569, DOI 10.1111/j.1432-1033.1977.tb11770.x; Wang Dong, 2009, GENEREVIEWS R, P1993; Wojtkowiak JW, 2015, CANCER METAB, V3, DOI 10.1186/s40170-014-0026-z; Zacharias NM, 2019, MOL CANCER THER, V18, P1937, DOI 10.1158/1535-7163.MCT-18-0985	38	11	11	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100775	10.1016/j.jbc.2021.100775	http://dx.doi.org/10.1016/j.jbc.2021.100775			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34022218	Green Published, gold			2022-12-28	WOS:000678068400005
J	Trenker, R; Wu, XY; Nguyen, JV; Wilcox, S; Rubin, AF; Call, ME; Call, MJ				Trenker, Raphael; Wu, Xinyu; Nguyen, Julie, V; Wilcox, Stephen; Rubin, Alan F.; Call, Matthew E.; Call, Melissa J.			Human and viral membrane-associated E3 ubiquitin ligases MARCH1 and MIR2 recognize different features of CD86 to downregulate surface expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEX CLASS-I; PROTEIN; CHAINS; DRIVE; B7-2	Immune-stimulatory ligands, such as major histocompatibility complex molecules and the T-cell costimulatory ligand CD86, are central to productive immunity. Endogenous mammalian membrane-associated RING-CHs (MARCH) act on these and other targets to regulate antigen presentation and activation of adaptive immunity, whereas virus-encoded homologs target the same molecules to evade immune responses. Substrate specificity is encoded in or near the membrane-embedded domains of MARCHs and the proteins they regulate, but the exact sequences that distinguish substrates from nonsubstrates are poorly understood. Here, we examined the requirements for recognition of the costimulatory ligand CD86 by two different MARCH-family proteins, human MARCH1 and Kaposi's sarcoma herpesvirus modulator of immune recognition 2 (MIR2), using deep mutational scanning. We identified a highly specific recognition surface in the hydrophobic core of the CD86 transmembrane (TM) domain (TMD) that is required for recognition by MARCH1 and prominently features a proline at position 254. In contrast, MIR2 requires no specific sequences in the CD86 TMD but relies primarily on an aspartic acid at position 244 in the CD86 extracellular juxtamembrane region. Surprisingly, MIR2 recognized CD86 with a TMD composed entirely of valine, whereas many different single amino acid substitutions in the context of the native TM sequence conferred MIR2 resistance. These results show that the human and viral proteins evolved completely different recognition modes for the same substrate. That some TM sequences are incompatible with MIR2 activity, even when no specific recognition motif is required, suggests a more complicated mechanism of immune modulation via CD86 than was previously appreciated.	[Trenker, Raphael; Wu, Xinyu; Nguyen, Julie, V; Wilcox, Stephen; Call, Matthew E.; Call, Melissa J.] Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia; [Trenker, Raphael; Wu, Xinyu; Wilcox, Stephen; Rubin, Alan F.; Call, Matthew E.; Call, Melissa J.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia; [Wilcox, Stephen] Walter & Eliza Hall Inst Med Res, Genom Lab, Parkville, Vic, Australia; [Rubin, Alan F.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Parkville, Vic, Australia; [Trenker, Raphael] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94158 USA	Walter & Eliza Hall Institute; University of Melbourne; Walter & Eliza Hall Institute; Walter & Eliza Hall Institute; University of California System; University of California San Francisco	Call, ME; Call, MJ (corresponding author), Walter & Eliza Hall Inst Med Res, Struct Biol Div, Parkville, Vic, Australia.; Call, ME; Call, MJ (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	call@wehi.edu.au; call@wehi.edu.au	Call, Melissa/HHZ-6671-2022	Call, Melissa/0000-0001-7684-5841; Call, Matthew/0000-0001-5846-6469; Rubin, Alan/0000-0003-1474-605X	National Health and Medical Research Council [GNT1030902]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council project grant GNT1030902 to M. E. C. and M. J. C.	Anania VG, 2011, J VIROL, V85, P2288, DOI 10.1128/JVI.01961-10; Aubrey BJ, 2015, CELL REP, V10, P1422, DOI 10.1016/j.celrep.2015.02.002; Babon JJ, 2019, BIOCHEM J, V476, P2869, DOI 10.1042/BCJ20190577; Baravalle G, 2011, J IMMUNOL, V187, P2966, DOI 10.4049/jimmunol.1101643; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bridgford JL, 2020, BLOOD, V135, P287, DOI 10.1182/blood.2019002561; Charollais J, 2009, MOL MEMBR BIOL, V26, P55, DOI 10.1080/09687680802620369; Corcoran K, 2011, J BIOL CHEM, V286, P37168, DOI 10.1074/jbc.M110.204040; Coscoy L, 2000, P NATL ACAD SCI USA, V97, P8051, DOI 10.1073/pnas.140129797; Coscoy L, 2001, J CELL BIOL, V155, P1265, DOI 10.1083/jcb.200111010; Coscoy L, 2001, J CLIN INVEST, V107, P1599, DOI 10.1172/JCI12432; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elazar A, 2016, ELIFE, V5, DOI 10.7554/eLife.12125; Fowler DM, 2014, NAT METHODS, V11, P801, DOI [10.1038/NMETH.3027, 10.1038/nmeth.3027]; Fu QS, 2016, MOL CELL, V61, P602, DOI 10.1016/j.molcel.2016.01.009; Gofman Y, 2012, J CHEM THEORY COMPUT, V8, P2896, DOI 10.1021/ct300128x; Goto E, 2003, J BIOL CHEM, V278, P14657, DOI 10.1074/jbc.M211285200; Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880; Hoer S, 2007, FEBS LETT, V581, P45, DOI 10.1016/j.febslet.2006.11.075; Hor S, 2009, MOL CELL PROTEOMICS, V8, P1959, DOI 10.1074/mcp.M900174-MCP200; Ishido S, 2000, IMMUNITY, V13, P365, DOI 10.1016/S1074-7613(00)00036-4; Ishido S, 2000, J VIROL, V74, P5300, DOI 10.1128/JVI.74.11.5300-5309.2000; Jabbour M, 2009, J IMMUNOL, V183, P6500, DOI 10.4049/jimmunol.0901521; Jahnke M, 2012, J BIOL CHEM, V287, P28779, DOI 10.1074/jbc.M112.381541; Kajikawa M, 2012, J VIROL, V86, P5288, DOI 10.1128/JVI.00219-12; Lin H, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01751; Lin H, 2018, P NATL ACAD SCI USA, V115, P12483, DOI 10.1073/pnas.1806217115; Liu HY, 2019, CURR OPIN IMMUNOL, V58, P38, DOI 10.1016/j.coi.2019.03.001; Liu HY, 2016, J EXP MED, V213, P1695, DOI 10.1084/jem.20160312; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Rubin AF, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1272-5; Sanchez DJ, 2002, J BIOL CHEM, V277, P6124, DOI 10.1074/jbc.M110265200; Schanzenbach C, 2017, SCI REP-UK, V7, DOI 10.1038/srep43476; Shelar A, 2016, BBA-BIOMEMBRANES, V1858, P2804, DOI 10.1016/j.bbamem.2016.08.003; Smith T, 2017, GENOME RES, V27, P491, DOI 10.1101/gr.209601.116; Tan C, 2019, J BIOL CHEM, V294, P2470, DOI 10.1074/jbc.RA118.004836; Ulmschneider MB, 2001, BBA-BIOMEMBRANES, V1512, P1, DOI 10.1016/S0005-2736(01)00299-1; von Rohrscheidt J, 2016, J EXP MED, V213, P1685, DOI 10.1084/jem.20160316; VONHEIJNE G, 1991, J MOL BIOL, V218, P499, DOI 10.1016/0022-2836(91)90695-3; Wang XL, 2008, SEMIN CANCER BIOL, V18, P441, DOI 10.1016/j.semcancer.2008.09.002; Wilson AA, 2008, AM J RESP CELL MOL, V39, P133, DOI 10.1165/rcmb.2007-0133OC; Young LJ, 2008, NAT IMMUNOL, V9, P1244, DOI 10.1038/ni.1665; Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698	45	3	3	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100900	10.1016/j.jbc.2021.100900	http://dx.doi.org/10.1016/j.jbc.2021.100900			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34157285	Green Published, gold			2022-12-28	WOS:000678068400089
J	Tsvetanova, NG; Trester-Zedlitz, M; Newton, BW; Peng, GE; Johnson, JR; Jimenez-Morales, D; Kurland, AP; Krogan, NJ; von Zastrow, M				Tsvetanova, Nikoleta G.; Trester-Zedlitz, Michelle; Newton, Billy W.; Peng, Grace E.; Johnson, Jeffrey R.; Jimenez-Morales, David; Kurland, Andrew P.; Krogan, Nevan J.; von Zastrow, Mark			Endosomal cAMP production broadly impacts the cellular phosphoproteome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; SIGNALING PATHWAYS; PHOSPHORYLATION; IDENTIFICATION; VISUALIZATION; SPECIFICITY; PP2A; PKA	Endosomal signaling downstream of G-protein-coupled receptors (GPCRs) has emerged as a novel paradigm with important pharmacological and physiological implications. However, our knowledge of the functional consequences of intracellular signaling is incomplete. To begin to address this gap, we combined an optogenetic approach for site-specific generation of the prototypical second messenger generated by active GPCRs, cyclic AMP (cAMP), with unbiased mass-spectrometry-based analysis of the phosphoproteome. We identified 218 unique, high-confidence sites whose phosphorylation is either increased or decreased in response to cAMP elevation. We next determined that the same amount of cAMP produced from the endosomal membrane led to more robust changes in phosphorylation than the plasma membrane. Remarkably, this was true for the entire repertoire of 218 identified targets and irrespective of their annotated subcellular localizations (endosome, cell surface, nucleus, cytosol). Furthermore, we identified a particularly strong endosome bias for a subset of proteins that are dephosphorylated in response to cAMP. Through bioinformatics analysis, we established these targets as putative substrates for protein phosphatase 2A (PP2A), and we propose compartmentalized activation of PP2A by cAMP-responsive kinases as the likely underlying mechanism. Altogether, our study extends the concept that endosomal signaling is a significant functional contributor to cellular responsiveness to cAMP by establishing a unique role for localized cAMP production in defining categorically distinct phosphoresponses.	[Tsvetanova, Nikoleta G.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA; [Tsvetanova, Nikoleta G.; Trester-Zedlitz, Michelle; von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Newton, Billy W.; Johnson, Jeffrey R.; Jimenez-Morales, David; Krogan, Nevan J.; von Zastrow, Mark] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Newton, Billy W.; Johnson, Jeffrey R.; Jimenez-Morales, David; Krogan, Nevan J.] Univ Calif San Francisco, Quantitat Biosci Inst, San Francisco, CA 94143 USA; [Peng, Grace E.] Univ Calif San Francisco, Program Cell Biol, San Francisco, CA 94143 USA; [Johnson, Jeffrey R.; Kurland, Andrew P.] Icahn Sch Med Mt Sinai, Microbiol Dept, New York, NY 10029 USA; [Jimenez-Morales, David] Stanford Univ, Dept Med, Div Cardiovasc Med, Sch Med, Stanford, CA 94305 USA; [Krogan, Nevan J.] J David Gladstone Inst, San Francisco, CA USA; [Tsvetanova, Nikoleta G.] Duke Univ, Dept Pharmacol & Canc Biol, 308 Res Dr,LSRC Room C370A, Durham, NC 27710 USA; [von Zastrow, Mark] Univ Calif San Francisco, Dept Psychiat, 600 16th St,Genentech Hall Room N216, San Francisco, CA 94158 USA	Duke University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Icahn School of Medicine at Mount Sinai; Stanford University; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University; University of California System; University of California San Francisco	Tsvetanova, NG (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA.; Tsvetanova, NG; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA.; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Tsvetanova, NG (corresponding author), Duke Univ, Dept Pharmacol & Canc Biol, 308 Res Dr,LSRC Room C370A, Durham, NC 27710 USA.; von Zastrow, M (corresponding author), Univ Calif San Francisco, Dept Psychiat, 600 16th St,Genentech Hall Room N216, San Francisco, CA 94158 USA.	Nikoleta.Tsvetanova@duke.edu; Mark.vonZastrow@ucsf.edu	Jimenez-Morales, David/AAE-9289-2019	Jimenez-Morales, David/0000-0003-4356-6461; Tsvetanova, Nikoleta/0000-0001-6533-187X; Peng, Grace/0000-0002-8901-725X	National Institute of Health [MH109633, HL129689, DA010711, DA012864, GM081879, GM082250, GM107671, U19 AI106754]; American Heart Association [16PRE26420057]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported by the National Institute of Health (Grants MH109633 to N. G. T; HL129689 to G. E. P.; DA010711 and DA012864 to M. v. Z.; GM081879, GM082250, GM107671, and U19 AI106754 to N. J. K.). G. E. P. was also supported by the American Heart Association (16PRE26420057). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Benjamini Y, 2006, BIOMETRIKA, V93, P491, DOI 10.1093/biomet/93.3.491; Bowman SL, 2016, J CELL BIOL, V214, P797, DOI 10.1083/jcb.201512068; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Chou Michael F, 2011, Curr Protoc Bioinformatics, VChapter 13, DOI [10.1002/0471250953.bi1315s35, 10.1002/0471250953.bi1316s36]; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Feinstein TN, 2013, J BIOL CHEM, V288, P27849, DOI 10.1074/jbc.M112.445098; Giansanti P, 2013, MOL CELL PROTEOMICS, V12, P3350, DOI 10.1074/mcp.O113.028456; Gunaratne R, 2010, P NATL ACAD SCI USA, V107, P15653, DOI 10.1073/pnas.1007424107; Hoffert JD, 2011, EXPERT REV PROTEOMIC, V8, P157, DOI [10.1586/EPR.11.14, 10.1586/epr.11.14]; Howe AK, 2004, BBA-MOL CELL RES, V1692, P159, DOI 10.1016/j.bbamcr.2004.03.005; Inda C, 2016, J CELL BIOL, V214, P181, DOI 10.1083/jcb.201512075; Irannejad R, 2013, NATURE, V495, P534, DOI 10.1038/nature12000; Isobe K, 2017, P NATL ACAD SCI USA, V114, pE8875, DOI 10.1073/pnas.1709123114; Jong CJ, 2020, J BIOL CHEM, V295, P5654, DOI 10.1074/jbc.RA119.011270; KENNELLY PJ, 1991, J BIOL CHEM, V266, P15555; Lundby A, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003506; McCluskey A, 2013, TRAFFIC, V14, P1272, DOI 10.1111/tra.12119; McCright B, 1996, J BIOL CHEM, V271, P22081, DOI 10.1074/jbc.271.36.22081; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Moorhead GBG, 2007, NAT REV MOL CELL BIO, V8, P234, DOI 10.1038/nrm2126; Peng GE, 2021, NAT CHEM BIOL, V17, P558, DOI 10.1038/s41589-021-00747-0; Ranieri A, 2018, J MOL CELL CARDIOL, V115, P20, DOI 10.1016/j.yjmcc.2017.12.016; Rinschen MM, 2010, P NATL ACAD SCI USA, V107, P3882, DOI 10.1073/pnas.0910646107; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sriram K, 2018, MOL PHARMACOL, V93, P251, DOI 10.1124/mol.117.111062; Stierl M, 2011, J BIOL CHEM, V286, P1181, DOI 10.1074/jbc.M110.185496; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Thomsen ARB, 2018, TRENDS PHARMACOL SCI, V39, P879, DOI 10.1016/j.tips.2018.08.003; Thul PJ, 2017, SCIENCE, V356, DOI 10.1126/science.aal3321; Tsvetanova NG, 2017, MOL PHARMACOL, V91, P145, DOI 10.1124/mol.116.106369; Tsvetanova NG, 2015, J BIOL CHEM, V290, P6689, DOI 10.1074/jbc.R114.617951; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Tyanova S, 2015, PROTEOMICS, V15, P1453, DOI 10.1002/pmic.201400449; Usui H, 1998, FEBS LETT, V430, P312, DOI 10.1016/S0014-5793(98)00684-X; Vilardaga JP, 2014, NAT CHEM BIOL, V10, P700, DOI [10.1038/NCHEMBIO.1611, 10.1038/nchembio.1611]; Wurzenberger C, 2011, NAT REV MOL CELL BIO, V12, P469, DOI 10.1038/nrm3149; Zaccolo M, 2006, EUR J CELL BIOL, V85, P693, DOI 10.1016/j.ejcb.2006.01.002	39	10	10	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100907	10.1016/j.jbc.2021.100907	http://dx.doi.org/10.1016/j.jbc.2021.100907			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34166681	Green Submitted, gold, Green Published			2022-12-28	WOS:000678068400094
J	Yano, K; Takahashi, RU; Shiotani, B; Abe, J; Shidooka, T; Sudo, Y; Yamamoto, Y; Kan, SS; Sakagami, H; Tahara, H				Yano, Kimiyoshi; Takahashi, Ryou-U; Shiotani, Bunsyo; Abe, Junko; Shidooka, Tomoki; Sudo, Yuki; Yamamoto, Yusuke; Kan, Shisei; Sakagami, Hiroki; Tahara, Hidetoshi			PRPF19 regulates p53-dependent cellular senescence by modulating alternative splicing of MDM4 mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; TUMOR-FORMATION; P53 PATHWAY; HUMAN-CELLS; PHOSPHORYLATION; UBIQUITINATION; DEGRADATION; ACTIVATION; EXPRESSION; P53-BETA	Alteration of RNA splicing is a hallmark of cellular senescence, which is associated with age-related disease and cancer development. However, the roles of splicing factors in cellular senescence are not fully understood. In this study, we identified the splicing factor PRPF19 as a critical regulator of cellular senescence in normal human diploid fibroblasts. PRPF19 was downregulated during replicative senescence, and PRPF19 knockdown prematurely induced senescence-like cell cycle arrest through the p53-p21 pathway. RNA-sequencing analysis revealed that PRPF19 knockdown caused a switch of the MDM4 splicing isoform from stable full-length MDM4-FL to unstable MDM4-S lacking exon 6. We also found that PRPF19 regulates MDM4 splicing by promoting the physical interaction of other splicing factors, PRPF3 and PRPF8, which are key components of the core spliceosome, U4/U6.U5 tri-snRNP. Given that MDM4 is a major negative regulator of p53, our findings imply that PRPF19 downregulation inhibits MDM4-mediated p53 inactivation, resulting in induction of cellular senescence. Thus, PRPF19 plays an important role in the induction of p53-dependent cellular senescence.	[Yano, Kimiyoshi; Takahashi, Ryou-U; Abe, Junko; Shidooka, Tomoki; Sudo, Yuki; Kan, Shisei; Sakagami, Hiroki; Tahara, Hidetoshi] Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima, Japan; [Shiotani, Bunsyo; Yamamoto, Yusuke] Natl Canc Ctr, Div Cellular Signaling, Res Inst, Tokyo, Japan	Hiroshima University; National Cancer Center - Japan	Tahara, H (corresponding author), Hiroshima Univ, Grad Sch Biomed Sci, Dept Cellular & Mol Biol, Hiroshima, Japan.	toshi@hiroshima-u.ac.jp		Tahara, Hidetoshi/0000-0003-3054-4175	JSPS KAKENHI [18J20013]; KAKENHI Grant [21K086700A]; Takeda Science Foundation; Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT, Japan	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); KAKENHI Grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JSPS KAKENHI Grant Number: 18J20013 (K. Y.), KAKENHI Grant Number: 21K086700A (R. T.), a Grant-in Aid from the Takeda Science Foundation (R. T.), and the Project for Development of Innovative Research on Cancer Therapeutics (P-Direct), MEXT, Japan (H. T.).	Aird Katherine M, 2013, Methods Mol Biol, V965, P185, DOI 10.1007/978-1-62703-239-1_12; Amor C, 2020, NATURE, V583, P127, DOI 10.1038/s41586-020-2403-9; Baker DJ, 2016, NATURE, V530, P184, DOI 10.1038/nature16932; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Campisi J, 2001, TRENDS CELL BIOL, V11, pS27, DOI 10.1016/S0962-8924(01)02151-1; Canman CE, 1998, SCIENCE, V281, P1677, DOI 10.1126/science.281.5383.1677; Carrillo AM, 2015, ONCOGENE, V34, P846, DOI 10.1038/onc.2014.27; Chen J, 2017, CANCER DISCOV, V7, P766, DOI 10.1158/2159-8290.CD-16-0908; CRISTOFA.VJ, 1969, MED EXP, V19, P313; Danovi D, 2004, MOL CELL BIOL, V24, P5835, DOI 10.1128/MCB.24.13.5835-5843.2004; De Clercq S, 2010, MOL CELL BIOL, V30, P5394, DOI 10.1128/MCB.00330-10; de Lange J, 2012, AM J CANCER RES, V2, P492; Deschenes M, 2017, AGING CELL, V16, P918, DOI 10.1111/acel.12646; Deschenes-Simard X, 2013, GENE DEV, V27, P900, DOI 10.1101/gad.203984.112; Dewaele M, 2016, J CLIN INVEST, V126, P68, DOI 10.1172/JCI82534; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fujita K, 2009, NAT CELL BIOL, V11, P1135, DOI 10.1038/ncb1928; Gembarska A, 2012, NAT MED, V18, P1239, DOI 10.1038/nm.2863; Gilkes DM, 2008, MOL CELL BIOL, V28, P1999, DOI 10.1128/MCB.01633-07; Giono LE, 2016, J MOL BIOL, V428, P2636, DOI 10.1016/j.jmb.2016.03.004; Harries LW, 2011, AGING CELL, V10, P868, DOI 10.1111/j.1474-9726.2011.00726.x; He SH, 2017, CELL, V169, P1000, DOI 10.1016/j.cell.2017.05.015; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Hernandez-Segura A, 2018, TRENDS CELL BIOL, V28, P436, DOI 10.1016/j.tcb.2018.02.001; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Laurie NA, 2006, NATURE, V444, P61, DOI 10.1038/nature05194; Linares LK, 2003, P NATL ACAD SCI USA, V100, P12009, DOI 10.1073/pnas.2030930100; Ling X, 2014, CANCER RES, V74, P7487, DOI 10.1158/0008-5472.CAN-14-0683; Marechal A, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012716; Marine JC, 2016, CSH PERSPECT MED, V6, DOI 10.1101/cshperspect.a026237; Mukherjee B, 2015, METHODS MOL BIOL, V1292, P67, DOI 10.1007/978-1-4939-2522-3_5; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Olive PL, 2006, NAT PROTOC, V1, P23, DOI 10.1038/nprot.2006.5; Parant J, 2001, NAT GENET, V29, P92, DOI 10.1038/ng714; Song EJ, 2010, GENE DEV, V24, P1434, DOI 10.1101/gad.1925010; Stein GH, 1999, MOL CELL BIOL, V19, P2109; Tang Y, 2013, ONCOGENE, V32, P2792, DOI 10.1038/onc.2012.288; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wade M, 2010, TRENDS CELL BIOL, V20, P299, DOI 10.1016/j.tcb.2010.01.009; Will CL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003707; Yin J, 2012, BIOL CELL, V104, P695, DOI 10.1111/boc.201200011; Zhang PS, 2019, NAT NEUROSCI, V22, P719, DOI 10.1038/s41593-019-0372-9	47	6	6	3	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100882	10.1016/j.jbc.2021.100882	http://dx.doi.org/10.1016/j.jbc.2021.100882			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34144037	Green Published, gold			2022-12-28	WOS:000678068400081
J	Carpinteiro, A; Gripp, B; Hoffmann, M; Pohlmann, S; Hoertel, N; Edwards, MJ; Kamler, M; Kornhuber, J; Becker, KA; Gulbins, E				Carpinteiro, Alexander; Gripp, Barbara; Hoffmann, Markus; Poehlmann, Stefan; Hoertel, Nicolas; Edwards, Michael J.; Kamler, Markus; Kornhuber, Johannes; Becker, Katrin Anne; Gulbins, Erich			Inhibition of acid sphingomyelinase by ambroxol prevents SARS-CoV-2 entry into epithelial cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERAMIDE; INFECTION; TMPRSS2; MICE	The acid sphingomyelinase/ceramide system has been shown to be important for cellular infection with at least some viruses, for instance, rhinovirus or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Functional inhibition of the acid sphingomyelinase using tricyclic antidepressants prevented infection of epithelial cells, for instance with SARS-CoV-2. The structure of ambroxol, that is, trans-4-[(2,4-dibromanilin-6-yl)-methyamino]-cyclohexanol, a mucolytic drug applied by inhalation, suggests that the drug might inhibit the acid sphingomyelinase and thereby infection with SARS-CoV-2. To test this, we used vesicular stomatitis virus pseudoviral particles presenting SARS-CoV-2 spike protein on their surface (ppVSV-SARS-CoV-2 spike), a bona fide system for mimicking SARS-CoV-2 entry into cells. Viral uptake and formation of ceramide localization were determined by fluorescence microscopy, activity of the acid sphingomyelinase by consumption of [C-14]sphingomyelin and ceramide was quantified by a kinase method. We found that entry of pp-VSV-SARS-CoV-2 spike required activation of acid sphingomyelinase and release of ceramide, events that were all prevented by pretreatment with ambroxol. We also obtained nasal epithelial cells from human volunteers prior to and after inhalation of ambroxol. Inhalation of ambroxol reduced acid sphingomyelinase activity in nasal epithelial cells and prevented pp-VSV-SARS-CoV-2 spike-induced acid sphingomyelinase activation, ceramide release, and entry of pp-VSV-SARS-CoV-2 spike ex vivo. The addition of purified acid sphingomyelinase or C16 ceramide restored entry of pp-VSV-SARS-CoV-2 spike into ambroxol-treated epithelial cells. We propose that ambroxol might be suitable for clinical studies to prevent coronavirus disease 2019.	[Carpinteiro, Alexander; Becker, Katrin Anne; Gulbins, Erich] Univ Duisburg Essen, Univ Hosp Essen, Inst Mol Biol, Essen, Germany; [Carpinteiro, Alexander] Univ Duisburg Essen, Univ Hosp Essen, Dept Hematol, Essen, Germany; [Gripp, Barbara] Sana Klinikum Remscheid GmbH, Zentrum Seel Gesundheit Kindes & Jugendalters, Remscheid, Germany; [Hoffmann, Markus; Poehlmann, Stefan] Leibniz Inst Primate Res, German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Hoffmann, Markus; Poehlmann, Stefan] Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany; [Hoertel, Nicolas] Ctr Univ Paris, Hop Corentin Celton, AP HP, Dept Psychiat, Issy Les Moulineaux, France; [Hoertel, Nicolas] Univ Paris, INSERM, Inst Psychiat & Neurosci Paris, UMR S1266, Paris, France; [Hoertel, Nicolas] UFR Med, Fac Sante, Paris, France; [Edwards, Michael J.; Gulbins, Erich] Univ Cincinnati, Sch Med, Dept Surg, Cincinnati, OH 45221 USA; [Kamler, Markus] Univ Hosp Essen, Dept Thorac & Cardiovasc Surg, Div Thorac Transplantat, Essen, Germany; [Kornhuber, Johannes] Friedrich Alexander Univ Erlangen Nurnberg FA, Univ Hosp Erlangen, Dept Psychiat & Psychotherapy, Erlangen, Germany	University of Duisburg Essen; University of Duisburg Essen; Deutsches Primatenzentrum (DPZ); University of Gottingen; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Corentin-Celton - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; University System of Ohio; University of Cincinnati; University of Duisburg Essen; University of Erlangen Nuremberg	Gulbins, E (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Mol Biol, Essen, Germany.; Gulbins, E (corresponding author), Univ Cincinnati, Sch Med, Dept Surg, Cincinnati, OH 45221 USA.	erich.gulbins@uni-due.de	Pöhlmann, Stefan/H-2395-2011; Hoffmann, Markus/J-7836-2018; , Hoertel/H-9457-2015	Pöhlmann, Stefan/0000-0001-6086-9136; Hoffmann, Markus/0000-0003-4603-7696; , Hoertel/0000-0002-7890-1349; Kamler, Markus/0000-0001-6608-8496	Deutsche Forschungsgemeinschaft [Gu-335-35/1, Gu335-38/1]; Bundesministerium fur Bildung und Forschung (BMBF) [01KI1723D, 01KI2006D, 01KI20328A, 01KI20396]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	The study was supported by Deutsche Forschungsgemeinschaft grants Gu-335-35/1 and Gu335-38/1 to E. G. and Bundesministerium fur Bildung und Forschung (BMBF) grants to S. P. (The "Risikobewertung bei prapandemischen respiratorischen Infektionserkrankungen" (RAPID) Consortium: 01KI1723D and 01KI2006D; "Repurposing of Nafamostatmesylat for treatment of COVID-19" (RENACO) Consortium: 01KI20328A and 01KI20396).	Audi A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00612; Avota E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001290; Becker KA, 2010, AM J RESP CELL MOL, V42, P716, DOI 10.1165/rcmb.2009-0174OC; Bradfute Steven B, 2020, bioRxiv, DOI 10.1101/2020.08.11.245100; Breiden B, 2020, BIOL CHEM, V401, P31, DOI 10.1515/hsz-2019-0270; Carpinteiro A, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100142; Edwards MJ, 2020, J BIOL CHEM, V295, P15174, DOI 10.1074/jbc.RA120.015249; Grassme H, 2005, J BIOL CHEM, V280, P26256, DOI 10.1074/jbc.M500835200; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; Grassme H, 2001, J BIOL CHEM, V276, P20589, DOI 10.1074/jbc.M101207200; Grassme H., 2017, CELL HOST MICROBE, V21, P707; Gulbins A, 2018, MOL PSYCHIATR, V23, P2324, DOI 10.1038/s41380-018-0090-9; Gulbins E, 2003, ONCOGENE, V22, P7070, DOI 10.1038/sj.onc.1207146; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Keitsch S, 2018, BIOL CHEM, V399, P1203, DOI 10.1515/hsz-2018-0161; Kleine-Weber H, 2019, J VIROL, V93, DOI 10.1128/JVI.01381-18; Kolesnick RN, 2000, J CELL PHYSIOL, V184, P285; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Kornhuber J, 2008, J MED CHEM, V51, P219, DOI 10.1021/jm070524a; Kornhuber J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023852; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Lang J, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15072-8; Li PL, 2007, ANTIOXID REDOX SIGN, V9, P1411, DOI 10.1089/ars.2007.1736; Lucas JM, 2014, CANCER DISCOV, V4, P1310, DOI 10.1158/2159-8290.CD-13-1010; Matsuyama S, 2010, J VIROL, V84, P12658, DOI 10.1128/JVI.01542-10; Miller ME, 2012, J VIROL, V86, P7473, DOI 10.1128/JVI.00136-12; Nurminen TA, 2002, J AM CHEM SOC, V124, P12129, DOI 10.1021/ja017807r; Olaleye O.O., 2021, BIORXIV, DOI [10.1101/2020.09.13.295691, DOI 10.1101/2020.09.13,295691]; Peng HM, 2015, J MOL MED, V93, P675, DOI 10.1007/s00109-014-1246-y; Pewzner-Jung Y, 2014, EMBO MOL MED, V6, P1205, DOI 10.15252/emmm.201404075; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Serafim RB, 2021, CLIN MICROBIOL INFEC, V27, P47, DOI 10.1016/j.cmi.2020.10.017; Simmons G, 2005, P NATL ACAD SCI USA, V102, P11876, DOI 10.1073/pnas.0505577102; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Soudani N, 2019, J VIROL, V93, DOI 10.1128/JVI.00053-19; Tani H, 2010, J VIROL, V84, P2798, DOI 10.1128/JVI.02499-09; Wang QH, 2020, CELL, V181, P894, DOI 10.1016/j.cell.2020.03.045; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1126/science.abb2507, 10.1101/2020.02.11.944462]; Zhou P., 2020, PNEUMOSAIA OUTBREAK, V270, P273	41	37	37	3	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100701	10.1016/j.jbc.2021.100701	http://dx.doi.org/10.1016/j.jbc.2021.100701			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895135	gold, Green Published			2022-12-28	WOS:000672866400672
J	Choi, S; Kim, BS; Hwang, J; Kim, MH				Choi, Sanghyeon; Kim, Byoung Sik; Hwang, Jungwon; Kim, Myung Hee			Reduced virulence of the MARTX toxin increases the persistence of outbreak-associated Vibrio vulnificus in host reservoirs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RTX TOXIN; RHO-GTPASES; ACTIVATION; INACTIVATION; EXPRESSION; INFECTION; DOMAIN	Opportunistic bacteria strategically dampen their virulence to allow them to survive and propagate in hosts. However, the molecular mechanisms underlying virulence control are not clearly understood. Here, we found that the opportunistic pathogen Vibrio vulnificus biotype 3, which caused an outbreak of severe wound and intestinal infections associated with farmed tilapia, secretes significantly less virulent multifunctional autoprocessing repeats-in-toxin (MARTX) toxin, which is the most critical virulence factor in other clinical Vibrio strains. The biotype 3 MARTX toxin contains a cysteine protease domain (CPD) evolutionarily retaining a unique autocleavage site and a distinct beta-flap region. CPD autoproteolytic activity is attenuated following its autocleavage because of the beta-flap region. This beta-flap blocks the active site, disabling further autoproteolytic processing and release of the modularly structured effector domains within the toxin. Expression of this altered CPD consequently results in attenuated release of effectors by the toxin and significantly reduces the virulence of V. vulnificus biotype 3 in cells and in mice. Bioinformatic analysis revealed that this virulence mechanism is shared in all biotype 3 strains. Thus, these data provide new insights into the mechanisms by which opportunistic bacteria persist in an environmental reservoir, prolonging the potential to cause outbreaks.	[Choi, Sanghyeon; Hwang, Jungwon; Kim, Myung Hee] Korea Res Inst Biosci & Biotechnol KRIBB, Metab Regulat Res Ctr, Infect & Immun Res Lab, Daejeon, South Korea; [Choi, Sanghyeon] Korea Adv Inst Sci & Technol, Dept Biol Sci, Daejeon, South Korea; [Kim, Byoung Sik] Ewha Womans Univ, Dept Food Sci & Engn, Seoul, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea Advanced Institute of Science & Technology (KAIST); Ewha Womans University	Hwang, J; Kim, MH (corresponding author), Korea Res Inst Biosci & Biotechnol KRIBB, Metab Regulat Res Ctr, Infect & Immun Res Lab, Daejeon, South Korea.	jwhwang@kribb.re.kr; mhk8n@kribb.re.kr		Kim, Byoung Sik/0000-0001-9820-6071	Ministry of Science and Information and Communications Technology (ICT) of Korea [2014R1A2A1A01005971, 2017R1A2B3007317]; KRIBB Initiative Program [KGM2112133]	Ministry of Science and Information and Communications Technology (ICT) of Korea; KRIBB Initiative Program	This work was supported by the Ministry of Science and Information and Communications Technology (ICT) of Korea (2014R1A2A1A01005971 and 2017R1A2B3007317 to M. H. K.) and the KRIBB Initiative Program (KGM2112133 to M. H. K.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Agarwal S, 2015, CELL MICROBIOL, V17, P1494, DOI 10.1111/cmi.12451; Agarwal S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9745; Ahrens S, 2013, J BIOL CHEM, V288, P1397, DOI 10.1074/jbc.M112.396309; Baker-Austin C, 2018, ENVIRON MICROBIOL, V20, P423, DOI 10.1111/1462-2920.13955; Baker-Austin C, 2017, TRENDS MICROBIOL, V25, P76, DOI 10.1016/j.tim.2016.09.008; BIOSCA EG, 1993, INFECT IMMUN, V61, P1611, DOI 10.1128/IAI.61.5.1611-1618.1993; Bisharat N, 1996, LANCET, V348, P1585, DOI 10.1016/S0140-6736(05)66199-5; Diard M, 2017, FEMS MICROBIOL REV, V41, P679, DOI 10.1093/femsre/fux023; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Froelich BA, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0209; Froelich BA, 2014, APPL ENVIRON MICROB, V80, P7454, DOI 10.1128/AEM.02042-14; Gavin HE, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006119; Hernandez-Cabanyero C, 2020, ENVIRON MICROBIOL, V22, P4133, DOI 10.1111/1462-2920.15137; Hori M., 2017, JMM CASE REP, V4; Jeong HG, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002581; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Kim BS, 2020, TOXINS, V12, DOI 10.3390/toxins12090544; Kim BS, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00659-20; Kim BS, 2017, MSPHERE, V2, DOI 10.1128/mSphereDirect.00272-17; Kim BS, 2016, CELL MICROBIOL, V18, P1078, DOI 10.1111/cmi.12568; Kim YR, 2008, CELL MICROBIOL, V10, P848, DOI 10.1111/j.1462-5822.2007.01088.x; King M, 2019, ANN INTERN MED, V171, P520, DOI 10.7326/L19-0133; Koton Y, 2015, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00803; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Kwon SY, 2005, PLASMID, V53, P274, DOI 10.1016/j.plasmid.2004.11.006; Lee Y, 2019, P NATL ACAD SCI USA, V116, P18031, DOI 10.1073/pnas.1905095116; Lo HR, 2011, J INFECT DIS, V203, P1866, DOI 10.1093/infdis/jir070; Lupardus PJ, 2008, SCIENCE, V322, P265, DOI 10.1126/science.1162403; Mikonranta L, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0447-5; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Philippe N, 2004, PLASMID, V51, P246, DOI 10.1016/j.plasmid.2004.02.003; Raz N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114576; Satchell KJF, 2011, ANNU REV MICROBIOL, V65, P71, DOI 10.1146/annurev-micro-090110-102943; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sheahan KL, 2007, EMBO J, V26, P2552, DOI 10.1038/sj.emboj.7601700; Sheahan KL, 2007, CELL MICROBIOL, V9, P1324, DOI 10.1111/j.1462-5822.2006.00876.x; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shen A, 2009, NAT CHEM BIOL, V5, P469, DOI 10.1038/nchembio.178; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Vezzulli L, 2016, P NATL ACAD SCI USA, V113, pE5062, DOI 10.1073/pnas.1609157113; Woida PJ, 2018, MOL MICROBIOL, V107, P133, DOI 10.1111/mmi.13875; Zaidenstein R, 2008, EMERG INFECT DIS, V14, P1875, DOI 10.3201/eid1412.080499; Zhou Y, 2017, SCIENCE, V358, P528, DOI 10.1126/science.aam8659; Ziolo KJ, 2014, INFECT IMMUN, V82, P2148, DOI 10.1128/IAI.00017-14	45	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100777	10.1016/j.jbc.2021.100777	http://dx.doi.org/10.1016/j.jbc.2021.100777			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33992647	Green Published, gold			2022-12-28	WOS:000672866400743
J	Cook, B; Walker, N; Zhang, QS; Chen, SB; Evans, T				Cook, Brandoch; Walker, Nicholas; Zhang, Qisheng; Chen, Shuibing; Evans, Todd			The small molecule DIPQUO promotes osteogenic differentiation via inhibition of glycogen synthase kinase 3-beta signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DRUG TARGET ENGAGEMENT; OSTEOBLAST DIFFERENTIATION; BONE; TAU; PHOSPHORYLATION; DISEASE; PATHWAY; BETA	Bone fractures are common impact injuries typically resolved through natural processes of osteogenic regeneration and bone remodeling, restoring the biological and mechanical function. However, dysfunctionality in bone healing and repair often arises in the context of aging-related chronic disorders, such as Alzheimer's disease (AD). There is unmet need for effective pharmacological modulators of osteogenic differentiation and an opportunity to probe the complex links between bone biology and cognitive disorders. We previously discovered the small molecule DIPQUO, which promotes osteoblast differentiation and bone mineralization in mouse and human cell culture models, and in zebrafish developmental and regenerative models. Here, we examined the detailed function of this molecule. First, we used kinase profiling, cellular thermal shift assays, and functional studies to identify glycogen synthase kinase 3-beta (GSK3-beta) inhibition as a mechanism of DIPQUO action. Treatment of mouse C2C12 myoblasts with DIPQUO promoted alkaline phosphatase expression and activity, which could be enhanced synergistically by treatment with other GSK3-beta inhibitors. Suppression of the expression or function of GSK3-beta attenuated DIPQUO-dependent osteogenic differentiation. In addition, DIPQUO synergized with GSK3-beta inhibitors to stimulate expression of osteoblast genes in human multipotent progenitors. Accordingly, DIPQUO promoted accumulation and activation of beta-catenin. Moreover, DIPQUO suppressed activation of tau microtubule-associated protein, an AD-related effector of GSK3-beta signaling. Therefore, DIPQUO has potential as both a lead candidate for bone therapeutic development and a pharmacological modulator of GSK3-beta signaling in cell culture and animal models of disorders including AD.	[Cook, Brandoch; Walker, Nicholas; Chen, Shuibing; Evans, Todd] Weill Cornell Med, Dept Surg, New York, NY 10065 USA; [Walker, Nicholas] Weill Cornell Med, Program Physiol Biophys & Syst Biol, New York, NY USA; [Zhang, Qisheng] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27515 USA	Cornell University; Cornell University; University of North Carolina; University of North Carolina Chapel Hill	Cook, B (corresponding author), Weill Cornell Med, Dept Surg, New York, NY 10065 USA.	brc2018@med.cornell.edu		Chen, Shuibing/0000-0002-6294-5187; Walker, Nicholas/0000-0002-6054-8989				Beurel E, 2015, PHARMACOL THERAPEUT, V148, P114, DOI 10.1016/j.pharmthera.2014.11.016; Bhat RV, 2018, J ALZHEIMERS DIS, V64, pS547, DOI 10.3233/JAD-179934; Bradburn S, 2016, AGE AGEING, V45, P844, DOI 10.1093/ageing/afw137; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Cook B, 2019, CELL CHEM BIOL, V26, P926, DOI 10.1016/j.chembiol.2019.03.009; Cornelius C, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00120; Duan PP, 2016, INT J BIOCHEM CELL B, V77, P23, DOI 10.1016/j.biocel.2016.05.015; Evans DB, 2000, J BIOL CHEM, V275, P24977, DOI 10.1074/jbc.M000808200; Fei YR, 2011, J BIOL CHEM, V286, P40575, DOI 10.1074/jbc.M111.274910; Freland L, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00014; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; Gillespie JR, 2013, ENDOCRINOLOGY, V154, P3702, DOI 10.1210/en.2013-1155; Greenblatt MB, 2010, J CLIN INVEST, V120, P2457, DOI 10.1172/JCI42285; Hooper C, 2008, J NEUROCHEM, V104, P1433, DOI 10.1111/j.1471-4159.2007.05194.x; Houschyar KS, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00170; Jhang KA, 2017, J AGR FOOD CHEM, V65, P9626, DOI 10.1021/acs.jafc.7b03252; Kawamura N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001058; Kimura T, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00044; Kimura T, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00065; Li JJ, 2012, PHARMACOL BIOCHEM BE, V101, P564, DOI 10.1016/j.pbb.2012.03.002; Li L, 2017, SCI REP-UK, V7, DOI 10.1038/srep45204; LOVESTONE S, 1994, CURR BIOL, V4, P1077, DOI 10.1016/S0960-9822(00)00246-3; Marsell R, 2012, BONE, V50, P619, DOI 10.1016/j.bone.2011.11.007; Medina M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00024; Molina DM, 2016, ANNU REV PHARMACOL, V56, P141, DOI 10.1146/annurev-pharmtox-010715-103715; Molina DM, 2013, SCIENCE, V341, P84, DOI 10.1126/science.1233606; Nusse R, 2017, CELL, V169, P985, DOI 10.1016/j.cell.2017.05.016; Oishi T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056641; Pan JX, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1123-7; Pei JJ, 2006, FEBS LETT, V580, P107, DOI 10.1016/j.febslet.2005.11.059; Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403; Planel E, 2007, J NEUROSCI, V27, P13635, DOI 10.1523/JNEUROSCI.3949-07.2007; Rodriguez-Carballo E, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00040; Roos PM, 2014, J TRACE ELEM MED BIO, V28, P418, DOI 10.1016/j.jtemb.2014.08.010; Sisask G, 2013, BONE, V54, P126, DOI 10.1016/j.bone.2013.01.019; Stepanov A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192519; Thouverey C, 2015, BONEKEY REP, V4, DOI 10.1038/bonekey.2015.80; Valta MP, 2006, ENDOCRINOLOGY, V147, P2171, DOI 10.1210/en.2005-1502; Wada MR, 2002, DEVELOPMENT, V129, P2987; Wagner U, 1996, J CELL SCI, V109, P1537; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Yamauchi K, 2009, ARCH DERMATOL RES, V301, P357, DOI 10.1007/s00403-009-0929-7; Ye SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035892; Yu K, 2003, DEVELOPMENT, V130, P3063, DOI 10.1242/dev.00491; Zamani A, 2009, BONE, V44, P331, DOI 10.1016/j.bone.2008.10.001	45	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100696	10.1016/j.jbc.2021.100696	http://dx.doi.org/10.1016/j.jbc.2021.100696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895139	Green Published, gold			2022-12-28	WOS:000672866400667
J	Jez, JM				Jez, Joseph M.			The tail of chlorophyll: Fates for phytol	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							DEGRADATION; MUTANT	Understanding the pathways involved in chlorophyll breakdown provides a molecular map to the color changes observed in plant life on a global scale each fall. Surprisingly, little is known about the fate of phytol, chlorophyll's 20-carbon branched-chain tail, during this process. A recent study from Gutbrod et al. provides evidence using physiological, genetic, and exquisitely sensitive analytical approaches that phytenal is an intermediate in plant phytol catabolism. These insights and techniques open the door to further investigation of this complicated metabolic system, with implications for plant health and agriculture.						Welti, Ruth/0000-0003-4373-2538	USDA National Institute of Food and Agriculture [1013013]	USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	Research on plant lipid metabolism in the Durrett and Welti groups is supported by the USDA National Institute of Food and Agriculture, Hatch/Multi-State project 1013013. This is contribution 21-255-J from the Kansas Agricultural Experiment Station.	Gutbrod K, 2019, PROG LIPID RES, V74, P1, DOI 10.1016/j.plipres.2019.01.002; Gutbrod P., 2021, J BIOL CHEM, V296; Hortensteiner S, 2006, ANNU REV PLANT BIOL, V57, P55, DOI 10.1146/annurev.arplant.57.032905.105212; Ishizaki K, 2005, PLANT CELL, V17, P2587, DOI 10.1105/tpc.105.035162; Lippold F, 2012, PLANT CELL, V24, P2001, DOI 10.1105/tpc.112.095588; Rontani JF, 1996, PHYTOCHEMISTRY, V42, P347, DOI 10.1016/0031-9422(95)00872-1; Shimada H, 2005, PLANT J, V41, P627, DOI 10.1111/j.1365-313X.2004.02326.x; Valentin HE, 2006, PLANT CELL, V18, P212, DOI 10.1105/tpc.105.037077; van den Brink DM, 2005, J BIOL CHEM, V280, P26838, DOI 10.1074/jbc.M501861200; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395	10	1	1	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100802	10.1016/j.jbc.2021.100802	http://dx.doi.org/10.1016/j.jbc.2021.100802			3	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34022219	gold, Green Published			2022-12-28	WOS:000674717300022
J	Komeno, M; Pang, XL; Shimizu, A; Molla, MR; Yasuda-Yamahara, M; Kume, S; Rahman, NIA; Soh, JEC; Nguyen, LKC; Amin, MKBA; Kokami, N; Sato, A; Asano, Y; Maegawa, H; Ogita, H				Komeno, Masahiro; Pang, Xiaoling; Shimizu, Akio; Molla, Md Rasel; Yasuda-Yamahara, Mako; Kume, Shinji; Rahman, Nor Idayu A.; Soh, Joanne Ern Chi; Le Kim Chi Nguyen; Amin, Mohammad Khusni B. Ahmat; Kokami, Nao; Sato, Akira; Asano, Yoshihiro; Maegawa, Hiroshi; Ogita, Hisakazu			Cardio- and reno-protective effects of dipeptidyl peptidase III in diabetic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIOVASCULAR-DISEASE; VASCULAR COMPLICATIONS; PRESSURE-OVERLOAD; GLUCOSE CONTROL; HEART-FAILURE; RISK-FACTORS; RHO-GTPASES; PREVALENCE; TYPE-1; INTERVENTIONS	Diabetes mellitus (DM) causes injury to tissues and organs, including to the heart and kidney, resulting in increased morbidity and mortality. Thus, novel potential therapeutics are continuously required to minimize DM-related organ damage. We have previously shown that dipeptidyl peptidase III (DPPIII) has beneficial roles in a hypertensive mouse model, but it is unknown whether DPPIII has any effects on DM. In this study, we found that intravenous administration of recombinant DPPIII in diabetic db/db mice for 8 weeks suppressed the DM-induced cardiac diastolic dysfunctions and renal injury without alteration of the blood glucose level. This treatment inhibited inflammatory cell infiltration and fibrosis in the heart and blocked the increase in albuminuria by attenuating the disruption of the glomerular microvasculature and inhibiting the effacement of podocyte foot processes in the kidney. The beneficial role of DPPIII was, at least in part, mediated by the cleavage of a cytotoxic peptide, named Peptide 2, which was increased in db/db mice compared with normal mice. This peptide consisted of nine amino acids, was a digested fragment of complement component 3 (C3), and had an anaphylatoxin-like effect determined by the Miles assay and chemoattractant analysis. The effect was dependent on its interaction with the C3a receptor and protein kinase C-mediated RhoA activation downstream of the receptor in endothelial cells. In conclusion, DPPIII plays a protective role in the heart and kidney in a DM animal model through cleavage of a peptide that is a part of C3.	[Komeno, Masahiro; Pang, Xiaoling; Shimizu, Akio; Molla, Md Rasel; Rahman, Nor Idayu A.; Soh, Joanne Ern Chi; Le Kim Chi Nguyen; Amin, Mohammad Khusni B. Ahmat; Kokami, Nao; Sato, Akira; Ogita, Hisakazu] Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Otsu, Shiga, Japan; [Pang, Xiaoling] China Med Univ, Affiliated Hosp 4, Dept Emergency, Shenyang, Peoples R China; [Yasuda-Yamahara, Mako; Kume, Shinji; Maegawa, Hiroshi] Shiga Univ Med Sci, Dept Med, Otsu, Shiga, Japan; [Asano, Yoshihiro] Osaka Univ, Dept Cardiovasc Med, Grad Sch Med, Suita, Osaka, Japan	Shiga University of Medical Science; China Medical University; Shiga University of Medical Science; Osaka University	Ogita, H (corresponding author), Shiga Univ Med Sci, Dept Biochem & Mol Biol, Div Mol Med Biochem, Otsu, Shiga, Japan.	hogita@belle.shiga-med.ac.jp	A. Rahman, Nor Idayu/AAJ-9415-2020; Ahmat Amin, Mohammad Khusni Bin/C-7336-2012; Pang, Xiaoling/GRY-1378-2022	A. Rahman, Nor Idayu/0000-0003-3394-5687; Ahmat Amin, Mohammad Khusni Bin/0000-0002-1948-4071; Ogita, Hisakazu/0000-0001-6750-1668	Postdoctoral Enrichment Program Award from the Burroughs Welcome Fund [BWF-1017399]; Alzheimer's Association fellowship [AARFD-16-442630]	Postdoctoral Enrichment Program Award from the Burroughs Welcome Fund; Alzheimer's Association fellowship	S. O. was supported by a Postdoctoral Enrichment Program Award from the Burroughs Welcome Fund (BWF-1017399) and an Alzheimer's Association fellowship (AARFD-16-442630).	Abdurrachim D, 2017, CARDIOVASC RES, V113, P1148, DOI 10.1093/cvr/cvx100; Abramic M, 2004, INT J BIOCHEM CELL B, V36, P434, DOI 10.1016/S1357-2725(03)00267-X; Alex L, 2018, AM J PHYSIOL-HEART C, V315, pH934, DOI 10.1152/ajpheart.00238.2018; Amin MKBA, 2018, ONCOGENE, V37, P5416, DOI 10.1038/s41388-018-0286-0; Anders HJ, 2018, NAT REV NEPHROL, V14, P361, DOI 10.1038/s41581-018-0001-y; Anzai T, 2018, CIRC J, V82, P629, DOI 10.1253/circj.CJ-18-0063; Boudina S, 2010, REV ENDOCR METAB DIS, V11, P31, DOI 10.1007/s11154-010-9131-7; Braga VMM, 2002, CURR OPIN CELL BIOL, V14, P546, DOI 10.1016/S0955-0674(02)00373-3; Bullard KM, 2018, MMWR-MORBID MORTAL W, V67, P359, DOI 10.15585/mmwr.mm6712a2; Coleman D L, 1967, Diabetologia, V3, P238, DOI 10.1007/BF01222201; Constantino MI, 2013, DIABETES CARE, V36, P3863, DOI 10.2337/dc12-2455; Cui J, 2019, AM J PHYSIOL-RENAL, V317, pF1171, DOI 10.1152/ajprenal.00165.2019; Deniau B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238039; Deniau B, 2020, EUR J HEART FAIL, V22, P290, DOI 10.1002/ejhf.1601; Depret F, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02888-5; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Ford ES, 2011, J DIABETES, V3, P337, DOI 10.1111/j.1753-0407.2011.00148.x; FUKUOKA Y, 1994, IMMUNOPHARMACOLOGY, V28, P95, DOI 10.1016/0162-3109(94)90025-6; Gamrekelashvili J, 2013, J CLIN INVEST, V123, P4755, DOI 10.1172/JCI65698; GANU VS, 1989, MOL IMMUNOL, V26, P939, DOI 10.1016/0161-5890(89)90112-0; Garcia-Fernandez N, 2020, J CLIN MED, V9, DOI 10.3390/jcm9020472; Gluhovschi C, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/4626125; Gombos T, 2012, CLIN RES CARDIOL, V101, P607, DOI 10.1007/s00392-012-0432-6; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harding JL, 2019, DIABETOLOGIA, V62, P3, DOI 10.1007/s00125-018-4711-2; Hast BE, 2013, CANCER RES, V73, P2199, DOI 10.1158/0008-5472.CAN-12-4400; Jamwal S, 2018, INFLAMM RES, V67, P391, DOI 10.1007/s00011-018-1129-8; Jia GH, 2018, DIABETOLOGIA, V61, P21, DOI 10.1007/s00125-017-4390-4; Lara-Astiaso D, 2012, SPRINGERPLUS, V1, DOI 10.1186/2193-1801-1-63; LEE CM, 1982, J BIOL CHEM, V257, P2043; Li N, 2000, J IMMUNOL, V165, P3393, DOI 10.4049/jimmunol.165.6.3393; Li XQ, 2019, BMJ OPEN DIAB RES CA, V7, DOI 10.1136/bmjdrc-2019-000817; Lin YC, 2018, J FORMOS MED ASSOC, V117, P662, DOI 10.1016/j.jfma.2018.02.007; Majima T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068134; McMahon M, 2003, J BIOL CHEM, V278, P21592, DOI 10.1074/jbc.M300931200; Mehta D, 2001, J BIOL CHEM, V276, P22614, DOI 10.1074/jbc.M101927200; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Morigi M, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.131849; Muddu M, 2016, AFR HEALTH SCI, V16, P183, DOI 10.4314/ahs.v16i1.25; MULLEREBERHARD HJ, 1988, ANNU REV BIOCHEM, V57, P321, DOI 10.1146/annurev.biochem.57.1.321; Nathan DM, 2014, DIABETES CARE, V37, P9, DOI 10.2337/dc13-2112; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Neal B, 2017, NEW ENGL J MED, V377, P644, DOI 10.1056/NEJMoa1611925; Ogurtsova K, 2017, DIABETES RES CLIN PR, V128, P40, DOI 10.1016/j.diabres.2017.03.024; Pambianco G, 2006, DIABETES, V55, P1463, DOI 10.2337/db05-1423; Pang XL, 2016, HYPERTENSION, V68, P630, DOI 10.1161/HYPERTENSIONAHA.116.07357; Parving HH, 2006, KIDNEY INT, V69, P2057, DOI 10.1038/sj.ki.5000377; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petersmann A, 2019, EXP CLIN ENDOCR DIAB, V127, pS1, DOI 10.1055/a-1018-9078; Prajapati SC, 2011, FEBS J, V278, P3256, DOI 10.1111/j.1742-4658.2011.08275.x; PREKOVIC V, 2019, N ENGL L MED, V380, P2295; Rangaswami J, 2019, CIRCULATION, V139, pE840, DOI 10.1161/CIR.0000000000000664; Rask-Madsen C, 2013, CELL METAB, V17, P20, DOI 10.1016/j.cmet.2012.11.012; Rawshani A, 2017, NEW ENGL J MED, V376, P1407, DOI 10.1056/NEJMoa1608664; Rossignol P, 2019, LANCET, V393, P1034, DOI 10.1016/S0140-6736(18)31808-7; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Sarafidis PA, 2014, KIDNEY INT, V85, P536, DOI 10.1038/ki.2013.355; Schraufstatter IU, 2002, J IMMUNOL, V169, P2102, DOI 10.4049/jimmunol.169.4.2102; Skyler JS, 2017, DIABETES, V66, P241, DOI 10.2337/db16-0806; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Takakuwa Y, 2011, ARTHRITIS RHEUM-US, V63, P3613, DOI 10.1002/art.30560; Thomas MC, 2015, NAT REV DIS PRIMERS, V1, DOI 10.1038/nrdp.2015.18; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Tuttle K R, 2014, Am J Kidney Dis, V37, P2864; Villanueva J, 2006, MOL CELL PROTEOMICS, V5, P1840, DOI 10.1074/mcp.M600229-MCP200; Wang L, 2019, MOL MED REP, V19, P4553, DOI 10.3892/mmr.2019.10167; Wilkinson MJ, 2019, AM J CARDIOL, V124, pS3, DOI 10.1016/j.amjcard.2019.10.024; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yadava S K, 2017, Kathmandu Univ Med J (KUMJ), V15, P212; Yuan SY, 2007, MICROCIRCULATION, V14, P363, DOI 10.1080/10739680701283091; Zankov DP, 2017, SCI REP-UK, V7, DOI 10.1038/srep39335; Zipfel PF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02166	72	5	6	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100761	10.1016/j.jbc.2021.100761	http://dx.doi.org/10.1016/j.jbc.2021.100761			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33971198	Green Published, gold			2022-12-28	WOS:000672866400729
J	Matsubara, T; Addison, WN; Kokabu, S; Neff, L; Horne, W; Gori, F; Baron, R				Matsubara, Takuma; Addison, William N.; Kokabu, Shoichiro; Neff, Lynn; Horne, William; Gori, Francesca; Baron, Roland			Characterization of unique functionalities in c-Src domains required for osteoclast podosome belt formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-ACTIVITY; FAMILY KINASES; TYROSINE KINASES; LIPID RAFTS; SH3 DOMAINS; CBL; DIFFERENTIATION; BINDING; BONE; GENE	Deletion of c-Src, a ubiquitously expressed tyrosine kinase, results in osteoclast dysfunction and osteopetrosis, in which bones harden into "stone." In contrast, deletion of the genes encoding other members of the Src family kinase (SFK) fails to produce an osteopetrotic phenotype. This suggests that c-Src performs a unique function in the osteoclast that cannot be compensated for by other SFKs. We aimed to identify the molecular basis of this unique role in osteoclasts and bone resorption. We found that c-Src, Lyn, and Fyn were the most highly expressed SFKs in WT osteoclasts, whereas Hck, Lck, Blk, and Fgr displayed low levels of expression. Formation of the podosome belt, clusters of unique actin assemblies, was disrupted in src(-/-) osteoclasts; introduction of constitutively activated SFKs revealed that only c-Src and Fyn could restore this process. To identify the key structural domains responsible, we constructed chimeric Src-Hck and Src-Lyn constructs in which the unique, SH3, SH2, or catalytic domains had been swapped. We found that the Src unique, SH3, and kinase domains were each crucial to establish Src functionality. The SH2 domain could however be substituted with Lyn or Hck SH2 domains. Furthermore, we demonstrate that c-Src's functionality is, in part, derived from an SH3-proximal proline-rich domain interaction with c-Cbl, leading to phosphorylation of c-Cbl Tyr700. These data help clarify Src's unique functionality in the organization of the cytoskeleton in osteoclasts, required for efficient bone resorption and explain why c-Src cannot be replaced, in osteoclasts, by other SFKs.	[Matsubara, Takuma; Addison, William N.; Neff, Lynn; Horne, William; Gori, Francesca; Baron, Roland] Harvard Sch Dent Med, Div Bone & Mineral Res, Oral Med Infect & Immun, Boston, MA 02115 USA; [Matsubara, Takuma; Addison, William N.; Kokabu, Shoichiro] Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Fukuoka, Japan; [Baron, Roland] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Baron, Roland] MGH, Endocrine Unit, Boston, MA 02114 USA	Harvard University; Harvard School of Dental Medicine; Kyushu Dental University; Harvard University; Harvard Medical School	Matsubara, T; Baron, R (corresponding author), Harvard Sch Dent Med, Div Bone & Mineral Res, Oral Med Infect & Immun, Boston, MA 02115 USA.; Matsubara, T (corresponding author), Kyushu Dent Univ, Dept Hlth Improvement, Div Mol Signaling & Biochem, Fukuoka, Japan.; Baron, R (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.; Baron, R (corresponding author), MGH, Endocrine Unit, Boston, MA 02114 USA.	r15matsubara@fa.kyu-dent.ac.jp; Roland_Baron@hsdm.harvard.edu		Kokabu, Shoichiro/0000-0002-6663-4327	Japan Society for the Promotion of Science [18K09509, 18K09524, 22-43]; NIH [R01AR042927, R01-AR062054]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported by the Japan Society for the Promotion of Science (Postdoctoral fellowship for research abroad 22-43 and 18K09509 for T. M. and 18K09524 for S. K.) and Grants from the NIH to R. B. (R01AR042927 and R01-AR062054). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bao J, 2003, P NATL ACAD SCI USA, V100, P2438, DOI 10.1073/pnas.0437945100; BOLEN JB, 1992, FASEB J, V6, P3403, DOI 10.1096/fasebj.6.15.1281458; BOYCE BF, 1992, J CLIN INVEST, V90, P1622, DOI 10.1172/JCI116032; Brdickova N, 2003, J EXP MED, V198, P1453, DOI 10.1084/jem.20031484; Bruzzaniti A, 2005, MOL BIOL CELL, V16, P3301, DOI 10.1091/mbc.e04-12-1117; Bruzzaniti A, 2006, REV ENDOCR METAB DIS, V7, P123, DOI 10.1007/s11154-006-9009-x; Cai HJ, 2011, P NATL ACAD SCI USA, V108, P6579, DOI 10.1073/pnas.1103904108; Chiusaroli R, 2003, DEV BIOL, V261, P537, DOI 10.1016/S0012-1606(03)00299-9; Destaing O, 2008, MOL BIOL CELL, V19, P394, DOI 10.1091/mbc.E07-03-0227; Feshchenko EA, 1998, J BIOL CHEM, V273, P8323, DOI 10.1074/jbc.273.14.8323; Haglund K, 2004, J CELL SCI, V117, P2557, DOI 10.1242/jcs.01148; Horne WC, 2005, IMMUNOL REV, V208, P106, DOI 10.1111/j.0105-2896.2005.00335.x; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kelley LC, 2010, J CELL SCI, V123, P3923, DOI 10.1242/jcs.075200; Kim HJ, 2009, P NATL ACAD SCI USA, V106, P2325, DOI 10.1073/pnas.0806963106; KOCH CA, 1991, SCIENCE, V252, P668, DOI 10.1126/science.1708916; Kojima H, 2005, J BIOL CHEM, V280, P2944, DOI 10.1074/jbc.M311598200; LEVINSON AD, 1980, J BIOL CHEM, V255, P1973; LOWE C, 1993, P NATL ACAD SCI USA, V90, P4485, DOI 10.1073/pnas.90.10.4485; LOWELL CA, 1994, GENE DEV, V8, P387, DOI 10.1101/gad.8.4.387; Lowell CA, 1996, GENE DEV, V10, P1845, DOI 10.1101/gad.10.15.1845; Lowell CA, 1996, BLOOD, V87, P1780; Matsubara T, 2010, J BONE MINER RES, V25, P1068, DOI 10.1359/jbmr.091039; Miyazaki T, 2004, J BIOL CHEM, V279, P17660, DOI 10.1074/jbc.M311032200; Miyazaki Tsuyoshi, 2006, Mod Rheumatol, V16, P68; Nakamura I, 2007, J BONE MINER METAB, V25, P337, DOI 10.1007/s00774-007-0773-9; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; PAWSON T, 1992, CELL, V71, P359, DOI 10.1016/0092-8674(92)90504-6; Purev E, 2009, MOL BIOL CELL, V20, P4021, DOI 10.1091/mbc.E09-03-0248; REN RB, 1993, SCIENCE, V259, P1157, DOI 10.1126/science.8438166; RESH MD, 1994, CELL, V76, P411, DOI 10.1016/0092-8674(94)90104-X; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; Sanjay A, 2006, FEBS J, V273, P5442, DOI 10.1111/j.1742-4658.2006.05535.x; Scaife RM, 2000, J CELL SCI, V113, P215; Sirvent A, 2008, ONCOGENE, V27, P3494, DOI 10.1038/sj.onc.1211011; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; Szymkiewicz I, 2004, FEBS LETT, V565, P33, DOI 10.1016/j.febslet.2004.03.100; Teitelbaum SL, 2011, ANN NY ACAD SCI, V1240, P14, DOI 10.1111/j.1749-6632.2011.06283.x; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Yokouchi M, 2001, J BIOL CHEM, V276, P35185, DOI 10.1074/jbc.M102219200; Yoon SH, 2009, FEBS LETT, V583, P1164, DOI 10.1016/j.febslet.2009.03.005; YU HT, 1994, CELL, V76, P933, DOI 10.1016/0092-8674(94)90367-0; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	46	4	4	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100790	10.1016/j.jbc.2021.100790	http://dx.doi.org/10.1016/j.jbc.2021.100790			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019873	Green Published, gold			2022-12-28	WOS:000674717300011
J	Sosa, CJM; Issoglio, FM; Carrizo, ME				Munoz Sosa, Christian J.; Issoglio, Federico M.; Carrizo, Maria E.			Crystal structure and mutational analysis of the human TRIM7 B30.2 domain provide insights into the molecular basis of its binding to glycogenin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E3 UBIQUITIN LIGASE; FAMILY PROTEINS; SPRY DOMAIN; RECOGNITION; PHOSPHOANTIGENS; RESTRICTION; DYNAMICS; ROLES	Tripartite motif (TRIM)7 is an E3 ubiquitin ligase that was first identified through its interaction with glycogenin-1 (GN1), the autoglucosyltransferase that initiates glycogen biosynthesis. A growing body of evidence indicates that TRIM7 plays an important role in cancer development, viral pathogenesis, and atherosclerosis and, thus, represents a potential therapeutic target. TRIM family proteins share a multidomain architecture with a conserved N-terminal TRIM and a variable C-terminal domain. Human TRIM7 contains the canonical TRIM motif and a B30.2 domain at the C terminus. To contribute to the understanding of the mechanism of action of TRIM7, we solved the X-ray crystal structure of its B30.2 domain (TRIM7(B30.2)) in two crystal forms at resolutions of 1.6 A and 1.8 A. TRIM7(B30.2) exhibits the typical B30.2 domain fold, consisting of two antiparallel beta-sheets of seven and six strands, arranged as a distorted beta-sandwich. Furthermore, two long loops partially cover the concave face of the beta-sandwich defined by the beta-sheet of six strands, thus forming a positively charged cavity. We used sequence conservation and mutational analyses to provide evidence of a putative binding interface for GN1. These studies showed that Leu423, Ser499, and Cys501 of TRIM7(B30.2) and the C-terminal 33 amino acids of GN1 are critical for this binding interaction. Molecular dynamics simulations also revealed that hydrogen bond and hydrophobic interactions play a major role in the stability of a modeled TRIM7(B30.2)-GN1 C-terminal peptide complex. These data provide useful information that could be used to target this interaction for the development of potential therapeutic agents.	[Munoz Sosa, Christian J.; Carrizo, Maria E.] Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Cordoba, Argentina; [Munoz Sosa, Christian J.; Carrizo, Maria E.] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina; [Issoglio, Federico M.] Univ Nova Lisboa ITQB NOVA, Inst Tecnol Quim & Biol Antonio Xavier, Oeiras, Portugal; [Issoglio, Federico M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat IQUIBICEN, Inst Quim Biol, CONICET, Buenos Aires, DF, Argentina; [Issoglio, Federico M.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires; University of Buenos Aires	Carrizo, ME (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Cordoba, Argentina.; Carrizo, ME (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol Ranwel Caputto, Cordoba, Argentina.	mariae.carrizo@unc.edu.ar		Issoglio, Federico/0000-0001-9225-7855; Carrizo, Maria Elena/0000-0003-0501-8894	National Institutes of Health [NS102722, DE026806, DE029951, DK118971]; Department of Defence [W81XWH1810431]; National Health and Medical Research Council [63303, 1049682, 1031886, 1083054]; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology [CE14100036]; Medical Research Council [MR/N020081/1]; NHMRC [1061687]; Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defence; National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ARC Centre of Excellence in Convergent Bio-Nano Science and Technology(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK)	This work was supported by grants from the National Institutes of Health (NS102722, DE026806, DE029951, DK118971 to N. W. B), Department of Defence (W81XWH1810431 to N. W. B.), National Health and Medical Research Council (63303 to N. W. B., 1049682 to N. W. B. and B. G., 1031886 to N. W. B. and D. P. P, 1083054 to N. W. B., M. L. H., M. C., C. J. P., and T. P. D.), ARC Centre of Excellence in Convergent Bio-Nano Science and Technology (CE14100036 to N. W. B., T. P. D., C. J. P., N. A. V.), and Medical Research Council (MR/N020081/1 to S. J. B., S. J. H.). M. L. H. was an NHMRC RD Wright Fellow (1061687). Q. N. M. was part of the Joint Award Doctoral Training Centre in Molecular Pharmacology and Drug Discovery at Monash University (Australia) and the University of Nottingham (UK).	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Biris N, 2012, P NATL ACAD SCI USA, V109, P13278, DOI 10.1073/pnas.1203536109; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Filippakopoulos P, 2010, J MOL BIOL, V401, P389, DOI 10.1016/j.jmb.2010.06.017; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Hedberg-Oldfors C, 2018, ACTA NEUROL SCAND, V137, P308, DOI 10.1111/ane.12865; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lerner MG, 2006, APBS PLUGIN PYMOL; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Luo SS, 2015, NEUROMUSCULAR DISORD, V25, P780, DOI 10.1016/j.nmd.2015.07.007; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Malfatti E, 2014, ANN NEUROL, V76, P891, DOI 10.1002/ana.24284; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Moslemi AR, 2010, NEW ENGL J MED, V362, P1203, DOI 10.1056/NEJMoa0900661; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Roe DR, 2013, J CHEM THEORY COMPUT, V9, P3084, DOI 10.1021/ct400341p; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2006, ARCH BIOCHEM BIOPHYS, V456, P93, DOI 10.1016/j.abb.2006.09.024; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; SMYTHE C, 1990, EUR J BIOCHEM, V189, P199, DOI 10.1111/j.1432-1033.1990.tb15477.x; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woo JS, 2006, MOL CELL, V24, P967, DOI 10.1016/j.molcel.2006.11.009; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhang P, 2015, GENE DEV, V29, P123, DOI 10.1101/gad.254870.114; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	69	5	5	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100772	10.1016/j.jbc.2021.100772	http://dx.doi.org/10.1016/j.jbc.2021.100772			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33989636	gold, Green Published			2022-12-28	WOS:000672866400739
J	Wang, ML; Liu, J; Tu, YZ; Zhao, ZH; Qu, JJ; Chen, K; Chen, YL; Sun, Y; Zhao, H; Deng, Y; Wu, CY				Wang, Meiling; Liu, Jie; Tu, Yizeng; Zhao, Zihan; Qu, Jingjing; Chen, Ka; Chen, Yonglong; Sun, Ying; Zhao, Hui; Deng, Yi; Wu, Chuanyue			RSU-1 interaction with prohibitin-2 links cell-extracellular matrix detachment to downregulation of ERK signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAS SUPPRESSOR RSU-1; ONLY PROTEIN PINCH; LIPID RAFTS; INTEGRIN ADHESOME; ADAPTER PROTEIN; KINASE; GROWTH; ACTIVATION; ADHESION; TRANSDUCTION	Cell-extracellular matrix (ECM) detachment is known to decrease extracellular signal-regulated kinase (ERK) signaling, an intracellular pathway that is central for control of cell behavior. How cell-ECM detachment is linked to down-regulation of ERK signaling, however, is incompletely understood. We show here that focal adhesion protein Ras Suppressor 1 (RSU1) plays a critical role in cell-ECM detachment induced suppression of ERK signaling. We have identified prohibitin 2 (PHB2), a component of membrane lipid rafts, as a novel binding protein of RSU1, and mapped a major RSU1-binding site to PHB2 amino acids 150 to 206 in the C-terminal region of the PHB/SPFH (stomatin/prohibitin/flotillin/HflKC) domain. The PHB2 binding is mediated by multiple sites located in the N-terminal leucine-rich repeat region of RSU1. Depletion of PHB2 suppressed cell-ECM adhesion-induced ERK activation. Furthermore, cell-ECM detachment increased RSU1 association with membrane lipid rafts and interaction with PHB2. Finally, knockout of RSU1 or inhibition of RSU1 interaction with PHB2 by overexpression of the major RSU1-binding PHB2 fragment (amino acids 150-206) effectively suppressed the cell-ECM detachment induced downregulation of ERK signaling. Additionally, expression of venus-tagged wild-type RSU1 restored ERK signaling, while expression of venus-tagged PHB2-binding defective RSU1 mutant in which the N-terminal leucine-rich repeat region is deleted did not. Taken together, Our findings identify a novel RSU1-PHB2 signaling axis that senses cell-ECM detachment and links it to decreased ERK signaling.	[Wang, Meiling] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China; [Wang, Meiling; Liu, Jie; Zhao, Zihan; Qu, Jingjing; Chen, Yonglong; Sun, Ying; Deng, Yi] Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Peoples R China; [Wang, Meiling; Liu, Jie; Zhao, Zihan; Qu, Jingjing; Chen, Yonglong; Sun, Ying; Deng, Yi] Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China; [Tu, Yizeng; Chen, Ka; Wu, Chuanyue] Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15213 USA; [Zhao, Zihan] Univ Macau, Fac Hlth Sci, Macau, Peoples R China; [Zhao, Hui] Chinese Univ Hong Kong, Sch Biomed Sci, Fac Med, Hong Kong, Peoples R China	Harbin Institute of Technology; Southern University of Science & Technology; Southern University of Science & Technology; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Macau; Chinese University of Hong Kong	Deng, Y (corresponding author), Southern Univ Sci & Technol, Dept Biol, Guangdong Prov Key Lab Cell Microenvironm & Dis R, Shenzhen, Peoples R China.; Deng, Y (corresponding author), Southern Univ Sci & Technol, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China.; Wu, CY (corresponding author), Univ Pittsburgh, Dept Pathol, Sch Med, Pittsburgh, PA 15213 USA.	dengy@sustech.edu.cn; carywu@pitt.edu	; Zhao, Hui/B-8429-2016	, Yonglong/0000-0002-4933-113X; Zhao, Hui/0000-0001-8160-6415	Guangdong Natural Science of Foundation [2017A030313209, 2020A1515011305]; Chinese Ministry of Science and Technology [2016YFC1302100]; Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research [2017B030301018]; Shenzhen Key Laboratory of Cell Microenvironment [ZDSYS20140509142721429]; Shenzhen Innovation Committee of Science and Technology [JCYJ20170412152835439]; Shenzhen Health Family Planning System Research Project [SZBC2018012]; Research Grants Council, University Grants Committee [14167017, 14112618]; National Key R&D Program of China, Synthetic Biology Research [2019YFA0904500]	Guangdong Natural Science of Foundation; Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research; Shenzhen Key Laboratory of Cell Microenvironment; Shenzhen Innovation Committee of Science and Technology; Shenzhen Health Family Planning System Research Project; Research Grants Council, University Grants Committee; National Key R&D Program of China, Synthetic Biology Research	This work was supported by grants from Guangdong Natural Science of Foundation (2017A030313209, 2020A1515011305), the Chinese Ministry of Science and Technology (2016YFC1302100), Guangdong Provincial Key Laboratory of Cell Microenvironment and Disease Research (2017B030301018), Shenzhen Key Laboratory of Cell Microenvironment (ZDSYS20140509142721429), Shenzhen Innovation Committee of Science and Technology grants (JCYJ20170412152835439), and Shenzhen Health Family Planning System Research Project (SZBC2018012). H. Z. is supported by grants from the Research Grants Council, University Grants Committee (14167017, and 14112618) and National Key R&D Program of China, Synthetic Biology Research (2019YFA0904500).	Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Cabodi S, 2010, NAT REV CANCER, V10, P858, DOI 10.1038/nrc2967; Chen K, 2008, J BIOL CHEM, V283, P2508, DOI 10.1074/jbc.M707307200; Chiu CF, 2013, ONCOGENE, V32, P777, DOI 10.1038/onc.2012.86; Chunduru S, 2002, J NEURO-ONCOL, V60, P201, DOI 10.1023/A:1021130620178; CUTLER ML, 1992, MOL CELL BIOL, V12, P3750, DOI 10.1128/MCB.12.9.3750; del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293; Del Pozo MA, 2004, CELL CYCLE, V3, P725; del Pozo MA, 2004, SCIENCE, V303, P839, DOI 10.1126/science.1092571; Del Pozo MA, 2007, TRENDS CELL BIOL, V17, P246, DOI 10.1016/j.tcb.2007.03.001; Donthamsetty S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074625; Dougherty GW, 2008, EUR J CELL BIOL, V87, P721, DOI 10.1016/j.ejcb.2008.02.011; Dougherty GW, 2005, EXP CELL RES, V306, P168, DOI 10.1016/j.yexcr.2005.01.025; Eblen ST, 2002, MOL CELL BIOL, V22, P6023, DOI 10.1128/MCB.22.17.6023-6033.2002; Edin ML, 2005, MOL CELL BIOL, V25, P4466, DOI 10.1128/MCB.25.11.4466-4475.2005; Eke I, 2010, J CLIN INVEST, V120, P2516, DOI 10.1172/JCI41078; Fernandez-Medarde Alberto, 2011, Genes Cancer, V2, P344, DOI 10.1177/1947601911411084; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Galbiati F, 2001, CELL, V106, P403, DOI 10.1016/S0092-8674(01)00472-X; Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034; Geiger B, 2001, NAT REV MOL CELL BIO, V2, P793, DOI 10.1038/35099066; Gkretsi V, 2017, ONCOTARGET, V8, P27364, DOI 10.18632/oncotarget.16062; Gonzalez-Nieves R, 2013, J CELL COMMUN SIGNAL, V7, P279, DOI 10.1007/s12079-013-0207-5; Guan JL, 2004, SCIENCE, V303, P773, DOI 10.1126/science.1094376; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Horbinski C, 2010, AM J PATHOL, V177, P1044, DOI 10.2353/ajpath.2010.091270; Horton ER, 2015, NAT CELL BIOL, V17, P1577, DOI 10.1038/ncb3257; Howe AK, 2000, NAT CELL BIOL, V2, P593, DOI 10.1038/35023536; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kadrmas JL, 2004, J CELL BIOL, V167, P1019, DOI 10.1083/jcb.200408090; Kim YC, 2015, CELL ADHES MIGR, V9, P227, DOI 10.4161/19336918.2014.972775; Lee JW, 2004, MOL CELLS, V17, P188; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Li HD, 2017, P NATL ACAD SCI USA, V114, P9349, DOI 10.1073/pnas.1703064114; Lin TH, 1997, J BIOL CHEM, V272, P8849; Lingwood D, 2009, BIOCHEM SOC T, V37, P955, DOI 10.1042/BST0370955; Masuelli L, 1996, MOL CELL BIOL, V16, P5466; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Merkwirth C, 2009, BBA-MOL CELL RES, V1793, P27, DOI 10.1016/j.bbamcr.2008.05.013; Miranti CK, 2002, NAT CELL BIOL, V4, pE83, DOI 10.1038/ncb0402-e83; Nalesnik MA, 2012, AM J PATHOL, V180, P1495, DOI 10.1016/j.ajpath.2011.12.021; Paoli P, 2013, BBA-MOL CELL RES, V1833, P3481, DOI 10.1016/j.bbamcr.2013.06.026; Polier G, 2012, CHEM BIOL, V19, P1093, DOI 10.1016/j.chembiol.2012.07.012; Rajalingam K, 2005, NAT CELL BIOL, V7, P837, DOI 10.1038/ncb1283; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Rajalingam K, 2012, CHEM BIOL, V19, P1077, DOI 10.1016/j.chembiol.2012.09.004; Renshaw MW, 1997, EMBO J, V16, P5592, DOI 10.1093/emboj/16.18.5592; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Schwartz MA, 1995, ANNU REV CELL DEV BI, V11, P549, DOI 10.1146/annurev.cellbio.11.1.549; Schwartz MA, 2001, J CELL SCI, V114, P2553; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Slack-Davis JK, 2003, J CELL BIOL, V162, P281, DOI 10.1083/jcb.200212141; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Tatsuta T, 2017, CURR BIOL, V27, pR629, DOI 10.1016/j.cub.2017.04.030; Theisen U, 2012, DEV CELL, V23, P1153, DOI 10.1016/j.devcel.2012.11.005; TSUDA T, 1993, GENOMICS, V18, P461, DOI 10.1006/geno.1993.1503; Tu YZ, 2001, J CELL BIOL, V153, P585, DOI 10.1083/jcb.153.3.585; Tu YZ, 1998, MOL BIOL CELL, V9, P3367, DOI 10.1091/mbc.9.12.3367; Tu YZ, 1999, MOL CELL BIOL, V19, P2425; Vasaturo F, 2000, BREAST CANCER RES TR, V61, P69, DOI 10.1023/A:1006462323260; Winograd-Katz SE, 2014, NAT REV MOL CELL BIO, V15, P273, DOI 10.1038/nrm3769; Wu CY, 2004, BBA-MOL CELL RES, V1692, P55, DOI 10.1016/j.bbamcr.2004.01.006	66	2	2	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100109	10.1074/jbc.RA120.014413RSU-1	http://dx.doi.org/10.1074/jbc.RA120.014413RSU-1			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33853759				2022-12-28	WOS:000672866400089
J	Cao, C; Han, PY; Liu, L; Tang, YM; Tian, SS; Zhang, K; Shi, L; Liu, ZQ; Zhuo, DX; Ge, WS; Gong, WC				Cao, Cheng; Han, Peiyi; Liu, Ling; Tang, Yiman; Tian, Shanshan; Zhang, Kai; Shi, Lei; Liu, Zhiqiang; Zhuo, Dexiang; Ge, Wenshu; Gong, Wenchen			Epithelial cell transforming factor ECT2 is an important regulator of DNA double-strand break repair and genome stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBOSOMAL-RNA SYNTHESIS; BRCT DOMAINS; DAMAGE RESPONSE; HISTONE H2AX; BINDING; PROTEIN; COMPLEX; MDC1; ATR; CYTOKINESIS	Proteins containing breast cancer type 1 (BRCA1) C-terminal domains play crucial roles in response to and repair of DNA damage. Epithelial cell transforming factor (epithelial cell transforming sequence 2 [ECT2]) is a member of the BRCA1 C-terminal protein family, but it is not known if ECT2 directly contributes to DNA repair. In this study, we report that ECT2 is recruited to DNA lesions in a poly (ADP-ribose) polymerase 1- dependent manner. Using co-immunoprecipitation analysis, we showed that ECT2 physically associates with KU70-KU80 and BRCA1, proteins involved in nonhomologous end joining and homologous recombination, respectively. ECT2 deficiency impairs the recruitment of KU70 and BRCA1 to DNA damage sites, resulting in defective DNA double-strand break repair, an accumulation of damaged DNA, and hypersensitivity of cells to genotoxic insults. Interestingly, we demonstrated that ECT2 promotes DNA repair and genome integrity largely independently of its canonical guanine nucleotide exchange activity. Together, these results suggest that ECT2 is directly involved in DNA double-strand break repair and is an important genome caretaker.	[Cao, Cheng; Han, Peiyi; Liu, Ling; Tian, Shanshan; Zhang, Kai; Shi, Lei; Liu, Zhiqiang; Gong, Wenchen] Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Prov & Minist Cosponsored Collaborat Innovat Ctr, Sch Basic Med Sci,Minist Educ,Key Lab Immune Micr, Tianjin, Peoples R China; [Tang, Yiman; Ge, Wenshu] Peking Univ, Dept Gen Dent 2, Sch & Hosp Stomatol, Beijing, Peoples R China; [Zhuo, Dexiang] Fujian Med Univ, Dept Lab Med, Cent Lab, Sanming Hosp 1, Sanming, Peoples R China	Tianjin Medical University; Peking University; Fujian Medical University	Gong, WC (corresponding author), Tianjin Med Univ, Tianjin Med Univ Canc Inst & Hosp, Prov & Minist Cosponsored Collaborat Innovat Ctr, Sch Basic Med Sci,Minist Educ,Key Lab Immune Micr, Tianjin, Peoples R China.; Ge, WS (corresponding author), Peking Univ, Dept Gen Dent 2, Sch & Hosp Stomatol, Beijing, Peoples R China.; Zhuo, DX (corresponding author), Fujian Med Univ, Dept Lab Med, Cent Lab, Sanming Hosp 1, Sanming, Peoples R China.	wubishou@fjmu.edu.cn; esther1234@hsc.pku.edu.cn; gongwenchen@tmu.edu.cn	Liu, Zhiqiang/E-6950-2014	Liu, Zhiqiang/0000-0002-0677-8097; Han, Peiyi/0000-0001-9057-6676; Gong, Wenchen/0000-0002-7637-3538	National Natural Science Foundation of China [82071089, 81272827]; Tianjin Municipal Education Com-mission Scientific Research Project [2019KJ182]; Tianjin Fund for Distinguished Young Scientists [17JCJQJC46100, 18JCZDJC97400]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Education Com-mission Scientific Research Project; Tianjin Fund for Distinguished Young Scientists	This work was supported by grants (82071089 to Wenshu Ge and 81272827 to D. Z.) from the National Natural Science Foundation of China, a grant (2019KJ182 to Wenchen Gong) from the Tianjin Municipal Education Com-mission Scientific Research Project, and grants (17JCJQJC46100 and 18JCZDJC97400 to L. S.) from the Tianjin Fund for Distinguished Young Scientists.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Blackford AN, 2017, MOL CELL, V66, P801, DOI 10.1016/j.molcel.2017.05.015; Cantor S, 2004, P NATL ACAD SCI USA, V101, P2357, DOI 10.1073/pnas.0308717101; Cantor SB, 2001, CELL, V105, P149, DOI 10.1016/S0092-8674(01)00304-X; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chapman JR, 2012, MOL CELL, V47, P497, DOI 10.1016/j.molcel.2012.07.029; Chen LC, 2008, J BIOL CHEM, V283, P7713, DOI 10.1074/jbc.M710245200; Chen MR, 2020, P NATL ACAD SCI USA, V117, P1027, DOI 10.1073/pnas.1913054117; Clouaire T, 2015, NUCLEUS-PHILA, V6, P107, DOI 10.1080/19491034.2015.1010946; Clouaire T, 2018, MOL CELL, V72, P250, DOI 10.1016/j.molcel.2018.08.020; Cook DR, 2014, ONCOGENE, V33, P4021, DOI 10.1038/onc.2013.362; Daulat AM, 2019, BRIT J CANCER, V120, P931, DOI 10.1038/s41416-019-0448-z; Day M, 2018, ELIFE, V7, DOI 10.7554/eLife.39979; Fernandez-Capetillo O, 2002, NAT CELL BIOL, V4, P993, DOI 10.1038/ncb884; Fields AP, 2010, ADV ENZYME REGUL, V50, P190, DOI 10.1016/j.advenzreg.2009.10.010; Gerloff DL, 2012, FEBS LETT, V586, P2711, DOI 10.1016/j.febslet.2012.05.005; He D, 2016, SCI REP-UK, V6, DOI 10.1038/srep24504; Hodge RG, 2016, NAT REV MOL CELL BIO, V17, P496, DOI 10.1038/nrm.2016.67; Huff Lauren P, 2013, Genes Cancer, V4, P460, DOI 10.1177/1947601913514851; Iacovoni JS, 2010, EMBO J, V29, P1446, DOI 10.1038/emboj.2010.38; Jacquet K, 2016, MOL CELL, V62, P409, DOI 10.1016/j.molcel.2016.03.031; Justilien V, 2009, ONCOGENE, V28, P3597, DOI 10.1038/onc.2009.217; Justilien V, 2020, J BIOL CHEM, V295, P8214, DOI 10.1074/jbc.RA120.013175; Justilien V, 2017, CANCER CELL, V31, P256, DOI 10.1016/j.ccell.2016.12.010; Justilien V, 2011, J BIOL CHEM, V286, P8149, DOI 10.1074/jbc.M110.196113; Kim JE, 2005, J BIOL CHEM, V280, P5733, DOI 10.1074/jbc.M409298200; Kimura K, 2000, J BIOL CHEM, V275, P17233, DOI 10.1074/jbc.C000212200; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lagana A, 2010, NAT CELL BIOL, V12, P1186, DOI 10.1038/ncb2129; Li M, 2014, CELL CYCLE, V13, P2944, DOI 10.4161/15384101.2014.947197; Li M, 2013, GENE DEV, V27, P1752, DOI 10.1101/gad.226357.113; Li M, 2013, CANCER CELL, V23, P693, DOI 10.1016/j.ccr.2013.03.025; Li ZM, 2018, CELL RES, V28, P756, DOI 10.1038/s41422-018-0048-0; Luijsterburg MS, 2016, MOL CELL, V61, P547, DOI 10.1016/j.molcel.2016.01.019; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Myler LR, 2017, MOL CELL, V67, P891, DOI 10.1016/j.molcel.2017.08.002; O'Connor MJ, 2015, MOL CELL, V60, P547, DOI 10.1016/j.molcel.2015.10.040; Peterson CL, 2004, GENE DEV, V18, P602, DOI 10.1101/gad.1182704; Saito S, 2004, J BIOL CHEM, V279, P7169, DOI 10.1074/jbc.M306725200; Savic V, 2009, MOL CELL, V34, P298, DOI 10.1016/j.molcel.2009.04.012; Schwertman P, 2016, NAT REV MOL CELL BIO, V17, P379, DOI 10.1038/nrm.2016.58; Scully R, 2019, NAT REV MOL CELL BIO, V20, P698, DOI 10.1038/s41580-019-0152-0; Seeber A, 2017, CURR OPIN GENET DEV, V43, P9, DOI 10.1016/j.gde.2016.10.005; Sheng ZZ, 2011, EVOL BIOINFORM, V7, P87, DOI 10.4137/EBO.S7084; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tanaka I, 2020, NUCLEIC ACIDS RES, V48, P2676, DOI 10.1093/nar/gkz1213; Vigil D, 2010, NAT REV CANCER, V10, P842, DOI 10.1038/nrc2960; Wang HK, 2018, J CLIN PATHOL, V71, P442, DOI 10.1136/jclinpath-2017-204569; Wang HK, 2020, ONCOTARGETS THER, V13, P12905, DOI 10.2147/OTT.S275725; Wang Q, 2016, J CLIN INVEST, V126, P2205, DOI 10.1172/JCI85747; Xiu YY, 2019, MOL CLIN ONCOL, V10, P497, DOI 10.3892/mco.2019.1832; Zhang Q, 2020, THERANOSTICS, V10, P10769, DOI 10.7150/thno.46878	57	1	1	0	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101036	10.1016/j.jbc.2021.101036	http://dx.doi.org/10.1016/j.jbc.2021.101036			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WC6MA	34343566	Green Published, gold			2022-12-28	WOS:000704369100014
J	Warwick, CA; Keyes, AL; Woodruff, TM; Usachev, YM				Warwick, Charles A.; Keyes, Alex L.; Woodruff, Trent M.; Usachev, Yuriy M.			The complement cascade in the regulation of neuroinflammation, nociceptive sensitization, and pain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							NERVE GROWTH-FACTOR; MEMBRANE ATTACK COMPLEX; C5A RECEPTOR ANTAGONISTS; DORSAL-ROOT GANGLIA; SPINAL-CORD; NEUROPATHIC PAIN; COMPONENT C5A; MOUSE MODEL; INFLAMMATORY RESPONSE; SYNAPTIC PLASTICITY	The complement cascade is a key component of the innate immune system that is rapidly recruited through a cascade of enzymatic reactions to enable the recognition and clearance of pathogens and promote tissue repair. Despite its well-understood role in immunology, recent studies have high-lighted new and unexpected roles of the complement cascade in neuroimmune interaction and in the regulation of neuronal processes during development, aging, and in disease states. Complement signaling is particularly important in directing neuronal responses to tissue injury, neurotrauma, and nerve lesions. Under physiological conditions, complement-dependent changes in neuronal excitability, synaptic strength, and neurite remodeling promote nerve regeneration, tissue repair, and healing. However, in a variety of pathologies, dys-regulation of the complement cascade leads to chronic inflammation, persistent pain, and neural dysfunction. This review describes recent advances in our understanding of the multifaceted cross-communication that takes place between the complement system and neurons. In particular, we focus on the molecular and cellular mechanisms through which com-plement signaling regulates neuronal excitability and synaptic plasticity in the nociceptive pathways involved in pain pro-cessing in both health and disease. Finally, we discuss the future of this rapidly growing field and what we believe to be the significant knowledge gaps that need to be addressed.	[Warwick, Charles A.] Univ Pittsburgh, Dept Neurobiol, Pittsburgh Ctr Pain Res, Pittsburgh, PA 15260 USA; [Keyes, Alex L.; Usachev, Yuriy M.] Univ Iowa, Iowa Neurosci Inst, Dept Neurosci & Pharmacol, Iowa City, IA 52242 USA; [Woodruff, Trent M.] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Woodruff, Trent M.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Iowa; University of Queensland; University of Queensland	Warwick, CA (corresponding author), Univ Pittsburgh, Dept Neurobiol, Pittsburgh Ctr Pain Res, Pittsburgh, PA 15260 USA.; Usachev, YM (corresponding author), Univ Iowa, Iowa Neurosci Inst, Dept Neurosci & Pharmacol, Iowa City, IA 52242 USA.	warwickc@pitt.edu; yuriy-usachev@uiowa.edu	Warwick, Charles/GZL-8617-2022; Woodruff, Trent M/B-4861-2009	Warwick, Charles/0000-0001-6244-9821; Woodruff, Trent M/0000-0003-1382-911X; Usachev, Yuriy/0000-0002-6948-4627	National Institutes of Health [NS096246, DK116624, NS113189]; National Health and Medical Research Council [1082271]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Institutes of Health grants NS096246, DK116624 and NS113189, and National Health and Medical Research Council grant 1082271.	Anderson AJ, 2004, J NEUROTRAUM, V21, P1831, DOI 10.1089/0897715042664894; Anderson SR, 2019, J NEUROSCI, V39, P2025, DOI 10.1523/JNEUROSCI.1854-18.2018; Anghelescu DL, 2015, PEDIATR BLOOD CANCER, V62, P224, DOI 10.1002/pbc.25280; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Bahia El Idrissi N., 2016, ANN NEURODEGENER DIS, V1, P1015; Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Barnum SR, 2015, J INNATE IMMUN, V7, P333, DOI 10.1159/000371423; Beck KD, 2010, BRAIN, V133, P433, DOI 10.1093/brain/awp322; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; BENGTSSON A, 1990, J INTERN MED, V228, P173, DOI 10.1111/j.1365-2796.1990.tb00212.x; Bennett S, 2012, ALZ DIS ASSOC DIS, V26, P329, DOI 10.1097/WAD.0b013e318239dcbd; Benoit ME, 2011, J NEUROSCI, V31, P3459, DOI 10.1523/JNEUROSCI.3932-10.2011; Biggins PJC, 2017, J NEUROTRAUM, V34, P2075, DOI 10.1089/neu.2016.4701; Binshtok AM, 2008, J NEUROSCI, V28, P14062, DOI 10.1523/JNEUROSCI.3795-08.2008; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Chaudhry N, 2007, J CEREBR BLOOD F MET, V27, P1096, DOI 10.1038/sj.jcbfm.9600407; Chello M, 1997, EUR J CARDIO-THORAC, V11, P162, DOI 10.1016/S1010-7940(96)01102-5; Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Chen WT, 2020, CELL, V182, P976, DOI 10.1016/j.cell.2020.06.038; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Clark JD, 2006, ANESTHESIOLOGY, V104, P1274, DOI 10.1097/00000542-200606000-00024; Clark SJ, 2013, J IMMUNOL, V190, P2049, DOI 10.4049/jimmunol.1201751; Coulthard LG, 2018, TRENDS NEUROSCI, V41, P373, DOI 10.1016/j.tins.2018.03.009; Dejanovic B, 2018, NEURON, V100, P1322, DOI 10.1016/j.neuron.2018.10.014; Dib-Hajj SD, 2010, ANNU REV NEUROSCI, V33, P325, DOI 10.1146/annurev-neuro-060909-153234; Doolen S, 2017, GLIA, V65, P1976, DOI 10.1002/glia.23208; Drouin SM, 2001, J IMMUNOL, V166, P2025, DOI 10.4049/jimmunol.166.3.2025; Dunkelberger J, 2012, J IMMUNOL, V188, P4032, DOI 10.4049/jimmunol.1103141; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Dunn HA, 2019, PHARMACOL REV, V71, P503, DOI 10.1124/pr.119.018044; Ebanks RO, 1996, MOL IMMUNOL, V33, P297, DOI 10.1016/0161-5890(95)00135-2; El Idrissi NB, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0538-2; Elmadany N, 2020, J NEUROSCI, V40, P3320, DOI 10.1523/JNEUROSCI.1458-19.2020; Eskander MA, 2015, J NEUROSCI, V35, P8593, DOI 10.1523/JNEUROSCI.3993-14.2015; Fairbanks CA, 2014, PAIN, V155, P1229, DOI 10.1016/j.pain.2014.03.012; FOSSE E, 1987, J THORAC CARDIOV SUR, V93, P860; Frank MM, 2008, J ALLERGY CLIN IMMUN, V121, P272, DOI 10.1016/j.jaci.2007.11.019; GASQUE P, 1995, J IMMUNOL, V155, P4882; Gaudet AD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-110; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Giorgio C, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9040399; Grant EP, 2002, J EXP MED, V196, P1461, DOI 10.1084/jem.20020205; Griffin RS, 2007, J NEUROSCI, V27, P8699, DOI 10.1523/JNEUROSCI.2018-07.2007; Groves MJ, 1997, J NEUROCYTOL, V26, P615, DOI 10.1023/A:1018541726460; Groves MJ, 1996, J NEUROCYTOL, V25, P219, DOI 10.1007/BF02284798; Guttikonda SR, 2021, NAT NEUROSCI, V24, P343, DOI 10.1038/s41593-020-00796-z; Harboe M, 2008, J CELL MOL MED, V12, P1074, DOI 10.1111/j.1582-4934.2008.00350.x; Harhausen D, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-15; Hess C, 2016, IMMUNITY, V45, P240, DOI 10.1016/j.immuni.2016.08.003; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hu P, 2007, BRAIN BEHAV IMMUN, V21, P599, DOI 10.1016/j.bbi.2006.10.013; Huang XX, 2018, BRAIN RES, V1698, P81, DOI 10.1016/j.brainres.2018.06.011; Humayun S, 2009, J NEUROIMMUNOL, V210, P52, DOI 10.1016/j.jneuroim.2009.01.028; Inoue K, 2018, NAT REV NEUROSCI, V19, P138, DOI 10.1038/nrn.2018.2; Jane-wit D, 2013, CIRCULATION, V128, P2504, DOI 10.1161/CIRCULATIONAHA.113.002972; Janeway CA., 2001, IMMUNOBIOLOGY IMMUNE, V5th; Jang JH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-80; Jang JH, 2010, PAIN, V148, P343, DOI 10.1016/j.pain.2009.11.021; Jayne DRW, 2021, NEW ENGL J MED, V384, P599, DOI 10.1056/NEJMoa2023386; Jayne DRW, 2017, J AM SOC NEPHROL, V28, P2756, DOI 10.1681/ASN.2016111179; JOSE PJ, 1990, ANN RHEUM DIS, V49, P747, DOI 10.1136/ard.49.10.747; Kakegawa W, 2015, NEURON, V85, P316, DOI 10.1016/j.neuron.2014.12.020; Karsten CM, 2017, J IMMUNOL, V199, P3234, DOI 10.4049/jimmunol.1700710; Karsten CM, 2015, J IMMUNOL, V194, P1841, DOI 10.4049/jimmunol.1401401; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Kemper C, 2014, MOL IMMUNOL, V61, P56, DOI 10.1016/j.molimm.2014.07.004; Kiener HP, 1998, ARTHRITIS RHEUM-US, V41, P233, DOI 10.1002/1529-0131(199802)41:2<233::AID-ART7>3.0.CO;2-V; Kilgore KS, 1997, AM J PATHOL, V150, P2019; Klos A, 2013, PHARMACOL REV, V65, P500, DOI 10.1124/pr.111.005223; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Kumar V, 2020, ACS OMEGA, V5, P2345, DOI 10.1021/acsomega.9b03735; Kuner R, 2017, NAT REV NEUROSCI, V18, P20, DOI 10.1038/nrn.2016.162; LaCroix-Fralish ML, 2011, PAIN, V152, P1888, DOI 10.1016/j.pain.2011.04.014; LACY M, 1995, J NEUROIMMUNOL, V61, P71, DOI 10.1016/0165-5728(95)00075-D; Langford-Smith A, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00025; Laumonnier Yves, 2020, Curr Protoc Immunol, V130, pe100, DOI 10.1002/cpim.100; Lee JD, 2019, SEMIN IMMUNOL, V45, DOI 10.1016/j.smim.2019.101340; Lee JD, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1217-2; Lee JD, 2017, BRIT J PHARMACOL, V174, P689, DOI 10.1111/bph.13730; Lee JD, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-119; Levin ME, 2008, PAIN, V137, P182, DOI 10.1016/j.pain.2007.11.005; Li M, 2007, EUR J NEUROSCI, V26, P3486, DOI 10.1111/j.1460-9568.2007.05971.x; Li WW, 2014, PAIN, V155, P2377, DOI 10.1016/j.pain.2014.09.007; Li XX, 2020, J IMMUNOL, V205, P1102, DOI 10.4049/jimmunol.2000407; Li ZL, 2016, BRAIN BEHAV IMMUN, V58, P107, DOI 10.1016/j.bbi.2016.05.021; Lian H, 2016, J NEUROSCI, V36, P577, DOI 10.1523/JNEUROSCI.2117-15.2016; Liang DY, 2012, PAIN, V153, P366, DOI 10.1016/j.pain.2011.10.032; Litvinchuk A, 2018, NEURON, V100, P1337, DOI 10.1016/j.neuron.2018.10.031; LIU L, 1995, NEUROSCIENCE, V68, P167, DOI 10.1016/0306-4522(95)00103-P; Liu Y, 2017, J NEUROSCI, V37, P871, DOI 10.1523/JNEUROSCI.2235-16.2016; Loeven MA, 2015, MOL IMMUNOL, V63, P203, DOI 10.1016/j.molimm.2014.08.005; Maier M, 2008, J NEUROSCI, V28, P6333, DOI 10.1523/JNEUROSCI.0829-08.2008; Mantovani S, 2014, J NEUROIMMUNOL, V276, P213, DOI 10.1016/j.jneuroim.2014.09.005; Mantyh PW, 2011, ANESTHESIOLOGY, V115, P189, DOI 10.1097/ALN.0b013e31821b1ac5; Marcinkiewicz M, 1999, J COMP NEUROL, V403, P471, DOI 10.1002/(SICI)1096-9861(19990125)403:4<471::AID-CNE4>3.0.CO;2-S; Martinelli DC, 2016, NEURON, V91, P1034, DOI 10.1016/j.neuron.2016.07.002; Mastellos DC, 2019, NAT REV DRUG DISCOV, V18, P707, DOI 10.1038/s41573-019-0031-6; Mika J, 2011, NEUROSCIENCE, V175, P358, DOI 10.1016/j.neuroscience.2010.11.040; Mika J, 2010, NEUROSCIENCE, V165, P1420, DOI 10.1016/j.neuroscience.2009.11.064; Mika J, 2009, EUR J PHARMACOL, V623, P65, DOI 10.1016/j.ejphar.2009.09.030; Mocco J, 2006, NEUROSURGERY, V59, P28, DOI [10.1227/01.NEU.0000219221.14280.65, 10.1227/01.neu.0000243280.75920.f4]; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Morgan BP, 2018, SEMIN IMMUNOPATHOL, V40, P113, DOI 10.1007/s00281-017-0662-9; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Moriconi A, 2014, P NATL ACAD SCI USA, V111, P16937, DOI 10.1073/pnas.1417365111; Mullard A, 2021, NAT REV DRUG DISCOV, V20, P496, DOI 10.1038/d41573-021-00094-8; Natura G, 2005, PAIN, V116, P194, DOI 10.1016/j.pain.2005.04.002; Nie FC, 2013, INT J MOL MED, V31, P1333, DOI 10.3892/ijmm.2013.1344; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Oppenheim JJ, 2005, CURR OPIN IMMUNOL, V17, P359, DOI 10.1016/j.coi.2005.06.002; Pavlovski D, 2012, FASEB J, V26, P3680, DOI 10.1096/fj.11-202382; Pedersen ED, 2009, SCAND J IMMUNOL, V69, P555, DOI 10.1111/j.1365-3083.2009.02253.x; Pedersen ED, 2004, CLIN EXP IMMUNOL, V137, P117, DOI 10.1111/j.1365-2249.2004.02489.x; Perkins SJ, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00126; Peterson SL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11410-x; Peterson SL, 2015, J NEUROSCI, V35, P4332, DOI 10.1523/JNEUROSCI.4473-12.2015; Planells-Cases R, 2005, PFLUG ARCH EUR J PHY, V451, P151, DOI 10.1007/s00424-005-1423-5; Qiao F, 2010, AM J PATHOL, V177, P3061, DOI 10.2353/ajpath.2010.100158; Quadros AU, 2016, PHARMACOL RES, V112, P58, DOI 10.1016/j.phrs.2016.02.004; Quell KM, 2017, J IMMUNOL, V199, P688, DOI 10.4049/jimmunol.1700318; Rahpeymai Y, 2006, EMBO J, V25, P1364, DOI 10.1038/sj.emboj.7601004; Renthal W, 2021, NEURON, V109, P1426, DOI 10.1016/j.neuron.2021.04.005; Renthal W, 2020, NEURON, V108, P128, DOI 10.1016/j.neuron.2020.07.026; Richardson JD, 2002, J PHARMACOL EXP THER, V302, P839, DOI 10.1124/jpet.102.032797; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Risitano AM, 2012, IMMUNOBIOLOGY, V217, P1080, DOI 10.1016/j.imbio.2012.07.014; ROXVALL L, 1989, J SURG RES, V47, P138, DOI 10.1016/0022-4804(89)90078-4; Sahbaie P, 2012, ANESTHESIOLOGY, V117, P602, DOI 10.1097/ALN.0b013e3182655f9f; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Schatz-Jakobsen JA, 2014, ACTA CRYSTALLOGR D, V70, P1704, DOI 10.1107/S139900471400844X; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sellgren CM, 2019, NAT NEUROSCI, V22, P374, DOI 10.1038/s41593-018-0334-7; Shepherd AJ, 2018, P NATL ACAD SCI USA, V115, pE8057, DOI 10.1073/pnas.1721815115; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Shi XY, 2021, PAIN, V162, P1400, DOI 10.1097/j.pain.0000000000002150; Shutov LP, 2016, J NEUROSCI, V36, P5055, DOI 10.1523/JNEUROSCI.3249-15.2016; Simonetti M, 2013, NEURON, V77, P43, DOI 10.1016/j.neuron.2012.10.037; Sjoberg AP, 2009, TRENDS IMMUNOL, V30, P83, DOI 10.1016/j.it.2008.11.003; Socie G, 2019, BRIT J HAEMATOL, V185, P297, DOI 10.1111/bjh.15790; Sorkin LS, 2010, PAIN, V149, P135, DOI 10.1016/j.pain.2010.01.024; Sta M, 2011, NEUROBIOL DIS, V42, P211, DOI 10.1016/j.nbd.2011.01.002; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stephan AH, 2012, ANNU REV NEUROSCI, V35, P369, DOI 10.1146/annurev-neuro-061010-113810; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Stokowska A, 2017, BRAIN, V140, P353, DOI 10.1093/brain/aww314; Stokowska A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072133; Strohmeyer R, 2002, J NEUROIMMUNOL, V131, P135, DOI 10.1016/S0165-5728(02)00272-2; STRUNK RC, 1988, J CLIN INVEST, V81, P1419, DOI 10.1172/JCI113472; Szeplaki G, 2009, ATHEROSCLEROSIS, V204, P315, DOI 10.1016/j.atherosclerosis.2008.07.044; Tandrup T, 2000, J COMP NEUROL, V422, P172, DOI 10.1002/(SICI)1096-9861(20000626)422:2<172::AID-CNE2>3.0.CO;2-H; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; Tenner AJ, 2020, J IMMUNOL, V204, P306, DOI 10.4049/jimmunol.1901068; Tenner AJ, 2018, MOL IMMUNOL, V102, P3, DOI 10.1016/j.molimm.2018.06.264; Thielens NM, 2017, MOL IMMUNOL, V89, P73, DOI 10.1016/j.molimm.2017.05.025; Tikka T, 2001, J NEUROSCI, V21, P2580, DOI 10.1523/JNEUROSCI.21-08-02580.2001; Ting E, 2008, BRIT J PHARMACOL, V153, P1043, DOI 10.1038/sj.bjp.0707640; Twining CM, 2004, PAIN, V110, P299, DOI 10.1016/j.pain.2004.04.008; Urbanyi Z, 2005, NEUROCHEM INT, V46, P471, DOI 10.1016/j.neuint.2004.12.001; Usoskin D, 2015, NAT NEUROSCI, V18, P145, DOI 10.1038/nn.3881; Valtcheva MV, 2016, NAT PROTOC, V11, P1877, DOI 10.1038/nprot.2016.111; Vergunst CE, 2007, RHEUMATOLOGY, V46, P1773, DOI 10.1093/rheumatology/kem222; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Wang Q, 2011, NAT MED, V17, P1674, DOI 10.1038/nm.2543; Warwick CA, 2019, PAIN, V160, P702, DOI 10.1097/j.pain.0000000000001449; Woodruff TM, 2014, P NATL ACAD SCI USA, V111, pE3, DOI 10.1073/pnas.1321248111; Woodruff TM, 2008, J IMMUNOL, V181, P8727, DOI 10.4049/jimmunol.181.12.8727; Wu MCL, 2020, J IMMUNOL, V205, P2834, DOI 10.4049/jimmunol.2000778; Wyss-Coray T, 2002, P NATL ACAD SCI USA, V99, P10837, DOI 10.1073/pnas.162350199; Xie CB, 2020, AM J PATHOL, V190, P1138, DOI 10.1016/j.ajpath.2020.02.006; Xu JJ, 2018, J IMMUNOL, V200, P4094, DOI 10.4049/jimmunol.1701716; Yang CQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep34643; Yilmaz M, 2021, NAT NEUROSCI, V24, P214, DOI 10.1038/s41593-020-00763-8; Yrjanheikki J, 1998, P NATL ACAD SCI USA, V95, P15769, DOI 10.1073/pnas.95.26.15769; Yu XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13839-2; Zhang XL, 2017, ELIFE, V6, DOI 10.7554/eLife.23235; Zhang XM, 2005, EMBO J, V24, P4211, DOI 10.1038/sj.emboj.7600893; Zhou LJ, 2019, CELL REP, V27, P3844, DOI 10.1016/j.celrep.2019.05.087; Zhu WG, 2007, MOL CELL NEUROSCI, V34, P689, DOI 10.1016/j.mcn.2007.01.005	186	4	5	2	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101085	10.1016/j.jbc.2021.101085	http://dx.doi.org/10.1016/j.jbc.2021.101085			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34411562	gold, Green Published			2022-12-28	WOS:000706409200003
J	Yao, LD; Zhou, YL; Li, JJ; Wickens, L; Conforti, F; Rattu, A; Ibrahim, FM; Alzetani, A; Marshall, B; Fletcher, SV; Hancock, D; Wallis, T; Downward, J; Ewing, RM; Richeldi, L; Skipp, P; Davies, DE; Jones, MG; Wang, YH				Yao, Liudi; Zhou, Yilu; Li, Juanjuan; Wickens, Leanne; Conforti, Franco; Rattu, Anna; Ibrahim, Fathima Maneesha; Alzetani, Aiman; Marshall, Ben G.; Fletcher, Sophie, V; Hancock, David; Wallis, Tim; Downward, Julian; Ewing, Rob M.; Richeldi, Luca; Skipp, Paul; Davies, Donna E.; Jones, Mark G.; Wang, Yihua			Bidirectional epithelial-mesenchymal crosstalk provides self-sustaining profibrotic signals in pulmonary fibrosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FIBROBLASTS; APOPTOSIS; SPARC; ACTIVATION; RECEPTOR; CANCER; MECHANISMS; MIGRATION; CONTRIBUTES	Idiopathic pulmonary fibrosis (IPF) is the prototypic progressive fibrotic lung disease with a median survival of 2 to 4 years. Injury to and/or dysfunction of the alveolar epithelium is strongly implicated in IPF disease initiation, but the factors that determine whether fibrosis progresses rather than normal tissue repair occurs remain poorly understood. We previously demonstrated that zinc finger E-box-binding homeobox 1-mediated epithelial- mesenchymal transition in human alveolar epithelial type II (ATII) cells augments transforming growth factor-fl-induced profibrogenic responses in underlying lung fibroblasts via paracrine signaling. Here, we investigated bidirectional epithelial- mesenchymal crosstalk and its potential to drive fibrosis progression. RNA-Seq of lung fibroblasts exposed to conditioned media from ATII cells undergoing RAS-induced epithelial- mesenchymal transition identified many differentially expressed genes including those involved in cell migration and extracellular matrix regulation. We confirmed that paracrine signaling between RAS-activated ATII cells and fibroblasts augmented fibroblast recruitment and demonstrated that this involved a zinc finger E-box-binding homeobox 1-tissue plasminogen activator axis. In a reciprocal fashion, paracrine signaling from transforming growth factor-fl-activated lung fibroblasts or IPF fibroblasts induced RAS activation in ATII cells, at least partially through the secreted protein acidic and rich in cysteine, which may signal via the epithelial growth factor receptor via epithelial growth factor- like repeats. Together, these data identify that aberrant bidirectional epithelial-mesenchymal crosstalk in IPF drives a chronic feedback loop that maintains a wound-healing phenotype and provides self-sustaining profibrotic signals.	[Yao, Liudi; Zhou, Yilu; Li, Juanjuan; Rattu, Anna; Ibrahim, Fathima Maneesha; Ewing, Rob M.; Skipp, Paul; Wang, Yihua] Univ Southampton, Fac Environm & Life Sci, Biol Sci, Southampton, Hants, England; [Zhou, Yilu; Ewing, Rob M.; Skipp, Paul; Davies, Donna E.; Jones, Mark G.; Wang, Yihua] Univ Southampton, Fac Med, Inst Life Sci, Southampton, Hants, England; [Wickens, Leanne; Skipp, Paul] Univ Southampton, Fac Med, Ctr Prote Res, Inst Life Sci, Southampton, Hants, England; [Wickens, Leanne; Conforti, Franco; Richeldi, Luca; Davies, Donna E.; Jones, Mark G.] Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England; [Wickens, Leanne; Conforti, Franco; Alzetani, Aiman; Marshall, Ben G.; Fletcher, Sophie, V; Wallis, Tim; Richeldi, Luca; Davies, Donna E.; Jones, Mark G.; Wang, Yihua] Univ Hosp Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Alzetani, Aiman; Marshall, Ben G.; Fletcher, Sophie, V; Wallis, Tim] Univ Hosp Southampton, Southampton, Hants, England; [Hancock, David; Downward, Julian] Francis Crick Inst, Oncogene Biol, London, England; [Richeldi, Luca] Univ Cattolica Sacro Cuore, Fdn Policlin A Gemelli, Unita Operat Complessa Pneumol, Rome, Italy	University of Southampton; University of Southampton; University of Southampton; University of Southampton; Francis Crick Institute; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Wang, YH (corresponding author), Univ Southampton, Fac Environm & Life Sci, Biol Sci, Southampton, Hants, England.; Jones, MG; Wang, YH (corresponding author), Univ Southampton, Fac Med, Inst Life Sci, Southampton, Hants, England.; Jones, MG (corresponding author), Univ Southampton, Fac Med, Clin & Expt Sci, Southampton, Hants, England.; Jones, MG; Wang, YH (corresponding author), Univ Hosp Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.	mark.jones@soton.ac.uk; yihua.wang@soton.ac.uk		Wallis, Timothy/0000-0001-7936-9764; Wang, Yihua/0000-0001-5561-0648; Davies, Donna/0000-0002-5117-2991; Downward, Julian/0000-0002-2331-4729; MARSHALL, BEN/0000-0003-0946-0399; Li, Juanjuan/0000-0003-2164-094X; Jones, Mark/0000-0001-6308-6014; Rattu, Anna/0000-0002-7497-9552	China Scholarship Council; Institute for Life Sciences PhD Studentship; Medical Research Foundation [MRF-091-0003-RG-CONFO]; Francis Crick Institute; Cancer Research UK [FC001070]; UK Medical Research Council [FC001070]; Wellcome Trust [FC001070]	China Scholarship Council(China Scholarship Council); Institute for Life Sciences PhD Studentship; Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)	L. Y. was supported by the China Scholarship Council. Y. Z. was supported by an Institute for Life Sciences PhD Studentship. F. C. was supported by the Medical Research Foundation (MRF-091-0003-RG-CONFO) . J. D. was supported by the Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001070) , the UK Medical Research Council (FC001070) , and the Wellcome Trust (FC001070) .	Alvarez MJ, 2005, CANCER RES, V65, P5123, DOI 10.1158/0008-5472.CAN-04-1102; Bhaskaran M, 2003, AM J PHYSIOL-RENAL, V284, pF955, DOI 10.1152/ajprenal.00246.2002; Brezniceanu ML, 2010, J AM SOC NEPHROL, V21, P943, DOI 10.1681/ASN.2009030242; Camino AM, 2008, J GENE MED, V10, P993, DOI 10.1002/jgm.1228; Chang CH, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18071556; Chang W, 2010, J BIOL CHEM, V285, P8196, DOI 10.1074/jbc.M109.025684; Coelho MA, 2017, IMMUNITY, V47, P1083, DOI 10.1016/j.immuni.2017.11.016; Conforti F, 2020, CELL DEATH DISCOV, V6, DOI 10.1038/s41420-020-0289-9; Conforti F, 2017, ONCOTARGET, V8, P48737, DOI 10.18632/oncotarget.17114; Demopoulos K, 2002, J CELL MOL MED, V6, P215, DOI 10.1111/j.1582-4934.2002.tb00188.x; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; FRIZELL E, 1995, HEPATOLOGY, V21, P847, DOI 10.1002/hep.1840210335; Ghatak S, 2014, J BIOL CHEM, V289, P7856, DOI 10.1074/jbc.M113.505065; Grahovac J, 2014, LAB INVEST, V94, P31, DOI 10.1038/labinvest.2013.132; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hill C, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1820-x; Hill Charlotte, 2019, J Lung Health Dis, V3, P31; Hohenester E, 1997, EMBO J, V16, P3778, DOI 10.1093/emboj/16.13.3778; Hu KB, 2008, J AM SOC NEPHROL, V19, P503, DOI 10.1681/ASN.2007030300; Hu K, 2007, J CLIN INVEST, V117, P3821, DOI 10.1172/JCI32301; Iyer AKV, 2008, J CELL PHYSIOL, V214, P504, DOI 10.1002/jcp.21232; Iyer AKV, 2007, J CELL PHYSIOL, V211, P748, DOI 10.1002/jcp.20986; Jones MG, 2018, ELIFE, V7, DOI 10.7554/eLife.36354; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kim J, 2009, AM J PHYSIOL-RENAL, V297, pF461, DOI 10.1152/ajprenal.90735.2008; Kim SH, 2012, LAB INVEST, V92, P488, DOI 10.1038/labinvest.2011.194; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liu D, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2415-2; Liu Y, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00813; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Luzina IG, 2018, CELL IMMUNOL, V325, P1, DOI 10.1016/j.cellimm.2018.01.002; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Molina-Arcas M, 2013, CANCER DISCOV, V3, P548, DOI 10.1158/2159-8290.CD-12-0446; Nici L, 2006, AM J RESP CRIT CARE, V173, P1390, DOI 10.1164/rccm.200508-1211ST; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Pierce EM, 2007, EUR RESPIR J, V29, P1082, DOI 10.1183/09031936.00122806; Prunotto M, 2012, J PATHOL, V228, P131, DOI 10.1002/path.4049; Putman RK, 2016, JAMA-J AM MED ASSOC, V315, P672, DOI 10.1001/jama.2016.0518; QUAX PHA, 1994, FIBRINOLYSIS, V8, P221, DOI 10.1016/0268-9499(94)90047-7; Raghu G, 2018, AM J RESP CRIT CARE, V198, pE44, DOI 10.1164/rccm.201807-1255ST; Ramos C, 2001, AM J RESP CELL MOL, V24, P591, DOI 10.1165/ajrcmb.24.5.4333; Richeldi L, 2017, LANCET, V389, P1941, DOI 10.1016/S0140-6736(17)30866-8; Said NA, 2008, NEOPLASIA, V10, P1092, DOI 10.1593/neo.08672; Sakai N, 2013, BBA-MOL BASIS DIS, V1832, P911, DOI 10.1016/j.bbadis.2013.03.001; Sasaki T, 1998, EMBO J, V17, P1625, DOI 10.1093/emboj/17.6.1625; Schafer MJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14532; Senavirathna LK, 2020, PHYSIOL REP, V8, DOI 10.14814/phy2.14343; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; SUGANUMA H, 1995, THORAX, V50, P984, DOI 10.1136/thx.50.9.984; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Swindle CS, 2001, J CELL BIOL, V154, P459, DOI 10.1083/jcb.200103103; Wang JX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03650-8; Wang QJ, 2019, BIOSCIENCE REP, V39, DOI 10.1042/BSR20191805; Wang YH, 2019, AUTOPHAGY, V15, P886, DOI 10.1080/15548627.2019.1569912; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yao LD, 2019, CELL DEATH DIFFER, V26, P943, DOI 10.1038/s41418-018-0175-7	59	9	9	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	SEP	2021	297	3							101096	10.1016/j.jbc.2021.101096	http://dx.doi.org/10.1016/j.jbc.2021.101096			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	WF6JK	34418430	Green Published, Green Accepted, gold			2022-12-28	WOS:000706409200001
J	Carballal, S; Vitvitsky, V; Kumar, R; Hanna, DA; Libiad, M; Gupta, A; Jones, JW; Banerjee, R				Carballal, Sebastian; Vitvitsky, Victor; Kumar, Roshan; Hanna, David A.; Libiad, Marouane; Gupta, Aditi; Jones, Jace W.; Banerjee, Ruma			Hydrogen sulfide stimulates lipid biogenesis from glutamine that is dependent on the mitochondrial NAD(P)H pool	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FATTY-ACID SYNTHESIS; REDUCTIVE CARBOXYLATION; OXIDATION; METABOLISM; GROWTH; METABOLOMICS; MANIPULATION; INHIBITION; CYSTEINE; SULFUR	Mammalian cells synthesize H2S from sulfur-containing amino acids and are also exposed to exogenous sources of this signaling molecule, notably from gut microbes. As an inhibitor of complex IV in the electron transport chain, H2S can have a profound impact on metabolism, suggesting the hypothesis that metabolic reprogramming is a primary mechanism by which H2S signals. In this study, we report that H2S increases lipogenesis in many cell types, using carbon derived from glutamine rather than from glucose. H2S-stimulated lipid synthesis is sensitive to the mitochondrial NAD(P)H pools and is enabled by reductive carboxylation of alpha-ketoglutarate. Lipidomics analysis revealed that H2S elicits time-dependent changes across several lipid classes, e.g., upregulating triglycerides while downregulating phosphatidylcholine. Direct analysis of triglyceride concentration revealed that H2S induces a net increase in the size of this lipid pool. These results provide a mechanistic framework for understanding the effects of H2S on increasing lipid droplets in adipocytes and population studies that have pointed to a positive correlation between cysteine (a substrate for H2S synthesis) and fat mass.	[Carballal, Sebastian; Vitvitsky, Victor; Kumar, Roshan; Hanna, David A.; Libiad, Marouane; Gupta, Aditi; Banerjee, Ruma] Univ Michigan, Dept Biol Chem, Michigan Med, Ann Arbor, MI 48109 USA; [Carballal, Sebastian] Univ Republica, Fac Med, Dept Bioquim, Montevideo, Uruguay; [Carballal, Sebastian] Univ Republica, Ctr Invest Biomed CEINBIO, Montevideo, Uruguay; [Jones, Jace W.] Univ Maryland, Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA	University of Michigan System; University of Michigan; Universidad de la Republica, Uruguay; Universidad de la Republica, Uruguay; University System of Maryland; University of Maryland Baltimore	Banerjee, R (corresponding author), Univ Michigan, Dept Biol Chem, Michigan Med, Ann Arbor, MI 48109 USA.	rbanerje@umich.edu	Vitvitsky, Victor/ABA-2967-2021	Vitvitsky, Victor/0000-0001-6251-6115; Libiad, Marouane/0000-0003-1717-9206; Gupta, Aditi/0000-0002-1807-8266; Hanna, David/0000-0003-0726-8707	National Institutes of Health [GM130183]; American Heart Association [826245]; University of Michigan Postdoctoral Pioneer Program; University of Maryland School of Pharmacy and its Mass Spectrometry Center [SOP1841-IQB2014]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); University of Michigan Postdoctoral Pioneer Program; University of Maryland School of Pharmacy and its Mass Spectrometry Center	This work was supported in part by grants from the National Institutes of Health (GM130183 to R. B.) and the American Heart Association (826245 to R. K.) and University of Michigan Postdoctoral Pioneer Program (to D. A. H.). J. W. J. acknowledges start-up funds from the University of Maryland School of Pharmacy and its Mass Spectrometry Center (SOP1841-IQB2014). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aasheim ET, 2011, BRIT J NUTR, V106, P432, DOI 10.1017/S0007114511000201; Carter RN, 2016, J PATHOL, V238, P321, DOI 10.1002/path.4659; Cheng J, 2020, ACS SUSTAIN CHEM ENG, V8, P2481, DOI 10.1021/acssuschemeng.9b06748; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cracan V, 2017, NAT CHEM BIOL, V13, P1088, DOI [10.1038/NCHEMBIO.2454, 10.1038/nchembio.2454]; DePlancke B, 2003, EXP BIOL MED, V228, P424, DOI 10.1177/153537020322800413; Doka E, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1500968; Elshorbagy AK, 2008, AM J CLIN NUTR, V88, P738, DOI 10.1093/ajcn/88.3.738; Filipovic MR, 2018, CHEM REV, V118, P377, DOI 10.1021/acs.chemrev.7b00205; Friederich MW, 2020, J INHERIT METAB DIS, V43, P1024, DOI 10.1002/jimd.12232; Furne J, 2008, AM J PHYSIOL-REG I, V295, pR1479, DOI 10.1152/ajpregu.90566.2008; Gameiro PA, 2013, J BIOL CHEM, V288, P12967, DOI 10.1074/jbc.M112.396796; Gao XH, 2015, ELIFE, V4, DOI 10.7554/eLife.10067; Hildebrandt TM, 2008, FEBS J, V275, P3352, DOI 10.1111/j.1742-4658.2008.06482.x; Jain SK, 2012, ATHEROSCLEROSIS, V225, P242, DOI 10.1016/j.atherosclerosis.2012.08.036; Kabil O, 2018, J BIOL CHEM, V293, P12429, DOI 10.1074/jbc.RA118.004096; Kabil O, 2014, ANNU REV NUTR, V34, P171, DOI 10.1146/annurev-nutr-071813-105654; Kumar R, 2021, CRIT REV BIOCHEM MOL, V56, P221, DOI 10.1080/10409238.2021.1893641; Landry AP, 2021, CHEMBIOCHEM, V22, P949, DOI 10.1002/cbic.202000661; Landry AP, 2017, J BIOL CHEM, V292, P11641, DOI 10.1074/jbc.M117.788547; Libiad M, 2019, J BIOL CHEM, V294, P12077, DOI 10.1074/jbc.RA119.009442; Libiad M, 2014, J BIOL CHEM, V289, P30901, DOI 10.1074/jbc.M114.602664; MACFARLANE GT, 1992, J APPL BACTERIOL, V72, P57, DOI 10.1111/j.1365-2672.1992.tb05187.x; Mani S, 2011, FREE RADICAL BIO MED, V50, P1280, DOI 10.1016/j.freeradbiomed.2011.01.038; Metallo CM, 2012, NATURE, V481, P380, DOI 10.1038/nature10602; Mishanina TV, 2015, J BIOL CHEM, V290, P25072, DOI 10.1074/jbc.M115.682369; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; NICHOLLS P, 1982, CAN J BIOCHEM CELL B, V60, P613, DOI 10.1139/o82-076; Nowinski SM, 2020, ELIFE, V9, DOI 10.7554/eLife.58041; Paglia G, 2017, NAT PROTOC, V12, P797, DOI 10.1038/nprot.2017.013; Pizer ES, 1996, CANCER RES, V56, P1189; Singh S, 2011, BBA-PROTEINS PROTEOM, V1814, P1518, DOI 10.1016/j.bbapap.2011.02.004; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Sun RC, 2014, CELL METAB, V19, P285, DOI 10.1016/j.cmet.2013.11.022; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Titov DV, 2016, SCIENCE, V352, P231, DOI 10.1126/science.aad4017; Tsai CY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119511; Vitvitsky V, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100736; Vitvitsky V, 2012, ANTIOXID REDOX SIGN, V17, P22, DOI 10.1089/ars.2011.4310; Wang C, 2009, BIOCHEM BIOPH RES CO, V385, P302, DOI 10.1016/j.bbrc.2009.05.045; Warita K, 2014, SCI REP-UK, V4, DOI 10.1038/srep07593; Wise DR, 2011, P NATL ACAD SCI USA, V108, P19611, DOI 10.1073/pnas.1117773108; Xia Jianguo, 2016, Curr Protoc Bioinformatics, V55, DOI 10.1002/cpbi.11; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Yadav PK, 2020, J BIOL CHEM, V295, P6299, DOI 10.1074/jbc.RA120.012616	45	3	3	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100950	10.1016/j.jbc.2021.100950	http://dx.doi.org/10.1016/j.jbc.2021.100950			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34252456	gold, Green Published			2022-12-28	WOS:000690873500005
J	Pearce, AC; Bamford, MJ; Barber, R; Bridges, A; Convery, MA; Demetriou, C; Evans, S; Gobbetti, T; Hirst, DJ; Holmes, DS; Hutchinson, JP; Jayne, S; Lezina, L; McCabe, MT; Messenger, C; Morley, J; Musso, MC; Scott-Stevens, P; Manso, AS; Schofield, J; Slocombe, T; Somers, D; Walker, AL; Wyce, A; Zhang, XP; Wagner, SD				Pearce, Andrew C.; Bamford, Mark J.; Barber, Ruth; Bridges, Angela; Convery, Maire A.; Demetriou, Constantinos; Evans, Sian; Gobbetti, Thomas; Hirst, David J.; Holmes, Duncan S.; Hutchinson, Jonathan P.; Jayne, Sandrine; Lezina, Larissa; McCabe, Michael T.; Messenger, Cassie; Morley, Joanne; Musso, Melissa C.; Scott-Stevens, Paul; Manso, Ana Sousa; Schofield, Jennifer; Slocombe, Tom; Somers, Don; Walker, Ann L.; Wyce, Anastasia; Zhang, Xi-Ping; Wagner, Simon D.			GSK137, a potent small-molecule BCL6 inhibitor with in vivo activity, suppresses antibody responses in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GERMINAL-CENTER FORMATION; HELPER T-CELLS; MEMORY B-CELLS; BREAST-CANCER; BTB DOMAIN; INFLAMMATION; COREPRESSOR; DISCOVERY; PEPTIDE; PROTEIN	B-cell lymphoma 6 (BCL6) is a zinc finger transcriptional repressor possessing a BTB-POZ (BR-C, ttk, and bab for BTB; pox virus and zinc finger for POZ) domain, which is required for homodimerization and association with corepressors. BCL6 has multiple roles in normal immunity, autoimmunity, and some types of lymphoma. Mice bearing disrupted BCL6 loci demonstrate suppressed high-affinity antibody responses to T-dependent antigens. The corepressor binding groove in the BTB-POZ domain is a potential target for small compound mediated therapy. Several inhibitors targeting this binding groove have been described, but these compounds have limited or absent in vivo activity. Biophysical studies of a novel compound, GSK137, showed an in vitro pIC(50) of 8 and a cellular pIC50 of 7.3 for blocking binding of a peptide derived from the corepressor silencing mediator for retinoid or thyroid hormone receptors to the BCL6 BTB-POZ domain. The compound has good solubility (128 mu g/ml) and permeability (86 nM/s). GSK137 caused little change in cell viability or proliferation in four BCL6-expressing B-cell lymphoma lines, although there was modest dose-dependent accumulation of G1 phase cells. Pharmacokinetic studies in mice showed a profile compatible with achieving good levels of target engagement. GSK137, administered orally, suppressed immunoglobulin G responses and reduced numbers of germinal centers and germinal center B cells following immunization of mice with the hapten trinitrophenol. Overall, we report a novel small-molecule BCL6 inhibitor with in vivo activity that inhibits the T-dependent antigen immune response.	[Pearce, Andrew C.; Bamford, Mark J.; Bridges, Angela; Convery, Maire A.; Gobbetti, Thomas; Hirst, David J.; Holmes, Duncan S.; Hutchinson, Jonathan P.; Messenger, Cassie; Morley, Joanne; Scott-Stevens, Paul; Slocombe, Tom; Somers, Don; Walker, Ann L.] GlaxoSmithKline, Med Res Ctr, Stevenage, Herts, England; [Barber, Ruth; Evans, Sian; Lezina, Larissa; Manso, Ana Sousa; Schofield, Jennifer] Univ Leicester, Leicester Drug Discovery & Diagnost, Leicester, Leics, England; [Demetriou, Constantinos; Jayne, Sandrine; Lezina, Larissa; Manso, Ana Sousa; Wagner, Simon D.] Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England; [Demetriou, Constantinos; Jayne, Sandrine; Lezina, Larissa; Manso, Ana Sousa; Wagner, Simon D.] Univ Leicester, Ernest & Helen Scott Haematol Res Unit, Leicester, Leics, England; [McCabe, Michael T.; Musso, Melissa C.; Wyce, Anastasia; Zhang, Xi-Ping] GlaxoSmithKline, Collegeville, PA USA	GlaxoSmithKline; University of Leicester; University of Leicester; University of Leicester; GlaxoSmithKline	Wagner, SD (corresponding author), Univ Leicester, Leicester Canc Res Ctr, Leicester, Leics, England.; Wagner, SD (corresponding author), Univ Leicester, Ernest & Helen Scott Haematol Res Unit, Leicester, Leics, England.	sw227@le.ac.uk			Discovery Partnership with Academia (DPAc) grant from GSK	Discovery Partnership with Academia (DPAc) grant from GSK	This work was supported by a Discovery Partnership with Academia (DPAc) grant from GSK to S. D. W.	Ahmad KF, 2003, MOL CELL, V12, P1551, DOI 10.1016/S1097-2765(03)00454-4; Allman D, 1996, BLOOD, V87, P5257, DOI 10.1182/blood.V87.12.5257.bloodjournal87125257; Arce E, 2001, J IMMUNOL, V167, P2361, DOI 10.4049/jimmunol.167.4.2361; Bellenie BR, 2020, J MED CHEM, V63, P4047, DOI 10.1021/acs.jmedchem.9b02076; Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Brink R, 2014, CURR OPIN IMMUNOL, V28, P97, DOI 10.1016/j.coi.2014.03.001; Cardenas MG, 2016, J CLIN INVEST, V126, P3351, DOI 10.1172/JCI85795; Cerchietti LC, 2010, CANCER CELL, V17, P400, DOI 10.1016/j.ccr.2009.12.050; Cerchietti LC, 2009, BLOOD, V113, P3397, DOI 10.1182/blood-2008-07-168773; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chevallier N, 2004, BLOOD, V103, P1454, DOI 10.1182/blood-2003-06-2081; Crotty S, 2015, NAT REV IMMUNOL, V15, P185, DOI 10.1038/nri3803; de Leval L, 2010, BRIT J HAEMATOL, V148, P673, DOI 10.1111/j.1365-2141.2009.08003.x; Deb D, 2017, CANCER RES, V77, P3070, DOI 10.1158/0008-5472.CAN-15-3052; Delano W.L., 2002, CCP4 NEWSLETTER PROC, V40, P82; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Duan S, 2012, NATURE, V481, P90, DOI 10.1038/nature10688; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fukuda T, 1997, J EXP MED, V186, P439, DOI 10.1084/jem.186.3.439; Ghetu AF, 2008, MOL CELL, V29, P384, DOI 10.1016/j.molcel.2007.12.026; Green MR, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4904; Guo WK, 2020, J MED CHEM, V63, P676, DOI 10.1021/acs.jmedchem.9b01618; Guo WZ, 2010, J EXP MED, V207, P2225, DOI 10.1084/jem.20092712; Hara Y, 2015, MOL IMMUNOL, V68, P617, DOI 10.1016/j.molimm.2015.10.003; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Huang CX, 2014, CELL REP, V8, P1497, DOI 10.1016/j.celrep.2014.07.059; Huang CX, 2013, NAT IMMUNOL, V14, P380, DOI 10.1038/ni.2543; Iqbal J, 2007, LEUKEMIA, V21, P2332, DOI 10.1038/sj.leu.2404856; Kerres N, 2017, CELL REP, V20, P2860, DOI 10.1016/j.celrep.2017.08.081; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Logarajah S, 2003, ONCOGENE, V22, P5572, DOI 10.1038/sj.onc.1206689; Luzina IG, 2001, J LEUKOCYTE BIOL, V70, P578; McCoull W, 2018, ACS CHEM BIOL, V13, P3131, DOI 10.1021/acschembio.8b00698; McCoull W, 2017, J MED CHEM, V60, P4386, DOI 10.1021/acs.jmedchem.7b00359; Melnick A, 2002, MOL CELL BIOL, V22, P1804, DOI 10.1128/MCB.22.6.1804-1818.2002; Mietzner B, 2008, P NATL ACAD SCI USA, V105, P9727, DOI 10.1073/pnas.0803644105; Murphy G, 2020, CURR OPIN RHEUMATOL, V32, P597, DOI 10.1097/BOR.0000000000000736; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; Osher EL, 2018, BIOORGAN MED CHEM, V26, P3034, DOI 10.1016/j.bmc.2018.03.012; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Polo JM, 2004, NAT MED, V10, P1329, DOI 10.1038/nm1134; Pracht K, 2017, EUR J IMMUNOL, V47, P1389, DOI 10.1002/eji.201747019; Rees F, 2016, ANN RHEUM DIS, V75, P136, DOI 10.1136/annrheumdis-2014-206334; Reljic R, 2000, J EXP MED, V192, P1841, DOI 10.1084/jem.192.12.1841; Sakamoto K, 2017, BIOCHEM BIOPH RES CO, V482, P310, DOI 10.1016/j.bbrc.2016.11.060; Sameshima T, 2018, BIOCHEMISTRY-US, V57, P1369, DOI 10.1021/acs.biochem.7b00732; Shaffer AL, 2000, IMMUNITY, V13, P199, DOI 10.1016/S1074-7613(00)00020-0; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Smart O. S., 2011, GRAD VERS 1 2 15; Tangye SG, 2007, J IMMUNOL, V179, P13, DOI 10.4049/jimmunol.179.1.13; Tickle I. J., 2019, STARANISO; Valls E, 2017, CANCER DISCOV, V7, P506, DOI 10.1158/2159-8290.CD-16-1189; Walker SR, 2015, ONCOGENE, V34, P1073, DOI 10.1038/onc.2014.61; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Ye BH, 1997, NAT GENET, V16, P161, DOI 10.1038/ng0697-161; YE BHH, 1993, CANCER RES, V53, P2732; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zhang X, 2015, LUPUS, V24, P909, DOI 10.1177/0961203314567750	61	5	5	1	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100928	10.1016/j.jbc.2021.100928	http://dx.doi.org/10.1016/j.jbc.2021.100928			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34274316	gold, Green Published			2022-12-28	WOS:000690879300003
J	Duong, P; Ma, KH; Ramesh, R; Moran, JJ; Won, S; Svaren, J				Duong, Phu; Ma, Ki H.; Ramesh, Raghu; Moran, John J.; Won, Seongsik; Svaren, John			H3K27 demethylases are dispensable for activation of Polycomb-regulated injury response genes in peripheral nerve	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHWANN-CELL DIFFERENTIATION; C-JUN; SCIATIC-NERVE; COMPLEX; MYELINATION; CHROMATIN; PRC2; ENZYMES; JMJD3; TRANSCRIPTION	The induction of nerve injury response genes in Schwann cells depends on both transcriptional and epigenomic reprogramming. The nerve injury response program is regulated by the repressive histone mark H3K27 trimethylation (H3K27me3), deposited by Polycomb repressive complex 2 (PRC2). Loss of PRC2 function leads to early and augmented induction of the injury response gene network in peripheral nerves, suggesting H3K27 demethylases are required for derepression of Polycomb-regulated nerve injury genes. To determine the function of H3K27 demethylases in nerve injury, we generated Schwann cell-specific knockouts of H3K27 demethylase Kdm6b and double knockouts of Kdm6b/Kdm6a (encoding JMJD3 and UTX). We found that H3K27 demethylases are largely dispensable for Schwann cell development and myelination. In testing the function of H3K27 demethylases after injury, we found early induction of some nerve injury genes was diminished compared with control, but most injury genes were largely unaffected at 1 and 7 days post injury. Although it was proposed that H3K27 demethylases are required to activate expression of the cyclin-dependent kinase inhibitor Cdkn2a in response to injury, Schwann cell-specific deletion of H3K27 demethylases affected neither the expression of this gene nor Schwann cell proliferation after nerve injury. To further characterize the regulation of nerve injury response genes, we found that injury genes are associated with repressive histone H2AK119 ubiquitination catalyzed by PRC1, which declines after injury. Overall, our results indicate H3K27 demethylation is not required for induction of injury response genes and that other mechanisms likely are involved in activating Polycomb-repressed injury genes in peripheral nerve.	[Duong, Phu; Ma, Ki H.; Ramesh, Raghu; Moran, John J.; Won, Seongsik; Svaren, John] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Duong, Phu; Ma, Ki H.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI USA; [Svaren, John] Univ Wisconsin, Dept Comparat Biosci, 2015 Linden Dr W, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Svaren, J (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	john.svaren@wisc.edu	Svaren, John/A-1605-2010	Svaren, John/0000-0003-2963-7921; Ma, Ki/0000-0003-3474-7287	National Institutes of Health [NS100510, HD090256, T32GM007215]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health: NS100510 to J. S., U54 core grant HD090256, and training grant T32GM007215 to P. D. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anders S, 2013, NAT PROTOC, V8, P1765, DOI 10.1038/nprot.2013.099; Gomez-Sanchez JA, 2013, BRAIN, V136, P2262, DOI 10.1093/brain/awt130; Arcipowski KM, 2016, CURR OPIN GENET DEV, V36, P59, DOI 10.1016/j.gde.2016.03.010; Arthur-Farraj PJ, 2017, CELL REP, V20, P2719, DOI 10.1016/j.celrep.2017.08.064; Arthur-Farraj PJ, 2012, NEURON, V75, P633, DOI 10.1016/j.neuron.2012.06.021; Barrette B, 2010, BRAIN BEHAV IMMUN, V24, P1254, DOI 10.1016/j.bbi.2010.07.249; Belle JI, 2014, INT J BIOCHEM CELL B, V50, P161, DOI 10.1016/j.biocel.2014.03.004; Blackledge NP, 2015, NAT REV MOL CELL BIO, V16, P643, DOI 10.1038/nrm4067; Campagne A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08255-x; Cheng HL, 1996, J NEUROCHEM, V66, P525; Clements MP, 2017, NEURON, V96, P98, DOI 10.1016/j.neuron.2017.09.008; Cohen I, 2021, GENE DEV, V35, P354, DOI 10.1101/gad.345363.120; Conway E, 2015, CURR OPIN CELL BIOL, V37, P42, DOI 10.1016/j.ceb.2015.10.003; De Raedt T, 2014, NATURE, V514, P247, DOI 10.1038/nature13561; Estaras C, 2013, MOL BIOL CELL, V24, P351, DOI 10.1091/mbc.E12-07-0561; Fazal SV, 2017, J NEUROSCI, V37, P12297, DOI 10.1523/JNEUROSCI.0986-17.2017; Feltri ML, 1999, ANN NY ACAD SCI, V883, P116, DOI 10.1111/j.1749-6632.1999.tb08574.x; Fontana X, 2012, J CELL BIOL, V198, P127, DOI 10.1083/jcb.201205025; Gomez-Sanchez JA, 2017, J NEUROSCI, V37, P9086, DOI 10.1523/JNEUROSCI.1453-17.2017; Gomez-Sanchez JA, 2015, J CELL BIOL, V210, P153, DOI 10.1083/jcb.201503019; Hashimoto M, 2008, J NEUROCHEM, V107, P918, DOI 10.1111/j.1471-4159.2008.05666.x; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hung H, 2012, J NEUROSCI, V32, P1517, DOI 10.1523/JNEUROSCI.2895-11.2012; Hung HA, 2015, J BIOL CHEM, V290, P6937, DOI 10.1074/jbc.M114.622878; Iwamori N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072689; Jacob C, 2017, CURR OPIN NEUROBIOL, V47, P24, DOI 10.1016/j.conb.2017.08.007; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Jessen KR, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020487; Kehrer-Sawatzki H, 2017, HUM GENET, V136, P349, DOI 10.1007/s00439-017-1766-y; Kresak JL, 2016, J PEDIATR GENET, V5, P98, DOI 10.1055/s-0036-1579766; Kuroda MI, 2020, ANNU REV BIOCHEM, V89, P235, DOI 10.1146/annurev-biochem-120219-103641; Le N, 2005, P NATL ACAD SCI USA, V102, P2596, DOI 10.1073/pnas.0407836102; Lee W, 2014, NAT GENET, V46, P1227, DOI 10.1038/ng.3095; Lin HP, 2015, J BIOL CHEM, V290, P24294, DOI 10.1074/jbc.M115.636407; Lindborg JA, 2017, J NEUROSCI, V37, P10258, DOI 10.1523/JNEUROSCI.2085-17.2017; Lutz AB, 2017, P NATL ACAD SCI USA, V114, pE8072, DOI 10.1073/pnas.1710566114; Ma KH, 2018, GLIA, V66, P2487, DOI 10.1002/glia.23500; Ma KH, 2018, NEUROSCIENTIST, V24, P627, DOI 10.1177/1073858417751112; Ma KH, 2016, J NEUROSCI, V36, P9135, DOI 10.1523/JNEUROSCI.1370-16.2016; Ma KH, 2015, J NEUROSCI, V35, P8640, DOI 10.1523/JNEUROSCI.2257-14.2015; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Nave KA, 2014, ANNU REV CELL DEV BI, V30, P503, DOI 10.1146/annurev-cellbio-100913-013101; Niemi JP, 2013, J NEUROSCI, V33, P16236, DOI 10.1523/JNEUROSCI.3319-12.2013; Piunti A, 2016, SCIENCE, V352, DOI 10.1126/science.aad9780; Quintes S, 2016, NAT NEUROSCI, V19, P1050, DOI 10.1038/nn.4321; Sawarkar R, 2010, DEV CELL, V19, P651, DOI 10.1016/j.devcel.2010.10.012; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Shan YL, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-14028-x; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Simon CM, 2015, ACTA NEUROPATHOL, V130, P373, DOI 10.1007/s00401-015-1446-8; Sohier P, 2017, GENE CHROMOSOME CANC, V56, P421, DOI 10.1002/gcc.22446; Stassart RM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00467; Stierli S, 2018, DEVELOPMENT, V145, DOI 10.1242/dev.170316; Tamburri S, 2020, MOL CELL, V77, P840, DOI 10.1016/j.molcel.2019.11.021; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; TOPILKO P, 1994, NATURE, V371, P796, DOI 10.1038/371796a0; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wu LMN, 2016, NAT NEUROSCI, V19, P1060, DOI 10.1038/nn.4322; Zigrnond RE, 2019, PROG NEUROBIOL, V173, P102, DOI 10.1016/j.pneurobio.2018.12.001	61	2	2	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100852	10.1016/j.jbc.2021.100852	http://dx.doi.org/10.1016/j.jbc.2021.100852			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34090875	gold, Green Published			2022-12-28	WOS:000678068400052
J	Yuan, BCA; Wu, ZW; Ji, W; Liu, D; Guo, X; Yang, DH; Fan, AL; Jia, HL; Ma, M; Lin, WH				Yuan, Bochuan; Wu, Ziwei; Ji, Wei; Liu, Dong; Guo, Xiang; Yang, Donghui; Fan, Aili; Jia, Hongli; Ma, Ming; Lin, Wenhan			Discovery of cyclohexadepsipeptides with anti-Zika virus activities and biosynthesis of the nonproteinogenic building block (3S)-methyl-L-proline	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BEAUVERIA-FELINA; INSECTICIDAL ACTIVITY; CYCLODEPSIPEPTIDES; FUNGUS; METABOLITES; DESTRUXINS; ACID; IDENTIFICATION; EXPRESSION; LEADS	The fungal cyclohexadepsipeptides destruxins (DTXs), isaridins (ISDs), and isariins (ISRs) are nonribosomal peptides whose structures include a 19-membered ring composed of five amino acid residues and one alpha- or beta-hydroxy acid residue. These cyclohexadepsipeptides contain unusual nonproteinogenic amino acid-building blocks and possess a range of antiviral, antibacterial, and other activities. The biosynthetic gene clusters for ISDs and ISRs have not been identified, and the biosynthesis of the nonproteinogenic (3S)-methyl-L-proline residue, which is found in DTXs, ISDs, and many other natural products, lacks full characterization. In an ongoing effort to identify compounds that can inhibit the Zika virus (ZIKV), we examined the extract of marine-derived fungus Beauveria felina SX-6-22 and discovered 30 DTXs, ISDs, and ISRs (1-30) including seven new compounds (1-7). The anti-ZIKV assays showed that 9-12 and 16-18 possess inhibitory activities against ZIKV RNA replication and NS5 (nonstructural protein 5) production in ZIKV-infected A549 cells. We sequenced the genome of B. felina SX-6-22 and identified three biosynthetic gene clusters detx, isd and isr, which are responsible for the biosynthesis of DTXs, ISDs, and ISRs, respectively. Comparative analyses of the three gene clusters clarified the biosynthetic relationships among these cyclohexadepsipeptides. Finally, we characterized the entire biosynthesis of nonproteinogenic building block (3S)-methyl-L-proline. The.1-pyrroline-5-carboxylate reductases (P5CRs), also used in the biosynthesis of L-proline, were demonstrated to catalyze the final reduction step in (3S)-methyl-L-proline formation, suggesting potential cross talk between primary and secondary metabolisms. These results provide opportunities for biosynthetic pathway engineering to generate new anti-ZIKV cyclohexadepsipeptides.	[Yuan, Bochuan; Wu, Ziwei; Liu, Dong; Guo, Xiang; Yang, Donghui; Fan, Aili; Jia, Hongli; Ma, Ming; Lin, Wenhan] Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China; [Ji, Wei] Peking Univ, Sch Basic Med Sci, Beijing, Peoples R China; [Lin, Wenhan] Peking Univ, Inst Ocean Res, Beijing, Peoples R China	Peking University; Peking University; Peking University	Ma, M; Lin, WH (corresponding author), Peking Univ, Sch Pharmaceut Sci, State Key Lab Nat & Biomimet Drugs, Beijing, Peoples R China.; Lin, WH (corresponding author), Peking Univ, Inst Ocean Res, Beijing, Peoples R China.	mma@bjmu.edu.cn; whlin@bjmu.edu.cn			National Natural Science Foundation of China [81991525-5, 81630089, 21861142006, 81872793]; MOST of China [2018ZX09711001-001-008, 2019YFC0312502]; COMRA [DY135-B-05]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); MOST of China(Ministry of Science and Technology, China); COMRA	This work was supported by grants from National Natural Science Foundation of China (81991525-5, 81630089, 21861142006, 81872793), COMRA (DY135-B-05), and MOST of China (2018ZX09711001-001-008, 2019YFC0312502).	Bezsudnova EY, 2017, BIOCHEMISTRY-MOSCOW+, V82, P1572, DOI 10.1134/S0006297917130028; Cavelier F, 1998, PESTIC SCI, V52, P81, DOI 10.1002/(SICI)1096-9063(199801)52:1&lt;81::AID-PS666&gt;3.0.CO;2-H; Chambellon E, 2009, J BACTERIOL, V191, P873, DOI 10.1128/JB.01114-08; Che Y, 2001, J NAT PROD, V64, P555, DOI 10.1021/np000547r; Chiang YM, 2008, CHEM BIOL, V15, P527, DOI 10.1016/j.chembiol.2008.05.010; Chooi YH, 2010, CHEM BIOL, V17, P791, DOI 10.1016/j.chembiol.2010.08.001; Chung YM, 2013, J NAT PROD, V76, P1260, DOI 10.1021/np400143j; Crone WJK, 2016, ANGEW CHEM INT EDIT, V55, P9639, DOI 10.1002/anie.201604304; de Vita-Marques AM, 2008, QUIM NOVA, V31, P1099, DOI 10.1590/S0100-40422008000500030; Delvecchio R, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8120322; Donnelly MI, 2006, PROTEIN EXPRES PURIF, V47, P446, DOI 10.1016/j.pep.2005.12.011; Du FY, 2014, J NAT PROD, V77, P1164, DOI 10.1021/np4011037; Du FY, 2014, MAR DRUGS, V12, P2816, DOI 10.3390/md12052816; Dusch N, 1999, APPL ENVIRON MICROB, V65, P1530; El-Elimat T, 2013, J NAT PROD, V76, P1709, DOI 10.1021/np4004307; Fichman Y, 2015, BIOL REV, V90, P1065, DOI 10.1111/brv.12146; Fredenhagen A, 2006, J ANTIBIOT, V59, P267, DOI 10.1038/ja.2006.38; Han PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060771; Hou XM, 2019, J ORG CHEM, V84, P1228, DOI 10.1021/acs.joc.8b02614; Jiang W, 2013, J AM CHEM SOC, V135, P4457, DOI 10.1021/ja312572v; Kim HM, 2019, BIOTECHNOL BIOFUELS, V12, DOI 10.1186/s13068-019-1530-8; Langenfeld A, 2011, J NAT PROD, V74, P825, DOI 10.1021/np100890n; Li L, 2018, J AM CHEM SOC, V140, P2067, DOI 10.1021/jacs.8b00056; Lim SP, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005737; Liu BL, 2012, BIOTECHNOL ADV, V30, P1242, DOI 10.1016/j.biotechadv.2011.10.006; Lozano-Tovar MD, 2015, J ECON ENTOMOL, V108, P462, DOI 10.1093/jee/tov041; Lukassen MB, 2015, MAR DRUGS, V13, P4331, DOI 10.3390/md13074331; Lukat P, 2017, CHEM SCI, V8, P7521, DOI 10.1039/c7sc02622f; Miller KI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035953; Morais-Urano RP, 2012, EXP PARASITOL, V132, P362, DOI 10.1016/j.exppara.2012.08.011; ODIER F, 1992, BIOL CELL, V74, P267, DOI 10.1016/0248-4900(92)90037-2; Olivon F, 2019, J NAT PROD, V82, P330, DOI 10.1021/acs.jnatprod.8b00800; Owczarek K, 2019, CELL COMMUN SIGNAL, V17, DOI 10.1186/s12964-019-0349-z; Prieto C, 2012, BIOINFORMATICS, V28, P426, DOI 10.1093/bioinformatics/btr659; Sabareesh V, 2007, J NAT PROD, V70, P715, DOI 10.1021/np060532e; Shimamura H, 2009, ANGEW CHEM INT EDIT, V48, P914, DOI 10.1002/anie.200804138; Stocking EM, 1996, J AM CHEM SOC, V118, P7008, DOI 10.1021/ja961322z; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tan LT, 2003, J ORG CHEM, V68, P8767, DOI 10.1021/jo030191z; Tanner JJ, 2018, BIOCHEMISTRY-US, V57, P3433, DOI 10.1021/acs.biochem.8b00215; VINING LC, 1962, CAN J CHEM, V40, P1579, DOI 10.1139/v62-239; Wang B, 2012, P NATL ACAD SCI USA, V109, P1287, DOI 10.1073/pnas.1115983109; Yeh SF, 1996, BIOCHEM BIOPH RES CO, V229, P65, DOI 10.1006/bbrc.1996.1758; Yoshida M, 2015, CHEM-EUR J, V21, P18417, DOI 10.1002/chem.201502970; Yoshida M, 2010, ORG LETT, V12, P3792, DOI 10.1021/ol101449x; Yuan BC, 2020, APPL MICROBIOL BIOT, V104, P6149, DOI 10.1007/s00253-020-10678-w; Zhou YM, 2018, MAR DRUGS, V16, DOI 10.3390/md16120519	47	3	3	3	16	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100822	10.1016/j.jbc.2021.100822	http://dx.doi.org/10.1016/j.jbc.2021.100822			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029593	gold, Green Published			2022-12-28	WOS:000678068400024
J	Allison, LA				Allison, Lizabeth A.			Getting there: Thyroid hormone receptor intracellular trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR IMPORT	A year ago, when I first contemplated writing this article, my intent was to provide a detailed review of the contributions of the diverse community of talented scientists in my lab to the nuclear receptor research field. In the throes of a deadly pandemic, political turmoil, and Black Lives Matter, however, I found myself compelled to tell a more personal story. While I will still cover milestones in our understanding of the intracellular trafficking of the thyroid hormone receptor, now these will be set against the backdrop of my path as a woman in STEM and on being intentionally inclusive. By sharing reflections on my journey, I hope to encourage young investigators to persist in their pursuit of a career in science.	[Allison, Lizabeth A.] William & Mary, Dept Biol, Williamsburg, VA 23185 USA		Allison, LA (corresponding author), William & Mary, Dept Biol, Williamsburg, VA 23185 USA.	laalli@wm.edu		Allison, Lizabeth/0000-0002-1897-2030	National Institutes of Health [2R15DK058028]; National Science Foundation [MCB1120513]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	This work was supported by Grant 2R15DK058028 from the National Institutes of Health and Grant MCB1120513 from the National Science Foundation (to L. A. A.). The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Anyetei-Anum CS, 2019, MOL CELL ENDOCRINOL, V495, DOI 10.1016/j.mce.2019.110509; Anyetei-Anum CS, 2018, J ENDOCRINOL, V237, pR19, DOI 10.1530/JOE-17-0708; Bonamy G. M, 2006, NUCL RECEPT SIGNAL, V4, pe008; Bonamy GMC, 2005, MOL ENDOCRINOL, V19, P1213, DOI 10.1210/me.2004-0204; Bondzi C, 2011, MOL CELL ENDOCRINOL, V332, P196, DOI 10.1016/j.mce.2010.10.012; Bunn CF, 2001, MOL ENDOCRINOL, V15, P512, DOI 10.1210/mend.15.4.0619; DeLong LJ, 2004, J BIOL CHEM, V279, P15356, DOI 10.1074/jbc.M308214200; Femia MR, 2020, J CELL BIOCHEM, V121, P2909, DOI 10.1002/jcb.29532; Grespin ME, 2008, J BIOL CHEM, V283, P25576, DOI 10.1074/jbc.M710482200; King Martin Luther Jr., 1958, STRIDE FREEDOM MONTG, P96; Mavinakere MS, 2012, J BIOL CHEM, V287, P31280, DOI 10.1074/jbc.M112.397745; Nicoll JB, 2003, MOL CELL ENDOCRINOL, V205, P65, DOI 10.1016/S0303-7207(03)00199-0; Roggero VR, 2016, MOL CELL ENDOCRINOL, V419, P185, DOI 10.1016/j.mce.2015.10.016; Stevens KR, 2021, CELL, V184, P561, DOI 10.1016/j.cell.2021.01.011; Subramanian KS, 2015, MOL CELL ENDOCRINOL, V411, P86, DOI 10.1016/j.mce.2015.04.014; Zhang JB, 2018, VITAM HORM, V106, P45, DOI 10.1016/bs.vh.2017.04.002	16	0	0	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100677	10.1016/j.jbc.2021.100677	http://dx.doi.org/10.1016/j.jbc.2021.100677			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33887322	gold, Green Published			2022-12-28	WOS:000672866400648
J	Brixius-Anderko, S; Scott, EE				Brixius-Anderko, Simone; Scott, Emily E.			Structural and functional insights into aldosterone synthase interaction with its redox partner protein adrenodoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONGENITAL ADRENAL-HYPERPLASIA; ELECTRON-TRANSFER; MOLECULAR RECOGNITION; REDUCTASE; CYP11B1; GENE; MUTATIONS; COMPLEX; HYPERTENSION; P450SCC	Aldosterone is the major mineralocorticoid in the human body controlling blood pressure and salt homeostasis. Over-production of aldosterone leads to primary aldosteronism, which is the most common form of secondary hypertension with limited treatment options. Production of aldosterone by cytochrome P450 11B2 (CYP11B2, aldosterone synthase) requires two reduction events with the electrons delivered by the iron/sulfur protein adrenodoxin. Very limited information is available about the structural and functional basis of adrenodoxin/CYP11B2 interaction, which impedes the development of new treatment options for primary aldosteronism. A systematic study was carried out to determine if adrenodoxin interaction with CYP11B2 might also have an allosteric component in addition to electron transfer. Indeed, local increases in adrenodoxin concentration promote binding of the substrate 11-deoxycorticosterone and the inhibitor osilodrostat (LCI699) in the active site-over 17 angstrom away-as well as enhance the inhibitory effect of this latter drug. The CYP11B2 structure in complex with adrenodoxin identified specific residues at the protein-protein interface interacting via five salt bridges and four hydrogen bonds. Comparisons with cholesterol-metabolizing CYP11A1 and cortisol-producing CYP11B1, which also bind adrenodoxin, revealed substantial structural differences in these regions. The structural and functional differences between different P450 interactions with adrenodoxin may provide valuable clues for an orthogonal treatment approach for primary aldosteronism by specifically targeting the interaction between CYP11B2 and adrenodoxin.	[Brixius-Anderko, Simone; Scott, Emily E.] Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA; [Scott, Emily E.] Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Scott, EE (corresponding author), Univ Michigan, Dept Med Chem, Ann Arbor, MI 48109 USA.; Scott, EE (corresponding author), Univ Michigan, Dept Pharmacol, Ann Arbor, MI 48109 USA.	scottee@umich.edu		Brixius-Anderko, Simone/0000-0002-3036-9285	DOE Office of Science [DE-AC02-06CH11357]; American Heart Association (AHA) [19POST34430199]; University of Michigan	DOE Office of Science(United States Department of Energy (DOE)); American Heart Association (AHA)(American Heart Association); University of Michigan(University of Michigan System)	This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. Constructs for expression of adrenodoxin and adrenodoxin reductase were gifts from Dr Richard Auchus at the University of Michigan. Generation of the CYP11B2 and Adx-CYP11B2 fusion constructs, expression, purification, and characterization was supported by startup funds from the University of Michigan. Adx-CYP11B2 coexpression with fadrozole, conducted binding and inhibition studies, protein crystallography and structure determination were supported by a Postdoctoral Fellowship Award of the American Heart Association (AHA, Award No. 19POST34430199). The content of this publication is solely the responsibility of the authors and do not necessarily represent the official views of AHA.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Amar L, 2010, HYPERTENSION, V56, P831, DOI 10.1161/HYPERTENSIONAHA.110.157271; Beckert V, 1997, J BIOL CHEM, V272, P4883, DOI 10.1074/jbc.272.8.4883; Birtcher KK, 2004, CIRCULATION, V110, pE296, DOI 10.1161/01.CIR.0000141564.89465.4E; Brixius-Anderko S., HYPERTENSION, V78, P751; Brixius-Anderko S, 2019, J BIOL CHEM, V294, P453, DOI 10.1074/jbc.RA118.006214; BROWNE LJ, 1991, J MED CHEM, V34, P725, DOI 10.1021/jm00106a038; Bureik M, 2002, BIOL CHEM, V383, P1537, DOI 10.1515/BC.2002.174; Chien Y, 2017, MOL CELL ENDOCRINOL, V441, P55, DOI 10.1016/j.mce.2016.10.030; Connell JMC, 2005, J ENDOCRINOL, V186, P1, DOI 10.1677/joe.1.06017; CURNOW KM, 1993, P NATL ACAD SCI USA, V90, P4552, DOI 10.1073/pnas.90.10.4552; Duggan S, 2020, DRUGS, V80, P495, DOI 10.1007/s40265-020-01277-0; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Ewen KM, 2012, IUBMB LIFE, V64, P506, DOI 10.1002/iub.1029; Funder JW, 2006, J HYPERTENS, V24, P16; Godamudunage MP, 2018, DRUG METAB DISPOS, V46, P1329, DOI 10.1124/dmd.118.082032; Hannemann F, 2007, BBA-GEN SUBJECTS, V1770, P330, DOI 10.1016/j.bbagen.2006.07.017; Hartfield KA, 2013, J STEROID BIOCHEM, V136, P47, DOI 10.1016/j.jsbmb.2012.11.001; Hiruma Y, 2013, J MOL BIOL, V425, P4353, DOI 10.1016/j.jmb.2013.07.006; Holloway CD, 2009, CLIN ENDOCRINOL, V70, P363, DOI 10.1111/j.1365-2265.2008.03383.x; Hu QZ, 2014, J MED CHEM, V57, P5011, DOI 10.1021/jm401430e; KATAGIRI M, 1977, BIOCHEM BIOPH RES CO, V77, P804, DOI 10.1016/S0006-291X(77)80049-1; Khattab A, 2017, P NATL ACAD SCI USA, V114, pE1933, DOI 10.1073/pnas.1621082114; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Kumar A, 2020, BIOCHEMISTRY-US, V59, P1537, DOI 10.1021/acs.biochem.0c00107; LAMBETH JD, 1976, J BIOL CHEM, V251, P7545; LIN D, 1990, P NATL ACAD SCI USA, V87, P8516, DOI 10.1073/pnas.87.21.8516; Mast N, 2011, J BIOL CHEM, V286, P5607, DOI 10.1074/jbc.M110.188433; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Monticone S, 2018, LANCET DIABETES ENDO, V6, P41, DOI 10.1016/S2213-8587(17)30319-4; Muller JJ, 2001, J BIOL CHEM, V276, P2786, DOI 10.1074/jbc.M008501200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parajes S, 2010, J CLIN ENDOCR METAB, V95, P779, DOI 10.1210/jc.2009-0651; Peng HM, 2018, J STEROID BIOCHEM, V181, P63, DOI 10.1016/j.jsbmb.2018.03.003; Peng HM, 2017, BIOCHEMISTRY-US, V56, P2282, DOI 10.1021/acs.biochem.7b00034; Reddish MJ, 2019, J BIOL CHEM, V294, P12975, DOI 10.1074/jbc.RA119.009830; Roumen L, 2007, J COMPUT AID MOL DES, V21, P455, DOI 10.1007/s10822-007-9128-9; Schiffer L, 2019, J STEROID BIOCHEM, V194, DOI 10.1016/j.jsbmb.2019.105439; Schiffer L, 2015, J STEROID BIOCHEM, V151, P38, DOI 10.1016/j.jsbmb.2014.10.011; Scott DE, 2016, NAT REV DRUG DISCOV, V15, P533, DOI 10.1038/nrd.2016.29; Strushkevich N, 2013, MOL ENDOCRINOL, V27, P315, DOI 10.1210/me.2012-1287; Strushkevich N, 2011, P NATL ACAD SCI USA, V108, P10139, DOI 10.1073/pnas.1019441108; Usanov SA, 2002, BIOCHEMISTRY-US, V41, P8310, DOI 10.1021/bi0255928; Vickery LE, 1997, STEROIDS, V62, P124, DOI 10.1016/S0039-128X(96)00170-5; Ye ZQ, 2010, CHINESE MED J-PEKING, V123, P1264, DOI 10.3760/cma.j.issn.0366-6999.2010.10.007; Zollner A, 2002, J INORG BIOCHEM, V91, P644, DOI 10.1016/S0162-0134(02)00463-4	46	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100794	10.1016/j.jbc.2021.100794	http://dx.doi.org/10.1016/j.jbc.2021.100794			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34015331	Green Published, gold			2022-12-28	WOS:000674717300014
J	Fleming, K				Fleming, Karen			Na(v)igating the intricacies of cellular machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Voltage-gated sodium channels (Na(V)s) underlie the initiation of action potentials in various excitable cell types and are regulated by channel-interacting proteins, including the cellular calcium sensor calmodulin and fibroblast growth factor homologous factors. Both of these are known to bind the Na-V cytosolic C-terminal domain and modulate the channel's electrophysiology, but it was unknown whether they had any allosteric interactions with each other. A recent rigorous study provides insights into the molecular interactions of these ion channels and their partners that crucially take the cellular landscape into consideration.					Gabelli, Sandra/A-3705-2008	Gabelli, Sandra/0000-0003-1205-5204	National Institutes of Health NHLBI [HL128743]	National Institutes of Health NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by National Institutes of Health NHLBI (HL128743).	Ben-Johny M, 2014, CELL, V157, P1657, DOI 10.1016/j.cell.2014.04.035; Dover K, 2010, J PHYSIOL-LONDON, V588, P3695, DOI 10.1113/jphysiol.2010.192559; Evans TIA, 2009, PROTEINS, V76, P47, DOI 10.1002/prot.22317; Goldfarb M, 2005, CYTOKINE GROWTH F R, V16, P215, DOI 10.1016/j.cytogfr.2005.02.002; Lou JY, 2005, J PHYSIOL-LONDON, V569, P179, DOI 10.1113/jphysiol.2005.097220; Mahling R., 2021, J BIOL CHEM, V296; Nathan S, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012722; Niu J, 2018, ELIFE, V7, DOI 10.7554/eLife.35222; Pitt GS, 2016, PROTEIN SCI, V25, P1573, DOI 10.1002/pro.2960; Yoder JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09570-7	10	0	0	1	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100832	10.1016/j.jbc.2021.100832	http://dx.doi.org/10.1016/j.jbc.2021.100832			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34048713	gold, Green Published			2022-12-28	WOS:000674717300027
J	Mehla, J; Liechti, G; Morgenstein, RM; Caufield, JH; Hosseinnia, A; Gagarinova, A; Phanse, S; Goodacre, N; Brockett, M; Sakhawalkar, N; Babu, M; Xiao, R; Montelione, GT; Vorobiev, S; den Blaauwen, T; Hunt, JF; Uetz, P				Mehla, Jitender; Liechti, George; Morgenstein, Randy M.; Caufield, J. Harry; Hosseinnia, Ali; Gagarinova, Alla; Phanse, Sadhna; Goodacre, Norman; Brockett, Mary; Sakhawalkar, Neha; Babu, Mohan; Xiao, Rong; Montelione, Gaetano T.; Vorobiev, Sergey; den Blaauwen, Tanneke; Hunt, John F.; Uetz, Peter			ZapG (YhcB/DUF1043), a novel cell division protein in gamma-proteobacteria linking the Z-ring to septal peptidoglycan synthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; BIOFILM FORMATION; COILED COILS; GENES; CRYSTALLIZATION; RESISTANCE; LANDSCAPE; PROGRAM; SYSTEM; MODEL	YhcB, a poorly understood protein conserved across gamma-proteobacteria, contains a domain of unknown function (DUF1043) and an N-terminal transmembrane domain. Here, we used an integrated approach including X-ray crystallography, genetics, and molecular biology to investigate the function and structure of YhcB. The Escherichia coli yhcB KO strain does not grow at 45 degrees C and is hypersensitive to cell wall-acting antibiotics, even in the stationary phase. The deletion of yhcB leads to filamentation, abnormal FtsZ ring formation, and aberrant septum development. The Z-ring is essential for the positioning of the septa and the initiation of cell division. We found that YhcB interacts with proteins of the divisome (e.g., FtsI, FtsQ) and elongasome (e.g., RodZ, RodA). Seven of these interactions are also conserved in Yersinia pestis and/or Vibrio cholerae. Furthermore, we mapped the amino acid residues likely involved in the interactions of YhcB with FtsI and RodZ. The 2.8 angstrom crystal structure of the cytosolic domain of Haemophilus ducreyi YhcB shows a unique tetrameric alpha-helical coiled-coil structure likely to be involved in linking the Z-ring to the septal peptidoglycan-synthesizing complexes. In summary, YhcB is a conserved and conditionally essential protein that plays a role in cell division and consequently affects envelope biogenesis. Based on these findings, we propose to rename YhcB to ZapG (Z-ring-associated protein G). This study will serve as a starting point for future studies on this protein family and on how cells transit from exponential to stationary survival.	[Mehla, Jitender; Caufield, J. Harry; Goodacre, Norman; Sakhawalkar, Neha; Uetz, Peter] Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA; [Liechti, George; Brockett, Mary] Uniformed Serv Univ Hlth Sci, Henry Jackson Fdn, Dept Microbiol & Immunol, Bethesda, MD 20814 USA; [Morgenstein, Randy M.] Oklahoma State Univ, Dept Microbiol & Mol Genet, Stillwater, OK 74078 USA; [Hosseinnia, Ali; Phanse, Sadhna; Babu, Mohan] Univ Regina, Res & Innovat Ctr, Dept Biochem, Regina, SK, Canada; [Gagarinova, Alla] Univ Saskatchewan, Coll Med, Dept Biochem, Saskatoon, SK, Canada; [Xiao, Rong] Nex Biosci Inc, Rocky Hill, NJ USA; [Xiao, Rong; Montelione, Gaetano T.; Vorobiev, Sergey; Hunt, John F.] Rensselaer Polytech Inst, Dept Chem & Chem Biol, Troy, NY USA; [Xiao, Rong; Montelione, Gaetano T.; Vorobiev, Sergey; Hunt, John F.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Sci, Troy, NY USA; [Vorobiev, Sergey; Hunt, John F.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [den Blaauwen, Tanneke] Univ Amsterdam, Swammerdam Inst Life Sci, Bacterial Cell Biol & Physiol, Amsterdam, Netherlands; [Mehla, Jitender] Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA	Virginia Commonwealth University; Uniformed Services University of the Health Sciences - USA; Oklahoma State University System; Oklahoma State University - Stillwater; University of Regina; University of Saskatchewan; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; Columbia University; University of Amsterdam; University of Oklahoma System; University of Oklahoma - Norman	Mehla, J; Uetz, P (corresponding author), Virginia Commonwealth Univ, Ctr Study Biol Complex, Med Coll Virginia Campus, Richmond, VA 23284 USA.; Mehla, J (corresponding author), Univ Oklahoma, Dept Chem & Biochem, Norman, OK 73019 USA.	jitendermehla@ou.edu; uetz@vcu.edu	Morgenstein, Randy/AAB-3430-2022; Uetz, Peter/A-7119-2012; Mehla, Jitender/M-6165-2016	Montelione, Gaetano/0000-0002-9440-3059; Hosseinnia, Ali/0000-0002-6499-0758; Uetz, Peter/0000-0001-6194-4927; Mehla, Jitender/0000-0002-7829-557X	Natural Sciences and Engineering Research Council of Canada [DG-20234]; NIH [5U54GM094597, GM138202, GM109895]; faculty start up award	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); faculty start up award	This work was supported by the Natural Sciences and Engineering Research Council of Canada Grant DG-20234 to Mohan Babu, NIH Grants 5U54GM094597 to G. T. M., GM138202 to G.L., and GM109895 to P. U. and a faculty start up award to G. L. The views expressed in this article are those of the authors and should not be construed as official or representing the views of the Department of Defense or the Uniformed Services University. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Baars L, 2008, J BACTERIOL, V190, P3505, DOI 10.1128/JB.01631-07; Baba Tomoya, 2006, Mol Syst Biol, V2; Babu M, 2018, NAT BIOTECHNOL, V36, P103, DOI 10.1038/nbt.4024; Babu M, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002377; Barton B, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.664281; Bastard Karine, 2014, Nat Chem Biol, V10, P42, DOI 10.1038/nchembio.1387; Bateman A, 2019, NUCLEIC ACIDS RES, V47, pD506, DOI 10.1093/nar/gky1049; Battesti A, 2012, METHODS, V58, P325, DOI 10.1016/j.ymeth.2012.07.018; Becket E, 2010, DNA REPAIR, V9, P949, DOI 10.1016/j.dnarep.2010.06.008; Brooks JF, 2014, P NATL ACAD SCI USA, V111, P17284, DOI 10.1073/pnas.1415957111; Buddelmeijer N, 2013, BIOPROTOC, V3, P852, DOI [10.21769/BioProtoc.852, DOI 10.21769/BIOPROTOC.852]; Buss J, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005128; Carlson ML, 2019, ELIFE, V8, DOI 10.7554/eLife.46615; CHAYEN NE, 1990, J APPL CRYSTALLOGR, V23, P297, DOI 10.1107/S0021889890003260; Cho H, 2014, CELL, V159, P1300, DOI 10.1016/j.cell.2014.11.017; Choi JS, 2018, RNA BIOL, V15, P1319, DOI 10.1080/15476286.2018.1532252; Du SS, 2017, MOL MICROBIOL, V105, P177, DOI 10.1111/mmi.13696; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ezemaduka AN, 2014, J BACTERIOL, V196, P2004, DOI 10.1128/JB.01473-14; Federhen S, 2012, NUCLEIC ACIDS RES, V40, pD136, DOI 10.1093/nar/gkr1178; Frohlich KS, 2016, NUCLEIC ACIDS RES, V44, P10406, DOI 10.1093/nar/gkw632; Gagarinova A, 2012, JOVE-J VIS EXP, DOI 10.3791/4056; Green MR., 2012, MOL CLONING LAB MANU; Hale CA, 2011, J BACTERIOL, V193, P1393, DOI 10.1128/JB.01245-10; Hartmann MD, 2014, J STRUCT BIOL, V186, P357, DOI 10.1016/j.jsb.2014.02.008; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Hopf TA, 2014, ELIFE, V3, DOI 10.7554/eLife.03430; Hu PZ, 2009, PLOS BIOL, V7, P929, DOI 10.1371/journal.pbio.1000096; Huerta-Cepas J, 2019, NUCLEIC ACIDS RES, V47, pD309, DOI 10.1093/nar/gky1085; Hugonnet JE, 2016, ELIFE, V5, DOI 10.7554/eLife.19469; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; Kamisetty H, 2013, P NATL ACAD SCI USA, V110, P15674, DOI 10.1073/pnas.1314045110; Klein G, 2014, J BIOL CHEM, V289, P14829, DOI 10.1074/jbc.M113.539494; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuru E, 2019, ACS CHEM BIOL, V14, P2745, DOI 10.1021/acschembio.9b00664; Kuru E, 2012, ANGEW CHEM INT EDIT, V51, P12519, DOI 10.1002/anie.201206749; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li G., 2012, ISRN MOL BIOL, V2012; Liechti GW, 2014, NATURE, V506, P507, DOI 10.1038/nature12892; Loo CY, 2000, J BACTERIOL, V182, P1374, DOI 10.1128/JB.182.5.1374-1382.2000; Luft JR, 2011, EXPERT OPIN DRUG DIS, V6, P465, DOI 10.1517/17460441.2011.566857; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Maisonneuve E, 2011, P NATL ACAD SCI USA, V108, P13206, DOI 10.1073/pnas.1100186108; Mehla J, 2017, METHOD ENZYMOL, V586, P333, DOI 10.1016/bs.mie.2016.10.020; Mehla J, 2011, APPL ENVIRON MICROB, V77, P786, DOI 10.1128/AEM.01496-10; Merdanovic M, 2011, ANNU REV MICROBIOL, V65, P149, DOI 10.1146/annurev-micro-090110-102925; Miller J.H, 1993, J BASIC MICROB, V33, P278; Mogi T., 2006, BIOCHIM BIOPHYS ACTA, V1757, P860; Murata M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020063; Niba ETE, 2007, DNA RES, V14, P237, DOI 10.1093/dnares/dsm024; Nichols RJ, 2011, CELL, V144, P143, DOI 10.1016/j.cell.2010.11.052; O'Reilly EK, 2004, J BACTERIOL, V186, P7149, DOI 10.1128/JB.186.21.7149-7160.2004; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ouellette SP, 2014, ENV MICROBIOL REP, V6, P259, DOI 10.1111/1758-2229.12123; Ovchinnikov S, 2014, ELIFE, V3, DOI 10.7554/eLife.02030; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Overbeek R., 2014, NUCL ACIDS RES, DOI 10.1093/nar/gkt1226; Paradis-Bleau C, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004056; Pazos M, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07559-2; Poirel L, 2017, CLIN MICROBIOL REV, V30, P557, DOI 10.1128/CMR.00064-16; Potluri LP, 2012, J BACTERIOL, V194, P5334, DOI 10.1128/JB.00859-12; Prakash A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025570; Rajagopala SV, 2014, NAT BIOTECHNOL, V32, P285, DOI 10.1038/nbt.2831; Rajagopala SV, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-470; Rice LM, 2000, ACTA CRYSTALLOGR D, V56, P1413, DOI 10.1107/S0907444900010039; Roseboom W, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19102928; Sargentini NJ, 2016, MUTAT RES-FUND MOL M, V793, P1, DOI 10.1016/j.mrfmmm.2016.10.001; Sauert M, 2016, NUCLEIC ACIDS RES, V44, P6660, DOI 10.1093/nar/gkw115; Schmidt A, 2016, NAT BIOTECHNOL, V34, P104, DOI 10.1038/nbt.3418; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stocks CJ, 2019, P NATL ACAD SCI USA, V116, P6341, DOI 10.1073/pnas.1820870116; Stokes JM, 2014, ELIFE, V3, DOI 10.7554/eLife.03574; Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454; Sung CG, 2020, J MICROBIOL, V58, P598, DOI 10.1007/s12275-020-0078-4; van den Ent F, 2014, ELIFE, V3, DOI 10.7554/eLife.02634; van der Ploeg R, 2015, INT J MOL SCI, V16, P17637, DOI 10.3390/ijms160817637; van der Ploeg R, 2013, MOL MICROBIOL, V87, P1074, DOI 10.1111/mmi.12150; Vischer NOE, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00586; Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545; Xiao R, 2010, J STRUCT BIOL, V172, P21, DOI 10.1016/j.jsb.2010.07.011; Yoshii Y, 2019, MOL MICROBIOL, V111, P1229, DOI 10.1111/mmi.14217; Zhang H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5339	85	3	3	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100700	10.1016/j.jbc.2021.100700	http://dx.doi.org/10.1016/j.jbc.2021.100700			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895137	Green Published, gold			2022-12-28	WOS:000672866400671
J	Murphy, SE				Murphy, Sharon E.			Biochemistry of nicotine metabolism and its relevance to lung cancer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							E3 UBIQUITIN LIGASE; TRIM FAMILY PROTEINS; CRYSTAL-STRUCTURE; B30.2 DOMAIN; PHOSPHOANTIGENS; RESTRICTION; ROLES	Nicotine is the key addictive constituent of tobacco. It is not a carcinogen, but it drives smoking and the continued exposure to the many carcinogens present in tobacco. The investigation into nicotine biotransformation has been ongoing for more than 60 years. The dominant pathway of nicotine metabolism in humans is the formation of cotinine, which occurs in two steps. The first step is cytochrome P450 (P450, CYP) 2A6-catalyzed 5'-oxidation to an iminium ion, and the second step is oxidation of the iminium ion to cotinine. The half-life of nicotine is longer in individuals with low P450 2A6 activity, and smokers with low activity often decrease either the intensity of their smoking or the number of cigarettes they use compared with those with "normal" activity. The effect of P450 2A6 activity on smoking may influence one's tobacco-related disease risk. This review provides an overview of nicotine metabolism and a summary of the use of nicotine metabolite biomarkers to define smoking dose. Some more recent findings, for example, the identification of uridine 5'-diphospho-glucuronosyltransferase 2B10 as the catalyst of nicotine N-glucuronidation, are discussed. We also describe epidemiology studies that establish the contribution of nicotine metabolism and CYP2A6 genotype to lung cancer risk, particularly with respect to specific racial/ethnic groups, such as those with Japanese, African, or European ancestry. We conclude that a model of nicotine metabolism and smoking dose could be combined with other lung cancer risk variables to more accurately identify former smokers at the highest risk of lung cancer and to intervene accordingly.	[Murphy, Sharon E.] Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Murphy, SE (corresponding author), Univ Minnesota, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	murph062@umn.edu			National Cancer Institute, National Institutes of Health [P01 CA-138338]	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grant P01 CA-138338 from the National Cancer Institute, National Institutes of Health. The content is solely the responsibility of the author and does not necessarily represent the official views of the National Institutes of Health.	Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Chakraborty A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7782; D'Cruz AA, 2013, BIOCHEM J, V456, P231, DOI 10.1042/BJ20121425; Giraldo MI, 2020, NATURE, V585, P414, DOI 10.1038/s41586-020-2457-8; Gu SY, 2017, P NATL ACAD SCI USA, V114, pE7311, DOI 10.1073/pnas.1707547114; Hatakeyama S, 2017, TRENDS BIOCHEM SCI, V42, P297, DOI 10.1016/j.tibs.2017.01.002; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Hu X, 2019, BIOCHEM BIOPH RES CO, V511, P889, DOI 10.1016/j.bbrc.2019.02.001; James LC, 2007, P NATL ACAD SCI USA, V104, P6200, DOI 10.1073/pnas.0609174104; Ji RJ, 2020, IUBMB LIFE, V72, P247, DOI 10.1002/iub.2181; Joazeiro CAP, 2000, CELL, V102, P549, DOI 10.1016/S0092-8674(00)00077-5; Kato K, 2021, MOL CELL, V81, DOI 10.1016/j.molcel.2020.11.047; Keeble AH, 2008, P NATL ACAD SCI USA, V105, P6045, DOI 10.1073/pnas.0800159105; Koliopoulos MG, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04214-8; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li X, 2008, J VIROL, V82, P11495, DOI 10.1128/JVI.01548-08; Lu MF, 2019, MOL IMMUNOL, V109, P126, DOI 10.1016/j.molimm.2019.01.015; Montori-Grau M, 2018, METABOLISM, V83, P177, DOI 10.1016/j.metabol.2018.02.005; Orchard RC, 2019, J VIROL, V93, DOI 10.1128/JVI.01324-18; Ozato K, 2008, NAT REV IMMUNOL, V8, P849, DOI 10.1038/nri2413; Park EY, 2010, PROTEINS, V78, P790, DOI 10.1002/prot.22647; Perfetto L, 2013, TRENDS BIOCHEM SCI, V38, P38, DOI 10.1016/j.tibs.2012.10.001; Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140; Salim M, 2017, ACS CHEM BIOL, V12, P2631, DOI 10.1021/acschembio.7b00694; Sanchez JG, 2014, P NATL ACAD SCI USA, V111, P2494, DOI 10.1073/pnas.1318962111; Sandstrom A, 2014, IMMUNITY, V40, P490, DOI 10.1016/j.immuni.2014.03.003; Sardiello M, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-225; Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Skurat AV, 2002, J BIOL CHEM, V277, P19331, DOI 10.1074/jbc.M201190200; Song B, 2005, J VIROL, V79, P3930, DOI 10.1128/JVI.79.7.3930-3937.2005; Song BW, 2005, J VIROL, V79, P6111, DOI 10.1128/JVI.79.10.6111-6121.2005; Tate JG, 2019, NUCLEIC ACIDS RES, V47, pD941, DOI 10.1093/nar/gky1015; van Gent M, 2018, ANNU REV VIROL, V5, P385, DOI 10.1146/annurev-virology-092917-043323; van Tol S, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5030023; Weinert C, 2009, J MOL BIOL, V394, P226, DOI 10.1016/j.jmb.2009.08.059; Woo JS, 2006, EMBO J, V25, P1353, DOI 10.1038/sj.emboj.7600994; Yang B, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008387; Yu Y, 2019, FEBS LETT, V593, P1122, DOI 10.1002/1873-3468.13386; Zeqiraj E, 2014, P NATL ACAD SCI USA, V111, pE2831, DOI 10.1073/pnas.1402926111; Zhai LM, 2004, ARCH BIOCHEM BIOPHYS, V421, P236, DOI 10.1016/j.abb.2003.11.017; Zhou CL, 2020, EBIOMEDICINE, V59, DOI 10.1016/j.ebiom.2020.102955; Zhu LH, 2020, CELL DEATH DIFFER, V27, P1819, DOI 10.1038/s41418-019-0464-9	44	12	12	3	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100722	10.1016/j.jbc.2021.100722	http://dx.doi.org/10.1016/j.jbc.2021.100722			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33932402	Green Published, gold			2022-12-28	WOS:000672866400692
J	Oechslin, F; Menzi, C; Moreillon, P; Resch, G				Oechslin, Frank; Menzi, Carmen; Moreillon, Philippe; Resch, Gregory			The multidomain architecture of a bacteriophage endolysin enables intramolecular synergism and regulation of bacterial lysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LACTOCOCCUS-LACTIS; STAPHYLOCOCCUS-AUREUS; N-ACETYLGLUCOSAMINIDASE; PEPTIDOGLYCAN; DOMAINS; BINDING; ENDOPEPTIDASE; AUTOLYSIS; AMIDASE; MOTIF	Endolysins are peptidoglycan hydrolases produced at the end of the bacteriophage (phage) replication cycle to lyse the host cell. Endolysins in Gram-positive phages come in a variety of multimodular forms that combine different catalytic and cell wall binding domains. However, the reason why phages adopt endolysins with such complex multidomain architecture is not well understood. In this study, we used the Streptococcus dysgalactiae phage endolysin PlySK1249 as a model to investigate the role of multidomain architecture in phage-induced bacterial lysis and lysis regulation. PlySK1249 consists of an amidase (Ami) domain that lyses bacterial cells, a nonbacteriolytic endopeptidase (CHAP) domain that acts as a dechaining enzyme, and a central LysM cell wall binding domain. We observed that the Ami and CHAP domains synergized for peptidoglycan digestion and bacteriolysis in the native enzyme or when expressed individually and reunified. The CHAP endopeptidase resolved complex polymers of stem-peptides to dimers and helped the Ami domain to digest peptidoglycan to completion. We also found that PlySK1249 was subject to proteolytic cleavage by host cell wall proteases both in vitro and after phage induction. Cleavage disconnected the different domains by hydrolyzing their linker regions, thus hindering their bacteriolytic cooperation and possibly modulating the lytic activity of the enzyme. PlySK1249 cleavage by cell-wall-associated proteases may represent another example of phage adaptation toward the use of existing bacterial regulation mechanism for their own advantage. In addition, understanding more thoroughly the multidomain interplay of PlySK1249 broadens our knowledge on the ideal architecture of therapeutic antibacterial endolysins.	[Oechslin, Frank; Menzi, Carmen; Moreillon, Philippe; Resch, Gregory] Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland; [Oechslin, Frank] Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada; [Resch, Gregory] Lausanne Univ Hosp, Ctr Res & Innovat Clin Pharmaceut Sci, Lausanne, Switzerland	University of Lausanne; Laval University; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Oechslin, F (corresponding author), Univ Lausanne, Dept Fundamental Microbiol, Lausanne, Switzerland.; Oechslin, F (corresponding author), Univ Laval, Dept Biochem Microbiol & Bioinformat, Quebec City, PQ, Canada.	Frank.Oechslin@gmail.com		Menzi, Carmen/0000-0002-8656-3183; moreillon, philippe/0000-0001-7745-5538; resch, gregory/0000-0003-2341-4591	Foundation for Advancement in Medical Microbiology and Infectious Diseases (FAMMID); Swiss National Science Foundation (SNSF) [P400PB_191059]	Foundation for Advancement in Medical Microbiology and Infectious Diseases (FAMMID); Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF))	This work was supported by a nonrestricted grant from the Foundation for Advancement in Medical Microbiology and Infectious Diseases (FAMMID) (P. M.). This work was also supported by the Swiss National Science Foundation (SNSF) under grant P400PB_191059 (F.O).	Becker SC, 2009, FEMS MICROBIOL LETT, V294, P52, DOI 10.1111/j.1574-6968.2009.01541.x; Broskey NT, 2013, J APPL PHYSIOL, V115, P765, DOI 10.1152/japplphysiol.00063.2013; Buist G, 1998, J BACTERIOL, V180, P5947, DOI 10.1128/JB.180.22.5947-5953.1998; Buist G, 2008, MOL MICROBIOL, V68, P838, DOI 10.1111/j.1365-2958.2008.06211.x; Christensen JE, 1999, ANTON LEEUW INT J G, V76, P217, DOI 10.1023/A:1002001919720; Donovan DM, 2008, FEMS MICROBIOL LETT, V287, P22, DOI 10.1111/j.1574-6968.2008.01287.x; Donovan DM, 2006, APPL ENVIRON MICROB, V72, P5108, DOI 10.1128/AEM.03065-05; Eckert C, 2006, J BACTERIOL, V188, P8513, DOI 10.1128/JB.01145-06; FAN DP, 1970, J BACTERIOL, V103, P494, DOI 10.1128/JB.103.2.494-499.1970; Fischetti VA, 2010, INT J MED MICROBIOL, V300, P357, DOI 10.1016/j.ijmm.2010.04.002; Fischetti VA, 2008, CURR OPIN MICROBIOL, V11, P393, DOI 10.1016/j.mib.2008.09.012; Gu JM, 2011, J CLIN MICROBIOL, V49, P111, DOI 10.1128/JCM.01144-10; HERBOLD DR, 1975, J BIOL CHEM, V250, P7231; Horgan M, 2009, APPL ENVIRON MICROB, V75, P872, DOI 10.1128/AEM.01831-08; Hyman P, 2012, ADV M C M, P1, DOI 10.1079/9781845939847.0000; Layec S, 2009, MOL MICROBIOL, V71, P1205, DOI 10.1111/j.1365-2958.2009.06595.x; Loessner MJ, 2002, MOL MICROBIOL, V44, P335, DOI 10.1046/j.1365-2958.2002.02889.x; Loessner MJ, 2005, CURR OPIN MICROBIOL, V8, P480, DOI 10.1016/j.mib.2005.06.002; Low LY, 2011, J BIOL CHEM, V286, P34391, DOI 10.1074/jbc.M111.244160; Majcherczyk PA, 1999, J BIOL CHEM, V274, P12537, DOI 10.1074/jbc.274.18.12537; Navarre WW, 1999, J BIOL CHEM, V274, P15847, DOI 10.1074/jbc.274.22.15847; Nelson DC, 2012, ADV VIRUS RES, V83, P299, DOI 10.1016/B978-0-12-394438-2.00007-4; O'Flaherty S, 2005, J BACTERIOL, V187, P7161, DOI 10.1128/JB.187.20.7161-7164.2005; Oechslin F, 2013, ANTIMICROB AGENTS CH, V57, P6276, DOI 10.1128/AAC.01701-13; Pritchard DG, 2007, APPL ENVIRON MICROB, V73, P7150, DOI 10.1128/AEM.01783-07; Pritchard DG, 2004, MICROBIOL-SGM, V150, P2079, DOI 10.1099/mic.0.27063-0; Que YA, 2000, INFECT IMMUN, V68, P3516, DOI 10.1128/IAI.68.6.3516-3522.2000; Rashel M, 2007, J INFECT DIS, V196, P1237, DOI 10.1086/521305; Rigden DJ, 2003, TRENDS BIOCHEM SCI, V28, P230, DOI 10.1016/S0968-0004(03)00062-8; SCHLEIFER KH, 1972, BACTERIOL REV, V36, P407, DOI 10.1128/MMBR.36.4.407-477.1972; Schmelcher M, 2015, J ANTIMICROB CHEMOTH, V70, P1453, DOI 10.1093/jac/dku552; Sheychenko A, 2006, NAT PROTOC, V1, p2856 2860; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2005, J BACTERIOL, V187, P114, DOI 10.1128/JB.187.1.114-124.2005; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Visweswaran GRR, 2014, APPL MICROBIOL BIOT, V98, P4331, DOI 10.1007/s00253-014-5633-7; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; WANG X, 1991, GENE, V102, P105; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Wong JEMM, 2015, ACTA CRYSTALLOGR D, V71, P592, DOI 10.1107/S139900471402793X; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z	41	6	6	6	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100639	10.1016/j.jbc.2021.100639	http://dx.doi.org/10.1016/j.jbc.2021.100639			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33838182	gold, Green Published			2022-12-28	WOS:000672866400610
J	Huang, YY; Lu, JL; Zhan, L; Wang, M; Shi, RH; Yuan, X; Gao, XJ; Liu, X; Zang, JY; Liu, W; Yao, XB				Huang, Yuanyuan; Lu, Jianlin; Zhan, Li; Wang, Ming; Shi, Ronghua; Yuan, Xiao; Gao, Xinjiao; Liu, Xing; Zang, Jianye; Liu, Wei; Yao, Xuebiao			Resveratrol-induced Sirt1 phosphorylation by LKB1 mediates mitochondrial metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR LKB1; SMALL-MOLECULE ACTIVATORS; CELL-CYCLE; DEACETYLASE ACTIVITY; CALORIE RESTRICTION; PROTEIN SIR2; KINASE; AMPK; P53; TRANSCRIPTION	The NAD(+)-dependent deacetylase Sirt1 has been implicated in the prevention of many age-related diseases, including cancer, type 2 diabetes, and cardiovascular disease. Resveratrol, a plant polyphenol, exhibits antiaging, antitumor, and vascular protection effects by activating Sirt1. However, the molecular mechanism of Sirt1 activation as induced by resveratrol remains unclear. By knockdown/rescue experiments, fluoro-metric Sirt1 activity assay, immunoprecipitation, and pull down assays, we identify here that the tumor suppressor LKB1 (liver kinase B1) as a direct activator of Sirt1 elicited by resveratrol. Resveratrol promotes the binding between LKB1 and Sirt1, which we first reported, and this binding leads to LKB1-mediated phosphorylation of Sirt1 at three different serine residues in the C terminus of Sirt1. Mechanistically, LKB1-mediated phosphorylation increases intramolecular interactions in Sirt1, such as the binding of the C terminus to the deacetylase core domain, thereby eliminating DBC1 (Deleted in Breast Cancer 1, Sirt1 endogenous inhibitor) inhibition and promoting Sirt1-substrate interaction. Functionally, LKB1dependent Sirt1 activation increases mitochondrial biogenesis and respiration through deacetylation and activation of the transcriptional coactivator PGC-1 alpha. These results identify Sirt1 as a context-dependent target of LKB1 and suggest that a resveratrol-stimulated LKB1-Sirt1 pathway plays a vital role in mitochondrial metabolism, a key physiological process that contributes to numerous age-related diseases.	[Huang, Yuanyuan; Lu, Jianlin; Zhan, Li; Wang, Ming; Shi, Ronghua; Yuan, Xiao; Gao, Xinjiao; Liu, Xing; Zang, Jianye; Yao, Xuebiao] Univ Sci & Technol China, MOE Key Lab Cellular Dynam, Sch Life Sci, Hefei, Peoples R China; [Huang, Yuanyuan; Lu, Jianlin; Zhan, Li; Wang, Ming; Shi, Ronghua; Yuan, Xiao; Gao, Xinjiao; Liu, Xing; Zang, Jianye; Yao, Xuebiao] CAS Ctr Excellence Mol Cell Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China; [Huang, Yuanyuan; Lu, Jianlin; Zhan, Li; Wang, Ming; Shi, Ronghua; Yuan, Xiao; Gao, Xinjiao; Liu, Xing; Zang, Jianye; Yao, Xuebiao] Hefei Natl Sci Ctr Phys Sci Microscale, Hefei, Anhui, Peoples R China; [Liu, Xing; Yao, Xuebiao] Morehouse Sch Med, Keck Ctr Organoids Plast, Atlanta, GA 30310 USA; [Liu, Wei] Zhejiang Univ, Affiliated Hosp 2, Dept Biochem, Sch Med, Hangzhou, Zhejiang, Peoples R China; [Liu, Wei] Zhejiang Univ, Affiliated Hosp 2, Dept Cardiol, Sch Med, Hangzhou, Zhejiang, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Morehouse School of Medicine; Zhejiang University; Zhejiang University	Yao, XB (corresponding author), Univ Sci & Technol China, MOE Key Lab Cellular Dynam, Sch Life Sci, Hefei, Peoples R China.; Yao, XB (corresponding author), CAS Ctr Excellence Mol Cell Sci, Anhui Key Lab Cellular Dynam & Chem Biol, Hefei, Anhui, Peoples R China.; Yao, XB (corresponding author), Hefei Natl Sci Ctr Phys Sci Microscale, Hefei, Anhui, Peoples R China.; Yao, XB (corresponding author), Morehouse Sch Med, Keck Ctr Organoids Plast, Atlanta, GA 30310 USA.	yaoxb@ustc.edu.cn	Zang, Jianye/E-5228-2013	Wang, Ming/0000-0002-7000-1063; Gao, Xinjiao/0000-0002-9567-5937	National Key Research and Development Program of China [2017YFA0503600, 2016YFA0100500]; National Natural Science Foundation of China [31320103904, 31430054, 91313303, 31621002, 91854203, 91853115, 31671405, 21922706]; "Strategic Priority Research Program" of the Chinese Academy of Sciences [XDB19000000]; CAS Center for Excellence in Molecular Cell Science [2015HSC-UE010]; MOE Innovative team [IRT_17R102]; National Institutes of Health [DK56292, DK115812, CA164133]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "Strategic Priority Research Program" of the Chinese Academy of Sciences(Chinese Academy of Sciences); CAS Center for Excellence in Molecular Cell Science; MOE Innovative team; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Prof. Daan M. F. van Aalten for providing the baculovirus-based His-LKB1-STRADa-MO25a coexpression plasmid. We thank all the members of our laboratories for discussion. This work was supported in part by the National Key Research and Development Program of China (2017YFA0503600, 2016YFA0100500), National Natural Science Foundation of China (31320103904, 31430054, 91313303, 31621002, 91854203, 91853115, 31671405, and 21922706), "Strategic Priority Research Program" of the Chinese Academy of Sciences (XDB19000000), CAS Center for Excellence in Molecular Cell Science (2015HSC-UE010), MOE Innovative team (IRT_17R102), and the National Institutes of Health (DK56292, DK115812, and CA164133)	Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Atkins KM, 2014, CELL REP, V8, P1545, DOI 10.1016/j.celrep.2014.07.049; Avizienyte E, 1999, AM J PATHOL, V154, P677, DOI 10.1016/S0002-9440(10)65314-X; Baas AF, 2003, EMBO J, V22, P3062, DOI 10.1093/emboj/cdg292; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Barger JL, 2008, EXP GERONTOL, V43, P859, DOI 10.1016/j.exger.2008.06.013; Barger JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002264; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Baur JA, 2006, NAT REV DRUG DISCOV, V5, P493, DOI 10.1038/nrd2060; Beher D, 2009, CHEM BIOL DRUG DES, V74, P619, DOI 10.1111/j.1747-0285.2009.00901.x; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Borra MT, 2005, J BIOL CHEM, V280, P17187, DOI 10.1074/jbc.M501250200; Boudeau J, 2004, J CELL SCI, V117, P6365, DOI 10.1242/jcs.01571; Boudeau J, 2003, EMBO J, V22, P5102, DOI 10.1093/emboj/cdg490; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chang CM, 2015, MOL CELL, V60, P930, DOI 10.1016/j.molcel.2015.10.037; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Dasgupta B, 2007, P NATL ACAD SCI USA, V104, P7217, DOI 10.1073/pnas.0610068104; Dvir-Ginzberg M., 2011, ARTHRITIS RHEUM-US, V63, P2363, DOI DOI 10.1002/art.30279; Fulco M, 2008, CELL CYCLE, V7, P3669, DOI 10.4161/cc.7.23.7164; Gan BY, 2010, NATURE, V468, P701, DOI 10.1038/nature09595; Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P13632, DOI 10.1073/pnas.0706290104; Goodwin JM, 2014, MOL CELL, V55, P436, DOI 10.1016/j.molcel.2014.06.021; Guarente L, 2000, GENE DEV, V14, P1021; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Gurumurthy S, 2010, NATURE, V468, P659, DOI 10.1038/nature09572; Han CF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01654-6; Hawley Simon A, 2003, J Biol, V2, P28, DOI 10.1186/1475-4924-2-28; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Hemminki A, 1998, NATURE, V391, P184, DOI 10.1038/34432; Herranz D, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1001; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Kang H, 2011, MOL CELL, V44, P203, DOI 10.1016/j.molcel.2011.07.038; Kang H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006611; Kaufmann U, 2019, CELL METAB, V29, P1104, DOI 10.1016/j.cmet.2019.01.019; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Krock B, 2011, CELL METAB, V13, P8, DOI 10.1016/j.cmet.2010.12.015; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Langley E, 2002, EMBO J, V21, P2383, DOI 10.1093/emboj/21.10.2383; Lau AW, 2014, AM J CANCER RES, V4, P245; Lee SW, 2015, MOL CELL, V57, P1022, DOI 10.1016/j.molcel.2015.01.015; Li FM, 2015, CANCER CELL, V27, P698, DOI 10.1016/j.ccell.2015.04.001; Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Lu JL, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2021.102363; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Nakada D, 2010, NATURE, V468, P653, DOI 10.1038/nature09571; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Neumann H, 2009, MOL CELL, V36, P153, DOI 10.1016/j.molcel.2009.07.027; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Park CE, 2007, EXP MOL MED, V39, P222, DOI 10.1038/emm.2007.25; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pearson KJ, 2008, CELL METAB, V8, P157, DOI 10.1016/j.cmet.2008.06.011; Pfanner N, 2019, NAT REV MOL CELL BIO, V20, P267, DOI 10.1038/s41580-018-0092-0; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Price NL, 2012, CELL METAB, V15, P675, DOI 10.1016/j.cmet.2012.04.003; Raynes Rachel, 2013, Genes Cancer, V4, P172, DOI 10.1177/1947601913484497; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Shaw RJ, 2004, P NATL ACAD SCI USA, V101, P3329, DOI 10.1073/pnas.0308061100; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Smith JS, 2000, P NATL ACAD SCI USA, V97, P6658, DOI 10.1073/pnas.97.12.6658; Tarumoto Y, 2018, MOL CELL, V69, P1017, DOI 10.1016/j.molcel.2018.02.011; ten Klooster JP, 2009, DEV CELL, V16, P551, DOI 10.1016/j.devcel.2009.01.016; Um JH, 2010, DIABETES, V59, P554, DOI 10.2337/db09-0482; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wan W, 2017, MOL CELL, V68, P323, DOI 10.1016/j.molcel.2017.09.020; Wen L, 2013, P NATL ACAD SCI USA, V110, pE2420, DOI 10.1073/pnas.1309354110; Werle K, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.135; Xia P, 2012, P NATL ACAD SCI USA, V109, P16564, DOI 10.1073/pnas.1202639109; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Zeqiraj E, 2009, SCIENCE, V326, P1707, DOI 10.1126/science.1178377; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Zheng B, 2009, MOL CELL, V33, P237, DOI 10.1016/j.molcel.2008.12.026	86	12	13	5	18	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100929	10.1016/j.jbc.2021.100929	http://dx.doi.org/10.1016/j.jbc.2021.100929			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34216621	gold, Green Published			2022-12-28	WOS:000690879300012
J	Li, DP; Xie, LF; Qiao, ZG; Mai, SY; Zhu, JF; Zhang, F; Chen, SC; Li, L; Shen, FR; Qin, YH; Yao, HP; He, SD; Ma, F				Li, Dapei; Xie, Lifen; Qiao, Zigang; Mai, Sanyue; Zhu, Jingfei; Zhang, Fan; Chen, Shengchuan; Li, Liang; Shen, Fangrong; Qin, Yanghua; Yao, Haiping; He, Sudan; Ma, Feng			STING-mediated degradation of IFI16 negatively regulates apoptosis by inhibiting p53 phosphorylation at serine 392	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR P53; NUCLEAR; PROTEIN; SENSOR; EXPRESSION; ASSOCIATION; ACTIVATION; IFI-16; FAMILY; GROWTH	Interferon-gamma-inducible factor 16 (IFI16) triggers stimulator of interferon (IFN) genes (STING)-dependent type I IFN production during host antiviral immunity and facilitates p53 dependent apoptosis during suppressing tumorigenesis. We have previously reported that STING-mediated IFI16 degradation negatively regulates type I IFN production. However, it is unknown whether STING also suppresses IFI16/p53dependent apoptosis via degradation of IFI16. Here, our results from flow cytometry apoptosis detection and immunoblot assays show that IFI16 and nutlin-3, a p53 pathway activator, synergistically induce apoptosis in U2OS and A549 cells. Protein kinase R-triggered phosphorylation of p53 at serine 392 is critical for the IFI16-p53-dependent apoptosis. However, overexpression of STING suppresses p53 serine 392 phosphorylation, p53 transcriptional activity, expression of p53 target genes, and p53-dependent mitochondrial depolarization and apoptosis. In summary, our current study demonstrates that STING-mediated IFI16 degradation negatively regulates IFI16-mediated p53-dependent apoptosis in osteosarcoma and non-small cell lung cancer cells, which suggests a protumorigenic role for STING in certain cancer types because of its potent ability to degrade upstream IFI16.	[Li, Dapei; Xie, Lifen; Qiao, Zigang; Zhu, Jingfei; Zhang, Fan; Li, Liang; Yao, Haiping; He, Sudan; Ma, Feng] Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China; [Li, Dapei; Xie, Lifen; Qiao, Zigang; Zhu, Jingfei; Zhang, Fan; Chen, Shengchuan; Li, Liang; Yao, Haiping; He, Sudan; Ma, Feng] Suzhou Inst Syst Med, Suzhou, Peoples R China; [Mai, Sanyue] 988 Cent Hosp Peoples Liberat Army, Dept Lab Med, Zhengzhou, Peoples R China; [Chen, Shengchuan; Li, Liang; Ma, Feng] Wenzhou Med Univ, Dept Hepatopancreatobiliary Surg, Affiliated Hosp 1, Wenzhou, Peoples R China; [Shen, Fangrong] Soochow Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Suzhou, Peoples R China; [Qin, Yanghua] Second Mil Med Univ, Dept Lab Diag, Changhai Hosp, Shanghai, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Wenzhou Medical University; Soochow University - China; Naval Medical University	Li, DP; Ma, F (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Ctr Syst Med, Inst Basic Med Sci, Beijing, Peoples R China.; Li, DP; Ma, F (corresponding author), Suzhou Inst Syst Med, Suzhou, Peoples R China.	dapei_1173@163.com; maf@ism.pumc.edu.cn	qin, yanghua/G-4424-2010	Qin, Yanghua/0000-0001-9516-7441	Natural Science Foundation of Jiangsu Province [BK20170408, BK20200004]; National Natural Science Foundation of China [31800760, 81900583, 31670883, 31771560]; National Key Research and Development Program of China [2018YFA0900803]; CAMS Initiative for Innovative Medicine [2016-I2M-1-005]; Non-profit Central Research Institute Fund of CAMS [2016ZX310189, 2016ZX310194, 2017NL31004, 2019PT310028]; Innovation Fund for Graduate Students of Peking Union Medical College [2019-1001-11]	Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; CAMS Initiative for Innovative Medicine; Non-profit Central Research Institute Fund of CAMS; Innovation Fund for Graduate Students of Peking Union Medical College	This work was supported by the Natural Science Foundation of Jiangsu Province (BK20170408 and BK20200004), National Natural Science Foundation of China (31800760, 81900583, 31670883, and 31771560), National Key Research and Development Program of China (2018YFA0900803), CAMS Initiative for Innovative Medicine (2016-I2M-1-005), Non-profit Central Research Institute Fund of CAMS (2016ZX310189, 2016ZX310194, 2017NL31004, and 2019PT310028), and the Innovation Fund for Graduate Students of Peking Union Medical College (2019-1001-11).	Almine JF, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14392; Ashcroft M, 1999, MOL CELL BIOL, V19, P1751; Baer AN, 2016, ARTHRIT CARE RES, V68, P254, DOI 10.1002/acr.22632; Bruins W, 2008, MOL CELL BIOL, V28, P1974, DOI 10.1128/MCB.01610-07; Castrogiovanni C, 2018, CELL DEATH DIFFER, V25, P190, DOI 10.1038/cdd.2017.143; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chipuk JE, 2005, SCIENCE, V309, P1732, DOI 10.1126/science.1114297; Choubey D, 2016, AGEING RES REV, V28, P27, DOI 10.1016/j.arr.2016.04.002; Choubey D, 2010, J INTERF CYTOK RES, V30, P371, DOI 10.1089/jir.2009.0096; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Cox ML, 2010, CELL SIGNAL, V22, P564, DOI 10.1016/j.cellsig.2009.11.014; Cuddihy AR, 1999, ONCOGENE, V18, P2690, DOI 10.1038/sj.onc.1202620; Dawson MJ, 1996, J LEUKOCYTE BIOL, V60, P310, DOI 10.1002/jlb.60.3.310; DAWSON MJ, 1995, J CELL BIOCHEM, V57, P39, DOI 10.1002/jcb.240570106; Ding QJ, 2013, J MED CHEM, V56, P5979, DOI 10.1021/jm400487c; Dowling JK, 2012, CRIT REV BIOCHEM MOL, V47, P424, DOI 10.3109/10409238.2012.694844; Fischer M, 2019, ONCOGENE, V38, P4095, DOI 10.1038/s41388-019-0706-9; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Fujiuchi N, 2004, J BIOL CHEM, V279, P20339, DOI 10.1074/jbc.M400344200; Hai J, 2015, J THORAC ONCOL, V10, P1172, DOI 10.1097/JTO.0000000000000584; HERRMANN CPE, 1991, ONCOGENE, V6, P877; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Huang CS, 1999, J BIOL CHEM, V274, P12229, DOI 10.1074/jbc.274.18.12229; Kerur N, 2011, CELL HOST MICROBE, V9, P363, DOI 10.1016/j.chom.2011.04.008; Kim H, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aaz5683; Kimkong I, 2009, LUPUS, V18, P1066, DOI 10.1177/0961203309106699; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Krzesniak M, 2020, CELL SIGNAL, V69, DOI 10.1016/j.cellsig.2020.109552; Lemos H, 2016, CANCER RES, V76, P2076, DOI 10.1158/0008-5472.CAN-15-1456; Li DP, 2019, CELL REP, V29, P1249, DOI 10.1016/j.celrep.2019.09.069; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liao JCC, 2011, STRUCTURE, V19, P418, DOI 10.1016/j.str.2010.12.015; Liu HP, 2018, NATURE, V563, P131, DOI 10.1038/s41586-018-0629-6; Lo Cigno I, 2015, J VIROL, V89, P7506, DOI 10.1128/JVI.00013-15; Lohrum M, 1996, ONCOGENE, V13, P2527; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; MIYASHITA T, 1995, CELL, V80, P293; Ou YH, 2005, MOL BIOL CELL, V16, P1684, DOI 10.1091/mbc.E04-08-0689; Paek AL, 2016, CELL, V165, P631, DOI 10.1016/j.cell.2016.03.025; Pillai GR, 2004, CANCER LETT, V208, P163, DOI 10.1016/j.canlet.2004.01.008; Pisano G, 2017, VIROL J, V14, DOI 10.1186/s12985-017-0891-5; Ramanjulu JM, 2018, NATURE, V564, P439, DOI 10.1038/s41586-018-0705-y; Ray-Coquard I, 2012, LANCET ONCOL, V13, P1133, DOI 10.1016/S1470-2045(12)70474-6; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shalem O, 2014, SCIENCE, V343, P84, DOI 10.1126/science.1247005; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sivandzade F, 2019, BIO-PROTOCOL, V9, DOI 10.21769/BioProtoc.3128; Stehlik C, 2007, CURR PROTEIN PEPT SC, V8, P293, DOI 10.2174/138920307780831857; Unterholzner L, 2010, NAT IMMUNOL, V11, P997, DOI 10.1038/ni.1932; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang XW, 2012, NUCLEIC ACIDS RES, V40, pD1144, DOI 10.1093/nar/gkr1013; Xin H, 2003, ONCOGENE, V22, P4831, DOI 10.1038/sj.onc.1206754; Yang SY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061587; Zhang Y, 2007, FRONT BIOSCI, V12, P4855, DOI 10.2741/2433	55	1	1	3	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100930	10.1016/j.jbc.2021.100930	http://dx.doi.org/10.1016/j.jbc.2021.100930			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8WG	34216619	gold, Green Published			2022-12-28	WOS:000690879300004
J	Rijo, MP; Diani-Moore, S; Yang, CY; Zhou, PB; Rifkind, AB				Rijo, Mercedes Paz; Diani-Moore, Silvia; Yang, Chenyi; Zhou, Pengbo; Rifkind, Arleen B.			Roles of the ubiquitin ligase CUL4B and ADP-ribosyltransferase TiPARP in TCDD-induced nuclear export and proteasomal degradation of the transcription factor AHR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROCARBON RECEPTOR AHR; POLY(ADP-RIBOSE) POLYMERASE; LOCALIZATION; INDUCTION; BINDING; RIBOSYLATION; RECOGNITION; INHIBITION; MECHANISMS; EXPRESSION	The aryl hydrocarbon receptor (AHR) is a transcription factor activated by exogenous halogenated polycyclic aromatic hydrocarbon compounds, including the environmental toxin TCDD, 2,3,7,8-tetrachlorodibenzo-p-dioxin, and naturally occurring dietary and endogenous compounds. The activated AHR enhances transcription of specific genes including phase I and phase II metabolism enzymes and other targets genes such as the TCDD-inducible poly(ADP-ribose) polymerase (TiPARP). The regulation of AHR activation is a dynamic process: immediately after transcriptional activation of the AHR by TCDD, the AHR is exported from the nucleus to the cytoplasm where it is subjected to proteasomal degradation. However, the mechanisms regulating AHR degradation are not well understood. Here, we studied the role of two enzymes reported to enhance AHR breakdown: the cullin 4B (CUL4-B)AHR complex, an E3 ubiquitin ligase that targets the AHR and other proteins for ubiquitination, and TiPARP, which targets proteins for ADP-ribosylation, a posttranslational modification that can increase susceptibility to degradation. Using a WT mouse embryonic fibroblast (MEF) cell line and an MEF cell line in which CUL4B has been deleted (MEFCul4b-null), we discovered that loss of CUL4B partially prevented AHR degradation after TCDD exposure, while knocking down TiPARP in MEFCul4b-null cells completely abolished AHR degradation upon TCDD treatment. Increased TCDD-activated AHR protein levels in MEFCul4b-null and MEFCul4b-null cells in which TiPARP was knocked down led to enhanced AHR transcriptional activity, indicating that CUL4B and TiPARP restrain AHR action. This study reveals a novel function of TiPARP in controlling TCDD-activated AHR nuclear export and subsequent proteasomal degradation.	[Rijo, Mercedes Paz; Diani-Moore, Silvia; Rifkind, Arleen B.] Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA; [Yang, Chenyi; Zhou, Pengbo] Weill Cornell Med, Dept Pathol & Lab Med, New York, NY USA	Cornell University; Cornell University	Diani-Moore, S (corresponding author), Weill Cornell Med, Dept Pharmacol, New York, NY 10065 USA.	sim2003@med.cornell.edu		Paz, Mercedes/0000-0002-9700-0327	National Institute of Environmental Health Sciences, National Institutes of Health [R01ES027488]; National Cancer Institute, National Institutes of Health [R01CA213992, R01CA221152]	National Institute of Environmental Health Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institute of Environmental Health Sciences, National Institutes of Health, Grant #R01ES027488 to A. B. R. and S. D.-M.; National Cancer Institute, National Institutes of Health, Grants #R01CA213992 and R01CA221152 to P. Z. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abd Elmageed ZY, 2012, CELL SIGNAL, V24, P1, DOI 10.1016/j.cellsig.2011.07.019; Ahmed S, 2015, J BIOL CHEM, V290, P16824, DOI 10.1074/jbc.M115.660100; Beischlag TV, 2008, CRIT REV EUKAR GENE, V18, P207, DOI 10.1615/CritRevEukarGeneExpr.v18.i3.20; Berg P, 2001, J BIOL CHEM, V276, P43231, DOI 10.1074/jbc.M105261200; Bock KW, 2006, BIOCHEM PHARMACOL, V72, P393, DOI 10.1016/j.bcp.2006.01.017; Davarinos NA, 1999, J BIOL CHEM, V274, P28708, DOI 10.1074/jbc.274.40.28708; Denison MS, 2011, TOXICOL SCI, V124, P1, DOI 10.1093/toxsci/kfr218; Diani-Moore S, 2006, TOXICOL SCI, V90, P96, DOI 10.1093/toxsci/kfj065; Diani-Moore S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02332-9; Diani-Moore S, 2013, J BIOL CHEM, V288, P21514, DOI 10.1074/jbc.M113.458067; Dou H, 2019, J BIOL CHEM, V294, P18504, DOI 10.1074/jbc.RA119.009282; Gomez A, 2018, BIOCHEM J, V475, P3827, DOI 10.1042/BCJ20180347; Greb-Markiewicz B, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20194746; Grimaldi G, 2019, BIOCHEM SOC T, V47, P357, DOI 10.1042/BST20180416; Gupte R, 2017, GENE DEV, V31, P101, DOI 10.1101/gad.291518.116; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Hannah J, 2015, GENE, V573, P33, DOI 10.1016/j.gene.2015.08.064; Hu KS, 2019, EMBO REP, V20, DOI 10.15252/embr.201846166; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Ikuta T, 1998, J BIOL CHEM, V273, P2895, DOI 10.1074/jbc.273.5.2895; Kang HC, 2011, P NATL ACAD SCI USA, V108, P14103, DOI 10.1073/pnas.1108799108; Kawajiri K, 2009, P NATL ACAD SCI USA, V106, P13481, DOI 10.1073/pnas.0902132106; Kraus WL, 2020, GENE DEV, V34, P251, DOI 10.1101/gad.336420.120; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Liu LR, 2012, CELL RES, V22, P1258, DOI 10.1038/cr.2012.48; Ma Q, 2000, J BIOL CHEM, V275, P8432, DOI 10.1074/jbc.275.12.8432; Ma Q, 2001, BIOCHEM BIOPH RES CO, V289, P499, DOI 10.1006/bbrc.2001.5987; MacPherson L, 2014, INT J MOL SCI, V15, P7939, DOI 10.3390/ijms15057939; MacPherson L, 2013, NUCLEIC ACIDS RES, V41, P1604, DOI 10.1093/nar/gks1337; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Pahl HL, 1996, CURR OPIN CELL BIOL, V8, P340, DOI 10.1016/S0955-0674(96)80007-X; Petrulis JR, 2003, J BIOL CHEM, V278, P2677, DOI 10.1074/jbc.M209331200; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Pollenz RS, 2006, MOL PHARMACOL, V70, P1369, DOI 10.1124/mol.106.027672; Pollenz RS, 2000, MOL CELL BIOL, V20, P6095, DOI 10.1128/MCB.20.16.6095-6104.2000; Pollenz RS, 2002, CHEM-BIOL INTERACT, V141, P41, DOI 10.1016/S0009-2797(02)00065-0; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Seok SH, 2017, P NATL ACAD SCI USA, V114, P5431, DOI 10.1073/pnas.1617035114; Song ZJ, 2002, MOL PHARMACOL, V62, P806, DOI 10.1124/mol.62.4.806; Stockinger B, 2011, SEMIN IMMUNOL, V23, P99, DOI 10.1016/j.smim.2011.01.008; Tkachenko A, 2016, SCI REP-UK, V6, DOI 10.1038/srep32009; Whitlock JP, 1999, ANNU REV PHARMACOL, V39, P103, DOI 10.1146/annurev.pharmtox.39.1.103; Yamada T, 2016, NAT IMMUNOL, V17, P687, DOI 10.1038/ni.3422; Zhang L, 2020, P NATL ACAD SCI USA, V117, P13447, DOI 10.1073/pnas.1921815117	46	5	5	2	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100886	10.1016/j.jbc.2021.100886	http://dx.doi.org/10.1016/j.jbc.2021.100886			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8UA	34146543	gold, Green Published			2022-12-28	WOS:000690873500016
J	Watanabe, Y; Sasaki, T; Miyoshi, S; Shimizu, M; Yamauchi, Y; Sato, R				Watanabe, Yuichi; Sasaki, Takashi; Miyoshi, Shoko; Shimizu, Makoto; Yamauchi, Yoshio; Sato, Ryuichiro			Insulin-induced genes INSIG1 and INSIG2 mediate oxysterol-dependent activation of the PERK-eIF2 alpha-ATF4 axis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UNFOLDED PROTEIN RESPONSE; INTEGRATED STRESS-RESPONSE; HAMSTER OVARY CELLS; ER-STRESS; ENDOPLASMIC-RETICULUM; BINDING; ATF4; 25-HYDROXYCHOLESTEROL; TRANSCRIPTION; TRANSLATION	Y Insulin-induced genes (INSIGs) encode endoplasmic reticulum-resident proteins that regulate intracellular choles-terol metabolism. Oxysterols are oxygenated derivatives of cholesterol, some of which orchestrate lipid metabolism via interaction with INSIGs. Recently, it was reported that expression of activating transcription factor-4 (ATF4) was induced by certain oxysterols; the precise of mechanism is unclear. Herein, we show that INSIGs mediate ATF4 upregu-lation upon interaction with oxysterol. Oxysterols that possess a high affinity for INSIG, such as 27-and 25-hydroxycholesterol (25HC), markedly induced the increase of ATF4 protein when compared with other oxysterols. In addi-tion, ATF4 upregulation by these oxysterols was attenuated in INSIG1/2-deficient Chinese hamster ovary cells and recovered by either INSIG1 or INSIG2 rescue. Mechanistic studies revealed that the binding of 25HC to INSIG is critical for increased ATF4 protein via activation of protein kinase RNA-activated-like ER kinase and eukaryotic translation initiation factor 2 alpha. Knockout of INSIG1 or INSIG2 in human hepatoma Huh7 cells attenuated ATF4 protein upregulation, indicating that only one of the endogenous INSIGs, unlike overexpression of intrinsic INSIG1 or INSIG2, was insufficient for ATF4 in-duction. Furthermore, ATF4 proactively upregulated the cell death-inducible gene expression, such as Chop, Chac1, and Trb3, thereby markedly reducing cell viability with 25HC. These findings support a model whereby that INSIGs sense an increase in oxysterol in the endoplasmic reticulum and induce an increase of ATF4 protein via the protein kinase RNA-acti-vated-like ER kinase-eukaryotic translation initiation factor 2 alpha pathway, thereby promoting cell death.	[Watanabe, Yuichi; Sasaki, Takashi; Miyoshi, Shoko; Yamauchi, Yoshio; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan; [Shimizu, Makoto; Sato, Ryuichiro] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutrilife Sci Lab, Tokyo, Japan; [Sato, Ryuichiro] Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan	University of Tokyo; University of Tokyo	Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Food Biochem Lab, Tokyo, Japan.; Sato, R (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Appl Biol Chem, Nutrilife Sci Lab, Tokyo, Japan.; Sato, R (corresponding author), Japan Agcy Med Res & Dev, AMED CREST, Tokyo, Japan.	roysato@g.ecc.u-tokyo.ac.jp	Yamauchi, Yoshio/I-7539-2014; 渡邉, 雄一/AAX-1904-2021	Yamauchi, Yoshio/0000-0001-5559-4596; 渡邉, 雄一/0000-0002-1796-0660; Sasaki, Takashi/0000-0002-3352-0753	Japan Society for the Promotion of Science KAKENHI [JP15H05781, JP20H00408, JP17K15266, JP19K15764]; Japan Agency for Medical Research and Development (AMED-CREST) [16gm0910008h0001]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Agency for Medical Research and Development (AMED-CREST)(Japan Agency for Medical Research and Development (AMED))	This work was supported by Japan Society for the Promotion of Science KAKENHI Grant-in-aid for Scientific Research (S) JP15H05781 and (A) JP20H00408 (to R. S.), Grant-in-aid for Young Scientists JP17K15266 and JP19K15764 (to Y. W.), and the Japan Agency for Medical Research and Development (AMED-CREST) grant 16gm0910008h0001 (to R. S.).	Adams CM, 2007, J BIOL CHEM, V282, P16744, DOI 10.1074/jbc.M610510200; Baek AE, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00910-z; Brown AJ, 2009, MOL ASPECTS MED, V30, P111, DOI 10.1016/j.mam.2009.02.005; Fu X, 2001, J BIOL CHEM, V276, P38378, DOI 10.1074/jbc.M105805200; Griffiths WJ, 2020, PROSTAG OTH LIPID M, V147, DOI 10.1016/j.prostaglandins.2019.106381; Guillemot-Legris O, 2016, TRENDS MOL MED, V22, P594, DOI 10.1016/j.molmed.2016.05.006; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Hannedouche S, 2011, NATURE, V475, P524, DOI 10.1038/nature10280; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jang J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13129; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Jo Y, 2011, P NATL ACAD SCI USA, V108, P20503, DOI 10.1073/pnas.1112831108; Jo Y, 2010, CRIT REV BIOCHEM MOL, V45, P185, DOI 10.3109/10409238.2010.485605; Kim SM, 2017, ONCOTARGET, V8, P11855, DOI 10.18632/oncotarget.14416; Kranz P, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.369; Kuan YC, 2020, J BIOL CHEM, V295, P3918, DOI 10.1074/jbc.RA119.011849; Lee PCW, 2005, J BIOL CHEM, V280, P25242, DOI 10.1074/jbc.M502989200; Li CF, 2017, IMMUNITY, V46, P446, DOI 10.1016/j.immuni.2017.02.012; Li JW, 2016, J LIPID RES, V57, P1845, DOI 10.1194/jlr.M069906; Liu CL, 2011, NATURE, V475, P519, DOI 10.1038/nature10226; Matsumoto H, 2013, BIOL OPEN, V2, P1084, DOI 10.1242/bio.20135033; Mungrue IN, 2009, J IMMUNOL, V182, P466, DOI 10.4049/jimmunol.182.1.466; Mutemberezi V, 2016, PROG LIPID RES, V64, P152, DOI 10.1016/j.plipres.2016.09.002; Novoa I, 2003, EMBO J, V22, P1180, DOI 10.1093/emboj/cdg112; Novoa I, 2001, J CELL BIOL, V153, P1011, DOI 10.1083/jcb.153.5.1011; Pakos-Zebrucka K, 2016, EMBO REP, V17, P1374, DOI 10.15252/embr.201642195; Qi XF, 2019, NATURE, V571, P279, DOI 10.1038/s41586-019-1286-0; Quiros PM, 2017, J CELL BIOL, V216, P2027, DOI 10.1083/jcb.201702058; Radhakrishnan A, 2007, P NATL ACAD SCI USA, V104, P6511, DOI 10.1073/pnas.0700899104; Rawson RB, 1999, J BIOL CHEM, V274, P28549, DOI 10.1074/jbc.274.40.28549; SATO R, 1993, P NATL ACAD SCI USA, V90, P9261, DOI 10.1073/pnas.90.20.9261; Sekiya M, 2014, J LIPID RES, V55, P2082, DOI 10.1194/jlr.M050864; Sever N, 2003, MOL CELL, V11, P25, DOI 10.1016/S1097-2765(02)00822-5; Shibata N, 2013, J BIOL CHEM, V288, P35812, DOI 10.1074/jbc.M113.519637; Su N, 2008, J BIOL CHEM, V283, P35106, DOI 10.1074/jbc.M806874200; Suchanek M, 2007, BIOCHEM J, V405, P473, DOI 10.1042/BJ20070176; Takabe W, 2016, J LIPID RES, V57, P2005, DOI 10.1194/jlr.M068775; Tyagi R, 2015, CELL REP, V10, P684, DOI 10.1016/j.celrep.2015.01.014; Umetani M, 2014, CELL METAB, V20, P172, DOI 10.1016/j.cmet.2014.05.013; Vattem KM, 2004, P NATL ACAD SCI USA, V101, P11269, DOI 10.1073/pnas.0400541101; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wortel IMN, 2017, TRENDS ENDOCRIN MET, V28, P794, DOI 10.1016/j.tem.2017.07.003; Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Yuan Xi-Ming, 2016, J Cell Death, V9, P1, DOI 10.4137/JCD.S37841; Zu SL, 2020, CELL RES, V30, P1043, DOI 10.1038/s41422-020-00398-1	48	0	0	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100989	10.1016/j.jbc.2021.100989	http://dx.doi.org/10.1016/j.jbc.2021.100989			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8RY	34298014	gold, Green Published			2022-12-28	WOS:000690868100008
J	Zhao, YH; Li, H; Zhao, H; Sun, WK; Wang, Q; Li, WW				Zhao, Yue-Hong; Li, Hao; Zhao, Hui; Sun, Wei-Kang; Wang, Qun; Li, Wei-Wei			An ancient interleukin-16-like molecule regulates hemocyte proliferation via integrin beta 1 in invertebrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DROSOPHILA; IDENTIFICATION; HEMATOPOIESIS; GENE; PRO-INTERLEUKIN-16; ACTIVATION; MIGRATION; IMMUNITY; SUBUNIT; EXPRESS	Interleukins (ILs) are cytokines with crucial functions in innate and adaptive immunity. IL genes are only found in vertebrates, except for IL-16, which has been cloned in some arthropod species. However, the function of this gene in invertebrates is unknown. In the present study, an IL-16-like gene (EsIL-16) was identified from the Chinese mitten crab Eriocheir sinensis. EsIL-16 was predicted to encode a precursor (proEsIL-16) that shares similarities with pro-IL-16 proteins from insects and vertebrates. We show that caspase-3 processes proEsIL-16 into an approximately 144-kDa N-terminal prodomain with nuclear import activity and an approximately 34-kDa mature peptide that might be secreted into the extracellular region. EsIL-16 mRNA could be detected in all analyzed tissues and was significantly upregulated after immune challenge both in vitro and in vivo. T7 phage display library screening suggested potential binding activity between EsIL-16 and integrin, which was confirmed by coimmunoprecipitation assay. Interestingly, EsIL-16 promoted cell proliferation via integrin beta 1 in primary cultured crab hemocytes and Drosophila S2 cells. Furthermore, the interaction between EsIL-16 and integrin beta 1 was necessary to efficiently protect the host from bacterial infection. To our knowledge, this study revealed integrin beta 1 as a receptor for IL-16 and the function of this interaction in hemocyte proliferation in invertebrates for the first time. These results provide new insights into the regulation of innate immune responses in invertebrates and shed the light on the evolution of ILs within the animal kingdom.	[Zhao, Yue-Hong; Li, Hao; Zhao, Hui; Sun, Wei-Kang; Wang, Qun; Li, Wei-Wei] East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def & Reprod Biol, Shanghai, Peoples R China	East China Normal University	Wang, Q; Li, WW (corresponding author), East China Normal Univ, Sch Life Sci, Lab Invertebrate Immunol Def & Reprod Biol, Shanghai, Peoples R China.	qwang@bio.ecnu.edu.cn; wwli@bio.ecnu.edu.cn	Wang, Qun/I-7778-2013	Wang, Qun/0000-0001-7929-7692	National Natural Science Foundation of China [31972820, 31970490]; Shanghai Rising-Star Program [20QA1403000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program	This work was supported by the National Natural Science Foundation of China (Grants 31972820 to W.-W. L. and 31970490 to Q. W.) and Shanghai Rising-Star Program (Grant 20QA1403000 to W.-W. L.).	Brocker Chad, 2010, Human Genomics, V5, P30; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Burke RD, 1999, INT REV CYTOL, V191, P257, DOI 10.1016/S0074-7696(08)60161-8; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Conti P, 2002, ALLERGY ASTHMA PROC, V23, P103; CRUIKSHANK W, 1982, J IMMUNOL, V128, P2569; Cruikshank W, 2008, CRIT REV IMMUNOL, V28, P467; DINARELLO CA, 1986, ANNU REV MED, V37, P173; Dinkins MB, 2008, DEV DYNAM, V237, P3927, DOI 10.1002/dvdy.21802; Gu WB, 2017, FISH SHELLFISH IMMUN, V70, P701, DOI 10.1016/j.fsi.2017.09.057; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Holmblad T, 1997, J EXP ZOOL, V277, P255, DOI 10.1002/(SICI)1097-010X(19970215)277:3<255::AID-JEZ6>3.0.CO;2-N; Humphries MJ, 2000, BIOCHEM SOC T, V28, P311, DOI 10.1042/0300-5127:0280311; Jeibmann A, 2015, J NEURO-ONCOL, V124, P373, DOI 10.1007/s11060-015-1864-4; Junkunlo K, 2019, J BIOL CHEM, V294, P708, DOI 10.1074/jbc.RA118.005489; Junkunlo K, 2016, J BIOL CHEM, V291, P17593, DOI 10.1074/jbc.M116.741348; Lanot R, 2001, DEV BIOL, V230, P243, DOI 10.1006/dbio.2000.0123; Lavine MD, 2003, INSECT MOL BIOL, V12, P441, DOI 10.1046/j.1365-2583.2003.00428.x; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Levin DM, 2005, INSECT BIOCHEM MOLEC, V35, P369, DOI 10.1016/j.ibmb.2005.01.003; Li D, 2019, J BIOL CHEM, V294, P16440, DOI 10.1074/jbc.RA119.010247; Liang QH, 2017, DEV COMP IMMUNOL, V74, P49, DOI 10.1016/j.dci.2017.04.011; Little TJ, 2005, NAT IMMUNOL, V6, P651, DOI 10.1038/ni1219; Liu C, 2007, CYTOKINE, V38, P145, DOI 10.1016/j.cyto.2007.05.016; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; LUO H, 1995, EMBO J, V14, P1412, DOI 10.1002/j.1460-2075.1995.tb07127.x; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Myers EW, 2000, SCIENCE, V287, P2196, DOI 10.1126/science.287.5461.2196; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; O'Reilly AM, 2008, J CELL BIOL, V182, P801, DOI 10.1083/jcb.200710141; Ponting CP, 1997, PROTEIN SCI, V6, P464; Richmond J, 2014, J CELL PHYSIOL, V229, P139, DOI 10.1002/jcp.24441; Rowley AF, 2007, J IMMUNOL, V179, P7209, DOI 10.4049/jimmunol.179.11.7209; Santos HM, 2020, AQUACULT INT, V28, P169, DOI 10.1007/s10499-019-00451-w; Secombes CJ, 2011, DEV COMP IMMUNOL, V35, P1336, DOI 10.1016/j.dci.2011.05.001; Seetharaman S, 2018, BIOL CELL, V110, P49, DOI 10.1111/boc.201700060; Sharma V, 2000, IMMUNOLOGY, V99, P266, DOI 10.1046/j.1365-2567.2000.00959.x; Skundric DS, 2006, J NEUROINFLAMM, V3, DOI 10.1186/1742-2094-3-13; Song LS, 2016, GIGASCIENCE, V5, DOI 10.1186/s13742-016-0112-y; Tang BP, 2020, FRONT GENET, V10, DOI 10.3389/fgene.2019.01340; Wang XW, 2014, J BIOL CHEM, V289, P2405, DOI 10.1074/jbc.M113.528885; Yang L, 2019, J BIOL CHEM, V294, P14704, DOI 10.1074/jbc.RA119.009559; YEE GH, 1993, DEVELOPMENT, V118, P845; Zhang XJ, 2019, NAT COMMUN, V10, DOI [10.1038/s41467-018-08197-4, 10.1038/s41467-019-13333-9]; Zhang YJ, 1998, J BIOL CHEM, V273, P1144, DOI 10.1074/jbc.273.2.1144	46	5	5	4	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG	2021	297	2							100943	10.1016/j.jbc.2021.100943	http://dx.doi.org/10.1016/j.jbc.2021.100943			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	UI8TB	34245782	Green Published, gold			2022-12-28	WOS:000690871000006
J	Ashami, K; Falk, AS; Hurd, C; Garg, S; Cervantes, SA; Rawat, A; Siemer, AB				Ashami, Kidist; Falk, Alexander S.; Hurd, Connor; Garg, Samridhi; Cervantes, Silvia A.; Rawat, Anoop; Siemer, Ansgar B.			Droplet and fibril formation of the functional amyloid Orb2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SOLID-STATE NMR; LIQUID PHASE-SEPARATION; DOMAINS; ORGANIZATION; TRANSITION; RESONANCE; PROTEINS; CORE	The functional amyloid Orb2 belongs to the cytoplasmic polyadenylation element binding (CPEB) protein family and plays an important role in long-term memory formation in Drosophila. The Orb2 domain structure combines RNA recognition motifs with low-complexity sequences similar to many RNA-binding proteins shown to form protein droplets via liquid-liquid phase separation (LLPS) in vivo and in vitro. This similarity suggests that Orb2 might also undergo LLPS. However, cellular Orb2 puncta have very little internal protein mobility, and Orb2 forms fibrils in Drosophila brains that are functionally active indicating that LLPS might not play a role for Orb2. In the present work, we reconcile these two views on Orb2 droplet formation. Using fluorescence microscopy, we show that soluble Orb2 can indeed phase separate into protein droplets. However, fluorescence recovery after photobleaching (FRAP) data shows that these droplets have either no or only an extremely short-lived liquid phase and appear maturated right after formation. Orb2 fragments that lack the C-terminal RNA-binding domain (RBD) form fibrils out of these droplets. Solid-state NMR shows that these fibrils have well-ordered static domains in addition to the Gln/His-rich fibril core. Further, we find that full-length Orb2B, which is by far the major component of Orb2 fibrils in vivo, does not transition into fibrils but remains in the droplet phase. Together, our data suggest that phase separation might play a role in initiating the formation of functional Orb2 fibrils.	[Ashami, Kidist; Falk, Alexander S.; Hurd, Connor; Garg, Samridhi; Cervantes, Silvia A.; Rawat, Anoop; Siemer, Ansgar B.] Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA; [Falk, Alexander S.] Kite Pharma, Emeryville, CA USA; [Garg, Samridhi] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA	University of Southern California; University of Wisconsin System; University of Wisconsin Madison	Siemer, AB (corresponding author), Univ Southern Calif, Keck Sch Med, Zilkha Neurogenet Inst, Dept Physiol & Neurosci, Los Angeles, CA 90007 USA.	asiemer@usc.edu	Rawat, Anoop/GPS-5531-2022; Rawat, Anoop/AAO-6795-2021	Rawat, Anoop/0000-0002-5838-0275; Siemer, Ansgar B./0000-0003-0901-011X	National Institutes of Health [F31GM120858]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	A.B.S. would like to acknowledge funding from the National Institutes of Health (R01NS084345, R01GM110521). A.S.F. would like to acknowledge funding from the National Institutes of Health (F31GM120858). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Audas TE, 2016, DEV CELL, V39, P155, DOI 10.1016/j.devcel.2016.09.002; Babinchak WM, 2020, J MOL BIOL, V432, P1910, DOI 10.1016/j.jmb.2020.03.004; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Boke E, 2016, CELL, V166, P637, DOI 10.1016/j.cell.2016.06.051; Bugg CW, 2012, J BIOL CHEM, V287, P31739, DOI 10.1074/jbc.M112.353839; Cervantes SA, 2016, SCI REP-UK, V6, DOI 10.1038/srep38265; Chen XD, 2020, NAT NEUROSCI, V23, P301, DOI 10.1038/s41593-019-0579-9; Darling AL, 2021, BBA-MOL CELL RES, V1868, DOI 10.1016/j.bbamcr.2021.118984; Detken A, 2002, CHEM PHYS LETT, V356, P298, DOI 10.1016/S0009-2614(02)00335-4; Freeman R., 2007, ENCY MAGNETIC RESONA; Halfmann R, 2016, CURR OPIN STRUC BIOL, V38, P18, DOI 10.1016/j.sbi.2016.05.002; Han B, 2011, J BIOMOL NMR, V50, P43, DOI 10.1007/s10858-011-9478-4; Hardenberg M, 2020, P NATL ACAD SCI USA, V117, P33254, DOI 10.1073/pnas.2007670117; Helmus JJ, 2013, J BIOMOL NMR, V55, P355, DOI 10.1007/s10858-013-9718-x; Hervas R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21186910; Hervas R, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002361; Hoop CL, 2016, P NATL ACAD SCI USA, V113, P1546, DOI 10.1073/pnas.1521933113; Hoop CL, 2014, BIOCHEMISTRY-US, V53, P6653, DOI 10.1021/bi501010q; Hunter JD, 2007, COMPUT SCI ENG, V9, P90, DOI 10.1109/MCSE.2007.55; Isas JM, 2017, BIOCHEMISTRY-US, V56, P3579, DOI 10.1021/acs.biochem.7b00138; Isas JM, 2015, BIOCHEMISTRY-US, V54, P3942, DOI 10.1021/acs.biochem.5b00281; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996; King OD, 2012, BRAIN RES, V1462, P61, DOI 10.1016/j.brainres.2012.01.016; Kruttner S, 2012, NEURON, V76, P383, DOI 10.1016/j.neuron.2012.08.028; Li JX, 2012, CELL, V150, P339, DOI 10.1016/j.cell.2012.06.019; Li LY, 2016, CURR BIOL, V26, P3143, DOI 10.1016/j.cub.2016.09.054; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Majumdar A, 2012, CELL, V148, P515, DOI 10.1016/j.cell.2012.01.004; Pandey NK, 2018, J BIOL CHEM, V293, P2597, DOI 10.1074/jbc.M117.813667; Patel A, 2015, CELL, V162, P1066, DOI 10.1016/j.cell.2015.07.047; Peskett TR, 2018, MOL CELL, V70, P588, DOI 10.1016/j.molcel.2018.04.007; Rueden CT, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1934-z; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmidt M, 2015, P NATL ACAD SCI USA, V112, P11858, DOI 10.1073/pnas.1503455112; Schneider R, 2011, J MOL BIOL, V412, P121, DOI 10.1016/j.jmb.2011.06.045; Schutz AK, 2014, BIOMOL NMR ASSIGN, V8, P349, DOI 10.1007/s12104-013-9515-1; Shewmaker F, 2009, BIOCHEMISTRY-US, V48, P5074, DOI 10.1021/bi900345q; Si K, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a021774; Siemer AB, 2006, J AM CHEM SOC, V128, P13224, DOI 10.1021/ja063639x; Siemer AB, 2020, SOLID STATE NUCL MAG, V106, DOI 10.1016/j.ssnmr.2020.101643; Sivanandam VN, 2011, J AM CHEM SOC, V133, P4558, DOI 10.1021/ja110715f; Sokolov PA, 2017, COMPUT PHYS COMMUN, V214, P199, DOI 10.1016/j.cpc.2017.01.011; Takashimizu Y, 2016, PROG EARTH PLANET SC, V3, DOI 10.1186/s40645-015-0078-x; Takegoshi K, 2001, CHEM PHYS LETT, V344, P631, DOI 10.1016/S0009-2614(01)00791-6; Taylor NO, 2019, BIOPHYS J, V117, P1285, DOI 10.1016/j.bpj.2019.08.030; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; White-Grindley E, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001786; Woodruff JB, 2018, TRENDS BIOCHEM SCI, V43, P81, DOI 10.1016/j.tibs.2017.11.005; Wu XD, 2020, DEV CELL, V55, P18, DOI 10.1016/j.devcel.2020.06.012; Zhang HY, 2015, MOL CELL, V60, P220, DOI 10.1016/j.molcel.2015.09.017	51	2	2	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100804	10.1016/j.jbc.2021.100804	http://dx.doi.org/10.1016/j.jbc.2021.100804			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34044018	gold, Green Submitted, Green Published			2022-12-28	WOS:000678068400010
J	Cai, T; Yu, ZB; Wang, Z; Liang, C; Richard, S				Cai, Ting; Yu, Zhenbao; Wang, Zhen; Liang, Chen; Richard, Stephane			Arginine methylation of SARS-Cov-2 nucleocapsid protein regulates RNA binding, its ability to suppress stress granule formation, and viral replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHASE-SEPARATION; PHOSPHORYLATION; METHYLTRANSFERASE; IDENTIFICATION; VIRUS; SITES; LOCALIZATION; RECRUITMENT; INHIBITOR; CHROMATIN	Viral proteins are known to be methylated by host protein arginine methyltransferases (PRMTs) necessary for the viral life cycle, but it remains unknown whether severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteins are methylated. Herein, we show that PRMT1 methylates SARS-CoV-2 nucleocapsid (N) protein at residues R95 and R177 within RGG/RG motifs, preferred PRMT target sequences. We confirmed arginine methylation of N protein by immunoblotting viral proteins extracted from SARS-CoV-2 virions isolated from cell culture. Type I PRMT inhibitor (MS023) or substitution of R95 or R177 with lysine inhibited interaction of N protein with the 5'-UTR of SARS-CoV-2 genomic RNA, a property required for viral packaging. We also defined the N protein interactome in HEK293 cells, which identified PRMT1 and many of its RGG/RG substrates, including the known interacting protein G3BP1 as well as other components of stress granules (SGs), which are part of the host antiviral response. Methylation of R95 regulated the ability of N protein to suppress the formation of SGs, as R95K substitution or MS023 treatment blocked N-mediated suppression of SGs. Also, the coexpression of methylarginine reader Tudor domain-containing protein 3 quenched N protein-mediated suppression of SGs in a dose-dependent manner. Finally, pretreatment of VeroE6 cells with MS023 significantly reduced SARS-CoV-2 replication. Because type I PRMT inhibitors are already undergoing clinical trials for cancer treatment, inhibiting arginine methylation to target the later stages of the viral life cycle such as viral genome packaging and assembly of virions may represent an additional therapeutic application of these drugs.	[Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Biochem, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Human Genet, Montreal, PQ, Canada; [Cai, Ting; Yu, Zhenbao; Richard, Stephane] McGill Univ, Dept Med, Montreal, PQ, Canada; [Wang, Zhen; Liang, Chen] McGill Univ, McGill Ctr Viral Dis, Lady Davis Inst Med Res, Montreal, PQ, Canada; [Wang, Zhen; Liang, Chen] McGill Univ, Dept Med, Dept Microbiol & Immunol, Montreal, PQ, Canada	Lady Davis Institute; McGill University; McGill University; McGill University; McGill University; McGill University; Lady Davis Institute; McGill University; McGill University	Richard, S (corresponding author), McGill Univ, Lady Davis Inst Med Res, Segal Canc Ctr, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Gerald Bronfman Dept Oncol, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Dept Biochem, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Dept Human Genet, Montreal, PQ, Canada.; Richard, S (corresponding author), McGill Univ, Dept Med, Montreal, PQ, Canada.	stephane.richard@mcgill.ca			Canadian Institutes of Health Research [FDN-154303]; Fonds de recherche du Quebec en Sante studentship award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de recherche du Quebec en Sante studentship award	This work was funded by a Canadian Institutes of Health Research FDN-154303 award (to S. R.). T. C. holds a Fonds de recherche du Quebec en Sante studentship award.	Akter KA, 2016, TUMOR BIOL, V37, P4531, DOI 10.1007/s13277-015-4310-5; Barrera A, 2020, NUCLEIC ACIDS RES, V48, P10479, DOI 10.1093/nar/gkaa765; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Boisvert FM, 2002, J CELL BIOL, V159, P957, DOI 10.1083/jcb.200207028; Boulanger MC, 2005, J VIROL, V79, P124, DOI 10.1128/JVI.79.1.124-131.2005; Burbelo PD, 2020, J INFECT DIS, DOI DOI 10.1093/INFDIS/JIAA273; Carlson CR, 2020, MOL CELL, V80, P1092, DOI 10.1016/j.molcel.2020.11.025; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chen H, 2020, CELL RES, V30, P1143, DOI 10.1038/s41422-020-00408-2; Chen SC, 2010, VIROLOGY, V401, P29, DOI 10.1016/j.virol.2010.02.007; Chong PA, 2018, J MOL BIOL, V430, P4650, DOI 10.1016/j.jmb.2018.06.014; Chua RL, 2020, NAT BIOTECHNOL, V38, P970, DOI 10.1038/s41587-020-0602-4; Corbet Giulia Ada, 2019, Cold Spring Harb Symp Quant Biol, V84, P203, DOI 10.1101/sqb.2019.84.040329; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Cubuk J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21953-3; Denison MR, 1999, J VIROL, V73, P6862, DOI 10.1128/JVI.73.8.6862-6871.1999; Dinesh DC, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1009100; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Fedoriw A, 2019, CANCER CELL, V36, P100, DOI 10.1016/j.ccell.2019.05.014; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Gao B, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1008690; Gayatri S, 2014, BBA-GENE REGUL MECH, V1839, P702, DOI 10.1016/j.bbagrm.2014.02.015; Gordon David E, 2020, bioRxiv, DOI 10.1101/2020.03.22.002386; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Guccione E, 2019, NAT REV MOL CELL BIO, V20, P642, DOI 10.1038/s41580-019-0155-x; Guillen-Boixet J, 2020, CELL, V181, P346, DOI 10.1016/j.cell.2020.03.049; Gurunathan G, 2015, SCI REP-UK, V5, DOI 10.1038/srep10475; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Heaton B.E., 2020, SRSF PROTEIN KINASES, DOI [10.1101/2020.08.14.251207, DOI 10.1101/2020.08.14.251207]; Hofweber M, 2018, CELL, V173, P706, DOI 10.1016/j.cell.2018.03.004; Hsu JM, 2011, NAT CELL BIOL, V13, P174, DOI 10.1038/ncb2158; Hu Y, 2017, J VIROL, V91, DOI 10.1128/JVI.02143-16; Huang CY, 2020, CELL DEATH DIFFER, V27, P227, DOI 10.1038/s41418-019-0350-5; Iserman C, 2020, MOL CELL, V80, P1078, DOI 10.1016/j.molcel.2020.11.041; Jack A, 2021, PLOS BIOL, V19, DOI [10.1371/journal.pbio.3001425, 10.1101/2020.09.14.295824]; Jarrold J, 2019, TRENDS MOL MED, V25, P993, DOI 10.1016/j.molmed.2019.05.007; Kang SS, 2020, ACTA PHARM SIN B, V10, P1228, DOI 10.1016/j.apsb.2020.04.009; Khan S, 2022, J BIOMOL STRUCT DYN, V40, P6286, DOI 10.1080/07391102.2021.1882337; Kim D, 2020, CELL, V181, P914, DOI 10.1016/j.cell.2020.04.011; Lee YJ, 2012, J CELL BIOCHEM, V113, P2721, DOI 10.1002/jcb.24151; Li JJ, 2021, MED-CAMBRIDGE, V2, P99, DOI 10.1016/j.medj.2020.07.002; Lin SM, 2020, J MED CHEM, V63, P3131, DOI 10.1021/acs.jmedchem.9b01913; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Lu S, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20768-y; Lubyova B, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186982; Luo LL, 2021, SCI BULL, V66, P1194, DOI 10.1016/j.scib.2021.01.013; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; McCormick C, 2017, NAT REV IMMUNOL, V17, P647, DOI 10.1038/nri.2017.63; Nabeel-Shah S, 2020, SARS COV 2 NUCLEOCAP, DOI [10.1101/2020.10.23.342113, DOI 10.1101/2020.10.23.342113]; Nakagawa K, 2018, J VIROL, V92, DOI 10.1128/JVI.00902-18; Nakayama Kazuhide, 2018, Oncotarget, V9, P18480, DOI 10.18632/oncotarget.24883; Nikolakaki E, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00219; Noorimotlagh Z, 2020, INT IMMUNOPHARMACOL, V86, DOI 10.1016/j.intimp.2020.106738; Omer A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18734-9; Paris J, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0428-z; Peng TY, 2008, FEBS J, V275, P4152, DOI 10.1111/j.1742-4658.2008.06564.x; Perdikari TM, 2020, EMBO J, V39, DOI 10.15252/embj.2020106478; Qamar S, 2018, CELL, V173, P720, DOI 10.1016/j.cell.2018.03.056; Rabouw HH, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005982; Hernandez ER, 2021, VIRAL IMMUNOL, V34, P165, DOI 10.1089/vim.2020.0174; Ray Manisha, 2020, Genomics & Informatics, V18, pe43, DOI 10.5808/GI.2020.18.4.e43; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sarkar B., 2020, ESSENTIAL FACTS WUHA, DOI [DOI 10.1101/2020.02.05.935072, 10.1101/2020.02.05.935072]; Savastano A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19843-1; Schneider WM, 2021, CELL, V184, P120, DOI 10.1016/j.cell.2020.12.006; Shen YD, 2020, J MED CHEM, V63, P9977, DOI 10.1021/acs.jmedchem.0c01111; Song JW, 2015, MOL CELL BIOL, V35, P1926, DOI 10.1128/MCB.01488-14; Stertz S, 2007, VIROLOGY, V361, P304, DOI 10.1016/j.virol.2006.11.027; Stetler A, 2006, HUM MOL GENET, V15, P87, DOI 10.1093/hmg/ddi429; STOHLMAN SA, 1988, J VIROL, V62, P4288, DOI 10.1128/JVI.62.11.4288-4295.1988; Sun L, 2021, CELL, V184, P1865, DOI 10.1016/j.cell.2021.02.008; Szewczyk MM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16271-z; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang J, 2000, J BIOL CHEM, V275, P19866, DOI 10.1074/jbc.M000023200; Thandapani P, 2013, MOL CELL, V50, P613, DOI 10.1016/j.molcel.2013.05.021; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tsai WC, 2016, J BIOL CHEM, V291, P22671, DOI 10.1074/jbc.M116.739573; Tugaeva KV, 2021, J MOL BIOL, V433, DOI 10.1016/j.jmb.2021.166875; Wall ML, 2017, J MOL BIOL, V429, P295, DOI 10.1016/j.jmb.2016.12.011; Wang J, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-020-00240-3; Wang R, 2021, CELL, V184, P106, DOI 10.1016/j.cell.2020.12.004; Wei J, 2021, CELL, V184, P76, DOI 10.1016/j.cell.2020.10.028; Wei Jin, 2020, bioRxiv, DOI 10.1101/2020.06.16.155101; White JP, 2012, TRENDS MICROBIOL, V20, P175, DOI 10.1016/j.tim.2012.02.001; Woodsmith J, 2018, LIFE SCI ALLIANCE, V1, DOI 10.26508/lsa.201800178; Wu CH, 2014, CELL HOST MICROBE, V16, P462, DOI 10.1016/j.chom.2014.09.009; Wu CH, 2009, J BIOL CHEM, V284, P5229, DOI 10.1074/jbc.M805747200; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang PG, 2020, CELL, V181, P325, DOI 10.1016/j.cell.2020.03.046; Yang YZ, 2014, MOL CELL, V53, P484, DOI 10.1016/j.molcel.2014.01.011; Yao HP, 2020, CELL, V183, P730, DOI 10.1016/j.cell.2020.09.018; Ye QZ, 2020, PROTEIN SCI, V29, P1890, DOI [10.1002/pro.3909, 10.1101/2020.05.17.100685]; Zhu YK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21213-4	93	19	20	4	17	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100821	10.1016/j.jbc.2021.100821	http://dx.doi.org/10.1016/j.jbc.2021.100821			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029587	Green Published, gold			2022-12-28	WOS:000678068400023
J	Ide, K; Takahashi, S; Sakai, K; Taga, Y; Ueno, T; Dickens, D; Jenkins, R; Falciani, F; Sasaki, T; Ooi, K; Kawashiri, S; Mizuno, K; Hattori, S; Sakai, T				Ide, Kentaro; Takahashi, Sanai; Sakai, Keiko; Taga, Yuki; Ueno, Tomonori; Dickens, David; Jenkins, Rosalind; Falciani, Francesco; Sasaki, Takako; Ooi, Kazuhiro; Kawashiri, Shuichi; Mizuno, Kazunori; Hattori, Shunji; Sakai, Takao			The dipeptide prolyl-hydroxyproline promotes cellular homeostasis and lamellipodia-driven motility via active beta 1-integrin in adult tendon cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLLAGEN-DERIVED DIPEPTIDE; HUMAN-BLOOD; TGF-BETA; EXTRACELLULAR-MATRIX; ADHESION DYNAMICS; HOMEOBOX GENE; INTEGRIN; DIFFERENTIATION; SCLERAXIS; MIGRATION	Collagen-derived hydroxyproline (Hyp)-containing peptides have a variety of biological effects on cells. These bioactive collagen peptides are locally generated by the degradation of endogenous collagen in response to injury. However, no comprehensive study has yet explored the functional links between Hyp-containing peptides and cellular behavior. Here, we show that the dipeptide prolyl-4-hydroxyproline (Pro-Hyp) exhibits pronounced effects on mouse tendon cells. Pro-Hyp promotes differentiation/maturation of tendon cells with modulation of lineage-specific factors and induces significant chemotactic activity in vitro. In addition, Pro-Hyp has pro-found effects on cell proliferation, with significantly upregulated extracellular signal-regulated kinase phosphorylation and extracellular matrix production and increased type I collagen network organization. Using proteomics, we have predicted molecular transport, cellular assembly and organization, and cellular movement as potential linked-network pathways that could be altered in response to Pro-Hyp. Mechanistically, cells treated with Pro-Hyp demonstrate increased directional persistence and significantly increased directed motility and migration velocity. They are accompanied by elongated lamellipodial protrusions with increased levels of active beta 1-integrin-containing focal contacts, as well as reorganization of thicker peripheral F-actin fibrils. Pro-Hyp-mediated chemotactic activity is significantly reduced (p < 0.001) in cells treated with the mitogen-activated protein kinase kinase 1/2 inhibitor PD98059 or the alpha 5 beta 1-integrin antagonist ATN-161. Furthermore, ATN-161 significantly inhibits uptake of Pro-Hyp into adult tenocytes. Thus, our findings document the molecular basis of the functional benefits of the Pro-Hyp dipeptide in cellular behavior. These dynamic properties of collagen-derived Pro-Hyp dipeptide could lead the way to its application in translational medicine.	[Ide, Kentaro; Takahashi, Sanai; Sakai, Keiko; Dickens, David; Jenkins, Rosalind; Sakai, Takao] Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Syst Mol & Integrat Biol, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England; [Taga, Yuki; Ueno, Tomonori; Mizuno, Kazunori; Hattori, Shunji] Nippi Res Inst Biomatrix, Toride, Ibaraki, Japan; [Falciani, Francesco] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Biochem & Syst Biol, Liverpool, Merseyside, England; [Sasaki, Takako] Oita Univ, Fac Med, Dept Biochem, Oita, Japan; [Ide, Kentaro; Ooi, Kazuhiro; Kawashiri, Shuichi] Kanazawa Univ, Dept Oral & Maxillofacial Surg, Grad Sch Med Sci, Kanazawa, Ishikawa, Japan	University of Liverpool; University of Liverpool; Oita University; Kanazawa University	Sakai, T (corresponding author), Univ Liverpool, MRC Ctr Drug Safety Sci, Inst Syst Mol & Integrat Biol, Dept Pharmacol & Therapeut, Liverpool, Merseyside, England.	sakait@liverpool.ac.uk	Taga, Yuki/I-2781-2019; Mizuno, Kazunori/AAY-7613-2021; Dickens, David/H-3105-2016	Taga, Yuki/0000-0001-9100-758X; Mizuno, Kazunori/0000-0003-3354-6264; Ide, Kentaro/0000-0003-0701-1207; Dickens, David/0000-0001-8295-0752	Knowledge Exchange Funding Scheme, University of Liverpool, United Kingdom; Nippi, Inc, Japan	Knowledge Exchange Funding Scheme, University of Liverpool, United Kingdom; Nippi, Inc, Japan	This work was supported in part by the Knowledge Exchange Funding Scheme, University of Liverpool, United Kingdom, and Nippi, Inc, Japan (to T. S.).	Anderson DM, 2006, DEV DYNAM, V235, P792, DOI 10.1002/dvdy.20671; Aslan H, 2008, J CLIN INVEST, V118, P439, DOI 10.1172/JCI33944; Asou Y, 2002, J ORTHOPAED RES, V20, P827, DOI 10.1016/S0736-0266(01)00169-3; Bachinger HP, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 5: AMINO ACIDS, PEPTIDES AND PROTEINS, P469; Bagchi RA, 2012, BBA-MOL CELL RES, V1823, P1936, DOI 10.1016/j.bbamcr.2012.07.002; Barkan D, 2011, CLIN CANCER RES, V17, P7219, DOI 10.1158/1078-0432.CCR-11-0642; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7; Canty EG, 2005, J CELL SCI, V118, P1341, DOI 10.1242/jcs.01731; DeMali KA, 2003, CURR OPIN CELL BIOL, V15, P572, DOI 10.1016/S0955-0674(03)00109-1; Docheva D, 2005, MOL CELL BIOL, V25, P699, DOI 10.1128/MCB.25.2.699-705.2005; Durzynska J, 2015, J PHARMACOL EXP THER, V354, P32, DOI 10.1124/jpet.115.223305; Espira L, 2009, J MOL CELL CARDIOL, V47, P188, DOI 10.1016/j.yjmcc.2009.03.024; Galbraith CG, 2007, SCIENCE, V315, P992, DOI 10.1126/science.1137904; Gallo M, 2019, ARCH BIOCHEM BIOPHYS, V661, P74, DOI 10.1016/j.abb.2018.11.010; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Gorelik R, 2014, NAT PROTOC, V9, P1931, DOI 10.1038/nprot.2014.131; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Havis E, 2016, DEVELOPMENT, V143, P3839, DOI 10.1242/dev.136242; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Huang AH, 2015, J ORTHOP RES, V33, P800, DOI 10.1002/jor.22834; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hughes PE, 1998, TRENDS CELL BIOL, V8, P359, DOI 10.1016/S0962-8924(98)01339-7; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Innocenti M, 2018, CELL ADHES MIGR, V12, P401, DOI 10.1080/19336918.2018.1448352; Ito Y, 2010, P NATL ACAD SCI USA, V107, P10538, DOI 10.1073/pnas.1000525107; Iwai K, 2005, J AGR FOOD CHEM, V53, P6531, DOI 10.1021/jf050206p; Iwasaki A, 2016, J BIOL CHEM, V291, P72, DOI 10.1074/jbc.M115.691519; Jain P, 2012, JOVE-J VIS EXP, DOI 10.3791/3585; Jimi S., 2017, CLIN RES DERMATOL OP, V4, P1, DOI [10.15226/2378-1726/4/2/00155, DOI 10.15226/2378-1726/4/2/00155]; Kimira Y, 2017, CELL MOL BIOL LETT, V22, DOI 10.1186/s11658-017-0060-2; Kimira Y, 2014, BIOCHEM BIOPH RES CO, V453, P498, DOI 10.1016/j.bbrc.2014.09.121; Kitakaze T, 2016, BIOCHEM BIOPH RES CO, V478, P1292, DOI 10.1016/j.bbrc.2016.08.114; Kjaer M, 2004, PHYSIOL REV, V84, P649, DOI 10.1152/physrev.00031.2003; Krause M, 2014, NAT REV MOL CELL BIO, V15, P577, DOI 10.1038/nrm3861; Kumagai K, 2012, OSTEOARTHR CARTILAGE, V20, P1258, DOI 10.1016/j.joca.2012.07.013; Kusubata M, 2015, BIOSCI BIOTECH BIOCH, V79, P1356, DOI 10.1080/09168451.2015.1027653; LASKIN DL, 1986, J LEUKOCYTE BIOL, V39, P255, DOI 10.1002/jlb.39.3.255; Lauffenburger DA, 1996, CELL, V84, P359, DOI 10.1016/S0092-8674(00)81280-5; Lejard V, 2007, J BIOL CHEM, V282, P17665, DOI 10.1074/jbc.M610113200; Liu HH, 2015, STEM CELLS, V33, P443, DOI 10.1002/stem.1866; Liu ZH, 2011, PEPTIDES, V32, P747, DOI 10.1016/j.peptides.2011.01.019; Maeda T, 2011, CURR BIOL, V21, P933, DOI 10.1016/j.cub.2011.04.007; Mana G, 2020, BIOCHEM SOC T, V48, P83, DOI 10.1042/BST20190309; Manohar A, 2004, J CELL SCI, V117, P4043, DOI 10.1242/jcs.01277; Minaguchi J, 2005, J NUTR SCI VITAMINOL, V51, P169, DOI 10.3177/jnsv.51.169; Moreno-Layseca P, 2019, NAT CELL BIOL, V21, P122, DOI 10.1038/s41556-018-0223-z; Moriya K, 2011, GASTROENTEROLOGY, V140, P1653, DOI 10.1053/j.gastro.2011.02.005; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Nakatani S, 2009, OSTEOARTHR CARTILAGE, V17, P1620, DOI 10.1016/j.joca.2009.07.001; Nigam SK, 2015, NAT REV DRUG DISCOV, V14, P29, DOI 10.1038/nrd4461; OBrien M, 1997, SCAND J MED SCI SPOR, V7, P55; Ogese MO, 2019, HEPATOLOGY, V70, P1732, DOI 10.1002/hep.30701; Ohara H, 2010, J DERMATOL, V37, P330, DOI 10.1111/j.1346-8138.2010.00827.x; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; POSTLETHWAITE AE, 1976, J EXP MED, V143, P1299, DOI 10.1084/jem.143.6.1299; POSTLETHWAITE AE, 1978, P NATL ACAD SCI USA, V75, P871, DOI 10.1073/pnas.75.2.871; Pozzi M, 1998, J CELL BIOL, V142, P587; Praet SFE, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010076; Ricard-Blum S, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004978; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sakabe T, 2018, J BIOL CHEM, V293, P5766, DOI 10.1074/jbc.RA118.001987; Sakabe T, 2011, BRIT MED BULL, V99, P211, DOI 10.1093/bmb/ldr025; Sakai T, 1998, J CELL BIOL, V141, P527, DOI 10.1083/jcb.141.2.527; Sakai T, 1998, J BIOL CHEM, V273, P19378, DOI 10.1074/jbc.273.31.19378; Sakai T, 2003, GENE DEV, V17, P926, DOI 10.1101/gad.255603; Saneyasu T., 2016, COMPOSITION FUNCTION, P235; Sastry SK, 1999, J CELL BIOL, V144, P1295, DOI 10.1083/jcb.144.6.1295; Sato K, 2019, INT J FOOD SCI TECH, V54, P1976, DOI 10.1111/ijfs.14145; Schunck M., 2013, J INT SOC SPORTS NUT, V10, pP23, DOI [10.1186/1550-2783-10-S1-P23, DOI 10.1186/1550-2783-10-S1-P23]; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Sharma P., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P181; Shigemura Y, 2009, J AGR FOOD CHEM, V57, P444, DOI 10.1021/jf802785h; Shukunami C, 2006, DEV BIOL, V298, P234, DOI 10.1016/j.ydbio.2006.06.036; Tabujew I., 2015, BIONANOMATERIALS, V16, P59, DOI [10.1515/bnm-2015-0001, DOI 10.1515/BNM-2015-0001]; Taga Y, 2019, J AGR FOOD CHEM, V67, P4671, DOI 10.1021/acs.jafc.9b00571; Taga Y, 2018, J AGR FOOD CHEM, V66, P8737, DOI 10.1021/acs.jafc.8b03648; Taga Y, 2018, J FUNCT FOODS, V46, P456, DOI 10.1016/j.jff.2018.05.017; Taga Y, 2014, J AGR FOOD CHEM, V62, P12096, DOI 10.1021/jf5039597; Tanimura S, 2017, J BIOCHEM, V162, P145, DOI 10.1093/jb/mvx048; Tozer Samuel, 2005, Birth Defects Research, V75, P226, DOI 10.1002/bdrc.20049; Truong H, 2009, CELL ADHES MIGR, V3, P179, DOI 10.4161/cam.3.2.8036; Tsuruoka N, 2007, BIOSCI BIOTECH BIOCH, V71, P2680, DOI 10.1271/bbb.70287; Ueda H, 2008, J VET MED SCI, V70, P1295, DOI 10.1292/jvms.70.1295; Vicente-Manzanares M, 2011, J CELL SCI, V124, P3923, DOI 10.1242/jcs.095653; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Wu J, 2004, J BONE MINER METAB, V22, P547, DOI 10.1007/s00774-004-0522-2; Zhang G., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P5; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	95	6	6	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100819	10.1016/j.jbc.2021.100819	http://dx.doi.org/10.1016/j.jbc.2021.100819			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34029590	Green Published, gold			2022-12-28	WOS:000678068400021
J	Sohlenkamp, C				Sohlenkamp, Christian			Crossing the lipid divide	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material							BIOSYNTHESIS; BACTERIAL	Archaeal membrane lipids are structurally different from bacterial and eukaryotic membrane lipids, but little is known about the enzymes involved in their synthesis. In a recent study, Exterkate et al. identified and characterized a cardiolipin synthase from the archaeon Methanospirillum hungatei. This enzyme can synthesize archaeal, bacterial, and mixed archaeal/bacterial cardiolipin species from a wide variety of substrates, some of which are not even naturally occurring. This discovery could revolutionize synthetic lipid biology, being used to construct a variety of lipids with nonnatural head groups and mixed archaeal/bacterial hydrophobic chains.	[Sohlenkamp, Christian] Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico	Sohlenkamp, C (corresponding author), Univ Nacl Autonoma Mexico, Ctr Ciencias Genom, Cuernavaca, Morelos, Mexico.	chsohlen@ccg.unam.mx		Sohlenkamp, Christian/0000-0002-9962-2859	CONACYT [425886]; PAPIIT-UNAM [IN208116, IN208319]; UC MEXUS-CONACYT [CN-20-107]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); PAPIIT-UNAM(Programa de Apoyo a Proyectos de Investigacion e Innovacion Tecnologica (PAPIIT)Universidad Nacional Autonoma de Mexico); UC MEXUS-CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	Research in our group is supported by grants from CONACYT (425886) and PAPIIT-UNAM (IN208116 and IN208319) and UC MEXUS-CONACYT (CN-20-107).	Corcelli A, 2009, BBA-BIOMEMBRANES, V1788, P2101, DOI 10.1016/j.bbamem.2009.05.010; Exterkate M., 2021, J BIOL CHEM, V296; Jain S, 2014, CHEM BIOL, V21, P1392, DOI 10.1016/j.chembiol.2014.07.022; Klug L, 2014, FEMS YEAST RES, V14, P369, DOI 10.1111/1567-1364.12141; RAETZ CRH, 1990, J BIOL CHEM, V265, P1235; Schlame M, 2008, J LIPID RES, V49, P1607, DOI 10.1194/jlr.R700018-JLR200; Sohlenkamp C, 2016, FEMS MICROBIOL REV, V40, P133, DOI 10.1093/femsre/fuv008; Villanueva L, 2021, ISME J, V15, P168, DOI 10.1038/s41396-020-00772-2	8	1	1	2	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL	2021	297	1							100859	10.1016/j.jbc.2021.100859	http://dx.doi.org/10.1016/j.jbc.2021.100859			2	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TQ1SY	34097872	Green Published, gold			2022-12-28	WOS:000678068400059
J	Adariani, SR; Jasemi, NSK; Bazgir, F; Wittich, C; Amin, E; Seidel, CAM; Dvorsky, R; Ahmadian, MR				Adariani, Soheila Rezaei; Jasemi, Neda S. Kazemein; Bazgir, Farhad; Wittich, Christoph; Amin, Ehsan; Seidel, Claus A. M.; Dvorsky, Radovan; Ahmadian, Mohammad R.			A comprehensive analysis of RAS-effector interactions reveals interaction hotspots and new binding partners	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; GROWTH-FACTOR; K-RAS; FAMILY PROTEINS; ASSOCIATION; DOMAINS; SWITCH; ACTIVATION; REGULATORS; MUTATIONS	RAS effectors specifically interact with GTP-bound RAS proteins to link extracellular signals to downstream signaling pathways. These interactions rely on two types of domains, called RAS-binding (RB) and RAS association (RA) domains, which share common structural characteristics. Although the molecular nature of RAS-effector interactions is well-studied for some proteins, most of the RA/RB-domain-containing proteins remain largely uncharacterized. Here, we searched through human proteome databases, extracting 41 RA domains in 39 proteins and 16 RB domains in 14 proteins, each of which can specifically select at least one of the 25 members in the RAS family. We next comprehensively investigated the sequence-structure-function relationship between different representatives of the RAS family, including HRAS, RRAS, RALA, RAP1B, RAP2A, RHEB1, and RIT1, with all members of RA domain family proteins (RASSFs) and the RB-domain-containing CRAF. The binding affinity for RAS-effector interactions, determined using fluorescence polarization, broadly ranged between high (0.3 mu M) and very low (500 mu M) affinities, raising interesting questions about the consequence of these variable binding affinities in the regulation of signaling events. Sequence and structural alignments pointed to two interaction hotspots in the RA/RB domains, consisting of an average of 19 RAS-binding residues. Moreover, we found novel interactions between RRAS1, RIT1, and RALA and RASSF7, RASSF9, and RASSF1, respectively, which were systematically explored in sequence-structure-property relationship analysis, and validated by mutational analysis. These data provide a set of distinct functional properties and putative biological roles that should now be investigated in the cellular context.	[Adariani, Soheila Rezaei; Jasemi, Neda S. Kazemein; Bazgir, Farhad; Wittich, Christoph; Amin, Ehsan; Dvorsky, Radovan; Ahmadian, Mohammad R.] Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Amin, Ehsan] Heinrich Heine Univ, Med Fac, Inst Neural & Sensory Physiol, Dusseldorf, Germany; [Seidel, Claus A. M.] Heinrich Heine Univ, Mol Phys Chem, Dusseldorf, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf	Ahmadian, MR (corresponding author), Heinrich Heine Univ, Med Fac, Inst Biochem & Mol Biol 2, Dusseldorf, Germany.	reza.ahmadian@hhu.de	Amin, Ehsan/GPC-5382-2022	Amin, Ehsan/0000-0003-2995-8864; Kazemein jasemi, Neda sadat/0000-0002-7842-6998; Bazgir, Farhad/0000-0002-0689-7926	European Network on Noonan Syndrome and Related Disorders (NSEuroNet) [01GM1621B]; German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) [IRTG 1902-p6]; German Federal Ministry of Education and Research (BMBF)-German Network of RASopathy Research (GeNeRARe) [01GM1902C]	European Network on Noonan Syndrome and Related Disorders (NSEuroNet); German Research Foundation (Deutsche Forschungsgemeinschaft or DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)-German Network of RASopathy Research (GeNeRARe)(Federal Ministry of Education & Research (BMBF))	This study was supported by the European Network on Noonan Syndrome and Related Disorders (NSEuroNet, grant number: 01GM1621B); the German Research Foundation (Deutsche Forschungsgemeinschaft or DFG) through the International Research Training Group "Intra-and interorgan communication of the cardiovascular system" (grant number: IRTG 1902-p6); the German Federal Ministry of Education and Research (BMBF)-German Network of RASopathy Research (GeNeRARe, grant numbers: 01GM1902C).	Abankwa D, 2007, SEMIN CELL DEV BIOL, V18, P599, DOI 10.1016/j.semcdb.2007.08.003; Abankwa D, 2010, P NATL ACAD SCI USA, V107, P1130, DOI 10.1073/pnas.0903907107; Adariani SR, 2018, BIOCHEM SOC T, V46, P1393, DOI 10.1042/BST20170528; Ahearn IM, 2012, NAT REV MOL CELL BIO, V13, P39, DOI 10.1038/nrm3255; Amendola CR, 2019, NATURE, V576, P482, DOI 10.1038/s41586-019-1832-9; Banani SF, 2017, NAT REV MOL CELL BIO, V18, P285, DOI 10.1038/nrm.2017.7; Barcelo C, 2014, CANCER RES, V74, P1190, DOI 10.1158/0008-5472.CAN-13-1750; Bauer B, 1999, J BIOL CHEM, V274, P17763, DOI 10.1074/jbc.274.25.17763; Bratek-Skicki A, 2020, FEBS J, V287, P1924, DOI 10.1111/febs.15254; Bunda S, 2014, P NATL ACAD SCI USA, V111, pE3785, DOI 10.1073/pnas.1406559111; Bunney TD, 2006, MOL CELL, V21, P495, DOI 10.1016/j.molcel.2006.01.008; Bunney TD, 2011, TRENDS BIOCHEM SCI, V36, P88, DOI 10.1016/j.tibs.2010.08.003; Cai QX, 2020, STRUCTURE, V28, P290, DOI 10.1016/j.str.2019.11.018; Case LB, 2019, ANNU REV BIOPHYS, V48, P465, DOI 10.1146/annurev-biophys-052118-115534; Castellano Esther, 2011, Genes Cancer, V2, P261, DOI 10.1177/1947601911408079; Castellano E, 2010, CURR TOP MICROBIOL, V346, P143, DOI 10.1007/82_2010_56; Chan Jia Jia, 2013, Advances in Biological Regulation, V53, P258, DOI [10.1016/j.jbior.2013.07.008, 10.1016/j.jbior.2012.12.001]; Chavan TS., 2015, CELL LOGIST, V5, DOI DOI 10.1080/21592799.2015.1136374; Chowdhury D, 2020, STRUCTURE, V28, P274, DOI 10.1016/j.str.2020.02.003; Cirstea IC, 2010, NAT GENET, V42, P27, DOI 10.1038/ng.497; Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163; Desideri E, 2015, CELL, V161, P967, DOI 10.1016/j.cell.2015.04.045; Devanand T, 2019, J MEMBRANE BIOL, V252, P331, DOI 10.1007/s00232-019-00072-7; Devanand T., 2018, SCI REP-UK, V8, P1; Dhanaraman T, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.abb4778; Donninger H, 2016, SEMIN CELL DEV BIOL, V58, P86, DOI 10.1016/j.semcdb.2016.06.007; Erijman A, 2016, MINI-REV MED CHEM, V16, P370, DOI 10.2174/1389557515666151001141838; Erwin N, 2017, BIOL CHEM, V398, P547, DOI 10.1515/hsz-2016-0289; Ferro E, 2010, CELL SIGNAL, V22, P1804, DOI 10.1016/j.cellsig.2010.05.010; Filchtinski D, 2010, J MOL BIOL, V399, P422, DOI 10.1016/j.jmb.2010.03.046; Fischer A, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M607458200; Ghai R., 2011, SMALL GTPASES, V2, p7763 7768; Ghai R, 2011, P NATL ACAD SCI USA, V108, P7763, DOI 10.1073/pnas.1017110108; Goddard TD, 2018, PROTEIN SCI, V27, P14, DOI 10.1002/pro.3235; Gordon N4, 2011, SMALL GTPASES, V2, p5729 5740; Gremer L, 2011, HUM MUTAT, V32, P33, DOI 10.1002/humu.21377; Gutierrez-Erlandsson S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-127; Haghighi F, 2018, CELL COMMUN SIGNAL, V16, DOI 10.1186/s12964-018-0307-1; HaII T. A, 1999, NUCL ACIDS S SERIES; Heard JJ, 2018, BMC CANCER, V18, DOI 10.1186/s12885-017-3938-5; Hennig A, 2015, BIOL CHEM, V396, P831, DOI 10.1515/hsz-2014-0257; Herrmann C, 2003, CURR OPIN STRUC BIOL, V13, P122, DOI 10.1016/S0959-440X(02)00007-6; Hu CD, 1995, J BIOL CHEM, V270, P30274, DOI 10.1074/jbc.270.51.30274; Ibanez Gaspar Veronica, 2021, Small GTPases, V12, P209, DOI 10.1080/21541248.2020.1724596; Iwasa H, 2018, CELL MOL LIFE SCI, V75, P1773, DOI 10.1007/s00018-018-2756-5; Jaiswal M, 2014, J BIOL CHEM, V289, P6839, DOI 10.1074/jbc.M113.527655; Jang H, 2020, COMPUT STRUCT BIOTEC, V18, P737, DOI 10.1016/j.csbj.2020.03.018; Kano Y, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08115-8; Kapoor S, 2012, P NATL ACAD SCI USA, V109, P460, DOI 10.1073/pnas.1110553109; Karbowniczek M, 2006, J BIOL CHEM, V281, P25447, DOI 10.1074/jbc.M605273200; Karnoub AE, 2008, NAT REV MOL CELL BIO, V9, P517, DOI 10.1038/nrm2438; Ke H, 2017, FEBS LETT, V591, P2470, DOI 10.1002/1873-3468.12759; Kelley GG, 2001, EMBO J, V20, P743, DOI 10.1093/emboj/20.4.743; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kiel C, 2005, J MOL BIOL, V348, P759, DOI 10.1016/j.jmb.2005.02.046; Kiel C, 2004, P NATL ACAD SCI USA, V101, P9223, DOI 10.1073/pnas.0401160101; Kiel C, 2007, J MOL BIOL, V370, P1020, DOI 10.1016/j.jmb.2007.05.015; Kiel C, 2009, J BIOL CHEM, V284, P31893, DOI 10.1074/jbc.M109.031153; Lakshman B, 2019, J BIOL CHEM, V294, P2193, DOI 10.1074/jbc.RA118.005669; Li ZL, 2018, ACS CENTRAL SCI, V4, P298, DOI 10.1021/acscentsci.7b00593; Malliri A, 2003, CURR OPIN CELL BIOL, V15, P583, DOI 10.1016/S0955-0674(03)00098-X; Mazhab-Jafari MT, 2015, P NATL ACAD SCI USA, V112, P6625, DOI 10.1073/pnas.1419895112; MIYAZAKI J, 2019, BMC CANCER, V19, DOI DOI 10.1186/S12894-019-0569-Y; Mott HR, 2015, CRIT REV BIOCHEM MOL, V50, P85, DOI 10.3109/10409238.2014.999191; Nakhaei-Rad S, 2018, CRIT REV BIOCHEM MOL, V53, P130, DOI 10.1080/10409238.2018.1431605; Nakhaei-Rad S, 2016, J BIOL CHEM, V291, P8399, DOI 10.1074/jbc.M115.700088; Nakhaeizadeh H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167145; NASSAR M, 1995, NATURE, V375, P554, DOI 10.1038/375554a0; Nassar N, 1996, NAT STRUCT BIOL, V3, P723, DOI 10.1038/nsb0896-723; Nelson N, 2016, ONCOTARGET, V7, P33821, DOI 10.18632/oncotarget.8447; NGUYEN TL, 2018, STRUCTURE, V20, DOI DOI 10.1186/S13058-018-1081-0; Nouri K, 2016, J BIOL CHEM, V291, P26364, DOI 10.1074/jbc.M116.752121; Nussinov R, 2020, CURR OPIN STRUC BIOL, V62, P140, DOI 10.1016/j.sbi.2020.01.009; Nussinov R, 2019, SEMIN CANCER BIOL, V54, P114, DOI 10.1016/j.semcancer.2018.01.002; Nussinov R, 2015, EXPERT REV PROTEOMIC, V12, P669, DOI 10.1586/14789450.2015.1100079; Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3; Park E, 2019, NATURE, V575, P545, DOI 10.1038/s41586-019-1660-y; Rajalingam K, 2007, BBA-MOL CELL RES, V1773, P1177, DOI 10.1016/j.bbamcr.2007.01.012; Repasky GA, 2004, TRENDS CELL BIOL, V14, P639, DOI 10.1016/j.tcb.2004.09.014; Rooney C, 2010, EMBO REP, V11, P292, DOI 10.1038/embor.2010.10; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Schreiber G, 2009, CHEM REV, V109, P839, DOI 10.1021/cr800373w; Shao HP, 1999, ARCH BIOCHEM BIOPHYS, V371, P207, DOI 10.1006/abbi.1999.1448; Shi GX, 2005, MOL CELL BIOL, V25, P830, DOI 10.1128/MCB.25.2.830-846.2005; Shima F, 2000, MOL CELL BIOL, V20, P26, DOI 10.1128/MCB.20.1.26-33.2000; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Smith MJ, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01326-5; Sperlich B, 2016, BIOPHYS J, V111, P113, DOI 10.1016/j.bpj.2016.05.042; Stieglitz B, 2008, EMBO J, V27, P1995, DOI 10.1038/emboj.2008.125; Sukenik S, 2017, P NATL ACAD SCI USA, V114, P6776, DOI 10.1073/pnas.1700818114; Thapar R, 2004, J MOL BIOL, V343, P1391, DOI 10.1016/j.jmb.2004.08.106; Thillaivillalan D., 2020, BIORXIV, DOI DOI 10.1101/2020.02.05.923433; Thurman Ryan, 2020, Small GTPases, V11, P180, DOI 10.1080/21541248.2017.1371267; Travers T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26832-4; van der Weyden L, 2007, BBA-REV CANCER, V1776, P58, DOI 10.1016/j.bbcan.2007.06.003; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogel A, 2014, BIOL CHEM, V395, P779, DOI 10.1515/hsz-2013-0294; Willard FS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004884; Williams JG, 2000, J BIOL CHEM, V275, P22172, DOI 10.1074/jbc.M000397200; Wohlgemuth S, 2005, J MOL BIOL, V348, P741, DOI 10.1016/j.jmb.2005.02.048; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yaoita M, 2016, HUM GENET, V135, P209, DOI 10.1007/s00439-015-1627-5; Yee WM, 1997, MOL CELL BIOL, V17, P921, DOI 10.1128/MCB.17.2.921; Yoon SY, 2000, ACTA HAEMATOL-BASEL, V104, P151, DOI 10.1159/000046507; Zhou Y, 2018, TRAFFIC, V19, P157, DOI 10.1111/tra.12541	105	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100626	10.1016/j.jbc.2021.100626	http://dx.doi.org/10.1016/j.jbc.2021.100626			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33930461	Green Published, gold			2022-12-28	WOS:000672866400597
J	Brewster, JL; Pachl, P; McKellar, JLO; Selmer, M; Squire, CJ; Patrick, WM				Brewster, Jodi L.; Pachl, Petr; McKellar, James L. O.; Selmer, Maria; Squire, Christopher J.; Patrick, Wayne M.			Structures and kinetics of Thermotoga maritima MetY reveal new insights into the predominant sulfurylation enzyme of bacterial methionine biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTATHIONINE GAMMA-SYNTHASE; O-ACETYLHOMOSERINE SULFHYDRYLASE; L-HOMOSERINE SULFHYDRYLASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PARTIAL-PURIFICATION; BETA-LYASE; HOMOCYSTEINE; METABOLISM; SOFTWARE	Bacterial methionine biosynthesis can take place by either the trans-sulfurylation route or direct sulfurylation. The enzymes responsible for trans-sulfurylation have been characterized extensively because they occur in model organisms such as Escherichia coli. However, direct sulfurylation is actually the predominant route for methionine biosynthesis across the phylogenetic tree. In this pathway, most bacteria use an Oacetylhomo-serine aminocarboxypropyltransferase (MetY) to catalyze the formation of homocysteine from O-acetylhomoserine and bisulfide. Despite the widespread distribution of MetY, this pyridoxal 50-phosphate-dependent enzyme remains comparatively understudied. To address this knowledge gap, we have characterized the MetY from Thermotoga maritima (TmMetY). At its optimal temperature of 70 degrees C, TmMetY has a turnover number (apparent k(cat) = 900 s(-1)) that is 10- to 700-fold higher than the three other MetY enzymes for which data are available. We also present crystal structures of TmMetY in the internal aldimine form and, fortuitously, with a beta,gamma-unsaturated ketimine reaction intermediate. This intermediate is identical to that found in the catalytic cycle of cystathionine.-synthase (MetB), which is a homologous enzyme from the trans-sulfurylation pathway. By comparing the TmMetY and MetB structures, we have identified Arg270 as a critical determinant of specificity. It helps to wall off the active site of TmMetY, disfavoring the binding of the first MetB substrate, O-succinylhomoserine. It also ensures a strict specificity for bisulfide as the second substrate of MetY by occluding the larger MetB substrate, cysteine. Overall, this work illuminates the subtle structural mechanisms by which homologous pyridoxal 50-phosphate-dependent enzymes can effect different catalytic, and therefore metabolic, outcomes.	[Brewster, Jodi L.; McKellar, James L. O.] Univ Otago, Dept Biochem, Dunedin, New Zealand; [Pachl, Petr] Czech Acad Sci, Inst Organ Chem & Biochem, Prague, Czech Republic; [Selmer, Maria] Uppsala Univ, Dept Cell & Mol Biol, Uppsala, Sweden; [Squire, Christopher J.] Univ Auckland, Sch Biol Sci, Auckland, New Zealand; [Patrick, Wayne M.] Victoria Univ Wellington, Ctr Biodiscovery, Sch Biol Sci, Wellington, New Zealand; [Brewster, Jodi L.] Univ Wollongong, Sch Chem & Mol Biosci, Wollongong, NSW 2522, Australia	University of Otago; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences; Uppsala University; University of Auckland; Victoria University Wellington; University of Wollongong	Patrick, WM (corresponding author), Victoria Univ Wellington, Ctr Biodiscovery, Sch Biol Sci, Wellington, New Zealand.	wayne.patrick@vuw.ac.nz	Pachl, Petr/H-1344-2014; Brewster, Jodi/AAP-6952-2021	Pachl, Petr/0000-0001-9215-9817; Brewster, Jodi/0000-0001-8569-1813; Selmer, Maria/0000-0001-9079-2774	Marsden Fund [18-VUW-050]; Rutherford Discovery Fellowship	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Rutherford Discovery Fellowship	This work was supported by a grant from the Marsden Fund (18-VUW-050) and the award of a Rutherford Discovery Fellowship, both to W. M. P.	Adams PD, 2011, METHODS, V55, P94, DOI 10.1016/j.ymeth.2011.07.005; Aitken SM, 2005, ARCH BIOCHEM BIOPHYS, V433, P166, DOI 10.1016/j.abb.2004.08.024; Aitken SM, 2003, BIOCHEMISTRY-US, V42, P11297, DOI 10.1021/bi035107o; Aitken SM, 2011, BBA-PROTEINS PROTEOM, V1814, P1511, DOI 10.1016/j.bbapap.2011.03.006; Aledo JC, 2019, PROTEIN SCI, V28, P1785, DOI 10.1002/pro.3698; Bastard K, 2017, NAT CHEM BIOL, V13, P858, DOI 10.1038/nchembio.2397; Berney M, 2015, P NATL ACAD SCI USA, V112, P10008, DOI 10.1073/pnas.1513033112; BRZOVIC P, 1990, BIOCHEMISTRY-US, V29, P442, DOI 10.1021/bi00454a020; Chaton CT, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-56722-2; Choi CK, 2005, SEP SCI TECHNOL-SER, V6, P123; Clausen T, 1998, EMBO J, V17, P6827, DOI 10.1093/emboj/17.23.6827; Clausen T, 1996, J MOL BIOL, V262, P202, DOI 10.1006/jmbi.1996.0508; Clausen T, 1997, BIOCHEMISTRY-US, V36, P12633, DOI 10.1021/bi970630m; Davidi D, 2020, EMBO J, V39, DOI 10.15252/embj.2019104081; Dou C, 2005, CLIN CHEM, V51, P1987, DOI 10.1373/clinchem.2005.053421; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ELLMAN GL, 1961, BIOCHEM PHARMACOL, V7, P88, DOI 10.1016/0006-2952(61)90145-9; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferla MP, 2017, MOL MICROBIOL, V105, P508, DOI 10.1111/mmi.13737; Ferla MP, 2014, MICROBIOL-SGM, V160, P1571, DOI 10.1099/mic.0.077826-0; Frick B, 2003, CLIN CHIM ACTA, V331, P19, DOI 10.1016/S0009-8981(03)00076-7; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Giardina G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11948-w; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; Goudarzi M, 2006, EXTREMOPHILES, V10, P469, DOI 10.1007/s00792-006-0522-3; Hacham Y, 2003, MOL BIOL EVOL, V20, P1513, DOI 10.1093/molbev/msg169; Hesse H, 2004, J EXP BOT, V55, P1799, DOI 10.1093/jxb/erh139; Ngo HPT, 2012, ACTA CRYSTALLOGR F, V68, P1515, DOI 10.1107/S1744309112042819; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; Hwang BJ, 2007, J MICROBIOL BIOTECHN, V17, P1010; Imagawa T., 2005, PDB ID 2CTZ CRYSTAL; Imagawa T., 2007, PDB ID 2CB1 CRYSTAL; Iwama T, 2004, BIOSCI BIOTECH BIOCH, V68, P1357, DOI 10.1271/bbb.68.1357; Jeske L, 2019, NUCLEIC ACIDS RES, V47, pD542, DOI 10.1093/nar/gky1048; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KAPLAN MM, 1966, J BIOL CHEM, V241, P5781; KERR DS, 1971, J BIOL CHEM, V246, P95; Kulikova V. V., 2021, PROTEIN EXPRES PURIF, V180; Kulikova VV, 2019, IUBMB LIFE, V71, P1815, DOI 10.1002/iub.2139; Kusmierek K, 2009, J CHROMATOGR B, V877, P3300, DOI 10.1016/j.jchromb.2009.03.038; Lesley SA, 2002, P NATL ACAD SCI USA, V99, P11664, DOI 10.1073/pnas.142413399; Liang J, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00004; Liebschner D, 2017, ACTA CRYSTALLOGR D, V73, P148, DOI 10.1107/S2059798316018210; Liu HT, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-91; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Messerschmidt A, 2003, BIOL CHEM, V384, P373, DOI 10.1515/BC.2003.043; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; Ngo H. P. T., 2020, PDB ID 6LD8 CRYSTAL, DOI [10.2210/pdb2216LD2218/pdb, DOI 10.2210/PDB2216LD2218/PDB]; Omura H, 2003, J BIOSCI BIOENG, V96, P53, DOI 10.1016/S1389-1723(03)90096-X; OZAKI H, 1982, J BIOCHEM-TOKYO, V91, P1163, DOI 10.1093/oxfordjournals.jbchem.a133799; Raboni S, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P273; Ravanel S, 1998, P NATL ACAD SCI USA, V95, P7805, DOI 10.1073/pnas.95.13.7805; Richard JP, 2009, CURR OPIN CHEM BIOL, V13, P475, DOI 10.1016/j.cbpa.2009.06.023; ROWBURY RJ, 1964, J GEN MICROBIOL, V36, P341, DOI 10.1099/00221287-36-3-341; ROWBURY RJ, 1964, NATURE, V203, P977, DOI 10.1038/203977a0; Savchenko A., 2014, PDB ID 4OC9 235 RESO; Shimizu H, 2001, BBA-PROTEIN STRUCT M, V1549, P61, DOI 10.1016/S0167-4838(01)00245-X; SMITH DA, 1966, HEREDITY, V21, P265, DOI 10.1038/hdy.1966.22; Soo VWC, 2016, J BIOL CHEM, V291, P19873, DOI 10.1074/jbc.M116.739557; Tawfik DS, 2016, CURR OPIN CHEM BIOL, V31, pV, DOI 10.1016/j.cbpa.2016.03.002; Toney MD, 2011, BBA-PROTEINS PROTEOM, V1814, P1407, DOI 10.1016/j.bbapap.2011.05.019; Tran TH, 2011, ACTA CRYSTALLOGR D, V67, P831, DOI 10.1107/S0907444911028010; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tu YP, 2018, BIOCHEMISTRY-US, V57, P3134, DOI 10.1021/acs.biochem.8b00092; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Vickers CJ, 2021, PROTEIN SCI, V30, P914, DOI 10.1002/pro.4041; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046463; YAMAGATA S, 1984, J BIOCHEM, V96, P1511, DOI 10.1093/oxfordjournals.jbchem.a134980; YAMAGATA S, 1971, J BIOCHEM-TOKYO, V70, P1035, DOI 10.1093/oxfordjournals.jbchem.a129712; Zierenberg RA, 2000, P NATL ACAD SCI USA, V97, P12961, DOI 10.1073/pnas.210395997	71	1	1	5	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100797	10.1016/j.jbc.2021.100797	http://dx.doi.org/10.1016/j.jbc.2021.100797			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TL2WM	34019879	gold, Green Published			2022-12-28	WOS:000674717300017
J	Kritsiligkou, P; Nowicki-Osuch, K; Carter, Z; Kershaw, CJ; Creamer, DR; Weids, AJ; Grant, CM				Kritsiligkou, Paraskevi; Nowicki-Osuch, Karol; Carter, Zorana; Kershaw, Chris J.; Creamer, Declan R.; Weids, Alan J.; Grant, Chris M.			Tolerance to nascent protein misfolding stress requires fine-tuning of the cAMP/PKA pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							YEAST TSA1 PEROXIREDOXIN; OXIDATIVE STRESS; HYDROGEN-PEROXIDE; CATALYTIC SUBUNITS; REGULATORY SUBUNIT; MUTANT HUNTINGTIN; QUALITY-CONTROL; KINASE; PKA; EXPRESSION	Protein aggregation is the abnormal association of misfolded proteins into larger, often insoluble structures that can be toxic during aging and in protein aggregation-associated diseases. Previous research has established a role for the cytosolic Tsa1 peroxiredoxin in responding to protein misfolding stress. Tsa1 is also known to downregulate the cAMP/protein kinase A (PKA) pathway as part of the response to hydrogen peroxide stress. However, whether the cAMP/PKA pathway is involved in protein misfolding stress is not known. Using transcriptomics, we examined the response to protein misfolding stress and found upregulation of numerous stress gene functions and downregulation of many genes related to protein synthesis and other growth-related processes consistent with the well-characterized environmental stress response. The scope of the transcriptional response is largely similar in wildtype and tsa1 mutant strains, but the magnitude is dampened in the strain lacking Tsa1. We identified a direct protein interaction between Tsa1 and the Bcy1 regulatory subunit of PKA that is present under normal growth conditions and explains the observed differences in gene expression profiles. This interaction is increased in a redox-dependent manner in response to nascent protein misfolding, via Tsa1-mediated oxidation of Bcy1. Oxidation of Bcy1 causes a reduction in cAMP binding by Bcy1, which dampens PKA pathway activity, leading to a targeted reprogramming of gene expression. Redox regulation of the regulatory subunit of PKA provides a mechanism to mitigate the toxic consequences of protein misfolding stress that is distinct to stress caused by exogenous sources of reactive oxygen species.	[Kritsiligkou, Paraskevi; Nowicki-Osuch, Karol; Carter, Zorana; Kershaw, Chris J.; Creamer, Declan R.; Weids, Alan J.; Grant, Chris M.] Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; [Kritsiligkou, Paraskevi] German Canc Res Ctr, Div Redox Regulat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Nowicki-Osuch, Karol] Columbia Univ, Irving Inst Canc Dynam, Schermerhorn Hall,Suite 601,1190 Amsterdam Ave, New York, NY 10027 USA	University of Manchester; Helmholtz Association; German Cancer Research Center (DKFZ); Columbia University	Kritsiligkou, P; Grant, CM (corresponding author), Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England.; Kritsiligkou, P (corresponding author), German Canc Res Ctr, Div Redox Regulat, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	p.kritsiligkou@dkfz-heidelberg.de; chris.grant@manchester.ac.uk	Kritsiligkou, Paraskevi/W-9399-2019; Nowicki-Osuch, Karol/AAC-7872-2022	Kritsiligkou, Paraskevi/0000-0003-2452-141X; Nowicki-Osuch, Karol/0000-0003-3828-8620; Grant, Chris/0000-0002-0616-6576; Kershaw, Christopher/0000-0001-6625-7894				Ashe MP, 2000, MOL BIOL CELL, V11, P833, DOI 10.1091/mbc.11.3.833; Baccarini L, 2015, BBA-GENE REGUL MECH, V1849, P1329, DOI 10.1016/j.bbagrm.2015.09.007; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bodvard K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14791; Bossy-Wetzel E, 2008, TRENDS NEUROSCI, V31, P609, DOI 10.1016/j.tins.2008.09.004; Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998; Brennan JP, 2006, J BIOL CHEM, V281, P21827, DOI 10.1074/jbc.M603952200; Burgoyne JR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8920; Byrne DP, 2020, SCI SIGNAL, V13, DOI 10.1126/scisignal.aax2713; CAMERON S, 1988, CELL, V53, P555, DOI 10.1016/0092-8674(88)90572-7; Carmel-Harel O, 2001, MOL MICROBIOL, V39, P595, DOI 10.1046/j.1365-2958.2001.02255.x; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; Conrad M, 2014, FEMS MICROBIOL REV, V38, P254, DOI 10.1111/1574-6976.12065; Dean RT, 1997, BIOCHEM J, V324, P1; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; ESTRUCH F, 1993, MOL CELL BIOL, V13, P3872, DOI 10.1128/MCB.13.7.3872; Fingerman I, 2003, EUKARYOT CELL, V2, P1061, DOI 10.1128/EC.2.5.1061-1068.2003; FIRST EA, 1988, J BIOL CHEM, V263, P5176; FLYNN GC, 1991, NATURE, V353, P726, DOI 10.1038/353726a0; Galello F, 2014, J PROTEOMICS, V109, P261, DOI 10.1016/j.jprot.2014.07.008; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Bardeci NG, 2016, J STRUCT BIOL, V193, P141, DOI 10.1016/j.jsb.2015.12.001; Gorner W, 1998, GENE DEV, V12, P586, DOI 10.1101/gad.12.4.586; Gutin J, 2015, MOL SYST BIOL, V11, DOI 10.15252/msb.20156451; Hands S, 2011, J BIOL CHEM, V286, P44512, DOI 10.1074/jbc.M111.307587; Hanzen S, 2016, CELL, V166, P140, DOI 10.1016/j.cell.2016.05.006; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Hipp MS, 2014, TRENDS CELL BIOL, V24, P506, DOI 10.1016/j.tcb.2014.05.003; Holmstrom KM, 2014, NAT REV MOL CELL BIO, V15, P411, DOI 10.1038/nrm3801; Humphries KM, 2007, J BIOL CHEM, V282, P22072, DOI 10.1074/jbc.M702582200; Humphries KM, 2002, J BIOL CHEM, V277, P43505, DOI 10.1074/jbc.M207088200; Irokawa H, 2016, SCI REP-UK, V6, DOI 10.1038/srep33536; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Johnston AS, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00166; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Labbadia J, 2015, ANNU REV BIOCHEM, V84, P435, DOI 10.1146/annurev-biochem-060614-033955; Lee P, 2008, MOL MICROBIOL, V70, P882, DOI 10.1111/j.1365-2958.2008.06450.x; Leichert LI, 2015, BIOL CHEM, V396, P389, DOI 10.1515/hsz-2014-0314; Levy E, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20163896; Ling JQ, 2012, MOL CELL, V48, P713, DOI 10.1016/j.molcel.2012.10.001; MacDiarmid CW, 2013, J BIOL CHEM, V288, P31313, DOI 10.1074/jbc.M113.512384; Marion RM, 2004, P NATL ACAD SCI USA, V101, P14315, DOI 10.1073/pnas.0405353101; Mogk A, 2019, ANNU REV MICROBIOL, V73, P89, DOI 10.1146/annurev-micro-020518-115515; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Perkins A, 2015, TRENDS BIOCHEM SCI, V40, P435, DOI 10.1016/j.tibs.2015.05.001; Rand JD, 2006, MOL BIOL CELL, V17, P387, DOI 10.1091/mbc.E05-06-0520; Reeve AK, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.166; Rhee SG, 2012, J BIOL CHEM, V287, P4403, DOI 10.1074/jbc.R111.283432; Roger F, 2020, ELIFE, V9, DOI 10.7554/eLife.60346; Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894; Schawalder SB, 2004, NATURE, V432, P1058, DOI 10.1038/nature03200; Sideri TC, 2010, P NATL ACAD SCI USA, V107, P6394, DOI 10.1073/pnas.1000347107; SIKORSKI RS, 1989, GENETICS, V122, P19; Smith A, 1998, EMBO J, V17, P3556, DOI 10.1093/emboj/17.13.3556; Solans A, 2006, HUM MOL GENET, V15, P3063, DOI 10.1093/hmg/ddl248; Solis EJ, 2016, MOL CELL, V63, P60, DOI 10.1016/j.molcel.2016.05.014; Stocker S, 2018, NAT CHEM BIOL, V14, P148, DOI 10.1038/nchembio.2536; Tachibana T, 2009, J BIOL CHEM, V284, P4464, DOI 10.1074/jbc.M807583200; TODA T, 1987, CELL, V50, P277, DOI 10.1016/0092-8674(87)90223-6; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trotter EW, 2008, BIOCHEM J, V412, P73, DOI 10.1042/BJ20071634; Trotter EW, 2002, J BIOL CHEM, V277, P44817, DOI 10.1074/jbc.M204686200; Trotter EW, 2003, EMBO REP, V4, P184, DOI 10.1038/sj.embor.embor729; Trotter EW, 2001, P NATL ACAD SCI USA, V98, P7313, DOI 10.1073/pnas.121172998; Tye BW, 2019, ELIFE, V8, DOI 10.7554/eLife.43002; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016; Vecchi G, 2020, P NATL ACAD SCI USA, V117, P1015, DOI 10.1073/pnas.1910444117; Wang LG, 2012, BIOINFORMATICS, V28, P2184, DOI 10.1093/bioinformatics/bts356; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Weids AJ, 2014, J CELL SCI, V127, P1327, DOI 10.1242/jcs.144022; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; de Pina MZ, 2008, J BIOL CHEM, V283, P12373, DOI 10.1074/jbc.M706832200	79	2	2	0	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100690	10.1016/j.jbc.2021.100690	http://dx.doi.org/10.1016/j.jbc.2021.100690			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33894203	Green Published, gold			2022-12-28	WOS:000672866400661
J	Lora, J; Weskamp, G; Li, TM; Maretzky, T; Shola, DTN; Monette, S; Lichtenthaler, SF; Lu, TT; Yang, CW; Blobel, CP				Lora, Jose; Weskamp, Gisela; Li, Thomas M.; Maretzky, Thorsten; Shola, Dorjee T. N.; Monette, Sebastien; Lichtenthaler, Stefan F.; Lu, Theresa T.; Yang, Chingwen; Blobel, Carl P.			Targeted truncation of the ADAM17 cytoplasmic domain in mice results in protein destabilization and a hypomorphic phenotype	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								A disintegrin and metalloprotease 17 (ADAM17) is a cellsurface metalloprotease that serves as the principle sheddase for tumor necrosis factor alpha (TNF alpha), interleukin-6 receptor (IL6R), and several ligands of the epidermal growth factor receptor (EGFR), regulating these crucial signaling pathways. ADAM17 activation requires its transmembrane domain, but not its cytoplasmic domain, and little is known about the role of this domain in vivo. To investigate, we used CRISPR-Cas9 to mutate the endogenous Adam17 locus in mice to produce a mutant ADAM17 lacking its cytoplasmic domain (Adam17 Delta cyto). Homozygous Adam17 Delta cyto animals were born at a Mendelian ratio and survived into adulthood with slightly wavy hair and curled whiskers, consistent with defects in ADAM17/EGFR signaling. At birth, Adam17 Delta cyto mice resembled Adam17-/- mice in that they had open eyes and enlarged semilunar heart valves, but they did not have bone growth plate defects. The deletion of the cytoplasmic domain resulted in strongly decreased ADAM17 protein levels in all tissues and cells examined, providing a likely cause for the hypomorphic phenotype. In functional assays, Adam17 Delta cyto mouse embryonic fibroblasts and bone-marrow-derived macrophages had strongly reduced ADAM17 activity, consistent with the reduced protein levels. Nevertheless, ADAM17 Delta cyto could be stimulated by PMA, a well-characterized posttranslational activator of ADAM17, corroborating that the cytoplasmic domain of endogenous ADAM17 is not required for its rapid response to PMA. Taken together, these results provide the first evidence that the cytoplasmic domain of ADAM17 plays a pivotal role in vivo in regulating ADAM17 levels and function.	[Lora, Jose; Blobel, Carl P.] Weill Cornell Med, Physiol Biophys & Syst Biol Program, New York, NY 10065 USA; [Lora, Jose; Weskamp, Gisela; Blobel, Carl P.] Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA; [Li, Thomas M.; Lu, Theresa T.] Hosp Special Surg, Autoimmun & Inflammat Program, 535 E 70th St, New York, NY 10021 USA; [Maretzky, Thorsten] Univ Iowa, Roy J & Lucille A Carver Coll Med, Inflammat Program, Iowa City, IA USA; [Maretzky, Thorsten] Univ Iowa, Roy J & Lucille A Carver Coll Med, Dept Internal Med, Iowa City, IA USA; [Shola, Dorjee T. N.; Yang, Chingwen] Rockefeller Univ, CRISPR, 1230 York Ave, New York, NY 10021 USA; [Shola, Dorjee T. N.; Yang, Chingwen] Rockefeller Univ, Editing Resource Ctr, 1230 York Ave, New York, NY 10021 USA; [Monette, Sebastien] Sloan Kettering Inst, Triinst Lab Comparat Pathol, New York, NY USA; [Lichtenthaler, Stefan F.] Tech Univ Munich, German Ctr Neurodegenerat Dis DZNE, Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, Sch Med Klinikum Rechts Isar, Neuroprote, Munich, Germany; [Lichtenthaler, Stefan F.] Tech Univ Munich, Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Lichtenthaler, Stefan F.; Blobel, Carl P.] Tech Univ Munich, Inst Adv Study, Garching, Germany; [Lu, Theresa T.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Blobel, Carl P.] Weill Cornell Med, Dept Med, New York, NY 10065 USA; [Blobel, Carl P.] Weill Cornell Med, Dept Biophys Physiol & Syst Biol, New York, NY 10065 USA	Cornell University; University of Iowa; University of Iowa; Rockefeller University; Rockefeller University; Memorial Sloan Kettering Cancer Center; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Technical University of Munich; Technical University of Munich; Technical University of Munich; University of Munich; Technical University of Munich; Cornell University; Cornell University; Cornell University	Blobel, CP (corresponding author), Weill Cornell Med, Physiol Biophys & Syst Biol Program, New York, NY 10065 USA.; Blobel, CP (corresponding author), Hosp Special Surg, Arthrit & Tissue Degenerat Program, 535 E 70th St, New York, NY 10021 USA.; Blobel, CP (corresponding author), Tech Univ Munich, Inst Adv Study, Garching, Germany.; Blobel, CP (corresponding author), Weill Cornell Med, Dept Med, New York, NY 10065 USA.; Blobel, CP (corresponding author), Weill Cornell Med, Dept Biophys Physiol & Syst Biol, New York, NY 10065 USA.	blobelc@hss.edu	Maretzky, Thorsten/GSN-2981-2022; Shola, Dorjee/AAE-1443-2019; Maretzky, Thorsten/AEN-1915-2022	Shola, Dorjee/0000-0001-7236-5912; Maretzky, Thorsten/0000-0003-1282-6080; Li, Thomas/0000-0003-3503-3593	NIH [F31 GM136144, R35 GM134907]; Cancer Center Support Grant [P30CA008748]; Rockefeller University through the CRISPR & Genome Editing Resource Center; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [390857198];  [T32 GM008539]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support Grant; Rockefeller University through the CRISPR & Genome Editing Resource Center; Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG)); 	J. L. is supported by NIH F31 GM136144 and was previously supported by T32 GM008539. S. M. and the Laboratory of Comparative Pathology are supported in part by Cancer Center Support Grant P30CA008748. D. T. N. S. and C. Y. are supported by The Rockefeller University through the CRISPR & Genome Editing Resource Center. This work was also funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the framework of the Munich Cluster for Systems Neurology (EXC 2145 SyNergy-ID 390857198). Support for this project was provided by NIH R35 GM134907 to C. P. B. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.		0	3	3	3	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100733	10.1016/j.jbc.2021.100733	http://dx.doi.org/10.1016/j.jbc.2021.100733			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957124	Green Published, gold			2022-12-28	WOS:000672866400702
J	Mace, PD; Murphy, JM				Mace, Peter D.; Murphy, James M.			There's more to death than life: Noncatalytic functions in kinase and pseudokinase signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review								Protein kinases are present in all domains of life and play diverse roles in cellular signaling. Whereas the impact of substrate phosphorylation by protein kinases has long been appreciated, it is becoming increasingly clear that protein kinases also play other, noncatalytic, functions. Here, we review recent developments in understanding the noncatalytic functions of protein kinases. Many noncatalytic activities are best exemplified by protein kinases that are devoid of enzymatic activity altogether-known as pseudokinases. These dead proteins illustrate that, beyond conventional notions of kinase function, catalytic activity can be dispensable for biological function. Through key examples we illustrate diverse mechanisms of noncatalytic kinase activity: as allosteric modulators; protein-based switches; scaffolds for complex assembly; and as competitive inhibitors in signaling pathways. In common, these noncatalytic mechanisms exploit the nature of the protein kinase fold as a versatile protein-protein interaction module. Many examples are also intrinsically linked to the ability of the protein kinase to switch between multiple states, a function shared with catalytic protein kinases. Finally, we consider the contemporary landscape of small molecules to modulate non-catalytic functions of protein kinases, which, although challenging, has significant potential given the scope of noncatalytic protein kinase function in health and disease.	[Mace, Peter D.] Univ Otago, Sch Biomed Sci, Biochem Dept, Dunedin, New Zealand; [Murphy, James M.] Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia; [Murphy, James M.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	University of Otago; Walter & Eliza Hall Institute; University of Melbourne	Mace, PD (corresponding author), Univ Otago, Sch Biomed Sci, Biochem Dept, Dunedin, New Zealand.; Murphy, JM (corresponding author), Walter & Eliza Hall Inst Med Res, Inflammat Div, Parkville, Vic, Australia.; Murphy, JM (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	peter.mace@otago.ac.nz; jamesm@wehi.edu.au	Murphy, James/B-4863-2017	Murphy, James/0000-0003-0195-3949; Mace, Peter/0000-0003-2175-9537	Health Research Council of New Zealand; Rutherford Discovery Fellowship; National Health and Medical Research Council of Australia [1172929, 9000653]	Health Research Council of New Zealand(Health Research Council of New Zealand); Rutherford Discovery Fellowship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Pseudokinase work by P. D. M. has been supported by the Health Research Council of New Zealand and a Rutherford Discovery Fellowship administered by the Royal Society of New Zealand. J. M. M. gratefully acknowledges the National Health and Medical Research Council of Australia for fellowship (1172929) and infrastructure (9000653) support and the Victorian Government Operational Infrastructure Support Scheme.	Huang YJ, 2019, CELL RES, V29, P562, DOI 10.1038/s41422-019-0178-z	1	27	27	3	14	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100705	10.1016/j.jbc.2021.100705	http://dx.doi.org/10.1016/j.jbc.2021.100705			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33895136	gold, Green Published			2022-12-28	WOS:000672866400676
J	Robinson, KP; Jochem, A; Johnson, SE; Reddy, TR; Russell, JD; Coon, JJ; Pagliarini, DJ				Robinson, Kyle P.; Jochem, Adam; Johnson, Sheila E.; Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.; Pagliarini, David J.			Defining intermediates and redundancies in coenzyme Q precursor biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SACCHAROMYCES-CEREVISIAE; GENETIC ROBUSTNESS; ACID; METABOLISM; PATHWAY; MUTANTS	Coenzyme Q (CoQ), a redox-active lipid essential for oxidative phosphorylation, is synthesized by virtually all cells, but how eukaryotes make the universal CoQ head group precursor 4-hydroxybenzoate (4-HB) from tyrosine is unknown. The first and last steps of this pathway have been defined in Saccharomyces cerevisiae, but the intermediates and enzymes involved in converting 4-hydroxyphenylpyruvate (4-HPP) to 4-hydroxybenzaldehyde (4-HBz) have not been described. Here, we interrogate this pathway with genetic screens, targeted LC-MS, and chemical genetics. We identify three redundant aminotransferases (Bna3, Bat2, and Aat2) that support CoQ biosynthesis in the absence of the established pathway tyrosine aminotransferases, Aro8 and Aro9. We use isotope labeling to identify bona fide tyrosine catabolites, including 4-hydroxyphenylacetate (4-HPA) and 4-hydroxyphenyllactate (4-HPL). Additionally, we find multiple compounds that rescue this pathway when exogenously supplemented, most notably 4-hydroxyphenylacetaldehyde (4-HPAA) and 4-hydroxymandelate (4-HMA). Finally, we show that the Ehrlich pathway decarboxylase Aro10 is dispensable for 4-HB production. These results define new features of 4-HB synthesis in yeast, demonstrate the redundant nature of this pathway, and provide a foundation for further study.	[Robinson, Kyle P.; Johnson, Sheila E.; Pagliarini, David J.] Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA; [Robinson, Kyle P.; Jochem, Adam; Johnson, Sheila E.; Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.; Pagliarini, David J.] Morgridge Inst Res, Madison, WI 53715 USA; [Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.; Pagliarini, David J.] Natl Ctr Quantitat Biol Complex Syst, Madison, WI 53706 USA; [Reddy, Thiruchelvi R.; Russell, Jason D.; Coon, Joshua J.] Univ Wisconsin, Great Lakes Bioenergy Res Ctr, Madison, WI USA; [Coon, Joshua J.] Univ Wisconsin, Dept Chem, 1101 Univ Ave, Madison, WI 53706 USA; [Coon, Joshua J.] Univ Wisconsin, Dept Biomol Chem, Madison, WI USA; [Pagliarini, David J.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Pagliarini, David J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA; [Pagliarini, David J.] Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; United States Department of Energy (DOE); University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Pagliarini, DJ (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.; Pagliarini, DJ (corresponding author), Morgridge Inst Res, Madison, WI 53715 USA.; Pagliarini, DJ (corresponding author), Natl Ctr Quantitat Biol Complex Syst, Madison, WI 53706 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA.; Pagliarini, DJ (corresponding author), Washington Univ, Sch Med, Dept Genet, St Louis, MO 63110 USA.	pagliarini@wustl.edu			National Institutes of Health [R01 ES026955, R01 ES010546, P01 CA160032]; Vanderbilt-Ingram Cancer Center [P30 CA-068485]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt-Ingram Cancer Center	This work was supported, in whole or in part, by National Institutes of Health Grants R01 ES026955 (to F. P. G. and M. E.), R01 ES010546 (to F. P. G.), P01 CA160032 (to M. E. and C. J. R.), and Vanderbilt-Ingram Cancer Center (P30 CA-068485). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Acosta MJ, 2016, BBA-BIOENERGETICS, V1857, P1079, DOI 10.1016/j.bbabio.2016.03.036; ASHBY MN, 1992, J BIOL CHEM, V267, P4128; BAUDIN A, 1993, NUCLEIC ACIDS RES, V21, P3329, DOI 10.1093/nar/21.14.3329; Block A, 2014, PLANT CELL, V26, P1938, DOI 10.1105/tpc.114.125807; Botet J, 2007, EUKARYOT CELL, V6, P2102, DOI 10.1128/EC.00266-07; BRAUS GH, 1991, MICROBIOL REV, V55, P349, DOI 10.1128/MMBR.55.3.349-370.1991; Cheng W, 2014, SCIENCE, V343, P878, DOI 10.1126/science.1246774; COX GB, 1964, BIOCHIM BIOPHYS ACTA, V93, P204, DOI 10.1016/0304-4165(64)90285-5; Deutscher D, 2006, NAT GENET, V38, P993, DOI 10.1038/ng1856; EDMAN JC, 1993, YEAST, V9, P669, DOI 10.1002/yea.320090613; Generoso WC, 2016, J MICROBIOL METH, V127, P203, DOI 10.1016/j.mimet.2016.06.020; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Gu ZL, 2003, NATURE, V421, P63, DOI 10.1038/nature01198; Harrison R, 2007, P NATL ACAD SCI USA, V104, P2307, DOI 10.1073/pnas.0607153104; Hazelwood LA, 2008, APPL ENVIRON MICROB, V74, P2259, DOI 10.1128/AEM.02625-07; Valera MJ, 2020, YEAST, V37, P427, DOI 10.1002/yea.3508; Valera MJ, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.00701-20; Kemmerer Z.A., 2020, BIORXIV, DOI [10.1101/2020.12.09.418202, DOI 10.1101/2020.12.09.418202]; KISHORE G, 1976, J BACTERIOL, V128, P182, DOI 10.1128/JB.128.1.182-191.1976; Kneen MM, 2011, FEBS J, V278, P1842, DOI 10.1111/j.1742-4658.2011.08103.x; LESTER RL, 1959, J BIOL CHEM, V234, P2169; Loke WM, 2009, J NUTR, V139, P2309, DOI 10.3945/jn.109.113613; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Munier-Lehmann H, 2013, J MED CHEM, V56, P3148, DOI 10.1021/jm301848w; OLSON RE, 1963, J BIOL CHEM, V238, P3146; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Payet LA, 2016, CELL CHEM BIOL, V23, P1241, DOI 10.1016/j.chembiol.2016.08.008; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; RAO DNR, 1977, CAN J MICROBIOL, V23, P1496, DOI 10.1139/m77-222; Romagnoli G, 2012, APPL ENVIRON MICROB, V78, P7538, DOI 10.1128/AEM.01675-12; Salviati L, 2017, GENEREVIEWS R; Soubeyrand E, 2018, PLANT CELL, V30, P2910, DOI 10.1105/tpc.18.00688; Stefely JA, 2017, TRENDS BIOCHEM SCI, V42, P824, DOI 10.1016/j.tibs.2017.06.008; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; uo X., 2010, NAT BIOTECHNOL; Urrestarazu A, 1998, MOL GEN GENET, V257, P230, DOI 10.1007/s004380050643; Xie LTX, 2015, J LIPID RES, V56, P909, DOI 10.1194/jlr.M057919; Zhang Y, 2020, BIORESOUR TECHNOL RE, V11, DOI DOI 10.1016/J.BITEB.2020.100517; Ziosi M, 2017, EMBO MOL MED, V9, P96, DOI 10.15252/emmm.201606356	41	6	6	1	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100643	10.1016/j.jbc.2021.100643	http://dx.doi.org/10.1016/j.jbc.2021.100643			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33862086	Green Published, gold			2022-12-28	WOS:000672866400614
J	Wagner, S; Lee, C; Rojas, L; Specht, CG; Rhee, J; Brose, N; Papadopoulos, T				Wagner, Sven; Lee, ChoongKu; Rojas, Lucia; Specht, Christian G.; Rhee, JeongSeop; Brose, Nils; Papadopoulos, Theofilos			The alpha 3 subunit of GABA(A) receptors promotes formation of inhibitory synapses in the absence of collybistin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article								Signaling at nerve cell synapses is a key determinant of proper brain function, and synaptic defects-or synaptopathies-are at the basis of many neurological and psychiatric disorders. Collybistin (CB), a brain-specific guanine nucleotide exchange factor, is essential for the formation of gamma-aminobutyric acidergic (GABAergic) postsynapses in defined regions of the mammalian forebrain, including the hippocampus and basolateral amygdala. This process depends on a direct interaction of CB with the scaffolding protein gephyrin, which leads to the redistribution of gephyrin into submembranous clusters at nascent inhibitory synapses. Strikingly, synaptic clustering of gephyrin and GABA(A) type A receptors (GABA(A)Rs) in several brain regions, including the cerebral cortex and certain thalamic areas, is unperturbed in CB-deficient mice, indicating that the formation of a substantial subset of inhibitory post-synapses must be controlled by gephyrin-interacting proteins other than CB. Previous studies indicated that the alpha 3 subunit of GABA(A)Rs (GABA(A)R-alpha 3) binds directly and with high affinity to gephyrin. Here, we provide evidence (i) that a homooligomeric GABA(A)R-alpha 3(A343W) mutant induces the formation of submembranous gephyrin clusters independently of CB in COS-7 cells, (ii) that gephyrin clustering is unaltered in the neuronal subpopulations endogenously expressing the GABA(A)R-alpha 3 in CB-deficient brains, and (iii) that exogenous expression of GABA(A)R-alpha 3 partially rescues impaired gephyrin clustering in CB-deficient hippocampal neurons. Our results identify an important role of GABA(A)R-alpha 3 in promoting gephyrin-mediated and CB-independent formation of inhibitory postsynapses.	[Wagner, Sven; Lee, ChoongKu; Rojas, Lucia; Rhee, JeongSeop; Brose, Nils] Max Planck Inst Expt Med, Dept Mol Neurobiol, Gottingen, Germany; [Specht, Christian G.] Univ Paris Saclay, Inserm U1195, Dis & Hormones Nervous Syst DHNS, Le Kremlin Bicetre, France; [Papadopoulos, Theofilos] Univ Med Gottingen, Dept Mol Biol, Gottingen, Germany	Max Planck Society; UDICE-French Research Universities; Universite Paris Saclay; University of Gottingen	Papadopoulos, T (corresponding author), Univ Med Gottingen, Dept Mol Biol, Gottingen, Germany.	theofilos.papadopoulos@med.uni-goettingen.de	Wagner, Sven/HHD-1329-2022	Specht, Christian G/0000-0001-6038-7735	Deutsche Forschungsgemeinschaft [PA 2087/1-4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (grant PA 2087/1-4 to T. P.).		0	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100709	10.1016/j.jbc.2021.100709	http://dx.doi.org/10.1016/j.jbc.2021.100709			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33901490	gold, Green Published			2022-12-28	WOS:000672866400680
J	Wolberger, C				Wolberger, Cynthia			How structural biology transformed studies of transcription regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							A BETA-LACTAMASE; CARBAPENEM ANTIBIOTICS; CATALYZED HYDROLYSIS; SUBSTRATE PROFILE; MOLECULAR-BASIS; ACTIVE-SITE; INHIBITION; ENZYME; RESISTANCE; KINETICS	The past 4 decades have seen remarkable advances in our understanding of the structural basis of gene regulation. Technological advances in protein expression, nucleic acid synthesis, and structural biology made it possible to study the proteins that regulate transcription in the context of ever larger complexes containing proteins bound to DNA. This review, written on the occasion of the 50th anniversary of the founding of the Protein Data Bank focuses on the insights gained from structural studies of protein-DNA complexes and the role the PDB has played in driving this research. I cover highlights in the field, beginning with X-ray crystal structures of the first DNA-binding domains to be studied, through recent cryo-EM structures of transcription factor binding to nucleosomal DNA.	[Wolberger, Cynthia] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA	Johns Hopkins University	Wolberger, C (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA.	cwolberg@jhmi.edu		Wolberger, Cynthia/0000-0001-8578-2969	NIGMS, National Institutes of Health [GM130393]	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIGMS, National Institutes of Health grant GM130393 (C. W.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Adamski CJ, 2015, BIOCHEMISTRY-US, V54, P447, DOI 10.1021/bi501195g; Akhtar A, 2020, ACS INFECT DIS, V6, P261, DOI 10.1021/acsinfecdis.9b00304; AMANN E, 1983, GENE, V25, P167, DOI 10.1016/0378-1119(83)90222-6; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; Andrews LD, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001599; Artimo P, 2012, NUCLEIC ACIDS RES, V40, pW597, DOI 10.1093/nar/gks400; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083; BIRNBAUM J, 1985, AM J MED, V78, P3, DOI 10.1016/0002-9343(85)90097-X; Brown NG, 2009, J BIOL CHEM, V284, P33703, DOI 10.1074/jbc.M109.053819; Chen Y, 2005, J MOL BIOL, V348, P349, DOI 10.1016/j.jmb.2005.02.010; Cortina GA, 2018, ACS CATAL, V8, P2741, DOI 10.1021/acscatal.7b03832; Damblon C, 1996, P NATL ACAD SCI USA, V93, P1747, DOI 10.1073/pnas.93.5.1747; Delmas J, 2010, J MOL BIOL, V400, P108, DOI 10.1016/j.jmb.2010.04.062; EASTON CJ, 1982, BIOCHEMISTRY-US, V21, P2857, DOI 10.1021/bi00541a008; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fisher JF, 2009, CURR PROTEIN PEPT SC, V10, P401, DOI 10.2174/138920309789351967; Fonseca F, 2007, ANTIMICROB AGENTS CH, V51, P4512, DOI 10.1128/AAC.00491-07; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Frere JM, 2014, CURR OPIN PHARMACOL, V18, P112, DOI 10.1016/j.coph.2014.09.012; Galleni Moreno, 2007, P195; Henriques I, 2004, ANTIMICROB AGENTS CH, V48, P2321, DOI 10.1128/AAC.48.6.2321-2324.2004; Hidalgo-Grass C, 2012, ANTIMICROB AGENTS CH, V56, P6057, DOI 10.1128/AAC.01156-12; HOLLAWAY MR, 1969, FEBS LETT, V4, P299, DOI 10.1016/0014-5793(69)80261-9; Johnson K. A., 2019, KINETIC ANAL NEW ENZ, V1st; Kalp M, 2008, BIOCHEMISTRY-US, V47, P11830, DOI 10.1021/bi800833u; Ke W, 2007, BIOCHEMISTRY-US, V46, P5732, DOI 10.1021/bi700300u; KEZDY FJ, 1962, BIOCHEMISTRY-US, V1, P1097, DOI 10.1021/bi00912a021; KOERBER SC, 1987, ANAL BIOCHEM, V165, P75, DOI 10.1016/0003-2697(87)90203-X; Lamoureaux TL, 2012, ANTIMICROB AGENTS CH, V56, P6006, DOI 10.1128/AAC.01338-12; Lascols C, 2012, J CLIN MICROBIOL, V50, P1632, DOI 10.1128/JCM.06115-11; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Majiduddin FK, 2005, ANTIMICROB AGENTS CH, V49, P3421, DOI 10.1128/AAC.49.8.3421-3427.2005; Majiduddin FK, 2003, ANTIMICROB AGENTS CH, V47, P1062, DOI 10.1128/AAC.47.3.1062-1067.2003; MariotteBoyer S, 1996, FEMS MICROBIOL LETT, V143, P29, DOI 10.1016/0378-1097(96)00288-1; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mehta SC, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004949; Minasov G, 2002, J AM CHEM SOC, V124, P5333, DOI 10.1021/ja0259640; MONKS J, 1988, BIOCHEM J, V253, P323, DOI 10.1042/bj2530323; Moriarty NW, 2009, ACTA CRYSTALLOGR D, V65, P1074, DOI 10.1107/S0907444909029436; Mourey L, 1998, J AM CHEM SOC, V120, P9382, DOI 10.1021/ja9817996; NAAS T, 1994, ANTIMICROB AGENTS CH, V38, P1262, DOI 10.1128/AAC.38.6.1262; Nukaga M, 2008, J AM CHEM SOC, V130, P12656, DOI 10.1021/ja7111146; Palzkill T, 2018, FRONT MOL BIOSCI, V5, DOI 10.3389/fmolb.2018.00016; Palzkill T, 2013, ANN NY ACAD SCI, V1277, P91, DOI 10.1111/j.1749-6632.2012.06796.x; Patel MP, 2017, BIOCHEMISTRY-US, V56, P3443, DOI 10.1021/acs.biochem.7b00176; Pemberton OA, 2017, J MED CHEM, V60, P3525, DOI 10.1021/acs.jmedchem.7b00158; Petrosino J, 1999, J BIOL CHEM, V274, P2394, DOI 10.1074/jbc.274.4.2394; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; STRYNADKA NCJ, 1992, NATURE, V359, P700, DOI 10.1038/359700a0; TAIBI P, 1995, J AM CHEM SOC, V117, P7600, DOI 10.1021/ja00134a003; Terwilliger TC, 2008, ACTA CRYSTALLOGR D, V64, P515, DOI 10.1107/S0907444908004319; Tremblay LW, 2010, BIOCHEMISTRY-US, V49, P3766, DOI 10.1021/bi100232q; Wilson APR, 2017, J ANTIMICROB CHEMOTH, V72, P2410, DOI 10.1093/jac/dkx181; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Woodford N, 2004, ANTIMICROB AGENTS CH, V48, P4793, DOI 10.1128/AAC.48.12.4793-4799.2004; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; ZAFARALLA G, 1992, J AM CHEM SOC, V114, P1505, DOI 10.1021/ja00030a070	65	7	7	0	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100741	10.1016/j.jbc.2021.100741	http://dx.doi.org/10.1016/j.jbc.2021.100741			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957125	gold, Green Published			2022-12-28	WOS:000672866400710
J	Yu, HJ; Schut, GJ; Haja, DK; Adams, MWW; Li, HL				Yu, Hongjun; Schut, Gerrit J.; Haja, Domink K.; Adams, Michael W. W.; Li, Huilin			Evolution of complex I-like respiratory complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; ELEMENTAL SULFUR; MECHANISM; ARCHAEA; STOICHIOMETRY; ARCHITECTURE; ADAPTATIONS; METABOLISM; REDUCTION	The modern-day respiratory complex I shares a common ancestor with the membrane-bound hydrogenase (MBH) and membrane-bound sulfane sulfur reductase (MBS). MBH and MBS use protons and sulfur as their respective electron sinks, which helped to conserve energy during early life in the Proterozoic era when the Earth's atmosphere was low in oxygen. MBH and MBS likely evolved from an integration of an ancestral, membrane-embedded, multiple resistance and pH antiporter and a soluble redox-active module encompassing a [NiFe] hydrogenase. In this review, we discuss how the structures of MBH, MBS, multiple resistance and pH, photosynthetic NADH dehydrogenase-like complex type-1, and complex I, which have been determined recently, thanks to the advent of high-resolution cryo-EM, have significantly improved our understanding of the catalytic reaction mechanisms and the evolutionary relationships of the respiratory complexes.	[Yu, Hongjun] Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Peoples R China; [Yu, Hongjun] Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Peoples R China; [Schut, Gerrit J.; Haja, Domink K.; Adams, Michael W. W.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA; [Li, Huilin] Van Andel Inst, Dept Struct Biol, Grand Rapids, MI 49503 USA	Huazhong University of Science & Technology; Huazhong University of Science & Technology; University System of Georgia; University of Georgia; Van Andel Institute	Yu, HJ (corresponding author), Huazhong Univ Sci & Technol, Sch Basic Med, Dept Biochem & Mol Biol, Wuhan, Peoples R China.; Yu, HJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Wuhan, Peoples R China.; Adams, MWW (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA.; Li, HL (corresponding author), Van Andel Inst, Dept Struct Biol, Grand Rapids, MI 49503 USA.	hongjun_yu@hust.edu.cn; adamsm@uga.edu; Huilin.Li@vai.org		Yu, Hongjun/0000-0002-1483-2962; Li, Huilin/0000-0001-8085-8928	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy [DE-SC0020085, DE-FG02-95ER20175]	Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy(United States Department of Energy (DOE))	This work was funded by grants from the Division of Chemical Sciences, Geosciences and Biosciences, Office of Basic Energy Sciences of the US Department of Energy (DE-SC0020085 to H. L. and DE-FG02-95ER20175 to M. W. W. A.).	Agip ANA, 2019, ANNU REV BIOPHYS, V48, P165, DOI 10.1146/annurev-biophys-052118-115704; Agip ANA, 2018, NAT STRUCT MOL BIOL, V25, P548, DOI 10.1038/s41594-018-0073-1; Baradaran R, 2013, NATURE, V494, P443, DOI 10.1038/nature11871; Beievich G., 2011, MOL MICROBIOL, V82, P1086; Berrisford JM, 2016, BBA-BIOENERGETICS, V1857, P892, DOI 10.1016/j.bbabio.2016.01.012; Brandt U, 2019, SCIENCE, V363, P230, DOI 10.1126/science.aaw0493; Bridger SL, 2011, J BACTERIOL, V193, P6498, DOI 10.1128/JB.05445-11; Cabrera-Orefice A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06955-y; Coincon M, 2016, NAT STRUCT MOL BIOL, V23, P248, DOI 10.1038/nsmb.3164; Di Luca A, 2017, P NATL ACAD SCI USA, V114, pE6314, DOI 10.1073/pnas.1706278114; Efremov RG, 2012, BBA-BIOENERGETICS, V1817, P1785, DOI 10.1016/j.bbabio.2012.02.015; Efremov RG, 2011, NATURE, V476, P414, DOI 10.1038/nature10330; Enemark JH, 2002, MET IONS BIOL SYST, V39, P621; Euro L, 2008, BBA-BIOENERGETICS, V1777, P1166, DOI 10.1016/j.bbabio.2008.06.001; Fiedorczuk K, 2016, NATURE, V538, P406, DOI 10.1038/nature19794; Galkin A, 2006, BBA-BIOENERGETICS, V1757, P1575, DOI 10.1016/j.bbabio.2006.10.001; Galkin AS, 1999, FEBS LETT, V451, P157, DOI 10.1016/S0014-5793(99)00575-X; Guo R., 2017, CELL, V170; Hedderich R, 2004, J BIOENERG BIOMEMBR, V36, P65, DOI 10.1023/B:JOBB.0000019599.43969.33; Hirst J, 2013, ANNU REV BIOCHEM, V82, P551, DOI 10.1146/annurev-biochem-070511-103700; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Jormakka M, 2008, NAT STRUCT MOL BIOL, V15, P730, DOI 10.1038/nsmb.1434; Kaila VRI, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2017.0916; Kaila VRI, 2014, P NATL ACAD SCI USA, V111, P6988, DOI 10.1073/pnas.1319156111; Kampjut D, 2020, SCIENCE, V370, P547, DOI 10.1126/science.abc4209; Kashani-Poor N, 2001, J BIOL CHEM, V276, P24082, DOI 10.1074/jbc.M102296200; Kengen SWM, 2017, MICROB BIOTECHNOL, V10, P1441, DOI 10.1111/1751-7915.12695; Kim YJ, 2010, NATURE, V467, P352, DOI 10.1038/nature09375; Laughlin TG, 2019, NATURE, V566, P411, DOI 10.1038/s41586-019-0921-0; Lee C, 2013, NATURE, V501, P573, DOI 10.1038/nature12484; Letts JA, 2019, MOL CELL, V75, P1131, DOI 10.1016/j.molcel.2019.07.022; Letts JA, 2017, NAT STRUCT MOL BIOL, V24, P800, DOI 10.1038/nsmb.3460; Letts JA, 2016, NATURE, V537, P644, DOI 10.1038/nature19774; Li B, 2020, P NATL ACAD SCI USA, V117, P31166, DOI 10.1073/pnas.2006276117; Lim JK, 2014, P NATL ACAD SCI USA, V111, P11497, DOI 10.1073/pnas.1407056111; Mayer F, 2014, FEMS MICROBIOL REV, V38, P449, DOI 10.1111/1574-6976.12043; McTernan PM, 2014, J BIOL CHEM, V289, P19364, DOI 10.1074/jbc.M114.567255; Morino M, 2010, J BIOL CHEM, V285, P30942, DOI 10.1074/jbc.M110.118661; Nisbet EG, 2001, NATURE, V409, P1083, DOI 10.1038/35059210; Page CC, 1999, NATURE, V402, P47, DOI 10.1038/46972; Pan XW, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14456-0; Parey K, 2020, CURR OPIN STRUC BIOL, V63, P1, DOI 10.1016/j.sbi.2020.01.004; Parey K, 2018, ELIFE, V7, DOI 10.7554/eLife.39213; Peltier G, 2016, ANNU REV PLANT BIOL, V67, P55, DOI 10.1146/annurev-arplant-043014-114752; Pisa KY, 2007, FEBS J, V274, P3928, DOI 10.1111/j.1742-4658.2007.05925.x; Sapra R, 2003, P NATL ACAD SCI USA, V100, P7545, DOI 10.1073/pnas.1331436100; Sazanov LA, 2006, SCIENCE, V311, P1430, DOI 10.1126/science.1123809; Sazanov LA, 2015, NAT REV MOL CELL BIO, V16, P375, DOI 10.1038/nrm3997; SCHICHO RN, 1993, J BACTERIOL, V175, P1823, DOI 10.1128/JB.175.6.1823-1830.1993; Schuller JM, 2019, SCIENCE, V363, P257, DOI 10.1126/science.aau3613; Schut GJ, 2007, J BACTERIOL, V189, P4431, DOI 10.1128/JB.00031-07; Schut GJ, 2016, BBA-BIOENERGETICS, V1857, P958, DOI 10.1016/j.bbabio.2016.01.010; Schut GJ, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00029; Schut GJ, 2013, FEMS MICROBIOL REV, V37, P182, DOI 10.1111/j.1574-6976.2012.00346.x; Shikanai T, 2016, BBA-BIOENERGETICS, V1857, P1015, DOI 10.1016/j.bbabio.2015.10.013; Steiner J, 2020, ELIFE, V9, DOI 10.7554/eLife.59407; Vinothkumar KR, 2014, NATURE, V515, P80, DOI 10.1038/nature13686; Wikstrorn M, 1984, FEBS LETT, V169, P300; Wohlert D, 2014, ELIFE, V3, DOI 10.7554/eLife.03579; Wu CH, 2018, J BIOL CHEM, V293, P16687, DOI 10.1074/jbc.RA118.005092; Yoga EG, 2020, BBA-BIOENERGETICS, V1861, DOI 10.1016/j.bbabio.2020.148153; Yu HJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19697-7; Yu HJ, 2018, CELL, V173, P1636, DOI 10.1016/j.cell.2018.03.071; Zhu JP, 2016, NATURE, V536, P354, DOI 10.1038/nature19095; Zhu ST, 2015, J BIOL CHEM, V290, P20761, DOI 10.1074/jbc.M115.660381; Zickermann V, 2015, SCIENCE, V347, P44, DOI 10.1126/science.1259859	66	8	8	4	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN-JUN	2021	296								100740	10.1016/j.jbc.2021.100740	http://dx.doi.org/10.1016/j.jbc.2021.100740			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	TI5TQ	33957129	Green Published, gold			2022-12-28	WOS:000672866400709
